Provinces;Age ranges;Cohorts;Sex;Demographic Concepts;Periodo;Total
National Total;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
National Total;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
National Total;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
National Total;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QI;3.019.665
National Total;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
National Total;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
National Total;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
National Total;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QI;2.964.241
National Total;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
National Total;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
National Total;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
National Total;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QI;2.997.941
National Total;All ages;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
National Total;All ages;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
National Total;All ages;Cohort January 1;Total;Survival in the first trimester;2022QII;""
National Total;All ages;Cohort January 1;Total;Survival in the first trimester;2022QI;2.916.799
National Total;All ages;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
National Total;All ages;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
National Total;All ages;Cohort January 1;Total;Survival in the first trimester;2021QII;""
National Total;All ages;Cohort January 1;Total;Survival in the first trimester;2021QI;2.884.077
National Total;All ages;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
National Total;All ages;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
National Total;All ages;Cohort January 1;Total;Survival in the first trimester;2020QII;""
National Total;All ages;Cohort January 1;Total;Survival in the first trimester;2020QI;2.807.861
National Total;All ages;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
National Total;All ages;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
National Total;All ages;Cohort January 1;Total;Survival in the second trimester;2022QII;2.819.891
National Total;All ages;Cohort January 1;Total;Survival in the second trimester;2022QI;""
National Total;All ages;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
National Total;All ages;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
National Total;All ages;Cohort January 1;Total;Survival in the second trimester;2021QII;2.800.408
National Total;All ages;Cohort January 1;Total;Survival in the second trimester;2021QI;""
National Total;All ages;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
National Total;All ages;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
National Total;All ages;Cohort January 1;Total;Survival in the second trimester;2020QII;2.748.666
National Total;All ages;Cohort January 1;Total;Survival in the second trimester;2020QI;""
National Total;All ages;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
National Total;All ages;Cohort January 1;Total;Survival in the third trimester;2022QIII;2.739.925
National Total;All ages;Cohort January 1;Total;Survival in the third trimester;2022QII;""
National Total;All ages;Cohort January 1;Total;Survival in the third trimester;2022QI;""
National Total;All ages;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
National Total;All ages;Cohort January 1;Total;Survival in the third trimester;2021QIII;2.728.428
National Total;All ages;Cohort January 1;Total;Survival in the third trimester;2021QII;""
National Total;All ages;Cohort January 1;Total;Survival in the third trimester;2021QI;""
National Total;All ages;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
National Total;All ages;Cohort January 1;Total;Survival in the third trimester;2020QIII;2.673.302
National Total;All ages;Cohort January 1;Total;Survival in the third trimester;2020QII;""
National Total;All ages;Cohort January 1;Total;Survival in the third trimester;2020QI;""
National Total;All ages;Cohort January 1;Total;Survival in the third trimester;2022QIV;2.647.603
National Total;All ages;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
National Total;All ages;Cohort January 1;Total;Survival in the third trimester;2022QII;""
National Total;All ages;Cohort January 1;Total;Survival in the third trimester;2022QI;""
National Total;All ages;Cohort January 1;Total;Survival in the third trimester;2021QIV;2.648.989
National Total;All ages;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
National Total;All ages;Cohort January 1;Total;Survival in the third trimester;2021QII;""
National Total;All ages;Cohort January 1;Total;Survival in the third trimester;2021QI;""
National Total;All ages;Cohort January 1;Total;Survival in the third trimester;2020QIV;2.597.708
National Total;All ages;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
National Total;All ages;Cohort January 1;Total;Survival in the third trimester;2020QII;""
National Total;All ages;Cohort January 1;Total;Survival in the third trimester;2020QI;""
National Total;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
National Total;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
National Total;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
National Total;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
National Total;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
National Total;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
National Total;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
National Total;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
National Total;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
National Total;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
National Total;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
National Total;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
National Total;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
National Total;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
National Total;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
National Total;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;96,59
National Total;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
National Total;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
National Total;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
National Total;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;97,3
National Total;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
National Total;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
National Total;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
National Total;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;93,66
National Total;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
National Total;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
National Total;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;93,38
National Total;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
National Total;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
National Total;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
National Total;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;94,47
National Total;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
National Total;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
National Total;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
National Total;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;91,69
National Total;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
National Total;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
National Total;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;90,74
National Total;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
National Total;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
National Total;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
National Total;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;92,04
National Total;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
National Total;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
National Total;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
National Total;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;89,17
National Total;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
National Total;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
National Total;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;87,68
National Total;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
National Total;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
National Total;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
National Total;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;89,36
National Total;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
National Total;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
National Total;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
National Total;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;86,65
National Total;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
National Total;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
National Total;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
National Total;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
National Total;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
National Total;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
National Total;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QI;1.909.026
National Total;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
National Total;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
National Total;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
National Total;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QI;1.887.020
National Total;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
National Total;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
National Total;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
National Total;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QI;1.906.102
National Total;All ages;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
National Total;All ages;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
National Total;All ages;Cohort January 1;Males;Survival in the first trimester;2022QII;""
National Total;All ages;Cohort January 1;Males;Survival in the first trimester;2022QI;1.847.447
National Total;All ages;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
National Total;All ages;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
National Total;All ages;Cohort January 1;Males;Survival in the first trimester;2021QII;""
National Total;All ages;Cohort January 1;Males;Survival in the first trimester;2021QI;1.837.622
National Total;All ages;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
National Total;All ages;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
National Total;All ages;Cohort January 1;Males;Survival in the first trimester;2020QII;""
National Total;All ages;Cohort January 1;Males;Survival in the first trimester;2020QI;1.792.773
National Total;All ages;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
National Total;All ages;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
National Total;All ages;Cohort January 1;Males;Survival in the second trimester;2022QII;1.791.684
National Total;All ages;Cohort January 1;Males;Survival in the second trimester;2022QI;""
National Total;All ages;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
National Total;All ages;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
National Total;All ages;Cohort January 1;Males;Survival in the second trimester;2021QII;1.787.670
National Total;All ages;Cohort January 1;Males;Survival in the second trimester;2021QI;""
National Total;All ages;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
National Total;All ages;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
National Total;All ages;Cohort January 1;Males;Survival in the second trimester;2020QII;1.758.590
National Total;All ages;Cohort January 1;Males;Survival in the second trimester;2020QI;""
National Total;All ages;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
National Total;All ages;Cohort January 1;Males;Survival in the third trimester;2022QIII;1.744.993
National Total;All ages;Cohort January 1;Males;Survival in the third trimester;2022QII;""
National Total;All ages;Cohort January 1;Males;Survival in the third trimester;2022QI;""
National Total;All ages;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
National Total;All ages;Cohort January 1;Males;Survival in the third trimester;2021QIII;1.744.182
National Total;All ages;Cohort January 1;Males;Survival in the third trimester;2021QII;""
National Total;All ages;Cohort January 1;Males;Survival in the third trimester;2021QI;""
National Total;All ages;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
National Total;All ages;Cohort January 1;Males;Survival in the third trimester;2020QIII;1.714.569
National Total;All ages;Cohort January 1;Males;Survival in the third trimester;2020QII;""
National Total;All ages;Cohort January 1;Males;Survival in the third trimester;2020QI;""
National Total;All ages;Cohort January 1;Males;Survival in the third trimester;2022QIV;1.689.196
National Total;All ages;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
National Total;All ages;Cohort January 1;Males;Survival in the third trimester;2022QII;""
National Total;All ages;Cohort January 1;Males;Survival in the third trimester;2022QI;""
National Total;All ages;Cohort January 1;Males;Survival in the third trimester;2021QIV;1.695.728
National Total;All ages;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
National Total;All ages;Cohort January 1;Males;Survival in the third trimester;2021QII;""
National Total;All ages;Cohort January 1;Males;Survival in the third trimester;2021QI;""
National Total;All ages;Cohort January 1;Males;Survival in the third trimester;2020QIV;1.668.962
National Total;All ages;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
National Total;All ages;Cohort January 1;Males;Survival in the third trimester;2020QII;""
National Total;All ages;Cohort January 1;Males;Survival in the third trimester;2020QI;""
National Total;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
National Total;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
National Total;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
National Total;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
National Total;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
National Total;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
National Total;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
National Total;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
National Total;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
National Total;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
National Total;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
National Total;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
National Total;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
National Total;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
National Total;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
National Total;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;96,77
National Total;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
National Total;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
National Total;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
National Total;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;97,38
National Total;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
National Total;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
National Total;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
National Total;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;94,05
National Total;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
National Total;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
National Total;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;93,85
National Total;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
National Total;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
National Total;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
National Total;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;94,74
National Total;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
National Total;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
National Total;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
National Total;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;92,26
National Total;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
National Total;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
National Total;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;91,41
National Total;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
National Total;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
National Total;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
National Total;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;92,43
National Total;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
National Total;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
National Total;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
National Total;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;89,95
National Total;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
National Total;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
National Total;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;88,48
National Total;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
National Total;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
National Total;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
National Total;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;89,86
National Total;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
National Total;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
National Total;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
National Total;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;87,56
National Total;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
National Total;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
National Total;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
National Total;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
National Total;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
National Total;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
National Total;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QI;1.110.639
National Total;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
National Total;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
National Total;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
National Total;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QI;1.077.221
National Total;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
National Total;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
National Total;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
National Total;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QI;1.091.839
National Total;All ages;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
National Total;All ages;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
National Total;All ages;Cohort January 1;Females;Survival in the first trimester;2022QII;""
National Total;All ages;Cohort January 1;Females;Survival in the first trimester;2022QI;1.069.352
National Total;All ages;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
National Total;All ages;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
National Total;All ages;Cohort January 1;Females;Survival in the first trimester;2021QII;""
National Total;All ages;Cohort January 1;Females;Survival in the first trimester;2021QI;1.046.455
National Total;All ages;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
National Total;All ages;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
National Total;All ages;Cohort January 1;Females;Survival in the first trimester;2020QII;""
National Total;All ages;Cohort January 1;Females;Survival in the first trimester;2020QI;1.015.088
National Total;All ages;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
National Total;All ages;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
National Total;All ages;Cohort January 1;Females;Survival in the second trimester;2022QII;1.028.207
National Total;All ages;Cohort January 1;Females;Survival in the second trimester;2022QI;""
National Total;All ages;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
National Total;All ages;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
National Total;All ages;Cohort January 1;Females;Survival in the second trimester;2021QII;1.012.738
National Total;All ages;Cohort January 1;Females;Survival in the second trimester;2021QI;""
National Total;All ages;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
National Total;All ages;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
National Total;All ages;Cohort January 1;Females;Survival in the second trimester;2020QII;990.076
National Total;All ages;Cohort January 1;Females;Survival in the second trimester;2020QI;""
National Total;All ages;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
National Total;All ages;Cohort January 1;Females;Survival in the third trimester;2022QIII;994.932
National Total;All ages;Cohort January 1;Females;Survival in the third trimester;2022QII;""
National Total;All ages;Cohort January 1;Females;Survival in the third trimester;2022QI;""
National Total;All ages;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
National Total;All ages;Cohort January 1;Females;Survival in the third trimester;2021QIII;984.246
National Total;All ages;Cohort January 1;Females;Survival in the third trimester;2021QII;""
National Total;All ages;Cohort January 1;Females;Survival in the third trimester;2021QI;""
National Total;All ages;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
National Total;All ages;Cohort January 1;Females;Survival in the third trimester;2020QIII;958.733
National Total;All ages;Cohort January 1;Females;Survival in the third trimester;2020QII;""
National Total;All ages;Cohort January 1;Females;Survival in the third trimester;2020QI;""
National Total;All ages;Cohort January 1;Females;Survival in the third trimester;2022QIV;958.407
National Total;All ages;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
National Total;All ages;Cohort January 1;Females;Survival in the third trimester;2022QII;""
National Total;All ages;Cohort January 1;Females;Survival in the third trimester;2022QI;""
National Total;All ages;Cohort January 1;Females;Survival in the third trimester;2021QIV;953.261
National Total;All ages;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
National Total;All ages;Cohort January 1;Females;Survival in the third trimester;2021QII;""
National Total;All ages;Cohort January 1;Females;Survival in the third trimester;2021QI;""
National Total;All ages;Cohort January 1;Females;Survival in the third trimester;2020QIV;928.746
National Total;All ages;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
National Total;All ages;Cohort January 1;Females;Survival in the third trimester;2020QII;""
National Total;All ages;Cohort January 1;Females;Survival in the third trimester;2020QI;""
National Total;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
National Total;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
National Total;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
National Total;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
National Total;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
National Total;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
National Total;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
National Total;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
National Total;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
National Total;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
National Total;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
National Total;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
National Total;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
National Total;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
National Total;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
National Total;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;96,28
National Total;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
National Total;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
National Total;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
National Total;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;97,14
National Total;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
National Total;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
National Total;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
National Total;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;92,97
National Total;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
National Total;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
National Total;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;92,58
National Total;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
National Total;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
National Total;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
National Total;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;94,01
National Total;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
National Total;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
National Total;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
National Total;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;90,68
National Total;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
National Total;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
National Total;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;89,58
National Total;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
National Total;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
National Total;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
National Total;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;91,37
National Total;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
National Total;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
National Total;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
National Total;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;87,81
National Total;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
National Total;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
National Total;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;86,29
National Total;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
National Total;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
National Total;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
National Total;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;88,49
National Total;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
National Total;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
National Total;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
National Total;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;85,06
National Total;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
National Total;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
National Total;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
National Total;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
National Total;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
National Total;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QII;3.031.866
National Total;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
National Total;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
National Total;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
National Total;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QII;2.993.411
National Total;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
National Total;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
National Total;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
National Total;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QII;2.938.754
National Total;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
National Total;All ages;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
National Total;All ages;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
National Total;All ages;Cohort April 1;Total;Survival in the first trimester;2022QII;2.923.775
National Total;All ages;Cohort April 1;Total;Survival in the first trimester;2022QI;""
National Total;All ages;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
National Total;All ages;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
National Total;All ages;Cohort April 1;Total;Survival in the first trimester;2021QII;2.898.267
National Total;All ages;Cohort April 1;Total;Survival in the first trimester;2021QI;""
National Total;All ages;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
National Total;All ages;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
National Total;All ages;Cohort April 1;Total;Survival in the first trimester;2020QII;2.872.111
National Total;All ages;Cohort April 1;Total;Survival in the first trimester;2020QI;""
National Total;All ages;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
National Total;All ages;Cohort April 1;Total;Survival in the second trimester;2022QIII;2.835.984
National Total;All ages;Cohort April 1;Total;Survival in the second trimester;2022QII;""
National Total;All ages;Cohort April 1;Total;Survival in the second trimester;2022QI;""
National Total;All ages;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
National Total;All ages;Cohort April 1;Total;Survival in the second trimester;2021QIII;2.818.087
National Total;All ages;Cohort April 1;Total;Survival in the second trimester;2021QII;""
National Total;All ages;Cohort April 1;Total;Survival in the second trimester;2021QI;""
National Total;All ages;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
National Total;All ages;Cohort April 1;Total;Survival in the second trimester;2020QIII;2.784.268
National Total;All ages;Cohort April 1;Total;Survival in the second trimester;2020QII;""
National Total;All ages;Cohort April 1;Total;Survival in the second trimester;2020QI;""
National Total;All ages;Cohort April 1;Total;Survival in the third trimester;2022QIV;2.734.804
National Total;All ages;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
National Total;All ages;Cohort April 1;Total;Survival in the third trimester;2022QII;""
National Total;All ages;Cohort April 1;Total;Survival in the third trimester;2022QI;""
National Total;All ages;Cohort April 1;Total;Survival in the third trimester;2021QIV;2.730.809
National Total;All ages;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
National Total;All ages;Cohort April 1;Total;Survival in the third trimester;2021QII;""
National Total;All ages;Cohort April 1;Total;Survival in the third trimester;2021QI;""
National Total;All ages;Cohort April 1;Total;Survival in the third trimester;2020QIV;2.700.506
National Total;All ages;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
National Total;All ages;Cohort April 1;Total;Survival in the third trimester;2020QII;""
National Total;All ages;Cohort April 1;Total;Survival in the third trimester;2020QI;""
National Total;All ages;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
National Total;All ages;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
National Total;All ages;Cohort April 1;Total;Survival in the third trimester;2022QII;""
National Total;All ages;Cohort April 1;Total;Survival in the third trimester;2022QI;2.652.858
National Total;All ages;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
National Total;All ages;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
National Total;All ages;Cohort April 1;Total;Survival in the third trimester;2021QII;""
National Total;All ages;Cohort April 1;Total;Survival in the third trimester;2021QI;2.641.443
National Total;All ages;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
National Total;All ages;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
National Total;All ages;Cohort April 1;Total;Survival in the third trimester;2020QII;""
National Total;All ages;Cohort April 1;Total;Survival in the third trimester;2020QI;""
National Total;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
National Total;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
National Total;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
National Total;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
National Total;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
National Total;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
National Total;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
National Total;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
National Total;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
National Total;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
National Total;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
National Total;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
National Total;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
National Total;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
National Total;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;96,43
National Total;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
National Total;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
National Total;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
National Total;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;96,82
National Total;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
National Total;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
National Total;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
National Total;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;97,73
National Total;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
National Total;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
National Total;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;93,54
National Total;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
National Total;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
National Total;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
National Total;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;94,14
National Total;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
National Total;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
National Total;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
National Total;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;94,74
National Total;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
National Total;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
National Total;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;90,2
National Total;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
National Total;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
National Total;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
National Total;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;91,23
National Total;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
National Total;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
National Total;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
National Total;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;91,89
National Total;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
National Total;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
National Total;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
National Total;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
National Total;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
National Total;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
National Total;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;88,62
National Total;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
National Total;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
National Total;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
National Total;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;89,88
National Total;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
National Total;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
National Total;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
National Total;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
National Total;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
National Total;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
National Total;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QII;1.914.547
National Total;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
National Total;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
National Total;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
National Total;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QII;1.903.642
National Total;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
National Total;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
National Total;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
National Total;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QII;1.870.987
National Total;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
National Total;All ages;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
National Total;All ages;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
National Total;All ages;Cohort April 1;Males;Survival in the first trimester;2022QII;1.851.965
National Total;All ages;Cohort April 1;Males;Survival in the first trimester;2022QI;""
National Total;All ages;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
National Total;All ages;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
National Total;All ages;Cohort April 1;Males;Survival in the first trimester;2021QII;1.846.341
National Total;All ages;Cohort April 1;Males;Survival in the first trimester;2021QI;""
National Total;All ages;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
National Total;All ages;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
National Total;All ages;Cohort April 1;Males;Survival in the first trimester;2020QII;1.832.190
National Total;All ages;Cohort April 1;Males;Survival in the first trimester;2020QI;""
National Total;All ages;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
National Total;All ages;Cohort April 1;Males;Survival in the second trimester;2022QIII;1.800.503
National Total;All ages;Cohort April 1;Males;Survival in the second trimester;2022QII;""
National Total;All ages;Cohort April 1;Males;Survival in the second trimester;2022QI;""
National Total;All ages;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
National Total;All ages;Cohort April 1;Males;Survival in the second trimester;2021QIII;1.797.629
National Total;All ages;Cohort April 1;Males;Survival in the second trimester;2021QII;""
National Total;All ages;Cohort April 1;Males;Survival in the second trimester;2021QI;""
National Total;All ages;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
National Total;All ages;Cohort April 1;Males;Survival in the second trimester;2020QIII;1.780.128
National Total;All ages;Cohort April 1;Males;Survival in the second trimester;2020QII;""
National Total;All ages;Cohort April 1;Males;Survival in the second trimester;2020QI;""
National Total;All ages;Cohort April 1;Males;Survival in the third trimester;2022QIV;1.739.459
National Total;All ages;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
National Total;All ages;Cohort April 1;Males;Survival in the third trimester;2022QII;""
National Total;All ages;Cohort April 1;Males;Survival in the third trimester;2022QI;""
National Total;All ages;Cohort April 1;Males;Survival in the third trimester;2021QIV;1.744.399
National Total;All ages;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
National Total;All ages;Cohort April 1;Males;Survival in the third trimester;2021QII;""
National Total;All ages;Cohort April 1;Males;Survival in the third trimester;2021QI;""
National Total;All ages;Cohort April 1;Males;Survival in the third trimester;2020QIV;1.729.570
National Total;All ages;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
National Total;All ages;Cohort April 1;Males;Survival in the third trimester;2020QII;""
National Total;All ages;Cohort April 1;Males;Survival in the third trimester;2020QI;""
National Total;All ages;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
National Total;All ages;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
National Total;All ages;Cohort April 1;Males;Survival in the third trimester;2022QII;""
National Total;All ages;Cohort April 1;Males;Survival in the third trimester;2022QI;1.697.878
National Total;All ages;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
National Total;All ages;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
National Total;All ages;Cohort April 1;Males;Survival in the third trimester;2021QII;""
National Total;All ages;Cohort April 1;Males;Survival in the third trimester;2021QI;1.693.393
National Total;All ages;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
National Total;All ages;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
National Total;All ages;Cohort April 1;Males;Survival in the third trimester;2020QII;""
National Total;All ages;Cohort April 1;Males;Survival in the third trimester;2020QI;""
National Total;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
National Total;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
National Total;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
National Total;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
National Total;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
National Total;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
National Total;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
National Total;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
National Total;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
National Total;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
National Total;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
National Total;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
National Total;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
National Total;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
National Total;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;96,73
National Total;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
National Total;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
National Total;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
National Total;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;96,99
National Total;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
National Total;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
National Total;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
National Total;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;97,93
National Total;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
National Total;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
National Total;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;94,04
National Total;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
National Total;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
National Total;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
National Total;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;94,43
National Total;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
National Total;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
National Total;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
National Total;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;95,14
National Total;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
National Total;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
National Total;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;90,85
National Total;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
National Total;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
National Total;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
National Total;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;91,63
National Total;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
National Total;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
National Total;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
National Total;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;92,44
National Total;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
National Total;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
National Total;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
National Total;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
National Total;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
National Total;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
National Total;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;89,19
National Total;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
National Total;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
National Total;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
National Total;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;90,51
National Total;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
National Total;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
National Total;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
National Total;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
National Total;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
National Total;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
National Total;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QII;1.117.319
National Total;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
National Total;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
National Total;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
National Total;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QII;1.089.769
National Total;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
National Total;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
National Total;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
National Total;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QII;1.067.767
National Total;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
National Total;All ages;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
National Total;All ages;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
National Total;All ages;Cohort April 1;Females;Survival in the first trimester;2022QII;1.071.810
National Total;All ages;Cohort April 1;Females;Survival in the first trimester;2022QI;""
National Total;All ages;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
National Total;All ages;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
National Total;All ages;Cohort April 1;Females;Survival in the first trimester;2021QII;1.051.926
National Total;All ages;Cohort April 1;Females;Survival in the first trimester;2021QI;""
National Total;All ages;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
National Total;All ages;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
National Total;All ages;Cohort April 1;Females;Survival in the first trimester;2020QII;1.039.921
National Total;All ages;Cohort April 1;Females;Survival in the first trimester;2020QI;""
National Total;All ages;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
National Total;All ages;Cohort April 1;Females;Survival in the second trimester;2022QIII;1.035.481
National Total;All ages;Cohort April 1;Females;Survival in the second trimester;2022QII;""
National Total;All ages;Cohort April 1;Females;Survival in the second trimester;2022QI;""
National Total;All ages;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
National Total;All ages;Cohort April 1;Females;Survival in the second trimester;2021QIII;1.020.458
National Total;All ages;Cohort April 1;Females;Survival in the second trimester;2021QII;""
National Total;All ages;Cohort April 1;Females;Survival in the second trimester;2021QI;""
National Total;All ages;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
National Total;All ages;Cohort April 1;Females;Survival in the second trimester;2020QIII;1.004.140
National Total;All ages;Cohort April 1;Females;Survival in the second trimester;2020QII;""
National Total;All ages;Cohort April 1;Females;Survival in the second trimester;2020QI;""
National Total;All ages;Cohort April 1;Females;Survival in the third trimester;2022QIV;995.345
National Total;All ages;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
National Total;All ages;Cohort April 1;Females;Survival in the third trimester;2022QII;""
National Total;All ages;Cohort April 1;Females;Survival in the third trimester;2022QI;""
National Total;All ages;Cohort April 1;Females;Survival in the third trimester;2021QIV;986.410
National Total;All ages;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
National Total;All ages;Cohort April 1;Females;Survival in the third trimester;2021QII;""
National Total;All ages;Cohort April 1;Females;Survival in the third trimester;2021QI;""
National Total;All ages;Cohort April 1;Females;Survival in the third trimester;2020QIV;970.936
National Total;All ages;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
National Total;All ages;Cohort April 1;Females;Survival in the third trimester;2020QII;""
National Total;All ages;Cohort April 1;Females;Survival in the third trimester;2020QI;""
National Total;All ages;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
National Total;All ages;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
National Total;All ages;Cohort April 1;Females;Survival in the third trimester;2022QII;""
National Total;All ages;Cohort April 1;Females;Survival in the third trimester;2022QI;954.980
National Total;All ages;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
National Total;All ages;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
National Total;All ages;Cohort April 1;Females;Survival in the third trimester;2021QII;""
National Total;All ages;Cohort April 1;Females;Survival in the third trimester;2021QI;948.050
National Total;All ages;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
National Total;All ages;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
National Total;All ages;Cohort April 1;Females;Survival in the third trimester;2020QII;""
National Total;All ages;Cohort April 1;Females;Survival in the third trimester;2020QI;""
National Total;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
National Total;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
National Total;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
National Total;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
National Total;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
National Total;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
National Total;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
National Total;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
National Total;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
National Total;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
National Total;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
National Total;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
National Total;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
National Total;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
National Total;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;95,93
National Total;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
National Total;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
National Total;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
National Total;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;96,53
National Total;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
National Total;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
National Total;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
National Total;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;97,39
National Total;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
National Total;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
National Total;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;92,68
National Total;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
National Total;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
National Total;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
National Total;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;93,64
National Total;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
National Total;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
National Total;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
National Total;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;94,04
National Total;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
National Total;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
National Total;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;89,08
National Total;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
National Total;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
National Total;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
National Total;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;90,52
National Total;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
National Total;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
National Total;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
National Total;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;90,93
National Total;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
National Total;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
National Total;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
National Total;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
National Total;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
National Total;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
National Total;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;87,63
National Total;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
National Total;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
National Total;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
National Total;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;88,79
National Total;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
National Total;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
National Total;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
National Total;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
National Total;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
National Total;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QIII;3.046.771
National Total;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
National Total;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
National Total;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
National Total;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QIII;3.022.855
National Total;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
National Total;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
National Total;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
National Total;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QIII;2.962.399
National Total;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
National Total;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
National Total;All ages;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
National Total;All ages;Cohort July 1;Total;Survival in the first trimester;2022QIII;2.940.248
National Total;All ages;Cohort July 1;Total;Survival in the first trimester;2022QII;""
National Total;All ages;Cohort July 1;Total;Survival in the first trimester;2022QI;""
National Total;All ages;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
National Total;All ages;Cohort July 1;Total;Survival in the first trimester;2021QIII;2.925.120
National Total;All ages;Cohort July 1;Total;Survival in the first trimester;2021QII;""
National Total;All ages;Cohort July 1;Total;Survival in the first trimester;2021QI;""
National Total;All ages;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
National Total;All ages;Cohort July 1;Total;Survival in the first trimester;2020QIII;2.860.164
National Total;All ages;Cohort July 1;Total;Survival in the first trimester;2020QII;""
National Total;All ages;Cohort July 1;Total;Survival in the first trimester;2020QI;""
National Total;All ages;Cohort July 1;Total;Survival in the second trimester;2022QIV;2.823.656
National Total;All ages;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
National Total;All ages;Cohort July 1;Total;Survival in the second trimester;2022QII;""
National Total;All ages;Cohort July 1;Total;Survival in the second trimester;2022QI;""
National Total;All ages;Cohort July 1;Total;Survival in the second trimester;2021QIV;2.823.859
National Total;All ages;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
National Total;All ages;Cohort July 1;Total;Survival in the second trimester;2021QII;""
National Total;All ages;Cohort July 1;Total;Survival in the second trimester;2021QI;""
National Total;All ages;Cohort July 1;Total;Survival in the second trimester;2020QIV;2.767.434
National Total;All ages;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
National Total;All ages;Cohort July 1;Total;Survival in the second trimester;2020QII;""
National Total;All ages;Cohort July 1;Total;Survival in the second trimester;2020QI;""
National Total;All ages;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
National Total;All ages;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
National Total;All ages;Cohort July 1;Total;Survival in the third trimester;2022QII;""
National Total;All ages;Cohort July 1;Total;Survival in the third trimester;2022QI;2.739.262
National Total;All ages;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
National Total;All ages;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
National Total;All ages;Cohort July 1;Total;Survival in the third trimester;2021QII;""
National Total;All ages;Cohort July 1;Total;Survival in the third trimester;2021QI;2.704.508
National Total;All ages;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
National Total;All ages;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
National Total;All ages;Cohort July 1;Total;Survival in the third trimester;2020QII;""
National Total;All ages;Cohort July 1;Total;Survival in the third trimester;2020QI;""
National Total;All ages;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
National Total;All ages;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
National Total;All ages;Cohort July 1;Total;Survival in the third trimester;2022QII;2.659.900
National Total;All ages;Cohort July 1;Total;Survival in the third trimester;2022QI;""
National Total;All ages;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
National Total;All ages;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
National Total;All ages;Cohort July 1;Total;Survival in the third trimester;2021QII;2.637.789
National Total;All ages;Cohort July 1;Total;Survival in the third trimester;2021QI;""
National Total;All ages;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
National Total;All ages;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
National Total;All ages;Cohort July 1;Total;Survival in the third trimester;2020QII;""
National Total;All ages;Cohort July 1;Total;Survival in the third trimester;2020QI;""
National Total;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
National Total;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
National Total;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
National Total;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
National Total;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
National Total;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
National Total;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
National Total;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
National Total;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
National Total;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
National Total;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
National Total;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
National Total;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
National Total;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;96,5
National Total;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
National Total;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
National Total;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
National Total;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;96,77
National Total;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
National Total;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
National Total;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
National Total;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;96,55
National Total;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
National Total;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
National Total;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;92,68
National Total;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
National Total;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
National Total;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
National Total;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;93,42
National Total;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
National Total;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
National Total;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
National Total;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;93,42
National Total;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
National Total;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
National Total;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
National Total;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
National Total;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
National Total;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
National Total;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;90,62
National Total;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
National Total;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
National Total;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
National Total;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;91,29
National Total;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
National Total;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
National Total;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
National Total;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
National Total;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
National Total;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
National Total;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;87,99
National Total;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
National Total;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
National Total;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
National Total;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;89,04
National Total;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
National Total;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
National Total;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
National Total;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
National Total;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
National Total;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
National Total;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QIII;1.922.877
National Total;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
National Total;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
National Total;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
National Total;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QIII;1.919.112
National Total;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
National Total;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
National Total;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
National Total;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QIII;1.889.600
National Total;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
National Total;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
National Total;All ages;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
National Total;All ages;Cohort July 1;Males;Survival in the first trimester;2022QIII;1.860.586
National Total;All ages;Cohort July 1;Males;Survival in the first trimester;2022QII;""
National Total;All ages;Cohort July 1;Males;Survival in the first trimester;2022QI;""
National Total;All ages;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
National Total;All ages;Cohort July 1;Males;Survival in the first trimester;2021QIII;1.859.912
National Total;All ages;Cohort July 1;Males;Survival in the first trimester;2021QII;""
National Total;All ages;Cohort July 1;Males;Survival in the first trimester;2021QI;""
National Total;All ages;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
National Total;All ages;Cohort July 1;Males;Survival in the first trimester;2020QIII;1.828.450
National Total;All ages;Cohort July 1;Males;Survival in the first trimester;2020QII;""
National Total;All ages;Cohort July 1;Males;Survival in the first trimester;2020QI;""
National Total;All ages;Cohort July 1;Males;Survival in the second trimester;2022QIV;1.790.526
National Total;All ages;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
National Total;All ages;Cohort July 1;Males;Survival in the second trimester;2022QII;""
National Total;All ages;Cohort July 1;Males;Survival in the second trimester;2022QI;""
National Total;All ages;Cohort July 1;Males;Survival in the second trimester;2021QIV;1.798.405
National Total;All ages;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
National Total;All ages;Cohort July 1;Males;Survival in the second trimester;2021QII;""
National Total;All ages;Cohort July 1;Males;Survival in the second trimester;2021QI;""
National Total;All ages;Cohort July 1;Males;Survival in the second trimester;2020QIV;1.772.072
National Total;All ages;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
National Total;All ages;Cohort July 1;Males;Survival in the second trimester;2020QII;""
National Total;All ages;Cohort July 1;Males;Survival in the second trimester;2020QI;""
National Total;All ages;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
National Total;All ages;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
National Total;All ages;Cohort July 1;Males;Survival in the third trimester;2022QII;""
National Total;All ages;Cohort July 1;Males;Survival in the third trimester;2022QI;1.747.885
National Total;All ages;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
National Total;All ages;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
National Total;All ages;Cohort July 1;Males;Survival in the third trimester;2021QII;""
National Total;All ages;Cohort July 1;Males;Survival in the third trimester;2021QI;1.733.404
National Total;All ages;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
National Total;All ages;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
National Total;All ages;Cohort July 1;Males;Survival in the third trimester;2020QII;""
National Total;All ages;Cohort July 1;Males;Survival in the third trimester;2020QI;""
National Total;All ages;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
National Total;All ages;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
National Total;All ages;Cohort July 1;Males;Survival in the third trimester;2022QII;1.701.538
National Total;All ages;Cohort July 1;Males;Survival in the third trimester;2022QI;""
National Total;All ages;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
National Total;All ages;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
National Total;All ages;Cohort July 1;Males;Survival in the third trimester;2021QII;1.693.305
National Total;All ages;Cohort July 1;Males;Survival in the third trimester;2021QI;""
National Total;All ages;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
National Total;All ages;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
National Total;All ages;Cohort July 1;Males;Survival in the third trimester;2020QII;""
National Total;All ages;Cohort July 1;Males;Survival in the third trimester;2020QI;""
National Total;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
National Total;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
National Total;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
National Total;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
National Total;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
National Total;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
National Total;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
National Total;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
National Total;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
National Total;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
National Total;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
National Total;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
National Total;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
National Total;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;96,76
National Total;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
National Total;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
National Total;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
National Total;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;96,92
National Total;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
National Total;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
National Total;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
National Total;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;96,76
National Total;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
National Total;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
National Total;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;93,12
National Total;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
National Total;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
National Total;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
National Total;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;93,71
National Total;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
National Total;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
National Total;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
National Total;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;93,78
National Total;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
National Total;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
National Total;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
National Total;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
National Total;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
National Total;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
National Total;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;91,08
National Total;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
National Total;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
National Total;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
National Total;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;91,73
National Total;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
National Total;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
National Total;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
National Total;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
National Total;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
National Total;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
National Total;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;88,66
National Total;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
National Total;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
National Total;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
National Total;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;89,61
National Total;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
National Total;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
National Total;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
National Total;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
National Total;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
National Total;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
National Total;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QIII;1.123.894
National Total;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
National Total;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
National Total;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
National Total;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QIII;1.103.743
National Total;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
National Total;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
National Total;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
National Total;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QIII;1.072.799
National Total;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
National Total;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
National Total;All ages;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
National Total;All ages;Cohort July 1;Females;Survival in the first trimester;2022QIII;1.079.662
National Total;All ages;Cohort July 1;Females;Survival in the first trimester;2022QII;""
National Total;All ages;Cohort July 1;Females;Survival in the first trimester;2022QI;""
National Total;All ages;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
National Total;All ages;Cohort July 1;Females;Survival in the first trimester;2021QIII;1.065.208
National Total;All ages;Cohort July 1;Females;Survival in the first trimester;2021QII;""
National Total;All ages;Cohort July 1;Females;Survival in the first trimester;2021QI;""
National Total;All ages;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
National Total;All ages;Cohort July 1;Females;Survival in the first trimester;2020QIII;1.031.714
National Total;All ages;Cohort July 1;Females;Survival in the first trimester;2020QII;""
National Total;All ages;Cohort July 1;Females;Survival in the first trimester;2020QI;""
National Total;All ages;Cohort July 1;Females;Survival in the second trimester;2022QIV;1.033.130
National Total;All ages;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
National Total;All ages;Cohort July 1;Females;Survival in the second trimester;2022QII;""
National Total;All ages;Cohort July 1;Females;Survival in the second trimester;2022QI;""
National Total;All ages;Cohort July 1;Females;Survival in the second trimester;2021QIV;1.025.454
National Total;All ages;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
National Total;All ages;Cohort July 1;Females;Survival in the second trimester;2021QII;""
National Total;All ages;Cohort July 1;Females;Survival in the second trimester;2021QI;""
National Total;All ages;Cohort July 1;Females;Survival in the second trimester;2020QIV;995.362
National Total;All ages;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
National Total;All ages;Cohort July 1;Females;Survival in the second trimester;2020QII;""
National Total;All ages;Cohort July 1;Females;Survival in the second trimester;2020QI;""
National Total;All ages;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
National Total;All ages;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
National Total;All ages;Cohort July 1;Females;Survival in the third trimester;2022QII;""
National Total;All ages;Cohort July 1;Females;Survival in the third trimester;2022QI;991.377
National Total;All ages;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
National Total;All ages;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
National Total;All ages;Cohort July 1;Females;Survival in the third trimester;2021QII;""
National Total;All ages;Cohort July 1;Females;Survival in the third trimester;2021QI;971.104
National Total;All ages;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
National Total;All ages;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
National Total;All ages;Cohort July 1;Females;Survival in the third trimester;2020QII;""
National Total;All ages;Cohort July 1;Females;Survival in the third trimester;2020QI;""
National Total;All ages;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
National Total;All ages;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
National Total;All ages;Cohort July 1;Females;Survival in the third trimester;2022QII;958.362
National Total;All ages;Cohort July 1;Females;Survival in the third trimester;2022QI;""
National Total;All ages;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
National Total;All ages;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
National Total;All ages;Cohort July 1;Females;Survival in the third trimester;2021QII;944.484
National Total;All ages;Cohort July 1;Females;Survival in the third trimester;2021QI;""
National Total;All ages;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
National Total;All ages;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
National Total;All ages;Cohort July 1;Females;Survival in the third trimester;2020QII;""
National Total;All ages;Cohort July 1;Females;Survival in the third trimester;2020QI;""
National Total;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
National Total;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
National Total;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
National Total;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
National Total;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
National Total;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
National Total;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
National Total;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
National Total;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
National Total;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
National Total;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
National Total;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
National Total;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
National Total;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;96,06
National Total;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
National Total;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
National Total;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
National Total;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;96,51
National Total;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
National Total;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
National Total;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
National Total;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;96,17
National Total;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
National Total;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
National Total;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;91,92
National Total;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
National Total;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
National Total;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
National Total;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;92,91
National Total;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
National Total;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
National Total;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
National Total;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;92,78
National Total;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
National Total;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
National Total;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
National Total;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
National Total;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
National Total;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
National Total;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;89,82
National Total;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
National Total;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
National Total;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
National Total;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;90,52
National Total;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
National Total;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
National Total;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
National Total;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
National Total;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
National Total;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
National Total;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;86,83
National Total;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
National Total;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
National Total;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
National Total;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;88,04
National Total;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
National Total;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
National Total;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
National Total;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
National Total;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
National Total;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QIV;3.034.840
National Total;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
National Total;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
National Total;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
National Total;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QIV;3.022.819
National Total;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
National Total;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
National Total;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
National Total;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QIV;2.963.105
National Total;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
National Total;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
National Total;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
National Total;All ages;Cohort October 1;Total;Survival in the first trimester;2022QIV;2.907.085
National Total;All ages;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
National Total;All ages;Cohort October 1;Total;Survival in the first trimester;2022QII;""
National Total;All ages;Cohort October 1;Total;Survival in the first trimester;2022QI;""
National Total;All ages;Cohort October 1;Total;Survival in the first trimester;2021QIV;2.909.698
National Total;All ages;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
National Total;All ages;Cohort October 1;Total;Survival in the first trimester;2021QII;""
National Total;All ages;Cohort October 1;Total;Survival in the first trimester;2021QI;""
National Total;All ages;Cohort October 1;Total;Survival in the first trimester;2020QIV;2.856.926
National Total;All ages;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
National Total;All ages;Cohort October 1;Total;Survival in the first trimester;2020QII;""
National Total;All ages;Cohort October 1;Total;Survival in the first trimester;2020QI;""
National Total;All ages;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
National Total;All ages;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
National Total;All ages;Cohort October 1;Total;Survival in the second trimester;2022QII;""
National Total;All ages;Cohort October 1;Total;Survival in the second trimester;2022QI;2.818.422
National Total;All ages;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
National Total;All ages;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
National Total;All ages;Cohort October 1;Total;Survival in the second trimester;2021QII;""
National Total;All ages;Cohort October 1;Total;Survival in the second trimester;2021QI;2.787.463
National Total;All ages;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
National Total;All ages;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
National Total;All ages;Cohort October 1;Total;Survival in the second trimester;2020QII;""
National Total;All ages;Cohort October 1;Total;Survival in the second trimester;2020QI;""
National Total;All ages;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
National Total;All ages;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
National Total;All ages;Cohort October 1;Total;Survival in the third trimester;2022QII;2.732.251
National Total;All ages;Cohort October 1;Total;Survival in the third trimester;2022QI;""
National Total;All ages;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
National Total;All ages;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
National Total;All ages;Cohort October 1;Total;Survival in the third trimester;2021QII;2.714.054
National Total;All ages;Cohort October 1;Total;Survival in the third trimester;2021QI;""
National Total;All ages;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
National Total;All ages;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
National Total;All ages;Cohort October 1;Total;Survival in the third trimester;2020QII;""
National Total;All ages;Cohort October 1;Total;Survival in the third trimester;2020QI;""
National Total;All ages;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
National Total;All ages;Cohort October 1;Total;Survival in the third trimester;2022QIII;2.658.652
National Total;All ages;Cohort October 1;Total;Survival in the third trimester;2022QII;""
National Total;All ages;Cohort October 1;Total;Survival in the third trimester;2022QI;""
National Total;All ages;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
National Total;All ages;Cohort October 1;Total;Survival in the third trimester;2021QIII;2.648.744
National Total;All ages;Cohort October 1;Total;Survival in the third trimester;2021QII;""
National Total;All ages;Cohort October 1;Total;Survival in the third trimester;2021QI;""
National Total;All ages;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
National Total;All ages;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
National Total;All ages;Cohort October 1;Total;Survival in the third trimester;2020QII;""
National Total;All ages;Cohort October 1;Total;Survival in the third trimester;2020QI;""
National Total;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
National Total;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
National Total;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
National Total;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
National Total;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
National Total;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
National Total;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
National Total;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
National Total;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
National Total;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
National Total;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
National Total;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
National Total;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;95,79
National Total;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
National Total;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
National Total;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
National Total;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;96,26
National Total;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
National Total;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
National Total;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
National Total;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;96,42
National Total;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
National Total;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
National Total;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
National Total;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
National Total;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
National Total;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
National Total;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;93,24
National Total;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
National Total;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
National Total;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
National Total;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;94,07
National Total;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
National Total;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
National Total;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
National Total;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
National Total;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
National Total;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
National Total;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;90,39
National Total;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
National Total;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
National Total;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
National Total;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;91,59
National Total;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
National Total;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
National Total;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
National Total;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
National Total;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
National Total;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
National Total;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;87,95
National Total;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
National Total;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
National Total;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
National Total;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;89,39
National Total;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
National Total;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
National Total;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
National Total;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
National Total;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
National Total;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
National Total;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QIV;1.914.605
National Total;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
National Total;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
National Total;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
National Total;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QIV;1.915.994
National Total;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
National Total;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
National Total;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
National Total;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QIV;1.889.503
National Total;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
National Total;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
National Total;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
National Total;All ages;Cohort October 1;Males;Survival in the first trimester;2022QIV;1.837.768
National Total;All ages;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
National Total;All ages;Cohort October 1;Males;Survival in the first trimester;2022QII;""
National Total;All ages;Cohort October 1;Males;Survival in the first trimester;2022QI;""
National Total;All ages;Cohort October 1;Males;Survival in the first trimester;2021QIV;1.847.288
National Total;All ages;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
National Total;All ages;Cohort October 1;Males;Survival in the first trimester;2021QII;""
National Total;All ages;Cohort October 1;Males;Survival in the first trimester;2021QI;""
National Total;All ages;Cohort October 1;Males;Survival in the first trimester;2020QIV;1.824.876
National Total;All ages;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
National Total;All ages;Cohort October 1;Males;Survival in the first trimester;2020QII;""
National Total;All ages;Cohort October 1;Males;Survival in the first trimester;2020QI;""
National Total;All ages;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
National Total;All ages;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
National Total;All ages;Cohort October 1;Males;Survival in the second trimester;2022QII;""
National Total;All ages;Cohort October 1;Males;Survival in the second trimester;2022QI;1.792.791
National Total;All ages;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
National Total;All ages;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
National Total;All ages;Cohort October 1;Males;Survival in the second trimester;2021QII;""
National Total;All ages;Cohort October 1;Males;Survival in the second trimester;2021QI;1.782.187
National Total;All ages;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
National Total;All ages;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
National Total;All ages;Cohort October 1;Males;Survival in the second trimester;2020QII;""
National Total;All ages;Cohort October 1;Males;Survival in the second trimester;2020QI;""
National Total;All ages;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
National Total;All ages;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
National Total;All ages;Cohort October 1;Males;Survival in the third trimester;2022QII;1.742.733
National Total;All ages;Cohort October 1;Males;Survival in the third trimester;2022QI;""
National Total;All ages;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
National Total;All ages;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
National Total;All ages;Cohort October 1;Males;Survival in the third trimester;2021QII;1.738.227
National Total;All ages;Cohort October 1;Males;Survival in the third trimester;2021QI;""
National Total;All ages;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
National Total;All ages;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
National Total;All ages;Cohort October 1;Males;Survival in the third trimester;2020QII;""
National Total;All ages;Cohort October 1;Males;Survival in the third trimester;2020QI;""
National Total;All ages;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
National Total;All ages;Cohort October 1;Males;Survival in the third trimester;2022QIII;1.699.638
National Total;All ages;Cohort October 1;Males;Survival in the third trimester;2022QII;""
National Total;All ages;Cohort October 1;Males;Survival in the third trimester;2022QI;""
National Total;All ages;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
National Total;All ages;Cohort October 1;Males;Survival in the third trimester;2021QIII;1.698.640
National Total;All ages;Cohort October 1;Males;Survival in the third trimester;2021QII;""
National Total;All ages;Cohort October 1;Males;Survival in the third trimester;2021QI;""
National Total;All ages;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
National Total;All ages;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
National Total;All ages;Cohort October 1;Males;Survival in the third trimester;2020QII;""
National Total;All ages;Cohort October 1;Males;Survival in the third trimester;2020QI;""
National Total;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
National Total;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
National Total;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
National Total;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
National Total;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
National Total;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
National Total;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
National Total;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
National Total;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
National Total;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
National Total;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
National Total;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
National Total;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;95,99
National Total;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
National Total;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
National Total;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
National Total;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;96,41
National Total;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
National Total;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
National Total;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
National Total;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;96,58
National Total;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
National Total;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
National Total;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
National Total;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
National Total;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
National Total;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
National Total;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;93,57
National Total;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
National Total;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
National Total;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
National Total;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;94,32
National Total;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
National Total;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
National Total;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
National Total;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
National Total;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
National Total;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
National Total;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;90,96
National Total;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
National Total;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
National Total;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
National Total;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;91,99
National Total;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
National Total;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
National Total;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
National Total;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
National Total;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
National Total;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
National Total;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;88,71
National Total;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
National Total;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
National Total;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
National Total;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;89,9
National Total;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
National Total;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
National Total;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
National Total;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
National Total;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
National Total;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
National Total;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QIV;1.120.235
National Total;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
National Total;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
National Total;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
National Total;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QIV;1.106.825
National Total;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
National Total;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
National Total;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
National Total;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QIV;1.073.602
National Total;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
National Total;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
National Total;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
National Total;All ages;Cohort October 1;Females;Survival in the first trimester;2022QIV;1.069.317
National Total;All ages;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
National Total;All ages;Cohort October 1;Females;Survival in the first trimester;2022QII;""
National Total;All ages;Cohort October 1;Females;Survival in the first trimester;2022QI;""
National Total;All ages;Cohort October 1;Females;Survival in the first trimester;2021QIV;1.062.410
National Total;All ages;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
National Total;All ages;Cohort October 1;Females;Survival in the first trimester;2021QII;""
National Total;All ages;Cohort October 1;Females;Survival in the first trimester;2021QI;""
National Total;All ages;Cohort October 1;Females;Survival in the first trimester;2020QIV;1.032.050
National Total;All ages;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
National Total;All ages;Cohort October 1;Females;Survival in the first trimester;2020QII;""
National Total;All ages;Cohort October 1;Females;Survival in the first trimester;2020QI;""
National Total;All ages;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
National Total;All ages;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
National Total;All ages;Cohort October 1;Females;Survival in the second trimester;2022QII;""
National Total;All ages;Cohort October 1;Females;Survival in the second trimester;2022QI;1.025.631
National Total;All ages;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
National Total;All ages;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
National Total;All ages;Cohort October 1;Females;Survival in the second trimester;2021QII;""
National Total;All ages;Cohort October 1;Females;Survival in the second trimester;2021QI;1.005.276
National Total;All ages;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
National Total;All ages;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
National Total;All ages;Cohort October 1;Females;Survival in the second trimester;2020QII;""
National Total;All ages;Cohort October 1;Females;Survival in the second trimester;2020QI;""
National Total;All ages;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
National Total;All ages;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
National Total;All ages;Cohort October 1;Females;Survival in the third trimester;2022QII;989.518
National Total;All ages;Cohort October 1;Females;Survival in the third trimester;2022QI;""
National Total;All ages;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
National Total;All ages;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
National Total;All ages;Cohort October 1;Females;Survival in the third trimester;2021QII;975.827
National Total;All ages;Cohort October 1;Females;Survival in the third trimester;2021QI;""
National Total;All ages;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
National Total;All ages;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
National Total;All ages;Cohort October 1;Females;Survival in the third trimester;2020QII;""
National Total;All ages;Cohort October 1;Females;Survival in the third trimester;2020QI;""
National Total;All ages;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
National Total;All ages;Cohort October 1;Females;Survival in the third trimester;2022QIII;959.014
National Total;All ages;Cohort October 1;Females;Survival in the third trimester;2022QII;""
National Total;All ages;Cohort October 1;Females;Survival in the third trimester;2022QI;""
National Total;All ages;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
National Total;All ages;Cohort October 1;Females;Survival in the third trimester;2021QIII;950.104
National Total;All ages;Cohort October 1;Females;Survival in the third trimester;2021QII;""
National Total;All ages;Cohort October 1;Females;Survival in the third trimester;2021QI;""
National Total;All ages;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
National Total;All ages;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
National Total;All ages;Cohort October 1;Females;Survival in the third trimester;2020QII;""
National Total;All ages;Cohort October 1;Females;Survival in the third trimester;2020QI;""
National Total;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
National Total;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
National Total;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
National Total;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
National Total;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
National Total;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
National Total;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
National Total;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
National Total;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
National Total;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
National Total;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
National Total;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
National Total;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;95,45
National Total;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
National Total;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
National Total;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
National Total;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;95,99
National Total;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
National Total;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
National Total;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
National Total;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;96,13
National Total;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
National Total;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
National Total;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
National Total;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
National Total;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
National Total;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
National Total;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;92,66
National Total;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
National Total;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
National Total;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
National Total;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;93,64
National Total;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
National Total;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
National Total;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
National Total;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
National Total;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
National Total;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
National Total;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;89,4
National Total;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
National Total;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
National Total;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
National Total;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;90,89
National Total;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
National Total;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
National Total;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
National Total;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
National Total;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
National Total;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
National Total;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;86,65
National Total;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
National Total;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
National Total;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
National Total;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;88,5
National Total;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
National Total;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
National Total;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
National Total;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
National Total;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
National Total;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
National Total;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
National Total;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
National Total;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
National Total;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QI;198.868
National Total;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
National Total;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
National Total;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
National Total;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QI;189.916
National Total;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
National Total;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
National Total;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
National Total;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QI;156.708
National Total;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
National Total;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
National Total;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2022QII;""
National Total;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2022QI;183.803
National Total;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
National Total;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
National Total;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2021QII;""
National Total;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2021QI;178.450
National Total;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
National Total;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
National Total;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2020QII;""
National Total;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2020QI;136.941
National Total;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
National Total;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
National Total;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2022QII;171.004
National Total;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2022QI;""
National Total;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
National Total;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
National Total;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2021QII;166.854
National Total;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2021QI;""
National Total;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
National Total;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
National Total;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2020QII;131.786
National Total;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2020QI;""
National Total;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
National Total;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QIII;160.060
National Total;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QII;""
National Total;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QI;""
National Total;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
National Total;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QIII;156.448
National Total;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QII;""
National Total;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QI;""
National Total;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
National Total;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QIII;124.315
National Total;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QII;""
National Total;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QI;""
National Total;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QIV;149.805
National Total;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
National Total;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QII;""
National Total;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QI;""
National Total;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QIV;147.070
National Total;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
National Total;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QII;""
National Total;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QI;""
National Total;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QIV;117.601
National Total;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
National Total;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QII;""
National Total;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QI;""
National Total;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
National Total;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
National Total;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
National Total;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
National Total;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
National Total;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
National Total;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
National Total;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
National Total;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
National Total;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
National Total;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
National Total;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
National Total;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
National Total;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
National Total;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
National Total;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;92,42
National Total;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
National Total;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
National Total;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
National Total;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;93,96
National Total;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
National Total;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
National Total;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
National Total;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;87,39
National Total;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
National Total;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
National Total;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;85,99
National Total;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
National Total;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
National Total;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
National Total;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;87,86
National Total;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
National Total;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
National Total;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
National Total;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;84,1
National Total;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
National Total;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
National Total;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;80,49
National Total;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
National Total;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
National Total;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
National Total;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;82,38
National Total;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
National Total;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
National Total;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
National Total;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;79,33
National Total;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
National Total;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
National Total;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;75,33
National Total;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
National Total;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
National Total;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
National Total;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;77,44
National Total;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
National Total;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
National Total;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
National Total;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;75,04
National Total;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
National Total;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
National Total;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
National Total;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
National Total;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
National Total;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
National Total;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QI;121.737
National Total;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
National Total;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
National Total;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
National Total;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QI;118.096
National Total;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
National Total;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
National Total;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
National Total;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QI;97.866
National Total;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
National Total;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
National Total;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2022QII;""
National Total;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2022QI;112.762
National Total;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
National Total;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
National Total;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2021QII;""
National Total;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2021QI;111.037
National Total;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
National Total;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
National Total;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2020QII;""
National Total;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2020QI;85.937
National Total;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
National Total;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
National Total;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2022QII;105.252
National Total;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2022QI;""
National Total;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
National Total;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
National Total;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2021QII;103.921
National Total;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2021QI;""
National Total;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
National Total;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
National Total;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2020QII;82.868
National Total;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2020QI;""
National Total;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
National Total;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QIII;98.860
National Total;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QII;""
National Total;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QI;""
National Total;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
National Total;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QIII;97.616
National Total;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QII;""
National Total;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QI;""
National Total;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
National Total;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QIII;78.534
National Total;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QII;""
National Total;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QI;""
National Total;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QIV;92.841
National Total;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
National Total;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QII;""
National Total;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QI;""
National Total;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QIV;91.952
National Total;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
National Total;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QII;""
National Total;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QI;""
National Total;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QIV;74.474
National Total;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
National Total;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QII;""
National Total;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QI;""
National Total;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
National Total;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
National Total;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
National Total;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
National Total;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
National Total;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
National Total;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
National Total;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
National Total;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
National Total;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
National Total;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
National Total;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
National Total;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
National Total;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
National Total;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
National Total;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;92,63
National Total;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
National Total;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
National Total;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
National Total;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;94,02
National Total;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
National Total;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
National Total;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
National Total;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;87,81
National Total;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
National Total;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
National Total;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;86,46
National Total;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
National Total;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
National Total;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
National Total;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;88
National Total;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
National Total;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
National Total;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
National Total;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;84,67
National Total;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
National Total;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
National Total;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;81,21
National Total;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
National Total;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
National Total;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
National Total;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;82,66
National Total;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
National Total;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
National Total;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
National Total;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;80,25
National Total;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
National Total;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
National Total;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;76,26
National Total;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
National Total;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
National Total;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
National Total;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;77,86
National Total;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
National Total;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
National Total;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
National Total;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;76,1
National Total;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
National Total;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
National Total;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
National Total;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
National Total;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
National Total;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
National Total;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QI;77.131
National Total;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
National Total;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
National Total;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
National Total;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QI;71.820
National Total;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
National Total;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
National Total;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
National Total;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QI;58.842
National Total;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
National Total;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
National Total;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2022QII;""
National Total;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2022QI;71.041
National Total;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
National Total;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
National Total;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2021QII;""
National Total;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2021QI;67.413
National Total;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
National Total;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
National Total;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2020QII;""
National Total;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2020QI;51.004
National Total;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
National Total;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
National Total;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2022QII;65.752
National Total;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2022QI;""
National Total;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
National Total;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
National Total;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2021QII;62.933
National Total;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2021QI;""
National Total;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
National Total;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
National Total;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2020QII;48.918
National Total;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2020QI;""
National Total;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
National Total;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QIII;61.200
National Total;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QII;""
National Total;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QI;""
National Total;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
National Total;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QIII;58.832
National Total;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QII;""
National Total;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QI;""
National Total;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
National Total;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QIII;45.781
National Total;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QII;""
National Total;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QI;""
National Total;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QIV;56.964
National Total;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
National Total;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QII;""
National Total;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QI;""
National Total;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QIV;55.118
National Total;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
National Total;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QII;""
National Total;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QI;""
National Total;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QIV;43.127
National Total;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
National Total;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QII;""
National Total;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QI;""
National Total;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
National Total;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
National Total;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
National Total;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
National Total;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
National Total;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
National Total;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
National Total;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
National Total;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
National Total;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
National Total;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
National Total;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
National Total;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
National Total;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
National Total;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
National Total;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;92,1
National Total;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
National Total;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
National Total;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
National Total;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;93,86
National Total;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
National Total;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
National Total;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
National Total;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;86,68
National Total;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
National Total;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
National Total;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;85,25
National Total;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
National Total;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
National Total;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
National Total;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;87,63
National Total;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
National Total;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
National Total;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
National Total;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;83,13
National Total;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
National Total;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
National Total;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;79,35
National Total;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
National Total;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
National Total;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
National Total;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;81,92
National Total;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
National Total;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
National Total;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
National Total;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;77,8
National Total;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
National Total;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
National Total;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;73,85
National Total;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
National Total;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
National Total;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
National Total;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;76,74
National Total;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
National Total;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
National Total;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
National Total;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;73,29
National Total;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
National Total;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
National Total;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
National Total;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
National Total;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
National Total;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QII;175.453
National Total;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
National Total;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
National Total;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
National Total;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QII;170.321
National Total;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
National Total;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
National Total;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
National Total;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QII;158.893
National Total;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
National Total;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
National Total;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
National Total;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2022QII;161.810
National Total;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2022QI;""
National Total;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
National Total;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
National Total;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2021QII;157.209
National Total;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2021QI;""
National Total;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
National Total;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
National Total;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2020QII;152.252
National Total;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2020QI;""
National Total;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
National Total;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2022QIII;150.540
National Total;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2022QII;""
National Total;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2022QI;""
National Total;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
National Total;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2021QIII;145.911
National Total;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2021QII;""
National Total;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2021QI;""
National Total;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
National Total;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2020QIII;142.745
National Total;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2020QII;""
National Total;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2020QI;""
National Total;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QIV;139.969
National Total;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
National Total;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QII;""
National Total;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QI;""
National Total;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QIV;136.172
National Total;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
National Total;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QII;""
National Total;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QI;""
National Total;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QIV;134.403
National Total;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
National Total;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QII;""
National Total;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QI;""
National Total;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
National Total;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
National Total;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QII;""
National Total;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QI;127.320
National Total;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
National Total;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
National Total;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QII;""
National Total;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QI;128.207
National Total;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
National Total;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
National Total;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QII;""
National Total;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QI;""
National Total;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
National Total;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
National Total;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
National Total;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
National Total;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
National Total;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
National Total;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
National Total;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
National Total;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
National Total;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
National Total;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
National Total;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
National Total;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
National Total;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
National Total;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;92,22
National Total;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
National Total;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
National Total;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
National Total;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;92,3
National Total;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
National Total;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
National Total;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
National Total;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;95,82
National Total;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
National Total;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
National Total;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;85,8
National Total;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
National Total;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
National Total;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
National Total;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;85,67
National Total;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
National Total;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
National Total;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
National Total;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;89,84
National Total;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
National Total;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
National Total;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;79,78
National Total;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
National Total;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
National Total;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
National Total;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;79,95
National Total;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
National Total;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
National Total;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
National Total;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;84,59
National Total;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
National Total;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
National Total;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
National Total;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
National Total;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
National Total;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
National Total;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;74,75
National Total;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
National Total;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
National Total;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
National Total;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;80,69
National Total;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
National Total;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
National Total;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
National Total;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
National Total;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
National Total;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
National Total;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QII;107.977
National Total;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
National Total;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
National Total;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
National Total;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QII;106.510
National Total;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
National Total;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
National Total;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
National Total;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QII;99.208
National Total;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
National Total;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
National Total;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
National Total;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2022QII;99.851
National Total;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2022QI;""
National Total;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
National Total;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
National Total;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2021QII;98.314
National Total;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2021QI;""
National Total;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
National Total;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
National Total;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2020QII;95.200
National Total;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2020QI;""
National Total;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
National Total;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2022QIII;93.196
National Total;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2022QII;""
National Total;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2022QI;""
National Total;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
National Total;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2021QIII;91.392
National Total;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2021QII;""
National Total;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2021QI;""
National Total;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
National Total;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2020QIII;89.622
National Total;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2020QII;""
National Total;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2020QI;""
National Total;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QIV;86.935
National Total;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
National Total;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QII;""
National Total;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QI;""
National Total;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QIV;85.515
National Total;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
National Total;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QII;""
National Total;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QI;""
National Total;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QIV;84.565
National Total;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
National Total;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QII;""
National Total;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QI;""
National Total;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
National Total;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
National Total;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QII;""
National Total;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QI;80.201
National Total;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
National Total;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
National Total;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QII;""
National Total;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QI;80.766
National Total;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
National Total;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
National Total;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QII;""
National Total;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QI;""
National Total;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
National Total;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
National Total;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
National Total;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
National Total;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
National Total;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
National Total;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
National Total;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
National Total;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
National Total;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
National Total;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
National Total;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
National Total;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
National Total;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
National Total;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;92,47
National Total;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
National Total;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
National Total;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
National Total;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;92,3
National Total;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
National Total;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
National Total;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
National Total;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;95,96
National Total;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
National Total;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
National Total;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;86,31
National Total;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
National Total;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
National Total;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
National Total;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;85,81
National Total;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
National Total;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
National Total;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
National Total;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;90,34
National Total;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
National Total;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
National Total;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;80,51
National Total;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
National Total;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
National Total;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
National Total;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;80,29
National Total;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
National Total;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
National Total;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
National Total;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;85,24
National Total;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
National Total;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
National Total;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
National Total;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
National Total;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
National Total;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
National Total;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;75,3
National Total;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
National Total;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
National Total;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
National Total;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;81,41
National Total;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
National Total;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
National Total;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
National Total;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
National Total;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
National Total;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
National Total;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QII;67.476
National Total;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
National Total;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
National Total;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
National Total;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QII;63.811
National Total;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
National Total;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
National Total;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
National Total;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QII;59.685
National Total;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
National Total;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
National Total;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
National Total;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2022QII;61.959
National Total;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2022QI;""
National Total;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
National Total;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
National Total;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2021QII;58.895
National Total;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2021QI;""
National Total;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
National Total;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
National Total;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2020QII;57.052
National Total;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2020QI;""
National Total;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
National Total;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2022QIII;57.344
National Total;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2022QII;""
National Total;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2022QI;""
National Total;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
National Total;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2021QIII;54.519
National Total;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2021QII;""
National Total;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2021QI;""
National Total;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
National Total;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2020QIII;53.123
National Total;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2020QII;""
National Total;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2020QI;""
National Total;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QIV;53.034
National Total;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
National Total;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QII;""
National Total;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QI;""
National Total;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QIV;50.657
National Total;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
National Total;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QII;""
National Total;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QI;""
National Total;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QIV;49.838
National Total;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
National Total;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QII;""
National Total;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QI;""
National Total;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
National Total;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
National Total;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QII;""
National Total;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QI;47.119
National Total;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
National Total;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
National Total;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QII;""
National Total;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QI;47.441
National Total;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
National Total;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
National Total;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QII;""
National Total;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QI;""
National Total;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
National Total;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
National Total;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
National Total;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
National Total;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
National Total;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
National Total;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
National Total;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
National Total;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
National Total;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
National Total;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
National Total;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
National Total;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
National Total;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
National Total;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;91,82
National Total;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
National Total;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
National Total;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
National Total;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;92,3
National Total;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
National Total;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
National Total;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
National Total;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;95,59
National Total;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
National Total;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
National Total;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;84,98
National Total;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
National Total;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
National Total;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
National Total;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;85,44
National Total;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
National Total;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
National Total;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
National Total;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;89,01
National Total;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
National Total;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
National Total;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;78,6
National Total;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
National Total;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
National Total;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
National Total;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;79,39
National Total;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
National Total;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
National Total;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
National Total;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;83,5
National Total;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
National Total;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
National Total;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
National Total;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
National Total;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
National Total;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
National Total;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;73,84
National Total;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
National Total;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
National Total;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
National Total;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;79,49
National Total;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
National Total;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
National Total;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
National Total;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
National Total;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
National Total;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QIII;186.480
National Total;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
National Total;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
National Total;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
National Total;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QIII;183.031
National Total;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
National Total;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
National Total;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
National Total;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QIII;168.357
National Total;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
National Total;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
National Total;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
National Total;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2022QIII;170.876
National Total;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2022QII;""
National Total;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2022QI;""
National Total;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
National Total;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2021QIII;167.232
National Total;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2021QII;""
National Total;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2021QI;""
National Total;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
National Total;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2020QIII;155.457
National Total;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2020QII;""
National Total;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2020QI;""
National Total;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2022QIV;157.922
National Total;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
National Total;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2022QII;""
National Total;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2022QI;""
National Total;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2021QIV;155.043
National Total;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
National Total;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2021QII;""
National Total;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2021QI;""
National Total;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2020QIV;145.606
National Total;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
National Total;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2020QII;""
National Total;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2020QI;""
National Total;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
National Total;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
National Total;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QII;""
National Total;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QI;144.564
National Total;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
National Total;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
National Total;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QII;""
National Total;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QI;138.543
National Total;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
National Total;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
National Total;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QII;""
National Total;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QI;""
National Total;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
National Total;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
National Total;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QII;135.558
National Total;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QI;""
National Total;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
National Total;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
National Total;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QII;131.224
National Total;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QI;""
National Total;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
National Total;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
National Total;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QII;""
National Total;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QI;""
National Total;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
National Total;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
National Total;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
National Total;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
National Total;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
National Total;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
National Total;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
National Total;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
National Total;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
National Total;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
National Total;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
National Total;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
National Total;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
National Total;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;91,63
National Total;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
National Total;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
National Total;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
National Total;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;91,37
National Total;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
National Total;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
National Total;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
National Total;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;92,34
National Total;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
National Total;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
National Total;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;84,69
National Total;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
National Total;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
National Total;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
National Total;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;84,71
National Total;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
National Total;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
National Total;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
National Total;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;86,49
National Total;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
National Total;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
National Total;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
National Total;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
National Total;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
National Total;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
National Total;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;78,98
National Total;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
National Total;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
National Total;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
National Total;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;82,29
National Total;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
National Total;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
National Total;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
National Total;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
National Total;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
National Total;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
National Total;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;74,06
National Total;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
National Total;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
National Total;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
National Total;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;77,94
National Total;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
National Total;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
National Total;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
National Total;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
National Total;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
National Total;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
National Total;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QIII;114.737
National Total;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
National Total;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
National Total;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
National Total;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QIII;113.608
National Total;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
National Total;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
National Total;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
National Total;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QIII;105.595
National Total;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
National Total;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
National Total;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
National Total;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2022QIII;105.464
National Total;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2022QII;""
National Total;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2022QI;""
National Total;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
National Total;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2021QIII;103.859
National Total;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2021QII;""
National Total;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2021QI;""
National Total;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
National Total;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2020QIII;97.788
National Total;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2020QII;""
National Total;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2020QI;""
National Total;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2022QIV;97.748
National Total;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
National Total;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2022QII;""
National Total;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2022QI;""
National Total;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2021QIV;96.570
National Total;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
National Total;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2021QII;""
National Total;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2021QI;""
National Total;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2020QIV;91.723
National Total;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
National Total;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2020QII;""
National Total;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2020QI;""
National Total;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
National Total;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
National Total;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QII;""
National Total;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QI;90.301
National Total;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
National Total;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
National Total;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QII;""
National Total;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QI;87.381
National Total;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
National Total;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
National Total;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QII;""
National Total;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QI;""
National Total;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
National Total;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
National Total;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QII;84.988
National Total;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QI;""
National Total;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
National Total;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
National Total;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QII;82.919
National Total;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QI;""
National Total;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
National Total;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
National Total;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QII;""
National Total;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QI;""
National Total;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
National Total;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
National Total;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
National Total;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
National Total;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
National Total;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
National Total;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
National Total;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
National Total;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
National Total;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
National Total;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
National Total;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
National Total;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
National Total;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;91,92
National Total;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
National Total;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
National Total;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
National Total;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;91,42
National Total;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
National Total;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
National Total;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
National Total;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;92,61
National Total;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
National Total;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
National Total;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;85,19
National Total;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
National Total;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
National Total;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
National Total;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;85
National Total;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
National Total;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
National Total;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
National Total;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;86,86
National Total;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
National Total;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
National Total;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
National Total;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
National Total;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
National Total;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
National Total;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;79,48
National Total;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
National Total;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
National Total;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
National Total;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;82,75
National Total;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
National Total;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
National Total;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
National Total;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
National Total;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
National Total;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
National Total;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;74,81
National Total;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
National Total;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
National Total;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
National Total;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;78,53
National Total;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
National Total;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
National Total;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
National Total;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
National Total;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
National Total;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
National Total;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QIII;71.743
National Total;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
National Total;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
National Total;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
National Total;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QIII;69.423
National Total;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
National Total;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
National Total;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
National Total;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QIII;62.762
National Total;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
National Total;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
National Total;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
National Total;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2022QIII;65.412
National Total;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2022QII;""
National Total;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2022QI;""
National Total;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
National Total;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2021QIII;63.373
National Total;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2021QII;""
National Total;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2021QI;""
National Total;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
National Total;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2020QIII;57.669
National Total;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2020QII;""
National Total;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2020QI;""
National Total;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2022QIV;60.174
National Total;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
National Total;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2022QII;""
National Total;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2022QI;""
National Total;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2021QIV;58.473
National Total;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
National Total;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2021QII;""
National Total;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2021QI;""
National Total;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2020QIV;53.883
National Total;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
National Total;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2020QII;""
National Total;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2020QI;""
National Total;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
National Total;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
National Total;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QII;""
National Total;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QI;54.263
National Total;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
National Total;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
National Total;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QII;""
National Total;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QI;51.162
National Total;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
National Total;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
National Total;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QII;""
National Total;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QI;""
National Total;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
National Total;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
National Total;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QII;50.570
National Total;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QI;""
National Total;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
National Total;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
National Total;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QII;48.305
National Total;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QI;""
National Total;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
National Total;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
National Total;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QII;""
National Total;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QI;""
National Total;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
National Total;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
National Total;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
National Total;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
National Total;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
National Total;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
National Total;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
National Total;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
National Total;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
National Total;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
National Total;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
National Total;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
National Total;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
National Total;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;91,18
National Total;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
National Total;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
National Total;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
National Total;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;91,29
National Total;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
National Total;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
National Total;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
National Total;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;91,89
National Total;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
National Total;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
National Total;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;83,87
National Total;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
National Total;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
National Total;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
National Total;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;84,23
National Total;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
National Total;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
National Total;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
National Total;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;85,85
National Total;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
National Total;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
National Total;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
National Total;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
National Total;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
National Total;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
National Total;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;78,16
National Total;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
National Total;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
National Total;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
National Total;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;81,52
National Total;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
National Total;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
National Total;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
National Total;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
National Total;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
National Total;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
National Total;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;72,84
National Total;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
National Total;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
National Total;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
National Total;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;76,97
National Total;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
National Total;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
National Total;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
National Total;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
National Total;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
National Total;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QIV;192.026
National Total;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
National Total;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
National Total;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
National Total;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QIV;189.202
National Total;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
National Total;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
National Total;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
National Total;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QIV;177.790
National Total;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
National Total;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
National Total;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
National Total;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2022QIV;176.565
National Total;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
National Total;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2022QII;""
National Total;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2022QI;""
National Total;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2021QIV;174.449
National Total;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
National Total;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2021QII;""
National Total;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2021QI;""
National Total;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2020QIV;165.050
National Total;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
National Total;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2020QII;""
National Total;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2020QI;""
National Total;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
National Total;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
National Total;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2022QII;""
National Total;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2022QI;162.210
National Total;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
National Total;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
National Total;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2021QII;""
National Total;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2021QI;156.380
National Total;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
National Total;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
National Total;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2020QII;""
National Total;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2020QI;""
National Total;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
National Total;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
National Total;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QII;151.682
National Total;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QI;""
National Total;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
National Total;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
National Total;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QII;147.381
National Total;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QI;""
National Total;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
National Total;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
National Total;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QII;""
National Total;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QI;""
National Total;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
National Total;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QIII;142.422
National Total;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QII;""
National Total;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QI;""
National Total;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
National Total;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QIII;138.935
National Total;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QII;""
National Total;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QI;""
National Total;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
National Total;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
National Total;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QII;""
National Total;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QI;""
National Total;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
National Total;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
National Total;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
National Total;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
National Total;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
National Total;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
National Total;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
National Total;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
National Total;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
National Total;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
National Total;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
National Total;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
National Total;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;91,95
National Total;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
National Total;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
National Total;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
National Total;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;92,2
National Total;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
National Total;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
National Total;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
National Total;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;92,83
National Total;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
National Total;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
National Total;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
National Total;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
National Total;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
National Total;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
National Total;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;85,73
National Total;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
National Total;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
National Total;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
National Total;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;87,96
National Total;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
National Total;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
National Total;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
National Total;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
National Total;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
National Total;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
National Total;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;80,17
National Total;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
National Total;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
National Total;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
National Total;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;82,9
National Total;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
National Total;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
National Total;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
National Total;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
National Total;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
National Total;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
National Total;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;75,28
National Total;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
National Total;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
National Total;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
National Total;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;78,15
National Total;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
National Total;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
National Total;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
National Total;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
National Total;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
National Total;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
National Total;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QIV;117.893
National Total;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
National Total;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
National Total;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
National Total;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QIV;116.500
National Total;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
National Total;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
National Total;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
National Total;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QIV;111.248
National Total;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
National Total;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
National Total;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
National Total;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2022QIV;108.658
National Total;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
National Total;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2022QII;""
National Total;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2022QI;""
National Total;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2021QIV;107.665
National Total;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
National Total;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2021QII;""
National Total;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2021QI;""
National Total;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2020QIV;103.384
National Total;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
National Total;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2020QII;""
National Total;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2020QI;""
National Total;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
National Total;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
National Total;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2022QII;""
National Total;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2022QI;100.396
National Total;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
National Total;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
National Total;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2021QII;""
National Total;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2021QI;98.083
National Total;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
National Total;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
National Total;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2020QII;""
National Total;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2020QI;""
National Total;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
National Total;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
National Total;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QII;94.201
National Total;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QI;""
National Total;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
National Total;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
National Total;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QII;92.593
National Total;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QI;""
National Total;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
National Total;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
National Total;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QII;""
National Total;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QI;""
National Total;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
National Total;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QIII;88.782
National Total;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QII;""
National Total;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QI;""
National Total;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
National Total;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QIII;87.432
National Total;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QII;""
National Total;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QI;""
National Total;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
National Total;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
National Total;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QII;""
National Total;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QI;""
National Total;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
National Total;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
National Total;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
National Total;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
National Total;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
National Total;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
National Total;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
National Total;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
National Total;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
National Total;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
National Total;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
National Total;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
National Total;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;92,17
National Total;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
National Total;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
National Total;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
National Total;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;92,42
National Total;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
National Total;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
National Total;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
National Total;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;92,93
National Total;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
National Total;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
National Total;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
National Total;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
National Total;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
National Total;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
National Total;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;86,18
National Total;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
National Total;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
National Total;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
National Total;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;88,17
National Total;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
National Total;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
National Total;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
National Total;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
National Total;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
National Total;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
National Total;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;80,86
National Total;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
National Total;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
National Total;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
National Total;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;83,23
National Total;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
National Total;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
National Total;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
National Total;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
National Total;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
National Total;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
National Total;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;76,21
National Total;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
National Total;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
National Total;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
National Total;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;78,59
National Total;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
National Total;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
National Total;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
National Total;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
National Total;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
National Total;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
National Total;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QIV;74.133
National Total;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
National Total;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
National Total;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
National Total;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QIV;72.702
National Total;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
National Total;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
National Total;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
National Total;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QIV;66.542
National Total;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
National Total;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
National Total;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
National Total;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2022QIV;67.907
National Total;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
National Total;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2022QII;""
National Total;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2022QI;""
National Total;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2021QIV;66.784
National Total;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
National Total;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2021QII;""
National Total;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2021QI;""
National Total;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2020QIV;61.666
National Total;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
National Total;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2020QII;""
National Total;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2020QI;""
National Total;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
National Total;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
National Total;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2022QII;""
National Total;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2022QI;61.814
National Total;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
National Total;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
National Total;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2021QII;""
National Total;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2021QI;58.297
National Total;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
National Total;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
National Total;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2020QII;""
National Total;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2020QI;""
National Total;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
National Total;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
National Total;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QII;57.481
National Total;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QI;""
National Total;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
National Total;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
National Total;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QII;54.788
National Total;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QI;""
National Total;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
National Total;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
National Total;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QII;""
National Total;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QI;""
National Total;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
National Total;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QIII;53.640
National Total;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QII;""
National Total;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QI;""
National Total;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
National Total;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QIII;51.503
National Total;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QII;""
National Total;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QI;""
National Total;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
National Total;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
National Total;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QII;""
National Total;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QI;""
National Total;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
National Total;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
National Total;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
National Total;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
National Total;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
National Total;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
National Total;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
National Total;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
National Total;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
National Total;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
National Total;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
National Total;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
National Total;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;91,6
National Total;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
National Total;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
National Total;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
National Total;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;91,86
National Total;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
National Total;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
National Total;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
National Total;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;92,67
National Total;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
National Total;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
National Total;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
National Total;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
National Total;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
National Total;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
National Total;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;85,02
National Total;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
National Total;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
National Total;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
National Total;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;87,61
National Total;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
National Total;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
National Total;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
National Total;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
National Total;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
National Total;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
National Total;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;79,06
National Total;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
National Total;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
National Total;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
National Total;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;82,34
National Total;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
National Total;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
National Total;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
National Total;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
National Total;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
National Total;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
National Total;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;73,78
National Total;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
National Total;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
National Total;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
National Total;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;77,4
National Total;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
National Total;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
National Total;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
National Total;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
National Total;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
National Total;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
National Total;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
National Total;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
National Total;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
National Total;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QI;558.701
National Total;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
National Total;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
National Total;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
National Total;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QI;562.747
National Total;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
National Total;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
National Total;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
National Total;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QI;548.319
National Total;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
National Total;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
National Total;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2022QII;""
National Total;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2022QI;534.988
National Total;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
National Total;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
National Total;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2021QII;""
National Total;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2021QI;544.487
National Total;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
National Total;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
National Total;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2020QII;""
National Total;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2020QI;505.328
National Total;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
National Total;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
National Total;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2022QII;512.740
National Total;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2022QI;""
National Total;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
National Total;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
National Total;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2021QII;525.185
National Total;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2021QI;""
National Total;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
National Total;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
National Total;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2020QII;492.865
National Total;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2020QI;""
National Total;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
National Total;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QIII;494.772
National Total;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QII;""
National Total;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QI;""
National Total;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
National Total;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QIII;508.706
National Total;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QII;""
National Total;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QI;""
National Total;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
National Total;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QIII;476.088
National Total;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QII;""
National Total;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QI;""
National Total;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QIV;476.078
National Total;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
National Total;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QII;""
National Total;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QI;""
National Total;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QIV;491.406
National Total;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
National Total;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QII;""
National Total;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QI;""
National Total;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QIV;460.343
National Total;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
National Total;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QII;""
National Total;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QI;""
National Total;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
National Total;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
National Total;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
National Total;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
National Total;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
National Total;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
National Total;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
National Total;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
National Total;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
National Total;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
National Total;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
National Total;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
National Total;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
National Total;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
National Total;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
National Total;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;95,76
National Total;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
National Total;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
National Total;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
National Total;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;96,76
National Total;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
National Total;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
National Total;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
National Total;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;92,16
National Total;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
National Total;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
National Total;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;91,77
National Total;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
National Total;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
National Total;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
National Total;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;93,33
National Total;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
National Total;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
National Total;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
National Total;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;89,89
National Total;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
National Total;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
National Total;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;88,56
National Total;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
National Total;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
National Total;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
National Total;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;90,4
National Total;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
National Total;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
National Total;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
National Total;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;86,83
National Total;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
National Total;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
National Total;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;85,21
National Total;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
National Total;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
National Total;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
National Total;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;87,32
National Total;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
National Total;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
National Total;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
National Total;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;83,96
National Total;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
National Total;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
National Total;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
National Total;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
National Total;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
National Total;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
National Total;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QI;333.853
National Total;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
National Total;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
National Total;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
National Total;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QI;340.592
National Total;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
National Total;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
National Total;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
National Total;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QI;330.292
National Total;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
National Total;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
National Total;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2022QII;""
National Total;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2022QI;320.403
National Total;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
National Total;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
National Total;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2021QII;""
National Total;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2021QI;329.849
National Total;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
National Total;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
National Total;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2020QII;""
National Total;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2020QI;306.109
National Total;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
National Total;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
National Total;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2022QII;308.209
National Total;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2022QI;""
National Total;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
National Total;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
National Total;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2021QII;318.656
National Total;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2021QI;""
National Total;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
National Total;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
National Total;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2020QII;299.361
National Total;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2020QI;""
National Total;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
National Total;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QIII;298.259
National Total;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QII;""
National Total;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QI;""
National Total;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
National Total;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QIII;309.081
National Total;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QII;""
National Total;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QI;""
National Total;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
National Total;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QIII;290.116
National Total;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QII;""
National Total;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QI;""
National Total;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QIV;287.626
National Total;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
National Total;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QII;""
National Total;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QI;""
National Total;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QIV;299.001
National Total;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
National Total;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QII;""
National Total;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QI;""
National Total;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QIV;281.106
National Total;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
National Total;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QII;""
National Total;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QI;""
National Total;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
National Total;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
National Total;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
National Total;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
National Total;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
National Total;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
National Total;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
National Total;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
National Total;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
National Total;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
National Total;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
National Total;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
National Total;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
National Total;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
National Total;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
National Total;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;95,97
National Total;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
National Total;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
National Total;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
National Total;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;96,85
National Total;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
National Total;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
National Total;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
National Total;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;92,68
National Total;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
National Total;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
National Total;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;92,32
National Total;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
National Total;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
National Total;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
National Total;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;93,56
National Total;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
National Total;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
National Total;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
National Total;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;90,64
National Total;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
National Total;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
National Total;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;89,34
National Total;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
National Total;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
National Total;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
National Total;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;90,75
National Total;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
National Total;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
National Total;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
National Total;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;87,84
National Total;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
National Total;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
National Total;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;86,15
National Total;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
National Total;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
National Total;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
National Total;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;87,79
National Total;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
National Total;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
National Total;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
National Total;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;85,11
National Total;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
National Total;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
National Total;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
National Total;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
National Total;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
National Total;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
National Total;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QI;224.848
National Total;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
National Total;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
National Total;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
National Total;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QI;222.155
National Total;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
National Total;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
National Total;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
National Total;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QI;218.027
National Total;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
National Total;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
National Total;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2022QII;""
National Total;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2022QI;214.585
National Total;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
National Total;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
National Total;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2021QII;""
National Total;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2021QI;214.638
National Total;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
National Total;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
National Total;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2020QII;""
National Total;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2020QI;199.219
National Total;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
National Total;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
National Total;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2022QII;204.531
National Total;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2022QI;""
National Total;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
National Total;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
National Total;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2021QII;206.529
National Total;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2021QI;""
National Total;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
National Total;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
National Total;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2020QII;193.504
National Total;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2020QI;""
National Total;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
National Total;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QIII;196.513
National Total;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QII;""
National Total;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QI;""
National Total;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
National Total;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QIII;199.625
National Total;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QII;""
National Total;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QI;""
National Total;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
National Total;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QIII;185.972
National Total;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QII;""
National Total;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QI;""
National Total;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QIV;188.452
National Total;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
National Total;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QII;""
National Total;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QI;""
National Total;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QIV;192.405
National Total;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
National Total;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QII;""
National Total;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QI;""
National Total;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QIV;179.237
National Total;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
National Total;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QII;""
National Total;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QI;""
National Total;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
National Total;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
National Total;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
National Total;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
National Total;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
National Total;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
National Total;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
National Total;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
National Total;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
National Total;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
National Total;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
National Total;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
National Total;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
National Total;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
National Total;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
National Total;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;95,44
National Total;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
National Total;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
National Total;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
National Total;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;96,62
National Total;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
National Total;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
National Total;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
National Total;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;91,37
National Total;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
National Total;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
National Total;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;90,96
National Total;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
National Total;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
National Total;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
National Total;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;92,97
National Total;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
National Total;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
National Total;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
National Total;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;88,75
National Total;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
National Total;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
National Total;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;87,4
National Total;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
National Total;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
National Total;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
National Total;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;89,86
National Total;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
National Total;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
National Total;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
National Total;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;85,3
National Total;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
National Total;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
National Total;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;83,81
National Total;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
National Total;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
National Total;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
National Total;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;86,61
National Total;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
National Total;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
National Total;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
National Total;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;82,21
National Total;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
National Total;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
National Total;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
National Total;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
National Total;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
National Total;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QII;528.099
National Total;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
National Total;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
National Total;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
National Total;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QII;534.325
National Total;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
National Total;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
National Total;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
National Total;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QII;540.235
National Total;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
National Total;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
National Total;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
National Total;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2022QII;503.828
National Total;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2022QI;""
National Total;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
National Total;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
National Total;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2021QII;512.689
National Total;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2021QI;""
National Total;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
National Total;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
National Total;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2020QII;525.938
National Total;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2020QI;""
National Total;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
National Total;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2022QIII;484.358
National Total;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2022QII;""
National Total;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2022QI;""
National Total;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
National Total;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2021QIII;494.381
National Total;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2021QII;""
National Total;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2021QI;""
National Total;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
National Total;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2020QIII;506.652
National Total;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2020QII;""
National Total;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2020QI;""
National Total;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QIV;464.083
National Total;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
National Total;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QII;""
National Total;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QI;""
National Total;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QIV;475.715
National Total;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
National Total;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QII;""
National Total;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QI;""
National Total;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QIV;488.734
National Total;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
National Total;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QII;""
National Total;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QI;""
National Total;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
National Total;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
National Total;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QII;""
National Total;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QI;458.569
National Total;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
National Total;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
National Total;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QII;""
National Total;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QI;476.009
National Total;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
National Total;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
National Total;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QII;""
National Total;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QI;""
National Total;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
National Total;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
National Total;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
National Total;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
National Total;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
National Total;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
National Total;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
National Total;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
National Total;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
National Total;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
National Total;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
National Total;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
National Total;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
National Total;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
National Total;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;95,4
National Total;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
National Total;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
National Total;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
National Total;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;95,95
National Total;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
National Total;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
National Total;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
National Total;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;97,35
National Total;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
National Total;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
National Total;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;91,72
National Total;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
National Total;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
National Total;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
National Total;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;92,52
National Total;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
National Total;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
National Total;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
National Total;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;93,78
National Total;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
National Total;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
National Total;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;87,88
National Total;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
National Total;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
National Total;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
National Total;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;89,03
National Total;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
National Total;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
National Total;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
National Total;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;90,47
National Total;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
National Total;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
National Total;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
National Total;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
National Total;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
National Total;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
National Total;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;85,82
National Total;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
National Total;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
National Total;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
National Total;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;88,11
National Total;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
National Total;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
National Total;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
National Total;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
National Total;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
National Total;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
National Total;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QII;313.948
National Total;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
National Total;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
National Total;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
National Total;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QII;321.652
National Total;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
National Total;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
National Total;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
National Total;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QII;326.187
National Total;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
National Total;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
National Total;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
National Total;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2022QII;300.514
National Total;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2022QI;""
National Total;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
National Total;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
National Total;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2021QII;309.001
National Total;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2021QI;""
National Total;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
National Total;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
National Total;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2020QII;318.357
National Total;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2020QI;""
National Total;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
National Total;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2022QIII;289.630
National Total;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2022QII;""
National Total;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2022QI;""
National Total;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
National Total;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2021QIII;298.281
National Total;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2021QII;""
National Total;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2021QI;""
National Total;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
National Total;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2020QIII;307.661
National Total;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2020QII;""
National Total;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2020QI;""
National Total;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QIV;278.108
National Total;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
National Total;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QII;""
National Total;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QI;""
National Total;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QIV;287.377
National Total;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
National Total;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QII;""
National Total;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QI;""
National Total;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QIV;297.351
National Total;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
National Total;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QII;""
National Total;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QI;""
National Total;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
National Total;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
National Total;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QII;""
National Total;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QI;277.753
National Total;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
National Total;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
National Total;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QII;""
National Total;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QI;289.978
National Total;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
National Total;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
National Total;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QII;""
National Total;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QI;""
National Total;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
National Total;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
National Total;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
National Total;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
National Total;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
National Total;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
National Total;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
National Total;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
National Total;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
National Total;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
National Total;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
National Total;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
National Total;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
National Total;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
National Total;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;95,72
National Total;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
National Total;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
National Total;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
National Total;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;96,07
National Total;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
National Total;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
National Total;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
National Total;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;97,6
National Total;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
National Total;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
National Total;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;92,25
National Total;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
National Total;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
National Total;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
National Total;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;92,73
National Total;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
National Total;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
National Total;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
National Total;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;94,32
National Total;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
National Total;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
National Total;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;88,58
National Total;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
National Total;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
National Total;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
National Total;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;89,34
National Total;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
National Total;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
National Total;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
National Total;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;91,16
National Total;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
National Total;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
National Total;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
National Total;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
National Total;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
National Total;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
National Total;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;86,35
National Total;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
National Total;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
National Total;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
National Total;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;88,9
National Total;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
National Total;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
National Total;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
National Total;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
National Total;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
National Total;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
National Total;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QII;214.151
National Total;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
National Total;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
National Total;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
National Total;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QII;212.673
National Total;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
National Total;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
National Total;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
National Total;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QII;214.048
National Total;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
National Total;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
National Total;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
National Total;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2022QII;203.314
National Total;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2022QI;""
National Total;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
National Total;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
National Total;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2021QII;203.688
National Total;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2021QI;""
National Total;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
National Total;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
National Total;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2020QII;207.581
National Total;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2020QI;""
National Total;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
National Total;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2022QIII;194.728
National Total;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2022QII;""
National Total;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2022QI;""
National Total;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
National Total;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2021QIII;196.100
National Total;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2021QII;""
National Total;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2021QI;""
National Total;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
National Total;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2020QIII;198.991
National Total;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2020QII;""
National Total;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2020QI;""
National Total;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QIV;185.975
National Total;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
National Total;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QII;""
National Total;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QI;""
National Total;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QIV;188.338
National Total;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
National Total;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QII;""
National Total;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QI;""
National Total;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QIV;191.383
National Total;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
National Total;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QII;""
National Total;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QI;""
National Total;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
National Total;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
National Total;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QII;""
National Total;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QI;180.816
National Total;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
National Total;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
National Total;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QII;""
National Total;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QI;186.031
National Total;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
National Total;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
National Total;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QII;""
National Total;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QI;""
National Total;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
National Total;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
National Total;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
National Total;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
National Total;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
National Total;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
National Total;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
National Total;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
National Total;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
National Total;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
National Total;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
National Total;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
National Total;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
National Total;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
National Total;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;94,94
National Total;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
National Total;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
National Total;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
National Total;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;95,78
National Total;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
National Total;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
National Total;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
National Total;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;96,98
National Total;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
National Total;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
National Total;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;90,93
National Total;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
National Total;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
National Total;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
National Total;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;92,21
National Total;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
National Total;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
National Total;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
National Total;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;92,97
National Total;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
National Total;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
National Total;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;86,84
National Total;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
National Total;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
National Total;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
National Total;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;88,56
National Total;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
National Total;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
National Total;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
National Total;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;89,41
National Total;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
National Total;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
National Total;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
National Total;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
National Total;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
National Total;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
National Total;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;85,02
National Total;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
National Total;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
National Total;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
National Total;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;86,91
National Total;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
National Total;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
National Total;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
National Total;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
National Total;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
National Total;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QIII;536.903
National Total;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
National Total;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
National Total;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
National Total;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QIII;546.696
National Total;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
National Total;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
National Total;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
National Total;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QIII;549.416
National Total;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
National Total;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
National Total;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
National Total;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2022QIII;513.449
National Total;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2022QII;""
National Total;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2022QI;""
National Total;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
National Total;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2021QIII;524.529
National Total;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2021QII;""
National Total;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2021QI;""
National Total;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
National Total;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2020QIII;527.066
National Total;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2020QII;""
National Total;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2020QI;""
National Total;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2022QIV;489.722
National Total;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
National Total;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2022QII;""
National Total;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2022QI;""
National Total;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2021QIV;502.633
National Total;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
National Total;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2021QII;""
National Total;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2021QI;""
National Total;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2020QIV;507.054
National Total;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
National Total;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2020QII;""
National Total;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2020QI;""
National Total;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
National Total;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
National Total;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QII;""
National Total;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QI;483.591
National Total;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
National Total;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
National Total;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QII;""
National Total;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QI;493.261
National Total;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
National Total;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
National Total;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QII;""
National Total;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QI;""
National Total;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
National Total;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
National Total;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QII;465.918
National Total;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QI;""
National Total;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
National Total;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
National Total;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QII;478.431
National Total;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QI;""
National Total;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
National Total;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
National Total;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QII;""
National Total;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QI;""
National Total;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
National Total;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
National Total;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
National Total;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
National Total;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
National Total;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
National Total;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
National Total;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
National Total;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
National Total;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
National Total;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
National Total;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
National Total;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
National Total;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;95,63
National Total;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
National Total;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
National Total;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
National Total;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;95,95
National Total;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
National Total;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
National Total;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
National Total;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;95,93
National Total;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
National Total;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
National Total;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;91,21
National Total;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
National Total;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
National Total;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
National Total;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;91,94
National Total;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
National Total;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
National Total;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
National Total;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;92,29
National Total;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
National Total;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
National Total;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
National Total;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
National Total;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
National Total;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
National Total;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;88,46
National Total;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
National Total;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
National Total;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
National Total;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;89,78
National Total;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
National Total;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
National Total;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
National Total;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
National Total;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
National Total;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
National Total;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;85,22
National Total;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
National Total;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
National Total;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
National Total;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;87,08
National Total;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
National Total;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
National Total;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
National Total;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
National Total;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
National Total;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
National Total;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QIII;319.185
National Total;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
National Total;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
National Total;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
National Total;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QIII;328.527
National Total;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
National Total;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
National Total;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
National Total;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QIII;332.967
National Total;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
National Total;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
National Total;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
National Total;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2022QIII;306.031
National Total;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2022QII;""
National Total;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2022QI;""
National Total;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
National Total;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2021QIII;315.508
National Total;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2021QII;""
National Total;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2021QI;""
National Total;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
National Total;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2020QIII;320.335
National Total;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2020QII;""
National Total;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2020QI;""
National Total;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2022QIV;292.523
National Total;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
National Total;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2022QII;""
National Total;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2022QI;""
National Total;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2021QIV;302.714
National Total;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
National Total;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2021QII;""
National Total;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2021QI;""
National Total;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2020QIV;308.663
National Total;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
National Total;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2020QII;""
National Total;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2020QI;""
National Total;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
National Total;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
National Total;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QII;""
National Total;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QI;291.997
National Total;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
National Total;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
National Total;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QII;""
National Total;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QI;300.599
National Total;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
National Total;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
National Total;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QII;""
National Total;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QI;""
National Total;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
National Total;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
National Total;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QII;282.265
National Total;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QI;""
National Total;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
National Total;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
National Total;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QII;292.009
National Total;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QI;""
National Total;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
National Total;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
National Total;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QII;""
National Total;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QI;""
National Total;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
National Total;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
National Total;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
National Total;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
National Total;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
National Total;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
National Total;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
National Total;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
National Total;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
National Total;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
National Total;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
National Total;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
National Total;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
National Total;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;95,88
National Total;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
National Total;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
National Total;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
National Total;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;96,04
National Total;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
National Total;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
National Total;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
National Total;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;96,21
National Total;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
National Total;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
National Total;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;91,65
National Total;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
National Total;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
National Total;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
National Total;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;92,14
National Total;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
National Total;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
National Total;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
National Total;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;92,7
National Total;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
National Total;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
National Total;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
National Total;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
National Total;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
National Total;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
National Total;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;88,88
National Total;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
National Total;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
National Total;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
National Total;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;90,28
National Total;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
National Total;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
National Total;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
National Total;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
National Total;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
National Total;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
National Total;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;85,92
National Total;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
National Total;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
National Total;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
National Total;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;87,7
National Total;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
National Total;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
National Total;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
National Total;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
National Total;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
National Total;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
National Total;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QIII;217.718
National Total;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
National Total;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
National Total;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
National Total;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QIII;218.169
National Total;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
National Total;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
National Total;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
National Total;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QIII;216.449
National Total;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
National Total;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
National Total;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
National Total;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2022QIII;207.418
National Total;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2022QII;""
National Total;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2022QI;""
National Total;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
National Total;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2021QIII;209.021
National Total;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2021QII;""
National Total;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2021QI;""
National Total;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
National Total;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2020QIII;206.731
National Total;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2020QII;""
National Total;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2020QI;""
National Total;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2022QIV;197.199
National Total;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
National Total;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2022QII;""
National Total;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2022QI;""
National Total;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2021QIV;199.919
National Total;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
National Total;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2021QII;""
National Total;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2021QI;""
National Total;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2020QIV;198.391
National Total;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
National Total;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2020QII;""
National Total;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2020QI;""
National Total;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
National Total;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
National Total;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QII;""
National Total;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QI;191.594
National Total;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
National Total;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
National Total;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QII;""
National Total;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QI;192.662
National Total;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
National Total;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
National Total;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QII;""
National Total;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QI;""
National Total;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
National Total;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
National Total;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QII;183.653
National Total;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QI;""
National Total;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
National Total;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
National Total;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QII;186.422
National Total;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QI;""
National Total;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
National Total;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
National Total;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QII;""
National Total;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QI;""
National Total;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
National Total;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
National Total;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
National Total;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
National Total;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
National Total;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
National Total;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
National Total;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
National Total;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
National Total;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
National Total;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
National Total;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
National Total;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
National Total;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;95,27
National Total;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
National Total;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
National Total;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
National Total;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;95,81
National Total;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
National Total;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
National Total;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
National Total;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;95,51
National Total;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
National Total;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
National Total;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;90,58
National Total;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
National Total;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
National Total;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
National Total;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;91,63
National Total;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
National Total;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
National Total;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
National Total;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;91,66
National Total;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
National Total;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
National Total;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
National Total;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
National Total;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
National Total;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
National Total;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;87,82
National Total;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
National Total;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
National Total;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
National Total;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;89,01
National Total;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
National Total;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
National Total;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
National Total;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
National Total;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
National Total;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
National Total;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;84,18
National Total;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
National Total;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
National Total;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
National Total;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;86,13
National Total;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
National Total;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
National Total;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
National Total;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
National Total;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
National Total;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QIV;539.767
National Total;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
National Total;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
National Total;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
National Total;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QIV;552.193
National Total;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
National Total;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
National Total;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
National Total;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QIV;555.513
National Total;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
National Total;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
National Total;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
National Total;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2022QIV;513.433
National Total;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
National Total;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2022QII;""
National Total;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2022QI;""
National Total;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2021QIV;527.430
National Total;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
National Total;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2021QII;""
National Total;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2021QI;""
National Total;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2020QIV;532.370
National Total;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
National Total;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2020QII;""
National Total;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2020QI;""
National Total;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
National Total;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
National Total;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2022QII;""
National Total;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2022QI;506.560
National Total;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
National Total;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
National Total;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2021QII;""
National Total;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2021QI;516.799
National Total;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
National Total;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
National Total;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2020QII;""
National Total;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2020QI;""
National Total;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
National Total;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
National Total;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QII;487.044
National Total;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QI;""
National Total;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
National Total;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
National Total;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QII;500.170
National Total;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QI;""
National Total;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
National Total;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
National Total;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QII;""
National Total;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QI;""
National Total;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
National Total;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QIII;470.823
National Total;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QII;""
National Total;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QI;""
National Total;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
National Total;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QIII;485.539
National Total;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QII;""
National Total;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QI;""
National Total;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
National Total;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
National Total;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QII;""
National Total;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QI;""
National Total;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
National Total;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
National Total;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
National Total;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
National Total;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
National Total;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
National Total;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
National Total;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
National Total;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
National Total;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
National Total;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
National Total;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
National Total;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;95,12
National Total;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
National Total;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
National Total;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
National Total;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;95,52
National Total;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
National Total;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
National Total;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
National Total;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;95,83
National Total;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
National Total;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
National Total;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
National Total;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
National Total;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
National Total;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
National Total;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;91,74
National Total;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
National Total;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
National Total;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
National Total;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;93,03
National Total;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
National Total;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
National Total;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
National Total;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
National Total;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
National Total;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
National Total;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;88,2
National Total;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
National Total;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
National Total;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
National Total;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;90,04
National Total;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
National Total;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
National Total;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
National Total;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
National Total;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
National Total;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
National Total;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;85,26
National Total;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
National Total;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
National Total;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
National Total;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;87,4
National Total;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
National Total;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
National Total;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
National Total;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
National Total;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
National Total;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
National Total;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QIV;320.784
National Total;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
National Total;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
National Total;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
National Total;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QIV;331.164
National Total;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
National Total;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
National Total;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
National Total;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QIV;336.917
National Total;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
National Total;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
National Total;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
National Total;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2022QIV;305.750
National Total;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
National Total;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2022QII;""
National Total;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2022QI;""
National Total;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2021QIV;316.652
National Total;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
National Total;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2021QII;""
National Total;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2021QI;""
National Total;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2020QIV;323.354
National Total;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
National Total;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2020QII;""
National Total;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2020QI;""
National Total;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
National Total;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
National Total;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2022QII;""
National Total;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2022QI;304.876
National Total;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
National Total;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
National Total;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2021QII;""
National Total;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2021QI;314.246
National Total;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
National Total;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
National Total;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2020QII;""
National Total;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2020QI;""
National Total;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
National Total;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
National Total;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QII;294.116
National Total;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QI;""
National Total;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
National Total;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
National Total;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QII;304.628
National Total;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QI;""
National Total;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
National Total;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
National Total;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QII;""
National Total;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QI;""
National Total;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
National Total;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QIII;285.095
National Total;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QII;""
National Total;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QI;""
National Total;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
National Total;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QIII;296.108
National Total;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QII;""
National Total;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QI;""
National Total;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
National Total;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
National Total;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QII;""
National Total;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QI;""
National Total;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
National Total;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
National Total;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
National Total;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
National Total;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
National Total;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
National Total;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
National Total;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
National Total;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
National Total;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
National Total;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
National Total;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
National Total;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;95,31
National Total;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
National Total;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
National Total;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
National Total;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;95,62
National Total;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
National Total;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
National Total;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
National Total;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;95,97
National Total;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
National Total;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
National Total;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
National Total;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
National Total;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
National Total;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
National Total;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;92,06
National Total;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
National Total;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
National Total;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
National Total;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;93,27
National Total;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
National Total;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
National Total;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
National Total;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
National Total;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
National Total;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
National Total;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;88,81
National Total;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
National Total;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
National Total;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
National Total;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;90,42
National Total;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
National Total;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
National Total;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
National Total;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
National Total;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
National Total;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
National Total;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;86,09
National Total;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
National Total;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
National Total;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
National Total;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;87,89
National Total;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
National Total;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
National Total;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
National Total;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
National Total;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
National Total;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
National Total;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QIV;218.983
National Total;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
National Total;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
National Total;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
National Total;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QIV;221.029
National Total;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
National Total;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
National Total;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
National Total;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QIV;218.596
National Total;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
National Total;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
National Total;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
National Total;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2022QIV;207.683
National Total;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
National Total;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2022QII;""
National Total;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2022QI;""
National Total;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2021QIV;210.778
National Total;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
National Total;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2021QII;""
National Total;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2021QI;""
National Total;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2020QIV;209.016
National Total;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
National Total;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2020QII;""
National Total;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2020QI;""
National Total;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
National Total;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
National Total;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2022QII;""
National Total;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2022QI;201.684
National Total;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
National Total;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
National Total;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2021QII;""
National Total;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2021QI;202.553
National Total;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
National Total;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
National Total;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2020QII;""
National Total;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2020QI;""
National Total;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
National Total;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
National Total;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QII;192.928
National Total;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QI;""
National Total;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
National Total;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
National Total;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QII;195.542
National Total;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QI;""
National Total;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
National Total;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
National Total;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QII;""
National Total;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QI;""
National Total;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
National Total;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QIII;185.728
National Total;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QII;""
National Total;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QI;""
National Total;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
National Total;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QIII;189.431
National Total;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QII;""
National Total;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QI;""
National Total;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
National Total;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
National Total;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QII;""
National Total;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QI;""
National Total;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
National Total;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
National Total;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
National Total;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
National Total;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
National Total;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
National Total;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
National Total;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
National Total;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
National Total;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
National Total;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
National Total;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
National Total;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;94,84
National Total;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
National Total;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
National Total;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
National Total;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;95,36
National Total;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
National Total;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
National Total;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
National Total;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;95,62
National Total;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
National Total;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
National Total;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
National Total;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
National Total;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
National Total;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
National Total;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;91,25
National Total;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
National Total;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
National Total;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
National Total;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;92,66
National Total;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
National Total;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
National Total;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
National Total;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
National Total;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
National Total;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
National Total;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;87,29
National Total;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
National Total;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
National Total;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
National Total;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;89,45
National Total;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
National Total;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
National Total;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
National Total;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
National Total;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
National Total;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
National Total;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;84,03
National Total;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
National Total;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
National Total;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
National Total;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;86,66
National Total;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
National Total;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
National Total;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
National Total;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
National Total;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
National Total;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
National Total;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
National Total;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
National Total;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
National Total;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QI;955.598
National Total;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
National Total;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
National Total;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
National Total;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QI;952.274
National Total;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
National Total;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
National Total;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
National Total;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QI;957.747
National Total;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
National Total;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
National Total;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2022QII;""
National Total;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2022QI;927.460
National Total;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
National Total;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
National Total;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2021QII;""
National Total;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2021QI;931.271
National Total;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
National Total;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
National Total;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2020QII;""
National Total;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2020QI;900.276
National Total;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
National Total;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
National Total;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2022QII;900.542
National Total;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2022QI;""
National Total;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
National Total;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
National Total;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2021QII;908.813
National Total;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2021QI;""
National Total;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
National Total;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
National Total;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2020QII;883.970
National Total;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2020QI;""
National Total;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
National Total;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QIII;879.577
National Total;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QII;""
National Total;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QI;""
National Total;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
National Total;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QIII;890.178
National Total;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QII;""
National Total;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QI;""
National Total;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
National Total;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QIII;863.969
National Total;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QII;""
National Total;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QI;""
National Total;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QIV;856.691
National Total;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
National Total;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QII;""
National Total;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QI;""
National Total;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QIV;869.496
National Total;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
National Total;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QII;""
National Total;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QI;""
National Total;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QIV;844.153
National Total;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
National Total;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QII;""
National Total;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QI;""
National Total;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
National Total;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
National Total;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
National Total;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
National Total;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
National Total;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
National Total;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
National Total;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
National Total;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
National Total;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
National Total;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
National Total;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
National Total;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
National Total;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
National Total;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
National Total;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;97,06
National Total;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
National Total;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
National Total;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
National Total;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;97,79
National Total;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
National Total;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
National Total;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
National Total;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;94
National Total;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
National Total;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
National Total;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;94,24
National Total;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
National Total;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
National Total;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
National Total;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;95,44
National Total;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
National Total;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
National Total;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
National Total;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;92,3
National Total;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
National Total;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
National Total;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;92,04
National Total;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
National Total;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
National Total;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
National Total;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;93,48
National Total;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
National Total;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
National Total;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
National Total;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;90,21
National Total;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
National Total;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
National Total;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;89,65
National Total;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
National Total;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
National Total;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
National Total;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;91,31
National Total;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
National Total;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
National Total;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
National Total;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;88,14
National Total;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
National Total;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
National Total;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
National Total;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
National Total;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
National Total;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
National Total;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QI;607.355
National Total;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
National Total;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
National Total;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
National Total;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QI;610.203
National Total;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
National Total;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
National Total;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
National Total;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QI;612.456
National Total;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
National Total;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
National Total;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2022QII;""
National Total;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2022QI;590.658
National Total;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
National Total;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
National Total;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2021QII;""
National Total;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2021QI;597.270
National Total;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
National Total;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
National Total;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2020QII;""
National Total;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2020QI;578.378
National Total;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
National Total;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
National Total;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2022QII;575.438
National Total;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2022QI;""
National Total;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
National Total;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
National Total;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2021QII;584.085
National Total;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2021QI;""
National Total;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
National Total;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
National Total;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2020QII;569.184
National Total;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2020QI;""
National Total;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
National Total;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QIII;563.306
National Total;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QII;""
National Total;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QI;""
National Total;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
National Total;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QIII;572.852
National Total;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QII;""
National Total;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QI;""
National Total;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
National Total;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QIII;557.600
National Total;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QII;""
National Total;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QI;""
National Total;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QIV;549.715
National Total;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
National Total;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QII;""
National Total;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QI;""
National Total;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QIV;560.205
National Total;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
National Total;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QII;""
National Total;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QI;""
National Total;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QIV;545.781
National Total;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
National Total;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QII;""
National Total;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QI;""
National Total;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
National Total;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
National Total;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
National Total;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
National Total;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
National Total;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
National Total;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
National Total;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
National Total;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
National Total;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
National Total;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
National Total;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
National Total;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
National Total;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
National Total;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
National Total;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;97,25
National Total;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
National Total;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
National Total;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
National Total;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;97,88
National Total;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
National Total;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
National Total;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
National Total;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;94,44
National Total;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
National Total;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
National Total;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;94,74
National Total;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
National Total;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
National Total;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
National Total;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;95,72
National Total;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
National Total;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
National Total;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
National Total;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;92,93
National Total;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
National Total;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
National Total;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;92,75
National Total;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
National Total;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
National Total;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
National Total;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;93,88
National Total;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
National Total;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
National Total;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
National Total;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;91,04
National Total;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
National Total;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
National Total;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;90,51
National Total;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
National Total;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
National Total;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
National Total;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;91,81
National Total;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
National Total;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
National Total;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
National Total;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;89,11
National Total;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
National Total;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
National Total;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
National Total;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
National Total;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
National Total;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
National Total;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QI;348.243
National Total;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
National Total;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
National Total;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
National Total;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QI;342.071
National Total;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
National Total;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
National Total;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
National Total;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QI;345.291
National Total;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
National Total;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
National Total;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2022QII;""
National Total;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2022QI;336.802
National Total;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
National Total;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
National Total;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2021QII;""
National Total;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2021QI;334.001
National Total;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
National Total;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
National Total;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2020QII;""
National Total;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2020QI;321.898
National Total;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
National Total;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
National Total;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2022QII;325.104
National Total;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2022QI;""
National Total;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
National Total;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
National Total;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2021QII;324.728
National Total;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2021QI;""
National Total;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
National Total;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
National Total;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2020QII;314.786
National Total;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2020QI;""
National Total;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
National Total;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QIII;316.271
National Total;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QII;""
National Total;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QI;""
National Total;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
National Total;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QIII;317.326
National Total;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QII;""
National Total;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QI;""
National Total;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
National Total;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QIII;306.369
National Total;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QII;""
National Total;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QI;""
National Total;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QIV;306.976
National Total;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
National Total;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QII;""
National Total;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QI;""
National Total;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QIV;309.291
National Total;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
National Total;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QII;""
National Total;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QI;""
National Total;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QIV;298.372
National Total;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
National Total;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QII;""
National Total;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QI;""
National Total;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
National Total;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
National Total;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
National Total;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
National Total;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
National Total;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
National Total;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
National Total;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
National Total;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
National Total;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
National Total;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
National Total;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
National Total;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
National Total;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
National Total;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
National Total;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;96,71
National Total;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
National Total;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
National Total;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
National Total;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;97,64
National Total;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
National Total;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
National Total;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
National Total;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;93,23
National Total;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
National Total;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
National Total;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;93,36
National Total;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
National Total;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
National Total;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
National Total;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;94,93
National Total;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
National Total;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
National Total;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
National Total;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;91,17
National Total;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
National Total;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
National Total;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;90,82
National Total;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
National Total;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
National Total;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
National Total;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;92,77
National Total;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
National Total;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
National Total;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
National Total;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;88,73
National Total;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
National Total;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
National Total;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;88,15
National Total;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
National Total;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
National Total;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
National Total;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;90,42
National Total;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
National Total;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
National Total;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
National Total;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;86,41
National Total;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
National Total;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
National Total;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
National Total;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
National Total;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
National Total;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QII;937.068
National Total;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
National Total;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
National Total;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
National Total;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QII;942.311
National Total;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
National Total;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
National Total;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
National Total;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QII;938.218
National Total;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
National Total;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
National Total;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
National Total;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2022QII;906.849
National Total;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2022QI;""
National Total;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
National Total;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
National Total;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2021QII;916.602
National Total;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2021QI;""
National Total;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
National Total;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
National Total;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2020QII;919.803
National Total;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2020QI;""
National Total;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
National Total;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2022QIII;883.557
National Total;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2022QII;""
National Total;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2022QI;""
National Total;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
National Total;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2021QIII;895.619
National Total;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2021QII;""
National Total;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2021QI;""
National Total;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
National Total;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2020QIII;896.953
National Total;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2020QII;""
National Total;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2020QI;""
National Total;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QIV;858.120
National Total;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
National Total;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QII;""
National Total;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QI;""
National Total;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QIV;872.521
National Total;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
National Total;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QII;""
National Total;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QI;""
National Total;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QIV;874.793
National Total;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
National Total;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QII;""
National Total;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QI;""
National Total;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
National Total;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
National Total;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QII;""
National Total;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QI;851.256
National Total;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
National Total;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
National Total;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QII;""
National Total;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QI;859.509
National Total;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
National Total;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
National Total;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QII;""
National Total;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QI;""
National Total;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
National Total;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
National Total;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
National Total;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
National Total;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
National Total;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
National Total;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
National Total;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
National Total;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
National Total;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
National Total;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
National Total;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
National Total;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
National Total;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
National Total;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;96,78
National Total;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
National Total;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
National Total;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
National Total;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;97,27
National Total;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
National Total;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
National Total;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
National Total;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;98,04
National Total;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
National Total;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
National Total;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;94,29
National Total;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
National Total;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
National Total;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
National Total;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;95,04
National Total;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
National Total;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
National Total;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
National Total;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;95,6
National Total;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
National Total;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
National Total;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;91,57
National Total;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
National Total;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
National Total;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
National Total;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;92,59
National Total;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
National Total;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
National Total;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
National Total;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;93,24
National Total;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
National Total;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
National Total;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
National Total;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
National Total;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
National Total;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
National Total;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;90,34
National Total;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
National Total;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
National Total;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
National Total;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;91,61
National Total;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
National Total;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
National Total;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
National Total;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
National Total;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
National Total;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
National Total;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QII;592.966
National Total;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
National Total;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
National Total;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
National Total;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QII;601.852
National Total;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
National Total;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
National Total;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
National Total;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QII;600.888
National Total;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
National Total;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
National Total;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
National Total;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2022QII;575.764
National Total;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2022QI;""
National Total;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
National Total;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
National Total;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2021QII;586.584
National Total;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2021QI;""
National Total;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
National Total;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
National Total;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2020QII;590.404
National Total;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2020QI;""
National Total;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
National Total;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2022QIII;562.264
National Total;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2022QII;""
National Total;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2022QI;""
National Total;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
National Total;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2021QIII;573.852
National Total;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2021QII;""
National Total;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2021QI;""
National Total;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
National Total;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2020QIII;577.022
National Total;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2020QII;""
National Total;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2020QI;""
National Total;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QIV;547.196
National Total;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
National Total;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QII;""
National Total;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QI;""
National Total;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QIV;559.730
National Total;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
National Total;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QII;""
National Total;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QI;""
National Total;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QIV;563.834
National Total;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
National Total;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QII;""
National Total;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QI;""
National Total;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
National Total;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
National Total;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QII;""
National Total;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QI;547.244
National Total;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
National Total;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
National Total;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QII;""
National Total;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QI;554.543
National Total;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
National Total;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
National Total;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QII;""
National Total;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QI;""
National Total;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
National Total;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
National Total;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
National Total;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
National Total;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
National Total;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
National Total;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
National Total;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
National Total;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
National Total;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
National Total;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
National Total;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
National Total;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
National Total;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
National Total;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;97,1
National Total;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
National Total;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
National Total;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
National Total;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;97,46
National Total;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
National Total;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
National Total;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
National Total;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;98,26
National Total;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
National Total;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
National Total;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;94,82
National Total;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
National Total;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
National Total;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
National Total;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;95,35
National Total;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
National Total;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
National Total;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
National Total;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;96,03
National Total;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
National Total;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
National Total;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;92,28
National Total;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
National Total;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
National Total;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
National Total;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;93
National Total;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
National Total;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
National Total;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
National Total;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;93,83
National Total;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
National Total;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
National Total;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
National Total;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
National Total;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
National Total;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
National Total;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;90,93
National Total;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
National Total;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
National Total;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
National Total;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;92,29
National Total;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
National Total;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
National Total;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
National Total;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
National Total;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
National Total;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
National Total;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QII;344.102
National Total;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
National Total;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
National Total;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
National Total;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QII;340.459
National Total;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
National Total;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
National Total;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
National Total;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QII;337.330
National Total;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
National Total;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
National Total;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
National Total;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2022QII;331.085
National Total;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2022QI;""
National Total;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
National Total;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
National Total;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2021QII;330.018
National Total;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2021QI;""
National Total;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
National Total;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
National Total;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2020QII;329.399
National Total;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2020QI;""
National Total;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
National Total;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2022QIII;321.293
National Total;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2022QII;""
National Total;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2022QI;""
National Total;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
National Total;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2021QIII;321.767
National Total;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2021QII;""
National Total;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2021QI;""
National Total;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
National Total;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2020QIII;319.931
National Total;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2020QII;""
National Total;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2020QI;""
National Total;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QIV;310.924
National Total;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
National Total;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QII;""
National Total;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QI;""
National Total;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QIV;312.791
National Total;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
National Total;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QII;""
National Total;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QI;""
National Total;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QIV;310.959
National Total;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
National Total;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QII;""
National Total;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QI;""
National Total;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
National Total;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
National Total;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QII;""
National Total;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QI;304.012
National Total;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
National Total;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
National Total;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QII;""
National Total;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QI;304.966
National Total;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
National Total;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
National Total;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QII;""
National Total;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QI;""
National Total;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
National Total;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
National Total;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
National Total;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
National Total;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
National Total;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
National Total;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
National Total;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
National Total;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
National Total;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
National Total;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
National Total;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
National Total;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
National Total;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
National Total;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;96,22
National Total;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
National Total;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
National Total;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
National Total;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;96,93
National Total;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
National Total;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
National Total;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
National Total;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;97,65
National Total;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
National Total;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
National Total;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;93,37
National Total;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
National Total;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
National Total;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
National Total;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;94,51
National Total;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
National Total;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
National Total;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
National Total;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;94,84
National Total;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
National Total;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
National Total;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;90,36
National Total;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
National Total;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
National Total;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
National Total;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;91,87
National Total;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
National Total;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
National Total;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
National Total;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;92,18
National Total;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
National Total;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
National Total;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
National Total;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
National Total;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
National Total;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
National Total;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;89,29
National Total;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
National Total;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
National Total;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
National Total;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;90,41
National Total;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
National Total;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
National Total;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
National Total;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
National Total;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
National Total;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QIII;942.176
National Total;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
National Total;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
National Total;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
National Total;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QIII;952.523
National Total;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
National Total;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
National Total;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
National Total;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QIII;947.899
National Total;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
National Total;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
National Total;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
National Total;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2022QIII;913.860
National Total;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2022QII;""
National Total;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2022QI;""
National Total;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
National Total;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2021QIII;926.973
National Total;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2021QII;""
National Total;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2021QI;""
National Total;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
National Total;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2020QIII;921.053
National Total;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2020QII;""
National Total;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2020QI;""
National Total;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2022QIV;883.890
National Total;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
National Total;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2022QII;""
National Total;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2022QI;""
National Total;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2021QIV;899.800
National Total;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
National Total;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2021QII;""
National Total;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2021QI;""
National Total;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2020QIV;896.194
National Total;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
National Total;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2020QII;""
National Total;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2020QI;""
National Total;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
National Total;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
National Total;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QII;""
National Total;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QI;876.690
National Total;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
National Total;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
National Total;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QII;""
National Total;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QI;879.837
National Total;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
National Total;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
National Total;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QII;""
National Total;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QI;""
National Total;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
National Total;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
National Total;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QII;854.796
National Total;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QI;""
National Total;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
National Total;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
National Total;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QII;862.040
National Total;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QI;""
National Total;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
National Total;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
National Total;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QII;""
National Total;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QI;""
National Total;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
National Total;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
National Total;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
National Total;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
National Total;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
National Total;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
National Total;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
National Total;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
National Total;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
National Total;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
National Total;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
National Total;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
National Total;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
National Total;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;96,99
National Total;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
National Total;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
National Total;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
National Total;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;97,32
National Total;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
National Total;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
National Total;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
National Total;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;97,17
National Total;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
National Total;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
National Total;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;93,81
National Total;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
National Total;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
National Total;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
National Total;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;94,46
National Total;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
National Total;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
National Total;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
National Total;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;94,55
National Total;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
National Total;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
National Total;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
National Total;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
National Total;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
National Total;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
National Total;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;92,04
National Total;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
National Total;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
National Total;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
National Total;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;92,82
National Total;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
National Total;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
National Total;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
National Total;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
National Total;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
National Total;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
National Total;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;89,74
National Total;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
National Total;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
National Total;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
National Total;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;90,94
National Total;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
National Total;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
National Total;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
National Total;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
National Total;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
National Total;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
National Total;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QIII;596.025
National Total;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
National Total;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
National Total;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
National Total;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QIII;607.775
National Total;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
National Total;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
National Total;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
National Total;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QIII;608.366
National Total;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
National Total;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
National Total;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
National Total;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2022QIII;579.599
National Total;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2022QII;""
National Total;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2022QI;""
National Total;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
National Total;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2021QIII;592.323
National Total;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2021QII;""
National Total;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2021QI;""
National Total;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
National Total;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2020QIII;592.446
National Total;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2020QII;""
National Total;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2020QI;""
National Total;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2022QIV;561.879
National Total;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
National Total;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2022QII;""
National Total;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2022QI;""
National Total;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2021QIV;575.742
National Total;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
National Total;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2021QII;""
National Total;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2021QI;""
National Total;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2020QIV;577.512
National Total;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
National Total;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2020QII;""
National Total;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2020QI;""
National Total;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
National Total;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
National Total;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QII;""
National Total;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QI;562.131
National Total;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
National Total;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
National Total;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QII;""
National Total;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QI;567.524
National Total;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
National Total;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
National Total;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QII;""
National Total;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QI;""
National Total;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
National Total;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
National Total;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QII;549.527
National Total;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QI;""
National Total;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
National Total;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
National Total;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QII;556.978
National Total;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QI;""
National Total;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
National Total;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
National Total;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QII;""
National Total;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QI;""
National Total;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
National Total;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
National Total;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
National Total;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
National Total;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
National Total;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
National Total;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
National Total;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
National Total;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
National Total;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
National Total;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
National Total;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
National Total;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
National Total;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;97,24
National Total;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
National Total;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
National Total;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
National Total;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;97,46
National Total;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
National Total;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
National Total;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
National Total;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;97,38
National Total;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
National Total;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
National Total;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;94,27
National Total;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
National Total;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
National Total;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
National Total;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;94,73
National Total;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
National Total;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
National Total;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
National Total;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;94,93
National Total;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
National Total;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
National Total;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
National Total;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
National Total;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
National Total;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
National Total;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;92,49
National Total;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
National Total;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
National Total;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
National Total;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;93,29
National Total;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
National Total;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
National Total;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
National Total;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
National Total;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
National Total;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
National Total;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;90,42
National Total;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
National Total;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
National Total;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
National Total;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;91,55
National Total;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
National Total;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
National Total;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
National Total;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
National Total;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
National Total;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
National Total;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QIII;346.151
National Total;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
National Total;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
National Total;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
National Total;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QIII;344.748
National Total;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
National Total;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
National Total;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
National Total;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QIII;339.533
National Total;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
National Total;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
National Total;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
National Total;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2022QIII;334.261
National Total;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2022QII;""
National Total;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2022QI;""
National Total;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
National Total;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2021QIII;334.650
National Total;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2021QII;""
National Total;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2021QI;""
National Total;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
National Total;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2020QIII;328.607
National Total;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2020QII;""
National Total;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2020QI;""
National Total;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2022QIV;322.011
National Total;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
National Total;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2022QII;""
National Total;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2022QI;""
National Total;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2021QIV;324.058
National Total;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
National Total;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2021QII;""
National Total;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2021QI;""
National Total;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2020QIV;318.682
National Total;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
National Total;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2020QII;""
National Total;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2020QI;""
National Total;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
National Total;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
National Total;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QII;""
National Total;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QI;314.559
National Total;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
National Total;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
National Total;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QII;""
National Total;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QI;312.313
National Total;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
National Total;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
National Total;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QII;""
National Total;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QI;""
National Total;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
National Total;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
National Total;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QII;305.269
National Total;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QI;""
National Total;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
National Total;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
National Total;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QII;305.062
National Total;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QI;""
National Total;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
National Total;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
National Total;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QII;""
National Total;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QI;""
National Total;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
National Total;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
National Total;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
National Total;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
National Total;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
National Total;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
National Total;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
National Total;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
National Total;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
National Total;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
National Total;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
National Total;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
National Total;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
National Total;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;96,57
National Total;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
National Total;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
National Total;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
National Total;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;97,07
National Total;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
National Total;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
National Total;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
National Total;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;96,78
National Total;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
National Total;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
National Total;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;93,03
National Total;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
National Total;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
National Total;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
National Total;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;94
National Total;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
National Total;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
National Total;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
National Total;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;93,86
National Total;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
National Total;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
National Total;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
National Total;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
National Total;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
National Total;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
National Total;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;91,24
National Total;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
National Total;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
National Total;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
National Total;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;91,98
National Total;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
National Total;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
National Total;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
National Total;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
National Total;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
National Total;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
National Total;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;88,55
National Total;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
National Total;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
National Total;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
National Total;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;89,85
National Total;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
National Total;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
National Total;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
National Total;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
National Total;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
National Total;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QIV;940.434
National Total;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
National Total;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
National Total;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
National Total;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QIV;954.786
National Total;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
National Total;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
National Total;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
National Total;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QIV;950.501
National Total;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
National Total;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
National Total;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
National Total;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2022QIV;907.302
National Total;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
National Total;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2022QII;""
National Total;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2022QI;""
National Total;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2021QIV;924.236
National Total;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
National Total;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2021QII;""
National Total;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2021QI;""
National Total;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2020QIV;921.815
National Total;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
National Total;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2020QII;""
National Total;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2020QI;""
National Total;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
National Total;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
National Total;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2022QII;""
National Total;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2022QI;899.371
National Total;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
National Total;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
National Total;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2021QII;""
National Total;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2021QI;903.737
National Total;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
National Total;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
National Total;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2020QII;""
National Total;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2020QI;""
National Total;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
National Total;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
National Total;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QII;875.512
National Total;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QI;""
National Total;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
National Total;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
National Total;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QII;884.111
National Total;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QI;""
National Total;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
National Total;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
National Total;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QII;""
National Total;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QI;""
National Total;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
National Total;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QIII;856.220
National Total;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QII;""
National Total;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QI;""
National Total;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
National Total;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QIII;867.142
National Total;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QII;""
National Total;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QI;""
National Total;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
National Total;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
National Total;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QII;""
National Total;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QI;""
National Total;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
National Total;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
National Total;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
National Total;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
National Total;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
National Total;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
National Total;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
National Total;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
National Total;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
National Total;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
National Total;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
National Total;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
National Total;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;96,48
National Total;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
National Total;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
National Total;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
National Total;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;96,8
National Total;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
National Total;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
National Total;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
National Total;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;96,98
National Total;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
National Total;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
National Total;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
National Total;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
National Total;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
National Total;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
National Total;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;94,2
National Total;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
National Total;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
National Total;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
National Total;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;95,08
National Total;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
National Total;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
National Total;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
National Total;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
National Total;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
National Total;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
National Total;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;91,7
National Total;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
National Total;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
National Total;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
National Total;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;93,02
National Total;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
National Total;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
National Total;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
National Total;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
National Total;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
National Total;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
National Total;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;89,68
National Total;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
National Total;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
National Total;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
National Total;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;91,23
National Total;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
National Total;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
National Total;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
National Total;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
National Total;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
National Total;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
National Total;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QIV;594.620
National Total;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
National Total;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
National Total;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
National Total;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QIV;608.470
National Total;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
National Total;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
National Total;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
National Total;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QIV;609.912
National Total;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
National Total;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
National Total;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
National Total;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2022QIV;574.992
National Total;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
National Total;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2022QII;""
National Total;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2022QI;""
National Total;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2021QIV;589.805
National Total;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
National Total;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2021QII;""
National Total;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2021QI;""
National Total;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2020QIV;592.630
National Total;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
National Total;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2020QII;""
National Total;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2020QI;""
National Total;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
National Total;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
National Total;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2022QII;""
National Total;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2022QI;575.094
National Total;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
National Total;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
National Total;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2021QII;""
National Total;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2021QI;581.551
National Total;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
National Total;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
National Total;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2020QII;""
National Total;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2020QI;""
National Total;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
National Total;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
National Total;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QII;561.449
National Total;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QI;""
National Total;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
National Total;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
National Total;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QII;569.955
National Total;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QI;""
National Total;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
National Total;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
National Total;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QII;""
National Total;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QI;""
National Total;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
National Total;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QIII;550.258
National Total;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QII;""
National Total;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QI;""
National Total;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
National Total;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QIII;559.724
National Total;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QII;""
National Total;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QI;""
National Total;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
National Total;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
National Total;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QII;""
National Total;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QI;""
National Total;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
National Total;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
National Total;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
National Total;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
National Total;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
National Total;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
National Total;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
National Total;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
National Total;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
National Total;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
National Total;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
National Total;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
National Total;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;96,7
National Total;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
National Total;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
National Total;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
National Total;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;96,93
National Total;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
National Total;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
National Total;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
National Total;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;97,17
National Total;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
National Total;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
National Total;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
National Total;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
National Total;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
National Total;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
National Total;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;94,51
National Total;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
National Total;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
National Total;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
National Total;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;95,35
National Total;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
National Total;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
National Total;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
National Total;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
National Total;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
National Total;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
National Total;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;92,27
National Total;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
National Total;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
National Total;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
National Total;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;93,45
National Total;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
National Total;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
National Total;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
National Total;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
National Total;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
National Total;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
National Total;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;90,43
National Total;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
National Total;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
National Total;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
National Total;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;91,77
National Total;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
National Total;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
National Total;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
National Total;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
National Total;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
National Total;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
National Total;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QIV;345.814
National Total;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
National Total;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
National Total;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
National Total;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QIV;346.316
National Total;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
National Total;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
National Total;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
National Total;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QIV;340.589
National Total;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
National Total;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
National Total;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
National Total;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2022QIV;332.310
National Total;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
National Total;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2022QII;""
National Total;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2022QI;""
National Total;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2021QIV;334.431
National Total;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
National Total;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2021QII;""
National Total;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2021QI;""
National Total;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2020QIV;329.185
National Total;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
National Total;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2020QII;""
National Total;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2020QI;""
National Total;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
National Total;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
National Total;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2022QII;""
National Total;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2022QI;324.277
National Total;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
National Total;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
National Total;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2021QII;""
National Total;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2021QI;322.186
National Total;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
National Total;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
National Total;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2020QII;""
National Total;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2020QI;""
National Total;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
National Total;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
National Total;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QII;314.063
National Total;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QI;""
National Total;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
National Total;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
National Total;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QII;314.156
National Total;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QI;""
National Total;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
National Total;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
National Total;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QII;""
National Total;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QI;""
National Total;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
National Total;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QIII;305.962
National Total;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QII;""
National Total;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QI;""
National Total;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
National Total;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QIII;307.418
National Total;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QII;""
National Total;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QI;""
National Total;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
National Total;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
National Total;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QII;""
National Total;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QI;""
National Total;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
National Total;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
National Total;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
National Total;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
National Total;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
National Total;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
National Total;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
National Total;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
National Total;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
National Total;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
National Total;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
National Total;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
National Total;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;96,1
National Total;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
National Total;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
National Total;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
National Total;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;96,57
National Total;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
National Total;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
National Total;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
National Total;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;96,65
National Total;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
National Total;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
National Total;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
National Total;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
National Total;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
National Total;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
National Total;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;93,64
National Total;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
National Total;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
National Total;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
National Total;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;94,6
National Total;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
National Total;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
National Total;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
National Total;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
National Total;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
National Total;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
National Total;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;90,69
National Total;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
National Total;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
National Total;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
National Total;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;92,24
National Total;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
National Total;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
National Total;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
National Total;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
National Total;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
National Total;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
National Total;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;88,35
National Total;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
National Total;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
National Total;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
National Total;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;90,26
National Total;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
National Total;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
National Total;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
National Total;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
National Total;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
National Total;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
National Total;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
National Total;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
National Total;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
National Total;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QI;884.556
National Total;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
National Total;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
National Total;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
National Total;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QI;859.507
National Total;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
National Total;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
National Total;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
National Total;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QI;877.549
National Total;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
National Total;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
National Total;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2022QII;""
National Total;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2022QI;864.604
National Total;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
National Total;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
National Total;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2021QII;""
National Total;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2021QI;844.454
National Total;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
National Total;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
National Total;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2020QII;""
National Total;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2020QI;837.119
National Total;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
National Total;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
National Total;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2022QII;845.228
National Total;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2022QI;""
National Total;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
National Total;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
National Total;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2021QII;828.681
National Total;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2021QI;""
National Total;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
National Total;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
National Total;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2020QII;824.923
National Total;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2020QI;""
National Total;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
National Total;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QIII;829.799
National Total;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QII;""
National Total;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QI;""
National Total;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
National Total;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QIII;815.652
National Total;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QII;""
National Total;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QI;""
National Total;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
National Total;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QIII;810.136
National Total;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QII;""
National Total;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QI;""
National Total;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QIV;811.874
National Total;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
National Total;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QII;""
National Total;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QI;""
National Total;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QIV;800.689
National Total;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
National Total;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QII;""
National Total;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QI;""
National Total;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QIV;795.534
National Total;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
National Total;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QII;""
National Total;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QI;""
National Total;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
National Total;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
National Total;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
National Total;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
National Total;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
National Total;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
National Total;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
National Total;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
National Total;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
National Total;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
National Total;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
National Total;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
National Total;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
National Total;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
National Total;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
National Total;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;97,74
National Total;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
National Total;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
National Total;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
National Total;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;98,25
National Total;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
National Total;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
National Total;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
National Total;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;95,39
National Total;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
National Total;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
National Total;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;95,55
National Total;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
National Total;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
National Total;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
National Total;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;96,41
National Total;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
National Total;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
National Total;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
National Total;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;94
National Total;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
National Total;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
National Total;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;93,81
National Total;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
National Total;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
National Total;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
National Total;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;94,9
National Total;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
National Total;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
National Total;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
National Total;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;92,32
National Total;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
National Total;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
National Total;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;91,78
National Total;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
National Total;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
National Total;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
National Total;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;93,16
National Total;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
National Total;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
National Total;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
National Total;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;90,65
National Total;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
National Total;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
National Total;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
National Total;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
National Total;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
National Total;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
National Total;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QI;569.638
National Total;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
National Total;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
National Total;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
National Total;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QI;556.014
National Total;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
National Total;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
National Total;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
National Total;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QI;566.720
National Total;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
National Total;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
National Total;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2022QII;""
National Total;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2022QI;557.473
National Total;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
National Total;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
National Total;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2021QII;""
National Total;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2021QI;546.791
National Total;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
National Total;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
National Total;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2020QII;""
National Total;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2020QI;542.289
National Total;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
National Total;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
National Total;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2022QII;546.312
National Total;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2022QI;""
National Total;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
National Total;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
National Total;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2021QII;537.423
National Total;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2021QI;""
National Total;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
National Total;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
National Total;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2020QII;535.184
National Total;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2020QI;""
National Total;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
National Total;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QIII;537.181
National Total;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QII;""
National Total;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QI;""
National Total;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
National Total;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QIII;529.473
National Total;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QII;""
National Total;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QI;""
National Total;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
National Total;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QIII;526.525
National Total;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QII;""
National Total;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QI;""
National Total;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QIV;526.508
National Total;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
National Total;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QII;""
National Total;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QI;""
National Total;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QIV;520.312
National Total;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
National Total;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QII;""
National Total;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QI;""
National Total;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QIV;517.649
National Total;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
National Total;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QII;""
National Total;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QI;""
National Total;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
National Total;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
National Total;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
National Total;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
National Total;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
National Total;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
National Total;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
National Total;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
National Total;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
National Total;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
National Total;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
National Total;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
National Total;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
National Total;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
National Total;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
National Total;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;97,86
National Total;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
National Total;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
National Total;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
National Total;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;98,34
National Total;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
National Total;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
National Total;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
National Total;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;95,69
National Total;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
National Total;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
National Total;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;95,91
National Total;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
National Total;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
National Total;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
National Total;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;96,66
National Total;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
National Total;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
National Total;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
National Total;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;94,44
National Total;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
National Total;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
National Total;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;94,3
National Total;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
National Total;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
National Total;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
National Total;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;95,23
National Total;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
National Total;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
National Total;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
National Total;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;92,91
National Total;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
National Total;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
National Total;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;92,43
National Total;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
National Total;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
National Total;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
National Total;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;93,58
National Total;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
National Total;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
National Total;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
National Total;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;91,34
National Total;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
National Total;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
National Total;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
National Total;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
National Total;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
National Total;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
National Total;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QI;314.918
National Total;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
National Total;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
National Total;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
National Total;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QI;303.493
National Total;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
National Total;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
National Total;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
National Total;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QI;310.829
National Total;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
National Total;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
National Total;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2022QII;""
National Total;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2022QI;307.131
National Total;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
National Total;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
National Total;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2021QII;""
National Total;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2021QI;297.663
National Total;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
National Total;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
National Total;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2020QII;""
National Total;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2020QI;294.830
National Total;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
National Total;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
National Total;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2022QII;298.916
National Total;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2022QI;""
National Total;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
National Total;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
National Total;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2021QII;291.258
National Total;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2021QI;""
National Total;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
National Total;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
National Total;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2020QII;289.739
National Total;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2020QI;""
National Total;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
National Total;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QIII;292.618
National Total;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QII;""
National Total;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QI;""
National Total;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
National Total;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QIII;286.179
National Total;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QII;""
National Total;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QI;""
National Total;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
National Total;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QIII;283.611
National Total;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QII;""
National Total;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QI;""
National Total;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QIV;285.366
National Total;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
National Total;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QII;""
National Total;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QI;""
National Total;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QIV;280.377
National Total;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
National Total;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QII;""
National Total;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QI;""
National Total;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QIV;277.885
National Total;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
National Total;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QII;""
National Total;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QI;""
National Total;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
National Total;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
National Total;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
National Total;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
National Total;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
National Total;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
National Total;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
National Total;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
National Total;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
National Total;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
National Total;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
National Total;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
National Total;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
National Total;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
National Total;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
National Total;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;97,53
National Total;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
National Total;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
National Total;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
National Total;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;98,08
National Total;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
National Total;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
National Total;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
National Total;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;94,85
National Total;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
National Total;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
National Total;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;94,92
National Total;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
National Total;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
National Total;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
National Total;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;95,97
National Total;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
National Total;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
National Total;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
National Total;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;93,21
National Total;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
National Total;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
National Total;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;92,92
National Total;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
National Total;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
National Total;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
National Total;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;94,3
National Total;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
National Total;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
National Total;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
National Total;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;91,24
National Total;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
National Total;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
National Total;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;90,62
National Total;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
National Total;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
National Total;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
National Total;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;92,38
National Total;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
National Total;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
National Total;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
National Total;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;89,4
National Total;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
National Total;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
National Total;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
National Total;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
National Total;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
National Total;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QII;909.180
National Total;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
National Total;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
National Total;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
National Total;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QII;887.892
National Total;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
National Total;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
National Total;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
National Total;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QII;862.462
National Total;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
National Total;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
National Total;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
National Total;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2022QII;886.861
National Total;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2022QI;""
National Total;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
National Total;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
National Total;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2021QII;869.522
National Total;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2021QI;""
National Total;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
National Total;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
National Total;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2020QII;848.899
National Total;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2020QI;""
National Total;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
National Total;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2022QIII;869.366
National Total;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2022QII;""
National Total;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2022QI;""
National Total;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
National Total;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2021QIII;854.771
National Total;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2021QII;""
National Total;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2021QI;""
National Total;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
National Total;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2020QIII;831.387
National Total;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2020QII;""
National Total;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2020QI;""
National Total;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QIV;849.181
National Total;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
National Total;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QII;""
National Total;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QI;""
National Total;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QIV;837.769
National Total;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
National Total;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QII;""
National Total;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QI;""
National Total;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QIV;815.359
National Total;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
National Total;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QII;""
National Total;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QI;""
National Total;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
National Total;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
National Total;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QII;""
National Total;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QI;821.721
National Total;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
National Total;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
National Total;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QII;""
National Total;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QI;803.727
National Total;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
National Total;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
National Total;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QII;""
National Total;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QI;""
National Total;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
National Total;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
National Total;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
National Total;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
National Total;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
National Total;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
National Total;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
National Total;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
National Total;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
National Total;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
National Total;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
National Total;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
National Total;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
National Total;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
National Total;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;97,55
National Total;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
National Total;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
National Total;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
National Total;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;97,93
National Total;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
National Total;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
National Total;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
National Total;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;98,43
National Total;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
National Total;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
National Total;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;95,62
National Total;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
National Total;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
National Total;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
National Total;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;96,27
National Total;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
National Total;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
National Total;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
National Total;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;96,4
National Total;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
National Total;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
National Total;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;93,4
National Total;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
National Total;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
National Total;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
National Total;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;94,35
National Total;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
National Total;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
National Total;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
National Total;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;94,54
National Total;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
National Total;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
National Total;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
National Total;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
National Total;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
National Total;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
National Total;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;92,55
National Total;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
National Total;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
National Total;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
National Total;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;93,19
National Total;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
National Total;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
National Total;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
National Total;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
National Total;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
National Total;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
National Total;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QII;584.050
National Total;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
National Total;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
National Total;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
National Total;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QII;573.327
National Total;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
National Total;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
National Total;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
National Total;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QII;557.722
National Total;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
National Total;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
National Total;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
National Total;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2022QII;571.162
National Total;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2022QI;""
National Total;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
National Total;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
National Total;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2021QII;562.337
National Total;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2021QI;""
National Total;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
National Total;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
National Total;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2020QII;549.767
National Total;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2020QI;""
National Total;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
National Total;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2022QIII;560.789
National Total;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2022QII;""
National Total;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2022QI;""
National Total;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
National Total;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2021QIII;553.321
National Total;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2021QII;""
National Total;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2021QI;""
National Total;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
National Total;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2020QIII;539.214
National Total;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2020QII;""
National Total;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2020QI;""
National Total;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QIV;548.782
National Total;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
National Total;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QII;""
National Total;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QI;""
National Total;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QIV;542.909
National Total;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
National Total;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QII;""
National Total;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QI;""
National Total;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QIV;529.432
National Total;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
National Total;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QII;""
National Total;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QI;""
National Total;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
National Total;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
National Total;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QII;""
National Total;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QI;533.229
National Total;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
National Total;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
National Total;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QII;""
National Total;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QI;522.376
National Total;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
National Total;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
National Total;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QII;""
National Total;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QI;""
National Total;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
National Total;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
National Total;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
National Total;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
National Total;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
National Total;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
National Total;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
National Total;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
National Total;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
National Total;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
National Total;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
National Total;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
National Total;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
National Total;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
National Total;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;97,79
National Total;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
National Total;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
National Total;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
National Total;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;98,08
National Total;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
National Total;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
National Total;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
National Total;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;98,57
National Total;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
National Total;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
National Total;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;96,02
National Total;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
National Total;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
National Total;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
National Total;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;96,51
National Total;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
National Total;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
National Total;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
National Total;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;96,68
National Total;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
National Total;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
National Total;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;93,96
National Total;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
National Total;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
National Total;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
National Total;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;94,69
National Total;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
National Total;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
National Total;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
National Total;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;94,93
National Total;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
National Total;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
National Total;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
National Total;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
National Total;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
National Total;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
National Total;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;93,01
National Total;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
National Total;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
National Total;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
National Total;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;93,66
National Total;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
National Total;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
National Total;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
National Total;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
National Total;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
National Total;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
National Total;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QII;325.130
National Total;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
National Total;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
National Total;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
National Total;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QII;314.565
National Total;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
National Total;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
National Total;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
National Total;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QII;304.740
National Total;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
National Total;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
National Total;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
National Total;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2022QII;315.699
National Total;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2022QI;""
National Total;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
National Total;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
National Total;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2021QII;307.185
National Total;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2021QI;""
National Total;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
National Total;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
National Total;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2020QII;299.132
National Total;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2020QI;""
National Total;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
National Total;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2022QIII;308.577
National Total;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2022QII;""
National Total;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2022QI;""
National Total;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
National Total;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2021QIII;301.450
National Total;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2021QII;""
National Total;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2021QI;""
National Total;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
National Total;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2020QIII;292.173
National Total;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2020QII;""
National Total;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2020QI;""
National Total;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QIV;300.399
National Total;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
National Total;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QII;""
National Total;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QI;""
National Total;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QIV;294.860
National Total;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
National Total;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QII;""
National Total;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QI;""
National Total;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QIV;285.927
National Total;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
National Total;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QII;""
National Total;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QI;""
National Total;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
National Total;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
National Total;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QII;""
National Total;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QI;288.492
National Total;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
National Total;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
National Total;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QII;""
National Total;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QI;281.351
National Total;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
National Total;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
National Total;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QII;""
National Total;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QI;""
National Total;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
National Total;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
National Total;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
National Total;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
National Total;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
National Total;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
National Total;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
National Total;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
National Total;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
National Total;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
National Total;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
National Total;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
National Total;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
National Total;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
National Total;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;97,1
National Total;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
National Total;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
National Total;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
National Total;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;97,65
National Total;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
National Total;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
National Total;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
National Total;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;98,16
National Total;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
National Total;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
National Total;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;94,91
National Total;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
National Total;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
National Total;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
National Total;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;95,83
National Total;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
National Total;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
National Total;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
National Total;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;95,88
National Total;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
National Total;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
National Total;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;92,39
National Total;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
National Total;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
National Total;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
National Total;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;93,74
National Total;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
National Total;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
National Total;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
National Total;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;93,83
National Total;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
National Total;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
National Total;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
National Total;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
National Total;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
National Total;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
National Total;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;91,71
National Total;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
National Total;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
National Total;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
National Total;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;92,32
National Total;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
National Total;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
National Total;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
National Total;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
National Total;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
National Total;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QIII;909.069
National Total;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
National Total;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
National Total;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
National Total;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QIII;891.052
National Total;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
National Total;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
National Total;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
National Total;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QIII;866.169
National Total;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
National Total;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
National Total;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
National Total;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2022QIII;887.913
National Total;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2022QII;""
National Total;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2022QI;""
National Total;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
National Total;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2021QIII;873.138
National Total;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2021QII;""
National Total;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2021QI;""
National Total;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
National Total;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2020QIII;845.917
National Total;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2020QII;""
National Total;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2020QI;""
National Total;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2022QIV;864.374
National Total;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
National Total;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2022QII;""
National Total;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2022QI;""
National Total;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2021QIV;853.296
National Total;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
National Total;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2021QII;""
National Total;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2021QI;""
National Total;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2020QIV;827.982
National Total;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
National Total;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2020QII;""
National Total;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2020QI;""
National Total;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
National Total;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
National Total;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QII;""
National Total;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QI;836.306
National Total;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
National Total;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
National Total;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QII;""
National Total;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QI;815.703
National Total;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
National Total;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
National Total;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QII;""
National Total;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QI;""
National Total;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
National Total;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
National Total;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QII;820.091
National Total;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QI;""
National Total;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
National Total;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
National Total;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QII;802.573
National Total;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QI;""
National Total;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
National Total;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
National Total;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QII;""
National Total;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QI;""
National Total;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
National Total;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
National Total;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
National Total;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
National Total;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
National Total;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
National Total;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
National Total;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
National Total;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
National Total;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
National Total;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
National Total;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
National Total;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
National Total;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;97,67
National Total;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
National Total;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
National Total;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
National Total;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;97,99
National Total;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
National Total;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
National Total;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
National Total;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;97,66
National Total;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
National Total;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
National Total;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;95,08
National Total;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
National Total;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
National Total;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
National Total;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;95,76
National Total;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
National Total;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
National Total;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
National Total;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;95,59
National Total;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
National Total;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
National Total;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
National Total;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
National Total;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
National Total;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
National Total;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;93,86
National Total;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
National Total;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
National Total;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
National Total;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;94,17
National Total;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
National Total;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
National Total;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
National Total;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
National Total;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
National Total;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
National Total;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;92,04
National Total;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
National Total;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
National Total;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
National Total;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;92,66
National Total;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
National Total;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
National Total;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
National Total;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
National Total;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
National Total;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
National Total;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QIII;583.871
National Total;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
National Total;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
National Total;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
National Total;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QIII;574.876
National Total;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
National Total;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
National Total;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
National Total;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QIII;560.822
National Total;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
National Total;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
National Total;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
National Total;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2022QIII;571.410
National Total;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2022QII;""
National Total;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2022QI;""
National Total;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
National Total;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2021QIII;564.036
National Total;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2021QII;""
National Total;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2021QI;""
National Total;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
National Total;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2020QIII;548.605
National Total;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2020QII;""
National Total;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2020QI;""
National Total;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2022QIV;557.467
National Total;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
National Total;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2022QII;""
National Total;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2022QI;""
National Total;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2021QIV;551.921
National Total;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
National Total;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2021QII;""
National Total;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2021QI;""
National Total;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2020QIV;537.590
National Total;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
National Total;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2020QII;""
National Total;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2020QI;""
National Total;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
National Total;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
National Total;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QII;""
National Total;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QI;541.630
National Total;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
National Total;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
National Total;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QII;""
National Total;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QI;530.113
National Total;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
National Total;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
National Total;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QII;""
National Total;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QI;""
National Total;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
National Total;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
National Total;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QII;532.074
National Total;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QI;""
National Total;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
National Total;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
National Total;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QII;522.180
National Total;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QI;""
National Total;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
National Total;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
National Total;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QII;""
National Total;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QI;""
National Total;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
National Total;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
National Total;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
National Total;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
National Total;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
National Total;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
National Total;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
National Total;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
National Total;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
National Total;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
National Total;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
National Total;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
National Total;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
National Total;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;97,87
National Total;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
National Total;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
National Total;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
National Total;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;98,11
National Total;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
National Total;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
National Total;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
National Total;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;97,82
National Total;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
National Total;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
National Total;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;95,48
National Total;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
National Total;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
National Total;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
National Total;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;96,01
National Total;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
National Total;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
National Total;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
National Total;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;95,86
National Total;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
National Total;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
National Total;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
National Total;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
National Total;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
National Total;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
National Total;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;94,22
National Total;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
National Total;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
National Total;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
National Total;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;94,52
National Total;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
National Total;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
National Total;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
National Total;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
National Total;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
National Total;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
National Total;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;92,55
National Total;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
National Total;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
National Total;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
National Total;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;93,11
National Total;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
National Total;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
National Total;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
National Total;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
National Total;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
National Total;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
National Total;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QIII;325.198
National Total;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
National Total;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
National Total;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
National Total;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QIII;316.176
National Total;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
National Total;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
National Total;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
National Total;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QIII;305.347
National Total;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
National Total;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
National Total;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
National Total;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2022QIII;316.503
National Total;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2022QII;""
National Total;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2022QI;""
National Total;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
National Total;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2021QIII;309.102
National Total;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2021QII;""
National Total;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2021QI;""
National Total;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
National Total;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2020QIII;297.312
National Total;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2020QII;""
National Total;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2020QI;""
National Total;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2022QIV;306.907
National Total;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
National Total;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2022QII;""
National Total;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2022QI;""
National Total;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2021QIV;301.375
National Total;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
National Total;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2021QII;""
National Total;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2021QI;""
National Total;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2020QIV;290.392
National Total;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
National Total;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2020QII;""
National Total;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2020QI;""
National Total;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
National Total;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
National Total;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QII;""
National Total;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QI;294.676
National Total;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
National Total;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
National Total;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QII;""
National Total;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QI;285.590
National Total;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
National Total;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
National Total;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QII;""
National Total;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QI;""
National Total;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
National Total;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
National Total;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QII;288.017
National Total;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QI;""
National Total;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
National Total;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
National Total;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QII;280.393
National Total;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QI;""
National Total;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
National Total;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
National Total;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QII;""
National Total;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QI;""
National Total;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
National Total;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
National Total;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
National Total;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
National Total;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
National Total;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
National Total;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
National Total;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
National Total;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
National Total;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
National Total;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
National Total;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
National Total;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
National Total;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;97,33
National Total;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
National Total;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
National Total;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
National Total;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;97,76
National Total;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
National Total;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
National Total;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
National Total;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;97,37
National Total;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
National Total;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
National Total;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;94,38
National Total;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
National Total;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
National Total;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
National Total;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;95,32
National Total;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
National Total;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
National Total;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
National Total;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;95,1
National Total;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
National Total;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
National Total;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
National Total;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
National Total;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
National Total;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
National Total;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;93,2
National Total;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
National Total;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
National Total;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
National Total;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;93,53
National Total;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
National Total;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
National Total;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
National Total;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
National Total;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
National Total;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
National Total;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;91,09
National Total;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
National Total;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
National Total;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
National Total;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;91,83
National Total;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
National Total;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
National Total;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
National Total;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
National Total;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
National Total;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QIV;903.694
National Total;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
National Total;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
National Total;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
National Total;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QIV;888.774
National Total;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
National Total;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
National Total;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
National Total;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QIV;863.213
National Total;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
National Total;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
National Total;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
National Total;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2022QIV;878.067
National Total;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
National Total;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2022QII;""
National Total;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2022QI;""
National Total;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2021QIV;866.817
National Total;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
National Total;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2021QII;""
National Total;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2021QI;""
National Total;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2020QIV;842.709
National Total;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
National Total;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2020QII;""
National Total;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2020QI;""
National Total;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
National Total;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
National Total;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2022QII;""
National Total;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2022QI;848.800
National Total;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
National Total;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
National Total;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2021QII;""
National Total;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2021QI;829.357
National Total;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
National Total;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
National Total;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2020QII;""
National Total;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2020QI;""
National Total;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
National Total;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
National Total;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QII;831.433
National Total;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QI;""
National Total;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
National Total;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
National Total;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QII;815.205
National Total;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QI;""
National Total;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
National Total;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
National Total;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QII;""
National Total;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QI;""
National Total;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
National Total;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QIII;816.964
National Total;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QII;""
National Total;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QI;""
National Total;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
National Total;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QIII;803.074
National Total;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QII;""
National Total;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QI;""
National Total;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
National Total;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
National Total;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QII;""
National Total;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QI;""
National Total;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
National Total;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
National Total;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
National Total;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
National Total;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
National Total;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
National Total;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
National Total;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
National Total;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
National Total;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
National Total;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
National Total;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
National Total;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;97,16
National Total;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
National Total;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
National Total;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
National Total;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;97,53
National Total;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
National Total;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
National Total;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
National Total;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;97,62
National Total;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
National Total;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
National Total;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
National Total;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
National Total;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
National Total;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
National Total;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;95,5
National Total;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
National Total;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
National Total;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
National Total;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;96,08
National Total;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
National Total;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
National Total;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
National Total;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
National Total;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
National Total;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
National Total;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;93,55
National Total;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
National Total;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
National Total;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
National Total;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;94,44
National Total;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
National Total;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
National Total;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
National Total;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
National Total;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
National Total;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
National Total;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;91,92
National Total;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
National Total;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
National Total;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
National Total;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;93,03
National Total;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
National Total;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
National Total;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
National Total;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
National Total;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
National Total;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
National Total;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QIV;580.440
National Total;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
National Total;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
National Total;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
National Total;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QIV;573.017
National Total;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
National Total;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
National Total;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
National Total;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QIV;558.796
National Total;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
National Total;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
National Total;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
National Total;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2022QIV;565.182
National Total;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
National Total;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2022QII;""
National Total;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2022QI;""
National Total;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2021QIV;559.652
National Total;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
National Total;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2021QII;""
National Total;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2021QI;""
National Total;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2020QIV;546.224
National Total;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
National Total;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2020QII;""
National Total;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2020QI;""
National Total;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
National Total;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
National Total;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2022QII;""
National Total;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2022QI;548.737
National Total;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
National Total;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
National Total;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2021QII;""
National Total;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2021QI;538.073
National Total;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
National Total;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
National Total;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2020QII;""
National Total;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2020QI;""
National Total;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
National Total;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
National Total;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QII;538.600
National Total;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QI;""
National Total;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
National Total;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
National Total;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QII;529.585
National Total;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QI;""
National Total;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
National Total;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
National Total;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QII;""
National Total;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QI;""
National Total;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
National Total;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QIII;530.048
National Total;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QII;""
National Total;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QI;""
National Total;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
National Total;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QIII;522.166
National Total;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QII;""
National Total;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QI;""
National Total;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
National Total;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
National Total;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QII;""
National Total;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QI;""
National Total;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
National Total;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
National Total;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
National Total;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
National Total;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
National Total;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
National Total;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
National Total;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
National Total;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
National Total;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
National Total;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
National Total;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
National Total;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;97,37
National Total;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
National Total;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
National Total;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
National Total;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;97,67
National Total;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
National Total;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
National Total;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
National Total;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;97,75
National Total;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
National Total;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
National Total;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
National Total;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
National Total;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
National Total;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
National Total;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;95,76
National Total;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
National Total;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
National Total;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
National Total;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;96,29
National Total;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
National Total;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
National Total;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
National Total;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
National Total;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
National Total;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
National Total;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;93,99
National Total;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
National Total;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
National Total;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
National Total;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;94,77
National Total;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
National Total;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
National Total;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
National Total;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
National Total;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
National Total;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
National Total;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;92,5
National Total;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
National Total;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
National Total;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
National Total;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;93,44
National Total;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
National Total;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
National Total;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
National Total;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
National Total;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
National Total;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
National Total;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QIV;323.254
National Total;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
National Total;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
National Total;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
National Total;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QIV;315.757
National Total;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
National Total;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
National Total;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
National Total;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QIV;304.417
National Total;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
National Total;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
National Total;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
National Total;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2022QIV;312.885
National Total;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
National Total;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2022QII;""
National Total;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2022QI;""
National Total;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2021QIV;307.165
National Total;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
National Total;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2021QII;""
National Total;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2021QI;""
National Total;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2020QIV;296.485
National Total;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
National Total;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2020QII;""
National Total;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2020QI;""
National Total;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
National Total;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
National Total;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2022QII;""
National Total;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2022QI;300.063
National Total;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
National Total;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
National Total;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2021QII;""
National Total;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2021QI;291.284
National Total;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
National Total;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
National Total;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2020QII;""
National Total;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2020QI;""
National Total;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
National Total;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
National Total;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QII;292.833
National Total;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QI;""
National Total;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
National Total;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
National Total;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QII;285.620
National Total;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QI;""
National Total;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
National Total;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
National Total;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QII;""
National Total;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QI;""
National Total;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
National Total;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QIII;286.916
National Total;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QII;""
National Total;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QI;""
National Total;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
National Total;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QIII;280.908
National Total;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QII;""
National Total;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QI;""
National Total;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
National Total;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
National Total;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QII;""
National Total;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QI;""
National Total;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
National Total;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
National Total;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
National Total;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
National Total;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
National Total;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
National Total;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
National Total;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
National Total;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
National Total;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
National Total;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
National Total;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
National Total;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;96,79
National Total;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
National Total;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
National Total;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
National Total;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;97,28
National Total;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
National Total;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
National Total;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
National Total;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;97,39
National Total;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
National Total;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
National Total;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
National Total;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
National Total;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
National Total;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
National Total;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;95,03
National Total;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
National Total;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
National Total;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
National Total;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;95,69
National Total;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
National Total;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
National Total;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
National Total;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
National Total;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
National Total;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
National Total;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;92,74
National Total;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
National Total;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
National Total;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
National Total;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;93,83
National Total;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
National Total;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
National Total;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
National Total;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
National Total;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
National Total;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
National Total;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;90,87
National Total;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
National Total;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
National Total;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
National Total;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;92,28
National Total;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
National Total;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
National Total;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
National Total;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
National Total;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
National Total;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
National Total;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
National Total;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
National Total;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
National Total;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QI;421.942
National Total;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
National Total;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
National Total;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
National Total;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QI;399.797
National Total;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
National Total;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
National Total;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
National Total;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QI;457.618
National Total;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
National Total;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
National Total;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2022QII;""
National Total;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2022QI;405.944
National Total;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
National Total;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
National Total;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2021QII;""
National Total;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2021QI;385.415
National Total;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
National Total;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
National Total;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2020QII;""
National Total;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2020QI;428.197
National Total;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
National Total;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
National Total;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2022QII;390.377
National Total;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2022QI;""
National Total;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
National Total;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
National Total;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2021QII;370.875
National Total;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2021QI;""
National Total;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
National Total;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
National Total;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2020QII;415.122
National Total;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2020QI;""
National Total;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
National Total;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QIII;375.717
National Total;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QII;""
National Total;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QI;""
National Total;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
National Total;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QIII;357.444
National Total;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QII;""
National Total;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QI;""
National Total;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
National Total;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QIII;398.794
National Total;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QII;""
National Total;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QI;""
National Total;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QIV;353.155
National Total;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
National Total;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QII;""
National Total;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QI;""
National Total;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QIV;340.328
National Total;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
National Total;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QII;""
National Total;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QI;""
National Total;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QIV;380.077
National Total;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
National Total;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QII;""
National Total;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QI;""
National Total;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
National Total;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
National Total;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
National Total;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
National Total;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
National Total;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
National Total;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
National Total;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
National Total;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
National Total;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
National Total;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
National Total;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
National Total;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
National Total;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
National Total;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
National Total;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;96,21
National Total;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
National Total;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
National Total;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
National Total;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;96,4
National Total;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
National Total;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
National Total;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
National Total;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;93,57
National Total;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
National Total;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
National Total;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;92,52
National Total;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
National Total;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
National Total;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
National Total;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;92,77
National Total;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
National Total;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
National Total;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
National Total;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;90,71
National Total;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
National Total;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
National Total;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;89,04
National Total;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
National Total;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
National Total;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
National Total;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;89,41
National Total;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
National Total;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
National Total;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
National Total;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;87,15
National Total;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
National Total;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
National Total;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;83,7
National Total;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
National Total;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
National Total;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
National Total;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;85,13
National Total;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
National Total;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
National Total;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
National Total;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;83,06
National Total;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
National Total;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
National Total;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
National Total;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
National Total;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
National Total;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
National Total;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QI;276.443
National Total;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
National Total;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
National Total;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
National Total;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QI;262.115
National Total;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
National Total;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
National Total;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
National Total;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QI;298.768
National Total;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
National Total;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
National Total;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2022QII;""
National Total;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2022QI;266.151
National Total;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
National Total;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
National Total;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2021QII;""
National Total;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2021QI;252.675
National Total;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
National Total;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
National Total;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2020QII;""
National Total;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2020QI;280.060
National Total;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
National Total;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
National Total;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2022QII;256.473
National Total;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2022QI;""
National Total;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
National Total;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
National Total;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2021QII;243.585
National Total;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2021QI;""
National Total;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
National Total;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
National Total;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2020QII;271.993
National Total;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2020QI;""
National Total;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
National Total;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QIII;247.387
National Total;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QII;""
National Total;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QI;""
National Total;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
National Total;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QIII;235.160
National Total;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QII;""
National Total;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QI;""
National Total;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
National Total;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QIII;261.794
National Total;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QII;""
National Total;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QI;""
National Total;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QIV;232.506
National Total;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
National Total;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QII;""
National Total;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QI;""
National Total;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QIV;224.258
National Total;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
National Total;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QII;""
National Total;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QI;""
National Total;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QIV;249.952
National Total;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
National Total;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QII;""
National Total;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QI;""
National Total;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
National Total;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
National Total;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
National Total;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
National Total;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
National Total;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
National Total;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
National Total;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
National Total;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
National Total;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
National Total;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
National Total;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
National Total;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
National Total;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
National Total;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
National Total;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;96,28
National Total;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
National Total;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
National Total;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
National Total;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;96,4
National Total;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
National Total;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
National Total;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
National Total;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;93,74
National Total;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
National Total;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
National Total;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;92,78
National Total;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
National Total;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
National Total;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
National Total;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;92,93
National Total;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
National Total;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
National Total;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
National Total;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;91,04
National Total;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
National Total;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
National Total;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;89,49
National Total;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
National Total;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
National Total;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
National Total;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;89,72
National Total;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
National Total;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
National Total;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
National Total;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;87,62
National Total;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
National Total;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
National Total;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;84,11
National Total;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
National Total;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
National Total;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
National Total;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;85,56
National Total;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
National Total;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
National Total;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
National Total;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;83,66
National Total;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
National Total;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
National Total;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
National Total;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
National Total;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
National Total;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
National Total;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QI;145.499
National Total;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
National Total;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
National Total;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
National Total;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QI;137.682
National Total;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
National Total;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
National Total;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
National Total;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QI;158.850
National Total;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
National Total;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
National Total;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2022QII;""
National Total;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2022QI;139.793
National Total;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
National Total;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
National Total;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2021QII;""
National Total;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2021QI;132.740
National Total;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
National Total;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
National Total;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2020QII;""
National Total;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2020QI;148.137
National Total;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
National Total;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
National Total;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2022QII;133.904
National Total;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2022QI;""
National Total;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
National Total;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
National Total;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2021QII;127.290
National Total;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2021QI;""
National Total;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
National Total;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
National Total;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2020QII;143.129
National Total;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2020QI;""
National Total;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
National Total;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QIII;128.330
National Total;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QII;""
National Total;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QI;""
National Total;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
National Total;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QIII;122.284
National Total;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QII;""
National Total;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QI;""
National Total;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
National Total;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QIII;137.000
National Total;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QII;""
National Total;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QI;""
National Total;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QIV;120.649
National Total;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
National Total;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QII;""
National Total;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QI;""
National Total;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QIV;116.070
National Total;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
National Total;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QII;""
National Total;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QI;""
National Total;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QIV;130.125
National Total;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
National Total;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QII;""
National Total;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QI;""
National Total;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
National Total;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
National Total;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
National Total;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
National Total;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
National Total;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
National Total;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
National Total;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
National Total;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
National Total;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
National Total;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
National Total;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
National Total;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
National Total;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
National Total;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
National Total;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;96,08
National Total;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
National Total;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
National Total;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
National Total;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;96,41
National Total;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
National Total;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
National Total;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
National Total;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;93,26
National Total;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
National Total;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
National Total;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;92,03
National Total;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
National Total;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
National Total;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
National Total;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;92,45
National Total;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
National Total;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
National Total;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
National Total;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;90,1
National Total;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
National Total;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
National Total;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;88,2
National Total;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
National Total;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
National Total;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
National Total;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;88,82
National Total;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
National Total;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
National Total;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
National Total;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;86,24
National Total;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
National Total;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
National Total;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;82,92
National Total;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
National Total;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
National Total;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
National Total;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;84,3
National Total;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
National Total;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
National Total;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
National Total;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;81,92
National Total;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
National Total;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
National Total;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
National Total;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
National Total;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
National Total;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QII;482.066
National Total;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
National Total;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
National Total;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
National Total;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QII;458.562
National Total;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
National Total;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
National Total;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
National Total;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QII;438.946
National Total;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
National Total;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
National Total;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
National Total;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2022QII;464.427
National Total;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2022QI;""
National Total;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
National Total;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
National Total;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2021QII;442.245
National Total;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2021QI;""
National Total;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
National Total;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
National Total;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2020QII;425.219
National Total;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2020QI;""
National Total;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
National Total;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2022QIII;448.163
National Total;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2022QII;""
National Total;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2022QI;""
National Total;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
National Total;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2021QIII;427.405
National Total;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2021QII;""
National Total;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2021QI;""
National Total;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
National Total;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2020QIII;406.531
National Total;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2020QII;""
National Total;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2020QI;""
National Total;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QIV;423.451
National Total;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
National Total;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QII;""
National Total;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QI;""
National Total;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QIV;408.632
National Total;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
National Total;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QII;""
National Total;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QI;""
National Total;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QIV;387.217
National Total;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
National Total;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QII;""
National Total;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QI;""
National Total;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
National Total;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
National Total;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QII;""
National Total;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QI;393.992
National Total;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
National Total;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
National Total;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QII;""
National Total;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QI;373.991
National Total;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
National Total;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
National Total;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QII;""
National Total;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QI;""
National Total;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
National Total;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
National Total;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
National Total;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
National Total;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
National Total;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
National Total;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
National Total;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
National Total;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
National Total;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
National Total;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
National Total;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
National Total;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
National Total;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
National Total;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;96,34
National Total;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
National Total;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
National Total;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
National Total;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;96,44
National Total;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
National Total;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
National Total;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
National Total;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;96,87
National Total;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
National Total;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
National Total;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;92,97
National Total;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
National Total;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
National Total;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
National Total;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;93,21
National Total;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
National Total;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
National Total;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
National Total;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;92,62
National Total;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
National Total;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
National Total;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;87,84
National Total;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
National Total;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
National Total;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
National Total;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;89,11
National Total;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
National Total;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
National Total;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
National Total;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;88,22
National Total;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
National Total;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
National Total;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
National Total;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
National Total;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
National Total;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
National Total;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;85,92
National Total;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
National Total;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
National Total;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
National Total;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;85,2
National Total;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
National Total;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
National Total;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
National Total;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
National Total;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
National Total;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
National Total;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QII;315.606
National Total;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
National Total;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
National Total;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
National Total;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QII;300.301
National Total;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
National Total;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
National Total;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
National Total;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QII;286.982
National Total;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
National Total;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
National Total;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
National Total;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2022QII;304.674
National Total;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2022QI;""
National Total;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
National Total;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
National Total;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2021QII;290.105
National Total;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2021QI;""
National Total;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
National Total;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
National Total;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2020QII;278.462
National Total;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2020QI;""
National Total;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
National Total;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2022QIII;294.624
National Total;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2022QII;""
National Total;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2022QI;""
National Total;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
National Total;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2021QIII;280.783
National Total;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2021QII;""
National Total;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2021QI;""
National Total;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
National Total;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2020QIII;266.609
National Total;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2020QII;""
National Total;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2020QI;""
National Total;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QIV;278.438
National Total;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
National Total;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QII;""
National Total;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QI;""
National Total;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QIV;268.868
National Total;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
National Total;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QII;""
National Total;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QI;""
National Total;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QIV;254.388
National Total;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
National Total;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QII;""
National Total;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QI;""
National Total;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
National Total;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
National Total;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QII;""
National Total;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QI;259.451
National Total;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
National Total;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
National Total;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QII;""
National Total;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QI;245.730
National Total;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
National Total;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
National Total;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QII;""
National Total;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QI;""
National Total;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
National Total;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
National Total;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
National Total;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
National Total;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
National Total;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
National Total;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
National Total;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
National Total;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
National Total;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
National Total;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
National Total;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
National Total;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
National Total;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
National Total;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;96,54
National Total;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
National Total;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
National Total;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
National Total;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;96,6
National Total;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
National Total;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
National Total;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
National Total;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;97,03
National Total;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
National Total;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
National Total;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;93,35
National Total;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
National Total;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
National Total;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
National Total;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;93,5
National Total;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
National Total;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
National Total;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
National Total;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;92,9
National Total;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
National Total;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
National Total;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;88,22
National Total;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
National Total;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
National Total;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
National Total;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;89,53
National Total;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
National Total;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
National Total;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
National Total;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;88,64
National Total;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
National Total;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
National Total;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
National Total;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
National Total;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
National Total;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
National Total;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;86,4
National Total;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
National Total;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
National Total;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
National Total;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;85,63
National Total;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
National Total;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
National Total;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
National Total;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
National Total;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
National Total;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
National Total;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QII;166.460
National Total;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
National Total;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
National Total;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
National Total;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QII;158.261
National Total;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
National Total;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
National Total;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
National Total;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QII;151.964
National Total;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
National Total;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
National Total;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
National Total;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2022QII;159.753
National Total;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2022QI;""
National Total;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
National Total;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
National Total;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2021QII;152.140
National Total;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2021QI;""
National Total;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
National Total;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
National Total;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2020QII;146.757
National Total;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2020QI;""
National Total;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
National Total;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2022QIII;153.539
National Total;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2022QII;""
National Total;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2022QI;""
National Total;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
National Total;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2021QIII;146.622
National Total;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2021QII;""
National Total;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2021QI;""
National Total;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
National Total;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2020QIII;139.922
National Total;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2020QII;""
National Total;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2020QI;""
National Total;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QIV;145.013
National Total;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
National Total;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QII;""
National Total;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QI;""
National Total;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QIV;139.764
National Total;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
National Total;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QII;""
National Total;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QI;""
National Total;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QIV;132.829
National Total;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
National Total;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QII;""
National Total;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QI;""
National Total;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
National Total;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
National Total;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QII;""
National Total;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QI;134.541
National Total;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
National Total;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
National Total;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QII;""
National Total;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QI;128.261
National Total;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
National Total;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
National Total;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QII;""
National Total;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QI;""
National Total;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
National Total;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
National Total;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
National Total;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
National Total;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
National Total;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
National Total;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
National Total;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
National Total;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
National Total;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
National Total;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
National Total;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
National Total;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
National Total;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
National Total;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;95,97
National Total;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
National Total;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
National Total;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
National Total;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;96,13
National Total;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
National Total;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
National Total;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
National Total;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;96,57
National Total;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
National Total;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
National Total;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;92,24
National Total;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
National Total;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
National Total;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
National Total;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;92,65
National Total;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
National Total;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
National Total;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
National Total;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;92,08
National Total;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
National Total;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
National Total;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;87,12
National Total;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
National Total;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
National Total;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
National Total;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;88,31
National Total;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
National Total;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
National Total;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
National Total;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;87,41
National Total;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
National Total;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
National Total;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
National Total;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
National Total;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
National Total;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
National Total;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;85,01
National Total;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
National Total;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
National Total;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
National Total;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;84,4
National Total;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
National Total;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
National Total;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
National Total;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
National Total;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
National Total;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QIII;472.143
National Total;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
National Total;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
National Total;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
National Total;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QIII;449.553
National Total;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
National Total;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
National Total;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
National Total;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QIII;430.558
National Total;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
National Total;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
National Total;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
National Total;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2022QIII;454.150
National Total;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2022QII;""
National Total;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2022QI;""
National Total;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
National Total;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2021QIII;433.248
National Total;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2021QII;""
National Total;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2021QI;""
National Total;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
National Total;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2020QIII;410.671
National Total;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2020QII;""
National Total;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2020QI;""
National Total;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2022QIV;427.748
National Total;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
National Total;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2022QII;""
National Total;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2022QI;""
National Total;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2021QIV;413.087
National Total;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
National Total;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2021QII;""
National Total;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2021QI;""
National Total;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2020QIV;390.598
National Total;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
National Total;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2020QII;""
National Total;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2020QI;""
National Total;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
National Total;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
National Total;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QII;""
National Total;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QI;398.111
National Total;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
National Total;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
National Total;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QII;""
National Total;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QI;377.164
National Total;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
National Total;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
National Total;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QII;""
National Total;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QI;""
National Total;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
National Total;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
National Total;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QII;383.537
National Total;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QI;""
National Total;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
National Total;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
National Total;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QII;363.521
National Total;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QI;""
National Total;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
National Total;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
National Total;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QII;""
National Total;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QI;""
National Total;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
National Total;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
National Total;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
National Total;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
National Total;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
National Total;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
National Total;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
National Total;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
National Total;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
National Total;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
National Total;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
National Total;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
National Total;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
National Total;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;96,19
National Total;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
National Total;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
National Total;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
National Total;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;96,37
National Total;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
National Total;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
National Total;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
National Total;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;95,38
National Total;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
National Total;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
National Total;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;90,6
National Total;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
National Total;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
National Total;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
National Total;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;91,89
National Total;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
National Total;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
National Total;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
National Total;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;90,72
National Total;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
National Total;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
National Total;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
National Total;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
National Total;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
National Total;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
National Total;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;88,56
National Total;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
National Total;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
National Total;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
National Total;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;87,6
National Total;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
National Total;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
National Total;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
National Total;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
National Total;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
National Total;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
National Total;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;85,32
National Total;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
National Total;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
National Total;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
National Total;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;84,43
National Total;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
National Total;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
National Total;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
National Total;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
National Total;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
National Total;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
National Total;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QIII;309.059
National Total;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
National Total;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
National Total;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
National Total;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QIII;294.326
National Total;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
National Total;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
National Total;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
National Total;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QIII;281.850
National Total;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
National Total;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
National Total;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
National Total;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2022QIII;298.082
National Total;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2022QII;""
National Total;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2022QI;""
National Total;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
National Total;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2021QIII;284.186
National Total;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2021QII;""
National Total;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2021QI;""
National Total;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
National Total;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2020QIII;269.276
National Total;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2020QII;""
National Total;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2020QI;""
National Total;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2022QIV;280.909
National Total;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
National Total;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2022QII;""
National Total;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2022QI;""
National Total;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2021QIV;271.458
National Total;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
National Total;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2021QII;""
National Total;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2021QI;""
National Total;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2020QIV;256.584
National Total;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
National Total;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2020QII;""
National Total;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2020QI;""
National Total;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
National Total;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
National Total;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QII;""
National Total;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QI;261.826
National Total;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
National Total;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
National Total;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QII;""
National Total;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QI;247.787
National Total;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
National Total;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
National Total;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QII;""
National Total;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QI;""
National Total;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
National Total;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
National Total;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QII;252.684
National Total;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QI;""
National Total;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
National Total;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
National Total;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QII;239.219
National Total;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QI;""
National Total;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
National Total;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
National Total;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QII;""
National Total;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QI;""
National Total;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
National Total;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
National Total;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
National Total;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
National Total;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
National Total;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
National Total;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
National Total;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
National Total;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
National Total;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
National Total;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
National Total;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
National Total;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
National Total;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;96,45
National Total;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
National Total;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
National Total;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
National Total;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;96,55
National Total;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
National Total;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
National Total;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
National Total;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;95,54
National Total;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
National Total;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
National Total;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;90,89
National Total;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
National Total;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
National Total;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
National Total;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;92,23
National Total;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
National Total;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
National Total;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
National Total;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;91,04
National Total;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
National Total;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
National Total;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
National Total;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
National Total;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
National Total;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
National Total;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;88,96
National Total;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
National Total;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
National Total;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
National Total;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;87,91
National Total;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
National Total;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
National Total;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
National Total;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
National Total;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
National Total;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
National Total;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;85,85
National Total;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
National Total;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
National Total;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
National Total;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;84,87
National Total;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
National Total;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
National Total;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
National Total;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
National Total;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
National Total;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
National Total;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QIII;163.084
National Total;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
National Total;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
National Total;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
National Total;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QIII;155.227
National Total;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
National Total;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
National Total;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
National Total;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QIII;148.708
National Total;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
National Total;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
National Total;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
National Total;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2022QIII;156.068
National Total;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2022QII;""
National Total;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2022QI;""
National Total;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
National Total;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2021QIII;149.062
National Total;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2021QII;""
National Total;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2021QI;""
National Total;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
National Total;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2020QIII;141.395
National Total;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2020QII;""
National Total;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2020QI;""
National Total;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2022QIV;146.839
National Total;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
National Total;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2022QII;""
National Total;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2022QI;""
National Total;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2021QIV;141.629
National Total;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
National Total;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2021QII;""
National Total;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2021QI;""
National Total;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2020QIV;134.014
National Total;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
National Total;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2020QII;""
National Total;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2020QI;""
National Total;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
National Total;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
National Total;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QII;""
National Total;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QI;136.285
National Total;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
National Total;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
National Total;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QII;""
National Total;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QI;129.377
National Total;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
National Total;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
National Total;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QII;""
National Total;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QI;""
National Total;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
National Total;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
National Total;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QII;130.853
National Total;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QI;""
National Total;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
National Total;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
National Total;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QII;124.302
National Total;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QI;""
National Total;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
National Total;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
National Total;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QII;""
National Total;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QI;""
National Total;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
National Total;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
National Total;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
National Total;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
National Total;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
National Total;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
National Total;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
National Total;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
National Total;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
National Total;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
National Total;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
National Total;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
National Total;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
National Total;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;95,7
National Total;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
National Total;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
National Total;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
National Total;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;96,03
National Total;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
National Total;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
National Total;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
National Total;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;95,08
National Total;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
National Total;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
National Total;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;90,04
National Total;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
National Total;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
National Total;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
National Total;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;91,24
National Total;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
National Total;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
National Total;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
National Total;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;90,12
National Total;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
National Total;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
National Total;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
National Total;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
National Total;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
National Total;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
National Total;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;87,8
National Total;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
National Total;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
National Total;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
National Total;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;87
National Total;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
National Total;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
National Total;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
National Total;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
National Total;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
National Total;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
National Total;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;84,3
National Total;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
National Total;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
National Total;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
National Total;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;83,59
National Total;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
National Total;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
National Total;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
National Total;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
National Total;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
National Total;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QIV;458.919
National Total;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
National Total;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
National Total;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
National Total;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QIV;437.864
National Total;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
National Total;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
National Total;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
National Total;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QIV;416.088
National Total;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
National Total;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
National Total;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
National Total;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2022QIV;431.718
National Total;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
National Total;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2022QII;""
National Total;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2022QI;""
National Total;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2021QIV;416.766
National Total;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
National Total;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2021QII;""
National Total;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2021QI;""
National Total;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2020QIV;394.982
National Total;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
National Total;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2020QII;""
National Total;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2020QI;""
National Total;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
National Total;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
National Total;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2022QII;""
National Total;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2022QI;401.481
National Total;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
National Total;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
National Total;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2021QII;""
National Total;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2021QI;381.190
National Total;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
National Total;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
National Total;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2020QII;""
National Total;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2020QI;""
National Total;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
National Total;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
National Total;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QII;386.580
National Total;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QI;""
National Total;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
National Total;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
National Total;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QII;367.187
National Total;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QI;""
National Total;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
National Total;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
National Total;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QII;""
National Total;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QI;""
National Total;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
National Total;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QIII;372.223
National Total;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QII;""
National Total;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QI;""
National Total;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
National Total;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QIII;354.054
National Total;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QII;""
National Total;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QI;""
National Total;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
National Total;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
National Total;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QII;""
National Total;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QI;""
National Total;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
National Total;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
National Total;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
National Total;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
National Total;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
National Total;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
National Total;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
National Total;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
National Total;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
National Total;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
National Total;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
National Total;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
National Total;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;94,07
National Total;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
National Total;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
National Total;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
National Total;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;95,18
National Total;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
National Total;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
National Total;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
National Total;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;94,93
National Total;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
National Total;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
National Total;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
National Total;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
National Total;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
National Total;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
National Total;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;91,69
National Total;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
National Total;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
National Total;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
National Total;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;91,61
National Total;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
National Total;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
National Total;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
National Total;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
National Total;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
National Total;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
National Total;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;88,29
National Total;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
National Total;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
National Total;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
National Total;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;88,25
National Total;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
National Total;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
National Total;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
National Total;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
National Total;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
National Total;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
National Total;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;85,01
National Total;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
National Total;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
National Total;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
National Total;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;85,09
National Total;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
National Total;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
National Total;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
National Total;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
National Total;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
National Total;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
National Total;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QIV;300.868
National Total;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
National Total;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
National Total;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
National Total;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QIV;286.843
National Total;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
National Total;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
National Total;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
National Total;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QIV;272.630
National Total;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
National Total;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
National Total;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
National Total;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2022QIV;283.186
National Total;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
National Total;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2022QII;""
National Total;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2022QI;""
National Total;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2021QIV;273.514
National Total;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
National Total;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2021QII;""
National Total;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2021QI;""
National Total;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2020QIV;259.284
National Total;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
National Total;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2020QII;""
National Total;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2020QI;""
National Total;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
National Total;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
National Total;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2022QII;""
National Total;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2022QI;263.688
National Total;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
National Total;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
National Total;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2021QII;""
National Total;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2021QI;250.234
National Total;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
National Total;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
National Total;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2020QII;""
National Total;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2020QI;""
National Total;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
National Total;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
National Total;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QII;254.367
National Total;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QI;""
National Total;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
National Total;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
National Total;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QII;241.466
National Total;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QI;""
National Total;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
National Total;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
National Total;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QII;""
National Total;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QI;""
National Total;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
National Total;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QIII;245.455
National Total;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QII;""
National Total;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QI;""
National Total;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
National Total;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QIII;233.210
National Total;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QII;""
National Total;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QI;""
National Total;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
National Total;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
National Total;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QII;""
National Total;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QI;""
National Total;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
National Total;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
National Total;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
National Total;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
National Total;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
National Total;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
National Total;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
National Total;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
National Total;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
National Total;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
National Total;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
National Total;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
National Total;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;94,12
National Total;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
National Total;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
National Total;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
National Total;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;95,35
National Total;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
National Total;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
National Total;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
National Total;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;95,1
National Total;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
National Total;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
National Total;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
National Total;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
National Total;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
National Total;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
National Total;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;91,93
National Total;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
National Total;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
National Total;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
National Total;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;91,79
National Total;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
National Total;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
National Total;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
National Total;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
National Total;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
National Total;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
National Total;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;88,68
National Total;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
National Total;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
National Total;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
National Total;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;88,57
National Total;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
National Total;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
National Total;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
National Total;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
National Total;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
National Total;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
National Total;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;85,57
National Total;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
National Total;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
National Total;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
National Total;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;85,54
National Total;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
National Total;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
National Total;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
National Total;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
National Total;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
National Total;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
National Total;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QIV;158.051
National Total;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
National Total;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
National Total;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
National Total;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QIV;151.021
National Total;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
National Total;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
National Total;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
National Total;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QIV;143.458
National Total;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
National Total;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
National Total;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
National Total;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2022QIV;148.532
National Total;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
National Total;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2022QII;""
National Total;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2022QI;""
National Total;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2021QIV;143.252
National Total;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
National Total;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2021QII;""
National Total;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2021QI;""
National Total;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2020QIV;135.698
National Total;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
National Total;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2020QII;""
National Total;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2020QI;""
National Total;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
National Total;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
National Total;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2022QII;""
National Total;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2022QI;137.793
National Total;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
National Total;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
National Total;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2021QII;""
National Total;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2021QI;130.956
National Total;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
National Total;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
National Total;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2020QII;""
National Total;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2020QI;""
National Total;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
National Total;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
National Total;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QII;132.213
National Total;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QI;""
National Total;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
National Total;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
National Total;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QII;125.721
National Total;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QI;""
National Total;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
National Total;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
National Total;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QII;""
National Total;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QI;""
National Total;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
National Total;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QIII;126.768
National Total;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QII;""
National Total;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QI;""
National Total;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
National Total;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QIII;120.844
National Total;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QII;""
National Total;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QI;""
National Total;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
National Total;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
National Total;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QII;""
National Total;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QI;""
National Total;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
National Total;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
National Total;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
National Total;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
National Total;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
National Total;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
National Total;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
National Total;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
National Total;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
National Total;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
National Total;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
National Total;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
National Total;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;93,98
National Total;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
National Total;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
National Total;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
National Total;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;94,86
National Total;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
National Total;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
National Total;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
National Total;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;94,59
National Total;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
National Total;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
National Total;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
National Total;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
National Total;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
National Total;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
National Total;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;91,24
National Total;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
National Total;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
National Total;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
National Total;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;91,29
National Total;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
National Total;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
National Total;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
National Total;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
National Total;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
National Total;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
National Total;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;87,55
National Total;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
National Total;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
National Total;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
National Total;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;87,64
National Total;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
National Total;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
National Total;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
National Total;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
National Total;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
National Total;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
National Total;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;83,94
National Total;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
National Total;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
National Total;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
National Total;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;84,24
National Total;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
National Total;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
National Total;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
National Total;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
National Total;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
National Total;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
02 Albacete;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
02 Albacete;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
02 Albacete;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
02 Albacete;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QI;25.421
02 Albacete;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
02 Albacete;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
02 Albacete;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
02 Albacete;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QI;25.126
02 Albacete;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
02 Albacete;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
02 Albacete;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
02 Albacete;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QI;25.415
02 Albacete;All ages;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
02 Albacete;All ages;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
02 Albacete;All ages;Cohort January 1;Total;Survival in the first trimester;2022QII;""
02 Albacete;All ages;Cohort January 1;Total;Survival in the first trimester;2022QI;24.662
02 Albacete;All ages;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
02 Albacete;All ages;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
02 Albacete;All ages;Cohort January 1;Total;Survival in the first trimester;2021QII;""
02 Albacete;All ages;Cohort January 1;Total;Survival in the first trimester;2021QI;24.615
02 Albacete;All ages;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
02 Albacete;All ages;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
02 Albacete;All ages;Cohort January 1;Total;Survival in the first trimester;2020QII;""
02 Albacete;All ages;Cohort January 1;Total;Survival in the first trimester;2020QI;23.847
02 Albacete;All ages;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
02 Albacete;All ages;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
02 Albacete;All ages;Cohort January 1;Total;Survival in the second trimester;2022QII;23.867
02 Albacete;All ages;Cohort January 1;Total;Survival in the second trimester;2022QI;""
02 Albacete;All ages;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
02 Albacete;All ages;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
02 Albacete;All ages;Cohort January 1;Total;Survival in the second trimester;2021QII;24.003
02 Albacete;All ages;Cohort January 1;Total;Survival in the second trimester;2021QI;""
02 Albacete;All ages;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
02 Albacete;All ages;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
02 Albacete;All ages;Cohort January 1;Total;Survival in the second trimester;2020QII;23.440
02 Albacete;All ages;Cohort January 1;Total;Survival in the second trimester;2020QI;""
02 Albacete;All ages;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
02 Albacete;All ages;Cohort January 1;Total;Survival in the third trimester;2022QIII;23.242
02 Albacete;All ages;Cohort January 1;Total;Survival in the third trimester;2022QII;""
02 Albacete;All ages;Cohort January 1;Total;Survival in the third trimester;2022QI;""
02 Albacete;All ages;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
02 Albacete;All ages;Cohort January 1;Total;Survival in the third trimester;2021QIII;23.448
02 Albacete;All ages;Cohort January 1;Total;Survival in the third trimester;2021QII;""
02 Albacete;All ages;Cohort January 1;Total;Survival in the third trimester;2021QI;""
02 Albacete;All ages;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
02 Albacete;All ages;Cohort January 1;Total;Survival in the third trimester;2020QIII;22.899
02 Albacete;All ages;Cohort January 1;Total;Survival in the third trimester;2020QII;""
02 Albacete;All ages;Cohort January 1;Total;Survival in the third trimester;2020QI;""
02 Albacete;All ages;Cohort January 1;Total;Survival in the third trimester;2022QIV;22.525
02 Albacete;All ages;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
02 Albacete;All ages;Cohort January 1;Total;Survival in the third trimester;2022QII;""
02 Albacete;All ages;Cohort January 1;Total;Survival in the third trimester;2022QI;""
02 Albacete;All ages;Cohort January 1;Total;Survival in the third trimester;2021QIV;22.854
02 Albacete;All ages;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
02 Albacete;All ages;Cohort January 1;Total;Survival in the third trimester;2021QII;""
02 Albacete;All ages;Cohort January 1;Total;Survival in the third trimester;2021QI;""
02 Albacete;All ages;Cohort January 1;Total;Survival in the third trimester;2020QIV;22.400
02 Albacete;All ages;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
02 Albacete;All ages;Cohort January 1;Total;Survival in the third trimester;2020QII;""
02 Albacete;All ages;Cohort January 1;Total;Survival in the third trimester;2020QI;""
02 Albacete;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
02 Albacete;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
02 Albacete;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
02 Albacete;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
02 Albacete;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
02 Albacete;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
02 Albacete;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
02 Albacete;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
02 Albacete;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
02 Albacete;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
02 Albacete;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
02 Albacete;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
02 Albacete;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
02 Albacete;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
02 Albacete;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
02 Albacete;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;97,01
02 Albacete;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
02 Albacete;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
02 Albacete;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
02 Albacete;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;97,97
02 Albacete;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
02 Albacete;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
02 Albacete;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
02 Albacete;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;93,83
02 Albacete;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
02 Albacete;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
02 Albacete;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;93,89
02 Albacete;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
02 Albacete;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
02 Albacete;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
02 Albacete;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;95,53
02 Albacete;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
02 Albacete;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
02 Albacete;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
02 Albacete;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;92,23
02 Albacete;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
02 Albacete;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
02 Albacete;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;91,43
02 Albacete;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
02 Albacete;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
02 Albacete;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
02 Albacete;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;93,32
02 Albacete;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
02 Albacete;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
02 Albacete;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
02 Albacete;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;90,1
02 Albacete;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
02 Albacete;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
02 Albacete;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;88,61
02 Albacete;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
02 Albacete;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
02 Albacete;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
02 Albacete;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;90,96
02 Albacete;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
02 Albacete;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
02 Albacete;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
02 Albacete;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;88,14
02 Albacete;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
02 Albacete;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
02 Albacete;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
02 Albacete;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
02 Albacete;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
02 Albacete;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
02 Albacete;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QI;16.848
02 Albacete;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
02 Albacete;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
02 Albacete;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
02 Albacete;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QI;16.817
02 Albacete;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
02 Albacete;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
02 Albacete;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
02 Albacete;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QI;17.020
02 Albacete;All ages;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
02 Albacete;All ages;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
02 Albacete;All ages;Cohort January 1;Males;Survival in the first trimester;2022QII;""
02 Albacete;All ages;Cohort January 1;Males;Survival in the first trimester;2022QI;16.418
02 Albacete;All ages;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
02 Albacete;All ages;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
02 Albacete;All ages;Cohort January 1;Males;Survival in the first trimester;2021QII;""
02 Albacete;All ages;Cohort January 1;Males;Survival in the first trimester;2021QI;16.476
02 Albacete;All ages;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
02 Albacete;All ages;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
02 Albacete;All ages;Cohort January 1;Males;Survival in the first trimester;2020QII;""
02 Albacete;All ages;Cohort January 1;Males;Survival in the first trimester;2020QI;16.032
02 Albacete;All ages;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
02 Albacete;All ages;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
02 Albacete;All ages;Cohort January 1;Males;Survival in the second trimester;2022QII;15.962
02 Albacete;All ages;Cohort January 1;Males;Survival in the second trimester;2022QI;""
02 Albacete;All ages;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
02 Albacete;All ages;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
02 Albacete;All ages;Cohort January 1;Males;Survival in the second trimester;2021QII;16.132
02 Albacete;All ages;Cohort January 1;Males;Survival in the second trimester;2021QI;""
02 Albacete;All ages;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
02 Albacete;All ages;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
02 Albacete;All ages;Cohort January 1;Males;Survival in the second trimester;2020QII;15.807
02 Albacete;All ages;Cohort January 1;Males;Survival in the second trimester;2020QI;""
02 Albacete;All ages;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
02 Albacete;All ages;Cohort January 1;Males;Survival in the third trimester;2022QIII;15.584
02 Albacete;All ages;Cohort January 1;Males;Survival in the third trimester;2022QII;""
02 Albacete;All ages;Cohort January 1;Males;Survival in the third trimester;2022QI;""
02 Albacete;All ages;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
02 Albacete;All ages;Cohort January 1;Males;Survival in the third trimester;2021QIII;15.776
02 Albacete;All ages;Cohort January 1;Males;Survival in the third trimester;2021QII;""
02 Albacete;All ages;Cohort January 1;Males;Survival in the third trimester;2021QI;""
02 Albacete;All ages;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
02 Albacete;All ages;Cohort January 1;Males;Survival in the third trimester;2020QIII;15.469
02 Albacete;All ages;Cohort January 1;Males;Survival in the third trimester;2020QII;""
02 Albacete;All ages;Cohort January 1;Males;Survival in the third trimester;2020QI;""
02 Albacete;All ages;Cohort January 1;Males;Survival in the third trimester;2022QIV;15.128
02 Albacete;All ages;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
02 Albacete;All ages;Cohort January 1;Males;Survival in the third trimester;2022QII;""
02 Albacete;All ages;Cohort January 1;Males;Survival in the third trimester;2022QI;""
02 Albacete;All ages;Cohort January 1;Males;Survival in the third trimester;2021QIV;15.402
02 Albacete;All ages;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
02 Albacete;All ages;Cohort January 1;Males;Survival in the third trimester;2021QII;""
02 Albacete;All ages;Cohort January 1;Males;Survival in the third trimester;2021QI;""
02 Albacete;All ages;Cohort January 1;Males;Survival in the third trimester;2020QIV;15.161
02 Albacete;All ages;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
02 Albacete;All ages;Cohort January 1;Males;Survival in the third trimester;2020QII;""
02 Albacete;All ages;Cohort January 1;Males;Survival in the third trimester;2020QI;""
02 Albacete;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
02 Albacete;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
02 Albacete;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
02 Albacete;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
02 Albacete;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
02 Albacete;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
02 Albacete;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
02 Albacete;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
02 Albacete;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
02 Albacete;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
02 Albacete;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
02 Albacete;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
02 Albacete;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
02 Albacete;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
02 Albacete;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
02 Albacete;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;97,45
02 Albacete;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
02 Albacete;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
02 Albacete;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
02 Albacete;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;97,97
02 Albacete;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
02 Albacete;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
02 Albacete;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
02 Albacete;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;94,2
02 Albacete;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
02 Albacete;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
02 Albacete;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;94,74
02 Albacete;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
02 Albacete;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
02 Albacete;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
02 Albacete;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;95,93
02 Albacete;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
02 Albacete;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
02 Albacete;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
02 Albacete;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;92,87
02 Albacete;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
02 Albacete;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
02 Albacete;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;92,5
02 Albacete;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
02 Albacete;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
02 Albacete;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
02 Albacete;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;93,81
02 Albacete;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
02 Albacete;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
02 Albacete;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
02 Albacete;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;90,89
02 Albacete;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
02 Albacete;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
02 Albacete;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;89,79
02 Albacete;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
02 Albacete;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
02 Albacete;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
02 Albacete;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;91,59
02 Albacete;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
02 Albacete;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
02 Albacete;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
02 Albacete;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;89,08
02 Albacete;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
02 Albacete;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
02 Albacete;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
02 Albacete;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
02 Albacete;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
02 Albacete;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
02 Albacete;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QI;8.573
02 Albacete;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
02 Albacete;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
02 Albacete;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
02 Albacete;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QI;8.309
02 Albacete;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
02 Albacete;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
02 Albacete;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
02 Albacete;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QI;8.395
02 Albacete;All ages;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
02 Albacete;All ages;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
02 Albacete;All ages;Cohort January 1;Females;Survival in the first trimester;2022QII;""
02 Albacete;All ages;Cohort January 1;Females;Survival in the first trimester;2022QI;8.244
02 Albacete;All ages;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
02 Albacete;All ages;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
02 Albacete;All ages;Cohort January 1;Females;Survival in the first trimester;2021QII;""
02 Albacete;All ages;Cohort January 1;Females;Survival in the first trimester;2021QI;8.139
02 Albacete;All ages;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
02 Albacete;All ages;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
02 Albacete;All ages;Cohort January 1;Females;Survival in the first trimester;2020QII;""
02 Albacete;All ages;Cohort January 1;Females;Survival in the first trimester;2020QI;7.815
02 Albacete;All ages;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
02 Albacete;All ages;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
02 Albacete;All ages;Cohort January 1;Females;Survival in the second trimester;2022QII;7.905
02 Albacete;All ages;Cohort January 1;Females;Survival in the second trimester;2022QI;""
02 Albacete;All ages;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
02 Albacete;All ages;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
02 Albacete;All ages;Cohort January 1;Females;Survival in the second trimester;2021QII;7.871
02 Albacete;All ages;Cohort January 1;Females;Survival in the second trimester;2021QI;""
02 Albacete;All ages;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
02 Albacete;All ages;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
02 Albacete;All ages;Cohort January 1;Females;Survival in the second trimester;2020QII;7.633
02 Albacete;All ages;Cohort January 1;Females;Survival in the second trimester;2020QI;""
02 Albacete;All ages;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
02 Albacete;All ages;Cohort January 1;Females;Survival in the third trimester;2022QIII;7.658
02 Albacete;All ages;Cohort January 1;Females;Survival in the third trimester;2022QII;""
02 Albacete;All ages;Cohort January 1;Females;Survival in the third trimester;2022QI;""
02 Albacete;All ages;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
02 Albacete;All ages;Cohort January 1;Females;Survival in the third trimester;2021QIII;7.672
02 Albacete;All ages;Cohort January 1;Females;Survival in the third trimester;2021QII;""
02 Albacete;All ages;Cohort January 1;Females;Survival in the third trimester;2021QI;""
02 Albacete;All ages;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
02 Albacete;All ages;Cohort January 1;Females;Survival in the third trimester;2020QIII;7.430
02 Albacete;All ages;Cohort January 1;Females;Survival in the third trimester;2020QII;""
02 Albacete;All ages;Cohort January 1;Females;Survival in the third trimester;2020QI;""
02 Albacete;All ages;Cohort January 1;Females;Survival in the third trimester;2022QIV;7.397
02 Albacete;All ages;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
02 Albacete;All ages;Cohort January 1;Females;Survival in the third trimester;2022QII;""
02 Albacete;All ages;Cohort January 1;Females;Survival in the third trimester;2022QI;""
02 Albacete;All ages;Cohort January 1;Females;Survival in the third trimester;2021QIV;7.452
02 Albacete;All ages;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
02 Albacete;All ages;Cohort January 1;Females;Survival in the third trimester;2021QII;""
02 Albacete;All ages;Cohort January 1;Females;Survival in the third trimester;2021QI;""
02 Albacete;All ages;Cohort January 1;Females;Survival in the third trimester;2020QIV;7.239
02 Albacete;All ages;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
02 Albacete;All ages;Cohort January 1;Females;Survival in the third trimester;2020QII;""
02 Albacete;All ages;Cohort January 1;Females;Survival in the third trimester;2020QI;""
02 Albacete;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
02 Albacete;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
02 Albacete;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
02 Albacete;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
02 Albacete;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
02 Albacete;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
02 Albacete;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
02 Albacete;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
02 Albacete;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
02 Albacete;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
02 Albacete;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
02 Albacete;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
02 Albacete;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
02 Albacete;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
02 Albacete;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
02 Albacete;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;96,16
02 Albacete;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
02 Albacete;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
02 Albacete;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
02 Albacete;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;97,95
02 Albacete;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
02 Albacete;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
02 Albacete;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
02 Albacete;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;93,09
02 Albacete;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
02 Albacete;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
02 Albacete;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;92,21
02 Albacete;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
02 Albacete;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
02 Albacete;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
02 Albacete;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;94,73
02 Albacete;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
02 Albacete;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
02 Albacete;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
02 Albacete;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;90,92
02 Albacete;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
02 Albacete;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
02 Albacete;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;89,33
02 Albacete;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
02 Albacete;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
02 Albacete;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
02 Albacete;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;92,33
02 Albacete;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
02 Albacete;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
02 Albacete;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
02 Albacete;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;88,51
02 Albacete;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
02 Albacete;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
02 Albacete;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;86,28
02 Albacete;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
02 Albacete;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
02 Albacete;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
02 Albacete;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;89,69
02 Albacete;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
02 Albacete;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
02 Albacete;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
02 Albacete;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;86,23
02 Albacete;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
02 Albacete;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
02 Albacete;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
02 Albacete;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
02 Albacete;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
02 Albacete;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QII;25.439
02 Albacete;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
02 Albacete;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
02 Albacete;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
02 Albacete;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QII;25.419
02 Albacete;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
02 Albacete;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
02 Albacete;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
02 Albacete;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QII;24.730
02 Albacete;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
02 Albacete;All ages;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
02 Albacete;All ages;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
02 Albacete;All ages;Cohort April 1;Total;Survival in the first trimester;2022QII;24.552
02 Albacete;All ages;Cohort April 1;Total;Survival in the first trimester;2022QI;""
02 Albacete;All ages;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
02 Albacete;All ages;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
02 Albacete;All ages;Cohort April 1;Total;Survival in the first trimester;2021QII;24.719
02 Albacete;All ages;Cohort April 1;Total;Survival in the first trimester;2021QI;""
02 Albacete;All ages;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
02 Albacete;All ages;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
02 Albacete;All ages;Cohort April 1;Total;Survival in the first trimester;2020QII;24.286
02 Albacete;All ages;Cohort April 1;Total;Survival in the first trimester;2020QI;""
02 Albacete;All ages;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
02 Albacete;All ages;Cohort April 1;Total;Survival in the second trimester;2022QIII;23.864
02 Albacete;All ages;Cohort April 1;Total;Survival in the second trimester;2022QII;""
02 Albacete;All ages;Cohort April 1;Total;Survival in the second trimester;2022QI;""
02 Albacete;All ages;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
02 Albacete;All ages;Cohort April 1;Total;Survival in the second trimester;2021QIII;24.090
02 Albacete;All ages;Cohort April 1;Total;Survival in the second trimester;2021QII;""
02 Albacete;All ages;Cohort April 1;Total;Survival in the second trimester;2021QI;""
02 Albacete;All ages;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
02 Albacete;All ages;Cohort April 1;Total;Survival in the second trimester;2020QIII;23.678
02 Albacete;All ages;Cohort April 1;Total;Survival in the second trimester;2020QII;""
02 Albacete;All ages;Cohort April 1;Total;Survival in the second trimester;2020QI;""
02 Albacete;All ages;Cohort April 1;Total;Survival in the third trimester;2022QIV;23.095
02 Albacete;All ages;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
02 Albacete;All ages;Cohort April 1;Total;Survival in the third trimester;2022QII;""
02 Albacete;All ages;Cohort April 1;Total;Survival in the third trimester;2022QI;""
02 Albacete;All ages;Cohort April 1;Total;Survival in the third trimester;2021QIV;23.438
02 Albacete;All ages;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
02 Albacete;All ages;Cohort April 1;Total;Survival in the third trimester;2021QII;""
02 Albacete;All ages;Cohort April 1;Total;Survival in the third trimester;2021QI;""
02 Albacete;All ages;Cohort April 1;Total;Survival in the third trimester;2020QIV;23.134
02 Albacete;All ages;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
02 Albacete;All ages;Cohort April 1;Total;Survival in the third trimester;2020QII;""
02 Albacete;All ages;Cohort April 1;Total;Survival in the third trimester;2020QI;""
02 Albacete;All ages;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
02 Albacete;All ages;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
02 Albacete;All ages;Cohort April 1;Total;Survival in the third trimester;2022QII;""
02 Albacete;All ages;Cohort April 1;Total;Survival in the third trimester;2022QI;22.860
02 Albacete;All ages;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
02 Albacete;All ages;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
02 Albacete;All ages;Cohort April 1;Total;Survival in the third trimester;2021QII;""
02 Albacete;All ages;Cohort April 1;Total;Survival in the third trimester;2021QI;22.761
02 Albacete;All ages;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
02 Albacete;All ages;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
02 Albacete;All ages;Cohort April 1;Total;Survival in the third trimester;2020QII;""
02 Albacete;All ages;Cohort April 1;Total;Survival in the third trimester;2020QI;""
02 Albacete;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
02 Albacete;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
02 Albacete;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
02 Albacete;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
02 Albacete;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
02 Albacete;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
02 Albacete;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
02 Albacete;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
02 Albacete;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
02 Albacete;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
02 Albacete;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
02 Albacete;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
02 Albacete;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
02 Albacete;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
02 Albacete;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;96,51
02 Albacete;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
02 Albacete;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
02 Albacete;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
02 Albacete;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;97,25
02 Albacete;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
02 Albacete;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
02 Albacete;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
02 Albacete;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;98,2
02 Albacete;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
02 Albacete;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
02 Albacete;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;93,81
02 Albacete;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
02 Albacete;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
02 Albacete;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
02 Albacete;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;94,77
02 Albacete;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
02 Albacete;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
02 Albacete;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
02 Albacete;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;95,75
02 Albacete;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
02 Albacete;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
02 Albacete;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;90,79
02 Albacete;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
02 Albacete;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
02 Albacete;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
02 Albacete;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;92,21
02 Albacete;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
02 Albacete;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
02 Albacete;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
02 Albacete;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;93,55
02 Albacete;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
02 Albacete;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
02 Albacete;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
02 Albacete;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
02 Albacete;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
02 Albacete;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
02 Albacete;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;89,93
02 Albacete;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
02 Albacete;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
02 Albacete;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
02 Albacete;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;92,04
02 Albacete;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
02 Albacete;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
02 Albacete;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
02 Albacete;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
02 Albacete;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
02 Albacete;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
02 Albacete;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QII;16.885
02 Albacete;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
02 Albacete;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
02 Albacete;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
02 Albacete;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QII;16.973
02 Albacete;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
02 Albacete;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
02 Albacete;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
02 Albacete;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QII;16.521
02 Albacete;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
02 Albacete;All ages;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
02 Albacete;All ages;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
02 Albacete;All ages;Cohort April 1;Males;Survival in the first trimester;2022QII;16.370
02 Albacete;All ages;Cohort April 1;Males;Survival in the first trimester;2022QI;""
02 Albacete;All ages;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
02 Albacete;All ages;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
02 Albacete;All ages;Cohort April 1;Males;Survival in the first trimester;2021QII;16.571
02 Albacete;All ages;Cohort April 1;Males;Survival in the first trimester;2021QI;""
02 Albacete;All ages;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
02 Albacete;All ages;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
02 Albacete;All ages;Cohort April 1;Males;Survival in the first trimester;2020QII;16.275
02 Albacete;All ages;Cohort April 1;Males;Survival in the first trimester;2020QI;""
02 Albacete;All ages;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
02 Albacete;All ages;Cohort April 1;Males;Survival in the second trimester;2022QIII;15.953
02 Albacete;All ages;Cohort April 1;Males;Survival in the second trimester;2022QII;""
02 Albacete;All ages;Cohort April 1;Males;Survival in the second trimester;2022QI;""
02 Albacete;All ages;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
02 Albacete;All ages;Cohort April 1;Males;Survival in the second trimester;2021QIII;16.166
02 Albacete;All ages;Cohort April 1;Males;Survival in the second trimester;2021QII;""
02 Albacete;All ages;Cohort April 1;Males;Survival in the second trimester;2021QI;""
02 Albacete;All ages;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
02 Albacete;All ages;Cohort April 1;Males;Survival in the second trimester;2020QIII;15.900
02 Albacete;All ages;Cohort April 1;Males;Survival in the second trimester;2020QII;""
02 Albacete;All ages;Cohort April 1;Males;Survival in the second trimester;2020QI;""
02 Albacete;All ages;Cohort April 1;Males;Survival in the third trimester;2022QIV;15.456
02 Albacete;All ages;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
02 Albacete;All ages;Cohort April 1;Males;Survival in the third trimester;2022QII;""
02 Albacete;All ages;Cohort April 1;Males;Survival in the third trimester;2022QI;""
02 Albacete;All ages;Cohort April 1;Males;Survival in the third trimester;2021QIV;15.749
02 Albacete;All ages;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
02 Albacete;All ages;Cohort April 1;Males;Survival in the third trimester;2021QII;""
02 Albacete;All ages;Cohort April 1;Males;Survival in the third trimester;2021QI;""
02 Albacete;All ages;Cohort April 1;Males;Survival in the third trimester;2020QIV;15.567
02 Albacete;All ages;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
02 Albacete;All ages;Cohort April 1;Males;Survival in the third trimester;2020QII;""
02 Albacete;All ages;Cohort April 1;Males;Survival in the third trimester;2020QI;""
02 Albacete;All ages;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
02 Albacete;All ages;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
02 Albacete;All ages;Cohort April 1;Males;Survival in the third trimester;2022QII;""
02 Albacete;All ages;Cohort April 1;Males;Survival in the third trimester;2022QI;15.422
02 Albacete;All ages;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
02 Albacete;All ages;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
02 Albacete;All ages;Cohort April 1;Males;Survival in the third trimester;2021QII;""
02 Albacete;All ages;Cohort April 1;Males;Survival in the third trimester;2021QI;15.322
02 Albacete;All ages;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
02 Albacete;All ages;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
02 Albacete;All ages;Cohort April 1;Males;Survival in the third trimester;2020QII;""
02 Albacete;All ages;Cohort April 1;Males;Survival in the third trimester;2020QI;""
02 Albacete;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
02 Albacete;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
02 Albacete;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
02 Albacete;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
02 Albacete;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
02 Albacete;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
02 Albacete;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
02 Albacete;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
02 Albacete;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
02 Albacete;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
02 Albacete;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
02 Albacete;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
02 Albacete;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
02 Albacete;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
02 Albacete;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;96,95
02 Albacete;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
02 Albacete;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
02 Albacete;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
02 Albacete;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;97,63
02 Albacete;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
02 Albacete;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
02 Albacete;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
02 Albacete;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;98,51
02 Albacete;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
02 Albacete;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
02 Albacete;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;94,48
02 Albacete;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
02 Albacete;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
02 Albacete;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
02 Albacete;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;95,25
02 Albacete;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
02 Albacete;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
02 Albacete;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
02 Albacete;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;96,24
02 Albacete;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
02 Albacete;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
02 Albacete;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;91,54
02 Albacete;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
02 Albacete;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
02 Albacete;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
02 Albacete;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;92,79
02 Albacete;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
02 Albacete;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
02 Albacete;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
02 Albacete;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;94,23
02 Albacete;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
02 Albacete;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
02 Albacete;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
02 Albacete;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
02 Albacete;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
02 Albacete;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
02 Albacete;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;90,86
02 Albacete;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
02 Albacete;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
02 Albacete;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
02 Albacete;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;92,74
02 Albacete;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
02 Albacete;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
02 Albacete;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
02 Albacete;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
02 Albacete;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
02 Albacete;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
02 Albacete;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QII;8.554
02 Albacete;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
02 Albacete;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
02 Albacete;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
02 Albacete;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QII;8.446
02 Albacete;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
02 Albacete;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
02 Albacete;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
02 Albacete;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QII;8.209
02 Albacete;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
02 Albacete;All ages;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
02 Albacete;All ages;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
02 Albacete;All ages;Cohort April 1;Females;Survival in the first trimester;2022QII;8.182
02 Albacete;All ages;Cohort April 1;Females;Survival in the first trimester;2022QI;""
02 Albacete;All ages;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
02 Albacete;All ages;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
02 Albacete;All ages;Cohort April 1;Females;Survival in the first trimester;2021QII;8.148
02 Albacete;All ages;Cohort April 1;Females;Survival in the first trimester;2021QI;""
02 Albacete;All ages;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
02 Albacete;All ages;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
02 Albacete;All ages;Cohort April 1;Females;Survival in the first trimester;2020QII;8.011
02 Albacete;All ages;Cohort April 1;Females;Survival in the first trimester;2020QI;""
02 Albacete;All ages;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
02 Albacete;All ages;Cohort April 1;Females;Survival in the second trimester;2022QIII;7.911
02 Albacete;All ages;Cohort April 1;Females;Survival in the second trimester;2022QII;""
02 Albacete;All ages;Cohort April 1;Females;Survival in the second trimester;2022QI;""
02 Albacete;All ages;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
02 Albacete;All ages;Cohort April 1;Females;Survival in the second trimester;2021QIII;7.924
02 Albacete;All ages;Cohort April 1;Females;Survival in the second trimester;2021QII;""
02 Albacete;All ages;Cohort April 1;Females;Survival in the second trimester;2021QI;""
02 Albacete;All ages;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
02 Albacete;All ages;Cohort April 1;Females;Survival in the second trimester;2020QIII;7.778
02 Albacete;All ages;Cohort April 1;Females;Survival in the second trimester;2020QII;""
02 Albacete;All ages;Cohort April 1;Females;Survival in the second trimester;2020QI;""
02 Albacete;All ages;Cohort April 1;Females;Survival in the third trimester;2022QIV;7.639
02 Albacete;All ages;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
02 Albacete;All ages;Cohort April 1;Females;Survival in the third trimester;2022QII;""
02 Albacete;All ages;Cohort April 1;Females;Survival in the third trimester;2022QI;""
02 Albacete;All ages;Cohort April 1;Females;Survival in the third trimester;2021QIV;7.689
02 Albacete;All ages;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
02 Albacete;All ages;Cohort April 1;Females;Survival in the third trimester;2021QII;""
02 Albacete;All ages;Cohort April 1;Females;Survival in the third trimester;2021QI;""
02 Albacete;All ages;Cohort April 1;Females;Survival in the third trimester;2020QIV;7.567
02 Albacete;All ages;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
02 Albacete;All ages;Cohort April 1;Females;Survival in the third trimester;2020QII;""
02 Albacete;All ages;Cohort April 1;Females;Survival in the third trimester;2020QI;""
02 Albacete;All ages;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
02 Albacete;All ages;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
02 Albacete;All ages;Cohort April 1;Females;Survival in the third trimester;2022QII;""
02 Albacete;All ages;Cohort April 1;Females;Survival in the third trimester;2022QI;7.438
02 Albacete;All ages;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
02 Albacete;All ages;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
02 Albacete;All ages;Cohort April 1;Females;Survival in the third trimester;2021QII;""
02 Albacete;All ages;Cohort April 1;Females;Survival in the third trimester;2021QI;7.439
02 Albacete;All ages;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
02 Albacete;All ages;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
02 Albacete;All ages;Cohort April 1;Females;Survival in the third trimester;2020QII;""
02 Albacete;All ages;Cohort April 1;Females;Survival in the third trimester;2020QI;""
02 Albacete;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
02 Albacete;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
02 Albacete;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
02 Albacete;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
02 Albacete;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
02 Albacete;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
02 Albacete;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
02 Albacete;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
02 Albacete;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
02 Albacete;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
02 Albacete;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
02 Albacete;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
02 Albacete;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
02 Albacete;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
02 Albacete;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;95,65
02 Albacete;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
02 Albacete;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
02 Albacete;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
02 Albacete;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;96,47
02 Albacete;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
02 Albacete;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
02 Albacete;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
02 Albacete;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;97,59
02 Albacete;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
02 Albacete;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
02 Albacete;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;92,48
02 Albacete;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
02 Albacete;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
02 Albacete;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
02 Albacete;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;93,82
02 Albacete;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
02 Albacete;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
02 Albacete;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
02 Albacete;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;94,75
02 Albacete;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
02 Albacete;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
02 Albacete;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;89,3
02 Albacete;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
02 Albacete;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
02 Albacete;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
02 Albacete;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;91,04
02 Albacete;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
02 Albacete;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
02 Albacete;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
02 Albacete;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;92,18
02 Albacete;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
02 Albacete;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
02 Albacete;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
02 Albacete;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
02 Albacete;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
02 Albacete;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
02 Albacete;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;88,07
02 Albacete;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
02 Albacete;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
02 Albacete;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
02 Albacete;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;90,62
02 Albacete;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
02 Albacete;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
02 Albacete;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
02 Albacete;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
02 Albacete;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
02 Albacete;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QIII;25.384
02 Albacete;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
02 Albacete;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
02 Albacete;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
02 Albacete;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QIII;25.568
02 Albacete;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
02 Albacete;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
02 Albacete;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
02 Albacete;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QIII;25.168
02 Albacete;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
02 Albacete;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
02 Albacete;All ages;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
02 Albacete;All ages;Cohort July 1;Total;Survival in the first trimester;2022QIII;24.545
02 Albacete;All ages;Cohort July 1;Total;Survival in the first trimester;2022QII;""
02 Albacete;All ages;Cohort July 1;Total;Survival in the first trimester;2022QI;""
02 Albacete;All ages;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
02 Albacete;All ages;Cohort July 1;Total;Survival in the first trimester;2021QIII;24.795
02 Albacete;All ages;Cohort July 1;Total;Survival in the first trimester;2021QII;""
02 Albacete;All ages;Cohort July 1;Total;Survival in the first trimester;2021QI;""
02 Albacete;All ages;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
02 Albacete;All ages;Cohort July 1;Total;Survival in the first trimester;2020QIII;24.405
02 Albacete;All ages;Cohort July 1;Total;Survival in the first trimester;2020QII;""
02 Albacete;All ages;Cohort July 1;Total;Survival in the first trimester;2020QI;""
02 Albacete;All ages;Cohort July 1;Total;Survival in the second trimester;2022QIV;23.702
02 Albacete;All ages;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
02 Albacete;All ages;Cohort July 1;Total;Survival in the second trimester;2022QII;""
02 Albacete;All ages;Cohort July 1;Total;Survival in the second trimester;2022QI;""
02 Albacete;All ages;Cohort July 1;Total;Survival in the second trimester;2021QIV;24.059
02 Albacete;All ages;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
02 Albacete;All ages;Cohort July 1;Total;Survival in the second trimester;2021QII;""
02 Albacete;All ages;Cohort July 1;Total;Survival in the second trimester;2021QI;""
02 Albacete;All ages;Cohort July 1;Total;Survival in the second trimester;2020QIV;23.769
02 Albacete;All ages;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
02 Albacete;All ages;Cohort July 1;Total;Survival in the second trimester;2020QII;""
02 Albacete;All ages;Cohort July 1;Total;Survival in the second trimester;2020QI;""
02 Albacete;All ages;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
02 Albacete;All ages;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
02 Albacete;All ages;Cohort July 1;Total;Survival in the third trimester;2022QII;""
02 Albacete;All ages;Cohort July 1;Total;Survival in the third trimester;2022QI;23.436
02 Albacete;All ages;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
02 Albacete;All ages;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
02 Albacete;All ages;Cohort July 1;Total;Survival in the third trimester;2021QII;""
02 Albacete;All ages;Cohort July 1;Total;Survival in the third trimester;2021QI;23.372
02 Albacete;All ages;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
02 Albacete;All ages;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
02 Albacete;All ages;Cohort July 1;Total;Survival in the third trimester;2020QII;""
02 Albacete;All ages;Cohort July 1;Total;Survival in the third trimester;2020QI;""
02 Albacete;All ages;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
02 Albacete;All ages;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
02 Albacete;All ages;Cohort July 1;Total;Survival in the third trimester;2022QII;22.789
02 Albacete;All ages;Cohort July 1;Total;Survival in the third trimester;2022QI;""
02 Albacete;All ages;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
02 Albacete;All ages;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
02 Albacete;All ages;Cohort July 1;Total;Survival in the third trimester;2021QII;22.866
02 Albacete;All ages;Cohort July 1;Total;Survival in the third trimester;2021QI;""
02 Albacete;All ages;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
02 Albacete;All ages;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
02 Albacete;All ages;Cohort July 1;Total;Survival in the third trimester;2020QII;""
02 Albacete;All ages;Cohort July 1;Total;Survival in the third trimester;2020QI;""
02 Albacete;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
02 Albacete;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
02 Albacete;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
02 Albacete;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
02 Albacete;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
02 Albacete;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
02 Albacete;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
02 Albacete;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
02 Albacete;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
02 Albacete;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
02 Albacete;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
02 Albacete;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
02 Albacete;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
02 Albacete;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;96,69
02 Albacete;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
02 Albacete;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
02 Albacete;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
02 Albacete;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;96,98
02 Albacete;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
02 Albacete;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
02 Albacete;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
02 Albacete;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;96,97
02 Albacete;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
02 Albacete;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
02 Albacete;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;93,37
02 Albacete;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
02 Albacete;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
02 Albacete;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
02 Albacete;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;94,1
02 Albacete;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
02 Albacete;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
02 Albacete;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
02 Albacete;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;94,44
02 Albacete;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
02 Albacete;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
02 Albacete;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
02 Albacete;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
02 Albacete;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
02 Albacete;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
02 Albacete;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;91,66
02 Albacete;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
02 Albacete;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
02 Albacete;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
02 Albacete;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;92,86
02 Albacete;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
02 Albacete;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
02 Albacete;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
02 Albacete;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
02 Albacete;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
02 Albacete;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
02 Albacete;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;89,13
02 Albacete;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
02 Albacete;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
02 Albacete;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
02 Albacete;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;90,85
02 Albacete;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
02 Albacete;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
02 Albacete;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
02 Albacete;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
02 Albacete;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
02 Albacete;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
02 Albacete;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QIII;16.852
02 Albacete;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
02 Albacete;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
02 Albacete;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
02 Albacete;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QIII;17.083
02 Albacete;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
02 Albacete;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
02 Albacete;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
02 Albacete;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QIII;16.892
02 Albacete;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
02 Albacete;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
02 Albacete;All ages;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
02 Albacete;All ages;Cohort July 1;Males;Survival in the first trimester;2022QIII;16.346
02 Albacete;All ages;Cohort July 1;Males;Survival in the first trimester;2022QII;""
02 Albacete;All ages;Cohort July 1;Males;Survival in the first trimester;2022QI;""
02 Albacete;All ages;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
02 Albacete;All ages;Cohort July 1;Males;Survival in the first trimester;2021QIII;16.588
02 Albacete;All ages;Cohort July 1;Males;Survival in the first trimester;2021QII;""
02 Albacete;All ages;Cohort July 1;Males;Survival in the first trimester;2021QI;""
02 Albacete;All ages;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
02 Albacete;All ages;Cohort July 1;Males;Survival in the first trimester;2020QIII;16.413
02 Albacete;All ages;Cohort July 1;Males;Survival in the first trimester;2020QII;""
02 Albacete;All ages;Cohort July 1;Males;Survival in the first trimester;2020QI;""
02 Albacete;All ages;Cohort July 1;Males;Survival in the second trimester;2022QIV;15.796
02 Albacete;All ages;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
02 Albacete;All ages;Cohort July 1;Males;Survival in the second trimester;2022QII;""
02 Albacete;All ages;Cohort July 1;Males;Survival in the second trimester;2022QI;""
02 Albacete;All ages;Cohort July 1;Males;Survival in the second trimester;2021QIV;16.126
02 Albacete;All ages;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
02 Albacete;All ages;Cohort July 1;Males;Survival in the second trimester;2021QII;""
02 Albacete;All ages;Cohort July 1;Males;Survival in the second trimester;2021QI;""
02 Albacete;All ages;Cohort July 1;Males;Survival in the second trimester;2020QIV;16.011
02 Albacete;All ages;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
02 Albacete;All ages;Cohort July 1;Males;Survival in the second trimester;2020QII;""
02 Albacete;All ages;Cohort July 1;Males;Survival in the second trimester;2020QI;""
02 Albacete;All ages;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
02 Albacete;All ages;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
02 Albacete;All ages;Cohort July 1;Males;Survival in the third trimester;2022QII;""
02 Albacete;All ages;Cohort July 1;Males;Survival in the third trimester;2022QI;15.779
02 Albacete;All ages;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
02 Albacete;All ages;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
02 Albacete;All ages;Cohort July 1;Males;Survival in the third trimester;2021QII;""
02 Albacete;All ages;Cohort July 1;Males;Survival in the third trimester;2021QI;15.749
02 Albacete;All ages;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
02 Albacete;All ages;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
02 Albacete;All ages;Cohort July 1;Males;Survival in the third trimester;2020QII;""
02 Albacete;All ages;Cohort July 1;Males;Survival in the third trimester;2020QI;""
02 Albacete;All ages;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
02 Albacete;All ages;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
02 Albacete;All ages;Cohort July 1;Males;Survival in the third trimester;2022QII;15.391
02 Albacete;All ages;Cohort July 1;Males;Survival in the third trimester;2022QI;""
02 Albacete;All ages;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
02 Albacete;All ages;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
02 Albacete;All ages;Cohort July 1;Males;Survival in the third trimester;2021QII;15.460
02 Albacete;All ages;Cohort July 1;Males;Survival in the third trimester;2021QI;""
02 Albacete;All ages;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
02 Albacete;All ages;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
02 Albacete;All ages;Cohort July 1;Males;Survival in the third trimester;2020QII;""
02 Albacete;All ages;Cohort July 1;Males;Survival in the third trimester;2020QI;""
02 Albacete;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
02 Albacete;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
02 Albacete;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
02 Albacete;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
02 Albacete;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
02 Albacete;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
02 Albacete;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
02 Albacete;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
02 Albacete;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
02 Albacete;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
02 Albacete;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
02 Albacete;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
02 Albacete;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
02 Albacete;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;97
02 Albacete;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
02 Albacete;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
02 Albacete;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
02 Albacete;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;97,1
02 Albacete;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
02 Albacete;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
02 Albacete;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
02 Albacete;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;97,16
02 Albacete;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
02 Albacete;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
02 Albacete;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;93,73
02 Albacete;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
02 Albacete;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
02 Albacete;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
02 Albacete;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;94,4
02 Albacete;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
02 Albacete;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
02 Albacete;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
02 Albacete;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;94,78
02 Albacete;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
02 Albacete;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
02 Albacete;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
02 Albacete;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
02 Albacete;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
02 Albacete;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
02 Albacete;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;92,37
02 Albacete;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
02 Albacete;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
02 Albacete;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
02 Albacete;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;93,23
02 Albacete;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
02 Albacete;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
02 Albacete;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
02 Albacete;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
02 Albacete;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
02 Albacete;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
02 Albacete;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;90,1
02 Albacete;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
02 Albacete;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
02 Albacete;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
02 Albacete;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;91,52
02 Albacete;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
02 Albacete;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
02 Albacete;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
02 Albacete;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
02 Albacete;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
02 Albacete;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
02 Albacete;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QIII;8.532
02 Albacete;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
02 Albacete;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
02 Albacete;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
02 Albacete;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QIII;8.485
02 Albacete;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
02 Albacete;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
02 Albacete;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
02 Albacete;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QIII;8.276
02 Albacete;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
02 Albacete;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
02 Albacete;All ages;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
02 Albacete;All ages;Cohort July 1;Females;Survival in the first trimester;2022QIII;8.199
02 Albacete;All ages;Cohort July 1;Females;Survival in the first trimester;2022QII;""
02 Albacete;All ages;Cohort July 1;Females;Survival in the first trimester;2022QI;""
02 Albacete;All ages;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
02 Albacete;All ages;Cohort July 1;Females;Survival in the first trimester;2021QIII;8.207
02 Albacete;All ages;Cohort July 1;Females;Survival in the first trimester;2021QII;""
02 Albacete;All ages;Cohort July 1;Females;Survival in the first trimester;2021QI;""
02 Albacete;All ages;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
02 Albacete;All ages;Cohort July 1;Females;Survival in the first trimester;2020QIII;7.992
02 Albacete;All ages;Cohort July 1;Females;Survival in the first trimester;2020QII;""
02 Albacete;All ages;Cohort July 1;Females;Survival in the first trimester;2020QI;""
02 Albacete;All ages;Cohort July 1;Females;Survival in the second trimester;2022QIV;7.906
02 Albacete;All ages;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
02 Albacete;All ages;Cohort July 1;Females;Survival in the second trimester;2022QII;""
02 Albacete;All ages;Cohort July 1;Females;Survival in the second trimester;2022QI;""
02 Albacete;All ages;Cohort July 1;Females;Survival in the second trimester;2021QIV;7.933
02 Albacete;All ages;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
02 Albacete;All ages;Cohort July 1;Females;Survival in the second trimester;2021QII;""
02 Albacete;All ages;Cohort July 1;Females;Survival in the second trimester;2021QI;""
02 Albacete;All ages;Cohort July 1;Females;Survival in the second trimester;2020QIV;7.758
02 Albacete;All ages;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
02 Albacete;All ages;Cohort July 1;Females;Survival in the second trimester;2020QII;""
02 Albacete;All ages;Cohort July 1;Females;Survival in the second trimester;2020QI;""
02 Albacete;All ages;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
02 Albacete;All ages;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
02 Albacete;All ages;Cohort July 1;Females;Survival in the third trimester;2022QII;""
02 Albacete;All ages;Cohort July 1;Females;Survival in the third trimester;2022QI;7.657
02 Albacete;All ages;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
02 Albacete;All ages;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
02 Albacete;All ages;Cohort July 1;Females;Survival in the third trimester;2021QII;""
02 Albacete;All ages;Cohort July 1;Females;Survival in the third trimester;2021QI;7.623
02 Albacete;All ages;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
02 Albacete;All ages;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
02 Albacete;All ages;Cohort July 1;Females;Survival in the third trimester;2020QII;""
02 Albacete;All ages;Cohort July 1;Females;Survival in the third trimester;2020QI;""
02 Albacete;All ages;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
02 Albacete;All ages;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
02 Albacete;All ages;Cohort July 1;Females;Survival in the third trimester;2022QII;7.398
02 Albacete;All ages;Cohort July 1;Females;Survival in the third trimester;2022QI;""
02 Albacete;All ages;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
02 Albacete;All ages;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
02 Albacete;All ages;Cohort July 1;Females;Survival in the third trimester;2021QII;7.406
02 Albacete;All ages;Cohort July 1;Females;Survival in the third trimester;2021QI;""
02 Albacete;All ages;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
02 Albacete;All ages;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
02 Albacete;All ages;Cohort July 1;Females;Survival in the third trimester;2020QII;""
02 Albacete;All ages;Cohort July 1;Females;Survival in the third trimester;2020QI;""
02 Albacete;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
02 Albacete;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
02 Albacete;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
02 Albacete;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
02 Albacete;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
02 Albacete;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
02 Albacete;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
02 Albacete;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
02 Albacete;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
02 Albacete;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
02 Albacete;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
02 Albacete;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
02 Albacete;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
02 Albacete;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;96,1
02 Albacete;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
02 Albacete;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
02 Albacete;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
02 Albacete;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;96,72
02 Albacete;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
02 Albacete;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
02 Albacete;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
02 Albacete;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;96,57
02 Albacete;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
02 Albacete;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
02 Albacete;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;92,66
02 Albacete;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
02 Albacete;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
02 Albacete;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
02 Albacete;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;93,49
02 Albacete;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
02 Albacete;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
02 Albacete;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
02 Albacete;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;93,74
02 Albacete;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
02 Albacete;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
02 Albacete;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
02 Albacete;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
02 Albacete;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
02 Albacete;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
02 Albacete;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;90,24
02 Albacete;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
02 Albacete;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
02 Albacete;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
02 Albacete;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;92,11
02 Albacete;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
02 Albacete;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
02 Albacete;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
02 Albacete;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
02 Albacete;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
02 Albacete;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
02 Albacete;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;87,19
02 Albacete;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
02 Albacete;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
02 Albacete;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
02 Albacete;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;89,49
02 Albacete;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
02 Albacete;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
02 Albacete;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
02 Albacete;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
02 Albacete;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
02 Albacete;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QIV;25.209
02 Albacete;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
02 Albacete;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
02 Albacete;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
02 Albacete;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QIV;25.481
02 Albacete;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
02 Albacete;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
02 Albacete;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
02 Albacete;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QIV;25.183
02 Albacete;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
02 Albacete;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
02 Albacete;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
02 Albacete;All ages;Cohort October 1;Total;Survival in the first trimester;2022QIV;24.279
02 Albacete;All ages;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
02 Albacete;All ages;Cohort October 1;Total;Survival in the first trimester;2022QII;""
02 Albacete;All ages;Cohort October 1;Total;Survival in the first trimester;2022QI;""
02 Albacete;All ages;Cohort October 1;Total;Survival in the first trimester;2021QIV;24.645
02 Albacete;All ages;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
02 Albacete;All ages;Cohort October 1;Total;Survival in the first trimester;2021QII;""
02 Albacete;All ages;Cohort October 1;Total;Survival in the first trimester;2021QI;""
02 Albacete;All ages;Cohort October 1;Total;Survival in the first trimester;2020QIV;24.435
02 Albacete;All ages;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
02 Albacete;All ages;Cohort October 1;Total;Survival in the first trimester;2020QII;""
02 Albacete;All ages;Cohort October 1;Total;Survival in the first trimester;2020QI;""
02 Albacete;All ages;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
02 Albacete;All ages;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
02 Albacete;All ages;Cohort October 1;Total;Survival in the second trimester;2022QII;""
02 Albacete;All ages;Cohort October 1;Total;Survival in the second trimester;2022QI;23.972
02 Albacete;All ages;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
02 Albacete;All ages;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
02 Albacete;All ages;Cohort October 1;Total;Survival in the second trimester;2021QII;""
02 Albacete;All ages;Cohort October 1;Total;Survival in the second trimester;2021QI;23.991
02 Albacete;All ages;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
02 Albacete;All ages;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
02 Albacete;All ages;Cohort October 1;Total;Survival in the second trimester;2020QII;""
02 Albacete;All ages;Cohort October 1;Total;Survival in the second trimester;2020QI;""
02 Albacete;All ages;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
02 Albacete;All ages;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
02 Albacete;All ages;Cohort October 1;Total;Survival in the third trimester;2022QII;23.275
02 Albacete;All ages;Cohort October 1;Total;Survival in the third trimester;2022QI;""
02 Albacete;All ages;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
02 Albacete;All ages;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
02 Albacete;All ages;Cohort October 1;Total;Survival in the third trimester;2021QII;23.453
02 Albacete;All ages;Cohort October 1;Total;Survival in the third trimester;2021QI;""
02 Albacete;All ages;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
02 Albacete;All ages;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
02 Albacete;All ages;Cohort October 1;Total;Survival in the third trimester;2020QII;""
02 Albacete;All ages;Cohort October 1;Total;Survival in the third trimester;2020QI;""
02 Albacete;All ages;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
02 Albacete;All ages;Cohort October 1;Total;Survival in the third trimester;2022QIII;22.689
02 Albacete;All ages;Cohort October 1;Total;Survival in the third trimester;2022QII;""
02 Albacete;All ages;Cohort October 1;Total;Survival in the third trimester;2022QI;""
02 Albacete;All ages;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
02 Albacete;All ages;Cohort October 1;Total;Survival in the third trimester;2021QIII;22.944
02 Albacete;All ages;Cohort October 1;Total;Survival in the third trimester;2021QII;""
02 Albacete;All ages;Cohort October 1;Total;Survival in the third trimester;2021QI;""
02 Albacete;All ages;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
02 Albacete;All ages;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
02 Albacete;All ages;Cohort October 1;Total;Survival in the third trimester;2020QII;""
02 Albacete;All ages;Cohort October 1;Total;Survival in the third trimester;2020QI;""
02 Albacete;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
02 Albacete;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
02 Albacete;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
02 Albacete;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
02 Albacete;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
02 Albacete;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
02 Albacete;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
02 Albacete;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
02 Albacete;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
02 Albacete;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
02 Albacete;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
02 Albacete;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
02 Albacete;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;96,31
02 Albacete;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
02 Albacete;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
02 Albacete;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
02 Albacete;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;96,72
02 Albacete;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
02 Albacete;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
02 Albacete;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
02 Albacete;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;97,03
02 Albacete;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
02 Albacete;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
02 Albacete;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
02 Albacete;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
02 Albacete;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
02 Albacete;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
02 Albacete;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;94,08
02 Albacete;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
02 Albacete;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
02 Albacete;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
02 Albacete;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;95,27
02 Albacete;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
02 Albacete;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
02 Albacete;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
02 Albacete;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
02 Albacete;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
02 Albacete;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
02 Albacete;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;91,34
02 Albacete;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
02 Albacete;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
02 Albacete;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
02 Albacete;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;93,13
02 Albacete;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
02 Albacete;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
02 Albacete;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
02 Albacete;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
02 Albacete;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
02 Albacete;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
02 Albacete;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;89,04
02 Albacete;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
02 Albacete;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
02 Albacete;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
02 Albacete;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;91,11
02 Albacete;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
02 Albacete;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
02 Albacete;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
02 Albacete;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
02 Albacete;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
02 Albacete;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
02 Albacete;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QIV;16.712
02 Albacete;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
02 Albacete;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
02 Albacete;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
02 Albacete;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QIV;16.972
02 Albacete;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
02 Albacete;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
02 Albacete;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
02 Albacete;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QIV;16.908
02 Albacete;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
02 Albacete;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
02 Albacete;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
02 Albacete;All ages;Cohort October 1;Males;Survival in the first trimester;2022QIV;16.098
02 Albacete;All ages;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
02 Albacete;All ages;Cohort October 1;Males;Survival in the first trimester;2022QII;""
02 Albacete;All ages;Cohort October 1;Males;Survival in the first trimester;2022QI;""
02 Albacete;All ages;Cohort October 1;Males;Survival in the first trimester;2021QIV;16.445
02 Albacete;All ages;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
02 Albacete;All ages;Cohort October 1;Males;Survival in the first trimester;2021QII;""
02 Albacete;All ages;Cohort October 1;Males;Survival in the first trimester;2021QI;""
02 Albacete;All ages;Cohort October 1;Males;Survival in the first trimester;2020QIV;16.424
02 Albacete;All ages;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
02 Albacete;All ages;Cohort October 1;Males;Survival in the first trimester;2020QII;""
02 Albacete;All ages;Cohort October 1;Males;Survival in the first trimester;2020QI;""
02 Albacete;All ages;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
02 Albacete;All ages;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
02 Albacete;All ages;Cohort October 1;Males;Survival in the second trimester;2022QII;""
02 Albacete;All ages;Cohort October 1;Males;Survival in the second trimester;2022QI;16.064
02 Albacete;All ages;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
02 Albacete;All ages;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
02 Albacete;All ages;Cohort October 1;Males;Survival in the second trimester;2021QII;""
02 Albacete;All ages;Cohort October 1;Males;Survival in the second trimester;2021QI;16.132
02 Albacete;All ages;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
02 Albacete;All ages;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
02 Albacete;All ages;Cohort October 1;Males;Survival in the second trimester;2020QII;""
02 Albacete;All ages;Cohort October 1;Males;Survival in the second trimester;2020QI;""
02 Albacete;All ages;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
02 Albacete;All ages;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
02 Albacete;All ages;Cohort October 1;Males;Survival in the third trimester;2022QII;15.656
02 Albacete;All ages;Cohort October 1;Males;Survival in the third trimester;2022QI;""
02 Albacete;All ages;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
02 Albacete;All ages;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
02 Albacete;All ages;Cohort October 1;Males;Survival in the third trimester;2021QII;15.828
02 Albacete;All ages;Cohort October 1;Males;Survival in the third trimester;2021QI;""
02 Albacete;All ages;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
02 Albacete;All ages;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
02 Albacete;All ages;Cohort October 1;Males;Survival in the third trimester;2020QII;""
02 Albacete;All ages;Cohort October 1;Males;Survival in the third trimester;2020QI;""
02 Albacete;All ages;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
02 Albacete;All ages;Cohort October 1;Males;Survival in the third trimester;2022QIII;15.301
02 Albacete;All ages;Cohort October 1;Males;Survival in the third trimester;2022QII;""
02 Albacete;All ages;Cohort October 1;Males;Survival in the third trimester;2022QI;""
02 Albacete;All ages;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
02 Albacete;All ages;Cohort October 1;Males;Survival in the third trimester;2021QIII;15.504
02 Albacete;All ages;Cohort October 1;Males;Survival in the third trimester;2021QII;""
02 Albacete;All ages;Cohort October 1;Males;Survival in the third trimester;2021QI;""
02 Albacete;All ages;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
02 Albacete;All ages;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
02 Albacete;All ages;Cohort October 1;Males;Survival in the third trimester;2020QII;""
02 Albacete;All ages;Cohort October 1;Males;Survival in the third trimester;2020QI;""
02 Albacete;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
02 Albacete;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
02 Albacete;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
02 Albacete;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
02 Albacete;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
02 Albacete;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
02 Albacete;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
02 Albacete;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
02 Albacete;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
02 Albacete;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
02 Albacete;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
02 Albacete;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
02 Albacete;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;96,33
02 Albacete;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
02 Albacete;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
02 Albacete;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
02 Albacete;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;96,89
02 Albacete;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
02 Albacete;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
02 Albacete;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
02 Albacete;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;97,14
02 Albacete;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
02 Albacete;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
02 Albacete;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
02 Albacete;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
02 Albacete;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
02 Albacete;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
02 Albacete;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;94,65
02 Albacete;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
02 Albacete;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
02 Albacete;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
02 Albacete;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;95,41
02 Albacete;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
02 Albacete;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
02 Albacete;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
02 Albacete;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
02 Albacete;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
02 Albacete;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
02 Albacete;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;92,25
02 Albacete;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
02 Albacete;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
02 Albacete;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
02 Albacete;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;93,61
02 Albacete;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
02 Albacete;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
02 Albacete;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
02 Albacete;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
02 Albacete;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
02 Albacete;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
02 Albacete;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;90,15
02 Albacete;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
02 Albacete;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
02 Albacete;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
02 Albacete;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;91,7
02 Albacete;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
02 Albacete;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
02 Albacete;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
02 Albacete;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
02 Albacete;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
02 Albacete;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
02 Albacete;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QIV;8.497
02 Albacete;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
02 Albacete;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
02 Albacete;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
02 Albacete;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QIV;8.509
02 Albacete;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
02 Albacete;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
02 Albacete;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
02 Albacete;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QIV;8.275
02 Albacete;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
02 Albacete;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
02 Albacete;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
02 Albacete;All ages;Cohort October 1;Females;Survival in the first trimester;2022QIV;8.181
02 Albacete;All ages;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
02 Albacete;All ages;Cohort October 1;Females;Survival in the first trimester;2022QII;""
02 Albacete;All ages;Cohort October 1;Females;Survival in the first trimester;2022QI;""
02 Albacete;All ages;Cohort October 1;Females;Survival in the first trimester;2021QIV;8.200
02 Albacete;All ages;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
02 Albacete;All ages;Cohort October 1;Females;Survival in the first trimester;2021QII;""
02 Albacete;All ages;Cohort October 1;Females;Survival in the first trimester;2021QI;""
02 Albacete;All ages;Cohort October 1;Females;Survival in the first trimester;2020QIV;8.011
02 Albacete;All ages;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
02 Albacete;All ages;Cohort October 1;Females;Survival in the first trimester;2020QII;""
02 Albacete;All ages;Cohort October 1;Females;Survival in the first trimester;2020QI;""
02 Albacete;All ages;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
02 Albacete;All ages;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
02 Albacete;All ages;Cohort October 1;Females;Survival in the second trimester;2022QII;""
02 Albacete;All ages;Cohort October 1;Females;Survival in the second trimester;2022QI;7.908
02 Albacete;All ages;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
02 Albacete;All ages;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
02 Albacete;All ages;Cohort October 1;Females;Survival in the second trimester;2021QII;""
02 Albacete;All ages;Cohort October 1;Females;Survival in the second trimester;2021QI;7.859
02 Albacete;All ages;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
02 Albacete;All ages;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
02 Albacete;All ages;Cohort October 1;Females;Survival in the second trimester;2020QII;""
02 Albacete;All ages;Cohort October 1;Females;Survival in the second trimester;2020QI;""
02 Albacete;All ages;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
02 Albacete;All ages;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
02 Albacete;All ages;Cohort October 1;Females;Survival in the third trimester;2022QII;7.619
02 Albacete;All ages;Cohort October 1;Females;Survival in the third trimester;2022QI;""
02 Albacete;All ages;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
02 Albacete;All ages;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
02 Albacete;All ages;Cohort October 1;Females;Survival in the third trimester;2021QII;7.625
02 Albacete;All ages;Cohort October 1;Females;Survival in the third trimester;2021QI;""
02 Albacete;All ages;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
02 Albacete;All ages;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
02 Albacete;All ages;Cohort October 1;Females;Survival in the third trimester;2020QII;""
02 Albacete;All ages;Cohort October 1;Females;Survival in the third trimester;2020QI;""
02 Albacete;All ages;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
02 Albacete;All ages;Cohort October 1;Females;Survival in the third trimester;2022QIII;7.388
02 Albacete;All ages;Cohort October 1;Females;Survival in the third trimester;2022QII;""
02 Albacete;All ages;Cohort October 1;Females;Survival in the third trimester;2022QI;""
02 Albacete;All ages;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
02 Albacete;All ages;Cohort October 1;Females;Survival in the third trimester;2021QIII;7.440
02 Albacete;All ages;Cohort October 1;Females;Survival in the third trimester;2021QII;""
02 Albacete;All ages;Cohort October 1;Females;Survival in the third trimester;2021QI;""
02 Albacete;All ages;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
02 Albacete;All ages;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
02 Albacete;All ages;Cohort October 1;Females;Survival in the third trimester;2020QII;""
02 Albacete;All ages;Cohort October 1;Females;Survival in the third trimester;2020QI;""
02 Albacete;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
02 Albacete;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
02 Albacete;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
02 Albacete;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
02 Albacete;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
02 Albacete;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
02 Albacete;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
02 Albacete;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
02 Albacete;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
02 Albacete;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
02 Albacete;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
02 Albacete;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
02 Albacete;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;96,28
02 Albacete;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
02 Albacete;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
02 Albacete;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
02 Albacete;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;96,37
02 Albacete;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
02 Albacete;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
02 Albacete;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
02 Albacete;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;96,81
02 Albacete;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
02 Albacete;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
02 Albacete;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
02 Albacete;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
02 Albacete;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
02 Albacete;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
02 Albacete;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;92,94
02 Albacete;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
02 Albacete;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
02 Albacete;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
02 Albacete;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;94,97
02 Albacete;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
02 Albacete;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
02 Albacete;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
02 Albacete;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
02 Albacete;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
02 Albacete;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
02 Albacete;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;89,54
02 Albacete;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
02 Albacete;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
02 Albacete;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
02 Albacete;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;92,15
02 Albacete;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
02 Albacete;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
02 Albacete;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
02 Albacete;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
02 Albacete;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
02 Albacete;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
02 Albacete;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;86,83
02 Albacete;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
02 Albacete;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
02 Albacete;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
02 Albacete;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;89,91
02 Albacete;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
02 Albacete;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
02 Albacete;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
02 Albacete;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
02 Albacete;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
02 Albacete;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
02 Albacete;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
02 Albacete;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
02 Albacete;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
02 Albacete;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QI;1.730
02 Albacete;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
02 Albacete;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
02 Albacete;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
02 Albacete;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QI;1.702
02 Albacete;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
02 Albacete;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
02 Albacete;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
02 Albacete;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QI;1.405
02 Albacete;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
02 Albacete;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
02 Albacete;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2022QII;""
02 Albacete;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2022QI;1.612
02 Albacete;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
02 Albacete;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
02 Albacete;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2021QII;""
02 Albacete;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2021QI;1.615
02 Albacete;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
02 Albacete;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
02 Albacete;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2020QII;""
02 Albacete;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2020QI;1.250
02 Albacete;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
02 Albacete;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
02 Albacete;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2022QII;1.500
02 Albacete;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2022QI;""
02 Albacete;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
02 Albacete;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
02 Albacete;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2021QII;1.538
02 Albacete;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2021QI;""
02 Albacete;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
02 Albacete;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
02 Albacete;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2020QII;1.210
02 Albacete;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2020QI;""
02 Albacete;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
02 Albacete;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QIII;1.413
02 Albacete;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QII;""
02 Albacete;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QI;""
02 Albacete;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
02 Albacete;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QIII;1.442
02 Albacete;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QII;""
02 Albacete;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QI;""
02 Albacete;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
02 Albacete;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QIII;1.151
02 Albacete;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QII;""
02 Albacete;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QI;""
02 Albacete;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QIV;1.333
02 Albacete;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
02 Albacete;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QII;""
02 Albacete;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QI;""
02 Albacete;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QIV;1.371
02 Albacete;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
02 Albacete;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QII;""
02 Albacete;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QI;""
02 Albacete;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QIV;1.103
02 Albacete;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
02 Albacete;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QII;""
02 Albacete;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QI;""
02 Albacete;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
02 Albacete;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
02 Albacete;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
02 Albacete;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
02 Albacete;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
02 Albacete;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
02 Albacete;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
02 Albacete;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
02 Albacete;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
02 Albacete;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
02 Albacete;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
02 Albacete;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
02 Albacete;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
02 Albacete;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
02 Albacete;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
02 Albacete;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;93,18
02 Albacete;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
02 Albacete;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
02 Albacete;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
02 Albacete;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;94,89
02 Albacete;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
02 Albacete;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
02 Albacete;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
02 Albacete;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;88,97
02 Albacete;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
02 Albacete;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
02 Albacete;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;86,71
02 Albacete;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
02 Albacete;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
02 Albacete;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
02 Albacete;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;90,36
02 Albacete;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
02 Albacete;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
02 Albacete;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
02 Albacete;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;86,12
02 Albacete;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
02 Albacete;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
02 Albacete;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;81,68
02 Albacete;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
02 Albacete;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
02 Albacete;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
02 Albacete;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;84,72
02 Albacete;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
02 Albacete;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
02 Albacete;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
02 Albacete;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;81,92
02 Albacete;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
02 Albacete;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
02 Albacete;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;77,05
02 Albacete;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
02 Albacete;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
02 Albacete;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
02 Albacete;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;80,55
02 Albacete;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
02 Albacete;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
02 Albacete;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
02 Albacete;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;78,51
02 Albacete;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
02 Albacete;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
02 Albacete;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
02 Albacete;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
02 Albacete;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
02 Albacete;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
02 Albacete;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QI;1.064
02 Albacete;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
02 Albacete;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
02 Albacete;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
02 Albacete;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QI;1.091
02 Albacete;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
02 Albacete;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
02 Albacete;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
02 Albacete;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QI;918
02 Albacete;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
02 Albacete;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
02 Albacete;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2022QII;""
02 Albacete;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2022QI;1.002
02 Albacete;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
02 Albacete;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
02 Albacete;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2021QII;""
02 Albacete;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2021QI;1.034
02 Albacete;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
02 Albacete;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
02 Albacete;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2020QII;""
02 Albacete;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2020QI;823
02 Albacete;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
02 Albacete;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
02 Albacete;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2022QII;937
02 Albacete;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2022QI;""
02 Albacete;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
02 Albacete;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
02 Albacete;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2021QII;988
02 Albacete;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2021QI;""
02 Albacete;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
02 Albacete;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
02 Albacete;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2020QII;799
02 Albacete;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2020QI;""
02 Albacete;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
02 Albacete;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QIII;883
02 Albacete;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QII;""
02 Albacete;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QI;""
02 Albacete;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
02 Albacete;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QIII;918
02 Albacete;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QII;""
02 Albacete;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QI;""
02 Albacete;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
02 Albacete;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QIII;763
02 Albacete;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QII;""
02 Albacete;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QI;""
02 Albacete;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QIV;829
02 Albacete;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
02 Albacete;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QII;""
02 Albacete;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QI;""
02 Albacete;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QIV;875
02 Albacete;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
02 Albacete;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QII;""
02 Albacete;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QI;""
02 Albacete;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QIV;738
02 Albacete;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
02 Albacete;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QII;""
02 Albacete;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QI;""
02 Albacete;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
02 Albacete;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
02 Albacete;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
02 Albacete;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
02 Albacete;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
02 Albacete;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
02 Albacete;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
02 Albacete;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
02 Albacete;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
02 Albacete;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
02 Albacete;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
02 Albacete;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
02 Albacete;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
02 Albacete;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
02 Albacete;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
02 Albacete;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;94,17
02 Albacete;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
02 Albacete;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
02 Albacete;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
02 Albacete;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;94,78
02 Albacete;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
02 Albacete;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
02 Albacete;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
02 Albacete;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;89,65
02 Albacete;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
02 Albacete;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
02 Albacete;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;88,06
02 Albacete;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
02 Albacete;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
02 Albacete;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
02 Albacete;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;90,56
02 Albacete;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
02 Albacete;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
02 Albacete;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
02 Albacete;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;87,04
02 Albacete;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
02 Albacete;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
02 Albacete;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;82,99
02 Albacete;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
02 Albacete;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
02 Albacete;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
02 Albacete;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;84,14
02 Albacete;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
02 Albacete;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
02 Albacete;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
02 Albacete;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;83,12
02 Albacete;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
02 Albacete;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
02 Albacete;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;77,91
02 Albacete;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
02 Albacete;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
02 Albacete;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
02 Albacete;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;80,2
02 Albacete;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
02 Albacete;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
02 Albacete;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
02 Albacete;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;80,39
02 Albacete;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
02 Albacete;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
02 Albacete;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
02 Albacete;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
02 Albacete;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
02 Albacete;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
02 Albacete;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QI;666
02 Albacete;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
02 Albacete;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
02 Albacete;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
02 Albacete;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QI;611
02 Albacete;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
02 Albacete;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
02 Albacete;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
02 Albacete;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QI;487
02 Albacete;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
02 Albacete;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
02 Albacete;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2022QII;""
02 Albacete;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2022QI;610
02 Albacete;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
02 Albacete;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
02 Albacete;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2021QII;""
02 Albacete;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2021QI;581
02 Albacete;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
02 Albacete;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
02 Albacete;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2020QII;""
02 Albacete;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2020QI;427
02 Albacete;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
02 Albacete;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
02 Albacete;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2022QII;563
02 Albacete;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2022QI;""
02 Albacete;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
02 Albacete;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
02 Albacete;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2021QII;550
02 Albacete;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2021QI;""
02 Albacete;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
02 Albacete;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
02 Albacete;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2020QII;411
02 Albacete;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2020QI;""
02 Albacete;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
02 Albacete;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QIII;530
02 Albacete;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QII;""
02 Albacete;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QI;""
02 Albacete;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
02 Albacete;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QIII;524
02 Albacete;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QII;""
02 Albacete;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QI;""
02 Albacete;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
02 Albacete;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QIII;388
02 Albacete;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QII;""
02 Albacete;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QI;""
02 Albacete;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QIV;504
02 Albacete;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
02 Albacete;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QII;""
02 Albacete;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QI;""
02 Albacete;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QIV;496
02 Albacete;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
02 Albacete;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QII;""
02 Albacete;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QI;""
02 Albacete;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QIV;365
02 Albacete;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
02 Albacete;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QII;""
02 Albacete;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QI;""
02 Albacete;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
02 Albacete;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
02 Albacete;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
02 Albacete;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
02 Albacete;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
02 Albacete;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
02 Albacete;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
02 Albacete;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
02 Albacete;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
02 Albacete;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
02 Albacete;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
02 Albacete;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
02 Albacete;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
02 Albacete;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
02 Albacete;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
02 Albacete;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;91,59
02 Albacete;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
02 Albacete;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
02 Albacete;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
02 Albacete;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;95,09
02 Albacete;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
02 Albacete;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
02 Albacete;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
02 Albacete;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;87,68
02 Albacete;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
02 Albacete;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
02 Albacete;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;84,53
02 Albacete;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
02 Albacete;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
02 Albacete;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
02 Albacete;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;90,02
02 Albacete;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
02 Albacete;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
02 Albacete;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
02 Albacete;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;84,39
02 Albacete;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
02 Albacete;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
02 Albacete;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;79,58
02 Albacete;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
02 Albacete;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
02 Albacete;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
02 Albacete;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;85,76
02 Albacete;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
02 Albacete;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
02 Albacete;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
02 Albacete;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;79,67
02 Albacete;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
02 Albacete;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
02 Albacete;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;75,68
02 Albacete;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
02 Albacete;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
02 Albacete;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
02 Albacete;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;81,18
02 Albacete;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
02 Albacete;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
02 Albacete;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
02 Albacete;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;74,95
02 Albacete;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
02 Albacete;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
02 Albacete;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
02 Albacete;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
02 Albacete;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
02 Albacete;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QII;1.497
02 Albacete;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
02 Albacete;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
02 Albacete;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
02 Albacete;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QII;1.504
02 Albacete;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
02 Albacete;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
02 Albacete;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
02 Albacete;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QII;1.426
02 Albacete;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
02 Albacete;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
02 Albacete;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
02 Albacete;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2022QII;1.368
02 Albacete;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2022QI;""
02 Albacete;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
02 Albacete;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
02 Albacete;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2021QII;1.411
02 Albacete;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2021QI;""
02 Albacete;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
02 Albacete;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
02 Albacete;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2020QII;1.374
02 Albacete;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2020QI;""
02 Albacete;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
02 Albacete;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2022QIII;1.284
02 Albacete;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2022QII;""
02 Albacete;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2022QI;""
02 Albacete;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
02 Albacete;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2021QIII;1.308
02 Albacete;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2021QII;""
02 Albacete;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2021QI;""
02 Albacete;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
02 Albacete;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2020QIII;1.295
02 Albacete;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2020QII;""
02 Albacete;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2020QI;""
02 Albacete;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QIV;1.201
02 Albacete;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
02 Albacete;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QII;""
02 Albacete;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QI;""
02 Albacete;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QIV;1.234
02 Albacete;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
02 Albacete;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QII;""
02 Albacete;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QI;""
02 Albacete;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QIV;1.236
02 Albacete;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
02 Albacete;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QII;""
02 Albacete;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QI;""
02 Albacete;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
02 Albacete;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
02 Albacete;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QII;""
02 Albacete;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QI;1.173
02 Albacete;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
02 Albacete;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
02 Albacete;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QII;""
02 Albacete;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QI;1.200
02 Albacete;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
02 Albacete;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
02 Albacete;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QII;""
02 Albacete;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QI;""
02 Albacete;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
02 Albacete;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
02 Albacete;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
02 Albacete;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
02 Albacete;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
02 Albacete;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
02 Albacete;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
02 Albacete;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
02 Albacete;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
02 Albacete;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
02 Albacete;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
02 Albacete;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
02 Albacete;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
02 Albacete;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
02 Albacete;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;91,38
02 Albacete;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
02 Albacete;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
02 Albacete;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
02 Albacete;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;93,82
02 Albacete;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
02 Albacete;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
02 Albacete;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
02 Albacete;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;96,35
02 Albacete;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
02 Albacete;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
02 Albacete;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;85,77
02 Albacete;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
02 Albacete;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
02 Albacete;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
02 Albacete;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;86,97
02 Albacete;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
02 Albacete;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
02 Albacete;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
02 Albacete;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;90,81
02 Albacete;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
02 Albacete;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
02 Albacete;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;80,23
02 Albacete;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
02 Albacete;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
02 Albacete;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
02 Albacete;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;82,05
02 Albacete;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
02 Albacete;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
02 Albacete;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
02 Albacete;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;86,68
02 Albacete;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
02 Albacete;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
02 Albacete;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
02 Albacete;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
02 Albacete;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
02 Albacete;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
02 Albacete;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;77,99
02 Albacete;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
02 Albacete;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
02 Albacete;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
02 Albacete;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;84,15
02 Albacete;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
02 Albacete;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
02 Albacete;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
02 Albacete;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
02 Albacete;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
02 Albacete;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
02 Albacete;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QII;932
02 Albacete;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
02 Albacete;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
02 Albacete;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
02 Albacete;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QII;962
02 Albacete;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
02 Albacete;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
02 Albacete;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
02 Albacete;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QII;926
02 Albacete;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
02 Albacete;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
02 Albacete;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
02 Albacete;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2022QII;858
02 Albacete;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2022QI;""
02 Albacete;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
02 Albacete;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
02 Albacete;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2021QII;904
02 Albacete;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2021QI;""
02 Albacete;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
02 Albacete;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
02 Albacete;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2020QII;892
02 Albacete;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2020QI;""
02 Albacete;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
02 Albacete;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2022QIII;804
02 Albacete;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2022QII;""
02 Albacete;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2022QI;""
02 Albacete;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
02 Albacete;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2021QIII;833
02 Albacete;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2021QII;""
02 Albacete;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2021QI;""
02 Albacete;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
02 Albacete;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2020QIII;844
02 Albacete;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2020QII;""
02 Albacete;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2020QI;""
02 Albacete;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QIV;750
02 Albacete;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
02 Albacete;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QII;""
02 Albacete;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QI;""
02 Albacete;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QIV;787
02 Albacete;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
02 Albacete;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QII;""
02 Albacete;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QI;""
02 Albacete;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QIV;812
02 Albacete;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
02 Albacete;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QII;""
02 Albacete;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QI;""
02 Albacete;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
02 Albacete;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
02 Albacete;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QII;""
02 Albacete;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QI;752
02 Albacete;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
02 Albacete;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
02 Albacete;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QII;""
02 Albacete;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QI;788
02 Albacete;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
02 Albacete;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
02 Albacete;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QII;""
02 Albacete;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QI;""
02 Albacete;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
02 Albacete;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
02 Albacete;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
02 Albacete;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
02 Albacete;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
02 Albacete;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
02 Albacete;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
02 Albacete;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
02 Albacete;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
02 Albacete;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
02 Albacete;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
02 Albacete;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
02 Albacete;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
02 Albacete;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
02 Albacete;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;92,06
02 Albacete;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
02 Albacete;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
02 Albacete;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
02 Albacete;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;93,97
02 Albacete;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
02 Albacete;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
02 Albacete;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
02 Albacete;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;96,33
02 Albacete;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
02 Albacete;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
02 Albacete;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;86,27
02 Albacete;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
02 Albacete;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
02 Albacete;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
02 Albacete;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;86,59
02 Albacete;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
02 Albacete;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
02 Albacete;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
02 Albacete;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;91,14
02 Albacete;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
02 Albacete;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
02 Albacete;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;80,47
02 Albacete;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
02 Albacete;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
02 Albacete;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
02 Albacete;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;81,81
02 Albacete;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
02 Albacete;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
02 Albacete;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
02 Albacete;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;87,69
02 Albacete;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
02 Albacete;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
02 Albacete;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
02 Albacete;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
02 Albacete;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
02 Albacete;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
02 Albacete;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;78,17
02 Albacete;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
02 Albacete;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
02 Albacete;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
02 Albacete;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;85,1
02 Albacete;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
02 Albacete;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
02 Albacete;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
02 Albacete;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
02 Albacete;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
02 Albacete;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
02 Albacete;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QII;565
02 Albacete;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
02 Albacete;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
02 Albacete;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
02 Albacete;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QII;542
02 Albacete;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
02 Albacete;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
02 Albacete;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
02 Albacete;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QII;500
02 Albacete;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
02 Albacete;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
02 Albacete;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
02 Albacete;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2022QII;510
02 Albacete;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2022QI;""
02 Albacete;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
02 Albacete;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
02 Albacete;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2021QII;507
02 Albacete;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2021QI;""
02 Albacete;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
02 Albacete;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
02 Albacete;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2020QII;482
02 Albacete;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2020QI;""
02 Albacete;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
02 Albacete;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2022QIII;480
02 Albacete;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2022QII;""
02 Albacete;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2022QI;""
02 Albacete;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
02 Albacete;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2021QIII;475
02 Albacete;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2021QII;""
02 Albacete;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2021QI;""
02 Albacete;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
02 Albacete;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2020QIII;451
02 Albacete;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2020QII;""
02 Albacete;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2020QI;""
02 Albacete;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QIV;451
02 Albacete;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
02 Albacete;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QII;""
02 Albacete;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QI;""
02 Albacete;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QIV;447
02 Albacete;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
02 Albacete;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QII;""
02 Albacete;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QI;""
02 Albacete;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QIV;424
02 Albacete;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
02 Albacete;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QII;""
02 Albacete;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QI;""
02 Albacete;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
02 Albacete;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
02 Albacete;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QII;""
02 Albacete;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QI;421
02 Albacete;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
02 Albacete;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
02 Albacete;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QII;""
02 Albacete;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QI;412
02 Albacete;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
02 Albacete;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
02 Albacete;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QII;""
02 Albacete;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QI;""
02 Albacete;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
02 Albacete;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
02 Albacete;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
02 Albacete;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
02 Albacete;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
02 Albacete;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
02 Albacete;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
02 Albacete;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
02 Albacete;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
02 Albacete;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
02 Albacete;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
02 Albacete;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
02 Albacete;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
02 Albacete;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
02 Albacete;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;90,27
02 Albacete;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
02 Albacete;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
02 Albacete;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
02 Albacete;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;93,54
02 Albacete;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
02 Albacete;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
02 Albacete;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
02 Albacete;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;96,4
02 Albacete;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
02 Albacete;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
02 Albacete;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;84,96
02 Albacete;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
02 Albacete;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
02 Albacete;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
02 Albacete;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;87,64
02 Albacete;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
02 Albacete;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
02 Albacete;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
02 Albacete;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;90,2
02 Albacete;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
02 Albacete;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
02 Albacete;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;79,82
02 Albacete;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
02 Albacete;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
02 Albacete;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
02 Albacete;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;82,47
02 Albacete;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
02 Albacete;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
02 Albacete;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
02 Albacete;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;84,8
02 Albacete;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
02 Albacete;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
02 Albacete;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
02 Albacete;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
02 Albacete;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
02 Albacete;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
02 Albacete;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;77,68
02 Albacete;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
02 Albacete;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
02 Albacete;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
02 Albacete;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;82,4
02 Albacete;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
02 Albacete;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
02 Albacete;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
02 Albacete;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
02 Albacete;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
02 Albacete;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QIII;1.565
02 Albacete;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
02 Albacete;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
02 Albacete;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
02 Albacete;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QIII;1.633
02 Albacete;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
02 Albacete;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
02 Albacete;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
02 Albacete;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QIII;1.537
02 Albacete;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
02 Albacete;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
02 Albacete;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
02 Albacete;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2022QIII;1.434
02 Albacete;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2022QII;""
02 Albacete;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2022QI;""
02 Albacete;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
02 Albacete;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2021QIII;1.478
02 Albacete;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2021QII;""
02 Albacete;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2021QI;""
02 Albacete;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
02 Albacete;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2020QIII;1.413
02 Albacete;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2020QII;""
02 Albacete;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2020QI;""
02 Albacete;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2022QIV;1.332
02 Albacete;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
02 Albacete;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2022QII;""
02 Albacete;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2022QI;""
02 Albacete;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2021QIV;1.386
02 Albacete;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
02 Albacete;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2021QII;""
02 Albacete;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2021QI;""
02 Albacete;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2020QIV;1.337
02 Albacete;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
02 Albacete;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2020QII;""
02 Albacete;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2020QI;""
02 Albacete;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
02 Albacete;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
02 Albacete;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QII;""
02 Albacete;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QI;1.308
02 Albacete;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
02 Albacete;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
02 Albacete;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QII;""
02 Albacete;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QI;1.293
02 Albacete;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
02 Albacete;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
02 Albacete;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QII;""
02 Albacete;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QI;""
02 Albacete;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
02 Albacete;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
02 Albacete;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QII;1.230
02 Albacete;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QI;""
02 Albacete;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
02 Albacete;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
02 Albacete;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QII;1.242
02 Albacete;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QI;""
02 Albacete;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
02 Albacete;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
02 Albacete;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QII;""
02 Albacete;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QI;""
02 Albacete;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
02 Albacete;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
02 Albacete;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
02 Albacete;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
02 Albacete;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
02 Albacete;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
02 Albacete;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
02 Albacete;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
02 Albacete;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
02 Albacete;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
02 Albacete;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
02 Albacete;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
02 Albacete;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
02 Albacete;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;91,63
02 Albacete;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
02 Albacete;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
02 Albacete;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
02 Albacete;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;90,51
02 Albacete;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
02 Albacete;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
02 Albacete;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
02 Albacete;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;91,93
02 Albacete;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
02 Albacete;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
02 Albacete;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;85,11
02 Albacete;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
02 Albacete;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
02 Albacete;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
02 Albacete;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;84,87
02 Albacete;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
02 Albacete;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
02 Albacete;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
02 Albacete;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;86,99
02 Albacete;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
02 Albacete;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
02 Albacete;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
02 Albacete;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
02 Albacete;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
02 Albacete;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
02 Albacete;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;80,1
02 Albacete;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
02 Albacete;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
02 Albacete;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
02 Albacete;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;84,12
02 Albacete;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
02 Albacete;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
02 Albacete;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
02 Albacete;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
02 Albacete;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
02 Albacete;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
02 Albacete;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;75,32
02 Albacete;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
02 Albacete;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
02 Albacete;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
02 Albacete;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;80,81
02 Albacete;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
02 Albacete;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
02 Albacete;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
02 Albacete;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
02 Albacete;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
02 Albacete;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
02 Albacete;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QIII;988
02 Albacete;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
02 Albacete;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
02 Albacete;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
02 Albacete;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QIII;1.034
02 Albacete;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
02 Albacete;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
02 Albacete;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
02 Albacete;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QIII;1.000
02 Albacete;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
02 Albacete;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
02 Albacete;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
02 Albacete;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2022QIII;905
02 Albacete;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2022QII;""
02 Albacete;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2022QI;""
02 Albacete;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
02 Albacete;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2021QIII;928
02 Albacete;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2021QII;""
02 Albacete;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2021QI;""
02 Albacete;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
02 Albacete;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2020QIII;924
02 Albacete;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2020QII;""
02 Albacete;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2020QI;""
02 Albacete;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2022QIV;838
02 Albacete;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
02 Albacete;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2022QII;""
02 Albacete;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2022QI;""
02 Albacete;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2021QIV;872
02 Albacete;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
02 Albacete;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2021QII;""
02 Albacete;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2021QI;""
02 Albacete;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2020QIV;878
02 Albacete;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
02 Albacete;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2020QII;""
02 Albacete;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2020QI;""
02 Albacete;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
02 Albacete;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
02 Albacete;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QII;""
02 Albacete;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QI;830
02 Albacete;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
02 Albacete;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
02 Albacete;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QII;""
02 Albacete;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QI;849
02 Albacete;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
02 Albacete;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
02 Albacete;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QII;""
02 Albacete;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QI;""
02 Albacete;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
02 Albacete;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
02 Albacete;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QII;781
02 Albacete;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QI;""
02 Albacete;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
02 Albacete;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
02 Albacete;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QII;817
02 Albacete;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QI;""
02 Albacete;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
02 Albacete;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
02 Albacete;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QII;""
02 Albacete;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QI;""
02 Albacete;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
02 Albacete;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
02 Albacete;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
02 Albacete;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
02 Albacete;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
02 Albacete;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
02 Albacete;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
02 Albacete;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
02 Albacete;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
02 Albacete;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
02 Albacete;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
02 Albacete;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
02 Albacete;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
02 Albacete;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;91,6
02 Albacete;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
02 Albacete;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
02 Albacete;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
02 Albacete;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;89,75
02 Albacete;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
02 Albacete;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
02 Albacete;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
02 Albacete;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;92,4
02 Albacete;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
02 Albacete;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
02 Albacete;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;84,82
02 Albacete;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
02 Albacete;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
02 Albacete;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
02 Albacete;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;84,33
02 Albacete;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
02 Albacete;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
02 Albacete;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
02 Albacete;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;87,8
02 Albacete;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
02 Albacete;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
02 Albacete;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
02 Albacete;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
02 Albacete;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
02 Albacete;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
02 Albacete;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;80,27
02 Albacete;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
02 Albacete;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
02 Albacete;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
02 Albacete;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;84,9
02 Albacete;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
02 Albacete;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
02 Albacete;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
02 Albacete;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
02 Albacete;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
02 Albacete;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
02 Albacete;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;75,53
02 Albacete;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
02 Albacete;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
02 Albacete;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
02 Albacete;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;81,7
02 Albacete;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
02 Albacete;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
02 Albacete;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
02 Albacete;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
02 Albacete;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
02 Albacete;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
02 Albacete;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QIII;577
02 Albacete;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
02 Albacete;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
02 Albacete;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
02 Albacete;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QIII;599
02 Albacete;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
02 Albacete;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
02 Albacete;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
02 Albacete;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QIII;537
02 Albacete;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
02 Albacete;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
02 Albacete;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
02 Albacete;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2022QIII;529
02 Albacete;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2022QII;""
02 Albacete;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2022QI;""
02 Albacete;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
02 Albacete;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2021QIII;550
02 Albacete;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2021QII;""
02 Albacete;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2021QI;""
02 Albacete;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
02 Albacete;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2020QIII;489
02 Albacete;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2020QII;""
02 Albacete;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2020QI;""
02 Albacete;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2022QIV;494
02 Albacete;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
02 Albacete;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2022QII;""
02 Albacete;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2022QI;""
02 Albacete;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2021QIV;514
02 Albacete;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
02 Albacete;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2021QII;""
02 Albacete;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2021QI;""
02 Albacete;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2020QIV;459
02 Albacete;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
02 Albacete;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2020QII;""
02 Albacete;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2020QI;""
02 Albacete;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
02 Albacete;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
02 Albacete;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QII;""
02 Albacete;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QI;478
02 Albacete;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
02 Albacete;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
02 Albacete;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QII;""
02 Albacete;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QI;444
02 Albacete;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
02 Albacete;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
02 Albacete;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QII;""
02 Albacete;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QI;""
02 Albacete;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
02 Albacete;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
02 Albacete;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QII;449
02 Albacete;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QI;""
02 Albacete;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
02 Albacete;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
02 Albacete;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QII;425
02 Albacete;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QI;""
02 Albacete;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
02 Albacete;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
02 Albacete;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QII;""
02 Albacete;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QI;""
02 Albacete;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
02 Albacete;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
02 Albacete;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
02 Albacete;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
02 Albacete;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
02 Albacete;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
02 Albacete;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
02 Albacete;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
02 Albacete;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
02 Albacete;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
02 Albacete;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
02 Albacete;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
02 Albacete;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
02 Albacete;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;91,68
02 Albacete;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
02 Albacete;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
02 Albacete;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
02 Albacete;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;91,82
02 Albacete;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
02 Albacete;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
02 Albacete;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
02 Albacete;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;91,06
02 Albacete;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
02 Albacete;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
02 Albacete;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;85,62
02 Albacete;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
02 Albacete;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
02 Albacete;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
02 Albacete;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;85,81
02 Albacete;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
02 Albacete;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
02 Albacete;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
02 Albacete;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;85,47
02 Albacete;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
02 Albacete;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
02 Albacete;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
02 Albacete;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
02 Albacete;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
02 Albacete;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
02 Albacete;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;79,8
02 Albacete;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
02 Albacete;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
02 Albacete;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
02 Albacete;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;82,68
02 Albacete;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
02 Albacete;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
02 Albacete;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
02 Albacete;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
02 Albacete;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
02 Albacete;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
02 Albacete;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;74,96
02 Albacete;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
02 Albacete;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
02 Albacete;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
02 Albacete;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;79,14
02 Albacete;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
02 Albacete;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
02 Albacete;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
02 Albacete;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
02 Albacete;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
02 Albacete;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QIV;1.608
02 Albacete;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
02 Albacete;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
02 Albacete;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
02 Albacete;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QIV;1.656
02 Albacete;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
02 Albacete;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
02 Albacete;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
02 Albacete;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QIV;1.612
02 Albacete;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
02 Albacete;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
02 Albacete;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
02 Albacete;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2022QIV;1.477
02 Albacete;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
02 Albacete;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2022QII;""
02 Albacete;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2022QI;""
02 Albacete;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2021QIV;1.536
02 Albacete;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
02 Albacete;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2021QII;""
02 Albacete;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2021QI;""
02 Albacete;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2020QIV;1.504
02 Albacete;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
02 Albacete;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2020QII;""
02 Albacete;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2020QI;""
02 Albacete;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
02 Albacete;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
02 Albacete;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2022QII;""
02 Albacete;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2022QI;1.444
02 Albacete;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
02 Albacete;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
02 Albacete;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2021QII;""
02 Albacete;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2021QI;1.442
02 Albacete;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
02 Albacete;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
02 Albacete;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2020QII;""
02 Albacete;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2020QI;""
02 Albacete;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
02 Albacete;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
02 Albacete;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QII;1.359
02 Albacete;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QI;""
02 Albacete;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
02 Albacete;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
02 Albacete;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QII;1.385
02 Albacete;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QI;""
02 Albacete;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
02 Albacete;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
02 Albacete;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QII;""
02 Albacete;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QI;""
02 Albacete;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
02 Albacete;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QIII;1.282
02 Albacete;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QII;""
02 Albacete;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QI;""
02 Albacete;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
02 Albacete;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QIII;1.307
02 Albacete;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QII;""
02 Albacete;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QI;""
02 Albacete;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
02 Albacete;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
02 Albacete;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QII;""
02 Albacete;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QI;""
02 Albacete;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
02 Albacete;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
02 Albacete;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
02 Albacete;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
02 Albacete;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
02 Albacete;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
02 Albacete;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
02 Albacete;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
02 Albacete;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
02 Albacete;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
02 Albacete;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
02 Albacete;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
02 Albacete;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;91,85
02 Albacete;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
02 Albacete;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
02 Albacete;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
02 Albacete;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;92,75
02 Albacete;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
02 Albacete;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
02 Albacete;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
02 Albacete;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;93,3
02 Albacete;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
02 Albacete;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
02 Albacete;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
02 Albacete;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
02 Albacete;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
02 Albacete;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
02 Albacete;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;87,2
02 Albacete;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
02 Albacete;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
02 Albacete;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
02 Albacete;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;89,45
02 Albacete;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
02 Albacete;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
02 Albacete;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
02 Albacete;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
02 Albacete;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
02 Albacete;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
02 Albacete;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;82,07
02 Albacete;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
02 Albacete;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
02 Albacete;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
02 Albacete;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;85,92
02 Albacete;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
02 Albacete;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
02 Albacete;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
02 Albacete;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
02 Albacete;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
02 Albacete;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
02 Albacete;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;77,42
02 Albacete;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
02 Albacete;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
02 Albacete;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
02 Albacete;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;81,08
02 Albacete;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
02 Albacete;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
02 Albacete;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
02 Albacete;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
02 Albacete;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
02 Albacete;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
02 Albacete;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QIV;1.008
02 Albacete;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
02 Albacete;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
02 Albacete;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
02 Albacete;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QIV;1.034
02 Albacete;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
02 Albacete;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
02 Albacete;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
02 Albacete;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QIV;1.053
02 Albacete;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
02 Albacete;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
02 Albacete;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
02 Albacete;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2022QIV;920
02 Albacete;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
02 Albacete;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2022QII;""
02 Albacete;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2022QI;""
02 Albacete;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2021QIV;962
02 Albacete;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
02 Albacete;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2021QII;""
02 Albacete;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2021QI;""
02 Albacete;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2020QIV;982
02 Albacete;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
02 Albacete;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2020QII;""
02 Albacete;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2020QI;""
02 Albacete;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
02 Albacete;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
02 Albacete;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2022QII;""
02 Albacete;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2022QI;912
02 Albacete;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
02 Albacete;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
02 Albacete;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2021QII;""
02 Albacete;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2021QI;942
02 Albacete;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
02 Albacete;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
02 Albacete;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2020QII;""
02 Albacete;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2020QI;""
02 Albacete;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
02 Albacete;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
02 Albacete;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QII;860
02 Albacete;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QI;""
02 Albacete;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
02 Albacete;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
02 Albacete;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QII;908
02 Albacete;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QI;""
02 Albacete;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
02 Albacete;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
02 Albacete;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QII;""
02 Albacete;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QI;""
02 Albacete;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
02 Albacete;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QIII;812
02 Albacete;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QII;""
02 Albacete;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QI;""
02 Albacete;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
02 Albacete;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QIII;851
02 Albacete;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QII;""
02 Albacete;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QI;""
02 Albacete;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
02 Albacete;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
02 Albacete;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QII;""
02 Albacete;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QI;""
02 Albacete;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
02 Albacete;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
02 Albacete;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
02 Albacete;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
02 Albacete;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
02 Albacete;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
02 Albacete;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
02 Albacete;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
02 Albacete;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
02 Albacete;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
02 Albacete;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
02 Albacete;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
02 Albacete;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;91,27
02 Albacete;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
02 Albacete;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
02 Albacete;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
02 Albacete;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;93,04
02 Albacete;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
02 Albacete;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
02 Albacete;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
02 Albacete;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;93,26
02 Albacete;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
02 Albacete;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
02 Albacete;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
02 Albacete;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
02 Albacete;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
02 Albacete;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
02 Albacete;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;88,2
02 Albacete;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
02 Albacete;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
02 Albacete;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
02 Albacete;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;89,46
02 Albacete;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
02 Albacete;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
02 Albacete;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
02 Albacete;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
02 Albacete;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
02 Albacete;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
02 Albacete;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;83,17
02 Albacete;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
02 Albacete;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
02 Albacete;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
02 Albacete;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;86,23
02 Albacete;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
02 Albacete;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
02 Albacete;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
02 Albacete;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
02 Albacete;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
02 Albacete;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
02 Albacete;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;78,53
02 Albacete;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
02 Albacete;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
02 Albacete;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
02 Albacete;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;80,82
02 Albacete;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
02 Albacete;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
02 Albacete;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
02 Albacete;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
02 Albacete;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
02 Albacete;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
02 Albacete;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QIV;600
02 Albacete;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
02 Albacete;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
02 Albacete;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
02 Albacete;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QIV;622
02 Albacete;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
02 Albacete;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
02 Albacete;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
02 Albacete;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QIV;559
02 Albacete;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
02 Albacete;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
02 Albacete;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
02 Albacete;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2022QIV;557
02 Albacete;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
02 Albacete;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2022QII;""
02 Albacete;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2022QI;""
02 Albacete;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2021QIV;574
02 Albacete;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
02 Albacete;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2021QII;""
02 Albacete;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2021QI;""
02 Albacete;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2020QIV;522
02 Albacete;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
02 Albacete;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2020QII;""
02 Albacete;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2020QI;""
02 Albacete;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
02 Albacete;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
02 Albacete;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2022QII;""
02 Albacete;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2022QI;532
02 Albacete;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
02 Albacete;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
02 Albacete;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2021QII;""
02 Albacete;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2021QI;500
02 Albacete;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
02 Albacete;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
02 Albacete;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2020QII;""
02 Albacete;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2020QI;""
02 Albacete;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
02 Albacete;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
02 Albacete;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QII;499
02 Albacete;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QI;""
02 Albacete;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
02 Albacete;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
02 Albacete;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QII;477
02 Albacete;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QI;""
02 Albacete;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
02 Albacete;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
02 Albacete;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QII;""
02 Albacete;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QI;""
02 Albacete;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
02 Albacete;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QIII;470
02 Albacete;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QII;""
02 Albacete;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QI;""
02 Albacete;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
02 Albacete;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QIII;456
02 Albacete;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QII;""
02 Albacete;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QI;""
02 Albacete;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
02 Albacete;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
02 Albacete;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QII;""
02 Albacete;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QI;""
02 Albacete;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
02 Albacete;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
02 Albacete;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
02 Albacete;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
02 Albacete;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
02 Albacete;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
02 Albacete;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
02 Albacete;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
02 Albacete;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
02 Albacete;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
02 Albacete;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
02 Albacete;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
02 Albacete;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;92,83
02 Albacete;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
02 Albacete;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
02 Albacete;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
02 Albacete;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;92,28
02 Albacete;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
02 Albacete;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
02 Albacete;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
02 Albacete;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;93,38
02 Albacete;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
02 Albacete;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
02 Albacete;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
02 Albacete;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
02 Albacete;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
02 Albacete;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
02 Albacete;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;85,53
02 Albacete;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
02 Albacete;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
02 Albacete;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
02 Albacete;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;89,45
02 Albacete;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
02 Albacete;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
02 Albacete;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
02 Albacete;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
02 Albacete;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
02 Albacete;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
02 Albacete;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;80,23
02 Albacete;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
02 Albacete;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
02 Albacete;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
02 Albacete;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;85,33
02 Albacete;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
02 Albacete;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
02 Albacete;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
02 Albacete;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
02 Albacete;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
02 Albacete;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
02 Albacete;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;75,56
02 Albacete;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
02 Albacete;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
02 Albacete;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
02 Albacete;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;81,57
02 Albacete;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
02 Albacete;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
02 Albacete;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
02 Albacete;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
02 Albacete;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
02 Albacete;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
02 Albacete;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
02 Albacete;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
02 Albacete;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
02 Albacete;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QI;4.618
02 Albacete;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
02 Albacete;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
02 Albacete;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
02 Albacete;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QI;4.662
02 Albacete;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
02 Albacete;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
02 Albacete;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
02 Albacete;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QI;4.669
02 Albacete;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
02 Albacete;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
02 Albacete;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2022QII;""
02 Albacete;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2022QI;4.457
02 Albacete;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
02 Albacete;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
02 Albacete;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2021QII;""
02 Albacete;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2021QI;4.566
02 Albacete;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
02 Albacete;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
02 Albacete;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2020QII;""
02 Albacete;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2020QI;4.263
02 Albacete;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
02 Albacete;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
02 Albacete;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2022QII;4.273
02 Albacete;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2022QI;""
02 Albacete;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
02 Albacete;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
02 Albacete;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2021QII;4.408
02 Albacete;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2021QI;""
02 Albacete;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
02 Albacete;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
02 Albacete;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2020QII;4.175
02 Albacete;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2020QI;""
02 Albacete;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
02 Albacete;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QIII;4.144
02 Albacete;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QII;""
02 Albacete;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QI;""
02 Albacete;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
02 Albacete;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QIII;4.286
02 Albacete;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QII;""
02 Albacete;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QI;""
02 Albacete;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
02 Albacete;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QIII;4.074
02 Albacete;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QII;""
02 Albacete;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QI;""
02 Albacete;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QIV;4.007
02 Albacete;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
02 Albacete;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QII;""
02 Albacete;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QI;""
02 Albacete;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QIV;4.171
02 Albacete;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
02 Albacete;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QII;""
02 Albacete;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QI;""
02 Albacete;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QIV;3.976
02 Albacete;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
02 Albacete;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QII;""
02 Albacete;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QI;""
02 Albacete;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
02 Albacete;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
02 Albacete;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
02 Albacete;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
02 Albacete;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
02 Albacete;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
02 Albacete;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
02 Albacete;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
02 Albacete;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
02 Albacete;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
02 Albacete;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
02 Albacete;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
02 Albacete;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
02 Albacete;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
02 Albacete;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
02 Albacete;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;96,51
02 Albacete;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
02 Albacete;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
02 Albacete;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
02 Albacete;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;97,94
02 Albacete;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
02 Albacete;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
02 Albacete;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
02 Albacete;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;91,3
02 Albacete;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
02 Albacete;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
02 Albacete;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;92,53
02 Albacete;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
02 Albacete;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
02 Albacete;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
02 Albacete;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;94,55
02 Albacete;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
02 Albacete;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
02 Albacete;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
02 Albacete;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;89,42
02 Albacete;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
02 Albacete;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
02 Albacete;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;89,74
02 Albacete;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
02 Albacete;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
02 Albacete;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
02 Albacete;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;91,93
02 Albacete;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
02 Albacete;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
02 Albacete;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
02 Albacete;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;87,26
02 Albacete;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
02 Albacete;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
02 Albacete;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;86,77
02 Albacete;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
02 Albacete;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
02 Albacete;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
02 Albacete;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;89,47
02 Albacete;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
02 Albacete;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
02 Albacete;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
02 Albacete;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;85,16
02 Albacete;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
02 Albacete;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
02 Albacete;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
02 Albacete;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
02 Albacete;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
02 Albacete;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
02 Albacete;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QI;2.911
02 Albacete;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
02 Albacete;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
02 Albacete;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
02 Albacete;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QI;2.957
02 Albacete;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
02 Albacete;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
02 Albacete;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
02 Albacete;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QI;2.931
02 Albacete;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
02 Albacete;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
02 Albacete;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2022QII;""
02 Albacete;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2022QI;2.826
02 Albacete;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
02 Albacete;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
02 Albacete;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2021QII;""
02 Albacete;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2021QI;2.899
02 Albacete;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
02 Albacete;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
02 Albacete;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2020QII;""
02 Albacete;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2020QI;2.675
02 Albacete;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
02 Albacete;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
02 Albacete;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2022QII;2.729
02 Albacete;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2022QI;""
02 Albacete;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
02 Albacete;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
02 Albacete;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2021QII;2.808
02 Albacete;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2021QI;""
02 Albacete;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
02 Albacete;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
02 Albacete;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2020QII;2.629
02 Albacete;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2020QI;""
02 Albacete;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
02 Albacete;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QIII;2.665
02 Albacete;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QII;""
02 Albacete;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QI;""
02 Albacete;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
02 Albacete;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QIII;2.742
02 Albacete;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QII;""
02 Albacete;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QI;""
02 Albacete;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
02 Albacete;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QIII;2.574
02 Albacete;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QII;""
02 Albacete;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QI;""
02 Albacete;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QIV;2.580
02 Albacete;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
02 Albacete;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QII;""
02 Albacete;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QI;""
02 Albacete;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QIV;2.674
02 Albacete;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
02 Albacete;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QII;""
02 Albacete;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QI;""
02 Albacete;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QIV;2.521
02 Albacete;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
02 Albacete;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QII;""
02 Albacete;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QI;""
02 Albacete;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
02 Albacete;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
02 Albacete;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
02 Albacete;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
02 Albacete;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
02 Albacete;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
02 Albacete;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
02 Albacete;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
02 Albacete;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
02 Albacete;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
02 Albacete;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
02 Albacete;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
02 Albacete;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
02 Albacete;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
02 Albacete;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
02 Albacete;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;97,08
02 Albacete;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
02 Albacete;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
02 Albacete;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
02 Albacete;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;98,04
02 Albacete;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
02 Albacete;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
02 Albacete;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
02 Albacete;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;91,27
02 Albacete;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
02 Albacete;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
02 Albacete;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;93,75
02 Albacete;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
02 Albacete;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
02 Albacete;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
02 Albacete;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;94,96
02 Albacete;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
02 Albacete;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
02 Albacete;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
02 Albacete;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;89,7
02 Albacete;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
02 Albacete;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
02 Albacete;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;91,55
02 Albacete;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
02 Albacete;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
02 Albacete;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
02 Albacete;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;92,73
02 Albacete;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
02 Albacete;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
02 Albacete;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
02 Albacete;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;87,82
02 Albacete;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
02 Albacete;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
02 Albacete;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;88,63
02 Albacete;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
02 Albacete;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
02 Albacete;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
02 Albacete;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;90,43
02 Albacete;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
02 Albacete;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
02 Albacete;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
02 Albacete;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;86,01
02 Albacete;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
02 Albacete;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
02 Albacete;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
02 Albacete;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
02 Albacete;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
02 Albacete;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
02 Albacete;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QI;1.707
02 Albacete;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
02 Albacete;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
02 Albacete;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
02 Albacete;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QI;1.705
02 Albacete;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
02 Albacete;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
02 Albacete;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
02 Albacete;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QI;1.738
02 Albacete;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
02 Albacete;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
02 Albacete;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2022QII;""
02 Albacete;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2022QI;1.631
02 Albacete;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
02 Albacete;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
02 Albacete;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2021QII;""
02 Albacete;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2021QI;1.667
02 Albacete;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
02 Albacete;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
02 Albacete;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2020QII;""
02 Albacete;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2020QI;1.588
02 Albacete;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
02 Albacete;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
02 Albacete;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2022QII;1.544
02 Albacete;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2022QI;""
02 Albacete;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
02 Albacete;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
02 Albacete;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2021QII;1.600
02 Albacete;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2021QI;""
02 Albacete;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
02 Albacete;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
02 Albacete;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2020QII;1.546
02 Albacete;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2020QI;""
02 Albacete;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
02 Albacete;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QIII;1.479
02 Albacete;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QII;""
02 Albacete;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QI;""
02 Albacete;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
02 Albacete;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QIII;1.544
02 Albacete;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QII;""
02 Albacete;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QI;""
02 Albacete;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
02 Albacete;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QIII;1.500
02 Albacete;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QII;""
02 Albacete;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QI;""
02 Albacete;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QIV;1.427
02 Albacete;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
02 Albacete;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QII;""
02 Albacete;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QI;""
02 Albacete;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QIV;1.497
02 Albacete;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
02 Albacete;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QII;""
02 Albacete;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QI;""
02 Albacete;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QIV;1.455
02 Albacete;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
02 Albacete;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QII;""
02 Albacete;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QI;""
02 Albacete;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
02 Albacete;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
02 Albacete;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
02 Albacete;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
02 Albacete;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
02 Albacete;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
02 Albacete;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
02 Albacete;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
02 Albacete;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
02 Albacete;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
02 Albacete;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
02 Albacete;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
02 Albacete;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
02 Albacete;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
02 Albacete;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
02 Albacete;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;95,55
02 Albacete;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
02 Albacete;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
02 Albacete;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
02 Albacete;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;97,77
02 Albacete;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
02 Albacete;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
02 Albacete;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
02 Albacete;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;91,37
02 Albacete;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
02 Albacete;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
02 Albacete;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;90,45
02 Albacete;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
02 Albacete;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
02 Albacete;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
02 Albacete;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;93,84
02 Albacete;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
02 Albacete;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
02 Albacete;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
02 Albacete;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;88,95
02 Albacete;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
02 Albacete;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
02 Albacete;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;86,64
02 Albacete;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
02 Albacete;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
02 Albacete;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
02 Albacete;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;90,56
02 Albacete;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
02 Albacete;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
02 Albacete;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
02 Albacete;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;86,31
02 Albacete;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
02 Albacete;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
02 Albacete;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;83,6
02 Albacete;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
02 Albacete;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
02 Albacete;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
02 Albacete;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;87,8
02 Albacete;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
02 Albacete;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
02 Albacete;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
02 Albacete;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;83,72
02 Albacete;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
02 Albacete;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
02 Albacete;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
02 Albacete;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
02 Albacete;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
02 Albacete;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QII;4.358
02 Albacete;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
02 Albacete;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
02 Albacete;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
02 Albacete;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QII;4.497
02 Albacete;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
02 Albacete;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
02 Albacete;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
02 Albacete;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QII;4.478
02 Albacete;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
02 Albacete;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
02 Albacete;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
02 Albacete;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2022QII;4.165
02 Albacete;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2022QI;""
02 Albacete;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
02 Albacete;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
02 Albacete;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2021QII;4.325
02 Albacete;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2021QI;""
02 Albacete;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
02 Albacete;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
02 Albacete;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2020QII;4.385
02 Albacete;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2020QI;""
02 Albacete;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
02 Albacete;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2022QIII;4.009
02 Albacete;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2022QII;""
02 Albacete;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2022QI;""
02 Albacete;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
02 Albacete;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2021QIII;4.179
02 Albacete;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2021QII;""
02 Albacete;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2021QI;""
02 Albacete;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
02 Albacete;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2020QIII;4.273
02 Albacete;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2020QII;""
02 Albacete;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2020QI;""
02 Albacete;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QIV;3.866
02 Albacete;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
02 Albacete;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QII;""
02 Albacete;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QI;""
02 Albacete;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QIV;4.058
02 Albacete;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
02 Albacete;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QII;""
02 Albacete;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QI;""
02 Albacete;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QIV;4.165
02 Albacete;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
02 Albacete;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QII;""
02 Albacete;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QI;""
02 Albacete;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
02 Albacete;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
02 Albacete;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QII;""
02 Albacete;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QI;3.930
02 Albacete;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
02 Albacete;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
02 Albacete;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QII;""
02 Albacete;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QI;4.098
02 Albacete;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
02 Albacete;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
02 Albacete;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QII;""
02 Albacete;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QI;""
02 Albacete;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
02 Albacete;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
02 Albacete;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
02 Albacete;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
02 Albacete;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
02 Albacete;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
02 Albacete;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
02 Albacete;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
02 Albacete;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
02 Albacete;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
02 Albacete;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
02 Albacete;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
02 Albacete;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
02 Albacete;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
02 Albacete;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;95,57
02 Albacete;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
02 Albacete;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
02 Albacete;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
02 Albacete;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;96,18
02 Albacete;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
02 Albacete;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
02 Albacete;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
02 Albacete;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;97,92
02 Albacete;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
02 Albacete;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
02 Albacete;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;91,99
02 Albacete;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
02 Albacete;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
02 Albacete;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
02 Albacete;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;92,93
02 Albacete;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
02 Albacete;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
02 Albacete;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
02 Albacete;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;95,42
02 Albacete;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
02 Albacete;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
02 Albacete;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;88,71
02 Albacete;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
02 Albacete;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
02 Albacete;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
02 Albacete;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;90,24
02 Albacete;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
02 Albacete;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
02 Albacete;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
02 Albacete;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;93,01
02 Albacete;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
02 Albacete;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
02 Albacete;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
02 Albacete;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
02 Albacete;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
02 Albacete;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
02 Albacete;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;87,39
02 Albacete;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
02 Albacete;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
02 Albacete;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
02 Albacete;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;91,51
02 Albacete;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
02 Albacete;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
02 Albacete;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
02 Albacete;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
02 Albacete;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
02 Albacete;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
02 Albacete;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QII;2.732
02 Albacete;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
02 Albacete;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
02 Albacete;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
02 Albacete;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QII;2.859
02 Albacete;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
02 Albacete;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
02 Albacete;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
02 Albacete;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QII;2.795
02 Albacete;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
02 Albacete;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
02 Albacete;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
02 Albacete;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2022QII;2.628
02 Albacete;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2022QI;""
02 Albacete;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
02 Albacete;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
02 Albacete;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2021QII;2.758
02 Albacete;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2021QI;""
02 Albacete;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
02 Albacete;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
02 Albacete;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2020QII;2.748
02 Albacete;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2020QI;""
02 Albacete;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
02 Albacete;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2022QIII;2.546
02 Albacete;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2022QII;""
02 Albacete;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2022QI;""
02 Albacete;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
02 Albacete;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2021QIII;2.671
02 Albacete;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2021QII;""
02 Albacete;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2021QI;""
02 Albacete;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
02 Albacete;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2020QIII;2.686
02 Albacete;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2020QII;""
02 Albacete;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2020QI;""
02 Albacete;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QIV;2.454
02 Albacete;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
02 Albacete;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QII;""
02 Albacete;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QI;""
02 Albacete;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QIV;2.596
02 Albacete;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
02 Albacete;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QII;""
02 Albacete;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QI;""
02 Albacete;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QIV;2.628
02 Albacete;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
02 Albacete;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QII;""
02 Albacete;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QI;""
02 Albacete;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
02 Albacete;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
02 Albacete;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QII;""
02 Albacete;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QI;2.533
02 Albacete;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
02 Albacete;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
02 Albacete;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QII;""
02 Albacete;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QI;2.592
02 Albacete;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
02 Albacete;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
02 Albacete;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QII;""
02 Albacete;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QI;""
02 Albacete;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
02 Albacete;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
02 Albacete;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
02 Albacete;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
02 Albacete;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
02 Albacete;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
02 Albacete;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
02 Albacete;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
02 Albacete;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
02 Albacete;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
02 Albacete;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
02 Albacete;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
02 Albacete;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
02 Albacete;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
02 Albacete;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;96,19
02 Albacete;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
02 Albacete;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
02 Albacete;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
02 Albacete;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;96,47
02 Albacete;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
02 Albacete;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
02 Albacete;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
02 Albacete;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;98,32
02 Albacete;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
02 Albacete;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
02 Albacete;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;93,19
02 Albacete;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
02 Albacete;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
02 Albacete;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
02 Albacete;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;93,42
02 Albacete;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
02 Albacete;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
02 Albacete;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
02 Albacete;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;96,1
02 Albacete;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
02 Albacete;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
02 Albacete;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;89,82
02 Albacete;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
02 Albacete;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
02 Albacete;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
02 Albacete;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;90,8
02 Albacete;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
02 Albacete;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
02 Albacete;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
02 Albacete;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;94,03
02 Albacete;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
02 Albacete;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
02 Albacete;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
02 Albacete;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
02 Albacete;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
02 Albacete;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
02 Albacete;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;88,6
02 Albacete;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
02 Albacete;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
02 Albacete;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
02 Albacete;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;92,74
02 Albacete;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
02 Albacete;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
02 Albacete;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
02 Albacete;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
02 Albacete;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
02 Albacete;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
02 Albacete;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QII;1.626
02 Albacete;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
02 Albacete;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
02 Albacete;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
02 Albacete;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QII;1.638
02 Albacete;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
02 Albacete;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
02 Albacete;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
02 Albacete;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QII;1.683
02 Albacete;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
02 Albacete;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
02 Albacete;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
02 Albacete;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2022QII;1.537
02 Albacete;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2022QI;""
02 Albacete;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
02 Albacete;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
02 Albacete;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2021QII;1.567
02 Albacete;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2021QI;""
02 Albacete;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
02 Albacete;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
02 Albacete;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2020QII;1.637
02 Albacete;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2020QI;""
02 Albacete;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
02 Albacete;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2022QIII;1.463
02 Albacete;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2022QII;""
02 Albacete;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2022QI;""
02 Albacete;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
02 Albacete;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2021QIII;1.508
02 Albacete;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2021QII;""
02 Albacete;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2021QI;""
02 Albacete;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
02 Albacete;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2020QIII;1.587
02 Albacete;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2020QII;""
02 Albacete;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2020QI;""
02 Albacete;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QIV;1.412
02 Albacete;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
02 Albacete;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QII;""
02 Albacete;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QI;""
02 Albacete;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QIV;1.462
02 Albacete;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
02 Albacete;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QII;""
02 Albacete;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QI;""
02 Albacete;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QIV;1.537
02 Albacete;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
02 Albacete;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QII;""
02 Albacete;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QI;""
02 Albacete;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
02 Albacete;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
02 Albacete;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QII;""
02 Albacete;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QI;1.397
02 Albacete;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
02 Albacete;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
02 Albacete;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QII;""
02 Albacete;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QI;1.506
02 Albacete;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
02 Albacete;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
02 Albacete;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QII;""
02 Albacete;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QI;""
02 Albacete;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
02 Albacete;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
02 Albacete;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
02 Albacete;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
02 Albacete;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
02 Albacete;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
02 Albacete;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
02 Albacete;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
02 Albacete;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
02 Albacete;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
02 Albacete;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
02 Albacete;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
02 Albacete;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
02 Albacete;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
02 Albacete;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;94,53
02 Albacete;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
02 Albacete;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
02 Albacete;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
02 Albacete;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;95,67
02 Albacete;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
02 Albacete;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
02 Albacete;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
02 Albacete;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;97,27
02 Albacete;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
02 Albacete;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
02 Albacete;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;89,98
02 Albacete;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
02 Albacete;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
02 Albacete;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
02 Albacete;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;92,06
02 Albacete;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
02 Albacete;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
02 Albacete;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
02 Albacete;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;94,3
02 Albacete;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
02 Albacete;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
02 Albacete;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;86,84
02 Albacete;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
02 Albacete;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
02 Albacete;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
02 Albacete;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;89,26
02 Albacete;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
02 Albacete;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
02 Albacete;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
02 Albacete;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;91,33
02 Albacete;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
02 Albacete;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
02 Albacete;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
02 Albacete;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
02 Albacete;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
02 Albacete;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
02 Albacete;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;85,29
02 Albacete;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
02 Albacete;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
02 Albacete;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
02 Albacete;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;89,48
02 Albacete;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
02 Albacete;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
02 Albacete;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
02 Albacete;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
02 Albacete;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
02 Albacete;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QIII;4.366
02 Albacete;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
02 Albacete;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
02 Albacete;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
02 Albacete;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QIII;4.540
02 Albacete;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
02 Albacete;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
02 Albacete;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
02 Albacete;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QIII;4.601
02 Albacete;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
02 Albacete;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
02 Albacete;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
02 Albacete;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2022QIII;4.181
02 Albacete;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2022QII;""
02 Albacete;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2022QI;""
02 Albacete;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
02 Albacete;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2021QIII;4.368
02 Albacete;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2021QII;""
02 Albacete;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2021QI;""
02 Albacete;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
02 Albacete;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2020QIII;4.455
02 Albacete;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2020QII;""
02 Albacete;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2020QI;""
02 Albacete;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2022QIV;4.026
02 Albacete;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
02 Albacete;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2022QII;""
02 Albacete;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2022QI;""
02 Albacete;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2021QIV;4.225
02 Albacete;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
02 Albacete;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2021QII;""
02 Albacete;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2021QI;""
02 Albacete;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2020QIV;4.325
02 Albacete;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
02 Albacete;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2020QII;""
02 Albacete;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2020QI;""
02 Albacete;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
02 Albacete;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
02 Albacete;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QII;""
02 Albacete;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QI;4.089
02 Albacete;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
02 Albacete;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
02 Albacete;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QII;""
02 Albacete;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QI;4.252
02 Albacete;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
02 Albacete;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
02 Albacete;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QII;""
02 Albacete;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QI;""
02 Albacete;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
02 Albacete;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
02 Albacete;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QII;3.947
02 Albacete;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QI;""
02 Albacete;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
02 Albacete;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
02 Albacete;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QII;4.119
02 Albacete;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QI;""
02 Albacete;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
02 Albacete;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
02 Albacete;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QII;""
02 Albacete;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QI;""
02 Albacete;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
02 Albacete;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
02 Albacete;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
02 Albacete;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
02 Albacete;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
02 Albacete;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
02 Albacete;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
02 Albacete;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
02 Albacete;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
02 Albacete;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
02 Albacete;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
02 Albacete;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
02 Albacete;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
02 Albacete;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;95,76
02 Albacete;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
02 Albacete;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
02 Albacete;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
02 Albacete;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;96,21
02 Albacete;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
02 Albacete;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
02 Albacete;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
02 Albacete;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;96,83
02 Albacete;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
02 Albacete;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
02 Albacete;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;92,21
02 Albacete;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
02 Albacete;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
02 Albacete;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
02 Albacete;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;93,06
02 Albacete;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
02 Albacete;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
02 Albacete;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
02 Albacete;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;94
02 Albacete;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
02 Albacete;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
02 Albacete;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
02 Albacete;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
02 Albacete;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
02 Albacete;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
02 Albacete;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;90,07
02 Albacete;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
02 Albacete;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
02 Albacete;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
02 Albacete;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;92,41
02 Albacete;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
02 Albacete;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
02 Albacete;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
02 Albacete;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
02 Albacete;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
02 Albacete;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
02 Albacete;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;86,94
02 Albacete;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
02 Albacete;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
02 Albacete;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
02 Albacete;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;89,52
02 Albacete;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
02 Albacete;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
02 Albacete;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
02 Albacete;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
02 Albacete;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
02 Albacete;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
02 Albacete;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QIII;2.743
02 Albacete;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
02 Albacete;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
02 Albacete;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
02 Albacete;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QIII;2.892
02 Albacete;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
02 Albacete;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
02 Albacete;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
02 Albacete;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QIII;2.901
02 Albacete;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
02 Albacete;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
02 Albacete;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
02 Albacete;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2022QIII;2.645
02 Albacete;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2022QII;""
02 Albacete;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2022QI;""
02 Albacete;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
02 Albacete;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2021QIII;2.787
02 Albacete;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2021QII;""
02 Albacete;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2021QI;""
02 Albacete;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
02 Albacete;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2020QIII;2.819
02 Albacete;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2020QII;""
02 Albacete;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2020QI;""
02 Albacete;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2022QIV;2.542
02 Albacete;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
02 Albacete;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2022QII;""
02 Albacete;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2022QI;""
02 Albacete;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2021QIV;2.700
02 Albacete;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
02 Albacete;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2021QII;""
02 Albacete;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2021QI;""
02 Albacete;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2020QIV;2.743
02 Albacete;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
02 Albacete;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2020QII;""
02 Albacete;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2020QI;""
02 Albacete;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
02 Albacete;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
02 Albacete;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QII;""
02 Albacete;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QI;2.631
02 Albacete;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
02 Albacete;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
02 Albacete;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QII;""
02 Albacete;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QI;2.702
02 Albacete;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
02 Albacete;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
02 Albacete;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QII;""
02 Albacete;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QI;""
02 Albacete;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
02 Albacete;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
02 Albacete;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QII;2.557
02 Albacete;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QI;""
02 Albacete;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
02 Albacete;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
02 Albacete;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QII;2.628
02 Albacete;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QI;""
02 Albacete;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
02 Albacete;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
02 Albacete;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QII;""
02 Albacete;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QI;""
02 Albacete;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
02 Albacete;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
02 Albacete;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
02 Albacete;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
02 Albacete;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
02 Albacete;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
02 Albacete;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
02 Albacete;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
02 Albacete;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
02 Albacete;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
02 Albacete;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
02 Albacete;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
02 Albacete;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
02 Albacete;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;96,43
02 Albacete;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
02 Albacete;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
02 Albacete;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
02 Albacete;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;96,37
02 Albacete;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
02 Albacete;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
02 Albacete;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
02 Albacete;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;97,17
02 Albacete;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
02 Albacete;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
02 Albacete;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;92,67
02 Albacete;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
02 Albacete;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
02 Albacete;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
02 Albacete;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;93,36
02 Albacete;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
02 Albacete;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
02 Albacete;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
02 Albacete;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;94,55
02 Albacete;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
02 Albacete;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
02 Albacete;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
02 Albacete;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
02 Albacete;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
02 Albacete;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
02 Albacete;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;90,98
02 Albacete;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
02 Albacete;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
02 Albacete;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
02 Albacete;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;93,14
02 Albacete;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
02 Albacete;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
02 Albacete;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
02 Albacete;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
02 Albacete;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
02 Albacete;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
02 Albacete;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;88,42
02 Albacete;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
02 Albacete;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
02 Albacete;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
02 Albacete;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;90,59
02 Albacete;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
02 Albacete;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
02 Albacete;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
02 Albacete;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
02 Albacete;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
02 Albacete;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
02 Albacete;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QIII;1.623
02 Albacete;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
02 Albacete;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
02 Albacete;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
02 Albacete;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QIII;1.648
02 Albacete;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
02 Albacete;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
02 Albacete;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
02 Albacete;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QIII;1.700
02 Albacete;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
02 Albacete;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
02 Albacete;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
02 Albacete;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2022QIII;1.536
02 Albacete;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2022QII;""
02 Albacete;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2022QI;""
02 Albacete;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
02 Albacete;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2021QIII;1.581
02 Albacete;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2021QII;""
02 Albacete;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2021QI;""
02 Albacete;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
02 Albacete;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2020QIII;1.636
02 Albacete;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2020QII;""
02 Albacete;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2020QI;""
02 Albacete;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2022QIV;1.484
02 Albacete;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
02 Albacete;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2022QII;""
02 Albacete;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2022QI;""
02 Albacete;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2021QIV;1.525
02 Albacete;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
02 Albacete;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2021QII;""
02 Albacete;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2021QI;""
02 Albacete;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2020QIV;1.582
02 Albacete;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
02 Albacete;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2020QII;""
02 Albacete;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2020QI;""
02 Albacete;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
02 Albacete;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
02 Albacete;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QII;""
02 Albacete;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QI;1.458
02 Albacete;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
02 Albacete;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
02 Albacete;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QII;""
02 Albacete;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QI;1.550
02 Albacete;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
02 Albacete;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
02 Albacete;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QII;""
02 Albacete;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QI;""
02 Albacete;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
02 Albacete;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
02 Albacete;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QII;1.390
02 Albacete;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QI;""
02 Albacete;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
02 Albacete;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
02 Albacete;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QII;1.491
02 Albacete;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QI;""
02 Albacete;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
02 Albacete;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
02 Albacete;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QII;""
02 Albacete;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QI;""
02 Albacete;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
02 Albacete;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
02 Albacete;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
02 Albacete;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
02 Albacete;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
02 Albacete;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
02 Albacete;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
02 Albacete;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
02 Albacete;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
02 Albacete;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
02 Albacete;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
02 Albacete;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
02 Albacete;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
02 Albacete;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;94,64
02 Albacete;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
02 Albacete;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
02 Albacete;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
02 Albacete;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;95,93
02 Albacete;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
02 Albacete;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
02 Albacete;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
02 Albacete;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;96,24
02 Albacete;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
02 Albacete;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
02 Albacete;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;91,44
02 Albacete;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
02 Albacete;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
02 Albacete;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
02 Albacete;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;92,54
02 Albacete;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
02 Albacete;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
02 Albacete;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
02 Albacete;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;93,06
02 Albacete;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
02 Albacete;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
02 Albacete;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
02 Albacete;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
02 Albacete;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
02 Albacete;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
02 Albacete;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;88,47
02 Albacete;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
02 Albacete;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
02 Albacete;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
02 Albacete;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;91,18
02 Albacete;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
02 Albacete;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
02 Albacete;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
02 Albacete;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
02 Albacete;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
02 Albacete;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
02 Albacete;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;84,34
02 Albacete;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
02 Albacete;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
02 Albacete;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
02 Albacete;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;87,71
02 Albacete;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
02 Albacete;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
02 Albacete;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
02 Albacete;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
02 Albacete;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
02 Albacete;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QIV;4.337
02 Albacete;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
02 Albacete;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
02 Albacete;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
02 Albacete;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QIV;4.552
02 Albacete;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
02 Albacete;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
02 Albacete;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
02 Albacete;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QIV;4.642
02 Albacete;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
02 Albacete;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
02 Albacete;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
02 Albacete;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2022QIV;4.173
02 Albacete;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
02 Albacete;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2022QII;""
02 Albacete;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2022QI;""
02 Albacete;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2021QIV;4.389
02 Albacete;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
02 Albacete;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2021QII;""
02 Albacete;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2021QI;""
02 Albacete;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2020QIV;4.489
02 Albacete;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
02 Albacete;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2020QII;""
02 Albacete;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2020QI;""
02 Albacete;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
02 Albacete;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
02 Albacete;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2022QII;""
02 Albacete;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2022QI;4.242
02 Albacete;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
02 Albacete;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
02 Albacete;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2021QII;""
02 Albacete;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2021QI;4.407
02 Albacete;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
02 Albacete;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
02 Albacete;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2020QII;""
02 Albacete;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2020QI;""
02 Albacete;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
02 Albacete;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
02 Albacete;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QII;4.083
02 Albacete;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QI;""
02 Albacete;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
02 Albacete;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
02 Albacete;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QII;4.268
02 Albacete;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QI;""
02 Albacete;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
02 Albacete;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
02 Albacete;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QII;""
02 Albacete;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QI;""
02 Albacete;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
02 Albacete;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QIII;3.970
02 Albacete;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QII;""
02 Albacete;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QI;""
02 Albacete;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
02 Albacete;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QIII;4.156
02 Albacete;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QII;""
02 Albacete;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QI;""
02 Albacete;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
02 Albacete;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
02 Albacete;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QII;""
02 Albacete;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QI;""
02 Albacete;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
02 Albacete;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
02 Albacete;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
02 Albacete;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
02 Albacete;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
02 Albacete;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
02 Albacete;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
02 Albacete;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
02 Albacete;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
02 Albacete;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
02 Albacete;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
02 Albacete;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
02 Albacete;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;96,22
02 Albacete;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
02 Albacete;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
02 Albacete;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
02 Albacete;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;96,42
02 Albacete;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
02 Albacete;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
02 Albacete;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
02 Albacete;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;96,7
02 Albacete;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
02 Albacete;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
02 Albacete;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
02 Albacete;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
02 Albacete;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
02 Albacete;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
02 Albacete;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;93,19
02 Albacete;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
02 Albacete;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
02 Albacete;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
02 Albacete;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;94,94
02 Albacete;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
02 Albacete;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
02 Albacete;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
02 Albacete;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
02 Albacete;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
02 Albacete;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
02 Albacete;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;89,7
02 Albacete;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
02 Albacete;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
02 Albacete;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
02 Albacete;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;91,94
02 Albacete;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
02 Albacete;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
02 Albacete;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
02 Albacete;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
02 Albacete;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
02 Albacete;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
02 Albacete;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;87,21
02 Albacete;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
02 Albacete;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
02 Albacete;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
02 Albacete;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;89,53
02 Albacete;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
02 Albacete;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
02 Albacete;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
02 Albacete;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
02 Albacete;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
02 Albacete;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
02 Albacete;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QIV;2.724
02 Albacete;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
02 Albacete;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
02 Albacete;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
02 Albacete;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QIV;2.899
02 Albacete;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
02 Albacete;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
02 Albacete;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
02 Albacete;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QIV;2.945
02 Albacete;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
02 Albacete;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
02 Albacete;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
02 Albacete;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2022QIV;2.614
02 Albacete;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
02 Albacete;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2022QII;""
02 Albacete;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2022QI;""
02 Albacete;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2021QIV;2.797
02 Albacete;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
02 Albacete;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2021QII;""
02 Albacete;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2021QI;""
02 Albacete;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2020QIV;2.853
02 Albacete;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
02 Albacete;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2020QII;""
02 Albacete;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2020QI;""
02 Albacete;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
02 Albacete;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
02 Albacete;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2022QII;""
02 Albacete;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2022QI;2.719
02 Albacete;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
02 Albacete;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
02 Albacete;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2021QII;""
02 Albacete;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2021QI;2.808
02 Albacete;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
02 Albacete;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
02 Albacete;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2020QII;""
02 Albacete;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2020QI;""
02 Albacete;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
02 Albacete;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
02 Albacete;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QII;2.636
02 Albacete;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QI;""
02 Albacete;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
02 Albacete;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
02 Albacete;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QII;2.730
02 Albacete;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QI;""
02 Albacete;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
02 Albacete;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
02 Albacete;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QII;""
02 Albacete;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QI;""
02 Albacete;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
02 Albacete;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QIII;2.581
02 Albacete;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QII;""
02 Albacete;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QI;""
02 Albacete;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
02 Albacete;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QIII;2.667
02 Albacete;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QII;""
02 Albacete;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QI;""
02 Albacete;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
02 Albacete;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
02 Albacete;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QII;""
02 Albacete;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QI;""
02 Albacete;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
02 Albacete;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
02 Albacete;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
02 Albacete;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
02 Albacete;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
02 Albacete;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
02 Albacete;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
02 Albacete;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
02 Albacete;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
02 Albacete;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
02 Albacete;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
02 Albacete;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
02 Albacete;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;95,96
02 Albacete;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
02 Albacete;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
02 Albacete;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
02 Albacete;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;96,48
02 Albacete;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
02 Albacete;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
02 Albacete;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
02 Albacete;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;96,88
02 Albacete;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
02 Albacete;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
02 Albacete;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
02 Albacete;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
02 Albacete;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
02 Albacete;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
02 Albacete;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;93,79
02 Albacete;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
02 Albacete;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
02 Albacete;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
02 Albacete;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;95,35
02 Albacete;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
02 Albacete;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
02 Albacete;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
02 Albacete;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
02 Albacete;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
02 Albacete;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
02 Albacete;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;90,93
02 Albacete;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
02 Albacete;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
02 Albacete;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
02 Albacete;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;92,7
02 Albacete;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
02 Albacete;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
02 Albacete;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
02 Albacete;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
02 Albacete;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
02 Albacete;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
02 Albacete;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;89,03
02 Albacete;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
02 Albacete;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
02 Albacete;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
02 Albacete;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;90,56
02 Albacete;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
02 Albacete;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
02 Albacete;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
02 Albacete;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
02 Albacete;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
02 Albacete;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
02 Albacete;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QIV;1.613
02 Albacete;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
02 Albacete;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
02 Albacete;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
02 Albacete;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QIV;1.653
02 Albacete;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
02 Albacete;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
02 Albacete;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
02 Albacete;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QIV;1.697
02 Albacete;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
02 Albacete;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
02 Albacete;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
02 Albacete;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2022QIV;1.559
02 Albacete;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
02 Albacete;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2022QII;""
02 Albacete;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2022QI;""
02 Albacete;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2021QIV;1.592
02 Albacete;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
02 Albacete;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2021QII;""
02 Albacete;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2021QI;""
02 Albacete;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2020QIV;1.636
02 Albacete;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
02 Albacete;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2020QII;""
02 Albacete;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2020QI;""
02 Albacete;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
02 Albacete;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
02 Albacete;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2022QII;""
02 Albacete;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2022QI;1.523
02 Albacete;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
02 Albacete;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
02 Albacete;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2021QII;""
02 Albacete;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2021QI;1.599
02 Albacete;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
02 Albacete;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
02 Albacete;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2020QII;""
02 Albacete;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2020QI;""
02 Albacete;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
02 Albacete;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
02 Albacete;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QII;1.447
02 Albacete;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QI;""
02 Albacete;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
02 Albacete;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
02 Albacete;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QII;1.538
02 Albacete;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QI;""
02 Albacete;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
02 Albacete;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
02 Albacete;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QII;""
02 Albacete;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QI;""
02 Albacete;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
02 Albacete;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QIII;1.389
02 Albacete;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QII;""
02 Albacete;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QI;""
02 Albacete;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
02 Albacete;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QIII;1.489
02 Albacete;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QII;""
02 Albacete;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QI;""
02 Albacete;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
02 Albacete;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
02 Albacete;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QII;""
02 Albacete;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QI;""
02 Albacete;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
02 Albacete;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
02 Albacete;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
02 Albacete;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
02 Albacete;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
02 Albacete;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
02 Albacete;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
02 Albacete;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
02 Albacete;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
02 Albacete;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
02 Albacete;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
02 Albacete;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
02 Albacete;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;96,65
02 Albacete;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
02 Albacete;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
02 Albacete;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
02 Albacete;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;96,31
02 Albacete;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
02 Albacete;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
02 Albacete;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
02 Albacete;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;96,41
02 Albacete;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
02 Albacete;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
02 Albacete;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
02 Albacete;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
02 Albacete;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
02 Albacete;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
02 Albacete;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;92,14
02 Albacete;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
02 Albacete;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
02 Albacete;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
02 Albacete;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;94,23
02 Albacete;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
02 Albacete;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
02 Albacete;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
02 Albacete;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
02 Albacete;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
02 Albacete;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
02 Albacete;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;87,54
02 Albacete;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
02 Albacete;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
02 Albacete;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
02 Albacete;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;90,63
02 Albacete;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
02 Albacete;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
02 Albacete;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
02 Albacete;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
02 Albacete;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
02 Albacete;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
02 Albacete;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;84,03
02 Albacete;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
02 Albacete;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
02 Albacete;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
02 Albacete;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;87,74
02 Albacete;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
02 Albacete;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
02 Albacete;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
02 Albacete;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
02 Albacete;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
02 Albacete;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
02 Albacete;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
02 Albacete;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
02 Albacete;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
02 Albacete;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QI;7.497
02 Albacete;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
02 Albacete;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
02 Albacete;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
02 Albacete;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QI;7.597
02 Albacete;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
02 Albacete;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
02 Albacete;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
02 Albacete;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QI;7.632
02 Albacete;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
02 Albacete;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
02 Albacete;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2022QII;""
02 Albacete;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2022QI;7.311
02 Albacete;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
02 Albacete;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
02 Albacete;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2021QII;""
02 Albacete;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2021QI;7.485
02 Albacete;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
02 Albacete;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
02 Albacete;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2020QII;""
02 Albacete;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2020QI;7.200
02 Albacete;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
02 Albacete;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
02 Albacete;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2022QII;7.119
02 Albacete;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2022QI;""
02 Albacete;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
02 Albacete;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
02 Albacete;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2021QII;7.333
02 Albacete;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2021QI;""
02 Albacete;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
02 Albacete;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
02 Albacete;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2020QII;7.087
02 Albacete;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2020QI;""
02 Albacete;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
02 Albacete;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QIII;6.956
02 Albacete;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QII;""
02 Albacete;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QI;""
02 Albacete;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
02 Albacete;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QIII;7.210
02 Albacete;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QII;""
02 Albacete;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QI;""
02 Albacete;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
02 Albacete;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QIII;6.963
02 Albacete;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QII;""
02 Albacete;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QI;""
02 Albacete;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QIV;6.816
02 Albacete;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
02 Albacete;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QII;""
02 Albacete;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QI;""
02 Albacete;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QIV;7.065
02 Albacete;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
02 Albacete;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QII;""
02 Albacete;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QI;""
02 Albacete;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QIV;6.842
02 Albacete;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
02 Albacete;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QII;""
02 Albacete;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QI;""
02 Albacete;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
02 Albacete;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
02 Albacete;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
02 Albacete;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
02 Albacete;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
02 Albacete;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
02 Albacete;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
02 Albacete;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
02 Albacete;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
02 Albacete;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
02 Albacete;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
02 Albacete;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
02 Albacete;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
02 Albacete;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
02 Albacete;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
02 Albacete;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;97,52
02 Albacete;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
02 Albacete;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
02 Albacete;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
02 Albacete;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;98,53
02 Albacete;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
02 Albacete;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
02 Albacete;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
02 Albacete;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;94,34
02 Albacete;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
02 Albacete;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
02 Albacete;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;94,96
02 Albacete;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
02 Albacete;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
02 Albacete;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
02 Albacete;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;96,52
02 Albacete;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
02 Albacete;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
02 Albacete;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
02 Albacete;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;92,86
02 Albacete;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
02 Albacete;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
02 Albacete;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;92,78
02 Albacete;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
02 Albacete;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
02 Albacete;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
02 Albacete;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;94,91
02 Albacete;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
02 Albacete;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
02 Albacete;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
02 Albacete;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;91,23
02 Albacete;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
02 Albacete;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
02 Albacete;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;90,92
02 Albacete;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
02 Albacete;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
02 Albacete;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
02 Albacete;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;93
02 Albacete;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
02 Albacete;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
02 Albacete;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
02 Albacete;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;89,65
02 Albacete;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
02 Albacete;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
02 Albacete;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
02 Albacete;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
02 Albacete;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
02 Albacete;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
02 Albacete;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QI;5.008
02 Albacete;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
02 Albacete;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
02 Albacete;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
02 Albacete;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QI;5.133
02 Albacete;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
02 Albacete;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
02 Albacete;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
02 Albacete;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QI;5.158
02 Albacete;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
02 Albacete;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
02 Albacete;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2022QII;""
02 Albacete;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2022QI;4.898
02 Albacete;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
02 Albacete;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
02 Albacete;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2021QII;""
02 Albacete;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2021QI;5.052
02 Albacete;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
02 Albacete;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
02 Albacete;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2020QII;""
02 Albacete;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2020QI;4.883
02 Albacete;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
02 Albacete;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
02 Albacete;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2022QII;4.788
02 Albacete;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2022QI;""
02 Albacete;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
02 Albacete;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
02 Albacete;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2021QII;4.976
02 Albacete;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2021QI;""
02 Albacete;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
02 Albacete;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
02 Albacete;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2020QII;4.820
02 Albacete;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2020QI;""
02 Albacete;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
02 Albacete;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QIII;4.682
02 Albacete;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QII;""
02 Albacete;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QI;""
02 Albacete;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
02 Albacete;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QIII;4.892
02 Albacete;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QII;""
02 Albacete;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QI;""
02 Albacete;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
02 Albacete;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QIII;4.736
02 Albacete;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QII;""
02 Albacete;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QI;""
02 Albacete;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QIV;4.600
02 Albacete;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
02 Albacete;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QII;""
02 Albacete;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QI;""
02 Albacete;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QIV;4.796
02 Albacete;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
02 Albacete;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QII;""
02 Albacete;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QI;""
02 Albacete;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QIV;4.660
02 Albacete;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
02 Albacete;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QII;""
02 Albacete;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QI;""
02 Albacete;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
02 Albacete;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
02 Albacete;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
02 Albacete;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
02 Albacete;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
02 Albacete;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
02 Albacete;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
02 Albacete;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
02 Albacete;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
02 Albacete;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
02 Albacete;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
02 Albacete;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
02 Albacete;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
02 Albacete;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
02 Albacete;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
02 Albacete;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;97,8
02 Albacete;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
02 Albacete;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
02 Albacete;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
02 Albacete;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;98,42
02 Albacete;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
02 Albacete;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
02 Albacete;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
02 Albacete;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;94,67
02 Albacete;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
02 Albacete;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
02 Albacete;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;95,61
02 Albacete;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
02 Albacete;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
02 Albacete;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
02 Albacete;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;96,94
02 Albacete;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
02 Albacete;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
02 Albacete;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
02 Albacete;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;93,45
02 Albacete;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
02 Albacete;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
02 Albacete;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;93,49
02 Albacete;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
02 Albacete;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
02 Albacete;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
02 Albacete;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;95,3
02 Albacete;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
02 Albacete;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
02 Albacete;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
02 Albacete;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;91,82
02 Albacete;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
02 Albacete;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
02 Albacete;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;91,85
02 Albacete;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
02 Albacete;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
02 Albacete;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
02 Albacete;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;93,43
02 Albacete;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
02 Albacete;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
02 Albacete;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
02 Albacete;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;90,35
02 Albacete;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
02 Albacete;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
02 Albacete;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
02 Albacete;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
02 Albacete;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
02 Albacete;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
02 Albacete;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QI;2.489
02 Albacete;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
02 Albacete;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
02 Albacete;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
02 Albacete;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QI;2.464
02 Albacete;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
02 Albacete;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
02 Albacete;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
02 Albacete;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QI;2.474
02 Albacete;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
02 Albacete;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
02 Albacete;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2022QII;""
02 Albacete;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2022QI;2.413
02 Albacete;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
02 Albacete;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
02 Albacete;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2021QII;""
02 Albacete;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2021QI;2.433
02 Albacete;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
02 Albacete;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
02 Albacete;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2020QII;""
02 Albacete;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2020QI;2.317
02 Albacete;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
02 Albacete;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
02 Albacete;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2022QII;2.331
02 Albacete;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2022QI;""
02 Albacete;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
02 Albacete;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
02 Albacete;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2021QII;2.357
02 Albacete;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2021QI;""
02 Albacete;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
02 Albacete;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
02 Albacete;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2020QII;2.267
02 Albacete;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2020QI;""
02 Albacete;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
02 Albacete;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QIII;2.274
02 Albacete;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QII;""
02 Albacete;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QI;""
02 Albacete;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
02 Albacete;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QIII;2.318
02 Albacete;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QII;""
02 Albacete;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QI;""
02 Albacete;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
02 Albacete;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QIII;2.227
02 Albacete;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QII;""
02 Albacete;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QI;""
02 Albacete;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QIV;2.216
02 Albacete;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
02 Albacete;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QII;""
02 Albacete;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QI;""
02 Albacete;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QIV;2.269
02 Albacete;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
02 Albacete;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QII;""
02 Albacete;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QI;""
02 Albacete;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QIV;2.182
02 Albacete;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
02 Albacete;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QII;""
02 Albacete;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QI;""
02 Albacete;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
02 Albacete;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
02 Albacete;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
02 Albacete;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
02 Albacete;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
02 Albacete;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
02 Albacete;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
02 Albacete;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
02 Albacete;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
02 Albacete;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
02 Albacete;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
02 Albacete;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
02 Albacete;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
02 Albacete;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
02 Albacete;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
02 Albacete;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;96,95
02 Albacete;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
02 Albacete;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
02 Albacete;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
02 Albacete;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;98,74
02 Albacete;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
02 Albacete;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
02 Albacete;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
02 Albacete;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;93,65
02 Albacete;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
02 Albacete;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
02 Albacete;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;93,65
02 Albacete;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
02 Albacete;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
02 Albacete;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
02 Albacete;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;95,66
02 Albacete;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
02 Albacete;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
02 Albacete;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
02 Albacete;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;91,63
02 Albacete;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
02 Albacete;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
02 Albacete;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;91,36
02 Albacete;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
02 Albacete;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
02 Albacete;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
02 Albacete;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;94,07
02 Albacete;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
02 Albacete;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
02 Albacete;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
02 Albacete;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;90,02
02 Albacete;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
02 Albacete;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
02 Albacete;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;89,03
02 Albacete;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
02 Albacete;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
02 Albacete;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
02 Albacete;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;92,09
02 Albacete;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
02 Albacete;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
02 Albacete;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
02 Albacete;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;88,2
02 Albacete;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
02 Albacete;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
02 Albacete;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
02 Albacete;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
02 Albacete;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
02 Albacete;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QII;7.353
02 Albacete;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
02 Albacete;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
02 Albacete;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
02 Albacete;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QII;7.475
02 Albacete;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
02 Albacete;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
02 Albacete;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
02 Albacete;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QII;7.445
02 Albacete;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
02 Albacete;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
02 Albacete;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
02 Albacete;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2022QII;7.139
02 Albacete;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2022QI;""
02 Albacete;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
02 Albacete;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
02 Albacete;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2021QII;7.303
02 Albacete;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2021QI;""
02 Albacete;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
02 Albacete;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
02 Albacete;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2020QII;7.323
02 Albacete;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2020QI;""
02 Albacete;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
02 Albacete;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2022QIII;6.966
02 Albacete;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2022QII;""
02 Albacete;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2022QI;""
02 Albacete;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
02 Albacete;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2021QIII;7.158
02 Albacete;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2021QII;""
02 Albacete;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2021QI;""
02 Albacete;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
02 Albacete;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2020QIII;7.185
02 Albacete;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2020QII;""
02 Albacete;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2020QI;""
02 Albacete;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QIV;6.809
02 Albacete;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
02 Albacete;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QII;""
02 Albacete;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QI;""
02 Albacete;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QIV;6.991
02 Albacete;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
02 Albacete;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QII;""
02 Albacete;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QI;""
02 Albacete;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QIV;7.051
02 Albacete;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
02 Albacete;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QII;""
02 Albacete;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QI;""
02 Albacete;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
02 Albacete;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
02 Albacete;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QII;""
02 Albacete;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QI;6.860
02 Albacete;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
02 Albacete;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
02 Albacete;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QII;""
02 Albacete;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QI;6.972
02 Albacete;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
02 Albacete;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
02 Albacete;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QII;""
02 Albacete;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QI;""
02 Albacete;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
02 Albacete;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
02 Albacete;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
02 Albacete;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
02 Albacete;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
02 Albacete;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
02 Albacete;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
02 Albacete;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
02 Albacete;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
02 Albacete;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
02 Albacete;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
02 Albacete;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
02 Albacete;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
02 Albacete;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
02 Albacete;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;97,09
02 Albacete;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
02 Albacete;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
02 Albacete;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
02 Albacete;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;97,7
02 Albacete;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
02 Albacete;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
02 Albacete;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
02 Albacete;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;98,36
02 Albacete;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
02 Albacete;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
02 Albacete;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;94,74
02 Albacete;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
02 Albacete;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
02 Albacete;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
02 Albacete;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;95,76
02 Albacete;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
02 Albacete;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
02 Albacete;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
02 Albacete;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;96,51
02 Albacete;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
02 Albacete;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
02 Albacete;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;92,6
02 Albacete;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
02 Albacete;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
02 Albacete;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
02 Albacete;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;93,53
02 Albacete;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
02 Albacete;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
02 Albacete;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
02 Albacete;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;94,71
02 Albacete;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
02 Albacete;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
02 Albacete;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
02 Albacete;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
02 Albacete;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
02 Albacete;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
02 Albacete;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;91,77
02 Albacete;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
02 Albacete;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
02 Albacete;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
02 Albacete;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;93,65
02 Albacete;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
02 Albacete;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
02 Albacete;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
02 Albacete;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
02 Albacete;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
02 Albacete;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
02 Albacete;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QII;4.922
02 Albacete;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
02 Albacete;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
02 Albacete;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
02 Albacete;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QII;5.018
02 Albacete;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
02 Albacete;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
02 Albacete;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
02 Albacete;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QII;5.019
02 Albacete;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
02 Albacete;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
02 Albacete;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
02 Albacete;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2022QII;4.799
02 Albacete;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2022QI;""
02 Albacete;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
02 Albacete;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
02 Albacete;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2021QII;4.929
02 Albacete;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2021QI;""
02 Albacete;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
02 Albacete;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
02 Albacete;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2020QII;4.952
02 Albacete;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2020QI;""
02 Albacete;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
02 Albacete;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2022QIII;4.688
02 Albacete;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2022QII;""
02 Albacete;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2022QI;""
02 Albacete;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
02 Albacete;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2021QIII;4.829
02 Albacete;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2021QII;""
02 Albacete;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2021QI;""
02 Albacete;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
02 Albacete;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2020QIII;4.861
02 Albacete;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2020QII;""
02 Albacete;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2020QI;""
02 Albacete;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QIV;4.591
02 Albacete;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
02 Albacete;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QII;""
02 Albacete;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QI;""
02 Albacete;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QIV;4.719
02 Albacete;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
02 Albacete;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QII;""
02 Albacete;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QI;""
02 Albacete;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QIV;4.779
02 Albacete;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
02 Albacete;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QII;""
02 Albacete;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QI;""
02 Albacete;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
02 Albacete;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
02 Albacete;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QII;""
02 Albacete;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QI;4.642
02 Albacete;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
02 Albacete;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
02 Albacete;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QII;""
02 Albacete;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QI;4.720
02 Albacete;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
02 Albacete;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
02 Albacete;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QII;""
02 Albacete;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QI;""
02 Albacete;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
02 Albacete;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
02 Albacete;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
02 Albacete;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
02 Albacete;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
02 Albacete;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
02 Albacete;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
02 Albacete;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
02 Albacete;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
02 Albacete;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
02 Albacete;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
02 Albacete;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
02 Albacete;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
02 Albacete;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
02 Albacete;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;97,5
02 Albacete;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
02 Albacete;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
02 Albacete;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
02 Albacete;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;98,23
02 Albacete;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
02 Albacete;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
02 Albacete;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
02 Albacete;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;98,67
02 Albacete;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
02 Albacete;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
02 Albacete;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;95,25
02 Albacete;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
02 Albacete;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
02 Albacete;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
02 Albacete;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;96,23
02 Albacete;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
02 Albacete;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
02 Albacete;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
02 Albacete;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;96,85
02 Albacete;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
02 Albacete;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
02 Albacete;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;93,28
02 Albacete;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
02 Albacete;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
02 Albacete;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
02 Albacete;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;94,04
02 Albacete;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
02 Albacete;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
02 Albacete;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
02 Albacete;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;95,22
02 Albacete;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
02 Albacete;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
02 Albacete;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
02 Albacete;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
02 Albacete;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
02 Albacete;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
02 Albacete;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;92,51
02 Albacete;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
02 Albacete;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
02 Albacete;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
02 Albacete;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;94,04
02 Albacete;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
02 Albacete;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
02 Albacete;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
02 Albacete;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
02 Albacete;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
02 Albacete;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
02 Albacete;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QII;2.431
02 Albacete;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
02 Albacete;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
02 Albacete;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
02 Albacete;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QII;2.457
02 Albacete;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
02 Albacete;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
02 Albacete;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
02 Albacete;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QII;2.426
02 Albacete;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
02 Albacete;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
02 Albacete;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
02 Albacete;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2022QII;2.340
02 Albacete;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2022QI;""
02 Albacete;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
02 Albacete;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
02 Albacete;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2021QII;2.374
02 Albacete;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2021QI;""
02 Albacete;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
02 Albacete;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
02 Albacete;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2020QII;2.371
02 Albacete;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2020QI;""
02 Albacete;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
02 Albacete;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2022QIII;2.278
02 Albacete;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2022QII;""
02 Albacete;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2022QI;""
02 Albacete;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
02 Albacete;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2021QIII;2.329
02 Albacete;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2021QII;""
02 Albacete;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2021QI;""
02 Albacete;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
02 Albacete;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2020QIII;2.324
02 Albacete;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2020QII;""
02 Albacete;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2020QI;""
02 Albacete;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QIV;2.218
02 Albacete;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
02 Albacete;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QII;""
02 Albacete;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QI;""
02 Albacete;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QIV;2.272
02 Albacete;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
02 Albacete;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QII;""
02 Albacete;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QI;""
02 Albacete;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QIV;2.272
02 Albacete;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
02 Albacete;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QII;""
02 Albacete;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QI;""
02 Albacete;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
02 Albacete;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
02 Albacete;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QII;""
02 Albacete;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QI;2.218
02 Albacete;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
02 Albacete;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
02 Albacete;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QII;""
02 Albacete;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QI;2.252
02 Albacete;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
02 Albacete;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
02 Albacete;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QII;""
02 Albacete;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QI;""
02 Albacete;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
02 Albacete;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
02 Albacete;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
02 Albacete;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
02 Albacete;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
02 Albacete;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
02 Albacete;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
02 Albacete;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
02 Albacete;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
02 Albacete;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
02 Albacete;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
02 Albacete;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
02 Albacete;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
02 Albacete;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
02 Albacete;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;96,26
02 Albacete;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
02 Albacete;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
02 Albacete;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
02 Albacete;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;96,62
02 Albacete;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
02 Albacete;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
02 Albacete;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
02 Albacete;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;97,73
02 Albacete;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
02 Albacete;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
02 Albacete;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;93,71
02 Albacete;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
02 Albacete;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
02 Albacete;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
02 Albacete;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;94,79
02 Albacete;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
02 Albacete;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
02 Albacete;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
02 Albacete;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;95,8
02 Albacete;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
02 Albacete;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
02 Albacete;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;91,24
02 Albacete;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
02 Albacete;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
02 Albacete;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
02 Albacete;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;92,47
02 Albacete;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
02 Albacete;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
02 Albacete;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
02 Albacete;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;93,65
02 Albacete;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
02 Albacete;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
02 Albacete;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
02 Albacete;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
02 Albacete;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
02 Albacete;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
02 Albacete;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;90,27
02 Albacete;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
02 Albacete;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
02 Albacete;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
02 Albacete;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;92,83
02 Albacete;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
02 Albacete;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
02 Albacete;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
02 Albacete;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
02 Albacete;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
02 Albacete;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QIII;7.367
02 Albacete;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
02 Albacete;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
02 Albacete;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
02 Albacete;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QIII;7.521
02 Albacete;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
02 Albacete;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
02 Albacete;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
02 Albacete;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QIII;7.594
02 Albacete;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
02 Albacete;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
02 Albacete;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
02 Albacete;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2022QIII;7.162
02 Albacete;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2022QII;""
02 Albacete;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2022QI;""
02 Albacete;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
02 Albacete;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2021QIII;7.343
02 Albacete;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2021QII;""
02 Albacete;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2021QI;""
02 Albacete;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
02 Albacete;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2020QIII;7.418
02 Albacete;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2020QII;""
02 Albacete;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2020QI;""
02 Albacete;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2022QIV;6.987
02 Albacete;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
02 Albacete;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2022QII;""
02 Albacete;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2022QI;""
02 Albacete;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2021QIV;7.153
02 Albacete;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
02 Albacete;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2021QII;""
02 Albacete;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2021QI;""
02 Albacete;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2020QIV;7.251
02 Albacete;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
02 Albacete;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2020QII;""
02 Albacete;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2020QI;""
02 Albacete;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
02 Albacete;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
02 Albacete;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QII;""
02 Albacete;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QI;7.008
02 Albacete;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
02 Albacete;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
02 Albacete;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QII;""
02 Albacete;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QI;7.165
02 Albacete;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
02 Albacete;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
02 Albacete;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QII;""
02 Albacete;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QI;""
02 Albacete;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
02 Albacete;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
02 Albacete;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QII;6.852
02 Albacete;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QI;""
02 Albacete;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
02 Albacete;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
02 Albacete;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QII;7.043
02 Albacete;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QI;""
02 Albacete;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
02 Albacete;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
02 Albacete;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QII;""
02 Albacete;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QI;""
02 Albacete;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
02 Albacete;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
02 Albacete;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
02 Albacete;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
02 Albacete;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
02 Albacete;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
02 Albacete;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
02 Albacete;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
02 Albacete;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
02 Albacete;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
02 Albacete;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
02 Albacete;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
02 Albacete;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
02 Albacete;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;97,22
02 Albacete;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
02 Albacete;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
02 Albacete;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
02 Albacete;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;97,63
02 Albacete;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
02 Albacete;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
02 Albacete;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
02 Albacete;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;97,68
02 Albacete;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
02 Albacete;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
02 Albacete;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;94,84
02 Albacete;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
02 Albacete;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
02 Albacete;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
02 Albacete;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;95,11
02 Albacete;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
02 Albacete;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
02 Albacete;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
02 Albacete;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;95,48
02 Albacete;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
02 Albacete;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
02 Albacete;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
02 Albacete;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
02 Albacete;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
02 Albacete;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
02 Albacete;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;93,18
02 Albacete;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
02 Albacete;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
02 Albacete;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
02 Albacete;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;94,35
02 Albacete;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
02 Albacete;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
02 Albacete;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
02 Albacete;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
02 Albacete;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
02 Albacete;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
02 Albacete;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;91,1
02 Albacete;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
02 Albacete;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
02 Albacete;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
02 Albacete;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;92,74
02 Albacete;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
02 Albacete;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
02 Albacete;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
02 Albacete;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
02 Albacete;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
02 Albacete;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
02 Albacete;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QIII;4.922
02 Albacete;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
02 Albacete;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
02 Albacete;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
02 Albacete;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QIII;5.053
02 Albacete;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
02 Albacete;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
02 Albacete;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
02 Albacete;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QIII;5.155
02 Albacete;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
02 Albacete;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
02 Albacete;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
02 Albacete;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2022QIII;4.794
02 Albacete;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2022QII;""
02 Albacete;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2022QI;""
02 Albacete;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
02 Albacete;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2021QIII;4.939
02 Albacete;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2021QII;""
02 Albacete;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2021QI;""
02 Albacete;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
02 Albacete;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2020QIII;5.039
02 Albacete;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2020QII;""
02 Albacete;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2020QI;""
02 Albacete;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2022QIV;4.687
02 Albacete;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
02 Albacete;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2022QII;""
02 Albacete;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2022QI;""
02 Albacete;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2021QIV;4.818
02 Albacete;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
02 Albacete;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2021QII;""
02 Albacete;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2021QI;""
02 Albacete;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2020QIV;4.930
02 Albacete;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
02 Albacete;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2020QII;""
02 Albacete;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2020QI;""
02 Albacete;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
02 Albacete;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
02 Albacete;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QII;""
02 Albacete;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QI;4.737
02 Albacete;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
02 Albacete;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
02 Albacete;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QII;""
02 Albacete;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QI;4.865
02 Albacete;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
02 Albacete;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
02 Albacete;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QII;""
02 Albacete;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QI;""
02 Albacete;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
02 Albacete;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
02 Albacete;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QII;4.644
02 Albacete;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QI;""
02 Albacete;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
02 Albacete;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
02 Albacete;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QII;4.802
02 Albacete;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QI;""
02 Albacete;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
02 Albacete;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
02 Albacete;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QII;""
02 Albacete;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QI;""
02 Albacete;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
02 Albacete;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
02 Albacete;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
02 Albacete;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
02 Albacete;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
02 Albacete;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
02 Albacete;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
02 Albacete;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
02 Albacete;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
02 Albacete;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
02 Albacete;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
02 Albacete;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
02 Albacete;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
02 Albacete;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;97,4
02 Albacete;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
02 Albacete;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
02 Albacete;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
02 Albacete;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;97,74
02 Albacete;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
02 Albacete;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
02 Albacete;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
02 Albacete;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;97,75
02 Albacete;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
02 Albacete;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
02 Albacete;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;95,23
02 Albacete;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
02 Albacete;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
02 Albacete;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
02 Albacete;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;95,35
02 Albacete;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
02 Albacete;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
02 Albacete;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
02 Albacete;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;95,64
02 Albacete;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
02 Albacete;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
02 Albacete;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
02 Albacete;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
02 Albacete;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
02 Albacete;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
02 Albacete;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;93,75
02 Albacete;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
02 Albacete;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
02 Albacete;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
02 Albacete;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;94,37
02 Albacete;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
02 Albacete;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
02 Albacete;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
02 Albacete;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
02 Albacete;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
02 Albacete;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
02 Albacete;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;91,91
02 Albacete;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
02 Albacete;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
02 Albacete;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
02 Albacete;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;93,15
02 Albacete;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
02 Albacete;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
02 Albacete;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
02 Albacete;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
02 Albacete;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
02 Albacete;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
02 Albacete;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QIII;2.445
02 Albacete;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
02 Albacete;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
02 Albacete;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
02 Albacete;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QIII;2.468
02 Albacete;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
02 Albacete;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
02 Albacete;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
02 Albacete;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QIII;2.439
02 Albacete;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
02 Albacete;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
02 Albacete;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
02 Albacete;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2022QIII;2.368
02 Albacete;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2022QII;""
02 Albacete;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2022QI;""
02 Albacete;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
02 Albacete;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2021QIII;2.404
02 Albacete;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2021QII;""
02 Albacete;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2021QI;""
02 Albacete;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
02 Albacete;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2020QIII;2.379
02 Albacete;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2020QII;""
02 Albacete;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2020QI;""
02 Albacete;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2022QIV;2.300
02 Albacete;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
02 Albacete;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2022QII;""
02 Albacete;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2022QI;""
02 Albacete;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2021QIV;2.335
02 Albacete;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
02 Albacete;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2021QII;""
02 Albacete;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2021QI;""
02 Albacete;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2020QIV;2.321
02 Albacete;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
02 Albacete;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2020QII;""
02 Albacete;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2020QI;""
02 Albacete;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
02 Albacete;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
02 Albacete;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QII;""
02 Albacete;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QI;2.271
02 Albacete;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
02 Albacete;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
02 Albacete;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QII;""
02 Albacete;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QI;2.300
02 Albacete;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
02 Albacete;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
02 Albacete;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QII;""
02 Albacete;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QI;""
02 Albacete;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
02 Albacete;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
02 Albacete;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QII;2.208
02 Albacete;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QI;""
02 Albacete;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
02 Albacete;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
02 Albacete;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QII;2.241
02 Albacete;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QI;""
02 Albacete;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
02 Albacete;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
02 Albacete;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QII;""
02 Albacete;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QI;""
02 Albacete;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
02 Albacete;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
02 Albacete;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
02 Albacete;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
02 Albacete;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
02 Albacete;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
02 Albacete;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
02 Albacete;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
02 Albacete;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
02 Albacete;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
02 Albacete;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
02 Albacete;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
02 Albacete;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
02 Albacete;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;96,85
02 Albacete;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
02 Albacete;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
02 Albacete;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
02 Albacete;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;97,41
02 Albacete;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
02 Albacete;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
02 Albacete;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
02 Albacete;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;97,54
02 Albacete;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
02 Albacete;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
02 Albacete;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;94,07
02 Albacete;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
02 Albacete;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
02 Albacete;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
02 Albacete;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;94,61
02 Albacete;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
02 Albacete;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
02 Albacete;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
02 Albacete;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;95,16
02 Albacete;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
02 Albacete;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
02 Albacete;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
02 Albacete;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
02 Albacete;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
02 Albacete;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
02 Albacete;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;92,02
02 Albacete;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
02 Albacete;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
02 Albacete;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
02 Albacete;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;94,3
02 Albacete;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
02 Albacete;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
02 Albacete;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
02 Albacete;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
02 Albacete;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
02 Albacete;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
02 Albacete;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;89,47
02 Albacete;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
02 Albacete;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
02 Albacete;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
02 Albacete;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;91,88
02 Albacete;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
02 Albacete;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
02 Albacete;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
02 Albacete;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
02 Albacete;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
02 Albacete;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QIV;7.350
02 Albacete;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
02 Albacete;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
02 Albacete;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
02 Albacete;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QIV;7.522
02 Albacete;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
02 Albacete;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
02 Albacete;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
02 Albacete;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QIV;7.611
02 Albacete;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
02 Albacete;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
02 Albacete;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
02 Albacete;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2022QIV;7.146
02 Albacete;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
02 Albacete;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2022QII;""
02 Albacete;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2022QI;""
02 Albacete;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2021QIV;7.307
02 Albacete;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
02 Albacete;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2021QII;""
02 Albacete;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2021QI;""
02 Albacete;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2020QIV;7.409
02 Albacete;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
02 Albacete;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2020QII;""
02 Albacete;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2020QI;""
02 Albacete;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
02 Albacete;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
02 Albacete;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2022QII;""
02 Albacete;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2022QI;7.150
02 Albacete;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
02 Albacete;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
02 Albacete;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2021QII;""
02 Albacete;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2021QI;7.314
02 Albacete;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
02 Albacete;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
02 Albacete;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2020QII;""
02 Albacete;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2020QI;""
02 Albacete;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
02 Albacete;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
02 Albacete;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QII;6.979
02 Albacete;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QI;""
02 Albacete;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
02 Albacete;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
02 Albacete;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QII;7.184
02 Albacete;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QI;""
02 Albacete;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
02 Albacete;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
02 Albacete;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QII;""
02 Albacete;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QI;""
02 Albacete;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
02 Albacete;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QIII;6.824
02 Albacete;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QII;""
02 Albacete;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QI;""
02 Albacete;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
02 Albacete;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QIII;7.074
02 Albacete;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QII;""
02 Albacete;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QI;""
02 Albacete;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
02 Albacete;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
02 Albacete;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QII;""
02 Albacete;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QI;""
02 Albacete;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
02 Albacete;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
02 Albacete;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
02 Albacete;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
02 Albacete;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
02 Albacete;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
02 Albacete;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
02 Albacete;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
02 Albacete;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
02 Albacete;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
02 Albacete;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
02 Albacete;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
02 Albacete;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;97,22
02 Albacete;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
02 Albacete;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
02 Albacete;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
02 Albacete;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;97,14
02 Albacete;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
02 Albacete;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
02 Albacete;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
02 Albacete;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;97,35
02 Albacete;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
02 Albacete;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
02 Albacete;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
02 Albacete;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
02 Albacete;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
02 Albacete;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
02 Albacete;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;95,05
02 Albacete;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
02 Albacete;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
02 Albacete;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
02 Albacete;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;96,1
02 Albacete;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
02 Albacete;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
02 Albacete;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
02 Albacete;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
02 Albacete;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
02 Albacete;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
02 Albacete;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;92,78
02 Albacete;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
02 Albacete;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
02 Albacete;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
02 Albacete;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;94,39
02 Albacete;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
02 Albacete;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
02 Albacete;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
02 Albacete;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
02 Albacete;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
02 Albacete;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
02 Albacete;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;90,72
02 Albacete;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
02 Albacete;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
02 Albacete;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
02 Albacete;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;92,94
02 Albacete;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
02 Albacete;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
02 Albacete;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
02 Albacete;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
02 Albacete;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
02 Albacete;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
02 Albacete;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QIV;4.899
02 Albacete;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
02 Albacete;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
02 Albacete;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
02 Albacete;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QIV;5.036
02 Albacete;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
02 Albacete;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
02 Albacete;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
02 Albacete;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QIV;5.158
02 Albacete;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
02 Albacete;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
02 Albacete;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
02 Albacete;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2022QIV;4.772
02 Albacete;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
02 Albacete;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2022QII;""
02 Albacete;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2022QI;""
02 Albacete;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2021QIV;4.896
02 Albacete;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
02 Albacete;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2021QII;""
02 Albacete;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2021QI;""
02 Albacete;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2020QIV;5.024
02 Albacete;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
02 Albacete;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2020QII;""
02 Albacete;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2020QI;""
02 Albacete;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
02 Albacete;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
02 Albacete;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2022QII;""
02 Albacete;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2022QI;4.807
02 Albacete;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
02 Albacete;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
02 Albacete;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2021QII;""
02 Albacete;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2021QI;4.953
02 Albacete;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
02 Albacete;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
02 Albacete;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2020QII;""
02 Albacete;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2020QI;""
02 Albacete;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
02 Albacete;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
02 Albacete;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QII;4.709
02 Albacete;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QI;""
02 Albacete;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
02 Albacete;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
02 Albacete;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QII;4.885
02 Albacete;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QI;""
02 Albacete;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
02 Albacete;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
02 Albacete;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QII;""
02 Albacete;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QI;""
02 Albacete;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
02 Albacete;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QIII;4.607
02 Albacete;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QII;""
02 Albacete;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QI;""
02 Albacete;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
02 Albacete;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QIII;4.813
02 Albacete;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QII;""
02 Albacete;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QI;""
02 Albacete;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
02 Albacete;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
02 Albacete;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QII;""
02 Albacete;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QI;""
02 Albacete;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
02 Albacete;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
02 Albacete;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
02 Albacete;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
02 Albacete;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
02 Albacete;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
02 Albacete;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
02 Albacete;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
02 Albacete;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
02 Albacete;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
02 Albacete;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
02 Albacete;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
02 Albacete;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;97,41
02 Albacete;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
02 Albacete;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
02 Albacete;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
02 Albacete;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;97,22
02 Albacete;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
02 Albacete;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
02 Albacete;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
02 Albacete;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;97,4
02 Albacete;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
02 Albacete;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
02 Albacete;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
02 Albacete;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
02 Albacete;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
02 Albacete;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
02 Albacete;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;95,45
02 Albacete;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
02 Albacete;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
02 Albacete;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
02 Albacete;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;96,03
02 Albacete;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
02 Albacete;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
02 Albacete;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
02 Albacete;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
02 Albacete;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
02 Albacete;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
02 Albacete;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;93,51
02 Albacete;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
02 Albacete;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
02 Albacete;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
02 Albacete;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;94,71
02 Albacete;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
02 Albacete;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
02 Albacete;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
02 Albacete;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
02 Albacete;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
02 Albacete;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
02 Albacete;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;91,48
02 Albacete;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
02 Albacete;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
02 Albacete;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
02 Albacete;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;93,31
02 Albacete;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
02 Albacete;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
02 Albacete;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
02 Albacete;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
02 Albacete;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
02 Albacete;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
02 Albacete;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QIV;2.451
02 Albacete;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
02 Albacete;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
02 Albacete;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
02 Albacete;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QIV;2.486
02 Albacete;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
02 Albacete;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
02 Albacete;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
02 Albacete;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QIV;2.453
02 Albacete;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
02 Albacete;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
02 Albacete;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
02 Albacete;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2022QIV;2.374
02 Albacete;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
02 Albacete;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2022QII;""
02 Albacete;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2022QI;""
02 Albacete;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2021QIV;2.411
02 Albacete;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
02 Albacete;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2021QII;""
02 Albacete;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2021QI;""
02 Albacete;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2020QIV;2.385
02 Albacete;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
02 Albacete;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2020QII;""
02 Albacete;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2020QI;""
02 Albacete;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
02 Albacete;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
02 Albacete;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2022QII;""
02 Albacete;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2022QI;2.343
02 Albacete;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
02 Albacete;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
02 Albacete;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2021QII;""
02 Albacete;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2021QI;2.361
02 Albacete;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
02 Albacete;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
02 Albacete;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2020QII;""
02 Albacete;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2020QI;""
02 Albacete;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
02 Albacete;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
02 Albacete;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QII;2.270
02 Albacete;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QI;""
02 Albacete;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
02 Albacete;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
02 Albacete;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QII;2.299
02 Albacete;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QI;""
02 Albacete;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
02 Albacete;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
02 Albacete;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QII;""
02 Albacete;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QI;""
02 Albacete;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
02 Albacete;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QIII;2.217
02 Albacete;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QII;""
02 Albacete;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QI;""
02 Albacete;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
02 Albacete;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QIII;2.261
02 Albacete;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QII;""
02 Albacete;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QI;""
02 Albacete;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
02 Albacete;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
02 Albacete;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QII;""
02 Albacete;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QI;""
02 Albacete;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
02 Albacete;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
02 Albacete;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
02 Albacete;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
02 Albacete;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
02 Albacete;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
02 Albacete;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
02 Albacete;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
02 Albacete;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
02 Albacete;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
02 Albacete;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
02 Albacete;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
02 Albacete;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;96,86
02 Albacete;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
02 Albacete;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
02 Albacete;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
02 Albacete;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;96,98
02 Albacete;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
02 Albacete;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
02 Albacete;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
02 Albacete;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;97,23
02 Albacete;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
02 Albacete;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
02 Albacete;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
02 Albacete;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
02 Albacete;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
02 Albacete;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
02 Albacete;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;94,25
02 Albacete;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
02 Albacete;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
02 Albacete;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
02 Albacete;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;96,25
02 Albacete;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
02 Albacete;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
02 Albacete;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
02 Albacete;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
02 Albacete;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
02 Albacete;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
02 Albacete;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;91,31
02 Albacete;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
02 Albacete;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
02 Albacete;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
02 Albacete;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;93,72
02 Albacete;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
02 Albacete;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
02 Albacete;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
02 Albacete;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
02 Albacete;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
02 Albacete;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
02 Albacete;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;89,18
02 Albacete;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
02 Albacete;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
02 Albacete;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
02 Albacete;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;92,17
02 Albacete;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
02 Albacete;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
02 Albacete;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
02 Albacete;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
02 Albacete;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
02 Albacete;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
02 Albacete;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
02 Albacete;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
02 Albacete;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
02 Albacete;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QI;7.967
02 Albacete;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
02 Albacete;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
02 Albacete;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
02 Albacete;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QI;7.853
02 Albacete;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
02 Albacete;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
02 Albacete;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
02 Albacete;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QI;7.961
02 Albacete;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
02 Albacete;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
02 Albacete;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2022QII;""
02 Albacete;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2022QI;7.810
02 Albacete;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
02 Albacete;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
02 Albacete;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2021QII;""
02 Albacete;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2021QI;7.743
02 Albacete;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
02 Albacete;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
02 Albacete;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2020QII;""
02 Albacete;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2020QI;7.607
02 Albacete;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
02 Albacete;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
02 Albacete;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2022QII;7.642
02 Albacete;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2022QI;""
02 Albacete;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
02 Albacete;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
02 Albacete;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2021QII;7.621
02 Albacete;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2021QI;""
02 Albacete;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
02 Albacete;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
02 Albacete;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2020QII;7.530
02 Albacete;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2020QI;""
02 Albacete;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
02 Albacete;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QIII;7.515
02 Albacete;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QII;""
02 Albacete;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QI;""
02 Albacete;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
02 Albacete;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QIII;7.524
02 Albacete;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QII;""
02 Albacete;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QI;""
02 Albacete;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
02 Albacete;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QIII;7.404
02 Albacete;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QII;""
02 Albacete;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QI;""
02 Albacete;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QIV;7.363
02 Albacete;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
02 Albacete;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QII;""
02 Albacete;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QI;""
02 Albacete;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QIV;7.400
02 Albacete;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
02 Albacete;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QII;""
02 Albacete;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QI;""
02 Albacete;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QIV;7.311
02 Albacete;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
02 Albacete;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QII;""
02 Albacete;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QI;""
02 Albacete;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
02 Albacete;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
02 Albacete;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
02 Albacete;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
02 Albacete;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
02 Albacete;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
02 Albacete;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
02 Albacete;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
02 Albacete;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
02 Albacete;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
02 Albacete;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
02 Albacete;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
02 Albacete;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
02 Albacete;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
02 Albacete;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
02 Albacete;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;98,03
02 Albacete;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
02 Albacete;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
02 Albacete;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
02 Albacete;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;98,6
02 Albacete;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
02 Albacete;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
02 Albacete;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
02 Albacete;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;95,55
02 Albacete;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
02 Albacete;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
02 Albacete;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;95,92
02 Albacete;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
02 Albacete;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
02 Albacete;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
02 Albacete;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;97,05
02 Albacete;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
02 Albacete;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
02 Albacete;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
02 Albacete;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;94,59
02 Albacete;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
02 Albacete;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
02 Albacete;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;94,33
02 Albacete;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
02 Albacete;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
02 Albacete;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
02 Albacete;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;95,81
02 Albacete;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
02 Albacete;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
02 Albacete;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
02 Albacete;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;93
02 Albacete;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
02 Albacete;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
02 Albacete;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;92,42
02 Albacete;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
02 Albacete;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
02 Albacete;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
02 Albacete;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;94,23
02 Albacete;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
02 Albacete;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
02 Albacete;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
02 Albacete;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;91,84
02 Albacete;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
02 Albacete;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
02 Albacete;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
02 Albacete;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
02 Albacete;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
02 Albacete;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
02 Albacete;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QI;5.356
02 Albacete;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
02 Albacete;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
02 Albacete;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
02 Albacete;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QI;5.333
02 Albacete;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
02 Albacete;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
02 Albacete;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
02 Albacete;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QI;5.437
02 Albacete;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
02 Albacete;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
02 Albacete;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2022QII;""
02 Albacete;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2022QI;5.265
02 Albacete;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
02 Albacete;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
02 Albacete;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2021QII;""
02 Albacete;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2021QI;5.262
02 Albacete;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
02 Albacete;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
02 Albacete;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2020QII;""
02 Albacete;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2020QI;5.207
02 Albacete;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
02 Albacete;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
02 Albacete;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2022QII;5.168
02 Albacete;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2022QI;""
02 Albacete;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
02 Albacete;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
02 Albacete;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2021QII;5.194
02 Albacete;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2021QI;""
02 Albacete;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
02 Albacete;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
02 Albacete;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2020QII;5.164
02 Albacete;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2020QI;""
02 Albacete;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
02 Albacete;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QIII;5.096
02 Albacete;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QII;""
02 Albacete;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QI;""
02 Albacete;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
02 Albacete;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QIII;5.134
02 Albacete;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QII;""
02 Albacete;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QI;""
02 Albacete;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
02 Albacete;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QIII;5.081
02 Albacete;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QII;""
02 Albacete;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QI;""
02 Albacete;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QIV;5.014
02 Albacete;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
02 Albacete;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QII;""
02 Albacete;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QI;""
02 Albacete;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QIV;5.059
02 Albacete;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
02 Albacete;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QII;""
02 Albacete;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QI;""
02 Albacete;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QIV;5.022
02 Albacete;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
02 Albacete;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QII;""
02 Albacete;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QI;""
02 Albacete;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
02 Albacete;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
02 Albacete;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
02 Albacete;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
02 Albacete;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
02 Albacete;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
02 Albacete;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
02 Albacete;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
02 Albacete;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
02 Albacete;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
02 Albacete;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
02 Albacete;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
02 Albacete;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
02 Albacete;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
02 Albacete;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
02 Albacete;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;98,3
02 Albacete;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
02 Albacete;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
02 Albacete;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
02 Albacete;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;98,67
02 Albacete;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
02 Albacete;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
02 Albacete;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
02 Albacete;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;95,77
02 Albacete;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
02 Albacete;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
02 Albacete;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;96,49
02 Albacete;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
02 Albacete;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
02 Albacete;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
02 Albacete;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;97,39
02 Albacete;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
02 Albacete;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
02 Albacete;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
02 Albacete;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;94,98
02 Albacete;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
02 Albacete;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
02 Albacete;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;95,15
02 Albacete;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
02 Albacete;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
02 Albacete;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
02 Albacete;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;96,27
02 Albacete;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
02 Albacete;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
02 Albacete;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
02 Albacete;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;93,45
02 Albacete;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
02 Albacete;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
02 Albacete;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;93,61
02 Albacete;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
02 Albacete;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
02 Albacete;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
02 Albacete;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;94,86
02 Albacete;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
02 Albacete;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
02 Albacete;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
02 Albacete;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;92,37
02 Albacete;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
02 Albacete;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
02 Albacete;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
02 Albacete;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
02 Albacete;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
02 Albacete;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
02 Albacete;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QI;2.611
02 Albacete;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
02 Albacete;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
02 Albacete;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
02 Albacete;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QI;2.520
02 Albacete;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
02 Albacete;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
02 Albacete;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
02 Albacete;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QI;2.524
02 Albacete;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
02 Albacete;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
02 Albacete;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2022QII;""
02 Albacete;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2022QI;2.545
02 Albacete;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
02 Albacete;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
02 Albacete;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2021QII;""
02 Albacete;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2021QI;2.481
02 Albacete;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
02 Albacete;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
02 Albacete;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2020QII;""
02 Albacete;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2020QI;2.400
02 Albacete;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
02 Albacete;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
02 Albacete;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2022QII;2.474
02 Albacete;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2022QI;""
02 Albacete;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
02 Albacete;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
02 Albacete;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2021QII;2.427
02 Albacete;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2021QI;""
02 Albacete;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
02 Albacete;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
02 Albacete;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2020QII;2.366
02 Albacete;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2020QI;""
02 Albacete;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
02 Albacete;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QIII;2.419
02 Albacete;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QII;""
02 Albacete;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QI;""
02 Albacete;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
02 Albacete;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QIII;2.390
02 Albacete;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QII;""
02 Albacete;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QI;""
02 Albacete;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
02 Albacete;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QIII;2.323
02 Albacete;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QII;""
02 Albacete;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QI;""
02 Albacete;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QIV;2.349
02 Albacete;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
02 Albacete;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QII;""
02 Albacete;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QI;""
02 Albacete;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QIV;2.341
02 Albacete;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
02 Albacete;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QII;""
02 Albacete;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QI;""
02 Albacete;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QIV;2.289
02 Albacete;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
02 Albacete;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QII;""
02 Albacete;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QI;""
02 Albacete;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
02 Albacete;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
02 Albacete;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
02 Albacete;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
02 Albacete;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
02 Albacete;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
02 Albacete;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
02 Albacete;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
02 Albacete;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
02 Albacete;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
02 Albacete;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
02 Albacete;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
02 Albacete;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
02 Albacete;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
02 Albacete;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
02 Albacete;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;97,47
02 Albacete;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
02 Albacete;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
02 Albacete;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
02 Albacete;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;98,45
02 Albacete;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
02 Albacete;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
02 Albacete;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
02 Albacete;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;95,09
02 Albacete;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
02 Albacete;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
02 Albacete;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;94,75
02 Albacete;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
02 Albacete;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
02 Albacete;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
02 Albacete;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;96,31
02 Albacete;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
02 Albacete;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
02 Albacete;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
02 Albacete;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;93,74
02 Albacete;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
02 Albacete;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
02 Albacete;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;92,65
02 Albacete;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
02 Albacete;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
02 Albacete;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
02 Albacete;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;94,84
02 Albacete;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
02 Albacete;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
02 Albacete;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
02 Albacete;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;92,04
02 Albacete;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
02 Albacete;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
02 Albacete;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;89,97
02 Albacete;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
02 Albacete;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
02 Albacete;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
02 Albacete;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;92,9
02 Albacete;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
02 Albacete;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
02 Albacete;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
02 Albacete;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;90,69
02 Albacete;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
02 Albacete;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
02 Albacete;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
02 Albacete;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
02 Albacete;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
02 Albacete;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QII;8.055
02 Albacete;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
02 Albacete;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
02 Albacete;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
02 Albacete;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QII;8.032
02 Albacete;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
02 Albacete;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
02 Albacete;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
02 Albacete;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QII;7.789
02 Albacete;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
02 Albacete;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
02 Albacete;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
02 Albacete;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2022QII;7.863
02 Albacete;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2022QI;""
02 Albacete;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
02 Albacete;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
02 Albacete;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2021QII;7.887
02 Albacete;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2021QI;""
02 Albacete;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
02 Albacete;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
02 Albacete;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2020QII;7.705
02 Albacete;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2020QI;""
02 Albacete;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
02 Albacete;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2022QIII;7.721
02 Albacete;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2022QII;""
02 Albacete;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2022QI;""
02 Albacete;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
02 Albacete;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2021QIII;7.779
02 Albacete;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2021QII;""
02 Albacete;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2021QI;""
02 Albacete;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
02 Albacete;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2020QIII;7.567
02 Albacete;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2020QII;""
02 Albacete;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2020QI;""
02 Albacete;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QIV;7.563
02 Albacete;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
02 Albacete;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QII;""
02 Albacete;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QI;""
02 Albacete;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QIV;7.647
02 Albacete;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
02 Albacete;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QII;""
02 Albacete;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QI;""
02 Albacete;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QIV;7.465
02 Albacete;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
02 Albacete;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QII;""
02 Albacete;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QI;""
02 Albacete;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
02 Albacete;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
02 Albacete;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QII;""
02 Albacete;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QI;7.515
02 Albacete;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
02 Albacete;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
02 Albacete;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QII;""
02 Albacete;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QI;7.378
02 Albacete;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
02 Albacete;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
02 Albacete;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QII;""
02 Albacete;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QI;""
02 Albacete;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
02 Albacete;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
02 Albacete;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
02 Albacete;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
02 Albacete;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
02 Albacete;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
02 Albacete;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
02 Albacete;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
02 Albacete;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
02 Albacete;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
02 Albacete;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
02 Albacete;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
02 Albacete;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
02 Albacete;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
02 Albacete;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;97,62
02 Albacete;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
02 Albacete;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
02 Albacete;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
02 Albacete;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;98,19
02 Albacete;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
02 Albacete;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
02 Albacete;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
02 Albacete;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;98,92
02 Albacete;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
02 Albacete;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
02 Albacete;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;95,85
02 Albacete;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
02 Albacete;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
02 Albacete;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
02 Albacete;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;96,85
02 Albacete;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
02 Albacete;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
02 Albacete;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
02 Albacete;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;97,15
02 Albacete;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
02 Albacete;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
02 Albacete;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;93,89
02 Albacete;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
02 Albacete;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
02 Albacete;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
02 Albacete;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;95,21
02 Albacete;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
02 Albacete;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
02 Albacete;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
02 Albacete;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;95,84
02 Albacete;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
02 Albacete;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
02 Albacete;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
02 Albacete;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
02 Albacete;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
02 Albacete;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
02 Albacete;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;93,56
02 Albacete;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
02 Albacete;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
02 Albacete;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
02 Albacete;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;94,72
02 Albacete;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
02 Albacete;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
02 Albacete;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
02 Albacete;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
02 Albacete;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
02 Albacete;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
02 Albacete;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QII;5.383
02 Albacete;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
02 Albacete;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
02 Albacete;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
02 Albacete;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QII;5.415
02 Albacete;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
02 Albacete;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
02 Albacete;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
02 Albacete;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QII;5.302
02 Albacete;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
02 Albacete;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
02 Albacete;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
02 Albacete;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2022QII;5.269
02 Albacete;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2022QI;""
02 Albacete;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
02 Albacete;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
02 Albacete;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2021QII;5.336
02 Albacete;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2021QI;""
02 Albacete;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
02 Albacete;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
02 Albacete;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2020QII;5.255
02 Albacete;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2020QI;""
02 Albacete;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
02 Albacete;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2022QIII;5.188
02 Albacete;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2022QII;""
02 Albacete;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2022QI;""
02 Albacete;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
02 Albacete;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2021QIII;5.267
02 Albacete;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2021QII;""
02 Albacete;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2021QI;""
02 Albacete;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
02 Albacete;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2020QIII;5.166
02 Albacete;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2020QII;""
02 Albacete;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2020QI;""
02 Albacete;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QIV;5.100
02 Albacete;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
02 Albacete;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QII;""
02 Albacete;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QI;""
02 Albacete;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QIV;5.186
02 Albacete;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
02 Albacete;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QII;""
02 Albacete;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QI;""
02 Albacete;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QIV;5.102
02 Albacete;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
02 Albacete;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QII;""
02 Albacete;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QI;""
02 Albacete;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
02 Albacete;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
02 Albacete;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QII;""
02 Albacete;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QI;5.109
02 Albacete;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
02 Albacete;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
02 Albacete;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QII;""
02 Albacete;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QI;5.048
02 Albacete;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
02 Albacete;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
02 Albacete;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QII;""
02 Albacete;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QI;""
02 Albacete;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
02 Albacete;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
02 Albacete;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
02 Albacete;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
02 Albacete;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
02 Albacete;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
02 Albacete;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
02 Albacete;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
02 Albacete;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
02 Albacete;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
02 Albacete;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
02 Albacete;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
02 Albacete;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
02 Albacete;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
02 Albacete;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;97,88
02 Albacete;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
02 Albacete;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
02 Albacete;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
02 Albacete;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;98,54
02 Albacete;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
02 Albacete;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
02 Albacete;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
02 Albacete;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;99,11
02 Albacete;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
02 Albacete;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
02 Albacete;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;96,38
02 Albacete;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
02 Albacete;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
02 Albacete;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
02 Albacete;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;97,27
02 Albacete;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
02 Albacete;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
02 Albacete;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
02 Albacete;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;97,43
02 Albacete;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
02 Albacete;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
02 Albacete;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;94,74
02 Albacete;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
02 Albacete;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
02 Albacete;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
02 Albacete;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;95,77
02 Albacete;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
02 Albacete;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
02 Albacete;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
02 Albacete;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;96,23
02 Albacete;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
02 Albacete;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
02 Albacete;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
02 Albacete;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
02 Albacete;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
02 Albacete;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
02 Albacete;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;94,35
02 Albacete;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
02 Albacete;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
02 Albacete;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
02 Albacete;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;95,21
02 Albacete;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
02 Albacete;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
02 Albacete;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
02 Albacete;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
02 Albacete;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
02 Albacete;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
02 Albacete;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QII;2.672
02 Albacete;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
02 Albacete;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
02 Albacete;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
02 Albacete;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QII;2.617
02 Albacete;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
02 Albacete;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
02 Albacete;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
02 Albacete;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QII;2.487
02 Albacete;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
02 Albacete;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
02 Albacete;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
02 Albacete;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2022QII;2.594
02 Albacete;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2022QI;""
02 Albacete;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
02 Albacete;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
02 Albacete;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2021QII;2.551
02 Albacete;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2021QI;""
02 Albacete;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
02 Albacete;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
02 Albacete;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2020QII;2.450
02 Albacete;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2020QI;""
02 Albacete;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
02 Albacete;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2022QIII;2.533
02 Albacete;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2022QII;""
02 Albacete;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2022QI;""
02 Albacete;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
02 Albacete;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2021QIII;2.512
02 Albacete;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2021QII;""
02 Albacete;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2021QI;""
02 Albacete;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
02 Albacete;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2020QIII;2.401
02 Albacete;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2020QII;""
02 Albacete;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2020QI;""
02 Albacete;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QIV;2.463
02 Albacete;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
02 Albacete;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QII;""
02 Albacete;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QI;""
02 Albacete;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QIV;2.461
02 Albacete;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
02 Albacete;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QII;""
02 Albacete;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QI;""
02 Albacete;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QIV;2.363
02 Albacete;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
02 Albacete;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QII;""
02 Albacete;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QI;""
02 Albacete;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
02 Albacete;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
02 Albacete;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QII;""
02 Albacete;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QI;2.406
02 Albacete;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
02 Albacete;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
02 Albacete;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QII;""
02 Albacete;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QI;2.330
02 Albacete;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
02 Albacete;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
02 Albacete;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QII;""
02 Albacete;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QI;""
02 Albacete;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
02 Albacete;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
02 Albacete;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
02 Albacete;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
02 Albacete;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
02 Albacete;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
02 Albacete;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
02 Albacete;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
02 Albacete;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
02 Albacete;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
02 Albacete;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
02 Albacete;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
02 Albacete;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
02 Albacete;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
02 Albacete;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;97,08
02 Albacete;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
02 Albacete;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
02 Albacete;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
02 Albacete;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;97,48
02 Albacete;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
02 Albacete;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
02 Albacete;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
02 Albacete;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;98,51
02 Albacete;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
02 Albacete;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
02 Albacete;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;94,8
02 Albacete;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
02 Albacete;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
02 Albacete;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
02 Albacete;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;95,99
02 Albacete;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
02 Albacete;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
02 Albacete;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
02 Albacete;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;96,54
02 Albacete;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
02 Albacete;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
02 Albacete;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;92,18
02 Albacete;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
02 Albacete;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
02 Albacete;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
02 Albacete;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;94,04
02 Albacete;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
02 Albacete;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
02 Albacete;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
02 Albacete;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;95,01
02 Albacete;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
02 Albacete;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
02 Albacete;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
02 Albacete;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
02 Albacete;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
02 Albacete;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
02 Albacete;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;91,94
02 Albacete;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
02 Albacete;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
02 Albacete;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
02 Albacete;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;93,69
02 Albacete;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
02 Albacete;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
02 Albacete;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
02 Albacete;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
02 Albacete;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
02 Albacete;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QIII;8.017
02 Albacete;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
02 Albacete;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
02 Albacete;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
02 Albacete;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QIII;8.024
02 Albacete;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
02 Albacete;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
02 Albacete;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
02 Albacete;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QIII;7.896
02 Albacete;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
02 Albacete;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
02 Albacete;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
02 Albacete;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2022QIII;7.845
02 Albacete;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2022QII;""
02 Albacete;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2022QI;""
02 Albacete;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
02 Albacete;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2021QIII;7.893
02 Albacete;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2021QII;""
02 Albacete;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2021QI;""
02 Albacete;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
02 Albacete;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2020QIII;7.726
02 Albacete;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2020QII;""
02 Albacete;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2020QI;""
02 Albacete;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2022QIV;7.669
02 Albacete;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
02 Albacete;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2022QII;""
02 Albacete;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2022QI;""
02 Albacete;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2021QIV;7.750
02 Albacete;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
02 Albacete;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2021QII;""
02 Albacete;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2021QI;""
02 Albacete;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2020QIV;7.609
02 Albacete;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
02 Albacete;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2020QII;""
02 Albacete;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2020QI;""
02 Albacete;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
02 Albacete;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
02 Albacete;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QII;""
02 Albacete;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QI;7.615
02 Albacete;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
02 Albacete;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
02 Albacete;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QII;""
02 Albacete;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QI;7.519
02 Albacete;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
02 Albacete;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
02 Albacete;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QII;""
02 Albacete;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QI;""
02 Albacete;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
02 Albacete;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
02 Albacete;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QII;7.473
02 Albacete;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QI;""
02 Albacete;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
02 Albacete;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
02 Albacete;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QII;7.414
02 Albacete;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QI;""
02 Albacete;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
02 Albacete;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
02 Albacete;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QII;""
02 Albacete;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QI;""
02 Albacete;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
02 Albacete;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
02 Albacete;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
02 Albacete;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
02 Albacete;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
02 Albacete;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
02 Albacete;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
02 Albacete;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
02 Albacete;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
02 Albacete;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
02 Albacete;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
02 Albacete;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
02 Albacete;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
02 Albacete;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;97,85
02 Albacete;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
02 Albacete;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
02 Albacete;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
02 Albacete;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;98,37
02 Albacete;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
02 Albacete;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
02 Albacete;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
02 Albacete;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;97,85
02 Albacete;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
02 Albacete;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
02 Albacete;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;95,66
02 Albacete;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
02 Albacete;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
02 Albacete;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
02 Albacete;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;96,59
02 Albacete;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
02 Albacete;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
02 Albacete;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
02 Albacete;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;96,37
02 Albacete;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
02 Albacete;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
02 Albacete;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
02 Albacete;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
02 Albacete;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
02 Albacete;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
02 Albacete;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;94,9
02 Albacete;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
02 Albacete;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
02 Albacete;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
02 Albacete;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;95,23
02 Albacete;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
02 Albacete;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
02 Albacete;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
02 Albacete;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
02 Albacete;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
02 Albacete;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
02 Albacete;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;93,13
02 Albacete;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
02 Albacete;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
02 Albacete;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
02 Albacete;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;93,9
02 Albacete;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
02 Albacete;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
02 Albacete;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
02 Albacete;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
02 Albacete;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
02 Albacete;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
02 Albacete;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QIII;5.355
02 Albacete;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
02 Albacete;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
02 Albacete;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
02 Albacete;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QIII;5.430
02 Albacete;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
02 Albacete;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
02 Albacete;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
02 Albacete;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QIII;5.380
02 Albacete;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
02 Albacete;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
02 Albacete;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
02 Albacete;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2022QIII;5.254
02 Albacete;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2022QII;""
02 Albacete;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2022QI;""
02 Albacete;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
02 Albacete;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2021QIII;5.344
02 Albacete;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2021QII;""
02 Albacete;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2021QI;""
02 Albacete;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
02 Albacete;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2020QIII;5.263
02 Albacete;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2020QII;""
02 Albacete;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2020QI;""
02 Albacete;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2022QIV;5.152
02 Albacete;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
02 Albacete;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2022QII;""
02 Albacete;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2022QI;""
02 Albacete;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2021QIV;5.257
02 Albacete;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
02 Albacete;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2021QII;""
02 Albacete;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2021QI;""
02 Albacete;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2020QIV;5.193
02 Albacete;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
02 Albacete;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2020QII;""
02 Albacete;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2020QI;""
02 Albacete;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
02 Albacete;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
02 Albacete;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QII;""
02 Albacete;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QI;5.178
02 Albacete;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
02 Albacete;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
02 Albacete;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QII;""
02 Albacete;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QI;5.138
02 Albacete;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
02 Albacete;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
02 Albacete;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QII;""
02 Albacete;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QI;""
02 Albacete;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
02 Albacete;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
02 Albacete;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QII;5.088
02 Albacete;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QI;""
02 Albacete;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
02 Albacete;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
02 Albacete;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QII;5.077
02 Albacete;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QI;""
02 Albacete;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
02 Albacete;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
02 Albacete;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QII;""
02 Albacete;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QI;""
02 Albacete;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
02 Albacete;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
02 Albacete;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
02 Albacete;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
02 Albacete;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
02 Albacete;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
02 Albacete;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
02 Albacete;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
02 Albacete;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
02 Albacete;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
02 Albacete;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
02 Albacete;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
02 Albacete;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
02 Albacete;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;98,11
02 Albacete;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
02 Albacete;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
02 Albacete;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
02 Albacete;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;98,42
02 Albacete;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
02 Albacete;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
02 Albacete;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
02 Albacete;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;97,83
02 Albacete;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
02 Albacete;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
02 Albacete;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;96,21
02 Albacete;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
02 Albacete;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
02 Albacete;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
02 Albacete;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;96,81
02 Albacete;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
02 Albacete;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
02 Albacete;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
02 Albacete;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;96,52
02 Albacete;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
02 Albacete;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
02 Albacete;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
02 Albacete;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
02 Albacete;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
02 Albacete;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
02 Albacete;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;95,36
02 Albacete;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
02 Albacete;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
02 Albacete;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
02 Albacete;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;95,5
02 Albacete;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
02 Albacete;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
02 Albacete;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
02 Albacete;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
02 Albacete;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
02 Albacete;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
02 Albacete;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;93,7
02 Albacete;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
02 Albacete;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
02 Albacete;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
02 Albacete;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;94,37
02 Albacete;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
02 Albacete;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
02 Albacete;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
02 Albacete;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
02 Albacete;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
02 Albacete;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
02 Albacete;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QIII;2.662
02 Albacete;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
02 Albacete;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
02 Albacete;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
02 Albacete;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QIII;2.594
02 Albacete;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
02 Albacete;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
02 Albacete;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
02 Albacete;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QIII;2.516
02 Albacete;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
02 Albacete;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
02 Albacete;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
02 Albacete;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2022QIII;2.591
02 Albacete;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2022QII;""
02 Albacete;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2022QI;""
02 Albacete;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
02 Albacete;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2021QIII;2.549
02 Albacete;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2021QII;""
02 Albacete;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2021QI;""
02 Albacete;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
02 Albacete;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2020QIII;2.463
02 Albacete;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2020QII;""
02 Albacete;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2020QI;""
02 Albacete;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2022QIV;2.517
02 Albacete;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
02 Albacete;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2022QII;""
02 Albacete;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2022QI;""
02 Albacete;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2021QIV;2.493
02 Albacete;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
02 Albacete;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2021QII;""
02 Albacete;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2021QI;""
02 Albacete;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2020QIV;2.416
02 Albacete;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
02 Albacete;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2020QII;""
02 Albacete;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2020QI;""
02 Albacete;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
02 Albacete;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
02 Albacete;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QII;""
02 Albacete;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QI;2.437
02 Albacete;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
02 Albacete;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
02 Albacete;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QII;""
02 Albacete;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QI;2.381
02 Albacete;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
02 Albacete;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
02 Albacete;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QII;""
02 Albacete;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QI;""
02 Albacete;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
02 Albacete;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
02 Albacete;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QII;2.385
02 Albacete;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QI;""
02 Albacete;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
02 Albacete;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
02 Albacete;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QII;2.337
02 Albacete;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QI;""
02 Albacete;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
02 Albacete;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
02 Albacete;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QII;""
02 Albacete;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QI;""
02 Albacete;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
02 Albacete;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
02 Albacete;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
02 Albacete;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
02 Albacete;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
02 Albacete;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
02 Albacete;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
02 Albacete;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
02 Albacete;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
02 Albacete;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
02 Albacete;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
02 Albacete;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
02 Albacete;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
02 Albacete;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;97,33
02 Albacete;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
02 Albacete;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
02 Albacete;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
02 Albacete;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;98,27
02 Albacete;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
02 Albacete;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
02 Albacete;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
02 Albacete;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;97,89
02 Albacete;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
02 Albacete;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
02 Albacete;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;94,55
02 Albacete;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
02 Albacete;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
02 Albacete;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
02 Albacete;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;96,11
02 Albacete;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
02 Albacete;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
02 Albacete;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
02 Albacete;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;96,03
02 Albacete;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
02 Albacete;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
02 Albacete;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
02 Albacete;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
02 Albacete;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
02 Albacete;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
02 Albacete;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;93,95
02 Albacete;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
02 Albacete;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
02 Albacete;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
02 Albacete;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;94,63
02 Albacete;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
02 Albacete;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
02 Albacete;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
02 Albacete;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
02 Albacete;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
02 Albacete;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
02 Albacete;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;91,94
02 Albacete;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
02 Albacete;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
02 Albacete;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
02 Albacete;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;92,89
02 Albacete;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
02 Albacete;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
02 Albacete;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
02 Albacete;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
02 Albacete;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
02 Albacete;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QIV;7.951
02 Albacete;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
02 Albacete;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
02 Albacete;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
02 Albacete;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QIV;8.007
02 Albacete;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
02 Albacete;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
02 Albacete;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
02 Albacete;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QIV;7.890
02 Albacete;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
02 Albacete;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
02 Albacete;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
02 Albacete;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2022QIV;7.761
02 Albacete;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
02 Albacete;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2022QII;""
02 Albacete;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2022QI;""
02 Albacete;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2021QIV;7.843
02 Albacete;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
02 Albacete;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2021QII;""
02 Albacete;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2021QI;""
02 Albacete;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2020QIV;7.755
02 Albacete;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
02 Albacete;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2020QII;""
02 Albacete;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2020QI;""
02 Albacete;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
02 Albacete;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
02 Albacete;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2022QII;""
02 Albacete;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2022QI;7.698
02 Albacete;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
02 Albacete;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
02 Albacete;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2021QII;""
02 Albacete;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2021QI;7.655
02 Albacete;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
02 Albacete;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
02 Albacete;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2020QII;""
02 Albacete;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2020QI;""
02 Albacete;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
02 Albacete;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
02 Albacete;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QII;7.548
02 Albacete;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QI;""
02 Albacete;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
02 Albacete;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
02 Albacete;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QII;7.541
02 Albacete;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QI;""
02 Albacete;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
02 Albacete;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
02 Albacete;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QII;""
02 Albacete;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QI;""
02 Albacete;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
02 Albacete;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QIII;7.426
02 Albacete;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QII;""
02 Albacete;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QI;""
02 Albacete;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
02 Albacete;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QIII;7.448
02 Albacete;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QII;""
02 Albacete;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QI;""
02 Albacete;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
02 Albacete;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
02 Albacete;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QII;""
02 Albacete;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QI;""
02 Albacete;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
02 Albacete;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
02 Albacete;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
02 Albacete;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
02 Albacete;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
02 Albacete;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
02 Albacete;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
02 Albacete;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
02 Albacete;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
02 Albacete;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
02 Albacete;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
02 Albacete;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
02 Albacete;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;97,61
02 Albacete;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
02 Albacete;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
02 Albacete;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
02 Albacete;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;97,95
02 Albacete;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
02 Albacete;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
02 Albacete;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
02 Albacete;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;98,29
02 Albacete;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
02 Albacete;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
02 Albacete;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
02 Albacete;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
02 Albacete;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
02 Albacete;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
02 Albacete;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;96,14
02 Albacete;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
02 Albacete;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
02 Albacete;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
02 Albacete;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;97,02
02 Albacete;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
02 Albacete;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
02 Albacete;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
02 Albacete;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
02 Albacete;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
02 Albacete;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
02 Albacete;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;94,27
02 Albacete;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
02 Albacete;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
02 Albacete;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
02 Albacete;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;95,58
02 Albacete;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
02 Albacete;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
02 Albacete;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
02 Albacete;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
02 Albacete;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
02 Albacete;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
02 Albacete;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;92,74
02 Albacete;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
02 Albacete;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
02 Albacete;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
02 Albacete;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;94,4
02 Albacete;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
02 Albacete;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
02 Albacete;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
02 Albacete;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
02 Albacete;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
02 Albacete;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
02 Albacete;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QIV;5.314
02 Albacete;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
02 Albacete;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
02 Albacete;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
02 Albacete;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QIV;5.397
02 Albacete;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
02 Albacete;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
02 Albacete;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
02 Albacete;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QIV;5.362
02 Albacete;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
02 Albacete;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
02 Albacete;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
02 Albacete;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2022QIV;5.201
02 Albacete;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
02 Albacete;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2022QII;""
02 Albacete;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2022QI;""
02 Albacete;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2021QIV;5.300
02 Albacete;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
02 Albacete;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2021QII;""
02 Albacete;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2021QI;""
02 Albacete;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2020QIV;5.280
02 Albacete;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
02 Albacete;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2020QII;""
02 Albacete;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2020QI;""
02 Albacete;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
02 Albacete;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
02 Albacete;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2022QII;""
02 Albacete;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2022QI;5.215
02 Albacete;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
02 Albacete;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
02 Albacete;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2021QII;""
02 Albacete;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2021QI;5.217
02 Albacete;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
02 Albacete;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
02 Albacete;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2020QII;""
02 Albacete;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2020QI;""
02 Albacete;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
02 Albacete;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
02 Albacete;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QII;5.124
02 Albacete;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QI;""
02 Albacete;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
02 Albacete;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
02 Albacete;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QII;5.153
02 Albacete;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QI;""
02 Albacete;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
02 Albacete;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
02 Albacete;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QII;""
02 Albacete;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QI;""
02 Albacete;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
02 Albacete;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QIII;5.056
02 Albacete;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QII;""
02 Albacete;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QI;""
02 Albacete;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
02 Albacete;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QIII;5.096
02 Albacete;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QII;""
02 Albacete;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QI;""
02 Albacete;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
02 Albacete;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
02 Albacete;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QII;""
02 Albacete;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QI;""
02 Albacete;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
02 Albacete;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
02 Albacete;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
02 Albacete;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
02 Albacete;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
02 Albacete;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
02 Albacete;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
02 Albacete;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
02 Albacete;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
02 Albacete;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
02 Albacete;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
02 Albacete;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
02 Albacete;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;97,87
02 Albacete;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
02 Albacete;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
02 Albacete;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
02 Albacete;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;98,2
02 Albacete;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
02 Albacete;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
02 Albacete;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
02 Albacete;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;98,47
02 Albacete;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
02 Albacete;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
02 Albacete;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
02 Albacete;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
02 Albacete;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
02 Albacete;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
02 Albacete;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;96,63
02 Albacete;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
02 Albacete;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
02 Albacete;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
02 Albacete;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;97,3
02 Albacete;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
02 Albacete;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
02 Albacete;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
02 Albacete;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
02 Albacete;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
02 Albacete;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
02 Albacete;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;94,94
02 Albacete;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
02 Albacete;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
02 Albacete;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
02 Albacete;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;96,1
02 Albacete;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
02 Albacete;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
02 Albacete;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
02 Albacete;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
02 Albacete;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
02 Albacete;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
02 Albacete;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;93,68
02 Albacete;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
02 Albacete;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
02 Albacete;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
02 Albacete;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;95,04
02 Albacete;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
02 Albacete;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
02 Albacete;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
02 Albacete;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
02 Albacete;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
02 Albacete;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
02 Albacete;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QIV;2.637
02 Albacete;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
02 Albacete;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
02 Albacete;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
02 Albacete;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QIV;2.610
02 Albacete;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
02 Albacete;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
02 Albacete;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
02 Albacete;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QIV;2.528
02 Albacete;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
02 Albacete;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
02 Albacete;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
02 Albacete;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2022QIV;2.560
02 Albacete;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
02 Albacete;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2022QII;""
02 Albacete;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2022QI;""
02 Albacete;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2021QIV;2.543
02 Albacete;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
02 Albacete;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2021QII;""
02 Albacete;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2021QI;""
02 Albacete;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2020QIV;2.475
02 Albacete;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
02 Albacete;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2020QII;""
02 Albacete;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2020QI;""
02 Albacete;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
02 Albacete;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
02 Albacete;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2022QII;""
02 Albacete;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2022QI;2.483
02 Albacete;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
02 Albacete;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
02 Albacete;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2021QII;""
02 Albacete;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2021QI;2.438
02 Albacete;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
02 Albacete;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
02 Albacete;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2020QII;""
02 Albacete;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2020QI;""
02 Albacete;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
02 Albacete;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
02 Albacete;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QII;2.424
02 Albacete;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QI;""
02 Albacete;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
02 Albacete;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
02 Albacete;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QII;2.388
02 Albacete;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QI;""
02 Albacete;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
02 Albacete;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
02 Albacete;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QII;""
02 Albacete;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QI;""
02 Albacete;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
02 Albacete;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QIII;2.370
02 Albacete;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QII;""
02 Albacete;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QI;""
02 Albacete;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
02 Albacete;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QIII;2.352
02 Albacete;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QII;""
02 Albacete;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QI;""
02 Albacete;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
02 Albacete;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
02 Albacete;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QII;""
02 Albacete;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QI;""
02 Albacete;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
02 Albacete;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
02 Albacete;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
02 Albacete;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
02 Albacete;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
02 Albacete;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
02 Albacete;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
02 Albacete;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
02 Albacete;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
02 Albacete;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
02 Albacete;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
02 Albacete;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
02 Albacete;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;97,08
02 Albacete;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
02 Albacete;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
02 Albacete;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
02 Albacete;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;97,43
02 Albacete;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
02 Albacete;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
02 Albacete;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
02 Albacete;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;97,9
02 Albacete;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
02 Albacete;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
02 Albacete;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
02 Albacete;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
02 Albacete;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
02 Albacete;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
02 Albacete;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;95,13
02 Albacete;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
02 Albacete;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
02 Albacete;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
02 Albacete;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;96,44
02 Albacete;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
02 Albacete;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
02 Albacete;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
02 Albacete;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
02 Albacete;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
02 Albacete;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
02 Albacete;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;92,87
02 Albacete;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
02 Albacete;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
02 Albacete;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
02 Albacete;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;94,46
02 Albacete;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
02 Albacete;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
02 Albacete;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
02 Albacete;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
02 Albacete;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
02 Albacete;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
02 Albacete;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;90,8
02 Albacete;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
02 Albacete;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
02 Albacete;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
02 Albacete;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;93,04
02 Albacete;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
02 Albacete;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
02 Albacete;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
02 Albacete;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
02 Albacete;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
02 Albacete;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
02 Albacete;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
02 Albacete;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
02 Albacete;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
02 Albacete;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QI;3.609
02 Albacete;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
02 Albacete;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
02 Albacete;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
02 Albacete;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QI;3.312
02 Albacete;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
02 Albacete;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
02 Albacete;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
02 Albacete;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QI;3.748
02 Albacete;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
02 Albacete;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
02 Albacete;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2022QII;""
02 Albacete;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2022QI;3.472
02 Albacete;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
02 Albacete;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
02 Albacete;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2021QII;""
02 Albacete;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2021QI;3.206
02 Albacete;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
02 Albacete;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
02 Albacete;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2020QII;""
02 Albacete;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2020QI;3.527
02 Albacete;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
02 Albacete;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
02 Albacete;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2022QII;3.333
02 Albacete;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2022QI;""
02 Albacete;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
02 Albacete;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
02 Albacete;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2021QII;3.103
02 Albacete;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2021QI;""
02 Albacete;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
02 Albacete;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
02 Albacete;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2020QII;3.438
02 Albacete;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2020QI;""
02 Albacete;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
02 Albacete;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QIII;3.214
02 Albacete;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QII;""
02 Albacete;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QI;""
02 Albacete;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
02 Albacete;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QIII;2.986
02 Albacete;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QII;""
02 Albacete;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QI;""
02 Albacete;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
02 Albacete;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QIII;3.307
02 Albacete;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QII;""
02 Albacete;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QI;""
02 Albacete;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QIV;3.006
02 Albacete;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
02 Albacete;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QII;""
02 Albacete;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QI;""
02 Albacete;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QIV;2.847
02 Albacete;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
02 Albacete;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QII;""
02 Albacete;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QI;""
02 Albacete;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QIV;3.168
02 Albacete;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
02 Albacete;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QII;""
02 Albacete;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QI;""
02 Albacete;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
02 Albacete;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
02 Albacete;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
02 Albacete;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
02 Albacete;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
02 Albacete;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
02 Albacete;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
02 Albacete;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
02 Albacete;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
02 Albacete;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
02 Albacete;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
02 Albacete;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
02 Albacete;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
02 Albacete;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
02 Albacete;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
02 Albacete;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;96,2
02 Albacete;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
02 Albacete;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
02 Albacete;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
02 Albacete;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;96,8
02 Albacete;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
02 Albacete;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
02 Albacete;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
02 Albacete;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;94,1
02 Albacete;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
02 Albacete;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
02 Albacete;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;92,35
02 Albacete;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
02 Albacete;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
02 Albacete;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
02 Albacete;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;93,69
02 Albacete;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
02 Albacete;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
02 Albacete;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
02 Albacete;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;91,73
02 Albacete;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
02 Albacete;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
02 Albacete;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;89,06
02 Albacete;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
02 Albacete;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
02 Albacete;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
02 Albacete;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;90,16
02 Albacete;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
02 Albacete;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
02 Albacete;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
02 Albacete;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;88,23
02 Albacete;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
02 Albacete;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
02 Albacete;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;83,29
02 Albacete;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
02 Albacete;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
02 Albacete;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
02 Albacete;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;85,96
02 Albacete;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
02 Albacete;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
02 Albacete;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
02 Albacete;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;84,53
02 Albacete;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
02 Albacete;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
02 Albacete;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
02 Albacete;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
02 Albacete;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
02 Albacete;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
02 Albacete;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QI;2.509
02 Albacete;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
02 Albacete;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
02 Albacete;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
02 Albacete;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QI;2.303
02 Albacete;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
02 Albacete;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
02 Albacete;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
02 Albacete;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QI;2.576
02 Albacete;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
02 Albacete;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
02 Albacete;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2022QII;""
02 Albacete;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2022QI;2.427
02 Albacete;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
02 Albacete;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
02 Albacete;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2021QII;""
02 Albacete;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2021QI;2.229
02 Albacete;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
02 Albacete;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
02 Albacete;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2020QII;""
02 Albacete;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2020QI;2.444
02 Albacete;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
02 Albacete;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
02 Albacete;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2022QII;2.340
02 Albacete;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2022QI;""
02 Albacete;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
02 Albacete;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
02 Albacete;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2021QII;2.166
02 Albacete;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2021QI;""
02 Albacete;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
02 Albacete;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
02 Albacete;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2020QII;2.395
02 Albacete;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2020QI;""
02 Albacete;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
02 Albacete;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QIII;2.258
02 Albacete;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QII;""
02 Albacete;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QI;""
02 Albacete;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
02 Albacete;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QIII;2.090
02 Albacete;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QII;""
02 Albacete;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QI;""
02 Albacete;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
02 Albacete;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QIII;2.315
02 Albacete;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QII;""
02 Albacete;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QI;""
02 Albacete;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QIV;2.105
02 Albacete;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
02 Albacete;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QII;""
02 Albacete;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QI;""
02 Albacete;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QIV;1.998
02 Albacete;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
02 Albacete;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QII;""
02 Albacete;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QI;""
02 Albacete;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QIV;2.220
02 Albacete;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
02 Albacete;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QII;""
02 Albacete;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QI;""
02 Albacete;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
02 Albacete;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
02 Albacete;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
02 Albacete;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
02 Albacete;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
02 Albacete;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
02 Albacete;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
02 Albacete;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
02 Albacete;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
02 Albacete;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
02 Albacete;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
02 Albacete;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
02 Albacete;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
02 Albacete;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
02 Albacete;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
02 Albacete;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;96,73
02 Albacete;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
02 Albacete;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
02 Albacete;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
02 Albacete;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;96,79
02 Albacete;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
02 Albacete;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
02 Albacete;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
02 Albacete;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;94,88
02 Albacete;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
02 Albacete;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
02 Albacete;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;93,26
02 Albacete;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
02 Albacete;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
02 Albacete;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
02 Albacete;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;94,05
02 Albacete;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
02 Albacete;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
02 Albacete;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
02 Albacete;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;92,97
02 Albacete;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
02 Albacete;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
02 Albacete;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;90
02 Albacete;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
02 Albacete;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
02 Albacete;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
02 Albacete;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;90,75
02 Albacete;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
02 Albacete;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
02 Albacete;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
02 Albacete;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;89,87
02 Albacete;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
02 Albacete;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
02 Albacete;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;83,9
02 Albacete;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
02 Albacete;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
02 Albacete;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
02 Albacete;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;86,76
02 Albacete;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
02 Albacete;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
02 Albacete;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
02 Albacete;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;86,18
02 Albacete;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
02 Albacete;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
02 Albacete;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
02 Albacete;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
02 Albacete;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
02 Albacete;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
02 Albacete;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QI;1.100
02 Albacete;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
02 Albacete;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
02 Albacete;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
02 Albacete;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QI;1.009
02 Albacete;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
02 Albacete;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
02 Albacete;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
02 Albacete;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QI;1.172
02 Albacete;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
02 Albacete;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
02 Albacete;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2022QII;""
02 Albacete;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2022QI;1.045
02 Albacete;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
02 Albacete;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
02 Albacete;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2021QII;""
02 Albacete;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2021QI;977
02 Albacete;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
02 Albacete;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
02 Albacete;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2020QII;""
02 Albacete;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2020QI;1.083
02 Albacete;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
02 Albacete;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
02 Albacete;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2022QII;993
02 Albacete;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2022QI;""
02 Albacete;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
02 Albacete;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
02 Albacete;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2021QII;937
02 Albacete;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2021QI;""
02 Albacete;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
02 Albacete;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
02 Albacete;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2020QII;1.043
02 Albacete;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2020QI;""
02 Albacete;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
02 Albacete;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QIII;956
02 Albacete;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QII;""
02 Albacete;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QI;""
02 Albacete;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
02 Albacete;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QIII;896
02 Albacete;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QII;""
02 Albacete;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QI;""
02 Albacete;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
02 Albacete;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QIII;992
02 Albacete;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QII;""
02 Albacete;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QI;""
02 Albacete;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QIV;901
02 Albacete;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
02 Albacete;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QII;""
02 Albacete;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QI;""
02 Albacete;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QIV;849
02 Albacete;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
02 Albacete;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QII;""
02 Albacete;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QI;""
02 Albacete;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QIV;948
02 Albacete;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
02 Albacete;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QII;""
02 Albacete;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QI;""
02 Albacete;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
02 Albacete;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
02 Albacete;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
02 Albacete;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
02 Albacete;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
02 Albacete;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
02 Albacete;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
02 Albacete;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
02 Albacete;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
02 Albacete;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
02 Albacete;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
02 Albacete;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
02 Albacete;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
02 Albacete;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
02 Albacete;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
02 Albacete;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;95
02 Albacete;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
02 Albacete;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
02 Albacete;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
02 Albacete;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;96,83
02 Albacete;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
02 Albacete;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
02 Albacete;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
02 Albacete;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;92,41
02 Albacete;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
02 Albacete;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
02 Albacete;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;90,27
02 Albacete;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
02 Albacete;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
02 Albacete;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
02 Albacete;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;92,86
02 Albacete;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
02 Albacete;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
02 Albacete;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
02 Albacete;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;88,99
02 Albacete;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
02 Albacete;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
02 Albacete;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;86,91
02 Albacete;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
02 Albacete;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
02 Albacete;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
02 Albacete;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;88,8
02 Albacete;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
02 Albacete;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
02 Albacete;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
02 Albacete;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;84,64
02 Albacete;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
02 Albacete;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
02 Albacete;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;81,91
02 Albacete;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
02 Albacete;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
02 Albacete;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
02 Albacete;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;84,14
02 Albacete;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
02 Albacete;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
02 Albacete;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
02 Albacete;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;80,89
02 Albacete;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
02 Albacete;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
02 Albacete;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
02 Albacete;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
02 Albacete;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
02 Albacete;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QII;4.176
02 Albacete;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
02 Albacete;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
02 Albacete;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
02 Albacete;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QII;3.911
02 Albacete;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
02 Albacete;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
02 Albacete;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
02 Albacete;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QII;3.592
02 Albacete;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
02 Albacete;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
02 Albacete;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
02 Albacete;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2022QII;4.017
02 Albacete;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2022QI;""
02 Albacete;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
02 Albacete;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
02 Albacete;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2021QII;3.793
02 Albacete;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2021QI;""
02 Albacete;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
02 Albacete;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
02 Albacete;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2020QII;3.499
02 Albacete;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2020QI;""
02 Albacete;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
02 Albacete;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2022QIII;3.884
02 Albacete;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2022QII;""
02 Albacete;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2022QI;""
02 Albacete;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
02 Albacete;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2021QIII;3.666
02 Albacete;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2021QII;""
02 Albacete;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2021QI;""
02 Albacete;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
02 Albacete;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2020QIII;3.358
02 Albacete;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2020QII;""
02 Albacete;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2020QI;""
02 Albacete;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QIV;3.656
02 Albacete;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
02 Albacete;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QII;""
02 Albacete;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QI;""
02 Albacete;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QIV;3.508
02 Albacete;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
02 Albacete;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QII;""
02 Albacete;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QI;""
02 Albacete;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QIV;3.217
02 Albacete;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
02 Albacete;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QII;""
02 Albacete;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QI;""
02 Albacete;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
02 Albacete;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
02 Albacete;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QII;""
02 Albacete;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QI;3.382
02 Albacete;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
02 Albacete;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
02 Albacete;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QII;""
02 Albacete;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QI;3.113
02 Albacete;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
02 Albacete;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
02 Albacete;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QII;""
02 Albacete;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QI;""
02 Albacete;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
02 Albacete;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
02 Albacete;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
02 Albacete;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
02 Albacete;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
02 Albacete;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
02 Albacete;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
02 Albacete;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
02 Albacete;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
02 Albacete;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
02 Albacete;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
02 Albacete;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
02 Albacete;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
02 Albacete;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
02 Albacete;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;96,19
02 Albacete;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
02 Albacete;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
02 Albacete;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
02 Albacete;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;96,98
02 Albacete;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
02 Albacete;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
02 Albacete;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
02 Albacete;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;97,41
02 Albacete;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
02 Albacete;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
02 Albacete;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;93,01
02 Albacete;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
02 Albacete;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
02 Albacete;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
02 Albacete;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;93,74
02 Albacete;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
02 Albacete;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
02 Albacete;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
02 Albacete;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;93,49
02 Albacete;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
02 Albacete;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
02 Albacete;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;87,55
02 Albacete;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
02 Albacete;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
02 Albacete;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
02 Albacete;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;89,7
02 Albacete;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
02 Albacete;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
02 Albacete;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
02 Albacete;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;89,56
02 Albacete;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
02 Albacete;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
02 Albacete;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
02 Albacete;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
02 Albacete;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
02 Albacete;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
02 Albacete;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;86,47
02 Albacete;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
02 Albacete;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
02 Albacete;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
02 Albacete;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;86,66
02 Albacete;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
02 Albacete;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
02 Albacete;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
02 Albacete;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
02 Albacete;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
02 Albacete;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
02 Albacete;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QII;2.916
02 Albacete;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
02 Albacete;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
02 Albacete;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
02 Albacete;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QII;2.719
02 Albacete;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
02 Albacete;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
02 Albacete;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
02 Albacete;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QII;2.479
02 Albacete;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
02 Albacete;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
02 Albacete;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
02 Albacete;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2022QII;2.816
02 Albacete;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2022QI;""
02 Albacete;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
02 Albacete;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
02 Albacete;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2021QII;2.644
02 Albacete;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2021QI;""
02 Albacete;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
02 Albacete;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
02 Albacete;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2020QII;2.428
02 Albacete;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2020QI;""
02 Albacete;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
02 Albacete;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2022QIII;2.727
02 Albacete;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2022QII;""
02 Albacete;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2022QI;""
02 Albacete;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
02 Albacete;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2021QIII;2.566
02 Albacete;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2021QII;""
02 Albacete;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2021QI;""
02 Albacete;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
02 Albacete;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2020QIII;2.343
02 Albacete;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2020QII;""
02 Albacete;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2020QI;""
02 Albacete;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QIV;2.561
02 Albacete;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
02 Albacete;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QII;""
02 Albacete;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QI;""
02 Albacete;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QIV;2.461
02 Albacete;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
02 Albacete;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QII;""
02 Albacete;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QI;""
02 Albacete;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QIV;2.246
02 Albacete;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
02 Albacete;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QII;""
02 Albacete;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QI;""
02 Albacete;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
02 Albacete;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
02 Albacete;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QII;""
02 Albacete;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QI;2.386
02 Albacete;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
02 Albacete;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
02 Albacete;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QII;""
02 Albacete;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QI;2.174
02 Albacete;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
02 Albacete;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
02 Albacete;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QII;""
02 Albacete;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QI;""
02 Albacete;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
02 Albacete;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
02 Albacete;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
02 Albacete;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
02 Albacete;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
02 Albacete;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
02 Albacete;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
02 Albacete;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
02 Albacete;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
02 Albacete;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
02 Albacete;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
02 Albacete;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
02 Albacete;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
02 Albacete;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
02 Albacete;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;96,57
02 Albacete;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
02 Albacete;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
02 Albacete;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
02 Albacete;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;97,24
02 Albacete;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
02 Albacete;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
02 Albacete;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
02 Albacete;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;97,94
02 Albacete;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
02 Albacete;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
02 Albacete;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;93,52
02 Albacete;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
02 Albacete;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
02 Albacete;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
02 Albacete;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;94,37
02 Albacete;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
02 Albacete;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
02 Albacete;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
02 Albacete;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;94,51
02 Albacete;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
02 Albacete;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
02 Albacete;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;87,83
02 Albacete;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
02 Albacete;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
02 Albacete;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
02 Albacete;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;90,51
02 Albacete;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
02 Albacete;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
02 Albacete;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
02 Albacete;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;90,6
02 Albacete;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
02 Albacete;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
02 Albacete;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
02 Albacete;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
02 Albacete;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
02 Albacete;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
02 Albacete;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;87,75
02 Albacete;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
02 Albacete;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
02 Albacete;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
02 Albacete;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;87,7
02 Albacete;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
02 Albacete;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
02 Albacete;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
02 Albacete;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
02 Albacete;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
02 Albacete;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
02 Albacete;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QII;1.260
02 Albacete;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
02 Albacete;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
02 Albacete;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
02 Albacete;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QII;1.192
02 Albacete;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
02 Albacete;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
02 Albacete;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
02 Albacete;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QII;1.113
02 Albacete;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
02 Albacete;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
02 Albacete;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
02 Albacete;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2022QII;1.201
02 Albacete;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2022QI;""
02 Albacete;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
02 Albacete;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
02 Albacete;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2021QII;1.149
02 Albacete;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2021QI;""
02 Albacete;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
02 Albacete;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
02 Albacete;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2020QII;1.071
02 Albacete;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2020QI;""
02 Albacete;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
02 Albacete;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2022QIII;1.157
02 Albacete;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2022QII;""
02 Albacete;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2022QI;""
02 Albacete;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
02 Albacete;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2021QIII;1.100
02 Albacete;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2021QII;""
02 Albacete;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2021QI;""
02 Albacete;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
02 Albacete;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2020QIII;1.015
02 Albacete;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2020QII;""
02 Albacete;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2020QI;""
02 Albacete;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QIV;1.095
02 Albacete;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
02 Albacete;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QII;""
02 Albacete;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QI;""
02 Albacete;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QIV;1.047
02 Albacete;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
02 Albacete;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QII;""
02 Albacete;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QI;""
02 Albacete;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QIV;971
02 Albacete;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
02 Albacete;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QII;""
02 Albacete;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QI;""
02 Albacete;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
02 Albacete;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
02 Albacete;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QII;""
02 Albacete;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QI;996
02 Albacete;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
02 Albacete;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
02 Albacete;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QII;""
02 Albacete;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QI;939
02 Albacete;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
02 Albacete;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
02 Albacete;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QII;""
02 Albacete;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QI;""
02 Albacete;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
02 Albacete;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
02 Albacete;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
02 Albacete;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
02 Albacete;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
02 Albacete;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
02 Albacete;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
02 Albacete;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
02 Albacete;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
02 Albacete;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
02 Albacete;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
02 Albacete;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
02 Albacete;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
02 Albacete;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
02 Albacete;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;95,32
02 Albacete;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
02 Albacete;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
02 Albacete;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
02 Albacete;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;96,39
02 Albacete;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
02 Albacete;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
02 Albacete;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
02 Albacete;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;96,23
02 Albacete;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
02 Albacete;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
02 Albacete;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;91,83
02 Albacete;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
02 Albacete;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
02 Albacete;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
02 Albacete;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;92,28
02 Albacete;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
02 Albacete;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
02 Albacete;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
02 Albacete;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;91,19
02 Albacete;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
02 Albacete;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
02 Albacete;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;86,9
02 Albacete;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
02 Albacete;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
02 Albacete;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
02 Albacete;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;87,84
02 Albacete;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
02 Albacete;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
02 Albacete;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
02 Albacete;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;87,24
02 Albacete;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
02 Albacete;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
02 Albacete;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
02 Albacete;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
02 Albacete;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
02 Albacete;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
02 Albacete;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;83,56
02 Albacete;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
02 Albacete;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
02 Albacete;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
02 Albacete;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;84,37
02 Albacete;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
02 Albacete;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
02 Albacete;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
02 Albacete;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
02 Albacete;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
02 Albacete;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QIII;4.069
02 Albacete;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
02 Albacete;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
02 Albacete;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
02 Albacete;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QIII;3.850
02 Albacete;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
02 Albacete;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
02 Albacete;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
02 Albacete;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QIII;3.540
02 Albacete;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
02 Albacete;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
02 Albacete;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
02 Albacete;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2022QIII;3.923
02 Albacete;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2022QII;""
02 Albacete;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2022QI;""
02 Albacete;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
02 Albacete;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2021QIII;3.713
02 Albacete;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2021QII;""
02 Albacete;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2021QI;""
02 Albacete;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
02 Albacete;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2020QIII;3.393
02 Albacete;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2020QII;""
02 Albacete;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2020QI;""
02 Albacete;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2022QIV;3.688
02 Albacete;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
02 Albacete;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2022QII;""
02 Albacete;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2022QI;""
02 Albacete;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2021QIV;3.545
02 Albacete;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
02 Albacete;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2021QII;""
02 Albacete;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2021QI;""
02 Albacete;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2020QIV;3.247
02 Albacete;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
02 Albacete;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2020QII;""
02 Albacete;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2020QI;""
02 Albacete;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
02 Albacete;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
02 Albacete;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QII;""
02 Albacete;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QI;3.416
02 Albacete;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
02 Albacete;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
02 Albacete;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QII;""
02 Albacete;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QI;3.143
02 Albacete;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
02 Albacete;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
02 Albacete;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QII;""
02 Albacete;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QI;""
02 Albacete;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
02 Albacete;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
02 Albacete;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QII;3.287
02 Albacete;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QI;""
02 Albacete;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
02 Albacete;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
02 Albacete;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QII;3.048
02 Albacete;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QI;""
02 Albacete;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
02 Albacete;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
02 Albacete;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QII;""
02 Albacete;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QI;""
02 Albacete;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
02 Albacete;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
02 Albacete;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
02 Albacete;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
02 Albacete;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
02 Albacete;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
02 Albacete;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
02 Albacete;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
02 Albacete;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
02 Albacete;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
02 Albacete;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
02 Albacete;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
02 Albacete;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
02 Albacete;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;96,41
02 Albacete;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
02 Albacete;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
02 Albacete;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
02 Albacete;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;96,44
02 Albacete;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
02 Albacete;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
02 Albacete;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
02 Albacete;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;95,85
02 Albacete;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
02 Albacete;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
02 Albacete;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;90,64
02 Albacete;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
02 Albacete;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
02 Albacete;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
02 Albacete;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;92,08
02 Albacete;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
02 Albacete;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
02 Albacete;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
02 Albacete;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;91,72
02 Albacete;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
02 Albacete;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
02 Albacete;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
02 Albacete;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
02 Albacete;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
02 Albacete;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
02 Albacete;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;88,73
02 Albacete;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
02 Albacete;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
02 Albacete;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
02 Albacete;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;88,79
02 Albacete;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
02 Albacete;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
02 Albacete;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
02 Albacete;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
02 Albacete;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
02 Albacete;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
02 Albacete;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;85,38
02 Albacete;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
02 Albacete;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
02 Albacete;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
02 Albacete;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;86,1
02 Albacete;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
02 Albacete;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
02 Albacete;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
02 Albacete;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
02 Albacete;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
02 Albacete;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
02 Albacete;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QIII;2.844
02 Albacete;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
02 Albacete;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
02 Albacete;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
02 Albacete;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QIII;2.674
02 Albacete;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
02 Albacete;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
02 Albacete;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
02 Albacete;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QIII;2.456
02 Albacete;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
02 Albacete;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
02 Albacete;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
02 Albacete;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2022QIII;2.748
02 Albacete;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2022QII;""
02 Albacete;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2022QI;""
02 Albacete;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
02 Albacete;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2021QIII;2.590
02 Albacete;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2021QII;""
02 Albacete;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2021QI;""
02 Albacete;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
02 Albacete;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2020QIII;2.368
02 Albacete;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2020QII;""
02 Albacete;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2020QI;""
02 Albacete;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2022QIV;2.577
02 Albacete;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
02 Albacete;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2022QII;""
02 Albacete;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2022QI;""
02 Albacete;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2021QIV;2.479
02 Albacete;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
02 Albacete;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2021QII;""
02 Albacete;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2021QI;""
02 Albacete;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2020QIV;2.267
02 Albacete;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
02 Albacete;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2020QII;""
02 Albacete;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2020QI;""
02 Albacete;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
02 Albacete;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
02 Albacete;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QII;""
02 Albacete;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QI;2.403
02 Albacete;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
02 Albacete;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
02 Albacete;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QII;""
02 Albacete;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QI;2.195
02 Albacete;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
02 Albacete;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
02 Albacete;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QII;""
02 Albacete;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QI;""
02 Albacete;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
02 Albacete;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
02 Albacete;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QII;2.321
02 Albacete;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QI;""
02 Albacete;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
02 Albacete;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
02 Albacete;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QII;2.136
02 Albacete;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QI;""
02 Albacete;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
02 Albacete;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
02 Albacete;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QII;""
02 Albacete;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QI;""
02 Albacete;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
02 Albacete;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
02 Albacete;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
02 Albacete;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
02 Albacete;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
02 Albacete;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
02 Albacete;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
02 Albacete;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
02 Albacete;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
02 Albacete;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
02 Albacete;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
02 Albacete;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
02 Albacete;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
02 Albacete;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;96,62
02 Albacete;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
02 Albacete;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
02 Albacete;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
02 Albacete;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;96,86
02 Albacete;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
02 Albacete;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
02 Albacete;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
02 Albacete;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;96,42
02 Albacete;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
02 Albacete;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
02 Albacete;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;90,61
02 Albacete;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
02 Albacete;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
02 Albacete;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
02 Albacete;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;92,71
02 Albacete;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
02 Albacete;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
02 Albacete;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
02 Albacete;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;92,3
02 Albacete;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
02 Albacete;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
02 Albacete;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
02 Albacete;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
02 Albacete;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
02 Albacete;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
02 Albacete;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;89,87
02 Albacete;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
02 Albacete;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
02 Albacete;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
02 Albacete;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;89,37
02 Albacete;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
02 Albacete;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
02 Albacete;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
02 Albacete;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
02 Albacete;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
02 Albacete;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
02 Albacete;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;86,8
02 Albacete;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
02 Albacete;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
02 Albacete;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
02 Albacete;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;86,97
02 Albacete;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
02 Albacete;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
02 Albacete;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
02 Albacete;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
02 Albacete;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
02 Albacete;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
02 Albacete;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QIII;1.225
02 Albacete;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
02 Albacete;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
02 Albacete;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
02 Albacete;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QIII;1.176
02 Albacete;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
02 Albacete;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
02 Albacete;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
02 Albacete;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QIII;1.084
02 Albacete;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
02 Albacete;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
02 Albacete;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
02 Albacete;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2022QIII;1.175
02 Albacete;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2022QII;""
02 Albacete;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2022QI;""
02 Albacete;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
02 Albacete;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2021QIII;1.123
02 Albacete;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2021QII;""
02 Albacete;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2021QI;""
02 Albacete;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
02 Albacete;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2020QIII;1.025
02 Albacete;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2020QII;""
02 Albacete;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2020QI;""
02 Albacete;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2022QIV;1.111
02 Albacete;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
02 Albacete;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2022QII;""
02 Albacete;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2022QI;""
02 Albacete;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2021QIV;1.066
02 Albacete;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
02 Albacete;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2021QII;""
02 Albacete;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2021QI;""
02 Albacete;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2020QIV;980
02 Albacete;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
02 Albacete;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2020QII;""
02 Albacete;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2020QI;""
02 Albacete;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
02 Albacete;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
02 Albacete;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QII;""
02 Albacete;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QI;1.013
02 Albacete;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
02 Albacete;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
02 Albacete;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QII;""
02 Albacete;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QI;948
02 Albacete;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
02 Albacete;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
02 Albacete;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QII;""
02 Albacete;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QI;""
02 Albacete;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
02 Albacete;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
02 Albacete;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QII;966
02 Albacete;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QI;""
02 Albacete;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
02 Albacete;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
02 Albacete;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QII;912
02 Albacete;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QI;""
02 Albacete;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
02 Albacete;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
02 Albacete;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QII;""
02 Albacete;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QI;""
02 Albacete;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
02 Albacete;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
02 Albacete;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
02 Albacete;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
02 Albacete;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
02 Albacete;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
02 Albacete;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
02 Albacete;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
02 Albacete;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
02 Albacete;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
02 Albacete;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
02 Albacete;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
02 Albacete;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
02 Albacete;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;95,92
02 Albacete;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
02 Albacete;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
02 Albacete;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
02 Albacete;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;95,49
02 Albacete;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
02 Albacete;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
02 Albacete;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
02 Albacete;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;94,56
02 Albacete;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
02 Albacete;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
02 Albacete;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;90,69
02 Albacete;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
02 Albacete;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
02 Albacete;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
02 Albacete;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;90,65
02 Albacete;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
02 Albacete;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
02 Albacete;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
02 Albacete;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;90,41
02 Albacete;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
02 Albacete;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
02 Albacete;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
02 Albacete;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
02 Albacete;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
02 Albacete;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
02 Albacete;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;86,14
02 Albacete;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
02 Albacete;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
02 Albacete;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
02 Albacete;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;87,45
02 Albacete;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
02 Albacete;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
02 Albacete;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
02 Albacete;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
02 Albacete;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
02 Albacete;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
02 Albacete;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;82,14
02 Albacete;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
02 Albacete;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
02 Albacete;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
02 Albacete;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;84,13
02 Albacete;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
02 Albacete;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
02 Albacete;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
02 Albacete;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
02 Albacete;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
02 Albacete;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QIV;3.963
02 Albacete;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
02 Albacete;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
02 Albacete;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
02 Albacete;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QIV;3.744
02 Albacete;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
02 Albacete;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
02 Albacete;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
02 Albacete;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QIV;3.428
02 Albacete;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
02 Albacete;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
02 Albacete;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
02 Albacete;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2022QIV;3.722
02 Albacete;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
02 Albacete;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2022QII;""
02 Albacete;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2022QI;""
02 Albacete;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2021QIV;3.570
02 Albacete;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
02 Albacete;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2021QII;""
02 Albacete;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2021QI;""
02 Albacete;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2020QIV;3.278
02 Albacete;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
02 Albacete;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2020QII;""
02 Albacete;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2020QI;""
02 Albacete;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
02 Albacete;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
02 Albacete;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2022QII;""
02 Albacete;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2022QI;3.438
02 Albacete;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
02 Albacete;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
02 Albacete;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2021QII;""
02 Albacete;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2021QI;3.173
02 Albacete;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
02 Albacete;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
02 Albacete;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2020QII;""
02 Albacete;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2020QI;""
02 Albacete;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
02 Albacete;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
02 Albacete;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QII;3.306
02 Albacete;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QI;""
02 Albacete;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
02 Albacete;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
02 Albacete;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QII;3.075
02 Albacete;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QI;""
02 Albacete;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
02 Albacete;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
02 Albacete;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QII;""
02 Albacete;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QI;""
02 Albacete;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
02 Albacete;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QIII;3.187
02 Albacete;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QII;""
02 Albacete;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QI;""
02 Albacete;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
02 Albacete;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QIII;2.959
02 Albacete;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QII;""
02 Albacete;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QI;""
02 Albacete;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
02 Albacete;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
02 Albacete;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QII;""
02 Albacete;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QI;""
02 Albacete;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
02 Albacete;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
02 Albacete;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
02 Albacete;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
02 Albacete;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
02 Albacete;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
02 Albacete;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
02 Albacete;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
02 Albacete;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
02 Albacete;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
02 Albacete;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
02 Albacete;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
02 Albacete;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;93,92
02 Albacete;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
02 Albacete;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
02 Albacete;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
02 Albacete;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;95,35
02 Albacete;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
02 Albacete;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
02 Albacete;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
02 Albacete;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;95,62
02 Albacete;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
02 Albacete;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
02 Albacete;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
02 Albacete;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
02 Albacete;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
02 Albacete;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
02 Albacete;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;91,83
02 Albacete;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
02 Albacete;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
02 Albacete;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
02 Albacete;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;92,56
02 Albacete;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
02 Albacete;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
02 Albacete;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
02 Albacete;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
02 Albacete;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
02 Albacete;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
02 Albacete;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;88,3
02 Albacete;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
02 Albacete;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
02 Albacete;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
02 Albacete;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;89,7
02 Albacete;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
02 Albacete;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
02 Albacete;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
02 Albacete;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
02 Albacete;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
02 Albacete;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
02 Albacete;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;85,12
02 Albacete;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
02 Albacete;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
02 Albacete;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
02 Albacete;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;86,32
02 Albacete;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
02 Albacete;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
02 Albacete;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
02 Albacete;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
02 Albacete;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
02 Albacete;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
02 Albacete;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QIV;2.767
02 Albacete;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
02 Albacete;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
02 Albacete;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
02 Albacete;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QIV;2.606
02 Albacete;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
02 Albacete;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
02 Albacete;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
02 Albacete;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QIV;2.390
02 Albacete;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
02 Albacete;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
02 Albacete;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
02 Albacete;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2022QIV;2.591
02 Albacete;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
02 Albacete;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2022QII;""
02 Albacete;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2022QI;""
02 Albacete;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2021QIV;2.490
02 Albacete;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
02 Albacete;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2021QII;""
02 Albacete;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2021QI;""
02 Albacete;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2020QIV;2.285
02 Albacete;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
02 Albacete;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2020QII;""
02 Albacete;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2020QI;""
02 Albacete;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
02 Albacete;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
02 Albacete;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2022QII;""
02 Albacete;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2022QI;2.411
02 Albacete;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
02 Albacete;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
02 Albacete;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2021QII;""
02 Albacete;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2021QI;2.212
02 Albacete;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
02 Albacete;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
02 Albacete;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2020QII;""
02 Albacete;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2020QI;""
02 Albacete;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
02 Albacete;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
02 Albacete;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QII;2.327
02 Albacete;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QI;""
02 Albacete;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
02 Albacete;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
02 Albacete;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QII;2.152
02 Albacete;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QI;""
02 Albacete;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
02 Albacete;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
02 Albacete;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QII;""
02 Albacete;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QI;""
02 Albacete;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
02 Albacete;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QIII;2.245
02 Albacete;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QII;""
02 Albacete;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QI;""
02 Albacete;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
02 Albacete;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QIII;2.077
02 Albacete;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QII;""
02 Albacete;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QI;""
02 Albacete;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
02 Albacete;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
02 Albacete;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QII;""
02 Albacete;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QI;""
02 Albacete;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
02 Albacete;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
02 Albacete;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
02 Albacete;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
02 Albacete;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
02 Albacete;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
02 Albacete;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
02 Albacete;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
02 Albacete;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
02 Albacete;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
02 Albacete;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
02 Albacete;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
02 Albacete;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;93,64
02 Albacete;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
02 Albacete;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
02 Albacete;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
02 Albacete;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;95,55
02 Albacete;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
02 Albacete;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
02 Albacete;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
02 Albacete;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;95,61
02 Albacete;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
02 Albacete;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
02 Albacete;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
02 Albacete;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
02 Albacete;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
02 Albacete;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
02 Albacete;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;92,52
02 Albacete;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
02 Albacete;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
02 Albacete;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
02 Albacete;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;92,55
02 Albacete;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
02 Albacete;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
02 Albacete;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
02 Albacete;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
02 Albacete;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
02 Albacete;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
02 Albacete;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;89,29
02 Albacete;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
02 Albacete;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
02 Albacete;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
02 Albacete;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;90,04
02 Albacete;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
02 Albacete;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
02 Albacete;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
02 Albacete;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
02 Albacete;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
02 Albacete;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
02 Albacete;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;86,15
02 Albacete;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
02 Albacete;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
02 Albacete;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
02 Albacete;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;86,9
02 Albacete;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
02 Albacete;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
02 Albacete;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
02 Albacete;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
02 Albacete;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
02 Albacete;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
02 Albacete;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QIV;1.196
02 Albacete;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
02 Albacete;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
02 Albacete;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
02 Albacete;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QIV;1.138
02 Albacete;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
02 Albacete;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
02 Albacete;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
02 Albacete;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QIV;1.038
02 Albacete;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
02 Albacete;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
02 Albacete;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
02 Albacete;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2022QIV;1.131
02 Albacete;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
02 Albacete;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2022QII;""
02 Albacete;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2022QI;""
02 Albacete;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2021QIV;1.080
02 Albacete;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
02 Albacete;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2021QII;""
02 Albacete;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2021QI;""
02 Albacete;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2020QIV;993
02 Albacete;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
02 Albacete;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2020QII;""
02 Albacete;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2020QI;""
02 Albacete;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
02 Albacete;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
02 Albacete;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2022QII;""
02 Albacete;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2022QI;1.027
02 Albacete;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
02 Albacete;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
02 Albacete;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2021QII;""
02 Albacete;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2021QI;961
02 Albacete;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
02 Albacete;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
02 Albacete;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2020QII;""
02 Albacete;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2020QI;""
02 Albacete;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
02 Albacete;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
02 Albacete;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QII;979
02 Albacete;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QI;""
02 Albacete;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
02 Albacete;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
02 Albacete;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QII;923
02 Albacete;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QI;""
02 Albacete;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
02 Albacete;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
02 Albacete;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QII;""
02 Albacete;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QI;""
02 Albacete;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
02 Albacete;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QIII;942
02 Albacete;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QII;""
02 Albacete;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QI;""
02 Albacete;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
02 Albacete;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QIII;882
02 Albacete;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QII;""
02 Albacete;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QI;""
02 Albacete;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
02 Albacete;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
02 Albacete;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QII;""
02 Albacete;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QI;""
02 Albacete;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
02 Albacete;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
02 Albacete;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
02 Albacete;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
02 Albacete;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
02 Albacete;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
02 Albacete;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
02 Albacete;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
02 Albacete;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
02 Albacete;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
02 Albacete;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
02 Albacete;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
02 Albacete;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;94,57
02 Albacete;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
02 Albacete;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
02 Albacete;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
02 Albacete;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;94,9
02 Albacete;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
02 Albacete;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
02 Albacete;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
02 Albacete;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;95,66
02 Albacete;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
02 Albacete;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
02 Albacete;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
02 Albacete;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
02 Albacete;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
02 Albacete;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
02 Albacete;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;90,25
02 Albacete;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
02 Albacete;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
02 Albacete;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
02 Albacete;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;92,58
02 Albacete;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
02 Albacete;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
02 Albacete;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
02 Albacete;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
02 Albacete;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
02 Albacete;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
02 Albacete;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;86,03
02 Albacete;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
02 Albacete;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
02 Albacete;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
02 Albacete;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;88,92
02 Albacete;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
02 Albacete;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
02 Albacete;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
02 Albacete;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
02 Albacete;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
02 Albacete;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
02 Albacete;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;82,78
02 Albacete;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
02 Albacete;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
02 Albacete;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
02 Albacete;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;84,97
02 Albacete;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
02 Albacete;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
02 Albacete;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
02 Albacete;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
02 Albacete;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
02 Albacete;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
03 Alicante/Alacant;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
03 Alicante/Alacant;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
03 Alicante/Alacant;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
03 Alicante/Alacant;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QI;131.426
03 Alicante/Alacant;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
03 Alicante/Alacant;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
03 Alicante/Alacant;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
03 Alicante/Alacant;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QI;128.404
03 Alicante/Alacant;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
03 Alicante/Alacant;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
03 Alicante/Alacant;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
03 Alicante/Alacant;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QI;128.995
03 Alicante/Alacant;All ages;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
03 Alicante/Alacant;All ages;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
03 Alicante/Alacant;All ages;Cohort January 1;Total;Survival in the first trimester;2022QII;""
03 Alicante/Alacant;All ages;Cohort January 1;Total;Survival in the first trimester;2022QI;126.592
03 Alicante/Alacant;All ages;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
03 Alicante/Alacant;All ages;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
03 Alicante/Alacant;All ages;Cohort January 1;Total;Survival in the first trimester;2021QII;""
03 Alicante/Alacant;All ages;Cohort January 1;Total;Survival in the first trimester;2021QI;124.465
03 Alicante/Alacant;All ages;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
03 Alicante/Alacant;All ages;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
03 Alicante/Alacant;All ages;Cohort January 1;Total;Survival in the first trimester;2020QII;""
03 Alicante/Alacant;All ages;Cohort January 1;Total;Survival in the first trimester;2020QI;119.770
03 Alicante/Alacant;All ages;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
03 Alicante/Alacant;All ages;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
03 Alicante/Alacant;All ages;Cohort January 1;Total;Survival in the second trimester;2022QII;122.088
03 Alicante/Alacant;All ages;Cohort January 1;Total;Survival in the second trimester;2022QI;""
03 Alicante/Alacant;All ages;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
03 Alicante/Alacant;All ages;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
03 Alicante/Alacant;All ages;Cohort January 1;Total;Survival in the second trimester;2021QII;120.561
03 Alicante/Alacant;All ages;Cohort January 1;Total;Survival in the second trimester;2021QI;""
03 Alicante/Alacant;All ages;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
03 Alicante/Alacant;All ages;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
03 Alicante/Alacant;All ages;Cohort January 1;Total;Survival in the second trimester;2020QII;117.048
03 Alicante/Alacant;All ages;Cohort January 1;Total;Survival in the second trimester;2020QI;""
03 Alicante/Alacant;All ages;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
03 Alicante/Alacant;All ages;Cohort January 1;Total;Survival in the third trimester;2022QIII;118.258
03 Alicante/Alacant;All ages;Cohort January 1;Total;Survival in the third trimester;2022QII;""
03 Alicante/Alacant;All ages;Cohort January 1;Total;Survival in the third trimester;2022QI;""
03 Alicante/Alacant;All ages;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
03 Alicante/Alacant;All ages;Cohort January 1;Total;Survival in the third trimester;2021QIII;117.060
03 Alicante/Alacant;All ages;Cohort January 1;Total;Survival in the third trimester;2021QII;""
03 Alicante/Alacant;All ages;Cohort January 1;Total;Survival in the third trimester;2021QI;""
03 Alicante/Alacant;All ages;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
03 Alicante/Alacant;All ages;Cohort January 1;Total;Survival in the third trimester;2020QIII;113.352
03 Alicante/Alacant;All ages;Cohort January 1;Total;Survival in the third trimester;2020QII;""
03 Alicante/Alacant;All ages;Cohort January 1;Total;Survival in the third trimester;2020QI;""
03 Alicante/Alacant;All ages;Cohort January 1;Total;Survival in the third trimester;2022QIV;114.045
03 Alicante/Alacant;All ages;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
03 Alicante/Alacant;All ages;Cohort January 1;Total;Survival in the third trimester;2022QII;""
03 Alicante/Alacant;All ages;Cohort January 1;Total;Survival in the third trimester;2022QI;""
03 Alicante/Alacant;All ages;Cohort January 1;Total;Survival in the third trimester;2021QIV;113.332
03 Alicante/Alacant;All ages;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
03 Alicante/Alacant;All ages;Cohort January 1;Total;Survival in the third trimester;2021QII;""
03 Alicante/Alacant;All ages;Cohort January 1;Total;Survival in the third trimester;2021QI;""
03 Alicante/Alacant;All ages;Cohort January 1;Total;Survival in the third trimester;2020QIV;109.615
03 Alicante/Alacant;All ages;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
03 Alicante/Alacant;All ages;Cohort January 1;Total;Survival in the third trimester;2020QII;""
03 Alicante/Alacant;All ages;Cohort January 1;Total;Survival in the third trimester;2020QI;""
03 Alicante/Alacant;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
03 Alicante/Alacant;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
03 Alicante/Alacant;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
03 Alicante/Alacant;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
03 Alicante/Alacant;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
03 Alicante/Alacant;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
03 Alicante/Alacant;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
03 Alicante/Alacant;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
03 Alicante/Alacant;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
03 Alicante/Alacant;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
03 Alicante/Alacant;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
03 Alicante/Alacant;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
03 Alicante/Alacant;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
03 Alicante/Alacant;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
03 Alicante/Alacant;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
03 Alicante/Alacant;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;96,32
03 Alicante/Alacant;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
03 Alicante/Alacant;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
03 Alicante/Alacant;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
03 Alicante/Alacant;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;96,93
03 Alicante/Alacant;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
03 Alicante/Alacant;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
03 Alicante/Alacant;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
03 Alicante/Alacant;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;92,85
03 Alicante/Alacant;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
03 Alicante/Alacant;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
03 Alicante/Alacant;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;92,89
03 Alicante/Alacant;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
03 Alicante/Alacant;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
03 Alicante/Alacant;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
03 Alicante/Alacant;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;93,89
03 Alicante/Alacant;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
03 Alicante/Alacant;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
03 Alicante/Alacant;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
03 Alicante/Alacant;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;90,74
03 Alicante/Alacant;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
03 Alicante/Alacant;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
03 Alicante/Alacant;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;89,98
03 Alicante/Alacant;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
03 Alicante/Alacant;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
03 Alicante/Alacant;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
03 Alicante/Alacant;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;91,17
03 Alicante/Alacant;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
03 Alicante/Alacant;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
03 Alicante/Alacant;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
03 Alicante/Alacant;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;87,87
03 Alicante/Alacant;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
03 Alicante/Alacant;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
03 Alicante/Alacant;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;86,78
03 Alicante/Alacant;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
03 Alicante/Alacant;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
03 Alicante/Alacant;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
03 Alicante/Alacant;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;88,26
03 Alicante/Alacant;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
03 Alicante/Alacant;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
03 Alicante/Alacant;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
03 Alicante/Alacant;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;84,98
03 Alicante/Alacant;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
03 Alicante/Alacant;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
03 Alicante/Alacant;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
03 Alicante/Alacant;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
03 Alicante/Alacant;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
03 Alicante/Alacant;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
03 Alicante/Alacant;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QI;83.792
03 Alicante/Alacant;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
03 Alicante/Alacant;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
03 Alicante/Alacant;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
03 Alicante/Alacant;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QI;82.397
03 Alicante/Alacant;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
03 Alicante/Alacant;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
03 Alicante/Alacant;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
03 Alicante/Alacant;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QI;82.714
03 Alicante/Alacant;All ages;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
03 Alicante/Alacant;All ages;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
03 Alicante/Alacant;All ages;Cohort January 1;Males;Survival in the first trimester;2022QII;""
03 Alicante/Alacant;All ages;Cohort January 1;Males;Survival in the first trimester;2022QI;80.875
03 Alicante/Alacant;All ages;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
03 Alicante/Alacant;All ages;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
03 Alicante/Alacant;All ages;Cohort January 1;Males;Survival in the first trimester;2021QII;""
03 Alicante/Alacant;All ages;Cohort January 1;Males;Survival in the first trimester;2021QI;79.993
03 Alicante/Alacant;All ages;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
03 Alicante/Alacant;All ages;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
03 Alicante/Alacant;All ages;Cohort January 1;Males;Survival in the first trimester;2020QII;""
03 Alicante/Alacant;All ages;Cohort January 1;Males;Survival in the first trimester;2020QI;77.251
03 Alicante/Alacant;All ages;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
03 Alicante/Alacant;All ages;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
03 Alicante/Alacant;All ages;Cohort January 1;Males;Survival in the second trimester;2022QII;78.263
03 Alicante/Alacant;All ages;Cohort January 1;Males;Survival in the second trimester;2022QI;""
03 Alicante/Alacant;All ages;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
03 Alicante/Alacant;All ages;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
03 Alicante/Alacant;All ages;Cohort January 1;Males;Survival in the second trimester;2021QII;77.662
03 Alicante/Alacant;All ages;Cohort January 1;Males;Survival in the second trimester;2021QI;""
03 Alicante/Alacant;All ages;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
03 Alicante/Alacant;All ages;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
03 Alicante/Alacant;All ages;Cohort January 1;Males;Survival in the second trimester;2020QII;75.642
03 Alicante/Alacant;All ages;Cohort January 1;Males;Survival in the second trimester;2020QI;""
03 Alicante/Alacant;All ages;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
03 Alicante/Alacant;All ages;Cohort January 1;Males;Survival in the third trimester;2022QIII;75.998
03 Alicante/Alacant;All ages;Cohort January 1;Males;Survival in the third trimester;2022QII;""
03 Alicante/Alacant;All ages;Cohort January 1;Males;Survival in the third trimester;2022QI;""
03 Alicante/Alacant;All ages;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
03 Alicante/Alacant;All ages;Cohort January 1;Males;Survival in the third trimester;2021QIII;75.506
03 Alicante/Alacant;All ages;Cohort January 1;Males;Survival in the third trimester;2021QII;""
03 Alicante/Alacant;All ages;Cohort January 1;Males;Survival in the third trimester;2021QI;""
03 Alicante/Alacant;All ages;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
03 Alicante/Alacant;All ages;Cohort January 1;Males;Survival in the third trimester;2020QIII;73.427
03 Alicante/Alacant;All ages;Cohort January 1;Males;Survival in the third trimester;2020QII;""
03 Alicante/Alacant;All ages;Cohort January 1;Males;Survival in the third trimester;2020QI;""
03 Alicante/Alacant;All ages;Cohort January 1;Males;Survival in the third trimester;2022QIV;73.427
03 Alicante/Alacant;All ages;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
03 Alicante/Alacant;All ages;Cohort January 1;Males;Survival in the third trimester;2022QII;""
03 Alicante/Alacant;All ages;Cohort January 1;Males;Survival in the third trimester;2022QI;""
03 Alicante/Alacant;All ages;Cohort January 1;Males;Survival in the third trimester;2021QIV;73.238
03 Alicante/Alacant;All ages;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
03 Alicante/Alacant;All ages;Cohort January 1;Males;Survival in the third trimester;2021QII;""
03 Alicante/Alacant;All ages;Cohort January 1;Males;Survival in the third trimester;2021QI;""
03 Alicante/Alacant;All ages;Cohort January 1;Males;Survival in the third trimester;2020QIV;71.172
03 Alicante/Alacant;All ages;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
03 Alicante/Alacant;All ages;Cohort January 1;Males;Survival in the third trimester;2020QII;""
03 Alicante/Alacant;All ages;Cohort January 1;Males;Survival in the third trimester;2020QI;""
03 Alicante/Alacant;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
03 Alicante/Alacant;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
03 Alicante/Alacant;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
03 Alicante/Alacant;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
03 Alicante/Alacant;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
03 Alicante/Alacant;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
03 Alicante/Alacant;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
03 Alicante/Alacant;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
03 Alicante/Alacant;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
03 Alicante/Alacant;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
03 Alicante/Alacant;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
03 Alicante/Alacant;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
03 Alicante/Alacant;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
03 Alicante/Alacant;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
03 Alicante/Alacant;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
03 Alicante/Alacant;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;96,52
03 Alicante/Alacant;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
03 Alicante/Alacant;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
03 Alicante/Alacant;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
03 Alicante/Alacant;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;97,08
03 Alicante/Alacant;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
03 Alicante/Alacant;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
03 Alicante/Alacant;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
03 Alicante/Alacant;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;93,4
03 Alicante/Alacant;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
03 Alicante/Alacant;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
03 Alicante/Alacant;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;93,4
03 Alicante/Alacant;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
03 Alicante/Alacant;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
03 Alicante/Alacant;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
03 Alicante/Alacant;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;94,25
03 Alicante/Alacant;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
03 Alicante/Alacant;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
03 Alicante/Alacant;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
03 Alicante/Alacant;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;91,45
03 Alicante/Alacant;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
03 Alicante/Alacant;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
03 Alicante/Alacant;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;90,7
03 Alicante/Alacant;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
03 Alicante/Alacant;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
03 Alicante/Alacant;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
03 Alicante/Alacant;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;91,64
03 Alicante/Alacant;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
03 Alicante/Alacant;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
03 Alicante/Alacant;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
03 Alicante/Alacant;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;88,77
03 Alicante/Alacant;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
03 Alicante/Alacant;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
03 Alicante/Alacant;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;87,63
03 Alicante/Alacant;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
03 Alicante/Alacant;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
03 Alicante/Alacant;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
03 Alicante/Alacant;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;88,88
03 Alicante/Alacant;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
03 Alicante/Alacant;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
03 Alicante/Alacant;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
03 Alicante/Alacant;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;86,05
03 Alicante/Alacant;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
03 Alicante/Alacant;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
03 Alicante/Alacant;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
03 Alicante/Alacant;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
03 Alicante/Alacant;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
03 Alicante/Alacant;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
03 Alicante/Alacant;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QI;47.634
03 Alicante/Alacant;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
03 Alicante/Alacant;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
03 Alicante/Alacant;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
03 Alicante/Alacant;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QI;46.007
03 Alicante/Alacant;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
03 Alicante/Alacant;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
03 Alicante/Alacant;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
03 Alicante/Alacant;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QI;46.281
03 Alicante/Alacant;All ages;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
03 Alicante/Alacant;All ages;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
03 Alicante/Alacant;All ages;Cohort January 1;Females;Survival in the first trimester;2022QII;""
03 Alicante/Alacant;All ages;Cohort January 1;Females;Survival in the first trimester;2022QI;45.717
03 Alicante/Alacant;All ages;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
03 Alicante/Alacant;All ages;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
03 Alicante/Alacant;All ages;Cohort January 1;Females;Survival in the first trimester;2021QII;""
03 Alicante/Alacant;All ages;Cohort January 1;Females;Survival in the first trimester;2021QI;44.472
03 Alicante/Alacant;All ages;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
03 Alicante/Alacant;All ages;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
03 Alicante/Alacant;All ages;Cohort January 1;Females;Survival in the first trimester;2020QII;""
03 Alicante/Alacant;All ages;Cohort January 1;Females;Survival in the first trimester;2020QI;42.519
03 Alicante/Alacant;All ages;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
03 Alicante/Alacant;All ages;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
03 Alicante/Alacant;All ages;Cohort January 1;Females;Survival in the second trimester;2022QII;43.825
03 Alicante/Alacant;All ages;Cohort January 1;Females;Survival in the second trimester;2022QI;""
03 Alicante/Alacant;All ages;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
03 Alicante/Alacant;All ages;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
03 Alicante/Alacant;All ages;Cohort January 1;Females;Survival in the second trimester;2021QII;42.899
03 Alicante/Alacant;All ages;Cohort January 1;Females;Survival in the second trimester;2021QI;""
03 Alicante/Alacant;All ages;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
03 Alicante/Alacant;All ages;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
03 Alicante/Alacant;All ages;Cohort January 1;Females;Survival in the second trimester;2020QII;41.406
03 Alicante/Alacant;All ages;Cohort January 1;Females;Survival in the second trimester;2020QI;""
03 Alicante/Alacant;All ages;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
03 Alicante/Alacant;All ages;Cohort January 1;Females;Survival in the third trimester;2022QIII;42.260
03 Alicante/Alacant;All ages;Cohort January 1;Females;Survival in the third trimester;2022QII;""
03 Alicante/Alacant;All ages;Cohort January 1;Females;Survival in the third trimester;2022QI;""
03 Alicante/Alacant;All ages;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
03 Alicante/Alacant;All ages;Cohort January 1;Females;Survival in the third trimester;2021QIII;41.554
03 Alicante/Alacant;All ages;Cohort January 1;Females;Survival in the third trimester;2021QII;""
03 Alicante/Alacant;All ages;Cohort January 1;Females;Survival in the third trimester;2021QI;""
03 Alicante/Alacant;All ages;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
03 Alicante/Alacant;All ages;Cohort January 1;Females;Survival in the third trimester;2020QIII;39.925
03 Alicante/Alacant;All ages;Cohort January 1;Females;Survival in the third trimester;2020QII;""
03 Alicante/Alacant;All ages;Cohort January 1;Females;Survival in the third trimester;2020QI;""
03 Alicante/Alacant;All ages;Cohort January 1;Females;Survival in the third trimester;2022QIV;40.618
03 Alicante/Alacant;All ages;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
03 Alicante/Alacant;All ages;Cohort January 1;Females;Survival in the third trimester;2022QII;""
03 Alicante/Alacant;All ages;Cohort January 1;Females;Survival in the third trimester;2022QI;""
03 Alicante/Alacant;All ages;Cohort January 1;Females;Survival in the third trimester;2021QIV;40.094
03 Alicante/Alacant;All ages;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
03 Alicante/Alacant;All ages;Cohort January 1;Females;Survival in the third trimester;2021QII;""
03 Alicante/Alacant;All ages;Cohort January 1;Females;Survival in the third trimester;2021QI;""
03 Alicante/Alacant;All ages;Cohort January 1;Females;Survival in the third trimester;2020QIV;38.443
03 Alicante/Alacant;All ages;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
03 Alicante/Alacant;All ages;Cohort January 1;Females;Survival in the third trimester;2020QII;""
03 Alicante/Alacant;All ages;Cohort January 1;Females;Survival in the third trimester;2020QI;""
03 Alicante/Alacant;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
03 Alicante/Alacant;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
03 Alicante/Alacant;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
03 Alicante/Alacant;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
03 Alicante/Alacant;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
03 Alicante/Alacant;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
03 Alicante/Alacant;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
03 Alicante/Alacant;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
03 Alicante/Alacant;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
03 Alicante/Alacant;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
03 Alicante/Alacant;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
03 Alicante/Alacant;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
03 Alicante/Alacant;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
03 Alicante/Alacant;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
03 Alicante/Alacant;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
03 Alicante/Alacant;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;95,98
03 Alicante/Alacant;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
03 Alicante/Alacant;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
03 Alicante/Alacant;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
03 Alicante/Alacant;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;96,66
03 Alicante/Alacant;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
03 Alicante/Alacant;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
03 Alicante/Alacant;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
03 Alicante/Alacant;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;91,87
03 Alicante/Alacant;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
03 Alicante/Alacant;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
03 Alicante/Alacant;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;92
03 Alicante/Alacant;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
03 Alicante/Alacant;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
03 Alicante/Alacant;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
03 Alicante/Alacant;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;93,24
03 Alicante/Alacant;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
03 Alicante/Alacant;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
03 Alicante/Alacant;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
03 Alicante/Alacant;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;89,47
03 Alicante/Alacant;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
03 Alicante/Alacant;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
03 Alicante/Alacant;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;88,72
03 Alicante/Alacant;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
03 Alicante/Alacant;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
03 Alicante/Alacant;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
03 Alicante/Alacant;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;90,32
03 Alicante/Alacant;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
03 Alicante/Alacant;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
03 Alicante/Alacant;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
03 Alicante/Alacant;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;86,27
03 Alicante/Alacant;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
03 Alicante/Alacant;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
03 Alicante/Alacant;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;85,27
03 Alicante/Alacant;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
03 Alicante/Alacant;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
03 Alicante/Alacant;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
03 Alicante/Alacant;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;87,15
03 Alicante/Alacant;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
03 Alicante/Alacant;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
03 Alicante/Alacant;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
03 Alicante/Alacant;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;83,06
03 Alicante/Alacant;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
03 Alicante/Alacant;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
03 Alicante/Alacant;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
03 Alicante/Alacant;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
03 Alicante/Alacant;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
03 Alicante/Alacant;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QII;132.403
03 Alicante/Alacant;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
03 Alicante/Alacant;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
03 Alicante/Alacant;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
03 Alicante/Alacant;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QII;129.744
03 Alicante/Alacant;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
03 Alicante/Alacant;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
03 Alicante/Alacant;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
03 Alicante/Alacant;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QII;126.530
03 Alicante/Alacant;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
03 Alicante/Alacant;All ages;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
03 Alicante/Alacant;All ages;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
03 Alicante/Alacant;All ages;Cohort April 1;Total;Survival in the first trimester;2022QII;127.369
03 Alicante/Alacant;All ages;Cohort April 1;Total;Survival in the first trimester;2022QI;""
03 Alicante/Alacant;All ages;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
03 Alicante/Alacant;All ages;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
03 Alicante/Alacant;All ages;Cohort April 1;Total;Survival in the first trimester;2021QII;125.327
03 Alicante/Alacant;All ages;Cohort April 1;Total;Survival in the first trimester;2021QI;""
03 Alicante/Alacant;All ages;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
03 Alicante/Alacant;All ages;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
03 Alicante/Alacant;All ages;Cohort April 1;Total;Survival in the first trimester;2020QII;123.499
03 Alicante/Alacant;All ages;Cohort April 1;Total;Survival in the first trimester;2020QI;""
03 Alicante/Alacant;All ages;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
03 Alicante/Alacant;All ages;Cohort April 1;Total;Survival in the second trimester;2022QIII;123.102
03 Alicante/Alacant;All ages;Cohort April 1;Total;Survival in the second trimester;2022QII;""
03 Alicante/Alacant;All ages;Cohort April 1;Total;Survival in the second trimester;2022QI;""
03 Alicante/Alacant;All ages;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
03 Alicante/Alacant;All ages;Cohort April 1;Total;Survival in the second trimester;2021QIII;121.418
03 Alicante/Alacant;All ages;Cohort April 1;Total;Survival in the second trimester;2021QII;""
03 Alicante/Alacant;All ages;Cohort April 1;Total;Survival in the second trimester;2021QI;""
03 Alicante/Alacant;All ages;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
03 Alicante/Alacant;All ages;Cohort April 1;Total;Survival in the second trimester;2020QIII;119.187
03 Alicante/Alacant;All ages;Cohort April 1;Total;Survival in the second trimester;2020QII;""
03 Alicante/Alacant;All ages;Cohort April 1;Total;Survival in the second trimester;2020QI;""
03 Alicante/Alacant;All ages;Cohort April 1;Total;Survival in the third trimester;2022QIV;118.436
03 Alicante/Alacant;All ages;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
03 Alicante/Alacant;All ages;Cohort April 1;Total;Survival in the third trimester;2022QII;""
03 Alicante/Alacant;All ages;Cohort April 1;Total;Survival in the third trimester;2022QI;""
03 Alicante/Alacant;All ages;Cohort April 1;Total;Survival in the third trimester;2021QIV;117.293
03 Alicante/Alacant;All ages;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
03 Alicante/Alacant;All ages;Cohort April 1;Total;Survival in the third trimester;2021QII;""
03 Alicante/Alacant;All ages;Cohort April 1;Total;Survival in the third trimester;2021QI;""
03 Alicante/Alacant;All ages;Cohort April 1;Total;Survival in the third trimester;2020QIV;114.964
03 Alicante/Alacant;All ages;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
03 Alicante/Alacant;All ages;Cohort April 1;Total;Survival in the third trimester;2020QII;""
03 Alicante/Alacant;All ages;Cohort April 1;Total;Survival in the third trimester;2020QI;""
03 Alicante/Alacant;All ages;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
03 Alicante/Alacant;All ages;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
03 Alicante/Alacant;All ages;Cohort April 1;Total;Survival in the third trimester;2022QII;""
03 Alicante/Alacant;All ages;Cohort April 1;Total;Survival in the third trimester;2022QI;113.681
03 Alicante/Alacant;All ages;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
03 Alicante/Alacant;All ages;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
03 Alicante/Alacant;All ages;Cohort April 1;Total;Survival in the third trimester;2021QII;""
03 Alicante/Alacant;All ages;Cohort April 1;Total;Survival in the third trimester;2021QI;112.093
03 Alicante/Alacant;All ages;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
03 Alicante/Alacant;All ages;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
03 Alicante/Alacant;All ages;Cohort April 1;Total;Survival in the third trimester;2020QII;""
03 Alicante/Alacant;All ages;Cohort April 1;Total;Survival in the third trimester;2020QI;""
03 Alicante/Alacant;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
03 Alicante/Alacant;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
03 Alicante/Alacant;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
03 Alicante/Alacant;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
03 Alicante/Alacant;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
03 Alicante/Alacant;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
03 Alicante/Alacant;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
03 Alicante/Alacant;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
03 Alicante/Alacant;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
03 Alicante/Alacant;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
03 Alicante/Alacant;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
03 Alicante/Alacant;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
03 Alicante/Alacant;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
03 Alicante/Alacant;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
03 Alicante/Alacant;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;96,2
03 Alicante/Alacant;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
03 Alicante/Alacant;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
03 Alicante/Alacant;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
03 Alicante/Alacant;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;96,6
03 Alicante/Alacant;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
03 Alicante/Alacant;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
03 Alicante/Alacant;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
03 Alicante/Alacant;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;97,6
03 Alicante/Alacant;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
03 Alicante/Alacant;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
03 Alicante/Alacant;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;92,98
03 Alicante/Alacant;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
03 Alicante/Alacant;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
03 Alicante/Alacant;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
03 Alicante/Alacant;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;93,58
03 Alicante/Alacant;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
03 Alicante/Alacant;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
03 Alicante/Alacant;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
03 Alicante/Alacant;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;94,2
03 Alicante/Alacant;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
03 Alicante/Alacant;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
03 Alicante/Alacant;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;89,45
03 Alicante/Alacant;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
03 Alicante/Alacant;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
03 Alicante/Alacant;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
03 Alicante/Alacant;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;90,4
03 Alicante/Alacant;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
03 Alicante/Alacant;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
03 Alicante/Alacant;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
03 Alicante/Alacant;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;90,86
03 Alicante/Alacant;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
03 Alicante/Alacant;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
03 Alicante/Alacant;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
03 Alicante/Alacant;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
03 Alicante/Alacant;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
03 Alicante/Alacant;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
03 Alicante/Alacant;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;87,62
03 Alicante/Alacant;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
03 Alicante/Alacant;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
03 Alicante/Alacant;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
03 Alicante/Alacant;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;88,59
03 Alicante/Alacant;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
03 Alicante/Alacant;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
03 Alicante/Alacant;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
03 Alicante/Alacant;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
03 Alicante/Alacant;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
03 Alicante/Alacant;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
03 Alicante/Alacant;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QII;84.293
03 Alicante/Alacant;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
03 Alicante/Alacant;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
03 Alicante/Alacant;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
03 Alicante/Alacant;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QII;83.182
03 Alicante/Alacant;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
03 Alicante/Alacant;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
03 Alicante/Alacant;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
03 Alicante/Alacant;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QII;81.300
03 Alicante/Alacant;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
03 Alicante/Alacant;All ages;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
03 Alicante/Alacant;All ages;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
03 Alicante/Alacant;All ages;Cohort April 1;Males;Survival in the first trimester;2022QII;81.360
03 Alicante/Alacant;All ages;Cohort April 1;Males;Survival in the first trimester;2022QI;""
03 Alicante/Alacant;All ages;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
03 Alicante/Alacant;All ages;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
03 Alicante/Alacant;All ages;Cohort April 1;Males;Survival in the first trimester;2021QII;80.533
03 Alicante/Alacant;All ages;Cohort April 1;Males;Survival in the first trimester;2021QI;""
03 Alicante/Alacant;All ages;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
03 Alicante/Alacant;All ages;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
03 Alicante/Alacant;All ages;Cohort April 1;Males;Survival in the first trimester;2020QII;79.485
03 Alicante/Alacant;All ages;Cohort April 1;Males;Survival in the first trimester;2020QI;""
03 Alicante/Alacant;All ages;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
03 Alicante/Alacant;All ages;Cohort April 1;Males;Survival in the second trimester;2022QIII;78.813
03 Alicante/Alacant;All ages;Cohort April 1;Males;Survival in the second trimester;2022QII;""
03 Alicante/Alacant;All ages;Cohort April 1;Males;Survival in the second trimester;2022QI;""
03 Alicante/Alacant;All ages;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
03 Alicante/Alacant;All ages;Cohort April 1;Males;Survival in the second trimester;2021QIII;78.127
03 Alicante/Alacant;All ages;Cohort April 1;Males;Survival in the second trimester;2021QII;""
03 Alicante/Alacant;All ages;Cohort April 1;Males;Survival in the second trimester;2021QI;""
03 Alicante/Alacant;All ages;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
03 Alicante/Alacant;All ages;Cohort April 1;Males;Survival in the second trimester;2020QIII;76.892
03 Alicante/Alacant;All ages;Cohort April 1;Males;Survival in the second trimester;2020QII;""
03 Alicante/Alacant;All ages;Cohort April 1;Males;Survival in the second trimester;2020QI;""
03 Alicante/Alacant;All ages;Cohort April 1;Males;Survival in the third trimester;2022QIV;75.997
03 Alicante/Alacant;All ages;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
03 Alicante/Alacant;All ages;Cohort April 1;Males;Survival in the third trimester;2022QII;""
03 Alicante/Alacant;All ages;Cohort April 1;Males;Survival in the third trimester;2022QI;""
03 Alicante/Alacant;All ages;Cohort April 1;Males;Survival in the third trimester;2021QIV;75.636
03 Alicante/Alacant;All ages;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
03 Alicante/Alacant;All ages;Cohort April 1;Males;Survival in the third trimester;2021QII;""
03 Alicante/Alacant;All ages;Cohort April 1;Males;Survival in the third trimester;2021QI;""
03 Alicante/Alacant;All ages;Cohort April 1;Males;Survival in the third trimester;2020QIV;74.341
03 Alicante/Alacant;All ages;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
03 Alicante/Alacant;All ages;Cohort April 1;Males;Survival in the third trimester;2020QII;""
03 Alicante/Alacant;All ages;Cohort April 1;Males;Survival in the third trimester;2020QI;""
03 Alicante/Alacant;All ages;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
03 Alicante/Alacant;All ages;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
03 Alicante/Alacant;All ages;Cohort April 1;Males;Survival in the third trimester;2022QII;""
03 Alicante/Alacant;All ages;Cohort April 1;Males;Survival in the third trimester;2022QI;73.471
03 Alicante/Alacant;All ages;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
03 Alicante/Alacant;All ages;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
03 Alicante/Alacant;All ages;Cohort April 1;Males;Survival in the third trimester;2021QII;""
03 Alicante/Alacant;All ages;Cohort April 1;Males;Survival in the third trimester;2021QI;72.599
03 Alicante/Alacant;All ages;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
03 Alicante/Alacant;All ages;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
03 Alicante/Alacant;All ages;Cohort April 1;Males;Survival in the third trimester;2020QII;""
03 Alicante/Alacant;All ages;Cohort April 1;Males;Survival in the third trimester;2020QI;""
03 Alicante/Alacant;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
03 Alicante/Alacant;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
03 Alicante/Alacant;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
03 Alicante/Alacant;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
03 Alicante/Alacant;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
03 Alicante/Alacant;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
03 Alicante/Alacant;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
03 Alicante/Alacant;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
03 Alicante/Alacant;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
03 Alicante/Alacant;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
03 Alicante/Alacant;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
03 Alicante/Alacant;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
03 Alicante/Alacant;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
03 Alicante/Alacant;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
03 Alicante/Alacant;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;96,52
03 Alicante/Alacant;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
03 Alicante/Alacant;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
03 Alicante/Alacant;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
03 Alicante/Alacant;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;96,82
03 Alicante/Alacant;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
03 Alicante/Alacant;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
03 Alicante/Alacant;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
03 Alicante/Alacant;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;97,77
03 Alicante/Alacant;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
03 Alicante/Alacant;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
03 Alicante/Alacant;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;93,5
03 Alicante/Alacant;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
03 Alicante/Alacant;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
03 Alicante/Alacant;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
03 Alicante/Alacant;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;93,92
03 Alicante/Alacant;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
03 Alicante/Alacant;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
03 Alicante/Alacant;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
03 Alicante/Alacant;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;94,58
03 Alicante/Alacant;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
03 Alicante/Alacant;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
03 Alicante/Alacant;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;90,16
03 Alicante/Alacant;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
03 Alicante/Alacant;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
03 Alicante/Alacant;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
03 Alicante/Alacant;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;90,93
03 Alicante/Alacant;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
03 Alicante/Alacant;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
03 Alicante/Alacant;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
03 Alicante/Alacant;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;91,44
03 Alicante/Alacant;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
03 Alicante/Alacant;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
03 Alicante/Alacant;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
03 Alicante/Alacant;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
03 Alicante/Alacant;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
03 Alicante/Alacant;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
03 Alicante/Alacant;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;88,33
03 Alicante/Alacant;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
03 Alicante/Alacant;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
03 Alicante/Alacant;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
03 Alicante/Alacant;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;89,3
03 Alicante/Alacant;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
03 Alicante/Alacant;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
03 Alicante/Alacant;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
03 Alicante/Alacant;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
03 Alicante/Alacant;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
03 Alicante/Alacant;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
03 Alicante/Alacant;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QII;48.110
03 Alicante/Alacant;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
03 Alicante/Alacant;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
03 Alicante/Alacant;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
03 Alicante/Alacant;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QII;46.562
03 Alicante/Alacant;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
03 Alicante/Alacant;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
03 Alicante/Alacant;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
03 Alicante/Alacant;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QII;45.230
03 Alicante/Alacant;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
03 Alicante/Alacant;All ages;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
03 Alicante/Alacant;All ages;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
03 Alicante/Alacant;All ages;Cohort April 1;Females;Survival in the first trimester;2022QII;46.009
03 Alicante/Alacant;All ages;Cohort April 1;Females;Survival in the first trimester;2022QI;""
03 Alicante/Alacant;All ages;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
03 Alicante/Alacant;All ages;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
03 Alicante/Alacant;All ages;Cohort April 1;Females;Survival in the first trimester;2021QII;44.794
03 Alicante/Alacant;All ages;Cohort April 1;Females;Survival in the first trimester;2021QI;""
03 Alicante/Alacant;All ages;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
03 Alicante/Alacant;All ages;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
03 Alicante/Alacant;All ages;Cohort April 1;Females;Survival in the first trimester;2020QII;44.014
03 Alicante/Alacant;All ages;Cohort April 1;Females;Survival in the first trimester;2020QI;""
03 Alicante/Alacant;All ages;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
03 Alicante/Alacant;All ages;Cohort April 1;Females;Survival in the second trimester;2022QIII;44.289
03 Alicante/Alacant;All ages;Cohort April 1;Females;Survival in the second trimester;2022QII;""
03 Alicante/Alacant;All ages;Cohort April 1;Females;Survival in the second trimester;2022QI;""
03 Alicante/Alacant;All ages;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
03 Alicante/Alacant;All ages;Cohort April 1;Females;Survival in the second trimester;2021QIII;43.291
03 Alicante/Alacant;All ages;Cohort April 1;Females;Survival in the second trimester;2021QII;""
03 Alicante/Alacant;All ages;Cohort April 1;Females;Survival in the second trimester;2021QI;""
03 Alicante/Alacant;All ages;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
03 Alicante/Alacant;All ages;Cohort April 1;Females;Survival in the second trimester;2020QIII;42.295
03 Alicante/Alacant;All ages;Cohort April 1;Females;Survival in the second trimester;2020QII;""
03 Alicante/Alacant;All ages;Cohort April 1;Females;Survival in the second trimester;2020QI;""
03 Alicante/Alacant;All ages;Cohort April 1;Females;Survival in the third trimester;2022QIV;42.439
03 Alicante/Alacant;All ages;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
03 Alicante/Alacant;All ages;Cohort April 1;Females;Survival in the third trimester;2022QII;""
03 Alicante/Alacant;All ages;Cohort April 1;Females;Survival in the third trimester;2022QI;""
03 Alicante/Alacant;All ages;Cohort April 1;Females;Survival in the third trimester;2021QIV;41.657
03 Alicante/Alacant;All ages;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
03 Alicante/Alacant;All ages;Cohort April 1;Females;Survival in the third trimester;2021QII;""
03 Alicante/Alacant;All ages;Cohort April 1;Females;Survival in the third trimester;2021QI;""
03 Alicante/Alacant;All ages;Cohort April 1;Females;Survival in the third trimester;2020QIV;40.623
03 Alicante/Alacant;All ages;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
03 Alicante/Alacant;All ages;Cohort April 1;Females;Survival in the third trimester;2020QII;""
03 Alicante/Alacant;All ages;Cohort April 1;Females;Survival in the third trimester;2020QI;""
03 Alicante/Alacant;All ages;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
03 Alicante/Alacant;All ages;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
03 Alicante/Alacant;All ages;Cohort April 1;Females;Survival in the third trimester;2022QII;""
03 Alicante/Alacant;All ages;Cohort April 1;Females;Survival in the third trimester;2022QI;40.210
03 Alicante/Alacant;All ages;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
03 Alicante/Alacant;All ages;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
03 Alicante/Alacant;All ages;Cohort April 1;Females;Survival in the third trimester;2021QII;""
03 Alicante/Alacant;All ages;Cohort April 1;Females;Survival in the third trimester;2021QI;39.494
03 Alicante/Alacant;All ages;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
03 Alicante/Alacant;All ages;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
03 Alicante/Alacant;All ages;Cohort April 1;Females;Survival in the third trimester;2020QII;""
03 Alicante/Alacant;All ages;Cohort April 1;Females;Survival in the third trimester;2020QI;""
03 Alicante/Alacant;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
03 Alicante/Alacant;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
03 Alicante/Alacant;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
03 Alicante/Alacant;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
03 Alicante/Alacant;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
03 Alicante/Alacant;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
03 Alicante/Alacant;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
03 Alicante/Alacant;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
03 Alicante/Alacant;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
03 Alicante/Alacant;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
03 Alicante/Alacant;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
03 Alicante/Alacant;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
03 Alicante/Alacant;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
03 Alicante/Alacant;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
03 Alicante/Alacant;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;95,63
03 Alicante/Alacant;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
03 Alicante/Alacant;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
03 Alicante/Alacant;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
03 Alicante/Alacant;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;96,2
03 Alicante/Alacant;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
03 Alicante/Alacant;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
03 Alicante/Alacant;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
03 Alicante/Alacant;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;97,31
03 Alicante/Alacant;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
03 Alicante/Alacant;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
03 Alicante/Alacant;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;92,06
03 Alicante/Alacant;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
03 Alicante/Alacant;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
03 Alicante/Alacant;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
03 Alicante/Alacant;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;92,97
03 Alicante/Alacant;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
03 Alicante/Alacant;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
03 Alicante/Alacant;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
03 Alicante/Alacant;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;93,51
03 Alicante/Alacant;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
03 Alicante/Alacant;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
03 Alicante/Alacant;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;88,21
03 Alicante/Alacant;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
03 Alicante/Alacant;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
03 Alicante/Alacant;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
03 Alicante/Alacant;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;89,47
03 Alicante/Alacant;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
03 Alicante/Alacant;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
03 Alicante/Alacant;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
03 Alicante/Alacant;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;89,81
03 Alicante/Alacant;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
03 Alicante/Alacant;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
03 Alicante/Alacant;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
03 Alicante/Alacant;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
03 Alicante/Alacant;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
03 Alicante/Alacant;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
03 Alicante/Alacant;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;86,36
03 Alicante/Alacant;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
03 Alicante/Alacant;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
03 Alicante/Alacant;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
03 Alicante/Alacant;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;87,32
03 Alicante/Alacant;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
03 Alicante/Alacant;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
03 Alicante/Alacant;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
03 Alicante/Alacant;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
03 Alicante/Alacant;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
03 Alicante/Alacant;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QIII;133.497
03 Alicante/Alacant;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
03 Alicante/Alacant;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
03 Alicante/Alacant;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
03 Alicante/Alacant;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QIII;131.394
03 Alicante/Alacant;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
03 Alicante/Alacant;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
03 Alicante/Alacant;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
03 Alicante/Alacant;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QIII;128.489
03 Alicante/Alacant;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
03 Alicante/Alacant;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
03 Alicante/Alacant;All ages;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
03 Alicante/Alacant;All ages;Cohort July 1;Total;Survival in the first trimester;2022QIII;128.313
03 Alicante/Alacant;All ages;Cohort July 1;Total;Survival in the first trimester;2022QII;""
03 Alicante/Alacant;All ages;Cohort July 1;Total;Survival in the first trimester;2022QI;""
03 Alicante/Alacant;All ages;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
03 Alicante/Alacant;All ages;Cohort July 1;Total;Survival in the first trimester;2021QIII;126.598
03 Alicante/Alacant;All ages;Cohort July 1;Total;Survival in the first trimester;2021QII;""
03 Alicante/Alacant;All ages;Cohort July 1;Total;Survival in the first trimester;2021QI;""
03 Alicante/Alacant;All ages;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
03 Alicante/Alacant;All ages;Cohort July 1;Total;Survival in the first trimester;2020QIII;123.388
03 Alicante/Alacant;All ages;Cohort July 1;Total;Survival in the first trimester;2020QII;""
03 Alicante/Alacant;All ages;Cohort July 1;Total;Survival in the first trimester;2020QI;""
03 Alicante/Alacant;All ages;Cohort July 1;Total;Survival in the second trimester;2022QIV;123.029
03 Alicante/Alacant;All ages;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
03 Alicante/Alacant;All ages;Cohort July 1;Total;Survival in the second trimester;2022QII;""
03 Alicante/Alacant;All ages;Cohort July 1;Total;Survival in the second trimester;2022QI;""
03 Alicante/Alacant;All ages;Cohort July 1;Total;Survival in the second trimester;2021QIV;121.865
03 Alicante/Alacant;All ages;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
03 Alicante/Alacant;All ages;Cohort July 1;Total;Survival in the second trimester;2021QII;""
03 Alicante/Alacant;All ages;Cohort July 1;Total;Survival in the second trimester;2021QI;""
03 Alicante/Alacant;All ages;Cohort July 1;Total;Survival in the second trimester;2020QIV;118.666
03 Alicante/Alacant;All ages;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
03 Alicante/Alacant;All ages;Cohort July 1;Total;Survival in the second trimester;2020QII;""
03 Alicante/Alacant;All ages;Cohort July 1;Total;Survival in the second trimester;2020QI;""
03 Alicante/Alacant;All ages;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
03 Alicante/Alacant;All ages;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
03 Alicante/Alacant;All ages;Cohort July 1;Total;Survival in the third trimester;2022QII;""
03 Alicante/Alacant;All ages;Cohort July 1;Total;Survival in the third trimester;2022QI;117.923
03 Alicante/Alacant;All ages;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
03 Alicante/Alacant;All ages;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
03 Alicante/Alacant;All ages;Cohort July 1;Total;Survival in the third trimester;2021QII;""
03 Alicante/Alacant;All ages;Cohort July 1;Total;Survival in the third trimester;2021QI;115.574
03 Alicante/Alacant;All ages;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
03 Alicante/Alacant;All ages;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
03 Alicante/Alacant;All ages;Cohort July 1;Total;Survival in the third trimester;2020QII;""
03 Alicante/Alacant;All ages;Cohort July 1;Total;Survival in the third trimester;2020QI;""
03 Alicante/Alacant;All ages;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
03 Alicante/Alacant;All ages;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
03 Alicante/Alacant;All ages;Cohort July 1;Total;Survival in the third trimester;2022QII;114.308
03 Alicante/Alacant;All ages;Cohort July 1;Total;Survival in the third trimester;2022QI;""
03 Alicante/Alacant;All ages;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
03 Alicante/Alacant;All ages;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
03 Alicante/Alacant;All ages;Cohort July 1;Total;Survival in the third trimester;2021QII;112.451
03 Alicante/Alacant;All ages;Cohort July 1;Total;Survival in the third trimester;2021QI;""
03 Alicante/Alacant;All ages;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
03 Alicante/Alacant;All ages;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
03 Alicante/Alacant;All ages;Cohort July 1;Total;Survival in the third trimester;2020QII;""
03 Alicante/Alacant;All ages;Cohort July 1;Total;Survival in the third trimester;2020QI;""
03 Alicante/Alacant;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
03 Alicante/Alacant;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
03 Alicante/Alacant;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
03 Alicante/Alacant;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
03 Alicante/Alacant;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
03 Alicante/Alacant;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
03 Alicante/Alacant;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
03 Alicante/Alacant;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
03 Alicante/Alacant;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
03 Alicante/Alacant;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
03 Alicante/Alacant;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
03 Alicante/Alacant;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
03 Alicante/Alacant;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
03 Alicante/Alacant;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;96,12
03 Alicante/Alacant;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
03 Alicante/Alacant;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
03 Alicante/Alacant;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
03 Alicante/Alacant;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;96,35
03 Alicante/Alacant;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
03 Alicante/Alacant;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
03 Alicante/Alacant;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
03 Alicante/Alacant;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;96,03
03 Alicante/Alacant;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
03 Alicante/Alacant;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
03 Alicante/Alacant;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;92,16
03 Alicante/Alacant;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
03 Alicante/Alacant;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
03 Alicante/Alacant;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
03 Alicante/Alacant;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;92,75
03 Alicante/Alacant;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
03 Alicante/Alacant;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
03 Alicante/Alacant;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
03 Alicante/Alacant;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;92,35
03 Alicante/Alacant;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
03 Alicante/Alacant;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
03 Alicante/Alacant;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
03 Alicante/Alacant;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
03 Alicante/Alacant;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
03 Alicante/Alacant;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
03 Alicante/Alacant;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;89,75
03 Alicante/Alacant;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
03 Alicante/Alacant;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
03 Alicante/Alacant;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
03 Alicante/Alacant;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;89,95
03 Alicante/Alacant;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
03 Alicante/Alacant;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
03 Alicante/Alacant;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
03 Alicante/Alacant;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
03 Alicante/Alacant;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
03 Alicante/Alacant;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
03 Alicante/Alacant;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;87
03 Alicante/Alacant;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
03 Alicante/Alacant;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
03 Alicante/Alacant;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
03 Alicante/Alacant;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;87,52
03 Alicante/Alacant;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
03 Alicante/Alacant;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
03 Alicante/Alacant;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
03 Alicante/Alacant;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
03 Alicante/Alacant;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
03 Alicante/Alacant;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
03 Alicante/Alacant;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QIII;84.916
03 Alicante/Alacant;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
03 Alicante/Alacant;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
03 Alicante/Alacant;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
03 Alicante/Alacant;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QIII;84.073
03 Alicante/Alacant;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
03 Alicante/Alacant;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
03 Alicante/Alacant;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
03 Alicante/Alacant;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QIII;82.737
03 Alicante/Alacant;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
03 Alicante/Alacant;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
03 Alicante/Alacant;All ages;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
03 Alicante/Alacant;All ages;Cohort July 1;Males;Survival in the first trimester;2022QIII;81.813
03 Alicante/Alacant;All ages;Cohort July 1;Males;Survival in the first trimester;2022QII;""
03 Alicante/Alacant;All ages;Cohort July 1;Males;Survival in the first trimester;2022QI;""
03 Alicante/Alacant;All ages;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
03 Alicante/Alacant;All ages;Cohort July 1;Males;Survival in the first trimester;2021QIII;81.134
03 Alicante/Alacant;All ages;Cohort July 1;Males;Survival in the first trimester;2021QII;""
03 Alicante/Alacant;All ages;Cohort July 1;Males;Survival in the first trimester;2021QI;""
03 Alicante/Alacant;All ages;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
03 Alicante/Alacant;All ages;Cohort July 1;Males;Survival in the first trimester;2020QIII;79.621
03 Alicante/Alacant;All ages;Cohort July 1;Males;Survival in the first trimester;2020QII;""
03 Alicante/Alacant;All ages;Cohort July 1;Males;Survival in the first trimester;2020QI;""
03 Alicante/Alacant;All ages;Cohort July 1;Males;Survival in the second trimester;2022QIV;78.643
03 Alicante/Alacant;All ages;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
03 Alicante/Alacant;All ages;Cohort July 1;Males;Survival in the second trimester;2022QII;""
03 Alicante/Alacant;All ages;Cohort July 1;Males;Survival in the second trimester;2022QI;""
03 Alicante/Alacant;All ages;Cohort July 1;Males;Survival in the second trimester;2021QIV;78.302
03 Alicante/Alacant;All ages;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
03 Alicante/Alacant;All ages;Cohort July 1;Males;Survival in the second trimester;2021QII;""
03 Alicante/Alacant;All ages;Cohort July 1;Males;Survival in the second trimester;2021QI;""
03 Alicante/Alacant;All ages;Cohort July 1;Males;Survival in the second trimester;2020QIV;76.744
03 Alicante/Alacant;All ages;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
03 Alicante/Alacant;All ages;Cohort July 1;Males;Survival in the second trimester;2020QII;""
03 Alicante/Alacant;All ages;Cohort July 1;Males;Survival in the second trimester;2020QI;""
03 Alicante/Alacant;All ages;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
03 Alicante/Alacant;All ages;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
03 Alicante/Alacant;All ages;Cohort July 1;Males;Survival in the third trimester;2022QII;""
03 Alicante/Alacant;All ages;Cohort July 1;Males;Survival in the third trimester;2022QI;75.939
03 Alicante/Alacant;All ages;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
03 Alicante/Alacant;All ages;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
03 Alicante/Alacant;All ages;Cohort July 1;Males;Survival in the third trimester;2021QII;""
03 Alicante/Alacant;All ages;Cohort July 1;Males;Survival in the third trimester;2021QI;74.862
03 Alicante/Alacant;All ages;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
03 Alicante/Alacant;All ages;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
03 Alicante/Alacant;All ages;Cohort July 1;Males;Survival in the third trimester;2020QII;""
03 Alicante/Alacant;All ages;Cohort July 1;Males;Survival in the third trimester;2020QI;""
03 Alicante/Alacant;All ages;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
03 Alicante/Alacant;All ages;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
03 Alicante/Alacant;All ages;Cohort July 1;Males;Survival in the third trimester;2022QII;73.818
03 Alicante/Alacant;All ages;Cohort July 1;Males;Survival in the third trimester;2022QI;""
03 Alicante/Alacant;All ages;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
03 Alicante/Alacant;All ages;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
03 Alicante/Alacant;All ages;Cohort July 1;Males;Survival in the third trimester;2021QII;72.963
03 Alicante/Alacant;All ages;Cohort July 1;Males;Survival in the third trimester;2021QI;""
03 Alicante/Alacant;All ages;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
03 Alicante/Alacant;All ages;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
03 Alicante/Alacant;All ages;Cohort July 1;Males;Survival in the third trimester;2020QII;""
03 Alicante/Alacant;All ages;Cohort July 1;Males;Survival in the third trimester;2020QI;""
03 Alicante/Alacant;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
03 Alicante/Alacant;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
03 Alicante/Alacant;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
03 Alicante/Alacant;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
03 Alicante/Alacant;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
03 Alicante/Alacant;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
03 Alicante/Alacant;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
03 Alicante/Alacant;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
03 Alicante/Alacant;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
03 Alicante/Alacant;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
03 Alicante/Alacant;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
03 Alicante/Alacant;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
03 Alicante/Alacant;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
03 Alicante/Alacant;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;96,35
03 Alicante/Alacant;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
03 Alicante/Alacant;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
03 Alicante/Alacant;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
03 Alicante/Alacant;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;96,5
03 Alicante/Alacant;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
03 Alicante/Alacant;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
03 Alicante/Alacant;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
03 Alicante/Alacant;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;96,23
03 Alicante/Alacant;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
03 Alicante/Alacant;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
03 Alicante/Alacant;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;92,61
03 Alicante/Alacant;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
03 Alicante/Alacant;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
03 Alicante/Alacant;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
03 Alicante/Alacant;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;93,14
03 Alicante/Alacant;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
03 Alicante/Alacant;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
03 Alicante/Alacant;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
03 Alicante/Alacant;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;92,76
03 Alicante/Alacant;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
03 Alicante/Alacant;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
03 Alicante/Alacant;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
03 Alicante/Alacant;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
03 Alicante/Alacant;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
03 Alicante/Alacant;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
03 Alicante/Alacant;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;90,33
03 Alicante/Alacant;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
03 Alicante/Alacant;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
03 Alicante/Alacant;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
03 Alicante/Alacant;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;90,48
03 Alicante/Alacant;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
03 Alicante/Alacant;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
03 Alicante/Alacant;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
03 Alicante/Alacant;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
03 Alicante/Alacant;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
03 Alicante/Alacant;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
03 Alicante/Alacant;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;87,8
03 Alicante/Alacant;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
03 Alicante/Alacant;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
03 Alicante/Alacant;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
03 Alicante/Alacant;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;88,19
03 Alicante/Alacant;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
03 Alicante/Alacant;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
03 Alicante/Alacant;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
03 Alicante/Alacant;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
03 Alicante/Alacant;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
03 Alicante/Alacant;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
03 Alicante/Alacant;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QIII;48.581
03 Alicante/Alacant;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
03 Alicante/Alacant;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
03 Alicante/Alacant;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
03 Alicante/Alacant;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QIII;47.321
03 Alicante/Alacant;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
03 Alicante/Alacant;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
03 Alicante/Alacant;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
03 Alicante/Alacant;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QIII;45.752
03 Alicante/Alacant;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
03 Alicante/Alacant;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
03 Alicante/Alacant;All ages;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
03 Alicante/Alacant;All ages;Cohort July 1;Females;Survival in the first trimester;2022QIII;46.500
03 Alicante/Alacant;All ages;Cohort July 1;Females;Survival in the first trimester;2022QII;""
03 Alicante/Alacant;All ages;Cohort July 1;Females;Survival in the first trimester;2022QI;""
03 Alicante/Alacant;All ages;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
03 Alicante/Alacant;All ages;Cohort July 1;Females;Survival in the first trimester;2021QIII;45.464
03 Alicante/Alacant;All ages;Cohort July 1;Females;Survival in the first trimester;2021QII;""
03 Alicante/Alacant;All ages;Cohort July 1;Females;Survival in the first trimester;2021QI;""
03 Alicante/Alacant;All ages;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
03 Alicante/Alacant;All ages;Cohort July 1;Females;Survival in the first trimester;2020QIII;43.767
03 Alicante/Alacant;All ages;Cohort July 1;Females;Survival in the first trimester;2020QII;""
03 Alicante/Alacant;All ages;Cohort July 1;Females;Survival in the first trimester;2020QI;""
03 Alicante/Alacant;All ages;Cohort July 1;Females;Survival in the second trimester;2022QIV;44.386
03 Alicante/Alacant;All ages;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
03 Alicante/Alacant;All ages;Cohort July 1;Females;Survival in the second trimester;2022QII;""
03 Alicante/Alacant;All ages;Cohort July 1;Females;Survival in the second trimester;2022QI;""
03 Alicante/Alacant;All ages;Cohort July 1;Females;Survival in the second trimester;2021QIV;43.563
03 Alicante/Alacant;All ages;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
03 Alicante/Alacant;All ages;Cohort July 1;Females;Survival in the second trimester;2021QII;""
03 Alicante/Alacant;All ages;Cohort July 1;Females;Survival in the second trimester;2021QI;""
03 Alicante/Alacant;All ages;Cohort July 1;Females;Survival in the second trimester;2020QIV;41.922
03 Alicante/Alacant;All ages;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
03 Alicante/Alacant;All ages;Cohort July 1;Females;Survival in the second trimester;2020QII;""
03 Alicante/Alacant;All ages;Cohort July 1;Females;Survival in the second trimester;2020QI;""
03 Alicante/Alacant;All ages;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
03 Alicante/Alacant;All ages;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
03 Alicante/Alacant;All ages;Cohort July 1;Females;Survival in the third trimester;2022QII;""
03 Alicante/Alacant;All ages;Cohort July 1;Females;Survival in the third trimester;2022QI;41.984
03 Alicante/Alacant;All ages;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
03 Alicante/Alacant;All ages;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
03 Alicante/Alacant;All ages;Cohort July 1;Females;Survival in the third trimester;2021QII;""
03 Alicante/Alacant;All ages;Cohort July 1;Females;Survival in the third trimester;2021QI;40.712
03 Alicante/Alacant;All ages;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
03 Alicante/Alacant;All ages;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
03 Alicante/Alacant;All ages;Cohort July 1;Females;Survival in the third trimester;2020QII;""
03 Alicante/Alacant;All ages;Cohort July 1;Females;Survival in the third trimester;2020QI;""
03 Alicante/Alacant;All ages;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
03 Alicante/Alacant;All ages;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
03 Alicante/Alacant;All ages;Cohort July 1;Females;Survival in the third trimester;2022QII;40.490
03 Alicante/Alacant;All ages;Cohort July 1;Females;Survival in the third trimester;2022QI;""
03 Alicante/Alacant;All ages;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
03 Alicante/Alacant;All ages;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
03 Alicante/Alacant;All ages;Cohort July 1;Females;Survival in the third trimester;2021QII;39.488
03 Alicante/Alacant;All ages;Cohort July 1;Females;Survival in the third trimester;2021QI;""
03 Alicante/Alacant;All ages;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
03 Alicante/Alacant;All ages;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
03 Alicante/Alacant;All ages;Cohort July 1;Females;Survival in the third trimester;2020QII;""
03 Alicante/Alacant;All ages;Cohort July 1;Females;Survival in the third trimester;2020QI;""
03 Alicante/Alacant;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
03 Alicante/Alacant;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
03 Alicante/Alacant;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
03 Alicante/Alacant;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
03 Alicante/Alacant;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
03 Alicante/Alacant;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
03 Alicante/Alacant;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
03 Alicante/Alacant;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
03 Alicante/Alacant;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
03 Alicante/Alacant;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
03 Alicante/Alacant;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
03 Alicante/Alacant;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
03 Alicante/Alacant;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
03 Alicante/Alacant;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;95,72
03 Alicante/Alacant;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
03 Alicante/Alacant;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
03 Alicante/Alacant;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
03 Alicante/Alacant;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;96,08
03 Alicante/Alacant;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
03 Alicante/Alacant;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
03 Alicante/Alacant;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
03 Alicante/Alacant;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;95,66
03 Alicante/Alacant;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
03 Alicante/Alacant;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
03 Alicante/Alacant;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;91,36
03 Alicante/Alacant;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
03 Alicante/Alacant;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
03 Alicante/Alacant;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
03 Alicante/Alacant;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;92,06
03 Alicante/Alacant;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
03 Alicante/Alacant;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
03 Alicante/Alacant;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
03 Alicante/Alacant;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;91,63
03 Alicante/Alacant;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
03 Alicante/Alacant;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
03 Alicante/Alacant;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
03 Alicante/Alacant;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
03 Alicante/Alacant;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
03 Alicante/Alacant;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
03 Alicante/Alacant;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;88,72
03 Alicante/Alacant;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
03 Alicante/Alacant;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
03 Alicante/Alacant;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
03 Alicante/Alacant;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;88,98
03 Alicante/Alacant;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
03 Alicante/Alacant;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
03 Alicante/Alacant;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
03 Alicante/Alacant;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
03 Alicante/Alacant;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
03 Alicante/Alacant;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
03 Alicante/Alacant;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;85,56
03 Alicante/Alacant;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
03 Alicante/Alacant;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
03 Alicante/Alacant;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
03 Alicante/Alacant;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;86,31
03 Alicante/Alacant;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
03 Alicante/Alacant;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
03 Alicante/Alacant;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
03 Alicante/Alacant;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
03 Alicante/Alacant;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
03 Alicante/Alacant;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QIV;132.959
03 Alicante/Alacant;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
03 Alicante/Alacant;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
03 Alicante/Alacant;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
03 Alicante/Alacant;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QIV;131.490
03 Alicante/Alacant;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
03 Alicante/Alacant;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
03 Alicante/Alacant;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
03 Alicante/Alacant;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QIV;128.648
03 Alicante/Alacant;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
03 Alicante/Alacant;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
03 Alicante/Alacant;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
03 Alicante/Alacant;All ages;Cohort October 1;Total;Survival in the first trimester;2022QIV;127.179
03 Alicante/Alacant;All ages;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
03 Alicante/Alacant;All ages;Cohort October 1;Total;Survival in the first trimester;2022QII;""
03 Alicante/Alacant;All ages;Cohort October 1;Total;Survival in the first trimester;2022QI;""
03 Alicante/Alacant;All ages;Cohort October 1;Total;Survival in the first trimester;2021QIV;126.134
03 Alicante/Alacant;All ages;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
03 Alicante/Alacant;All ages;Cohort October 1;Total;Survival in the first trimester;2021QII;""
03 Alicante/Alacant;All ages;Cohort October 1;Total;Survival in the first trimester;2021QI;""
03 Alicante/Alacant;All ages;Cohort October 1;Total;Survival in the first trimester;2020QIV;123.237
03 Alicante/Alacant;All ages;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
03 Alicante/Alacant;All ages;Cohort October 1;Total;Survival in the first trimester;2020QII;""
03 Alicante/Alacant;All ages;Cohort October 1;Total;Survival in the first trimester;2020QI;""
03 Alicante/Alacant;All ages;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
03 Alicante/Alacant;All ages;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
03 Alicante/Alacant;All ages;Cohort October 1;Total;Survival in the second trimester;2022QII;""
03 Alicante/Alacant;All ages;Cohort October 1;Total;Survival in the second trimester;2022QI;121.842
03 Alicante/Alacant;All ages;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
03 Alicante/Alacant;All ages;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
03 Alicante/Alacant;All ages;Cohort October 1;Total;Survival in the second trimester;2021QII;""
03 Alicante/Alacant;All ages;Cohort October 1;Total;Survival in the second trimester;2021QI;119.790
03 Alicante/Alacant;All ages;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
03 Alicante/Alacant;All ages;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
03 Alicante/Alacant;All ages;Cohort October 1;Total;Survival in the second trimester;2020QII;""
03 Alicante/Alacant;All ages;Cohort October 1;Total;Survival in the second trimester;2020QI;""
03 Alicante/Alacant;All ages;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
03 Alicante/Alacant;All ages;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
03 Alicante/Alacant;All ages;Cohort October 1;Total;Survival in the third trimester;2022QII;117.879
03 Alicante/Alacant;All ages;Cohort October 1;Total;Survival in the third trimester;2022QI;""
03 Alicante/Alacant;All ages;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
03 Alicante/Alacant;All ages;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
03 Alicante/Alacant;All ages;Cohort October 1;Total;Survival in the third trimester;2021QII;116.329
03 Alicante/Alacant;All ages;Cohort October 1;Total;Survival in the third trimester;2021QI;""
03 Alicante/Alacant;All ages;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
03 Alicante/Alacant;All ages;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
03 Alicante/Alacant;All ages;Cohort October 1;Total;Survival in the third trimester;2020QII;""
03 Alicante/Alacant;All ages;Cohort October 1;Total;Survival in the third trimester;2020QI;""
03 Alicante/Alacant;All ages;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
03 Alicante/Alacant;All ages;Cohort October 1;Total;Survival in the third trimester;2022QIII;114.393
03 Alicante/Alacant;All ages;Cohort October 1;Total;Survival in the third trimester;2022QII;""
03 Alicante/Alacant;All ages;Cohort October 1;Total;Survival in the third trimester;2022QI;""
03 Alicante/Alacant;All ages;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
03 Alicante/Alacant;All ages;Cohort October 1;Total;Survival in the third trimester;2021QIII;113.176
03 Alicante/Alacant;All ages;Cohort October 1;Total;Survival in the third trimester;2021QII;""
03 Alicante/Alacant;All ages;Cohort October 1;Total;Survival in the third trimester;2021QI;""
03 Alicante/Alacant;All ages;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
03 Alicante/Alacant;All ages;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
03 Alicante/Alacant;All ages;Cohort October 1;Total;Survival in the third trimester;2020QII;""
03 Alicante/Alacant;All ages;Cohort October 1;Total;Survival in the third trimester;2020QI;""
03 Alicante/Alacant;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
03 Alicante/Alacant;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
03 Alicante/Alacant;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
03 Alicante/Alacant;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
03 Alicante/Alacant;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
03 Alicante/Alacant;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
03 Alicante/Alacant;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
03 Alicante/Alacant;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
03 Alicante/Alacant;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
03 Alicante/Alacant;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
03 Alicante/Alacant;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
03 Alicante/Alacant;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
03 Alicante/Alacant;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;95,65
03 Alicante/Alacant;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
03 Alicante/Alacant;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
03 Alicante/Alacant;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
03 Alicante/Alacant;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;95,93
03 Alicante/Alacant;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
03 Alicante/Alacant;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
03 Alicante/Alacant;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
03 Alicante/Alacant;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;95,79
03 Alicante/Alacant;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
03 Alicante/Alacant;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
03 Alicante/Alacant;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
03 Alicante/Alacant;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
03 Alicante/Alacant;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
03 Alicante/Alacant;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
03 Alicante/Alacant;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;92,66
03 Alicante/Alacant;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
03 Alicante/Alacant;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
03 Alicante/Alacant;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
03 Alicante/Alacant;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;93,11
03 Alicante/Alacant;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
03 Alicante/Alacant;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
03 Alicante/Alacant;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
03 Alicante/Alacant;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
03 Alicante/Alacant;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
03 Alicante/Alacant;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
03 Alicante/Alacant;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;89,65
03 Alicante/Alacant;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
03 Alicante/Alacant;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
03 Alicante/Alacant;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
03 Alicante/Alacant;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;90,42
03 Alicante/Alacant;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
03 Alicante/Alacant;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
03 Alicante/Alacant;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
03 Alicante/Alacant;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
03 Alicante/Alacant;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
03 Alicante/Alacant;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
03 Alicante/Alacant;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;87
03 Alicante/Alacant;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
03 Alicante/Alacant;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
03 Alicante/Alacant;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
03 Alicante/Alacant;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;87,97
03 Alicante/Alacant;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
03 Alicante/Alacant;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
03 Alicante/Alacant;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
03 Alicante/Alacant;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
03 Alicante/Alacant;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
03 Alicante/Alacant;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
03 Alicante/Alacant;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QIV;84.510
03 Alicante/Alacant;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
03 Alicante/Alacant;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
03 Alicante/Alacant;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
03 Alicante/Alacant;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QIV;83.953
03 Alicante/Alacant;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
03 Alicante/Alacant;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
03 Alicante/Alacant;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
03 Alicante/Alacant;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QIV;82.694
03 Alicante/Alacant;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
03 Alicante/Alacant;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
03 Alicante/Alacant;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
03 Alicante/Alacant;All ages;Cohort October 1;Males;Survival in the first trimester;2022QIV;81.040
03 Alicante/Alacant;All ages;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
03 Alicante/Alacant;All ages;Cohort October 1;Males;Survival in the first trimester;2022QII;""
03 Alicante/Alacant;All ages;Cohort October 1;Males;Survival in the first trimester;2022QI;""
03 Alicante/Alacant;All ages;Cohort October 1;Males;Survival in the first trimester;2021QIV;80.734
03 Alicante/Alacant;All ages;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
03 Alicante/Alacant;All ages;Cohort October 1;Males;Survival in the first trimester;2021QII;""
03 Alicante/Alacant;All ages;Cohort October 1;Males;Survival in the first trimester;2021QI;""
03 Alicante/Alacant;All ages;Cohort October 1;Males;Survival in the first trimester;2020QIV;79.393
03 Alicante/Alacant;All ages;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
03 Alicante/Alacant;All ages;Cohort October 1;Males;Survival in the first trimester;2020QII;""
03 Alicante/Alacant;All ages;Cohort October 1;Males;Survival in the first trimester;2020QI;""
03 Alicante/Alacant;All ages;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
03 Alicante/Alacant;All ages;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
03 Alicante/Alacant;All ages;Cohort October 1;Males;Survival in the second trimester;2022QII;""
03 Alicante/Alacant;All ages;Cohort October 1;Males;Survival in the second trimester;2022QI;78.158
03 Alicante/Alacant;All ages;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
03 Alicante/Alacant;All ages;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
03 Alicante/Alacant;All ages;Cohort October 1;Males;Survival in the second trimester;2021QII;""
03 Alicante/Alacant;All ages;Cohort October 1;Males;Survival in the second trimester;2021QI;77.299
03 Alicante/Alacant;All ages;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
03 Alicante/Alacant;All ages;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
03 Alicante/Alacant;All ages;Cohort October 1;Males;Survival in the second trimester;2020QII;""
03 Alicante/Alacant;All ages;Cohort October 1;Males;Survival in the second trimester;2020QI;""
03 Alicante/Alacant;All ages;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
03 Alicante/Alacant;All ages;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
03 Alicante/Alacant;All ages;Cohort October 1;Males;Survival in the third trimester;2022QII;75.843
03 Alicante/Alacant;All ages;Cohort October 1;Males;Survival in the third trimester;2022QI;""
03 Alicante/Alacant;All ages;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
03 Alicante/Alacant;All ages;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
03 Alicante/Alacant;All ages;Cohort October 1;Males;Survival in the third trimester;2021QII;75.223
03 Alicante/Alacant;All ages;Cohort October 1;Males;Survival in the third trimester;2021QI;""
03 Alicante/Alacant;All ages;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
03 Alicante/Alacant;All ages;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
03 Alicante/Alacant;All ages;Cohort October 1;Males;Survival in the third trimester;2020QII;""
03 Alicante/Alacant;All ages;Cohort October 1;Males;Survival in the third trimester;2020QI;""
03 Alicante/Alacant;All ages;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
03 Alicante/Alacant;All ages;Cohort October 1;Males;Survival in the third trimester;2022QIII;73.779
03 Alicante/Alacant;All ages;Cohort October 1;Males;Survival in the third trimester;2022QII;""
03 Alicante/Alacant;All ages;Cohort October 1;Males;Survival in the third trimester;2022QI;""
03 Alicante/Alacant;All ages;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
03 Alicante/Alacant;All ages;Cohort October 1;Males;Survival in the third trimester;2021QIII;73.276
03 Alicante/Alacant;All ages;Cohort October 1;Males;Survival in the third trimester;2021QII;""
03 Alicante/Alacant;All ages;Cohort October 1;Males;Survival in the third trimester;2021QI;""
03 Alicante/Alacant;All ages;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
03 Alicante/Alacant;All ages;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
03 Alicante/Alacant;All ages;Cohort October 1;Males;Survival in the third trimester;2020QII;""
03 Alicante/Alacant;All ages;Cohort October 1;Males;Survival in the third trimester;2020QI;""
03 Alicante/Alacant;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
03 Alicante/Alacant;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
03 Alicante/Alacant;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
03 Alicante/Alacant;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
03 Alicante/Alacant;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
03 Alicante/Alacant;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
03 Alicante/Alacant;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
03 Alicante/Alacant;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
03 Alicante/Alacant;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
03 Alicante/Alacant;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
03 Alicante/Alacant;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
03 Alicante/Alacant;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
03 Alicante/Alacant;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;95,89
03 Alicante/Alacant;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
03 Alicante/Alacant;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
03 Alicante/Alacant;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
03 Alicante/Alacant;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;96,17
03 Alicante/Alacant;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
03 Alicante/Alacant;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
03 Alicante/Alacant;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
03 Alicante/Alacant;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;96,01
03 Alicante/Alacant;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
03 Alicante/Alacant;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
03 Alicante/Alacant;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
03 Alicante/Alacant;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
03 Alicante/Alacant;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
03 Alicante/Alacant;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
03 Alicante/Alacant;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;93,1
03 Alicante/Alacant;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
03 Alicante/Alacant;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
03 Alicante/Alacant;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
03 Alicante/Alacant;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;93,48
03 Alicante/Alacant;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
03 Alicante/Alacant;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
03 Alicante/Alacant;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
03 Alicante/Alacant;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
03 Alicante/Alacant;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
03 Alicante/Alacant;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
03 Alicante/Alacant;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;90,34
03 Alicante/Alacant;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
03 Alicante/Alacant;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
03 Alicante/Alacant;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
03 Alicante/Alacant;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;90,97
03 Alicante/Alacant;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
03 Alicante/Alacant;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
03 Alicante/Alacant;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
03 Alicante/Alacant;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
03 Alicante/Alacant;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
03 Alicante/Alacant;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
03 Alicante/Alacant;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;87,88
03 Alicante/Alacant;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
03 Alicante/Alacant;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
03 Alicante/Alacant;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
03 Alicante/Alacant;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;88,61
03 Alicante/Alacant;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
03 Alicante/Alacant;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
03 Alicante/Alacant;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
03 Alicante/Alacant;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
03 Alicante/Alacant;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
03 Alicante/Alacant;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
03 Alicante/Alacant;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QIV;48.449
03 Alicante/Alacant;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
03 Alicante/Alacant;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
03 Alicante/Alacant;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
03 Alicante/Alacant;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QIV;47.537
03 Alicante/Alacant;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
03 Alicante/Alacant;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
03 Alicante/Alacant;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
03 Alicante/Alacant;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QIV;45.954
03 Alicante/Alacant;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
03 Alicante/Alacant;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
03 Alicante/Alacant;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
03 Alicante/Alacant;All ages;Cohort October 1;Females;Survival in the first trimester;2022QIV;46.139
03 Alicante/Alacant;All ages;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
03 Alicante/Alacant;All ages;Cohort October 1;Females;Survival in the first trimester;2022QII;""
03 Alicante/Alacant;All ages;Cohort October 1;Females;Survival in the first trimester;2022QI;""
03 Alicante/Alacant;All ages;Cohort October 1;Females;Survival in the first trimester;2021QIV;45.400
03 Alicante/Alacant;All ages;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
03 Alicante/Alacant;All ages;Cohort October 1;Females;Survival in the first trimester;2021QII;""
03 Alicante/Alacant;All ages;Cohort October 1;Females;Survival in the first trimester;2021QI;""
03 Alicante/Alacant;All ages;Cohort October 1;Females;Survival in the first trimester;2020QIV;43.844
03 Alicante/Alacant;All ages;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
03 Alicante/Alacant;All ages;Cohort October 1;Females;Survival in the first trimester;2020QII;""
03 Alicante/Alacant;All ages;Cohort October 1;Females;Survival in the first trimester;2020QI;""
03 Alicante/Alacant;All ages;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
03 Alicante/Alacant;All ages;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
03 Alicante/Alacant;All ages;Cohort October 1;Females;Survival in the second trimester;2022QII;""
03 Alicante/Alacant;All ages;Cohort October 1;Females;Survival in the second trimester;2022QI;43.684
03 Alicante/Alacant;All ages;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
03 Alicante/Alacant;All ages;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
03 Alicante/Alacant;All ages;Cohort October 1;Females;Survival in the second trimester;2021QII;""
03 Alicante/Alacant;All ages;Cohort October 1;Females;Survival in the second trimester;2021QI;42.491
03 Alicante/Alacant;All ages;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
03 Alicante/Alacant;All ages;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
03 Alicante/Alacant;All ages;Cohort October 1;Females;Survival in the second trimester;2020QII;""
03 Alicante/Alacant;All ages;Cohort October 1;Females;Survival in the second trimester;2020QI;""
03 Alicante/Alacant;All ages;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
03 Alicante/Alacant;All ages;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
03 Alicante/Alacant;All ages;Cohort October 1;Females;Survival in the third trimester;2022QII;42.036
03 Alicante/Alacant;All ages;Cohort October 1;Females;Survival in the third trimester;2022QI;""
03 Alicante/Alacant;All ages;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
03 Alicante/Alacant;All ages;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
03 Alicante/Alacant;All ages;Cohort October 1;Females;Survival in the third trimester;2021QII;41.106
03 Alicante/Alacant;All ages;Cohort October 1;Females;Survival in the third trimester;2021QI;""
03 Alicante/Alacant;All ages;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
03 Alicante/Alacant;All ages;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
03 Alicante/Alacant;All ages;Cohort October 1;Females;Survival in the third trimester;2020QII;""
03 Alicante/Alacant;All ages;Cohort October 1;Females;Survival in the third trimester;2020QI;""
03 Alicante/Alacant;All ages;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
03 Alicante/Alacant;All ages;Cohort October 1;Females;Survival in the third trimester;2022QIII;40.614
03 Alicante/Alacant;All ages;Cohort October 1;Females;Survival in the third trimester;2022QII;""
03 Alicante/Alacant;All ages;Cohort October 1;Females;Survival in the third trimester;2022QI;""
03 Alicante/Alacant;All ages;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
03 Alicante/Alacant;All ages;Cohort October 1;Females;Survival in the third trimester;2021QIII;39.900
03 Alicante/Alacant;All ages;Cohort October 1;Females;Survival in the third trimester;2021QII;""
03 Alicante/Alacant;All ages;Cohort October 1;Females;Survival in the third trimester;2021QI;""
03 Alicante/Alacant;All ages;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
03 Alicante/Alacant;All ages;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
03 Alicante/Alacant;All ages;Cohort October 1;Females;Survival in the third trimester;2020QII;""
03 Alicante/Alacant;All ages;Cohort October 1;Females;Survival in the third trimester;2020QI;""
03 Alicante/Alacant;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
03 Alicante/Alacant;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
03 Alicante/Alacant;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
03 Alicante/Alacant;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
03 Alicante/Alacant;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
03 Alicante/Alacant;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
03 Alicante/Alacant;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
03 Alicante/Alacant;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
03 Alicante/Alacant;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
03 Alicante/Alacant;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
03 Alicante/Alacant;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
03 Alicante/Alacant;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
03 Alicante/Alacant;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;95,23
03 Alicante/Alacant;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
03 Alicante/Alacant;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
03 Alicante/Alacant;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
03 Alicante/Alacant;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;95,5
03 Alicante/Alacant;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
03 Alicante/Alacant;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
03 Alicante/Alacant;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
03 Alicante/Alacant;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;95,41
03 Alicante/Alacant;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
03 Alicante/Alacant;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
03 Alicante/Alacant;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
03 Alicante/Alacant;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
03 Alicante/Alacant;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
03 Alicante/Alacant;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
03 Alicante/Alacant;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;91,89
03 Alicante/Alacant;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
03 Alicante/Alacant;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
03 Alicante/Alacant;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
03 Alicante/Alacant;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;92,46
03 Alicante/Alacant;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
03 Alicante/Alacant;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
03 Alicante/Alacant;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
03 Alicante/Alacant;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
03 Alicante/Alacant;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
03 Alicante/Alacant;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
03 Alicante/Alacant;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;88,43
03 Alicante/Alacant;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
03 Alicante/Alacant;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
03 Alicante/Alacant;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
03 Alicante/Alacant;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;89,45
03 Alicante/Alacant;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
03 Alicante/Alacant;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
03 Alicante/Alacant;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
03 Alicante/Alacant;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
03 Alicante/Alacant;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
03 Alicante/Alacant;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
03 Alicante/Alacant;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;85,44
03 Alicante/Alacant;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
03 Alicante/Alacant;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
03 Alicante/Alacant;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
03 Alicante/Alacant;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;86,83
03 Alicante/Alacant;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
03 Alicante/Alacant;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
03 Alicante/Alacant;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
03 Alicante/Alacant;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
03 Alicante/Alacant;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
03 Alicante/Alacant;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QI;8.449
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QI;8.095
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QI;6.569
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2022QII;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2022QI;7.777
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2021QII;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2021QI;7.555
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2020QII;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2020QI;5.677
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2022QII;7.211
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2022QI;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2021QII;7.053
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2021QI;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2020QII;5.470
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2020QI;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QIII;6.718
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QII;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QI;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QIII;6.598
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QII;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QI;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QIII;5.146
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QII;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QI;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QIV;6.261
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QII;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QI;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QIV;6.190
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QII;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QI;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QIV;4.834
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QII;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QI;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;92,05
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;93,33
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;86,42
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;85,35
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;87,13
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;83,27
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;79,51
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;81,51
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;78,34
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;74,1
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;76,47
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;73,59
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QI;5.262
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QI;5.071
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QI;4.160
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2022QII;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2022QI;4.861
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2021QII;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2021QI;4.753
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2020QII;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2020QI;3.625
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2022QII;4.525
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2022QI;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2021QII;4.457
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2021QI;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2020QII;3.510
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2020QI;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QIII;4.254
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QII;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QI;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QIII;4.188
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QII;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QI;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QIII;3.302
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QII;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QI;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QIV;3.968
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QII;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QI;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QIV;3.929
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QII;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QI;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QIV;3.112
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QII;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QI;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;92,38
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;93,73
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;87,14
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;85,99
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;87,89
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;84,38
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;80,84
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;82,59
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;79,38
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;75,41
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;77,48
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;74,81
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QI;3.187
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QI;3.024
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QI;2.409
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2022QII;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2022QI;2.916
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2021QII;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2021QI;2.802
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2020QII;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2020QI;2.052
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2022QII;2.686
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2022QI;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2021QII;2.596
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2021QI;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2020QII;1.960
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2020QI;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QIII;2.464
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QII;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QI;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QIII;2.410
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QII;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QI;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QIII;1.844
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QII;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QI;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QIV;2.293
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QII;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QI;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QIV;2.261
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QII;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QI;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QIV;1.722
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QII;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QI;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;91,5
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;92,66
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;85,18
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;84,28
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;85,85
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;81,36
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;77,31
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;79,7
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;76,55
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;71,95
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;74,77
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;71,48
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QII;7.639
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QII;7.222
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QII;6.741
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2022QII;7.034
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2022QI;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2021QII;6.650
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2021QI;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2020QII;6.459
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2020QI;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2022QIII;6.497
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2022QII;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2022QI;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2021QIII;6.162
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2021QII;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2021QI;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2020QIII;6.037
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2020QII;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2020QI;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QIV;5.993
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QII;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QI;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QIV;5.745
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QII;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QI;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QIV;5.649
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QII;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QI;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QII;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QI;5.344
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QII;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QI;5.354
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QII;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QI;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;92,08
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;92,08
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;95,82
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;85,05
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;85,32
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;89,56
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;78,45
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;79,55
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;83,8
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;74
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;79,42
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QII;4.767
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QII;4.557
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QII;4.304
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2022QII;4.397
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2022QI;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2021QII;4.212
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2021QI;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2020QII;4.137
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2020QI;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2022QIII;4.111
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2022QII;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2022QI;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2021QIII;3.924
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2021QII;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2021QI;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2020QIII;3.871
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2020QII;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2020QI;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QIV;3.803
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QII;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QI;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QIV;3.663
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QII;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QI;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QIV;3.629
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QII;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QI;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QII;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QI;3.424
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QII;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QI;3.451
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QII;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QI;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;92,24
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;92,43
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;96,12
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;86,24
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;86,11
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;89,94
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;79,78
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;80,38
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;84,32
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;75,14
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;80,18
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QII;2.872
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QII;2.665
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QII;2.437
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2022QII;2.637
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2022QI;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2021QII;2.438
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2021QI;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2020QII;2.322
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2020QI;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2022QIII;2.386
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2022QII;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2022QI;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2021QIII;2.238
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2021QII;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2021QI;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2020QIII;2.166
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2020QII;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2020QI;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QIV;2.190
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QII;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QI;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QIV;2.082
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QII;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QI;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QIV;2.020
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QII;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QI;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QII;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QI;1.920
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QII;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QI;1.903
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QII;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QI;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;91,82
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;91,48
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;95,28
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;83,08
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;83,98
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;88,88
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;76,25
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;78,12
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;82,89
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;72,05
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;78,09
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QIII;8.224
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QIII;7.840
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QIII;7.222
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2022QIII;7.484
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2022QII;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2022QI;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2021QIII;7.149
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2021QII;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2021QI;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2020QIII;6.644
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2020QII;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2020QI;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2022QIV;6.869
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2022QII;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2022QI;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2021QIV;6.607
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2021QII;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2021QI;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2020QIV;6.167
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2020QII;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2020QI;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QII;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QI;6.129
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QII;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QI;5.824
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QII;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QI;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QII;5.724
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QI;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QII;5.494
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QI;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QII;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QI;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;91
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;91,19
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;92
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;83,52
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;84,27
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;85,39
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;78,18
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;80,64
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;73,01
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;76,07
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QIII;5.157
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QIII;4.933
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QIII;4.640
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2022QIII;4.733
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2022QII;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2022QI;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2021QIII;4.509
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2021QII;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2021QI;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2020QIII;4.266
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2020QII;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2020QI;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2022QIV;4.358
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2022QII;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2022QI;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2021QIV;4.186
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2021QII;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2021QI;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2020QIV;3.963
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2020QII;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2020QI;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QII;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QI;3.900
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QII;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QI;3.756
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QII;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QI;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QII;3.664
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QI;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QII;3.555
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QI;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QII;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QI;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;91,78
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;91,4
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;91,94
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;84,51
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;84,86
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;85,41
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;79,06
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;80,95
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;74,28
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;76,62
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QIII;3.067
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QIII;2.907
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QIII;2.582
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2022QIII;2.751
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2022QII;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2022QI;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2021QIII;2.640
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2021QII;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2021QI;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2020QIII;2.378
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2020QII;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2020QI;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2022QIV;2.511
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2022QII;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2022QI;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2021QIV;2.421
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2021QII;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2021QI;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2020QIV;2.204
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2020QII;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2020QI;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QII;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QI;2.229
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QII;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QI;2.068
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QII;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QI;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QII;2.060
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QI;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QII;1.939
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QI;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QII;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QI;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;89,7
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;90,82
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;92,1
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;81,87
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;83,28
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;85,36
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;76,68
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;80,09
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;70,86
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;75,1
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QIV;8.403
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QIV;8.109
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QIV;7.690
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2022QIV;7.676
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2022QII;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2022QI;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2021QIV;7.442
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2021QII;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2021QI;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2020QIV;7.062
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2020QII;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2020QI;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2022QII;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2022QI;6.882
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2021QII;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2021QI;6.638
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2020QII;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2020QI;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QII;6.409
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QI;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QII;6.227
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QI;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QII;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QI;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QIII;6.003
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QII;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QI;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QIII;5.862
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QII;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QI;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QII;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QI;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;91,35
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;91,77
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;91,83
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;84,87
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;86,32
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;79,04
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;80,98
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;74,03
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;76,23
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QIV;5.274
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QIV;5.072
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QIV;4.880
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2022QIV;4.835
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2022QII;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2022QI;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2021QIV;4.670
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2021QII;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2021QI;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2020QIV;4.480
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2020QII;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2020QI;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2022QII;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2022QI;4.338
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2021QII;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2021QI;4.232
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2020QII;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2020QI;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QII;4.062
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QI;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QII;3.985
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QI;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QII;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QI;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QIII;3.842
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QII;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QI;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QIII;3.760
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QII;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QI;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QII;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QI;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;91,68
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;92,07
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;91,8
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;85,53
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;86,72
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;80,09
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;81,66
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;75,75
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;77,05
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QIV;3.129
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QIV;3.037
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QIV;2.810
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2022QIV;2.841
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2022QII;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2022QI;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2021QIV;2.772
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2021QII;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2021QI;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2020QIV;2.582
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2020QII;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2020QI;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2022QII;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2022QI;2.544
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2021QII;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2021QI;2.406
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2020QII;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2020QI;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QII;2.347
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QI;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QII;2.242
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QI;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QII;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QI;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QIII;2.161
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QII;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QI;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QIII;2.102
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QII;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QI;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QII;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QI;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;90,8
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;91,27
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;91,89
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;83,77
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;85,62
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;77,28
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;79,79
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;71,16
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;74,8
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QI;23.646
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QI;23.564
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QI;22.746
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2022QII;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2022QI;22.569
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2021QII;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2021QI;22.766
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2020QII;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2020QI;20.868
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2022QII;21.602
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2022QI;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2021QII;21.943
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2021QI;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2020QII;20.354
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2020QI;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QIII;20.806
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QII;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QI;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QIII;21.210
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QII;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QI;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QIII;19.622
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QII;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QI;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QIV;19.975
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QII;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QI;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QIV;20.432
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QII;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QI;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QIV;18.857
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QII;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QI;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;95,45
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;96,61
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;91,74
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;91,36
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;93,12
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;89,48
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;87,99
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;90,01
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;86,27
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;84,48
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;86,71
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;82,9
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QI;14.246
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QI;14.394
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QI;13.785
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2022QII;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2022QI;13.601
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2021QII;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2021QI;13.915
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2020QII;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2020QI;12.754
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2022QII;13.056
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2022QI;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2021QII;13.438
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2021QI;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2020QII;12.476
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2020QI;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QIII;12.606
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QII;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QI;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QIII;13.013
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QII;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QI;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QIII;12.072
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QII;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QI;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QIV;12.116
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QII;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QI;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QIV;12.548
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QII;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QI;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QIV;11.640
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QII;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QI;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;95,47
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;96,67
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;92,52
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;91,65
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;93,36
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;90,5
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;88,49
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;90,41
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;87,57
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;85,05
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;87,18
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;84,44
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QI;9.400
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QI;9.170
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QI;8.961
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2022QII;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2022QI;8.968
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2021QII;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2021QI;8.851
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2020QII;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2020QI;8.114
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2022QII;8.546
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2022QI;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2021QII;8.505
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2021QI;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2020QII;7.878
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2020QI;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QIII;8.200
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QII;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QI;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QIII;8.197
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QII;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QI;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QIII;7.550
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QII;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QI;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QIV;7.859
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QII;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QI;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QIV;7.884
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QII;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QI;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QIV;7.217
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QII;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QI;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;95,4
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;96,52
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;90,55
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;90,91
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;92,75
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;87,91
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;87,23
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;89,39
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;84,25
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;83,61
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;85,98
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;80,54
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QII;22.274
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QII;22.334
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QII;22.501
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2022QII;21.213
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2022QI;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2021QII;21.436
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2021QI;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2020QII;21.917
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2020QI;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2022QIII;20.359
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2022QII;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2022QI;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2021QIII;20.648
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2021QII;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2021QI;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2020QIII;21.057
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2020QII;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2020QI;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QIV;19.475
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QII;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QI;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QIV;19.805
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QII;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QI;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QIV;20.169
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QII;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QI;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QII;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QI;19.039
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QII;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QI;19.608
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QII;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QI;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;95,24
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;95,98
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;97,4
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;91,4
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;92,45
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;93,58
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;87,43
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;88,68
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;89,64
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;85,25
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;87,14
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QII;13.334
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QII;13.531
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QII;13.702
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2022QII;12.722
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2022QI;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2021QII;13.024
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2021QI;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2020QII;13.381
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2020QI;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2022QIII;12.221
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2022QII;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2022QI;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2021QIII;12.565
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2021QII;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2021QI;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2020QIII;12.908
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2020QII;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2020QI;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QIV;11.714
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QII;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QI;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QIV;12.078
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QII;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QI;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QIV;12.402
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QII;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QI;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QII;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QI;11.618
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QII;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QI;12.068
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QII;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QI;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;95,41
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;96,25
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;97,66
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;91,65
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;92,86
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;94,21
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;87,85
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;89,26
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;90,51
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;85,86
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;88,07
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QII;8.940
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QII;8.803
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QII;8.799
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2022QII;8.491
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2022QI;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2021QII;8.412
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2021QI;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2020QII;8.536
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2020QI;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2022QIII;8.138
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2022QII;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2022QI;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2021QIII;8.083
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2021QII;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2021QI;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2020QIII;8.149
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2020QII;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2020QI;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QIV;7.761
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QII;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QI;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QIV;7.727
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QII;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QI;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QIV;7.767
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QII;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QI;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QII;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QI;7.421
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QII;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QI;7.540
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QII;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QI;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;94,98
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;95,56
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;97,01
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;91,03
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;91,82
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;92,61
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;86,81
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;87,78
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;88,27
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;84,3
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;85,69
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QIII;22.751
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QIII;22.978
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QIII;23.069
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2022QIII;21.725
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2022QII;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2022QI;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2021QIII;22.020
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2021QII;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2021QI;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2020QIII;22.051
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2020QII;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2020QI;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2022QIV;20.706
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2022QII;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2022QI;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2021QIV;21.056
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2021QII;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2021QI;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2020QIV;21.068
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2020QII;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2020QI;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QII;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QI;20.201
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QII;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QI;20.453
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QII;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QI;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QII;19.452
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QI;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QII;19.820
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QI;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QII;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QI;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;95,49
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;95,83
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;95,59
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;91,01
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;91,64
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;91,33
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;87,91
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;88,66
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;84,65
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;85,92
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QIII;13.567
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QIII;13.918
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QIII;14.128
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2022QIII;12.969
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2022QII;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2022QI;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2021QIII;13.355
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2021QII;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2021QI;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2020QIII;13.544
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2020QII;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2020QI;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2022QIV;12.384
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2022QII;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2022QI;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2021QIV;12.792
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2021QII;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2021QI;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2020QIV;12.968
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2020QII;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2020QI;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QII;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QI;12.276
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QII;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QI;12.603
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QII;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QI;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QII;11.849
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QI;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QII;12.235
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QI;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QII;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QI;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;95,59
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;95,95
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;95,87
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;91,28
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;91,91
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;91,79
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;88,2
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;89,21
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;85,13
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;86,6
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QIII;9.184
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QIII;9.060
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QIII;8.941
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2022QIII;8.756
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2022QII;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2022QI;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2021QIII;8.665
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2021QII;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2021QI;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2020QIII;8.507
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2020QII;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2020QI;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2022QIV;8.322
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2022QII;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2022QI;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2021QIV;8.264
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2021QII;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2021QI;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2020QIV;8.100
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2020QII;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2020QI;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QII;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QI;7.925
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QII;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QI;7.850
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QII;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QI;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QII;7.603
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QI;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QII;7.585
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QI;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QII;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QI;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;95,34
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;95,64
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;95,15
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;90,61
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;91,21
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;90,59
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;87,47
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;87,8
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;83,92
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;84,83
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QIV;22.976
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QIV;23.348
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QIV;23.369
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2022QIV;21.850
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2022QII;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2022QI;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2021QIV;22.251
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2021QII;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2021QI;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2020QIV;22.240
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2020QII;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2020QI;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2022QII;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2022QI;21.312
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2021QII;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2021QI;21.546
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2020QII;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2020QI;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QII;20.469
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QI;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QII;20.823
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QI;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QII;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QI;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QIII;19.763
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QII;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QI;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QIII;20.176
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QII;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QI;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QII;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QI;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;95,1
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;95,3
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;95,17
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;91,28
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;92,2
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;87,67
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;89,11
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;84,65
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;86,34
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QIV;13.667
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QIV;14.104
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QIV;14.309
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2022QIV;13.016
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2022QII;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2022QI;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2021QIV;13.453
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2021QII;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2021QI;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2020QIV;13.640
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2020QII;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2020QI;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2022QII;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2022QI;12.887
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2021QII;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2021QI;13.225
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2020QII;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2020QI;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QII;12.408
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QI;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QII;12.804
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QI;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QII;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QI;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QIII;12.007
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QII;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QI;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QIII;12.433
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QII;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QI;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QII;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QI;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;95,24
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;95,38
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;95,32
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;91,37
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;92,42
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;87,98
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;89,48
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;85,13
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;86,89
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QIV;9.309
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QIV;9.244
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QIV;9.060
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2022QIV;8.834
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2022QII;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2022QI;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2021QIV;8.798
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2021QII;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2021QI;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2020QIV;8.600
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2020QII;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2020QI;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2022QII;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2022QI;8.425
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2021QII;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2021QI;8.321
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2020QII;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2020QI;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QII;8.061
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QI;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QII;8.019
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QI;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QII;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QI;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QIII;7.756
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QII;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QI;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QIII;7.743
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QII;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QI;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QII;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QI;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;94,9
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;95,18
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;94,92
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;91,14
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;91,84
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;87,2
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;88,51
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;83,9
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;85,46
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QI;41.441
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QI;41.099
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QI;41.023
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2022QII;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2022QI;40.095
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2021QII;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2021QI;40.082
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2020QII;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2020QI;38.141
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2022QII;38.849
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2022QI;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2021QII;38.990
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2021QI;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2020QII;37.393
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2020QI;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QIII;37.813
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QII;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QI;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QIII;38.044
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QII;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QI;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QIII;36.372
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QII;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QI;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QIV;36.748
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QII;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QI;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QIV;37.050
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QII;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QI;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QIV;35.369
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QII;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QI;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;96,75
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;97,53
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;92,97
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;93,75
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;94,87
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;91,15
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;91,25
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;92,57
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;88,66
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;88,68
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;90,15
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;86,22
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QI;26.412
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QI;26.407
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QI;26.324
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2022QII;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2022QI;25.641
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2021QII;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2021QI;25.801
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2020QII;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2020QI;24.613
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2022QII;24.950
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2022QI;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2021QII;25.145
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2021QI;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2020QII;24.172
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2020QI;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QIII;24.328
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QII;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QI;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QIII;24.540
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QII;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QI;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QIII;23.571
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QII;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QI;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QIV;23.685
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QII;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QI;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QIV;23.952
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QII;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QI;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QIV;22.959
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QII;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QI;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;97,08
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;97,71
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;93,5
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;94,46
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;95,22
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;91,82
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;92,11
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;92,93
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;89,54
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;89,68
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;90,7
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;87,22
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QI;15.029
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QI;14.692
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QI;14.699
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2022QII;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2022QI;14.454
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2021QII;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2021QI;14.281
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2020QII;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2020QI;13.528
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2022QII;13.899
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2022QI;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2021QII;13.845
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2021QI;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2020QII;13.221
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2020QI;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QIII;13.485
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QII;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QI;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QIII;13.504
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QII;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QI;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QIII;12.801
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QII;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QI;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QIV;13.063
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QII;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QI;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QIV;13.098
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QII;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QI;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QIV;12.410
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QII;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QI;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;96,17
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;97,2
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;92,03
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;92,48
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;94,23
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;89,94
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;89,73
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;91,91
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;87,09
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;86,92
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;89,15
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;84,43
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QII;40.787
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QII;40.701
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QII;40.145
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2022QII;39.402
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2022QI;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2021QII;39.466
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2021QI;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2020QII;39.324
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2020QI;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2022QIII;38.239
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2022QII;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2022QI;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2021QIII;38.380
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2021QII;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2021QI;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2020QIII;38.144
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2020QII;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2020QI;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QIV;37.057
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QII;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QI;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QIV;37.257
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QII;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QI;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QIV;36.993
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QII;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QI;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QII;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QI;36.254
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QII;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QI;36.245
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QII;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QI;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;96,6
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;96,97
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;97,95
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;93,75
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;94,3
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;95,02
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;90,85
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;91,54
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;92,15
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;89,07
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;90,29
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QII;25.903
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QII;26.105
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QII;25.790
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2022QII;25.136
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2022QI;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2021QII;25.358
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2021QI;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2020QII;25.301
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2020QI;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2022QIII;24.432
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2022QII;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2022QI;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2021QIII;24.670
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2021QII;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2021QI;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2020QIII;24.606
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2020QII;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2020QI;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QIV;23.724
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QII;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QI;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QIV;24.000
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QII;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QI;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QIV;23.910
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QII;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QI;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QII;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QI;23.438
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QII;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QI;23.470
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QII;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QI;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;97,04
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;97,14
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;98,1
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;94,32
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;94,5
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;95,41
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;91,59
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;91,94
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;92,71
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;89,78
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;91
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QII;14.884
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QII;14.596
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QII;14.355
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2022QII;14.266
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2022QI;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2021QII;14.108
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2021QI;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2020QII;14.023
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2020QI;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2022QIII;13.807
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2022QII;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2022QI;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2021QIII;13.710
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2021QII;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2021QI;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2020QIII;13.538
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2020QII;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2020QI;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QIV;13.333
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QII;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QI;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QIV;13.257
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QII;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QI;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QIV;13.083
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QII;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QI;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QII;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QI;12.816
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QII;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QI;12.775
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QII;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QI;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;95,85
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;96,66
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;97,69
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;92,76
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;93,93
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;94,31
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;89,58
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;90,83
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;91,14
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;87,8
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;88,99
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QIII;41.130
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QIII;41.188
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QIII;40.974
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2022QIII;39.729
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2022QII;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2022QI;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2021QIII;39.871
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2021QII;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2021QI;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2020QIII;39.557
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2020QII;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2020QI;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2022QIV;38.384
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2022QII;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2022QI;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2021QIV;38.569
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2021QII;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2021QI;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2020QIV;38.245
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2020QII;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2020QI;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QII;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QI;37.475
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QII;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QI;37.433
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QII;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QI;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QII;36.506
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QI;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QII;36.569
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QI;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QII;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QI;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;96,59
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;96,8
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;96,54
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;93,32
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;93,64
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;93,34
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;90,99
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;91,36
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;88,63
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;89,25
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QIII;26.113
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QIII;26.371
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QIII;26.374
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2022QIII;25.273
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2022QII;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2022QI;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2021QIII;25.544
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2021QII;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2021QI;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2020QIII;25.517
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2020QII;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2020QI;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2022QIV;24.475
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2022QII;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2022QI;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2021QIV;24.773
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2021QII;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2021QI;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2020QIV;24.726
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2020QII;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2020QI;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QII;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QI;24.156
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QII;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QI;24.245
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QII;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QI;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QII;23.608
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QI;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QII;23.714
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QI;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QII;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QI;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;96,78
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;96,86
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;96,75
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;93,73
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;93,94
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;93,75
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;91,6
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;91,93
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;89,52
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;89,91
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QIII;15.017
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QIII;14.817
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QIII;14.600
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2022QIII;14.456
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2022QII;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2022QI;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2021QIII;14.327
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2021QII;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2021QI;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2020QIII;14.040
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2020QII;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2020QI;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2022QIV;13.909
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2022QII;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2022QI;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2021QIV;13.796
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2021QII;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2021QI;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2020QIV;13.519
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2020QII;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2020QI;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QII;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QI;13.319
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QII;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QI;13.188
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QII;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QI;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QII;12.898
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QI;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QII;12.855
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QI;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QII;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QI;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;96,26
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;96,69
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;96,16
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;92,62
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;93,11
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;92,6
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;89,89
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;90,33
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;87,05
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;88,05
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QIV;41.071
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QIV;41.290
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QIV;41.061
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2022QIV;39.571
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2022QII;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2022QI;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2021QIV;39.825
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2021QII;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2021QI;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2020QIV;39.568
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2020QII;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2020QI;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2022QII;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2022QI;38.641
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2021QII;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2021QI;38.680
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2020QII;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2020QI;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QII;37.563
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QI;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QII;37.724
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QI;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QII;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QI;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QIII;36.621
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QII;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QI;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QIII;36.876
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QII;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QI;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QII;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QI;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;96,35
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;96,45
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;96,36
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;93,58
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;94,2
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;90,97
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;91,87
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;88,69
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;89,81
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QIV;26.053
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QIV;26.357
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QIV;26.381
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2022QIV;25.165
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2022QII;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2022QI;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2021QIV;25.484
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2021QII;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2021QI;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2020QIV;25.489
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2020QII;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2020QI;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2022QII;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2022QI;24.812
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2021QII;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2021QI;24.962
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2020QII;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2020QI;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QII;24.203
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QI;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QII;24.388
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QI;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QII;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QI;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QIII;23.640
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QII;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QI;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QIII;23.849
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QII;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QI;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QII;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QI;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;96,59
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;96,69
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;96,62
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;94,14
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;94,62
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;91,83
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;92,45
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;89,69
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;90,4
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QIV;15.018
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QIV;14.933
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QIV;14.680
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2022QIV;14.406
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2022QII;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2022QI;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2021QIV;14.341
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2021QII;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2021QI;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2020QIV;14.079
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2020QII;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2020QI;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2022QII;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2022QI;13.829
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2021QII;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2021QI;13.718
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2020QII;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2020QI;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QII;13.360
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QI;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QII;13.336
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QI;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QII;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QI;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QIII;12.981
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QII;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QI;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QIII;13.027
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QII;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QI;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QII;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QI;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;95,92
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;96,04
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;95,91
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;92,61
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;93,45
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;89,47
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;90,84
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;86,93
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;88,74
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QI;39.505
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QI;38.281
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QI;38.711
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2022QII;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2022QI;38.536
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2021QII;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2021QI;37.438
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2020QII;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2020QI;36.637
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2022QII;37.534
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2022QI;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2021QII;36.621
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2021QI;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2020QII;36.022
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2020QI;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QIII;36.748
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QII;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QI;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QIII;35.948
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QII;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QI;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QIII;35.197
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QII;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QI;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QIV;35.858
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QII;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QI;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QIV;35.149
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QII;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QI;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QIV;34.420
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QII;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QI;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;97,55
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;97,8
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;94,64
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;95,01
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;95,66
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;93,05
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;93,02
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;93,91
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;90,92
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;90,77
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;91,82
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;88,92
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QI;25.663
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QI;25.053
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QI;25.252
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2022QII;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2022QI;25.081
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2021QII;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2021QI;24.535
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2020QII;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2020QI;24.033
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2022QII;24.493
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2022QI;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2021QII;24.046
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2021QI;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2020QII;23.667
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2020QI;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QIII;24.014
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QII;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QI;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QIII;23.629
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QII;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QI;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QIII;23.198
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QII;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QI;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QIV;23.507
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QII;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QI;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QIV;23.131
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QII;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QI;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QIV;22.734
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QII;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QI;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;97,73
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;97,93
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;95,17
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;95,44
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;95,98
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;93,72
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;93,57
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;94,32
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;91,87
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;91,6
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;92,33
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;90,03
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QI;13.842
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QI;13.228
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QI;13.459
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2022QII;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2022QI;13.455
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2021QII;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2021QI;12.903
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2020QII;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2020QI;12.604
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2022QII;13.041
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2022QI;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2021QII;12.575
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2021QI;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2020QII;12.355
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2020QI;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QIII;12.734
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QII;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QI;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QIII;12.319
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QII;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QI;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QIII;11.999
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QII;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QI;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QIV;12.351
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QII;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QI;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QIV;12.018
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QII;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QI;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QIV;11.686
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QII;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QI;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;97,2
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;97,54
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;93,65
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;94,21
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;95,06
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;91,8
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;92
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;93,13
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;89,15
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;89,23
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;90,85
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;86,83
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QII;40.535
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QII;39.498
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QII;38.112
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2022QII;39.394
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2022QI;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2021QII;38.547
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2021QI;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2020QII;37.446
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2020QI;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2022QIII;38.475
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2022QII;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2022QI;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2021QIII;37.787
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2021QII;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2021QI;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2020QIII;36.474
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2020QII;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2020QI;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QIV;37.464
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QII;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QI;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QIV;36.885
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QII;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QI;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QIV;35.601
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QII;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QI;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QII;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QI;36.137
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QII;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QI;34.988
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QII;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QI;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;97,19
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;97,59
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;98,25
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;94,92
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;95,67
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;95,7
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;92,42
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;93,38
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;93,41
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;91,49
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;91,8
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QII;26.274
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QII;25.780
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QII;24.930
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2022QII;25.618
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2022QI;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2021QII;25.202
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2021QI;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2020QII;24.526
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2020QI;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2022QIII;25.050
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2022QII;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2022QI;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2021QIII;24.727
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2021QII;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2021QI;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2020QIII;23.958
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2020QII;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2020QI;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QIV;24.472
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QII;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QI;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QIV;24.165
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QII;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QI;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QIV;23.435
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QII;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QI;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QII;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QI;23.722
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QII;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QI;23.063
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QII;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QI;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;97,5
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;97,76
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;98,38
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;95,34
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;95,92
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;96,1
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;93,14
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;93,74
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;94
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;92,02
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;92,51
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QII;14.261
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QII;13.718
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QII;13.182
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2022QII;13.776
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2022QI;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2021QII;13.345
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2021QI;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2020QII;12.920
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2020QI;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2022QIII;13.425
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2022QII;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2022QI;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2021QIII;13.060
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2021QII;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2021QI;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2020QIII;12.516
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2020QII;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2020QI;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QIV;12.992
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QII;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QI;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QIV;12.720
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QII;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QI;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QIV;12.166
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QII;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QI;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QII;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QI;12.415
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QII;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QI;11.925
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QII;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QI;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;96,6
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;97,28
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;98,01
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;94,14
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;95,2
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;94,95
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;91,1
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;92,72
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;92,29
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;90,5
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;90,46
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QIII;40.603
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QIII;39.733
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QIII;38.529
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2022QIII;39.484
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2022QII;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2022QI;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2021QIII;38.774
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2021QII;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2021QI;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2020QIII;37.390
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2020QII;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2020QI;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2022QIV;38.326
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2022QII;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2022QI;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2021QIV;37.751
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2021QII;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2021QI;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2020QIV;36.407
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2020QII;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2020QI;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QII;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QI;36.954
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QII;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QI;35.755
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QII;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QI;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QII;36.129
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QI;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QII;35.080
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QI;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QII;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QI;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;97,24
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;97,59
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;97,04
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;94,39
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;95,01
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;94,49
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;93,01
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;92,8
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;90,93
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;91,05
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QIII;26.322
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QIII;25.858
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QIII;25.231
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2022QIII;25.630
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2022QII;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2022QI;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2021QIII;25.275
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2021QII;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2021QI;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2020QIII;24.562
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2020QII;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2020QI;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2022QIV;24.971
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2022QII;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2022QI;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2021QIV;24.645
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2021QII;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2021QI;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2020QIV;23.968
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2020QII;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2020QI;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QII;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QI;24.176
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QII;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QI;23.570
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QII;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QI;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QII;23.689
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QI;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QII;23.159
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QI;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QII;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QI;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;97,37
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;97,75
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;97,35
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;94,87
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;95,31
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;94,99
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;93,5
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;93,42
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;91,61
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;91,79
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QIII;14.281
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QIII;13.875
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QIII;13.298
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2022QIII;13.854
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2022QII;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2022QI;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2021QIII;13.499
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2021QII;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2021QI;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2020QIII;12.828
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2020QII;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2020QI;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2022QIV;13.355
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2022QII;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2022QI;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2021QIV;13.106
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2021QII;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2021QI;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2020QIV;12.439
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2020QII;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2020QI;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QII;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QI;12.778
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QII;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QI;12.185
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QII;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QI;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QII;12.440
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QI;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QII;11.921
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QI;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QII;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QI;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;97,01
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;97,29
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;96,47
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;93,52
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;94,46
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;93,54
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;92,09
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;91,63
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;89,66
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;89,65
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QIV;40.307
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QIV;39.686
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QIV;38.402
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2022QIV;39.067
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2022QII;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2022QI;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2021QIV;38.524
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2021QII;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2021QI;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2020QIV;37.278
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2020QII;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2020QI;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2022QII;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2022QI;37.652
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2021QII;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2021QI;36.541
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2020QII;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2020QI;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QII;36.765
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QI;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QII;35.814
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QI;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QII;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QI;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QIII;36.036
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QII;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QI;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QIII;35.189
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QII;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QI;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QII;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QI;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;96,92
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;97,07
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;97,07
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;94,87
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;95,15
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;92,64
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;93,26
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;90,8
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;91,63
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QIV;26.123
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QIV;25.802
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QIV;25.144
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2022QIV;25.413
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2022QII;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2022QI;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2021QIV;25.095
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2021QII;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2021QI;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2020QIV;24.468
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2020QII;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2020QI;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2022QII;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2022QI;24.580
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2021QII;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2021QI;24.022
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2020QII;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2020QI;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QII;24.060
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QI;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QII;23.584
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QI;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QII;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QI;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QIII;23.612
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QII;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QI;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QIII;23.199
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QII;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QI;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QII;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QI;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;97,28
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;97,26
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;97,31
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;95,26
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;95,54
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;93,25
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;93,8
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;91,51
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;92,26
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QIV;14.184
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QIV;13.884
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QIV;13.258
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2022QIV;13.654
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2022QII;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2022QI;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2021QIV;13.429
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2021QII;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2021QI;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2020QIV;12.810
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2020QII;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2020QI;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2022QII;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2022QI;13.072
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2021QII;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2021QI;12.519
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2020QII;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2020QI;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QII;12.705
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QI;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QII;12.230
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QI;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QII;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QI;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QIII;12.424
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QII;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QI;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QIII;11.990
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QII;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QI;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QII;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QI;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;96,26
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;96,72
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;96,62
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;94,15
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;94,43
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;91,51
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;92,25
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;89,48
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;90,44
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QI;18.385
03 Alicante/Alacant;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QI;17.365
03 Alicante/Alacant;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QI;19.946
03 Alicante/Alacant;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2022QII;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2022QI;17.615
03 Alicante/Alacant;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2021QII;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2021QI;16.624
03 Alicante/Alacant;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2020QII;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2020QI;18.447
03 Alicante/Alacant;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2022QII;16.892
03 Alicante/Alacant;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2022QI;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2021QII;15.954
03 Alicante/Alacant;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2021QI;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2020QII;17.809
03 Alicante/Alacant;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2020QI;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QIII;16.173
03 Alicante/Alacant;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QII;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QI;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QIII;15.260
03 Alicante/Alacant;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QII;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QI;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QIII;17.015
03 Alicante/Alacant;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QII;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QI;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QIV;15.203
03 Alicante/Alacant;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QII;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QI;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QIV;14.511
03 Alicante/Alacant;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QII;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QI;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QIV;16.135
03 Alicante/Alacant;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QII;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QI;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
03 Alicante/Alacant;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
03 Alicante/Alacant;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
03 Alicante/Alacant;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;95,81
03 Alicante/Alacant;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;95,73
03 Alicante/Alacant;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;92,48
03 Alicante/Alacant;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;91,88
03 Alicante/Alacant;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;91,87
03 Alicante/Alacant;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;89,29
03 Alicante/Alacant;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;87,97
03 Alicante/Alacant;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;87,88
03 Alicante/Alacant;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;85,31
03 Alicante/Alacant;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;82,69
03 Alicante/Alacant;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;83,56
03 Alicante/Alacant;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;80,89
03 Alicante/Alacant;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QI;12.209
03 Alicante/Alacant;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QI;11.472
03 Alicante/Alacant;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QI;13.193
03 Alicante/Alacant;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2022QII;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2022QI;11.691
03 Alicante/Alacant;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2021QII;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2021QI;10.989
03 Alicante/Alacant;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2020QII;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2020QI;12.226
03 Alicante/Alacant;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2022QII;11.239
03 Alicante/Alacant;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2022QI;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2021QII;10.576
03 Alicante/Alacant;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2021QI;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2020QII;11.817
03 Alicante/Alacant;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2020QI;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QIII;10.796
03 Alicante/Alacant;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QII;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QI;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QIII;10.136
03 Alicante/Alacant;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QII;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QI;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QIII;11.284
03 Alicante/Alacant;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QII;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QI;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QIV;10.151
03 Alicante/Alacant;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QII;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QI;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QIV;9.678
03 Alicante/Alacant;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QII;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QI;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QIV;10.727
03 Alicante/Alacant;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QII;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QI;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
03 Alicante/Alacant;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
03 Alicante/Alacant;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
03 Alicante/Alacant;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;95,76
03 Alicante/Alacant;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;95,79
03 Alicante/Alacant;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;92,67
03 Alicante/Alacant;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;92,06
03 Alicante/Alacant;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;92,19
03 Alicante/Alacant;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;89,57
03 Alicante/Alacant;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;88,43
03 Alicante/Alacant;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;88,35
03 Alicante/Alacant;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;85,53
03 Alicante/Alacant;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;83,14
03 Alicante/Alacant;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;84,36
03 Alicante/Alacant;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;81,31
03 Alicante/Alacant;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QI;6.176
03 Alicante/Alacant;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QI;5.893
03 Alicante/Alacant;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QI;6.753
03 Alicante/Alacant;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2022QII;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2022QI;5.924
03 Alicante/Alacant;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2021QII;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2021QI;5.635
03 Alicante/Alacant;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2020QII;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2020QI;6.221
03 Alicante/Alacant;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2022QII;5.653
03 Alicante/Alacant;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2022QI;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2021QII;5.378
03 Alicante/Alacant;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2021QI;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2020QII;5.992
03 Alicante/Alacant;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2020QI;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QIII;5.377
03 Alicante/Alacant;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QII;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QI;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QIII;5.124
03 Alicante/Alacant;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QII;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QI;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QIII;5.731
03 Alicante/Alacant;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QII;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QI;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QIV;5.052
03 Alicante/Alacant;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QII;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QI;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QIV;4.833
03 Alicante/Alacant;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QII;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QI;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QIV;5.408
03 Alicante/Alacant;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QII;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QI;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
03 Alicante/Alacant;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
03 Alicante/Alacant;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
03 Alicante/Alacant;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;95,92
03 Alicante/Alacant;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;95,62
03 Alicante/Alacant;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;92,12
03 Alicante/Alacant;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;91,53
03 Alicante/Alacant;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;91,26
03 Alicante/Alacant;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;88,73
03 Alicante/Alacant;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;87,06
03 Alicante/Alacant;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;86,95
03 Alicante/Alacant;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;84,87
03 Alicante/Alacant;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;81,8
03 Alicante/Alacant;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;82,01
03 Alicante/Alacant;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;80,08
03 Alicante/Alacant;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QII;21.168
03 Alicante/Alacant;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QII;19.989
03 Alicante/Alacant;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QII;19.031
03 Alicante/Alacant;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2022QII;20.326
03 Alicante/Alacant;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2022QI;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2021QII;19.228
03 Alicante/Alacant;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2021QI;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2020QII;18.353
03 Alicante/Alacant;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2020QI;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2022QIII;19.532
03 Alicante/Alacant;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2022QII;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2022QI;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2021QIII;18.441
03 Alicante/Alacant;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2021QII;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2021QI;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2020QIII;17.475
03 Alicante/Alacant;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2020QII;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2020QI;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QIV;18.447
03 Alicante/Alacant;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QII;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QI;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QIV;17.601
03 Alicante/Alacant;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QII;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QI;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QIV;16.552
03 Alicante/Alacant;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QII;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QI;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QII;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QI;16.907
03 Alicante/Alacant;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QII;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QI;15.898
03 Alicante/Alacant;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QII;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QI;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
03 Alicante/Alacant;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
03 Alicante/Alacant;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
03 Alicante/Alacant;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;96,02
03 Alicante/Alacant;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;96,19
03 Alicante/Alacant;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;96,44
03 Alicante/Alacant;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;92,27
03 Alicante/Alacant;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;92,26
03 Alicante/Alacant;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;91,82
03 Alicante/Alacant;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;87,15
03 Alicante/Alacant;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;88,05
03 Alicante/Alacant;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;86,97
03 Alicante/Alacant;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;84,58
03 Alicante/Alacant;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;83,54
03 Alicante/Alacant;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QII;14.015
03 Alicante/Alacant;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QII;13.209
03 Alicante/Alacant;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QII;12.574
03 Alicante/Alacant;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2022QII;13.487
03 Alicante/Alacant;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2022QI;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2021QII;12.737
03 Alicante/Alacant;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2021QI;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2020QII;12.140
03 Alicante/Alacant;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2020QI;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2022QIII;12.999
03 Alicante/Alacant;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2022QII;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2022QI;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2021QIII;12.241
03 Alicante/Alacant;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2021QII;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2021QI;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2020QIII;11.549
03 Alicante/Alacant;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2020QII;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2020QI;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QIV;12.284
03 Alicante/Alacant;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QII;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QI;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QIV;11.730
03 Alicante/Alacant;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QII;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QI;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QIV;10.965
03 Alicante/Alacant;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QII;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QI;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QII;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QI;11.269
03 Alicante/Alacant;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QII;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QI;10.547
03 Alicante/Alacant;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QII;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QI;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
03 Alicante/Alacant;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
03 Alicante/Alacant;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
03 Alicante/Alacant;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;96,23
03 Alicante/Alacant;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;96,43
03 Alicante/Alacant;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;96,55
03 Alicante/Alacant;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;92,75
03 Alicante/Alacant;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;92,67
03 Alicante/Alacant;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;91,85
03 Alicante/Alacant;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;87,65
03 Alicante/Alacant;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;88,8
03 Alicante/Alacant;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;87,2
03 Alicante/Alacant;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;85,31
03 Alicante/Alacant;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;83,88
03 Alicante/Alacant;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QII;7.153
03 Alicante/Alacant;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QII;6.780
03 Alicante/Alacant;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QII;6.457
03 Alicante/Alacant;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2022QII;6.839
03 Alicante/Alacant;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2022QI;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2021QII;6.491
03 Alicante/Alacant;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2021QI;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2020QII;6.213
03 Alicante/Alacant;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2020QI;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2022QIII;6.533
03 Alicante/Alacant;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2022QII;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2022QI;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2021QIII;6.200
03 Alicante/Alacant;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2021QII;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2021QI;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2020QIII;5.926
03 Alicante/Alacant;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2020QII;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2020QI;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QIV;6.163
03 Alicante/Alacant;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QII;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QI;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QIV;5.871
03 Alicante/Alacant;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QII;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QI;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QIV;5.587
03 Alicante/Alacant;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QII;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QI;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QII;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QI;5.638
03 Alicante/Alacant;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QII;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QI;5.351
03 Alicante/Alacant;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QII;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QI;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
03 Alicante/Alacant;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
03 Alicante/Alacant;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
03 Alicante/Alacant;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;95,61
03 Alicante/Alacant;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;95,74
03 Alicante/Alacant;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;96,22
03 Alicante/Alacant;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;91,33
03 Alicante/Alacant;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;91,45
03 Alicante/Alacant;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;91,78
03 Alicante/Alacant;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;86,16
03 Alicante/Alacant;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;86,59
03 Alicante/Alacant;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;86,53
03 Alicante/Alacant;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;83,16
03 Alicante/Alacant;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;82,87
03 Alicante/Alacant;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QIII;20.789
03 Alicante/Alacant;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QIII;19.655
03 Alicante/Alacant;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QIII;18.695
03 Alicante/Alacant;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2022QIII;19.891
03 Alicante/Alacant;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2022QII;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2022QI;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2021QIII;18.784
03 Alicante/Alacant;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2021QII;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2021QI;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2020QIII;17.746
03 Alicante/Alacant;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2020QII;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2020QI;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2022QIV;18.744
03 Alicante/Alacant;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2022QII;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2022QI;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2021QIV;17.882
03 Alicante/Alacant;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2021QII;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2021QI;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2020QIV;16.779
03 Alicante/Alacant;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2020QII;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2020QI;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QII;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QI;17.164
03 Alicante/Alacant;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QII;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QI;16.109
03 Alicante/Alacant;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QII;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QI;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QII;16.497
03 Alicante/Alacant;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QI;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QII;15.488
03 Alicante/Alacant;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QI;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QII;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QI;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
03 Alicante/Alacant;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
03 Alicante/Alacant;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
03 Alicante/Alacant;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;95,68
03 Alicante/Alacant;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;95,57
03 Alicante/Alacant;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;94,92
03 Alicante/Alacant;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;90,16
03 Alicante/Alacant;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;90,98
03 Alicante/Alacant;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;89,75
03 Alicante/Alacant;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;87,33
03 Alicante/Alacant;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;86,17
03 Alicante/Alacant;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;83,93
03 Alicante/Alacant;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;82,85
03 Alicante/Alacant;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QIII;13.757
03 Alicante/Alacant;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QIII;12.993
03 Alicante/Alacant;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QIII;12.364
03 Alicante/Alacant;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2022QIII;13.208
03 Alicante/Alacant;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2022QII;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2022QI;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2021QIII;12.451
03 Alicante/Alacant;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2021QII;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2021QI;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2020QIII;11.732
03 Alicante/Alacant;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2020QII;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2020QI;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2022QIV;12.455
03 Alicante/Alacant;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2022QII;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2022QI;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2021QIV;11.906
03 Alicante/Alacant;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2021QII;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2021QI;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2020QIV;11.119
03 Alicante/Alacant;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2020QII;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2020QI;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QII;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QI;11.431
03 Alicante/Alacant;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QII;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QI;10.688
03 Alicante/Alacant;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QII;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QI;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QII;11.008
03 Alicante/Alacant;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QI;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QII;10.300
03 Alicante/Alacant;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QI;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QII;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QI;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
03 Alicante/Alacant;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
03 Alicante/Alacant;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
03 Alicante/Alacant;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;96,01
03 Alicante/Alacant;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;95,83
03 Alicante/Alacant;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;94,89
03 Alicante/Alacant;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;90,54
03 Alicante/Alacant;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;91,63
03 Alicante/Alacant;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;89,93
03 Alicante/Alacant;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;87,98
03 Alicante/Alacant;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;86,44
03 Alicante/Alacant;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;84,72
03 Alicante/Alacant;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;83,31
03 Alicante/Alacant;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QIII;7.032
03 Alicante/Alacant;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QIII;6.662
03 Alicante/Alacant;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QIII;6.331
03 Alicante/Alacant;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2022QIII;6.683
03 Alicante/Alacant;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2022QII;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2022QI;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2021QIII;6.333
03 Alicante/Alacant;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2021QII;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2021QI;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2020QIII;6.014
03 Alicante/Alacant;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2020QII;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2020QI;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2022QIV;6.289
03 Alicante/Alacant;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2022QII;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2022QI;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2021QIV;5.976
03 Alicante/Alacant;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2021QII;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2021QI;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2020QIV;5.660
03 Alicante/Alacant;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2020QII;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2020QI;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QII;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QI;5.733
03 Alicante/Alacant;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QII;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QI;5.421
03 Alicante/Alacant;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QII;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QI;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QII;5.489
03 Alicante/Alacant;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QI;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QII;5.188
03 Alicante/Alacant;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QI;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QII;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QI;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
03 Alicante/Alacant;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
03 Alicante/Alacant;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
03 Alicante/Alacant;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;95,04
03 Alicante/Alacant;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;95,06
03 Alicante/Alacant;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;94,99
03 Alicante/Alacant;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;89,43
03 Alicante/Alacant;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;89,7
03 Alicante/Alacant;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;89,4
03 Alicante/Alacant;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;86,06
03 Alicante/Alacant;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;85,63
03 Alicante/Alacant;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;82,39
03 Alicante/Alacant;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;81,95
03 Alicante/Alacant;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QIV;20.202
03 Alicante/Alacant;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QIV;19.057
03 Alicante/Alacant;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QIV;18.126
03 Alicante/Alacant;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2022QIV;19.015
03 Alicante/Alacant;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2022QII;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2022QI;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2021QIV;18.092
03 Alicante/Alacant;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2021QII;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2021QI;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2020QIV;17.089
03 Alicante/Alacant;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2020QII;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2020QI;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2022QII;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2022QI;17.355
03 Alicante/Alacant;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2021QII;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2021QI;16.385
03 Alicante/Alacant;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2020QII;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2020QI;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QII;16.673
03 Alicante/Alacant;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QI;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QII;15.741
03 Alicante/Alacant;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QI;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QII;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QI;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QIII;15.970
03 Alicante/Alacant;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QII;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QI;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QIII;15.073
03 Alicante/Alacant;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QII;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QI;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QII;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QI;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
03 Alicante/Alacant;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
03 Alicante/Alacant;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
03 Alicante/Alacant;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;94,12
03 Alicante/Alacant;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;94,94
03 Alicante/Alacant;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;94,28
03 Alicante/Alacant;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;91,07
03 Alicante/Alacant;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;90,4
03 Alicante/Alacant;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;87,49
03 Alicante/Alacant;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;86,84
03 Alicante/Alacant;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;83,8
03 Alicante/Alacant;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;83,16
03 Alicante/Alacant;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QIV;13.393
03 Alicante/Alacant;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QIV;12.618
03 Alicante/Alacant;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QIV;11.980
03 Alicante/Alacant;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2022QIV;12.611
03 Alicante/Alacant;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2022QII;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2022QI;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2021QIV;12.032
03 Alicante/Alacant;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2021QII;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2021QI;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2020QIV;11.316
03 Alicante/Alacant;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2020QII;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2020QI;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2022QII;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2022QI;11.541
03 Alicante/Alacant;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2021QII;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2021QI;10.858
03 Alicante/Alacant;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2020QII;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2020QI;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QII;11.110
03 Alicante/Alacant;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QI;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QII;10.462
03 Alicante/Alacant;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QI;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QII;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QI;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QIII;10.678
03 Alicante/Alacant;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QII;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QI;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QIII;10.035
03 Alicante/Alacant;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QII;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QI;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QII;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QI;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
03 Alicante/Alacant;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
03 Alicante/Alacant;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
03 Alicante/Alacant;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;94,16
03 Alicante/Alacant;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;95,36
03 Alicante/Alacant;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;94,46
03 Alicante/Alacant;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;91,46
03 Alicante/Alacant;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;90,63
03 Alicante/Alacant;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;88,05
03 Alicante/Alacant;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;87,33
03 Alicante/Alacant;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;84,63
03 Alicante/Alacant;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;83,76
03 Alicante/Alacant;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QIV;6.809
03 Alicante/Alacant;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QIV;6.439
03 Alicante/Alacant;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QIV;6.146
03 Alicante/Alacant;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2022QIV;6.404
03 Alicante/Alacant;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2022QII;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2022QI;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2021QIV;6.060
03 Alicante/Alacant;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2021QII;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2021QI;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2020QIV;5.773
03 Alicante/Alacant;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2020QII;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2020QI;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2022QII;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2022QI;5.814
03 Alicante/Alacant;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2021QII;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2021QI;5.527
03 Alicante/Alacant;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2020QII;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2020QI;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QII;5.563
03 Alicante/Alacant;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QI;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QII;5.279
03 Alicante/Alacant;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QI;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QII;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QI;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QIII;5.292
03 Alicante/Alacant;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QII;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QI;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QIII;5.038
03 Alicante/Alacant;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QII;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QI;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QII;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QI;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
03 Alicante/Alacant;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
03 Alicante/Alacant;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
03 Alicante/Alacant;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;94,05
03 Alicante/Alacant;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;94,11
03 Alicante/Alacant;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;93,93
03 Alicante/Alacant;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;90,29
03 Alicante/Alacant;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;89,93
03 Alicante/Alacant;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;86,4
03 Alicante/Alacant;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;85,89
03 Alicante/Alacant;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;82,19
03 Alicante/Alacant;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;81,97
03 Alicante/Alacant;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
04 Almería;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
04 Almería;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
04 Almería;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
04 Almería;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QI;40.889
04 Almería;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
04 Almería;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
04 Almería;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
04 Almería;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QI;40.118
04 Almería;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
04 Almería;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
04 Almería;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
04 Almería;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QI;39.813
04 Almería;All ages;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
04 Almería;All ages;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
04 Almería;All ages;Cohort January 1;Total;Survival in the first trimester;2022QII;""
04 Almería;All ages;Cohort January 1;Total;Survival in the first trimester;2022QI;39.555
04 Almería;All ages;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
04 Almería;All ages;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
04 Almería;All ages;Cohort January 1;Total;Survival in the first trimester;2021QII;""
04 Almería;All ages;Cohort January 1;Total;Survival in the first trimester;2021QI;38.973
04 Almería;All ages;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
04 Almería;All ages;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
04 Almería;All ages;Cohort January 1;Total;Survival in the first trimester;2020QII;""
04 Almería;All ages;Cohort January 1;Total;Survival in the first trimester;2020QI;37.337
04 Almería;All ages;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
04 Almería;All ages;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
04 Almería;All ages;Cohort January 1;Total;Survival in the second trimester;2022QII;38.296
04 Almería;All ages;Cohort January 1;Total;Survival in the second trimester;2022QI;""
04 Almería;All ages;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
04 Almería;All ages;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
04 Almería;All ages;Cohort January 1;Total;Survival in the second trimester;2021QII;37.859
04 Almería;All ages;Cohort January 1;Total;Survival in the second trimester;2021QI;""
04 Almería;All ages;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
04 Almería;All ages;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
04 Almería;All ages;Cohort January 1;Total;Survival in the second trimester;2020QII;36.548
04 Almería;All ages;Cohort January 1;Total;Survival in the second trimester;2020QI;""
04 Almería;All ages;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
04 Almería;All ages;Cohort January 1;Total;Survival in the third trimester;2022QIII;37.075
04 Almería;All ages;Cohort January 1;Total;Survival in the third trimester;2022QII;""
04 Almería;All ages;Cohort January 1;Total;Survival in the third trimester;2022QI;""
04 Almería;All ages;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
04 Almería;All ages;Cohort January 1;Total;Survival in the third trimester;2021QIII;36.841
04 Almería;All ages;Cohort January 1;Total;Survival in the third trimester;2021QII;""
04 Almería;All ages;Cohort January 1;Total;Survival in the third trimester;2021QI;""
04 Almería;All ages;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
04 Almería;All ages;Cohort January 1;Total;Survival in the third trimester;2020QIII;35.507
04 Almería;All ages;Cohort January 1;Total;Survival in the third trimester;2020QII;""
04 Almería;All ages;Cohort January 1;Total;Survival in the third trimester;2020QI;""
04 Almería;All ages;Cohort January 1;Total;Survival in the third trimester;2022QIV;35.809
04 Almería;All ages;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
04 Almería;All ages;Cohort January 1;Total;Survival in the third trimester;2022QII;""
04 Almería;All ages;Cohort January 1;Total;Survival in the third trimester;2022QI;""
04 Almería;All ages;Cohort January 1;Total;Survival in the third trimester;2021QIV;35.748
04 Almería;All ages;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
04 Almería;All ages;Cohort January 1;Total;Survival in the third trimester;2021QII;""
04 Almería;All ages;Cohort January 1;Total;Survival in the third trimester;2021QI;""
04 Almería;All ages;Cohort January 1;Total;Survival in the third trimester;2020QIV;34.508
04 Almería;All ages;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
04 Almería;All ages;Cohort January 1;Total;Survival in the third trimester;2020QII;""
04 Almería;All ages;Cohort January 1;Total;Survival in the third trimester;2020QI;""
04 Almería;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
04 Almería;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
04 Almería;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
04 Almería;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
04 Almería;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
04 Almería;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
04 Almería;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
04 Almería;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
04 Almería;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
04 Almería;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
04 Almería;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
04 Almería;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
04 Almería;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
04 Almería;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
04 Almería;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
04 Almería;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;96,74
04 Almería;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
04 Almería;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
04 Almería;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
04 Almería;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;97,15
04 Almería;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
04 Almería;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
04 Almería;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
04 Almería;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;93,78
04 Almería;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
04 Almería;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
04 Almería;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;93,66
04 Almería;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
04 Almería;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
04 Almería;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
04 Almería;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;94,37
04 Almería;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
04 Almería;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
04 Almería;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
04 Almería;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;91,8
04 Almería;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
04 Almería;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
04 Almería;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;90,67
04 Almería;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
04 Almería;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
04 Almería;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
04 Almería;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;91,83
04 Almería;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
04 Almería;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
04 Almería;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
04 Almería;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;89,18
04 Almería;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
04 Almería;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
04 Almería;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;87,58
04 Almería;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
04 Almería;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
04 Almería;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
04 Almería;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;89,11
04 Almería;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
04 Almería;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
04 Almería;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
04 Almería;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;86,68
04 Almería;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
04 Almería;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
04 Almería;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
04 Almería;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
04 Almería;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
04 Almería;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
04 Almería;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QI;25.531
04 Almería;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
04 Almería;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
04 Almería;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
04 Almería;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QI;25.237
04 Almería;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
04 Almería;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
04 Almería;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
04 Almería;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QI;24.871
04 Almería;All ages;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
04 Almería;All ages;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
04 Almería;All ages;Cohort January 1;Males;Survival in the first trimester;2022QII;""
04 Almería;All ages;Cohort January 1;Males;Survival in the first trimester;2022QI;24.735
04 Almería;All ages;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
04 Almería;All ages;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
04 Almería;All ages;Cohort January 1;Males;Survival in the first trimester;2021QII;""
04 Almería;All ages;Cohort January 1;Males;Survival in the first trimester;2021QI;24.532
04 Almería;All ages;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
04 Almería;All ages;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
04 Almería;All ages;Cohort January 1;Males;Survival in the first trimester;2020QII;""
04 Almería;All ages;Cohort January 1;Males;Survival in the first trimester;2020QI;23.407
04 Almería;All ages;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
04 Almería;All ages;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
04 Almería;All ages;Cohort January 1;Males;Survival in the second trimester;2022QII;24.016
04 Almería;All ages;Cohort January 1;Males;Survival in the second trimester;2022QI;""
04 Almería;All ages;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
04 Almería;All ages;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
04 Almería;All ages;Cohort January 1;Males;Survival in the second trimester;2021QII;23.840
04 Almería;All ages;Cohort January 1;Males;Survival in the second trimester;2021QI;""
04 Almería;All ages;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
04 Almería;All ages;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
04 Almería;All ages;Cohort January 1;Males;Survival in the second trimester;2020QII;22.951
04 Almería;All ages;Cohort January 1;Males;Survival in the second trimester;2020QI;""
04 Almería;All ages;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
04 Almería;All ages;Cohort January 1;Males;Survival in the third trimester;2022QIII;23.307
04 Almería;All ages;Cohort January 1;Males;Survival in the third trimester;2022QII;""
04 Almería;All ages;Cohort January 1;Males;Survival in the third trimester;2022QI;""
04 Almería;All ages;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
04 Almería;All ages;Cohort January 1;Males;Survival in the third trimester;2021QIII;23.233
04 Almería;All ages;Cohort January 1;Males;Survival in the third trimester;2021QII;""
04 Almería;All ages;Cohort January 1;Males;Survival in the third trimester;2021QI;""
04 Almería;All ages;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
04 Almería;All ages;Cohort January 1;Males;Survival in the third trimester;2020QIII;22.376
04 Almería;All ages;Cohort January 1;Males;Survival in the third trimester;2020QII;""
04 Almería;All ages;Cohort January 1;Males;Survival in the third trimester;2020QI;""
04 Almería;All ages;Cohort January 1;Males;Survival in the third trimester;2022QIV;22.541
04 Almería;All ages;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
04 Almería;All ages;Cohort January 1;Males;Survival in the third trimester;2022QII;""
04 Almería;All ages;Cohort January 1;Males;Survival in the third trimester;2022QI;""
04 Almería;All ages;Cohort January 1;Males;Survival in the third trimester;2021QIV;22.574
04 Almería;All ages;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
04 Almería;All ages;Cohort January 1;Males;Survival in the third trimester;2021QII;""
04 Almería;All ages;Cohort January 1;Males;Survival in the third trimester;2021QI;""
04 Almería;All ages;Cohort January 1;Males;Survival in the third trimester;2020QIV;21.798
04 Almería;All ages;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
04 Almería;All ages;Cohort January 1;Males;Survival in the third trimester;2020QII;""
04 Almería;All ages;Cohort January 1;Males;Survival in the third trimester;2020QI;""
04 Almería;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
04 Almería;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
04 Almería;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
04 Almería;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
04 Almería;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
04 Almería;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
04 Almería;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
04 Almería;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
04 Almería;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
04 Almería;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
04 Almería;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
04 Almería;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
04 Almería;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
04 Almería;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
04 Almería;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
04 Almería;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;96,88
04 Almería;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
04 Almería;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
04 Almería;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
04 Almería;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;97,21
04 Almería;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
04 Almería;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
04 Almería;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
04 Almería;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;94,11
04 Almería;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
04 Almería;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
04 Almería;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;94,07
04 Almería;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
04 Almería;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
04 Almería;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
04 Almería;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;94,46
04 Almería;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
04 Almería;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
04 Almería;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
04 Almería;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;92,28
04 Almería;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
04 Almería;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
04 Almería;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;91,29
04 Almería;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
04 Almería;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
04 Almería;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
04 Almería;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;92,06
04 Almería;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
04 Almería;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
04 Almería;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
04 Almería;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;89,97
04 Almería;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
04 Almería;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
04 Almería;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;88,29
04 Almería;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
04 Almería;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
04 Almería;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
04 Almería;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;89,45
04 Almería;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
04 Almería;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
04 Almería;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
04 Almería;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;87,64
04 Almería;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
04 Almería;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
04 Almería;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
04 Almería;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
04 Almería;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
04 Almería;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
04 Almería;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QI;15.358
04 Almería;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
04 Almería;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
04 Almería;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
04 Almería;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QI;14.881
04 Almería;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
04 Almería;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
04 Almería;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
04 Almería;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QI;14.942
04 Almería;All ages;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
04 Almería;All ages;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
04 Almería;All ages;Cohort January 1;Females;Survival in the first trimester;2022QII;""
04 Almería;All ages;Cohort January 1;Females;Survival in the first trimester;2022QI;14.820
04 Almería;All ages;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
04 Almería;All ages;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
04 Almería;All ages;Cohort January 1;Females;Survival in the first trimester;2021QII;""
04 Almería;All ages;Cohort January 1;Females;Survival in the first trimester;2021QI;14.441
04 Almería;All ages;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
04 Almería;All ages;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
04 Almería;All ages;Cohort January 1;Females;Survival in the first trimester;2020QII;""
04 Almería;All ages;Cohort January 1;Females;Survival in the first trimester;2020QI;13.930
04 Almería;All ages;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
04 Almería;All ages;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
04 Almería;All ages;Cohort January 1;Females;Survival in the second trimester;2022QII;14.280
04 Almería;All ages;Cohort January 1;Females;Survival in the second trimester;2022QI;""
04 Almería;All ages;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
04 Almería;All ages;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
04 Almería;All ages;Cohort January 1;Females;Survival in the second trimester;2021QII;14.019
04 Almería;All ages;Cohort January 1;Females;Survival in the second trimester;2021QI;""
04 Almería;All ages;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
04 Almería;All ages;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
04 Almería;All ages;Cohort January 1;Females;Survival in the second trimester;2020QII;13.597
04 Almería;All ages;Cohort January 1;Females;Survival in the second trimester;2020QI;""
04 Almería;All ages;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
04 Almería;All ages;Cohort January 1;Females;Survival in the third trimester;2022QIII;13.768
04 Almería;All ages;Cohort January 1;Females;Survival in the third trimester;2022QII;""
04 Almería;All ages;Cohort January 1;Females;Survival in the third trimester;2022QI;""
04 Almería;All ages;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
04 Almería;All ages;Cohort January 1;Females;Survival in the third trimester;2021QIII;13.608
04 Almería;All ages;Cohort January 1;Females;Survival in the third trimester;2021QII;""
04 Almería;All ages;Cohort January 1;Females;Survival in the third trimester;2021QI;""
04 Almería;All ages;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
04 Almería;All ages;Cohort January 1;Females;Survival in the third trimester;2020QIII;13.131
04 Almería;All ages;Cohort January 1;Females;Survival in the third trimester;2020QII;""
04 Almería;All ages;Cohort January 1;Females;Survival in the third trimester;2020QI;""
04 Almería;All ages;Cohort January 1;Females;Survival in the third trimester;2022QIV;13.268
04 Almería;All ages;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
04 Almería;All ages;Cohort January 1;Females;Survival in the third trimester;2022QII;""
04 Almería;All ages;Cohort January 1;Females;Survival in the third trimester;2022QI;""
04 Almería;All ages;Cohort January 1;Females;Survival in the third trimester;2021QIV;13.174
04 Almería;All ages;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
04 Almería;All ages;Cohort January 1;Females;Survival in the third trimester;2021QII;""
04 Almería;All ages;Cohort January 1;Females;Survival in the third trimester;2021QI;""
04 Almería;All ages;Cohort January 1;Females;Survival in the third trimester;2020QIV;12.710
04 Almería;All ages;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
04 Almería;All ages;Cohort January 1;Females;Survival in the third trimester;2020QII;""
04 Almería;All ages;Cohort January 1;Females;Survival in the third trimester;2020QI;""
04 Almería;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
04 Almería;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
04 Almería;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
04 Almería;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
04 Almería;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
04 Almería;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
04 Almería;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
04 Almería;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
04 Almería;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
04 Almería;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
04 Almería;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
04 Almería;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
04 Almería;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
04 Almería;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
04 Almería;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
04 Almería;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;96,5
04 Almería;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
04 Almería;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
04 Almería;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
04 Almería;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;97,04
04 Almería;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
04 Almería;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
04 Almería;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
04 Almería;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;93,23
04 Almería;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
04 Almería;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
04 Almería;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;92,98
04 Almería;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
04 Almería;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
04 Almería;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
04 Almería;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;94,21
04 Almería;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
04 Almería;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
04 Almería;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
04 Almería;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;91
04 Almería;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
04 Almería;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
04 Almería;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;89,65
04 Almería;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
04 Almería;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
04 Almería;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
04 Almería;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;91,45
04 Almería;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
04 Almería;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
04 Almería;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
04 Almería;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;87,88
04 Almería;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
04 Almería;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
04 Almería;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;86,39
04 Almería;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
04 Almería;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
04 Almería;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
04 Almería;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;88,53
04 Almería;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
04 Almería;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
04 Almería;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
04 Almería;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;85,06
04 Almería;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
04 Almería;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
04 Almería;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
04 Almería;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
04 Almería;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
04 Almería;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QII;41.079
04 Almería;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
04 Almería;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
04 Almería;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
04 Almería;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QII;40.472
04 Almería;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
04 Almería;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
04 Almería;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
04 Almería;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QII;39.124
04 Almería;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
04 Almería;All ages;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
04 Almería;All ages;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
04 Almería;All ages;Cohort April 1;Total;Survival in the first trimester;2022QII;39.673
04 Almería;All ages;Cohort April 1;Total;Survival in the first trimester;2022QI;""
04 Almería;All ages;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
04 Almería;All ages;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
04 Almería;All ages;Cohort April 1;Total;Survival in the first trimester;2021QII;39.203
04 Almería;All ages;Cohort April 1;Total;Survival in the first trimester;2021QI;""
04 Almería;All ages;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
04 Almería;All ages;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
04 Almería;All ages;Cohort April 1;Total;Survival in the first trimester;2020QII;38.244
04 Almería;All ages;Cohort April 1;Total;Survival in the first trimester;2020QI;""
04 Almería;All ages;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
04 Almería;All ages;Cohort April 1;Total;Survival in the second trimester;2022QIII;38.338
04 Almería;All ages;Cohort April 1;Total;Survival in the second trimester;2022QII;""
04 Almería;All ages;Cohort April 1;Total;Survival in the second trimester;2022QI;""
04 Almería;All ages;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
04 Almería;All ages;Cohort April 1;Total;Survival in the second trimester;2021QIII;38.053
04 Almería;All ages;Cohort April 1;Total;Survival in the second trimester;2021QII;""
04 Almería;All ages;Cohort April 1;Total;Survival in the second trimester;2021QI;""
04 Almería;All ages;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
04 Almería;All ages;Cohort April 1;Total;Survival in the second trimester;2020QIII;37.055
04 Almería;All ages;Cohort April 1;Total;Survival in the second trimester;2020QII;""
04 Almería;All ages;Cohort April 1;Total;Survival in the second trimester;2020QI;""
04 Almería;All ages;Cohort April 1;Total;Survival in the third trimester;2022QIV;36.947
04 Almería;All ages;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
04 Almería;All ages;Cohort April 1;Total;Survival in the third trimester;2022QII;""
04 Almería;All ages;Cohort April 1;Total;Survival in the third trimester;2022QI;""
04 Almería;All ages;Cohort April 1;Total;Survival in the third trimester;2021QIV;36.869
04 Almería;All ages;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
04 Almería;All ages;Cohort April 1;Total;Survival in the third trimester;2021QII;""
04 Almería;All ages;Cohort April 1;Total;Survival in the third trimester;2021QI;""
04 Almería;All ages;Cohort April 1;Total;Survival in the third trimester;2020QIV;35.938
04 Almería;All ages;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
04 Almería;All ages;Cohort April 1;Total;Survival in the third trimester;2020QII;""
04 Almería;All ages;Cohort April 1;Total;Survival in the third trimester;2020QI;""
04 Almería;All ages;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
04 Almería;All ages;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
04 Almería;All ages;Cohort April 1;Total;Survival in the third trimester;2022QII;""
04 Almería;All ages;Cohort April 1;Total;Survival in the third trimester;2022QI;35.847
04 Almería;All ages;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
04 Almería;All ages;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
04 Almería;All ages;Cohort April 1;Total;Survival in the third trimester;2021QII;""
04 Almería;All ages;Cohort April 1;Total;Survival in the third trimester;2021QI;35.124
04 Almería;All ages;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
04 Almería;All ages;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
04 Almería;All ages;Cohort April 1;Total;Survival in the third trimester;2020QII;""
04 Almería;All ages;Cohort April 1;Total;Survival in the third trimester;2020QI;""
04 Almería;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
04 Almería;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
04 Almería;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
04 Almería;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
04 Almería;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
04 Almería;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
04 Almería;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
04 Almería;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
04 Almería;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
04 Almería;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
04 Almería;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
04 Almería;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
04 Almería;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
04 Almería;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
04 Almería;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;96,58
04 Almería;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
04 Almería;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
04 Almería;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
04 Almería;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;96,86
04 Almería;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
04 Almería;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
04 Almería;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
04 Almería;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;97,75
04 Almería;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
04 Almería;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
04 Almería;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;93,33
04 Almería;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
04 Almería;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
04 Almería;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
04 Almería;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;94,02
04 Almería;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
04 Almería;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
04 Almería;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
04 Almería;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;94,71
04 Almería;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
04 Almería;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
04 Almería;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;89,94
04 Almería;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
04 Almería;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
04 Almería;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
04 Almería;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;91,1
04 Almería;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
04 Almería;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
04 Almería;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
04 Almería;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;91,86
04 Almería;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
04 Almería;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
04 Almería;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
04 Almería;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
04 Almería;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
04 Almería;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
04 Almería;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;88,57
04 Almería;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
04 Almería;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
04 Almería;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
04 Almería;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;89,78
04 Almería;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
04 Almería;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
04 Almería;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
04 Almería;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
04 Almería;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
04 Almería;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
04 Almería;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QII;25.612
04 Almería;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
04 Almería;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
04 Almería;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
04 Almería;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QII;25.464
04 Almería;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
04 Almería;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
04 Almería;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
04 Almería;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QII;24.496
04 Almería;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
04 Almería;All ages;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
04 Almería;All ages;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
04 Almería;All ages;Cohort April 1;Males;Survival in the first trimester;2022QII;24.808
04 Almería;All ages;Cohort April 1;Males;Survival in the first trimester;2022QI;""
04 Almería;All ages;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
04 Almería;All ages;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
04 Almería;All ages;Cohort April 1;Males;Survival in the first trimester;2021QII;24.660
04 Almería;All ages;Cohort April 1;Males;Survival in the first trimester;2021QI;""
04 Almería;All ages;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
04 Almería;All ages;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
04 Almería;All ages;Cohort April 1;Males;Survival in the first trimester;2020QII;23.981
04 Almería;All ages;Cohort April 1;Males;Survival in the first trimester;2020QI;""
04 Almería;All ages;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
04 Almería;All ages;Cohort April 1;Males;Survival in the second trimester;2022QIII;24.034
04 Almería;All ages;Cohort April 1;Males;Survival in the second trimester;2022QII;""
04 Almería;All ages;Cohort April 1;Males;Survival in the second trimester;2022QI;""
04 Almería;All ages;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
04 Almería;All ages;Cohort April 1;Males;Survival in the second trimester;2021QIII;23.971
04 Almería;All ages;Cohort April 1;Males;Survival in the second trimester;2021QII;""
04 Almería;All ages;Cohort April 1;Males;Survival in the second trimester;2021QI;""
04 Almería;All ages;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
04 Almería;All ages;Cohort April 1;Males;Survival in the second trimester;2020QIII;23.307
04 Almería;All ages;Cohort April 1;Males;Survival in the second trimester;2020QII;""
04 Almería;All ages;Cohort April 1;Males;Survival in the second trimester;2020QI;""
04 Almería;All ages;Cohort April 1;Males;Survival in the third trimester;2022QIV;23.191
04 Almería;All ages;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
04 Almería;All ages;Cohort April 1;Males;Survival in the third trimester;2022QII;""
04 Almería;All ages;Cohort April 1;Males;Survival in the third trimester;2022QI;""
04 Almería;All ages;Cohort April 1;Males;Survival in the third trimester;2021QIV;23.256
04 Almería;All ages;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
04 Almería;All ages;Cohort April 1;Males;Survival in the third trimester;2021QII;""
04 Almería;All ages;Cohort April 1;Males;Survival in the third trimester;2021QI;""
04 Almería;All ages;Cohort April 1;Males;Survival in the third trimester;2020QIV;22.655
04 Almería;All ages;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
04 Almería;All ages;Cohort April 1;Males;Survival in the third trimester;2020QII;""
04 Almería;All ages;Cohort April 1;Males;Survival in the third trimester;2020QI;""
04 Almería;All ages;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
04 Almería;All ages;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
04 Almería;All ages;Cohort April 1;Males;Survival in the third trimester;2022QII;""
04 Almería;All ages;Cohort April 1;Males;Survival in the third trimester;2022QI;22.652
04 Almería;All ages;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
04 Almería;All ages;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
04 Almería;All ages;Cohort April 1;Males;Survival in the third trimester;2021QII;""
04 Almería;All ages;Cohort April 1;Males;Survival in the third trimester;2021QI;22.163
04 Almería;All ages;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
04 Almería;All ages;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
04 Almería;All ages;Cohort April 1;Males;Survival in the third trimester;2020QII;""
04 Almería;All ages;Cohort April 1;Males;Survival in the third trimester;2020QI;""
04 Almería;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
04 Almería;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
04 Almería;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
04 Almería;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
04 Almería;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
04 Almería;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
04 Almería;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
04 Almería;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
04 Almería;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
04 Almería;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
04 Almería;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
04 Almería;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
04 Almería;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
04 Almería;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
04 Almería;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;96,86
04 Almería;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
04 Almería;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
04 Almería;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
04 Almería;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;96,84
04 Almería;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
04 Almería;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
04 Almería;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
04 Almería;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;97,9
04 Almería;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
04 Almería;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
04 Almería;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;93,84
04 Almería;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
04 Almería;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
04 Almería;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
04 Almería;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;94,14
04 Almería;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
04 Almería;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
04 Almería;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
04 Almería;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;95,15
04 Almería;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
04 Almería;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
04 Almería;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;90,55
04 Almería;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
04 Almería;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
04 Almería;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
04 Almería;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;91,33
04 Almería;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
04 Almería;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
04 Almería;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
04 Almería;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;92,48
04 Almería;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
04 Almería;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
04 Almería;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
04 Almería;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
04 Almería;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
04 Almería;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
04 Almería;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;88,96
04 Almería;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
04 Almería;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
04 Almería;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
04 Almería;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;90,48
04 Almería;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
04 Almería;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
04 Almería;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
04 Almería;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
04 Almería;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
04 Almería;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
04 Almería;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QII;15.467
04 Almería;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
04 Almería;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
04 Almería;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
04 Almería;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QII;15.008
04 Almería;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
04 Almería;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
04 Almería;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
04 Almería;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QII;14.628
04 Almería;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
04 Almería;All ages;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
04 Almería;All ages;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
04 Almería;All ages;Cohort April 1;Females;Survival in the first trimester;2022QII;14.865
04 Almería;All ages;Cohort April 1;Females;Survival in the first trimester;2022QI;""
04 Almería;All ages;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
04 Almería;All ages;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
04 Almería;All ages;Cohort April 1;Females;Survival in the first trimester;2021QII;14.543
04 Almería;All ages;Cohort April 1;Females;Survival in the first trimester;2021QI;""
04 Almería;All ages;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
04 Almería;All ages;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
04 Almería;All ages;Cohort April 1;Females;Survival in the first trimester;2020QII;14.263
04 Almería;All ages;Cohort April 1;Females;Survival in the first trimester;2020QI;""
04 Almería;All ages;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
04 Almería;All ages;Cohort April 1;Females;Survival in the second trimester;2022QIII;14.304
04 Almería;All ages;Cohort April 1;Females;Survival in the second trimester;2022QII;""
04 Almería;All ages;Cohort April 1;Females;Survival in the second trimester;2022QI;""
04 Almería;All ages;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
04 Almería;All ages;Cohort April 1;Females;Survival in the second trimester;2021QIII;14.082
04 Almería;All ages;Cohort April 1;Females;Survival in the second trimester;2021QII;""
04 Almería;All ages;Cohort April 1;Females;Survival in the second trimester;2021QI;""
04 Almería;All ages;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
04 Almería;All ages;Cohort April 1;Females;Survival in the second trimester;2020QIII;13.748
04 Almería;All ages;Cohort April 1;Females;Survival in the second trimester;2020QII;""
04 Almería;All ages;Cohort April 1;Females;Survival in the second trimester;2020QI;""
04 Almería;All ages;Cohort April 1;Females;Survival in the third trimester;2022QIV;13.756
04 Almería;All ages;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
04 Almería;All ages;Cohort April 1;Females;Survival in the third trimester;2022QII;""
04 Almería;All ages;Cohort April 1;Females;Survival in the third trimester;2022QI;""
04 Almería;All ages;Cohort April 1;Females;Survival in the third trimester;2021QIV;13.613
04 Almería;All ages;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
04 Almería;All ages;Cohort April 1;Females;Survival in the third trimester;2021QII;""
04 Almería;All ages;Cohort April 1;Females;Survival in the third trimester;2021QI;""
04 Almería;All ages;Cohort April 1;Females;Survival in the third trimester;2020QIV;13.283
04 Almería;All ages;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
04 Almería;All ages;Cohort April 1;Females;Survival in the third trimester;2020QII;""
04 Almería;All ages;Cohort April 1;Females;Survival in the third trimester;2020QI;""
04 Almería;All ages;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
04 Almería;All ages;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
04 Almería;All ages;Cohort April 1;Females;Survival in the third trimester;2022QII;""
04 Almería;All ages;Cohort April 1;Females;Survival in the third trimester;2022QI;13.195
04 Almería;All ages;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
04 Almería;All ages;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
04 Almería;All ages;Cohort April 1;Females;Survival in the third trimester;2021QII;""
04 Almería;All ages;Cohort April 1;Females;Survival in the third trimester;2021QI;12.961
04 Almería;All ages;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
04 Almería;All ages;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
04 Almería;All ages;Cohort April 1;Females;Survival in the third trimester;2020QII;""
04 Almería;All ages;Cohort April 1;Females;Survival in the third trimester;2020QI;""
04 Almería;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
04 Almería;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
04 Almería;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
04 Almería;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
04 Almería;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
04 Almería;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
04 Almería;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
04 Almería;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
04 Almería;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
04 Almería;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
04 Almería;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
04 Almería;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
04 Almería;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
04 Almería;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
04 Almería;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;96,11
04 Almería;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
04 Almería;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
04 Almería;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
04 Almería;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;96,9
04 Almería;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
04 Almería;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
04 Almería;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
04 Almería;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;97,5
04 Almería;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
04 Almería;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
04 Almería;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;92,48
04 Almería;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
04 Almería;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
04 Almería;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
04 Almería;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;93,83
04 Almería;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
04 Almería;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
04 Almería;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
04 Almería;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;93,98
04 Almería;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
04 Almería;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
04 Almería;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;88,94
04 Almería;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
04 Almería;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
04 Almería;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
04 Almería;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;90,7
04 Almería;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
04 Almería;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
04 Almería;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
04 Almería;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;90,81
04 Almería;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
04 Almería;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
04 Almería;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
04 Almería;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
04 Almería;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
04 Almería;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
04 Almería;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;87,92
04 Almería;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
04 Almería;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
04 Almería;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
04 Almería;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;88,6
04 Almería;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
04 Almería;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
04 Almería;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
04 Almería;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
04 Almería;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
04 Almería;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QIII;41.440
04 Almería;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
04 Almería;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
04 Almería;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
04 Almería;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QIII;41.046
04 Almería;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
04 Almería;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
04 Almería;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
04 Almería;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QIII;39.805
04 Almería;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
04 Almería;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
04 Almería;All ages;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
04 Almería;All ages;Cohort July 1;Total;Survival in the first trimester;2022QIII;39.810
04 Almería;All ages;Cohort July 1;Total;Survival in the first trimester;2022QII;""
04 Almería;All ages;Cohort July 1;Total;Survival in the first trimester;2022QI;""
04 Almería;All ages;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
04 Almería;All ages;Cohort July 1;Total;Survival in the first trimester;2021QIII;39.643
04 Almería;All ages;Cohort July 1;Total;Survival in the first trimester;2021QII;""
04 Almería;All ages;Cohort July 1;Total;Survival in the first trimester;2021QI;""
04 Almería;All ages;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
04 Almería;All ages;Cohort July 1;Total;Survival in the first trimester;2020QIII;38.359
04 Almería;All ages;Cohort July 1;Total;Survival in the first trimester;2020QII;""
04 Almería;All ages;Cohort July 1;Total;Survival in the first trimester;2020QI;""
04 Almería;All ages;Cohort July 1;Total;Survival in the second trimester;2022QIV;38.201
04 Almería;All ages;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
04 Almería;All ages;Cohort July 1;Total;Survival in the second trimester;2022QII;""
04 Almería;All ages;Cohort July 1;Total;Survival in the second trimester;2022QI;""
04 Almería;All ages;Cohort July 1;Total;Survival in the second trimester;2021QIV;38.248
04 Almería;All ages;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
04 Almería;All ages;Cohort July 1;Total;Survival in the second trimester;2021QII;""
04 Almería;All ages;Cohort July 1;Total;Survival in the second trimester;2021QI;""
04 Almería;All ages;Cohort July 1;Total;Survival in the second trimester;2020QIV;37.095
04 Almería;All ages;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
04 Almería;All ages;Cohort July 1;Total;Survival in the second trimester;2020QII;""
04 Almería;All ages;Cohort July 1;Total;Survival in the second trimester;2020QI;""
04 Almería;All ages;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
04 Almería;All ages;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
04 Almería;All ages;Cohort July 1;Total;Survival in the third trimester;2022QII;""
04 Almería;All ages;Cohort July 1;Total;Survival in the third trimester;2022QI;37.127
04 Almería;All ages;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
04 Almería;All ages;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
04 Almería;All ages;Cohort July 1;Total;Survival in the third trimester;2021QII;""
04 Almería;All ages;Cohort July 1;Total;Survival in the third trimester;2021QI;36.192
04 Almería;All ages;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
04 Almería;All ages;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
04 Almería;All ages;Cohort July 1;Total;Survival in the third trimester;2020QII;""
04 Almería;All ages;Cohort July 1;Total;Survival in the third trimester;2020QI;""
04 Almería;All ages;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
04 Almería;All ages;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
04 Almería;All ages;Cohort July 1;Total;Survival in the third trimester;2022QII;36.115
04 Almería;All ages;Cohort July 1;Total;Survival in the third trimester;2022QI;""
04 Almería;All ages;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
04 Almería;All ages;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
04 Almería;All ages;Cohort July 1;Total;Survival in the third trimester;2021QII;35.317
04 Almería;All ages;Cohort July 1;Total;Survival in the third trimester;2021QI;""
04 Almería;All ages;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
04 Almería;All ages;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
04 Almería;All ages;Cohort July 1;Total;Survival in the third trimester;2020QII;""
04 Almería;All ages;Cohort July 1;Total;Survival in the third trimester;2020QI;""
04 Almería;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
04 Almería;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
04 Almería;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
04 Almería;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
04 Almería;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
04 Almería;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
04 Almería;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
04 Almería;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
04 Almería;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
04 Almería;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
04 Almería;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
04 Almería;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
04 Almería;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
04 Almería;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;96,07
04 Almería;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
04 Almería;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
04 Almería;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
04 Almería;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;96,58
04 Almería;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
04 Almería;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
04 Almería;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
04 Almería;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;96,37
04 Almería;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
04 Almería;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
04 Almería;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;92,18
04 Almería;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
04 Almería;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
04 Almería;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
04 Almería;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;93,18
04 Almería;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
04 Almería;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
04 Almería;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
04 Almería;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;93,19
04 Almería;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
04 Almería;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
04 Almería;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
04 Almería;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
04 Almería;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
04 Almería;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
04 Almería;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;90,45
04 Almería;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
04 Almería;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
04 Almería;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
04 Almería;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;90,92
04 Almería;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
04 Almería;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
04 Almería;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
04 Almería;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
04 Almería;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
04 Almería;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
04 Almería;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;87,99
04 Almería;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
04 Almería;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
04 Almería;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
04 Almería;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;88,73
04 Almería;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
04 Almería;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
04 Almería;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
04 Almería;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
04 Almería;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
04 Almería;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
04 Almería;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QIII;25.865
04 Almería;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
04 Almería;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
04 Almería;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
04 Almería;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QIII;25.706
04 Almería;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
04 Almería;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
04 Almería;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
04 Almería;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QIII;24.987
04 Almería;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
04 Almería;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
04 Almería;All ages;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
04 Almería;All ages;Cohort July 1;Males;Survival in the first trimester;2022QIII;24.917
04 Almería;All ages;Cohort July 1;Males;Survival in the first trimester;2022QII;""
04 Almería;All ages;Cohort July 1;Males;Survival in the first trimester;2022QI;""
04 Almería;All ages;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
04 Almería;All ages;Cohort July 1;Males;Survival in the first trimester;2021QIII;24.882
04 Almería;All ages;Cohort July 1;Males;Survival in the first trimester;2021QII;""
04 Almería;All ages;Cohort July 1;Males;Survival in the first trimester;2021QI;""
04 Almería;All ages;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
04 Almería;All ages;Cohort July 1;Males;Survival in the first trimester;2020QIII;24.144
04 Almería;All ages;Cohort July 1;Males;Survival in the first trimester;2020QII;""
04 Almería;All ages;Cohort July 1;Males;Survival in the first trimester;2020QI;""
04 Almería;All ages;Cohort July 1;Males;Survival in the second trimester;2022QIV;23.942
04 Almería;All ages;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
04 Almería;All ages;Cohort July 1;Males;Survival in the second trimester;2022QII;""
04 Almería;All ages;Cohort July 1;Males;Survival in the second trimester;2022QI;""
04 Almería;All ages;Cohort July 1;Males;Survival in the second trimester;2021QIV;24.040
04 Almería;All ages;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
04 Almería;All ages;Cohort July 1;Males;Survival in the second trimester;2021QII;""
04 Almería;All ages;Cohort July 1;Males;Survival in the second trimester;2021QI;""
04 Almería;All ages;Cohort July 1;Males;Survival in the second trimester;2020QIV;23.406
04 Almería;All ages;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
04 Almería;All ages;Cohort July 1;Males;Survival in the second trimester;2020QII;""
04 Almería;All ages;Cohort July 1;Males;Survival in the second trimester;2020QI;""
04 Almería;All ages;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
04 Almería;All ages;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
04 Almería;All ages;Cohort July 1;Males;Survival in the third trimester;2022QII;""
04 Almería;All ages;Cohort July 1;Males;Survival in the third trimester;2022QI;23.382
04 Almería;All ages;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
04 Almería;All ages;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
04 Almería;All ages;Cohort July 1;Males;Survival in the third trimester;2021QII;""
04 Almería;All ages;Cohort July 1;Males;Survival in the third trimester;2021QI;22.866
04 Almería;All ages;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
04 Almería;All ages;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
04 Almería;All ages;Cohort July 1;Males;Survival in the third trimester;2020QII;""
04 Almería;All ages;Cohort July 1;Males;Survival in the third trimester;2020QI;""
04 Almería;All ages;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
04 Almería;All ages;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
04 Almería;All ages;Cohort July 1;Males;Survival in the third trimester;2022QII;22.795
04 Almería;All ages;Cohort July 1;Males;Survival in the third trimester;2022QI;""
04 Almería;All ages;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
04 Almería;All ages;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
04 Almería;All ages;Cohort July 1;Males;Survival in the third trimester;2021QII;22.333
04 Almería;All ages;Cohort July 1;Males;Survival in the third trimester;2021QI;""
04 Almería;All ages;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
04 Almería;All ages;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
04 Almería;All ages;Cohort July 1;Males;Survival in the third trimester;2020QII;""
04 Almería;All ages;Cohort July 1;Males;Survival in the third trimester;2020QI;""
04 Almería;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
04 Almería;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
04 Almería;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
04 Almería;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
04 Almería;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
04 Almería;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
04 Almería;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
04 Almería;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
04 Almería;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
04 Almería;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
04 Almería;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
04 Almería;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
04 Almería;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
04 Almería;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;96,33
04 Almería;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
04 Almería;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
04 Almería;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
04 Almería;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;96,79
04 Almería;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
04 Almería;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
04 Almería;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
04 Almería;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;96,63
04 Almería;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
04 Almería;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
04 Almería;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;92,57
04 Almería;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
04 Almería;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
04 Almería;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
04 Almería;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;93,52
04 Almería;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
04 Almería;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
04 Almería;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
04 Almería;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;93,67
04 Almería;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
04 Almería;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
04 Almería;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
04 Almería;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
04 Almería;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
04 Almería;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
04 Almería;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;90,96
04 Almería;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
04 Almería;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
04 Almería;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
04 Almería;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;91,51
04 Almería;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
04 Almería;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
04 Almería;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
04 Almería;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
04 Almería;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
04 Almería;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
04 Almería;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;88,68
04 Almería;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
04 Almería;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
04 Almería;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
04 Almería;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;89,38
04 Almería;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
04 Almería;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
04 Almería;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
04 Almería;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
04 Almería;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
04 Almería;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
04 Almería;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QIII;15.575
04 Almería;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
04 Almería;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
04 Almería;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
04 Almería;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QIII;15.340
04 Almería;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
04 Almería;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
04 Almería;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
04 Almería;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QIII;14.818
04 Almería;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
04 Almería;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
04 Almería;All ages;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
04 Almería;All ages;Cohort July 1;Females;Survival in the first trimester;2022QIII;14.893
04 Almería;All ages;Cohort July 1;Females;Survival in the first trimester;2022QII;""
04 Almería;All ages;Cohort July 1;Females;Survival in the first trimester;2022QI;""
04 Almería;All ages;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
04 Almería;All ages;Cohort July 1;Females;Survival in the first trimester;2021QIII;14.761
04 Almería;All ages;Cohort July 1;Females;Survival in the first trimester;2021QII;""
04 Almería;All ages;Cohort July 1;Females;Survival in the first trimester;2021QI;""
04 Almería;All ages;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
04 Almería;All ages;Cohort July 1;Females;Survival in the first trimester;2020QIII;14.215
04 Almería;All ages;Cohort July 1;Females;Survival in the first trimester;2020QII;""
04 Almería;All ages;Cohort July 1;Females;Survival in the first trimester;2020QI;""
04 Almería;All ages;Cohort July 1;Females;Survival in the second trimester;2022QIV;14.259
04 Almería;All ages;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
04 Almería;All ages;Cohort July 1;Females;Survival in the second trimester;2022QII;""
04 Almería;All ages;Cohort July 1;Females;Survival in the second trimester;2022QI;""
04 Almería;All ages;Cohort July 1;Females;Survival in the second trimester;2021QIV;14.208
04 Almería;All ages;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
04 Almería;All ages;Cohort July 1;Females;Survival in the second trimester;2021QII;""
04 Almería;All ages;Cohort July 1;Females;Survival in the second trimester;2021QI;""
04 Almería;All ages;Cohort July 1;Females;Survival in the second trimester;2020QIV;13.689
04 Almería;All ages;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
04 Almería;All ages;Cohort July 1;Females;Survival in the second trimester;2020QII;""
04 Almería;All ages;Cohort July 1;Females;Survival in the second trimester;2020QI;""
04 Almería;All ages;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
04 Almería;All ages;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
04 Almería;All ages;Cohort July 1;Females;Survival in the third trimester;2022QII;""
04 Almería;All ages;Cohort July 1;Females;Survival in the third trimester;2022QI;13.745
04 Almería;All ages;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
04 Almería;All ages;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
04 Almería;All ages;Cohort July 1;Females;Survival in the third trimester;2021QII;""
04 Almería;All ages;Cohort July 1;Females;Survival in the third trimester;2021QI;13.326
04 Almería;All ages;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
04 Almería;All ages;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
04 Almería;All ages;Cohort July 1;Females;Survival in the third trimester;2020QII;""
04 Almería;All ages;Cohort July 1;Females;Survival in the third trimester;2020QI;""
04 Almería;All ages;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
04 Almería;All ages;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
04 Almería;All ages;Cohort July 1;Females;Survival in the third trimester;2022QII;13.320
04 Almería;All ages;Cohort July 1;Females;Survival in the third trimester;2022QI;""
04 Almería;All ages;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
04 Almería;All ages;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
04 Almería;All ages;Cohort July 1;Females;Survival in the third trimester;2021QII;12.984
04 Almería;All ages;Cohort July 1;Females;Survival in the third trimester;2021QI;""
04 Almería;All ages;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
04 Almería;All ages;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
04 Almería;All ages;Cohort July 1;Females;Survival in the third trimester;2020QII;""
04 Almería;All ages;Cohort July 1;Females;Survival in the third trimester;2020QI;""
04 Almería;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
04 Almería;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
04 Almería;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
04 Almería;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
04 Almería;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
04 Almería;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
04 Almería;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
04 Almería;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
04 Almería;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
04 Almería;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
04 Almería;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
04 Almería;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
04 Almería;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
04 Almería;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;95,62
04 Almería;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
04 Almería;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
04 Almería;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
04 Almería;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;96,23
04 Almería;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
04 Almería;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
04 Almería;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
04 Almería;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;95,93
04 Almería;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
04 Almería;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
04 Almería;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;91,55
04 Almería;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
04 Almería;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
04 Almería;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
04 Almería;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;92,62
04 Almería;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
04 Almería;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
04 Almería;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
04 Almería;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;92,38
04 Almería;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
04 Almería;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
04 Almería;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
04 Almería;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
04 Almería;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
04 Almería;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
04 Almería;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;89,6
04 Almería;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
04 Almería;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
04 Almería;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
04 Almería;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;89,93
04 Almería;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
04 Almería;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
04 Almería;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
04 Almería;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
04 Almería;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
04 Almería;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
04 Almería;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;86,83
04 Almería;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
04 Almería;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
04 Almería;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
04 Almería;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;87,62
04 Almería;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
04 Almería;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
04 Almería;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
04 Almería;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
04 Almería;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
04 Almería;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QIV;41.151
04 Almería;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
04 Almería;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
04 Almería;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
04 Almería;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QIV;41.013
04 Almería;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
04 Almería;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
04 Almería;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
04 Almería;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QIV;39.864
04 Almería;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
04 Almería;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
04 Almería;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
04 Almería;All ages;Cohort October 1;Total;Survival in the first trimester;2022QIV;39.385
04 Almería;All ages;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
04 Almería;All ages;Cohort October 1;Total;Survival in the first trimester;2022QII;""
04 Almería;All ages;Cohort October 1;Total;Survival in the first trimester;2022QI;""
04 Almería;All ages;Cohort October 1;Total;Survival in the first trimester;2021QIV;39.463
04 Almería;All ages;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
04 Almería;All ages;Cohort October 1;Total;Survival in the first trimester;2021QII;""
04 Almería;All ages;Cohort October 1;Total;Survival in the first trimester;2021QI;""
04 Almería;All ages;Cohort October 1;Total;Survival in the first trimester;2020QIV;38.421
04 Almería;All ages;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
04 Almería;All ages;Cohort October 1;Total;Survival in the first trimester;2020QII;""
04 Almería;All ages;Cohort October 1;Total;Survival in the first trimester;2020QI;""
04 Almería;All ages;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
04 Almería;All ages;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
04 Almería;All ages;Cohort October 1;Total;Survival in the second trimester;2022QII;""
04 Almería;All ages;Cohort October 1;Total;Survival in the second trimester;2022QI;38.260
04 Almería;All ages;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
04 Almería;All ages;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
04 Almería;All ages;Cohort October 1;Total;Survival in the second trimester;2021QII;""
04 Almería;All ages;Cohort October 1;Total;Survival in the second trimester;2021QI;37.422
04 Almería;All ages;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
04 Almería;All ages;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
04 Almería;All ages;Cohort October 1;Total;Survival in the second trimester;2020QII;""
04 Almería;All ages;Cohort October 1;Total;Survival in the second trimester;2020QI;""
04 Almería;All ages;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
04 Almería;All ages;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
04 Almería;All ages;Cohort October 1;Total;Survival in the third trimester;2022QII;37.154
04 Almería;All ages;Cohort October 1;Total;Survival in the third trimester;2022QI;""
04 Almería;All ages;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
04 Almería;All ages;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
04 Almería;All ages;Cohort October 1;Total;Survival in the third trimester;2021QII;36.468
04 Almería;All ages;Cohort October 1;Total;Survival in the third trimester;2021QI;""
04 Almería;All ages;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
04 Almería;All ages;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
04 Almería;All ages;Cohort October 1;Total;Survival in the third trimester;2020QII;""
04 Almería;All ages;Cohort October 1;Total;Survival in the third trimester;2020QI;""
04 Almería;All ages;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
04 Almería;All ages;Cohort October 1;Total;Survival in the third trimester;2022QIII;36.040
04 Almería;All ages;Cohort October 1;Total;Survival in the third trimester;2022QII;""
04 Almería;All ages;Cohort October 1;Total;Survival in the third trimester;2022QI;""
04 Almería;All ages;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
04 Almería;All ages;Cohort October 1;Total;Survival in the third trimester;2021QIII;35.558
04 Almería;All ages;Cohort October 1;Total;Survival in the third trimester;2021QII;""
04 Almería;All ages;Cohort October 1;Total;Survival in the third trimester;2021QI;""
04 Almería;All ages;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
04 Almería;All ages;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
04 Almería;All ages;Cohort October 1;Total;Survival in the third trimester;2020QII;""
04 Almería;All ages;Cohort October 1;Total;Survival in the third trimester;2020QI;""
04 Almería;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
04 Almería;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
04 Almería;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
04 Almería;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
04 Almería;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
04 Almería;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
04 Almería;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
04 Almería;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
04 Almería;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
04 Almería;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
04 Almería;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
04 Almería;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
04 Almería;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;95,71
04 Almería;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
04 Almería;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
04 Almería;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
04 Almería;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;96,22
04 Almería;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
04 Almería;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
04 Almería;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
04 Almería;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;96,38
04 Almería;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
04 Almería;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
04 Almería;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
04 Almería;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
04 Almería;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
04 Almería;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
04 Almería;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;93,29
04 Almería;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
04 Almería;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
04 Almería;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
04 Almería;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;93,87
04 Almería;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
04 Almería;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
04 Almería;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
04 Almería;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
04 Almería;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
04 Almería;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
04 Almería;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;90,59
04 Almería;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
04 Almería;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
04 Almería;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
04 Almería;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;91,48
04 Almería;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
04 Almería;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
04 Almería;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
04 Almería;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
04 Almería;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
04 Almería;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
04 Almería;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;87,87
04 Almería;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
04 Almería;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
04 Almería;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
04 Almería;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;89,2
04 Almería;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
04 Almería;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
04 Almería;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
04 Almería;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
04 Almería;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
04 Almería;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
04 Almería;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QIV;25.636
04 Almería;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
04 Almería;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
04 Almería;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
04 Almería;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QIV;25.649
04 Almería;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
04 Almería;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
04 Almería;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
04 Almería;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QIV;25.075
04 Almería;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
04 Almería;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
04 Almería;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
04 Almería;All ages;Cohort October 1;Males;Survival in the first trimester;2022QIV;24.563
04 Almería;All ages;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
04 Almería;All ages;Cohort October 1;Males;Survival in the first trimester;2022QII;""
04 Almería;All ages;Cohort October 1;Males;Survival in the first trimester;2022QI;""
04 Almería;All ages;Cohort October 1;Males;Survival in the first trimester;2021QIV;24.713
04 Almería;All ages;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
04 Almería;All ages;Cohort October 1;Males;Survival in the first trimester;2021QII;""
04 Almería;All ages;Cohort October 1;Males;Survival in the first trimester;2021QI;""
04 Almería;All ages;Cohort October 1;Males;Survival in the first trimester;2020QIV;24.219
04 Almería;All ages;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
04 Almería;All ages;Cohort October 1;Males;Survival in the first trimester;2020QII;""
04 Almería;All ages;Cohort October 1;Males;Survival in the first trimester;2020QI;""
04 Almería;All ages;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
04 Almería;All ages;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
04 Almería;All ages;Cohort October 1;Males;Survival in the second trimester;2022QII;""
04 Almería;All ages;Cohort October 1;Males;Survival in the second trimester;2022QI;24.003
04 Almería;All ages;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
04 Almería;All ages;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
04 Almería;All ages;Cohort October 1;Males;Survival in the second trimester;2021QII;""
04 Almería;All ages;Cohort October 1;Males;Survival in the second trimester;2021QI;23.616
04 Almería;All ages;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
04 Almería;All ages;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
04 Almería;All ages;Cohort October 1;Males;Survival in the second trimester;2020QII;""
04 Almería;All ages;Cohort October 1;Males;Survival in the second trimester;2020QI;""
04 Almería;All ages;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
04 Almería;All ages;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
04 Almería;All ages;Cohort October 1;Males;Survival in the third trimester;2022QII;23.367
04 Almería;All ages;Cohort October 1;Males;Survival in the third trimester;2022QI;""
04 Almería;All ages;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
04 Almería;All ages;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
04 Almería;All ages;Cohort October 1;Males;Survival in the third trimester;2021QII;23.029
04 Almería;All ages;Cohort October 1;Males;Survival in the third trimester;2021QI;""
04 Almería;All ages;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
04 Almería;All ages;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
04 Almería;All ages;Cohort October 1;Males;Survival in the third trimester;2020QII;""
04 Almería;All ages;Cohort October 1;Males;Survival in the third trimester;2020QI;""
04 Almería;All ages;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
04 Almería;All ages;Cohort October 1;Males;Survival in the third trimester;2022QIII;22.724
04 Almería;All ages;Cohort October 1;Males;Survival in the third trimester;2022QII;""
04 Almería;All ages;Cohort October 1;Males;Survival in the third trimester;2022QI;""
04 Almería;All ages;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
04 Almería;All ages;Cohort October 1;Males;Survival in the third trimester;2021QIII;22.484
04 Almería;All ages;Cohort October 1;Males;Survival in the third trimester;2021QII;""
04 Almería;All ages;Cohort October 1;Males;Survival in the third trimester;2021QI;""
04 Almería;All ages;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
04 Almería;All ages;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
04 Almería;All ages;Cohort October 1;Males;Survival in the third trimester;2020QII;""
04 Almería;All ages;Cohort October 1;Males;Survival in the third trimester;2020QI;""
04 Almería;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
04 Almería;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
04 Almería;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
04 Almería;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
04 Almería;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
04 Almería;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
04 Almería;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
04 Almería;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
04 Almería;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
04 Almería;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
04 Almería;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
04 Almería;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
04 Almería;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;95,81
04 Almería;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
04 Almería;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
04 Almería;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
04 Almería;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;96,35
04 Almería;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
04 Almería;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
04 Almería;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
04 Almería;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;96,59
04 Almería;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
04 Almería;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
04 Almería;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
04 Almería;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
04 Almería;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
04 Almería;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
04 Almería;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;93,58
04 Almería;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
04 Almería;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
04 Almería;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
04 Almería;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;94,18
04 Almería;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
04 Almería;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
04 Almería;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
04 Almería;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
04 Almería;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
04 Almería;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
04 Almería;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;91,1
04 Almería;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
04 Almería;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
04 Almería;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
04 Almería;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;91,84
04 Almería;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
04 Almería;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
04 Almería;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
04 Almería;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
04 Almería;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
04 Almería;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
04 Almería;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;88,6
04 Almería;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
04 Almería;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
04 Almería;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
04 Almería;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;89,67
04 Almería;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
04 Almería;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
04 Almería;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
04 Almería;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
04 Almería;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
04 Almería;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
04 Almería;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QIV;15.515
04 Almería;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
04 Almería;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
04 Almería;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
04 Almería;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QIV;15.364
04 Almería;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
04 Almería;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
04 Almería;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
04 Almería;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QIV;14.789
04 Almería;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
04 Almería;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
04 Almería;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
04 Almería;All ages;Cohort October 1;Females;Survival in the first trimester;2022QIV;14.822
04 Almería;All ages;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
04 Almería;All ages;Cohort October 1;Females;Survival in the first trimester;2022QII;""
04 Almería;All ages;Cohort October 1;Females;Survival in the first trimester;2022QI;""
04 Almería;All ages;Cohort October 1;Females;Survival in the first trimester;2021QIV;14.750
04 Almería;All ages;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
04 Almería;All ages;Cohort October 1;Females;Survival in the first trimester;2021QII;""
04 Almería;All ages;Cohort October 1;Females;Survival in the first trimester;2021QI;""
04 Almería;All ages;Cohort October 1;Females;Survival in the first trimester;2020QIV;14.202
04 Almería;All ages;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
04 Almería;All ages;Cohort October 1;Females;Survival in the first trimester;2020QII;""
04 Almería;All ages;Cohort October 1;Females;Survival in the first trimester;2020QI;""
04 Almería;All ages;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
04 Almería;All ages;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
04 Almería;All ages;Cohort October 1;Females;Survival in the second trimester;2022QII;""
04 Almería;All ages;Cohort October 1;Females;Survival in the second trimester;2022QI;14.257
04 Almería;All ages;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
04 Almería;All ages;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
04 Almería;All ages;Cohort October 1;Females;Survival in the second trimester;2021QII;""
04 Almería;All ages;Cohort October 1;Females;Survival in the second trimester;2021QI;13.806
04 Almería;All ages;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
04 Almería;All ages;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
04 Almería;All ages;Cohort October 1;Females;Survival in the second trimester;2020QII;""
04 Almería;All ages;Cohort October 1;Females;Survival in the second trimester;2020QI;""
04 Almería;All ages;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
04 Almería;All ages;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
04 Almería;All ages;Cohort October 1;Females;Survival in the third trimester;2022QII;13.787
04 Almería;All ages;Cohort October 1;Females;Survival in the third trimester;2022QI;""
04 Almería;All ages;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
04 Almería;All ages;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
04 Almería;All ages;Cohort October 1;Females;Survival in the third trimester;2021QII;13.439
04 Almería;All ages;Cohort October 1;Females;Survival in the third trimester;2021QI;""
04 Almería;All ages;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
04 Almería;All ages;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
04 Almería;All ages;Cohort October 1;Females;Survival in the third trimester;2020QII;""
04 Almería;All ages;Cohort October 1;Females;Survival in the third trimester;2020QI;""
04 Almería;All ages;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
04 Almería;All ages;Cohort October 1;Females;Survival in the third trimester;2022QIII;13.316
04 Almería;All ages;Cohort October 1;Females;Survival in the third trimester;2022QII;""
04 Almería;All ages;Cohort October 1;Females;Survival in the third trimester;2022QI;""
04 Almería;All ages;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
04 Almería;All ages;Cohort October 1;Females;Survival in the third trimester;2021QIII;13.074
04 Almería;All ages;Cohort October 1;Females;Survival in the third trimester;2021QII;""
04 Almería;All ages;Cohort October 1;Females;Survival in the third trimester;2021QI;""
04 Almería;All ages;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
04 Almería;All ages;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
04 Almería;All ages;Cohort October 1;Females;Survival in the third trimester;2020QII;""
04 Almería;All ages;Cohort October 1;Females;Survival in the third trimester;2020QI;""
04 Almería;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
04 Almería;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
04 Almería;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
04 Almería;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
04 Almería;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
04 Almería;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
04 Almería;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
04 Almería;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
04 Almería;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
04 Almería;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
04 Almería;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
04 Almería;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
04 Almería;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;95,53
04 Almería;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
04 Almería;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
04 Almería;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
04 Almería;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;96
04 Almería;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
04 Almería;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
04 Almería;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
04 Almería;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;96,03
04 Almería;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
04 Almería;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
04 Almería;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
04 Almería;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
04 Almería;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
04 Almería;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
04 Almería;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;92,79
04 Almería;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
04 Almería;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
04 Almería;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
04 Almería;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;93,35
04 Almería;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
04 Almería;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
04 Almería;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
04 Almería;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
04 Almería;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
04 Almería;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
04 Almería;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;89,74
04 Almería;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
04 Almería;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
04 Almería;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
04 Almería;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;90,87
04 Almería;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
04 Almería;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
04 Almería;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
04 Almería;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
04 Almería;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
04 Almería;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
04 Almería;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;86,67
04 Almería;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
04 Almería;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
04 Almería;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
04 Almería;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;88,4
04 Almería;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
04 Almería;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
04 Almería;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
04 Almería;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
04 Almería;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
04 Almería;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
04 Almería;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
04 Almería;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
04 Almería;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
04 Almería;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QI;2.908
04 Almería;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
04 Almería;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
04 Almería;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
04 Almería;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QI;2.813
04 Almería;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
04 Almería;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
04 Almería;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
04 Almería;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QI;2.194
04 Almería;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
04 Almería;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
04 Almería;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2022QII;""
04 Almería;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2022QI;2.718
04 Almería;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
04 Almería;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
04 Almería;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2021QII;""
04 Almería;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2021QI;2.631
04 Almería;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
04 Almería;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
04 Almería;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2020QII;""
04 Almería;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2020QI;1.936
04 Almería;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
04 Almería;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
04 Almería;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2022QII;2.543
04 Almería;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2022QI;""
04 Almería;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
04 Almería;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
04 Almería;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2021QII;2.475
04 Almería;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2021QI;""
04 Almería;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
04 Almería;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
04 Almería;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2020QII;1.872
04 Almería;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2020QI;""
04 Almería;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
04 Almería;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QIII;2.362
04 Almería;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QII;""
04 Almería;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QI;""
04 Almería;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
04 Almería;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QIII;2.307
04 Almería;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QII;""
04 Almería;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QI;""
04 Almería;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
04 Almería;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QIII;1.772
04 Almería;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QII;""
04 Almería;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QI;""
04 Almería;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QIV;2.210
04 Almería;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
04 Almería;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QII;""
04 Almería;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QI;""
04 Almería;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QIV;2.169
04 Almería;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
04 Almería;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QII;""
04 Almería;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QI;""
04 Almería;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QIV;1.681
04 Almería;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
04 Almería;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QII;""
04 Almería;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QI;""
04 Almería;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
04 Almería;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
04 Almería;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
04 Almería;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
04 Almería;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
04 Almería;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
04 Almería;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
04 Almería;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
04 Almería;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
04 Almería;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
04 Almería;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
04 Almería;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
04 Almería;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
04 Almería;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
04 Almería;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
04 Almería;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;93,47
04 Almería;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
04 Almería;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
04 Almería;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
04 Almería;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;93,53
04 Almería;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
04 Almería;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
04 Almería;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
04 Almería;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;88,24
04 Almería;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
04 Almería;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
04 Almería;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;87,45
04 Almería;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
04 Almería;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
04 Almería;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
04 Almería;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;87,98
04 Almería;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
04 Almería;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
04 Almería;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
04 Almería;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;85,32
04 Almería;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
04 Almería;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
04 Almería;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;81,22
04 Almería;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
04 Almería;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
04 Almería;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
04 Almería;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;82,01
04 Almería;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
04 Almería;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
04 Almería;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
04 Almería;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;80,77
04 Almería;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
04 Almería;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
04 Almería;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;76
04 Almería;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
04 Almería;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
04 Almería;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
04 Almería;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;77,11
04 Almería;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
04 Almería;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
04 Almería;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
04 Almería;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;76,62
04 Almería;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
04 Almería;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
04 Almería;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
04 Almería;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
04 Almería;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
04 Almería;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
04 Almería;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QI;1.788
04 Almería;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
04 Almería;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
04 Almería;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
04 Almería;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QI;1.757
04 Almería;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
04 Almería;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
04 Almería;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
04 Almería;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QI;1.355
04 Almería;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
04 Almería;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
04 Almería;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2022QII;""
04 Almería;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2022QI;1.690
04 Almería;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
04 Almería;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
04 Almería;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2021QII;""
04 Almería;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2021QI;1.648
04 Almería;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
04 Almería;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
04 Almería;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2020QII;""
04 Almería;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2020QI;1.199
04 Almería;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
04 Almería;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
04 Almería;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2022QII;1.587
04 Almería;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2022QI;""
04 Almería;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
04 Almería;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
04 Almería;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2021QII;1.549
04 Almería;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2021QI;""
04 Almería;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
04 Almería;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
04 Almería;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2020QII;1.163
04 Almería;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2020QI;""
04 Almería;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
04 Almería;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QIII;1.472
04 Almería;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QII;""
04 Almería;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QI;""
04 Almería;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
04 Almería;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QIII;1.451
04 Almería;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QII;""
04 Almería;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QI;""
04 Almería;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
04 Almería;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QIII;1.109
04 Almería;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QII;""
04 Almería;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QI;""
04 Almería;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QIV;1.383
04 Almería;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
04 Almería;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QII;""
04 Almería;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QI;""
04 Almería;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QIV;1.366
04 Almería;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
04 Almería;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QII;""
04 Almería;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QI;""
04 Almería;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QIV;1.048
04 Almería;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
04 Almería;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QII;""
04 Almería;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QI;""
04 Almería;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
04 Almería;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
04 Almería;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
04 Almería;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
04 Almería;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
04 Almería;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
04 Almería;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
04 Almería;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
04 Almería;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
04 Almería;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
04 Almería;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
04 Almería;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
04 Almería;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
04 Almería;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
04 Almería;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
04 Almería;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;94,52
04 Almería;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
04 Almería;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
04 Almería;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
04 Almería;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;93,8
04 Almería;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
04 Almería;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
04 Almería;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
04 Almería;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;88,49
04 Almería;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
04 Almería;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
04 Almería;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;88,76
04 Almería;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
04 Almería;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
04 Almería;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
04 Almería;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;88,16
04 Almería;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
04 Almería;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
04 Almería;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
04 Almería;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;85,83
04 Almería;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
04 Almería;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
04 Almería;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;82,33
04 Almería;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
04 Almería;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
04 Almería;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
04 Almería;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;82,58
04 Almería;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
04 Almería;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
04 Almería;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
04 Almería;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;81,85
04 Almería;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
04 Almería;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
04 Almería;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;77,35
04 Almería;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
04 Almería;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
04 Almería;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
04 Almería;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;77,75
04 Almería;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
04 Almería;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
04 Almería;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
04 Almería;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;77,34
04 Almería;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
04 Almería;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
04 Almería;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
04 Almería;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
04 Almería;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
04 Almería;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
04 Almería;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QI;1.120
04 Almería;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
04 Almería;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
04 Almería;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
04 Almería;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QI;1.056
04 Almería;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
04 Almería;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
04 Almería;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
04 Almería;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QI;839
04 Almería;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
04 Almería;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
04 Almería;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2022QII;""
04 Almería;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2022QI;1.028
04 Almería;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
04 Almería;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
04 Almería;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2021QII;""
04 Almería;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2021QI;983
04 Almería;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
04 Almería;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
04 Almería;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2020QII;""
04 Almería;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2020QI;737
04 Almería;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
04 Almería;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
04 Almería;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2022QII;956
04 Almería;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2022QI;""
04 Almería;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
04 Almería;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
04 Almería;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2021QII;926
04 Almería;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2021QI;""
04 Almería;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
04 Almería;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
04 Almería;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2020QII;709
04 Almería;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2020QI;""
04 Almería;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
04 Almería;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QIII;890
04 Almería;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QII;""
04 Almería;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QI;""
04 Almería;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
04 Almería;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QIII;856
04 Almería;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QII;""
04 Almería;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QI;""
04 Almería;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
04 Almería;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QIII;663
04 Almería;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QII;""
04 Almería;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QI;""
04 Almería;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QIV;827
04 Almería;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
04 Almería;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QII;""
04 Almería;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QI;""
04 Almería;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QIV;803
04 Almería;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
04 Almería;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QII;""
04 Almería;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QI;""
04 Almería;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QIV;633
04 Almería;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
04 Almería;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QII;""
04 Almería;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QI;""
04 Almería;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
04 Almería;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
04 Almería;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
04 Almería;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
04 Almería;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
04 Almería;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
04 Almería;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
04 Almería;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
04 Almería;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
04 Almería;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
04 Almería;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
04 Almería;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
04 Almería;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
04 Almería;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
04 Almería;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
04 Almería;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;91,79
04 Almería;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
04 Almería;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
04 Almería;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
04 Almería;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;93,09
04 Almería;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
04 Almería;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
04 Almería;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
04 Almería;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;87,84
04 Almería;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
04 Almería;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
04 Almería;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;85,36
04 Almería;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
04 Almería;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
04 Almería;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
04 Almería;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;87,69
04 Almería;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
04 Almería;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
04 Almería;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
04 Almería;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;84,51
04 Almería;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
04 Almería;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
04 Almería;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;79,46
04 Almería;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
04 Almería;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
04 Almería;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
04 Almería;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;81,06
04 Almería;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
04 Almería;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
04 Almería;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
04 Almería;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;79,02
04 Almería;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
04 Almería;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
04 Almería;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;73,84
04 Almería;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
04 Almería;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
04 Almería;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
04 Almería;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;76,04
04 Almería;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
04 Almería;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
04 Almería;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
04 Almería;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;75,45
04 Almería;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
04 Almería;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
04 Almería;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
04 Almería;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
04 Almería;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
04 Almería;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QII;2.573
04 Almería;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
04 Almería;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
04 Almería;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
04 Almería;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QII;2.462
04 Almería;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
04 Almería;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
04 Almería;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
04 Almería;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QII;2.266
04 Almería;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
04 Almería;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
04 Almería;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
04 Almería;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2022QII;2.383
04 Almería;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2022QI;""
04 Almería;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
04 Almería;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
04 Almería;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2021QII;2.298
04 Almería;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2021QI;""
04 Almería;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
04 Almería;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
04 Almería;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2020QII;2.180
04 Almería;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2020QI;""
04 Almería;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
04 Almería;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2022QIII;2.203
04 Almería;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2022QII;""
04 Almería;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2022QI;""
04 Almería;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
04 Almería;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2021QIII;2.124
04 Almería;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2021QII;""
04 Almería;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2021QI;""
04 Almería;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
04 Almería;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2020QIII;2.048
04 Almería;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2020QII;""
04 Almería;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2020QI;""
04 Almería;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QIV;2.039
04 Almería;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
04 Almería;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QII;""
04 Almería;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QI;""
04 Almería;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QIV;1.993
04 Almería;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
04 Almería;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QII;""
04 Almería;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QI;""
04 Almería;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QIV;1.940
04 Almería;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
04 Almería;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QII;""
04 Almería;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QI;""
04 Almería;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
04 Almería;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
04 Almería;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QII;""
04 Almería;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QI;1.878
04 Almería;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
04 Almería;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
04 Almería;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QII;""
04 Almería;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QI;1.847
04 Almería;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
04 Almería;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
04 Almería;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QII;""
04 Almería;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QI;""
04 Almería;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
04 Almería;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
04 Almería;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
04 Almería;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
04 Almería;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
04 Almería;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
04 Almería;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
04 Almería;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
04 Almería;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
04 Almería;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
04 Almería;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
04 Almería;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
04 Almería;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
04 Almería;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
04 Almería;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;92,62
04 Almería;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
04 Almería;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
04 Almería;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
04 Almería;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;93,34
04 Almería;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
04 Almería;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
04 Almería;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
04 Almería;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;96,2
04 Almería;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
04 Almería;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
04 Almería;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;85,62
04 Almería;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
04 Almería;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
04 Almería;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
04 Almería;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;86,27
04 Almería;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
04 Almería;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
04 Almería;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
04 Almería;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;90,38
04 Almería;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
04 Almería;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
04 Almería;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;79,25
04 Almería;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
04 Almería;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
04 Almería;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
04 Almería;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;80,95
04 Almería;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
04 Almería;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
04 Almería;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
04 Almería;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;85,61
04 Almería;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
04 Almería;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
04 Almería;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
04 Almería;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
04 Almería;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
04 Almería;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
04 Almería;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;76,28
04 Almería;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
04 Almería;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
04 Almería;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
04 Almería;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;81,51
04 Almería;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
04 Almería;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
04 Almería;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
04 Almería;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
04 Almería;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
04 Almería;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
04 Almería;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QII;1.590
04 Almería;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
04 Almería;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
04 Almería;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
04 Almería;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QII;1.561
04 Almería;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
04 Almería;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
04 Almería;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
04 Almería;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QII;1.407
04 Almería;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
04 Almería;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
04 Almería;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
04 Almería;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2022QII;1.480
04 Almería;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2022QI;""
04 Almería;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
04 Almería;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
04 Almería;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2021QII;1.456
04 Almería;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2021QI;""
04 Almería;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
04 Almería;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
04 Almería;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2020QII;1.355
04 Almería;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2020QI;""
04 Almería;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
04 Almería;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2022QIII;1.362
04 Almería;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2022QII;""
04 Almería;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2022QI;""
04 Almería;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
04 Almería;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2021QIII;1.352
04 Almería;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2021QII;""
04 Almería;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2021QI;""
04 Almería;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
04 Almería;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2020QIII;1.280
04 Almería;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2020QII;""
04 Almería;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2020QI;""
04 Almería;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QIV;1.262
04 Almería;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
04 Almería;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QII;""
04 Almería;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QI;""
04 Almería;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QIV;1.273
04 Almería;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
04 Almería;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QII;""
04 Almería;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QI;""
04 Almería;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QIV;1.206
04 Almería;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
04 Almería;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QII;""
04 Almería;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QI;""
04 Almería;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
04 Almería;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
04 Almería;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QII;""
04 Almería;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QI;1.216
04 Almería;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
04 Almería;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
04 Almería;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QII;""
04 Almería;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QI;1.156
04 Almería;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
04 Almería;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
04 Almería;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QII;""
04 Almería;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QI;""
04 Almería;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
04 Almería;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
04 Almería;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
04 Almería;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
04 Almería;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
04 Almería;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
04 Almería;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
04 Almería;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
04 Almería;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
04 Almería;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
04 Almería;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
04 Almería;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
04 Almería;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
04 Almería;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
04 Almería;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;93,08
04 Almería;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
04 Almería;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
04 Almería;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
04 Almería;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;93,27
04 Almería;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
04 Almería;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
04 Almería;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
04 Almería;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;96,3
04 Almería;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
04 Almería;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
04 Almería;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;85,66
04 Almería;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
04 Almería;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
04 Almería;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
04 Almería;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;86,61
04 Almería;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
04 Almería;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
04 Almería;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
04 Almería;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;90,97
04 Almería;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
04 Almería;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
04 Almería;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;79,37
04 Almería;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
04 Almería;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
04 Almería;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
04 Almería;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;81,55
04 Almería;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
04 Almería;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
04 Almería;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
04 Almería;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;85,71
04 Almería;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
04 Almería;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
04 Almería;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
04 Almería;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
04 Almería;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
04 Almería;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
04 Almería;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;77,9
04 Almería;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
04 Almería;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
04 Almería;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
04 Almería;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;82,16
04 Almería;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
04 Almería;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
04 Almería;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
04 Almería;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
04 Almería;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
04 Almería;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
04 Almería;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QII;983
04 Almería;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
04 Almería;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
04 Almería;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
04 Almería;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QII;901
04 Almería;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
04 Almería;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
04 Almería;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
04 Almería;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QII;859
04 Almería;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
04 Almería;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
04 Almería;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
04 Almería;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2022QII;903
04 Almería;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2022QI;""
04 Almería;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
04 Almería;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
04 Almería;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2021QII;842
04 Almería;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2021QI;""
04 Almería;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
04 Almería;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
04 Almería;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2020QII;825
04 Almería;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2020QI;""
04 Almería;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
04 Almería;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2022QIII;841
04 Almería;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2022QII;""
04 Almería;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2022QI;""
04 Almería;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
04 Almería;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2021QIII;772
04 Almería;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2021QII;""
04 Almería;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2021QI;""
04 Almería;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
04 Almería;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2020QIII;768
04 Almería;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2020QII;""
04 Almería;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2020QI;""
04 Almería;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QIV;777
04 Almería;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
04 Almería;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QII;""
04 Almería;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QI;""
04 Almería;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QIV;720
04 Almería;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
04 Almería;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QII;""
04 Almería;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QI;""
04 Almería;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QIV;734
04 Almería;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
04 Almería;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QII;""
04 Almería;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QI;""
04 Almería;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
04 Almería;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
04 Almería;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QII;""
04 Almería;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QI;662
04 Almería;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
04 Almería;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
04 Almería;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QII;""
04 Almería;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QI;691
04 Almería;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
04 Almería;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
04 Almería;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QII;""
04 Almería;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QI;""
04 Almería;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
04 Almería;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
04 Almería;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
04 Almería;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
04 Almería;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
04 Almería;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
04 Almería;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
04 Almería;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
04 Almería;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
04 Almería;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
04 Almería;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
04 Almería;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
04 Almería;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
04 Almería;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
04 Almería;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;91,86
04 Almería;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
04 Almería;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
04 Almería;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
04 Almería;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;93,45
04 Almería;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
04 Almería;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
04 Almería;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
04 Almería;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;96,04
04 Almería;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
04 Almería;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
04 Almería;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;85,55
04 Almería;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
04 Almería;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
04 Almería;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
04 Almería;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;85,68
04 Almería;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
04 Almería;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
04 Almería;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
04 Almería;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;89,41
04 Almería;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
04 Almería;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
04 Almería;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;79,04
04 Almería;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
04 Almería;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
04 Almería;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
04 Almería;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;79,91
04 Almería;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
04 Almería;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
04 Almería;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
04 Almería;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;85,45
04 Almería;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
04 Almería;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
04 Almería;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
04 Almería;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
04 Almería;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
04 Almería;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
04 Almería;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;73,47
04 Almería;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
04 Almería;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
04 Almería;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
04 Almería;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;80,44
04 Almería;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
04 Almería;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
04 Almería;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
04 Almería;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
04 Almería;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
04 Almería;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QIII;2.789
04 Almería;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
04 Almería;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
04 Almería;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
04 Almería;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QIII;2.706
04 Almería;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
04 Almería;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
04 Almería;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
04 Almería;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QIII;2.486
04 Almería;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
04 Almería;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
04 Almería;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
04 Almería;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2022QIII;2.538
04 Almería;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2022QII;""
04 Almería;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2022QI;""
04 Almería;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
04 Almería;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2021QIII;2.460
04 Almería;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2021QII;""
04 Almería;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2021QI;""
04 Almería;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
04 Almería;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2020QIII;2.290
04 Almería;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2020QII;""
04 Almería;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2020QI;""
04 Almería;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2022QIV;2.340
04 Almería;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
04 Almería;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2022QII;""
04 Almería;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2022QI;""
04 Almería;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2021QIV;2.287
04 Almería;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
04 Almería;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2021QII;""
04 Almería;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2021QI;""
04 Almería;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2020QIV;2.153
04 Almería;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
04 Almería;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2020QII;""
04 Almería;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2020QI;""
04 Almería;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
04 Almería;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
04 Almería;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QII;""
04 Almería;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QI;2.156
04 Almería;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
04 Almería;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
04 Almería;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QII;""
04 Almería;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QI;2.042
04 Almería;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
04 Almería;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
04 Almería;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QII;""
04 Almería;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QI;""
04 Almería;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
04 Almería;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
04 Almería;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QII;2.036
04 Almería;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QI;""
04 Almería;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
04 Almería;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
04 Almería;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QII;1.940
04 Almería;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QI;""
04 Almería;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
04 Almería;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
04 Almería;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QII;""
04 Almería;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QI;""
04 Almería;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
04 Almería;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
04 Almería;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
04 Almería;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
04 Almería;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
04 Almería;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
04 Almería;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
04 Almería;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
04 Almería;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
04 Almería;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
04 Almería;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
04 Almería;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
04 Almería;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
04 Almería;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;91
04 Almería;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
04 Almería;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
04 Almería;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
04 Almería;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;90,91
04 Almería;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
04 Almería;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
04 Almería;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
04 Almería;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;92,12
04 Almería;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
04 Almería;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
04 Almería;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;83,9
04 Almería;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
04 Almería;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
04 Almería;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
04 Almería;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;84,52
04 Almería;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
04 Almería;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
04 Almería;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
04 Almería;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;86,6
04 Almería;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
04 Almería;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
04 Almería;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
04 Almería;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
04 Almería;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
04 Almería;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
04 Almería;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;79,67
04 Almería;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
04 Almería;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
04 Almería;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
04 Almería;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;82,14
04 Almería;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
04 Almería;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
04 Almería;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
04 Almería;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
04 Almería;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
04 Almería;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
04 Almería;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;75,24
04 Almería;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
04 Almería;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
04 Almería;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
04 Almería;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;78,04
04 Almería;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
04 Almería;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
04 Almería;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
04 Almería;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
04 Almería;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
04 Almería;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
04 Almería;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QIII;1.731
04 Almería;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
04 Almería;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
04 Almería;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
04 Almería;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QIII;1.693
04 Almería;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
04 Almería;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
04 Almería;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
04 Almería;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QIII;1.556
04 Almería;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
04 Almería;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
04 Almería;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
04 Almería;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2022QIII;1.570
04 Almería;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2022QII;""
04 Almería;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2022QI;""
04 Almería;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
04 Almería;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2021QIII;1.544
04 Almería;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2021QII;""
04 Almería;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2021QI;""
04 Almería;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
04 Almería;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2020QIII;1.435
04 Almería;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2020QII;""
04 Almería;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2020QI;""
04 Almería;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2022QIV;1.451
04 Almería;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
04 Almería;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2022QII;""
04 Almería;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2022QI;""
04 Almería;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2021QIV;1.443
04 Almería;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
04 Almería;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2021QII;""
04 Almería;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2021QI;""
04 Almería;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2020QIV;1.343
04 Almería;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
04 Almería;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2020QII;""
04 Almería;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2020QI;""
04 Almería;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
04 Almería;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
04 Almería;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QII;""
04 Almería;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QI;1.376
04 Almería;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
04 Almería;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
04 Almería;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QII;""
04 Almería;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QI;1.283
04 Almería;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
04 Almería;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
04 Almería;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QII;""
04 Almería;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QI;""
04 Almería;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
04 Almería;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
04 Almería;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QII;1.304
04 Almería;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QI;""
04 Almería;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
04 Almería;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
04 Almería;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QII;1.227
04 Almería;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QI;""
04 Almería;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
04 Almería;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
04 Almería;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QII;""
04 Almería;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QI;""
04 Almería;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
04 Almería;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
04 Almería;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
04 Almería;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
04 Almería;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
04 Almería;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
04 Almería;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
04 Almería;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
04 Almería;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
04 Almería;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
04 Almería;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
04 Almería;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
04 Almería;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
04 Almería;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;90,7
04 Almería;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
04 Almería;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
04 Almería;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
04 Almería;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;91,2
04 Almería;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
04 Almería;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
04 Almería;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
04 Almería;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;92,22
04 Almería;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
04 Almería;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
04 Almería;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;83,82
04 Almería;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
04 Almería;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
04 Almería;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
04 Almería;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;85,23
04 Almería;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
04 Almería;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
04 Almería;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
04 Almería;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;86,31
04 Almería;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
04 Almería;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
04 Almería;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
04 Almería;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
04 Almería;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
04 Almería;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
04 Almería;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;81,28
04 Almería;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
04 Almería;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
04 Almería;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
04 Almería;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;82,46
04 Almería;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
04 Almería;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
04 Almería;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
04 Almería;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
04 Almería;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
04 Almería;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
04 Almería;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;77,02
04 Almería;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
04 Almería;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
04 Almería;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
04 Almería;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;78,86
04 Almería;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
04 Almería;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
04 Almería;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
04 Almería;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
04 Almería;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
04 Almería;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
04 Almería;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QIII;1.058
04 Almería;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
04 Almería;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
04 Almería;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
04 Almería;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QIII;1.013
04 Almería;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
04 Almería;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
04 Almería;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
04 Almería;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QIII;930
04 Almería;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
04 Almería;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
04 Almería;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
04 Almería;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2022QIII;968
04 Almería;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2022QII;""
04 Almería;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2022QI;""
04 Almería;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
04 Almería;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2021QIII;916
04 Almería;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2021QII;""
04 Almería;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2021QI;""
04 Almería;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
04 Almería;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2020QIII;855
04 Almería;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2020QII;""
04 Almería;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2020QI;""
04 Almería;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2022QIV;889
04 Almería;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
04 Almería;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2022QII;""
04 Almería;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2022QI;""
04 Almería;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2021QIV;844
04 Almería;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
04 Almería;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2021QII;""
04 Almería;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2021QI;""
04 Almería;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2020QIV;810
04 Almería;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
04 Almería;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2020QII;""
04 Almería;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2020QI;""
04 Almería;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
04 Almería;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
04 Almería;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QII;""
04 Almería;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QI;780
04 Almería;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
04 Almería;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
04 Almería;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QII;""
04 Almería;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QI;759
04 Almería;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
04 Almería;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
04 Almería;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QII;""
04 Almería;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QI;""
04 Almería;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
04 Almería;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
04 Almería;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QII;732
04 Almería;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QI;""
04 Almería;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
04 Almería;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
04 Almería;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QII;713
04 Almería;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QI;""
04 Almería;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
04 Almería;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
04 Almería;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QII;""
04 Almería;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QI;""
04 Almería;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
04 Almería;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
04 Almería;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
04 Almería;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
04 Almería;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
04 Almería;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
04 Almería;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
04 Almería;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
04 Almería;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
04 Almería;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
04 Almería;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
04 Almería;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
04 Almería;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
04 Almería;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;91,49
04 Almería;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
04 Almería;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
04 Almería;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
04 Almería;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;90,42
04 Almería;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
04 Almería;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
04 Almería;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
04 Almería;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;91,94
04 Almería;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
04 Almería;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
04 Almería;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;84,03
04 Almería;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
04 Almería;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
04 Almería;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
04 Almería;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;83,32
04 Almería;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
04 Almería;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
04 Almería;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
04 Almería;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;87,1
04 Almería;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
04 Almería;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
04 Almería;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
04 Almería;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
04 Almería;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
04 Almería;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
04 Almería;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;77
04 Almería;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
04 Almería;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
04 Almería;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
04 Almería;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;81,61
04 Almería;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
04 Almería;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
04 Almería;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
04 Almería;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
04 Almería;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
04 Almería;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
04 Almería;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;72,26
04 Almería;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
04 Almería;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
04 Almería;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
04 Almería;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;76,67
04 Almería;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
04 Almería;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
04 Almería;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
04 Almería;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
04 Almería;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
04 Almería;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QIV;2.848
04 Almería;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
04 Almería;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
04 Almería;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
04 Almería;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QIV;2.797
04 Almería;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
04 Almería;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
04 Almería;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
04 Almería;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QIV;2.614
04 Almería;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
04 Almería;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
04 Almería;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
04 Almería;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2022QIV;2.612
04 Almería;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
04 Almería;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2022QII;""
04 Almería;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2022QI;""
04 Almería;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2021QIV;2.577
04 Almería;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
04 Almería;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2021QII;""
04 Almería;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2021QI;""
04 Almería;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2020QIV;2.438
04 Almería;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
04 Almería;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2020QII;""
04 Almería;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2020QI;""
04 Almería;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
04 Almería;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
04 Almería;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2022QII;""
04 Almería;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2022QI;2.422
04 Almería;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
04 Almería;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
04 Almería;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2021QII;""
04 Almería;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2021QI;2.301
04 Almería;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
04 Almería;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
04 Almería;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2020QII;""
04 Almería;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2020QI;""
04 Almería;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
04 Almería;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
04 Almería;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QII;2.278
04 Almería;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QI;""
04 Almería;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
04 Almería;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
04 Almería;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QII;2.182
04 Almería;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QI;""
04 Almería;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
04 Almería;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
04 Almería;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QII;""
04 Almería;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QI;""
04 Almería;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
04 Almería;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QIII;2.134
04 Almería;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QII;""
04 Almería;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QI;""
04 Almería;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
04 Almería;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QIII;2.042
04 Almería;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QII;""
04 Almería;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QI;""
04 Almería;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
04 Almería;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
04 Almería;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QII;""
04 Almería;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QI;""
04 Almería;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
04 Almería;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
04 Almería;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
04 Almería;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
04 Almería;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
04 Almería;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
04 Almería;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
04 Almería;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
04 Almería;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
04 Almería;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
04 Almería;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
04 Almería;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
04 Almería;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;91,71
04 Almería;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
04 Almería;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
04 Almería;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
04 Almería;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;92,13
04 Almería;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
04 Almería;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
04 Almería;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
04 Almería;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;93,27
04 Almería;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
04 Almería;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
04 Almería;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
04 Almería;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
04 Almería;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
04 Almería;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
04 Almería;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;86,59
04 Almería;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
04 Almería;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
04 Almería;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
04 Almería;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;88,03
04 Almería;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
04 Almería;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
04 Almería;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
04 Almería;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
04 Almería;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
04 Almería;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
04 Almería;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;81,44
04 Almería;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
04 Almería;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
04 Almería;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
04 Almería;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;83,47
04 Almería;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
04 Almería;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
04 Almería;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
04 Almería;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
04 Almería;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
04 Almería;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
04 Almería;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;76,3
04 Almería;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
04 Almería;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
04 Almería;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
04 Almería;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;78,12
04 Almería;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
04 Almería;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
04 Almería;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
04 Almería;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
04 Almería;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
04 Almería;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
04 Almería;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QIV;1.734
04 Almería;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
04 Almería;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
04 Almería;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
04 Almería;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QIV;1.721
04 Almería;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
04 Almería;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
04 Almería;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
04 Almería;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QIV;1.646
04 Almería;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
04 Almería;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
04 Almería;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
04 Almería;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2022QIV;1.588
04 Almería;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
04 Almería;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2022QII;""
04 Almería;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2022QI;""
04 Almería;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2021QIV;1.591
04 Almería;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
04 Almería;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2021QII;""
04 Almería;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2021QI;""
04 Almería;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2020QIV;1.530
04 Almería;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
04 Almería;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2020QII;""
04 Almería;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2020QI;""
04 Almería;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
04 Almería;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
04 Almería;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2022QII;""
04 Almería;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2022QI;1.512
04 Almería;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
04 Almería;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
04 Almería;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2021QII;""
04 Almería;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2021QI;1.452
04 Almería;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
04 Almería;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
04 Almería;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2020QII;""
04 Almería;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2020QI;""
04 Almería;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
04 Almería;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
04 Almería;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QII;1.425
04 Almería;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QI;""
04 Almería;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
04 Almería;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
04 Almería;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QII;1.382
04 Almería;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QI;""
04 Almería;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
04 Almería;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
04 Almería;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QII;""
04 Almería;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QI;""
04 Almería;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
04 Almería;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QIII;1.337
04 Almería;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QII;""
04 Almería;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QI;""
04 Almería;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
04 Almería;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QIII;1.298
04 Almería;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QII;""
04 Almería;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QI;""
04 Almería;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
04 Almería;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
04 Almería;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QII;""
04 Almería;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QI;""
04 Almería;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
04 Almería;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
04 Almería;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
04 Almería;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
04 Almería;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
04 Almería;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
04 Almería;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
04 Almería;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
04 Almería;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
04 Almería;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
04 Almería;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
04 Almería;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
04 Almería;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;91,58
04 Almería;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
04 Almería;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
04 Almería;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
04 Almería;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;92,45
04 Almería;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
04 Almería;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
04 Almería;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
04 Almería;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;92,95
04 Almería;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
04 Almería;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
04 Almería;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
04 Almería;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
04 Almería;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
04 Almería;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
04 Almería;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;87,86
04 Almería;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
04 Almería;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
04 Almería;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
04 Almería;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;88,21
04 Almería;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
04 Almería;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
04 Almería;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
04 Almería;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
04 Almería;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
04 Almería;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
04 Almería;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;82,8
04 Almería;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
04 Almería;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
04 Almería;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
04 Almería;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;83,96
04 Almería;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
04 Almería;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
04 Almería;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
04 Almería;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
04 Almería;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
04 Almería;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
04 Almería;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;77,69
04 Almería;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
04 Almería;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
04 Almería;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
04 Almería;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;78,86
04 Almería;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
04 Almería;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
04 Almería;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
04 Almería;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
04 Almería;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
04 Almería;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
04 Almería;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QIV;1.114
04 Almería;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
04 Almería;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
04 Almería;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
04 Almería;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QIV;1.076
04 Almería;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
04 Almería;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
04 Almería;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
04 Almería;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QIV;968
04 Almería;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
04 Almería;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
04 Almería;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
04 Almería;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2022QIV;1.024
04 Almería;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
04 Almería;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2022QII;""
04 Almería;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2022QI;""
04 Almería;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2021QIV;986
04 Almería;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
04 Almería;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2021QII;""
04 Almería;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2021QI;""
04 Almería;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2020QIV;908
04 Almería;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
04 Almería;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2020QII;""
04 Almería;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2020QI;""
04 Almería;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
04 Almería;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
04 Almería;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2022QII;""
04 Almería;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2022QI;910
04 Almería;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
04 Almería;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
04 Almería;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2021QII;""
04 Almería;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2021QI;849
04 Almería;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
04 Almería;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
04 Almería;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2020QII;""
04 Almería;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2020QI;""
04 Almería;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
04 Almería;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
04 Almería;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QII;853
04 Almería;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QI;""
04 Almería;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
04 Almería;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
04 Almería;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QII;800
04 Almería;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QI;""
04 Almería;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
04 Almería;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
04 Almería;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QII;""
04 Almería;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QI;""
04 Almería;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
04 Almería;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QIII;797
04 Almería;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QII;""
04 Almería;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QI;""
04 Almería;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
04 Almería;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QIII;744
04 Almería;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QII;""
04 Almería;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QI;""
04 Almería;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
04 Almería;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
04 Almería;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QII;""
04 Almería;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QI;""
04 Almería;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
04 Almería;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
04 Almería;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
04 Almería;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
04 Almería;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
04 Almería;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
04 Almería;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
04 Almería;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
04 Almería;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
04 Almería;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
04 Almería;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
04 Almería;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
04 Almería;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;91,92
04 Almería;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
04 Almería;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
04 Almería;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
04 Almería;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;91,64
04 Almería;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
04 Almería;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
04 Almería;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
04 Almería;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;93,8
04 Almería;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
04 Almería;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
04 Almería;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
04 Almería;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
04 Almería;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
04 Almería;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
04 Almería;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;84,57
04 Almería;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
04 Almería;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
04 Almería;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
04 Almería;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;87,71
04 Almería;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
04 Almería;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
04 Almería;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
04 Almería;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
04 Almería;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
04 Almería;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
04 Almería;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;79,28
04 Almería;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
04 Almería;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
04 Almería;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
04 Almería;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;82,64
04 Almería;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
04 Almería;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
04 Almería;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
04 Almería;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
04 Almería;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
04 Almería;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
04 Almería;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;74,07
04 Almería;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
04 Almería;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
04 Almería;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
04 Almería;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;76,86
04 Almería;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
04 Almería;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
04 Almería;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
04 Almería;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
04 Almería;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
04 Almería;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
04 Almería;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
04 Almería;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
04 Almería;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
04 Almería;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QI;8.202
04 Almería;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
04 Almería;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
04 Almería;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
04 Almería;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QI;8.398
04 Almería;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
04 Almería;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
04 Almería;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
04 Almería;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QI;8.036
04 Almería;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
04 Almería;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
04 Almería;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2022QII;""
04 Almería;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2022QI;7.904
04 Almería;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
04 Almería;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
04 Almería;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2021QII;""
04 Almería;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2021QI;8.125
04 Almería;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
04 Almería;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
04 Almería;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2020QII;""
04 Almería;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2020QI;7.476
04 Almería;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
04 Almería;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
04 Almería;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2022QII;7.609
04 Almería;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2022QI;""
04 Almería;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
04 Almería;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
04 Almería;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2021QII;7.844
04 Almería;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2021QI;""
04 Almería;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
04 Almería;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
04 Almería;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2020QII;7.301
04 Almería;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2020QI;""
04 Almería;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
04 Almería;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QIII;7.322
04 Almería;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QII;""
04 Almería;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QI;""
04 Almería;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
04 Almería;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QIII;7.593
04 Almería;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QII;""
04 Almería;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QI;""
04 Almería;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
04 Almería;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QIII;7.061
04 Almería;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QII;""
04 Almería;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QI;""
04 Almería;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QIV;7.078
04 Almería;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
04 Almería;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QII;""
04 Almería;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QI;""
04 Almería;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QIV;7.329
04 Almería;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
04 Almería;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QII;""
04 Almería;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QI;""
04 Almería;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QIV;6.823
04 Almería;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
04 Almería;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QII;""
04 Almería;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QI;""
04 Almería;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
04 Almería;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
04 Almería;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
04 Almería;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
04 Almería;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
04 Almería;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
04 Almería;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
04 Almería;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
04 Almería;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
04 Almería;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
04 Almería;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
04 Almería;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
04 Almería;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
04 Almería;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
04 Almería;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
04 Almería;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;96,37
04 Almería;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
04 Almería;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
04 Almería;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
04 Almería;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;96,75
04 Almería;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
04 Almería;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
04 Almería;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
04 Almería;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;93,03
04 Almería;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
04 Almería;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
04 Almería;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;92,77
04 Almería;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
04 Almería;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
04 Almería;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
04 Almería;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;93,4
04 Almería;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
04 Almería;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
04 Almería;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
04 Almería;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;90,85
04 Almería;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
04 Almería;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
04 Almería;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;89,27
04 Almería;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
04 Almería;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
04 Almería;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
04 Almería;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;90,41
04 Almería;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
04 Almería;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
04 Almería;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
04 Almería;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;87,87
04 Almería;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
04 Almería;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
04 Almería;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;86,3
04 Almería;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
04 Almería;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
04 Almería;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
04 Almería;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;87,27
04 Almería;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
04 Almería;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
04 Almería;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
04 Almería;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;84,91
04 Almería;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
04 Almería;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
04 Almería;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
04 Almería;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
04 Almería;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
04 Almería;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
04 Almería;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QI;4.850
04 Almería;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
04 Almería;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
04 Almería;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
04 Almería;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QI;5.014
04 Almería;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
04 Almería;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
04 Almería;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
04 Almería;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QI;4.747
04 Almería;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
04 Almería;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
04 Almería;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2022QII;""
04 Almería;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2022QI;4.680
04 Almería;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
04 Almería;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
04 Almería;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2021QII;""
04 Almería;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2021QI;4.861
04 Almería;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
04 Almería;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
04 Almería;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2020QII;""
04 Almería;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2020QI;4.421
04 Almería;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
04 Almería;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
04 Almería;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2022QII;4.518
04 Almería;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2022QI;""
04 Almería;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
04 Almería;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
04 Almería;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2021QII;4.704
04 Almería;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2021QI;""
04 Almería;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
04 Almería;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
04 Almería;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2020QII;4.329
04 Almería;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2020QI;""
04 Almería;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
04 Almería;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QIII;4.367
04 Almería;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QII;""
04 Almería;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QI;""
04 Almería;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
04 Almería;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QIII;4.550
04 Almería;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QII;""
04 Almería;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QI;""
04 Almería;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
04 Almería;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QIII;4.201
04 Almería;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QII;""
04 Almería;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QI;""
04 Almería;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QIV;4.218
04 Almería;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
04 Almería;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QII;""
04 Almería;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QI;""
04 Almería;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QIV;4.408
04 Almería;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
04 Almería;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QII;""
04 Almería;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QI;""
04 Almería;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QIV;4.063
04 Almería;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
04 Almería;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QII;""
04 Almería;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QI;""
04 Almería;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
04 Almería;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
04 Almería;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
04 Almería;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
04 Almería;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
04 Almería;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
04 Almería;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
04 Almería;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
04 Almería;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
04 Almería;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
04 Almería;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
04 Almería;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
04 Almería;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
04 Almería;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
04 Almería;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
04 Almería;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;96,49
04 Almería;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
04 Almería;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
04 Almería;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
04 Almería;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;96,95
04 Almería;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
04 Almería;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
04 Almería;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
04 Almería;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;93,13
04 Almería;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
04 Almería;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
04 Almería;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;93,15
04 Almería;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
04 Almería;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
04 Almería;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
04 Almería;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;93,82
04 Almería;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
04 Almería;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
04 Almería;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
04 Almería;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;91,19
04 Almería;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
04 Almería;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
04 Almería;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;90,04
04 Almería;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
04 Almería;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
04 Almería;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
04 Almería;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;90,75
04 Almería;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
04 Almería;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
04 Almería;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
04 Almería;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;88,5
04 Almería;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
04 Almería;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
04 Almería;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;86,97
04 Almería;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
04 Almería;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
04 Almería;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
04 Almería;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;87,91
04 Almería;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
04 Almería;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
04 Almería;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
04 Almería;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;85,59
04 Almería;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
04 Almería;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
04 Almería;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
04 Almería;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
04 Almería;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
04 Almería;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
04 Almería;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QI;3.352
04 Almería;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
04 Almería;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
04 Almería;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
04 Almería;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QI;3.384
04 Almería;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
04 Almería;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
04 Almería;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
04 Almería;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QI;3.289
04 Almería;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
04 Almería;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
04 Almería;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2022QII;""
04 Almería;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2022QI;3.224
04 Almería;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
04 Almería;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
04 Almería;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2021QII;""
04 Almería;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2021QI;3.264
04 Almería;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
04 Almería;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
04 Almería;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2020QII;""
04 Almería;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2020QI;3.055
04 Almería;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
04 Almería;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
04 Almería;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2022QII;3.091
04 Almería;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2022QI;""
04 Almería;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
04 Almería;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
04 Almería;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2021QII;3.140
04 Almería;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2021QI;""
04 Almería;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
04 Almería;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
04 Almería;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2020QII;2.972
04 Almería;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2020QI;""
04 Almería;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
04 Almería;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QIII;2.955
04 Almería;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QII;""
04 Almería;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QI;""
04 Almería;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
04 Almería;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QIII;3.043
04 Almería;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QII;""
04 Almería;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QI;""
04 Almería;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
04 Almería;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QIII;2.860
04 Almería;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QII;""
04 Almería;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QI;""
04 Almería;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QIV;2.860
04 Almería;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
04 Almería;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QII;""
04 Almería;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QI;""
04 Almería;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QIV;2.921
04 Almería;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
04 Almería;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QII;""
04 Almería;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QI;""
04 Almería;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QIV;2.760
04 Almería;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
04 Almería;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QII;""
04 Almería;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QI;""
04 Almería;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
04 Almería;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
04 Almería;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
04 Almería;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
04 Almería;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
04 Almería;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
04 Almería;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
04 Almería;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
04 Almería;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
04 Almería;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
04 Almería;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
04 Almería;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
04 Almería;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
04 Almería;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
04 Almería;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
04 Almería;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;96,18
04 Almería;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
04 Almería;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
04 Almería;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
04 Almería;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;96,45
04 Almería;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
04 Almería;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
04 Almería;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
04 Almería;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;92,89
04 Almería;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
04 Almería;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
04 Almería;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;92,21
04 Almería;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
04 Almería;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
04 Almería;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
04 Almería;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;92,79
04 Almería;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
04 Almería;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
04 Almería;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
04 Almería;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;90,36
04 Almería;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
04 Almería;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
04 Almería;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;88,16
04 Almería;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
04 Almería;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
04 Almería;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
04 Almería;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;89,92
04 Almería;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
04 Almería;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
04 Almería;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
04 Almería;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;86,96
04 Almería;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
04 Almería;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
04 Almería;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;85,32
04 Almería;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
04 Almería;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
04 Almería;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
04 Almería;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;86,32
04 Almería;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
04 Almería;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
04 Almería;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
04 Almería;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;83,92
04 Almería;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
04 Almería;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
04 Almería;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
04 Almería;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
04 Almería;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
04 Almería;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QII;7.769
04 Almería;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
04 Almería;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
04 Almería;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
04 Almería;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QII;7.898
04 Almería;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
04 Almería;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
04 Almería;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
04 Almería;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QII;7.965
04 Almería;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
04 Almería;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
04 Almería;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
04 Almería;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2022QII;7.445
04 Almería;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2022QI;""
04 Almería;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
04 Almería;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
04 Almería;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2021QII;7.585
04 Almería;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2021QI;""
04 Almería;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
04 Almería;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
04 Almería;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2020QII;7.773
04 Almería;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2020QI;""
04 Almería;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
04 Almería;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2022QIII;7.125
04 Almería;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2022QII;""
04 Almería;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2022QI;""
04 Almería;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
04 Almería;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2021QIII;7.310
04 Almería;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2021QII;""
04 Almería;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2021QI;""
04 Almería;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
04 Almería;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2020QIII;7.502
04 Almería;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2020QII;""
04 Almería;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2020QI;""
04 Almería;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QIV;6.867
04 Almería;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
04 Almería;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QII;""
04 Almería;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QI;""
04 Almería;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QIV;7.028
04 Almería;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
04 Almería;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QII;""
04 Almería;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QI;""
04 Almería;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QIV;7.228
04 Almería;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
04 Almería;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QII;""
04 Almería;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QI;""
04 Almería;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
04 Almería;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
04 Almería;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QII;""
04 Almería;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QI;6.811
04 Almería;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
04 Almería;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
04 Almería;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QII;""
04 Almería;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QI;7.042
04 Almería;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
04 Almería;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
04 Almería;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QII;""
04 Almería;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QI;""
04 Almería;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
04 Almería;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
04 Almería;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
04 Almería;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
04 Almería;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
04 Almería;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
04 Almería;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
04 Almería;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
04 Almería;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
04 Almería;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
04 Almería;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
04 Almería;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
04 Almería;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
04 Almería;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
04 Almería;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;95,83
04 Almería;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
04 Almería;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
04 Almería;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
04 Almería;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;96,04
04 Almería;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
04 Almería;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
04 Almería;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
04 Almería;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;97,59
04 Almería;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
04 Almería;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
04 Almería;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;91,71
04 Almería;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
04 Almería;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
04 Almería;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
04 Almería;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;92,56
04 Almería;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
04 Almería;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
04 Almería;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
04 Almería;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;94,19
04 Almería;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
04 Almería;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
04 Almería;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;88,39
04 Almería;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
04 Almería;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
04 Almería;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
04 Almería;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;88,98
04 Almería;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
04 Almería;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
04 Almería;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
04 Almería;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;90,75
04 Almería;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
04 Almería;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
04 Almería;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
04 Almería;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
04 Almería;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
04 Almería;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
04 Almería;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;86,24
04 Almería;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
04 Almería;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
04 Almería;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
04 Almería;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;88,41
04 Almería;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
04 Almería;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
04 Almería;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
04 Almería;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
04 Almería;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
04 Almería;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
04 Almería;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QII;4.590
04 Almería;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
04 Almería;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
04 Almería;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
04 Almería;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QII;4.730
04 Almería;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
04 Almería;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
04 Almería;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
04 Almería;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QII;4.714
04 Almería;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
04 Almería;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
04 Almería;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
04 Almería;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2022QII;4.407
04 Almería;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2022QI;""
04 Almería;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
04 Almería;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
04 Almería;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2021QII;4.546
04 Almería;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2021QI;""
04 Almería;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
04 Almería;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
04 Almería;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2020QII;4.614
04 Almería;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2020QI;""
04 Almería;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
04 Almería;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2022QIII;4.238
04 Almería;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2022QII;""
04 Almería;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2022QI;""
04 Almería;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
04 Almería;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2021QIII;4.377
04 Almería;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2021QII;""
04 Almería;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2021QI;""
04 Almería;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
04 Almería;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2020QIII;4.462
04 Almería;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2020QII;""
04 Almería;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2020QI;""
04 Almería;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QIV;4.084
04 Almería;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
04 Almería;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QII;""
04 Almería;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QI;""
04 Almería;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QIV;4.216
04 Almería;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
04 Almería;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QII;""
04 Almería;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QI;""
04 Almería;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QIV;4.303
04 Almería;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
04 Almería;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QII;""
04 Almería;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QI;""
04 Almería;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
04 Almería;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
04 Almería;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QII;""
04 Almería;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QI;4.090
04 Almería;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
04 Almería;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
04 Almería;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QII;""
04 Almería;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QI;4.204
04 Almería;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
04 Almería;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
04 Almería;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QII;""
04 Almería;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QI;""
04 Almería;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
04 Almería;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
04 Almería;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
04 Almería;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
04 Almería;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
04 Almería;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
04 Almería;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
04 Almería;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
04 Almería;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
04 Almería;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
04 Almería;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
04 Almería;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
04 Almería;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
04 Almería;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
04 Almería;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;96,01
04 Almería;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
04 Almería;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
04 Almería;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
04 Almería;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;96,11
04 Almería;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
04 Almería;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
04 Almería;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
04 Almería;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;97,88
04 Almería;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
04 Almería;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
04 Almería;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;92,33
04 Almería;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
04 Almería;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
04 Almería;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
04 Almería;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;92,54
04 Almería;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
04 Almería;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
04 Almería;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
04 Almería;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;94,65
04 Almería;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
04 Almería;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
04 Almería;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;88,98
04 Almería;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
04 Almería;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
04 Almería;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
04 Almería;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;89,13
04 Almería;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
04 Almería;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
04 Almería;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
04 Almería;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;91,28
04 Almería;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
04 Almería;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
04 Almería;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
04 Almería;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
04 Almería;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
04 Almería;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
04 Almería;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;86,47
04 Almería;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
04 Almería;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
04 Almería;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
04 Almería;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;89,18
04 Almería;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
04 Almería;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
04 Almería;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
04 Almería;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
04 Almería;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
04 Almería;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
04 Almería;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QII;3.179
04 Almería;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
04 Almería;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
04 Almería;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
04 Almería;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QII;3.168
04 Almería;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
04 Almería;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
04 Almería;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
04 Almería;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QII;3.251
04 Almería;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
04 Almería;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
04 Almería;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
04 Almería;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2022QII;3.038
04 Almería;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2022QI;""
04 Almería;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
04 Almería;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
04 Almería;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2021QII;3.039
04 Almería;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2021QI;""
04 Almería;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
04 Almería;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
04 Almería;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2020QII;3.159
04 Almería;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2020QI;""
04 Almería;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
04 Almería;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2022QIII;2.887
04 Almería;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2022QII;""
04 Almería;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2022QI;""
04 Almería;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
04 Almería;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2021QIII;2.933
04 Almería;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2021QII;""
04 Almería;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2021QI;""
04 Almería;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
04 Almería;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2020QIII;3.040
04 Almería;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2020QII;""
04 Almería;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2020QI;""
04 Almería;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QIV;2.783
04 Almería;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
04 Almería;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QII;""
04 Almería;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QI;""
04 Almería;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QIV;2.812
04 Almería;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
04 Almería;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QII;""
04 Almería;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QI;""
04 Almería;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QIV;2.925
04 Almería;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
04 Almería;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QII;""
04 Almería;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QI;""
04 Almería;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
04 Almería;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
04 Almería;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QII;""
04 Almería;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QI;2.721
04 Almería;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
04 Almería;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
04 Almería;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QII;""
04 Almería;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QI;2.838
04 Almería;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
04 Almería;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
04 Almería;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QII;""
04 Almería;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QI;""
04 Almería;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
04 Almería;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
04 Almería;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
04 Almería;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
04 Almería;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
04 Almería;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
04 Almería;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
04 Almería;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
04 Almería;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
04 Almería;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
04 Almería;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
04 Almería;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
04 Almería;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
04 Almería;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
04 Almería;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;95,56
04 Almería;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
04 Almería;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
04 Almería;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
04 Almería;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;95,93
04 Almería;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
04 Almería;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
04 Almería;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
04 Almería;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;97,17
04 Almería;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
04 Almería;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
04 Almería;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;90,81
04 Almería;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
04 Almería;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
04 Almería;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
04 Almería;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;92,58
04 Almería;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
04 Almería;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
04 Almería;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
04 Almería;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;93,51
04 Almería;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
04 Almería;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
04 Almería;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;87,54
04 Almería;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
04 Almería;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
04 Almería;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
04 Almería;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;88,76
04 Almería;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
04 Almería;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
04 Almería;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
04 Almería;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;89,97
04 Almería;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
04 Almería;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
04 Almería;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
04 Almería;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
04 Almería;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
04 Almería;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
04 Almería;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;85,89
04 Almería;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
04 Almería;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
04 Almería;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
04 Almería;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;87,3
04 Almería;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
04 Almería;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
04 Almería;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
04 Almería;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
04 Almería;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
04 Almería;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QIII;7.870
04 Almería;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
04 Almería;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
04 Almería;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
04 Almería;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QIII;8.122
04 Almería;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
04 Almería;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
04 Almería;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
04 Almería;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QIII;8.178
04 Almería;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
04 Almería;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
04 Almería;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
04 Almería;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2022QIII;7.491
04 Almería;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2022QII;""
04 Almería;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2022QI;""
04 Almería;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
04 Almería;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2021QIII;7.786
04 Almería;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2021QII;""
04 Almería;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2021QI;""
04 Almería;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
04 Almería;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2020QIII;7.846
04 Almería;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2020QII;""
04 Almería;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2020QI;""
04 Almería;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2022QIV;7.183
04 Almería;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
04 Almería;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2022QII;""
04 Almería;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2022QI;""
04 Almería;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2021QIV;7.451
04 Almería;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
04 Almería;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2021QII;""
04 Almería;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2021QI;""
04 Almería;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2020QIV;7.536
04 Almería;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
04 Almería;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2020QII;""
04 Almería;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2020QI;""
04 Almería;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
04 Almería;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
04 Almería;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QII;""
04 Almería;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QI;7.204
04 Almería;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
04 Almería;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
04 Almería;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QII;""
04 Almería;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QI;7.323
04 Almería;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
04 Almería;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
04 Almería;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QII;""
04 Almería;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QI;""
04 Almería;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
04 Almería;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
04 Almería;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QII;6.967
04 Almería;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QI;""
04 Almería;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
04 Almería;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
04 Almería;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QII;7.115
04 Almería;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QI;""
04 Almería;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
04 Almería;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
04 Almería;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QII;""
04 Almería;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QI;""
04 Almería;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
04 Almería;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
04 Almería;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
04 Almería;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
04 Almería;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
04 Almería;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
04 Almería;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
04 Almería;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
04 Almería;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
04 Almería;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
04 Almería;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
04 Almería;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
04 Almería;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
04 Almería;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;95,18
04 Almería;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
04 Almería;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
04 Almería;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
04 Almería;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;95,86
04 Almería;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
04 Almería;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
04 Almería;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
04 Almería;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;95,94
04 Almería;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
04 Almería;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
04 Almería;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;91,27
04 Almería;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
04 Almería;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
04 Almería;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
04 Almería;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;91,74
04 Almería;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
04 Almería;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
04 Almería;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
04 Almería;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;92,15
04 Almería;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
04 Almería;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
04 Almería;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
04 Almería;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
04 Almería;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
04 Almería;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
04 Almería;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;88,7
04 Almería;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
04 Almería;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
04 Almería;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
04 Almería;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;89,55
04 Almería;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
04 Almería;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
04 Almería;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
04 Almería;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
04 Almería;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
04 Almería;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
04 Almería;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;85,78
04 Almería;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
04 Almería;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
04 Almería;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
04 Almería;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;87
04 Almería;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
04 Almería;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
04 Almería;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
04 Almería;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
04 Almería;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
04 Almería;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
04 Almería;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QIII;4.661
04 Almería;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
04 Almería;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
04 Almería;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
04 Almería;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QIII;4.845
04 Almería;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
04 Almería;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
04 Almería;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
04 Almería;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QIII;4.886
04 Almería;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
04 Almería;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
04 Almería;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
04 Almería;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2022QIII;4.456
04 Almería;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2022QII;""
04 Almería;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2022QI;""
04 Almería;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
04 Almería;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2021QIII;4.643
04 Almería;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2021QII;""
04 Almería;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2021QI;""
04 Almería;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
04 Almería;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2020QIII;4.690
04 Almería;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2020QII;""
04 Almería;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2020QI;""
04 Almería;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2022QIV;4.271
04 Almería;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
04 Almería;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2022QII;""
04 Almería;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2022QI;""
04 Almería;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2021QIV;4.450
04 Almería;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
04 Almería;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2021QII;""
04 Almería;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2021QI;""
04 Almería;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2020QIV;4.507
04 Almería;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
04 Almería;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2020QII;""
04 Almería;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2020QI;""
04 Almería;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
04 Almería;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
04 Almería;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QII;""
04 Almería;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QI;4.312
04 Almería;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
04 Almería;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
04 Almería;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QII;""
04 Almería;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QI;4.395
04 Almería;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
04 Almería;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
04 Almería;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QII;""
04 Almería;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QI;""
04 Almería;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
04 Almería;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
04 Almería;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QII;4.181
04 Almería;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QI;""
04 Almería;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
04 Almería;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
04 Almería;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QII;4.281
04 Almería;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QI;""
04 Almería;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
04 Almería;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
04 Almería;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QII;""
04 Almería;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QI;""
04 Almería;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
04 Almería;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
04 Almería;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
04 Almería;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
04 Almería;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
04 Almería;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
04 Almería;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
04 Almería;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
04 Almería;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
04 Almería;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
04 Almería;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
04 Almería;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
04 Almería;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
04 Almería;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;95,6
04 Almería;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
04 Almería;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
04 Almería;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
04 Almería;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;95,83
04 Almería;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
04 Almería;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
04 Almería;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
04 Almería;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;95,99
04 Almería;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
04 Almería;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
04 Almería;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;91,63
04 Almería;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
04 Almería;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
04 Almería;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
04 Almería;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;91,85
04 Almería;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
04 Almería;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
04 Almería;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
04 Almería;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;92,24
04 Almería;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
04 Almería;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
04 Almería;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
04 Almería;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
04 Almería;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
04 Almería;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
04 Almería;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;89
04 Almería;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
04 Almería;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
04 Almería;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
04 Almería;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;89,95
04 Almería;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
04 Almería;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
04 Almería;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
04 Almería;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
04 Almería;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
04 Almería;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
04 Almería;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;86,3
04 Almería;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
04 Almería;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
04 Almería;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
04 Almería;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;87,62
04 Almería;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
04 Almería;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
04 Almería;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
04 Almería;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
04 Almería;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
04 Almería;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
04 Almería;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QIII;3.209
04 Almería;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
04 Almería;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
04 Almería;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
04 Almería;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QIII;3.277
04 Almería;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
04 Almería;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
04 Almería;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
04 Almería;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QIII;3.292
04 Almería;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
04 Almería;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
04 Almería;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
04 Almería;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2022QIII;3.035
04 Almería;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2022QII;""
04 Almería;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2022QI;""
04 Almería;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
04 Almería;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2021QIII;3.143
04 Almería;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2021QII;""
04 Almería;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2021QI;""
04 Almería;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
04 Almería;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2020QIII;3.156
04 Almería;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2020QII;""
04 Almería;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2020QI;""
04 Almería;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2022QIV;2.912
04 Almería;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
04 Almería;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2022QII;""
04 Almería;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2022QI;""
04 Almería;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2021QIV;3.001
04 Almería;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
04 Almería;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2021QII;""
04 Almería;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2021QI;""
04 Almería;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2020QIV;3.029
04 Almería;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
04 Almería;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2020QII;""
04 Almería;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2020QI;""
04 Almería;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
04 Almería;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
04 Almería;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QII;""
04 Almería;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QI;2.892
04 Almería;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
04 Almería;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
04 Almería;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QII;""
04 Almería;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QI;2.928
04 Almería;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
04 Almería;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
04 Almería;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QII;""
04 Almería;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QI;""
04 Almería;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
04 Almería;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
04 Almería;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QII;2.786
04 Almería;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QI;""
04 Almería;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
04 Almería;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
04 Almería;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QII;2.834
04 Almería;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QI;""
04 Almería;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
04 Almería;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
04 Almería;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QII;""
04 Almería;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QI;""
04 Almería;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
04 Almería;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
04 Almería;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
04 Almería;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
04 Almería;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
04 Almería;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
04 Almería;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
04 Almería;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
04 Almería;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
04 Almería;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
04 Almería;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
04 Almería;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
04 Almería;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
04 Almería;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;94,58
04 Almería;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
04 Almería;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
04 Almería;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
04 Almería;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;95,91
04 Almería;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
04 Almería;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
04 Almería;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
04 Almería;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;95,87
04 Almería;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
04 Almería;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
04 Almería;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;90,74
04 Almería;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
04 Almería;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
04 Almería;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
04 Almería;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;91,58
04 Almería;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
04 Almería;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
04 Almería;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
04 Almería;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;92,01
04 Almería;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
04 Almería;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
04 Almería;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
04 Almería;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
04 Almería;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
04 Almería;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
04 Almería;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;88,25
04 Almería;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
04 Almería;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
04 Almería;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
04 Almería;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;88,94
04 Almería;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
04 Almería;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
04 Almería;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
04 Almería;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
04 Almería;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
04 Almería;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
04 Almería;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;85,02
04 Almería;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
04 Almería;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
04 Almería;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
04 Almería;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;86,09
04 Almería;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
04 Almería;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
04 Almería;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
04 Almería;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
04 Almería;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
04 Almería;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QIV;7.862
04 Almería;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
04 Almería;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
04 Almería;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
04 Almería;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QIV;8.164
04 Almería;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
04 Almería;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
04 Almería;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
04 Almería;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QIV;8.277
04 Almería;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
04 Almería;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
04 Almería;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
04 Almería;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2022QIV;7.511
04 Almería;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
04 Almería;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2022QII;""
04 Almería;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2022QI;""
04 Almería;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2021QIV;7.788
04 Almería;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
04 Almería;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2021QII;""
04 Almería;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2021QI;""
04 Almería;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2020QIV;7.929
04 Almería;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
04 Almería;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2020QII;""
04 Almería;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2020QI;""
04 Almería;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
04 Almería;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
04 Almería;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2022QII;""
04 Almería;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2022QI;7.518
04 Almería;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
04 Almería;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
04 Almería;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2021QII;""
04 Almería;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2021QI;7.693
04 Almería;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
04 Almería;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
04 Almería;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2020QII;""
04 Almería;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2020QI;""
04 Almería;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
04 Almería;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
04 Almería;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QII;7.262
04 Almería;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QI;""
04 Almería;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
04 Almería;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
04 Almería;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QII;7.464
04 Almería;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QI;""
04 Almería;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
04 Almería;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
04 Almería;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QII;""
04 Almería;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QI;""
04 Almería;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
04 Almería;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QIII;7.016
04 Almería;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QII;""
04 Almería;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QI;""
04 Almería;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
04 Almería;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QIII;7.238
04 Almería;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QII;""
04 Almería;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QI;""
04 Almería;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
04 Almería;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
04 Almería;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QII;""
04 Almería;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QI;""
04 Almería;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
04 Almería;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
04 Almería;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
04 Almería;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
04 Almería;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
04 Almería;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
04 Almería;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
04 Almería;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
04 Almería;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
04 Almería;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
04 Almería;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
04 Almería;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
04 Almería;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;95,54
04 Almería;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
04 Almería;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
04 Almería;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
04 Almería;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;95,39
04 Almería;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
04 Almería;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
04 Almería;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
04 Almería;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;95,8
04 Almería;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
04 Almería;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
04 Almería;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
04 Almería;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
04 Almería;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
04 Almería;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
04 Almería;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;92,09
04 Almería;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
04 Almería;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
04 Almería;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
04 Almería;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;92,94
04 Almería;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
04 Almería;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
04 Almería;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
04 Almería;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
04 Almería;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
04 Almería;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
04 Almería;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;88,95
04 Almería;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
04 Almería;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
04 Almería;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
04 Almería;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;90,18
04 Almería;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
04 Almería;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
04 Almería;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
04 Almería;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
04 Almería;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
04 Almería;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
04 Almería;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;85,94
04 Almería;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
04 Almería;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
04 Almería;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
04 Almería;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;87,45
04 Almería;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
04 Almería;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
04 Almería;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
04 Almería;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
04 Almería;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
04 Almería;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
04 Almería;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QIV;4.644
04 Almería;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
04 Almería;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
04 Almería;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
04 Almería;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QIV;4.845
04 Almería;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
04 Almería;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
04 Almería;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
04 Almería;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QIV;4.955
04 Almería;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
04 Almería;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
04 Almería;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
04 Almería;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2022QIV;4.439
04 Almería;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
04 Almería;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2022QII;""
04 Almería;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2022QI;""
04 Almería;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2021QIV;4.630
04 Almería;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
04 Almería;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2021QII;""
04 Almería;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2021QI;""
04 Almería;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2020QIV;4.747
04 Almería;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
04 Almería;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2020QII;""
04 Almería;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2020QI;""
04 Almería;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
04 Almería;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
04 Almería;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2022QII;""
04 Almería;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2022QI;4.477
04 Almería;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
04 Almería;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
04 Almería;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2021QII;""
04 Almería;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2021QI;4.621
04 Almería;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
04 Almería;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
04 Almería;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2020QII;""
04 Almería;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2020QI;""
04 Almería;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
04 Almería;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
04 Almería;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QII;4.338
04 Almería;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QI;""
04 Almería;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
04 Almería;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
04 Almería;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QII;4.493
04 Almería;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QI;""
04 Almería;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
04 Almería;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
04 Almería;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QII;""
04 Almería;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QI;""
04 Almería;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
04 Almería;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QIII;4.208
04 Almería;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QII;""
04 Almería;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QI;""
04 Almería;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
04 Almería;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QIII;4.354
04 Almería;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QII;""
04 Almería;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QI;""
04 Almería;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
04 Almería;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
04 Almería;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QII;""
04 Almería;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QI;""
04 Almería;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
04 Almería;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
04 Almería;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
04 Almería;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
04 Almería;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
04 Almería;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
04 Almería;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
04 Almería;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
04 Almería;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
04 Almería;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
04 Almería;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
04 Almería;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
04 Almería;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;95,59
04 Almería;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
04 Almería;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
04 Almería;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
04 Almería;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;95,56
04 Almería;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
04 Almería;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
04 Almería;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
04 Almería;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;95,8
04 Almería;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
04 Almería;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
04 Almería;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
04 Almería;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
04 Almería;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
04 Almería;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
04 Almería;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;92,4
04 Almería;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
04 Almería;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
04 Almería;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
04 Almería;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;93,26
04 Almería;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
04 Almería;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
04 Almería;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
04 Almería;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
04 Almería;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
04 Almería;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
04 Almería;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;89,54
04 Almería;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
04 Almería;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
04 Almería;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
04 Almería;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;90,68
04 Almería;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
04 Almería;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
04 Almería;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
04 Almería;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
04 Almería;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
04 Almería;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
04 Almería;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;86,85
04 Almería;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
04 Almería;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
04 Almería;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
04 Almería;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;87,87
04 Almería;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
04 Almería;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
04 Almería;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
04 Almería;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
04 Almería;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
04 Almería;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
04 Almería;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QIV;3.218
04 Almería;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
04 Almería;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
04 Almería;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
04 Almería;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QIV;3.319
04 Almería;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
04 Almería;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
04 Almería;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
04 Almería;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QIV;3.322
04 Almería;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
04 Almería;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
04 Almería;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
04 Almería;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2022QIV;3.072
04 Almería;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
04 Almería;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2022QII;""
04 Almería;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2022QI;""
04 Almería;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2021QIV;3.158
04 Almería;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
04 Almería;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2021QII;""
04 Almería;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2021QI;""
04 Almería;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2020QIV;3.182
04 Almería;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
04 Almería;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2020QII;""
04 Almería;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2020QI;""
04 Almería;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
04 Almería;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
04 Almería;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2022QII;""
04 Almería;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2022QI;3.041
04 Almería;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
04 Almería;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
04 Almería;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2021QII;""
04 Almería;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2021QI;3.072
04 Almería;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
04 Almería;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
04 Almería;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2020QII;""
04 Almería;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2020QI;""
04 Almería;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
04 Almería;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
04 Almería;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QII;2.924
04 Almería;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QI;""
04 Almería;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
04 Almería;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
04 Almería;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QII;2.971
04 Almería;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QI;""
04 Almería;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
04 Almería;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
04 Almería;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QII;""
04 Almería;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QI;""
04 Almería;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
04 Almería;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QIII;2.808
04 Almería;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QII;""
04 Almería;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QI;""
04 Almería;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
04 Almería;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QIII;2.884
04 Almería;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QII;""
04 Almería;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QI;""
04 Almería;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
04 Almería;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
04 Almería;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QII;""
04 Almería;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QI;""
04 Almería;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
04 Almería;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
04 Almería;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
04 Almería;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
04 Almería;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
04 Almería;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
04 Almería;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
04 Almería;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
04 Almería;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
04 Almería;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
04 Almería;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
04 Almería;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
04 Almería;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;95,46
04 Almería;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
04 Almería;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
04 Almería;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
04 Almería;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;95,15
04 Almería;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
04 Almería;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
04 Almería;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
04 Almería;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;95,79
04 Almería;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
04 Almería;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
04 Almería;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
04 Almería;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
04 Almería;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
04 Almería;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
04 Almería;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;91,62
04 Almería;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
04 Almería;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
04 Almería;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
04 Almería;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;92,47
04 Almería;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
04 Almería;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
04 Almería;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
04 Almería;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
04 Almería;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
04 Almería;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
04 Almería;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;88,1
04 Almería;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
04 Almería;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
04 Almería;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
04 Almería;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;89,43
04 Almería;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
04 Almería;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
04 Almería;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
04 Almería;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
04 Almería;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
04 Almería;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
04 Almería;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;84,6
04 Almería;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
04 Almería;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
04 Almería;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
04 Almería;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;86,82
04 Almería;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
04 Almería;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
04 Almería;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
04 Almería;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
04 Almería;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
04 Almería;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
04 Almería;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
04 Almería;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
04 Almería;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
04 Almería;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QI;13.075
04 Almería;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
04 Almería;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
04 Almería;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
04 Almería;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QI;12.883
04 Almería;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
04 Almería;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
04 Almería;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
04 Almería;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QI;12.845
04 Almería;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
04 Almería;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
04 Almería;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2022QII;""
04 Almería;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2022QI;12.706
04 Almería;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
04 Almería;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
04 Almería;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2021QII;""
04 Almería;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2021QI;12.597
04 Almería;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
04 Almería;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
04 Almería;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2020QII;""
04 Almería;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2020QI;12.051
04 Almería;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
04 Almería;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
04 Almería;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2022QII;12.357
04 Almería;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2022QI;""
04 Almería;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
04 Almería;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
04 Almería;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2021QII;12.336
04 Almería;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2021QI;""
04 Almería;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
04 Almería;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
04 Almería;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2020QII;11.838
04 Almería;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2020QI;""
04 Almería;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
04 Almería;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QIII;12.021
04 Almería;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QII;""
04 Almería;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QI;""
04 Almería;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
04 Almería;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QIII;12.067
04 Almería;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QII;""
04 Almería;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QI;""
04 Almería;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
04 Almería;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QIII;11.558
04 Almería;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QII;""
04 Almería;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QI;""
04 Almería;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QIV;11.692
04 Almería;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
04 Almería;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QII;""
04 Almería;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QI;""
04 Almería;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QIV;11.780
04 Almería;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
04 Almería;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QII;""
04 Almería;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QI;""
04 Almería;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QIV;11.270
04 Almería;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
04 Almería;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QII;""
04 Almería;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QI;""
04 Almería;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
04 Almería;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
04 Almería;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
04 Almería;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
04 Almería;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
04 Almería;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
04 Almería;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
04 Almería;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
04 Almería;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
04 Almería;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
04 Almería;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
04 Almería;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
04 Almería;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
04 Almería;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
04 Almería;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
04 Almería;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;97,18
04 Almería;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
04 Almería;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
04 Almería;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
04 Almería;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;97,78
04 Almería;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
04 Almería;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
04 Almería;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
04 Almería;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;93,82
04 Almería;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
04 Almería;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
04 Almería;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;94,51
04 Almería;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
04 Almería;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
04 Almería;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
04 Almería;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;95,75
04 Almería;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
04 Almería;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
04 Almería;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
04 Almería;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;92,16
04 Almería;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
04 Almería;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
04 Almería;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;91,94
04 Almería;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
04 Almería;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
04 Almería;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
04 Almería;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;93,67
04 Almería;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
04 Almería;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
04 Almería;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
04 Almería;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;89,98
04 Almería;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
04 Almería;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
04 Almería;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;89,42
04 Almería;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
04 Almería;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
04 Almería;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
04 Almería;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;91,44
04 Almería;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
04 Almería;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
04 Almería;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
04 Almería;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;87,74
04 Almería;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
04 Almería;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
04 Almería;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
04 Almería;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
04 Almería;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
04 Almería;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
04 Almería;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QI;8.220
04 Almería;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
04 Almería;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
04 Almería;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
04 Almería;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QI;8.107
04 Almería;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
04 Almería;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
04 Almería;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
04 Almería;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QI;8.044
04 Almería;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
04 Almería;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
04 Almería;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2022QII;""
04 Almería;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2022QI;7.993
04 Almería;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
04 Almería;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
04 Almería;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2021QII;""
04 Almería;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2021QI;7.917
04 Almería;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
04 Almería;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
04 Almería;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2020QII;""
04 Almería;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2020QI;7.572
04 Almería;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
04 Almería;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
04 Almería;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2022QII;7.801
04 Almería;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2022QI;""
04 Almería;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
04 Almería;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
04 Almería;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2021QII;7.751
04 Almería;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2021QI;""
04 Almería;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
04 Almería;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
04 Almería;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2020QII;7.446
04 Almería;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2020QI;""
04 Almería;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
04 Almería;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QIII;7.618
04 Almería;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QII;""
04 Almería;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QI;""
04 Almería;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
04 Almería;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QIII;7.600
04 Almería;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QII;""
04 Almería;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QI;""
04 Almería;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
04 Almería;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QIII;7.291
04 Almería;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QII;""
04 Almería;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QI;""
04 Almería;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QIV;7.415
04 Almería;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
04 Almería;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QII;""
04 Almería;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QI;""
04 Almería;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QIV;7.424
04 Almería;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
04 Almería;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QII;""
04 Almería;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QI;""
04 Almería;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QIV;7.141
04 Almería;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
04 Almería;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QII;""
04 Almería;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QI;""
04 Almería;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
04 Almería;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
04 Almería;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
04 Almería;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
04 Almería;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
04 Almería;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
04 Almería;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
04 Almería;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
04 Almería;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
04 Almería;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
04 Almería;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
04 Almería;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
04 Almería;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
04 Almería;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
04 Almería;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
04 Almería;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;97,24
04 Almería;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
04 Almería;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
04 Almería;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
04 Almería;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;97,66
04 Almería;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
04 Almería;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
04 Almería;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
04 Almería;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;94,13
04 Almería;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
04 Almería;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
04 Almería;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;94,9
04 Almería;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
04 Almería;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
04 Almería;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
04 Almería;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;95,61
04 Almería;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
04 Almería;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
04 Almería;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
04 Almería;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;92,57
04 Almería;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
04 Almería;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
04 Almería;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;92,68
04 Almería;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
04 Almería;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
04 Almería;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
04 Almería;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;93,75
04 Almería;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
04 Almería;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
04 Almería;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
04 Almería;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;90,64
04 Almería;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
04 Almería;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
04 Almería;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;90,21
04 Almería;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
04 Almería;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
04 Almería;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
04 Almería;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;91,58
04 Almería;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
04 Almería;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
04 Almería;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
04 Almería;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;88,77
04 Almería;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
04 Almería;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
04 Almería;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
04 Almería;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
04 Almería;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
04 Almería;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
04 Almería;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QI;4.855
04 Almería;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
04 Almería;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
04 Almería;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
04 Almería;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QI;4.776
04 Almería;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
04 Almería;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
04 Almería;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
04 Almería;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QI;4.801
04 Almería;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
04 Almería;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
04 Almería;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2022QII;""
04 Almería;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2022QI;4.713
04 Almería;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
04 Almería;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
04 Almería;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2021QII;""
04 Almería;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2021QI;4.680
04 Almería;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
04 Almería;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
04 Almería;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2020QII;""
04 Almería;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2020QI;4.479
04 Almería;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
04 Almería;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
04 Almería;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2022QII;4.556
04 Almería;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2022QI;""
04 Almería;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
04 Almería;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
04 Almería;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2021QII;4.585
04 Almería;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2021QI;""
04 Almería;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
04 Almería;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
04 Almería;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2020QII;4.392
04 Almería;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2020QI;""
04 Almería;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
04 Almería;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QIII;4.403
04 Almería;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QII;""
04 Almería;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QI;""
04 Almería;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
04 Almería;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QIII;4.467
04 Almería;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QII;""
04 Almería;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QI;""
04 Almería;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
04 Almería;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QIII;4.267
04 Almería;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QII;""
04 Almería;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QI;""
04 Almería;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QIV;4.277
04 Almería;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
04 Almería;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QII;""
04 Almería;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QI;""
04 Almería;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QIV;4.356
04 Almería;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
04 Almería;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QII;""
04 Almería;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QI;""
04 Almería;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QIV;4.129
04 Almería;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
04 Almería;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QII;""
04 Almería;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QI;""
04 Almería;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
04 Almería;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
04 Almería;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
04 Almería;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
04 Almería;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
04 Almería;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
04 Almería;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
04 Almería;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
04 Almería;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
04 Almería;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
04 Almería;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
04 Almería;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
04 Almería;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
04 Almería;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
04 Almería;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
04 Almería;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;97,08
04 Almería;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
04 Almería;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
04 Almería;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
04 Almería;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;97,99
04 Almería;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
04 Almería;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
04 Almería;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
04 Almería;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;93,29
04 Almería;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
04 Almería;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
04 Almería;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;93,84
04 Almería;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
04 Almería;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
04 Almería;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
04 Almería;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;96
04 Almería;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
04 Almería;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
04 Almería;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
04 Almería;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;91,48
04 Almería;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
04 Almería;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
04 Almería;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;90,69
04 Almería;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
04 Almería;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
04 Almería;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
04 Almería;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;93,53
04 Almería;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
04 Almería;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
04 Almería;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
04 Almería;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;88,88
04 Almería;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
04 Almería;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
04 Almería;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;88,09
04 Almería;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
04 Almería;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
04 Almería;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
04 Almería;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;91,21
04 Almería;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
04 Almería;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
04 Almería;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
04 Almería;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;86
04 Almería;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
04 Almería;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
04 Almería;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
04 Almería;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
04 Almería;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
04 Almería;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QII;12.918
04 Almería;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
04 Almería;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
04 Almería;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
04 Almería;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QII;12.912
04 Almería;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
04 Almería;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
04 Almería;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
04 Almería;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QII;12.562
04 Almería;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
04 Almería;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
04 Almería;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
04 Almería;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2022QII;12.520
04 Almería;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2022QI;""
04 Almería;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
04 Almería;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
04 Almería;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2021QII;12.598
04 Almería;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2021QI;""
04 Almería;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
04 Almería;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
04 Almería;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2020QII;12.321
04 Almería;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2020QI;""
04 Almería;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
04 Almería;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2022QIII;12.150
04 Almería;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2022QII;""
04 Almería;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2022QI;""
04 Almería;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
04 Almería;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2021QIII;12.281
04 Almería;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2021QII;""
04 Almería;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2021QI;""
04 Almería;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
04 Almería;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2020QIII;12.011
04 Almería;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2020QII;""
04 Almería;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2020QI;""
04 Almería;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QIV;11.791
04 Almería;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
04 Almería;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QII;""
04 Almería;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QI;""
04 Almería;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QIV;11.969
04 Almería;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
04 Almería;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QII;""
04 Almería;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QI;""
04 Almería;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QIV;11.694
04 Almería;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
04 Almería;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QII;""
04 Almería;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QI;""
04 Almería;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
04 Almería;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
04 Almería;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QII;""
04 Almería;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QI;11.690
04 Almería;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
04 Almería;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
04 Almería;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QII;""
04 Almería;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QI;11.496
04 Almería;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
04 Almería;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
04 Almería;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QII;""
04 Almería;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QI;""
04 Almería;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
04 Almería;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
04 Almería;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
04 Almería;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
04 Almería;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
04 Almería;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
04 Almería;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
04 Almería;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
04 Almería;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
04 Almería;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
04 Almería;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
04 Almería;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
04 Almería;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
04 Almería;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
04 Almería;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;96,92
04 Almería;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
04 Almería;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
04 Almería;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
04 Almería;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;97,57
04 Almería;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
04 Almería;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
04 Almería;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
04 Almería;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;98,08
04 Almería;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
04 Almería;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
04 Almería;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;94,05
04 Almería;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
04 Almería;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
04 Almería;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
04 Almería;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;95,11
04 Almería;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
04 Almería;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
04 Almería;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
04 Almería;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;95,61
04 Almería;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
04 Almería;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
04 Almería;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;91,28
04 Almería;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
04 Almería;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
04 Almería;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
04 Almería;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;92,7
04 Almería;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
04 Almería;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
04 Almería;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
04 Almería;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;93,09
04 Almería;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
04 Almería;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
04 Almería;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
04 Almería;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
04 Almería;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
04 Almería;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
04 Almería;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;90,54
04 Almería;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
04 Almería;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
04 Almería;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
04 Almería;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;91,51
04 Almería;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
04 Almería;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
04 Almería;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
04 Almería;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
04 Almería;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
04 Almería;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
04 Almería;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QII;8.087
04 Almería;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
04 Almería;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
04 Almería;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
04 Almería;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QII;8.114
04 Almería;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
04 Almería;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
04 Almería;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
04 Almería;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QII;7.877
04 Almería;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
04 Almería;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
04 Almería;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
04 Almería;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2022QII;7.866
04 Almería;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2022QI;""
04 Almería;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
04 Almería;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
04 Almería;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2021QII;7.917
04 Almería;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2021QI;""
04 Almería;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
04 Almería;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
04 Almería;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2020QII;7.734
04 Almería;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2020QI;""
04 Almería;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
04 Almería;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2022QIII;7.666
04 Almería;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2022QII;""
04 Almería;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2022QI;""
04 Almería;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
04 Almería;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2021QIII;7.738
04 Almería;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2021QII;""
04 Almería;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2021QI;""
04 Almería;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
04 Almería;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2020QIII;7.564
04 Almería;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2020QII;""
04 Almería;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2020QI;""
04 Almería;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QIV;7.446
04 Almería;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
04 Almería;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QII;""
04 Almería;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QI;""
04 Almería;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QIV;7.551
04 Almería;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
04 Almería;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QII;""
04 Almería;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QI;""
04 Almería;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QIV;7.398
04 Almería;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
04 Almería;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QII;""
04 Almería;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QI;""
04 Almería;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
04 Almería;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
04 Almería;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QII;""
04 Almería;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QI;7.385
04 Almería;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
04 Almería;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
04 Almería;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QII;""
04 Almería;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QI;7.264
04 Almería;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
04 Almería;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
04 Almería;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QII;""
04 Almería;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QI;""
04 Almería;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
04 Almería;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
04 Almería;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
04 Almería;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
04 Almería;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
04 Almería;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
04 Almería;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
04 Almería;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
04 Almería;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
04 Almería;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
04 Almería;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
04 Almería;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
04 Almería;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
04 Almería;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
04 Almería;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;97,27
04 Almería;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
04 Almería;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
04 Almería;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
04 Almería;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;97,57
04 Almería;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
04 Almería;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
04 Almería;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
04 Almería;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;98,18
04 Almería;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
04 Almería;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
04 Almería;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;94,79
04 Almería;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
04 Almería;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
04 Almería;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
04 Almería;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;95,37
04 Almería;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
04 Almería;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
04 Almería;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
04 Almería;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;96,03
04 Almería;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
04 Almería;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
04 Almería;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;92,07
04 Almería;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
04 Almería;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
04 Almería;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
04 Almería;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;93,06
04 Almería;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
04 Almería;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
04 Almería;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
04 Almería;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;93,92
04 Almería;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
04 Almería;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
04 Almería;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
04 Almería;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
04 Almería;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
04 Almería;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
04 Almería;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;91,02
04 Almería;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
04 Almería;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
04 Almería;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
04 Almería;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;92,22
04 Almería;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
04 Almería;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
04 Almería;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
04 Almería;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
04 Almería;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
04 Almería;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
04 Almería;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QII;4.831
04 Almería;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
04 Almería;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
04 Almería;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
04 Almería;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QII;4.798
04 Almería;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
04 Almería;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
04 Almería;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
04 Almería;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QII;4.685
04 Almería;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
04 Almería;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
04 Almería;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
04 Almería;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2022QII;4.654
04 Almería;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2022QI;""
04 Almería;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
04 Almería;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
04 Almería;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2021QII;4.681
04 Almería;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2021QI;""
04 Almería;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
04 Almería;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
04 Almería;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2020QII;4.587
04 Almería;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2020QI;""
04 Almería;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
04 Almería;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2022QIII;4.484
04 Almería;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2022QII;""
04 Almería;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2022QI;""
04 Almería;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
04 Almería;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2021QIII;4.543
04 Almería;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2021QII;""
04 Almería;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2021QI;""
04 Almería;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
04 Almería;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2020QIII;4.447
04 Almería;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2020QII;""
04 Almería;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2020QI;""
04 Almería;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QIV;4.345
04 Almería;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
04 Almería;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QII;""
04 Almería;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QI;""
04 Almería;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QIV;4.418
04 Almería;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
04 Almería;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QII;""
04 Almería;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QI;""
04 Almería;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QIV;4.296
04 Almería;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
04 Almería;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QII;""
04 Almería;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QI;""
04 Almería;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
04 Almería;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
04 Almería;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QII;""
04 Almería;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QI;4.305
04 Almería;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
04 Almería;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
04 Almería;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QII;""
04 Almería;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QI;4.232
04 Almería;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
04 Almería;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
04 Almería;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QII;""
04 Almería;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QI;""
04 Almería;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
04 Almería;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
04 Almería;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
04 Almería;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
04 Almería;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
04 Almería;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
04 Almería;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
04 Almería;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
04 Almería;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
04 Almería;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
04 Almería;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
04 Almería;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
04 Almería;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
04 Almería;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
04 Almería;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;96,34
04 Almería;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
04 Almería;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
04 Almería;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
04 Almería;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;97,56
04 Almería;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
04 Almería;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
04 Almería;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
04 Almería;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;97,91
04 Almería;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
04 Almería;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
04 Almería;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;92,82
04 Almería;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
04 Almería;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
04 Almería;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
04 Almería;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;94,69
04 Almería;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
04 Almería;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
04 Almería;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
04 Almería;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;94,92
04 Almería;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
04 Almería;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
04 Almería;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;89,94
04 Almería;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
04 Almería;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
04 Almería;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
04 Almería;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;92,08
04 Almería;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
04 Almería;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
04 Almería;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
04 Almería;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;91,7
04 Almería;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
04 Almería;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
04 Almería;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
04 Almería;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
04 Almería;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
04 Almería;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
04 Almería;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;89,72
04 Almería;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
04 Almería;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
04 Almería;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
04 Almería;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;90,33
04 Almería;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
04 Almería;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
04 Almería;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
04 Almería;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
04 Almería;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
04 Almería;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QIII;13.049
04 Almería;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
04 Almería;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
04 Almería;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
04 Almería;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QIII;13.081
04 Almería;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
04 Almería;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
04 Almería;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
04 Almería;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QIII;12.795
04 Almería;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
04 Almería;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
04 Almería;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
04 Almería;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2022QIII;12.590
04 Almería;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2022QII;""
04 Almería;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2022QI;""
04 Almería;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
04 Almería;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2021QIII;12.702
04 Almería;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2021QII;""
04 Almería;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2021QI;""
04 Almería;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
04 Almería;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2020QIII;12.415
04 Almería;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2020QII;""
04 Almería;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2020QI;""
04 Almería;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2022QIV;12.169
04 Almería;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
04 Almería;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2022QII;""
04 Almería;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2022QI;""
04 Almería;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2021QIV;12.337
04 Almería;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
04 Almería;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2021QII;""
04 Almería;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2021QI;""
04 Almería;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2020QIV;12.056
04 Almería;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
04 Almería;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2020QII;""
04 Almería;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2020QI;""
04 Almería;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
04 Almería;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
04 Almería;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QII;""
04 Almería;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QI;12.030
04 Almería;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
04 Almería;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
04 Almería;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QII;""
04 Almería;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QI;11.835
04 Almería;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
04 Almería;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
04 Almería;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QII;""
04 Almería;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QI;""
04 Almería;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
04 Almería;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
04 Almería;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QII;11.752
04 Almería;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QI;""
04 Almería;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
04 Almería;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
04 Almería;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QII;11.626
04 Almería;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QI;""
04 Almería;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
04 Almería;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
04 Almería;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QII;""
04 Almería;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QI;""
04 Almería;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
04 Almería;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
04 Almería;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
04 Almería;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
04 Almería;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
04 Almería;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
04 Almería;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
04 Almería;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
04 Almería;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
04 Almería;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
04 Almería;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
04 Almería;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
04 Almería;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
04 Almería;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;96,48
04 Almería;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
04 Almería;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
04 Almería;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
04 Almería;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;97,1
04 Almería;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
04 Almería;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
04 Almería;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
04 Almería;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;97,03
04 Almería;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
04 Almería;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
04 Almería;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;93,26
04 Almería;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
04 Almería;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
04 Almería;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
04 Almería;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;94,31
04 Almería;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
04 Almería;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
04 Almería;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
04 Almería;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;94,22
04 Almería;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
04 Almería;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
04 Almería;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
04 Almería;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
04 Almería;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
04 Almería;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
04 Almería;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;91,97
04 Almería;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
04 Almería;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
04 Almería;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
04 Almería;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;92,5
04 Almería;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
04 Almería;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
04 Almería;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
04 Almería;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
04 Almería;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
04 Almería;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
04 Almería;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;89,84
04 Almería;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
04 Almería;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
04 Almería;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
04 Almería;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;90,86
04 Almería;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
04 Almería;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
04 Almería;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
04 Almería;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
04 Almería;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
04 Almería;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
04 Almería;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QIII;8.172
04 Almería;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
04 Almería;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
04 Almería;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
04 Almería;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QIII;8.200
04 Almería;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
04 Almería;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
04 Almería;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
04 Almería;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QIII;8.023
04 Almería;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
04 Almería;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
04 Almería;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
04 Almería;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2022QIII;7.919
04 Almería;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2022QII;""
04 Almería;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2022QI;""
04 Almería;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
04 Almería;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2021QIII;7.991
04 Almería;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2021QII;""
04 Almería;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2021QI;""
04 Almería;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
04 Almería;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2020QIII;7.809
04 Almería;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2020QII;""
04 Almería;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2020QI;""
04 Almería;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2022QIV;7.664
04 Almería;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
04 Almería;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2022QII;""
04 Almería;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2022QI;""
04 Almería;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2021QIV;7.773
04 Almería;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
04 Almería;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2021QII;""
04 Almería;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2021QI;""
04 Almería;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2020QIV;7.624
04 Almería;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
04 Almería;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2020QII;""
04 Almería;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2020QI;""
04 Almería;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
04 Almería;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
04 Almería;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QII;""
04 Almería;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QI;7.592
04 Almería;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
04 Almería;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
04 Almería;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QII;""
04 Almería;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QI;7.478
04 Almería;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
04 Almería;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
04 Almería;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QII;""
04 Almería;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QI;""
04 Almería;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
04 Almería;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
04 Almería;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QII;7.438
04 Almería;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QI;""
04 Almería;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
04 Almería;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
04 Almería;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QII;7.348
04 Almería;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QI;""
04 Almería;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
04 Almería;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
04 Almería;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QII;""
04 Almería;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QI;""
04 Almería;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
04 Almería;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
04 Almería;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
04 Almería;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
04 Almería;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
04 Almería;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
04 Almería;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
04 Almería;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
04 Almería;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
04 Almería;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
04 Almería;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
04 Almería;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
04 Almería;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
04 Almería;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;96,9
04 Almería;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
04 Almería;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
04 Almería;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
04 Almería;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;97,45
04 Almería;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
04 Almería;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
04 Almería;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
04 Almería;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;97,33
04 Almería;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
04 Almería;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
04 Almería;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;93,78
04 Almería;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
04 Almería;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
04 Almería;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
04 Almería;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;94,79
04 Almería;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
04 Almería;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
04 Almería;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
04 Almería;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;95,03
04 Almería;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
04 Almería;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
04 Almería;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
04 Almería;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
04 Almería;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
04 Almería;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
04 Almería;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;92,59
04 Almería;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
04 Almería;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
04 Almería;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
04 Almería;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;93,21
04 Almería;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
04 Almería;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
04 Almería;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
04 Almería;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
04 Almería;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
04 Almería;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
04 Almería;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;90,71
04 Almería;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
04 Almería;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
04 Almería;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
04 Almería;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;91,59
04 Almería;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
04 Almería;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
04 Almería;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
04 Almería;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
04 Almería;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
04 Almería;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
04 Almería;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QIII;4.877
04 Almería;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
04 Almería;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
04 Almería;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
04 Almería;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QIII;4.881
04 Almería;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
04 Almería;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
04 Almería;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
04 Almería;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QIII;4.772
04 Almería;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
04 Almería;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
04 Almería;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
04 Almería;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2022QIII;4.671
04 Almería;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2022QII;""
04 Almería;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2022QI;""
04 Almería;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
04 Almería;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2021QIII;4.711
04 Almería;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2021QII;""
04 Almería;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2021QI;""
04 Almería;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
04 Almería;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2020QIII;4.606
04 Almería;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2020QII;""
04 Almería;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2020QI;""
04 Almería;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2022QIV;4.505
04 Almería;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
04 Almería;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2022QII;""
04 Almería;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2022QI;""
04 Almería;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2021QIV;4.564
04 Almería;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
04 Almería;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2021QII;""
04 Almería;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2021QI;""
04 Almería;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2020QIV;4.432
04 Almería;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
04 Almería;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2020QII;""
04 Almería;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2020QI;""
04 Almería;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
04 Almería;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
04 Almería;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QII;""
04 Almería;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QI;4.438
04 Almería;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
04 Almería;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
04 Almería;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QII;""
04 Almería;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QI;4.357
04 Almería;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
04 Almería;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
04 Almería;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QII;""
04 Almería;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QI;""
04 Almería;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
04 Almería;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
04 Almería;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QII;4.314
04 Almería;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QI;""
04 Almería;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
04 Almería;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
04 Almería;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QII;4.278
04 Almería;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QI;""
04 Almería;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
04 Almería;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
04 Almería;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QII;""
04 Almería;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QI;""
04 Almería;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
04 Almería;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
04 Almería;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
04 Almería;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
04 Almería;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
04 Almería;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
04 Almería;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
04 Almería;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
04 Almería;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
04 Almería;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
04 Almería;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
04 Almería;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
04 Almería;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
04 Almería;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;95,78
04 Almería;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
04 Almería;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
04 Almería;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
04 Almería;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;96,52
04 Almería;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
04 Almería;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
04 Almería;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
04 Almería;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;96,52
04 Almería;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
04 Almería;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
04 Almería;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;92,37
04 Almería;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
04 Almería;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
04 Almería;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
04 Almería;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;93,51
04 Almería;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
04 Almería;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
04 Almería;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
04 Almería;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;92,88
04 Almería;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
04 Almería;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
04 Almería;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
04 Almería;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
04 Almería;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
04 Almería;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
04 Almería;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;90,92
04 Almería;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
04 Almería;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
04 Almería;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
04 Almería;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;91,3
04 Almería;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
04 Almería;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
04 Almería;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
04 Almería;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
04 Almería;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
04 Almería;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
04 Almería;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;88,38
04 Almería;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
04 Almería;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
04 Almería;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
04 Almería;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;89,65
04 Almería;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
04 Almería;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
04 Almería;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
04 Almería;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
04 Almería;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
04 Almería;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QIV;12.975
04 Almería;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
04 Almería;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
04 Almería;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
04 Almería;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QIV;13.093
04 Almería;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
04 Almería;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
04 Almería;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
04 Almería;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QIV;12.853
04 Almería;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
04 Almería;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
04 Almería;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
04 Almería;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2022QIV;12.509
04 Almería;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
04 Almería;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2022QII;""
04 Almería;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2022QI;""
04 Almería;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2021QIV;12.687
04 Almería;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
04 Almería;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2021QII;""
04 Almería;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2021QI;""
04 Almería;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2020QIV;12.433
04 Almería;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
04 Almería;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2020QII;""
04 Almería;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2020QI;""
04 Almería;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
04 Almería;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
04 Almería;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2022QII;""
04 Almería;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2022QI;12.357
04 Almería;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
04 Almería;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
04 Almería;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2021QII;""
04 Almería;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2021QI;12.181
04 Almería;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
04 Almería;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
04 Almería;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2020QII;""
04 Almería;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2020QI;""
04 Almería;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
04 Almería;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
04 Almería;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QII;12.048
04 Almería;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QI;""
04 Almería;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
04 Almería;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
04 Almería;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QII;11.950
04 Almería;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QI;""
04 Almería;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
04 Almería;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
04 Almería;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QII;""
04 Almería;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QI;""
04 Almería;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
04 Almería;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QIII;11.728
04 Almería;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QII;""
04 Almería;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QI;""
04 Almería;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
04 Almería;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QIII;11.712
04 Almería;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QII;""
04 Almería;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QI;""
04 Almería;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
04 Almería;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
04 Almería;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QII;""
04 Almería;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QI;""
04 Almería;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
04 Almería;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
04 Almería;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
04 Almería;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
04 Almería;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
04 Almería;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
04 Almería;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
04 Almería;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
04 Almería;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
04 Almería;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
04 Almería;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
04 Almería;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
04 Almería;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;96,41
04 Almería;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
04 Almería;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
04 Almería;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
04 Almería;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;96,9
04 Almería;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
04 Almería;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
04 Almería;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
04 Almería;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;96,73
04 Almería;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
04 Almería;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
04 Almería;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
04 Almería;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
04 Almería;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
04 Almería;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
04 Almería;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;94,38
04 Almería;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
04 Almería;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
04 Almería;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
04 Almería;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;94,77
04 Almería;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
04 Almería;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
04 Almería;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
04 Almería;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
04 Almería;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
04 Almería;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
04 Almería;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;92,02
04 Almería;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
04 Almería;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
04 Almería;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
04 Almería;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;92,97
04 Almería;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
04 Almería;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
04 Almería;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
04 Almería;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
04 Almería;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
04 Almería;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
04 Almería;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;89,57
04 Almería;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
04 Almería;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
04 Almería;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
04 Almería;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;91,12
04 Almería;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
04 Almería;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
04 Almería;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
04 Almería;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
04 Almería;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
04 Almería;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
04 Almería;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QIV;8.135
04 Almería;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
04 Almería;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
04 Almería;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
04 Almería;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QIV;8.232
04 Almería;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
04 Almería;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
04 Almería;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
04 Almería;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QIV;8.071
04 Almería;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
04 Almería;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
04 Almería;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
04 Almería;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2022QIV;7.850
04 Almería;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
04 Almería;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2022QII;""
04 Almería;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2022QI;""
04 Almería;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2021QIV;7.989
04 Almería;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
04 Almería;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2021QII;""
04 Almería;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2021QI;""
04 Almería;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2020QIV;7.843
04 Almería;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
04 Almería;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2020QII;""
04 Almería;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2020QI;""
04 Almería;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
04 Almería;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
04 Almería;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2022QII;""
04 Almería;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2022QI;7.790
04 Almería;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
04 Almería;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
04 Almería;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2021QII;""
04 Almería;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2021QI;7.676
04 Almería;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
04 Almería;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
04 Almería;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2020QII;""
04 Almería;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2020QI;""
04 Almería;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
04 Almería;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
04 Almería;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QII;7.621
04 Almería;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QI;""
04 Almería;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
04 Almería;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
04 Almería;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QII;7.533
04 Almería;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QI;""
04 Almería;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
04 Almería;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
04 Almería;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QII;""
04 Almería;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QI;""
04 Almería;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
04 Almería;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QIII;7.446
04 Almería;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QII;""
04 Almería;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QI;""
04 Almería;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
04 Almería;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QIII;7.399
04 Almería;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QII;""
04 Almería;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QI;""
04 Almería;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
04 Almería;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
04 Almería;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QII;""
04 Almería;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QI;""
04 Almería;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
04 Almería;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
04 Almería;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
04 Almería;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
04 Almería;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
04 Almería;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
04 Almería;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
04 Almería;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
04 Almería;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
04 Almería;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
04 Almería;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
04 Almería;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
04 Almería;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;96,5
04 Almería;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
04 Almería;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
04 Almería;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
04 Almería;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;97,05
04 Almería;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
04 Almería;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
04 Almería;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
04 Almería;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;97,18
04 Almería;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
04 Almería;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
04 Almería;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
04 Almería;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
04 Almería;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
04 Almería;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
04 Almería;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;94,63
04 Almería;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
04 Almería;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
04 Almería;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
04 Almería;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;95,11
04 Almería;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
04 Almería;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
04 Almería;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
04 Almería;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
04 Almería;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
04 Almería;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
04 Almería;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;92,58
04 Almería;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
04 Almería;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
04 Almería;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
04 Almería;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;93,33
04 Almería;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
04 Almería;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
04 Almería;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
04 Almería;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
04 Almería;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
04 Almería;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
04 Almería;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;90,45
04 Almería;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
04 Almería;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
04 Almería;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
04 Almería;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;91,67
04 Almería;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
04 Almería;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
04 Almería;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
04 Almería;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
04 Almería;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
04 Almería;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
04 Almería;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QIV;4.840
04 Almería;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
04 Almería;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
04 Almería;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
04 Almería;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QIV;4.861
04 Almería;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
04 Almería;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
04 Almería;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
04 Almería;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QIV;4.782
04 Almería;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
04 Almería;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
04 Almería;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
04 Almería;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2022QIV;4.659
04 Almería;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
04 Almería;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2022QII;""
04 Almería;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2022QI;""
04 Almería;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2021QIV;4.698
04 Almería;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
04 Almería;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2021QII;""
04 Almería;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2021QI;""
04 Almería;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2020QIV;4.590
04 Almería;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
04 Almería;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2020QII;""
04 Almería;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2020QI;""
04 Almería;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
04 Almería;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
04 Almería;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2022QII;""
04 Almería;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2022QI;4.567
04 Almería;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
04 Almería;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
04 Almería;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2021QII;""
04 Almería;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2021QI;4.505
04 Almería;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
04 Almería;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
04 Almería;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2020QII;""
04 Almería;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2020QI;""
04 Almería;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
04 Almería;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
04 Almería;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QII;4.427
04 Almería;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QI;""
04 Almería;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
04 Almería;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
04 Almería;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QII;4.417
04 Almería;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QI;""
04 Almería;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
04 Almería;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
04 Almería;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QII;""
04 Almería;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QI;""
04 Almería;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
04 Almería;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QIII;4.282
04 Almería;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QII;""
04 Almería;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QI;""
04 Almería;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
04 Almería;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QIII;4.313
04 Almería;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QII;""
04 Almería;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QI;""
04 Almería;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
04 Almería;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
04 Almería;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QII;""
04 Almería;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QI;""
04 Almería;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
04 Almería;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
04 Almería;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
04 Almería;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
04 Almería;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
04 Almería;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
04 Almería;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
04 Almería;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
04 Almería;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
04 Almería;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
04 Almería;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
04 Almería;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
04 Almería;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;96,26
04 Almería;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
04 Almería;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
04 Almería;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
04 Almería;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;96,65
04 Almería;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
04 Almería;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
04 Almería;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
04 Almería;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;95,98
04 Almería;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
04 Almería;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
04 Almería;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
04 Almería;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
04 Almería;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
04 Almería;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
04 Almería;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;93,95
04 Almería;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
04 Almería;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
04 Almería;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
04 Almería;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;94,21
04 Almería;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
04 Almería;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
04 Almería;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
04 Almería;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
04 Almería;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
04 Almería;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
04 Almería;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;91,07
04 Almería;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
04 Almería;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
04 Almería;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
04 Almería;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;92,37
04 Almería;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
04 Almería;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
04 Almería;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
04 Almería;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
04 Almería;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
04 Almería;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
04 Almería;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;88,09
04 Almería;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
04 Almería;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
04 Almería;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
04 Almería;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;90,19
04 Almería;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
04 Almería;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
04 Almería;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
04 Almería;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
04 Almería;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
04 Almería;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
04 Almería;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
04 Almería;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
04 Almería;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
04 Almería;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QI;11.313
04 Almería;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
04 Almería;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
04 Almería;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
04 Almería;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QI;10.964
04 Almería;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
04 Almería;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
04 Almería;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
04 Almería;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QI;11.078
04 Almería;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
04 Almería;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
04 Almería;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2022QII;""
04 Almería;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2022QI;11.052
04 Almería;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
04 Almería;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
04 Almería;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2021QII;""
04 Almería;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2021QI;10.735
04 Almería;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
04 Almería;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
04 Almería;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2020QII;""
04 Almería;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2020QI;10.567
04 Almería;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
04 Almería;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
04 Almería;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2022QII;10.825
04 Almería;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2022QI;""
04 Almería;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
04 Almería;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
04 Almería;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2021QII;10.515
04 Almería;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2021QI;""
04 Almería;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
04 Almería;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
04 Almería;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2020QII;10.391
04 Almería;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2020QI;""
04 Almería;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
04 Almería;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QIII;10.622
04 Almería;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QII;""
04 Almería;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QI;""
04 Almería;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
04 Almería;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QIII;10.352
04 Almería;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QII;""
04 Almería;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QI;""
04 Almería;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
04 Almería;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QIII;10.174
04 Almería;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QII;""
04 Almería;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QI;""
04 Almería;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QIV;10.370
04 Almería;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
04 Almería;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QII;""
04 Almería;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QI;""
04 Almería;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QIV;10.153
04 Almería;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
04 Almería;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QII;""
04 Almería;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QI;""
04 Almería;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QIV;9.995
04 Almería;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
04 Almería;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QII;""
04 Almería;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QI;""
04 Almería;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
04 Almería;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
04 Almería;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
04 Almería;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
04 Almería;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
04 Almería;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
04 Almería;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
04 Almería;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
04 Almería;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
04 Almería;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
04 Almería;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
04 Almería;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
04 Almería;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
04 Almería;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
04 Almería;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
04 Almería;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;97,69
04 Almería;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
04 Almería;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
04 Almería;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
04 Almería;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;97,91
04 Almería;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
04 Almería;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
04 Almería;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
04 Almería;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;95,39
04 Almería;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
04 Almería;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
04 Almería;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;95,69
04 Almería;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
04 Almería;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
04 Almería;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
04 Almería;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;95,9
04 Almería;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
04 Almería;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
04 Almería;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
04 Almería;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;93,8
04 Almería;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
04 Almería;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
04 Almería;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;93,89
04 Almería;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
04 Almería;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
04 Almería;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
04 Almería;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;94,42
04 Almería;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
04 Almería;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
04 Almería;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
04 Almería;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;91,84
04 Almería;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
04 Almería;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
04 Almería;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;91,66
04 Almería;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
04 Almería;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
04 Almería;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
04 Almería;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;92,6
04 Almería;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
04 Almería;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
04 Almería;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
04 Almería;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;90,22
04 Almería;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
04 Almería;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
04 Almería;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
04 Almería;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
04 Almería;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
04 Almería;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
04 Almería;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QI;7.143
04 Almería;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
04 Almería;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
04 Almería;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
04 Almería;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QI;7.041
04 Almería;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
04 Almería;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
04 Almería;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
04 Almería;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QI;7.055
04 Almería;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
04 Almería;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
04 Almería;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2022QII;""
04 Almería;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2022QI;6.981
04 Almería;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
04 Almería;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
04 Almería;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2021QII;""
04 Almería;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2021QI;6.902
04 Almería;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
04 Almería;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
04 Almería;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2020QII;""
04 Almería;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2020QI;6.761
04 Almería;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
04 Almería;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
04 Almería;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2022QII;6.849
04 Almería;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2022QI;""
04 Almería;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
04 Almería;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
04 Almería;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2021QII;6.760
04 Almería;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2021QI;""
04 Almería;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
04 Almería;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
04 Almería;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2020QII;6.660
04 Almería;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2020QI;""
04 Almería;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
04 Almería;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QIII;6.729
04 Almería;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QII;""
04 Almería;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QI;""
04 Almería;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
04 Almería;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QIII;6.657
04 Almería;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QII;""
04 Almería;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QI;""
04 Almería;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
04 Almería;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QIII;6.541
04 Almería;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QII;""
04 Almería;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QI;""
04 Almería;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QIV;6.588
04 Almería;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
04 Almería;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QII;""
04 Almería;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QI;""
04 Almería;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QIV;6.542
04 Almería;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
04 Almería;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QII;""
04 Almería;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QI;""
04 Almería;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QIV;6.434
04 Almería;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
04 Almería;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QII;""
04 Almería;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QI;""
04 Almería;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
04 Almería;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
04 Almería;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
04 Almería;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
04 Almería;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
04 Almería;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
04 Almería;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
04 Almería;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
04 Almería;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
04 Almería;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
04 Almería;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
04 Almería;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
04 Almería;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
04 Almería;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
04 Almería;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
04 Almería;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;97,73
04 Almería;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
04 Almería;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
04 Almería;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
04 Almería;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;98,03
04 Almería;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
04 Almería;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
04 Almería;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
04 Almería;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;95,83
04 Almería;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
04 Almería;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
04 Almería;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;95,88
04 Almería;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
04 Almería;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
04 Almería;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
04 Almería;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;96,01
04 Almería;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
04 Almería;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
04 Almería;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
04 Almería;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;94,4
04 Almería;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
04 Almería;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
04 Almería;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;94,2
04 Almería;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
04 Almería;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
04 Almería;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
04 Almería;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;94,55
04 Almería;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
04 Almería;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
04 Almería;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
04 Almería;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;92,71
04 Almería;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
04 Almería;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
04 Almería;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;92,23
04 Almería;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
04 Almería;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
04 Almería;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
04 Almería;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;92,91
04 Almería;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
04 Almería;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
04 Almería;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
04 Almería;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;91,2
04 Almería;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
04 Almería;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
04 Almería;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
04 Almería;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
04 Almería;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
04 Almería;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
04 Almería;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QI;4.170
04 Almería;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
04 Almería;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
04 Almería;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
04 Almería;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QI;3.923
04 Almería;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
04 Almería;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
04 Almería;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
04 Almería;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QI;4.023
04 Almería;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
04 Almería;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
04 Almería;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2022QII;""
04 Almería;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2022QI;4.071
04 Almería;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
04 Almería;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
04 Almería;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2021QII;""
04 Almería;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2021QI;3.833
04 Almería;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
04 Almería;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
04 Almería;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2020QII;""
04 Almería;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2020QI;3.806
04 Almería;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
04 Almería;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
04 Almería;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2022QII;3.976
04 Almería;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2022QI;""
04 Almería;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
04 Almería;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
04 Almería;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2021QII;3.755
04 Almería;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2021QI;""
04 Almería;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
04 Almería;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
04 Almería;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2020QII;3.731
04 Almería;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2020QI;""
04 Almería;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
04 Almería;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QIII;3.893
04 Almería;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QII;""
04 Almería;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QI;""
04 Almería;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
04 Almería;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QIII;3.695
04 Almería;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QII;""
04 Almería;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QI;""
04 Almería;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
04 Almería;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QIII;3.633
04 Almería;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QII;""
04 Almería;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QI;""
04 Almería;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QIV;3.782
04 Almería;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
04 Almería;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QII;""
04 Almería;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QI;""
04 Almería;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QIV;3.611
04 Almería;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
04 Almería;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QII;""
04 Almería;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QI;""
04 Almería;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QIV;3.561
04 Almería;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
04 Almería;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QII;""
04 Almería;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QI;""
04 Almería;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
04 Almería;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
04 Almería;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
04 Almería;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
04 Almería;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
04 Almería;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
04 Almería;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
04 Almería;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
04 Almería;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
04 Almería;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
04 Almería;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
04 Almería;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
04 Almería;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
04 Almería;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
04 Almería;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
04 Almería;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;97,63
04 Almería;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
04 Almería;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
04 Almería;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
04 Almería;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;97,71
04 Almería;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
04 Almería;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
04 Almería;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
04 Almería;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;94,61
04 Almería;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
04 Almería;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
04 Almería;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;95,35
04 Almería;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
04 Almería;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
04 Almería;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
04 Almería;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;95,72
04 Almería;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
04 Almería;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
04 Almería;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
04 Almería;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;92,74
04 Almería;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
04 Almería;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
04 Almería;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;93,36
04 Almería;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
04 Almería;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
04 Almería;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
04 Almería;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;94,19
04 Almería;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
04 Almería;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
04 Almería;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
04 Almería;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;90,31
04 Almería;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
04 Almería;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
04 Almería;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;90,7
04 Almería;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
04 Almería;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
04 Almería;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
04 Almería;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;92,05
04 Almería;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
04 Almería;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
04 Almería;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
04 Almería;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;88,52
04 Almería;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
04 Almería;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
04 Almería;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
04 Almería;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
04 Almería;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
04 Almería;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QII;11.670
04 Almería;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
04 Almería;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
04 Almería;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
04 Almería;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QII;11.356
04 Almería;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
04 Almería;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
04 Almería;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
04 Almería;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QII;10.892
04 Almería;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
04 Almería;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
04 Almería;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
04 Almería;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2022QII;11.416
04 Almería;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2022QI;""
04 Almería;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
04 Almería;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
04 Almería;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2021QII;11.101
04 Almería;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2021QI;""
04 Almería;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
04 Almería;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
04 Almería;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2020QII;10.699
04 Almería;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2020QI;""
04 Almería;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
04 Almería;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2022QIII;11.193
04 Almería;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2022QII;""
04 Almería;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2022QI;""
04 Almería;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
04 Almería;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2021QIII;10.911
04 Almería;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2021QII;""
04 Almería;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2021QI;""
04 Almería;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
04 Almería;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2020QIII;10.444
04 Almería;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2020QII;""
04 Almería;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2020QI;""
04 Almería;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QIV;10.906
04 Almería;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
04 Almería;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QII;""
04 Almería;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QI;""
04 Almería;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QIV;10.682
04 Almería;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
04 Almería;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QII;""
04 Almería;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QI;""
04 Almería;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QIV;10.244
04 Almería;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
04 Almería;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QII;""
04 Almería;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QI;""
04 Almería;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
04 Almería;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
04 Almería;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QII;""
04 Almería;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QI;10.469
04 Almería;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
04 Almería;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
04 Almería;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QII;""
04 Almería;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QI;10.068
04 Almería;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
04 Almería;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
04 Almería;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QII;""
04 Almería;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QI;""
04 Almería;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
04 Almería;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
04 Almería;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
04 Almería;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
04 Almería;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
04 Almería;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
04 Almería;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
04 Almería;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
04 Almería;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
04 Almería;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
04 Almería;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
04 Almería;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
04 Almería;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
04 Almería;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
04 Almería;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;97,82
04 Almería;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
04 Almería;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
04 Almería;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
04 Almería;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;97,75
04 Almería;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
04 Almería;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
04 Almería;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
04 Almería;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;98,23
04 Almería;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
04 Almería;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
04 Almería;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;95,91
04 Almería;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
04 Almería;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
04 Almería;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
04 Almería;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;96,08
04 Almería;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
04 Almería;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
04 Almería;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
04 Almería;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;95,89
04 Almería;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
04 Almería;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
04 Almería;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;93,45
04 Almería;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
04 Almería;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
04 Almería;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
04 Almería;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;94,06
04 Almería;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
04 Almería;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
04 Almería;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
04 Almería;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;94,05
04 Almería;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
04 Almería;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
04 Almería;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
04 Almería;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
04 Almería;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
04 Almería;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
04 Almería;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;92,19
04 Almería;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
04 Almería;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
04 Almería;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
04 Almería;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;92,43
04 Almería;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
04 Almería;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
04 Almería;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
04 Almería;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
04 Almería;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
04 Almería;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
04 Almería;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QII;7.343
04 Almería;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
04 Almería;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
04 Almería;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
04 Almería;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QII;7.226
04 Almería;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
04 Almería;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
04 Almería;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
04 Almería;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QII;6.958
04 Almería;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
04 Almería;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
04 Almería;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
04 Almería;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2022QII;7.196
04 Almería;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2022QI;""
04 Almería;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
04 Almería;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
04 Almería;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2021QII;7.050
04 Almería;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2021QI;""
04 Almería;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
04 Almería;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
04 Almería;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2020QII;6.845
04 Almería;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2020QI;""
04 Almería;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
04 Almería;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2022QIII;7.064
04 Almería;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2022QII;""
04 Almería;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2022QI;""
04 Almería;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
04 Almería;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2021QIII;6.931
04 Almería;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2021QII;""
04 Almería;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2021QI;""
04 Almería;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
04 Almería;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2020QIII;6.698
04 Almería;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2020QII;""
04 Almería;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2020QI;""
04 Almería;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QIV;6.900
04 Almería;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
04 Almería;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QII;""
04 Almería;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QI;""
04 Almería;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QIV;6.803
04 Almería;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
04 Almería;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QII;""
04 Almería;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QI;""
04 Almería;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QIV;6.577
04 Almería;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
04 Almería;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QII;""
04 Almería;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QI;""
04 Almería;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
04 Almería;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
04 Almería;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QII;""
04 Almería;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QI;6.673
04 Almería;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
04 Almería;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
04 Almería;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QII;""
04 Almería;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QI;6.473
04 Almería;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
04 Almería;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
04 Almería;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QII;""
04 Almería;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QI;""
04 Almería;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
04 Almería;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
04 Almería;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
04 Almería;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
04 Almería;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
04 Almería;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
04 Almería;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
04 Almería;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
04 Almería;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
04 Almería;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
04 Almería;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
04 Almería;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
04 Almería;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
04 Almería;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
04 Almería;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;98
04 Almería;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
04 Almería;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
04 Almería;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
04 Almería;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;97,56
04 Almería;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
04 Almería;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
04 Almería;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
04 Almería;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;98,38
04 Almería;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
04 Almería;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
04 Almería;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;96,2
04 Almería;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
04 Almería;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
04 Almería;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
04 Almería;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;95,92
04 Almería;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
04 Almería;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
04 Almería;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
04 Almería;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;96,26
04 Almería;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
04 Almería;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
04 Almería;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;93,97
04 Almería;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
04 Almería;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
04 Almería;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
04 Almería;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;94,15
04 Almería;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
04 Almería;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
04 Almería;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
04 Almería;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;94,52
04 Almería;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
04 Almería;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
04 Almería;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
04 Almería;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
04 Almería;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
04 Almería;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
04 Almería;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;92,35
04 Almería;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
04 Almería;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
04 Almería;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
04 Almería;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;93,03
04 Almería;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
04 Almería;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
04 Almería;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
04 Almería;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
04 Almería;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
04 Almería;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
04 Almería;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QII;4.327
04 Almería;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
04 Almería;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
04 Almería;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
04 Almería;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QII;4.130
04 Almería;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
04 Almería;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
04 Almería;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
04 Almería;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QII;3.934
04 Almería;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
04 Almería;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
04 Almería;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
04 Almería;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2022QII;4.220
04 Almería;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2022QI;""
04 Almería;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
04 Almería;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
04 Almería;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2021QII;4.051
04 Almería;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2021QI;""
04 Almería;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
04 Almería;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
04 Almería;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2020QII;3.854
04 Almería;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2020QI;""
04 Almería;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
04 Almería;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2022QIII;4.129
04 Almería;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2022QII;""
04 Almería;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2022QI;""
04 Almería;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
04 Almería;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2021QIII;3.980
04 Almería;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2021QII;""
04 Almería;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2021QI;""
04 Almería;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
04 Almería;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2020QIII;3.746
04 Almería;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2020QII;""
04 Almería;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2020QI;""
04 Almería;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QIV;4.006
04 Almería;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
04 Almería;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QII;""
04 Almería;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QI;""
04 Almería;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QIV;3.879
04 Almería;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
04 Almería;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QII;""
04 Almería;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QI;""
04 Almería;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QIV;3.667
04 Almería;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
04 Almería;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QII;""
04 Almería;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QI;""
04 Almería;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
04 Almería;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
04 Almería;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QII;""
04 Almería;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QI;3.796
04 Almería;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
04 Almería;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
04 Almería;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QII;""
04 Almería;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QI;3.595
04 Almería;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
04 Almería;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
04 Almería;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QII;""
04 Almería;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QI;""
04 Almería;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
04 Almería;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
04 Almería;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
04 Almería;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
04 Almería;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
04 Almería;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
04 Almería;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
04 Almería;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
04 Almería;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
04 Almería;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
04 Almería;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
04 Almería;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
04 Almería;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
04 Almería;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
04 Almería;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;97,53
04 Almería;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
04 Almería;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
04 Almería;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
04 Almería;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;98,09
04 Almería;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
04 Almería;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
04 Almería;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
04 Almería;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;97,97
04 Almería;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
04 Almería;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
04 Almería;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;95,42
04 Almería;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
04 Almería;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
04 Almería;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
04 Almería;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;96,37
04 Almería;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
04 Almería;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
04 Almería;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
04 Almería;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;95,22
04 Almería;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
04 Almería;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
04 Almería;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;92,58
04 Almería;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
04 Almería;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
04 Almería;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
04 Almería;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;93,92
04 Almería;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
04 Almería;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
04 Almería;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
04 Almería;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;93,21
04 Almería;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
04 Almería;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
04 Almería;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
04 Almería;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
04 Almería;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
04 Almería;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
04 Almería;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;91,91
04 Almería;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
04 Almería;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
04 Almería;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
04 Almería;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;91,38
04 Almería;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
04 Almería;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
04 Almería;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
04 Almería;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
04 Almería;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
04 Almería;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QIII;11.722
04 Almería;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
04 Almería;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
04 Almería;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
04 Almería;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QIII;11.404
04 Almería;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
04 Almería;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
04 Almería;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
04 Almería;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QIII;10.983
04 Almería;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
04 Almería;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
04 Almería;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
04 Almería;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2022QIII;11.449
04 Almería;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2022QII;""
04 Almería;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2022QI;""
04 Almería;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
04 Almería;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2021QIII;11.174
04 Almería;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2021QII;""
04 Almería;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2021QI;""
04 Almería;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
04 Almería;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2020QIII;10.684
04 Almería;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2020QII;""
04 Almería;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2020QI;""
04 Almería;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2022QIV;11.109
04 Almería;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
04 Almería;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2022QII;""
04 Almería;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2022QI;""
04 Almería;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2021QIV;10.903
04 Almería;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
04 Almería;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2021QII;""
04 Almería;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2021QI;""
04 Almería;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2020QIV;10.451
04 Almería;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
04 Almería;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2020QII;""
04 Almería;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2020QI;""
04 Almería;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
04 Almería;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
04 Almería;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QII;""
04 Almería;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QI;10.672
04 Almería;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
04 Almería;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
04 Almería;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QII;""
04 Almería;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QI;10.258
04 Almería;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
04 Almería;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
04 Almería;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QII;""
04 Almería;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QI;""
04 Almería;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
04 Almería;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
04 Almería;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QII;10.492
04 Almería;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QI;""
04 Almería;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
04 Almería;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
04 Almería;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QII;10.081
04 Almería;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QI;""
04 Almería;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
04 Almería;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
04 Almería;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QII;""
04 Almería;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QI;""
04 Almería;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
04 Almería;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
04 Almería;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
04 Almería;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
04 Almería;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
04 Almería;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
04 Almería;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
04 Almería;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
04 Almería;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
04 Almería;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
04 Almería;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
04 Almería;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
04 Almería;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
04 Almería;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;97,67
04 Almería;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
04 Almería;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
04 Almería;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
04 Almería;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;97,98
04 Almería;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
04 Almería;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
04 Almería;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
04 Almería;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;97,28
04 Almería;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
04 Almería;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
04 Almería;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;94,77
04 Almería;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
04 Almería;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
04 Almería;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
04 Almería;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;95,61
04 Almería;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
04 Almería;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
04 Almería;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
04 Almería;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;95,16
04 Almería;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
04 Almería;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
04 Almería;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
04 Almería;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
04 Almería;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
04 Almería;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
04 Almería;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;93,58
04 Almería;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
04 Almería;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
04 Almería;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
04 Almería;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;93,4
04 Almería;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
04 Almería;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
04 Almería;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
04 Almería;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
04 Almería;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
04 Almería;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
04 Almería;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;92
04 Almería;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
04 Almería;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
04 Almería;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
04 Almería;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;91,79
04 Almería;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
04 Almería;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
04 Almería;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
04 Almería;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
04 Almería;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
04 Almería;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
04 Almería;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QIII;7.370
04 Almería;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
04 Almería;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
04 Almería;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
04 Almería;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QIII;7.212
04 Almería;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
04 Almería;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
04 Almería;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
04 Almería;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QIII;7.024
04 Almería;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
04 Almería;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
04 Almería;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
04 Almería;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2022QIII;7.214
04 Almería;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2022QII;""
04 Almería;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2022QI;""
04 Almería;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
04 Almería;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2021QIII;7.076
04 Almería;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2021QII;""
04 Almería;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2021QI;""
04 Almería;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
04 Almería;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2020QIII;6.853
04 Almería;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2020QII;""
04 Almería;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2020QI;""
04 Almería;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2022QIV;7.019
04 Almería;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
04 Almería;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2022QII;""
04 Almería;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2022QI;""
04 Almería;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2021QIV;6.923
04 Almería;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
04 Almería;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2021QII;""
04 Almería;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2021QI;""
04 Almería;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2020QIV;6.712
04 Almería;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
04 Almería;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2020QII;""
04 Almería;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2020QI;""
04 Almería;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
04 Almería;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
04 Almería;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QII;""
04 Almería;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QI;6.781
04 Almería;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
04 Almería;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
04 Almería;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QII;""
04 Almería;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QI;6.597
04 Almería;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
04 Almería;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
04 Almería;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QII;""
04 Almería;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QI;""
04 Almería;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
04 Almería;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
04 Almería;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QII;6.672
04 Almería;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QI;""
04 Almería;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
04 Almería;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
04 Almería;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QII;6.484
04 Almería;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QI;""
04 Almería;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
04 Almería;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
04 Almería;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QII;""
04 Almería;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QI;""
04 Almería;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
04 Almería;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
04 Almería;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
04 Almería;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
04 Almería;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
04 Almería;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
04 Almería;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
04 Almería;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
04 Almería;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
04 Almería;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
04 Almería;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
04 Almería;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
04 Almería;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
04 Almería;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;97,88
04 Almería;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
04 Almería;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
04 Almería;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
04 Almería;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;98,11
04 Almería;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
04 Almería;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
04 Almería;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
04 Almería;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;97,57
04 Almería;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
04 Almería;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
04 Almería;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;95,24
04 Almería;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
04 Almería;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
04 Almería;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
04 Almería;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;95,99
04 Almería;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
04 Almería;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
04 Almería;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
04 Almería;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;95,56
04 Almería;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
04 Almería;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
04 Almería;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
04 Almería;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
04 Almería;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
04 Almería;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
04 Almería;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;94,02
04 Almería;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
04 Almería;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
04 Almería;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
04 Almería;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;93,92
04 Almería;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
04 Almería;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
04 Almería;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
04 Almería;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
04 Almería;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
04 Almería;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
04 Almería;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;92,51
04 Almería;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
04 Almería;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
04 Almería;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
04 Almería;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;92,31
04 Almería;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
04 Almería;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
04 Almería;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
04 Almería;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
04 Almería;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
04 Almería;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
04 Almería;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QIII;4.352
04 Almería;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
04 Almería;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
04 Almería;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
04 Almería;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QIII;4.192
04 Almería;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
04 Almería;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
04 Almería;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
04 Almería;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QIII;3.959
04 Almería;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
04 Almería;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
04 Almería;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
04 Almería;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2022QIII;4.235
04 Almería;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2022QII;""
04 Almería;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2022QI;""
04 Almería;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
04 Almería;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2021QIII;4.098
04 Almería;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2021QII;""
04 Almería;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2021QI;""
04 Almería;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
04 Almería;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2020QIII;3.831
04 Almería;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2020QII;""
04 Almería;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2020QI;""
04 Almería;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2022QIV;4.090
04 Almería;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
04 Almería;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2022QII;""
04 Almería;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2022QI;""
04 Almería;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2021QIV;3.980
04 Almería;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
04 Almería;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2021QII;""
04 Almería;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2021QI;""
04 Almería;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2020QIV;3.739
04 Almería;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
04 Almería;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2020QII;""
04 Almería;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2020QI;""
04 Almería;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
04 Almería;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
04 Almería;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QII;""
04 Almería;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QI;3.891
04 Almería;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
04 Almería;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
04 Almería;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QII;""
04 Almería;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QI;3.661
04 Almería;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
04 Almería;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
04 Almería;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QII;""
04 Almería;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QI;""
04 Almería;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
04 Almería;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
04 Almería;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QII;3.820
04 Almería;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QI;""
04 Almería;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
04 Almería;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
04 Almería;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QII;3.597
04 Almería;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QI;""
04 Almería;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
04 Almería;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
04 Almería;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QII;""
04 Almería;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QI;""
04 Almería;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
04 Almería;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
04 Almería;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
04 Almería;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
04 Almería;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
04 Almería;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
04 Almería;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
04 Almería;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
04 Almería;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
04 Almería;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
04 Almería;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
04 Almería;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
04 Almería;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
04 Almería;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;97,31
04 Almería;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
04 Almería;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
04 Almería;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
04 Almería;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;97,76
04 Almería;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
04 Almería;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
04 Almería;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
04 Almería;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;96,77
04 Almería;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
04 Almería;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
04 Almería;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;93,98
04 Almería;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
04 Almería;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
04 Almería;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
04 Almería;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;94,94
04 Almería;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
04 Almería;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
04 Almería;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
04 Almería;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;94,44
04 Almería;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
04 Almería;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
04 Almería;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
04 Almería;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
04 Almería;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
04 Almería;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
04 Almería;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;92,82
04 Almería;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
04 Almería;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
04 Almería;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
04 Almería;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;92,47
04 Almería;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
04 Almería;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
04 Almería;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
04 Almería;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
04 Almería;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
04 Almería;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
04 Almería;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;91,13
04 Almería;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
04 Almería;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
04 Almería;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
04 Almería;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;90,86
04 Almería;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
04 Almería;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
04 Almería;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
04 Almería;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
04 Almería;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
04 Almería;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QIV;11.642
04 Almería;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
04 Almería;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
04 Almería;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
04 Almería;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QIV;11.380
04 Almería;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
04 Almería;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
04 Almería;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
04 Almería;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QIV;10.917
04 Almería;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
04 Almería;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
04 Almería;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
04 Almería;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2022QIV;11.280
04 Almería;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
04 Almería;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2022QII;""
04 Almería;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2022QI;""
04 Almería;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2021QIV;11.088
04 Almería;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
04 Almería;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2021QII;""
04 Almería;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2021QI;""
04 Almería;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2020QIV;10.654
04 Almería;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
04 Almería;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2020QII;""
04 Almería;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2020QI;""
04 Almería;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
04 Almería;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
04 Almería;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2022QII;""
04 Almería;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2022QI;10.847
04 Almería;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
04 Almería;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
04 Almería;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2021QII;""
04 Almería;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2021QI;10.448
04 Almería;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
04 Almería;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
04 Almería;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2020QII;""
04 Almería;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2020QI;""
04 Almería;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
04 Almería;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
04 Almería;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QII;10.652
04 Almería;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QI;""
04 Almería;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
04 Almería;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
04 Almería;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QII;10.258
04 Almería;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QI;""
04 Almería;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
04 Almería;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
04 Almería;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QII;""
04 Almería;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QI;""
04 Almería;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
04 Almería;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QIII;10.460
04 Almería;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QII;""
04 Almería;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QI;""
04 Almería;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
04 Almería;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QIII;10.110
04 Almería;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QII;""
04 Almería;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QI;""
04 Almería;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
04 Almería;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
04 Almería;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QII;""
04 Almería;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QI;""
04 Almería;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
04 Almería;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
04 Almería;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
04 Almería;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
04 Almería;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
04 Almería;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
04 Almería;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
04 Almería;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
04 Almería;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
04 Almería;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
04 Almería;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
04 Almería;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
04 Almería;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;96,89
04 Almería;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
04 Almería;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
04 Almería;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
04 Almería;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;97,43
04 Almería;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
04 Almería;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
04 Almería;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
04 Almería;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;97,59
04 Almería;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
04 Almería;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
04 Almería;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
04 Almería;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
04 Almería;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
04 Almería;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
04 Almería;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;95,32
04 Almería;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
04 Almería;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
04 Almería;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
04 Almería;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;95,7
04 Almería;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
04 Almería;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
04 Almería;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
04 Almería;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
04 Almería;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
04 Almería;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
04 Almería;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;93,6
04 Almería;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
04 Almería;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
04 Almería;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
04 Almería;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;93,96
04 Almería;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
04 Almería;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
04 Almería;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
04 Almería;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
04 Almería;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
04 Almería;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
04 Almería;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;91,92
04 Almería;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
04 Almería;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
04 Almería;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
04 Almería;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;92,61
04 Almería;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
04 Almería;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
04 Almería;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
04 Almería;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
04 Almería;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
04 Almería;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
04 Almería;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QIV;7.317
04 Almería;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
04 Almería;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
04 Almería;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
04 Almería;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QIV;7.184
04 Almería;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
04 Almería;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
04 Almería;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
04 Almería;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QIV;7.001
04 Almería;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
04 Almería;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
04 Almería;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
04 Almería;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2022QIV;7.106
04 Almería;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
04 Almería;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2022QII;""
04 Almería;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2022QI;""
04 Almería;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2021QIV;7.016
04 Almería;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
04 Almería;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2021QII;""
04 Almería;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2021QI;""
04 Almería;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2020QIV;6.840
04 Almería;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
04 Almería;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2020QII;""
04 Almería;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2020QI;""
04 Almería;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
04 Almería;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
04 Almería;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2022QII;""
04 Almería;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2022QI;6.869
04 Almería;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
04 Almería;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
04 Almería;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2021QII;""
04 Almería;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2021QI;6.716
04 Almería;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
04 Almería;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
04 Almería;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2020QII;""
04 Almería;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2020QI;""
04 Almería;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
04 Almería;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
04 Almería;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QII;6.752
04 Almería;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QI;""
04 Almería;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
04 Almería;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
04 Almería;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QII;6.593
04 Almería;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QI;""
04 Almería;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
04 Almería;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
04 Almería;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QII;""
04 Almería;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QI;""
04 Almería;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
04 Almería;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QIII;6.641
04 Almería;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QII;""
04 Almería;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QI;""
04 Almería;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
04 Almería;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QIII;6.500
04 Almería;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QII;""
04 Almería;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QI;""
04 Almería;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
04 Almería;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
04 Almería;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QII;""
04 Almería;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QI;""
04 Almería;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
04 Almería;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
04 Almería;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
04 Almería;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
04 Almería;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
04 Almería;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
04 Almería;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
04 Almería;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
04 Almería;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
04 Almería;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
04 Almería;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
04 Almería;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
04 Almería;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;97,12
04 Almería;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
04 Almería;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
04 Almería;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
04 Almería;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;97,66
04 Almería;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
04 Almería;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
04 Almería;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
04 Almería;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;97,7
04 Almería;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
04 Almería;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
04 Almería;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
04 Almería;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
04 Almería;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
04 Almería;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
04 Almería;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;95,62
04 Almería;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
04 Almería;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
04 Almería;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
04 Almería;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;95,93
04 Almería;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
04 Almería;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
04 Almería;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
04 Almería;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
04 Almería;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
04 Almería;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
04 Almería;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;93,99
04 Almería;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
04 Almería;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
04 Almería;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
04 Almería;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;94,17
04 Almería;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
04 Almería;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
04 Almería;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
04 Almería;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
04 Almería;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
04 Almería;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
04 Almería;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;92,44
04 Almería;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
04 Almería;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
04 Almería;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
04 Almería;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;92,84
04 Almería;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
04 Almería;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
04 Almería;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
04 Almería;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
04 Almería;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
04 Almería;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
04 Almería;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QIV;4.325
04 Almería;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
04 Almería;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
04 Almería;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
04 Almería;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QIV;4.196
04 Almería;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
04 Almería;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
04 Almería;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
04 Almería;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QIV;3.916
04 Almería;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
04 Almería;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
04 Almería;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
04 Almería;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2022QIV;4.174
04 Almería;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
04 Almería;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2022QII;""
04 Almería;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2022QI;""
04 Almería;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2021QIV;4.072
04 Almería;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
04 Almería;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2021QII;""
04 Almería;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2021QI;""
04 Almería;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2020QIV;3.814
04 Almería;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
04 Almería;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2020QII;""
04 Almería;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2020QI;""
04 Almería;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
04 Almería;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
04 Almería;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2022QII;""
04 Almería;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2022QI;3.978
04 Almería;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
04 Almería;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
04 Almería;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2021QII;""
04 Almería;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2021QI;3.732
04 Almería;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
04 Almería;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
04 Almería;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2020QII;""
04 Almería;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2020QI;""
04 Almería;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
04 Almería;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
04 Almería;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QII;3.900
04 Almería;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QI;""
04 Almería;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
04 Almería;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
04 Almería;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QII;3.665
04 Almería;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QI;""
04 Almería;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
04 Almería;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
04 Almería;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QII;""
04 Almería;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QI;""
04 Almería;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
04 Almería;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QIII;3.819
04 Almería;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QII;""
04 Almería;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QI;""
04 Almería;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
04 Almería;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QIII;3.610
04 Almería;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QII;""
04 Almería;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QI;""
04 Almería;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
04 Almería;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
04 Almería;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QII;""
04 Almería;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QI;""
04 Almería;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
04 Almería;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
04 Almería;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
04 Almería;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
04 Almería;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
04 Almería;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
04 Almería;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
04 Almería;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
04 Almería;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
04 Almería;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
04 Almería;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
04 Almería;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
04 Almería;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;96,51
04 Almería;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
04 Almería;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
04 Almería;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
04 Almería;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;97,04
04 Almería;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
04 Almería;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
04 Almería;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
04 Almería;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;97,4
04 Almería;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
04 Almería;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
04 Almería;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
04 Almería;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
04 Almería;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
04 Almería;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
04 Almería;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;94,8
04 Almería;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
04 Almería;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
04 Almería;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
04 Almería;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;95,3
04 Almería;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
04 Almería;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
04 Almería;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
04 Almería;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
04 Almería;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
04 Almería;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
04 Almería;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;92,95
04 Almería;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
04 Almería;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
04 Almería;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
04 Almería;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;93,59
04 Almería;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
04 Almería;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
04 Almería;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
04 Almería;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
04 Almería;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
04 Almería;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
04 Almería;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;91,02
04 Almería;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
04 Almería;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
04 Almería;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
04 Almería;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;92,19
04 Almería;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
04 Almería;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
04 Almería;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
04 Almería;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
04 Almería;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
04 Almería;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
04 Almería;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
04 Almería;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
04 Almería;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
04 Almería;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QI;5.391
04 Almería;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
04 Almería;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
04 Almería;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
04 Almería;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QI;5.060
04 Almería;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
04 Almería;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
04 Almería;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
04 Almería;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QI;5.660
04 Almería;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
04 Almería;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
04 Almería;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2022QII;""
04 Almería;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2022QI;5.175
04 Almería;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
04 Almería;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
04 Almería;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2021QII;""
04 Almería;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2021QI;4.885
04 Almería;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
04 Almería;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
04 Almería;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2020QII;""
04 Almería;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2020QI;5.307
04 Almería;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
04 Almería;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
04 Almería;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2022QII;4.962
04 Almería;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2022QI;""
04 Almería;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
04 Almería;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
04 Almería;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2021QII;4.689
04 Almería;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2021QI;""
04 Almería;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
04 Almería;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
04 Almería;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2020QII;5.146
04 Almería;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2020QI;""
04 Almería;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
04 Almería;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QIII;4.748
04 Almería;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QII;""
04 Almería;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QI;""
04 Almería;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
04 Almería;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QIII;4.522
04 Almería;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QII;""
04 Almería;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QI;""
04 Almería;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
04 Almería;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QIII;4.942
04 Almería;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QII;""
04 Almería;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QI;""
04 Almería;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QIV;4.459
04 Almería;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
04 Almería;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QII;""
04 Almería;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QI;""
04 Almería;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QIV;4.317
04 Almería;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
04 Almería;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QII;""
04 Almería;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QI;""
04 Almería;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QIV;4.739
04 Almería;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
04 Almería;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QII;""
04 Almería;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QI;""
04 Almería;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
04 Almería;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
04 Almería;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
04 Almería;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
04 Almería;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
04 Almería;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
04 Almería;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
04 Almería;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
04 Almería;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
04 Almería;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
04 Almería;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
04 Almería;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
04 Almería;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
04 Almería;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
04 Almería;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
04 Almería;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;95,99
04 Almería;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
04 Almería;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
04 Almería;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
04 Almería;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;96,54
04 Almería;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
04 Almería;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
04 Almería;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
04 Almería;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;93,76
04 Almería;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
04 Almería;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
04 Almería;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;92,04
04 Almería;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
04 Almería;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
04 Almería;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
04 Almería;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;92,67
04 Almería;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
04 Almería;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
04 Almería;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
04 Almería;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;90,92
04 Almería;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
04 Almería;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
04 Almería;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;88,07
04 Almería;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
04 Almería;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
04 Almería;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
04 Almería;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;89,37
04 Almería;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
04 Almería;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
04 Almería;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
04 Almería;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;87,31
04 Almería;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
04 Almería;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
04 Almería;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;82,71
04 Almería;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
04 Almería;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
04 Almería;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
04 Almería;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;85,32
04 Almería;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
04 Almería;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
04 Almería;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
04 Almería;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;83,73
04 Almería;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
04 Almería;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
04 Almería;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
04 Almería;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
04 Almería;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
04 Almería;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
04 Almería;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QI;3.530
04 Almería;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
04 Almería;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
04 Almería;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
04 Almería;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QI;3.318
04 Almería;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
04 Almería;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
04 Almería;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
04 Almería;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QI;3.670
04 Almería;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
04 Almería;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
04 Almería;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2022QII;""
04 Almería;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2022QI;3.391
04 Almería;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
04 Almería;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
04 Almería;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2021QII;""
04 Almería;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2021QI;3.204
04 Almería;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
04 Almería;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
04 Almería;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2020QII;""
04 Almería;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2020QI;3.454
04 Almería;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
04 Almería;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
04 Almería;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2022QII;3.261
04 Almería;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2022QI;""
04 Almería;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
04 Almería;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
04 Almería;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2021QII;3.076
04 Almería;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2021QI;""
04 Almería;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
04 Almería;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
04 Almería;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2020QII;3.353
04 Almería;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2020QI;""
04 Almería;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
04 Almería;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QIII;3.121
04 Almería;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QII;""
04 Almería;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QI;""
04 Almería;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
04 Almería;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QIII;2.975
04 Almería;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QII;""
04 Almería;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QI;""
04 Almería;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
04 Almería;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QIII;3.234
04 Almería;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QII;""
04 Almería;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QI;""
04 Almería;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QIV;2.937
04 Almería;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
04 Almería;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QII;""
04 Almería;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QI;""
04 Almería;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QIV;2.834
04 Almería;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
04 Almería;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QII;""
04 Almería;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QI;""
04 Almería;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QIV;3.112
04 Almería;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
04 Almería;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QII;""
04 Almería;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QI;""
04 Almería;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
04 Almería;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
04 Almería;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
04 Almería;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
04 Almería;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
04 Almería;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
04 Almería;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
04 Almería;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
04 Almería;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
04 Almería;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
04 Almería;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
04 Almería;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
04 Almería;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
04 Almería;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
04 Almería;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
04 Almería;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;96,06
04 Almería;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
04 Almería;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
04 Almería;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
04 Almería;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;96,56
04 Almería;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
04 Almería;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
04 Almería;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
04 Almería;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;94,11
04 Almería;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
04 Almería;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
04 Almería;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;92,38
04 Almería;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
04 Almería;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
04 Almería;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
04 Almería;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;92,71
04 Almería;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
04 Almería;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
04 Almería;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
04 Almería;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;91,36
04 Almería;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
04 Almería;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
04 Almería;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;88,41
04 Almería;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
04 Almería;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
04 Almería;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
04 Almería;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;89,66
04 Almería;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
04 Almería;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
04 Almería;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
04 Almería;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;88,12
04 Almería;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
04 Almería;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
04 Almería;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;83,2
04 Almería;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
04 Almería;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
04 Almería;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
04 Almería;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;85,41
04 Almería;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
04 Almería;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
04 Almería;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
04 Almería;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;84,8
04 Almería;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
04 Almería;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
04 Almería;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
04 Almería;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
04 Almería;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
04 Almería;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
04 Almería;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QI;1.861
04 Almería;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
04 Almería;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
04 Almería;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
04 Almería;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QI;1.742
04 Almería;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
04 Almería;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
04 Almería;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
04 Almería;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QI;1.990
04 Almería;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
04 Almería;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
04 Almería;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2022QII;""
04 Almería;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2022QI;1.784
04 Almería;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
04 Almería;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
04 Almería;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2021QII;""
04 Almería;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2021QI;1.681
04 Almería;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
04 Almería;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
04 Almería;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2020QII;""
04 Almería;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2020QI;1.853
04 Almería;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
04 Almería;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
04 Almería;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2022QII;1.701
04 Almería;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2022QI;""
04 Almería;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
04 Almería;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
04 Almería;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2021QII;1.613
04 Almería;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2021QI;""
04 Almería;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
04 Almería;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
04 Almería;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2020QII;1.793
04 Almería;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2020QI;""
04 Almería;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
04 Almería;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QIII;1.627
04 Almería;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QII;""
04 Almería;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QI;""
04 Almería;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
04 Almería;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QIII;1.547
04 Almería;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QII;""
04 Almería;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QI;""
04 Almería;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
04 Almería;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QIII;1.708
04 Almería;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QII;""
04 Almería;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QI;""
04 Almería;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QIV;1.522
04 Almería;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
04 Almería;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QII;""
04 Almería;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QI;""
04 Almería;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QIV;1.483
04 Almería;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
04 Almería;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QII;""
04 Almería;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QI;""
04 Almería;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QIV;1.627
04 Almería;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
04 Almería;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QII;""
04 Almería;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QI;""
04 Almería;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
04 Almería;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
04 Almería;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
04 Almería;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
04 Almería;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
04 Almería;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
04 Almería;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
04 Almería;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
04 Almería;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
04 Almería;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
04 Almería;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
04 Almería;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
04 Almería;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
04 Almería;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
04 Almería;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
04 Almería;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;95,86
04 Almería;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
04 Almería;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
04 Almería;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
04 Almería;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;96,5
04 Almería;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
04 Almería;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
04 Almería;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
04 Almería;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;93,12
04 Almería;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
04 Almería;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
04 Almería;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;91,4
04 Almería;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
04 Almería;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
04 Almería;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
04 Almería;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;92,59
04 Almería;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
04 Almería;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
04 Almería;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
04 Almería;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;90,1
04 Almería;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
04 Almería;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
04 Almería;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;87,43
04 Almería;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
04 Almería;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
04 Almería;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
04 Almería;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;88,81
04 Almería;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
04 Almería;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
04 Almería;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
04 Almería;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;85,83
04 Almería;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
04 Almería;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
04 Almería;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;81,78
04 Almería;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
04 Almería;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
04 Almería;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
04 Almería;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;85,13
04 Almería;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
04 Almería;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
04 Almería;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
04 Almería;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;81,76
04 Almería;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
04 Almería;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
04 Almería;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
04 Almería;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
04 Almería;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
04 Almería;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QII;6.149
04 Almería;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
04 Almería;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
04 Almería;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
04 Almería;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QII;5.844
04 Almería;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
04 Almería;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
04 Almería;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
04 Almería;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QII;5.439
04 Almería;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
04 Almería;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
04 Almería;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
04 Almería;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2022QII;5.909
04 Almería;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2022QI;""
04 Almería;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
04 Almería;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
04 Almería;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2021QII;5.621
04 Almería;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2021QI;""
04 Almería;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
04 Almería;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
04 Almería;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2020QII;5.271
04 Almería;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2020QI;""
04 Almería;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
04 Almería;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2022QIII;5.667
04 Almería;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2022QII;""
04 Almería;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2022QI;""
04 Almería;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
04 Almería;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2021QIII;5.427
04 Almería;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2021QII;""
04 Almería;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2021QI;""
04 Almería;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
04 Almería;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2020QIII;5.050
04 Almería;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2020QII;""
04 Almería;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2020QI;""
04 Almería;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QIV;5.344
04 Almería;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
04 Almería;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QII;""
04 Almería;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QI;""
04 Almería;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QIV;5.197
04 Almería;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
04 Almería;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QII;""
04 Almería;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QI;""
04 Almería;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QIV;4.832
04 Almería;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
04 Almería;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QII;""
04 Almería;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QI;""
04 Almería;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
04 Almería;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
04 Almería;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QII;""
04 Almería;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QI;4.999
04 Almería;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
04 Almería;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
04 Almería;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QII;""
04 Almería;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QI;4.671
04 Almería;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
04 Almería;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
04 Almería;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QII;""
04 Almería;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QI;""
04 Almería;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
04 Almería;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
04 Almería;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
04 Almería;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
04 Almería;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
04 Almería;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
04 Almería;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
04 Almería;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
04 Almería;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
04 Almería;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
04 Almería;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
04 Almería;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
04 Almería;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
04 Almería;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
04 Almería;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;96,1
04 Almería;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
04 Almería;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
04 Almería;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
04 Almería;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;96,18
04 Almería;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
04 Almería;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
04 Almería;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
04 Almería;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;96,91
04 Almería;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
04 Almería;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
04 Almería;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;92,16
04 Almería;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
04 Almería;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
04 Almería;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
04 Almería;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;92,86
04 Almería;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
04 Almería;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
04 Almería;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
04 Almería;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;92,85
04 Almería;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
04 Almería;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
04 Almería;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;86,91
04 Almería;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
04 Almería;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
04 Almería;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
04 Almería;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;88,93
04 Almería;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
04 Almería;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
04 Almería;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
04 Almería;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;88,84
04 Almería;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
04 Almería;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
04 Almería;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
04 Almería;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
04 Almería;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
04 Almería;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
04 Almería;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;85,54
04 Almería;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
04 Almería;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
04 Almería;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
04 Almería;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;85,88
04 Almería;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
04 Almería;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
04 Almería;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
04 Almería;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
04 Almería;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
04 Almería;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
04 Almería;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QII;4.002
04 Almería;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
04 Almería;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
04 Almería;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
04 Almería;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QII;3.833
04 Almería;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
04 Almería;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
04 Almería;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
04 Almería;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QII;3.540
04 Almería;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
04 Almería;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
04 Almería;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
04 Almería;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2022QII;3.859
04 Almería;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2022QI;""
04 Almería;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
04 Almería;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
04 Almería;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2021QII;3.691
04 Almería;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2021QI;""
04 Almería;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
04 Almería;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
04 Almería;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2020QII;3.433
04 Almería;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2020QI;""
04 Almería;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
04 Almería;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2022QIII;3.704
04 Almería;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2022QII;""
04 Almería;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2022QI;""
04 Almería;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
04 Almería;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2021QIII;3.573
04 Almería;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2021QII;""
04 Almería;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2021QI;""
04 Almería;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
04 Almería;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2020QIII;3.303
04 Almería;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2020QII;""
04 Almería;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2020QI;""
04 Almería;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QIV;3.499
04 Almería;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
04 Almería;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QII;""
04 Almería;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QI;""
04 Almería;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QIV;3.413
04 Almería;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
04 Almería;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QII;""
04 Almería;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QI;""
04 Almería;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QIV;3.171
04 Almería;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
04 Almería;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QII;""
04 Almería;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QI;""
04 Almería;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
04 Almería;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
04 Almería;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QII;""
04 Almería;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QI;3.288
04 Almería;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
04 Almería;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
04 Almería;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QII;""
04 Almería;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QI;3.066
04 Almería;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
04 Almería;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
04 Almería;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QII;""
04 Almería;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QI;""
04 Almería;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
04 Almería;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
04 Almería;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
04 Almería;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
04 Almería;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
04 Almería;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
04 Almería;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
04 Almería;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
04 Almería;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
04 Almería;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
04 Almería;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
04 Almería;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
04 Almería;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
04 Almería;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
04 Almería;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;96,43
04 Almería;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
04 Almería;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
04 Almería;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
04 Almería;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;96,3
04 Almería;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
04 Almería;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
04 Almería;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
04 Almería;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;96,98
04 Almería;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
04 Almería;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
04 Almería;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;92,55
04 Almería;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
04 Almería;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
04 Almería;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
04 Almería;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;93,22
04 Almería;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
04 Almería;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
04 Almería;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
04 Almería;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;93,31
04 Almería;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
04 Almería;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
04 Almería;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;87,43
04 Almería;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
04 Almería;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
04 Almería;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
04 Almería;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;89,04
04 Almería;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
04 Almería;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
04 Almería;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
04 Almería;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;89,58
04 Almería;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
04 Almería;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
04 Almería;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
04 Almería;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
04 Almería;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
04 Almería;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
04 Almería;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;85,78
04 Almería;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
04 Almería;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
04 Almería;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
04 Almería;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;86,61
04 Almería;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
04 Almería;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
04 Almería;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
04 Almería;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
04 Almería;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
04 Almería;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
04 Almería;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QII;2.147
04 Almería;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
04 Almería;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
04 Almería;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
04 Almería;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QII;2.011
04 Almería;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
04 Almería;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
04 Almería;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
04 Almería;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QII;1.899
04 Almería;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
04 Almería;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
04 Almería;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
04 Almería;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2022QII;2.050
04 Almería;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2022QI;""
04 Almería;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
04 Almería;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
04 Almería;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2021QII;1.930
04 Almería;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2021QI;""
04 Almería;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
04 Almería;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
04 Almería;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2020QII;1.838
04 Almería;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2020QI;""
04 Almería;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
04 Almería;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2022QIII;1.963
04 Almería;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2022QII;""
04 Almería;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2022QI;""
04 Almería;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
04 Almería;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2021QIII;1.854
04 Almería;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2021QII;""
04 Almería;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2021QI;""
04 Almería;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
04 Almería;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2020QIII;1.747
04 Almería;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2020QII;""
04 Almería;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2020QI;""
04 Almería;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QIV;1.845
04 Almería;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
04 Almería;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QII;""
04 Almería;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QI;""
04 Almería;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QIV;1.784
04 Almería;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
04 Almería;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QII;""
04 Almería;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QI;""
04 Almería;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QIV;1.661
04 Almería;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
04 Almería;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QII;""
04 Almería;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QI;""
04 Almería;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
04 Almería;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
04 Almería;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QII;""
04 Almería;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QI;1.711
04 Almería;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
04 Almería;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
04 Almería;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QII;""
04 Almería;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QI;1.605
04 Almería;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
04 Almería;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
04 Almería;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QII;""
04 Almería;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QI;""
04 Almería;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
04 Almería;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
04 Almería;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
04 Almería;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
04 Almería;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
04 Almería;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
04 Almería;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
04 Almería;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
04 Almería;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
04 Almería;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
04 Almería;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
04 Almería;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
04 Almería;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
04 Almería;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
04 Almería;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;95,48
04 Almería;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
04 Almería;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
04 Almería;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
04 Almería;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;95,97
04 Almería;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
04 Almería;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
04 Almería;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
04 Almería;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;96,79
04 Almería;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
04 Almería;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
04 Almería;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;91,43
04 Almería;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
04 Almería;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
04 Almería;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
04 Almería;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;92,19
04 Almería;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
04 Almería;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
04 Almería;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
04 Almería;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;92
04 Almería;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
04 Almería;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
04 Almería;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;85,93
04 Almería;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
04 Almería;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
04 Almería;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
04 Almería;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;88,71
04 Almería;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
04 Almería;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
04 Almería;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
04 Almería;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;87,47
04 Almería;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
04 Almería;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
04 Almería;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
04 Almería;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
04 Almería;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
04 Almería;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
04 Almería;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;85,08
04 Almería;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
04 Almería;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
04 Almería;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
04 Almería;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;84,52
04 Almería;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
04 Almería;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
04 Almería;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
04 Almería;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
04 Almería;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
04 Almería;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QIII;6.010
04 Almería;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
04 Almería;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
04 Almería;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
04 Almería;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QIII;5.733
04 Almería;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
04 Almería;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
04 Almería;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
04 Almería;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QIII;5.363
04 Almería;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
04 Almería;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
04 Almería;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
04 Almería;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2022QIII;5.742
04 Almería;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2022QII;""
04 Almería;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2022QI;""
04 Almería;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
04 Almería;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2021QIII;5.521
04 Almería;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2021QII;""
04 Almería;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2021QI;""
04 Almería;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
04 Almería;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2020QIII;5.124
04 Almería;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2020QII;""
04 Almería;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2020QI;""
04 Almería;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2022QIV;5.400
04 Almería;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
04 Almería;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2022QII;""
04 Almería;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2022QI;""
04 Almería;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2021QIV;5.270
04 Almería;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
04 Almería;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2021QII;""
04 Almería;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2021QI;""
04 Almería;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2020QIV;4.899
04 Almería;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
04 Almería;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2020QII;""
04 Almería;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2020QI;""
04 Almería;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
04 Almería;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
04 Almería;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QII;""
04 Almería;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QI;5.065
04 Almería;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
04 Almería;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
04 Almería;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QII;""
04 Almería;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QI;4.734
04 Almería;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
04 Almería;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
04 Almería;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QII;""
04 Almería;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QI;""
04 Almería;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
04 Almería;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
04 Almería;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QII;4.868
04 Almería;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QI;""
04 Almería;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
04 Almería;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
04 Almería;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QII;4.555
04 Almería;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QI;""
04 Almería;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
04 Almería;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
04 Almería;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QII;""
04 Almería;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QI;""
04 Almería;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
04 Almería;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
04 Almería;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
04 Almería;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
04 Almería;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
04 Almería;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
04 Almería;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
04 Almería;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
04 Almería;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
04 Almería;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
04 Almería;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
04 Almería;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
04 Almería;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
04 Almería;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;95,54
04 Almería;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
04 Almería;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
04 Almería;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
04 Almería;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;96,3
04 Almería;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
04 Almería;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
04 Almería;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
04 Almería;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;95,54
04 Almería;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
04 Almería;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
04 Almería;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;89,85
04 Almería;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
04 Almería;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
04 Almería;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
04 Almería;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;91,92
04 Almería;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
04 Almería;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
04 Almería;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
04 Almería;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;91,35
04 Almería;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
04 Almería;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
04 Almería;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
04 Almería;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
04 Almería;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
04 Almería;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
04 Almería;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;88,35
04 Almería;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
04 Almería;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
04 Almería;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
04 Almería;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;88,27
04 Almería;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
04 Almería;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
04 Almería;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
04 Almería;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
04 Almería;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
04 Almería;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
04 Almería;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;84,91
04 Almería;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
04 Almería;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
04 Almería;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
04 Almería;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;84,93
04 Almería;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
04 Almería;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
04 Almería;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
04 Almería;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
04 Almería;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
04 Almería;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
04 Almería;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QIII;3.931
04 Almería;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
04 Almería;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
04 Almería;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
04 Almería;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QIII;3.756
04 Almería;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
04 Almería;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
04 Almería;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
04 Almería;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QIII;3.498
04 Almería;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
04 Almería;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
04 Almería;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
04 Almería;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2022QIII;3.758
04 Almería;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2022QII;""
04 Almería;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2022QI;""
04 Almería;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
04 Almería;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2021QIII;3.628
04 Almería;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2021QII;""
04 Almería;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2021QI;""
04 Almería;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
04 Almería;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2020QIII;3.357
04 Almería;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2020QII;""
04 Almería;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2020QI;""
04 Almería;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2022QIV;3.537
04 Almería;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
04 Almería;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2022QII;""
04 Almería;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2022QI;""
04 Almería;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2021QIV;3.451
04 Almería;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
04 Almería;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2021QII;""
04 Almería;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2021QI;""
04 Almería;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2020QIV;3.220
04 Almería;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
04 Almería;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2020QII;""
04 Almería;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2020QI;""
04 Almería;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
04 Almería;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
04 Almería;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QII;""
04 Almería;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QI;3.321
04 Almería;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
04 Almería;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
04 Almería;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QII;""
04 Almería;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QI;3.113
04 Almería;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
04 Almería;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
04 Almería;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QII;""
04 Almería;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QI;""
04 Almería;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
04 Almería;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
04 Almería;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QII;3.200
04 Almería;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QI;""
04 Almería;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
04 Almería;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
04 Almería;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QII;2.993
04 Almería;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QI;""
04 Almería;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
04 Almería;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
04 Almería;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QII;""
04 Almería;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QI;""
04 Almería;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
04 Almería;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
04 Almería;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
04 Almería;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
04 Almería;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
04 Almería;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
04 Almería;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
04 Almería;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
04 Almería;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
04 Almería;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
04 Almería;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
04 Almería;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
04 Almería;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
04 Almería;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;95,6
04 Almería;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
04 Almería;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
04 Almería;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
04 Almería;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;96,59
04 Almería;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
04 Almería;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
04 Almería;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
04 Almería;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;95,97
04 Almería;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
04 Almería;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
04 Almería;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;89,98
04 Almería;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
04 Almería;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
04 Almería;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
04 Almería;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;91,88
04 Almería;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
04 Almería;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
04 Almería;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
04 Almería;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;92,05
04 Almería;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
04 Almería;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
04 Almería;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
04 Almería;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
04 Almería;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
04 Almería;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
04 Almería;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;88,42
04 Almería;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
04 Almería;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
04 Almería;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
04 Almería;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;88,99
04 Almería;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
04 Almería;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
04 Almería;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
04 Almería;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
04 Almería;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
04 Almería;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
04 Almería;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;85,2
04 Almería;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
04 Almería;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
04 Almería;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
04 Almería;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;85,56
04 Almería;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
04 Almería;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
04 Almería;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
04 Almería;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
04 Almería;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
04 Almería;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
04 Almería;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QIII;2.079
04 Almería;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
04 Almería;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
04 Almería;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
04 Almería;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QIII;1.977
04 Almería;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
04 Almería;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
04 Almería;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
04 Almería;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QIII;1.865
04 Almería;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
04 Almería;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
04 Almería;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
04 Almería;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2022QIII;1.984
04 Almería;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2022QII;""
04 Almería;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2022QI;""
04 Almería;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
04 Almería;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2021QIII;1.893
04 Almería;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2021QII;""
04 Almería;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2021QI;""
04 Almería;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
04 Almería;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2020QIII;1.767
04 Almería;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2020QII;""
04 Almería;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2020QI;""
04 Almería;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2022QIV;1.863
04 Almería;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
04 Almería;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2022QII;""
04 Almería;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2022QI;""
04 Almería;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2021QIV;1.819
04 Almería;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
04 Almería;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2021QII;""
04 Almería;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2021QI;""
04 Almería;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2020QIV;1.679
04 Almería;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
04 Almería;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2020QII;""
04 Almería;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2020QI;""
04 Almería;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
04 Almería;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
04 Almería;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QII;""
04 Almería;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QI;1.744
04 Almería;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
04 Almería;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
04 Almería;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QII;""
04 Almería;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QI;1.621
04 Almería;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
04 Almería;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
04 Almería;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QII;""
04 Almería;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QI;""
04 Almería;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
04 Almería;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
04 Almería;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QII;1.668
04 Almería;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QI;""
04 Almería;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
04 Almería;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
04 Almería;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QII;1.562
04 Almería;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QI;""
04 Almería;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
04 Almería;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
04 Almería;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QII;""
04 Almería;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QI;""
04 Almería;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
04 Almería;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
04 Almería;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
04 Almería;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
04 Almería;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
04 Almería;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
04 Almería;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
04 Almería;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
04 Almería;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
04 Almería;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
04 Almería;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
04 Almería;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
04 Almería;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
04 Almería;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;95,43
04 Almería;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
04 Almería;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
04 Almería;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
04 Almería;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;95,75
04 Almería;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
04 Almería;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
04 Almería;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
04 Almería;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;94,75
04 Almería;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
04 Almería;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
04 Almería;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;89,61
04 Almería;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
04 Almería;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
04 Almería;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
04 Almería;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;92,01
04 Almería;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
04 Almería;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
04 Almería;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
04 Almería;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;90,03
04 Almería;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
04 Almería;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
04 Almería;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
04 Almería;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
04 Almería;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
04 Almería;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
04 Almería;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;88,21
04 Almería;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
04 Almería;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
04 Almería;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
04 Almería;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;86,92
04 Almería;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
04 Almería;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
04 Almería;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
04 Almería;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
04 Almería;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
04 Almería;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
04 Almería;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;84,37
04 Almería;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
04 Almería;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
04 Almería;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
04 Almería;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;83,75
04 Almería;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
04 Almería;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
04 Almería;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
04 Almería;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
04 Almería;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
04 Almería;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QIV;5.824
04 Almería;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
04 Almería;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
04 Almería;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
04 Almería;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QIV;5.579
04 Almería;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
04 Almería;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
04 Almería;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
04 Almería;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QIV;5.203
04 Almería;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
04 Almería;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
04 Almería;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
04 Almería;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2022QIV;5.473
04 Almería;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
04 Almería;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2022QII;""
04 Almería;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2022QI;""
04 Almería;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2021QIV;5.323
04 Almería;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
04 Almería;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2021QII;""
04 Almería;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2021QI;""
04 Almería;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2020QIV;4.967
04 Almería;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
04 Almería;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2020QII;""
04 Almería;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2020QI;""
04 Almería;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
04 Almería;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
04 Almería;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2022QII;""
04 Almería;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2022QI;5.116
04 Almería;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
04 Almería;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
04 Almería;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2021QII;""
04 Almería;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2021QI;4.799
04 Almería;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
04 Almería;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
04 Almería;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2020QII;""
04 Almería;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2020QI;""
04 Almería;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
04 Almería;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
04 Almería;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QII;4.914
04 Almería;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QI;""
04 Almería;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
04 Almería;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
04 Almería;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QII;4.614
04 Almería;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QI;""
04 Almería;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
04 Almería;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
04 Almería;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QII;""
04 Almería;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QI;""
04 Almería;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
04 Almería;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QIII;4.702
04 Almería;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QII;""
04 Almería;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QI;""
04 Almería;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
04 Almería;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QIII;4.456
04 Almería;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QII;""
04 Almería;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QI;""
04 Almería;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
04 Almería;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
04 Almería;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QII;""
04 Almería;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QI;""
04 Almería;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
04 Almería;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
04 Almería;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
04 Almería;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
04 Almería;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
04 Almería;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
04 Almería;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
04 Almería;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
04 Almería;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
04 Almería;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
04 Almería;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
04 Almería;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
04 Almería;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;93,97
04 Almería;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
04 Almería;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
04 Almería;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
04 Almería;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;95,41
04 Almería;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
04 Almería;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
04 Almería;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
04 Almería;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;95,46
04 Almería;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
04 Almería;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
04 Almería;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
04 Almería;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
04 Almería;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
04 Almería;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
04 Almería;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;91,7
04 Almería;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
04 Almería;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
04 Almería;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
04 Almería;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;92,24
04 Almería;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
04 Almería;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
04 Almería;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
04 Almería;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
04 Almería;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
04 Almería;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
04 Almería;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;88,08
04 Almería;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
04 Almería;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
04 Almería;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
04 Almería;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;88,68
04 Almería;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
04 Almería;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
04 Almería;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
04 Almería;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
04 Almería;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
04 Almería;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
04 Almería;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;84,28
04 Almería;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
04 Almería;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
04 Almería;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
04 Almería;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;85,64
04 Almería;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
04 Almería;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
04 Almería;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
04 Almería;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
04 Almería;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
04 Almería;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
04 Almería;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QIV;3.806
04 Almería;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
04 Almería;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
04 Almería;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
04 Almería;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QIV;3.667
04 Almería;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
04 Almería;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
04 Almería;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
04 Almería;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QIV;3.402
04 Almería;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
04 Almería;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
04 Almería;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
04 Almería;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2022QIV;3.580
04 Almería;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
04 Almería;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2022QII;""
04 Almería;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2022QI;""
04 Almería;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2021QIV;3.487
04 Almería;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
04 Almería;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2021QII;""
04 Almería;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2021QI;""
04 Almería;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2020QIV;3.259
04 Almería;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
04 Almería;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2020QII;""
04 Almería;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2020QI;""
04 Almería;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
04 Almería;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
04 Almería;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2022QII;""
04 Almería;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2022QI;3.355
04 Almería;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
04 Almería;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
04 Almería;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2021QII;""
04 Almería;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2021QI;3.151
04 Almería;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
04 Almería;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
04 Almería;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2020QII;""
04 Almería;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2020QI;""
04 Almería;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
04 Almería;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
04 Almería;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QII;3.231
04 Almería;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QI;""
04 Almería;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
04 Almería;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
04 Almería;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QII;3.028
04 Almería;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QI;""
04 Almería;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
04 Almería;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
04 Almería;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QII;""
04 Almería;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QI;""
04 Almería;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
04 Almería;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QIII;3.092
04 Almería;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QII;""
04 Almería;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QI;""
04 Almería;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
04 Almería;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QIII;2.933
04 Almería;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QII;""
04 Almería;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QI;""
04 Almería;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
04 Almería;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
04 Almería;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QII;""
04 Almería;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QI;""
04 Almería;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
04 Almería;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
04 Almería;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
04 Almería;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
04 Almería;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
04 Almería;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
04 Almería;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
04 Almería;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
04 Almería;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
04 Almería;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
04 Almería;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
04 Almería;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
04 Almería;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;94,06
04 Almería;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
04 Almería;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
04 Almería;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
04 Almería;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;95,09
04 Almería;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
04 Almería;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
04 Almería;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
04 Almería;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;95,8
04 Almería;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
04 Almería;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
04 Almería;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
04 Almería;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
04 Almería;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
04 Almería;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
04 Almería;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;91,49
04 Almería;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
04 Almería;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
04 Almería;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
04 Almería;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;92,62
04 Almería;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
04 Almería;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
04 Almería;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
04 Almería;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
04 Almería;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
04 Almería;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
04 Almería;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;88,11
04 Almería;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
04 Almería;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
04 Almería;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
04 Almería;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;89,01
04 Almería;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
04 Almería;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
04 Almería;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
04 Almería;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
04 Almería;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
04 Almería;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
04 Almería;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;84,32
04 Almería;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
04 Almería;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
04 Almería;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
04 Almería;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;86,21
04 Almería;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
04 Almería;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
04 Almería;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
04 Almería;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
04 Almería;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
04 Almería;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
04 Almería;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QIV;2.018
04 Almería;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
04 Almería;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
04 Almería;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
04 Almería;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QIV;1.912
04 Almería;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
04 Almería;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
04 Almería;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
04 Almería;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QIV;1.801
04 Almería;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
04 Almería;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
04 Almería;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
04 Almería;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2022QIV;1.893
04 Almería;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
04 Almería;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2022QII;""
04 Almería;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2022QI;""
04 Almería;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2021QIV;1.836
04 Almería;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
04 Almería;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2021QII;""
04 Almería;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2021QI;""
04 Almería;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2020QIV;1.708
04 Almería;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
04 Almería;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2020QII;""
04 Almería;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2020QI;""
04 Almería;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
04 Almería;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
04 Almería;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2022QII;""
04 Almería;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2022QI;1.761
04 Almería;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
04 Almería;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
04 Almería;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2021QII;""
04 Almería;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2021QI;1.648
04 Almería;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
04 Almería;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
04 Almería;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2020QII;""
04 Almería;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2020QI;""
04 Almería;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
04 Almería;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
04 Almería;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QII;1.683
04 Almería;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QI;""
04 Almería;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
04 Almería;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
04 Almería;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QII;1.586
04 Almería;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QI;""
04 Almería;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
04 Almería;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
04 Almería;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QII;""
04 Almería;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QI;""
04 Almería;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
04 Almería;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QIII;1.610
04 Almería;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QII;""
04 Almería;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QI;""
04 Almería;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
04 Almería;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QIII;1.523
04 Almería;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QII;""
04 Almería;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QI;""
04 Almería;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
04 Almería;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
04 Almería;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QII;""
04 Almería;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QI;""
04 Almería;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
04 Almería;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
04 Almería;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
04 Almería;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
04 Almería;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
04 Almería;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
04 Almería;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
04 Almería;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
04 Almería;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
04 Almería;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
04 Almería;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
04 Almería;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
04 Almería;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;93,81
04 Almería;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
04 Almería;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
04 Almería;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
04 Almería;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;96,03
04 Almería;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
04 Almería;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
04 Almería;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
04 Almería;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;94,84
04 Almería;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
04 Almería;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
04 Almería;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
04 Almería;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
04 Almería;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
04 Almería;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
04 Almería;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;92,1
04 Almería;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
04 Almería;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
04 Almería;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
04 Almería;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;91,5
04 Almería;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
04 Almería;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
04 Almería;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
04 Almería;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
04 Almería;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
04 Almería;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
04 Almería;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;88,02
04 Almería;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
04 Almería;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
04 Almería;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
04 Almería;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;88,06
04 Almería;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
04 Almería;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
04 Almería;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
04 Almería;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
04 Almería;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
04 Almería;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
04 Almería;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;84,21
04 Almería;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
04 Almería;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
04 Almería;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
04 Almería;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;84,56
04 Almería;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
04 Almería;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
04 Almería;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
04 Almería;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
04 Almería;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
04 Almería;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
01 Araba/Álava;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
01 Araba/Álava;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
01 Araba/Álava;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
01 Araba/Álava;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QI;18.102
01 Araba/Álava;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
01 Araba/Álava;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
01 Araba/Álava;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
01 Araba/Álava;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QI;18.049
01 Araba/Álava;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
01 Araba/Álava;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
01 Araba/Álava;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
01 Araba/Álava;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QI;18.303
01 Araba/Álava;All ages;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
01 Araba/Álava;All ages;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
01 Araba/Álava;All ages;Cohort January 1;Total;Survival in the first trimester;2022QII;""
01 Araba/Álava;All ages;Cohort January 1;Total;Survival in the first trimester;2022QI;17.586
01 Araba/Álava;All ages;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
01 Araba/Álava;All ages;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
01 Araba/Álava;All ages;Cohort January 1;Total;Survival in the first trimester;2021QII;""
01 Araba/Álava;All ages;Cohort January 1;Total;Survival in the first trimester;2021QI;17.573
01 Araba/Álava;All ages;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
01 Araba/Álava;All ages;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
01 Araba/Álava;All ages;Cohort January 1;Total;Survival in the first trimester;2020QII;""
01 Araba/Álava;All ages;Cohort January 1;Total;Survival in the first trimester;2020QI;17.432
01 Araba/Álava;All ages;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
01 Araba/Álava;All ages;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
01 Araba/Álava;All ages;Cohort January 1;Total;Survival in the second trimester;2022QII;17.029
01 Araba/Álava;All ages;Cohort January 1;Total;Survival in the second trimester;2022QI;""
01 Araba/Álava;All ages;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
01 Araba/Álava;All ages;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
01 Araba/Álava;All ages;Cohort January 1;Total;Survival in the second trimester;2021QII;17.092
01 Araba/Álava;All ages;Cohort January 1;Total;Survival in the second trimester;2021QI;""
01 Araba/Álava;All ages;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
01 Araba/Álava;All ages;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
01 Araba/Álava;All ages;Cohort January 1;Total;Survival in the second trimester;2020QII;17.074
01 Araba/Álava;All ages;Cohort January 1;Total;Survival in the second trimester;2020QI;""
01 Araba/Álava;All ages;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
01 Araba/Álava;All ages;Cohort January 1;Total;Survival in the third trimester;2022QIII;16.598
01 Araba/Álava;All ages;Cohort January 1;Total;Survival in the third trimester;2022QII;""
01 Araba/Álava;All ages;Cohort January 1;Total;Survival in the third trimester;2022QI;""
01 Araba/Álava;All ages;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
01 Araba/Álava;All ages;Cohort January 1;Total;Survival in the third trimester;2021QIII;16.703
01 Araba/Álava;All ages;Cohort January 1;Total;Survival in the third trimester;2021QII;""
01 Araba/Álava;All ages;Cohort January 1;Total;Survival in the third trimester;2021QI;""
01 Araba/Álava;All ages;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
01 Araba/Álava;All ages;Cohort January 1;Total;Survival in the third trimester;2020QIII;16.690
01 Araba/Álava;All ages;Cohort January 1;Total;Survival in the third trimester;2020QII;""
01 Araba/Álava;All ages;Cohort January 1;Total;Survival in the third trimester;2020QI;""
01 Araba/Álava;All ages;Cohort January 1;Total;Survival in the third trimester;2022QIV;16.065
01 Araba/Álava;All ages;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
01 Araba/Álava;All ages;Cohort January 1;Total;Survival in the third trimester;2022QII;""
01 Araba/Álava;All ages;Cohort January 1;Total;Survival in the third trimester;2022QI;""
01 Araba/Álava;All ages;Cohort January 1;Total;Survival in the third trimester;2021QIV;16.212
01 Araba/Álava;All ages;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
01 Araba/Álava;All ages;Cohort January 1;Total;Survival in the third trimester;2021QII;""
01 Araba/Álava;All ages;Cohort January 1;Total;Survival in the third trimester;2021QI;""
01 Araba/Álava;All ages;Cohort January 1;Total;Survival in the third trimester;2020QIV;16.191
01 Araba/Álava;All ages;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
01 Araba/Álava;All ages;Cohort January 1;Total;Survival in the third trimester;2020QII;""
01 Araba/Álava;All ages;Cohort January 1;Total;Survival in the third trimester;2020QI;""
01 Araba/Álava;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
01 Araba/Álava;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
01 Araba/Álava;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
01 Araba/Álava;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
01 Araba/Álava;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
01 Araba/Álava;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
01 Araba/Álava;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
01 Araba/Álava;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
01 Araba/Álava;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
01 Araba/Álava;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
01 Araba/Álava;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
01 Araba/Álava;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
01 Araba/Álava;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
01 Araba/Álava;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
01 Araba/Álava;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
01 Araba/Álava;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;97,15
01 Araba/Álava;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
01 Araba/Álava;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
01 Araba/Álava;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
01 Araba/Álava;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;97,36
01 Araba/Álava;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
01 Araba/Álava;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
01 Araba/Álava;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
01 Araba/Álava;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;95,24
01 Araba/Álava;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
01 Araba/Álava;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
01 Araba/Álava;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;94,07
01 Araba/Álava;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
01 Araba/Álava;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
01 Araba/Álava;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
01 Araba/Álava;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;94,7
01 Araba/Álava;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
01 Araba/Álava;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
01 Araba/Álava;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
01 Araba/Álava;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;93,29
01 Araba/Álava;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
01 Araba/Álava;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
01 Araba/Álava;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;91,69
01 Araba/Álava;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
01 Araba/Álava;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
01 Araba/Álava;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
01 Araba/Álava;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;92,54
01 Araba/Álava;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
01 Araba/Álava;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
01 Araba/Álava;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
01 Araba/Álava;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;91,19
01 Araba/Álava;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
01 Araba/Álava;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
01 Araba/Álava;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;88,75
01 Araba/Álava;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
01 Araba/Álava;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
01 Araba/Álava;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
01 Araba/Álava;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;89,82
01 Araba/Álava;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
01 Araba/Álava;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
01 Araba/Álava;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
01 Araba/Álava;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;88,46
01 Araba/Álava;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
01 Araba/Álava;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
01 Araba/Álava;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
01 Araba/Álava;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
01 Araba/Álava;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
01 Araba/Álava;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
01 Araba/Álava;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QI;11.433
01 Araba/Álava;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
01 Araba/Álava;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
01 Araba/Álava;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
01 Araba/Álava;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QI;11.454
01 Araba/Álava;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
01 Araba/Álava;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
01 Araba/Álava;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
01 Araba/Álava;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QI;11.608
01 Araba/Álava;All ages;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
01 Araba/Álava;All ages;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
01 Araba/Álava;All ages;Cohort January 1;Males;Survival in the first trimester;2022QII;""
01 Araba/Álava;All ages;Cohort January 1;Males;Survival in the first trimester;2022QI;11.108
01 Araba/Álava;All ages;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
01 Araba/Álava;All ages;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
01 Araba/Álava;All ages;Cohort January 1;Males;Survival in the first trimester;2021QII;""
01 Araba/Álava;All ages;Cohort January 1;Males;Survival in the first trimester;2021QI;11.166
01 Araba/Álava;All ages;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
01 Araba/Álava;All ages;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
01 Araba/Álava;All ages;Cohort January 1;Males;Survival in the first trimester;2020QII;""
01 Araba/Álava;All ages;Cohort January 1;Males;Survival in the first trimester;2020QI;11.098
01 Araba/Álava;All ages;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
01 Araba/Álava;All ages;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
01 Araba/Álava;All ages;Cohort January 1;Males;Survival in the second trimester;2022QII;10.775
01 Araba/Álava;All ages;Cohort January 1;Males;Survival in the second trimester;2022QI;""
01 Araba/Álava;All ages;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
01 Araba/Álava;All ages;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
01 Araba/Álava;All ages;Cohort January 1;Males;Survival in the second trimester;2021QII;10.875
01 Araba/Álava;All ages;Cohort January 1;Males;Survival in the second trimester;2021QI;""
01 Araba/Álava;All ages;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
01 Araba/Álava;All ages;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
01 Araba/Álava;All ages;Cohort January 1;Males;Survival in the second trimester;2020QII;10.896
01 Araba/Álava;All ages;Cohort January 1;Males;Survival in the second trimester;2020QI;""
01 Araba/Álava;All ages;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
01 Araba/Álava;All ages;Cohort January 1;Males;Survival in the third trimester;2022QIII;10.534
01 Araba/Álava;All ages;Cohort January 1;Males;Survival in the third trimester;2022QII;""
01 Araba/Álava;All ages;Cohort January 1;Males;Survival in the third trimester;2022QI;""
01 Araba/Álava;All ages;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
01 Araba/Álava;All ages;Cohort January 1;Males;Survival in the third trimester;2021QIII;10.640
01 Araba/Álava;All ages;Cohort January 1;Males;Survival in the third trimester;2021QII;""
01 Araba/Álava;All ages;Cohort January 1;Males;Survival in the third trimester;2021QI;""
01 Araba/Álava;All ages;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
01 Araba/Álava;All ages;Cohort January 1;Males;Survival in the third trimester;2020QIII;10.667
01 Araba/Álava;All ages;Cohort January 1;Males;Survival in the third trimester;2020QII;""
01 Araba/Álava;All ages;Cohort January 1;Males;Survival in the third trimester;2020QI;""
01 Araba/Álava;All ages;Cohort January 1;Males;Survival in the third trimester;2022QIV;10.185
01 Araba/Álava;All ages;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
01 Araba/Álava;All ages;Cohort January 1;Males;Survival in the third trimester;2022QII;""
01 Araba/Álava;All ages;Cohort January 1;Males;Survival in the third trimester;2022QI;""
01 Araba/Álava;All ages;Cohort January 1;Males;Survival in the third trimester;2021QIV;10.343
01 Araba/Álava;All ages;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
01 Araba/Álava;All ages;Cohort January 1;Males;Survival in the third trimester;2021QII;""
01 Araba/Álava;All ages;Cohort January 1;Males;Survival in the third trimester;2021QI;""
01 Araba/Álava;All ages;Cohort January 1;Males;Survival in the third trimester;2020QIV;10.373
01 Araba/Álava;All ages;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
01 Araba/Álava;All ages;Cohort January 1;Males;Survival in the third trimester;2020QII;""
01 Araba/Álava;All ages;Cohort January 1;Males;Survival in the third trimester;2020QI;""
01 Araba/Álava;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
01 Araba/Álava;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
01 Araba/Álava;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
01 Araba/Álava;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
01 Araba/Álava;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
01 Araba/Álava;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
01 Araba/Álava;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
01 Araba/Álava;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
01 Araba/Álava;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
01 Araba/Álava;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
01 Araba/Álava;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
01 Araba/Álava;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
01 Araba/Álava;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
01 Araba/Álava;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
01 Araba/Álava;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
01 Araba/Álava;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;97,16
01 Araba/Álava;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
01 Araba/Álava;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
01 Araba/Álava;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
01 Araba/Álava;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;97,49
01 Araba/Álava;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
01 Araba/Álava;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
01 Araba/Álava;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
01 Araba/Álava;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;95,61
01 Araba/Álava;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
01 Araba/Álava;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
01 Araba/Álava;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;94,24
01 Araba/Álava;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
01 Araba/Álava;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
01 Araba/Álava;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
01 Araba/Álava;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;94,94
01 Araba/Álava;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
01 Araba/Álava;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
01 Araba/Álava;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
01 Araba/Álava;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;93,87
01 Araba/Álava;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
01 Araba/Álava;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
01 Araba/Álava;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;92,14
01 Araba/Álava;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
01 Araba/Álava;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
01 Araba/Álava;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
01 Araba/Álava;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;92,89
01 Araba/Álava;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
01 Araba/Álava;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
01 Araba/Álava;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
01 Araba/Álava;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;91,89
01 Araba/Álava;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
01 Araba/Álava;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
01 Araba/Álava;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;89,08
01 Araba/Álava;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
01 Araba/Álava;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
01 Araba/Álava;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
01 Araba/Álava;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;90,3
01 Araba/Álava;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
01 Araba/Álava;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
01 Araba/Álava;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
01 Araba/Álava;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;89,36
01 Araba/Álava;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
01 Araba/Álava;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
01 Araba/Álava;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
01 Araba/Álava;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
01 Araba/Álava;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
01 Araba/Álava;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
01 Araba/Álava;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QI;6.669
01 Araba/Álava;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
01 Araba/Álava;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
01 Araba/Álava;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
01 Araba/Álava;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QI;6.595
01 Araba/Álava;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
01 Araba/Álava;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
01 Araba/Álava;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
01 Araba/Álava;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QI;6.695
01 Araba/Álava;All ages;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
01 Araba/Álava;All ages;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
01 Araba/Álava;All ages;Cohort January 1;Females;Survival in the first trimester;2022QII;""
01 Araba/Álava;All ages;Cohort January 1;Females;Survival in the first trimester;2022QI;6.478
01 Araba/Álava;All ages;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
01 Araba/Álava;All ages;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
01 Araba/Álava;All ages;Cohort January 1;Females;Survival in the first trimester;2021QII;""
01 Araba/Álava;All ages;Cohort January 1;Females;Survival in the first trimester;2021QI;6.407
01 Araba/Álava;All ages;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
01 Araba/Álava;All ages;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
01 Araba/Álava;All ages;Cohort January 1;Females;Survival in the first trimester;2020QII;""
01 Araba/Álava;All ages;Cohort January 1;Females;Survival in the first trimester;2020QI;6.334
01 Araba/Álava;All ages;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
01 Araba/Álava;All ages;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
01 Araba/Álava;All ages;Cohort January 1;Females;Survival in the second trimester;2022QII;6.254
01 Araba/Álava;All ages;Cohort January 1;Females;Survival in the second trimester;2022QI;""
01 Araba/Álava;All ages;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
01 Araba/Álava;All ages;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
01 Araba/Álava;All ages;Cohort January 1;Females;Survival in the second trimester;2021QII;6.217
01 Araba/Álava;All ages;Cohort January 1;Females;Survival in the second trimester;2021QI;""
01 Araba/Álava;All ages;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
01 Araba/Álava;All ages;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
01 Araba/Álava;All ages;Cohort January 1;Females;Survival in the second trimester;2020QII;6.178
01 Araba/Álava;All ages;Cohort January 1;Females;Survival in the second trimester;2020QI;""
01 Araba/Álava;All ages;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
01 Araba/Álava;All ages;Cohort January 1;Females;Survival in the third trimester;2022QIII;6.064
01 Araba/Álava;All ages;Cohort January 1;Females;Survival in the third trimester;2022QII;""
01 Araba/Álava;All ages;Cohort January 1;Females;Survival in the third trimester;2022QI;""
01 Araba/Álava;All ages;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
01 Araba/Álava;All ages;Cohort January 1;Females;Survival in the third trimester;2021QIII;6.063
01 Araba/Álava;All ages;Cohort January 1;Females;Survival in the third trimester;2021QII;""
01 Araba/Álava;All ages;Cohort January 1;Females;Survival in the third trimester;2021QI;""
01 Araba/Álava;All ages;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
01 Araba/Álava;All ages;Cohort January 1;Females;Survival in the third trimester;2020QIII;6.023
01 Araba/Álava;All ages;Cohort January 1;Females;Survival in the third trimester;2020QII;""
01 Araba/Álava;All ages;Cohort January 1;Females;Survival in the third trimester;2020QI;""
01 Araba/Álava;All ages;Cohort January 1;Females;Survival in the third trimester;2022QIV;5.880
01 Araba/Álava;All ages;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
01 Araba/Álava;All ages;Cohort January 1;Females;Survival in the third trimester;2022QII;""
01 Araba/Álava;All ages;Cohort January 1;Females;Survival in the third trimester;2022QI;""
01 Araba/Álava;All ages;Cohort January 1;Females;Survival in the third trimester;2021QIV;5.869
01 Araba/Álava;All ages;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
01 Araba/Álava;All ages;Cohort January 1;Females;Survival in the third trimester;2021QII;""
01 Araba/Álava;All ages;Cohort January 1;Females;Survival in the third trimester;2021QI;""
01 Araba/Álava;All ages;Cohort January 1;Females;Survival in the third trimester;2020QIV;5.818
01 Araba/Álava;All ages;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
01 Araba/Álava;All ages;Cohort January 1;Females;Survival in the third trimester;2020QII;""
01 Araba/Álava;All ages;Cohort January 1;Females;Survival in the third trimester;2020QI;""
01 Araba/Álava;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
01 Araba/Álava;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
01 Araba/Álava;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
01 Araba/Álava;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
01 Araba/Álava;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
01 Araba/Álava;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
01 Araba/Álava;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
01 Araba/Álava;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
01 Araba/Álava;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
01 Araba/Álava;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
01 Araba/Álava;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
01 Araba/Álava;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
01 Araba/Álava;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
01 Araba/Álava;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
01 Araba/Álava;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
01 Araba/Álava;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;97,14
01 Araba/Álava;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
01 Araba/Álava;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
01 Araba/Álava;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
01 Araba/Álava;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;97,15
01 Araba/Álava;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
01 Araba/Álava;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
01 Araba/Álava;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
01 Araba/Álava;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;94,61
01 Araba/Álava;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
01 Araba/Álava;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
01 Araba/Álava;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;93,78
01 Araba/Álava;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
01 Araba/Álava;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
01 Araba/Álava;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
01 Araba/Álava;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;94,27
01 Araba/Álava;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
01 Araba/Álava;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
01 Araba/Álava;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
01 Araba/Álava;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;92,28
01 Araba/Álava;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
01 Araba/Álava;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
01 Araba/Álava;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;90,93
01 Araba/Álava;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
01 Araba/Álava;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
01 Araba/Álava;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
01 Araba/Álava;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;91,93
01 Araba/Álava;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
01 Araba/Álava;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
01 Araba/Álava;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
01 Araba/Álava;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;89,96
01 Araba/Álava;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
01 Araba/Álava;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
01 Araba/Álava;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;88,17
01 Araba/Álava;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
01 Araba/Álava;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
01 Araba/Álava;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
01 Araba/Álava;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;88,99
01 Araba/Álava;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
01 Araba/Álava;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
01 Araba/Álava;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
01 Araba/Álava;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;86,9
01 Araba/Álava;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
01 Araba/Álava;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
01 Araba/Álava;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
01 Araba/Álava;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
01 Araba/Álava;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
01 Araba/Álava;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QII;18.211
01 Araba/Álava;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
01 Araba/Álava;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
01 Araba/Álava;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
01 Araba/Álava;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QII;18.109
01 Araba/Álava;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
01 Araba/Álava;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
01 Araba/Álava;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
01 Araba/Álava;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QII;18.098
01 Araba/Álava;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
01 Araba/Álava;All ages;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
01 Araba/Álava;All ages;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
01 Araba/Álava;All ages;Cohort April 1;Total;Survival in the first trimester;2022QII;17.593
01 Araba/Álava;All ages;Cohort April 1;Total;Survival in the first trimester;2022QI;""
01 Araba/Álava;All ages;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
01 Araba/Álava;All ages;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
01 Araba/Álava;All ages;Cohort April 1;Total;Survival in the first trimester;2021QII;17.554
01 Araba/Álava;All ages;Cohort April 1;Total;Survival in the first trimester;2021QI;""
01 Araba/Álava;All ages;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
01 Araba/Álava;All ages;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
01 Araba/Álava;All ages;Cohort April 1;Total;Survival in the first trimester;2020QII;17.704
01 Araba/Álava;All ages;Cohort April 1;Total;Survival in the first trimester;2020QI;""
01 Araba/Álava;All ages;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
01 Araba/Álava;All ages;Cohort April 1;Total;Survival in the second trimester;2022QIII;17.130
01 Araba/Álava;All ages;Cohort April 1;Total;Survival in the second trimester;2022QII;""
01 Araba/Álava;All ages;Cohort April 1;Total;Survival in the second trimester;2022QI;""
01 Araba/Álava;All ages;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
01 Araba/Álava;All ages;Cohort April 1;Total;Survival in the second trimester;2021QIII;17.122
01 Araba/Álava;All ages;Cohort April 1;Total;Survival in the second trimester;2021QII;""
01 Araba/Álava;All ages;Cohort April 1;Total;Survival in the second trimester;2021QI;""
01 Araba/Álava;All ages;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
01 Araba/Álava;All ages;Cohort April 1;Total;Survival in the second trimester;2020QIII;17.250
01 Araba/Álava;All ages;Cohort April 1;Total;Survival in the second trimester;2020QII;""
01 Araba/Álava;All ages;Cohort April 1;Total;Survival in the second trimester;2020QI;""
01 Araba/Álava;All ages;Cohort April 1;Total;Survival in the third trimester;2022QIV;16.552
01 Araba/Álava;All ages;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
01 Araba/Álava;All ages;Cohort April 1;Total;Survival in the third trimester;2022QII;""
01 Araba/Álava;All ages;Cohort April 1;Total;Survival in the third trimester;2022QI;""
01 Araba/Álava;All ages;Cohort April 1;Total;Survival in the third trimester;2021QIV;16.605
01 Araba/Álava;All ages;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
01 Araba/Álava;All ages;Cohort April 1;Total;Survival in the third trimester;2021QII;""
01 Araba/Álava;All ages;Cohort April 1;Total;Survival in the third trimester;2021QI;""
01 Araba/Álava;All ages;Cohort April 1;Total;Survival in the third trimester;2020QIV;16.710
01 Araba/Álava;All ages;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
01 Araba/Álava;All ages;Cohort April 1;Total;Survival in the third trimester;2020QII;""
01 Araba/Álava;All ages;Cohort April 1;Total;Survival in the third trimester;2020QI;""
01 Araba/Álava;All ages;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
01 Araba/Álava;All ages;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
01 Araba/Álava;All ages;Cohort April 1;Total;Survival in the third trimester;2022QII;""
01 Araba/Álava;All ages;Cohort April 1;Total;Survival in the third trimester;2022QI;16.235
01 Araba/Álava;All ages;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
01 Araba/Álava;All ages;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
01 Araba/Álava;All ages;Cohort April 1;Total;Survival in the third trimester;2021QII;""
01 Araba/Álava;All ages;Cohort April 1;Total;Survival in the third trimester;2021QI;16.339
01 Araba/Álava;All ages;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
01 Araba/Álava;All ages;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
01 Araba/Álava;All ages;Cohort April 1;Total;Survival in the third trimester;2020QII;""
01 Araba/Álava;All ages;Cohort April 1;Total;Survival in the third trimester;2020QI;""
01 Araba/Álava;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
01 Araba/Álava;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
01 Araba/Álava;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
01 Araba/Álava;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
01 Araba/Álava;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
01 Araba/Álava;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
01 Araba/Álava;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
01 Araba/Álava;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
01 Araba/Álava;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
01 Araba/Álava;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
01 Araba/Álava;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
01 Araba/Álava;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
01 Araba/Álava;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
01 Araba/Álava;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
01 Araba/Álava;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;96,61
01 Araba/Álava;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
01 Araba/Álava;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
01 Araba/Álava;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
01 Araba/Álava;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;96,94
01 Araba/Álava;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
01 Araba/Álava;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
01 Araba/Álava;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
01 Araba/Álava;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;97,82
01 Araba/Álava;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
01 Araba/Álava;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
01 Araba/Álava;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;94,06
01 Araba/Álava;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
01 Araba/Álava;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
01 Araba/Álava;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
01 Araba/Álava;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;94,55
01 Araba/Álava;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
01 Araba/Álava;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
01 Araba/Álava;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
01 Araba/Álava;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;95,31
01 Araba/Álava;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
01 Araba/Álava;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
01 Araba/Álava;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;90,89
01 Araba/Álava;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
01 Araba/Álava;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
01 Araba/Álava;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
01 Araba/Álava;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;91,69
01 Araba/Álava;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
01 Araba/Álava;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
01 Araba/Álava;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
01 Araba/Álava;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;92,33
01 Araba/Álava;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
01 Araba/Álava;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
01 Araba/Álava;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
01 Araba/Álava;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
01 Araba/Álava;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
01 Araba/Álava;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
01 Araba/Álava;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;89,65
01 Araba/Álava;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
01 Araba/Álava;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
01 Araba/Álava;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
01 Araba/Álava;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;90,28
01 Araba/Álava;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
01 Araba/Álava;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
01 Araba/Álava;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
01 Araba/Álava;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
01 Araba/Álava;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
01 Araba/Álava;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
01 Araba/Álava;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QII;11.488
01 Araba/Álava;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
01 Araba/Álava;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
01 Araba/Álava;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
01 Araba/Álava;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QII;11.506
01 Araba/Álava;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
01 Araba/Álava;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
01 Araba/Álava;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
01 Araba/Álava;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QII;11.504
01 Araba/Álava;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
01 Araba/Álava;All ages;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
01 Araba/Álava;All ages;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
01 Araba/Álava;All ages;Cohort April 1;Males;Survival in the first trimester;2022QII;11.116
01 Araba/Álava;All ages;Cohort April 1;Males;Survival in the first trimester;2022QI;""
01 Araba/Álava;All ages;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
01 Araba/Álava;All ages;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
01 Araba/Álava;All ages;Cohort April 1;Males;Survival in the first trimester;2021QII;11.172
01 Araba/Álava;All ages;Cohort April 1;Males;Survival in the first trimester;2021QI;""
01 Araba/Álava;All ages;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
01 Araba/Álava;All ages;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
01 Araba/Álava;All ages;Cohort April 1;Males;Survival in the first trimester;2020QII;11.284
01 Araba/Álava;All ages;Cohort April 1;Males;Survival in the first trimester;2020QI;""
01 Araba/Álava;All ages;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
01 Araba/Álava;All ages;Cohort April 1;Males;Survival in the second trimester;2022QIII;10.854
01 Araba/Álava;All ages;Cohort April 1;Males;Survival in the second trimester;2022QII;""
01 Araba/Álava;All ages;Cohort April 1;Males;Survival in the second trimester;2022QI;""
01 Araba/Álava;All ages;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
01 Araba/Álava;All ages;Cohort April 1;Males;Survival in the second trimester;2021QIII;10.909
01 Araba/Álava;All ages;Cohort April 1;Males;Survival in the second trimester;2021QII;""
01 Araba/Álava;All ages;Cohort April 1;Males;Survival in the second trimester;2021QI;""
01 Araba/Álava;All ages;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
01 Araba/Álava;All ages;Cohort April 1;Males;Survival in the second trimester;2020QIII;11.010
01 Araba/Álava;All ages;Cohort April 1;Males;Survival in the second trimester;2020QII;""
01 Araba/Álava;All ages;Cohort April 1;Males;Survival in the second trimester;2020QI;""
01 Araba/Álava;All ages;Cohort April 1;Males;Survival in the third trimester;2022QIV;10.475
01 Araba/Álava;All ages;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
01 Araba/Álava;All ages;Cohort April 1;Males;Survival in the third trimester;2022QII;""
01 Araba/Álava;All ages;Cohort April 1;Males;Survival in the third trimester;2022QI;""
01 Araba/Álava;All ages;Cohort April 1;Males;Survival in the third trimester;2021QIV;10.592
01 Araba/Álava;All ages;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
01 Araba/Álava;All ages;Cohort April 1;Males;Survival in the third trimester;2021QII;""
01 Araba/Álava;All ages;Cohort April 1;Males;Survival in the third trimester;2021QI;""
01 Araba/Álava;All ages;Cohort April 1;Males;Survival in the third trimester;2020QIV;10.693
01 Araba/Álava;All ages;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
01 Araba/Álava;All ages;Cohort April 1;Males;Survival in the third trimester;2020QII;""
01 Araba/Álava;All ages;Cohort April 1;Males;Survival in the third trimester;2020QI;""
01 Araba/Álava;All ages;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
01 Araba/Álava;All ages;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
01 Araba/Álava;All ages;Cohort April 1;Males;Survival in the third trimester;2022QII;""
01 Araba/Álava;All ages;Cohort April 1;Males;Survival in the third trimester;2022QI;10.357
01 Araba/Álava;All ages;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
01 Araba/Álava;All ages;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
01 Araba/Álava;All ages;Cohort April 1;Males;Survival in the third trimester;2021QII;""
01 Araba/Álava;All ages;Cohort April 1;Males;Survival in the third trimester;2021QI;10.465
01 Araba/Álava;All ages;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
01 Araba/Álava;All ages;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
01 Araba/Álava;All ages;Cohort April 1;Males;Survival in the third trimester;2020QII;""
01 Araba/Álava;All ages;Cohort April 1;Males;Survival in the third trimester;2020QI;""
01 Araba/Álava;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
01 Araba/Álava;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
01 Araba/Álava;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
01 Araba/Álava;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
01 Araba/Álava;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
01 Araba/Álava;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
01 Araba/Álava;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
01 Araba/Álava;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
01 Araba/Álava;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
01 Araba/Álava;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
01 Araba/Álava;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
01 Araba/Álava;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
01 Araba/Álava;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
01 Araba/Álava;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
01 Araba/Álava;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;96,76
01 Araba/Álava;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
01 Araba/Álava;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
01 Araba/Álava;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
01 Araba/Álava;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;97,1
01 Araba/Álava;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
01 Araba/Álava;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
01 Araba/Álava;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
01 Araba/Álava;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;98,09
01 Araba/Álava;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
01 Araba/Álava;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
01 Araba/Álava;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;94,48
01 Araba/Álava;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
01 Araba/Álava;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
01 Araba/Álava;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
01 Araba/Álava;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;94,81
01 Araba/Álava;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
01 Araba/Álava;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
01 Araba/Álava;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
01 Araba/Álava;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;95,71
01 Araba/Álava;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
01 Araba/Álava;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
01 Araba/Álava;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;91,18
01 Araba/Álava;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
01 Araba/Álava;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
01 Araba/Álava;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
01 Araba/Álava;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;92,06
01 Araba/Álava;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
01 Araba/Álava;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
01 Araba/Álava;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
01 Araba/Álava;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;92,95
01 Araba/Álava;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
01 Araba/Álava;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
01 Araba/Álava;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
01 Araba/Álava;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
01 Araba/Álava;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
01 Araba/Álava;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
01 Araba/Álava;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;90,01
01 Araba/Álava;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
01 Araba/Álava;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
01 Araba/Álava;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
01 Araba/Álava;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;90,97
01 Araba/Álava;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
01 Araba/Álava;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
01 Araba/Álava;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
01 Araba/Álava;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
01 Araba/Álava;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
01 Araba/Álava;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
01 Araba/Álava;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QII;6.723
01 Araba/Álava;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
01 Araba/Álava;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
01 Araba/Álava;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
01 Araba/Álava;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QII;6.603
01 Araba/Álava;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
01 Araba/Álava;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
01 Araba/Álava;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
01 Araba/Álava;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QII;6.594
01 Araba/Álava;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
01 Araba/Álava;All ages;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
01 Araba/Álava;All ages;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
01 Araba/Álava;All ages;Cohort April 1;Females;Survival in the first trimester;2022QII;6.477
01 Araba/Álava;All ages;Cohort April 1;Females;Survival in the first trimester;2022QI;""
01 Araba/Álava;All ages;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
01 Araba/Álava;All ages;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
01 Araba/Álava;All ages;Cohort April 1;Females;Survival in the first trimester;2021QII;6.382
01 Araba/Álava;All ages;Cohort April 1;Females;Survival in the first trimester;2021QI;""
01 Araba/Álava;All ages;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
01 Araba/Álava;All ages;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
01 Araba/Álava;All ages;Cohort April 1;Females;Survival in the first trimester;2020QII;6.420
01 Araba/Álava;All ages;Cohort April 1;Females;Survival in the first trimester;2020QI;""
01 Araba/Álava;All ages;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
01 Araba/Álava;All ages;Cohort April 1;Females;Survival in the second trimester;2022QIII;6.276
01 Araba/Álava;All ages;Cohort April 1;Females;Survival in the second trimester;2022QII;""
01 Araba/Álava;All ages;Cohort April 1;Females;Survival in the second trimester;2022QI;""
01 Araba/Álava;All ages;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
01 Araba/Álava;All ages;Cohort April 1;Females;Survival in the second trimester;2021QIII;6.213
01 Araba/Álava;All ages;Cohort April 1;Females;Survival in the second trimester;2021QII;""
01 Araba/Álava;All ages;Cohort April 1;Females;Survival in the second trimester;2021QI;""
01 Araba/Álava;All ages;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
01 Araba/Álava;All ages;Cohort April 1;Females;Survival in the second trimester;2020QIII;6.240
01 Araba/Álava;All ages;Cohort April 1;Females;Survival in the second trimester;2020QII;""
01 Araba/Álava;All ages;Cohort April 1;Females;Survival in the second trimester;2020QI;""
01 Araba/Álava;All ages;Cohort April 1;Females;Survival in the third trimester;2022QIV;6.077
01 Araba/Álava;All ages;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
01 Araba/Álava;All ages;Cohort April 1;Females;Survival in the third trimester;2022QII;""
01 Araba/Álava;All ages;Cohort April 1;Females;Survival in the third trimester;2022QI;""
01 Araba/Álava;All ages;Cohort April 1;Females;Survival in the third trimester;2021QIV;6.013
01 Araba/Álava;All ages;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
01 Araba/Álava;All ages;Cohort April 1;Females;Survival in the third trimester;2021QII;""
01 Araba/Álava;All ages;Cohort April 1;Females;Survival in the third trimester;2021QI;""
01 Araba/Álava;All ages;Cohort April 1;Females;Survival in the third trimester;2020QIV;6.017
01 Araba/Álava;All ages;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
01 Araba/Álava;All ages;Cohort April 1;Females;Survival in the third trimester;2020QII;""
01 Araba/Álava;All ages;Cohort April 1;Females;Survival in the third trimester;2020QI;""
01 Araba/Álava;All ages;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
01 Araba/Álava;All ages;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
01 Araba/Álava;All ages;Cohort April 1;Females;Survival in the third trimester;2022QII;""
01 Araba/Álava;All ages;Cohort April 1;Females;Survival in the third trimester;2022QI;5.878
01 Araba/Álava;All ages;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
01 Araba/Álava;All ages;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
01 Araba/Álava;All ages;Cohort April 1;Females;Survival in the third trimester;2021QII;""
01 Araba/Álava;All ages;Cohort April 1;Females;Survival in the third trimester;2021QI;5.874
01 Araba/Álava;All ages;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
01 Araba/Álava;All ages;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
01 Araba/Álava;All ages;Cohort April 1;Females;Survival in the third trimester;2020QII;""
01 Araba/Álava;All ages;Cohort April 1;Females;Survival in the third trimester;2020QI;""
01 Araba/Álava;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
01 Araba/Álava;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
01 Araba/Álava;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
01 Araba/Álava;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
01 Araba/Álava;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
01 Araba/Álava;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
01 Araba/Álava;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
01 Araba/Álava;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
01 Araba/Álava;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
01 Araba/Álava;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
01 Araba/Álava;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
01 Araba/Álava;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
01 Araba/Álava;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
01 Araba/Álava;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
01 Araba/Álava;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;96,34
01 Araba/Álava;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
01 Araba/Álava;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
01 Araba/Álava;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
01 Araba/Álava;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;96,65
01 Araba/Álava;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
01 Araba/Álava;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
01 Araba/Álava;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
01 Araba/Álava;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;97,36
01 Araba/Álava;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
01 Araba/Álava;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
01 Araba/Álava;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;93,35
01 Araba/Álava;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
01 Araba/Álava;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
01 Araba/Álava;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
01 Araba/Álava;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;94,09
01 Araba/Álava;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
01 Araba/Álava;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
01 Araba/Álava;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
01 Araba/Álava;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;94,63
01 Araba/Álava;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
01 Araba/Álava;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
01 Araba/Álava;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;90,39
01 Araba/Álava;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
01 Araba/Álava;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
01 Araba/Álava;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
01 Araba/Álava;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;91,06
01 Araba/Álava;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
01 Araba/Álava;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
01 Araba/Álava;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
01 Araba/Álava;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;91,25
01 Araba/Álava;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
01 Araba/Álava;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
01 Araba/Álava;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
01 Araba/Álava;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
01 Araba/Álava;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
01 Araba/Álava;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
01 Araba/Álava;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;89,02
01 Araba/Álava;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
01 Araba/Álava;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
01 Araba/Álava;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
01 Araba/Álava;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;89,08
01 Araba/Álava;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
01 Araba/Álava;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
01 Araba/Álava;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
01 Araba/Álava;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
01 Araba/Álava;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
01 Araba/Álava;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QIII;18.200
01 Araba/Álava;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
01 Araba/Álava;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
01 Araba/Álava;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
01 Araba/Álava;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QIII;18.135
01 Araba/Álava;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
01 Araba/Álava;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
01 Araba/Álava;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
01 Araba/Álava;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QIII;18.083
01 Araba/Álava;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
01 Araba/Álava;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
01 Araba/Álava;All ages;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
01 Araba/Álava;All ages;Cohort July 1;Total;Survival in the first trimester;2022QIII;17.652
01 Araba/Álava;All ages;Cohort July 1;Total;Survival in the first trimester;2022QII;""
01 Araba/Álava;All ages;Cohort July 1;Total;Survival in the first trimester;2022QI;""
01 Araba/Álava;All ages;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
01 Araba/Álava;All ages;Cohort July 1;Total;Survival in the first trimester;2021QIII;17.634
01 Araba/Álava;All ages;Cohort July 1;Total;Survival in the first trimester;2021QII;""
01 Araba/Álava;All ages;Cohort July 1;Total;Survival in the first trimester;2021QI;""
01 Araba/Álava;All ages;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
01 Araba/Álava;All ages;Cohort July 1;Total;Survival in the first trimester;2020QIII;17.582
01 Araba/Álava;All ages;Cohort July 1;Total;Survival in the first trimester;2020QII;""
01 Araba/Álava;All ages;Cohort July 1;Total;Survival in the first trimester;2020QI;""
01 Araba/Álava;All ages;Cohort July 1;Total;Survival in the second trimester;2022QIV;17.030
01 Araba/Álava;All ages;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
01 Araba/Álava;All ages;Cohort July 1;Total;Survival in the second trimester;2022QII;""
01 Araba/Álava;All ages;Cohort July 1;Total;Survival in the second trimester;2022QI;""
01 Araba/Álava;All ages;Cohort July 1;Total;Survival in the second trimester;2021QIV;17.078
01 Araba/Álava;All ages;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
01 Araba/Álava;All ages;Cohort July 1;Total;Survival in the second trimester;2021QII;""
01 Araba/Álava;All ages;Cohort July 1;Total;Survival in the second trimester;2021QI;""
01 Araba/Álava;All ages;Cohort July 1;Total;Survival in the second trimester;2020QIV;17.007
01 Araba/Álava;All ages;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
01 Araba/Álava;All ages;Cohort July 1;Total;Survival in the second trimester;2020QII;""
01 Araba/Álava;All ages;Cohort July 1;Total;Survival in the second trimester;2020QI;""
01 Araba/Álava;All ages;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
01 Araba/Álava;All ages;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
01 Araba/Álava;All ages;Cohort July 1;Total;Survival in the third trimester;2022QII;""
01 Araba/Álava;All ages;Cohort July 1;Total;Survival in the third trimester;2022QI;16.660
01 Araba/Álava;All ages;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
01 Araba/Álava;All ages;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
01 Araba/Álava;All ages;Cohort July 1;Total;Survival in the third trimester;2021QII;""
01 Araba/Álava;All ages;Cohort July 1;Total;Survival in the third trimester;2021QI;16.620
01 Araba/Álava;All ages;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
01 Araba/Álava;All ages;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
01 Araba/Álava;All ages;Cohort July 1;Total;Survival in the third trimester;2020QII;""
01 Araba/Álava;All ages;Cohort July 1;Total;Survival in the third trimester;2020QI;""
01 Araba/Álava;All ages;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
01 Araba/Álava;All ages;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
01 Araba/Álava;All ages;Cohort July 1;Total;Survival in the third trimester;2022QII;16.201
01 Araba/Álava;All ages;Cohort July 1;Total;Survival in the third trimester;2022QI;""
01 Araba/Álava;All ages;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
01 Araba/Álava;All ages;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
01 Araba/Álava;All ages;Cohort July 1;Total;Survival in the third trimester;2021QII;16.235
01 Araba/Álava;All ages;Cohort July 1;Total;Survival in the third trimester;2021QI;""
01 Araba/Álava;All ages;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
01 Araba/Álava;All ages;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
01 Araba/Álava;All ages;Cohort July 1;Total;Survival in the third trimester;2020QII;""
01 Araba/Álava;All ages;Cohort July 1;Total;Survival in the third trimester;2020QI;""
01 Araba/Álava;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
01 Araba/Álava;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
01 Araba/Álava;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
01 Araba/Álava;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
01 Araba/Álava;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
01 Araba/Álava;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
01 Araba/Álava;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
01 Araba/Álava;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
01 Araba/Álava;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
01 Araba/Álava;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
01 Araba/Álava;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
01 Araba/Álava;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
01 Araba/Álava;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
01 Araba/Álava;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;96,99
01 Araba/Álava;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
01 Araba/Álava;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
01 Araba/Álava;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
01 Araba/Álava;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;97,24
01 Araba/Álava;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
01 Araba/Álava;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
01 Araba/Álava;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
01 Araba/Álava;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;97,23
01 Araba/Álava;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
01 Araba/Álava;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
01 Araba/Álava;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;93,57
01 Araba/Álava;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
01 Araba/Álava;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
01 Araba/Álava;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
01 Araba/Álava;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;94,17
01 Araba/Álava;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
01 Araba/Álava;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
01 Araba/Álava;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
01 Araba/Álava;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;94,05
01 Araba/Álava;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
01 Araba/Álava;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
01 Araba/Álava;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
01 Araba/Álava;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
01 Araba/Álava;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
01 Araba/Álava;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
01 Araba/Álava;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;91,87
01 Araba/Álava;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
01 Araba/Álava;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
01 Araba/Álava;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
01 Araba/Álava;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;91,91
01 Araba/Álava;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
01 Araba/Álava;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
01 Araba/Álava;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
01 Araba/Álava;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
01 Araba/Álava;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
01 Araba/Álava;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
01 Araba/Álava;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;89,34
01 Araba/Álava;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
01 Araba/Álava;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
01 Araba/Álava;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
01 Araba/Álava;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;89,78
01 Araba/Álava;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
01 Araba/Álava;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
01 Araba/Álava;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
01 Araba/Álava;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
01 Araba/Álava;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
01 Araba/Álava;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
01 Araba/Álava;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QIII;11.433
01 Araba/Álava;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
01 Araba/Álava;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
01 Araba/Álava;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
01 Araba/Álava;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QIII;11.533
01 Araba/Álava;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
01 Araba/Álava;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
01 Araba/Álava;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
01 Araba/Álava;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QIII;11.521
01 Araba/Álava;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
01 Araba/Álava;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
01 Araba/Álava;All ages;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
01 Araba/Álava;All ages;Cohort July 1;Males;Survival in the first trimester;2022QIII;11.122
01 Araba/Álava;All ages;Cohort July 1;Males;Survival in the first trimester;2022QII;""
01 Araba/Álava;All ages;Cohort July 1;Males;Survival in the first trimester;2022QI;""
01 Araba/Álava;All ages;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
01 Araba/Álava;All ages;Cohort July 1;Males;Survival in the first trimester;2021QIII;11.219
01 Araba/Álava;All ages;Cohort July 1;Males;Survival in the first trimester;2021QII;""
01 Araba/Álava;All ages;Cohort July 1;Males;Survival in the first trimester;2021QI;""
01 Araba/Álava;All ages;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
01 Araba/Álava;All ages;Cohort July 1;Males;Survival in the first trimester;2020QIII;11.218
01 Araba/Álava;All ages;Cohort July 1;Males;Survival in the first trimester;2020QII;""
01 Araba/Álava;All ages;Cohort July 1;Males;Survival in the first trimester;2020QI;""
01 Araba/Álava;All ages;Cohort July 1;Males;Survival in the second trimester;2022QIV;10.725
01 Araba/Álava;All ages;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
01 Araba/Álava;All ages;Cohort July 1;Males;Survival in the second trimester;2022QII;""
01 Araba/Álava;All ages;Cohort July 1;Males;Survival in the second trimester;2022QI;""
01 Araba/Álava;All ages;Cohort July 1;Males;Survival in the second trimester;2021QIV;10.878
01 Araba/Álava;All ages;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
01 Araba/Álava;All ages;Cohort July 1;Males;Survival in the second trimester;2021QII;""
01 Araba/Álava;All ages;Cohort July 1;Males;Survival in the second trimester;2021QI;""
01 Araba/Álava;All ages;Cohort July 1;Males;Survival in the second trimester;2020QIV;10.884
01 Araba/Álava;All ages;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
01 Araba/Álava;All ages;Cohort July 1;Males;Survival in the second trimester;2020QII;""
01 Araba/Álava;All ages;Cohort July 1;Males;Survival in the second trimester;2020QI;""
01 Araba/Álava;All ages;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
01 Araba/Álava;All ages;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
01 Araba/Álava;All ages;Cohort July 1;Males;Survival in the third trimester;2022QII;""
01 Araba/Álava;All ages;Cohort July 1;Males;Survival in the third trimester;2022QI;10.607
01 Araba/Álava;All ages;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
01 Araba/Álava;All ages;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
01 Araba/Álava;All ages;Cohort July 1;Males;Survival in the third trimester;2021QII;""
01 Araba/Álava;All ages;Cohort July 1;Males;Survival in the third trimester;2021QI;10.647
01 Araba/Álava;All ages;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
01 Araba/Álava;All ages;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
01 Araba/Álava;All ages;Cohort July 1;Males;Survival in the third trimester;2020QII;""
01 Araba/Álava;All ages;Cohort July 1;Males;Survival in the third trimester;2020QI;""
01 Araba/Álava;All ages;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
01 Araba/Álava;All ages;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
01 Araba/Álava;All ages;Cohort July 1;Males;Survival in the third trimester;2022QII;10.328
01 Araba/Álava;All ages;Cohort July 1;Males;Survival in the third trimester;2022QI;""
01 Araba/Álava;All ages;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
01 Araba/Álava;All ages;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
01 Araba/Álava;All ages;Cohort July 1;Males;Survival in the third trimester;2021QII;10.404
01 Araba/Álava;All ages;Cohort July 1;Males;Survival in the third trimester;2021QI;""
01 Araba/Álava;All ages;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
01 Araba/Álava;All ages;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
01 Araba/Álava;All ages;Cohort July 1;Males;Survival in the third trimester;2020QII;""
01 Araba/Álava;All ages;Cohort July 1;Males;Survival in the third trimester;2020QI;""
01 Araba/Álava;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
01 Araba/Álava;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
01 Araba/Álava;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
01 Araba/Álava;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
01 Araba/Álava;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
01 Araba/Álava;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
01 Araba/Álava;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
01 Araba/Álava;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
01 Araba/Álava;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
01 Araba/Álava;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
01 Araba/Álava;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
01 Araba/Álava;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
01 Araba/Álava;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
01 Araba/Álava;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;97,28
01 Araba/Álava;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
01 Araba/Álava;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
01 Araba/Álava;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
01 Araba/Álava;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;97,28
01 Araba/Álava;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
01 Araba/Álava;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
01 Araba/Álava;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
01 Araba/Álava;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;97,37
01 Araba/Álava;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
01 Araba/Álava;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
01 Araba/Álava;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;93,81
01 Araba/Álava;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
01 Araba/Álava;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
01 Araba/Álava;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
01 Araba/Álava;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;94,32
01 Araba/Álava;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
01 Araba/Álava;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
01 Araba/Álava;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
01 Araba/Álava;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;94,47
01 Araba/Álava;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
01 Araba/Álava;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
01 Araba/Álava;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
01 Araba/Álava;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
01 Araba/Álava;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
01 Araba/Álava;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
01 Araba/Álava;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;91,97
01 Araba/Álava;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
01 Araba/Álava;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
01 Araba/Álava;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
01 Araba/Álava;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;92,41
01 Araba/Álava;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
01 Araba/Álava;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
01 Araba/Álava;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
01 Araba/Álava;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
01 Araba/Álava;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
01 Araba/Álava;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
01 Araba/Álava;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;89,55
01 Araba/Álava;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
01 Araba/Álava;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
01 Araba/Álava;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
01 Araba/Álava;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;90,3
01 Araba/Álava;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
01 Araba/Álava;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
01 Araba/Álava;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
01 Araba/Álava;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
01 Araba/Álava;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
01 Araba/Álava;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
01 Araba/Álava;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QIII;6.767
01 Araba/Álava;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
01 Araba/Álava;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
01 Araba/Álava;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
01 Araba/Álava;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QIII;6.602
01 Araba/Álava;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
01 Araba/Álava;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
01 Araba/Álava;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
01 Araba/Álava;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QIII;6.562
01 Araba/Álava;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
01 Araba/Álava;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
01 Araba/Álava;All ages;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
01 Araba/Álava;All ages;Cohort July 1;Females;Survival in the first trimester;2022QIII;6.530
01 Araba/Álava;All ages;Cohort July 1;Females;Survival in the first trimester;2022QII;""
01 Araba/Álava;All ages;Cohort July 1;Females;Survival in the first trimester;2022QI;""
01 Araba/Álava;All ages;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
01 Araba/Álava;All ages;Cohort July 1;Females;Survival in the first trimester;2021QIII;6.415
01 Araba/Álava;All ages;Cohort July 1;Females;Survival in the first trimester;2021QII;""
01 Araba/Álava;All ages;Cohort July 1;Females;Survival in the first trimester;2021QI;""
01 Araba/Álava;All ages;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
01 Araba/Álava;All ages;Cohort July 1;Females;Survival in the first trimester;2020QIII;6.364
01 Araba/Álava;All ages;Cohort July 1;Females;Survival in the first trimester;2020QII;""
01 Araba/Álava;All ages;Cohort July 1;Females;Survival in the first trimester;2020QI;""
01 Araba/Álava;All ages;Cohort July 1;Females;Survival in the second trimester;2022QIV;6.305
01 Araba/Álava;All ages;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
01 Araba/Álava;All ages;Cohort July 1;Females;Survival in the second trimester;2022QII;""
01 Araba/Álava;All ages;Cohort July 1;Females;Survival in the second trimester;2022QI;""
01 Araba/Álava;All ages;Cohort July 1;Females;Survival in the second trimester;2021QIV;6.200
01 Araba/Álava;All ages;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
01 Araba/Álava;All ages;Cohort July 1;Females;Survival in the second trimester;2021QII;""
01 Araba/Álava;All ages;Cohort July 1;Females;Survival in the second trimester;2021QI;""
01 Araba/Álava;All ages;Cohort July 1;Females;Survival in the second trimester;2020QIV;6.123
01 Araba/Álava;All ages;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
01 Araba/Álava;All ages;Cohort July 1;Females;Survival in the second trimester;2020QII;""
01 Araba/Álava;All ages;Cohort July 1;Females;Survival in the second trimester;2020QI;""
01 Araba/Álava;All ages;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
01 Araba/Álava;All ages;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
01 Araba/Álava;All ages;Cohort July 1;Females;Survival in the third trimester;2022QII;""
01 Araba/Álava;All ages;Cohort July 1;Females;Survival in the third trimester;2022QI;6.053
01 Araba/Álava;All ages;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
01 Araba/Álava;All ages;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
01 Araba/Álava;All ages;Cohort July 1;Females;Survival in the third trimester;2021QII;""
01 Araba/Álava;All ages;Cohort July 1;Females;Survival in the third trimester;2021QI;5.973
01 Araba/Álava;All ages;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
01 Araba/Álava;All ages;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
01 Araba/Álava;All ages;Cohort July 1;Females;Survival in the third trimester;2020QII;""
01 Araba/Álava;All ages;Cohort July 1;Females;Survival in the third trimester;2020QI;""
01 Araba/Álava;All ages;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
01 Araba/Álava;All ages;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
01 Araba/Álava;All ages;Cohort July 1;Females;Survival in the third trimester;2022QII;5.873
01 Araba/Álava;All ages;Cohort July 1;Females;Survival in the third trimester;2022QI;""
01 Araba/Álava;All ages;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
01 Araba/Álava;All ages;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
01 Araba/Álava;All ages;Cohort July 1;Females;Survival in the third trimester;2021QII;5.831
01 Araba/Álava;All ages;Cohort July 1;Females;Survival in the third trimester;2021QI;""
01 Araba/Álava;All ages;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
01 Araba/Álava;All ages;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
01 Araba/Álava;All ages;Cohort July 1;Females;Survival in the third trimester;2020QII;""
01 Araba/Álava;All ages;Cohort July 1;Females;Survival in the third trimester;2020QI;""
01 Araba/Álava;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
01 Araba/Álava;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
01 Araba/Álava;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
01 Araba/Álava;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
01 Araba/Álava;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
01 Araba/Álava;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
01 Araba/Álava;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
01 Araba/Álava;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
01 Araba/Álava;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
01 Araba/Álava;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
01 Araba/Álava;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
01 Araba/Álava;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
01 Araba/Álava;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
01 Araba/Álava;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;96,5
01 Araba/Álava;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
01 Araba/Álava;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
01 Araba/Álava;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
01 Araba/Álava;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;97,17
01 Araba/Álava;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
01 Araba/Álava;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
01 Araba/Álava;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
01 Araba/Álava;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;96,98
01 Araba/Álava;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
01 Araba/Álava;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
01 Araba/Álava;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;93,17
01 Araba/Álava;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
01 Araba/Álava;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
01 Araba/Álava;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
01 Araba/Álava;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;93,91
01 Araba/Álava;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
01 Araba/Álava;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
01 Araba/Álava;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
01 Araba/Álava;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;93,31
01 Araba/Álava;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
01 Araba/Álava;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
01 Araba/Álava;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
01 Araba/Álava;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
01 Araba/Álava;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
01 Araba/Álava;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
01 Araba/Álava;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;91,68
01 Araba/Álava;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
01 Araba/Álava;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
01 Araba/Álava;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
01 Araba/Álava;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;91,02
01 Araba/Álava;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
01 Araba/Álava;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
01 Araba/Álava;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
01 Araba/Álava;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
01 Araba/Álava;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
01 Araba/Álava;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
01 Araba/Álava;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;88,96
01 Araba/Álava;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
01 Araba/Álava;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
01 Araba/Álava;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
01 Araba/Álava;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;88,86
01 Araba/Álava;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
01 Araba/Álava;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
01 Araba/Álava;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
01 Araba/Álava;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
01 Araba/Álava;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
01 Araba/Álava;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QIV;18.142
01 Araba/Álava;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
01 Araba/Álava;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
01 Araba/Álava;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
01 Araba/Álava;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QIV;18.096
01 Araba/Álava;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
01 Araba/Álava;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
01 Araba/Álava;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
01 Araba/Álava;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QIV;18.092
01 Araba/Álava;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
01 Araba/Álava;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
01 Araba/Álava;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
01 Araba/Álava;All ages;Cohort October 1;Total;Survival in the first trimester;2022QIV;17.477
01 Araba/Álava;All ages;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
01 Araba/Álava;All ages;Cohort October 1;Total;Survival in the first trimester;2022QII;""
01 Araba/Álava;All ages;Cohort October 1;Total;Survival in the first trimester;2022QI;""
01 Araba/Álava;All ages;Cohort October 1;Total;Survival in the first trimester;2021QIV;17.487
01 Araba/Álava;All ages;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
01 Araba/Álava;All ages;Cohort October 1;Total;Survival in the first trimester;2021QII;""
01 Araba/Álava;All ages;Cohort October 1;Total;Survival in the first trimester;2021QI;""
01 Araba/Álava;All ages;Cohort October 1;Total;Survival in the first trimester;2020QIV;17.468
01 Araba/Álava;All ages;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
01 Araba/Álava;All ages;Cohort October 1;Total;Survival in the first trimester;2020QII;""
01 Araba/Álava;All ages;Cohort October 1;Total;Survival in the first trimester;2020QI;""
01 Araba/Álava;All ages;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
01 Araba/Álava;All ages;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
01 Araba/Álava;All ages;Cohort October 1;Total;Survival in the second trimester;2022QII;""
01 Araba/Álava;All ages;Cohort October 1;Total;Survival in the second trimester;2022QI;17.034
01 Araba/Álava;All ages;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
01 Araba/Álava;All ages;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
01 Araba/Álava;All ages;Cohort October 1;Total;Survival in the second trimester;2021QII;""
01 Araba/Álava;All ages;Cohort October 1;Total;Survival in the second trimester;2021QI;17.048
01 Araba/Álava;All ages;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
01 Araba/Álava;All ages;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
01 Araba/Álava;All ages;Cohort October 1;Total;Survival in the second trimester;2020QII;""
01 Araba/Álava;All ages;Cohort October 1;Total;Survival in the second trimester;2020QI;""
01 Araba/Álava;All ages;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
01 Araba/Álava;All ages;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
01 Araba/Álava;All ages;Cohort October 1;Total;Survival in the third trimester;2022QII;16.534
01 Araba/Álava;All ages;Cohort October 1;Total;Survival in the third trimester;2022QI;""
01 Araba/Álava;All ages;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
01 Araba/Álava;All ages;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
01 Araba/Álava;All ages;Cohort October 1;Total;Survival in the third trimester;2021QII;16.625
01 Araba/Álava;All ages;Cohort October 1;Total;Survival in the third trimester;2021QI;""
01 Araba/Álava;All ages;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
01 Araba/Álava;All ages;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
01 Araba/Álava;All ages;Cohort October 1;Total;Survival in the third trimester;2020QII;""
01 Araba/Álava;All ages;Cohort October 1;Total;Survival in the third trimester;2020QI;""
01 Araba/Álava;All ages;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
01 Araba/Álava;All ages;Cohort October 1;Total;Survival in the third trimester;2022QIII;16.136
01 Araba/Álava;All ages;Cohort October 1;Total;Survival in the third trimester;2022QII;""
01 Araba/Álava;All ages;Cohort October 1;Total;Survival in the third trimester;2022QI;""
01 Araba/Álava;All ages;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
01 Araba/Álava;All ages;Cohort October 1;Total;Survival in the third trimester;2021QIII;16.276
01 Araba/Álava;All ages;Cohort October 1;Total;Survival in the third trimester;2021QII;""
01 Araba/Álava;All ages;Cohort October 1;Total;Survival in the third trimester;2021QI;""
01 Araba/Álava;All ages;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
01 Araba/Álava;All ages;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
01 Araba/Álava;All ages;Cohort October 1;Total;Survival in the third trimester;2020QII;""
01 Araba/Álava;All ages;Cohort October 1;Total;Survival in the third trimester;2020QI;""
01 Araba/Álava;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
01 Araba/Álava;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
01 Araba/Álava;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
01 Araba/Álava;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
01 Araba/Álava;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
01 Araba/Álava;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
01 Araba/Álava;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
01 Araba/Álava;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
01 Araba/Álava;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
01 Araba/Álava;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
01 Araba/Álava;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
01 Araba/Álava;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
01 Araba/Álava;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;96,33
01 Araba/Álava;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
01 Araba/Álava;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
01 Araba/Álava;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
01 Araba/Álava;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;96,63
01 Araba/Álava;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
01 Araba/Álava;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
01 Araba/Álava;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
01 Araba/Álava;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;96,55
01 Araba/Álava;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
01 Araba/Álava;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
01 Araba/Álava;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
01 Araba/Álava;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
01 Araba/Álava;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
01 Araba/Álava;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
01 Araba/Álava;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;94,13
01 Araba/Álava;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
01 Araba/Álava;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
01 Araba/Álava;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
01 Araba/Álava;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;94,23
01 Araba/Álava;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
01 Araba/Álava;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
01 Araba/Álava;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
01 Araba/Álava;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
01 Araba/Álava;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
01 Araba/Álava;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
01 Araba/Álava;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;91,37
01 Araba/Álava;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
01 Araba/Álava;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
01 Araba/Álava;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
01 Araba/Álava;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;91,89
01 Araba/Álava;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
01 Araba/Álava;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
01 Araba/Álava;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
01 Araba/Álava;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
01 Araba/Álava;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
01 Araba/Álava;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
01 Araba/Álava;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;89,17
01 Araba/Álava;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
01 Araba/Álava;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
01 Araba/Álava;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
01 Araba/Álava;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;89,96
01 Araba/Álava;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
01 Araba/Álava;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
01 Araba/Álava;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
01 Araba/Álava;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
01 Araba/Álava;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
01 Araba/Álava;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
01 Araba/Álava;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QIV;11.391
01 Araba/Álava;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
01 Araba/Álava;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
01 Araba/Álava;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
01 Araba/Álava;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QIV;11.479
01 Araba/Álava;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
01 Araba/Álava;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
01 Araba/Álava;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
01 Araba/Álava;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QIV;11.509
01 Araba/Álava;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
01 Araba/Álava;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
01 Araba/Álava;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
01 Araba/Álava;All ages;Cohort October 1;Males;Survival in the first trimester;2022QIV;10.970
01 Araba/Álava;All ages;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
01 Araba/Álava;All ages;Cohort October 1;Males;Survival in the first trimester;2022QII;""
01 Araba/Álava;All ages;Cohort October 1;Males;Survival in the first trimester;2022QI;""
01 Araba/Álava;All ages;Cohort October 1;Males;Survival in the first trimester;2021QIV;11.103
01 Araba/Álava;All ages;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
01 Araba/Álava;All ages;Cohort October 1;Males;Survival in the first trimester;2021QII;""
01 Araba/Álava;All ages;Cohort October 1;Males;Survival in the first trimester;2021QI;""
01 Araba/Álava;All ages;Cohort October 1;Males;Survival in the first trimester;2020QIV;11.141
01 Araba/Álava;All ages;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
01 Araba/Álava;All ages;Cohort October 1;Males;Survival in the first trimester;2020QII;""
01 Araba/Álava;All ages;Cohort October 1;Males;Survival in the first trimester;2020QI;""
01 Araba/Álava;All ages;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
01 Araba/Álava;All ages;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
01 Araba/Álava;All ages;Cohort October 1;Males;Survival in the second trimester;2022QII;""
01 Araba/Álava;All ages;Cohort October 1;Males;Survival in the second trimester;2022QI;10.813
01 Araba/Álava;All ages;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
01 Araba/Álava;All ages;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
01 Araba/Álava;All ages;Cohort October 1;Males;Survival in the second trimester;2021QII;""
01 Araba/Álava;All ages;Cohort October 1;Males;Survival in the second trimester;2021QI;10.883
01 Araba/Álava;All ages;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
01 Araba/Álava;All ages;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
01 Araba/Álava;All ages;Cohort October 1;Males;Survival in the second trimester;2020QII;""
01 Araba/Álava;All ages;Cohort October 1;Males;Survival in the second trimester;2020QI;""
01 Araba/Álava;All ages;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
01 Araba/Álava;All ages;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
01 Araba/Álava;All ages;Cohort October 1;Males;Survival in the third trimester;2022QII;10.511
01 Araba/Álava;All ages;Cohort October 1;Males;Survival in the third trimester;2022QI;""
01 Araba/Álava;All ages;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
01 Araba/Álava;All ages;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
01 Araba/Álava;All ages;Cohort October 1;Males;Survival in the third trimester;2021QII;10.625
01 Araba/Álava;All ages;Cohort October 1;Males;Survival in the third trimester;2021QI;""
01 Araba/Álava;All ages;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
01 Araba/Álava;All ages;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
01 Araba/Álava;All ages;Cohort October 1;Males;Survival in the third trimester;2020QII;""
01 Araba/Álava;All ages;Cohort October 1;Males;Survival in the third trimester;2020QI;""
01 Araba/Álava;All ages;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
01 Araba/Álava;All ages;Cohort October 1;Males;Survival in the third trimester;2022QIII;10.282
01 Araba/Álava;All ages;Cohort October 1;Males;Survival in the third trimester;2022QII;""
01 Araba/Álava;All ages;Cohort October 1;Males;Survival in the third trimester;2022QI;""
01 Araba/Álava;All ages;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
01 Araba/Álava;All ages;Cohort October 1;Males;Survival in the third trimester;2021QIII;10.414
01 Araba/Álava;All ages;Cohort October 1;Males;Survival in the third trimester;2021QII;""
01 Araba/Álava;All ages;Cohort October 1;Males;Survival in the third trimester;2021QI;""
01 Araba/Álava;All ages;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
01 Araba/Álava;All ages;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
01 Araba/Álava;All ages;Cohort October 1;Males;Survival in the third trimester;2020QII;""
01 Araba/Álava;All ages;Cohort October 1;Males;Survival in the third trimester;2020QI;""
01 Araba/Álava;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
01 Araba/Álava;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
01 Araba/Álava;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
01 Araba/Álava;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
01 Araba/Álava;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
01 Araba/Álava;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
01 Araba/Álava;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
01 Araba/Álava;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
01 Araba/Álava;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
01 Araba/Álava;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
01 Araba/Álava;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
01 Araba/Álava;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
01 Araba/Álava;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;96,3
01 Araba/Álava;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
01 Araba/Álava;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
01 Araba/Álava;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
01 Araba/Álava;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;96,72
01 Araba/Álava;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
01 Araba/Álava;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
01 Araba/Álava;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
01 Araba/Álava;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;96,8
01 Araba/Álava;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
01 Araba/Álava;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
01 Araba/Álava;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
01 Araba/Álava;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
01 Araba/Álava;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
01 Araba/Álava;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
01 Araba/Álava;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;94,2
01 Araba/Álava;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
01 Araba/Álava;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
01 Araba/Álava;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
01 Araba/Álava;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;94,56
01 Araba/Álava;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
01 Araba/Álava;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
01 Araba/Álava;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
01 Araba/Álava;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
01 Araba/Álava;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
01 Araba/Álava;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
01 Araba/Álava;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;91,57
01 Araba/Álava;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
01 Araba/Álava;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
01 Araba/Álava;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
01 Araba/Álava;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;92,32
01 Araba/Álava;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
01 Araba/Álava;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
01 Araba/Álava;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
01 Araba/Álava;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
01 Araba/Álava;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
01 Araba/Álava;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
01 Araba/Álava;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;89,57
01 Araba/Álava;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
01 Araba/Álava;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
01 Araba/Álava;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
01 Araba/Álava;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;90,49
01 Araba/Álava;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
01 Araba/Álava;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
01 Araba/Álava;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
01 Araba/Álava;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
01 Araba/Álava;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
01 Araba/Álava;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
01 Araba/Álava;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QIV;6.751
01 Araba/Álava;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
01 Araba/Álava;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
01 Araba/Álava;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
01 Araba/Álava;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QIV;6.617
01 Araba/Álava;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
01 Araba/Álava;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
01 Araba/Álava;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
01 Araba/Álava;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QIV;6.583
01 Araba/Álava;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
01 Araba/Álava;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
01 Araba/Álava;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
01 Araba/Álava;All ages;Cohort October 1;Females;Survival in the first trimester;2022QIV;6.507
01 Araba/Álava;All ages;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
01 Araba/Álava;All ages;Cohort October 1;Females;Survival in the first trimester;2022QII;""
01 Araba/Álava;All ages;Cohort October 1;Females;Survival in the first trimester;2022QI;""
01 Araba/Álava;All ages;Cohort October 1;Females;Survival in the first trimester;2021QIV;6.384
01 Araba/Álava;All ages;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
01 Araba/Álava;All ages;Cohort October 1;Females;Survival in the first trimester;2021QII;""
01 Araba/Álava;All ages;Cohort October 1;Females;Survival in the first trimester;2021QI;""
01 Araba/Álava;All ages;Cohort October 1;Females;Survival in the first trimester;2020QIV;6.327
01 Araba/Álava;All ages;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
01 Araba/Álava;All ages;Cohort October 1;Females;Survival in the first trimester;2020QII;""
01 Araba/Álava;All ages;Cohort October 1;Females;Survival in the first trimester;2020QI;""
01 Araba/Álava;All ages;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
01 Araba/Álava;All ages;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
01 Araba/Álava;All ages;Cohort October 1;Females;Survival in the second trimester;2022QII;""
01 Araba/Álava;All ages;Cohort October 1;Females;Survival in the second trimester;2022QI;6.221
01 Araba/Álava;All ages;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
01 Araba/Álava;All ages;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
01 Araba/Álava;All ages;Cohort October 1;Females;Survival in the second trimester;2021QII;""
01 Araba/Álava;All ages;Cohort October 1;Females;Survival in the second trimester;2021QI;6.165
01 Araba/Álava;All ages;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
01 Araba/Álava;All ages;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
01 Araba/Álava;All ages;Cohort October 1;Females;Survival in the second trimester;2020QII;""
01 Araba/Álava;All ages;Cohort October 1;Females;Survival in the second trimester;2020QI;""
01 Araba/Álava;All ages;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
01 Araba/Álava;All ages;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
01 Araba/Álava;All ages;Cohort October 1;Females;Survival in the third trimester;2022QII;6.023
01 Araba/Álava;All ages;Cohort October 1;Females;Survival in the third trimester;2022QI;""
01 Araba/Álava;All ages;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
01 Araba/Álava;All ages;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
01 Araba/Álava;All ages;Cohort October 1;Females;Survival in the third trimester;2021QII;6.000
01 Araba/Álava;All ages;Cohort October 1;Females;Survival in the third trimester;2021QI;""
01 Araba/Álava;All ages;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
01 Araba/Álava;All ages;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
01 Araba/Álava;All ages;Cohort October 1;Females;Survival in the third trimester;2020QII;""
01 Araba/Álava;All ages;Cohort October 1;Females;Survival in the third trimester;2020QI;""
01 Araba/Álava;All ages;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
01 Araba/Álava;All ages;Cohort October 1;Females;Survival in the third trimester;2022QIII;5.854
01 Araba/Álava;All ages;Cohort October 1;Females;Survival in the third trimester;2022QII;""
01 Araba/Álava;All ages;Cohort October 1;Females;Survival in the third trimester;2022QI;""
01 Araba/Álava;All ages;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
01 Araba/Álava;All ages;Cohort October 1;Females;Survival in the third trimester;2021QIII;5.862
01 Araba/Álava;All ages;Cohort October 1;Females;Survival in the third trimester;2021QII;""
01 Araba/Álava;All ages;Cohort October 1;Females;Survival in the third trimester;2021QI;""
01 Araba/Álava;All ages;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
01 Araba/Álava;All ages;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
01 Araba/Álava;All ages;Cohort October 1;Females;Survival in the third trimester;2020QII;""
01 Araba/Álava;All ages;Cohort October 1;Females;Survival in the third trimester;2020QI;""
01 Araba/Álava;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
01 Araba/Álava;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
01 Araba/Álava;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
01 Araba/Álava;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
01 Araba/Álava;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
01 Araba/Álava;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
01 Araba/Álava;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
01 Araba/Álava;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
01 Araba/Álava;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
01 Araba/Álava;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
01 Araba/Álava;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
01 Araba/Álava;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
01 Araba/Álava;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;96,39
01 Araba/Álava;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
01 Araba/Álava;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
01 Araba/Álava;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
01 Araba/Álava;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;96,48
01 Araba/Álava;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
01 Araba/Álava;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
01 Araba/Álava;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
01 Araba/Álava;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;96,11
01 Araba/Álava;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
01 Araba/Álava;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
01 Araba/Álava;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
01 Araba/Álava;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
01 Araba/Álava;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
01 Araba/Álava;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
01 Araba/Álava;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;94,02
01 Araba/Álava;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
01 Araba/Álava;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
01 Araba/Álava;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
01 Araba/Álava;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;93,65
01 Araba/Álava;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
01 Araba/Álava;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
01 Araba/Álava;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
01 Araba/Álava;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
01 Araba/Álava;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
01 Araba/Álava;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
01 Araba/Álava;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;91,02
01 Araba/Álava;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
01 Araba/Álava;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
01 Araba/Álava;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
01 Araba/Álava;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;91,14
01 Araba/Álava;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
01 Araba/Álava;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
01 Araba/Álava;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
01 Araba/Álava;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
01 Araba/Álava;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
01 Araba/Álava;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
01 Araba/Álava;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;88,47
01 Araba/Álava;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
01 Araba/Álava;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
01 Araba/Álava;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
01 Araba/Álava;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;89,05
01 Araba/Álava;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
01 Araba/Álava;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
01 Araba/Álava;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
01 Araba/Álava;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
01 Araba/Álava;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
01 Araba/Álava;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QI;997
01 Araba/Álava;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QI;946
01 Araba/Álava;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QI;784
01 Araba/Álava;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2022QII;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2022QI;919
01 Araba/Álava;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2021QII;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2021QI;894
01 Araba/Álava;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2020QII;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2020QI;683
01 Araba/Álava;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2022QII;839
01 Araba/Álava;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2022QI;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2021QII;830
01 Araba/Álava;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2021QI;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2020QII;647
01 Araba/Álava;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2020QI;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QIII;786
01 Araba/Álava;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QII;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QI;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QIII;784
01 Araba/Álava;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QII;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QI;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QIII;606
01 Araba/Álava;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QII;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QI;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QIV;722
01 Araba/Álava;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QII;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QI;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QIV;728
01 Araba/Álava;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QII;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QI;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QIV;562
01 Araba/Álava;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QII;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QI;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
01 Araba/Álava;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
01 Araba/Álava;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
01 Araba/Álava;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;92,18
01 Araba/Álava;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;94,5
01 Araba/Álava;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;87,12
01 Araba/Álava;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;84,15
01 Araba/Álava;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;87,74
01 Araba/Álava;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;82,53
01 Araba/Álava;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;78,84
01 Araba/Álava;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;82,88
01 Araba/Álava;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;77,3
01 Araba/Álava;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;72,42
01 Araba/Álava;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;76,96
01 Araba/Álava;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;71,68
01 Araba/Álava;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QI;624
01 Araba/Álava;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QI;592
01 Araba/Álava;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QI;488
01 Araba/Álava;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2022QII;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2022QI;571
01 Araba/Álava;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2021QII;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2021QI;555
01 Araba/Álava;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2020QII;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2020QI;432
01 Araba/Álava;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2022QII;524
01 Araba/Álava;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2022QI;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2021QII;515
01 Araba/Álava;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2021QI;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2020QII;413
01 Araba/Álava;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2020QI;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QIII;491
01 Araba/Álava;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QII;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QI;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QIII;491
01 Araba/Álava;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QII;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QI;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QIII;387
01 Araba/Álava;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QII;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QI;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QIV;447
01 Araba/Álava;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QII;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QI;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QIV;455
01 Araba/Álava;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QII;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QI;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QIV;358
01 Araba/Álava;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QII;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QI;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
01 Araba/Álava;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
01 Araba/Álava;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
01 Araba/Álava;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;91,51
01 Araba/Álava;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;93,75
01 Araba/Álava;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;88,52
01 Araba/Álava;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;83,97
01 Araba/Álava;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;86,99
01 Araba/Álava;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;84,63
01 Araba/Álava;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;78,69
01 Araba/Álava;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;82,94
01 Araba/Álava;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;79,3
01 Araba/Álava;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;71,63
01 Araba/Álava;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;76,86
01 Araba/Álava;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;73,36
01 Araba/Álava;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QI;373
01 Araba/Álava;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QI;354
01 Araba/Álava;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QI;296
01 Araba/Álava;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2022QII;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2022QI;348
01 Araba/Álava;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2021QII;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2021QI;339
01 Araba/Álava;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2020QII;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2020QI;251
01 Araba/Álava;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2022QII;315
01 Araba/Álava;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2022QI;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2021QII;315
01 Araba/Álava;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2021QI;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2020QII;234
01 Araba/Álava;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2020QI;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QIII;295
01 Araba/Álava;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QII;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QI;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QIII;293
01 Araba/Álava;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QII;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QI;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QIII;219
01 Araba/Álava;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QII;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QI;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QIV;275
01 Araba/Álava;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QII;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QI;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QIV;273
01 Araba/Álava;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QII;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QI;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QIV;204
01 Araba/Álava;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QII;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QI;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
01 Araba/Álava;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
01 Araba/Álava;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
01 Araba/Álava;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;93,3
01 Araba/Álava;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;95,76
01 Araba/Álava;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;84,8
01 Araba/Álava;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;84,45
01 Araba/Álava;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;88,98
01 Araba/Álava;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;79,05
01 Araba/Álava;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;79,09
01 Araba/Álava;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;82,77
01 Araba/Álava;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;73,99
01 Araba/Álava;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;73,73
01 Araba/Álava;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;77,12
01 Araba/Álava;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;68,92
01 Araba/Álava;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QII;946
01 Araba/Álava;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QII;871
01 Araba/Álava;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QII;794
01 Araba/Álava;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2022QII;854
01 Araba/Álava;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2022QI;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2021QII;786
01 Araba/Álava;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2021QI;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2020QII;751
01 Araba/Álava;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2020QI;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2022QIII;793
01 Araba/Álava;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2022QII;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2022QI;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2021QIII;731
01 Araba/Álava;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2021QII;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2021QI;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2020QIII;702
01 Araba/Álava;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2020QII;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2020QI;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QIV;718
01 Araba/Álava;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QII;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QI;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QIV;675
01 Araba/Álava;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QII;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QI;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QIV;647
01 Araba/Álava;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QII;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QI;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QII;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QI;636
01 Araba/Álava;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QII;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QI;620
01 Araba/Álava;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QII;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QI;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
01 Araba/Álava;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
01 Araba/Álava;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
01 Araba/Álava;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;90,27
01 Araba/Álava;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;90,24
01 Araba/Álava;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;94,58
01 Araba/Álava;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;83,83
01 Araba/Álava;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;83,93
01 Araba/Álava;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;88,41
01 Araba/Álava;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;75,9
01 Araba/Álava;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;77,5
01 Araba/Álava;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;81,49
01 Araba/Álava;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;73,02
01 Araba/Álava;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;78,09
01 Araba/Álava;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QII;597
01 Araba/Álava;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QII;565
01 Araba/Álava;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QII;497
01 Araba/Álava;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2022QII;541
01 Araba/Álava;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2022QI;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2021QII;511
01 Araba/Álava;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2021QI;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2020QII;475
01 Araba/Álava;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2020QI;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2022QIII;502
01 Araba/Álava;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2022QII;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2022QI;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2021QIII;481
01 Araba/Álava;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2021QII;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2021QI;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2020QIII;446
01 Araba/Álava;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2020QII;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2020QI;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QIV;449
01 Araba/Álava;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QII;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QI;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QIV;442
01 Araba/Álava;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QII;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QI;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QIV;412
01 Araba/Álava;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QII;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QI;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QII;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QI;413
01 Araba/Álava;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QII;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QI;391
01 Araba/Álava;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QII;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QI;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
01 Araba/Álava;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
01 Araba/Álava;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
01 Araba/Álava;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;90,62
01 Araba/Álava;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;90,44
01 Araba/Álava;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;95,57
01 Araba/Álava;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;84,09
01 Araba/Álava;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;85,13
01 Araba/Álava;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;89,74
01 Araba/Álava;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;75,21
01 Araba/Álava;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;78,23
01 Araba/Álava;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;82,9
01 Araba/Álava;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;73,1
01 Araba/Álava;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;78,67
01 Araba/Álava;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QII;349
01 Araba/Álava;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QII;306
01 Araba/Álava;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QII;297
01 Araba/Álava;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2022QII;313
01 Araba/Álava;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2022QI;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2021QII;275
01 Araba/Álava;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2021QI;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2020QII;276
01 Araba/Álava;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2020QI;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2022QIII;291
01 Araba/Álava;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2022QII;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2022QI;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2021QIII;250
01 Araba/Álava;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2021QII;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2021QI;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2020QIII;256
01 Araba/Álava;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2020QII;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2020QI;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QIV;269
01 Araba/Álava;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QII;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QI;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QIV;233
01 Araba/Álava;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QII;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QI;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QIV;235
01 Araba/Álava;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QII;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QI;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QII;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QI;223
01 Araba/Álava;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QII;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QI;229
01 Araba/Álava;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QII;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QI;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
01 Araba/Álava;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
01 Araba/Álava;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
01 Araba/Álava;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;89,68
01 Araba/Álava;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;89,87
01 Araba/Álava;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;92,93
01 Araba/Álava;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;83,38
01 Araba/Álava;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;81,7
01 Araba/Álava;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;86,2
01 Araba/Álava;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;77,08
01 Araba/Álava;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;76,14
01 Araba/Álava;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;79,12
01 Araba/Álava;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;72,88
01 Araba/Álava;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;77,1
01 Araba/Álava;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QIII;1.022
01 Araba/Álava;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QIII;928
01 Araba/Álava;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QIII;829
01 Araba/Álava;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2022QIII;932
01 Araba/Álava;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2022QII;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2022QI;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2021QIII;847
01 Araba/Álava;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2021QII;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2021QI;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2020QIII;760
01 Araba/Álava;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2020QII;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2020QI;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2022QIV;848
01 Araba/Álava;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2022QII;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2022QI;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2021QIV;778
01 Araba/Álava;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2021QII;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2021QI;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2020QIV;697
01 Araba/Álava;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2020QII;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2020QI;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QII;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QI;727
01 Araba/Álava;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QII;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QI;666
01 Araba/Álava;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QII;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QI;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QII;676
01 Araba/Álava;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QI;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QII;623
01 Araba/Álava;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QI;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QII;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QI;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
01 Araba/Álava;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
01 Araba/Álava;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
01 Araba/Álava;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;91,19
01 Araba/Álava;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;91,27
01 Araba/Álava;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;91,68
01 Araba/Álava;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;82,97
01 Araba/Álava;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;83,84
01 Araba/Álava;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;84,08
01 Araba/Álava;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;78,34
01 Araba/Álava;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;80,34
01 Araba/Álava;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;72,84
01 Araba/Álava;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;75,15
01 Araba/Álava;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QIII;631
01 Araba/Álava;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QIII;596
01 Araba/Álava;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QIII;520
01 Araba/Álava;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2022QIII;577
01 Araba/Álava;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2022QII;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2022QI;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2021QIII;547
01 Araba/Álava;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2021QII;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2021QI;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2020QIII;481
01 Araba/Álava;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2020QII;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2020QI;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2022QIV;521
01 Araba/Álava;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2022QII;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2022QI;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2021QIV;502
01 Araba/Álava;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2021QII;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2021QI;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2020QIV;445
01 Araba/Álava;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2020QII;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2020QI;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QII;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QI;464
01 Araba/Álava;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QII;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QI;420
01 Araba/Álava;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QII;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QI;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QII;433
01 Araba/Álava;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QI;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QII;391
01 Araba/Álava;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QI;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QII;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QI;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
01 Araba/Álava;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
01 Araba/Álava;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
01 Araba/Álava;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;91,44
01 Araba/Álava;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;91,78
01 Araba/Álava;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;92,5
01 Araba/Álava;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;82,57
01 Araba/Álava;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;84,23
01 Araba/Álava;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;85,58
01 Araba/Álava;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;77,85
01 Araba/Álava;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;80,77
01 Araba/Álava;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;72,65
01 Araba/Álava;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;75,19
01 Araba/Álava;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QIII;391
01 Araba/Álava;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QIII;332
01 Araba/Álava;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QIII;309
01 Araba/Álava;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2022QIII;355
01 Araba/Álava;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2022QII;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2022QI;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2021QIII;300
01 Araba/Álava;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2021QII;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2021QI;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2020QIII;279
01 Araba/Álava;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2020QII;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2020QI;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2022QIV;327
01 Araba/Álava;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2022QII;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2022QI;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2021QIV;276
01 Araba/Álava;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2021QII;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2021QI;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2020QIV;252
01 Araba/Álava;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2020QII;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2020QI;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QII;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QI;263
01 Araba/Álava;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QII;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QI;246
01 Araba/Álava;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QII;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QI;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QII;243
01 Araba/Álava;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QI;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QII;232
01 Araba/Álava;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QI;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QII;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QI;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
01 Araba/Álava;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
01 Araba/Álava;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
01 Araba/Álava;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;90,79
01 Araba/Álava;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;90,36
01 Araba/Álava;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;90,29
01 Araba/Álava;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;83,63
01 Araba/Álava;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;83,13
01 Araba/Álava;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;81,55
01 Araba/Álava;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;79,22
01 Araba/Álava;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;79,61
01 Araba/Álava;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;73,19
01 Araba/Álava;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;75,08
01 Araba/Álava;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QIV;1.064
01 Araba/Álava;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QIV;949
01 Araba/Álava;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QIV;866
01 Araba/Álava;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2022QIV;966
01 Araba/Álava;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2022QII;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2022QI;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2021QIV;865
01 Araba/Álava;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2021QII;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2021QI;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2020QIV;791
01 Araba/Álava;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2020QII;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2020QI;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2022QII;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2022QI;804
01 Araba/Álava;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2021QII;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2021QI;752
01 Araba/Álava;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2020QII;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2020QI;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QII;741
01 Araba/Álava;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QI;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QII;703
01 Araba/Álava;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QI;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QII;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QI;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QIII;695
01 Araba/Álava;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QII;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QI;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QIII;669
01 Araba/Álava;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QII;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QI;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QII;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QI;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
01 Araba/Álava;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
01 Araba/Álava;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
01 Araba/Álava;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;90,79
01 Araba/Álava;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;91,15
01 Araba/Álava;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;91,34
01 Araba/Álava;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;84,72
01 Araba/Álava;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;86,84
01 Araba/Álava;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;78,08
01 Araba/Álava;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;81,18
01 Araba/Álava;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;73,23
01 Araba/Álava;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;77,25
01 Araba/Álava;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QIV;656
01 Araba/Álava;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QIV;604
01 Araba/Álava;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QIV;540
01 Araba/Álava;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2022QIV;594
01 Araba/Álava;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2022QII;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2022QI;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2021QIV;550
01 Araba/Álava;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2021QII;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2021QI;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2020QIV;496
01 Araba/Álava;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2020QII;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2020QI;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2022QII;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2022QI;506
01 Araba/Álava;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2021QII;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2021QI;465
01 Araba/Álava;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2020QII;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2020QI;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QII;468
01 Araba/Álava;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QI;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QII;433
01 Araba/Álava;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QI;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QII;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QI;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QIII;437
01 Araba/Álava;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QII;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QI;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QIII;417
01 Araba/Álava;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QII;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QI;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QII;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QI;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
01 Araba/Álava;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
01 Araba/Álava;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
01 Araba/Álava;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;90,55
01 Araba/Álava;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;91,06
01 Araba/Álava;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;91,85
01 Araba/Álava;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;83,77
01 Araba/Álava;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;86,11
01 Araba/Álava;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;77,48
01 Araba/Álava;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;80,19
01 Araba/Álava;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;72,35
01 Araba/Álava;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;77,22
01 Araba/Álava;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QIV;408
01 Araba/Álava;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QIV;345
01 Araba/Álava;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QIV;326
01 Araba/Álava;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2022QIV;372
01 Araba/Álava;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2022QII;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2022QI;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2021QIV;315
01 Araba/Álava;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2021QII;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2021QI;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2020QIV;295
01 Araba/Álava;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2020QII;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2020QI;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2022QII;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2022QI;298
01 Araba/Álava;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2021QII;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2021QI;287
01 Araba/Álava;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2020QII;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2020QI;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QII;273
01 Araba/Álava;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QI;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QII;270
01 Araba/Álava;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QI;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QII;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QI;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QIII;258
01 Araba/Álava;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QII;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QI;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QIII;252
01 Araba/Álava;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QII;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QI;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QII;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QI;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
01 Araba/Álava;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
01 Araba/Álava;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
01 Araba/Álava;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;91,18
01 Araba/Álava;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;91,3
01 Araba/Álava;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;90,49
01 Araba/Álava;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;86,38
01 Araba/Álava;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;88,04
01 Araba/Álava;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;79,13
01 Araba/Álava;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;82,82
01 Araba/Álava;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;74,78
01 Araba/Álava;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;77,3
01 Araba/Álava;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QI;2.911
01 Araba/Álava;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QI;2.943
01 Araba/Álava;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QI;2.816
01 Araba/Álava;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2022QII;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2022QI;2.800
01 Araba/Álava;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2021QII;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2021QI;2.834
01 Araba/Álava;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2020QII;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2020QI;2.648
01 Araba/Álava;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2022QII;2.690
01 Araba/Álava;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2022QI;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2021QII;2.718
01 Araba/Álava;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2021QI;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2020QII;2.604
01 Araba/Álava;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2020QI;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QIII;2.580
01 Araba/Álava;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QII;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QI;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QIII;2.634
01 Araba/Álava;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QII;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QI;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QIII;2.523
01 Araba/Álava;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QII;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QI;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QIV;2.500
01 Araba/Álava;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QII;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QI;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QIV;2.545
01 Araba/Álava;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QII;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QI;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QIV;2.443
01 Araba/Álava;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QII;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QI;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
01 Araba/Álava;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
01 Araba/Álava;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
01 Araba/Álava;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;96,19
01 Araba/Álava;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;96,3
01 Araba/Álava;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;94,03
01 Araba/Álava;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;92,41
01 Araba/Álava;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;92,35
01 Araba/Álava;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;92,47
01 Araba/Álava;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;88,63
01 Araba/Álava;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;89,5
01 Araba/Álava;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;89,6
01 Araba/Álava;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;85,88
01 Araba/Álava;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;86,48
01 Araba/Álava;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;86,75
01 Araba/Álava;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QI;1.713
01 Araba/Álava;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QI;1.783
01 Araba/Álava;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QI;1.716
01 Araba/Álava;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2022QII;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2022QI;1.647
01 Araba/Álava;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2021QII;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2021QI;1.714
01 Araba/Álava;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2020QII;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2020QI;1.621
01 Araba/Álava;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2022QII;1.577
01 Araba/Álava;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2022QI;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2021QII;1.643
01 Araba/Álava;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2021QI;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2020QII;1.593
01 Araba/Álava;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2020QI;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QIII;1.516
01 Araba/Álava;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QII;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QI;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QIII;1.586
01 Araba/Álava;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QII;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QI;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QIII;1.545
01 Araba/Álava;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QII;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QI;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QIV;1.471
01 Araba/Álava;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QII;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QI;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QIV;1.542
01 Araba/Álava;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QII;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QI;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QIV;1.496
01 Araba/Álava;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QII;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QI;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
01 Araba/Álava;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
01 Araba/Álava;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
01 Araba/Álava;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;96,15
01 Araba/Álava;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;96,13
01 Araba/Álava;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;94,46
01 Araba/Álava;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;92,06
01 Araba/Álava;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;92,15
01 Araba/Álava;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;92,83
01 Araba/Álava;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;88,5
01 Araba/Álava;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;88,95
01 Araba/Álava;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;90,03
01 Araba/Álava;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;85,87
01 Araba/Álava;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;86,48
01 Araba/Álava;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;87,18
01 Araba/Álava;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QI;1.198
01 Araba/Álava;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QI;1.160
01 Araba/Álava;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QI;1.100
01 Araba/Álava;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2022QII;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2022QI;1.153
01 Araba/Álava;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2021QII;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2021QI;1.120
01 Araba/Álava;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2020QII;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2020QI;1.027
01 Araba/Álava;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2022QII;1.113
01 Araba/Álava;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2022QI;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2021QII;1.075
01 Araba/Álava;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2021QI;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2020QII;1.011
01 Araba/Álava;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2020QI;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QIII;1.064
01 Araba/Álava;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QII;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QI;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QIII;1.048
01 Araba/Álava;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QII;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QI;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QIII;978
01 Araba/Álava;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QII;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QI;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QIV;1.029
01 Araba/Álava;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QII;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QI;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QIV;1.003
01 Araba/Álava;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QII;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QI;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QIV;947
01 Araba/Álava;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QII;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QI;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
01 Araba/Álava;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
01 Araba/Álava;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
01 Araba/Álava;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;96,24
01 Araba/Álava;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;96,55
01 Araba/Álava;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;93,36
01 Araba/Álava;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;92,9
01 Araba/Álava;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;92,67
01 Araba/Álava;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;91,91
01 Araba/Álava;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;88,81
01 Araba/Álava;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;90,34
01 Araba/Álava;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;88,91
01 Araba/Álava;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;85,89
01 Araba/Álava;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;86,47
01 Araba/Álava;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;86,09
01 Araba/Álava;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QII;2.739
01 Araba/Álava;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QII;2.769
01 Araba/Álava;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QII;2.825
01 Araba/Álava;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2022QII;2.625
01 Araba/Álava;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2022QI;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2021QII;2.653
01 Araba/Álava;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2021QI;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2020QII;2.771
01 Araba/Álava;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2020QI;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2022QIII;2.521
01 Araba/Álava;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2022QII;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2022QI;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2021QIII;2.555
01 Araba/Álava;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2021QII;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2021QI;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2020QIII;2.672
01 Araba/Álava;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2020QII;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2020QI;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QIV;2.437
01 Araba/Álava;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QII;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QI;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QIV;2.458
01 Araba/Álava;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QII;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QI;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QIV;2.586
01 Araba/Álava;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QII;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QI;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QII;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QI;2.375
01 Araba/Álava;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QII;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QI;2.507
01 Araba/Álava;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QII;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QI;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
01 Araba/Álava;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
01 Araba/Álava;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
01 Araba/Álava;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;95,84
01 Araba/Álava;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;95,81
01 Araba/Álava;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;98,09
01 Araba/Álava;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;92,04
01 Araba/Álava;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;92,27
01 Araba/Álava;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;94,58
01 Araba/Álava;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;88,97
01 Araba/Álava;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;88,77
01 Araba/Álava;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;91,54
01 Araba/Álava;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;85,77
01 Araba/Álava;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;88,74
01 Araba/Álava;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QII;1.608
01 Araba/Álava;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QII;1.643
01 Araba/Álava;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QII;1.724
01 Araba/Álava;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2022QII;1.539
01 Araba/Álava;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2022QI;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2021QII;1.572
01 Araba/Álava;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2021QI;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2020QII;1.689
01 Araba/Álava;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2020QI;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2022QIII;1.478
01 Araba/Álava;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2022QII;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2022QI;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2021QIII;1.509
01 Araba/Álava;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2021QII;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2021QI;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2020QIII;1.631
01 Araba/Álava;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2020QII;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2020QI;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QIV;1.428
01 Araba/Álava;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QII;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QI;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QIV;1.459
01 Araba/Álava;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QII;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QI;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QIV;1.580
01 Araba/Álava;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QII;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QI;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QII;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QI;1.415
01 Araba/Álava;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QII;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QI;1.532
01 Araba/Álava;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QII;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QI;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
01 Araba/Álava;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
01 Araba/Álava;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
01 Araba/Álava;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;95,71
01 Araba/Álava;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;95,68
01 Araba/Álava;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;97,97
01 Araba/Álava;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;91,92
01 Araba/Álava;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;91,84
01 Araba/Álava;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;94,61
01 Araba/Álava;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;88,81
01 Araba/Álava;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;88,8
01 Araba/Álava;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;91,65
01 Araba/Álava;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;86,12
01 Araba/Álava;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;88,86
01 Araba/Álava;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QII;1.131
01 Araba/Álava;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QII;1.126
01 Araba/Álava;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QII;1.101
01 Araba/Álava;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2022QII;1.086
01 Araba/Álava;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2022QI;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2021QII;1.081
01 Araba/Álava;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2021QI;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2020QII;1.082
01 Araba/Álava;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2020QI;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2022QIII;1.043
01 Araba/Álava;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2022QII;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2022QI;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2021QIII;1.046
01 Araba/Álava;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2021QII;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2021QI;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2020QIII;1.041
01 Araba/Álava;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2020QII;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2020QI;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QIV;1.009
01 Araba/Álava;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QII;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QI;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QIV;999
01 Araba/Álava;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QII;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QI;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QIV;1.006
01 Araba/Álava;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QII;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QI;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QII;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QI;960
01 Araba/Álava;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QII;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QI;975
01 Araba/Álava;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QII;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QI;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
01 Araba/Álava;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
01 Araba/Álava;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
01 Araba/Álava;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;96,02
01 Araba/Álava;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;96
01 Araba/Álava;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;98,27
01 Araba/Álava;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;92,22
01 Araba/Álava;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;92,9
01 Araba/Álava;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;94,55
01 Araba/Álava;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;89,21
01 Araba/Álava;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;88,72
01 Araba/Álava;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;91,37
01 Araba/Álava;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;85,26
01 Araba/Álava;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;88,56
01 Araba/Álava;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QIII;2.796
01 Araba/Álava;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QIII;2.823
01 Araba/Álava;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QIII;2.869
01 Araba/Álava;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2022QIII;2.677
01 Araba/Álava;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2022QII;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2022QI;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2021QIII;2.710
01 Araba/Álava;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2021QII;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2021QI;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2020QIII;2.762
01 Araba/Álava;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2020QII;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2020QI;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2022QIV;2.580
01 Araba/Álava;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2022QII;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2022QI;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2021QIV;2.604
01 Araba/Álava;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2021QII;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2021QI;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2020QIV;2.669
01 Araba/Álava;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2020QII;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2020QI;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QII;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QI;2.508
01 Araba/Álava;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QII;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QI;2.588
01 Araba/Álava;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QII;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QI;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QII;2.424
01 Araba/Álava;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QI;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QII;2.494
01 Araba/Álava;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QI;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QII;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QI;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
01 Araba/Álava;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
01 Araba/Álava;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
01 Araba/Álava;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;95,74
01 Araba/Álava;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;96
01 Araba/Álava;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;96,27
01 Araba/Álava;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;92,27
01 Araba/Álava;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;92,24
01 Araba/Álava;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;93,03
01 Araba/Álava;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;88,84
01 Araba/Álava;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;90,21
01 Araba/Álava;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;85,87
01 Araba/Álava;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;86,93
01 Araba/Álava;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QIII;1.614
01 Araba/Álava;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QIII;1.680
01 Araba/Álava;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QIII;1.752
01 Araba/Álava;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2022QIII;1.545
01 Araba/Álava;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2022QII;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2022QI;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2021QIII;1.604
01 Araba/Álava;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2021QII;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2021QI;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2020QIII;1.689
01 Araba/Álava;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2020QII;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2020QI;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2022QIV;1.489
01 Araba/Álava;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2022QII;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2022QI;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2021QIV;1.548
01 Araba/Álava;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2021QII;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2021QI;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2020QIV;1.633
01 Araba/Álava;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2020QII;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2020QI;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QII;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QI;1.494
01 Araba/Álava;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QII;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QI;1.584
01 Araba/Álava;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QII;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QI;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QII;1.439
01 Araba/Álava;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QI;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QII;1.523
01 Araba/Álava;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QI;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QII;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QI;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
01 Araba/Álava;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
01 Araba/Álava;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
01 Araba/Álava;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;95,72
01 Araba/Álava;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;95,48
01 Araba/Álava;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;96,4
01 Araba/Álava;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;92,26
01 Araba/Álava;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;92,14
01 Araba/Álava;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;93,21
01 Araba/Álava;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;88,93
01 Araba/Álava;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;90,41
01 Araba/Álava;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;85,65
01 Araba/Álava;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;86,93
01 Araba/Álava;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QIII;1.182
01 Araba/Álava;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QIII;1.143
01 Araba/Álava;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QIII;1.117
01 Araba/Álava;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2022QIII;1.132
01 Araba/Álava;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2022QII;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2022QI;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2021QIII;1.106
01 Araba/Álava;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2021QII;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2021QI;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2020QIII;1.073
01 Araba/Álava;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2020QII;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2020QI;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2022QIV;1.091
01 Araba/Álava;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2022QII;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2022QI;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2021QIV;1.056
01 Araba/Álava;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2021QII;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2021QI;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2020QIV;1.036
01 Araba/Álava;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2020QII;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2020QI;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QII;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QI;1.014
01 Araba/Álava;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QII;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QI;1.004
01 Araba/Álava;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QII;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QI;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QII;985
01 Araba/Álava;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QI;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QII;971
01 Araba/Álava;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QI;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QII;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QI;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
01 Araba/Álava;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
01 Araba/Álava;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
01 Araba/Álava;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;95,77
01 Araba/Álava;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;96,76
01 Araba/Álava;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;96,06
01 Araba/Álava;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;92,3
01 Araba/Álava;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;92,39
01 Araba/Álava;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;92,75
01 Araba/Álava;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;88,71
01 Araba/Álava;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;89,88
01 Araba/Álava;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;86,18
01 Araba/Álava;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;86,93
01 Araba/Álava;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QIV;2.814
01 Araba/Álava;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QIV;2.842
01 Araba/Álava;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QIV;2.889
01 Araba/Álava;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2022QIV;2.707
01 Araba/Álava;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2022QII;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2022QI;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2021QIV;2.728
01 Araba/Álava;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2021QII;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2021QI;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2020QIV;2.785
01 Araba/Álava;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2020QII;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2020QI;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2022QII;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2022QI;2.629
01 Araba/Álava;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2021QII;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2021QI;2.694
01 Araba/Álava;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2020QII;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2020QI;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QII;2.538
01 Araba/Álava;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QI;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QII;2.589
01 Araba/Álava;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QI;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QII;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QI;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QIII;2.439
01 Araba/Álava;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QII;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QI;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QIII;2.516
01 Araba/Álava;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QII;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QI;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QII;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QI;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
01 Araba/Álava;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
01 Araba/Álava;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
01 Araba/Álava;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;96,2
01 Araba/Álava;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;95,99
01 Araba/Álava;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;96,4
01 Araba/Álava;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;92,51
01 Araba/Álava;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;93,25
01 Araba/Álava;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;89,3
01 Araba/Álava;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;89,62
01 Araba/Álava;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;85,82
01 Araba/Álava;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;87,09
01 Araba/Álava;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QIV;1.623
01 Araba/Álava;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QIV;1.678
01 Araba/Álava;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QIV;1.759
01 Araba/Álava;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2022QIV;1.560
01 Araba/Álava;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2022QII;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2022QI;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2021QIV;1.617
01 Araba/Álava;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2021QII;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2021QI;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2020QIV;1.697
01 Araba/Álava;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2020QII;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2020QI;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2022QII;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2022QI;1.561
01 Araba/Álava;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2021QII;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2021QI;1.640
01 Araba/Álava;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2020QII;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2020QI;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QII;1.502
01 Araba/Álava;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QI;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QII;1.575
01 Araba/Álava;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QI;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QII;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QI;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QIII;1.444
01 Araba/Álava;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QII;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QI;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QIII;1.527
01 Araba/Álava;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QII;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QI;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QII;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QI;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
01 Araba/Álava;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
01 Araba/Álava;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
01 Araba/Álava;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;96,12
01 Araba/Álava;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;96,36
01 Araba/Álava;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;96,48
01 Araba/Álava;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;93,03
01 Araba/Álava;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;93,23
01 Araba/Álava;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;89,51
01 Araba/Álava;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;89,54
01 Araba/Álava;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;86,05
01 Araba/Álava;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;86,81
01 Araba/Álava;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QIV;1.191
01 Araba/Álava;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QIV;1.164
01 Araba/Álava;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QIV;1.130
01 Araba/Álava;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2022QIV;1.147
01 Araba/Álava;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2022QII;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2022QI;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2021QIV;1.111
01 Araba/Álava;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2021QII;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2021QI;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2020QIV;1.088
01 Araba/Álava;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2020QII;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2020QI;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2022QII;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2022QI;1.068
01 Araba/Álava;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2021QII;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2021QI;1.054
01 Araba/Álava;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2020QII;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2020QI;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QII;1.036
01 Araba/Álava;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QI;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QII;1.014
01 Araba/Álava;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QI;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QII;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QI;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QIII;995
01 Araba/Álava;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QII;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QI;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QIII;989
01 Araba/Álava;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QII;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QI;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QII;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QI;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
01 Araba/Álava;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
01 Araba/Álava;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
01 Araba/Álava;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;96,31
01 Araba/Álava;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;95,45
01 Araba/Álava;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;96,28
01 Araba/Álava;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;91,75
01 Araba/Álava;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;93,27
01 Araba/Álava;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;89
01 Araba/Álava;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;89,73
01 Araba/Álava;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;85,48
01 Araba/Álava;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;87,52
01 Araba/Álava;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QI;5.553
01 Araba/Álava;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QI;5.691
01 Araba/Álava;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QI;5.679
01 Araba/Álava;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2022QII;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2022QI;5.412
01 Araba/Álava;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2021QII;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2021QI;5.573
01 Araba/Álava;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2020QII;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2020QI;5.427
01 Araba/Álava;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2022QII;5.265
01 Araba/Álava;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2022QI;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2021QII;5.450
01 Araba/Álava;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2021QI;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2020QII;5.312
01 Araba/Álava;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2020QI;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QIII;5.177
01 Araba/Álava;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QII;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QI;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QIII;5.349
01 Araba/Álava;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QII;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QI;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QIII;5.234
01 Araba/Álava;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QII;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QI;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QIV;5.051
01 Araba/Álava;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QII;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QI;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QIV;5.237
01 Araba/Álava;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QII;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QI;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QIV;5.132
01 Araba/Álava;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QII;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QI;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
01 Araba/Álava;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
01 Araba/Álava;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
01 Araba/Álava;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;97,46
01 Araba/Álava;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;97,93
01 Araba/Álava;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;95,56
01 Araba/Álava;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;94,81
01 Araba/Álava;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;95,77
01 Araba/Álava;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;93,54
01 Araba/Álava;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;93,23
01 Araba/Álava;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;93,99
01 Araba/Álava;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;92,16
01 Araba/Álava;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;90,96
01 Araba/Álava;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;92,02
01 Araba/Álava;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;90,37
01 Araba/Álava;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QI;3.494
01 Araba/Álava;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QI;3.589
01 Araba/Álava;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QI;3.563
01 Araba/Álava;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2022QII;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2022QI;3.414
01 Araba/Álava;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2021QII;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2021QI;3.522
01 Araba/Álava;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2020QII;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2020QI;3.416
01 Araba/Álava;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2022QII;3.326
01 Araba/Álava;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2022QI;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2021QII;3.451
01 Araba/Álava;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2021QI;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2020QII;3.359
01 Araba/Álava;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2020QI;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QIII;3.285
01 Araba/Álava;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QII;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QI;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QIII;3.395
01 Araba/Álava;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QII;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QI;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QIII;3.315
01 Araba/Álava;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QII;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QI;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QIV;3.202
01 Araba/Álava;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QII;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QI;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QIV;3.322
01 Araba/Álava;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QII;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QI;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QIV;3.259
01 Araba/Álava;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QII;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QI;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
01 Araba/Álava;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
01 Araba/Álava;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
01 Araba/Álava;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;97,71
01 Araba/Álava;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;98,13
01 Araba/Álava;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;95,87
01 Araba/Álava;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;95,19
01 Araba/Álava;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;96,15
01 Araba/Álava;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;94,27
01 Araba/Álava;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;94,02
01 Araba/Álava;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;94,59
01 Araba/Álava;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;93,04
01 Araba/Álava;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;91,64
01 Araba/Álava;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;92,56
01 Araba/Álava;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;91,47
01 Araba/Álava;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QI;2.059
01 Araba/Álava;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QI;2.102
01 Araba/Álava;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QI;2.116
01 Araba/Álava;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2022QII;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2022QI;1.998
01 Araba/Álava;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2021QII;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2021QI;2.051
01 Araba/Álava;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2020QII;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2020QI;2.011
01 Araba/Álava;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2022QII;1.939
01 Araba/Álava;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2022QI;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2021QII;1.999
01 Araba/Álava;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2021QI;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2020QII;1.953
01 Araba/Álava;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2020QI;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QIII;1.892
01 Araba/Álava;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QII;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QI;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QIII;1.954
01 Araba/Álava;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QII;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QI;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QIII;1.919
01 Araba/Álava;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QII;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QI;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QIV;1.849
01 Araba/Álava;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QII;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QI;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QIV;1.915
01 Araba/Álava;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QII;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QI;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QIV;1.873
01 Araba/Álava;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QII;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QI;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
01 Araba/Álava;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
01 Araba/Álava;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
01 Araba/Álava;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;97,04
01 Araba/Álava;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;97,57
01 Araba/Álava;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;95,04
01 Araba/Álava;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;94,17
01 Araba/Álava;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;95,1
01 Araba/Álava;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;92,3
01 Araba/Álava;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;91,89
01 Araba/Álava;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;92,96
01 Araba/Álava;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;90,69
01 Araba/Álava;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;89,8
01 Araba/Álava;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;91,1
01 Araba/Álava;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;88,52
01 Araba/Álava;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QII;5.329
01 Araba/Álava;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QII;5.482
01 Araba/Álava;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QII;5.623
01 Araba/Álava;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2022QII;5.163
01 Araba/Álava;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2022QI;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2021QII;5.337
01 Araba/Álava;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2021QI;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2020QII;5.496
01 Araba/Álava;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2020QI;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2022QIII;5.063
01 Araba/Álava;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2022QII;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2022QI;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2021QIII;5.227
01 Araba/Álava;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2021QII;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2021QI;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2020QIII;5.398
01 Araba/Álava;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2020QII;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2020QI;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QIV;4.932
01 Araba/Álava;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QII;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QI;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QIV;5.109
01 Araba/Álava;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QII;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QI;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QIV;5.280
01 Araba/Álava;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QII;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QI;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QII;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QI;5.012
01 Araba/Álava;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QII;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QI;5.193
01 Araba/Álava;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QII;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QI;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
01 Araba/Álava;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
01 Araba/Álava;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
01 Araba/Álava;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;96,88
01 Araba/Álava;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;97,35
01 Araba/Álava;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;97,74
01 Araba/Álava;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;95,01
01 Araba/Álava;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;95,35
01 Araba/Álava;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;96
01 Araba/Álava;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;92,55
01 Araba/Álava;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;93,2
01 Araba/Álava;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;93,9
01 Araba/Álava;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;91,43
01 Araba/Álava;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;92,35
01 Araba/Álava;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QII;3.329
01 Araba/Álava;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QII;3.462
01 Araba/Álava;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QII;3.538
01 Araba/Álava;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2022QII;3.226
01 Araba/Álava;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2022QI;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2021QII;3.382
01 Araba/Álava;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2021QI;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2020QII;3.475
01 Araba/Álava;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2020QI;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2022QIII;3.180
01 Araba/Álava;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2022QII;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2022QI;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2021QIII;3.317
01 Araba/Álava;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2021QII;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2021QI;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2020QIII;3.420
01 Araba/Álava;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2020QII;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2020QI;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QIV;3.095
01 Araba/Álava;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QII;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QI;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QIV;3.241
01 Araba/Álava;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QII;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QI;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QIV;3.355
01 Araba/Álava;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QII;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QI;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QII;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QI;3.185
01 Araba/Álava;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QII;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QI;3.303
01 Araba/Álava;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QII;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QI;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
01 Araba/Álava;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
01 Araba/Álava;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
01 Araba/Álava;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;96,91
01 Araba/Álava;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;97,69
01 Araba/Álava;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;98,22
01 Araba/Álava;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;95,52
01 Araba/Álava;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;95,81
01 Araba/Álava;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;96,66
01 Araba/Álava;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;92,97
01 Araba/Álava;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;93,62
01 Araba/Álava;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;94,83
01 Araba/Álava;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;92
01 Araba/Álava;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;93,36
01 Araba/Álava;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QII;2.000
01 Araba/Álava;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QII;2.020
01 Araba/Álava;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QII;2.085
01 Araba/Álava;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2022QII;1.937
01 Araba/Álava;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2022QI;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2021QII;1.955
01 Araba/Álava;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2021QI;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2020QII;2.021
01 Araba/Álava;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2020QI;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2022QIII;1.883
01 Araba/Álava;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2022QII;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2022QI;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2021QIII;1.910
01 Araba/Álava;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2021QII;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2021QI;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2020QIII;1.978
01 Araba/Álava;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2020QII;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2020QI;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QIV;1.837
01 Araba/Álava;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QII;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QI;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QIV;1.868
01 Araba/Álava;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QII;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QI;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QIV;1.925
01 Araba/Álava;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QII;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QI;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QII;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QI;1.827
01 Araba/Álava;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QII;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QI;1.890
01 Araba/Álava;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QII;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QI;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
01 Araba/Álava;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
01 Araba/Álava;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
01 Araba/Álava;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;96,85
01 Araba/Álava;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;96,78
01 Araba/Álava;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;96,93
01 Araba/Álava;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;94,15
01 Araba/Álava;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;94,55
01 Araba/Álava;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;94,87
01 Araba/Álava;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;91,85
01 Araba/Álava;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;92,48
01 Araba/Álava;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;92,33
01 Araba/Álava;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;90,45
01 Araba/Álava;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;90,65
01 Araba/Álava;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QIII;5.337
01 Araba/Álava;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QIII;5.509
01 Araba/Álava;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QIII;5.627
01 Araba/Álava;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2022QIII;5.210
01 Araba/Álava;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2022QII;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2022QI;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2021QIII;5.384
01 Araba/Álava;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2021QII;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2021QI;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2020QIII;5.516
01 Araba/Álava;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2020QII;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2020QI;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2022QIV;5.067
01 Araba/Álava;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2022QII;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2022QI;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2021QIV;5.257
01 Araba/Álava;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2021QII;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2021QI;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2020QIV;5.388
01 Araba/Álava;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2020QII;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2020QI;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QII;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QI;5.147
01 Araba/Álava;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QII;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QI;5.295
01 Araba/Álava;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QII;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QI;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QII;5.020
01 Araba/Álava;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QI;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QII;5.197
01 Araba/Álava;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QI;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QII;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QI;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
01 Araba/Álava;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
01 Araba/Álava;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
01 Araba/Álava;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;97,62
01 Araba/Álava;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;97,73
01 Araba/Álava;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;98,03
01 Araba/Álava;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;94,94
01 Araba/Álava;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;95,43
01 Araba/Álava;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;95,75
01 Araba/Álava;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;93,43
01 Araba/Álava;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;94,1
01 Araba/Álava;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;91,12
01 Araba/Álava;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;92,36
01 Araba/Álava;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QIII;3.321
01 Araba/Álava;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QIII;3.493
01 Araba/Álava;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QIII;3.559
01 Araba/Álava;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2022QIII;3.259
01 Araba/Álava;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2022QII;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2022QI;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2021QIII;3.417
01 Araba/Álava;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2021QII;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2021QI;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2020QIII;3.495
01 Araba/Álava;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2020QII;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2020QI;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2022QIV;3.171
01 Araba/Álava;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2022QII;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2022QI;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2021QIV;3.335
01 Araba/Álava;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2021QII;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2021QI;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2020QIV;3.424
01 Araba/Álava;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2020QII;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2020QI;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QII;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QI;3.269
01 Araba/Álava;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QII;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QI;3.370
01 Araba/Álava;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QII;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QI;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QII;3.192
01 Araba/Álava;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QI;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QII;3.314
01 Araba/Álava;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QI;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QII;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QI;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
01 Araba/Álava;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
01 Araba/Álava;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
01 Araba/Álava;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;98,13
01 Araba/Álava;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;97,82
01 Araba/Álava;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;98,2
01 Araba/Álava;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;95,48
01 Araba/Álava;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;95,48
01 Araba/Álava;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;96,21
01 Araba/Álava;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;93,59
01 Araba/Álava;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;94,69
01 Araba/Álava;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;91,38
01 Araba/Álava;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;93,12
01 Araba/Álava;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QIII;2.016
01 Araba/Álava;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QIII;2.016
01 Araba/Álava;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QIII;2.068
01 Araba/Álava;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2022QIII;1.951
01 Araba/Álava;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2022QII;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2022QI;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2021QIII;1.967
01 Araba/Álava;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2021QII;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2021QI;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2020QIII;2.021
01 Araba/Álava;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2020QII;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2020QI;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2022QIV;1.896
01 Araba/Álava;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2022QII;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2022QI;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2021QIV;1.922
01 Araba/Álava;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2021QII;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2021QI;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2020QIV;1.964
01 Araba/Álava;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2020QII;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2020QI;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QII;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QI;1.878
01 Araba/Álava;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QII;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QI;1.925
01 Araba/Álava;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QII;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QI;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QII;1.828
01 Araba/Álava;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QI;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QII;1.883
01 Araba/Álava;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QI;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QII;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QI;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
01 Araba/Álava;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
01 Araba/Álava;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
01 Araba/Álava;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;96,78
01 Araba/Álava;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;97,57
01 Araba/Álava;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;97,73
01 Araba/Álava;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;94,05
01 Araba/Álava;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;95,34
01 Araba/Álava;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;94,97
01 Araba/Álava;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;93,15
01 Araba/Álava;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;93,09
01 Araba/Álava;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;90,67
01 Araba/Álava;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;91,05
01 Araba/Álava;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QIV;5.338
01 Araba/Álava;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QIV;5.515
01 Araba/Álava;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QIV;5.669
01 Araba/Álava;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2022QIV;5.186
01 Araba/Álava;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2022QII;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2022QI;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2021QIV;5.368
01 Araba/Álava;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2021QII;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2021QI;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2020QIV;5.526
01 Araba/Álava;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2020QII;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2020QI;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2022QII;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2022QI;5.247
01 Araba/Álava;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2021QII;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2021QI;5.423
01 Araba/Álava;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2020QII;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2020QI;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QII;5.109
01 Araba/Álava;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QI;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QII;5.317
01 Araba/Álava;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QI;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QII;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QI;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QIII;5.028
01 Araba/Álava;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QII;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QI;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QIII;5.227
01 Araba/Álava;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QII;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QI;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QII;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QI;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
01 Araba/Álava;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
01 Araba/Álava;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
01 Araba/Álava;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;97,15
01 Araba/Álava;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;97,33
01 Araba/Álava;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;97,48
01 Araba/Álava;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;95,14
01 Araba/Álava;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;95,66
01 Araba/Álava;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;92,64
01 Araba/Álava;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;93,79
01 Araba/Álava;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;91,17
01 Araba/Álava;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;92,2
01 Araba/Álava;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QIV;3.327
01 Araba/Álava;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QIV;3.498
01 Araba/Álava;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QIV;3.594
01 Araba/Álava;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2022QIV;3.233
01 Araba/Álava;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2022QII;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2022QI;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2021QIV;3.400
01 Araba/Álava;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2021QII;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2021QI;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2020QIV;3.511
01 Araba/Álava;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2020QII;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2020QI;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2022QII;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2022QI;3.330
01 Araba/Álava;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2021QII;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2021QI;3.452
01 Araba/Álava;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2020QII;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2020QI;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QII;3.247
01 Araba/Álava;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QI;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QII;3.392
01 Araba/Álava;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QI;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QII;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QI;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QIII;3.208
01 Araba/Álava;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QII;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QI;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QIII;3.340
01 Araba/Álava;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QII;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QI;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QII;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QI;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
01 Araba/Álava;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
01 Araba/Álava;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
01 Araba/Álava;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;97,17
01 Araba/Álava;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;97,2
01 Araba/Álava;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;97,69
01 Araba/Álava;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;95,2
01 Araba/Álava;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;96,05
01 Araba/Álava;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;92,82
01 Araba/Álava;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;94,38
01 Araba/Álava;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;91,71
01 Araba/Álava;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;92,93
01 Araba/Álava;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QIV;2.011
01 Araba/Álava;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QIV;2.017
01 Araba/Álava;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QIV;2.075
01 Araba/Álava;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2022QIV;1.953
01 Araba/Álava;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2022QII;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2022QI;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2021QIV;1.968
01 Araba/Álava;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2021QII;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2021QI;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2020QIV;2.015
01 Araba/Álava;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2020QII;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2020QI;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2022QII;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2022QI;1.917
01 Araba/Álava;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2021QII;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2021QI;1.971
01 Araba/Álava;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2020QII;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2020QI;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QII;1.862
01 Araba/Álava;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QI;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QII;1.925
01 Araba/Álava;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QI;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QII;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QI;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QIII;1.820
01 Araba/Álava;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QII;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QI;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QIII;1.887
01 Araba/Álava;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QII;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QI;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QII;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QI;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
01 Araba/Álava;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
01 Araba/Álava;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
01 Araba/Álava;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;97,12
01 Araba/Álava;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;97,57
01 Araba/Álava;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;97,11
01 Araba/Álava;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;95,04
01 Araba/Álava;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;94,99
01 Araba/Álava;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;92,32
01 Araba/Álava;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;92,77
01 Araba/Álava;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;90,23
01 Araba/Álava;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;90,94
01 Araba/Álava;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QI;5.875
01 Araba/Álava;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QI;5.843
01 Araba/Álava;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QI;5.947
01 Araba/Álava;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2022QII;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2022QI;5.773
01 Araba/Álava;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2021QII;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2021QI;5.763
01 Araba/Álava;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2020QII;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2020QI;5.774
01 Araba/Álava;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2022QII;5.667
01 Araba/Álava;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2022QI;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2021QII;5.676
01 Araba/Álava;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2021QI;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2020QII;5.698
01 Araba/Álava;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2020QI;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QIII;5.575
01 Araba/Álava;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QII;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QI;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QIII;5.611
01 Araba/Álava;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QII;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QI;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QIII;5.618
01 Araba/Álava;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QII;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QI;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QIV;5.480
01 Araba/Álava;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QII;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QI;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QIV;5.506
01 Araba/Álava;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QII;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QI;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QIV;5.509
01 Araba/Álava;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QII;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QI;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
01 Araba/Álava;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
01 Araba/Álava;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
01 Araba/Álava;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;98,26
01 Araba/Álava;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;98,63
01 Araba/Álava;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;97,09
01 Araba/Álava;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;96,46
01 Araba/Álava;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;97,14
01 Araba/Álava;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;95,81
01 Araba/Álava;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;94,89
01 Araba/Álava;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;96,03
01 Araba/Álava;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;94,47
01 Araba/Álava;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;93,28
01 Araba/Álava;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;94,23
01 Araba/Álava;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;92,63
01 Araba/Álava;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QI;3.765
01 Araba/Álava;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QI;3.755
01 Araba/Álava;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QI;3.823
01 Araba/Álava;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2022QII;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2022QI;3.698
01 Araba/Álava;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2021QII;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2021QI;3.715
01 Araba/Álava;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2020QII;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2020QI;3.724
01 Araba/Álava;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2022QII;3.642
01 Araba/Álava;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2022QI;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2021QII;3.664
01 Araba/Álava;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2021QI;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2020QII;3.677
01 Araba/Álava;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2020QI;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QIII;3.589
01 Araba/Álava;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QII;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QI;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QIII;3.623
01 Araba/Álava;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QII;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QI;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QIII;3.633
01 Araba/Álava;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QII;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QI;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QIV;3.525
01 Araba/Álava;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QII;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QI;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QIV;3.561
01 Araba/Álava;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QII;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QI;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QIV;3.574
01 Araba/Álava;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QII;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QI;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
01 Araba/Álava;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
01 Araba/Álava;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
01 Araba/Álava;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;98,22
01 Araba/Álava;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;98,93
01 Araba/Álava;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;97,41
01 Araba/Álava;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;96,73
01 Araba/Álava;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;97,58
01 Araba/Álava;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;96,18
01 Araba/Álava;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;95,33
01 Araba/Álava;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;96,48
01 Araba/Álava;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;95,03
01 Araba/Álava;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;93,63
01 Araba/Álava;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;94,83
01 Araba/Álava;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;93,49
01 Araba/Álava;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QI;2.110
01 Araba/Álava;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QI;2.088
01 Araba/Álava;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QI;2.124
01 Araba/Álava;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2022QII;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2022QI;2.075
01 Araba/Álava;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2021QII;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2021QI;2.048
01 Araba/Álava;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2020QII;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2020QI;2.050
01 Araba/Álava;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2022QII;2.025
01 Araba/Álava;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2022QI;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2021QII;2.012
01 Araba/Álava;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2021QI;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2020QII;2.021
01 Araba/Álava;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2020QI;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QIII;1.986
01 Araba/Álava;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QII;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QI;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QIII;1.988
01 Araba/Álava;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QII;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QI;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QIII;1.985
01 Araba/Álava;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QII;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QI;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QIV;1.955
01 Araba/Álava;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QII;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QI;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QIV;1.945
01 Araba/Álava;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QII;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QI;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QIV;1.935
01 Araba/Álava;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QII;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QI;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
01 Araba/Álava;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
01 Araba/Álava;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
01 Araba/Álava;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;98,34
01 Araba/Álava;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;98,08
01 Araba/Álava;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;96,52
01 Araba/Álava;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;95,97
01 Araba/Álava;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;96,36
01 Araba/Álava;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;95,15
01 Araba/Álava;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;94,12
01 Araba/Álava;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;95,21
01 Araba/Álava;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;93,46
01 Araba/Álava;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;92,65
01 Araba/Álava;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;93,15
01 Araba/Álava;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;91,1
01 Araba/Álava;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QII;5.981
01 Araba/Álava;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QII;5.940
01 Araba/Álava;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QII;5.911
01 Araba/Álava;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2022QII;5.860
01 Araba/Álava;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2022QI;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2021QII;5.834
01 Araba/Álava;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2021QI;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2020QII;5.830
01 Araba/Álava;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2020QI;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2022QIII;5.759
01 Araba/Álava;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2022QII;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2022QI;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2021QIII;5.765
01 Araba/Álava;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2021QII;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2021QI;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2020QIII;5.731
01 Araba/Álava;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2020QII;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2020QI;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QIV;5.647
01 Araba/Álava;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QII;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QI;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QIV;5.657
01 Araba/Álava;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QII;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QI;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QIV;5.617
01 Araba/Álava;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QII;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QI;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QII;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QI;5.584
01 Araba/Álava;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QII;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QI;5.550
01 Araba/Álava;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QII;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QI;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
01 Araba/Álava;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
01 Araba/Álava;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
01 Araba/Álava;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;97,98
01 Araba/Álava;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;98,22
01 Araba/Álava;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;98,63
01 Araba/Álava;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;96,29
01 Araba/Álava;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;97,05
01 Araba/Álava;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;96,95
01 Araba/Álava;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;94,42
01 Araba/Álava;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;95,24
01 Araba/Álava;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;95,03
01 Araba/Álava;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;94,01
01 Araba/Álava;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;93,89
01 Araba/Álava;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QII;3.814
01 Araba/Álava;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QII;3.821
01 Araba/Álava;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QII;3.812
01 Araba/Álava;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2022QII;3.748
01 Araba/Álava;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2022QI;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2021QII;3.755
01 Araba/Álava;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2021QI;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2020QII;3.763
01 Araba/Álava;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2020QI;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2022QIII;3.690
01 Araba/Álava;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2022QII;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2022QI;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2021QIII;3.713
01 Araba/Álava;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2021QII;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2021QI;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2020QIII;3.702
01 Araba/Álava;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2020QII;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2020QI;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QIV;3.617
01 Araba/Álava;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QII;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QI;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QIV;3.648
01 Araba/Álava;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QII;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QI;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QIV;3.639
01 Araba/Álava;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QII;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QI;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QII;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QI;3.599
01 Araba/Álava;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QII;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QI;3.602
01 Araba/Álava;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QII;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QI;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
01 Araba/Álava;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
01 Araba/Álava;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
01 Araba/Álava;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;98,27
01 Araba/Álava;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;98,27
01 Araba/Álava;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;98,71
01 Araba/Álava;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;96,75
01 Araba/Álava;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;97,17
01 Araba/Álava;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;97,11
01 Araba/Álava;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;94,83
01 Araba/Álava;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;95,47
01 Araba/Álava;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;95,46
01 Araba/Álava;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;94,19
01 Araba/Álava;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;94,49
01 Araba/Álava;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QII;2.167
01 Araba/Álava;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QII;2.119
01 Araba/Álava;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QII;2.099
01 Araba/Álava;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2022QII;2.112
01 Araba/Álava;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2022QI;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2021QII;2.079
01 Araba/Álava;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2021QI;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2020QII;2.067
01 Araba/Álava;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2020QI;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2022QIII;2.069
01 Araba/Álava;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2022QII;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2022QI;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2021QIII;2.052
01 Araba/Álava;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2021QII;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2021QI;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2020QIII;2.029
01 Araba/Álava;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2020QII;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2020QI;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QIV;2.030
01 Araba/Álava;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QII;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QI;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QIV;2.009
01 Araba/Álava;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QII;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QI;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QIV;1.978
01 Araba/Álava;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QII;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QI;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QII;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QI;1.985
01 Araba/Álava;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QII;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QI;1.948
01 Araba/Álava;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QII;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QI;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
01 Araba/Álava;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
01 Araba/Álava;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
01 Araba/Álava;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;97,46
01 Araba/Álava;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;98,11
01 Araba/Álava;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;98,48
01 Araba/Álava;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;95,48
01 Araba/Álava;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;96,84
01 Araba/Álava;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;96,67
01 Araba/Álava;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;93,68
01 Araba/Álava;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;94,81
01 Araba/Álava;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;94,24
01 Araba/Álava;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;93,68
01 Araba/Álava;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;92,81
01 Araba/Álava;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QIII;5.937
01 Araba/Álava;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QIII;5.902
01 Araba/Álava;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QIII;5.890
01 Araba/Álava;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2022QIII;5.823
01 Araba/Álava;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2022QII;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2022QI;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2021QIII;5.825
01 Araba/Álava;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2021QII;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2021QI;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2020QIII;5.786
01 Araba/Álava;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2020QII;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2020QI;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2022QIV;5.704
01 Araba/Álava;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2022QII;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2022QI;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2021QIV;5.713
01 Araba/Álava;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2021QII;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2021QI;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2020QIV;5.664
01 Araba/Álava;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2020QII;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2020QI;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QII;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QI;5.632
01 Araba/Álava;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QII;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QI;5.594
01 Araba/Álava;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QII;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QI;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QII;5.540
01 Araba/Álava;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QI;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QII;5.527
01 Araba/Álava;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QI;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QII;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QI;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
01 Araba/Álava;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
01 Araba/Álava;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
01 Araba/Álava;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;98,08
01 Araba/Álava;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;98,7
01 Araba/Álava;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;98,23
01 Araba/Álava;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;96,08
01 Araba/Álava;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;96,8
01 Araba/Álava;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;96,16
01 Araba/Álava;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;95,43
01 Araba/Álava;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;94,97
01 Araba/Álava;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;93,87
01 Araba/Álava;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;93,84
01 Araba/Álava;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QIII;3.795
01 Araba/Álava;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QIII;3.797
01 Araba/Álava;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QIII;3.800
01 Araba/Álava;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2022QIII;3.728
01 Araba/Álava;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2022QII;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2022QI;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2021QIII;3.747
01 Araba/Álava;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2021QII;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2021QI;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2020QIII;3.734
01 Araba/Álava;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2020QII;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2020QI;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2022QIV;3.650
01 Araba/Álava;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2022QII;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2022QI;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2021QIV;3.679
01 Araba/Álava;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2021QII;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2021QI;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2020QIV;3.668
01 Araba/Álava;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2020QII;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2020QI;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QII;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QI;3.624
01 Araba/Álava;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QII;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QI;3.630
01 Araba/Álava;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QII;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QI;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QII;3.575
01 Araba/Álava;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QI;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QII;3.589
01 Araba/Álava;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QI;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QII;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QI;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
01 Araba/Álava;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
01 Araba/Álava;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
01 Araba/Álava;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;98,23
01 Araba/Álava;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;98,68
01 Araba/Álava;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;98,26
01 Araba/Álava;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;96,18
01 Araba/Álava;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;96,89
01 Araba/Álava;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;96,53
01 Araba/Álava;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;95,44
01 Araba/Álava;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;95,53
01 Araba/Álava;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;94,15
01 Araba/Álava;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;94,45
01 Araba/Álava;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QIII;2.142
01 Araba/Álava;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QIII;2.105
01 Araba/Álava;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QIII;2.090
01 Araba/Álava;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2022QIII;2.095
01 Araba/Álava;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2022QII;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2022QI;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2021QIII;2.078
01 Araba/Álava;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2021QII;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2021QI;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2020QIII;2.052
01 Araba/Álava;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2020QII;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2020QI;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2022QIV;2.054
01 Araba/Álava;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2022QII;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2022QI;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2021QIV;2.034
01 Araba/Álava;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2021QII;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2021QI;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2020QIV;1.996
01 Araba/Álava;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2020QII;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2020QI;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QII;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QI;2.008
01 Araba/Álava;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QII;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QI;1.964
01 Araba/Álava;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QII;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QI;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QII;1.965
01 Araba/Álava;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QI;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QII;1.938
01 Araba/Álava;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QI;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QII;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QI;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
01 Araba/Álava;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
01 Araba/Álava;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
01 Araba/Álava;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;97,81
01 Araba/Álava;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;98,72
01 Araba/Álava;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;98,18
01 Araba/Álava;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;95,89
01 Araba/Álava;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;96,63
01 Araba/Álava;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;95,5
01 Araba/Álava;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;95,39
01 Araba/Álava;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;93,97
01 Araba/Álava;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;93,35
01 Araba/Álava;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;92,73
01 Araba/Álava;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QIV;5.896
01 Araba/Álava;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QIV;5.903
01 Araba/Álava;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QIV;5.892
01 Araba/Álava;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2022QIV;5.771
01 Araba/Álava;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2022QII;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2022QI;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2021QIV;5.785
01 Araba/Álava;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2021QII;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2021QI;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2020QIV;5.764
01 Araba/Álava;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2020QII;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2020QI;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2022QII;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2022QI;5.695
01 Araba/Álava;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2021QII;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2021QI;5.690
01 Araba/Álava;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2020QII;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2020QI;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QII;5.596
01 Araba/Álava;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QI;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QII;5.614
01 Araba/Álava;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QI;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QII;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QI;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QIII;5.512
01 Araba/Álava;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QII;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QI;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QIII;5.553
01 Araba/Álava;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QII;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QI;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QII;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QI;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
01 Araba/Álava;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
01 Araba/Álava;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
01 Araba/Álava;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;97,88
01 Araba/Álava;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;98
01 Araba/Álava;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;97,83
01 Araba/Álava;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;96,48
01 Araba/Álava;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;96,57
01 Araba/Álava;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;94,8
01 Araba/Álava;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;95,28
01 Araba/Álava;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;93,38
01 Araba/Álava;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;94,25
01 Araba/Álava;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QIV;3.760
01 Araba/Álava;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QIV;3.785
01 Araba/Álava;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QIV;3.788
01 Araba/Álava;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2022QIV;3.680
01 Araba/Álava;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2022QII;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2022QI;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2021QIV;3.714
01 Araba/Álava;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2021QII;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2021QI;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2020QIV;3.717
01 Araba/Álava;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2020QII;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2020QI;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2022QII;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2022QI;3.652
01 Araba/Álava;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2021QII;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2021QI;3.678
01 Araba/Álava;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2020QII;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2020QI;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QII;3.600
01 Araba/Álava;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QI;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QII;3.634
01 Araba/Álava;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QI;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QII;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QI;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QIII;3.552
01 Araba/Álava;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QII;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QI;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QIII;3.595
01 Araba/Álava;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QII;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QI;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QII;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QI;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
01 Araba/Álava;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
01 Araba/Álava;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
01 Araba/Álava;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;97,87
01 Araba/Álava;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;98,12
01 Araba/Álava;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;98,13
01 Araba/Álava;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;96,49
01 Araba/Álava;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;97,1
01 Araba/Álava;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;95,11
01 Araba/Álava;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;95,93
01 Araba/Álava;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;93,84
01 Araba/Álava;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;94,9
01 Araba/Álava;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QIV;2.136
01 Araba/Álava;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QIV;2.118
01 Araba/Álava;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QIV;2.104
01 Araba/Álava;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2022QIV;2.091
01 Araba/Álava;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2022QII;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2022QI;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2021QIV;2.071
01 Araba/Álava;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2021QII;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2021QI;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2020QIV;2.047
01 Araba/Álava;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2020QII;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2020QI;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2022QII;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2022QI;2.043
01 Araba/Álava;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2021QII;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2021QI;2.012
01 Araba/Álava;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2020QII;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2020QI;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QII;1.996
01 Araba/Álava;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QI;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QII;1.980
01 Araba/Álava;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QI;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QII;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QI;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QIII;1.960
01 Araba/Álava;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QII;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QI;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QIII;1.958
01 Araba/Álava;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QII;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QI;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QII;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QI;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
01 Araba/Álava;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
01 Araba/Álava;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
01 Araba/Álava;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;97,89
01 Araba/Álava;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;97,78
01 Araba/Álava;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;97,29
01 Araba/Álava;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;96,46
01 Araba/Álava;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;95,63
01 Araba/Álava;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;94,24
01 Araba/Álava;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;94,11
01 Araba/Álava;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;92,54
01 Araba/Álava;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;93,06
01 Araba/Álava;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
01 Araba/Álava;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
01 Araba/Álava;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
01 Araba/Álava;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
01 Araba/Álava;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QI;2.766
01 Araba/Álava;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
01 Araba/Álava;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
01 Araba/Álava;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
01 Araba/Álava;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QI;2.626
01 Araba/Álava;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
01 Araba/Álava;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
01 Araba/Álava;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
01 Araba/Álava;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QI;3.077
01 Araba/Álava;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
01 Araba/Álava;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
01 Araba/Álava;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2022QII;""
01 Araba/Álava;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2022QI;2.682
01 Araba/Álava;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
01 Araba/Álava;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
01 Araba/Álava;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2021QII;""
01 Araba/Álava;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2021QI;2.509
01 Araba/Álava;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
01 Araba/Álava;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
01 Araba/Álava;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2020QII;""
01 Araba/Álava;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2020QI;2.900
01 Araba/Álava;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
01 Araba/Álava;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
01 Araba/Álava;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2022QII;2.568
01 Araba/Álava;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2022QI;""
01 Araba/Álava;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
01 Araba/Álava;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
01 Araba/Álava;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2021QII;2.418
01 Araba/Álava;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2021QI;""
01 Araba/Álava;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
01 Araba/Álava;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
01 Araba/Álava;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2020QII;2.813
01 Araba/Álava;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2020QI;""
01 Araba/Álava;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
01 Araba/Álava;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QIII;2.480
01 Araba/Álava;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QII;""
01 Araba/Álava;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QI;""
01 Araba/Álava;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
01 Araba/Álava;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QIII;2.325
01 Araba/Álava;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QII;""
01 Araba/Álava;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QI;""
01 Araba/Álava;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
01 Araba/Álava;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QIII;2.709
01 Araba/Álava;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QII;""
01 Araba/Álava;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QI;""
01 Araba/Álava;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QIV;2.312
01 Araba/Álava;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
01 Araba/Álava;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QII;""
01 Araba/Álava;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QI;""
01 Araba/Álava;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QIV;2.196
01 Araba/Álava;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
01 Araba/Álava;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QII;""
01 Araba/Álava;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QI;""
01 Araba/Álava;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QIV;2.545
01 Araba/Álava;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
01 Araba/Álava;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QII;""
01 Araba/Álava;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QI;""
01 Araba/Álava;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
01 Araba/Álava;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
01 Araba/Álava;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
01 Araba/Álava;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
01 Araba/Álava;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
01 Araba/Álava;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
01 Araba/Álava;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
01 Araba/Álava;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
01 Araba/Álava;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
01 Araba/Álava;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
01 Araba/Álava;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
01 Araba/Álava;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
01 Araba/Álava;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
01 Araba/Álava;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
01 Araba/Álava;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
01 Araba/Álava;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;96,96
01 Araba/Álava;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
01 Araba/Álava;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
01 Araba/Álava;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
01 Araba/Álava;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;95,54
01 Araba/Álava;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
01 Araba/Álava;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
01 Araba/Álava;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
01 Araba/Álava;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;94,25
01 Araba/Álava;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
01 Araba/Álava;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
01 Araba/Álava;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;92,84
01 Araba/Álava;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
01 Araba/Álava;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
01 Araba/Álava;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
01 Araba/Álava;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;92,08
01 Araba/Álava;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
01 Araba/Álava;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
01 Araba/Álava;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
01 Araba/Álava;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;91,42
01 Araba/Álava;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
01 Araba/Álava;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
01 Araba/Álava;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;89,66
01 Araba/Álava;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
01 Araba/Álava;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
01 Araba/Álava;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
01 Araba/Álava;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;88,54
01 Araba/Álava;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
01 Araba/Álava;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
01 Araba/Álava;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
01 Araba/Álava;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;88,04
01 Araba/Álava;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
01 Araba/Álava;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
01 Araba/Álava;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;83,59
01 Araba/Álava;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
01 Araba/Álava;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
01 Araba/Álava;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
01 Araba/Álava;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;83,63
01 Araba/Álava;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
01 Araba/Álava;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
01 Araba/Álava;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
01 Araba/Álava;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;82,71
01 Araba/Álava;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
01 Araba/Álava;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
01 Araba/Álava;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
01 Araba/Álava;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
01 Araba/Álava;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
01 Araba/Álava;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
01 Araba/Álava;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QI;1.837
01 Araba/Álava;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
01 Araba/Álava;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
01 Araba/Álava;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
01 Araba/Álava;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QI;1.735
01 Araba/Álava;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
01 Araba/Álava;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
01 Araba/Álava;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
01 Araba/Álava;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QI;2.018
01 Araba/Álava;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
01 Araba/Álava;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
01 Araba/Álava;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2022QII;""
01 Araba/Álava;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2022QI;1.778
01 Araba/Álava;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
01 Araba/Álava;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
01 Araba/Álava;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2021QII;""
01 Araba/Álava;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2021QI;1.660
01 Araba/Álava;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
01 Araba/Álava;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
01 Araba/Álava;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2020QII;""
01 Araba/Álava;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2020QI;1.905
01 Araba/Álava;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
01 Araba/Álava;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
01 Araba/Álava;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2022QII;1.706
01 Araba/Álava;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2022QI;""
01 Araba/Álava;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
01 Araba/Álava;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
01 Araba/Álava;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2021QII;1.602
01 Araba/Álava;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2021QI;""
01 Araba/Álava;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
01 Araba/Álava;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
01 Araba/Álava;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2020QII;1.854
01 Araba/Álava;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2020QI;""
01 Araba/Álava;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
01 Araba/Álava;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QIII;1.653
01 Araba/Álava;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QII;""
01 Araba/Álava;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QI;""
01 Araba/Álava;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
01 Araba/Álava;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QIII;1.545
01 Araba/Álava;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QII;""
01 Araba/Álava;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QI;""
01 Araba/Álava;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
01 Araba/Álava;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QIII;1.787
01 Araba/Álava;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QII;""
01 Araba/Álava;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QI;""
01 Araba/Álava;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QIV;1.540
01 Araba/Álava;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
01 Araba/Álava;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QII;""
01 Araba/Álava;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QI;""
01 Araba/Álava;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QIV;1.463
01 Araba/Álava;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
01 Araba/Álava;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QII;""
01 Araba/Álava;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QI;""
01 Araba/Álava;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QIV;1.686
01 Araba/Álava;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
01 Araba/Álava;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QII;""
01 Araba/Álava;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QI;""
01 Araba/Álava;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
01 Araba/Álava;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
01 Araba/Álava;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
01 Araba/Álava;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
01 Araba/Álava;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
01 Araba/Álava;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
01 Araba/Álava;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
01 Araba/Álava;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
01 Araba/Álava;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
01 Araba/Álava;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
01 Araba/Álava;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
01 Araba/Álava;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
01 Araba/Álava;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
01 Araba/Álava;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
01 Araba/Álava;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
01 Araba/Álava;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;96,79
01 Araba/Álava;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
01 Araba/Álava;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
01 Araba/Álava;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
01 Araba/Álava;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;95,68
01 Araba/Álava;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
01 Araba/Álava;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
01 Araba/Álava;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
01 Araba/Álava;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;94,4
01 Araba/Álava;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
01 Araba/Álava;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
01 Araba/Álava;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;92,87
01 Araba/Álava;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
01 Araba/Álava;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
01 Araba/Álava;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
01 Araba/Álava;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;92,33
01 Araba/Álava;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
01 Araba/Álava;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
01 Araba/Álava;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
01 Araba/Álava;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;91,87
01 Araba/Álava;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
01 Araba/Álava;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
01 Araba/Álava;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;89,98
01 Araba/Álava;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
01 Araba/Álava;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
01 Araba/Álava;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
01 Araba/Álava;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;89,05
01 Araba/Álava;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
01 Araba/Álava;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
01 Araba/Álava;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
01 Araba/Álava;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;88,55
01 Araba/Álava;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
01 Araba/Álava;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
01 Araba/Álava;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;83,83
01 Araba/Álava;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
01 Araba/Álava;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
01 Araba/Álava;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
01 Araba/Álava;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;84,32
01 Araba/Álava;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
01 Araba/Álava;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
01 Araba/Álava;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
01 Araba/Álava;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;83,55
01 Araba/Álava;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
01 Araba/Álava;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
01 Araba/Álava;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
01 Araba/Álava;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
01 Araba/Álava;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
01 Araba/Álava;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
01 Araba/Álava;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QI;929
01 Araba/Álava;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
01 Araba/Álava;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
01 Araba/Álava;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
01 Araba/Álava;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QI;891
01 Araba/Álava;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
01 Araba/Álava;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
01 Araba/Álava;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
01 Araba/Álava;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QI;1.059
01 Araba/Álava;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
01 Araba/Álava;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
01 Araba/Álava;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2022QII;""
01 Araba/Álava;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2022QI;904
01 Araba/Álava;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
01 Araba/Álava;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
01 Araba/Álava;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2021QII;""
01 Araba/Álava;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2021QI;849
01 Araba/Álava;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
01 Araba/Álava;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
01 Araba/Álava;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2020QII;""
01 Araba/Álava;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2020QI;995
01 Araba/Álava;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
01 Araba/Álava;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
01 Araba/Álava;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2022QII;862
01 Araba/Álava;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2022QI;""
01 Araba/Álava;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
01 Araba/Álava;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
01 Araba/Álava;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2021QII;816
01 Araba/Álava;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2021QI;""
01 Araba/Álava;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
01 Araba/Álava;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
01 Araba/Álava;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2020QII;959
01 Araba/Álava;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2020QI;""
01 Araba/Álava;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
01 Araba/Álava;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QIII;827
01 Araba/Álava;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QII;""
01 Araba/Álava;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QI;""
01 Araba/Álava;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
01 Araba/Álava;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QIII;780
01 Araba/Álava;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QII;""
01 Araba/Álava;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QI;""
01 Araba/Álava;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
01 Araba/Álava;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QIII;922
01 Araba/Álava;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QII;""
01 Araba/Álava;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QI;""
01 Araba/Álava;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QIV;772
01 Araba/Álava;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
01 Araba/Álava;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QII;""
01 Araba/Álava;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QI;""
01 Araba/Álava;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QIV;733
01 Araba/Álava;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
01 Araba/Álava;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QII;""
01 Araba/Álava;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QI;""
01 Araba/Álava;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QIV;859
01 Araba/Álava;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
01 Araba/Álava;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QII;""
01 Araba/Álava;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QI;""
01 Araba/Álava;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
01 Araba/Álava;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
01 Araba/Álava;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
01 Araba/Álava;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
01 Araba/Álava;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
01 Araba/Álava;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
01 Araba/Álava;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
01 Araba/Álava;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
01 Araba/Álava;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
01 Araba/Álava;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
01 Araba/Álava;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
01 Araba/Álava;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
01 Araba/Álava;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
01 Araba/Álava;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
01 Araba/Álava;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
01 Araba/Álava;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;97,31
01 Araba/Álava;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
01 Araba/Álava;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
01 Araba/Álava;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
01 Araba/Álava;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;95,29
01 Araba/Álava;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
01 Araba/Álava;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
01 Araba/Álava;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
01 Araba/Álava;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;93,96
01 Araba/Álava;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
01 Araba/Álava;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
01 Araba/Álava;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;92,79
01 Araba/Álava;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
01 Araba/Álava;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
01 Araba/Álava;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
01 Araba/Álava;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;91,58
01 Araba/Álava;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
01 Araba/Álava;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
01 Araba/Álava;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
01 Araba/Álava;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;90,56
01 Araba/Álava;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
01 Araba/Álava;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
01 Araba/Álava;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;89,02
01 Araba/Álava;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
01 Araba/Álava;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
01 Araba/Álava;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
01 Araba/Álava;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;87,54
01 Araba/Álava;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
01 Araba/Álava;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
01 Araba/Álava;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
01 Araba/Álava;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;87,06
01 Araba/Álava;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
01 Araba/Álava;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
01 Araba/Álava;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;83,1
01 Araba/Álava;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
01 Araba/Álava;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
01 Araba/Álava;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
01 Araba/Álava;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;82,27
01 Araba/Álava;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
01 Araba/Álava;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
01 Araba/Álava;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
01 Araba/Álava;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;81,11
01 Araba/Álava;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
01 Araba/Álava;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
01 Araba/Álava;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
01 Araba/Álava;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
01 Araba/Álava;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
01 Araba/Álava;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QII;3.216
01 Araba/Álava;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
01 Araba/Álava;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
01 Araba/Álava;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
01 Araba/Álava;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QII;3.047
01 Araba/Álava;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
01 Araba/Álava;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
01 Araba/Álava;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
01 Araba/Álava;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QII;2.945
01 Araba/Álava;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
01 Araba/Álava;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
01 Araba/Álava;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
01 Araba/Álava;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2022QII;3.091
01 Araba/Álava;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2022QI;""
01 Araba/Álava;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
01 Araba/Álava;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
01 Araba/Álava;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2021QII;2.944
01 Araba/Álava;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2021QI;""
01 Araba/Álava;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
01 Araba/Álava;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
01 Araba/Álava;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2020QII;2.856
01 Araba/Álava;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2020QI;""
01 Araba/Álava;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
01 Araba/Álava;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2022QIII;2.994
01 Araba/Álava;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2022QII;""
01 Araba/Álava;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2022QI;""
01 Araba/Álava;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
01 Araba/Álava;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2021QIII;2.844
01 Araba/Álava;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2021QII;""
01 Araba/Álava;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2021QI;""
01 Araba/Álava;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
01 Araba/Álava;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2020QIII;2.747
01 Araba/Álava;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2020QII;""
01 Araba/Álava;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2020QI;""
01 Araba/Álava;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QIV;2.818
01 Araba/Álava;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
01 Araba/Álava;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QII;""
01 Araba/Álava;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QI;""
01 Araba/Álava;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QIV;2.706
01 Araba/Álava;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
01 Araba/Álava;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QII;""
01 Araba/Álava;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QI;""
01 Araba/Álava;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QIV;2.580
01 Araba/Álava;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
01 Araba/Álava;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QII;""
01 Araba/Álava;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QI;""
01 Araba/Álava;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
01 Araba/Álava;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
01 Araba/Álava;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QII;""
01 Araba/Álava;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QI;2.628
01 Araba/Álava;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
01 Araba/Álava;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
01 Araba/Álava;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QII;""
01 Araba/Álava;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QI;2.469
01 Araba/Álava;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
01 Araba/Álava;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
01 Araba/Álava;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QII;""
01 Araba/Álava;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QI;""
01 Araba/Álava;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
01 Araba/Álava;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
01 Araba/Álava;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
01 Araba/Álava;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
01 Araba/Álava;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
01 Araba/Álava;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
01 Araba/Álava;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
01 Araba/Álava;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
01 Araba/Álava;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
01 Araba/Álava;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
01 Araba/Álava;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
01 Araba/Álava;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
01 Araba/Álava;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
01 Araba/Álava;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
01 Araba/Álava;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;96,11
01 Araba/Álava;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
01 Araba/Álava;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
01 Araba/Álava;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
01 Araba/Álava;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;96,62
01 Araba/Álava;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
01 Araba/Álava;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
01 Araba/Álava;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
01 Araba/Álava;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;96,98
01 Araba/Álava;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
01 Araba/Álava;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
01 Araba/Álava;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;93,1
01 Araba/Álava;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
01 Araba/Álava;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
01 Araba/Álava;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
01 Araba/Álava;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;93,34
01 Araba/Álava;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
01 Araba/Álava;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
01 Araba/Álava;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
01 Araba/Álava;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;93,28
01 Araba/Álava;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
01 Araba/Álava;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
01 Araba/Álava;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;87,62
01 Araba/Álava;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
01 Araba/Álava;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
01 Araba/Álava;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
01 Araba/Álava;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;88,81
01 Araba/Álava;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
01 Araba/Álava;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
01 Araba/Álava;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
01 Araba/Álava;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;87,61
01 Araba/Álava;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
01 Araba/Álava;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
01 Araba/Álava;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
01 Araba/Álava;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
01 Araba/Álava;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
01 Araba/Álava;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
01 Araba/Álava;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;86,25
01 Araba/Álava;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
01 Araba/Álava;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
01 Araba/Álava;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
01 Araba/Álava;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;83,84
01 Araba/Álava;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
01 Araba/Álava;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
01 Araba/Álava;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
01 Araba/Álava;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
01 Araba/Álava;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
01 Araba/Álava;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
01 Araba/Álava;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QII;2.140
01 Araba/Álava;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
01 Araba/Álava;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
01 Araba/Álava;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
01 Araba/Álava;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QII;2.015
01 Araba/Álava;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
01 Araba/Álava;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
01 Araba/Álava;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
01 Araba/Álava;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QII;1.933
01 Araba/Álava;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
01 Araba/Álava;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
01 Araba/Álava;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
01 Araba/Álava;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2022QII;2.062
01 Araba/Álava;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2022QI;""
01 Araba/Álava;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
01 Araba/Álava;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
01 Araba/Álava;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2021QII;1.952
01 Araba/Álava;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2021QI;""
01 Araba/Álava;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
01 Araba/Álava;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
01 Araba/Álava;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2020QII;1.882
01 Araba/Álava;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2020QI;""
01 Araba/Álava;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
01 Araba/Álava;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2022QIII;2.004
01 Araba/Álava;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2022QII;""
01 Araba/Álava;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2022QI;""
01 Araba/Álava;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
01 Araba/Álava;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2021QIII;1.889
01 Araba/Álava;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2021QII;""
01 Araba/Álava;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2021QI;""
01 Araba/Álava;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
01 Araba/Álava;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2020QIII;1.811
01 Araba/Álava;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2020QII;""
01 Araba/Álava;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2020QI;""
01 Araba/Álava;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QIV;1.886
01 Araba/Álava;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
01 Araba/Álava;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QII;""
01 Araba/Álava;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QI;""
01 Araba/Álava;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QIV;1.802
01 Araba/Álava;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
01 Araba/Álava;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QII;""
01 Araba/Álava;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QI;""
01 Araba/Álava;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QIV;1.707
01 Araba/Álava;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
01 Araba/Álava;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QII;""
01 Araba/Álava;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QI;""
01 Araba/Álava;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
01 Araba/Álava;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
01 Araba/Álava;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QII;""
01 Araba/Álava;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QI;1.745
01 Araba/Álava;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
01 Araba/Álava;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
01 Araba/Álava;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QII;""
01 Araba/Álava;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QI;1.637
01 Araba/Álava;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
01 Araba/Álava;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
01 Araba/Álava;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QII;""
01 Araba/Álava;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QI;""
01 Araba/Álava;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
01 Araba/Álava;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
01 Araba/Álava;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
01 Araba/Álava;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
01 Araba/Álava;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
01 Araba/Álava;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
01 Araba/Álava;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
01 Araba/Álava;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
01 Araba/Álava;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
01 Araba/Álava;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
01 Araba/Álava;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
01 Araba/Álava;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
01 Araba/Álava;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
01 Araba/Álava;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
01 Araba/Álava;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;96,36
01 Araba/Álava;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
01 Araba/Álava;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
01 Araba/Álava;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
01 Araba/Álava;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;96,87
01 Araba/Álava;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
01 Araba/Álava;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
01 Araba/Álava;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
01 Araba/Álava;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;97,36
01 Araba/Álava;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
01 Araba/Álava;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
01 Araba/Álava;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;93,64
01 Araba/Álava;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
01 Araba/Álava;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
01 Araba/Álava;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
01 Araba/Álava;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;93,75
01 Araba/Álava;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
01 Araba/Álava;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
01 Araba/Álava;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
01 Araba/Álava;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;93,69
01 Araba/Álava;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
01 Araba/Álava;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
01 Araba/Álava;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;88,13
01 Araba/Álava;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
01 Araba/Álava;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
01 Araba/Álava;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
01 Araba/Álava;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;89,43
01 Araba/Álava;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
01 Araba/Álava;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
01 Araba/Álava;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
01 Araba/Álava;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;88,31
01 Araba/Álava;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
01 Araba/Álava;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
01 Araba/Álava;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
01 Araba/Álava;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
01 Araba/Álava;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
01 Araba/Álava;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
01 Araba/Álava;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;86,6
01 Araba/Álava;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
01 Araba/Álava;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
01 Araba/Álava;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
01 Araba/Álava;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;84,69
01 Araba/Álava;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
01 Araba/Álava;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
01 Araba/Álava;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
01 Araba/Álava;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
01 Araba/Álava;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
01 Araba/Álava;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
01 Araba/Álava;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QII;1.076
01 Araba/Álava;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
01 Araba/Álava;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
01 Araba/Álava;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
01 Araba/Álava;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QII;1.032
01 Araba/Álava;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
01 Araba/Álava;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
01 Araba/Álava;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
01 Araba/Álava;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QII;1.012
01 Araba/Álava;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
01 Araba/Álava;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
01 Araba/Álava;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
01 Araba/Álava;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2022QII;1.029
01 Araba/Álava;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2022QI;""
01 Araba/Álava;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
01 Araba/Álava;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
01 Araba/Álava;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2021QII;992
01 Araba/Álava;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2021QI;""
01 Araba/Álava;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
01 Araba/Álava;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
01 Araba/Álava;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2020QII;974
01 Araba/Álava;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2020QI;""
01 Araba/Álava;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
01 Araba/Álava;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2022QIII;990
01 Araba/Álava;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2022QII;""
01 Araba/Álava;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2022QI;""
01 Araba/Álava;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
01 Araba/Álava;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2021QIII;955
01 Araba/Álava;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2021QII;""
01 Araba/Álava;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2021QI;""
01 Araba/Álava;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
01 Araba/Álava;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2020QIII;936
01 Araba/Álava;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2020QII;""
01 Araba/Álava;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2020QI;""
01 Araba/Álava;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QIV;932
01 Araba/Álava;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
01 Araba/Álava;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QII;""
01 Araba/Álava;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QI;""
01 Araba/Álava;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QIV;904
01 Araba/Álava;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
01 Araba/Álava;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QII;""
01 Araba/Álava;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QI;""
01 Araba/Álava;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QIV;873
01 Araba/Álava;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
01 Araba/Álava;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QII;""
01 Araba/Álava;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QI;""
01 Araba/Álava;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
01 Araba/Álava;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
01 Araba/Álava;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QII;""
01 Araba/Álava;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QI;883
01 Araba/Álava;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
01 Araba/Álava;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
01 Araba/Álava;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QII;""
01 Araba/Álava;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QI;832
01 Araba/Álava;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
01 Araba/Álava;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
01 Araba/Álava;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QII;""
01 Araba/Álava;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QI;""
01 Araba/Álava;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
01 Araba/Álava;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
01 Araba/Álava;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
01 Araba/Álava;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
01 Araba/Álava;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
01 Araba/Álava;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
01 Araba/Álava;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
01 Araba/Álava;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
01 Araba/Álava;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
01 Araba/Álava;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
01 Araba/Álava;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
01 Araba/Álava;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
01 Araba/Álava;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
01 Araba/Álava;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
01 Araba/Álava;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;95,63
01 Araba/Álava;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
01 Araba/Álava;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
01 Araba/Álava;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
01 Araba/Álava;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;96,12
01 Araba/Álava;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
01 Araba/Álava;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
01 Araba/Álava;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
01 Araba/Álava;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;96,25
01 Araba/Álava;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
01 Araba/Álava;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
01 Araba/Álava;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;92,01
01 Araba/Álava;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
01 Araba/Álava;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
01 Araba/Álava;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
01 Araba/Álava;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;92,54
01 Araba/Álava;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
01 Araba/Álava;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
01 Araba/Álava;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
01 Araba/Álava;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;92,49
01 Araba/Álava;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
01 Araba/Álava;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
01 Araba/Álava;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;86,62
01 Araba/Álava;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
01 Araba/Álava;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
01 Araba/Álava;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
01 Araba/Álava;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;87,6
01 Araba/Álava;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
01 Araba/Álava;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
01 Araba/Álava;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
01 Araba/Álava;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;86,26
01 Araba/Álava;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
01 Araba/Álava;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
01 Araba/Álava;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
01 Araba/Álava;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
01 Araba/Álava;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
01 Araba/Álava;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
01 Araba/Álava;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;85,56
01 Araba/Álava;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
01 Araba/Álava;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
01 Araba/Álava;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
01 Araba/Álava;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;82,21
01 Araba/Álava;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
01 Araba/Álava;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
01 Araba/Álava;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
01 Araba/Álava;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
01 Araba/Álava;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
01 Araba/Álava;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QIII;3.108
01 Araba/Álava;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
01 Araba/Álava;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
01 Araba/Álava;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
01 Araba/Álava;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QIII;2.973
01 Araba/Álava;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
01 Araba/Álava;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
01 Araba/Álava;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
01 Araba/Álava;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QIII;2.868
01 Araba/Álava;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
01 Araba/Álava;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
01 Araba/Álava;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
01 Araba/Álava;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2022QIII;3.010
01 Araba/Álava;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2022QII;""
01 Araba/Álava;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2022QI;""
01 Araba/Álava;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
01 Araba/Álava;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2021QIII;2.868
01 Araba/Álava;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2021QII;""
01 Araba/Álava;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2021QI;""
01 Araba/Álava;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
01 Araba/Álava;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2020QIII;2.758
01 Araba/Álava;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2020QII;""
01 Araba/Álava;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2020QI;""
01 Araba/Álava;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2022QIV;2.831
01 Araba/Álava;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
01 Araba/Álava;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2022QII;""
01 Araba/Álava;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2022QI;""
01 Araba/Álava;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2021QIV;2.726
01 Araba/Álava;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
01 Araba/Álava;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2021QII;""
01 Araba/Álava;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2021QI;""
01 Araba/Álava;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2020QIV;2.589
01 Araba/Álava;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
01 Araba/Álava;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2020QII;""
01 Araba/Álava;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2020QI;""
01 Araba/Álava;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
01 Araba/Álava;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
01 Araba/Álava;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QII;""
01 Araba/Álava;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QI;2.646
01 Araba/Álava;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
01 Araba/Álava;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
01 Araba/Álava;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QII;""
01 Araba/Álava;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QI;2.477
01 Araba/Álava;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
01 Araba/Álava;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
01 Araba/Álava;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QII;""
01 Araba/Álava;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QI;""
01 Araba/Álava;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
01 Araba/Álava;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
01 Araba/Álava;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QII;2.541
01 Araba/Álava;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QI;""
01 Araba/Álava;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
01 Araba/Álava;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
01 Araba/Álava;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QII;2.394
01 Araba/Álava;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QI;""
01 Araba/Álava;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
01 Araba/Álava;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
01 Araba/Álava;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QII;""
01 Araba/Álava;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QI;""
01 Araba/Álava;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
01 Araba/Álava;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
01 Araba/Álava;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
01 Araba/Álava;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
01 Araba/Álava;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
01 Araba/Álava;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
01 Araba/Álava;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
01 Araba/Álava;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
01 Araba/Álava;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
01 Araba/Álava;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
01 Araba/Álava;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
01 Araba/Álava;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
01 Araba/Álava;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
01 Araba/Álava;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;96,85
01 Araba/Álava;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
01 Araba/Álava;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
01 Araba/Álava;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
01 Araba/Álava;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;96,47
01 Araba/Álava;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
01 Araba/Álava;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
01 Araba/Álava;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
01 Araba/Álava;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;96,16
01 Araba/Álava;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
01 Araba/Álava;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
01 Araba/Álava;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;91,09
01 Araba/Álava;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
01 Araba/Álava;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
01 Araba/Álava;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
01 Araba/Álava;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;91,69
01 Araba/Álava;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
01 Araba/Álava;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
01 Araba/Álava;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
01 Araba/Álava;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;90,27
01 Araba/Álava;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
01 Araba/Álava;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
01 Araba/Álava;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
01 Araba/Álava;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
01 Araba/Álava;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
01 Araba/Álava;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
01 Araba/Álava;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;89
01 Araba/Álava;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
01 Araba/Álava;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
01 Araba/Álava;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
01 Araba/Álava;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;86,37
01 Araba/Álava;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
01 Araba/Álava;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
01 Araba/Álava;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
01 Araba/Álava;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
01 Araba/Álava;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
01 Araba/Álava;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
01 Araba/Álava;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;85,47
01 Araba/Álava;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
01 Araba/Álava;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
01 Araba/Álava;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
01 Araba/Álava;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;83,47
01 Araba/Álava;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
01 Araba/Álava;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
01 Araba/Álava;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
01 Araba/Álava;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
01 Araba/Álava;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
01 Araba/Álava;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
01 Araba/Álava;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QIII;2.072
01 Araba/Álava;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
01 Araba/Álava;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
01 Araba/Álava;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
01 Araba/Álava;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QIII;1.967
01 Araba/Álava;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
01 Araba/Álava;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
01 Araba/Álava;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
01 Araba/Álava;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QIII;1.890
01 Araba/Álava;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
01 Araba/Álava;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
01 Araba/Álava;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
01 Araba/Álava;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2022QIII;2.013
01 Araba/Álava;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2022QII;""
01 Araba/Álava;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2022QI;""
01 Araba/Álava;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
01 Araba/Álava;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2021QIII;1.904
01 Araba/Álava;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2021QII;""
01 Araba/Álava;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2021QI;""
01 Araba/Álava;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
01 Araba/Álava;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2020QIII;1.819
01 Araba/Álava;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2020QII;""
01 Araba/Álava;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2020QI;""
01 Araba/Álava;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2022QIV;1.894
01 Araba/Álava;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
01 Araba/Álava;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2022QII;""
01 Araba/Álava;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2022QI;""
01 Araba/Álava;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2021QIV;1.814
01 Araba/Álava;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
01 Araba/Álava;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2021QII;""
01 Araba/Álava;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2021QI;""
01 Araba/Álava;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2020QIV;1.714
01 Araba/Álava;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
01 Araba/Álava;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2020QII;""
01 Araba/Álava;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2020QI;""
01 Araba/Álava;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
01 Araba/Álava;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
01 Araba/Álava;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QII;""
01 Araba/Álava;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QI;1.756
01 Araba/Álava;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
01 Araba/Álava;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
01 Araba/Álava;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QII;""
01 Araba/Álava;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QI;1.643
01 Araba/Álava;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
01 Araba/Álava;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
01 Araba/Álava;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QII;""
01 Araba/Álava;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QI;""
01 Araba/Álava;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
01 Araba/Álava;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
01 Araba/Álava;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QII;1.689
01 Araba/Álava;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QI;""
01 Araba/Álava;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
01 Araba/Álava;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
01 Araba/Álava;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QII;1.587
01 Araba/Álava;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QI;""
01 Araba/Álava;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
01 Araba/Álava;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
01 Araba/Álava;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QII;""
01 Araba/Álava;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QI;""
01 Araba/Álava;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
01 Araba/Álava;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
01 Araba/Álava;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
01 Araba/Álava;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
01 Araba/Álava;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
01 Araba/Álava;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
01 Araba/Álava;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
01 Araba/Álava;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
01 Araba/Álava;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
01 Araba/Álava;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
01 Araba/Álava;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
01 Araba/Álava;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
01 Araba/Álava;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
01 Araba/Álava;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;97,15
01 Araba/Álava;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
01 Araba/Álava;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
01 Araba/Álava;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
01 Araba/Álava;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;96,8
01 Araba/Álava;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
01 Araba/Álava;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
01 Araba/Álava;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
01 Araba/Álava;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;96,24
01 Araba/Álava;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
01 Araba/Álava;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
01 Araba/Álava;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;91,41
01 Araba/Álava;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
01 Araba/Álava;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
01 Araba/Álava;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
01 Araba/Álava;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;92,22
01 Araba/Álava;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
01 Araba/Álava;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
01 Araba/Álava;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
01 Araba/Álava;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;90,69
01 Araba/Álava;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
01 Araba/Álava;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
01 Araba/Álava;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
01 Araba/Álava;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
01 Araba/Álava;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
01 Araba/Álava;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
01 Araba/Álava;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;89,27
01 Araba/Álava;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
01 Araba/Álava;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
01 Araba/Álava;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
01 Araba/Álava;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;86,93
01 Araba/Álava;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
01 Araba/Álava;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
01 Araba/Álava;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
01 Araba/Álava;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
01 Araba/Álava;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
01 Araba/Álava;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
01 Araba/Álava;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;85,87
01 Araba/Álava;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
01 Araba/Álava;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
01 Araba/Álava;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
01 Araba/Álava;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;83,97
01 Araba/Álava;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
01 Araba/Álava;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
01 Araba/Álava;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
01 Araba/Álava;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
01 Araba/Álava;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
01 Araba/Álava;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
01 Araba/Álava;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QIII;1.036
01 Araba/Álava;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
01 Araba/Álava;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
01 Araba/Álava;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
01 Araba/Álava;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QIII;1.006
01 Araba/Álava;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
01 Araba/Álava;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
01 Araba/Álava;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
01 Araba/Álava;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QIII;978
01 Araba/Álava;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
01 Araba/Álava;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
01 Araba/Álava;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
01 Araba/Álava;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2022QIII;997
01 Araba/Álava;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2022QII;""
01 Araba/Álava;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2022QI;""
01 Araba/Álava;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
01 Araba/Álava;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2021QIII;964
01 Araba/Álava;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2021QII;""
01 Araba/Álava;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2021QI;""
01 Araba/Álava;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
01 Araba/Álava;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2020QIII;939
01 Araba/Álava;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2020QII;""
01 Araba/Álava;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2020QI;""
01 Araba/Álava;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2022QIV;937
01 Araba/Álava;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
01 Araba/Álava;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2022QII;""
01 Araba/Álava;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2022QI;""
01 Araba/Álava;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2021QIV;912
01 Araba/Álava;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
01 Araba/Álava;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2021QII;""
01 Araba/Álava;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2021QI;""
01 Araba/Álava;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2020QIV;875
01 Araba/Álava;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
01 Araba/Álava;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2020QII;""
01 Araba/Álava;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2020QI;""
01 Araba/Álava;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
01 Araba/Álava;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
01 Araba/Álava;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QII;""
01 Araba/Álava;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QI;890
01 Araba/Álava;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
01 Araba/Álava;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
01 Araba/Álava;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QII;""
01 Araba/Álava;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QI;834
01 Araba/Álava;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
01 Araba/Álava;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
01 Araba/Álava;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QII;""
01 Araba/Álava;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QI;""
01 Araba/Álava;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
01 Araba/Álava;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
01 Araba/Álava;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QII;852
01 Araba/Álava;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QI;""
01 Araba/Álava;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
01 Araba/Álava;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
01 Araba/Álava;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QII;807
01 Araba/Álava;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QI;""
01 Araba/Álava;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
01 Araba/Álava;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
01 Araba/Álava;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QII;""
01 Araba/Álava;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QI;""
01 Araba/Álava;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
01 Araba/Álava;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
01 Araba/Álava;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
01 Araba/Álava;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
01 Araba/Álava;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
01 Araba/Álava;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
01 Araba/Álava;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
01 Araba/Álava;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
01 Araba/Álava;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
01 Araba/Álava;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
01 Araba/Álava;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
01 Araba/Álava;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
01 Araba/Álava;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
01 Araba/Álava;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;96,24
01 Araba/Álava;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
01 Araba/Álava;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
01 Araba/Álava;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
01 Araba/Álava;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;95,83
01 Araba/Álava;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
01 Araba/Álava;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
01 Araba/Álava;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
01 Araba/Álava;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;96,01
01 Araba/Álava;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
01 Araba/Álava;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
01 Araba/Álava;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;90,44
01 Araba/Álava;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
01 Araba/Álava;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
01 Araba/Álava;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
01 Araba/Álava;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;90,66
01 Araba/Álava;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
01 Araba/Álava;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
01 Araba/Álava;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
01 Araba/Álava;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;89,47
01 Araba/Álava;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
01 Araba/Álava;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
01 Araba/Álava;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
01 Araba/Álava;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
01 Araba/Álava;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
01 Araba/Álava;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
01 Araba/Álava;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;88,47
01 Araba/Álava;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
01 Araba/Álava;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
01 Araba/Álava;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
01 Araba/Álava;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;85,28
01 Araba/Álava;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
01 Araba/Álava;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
01 Araba/Álava;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
01 Araba/Álava;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
01 Araba/Álava;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
01 Araba/Álava;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
01 Araba/Álava;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;84,69
01 Araba/Álava;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
01 Araba/Álava;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
01 Araba/Álava;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
01 Araba/Álava;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;82,52
01 Araba/Álava;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
01 Araba/Álava;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
01 Araba/Álava;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
01 Araba/Álava;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
01 Araba/Álava;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
01 Araba/Álava;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QIV;3.030
01 Araba/Álava;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
01 Araba/Álava;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
01 Araba/Álava;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
01 Araba/Álava;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QIV;2.887
01 Araba/Álava;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
01 Araba/Álava;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
01 Araba/Álava;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
01 Araba/Álava;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QIV;2.776
01 Araba/Álava;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
01 Araba/Álava;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
01 Araba/Álava;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
01 Araba/Álava;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2022QIV;2.847
01 Araba/Álava;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
01 Araba/Álava;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2022QII;""
01 Araba/Álava;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2022QI;""
01 Araba/Álava;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2021QIV;2.741
01 Araba/Álava;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
01 Araba/Álava;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2021QII;""
01 Araba/Álava;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2021QI;""
01 Araba/Álava;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2020QIV;2.602
01 Araba/Álava;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
01 Araba/Álava;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2020QII;""
01 Araba/Álava;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2020QI;""
01 Araba/Álava;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
01 Araba/Álava;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
01 Araba/Álava;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2022QII;""
01 Araba/Álava;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2022QI;2.659
01 Araba/Álava;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
01 Araba/Álava;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
01 Araba/Álava;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2021QII;""
01 Araba/Álava;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2021QI;2.489
01 Araba/Álava;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
01 Araba/Álava;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
01 Araba/Álava;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2020QII;""
01 Araba/Álava;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2020QI;""
01 Araba/Álava;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
01 Araba/Álava;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
01 Araba/Álava;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QII;2.550
01 Araba/Álava;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QI;""
01 Araba/Álava;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
01 Araba/Álava;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
01 Araba/Álava;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QII;2.402
01 Araba/Álava;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QI;""
01 Araba/Álava;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
01 Araba/Álava;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
01 Araba/Álava;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QII;""
01 Araba/Álava;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QI;""
01 Araba/Álava;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
01 Araba/Álava;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QIII;2.462
01 Araba/Álava;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QII;""
01 Araba/Álava;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QI;""
01 Araba/Álava;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
01 Araba/Álava;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QIII;2.311
01 Araba/Álava;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QII;""
01 Araba/Álava;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QI;""
01 Araba/Álava;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
01 Araba/Álava;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
01 Araba/Álava;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QII;""
01 Araba/Álava;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QI;""
01 Araba/Álava;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
01 Araba/Álava;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
01 Araba/Álava;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
01 Araba/Álava;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
01 Araba/Álava;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
01 Araba/Álava;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
01 Araba/Álava;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
01 Araba/Álava;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
01 Araba/Álava;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
01 Araba/Álava;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
01 Araba/Álava;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
01 Araba/Álava;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
01 Araba/Álava;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;93,96
01 Araba/Álava;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
01 Araba/Álava;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
01 Araba/Álava;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
01 Araba/Álava;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;94,94
01 Araba/Álava;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
01 Araba/Álava;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
01 Araba/Álava;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
01 Araba/Álava;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;93,73
01 Araba/Álava;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
01 Araba/Álava;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
01 Araba/Álava;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
01 Araba/Álava;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
01 Araba/Álava;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
01 Araba/Álava;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
01 Araba/Álava;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;92,1
01 Araba/Álava;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
01 Araba/Álava;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
01 Araba/Álava;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
01 Araba/Álava;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;89,66
01 Araba/Álava;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
01 Araba/Álava;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
01 Araba/Álava;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
01 Araba/Álava;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
01 Araba/Álava;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
01 Araba/Álava;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
01 Araba/Álava;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;88,33
01 Araba/Álava;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
01 Araba/Álava;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
01 Araba/Álava;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
01 Araba/Álava;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;86,53
01 Araba/Álava;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
01 Araba/Álava;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
01 Araba/Álava;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
01 Araba/Álava;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
01 Araba/Álava;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
01 Araba/Álava;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
01 Araba/Álava;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;85,28
01 Araba/Álava;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
01 Araba/Álava;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
01 Araba/Álava;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
01 Araba/Álava;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;83,25
01 Araba/Álava;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
01 Araba/Álava;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
01 Araba/Álava;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
01 Araba/Álava;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
01 Araba/Álava;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
01 Araba/Álava;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
01 Araba/Álava;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QIV;2.025
01 Araba/Álava;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
01 Araba/Álava;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
01 Araba/Álava;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
01 Araba/Álava;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QIV;1.914
01 Araba/Álava;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
01 Araba/Álava;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
01 Araba/Álava;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
01 Araba/Álava;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QIV;1.828
01 Araba/Álava;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
01 Araba/Álava;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
01 Araba/Álava;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
01 Araba/Álava;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2022QIV;1.903
01 Araba/Álava;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
01 Araba/Álava;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2022QII;""
01 Araba/Álava;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2022QI;""
01 Araba/Álava;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2021QIV;1.822
01 Araba/Álava;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
01 Araba/Álava;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2021QII;""
01 Araba/Álava;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2021QI;""
01 Araba/Álava;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2020QIV;1.720
01 Araba/Álava;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
01 Araba/Álava;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2020QII;""
01 Araba/Álava;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2020QI;""
01 Araba/Álava;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
01 Araba/Álava;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
01 Araba/Álava;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2022QII;""
01 Araba/Álava;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2022QI;1.764
01 Araba/Álava;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
01 Araba/Álava;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
01 Araba/Álava;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2021QII;""
01 Araba/Álava;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2021QI;1.648
01 Araba/Álava;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
01 Araba/Álava;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
01 Araba/Álava;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2020QII;""
01 Araba/Álava;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2020QI;""
01 Araba/Álava;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
01 Araba/Álava;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
01 Araba/Álava;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QII;1.694
01 Araba/Álava;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QI;""
01 Araba/Álava;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
01 Araba/Álava;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
01 Araba/Álava;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QII;1.591
01 Araba/Álava;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QI;""
01 Araba/Álava;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
01 Araba/Álava;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
01 Araba/Álava;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QII;""
01 Araba/Álava;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QI;""
01 Araba/Álava;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
01 Araba/Álava;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QIII;1.641
01 Araba/Álava;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QII;""
01 Araba/Álava;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QI;""
01 Araba/Álava;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
01 Araba/Álava;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QIII;1.535
01 Araba/Álava;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QII;""
01 Araba/Álava;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QI;""
01 Araba/Álava;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
01 Araba/Álava;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
01 Araba/Álava;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QII;""
01 Araba/Álava;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QI;""
01 Araba/Álava;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
01 Araba/Álava;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
01 Araba/Álava;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
01 Araba/Álava;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
01 Araba/Álava;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
01 Araba/Álava;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
01 Araba/Álava;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
01 Araba/Álava;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
01 Araba/Álava;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
01 Araba/Álava;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
01 Araba/Álava;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
01 Araba/Álava;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
01 Araba/Álava;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;93,98
01 Araba/Álava;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
01 Araba/Álava;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
01 Araba/Álava;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
01 Araba/Álava;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;95,19
01 Araba/Álava;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
01 Araba/Álava;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
01 Araba/Álava;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
01 Araba/Álava;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;94,09
01 Araba/Álava;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
01 Araba/Álava;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
01 Araba/Álava;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
01 Araba/Álava;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
01 Araba/Álava;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
01 Araba/Álava;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
01 Araba/Álava;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;92,16
01 Araba/Álava;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
01 Araba/Álava;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
01 Araba/Álava;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
01 Araba/Álava;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;90,15
01 Araba/Álava;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
01 Araba/Álava;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
01 Araba/Álava;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
01 Araba/Álava;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
01 Araba/Álava;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
01 Araba/Álava;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
01 Araba/Álava;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;88,51
01 Araba/Álava;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
01 Araba/Álava;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
01 Araba/Álava;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
01 Araba/Álava;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;87,04
01 Araba/Álava;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
01 Araba/Álava;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
01 Araba/Álava;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
01 Araba/Álava;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
01 Araba/Álava;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
01 Araba/Álava;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
01 Araba/Álava;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;85,74
01 Araba/Álava;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
01 Araba/Álava;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
01 Araba/Álava;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
01 Araba/Álava;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;83,97
01 Araba/Álava;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
01 Araba/Álava;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
01 Araba/Álava;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
01 Araba/Álava;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
01 Araba/Álava;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
01 Araba/Álava;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
01 Araba/Álava;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QIV;1.005
01 Araba/Álava;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
01 Araba/Álava;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
01 Araba/Álava;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
01 Araba/Álava;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QIV;973
01 Araba/Álava;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
01 Araba/Álava;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
01 Araba/Álava;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
01 Araba/Álava;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QIV;948
01 Araba/Álava;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
01 Araba/Álava;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
01 Araba/Álava;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
01 Araba/Álava;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2022QIV;944
01 Araba/Álava;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
01 Araba/Álava;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2022QII;""
01 Araba/Álava;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2022QI;""
01 Araba/Álava;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2021QIV;919
01 Araba/Álava;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
01 Araba/Álava;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2021QII;""
01 Araba/Álava;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2021QI;""
01 Araba/Álava;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2020QIV;882
01 Araba/Álava;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
01 Araba/Álava;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2020QII;""
01 Araba/Álava;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2020QI;""
01 Araba/Álava;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
01 Araba/Álava;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
01 Araba/Álava;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2022QII;""
01 Araba/Álava;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2022QI;895
01 Araba/Álava;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
01 Araba/Álava;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
01 Araba/Álava;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2021QII;""
01 Araba/Álava;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2021QI;841
01 Araba/Álava;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
01 Araba/Álava;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
01 Araba/Álava;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2020QII;""
01 Araba/Álava;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2020QI;""
01 Araba/Álava;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
01 Araba/Álava;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
01 Araba/Álava;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QII;856
01 Araba/Álava;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QI;""
01 Araba/Álava;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
01 Araba/Álava;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
01 Araba/Álava;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QII;811
01 Araba/Álava;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QI;""
01 Araba/Álava;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
01 Araba/Álava;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
01 Araba/Álava;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QII;""
01 Araba/Álava;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QI;""
01 Araba/Álava;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
01 Araba/Álava;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QIII;821
01 Araba/Álava;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QII;""
01 Araba/Álava;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QI;""
01 Araba/Álava;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
01 Araba/Álava;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QIII;776
01 Araba/Álava;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QII;""
01 Araba/Álava;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QI;""
01 Araba/Álava;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
01 Araba/Álava;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
01 Araba/Álava;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QII;""
01 Araba/Álava;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QI;""
01 Araba/Álava;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
01 Araba/Álava;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
01 Araba/Álava;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
01 Araba/Álava;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
01 Araba/Álava;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
01 Araba/Álava;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
01 Araba/Álava;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
01 Araba/Álava;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
01 Araba/Álava;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
01 Araba/Álava;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
01 Araba/Álava;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
01 Araba/Álava;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
01 Araba/Álava;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;93,93
01 Araba/Álava;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
01 Araba/Álava;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
01 Araba/Álava;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
01 Araba/Álava;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;94,45
01 Araba/Álava;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
01 Araba/Álava;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
01 Araba/Álava;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
01 Araba/Álava;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;93,04
01 Araba/Álava;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
01 Araba/Álava;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
01 Araba/Álava;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
01 Araba/Álava;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
01 Araba/Álava;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
01 Araba/Álava;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
01 Araba/Álava;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;91,98
01 Araba/Álava;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
01 Araba/Álava;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
01 Araba/Álava;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
01 Araba/Álava;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;88,71
01 Araba/Álava;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
01 Araba/Álava;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
01 Araba/Álava;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
01 Araba/Álava;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
01 Araba/Álava;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
01 Araba/Álava;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
01 Araba/Álava;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;87,98
01 Araba/Álava;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
01 Araba/Álava;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
01 Araba/Álava;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
01 Araba/Álava;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;85,55
01 Araba/Álava;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
01 Araba/Álava;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
01 Araba/Álava;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
01 Araba/Álava;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
01 Araba/Álava;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
01 Araba/Álava;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
01 Araba/Álava;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;84,38
01 Araba/Álava;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
01 Araba/Álava;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
01 Araba/Álava;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
01 Araba/Álava;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;81,86
01 Araba/Álava;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
01 Araba/Álava;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
01 Araba/Álava;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
01 Araba/Álava;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
01 Araba/Álava;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
01 Araba/Álava;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
33 Asturias;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
33 Asturias;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
33 Asturias;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
33 Asturias;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QI;63.454
33 Asturias;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
33 Asturias;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
33 Asturias;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
33 Asturias;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QI;63.205
33 Asturias;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
33 Asturias;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
33 Asturias;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
33 Asturias;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QI;64.351
33 Asturias;All ages;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
33 Asturias;All ages;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
33 Asturias;All ages;Cohort January 1;Total;Survival in the first trimester;2022QII;""
33 Asturias;All ages;Cohort January 1;Total;Survival in the first trimester;2022QI;61.710
33 Asturias;All ages;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
33 Asturias;All ages;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
33 Asturias;All ages;Cohort January 1;Total;Survival in the first trimester;2021QII;""
33 Asturias;All ages;Cohort January 1;Total;Survival in the first trimester;2021QI;61.792
33 Asturias;All ages;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
33 Asturias;All ages;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
33 Asturias;All ages;Cohort January 1;Total;Survival in the first trimester;2020QII;""
33 Asturias;All ages;Cohort January 1;Total;Survival in the first trimester;2020QI;60.846
33 Asturias;All ages;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
33 Asturias;All ages;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
33 Asturias;All ages;Cohort January 1;Total;Survival in the second trimester;2022QII;59.892
33 Asturias;All ages;Cohort January 1;Total;Survival in the second trimester;2022QI;""
33 Asturias;All ages;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
33 Asturias;All ages;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
33 Asturias;All ages;Cohort January 1;Total;Survival in the second trimester;2021QII;60.207
33 Asturias;All ages;Cohort January 1;Total;Survival in the second trimester;2021QI;""
33 Asturias;All ages;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
33 Asturias;All ages;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
33 Asturias;All ages;Cohort January 1;Total;Survival in the second trimester;2020QII;59.721
33 Asturias;All ages;Cohort January 1;Total;Survival in the second trimester;2020QI;""
33 Asturias;All ages;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
33 Asturias;All ages;Cohort January 1;Total;Survival in the third trimester;2022QIII;58.290
33 Asturias;All ages;Cohort January 1;Total;Survival in the third trimester;2022QII;""
33 Asturias;All ages;Cohort January 1;Total;Survival in the third trimester;2022QI;""
33 Asturias;All ages;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
33 Asturias;All ages;Cohort January 1;Total;Survival in the third trimester;2021QIII;58.846
33 Asturias;All ages;Cohort January 1;Total;Survival in the third trimester;2021QII;""
33 Asturias;All ages;Cohort January 1;Total;Survival in the third trimester;2021QI;""
33 Asturias;All ages;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
33 Asturias;All ages;Cohort January 1;Total;Survival in the third trimester;2020QIII;58.359
33 Asturias;All ages;Cohort January 1;Total;Survival in the third trimester;2020QII;""
33 Asturias;All ages;Cohort January 1;Total;Survival in the third trimester;2020QI;""
33 Asturias;All ages;Cohort January 1;Total;Survival in the third trimester;2022QIV;56.334
33 Asturias;All ages;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
33 Asturias;All ages;Cohort January 1;Total;Survival in the third trimester;2022QII;""
33 Asturias;All ages;Cohort January 1;Total;Survival in the third trimester;2022QI;""
33 Asturias;All ages;Cohort January 1;Total;Survival in the third trimester;2021QIV;57.242
33 Asturias;All ages;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
33 Asturias;All ages;Cohort January 1;Total;Survival in the third trimester;2021QII;""
33 Asturias;All ages;Cohort January 1;Total;Survival in the third trimester;2021QI;""
33 Asturias;All ages;Cohort January 1;Total;Survival in the third trimester;2020QIV;56.840
33 Asturias;All ages;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
33 Asturias;All ages;Cohort January 1;Total;Survival in the third trimester;2020QII;""
33 Asturias;All ages;Cohort January 1;Total;Survival in the third trimester;2020QI;""
33 Asturias;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
33 Asturias;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
33 Asturias;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
33 Asturias;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
33 Asturias;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
33 Asturias;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
33 Asturias;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
33 Asturias;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
33 Asturias;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
33 Asturias;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
33 Asturias;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
33 Asturias;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
33 Asturias;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
33 Asturias;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
33 Asturias;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
33 Asturias;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;97,25
33 Asturias;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
33 Asturias;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
33 Asturias;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
33 Asturias;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;97,76
33 Asturias;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
33 Asturias;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
33 Asturias;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
33 Asturias;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;94,55
33 Asturias;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
33 Asturias;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
33 Asturias;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;94,39
33 Asturias;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
33 Asturias;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
33 Asturias;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
33 Asturias;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;95,26
33 Asturias;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
33 Asturias;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
33 Asturias;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
33 Asturias;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;92,81
33 Asturias;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
33 Asturias;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
33 Asturias;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;91,86
33 Asturias;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
33 Asturias;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
33 Asturias;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
33 Asturias;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;93,1
33 Asturias;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
33 Asturias;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
33 Asturias;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
33 Asturias;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;90,69
33 Asturias;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
33 Asturias;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
33 Asturias;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;88,78
33 Asturias;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
33 Asturias;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
33 Asturias;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
33 Asturias;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;90,57
33 Asturias;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
33 Asturias;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
33 Asturias;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
33 Asturias;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;88,33
33 Asturias;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
33 Asturias;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
33 Asturias;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
33 Asturias;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
33 Asturias;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
33 Asturias;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
33 Asturias;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QI;37.970
33 Asturias;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
33 Asturias;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
33 Asturias;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
33 Asturias;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QI;37.977
33 Asturias;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
33 Asturias;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
33 Asturias;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
33 Asturias;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QI;38.539
33 Asturias;All ages;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
33 Asturias;All ages;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
33 Asturias;All ages;Cohort January 1;Males;Survival in the first trimester;2022QII;""
33 Asturias;All ages;Cohort January 1;Males;Survival in the first trimester;2022QI;36.899
33 Asturias;All ages;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
33 Asturias;All ages;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
33 Asturias;All ages;Cohort January 1;Males;Survival in the first trimester;2021QII;""
33 Asturias;All ages;Cohort January 1;Males;Survival in the first trimester;2021QI;37.125
33 Asturias;All ages;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
33 Asturias;All ages;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
33 Asturias;All ages;Cohort January 1;Males;Survival in the first trimester;2020QII;""
33 Asturias;All ages;Cohort January 1;Males;Survival in the first trimester;2020QI;36.483
33 Asturias;All ages;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
33 Asturias;All ages;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
33 Asturias;All ages;Cohort January 1;Males;Survival in the second trimester;2022QII;35.882
33 Asturias;All ages;Cohort January 1;Males;Survival in the second trimester;2022QI;""
33 Asturias;All ages;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
33 Asturias;All ages;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
33 Asturias;All ages;Cohort January 1;Males;Survival in the second trimester;2021QII;36.205
33 Asturias;All ages;Cohort January 1;Males;Survival in the second trimester;2021QI;""
33 Asturias;All ages;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
33 Asturias;All ages;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
33 Asturias;All ages;Cohort January 1;Males;Survival in the second trimester;2020QII;35.875
33 Asturias;All ages;Cohort January 1;Males;Survival in the second trimester;2020QI;""
33 Asturias;All ages;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
33 Asturias;All ages;Cohort January 1;Males;Survival in the third trimester;2022QIII;34.987
33 Asturias;All ages;Cohort January 1;Males;Survival in the third trimester;2022QII;""
33 Asturias;All ages;Cohort January 1;Males;Survival in the third trimester;2022QI;""
33 Asturias;All ages;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
33 Asturias;All ages;Cohort January 1;Males;Survival in the third trimester;2021QIII;35.408
33 Asturias;All ages;Cohort January 1;Males;Survival in the third trimester;2021QII;""
33 Asturias;All ages;Cohort January 1;Males;Survival in the third trimester;2021QI;""
33 Asturias;All ages;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
33 Asturias;All ages;Cohort January 1;Males;Survival in the third trimester;2020QIII;35.162
33 Asturias;All ages;Cohort January 1;Males;Survival in the third trimester;2020QII;""
33 Asturias;All ages;Cohort January 1;Males;Survival in the third trimester;2020QI;""
33 Asturias;All ages;Cohort January 1;Males;Survival in the third trimester;2022QIV;33.835
33 Asturias;All ages;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
33 Asturias;All ages;Cohort January 1;Males;Survival in the third trimester;2022QII;""
33 Asturias;All ages;Cohort January 1;Males;Survival in the third trimester;2022QI;""
33 Asturias;All ages;Cohort January 1;Males;Survival in the third trimester;2021QIV;34.491
33 Asturias;All ages;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
33 Asturias;All ages;Cohort January 1;Males;Survival in the third trimester;2021QII;""
33 Asturias;All ages;Cohort January 1;Males;Survival in the third trimester;2021QI;""
33 Asturias;All ages;Cohort January 1;Males;Survival in the third trimester;2020QIV;34.297
33 Asturias;All ages;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
33 Asturias;All ages;Cohort January 1;Males;Survival in the third trimester;2020QII;""
33 Asturias;All ages;Cohort January 1;Males;Survival in the third trimester;2020QI;""
33 Asturias;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
33 Asturias;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
33 Asturias;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
33 Asturias;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
33 Asturias;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
33 Asturias;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
33 Asturias;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
33 Asturias;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
33 Asturias;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
33 Asturias;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
33 Asturias;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
33 Asturias;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
33 Asturias;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
33 Asturias;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
33 Asturias;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
33 Asturias;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;97,18
33 Asturias;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
33 Asturias;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
33 Asturias;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
33 Asturias;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;97,76
33 Asturias;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
33 Asturias;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
33 Asturias;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
33 Asturias;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;94,67
33 Asturias;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
33 Asturias;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
33 Asturias;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;94,5
33 Asturias;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
33 Asturias;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
33 Asturias;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
33 Asturias;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;95,33
33 Asturias;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
33 Asturias;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
33 Asturias;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
33 Asturias;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;93,09
33 Asturias;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
33 Asturias;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
33 Asturias;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;92,14
33 Asturias;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
33 Asturias;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
33 Asturias;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
33 Asturias;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;93,24
33 Asturias;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
33 Asturias;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
33 Asturias;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
33 Asturias;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;91,24
33 Asturias;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
33 Asturias;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
33 Asturias;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;89,11
33 Asturias;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
33 Asturias;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
33 Asturias;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
33 Asturias;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;90,82
33 Asturias;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
33 Asturias;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
33 Asturias;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
33 Asturias;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;88,99
33 Asturias;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
33 Asturias;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
33 Asturias;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
33 Asturias;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
33 Asturias;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
33 Asturias;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
33 Asturias;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QI;25.484
33 Asturias;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
33 Asturias;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
33 Asturias;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
33 Asturias;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QI;25.228
33 Asturias;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
33 Asturias;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
33 Asturias;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
33 Asturias;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QI;25.812
33 Asturias;All ages;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
33 Asturias;All ages;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
33 Asturias;All ages;Cohort January 1;Females;Survival in the first trimester;2022QII;""
33 Asturias;All ages;Cohort January 1;Females;Survival in the first trimester;2022QI;24.811
33 Asturias;All ages;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
33 Asturias;All ages;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
33 Asturias;All ages;Cohort January 1;Females;Survival in the first trimester;2021QII;""
33 Asturias;All ages;Cohort January 1;Females;Survival in the first trimester;2021QI;24.667
33 Asturias;All ages;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
33 Asturias;All ages;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
33 Asturias;All ages;Cohort January 1;Females;Survival in the first trimester;2020QII;""
33 Asturias;All ages;Cohort January 1;Females;Survival in the first trimester;2020QI;24.363
33 Asturias;All ages;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
33 Asturias;All ages;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
33 Asturias;All ages;Cohort January 1;Females;Survival in the second trimester;2022QII;24.010
33 Asturias;All ages;Cohort January 1;Females;Survival in the second trimester;2022QI;""
33 Asturias;All ages;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
33 Asturias;All ages;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
33 Asturias;All ages;Cohort January 1;Females;Survival in the second trimester;2021QII;24.002
33 Asturias;All ages;Cohort January 1;Females;Survival in the second trimester;2021QI;""
33 Asturias;All ages;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
33 Asturias;All ages;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
33 Asturias;All ages;Cohort January 1;Females;Survival in the second trimester;2020QII;23.846
33 Asturias;All ages;Cohort January 1;Females;Survival in the second trimester;2020QI;""
33 Asturias;All ages;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
33 Asturias;All ages;Cohort January 1;Females;Survival in the third trimester;2022QIII;23.303
33 Asturias;All ages;Cohort January 1;Females;Survival in the third trimester;2022QII;""
33 Asturias;All ages;Cohort January 1;Females;Survival in the third trimester;2022QI;""
33 Asturias;All ages;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
33 Asturias;All ages;Cohort January 1;Females;Survival in the third trimester;2021QIII;23.438
33 Asturias;All ages;Cohort January 1;Females;Survival in the third trimester;2021QII;""
33 Asturias;All ages;Cohort January 1;Females;Survival in the third trimester;2021QI;""
33 Asturias;All ages;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
33 Asturias;All ages;Cohort January 1;Females;Survival in the third trimester;2020QIII;23.197
33 Asturias;All ages;Cohort January 1;Females;Survival in the third trimester;2020QII;""
33 Asturias;All ages;Cohort January 1;Females;Survival in the third trimester;2020QI;""
33 Asturias;All ages;Cohort January 1;Females;Survival in the third trimester;2022QIV;22.499
33 Asturias;All ages;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
33 Asturias;All ages;Cohort January 1;Females;Survival in the third trimester;2022QII;""
33 Asturias;All ages;Cohort January 1;Females;Survival in the third trimester;2022QI;""
33 Asturias;All ages;Cohort January 1;Females;Survival in the third trimester;2021QIV;22.751
33 Asturias;All ages;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
33 Asturias;All ages;Cohort January 1;Females;Survival in the third trimester;2021QII;""
33 Asturias;All ages;Cohort January 1;Females;Survival in the third trimester;2021QI;""
33 Asturias;All ages;Cohort January 1;Females;Survival in the third trimester;2020QIV;22.543
33 Asturias;All ages;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
33 Asturias;All ages;Cohort January 1;Females;Survival in the third trimester;2020QII;""
33 Asturias;All ages;Cohort January 1;Females;Survival in the third trimester;2020QI;""
33 Asturias;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
33 Asturias;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
33 Asturias;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
33 Asturias;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
33 Asturias;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
33 Asturias;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
33 Asturias;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
33 Asturias;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
33 Asturias;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
33 Asturias;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
33 Asturias;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
33 Asturias;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
33 Asturias;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
33 Asturias;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
33 Asturias;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
33 Asturias;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;97,36
33 Asturias;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
33 Asturias;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
33 Asturias;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
33 Asturias;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;97,78
33 Asturias;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
33 Asturias;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
33 Asturias;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
33 Asturias;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;94,39
33 Asturias;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
33 Asturias;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
33 Asturias;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;94,22
33 Asturias;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
33 Asturias;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
33 Asturias;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
33 Asturias;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;95,14
33 Asturias;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
33 Asturias;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
33 Asturias;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
33 Asturias;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;92,38
33 Asturias;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
33 Asturias;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
33 Asturias;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;91,44
33 Asturias;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
33 Asturias;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
33 Asturias;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
33 Asturias;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;92,9
33 Asturias;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
33 Asturias;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
33 Asturias;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
33 Asturias;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;89,87
33 Asturias;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
33 Asturias;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
33 Asturias;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;88,29
33 Asturias;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
33 Asturias;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
33 Asturias;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
33 Asturias;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;90,18
33 Asturias;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
33 Asturias;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
33 Asturias;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
33 Asturias;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;87,34
33 Asturias;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
33 Asturias;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
33 Asturias;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
33 Asturias;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
33 Asturias;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
33 Asturias;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QII;63.584
33 Asturias;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
33 Asturias;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
33 Asturias;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
33 Asturias;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QII;63.557
33 Asturias;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
33 Asturias;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
33 Asturias;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
33 Asturias;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QII;63.096
33 Asturias;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
33 Asturias;All ages;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
33 Asturias;All ages;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
33 Asturias;All ages;Cohort April 1;Total;Survival in the first trimester;2022QII;61.556
33 Asturias;All ages;Cohort April 1;Total;Survival in the first trimester;2022QI;""
33 Asturias;All ages;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
33 Asturias;All ages;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
33 Asturias;All ages;Cohort April 1;Total;Survival in the first trimester;2021QII;61.798
33 Asturias;All ages;Cohort April 1;Total;Survival in the first trimester;2021QI;""
33 Asturias;All ages;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
33 Asturias;All ages;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
33 Asturias;All ages;Cohort April 1;Total;Survival in the first trimester;2020QII;61.860
33 Asturias;All ages;Cohort April 1;Total;Survival in the first trimester;2020QI;""
33 Asturias;All ages;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
33 Asturias;All ages;Cohort April 1;Total;Survival in the second trimester;2022QIII;59.810
33 Asturias;All ages;Cohort April 1;Total;Survival in the second trimester;2022QII;""
33 Asturias;All ages;Cohort April 1;Total;Survival in the second trimester;2022QI;""
33 Asturias;All ages;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
33 Asturias;All ages;Cohort April 1;Total;Survival in the second trimester;2021QIII;60.303
33 Asturias;All ages;Cohort April 1;Total;Survival in the second trimester;2021QII;""
33 Asturias;All ages;Cohort April 1;Total;Survival in the second trimester;2021QI;""
33 Asturias;All ages;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
33 Asturias;All ages;Cohort April 1;Total;Survival in the second trimester;2020QIII;60.308
33 Asturias;All ages;Cohort April 1;Total;Survival in the second trimester;2020QII;""
33 Asturias;All ages;Cohort April 1;Total;Survival in the second trimester;2020QI;""
33 Asturias;All ages;Cohort April 1;Total;Survival in the third trimester;2022QIV;57.732
33 Asturias;All ages;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
33 Asturias;All ages;Cohort April 1;Total;Survival in the third trimester;2022QII;""
33 Asturias;All ages;Cohort April 1;Total;Survival in the third trimester;2022QI;""
33 Asturias;All ages;Cohort April 1;Total;Survival in the third trimester;2021QIV;58.582
33 Asturias;All ages;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
33 Asturias;All ages;Cohort April 1;Total;Survival in the third trimester;2021QII;""
33 Asturias;All ages;Cohort April 1;Total;Survival in the third trimester;2021QI;""
33 Asturias;All ages;Cohort April 1;Total;Survival in the third trimester;2020QIV;58.648
33 Asturias;All ages;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
33 Asturias;All ages;Cohort April 1;Total;Survival in the third trimester;2020QII;""
33 Asturias;All ages;Cohort April 1;Total;Survival in the third trimester;2020QI;""
33 Asturias;All ages;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
33 Asturias;All ages;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
33 Asturias;All ages;Cohort April 1;Total;Survival in the third trimester;2022QII;""
33 Asturias;All ages;Cohort April 1;Total;Survival in the third trimester;2022QI;57.237
33 Asturias;All ages;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
33 Asturias;All ages;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
33 Asturias;All ages;Cohort April 1;Total;Survival in the third trimester;2021QII;""
33 Asturias;All ages;Cohort April 1;Total;Survival in the third trimester;2021QI;57.597
33 Asturias;All ages;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
33 Asturias;All ages;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
33 Asturias;All ages;Cohort April 1;Total;Survival in the third trimester;2020QII;""
33 Asturias;All ages;Cohort April 1;Total;Survival in the third trimester;2020QI;""
33 Asturias;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
33 Asturias;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
33 Asturias;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
33 Asturias;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
33 Asturias;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
33 Asturias;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
33 Asturias;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
33 Asturias;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
33 Asturias;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
33 Asturias;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
33 Asturias;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
33 Asturias;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
33 Asturias;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
33 Asturias;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
33 Asturias;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;96,81
33 Asturias;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
33 Asturias;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
33 Asturias;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
33 Asturias;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;97,23
33 Asturias;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
33 Asturias;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
33 Asturias;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
33 Asturias;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;98,04
33 Asturias;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
33 Asturias;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
33 Asturias;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;94,06
33 Asturias;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
33 Asturias;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
33 Asturias;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
33 Asturias;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;94,88
33 Asturias;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
33 Asturias;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
33 Asturias;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
33 Asturias;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;95,58
33 Asturias;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
33 Asturias;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
33 Asturias;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;90,8
33 Asturias;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
33 Asturias;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
33 Asturias;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
33 Asturias;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;92,17
33 Asturias;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
33 Asturias;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
33 Asturias;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
33 Asturias;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;92,95
33 Asturias;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
33 Asturias;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
33 Asturias;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
33 Asturias;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
33 Asturias;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
33 Asturias;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
33 Asturias;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;90,06
33 Asturias;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
33 Asturias;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
33 Asturias;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
33 Asturias;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;91,28
33 Asturias;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
33 Asturias;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
33 Asturias;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
33 Asturias;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
33 Asturias;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
33 Asturias;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
33 Asturias;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QII;37.967
33 Asturias;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
33 Asturias;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
33 Asturias;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
33 Asturias;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QII;38.176
33 Asturias;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
33 Asturias;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
33 Asturias;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
33 Asturias;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QII;37.782
33 Asturias;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
33 Asturias;All ages;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
33 Asturias;All ages;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
33 Asturias;All ages;Cohort April 1;Males;Survival in the first trimester;2022QII;36.814
33 Asturias;All ages;Cohort April 1;Males;Survival in the first trimester;2022QI;""
33 Asturias;All ages;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
33 Asturias;All ages;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
33 Asturias;All ages;Cohort April 1;Males;Survival in the first trimester;2021QII;37.145
33 Asturias;All ages;Cohort April 1;Males;Survival in the first trimester;2021QI;""
33 Asturias;All ages;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
33 Asturias;All ages;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
33 Asturias;All ages;Cohort April 1;Males;Survival in the first trimester;2020QII;37.104
33 Asturias;All ages;Cohort April 1;Males;Survival in the first trimester;2020QI;""
33 Asturias;All ages;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
33 Asturias;All ages;Cohort April 1;Males;Survival in the second trimester;2022QIII;35.832
33 Asturias;All ages;Cohort April 1;Males;Survival in the second trimester;2022QII;""
33 Asturias;All ages;Cohort April 1;Males;Survival in the second trimester;2022QI;""
33 Asturias;All ages;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
33 Asturias;All ages;Cohort April 1;Males;Survival in the second trimester;2021QIII;36.261
33 Asturias;All ages;Cohort April 1;Males;Survival in the second trimester;2021QII;""
33 Asturias;All ages;Cohort April 1;Males;Survival in the second trimester;2021QI;""
33 Asturias;All ages;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
33 Asturias;All ages;Cohort April 1;Males;Survival in the second trimester;2020QIII;36.274
33 Asturias;All ages;Cohort April 1;Males;Survival in the second trimester;2020QII;""
33 Asturias;All ages;Cohort April 1;Males;Survival in the second trimester;2020QI;""
33 Asturias;All ages;Cohort April 1;Males;Survival in the third trimester;2022QIV;34.614
33 Asturias;All ages;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
33 Asturias;All ages;Cohort April 1;Males;Survival in the third trimester;2022QII;""
33 Asturias;All ages;Cohort April 1;Males;Survival in the third trimester;2022QI;""
33 Asturias;All ages;Cohort April 1;Males;Survival in the third trimester;2021QIV;35.271
33 Asturias;All ages;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
33 Asturias;All ages;Cohort April 1;Males;Survival in the third trimester;2021QII;""
33 Asturias;All ages;Cohort April 1;Males;Survival in the third trimester;2021QI;""
33 Asturias;All ages;Cohort April 1;Males;Survival in the third trimester;2020QIV;35.324
33 Asturias;All ages;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
33 Asturias;All ages;Cohort April 1;Males;Survival in the third trimester;2020QII;""
33 Asturias;All ages;Cohort April 1;Males;Survival in the third trimester;2020QI;""
33 Asturias;All ages;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
33 Asturias;All ages;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
33 Asturias;All ages;Cohort April 1;Males;Survival in the third trimester;2022QII;""
33 Asturias;All ages;Cohort April 1;Males;Survival in the third trimester;2022QI;34.459
33 Asturias;All ages;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
33 Asturias;All ages;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
33 Asturias;All ages;Cohort April 1;Males;Survival in the third trimester;2021QII;""
33 Asturias;All ages;Cohort April 1;Males;Survival in the third trimester;2021QI;34.702
33 Asturias;All ages;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
33 Asturias;All ages;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
33 Asturias;All ages;Cohort April 1;Males;Survival in the third trimester;2020QII;""
33 Asturias;All ages;Cohort April 1;Males;Survival in the third trimester;2020QI;""
33 Asturias;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
33 Asturias;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
33 Asturias;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
33 Asturias;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
33 Asturias;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
33 Asturias;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
33 Asturias;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
33 Asturias;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
33 Asturias;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
33 Asturias;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
33 Asturias;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
33 Asturias;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
33 Asturias;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
33 Asturias;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
33 Asturias;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;96,96
33 Asturias;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
33 Asturias;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
33 Asturias;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
33 Asturias;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;97,3
33 Asturias;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
33 Asturias;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
33 Asturias;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
33 Asturias;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;98,21
33 Asturias;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
33 Asturias;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
33 Asturias;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;94,38
33 Asturias;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
33 Asturias;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
33 Asturias;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
33 Asturias;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;94,98
33 Asturias;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
33 Asturias;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
33 Asturias;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
33 Asturias;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;96,01
33 Asturias;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
33 Asturias;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
33 Asturias;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;91,17
33 Asturias;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
33 Asturias;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
33 Asturias;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
33 Asturias;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;92,39
33 Asturias;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
33 Asturias;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
33 Asturias;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
33 Asturias;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;93,49
33 Asturias;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
33 Asturias;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
33 Asturias;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
33 Asturias;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
33 Asturias;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
33 Asturias;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
33 Asturias;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;90,26
33 Asturias;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
33 Asturias;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
33 Asturias;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
33 Asturias;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;91,85
33 Asturias;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
33 Asturias;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
33 Asturias;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
33 Asturias;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
33 Asturias;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
33 Asturias;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
33 Asturias;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QII;25.617
33 Asturias;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
33 Asturias;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
33 Asturias;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
33 Asturias;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QII;25.381
33 Asturias;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
33 Asturias;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
33 Asturias;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
33 Asturias;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QII;25.314
33 Asturias;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
33 Asturias;All ages;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
33 Asturias;All ages;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
33 Asturias;All ages;Cohort April 1;Females;Survival in the first trimester;2022QII;24.742
33 Asturias;All ages;Cohort April 1;Females;Survival in the first trimester;2022QI;""
33 Asturias;All ages;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
33 Asturias;All ages;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
33 Asturias;All ages;Cohort April 1;Females;Survival in the first trimester;2021QII;24.653
33 Asturias;All ages;Cohort April 1;Females;Survival in the first trimester;2021QI;""
33 Asturias;All ages;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
33 Asturias;All ages;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
33 Asturias;All ages;Cohort April 1;Females;Survival in the first trimester;2020QII;24.756
33 Asturias;All ages;Cohort April 1;Females;Survival in the first trimester;2020QI;""
33 Asturias;All ages;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
33 Asturias;All ages;Cohort April 1;Females;Survival in the second trimester;2022QIII;23.978
33 Asturias;All ages;Cohort April 1;Females;Survival in the second trimester;2022QII;""
33 Asturias;All ages;Cohort April 1;Females;Survival in the second trimester;2022QI;""
33 Asturias;All ages;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
33 Asturias;All ages;Cohort April 1;Females;Survival in the second trimester;2021QIII;24.042
33 Asturias;All ages;Cohort April 1;Females;Survival in the second trimester;2021QII;""
33 Asturias;All ages;Cohort April 1;Females;Survival in the second trimester;2021QI;""
33 Asturias;All ages;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
33 Asturias;All ages;Cohort April 1;Females;Survival in the second trimester;2020QIII;24.034
33 Asturias;All ages;Cohort April 1;Females;Survival in the second trimester;2020QII;""
33 Asturias;All ages;Cohort April 1;Females;Survival in the second trimester;2020QI;""
33 Asturias;All ages;Cohort April 1;Females;Survival in the third trimester;2022QIV;23.118
33 Asturias;All ages;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
33 Asturias;All ages;Cohort April 1;Females;Survival in the third trimester;2022QII;""
33 Asturias;All ages;Cohort April 1;Females;Survival in the third trimester;2022QI;""
33 Asturias;All ages;Cohort April 1;Females;Survival in the third trimester;2021QIV;23.311
33 Asturias;All ages;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
33 Asturias;All ages;Cohort April 1;Females;Survival in the third trimester;2021QII;""
33 Asturias;All ages;Cohort April 1;Females;Survival in the third trimester;2021QI;""
33 Asturias;All ages;Cohort April 1;Females;Survival in the third trimester;2020QIV;23.324
33 Asturias;All ages;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
33 Asturias;All ages;Cohort April 1;Females;Survival in the third trimester;2020QII;""
33 Asturias;All ages;Cohort April 1;Females;Survival in the third trimester;2020QI;""
33 Asturias;All ages;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
33 Asturias;All ages;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
33 Asturias;All ages;Cohort April 1;Females;Survival in the third trimester;2022QII;""
33 Asturias;All ages;Cohort April 1;Females;Survival in the third trimester;2022QI;22.778
33 Asturias;All ages;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
33 Asturias;All ages;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
33 Asturias;All ages;Cohort April 1;Females;Survival in the third trimester;2021QII;""
33 Asturias;All ages;Cohort April 1;Females;Survival in the third trimester;2021QI;22.895
33 Asturias;All ages;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
33 Asturias;All ages;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
33 Asturias;All ages;Cohort April 1;Females;Survival in the third trimester;2020QII;""
33 Asturias;All ages;Cohort April 1;Females;Survival in the third trimester;2020QI;""
33 Asturias;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
33 Asturias;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
33 Asturias;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
33 Asturias;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
33 Asturias;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
33 Asturias;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
33 Asturias;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
33 Asturias;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
33 Asturias;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
33 Asturias;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
33 Asturias;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
33 Asturias;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
33 Asturias;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
33 Asturias;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
33 Asturias;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;96,58
33 Asturias;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
33 Asturias;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
33 Asturias;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
33 Asturias;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;97,13
33 Asturias;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
33 Asturias;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
33 Asturias;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
33 Asturias;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;97,8
33 Asturias;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
33 Asturias;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
33 Asturias;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;93,6
33 Asturias;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
33 Asturias;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
33 Asturias;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
33 Asturias;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;94,72
33 Asturias;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
33 Asturias;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
33 Asturias;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
33 Asturias;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;94,94
33 Asturias;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
33 Asturias;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
33 Asturias;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;90,24
33 Asturias;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
33 Asturias;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
33 Asturias;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
33 Asturias;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;91,84
33 Asturias;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
33 Asturias;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
33 Asturias;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
33 Asturias;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;92,14
33 Asturias;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
33 Asturias;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
33 Asturias;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
33 Asturias;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
33 Asturias;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
33 Asturias;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
33 Asturias;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;89,74
33 Asturias;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
33 Asturias;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
33 Asturias;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
33 Asturias;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;90,44
33 Asturias;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
33 Asturias;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
33 Asturias;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
33 Asturias;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
33 Asturias;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
33 Asturias;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QIII;63.602
33 Asturias;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
33 Asturias;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
33 Asturias;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
33 Asturias;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QIII;63.866
33 Asturias;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
33 Asturias;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
33 Asturias;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
33 Asturias;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QIII;63.450
33 Asturias;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
33 Asturias;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
33 Asturias;All ages;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
33 Asturias;All ages;Cohort July 1;Total;Survival in the first trimester;2022QIII;61.487
33 Asturias;All ages;Cohort July 1;Total;Survival in the first trimester;2022QII;""
33 Asturias;All ages;Cohort July 1;Total;Survival in the first trimester;2022QI;""
33 Asturias;All ages;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
33 Asturias;All ages;Cohort July 1;Total;Survival in the first trimester;2021QIII;62.077
33 Asturias;All ages;Cohort July 1;Total;Survival in the first trimester;2021QII;""
33 Asturias;All ages;Cohort July 1;Total;Survival in the first trimester;2021QI;""
33 Asturias;All ages;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
33 Asturias;All ages;Cohort July 1;Total;Survival in the first trimester;2020QIII;61.641
33 Asturias;All ages;Cohort July 1;Total;Survival in the first trimester;2020QII;""
33 Asturias;All ages;Cohort July 1;Total;Survival in the first trimester;2020QI;""
33 Asturias;All ages;Cohort July 1;Total;Survival in the second trimester;2022QIV;59.187
33 Asturias;All ages;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
33 Asturias;All ages;Cohort July 1;Total;Survival in the second trimester;2022QII;""
33 Asturias;All ages;Cohort July 1;Total;Survival in the second trimester;2022QI;""
33 Asturias;All ages;Cohort July 1;Total;Survival in the second trimester;2021QIV;60.165
33 Asturias;All ages;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
33 Asturias;All ages;Cohort July 1;Total;Survival in the second trimester;2021QII;""
33 Asturias;All ages;Cohort July 1;Total;Survival in the second trimester;2021QI;""
33 Asturias;All ages;Cohort July 1;Total;Survival in the second trimester;2020QIV;59.811
33 Asturias;All ages;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
33 Asturias;All ages;Cohort July 1;Total;Survival in the second trimester;2020QII;""
33 Asturias;All ages;Cohort July 1;Total;Survival in the second trimester;2020QI;""
33 Asturias;All ages;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
33 Asturias;All ages;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
33 Asturias;All ages;Cohort July 1;Total;Survival in the third trimester;2022QII;""
33 Asturias;All ages;Cohort July 1;Total;Survival in the third trimester;2022QI;58.712
33 Asturias;All ages;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
33 Asturias;All ages;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
33 Asturias;All ages;Cohort July 1;Total;Survival in the third trimester;2021QII;""
33 Asturias;All ages;Cohort July 1;Total;Survival in the third trimester;2021QI;58.705
33 Asturias;All ages;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
33 Asturias;All ages;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
33 Asturias;All ages;Cohort July 1;Total;Survival in the third trimester;2020QII;""
33 Asturias;All ages;Cohort July 1;Total;Survival in the third trimester;2020QI;""
33 Asturias;All ages;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
33 Asturias;All ages;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
33 Asturias;All ages;Cohort July 1;Total;Survival in the third trimester;2022QII;57.196
33 Asturias;All ages;Cohort July 1;Total;Survival in the third trimester;2022QI;""
33 Asturias;All ages;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
33 Asturias;All ages;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
33 Asturias;All ages;Cohort July 1;Total;Survival in the third trimester;2021QII;57.427
33 Asturias;All ages;Cohort July 1;Total;Survival in the third trimester;2021QI;""
33 Asturias;All ages;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
33 Asturias;All ages;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
33 Asturias;All ages;Cohort July 1;Total;Survival in the third trimester;2020QII;""
33 Asturias;All ages;Cohort July 1;Total;Survival in the third trimester;2020QI;""
33 Asturias;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
33 Asturias;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
33 Asturias;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
33 Asturias;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
33 Asturias;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
33 Asturias;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
33 Asturias;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
33 Asturias;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
33 Asturias;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
33 Asturias;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
33 Asturias;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
33 Asturias;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
33 Asturias;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
33 Asturias;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;96,67
33 Asturias;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
33 Asturias;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
33 Asturias;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
33 Asturias;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;97,2
33 Asturias;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
33 Asturias;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
33 Asturias;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
33 Asturias;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;97,15
33 Asturias;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
33 Asturias;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
33 Asturias;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;93,06
33 Asturias;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
33 Asturias;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
33 Asturias;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
33 Asturias;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;94,21
33 Asturias;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
33 Asturias;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
33 Asturias;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
33 Asturias;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;94,26
33 Asturias;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
33 Asturias;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
33 Asturias;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
33 Asturias;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
33 Asturias;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
33 Asturias;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
33 Asturias;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;91,93
33 Asturias;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
33 Asturias;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
33 Asturias;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
33 Asturias;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;92,52
33 Asturias;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
33 Asturias;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
33 Asturias;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
33 Asturias;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
33 Asturias;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
33 Asturias;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
33 Asturias;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;89,56
33 Asturias;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
33 Asturias;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
33 Asturias;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
33 Asturias;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;90,51
33 Asturias;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
33 Asturias;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
33 Asturias;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
33 Asturias;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
33 Asturias;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
33 Asturias;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
33 Asturias;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QIII;37.921
33 Asturias;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
33 Asturias;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
33 Asturias;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
33 Asturias;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QIII;38.280
33 Asturias;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
33 Asturias;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
33 Asturias;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
33 Asturias;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QIII;38.088
33 Asturias;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
33 Asturias;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
33 Asturias;All ages;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
33 Asturias;All ages;Cohort July 1;Males;Survival in the first trimester;2022QIII;36.730
33 Asturias;All ages;Cohort July 1;Males;Survival in the first trimester;2022QII;""
33 Asturias;All ages;Cohort July 1;Males;Survival in the first trimester;2022QI;""
33 Asturias;All ages;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
33 Asturias;All ages;Cohort July 1;Males;Survival in the first trimester;2021QIII;37.237
33 Asturias;All ages;Cohort July 1;Males;Survival in the first trimester;2021QII;""
33 Asturias;All ages;Cohort July 1;Males;Survival in the first trimester;2021QI;""
33 Asturias;All ages;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
33 Asturias;All ages;Cohort July 1;Males;Survival in the first trimester;2020QIII;37.101
33 Asturias;All ages;Cohort July 1;Males;Survival in the first trimester;2020QII;""
33 Asturias;All ages;Cohort July 1;Males;Survival in the first trimester;2020QI;""
33 Asturias;All ages;Cohort July 1;Males;Survival in the second trimester;2022QIV;35.393
33 Asturias;All ages;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
33 Asturias;All ages;Cohort July 1;Males;Survival in the second trimester;2022QII;""
33 Asturias;All ages;Cohort July 1;Males;Survival in the second trimester;2022QI;""
33 Asturias;All ages;Cohort July 1;Males;Survival in the second trimester;2021QIV;36.143
33 Asturias;All ages;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
33 Asturias;All ages;Cohort July 1;Males;Survival in the second trimester;2021QII;""
33 Asturias;All ages;Cohort July 1;Males;Survival in the second trimester;2021QI;""
33 Asturias;All ages;Cohort July 1;Males;Survival in the second trimester;2020QIV;36.039
33 Asturias;All ages;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
33 Asturias;All ages;Cohort July 1;Males;Survival in the second trimester;2020QII;""
33 Asturias;All ages;Cohort July 1;Males;Survival in the second trimester;2020QI;""
33 Asturias;All ages;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
33 Asturias;All ages;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
33 Asturias;All ages;Cohort July 1;Males;Survival in the third trimester;2022QII;""
33 Asturias;All ages;Cohort July 1;Males;Survival in the third trimester;2022QI;35.261
33 Asturias;All ages;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
33 Asturias;All ages;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
33 Asturias;All ages;Cohort July 1;Males;Survival in the third trimester;2021QII;""
33 Asturias;All ages;Cohort July 1;Males;Survival in the third trimester;2021QI;35.381
33 Asturias;All ages;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
33 Asturias;All ages;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
33 Asturias;All ages;Cohort July 1;Males;Survival in the third trimester;2020QII;""
33 Asturias;All ages;Cohort July 1;Males;Survival in the third trimester;2020QI;""
33 Asturias;All ages;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
33 Asturias;All ages;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
33 Asturias;All ages;Cohort July 1;Males;Survival in the third trimester;2022QII;34.403
33 Asturias;All ages;Cohort July 1;Males;Survival in the third trimester;2022QI;""
33 Asturias;All ages;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
33 Asturias;All ages;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
33 Asturias;All ages;Cohort July 1;Males;Survival in the third trimester;2021QII;34.637
33 Asturias;All ages;Cohort July 1;Males;Survival in the third trimester;2021QI;""
33 Asturias;All ages;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
33 Asturias;All ages;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
33 Asturias;All ages;Cohort July 1;Males;Survival in the third trimester;2020QII;""
33 Asturias;All ages;Cohort July 1;Males;Survival in the third trimester;2020QI;""
33 Asturias;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
33 Asturias;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
33 Asturias;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
33 Asturias;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
33 Asturias;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
33 Asturias;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
33 Asturias;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
33 Asturias;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
33 Asturias;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
33 Asturias;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
33 Asturias;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
33 Asturias;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
33 Asturias;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
33 Asturias;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;96,86
33 Asturias;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
33 Asturias;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
33 Asturias;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
33 Asturias;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;97,28
33 Asturias;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
33 Asturias;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
33 Asturias;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
33 Asturias;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;97,41
33 Asturias;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
33 Asturias;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
33 Asturias;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;93,33
33 Asturias;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
33 Asturias;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
33 Asturias;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
33 Asturias;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;94,42
33 Asturias;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
33 Asturias;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
33 Asturias;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
33 Asturias;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;94,62
33 Asturias;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
33 Asturias;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
33 Asturias;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
33 Asturias;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
33 Asturias;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
33 Asturias;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
33 Asturias;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;92,11
33 Asturias;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
33 Asturias;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
33 Asturias;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
33 Asturias;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;92,89
33 Asturias;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
33 Asturias;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
33 Asturias;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
33 Asturias;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
33 Asturias;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
33 Asturias;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
33 Asturias;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;89,87
33 Asturias;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
33 Asturias;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
33 Asturias;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
33 Asturias;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;90,94
33 Asturias;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
33 Asturias;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
33 Asturias;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
33 Asturias;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
33 Asturias;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
33 Asturias;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
33 Asturias;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QIII;25.681
33 Asturias;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
33 Asturias;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
33 Asturias;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
33 Asturias;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QIII;25.586
33 Asturias;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
33 Asturias;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
33 Asturias;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
33 Asturias;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QIII;25.362
33 Asturias;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
33 Asturias;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
33 Asturias;All ages;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
33 Asturias;All ages;Cohort July 1;Females;Survival in the first trimester;2022QIII;24.757
33 Asturias;All ages;Cohort July 1;Females;Survival in the first trimester;2022QII;""
33 Asturias;All ages;Cohort July 1;Females;Survival in the first trimester;2022QI;""
33 Asturias;All ages;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
33 Asturias;All ages;Cohort July 1;Females;Survival in the first trimester;2021QIII;24.840
33 Asturias;All ages;Cohort July 1;Females;Survival in the first trimester;2021QII;""
33 Asturias;All ages;Cohort July 1;Females;Survival in the first trimester;2021QI;""
33 Asturias;All ages;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
33 Asturias;All ages;Cohort July 1;Females;Survival in the first trimester;2020QIII;24.540
33 Asturias;All ages;Cohort July 1;Females;Survival in the first trimester;2020QII;""
33 Asturias;All ages;Cohort July 1;Females;Survival in the first trimester;2020QI;""
33 Asturias;All ages;Cohort July 1;Females;Survival in the second trimester;2022QIV;23.794
33 Asturias;All ages;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
33 Asturias;All ages;Cohort July 1;Females;Survival in the second trimester;2022QII;""
33 Asturias;All ages;Cohort July 1;Females;Survival in the second trimester;2022QI;""
33 Asturias;All ages;Cohort July 1;Females;Survival in the second trimester;2021QIV;24.022
33 Asturias;All ages;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
33 Asturias;All ages;Cohort July 1;Females;Survival in the second trimester;2021QII;""
33 Asturias;All ages;Cohort July 1;Females;Survival in the second trimester;2021QI;""
33 Asturias;All ages;Cohort July 1;Females;Survival in the second trimester;2020QIV;23.772
33 Asturias;All ages;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
33 Asturias;All ages;Cohort July 1;Females;Survival in the second trimester;2020QII;""
33 Asturias;All ages;Cohort July 1;Females;Survival in the second trimester;2020QI;""
33 Asturias;All ages;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
33 Asturias;All ages;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
33 Asturias;All ages;Cohort July 1;Females;Survival in the third trimester;2022QII;""
33 Asturias;All ages;Cohort July 1;Females;Survival in the third trimester;2022QI;23.451
33 Asturias;All ages;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
33 Asturias;All ages;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
33 Asturias;All ages;Cohort July 1;Females;Survival in the third trimester;2021QII;""
33 Asturias;All ages;Cohort July 1;Females;Survival in the third trimester;2021QI;23.324
33 Asturias;All ages;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
33 Asturias;All ages;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
33 Asturias;All ages;Cohort July 1;Females;Survival in the third trimester;2020QII;""
33 Asturias;All ages;Cohort July 1;Females;Survival in the third trimester;2020QI;""
33 Asturias;All ages;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
33 Asturias;All ages;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
33 Asturias;All ages;Cohort July 1;Females;Survival in the third trimester;2022QII;22.793
33 Asturias;All ages;Cohort July 1;Females;Survival in the third trimester;2022QI;""
33 Asturias;All ages;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
33 Asturias;All ages;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
33 Asturias;All ages;Cohort July 1;Females;Survival in the third trimester;2021QII;22.790
33 Asturias;All ages;Cohort July 1;Females;Survival in the third trimester;2021QI;""
33 Asturias;All ages;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
33 Asturias;All ages;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
33 Asturias;All ages;Cohort July 1;Females;Survival in the third trimester;2020QII;""
33 Asturias;All ages;Cohort July 1;Females;Survival in the third trimester;2020QI;""
33 Asturias;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
33 Asturias;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
33 Asturias;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
33 Asturias;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
33 Asturias;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
33 Asturias;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
33 Asturias;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
33 Asturias;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
33 Asturias;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
33 Asturias;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
33 Asturias;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
33 Asturias;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
33 Asturias;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
33 Asturias;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;96,4
33 Asturias;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
33 Asturias;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
33 Asturias;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
33 Asturias;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;97,08
33 Asturias;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
33 Asturias;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
33 Asturias;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
33 Asturias;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;96,76
33 Asturias;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
33 Asturias;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
33 Asturias;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;92,65
33 Asturias;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
33 Asturias;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
33 Asturias;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
33 Asturias;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;93,89
33 Asturias;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
33 Asturias;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
33 Asturias;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
33 Asturias;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;93,73
33 Asturias;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
33 Asturias;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
33 Asturias;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
33 Asturias;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
33 Asturias;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
33 Asturias;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
33 Asturias;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;91,66
33 Asturias;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
33 Asturias;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
33 Asturias;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
33 Asturias;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;91,96
33 Asturias;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
33 Asturias;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
33 Asturias;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
33 Asturias;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
33 Asturias;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
33 Asturias;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
33 Asturias;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;89,08
33 Asturias;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
33 Asturias;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
33 Asturias;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
33 Asturias;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;89,86
33 Asturias;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
33 Asturias;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
33 Asturias;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
33 Asturias;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
33 Asturias;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
33 Asturias;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QIV;63.122
33 Asturias;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
33 Asturias;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
33 Asturias;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
33 Asturias;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QIV;63.711
33 Asturias;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
33 Asturias;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
33 Asturias;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
33 Asturias;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QIV;63.448
33 Asturias;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
33 Asturias;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
33 Asturias;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
33 Asturias;All ages;Cohort October 1;Total;Survival in the first trimester;2022QIV;60.611
33 Asturias;All ages;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
33 Asturias;All ages;Cohort October 1;Total;Survival in the first trimester;2022QII;""
33 Asturias;All ages;Cohort October 1;Total;Survival in the first trimester;2022QI;""
33 Asturias;All ages;Cohort October 1;Total;Survival in the first trimester;2021QIV;61.603
33 Asturias;All ages;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
33 Asturias;All ages;Cohort October 1;Total;Survival in the first trimester;2021QII;""
33 Asturias;All ages;Cohort October 1;Total;Survival in the first trimester;2021QI;""
33 Asturias;All ages;Cohort October 1;Total;Survival in the first trimester;2020QIV;61.372
33 Asturias;All ages;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
33 Asturias;All ages;Cohort October 1;Total;Survival in the first trimester;2020QII;""
33 Asturias;All ages;Cohort October 1;Total;Survival in the first trimester;2020QI;""
33 Asturias;All ages;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
33 Asturias;All ages;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
33 Asturias;All ages;Cohort October 1;Total;Survival in the second trimester;2022QII;""
33 Asturias;All ages;Cohort October 1;Total;Survival in the second trimester;2022QI;60.044
33 Asturias;All ages;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
33 Asturias;All ages;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
33 Asturias;All ages;Cohort October 1;Total;Survival in the second trimester;2021QII;""
33 Asturias;All ages;Cohort October 1;Total;Survival in the second trimester;2021QI;60.157
33 Asturias;All ages;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
33 Asturias;All ages;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
33 Asturias;All ages;Cohort October 1;Total;Survival in the second trimester;2020QII;""
33 Asturias;All ages;Cohort October 1;Total;Survival in the second trimester;2020QI;""
33 Asturias;All ages;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
33 Asturias;All ages;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
33 Asturias;All ages;Cohort October 1;Total;Survival in the third trimester;2022QII;58.419
33 Asturias;All ages;Cohort October 1;Total;Survival in the third trimester;2022QI;""
33 Asturias;All ages;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
33 Asturias;All ages;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
33 Asturias;All ages;Cohort October 1;Total;Survival in the third trimester;2021QII;58.775
33 Asturias;All ages;Cohort October 1;Total;Survival in the third trimester;2021QI;""
33 Asturias;All ages;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
33 Asturias;All ages;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
33 Asturias;All ages;Cohort October 1;Total;Survival in the third trimester;2020QII;""
33 Asturias;All ages;Cohort October 1;Total;Survival in the third trimester;2020QI;""
33 Asturias;All ages;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
33 Asturias;All ages;Cohort October 1;Total;Survival in the third trimester;2022QIII;56.939
33 Asturias;All ages;Cohort October 1;Total;Survival in the third trimester;2022QII;""
33 Asturias;All ages;Cohort October 1;Total;Survival in the third trimester;2022QI;""
33 Asturias;All ages;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
33 Asturias;All ages;Cohort October 1;Total;Survival in the third trimester;2021QIII;57.527
33 Asturias;All ages;Cohort October 1;Total;Survival in the third trimester;2021QII;""
33 Asturias;All ages;Cohort October 1;Total;Survival in the third trimester;2021QI;""
33 Asturias;All ages;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
33 Asturias;All ages;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
33 Asturias;All ages;Cohort October 1;Total;Survival in the third trimester;2020QII;""
33 Asturias;All ages;Cohort October 1;Total;Survival in the third trimester;2020QI;""
33 Asturias;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
33 Asturias;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
33 Asturias;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
33 Asturias;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
33 Asturias;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
33 Asturias;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
33 Asturias;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
33 Asturias;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
33 Asturias;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
33 Asturias;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
33 Asturias;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
33 Asturias;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
33 Asturias;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;96,02
33 Asturias;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
33 Asturias;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
33 Asturias;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
33 Asturias;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;96,69
33 Asturias;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
33 Asturias;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
33 Asturias;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
33 Asturias;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;96,73
33 Asturias;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
33 Asturias;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
33 Asturias;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
33 Asturias;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
33 Asturias;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
33 Asturias;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
33 Asturias;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;94,24
33 Asturias;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
33 Asturias;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
33 Asturias;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
33 Asturias;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;94,81
33 Asturias;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
33 Asturias;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
33 Asturias;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
33 Asturias;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
33 Asturias;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
33 Asturias;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
33 Asturias;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;91,69
33 Asturias;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
33 Asturias;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
33 Asturias;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
33 Asturias;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;92,63
33 Asturias;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
33 Asturias;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
33 Asturias;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
33 Asturias;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
33 Asturias;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
33 Asturias;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
33 Asturias;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;89,37
33 Asturias;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
33 Asturias;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
33 Asturias;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
33 Asturias;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;90,67
33 Asturias;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
33 Asturias;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
33 Asturias;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
33 Asturias;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
33 Asturias;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
33 Asturias;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
33 Asturias;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QIV;37.599
33 Asturias;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
33 Asturias;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
33 Asturias;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
33 Asturias;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QIV;38.184
33 Asturias;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
33 Asturias;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
33 Asturias;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
33 Asturias;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QIV;38.143
33 Asturias;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
33 Asturias;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
33 Asturias;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
33 Asturias;All ages;Cohort October 1;Males;Survival in the first trimester;2022QIV;36.151
33 Asturias;All ages;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
33 Asturias;All ages;Cohort October 1;Males;Survival in the first trimester;2022QII;""
33 Asturias;All ages;Cohort October 1;Males;Survival in the first trimester;2022QI;""
33 Asturias;All ages;Cohort October 1;Males;Survival in the first trimester;2021QIV;36.976
33 Asturias;All ages;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
33 Asturias;All ages;Cohort October 1;Males;Survival in the first trimester;2021QII;""
33 Asturias;All ages;Cohort October 1;Males;Survival in the first trimester;2021QI;""
33 Asturias;All ages;Cohort October 1;Males;Survival in the first trimester;2020QIV;36.934
33 Asturias;All ages;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
33 Asturias;All ages;Cohort October 1;Males;Survival in the first trimester;2020QII;""
33 Asturias;All ages;Cohort October 1;Males;Survival in the first trimester;2020QI;""
33 Asturias;All ages;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
33 Asturias;All ages;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
33 Asturias;All ages;Cohort October 1;Males;Survival in the second trimester;2022QII;""
33 Asturias;All ages;Cohort October 1;Males;Survival in the second trimester;2022QI;36.018
33 Asturias;All ages;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
33 Asturias;All ages;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
33 Asturias;All ages;Cohort October 1;Males;Survival in the second trimester;2021QII;""
33 Asturias;All ages;Cohort October 1;Males;Survival in the second trimester;2021QI;36.209
33 Asturias;All ages;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
33 Asturias;All ages;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
33 Asturias;All ages;Cohort October 1;Males;Survival in the second trimester;2020QII;""
33 Asturias;All ages;Cohort October 1;Males;Survival in the second trimester;2020QI;""
33 Asturias;All ages;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
33 Asturias;All ages;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
33 Asturias;All ages;Cohort October 1;Males;Survival in the third trimester;2022QII;35.091
33 Asturias;All ages;Cohort October 1;Males;Survival in the third trimester;2022QI;""
33 Asturias;All ages;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
33 Asturias;All ages;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
33 Asturias;All ages;Cohort October 1;Males;Survival in the third trimester;2021QII;35.400
33 Asturias;All ages;Cohort October 1;Males;Survival in the third trimester;2021QI;""
33 Asturias;All ages;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
33 Asturias;All ages;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
33 Asturias;All ages;Cohort October 1;Males;Survival in the third trimester;2020QII;""
33 Asturias;All ages;Cohort October 1;Males;Survival in the third trimester;2020QI;""
33 Asturias;All ages;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
33 Asturias;All ages;Cohort October 1;Males;Survival in the third trimester;2022QIII;34.258
33 Asturias;All ages;Cohort October 1;Males;Survival in the third trimester;2022QII;""
33 Asturias;All ages;Cohort October 1;Males;Survival in the third trimester;2022QI;""
33 Asturias;All ages;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
33 Asturias;All ages;Cohort October 1;Males;Survival in the third trimester;2021QIII;34.671
33 Asturias;All ages;Cohort October 1;Males;Survival in the third trimester;2021QII;""
33 Asturias;All ages;Cohort October 1;Males;Survival in the third trimester;2021QI;""
33 Asturias;All ages;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
33 Asturias;All ages;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
33 Asturias;All ages;Cohort October 1;Males;Survival in the third trimester;2020QII;""
33 Asturias;All ages;Cohort October 1;Males;Survival in the third trimester;2020QI;""
33 Asturias;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
33 Asturias;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
33 Asturias;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
33 Asturias;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
33 Asturias;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
33 Asturias;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
33 Asturias;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
33 Asturias;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
33 Asturias;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
33 Asturias;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
33 Asturias;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
33 Asturias;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
33 Asturias;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;96,15
33 Asturias;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
33 Asturias;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
33 Asturias;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
33 Asturias;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;96,84
33 Asturias;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
33 Asturias;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
33 Asturias;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
33 Asturias;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;96,83
33 Asturias;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
33 Asturias;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
33 Asturias;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
33 Asturias;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
33 Asturias;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
33 Asturias;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
33 Asturias;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;94,33
33 Asturias;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
33 Asturias;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
33 Asturias;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
33 Asturias;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;94,93
33 Asturias;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
33 Asturias;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
33 Asturias;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
33 Asturias;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
33 Asturias;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
33 Asturias;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
33 Asturias;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;91,9
33 Asturias;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
33 Asturias;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
33 Asturias;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
33 Asturias;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;92,81
33 Asturias;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
33 Asturias;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
33 Asturias;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
33 Asturias;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
33 Asturias;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
33 Asturias;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
33 Asturias;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;89,72
33 Asturias;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
33 Asturias;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
33 Asturias;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
33 Asturias;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;90,9
33 Asturias;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
33 Asturias;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
33 Asturias;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
33 Asturias;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
33 Asturias;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
33 Asturias;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
33 Asturias;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QIV;25.523
33 Asturias;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
33 Asturias;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
33 Asturias;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
33 Asturias;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QIV;25.527
33 Asturias;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
33 Asturias;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
33 Asturias;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
33 Asturias;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QIV;25.305
33 Asturias;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
33 Asturias;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
33 Asturias;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
33 Asturias;All ages;Cohort October 1;Females;Survival in the first trimester;2022QIV;24.460
33 Asturias;All ages;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
33 Asturias;All ages;Cohort October 1;Females;Survival in the first trimester;2022QII;""
33 Asturias;All ages;Cohort October 1;Females;Survival in the first trimester;2022QI;""
33 Asturias;All ages;Cohort October 1;Females;Survival in the first trimester;2021QIV;24.627
33 Asturias;All ages;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
33 Asturias;All ages;Cohort October 1;Females;Survival in the first trimester;2021QII;""
33 Asturias;All ages;Cohort October 1;Females;Survival in the first trimester;2021QI;""
33 Asturias;All ages;Cohort October 1;Females;Survival in the first trimester;2020QIV;24.438
33 Asturias;All ages;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
33 Asturias;All ages;Cohort October 1;Females;Survival in the first trimester;2020QII;""
33 Asturias;All ages;Cohort October 1;Females;Survival in the first trimester;2020QI;""
33 Asturias;All ages;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
33 Asturias;All ages;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
33 Asturias;All ages;Cohort October 1;Females;Survival in the second trimester;2022QII;""
33 Asturias;All ages;Cohort October 1;Females;Survival in the second trimester;2022QI;24.026
33 Asturias;All ages;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
33 Asturias;All ages;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
33 Asturias;All ages;Cohort October 1;Females;Survival in the second trimester;2021QII;""
33 Asturias;All ages;Cohort October 1;Females;Survival in the second trimester;2021QI;23.948
33 Asturias;All ages;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
33 Asturias;All ages;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
33 Asturias;All ages;Cohort October 1;Females;Survival in the second trimester;2020QII;""
33 Asturias;All ages;Cohort October 1;Females;Survival in the second trimester;2020QI;""
33 Asturias;All ages;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
33 Asturias;All ages;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
33 Asturias;All ages;Cohort October 1;Females;Survival in the third trimester;2022QII;23.328
33 Asturias;All ages;Cohort October 1;Females;Survival in the third trimester;2022QI;""
33 Asturias;All ages;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
33 Asturias;All ages;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
33 Asturias;All ages;Cohort October 1;Females;Survival in the third trimester;2021QII;23.375
33 Asturias;All ages;Cohort October 1;Females;Survival in the third trimester;2021QI;""
33 Asturias;All ages;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
33 Asturias;All ages;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
33 Asturias;All ages;Cohort October 1;Females;Survival in the third trimester;2020QII;""
33 Asturias;All ages;Cohort October 1;Females;Survival in the third trimester;2020QI;""
33 Asturias;All ages;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
33 Asturias;All ages;Cohort October 1;Females;Survival in the third trimester;2022QIII;22.681
33 Asturias;All ages;Cohort October 1;Females;Survival in the third trimester;2022QII;""
33 Asturias;All ages;Cohort October 1;Females;Survival in the third trimester;2022QI;""
33 Asturias;All ages;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
33 Asturias;All ages;Cohort October 1;Females;Survival in the third trimester;2021QIII;22.856
33 Asturias;All ages;Cohort October 1;Females;Survival in the third trimester;2021QII;""
33 Asturias;All ages;Cohort October 1;Females;Survival in the third trimester;2021QI;""
33 Asturias;All ages;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
33 Asturias;All ages;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
33 Asturias;All ages;Cohort October 1;Females;Survival in the third trimester;2020QII;""
33 Asturias;All ages;Cohort October 1;Females;Survival in the third trimester;2020QI;""
33 Asturias;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
33 Asturias;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
33 Asturias;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
33 Asturias;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
33 Asturias;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
33 Asturias;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
33 Asturias;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
33 Asturias;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
33 Asturias;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
33 Asturias;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
33 Asturias;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
33 Asturias;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
33 Asturias;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;95,84
33 Asturias;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
33 Asturias;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
33 Asturias;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
33 Asturias;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;96,47
33 Asturias;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
33 Asturias;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
33 Asturias;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
33 Asturias;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;96,57
33 Asturias;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
33 Asturias;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
33 Asturias;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
33 Asturias;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
33 Asturias;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
33 Asturias;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
33 Asturias;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;94,12
33 Asturias;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
33 Asturias;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
33 Asturias;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
33 Asturias;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;94,64
33 Asturias;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
33 Asturias;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
33 Asturias;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
33 Asturias;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
33 Asturias;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
33 Asturias;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
33 Asturias;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;91,39
33 Asturias;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
33 Asturias;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
33 Asturias;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
33 Asturias;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;92,37
33 Asturias;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
33 Asturias;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
33 Asturias;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
33 Asturias;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
33 Asturias;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
33 Asturias;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
33 Asturias;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;88,85
33 Asturias;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
33 Asturias;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
33 Asturias;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
33 Asturias;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;90,32
33 Asturias;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
33 Asturias;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
33 Asturias;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
33 Asturias;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
33 Asturias;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
33 Asturias;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
33 Asturias;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
33 Asturias;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
33 Asturias;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
33 Asturias;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QI;3.146
33 Asturias;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
33 Asturias;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
33 Asturias;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
33 Asturias;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QI;3.152
33 Asturias;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
33 Asturias;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
33 Asturias;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
33 Asturias;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QI;2.578
33 Asturias;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
33 Asturias;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
33 Asturias;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2022QII;""
33 Asturias;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2022QI;2.912
33 Asturias;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
33 Asturias;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
33 Asturias;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2021QII;""
33 Asturias;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2021QI;2.928
33 Asturias;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
33 Asturias;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
33 Asturias;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2020QII;""
33 Asturias;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2020QI;2.262
33 Asturias;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
33 Asturias;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
33 Asturias;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2022QII;2.719
33 Asturias;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2022QI;""
33 Asturias;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
33 Asturias;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
33 Asturias;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2021QII;2.738
33 Asturias;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2021QI;""
33 Asturias;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
33 Asturias;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
33 Asturias;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2020QII;2.187
33 Asturias;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2020QI;""
33 Asturias;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
33 Asturias;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QIII;2.538
33 Asturias;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QII;""
33 Asturias;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QI;""
33 Asturias;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
33 Asturias;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QIII;2.560
33 Asturias;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QII;""
33 Asturias;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QI;""
33 Asturias;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
33 Asturias;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QIII;2.053
33 Asturias;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QII;""
33 Asturias;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QI;""
33 Asturias;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QIV;2.353
33 Asturias;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
33 Asturias;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QII;""
33 Asturias;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QI;""
33 Asturias;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QIV;2.402
33 Asturias;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
33 Asturias;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QII;""
33 Asturias;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QI;""
33 Asturias;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QIV;1.963
33 Asturias;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
33 Asturias;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QII;""
33 Asturias;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QI;""
33 Asturias;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
33 Asturias;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
33 Asturias;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
33 Asturias;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
33 Asturias;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
33 Asturias;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
33 Asturias;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
33 Asturias;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
33 Asturias;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
33 Asturias;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
33 Asturias;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
33 Asturias;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
33 Asturias;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
33 Asturias;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
33 Asturias;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
33 Asturias;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;92,56
33 Asturias;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
33 Asturias;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
33 Asturias;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
33 Asturias;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;92,89
33 Asturias;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
33 Asturias;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
33 Asturias;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
33 Asturias;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;87,74
33 Asturias;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
33 Asturias;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
33 Asturias;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;86,43
33 Asturias;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
33 Asturias;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
33 Asturias;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
33 Asturias;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;86,87
33 Asturias;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
33 Asturias;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
33 Asturias;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
33 Asturias;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;84,83
33 Asturias;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
33 Asturias;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
33 Asturias;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;80,67
33 Asturias;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
33 Asturias;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
33 Asturias;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
33 Asturias;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;81,22
33 Asturias;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
33 Asturias;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
33 Asturias;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
33 Asturias;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;79,64
33 Asturias;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
33 Asturias;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
33 Asturias;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;74,79
33 Asturias;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
33 Asturias;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
33 Asturias;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
33 Asturias;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;76,21
33 Asturias;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
33 Asturias;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
33 Asturias;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
33 Asturias;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;76,14
33 Asturias;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
33 Asturias;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
33 Asturias;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
33 Asturias;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
33 Asturias;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
33 Asturias;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
33 Asturias;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QI;1.919
33 Asturias;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
33 Asturias;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
33 Asturias;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
33 Asturias;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QI;1.921
33 Asturias;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
33 Asturias;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
33 Asturias;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
33 Asturias;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QI;1.573
33 Asturias;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
33 Asturias;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
33 Asturias;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2022QII;""
33 Asturias;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2022QI;1.763
33 Asturias;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
33 Asturias;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
33 Asturias;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2021QII;""
33 Asturias;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2021QI;1.790
33 Asturias;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
33 Asturias;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
33 Asturias;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2020QII;""
33 Asturias;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2020QI;1.368
33 Asturias;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
33 Asturias;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
33 Asturias;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2022QII;1.648
33 Asturias;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2022QI;""
33 Asturias;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
33 Asturias;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
33 Asturias;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2021QII;1.675
33 Asturias;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2021QI;""
33 Asturias;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
33 Asturias;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
33 Asturias;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2020QII;1.323
33 Asturias;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2020QI;""
33 Asturias;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
33 Asturias;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QIII;1.531
33 Asturias;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QII;""
33 Asturias;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QI;""
33 Asturias;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
33 Asturias;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QIII;1.566
33 Asturias;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QII;""
33 Asturias;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QI;""
33 Asturias;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
33 Asturias;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QIII;1.248
33 Asturias;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QII;""
33 Asturias;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QI;""
33 Asturias;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QIV;1.421
33 Asturias;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
33 Asturias;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QII;""
33 Asturias;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QI;""
33 Asturias;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QIV;1.470
33 Asturias;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
33 Asturias;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QII;""
33 Asturias;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QI;""
33 Asturias;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QIV;1.201
33 Asturias;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
33 Asturias;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QII;""
33 Asturias;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QI;""
33 Asturias;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
33 Asturias;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
33 Asturias;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
33 Asturias;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
33 Asturias;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
33 Asturias;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
33 Asturias;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
33 Asturias;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
33 Asturias;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
33 Asturias;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
33 Asturias;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
33 Asturias;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
33 Asturias;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
33 Asturias;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
33 Asturias;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
33 Asturias;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;91,87
33 Asturias;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
33 Asturias;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
33 Asturias;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
33 Asturias;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;93,18
33 Asturias;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
33 Asturias;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
33 Asturias;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
33 Asturias;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;86,97
33 Asturias;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
33 Asturias;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
33 Asturias;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;85,88
33 Asturias;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
33 Asturias;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
33 Asturias;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
33 Asturias;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;87,19
33 Asturias;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
33 Asturias;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
33 Asturias;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
33 Asturias;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;84,11
33 Asturias;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
33 Asturias;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
33 Asturias;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;79,78
33 Asturias;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
33 Asturias;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
33 Asturias;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
33 Asturias;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;81,52
33 Asturias;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
33 Asturias;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
33 Asturias;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
33 Asturias;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;79,34
33 Asturias;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
33 Asturias;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
33 Asturias;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;74,05
33 Asturias;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
33 Asturias;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
33 Asturias;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
33 Asturias;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;76,52
33 Asturias;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
33 Asturias;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
33 Asturias;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
33 Asturias;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;76,35
33 Asturias;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
33 Asturias;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
33 Asturias;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
33 Asturias;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
33 Asturias;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
33 Asturias;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
33 Asturias;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QI;1.227
33 Asturias;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
33 Asturias;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
33 Asturias;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
33 Asturias;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QI;1.231
33 Asturias;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
33 Asturias;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
33 Asturias;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
33 Asturias;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QI;1.005
33 Asturias;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
33 Asturias;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
33 Asturias;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2022QII;""
33 Asturias;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2022QI;1.149
33 Asturias;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
33 Asturias;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
33 Asturias;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2021QII;""
33 Asturias;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2021QI;1.138
33 Asturias;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
33 Asturias;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
33 Asturias;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2020QII;""
33 Asturias;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2020QI;894
33 Asturias;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
33 Asturias;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
33 Asturias;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2022QII;1.071
33 Asturias;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2022QI;""
33 Asturias;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
33 Asturias;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
33 Asturias;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2021QII;1.063
33 Asturias;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2021QI;""
33 Asturias;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
33 Asturias;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
33 Asturias;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2020QII;864
33 Asturias;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2020QI;""
33 Asturias;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
33 Asturias;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QIII;1.007
33 Asturias;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QII;""
33 Asturias;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QI;""
33 Asturias;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
33 Asturias;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QIII;994
33 Asturias;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QII;""
33 Asturias;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QI;""
33 Asturias;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
33 Asturias;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QIII;805
33 Asturias;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QII;""
33 Asturias;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QI;""
33 Asturias;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QIV;932
33 Asturias;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
33 Asturias;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QII;""
33 Asturias;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QI;""
33 Asturias;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QIV;932
33 Asturias;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
33 Asturias;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QII;""
33 Asturias;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QI;""
33 Asturias;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QIV;762
33 Asturias;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
33 Asturias;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QII;""
33 Asturias;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QI;""
33 Asturias;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
33 Asturias;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
33 Asturias;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
33 Asturias;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
33 Asturias;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
33 Asturias;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
33 Asturias;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
33 Asturias;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
33 Asturias;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
33 Asturias;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
33 Asturias;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
33 Asturias;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
33 Asturias;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
33 Asturias;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
33 Asturias;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
33 Asturias;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;93,64
33 Asturias;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
33 Asturias;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
33 Asturias;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
33 Asturias;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;92,45
33 Asturias;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
33 Asturias;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
33 Asturias;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
33 Asturias;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;88,96
33 Asturias;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
33 Asturias;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
33 Asturias;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;87,29
33 Asturias;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
33 Asturias;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
33 Asturias;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
33 Asturias;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;86,35
33 Asturias;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
33 Asturias;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
33 Asturias;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
33 Asturias;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;85,97
33 Asturias;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
33 Asturias;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
33 Asturias;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;82,07
33 Asturias;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
33 Asturias;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
33 Asturias;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
33 Asturias;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;80,75
33 Asturias;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
33 Asturias;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
33 Asturias;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
33 Asturias;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;80,1
33 Asturias;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
33 Asturias;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
33 Asturias;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;75,96
33 Asturias;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
33 Asturias;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
33 Asturias;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
33 Asturias;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;75,71
33 Asturias;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
33 Asturias;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
33 Asturias;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
33 Asturias;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;75,82
33 Asturias;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
33 Asturias;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
33 Asturias;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
33 Asturias;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
33 Asturias;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
33 Asturias;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QII;2.760
33 Asturias;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
33 Asturias;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
33 Asturias;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
33 Asturias;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QII;2.731
33 Asturias;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
33 Asturias;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
33 Asturias;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
33 Asturias;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QII;2.640
33 Asturias;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
33 Asturias;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
33 Asturias;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
33 Asturias;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2022QII;2.544
33 Asturias;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2022QI;""
33 Asturias;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
33 Asturias;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
33 Asturias;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2021QII;2.525
33 Asturias;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2021QI;""
33 Asturias;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
33 Asturias;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
33 Asturias;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2020QII;2.531
33 Asturias;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2020QI;""
33 Asturias;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
33 Asturias;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2022QIII;2.341
33 Asturias;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2022QII;""
33 Asturias;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2022QI;""
33 Asturias;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
33 Asturias;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2021QIII;2.325
33 Asturias;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2021QII;""
33 Asturias;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2021QI;""
33 Asturias;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
33 Asturias;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2020QIII;2.359
33 Asturias;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2020QII;""
33 Asturias;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2020QI;""
33 Asturias;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QIV;2.162
33 Asturias;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
33 Asturias;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QII;""
33 Asturias;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QI;""
33 Asturias;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QIV;2.162
33 Asturias;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
33 Asturias;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QII;""
33 Asturias;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QI;""
33 Asturias;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QIV;2.241
33 Asturias;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
33 Asturias;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QII;""
33 Asturias;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QI;""
33 Asturias;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
33 Asturias;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
33 Asturias;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QII;""
33 Asturias;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QI;2.045
33 Asturias;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
33 Asturias;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
33 Asturias;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QII;""
33 Asturias;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QI;2.124
33 Asturias;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
33 Asturias;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
33 Asturias;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QII;""
33 Asturias;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QI;""
33 Asturias;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
33 Asturias;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
33 Asturias;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
33 Asturias;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
33 Asturias;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
33 Asturias;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
33 Asturias;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
33 Asturias;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
33 Asturias;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
33 Asturias;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
33 Asturias;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
33 Asturias;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
33 Asturias;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
33 Asturias;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
33 Asturias;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;92,17
33 Asturias;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
33 Asturias;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
33 Asturias;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
33 Asturias;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;92,46
33 Asturias;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
33 Asturias;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
33 Asturias;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
33 Asturias;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;95,87
33 Asturias;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
33 Asturias;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
33 Asturias;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;84,82
33 Asturias;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
33 Asturias;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
33 Asturias;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
33 Asturias;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;85,13
33 Asturias;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
33 Asturias;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
33 Asturias;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
33 Asturias;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;89,36
33 Asturias;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
33 Asturias;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
33 Asturias;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;78,33
33 Asturias;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
33 Asturias;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
33 Asturias;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
33 Asturias;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;79,17
33 Asturias;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
33 Asturias;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
33 Asturias;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
33 Asturias;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;84,89
33 Asturias;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
33 Asturias;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
33 Asturias;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
33 Asturias;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
33 Asturias;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
33 Asturias;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
33 Asturias;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;74,88
33 Asturias;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
33 Asturias;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
33 Asturias;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
33 Asturias;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;80,45
33 Asturias;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
33 Asturias;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
33 Asturias;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
33 Asturias;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
33 Asturias;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
33 Asturias;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
33 Asturias;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QII;1.697
33 Asturias;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
33 Asturias;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
33 Asturias;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
33 Asturias;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QII;1.693
33 Asturias;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
33 Asturias;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
33 Asturias;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
33 Asturias;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QII;1.603
33 Asturias;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
33 Asturias;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
33 Asturias;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
33 Asturias;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2022QII;1.560
33 Asturias;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2022QI;""
33 Asturias;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
33 Asturias;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
33 Asturias;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2021QII;1.566
33 Asturias;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2021QI;""
33 Asturias;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
33 Asturias;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
33 Asturias;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2020QII;1.539
33 Asturias;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2020QI;""
33 Asturias;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
33 Asturias;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2022QIII;1.424
33 Asturias;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2022QII;""
33 Asturias;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2022QI;""
33 Asturias;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
33 Asturias;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2021QIII;1.446
33 Asturias;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2021QII;""
33 Asturias;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2021QI;""
33 Asturias;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
33 Asturias;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2020QIII;1.436
33 Asturias;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2020QII;""
33 Asturias;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2020QI;""
33 Asturias;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QIV;1.317
33 Asturias;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
33 Asturias;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QII;""
33 Asturias;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QI;""
33 Asturias;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QIV;1.347
33 Asturias;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
33 Asturias;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QII;""
33 Asturias;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QI;""
33 Asturias;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QIV;1.369
33 Asturias;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
33 Asturias;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QII;""
33 Asturias;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QI;""
33 Asturias;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
33 Asturias;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
33 Asturias;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QII;""
33 Asturias;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QI;1.262
33 Asturias;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
33 Asturias;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
33 Asturias;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QII;""
33 Asturias;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QI;1.308
33 Asturias;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
33 Asturias;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
33 Asturias;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QII;""
33 Asturias;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QI;""
33 Asturias;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
33 Asturias;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
33 Asturias;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
33 Asturias;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
33 Asturias;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
33 Asturias;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
33 Asturias;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
33 Asturias;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
33 Asturias;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
33 Asturias;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
33 Asturias;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
33 Asturias;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
33 Asturias;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
33 Asturias;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
33 Asturias;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;91,93
33 Asturias;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
33 Asturias;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
33 Asturias;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
33 Asturias;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;92,5
33 Asturias;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
33 Asturias;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
33 Asturias;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
33 Asturias;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;96,01
33 Asturias;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
33 Asturias;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
33 Asturias;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;83,91
33 Asturias;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
33 Asturias;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
33 Asturias;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
33 Asturias;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;85,41
33 Asturias;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
33 Asturias;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
33 Asturias;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
33 Asturias;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;89,58
33 Asturias;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
33 Asturias;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
33 Asturias;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;77,61
33 Asturias;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
33 Asturias;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
33 Asturias;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
33 Asturias;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;79,56
33 Asturias;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
33 Asturias;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
33 Asturias;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
33 Asturias;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;85,4
33 Asturias;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
33 Asturias;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
33 Asturias;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
33 Asturias;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
33 Asturias;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
33 Asturias;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
33 Asturias;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;74,54
33 Asturias;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
33 Asturias;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
33 Asturias;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
33 Asturias;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;81,6
33 Asturias;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
33 Asturias;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
33 Asturias;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
33 Asturias;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
33 Asturias;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
33 Asturias;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
33 Asturias;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QII;1.063
33 Asturias;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
33 Asturias;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
33 Asturias;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
33 Asturias;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QII;1.038
33 Asturias;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
33 Asturias;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
33 Asturias;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
33 Asturias;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QII;1.037
33 Asturias;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
33 Asturias;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
33 Asturias;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
33 Asturias;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2022QII;984
33 Asturias;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2022QI;""
33 Asturias;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
33 Asturias;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
33 Asturias;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2021QII;959
33 Asturias;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2021QI;""
33 Asturias;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
33 Asturias;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
33 Asturias;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2020QII;992
33 Asturias;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2020QI;""
33 Asturias;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
33 Asturias;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2022QIII;917
33 Asturias;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2022QII;""
33 Asturias;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2022QI;""
33 Asturias;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
33 Asturias;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2021QIII;879
33 Asturias;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2021QII;""
33 Asturias;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2021QI;""
33 Asturias;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
33 Asturias;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2020QIII;923
33 Asturias;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2020QII;""
33 Asturias;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2020QI;""
33 Asturias;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QIV;845
33 Asturias;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
33 Asturias;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QII;""
33 Asturias;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QI;""
33 Asturias;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QIV;815
33 Asturias;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
33 Asturias;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QII;""
33 Asturias;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QI;""
33 Asturias;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QIV;872
33 Asturias;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
33 Asturias;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QII;""
33 Asturias;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QI;""
33 Asturias;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
33 Asturias;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
33 Asturias;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QII;""
33 Asturias;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QI;783
33 Asturias;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
33 Asturias;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
33 Asturias;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QII;""
33 Asturias;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QI;816
33 Asturias;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
33 Asturias;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
33 Asturias;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QII;""
33 Asturias;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QI;""
33 Asturias;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
33 Asturias;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
33 Asturias;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
33 Asturias;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
33 Asturias;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
33 Asturias;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
33 Asturias;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
33 Asturias;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
33 Asturias;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
33 Asturias;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
33 Asturias;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
33 Asturias;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
33 Asturias;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
33 Asturias;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
33 Asturias;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;92,57
33 Asturias;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
33 Asturias;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
33 Asturias;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
33 Asturias;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;92,39
33 Asturias;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
33 Asturias;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
33 Asturias;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
33 Asturias;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;95,66
33 Asturias;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
33 Asturias;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
33 Asturias;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;86,27
33 Asturias;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
33 Asturias;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
33 Asturias;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
33 Asturias;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;84,68
33 Asturias;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
33 Asturias;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
33 Asturias;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
33 Asturias;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;89,01
33 Asturias;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
33 Asturias;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
33 Asturias;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;79,49
33 Asturias;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
33 Asturias;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
33 Asturias;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
33 Asturias;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;78,52
33 Asturias;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
33 Asturias;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
33 Asturias;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
33 Asturias;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;84,09
33 Asturias;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
33 Asturias;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
33 Asturias;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
33 Asturias;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
33 Asturias;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
33 Asturias;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
33 Asturias;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;75,43
33 Asturias;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
33 Asturias;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
33 Asturias;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
33 Asturias;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;78,69
33 Asturias;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
33 Asturias;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
33 Asturias;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
33 Asturias;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
33 Asturias;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
33 Asturias;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QIII;2.902
33 Asturias;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
33 Asturias;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
33 Asturias;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
33 Asturias;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QIII;2.940
33 Asturias;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
33 Asturias;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
33 Asturias;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
33 Asturias;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QIII;2.787
33 Asturias;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
33 Asturias;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
33 Asturias;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
33 Asturias;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2022QIII;2.629
33 Asturias;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2022QII;""
33 Asturias;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2022QI;""
33 Asturias;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
33 Asturias;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2021QIII;2.680
33 Asturias;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2021QII;""
33 Asturias;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2021QI;""
33 Asturias;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
33 Asturias;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2020QIII;2.564
33 Asturias;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2020QII;""
33 Asturias;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2020QI;""
33 Asturias;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2022QIV;2.420
33 Asturias;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
33 Asturias;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2022QII;""
33 Asturias;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2022QI;""
33 Asturias;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2021QIV;2.478
33 Asturias;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
33 Asturias;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2021QII;""
33 Asturias;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2021QI;""
33 Asturias;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2020QIV;2.415
33 Asturias;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
33 Asturias;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2020QII;""
33 Asturias;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2020QI;""
33 Asturias;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
33 Asturias;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
33 Asturias;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QII;""
33 Asturias;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QI;2.330
33 Asturias;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
33 Asturias;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
33 Asturias;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QII;""
33 Asturias;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QI;2.284
33 Asturias;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
33 Asturias;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
33 Asturias;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QII;""
33 Asturias;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QI;""
33 Asturias;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
33 Asturias;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
33 Asturias;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QII;2.195
33 Asturias;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QI;""
33 Asturias;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
33 Asturias;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
33 Asturias;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QII;2.174
33 Asturias;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QI;""
33 Asturias;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
33 Asturias;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
33 Asturias;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QII;""
33 Asturias;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QI;""
33 Asturias;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
33 Asturias;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
33 Asturias;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
33 Asturias;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
33 Asturias;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
33 Asturias;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
33 Asturias;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
33 Asturias;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
33 Asturias;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
33 Asturias;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
33 Asturias;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
33 Asturias;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
33 Asturias;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
33 Asturias;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;90,59
33 Asturias;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
33 Asturias;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
33 Asturias;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
33 Asturias;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;91,16
33 Asturias;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
33 Asturias;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
33 Asturias;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
33 Asturias;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;92
33 Asturias;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
33 Asturias;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
33 Asturias;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;83,39
33 Asturias;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
33 Asturias;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
33 Asturias;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
33 Asturias;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;84,29
33 Asturias;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
33 Asturias;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
33 Asturias;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
33 Asturias;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;86,65
33 Asturias;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
33 Asturias;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
33 Asturias;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
33 Asturias;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
33 Asturias;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
33 Asturias;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
33 Asturias;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;79,25
33 Asturias;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
33 Asturias;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
33 Asturias;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
33 Asturias;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;81,95
33 Asturias;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
33 Asturias;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
33 Asturias;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
33 Asturias;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
33 Asturias;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
33 Asturias;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
33 Asturias;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;74,66
33 Asturias;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
33 Asturias;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
33 Asturias;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
33 Asturias;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;78,01
33 Asturias;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
33 Asturias;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
33 Asturias;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
33 Asturias;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
33 Asturias;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
33 Asturias;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
33 Asturias;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QIII;1.759
33 Asturias;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
33 Asturias;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
33 Asturias;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
33 Asturias;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QIII;1.809
33 Asturias;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
33 Asturias;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
33 Asturias;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
33 Asturias;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QIII;1.711
33 Asturias;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
33 Asturias;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
33 Asturias;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
33 Asturias;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2022QIII;1.581
33 Asturias;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2022QII;""
33 Asturias;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2022QI;""
33 Asturias;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
33 Asturias;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2021QIII;1.651
33 Asturias;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2021QII;""
33 Asturias;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2021QI;""
33 Asturias;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
33 Asturias;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2020QIII;1.572
33 Asturias;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2020QII;""
33 Asturias;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2020QI;""
33 Asturias;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2022QIV;1.457
33 Asturias;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
33 Asturias;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2022QII;""
33 Asturias;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2022QI;""
33 Asturias;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2021QIV;1.533
33 Asturias;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
33 Asturias;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2021QII;""
33 Asturias;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2021QI;""
33 Asturias;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2020QIV;1.482
33 Asturias;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
33 Asturias;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2020QII;""
33 Asturias;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2020QI;""
33 Asturias;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
33 Asturias;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
33 Asturias;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QII;""
33 Asturias;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QI;1.428
33 Asturias;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
33 Asturias;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
33 Asturias;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QII;""
33 Asturias;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QI;1.410
33 Asturias;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
33 Asturias;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
33 Asturias;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QII;""
33 Asturias;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QI;""
33 Asturias;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
33 Asturias;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
33 Asturias;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QII;1.343
33 Asturias;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QI;""
33 Asturias;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
33 Asturias;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
33 Asturias;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QII;1.342
33 Asturias;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QI;""
33 Asturias;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
33 Asturias;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
33 Asturias;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QII;""
33 Asturias;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QI;""
33 Asturias;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
33 Asturias;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
33 Asturias;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
33 Asturias;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
33 Asturias;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
33 Asturias;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
33 Asturias;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
33 Asturias;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
33 Asturias;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
33 Asturias;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
33 Asturias;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
33 Asturias;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
33 Asturias;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
33 Asturias;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;89,88
33 Asturias;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
33 Asturias;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
33 Asturias;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
33 Asturias;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;91,27
33 Asturias;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
33 Asturias;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
33 Asturias;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
33 Asturias;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;91,88
33 Asturias;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
33 Asturias;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
33 Asturias;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;82,83
33 Asturias;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
33 Asturias;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
33 Asturias;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
33 Asturias;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;84,74
33 Asturias;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
33 Asturias;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
33 Asturias;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
33 Asturias;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;86,62
33 Asturias;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
33 Asturias;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
33 Asturias;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
33 Asturias;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
33 Asturias;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
33 Asturias;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
33 Asturias;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;78,94
33 Asturias;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
33 Asturias;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
33 Asturias;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
33 Asturias;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;82,41
33 Asturias;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
33 Asturias;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
33 Asturias;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
33 Asturias;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
33 Asturias;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
33 Asturias;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
33 Asturias;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;74,24
33 Asturias;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
33 Asturias;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
33 Asturias;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
33 Asturias;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;78,43
33 Asturias;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
33 Asturias;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
33 Asturias;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
33 Asturias;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
33 Asturias;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
33 Asturias;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
33 Asturias;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QIII;1.143
33 Asturias;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
33 Asturias;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
33 Asturias;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
33 Asturias;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QIII;1.131
33 Asturias;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
33 Asturias;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
33 Asturias;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
33 Asturias;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QIII;1.076
33 Asturias;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
33 Asturias;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
33 Asturias;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
33 Asturias;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2022QIII;1.048
33 Asturias;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2022QII;""
33 Asturias;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2022QI;""
33 Asturias;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
33 Asturias;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2021QIII;1.029
33 Asturias;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2021QII;""
33 Asturias;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2021QI;""
33 Asturias;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
33 Asturias;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2020QIII;992
33 Asturias;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2020QII;""
33 Asturias;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2020QI;""
33 Asturias;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2022QIV;963
33 Asturias;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
33 Asturias;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2022QII;""
33 Asturias;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2022QI;""
33 Asturias;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2021QIV;945
33 Asturias;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
33 Asturias;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2021QII;""
33 Asturias;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2021QI;""
33 Asturias;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2020QIV;933
33 Asturias;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
33 Asturias;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2020QII;""
33 Asturias;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2020QI;""
33 Asturias;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
33 Asturias;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
33 Asturias;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QII;""
33 Asturias;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QI;902
33 Asturias;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
33 Asturias;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
33 Asturias;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QII;""
33 Asturias;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QI;874
33 Asturias;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
33 Asturias;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
33 Asturias;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QII;""
33 Asturias;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QI;""
33 Asturias;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
33 Asturias;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
33 Asturias;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QII;852
33 Asturias;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QI;""
33 Asturias;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
33 Asturias;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
33 Asturias;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QII;832
33 Asturias;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QI;""
33 Asturias;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
33 Asturias;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
33 Asturias;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QII;""
33 Asturias;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QI;""
33 Asturias;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
33 Asturias;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
33 Asturias;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
33 Asturias;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
33 Asturias;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
33 Asturias;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
33 Asturias;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
33 Asturias;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
33 Asturias;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
33 Asturias;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
33 Asturias;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
33 Asturias;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
33 Asturias;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
33 Asturias;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;91,69
33 Asturias;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
33 Asturias;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
33 Asturias;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
33 Asturias;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;90,98
33 Asturias;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
33 Asturias;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
33 Asturias;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
33 Asturias;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;92,19
33 Asturias;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
33 Asturias;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
33 Asturias;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;84,25
33 Asturias;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
33 Asturias;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
33 Asturias;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
33 Asturias;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;83,55
33 Asturias;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
33 Asturias;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
33 Asturias;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
33 Asturias;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;86,71
33 Asturias;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
33 Asturias;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
33 Asturias;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
33 Asturias;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
33 Asturias;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
33 Asturias;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
33 Asturias;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;79,75
33 Asturias;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
33 Asturias;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
33 Asturias;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
33 Asturias;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;81,23
33 Asturias;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
33 Asturias;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
33 Asturias;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
33 Asturias;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
33 Asturias;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
33 Asturias;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
33 Asturias;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;75,33
33 Asturias;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
33 Asturias;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
33 Asturias;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
33 Asturias;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;77,32
33 Asturias;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
33 Asturias;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
33 Asturias;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
33 Asturias;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
33 Asturias;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
33 Asturias;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QIV;2.987
33 Asturias;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
33 Asturias;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
33 Asturias;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
33 Asturias;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QIV;3.034
33 Asturias;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
33 Asturias;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
33 Asturias;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
33 Asturias;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QIV;2.948
33 Asturias;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
33 Asturias;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
33 Asturias;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
33 Asturias;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2022QIV;2.727
33 Asturias;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
33 Asturias;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2022QII;""
33 Asturias;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2022QI;""
33 Asturias;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2021QIV;2.785
33 Asturias;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
33 Asturias;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2021QII;""
33 Asturias;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2021QI;""
33 Asturias;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2020QIV;2.748
33 Asturias;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
33 Asturias;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2020QII;""
33 Asturias;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2020QI;""
33 Asturias;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
33 Asturias;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
33 Asturias;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2022QII;""
33 Asturias;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2022QI;2.605
33 Asturias;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
33 Asturias;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
33 Asturias;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2021QII;""
33 Asturias;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2021QI;2.584
33 Asturias;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
33 Asturias;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
33 Asturias;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2020QII;""
33 Asturias;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2020QI;""
33 Asturias;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
33 Asturias;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
33 Asturias;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QII;2.451
33 Asturias;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QI;""
33 Asturias;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
33 Asturias;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
33 Asturias;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QII;2.441
33 Asturias;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QI;""
33 Asturias;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
33 Asturias;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
33 Asturias;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QII;""
33 Asturias;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QI;""
33 Asturias;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
33 Asturias;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QIII;2.298
33 Asturias;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QII;""
33 Asturias;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QI;""
33 Asturias;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
33 Asturias;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QIII;2.299
33 Asturias;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QII;""
33 Asturias;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QI;""
33 Asturias;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
33 Asturias;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
33 Asturias;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QII;""
33 Asturias;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QI;""
33 Asturias;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
33 Asturias;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
33 Asturias;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
33 Asturias;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
33 Asturias;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
33 Asturias;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
33 Asturias;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
33 Asturias;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
33 Asturias;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
33 Asturias;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
33 Asturias;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
33 Asturias;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
33 Asturias;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;91,3
33 Asturias;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
33 Asturias;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
33 Asturias;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
33 Asturias;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;91,79
33 Asturias;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
33 Asturias;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
33 Asturias;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
33 Asturias;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;93,22
33 Asturias;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
33 Asturias;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
33 Asturias;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
33 Asturias;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
33 Asturias;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
33 Asturias;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
33 Asturias;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;85,86
33 Asturias;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
33 Asturias;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
33 Asturias;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
33 Asturias;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;87,65
33 Asturias;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
33 Asturias;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
33 Asturias;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
33 Asturias;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
33 Asturias;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
33 Asturias;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
33 Asturias;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;80,78
33 Asturias;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
33 Asturias;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
33 Asturias;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
33 Asturias;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;82,8
33 Asturias;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
33 Asturias;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
33 Asturias;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
33 Asturias;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
33 Asturias;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
33 Asturias;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
33 Asturias;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;75,74
33 Asturias;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
33 Asturias;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
33 Asturias;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
33 Asturias;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;77,99
33 Asturias;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
33 Asturias;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
33 Asturias;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
33 Asturias;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
33 Asturias;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
33 Asturias;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
33 Asturias;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QIV;1.788
33 Asturias;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
33 Asturias;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
33 Asturias;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
33 Asturias;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QIV;1.864
33 Asturias;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
33 Asturias;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
33 Asturias;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
33 Asturias;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QIV;1.810
33 Asturias;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
33 Asturias;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
33 Asturias;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
33 Asturias;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2022QIV;1.639
33 Asturias;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
33 Asturias;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2022QII;""
33 Asturias;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2022QI;""
33 Asturias;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2021QIV;1.716
33 Asturias;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
33 Asturias;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2021QII;""
33 Asturias;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2021QI;""
33 Asturias;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2020QIV;1.689
33 Asturias;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
33 Asturias;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2020QII;""
33 Asturias;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2020QI;""
33 Asturias;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
33 Asturias;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
33 Asturias;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2022QII;""
33 Asturias;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2022QI;1.589
33 Asturias;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
33 Asturias;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
33 Asturias;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2021QII;""
33 Asturias;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2021QI;1.596
33 Asturias;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
33 Asturias;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
33 Asturias;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2020QII;""
33 Asturias;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2020QI;""
33 Asturias;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
33 Asturias;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
33 Asturias;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QII;1.493
33 Asturias;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QI;""
33 Asturias;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
33 Asturias;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
33 Asturias;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QII;1.506
33 Asturias;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QI;""
33 Asturias;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
33 Asturias;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
33 Asturias;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QII;""
33 Asturias;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QI;""
33 Asturias;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
33 Asturias;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QIII;1.395
33 Asturias;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QII;""
33 Asturias;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QI;""
33 Asturias;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
33 Asturias;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QIII;1.422
33 Asturias;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QII;""
33 Asturias;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QI;""
33 Asturias;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
33 Asturias;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
33 Asturias;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QII;""
33 Asturias;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QI;""
33 Asturias;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
33 Asturias;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
33 Asturias;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
33 Asturias;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
33 Asturias;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
33 Asturias;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
33 Asturias;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
33 Asturias;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
33 Asturias;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
33 Asturias;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
33 Asturias;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
33 Asturias;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
33 Asturias;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;91,67
33 Asturias;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
33 Asturias;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
33 Asturias;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
33 Asturias;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;92,06
33 Asturias;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
33 Asturias;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
33 Asturias;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
33 Asturias;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;93,31
33 Asturias;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
33 Asturias;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
33 Asturias;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
33 Asturias;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
33 Asturias;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
33 Asturias;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
33 Asturias;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;85,25
33 Asturias;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
33 Asturias;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
33 Asturias;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
33 Asturias;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;88,18
33 Asturias;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
33 Asturias;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
33 Asturias;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
33 Asturias;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
33 Asturias;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
33 Asturias;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
33 Asturias;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;80,1
33 Asturias;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
33 Asturias;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
33 Asturias;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
33 Asturias;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;83,2
33 Asturias;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
33 Asturias;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
33 Asturias;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
33 Asturias;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
33 Asturias;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
33 Asturias;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
33 Asturias;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;74,84
33 Asturias;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
33 Asturias;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
33 Asturias;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
33 Asturias;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;78,56
33 Asturias;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
33 Asturias;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
33 Asturias;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
33 Asturias;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
33 Asturias;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
33 Asturias;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
33 Asturias;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QIV;1.199
33 Asturias;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
33 Asturias;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
33 Asturias;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
33 Asturias;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QIV;1.170
33 Asturias;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
33 Asturias;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
33 Asturias;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
33 Asturias;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QIV;1.138
33 Asturias;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
33 Asturias;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
33 Asturias;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
33 Asturias;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2022QIV;1.088
33 Asturias;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
33 Asturias;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2022QII;""
33 Asturias;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2022QI;""
33 Asturias;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2021QIV;1.069
33 Asturias;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
33 Asturias;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2021QII;""
33 Asturias;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2021QI;""
33 Asturias;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2020QIV;1.059
33 Asturias;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
33 Asturias;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2020QII;""
33 Asturias;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2020QI;""
33 Asturias;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
33 Asturias;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
33 Asturias;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2022QII;""
33 Asturias;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2022QI;1.016
33 Asturias;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
33 Asturias;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
33 Asturias;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2021QII;""
33 Asturias;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2021QI;988
33 Asturias;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
33 Asturias;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
33 Asturias;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2020QII;""
33 Asturias;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2020QI;""
33 Asturias;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
33 Asturias;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
33 Asturias;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QII;958
33 Asturias;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QI;""
33 Asturias;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
33 Asturias;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
33 Asturias;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QII;935
33 Asturias;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QI;""
33 Asturias;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
33 Asturias;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
33 Asturias;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QII;""
33 Asturias;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QI;""
33 Asturias;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
33 Asturias;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QIII;903
33 Asturias;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QII;""
33 Asturias;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QI;""
33 Asturias;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
33 Asturias;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QIII;877
33 Asturias;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QII;""
33 Asturias;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QI;""
33 Asturias;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
33 Asturias;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
33 Asturias;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QII;""
33 Asturias;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QI;""
33 Asturias;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
33 Asturias;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
33 Asturias;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
33 Asturias;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
33 Asturias;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
33 Asturias;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
33 Asturias;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
33 Asturias;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
33 Asturias;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
33 Asturias;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
33 Asturias;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
33 Asturias;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
33 Asturias;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;90,74
33 Asturias;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
33 Asturias;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
33 Asturias;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
33 Asturias;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;91,37
33 Asturias;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
33 Asturias;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
33 Asturias;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
33 Asturias;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;93,06
33 Asturias;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
33 Asturias;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
33 Asturias;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
33 Asturias;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
33 Asturias;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
33 Asturias;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
33 Asturias;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;86,84
33 Asturias;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
33 Asturias;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
33 Asturias;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
33 Asturias;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;86,82
33 Asturias;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
33 Asturias;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
33 Asturias;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
33 Asturias;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
33 Asturias;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
33 Asturias;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
33 Asturias;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;81,88
33 Asturias;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
33 Asturias;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
33 Asturias;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
33 Asturias;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;82,16
33 Asturias;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
33 Asturias;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
33 Asturias;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
33 Asturias;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
33 Asturias;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
33 Asturias;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
33 Asturias;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;77,18
33 Asturias;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
33 Asturias;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
33 Asturias;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
33 Asturias;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;77,07
33 Asturias;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
33 Asturias;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
33 Asturias;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
33 Asturias;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
33 Asturias;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
33 Asturias;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
33 Asturias;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
33 Asturias;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
33 Asturias;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
33 Asturias;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QI;10.356
33 Asturias;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
33 Asturias;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
33 Asturias;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
33 Asturias;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QI;10.803
33 Asturias;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
33 Asturias;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
33 Asturias;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
33 Asturias;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QI;10.531
33 Asturias;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
33 Asturias;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
33 Asturias;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2022QII;""
33 Asturias;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2022QI;10.013
33 Asturias;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
33 Asturias;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
33 Asturias;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2021QII;""
33 Asturias;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2021QI;10.533
33 Asturias;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
33 Asturias;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
33 Asturias;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2020QII;""
33 Asturias;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2020QI;9.836
33 Asturias;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
33 Asturias;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
33 Asturias;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2022QII;9.651
33 Asturias;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2022QI;""
33 Asturias;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
33 Asturias;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
33 Asturias;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2021QII;10.193
33 Asturias;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2021QI;""
33 Asturias;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
33 Asturias;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
33 Asturias;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2020QII;9.643
33 Asturias;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2020QI;""
33 Asturias;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
33 Asturias;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QIII;9.326
33 Asturias;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QII;""
33 Asturias;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QI;""
33 Asturias;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
33 Asturias;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QIII;9.939
33 Asturias;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QII;""
33 Asturias;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QI;""
33 Asturias;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
33 Asturias;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QIII;9.365
33 Asturias;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QII;""
33 Asturias;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QI;""
33 Asturias;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QIV;8.983
33 Asturias;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
33 Asturias;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QII;""
33 Asturias;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QI;""
33 Asturias;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QIV;9.629
33 Asturias;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
33 Asturias;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QII;""
33 Asturias;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QI;""
33 Asturias;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QIV;9.100
33 Asturias;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
33 Asturias;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QII;""
33 Asturias;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QI;""
33 Asturias;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
33 Asturias;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
33 Asturias;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
33 Asturias;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
33 Asturias;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
33 Asturias;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
33 Asturias;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
33 Asturias;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
33 Asturias;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
33 Asturias;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
33 Asturias;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
33 Asturias;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
33 Asturias;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
33 Asturias;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
33 Asturias;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
33 Asturias;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;96,69
33 Asturias;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
33 Asturias;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
33 Asturias;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
33 Asturias;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;97,5
33 Asturias;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
33 Asturias;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
33 Asturias;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
33 Asturias;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;93,4
33 Asturias;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
33 Asturias;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
33 Asturias;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;93,19
33 Asturias;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
33 Asturias;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
33 Asturias;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
33 Asturias;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;94,35
33 Asturias;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
33 Asturias;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
33 Asturias;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
33 Asturias;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;91,57
33 Asturias;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
33 Asturias;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
33 Asturias;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;90,05
33 Asturias;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
33 Asturias;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
33 Asturias;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
33 Asturias;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;92
33 Asturias;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
33 Asturias;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
33 Asturias;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
33 Asturias;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;88,93
33 Asturias;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
33 Asturias;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
33 Asturias;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;86,74
33 Asturias;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
33 Asturias;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
33 Asturias;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
33 Asturias;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;89,13
33 Asturias;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
33 Asturias;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
33 Asturias;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
33 Asturias;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;86,41
33 Asturias;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
33 Asturias;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
33 Asturias;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
33 Asturias;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
33 Asturias;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
33 Asturias;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
33 Asturias;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QI;5.898
33 Asturias;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
33 Asturias;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
33 Asturias;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
33 Asturias;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QI;6.222
33 Asturias;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
33 Asturias;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
33 Asturias;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
33 Asturias;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QI;6.008
33 Asturias;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
33 Asturias;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
33 Asturias;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2022QII;""
33 Asturias;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2022QI;5.697
33 Asturias;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
33 Asturias;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
33 Asturias;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2021QII;""
33 Asturias;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2021QI;6.063
33 Asturias;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
33 Asturias;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
33 Asturias;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2020QII;""
33 Asturias;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2020QI;5.610
33 Asturias;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
33 Asturias;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
33 Asturias;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2022QII;5.501
33 Asturias;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2022QI;""
33 Asturias;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
33 Asturias;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
33 Asturias;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2021QII;5.874
33 Asturias;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2021QI;""
33 Asturias;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
33 Asturias;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
33 Asturias;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2020QII;5.513
33 Asturias;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2020QI;""
33 Asturias;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
33 Asturias;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QIII;5.342
33 Asturias;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QII;""
33 Asturias;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QI;""
33 Asturias;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
33 Asturias;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QIII;5.727
33 Asturias;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QII;""
33 Asturias;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QI;""
33 Asturias;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
33 Asturias;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QIII;5.384
33 Asturias;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QII;""
33 Asturias;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QI;""
33 Asturias;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QIV;5.161
33 Asturias;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
33 Asturias;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QII;""
33 Asturias;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QI;""
33 Asturias;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QIV;5.545
33 Asturias;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
33 Asturias;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QII;""
33 Asturias;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QI;""
33 Asturias;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QIV;5.243
33 Asturias;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
33 Asturias;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QII;""
33 Asturias;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QI;""
33 Asturias;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
33 Asturias;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
33 Asturias;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
33 Asturias;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
33 Asturias;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
33 Asturias;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
33 Asturias;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
33 Asturias;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
33 Asturias;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
33 Asturias;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
33 Asturias;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
33 Asturias;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
33 Asturias;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
33 Asturias;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
33 Asturias;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
33 Asturias;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;96,59
33 Asturias;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
33 Asturias;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
33 Asturias;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
33 Asturias;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;97,44
33 Asturias;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
33 Asturias;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
33 Asturias;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
33 Asturias;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;93,38
33 Asturias;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
33 Asturias;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
33 Asturias;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;93,27
33 Asturias;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
33 Asturias;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
33 Asturias;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
33 Asturias;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;94,41
33 Asturias;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
33 Asturias;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
33 Asturias;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
33 Asturias;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;91,76
33 Asturias;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
33 Asturias;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
33 Asturias;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;90,57
33 Asturias;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
33 Asturias;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
33 Asturias;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
33 Asturias;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;92,04
33 Asturias;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
33 Asturias;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
33 Asturias;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
33 Asturias;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;89,61
33 Asturias;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
33 Asturias;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
33 Asturias;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;87,5
33 Asturias;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
33 Asturias;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
33 Asturias;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
33 Asturias;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;89,12
33 Asturias;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
33 Asturias;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
33 Asturias;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
33 Asturias;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;87,27
33 Asturias;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
33 Asturias;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
33 Asturias;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
33 Asturias;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
33 Asturias;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
33 Asturias;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
33 Asturias;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QI;4.458
33 Asturias;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
33 Asturias;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
33 Asturias;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
33 Asturias;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QI;4.581
33 Asturias;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
33 Asturias;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
33 Asturias;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
33 Asturias;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QI;4.523
33 Asturias;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
33 Asturias;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
33 Asturias;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2022QII;""
33 Asturias;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2022QI;4.316
33 Asturias;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
33 Asturias;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
33 Asturias;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2021QII;""
33 Asturias;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2021QI;4.470
33 Asturias;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
33 Asturias;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
33 Asturias;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2020QII;""
33 Asturias;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2020QI;4.226
33 Asturias;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
33 Asturias;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
33 Asturias;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2022QII;4.150
33 Asturias;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2022QI;""
33 Asturias;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
33 Asturias;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
33 Asturias;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2021QII;4.319
33 Asturias;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2021QI;""
33 Asturias;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
33 Asturias;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
33 Asturias;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2020QII;4.130
33 Asturias;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2020QI;""
33 Asturias;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
33 Asturias;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QIII;3.984
33 Asturias;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QII;""
33 Asturias;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QI;""
33 Asturias;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
33 Asturias;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QIII;4.212
33 Asturias;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QII;""
33 Asturias;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QI;""
33 Asturias;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
33 Asturias;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QIII;3.981
33 Asturias;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QII;""
33 Asturias;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QI;""
33 Asturias;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QIV;3.822
33 Asturias;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
33 Asturias;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QII;""
33 Asturias;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QI;""
33 Asturias;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QIV;4.084
33 Asturias;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
33 Asturias;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QII;""
33 Asturias;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QI;""
33 Asturias;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QIV;3.857
33 Asturias;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
33 Asturias;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QII;""
33 Asturias;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QI;""
33 Asturias;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
33 Asturias;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
33 Asturias;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
33 Asturias;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
33 Asturias;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
33 Asturias;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
33 Asturias;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
33 Asturias;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
33 Asturias;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
33 Asturias;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
33 Asturias;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
33 Asturias;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
33 Asturias;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
33 Asturias;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
33 Asturias;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
33 Asturias;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;96,81
33 Asturias;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
33 Asturias;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
33 Asturias;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
33 Asturias;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;97,58
33 Asturias;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
33 Asturias;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
33 Asturias;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
33 Asturias;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;93,43
33 Asturias;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
33 Asturias;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
33 Asturias;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;93,09
33 Asturias;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
33 Asturias;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
33 Asturias;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
33 Asturias;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;94,28
33 Asturias;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
33 Asturias;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
33 Asturias;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
33 Asturias;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;91,31
33 Asturias;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
33 Asturias;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
33 Asturias;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;89,37
33 Asturias;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
33 Asturias;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
33 Asturias;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
33 Asturias;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;91,94
33 Asturias;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
33 Asturias;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
33 Asturias;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
33 Asturias;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;88,02
33 Asturias;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
33 Asturias;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
33 Asturias;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;85,73
33 Asturias;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
33 Asturias;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
33 Asturias;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
33 Asturias;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;89,15
33 Asturias;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
33 Asturias;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
33 Asturias;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
33 Asturias;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;85,28
33 Asturias;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
33 Asturias;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
33 Asturias;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
33 Asturias;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
33 Asturias;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
33 Asturias;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QII;9.634
33 Asturias;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
33 Asturias;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
33 Asturias;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
33 Asturias;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QII;10.030
33 Asturias;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
33 Asturias;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
33 Asturias;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
33 Asturias;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QII;10.388
33 Asturias;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
33 Asturias;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
33 Asturias;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
33 Asturias;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2022QII;9.232
33 Asturias;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2022QI;""
33 Asturias;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
33 Asturias;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
33 Asturias;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2021QII;9.651
33 Asturias;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2021QI;""
33 Asturias;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
33 Asturias;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
33 Asturias;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2020QII;10.174
33 Asturias;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2020QI;""
33 Asturias;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
33 Asturias;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2022QIII;8.886
33 Asturias;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2022QII;""
33 Asturias;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2022QI;""
33 Asturias;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
33 Asturias;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2021QIII;9.369
33 Asturias;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2021QII;""
33 Asturias;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2021QI;""
33 Asturias;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
33 Asturias;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2020QIII;9.863
33 Asturias;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2020QII;""
33 Asturias;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2020QI;""
33 Asturias;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QIV;8.523
33 Asturias;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
33 Asturias;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QII;""
33 Asturias;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QI;""
33 Asturias;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QIV;9.052
33 Asturias;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
33 Asturias;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QII;""
33 Asturias;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QI;""
33 Asturias;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QIV;9.568
33 Asturias;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
33 Asturias;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QII;""
33 Asturias;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QI;""
33 Asturias;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
33 Asturias;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
33 Asturias;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QII;""
33 Asturias;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QI;8.802
33 Asturias;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
33 Asturias;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
33 Asturias;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QII;""
33 Asturias;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QI;9.387
33 Asturias;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
33 Asturias;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
33 Asturias;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QII;""
33 Asturias;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QI;""
33 Asturias;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
33 Asturias;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
33 Asturias;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
33 Asturias;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
33 Asturias;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
33 Asturias;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
33 Asturias;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
33 Asturias;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
33 Asturias;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
33 Asturias;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
33 Asturias;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
33 Asturias;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
33 Asturias;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
33 Asturias;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
33 Asturias;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;95,83
33 Asturias;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
33 Asturias;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
33 Asturias;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
33 Asturias;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;96,22
33 Asturias;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
33 Asturias;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
33 Asturias;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
33 Asturias;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;97,94
33 Asturias;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
33 Asturias;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
33 Asturias;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;92,24
33 Asturias;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
33 Asturias;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
33 Asturias;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
33 Asturias;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;93,41
33 Asturias;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
33 Asturias;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
33 Asturias;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
33 Asturias;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;94,95
33 Asturias;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
33 Asturias;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
33 Asturias;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;88,47
33 Asturias;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
33 Asturias;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
33 Asturias;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
33 Asturias;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;90,25
33 Asturias;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
33 Asturias;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
33 Asturias;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
33 Asturias;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;92,11
33 Asturias;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
33 Asturias;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
33 Asturias;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
33 Asturias;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
33 Asturias;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
33 Asturias;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
33 Asturias;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;87,76
33 Asturias;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
33 Asturias;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
33 Asturias;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
33 Asturias;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;90,36
33 Asturias;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
33 Asturias;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
33 Asturias;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
33 Asturias;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
33 Asturias;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
33 Asturias;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
33 Asturias;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QII;5.472
33 Asturias;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
33 Asturias;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
33 Asturias;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
33 Asturias;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QII;5.769
33 Asturias;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
33 Asturias;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
33 Asturias;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
33 Asturias;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QII;5.908
33 Asturias;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
33 Asturias;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
33 Asturias;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
33 Asturias;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2022QII;5.250
33 Asturias;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2022QI;""
33 Asturias;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
33 Asturias;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
33 Asturias;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2021QII;5.550
33 Asturias;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2021QI;""
33 Asturias;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
33 Asturias;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
33 Asturias;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2020QII;5.803
33 Asturias;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2020QI;""
33 Asturias;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
33 Asturias;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2022QIII;5.085
33 Asturias;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2022QII;""
33 Asturias;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2022QI;""
33 Asturias;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
33 Asturias;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2021QIII;5.382
33 Asturias;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2021QII;""
33 Asturias;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2021QI;""
33 Asturias;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
33 Asturias;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2020QIII;5.659
33 Asturias;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2020QII;""
33 Asturias;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2020QI;""
33 Asturias;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QIV;4.895
33 Asturias;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
33 Asturias;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QII;""
33 Asturias;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QI;""
33 Asturias;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QIV;5.196
33 Asturias;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
33 Asturias;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QII;""
33 Asturias;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QI;""
33 Asturias;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QIV;5.500
33 Asturias;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
33 Asturias;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QII;""
33 Asturias;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QI;""
33 Asturias;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
33 Asturias;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
33 Asturias;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QII;""
33 Asturias;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QI;5.057
33 Asturias;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
33 Asturias;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
33 Asturias;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QII;""
33 Asturias;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QI;5.398
33 Asturias;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
33 Asturias;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
33 Asturias;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QII;""
33 Asturias;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QI;""
33 Asturias;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
33 Asturias;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
33 Asturias;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
33 Asturias;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
33 Asturias;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
33 Asturias;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
33 Asturias;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
33 Asturias;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
33 Asturias;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
33 Asturias;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
33 Asturias;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
33 Asturias;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
33 Asturias;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
33 Asturias;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
33 Asturias;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;95,94
33 Asturias;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
33 Asturias;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
33 Asturias;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
33 Asturias;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;96,2
33 Asturias;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
33 Asturias;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
33 Asturias;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
33 Asturias;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;98,22
33 Asturias;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
33 Asturias;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
33 Asturias;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;92,93
33 Asturias;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
33 Asturias;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
33 Asturias;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
33 Asturias;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;93,29
33 Asturias;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
33 Asturias;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
33 Asturias;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
33 Asturias;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;95,79
33 Asturias;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
33 Asturias;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
33 Asturias;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;89,46
33 Asturias;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
33 Asturias;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
33 Asturias;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
33 Asturias;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;90,07
33 Asturias;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
33 Asturias;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
33 Asturias;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
33 Asturias;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;93,09
33 Asturias;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
33 Asturias;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
33 Asturias;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
33 Asturias;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
33 Asturias;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
33 Asturias;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
33 Asturias;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;87,66
33 Asturias;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
33 Asturias;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
33 Asturias;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
33 Asturias;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;91,37
33 Asturias;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
33 Asturias;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
33 Asturias;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
33 Asturias;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
33 Asturias;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
33 Asturias;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
33 Asturias;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QII;4.162
33 Asturias;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
33 Asturias;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
33 Asturias;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
33 Asturias;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QII;4.261
33 Asturias;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
33 Asturias;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
33 Asturias;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
33 Asturias;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QII;4.480
33 Asturias;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
33 Asturias;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
33 Asturias;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
33 Asturias;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2022QII;3.982
33 Asturias;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2022QI;""
33 Asturias;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
33 Asturias;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
33 Asturias;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2021QII;4.101
33 Asturias;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2021QI;""
33 Asturias;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
33 Asturias;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
33 Asturias;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2020QII;4.371
33 Asturias;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2020QI;""
33 Asturias;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
33 Asturias;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2022QIII;3.801
33 Asturias;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2022QII;""
33 Asturias;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2022QI;""
33 Asturias;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
33 Asturias;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2021QIII;3.987
33 Asturias;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2021QII;""
33 Asturias;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2021QI;""
33 Asturias;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
33 Asturias;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2020QIII;4.204
33 Asturias;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2020QII;""
33 Asturias;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2020QI;""
33 Asturias;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QIV;3.628
33 Asturias;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
33 Asturias;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QII;""
33 Asturias;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QI;""
33 Asturias;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QIV;3.856
33 Asturias;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
33 Asturias;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QII;""
33 Asturias;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QI;""
33 Asturias;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QIV;4.068
33 Asturias;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
33 Asturias;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QII;""
33 Asturias;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QI;""
33 Asturias;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
33 Asturias;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
33 Asturias;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QII;""
33 Asturias;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QI;3.745
33 Asturias;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
33 Asturias;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
33 Asturias;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QII;""
33 Asturias;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QI;3.989
33 Asturias;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
33 Asturias;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
33 Asturias;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QII;""
33 Asturias;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QI;""
33 Asturias;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
33 Asturias;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
33 Asturias;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
33 Asturias;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
33 Asturias;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
33 Asturias;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
33 Asturias;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
33 Asturias;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
33 Asturias;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
33 Asturias;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
33 Asturias;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
33 Asturias;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
33 Asturias;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
33 Asturias;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
33 Asturias;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;95,68
33 Asturias;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
33 Asturias;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
33 Asturias;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
33 Asturias;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;96,25
33 Asturias;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
33 Asturias;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
33 Asturias;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
33 Asturias;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;97,57
33 Asturias;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
33 Asturias;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
33 Asturias;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;91,33
33 Asturias;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
33 Asturias;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
33 Asturias;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
33 Asturias;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;93,57
33 Asturias;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
33 Asturias;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
33 Asturias;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
33 Asturias;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;93,84
33 Asturias;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
33 Asturias;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
33 Asturias;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;87,17
33 Asturias;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
33 Asturias;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
33 Asturias;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
33 Asturias;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;90,5
33 Asturias;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
33 Asturias;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
33 Asturias;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
33 Asturias;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;90,8
33 Asturias;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
33 Asturias;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
33 Asturias;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
33 Asturias;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
33 Asturias;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
33 Asturias;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
33 Asturias;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;87,89
33 Asturias;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
33 Asturias;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
33 Asturias;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
33 Asturias;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;89,04
33 Asturias;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
33 Asturias;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
33 Asturias;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
33 Asturias;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
33 Asturias;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
33 Asturias;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QIII;9.749
33 Asturias;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
33 Asturias;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
33 Asturias;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
33 Asturias;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QIII;10.171
33 Asturias;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
33 Asturias;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
33 Asturias;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
33 Asturias;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QIII;10.568
33 Asturias;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
33 Asturias;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
33 Asturias;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
33 Asturias;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2022QIII;9.325
33 Asturias;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2022QII;""
33 Asturias;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2022QI;""
33 Asturias;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
33 Asturias;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2021QIII;9.827
33 Asturias;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2021QII;""
33 Asturias;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2021QI;""
33 Asturias;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
33 Asturias;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2020QIII;10.204
33 Asturias;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2020QII;""
33 Asturias;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2020QI;""
33 Asturias;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2022QIV;8.916
33 Asturias;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
33 Asturias;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2022QII;""
33 Asturias;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2022QI;""
33 Asturias;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2021QIV;9.463
33 Asturias;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
33 Asturias;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2021QII;""
33 Asturias;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2021QI;""
33 Asturias;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2020QIV;9.872
33 Asturias;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
33 Asturias;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2020QII;""
33 Asturias;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2020QI;""
33 Asturias;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
33 Asturias;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
33 Asturias;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QII;""
33 Asturias;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QI;9.191
33 Asturias;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
33 Asturias;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
33 Asturias;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QII;""
33 Asturias;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QI;9.678
33 Asturias;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
33 Asturias;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
33 Asturias;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QII;""
33 Asturias;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QI;""
33 Asturias;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
33 Asturias;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
33 Asturias;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QII;8.905
33 Asturias;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QI;""
33 Asturias;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
33 Asturias;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
33 Asturias;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QII;9.424
33 Asturias;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QI;""
33 Asturias;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
33 Asturias;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
33 Asturias;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QII;""
33 Asturias;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QI;""
33 Asturias;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
33 Asturias;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
33 Asturias;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
33 Asturias;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
33 Asturias;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
33 Asturias;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
33 Asturias;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
33 Asturias;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
33 Asturias;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
33 Asturias;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
33 Asturias;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
33 Asturias;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
33 Asturias;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
33 Asturias;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;95,65
33 Asturias;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
33 Asturias;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
33 Asturias;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
33 Asturias;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;96,62
33 Asturias;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
33 Asturias;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
33 Asturias;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
33 Asturias;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;96,56
33 Asturias;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
33 Asturias;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
33 Asturias;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;91,46
33 Asturias;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
33 Asturias;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
33 Asturias;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
33 Asturias;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;93,04
33 Asturias;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
33 Asturias;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
33 Asturias;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
33 Asturias;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;93,41
33 Asturias;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
33 Asturias;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
33 Asturias;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
33 Asturias;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
33 Asturias;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
33 Asturias;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
33 Asturias;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;90,36
33 Asturias;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
33 Asturias;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
33 Asturias;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
33 Asturias;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;91,58
33 Asturias;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
33 Asturias;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
33 Asturias;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
33 Asturias;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
33 Asturias;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
33 Asturias;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
33 Asturias;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;87,55
33 Asturias;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
33 Asturias;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
33 Asturias;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
33 Asturias;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;89,17
33 Asturias;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
33 Asturias;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
33 Asturias;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
33 Asturias;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
33 Asturias;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
33 Asturias;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
33 Asturias;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QIII;5.541
33 Asturias;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
33 Asturias;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
33 Asturias;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
33 Asturias;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QIII;5.826
33 Asturias;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
33 Asturias;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
33 Asturias;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
33 Asturias;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QIII;6.041
33 Asturias;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
33 Asturias;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
33 Asturias;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
33 Asturias;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2022QIII;5.334
33 Asturias;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2022QII;""
33 Asturias;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2022QI;""
33 Asturias;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
33 Asturias;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2021QIII;5.627
33 Asturias;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2021QII;""
33 Asturias;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2021QI;""
33 Asturias;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
33 Asturias;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2020QIII;5.859
33 Asturias;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2020QII;""
33 Asturias;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2020QI;""
33 Asturias;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2022QIV;5.117
33 Asturias;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
33 Asturias;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2022QII;""
33 Asturias;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2022QI;""
33 Asturias;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2021QIV;5.415
33 Asturias;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
33 Asturias;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2021QII;""
33 Asturias;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2021QI;""
33 Asturias;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2020QIV;5.676
33 Asturias;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
33 Asturias;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2020QII;""
33 Asturias;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2020QI;""
33 Asturias;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
33 Asturias;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
33 Asturias;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QII;""
33 Asturias;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QI;5.261
33 Asturias;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
33 Asturias;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
33 Asturias;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QII;""
33 Asturias;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QI;5.567
33 Asturias;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
33 Asturias;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
33 Asturias;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QII;""
33 Asturias;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QI;""
33 Asturias;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
33 Asturias;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
33 Asturias;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QII;5.108
33 Asturias;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QI;""
33 Asturias;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
33 Asturias;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
33 Asturias;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QII;5.429
33 Asturias;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QI;""
33 Asturias;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
33 Asturias;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
33 Asturias;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QII;""
33 Asturias;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QI;""
33 Asturias;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
33 Asturias;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
33 Asturias;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
33 Asturias;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
33 Asturias;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
33 Asturias;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
33 Asturias;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
33 Asturias;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
33 Asturias;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
33 Asturias;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
33 Asturias;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
33 Asturias;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
33 Asturias;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
33 Asturias;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;96,26
33 Asturias;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
33 Asturias;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
33 Asturias;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
33 Asturias;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;96,58
33 Asturias;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
33 Asturias;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
33 Asturias;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
33 Asturias;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;96,99
33 Asturias;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
33 Asturias;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
33 Asturias;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;92,35
33 Asturias;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
33 Asturias;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
33 Asturias;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
33 Asturias;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;92,95
33 Asturias;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
33 Asturias;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
33 Asturias;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
33 Asturias;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;93,96
33 Asturias;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
33 Asturias;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
33 Asturias;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
33 Asturias;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
33 Asturias;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
33 Asturias;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
33 Asturias;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;90,3
33 Asturias;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
33 Asturias;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
33 Asturias;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
33 Asturias;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;92,15
33 Asturias;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
33 Asturias;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
33 Asturias;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
33 Asturias;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
33 Asturias;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
33 Asturias;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
33 Asturias;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;87,68
33 Asturias;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
33 Asturias;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
33 Asturias;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
33 Asturias;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;89,87
33 Asturias;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
33 Asturias;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
33 Asturias;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
33 Asturias;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
33 Asturias;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
33 Asturias;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
33 Asturias;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QIII;4.208
33 Asturias;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
33 Asturias;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
33 Asturias;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
33 Asturias;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QIII;4.345
33 Asturias;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
33 Asturias;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
33 Asturias;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
33 Asturias;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QIII;4.527
33 Asturias;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
33 Asturias;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
33 Asturias;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
33 Asturias;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2022QIII;3.991
33 Asturias;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2022QII;""
33 Asturias;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2022QI;""
33 Asturias;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
33 Asturias;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2021QIII;4.200
33 Asturias;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2021QII;""
33 Asturias;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2021QI;""
33 Asturias;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
33 Asturias;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2020QIII;4.345
33 Asturias;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2020QII;""
33 Asturias;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2020QI;""
33 Asturias;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2022QIV;3.799
33 Asturias;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
33 Asturias;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2022QII;""
33 Asturias;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2022QI;""
33 Asturias;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2021QIV;4.048
33 Asturias;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
33 Asturias;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2021QII;""
33 Asturias;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2021QI;""
33 Asturias;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2020QIV;4.196
33 Asturias;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
33 Asturias;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2020QII;""
33 Asturias;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2020QI;""
33 Asturias;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
33 Asturias;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
33 Asturias;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QII;""
33 Asturias;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QI;3.930
33 Asturias;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
33 Asturias;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
33 Asturias;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QII;""
33 Asturias;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QI;4.111
33 Asturias;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
33 Asturias;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
33 Asturias;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QII;""
33 Asturias;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QI;""
33 Asturias;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
33 Asturias;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
33 Asturias;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QII;3.797
33 Asturias;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QI;""
33 Asturias;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
33 Asturias;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
33 Asturias;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QII;3.995
33 Asturias;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QI;""
33 Asturias;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
33 Asturias;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
33 Asturias;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QII;""
33 Asturias;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QI;""
33 Asturias;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
33 Asturias;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
33 Asturias;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
33 Asturias;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
33 Asturias;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
33 Asturias;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
33 Asturias;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
33 Asturias;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
33 Asturias;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
33 Asturias;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
33 Asturias;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
33 Asturias;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
33 Asturias;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
33 Asturias;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;94,84
33 Asturias;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
33 Asturias;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
33 Asturias;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
33 Asturias;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;96,66
33 Asturias;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
33 Asturias;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
33 Asturias;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
33 Asturias;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;95,98
33 Asturias;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
33 Asturias;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
33 Asturias;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;90,28
33 Asturias;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
33 Asturias;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
33 Asturias;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
33 Asturias;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;93,16
33 Asturias;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
33 Asturias;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
33 Asturias;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
33 Asturias;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;92,69
33 Asturias;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
33 Asturias;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
33 Asturias;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
33 Asturias;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
33 Asturias;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
33 Asturias;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
33 Asturias;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;90,45
33 Asturias;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
33 Asturias;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
33 Asturias;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
33 Asturias;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;90,81
33 Asturias;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
33 Asturias;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
33 Asturias;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
33 Asturias;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
33 Asturias;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
33 Asturias;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
33 Asturias;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;87,39
33 Asturias;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
33 Asturias;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
33 Asturias;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
33 Asturias;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;88,25
33 Asturias;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
33 Asturias;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
33 Asturias;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
33 Asturias;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
33 Asturias;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
33 Asturias;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QIV;9.749
33 Asturias;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
33 Asturias;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
33 Asturias;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
33 Asturias;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QIV;10.249
33 Asturias;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
33 Asturias;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
33 Asturias;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
33 Asturias;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QIV;10.671
33 Asturias;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
33 Asturias;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
33 Asturias;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
33 Asturias;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2022QIV;9.302
33 Asturias;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
33 Asturias;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2022QII;""
33 Asturias;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2022QI;""
33 Asturias;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2021QIV;9.846
33 Asturias;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
33 Asturias;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2021QII;""
33 Asturias;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2021QI;""
33 Asturias;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2020QIV;10.282
33 Asturias;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
33 Asturias;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2020QII;""
33 Asturias;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2020QI;""
33 Asturias;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
33 Asturias;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
33 Asturias;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2022QII;""
33 Asturias;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2022QI;9.544
33 Asturias;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
33 Asturias;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
33 Asturias;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2021QII;""
33 Asturias;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2021QI;10.059
33 Asturias;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
33 Asturias;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
33 Asturias;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2020QII;""
33 Asturias;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2020QI;""
33 Asturias;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
33 Asturias;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
33 Asturias;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QII;9.232
33 Asturias;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QI;""
33 Asturias;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
33 Asturias;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
33 Asturias;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QII;9.778
33 Asturias;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QI;""
33 Asturias;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
33 Asturias;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
33 Asturias;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QII;""
33 Asturias;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QI;""
33 Asturias;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
33 Asturias;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QIII;8.942
33 Asturias;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QII;""
33 Asturias;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QI;""
33 Asturias;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
33 Asturias;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QIII;9.555
33 Asturias;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QII;""
33 Asturias;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QI;""
33 Asturias;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
33 Asturias;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
33 Asturias;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QII;""
33 Asturias;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QI;""
33 Asturias;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
33 Asturias;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
33 Asturias;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
33 Asturias;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
33 Asturias;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
33 Asturias;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
33 Asturias;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
33 Asturias;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
33 Asturias;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
33 Asturias;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
33 Asturias;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
33 Asturias;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
33 Asturias;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;95,41
33 Asturias;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
33 Asturias;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
33 Asturias;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
33 Asturias;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;96,07
33 Asturias;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
33 Asturias;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
33 Asturias;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
33 Asturias;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;96,35
33 Asturias;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
33 Asturias;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
33 Asturias;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
33 Asturias;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
33 Asturias;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
33 Asturias;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
33 Asturias;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;93,12
33 Asturias;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
33 Asturias;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
33 Asturias;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
33 Asturias;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;94,26
33 Asturias;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
33 Asturias;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
33 Asturias;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
33 Asturias;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
33 Asturias;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
33 Asturias;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
33 Asturias;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;90,08
33 Asturias;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
33 Asturias;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
33 Asturias;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
33 Asturias;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;91,63
33 Asturias;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
33 Asturias;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
33 Asturias;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
33 Asturias;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
33 Asturias;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
33 Asturias;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
33 Asturias;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;87,25
33 Asturias;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
33 Asturias;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
33 Asturias;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
33 Asturias;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;89,54
33 Asturias;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
33 Asturias;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
33 Asturias;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
33 Asturias;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
33 Asturias;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
33 Asturias;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
33 Asturias;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QIV;5.538
33 Asturias;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
33 Asturias;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
33 Asturias;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
33 Asturias;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QIV;5.873
33 Asturias;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
33 Asturias;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
33 Asturias;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
33 Asturias;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QIV;6.142
33 Asturias;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
33 Asturias;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
33 Asturias;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
33 Asturias;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2022QIV;5.305
33 Asturias;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
33 Asturias;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2022QII;""
33 Asturias;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2022QI;""
33 Asturias;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2021QIV;5.638
33 Asturias;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
33 Asturias;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2021QII;""
33 Asturias;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2021QI;""
33 Asturias;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2020QIV;5.924
33 Asturias;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
33 Asturias;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2020QII;""
33 Asturias;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2020QI;""
33 Asturias;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
33 Asturias;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
33 Asturias;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2022QII;""
33 Asturias;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2022QI;5.459
33 Asturias;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
33 Asturias;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
33 Asturias;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2021QII;""
33 Asturias;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2021QI;5.794
33 Asturias;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
33 Asturias;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
33 Asturias;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2020QII;""
33 Asturias;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2020QI;""
33 Asturias;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
33 Asturias;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
33 Asturias;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QII;5.286
33 Asturias;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QI;""
33 Asturias;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
33 Asturias;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
33 Asturias;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QII;5.641
33 Asturias;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QI;""
33 Asturias;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
33 Asturias;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
33 Asturias;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QII;""
33 Asturias;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QI;""
33 Asturias;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
33 Asturias;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QIII;5.143
33 Asturias;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QII;""
33 Asturias;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QI;""
33 Asturias;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
33 Asturias;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QIII;5.513
33 Asturias;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QII;""
33 Asturias;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QI;""
33 Asturias;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
33 Asturias;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
33 Asturias;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QII;""
33 Asturias;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QI;""
33 Asturias;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
33 Asturias;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
33 Asturias;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
33 Asturias;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
33 Asturias;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
33 Asturias;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
33 Asturias;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
33 Asturias;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
33 Asturias;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
33 Asturias;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
33 Asturias;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
33 Asturias;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
33 Asturias;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;95,79
33 Asturias;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
33 Asturias;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
33 Asturias;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
33 Asturias;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;96
33 Asturias;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
33 Asturias;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
33 Asturias;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
33 Asturias;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;96,45
33 Asturias;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
33 Asturias;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
33 Asturias;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
33 Asturias;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
33 Asturias;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
33 Asturias;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
33 Asturias;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;92,95
33 Asturias;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
33 Asturias;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
33 Asturias;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
33 Asturias;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;94,33
33 Asturias;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
33 Asturias;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
33 Asturias;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
33 Asturias;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
33 Asturias;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
33 Asturias;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
33 Asturias;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;90,01
33 Asturias;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
33 Asturias;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
33 Asturias;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
33 Asturias;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;91,84
33 Asturias;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
33 Asturias;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
33 Asturias;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
33 Asturias;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
33 Asturias;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
33 Asturias;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
33 Asturias;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;87,57
33 Asturias;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
33 Asturias;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
33 Asturias;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
33 Asturias;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;89,76
33 Asturias;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
33 Asturias;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
33 Asturias;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
33 Asturias;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
33 Asturias;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
33 Asturias;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
33 Asturias;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QIV;4.211
33 Asturias;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
33 Asturias;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
33 Asturias;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
33 Asturias;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QIV;4.376
33 Asturias;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
33 Asturias;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
33 Asturias;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
33 Asturias;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QIV;4.529
33 Asturias;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
33 Asturias;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
33 Asturias;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
33 Asturias;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2022QIV;3.997
33 Asturias;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
33 Asturias;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2022QII;""
33 Asturias;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2022QI;""
33 Asturias;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2021QIV;4.208
33 Asturias;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
33 Asturias;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2021QII;""
33 Asturias;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2021QI;""
33 Asturias;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2020QIV;4.358
33 Asturias;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
33 Asturias;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2020QII;""
33 Asturias;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2020QI;""
33 Asturias;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
33 Asturias;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
33 Asturias;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2022QII;""
33 Asturias;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2022QI;4.085
33 Asturias;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
33 Asturias;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
33 Asturias;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2021QII;""
33 Asturias;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2021QI;4.265
33 Asturias;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
33 Asturias;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
33 Asturias;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2020QII;""
33 Asturias;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2020QI;""
33 Asturias;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
33 Asturias;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
33 Asturias;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QII;3.946
33 Asturias;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QI;""
33 Asturias;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
33 Asturias;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
33 Asturias;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QII;4.137
33 Asturias;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QI;""
33 Asturias;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
33 Asturias;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
33 Asturias;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QII;""
33 Asturias;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QI;""
33 Asturias;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
33 Asturias;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QIII;3.799
33 Asturias;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QII;""
33 Asturias;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QI;""
33 Asturias;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
33 Asturias;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QIII;4.042
33 Asturias;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QII;""
33 Asturias;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QI;""
33 Asturias;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
33 Asturias;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
33 Asturias;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QII;""
33 Asturias;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QI;""
33 Asturias;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
33 Asturias;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
33 Asturias;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
33 Asturias;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
33 Asturias;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
33 Asturias;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
33 Asturias;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
33 Asturias;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
33 Asturias;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
33 Asturias;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
33 Asturias;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
33 Asturias;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
33 Asturias;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;94,92
33 Asturias;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
33 Asturias;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
33 Asturias;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
33 Asturias;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;96,16
33 Asturias;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
33 Asturias;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
33 Asturias;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
33 Asturias;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;96,22
33 Asturias;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
33 Asturias;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
33 Asturias;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
33 Asturias;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
33 Asturias;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
33 Asturias;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
33 Asturias;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;93,35
33 Asturias;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
33 Asturias;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
33 Asturias;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
33 Asturias;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;94,17
33 Asturias;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
33 Asturias;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
33 Asturias;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
33 Asturias;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
33 Asturias;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
33 Asturias;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
33 Asturias;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;90,17
33 Asturias;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
33 Asturias;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
33 Asturias;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
33 Asturias;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;91,34
33 Asturias;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
33 Asturias;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
33 Asturias;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
33 Asturias;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
33 Asturias;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
33 Asturias;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
33 Asturias;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;86,81
33 Asturias;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
33 Asturias;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
33 Asturias;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
33 Asturias;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;89,25
33 Asturias;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
33 Asturias;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
33 Asturias;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
33 Asturias;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
33 Asturias;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
33 Asturias;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
33 Asturias;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
33 Asturias;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
33 Asturias;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
33 Asturias;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QI;20.599
33 Asturias;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
33 Asturias;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
33 Asturias;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
33 Asturias;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QI;20.756
33 Asturias;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
33 Asturias;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
33 Asturias;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
33 Asturias;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QI;20.865
33 Asturias;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
33 Asturias;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
33 Asturias;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2022QII;""
33 Asturias;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2022QI;20.133
33 Asturias;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
33 Asturias;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
33 Asturias;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2021QII;""
33 Asturias;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2021QI;20.394
33 Asturias;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
33 Asturias;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
33 Asturias;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2020QII;""
33 Asturias;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2020QI;19.807
33 Asturias;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
33 Asturias;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
33 Asturias;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2022QII;19.590
33 Asturias;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2022QI;""
33 Asturias;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
33 Asturias;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
33 Asturias;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2021QII;19.994
33 Asturias;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2021QI;""
33 Asturias;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
33 Asturias;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
33 Asturias;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2020QII;19.494
33 Asturias;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2020QI;""
33 Asturias;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
33 Asturias;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QIII;19.144
33 Asturias;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QII;""
33 Asturias;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QI;""
33 Asturias;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
33 Asturias;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QIII;19.664
33 Asturias;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QII;""
33 Asturias;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QI;""
33 Asturias;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
33 Asturias;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QIII;19.171
33 Asturias;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QII;""
33 Asturias;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QI;""
33 Asturias;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QIV;18.686
33 Asturias;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
33 Asturias;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QII;""
33 Asturias;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QI;""
33 Asturias;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QIV;19.277
33 Asturias;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
33 Asturias;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QII;""
33 Asturias;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QI;""
33 Asturias;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QIV;18.810
33 Asturias;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
33 Asturias;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QII;""
33 Asturias;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QI;""
33 Asturias;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
33 Asturias;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
33 Asturias;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
33 Asturias;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
33 Asturias;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
33 Asturias;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
33 Asturias;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
33 Asturias;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
33 Asturias;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
33 Asturias;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
33 Asturias;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
33 Asturias;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
33 Asturias;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
33 Asturias;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
33 Asturias;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
33 Asturias;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;97,74
33 Asturias;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
33 Asturias;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
33 Asturias;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
33 Asturias;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;98,26
33 Asturias;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
33 Asturias;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
33 Asturias;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
33 Asturias;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;94,93
33 Asturias;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
33 Asturias;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
33 Asturias;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;95,1
33 Asturias;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
33 Asturias;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
33 Asturias;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
33 Asturias;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;96,33
33 Asturias;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
33 Asturias;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
33 Asturias;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
33 Asturias;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;93,43
33 Asturias;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
33 Asturias;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
33 Asturias;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;92,94
33 Asturias;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
33 Asturias;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
33 Asturias;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
33 Asturias;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;94,74
33 Asturias;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
33 Asturias;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
33 Asturias;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
33 Asturias;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;91,88
33 Asturias;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
33 Asturias;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
33 Asturias;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;90,71
33 Asturias;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
33 Asturias;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
33 Asturias;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
33 Asturias;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;92,87
33 Asturias;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
33 Asturias;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
33 Asturias;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
33 Asturias;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;90,15
33 Asturias;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
33 Asturias;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
33 Asturias;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
33 Asturias;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
33 Asturias;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
33 Asturias;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
33 Asturias;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QI;12.471
33 Asturias;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
33 Asturias;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
33 Asturias;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
33 Asturias;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QI;12.674
33 Asturias;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
33 Asturias;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
33 Asturias;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
33 Asturias;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QI;12.729
33 Asturias;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
33 Asturias;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
33 Asturias;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2022QII;""
33 Asturias;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2022QI;12.183
33 Asturias;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
33 Asturias;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
33 Asturias;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2021QII;""
33 Asturias;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2021QI;12.455
33 Asturias;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
33 Asturias;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
33 Asturias;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2020QII;""
33 Asturias;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2020QI;12.093
33 Asturias;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
33 Asturias;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
33 Asturias;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2022QII;11.895
33 Asturias;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2022QI;""
33 Asturias;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
33 Asturias;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
33 Asturias;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2021QII;12.218
33 Asturias;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2021QI;""
33 Asturias;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
33 Asturias;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
33 Asturias;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2020QII;11.930
33 Asturias;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2020QI;""
33 Asturias;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
33 Asturias;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QIII;11.645
33 Asturias;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QII;""
33 Asturias;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QI;""
33 Asturias;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
33 Asturias;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QIII;12.023
33 Asturias;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QII;""
33 Asturias;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QI;""
33 Asturias;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
33 Asturias;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QIII;11.768
33 Asturias;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QII;""
33 Asturias;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QI;""
33 Asturias;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QIV;11.388
33 Asturias;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
33 Asturias;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QII;""
33 Asturias;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QI;""
33 Asturias;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QIV;11.806
33 Asturias;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
33 Asturias;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QII;""
33 Asturias;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QI;""
33 Asturias;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QIV;11.558
33 Asturias;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
33 Asturias;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QII;""
33 Asturias;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QI;""
33 Asturias;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
33 Asturias;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
33 Asturias;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
33 Asturias;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
33 Asturias;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
33 Asturias;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
33 Asturias;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
33 Asturias;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
33 Asturias;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
33 Asturias;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
33 Asturias;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
33 Asturias;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
33 Asturias;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
33 Asturias;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
33 Asturias;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
33 Asturias;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;97,69
33 Asturias;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
33 Asturias;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
33 Asturias;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
33 Asturias;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;98,27
33 Asturias;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
33 Asturias;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
33 Asturias;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
33 Asturias;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;95
33 Asturias;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
33 Asturias;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
33 Asturias;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;95,38
33 Asturias;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
33 Asturias;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
33 Asturias;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
33 Asturias;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;96,4
33 Asturias;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
33 Asturias;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
33 Asturias;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
33 Asturias;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;93,72
33 Asturias;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
33 Asturias;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
33 Asturias;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;93,38
33 Asturias;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
33 Asturias;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
33 Asturias;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
33 Asturias;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;94,86
33 Asturias;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
33 Asturias;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
33 Asturias;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
33 Asturias;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;92,45
33 Asturias;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
33 Asturias;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
33 Asturias;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;91,32
33 Asturias;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
33 Asturias;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
33 Asturias;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
33 Asturias;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;93,15
33 Asturias;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
33 Asturias;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
33 Asturias;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
33 Asturias;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;90,8
33 Asturias;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
33 Asturias;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
33 Asturias;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
33 Asturias;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
33 Asturias;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
33 Asturias;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
33 Asturias;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QI;8.128
33 Asturias;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
33 Asturias;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
33 Asturias;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
33 Asturias;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QI;8.082
33 Asturias;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
33 Asturias;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
33 Asturias;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
33 Asturias;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QI;8.136
33 Asturias;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
33 Asturias;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
33 Asturias;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2022QII;""
33 Asturias;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2022QI;7.950
33 Asturias;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
33 Asturias;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
33 Asturias;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2021QII;""
33 Asturias;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2021QI;7.939
33 Asturias;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
33 Asturias;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
33 Asturias;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2020QII;""
33 Asturias;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2020QI;7.714
33 Asturias;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
33 Asturias;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
33 Asturias;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2022QII;7.695
33 Asturias;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2022QI;""
33 Asturias;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
33 Asturias;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
33 Asturias;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2021QII;7.776
33 Asturias;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2021QI;""
33 Asturias;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
33 Asturias;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
33 Asturias;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2020QII;7.564
33 Asturias;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2020QI;""
33 Asturias;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
33 Asturias;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QIII;7.499
33 Asturias;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QII;""
33 Asturias;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QI;""
33 Asturias;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
33 Asturias;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QIII;7.641
33 Asturias;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QII;""
33 Asturias;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QI;""
33 Asturias;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
33 Asturias;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QIII;7.403
33 Asturias;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QII;""
33 Asturias;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QI;""
33 Asturias;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QIV;7.298
33 Asturias;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
33 Asturias;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QII;""
33 Asturias;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QI;""
33 Asturias;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QIV;7.471
33 Asturias;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
33 Asturias;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QII;""
33 Asturias;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QI;""
33 Asturias;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QIV;7.252
33 Asturias;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
33 Asturias;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QII;""
33 Asturias;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QI;""
33 Asturias;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
33 Asturias;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
33 Asturias;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
33 Asturias;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
33 Asturias;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
33 Asturias;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
33 Asturias;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
33 Asturias;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
33 Asturias;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
33 Asturias;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
33 Asturias;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
33 Asturias;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
33 Asturias;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
33 Asturias;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
33 Asturias;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
33 Asturias;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;97,81
33 Asturias;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
33 Asturias;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
33 Asturias;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
33 Asturias;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;98,23
33 Asturias;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
33 Asturias;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
33 Asturias;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
33 Asturias;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;94,81
33 Asturias;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
33 Asturias;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
33 Asturias;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;94,67
33 Asturias;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
33 Asturias;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
33 Asturias;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
33 Asturias;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;96,21
33 Asturias;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
33 Asturias;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
33 Asturias;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
33 Asturias;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;92,97
33 Asturias;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
33 Asturias;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
33 Asturias;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;92,26
33 Asturias;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
33 Asturias;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
33 Asturias;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
33 Asturias;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;94,54
33 Asturias;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
33 Asturias;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
33 Asturias;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
33 Asturias;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;90,99
33 Asturias;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
33 Asturias;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
33 Asturias;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;89,79
33 Asturias;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
33 Asturias;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
33 Asturias;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
33 Asturias;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;92,44
33 Asturias;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
33 Asturias;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
33 Asturias;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
33 Asturias;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;89,13
33 Asturias;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
33 Asturias;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
33 Asturias;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
33 Asturias;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
33 Asturias;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
33 Asturias;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QII;19.890
33 Asturias;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
33 Asturias;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
33 Asturias;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
33 Asturias;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QII;20.319
33 Asturias;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
33 Asturias;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
33 Asturias;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
33 Asturias;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QII;20.490
33 Asturias;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
33 Asturias;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
33 Asturias;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
33 Asturias;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2022QII;19.312
33 Asturias;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2022QI;""
33 Asturias;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
33 Asturias;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
33 Asturias;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2021QII;19.875
33 Asturias;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2021QI;""
33 Asturias;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
33 Asturias;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
33 Asturias;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2020QII;20.153
33 Asturias;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2020QI;""
33 Asturias;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
33 Asturias;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2022QIII;18.845
33 Asturias;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2022QII;""
33 Asturias;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2022QI;""
33 Asturias;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
33 Asturias;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2021QIII;19.516
33 Asturias;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2021QII;""
33 Asturias;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2021QI;""
33 Asturias;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
33 Asturias;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2020QIII;19.784
33 Asturias;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2020QII;""
33 Asturias;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2020QI;""
33 Asturias;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QIV;18.359
33 Asturias;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
33 Asturias;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QII;""
33 Asturias;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QI;""
33 Asturias;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QIV;19.083
33 Asturias;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
33 Asturias;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QII;""
33 Asturias;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QI;""
33 Asturias;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QIV;19.383
33 Asturias;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
33 Asturias;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QII;""
33 Asturias;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QI;""
33 Asturias;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
33 Asturias;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
33 Asturias;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QII;""
33 Asturias;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QI;18.721
33 Asturias;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
33 Asturias;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
33 Asturias;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QII;""
33 Asturias;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QI;19.114
33 Asturias;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
33 Asturias;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
33 Asturias;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QII;""
33 Asturias;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QI;""
33 Asturias;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
33 Asturias;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
33 Asturias;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
33 Asturias;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
33 Asturias;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
33 Asturias;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
33 Asturias;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
33 Asturias;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
33 Asturias;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
33 Asturias;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
33 Asturias;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
33 Asturias;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
33 Asturias;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
33 Asturias;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
33 Asturias;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;97,09
33 Asturias;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
33 Asturias;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
33 Asturias;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
33 Asturias;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;97,81
33 Asturias;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
33 Asturias;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
33 Asturias;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
33 Asturias;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;98,36
33 Asturias;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
33 Asturias;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
33 Asturias;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;94,75
33 Asturias;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
33 Asturias;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
33 Asturias;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
33 Asturias;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;96,05
33 Asturias;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
33 Asturias;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
33 Asturias;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
33 Asturias;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;96,55
33 Asturias;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
33 Asturias;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
33 Asturias;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;92,3
33 Asturias;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
33 Asturias;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
33 Asturias;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
33 Asturias;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;93,92
33 Asturias;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
33 Asturias;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
33 Asturias;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
33 Asturias;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;94,6
33 Asturias;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
33 Asturias;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
33 Asturias;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
33 Asturias;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
33 Asturias;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
33 Asturias;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
33 Asturias;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;92,14
33 Asturias;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
33 Asturias;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
33 Asturias;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
33 Asturias;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;93,28
33 Asturias;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
33 Asturias;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
33 Asturias;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
33 Asturias;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
33 Asturias;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
33 Asturias;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
33 Asturias;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QII;11.979
33 Asturias;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
33 Asturias;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
33 Asturias;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
33 Asturias;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QII;12.379
33 Asturias;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
33 Asturias;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
33 Asturias;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
33 Asturias;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QII;12.491
33 Asturias;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
33 Asturias;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
33 Asturias;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
33 Asturias;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2022QII;11.656
33 Asturias;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2022QI;""
33 Asturias;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
33 Asturias;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
33 Asturias;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2021QII;12.120
33 Asturias;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2021QI;""
33 Asturias;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
33 Asturias;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
33 Asturias;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2020QII;12.311
33 Asturias;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2020QI;""
33 Asturias;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
33 Asturias;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2022QIII;11.392
33 Asturias;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2022QII;""
33 Asturias;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2022QI;""
33 Asturias;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
33 Asturias;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2021QIII;11.901
33 Asturias;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2021QII;""
33 Asturias;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2021QI;""
33 Asturias;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
33 Asturias;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2020QIII;12.121
33 Asturias;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2020QII;""
33 Asturias;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2020QI;""
33 Asturias;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QIV;11.117
33 Asturias;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
33 Asturias;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QII;""
33 Asturias;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QI;""
33 Asturias;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QIV;11.647
33 Asturias;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
33 Asturias;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QII;""
33 Asturias;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QI;""
33 Asturias;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QIV;11.890
33 Asturias;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
33 Asturias;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QII;""
33 Asturias;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QI;""
33 Asturias;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
33 Asturias;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
33 Asturias;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QII;""
33 Asturias;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QI;11.428
33 Asturias;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
33 Asturias;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
33 Asturias;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QII;""
33 Asturias;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QI;11.725
33 Asturias;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
33 Asturias;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
33 Asturias;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QII;""
33 Asturias;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QI;""
33 Asturias;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
33 Asturias;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
33 Asturias;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
33 Asturias;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
33 Asturias;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
33 Asturias;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
33 Asturias;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
33 Asturias;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
33 Asturias;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
33 Asturias;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
33 Asturias;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
33 Asturias;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
33 Asturias;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
33 Asturias;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
33 Asturias;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;97,3
33 Asturias;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
33 Asturias;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
33 Asturias;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
33 Asturias;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;97,91
33 Asturias;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
33 Asturias;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
33 Asturias;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
33 Asturias;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;98,56
33 Asturias;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
33 Asturias;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
33 Asturias;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;95,1
33 Asturias;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
33 Asturias;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
33 Asturias;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
33 Asturias;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;96,14
33 Asturias;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
33 Asturias;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
33 Asturias;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
33 Asturias;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;97,04
33 Asturias;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
33 Asturias;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
33 Asturias;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;92,8
33 Asturias;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
33 Asturias;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
33 Asturias;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
33 Asturias;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;94,09
33 Asturias;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
33 Asturias;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
33 Asturias;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
33 Asturias;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;95,19
33 Asturias;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
33 Asturias;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
33 Asturias;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
33 Asturias;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
33 Asturias;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
33 Asturias;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
33 Asturias;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;92,32
33 Asturias;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
33 Asturias;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
33 Asturias;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
33 Asturias;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;93,87
33 Asturias;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
33 Asturias;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
33 Asturias;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
33 Asturias;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
33 Asturias;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
33 Asturias;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
33 Asturias;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QII;7.911
33 Asturias;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
33 Asturias;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
33 Asturias;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
33 Asturias;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QII;7.940
33 Asturias;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
33 Asturias;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
33 Asturias;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
33 Asturias;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QII;7.999
33 Asturias;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
33 Asturias;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
33 Asturias;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
33 Asturias;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2022QII;7.656
33 Asturias;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2022QI;""
33 Asturias;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
33 Asturias;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
33 Asturias;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2021QII;7.755
33 Asturias;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2021QI;""
33 Asturias;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
33 Asturias;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
33 Asturias;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2020QII;7.842
33 Asturias;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2020QI;""
33 Asturias;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
33 Asturias;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2022QIII;7.453
33 Asturias;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2022QII;""
33 Asturias;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2022QI;""
33 Asturias;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
33 Asturias;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2021QIII;7.615
33 Asturias;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2021QII;""
33 Asturias;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2021QI;""
33 Asturias;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
33 Asturias;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2020QIII;7.663
33 Asturias;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2020QII;""
33 Asturias;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2020QI;""
33 Asturias;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QIV;7.242
33 Asturias;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
33 Asturias;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QII;""
33 Asturias;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QI;""
33 Asturias;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QIV;7.436
33 Asturias;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
33 Asturias;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QII;""
33 Asturias;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QI;""
33 Asturias;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QIV;7.493
33 Asturias;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
33 Asturias;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QII;""
33 Asturias;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QI;""
33 Asturias;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
33 Asturias;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
33 Asturias;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QII;""
33 Asturias;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QI;7.293
33 Asturias;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
33 Asturias;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
33 Asturias;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QII;""
33 Asturias;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QI;7.389
33 Asturias;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
33 Asturias;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
33 Asturias;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QII;""
33 Asturias;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QI;""
33 Asturias;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
33 Asturias;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
33 Asturias;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
33 Asturias;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
33 Asturias;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
33 Asturias;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
33 Asturias;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
33 Asturias;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
33 Asturias;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
33 Asturias;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
33 Asturias;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
33 Asturias;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
33 Asturias;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
33 Asturias;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
33 Asturias;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;96,78
33 Asturias;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
33 Asturias;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
33 Asturias;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
33 Asturias;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;97,67
33 Asturias;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
33 Asturias;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
33 Asturias;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
33 Asturias;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;98,04
33 Asturias;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
33 Asturias;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
33 Asturias;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;94,21
33 Asturias;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
33 Asturias;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
33 Asturias;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
33 Asturias;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;95,91
33 Asturias;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
33 Asturias;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
33 Asturias;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
33 Asturias;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;95,8
33 Asturias;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
33 Asturias;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
33 Asturias;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;91,54
33 Asturias;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
33 Asturias;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
33 Asturias;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
33 Asturias;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;93,65
33 Asturias;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
33 Asturias;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
33 Asturias;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
33 Asturias;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;93,67
33 Asturias;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
33 Asturias;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
33 Asturias;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
33 Asturias;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
33 Asturias;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
33 Asturias;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
33 Asturias;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;91,85
33 Asturias;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
33 Asturias;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
33 Asturias;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
33 Asturias;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;92,37
33 Asturias;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
33 Asturias;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
33 Asturias;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
33 Asturias;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
33 Asturias;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
33 Asturias;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QIII;19.965
33 Asturias;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
33 Asturias;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
33 Asturias;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
33 Asturias;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QIII;20.498
33 Asturias;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
33 Asturias;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
33 Asturias;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
33 Asturias;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QIII;20.712
33 Asturias;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
33 Asturias;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
33 Asturias;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
33 Asturias;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2022QIII;19.394
33 Asturias;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2022QII;""
33 Asturias;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2022QI;""
33 Asturias;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
33 Asturias;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2021QIII;20.057
33 Asturias;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2021QII;""
33 Asturias;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2021QI;""
33 Asturias;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
33 Asturias;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2020QIII;20.253
33 Asturias;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2020QII;""
33 Asturias;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2020QI;""
33 Asturias;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2022QIV;18.822
33 Asturias;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
33 Asturias;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2022QII;""
33 Asturias;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2022QI;""
33 Asturias;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2021QIV;19.566
33 Asturias;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
33 Asturias;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2021QII;""
33 Asturias;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2021QI;""
33 Asturias;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2020QIV;19.788
33 Asturias;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
33 Asturias;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2020QII;""
33 Asturias;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2020QI;""
33 Asturias;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
33 Asturias;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
33 Asturias;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QII;""
33 Asturias;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QI;19.180
33 Asturias;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
33 Asturias;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
33 Asturias;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QII;""
33 Asturias;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QI;19.500
33 Asturias;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
33 Asturias;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
33 Asturias;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QII;""
33 Asturias;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QI;""
33 Asturias;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
33 Asturias;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
33 Asturias;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QII;18.740
33 Asturias;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QI;""
33 Asturias;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
33 Asturias;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
33 Asturias;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QII;19.178
33 Asturias;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QI;""
33 Asturias;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
33 Asturias;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
33 Asturias;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QII;""
33 Asturias;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QI;""
33 Asturias;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
33 Asturias;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
33 Asturias;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
33 Asturias;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
33 Asturias;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
33 Asturias;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
33 Asturias;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
33 Asturias;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
33 Asturias;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
33 Asturias;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
33 Asturias;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
33 Asturias;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
33 Asturias;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
33 Asturias;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;97,14
33 Asturias;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
33 Asturias;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
33 Asturias;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
33 Asturias;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;97,85
33 Asturias;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
33 Asturias;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
33 Asturias;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
33 Asturias;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;97,78
33 Asturias;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
33 Asturias;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
33 Asturias;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;94,27
33 Asturias;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
33 Asturias;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
33 Asturias;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
33 Asturias;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;95,45
33 Asturias;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
33 Asturias;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
33 Asturias;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
33 Asturias;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;95,54
33 Asturias;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
33 Asturias;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
33 Asturias;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
33 Asturias;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
33 Asturias;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
33 Asturias;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
33 Asturias;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;93,57
33 Asturias;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
33 Asturias;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
33 Asturias;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
33 Asturias;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;94,15
33 Asturias;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
33 Asturias;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
33 Asturias;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
33 Asturias;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
33 Asturias;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
33 Asturias;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
33 Asturias;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;91,42
33 Asturias;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
33 Asturias;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
33 Asturias;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
33 Asturias;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;92,59
33 Asturias;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
33 Asturias;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
33 Asturias;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
33 Asturias;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
33 Asturias;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
33 Asturias;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
33 Asturias;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QIII;12.006
33 Asturias;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
33 Asturias;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
33 Asturias;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
33 Asturias;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QIII;12.465
33 Asturias;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
33 Asturias;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
33 Asturias;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
33 Asturias;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QIII;12.664
33 Asturias;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
33 Asturias;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
33 Asturias;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
33 Asturias;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2022QIII;11.676
33 Asturias;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2022QII;""
33 Asturias;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2022QI;""
33 Asturias;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
33 Asturias;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2021QIII;12.199
33 Asturias;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2021QII;""
33 Asturias;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2021QI;""
33 Asturias;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
33 Asturias;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2020QIII;12.422
33 Asturias;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2020QII;""
33 Asturias;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2020QI;""
33 Asturias;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2022QIV;11.356
33 Asturias;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
33 Asturias;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2022QII;""
33 Asturias;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2022QI;""
33 Asturias;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2021QIV;11.909
33 Asturias;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
33 Asturias;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2021QII;""
33 Asturias;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2021QI;""
33 Asturias;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2020QIV;12.146
33 Asturias;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
33 Asturias;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2020QII;""
33 Asturias;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2020QI;""
33 Asturias;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
33 Asturias;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
33 Asturias;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QII;""
33 Asturias;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QI;11.676
33 Asturias;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
33 Asturias;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
33 Asturias;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QII;""
33 Asturias;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QI;11.969
33 Asturias;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
33 Asturias;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
33 Asturias;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QII;""
33 Asturias;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QI;""
33 Asturias;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
33 Asturias;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
33 Asturias;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QII;11.441
33 Asturias;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QI;""
33 Asturias;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
33 Asturias;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
33 Asturias;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QII;11.776
33 Asturias;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QI;""
33 Asturias;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
33 Asturias;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
33 Asturias;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QII;""
33 Asturias;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QI;""
33 Asturias;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
33 Asturias;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
33 Asturias;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
33 Asturias;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
33 Asturias;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
33 Asturias;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
33 Asturias;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
33 Asturias;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
33 Asturias;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
33 Asturias;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
33 Asturias;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
33 Asturias;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
33 Asturias;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
33 Asturias;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;97,25
33 Asturias;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
33 Asturias;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
33 Asturias;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
33 Asturias;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;97,87
33 Asturias;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
33 Asturias;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
33 Asturias;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
33 Asturias;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;98,09
33 Asturias;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
33 Asturias;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
33 Asturias;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;94,59
33 Asturias;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
33 Asturias;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
33 Asturias;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
33 Asturias;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;95,54
33 Asturias;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
33 Asturias;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
33 Asturias;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
33 Asturias;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;95,91
33 Asturias;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
33 Asturias;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
33 Asturias;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
33 Asturias;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
33 Asturias;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
33 Asturias;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
33 Asturias;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;93,67
33 Asturias;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
33 Asturias;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
33 Asturias;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
33 Asturias;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;94,51
33 Asturias;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
33 Asturias;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
33 Asturias;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
33 Asturias;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
33 Asturias;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
33 Asturias;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
33 Asturias;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;91,78
33 Asturias;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
33 Asturias;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
33 Asturias;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
33 Asturias;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;92,99
33 Asturias;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
33 Asturias;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
33 Asturias;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
33 Asturias;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
33 Asturias;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
33 Asturias;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
33 Asturias;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QIII;7.959
33 Asturias;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
33 Asturias;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
33 Asturias;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
33 Asturias;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QIII;8.033
33 Asturias;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
33 Asturias;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
33 Asturias;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
33 Asturias;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QIII;8.048
33 Asturias;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
33 Asturias;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
33 Asturias;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
33 Asturias;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2022QIII;7.718
33 Asturias;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2022QII;""
33 Asturias;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2022QI;""
33 Asturias;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
33 Asturias;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2021QIII;7.858
33 Asturias;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2021QII;""
33 Asturias;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2021QI;""
33 Asturias;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
33 Asturias;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2020QIII;7.831
33 Asturias;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2020QII;""
33 Asturias;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2020QI;""
33 Asturias;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2022QIV;7.466
33 Asturias;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
33 Asturias;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2022QII;""
33 Asturias;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2022QI;""
33 Asturias;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2021QIV;7.657
33 Asturias;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
33 Asturias;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2021QII;""
33 Asturias;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2021QI;""
33 Asturias;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2020QIV;7.642
33 Asturias;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
33 Asturias;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2020QII;""
33 Asturias;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2020QI;""
33 Asturias;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
33 Asturias;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
33 Asturias;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QII;""
33 Asturias;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QI;7.504
33 Asturias;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
33 Asturias;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
33 Asturias;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QII;""
33 Asturias;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QI;7.531
33 Asturias;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
33 Asturias;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
33 Asturias;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QII;""
33 Asturias;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QI;""
33 Asturias;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
33 Asturias;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
33 Asturias;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QII;7.299
33 Asturias;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QI;""
33 Asturias;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
33 Asturias;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
33 Asturias;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QII;7.402
33 Asturias;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QI;""
33 Asturias;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
33 Asturias;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
33 Asturias;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QII;""
33 Asturias;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QI;""
33 Asturias;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
33 Asturias;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
33 Asturias;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
33 Asturias;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
33 Asturias;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
33 Asturias;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
33 Asturias;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
33 Asturias;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
33 Asturias;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
33 Asturias;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
33 Asturias;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
33 Asturias;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
33 Asturias;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
33 Asturias;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;96,97
33 Asturias;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
33 Asturias;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
33 Asturias;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
33 Asturias;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;97,82
33 Asturias;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
33 Asturias;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
33 Asturias;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
33 Asturias;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;97,3
33 Asturias;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
33 Asturias;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
33 Asturias;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;93,81
33 Asturias;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
33 Asturias;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
33 Asturias;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
33 Asturias;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;95,32
33 Asturias;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
33 Asturias;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
33 Asturias;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
33 Asturias;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;94,96
33 Asturias;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
33 Asturias;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
33 Asturias;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
33 Asturias;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
33 Asturias;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
33 Asturias;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
33 Asturias;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;93,41
33 Asturias;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
33 Asturias;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
33 Asturias;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
33 Asturias;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;93,58
33 Asturias;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
33 Asturias;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
33 Asturias;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
33 Asturias;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
33 Asturias;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
33 Asturias;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
33 Asturias;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;90,86
33 Asturias;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
33 Asturias;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
33 Asturias;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
33 Asturias;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;91,97
33 Asturias;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
33 Asturias;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
33 Asturias;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
33 Asturias;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
33 Asturias;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
33 Asturias;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QIV;19.860
33 Asturias;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
33 Asturias;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
33 Asturias;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
33 Asturias;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QIV;20.565
33 Asturias;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
33 Asturias;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
33 Asturias;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
33 Asturias;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QIV;20.780
33 Asturias;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
33 Asturias;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
33 Asturias;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
33 Asturias;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2022QIV;19.225
33 Asturias;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
33 Asturias;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2022QII;""
33 Asturias;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2022QI;""
33 Asturias;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2021QIV;20.024
33 Asturias;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
33 Asturias;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2021QII;""
33 Asturias;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2021QI;""
33 Asturias;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2020QIV;20.246
33 Asturias;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
33 Asturias;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2020QII;""
33 Asturias;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2020QI;""
33 Asturias;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
33 Asturias;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
33 Asturias;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2022QII;""
33 Asturias;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2022QI;19.609
33 Asturias;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
33 Asturias;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
33 Asturias;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2021QII;""
33 Asturias;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2021QI;19.937
33 Asturias;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
33 Asturias;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
33 Asturias;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2020QII;""
33 Asturias;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2020QI;""
33 Asturias;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
33 Asturias;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
33 Asturias;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QII;19.126
33 Asturias;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QI;""
33 Asturias;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
33 Asturias;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
33 Asturias;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QII;19.592
33 Asturias;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QI;""
33 Asturias;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
33 Asturias;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
33 Asturias;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QII;""
33 Asturias;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QI;""
33 Asturias;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
33 Asturias;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QIII;18.709
33 Asturias;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QII;""
33 Asturias;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QI;""
33 Asturias;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
33 Asturias;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QIII;19.281
33 Asturias;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QII;""
33 Asturias;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QI;""
33 Asturias;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
33 Asturias;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
33 Asturias;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QII;""
33 Asturias;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QI;""
33 Asturias;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
33 Asturias;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
33 Asturias;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
33 Asturias;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
33 Asturias;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
33 Asturias;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
33 Asturias;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
33 Asturias;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
33 Asturias;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
33 Asturias;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
33 Asturias;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
33 Asturias;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
33 Asturias;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;96,8
33 Asturias;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
33 Asturias;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
33 Asturias;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
33 Asturias;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;97,37
33 Asturias;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
33 Asturias;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
33 Asturias;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
33 Asturias;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;97,43
33 Asturias;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
33 Asturias;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
33 Asturias;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
33 Asturias;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
33 Asturias;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
33 Asturias;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
33 Asturias;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;95,35
33 Asturias;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
33 Asturias;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
33 Asturias;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
33 Asturias;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;95,94
33 Asturias;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
33 Asturias;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
33 Asturias;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
33 Asturias;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
33 Asturias;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
33 Asturias;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
33 Asturias;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;93
33 Asturias;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
33 Asturias;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
33 Asturias;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
33 Asturias;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;94,28
33 Asturias;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
33 Asturias;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
33 Asturias;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
33 Asturias;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
33 Asturias;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
33 Asturias;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
33 Asturias;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;90,97
33 Asturias;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
33 Asturias;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
33 Asturias;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
33 Asturias;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;92,79
33 Asturias;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
33 Asturias;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
33 Asturias;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
33 Asturias;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
33 Asturias;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
33 Asturias;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
33 Asturias;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QIV;11.921
33 Asturias;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
33 Asturias;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
33 Asturias;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
33 Asturias;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QIV;12.485
33 Asturias;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
33 Asturias;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
33 Asturias;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
33 Asturias;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QIV;12.709
33 Asturias;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
33 Asturias;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
33 Asturias;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
33 Asturias;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2022QIV;11.564
33 Asturias;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
33 Asturias;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2022QII;""
33 Asturias;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2022QI;""
33 Asturias;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2021QIV;12.163
33 Asturias;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
33 Asturias;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2021QII;""
33 Asturias;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2021QI;""
33 Asturias;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2020QIV;12.390
33 Asturias;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
33 Asturias;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2020QII;""
33 Asturias;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2020QI;""
33 Asturias;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
33 Asturias;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
33 Asturias;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2022QII;""
33 Asturias;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2022QI;11.911
33 Asturias;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
33 Asturias;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
33 Asturias;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2021QII;""
33 Asturias;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2021QI;12.203
33 Asturias;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
33 Asturias;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
33 Asturias;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2020QII;""
33 Asturias;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2020QI;""
33 Asturias;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
33 Asturias;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
33 Asturias;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QII;11.651
33 Asturias;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QI;""
33 Asturias;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
33 Asturias;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
33 Asturias;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QII;11.995
33 Asturias;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QI;""
33 Asturias;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
33 Asturias;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
33 Asturias;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QII;""
33 Asturias;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QI;""
33 Asturias;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
33 Asturias;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QIII;11.412
33 Asturias;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QII;""
33 Asturias;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QI;""
33 Asturias;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
33 Asturias;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QIII;11.810
33 Asturias;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QII;""
33 Asturias;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QI;""
33 Asturias;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
33 Asturias;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
33 Asturias;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QII;""
33 Asturias;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QI;""
33 Asturias;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
33 Asturias;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
33 Asturias;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
33 Asturias;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
33 Asturias;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
33 Asturias;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
33 Asturias;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
33 Asturias;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
33 Asturias;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
33 Asturias;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
33 Asturias;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
33 Asturias;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
33 Asturias;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;97,01
33 Asturias;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
33 Asturias;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
33 Asturias;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
33 Asturias;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;97,42
33 Asturias;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
33 Asturias;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
33 Asturias;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
33 Asturias;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;97,49
33 Asturias;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
33 Asturias;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
33 Asturias;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
33 Asturias;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
33 Asturias;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
33 Asturias;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
33 Asturias;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;95,4
33 Asturias;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
33 Asturias;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
33 Asturias;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
33 Asturias;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;96,02
33 Asturias;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
33 Asturias;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
33 Asturias;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
33 Asturias;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
33 Asturias;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
33 Asturias;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
33 Asturias;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;93,32
33 Asturias;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
33 Asturias;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
33 Asturias;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
33 Asturias;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;94,38
33 Asturias;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
33 Asturias;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
33 Asturias;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
33 Asturias;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
33 Asturias;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
33 Asturias;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
33 Asturias;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;91,41
33 Asturias;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
33 Asturias;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
33 Asturias;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
33 Asturias;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;92,93
33 Asturias;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
33 Asturias;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
33 Asturias;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
33 Asturias;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
33 Asturias;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
33 Asturias;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
33 Asturias;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QIV;7.939
33 Asturias;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
33 Asturias;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
33 Asturias;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
33 Asturias;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QIV;8.080
33 Asturias;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
33 Asturias;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
33 Asturias;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
33 Asturias;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QIV;8.071
33 Asturias;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
33 Asturias;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
33 Asturias;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
33 Asturias;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2022QIV;7.661
33 Asturias;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
33 Asturias;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2022QII;""
33 Asturias;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2022QI;""
33 Asturias;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2021QIV;7.861
33 Asturias;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
33 Asturias;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2021QII;""
33 Asturias;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2021QI;""
33 Asturias;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2020QIV;7.856
33 Asturias;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
33 Asturias;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2020QII;""
33 Asturias;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2020QI;""
33 Asturias;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
33 Asturias;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
33 Asturias;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2022QII;""
33 Asturias;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2022QI;7.698
33 Asturias;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
33 Asturias;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
33 Asturias;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2021QII;""
33 Asturias;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2021QI;7.734
33 Asturias;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
33 Asturias;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
33 Asturias;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2020QII;""
33 Asturias;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2020QI;""
33 Asturias;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
33 Asturias;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
33 Asturias;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QII;7.475
33 Asturias;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QI;""
33 Asturias;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
33 Asturias;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
33 Asturias;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QII;7.597
33 Asturias;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QI;""
33 Asturias;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
33 Asturias;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
33 Asturias;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QII;""
33 Asturias;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QI;""
33 Asturias;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
33 Asturias;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QIII;7.297
33 Asturias;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QII;""
33 Asturias;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QI;""
33 Asturias;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
33 Asturias;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QIII;7.471
33 Asturias;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QII;""
33 Asturias;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QI;""
33 Asturias;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
33 Asturias;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
33 Asturias;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QII;""
33 Asturias;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QI;""
33 Asturias;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
33 Asturias;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
33 Asturias;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
33 Asturias;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
33 Asturias;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
33 Asturias;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
33 Asturias;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
33 Asturias;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
33 Asturias;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
33 Asturias;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
33 Asturias;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
33 Asturias;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
33 Asturias;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;96,5
33 Asturias;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
33 Asturias;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
33 Asturias;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
33 Asturias;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;97,29
33 Asturias;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
33 Asturias;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
33 Asturias;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
33 Asturias;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;97,34
33 Asturias;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
33 Asturias;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
33 Asturias;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
33 Asturias;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
33 Asturias;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
33 Asturias;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
33 Asturias;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;95,27
33 Asturias;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
33 Asturias;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
33 Asturias;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
33 Asturias;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;95,82
33 Asturias;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
33 Asturias;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
33 Asturias;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
33 Asturias;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
33 Asturias;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
33 Asturias;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
33 Asturias;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;92,51
33 Asturias;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
33 Asturias;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
33 Asturias;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
33 Asturias;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;94,13
33 Asturias;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
33 Asturias;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
33 Asturias;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
33 Asturias;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
33 Asturias;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
33 Asturias;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
33 Asturias;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;90,31
33 Asturias;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
33 Asturias;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
33 Asturias;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
33 Asturias;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;92,57
33 Asturias;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
33 Asturias;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
33 Asturias;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
33 Asturias;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
33 Asturias;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
33 Asturias;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
33 Asturias;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
33 Asturias;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
33 Asturias;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
33 Asturias;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QI;19.497
33 Asturias;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
33 Asturias;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
33 Asturias;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
33 Asturias;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QI;19.087
33 Asturias;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
33 Asturias;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
33 Asturias;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
33 Asturias;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QI;19.441
33 Asturias;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
33 Asturias;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
33 Asturias;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2022QII;""
33 Asturias;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2022QI;19.163
33 Asturias;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
33 Asturias;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
33 Asturias;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2021QII;""
33 Asturias;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2021QI;18.844
33 Asturias;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
33 Asturias;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
33 Asturias;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2020QII;""
33 Asturias;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2020QI;18.664
33 Asturias;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
33 Asturias;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
33 Asturias;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2022QII;18.783
33 Asturias;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2022QI;""
33 Asturias;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
33 Asturias;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
33 Asturias;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2021QII;18.541
33 Asturias;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2021QI;""
33 Asturias;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
33 Asturias;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
33 Asturias;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2020QII;18.446
33 Asturias;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2020QI;""
33 Asturias;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
33 Asturias;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QIII;18.479
33 Asturias;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QII;""
33 Asturias;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QI;""
33 Asturias;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
33 Asturias;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QIII;18.296
33 Asturias;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QII;""
33 Asturias;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QI;""
33 Asturias;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
33 Asturias;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QIII;18.215
33 Asturias;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QII;""
33 Asturias;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QI;""
33 Asturias;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QIV;18.115
33 Asturias;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
33 Asturias;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QII;""
33 Asturias;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QI;""
33 Asturias;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QIV;18.007
33 Asturias;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
33 Asturias;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QII;""
33 Asturias;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QI;""
33 Asturias;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QIV;17.924
33 Asturias;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
33 Asturias;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QII;""
33 Asturias;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QI;""
33 Asturias;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
33 Asturias;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
33 Asturias;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
33 Asturias;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
33 Asturias;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
33 Asturias;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
33 Asturias;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
33 Asturias;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
33 Asturias;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
33 Asturias;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
33 Asturias;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
33 Asturias;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
33 Asturias;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
33 Asturias;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
33 Asturias;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
33 Asturias;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;98,29
33 Asturias;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
33 Asturias;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
33 Asturias;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
33 Asturias;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;98,73
33 Asturias;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
33 Asturias;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
33 Asturias;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
33 Asturias;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;96
33 Asturias;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
33 Asturias;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
33 Asturias;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;96,34
33 Asturias;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
33 Asturias;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
33 Asturias;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
33 Asturias;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;97,14
33 Asturias;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
33 Asturias;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
33 Asturias;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
33 Asturias;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;94,88
33 Asturias;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
33 Asturias;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
33 Asturias;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;94,78
33 Asturias;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
33 Asturias;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
33 Asturias;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
33 Asturias;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;95,86
33 Asturias;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
33 Asturias;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
33 Asturias;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
33 Asturias;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;93,69
33 Asturias;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
33 Asturias;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
33 Asturias;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;92,91
33 Asturias;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
33 Asturias;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
33 Asturias;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
33 Asturias;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;94,34
33 Asturias;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
33 Asturias;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
33 Asturias;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
33 Asturias;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;92,2
33 Asturias;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
33 Asturias;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
33 Asturias;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
33 Asturias;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
33 Asturias;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
33 Asturias;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
33 Asturias;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QI;11.851
33 Asturias;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
33 Asturias;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
33 Asturias;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
33 Asturias;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QI;11.618
33 Asturias;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
33 Asturias;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
33 Asturias;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
33 Asturias;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QI;11.790
33 Asturias;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
33 Asturias;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
33 Asturias;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2022QII;""
33 Asturias;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2022QI;11.642
33 Asturias;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
33 Asturias;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
33 Asturias;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2021QII;""
33 Asturias;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2021QI;11.466
33 Asturias;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
33 Asturias;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
33 Asturias;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2020QII;""
33 Asturias;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2020QI;11.357
33 Asturias;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
33 Asturias;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
33 Asturias;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2022QII;11.427
33 Asturias;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2022QI;""
33 Asturias;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
33 Asturias;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
33 Asturias;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2021QII;11.299
33 Asturias;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2021QI;""
33 Asturias;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
33 Asturias;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
33 Asturias;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2020QII;11.233
33 Asturias;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2020QI;""
33 Asturias;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
33 Asturias;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QIII;11.248
33 Asturias;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QII;""
33 Asturias;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QI;""
33 Asturias;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
33 Asturias;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QIII;11.157
33 Asturias;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QII;""
33 Asturias;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QI;""
33 Asturias;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
33 Asturias;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QIII;11.111
33 Asturias;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QII;""
33 Asturias;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QI;""
33 Asturias;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QIV;11.034
33 Asturias;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
33 Asturias;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QII;""
33 Asturias;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QI;""
33 Asturias;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QIV;10.996
33 Asturias;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
33 Asturias;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QII;""
33 Asturias;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QI;""
33 Asturias;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QIV;10.953
33 Asturias;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
33 Asturias;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QII;""
33 Asturias;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QI;""
33 Asturias;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
33 Asturias;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
33 Asturias;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
33 Asturias;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
33 Asturias;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
33 Asturias;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
33 Asturias;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
33 Asturias;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
33 Asturias;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
33 Asturias;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
33 Asturias;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
33 Asturias;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
33 Asturias;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
33 Asturias;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
33 Asturias;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
33 Asturias;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;98,24
33 Asturias;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
33 Asturias;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
33 Asturias;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
33 Asturias;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;98,69
33 Asturias;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
33 Asturias;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
33 Asturias;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
33 Asturias;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;96,33
33 Asturias;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
33 Asturias;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
33 Asturias;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;96,42
33 Asturias;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
33 Asturias;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
33 Asturias;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
33 Asturias;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;97,25
33 Asturias;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
33 Asturias;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
33 Asturias;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
33 Asturias;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;95,28
33 Asturias;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
33 Asturias;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
33 Asturias;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;94,91
33 Asturias;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
33 Asturias;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
33 Asturias;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
33 Asturias;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;96,03
33 Asturias;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
33 Asturias;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
33 Asturias;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
33 Asturias;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;94,24
33 Asturias;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
33 Asturias;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
33 Asturias;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;93,11
33 Asturias;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
33 Asturias;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
33 Asturias;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
33 Asturias;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;94,65
33 Asturias;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
33 Asturias;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
33 Asturias;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
33 Asturias;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;92,9
33 Asturias;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
33 Asturias;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
33 Asturias;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
33 Asturias;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
33 Asturias;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
33 Asturias;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
33 Asturias;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QI;7.646
33 Asturias;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
33 Asturias;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
33 Asturias;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
33 Asturias;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QI;7.469
33 Asturias;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
33 Asturias;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
33 Asturias;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
33 Asturias;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QI;7.651
33 Asturias;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
33 Asturias;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
33 Asturias;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2022QII;""
33 Asturias;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2022QI;7.521
33 Asturias;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
33 Asturias;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
33 Asturias;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2021QII;""
33 Asturias;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2021QI;7.378
33 Asturias;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
33 Asturias;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
33 Asturias;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2020QII;""
33 Asturias;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2020QI;7.307
33 Asturias;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
33 Asturias;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
33 Asturias;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2022QII;7.356
33 Asturias;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2022QI;""
33 Asturias;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
33 Asturias;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
33 Asturias;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2021QII;7.242
33 Asturias;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2021QI;""
33 Asturias;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
33 Asturias;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
33 Asturias;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2020QII;7.213
33 Asturias;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2020QI;""
33 Asturias;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
33 Asturias;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QIII;7.231
33 Asturias;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QII;""
33 Asturias;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QI;""
33 Asturias;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
33 Asturias;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QIII;7.139
33 Asturias;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QII;""
33 Asturias;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QI;""
33 Asturias;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
33 Asturias;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QIII;7.104
33 Asturias;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QII;""
33 Asturias;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QI;""
33 Asturias;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QIV;7.081
33 Asturias;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
33 Asturias;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QII;""
33 Asturias;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QI;""
33 Asturias;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QIV;7.011
33 Asturias;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
33 Asturias;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QII;""
33 Asturias;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QI;""
33 Asturias;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QIV;6.971
33 Asturias;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
33 Asturias;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QII;""
33 Asturias;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QI;""
33 Asturias;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
33 Asturias;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
33 Asturias;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
33 Asturias;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
33 Asturias;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
33 Asturias;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
33 Asturias;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
33 Asturias;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
33 Asturias;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
33 Asturias;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
33 Asturias;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
33 Asturias;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
33 Asturias;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
33 Asturias;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
33 Asturias;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
33 Asturias;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;98,37
33 Asturias;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
33 Asturias;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
33 Asturias;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
33 Asturias;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;98,78
33 Asturias;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
33 Asturias;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
33 Asturias;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
33 Asturias;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;95,5
33 Asturias;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
33 Asturias;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
33 Asturias;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;96,21
33 Asturias;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
33 Asturias;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
33 Asturias;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
33 Asturias;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;96,96
33 Asturias;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
33 Asturias;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
33 Asturias;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
33 Asturias;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;94,28
33 Asturias;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
33 Asturias;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
33 Asturias;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;94,57
33 Asturias;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
33 Asturias;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
33 Asturias;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
33 Asturias;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;95,58
33 Asturias;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
33 Asturias;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
33 Asturias;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
33 Asturias;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;92,85
33 Asturias;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
33 Asturias;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
33 Asturias;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;92,61
33 Asturias;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
33 Asturias;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
33 Asturias;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
33 Asturias;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;93,87
33 Asturias;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
33 Asturias;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
33 Asturias;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
33 Asturias;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;91,11
33 Asturias;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
33 Asturias;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
33 Asturias;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
33 Asturias;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
33 Asturias;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
33 Asturias;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QII;20.086
33 Asturias;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
33 Asturias;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
33 Asturias;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
33 Asturias;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QII;19.619
33 Asturias;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
33 Asturias;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
33 Asturias;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
33 Asturias;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QII;19.096
33 Asturias;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
33 Asturias;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
33 Asturias;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
33 Asturias;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2022QII;19.640
33 Asturias;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2022QI;""
33 Asturias;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
33 Asturias;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
33 Asturias;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2021QII;19.279
33 Asturias;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2021QI;""
33 Asturias;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
33 Asturias;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
33 Asturias;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2020QII;18.861
33 Asturias;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2020QI;""
33 Asturias;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
33 Asturias;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2022QIII;19.289
33 Asturias;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2022QII;""
33 Asturias;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2022QI;""
33 Asturias;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
33 Asturias;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2021QIII;19.004
33 Asturias;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2021QII;""
33 Asturias;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2021QI;""
33 Asturias;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
33 Asturias;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2020QIII;18.595
33 Asturias;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2020QII;""
33 Asturias;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2020QI;""
33 Asturias;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QIV;18.898
33 Asturias;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
33 Asturias;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QII;""
33 Asturias;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QI;""
33 Asturias;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QIV;18.687
33 Asturias;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
33 Asturias;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QII;""
33 Asturias;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QI;""
33 Asturias;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QIV;18.278
33 Asturias;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
33 Asturias;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QII;""
33 Asturias;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QI;""
33 Asturias;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
33 Asturias;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
33 Asturias;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QII;""
33 Asturias;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QI;18.408
33 Asturias;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
33 Asturias;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
33 Asturias;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QII;""
33 Asturias;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QI;18.092
33 Asturias;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
33 Asturias;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
33 Asturias;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QII;""
33 Asturias;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QI;""
33 Asturias;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
33 Asturias;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
33 Asturias;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
33 Asturias;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
33 Asturias;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
33 Asturias;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
33 Asturias;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
33 Asturias;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
33 Asturias;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
33 Asturias;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
33 Asturias;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
33 Asturias;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
33 Asturias;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
33 Asturias;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
33 Asturias;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;97,78
33 Asturias;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
33 Asturias;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
33 Asturias;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
33 Asturias;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;98,27
33 Asturias;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
33 Asturias;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
33 Asturias;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
33 Asturias;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;98,77
33 Asturias;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
33 Asturias;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
33 Asturias;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;96,03
33 Asturias;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
33 Asturias;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
33 Asturias;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
33 Asturias;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;96,87
33 Asturias;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
33 Asturias;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
33 Asturias;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
33 Asturias;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;97,38
33 Asturias;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
33 Asturias;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
33 Asturias;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;94,09
33 Asturias;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
33 Asturias;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
33 Asturias;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
33 Asturias;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;95,25
33 Asturias;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
33 Asturias;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
33 Asturias;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
33 Asturias;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;95,72
33 Asturias;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
33 Asturias;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
33 Asturias;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
33 Asturias;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
33 Asturias;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
33 Asturias;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
33 Asturias;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;93,83
33 Asturias;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
33 Asturias;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
33 Asturias;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
33 Asturias;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;94,74
33 Asturias;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
33 Asturias;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
33 Asturias;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
33 Asturias;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
33 Asturias;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
33 Asturias;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
33 Asturias;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QII;12.148
33 Asturias;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
33 Asturias;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
33 Asturias;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
33 Asturias;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QII;11.912
33 Asturias;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
33 Asturias;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
33 Asturias;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
33 Asturias;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QII;11.603
33 Asturias;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
33 Asturias;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
33 Asturias;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
33 Asturias;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2022QII;11.906
33 Asturias;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2022QI;""
33 Asturias;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
33 Asturias;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
33 Asturias;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2021QII;11.720
33 Asturias;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2021QI;""
33 Asturias;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
33 Asturias;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
33 Asturias;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2020QII;11.463
33 Asturias;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2020QI;""
33 Asturias;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
33 Asturias;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2022QIII;11.700
33 Asturias;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2022QII;""
33 Asturias;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2022QI;""
33 Asturias;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
33 Asturias;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2021QIII;11.562
33 Asturias;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2021QII;""
33 Asturias;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2021QI;""
33 Asturias;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
33 Asturias;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2020QIII;11.319
33 Asturias;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2020QII;""
33 Asturias;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2020QI;""
33 Asturias;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QIV;11.469
33 Asturias;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
33 Asturias;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QII;""
33 Asturias;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QI;""
33 Asturias;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QIV;11.390
33 Asturias;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
33 Asturias;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QII;""
33 Asturias;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QI;""
33 Asturias;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QIV;11.145
33 Asturias;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
33 Asturias;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QII;""
33 Asturias;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QI;""
33 Asturias;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
33 Asturias;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
33 Asturias;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QII;""
33 Asturias;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QI;11.220
33 Asturias;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
33 Asturias;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
33 Asturias;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QII;""
33 Asturias;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QI;11.031
33 Asturias;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
33 Asturias;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
33 Asturias;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QII;""
33 Asturias;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QI;""
33 Asturias;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
33 Asturias;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
33 Asturias;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
33 Asturias;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
33 Asturias;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
33 Asturias;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
33 Asturias;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
33 Asturias;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
33 Asturias;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
33 Asturias;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
33 Asturias;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
33 Asturias;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
33 Asturias;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
33 Asturias;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
33 Asturias;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;98,01
33 Asturias;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
33 Asturias;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
33 Asturias;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
33 Asturias;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;98,39
33 Asturias;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
33 Asturias;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
33 Asturias;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
33 Asturias;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;98,79
33 Asturias;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
33 Asturias;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
33 Asturias;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;96,31
33 Asturias;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
33 Asturias;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
33 Asturias;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
33 Asturias;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;97,06
33 Asturias;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
33 Asturias;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
33 Asturias;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
33 Asturias;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;97,55
33 Asturias;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
33 Asturias;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
33 Asturias;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;94,41
33 Asturias;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
33 Asturias;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
33 Asturias;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
33 Asturias;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;95,62
33 Asturias;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
33 Asturias;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
33 Asturias;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
33 Asturias;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;96,05
33 Asturias;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
33 Asturias;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
33 Asturias;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
33 Asturias;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
33 Asturias;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
33 Asturias;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
33 Asturias;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;94,19
33 Asturias;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
33 Asturias;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
33 Asturias;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
33 Asturias;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;95,07
33 Asturias;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
33 Asturias;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
33 Asturias;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
33 Asturias;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
33 Asturias;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
33 Asturias;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
33 Asturias;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QII;7.938
33 Asturias;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
33 Asturias;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
33 Asturias;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
33 Asturias;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QII;7.707
33 Asturias;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
33 Asturias;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
33 Asturias;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
33 Asturias;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QII;7.493
33 Asturias;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
33 Asturias;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
33 Asturias;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
33 Asturias;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2022QII;7.734
33 Asturias;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2022QI;""
33 Asturias;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
33 Asturias;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
33 Asturias;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2021QII;7.559
33 Asturias;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2021QI;""
33 Asturias;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
33 Asturias;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
33 Asturias;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2020QII;7.398
33 Asturias;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2020QI;""
33 Asturias;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
33 Asturias;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2022QIII;7.589
33 Asturias;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2022QII;""
33 Asturias;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2022QI;""
33 Asturias;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
33 Asturias;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2021QIII;7.442
33 Asturias;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2021QII;""
33 Asturias;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2021QI;""
33 Asturias;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
33 Asturias;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2020QIII;7.276
33 Asturias;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2020QII;""
33 Asturias;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2020QI;""
33 Asturias;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QIV;7.429
33 Asturias;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
33 Asturias;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QII;""
33 Asturias;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QI;""
33 Asturias;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QIV;7.297
33 Asturias;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
33 Asturias;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QII;""
33 Asturias;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QI;""
33 Asturias;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QIV;7.133
33 Asturias;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
33 Asturias;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QII;""
33 Asturias;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QI;""
33 Asturias;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
33 Asturias;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
33 Asturias;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QII;""
33 Asturias;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QI;7.188
33 Asturias;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
33 Asturias;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
33 Asturias;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QII;""
33 Asturias;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QI;7.061
33 Asturias;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
33 Asturias;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
33 Asturias;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QII;""
33 Asturias;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QI;""
33 Asturias;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
33 Asturias;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
33 Asturias;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
33 Asturias;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
33 Asturias;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
33 Asturias;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
33 Asturias;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
33 Asturias;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
33 Asturias;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
33 Asturias;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
33 Asturias;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
33 Asturias;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
33 Asturias;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
33 Asturias;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
33 Asturias;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;97,43
33 Asturias;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
33 Asturias;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
33 Asturias;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
33 Asturias;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;98,08
33 Asturias;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
33 Asturias;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
33 Asturias;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
33 Asturias;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;98,73
33 Asturias;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
33 Asturias;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
33 Asturias;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;95,6
33 Asturias;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
33 Asturias;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
33 Asturias;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
33 Asturias;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;96,56
33 Asturias;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
33 Asturias;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
33 Asturias;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
33 Asturias;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;97,1
33 Asturias;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
33 Asturias;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
33 Asturias;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;93,59
33 Asturias;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
33 Asturias;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
33 Asturias;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
33 Asturias;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;94,68
33 Asturias;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
33 Asturias;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
33 Asturias;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
33 Asturias;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;95,2
33 Asturias;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
33 Asturias;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
33 Asturias;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
33 Asturias;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
33 Asturias;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
33 Asturias;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
33 Asturias;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;93,27
33 Asturias;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
33 Asturias;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
33 Asturias;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
33 Asturias;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;94,23
33 Asturias;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
33 Asturias;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
33 Asturias;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
33 Asturias;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
33 Asturias;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
33 Asturias;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QIII;20.026
33 Asturias;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
33 Asturias;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
33 Asturias;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
33 Asturias;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QIII;19.659
33 Asturias;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
33 Asturias;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
33 Asturias;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
33 Asturias;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QIII;19.158
33 Asturias;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
33 Asturias;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
33 Asturias;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
33 Asturias;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2022QIII;19.602
33 Asturias;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2022QII;""
33 Asturias;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2022QI;""
33 Asturias;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
33 Asturias;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2021QIII;19.322
33 Asturias;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2021QII;""
33 Asturias;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2021QI;""
33 Asturias;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
33 Asturias;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2020QIII;18.849
33 Asturias;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2020QII;""
33 Asturias;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2020QI;""
33 Asturias;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2022QIV;19.170
33 Asturias;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
33 Asturias;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2022QII;""
33 Asturias;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2022QI;""
33 Asturias;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2021QIV;18.973
33 Asturias;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
33 Asturias;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2021QII;""
33 Asturias;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2021QI;""
33 Asturias;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2020QIV;18.508
33 Asturias;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
33 Asturias;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2020QII;""
33 Asturias;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2020QI;""
33 Asturias;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
33 Asturias;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
33 Asturias;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QII;""
33 Asturias;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QI;18.672
33 Asturias;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
33 Asturias;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
33 Asturias;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QII;""
33 Asturias;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QI;18.316
33 Asturias;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
33 Asturias;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
33 Asturias;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QII;""
33 Asturias;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QI;""
33 Asturias;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
33 Asturias;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
33 Asturias;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QII;18.343
33 Asturias;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QI;""
33 Asturias;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
33 Asturias;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
33 Asturias;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QII;18.053
33 Asturias;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QI;""
33 Asturias;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
33 Asturias;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
33 Asturias;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QII;""
33 Asturias;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QI;""
33 Asturias;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
33 Asturias;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
33 Asturias;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
33 Asturias;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
33 Asturias;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
33 Asturias;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
33 Asturias;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
33 Asturias;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
33 Asturias;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
33 Asturias;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
33 Asturias;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
33 Asturias;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
33 Asturias;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
33 Asturias;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;97,88
33 Asturias;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
33 Asturias;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
33 Asturias;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
33 Asturias;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;98,29
33 Asturias;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
33 Asturias;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
33 Asturias;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
33 Asturias;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;98,39
33 Asturias;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
33 Asturias;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
33 Asturias;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;95,73
33 Asturias;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
33 Asturias;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
33 Asturias;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
33 Asturias;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;96,51
33 Asturias;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
33 Asturias;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
33 Asturias;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
33 Asturias;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;96,61
33 Asturias;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
33 Asturias;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
33 Asturias;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
33 Asturias;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
33 Asturias;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
33 Asturias;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
33 Asturias;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;94,98
33 Asturias;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
33 Asturias;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
33 Asturias;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
33 Asturias;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;95,6
33 Asturias;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
33 Asturias;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
33 Asturias;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
33 Asturias;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
33 Asturias;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
33 Asturias;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
33 Asturias;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;93,31
33 Asturias;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
33 Asturias;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
33 Asturias;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
33 Asturias;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;94,23
33 Asturias;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
33 Asturias;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
33 Asturias;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
33 Asturias;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
33 Asturias;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
33 Asturias;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
33 Asturias;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QIII;12.108
33 Asturias;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
33 Asturias;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
33 Asturias;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
33 Asturias;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QIII;11.919
33 Asturias;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
33 Asturias;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
33 Asturias;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
33 Asturias;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QIII;11.641
33 Asturias;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
33 Asturias;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
33 Asturias;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
33 Asturias;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2022QIII;11.861
33 Asturias;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2022QII;""
33 Asturias;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2022QI;""
33 Asturias;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
33 Asturias;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2021QIII;11.734
33 Asturias;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2021QII;""
33 Asturias;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2021QI;""
33 Asturias;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
33 Asturias;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2020QIII;11.476
33 Asturias;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2020QII;""
33 Asturias;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2020QI;""
33 Asturias;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2022QIV;11.611
33 Asturias;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
33 Asturias;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2022QII;""
33 Asturias;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2022QI;""
33 Asturias;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2021QIV;11.548
33 Asturias;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
33 Asturias;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2021QII;""
33 Asturias;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2021QI;""
33 Asturias;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2020QIV;11.289
33 Asturias;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
33 Asturias;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2020QII;""
33 Asturias;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2020QI;""
33 Asturias;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
33 Asturias;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
33 Asturias;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QII;""
33 Asturias;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QI;11.363
33 Asturias;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
33 Asturias;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
33 Asturias;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QII;""
33 Asturias;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QI;11.170
33 Asturias;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
33 Asturias;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
33 Asturias;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QII;""
33 Asturias;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QI;""
33 Asturias;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
33 Asturias;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
33 Asturias;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QII;11.175
33 Asturias;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QI;""
33 Asturias;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
33 Asturias;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
33 Asturias;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QII;11.027
33 Asturias;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QI;""
33 Asturias;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
33 Asturias;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
33 Asturias;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QII;""
33 Asturias;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QI;""
33 Asturias;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
33 Asturias;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
33 Asturias;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
33 Asturias;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
33 Asturias;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
33 Asturias;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
33 Asturias;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
33 Asturias;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
33 Asturias;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
33 Asturias;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
33 Asturias;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
33 Asturias;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
33 Asturias;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
33 Asturias;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;97,96
33 Asturias;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
33 Asturias;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
33 Asturias;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
33 Asturias;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;98,45
33 Asturias;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
33 Asturias;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
33 Asturias;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
33 Asturias;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;98,58
33 Asturias;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
33 Asturias;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
33 Asturias;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;95,9
33 Asturias;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
33 Asturias;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
33 Asturias;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
33 Asturias;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;96,89
33 Asturias;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
33 Asturias;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
33 Asturias;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
33 Asturias;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;96,98
33 Asturias;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
33 Asturias;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
33 Asturias;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
33 Asturias;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
33 Asturias;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
33 Asturias;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
33 Asturias;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;95,34
33 Asturias;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
33 Asturias;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
33 Asturias;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
33 Asturias;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;95,95
33 Asturias;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
33 Asturias;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
33 Asturias;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
33 Asturias;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
33 Asturias;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
33 Asturias;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
33 Asturias;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;93,76
33 Asturias;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
33 Asturias;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
33 Asturias;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
33 Asturias;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;94,73
33 Asturias;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
33 Asturias;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
33 Asturias;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
33 Asturias;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
33 Asturias;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
33 Asturias;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
33 Asturias;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QIII;7.918
33 Asturias;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
33 Asturias;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
33 Asturias;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
33 Asturias;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QIII;7.740
33 Asturias;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
33 Asturias;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
33 Asturias;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
33 Asturias;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QIII;7.517
33 Asturias;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
33 Asturias;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
33 Asturias;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
33 Asturias;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2022QIII;7.741
33 Asturias;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2022QII;""
33 Asturias;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2022QI;""
33 Asturias;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
33 Asturias;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2021QIII;7.588
33 Asturias;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2021QII;""
33 Asturias;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2021QI;""
33 Asturias;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
33 Asturias;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2020QIII;7.373
33 Asturias;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2020QII;""
33 Asturias;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2020QI;""
33 Asturias;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2022QIV;7.559
33 Asturias;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
33 Asturias;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2022QII;""
33 Asturias;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2022QI;""
33 Asturias;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2021QIV;7.425
33 Asturias;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
33 Asturias;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2021QII;""
33 Asturias;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2021QI;""
33 Asturias;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2020QIV;7.219
33 Asturias;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
33 Asturias;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2020QII;""
33 Asturias;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2020QI;""
33 Asturias;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
33 Asturias;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
33 Asturias;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QII;""
33 Asturias;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QI;7.309
33 Asturias;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
33 Asturias;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
33 Asturias;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QII;""
33 Asturias;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QI;7.146
33 Asturias;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
33 Asturias;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
33 Asturias;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QII;""
33 Asturias;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QI;""
33 Asturias;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
33 Asturias;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
33 Asturias;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QII;7.168
33 Asturias;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QI;""
33 Asturias;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
33 Asturias;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
33 Asturias;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QII;7.026
33 Asturias;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QI;""
33 Asturias;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
33 Asturias;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
33 Asturias;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QII;""
33 Asturias;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QI;""
33 Asturias;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
33 Asturias;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
33 Asturias;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
33 Asturias;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
33 Asturias;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
33 Asturias;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
33 Asturias;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
33 Asturias;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
33 Asturias;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
33 Asturias;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
33 Asturias;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
33 Asturias;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
33 Asturias;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
33 Asturias;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;97,76
33 Asturias;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
33 Asturias;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
33 Asturias;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
33 Asturias;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;98,04
33 Asturias;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
33 Asturias;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
33 Asturias;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
33 Asturias;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;98,08
33 Asturias;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
33 Asturias;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
33 Asturias;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;95,47
33 Asturias;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
33 Asturias;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
33 Asturias;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
33 Asturias;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;95,93
33 Asturias;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
33 Asturias;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
33 Asturias;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
33 Asturias;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;96,04
33 Asturias;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
33 Asturias;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
33 Asturias;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
33 Asturias;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
33 Asturias;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
33 Asturias;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
33 Asturias;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;94,43
33 Asturias;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
33 Asturias;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
33 Asturias;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
33 Asturias;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;95,06
33 Asturias;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
33 Asturias;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
33 Asturias;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
33 Asturias;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
33 Asturias;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
33 Asturias;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
33 Asturias;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;92,61
33 Asturias;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
33 Asturias;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
33 Asturias;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
33 Asturias;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;93,47
33 Asturias;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
33 Asturias;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
33 Asturias;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
33 Asturias;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
33 Asturias;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
33 Asturias;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QIV;19.892
33 Asturias;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
33 Asturias;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
33 Asturias;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
33 Asturias;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QIV;19.588
33 Asturias;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
33 Asturias;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
33 Asturias;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
33 Asturias;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QIV;19.177
33 Asturias;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
33 Asturias;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
33 Asturias;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
33 Asturias;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2022QIV;19.418
33 Asturias;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
33 Asturias;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2022QII;""
33 Asturias;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2022QI;""
33 Asturias;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2021QIV;19.198
33 Asturias;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
33 Asturias;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2021QII;""
33 Asturias;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2021QI;""
33 Asturias;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2020QIV;18.785
33 Asturias;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
33 Asturias;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2020QII;""
33 Asturias;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2020QI;""
33 Asturias;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
33 Asturias;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
33 Asturias;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2022QII;""
33 Asturias;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2022QI;18.888
33 Asturias;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
33 Asturias;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
33 Asturias;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2021QII;""
33 Asturias;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2021QI;18.571
33 Asturias;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
33 Asturias;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
33 Asturias;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2020QII;""
33 Asturias;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2020QI;""
33 Asturias;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
33 Asturias;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
33 Asturias;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QII;18.543
33 Asturias;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QI;""
33 Asturias;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
33 Asturias;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
33 Asturias;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QII;18.296
33 Asturias;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QI;""
33 Asturias;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
33 Asturias;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
33 Asturias;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QII;""
33 Asturias;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QI;""
33 Asturias;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
33 Asturias;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QIII;18.261
33 Asturias;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QII;""
33 Asturias;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QI;""
33 Asturias;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
33 Asturias;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QIII;18.070
33 Asturias;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QII;""
33 Asturias;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QI;""
33 Asturias;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
33 Asturias;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
33 Asturias;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QII;""
33 Asturias;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QI;""
33 Asturias;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
33 Asturias;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
33 Asturias;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
33 Asturias;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
33 Asturias;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
33 Asturias;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
33 Asturias;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
33 Asturias;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
33 Asturias;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
33 Asturias;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
33 Asturias;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
33 Asturias;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
33 Asturias;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;97,62
33 Asturias;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
33 Asturias;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
33 Asturias;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
33 Asturias;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;98,01
33 Asturias;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
33 Asturias;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
33 Asturias;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
33 Asturias;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;97,96
33 Asturias;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
33 Asturias;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
33 Asturias;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
33 Asturias;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
33 Asturias;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
33 Asturias;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
33 Asturias;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;96,43
33 Asturias;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
33 Asturias;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
33 Asturias;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
33 Asturias;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;96,84
33 Asturias;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
33 Asturias;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
33 Asturias;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
33 Asturias;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
33 Asturias;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
33 Asturias;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
33 Asturias;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;94,67
33 Asturias;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
33 Asturias;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
33 Asturias;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
33 Asturias;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;95,41
33 Asturias;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
33 Asturias;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
33 Asturias;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
33 Asturias;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
33 Asturias;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
33 Asturias;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
33 Asturias;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;93,23
33 Asturias;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
33 Asturias;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
33 Asturias;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
33 Asturias;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;94,23
33 Asturias;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
33 Asturias;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
33 Asturias;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
33 Asturias;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
33 Asturias;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
33 Asturias;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
33 Asturias;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QIV;12.018
33 Asturias;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
33 Asturias;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
33 Asturias;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
33 Asturias;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QIV;11.889
33 Asturias;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
33 Asturias;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
33 Asturias;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
33 Asturias;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QIV;11.657
33 Asturias;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
33 Asturias;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
33 Asturias;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
33 Asturias;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2022QIV;11.744
33 Asturias;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
33 Asturias;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2022QII;""
33 Asturias;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2022QI;""
33 Asturias;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2021QIV;11.688
33 Asturias;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
33 Asturias;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2021QII;""
33 Asturias;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2021QI;""
33 Asturias;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2020QIV;11.443
33 Asturias;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
33 Asturias;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2020QII;""
33 Asturias;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2020QI;""
33 Asturias;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
33 Asturias;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
33 Asturias;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2022QII;""
33 Asturias;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2022QI;11.497
33 Asturias;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
33 Asturias;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
33 Asturias;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2021QII;""
33 Asturias;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2021QI;11.312
33 Asturias;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
33 Asturias;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
33 Asturias;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2020QII;""
33 Asturias;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2020QI;""
33 Asturias;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
33 Asturias;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
33 Asturias;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QII;11.300
33 Asturias;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QI;""
33 Asturias;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
33 Asturias;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
33 Asturias;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QII;11.161
33 Asturias;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QI;""
33 Asturias;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
33 Asturias;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
33 Asturias;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QII;""
33 Asturias;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QI;""
33 Asturias;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
33 Asturias;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QIII;11.132
33 Asturias;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QII;""
33 Asturias;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QI;""
33 Asturias;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
33 Asturias;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QIII;11.029
33 Asturias;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QII;""
33 Asturias;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QI;""
33 Asturias;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
33 Asturias;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
33 Asturias;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QII;""
33 Asturias;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QI;""
33 Asturias;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
33 Asturias;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
33 Asturias;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
33 Asturias;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
33 Asturias;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
33 Asturias;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
33 Asturias;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
33 Asturias;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
33 Asturias;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
33 Asturias;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
33 Asturias;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
33 Asturias;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
33 Asturias;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;97,72
33 Asturias;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
33 Asturias;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
33 Asturias;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
33 Asturias;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;98,31
33 Asturias;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
33 Asturias;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
33 Asturias;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
33 Asturias;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;98,16
33 Asturias;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
33 Asturias;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
33 Asturias;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
33 Asturias;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
33 Asturias;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
33 Asturias;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
33 Asturias;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;96,7
33 Asturias;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
33 Asturias;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
33 Asturias;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
33 Asturias;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;97,04
33 Asturias;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
33 Asturias;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
33 Asturias;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
33 Asturias;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
33 Asturias;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
33 Asturias;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
33 Asturias;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;95,05
33 Asturias;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
33 Asturias;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
33 Asturias;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
33 Asturias;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;95,75
33 Asturias;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
33 Asturias;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
33 Asturias;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
33 Asturias;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
33 Asturias;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
33 Asturias;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
33 Asturias;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;93,63
33 Asturias;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
33 Asturias;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
33 Asturias;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
33 Asturias;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;94,61
33 Asturias;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
33 Asturias;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
33 Asturias;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
33 Asturias;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
33 Asturias;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
33 Asturias;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
33 Asturias;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QIV;7.874
33 Asturias;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
33 Asturias;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
33 Asturias;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
33 Asturias;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QIV;7.699
33 Asturias;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
33 Asturias;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
33 Asturias;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
33 Asturias;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QIV;7.520
33 Asturias;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
33 Asturias;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
33 Asturias;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
33 Asturias;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2022QIV;7.674
33 Asturias;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
33 Asturias;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2022QII;""
33 Asturias;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2022QI;""
33 Asturias;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2021QIV;7.510
33 Asturias;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
33 Asturias;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2021QII;""
33 Asturias;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2021QI;""
33 Asturias;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2020QIV;7.342
33 Asturias;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
33 Asturias;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2020QII;""
33 Asturias;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2020QI;""
33 Asturias;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
33 Asturias;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
33 Asturias;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2022QII;""
33 Asturias;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2022QI;7.391
33 Asturias;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
33 Asturias;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
33 Asturias;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2021QII;""
33 Asturias;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2021QI;7.259
33 Asturias;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
33 Asturias;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
33 Asturias;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2020QII;""
33 Asturias;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2020QI;""
33 Asturias;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
33 Asturias;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
33 Asturias;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QII;7.243
33 Asturias;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QI;""
33 Asturias;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
33 Asturias;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
33 Asturias;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QII;7.135
33 Asturias;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QI;""
33 Asturias;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
33 Asturias;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
33 Asturias;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QII;""
33 Asturias;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QI;""
33 Asturias;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
33 Asturias;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QIII;7.129
33 Asturias;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QII;""
33 Asturias;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QI;""
33 Asturias;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
33 Asturias;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QIII;7.041
33 Asturias;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QII;""
33 Asturias;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QI;""
33 Asturias;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
33 Asturias;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
33 Asturias;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QII;""
33 Asturias;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QI;""
33 Asturias;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
33 Asturias;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
33 Asturias;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
33 Asturias;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
33 Asturias;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
33 Asturias;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
33 Asturias;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
33 Asturias;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
33 Asturias;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
33 Asturias;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
33 Asturias;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
33 Asturias;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
33 Asturias;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;97,46
33 Asturias;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
33 Asturias;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
33 Asturias;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
33 Asturias;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;97,55
33 Asturias;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
33 Asturias;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
33 Asturias;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
33 Asturias;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;97,63
33 Asturias;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
33 Asturias;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
33 Asturias;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
33 Asturias;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
33 Asturias;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
33 Asturias;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
33 Asturias;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;96
33 Asturias;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
33 Asturias;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
33 Asturias;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
33 Asturias;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;96,53
33 Asturias;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
33 Asturias;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
33 Asturias;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
33 Asturias;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
33 Asturias;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
33 Asturias;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
33 Asturias;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;94,08
33 Asturias;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
33 Asturias;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
33 Asturias;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
33 Asturias;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;94,88
33 Asturias;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
33 Asturias;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
33 Asturias;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
33 Asturias;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
33 Asturias;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
33 Asturias;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
33 Asturias;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;92,6
33 Asturias;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
33 Asturias;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
33 Asturias;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
33 Asturias;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;93,63
33 Asturias;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
33 Asturias;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
33 Asturias;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
33 Asturias;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
33 Asturias;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
33 Asturias;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
33 Asturias;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
33 Asturias;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
33 Asturias;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
33 Asturias;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QI;9.856
33 Asturias;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
33 Asturias;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
33 Asturias;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
33 Asturias;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QI;9.407
33 Asturias;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
33 Asturias;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
33 Asturias;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
33 Asturias;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QI;10.936
33 Asturias;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
33 Asturias;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
33 Asturias;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2022QII;""
33 Asturias;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2022QI;9.489
33 Asturias;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
33 Asturias;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
33 Asturias;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2021QII;""
33 Asturias;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2021QI;9.093
33 Asturias;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
33 Asturias;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
33 Asturias;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2020QII;""
33 Asturias;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2020QI;10.277
33 Asturias;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
33 Asturias;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
33 Asturias;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2022QII;9.149
33 Asturias;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2022QI;""
33 Asturias;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
33 Asturias;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
33 Asturias;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2021QII;8.741
33 Asturias;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2021QI;""
33 Asturias;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
33 Asturias;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
33 Asturias;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2020QII;9.951
33 Asturias;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2020QI;""
33 Asturias;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
33 Asturias;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QIII;8.803
33 Asturias;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QII;""
33 Asturias;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QI;""
33 Asturias;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
33 Asturias;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QIII;8.387
33 Asturias;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QII;""
33 Asturias;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QI;""
33 Asturias;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
33 Asturias;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QIII;9.555
33 Asturias;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QII;""
33 Asturias;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QI;""
33 Asturias;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QIV;8.197
33 Asturias;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
33 Asturias;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QII;""
33 Asturias;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QI;""
33 Asturias;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QIV;7.927
33 Asturias;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
33 Asturias;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QII;""
33 Asturias;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QI;""
33 Asturias;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QIV;9.043
33 Asturias;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
33 Asturias;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QII;""
33 Asturias;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QI;""
33 Asturias;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
33 Asturias;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
33 Asturias;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
33 Asturias;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
33 Asturias;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
33 Asturias;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
33 Asturias;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
33 Asturias;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
33 Asturias;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
33 Asturias;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
33 Asturias;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
33 Asturias;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
33 Asturias;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
33 Asturias;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
33 Asturias;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
33 Asturias;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;96,28
33 Asturias;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
33 Asturias;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
33 Asturias;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
33 Asturias;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;96,66
33 Asturias;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
33 Asturias;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
33 Asturias;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
33 Asturias;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;93,97
33 Asturias;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
33 Asturias;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
33 Asturias;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;92,83
33 Asturias;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
33 Asturias;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
33 Asturias;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
33 Asturias;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;92,92
33 Asturias;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
33 Asturias;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
33 Asturias;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
33 Asturias;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;90,99
33 Asturias;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
33 Asturias;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
33 Asturias;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;89,32
33 Asturias;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
33 Asturias;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
33 Asturias;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
33 Asturias;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;89,16
33 Asturias;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
33 Asturias;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
33 Asturias;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
33 Asturias;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;87,37
33 Asturias;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
33 Asturias;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
33 Asturias;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;83,17
33 Asturias;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
33 Asturias;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
33 Asturias;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
33 Asturias;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;84,27
33 Asturias;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
33 Asturias;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
33 Asturias;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
33 Asturias;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;82,69
33 Asturias;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
33 Asturias;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
33 Asturias;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
33 Asturias;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
33 Asturias;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
33 Asturias;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
33 Asturias;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QI;5.831
33 Asturias;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
33 Asturias;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
33 Asturias;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
33 Asturias;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QI;5.542
33 Asturias;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
33 Asturias;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
33 Asturias;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
33 Asturias;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QI;6.439
33 Asturias;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
33 Asturias;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
33 Asturias;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2022QII;""
33 Asturias;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2022QI;5.614
33 Asturias;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
33 Asturias;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
33 Asturias;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2021QII;""
33 Asturias;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2021QI;5.351
33 Asturias;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
33 Asturias;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
33 Asturias;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2020QII;""
33 Asturias;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2020QI;6.055
33 Asturias;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
33 Asturias;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
33 Asturias;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2022QII;5.411
33 Asturias;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2022QI;""
33 Asturias;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
33 Asturias;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
33 Asturias;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2021QII;5.139
33 Asturias;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2021QI;""
33 Asturias;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
33 Asturias;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
33 Asturias;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2020QII;5.876
33 Asturias;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2020QI;""
33 Asturias;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
33 Asturias;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QIII;5.221
33 Asturias;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QII;""
33 Asturias;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QI;""
33 Asturias;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
33 Asturias;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QIII;4.935
33 Asturias;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QII;""
33 Asturias;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QI;""
33 Asturias;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
33 Asturias;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QIII;5.651
33 Asturias;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QII;""
33 Asturias;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QI;""
33 Asturias;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QIV;4.831
33 Asturias;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
33 Asturias;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QII;""
33 Asturias;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QI;""
33 Asturias;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QIV;4.674
33 Asturias;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
33 Asturias;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QII;""
33 Asturias;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QI;""
33 Asturias;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QIV;5.342
33 Asturias;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
33 Asturias;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QII;""
33 Asturias;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QI;""
33 Asturias;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
33 Asturias;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
33 Asturias;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
33 Asturias;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
33 Asturias;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
33 Asturias;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
33 Asturias;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
33 Asturias;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
33 Asturias;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
33 Asturias;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
33 Asturias;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
33 Asturias;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
33 Asturias;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
33 Asturias;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
33 Asturias;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
33 Asturias;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;96,28
33 Asturias;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
33 Asturias;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
33 Asturias;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
33 Asturias;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;96,55
33 Asturias;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
33 Asturias;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
33 Asturias;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
33 Asturias;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;94,04
33 Asturias;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
33 Asturias;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
33 Asturias;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;92,8
33 Asturias;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
33 Asturias;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
33 Asturias;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
33 Asturias;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;92,73
33 Asturias;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
33 Asturias;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
33 Asturias;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
33 Asturias;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;91,26
33 Asturias;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
33 Asturias;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
33 Asturias;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;89,54
33 Asturias;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
33 Asturias;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
33 Asturias;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
33 Asturias;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;89,05
33 Asturias;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
33 Asturias;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
33 Asturias;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
33 Asturias;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;87,76
33 Asturias;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
33 Asturias;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
33 Asturias;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;82,85
33 Asturias;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
33 Asturias;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
33 Asturias;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
33 Asturias;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;84,34
33 Asturias;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
33 Asturias;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
33 Asturias;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
33 Asturias;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;82,96
33 Asturias;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
33 Asturias;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
33 Asturias;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
33 Asturias;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
33 Asturias;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
33 Asturias;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
33 Asturias;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QI;4.025
33 Asturias;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
33 Asturias;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
33 Asturias;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
33 Asturias;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QI;3.865
33 Asturias;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
33 Asturias;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
33 Asturias;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
33 Asturias;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QI;4.497
33 Asturias;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
33 Asturias;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
33 Asturias;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2022QII;""
33 Asturias;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2022QI;3.875
33 Asturias;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
33 Asturias;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
33 Asturias;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2021QII;""
33 Asturias;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2021QI;3.742
33 Asturias;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
33 Asturias;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
33 Asturias;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2020QII;""
33 Asturias;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2020QI;4.222
33 Asturias;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
33 Asturias;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
33 Asturias;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2022QII;3.738
33 Asturias;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2022QI;""
33 Asturias;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
33 Asturias;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
33 Asturias;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2021QII;3.602
33 Asturias;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2021QI;""
33 Asturias;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
33 Asturias;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
33 Asturias;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2020QII;4.075
33 Asturias;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2020QI;""
33 Asturias;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
33 Asturias;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QIII;3.582
33 Asturias;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QII;""
33 Asturias;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QI;""
33 Asturias;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
33 Asturias;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QIII;3.452
33 Asturias;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QII;""
33 Asturias;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QI;""
33 Asturias;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
33 Asturias;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QIII;3.904
33 Asturias;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QII;""
33 Asturias;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QI;""
33 Asturias;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QIV;3.366
33 Asturias;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
33 Asturias;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QII;""
33 Asturias;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QI;""
33 Asturias;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QIV;3.253
33 Asturias;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
33 Asturias;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QII;""
33 Asturias;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QI;""
33 Asturias;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QIV;3.701
33 Asturias;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
33 Asturias;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QII;""
33 Asturias;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QI;""
33 Asturias;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
33 Asturias;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
33 Asturias;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
33 Asturias;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
33 Asturias;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
33 Asturias;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
33 Asturias;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
33 Asturias;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
33 Asturias;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
33 Asturias;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
33 Asturias;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
33 Asturias;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
33 Asturias;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
33 Asturias;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
33 Asturias;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
33 Asturias;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;96,27
33 Asturias;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
33 Asturias;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
33 Asturias;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
33 Asturias;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;96,82
33 Asturias;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
33 Asturias;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
33 Asturias;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
33 Asturias;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;93,88
33 Asturias;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
33 Asturias;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
33 Asturias;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;92,87
33 Asturias;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
33 Asturias;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
33 Asturias;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
33 Asturias;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;93,2
33 Asturias;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
33 Asturias;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
33 Asturias;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
33 Asturias;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;90,62
33 Asturias;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
33 Asturias;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
33 Asturias;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;88,99
33 Asturias;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
33 Asturias;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
33 Asturias;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
33 Asturias;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;89,31
33 Asturias;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
33 Asturias;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
33 Asturias;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
33 Asturias;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;86,81
33 Asturias;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
33 Asturias;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
33 Asturias;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;83,63
33 Asturias;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
33 Asturias;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
33 Asturias;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
33 Asturias;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;84,17
33 Asturias;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
33 Asturias;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
33 Asturias;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
33 Asturias;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;82,3
33 Asturias;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
33 Asturias;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
33 Asturias;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
33 Asturias;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
33 Asturias;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
33 Asturias;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QII;11.214
33 Asturias;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
33 Asturias;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
33 Asturias;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
33 Asturias;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QII;10.858
33 Asturias;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
33 Asturias;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
33 Asturias;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
33 Asturias;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QII;10.482
33 Asturias;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
33 Asturias;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
33 Asturias;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
33 Asturias;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2022QII;10.828
33 Asturias;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2022QI;""
33 Asturias;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
33 Asturias;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
33 Asturias;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2021QII;10.468
33 Asturias;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2021QI;""
33 Asturias;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
33 Asturias;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
33 Asturias;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2020QII;10.141
33 Asturias;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2020QI;""
33 Asturias;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
33 Asturias;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2022QIII;10.449
33 Asturias;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2022QII;""
33 Asturias;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2022QI;""
33 Asturias;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
33 Asturias;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2021QIII;10.089
33 Asturias;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2021QII;""
33 Asturias;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2021QI;""
33 Asturias;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
33 Asturias;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2020QIII;9.707
33 Asturias;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2020QII;""
33 Asturias;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2020QI;""
33 Asturias;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QIV;9.790
33 Asturias;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
33 Asturias;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QII;""
33 Asturias;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QI;""
33 Asturias;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QIV;9.598
33 Asturias;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
33 Asturias;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QII;""
33 Asturias;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QI;""
33 Asturias;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QIV;9.178
33 Asturias;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
33 Asturias;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QII;""
33 Asturias;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QI;""
33 Asturias;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
33 Asturias;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
33 Asturias;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QII;""
33 Asturias;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QI;9.261
33 Asturias;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
33 Asturias;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
33 Asturias;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QII;""
33 Asturias;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QI;8.880
33 Asturias;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
33 Asturias;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
33 Asturias;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QII;""
33 Asturias;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QI;""
33 Asturias;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
33 Asturias;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
33 Asturias;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
33 Asturias;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
33 Asturias;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
33 Asturias;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
33 Asturias;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
33 Asturias;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
33 Asturias;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
33 Asturias;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
33 Asturias;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
33 Asturias;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
33 Asturias;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
33 Asturias;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
33 Asturias;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;96,56
33 Asturias;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
33 Asturias;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
33 Asturias;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
33 Asturias;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;96,41
33 Asturias;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
33 Asturias;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
33 Asturias;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
33 Asturias;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;96,75
33 Asturias;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
33 Asturias;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
33 Asturias;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;93,18
33 Asturias;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
33 Asturias;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
33 Asturias;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
33 Asturias;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;92,92
33 Asturias;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
33 Asturias;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
33 Asturias;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
33 Asturias;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;92,61
33 Asturias;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
33 Asturias;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
33 Asturias;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;87,3
33 Asturias;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
33 Asturias;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
33 Asturias;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
33 Asturias;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;88,4
33 Asturias;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
33 Asturias;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
33 Asturias;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
33 Asturias;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;87,56
33 Asturias;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
33 Asturias;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
33 Asturias;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
33 Asturias;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
33 Asturias;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
33 Asturias;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
33 Asturias;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;85,29
33 Asturias;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
33 Asturias;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
33 Asturias;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
33 Asturias;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;84,72
33 Asturias;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
33 Asturias;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
33 Asturias;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
33 Asturias;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
33 Asturias;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
33 Asturias;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
33 Asturias;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QII;6.671
33 Asturias;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
33 Asturias;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
33 Asturias;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
33 Asturias;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QII;6.423
33 Asturias;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
33 Asturias;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
33 Asturias;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
33 Asturias;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QII;6.177
33 Asturias;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
33 Asturias;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
33 Asturias;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
33 Asturias;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2022QII;6.442
33 Asturias;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2022QI;""
33 Asturias;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
33 Asturias;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
33 Asturias;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2021QII;6.189
33 Asturias;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2021QI;""
33 Asturias;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
33 Asturias;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
33 Asturias;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2020QII;5.988
33 Asturias;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2020QI;""
33 Asturias;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
33 Asturias;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2022QIII;6.231
33 Asturias;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2022QII;""
33 Asturias;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2022QI;""
33 Asturias;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
33 Asturias;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2021QIII;5.970
33 Asturias;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2021QII;""
33 Asturias;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2021QI;""
33 Asturias;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
33 Asturias;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2020QIII;5.739
33 Asturias;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2020QII;""
33 Asturias;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2020QI;""
33 Asturias;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QIV;5.816
33 Asturias;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
33 Asturias;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QII;""
33 Asturias;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QI;""
33 Asturias;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QIV;5.691
33 Asturias;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
33 Asturias;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QII;""
33 Asturias;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QI;""
33 Asturias;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QIV;5.420
33 Asturias;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
33 Asturias;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QII;""
33 Asturias;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QI;""
33 Asturias;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
33 Asturias;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
33 Asturias;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QII;""
33 Asturias;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QI;5.492
33 Asturias;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
33 Asturias;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
33 Asturias;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QII;""
33 Asturias;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QI;5.240
33 Asturias;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
33 Asturias;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
33 Asturias;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QII;""
33 Asturias;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QI;""
33 Asturias;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
33 Asturias;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
33 Asturias;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
33 Asturias;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
33 Asturias;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
33 Asturias;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
33 Asturias;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
33 Asturias;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
33 Asturias;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
33 Asturias;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
33 Asturias;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
33 Asturias;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
33 Asturias;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
33 Asturias;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
33 Asturias;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;96,57
33 Asturias;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
33 Asturias;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
33 Asturias;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
33 Asturias;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;96,36
33 Asturias;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
33 Asturias;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
33 Asturias;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
33 Asturias;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;96,94
33 Asturias;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
33 Asturias;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
33 Asturias;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;93,4
33 Asturias;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
33 Asturias;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
33 Asturias;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
33 Asturias;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;92,95
33 Asturias;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
33 Asturias;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
33 Asturias;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
33 Asturias;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;92,91
33 Asturias;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
33 Asturias;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
33 Asturias;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;87,18
33 Asturias;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
33 Asturias;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
33 Asturias;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
33 Asturias;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;88,6
33 Asturias;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
33 Asturias;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
33 Asturias;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
33 Asturias;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;87,74
33 Asturias;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
33 Asturias;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
33 Asturias;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
33 Asturias;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
33 Asturias;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
33 Asturias;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
33 Asturias;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;85,51
33 Asturias;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
33 Asturias;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
33 Asturias;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
33 Asturias;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;84,83
33 Asturias;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
33 Asturias;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
33 Asturias;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
33 Asturias;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
33 Asturias;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
33 Asturias;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
33 Asturias;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QII;4.543
33 Asturias;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
33 Asturias;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
33 Asturias;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
33 Asturias;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QII;4.435
33 Asturias;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
33 Asturias;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
33 Asturias;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
33 Asturias;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QII;4.305
33 Asturias;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
33 Asturias;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
33 Asturias;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
33 Asturias;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2022QII;4.386
33 Asturias;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2022QI;""
33 Asturias;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
33 Asturias;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
33 Asturias;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2021QII;4.279
33 Asturias;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2021QI;""
33 Asturias;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
33 Asturias;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
33 Asturias;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2020QII;4.153
33 Asturias;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2020QI;""
33 Asturias;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
33 Asturias;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2022QIII;4.218
33 Asturias;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2022QII;""
33 Asturias;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2022QI;""
33 Asturias;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
33 Asturias;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2021QIII;4.119
33 Asturias;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2021QII;""
33 Asturias;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2021QI;""
33 Asturias;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
33 Asturias;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2020QIII;3.968
33 Asturias;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2020QII;""
33 Asturias;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2020QI;""
33 Asturias;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QIV;3.974
33 Asturias;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
33 Asturias;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QII;""
33 Asturias;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QI;""
33 Asturias;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QIV;3.907
33 Asturias;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
33 Asturias;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QII;""
33 Asturias;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QI;""
33 Asturias;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QIV;3.758
33 Asturias;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
33 Asturias;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QII;""
33 Asturias;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QI;""
33 Asturias;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
33 Asturias;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
33 Asturias;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QII;""
33 Asturias;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QI;3.769
33 Asturias;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
33 Asturias;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
33 Asturias;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QII;""
33 Asturias;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QI;3.640
33 Asturias;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
33 Asturias;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
33 Asturias;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QII;""
33 Asturias;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QI;""
33 Asturias;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
33 Asturias;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
33 Asturias;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
33 Asturias;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
33 Asturias;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
33 Asturias;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
33 Asturias;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
33 Asturias;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
33 Asturias;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
33 Asturias;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
33 Asturias;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
33 Asturias;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
33 Asturias;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
33 Asturias;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
33 Asturias;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;96,54
33 Asturias;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
33 Asturias;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
33 Asturias;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
33 Asturias;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;96,48
33 Asturias;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
33 Asturias;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
33 Asturias;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
33 Asturias;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;96,47
33 Asturias;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
33 Asturias;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
33 Asturias;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;92,85
33 Asturias;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
33 Asturias;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
33 Asturias;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
33 Asturias;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;92,87
33 Asturias;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
33 Asturias;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
33 Asturias;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
33 Asturias;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;92,17
33 Asturias;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
33 Asturias;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
33 Asturias;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;87,48
33 Asturias;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
33 Asturias;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
33 Asturias;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
33 Asturias;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;88,09
33 Asturias;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
33 Asturias;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
33 Asturias;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
33 Asturias;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;87,29
33 Asturias;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
33 Asturias;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
33 Asturias;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
33 Asturias;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
33 Asturias;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
33 Asturias;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
33 Asturias;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;84,98
33 Asturias;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
33 Asturias;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
33 Asturias;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
33 Asturias;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;84,55
33 Asturias;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
33 Asturias;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
33 Asturias;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
33 Asturias;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
33 Asturias;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
33 Asturias;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QIII;10.960
33 Asturias;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
33 Asturias;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
33 Asturias;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
33 Asturias;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QIII;10.598
33 Asturias;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
33 Asturias;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
33 Asturias;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
33 Asturias;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QIII;10.225
33 Asturias;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
33 Asturias;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
33 Asturias;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
33 Asturias;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2022QIII;10.537
33 Asturias;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2022QII;""
33 Asturias;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2022QI;""
33 Asturias;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
33 Asturias;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2021QIII;10.191
33 Asturias;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2021QII;""
33 Asturias;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2021QI;""
33 Asturias;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
33 Asturias;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2020QIII;9.771
33 Asturias;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2020QII;""
33 Asturias;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2020QI;""
33 Asturias;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2022QIV;9.859
33 Asturias;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
33 Asturias;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2022QII;""
33 Asturias;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2022QI;""
33 Asturias;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2021QIV;9.685
33 Asturias;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
33 Asturias;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2021QII;""
33 Asturias;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2021QI;""
33 Asturias;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2020QIV;9.228
33 Asturias;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
33 Asturias;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2020QII;""
33 Asturias;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2020QI;""
33 Asturias;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
33 Asturias;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
33 Asturias;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QII;""
33 Asturias;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QI;9.339
33 Asturias;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
33 Asturias;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
33 Asturias;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QII;""
33 Asturias;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QI;8.927
33 Asturias;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
33 Asturias;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
33 Asturias;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QII;""
33 Asturias;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QI;""
33 Asturias;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
33 Asturias;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
33 Asturias;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QII;9.013
33 Asturias;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QI;""
33 Asturias;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
33 Asturias;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
33 Asturias;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QII;8.598
33 Asturias;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QI;""
33 Asturias;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
33 Asturias;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
33 Asturias;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QII;""
33 Asturias;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QI;""
33 Asturias;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
33 Asturias;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
33 Asturias;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
33 Asturias;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
33 Asturias;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
33 Asturias;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
33 Asturias;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
33 Asturias;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
33 Asturias;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
33 Asturias;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
33 Asturias;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
33 Asturias;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
33 Asturias;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
33 Asturias;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;96,14
33 Asturias;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
33 Asturias;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
33 Asturias;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
33 Asturias;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;96,16
33 Asturias;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
33 Asturias;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
33 Asturias;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
33 Asturias;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;95,56
33 Asturias;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
33 Asturias;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
33 Asturias;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;89,95
33 Asturias;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
33 Asturias;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
33 Asturias;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
33 Asturias;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;91,39
33 Asturias;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
33 Asturias;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
33 Asturias;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
33 Asturias;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;90,25
33 Asturias;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
33 Asturias;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
33 Asturias;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
33 Asturias;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
33 Asturias;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
33 Asturias;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
33 Asturias;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;88,12
33 Asturias;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
33 Asturias;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
33 Asturias;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
33 Asturias;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;87,31
33 Asturias;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
33 Asturias;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
33 Asturias;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
33 Asturias;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
33 Asturias;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
33 Asturias;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
33 Asturias;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;85,04
33 Asturias;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
33 Asturias;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
33 Asturias;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
33 Asturias;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;84,09
33 Asturias;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
33 Asturias;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
33 Asturias;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
33 Asturias;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
33 Asturias;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
33 Asturias;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
33 Asturias;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QIII;6.507
33 Asturias;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
33 Asturias;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
33 Asturias;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
33 Asturias;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QIII;6.261
33 Asturias;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
33 Asturias;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
33 Asturias;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
33 Asturias;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QIII;6.031
33 Asturias;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
33 Asturias;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
33 Asturias;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
33 Asturias;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2022QIII;6.278
33 Asturias;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2022QII;""
33 Asturias;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2022QI;""
33 Asturias;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
33 Asturias;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2021QIII;6.026
33 Asturias;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2021QII;""
33 Asturias;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2021QI;""
33 Asturias;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
33 Asturias;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2020QIII;5.772
33 Asturias;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2020QII;""
33 Asturias;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2020QI;""
33 Asturias;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2022QIV;5.852
33 Asturias;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
33 Asturias;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2022QII;""
33 Asturias;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2022QI;""
33 Asturias;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2021QIV;5.738
33 Asturias;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
33 Asturias;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2021QII;""
33 Asturias;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2021QI;""
33 Asturias;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2020QIV;5.446
33 Asturias;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
33 Asturias;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2020QII;""
33 Asturias;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2020QI;""
33 Asturias;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
33 Asturias;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
33 Asturias;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QII;""
33 Asturias;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QI;5.533
33 Asturias;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
33 Asturias;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
33 Asturias;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QII;""
33 Asturias;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QI;5.265
33 Asturias;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
33 Asturias;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
33 Asturias;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QII;""
33 Asturias;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QI;""
33 Asturias;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
33 Asturias;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
33 Asturias;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QII;5.336
33 Asturias;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QI;""
33 Asturias;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
33 Asturias;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
33 Asturias;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QII;5.063
33 Asturias;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QI;""
33 Asturias;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
33 Asturias;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
33 Asturias;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QII;""
33 Asturias;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QI;""
33 Asturias;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
33 Asturias;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
33 Asturias;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
33 Asturias;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
33 Asturias;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
33 Asturias;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
33 Asturias;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
33 Asturias;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
33 Asturias;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
33 Asturias;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
33 Asturias;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
33 Asturias;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
33 Asturias;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
33 Asturias;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;96,48
33 Asturias;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
33 Asturias;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
33 Asturias;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
33 Asturias;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;96,25
33 Asturias;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
33 Asturias;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
33 Asturias;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
33 Asturias;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;95,71
33 Asturias;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
33 Asturias;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
33 Asturias;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;89,93
33 Asturias;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
33 Asturias;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
33 Asturias;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
33 Asturias;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;91,65
33 Asturias;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
33 Asturias;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
33 Asturias;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
33 Asturias;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;90,3
33 Asturias;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
33 Asturias;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
33 Asturias;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
33 Asturias;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
33 Asturias;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
33 Asturias;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
33 Asturias;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;88,37
33 Asturias;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
33 Asturias;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
33 Asturias;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
33 Asturias;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;87,3
33 Asturias;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
33 Asturias;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
33 Asturias;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
33 Asturias;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
33 Asturias;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
33 Asturias;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
33 Asturias;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;85,23
33 Asturias;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
33 Asturias;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
33 Asturias;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
33 Asturias;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;83,95
33 Asturias;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
33 Asturias;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
33 Asturias;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
33 Asturias;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
33 Asturias;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
33 Asturias;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
33 Asturias;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QIII;4.453
33 Asturias;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
33 Asturias;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
33 Asturias;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
33 Asturias;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QIII;4.337
33 Asturias;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
33 Asturias;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
33 Asturias;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
33 Asturias;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QIII;4.194
33 Asturias;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
33 Asturias;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
33 Asturias;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
33 Asturias;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2022QIII;4.259
33 Asturias;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2022QII;""
33 Asturias;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2022QI;""
33 Asturias;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
33 Asturias;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2021QIII;4.165
33 Asturias;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2021QII;""
33 Asturias;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2021QI;""
33 Asturias;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
33 Asturias;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2020QIII;3.999
33 Asturias;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2020QII;""
33 Asturias;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2020QI;""
33 Asturias;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2022QIV;4.007
33 Asturias;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
33 Asturias;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2022QII;""
33 Asturias;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2022QI;""
33 Asturias;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2021QIV;3.947
33 Asturias;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
33 Asturias;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2021QII;""
33 Asturias;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2021QI;""
33 Asturias;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2020QIV;3.782
33 Asturias;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
33 Asturias;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2020QII;""
33 Asturias;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2020QI;""
33 Asturias;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
33 Asturias;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
33 Asturias;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QII;""
33 Asturias;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QI;3.806
33 Asturias;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
33 Asturias;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
33 Asturias;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QII;""
33 Asturias;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QI;3.662
33 Asturias;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
33 Asturias;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
33 Asturias;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QII;""
33 Asturias;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QI;""
33 Asturias;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
33 Asturias;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
33 Asturias;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QII;3.677
33 Asturias;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QI;""
33 Asturias;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
33 Asturias;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
33 Asturias;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QII;3.535
33 Asturias;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QI;""
33 Asturias;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
33 Asturias;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
33 Asturias;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QII;""
33 Asturias;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QI;""
33 Asturias;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
33 Asturias;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
33 Asturias;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
33 Asturias;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
33 Asturias;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
33 Asturias;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
33 Asturias;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
33 Asturias;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
33 Asturias;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
33 Asturias;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
33 Asturias;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
33 Asturias;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
33 Asturias;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
33 Asturias;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;95,64
33 Asturias;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
33 Asturias;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
33 Asturias;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
33 Asturias;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;96,03
33 Asturias;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
33 Asturias;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
33 Asturias;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
33 Asturias;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;95,35
33 Asturias;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
33 Asturias;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
33 Asturias;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;89,98
33 Asturias;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
33 Asturias;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
33 Asturias;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
33 Asturias;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;91,01
33 Asturias;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
33 Asturias;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
33 Asturias;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
33 Asturias;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;90,18
33 Asturias;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
33 Asturias;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
33 Asturias;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
33 Asturias;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
33 Asturias;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
33 Asturias;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
33 Asturias;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;87,76
33 Asturias;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
33 Asturias;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
33 Asturias;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
33 Asturias;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;87,32
33 Asturias;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
33 Asturias;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
33 Asturias;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
33 Asturias;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
33 Asturias;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
33 Asturias;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
33 Asturias;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;84,78
33 Asturias;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
33 Asturias;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
33 Asturias;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
33 Asturias;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;84,29
33 Asturias;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
33 Asturias;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
33 Asturias;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
33 Asturias;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
33 Asturias;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
33 Asturias;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QIV;10.634
33 Asturias;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
33 Asturias;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
33 Asturias;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
33 Asturias;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QIV;10.275
33 Asturias;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
33 Asturias;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
33 Asturias;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
33 Asturias;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QIV;9.872
33 Asturias;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
33 Asturias;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
33 Asturias;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
33 Asturias;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2022QIV;9.939
33 Asturias;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
33 Asturias;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2022QII;""
33 Asturias;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2022QI;""
33 Asturias;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2021QIV;9.750
33 Asturias;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
33 Asturias;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2021QII;""
33 Asturias;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2021QI;""
33 Asturias;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2020QIV;9.311
33 Asturias;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
33 Asturias;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2020QII;""
33 Asturias;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2020QI;""
33 Asturias;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
33 Asturias;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
33 Asturias;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2022QII;""
33 Asturias;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2022QI;9.398
33 Asturias;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
33 Asturias;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
33 Asturias;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2021QII;""
33 Asturias;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2021QI;9.006
33 Asturias;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
33 Asturias;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
33 Asturias;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2020QII;""
33 Asturias;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2020QI;""
33 Asturias;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
33 Asturias;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
33 Asturias;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QII;9.067
33 Asturias;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QI;""
33 Asturias;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
33 Asturias;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
33 Asturias;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QII;8.668
33 Asturias;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QI;""
33 Asturias;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
33 Asturias;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
33 Asturias;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QII;""
33 Asturias;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QI;""
33 Asturias;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
33 Asturias;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QIII;8.729
33 Asturias;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QII;""
33 Asturias;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QI;""
33 Asturias;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
33 Asturias;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QIII;8.322
33 Asturias;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QII;""
33 Asturias;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QI;""
33 Asturias;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
33 Asturias;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
33 Asturias;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QII;""
33 Asturias;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QI;""
33 Asturias;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
33 Asturias;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
33 Asturias;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
33 Asturias;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
33 Asturias;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
33 Asturias;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
33 Asturias;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
33 Asturias;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
33 Asturias;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
33 Asturias;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
33 Asturias;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
33 Asturias;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
33 Asturias;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;93,46
33 Asturias;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
33 Asturias;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
33 Asturias;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
33 Asturias;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;94,89
33 Asturias;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
33 Asturias;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
33 Asturias;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
33 Asturias;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;94,32
33 Asturias;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
33 Asturias;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
33 Asturias;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
33 Asturias;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
33 Asturias;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
33 Asturias;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
33 Asturias;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;91,46
33 Asturias;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
33 Asturias;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
33 Asturias;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
33 Asturias;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;91,23
33 Asturias;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
33 Asturias;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
33 Asturias;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
33 Asturias;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
33 Asturias;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
33 Asturias;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
33 Asturias;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;88,24
33 Asturias;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
33 Asturias;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
33 Asturias;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
33 Asturias;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;87,8
33 Asturias;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
33 Asturias;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
33 Asturias;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
33 Asturias;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
33 Asturias;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
33 Asturias;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
33 Asturias;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;84,95
33 Asturias;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
33 Asturias;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
33 Asturias;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
33 Asturias;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;84,3
33 Asturias;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
33 Asturias;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
33 Asturias;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
33 Asturias;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
33 Asturias;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
33 Asturias;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
33 Asturias;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QIV;6.334
33 Asturias;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
33 Asturias;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
33 Asturias;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
33 Asturias;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QIV;6.073
33 Asturias;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
33 Asturias;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
33 Asturias;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
33 Asturias;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QIV;5.825
33 Asturias;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
33 Asturias;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
33 Asturias;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
33 Asturias;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2022QIV;5.899
33 Asturias;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
33 Asturias;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2022QII;""
33 Asturias;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2022QI;""
33 Asturias;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2021QIV;5.771
33 Asturias;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
33 Asturias;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2021QII;""
33 Asturias;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2021QI;""
33 Asturias;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2020QIV;5.488
33 Asturias;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
33 Asturias;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2020QII;""
33 Asturias;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2020QI;""
33 Asturias;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
33 Asturias;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
33 Asturias;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2022QII;""
33 Asturias;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2022QI;5.562
33 Asturias;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
33 Asturias;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
33 Asturias;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2021QII;""
33 Asturias;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2021QI;5.304
33 Asturias;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
33 Asturias;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
33 Asturias;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2020QII;""
33 Asturias;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2020QI;""
33 Asturias;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
33 Asturias;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
33 Asturias;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QII;5.361
33 Asturias;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QI;""
33 Asturias;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
33 Asturias;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
33 Asturias;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QII;5.097
33 Asturias;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QI;""
33 Asturias;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
33 Asturias;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
33 Asturias;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QII;""
33 Asturias;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QI;""
33 Asturias;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
33 Asturias;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QIII;5.176
33 Asturias;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QII;""
33 Asturias;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QI;""
33 Asturias;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
33 Asturias;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QIII;4.897
33 Asturias;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QII;""
33 Asturias;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QI;""
33 Asturias;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
33 Asturias;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
33 Asturias;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QII;""
33 Asturias;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QI;""
33 Asturias;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
33 Asturias;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
33 Asturias;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
33 Asturias;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
33 Asturias;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
33 Asturias;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
33 Asturias;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
33 Asturias;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
33 Asturias;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
33 Asturias;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
33 Asturias;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
33 Asturias;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
33 Asturias;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;93,13
33 Asturias;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
33 Asturias;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
33 Asturias;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
33 Asturias;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;95,03
33 Asturias;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
33 Asturias;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
33 Asturias;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
33 Asturias;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;94,21
33 Asturias;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
33 Asturias;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
33 Asturias;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
33 Asturias;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
33 Asturias;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
33 Asturias;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
33 Asturias;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;91,59
33 Asturias;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
33 Asturias;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
33 Asturias;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
33 Asturias;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;91,06
33 Asturias;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
33 Asturias;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
33 Asturias;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
33 Asturias;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
33 Asturias;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
33 Asturias;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
33 Asturias;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;88,28
33 Asturias;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
33 Asturias;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
33 Asturias;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
33 Asturias;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;87,5
33 Asturias;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
33 Asturias;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
33 Asturias;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
33 Asturias;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
33 Asturias;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
33 Asturias;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
33 Asturias;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;85,23
33 Asturias;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
33 Asturias;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
33 Asturias;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
33 Asturias;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;84,07
33 Asturias;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
33 Asturias;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
33 Asturias;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
33 Asturias;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
33 Asturias;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
33 Asturias;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
33 Asturias;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QIV;4.300
33 Asturias;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
33 Asturias;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
33 Asturias;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
33 Asturias;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QIV;4.202
33 Asturias;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
33 Asturias;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
33 Asturias;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
33 Asturias;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QIV;4.047
33 Asturias;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
33 Asturias;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
33 Asturias;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
33 Asturias;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2022QIV;4.040
33 Asturias;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
33 Asturias;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2022QII;""
33 Asturias;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2022QI;""
33 Asturias;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2021QIV;3.979
33 Asturias;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
33 Asturias;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2021QII;""
33 Asturias;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2021QI;""
33 Asturias;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2020QIV;3.823
33 Asturias;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
33 Asturias;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2020QII;""
33 Asturias;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2020QI;""
33 Asturias;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
33 Asturias;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
33 Asturias;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2022QII;""
33 Asturias;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2022QI;3.836
33 Asturias;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
33 Asturias;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
33 Asturias;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2021QII;""
33 Asturias;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2021QI;3.702
33 Asturias;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
33 Asturias;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
33 Asturias;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2020QII;""
33 Asturias;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2020QI;""
33 Asturias;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
33 Asturias;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
33 Asturias;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QII;3.706
33 Asturias;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QI;""
33 Asturias;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
33 Asturias;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
33 Asturias;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QII;3.571
33 Asturias;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QI;""
33 Asturias;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
33 Asturias;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
33 Asturias;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QII;""
33 Asturias;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QI;""
33 Asturias;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
33 Asturias;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QIII;3.553
33 Asturias;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QII;""
33 Asturias;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QI;""
33 Asturias;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
33 Asturias;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QIII;3.425
33 Asturias;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QII;""
33 Asturias;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QI;""
33 Asturias;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
33 Asturias;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
33 Asturias;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QII;""
33 Asturias;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QI;""
33 Asturias;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
33 Asturias;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
33 Asturias;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
33 Asturias;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
33 Asturias;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
33 Asturias;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
33 Asturias;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
33 Asturias;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
33 Asturias;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
33 Asturias;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
33 Asturias;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
33 Asturias;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
33 Asturias;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;93,95
33 Asturias;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
33 Asturias;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
33 Asturias;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
33 Asturias;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;94,69
33 Asturias;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
33 Asturias;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
33 Asturias;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
33 Asturias;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;94,47
33 Asturias;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
33 Asturias;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
33 Asturias;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
33 Asturias;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
33 Asturias;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
33 Asturias;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
33 Asturias;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;91,29
33 Asturias;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
33 Asturias;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
33 Asturias;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
33 Asturias;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;91,48
33 Asturias;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
33 Asturias;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
33 Asturias;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
33 Asturias;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
33 Asturias;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
33 Asturias;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
33 Asturias;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;88,2
33 Asturias;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
33 Asturias;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
33 Asturias;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
33 Asturias;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;88,24
33 Asturias;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
33 Asturias;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
33 Asturias;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
33 Asturias;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
33 Asturias;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
33 Asturias;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
33 Asturias;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;84,55
33 Asturias;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
33 Asturias;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
33 Asturias;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
33 Asturias;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;84,63
33 Asturias;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
33 Asturias;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
33 Asturias;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
33 Asturias;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
33 Asturias;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
33 Asturias;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
05 Ávila;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
05 Ávila;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
05 Ávila;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
05 Ávila;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QI;10.701
05 Ávila;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
05 Ávila;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
05 Ávila;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
05 Ávila;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QI;10.710
05 Ávila;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
05 Ávila;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
05 Ávila;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
05 Ávila;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QI;10.954
05 Ávila;All ages;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
05 Ávila;All ages;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
05 Ávila;All ages;Cohort January 1;Total;Survival in the first trimester;2022QII;""
05 Ávila;All ages;Cohort January 1;Total;Survival in the first trimester;2022QI;10.429
05 Ávila;All ages;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
05 Ávila;All ages;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
05 Ávila;All ages;Cohort January 1;Total;Survival in the first trimester;2021QII;""
05 Ávila;All ages;Cohort January 1;Total;Survival in the first trimester;2021QI;10.452
05 Ávila;All ages;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
05 Ávila;All ages;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
05 Ávila;All ages;Cohort January 1;Total;Survival in the first trimester;2020QII;""
05 Ávila;All ages;Cohort January 1;Total;Survival in the first trimester;2020QI;10.411
05 Ávila;All ages;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
05 Ávila;All ages;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
05 Ávila;All ages;Cohort January 1;Total;Survival in the second trimester;2022QII;10.177
05 Ávila;All ages;Cohort January 1;Total;Survival in the second trimester;2022QI;""
05 Ávila;All ages;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
05 Ávila;All ages;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
05 Ávila;All ages;Cohort January 1;Total;Survival in the second trimester;2021QII;10.190
05 Ávila;All ages;Cohort January 1;Total;Survival in the second trimester;2021QI;""
05 Ávila;All ages;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
05 Ávila;All ages;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
05 Ávila;All ages;Cohort January 1;Total;Survival in the second trimester;2020QII;10.230
05 Ávila;All ages;Cohort January 1;Total;Survival in the second trimester;2020QI;""
05 Ávila;All ages;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
05 Ávila;All ages;Cohort January 1;Total;Survival in the third trimester;2022QIII;9.923
05 Ávila;All ages;Cohort January 1;Total;Survival in the third trimester;2022QII;""
05 Ávila;All ages;Cohort January 1;Total;Survival in the third trimester;2022QI;""
05 Ávila;All ages;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
05 Ávila;All ages;Cohort January 1;Total;Survival in the third trimester;2021QIII;9.982
05 Ávila;All ages;Cohort January 1;Total;Survival in the third trimester;2021QII;""
05 Ávila;All ages;Cohort January 1;Total;Survival in the third trimester;2021QI;""
05 Ávila;All ages;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
05 Ávila;All ages;Cohort January 1;Total;Survival in the third trimester;2020QIII;9.992
05 Ávila;All ages;Cohort January 1;Total;Survival in the third trimester;2020QII;""
05 Ávila;All ages;Cohort January 1;Total;Survival in the third trimester;2020QI;""
05 Ávila;All ages;Cohort January 1;Total;Survival in the third trimester;2022QIV;9.642
05 Ávila;All ages;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
05 Ávila;All ages;Cohort January 1;Total;Survival in the third trimester;2022QII;""
05 Ávila;All ages;Cohort January 1;Total;Survival in the third trimester;2022QI;""
05 Ávila;All ages;Cohort January 1;Total;Survival in the third trimester;2021QIV;9.717
05 Ávila;All ages;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
05 Ávila;All ages;Cohort January 1;Total;Survival in the third trimester;2021QII;""
05 Ávila;All ages;Cohort January 1;Total;Survival in the third trimester;2021QI;""
05 Ávila;All ages;Cohort January 1;Total;Survival in the third trimester;2020QIV;9.754
05 Ávila;All ages;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
05 Ávila;All ages;Cohort January 1;Total;Survival in the third trimester;2020QII;""
05 Ávila;All ages;Cohort January 1;Total;Survival in the third trimester;2020QI;""
05 Ávila;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
05 Ávila;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
05 Ávila;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
05 Ávila;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
05 Ávila;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
05 Ávila;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
05 Ávila;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
05 Ávila;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
05 Ávila;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
05 Ávila;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
05 Ávila;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
05 Ávila;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
05 Ávila;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
05 Ávila;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
05 Ávila;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
05 Ávila;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;97,46
05 Ávila;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
05 Ávila;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
05 Ávila;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
05 Ávila;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;97,59
05 Ávila;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
05 Ávila;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
05 Ávila;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
05 Ávila;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;95,04
05 Ávila;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
05 Ávila;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
05 Ávila;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;95,1
05 Ávila;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
05 Ávila;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
05 Ávila;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
05 Ávila;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;95,14
05 Ávila;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
05 Ávila;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
05 Ávila;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
05 Ávila;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;93,39
05 Ávila;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
05 Ávila;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
05 Ávila;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;92,73
05 Ávila;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
05 Ávila;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
05 Ávila;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
05 Ávila;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;93,2
05 Ávila;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
05 Ávila;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
05 Ávila;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
05 Ávila;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;91,22
05 Ávila;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
05 Ávila;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
05 Ávila;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;90,1
05 Ávila;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
05 Ávila;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
05 Ávila;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
05 Ávila;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;90,73
05 Ávila;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
05 Ávila;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
05 Ávila;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
05 Ávila;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;89,05
05 Ávila;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
05 Ávila;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
05 Ávila;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
05 Ávila;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
05 Ávila;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
05 Ávila;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
05 Ávila;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QI;7.071
05 Ávila;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
05 Ávila;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
05 Ávila;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
05 Ávila;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QI;7.105
05 Ávila;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
05 Ávila;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
05 Ávila;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
05 Ávila;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QI;7.267
05 Ávila;All ages;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
05 Ávila;All ages;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
05 Ávila;All ages;Cohort January 1;Males;Survival in the first trimester;2022QII;""
05 Ávila;All ages;Cohort January 1;Males;Survival in the first trimester;2022QI;6.890
05 Ávila;All ages;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
05 Ávila;All ages;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
05 Ávila;All ages;Cohort January 1;Males;Survival in the first trimester;2021QII;""
05 Ávila;All ages;Cohort January 1;Males;Survival in the first trimester;2021QI;6.932
05 Ávila;All ages;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
05 Ávila;All ages;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
05 Ávila;All ages;Cohort January 1;Males;Survival in the first trimester;2020QII;""
05 Ávila;All ages;Cohort January 1;Males;Survival in the first trimester;2020QI;6.935
05 Ávila;All ages;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
05 Ávila;All ages;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
05 Ávila;All ages;Cohort January 1;Males;Survival in the second trimester;2022QII;6.735
05 Ávila;All ages;Cohort January 1;Males;Survival in the second trimester;2022QI;""
05 Ávila;All ages;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
05 Ávila;All ages;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
05 Ávila;All ages;Cohort January 1;Males;Survival in the second trimester;2021QII;6.769
05 Ávila;All ages;Cohort January 1;Males;Survival in the second trimester;2021QI;""
05 Ávila;All ages;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
05 Ávila;All ages;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
05 Ávila;All ages;Cohort January 1;Males;Survival in the second trimester;2020QII;6.820
05 Ávila;All ages;Cohort January 1;Males;Survival in the second trimester;2020QI;""
05 Ávila;All ages;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
05 Ávila;All ages;Cohort January 1;Males;Survival in the third trimester;2022QIII;6.585
05 Ávila;All ages;Cohort January 1;Males;Survival in the third trimester;2022QII;""
05 Ávila;All ages;Cohort January 1;Males;Survival in the third trimester;2022QI;""
05 Ávila;All ages;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
05 Ávila;All ages;Cohort January 1;Males;Survival in the third trimester;2021QIII;6.652
05 Ávila;All ages;Cohort January 1;Males;Survival in the third trimester;2021QII;""
05 Ávila;All ages;Cohort January 1;Males;Survival in the third trimester;2021QI;""
05 Ávila;All ages;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
05 Ávila;All ages;Cohort January 1;Males;Survival in the third trimester;2020QIII;6.687
05 Ávila;All ages;Cohort January 1;Males;Survival in the third trimester;2020QII;""
05 Ávila;All ages;Cohort January 1;Males;Survival in the third trimester;2020QI;""
05 Ávila;All ages;Cohort January 1;Males;Survival in the third trimester;2022QIV;6.421
05 Ávila;All ages;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
05 Ávila;All ages;Cohort January 1;Males;Survival in the third trimester;2022QII;""
05 Ávila;All ages;Cohort January 1;Males;Survival in the third trimester;2022QI;""
05 Ávila;All ages;Cohort January 1;Males;Survival in the third trimester;2021QIV;6.489
05 Ávila;All ages;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
05 Ávila;All ages;Cohort January 1;Males;Survival in the third trimester;2021QII;""
05 Ávila;All ages;Cohort January 1;Males;Survival in the third trimester;2021QI;""
05 Ávila;All ages;Cohort January 1;Males;Survival in the third trimester;2020QIV;6.541
05 Ávila;All ages;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
05 Ávila;All ages;Cohort January 1;Males;Survival in the third trimester;2020QII;""
05 Ávila;All ages;Cohort January 1;Males;Survival in the third trimester;2020QI;""
05 Ávila;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
05 Ávila;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
05 Ávila;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
05 Ávila;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
05 Ávila;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
05 Ávila;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
05 Ávila;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
05 Ávila;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
05 Ávila;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
05 Ávila;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
05 Ávila;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
05 Ávila;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
05 Ávila;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
05 Ávila;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
05 Ávila;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
05 Ávila;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;97,44
05 Ávila;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
05 Ávila;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
05 Ávila;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
05 Ávila;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;97,57
05 Ávila;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
05 Ávila;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
05 Ávila;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
05 Ávila;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;95,43
05 Ávila;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
05 Ávila;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
05 Ávila;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;95,25
05 Ávila;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
05 Ávila;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
05 Ávila;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
05 Ávila;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;95,27
05 Ávila;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
05 Ávila;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
05 Ávila;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
05 Ávila;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;93,85
05 Ávila;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
05 Ávila;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
05 Ávila;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;93,13
05 Ávila;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
05 Ávila;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
05 Ávila;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
05 Ávila;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;93,62
05 Ávila;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
05 Ávila;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
05 Ávila;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
05 Ávila;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;92,02
05 Ávila;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
05 Ávila;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
05 Ávila;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;90,81
05 Ávila;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
05 Ávila;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
05 Ávila;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
05 Ávila;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;91,33
05 Ávila;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
05 Ávila;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
05 Ávila;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
05 Ávila;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;90,01
05 Ávila;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
05 Ávila;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
05 Ávila;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
05 Ávila;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
05 Ávila;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
05 Ávila;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
05 Ávila;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QI;3.630
05 Ávila;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
05 Ávila;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
05 Ávila;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
05 Ávila;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QI;3.605
05 Ávila;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
05 Ávila;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
05 Ávila;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
05 Ávila;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QI;3.687
05 Ávila;All ages;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
05 Ávila;All ages;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
05 Ávila;All ages;Cohort January 1;Females;Survival in the first trimester;2022QII;""
05 Ávila;All ages;Cohort January 1;Females;Survival in the first trimester;2022QI;3.539
05 Ávila;All ages;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
05 Ávila;All ages;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
05 Ávila;All ages;Cohort January 1;Females;Survival in the first trimester;2021QII;""
05 Ávila;All ages;Cohort January 1;Females;Survival in the first trimester;2021QI;3.520
05 Ávila;All ages;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
05 Ávila;All ages;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
05 Ávila;All ages;Cohort January 1;Females;Survival in the first trimester;2020QII;""
05 Ávila;All ages;Cohort January 1;Females;Survival in the first trimester;2020QI;3.476
05 Ávila;All ages;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
05 Ávila;All ages;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
05 Ávila;All ages;Cohort January 1;Females;Survival in the second trimester;2022QII;3.442
05 Ávila;All ages;Cohort January 1;Females;Survival in the second trimester;2022QI;""
05 Ávila;All ages;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
05 Ávila;All ages;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
05 Ávila;All ages;Cohort January 1;Females;Survival in the second trimester;2021QII;3.421
05 Ávila;All ages;Cohort January 1;Females;Survival in the second trimester;2021QI;""
05 Ávila;All ages;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
05 Ávila;All ages;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
05 Ávila;All ages;Cohort January 1;Females;Survival in the second trimester;2020QII;3.410
05 Ávila;All ages;Cohort January 1;Females;Survival in the second trimester;2020QI;""
05 Ávila;All ages;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
05 Ávila;All ages;Cohort January 1;Females;Survival in the third trimester;2022QIII;3.338
05 Ávila;All ages;Cohort January 1;Females;Survival in the third trimester;2022QII;""
05 Ávila;All ages;Cohort January 1;Females;Survival in the third trimester;2022QI;""
05 Ávila;All ages;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
05 Ávila;All ages;Cohort January 1;Females;Survival in the third trimester;2021QIII;3.330
05 Ávila;All ages;Cohort January 1;Females;Survival in the third trimester;2021QII;""
05 Ávila;All ages;Cohort January 1;Females;Survival in the third trimester;2021QI;""
05 Ávila;All ages;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
05 Ávila;All ages;Cohort January 1;Females;Survival in the third trimester;2020QIII;3.305
05 Ávila;All ages;Cohort January 1;Females;Survival in the third trimester;2020QII;""
05 Ávila;All ages;Cohort January 1;Females;Survival in the third trimester;2020QI;""
05 Ávila;All ages;Cohort January 1;Females;Survival in the third trimester;2022QIV;3.221
05 Ávila;All ages;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
05 Ávila;All ages;Cohort January 1;Females;Survival in the third trimester;2022QII;""
05 Ávila;All ages;Cohort January 1;Females;Survival in the third trimester;2022QI;""
05 Ávila;All ages;Cohort January 1;Females;Survival in the third trimester;2021QIV;3.228
05 Ávila;All ages;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
05 Ávila;All ages;Cohort January 1;Females;Survival in the third trimester;2021QII;""
05 Ávila;All ages;Cohort January 1;Females;Survival in the third trimester;2021QI;""
05 Ávila;All ages;Cohort January 1;Females;Survival in the third trimester;2020QIV;3.213
05 Ávila;All ages;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
05 Ávila;All ages;Cohort January 1;Females;Survival in the third trimester;2020QII;""
05 Ávila;All ages;Cohort January 1;Females;Survival in the third trimester;2020QI;""
05 Ávila;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
05 Ávila;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
05 Ávila;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
05 Ávila;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
05 Ávila;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
05 Ávila;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
05 Ávila;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
05 Ávila;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
05 Ávila;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
05 Ávila;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
05 Ávila;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
05 Ávila;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
05 Ávila;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
05 Ávila;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
05 Ávila;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
05 Ávila;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;97,49
05 Ávila;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
05 Ávila;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
05 Ávila;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
05 Ávila;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;97,64
05 Ávila;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
05 Ávila;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
05 Ávila;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
05 Ávila;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;94,28
05 Ávila;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
05 Ávila;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
05 Ávila;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;94,82
05 Ávila;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
05 Ávila;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
05 Ávila;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
05 Ávila;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;94,9
05 Ávila;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
05 Ávila;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
05 Ávila;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
05 Ávila;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;92,49
05 Ávila;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
05 Ávila;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
05 Ávila;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;91,96
05 Ávila;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
05 Ávila;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
05 Ávila;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
05 Ávila;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;92,37
05 Ávila;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
05 Ávila;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
05 Ávila;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
05 Ávila;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;89,64
05 Ávila;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
05 Ávila;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
05 Ávila;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;88,73
05 Ávila;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
05 Ávila;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
05 Ávila;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
05 Ávila;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;89,54
05 Ávila;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
05 Ávila;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
05 Ávila;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
05 Ávila;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;87,14
05 Ávila;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
05 Ávila;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
05 Ávila;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
05 Ávila;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
05 Ávila;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
05 Ávila;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QII;10.726
05 Ávila;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
05 Ávila;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
05 Ávila;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
05 Ávila;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QII;10.713
05 Ávila;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
05 Ávila;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
05 Ávila;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
05 Ávila;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QII;10.735
05 Ávila;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
05 Ávila;All ages;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
05 Ávila;All ages;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
05 Ávila;All ages;Cohort April 1;Total;Survival in the first trimester;2022QII;10.450
05 Ávila;All ages;Cohort April 1;Total;Survival in the first trimester;2022QI;""
05 Ávila;All ages;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
05 Ávila;All ages;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
05 Ávila;All ages;Cohort April 1;Total;Survival in the first trimester;2021QII;10.423
05 Ávila;All ages;Cohort April 1;Total;Survival in the first trimester;2021QI;""
05 Ávila;All ages;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
05 Ávila;All ages;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
05 Ávila;All ages;Cohort April 1;Total;Survival in the first trimester;2020QII;10.542
05 Ávila;All ages;Cohort April 1;Total;Survival in the first trimester;2020QI;""
05 Ávila;All ages;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
05 Ávila;All ages;Cohort April 1;Total;Survival in the second trimester;2022QIII;10.167
05 Ávila;All ages;Cohort April 1;Total;Survival in the second trimester;2022QII;""
05 Ávila;All ages;Cohort April 1;Total;Survival in the second trimester;2022QI;""
05 Ávila;All ages;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
05 Ávila;All ages;Cohort April 1;Total;Survival in the second trimester;2021QIII;10.200
05 Ávila;All ages;Cohort April 1;Total;Survival in the second trimester;2021QII;""
05 Ávila;All ages;Cohort April 1;Total;Survival in the second trimester;2021QI;""
05 Ávila;All ages;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
05 Ávila;All ages;Cohort April 1;Total;Survival in the second trimester;2020QIII;10.267
05 Ávila;All ages;Cohort April 1;Total;Survival in the second trimester;2020QII;""
05 Ávila;All ages;Cohort April 1;Total;Survival in the second trimester;2020QI;""
05 Ávila;All ages;Cohort April 1;Total;Survival in the third trimester;2022QIV;9.868
05 Ávila;All ages;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
05 Ávila;All ages;Cohort April 1;Total;Survival in the third trimester;2022QII;""
05 Ávila;All ages;Cohort April 1;Total;Survival in the third trimester;2022QI;""
05 Ávila;All ages;Cohort April 1;Total;Survival in the third trimester;2021QIV;9.918
05 Ávila;All ages;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
05 Ávila;All ages;Cohort April 1;Total;Survival in the third trimester;2021QII;""
05 Ávila;All ages;Cohort April 1;Total;Survival in the third trimester;2021QI;""
05 Ávila;All ages;Cohort April 1;Total;Survival in the third trimester;2020QIV;10.012
05 Ávila;All ages;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
05 Ávila;All ages;Cohort April 1;Total;Survival in the third trimester;2020QII;""
05 Ávila;All ages;Cohort April 1;Total;Survival in the third trimester;2020QI;""
05 Ávila;All ages;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
05 Ávila;All ages;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
05 Ávila;All ages;Cohort April 1;Total;Survival in the third trimester;2022QII;""
05 Ávila;All ages;Cohort April 1;Total;Survival in the third trimester;2022QI;9.713
05 Ávila;All ages;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
05 Ávila;All ages;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
05 Ávila;All ages;Cohort April 1;Total;Survival in the third trimester;2021QII;""
05 Ávila;All ages;Cohort April 1;Total;Survival in the third trimester;2021QI;9.830
05 Ávila;All ages;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
05 Ávila;All ages;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
05 Ávila;All ages;Cohort April 1;Total;Survival in the third trimester;2020QII;""
05 Ávila;All ages;Cohort April 1;Total;Survival in the third trimester;2020QI;""
05 Ávila;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
05 Ávila;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
05 Ávila;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
05 Ávila;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
05 Ávila;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
05 Ávila;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
05 Ávila;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
05 Ávila;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
05 Ávila;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
05 Ávila;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
05 Ávila;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
05 Ávila;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
05 Ávila;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
05 Ávila;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
05 Ávila;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;97,43
05 Ávila;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
05 Ávila;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
05 Ávila;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
05 Ávila;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;97,29
05 Ávila;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
05 Ávila;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
05 Ávila;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
05 Ávila;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;98,2
05 Ávila;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
05 Ávila;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
05 Ávila;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;94,79
05 Ávila;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
05 Ávila;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
05 Ávila;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
05 Ávila;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;95,21
05 Ávila;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
05 Ávila;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
05 Ávila;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
05 Ávila;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;95,64
05 Ávila;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
05 Ávila;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
05 Ávila;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;92
05 Ávila;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
05 Ávila;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
05 Ávila;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
05 Ávila;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;92,58
05 Ávila;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
05 Ávila;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
05 Ávila;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
05 Ávila;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;93,27
05 Ávila;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
05 Ávila;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
05 Ávila;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
05 Ávila;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
05 Ávila;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
05 Ávila;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
05 Ávila;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;90,67
05 Ávila;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
05 Ávila;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
05 Ávila;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
05 Ávila;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;91,57
05 Ávila;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
05 Ávila;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
05 Ávila;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
05 Ávila;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
05 Ávila;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
05 Ávila;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
05 Ávila;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QII;7.064
05 Ávila;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
05 Ávila;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
05 Ávila;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
05 Ávila;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QII;7.096
05 Ávila;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
05 Ávila;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
05 Ávila;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
05 Ávila;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QII;7.125
05 Ávila;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
05 Ávila;All ages;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
05 Ávila;All ages;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
05 Ávila;All ages;Cohort April 1;Males;Survival in the first trimester;2022QII;6.894
05 Ávila;All ages;Cohort April 1;Males;Survival in the first trimester;2022QI;""
05 Ávila;All ages;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
05 Ávila;All ages;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
05 Ávila;All ages;Cohort April 1;Males;Survival in the first trimester;2021QII;6.915
05 Ávila;All ages;Cohort April 1;Males;Survival in the first trimester;2021QI;""
05 Ávila;All ages;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
05 Ávila;All ages;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
05 Ávila;All ages;Cohort April 1;Males;Survival in the first trimester;2020QII;7.002
05 Ávila;All ages;Cohort April 1;Males;Survival in the first trimester;2020QI;""
05 Ávila;All ages;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
05 Ávila;All ages;Cohort April 1;Males;Survival in the second trimester;2022QIII;6.726
05 Ávila;All ages;Cohort April 1;Males;Survival in the second trimester;2022QII;""
05 Ávila;All ages;Cohort April 1;Males;Survival in the second trimester;2022QI;""
05 Ávila;All ages;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
05 Ávila;All ages;Cohort April 1;Males;Survival in the second trimester;2021QIII;6.789
05 Ávila;All ages;Cohort April 1;Males;Survival in the second trimester;2021QII;""
05 Ávila;All ages;Cohort April 1;Males;Survival in the second trimester;2021QI;""
05 Ávila;All ages;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
05 Ávila;All ages;Cohort April 1;Males;Survival in the second trimester;2020QIII;6.841
05 Ávila;All ages;Cohort April 1;Males;Survival in the second trimester;2020QII;""
05 Ávila;All ages;Cohort April 1;Males;Survival in the second trimester;2020QI;""
05 Ávila;All ages;Cohort April 1;Males;Survival in the third trimester;2022QIV;6.551
05 Ávila;All ages;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
05 Ávila;All ages;Cohort April 1;Males;Survival in the third trimester;2022QII;""
05 Ávila;All ages;Cohort April 1;Males;Survival in the third trimester;2022QI;""
05 Ávila;All ages;Cohort April 1;Males;Survival in the third trimester;2021QIV;6.612
05 Ávila;All ages;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
05 Ávila;All ages;Cohort April 1;Males;Survival in the third trimester;2021QII;""
05 Ávila;All ages;Cohort April 1;Males;Survival in the third trimester;2021QI;""
05 Ávila;All ages;Cohort April 1;Males;Survival in the third trimester;2020QIV;6.685
05 Ávila;All ages;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
05 Ávila;All ages;Cohort April 1;Males;Survival in the third trimester;2020QII;""
05 Ávila;All ages;Cohort April 1;Males;Survival in the third trimester;2020QI;""
05 Ávila;All ages;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
05 Ávila;All ages;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
05 Ávila;All ages;Cohort April 1;Males;Survival in the third trimester;2022QII;""
05 Ávila;All ages;Cohort April 1;Males;Survival in the third trimester;2022QI;6.478
05 Ávila;All ages;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
05 Ávila;All ages;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
05 Ávila;All ages;Cohort April 1;Males;Survival in the third trimester;2021QII;""
05 Ávila;All ages;Cohort April 1;Males;Survival in the third trimester;2021QI;6.561
05 Ávila;All ages;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
05 Ávila;All ages;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
05 Ávila;All ages;Cohort April 1;Males;Survival in the third trimester;2020QII;""
05 Ávila;All ages;Cohort April 1;Males;Survival in the third trimester;2020QI;""
05 Ávila;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
05 Ávila;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
05 Ávila;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
05 Ávila;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
05 Ávila;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
05 Ávila;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
05 Ávila;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
05 Ávila;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
05 Ávila;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
05 Ávila;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
05 Ávila;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
05 Ávila;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
05 Ávila;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
05 Ávila;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
05 Ávila;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;97,59
05 Ávila;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
05 Ávila;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
05 Ávila;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
05 Ávila;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;97,45
05 Ávila;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
05 Ávila;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
05 Ávila;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
05 Ávila;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;98,27
05 Ávila;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
05 Ávila;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
05 Ávila;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;95,22
05 Ávila;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
05 Ávila;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
05 Ávila;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
05 Ávila;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;95,67
05 Ávila;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
05 Ávila;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
05 Ávila;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
05 Ávila;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;96,01
05 Ávila;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
05 Ávila;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
05 Ávila;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;92,74
05 Ávila;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
05 Ávila;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
05 Ávila;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
05 Ávila;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;93,18
05 Ávila;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
05 Ávila;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
05 Ávila;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
05 Ávila;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;93,82
05 Ávila;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
05 Ávila;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
05 Ávila;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
05 Ávila;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
05 Ávila;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
05 Ávila;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
05 Ávila;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;91,29
05 Ávila;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
05 Ávila;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
05 Ávila;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
05 Ávila;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;92,08
05 Ávila;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
05 Ávila;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
05 Ávila;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
05 Ávila;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
05 Ávila;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
05 Ávila;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
05 Ávila;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QII;3.662
05 Ávila;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
05 Ávila;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
05 Ávila;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
05 Ávila;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QII;3.617
05 Ávila;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
05 Ávila;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
05 Ávila;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
05 Ávila;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QII;3.610
05 Ávila;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
05 Ávila;All ages;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
05 Ávila;All ages;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
05 Ávila;All ages;Cohort April 1;Females;Survival in the first trimester;2022QII;3.556
05 Ávila;All ages;Cohort April 1;Females;Survival in the first trimester;2022QI;""
05 Ávila;All ages;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
05 Ávila;All ages;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
05 Ávila;All ages;Cohort April 1;Females;Survival in the first trimester;2021QII;3.508
05 Ávila;All ages;Cohort April 1;Females;Survival in the first trimester;2021QI;""
05 Ávila;All ages;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
05 Ávila;All ages;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
05 Ávila;All ages;Cohort April 1;Females;Survival in the first trimester;2020QII;3.540
05 Ávila;All ages;Cohort April 1;Females;Survival in the first trimester;2020QI;""
05 Ávila;All ages;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
05 Ávila;All ages;Cohort April 1;Females;Survival in the second trimester;2022QIII;3.441
05 Ávila;All ages;Cohort April 1;Females;Survival in the second trimester;2022QII;""
05 Ávila;All ages;Cohort April 1;Females;Survival in the second trimester;2022QI;""
05 Ávila;All ages;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
05 Ávila;All ages;Cohort April 1;Females;Survival in the second trimester;2021QIII;3.411
05 Ávila;All ages;Cohort April 1;Females;Survival in the second trimester;2021QII;""
05 Ávila;All ages;Cohort April 1;Females;Survival in the second trimester;2021QI;""
05 Ávila;All ages;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
05 Ávila;All ages;Cohort April 1;Females;Survival in the second trimester;2020QIII;3.426
05 Ávila;All ages;Cohort April 1;Females;Survival in the second trimester;2020QII;""
05 Ávila;All ages;Cohort April 1;Females;Survival in the second trimester;2020QI;""
05 Ávila;All ages;Cohort April 1;Females;Survival in the third trimester;2022QIV;3.317
05 Ávila;All ages;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
05 Ávila;All ages;Cohort April 1;Females;Survival in the third trimester;2022QII;""
05 Ávila;All ages;Cohort April 1;Females;Survival in the third trimester;2022QI;""
05 Ávila;All ages;Cohort April 1;Females;Survival in the third trimester;2021QIV;3.306
05 Ávila;All ages;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
05 Ávila;All ages;Cohort April 1;Females;Survival in the third trimester;2021QII;""
05 Ávila;All ages;Cohort April 1;Females;Survival in the third trimester;2021QI;""
05 Ávila;All ages;Cohort April 1;Females;Survival in the third trimester;2020QIV;3.327
05 Ávila;All ages;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
05 Ávila;All ages;Cohort April 1;Females;Survival in the third trimester;2020QII;""
05 Ávila;All ages;Cohort April 1;Females;Survival in the third trimester;2020QI;""
05 Ávila;All ages;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
05 Ávila;All ages;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
05 Ávila;All ages;Cohort April 1;Females;Survival in the third trimester;2022QII;""
05 Ávila;All ages;Cohort April 1;Females;Survival in the third trimester;2022QI;3.235
05 Ávila;All ages;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
05 Ávila;All ages;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
05 Ávila;All ages;Cohort April 1;Females;Survival in the third trimester;2021QII;""
05 Ávila;All ages;Cohort April 1;Females;Survival in the third trimester;2021QI;3.269
05 Ávila;All ages;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
05 Ávila;All ages;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
05 Ávila;All ages;Cohort April 1;Females;Survival in the third trimester;2020QII;""
05 Ávila;All ages;Cohort April 1;Females;Survival in the third trimester;2020QI;""
05 Ávila;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
05 Ávila;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
05 Ávila;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
05 Ávila;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
05 Ávila;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
05 Ávila;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
05 Ávila;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
05 Ávila;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
05 Ávila;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
05 Ávila;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
05 Ávila;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
05 Ávila;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
05 Ávila;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
05 Ávila;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
05 Ávila;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;97,11
05 Ávila;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
05 Ávila;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
05 Ávila;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
05 Ávila;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;96,99
05 Ávila;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
05 Ávila;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
05 Ávila;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
05 Ávila;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;98,06
05 Ávila;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
05 Ávila;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
05 Ávila;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;93,97
05 Ávila;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
05 Ávila;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
05 Ávila;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
05 Ávila;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;94,3
05 Ávila;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
05 Ávila;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
05 Ávila;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
05 Ávila;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;94,9
05 Ávila;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
05 Ávila;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
05 Ávila;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;90,58
05 Ávila;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
05 Ávila;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
05 Ávila;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
05 Ávila;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;91,4
05 Ávila;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
05 Ávila;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
05 Ávila;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
05 Ávila;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;92,16
05 Ávila;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
05 Ávila;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
05 Ávila;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
05 Ávila;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
05 Ávila;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
05 Ávila;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
05 Ávila;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;89,44
05 Ávila;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
05 Ávila;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
05 Ávila;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
05 Ávila;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;90,55
05 Ávila;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
05 Ávila;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
05 Ávila;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
05 Ávila;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
05 Ávila;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
05 Ávila;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QIII;10.822
05 Ávila;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
05 Ávila;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
05 Ávila;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
05 Ávila;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QIII;10.828
05 Ávila;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
05 Ávila;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
05 Ávila;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
05 Ávila;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QIII;10.807
05 Ávila;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
05 Ávila;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
05 Ávila;All ages;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
05 Ávila;All ages;Cohort July 1;Total;Survival in the first trimester;2022QIII;10.452
05 Ávila;All ages;Cohort July 1;Total;Survival in the first trimester;2022QII;""
05 Ávila;All ages;Cohort July 1;Total;Survival in the first trimester;2022QI;""
05 Ávila;All ages;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
05 Ávila;All ages;Cohort July 1;Total;Survival in the first trimester;2021QIII;10.521
05 Ávila;All ages;Cohort July 1;Total;Survival in the first trimester;2021QII;""
05 Ávila;All ages;Cohort July 1;Total;Survival in the first trimester;2021QI;""
05 Ávila;All ages;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
05 Ávila;All ages;Cohort July 1;Total;Survival in the first trimester;2020QIII;10.479
05 Ávila;All ages;Cohort July 1;Total;Survival in the first trimester;2020QII;""
05 Ávila;All ages;Cohort July 1;Total;Survival in the first trimester;2020QI;""
05 Ávila;All ages;Cohort July 1;Total;Survival in the second trimester;2022QIV;10.115
05 Ávila;All ages;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
05 Ávila;All ages;Cohort July 1;Total;Survival in the second trimester;2022QII;""
05 Ávila;All ages;Cohort July 1;Total;Survival in the second trimester;2022QI;""
05 Ávila;All ages;Cohort July 1;Total;Survival in the second trimester;2021QIV;10.207
05 Ávila;All ages;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
05 Ávila;All ages;Cohort July 1;Total;Survival in the second trimester;2021QII;""
05 Ávila;All ages;Cohort July 1;Total;Survival in the second trimester;2021QI;""
05 Ávila;All ages;Cohort July 1;Total;Survival in the second trimester;2020QIV;10.191
05 Ávila;All ages;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
05 Ávila;All ages;Cohort July 1;Total;Survival in the second trimester;2020QII;""
05 Ávila;All ages;Cohort July 1;Total;Survival in the second trimester;2020QI;""
05 Ávila;All ages;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
05 Ávila;All ages;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
05 Ávila;All ages;Cohort July 1;Total;Survival in the third trimester;2022QII;""
05 Ávila;All ages;Cohort July 1;Total;Survival in the third trimester;2022QI;9.982
05 Ávila;All ages;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
05 Ávila;All ages;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
05 Ávila;All ages;Cohort July 1;Total;Survival in the third trimester;2021QII;""
05 Ávila;All ages;Cohort July 1;Total;Survival in the third trimester;2021QI;9.992
05 Ávila;All ages;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
05 Ávila;All ages;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
05 Ávila;All ages;Cohort July 1;Total;Survival in the third trimester;2020QII;""
05 Ávila;All ages;Cohort July 1;Total;Survival in the third trimester;2020QI;""
05 Ávila;All ages;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
05 Ávila;All ages;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
05 Ávila;All ages;Cohort July 1;Total;Survival in the third trimester;2022QII;9.768
05 Ávila;All ages;Cohort July 1;Total;Survival in the third trimester;2022QI;""
05 Ávila;All ages;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
05 Ávila;All ages;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
05 Ávila;All ages;Cohort July 1;Total;Survival in the third trimester;2021QII;9.765
05 Ávila;All ages;Cohort July 1;Total;Survival in the third trimester;2021QI;""
05 Ávila;All ages;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
05 Ávila;All ages;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
05 Ávila;All ages;Cohort July 1;Total;Survival in the third trimester;2020QII;""
05 Ávila;All ages;Cohort July 1;Total;Survival in the third trimester;2020QI;""
05 Ávila;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
05 Ávila;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
05 Ávila;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
05 Ávila;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
05 Ávila;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
05 Ávila;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
05 Ávila;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
05 Ávila;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
05 Ávila;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
05 Ávila;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
05 Ávila;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
05 Ávila;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
05 Ávila;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
05 Ávila;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;96,58
05 Ávila;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
05 Ávila;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
05 Ávila;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
05 Ávila;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;97,16
05 Ávila;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
05 Ávila;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
05 Ávila;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
05 Ávila;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;96,96
05 Ávila;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
05 Ávila;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
05 Ávila;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;93,47
05 Ávila;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
05 Ávila;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
05 Ávila;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
05 Ávila;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;94,26
05 Ávila;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
05 Ávila;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
05 Ávila;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
05 Ávila;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;94,3
05 Ávila;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
05 Ávila;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
05 Ávila;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
05 Ávila;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
05 Ávila;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
05 Ávila;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
05 Ávila;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;92,19
05 Ávila;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
05 Ávila;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
05 Ávila;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
05 Ávila;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;92,46
05 Ávila;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
05 Ávila;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
05 Ávila;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
05 Ávila;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
05 Ávila;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
05 Ávila;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
05 Ávila;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;90,21
05 Ávila;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
05 Ávila;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
05 Ávila;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
05 Ávila;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;90,36
05 Ávila;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
05 Ávila;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
05 Ávila;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
05 Ávila;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
05 Ávila;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
05 Ávila;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
05 Ávila;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QIII;7.116
05 Ávila;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
05 Ávila;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
05 Ávila;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
05 Ávila;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QIII;7.158
05 Ávila;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
05 Ávila;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
05 Ávila;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
05 Ávila;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QIII;7.178
05 Ávila;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
05 Ávila;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
05 Ávila;All ages;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
05 Ávila;All ages;Cohort July 1;Males;Survival in the first trimester;2022QIII;6.893
05 Ávila;All ages;Cohort July 1;Males;Survival in the first trimester;2022QII;""
05 Ávila;All ages;Cohort July 1;Males;Survival in the first trimester;2022QI;""
05 Ávila;All ages;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
05 Ávila;All ages;Cohort July 1;Males;Survival in the first trimester;2021QIII;6.982
05 Ávila;All ages;Cohort July 1;Males;Survival in the first trimester;2021QII;""
05 Ávila;All ages;Cohort July 1;Males;Survival in the first trimester;2021QI;""
05 Ávila;All ages;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
05 Ávila;All ages;Cohort July 1;Males;Survival in the first trimester;2020QIII;6.980
05 Ávila;All ages;Cohort July 1;Males;Survival in the first trimester;2020QII;""
05 Ávila;All ages;Cohort July 1;Males;Survival in the first trimester;2020QI;""
05 Ávila;All ages;Cohort July 1;Males;Survival in the second trimester;2022QIV;6.697
05 Ávila;All ages;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
05 Ávila;All ages;Cohort July 1;Males;Survival in the second trimester;2022QII;""
05 Ávila;All ages;Cohort July 1;Males;Survival in the second trimester;2022QI;""
05 Ávila;All ages;Cohort July 1;Males;Survival in the second trimester;2021QIV;6.783
05 Ávila;All ages;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
05 Ávila;All ages;Cohort July 1;Males;Survival in the second trimester;2021QII;""
05 Ávila;All ages;Cohort July 1;Males;Survival in the second trimester;2021QI;""
05 Ávila;All ages;Cohort July 1;Males;Survival in the second trimester;2020QIV;6.804
05 Ávila;All ages;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
05 Ávila;All ages;Cohort July 1;Males;Survival in the second trimester;2020QII;""
05 Ávila;All ages;Cohort July 1;Males;Survival in the second trimester;2020QI;""
05 Ávila;All ages;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
05 Ávila;All ages;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
05 Ávila;All ages;Cohort July 1;Males;Survival in the third trimester;2022QII;""
05 Ávila;All ages;Cohort July 1;Males;Survival in the third trimester;2022QI;6.637
05 Ávila;All ages;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
05 Ávila;All ages;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
05 Ávila;All ages;Cohort July 1;Males;Survival in the third trimester;2021QII;""
05 Ávila;All ages;Cohort July 1;Males;Survival in the third trimester;2021QI;6.671
05 Ávila;All ages;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
05 Ávila;All ages;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
05 Ávila;All ages;Cohort July 1;Males;Survival in the third trimester;2020QII;""
05 Ávila;All ages;Cohort July 1;Males;Survival in the third trimester;2020QI;""
05 Ávila;All ages;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
05 Ávila;All ages;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
05 Ávila;All ages;Cohort July 1;Males;Survival in the third trimester;2022QII;6.505
05 Ávila;All ages;Cohort July 1;Males;Survival in the third trimester;2022QI;""
05 Ávila;All ages;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
05 Ávila;All ages;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
05 Ávila;All ages;Cohort July 1;Males;Survival in the third trimester;2021QII;6.529
05 Ávila;All ages;Cohort July 1;Males;Survival in the third trimester;2021QI;""
05 Ávila;All ages;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
05 Ávila;All ages;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
05 Ávila;All ages;Cohort July 1;Males;Survival in the third trimester;2020QII;""
05 Ávila;All ages;Cohort July 1;Males;Survival in the third trimester;2020QI;""
05 Ávila;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
05 Ávila;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
05 Ávila;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
05 Ávila;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
05 Ávila;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
05 Ávila;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
05 Ávila;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
05 Ávila;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
05 Ávila;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
05 Ávila;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
05 Ávila;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
05 Ávila;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
05 Ávila;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
05 Ávila;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;96,87
05 Ávila;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
05 Ávila;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
05 Ávila;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
05 Ávila;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;97,54
05 Ávila;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
05 Ávila;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
05 Ávila;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
05 Ávila;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;97,24
05 Ávila;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
05 Ávila;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
05 Ávila;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;94,11
05 Ávila;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
05 Ávila;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
05 Ávila;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
05 Ávila;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;94,76
05 Ávila;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
05 Ávila;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
05 Ávila;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
05 Ávila;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;94,79
05 Ávila;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
05 Ávila;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
05 Ávila;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
05 Ávila;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
05 Ávila;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
05 Ávila;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
05 Ávila;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;92,72
05 Ávila;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
05 Ávila;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
05 Ávila;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
05 Ávila;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;92,94
05 Ávila;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
05 Ávila;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
05 Ávila;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
05 Ávila;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
05 Ávila;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
05 Ávila;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
05 Ávila;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;90,88
05 Ávila;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
05 Ávila;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
05 Ávila;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
05 Ávila;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;90,96
05 Ávila;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
05 Ávila;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
05 Ávila;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
05 Ávila;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
05 Ávila;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
05 Ávila;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
05 Ávila;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QIII;3.706
05 Ávila;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
05 Ávila;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
05 Ávila;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
05 Ávila;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QIII;3.670
05 Ávila;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
05 Ávila;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
05 Ávila;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
05 Ávila;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QIII;3.629
05 Ávila;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
05 Ávila;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
05 Ávila;All ages;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
05 Ávila;All ages;Cohort July 1;Females;Survival in the first trimester;2022QIII;3.559
05 Ávila;All ages;Cohort July 1;Females;Survival in the first trimester;2022QII;""
05 Ávila;All ages;Cohort July 1;Females;Survival in the first trimester;2022QI;""
05 Ávila;All ages;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
05 Ávila;All ages;Cohort July 1;Females;Survival in the first trimester;2021QIII;3.539
05 Ávila;All ages;Cohort July 1;Females;Survival in the first trimester;2021QII;""
05 Ávila;All ages;Cohort July 1;Females;Survival in the first trimester;2021QI;""
05 Ávila;All ages;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
05 Ávila;All ages;Cohort July 1;Females;Survival in the first trimester;2020QIII;3.499
05 Ávila;All ages;Cohort July 1;Females;Survival in the first trimester;2020QII;""
05 Ávila;All ages;Cohort July 1;Females;Survival in the first trimester;2020QI;""
05 Ávila;All ages;Cohort July 1;Females;Survival in the second trimester;2022QIV;3.418
05 Ávila;All ages;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
05 Ávila;All ages;Cohort July 1;Females;Survival in the second trimester;2022QII;""
05 Ávila;All ages;Cohort July 1;Females;Survival in the second trimester;2022QI;""
05 Ávila;All ages;Cohort July 1;Females;Survival in the second trimester;2021QIV;3.424
05 Ávila;All ages;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
05 Ávila;All ages;Cohort July 1;Females;Survival in the second trimester;2021QII;""
05 Ávila;All ages;Cohort July 1;Females;Survival in the second trimester;2021QI;""
05 Ávila;All ages;Cohort July 1;Females;Survival in the second trimester;2020QIV;3.387
05 Ávila;All ages;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
05 Ávila;All ages;Cohort July 1;Females;Survival in the second trimester;2020QII;""
05 Ávila;All ages;Cohort July 1;Females;Survival in the second trimester;2020QI;""
05 Ávila;All ages;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
05 Ávila;All ages;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
05 Ávila;All ages;Cohort July 1;Females;Survival in the third trimester;2022QII;""
05 Ávila;All ages;Cohort July 1;Females;Survival in the third trimester;2022QI;3.345
05 Ávila;All ages;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
05 Ávila;All ages;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
05 Ávila;All ages;Cohort July 1;Females;Survival in the third trimester;2021QII;""
05 Ávila;All ages;Cohort July 1;Females;Survival in the third trimester;2021QI;3.321
05 Ávila;All ages;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
05 Ávila;All ages;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
05 Ávila;All ages;Cohort July 1;Females;Survival in the third trimester;2020QII;""
05 Ávila;All ages;Cohort July 1;Females;Survival in the third trimester;2020QI;""
05 Ávila;All ages;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
05 Ávila;All ages;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
05 Ávila;All ages;Cohort July 1;Females;Survival in the third trimester;2022QII;3.263
05 Ávila;All ages;Cohort July 1;Females;Survival in the third trimester;2022QI;""
05 Ávila;All ages;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
05 Ávila;All ages;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
05 Ávila;All ages;Cohort July 1;Females;Survival in the third trimester;2021QII;3.236
05 Ávila;All ages;Cohort July 1;Females;Survival in the third trimester;2021QI;""
05 Ávila;All ages;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
05 Ávila;All ages;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
05 Ávila;All ages;Cohort July 1;Females;Survival in the third trimester;2020QII;""
05 Ávila;All ages;Cohort July 1;Females;Survival in the third trimester;2020QI;""
05 Ávila;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
05 Ávila;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
05 Ávila;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
05 Ávila;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
05 Ávila;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
05 Ávila;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
05 Ávila;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
05 Ávila;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
05 Ávila;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
05 Ávila;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
05 Ávila;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
05 Ávila;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
05 Ávila;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
05 Ávila;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;96,03
05 Ávila;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
05 Ávila;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
05 Ávila;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
05 Ávila;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;96,43
05 Ávila;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
05 Ávila;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
05 Ávila;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
05 Ávila;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;96,42
05 Ávila;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
05 Ávila;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
05 Ávila;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;92,23
05 Ávila;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
05 Ávila;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
05 Ávila;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
05 Ávila;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;93,3
05 Ávila;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
05 Ávila;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
05 Ávila;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
05 Ávila;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;93,33
05 Ávila;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
05 Ávila;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
05 Ávila;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
05 Ávila;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
05 Ávila;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
05 Ávila;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
05 Ávila;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;91,14
05 Ávila;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
05 Ávila;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
05 Ávila;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
05 Ávila;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;91,51
05 Ávila;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
05 Ávila;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
05 Ávila;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
05 Ávila;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
05 Ávila;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
05 Ávila;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
05 Ávila;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;88,91
05 Ávila;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
05 Ávila;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
05 Ávila;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
05 Ávila;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;89,17
05 Ávila;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
05 Ávila;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
05 Ávila;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
05 Ávila;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
05 Ávila;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
05 Ávila;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QIV;10.675
05 Ávila;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
05 Ávila;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
05 Ávila;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
05 Ávila;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QIV;10.783
05 Ávila;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
05 Ávila;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
05 Ávila;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
05 Ávila;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QIV;10.771
05 Ávila;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
05 Ávila;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
05 Ávila;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
05 Ávila;All ages;Cohort October 1;Total;Survival in the first trimester;2022QIV;10.312
05 Ávila;All ages;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
05 Ávila;All ages;Cohort October 1;Total;Survival in the first trimester;2022QII;""
05 Ávila;All ages;Cohort October 1;Total;Survival in the first trimester;2022QI;""
05 Ávila;All ages;Cohort October 1;Total;Survival in the first trimester;2021QIV;10.426
05 Ávila;All ages;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
05 Ávila;All ages;Cohort October 1;Total;Survival in the first trimester;2021QII;""
05 Ávila;All ages;Cohort October 1;Total;Survival in the first trimester;2021QI;""
05 Ávila;All ages;Cohort October 1;Total;Survival in the first trimester;2020QIV;10.441
05 Ávila;All ages;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
05 Ávila;All ages;Cohort October 1;Total;Survival in the first trimester;2020QII;""
05 Ávila;All ages;Cohort October 1;Total;Survival in the first trimester;2020QI;""
05 Ávila;All ages;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
05 Ávila;All ages;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
05 Ávila;All ages;Cohort October 1;Total;Survival in the second trimester;2022QII;""
05 Ávila;All ages;Cohort October 1;Total;Survival in the second trimester;2022QI;10.184
05 Ávila;All ages;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
05 Ávila;All ages;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
05 Ávila;All ages;Cohort October 1;Total;Survival in the second trimester;2021QII;""
05 Ávila;All ages;Cohort October 1;Total;Survival in the second trimester;2021QI;10.221
05 Ávila;All ages;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
05 Ávila;All ages;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
05 Ávila;All ages;Cohort October 1;Total;Survival in the second trimester;2020QII;""
05 Ávila;All ages;Cohort October 1;Total;Survival in the second trimester;2020QI;""
05 Ávila;All ages;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
05 Ávila;All ages;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
05 Ávila;All ages;Cohort October 1;Total;Survival in the third trimester;2022QII;9.954
05 Ávila;All ages;Cohort October 1;Total;Survival in the third trimester;2022QI;""
05 Ávila;All ages;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
05 Ávila;All ages;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
05 Ávila;All ages;Cohort October 1;Total;Survival in the third trimester;2021QII;9.985
05 Ávila;All ages;Cohort October 1;Total;Survival in the third trimester;2021QI;""
05 Ávila;All ages;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
05 Ávila;All ages;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
05 Ávila;All ages;Cohort October 1;Total;Survival in the third trimester;2020QII;""
05 Ávila;All ages;Cohort October 1;Total;Survival in the third trimester;2020QI;""
05 Ávila;All ages;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
05 Ávila;All ages;Cohort October 1;Total;Survival in the third trimester;2022QIII;9.730
05 Ávila;All ages;Cohort October 1;Total;Survival in the third trimester;2022QII;""
05 Ávila;All ages;Cohort October 1;Total;Survival in the third trimester;2022QI;""
05 Ávila;All ages;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
05 Ávila;All ages;Cohort October 1;Total;Survival in the third trimester;2021QIII;9.789
05 Ávila;All ages;Cohort October 1;Total;Survival in the third trimester;2021QII;""
05 Ávila;All ages;Cohort October 1;Total;Survival in the third trimester;2021QI;""
05 Ávila;All ages;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
05 Ávila;All ages;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
05 Ávila;All ages;Cohort October 1;Total;Survival in the third trimester;2020QII;""
05 Ávila;All ages;Cohort October 1;Total;Survival in the third trimester;2020QI;""
05 Ávila;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
05 Ávila;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
05 Ávila;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
05 Ávila;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
05 Ávila;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
05 Ávila;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
05 Ávila;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
05 Ávila;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
05 Ávila;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
05 Ávila;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
05 Ávila;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
05 Ávila;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
05 Ávila;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;96,6
05 Ávila;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
05 Ávila;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
05 Ávila;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
05 Ávila;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;96,69
05 Ávila;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
05 Ávila;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
05 Ávila;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
05 Ávila;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;96,94
05 Ávila;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
05 Ávila;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
05 Ávila;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
05 Ávila;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
05 Ávila;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
05 Ávila;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
05 Ávila;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;94,44
05 Ávila;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
05 Ávila;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
05 Ávila;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
05 Ávila;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;94,89
05 Ávila;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
05 Ávila;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
05 Ávila;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
05 Ávila;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
05 Ávila;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
05 Ávila;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
05 Ávila;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;92,31
05 Ávila;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
05 Ávila;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
05 Ávila;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
05 Ávila;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;92,7
05 Ávila;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
05 Ávila;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
05 Ávila;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
05 Ávila;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
05 Ávila;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
05 Ávila;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
05 Ávila;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;90,23
05 Ávila;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
05 Ávila;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
05 Ávila;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
05 Ávila;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;90,88
05 Ávila;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
05 Ávila;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
05 Ávila;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
05 Ávila;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
05 Ávila;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
05 Ávila;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
05 Ávila;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QIV;7.022
05 Ávila;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
05 Ávila;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
05 Ávila;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
05 Ávila;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QIV;7.138
05 Ávila;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
05 Ávila;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
05 Ávila;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
05 Ávila;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QIV;7.143
05 Ávila;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
05 Ávila;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
05 Ávila;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
05 Ávila;All ages;Cohort October 1;Males;Survival in the first trimester;2022QIV;6.813
05 Ávila;All ages;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
05 Ávila;All ages;Cohort October 1;Males;Survival in the first trimester;2022QII;""
05 Ávila;All ages;Cohort October 1;Males;Survival in the first trimester;2022QI;""
05 Ávila;All ages;Cohort October 1;Males;Survival in the first trimester;2021QIV;6.914
05 Ávila;All ages;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
05 Ávila;All ages;Cohort October 1;Males;Survival in the first trimester;2021QII;""
05 Ávila;All ages;Cohort October 1;Males;Survival in the first trimester;2021QI;""
05 Ávila;All ages;Cohort October 1;Males;Survival in the first trimester;2020QIV;6.940
05 Ávila;All ages;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
05 Ávila;All ages;Cohort October 1;Males;Survival in the first trimester;2020QII;""
05 Ávila;All ages;Cohort October 1;Males;Survival in the first trimester;2020QI;""
05 Ávila;All ages;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
05 Ávila;All ages;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
05 Ávila;All ages;Cohort October 1;Males;Survival in the second trimester;2022QII;""
05 Ávila;All ages;Cohort October 1;Males;Survival in the second trimester;2022QI;6.756
05 Ávila;All ages;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
05 Ávila;All ages;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
05 Ávila;All ages;Cohort October 1;Males;Survival in the second trimester;2021QII;""
05 Ávila;All ages;Cohort October 1;Males;Survival in the second trimester;2021QI;6.790
05 Ávila;All ages;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
05 Ávila;All ages;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
05 Ávila;All ages;Cohort October 1;Males;Survival in the second trimester;2020QII;""
05 Ávila;All ages;Cohort October 1;Males;Survival in the second trimester;2020QI;""
05 Ávila;All ages;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
05 Ávila;All ages;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
05 Ávila;All ages;Cohort October 1;Males;Survival in the third trimester;2022QII;6.614
05 Ávila;All ages;Cohort October 1;Males;Survival in the third trimester;2022QI;""
05 Ávila;All ages;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
05 Ávila;All ages;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
05 Ávila;All ages;Cohort October 1;Males;Survival in the third trimester;2021QII;6.643
05 Ávila;All ages;Cohort October 1;Males;Survival in the third trimester;2021QI;""
05 Ávila;All ages;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
05 Ávila;All ages;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
05 Ávila;All ages;Cohort October 1;Males;Survival in the third trimester;2020QII;""
05 Ávila;All ages;Cohort October 1;Males;Survival in the third trimester;2020QI;""
05 Ávila;All ages;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
05 Ávila;All ages;Cohort October 1;Males;Survival in the third trimester;2022QIII;6.480
05 Ávila;All ages;Cohort October 1;Males;Survival in the third trimester;2022QII;""
05 Ávila;All ages;Cohort October 1;Males;Survival in the third trimester;2022QI;""
05 Ávila;All ages;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
05 Ávila;All ages;Cohort October 1;Males;Survival in the third trimester;2021QIII;6.531
05 Ávila;All ages;Cohort October 1;Males;Survival in the third trimester;2021QII;""
05 Ávila;All ages;Cohort October 1;Males;Survival in the third trimester;2021QI;""
05 Ávila;All ages;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
05 Ávila;All ages;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
05 Ávila;All ages;Cohort October 1;Males;Survival in the third trimester;2020QII;""
05 Ávila;All ages;Cohort October 1;Males;Survival in the third trimester;2020QI;""
05 Ávila;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
05 Ávila;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
05 Ávila;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
05 Ávila;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
05 Ávila;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
05 Ávila;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
05 Ávila;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
05 Ávila;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
05 Ávila;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
05 Ávila;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
05 Ávila;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
05 Ávila;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
05 Ávila;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;97,02
05 Ávila;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
05 Ávila;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
05 Ávila;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
05 Ávila;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;96,86
05 Ávila;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
05 Ávila;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
05 Ávila;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
05 Ávila;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;97,16
05 Ávila;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
05 Ávila;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
05 Ávila;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
05 Ávila;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
05 Ávila;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
05 Ávila;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
05 Ávila;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;94,65
05 Ávila;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
05 Ávila;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
05 Ávila;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
05 Ávila;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;95,06
05 Ávila;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
05 Ávila;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
05 Ávila;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
05 Ávila;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
05 Ávila;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
05 Ávila;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
05 Ávila;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;92,66
05 Ávila;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
05 Ávila;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
05 Ávila;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
05 Ávila;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;93
05 Ávila;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
05 Ávila;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
05 Ávila;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
05 Ávila;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
05 Ávila;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
05 Ávila;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
05 Ávila;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;90,78
05 Ávila;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
05 Ávila;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
05 Ávila;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
05 Ávila;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;91,43
05 Ávila;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
05 Ávila;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
05 Ávila;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
05 Ávila;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
05 Ávila;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
05 Ávila;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
05 Ávila;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QIV;3.653
05 Ávila;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
05 Ávila;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
05 Ávila;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
05 Ávila;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QIV;3.645
05 Ávila;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
05 Ávila;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
05 Ávila;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
05 Ávila;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QIV;3.628
05 Ávila;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
05 Ávila;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
05 Ávila;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
05 Ávila;All ages;Cohort October 1;Females;Survival in the first trimester;2022QIV;3.499
05 Ávila;All ages;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
05 Ávila;All ages;Cohort October 1;Females;Survival in the first trimester;2022QII;""
05 Ávila;All ages;Cohort October 1;Females;Survival in the first trimester;2022QI;""
05 Ávila;All ages;Cohort October 1;Females;Survival in the first trimester;2021QIV;3.512
05 Ávila;All ages;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
05 Ávila;All ages;Cohort October 1;Females;Survival in the first trimester;2021QII;""
05 Ávila;All ages;Cohort October 1;Females;Survival in the first trimester;2021QI;""
05 Ávila;All ages;Cohort October 1;Females;Survival in the first trimester;2020QIV;3.501
05 Ávila;All ages;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
05 Ávila;All ages;Cohort October 1;Females;Survival in the first trimester;2020QII;""
05 Ávila;All ages;Cohort October 1;Females;Survival in the first trimester;2020QI;""
05 Ávila;All ages;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
05 Ávila;All ages;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
05 Ávila;All ages;Cohort October 1;Females;Survival in the second trimester;2022QII;""
05 Ávila;All ages;Cohort October 1;Females;Survival in the second trimester;2022QI;3.428
05 Ávila;All ages;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
05 Ávila;All ages;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
05 Ávila;All ages;Cohort October 1;Females;Survival in the second trimester;2021QII;""
05 Ávila;All ages;Cohort October 1;Females;Survival in the second trimester;2021QI;3.431
05 Ávila;All ages;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
05 Ávila;All ages;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
05 Ávila;All ages;Cohort October 1;Females;Survival in the second trimester;2020QII;""
05 Ávila;All ages;Cohort October 1;Females;Survival in the second trimester;2020QI;""
05 Ávila;All ages;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
05 Ávila;All ages;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
05 Ávila;All ages;Cohort October 1;Females;Survival in the third trimester;2022QII;3.340
05 Ávila;All ages;Cohort October 1;Females;Survival in the third trimester;2022QI;""
05 Ávila;All ages;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
05 Ávila;All ages;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
05 Ávila;All ages;Cohort October 1;Females;Survival in the third trimester;2021QII;3.342
05 Ávila;All ages;Cohort October 1;Females;Survival in the third trimester;2021QI;""
05 Ávila;All ages;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
05 Ávila;All ages;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
05 Ávila;All ages;Cohort October 1;Females;Survival in the third trimester;2020QII;""
05 Ávila;All ages;Cohort October 1;Females;Survival in the third trimester;2020QI;""
05 Ávila;All ages;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
05 Ávila;All ages;Cohort October 1;Females;Survival in the third trimester;2022QIII;3.250
05 Ávila;All ages;Cohort October 1;Females;Survival in the third trimester;2022QII;""
05 Ávila;All ages;Cohort October 1;Females;Survival in the third trimester;2022QI;""
05 Ávila;All ages;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
05 Ávila;All ages;Cohort October 1;Females;Survival in the third trimester;2021QIII;3.258
05 Ávila;All ages;Cohort October 1;Females;Survival in the third trimester;2021QII;""
05 Ávila;All ages;Cohort October 1;Females;Survival in the third trimester;2021QI;""
05 Ávila;All ages;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
05 Ávila;All ages;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
05 Ávila;All ages;Cohort October 1;Females;Survival in the third trimester;2020QII;""
05 Ávila;All ages;Cohort October 1;Females;Survival in the third trimester;2020QI;""
05 Ávila;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
05 Ávila;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
05 Ávila;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
05 Ávila;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
05 Ávila;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
05 Ávila;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
05 Ávila;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
05 Ávila;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
05 Ávila;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
05 Ávila;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
05 Ávila;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
05 Ávila;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
05 Ávila;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;95,78
05 Ávila;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
05 Ávila;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
05 Ávila;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
05 Ávila;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;96,35
05 Ávila;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
05 Ávila;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
05 Ávila;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
05 Ávila;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;96,5
05 Ávila;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
05 Ávila;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
05 Ávila;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
05 Ávila;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
05 Ávila;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
05 Ávila;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
05 Ávila;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;94,05
05 Ávila;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
05 Ávila;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
05 Ávila;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
05 Ávila;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;94,57
05 Ávila;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
05 Ávila;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
05 Ávila;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
05 Ávila;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
05 Ávila;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
05 Ávila;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
05 Ávila;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;91,63
05 Ávila;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
05 Ávila;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
05 Ávila;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
05 Ávila;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;92,12
05 Ávila;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
05 Ávila;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
05 Ávila;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
05 Ávila;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
05 Ávila;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
05 Ávila;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
05 Ávila;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;89,16
05 Ávila;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
05 Ávila;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
05 Ávila;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
05 Ávila;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;89,8
05 Ávila;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
05 Ávila;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
05 Ávila;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
05 Ávila;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
05 Ávila;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
05 Ávila;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
05 Ávila;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
05 Ávila;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
05 Ávila;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
05 Ávila;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QI;603
05 Ávila;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
05 Ávila;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
05 Ávila;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
05 Ávila;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QI;595
05 Ávila;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
05 Ávila;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
05 Ávila;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
05 Ávila;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QI;484
05 Ávila;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
05 Ávila;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
05 Ávila;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2022QII;""
05 Ávila;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2022QI;561
05 Ávila;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
05 Ávila;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
05 Ávila;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2021QII;""
05 Ávila;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2021QI;550
05 Ávila;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
05 Ávila;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
05 Ávila;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2020QII;""
05 Ávila;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2020QI;439
05 Ávila;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
05 Ávila;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
05 Ávila;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2022QII;527
05 Ávila;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2022QI;""
05 Ávila;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
05 Ávila;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
05 Ávila;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2021QII;522
05 Ávila;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2021QI;""
05 Ávila;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
05 Ávila;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
05 Ávila;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2020QII;428
05 Ávila;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2020QI;""
05 Ávila;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
05 Ávila;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QIII;491
05 Ávila;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QII;""
05 Ávila;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QI;""
05 Ávila;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
05 Ávila;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QIII;487
05 Ávila;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QII;""
05 Ávila;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QI;""
05 Ávila;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
05 Ávila;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QIII;399
05 Ávila;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QII;""
05 Ávila;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QI;""
05 Ávila;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QIV;473
05 Ávila;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
05 Ávila;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QII;""
05 Ávila;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QI;""
05 Ávila;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QIV;467
05 Ávila;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
05 Ávila;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QII;""
05 Ávila;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QI;""
05 Ávila;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QIV;390
05 Ávila;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
05 Ávila;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QII;""
05 Ávila;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QI;""
05 Ávila;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
05 Ávila;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
05 Ávila;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
05 Ávila;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
05 Ávila;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
05 Ávila;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
05 Ávila;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
05 Ávila;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
05 Ávila;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
05 Ávila;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
05 Ávila;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
05 Ávila;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
05 Ávila;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
05 Ávila;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
05 Ávila;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
05 Ávila;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;93,03
05 Ávila;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
05 Ávila;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
05 Ávila;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
05 Ávila;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;92,44
05 Ávila;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
05 Ávila;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
05 Ávila;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
05 Ávila;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;90,7
05 Ávila;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
05 Ávila;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
05 Ávila;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;87,4
05 Ávila;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
05 Ávila;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
05 Ávila;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
05 Ávila;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;87,73
05 Ávila;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
05 Ávila;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
05 Ávila;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
05 Ávila;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;88,43
05 Ávila;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
05 Ávila;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
05 Ávila;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;81,43
05 Ávila;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
05 Ávila;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
05 Ávila;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
05 Ávila;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;81,85
05 Ávila;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
05 Ávila;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
05 Ávila;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
05 Ávila;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;82,44
05 Ávila;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
05 Ávila;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
05 Ávila;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;78,44
05 Ávila;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
05 Ávila;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
05 Ávila;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
05 Ávila;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;78,49
05 Ávila;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
05 Ávila;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
05 Ávila;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
05 Ávila;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;80,58
05 Ávila;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
05 Ávila;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
05 Ávila;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
05 Ávila;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
05 Ávila;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
05 Ávila;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
05 Ávila;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QI;388
05 Ávila;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
05 Ávila;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
05 Ávila;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
05 Ávila;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QI;384
05 Ávila;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
05 Ávila;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
05 Ávila;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
05 Ávila;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QI;319
05 Ávila;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
05 Ávila;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
05 Ávila;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2022QII;""
05 Ávila;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2022QI;359
05 Ávila;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
05 Ávila;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
05 Ávila;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2021QII;""
05 Ávila;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2021QI;350
05 Ávila;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
05 Ávila;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
05 Ávila;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2020QII;""
05 Ávila;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2020QI;293
05 Ávila;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
05 Ávila;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
05 Ávila;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2022QII;334
05 Ávila;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2022QI;""
05 Ávila;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
05 Ávila;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
05 Ávila;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2021QII;331
05 Ávila;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2021QI;""
05 Ávila;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
05 Ávila;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
05 Ávila;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2020QII;283
05 Ávila;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2020QI;""
05 Ávila;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
05 Ávila;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QIII;314
05 Ávila;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QII;""
05 Ávila;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QI;""
05 Ávila;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
05 Ávila;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QIII;311
05 Ávila;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QII;""
05 Ávila;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QI;""
05 Ávila;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
05 Ávila;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QIII;264
05 Ávila;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QII;""
05 Ávila;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QI;""
05 Ávila;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QIV;304
05 Ávila;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
05 Ávila;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QII;""
05 Ávila;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QI;""
05 Ávila;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QIV;302
05 Ávila;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
05 Ávila;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QII;""
05 Ávila;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QI;""
05 Ávila;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QIV;257
05 Ávila;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
05 Ávila;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QII;""
05 Ávila;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QI;""
05 Ávila;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
05 Ávila;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
05 Ávila;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
05 Ávila;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
05 Ávila;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
05 Ávila;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
05 Ávila;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
05 Ávila;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
05 Ávila;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
05 Ávila;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
05 Ávila;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
05 Ávila;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
05 Ávila;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
05 Ávila;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
05 Ávila;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
05 Ávila;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;92,53
05 Ávila;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
05 Ávila;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
05 Ávila;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
05 Ávila;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;91,15
05 Ávila;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
05 Ávila;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
05 Ávila;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
05 Ávila;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;91,85
05 Ávila;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
05 Ávila;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
05 Ávila;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;86,08
05 Ávila;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
05 Ávila;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
05 Ávila;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
05 Ávila;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;86,2
05 Ávila;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
05 Ávila;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
05 Ávila;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
05 Ávila;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;88,71
05 Ávila;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
05 Ávila;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
05 Ávila;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;80,93
05 Ávila;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
05 Ávila;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
05 Ávila;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
05 Ávila;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;80,99
05 Ávila;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
05 Ávila;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
05 Ávila;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
05 Ávila;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;82,76
05 Ávila;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
05 Ávila;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
05 Ávila;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;78,35
05 Ávila;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
05 Ávila;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
05 Ávila;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
05 Ávila;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;78,65
05 Ávila;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
05 Ávila;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
05 Ávila;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
05 Ávila;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;80,56
05 Ávila;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
05 Ávila;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
05 Ávila;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
05 Ávila;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
05 Ávila;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
05 Ávila;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
05 Ávila;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QI;215
05 Ávila;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
05 Ávila;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
05 Ávila;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
05 Ávila;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QI;211
05 Ávila;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
05 Ávila;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
05 Ávila;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
05 Ávila;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QI;165
05 Ávila;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
05 Ávila;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
05 Ávila;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2022QII;""
05 Ávila;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2022QI;202
05 Ávila;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
05 Ávila;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
05 Ávila;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2021QII;""
05 Ávila;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2021QI;200
05 Ávila;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
05 Ávila;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
05 Ávila;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2020QII;""
05 Ávila;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2020QI;146
05 Ávila;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
05 Ávila;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
05 Ávila;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2022QII;193
05 Ávila;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2022QI;""
05 Ávila;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
05 Ávila;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
05 Ávila;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2021QII;191
05 Ávila;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2021QI;""
05 Ávila;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
05 Ávila;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
05 Ávila;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2020QII;145
05 Ávila;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2020QI;""
05 Ávila;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
05 Ávila;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QIII;177
05 Ávila;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QII;""
05 Ávila;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QI;""
05 Ávila;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
05 Ávila;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QIII;176
05 Ávila;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QII;""
05 Ávila;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QI;""
05 Ávila;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
05 Ávila;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QIII;135
05 Ávila;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QII;""
05 Ávila;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QI;""
05 Ávila;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QIV;169
05 Ávila;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
05 Ávila;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QII;""
05 Ávila;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QI;""
05 Ávila;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QIV;165
05 Ávila;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
05 Ávila;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QII;""
05 Ávila;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QI;""
05 Ávila;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QIV;133
05 Ávila;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
05 Ávila;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QII;""
05 Ávila;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QI;""
05 Ávila;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
05 Ávila;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
05 Ávila;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
05 Ávila;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
05 Ávila;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
05 Ávila;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
05 Ávila;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
05 Ávila;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
05 Ávila;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
05 Ávila;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
05 Ávila;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
05 Ávila;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
05 Ávila;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
05 Ávila;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
05 Ávila;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
05 Ávila;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;93,95
05 Ávila;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
05 Ávila;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
05 Ávila;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
05 Ávila;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;94,79
05 Ávila;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
05 Ávila;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
05 Ávila;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
05 Ávila;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;88,48
05 Ávila;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
05 Ávila;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
05 Ávila;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;89,77
05 Ávila;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
05 Ávila;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
05 Ávila;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
05 Ávila;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;90,52
05 Ávila;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
05 Ávila;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
05 Ávila;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
05 Ávila;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;87,88
05 Ávila;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
05 Ávila;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
05 Ávila;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;82,33
05 Ávila;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
05 Ávila;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
05 Ávila;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
05 Ávila;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;83,41
05 Ávila;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
05 Ávila;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
05 Ávila;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
05 Ávila;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;81,82
05 Ávila;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
05 Ávila;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
05 Ávila;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;78,6
05 Ávila;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
05 Ávila;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
05 Ávila;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
05 Ávila;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;78,2
05 Ávila;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
05 Ávila;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
05 Ávila;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
05 Ávila;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;80,61
05 Ávila;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
05 Ávila;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
05 Ávila;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
05 Ávila;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
05 Ávila;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
05 Ávila;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QII;519
05 Ávila;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
05 Ávila;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
05 Ávila;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
05 Ávila;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QII;517
05 Ávila;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
05 Ávila;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
05 Ávila;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
05 Ávila;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QII;492
05 Ávila;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
05 Ávila;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
05 Ávila;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
05 Ávila;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2022QII;483
05 Ávila;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2022QI;""
05 Ávila;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
05 Ávila;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
05 Ávila;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2021QII;489
05 Ávila;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2021QI;""
05 Ávila;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
05 Ávila;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
05 Ávila;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2020QII;477
05 Ávila;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2020QI;""
05 Ávila;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
05 Ávila;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2022QIII;446
05 Ávila;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2022QII;""
05 Ávila;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2022QI;""
05 Ávila;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
05 Ávila;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2021QIII;455
05 Ávila;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2021QII;""
05 Ávila;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2021QI;""
05 Ávila;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
05 Ávila;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2020QIII;443
05 Ávila;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2020QII;""
05 Ávila;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2020QI;""
05 Ávila;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QIV;424
05 Ávila;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
05 Ávila;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QII;""
05 Ávila;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QI;""
05 Ávila;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QIV;428
05 Ávila;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
05 Ávila;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QII;""
05 Ávila;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QI;""
05 Ávila;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QIV;432
05 Ávila;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
05 Ávila;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QII;""
05 Ávila;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QI;""
05 Ávila;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
05 Ávila;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
05 Ávila;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QII;""
05 Ávila;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QI;405
05 Ávila;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
05 Ávila;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
05 Ávila;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QII;""
05 Ávila;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QI;410
05 Ávila;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
05 Ávila;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
05 Ávila;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QII;""
05 Ávila;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QI;""
05 Ávila;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
05 Ávila;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
05 Ávila;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
05 Ávila;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
05 Ávila;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
05 Ávila;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
05 Ávila;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
05 Ávila;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
05 Ávila;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
05 Ávila;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
05 Ávila;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
05 Ávila;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
05 Ávila;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
05 Ávila;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
05 Ávila;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;93,06
05 Ávila;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
05 Ávila;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
05 Ávila;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
05 Ávila;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;94,58
05 Ávila;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
05 Ávila;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
05 Ávila;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
05 Ávila;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;96,95
05 Ávila;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
05 Ávila;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
05 Ávila;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;85,93
05 Ávila;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
05 Ávila;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
05 Ávila;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
05 Ávila;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;88,01
05 Ávila;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
05 Ávila;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
05 Ávila;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
05 Ávila;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;90,04
05 Ávila;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
05 Ávila;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
05 Ávila;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;81,7
05 Ávila;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
05 Ávila;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
05 Ávila;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
05 Ávila;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;82,79
05 Ávila;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
05 Ávila;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
05 Ávila;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
05 Ávila;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;87,8
05 Ávila;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
05 Ávila;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
05 Ávila;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
05 Ávila;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
05 Ávila;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
05 Ávila;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
05 Ávila;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;78,34
05 Ávila;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
05 Ávila;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
05 Ávila;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
05 Ávila;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;83,33
05 Ávila;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
05 Ávila;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
05 Ávila;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
05 Ávila;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
05 Ávila;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
05 Ávila;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
05 Ávila;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QII;336
05 Ávila;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
05 Ávila;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
05 Ávila;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
05 Ávila;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QII;329
05 Ávila;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
05 Ávila;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
05 Ávila;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
05 Ávila;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QII;327
05 Ávila;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
05 Ávila;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
05 Ávila;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
05 Ávila;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2022QII;309
05 Ávila;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2022QI;""
05 Ávila;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
05 Ávila;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
05 Ávila;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2021QII;310
05 Ávila;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2021QI;""
05 Ávila;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
05 Ávila;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
05 Ávila;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2020QII;313
05 Ávila;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2020QI;""
05 Ávila;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
05 Ávila;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2022QIII;285
05 Ávila;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2022QII;""
05 Ávila;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2022QI;""
05 Ávila;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
05 Ávila;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2021QIII;288
05 Ávila;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2021QII;""
05 Ávila;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2021QI;""
05 Ávila;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
05 Ávila;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2020QIII;290
05 Ávila;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2020QII;""
05 Ávila;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2020QI;""
05 Ávila;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QIV;272
05 Ávila;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
05 Ávila;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QII;""
05 Ávila;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QI;""
05 Ávila;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QIV;272
05 Ávila;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
05 Ávila;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QII;""
05 Ávila;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QI;""
05 Ávila;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QIV;282
05 Ávila;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
05 Ávila;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QII;""
05 Ávila;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QI;""
05 Ávila;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
05 Ávila;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
05 Ávila;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QII;""
05 Ávila;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QI;257
05 Ávila;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
05 Ávila;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
05 Ávila;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QII;""
05 Ávila;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QI;264
05 Ávila;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
05 Ávila;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
05 Ávila;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QII;""
05 Ávila;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QI;""
05 Ávila;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
05 Ávila;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
05 Ávila;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
05 Ávila;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
05 Ávila;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
05 Ávila;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
05 Ávila;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
05 Ávila;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
05 Ávila;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
05 Ávila;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
05 Ávila;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
05 Ávila;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
05 Ávila;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
05 Ávila;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
05 Ávila;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;91,96
05 Ávila;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
05 Ávila;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
05 Ávila;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
05 Ávila;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;94,22
05 Ávila;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
05 Ávila;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
05 Ávila;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
05 Ávila;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;95,72
05 Ávila;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
05 Ávila;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
05 Ávila;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;84,82
05 Ávila;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
05 Ávila;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
05 Ávila;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
05 Ávila;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;87,54
05 Ávila;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
05 Ávila;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
05 Ávila;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
05 Ávila;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;88,69
05 Ávila;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
05 Ávila;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
05 Ávila;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;80,95
05 Ávila;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
05 Ávila;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
05 Ávila;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
05 Ávila;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;82,67
05 Ávila;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
05 Ávila;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
05 Ávila;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
05 Ávila;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;86,24
05 Ávila;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
05 Ávila;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
05 Ávila;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
05 Ávila;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
05 Ávila;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
05 Ávila;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
05 Ávila;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;78,12
05 Ávila;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
05 Ávila;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
05 Ávila;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
05 Ávila;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;80,73
05 Ávila;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
05 Ávila;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
05 Ávila;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
05 Ávila;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
05 Ávila;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
05 Ávila;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
05 Ávila;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QII;183
05 Ávila;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
05 Ávila;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
05 Ávila;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
05 Ávila;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QII;188
05 Ávila;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
05 Ávila;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
05 Ávila;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
05 Ávila;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QII;165
05 Ávila;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
05 Ávila;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
05 Ávila;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
05 Ávila;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2022QII;174
05 Ávila;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2022QI;""
05 Ávila;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
05 Ávila;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
05 Ávila;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2021QII;179
05 Ávila;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2021QI;""
05 Ávila;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
05 Ávila;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
05 Ávila;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2020QII;164
05 Ávila;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2020QI;""
05 Ávila;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
05 Ávila;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2022QIII;161
05 Ávila;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2022QII;""
05 Ávila;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2022QI;""
05 Ávila;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
05 Ávila;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2021QIII;167
05 Ávila;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2021QII;""
05 Ávila;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2021QI;""
05 Ávila;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
05 Ávila;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2020QIII;153
05 Ávila;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2020QII;""
05 Ávila;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2020QI;""
05 Ávila;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QIV;152
05 Ávila;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
05 Ávila;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QII;""
05 Ávila;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QI;""
05 Ávila;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QIV;156
05 Ávila;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
05 Ávila;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QII;""
05 Ávila;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QI;""
05 Ávila;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QIV;150
05 Ávila;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
05 Ávila;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QII;""
05 Ávila;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QI;""
05 Ávila;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
05 Ávila;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
05 Ávila;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QII;""
05 Ávila;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QI;148
05 Ávila;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
05 Ávila;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
05 Ávila;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QII;""
05 Ávila;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QI;146
05 Ávila;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
05 Ávila;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
05 Ávila;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QII;""
05 Ávila;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QI;""
05 Ávila;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
05 Ávila;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
05 Ávila;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
05 Ávila;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
05 Ávila;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
05 Ávila;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
05 Ávila;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
05 Ávila;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
05 Ávila;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
05 Ávila;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
05 Ávila;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
05 Ávila;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
05 Ávila;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
05 Ávila;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
05 Ávila;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;95,08
05 Ávila;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
05 Ávila;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
05 Ávila;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
05 Ávila;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;95,21
05 Ávila;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
05 Ávila;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
05 Ávila;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
05 Ávila;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;99,39
05 Ávila;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
05 Ávila;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
05 Ávila;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;87,98
05 Ávila;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
05 Ávila;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
05 Ávila;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
05 Ávila;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;88,83
05 Ávila;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
05 Ávila;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
05 Ávila;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
05 Ávila;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;92,73
05 Ávila;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
05 Ávila;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
05 Ávila;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;83,06
05 Ávila;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
05 Ávila;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
05 Ávila;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
05 Ávila;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;82,98
05 Ávila;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
05 Ávila;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
05 Ávila;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
05 Ávila;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;90,91
05 Ávila;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
05 Ávila;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
05 Ávila;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
05 Ávila;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
05 Ávila;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
05 Ávila;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
05 Ávila;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;78,72
05 Ávila;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
05 Ávila;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
05 Ávila;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
05 Ávila;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;88,48
05 Ávila;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
05 Ávila;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
05 Ávila;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
05 Ávila;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
05 Ávila;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
05 Ávila;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QIII;568
05 Ávila;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
05 Ávila;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
05 Ávila;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
05 Ávila;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QIII;573
05 Ávila;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
05 Ávila;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
05 Ávila;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
05 Ávila;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QIII;538
05 Ávila;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
05 Ávila;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
05 Ávila;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
05 Ávila;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2022QIII;504
05 Ávila;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2022QII;""
05 Ávila;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2022QI;""
05 Ávila;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
05 Ávila;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2021QIII;520
05 Ávila;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2021QII;""
05 Ávila;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2021QI;""
05 Ávila;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
05 Ávila;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2020QIII;483
05 Ávila;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2020QII;""
05 Ávila;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2020QI;""
05 Ávila;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2022QIV;474
05 Ávila;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
05 Ávila;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2022QII;""
05 Ávila;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2022QI;""
05 Ávila;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2021QIV;485
05 Ávila;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
05 Ávila;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2021QII;""
05 Ávila;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2021QI;""
05 Ávila;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2020QIV;465
05 Ávila;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
05 Ávila;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2020QII;""
05 Ávila;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2020QI;""
05 Ávila;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
05 Ávila;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
05 Ávila;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QII;""
05 Ávila;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QI;456
05 Ávila;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
05 Ávila;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
05 Ávila;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QII;""
05 Ávila;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QI;440
05 Ávila;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
05 Ávila;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
05 Ávila;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QII;""
05 Ávila;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QI;""
05 Ávila;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
05 Ávila;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
05 Ávila;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QII;429
05 Ávila;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QI;""
05 Ávila;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
05 Ávila;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
05 Ávila;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QII;416
05 Ávila;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QI;""
05 Ávila;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
05 Ávila;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
05 Ávila;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QII;""
05 Ávila;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QI;""
05 Ávila;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
05 Ávila;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
05 Ávila;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
05 Ávila;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
05 Ávila;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
05 Ávila;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
05 Ávila;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
05 Ávila;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
05 Ávila;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
05 Ávila;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
05 Ávila;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
05 Ávila;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
05 Ávila;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
05 Ávila;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;88,73
05 Ávila;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
05 Ávila;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
05 Ávila;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
05 Ávila;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;90,75
05 Ávila;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
05 Ávila;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
05 Ávila;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
05 Ávila;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;89,78
05 Ávila;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
05 Ávila;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
05 Ávila;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;83,45
05 Ávila;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
05 Ávila;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
05 Ávila;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
05 Ávila;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;84,64
05 Ávila;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
05 Ávila;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
05 Ávila;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
05 Ávila;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;86,43
05 Ávila;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
05 Ávila;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
05 Ávila;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
05 Ávila;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
05 Ávila;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
05 Ávila;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
05 Ávila;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;79,58
05 Ávila;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
05 Ávila;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
05 Ávila;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
05 Ávila;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;81,78
05 Ávila;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
05 Ávila;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
05 Ávila;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
05 Ávila;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
05 Ávila;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
05 Ávila;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
05 Ávila;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;74,87
05 Ávila;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
05 Ávila;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
05 Ávila;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
05 Ávila;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;77,32
05 Ávila;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
05 Ávila;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
05 Ávila;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
05 Ávila;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
05 Ávila;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
05 Ávila;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
05 Ávila;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QIII;364
05 Ávila;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
05 Ávila;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
05 Ávila;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
05 Ávila;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QIII;362
05 Ávila;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
05 Ávila;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
05 Ávila;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
05 Ávila;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QIII;354
05 Ávila;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
05 Ávila;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
05 Ávila;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
05 Ávila;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2022QIII;322
05 Ávila;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2022QII;""
05 Ávila;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2022QI;""
05 Ávila;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
05 Ávila;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2021QIII;332
05 Ávila;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2021QII;""
05 Ávila;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2021QI;""
05 Ávila;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
05 Ávila;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2020QIII;318
05 Ávila;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2020QII;""
05 Ávila;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2020QI;""
05 Ávila;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2022QIV;302
05 Ávila;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
05 Ávila;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2022QII;""
05 Ávila;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2022QI;""
05 Ávila;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2021QIV;309
05 Ávila;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
05 Ávila;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2021QII;""
05 Ávila;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2021QI;""
05 Ávila;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2020QIV;305
05 Ávila;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
05 Ávila;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2020QII;""
05 Ávila;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2020QI;""
05 Ávila;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
05 Ávila;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
05 Ávila;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QII;""
05 Ávila;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QI;291
05 Ávila;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
05 Ávila;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
05 Ávila;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QII;""
05 Ávila;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QI;284
05 Ávila;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
05 Ávila;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
05 Ávila;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QII;""
05 Ávila;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QI;""
05 Ávila;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
05 Ávila;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
05 Ávila;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QII;272
05 Ávila;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QI;""
05 Ávila;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
05 Ávila;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
05 Ávila;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QII;268
05 Ávila;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QI;""
05 Ávila;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
05 Ávila;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
05 Ávila;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QII;""
05 Ávila;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QI;""
05 Ávila;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
05 Ávila;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
05 Ávila;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
05 Ávila;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
05 Ávila;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
05 Ávila;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
05 Ávila;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
05 Ávila;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
05 Ávila;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
05 Ávila;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
05 Ávila;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
05 Ávila;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
05 Ávila;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
05 Ávila;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;88,46
05 Ávila;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
05 Ávila;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
05 Ávila;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
05 Ávila;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;91,71
05 Ávila;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
05 Ávila;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
05 Ávila;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
05 Ávila;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;89,83
05 Ávila;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
05 Ávila;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
05 Ávila;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;82,97
05 Ávila;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
05 Ávila;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
05 Ávila;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
05 Ávila;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;85,36
05 Ávila;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
05 Ávila;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
05 Ávila;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
05 Ávila;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;86,16
05 Ávila;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
05 Ávila;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
05 Ávila;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
05 Ávila;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
05 Ávila;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
05 Ávila;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
05 Ávila;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;80,39
05 Ávila;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
05 Ávila;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
05 Ávila;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
05 Ávila;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;80,23
05 Ávila;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
05 Ávila;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
05 Ávila;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
05 Ávila;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
05 Ávila;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
05 Ávila;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
05 Ávila;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;75,14
05 Ávila;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
05 Ávila;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
05 Ávila;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
05 Ávila;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;75,71
05 Ávila;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
05 Ávila;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
05 Ávila;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
05 Ávila;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
05 Ávila;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
05 Ávila;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
05 Ávila;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QIII;204
05 Ávila;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
05 Ávila;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
05 Ávila;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
05 Ávila;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QIII;211
05 Ávila;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
05 Ávila;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
05 Ávila;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
05 Ávila;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QIII;184
05 Ávila;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
05 Ávila;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
05 Ávila;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
05 Ávila;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2022QIII;182
05 Ávila;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2022QII;""
05 Ávila;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2022QI;""
05 Ávila;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
05 Ávila;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2021QIII;188
05 Ávila;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2021QII;""
05 Ávila;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2021QI;""
05 Ávila;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
05 Ávila;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2020QIII;165
05 Ávila;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2020QII;""
05 Ávila;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2020QI;""
05 Ávila;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2022QIV;172
05 Ávila;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
05 Ávila;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2022QII;""
05 Ávila;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2022QI;""
05 Ávila;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2021QIV;176
05 Ávila;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
05 Ávila;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2021QII;""
05 Ávila;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2021QI;""
05 Ávila;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2020QIV;160
05 Ávila;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
05 Ávila;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2020QII;""
05 Ávila;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2020QI;""
05 Ávila;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
05 Ávila;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
05 Ávila;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QII;""
05 Ávila;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QI;165
05 Ávila;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
05 Ávila;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
05 Ávila;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QII;""
05 Ávila;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QI;156
05 Ávila;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
05 Ávila;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
05 Ávila;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QII;""
05 Ávila;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QI;""
05 Ávila;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
05 Ávila;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
05 Ávila;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QII;157
05 Ávila;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QI;""
05 Ávila;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
05 Ávila;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
05 Ávila;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QII;148
05 Ávila;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QI;""
05 Ávila;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
05 Ávila;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
05 Ávila;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QII;""
05 Ávila;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QI;""
05 Ávila;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
05 Ávila;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
05 Ávila;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
05 Ávila;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
05 Ávila;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
05 Ávila;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
05 Ávila;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
05 Ávila;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
05 Ávila;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
05 Ávila;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
05 Ávila;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
05 Ávila;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
05 Ávila;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
05 Ávila;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;89,22
05 Ávila;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
05 Ávila;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
05 Ávila;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
05 Ávila;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;89,1
05 Ávila;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
05 Ávila;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
05 Ávila;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
05 Ávila;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;89,67
05 Ávila;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
05 Ávila;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
05 Ávila;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;84,31
05 Ávila;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
05 Ávila;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
05 Ávila;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
05 Ávila;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;83,41
05 Ávila;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
05 Ávila;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
05 Ávila;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
05 Ávila;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;86,96
05 Ávila;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
05 Ávila;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
05 Ávila;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
05 Ávila;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
05 Ávila;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
05 Ávila;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
05 Ávila;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;78,2
05 Ávila;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
05 Ávila;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
05 Ávila;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
05 Ávila;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;84,78
05 Ávila;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
05 Ávila;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
05 Ávila;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
05 Ávila;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
05 Ávila;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
05 Ávila;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
05 Ávila;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;74,41
05 Ávila;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
05 Ávila;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
05 Ávila;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
05 Ávila;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;80,43
05 Ávila;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
05 Ávila;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
05 Ávila;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
05 Ávila;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
05 Ávila;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
05 Ávila;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QIV;554
05 Ávila;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
05 Ávila;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
05 Ávila;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
05 Ávila;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QIV;584
05 Ávila;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
05 Ávila;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
05 Ávila;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
05 Ávila;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QIV;550
05 Ávila;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
05 Ávila;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
05 Ávila;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
05 Ávila;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2022QIV;519
05 Ávila;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
05 Ávila;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2022QII;""
05 Ávila;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2022QI;""
05 Ávila;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2021QIV;541
05 Ávila;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
05 Ávila;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2021QII;""
05 Ávila;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2021QI;""
05 Ávila;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2020QIV;523
05 Ávila;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
05 Ávila;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2020QII;""
05 Ávila;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2020QI;""
05 Ávila;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
05 Ávila;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
05 Ávila;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2022QII;""
05 Ávila;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2022QI;506
05 Ávila;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
05 Ávila;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
05 Ávila;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2021QII;""
05 Ávila;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2021QI;491
05 Ávila;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
05 Ávila;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
05 Ávila;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2020QII;""
05 Ávila;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2020QI;""
05 Ávila;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
05 Ávila;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
05 Ávila;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QII;476
05 Ávila;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QI;""
05 Ávila;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
05 Ávila;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
05 Ávila;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QII;466
05 Ávila;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QI;""
05 Ávila;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
05 Ávila;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
05 Ávila;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QII;""
05 Ávila;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QI;""
05 Ávila;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
05 Ávila;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QIII;447
05 Ávila;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QII;""
05 Ávila;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QI;""
05 Ávila;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
05 Ávila;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QIII;437
05 Ávila;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QII;""
05 Ávila;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QI;""
05 Ávila;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
05 Ávila;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
05 Ávila;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QII;""
05 Ávila;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QI;""
05 Ávila;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
05 Ávila;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
05 Ávila;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
05 Ávila;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
05 Ávila;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
05 Ávila;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
05 Ávila;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
05 Ávila;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
05 Ávila;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
05 Ávila;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
05 Ávila;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
05 Ávila;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
05 Ávila;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;93,68
05 Ávila;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
05 Ávila;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
05 Ávila;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
05 Ávila;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;92,64
05 Ávila;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
05 Ávila;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
05 Ávila;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
05 Ávila;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;95,09
05 Ávila;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
05 Ávila;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
05 Ávila;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
05 Ávila;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
05 Ávila;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
05 Ávila;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
05 Ávila;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;86,64
05 Ávila;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
05 Ávila;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
05 Ávila;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
05 Ávila;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;89,27
05 Ávila;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
05 Ávila;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
05 Ávila;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
05 Ávila;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
05 Ávila;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
05 Ávila;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
05 Ávila;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;81,51
05 Ávila;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
05 Ávila;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
05 Ávila;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
05 Ávila;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;84,73
05 Ávila;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
05 Ávila;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
05 Ávila;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
05 Ávila;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
05 Ávila;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
05 Ávila;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
05 Ávila;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;76,54
05 Ávila;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
05 Ávila;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
05 Ávila;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
05 Ávila;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;79,45
05 Ávila;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
05 Ávila;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
05 Ávila;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
05 Ávila;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
05 Ávila;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
05 Ávila;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
05 Ávila;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QIV;351
05 Ávila;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
05 Ávila;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
05 Ávila;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
05 Ávila;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QIV;375
05 Ávila;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
05 Ávila;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
05 Ávila;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
05 Ávila;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QIV;355
05 Ávila;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
05 Ávila;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
05 Ávila;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
05 Ávila;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2022QIV;330
05 Ávila;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
05 Ávila;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2022QII;""
05 Ávila;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2022QI;""
05 Ávila;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2021QIV;348
05 Ávila;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
05 Ávila;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2021QII;""
05 Ávila;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2021QI;""
05 Ávila;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2020QIV;336
05 Ávila;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
05 Ávila;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2020QII;""
05 Ávila;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2020QI;""
05 Ávila;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
05 Ávila;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
05 Ávila;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2022QII;""
05 Ávila;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2022QI;326
05 Ávila;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
05 Ávila;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
05 Ávila;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2021QII;""
05 Ávila;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2021QI;310
05 Ávila;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
05 Ávila;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
05 Ávila;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2020QII;""
05 Ávila;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2020QI;""
05 Ávila;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
05 Ávila;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
05 Ávila;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QII;305
05 Ávila;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QI;""
05 Ávila;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
05 Ávila;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
05 Ávila;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QII;294
05 Ávila;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QI;""
05 Ávila;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
05 Ávila;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
05 Ávila;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QII;""
05 Ávila;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QI;""
05 Ávila;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
05 Ávila;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QIII;289
05 Ávila;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QII;""
05 Ávila;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QI;""
05 Ávila;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
05 Ávila;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QIII;276
05 Ávila;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QII;""
05 Ávila;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QI;""
05 Ávila;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
05 Ávila;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
05 Ávila;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QII;""
05 Ávila;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QI;""
05 Ávila;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
05 Ávila;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
05 Ávila;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
05 Ávila;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
05 Ávila;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
05 Ávila;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
05 Ávila;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
05 Ávila;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
05 Ávila;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
05 Ávila;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
05 Ávila;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
05 Ávila;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
05 Ávila;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;94,02
05 Ávila;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
05 Ávila;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
05 Ávila;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
05 Ávila;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;92,8
05 Ávila;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
05 Ávila;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
05 Ávila;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
05 Ávila;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;94,65
05 Ávila;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
05 Ávila;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
05 Ávila;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
05 Ávila;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
05 Ávila;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
05 Ávila;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
05 Ávila;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;86,93
05 Ávila;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
05 Ávila;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
05 Ávila;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
05 Ávila;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;87,32
05 Ávila;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
05 Ávila;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
05 Ávila;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
05 Ávila;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
05 Ávila;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
05 Ávila;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
05 Ávila;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;81,33
05 Ávila;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
05 Ávila;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
05 Ávila;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
05 Ávila;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;82,82
05 Ávila;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
05 Ávila;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
05 Ávila;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
05 Ávila;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
05 Ávila;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
05 Ávila;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
05 Ávila;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;77,07
05 Ávila;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
05 Ávila;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
05 Ávila;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
05 Ávila;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;77,75
05 Ávila;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
05 Ávila;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
05 Ávila;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
05 Ávila;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
05 Ávila;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
05 Ávila;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
05 Ávila;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QIV;203
05 Ávila;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
05 Ávila;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
05 Ávila;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
05 Ávila;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QIV;209
05 Ávila;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
05 Ávila;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
05 Ávila;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
05 Ávila;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QIV;195
05 Ávila;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
05 Ávila;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
05 Ávila;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
05 Ávila;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2022QIV;189
05 Ávila;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
05 Ávila;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2022QII;""
05 Ávila;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2022QI;""
05 Ávila;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2021QIV;193
05 Ávila;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
05 Ávila;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2021QII;""
05 Ávila;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2021QI;""
05 Ávila;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2020QIV;187
05 Ávila;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
05 Ávila;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2020QII;""
05 Ávila;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2020QI;""
05 Ávila;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
05 Ávila;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
05 Ávila;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2022QII;""
05 Ávila;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2022QI;180
05 Ávila;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
05 Ávila;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
05 Ávila;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2021QII;""
05 Ávila;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2021QI;181
05 Ávila;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
05 Ávila;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
05 Ávila;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2020QII;""
05 Ávila;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2020QI;""
05 Ávila;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
05 Ávila;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
05 Ávila;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QII;171
05 Ávila;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QI;""
05 Ávila;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
05 Ávila;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
05 Ávila;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QII;172
05 Ávila;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QI;""
05 Ávila;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
05 Ávila;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
05 Ávila;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QII;""
05 Ávila;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QI;""
05 Ávila;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
05 Ávila;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QIII;158
05 Ávila;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QII;""
05 Ávila;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QI;""
05 Ávila;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
05 Ávila;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QIII;161
05 Ávila;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QII;""
05 Ávila;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QI;""
05 Ávila;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
05 Ávila;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
05 Ávila;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QII;""
05 Ávila;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QI;""
05 Ávila;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
05 Ávila;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
05 Ávila;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
05 Ávila;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
05 Ávila;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
05 Ávila;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
05 Ávila;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
05 Ávila;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
05 Ávila;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
05 Ávila;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
05 Ávila;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
05 Ávila;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
05 Ávila;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;93,1
05 Ávila;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
05 Ávila;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
05 Ávila;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
05 Ávila;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;92,34
05 Ávila;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
05 Ávila;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
05 Ávila;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
05 Ávila;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;95,9
05 Ávila;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
05 Ávila;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
05 Ávila;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
05 Ávila;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
05 Ávila;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
05 Ávila;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
05 Ávila;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;86,12
05 Ávila;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
05 Ávila;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
05 Ávila;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
05 Ávila;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;92,82
05 Ávila;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
05 Ávila;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
05 Ávila;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
05 Ávila;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
05 Ávila;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
05 Ávila;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
05 Ávila;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;81,82
05 Ávila;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
05 Ávila;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
05 Ávila;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
05 Ávila;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;88,21
05 Ávila;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
05 Ávila;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
05 Ávila;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
05 Ávila;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
05 Ávila;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
05 Ávila;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
05 Ávila;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;75,6
05 Ávila;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
05 Ávila;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
05 Ávila;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
05 Ávila;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;82,56
05 Ávila;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
05 Ávila;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
05 Ávila;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
05 Ávila;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
05 Ávila;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
05 Ávila;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
05 Ávila;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
05 Ávila;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
05 Ávila;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
05 Ávila;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QI;1.687
05 Ávila;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
05 Ávila;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
05 Ávila;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
05 Ávila;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QI;1.739
05 Ávila;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
05 Ávila;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
05 Ávila;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
05 Ávila;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QI;1.729
05 Ávila;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
05 Ávila;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
05 Ávila;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2022QII;""
05 Ávila;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2022QI;1.635
05 Ávila;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
05 Ávila;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
05 Ávila;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2021QII;""
05 Ávila;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2021QI;1.695
05 Ávila;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
05 Ávila;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
05 Ávila;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2020QII;""
05 Ávila;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2020QI;1.625
05 Ávila;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
05 Ávila;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
05 Ávila;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2022QII;1.596
05 Ávila;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2022QI;""
05 Ávila;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
05 Ávila;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
05 Ávila;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2021QII;1.632
05 Ávila;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2021QI;""
05 Ávila;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
05 Ávila;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
05 Ávila;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2020QII;1.595
05 Ávila;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2020QI;""
05 Ávila;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
05 Ávila;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QIII;1.545
05 Ávila;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QII;""
05 Ávila;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QI;""
05 Ávila;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
05 Ávila;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QIII;1.596
05 Ávila;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QII;""
05 Ávila;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QI;""
05 Ávila;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
05 Ávila;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QIII;1.542
05 Ávila;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QII;""
05 Ávila;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QI;""
05 Ávila;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QIV;1.486
05 Ávila;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
05 Ávila;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QII;""
05 Ávila;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QI;""
05 Ávila;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QIV;1.542
05 Ávila;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
05 Ávila;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QII;""
05 Ávila;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QI;""
05 Ávila;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QIV;1.501
05 Ávila;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
05 Ávila;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QII;""
05 Ávila;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QI;""
05 Ávila;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
05 Ávila;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
05 Ávila;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
05 Ávila;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
05 Ávila;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
05 Ávila;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
05 Ávila;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
05 Ávila;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
05 Ávila;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
05 Ávila;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
05 Ávila;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
05 Ávila;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
05 Ávila;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
05 Ávila;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
05 Ávila;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
05 Ávila;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;96,92
05 Ávila;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
05 Ávila;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
05 Ávila;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
05 Ávila;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;97,47
05 Ávila;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
05 Ávila;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
05 Ávila;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
05 Ávila;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;93,98
05 Ávila;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
05 Ávila;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
05 Ávila;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;94,61
05 Ávila;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
05 Ávila;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
05 Ávila;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
05 Ávila;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;93,85
05 Ávila;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
05 Ávila;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
05 Ávila;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
05 Ávila;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;92,25
05 Ávila;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
05 Ávila;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
05 Ávila;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;91,58
05 Ávila;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
05 Ávila;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
05 Ávila;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
05 Ávila;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;91,78
05 Ávila;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
05 Ávila;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
05 Ávila;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
05 Ávila;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;89,18
05 Ávila;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
05 Ávila;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
05 Ávila;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;88,09
05 Ávila;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
05 Ávila;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
05 Ávila;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
05 Ávila;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;88,67
05 Ávila;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
05 Ávila;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
05 Ávila;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
05 Ávila;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;86,81
05 Ávila;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
05 Ávila;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
05 Ávila;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
05 Ávila;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
05 Ávila;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
05 Ávila;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
05 Ávila;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QI;1.078
05 Ávila;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
05 Ávila;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
05 Ávila;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
05 Ávila;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QI;1.102
05 Ávila;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
05 Ávila;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
05 Ávila;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
05 Ávila;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QI;1.095
05 Ávila;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
05 Ávila;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
05 Ávila;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2022QII;""
05 Ávila;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2022QI;1.050
05 Ávila;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
05 Ávila;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
05 Ávila;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2021QII;""
05 Ávila;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2021QI;1.076
05 Ávila;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
05 Ávila;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
05 Ávila;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2020QII;""
05 Ávila;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2020QI;1.030
05 Ávila;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
05 Ávila;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
05 Ávila;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2022QII;1.027
05 Ávila;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2022QI;""
05 Ávila;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
05 Ávila;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
05 Ávila;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2021QII;1.039
05 Ávila;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2021QI;""
05 Ávila;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
05 Ávila;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
05 Ávila;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2020QII;1.015
05 Ávila;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2020QI;""
05 Ávila;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
05 Ávila;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QIII;996
05 Ávila;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QII;""
05 Ávila;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QI;""
05 Ávila;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
05 Ávila;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QIII;1.019
05 Ávila;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QII;""
05 Ávila;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QI;""
05 Ávila;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
05 Ávila;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QIII;986
05 Ávila;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QII;""
05 Ávila;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QI;""
05 Ávila;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QIV;962
05 Ávila;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
05 Ávila;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QII;""
05 Ávila;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QI;""
05 Ávila;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QIV;982
05 Ávila;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
05 Ávila;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QII;""
05 Ávila;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QI;""
05 Ávila;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QIV;968
05 Ávila;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
05 Ávila;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QII;""
05 Ávila;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QI;""
05 Ávila;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
05 Ávila;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
05 Ávila;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
05 Ávila;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
05 Ávila;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
05 Ávila;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
05 Ávila;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
05 Ávila;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
05 Ávila;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
05 Ávila;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
05 Ávila;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
05 Ávila;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
05 Ávila;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
05 Ávila;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
05 Ávila;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
05 Ávila;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;97,4
05 Ávila;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
05 Ávila;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
05 Ávila;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
05 Ávila;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;97,64
05 Ávila;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
05 Ávila;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
05 Ávila;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
05 Ávila;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;94,06
05 Ávila;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
05 Ávila;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
05 Ávila;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;95,27
05 Ávila;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
05 Ávila;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
05 Ávila;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
05 Ávila;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;94,28
05 Ávila;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
05 Ávila;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
05 Ávila;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
05 Ávila;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;92,69
05 Ávila;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
05 Ávila;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
05 Ávila;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;92,39
05 Ávila;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
05 Ávila;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
05 Ávila;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
05 Ávila;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;92,47
05 Ávila;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
05 Ávila;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
05 Ávila;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
05 Ávila;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;90,05
05 Ávila;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
05 Ávila;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
05 Ávila;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;89,24
05 Ávila;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
05 Ávila;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
05 Ávila;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
05 Ávila;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;89,11
05 Ávila;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
05 Ávila;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
05 Ávila;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
05 Ávila;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;88,4
05 Ávila;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
05 Ávila;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
05 Ávila;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
05 Ávila;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
05 Ávila;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
05 Ávila;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
05 Ávila;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QI;609
05 Ávila;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
05 Ávila;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
05 Ávila;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
05 Ávila;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QI;637
05 Ávila;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
05 Ávila;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
05 Ávila;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
05 Ávila;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QI;634
05 Ávila;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
05 Ávila;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
05 Ávila;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2022QII;""
05 Ávila;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2022QI;585
05 Ávila;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
05 Ávila;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
05 Ávila;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2021QII;""
05 Ávila;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2021QI;619
05 Ávila;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
05 Ávila;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
05 Ávila;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2020QII;""
05 Ávila;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2020QI;595
05 Ávila;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
05 Ávila;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
05 Ávila;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2022QII;569
05 Ávila;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2022QI;""
05 Ávila;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
05 Ávila;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
05 Ávila;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2021QII;593
05 Ávila;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2021QI;""
05 Ávila;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
05 Ávila;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
05 Ávila;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2020QII;580
05 Ávila;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2020QI;""
05 Ávila;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
05 Ávila;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QIII;549
05 Ávila;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QII;""
05 Ávila;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QI;""
05 Ávila;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
05 Ávila;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QIII;577
05 Ávila;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QII;""
05 Ávila;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QI;""
05 Ávila;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
05 Ávila;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QIII;556
05 Ávila;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QII;""
05 Ávila;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QI;""
05 Ávila;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QIV;524
05 Ávila;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
05 Ávila;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QII;""
05 Ávila;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QI;""
05 Ávila;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QIV;560
05 Ávila;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
05 Ávila;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QII;""
05 Ávila;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QI;""
05 Ávila;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QIV;533
05 Ávila;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
05 Ávila;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QII;""
05 Ávila;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QI;""
05 Ávila;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
05 Ávila;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
05 Ávila;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
05 Ávila;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
05 Ávila;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
05 Ávila;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
05 Ávila;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
05 Ávila;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
05 Ávila;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
05 Ávila;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
05 Ávila;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
05 Ávila;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
05 Ávila;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
05 Ávila;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
05 Ávila;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
05 Ávila;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;96,06
05 Ávila;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
05 Ávila;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
05 Ávila;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
05 Ávila;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;97,17
05 Ávila;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
05 Ávila;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
05 Ávila;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
05 Ávila;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;93,85
05 Ávila;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
05 Ávila;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
05 Ávila;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;93,43
05 Ávila;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
05 Ávila;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
05 Ávila;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
05 Ávila;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;93,09
05 Ávila;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
05 Ávila;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
05 Ávila;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
05 Ávila;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;91,48
05 Ávila;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
05 Ávila;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
05 Ávila;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;90,15
05 Ávila;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
05 Ávila;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
05 Ávila;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
05 Ávila;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;90,58
05 Ávila;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
05 Ávila;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
05 Ávila;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
05 Ávila;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;87,7
05 Ávila;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
05 Ávila;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
05 Ávila;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;86,04
05 Ávila;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
05 Ávila;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
05 Ávila;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
05 Ávila;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;87,91
05 Ávila;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
05 Ávila;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
05 Ávila;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
05 Ávila;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;84,07
05 Ávila;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
05 Ávila;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
05 Ávila;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
05 Ávila;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
05 Ávila;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
05 Ávila;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QII;1.597
05 Ávila;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
05 Ávila;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
05 Ávila;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
05 Ávila;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QII;1.644
05 Ávila;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
05 Ávila;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
05 Ávila;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
05 Ávila;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QII;1.706
05 Ávila;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
05 Ávila;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
05 Ávila;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
05 Ávila;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2022QII;1.554
05 Ávila;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2022QI;""
05 Ávila;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
05 Ávila;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
05 Ávila;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2021QII;1.575
05 Ávila;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2021QI;""
05 Ávila;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
05 Ávila;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
05 Ávila;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2020QII;1.675
05 Ávila;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2020QI;""
05 Ávila;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
05 Ávila;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2022QIII;1.493
05 Ávila;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2022QII;""
05 Ávila;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2022QI;""
05 Ávila;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
05 Ávila;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2021QIII;1.535
05 Ávila;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2021QII;""
05 Ávila;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2021QI;""
05 Ávila;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
05 Ávila;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2020QIII;1.616
05 Ávila;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2020QII;""
05 Ávila;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2020QI;""
05 Ávila;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QIV;1.433
05 Ávila;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
05 Ávila;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QII;""
05 Ávila;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QI;""
05 Ávila;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QIV;1.484
05 Ávila;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
05 Ávila;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QII;""
05 Ávila;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QI;""
05 Ávila;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QIV;1.569
05 Ávila;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
05 Ávila;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QII;""
05 Ávila;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QI;""
05 Ávila;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
05 Ávila;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
05 Ávila;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QII;""
05 Ávila;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QI;1.446
05 Ávila;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
05 Ávila;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
05 Ávila;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QII;""
05 Ávila;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QI;1.541
05 Ávila;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
05 Ávila;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
05 Ávila;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QII;""
05 Ávila;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QI;""
05 Ávila;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
05 Ávila;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
05 Ávila;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
05 Ávila;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
05 Ávila;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
05 Ávila;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
05 Ávila;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
05 Ávila;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
05 Ávila;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
05 Ávila;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
05 Ávila;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
05 Ávila;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
05 Ávila;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
05 Ávila;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
05 Ávila;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;97,31
05 Ávila;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
05 Ávila;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
05 Ávila;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
05 Ávila;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;95,8
05 Ávila;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
05 Ávila;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
05 Ávila;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
05 Ávila;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;98,18
05 Ávila;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
05 Ávila;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
05 Ávila;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;93,49
05 Ávila;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
05 Ávila;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
05 Ávila;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
05 Ávila;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;93,37
05 Ávila;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
05 Ávila;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
05 Ávila;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
05 Ávila;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;94,72
05 Ávila;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
05 Ávila;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
05 Ávila;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;89,73
05 Ávila;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
05 Ávila;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
05 Ávila;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
05 Ávila;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;90,27
05 Ávila;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
05 Ávila;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
05 Ávila;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
05 Ávila;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;91,97
05 Ávila;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
05 Ávila;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
05 Ávila;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
05 Ávila;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
05 Ávila;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
05 Ávila;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
05 Ávila;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;87,96
05 Ávila;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
05 Ávila;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
05 Ávila;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
05 Ávila;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;90,33
05 Ávila;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
05 Ávila;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
05 Ávila;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
05 Ávila;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
05 Ávila;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
05 Ávila;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
05 Ávila;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QII;1.009
05 Ávila;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
05 Ávila;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
05 Ávila;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
05 Ávila;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QII;1.055
05 Ávila;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
05 Ávila;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
05 Ávila;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
05 Ávila;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QII;1.072
05 Ávila;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
05 Ávila;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
05 Ávila;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
05 Ávila;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2022QII;984
05 Ávila;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2022QI;""
05 Ávila;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
05 Ávila;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
05 Ávila;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2021QII;1.014
05 Ávila;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2021QI;""
05 Ávila;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
05 Ávila;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
05 Ávila;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2020QII;1.056
05 Ávila;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2020QI;""
05 Ávila;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
05 Ávila;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2022QIII;950
05 Ávila;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2022QII;""
05 Ávila;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2022QI;""
05 Ávila;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
05 Ávila;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2021QIII;996
05 Ávila;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2021QII;""
05 Ávila;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2021QI;""
05 Ávila;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
05 Ávila;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2020QIII;1.023
05 Ávila;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2020QII;""
05 Ávila;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2020QI;""
05 Ávila;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QIV;917
05 Ávila;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
05 Ávila;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QII;""
05 Ávila;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QI;""
05 Ávila;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QIV;962
05 Ávila;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
05 Ávila;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QII;""
05 Ávila;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QI;""
05 Ávila;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QIV;1.000
05 Ávila;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
05 Ávila;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QII;""
05 Ávila;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QI;""
05 Ávila;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
05 Ávila;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
05 Ávila;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QII;""
05 Ávila;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QI;941
05 Ávila;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
05 Ávila;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
05 Ávila;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QII;""
05 Ávila;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QI;981
05 Ávila;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
05 Ávila;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
05 Ávila;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QII;""
05 Ávila;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QI;""
05 Ávila;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
05 Ávila;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
05 Ávila;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
05 Ávila;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
05 Ávila;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
05 Ávila;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
05 Ávila;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
05 Ávila;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
05 Ávila;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
05 Ávila;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
05 Ávila;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
05 Ávila;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
05 Ávila;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
05 Ávila;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
05 Ávila;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;97,52
05 Ávila;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
05 Ávila;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
05 Ávila;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
05 Ávila;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;96,11
05 Ávila;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
05 Ávila;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
05 Ávila;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
05 Ávila;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;98,51
05 Ávila;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
05 Ávila;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
05 Ávila;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;94,15
05 Ávila;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
05 Ávila;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
05 Ávila;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
05 Ávila;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;94,41
05 Ávila;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
05 Ávila;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
05 Ávila;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
05 Ávila;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;95,43
05 Ávila;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
05 Ávila;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
05 Ávila;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;90,88
05 Ávila;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
05 Ávila;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
05 Ávila;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
05 Ávila;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;91,18
05 Ávila;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
05 Ávila;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
05 Ávila;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
05 Ávila;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;93,28
05 Ávila;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
05 Ávila;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
05 Ávila;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
05 Ávila;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
05 Ávila;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
05 Ávila;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
05 Ávila;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;89,19
05 Ávila;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
05 Ávila;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
05 Ávila;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
05 Ávila;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;91,51
05 Ávila;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
05 Ávila;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
05 Ávila;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
05 Ávila;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
05 Ávila;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
05 Ávila;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
05 Ávila;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QII;588
05 Ávila;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
05 Ávila;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
05 Ávila;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
05 Ávila;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QII;589
05 Ávila;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
05 Ávila;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
05 Ávila;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
05 Ávila;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QII;634
05 Ávila;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
05 Ávila;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
05 Ávila;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
05 Ávila;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2022QII;570
05 Ávila;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2022QI;""
05 Ávila;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
05 Ávila;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
05 Ávila;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2021QII;561
05 Ávila;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2021QI;""
05 Ávila;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
05 Ávila;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
05 Ávila;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2020QII;619
05 Ávila;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2020QI;""
05 Ávila;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
05 Ávila;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2022QIII;543
05 Ávila;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2022QII;""
05 Ávila;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2022QI;""
05 Ávila;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
05 Ávila;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2021QIII;539
05 Ávila;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2021QII;""
05 Ávila;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2021QI;""
05 Ávila;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
05 Ávila;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2020QIII;593
05 Ávila;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2020QII;""
05 Ávila;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2020QI;""
05 Ávila;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QIV;516
05 Ávila;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
05 Ávila;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QII;""
05 Ávila;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QI;""
05 Ávila;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QIV;522
05 Ávila;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
05 Ávila;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QII;""
05 Ávila;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QI;""
05 Ávila;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QIV;569
05 Ávila;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
05 Ávila;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QII;""
05 Ávila;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QI;""
05 Ávila;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
05 Ávila;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
05 Ávila;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QII;""
05 Ávila;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QI;505
05 Ávila;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
05 Ávila;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
05 Ávila;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QII;""
05 Ávila;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QI;560
05 Ávila;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
05 Ávila;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
05 Ávila;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QII;""
05 Ávila;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QI;""
05 Ávila;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
05 Ávila;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
05 Ávila;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
05 Ávila;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
05 Ávila;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
05 Ávila;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
05 Ávila;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
05 Ávila;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
05 Ávila;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
05 Ávila;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
05 Ávila;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
05 Ávila;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
05 Ávila;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
05 Ávila;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
05 Ávila;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;96,94
05 Ávila;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
05 Ávila;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
05 Ávila;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
05 Ávila;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;95,25
05 Ávila;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
05 Ávila;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
05 Ávila;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
05 Ávila;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;97,63
05 Ávila;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
05 Ávila;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
05 Ávila;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;92,35
05 Ávila;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
05 Ávila;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
05 Ávila;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
05 Ávila;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;91,51
05 Ávila;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
05 Ávila;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
05 Ávila;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
05 Ávila;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;93,53
05 Ávila;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
05 Ávila;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
05 Ávila;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;87,76
05 Ávila;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
05 Ávila;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
05 Ávila;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
05 Ávila;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;88,62
05 Ávila;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
05 Ávila;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
05 Ávila;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
05 Ávila;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;89,75
05 Ávila;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
05 Ávila;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
05 Ávila;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
05 Ávila;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
05 Ávila;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
05 Ávila;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
05 Ávila;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;85,74
05 Ávila;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
05 Ávila;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
05 Ávila;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
05 Ávila;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;88,33
05 Ávila;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
05 Ávila;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
05 Ávila;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
05 Ávila;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
05 Ávila;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
05 Ávila;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QIII;1.645
05 Ávila;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
05 Ávila;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
05 Ávila;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
05 Ávila;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QIII;1.667
05 Ávila;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
05 Ávila;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
05 Ávila;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
05 Ávila;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QIII;1.739
05 Ávila;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
05 Ávila;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
05 Ávila;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
05 Ávila;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2022QIII;1.567
05 Ávila;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2022QII;""
05 Ávila;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2022QI;""
05 Ávila;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
05 Ávila;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2021QIII;1.612
05 Ávila;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2021QII;""
05 Ávila;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2021QI;""
05 Ávila;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
05 Ávila;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2020QIII;1.670
05 Ávila;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2020QII;""
05 Ávila;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2020QI;""
05 Ávila;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2022QIV;1.501
05 Ávila;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
05 Ávila;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2022QII;""
05 Ávila;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2022QI;""
05 Ávila;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2021QIV;1.557
05 Ávila;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
05 Ávila;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2021QII;""
05 Ávila;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2021QI;""
05 Ávila;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2020QIV;1.618
05 Ávila;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
05 Ávila;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2020QII;""
05 Ávila;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2020QI;""
05 Ávila;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
05 Ávila;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
05 Ávila;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QII;""
05 Ávila;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QI;1.513
05 Ávila;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
05 Ávila;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
05 Ávila;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QII;""
05 Ávila;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QI;1.586
05 Ávila;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
05 Ávila;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
05 Ávila;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QII;""
05 Ávila;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QI;""
05 Ávila;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
05 Ávila;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
05 Ávila;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QII;1.483
05 Ávila;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QI;""
05 Ávila;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
05 Ávila;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
05 Ávila;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QII;1.533
05 Ávila;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QI;""
05 Ávila;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
05 Ávila;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
05 Ávila;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QII;""
05 Ávila;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QI;""
05 Ávila;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
05 Ávila;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
05 Ávila;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
05 Ávila;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
05 Ávila;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
05 Ávila;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
05 Ávila;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
05 Ávila;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
05 Ávila;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
05 Ávila;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
05 Ávila;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
05 Ávila;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
05 Ávila;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
05 Ávila;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;95,26
05 Ávila;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
05 Ávila;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
05 Ávila;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
05 Ávila;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;96,7
05 Ávila;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
05 Ávila;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
05 Ávila;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
05 Ávila;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;96,03
05 Ávila;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
05 Ávila;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
05 Ávila;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;91,25
05 Ávila;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
05 Ávila;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
05 Ávila;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
05 Ávila;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;93,4
05 Ávila;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
05 Ávila;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
05 Ávila;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
05 Ávila;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;93,04
05 Ávila;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
05 Ávila;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
05 Ávila;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
05 Ávila;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
05 Ávila;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
05 Ávila;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
05 Ávila;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;90,76
05 Ávila;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
05 Ávila;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
05 Ávila;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
05 Ávila;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;91,2
05 Ávila;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
05 Ávila;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
05 Ávila;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
05 Ávila;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
05 Ávila;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
05 Ávila;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
05 Ávila;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;88,96
05 Ávila;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
05 Ávila;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
05 Ávila;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
05 Ávila;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;88,15
05 Ávila;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
05 Ávila;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
05 Ávila;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
05 Ávila;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
05 Ávila;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
05 Ávila;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
05 Ávila;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QIII;1.037
05 Ávila;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
05 Ávila;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
05 Ávila;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
05 Ávila;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QIII;1.073
05 Ávila;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
05 Ávila;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
05 Ávila;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
05 Ávila;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QIII;1.097
05 Ávila;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
05 Ávila;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
05 Ávila;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
05 Ávila;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2022QIII;992
05 Ávila;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2022QII;""
05 Ávila;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2022QI;""
05 Ávila;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
05 Ávila;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2021QIII;1.043
05 Ávila;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2021QII;""
05 Ávila;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2021QI;""
05 Ávila;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
05 Ávila;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2020QIII;1.057
05 Ávila;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2020QII;""
05 Ávila;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2020QI;""
05 Ávila;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2022QIV;956
05 Ávila;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
05 Ávila;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2022QII;""
05 Ávila;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2022QI;""
05 Ávila;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2021QIV;1.005
05 Ávila;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
05 Ávila;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2021QII;""
05 Ávila;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2021QI;""
05 Ávila;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2020QIV;1.031
05 Ávila;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
05 Ávila;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2020QII;""
05 Ávila;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2020QI;""
05 Ávila;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
05 Ávila;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
05 Ávila;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QII;""
05 Ávila;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QI;982
05 Ávila;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
05 Ávila;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
05 Ávila;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QII;""
05 Ávila;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QI;1.011
05 Ávila;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
05 Ávila;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
05 Ávila;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QII;""
05 Ávila;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QI;""
05 Ávila;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
05 Ávila;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
05 Ávila;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QII;965
05 Ávila;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QI;""
05 Ávila;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
05 Ávila;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
05 Ávila;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QII;981
05 Ávila;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QI;""
05 Ávila;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
05 Ávila;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
05 Ávila;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QII;""
05 Ávila;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QI;""
05 Ávila;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
05 Ávila;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
05 Ávila;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
05 Ávila;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
05 Ávila;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
05 Ávila;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
05 Ávila;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
05 Ávila;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
05 Ávila;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
05 Ávila;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
05 Ávila;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
05 Ávila;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
05 Ávila;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
05 Ávila;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;95,66
05 Ávila;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
05 Ávila;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
05 Ávila;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
05 Ávila;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;97,2
05 Ávila;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
05 Ávila;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
05 Ávila;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
05 Ávila;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;96,35
05 Ávila;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
05 Ávila;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
05 Ávila;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;92,19
05 Ávila;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
05 Ávila;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
05 Ávila;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
05 Ávila;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;93,66
05 Ávila;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
05 Ávila;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
05 Ávila;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
05 Ávila;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;93,98
05 Ávila;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
05 Ávila;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
05 Ávila;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
05 Ávila;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
05 Ávila;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
05 Ávila;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
05 Ávila;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;91,52
05 Ávila;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
05 Ávila;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
05 Ávila;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
05 Ávila;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;92,16
05 Ávila;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
05 Ávila;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
05 Ávila;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
05 Ávila;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
05 Ávila;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
05 Ávila;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
05 Ávila;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;89,93
05 Ávila;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
05 Ávila;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
05 Ávila;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
05 Ávila;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;89,43
05 Ávila;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
05 Ávila;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
05 Ávila;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
05 Ávila;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
05 Ávila;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
05 Ávila;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
05 Ávila;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QIII;608
05 Ávila;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
05 Ávila;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
05 Ávila;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
05 Ávila;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QIII;594
05 Ávila;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
05 Ávila;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
05 Ávila;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
05 Ávila;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QIII;642
05 Ávila;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
05 Ávila;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
05 Ávila;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
05 Ávila;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2022QIII;575
05 Ávila;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2022QII;""
05 Ávila;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2022QI;""
05 Ávila;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
05 Ávila;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2021QIII;569
05 Ávila;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2021QII;""
05 Ávila;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2021QI;""
05 Ávila;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
05 Ávila;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2020QIII;613
05 Ávila;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2020QII;""
05 Ávila;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2020QI;""
05 Ávila;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2022QIV;545
05 Ávila;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
05 Ávila;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2022QII;""
05 Ávila;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2022QI;""
05 Ávila;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2021QIV;552
05 Ávila;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
05 Ávila;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2021QII;""
05 Ávila;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2021QI;""
05 Ávila;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2020QIV;587
05 Ávila;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
05 Ávila;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2020QII;""
05 Ávila;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2020QI;""
05 Ávila;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
05 Ávila;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
05 Ávila;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QII;""
05 Ávila;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QI;531
05 Ávila;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
05 Ávila;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
05 Ávila;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QII;""
05 Ávila;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QI;575
05 Ávila;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
05 Ávila;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
05 Ávila;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QII;""
05 Ávila;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QI;""
05 Ávila;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
05 Ávila;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
05 Ávila;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QII;518
05 Ávila;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QI;""
05 Ávila;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
05 Ávila;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
05 Ávila;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QII;552
05 Ávila;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QI;""
05 Ávila;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
05 Ávila;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
05 Ávila;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QII;""
05 Ávila;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QI;""
05 Ávila;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
05 Ávila;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
05 Ávila;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
05 Ávila;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
05 Ávila;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
05 Ávila;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
05 Ávila;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
05 Ávila;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
05 Ávila;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
05 Ávila;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
05 Ávila;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
05 Ávila;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
05 Ávila;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
05 Ávila;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;94,57
05 Ávila;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
05 Ávila;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
05 Ávila;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
05 Ávila;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;95,79
05 Ávila;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
05 Ávila;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
05 Ávila;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
05 Ávila;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;95,48
05 Ávila;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
05 Ávila;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
05 Ávila;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;89,64
05 Ávila;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
05 Ávila;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
05 Ávila;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
05 Ávila;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;92,93
05 Ávila;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
05 Ávila;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
05 Ávila;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
05 Ávila;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;91,43
05 Ávila;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
05 Ávila;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
05 Ávila;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
05 Ávila;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
05 Ávila;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
05 Ávila;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
05 Ávila;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;89,39
05 Ávila;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
05 Ávila;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
05 Ávila;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
05 Ávila;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;89,56
05 Ávila;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
05 Ávila;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
05 Ávila;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
05 Ávila;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
05 Ávila;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
05 Ávila;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
05 Ávila;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;87,21
05 Ávila;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
05 Ávila;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
05 Ávila;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
05 Ávila;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;85,98
05 Ávila;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
05 Ávila;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
05 Ávila;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
05 Ávila;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
05 Ávila;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
05 Ávila;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QIV;1.620
05 Ávila;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
05 Ávila;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
05 Ávila;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
05 Ávila;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QIV;1.684
05 Ávila;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
05 Ávila;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
05 Ávila;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
05 Ávila;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QIV;1.730
05 Ávila;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
05 Ávila;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
05 Ávila;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
05 Ávila;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2022QIV;1.548
05 Ávila;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
05 Ávila;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2022QII;""
05 Ávila;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2022QI;""
05 Ávila;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2021QIV;1.613
05 Ávila;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
05 Ávila;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2021QII;""
05 Ávila;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2021QI;""
05 Ávila;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2020QIV;1.671
05 Ávila;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
05 Ávila;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2020QII;""
05 Ávila;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2020QI;""
05 Ávila;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
05 Ávila;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
05 Ávila;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2022QII;""
05 Ávila;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2022QI;1.567
05 Ávila;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
05 Ávila;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
05 Ávila;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2021QII;""
05 Ávila;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2021QI;1.636
05 Ávila;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
05 Ávila;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
05 Ávila;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2020QII;""
05 Ávila;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2020QI;""
05 Ávila;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
05 Ávila;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
05 Ávila;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QII;1.530
05 Ávila;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QI;""
05 Ávila;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
05 Ávila;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
05 Ávila;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QII;1.581
05 Ávila;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QI;""
05 Ávila;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
05 Ávila;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
05 Ávila;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QII;""
05 Ávila;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QI;""
05 Ávila;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
05 Ávila;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QIII;1.489
05 Ávila;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QII;""
05 Ávila;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QI;""
05 Ávila;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
05 Ávila;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QIII;1.547
05 Ávila;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QII;""
05 Ávila;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QI;""
05 Ávila;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
05 Ávila;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
05 Ávila;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QII;""
05 Ávila;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QI;""
05 Ávila;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
05 Ávila;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
05 Ávila;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
05 Ávila;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
05 Ávila;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
05 Ávila;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
05 Ávila;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
05 Ávila;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
05 Ávila;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
05 Ávila;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
05 Ávila;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
05 Ávila;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
05 Ávila;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;95,56
05 Ávila;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
05 Ávila;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
05 Ávila;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
05 Ávila;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;95,78
05 Ávila;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
05 Ávila;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
05 Ávila;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
05 Ávila;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;96,59
05 Ávila;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
05 Ávila;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
05 Ávila;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
05 Ávila;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
05 Ávila;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
05 Ávila;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
05 Ávila;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;93,05
05 Ávila;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
05 Ávila;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
05 Ávila;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
05 Ávila;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;94,57
05 Ávila;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
05 Ávila;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
05 Ávila;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
05 Ávila;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
05 Ávila;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
05 Ávila;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
05 Ávila;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;90,86
05 Ávila;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
05 Ávila;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
05 Ávila;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
05 Ávila;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;91,39
05 Ávila;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
05 Ávila;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
05 Ávila;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
05 Ávila;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
05 Ávila;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
05 Ávila;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
05 Ávila;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;88,42
05 Ávila;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
05 Ávila;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
05 Ávila;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
05 Ávila;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;89,42
05 Ávila;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
05 Ávila;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
05 Ávila;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
05 Ávila;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
05 Ávila;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
05 Ávila;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
05 Ávila;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QIV;1.020
05 Ávila;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
05 Ávila;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
05 Ávila;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
05 Ávila;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QIV;1.087
05 Ávila;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
05 Ávila;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
05 Ávila;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
05 Ávila;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QIV;1.093
05 Ávila;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
05 Ávila;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
05 Ávila;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
05 Ávila;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2022QIV;982
05 Ávila;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
05 Ávila;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2022QII;""
05 Ávila;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2022QI;""
05 Ávila;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2021QIV;1.039
05 Ávila;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
05 Ávila;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2021QII;""
05 Ávila;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2021QI;""
05 Ávila;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2020QIV;1.063
05 Ávila;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
05 Ávila;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2020QII;""
05 Ávila;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2020QI;""
05 Ávila;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
05 Ávila;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
05 Ávila;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2022QII;""
05 Ávila;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2022QI;1.015
05 Ávila;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
05 Ávila;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
05 Ávila;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2021QII;""
05 Ávila;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2021QI;1.042
05 Ávila;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
05 Ávila;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
05 Ávila;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2020QII;""
05 Ávila;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2020QI;""
05 Ávila;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
05 Ávila;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
05 Ávila;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QII;993
05 Ávila;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QI;""
05 Ávila;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
05 Ávila;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
05 Ávila;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QII;1.011
05 Ávila;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QI;""
05 Ávila;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
05 Ávila;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
05 Ávila;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QII;""
05 Ávila;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QI;""
05 Ávila;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
05 Ávila;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QIII;966
05 Ávila;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QII;""
05 Ávila;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QI;""
05 Ávila;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
05 Ávila;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QIII;992
05 Ávila;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QII;""
05 Ávila;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QI;""
05 Ávila;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
05 Ávila;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
05 Ávila;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QII;""
05 Ávila;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QI;""
05 Ávila;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
05 Ávila;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
05 Ávila;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
05 Ávila;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
05 Ávila;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
05 Ávila;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
05 Ávila;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
05 Ávila;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
05 Ávila;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
05 Ávila;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
05 Ávila;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
05 Ávila;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
05 Ávila;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;96,27
05 Ávila;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
05 Ávila;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
05 Ávila;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
05 Ávila;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;95,58
05 Ávila;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
05 Ávila;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
05 Ávila;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
05 Ávila;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;97,26
05 Ávila;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
05 Ávila;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
05 Ávila;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
05 Ávila;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
05 Ávila;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
05 Ávila;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
05 Ávila;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;93,38
05 Ávila;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
05 Ávila;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
05 Ávila;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
05 Ávila;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;95,33
05 Ávila;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
05 Ávila;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
05 Ávila;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
05 Ávila;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
05 Ávila;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
05 Ávila;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
05 Ávila;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;91,35
05 Ávila;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
05 Ávila;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
05 Ávila;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
05 Ávila;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;92,5
05 Ávila;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
05 Ávila;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
05 Ávila;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
05 Ávila;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
05 Ávila;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
05 Ávila;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
05 Ávila;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;88,87
05 Ávila;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
05 Ávila;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
05 Ávila;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
05 Ávila;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;90,76
05 Ávila;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
05 Ávila;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
05 Ávila;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
05 Ávila;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
05 Ávila;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
05 Ávila;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
05 Ávila;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QIV;600
05 Ávila;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
05 Ávila;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
05 Ávila;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
05 Ávila;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QIV;597
05 Ávila;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
05 Ávila;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
05 Ávila;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
05 Ávila;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QIV;637
05 Ávila;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
05 Ávila;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
05 Ávila;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
05 Ávila;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2022QIV;566
05 Ávila;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
05 Ávila;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2022QII;""
05 Ávila;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2022QI;""
05 Ávila;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2021QIV;574
05 Ávila;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
05 Ávila;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2021QII;""
05 Ávila;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2021QI;""
05 Ávila;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2020QIV;608
05 Ávila;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
05 Ávila;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2020QII;""
05 Ávila;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2020QI;""
05 Ávila;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
05 Ávila;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
05 Ávila;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2022QII;""
05 Ávila;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2022QI;552
05 Ávila;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
05 Ávila;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
05 Ávila;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2021QII;""
05 Ávila;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2021QI;594
05 Ávila;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
05 Ávila;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
05 Ávila;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2020QII;""
05 Ávila;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2020QI;""
05 Ávila;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
05 Ávila;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
05 Ávila;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QII;537
05 Ávila;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QI;""
05 Ávila;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
05 Ávila;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
05 Ávila;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QII;570
05 Ávila;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QI;""
05 Ávila;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
05 Ávila;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
05 Ávila;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QII;""
05 Ávila;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QI;""
05 Ávila;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
05 Ávila;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QIII;523
05 Ávila;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QII;""
05 Ávila;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QI;""
05 Ávila;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
05 Ávila;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QIII;555
05 Ávila;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QII;""
05 Ávila;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QI;""
05 Ávila;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
05 Ávila;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
05 Ávila;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QII;""
05 Ávila;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QI;""
05 Ávila;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
05 Ávila;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
05 Ávila;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
05 Ávila;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
05 Ávila;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
05 Ávila;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
05 Ávila;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
05 Ávila;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
05 Ávila;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
05 Ávila;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
05 Ávila;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
05 Ávila;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
05 Ávila;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;94,33
05 Ávila;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
05 Ávila;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
05 Ávila;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
05 Ávila;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;96,15
05 Ávila;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
05 Ávila;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
05 Ávila;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
05 Ávila;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;95,45
05 Ávila;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
05 Ávila;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
05 Ávila;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
05 Ávila;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
05 Ávila;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
05 Ávila;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
05 Ávila;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;92,46
05 Ávila;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
05 Ávila;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
05 Ávila;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
05 Ávila;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;93,25
05 Ávila;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
05 Ávila;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
05 Ávila;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
05 Ávila;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
05 Ávila;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
05 Ávila;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
05 Ávila;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;89,95
05 Ávila;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
05 Ávila;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
05 Ávila;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
05 Ávila;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;89,48
05 Ávila;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
05 Ávila;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
05 Ávila;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
05 Ávila;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
05 Ávila;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
05 Ávila;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
05 Ávila;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;87,6
05 Ávila;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
05 Ávila;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
05 Ávila;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
05 Ávila;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;87,13
05 Ávila;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
05 Ávila;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
05 Ávila;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
05 Ávila;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
05 Ávila;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
05 Ávila;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
05 Ávila;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
05 Ávila;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
05 Ávila;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
05 Ávila;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QI;3.119
05 Ávila;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
05 Ávila;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
05 Ávila;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
05 Ávila;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QI;3.148
05 Ávila;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
05 Ávila;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
05 Ávila;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
05 Ávila;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QI;3.181
05 Ávila;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
05 Ávila;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
05 Ávila;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2022QII;""
05 Ávila;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2022QI;3.061
05 Ávila;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
05 Ávila;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
05 Ávila;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2021QII;""
05 Ávila;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2021QI;3.084
05 Ávila;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
05 Ávila;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
05 Ávila;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2020QII;""
05 Ávila;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2020QI;3.034
05 Ávila;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
05 Ávila;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
05 Ávila;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2022QII;2.992
05 Ávila;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2022QI;""
05 Ávila;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
05 Ávila;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
05 Ávila;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2021QII;3.012
05 Ávila;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2021QI;""
05 Ávila;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
05 Ávila;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
05 Ávila;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2020QII;2.977
05 Ávila;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2020QI;""
05 Ávila;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
05 Ávila;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QIII;2.942
05 Ávila;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QII;""
05 Ávila;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QI;""
05 Ávila;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
05 Ávila;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QIII;2.977
05 Ávila;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QII;""
05 Ávila;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QI;""
05 Ávila;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
05 Ávila;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QIII;2.929
05 Ávila;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QII;""
05 Ávila;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QI;""
05 Ávila;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QIV;2.891
05 Ávila;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
05 Ávila;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QII;""
05 Ávila;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QI;""
05 Ávila;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QIV;2.932
05 Ávila;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
05 Ávila;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QII;""
05 Ávila;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QI;""
05 Ávila;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QIV;2.880
05 Ávila;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
05 Ávila;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QII;""
05 Ávila;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QI;""
05 Ávila;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
05 Ávila;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
05 Ávila;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
05 Ávila;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
05 Ávila;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
05 Ávila;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
05 Ávila;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
05 Ávila;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
05 Ávila;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
05 Ávila;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
05 Ávila;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
05 Ávila;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
05 Ávila;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
05 Ávila;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
05 Ávila;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
05 Ávila;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;98,14
05 Ávila;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
05 Ávila;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
05 Ávila;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
05 Ávila;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;97,97
05 Ávila;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
05 Ávila;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
05 Ávila;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
05 Ávila;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;95,38
05 Ávila;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
05 Ávila;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
05 Ávila;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;95,93
05 Ávila;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
05 Ávila;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
05 Ávila;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
05 Ávila;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;95,68
05 Ávila;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
05 Ávila;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
05 Ávila;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
05 Ávila;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;93,59
05 Ávila;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
05 Ávila;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
05 Ávila;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;94,33
05 Ávila;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
05 Ávila;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
05 Ávila;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
05 Ávila;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;94,57
05 Ávila;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
05 Ávila;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
05 Ávila;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
05 Ávila;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;92,08
05 Ávila;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
05 Ávila;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
05 Ávila;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;92,69
05 Ávila;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
05 Ávila;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
05 Ávila;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
05 Ávila;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;93,14
05 Ávila;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
05 Ávila;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
05 Ávila;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
05 Ávila;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;90,54
05 Ávila;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
05 Ávila;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
05 Ávila;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
05 Ávila;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
05 Ávila;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
05 Ávila;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
05 Ávila;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QI;2.069
05 Ávila;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
05 Ávila;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
05 Ávila;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
05 Ávila;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QI;2.121
05 Ávila;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
05 Ávila;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
05 Ávila;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
05 Ávila;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QI;2.137
05 Ávila;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
05 Ávila;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
05 Ávila;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2022QII;""
05 Ávila;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2022QI;2.030
05 Ávila;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
05 Ávila;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
05 Ávila;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2021QII;""
05 Ávila;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2021QI;2.081
05 Ávila;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
05 Ávila;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
05 Ávila;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2020QII;""
05 Ávila;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2020QI;2.057
05 Ávila;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
05 Ávila;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
05 Ávila;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2022QII;1.990
05 Ávila;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2022QI;""
05 Ávila;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
05 Ávila;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
05 Ávila;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2021QII;2.035
05 Ávila;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2021QI;""
05 Ávila;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
05 Ávila;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
05 Ávila;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2020QII;2.021
05 Ávila;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2020QI;""
05 Ávila;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
05 Ávila;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QIII;1.957
05 Ávila;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QII;""
05 Ávila;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QI;""
05 Ávila;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
05 Ávila;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QIII;2.021
05 Ávila;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QII;""
05 Ávila;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QI;""
05 Ávila;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
05 Ávila;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QIII;1.996
05 Ávila;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QII;""
05 Ávila;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QI;""
05 Ávila;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QIV;1.928
05 Ávila;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
05 Ávila;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QII;""
05 Ávila;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QI;""
05 Ávila;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QIV;1.993
05 Ávila;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
05 Ávila;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QII;""
05 Ávila;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QI;""
05 Ávila;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QIV;1.965
05 Ávila;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
05 Ávila;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QII;""
05 Ávila;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QI;""
05 Ávila;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
05 Ávila;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
05 Ávila;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
05 Ávila;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
05 Ávila;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
05 Ávila;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
05 Ávila;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
05 Ávila;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
05 Ávila;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
05 Ávila;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
05 Ávila;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
05 Ávila;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
05 Ávila;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
05 Ávila;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
05 Ávila;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
05 Ávila;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;98,12
05 Ávila;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
05 Ávila;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
05 Ávila;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
05 Ávila;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;98,11
05 Ávila;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
05 Ávila;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
05 Ávila;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
05 Ávila;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;96,26
05 Ávila;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
05 Ávila;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
05 Ávila;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;96,18
05 Ávila;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
05 Ávila;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
05 Ávila;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
05 Ávila;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;95,95
05 Ávila;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
05 Ávila;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
05 Ávila;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
05 Ávila;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;94,57
05 Ávila;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
05 Ávila;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
05 Ávila;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;94,59
05 Ávila;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
05 Ávila;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
05 Ávila;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
05 Ávila;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;95,29
05 Ávila;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
05 Ávila;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
05 Ávila;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
05 Ávila;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;93,4
05 Ávila;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
05 Ávila;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
05 Ávila;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;93,19
05 Ávila;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
05 Ávila;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
05 Ávila;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
05 Ávila;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;93,97
05 Ávila;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
05 Ávila;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
05 Ávila;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
05 Ávila;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;91,95
05 Ávila;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
05 Ávila;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
05 Ávila;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
05 Ávila;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
05 Ávila;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
05 Ávila;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
05 Ávila;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QI;1.050
05 Ávila;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
05 Ávila;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
05 Ávila;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
05 Ávila;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QI;1.027
05 Ávila;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
05 Ávila;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
05 Ávila;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
05 Ávila;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QI;1.044
05 Ávila;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
05 Ávila;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
05 Ávila;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2022QII;""
05 Ávila;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2022QI;1.031
05 Ávila;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
05 Ávila;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
05 Ávila;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2021QII;""
05 Ávila;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2021QI;1.003
05 Ávila;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
05 Ávila;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
05 Ávila;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2020QII;""
05 Ávila;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2020QI;977
05 Ávila;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
05 Ávila;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
05 Ávila;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2022QII;1.002
05 Ávila;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2022QI;""
05 Ávila;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
05 Ávila;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
05 Ávila;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2021QII;977
05 Ávila;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2021QI;""
05 Ávila;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
05 Ávila;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
05 Ávila;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2020QII;956
05 Ávila;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2020QI;""
05 Ávila;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
05 Ávila;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QIII;985
05 Ávila;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QII;""
05 Ávila;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QI;""
05 Ávila;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
05 Ávila;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QIII;956
05 Ávila;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QII;""
05 Ávila;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QI;""
05 Ávila;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
05 Ávila;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QIII;933
05 Ávila;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QII;""
05 Ávila;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QI;""
05 Ávila;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QIV;963
05 Ávila;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
05 Ávila;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QII;""
05 Ávila;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QI;""
05 Ávila;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QIV;939
05 Ávila;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
05 Ávila;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QII;""
05 Ávila;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QI;""
05 Ávila;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QIV;915
05 Ávila;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
05 Ávila;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QII;""
05 Ávila;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QI;""
05 Ávila;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
05 Ávila;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
05 Ávila;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
05 Ávila;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
05 Ávila;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
05 Ávila;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
05 Ávila;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
05 Ávila;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
05 Ávila;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
05 Ávila;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
05 Ávila;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
05 Ávila;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
05 Ávila;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
05 Ávila;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
05 Ávila;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
05 Ávila;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;98,19
05 Ávila;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
05 Ávila;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
05 Ávila;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
05 Ávila;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;97,66
05 Ávila;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
05 Ávila;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
05 Ávila;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
05 Ávila;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;93,58
05 Ávila;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
05 Ávila;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
05 Ávila;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;95,43
05 Ávila;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
05 Ávila;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
05 Ávila;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
05 Ávila;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;95,13
05 Ávila;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
05 Ávila;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
05 Ávila;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
05 Ávila;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;91,57
05 Ávila;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
05 Ávila;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
05 Ávila;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;93,81
05 Ávila;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
05 Ávila;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
05 Ávila;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
05 Ávila;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;93,09
05 Ávila;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
05 Ávila;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
05 Ávila;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
05 Ávila;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;89,37
05 Ávila;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
05 Ávila;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
05 Ávila;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;91,71
05 Ávila;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
05 Ávila;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
05 Ávila;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
05 Ávila;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;91,43
05 Ávila;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
05 Ávila;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
05 Ávila;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
05 Ávila;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;87,64
05 Ávila;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
05 Ávila;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
05 Ávila;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
05 Ávila;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
05 Ávila;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
05 Ávila;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QII;3.013
05 Ávila;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
05 Ávila;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
05 Ávila;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
05 Ávila;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QII;3.064
05 Ávila;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
05 Ávila;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
05 Ávila;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
05 Ávila;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QII;3.113
05 Ávila;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
05 Ávila;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
05 Ávila;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
05 Ávila;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2022QII;2.944
05 Ávila;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2022QI;""
05 Ávila;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
05 Ávila;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
05 Ávila;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2021QII;2.986
05 Ávila;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2021QI;""
05 Ávila;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
05 Ávila;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
05 Ávila;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2020QII;3.053
05 Ávila;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2020QI;""
05 Ávila;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
05 Ávila;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2022QIII;2.890
05 Ávila;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2022QII;""
05 Ávila;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2022QI;""
05 Ávila;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
05 Ávila;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2021QIII;2.946
05 Ávila;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2021QII;""
05 Ávila;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2021QI;""
05 Ávila;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
05 Ávila;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2020QIII;3.001
05 Ávila;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2020QII;""
05 Ávila;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2020QI;""
05 Ávila;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QIV;2.844
05 Ávila;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
05 Ávila;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QII;""
05 Ávila;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QI;""
05 Ávila;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QIV;2.895
05 Ávila;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
05 Ávila;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QII;""
05 Ávila;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QI;""
05 Ávila;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QIV;2.946
05 Ávila;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
05 Ávila;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QII;""
05 Ávila;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QI;""
05 Ávila;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
05 Ávila;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
05 Ávila;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QII;""
05 Ávila;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QI;2.854
05 Ávila;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
05 Ávila;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
05 Ávila;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QII;""
05 Ávila;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QI;2.904
05 Ávila;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
05 Ávila;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
05 Ávila;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QII;""
05 Ávila;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QI;""
05 Ávila;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
05 Ávila;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
05 Ávila;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
05 Ávila;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
05 Ávila;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
05 Ávila;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
05 Ávila;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
05 Ávila;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
05 Ávila;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
05 Ávila;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
05 Ávila;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
05 Ávila;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
05 Ávila;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
05 Ávila;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
05 Ávila;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;97,71
05 Ávila;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
05 Ávila;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
05 Ávila;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
05 Ávila;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;97,45
05 Ávila;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
05 Ávila;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
05 Ávila;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
05 Ávila;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;98,07
05 Ávila;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
05 Ávila;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
05 Ávila;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;95,92
05 Ávila;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
05 Ávila;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
05 Ávila;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
05 Ávila;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;96,15
05 Ávila;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
05 Ávila;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
05 Ávila;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
05 Ávila;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;96,4
05 Ávila;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
05 Ávila;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
05 Ávila;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;94,39
05 Ávila;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
05 Ávila;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
05 Ávila;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
05 Ávila;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;94,48
05 Ávila;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
05 Ávila;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
05 Ávila;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
05 Ávila;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;94,64
05 Ávila;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
05 Ávila;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
05 Ávila;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
05 Ávila;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
05 Ávila;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
05 Ávila;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
05 Ávila;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;93,15
05 Ávila;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
05 Ávila;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
05 Ávila;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
05 Ávila;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;93,29
05 Ávila;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
05 Ávila;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
05 Ávila;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
05 Ávila;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
05 Ávila;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
05 Ávila;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
05 Ávila;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QII;1.988
05 Ávila;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
05 Ávila;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
05 Ávila;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
05 Ávila;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QII;2.040
05 Ávila;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
05 Ávila;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
05 Ávila;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
05 Ávila;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QII;2.101
05 Ávila;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
05 Ávila;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
05 Ávila;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
05 Ávila;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2022QII;1.946
05 Ávila;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2022QI;""
05 Ávila;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
05 Ávila;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
05 Ávila;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2021QII;1.991
05 Ávila;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2021QI;""
05 Ávila;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
05 Ávila;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
05 Ávila;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2020QII;2.064
05 Ávila;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2020QI;""
05 Ávila;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
05 Ávila;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2022QIII;1.912
05 Ávila;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2022QII;""
05 Ávila;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2022QI;""
05 Ávila;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
05 Ávila;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2021QIII;1.971
05 Ávila;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2021QII;""
05 Ávila;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2021QI;""
05 Ávila;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
05 Ávila;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2020QIII;2.036
05 Ávila;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2020QII;""
05 Ávila;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2020QI;""
05 Ávila;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QIV;1.888
05 Ávila;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
05 Ávila;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QII;""
05 Ávila;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QI;""
05 Ávila;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QIV;1.938
05 Ávila;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
05 Ávila;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QII;""
05 Ávila;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QI;""
05 Ávila;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QIV;2.002
05 Ávila;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
05 Ávila;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QII;""
05 Ávila;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QI;""
05 Ávila;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
05 Ávila;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
05 Ávila;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QII;""
05 Ávila;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QI;1.913
05 Ávila;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
05 Ávila;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
05 Ávila;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QII;""
05 Ávila;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QI;1.977
05 Ávila;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
05 Ávila;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
05 Ávila;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QII;""
05 Ávila;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QI;""
05 Ávila;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
05 Ávila;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
05 Ávila;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
05 Ávila;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
05 Ávila;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
05 Ávila;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
05 Ávila;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
05 Ávila;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
05 Ávila;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
05 Ávila;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
05 Ávila;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
05 Ávila;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
05 Ávila;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
05 Ávila;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
05 Ávila;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;97,89
05 Ávila;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
05 Ávila;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
05 Ávila;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
05 Ávila;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;97,6
05 Ávila;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
05 Ávila;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
05 Ávila;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
05 Ávila;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;98,24
05 Ávila;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
05 Ávila;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
05 Ávila;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;96,18
05 Ávila;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
05 Ávila;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
05 Ávila;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
05 Ávila;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;96,62
05 Ávila;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
05 Ávila;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
05 Ávila;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
05 Ávila;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;96,91
05 Ávila;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
05 Ávila;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
05 Ávila;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;94,97
05 Ávila;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
05 Ávila;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
05 Ávila;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
05 Ávila;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;95
05 Ávila;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
05 Ávila;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
05 Ávila;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
05 Ávila;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;95,29
05 Ávila;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
05 Ávila;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
05 Ávila;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
05 Ávila;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
05 Ávila;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
05 Ávila;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
05 Ávila;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;93,77
05 Ávila;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
05 Ávila;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
05 Ávila;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
05 Ávila;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;94,1
05 Ávila;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
05 Ávila;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
05 Ávila;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
05 Ávila;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
05 Ávila;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
05 Ávila;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
05 Ávila;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QII;1.025
05 Ávila;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
05 Ávila;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
05 Ávila;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
05 Ávila;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QII;1.024
05 Ávila;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
05 Ávila;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
05 Ávila;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
05 Ávila;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QII;1.012
05 Ávila;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
05 Ávila;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
05 Ávila;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
05 Ávila;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2022QII;998
05 Ávila;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2022QI;""
05 Ávila;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
05 Ávila;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
05 Ávila;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2021QII;995
05 Ávila;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2021QI;""
05 Ávila;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
05 Ávila;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
05 Ávila;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2020QII;989
05 Ávila;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2020QI;""
05 Ávila;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
05 Ávila;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2022QIII;978
05 Ávila;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2022QII;""
05 Ávila;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2022QI;""
05 Ávila;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
05 Ávila;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2021QIII;975
05 Ávila;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2021QII;""
05 Ávila;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2021QI;""
05 Ávila;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
05 Ávila;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2020QIII;965
05 Ávila;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2020QII;""
05 Ávila;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2020QI;""
05 Ávila;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QIV;956
05 Ávila;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
05 Ávila;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QII;""
05 Ávila;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QI;""
05 Ávila;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QIV;957
05 Ávila;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
05 Ávila;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QII;""
05 Ávila;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QI;""
05 Ávila;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QIV;944
05 Ávila;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
05 Ávila;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QII;""
05 Ávila;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QI;""
05 Ávila;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
05 Ávila;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
05 Ávila;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QII;""
05 Ávila;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QI;941
05 Ávila;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
05 Ávila;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
05 Ávila;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QII;""
05 Ávila;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QI;927
05 Ávila;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
05 Ávila;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
05 Ávila;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QII;""
05 Ávila;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QI;""
05 Ávila;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
05 Ávila;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
05 Ávila;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
05 Ávila;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
05 Ávila;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
05 Ávila;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
05 Ávila;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
05 Ávila;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
05 Ávila;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
05 Ávila;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
05 Ávila;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
05 Ávila;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
05 Ávila;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
05 Ávila;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
05 Ávila;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;97,37
05 Ávila;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
05 Ávila;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
05 Ávila;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
05 Ávila;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;97,17
05 Ávila;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
05 Ávila;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
05 Ávila;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
05 Ávila;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;97,73
05 Ávila;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
05 Ávila;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
05 Ávila;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;95,41
05 Ávila;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
05 Ávila;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
05 Ávila;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
05 Ávila;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;95,21
05 Ávila;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
05 Ávila;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
05 Ávila;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
05 Ávila;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;95,36
05 Ávila;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
05 Ávila;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
05 Ávila;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;93,27
05 Ávila;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
05 Ávila;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
05 Ávila;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
05 Ávila;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;93,46
05 Ávila;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
05 Ávila;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
05 Ávila;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
05 Ávila;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;93,28
05 Ávila;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
05 Ávila;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
05 Ávila;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
05 Ávila;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
05 Ávila;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
05 Ávila;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
05 Ávila;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;91,89
05 Ávila;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
05 Ávila;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
05 Ávila;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
05 Ávila;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;91,6
05 Ávila;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
05 Ávila;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
05 Ávila;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
05 Ávila;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
05 Ávila;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
05 Ávila;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QIII;3.030
05 Ávila;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
05 Ávila;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
05 Ávila;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
05 Ávila;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QIII;3.108
05 Ávila;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
05 Ávila;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
05 Ávila;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
05 Ávila;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QIII;3.126
05 Ávila;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
05 Ávila;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
05 Ávila;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
05 Ávila;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2022QIII;2.964
05 Ávila;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2022QII;""
05 Ávila;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2022QI;""
05 Ávila;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
05 Ávila;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2021QIII;3.048
05 Ávila;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2021QII;""
05 Ávila;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2021QI;""
05 Ávila;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
05 Ávila;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2020QIII;3.063
05 Ávila;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2020QII;""
05 Ávila;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2020QI;""
05 Ávila;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2022QIV;2.904
05 Ávila;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
05 Ávila;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2022QII;""
05 Ávila;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2022QI;""
05 Ávila;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2021QIV;2.987
05 Ávila;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
05 Ávila;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2021QII;""
05 Ávila;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2021QI;""
05 Ávila;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2020QIV;2.997
05 Ávila;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
05 Ávila;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2020QII;""
05 Ávila;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2020QI;""
05 Ávila;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
05 Ávila;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
05 Ávila;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QII;""
05 Ávila;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QI;2.942
05 Ávila;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
05 Ávila;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
05 Ávila;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QII;""
05 Ávila;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QI;2.949
05 Ávila;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
05 Ávila;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
05 Ávila;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QII;""
05 Ávila;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QI;""
05 Ávila;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
05 Ávila;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
05 Ávila;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QII;2.885
05 Ávila;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QI;""
05 Ávila;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
05 Ávila;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
05 Ávila;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QII;2.891
05 Ávila;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QI;""
05 Ávila;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
05 Ávila;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
05 Ávila;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QII;""
05 Ávila;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QI;""
05 Ávila;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
05 Ávila;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
05 Ávila;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
05 Ávila;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
05 Ávila;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
05 Ávila;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
05 Ávila;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
05 Ávila;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
05 Ávila;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
05 Ávila;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
05 Ávila;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
05 Ávila;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
05 Ávila;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
05 Ávila;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;97,82
05 Ávila;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
05 Ávila;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
05 Ávila;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
05 Ávila;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;98,07
05 Ávila;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
05 Ávila;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
05 Ávila;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
05 Ávila;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;97,98
05 Ávila;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
05 Ávila;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
05 Ávila;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;95,84
05 Ávila;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
05 Ávila;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
05 Ávila;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
05 Ávila;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;96,11
05 Ávila;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
05 Ávila;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
05 Ávila;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
05 Ávila;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;95,87
05 Ávila;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
05 Ávila;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
05 Ávila;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
05 Ávila;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
05 Ávila;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
05 Ávila;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
05 Ávila;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;94,66
05 Ávila;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
05 Ávila;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
05 Ávila;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
05 Ávila;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;94,34
05 Ávila;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
05 Ávila;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
05 Ávila;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
05 Ávila;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
05 Ávila;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
05 Ávila;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
05 Ávila;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;92,82
05 Ávila;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
05 Ávila;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
05 Ávila;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
05 Ávila;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;92,48
05 Ávila;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
05 Ávila;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
05 Ávila;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
05 Ávila;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
05 Ávila;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
05 Ávila;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
05 Ávila;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QIII;1.996
05 Ávila;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
05 Ávila;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
05 Ávila;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
05 Ávila;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QIII;2.067
05 Ávila;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
05 Ávila;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
05 Ávila;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
05 Ávila;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QIII;2.111
05 Ávila;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
05 Ávila;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
05 Ávila;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
05 Ávila;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2022QIII;1.954
05 Ávila;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2022QII;""
05 Ávila;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2022QI;""
05 Ávila;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
05 Ávila;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2021QIII;2.033
05 Ávila;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2021QII;""
05 Ávila;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2021QI;""
05 Ávila;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
05 Ávila;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2020QIII;2.073
05 Ávila;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2020QII;""
05 Ávila;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2020QI;""
05 Ávila;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2022QIV;1.923
05 Ávila;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
05 Ávila;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2022QII;""
05 Ávila;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2022QI;""
05 Ávila;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2021QIV;1.994
05 Ávila;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
05 Ávila;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2021QII;""
05 Ávila;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2021QI;""
05 Ávila;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2020QIV;2.033
05 Ávila;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
05 Ávila;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2020QII;""
05 Ávila;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2020QI;""
05 Ávila;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
05 Ávila;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
05 Ávila;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QII;""
05 Ávila;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QI;1.965
05 Ávila;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
05 Ávila;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
05 Ávila;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QII;""
05 Ávila;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QI;2.005
05 Ávila;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
05 Ávila;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
05 Ávila;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QII;""
05 Ávila;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QI;""
05 Ávila;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
05 Ávila;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
05 Ávila;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QII;1.930
05 Ávila;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QI;""
05 Ávila;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
05 Ávila;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
05 Ávila;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QII;1.966
05 Ávila;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QI;""
05 Ávila;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
05 Ávila;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
05 Ávila;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QII;""
05 Ávila;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QI;""
05 Ávila;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
05 Ávila;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
05 Ávila;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
05 Ávila;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
05 Ávila;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
05 Ávila;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
05 Ávila;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
05 Ávila;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
05 Ávila;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
05 Ávila;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
05 Ávila;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
05 Ávila;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
05 Ávila;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
05 Ávila;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;97,9
05 Ávila;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
05 Ávila;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
05 Ávila;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
05 Ávila;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;98,36
05 Ávila;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
05 Ávila;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
05 Ávila;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
05 Ávila;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;98,2
05 Ávila;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
05 Ávila;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
05 Ávila;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;96,34
05 Ávila;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
05 Ávila;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
05 Ávila;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
05 Ávila;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;96,47
05 Ávila;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
05 Ávila;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
05 Ávila;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
05 Ávila;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;96,31
05 Ávila;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
05 Ávila;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
05 Ávila;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
05 Ávila;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
05 Ávila;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
05 Ávila;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
05 Ávila;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;95,07
05 Ávila;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
05 Ávila;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
05 Ávila;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
05 Ávila;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;94,98
05 Ávila;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
05 Ávila;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
05 Ávila;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
05 Ávila;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
05 Ávila;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
05 Ávila;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
05 Ávila;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;93,37
05 Ávila;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
05 Ávila;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
05 Ávila;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
05 Ávila;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;93,13
05 Ávila;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
05 Ávila;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
05 Ávila;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
05 Ávila;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
05 Ávila;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
05 Ávila;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
05 Ávila;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QIII;1.034
05 Ávila;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
05 Ávila;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
05 Ávila;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
05 Ávila;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QIII;1.041
05 Ávila;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
05 Ávila;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
05 Ávila;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
05 Ávila;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QIII;1.015
05 Ávila;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
05 Ávila;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
05 Ávila;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
05 Ávila;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2022QIII;1.010
05 Ávila;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2022QII;""
05 Ávila;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2022QI;""
05 Ávila;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
05 Ávila;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2021QIII;1.015
05 Ávila;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2021QII;""
05 Ávila;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2021QI;""
05 Ávila;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
05 Ávila;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2020QIII;990
05 Ávila;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2020QII;""
05 Ávila;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2020QI;""
05 Ávila;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2022QIV;981
05 Ávila;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
05 Ávila;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2022QII;""
05 Ávila;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2022QI;""
05 Ávila;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2021QIV;993
05 Ávila;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
05 Ávila;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2021QII;""
05 Ávila;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2021QI;""
05 Ávila;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2020QIV;964
05 Ávila;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
05 Ávila;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2020QII;""
05 Ávila;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2020QI;""
05 Ávila;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
05 Ávila;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
05 Ávila;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QII;""
05 Ávila;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QI;977
05 Ávila;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
05 Ávila;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
05 Ávila;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QII;""
05 Ávila;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QI;944
05 Ávila;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
05 Ávila;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
05 Ávila;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QII;""
05 Ávila;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QI;""
05 Ávila;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
05 Ávila;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
05 Ávila;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QII;955
05 Ávila;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QI;""
05 Ávila;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
05 Ávila;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
05 Ávila;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QII;925
05 Ávila;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QI;""
05 Ávila;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
05 Ávila;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
05 Ávila;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QII;""
05 Ávila;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QI;""
05 Ávila;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
05 Ávila;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
05 Ávila;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
05 Ávila;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
05 Ávila;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
05 Ávila;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
05 Ávila;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
05 Ávila;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
05 Ávila;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
05 Ávila;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
05 Ávila;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
05 Ávila;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
05 Ávila;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
05 Ávila;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;97,68
05 Ávila;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
05 Ávila;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
05 Ávila;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
05 Ávila;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;97,5
05 Ávila;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
05 Ávila;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
05 Ávila;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
05 Ávila;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;97,54
05 Ávila;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
05 Ávila;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
05 Ávila;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;94,87
05 Ávila;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
05 Ávila;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
05 Ávila;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
05 Ávila;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;95,39
05 Ávila;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
05 Ávila;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
05 Ávila;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
05 Ávila;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;94,98
05 Ávila;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
05 Ávila;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
05 Ávila;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
05 Ávila;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
05 Ávila;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
05 Ávila;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
05 Ávila;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;93,85
05 Ávila;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
05 Ávila;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
05 Ávila;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
05 Ávila;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;93
05 Ávila;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
05 Ávila;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
05 Ávila;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
05 Ávila;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
05 Ávila;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
05 Ávila;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
05 Ávila;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;91,74
05 Ávila;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
05 Ávila;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
05 Ávila;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
05 Ávila;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;91,13
05 Ávila;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
05 Ávila;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
05 Ávila;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
05 Ávila;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
05 Ávila;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
05 Ávila;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QIV;3.025
05 Ávila;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
05 Ávila;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
05 Ávila;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
05 Ávila;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QIV;3.109
05 Ávila;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
05 Ávila;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
05 Ávila;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
05 Ávila;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QIV;3.139
05 Ávila;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
05 Ávila;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
05 Ávila;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
05 Ávila;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2022QIV;2.957
05 Ávila;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
05 Ávila;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2022QII;""
05 Ávila;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2022QI;""
05 Ávila;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2021QIV;3.037
05 Ávila;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
05 Ávila;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2021QII;""
05 Ávila;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2021QI;""
05 Ávila;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2020QIV;3.064
05 Ávila;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
05 Ávila;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2020QII;""
05 Ávila;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2020QI;""
05 Ávila;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
05 Ávila;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
05 Ávila;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2022QII;""
05 Ávila;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2022QI;2.988
05 Ávila;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
05 Ávila;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
05 Ávila;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2021QII;""
05 Ávila;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2021QI;3.011
05 Ávila;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
05 Ávila;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
05 Ávila;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2020QII;""
05 Ávila;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2020QI;""
05 Ávila;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
05 Ávila;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
05 Ávila;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QII;2.926
05 Ávila;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QI;""
05 Ávila;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
05 Ávila;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
05 Ávila;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QII;2.951
05 Ávila;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QI;""
05 Ávila;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
05 Ávila;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
05 Ávila;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QII;""
05 Ávila;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QI;""
05 Ávila;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
05 Ávila;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QIII;2.884
05 Ávila;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QII;""
05 Ávila;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QI;""
05 Ávila;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
05 Ávila;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QIII;2.919
05 Ávila;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QII;""
05 Ávila;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QI;""
05 Ávila;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
05 Ávila;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
05 Ávila;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QII;""
05 Ávila;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QI;""
05 Ávila;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
05 Ávila;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
05 Ávila;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
05 Ávila;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
05 Ávila;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
05 Ávila;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
05 Ávila;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
05 Ávila;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
05 Ávila;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
05 Ávila;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
05 Ávila;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
05 Ávila;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
05 Ávila;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;97,75
05 Ávila;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
05 Ávila;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
05 Ávila;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
05 Ávila;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;97,68
05 Ávila;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
05 Ávila;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
05 Ávila;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
05 Ávila;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;97,61
05 Ávila;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
05 Ávila;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
05 Ávila;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
05 Ávila;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
05 Ávila;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
05 Ávila;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
05 Ávila;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;96,11
05 Ávila;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
05 Ávila;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
05 Ávila;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
05 Ávila;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;95,92
05 Ávila;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
05 Ávila;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
05 Ávila;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
05 Ávila;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
05 Ávila;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
05 Ávila;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
05 Ávila;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;94,11
05 Ávila;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
05 Ávila;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
05 Ávila;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
05 Ávila;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;94,01
05 Ávila;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
05 Ávila;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
05 Ávila;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
05 Ávila;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
05 Ávila;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
05 Ávila;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
05 Ávila;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;92,76
05 Ávila;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
05 Ávila;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
05 Ávila;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
05 Ávila;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;92,99
05 Ávila;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
05 Ávila;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
05 Ávila;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
05 Ávila;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
05 Ávila;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
05 Ávila;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
05 Ávila;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QIV;1.990
05 Ávila;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
05 Ávila;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
05 Ávila;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
05 Ávila;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QIV;2.065
05 Ávila;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
05 Ávila;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
05 Ávila;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
05 Ávila;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QIV;2.113
05 Ávila;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
05 Ávila;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
05 Ávila;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
05 Ávila;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2022QIV;1.953
05 Ávila;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
05 Ávila;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2022QII;""
05 Ávila;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2022QI;""
05 Ávila;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2021QIV;2.020
05 Ávila;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
05 Ávila;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2021QII;""
05 Ávila;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2021QI;""
05 Ávila;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2020QIV;2.069
05 Ávila;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
05 Ávila;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2020QII;""
05 Ávila;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2020QI;""
05 Ávila;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
05 Ávila;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
05 Ávila;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2022QII;""
05 Ávila;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2022QI;1.987
05 Ávila;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
05 Ávila;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
05 Ávila;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2021QII;""
05 Ávila;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2021QI;2.036
05 Ávila;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
05 Ávila;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
05 Ávila;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2020QII;""
05 Ávila;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2020QI;""
05 Ávila;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
05 Ávila;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
05 Ávila;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QII;1.950
05 Ávila;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QI;""
05 Ávila;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
05 Ávila;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
05 Ávila;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QII;1.996
05 Ávila;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QI;""
05 Ávila;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
05 Ávila;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
05 Ávila;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QII;""
05 Ávila;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QI;""
05 Ávila;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
05 Ávila;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QIII;1.922
05 Ávila;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QII;""
05 Ávila;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QI;""
05 Ávila;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
05 Ávila;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QIII;1.983
05 Ávila;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QII;""
05 Ávila;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QI;""
05 Ávila;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
05 Ávila;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
05 Ávila;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QII;""
05 Ávila;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QI;""
05 Ávila;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
05 Ávila;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
05 Ávila;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
05 Ávila;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
05 Ávila;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
05 Ávila;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
05 Ávila;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
05 Ávila;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
05 Ávila;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
05 Ávila;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
05 Ávila;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
05 Ávila;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
05 Ávila;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;98,14
05 Ávila;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
05 Ávila;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
05 Ávila;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
05 Ávila;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;97,82
05 Ávila;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
05 Ávila;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
05 Ávila;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
05 Ávila;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;97,92
05 Ávila;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
05 Ávila;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
05 Ávila;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
05 Ávila;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
05 Ávila;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
05 Ávila;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
05 Ávila;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;96,22
05 Ávila;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
05 Ávila;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
05 Ávila;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
05 Ávila;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;96,36
05 Ávila;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
05 Ávila;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
05 Ávila;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
05 Ávila;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
05 Ávila;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
05 Ávila;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
05 Ávila;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;94,43
05 Ávila;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
05 Ávila;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
05 Ávila;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
05 Ávila;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;94,46
05 Ávila;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
05 Ávila;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
05 Ávila;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
05 Ávila;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
05 Ávila;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
05 Ávila;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
05 Ávila;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;93,08
05 Ávila;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
05 Ávila;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
05 Ávila;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
05 Ávila;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;93,85
05 Ávila;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
05 Ávila;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
05 Ávila;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
05 Ávila;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
05 Ávila;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
05 Ávila;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
05 Ávila;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QIV;1.035
05 Ávila;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
05 Ávila;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
05 Ávila;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
05 Ávila;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QIV;1.044
05 Ávila;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
05 Ávila;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
05 Ávila;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
05 Ávila;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QIV;1.026
05 Ávila;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
05 Ávila;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
05 Ávila;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
05 Ávila;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2022QIV;1.004
05 Ávila;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
05 Ávila;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2022QII;""
05 Ávila;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2022QI;""
05 Ávila;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2021QIV;1.017
05 Ávila;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
05 Ávila;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2021QII;""
05 Ávila;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2021QI;""
05 Ávila;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2020QIV;995
05 Ávila;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
05 Ávila;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2020QII;""
05 Ávila;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2020QI;""
05 Ávila;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
05 Ávila;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
05 Ávila;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2022QII;""
05 Ávila;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2022QI;1.001
05 Ávila;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
05 Ávila;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
05 Ávila;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2021QII;""
05 Ávila;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2021QI;975
05 Ávila;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
05 Ávila;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
05 Ávila;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2020QII;""
05 Ávila;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2020QI;""
05 Ávila;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
05 Ávila;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
05 Ávila;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QII;976
05 Ávila;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QI;""
05 Ávila;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
05 Ávila;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
05 Ávila;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QII;955
05 Ávila;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QI;""
05 Ávila;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
05 Ávila;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
05 Ávila;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QII;""
05 Ávila;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QI;""
05 Ávila;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
05 Ávila;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QIII;962
05 Ávila;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QII;""
05 Ávila;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QI;""
05 Ávila;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
05 Ávila;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QIII;936
05 Ávila;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QII;""
05 Ávila;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QI;""
05 Ávila;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
05 Ávila;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
05 Ávila;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QII;""
05 Ávila;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QI;""
05 Ávila;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
05 Ávila;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
05 Ávila;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
05 Ávila;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
05 Ávila;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
05 Ávila;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
05 Ávila;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
05 Ávila;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
05 Ávila;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
05 Ávila;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
05 Ávila;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
05 Ávila;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
05 Ávila;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;97
05 Ávila;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
05 Ávila;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
05 Ávila;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
05 Ávila;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;97,41
05 Ávila;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
05 Ávila;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
05 Ávila;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
05 Ávila;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;96,98
05 Ávila;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
05 Ávila;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
05 Ávila;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
05 Ávila;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
05 Ávila;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
05 Ávila;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
05 Ávila;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;95,88
05 Ávila;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
05 Ávila;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
05 Ávila;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
05 Ávila;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;95,03
05 Ávila;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
05 Ávila;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
05 Ávila;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
05 Ávila;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
05 Ávila;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
05 Ávila;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
05 Ávila;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;93,49
05 Ávila;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
05 Ávila;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
05 Ávila;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
05 Ávila;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;93,08
05 Ávila;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
05 Ávila;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
05 Ávila;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
05 Ávila;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
05 Ávila;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
05 Ávila;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
05 Ávila;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;92,15
05 Ávila;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
05 Ávila;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
05 Ávila;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
05 Ávila;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;91,23
05 Ávila;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
05 Ávila;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
05 Ávila;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
05 Ávila;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
05 Ávila;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
05 Ávila;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
05 Ávila;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
05 Ávila;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
05 Ávila;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
05 Ávila;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QI;3.418
05 Ávila;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
05 Ávila;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
05 Ávila;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
05 Ávila;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QI;3.456
05 Ávila;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
05 Ávila;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
05 Ávila;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
05 Ávila;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QI;3.513
05 Ávila;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
05 Ávila;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
05 Ávila;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2022QII;""
05 Ávila;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2022QI;3.362
05 Ávila;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
05 Ávila;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
05 Ávila;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2021QII;""
05 Ávila;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2021QI;3.409
05 Ávila;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
05 Ávila;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
05 Ávila;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2020QII;""
05 Ávila;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2020QI;3.389
05 Ávila;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
05 Ávila;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
05 Ávila;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2022QII;3.306
05 Ávila;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2022QI;""
05 Ávila;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
05 Ávila;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
05 Ávila;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2021QII;3.363
05 Ávila;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2021QI;""
05 Ávila;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
05 Ávila;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
05 Ávila;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2020QII;3.354
05 Ávila;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2020QI;""
05 Ávila;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
05 Ávila;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QIII;3.258
05 Ávila;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QII;""
05 Ávila;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QI;""
05 Ávila;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
05 Ávila;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QIII;3.316
05 Ávila;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QII;""
05 Ávila;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QI;""
05 Ávila;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
05 Ávila;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QIII;3.321
05 Ávila;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QII;""
05 Ávila;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QI;""
05 Ávila;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QIV;3.197
05 Ávila;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
05 Ávila;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QII;""
05 Ávila;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QI;""
05 Ávila;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QIV;3.252
05 Ávila;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
05 Ávila;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QII;""
05 Ávila;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QI;""
05 Ávila;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QIV;3.269
05 Ávila;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
05 Ávila;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QII;""
05 Ávila;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QI;""
05 Ávila;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
05 Ávila;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
05 Ávila;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
05 Ávila;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
05 Ávila;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
05 Ávila;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
05 Ávila;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
05 Ávila;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
05 Ávila;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
05 Ávila;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
05 Ávila;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
05 Ávila;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
05 Ávila;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
05 Ávila;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
05 Ávila;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
05 Ávila;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;98,36
05 Ávila;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
05 Ávila;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
05 Ávila;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
05 Ávila;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;98,64
05 Ávila;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
05 Ávila;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
05 Ávila;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
05 Ávila;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;96,47
05 Ávila;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
05 Ávila;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
05 Ávila;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;96,72
05 Ávila;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
05 Ávila;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
05 Ávila;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
05 Ávila;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;97,31
05 Ávila;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
05 Ávila;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
05 Ávila;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
05 Ávila;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;95,47
05 Ávila;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
05 Ávila;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
05 Ávila;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;95,32
05 Ávila;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
05 Ávila;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
05 Ávila;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
05 Ávila;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;95,95
05 Ávila;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
05 Ávila;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
05 Ávila;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
05 Ávila;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;94,53
05 Ávila;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
05 Ávila;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
05 Ávila;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;93,53
05 Ávila;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
05 Ávila;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
05 Ávila;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
05 Ávila;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;94,1
05 Ávila;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
05 Ávila;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
05 Ávila;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
05 Ávila;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;93,05
05 Ávila;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
05 Ávila;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
05 Ávila;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
05 Ávila;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
05 Ávila;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
05 Ávila;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
05 Ávila;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QI;2.235
05 Ávila;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
05 Ávila;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
05 Ávila;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
05 Ávila;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QI;2.270
05 Ávila;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
05 Ávila;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
05 Ávila;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
05 Ávila;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QI;2.308
05 Ávila;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
05 Ávila;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
05 Ávila;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2022QII;""
05 Ávila;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2022QI;2.197
05 Ávila;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
05 Ávila;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
05 Ávila;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2021QII;""
05 Ávila;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2021QI;2.240
05 Ávila;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
05 Ávila;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
05 Ávila;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2020QII;""
05 Ávila;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2020QI;2.229
05 Ávila;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
05 Ávila;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
05 Ávila;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2022QII;2.170
05 Ávila;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2022QI;""
05 Ávila;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
05 Ávila;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
05 Ávila;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2021QII;2.212
05 Ávila;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2021QI;""
05 Ávila;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
05 Ávila;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
05 Ávila;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2020QII;2.206
05 Ávila;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2020QI;""
05 Ávila;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
05 Ávila;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QIII;2.146
05 Ávila;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QII;""
05 Ávila;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QI;""
05 Ávila;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
05 Ávila;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QIII;2.181
05 Ávila;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QII;""
05 Ávila;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QI;""
05 Ávila;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
05 Ávila;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QIII;2.191
05 Ávila;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QII;""
05 Ávila;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QI;""
05 Ávila;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QIV;2.117
05 Ávila;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
05 Ávila;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QII;""
05 Ávila;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QI;""
05 Ávila;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QIV;2.145
05 Ávila;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
05 Ávila;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QII;""
05 Ávila;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QI;""
05 Ávila;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QIV;2.162
05 Ávila;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
05 Ávila;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QII;""
05 Ávila;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QI;""
05 Ávila;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
05 Ávila;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
05 Ávila;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
05 Ávila;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
05 Ávila;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
05 Ávila;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
05 Ávila;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
05 Ávila;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
05 Ávila;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
05 Ávila;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
05 Ávila;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
05 Ávila;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
05 Ávila;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
05 Ávila;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
05 Ávila;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
05 Ávila;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;98,3
05 Ávila;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
05 Ávila;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
05 Ávila;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
05 Ávila;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;98,68
05 Ávila;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
05 Ávila;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
05 Ávila;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
05 Ávila;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;96,58
05 Ávila;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
05 Ávila;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
05 Ávila;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;97,09
05 Ávila;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
05 Ávila;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
05 Ávila;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
05 Ávila;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;97,44
05 Ávila;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
05 Ávila;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
05 Ávila;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
05 Ávila;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;95,58
05 Ávila;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
05 Ávila;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
05 Ávila;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;96,02
05 Ávila;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
05 Ávila;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
05 Ávila;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
05 Ávila;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;96,08
05 Ávila;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
05 Ávila;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
05 Ávila;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
05 Ávila;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;94,93
05 Ávila;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
05 Ávila;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
05 Ávila;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;94,72
05 Ávila;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
05 Ávila;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
05 Ávila;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
05 Ávila;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;94,49
05 Ávila;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
05 Ávila;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
05 Ávila;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
05 Ávila;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;93,67
05 Ávila;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
05 Ávila;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
05 Ávila;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
05 Ávila;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
05 Ávila;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
05 Ávila;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
05 Ávila;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QI;1.183
05 Ávila;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
05 Ávila;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
05 Ávila;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
05 Ávila;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QI;1.186
05 Ávila;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
05 Ávila;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
05 Ávila;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
05 Ávila;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QI;1.205
05 Ávila;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
05 Ávila;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
05 Ávila;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2022QII;""
05 Ávila;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2022QI;1.165
05 Ávila;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
05 Ávila;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
05 Ávila;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2021QII;""
05 Ávila;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2021QI;1.169
05 Ávila;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
05 Ávila;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
05 Ávila;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2020QII;""
05 Ávila;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2020QI;1.160
05 Ávila;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
05 Ávila;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
05 Ávila;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2022QII;1.136
05 Ávila;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2022QI;""
05 Ávila;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
05 Ávila;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
05 Ávila;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2021QII;1.151
05 Ávila;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2021QI;""
05 Ávila;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
05 Ávila;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
05 Ávila;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2020QII;1.148
05 Ávila;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2020QI;""
05 Ávila;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
05 Ávila;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QIII;1.112
05 Ávila;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QII;""
05 Ávila;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QI;""
05 Ávila;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
05 Ávila;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QIII;1.135
05 Ávila;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QII;""
05 Ávila;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QI;""
05 Ávila;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
05 Ávila;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QIII;1.130
05 Ávila;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QII;""
05 Ávila;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QI;""
05 Ávila;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QIV;1.080
05 Ávila;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
05 Ávila;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QII;""
05 Ávila;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QI;""
05 Ávila;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QIV;1.107
05 Ávila;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
05 Ávila;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QII;""
05 Ávila;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QI;""
05 Ávila;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QIV;1.107
05 Ávila;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
05 Ávila;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QII;""
05 Ávila;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QI;""
05 Ávila;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
05 Ávila;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
05 Ávila;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
05 Ávila;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
05 Ávila;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
05 Ávila;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
05 Ávila;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
05 Ávila;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
05 Ávila;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
05 Ávila;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
05 Ávila;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
05 Ávila;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
05 Ávila;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
05 Ávila;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
05 Ávila;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
05 Ávila;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;98,48
05 Ávila;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
05 Ávila;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
05 Ávila;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
05 Ávila;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;98,57
05 Ávila;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
05 Ávila;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
05 Ávila;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
05 Ávila;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;96,27
05 Ávila;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
05 Ávila;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
05 Ávila;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;96,03
05 Ávila;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
05 Ávila;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
05 Ávila;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
05 Ávila;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;97,05
05 Ávila;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
05 Ávila;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
05 Ávila;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
05 Ávila;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;95,27
05 Ávila;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
05 Ávila;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
05 Ávila;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;94
05 Ávila;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
05 Ávila;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
05 Ávila;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
05 Ávila;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;95,7
05 Ávila;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
05 Ávila;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
05 Ávila;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
05 Ávila;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;93,78
05 Ávila;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
05 Ávila;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
05 Ávila;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;91,29
05 Ávila;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
05 Ávila;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
05 Ávila;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
05 Ávila;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;93,34
05 Ávila;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
05 Ávila;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
05 Ávila;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
05 Ávila;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;91,87
05 Ávila;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
05 Ávila;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
05 Ávila;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
05 Ávila;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
05 Ávila;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
05 Ávila;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QII;3.434
05 Ávila;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
05 Ávila;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
05 Ávila;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
05 Ávila;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QII;3.435
05 Ávila;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
05 Ávila;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
05 Ávila;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
05 Ávila;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QII;3.461
05 Ávila;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
05 Ávila;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
05 Ávila;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
05 Ávila;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2022QII;3.366
05 Ávila;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2022QI;""
05 Ávila;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
05 Ávila;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
05 Ávila;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2021QII;3.384
05 Ávila;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2021QI;""
05 Ávila;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
05 Ávila;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
05 Ávila;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2020QII;3.423
05 Ávila;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2020QI;""
05 Ávila;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
05 Ávila;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2022QIII;3.312
05 Ávila;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2022QII;""
05 Ávila;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2022QI;""
05 Ávila;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
05 Ávila;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2021QIII;3.336
05 Ávila;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2021QII;""
05 Ávila;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2021QI;""
05 Ávila;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
05 Ávila;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2020QIII;3.378
05 Ávila;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2020QII;""
05 Ávila;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2020QI;""
05 Ávila;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QIV;3.237
05 Ávila;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
05 Ávila;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QII;""
05 Ávila;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QI;""
05 Ávila;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QIV;3.274
05 Ávila;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
05 Ávila;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QII;""
05 Ávila;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QI;""
05 Ávila;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QIV;3.323
05 Ávila;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
05 Ávila;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QII;""
05 Ávila;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QI;""
05 Ávila;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
05 Ávila;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
05 Ávila;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QII;""
05 Ávila;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QI;3.232
05 Ávila;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
05 Ávila;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
05 Ávila;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QII;""
05 Ávila;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QI;3.285
05 Ávila;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
05 Ávila;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
05 Ávila;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QII;""
05 Ávila;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QI;""
05 Ávila;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
05 Ávila;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
05 Ávila;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
05 Ávila;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
05 Ávila;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
05 Ávila;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
05 Ávila;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
05 Ávila;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
05 Ávila;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
05 Ávila;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
05 Ávila;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
05 Ávila;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
05 Ávila;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
05 Ávila;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
05 Ávila;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;98,02
05 Ávila;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
05 Ávila;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
05 Ávila;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
05 Ávila;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;98,52
05 Ávila;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
05 Ávila;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
05 Ávila;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
05 Ávila;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;98,9
05 Ávila;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
05 Ávila;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
05 Ávila;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;96,45
05 Ávila;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
05 Ávila;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
05 Ávila;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
05 Ávila;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;97,12
05 Ávila;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
05 Ávila;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
05 Ávila;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
05 Ávila;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;97,6
05 Ávila;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
05 Ávila;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
05 Ávila;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;94,26
05 Ávila;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
05 Ávila;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
05 Ávila;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
05 Ávila;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;95,31
05 Ávila;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
05 Ávila;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
05 Ávila;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
05 Ávila;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;96,01
05 Ávila;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
05 Ávila;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
05 Ávila;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
05 Ávila;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
05 Ávila;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
05 Ávila;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
05 Ávila;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;94,09
05 Ávila;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
05 Ávila;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
05 Ávila;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
05 Ávila;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;94,91
05 Ávila;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
05 Ávila;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
05 Ávila;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
05 Ávila;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
05 Ávila;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
05 Ávila;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
05 Ávila;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QII;2.248
05 Ávila;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
05 Ávila;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
05 Ávila;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
05 Ávila;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QII;2.255
05 Ávila;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
05 Ávila;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
05 Ávila;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
05 Ávila;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QII;2.273
05 Ávila;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
05 Ávila;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
05 Ávila;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
05 Ávila;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2022QII;2.214
05 Ávila;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2022QI;""
05 Ávila;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
05 Ávila;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
05 Ávila;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2021QII;2.222
05 Ávila;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2021QI;""
05 Ávila;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
05 Ávila;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
05 Ávila;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2020QII;2.248
05 Ávila;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2020QI;""
05 Ávila;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
05 Ávila;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2022QIII;2.184
05 Ávila;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2022QII;""
05 Ávila;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2022QI;""
05 Ávila;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
05 Ávila;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2021QIII;2.193
05 Ávila;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2021QII;""
05 Ávila;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2021QI;""
05 Ávila;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
05 Ávila;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2020QIII;2.223
05 Ávila;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2020QII;""
05 Ávila;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2020QI;""
05 Ávila;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QIV;2.143
05 Ávila;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
05 Ávila;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QII;""
05 Ávila;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QI;""
05 Ávila;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QIV;2.158
05 Ávila;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
05 Ávila;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QII;""
05 Ávila;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QI;""
05 Ávila;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QIV;2.193
05 Ávila;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
05 Ávila;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QII;""
05 Ávila;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QI;""
05 Ávila;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
05 Ávila;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
05 Ávila;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QII;""
05 Ávila;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QI;2.129
05 Ávila;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
05 Ávila;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
05 Ávila;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QII;""
05 Ávila;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QI;2.168
05 Ávila;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
05 Ávila;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
05 Ávila;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QII;""
05 Ávila;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QI;""
05 Ávila;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
05 Ávila;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
05 Ávila;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
05 Ávila;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
05 Ávila;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
05 Ávila;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
05 Ávila;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
05 Ávila;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
05 Ávila;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
05 Ávila;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
05 Ávila;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
05 Ávila;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
05 Ávila;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
05 Ávila;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
05 Ávila;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;98,49
05 Ávila;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
05 Ávila;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
05 Ávila;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
05 Ávila;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;98,54
05 Ávila;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
05 Ávila;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
05 Ávila;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
05 Ávila;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;98,9
05 Ávila;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
05 Ávila;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
05 Ávila;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;97,15
05 Ávila;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
05 Ávila;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
05 Ávila;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
05 Ávila;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;97,25
05 Ávila;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
05 Ávila;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
05 Ávila;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
05 Ávila;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;97,8
05 Ávila;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
05 Ávila;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
05 Ávila;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;95,33
05 Ávila;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
05 Ávila;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
05 Ávila;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
05 Ávila;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;95,7
05 Ávila;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
05 Ávila;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
05 Ávila;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
05 Ávila;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;96,48
05 Ávila;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
05 Ávila;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
05 Ávila;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
05 Ávila;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
05 Ávila;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
05 Ávila;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
05 Ávila;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;94,41
05 Ávila;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
05 Ávila;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
05 Ávila;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
05 Ávila;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;95,38
05 Ávila;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
05 Ávila;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
05 Ávila;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
05 Ávila;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
05 Ávila;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
05 Ávila;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
05 Ávila;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QII;1.186
05 Ávila;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
05 Ávila;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
05 Ávila;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
05 Ávila;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QII;1.180
05 Ávila;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
05 Ávila;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
05 Ávila;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
05 Ávila;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QII;1.188
05 Ávila;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
05 Ávila;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
05 Ávila;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
05 Ávila;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2022QII;1.152
05 Ávila;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2022QI;""
05 Ávila;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
05 Ávila;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
05 Ávila;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2021QII;1.162
05 Ávila;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2021QI;""
05 Ávila;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
05 Ávila;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
05 Ávila;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2020QII;1.175
05 Ávila;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2020QI;""
05 Ávila;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
05 Ávila;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2022QIII;1.128
05 Ávila;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2022QII;""
05 Ávila;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2022QI;""
05 Ávila;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
05 Ávila;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2021QIII;1.143
05 Ávila;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2021QII;""
05 Ávila;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2021QI;""
05 Ávila;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
05 Ávila;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2020QIII;1.155
05 Ávila;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2020QII;""
05 Ávila;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2020QI;""
05 Ávila;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QIV;1.094
05 Ávila;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
05 Ávila;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QII;""
05 Ávila;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QI;""
05 Ávila;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QIV;1.116
05 Ávila;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
05 Ávila;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QII;""
05 Ávila;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QI;""
05 Ávila;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QIV;1.130
05 Ávila;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
05 Ávila;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QII;""
05 Ávila;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QI;""
05 Ávila;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
05 Ávila;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
05 Ávila;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QII;""
05 Ávila;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QI;1.103
05 Ávila;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
05 Ávila;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
05 Ávila;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QII;""
05 Ávila;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QI;1.117
05 Ávila;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
05 Ávila;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
05 Ávila;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QII;""
05 Ávila;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QI;""
05 Ávila;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
05 Ávila;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
05 Ávila;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
05 Ávila;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
05 Ávila;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
05 Ávila;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
05 Ávila;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
05 Ávila;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
05 Ávila;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
05 Ávila;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
05 Ávila;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
05 Ávila;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
05 Ávila;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
05 Ávila;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
05 Ávila;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;97,13
05 Ávila;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
05 Ávila;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
05 Ávila;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
05 Ávila;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;98,47
05 Ávila;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
05 Ávila;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
05 Ávila;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
05 Ávila;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;98,91
05 Ávila;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
05 Ávila;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
05 Ávila;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;95,11
05 Ávila;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
05 Ávila;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
05 Ávila;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
05 Ávila;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;96,86
05 Ávila;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
05 Ávila;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
05 Ávila;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
05 Ávila;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;97,22
05 Ávila;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
05 Ávila;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
05 Ávila;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;92,24
05 Ávila;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
05 Ávila;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
05 Ávila;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
05 Ávila;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;94,58
05 Ávila;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
05 Ávila;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
05 Ávila;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
05 Ávila;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;95,12
05 Ávila;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
05 Ávila;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
05 Ávila;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
05 Ávila;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
05 Ávila;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
05 Ávila;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
05 Ávila;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;93,47
05 Ávila;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
05 Ávila;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
05 Ávila;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
05 Ávila;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;94,02
05 Ávila;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
05 Ávila;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
05 Ávila;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
05 Ávila;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
05 Ávila;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
05 Ávila;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QIII;3.436
05 Ávila;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
05 Ávila;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
05 Ávila;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
05 Ávila;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QIII;3.462
05 Ávila;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
05 Ávila;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
05 Ávila;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
05 Ávila;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QIII;3.471
05 Ávila;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
05 Ávila;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
05 Ávila;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
05 Ávila;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2022QIII;3.364
05 Ávila;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2022QII;""
05 Ávila;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2022QI;""
05 Ávila;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
05 Ávila;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2021QIII;3.392
05 Ávila;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2021QII;""
05 Ávila;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2021QI;""
05 Ávila;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
05 Ávila;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2020QIII;3.421
05 Ávila;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2020QII;""
05 Ávila;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2020QI;""
05 Ávila;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2022QIV;3.284
05 Ávila;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
05 Ávila;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2022QII;""
05 Ávila;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2022QI;""
05 Ávila;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2021QIV;3.325
05 Ávila;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
05 Ávila;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2021QII;""
05 Ávila;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2021QI;""
05 Ávila;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2020QIV;3.360
05 Ávila;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
05 Ávila;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2020QII;""
05 Ávila;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2020QI;""
05 Ávila;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
05 Ávila;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
05 Ávila;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QII;""
05 Ávila;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QI;3.280
05 Ávila;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
05 Ávila;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
05 Ávila;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QII;""
05 Ávila;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QI;3.319
05 Ávila;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
05 Ávila;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
05 Ávila;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QII;""
05 Ávila;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QI;""
05 Ávila;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
05 Ávila;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
05 Ávila;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QII;3.234
05 Ávila;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QI;""
05 Ávila;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
05 Ávila;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
05 Ávila;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QII;3.279
05 Ávila;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QI;""
05 Ávila;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
05 Ávila;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
05 Ávila;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QII;""
05 Ávila;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QI;""
05 Ávila;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
05 Ávila;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
05 Ávila;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
05 Ávila;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
05 Ávila;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
05 Ávila;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
05 Ávila;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
05 Ávila;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
05 Ávila;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
05 Ávila;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
05 Ávila;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
05 Ávila;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
05 Ávila;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
05 Ávila;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;97,9
05 Ávila;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
05 Ávila;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
05 Ávila;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
05 Ávila;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;97,98
05 Ávila;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
05 Ávila;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
05 Ávila;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
05 Ávila;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;98,56
05 Ávila;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
05 Ávila;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
05 Ávila;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;95,58
05 Ávila;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
05 Ávila;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
05 Ávila;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
05 Ávila;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;96,04
05 Ávila;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
05 Ávila;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
05 Ávila;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
05 Ávila;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;96,8
05 Ávila;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
05 Ávila;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
05 Ávila;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
05 Ávila;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
05 Ávila;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
05 Ávila;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
05 Ávila;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;94,74
05 Ávila;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
05 Ávila;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
05 Ávila;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
05 Ávila;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;95,62
05 Ávila;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
05 Ávila;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
05 Ávila;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
05 Ávila;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
05 Ávila;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
05 Ávila;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
05 Ávila;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;93,41
05 Ávila;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
05 Ávila;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
05 Ávila;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
05 Ávila;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;94,47
05 Ávila;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
05 Ávila;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
05 Ávila;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
05 Ávila;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
05 Ávila;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
05 Ávila;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
05 Ávila;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QIII;2.251
05 Ávila;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
05 Ávila;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
05 Ávila;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
05 Ávila;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QIII;2.264
05 Ávila;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
05 Ávila;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
05 Ávila;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
05 Ávila;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QIII;2.278
05 Ávila;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
05 Ávila;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
05 Ávila;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
05 Ávila;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2022QIII;2.212
05 Ávila;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2022QII;""
05 Ávila;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2022QI;""
05 Ávila;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
05 Ávila;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2021QIII;2.224
05 Ávila;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2021QII;""
05 Ávila;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2021QI;""
05 Ávila;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
05 Ávila;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2020QIII;2.251
05 Ávila;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2020QII;""
05 Ávila;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2020QI;""
05 Ávila;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2022QIV;2.170
05 Ávila;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
05 Ávila;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2022QII;""
05 Ávila;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2022QI;""
05 Ávila;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2021QIV;2.187
05 Ávila;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
05 Ávila;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2021QII;""
05 Ávila;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2021QI;""
05 Ávila;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2020QIV;2.219
05 Ávila;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
05 Ávila;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2020QII;""
05 Ávila;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2020QI;""
05 Ávila;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
05 Ávila;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
05 Ávila;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QII;""
05 Ávila;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QI;2.156
05 Ávila;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
05 Ávila;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
05 Ávila;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QII;""
05 Ávila;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QI;2.193
05 Ávila;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
05 Ávila;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
05 Ávila;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QII;""
05 Ávila;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QI;""
05 Ávila;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
05 Ávila;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
05 Ávila;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QII;2.135
05 Ávila;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QI;""
05 Ávila;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
05 Ávila;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
05 Ávila;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QII;2.169
05 Ávila;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QI;""
05 Ávila;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
05 Ávila;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
05 Ávila;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QII;""
05 Ávila;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QI;""
05 Ávila;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
05 Ávila;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
05 Ávila;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
05 Ávila;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
05 Ávila;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
05 Ávila;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
05 Ávila;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
05 Ávila;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
05 Ávila;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
05 Ávila;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
05 Ávila;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
05 Ávila;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
05 Ávila;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
05 Ávila;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;98,27
05 Ávila;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
05 Ávila;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
05 Ávila;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
05 Ávila;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;98,23
05 Ávila;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
05 Ávila;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
05 Ávila;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
05 Ávila;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;98,81
05 Ávila;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
05 Ávila;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
05 Ávila;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;96,4
05 Ávila;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
05 Ávila;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
05 Ávila;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
05 Ávila;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;96,6
05 Ávila;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
05 Ávila;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
05 Ávila;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
05 Ávila;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;97,41
05 Ávila;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
05 Ávila;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
05 Ávila;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
05 Ávila;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
05 Ávila;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
05 Ávila;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
05 Ávila;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;95,23
05 Ávila;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
05 Ávila;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
05 Ávila;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
05 Ávila;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;96,27
05 Ávila;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
05 Ávila;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
05 Ávila;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
05 Ávila;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
05 Ávila;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
05 Ávila;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
05 Ávila;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;94,3
05 Ávila;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
05 Ávila;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
05 Ávila;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
05 Ávila;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;95,22
05 Ávila;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
05 Ávila;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
05 Ávila;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
05 Ávila;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
05 Ávila;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
05 Ávila;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
05 Ávila;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QIII;1.185
05 Ávila;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
05 Ávila;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
05 Ávila;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
05 Ávila;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QIII;1.198
05 Ávila;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
05 Ávila;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
05 Ávila;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
05 Ávila;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QIII;1.193
05 Ávila;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
05 Ávila;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
05 Ávila;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
05 Ávila;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2022QIII;1.152
05 Ávila;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2022QII;""
05 Ávila;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2022QI;""
05 Ávila;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
05 Ávila;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2021QIII;1.168
05 Ávila;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2021QII;""
05 Ávila;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2021QI;""
05 Ávila;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
05 Ávila;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2020QIII;1.170
05 Ávila;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2020QII;""
05 Ávila;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2020QI;""
05 Ávila;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2022QIV;1.114
05 Ávila;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
05 Ávila;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2022QII;""
05 Ávila;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2022QI;""
05 Ávila;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2021QIV;1.138
05 Ávila;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
05 Ávila;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2021QII;""
05 Ávila;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2021QI;""
05 Ávila;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2020QIV;1.141
05 Ávila;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
05 Ávila;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2020QII;""
05 Ávila;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2020QI;""
05 Ávila;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
05 Ávila;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
05 Ávila;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QII;""
05 Ávila;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QI;1.124
05 Ávila;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
05 Ávila;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
05 Ávila;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QII;""
05 Ávila;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QI;1.126
05 Ávila;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
05 Ávila;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
05 Ávila;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QII;""
05 Ávila;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QI;""
05 Ávila;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
05 Ávila;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
05 Ávila;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QII;1.099
05 Ávila;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QI;""
05 Ávila;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
05 Ávila;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
05 Ávila;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QII;1.110
05 Ávila;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QI;""
05 Ávila;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
05 Ávila;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
05 Ávila;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QII;""
05 Ávila;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QI;""
05 Ávila;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
05 Ávila;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
05 Ávila;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
05 Ávila;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
05 Ávila;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
05 Ávila;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
05 Ávila;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
05 Ávila;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
05 Ávila;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
05 Ávila;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
05 Ávila;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
05 Ávila;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
05 Ávila;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
05 Ávila;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;97,22
05 Ávila;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
05 Ávila;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
05 Ávila;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
05 Ávila;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;97,5
05 Ávila;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
05 Ávila;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
05 Ávila;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
05 Ávila;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;98,07
05 Ávila;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
05 Ávila;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
05 Ávila;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;94,01
05 Ávila;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
05 Ávila;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
05 Ávila;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
05 Ávila;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;94,99
05 Ávila;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
05 Ávila;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
05 Ávila;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
05 Ávila;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;95,64
05 Ávila;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
05 Ávila;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
05 Ávila;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
05 Ávila;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
05 Ávila;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
05 Ávila;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
05 Ávila;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;93,82
05 Ávila;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
05 Ávila;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
05 Ávila;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
05 Ávila;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;94,38
05 Ávila;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
05 Ávila;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
05 Ávila;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
05 Ávila;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
05 Ávila;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
05 Ávila;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
05 Ávila;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;91,74
05 Ávila;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
05 Ávila;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
05 Ávila;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
05 Ávila;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;93,04
05 Ávila;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
05 Ávila;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
05 Ávila;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
05 Ávila;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
05 Ávila;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
05 Ávila;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QIV;3.405
05 Ávila;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
05 Ávila;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
05 Ávila;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
05 Ávila;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QIV;3.445
05 Ávila;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
05 Ávila;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
05 Ávila;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
05 Ávila;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QIV;3.493
05 Ávila;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
05 Ávila;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
05 Ávila;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
05 Ávila;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2022QIV;3.319
05 Ávila;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
05 Ávila;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2022QII;""
05 Ávila;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2022QI;""
05 Ávila;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2021QIV;3.370
05 Ávila;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
05 Ávila;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2021QII;""
05 Ávila;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2021QI;""
05 Ávila;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2020QIV;3.418
05 Ávila;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
05 Ávila;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2020QII;""
05 Ávila;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2020QI;""
05 Ávila;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
05 Ávila;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
05 Ávila;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2022QII;""
05 Ávila;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2022QI;3.320
05 Ávila;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
05 Ávila;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
05 Ávila;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2021QII;""
05 Ávila;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2021QI;3.374
05 Ávila;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
05 Ávila;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
05 Ávila;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2020QII;""
05 Ávila;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2020QI;""
05 Ávila;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
05 Ávila;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
05 Ávila;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QII;3.273
05 Ávila;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QI;""
05 Ávila;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
05 Ávila;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
05 Ávila;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QII;3.331
05 Ávila;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QI;""
05 Ávila;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
05 Ávila;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
05 Ávila;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QII;""
05 Ávila;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QI;""
05 Ávila;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
05 Ávila;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QIII;3.228
05 Ávila;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QII;""
05 Ávila;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QI;""
05 Ávila;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
05 Ávila;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QIII;3.285
05 Ávila;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QII;""
05 Ávila;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QI;""
05 Ávila;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
05 Ávila;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
05 Ávila;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QII;""
05 Ávila;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QI;""
05 Ávila;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
05 Ávila;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
05 Ávila;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
05 Ávila;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
05 Ávila;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
05 Ávila;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
05 Ávila;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
05 Ávila;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
05 Ávila;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
05 Ávila;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
05 Ávila;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
05 Ávila;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
05 Ávila;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;97,47
05 Ávila;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
05 Ávila;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
05 Ávila;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
05 Ávila;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;97,82
05 Ávila;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
05 Ávila;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
05 Ávila;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
05 Ávila;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;97,85
05 Ávila;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
05 Ávila;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
05 Ávila;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
05 Ávila;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
05 Ávila;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
05 Ávila;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
05 Ávila;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;96,37
05 Ávila;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
05 Ávila;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
05 Ávila;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
05 Ávila;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;96,59
05 Ávila;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
05 Ávila;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
05 Ávila;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
05 Ávila;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
05 Ávila;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
05 Ávila;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
05 Ávila;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;95,01
05 Ávila;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
05 Ávila;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
05 Ávila;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
05 Ávila;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;95,36
05 Ávila;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
05 Ávila;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
05 Ávila;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
05 Ávila;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
05 Ávila;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
05 Ávila;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
05 Ávila;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;93,7
05 Ávila;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
05 Ávila;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
05 Ávila;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
05 Ávila;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;94,05
05 Ávila;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
05 Ávila;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
05 Ávila;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
05 Ávila;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
05 Ávila;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
05 Ávila;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
05 Ávila;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QIV;2.238
05 Ávila;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
05 Ávila;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
05 Ávila;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
05 Ávila;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QIV;2.254
05 Ávila;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
05 Ávila;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
05 Ávila;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
05 Ávila;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QIV;2.292
05 Ávila;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
05 Ávila;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
05 Ávila;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
05 Ávila;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2022QIV;2.193
05 Ávila;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
05 Ávila;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2022QII;""
05 Ávila;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2022QI;""
05 Ávila;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2021QIV;2.212
05 Ávila;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
05 Ávila;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2021QII;""
05 Ávila;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2021QI;""
05 Ávila;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2020QIV;2.249
05 Ávila;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
05 Ávila;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2020QII;""
05 Ávila;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2020QI;""
05 Ávila;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
05 Ávila;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
05 Ávila;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2022QII;""
05 Ávila;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2022QI;2.178
05 Ávila;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
05 Ávila;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
05 Ávila;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2021QII;""
05 Ávila;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2021QI;2.220
05 Ávila;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
05 Ávila;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
05 Ávila;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2020QII;""
05 Ávila;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2020QI;""
05 Ávila;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
05 Ávila;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
05 Ávila;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QII;2.156
05 Ávila;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QI;""
05 Ávila;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
05 Ávila;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
05 Ávila;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QII;2.193
05 Ávila;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QI;""
05 Ávila;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
05 Ávila;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
05 Ávila;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QII;""
05 Ávila;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QI;""
05 Ávila;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
05 Ávila;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QIII;2.134
05 Ávila;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QII;""
05 Ávila;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QI;""
05 Ávila;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
05 Ávila;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QIII;2.163
05 Ávila;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QII;""
05 Ávila;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QI;""
05 Ávila;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
05 Ávila;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
05 Ávila;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QII;""
05 Ávila;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QI;""
05 Ávila;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
05 Ávila;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
05 Ávila;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
05 Ávila;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
05 Ávila;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
05 Ávila;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
05 Ávila;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
05 Ávila;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
05 Ávila;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
05 Ávila;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
05 Ávila;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
05 Ávila;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
05 Ávila;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;97,99
05 Ávila;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
05 Ávila;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
05 Ávila;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
05 Ávila;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;98,14
05 Ávila;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
05 Ávila;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
05 Ávila;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
05 Ávila;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;98,12
05 Ávila;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
05 Ávila;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
05 Ávila;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
05 Ávila;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
05 Ávila;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
05 Ávila;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
05 Ávila;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;96,63
05 Ávila;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
05 Ávila;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
05 Ávila;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
05 Ávila;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;96,86
05 Ávila;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
05 Ávila;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
05 Ávila;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
05 Ávila;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
05 Ávila;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
05 Ávila;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
05 Ávila;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;95,65
05 Ávila;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
05 Ávila;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
05 Ávila;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
05 Ávila;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;95,68
05 Ávila;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
05 Ávila;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
05 Ávila;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
05 Ávila;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
05 Ávila;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
05 Ávila;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
05 Ávila;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;94,68
05 Ávila;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
05 Ávila;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
05 Ávila;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
05 Ávila;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;94,37
05 Ávila;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
05 Ávila;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
05 Ávila;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
05 Ávila;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
05 Ávila;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
05 Ávila;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
05 Ávila;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QIV;1.167
05 Ávila;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
05 Ávila;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
05 Ávila;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
05 Ávila;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QIV;1.191
05 Ávila;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
05 Ávila;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
05 Ávila;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
05 Ávila;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QIV;1.201
05 Ávila;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
05 Ávila;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
05 Ávila;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
05 Ávila;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2022QIV;1.126
05 Ávila;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
05 Ávila;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2022QII;""
05 Ávila;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2022QI;""
05 Ávila;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2021QIV;1.158
05 Ávila;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
05 Ávila;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2021QII;""
05 Ávila;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2021QI;""
05 Ávila;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2020QIV;1.169
05 Ávila;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
05 Ávila;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2020QII;""
05 Ávila;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2020QI;""
05 Ávila;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
05 Ávila;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
05 Ávila;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2022QII;""
05 Ávila;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2022QI;1.142
05 Ávila;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
05 Ávila;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
05 Ávila;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2021QII;""
05 Ávila;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2021QI;1.154
05 Ávila;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
05 Ávila;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
05 Ávila;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2020QII;""
05 Ávila;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2020QI;""
05 Ávila;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
05 Ávila;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
05 Ávila;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QII;1.117
05 Ávila;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QI;""
05 Ávila;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
05 Ávila;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
05 Ávila;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QII;1.138
05 Ávila;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QI;""
05 Ávila;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
05 Ávila;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
05 Ávila;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QII;""
05 Ávila;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QI;""
05 Ávila;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
05 Ávila;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QIII;1.094
05 Ávila;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QII;""
05 Ávila;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QI;""
05 Ávila;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
05 Ávila;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QIII;1.122
05 Ávila;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QII;""
05 Ávila;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QI;""
05 Ávila;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
05 Ávila;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
05 Ávila;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QII;""
05 Ávila;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QI;""
05 Ávila;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
05 Ávila;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
05 Ávila;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
05 Ávila;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
05 Ávila;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
05 Ávila;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
05 Ávila;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
05 Ávila;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
05 Ávila;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
05 Ávila;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
05 Ávila;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
05 Ávila;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
05 Ávila;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;96,49
05 Ávila;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
05 Ávila;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
05 Ávila;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
05 Ávila;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;97,23
05 Ávila;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
05 Ávila;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
05 Ávila;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
05 Ávila;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;97,34
05 Ávila;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
05 Ávila;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
05 Ávila;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
05 Ávila;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
05 Ávila;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
05 Ávila;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
05 Ávila;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;95,89
05 Ávila;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
05 Ávila;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
05 Ávila;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
05 Ávila;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;96,09
05 Ávila;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
05 Ávila;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
05 Ávila;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
05 Ávila;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
05 Ávila;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
05 Ávila;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
05 Ávila;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;93,79
05 Ávila;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
05 Ávila;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
05 Ávila;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
05 Ávila;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;94,75
05 Ávila;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
05 Ávila;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
05 Ávila;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
05 Ávila;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
05 Ávila;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
05 Ávila;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
05 Ávila;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;91,86
05 Ávila;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
05 Ávila;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
05 Ávila;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
05 Ávila;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;93,42
05 Ávila;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
05 Ávila;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
05 Ávila;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
05 Ávila;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
05 Ávila;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
05 Ávila;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
05 Ávila;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
05 Ávila;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
05 Ávila;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
05 Ávila;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QI;1.874
05 Ávila;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
05 Ávila;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
05 Ávila;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
05 Ávila;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QI;1.772
05 Ávila;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
05 Ávila;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
05 Ávila;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
05 Ávila;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QI;2.047
05 Ávila;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
05 Ávila;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
05 Ávila;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2022QII;""
05 Ávila;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2022QI;1.810
05 Ávila;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
05 Ávila;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
05 Ávila;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2021QII;""
05 Ávila;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2021QI;1.714
05 Ávila;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
05 Ávila;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
05 Ávila;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2020QII;""
05 Ávila;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2020QI;1.924
05 Ávila;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
05 Ávila;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
05 Ávila;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2022QII;1.756
05 Ávila;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2022QI;""
05 Ávila;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
05 Ávila;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
05 Ávila;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2021QII;1.661
05 Ávila;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2021QI;""
05 Ávila;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
05 Ávila;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
05 Ávila;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2020QII;1.876
05 Ávila;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2020QI;""
05 Ávila;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
05 Ávila;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QIII;1.687
05 Ávila;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QII;""
05 Ávila;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QI;""
05 Ávila;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
05 Ávila;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QIII;1.606
05 Ávila;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QII;""
05 Ávila;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QI;""
05 Ávila;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
05 Ávila;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QIII;1.801
05 Ávila;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QII;""
05 Ávila;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QI;""
05 Ávila;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QIV;1.595
05 Ávila;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
05 Ávila;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QII;""
05 Ávila;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QI;""
05 Ávila;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QIV;1.524
05 Ávila;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
05 Ávila;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QII;""
05 Ávila;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QI;""
05 Ávila;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QIV;1.714
05 Ávila;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
05 Ávila;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QII;""
05 Ávila;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QI;""
05 Ávila;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
05 Ávila;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
05 Ávila;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
05 Ávila;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
05 Ávila;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
05 Ávila;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
05 Ávila;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
05 Ávila;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
05 Ávila;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
05 Ávila;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
05 Ávila;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
05 Ávila;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
05 Ávila;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
05 Ávila;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
05 Ávila;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
05 Ávila;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;96,58
05 Ávila;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
05 Ávila;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
05 Ávila;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
05 Ávila;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;96,73
05 Ávila;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
05 Ávila;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
05 Ávila;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
05 Ávila;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;93,99
05 Ávila;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
05 Ávila;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
05 Ávila;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;93,7
05 Ávila;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
05 Ávila;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
05 Ávila;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
05 Ávila;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;93,74
05 Ávila;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
05 Ávila;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
05 Ávila;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
05 Ávila;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;91,65
05 Ávila;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
05 Ávila;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
05 Ávila;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;90,02
05 Ávila;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
05 Ávila;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
05 Ávila;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
05 Ávila;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;90,63
05 Ávila;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
05 Ávila;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
05 Ávila;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
05 Ávila;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;87,98
05 Ávila;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
05 Ávila;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
05 Ávila;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;85,11
05 Ávila;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
05 Ávila;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
05 Ávila;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
05 Ávila;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;86
05 Ávila;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
05 Ávila;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
05 Ávila;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
05 Ávila;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;83,73
05 Ávila;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
05 Ávila;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
05 Ávila;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
05 Ávila;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
05 Ávila;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
05 Ávila;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
05 Ávila;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QI;1.301
05 Ávila;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
05 Ávila;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
05 Ávila;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
05 Ávila;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QI;1.228
05 Ávila;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
05 Ávila;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
05 Ávila;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
05 Ávila;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QI;1.408
05 Ávila;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
05 Ávila;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
05 Ávila;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2022QII;""
05 Ávila;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2022QI;1.254
05 Ávila;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
05 Ávila;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
05 Ávila;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2021QII;""
05 Ávila;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2021QI;1.185
05 Ávila;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
05 Ávila;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
05 Ávila;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2020QII;""
05 Ávila;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2020QI;1.326
05 Ávila;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
05 Ávila;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
05 Ávila;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2022QII;1.214
05 Ávila;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2022QI;""
05 Ávila;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
05 Ávila;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
05 Ávila;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2021QII;1.152
05 Ávila;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2021QI;""
05 Ávila;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
05 Ávila;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
05 Ávila;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2020QII;1.295
05 Ávila;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2020QI;""
05 Ávila;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
05 Ávila;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QIII;1.172
05 Ávila;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QII;""
05 Ávila;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QI;""
05 Ávila;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
05 Ávila;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QIII;1.120
05 Ávila;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QII;""
05 Ávila;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QI;""
05 Ávila;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
05 Ávila;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QIII;1.250
05 Ávila;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QII;""
05 Ávila;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QI;""
05 Ávila;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QIV;1.110
05 Ávila;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
05 Ávila;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QII;""
05 Ávila;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QI;""
05 Ávila;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QIV;1.067
05 Ávila;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
05 Ávila;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QII;""
05 Ávila;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QI;""
05 Ávila;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QIV;1.189
05 Ávila;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
05 Ávila;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QII;""
05 Ávila;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QI;""
05 Ávila;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
05 Ávila;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
05 Ávila;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
05 Ávila;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
05 Ávila;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
05 Ávila;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
05 Ávila;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
05 Ávila;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
05 Ávila;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
05 Ávila;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
05 Ávila;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
05 Ávila;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
05 Ávila;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
05 Ávila;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
05 Ávila;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
05 Ávila;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;96,39
05 Ávila;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
05 Ávila;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
05 Ávila;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
05 Ávila;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;96,5
05 Ávila;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
05 Ávila;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
05 Ávila;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
05 Ávila;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;94,18
05 Ávila;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
05 Ávila;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
05 Ávila;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;93,31
05 Ávila;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
05 Ávila;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
05 Ávila;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
05 Ávila;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;93,81
05 Ávila;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
05 Ávila;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
05 Ávila;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
05 Ávila;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;91,97
05 Ávila;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
05 Ávila;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
05 Ávila;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;90,08
05 Ávila;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
05 Ávila;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
05 Ávila;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
05 Ávila;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;91,21
05 Ávila;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
05 Ávila;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
05 Ávila;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
05 Ávila;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;88,78
05 Ávila;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
05 Ávila;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
05 Ávila;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;85,32
05 Ávila;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
05 Ávila;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
05 Ávila;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
05 Ávila;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;86,89
05 Ávila;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
05 Ávila;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
05 Ávila;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
05 Ávila;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;84,45
05 Ávila;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
05 Ávila;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
05 Ávila;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
05 Ávila;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
05 Ávila;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
05 Ávila;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
05 Ávila;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QI;573
05 Ávila;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
05 Ávila;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
05 Ávila;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
05 Ávila;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QI;544
05 Ávila;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
05 Ávila;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
05 Ávila;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
05 Ávila;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QI;639
05 Ávila;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
05 Ávila;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
05 Ávila;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2022QII;""
05 Ávila;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2022QI;556
05 Ávila;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
05 Ávila;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
05 Ávila;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2021QII;""
05 Ávila;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2021QI;529
05 Ávila;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
05 Ávila;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
05 Ávila;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2020QII;""
05 Ávila;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2020QI;598
05 Ávila;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
05 Ávila;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
05 Ávila;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2022QII;542
05 Ávila;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2022QI;""
05 Ávila;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
05 Ávila;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
05 Ávila;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2021QII;509
05 Ávila;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2021QI;""
05 Ávila;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
05 Ávila;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
05 Ávila;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2020QII;581
05 Ávila;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2020QI;""
05 Ávila;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
05 Ávila;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QIII;515
05 Ávila;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QII;""
05 Ávila;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QI;""
05 Ávila;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
05 Ávila;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QIII;486
05 Ávila;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QII;""
05 Ávila;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QI;""
05 Ávila;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
05 Ávila;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QIII;551
05 Ávila;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QII;""
05 Ávila;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QI;""
05 Ávila;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QIV;485
05 Ávila;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
05 Ávila;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QII;""
05 Ávila;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QI;""
05 Ávila;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QIV;457
05 Ávila;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
05 Ávila;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QII;""
05 Ávila;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QI;""
05 Ávila;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QIV;525
05 Ávila;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
05 Ávila;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QII;""
05 Ávila;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QI;""
05 Ávila;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
05 Ávila;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
05 Ávila;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
05 Ávila;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
05 Ávila;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
05 Ávila;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
05 Ávila;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
05 Ávila;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
05 Ávila;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
05 Ávila;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
05 Ávila;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
05 Ávila;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
05 Ávila;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
05 Ávila;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
05 Ávila;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
05 Ávila;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;97,03
05 Ávila;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
05 Ávila;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
05 Ávila;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
05 Ávila;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;97,24
05 Ávila;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
05 Ávila;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
05 Ávila;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
05 Ávila;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;93,58
05 Ávila;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
05 Ávila;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
05 Ávila;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;94,59
05 Ávila;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
05 Ávila;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
05 Ávila;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
05 Ávila;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;93,57
05 Ávila;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
05 Ávila;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
05 Ávila;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
05 Ávila;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;90,92
05 Ávila;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
05 Ávila;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
05 Ávila;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;89,88
05 Ávila;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
05 Ávila;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
05 Ávila;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
05 Ávila;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;89,34
05 Ávila;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
05 Ávila;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
05 Ávila;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
05 Ávila;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;86,23
05 Ávila;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
05 Ávila;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
05 Ávila;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;84,64
05 Ávila;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
05 Ávila;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
05 Ávila;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
05 Ávila;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;84,01
05 Ávila;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
05 Ávila;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
05 Ávila;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
05 Ávila;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;82,16
05 Ávila;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
05 Ávila;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
05 Ávila;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
05 Ávila;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
05 Ávila;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
05 Ávila;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QII;2.163
05 Ávila;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
05 Ávila;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
05 Ávila;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
05 Ávila;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QII;2.053
05 Ávila;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
05 Ávila;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
05 Ávila;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
05 Ávila;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QII;1.963
05 Ávila;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
05 Ávila;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
05 Ávila;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
05 Ávila;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2022QII;2.103
05 Ávila;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2022QI;""
05 Ávila;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
05 Ávila;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
05 Ávila;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2021QII;1.989
05 Ávila;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2021QI;""
05 Ávila;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
05 Ávila;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
05 Ávila;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2020QII;1.914
05 Ávila;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2020QI;""
05 Ávila;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
05 Ávila;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2022QIII;2.026
05 Ávila;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2022QII;""
05 Ávila;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2022QI;""
05 Ávila;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
05 Ávila;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2021QIII;1.928
05 Ávila;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2021QII;""
05 Ávila;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2021QI;""
05 Ávila;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
05 Ávila;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2020QIII;1.829
05 Ávila;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2020QII;""
05 Ávila;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2020QI;""
05 Ávila;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QIV;1.930
05 Ávila;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
05 Ávila;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QII;""
05 Ávila;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QI;""
05 Ávila;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QIV;1.837
05 Ávila;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
05 Ávila;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QII;""
05 Ávila;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QI;""
05 Ávila;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QIV;1.742
05 Ávila;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
05 Ávila;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QII;""
05 Ávila;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QI;""
05 Ávila;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
05 Ávila;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
05 Ávila;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QII;""
05 Ávila;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QI;1.776
05 Ávila;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
05 Ávila;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
05 Ávila;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QII;""
05 Ávila;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QI;1.690
05 Ávila;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
05 Ávila;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
05 Ávila;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QII;""
05 Ávila;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QI;""
05 Ávila;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
05 Ávila;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
05 Ávila;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
05 Ávila;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
05 Ávila;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
05 Ávila;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
05 Ávila;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
05 Ávila;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
05 Ávila;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
05 Ávila;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
05 Ávila;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
05 Ávila;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
05 Ávila;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
05 Ávila;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
05 Ávila;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;97,23
05 Ávila;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
05 Ávila;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
05 Ávila;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
05 Ávila;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;96,88
05 Ávila;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
05 Ávila;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
05 Ávila;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
05 Ávila;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;97,5
05 Ávila;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
05 Ávila;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
05 Ávila;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;93,67
05 Ávila;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
05 Ávila;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
05 Ávila;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
05 Ávila;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;93,91
05 Ávila;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
05 Ávila;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
05 Ávila;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
05 Ávila;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;93,17
05 Ávila;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
05 Ávila;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
05 Ávila;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;89,23
05 Ávila;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
05 Ávila;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
05 Ávila;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
05 Ávila;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;89,48
05 Ávila;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
05 Ávila;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
05 Ávila;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
05 Ávila;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;88,74
05 Ávila;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
05 Ávila;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
05 Ávila;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
05 Ávila;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
05 Ávila;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
05 Ávila;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
05 Ávila;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;86,51
05 Ávila;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
05 Ávila;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
05 Ávila;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
05 Ávila;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;86,09
05 Ávila;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
05 Ávila;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
05 Ávila;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
05 Ávila;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
05 Ávila;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
05 Ávila;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
05 Ávila;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QII;1.483
05 Ávila;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
05 Ávila;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
05 Ávila;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
05 Ávila;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QII;1.417
05 Ávila;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
05 Ávila;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
05 Ávila;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
05 Ávila;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QII;1.352
05 Ávila;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
05 Ávila;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
05 Ávila;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
05 Ávila;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2022QII;1.441
05 Ávila;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2022QI;""
05 Ávila;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
05 Ávila;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
05 Ávila;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2021QII;1.378
05 Ávila;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2021QI;""
05 Ávila;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
05 Ávila;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
05 Ávila;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2020QII;1.321
05 Ávila;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2020QI;""
05 Ávila;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
05 Ávila;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2022QIII;1.395
05 Ávila;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2022QII;""
05 Ávila;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2022QI;""
05 Ávila;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
05 Ávila;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2021QIII;1.341
05 Ávila;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2021QII;""
05 Ávila;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2021QI;""
05 Ávila;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
05 Ávila;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2020QIII;1.269
05 Ávila;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2020QII;""
05 Ávila;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2020QI;""
05 Ávila;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QIV;1.331
05 Ávila;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
05 Ávila;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QII;""
05 Ávila;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QI;""
05 Ávila;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QIV;1.282
05 Ávila;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
05 Ávila;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QII;""
05 Ávila;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QI;""
05 Ávila;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QIV;1.208
05 Ávila;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
05 Ávila;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QII;""
05 Ávila;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QI;""
05 Ávila;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
05 Ávila;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
05 Ávila;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QII;""
05 Ávila;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QI;1.238
05 Ávila;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
05 Ávila;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
05 Ávila;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QII;""
05 Ávila;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QI;1.171
05 Ávila;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
05 Ávila;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
05 Ávila;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QII;""
05 Ávila;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QI;""
05 Ávila;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
05 Ávila;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
05 Ávila;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
05 Ávila;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
05 Ávila;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
05 Ávila;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
05 Ávila;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
05 Ávila;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
05 Ávila;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
05 Ávila;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
05 Ávila;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
05 Ávila;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
05 Ávila;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
05 Ávila;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
05 Ávila;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;97,17
05 Ávila;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
05 Ávila;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
05 Ávila;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
05 Ávila;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;97,25
05 Ávila;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
05 Ávila;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
05 Ávila;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
05 Ávila;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;97,71
05 Ávila;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
05 Ávila;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
05 Ávila;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;94,07
05 Ávila;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
05 Ávila;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
05 Ávila;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
05 Ávila;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;94,64
05 Ávila;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
05 Ávila;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
05 Ávila;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
05 Ávila;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;93,86
05 Ávila;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
05 Ávila;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
05 Ávila;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;89,75
05 Ávila;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
05 Ávila;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
05 Ávila;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
05 Ávila;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;90,47
05 Ávila;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
05 Ávila;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
05 Ávila;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
05 Ávila;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;89,35
05 Ávila;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
05 Ávila;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
05 Ávila;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
05 Ávila;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
05 Ávila;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
05 Ávila;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
05 Ávila;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;87,37
05 Ávila;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
05 Ávila;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
05 Ávila;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
05 Ávila;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;86,61
05 Ávila;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
05 Ávila;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
05 Ávila;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
05 Ávila;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
05 Ávila;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
05 Ávila;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
05 Ávila;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QII;680
05 Ávila;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
05 Ávila;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
05 Ávila;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
05 Ávila;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QII;636
05 Ávila;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
05 Ávila;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
05 Ávila;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
05 Ávila;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QII;611
05 Ávila;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
05 Ávila;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
05 Ávila;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
05 Ávila;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2022QII;662
05 Ávila;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2022QI;""
05 Ávila;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
05 Ávila;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
05 Ávila;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2021QII;611
05 Ávila;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2021QI;""
05 Ávila;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
05 Ávila;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
05 Ávila;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2020QII;593
05 Ávila;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2020QI;""
05 Ávila;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
05 Ávila;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2022QIII;631
05 Ávila;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2022QII;""
05 Ávila;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2022QI;""
05 Ávila;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
05 Ávila;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2021QIII;587
05 Ávila;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2021QII;""
05 Ávila;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2021QI;""
05 Ávila;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
05 Ávila;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2020QIII;560
05 Ávila;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2020QII;""
05 Ávila;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2020QI;""
05 Ávila;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QIV;599
05 Ávila;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
05 Ávila;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QII;""
05 Ávila;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QI;""
05 Ávila;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QIV;555
05 Ávila;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
05 Ávila;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QII;""
05 Ávila;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QI;""
05 Ávila;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QIV;534
05 Ávila;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
05 Ávila;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QII;""
05 Ávila;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QI;""
05 Ávila;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
05 Ávila;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
05 Ávila;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QII;""
05 Ávila;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QI;538
05 Ávila;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
05 Ávila;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
05 Ávila;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QII;""
05 Ávila;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QI;519
05 Ávila;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
05 Ávila;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
05 Ávila;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QII;""
05 Ávila;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QI;""
05 Ávila;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
05 Ávila;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
05 Ávila;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
05 Ávila;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
05 Ávila;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
05 Ávila;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
05 Ávila;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
05 Ávila;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
05 Ávila;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
05 Ávila;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
05 Ávila;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
05 Ávila;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
05 Ávila;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
05 Ávila;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
05 Ávila;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;97,35
05 Ávila;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
05 Ávila;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
05 Ávila;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
05 Ávila;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;96,07
05 Ávila;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
05 Ávila;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
05 Ávila;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
05 Ávila;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;97,05
05 Ávila;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
05 Ávila;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
05 Ávila;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;92,79
05 Ávila;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
05 Ávila;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
05 Ávila;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
05 Ávila;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;92,3
05 Ávila;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
05 Ávila;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
05 Ávila;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
05 Ávila;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;91,65
05 Ávila;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
05 Ávila;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
05 Ávila;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;88,09
05 Ávila;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
05 Ávila;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
05 Ávila;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
05 Ávila;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;87,26
05 Ávila;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
05 Ávila;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
05 Ávila;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
05 Ávila;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;87,4
05 Ávila;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
05 Ávila;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
05 Ávila;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
05 Ávila;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
05 Ávila;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
05 Ávila;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
05 Ávila;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;84,59
05 Ávila;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
05 Ávila;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
05 Ávila;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
05 Ávila;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;84,94
05 Ávila;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
05 Ávila;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
05 Ávila;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
05 Ávila;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
05 Ávila;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
05 Ávila;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QIII;2.143
05 Ávila;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
05 Ávila;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
05 Ávila;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
05 Ávila;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QIII;2.018
05 Ávila;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
05 Ávila;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
05 Ávila;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
05 Ávila;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QIII;1.933
05 Ávila;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
05 Ávila;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
05 Ávila;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
05 Ávila;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2022QIII;2.053
05 Ávila;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2022QII;""
05 Ávila;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2022QI;""
05 Ávila;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
05 Ávila;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2021QIII;1.949
05 Ávila;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2021QII;""
05 Ávila;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2021QI;""
05 Ávila;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
05 Ávila;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2020QIII;1.842
05 Ávila;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2020QII;""
05 Ávila;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2020QI;""
05 Ávila;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2022QIV;1.952
05 Ávila;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
05 Ávila;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2022QII;""
05 Ávila;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2022QI;""
05 Ávila;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2021QIV;1.853
05 Ávila;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
05 Ávila;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2021QII;""
05 Ávila;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2021QI;""
05 Ávila;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2020QIV;1.751
05 Ávila;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
05 Ávila;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2020QII;""
05 Ávila;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2020QI;""
05 Ávila;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
05 Ávila;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
05 Ávila;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QII;""
05 Ávila;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QI;1.791
05 Ávila;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
05 Ávila;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
05 Ávila;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QII;""
05 Ávila;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QI;1.698
05 Ávila;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
05 Ávila;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
05 Ávila;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QII;""
05 Ávila;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QI;""
05 Ávila;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
05 Ávila;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
05 Ávila;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QII;1.737
05 Ávila;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QI;""
05 Ávila;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
05 Ávila;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
05 Ávila;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QII;1.646
05 Ávila;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QI;""
05 Ávila;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
05 Ávila;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
05 Ávila;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QII;""
05 Ávila;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QI;""
05 Ávila;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
05 Ávila;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
05 Ávila;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
05 Ávila;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
05 Ávila;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
05 Ávila;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
05 Ávila;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
05 Ávila;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
05 Ávila;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
05 Ávila;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
05 Ávila;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
05 Ávila;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
05 Ávila;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
05 Ávila;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;95,8
05 Ávila;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
05 Ávila;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
05 Ávila;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
05 Ávila;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;96,58
05 Ávila;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
05 Ávila;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
05 Ávila;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
05 Ávila;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;95,29
05 Ávila;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
05 Ávila;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
05 Ávila;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;91,09
05 Ávila;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
05 Ávila;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
05 Ávila;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
05 Ávila;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;91,82
05 Ávila;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
05 Ávila;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
05 Ávila;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
05 Ávila;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;90,58
05 Ávila;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
05 Ávila;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
05 Ávila;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
05 Ávila;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
05 Ávila;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
05 Ávila;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
05 Ávila;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;88,75
05 Ávila;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
05 Ávila;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
05 Ávila;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
05 Ávila;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;87,84
05 Ávila;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
05 Ávila;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
05 Ávila;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
05 Ávila;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
05 Ávila;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
05 Ávila;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
05 Ávila;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;86,08
05 Ávila;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
05 Ávila;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
05 Ávila;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
05 Ávila;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;85,15
05 Ávila;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
05 Ávila;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
05 Ávila;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
05 Ávila;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
05 Ávila;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
05 Ávila;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
05 Ávila;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QIII;1.468
05 Ávila;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
05 Ávila;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
05 Ávila;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
05 Ávila;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QIII;1.392
05 Ávila;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
05 Ávila;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
05 Ávila;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
05 Ávila;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QIII;1.338
05 Ávila;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
05 Ávila;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
05 Ávila;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
05 Ávila;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2022QIII;1.413
05 Ávila;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2022QII;""
05 Ávila;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2022QI;""
05 Ávila;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
05 Ávila;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2021QIII;1.350
05 Ávila;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2021QII;""
05 Ávila;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2021QI;""
05 Ávila;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
05 Ávila;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2020QIII;1.281
05 Ávila;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2020QII;""
05 Ávila;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2020QI;""
05 Ávila;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2022QIV;1.346
05 Ávila;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
05 Ávila;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2022QII;""
05 Ávila;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2022QI;""
05 Ávila;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2021QIV;1.288
05 Ávila;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
05 Ávila;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2021QII;""
05 Ávila;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2021QI;""
05 Ávila;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2020QIV;1.216
05 Ávila;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
05 Ávila;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2020QII;""
05 Ávila;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2020QI;""
05 Ávila;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
05 Ávila;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
05 Ávila;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QII;""
05 Ávila;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QI;1.243
05 Ávila;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
05 Ávila;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
05 Ávila;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QII;""
05 Ávila;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QI;1.178
05 Ávila;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
05 Ávila;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
05 Ávila;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QII;""
05 Ávila;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QI;""
05 Ávila;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
05 Ávila;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
05 Ávila;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QII;1.203
05 Ávila;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QI;""
05 Ávila;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
05 Ávila;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
05 Ávila;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QII;1.145
05 Ávila;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QI;""
05 Ávila;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
05 Ávila;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
05 Ávila;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QII;""
05 Ávila;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QI;""
05 Ávila;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
05 Ávila;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
05 Ávila;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
05 Ávila;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
05 Ávila;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
05 Ávila;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
05 Ávila;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
05 Ávila;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
05 Ávila;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
05 Ávila;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
05 Ávila;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
05 Ávila;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
05 Ávila;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
05 Ávila;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;96,25
05 Ávila;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
05 Ávila;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
05 Ávila;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
05 Ávila;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;96,98
05 Ávila;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
05 Ávila;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
05 Ávila;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
05 Ávila;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;95,74
05 Ávila;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
05 Ávila;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
05 Ávila;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;91,69
05 Ávila;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
05 Ávila;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
05 Ávila;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
05 Ávila;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;92,53
05 Ávila;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
05 Ávila;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
05 Ávila;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
05 Ávila;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;90,88
05 Ávila;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
05 Ávila;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
05 Ávila;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
05 Ávila;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
05 Ávila;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
05 Ávila;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
05 Ávila;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;89,3
05 Ávila;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
05 Ávila;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
05 Ávila;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
05 Ávila;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;88,04
05 Ávila;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
05 Ávila;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
05 Ávila;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
05 Ávila;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
05 Ávila;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
05 Ávila;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
05 Ávila;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;86,42
05 Ávila;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
05 Ávila;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
05 Ávila;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
05 Ávila;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;85,58
05 Ávila;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
05 Ávila;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
05 Ávila;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
05 Ávila;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
05 Ávila;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
05 Ávila;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
05 Ávila;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QIII;675
05 Ávila;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
05 Ávila;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
05 Ávila;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
05 Ávila;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QIII;626
05 Ávila;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
05 Ávila;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
05 Ávila;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
05 Ávila;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QIII;595
05 Ávila;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
05 Ávila;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
05 Ávila;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
05 Ávila;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2022QIII;640
05 Ávila;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2022QII;""
05 Ávila;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2022QI;""
05 Ávila;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
05 Ávila;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2021QIII;599
05 Ávila;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2021QII;""
05 Ávila;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2021QI;""
05 Ávila;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
05 Ávila;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2020QIII;561
05 Ávila;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2020QII;""
05 Ávila;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2020QI;""
05 Ávila;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2022QIV;606
05 Ávila;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
05 Ávila;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2022QII;""
05 Ávila;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2022QI;""
05 Ávila;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2021QIV;565
05 Ávila;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
05 Ávila;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2021QII;""
05 Ávila;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2021QI;""
05 Ávila;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2020QIV;535
05 Ávila;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
05 Ávila;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2020QII;""
05 Ávila;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2020QI;""
05 Ávila;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
05 Ávila;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
05 Ávila;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QII;""
05 Ávila;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QI;548
05 Ávila;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
05 Ávila;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
05 Ávila;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QII;""
05 Ávila;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QI;520
05 Ávila;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
05 Ávila;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
05 Ávila;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QII;""
05 Ávila;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QI;""
05 Ávila;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
05 Ávila;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
05 Ávila;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QII;534
05 Ávila;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QI;""
05 Ávila;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
05 Ávila;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
05 Ávila;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QII;501
05 Ávila;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QI;""
05 Ávila;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
05 Ávila;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
05 Ávila;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QII;""
05 Ávila;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QI;""
05 Ávila;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
05 Ávila;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
05 Ávila;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
05 Ávila;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
05 Ávila;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
05 Ávila;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
05 Ávila;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
05 Ávila;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
05 Ávila;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
05 Ávila;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
05 Ávila;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
05 Ávila;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
05 Ávila;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
05 Ávila;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;94,81
05 Ávila;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
05 Ávila;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
05 Ávila;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
05 Ávila;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;95,69
05 Ávila;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
05 Ávila;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
05 Ávila;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
05 Ávila;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;94,29
05 Ávila;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
05 Ávila;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
05 Ávila;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;89,78
05 Ávila;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
05 Ávila;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
05 Ávila;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
05 Ávila;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;90,26
05 Ávila;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
05 Ávila;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
05 Ávila;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
05 Ávila;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;89,92
05 Ávila;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
05 Ávila;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
05 Ávila;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
05 Ávila;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
05 Ávila;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
05 Ávila;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
05 Ávila;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;87,54
05 Ávila;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
05 Ávila;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
05 Ávila;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
05 Ávila;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;87,39
05 Ávila;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
05 Ávila;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
05 Ávila;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
05 Ávila;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
05 Ávila;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
05 Ávila;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
05 Ávila;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;85,3
05 Ávila;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
05 Ávila;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
05 Ávila;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
05 Ávila;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;84,2
05 Ávila;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
05 Ávila;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
05 Ávila;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
05 Ávila;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
05 Ávila;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
05 Ávila;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QIV;2.071
05 Ávila;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
05 Ávila;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
05 Ávila;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
05 Ávila;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QIV;1.961
05 Ávila;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
05 Ávila;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
05 Ávila;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
05 Ávila;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QIV;1.859
05 Ávila;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
05 Ávila;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
05 Ávila;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
05 Ávila;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2022QIV;1.969
05 Ávila;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
05 Ávila;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2022QII;""
05 Ávila;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2022QI;""
05 Ávila;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2021QIV;1.865
05 Ávila;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
05 Ávila;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2021QII;""
05 Ávila;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2021QI;""
05 Ávila;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2020QIV;1.765
05 Ávila;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
05 Ávila;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2020QII;""
05 Ávila;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2020QI;""
05 Ávila;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
05 Ávila;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
05 Ávila;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2022QII;""
05 Ávila;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2022QI;1.803
05 Ávila;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
05 Ávila;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
05 Ávila;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2021QII;""
05 Ávila;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2021QI;1.709
05 Ávila;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
05 Ávila;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
05 Ávila;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2020QII;""
05 Ávila;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2020QI;""
05 Ávila;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
05 Ávila;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
05 Ávila;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QII;1.749
05 Ávila;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QI;""
05 Ávila;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
05 Ávila;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
05 Ávila;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QII;1.656
05 Ávila;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QI;""
05 Ávila;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
05 Ávila;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
05 Ávila;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QII;""
05 Ávila;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QI;""
05 Ávila;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
05 Ávila;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QIII;1.682
05 Ávila;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QII;""
05 Ávila;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QI;""
05 Ávila;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
05 Ávila;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QIII;1.601
05 Ávila;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QII;""
05 Ávila;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QI;""
05 Ávila;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
05 Ávila;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
05 Ávila;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QII;""
05 Ávila;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QI;""
05 Ávila;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
05 Ávila;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
05 Ávila;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
05 Ávila;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
05 Ávila;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
05 Ávila;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
05 Ávila;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
05 Ávila;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
05 Ávila;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
05 Ávila;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
05 Ávila;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
05 Ávila;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
05 Ávila;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;95,07
05 Ávila;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
05 Ávila;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
05 Ávila;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
05 Ávila;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;95,1
05 Ávila;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
05 Ávila;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
05 Ávila;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
05 Ávila;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;94,94
05 Ávila;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
05 Ávila;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
05 Ávila;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
05 Ávila;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
05 Ávila;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
05 Ávila;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
05 Ávila;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;91,94
05 Ávila;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
05 Ávila;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
05 Ávila;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
05 Ávila;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;91,93
05 Ávila;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
05 Ávila;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
05 Ávila;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
05 Ávila;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
05 Ávila;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
05 Ávila;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
05 Ávila;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;89,19
05 Ávila;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
05 Ávila;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
05 Ávila;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
05 Ávila;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;89,08
05 Ávila;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
05 Ávila;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
05 Ávila;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
05 Ávila;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
05 Ávila;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
05 Ávila;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
05 Ávila;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;85,77
05 Ávila;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
05 Ávila;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
05 Ávila;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
05 Ávila;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;86,12
05 Ávila;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
05 Ávila;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
05 Ávila;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
05 Ávila;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
05 Ávila;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
05 Ávila;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
05 Ávila;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QIV;1.423
05 Ávila;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
05 Ávila;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
05 Ávila;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
05 Ávila;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QIV;1.357
05 Ávila;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
05 Ávila;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
05 Ávila;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
05 Ávila;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QIV;1.290
05 Ávila;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
05 Ávila;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
05 Ávila;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
05 Ávila;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2022QIV;1.355
05 Ávila;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
05 Ávila;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2022QII;""
05 Ávila;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2022QI;""
05 Ávila;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2021QIV;1.295
05 Ávila;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
05 Ávila;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2021QII;""
05 Ávila;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2021QI;""
05 Ávila;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2020QIV;1.223
05 Ávila;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
05 Ávila;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2020QII;""
05 Ávila;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2020QI;""
05 Ávila;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
05 Ávila;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
05 Ávila;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2022QII;""
05 Ávila;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2022QI;1.250
05 Ávila;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
05 Ávila;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
05 Ávila;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2021QII;""
05 Ávila;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2021QI;1.182
05 Ávila;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
05 Ávila;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
05 Ávila;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2020QII;""
05 Ávila;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2020QI;""
05 Ávila;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
05 Ávila;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
05 Ávila;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QII;1.210
05 Ávila;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QI;""
05 Ávila;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
05 Ávila;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
05 Ávila;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QII;1.149
05 Ávila;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QI;""
05 Ávila;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
05 Ávila;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
05 Ávila;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QII;""
05 Ávila;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QI;""
05 Ávila;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
05 Ávila;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QIII;1.169
05 Ávila;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QII;""
05 Ávila;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QI;""
05 Ávila;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
05 Ávila;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QIII;1.117
05 Ávila;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QII;""
05 Ávila;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QI;""
05 Ávila;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
05 Ávila;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
05 Ávila;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QII;""
05 Ávila;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QI;""
05 Ávila;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
05 Ávila;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
05 Ávila;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
05 Ávila;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
05 Ávila;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
05 Ávila;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
05 Ávila;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
05 Ávila;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
05 Ávila;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
05 Ávila;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
05 Ávila;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
05 Ávila;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
05 Ávila;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;95,22
05 Ávila;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
05 Ávila;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
05 Ávila;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
05 Ávila;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;95,43
05 Ávila;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
05 Ávila;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
05 Ávila;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
05 Ávila;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;94,81
05 Ávila;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
05 Ávila;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
05 Ávila;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
05 Ávila;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
05 Ávila;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
05 Ávila;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
05 Ávila;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;92,11
05 Ávila;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
05 Ávila;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
05 Ávila;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
05 Ávila;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;91,63
05 Ávila;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
05 Ávila;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
05 Ávila;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
05 Ávila;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
05 Ávila;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
05 Ávila;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
05 Ávila;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;89,17
05 Ávila;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
05 Ávila;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
05 Ávila;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
05 Ávila;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;89,07
05 Ávila;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
05 Ávila;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
05 Ávila;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
05 Ávila;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
05 Ávila;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
05 Ávila;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
05 Ávila;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;86,15
05 Ávila;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
05 Ávila;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
05 Ávila;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
05 Ávila;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;86,59
05 Ávila;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
05 Ávila;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
05 Ávila;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
05 Ávila;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
05 Ávila;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
05 Ávila;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
05 Ávila;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QIV;648
05 Ávila;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
05 Ávila;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
05 Ávila;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
05 Ávila;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QIV;604
05 Ávila;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
05 Ávila;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
05 Ávila;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
05 Ávila;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QIV;569
05 Ávila;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
05 Ávila;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
05 Ávila;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
05 Ávila;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2022QIV;614
05 Ávila;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
05 Ávila;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2022QII;""
05 Ávila;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2022QI;""
05 Ávila;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2021QIV;570
05 Ávila;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
05 Ávila;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2021QII;""
05 Ávila;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2021QI;""
05 Ávila;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2020QIV;542
05 Ávila;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
05 Ávila;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2020QII;""
05 Ávila;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2020QI;""
05 Ávila;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
05 Ávila;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
05 Ávila;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2022QII;""
05 Ávila;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2022QI;553
05 Ávila;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
05 Ávila;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
05 Ávila;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2021QII;""
05 Ávila;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2021QI;527
05 Ávila;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
05 Ávila;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
05 Ávila;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2020QII;""
05 Ávila;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2020QI;""
05 Ávila;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
05 Ávila;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
05 Ávila;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QII;539
05 Ávila;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QI;""
05 Ávila;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
05 Ávila;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
05 Ávila;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QII;507
05 Ávila;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QI;""
05 Ávila;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
05 Ávila;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
05 Ávila;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QII;""
05 Ávila;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QI;""
05 Ávila;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
05 Ávila;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QIII;513
05 Ávila;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QII;""
05 Ávila;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QI;""
05 Ávila;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
05 Ávila;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QIII;484
05 Ávila;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QII;""
05 Ávila;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QI;""
05 Ávila;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
05 Ávila;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
05 Ávila;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QII;""
05 Ávila;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QI;""
05 Ávila;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
05 Ávila;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
05 Ávila;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
05 Ávila;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
05 Ávila;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
05 Ávila;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
05 Ávila;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
05 Ávila;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
05 Ávila;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
05 Ávila;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
05 Ávila;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
05 Ávila;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
05 Ávila;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;94,75
05 Ávila;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
05 Ávila;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
05 Ávila;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
05 Ávila;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;94,37
05 Ávila;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
05 Ávila;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
05 Ávila;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
05 Ávila;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;95,25
05 Ávila;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
05 Ávila;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
05 Ávila;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
05 Ávila;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
05 Ávila;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
05 Ávila;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
05 Ávila;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;91,56
05 Ávila;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
05 Ávila;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
05 Ávila;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
05 Ávila;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;92,62
05 Ávila;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
05 Ávila;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
05 Ávila;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
05 Ávila;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
05 Ávila;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
05 Ávila;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
05 Ávila;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;89,24
05 Ávila;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
05 Ávila;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
05 Ávila;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
05 Ávila;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;89,1
05 Ávila;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
05 Ávila;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
05 Ávila;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
05 Ávila;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
05 Ávila;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
05 Ávila;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
05 Ávila;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;84,93
05 Ávila;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
05 Ávila;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
05 Ávila;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
05 Ávila;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;85,06
05 Ávila;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
05 Ávila;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
05 Ávila;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
05 Ávila;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
05 Ávila;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
05 Ávila;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
06 Badajoz;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
06 Badajoz;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
06 Badajoz;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
06 Badajoz;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QI;39.419
06 Badajoz;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
06 Badajoz;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
06 Badajoz;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
06 Badajoz;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QI;38.751
06 Badajoz;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
06 Badajoz;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
06 Badajoz;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
06 Badajoz;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QI;39.490
06 Badajoz;All ages;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
06 Badajoz;All ages;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
06 Badajoz;All ages;Cohort January 1;Total;Survival in the first trimester;2022QII;""
06 Badajoz;All ages;Cohort January 1;Total;Survival in the first trimester;2022QI;38.154
06 Badajoz;All ages;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
06 Badajoz;All ages;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
06 Badajoz;All ages;Cohort January 1;Total;Survival in the first trimester;2021QII;""
06 Badajoz;All ages;Cohort January 1;Total;Survival in the first trimester;2021QI;37.898
06 Badajoz;All ages;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
06 Badajoz;All ages;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
06 Badajoz;All ages;Cohort January 1;Total;Survival in the first trimester;2020QII;""
06 Badajoz;All ages;Cohort January 1;Total;Survival in the first trimester;2020QI;37.080
06 Badajoz;All ages;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
06 Badajoz;All ages;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
06 Badajoz;All ages;Cohort January 1;Total;Survival in the second trimester;2022QII;37.057
06 Badajoz;All ages;Cohort January 1;Total;Survival in the second trimester;2022QI;""
06 Badajoz;All ages;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
06 Badajoz;All ages;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
06 Badajoz;All ages;Cohort January 1;Total;Survival in the second trimester;2021QII;36.927
06 Badajoz;All ages;Cohort January 1;Total;Survival in the second trimester;2021QI;""
06 Badajoz;All ages;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
06 Badajoz;All ages;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
06 Badajoz;All ages;Cohort January 1;Total;Survival in the second trimester;2020QII;36.460
06 Badajoz;All ages;Cohort January 1;Total;Survival in the second trimester;2020QI;""
06 Badajoz;All ages;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
06 Badajoz;All ages;Cohort January 1;Total;Survival in the third trimester;2022QIII;36.115
06 Badajoz;All ages;Cohort January 1;Total;Survival in the third trimester;2022QII;""
06 Badajoz;All ages;Cohort January 1;Total;Survival in the third trimester;2022QI;""
06 Badajoz;All ages;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
06 Badajoz;All ages;Cohort January 1;Total;Survival in the third trimester;2021QIII;36.161
06 Badajoz;All ages;Cohort January 1;Total;Survival in the third trimester;2021QII;""
06 Badajoz;All ages;Cohort January 1;Total;Survival in the third trimester;2021QI;""
06 Badajoz;All ages;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
06 Badajoz;All ages;Cohort January 1;Total;Survival in the third trimester;2020QIII;35.585
06 Badajoz;All ages;Cohort January 1;Total;Survival in the third trimester;2020QII;""
06 Badajoz;All ages;Cohort January 1;Total;Survival in the third trimester;2020QI;""
06 Badajoz;All ages;Cohort January 1;Total;Survival in the third trimester;2022QIV;35.116
06 Badajoz;All ages;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
06 Badajoz;All ages;Cohort January 1;Total;Survival in the third trimester;2022QII;""
06 Badajoz;All ages;Cohort January 1;Total;Survival in the third trimester;2022QI;""
06 Badajoz;All ages;Cohort January 1;Total;Survival in the third trimester;2021QIV;35.223
06 Badajoz;All ages;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
06 Badajoz;All ages;Cohort January 1;Total;Survival in the third trimester;2021QII;""
06 Badajoz;All ages;Cohort January 1;Total;Survival in the third trimester;2021QI;""
06 Badajoz;All ages;Cohort January 1;Total;Survival in the third trimester;2020QIV;34.649
06 Badajoz;All ages;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
06 Badajoz;All ages;Cohort January 1;Total;Survival in the third trimester;2020QII;""
06 Badajoz;All ages;Cohort January 1;Total;Survival in the third trimester;2020QI;""
06 Badajoz;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
06 Badajoz;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
06 Badajoz;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
06 Badajoz;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
06 Badajoz;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
06 Badajoz;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
06 Badajoz;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
06 Badajoz;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
06 Badajoz;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
06 Badajoz;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
06 Badajoz;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
06 Badajoz;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
06 Badajoz;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
06 Badajoz;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
06 Badajoz;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
06 Badajoz;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;96,79
06 Badajoz;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
06 Badajoz;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
06 Badajoz;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
06 Badajoz;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;97,8
06 Badajoz;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
06 Badajoz;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
06 Badajoz;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
06 Badajoz;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;93,9
06 Badajoz;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
06 Badajoz;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
06 Badajoz;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;94,01
06 Badajoz;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
06 Badajoz;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
06 Badajoz;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
06 Badajoz;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;95,29
06 Badajoz;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
06 Badajoz;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
06 Badajoz;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
06 Badajoz;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;92,33
06 Badajoz;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
06 Badajoz;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
06 Badajoz;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;91,62
06 Badajoz;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
06 Badajoz;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
06 Badajoz;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
06 Badajoz;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;93,32
06 Badajoz;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
06 Badajoz;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
06 Badajoz;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
06 Badajoz;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;90,11
06 Badajoz;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
06 Badajoz;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
06 Badajoz;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;89,08
06 Badajoz;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
06 Badajoz;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
06 Badajoz;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
06 Badajoz;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;90,9
06 Badajoz;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
06 Badajoz;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
06 Badajoz;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
06 Badajoz;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;87,74
06 Badajoz;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
06 Badajoz;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
06 Badajoz;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
06 Badajoz;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
06 Badajoz;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
06 Badajoz;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
06 Badajoz;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QI;25.666
06 Badajoz;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
06 Badajoz;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
06 Badajoz;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
06 Badajoz;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QI;25.371
06 Badajoz;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
06 Badajoz;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
06 Badajoz;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
06 Badajoz;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QI;25.919
06 Badajoz;All ages;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
06 Badajoz;All ages;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
06 Badajoz;All ages;Cohort January 1;Males;Survival in the first trimester;2022QII;""
06 Badajoz;All ages;Cohort January 1;Males;Survival in the first trimester;2022QI;24.970
06 Badajoz;All ages;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
06 Badajoz;All ages;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
06 Badajoz;All ages;Cohort January 1;Males;Survival in the first trimester;2021QII;""
06 Badajoz;All ages;Cohort January 1;Males;Survival in the first trimester;2021QI;24.875
06 Badajoz;All ages;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
06 Badajoz;All ages;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
06 Badajoz;All ages;Cohort January 1;Males;Survival in the first trimester;2020QII;""
06 Badajoz;All ages;Cohort January 1;Males;Survival in the first trimester;2020QI;24.445
06 Badajoz;All ages;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
06 Badajoz;All ages;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
06 Badajoz;All ages;Cohort January 1;Males;Survival in the second trimester;2022QII;24.345
06 Badajoz;All ages;Cohort January 1;Males;Survival in the second trimester;2022QI;""
06 Badajoz;All ages;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
06 Badajoz;All ages;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
06 Badajoz;All ages;Cohort January 1;Males;Survival in the second trimester;2021QII;24.322
06 Badajoz;All ages;Cohort January 1;Males;Survival in the second trimester;2021QI;""
06 Badajoz;All ages;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
06 Badajoz;All ages;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
06 Badajoz;All ages;Cohort January 1;Males;Survival in the second trimester;2020QII;24.056
06 Badajoz;All ages;Cohort January 1;Males;Survival in the second trimester;2020QI;""
06 Badajoz;All ages;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
06 Badajoz;All ages;Cohort January 1;Males;Survival in the third trimester;2022QIII;23.800
06 Badajoz;All ages;Cohort January 1;Males;Survival in the third trimester;2022QII;""
06 Badajoz;All ages;Cohort January 1;Males;Survival in the third trimester;2022QI;""
06 Badajoz;All ages;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
06 Badajoz;All ages;Cohort January 1;Males;Survival in the third trimester;2021QIII;23.862
06 Badajoz;All ages;Cohort January 1;Males;Survival in the third trimester;2021QII;""
06 Badajoz;All ages;Cohort January 1;Males;Survival in the third trimester;2021QI;""
06 Badajoz;All ages;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
06 Badajoz;All ages;Cohort January 1;Males;Survival in the third trimester;2020QIII;23.580
06 Badajoz;All ages;Cohort January 1;Males;Survival in the third trimester;2020QII;""
06 Badajoz;All ages;Cohort January 1;Males;Survival in the third trimester;2020QI;""
06 Badajoz;All ages;Cohort January 1;Males;Survival in the third trimester;2022QIV;23.211
06 Badajoz;All ages;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
06 Badajoz;All ages;Cohort January 1;Males;Survival in the third trimester;2022QII;""
06 Badajoz;All ages;Cohort January 1;Males;Survival in the third trimester;2022QI;""
06 Badajoz;All ages;Cohort January 1;Males;Survival in the third trimester;2021QIV;23.311
06 Badajoz;All ages;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
06 Badajoz;All ages;Cohort January 1;Males;Survival in the third trimester;2021QII;""
06 Badajoz;All ages;Cohort January 1;Males;Survival in the third trimester;2021QI;""
06 Badajoz;All ages;Cohort January 1;Males;Survival in the third trimester;2020QIV;23.008
06 Badajoz;All ages;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
06 Badajoz;All ages;Cohort January 1;Males;Survival in the third trimester;2020QII;""
06 Badajoz;All ages;Cohort January 1;Males;Survival in the third trimester;2020QI;""
06 Badajoz;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
06 Badajoz;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
06 Badajoz;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
06 Badajoz;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
06 Badajoz;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
06 Badajoz;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
06 Badajoz;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
06 Badajoz;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
06 Badajoz;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
06 Badajoz;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
06 Badajoz;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
06 Badajoz;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
06 Badajoz;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
06 Badajoz;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
06 Badajoz;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
06 Badajoz;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;97,29
06 Badajoz;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
06 Badajoz;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
06 Badajoz;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
06 Badajoz;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;98,05
06 Badajoz;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
06 Badajoz;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
06 Badajoz;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
06 Badajoz;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;94,31
06 Badajoz;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
06 Badajoz;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
06 Badajoz;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;94,85
06 Badajoz;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
06 Badajoz;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
06 Badajoz;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
06 Badajoz;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;95,87
06 Badajoz;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
06 Badajoz;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
06 Badajoz;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
06 Badajoz;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;92,81
06 Badajoz;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
06 Badajoz;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
06 Badajoz;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;92,73
06 Badajoz;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
06 Badajoz;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
06 Badajoz;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
06 Badajoz;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;94,05
06 Badajoz;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
06 Badajoz;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
06 Badajoz;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
06 Badajoz;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;90,98
06 Badajoz;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
06 Badajoz;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
06 Badajoz;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;90,43
06 Badajoz;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
06 Badajoz;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
06 Badajoz;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
06 Badajoz;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;91,88
06 Badajoz;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
06 Badajoz;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
06 Badajoz;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
06 Badajoz;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;88,77
06 Badajoz;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
06 Badajoz;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
06 Badajoz;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
06 Badajoz;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
06 Badajoz;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
06 Badajoz;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
06 Badajoz;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QI;13.753
06 Badajoz;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
06 Badajoz;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
06 Badajoz;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
06 Badajoz;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QI;13.380
06 Badajoz;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
06 Badajoz;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
06 Badajoz;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
06 Badajoz;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QI;13.571
06 Badajoz;All ages;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
06 Badajoz;All ages;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
06 Badajoz;All ages;Cohort January 1;Females;Survival in the first trimester;2022QII;""
06 Badajoz;All ages;Cohort January 1;Females;Survival in the first trimester;2022QI;13.184
06 Badajoz;All ages;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
06 Badajoz;All ages;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
06 Badajoz;All ages;Cohort January 1;Females;Survival in the first trimester;2021QII;""
06 Badajoz;All ages;Cohort January 1;Females;Survival in the first trimester;2021QI;13.023
06 Badajoz;All ages;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
06 Badajoz;All ages;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
06 Badajoz;All ages;Cohort January 1;Females;Survival in the first trimester;2020QII;""
06 Badajoz;All ages;Cohort January 1;Females;Survival in the first trimester;2020QI;12.635
06 Badajoz;All ages;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
06 Badajoz;All ages;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
06 Badajoz;All ages;Cohort January 1;Females;Survival in the second trimester;2022QII;12.712
06 Badajoz;All ages;Cohort January 1;Females;Survival in the second trimester;2022QI;""
06 Badajoz;All ages;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
06 Badajoz;All ages;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
06 Badajoz;All ages;Cohort January 1;Females;Survival in the second trimester;2021QII;12.605
06 Badajoz;All ages;Cohort January 1;Females;Survival in the second trimester;2021QI;""
06 Badajoz;All ages;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
06 Badajoz;All ages;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
06 Badajoz;All ages;Cohort January 1;Females;Survival in the second trimester;2020QII;12.404
06 Badajoz;All ages;Cohort January 1;Females;Survival in the second trimester;2020QI;""
06 Badajoz;All ages;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
06 Badajoz;All ages;Cohort January 1;Females;Survival in the third trimester;2022QIII;12.315
06 Badajoz;All ages;Cohort January 1;Females;Survival in the third trimester;2022QII;""
06 Badajoz;All ages;Cohort January 1;Females;Survival in the third trimester;2022QI;""
06 Badajoz;All ages;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
06 Badajoz;All ages;Cohort January 1;Females;Survival in the third trimester;2021QIII;12.299
06 Badajoz;All ages;Cohort January 1;Females;Survival in the third trimester;2021QII;""
06 Badajoz;All ages;Cohort January 1;Females;Survival in the third trimester;2021QI;""
06 Badajoz;All ages;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
06 Badajoz;All ages;Cohort January 1;Females;Survival in the third trimester;2020QIII;12.005
06 Badajoz;All ages;Cohort January 1;Females;Survival in the third trimester;2020QII;""
06 Badajoz;All ages;Cohort January 1;Females;Survival in the third trimester;2020QI;""
06 Badajoz;All ages;Cohort January 1;Females;Survival in the third trimester;2022QIV;11.905
06 Badajoz;All ages;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
06 Badajoz;All ages;Cohort January 1;Females;Survival in the third trimester;2022QII;""
06 Badajoz;All ages;Cohort January 1;Females;Survival in the third trimester;2022QI;""
06 Badajoz;All ages;Cohort January 1;Females;Survival in the third trimester;2021QIV;11.912
06 Badajoz;All ages;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
06 Badajoz;All ages;Cohort January 1;Females;Survival in the third trimester;2021QII;""
06 Badajoz;All ages;Cohort January 1;Females;Survival in the third trimester;2021QI;""
06 Badajoz;All ages;Cohort January 1;Females;Survival in the third trimester;2020QIV;11.641
06 Badajoz;All ages;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
06 Badajoz;All ages;Cohort January 1;Females;Survival in the third trimester;2020QII;""
06 Badajoz;All ages;Cohort January 1;Females;Survival in the third trimester;2020QI;""
06 Badajoz;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
06 Badajoz;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
06 Badajoz;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
06 Badajoz;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
06 Badajoz;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
06 Badajoz;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
06 Badajoz;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
06 Badajoz;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
06 Badajoz;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
06 Badajoz;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
06 Badajoz;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
06 Badajoz;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
06 Badajoz;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
06 Badajoz;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
06 Badajoz;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
06 Badajoz;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;95,86
06 Badajoz;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
06 Badajoz;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
06 Badajoz;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
06 Badajoz;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;97,33
06 Badajoz;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
06 Badajoz;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
06 Badajoz;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
06 Badajoz;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;93,1
06 Badajoz;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
06 Badajoz;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
06 Badajoz;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;92,43
06 Badajoz;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
06 Badajoz;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
06 Badajoz;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
06 Badajoz;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;94,21
06 Badajoz;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
06 Badajoz;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
06 Badajoz;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
06 Badajoz;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;91,4
06 Badajoz;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
06 Badajoz;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
06 Badajoz;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;89,54
06 Badajoz;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
06 Badajoz;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
06 Badajoz;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
06 Badajoz;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;91,92
06 Badajoz;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
06 Badajoz;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
06 Badajoz;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
06 Badajoz;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;88,46
06 Badajoz;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
06 Badajoz;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
06 Badajoz;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;86,56
06 Badajoz;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
06 Badajoz;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
06 Badajoz;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
06 Badajoz;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;89,03
06 Badajoz;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
06 Badajoz;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
06 Badajoz;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
06 Badajoz;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;85,78
06 Badajoz;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
06 Badajoz;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
06 Badajoz;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
06 Badajoz;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
06 Badajoz;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
06 Badajoz;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QII;39.943
06 Badajoz;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
06 Badajoz;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
06 Badajoz;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
06 Badajoz;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QII;38.886
06 Badajoz;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
06 Badajoz;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
06 Badajoz;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
06 Badajoz;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QII;38.749
06 Badajoz;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
06 Badajoz;All ages;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
06 Badajoz;All ages;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
06 Badajoz;All ages;Cohort April 1;Total;Survival in the first trimester;2022QII;38.746
06 Badajoz;All ages;Cohort April 1;Total;Survival in the first trimester;2022QI;""
06 Badajoz;All ages;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
06 Badajoz;All ages;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
06 Badajoz;All ages;Cohort April 1;Total;Survival in the first trimester;2021QII;37.801
06 Badajoz;All ages;Cohort April 1;Total;Survival in the first trimester;2021QI;""
06 Badajoz;All ages;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
06 Badajoz;All ages;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
06 Badajoz;All ages;Cohort April 1;Total;Survival in the first trimester;2020QII;38.076
06 Badajoz;All ages;Cohort April 1;Total;Survival in the first trimester;2020QI;""
06 Badajoz;All ages;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
06 Badajoz;All ages;Cohort April 1;Total;Survival in the second trimester;2022QIII;37.746
06 Badajoz;All ages;Cohort April 1;Total;Survival in the second trimester;2022QII;""
06 Badajoz;All ages;Cohort April 1;Total;Survival in the second trimester;2022QI;""
06 Badajoz;All ages;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
06 Badajoz;All ages;Cohort April 1;Total;Survival in the second trimester;2021QIII;36.971
06 Badajoz;All ages;Cohort April 1;Total;Survival in the second trimester;2021QII;""
06 Badajoz;All ages;Cohort April 1;Total;Survival in the second trimester;2021QI;""
06 Badajoz;All ages;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
06 Badajoz;All ages;Cohort April 1;Total;Survival in the second trimester;2020QIII;37.103
06 Badajoz;All ages;Cohort April 1;Total;Survival in the second trimester;2020QII;""
06 Badajoz;All ages;Cohort April 1;Total;Survival in the second trimester;2020QI;""
06 Badajoz;All ages;Cohort April 1;Total;Survival in the third trimester;2022QIV;36.692
06 Badajoz;All ages;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
06 Badajoz;All ages;Cohort April 1;Total;Survival in the third trimester;2022QII;""
06 Badajoz;All ages;Cohort April 1;Total;Survival in the third trimester;2022QI;""
06 Badajoz;All ages;Cohort April 1;Total;Survival in the third trimester;2021QIV;35.972
06 Badajoz;All ages;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
06 Badajoz;All ages;Cohort April 1;Total;Survival in the third trimester;2021QII;""
06 Badajoz;All ages;Cohort April 1;Total;Survival in the third trimester;2021QI;""
06 Badajoz;All ages;Cohort April 1;Total;Survival in the third trimester;2020QIV;36.109
06 Badajoz;All ages;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
06 Badajoz;All ages;Cohort April 1;Total;Survival in the third trimester;2020QII;""
06 Badajoz;All ages;Cohort April 1;Total;Survival in the third trimester;2020QI;""
06 Badajoz;All ages;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
06 Badajoz;All ages;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
06 Badajoz;All ages;Cohort April 1;Total;Survival in the third trimester;2022QII;""
06 Badajoz;All ages;Cohort April 1;Total;Survival in the third trimester;2022QI;34.894
06 Badajoz;All ages;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
06 Badajoz;All ages;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
06 Badajoz;All ages;Cohort April 1;Total;Survival in the third trimester;2021QII;""
06 Badajoz;All ages;Cohort April 1;Total;Survival in the third trimester;2021QI;35.441
06 Badajoz;All ages;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
06 Badajoz;All ages;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
06 Badajoz;All ages;Cohort April 1;Total;Survival in the third trimester;2020QII;""
06 Badajoz;All ages;Cohort April 1;Total;Survival in the third trimester;2020QI;""
06 Badajoz;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
06 Badajoz;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
06 Badajoz;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
06 Badajoz;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
06 Badajoz;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
06 Badajoz;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
06 Badajoz;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
06 Badajoz;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
06 Badajoz;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
06 Badajoz;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
06 Badajoz;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
06 Badajoz;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
06 Badajoz;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
06 Badajoz;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
06 Badajoz;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;97
06 Badajoz;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
06 Badajoz;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
06 Badajoz;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
06 Badajoz;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;97,21
06 Badajoz;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
06 Badajoz;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
06 Badajoz;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
06 Badajoz;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;98,26
06 Badajoz;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
06 Badajoz;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
06 Badajoz;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;94,5
06 Badajoz;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
06 Badajoz;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
06 Badajoz;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
06 Badajoz;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;95,08
06 Badajoz;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
06 Badajoz;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
06 Badajoz;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
06 Badajoz;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;95,75
06 Badajoz;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
06 Badajoz;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
06 Badajoz;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;91,86
06 Badajoz;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
06 Badajoz;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
06 Badajoz;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
06 Badajoz;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;92,51
06 Badajoz;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
06 Badajoz;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
06 Badajoz;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
06 Badajoz;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;93,19
06 Badajoz;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
06 Badajoz;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
06 Badajoz;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
06 Badajoz;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
06 Badajoz;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
06 Badajoz;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
06 Badajoz;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;89,73
06 Badajoz;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
06 Badajoz;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
06 Badajoz;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
06 Badajoz;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;91,46
06 Badajoz;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
06 Badajoz;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
06 Badajoz;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
06 Badajoz;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
06 Badajoz;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
06 Badajoz;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
06 Badajoz;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QII;25.943
06 Badajoz;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
06 Badajoz;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
06 Badajoz;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
06 Badajoz;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QII;25.517
06 Badajoz;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
06 Badajoz;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
06 Badajoz;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
06 Badajoz;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QII;25.363
06 Badajoz;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
06 Badajoz;All ages;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
06 Badajoz;All ages;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
06 Badajoz;All ages;Cohort April 1;Males;Survival in the first trimester;2022QII;25.256
06 Badajoz;All ages;Cohort April 1;Males;Survival in the first trimester;2022QI;""
06 Badajoz;All ages;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
06 Badajoz;All ages;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
06 Badajoz;All ages;Cohort April 1;Males;Survival in the first trimester;2021QII;24.891
06 Badajoz;All ages;Cohort April 1;Males;Survival in the first trimester;2021QI;""
06 Badajoz;All ages;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
06 Badajoz;All ages;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
06 Badajoz;All ages;Cohort April 1;Males;Survival in the first trimester;2020QII;24.943
06 Badajoz;All ages;Cohort April 1;Males;Survival in the first trimester;2020QI;""
06 Badajoz;All ages;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
06 Badajoz;All ages;Cohort April 1;Males;Survival in the second trimester;2022QIII;24.674
06 Badajoz;All ages;Cohort April 1;Males;Survival in the second trimester;2022QII;""
06 Badajoz;All ages;Cohort April 1;Males;Survival in the second trimester;2022QI;""
06 Badajoz;All ages;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
06 Badajoz;All ages;Cohort April 1;Males;Survival in the second trimester;2021QIII;24.385
06 Badajoz;All ages;Cohort April 1;Males;Survival in the second trimester;2021QII;""
06 Badajoz;All ages;Cohort April 1;Males;Survival in the second trimester;2021QI;""
06 Badajoz;All ages;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
06 Badajoz;All ages;Cohort April 1;Males;Survival in the second trimester;2020QIII;24.397
06 Badajoz;All ages;Cohort April 1;Males;Survival in the second trimester;2020QII;""
06 Badajoz;All ages;Cohort April 1;Males;Survival in the second trimester;2020QI;""
06 Badajoz;All ages;Cohort April 1;Males;Survival in the third trimester;2022QIV;24.054
06 Badajoz;All ages;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
06 Badajoz;All ages;Cohort April 1;Males;Survival in the third trimester;2022QII;""
06 Badajoz;All ages;Cohort April 1;Males;Survival in the third trimester;2022QI;""
06 Badajoz;All ages;Cohort April 1;Males;Survival in the third trimester;2021QIV;23.791
06 Badajoz;All ages;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
06 Badajoz;All ages;Cohort April 1;Males;Survival in the third trimester;2021QII;""
06 Badajoz;All ages;Cohort April 1;Males;Survival in the third trimester;2021QI;""
06 Badajoz;All ages;Cohort April 1;Males;Survival in the third trimester;2020QIV;23.789
06 Badajoz;All ages;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
06 Badajoz;All ages;Cohort April 1;Males;Survival in the third trimester;2020QII;""
06 Badajoz;All ages;Cohort April 1;Males;Survival in the third trimester;2020QI;""
06 Badajoz;All ages;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
06 Badajoz;All ages;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
06 Badajoz;All ages;Cohort April 1;Males;Survival in the third trimester;2022QII;""
06 Badajoz;All ages;Cohort April 1;Males;Survival in the third trimester;2022QI;23.215
06 Badajoz;All ages;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
06 Badajoz;All ages;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
06 Badajoz;All ages;Cohort April 1;Males;Survival in the third trimester;2021QII;""
06 Badajoz;All ages;Cohort April 1;Males;Survival in the third trimester;2021QI;23.415
06 Badajoz;All ages;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
06 Badajoz;All ages;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
06 Badajoz;All ages;Cohort April 1;Males;Survival in the third trimester;2020QII;""
06 Badajoz;All ages;Cohort April 1;Males;Survival in the third trimester;2020QI;""
06 Badajoz;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
06 Badajoz;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
06 Badajoz;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
06 Badajoz;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
06 Badajoz;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
06 Badajoz;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
06 Badajoz;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
06 Badajoz;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
06 Badajoz;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
06 Badajoz;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
06 Badajoz;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
06 Badajoz;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
06 Badajoz;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
06 Badajoz;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
06 Badajoz;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;97,35
06 Badajoz;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
06 Badajoz;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
06 Badajoz;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
06 Badajoz;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;97,55
06 Badajoz;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
06 Badajoz;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
06 Badajoz;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
06 Badajoz;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;98,34
06 Badajoz;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
06 Badajoz;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
06 Badajoz;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;95,11
06 Badajoz;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
06 Badajoz;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
06 Badajoz;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
06 Badajoz;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;95,56
06 Badajoz;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
06 Badajoz;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
06 Badajoz;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
06 Badajoz;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;96,19
06 Badajoz;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
06 Badajoz;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
06 Badajoz;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;92,72
06 Badajoz;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
06 Badajoz;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
06 Badajoz;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
06 Badajoz;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;93,24
06 Badajoz;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
06 Badajoz;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
06 Badajoz;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
06 Badajoz;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;93,79
06 Badajoz;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
06 Badajoz;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
06 Badajoz;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
06 Badajoz;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
06 Badajoz;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
06 Badajoz;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
06 Badajoz;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;90,98
06 Badajoz;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
06 Badajoz;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
06 Badajoz;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
06 Badajoz;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;92,32
06 Badajoz;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
06 Badajoz;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
06 Badajoz;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
06 Badajoz;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
06 Badajoz;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
06 Badajoz;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
06 Badajoz;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QII;14.000
06 Badajoz;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
06 Badajoz;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
06 Badajoz;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
06 Badajoz;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QII;13.369
06 Badajoz;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
06 Badajoz;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
06 Badajoz;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
06 Badajoz;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QII;13.386
06 Badajoz;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
06 Badajoz;All ages;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
06 Badajoz;All ages;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
06 Badajoz;All ages;Cohort April 1;Females;Survival in the first trimester;2022QII;13.490
06 Badajoz;All ages;Cohort April 1;Females;Survival in the first trimester;2022QI;""
06 Badajoz;All ages;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
06 Badajoz;All ages;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
06 Badajoz;All ages;Cohort April 1;Females;Survival in the first trimester;2021QII;12.910
06 Badajoz;All ages;Cohort April 1;Females;Survival in the first trimester;2021QI;""
06 Badajoz;All ages;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
06 Badajoz;All ages;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
06 Badajoz;All ages;Cohort April 1;Females;Survival in the first trimester;2020QII;13.133
06 Badajoz;All ages;Cohort April 1;Females;Survival in the first trimester;2020QI;""
06 Badajoz;All ages;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
06 Badajoz;All ages;Cohort April 1;Females;Survival in the second trimester;2022QIII;13.072
06 Badajoz;All ages;Cohort April 1;Females;Survival in the second trimester;2022QII;""
06 Badajoz;All ages;Cohort April 1;Females;Survival in the second trimester;2022QI;""
06 Badajoz;All ages;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
06 Badajoz;All ages;Cohort April 1;Females;Survival in the second trimester;2021QIII;12.586
06 Badajoz;All ages;Cohort April 1;Females;Survival in the second trimester;2021QII;""
06 Badajoz;All ages;Cohort April 1;Females;Survival in the second trimester;2021QI;""
06 Badajoz;All ages;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
06 Badajoz;All ages;Cohort April 1;Females;Survival in the second trimester;2020QIII;12.706
06 Badajoz;All ages;Cohort April 1;Females;Survival in the second trimester;2020QII;""
06 Badajoz;All ages;Cohort April 1;Females;Survival in the second trimester;2020QI;""
06 Badajoz;All ages;Cohort April 1;Females;Survival in the third trimester;2022QIV;12.638
06 Badajoz;All ages;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
06 Badajoz;All ages;Cohort April 1;Females;Survival in the third trimester;2022QII;""
06 Badajoz;All ages;Cohort April 1;Females;Survival in the third trimester;2022QI;""
06 Badajoz;All ages;Cohort April 1;Females;Survival in the third trimester;2021QIV;12.181
06 Badajoz;All ages;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
06 Badajoz;All ages;Cohort April 1;Females;Survival in the third trimester;2021QII;""
06 Badajoz;All ages;Cohort April 1;Females;Survival in the third trimester;2021QI;""
06 Badajoz;All ages;Cohort April 1;Females;Survival in the third trimester;2020QIV;12.320
06 Badajoz;All ages;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
06 Badajoz;All ages;Cohort April 1;Females;Survival in the third trimester;2020QII;""
06 Badajoz;All ages;Cohort April 1;Females;Survival in the third trimester;2020QI;""
06 Badajoz;All ages;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
06 Badajoz;All ages;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
06 Badajoz;All ages;Cohort April 1;Females;Survival in the third trimester;2022QII;""
06 Badajoz;All ages;Cohort April 1;Females;Survival in the third trimester;2022QI;11.679
06 Badajoz;All ages;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
06 Badajoz;All ages;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
06 Badajoz;All ages;Cohort April 1;Females;Survival in the third trimester;2021QII;""
06 Badajoz;All ages;Cohort April 1;Females;Survival in the third trimester;2021QI;12.026
06 Badajoz;All ages;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
06 Badajoz;All ages;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
06 Badajoz;All ages;Cohort April 1;Females;Survival in the third trimester;2020QII;""
06 Badajoz;All ages;Cohort April 1;Females;Survival in the third trimester;2020QI;""
06 Badajoz;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
06 Badajoz;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
06 Badajoz;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
06 Badajoz;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
06 Badajoz;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
06 Badajoz;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
06 Badajoz;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
06 Badajoz;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
06 Badajoz;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
06 Badajoz;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
06 Badajoz;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
06 Badajoz;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
06 Badajoz;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
06 Badajoz;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
06 Badajoz;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;96,36
06 Badajoz;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
06 Badajoz;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
06 Badajoz;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
06 Badajoz;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;96,57
06 Badajoz;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
06 Badajoz;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
06 Badajoz;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
06 Badajoz;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;98,11
06 Badajoz;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
06 Badajoz;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
06 Badajoz;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;93,37
06 Badajoz;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
06 Badajoz;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
06 Badajoz;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
06 Badajoz;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;94,14
06 Badajoz;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
06 Badajoz;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
06 Badajoz;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
06 Badajoz;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;94,92
06 Badajoz;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
06 Badajoz;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
06 Badajoz;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;90,27
06 Badajoz;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
06 Badajoz;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
06 Badajoz;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
06 Badajoz;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;91,11
06 Badajoz;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
06 Badajoz;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
06 Badajoz;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
06 Badajoz;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;92,04
06 Badajoz;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
06 Badajoz;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
06 Badajoz;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
06 Badajoz;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
06 Badajoz;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
06 Badajoz;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
06 Badajoz;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;87,36
06 Badajoz;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
06 Badajoz;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
06 Badajoz;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
06 Badajoz;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;89,84
06 Badajoz;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
06 Badajoz;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
06 Badajoz;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
06 Badajoz;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
06 Badajoz;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
06 Badajoz;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QIII;39.674
06 Badajoz;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
06 Badajoz;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
06 Badajoz;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
06 Badajoz;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QIII;39.180
06 Badajoz;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
06 Badajoz;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
06 Badajoz;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
06 Badajoz;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QIII;39.103
06 Badajoz;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
06 Badajoz;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
06 Badajoz;All ages;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
06 Badajoz;All ages;Cohort July 1;Total;Survival in the first trimester;2022QIII;38.487
06 Badajoz;All ages;Cohort July 1;Total;Survival in the first trimester;2022QII;""
06 Badajoz;All ages;Cohort July 1;Total;Survival in the first trimester;2022QI;""
06 Badajoz;All ages;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
06 Badajoz;All ages;Cohort July 1;Total;Survival in the first trimester;2021QIII;38.206
06 Badajoz;All ages;Cohort July 1;Total;Survival in the first trimester;2021QII;""
06 Badajoz;All ages;Cohort July 1;Total;Survival in the first trimester;2021QI;""
06 Badajoz;All ages;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
06 Badajoz;All ages;Cohort July 1;Total;Survival in the first trimester;2020QIII;37.965
06 Badajoz;All ages;Cohort July 1;Total;Survival in the first trimester;2020QII;""
06 Badajoz;All ages;Cohort July 1;Total;Survival in the first trimester;2020QI;""
06 Badajoz;All ages;Cohort July 1;Total;Survival in the second trimester;2022QIV;37.306
06 Badajoz;All ages;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
06 Badajoz;All ages;Cohort July 1;Total;Survival in the second trimester;2022QII;""
06 Badajoz;All ages;Cohort July 1;Total;Survival in the second trimester;2022QI;""
06 Badajoz;All ages;Cohort July 1;Total;Survival in the second trimester;2021QIV;37.101
06 Badajoz;All ages;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
06 Badajoz;All ages;Cohort July 1;Total;Survival in the second trimester;2021QII;""
06 Badajoz;All ages;Cohort July 1;Total;Survival in the second trimester;2021QI;""
06 Badajoz;All ages;Cohort July 1;Total;Survival in the second trimester;2020QIV;36.863
06 Badajoz;All ages;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
06 Badajoz;All ages;Cohort July 1;Total;Survival in the second trimester;2020QII;""
06 Badajoz;All ages;Cohort July 1;Total;Survival in the second trimester;2020QI;""
06 Badajoz;All ages;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
06 Badajoz;All ages;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
06 Badajoz;All ages;Cohort July 1;Total;Survival in the third trimester;2022QII;""
06 Badajoz;All ages;Cohort July 1;Total;Survival in the third trimester;2022QI;35.980
06 Badajoz;All ages;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
06 Badajoz;All ages;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
06 Badajoz;All ages;Cohort July 1;Total;Survival in the third trimester;2021QII;""
06 Badajoz;All ages;Cohort July 1;Total;Survival in the third trimester;2021QI;36.163
06 Badajoz;All ages;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
06 Badajoz;All ages;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
06 Badajoz;All ages;Cohort July 1;Total;Survival in the third trimester;2020QII;""
06 Badajoz;All ages;Cohort July 1;Total;Survival in the third trimester;2020QI;""
06 Badajoz;All ages;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
06 Badajoz;All ages;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
06 Badajoz;All ages;Cohort July 1;Total;Survival in the third trimester;2022QII;35.023
06 Badajoz;All ages;Cohort July 1;Total;Survival in the third trimester;2022QI;""
06 Badajoz;All ages;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
06 Badajoz;All ages;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
06 Badajoz;All ages;Cohort July 1;Total;Survival in the third trimester;2021QII;35.323
06 Badajoz;All ages;Cohort July 1;Total;Survival in the third trimester;2021QI;""
06 Badajoz;All ages;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
06 Badajoz;All ages;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
06 Badajoz;All ages;Cohort July 1;Total;Survival in the third trimester;2020QII;""
06 Badajoz;All ages;Cohort July 1;Total;Survival in the third trimester;2020QI;""
06 Badajoz;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
06 Badajoz;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
06 Badajoz;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
06 Badajoz;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
06 Badajoz;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
06 Badajoz;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
06 Badajoz;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
06 Badajoz;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
06 Badajoz;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
06 Badajoz;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
06 Badajoz;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
06 Badajoz;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
06 Badajoz;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
06 Badajoz;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;97,01
06 Badajoz;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
06 Badajoz;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
06 Badajoz;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
06 Badajoz;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;97,51
06 Badajoz;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
06 Badajoz;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
06 Badajoz;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
06 Badajoz;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;97,09
06 Badajoz;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
06 Badajoz;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
06 Badajoz;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;94,03
06 Badajoz;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
06 Badajoz;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
06 Badajoz;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
06 Badajoz;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;94,69
06 Badajoz;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
06 Badajoz;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
06 Badajoz;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
06 Badajoz;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;94,27
06 Badajoz;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
06 Badajoz;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
06 Badajoz;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
06 Badajoz;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
06 Badajoz;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
06 Badajoz;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
06 Badajoz;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;91,83
06 Badajoz;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
06 Badajoz;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
06 Badajoz;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
06 Badajoz;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;92,48
06 Badajoz;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
06 Badajoz;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
06 Badajoz;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
06 Badajoz;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
06 Badajoz;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
06 Badajoz;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
06 Badajoz;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;89,39
06 Badajoz;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
06 Badajoz;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
06 Badajoz;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
06 Badajoz;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;90,33
06 Badajoz;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
06 Badajoz;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
06 Badajoz;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
06 Badajoz;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
06 Badajoz;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
06 Badajoz;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
06 Badajoz;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QIII;25.835
06 Badajoz;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
06 Badajoz;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
06 Badajoz;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
06 Badajoz;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QIII;25.693
06 Badajoz;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
06 Badajoz;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
06 Badajoz;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
06 Badajoz;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QIII;25.654
06 Badajoz;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
06 Badajoz;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
06 Badajoz;All ages;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
06 Badajoz;All ages;Cohort July 1;Males;Survival in the first trimester;2022QIII;25.133
06 Badajoz;All ages;Cohort July 1;Males;Survival in the first trimester;2022QII;""
06 Badajoz;All ages;Cohort July 1;Males;Survival in the first trimester;2022QI;""
06 Badajoz;All ages;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
06 Badajoz;All ages;Cohort July 1;Males;Survival in the first trimester;2021QIII;25.092
06 Badajoz;All ages;Cohort July 1;Males;Survival in the first trimester;2021QII;""
06 Badajoz;All ages;Cohort July 1;Males;Survival in the first trimester;2021QI;""
06 Badajoz;All ages;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
06 Badajoz;All ages;Cohort July 1;Males;Survival in the first trimester;2020QIII;24.984
06 Badajoz;All ages;Cohort July 1;Males;Survival in the first trimester;2020QII;""
06 Badajoz;All ages;Cohort July 1;Males;Survival in the first trimester;2020QI;""
06 Badajoz;All ages;Cohort July 1;Males;Survival in the second trimester;2022QIV;24.425
06 Badajoz;All ages;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
06 Badajoz;All ages;Cohort July 1;Males;Survival in the second trimester;2022QII;""
06 Badajoz;All ages;Cohort July 1;Males;Survival in the second trimester;2022QI;""
06 Badajoz;All ages;Cohort July 1;Males;Survival in the second trimester;2021QIV;24.409
06 Badajoz;All ages;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
06 Badajoz;All ages;Cohort July 1;Males;Survival in the second trimester;2021QII;""
06 Badajoz;All ages;Cohort July 1;Males;Survival in the second trimester;2021QI;""
06 Badajoz;All ages;Cohort July 1;Males;Survival in the second trimester;2020QIV;24.288
06 Badajoz;All ages;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
06 Badajoz;All ages;Cohort July 1;Males;Survival in the second trimester;2020QII;""
06 Badajoz;All ages;Cohort July 1;Males;Survival in the second trimester;2020QI;""
06 Badajoz;All ages;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
06 Badajoz;All ages;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
06 Badajoz;All ages;Cohort July 1;Males;Survival in the third trimester;2022QII;""
06 Badajoz;All ages;Cohort July 1;Males;Survival in the third trimester;2022QI;23.805
06 Badajoz;All ages;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
06 Badajoz;All ages;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
06 Badajoz;All ages;Cohort July 1;Males;Survival in the third trimester;2021QII;""
06 Badajoz;All ages;Cohort July 1;Males;Survival in the third trimester;2021QI;23.891
06 Badajoz;All ages;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
06 Badajoz;All ages;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
06 Badajoz;All ages;Cohort July 1;Males;Survival in the third trimester;2020QII;""
06 Badajoz;All ages;Cohort July 1;Males;Survival in the third trimester;2020QI;""
06 Badajoz;All ages;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
06 Badajoz;All ages;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
06 Badajoz;All ages;Cohort July 1;Males;Survival in the third trimester;2022QII;23.254
06 Badajoz;All ages;Cohort July 1;Males;Survival in the third trimester;2022QI;""
06 Badajoz;All ages;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
06 Badajoz;All ages;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
06 Badajoz;All ages;Cohort July 1;Males;Survival in the third trimester;2021QII;23.411
06 Badajoz;All ages;Cohort July 1;Males;Survival in the third trimester;2021QI;""
06 Badajoz;All ages;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
06 Badajoz;All ages;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
06 Badajoz;All ages;Cohort July 1;Males;Survival in the third trimester;2020QII;""
06 Badajoz;All ages;Cohort July 1;Males;Survival in the third trimester;2020QI;""
06 Badajoz;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
06 Badajoz;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
06 Badajoz;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
06 Badajoz;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
06 Badajoz;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
06 Badajoz;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
06 Badajoz;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
06 Badajoz;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
06 Badajoz;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
06 Badajoz;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
06 Badajoz;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
06 Badajoz;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
06 Badajoz;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
06 Badajoz;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;97,28
06 Badajoz;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
06 Badajoz;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
06 Badajoz;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
06 Badajoz;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;97,66
06 Badajoz;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
06 Badajoz;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
06 Badajoz;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
06 Badajoz;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;97,39
06 Badajoz;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
06 Badajoz;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
06 Badajoz;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;94,54
06 Badajoz;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
06 Badajoz;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
06 Badajoz;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
06 Badajoz;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;95
06 Badajoz;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
06 Badajoz;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
06 Badajoz;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
06 Badajoz;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;94,68
06 Badajoz;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
06 Badajoz;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
06 Badajoz;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
06 Badajoz;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
06 Badajoz;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
06 Badajoz;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
06 Badajoz;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;92,65
06 Badajoz;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
06 Badajoz;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
06 Badajoz;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
06 Badajoz;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;93,13
06 Badajoz;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
06 Badajoz;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
06 Badajoz;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
06 Badajoz;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
06 Badajoz;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
06 Badajoz;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
06 Badajoz;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;90,51
06 Badajoz;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
06 Badajoz;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
06 Badajoz;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
06 Badajoz;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;91,26
06 Badajoz;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
06 Badajoz;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
06 Badajoz;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
06 Badajoz;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
06 Badajoz;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
06 Badajoz;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
06 Badajoz;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QIII;13.839
06 Badajoz;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
06 Badajoz;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
06 Badajoz;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
06 Badajoz;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QIII;13.487
06 Badajoz;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
06 Badajoz;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
06 Badajoz;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
06 Badajoz;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QIII;13.449
06 Badajoz;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
06 Badajoz;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
06 Badajoz;All ages;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
06 Badajoz;All ages;Cohort July 1;Females;Survival in the first trimester;2022QIII;13.354
06 Badajoz;All ages;Cohort July 1;Females;Survival in the first trimester;2022QII;""
06 Badajoz;All ages;Cohort July 1;Females;Survival in the first trimester;2022QI;""
06 Badajoz;All ages;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
06 Badajoz;All ages;Cohort July 1;Females;Survival in the first trimester;2021QIII;13.114
06 Badajoz;All ages;Cohort July 1;Females;Survival in the first trimester;2021QII;""
06 Badajoz;All ages;Cohort July 1;Females;Survival in the first trimester;2021QI;""
06 Badajoz;All ages;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
06 Badajoz;All ages;Cohort July 1;Females;Survival in the first trimester;2020QIII;12.981
06 Badajoz;All ages;Cohort July 1;Females;Survival in the first trimester;2020QII;""
06 Badajoz;All ages;Cohort July 1;Females;Survival in the first trimester;2020QI;""
06 Badajoz;All ages;Cohort July 1;Females;Survival in the second trimester;2022QIV;12.881
06 Badajoz;All ages;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
06 Badajoz;All ages;Cohort July 1;Females;Survival in the second trimester;2022QII;""
06 Badajoz;All ages;Cohort July 1;Females;Survival in the second trimester;2022QI;""
06 Badajoz;All ages;Cohort July 1;Females;Survival in the second trimester;2021QIV;12.692
06 Badajoz;All ages;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
06 Badajoz;All ages;Cohort July 1;Females;Survival in the second trimester;2021QII;""
06 Badajoz;All ages;Cohort July 1;Females;Survival in the second trimester;2021QI;""
06 Badajoz;All ages;Cohort July 1;Females;Survival in the second trimester;2020QIV;12.575
06 Badajoz;All ages;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
06 Badajoz;All ages;Cohort July 1;Females;Survival in the second trimester;2020QII;""
06 Badajoz;All ages;Cohort July 1;Females;Survival in the second trimester;2020QI;""
06 Badajoz;All ages;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
06 Badajoz;All ages;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
06 Badajoz;All ages;Cohort July 1;Females;Survival in the third trimester;2022QII;""
06 Badajoz;All ages;Cohort July 1;Females;Survival in the third trimester;2022QI;12.175
06 Badajoz;All ages;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
06 Badajoz;All ages;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
06 Badajoz;All ages;Cohort July 1;Females;Survival in the third trimester;2021QII;""
06 Badajoz;All ages;Cohort July 1;Females;Survival in the third trimester;2021QI;12.272
06 Badajoz;All ages;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
06 Badajoz;All ages;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
06 Badajoz;All ages;Cohort July 1;Females;Survival in the third trimester;2020QII;""
06 Badajoz;All ages;Cohort July 1;Females;Survival in the third trimester;2020QI;""
06 Badajoz;All ages;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
06 Badajoz;All ages;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
06 Badajoz;All ages;Cohort July 1;Females;Survival in the third trimester;2022QII;11.769
06 Badajoz;All ages;Cohort July 1;Females;Survival in the third trimester;2022QI;""
06 Badajoz;All ages;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
06 Badajoz;All ages;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
06 Badajoz;All ages;Cohort July 1;Females;Survival in the third trimester;2021QII;11.912
06 Badajoz;All ages;Cohort July 1;Females;Survival in the third trimester;2021QI;""
06 Badajoz;All ages;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
06 Badajoz;All ages;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
06 Badajoz;All ages;Cohort July 1;Females;Survival in the third trimester;2020QII;""
06 Badajoz;All ages;Cohort July 1;Females;Survival in the third trimester;2020QI;""
06 Badajoz;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
06 Badajoz;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
06 Badajoz;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
06 Badajoz;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
06 Badajoz;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
06 Badajoz;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
06 Badajoz;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
06 Badajoz;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
06 Badajoz;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
06 Badajoz;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
06 Badajoz;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
06 Badajoz;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
06 Badajoz;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
06 Badajoz;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;96,5
06 Badajoz;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
06 Badajoz;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
06 Badajoz;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
06 Badajoz;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;97,23
06 Badajoz;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
06 Badajoz;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
06 Badajoz;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
06 Badajoz;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;96,52
06 Badajoz;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
06 Badajoz;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
06 Badajoz;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;93,08
06 Badajoz;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
06 Badajoz;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
06 Badajoz;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
06 Badajoz;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;94,11
06 Badajoz;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
06 Badajoz;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
06 Badajoz;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
06 Badajoz;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;93,5
06 Badajoz;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
06 Badajoz;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
06 Badajoz;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
06 Badajoz;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
06 Badajoz;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
06 Badajoz;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
06 Badajoz;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;90,27
06 Badajoz;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
06 Badajoz;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
06 Badajoz;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
06 Badajoz;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;91,25
06 Badajoz;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
06 Badajoz;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
06 Badajoz;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
06 Badajoz;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
06 Badajoz;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
06 Badajoz;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
06 Badajoz;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;87,26
06 Badajoz;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
06 Badajoz;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
06 Badajoz;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
06 Badajoz;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;88,57
06 Badajoz;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
06 Badajoz;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
06 Badajoz;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
06 Badajoz;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
06 Badajoz;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
06 Badajoz;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QIV;39.370
06 Badajoz;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
06 Badajoz;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
06 Badajoz;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
06 Badajoz;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QIV;39.336
06 Badajoz;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
06 Badajoz;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
06 Badajoz;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
06 Badajoz;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QIV;39.045
06 Badajoz;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
06 Badajoz;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
06 Badajoz;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
06 Badajoz;All ages;Cohort October 1;Total;Survival in the first trimester;2022QIV;38.096
06 Badajoz;All ages;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
06 Badajoz;All ages;Cohort October 1;Total;Survival in the first trimester;2022QII;""
06 Badajoz;All ages;Cohort October 1;Total;Survival in the first trimester;2022QI;""
06 Badajoz;All ages;Cohort October 1;Total;Survival in the first trimester;2021QIV;38.109
06 Badajoz;All ages;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
06 Badajoz;All ages;Cohort October 1;Total;Survival in the first trimester;2021QII;""
06 Badajoz;All ages;Cohort October 1;Total;Survival in the first trimester;2021QI;""
06 Badajoz;All ages;Cohort October 1;Total;Survival in the first trimester;2020QIV;37.798
06 Badajoz;All ages;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
06 Badajoz;All ages;Cohort October 1;Total;Survival in the first trimester;2020QII;""
06 Badajoz;All ages;Cohort October 1;Total;Survival in the first trimester;2020QI;""
06 Badajoz;All ages;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
06 Badajoz;All ages;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
06 Badajoz;All ages;Cohort October 1;Total;Survival in the second trimester;2022QII;""
06 Badajoz;All ages;Cohort October 1;Total;Survival in the second trimester;2022QI;36.941
06 Badajoz;All ages;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
06 Badajoz;All ages;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
06 Badajoz;All ages;Cohort October 1;Total;Survival in the second trimester;2021QII;""
06 Badajoz;All ages;Cohort October 1;Total;Survival in the second trimester;2021QI;37.039
06 Badajoz;All ages;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
06 Badajoz;All ages;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
06 Badajoz;All ages;Cohort October 1;Total;Survival in the second trimester;2020QII;""
06 Badajoz;All ages;Cohort October 1;Total;Survival in the second trimester;2020QI;""
06 Badajoz;All ages;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
06 Badajoz;All ages;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
06 Badajoz;All ages;Cohort October 1;Total;Survival in the third trimester;2022QII;35.931
06 Badajoz;All ages;Cohort October 1;Total;Survival in the third trimester;2022QI;""
06 Badajoz;All ages;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
06 Badajoz;All ages;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
06 Badajoz;All ages;Cohort October 1;Total;Survival in the third trimester;2021QII;36.143
06 Badajoz;All ages;Cohort October 1;Total;Survival in the third trimester;2021QI;""
06 Badajoz;All ages;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
06 Badajoz;All ages;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
06 Badajoz;All ages;Cohort October 1;Total;Survival in the third trimester;2020QII;""
06 Badajoz;All ages;Cohort October 1;Total;Survival in the third trimester;2020QI;""
06 Badajoz;All ages;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
06 Badajoz;All ages;Cohort October 1;Total;Survival in the third trimester;2022QIII;35.044
06 Badajoz;All ages;Cohort October 1;Total;Survival in the third trimester;2022QII;""
06 Badajoz;All ages;Cohort October 1;Total;Survival in the third trimester;2022QI;""
06 Badajoz;All ages;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
06 Badajoz;All ages;Cohort October 1;Total;Survival in the third trimester;2021QIII;35.413
06 Badajoz;All ages;Cohort October 1;Total;Survival in the third trimester;2021QII;""
06 Badajoz;All ages;Cohort October 1;Total;Survival in the third trimester;2021QI;""
06 Badajoz;All ages;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
06 Badajoz;All ages;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
06 Badajoz;All ages;Cohort October 1;Total;Survival in the third trimester;2020QII;""
06 Badajoz;All ages;Cohort October 1;Total;Survival in the third trimester;2020QI;""
06 Badajoz;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
06 Badajoz;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
06 Badajoz;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
06 Badajoz;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
06 Badajoz;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
06 Badajoz;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
06 Badajoz;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
06 Badajoz;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
06 Badajoz;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
06 Badajoz;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
06 Badajoz;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
06 Badajoz;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
06 Badajoz;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;96,76
06 Badajoz;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
06 Badajoz;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
06 Badajoz;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
06 Badajoz;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;96,88
06 Badajoz;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
06 Badajoz;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
06 Badajoz;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
06 Badajoz;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;96,81
06 Badajoz;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
06 Badajoz;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
06 Badajoz;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
06 Badajoz;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
06 Badajoz;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
06 Badajoz;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
06 Badajoz;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;93,91
06 Badajoz;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
06 Badajoz;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
06 Badajoz;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
06 Badajoz;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;94,86
06 Badajoz;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
06 Badajoz;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
06 Badajoz;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
06 Badajoz;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
06 Badajoz;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
06 Badajoz;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
06 Badajoz;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;91,34
06 Badajoz;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
06 Badajoz;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
06 Badajoz;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
06 Badajoz;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;92,57
06 Badajoz;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
06 Badajoz;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
06 Badajoz;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
06 Badajoz;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
06 Badajoz;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
06 Badajoz;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
06 Badajoz;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;89,09
06 Badajoz;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
06 Badajoz;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
06 Badajoz;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
06 Badajoz;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;90,7
06 Badajoz;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
06 Badajoz;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
06 Badajoz;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
06 Badajoz;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
06 Badajoz;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
06 Badajoz;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
06 Badajoz;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QIV;25.629
06 Badajoz;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
06 Badajoz;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
06 Badajoz;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
06 Badajoz;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QIV;25.702
06 Badajoz;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
06 Badajoz;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
06 Badajoz;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
06 Badajoz;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QIV;25.629
06 Badajoz;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
06 Badajoz;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
06 Badajoz;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
06 Badajoz;All ages;Cohort October 1;Males;Survival in the first trimester;2022QIV;24.867
06 Badajoz;All ages;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
06 Badajoz;All ages;Cohort October 1;Males;Survival in the first trimester;2022QII;""
06 Badajoz;All ages;Cohort October 1;Males;Survival in the first trimester;2022QI;""
06 Badajoz;All ages;Cohort October 1;Males;Survival in the first trimester;2021QIV;24.940
06 Badajoz;All ages;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
06 Badajoz;All ages;Cohort October 1;Males;Survival in the first trimester;2021QII;""
06 Badajoz;All ages;Cohort October 1;Males;Survival in the first trimester;2021QI;""
06 Badajoz;All ages;Cohort October 1;Males;Survival in the first trimester;2020QIV;24.835
06 Badajoz;All ages;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
06 Badajoz;All ages;Cohort October 1;Males;Survival in the first trimester;2020QII;""
06 Badajoz;All ages;Cohort October 1;Males;Survival in the first trimester;2020QI;""
06 Badajoz;All ages;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
06 Badajoz;All ages;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
06 Badajoz;All ages;Cohort October 1;Males;Survival in the second trimester;2022QII;""
06 Badajoz;All ages;Cohort October 1;Males;Survival in the second trimester;2022QI;24.308
06 Badajoz;All ages;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
06 Badajoz;All ages;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
06 Badajoz;All ages;Cohort October 1;Males;Survival in the second trimester;2021QII;""
06 Badajoz;All ages;Cohort October 1;Males;Survival in the second trimester;2021QI;24.399
06 Badajoz;All ages;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
06 Badajoz;All ages;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
06 Badajoz;All ages;Cohort October 1;Males;Survival in the second trimester;2020QII;""
06 Badajoz;All ages;Cohort October 1;Males;Survival in the second trimester;2020QI;""
06 Badajoz;All ages;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
06 Badajoz;All ages;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
06 Badajoz;All ages;Cohort October 1;Males;Survival in the third trimester;2022QII;23.728
06 Badajoz;All ages;Cohort October 1;Males;Survival in the third trimester;2022QI;""
06 Badajoz;All ages;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
06 Badajoz;All ages;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
06 Badajoz;All ages;Cohort October 1;Males;Survival in the third trimester;2021QII;23.888
06 Badajoz;All ages;Cohort October 1;Males;Survival in the third trimester;2021QI;""
06 Badajoz;All ages;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
06 Badajoz;All ages;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
06 Badajoz;All ages;Cohort October 1;Males;Survival in the third trimester;2020QII;""
06 Badajoz;All ages;Cohort October 1;Males;Survival in the third trimester;2020QI;""
06 Badajoz;All ages;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
06 Badajoz;All ages;Cohort October 1;Males;Survival in the third trimester;2022QIII;23.217
06 Badajoz;All ages;Cohort October 1;Males;Survival in the third trimester;2022QII;""
06 Badajoz;All ages;Cohort October 1;Males;Survival in the third trimester;2022QI;""
06 Badajoz;All ages;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
06 Badajoz;All ages;Cohort October 1;Males;Survival in the third trimester;2021QIII;23.450
06 Badajoz;All ages;Cohort October 1;Males;Survival in the third trimester;2021QII;""
06 Badajoz;All ages;Cohort October 1;Males;Survival in the third trimester;2021QI;""
06 Badajoz;All ages;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
06 Badajoz;All ages;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
06 Badajoz;All ages;Cohort October 1;Males;Survival in the third trimester;2020QII;""
06 Badajoz;All ages;Cohort October 1;Males;Survival in the third trimester;2020QI;""
06 Badajoz;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
06 Badajoz;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
06 Badajoz;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
06 Badajoz;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
06 Badajoz;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
06 Badajoz;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
06 Badajoz;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
06 Badajoz;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
06 Badajoz;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
06 Badajoz;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
06 Badajoz;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
06 Badajoz;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
06 Badajoz;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;97,03
06 Badajoz;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
06 Badajoz;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
06 Badajoz;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
06 Badajoz;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;97,04
06 Badajoz;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
06 Badajoz;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
06 Badajoz;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
06 Badajoz;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;96,9
06 Badajoz;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
06 Badajoz;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
06 Badajoz;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
06 Badajoz;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
06 Badajoz;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
06 Badajoz;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
06 Badajoz;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;94,58
06 Badajoz;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
06 Badajoz;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
06 Badajoz;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
06 Badajoz;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;95,2
06 Badajoz;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
06 Badajoz;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
06 Badajoz;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
06 Badajoz;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
06 Badajoz;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
06 Badajoz;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
06 Badajoz;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;92,32
06 Badajoz;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
06 Badajoz;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
06 Badajoz;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
06 Badajoz;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;93,21
06 Badajoz;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
06 Badajoz;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
06 Badajoz;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
06 Badajoz;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
06 Badajoz;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
06 Badajoz;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
06 Badajoz;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;90,33
06 Badajoz;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
06 Badajoz;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
06 Badajoz;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
06 Badajoz;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;91,5
06 Badajoz;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
06 Badajoz;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
06 Badajoz;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
06 Badajoz;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
06 Badajoz;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
06 Badajoz;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
06 Badajoz;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QIV;13.741
06 Badajoz;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
06 Badajoz;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
06 Badajoz;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
06 Badajoz;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QIV;13.634
06 Badajoz;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
06 Badajoz;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
06 Badajoz;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
06 Badajoz;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QIV;13.416
06 Badajoz;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
06 Badajoz;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
06 Badajoz;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
06 Badajoz;All ages;Cohort October 1;Females;Survival in the first trimester;2022QIV;13.229
06 Badajoz;All ages;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
06 Badajoz;All ages;Cohort October 1;Females;Survival in the first trimester;2022QII;""
06 Badajoz;All ages;Cohort October 1;Females;Survival in the first trimester;2022QI;""
06 Badajoz;All ages;Cohort October 1;Females;Survival in the first trimester;2021QIV;13.169
06 Badajoz;All ages;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
06 Badajoz;All ages;Cohort October 1;Females;Survival in the first trimester;2021QII;""
06 Badajoz;All ages;Cohort October 1;Females;Survival in the first trimester;2021QI;""
06 Badajoz;All ages;Cohort October 1;Females;Survival in the first trimester;2020QIV;12.963
06 Badajoz;All ages;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
06 Badajoz;All ages;Cohort October 1;Females;Survival in the first trimester;2020QII;""
06 Badajoz;All ages;Cohort October 1;Females;Survival in the first trimester;2020QI;""
06 Badajoz;All ages;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
06 Badajoz;All ages;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
06 Badajoz;All ages;Cohort October 1;Females;Survival in the second trimester;2022QII;""
06 Badajoz;All ages;Cohort October 1;Females;Survival in the second trimester;2022QI;12.633
06 Badajoz;All ages;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
06 Badajoz;All ages;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
06 Badajoz;All ages;Cohort October 1;Females;Survival in the second trimester;2021QII;""
06 Badajoz;All ages;Cohort October 1;Females;Survival in the second trimester;2021QI;12.640
06 Badajoz;All ages;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
06 Badajoz;All ages;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
06 Badajoz;All ages;Cohort October 1;Females;Survival in the second trimester;2020QII;""
06 Badajoz;All ages;Cohort October 1;Females;Survival in the second trimester;2020QI;""
06 Badajoz;All ages;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
06 Badajoz;All ages;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
06 Badajoz;All ages;Cohort October 1;Females;Survival in the third trimester;2022QII;12.203
06 Badajoz;All ages;Cohort October 1;Females;Survival in the third trimester;2022QI;""
06 Badajoz;All ages;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
06 Badajoz;All ages;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
06 Badajoz;All ages;Cohort October 1;Females;Survival in the third trimester;2021QII;12.255
06 Badajoz;All ages;Cohort October 1;Females;Survival in the third trimester;2021QI;""
06 Badajoz;All ages;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
06 Badajoz;All ages;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
06 Badajoz;All ages;Cohort October 1;Females;Survival in the third trimester;2020QII;""
06 Badajoz;All ages;Cohort October 1;Females;Survival in the third trimester;2020QI;""
06 Badajoz;All ages;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
06 Badajoz;All ages;Cohort October 1;Females;Survival in the third trimester;2022QIII;11.827
06 Badajoz;All ages;Cohort October 1;Females;Survival in the third trimester;2022QII;""
06 Badajoz;All ages;Cohort October 1;Females;Survival in the third trimester;2022QI;""
06 Badajoz;All ages;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
06 Badajoz;All ages;Cohort October 1;Females;Survival in the third trimester;2021QIII;11.963
06 Badajoz;All ages;Cohort October 1;Females;Survival in the third trimester;2021QII;""
06 Badajoz;All ages;Cohort October 1;Females;Survival in the third trimester;2021QI;""
06 Badajoz;All ages;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
06 Badajoz;All ages;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
06 Badajoz;All ages;Cohort October 1;Females;Survival in the third trimester;2020QII;""
06 Badajoz;All ages;Cohort October 1;Females;Survival in the third trimester;2020QI;""
06 Badajoz;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
06 Badajoz;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
06 Badajoz;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
06 Badajoz;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
06 Badajoz;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
06 Badajoz;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
06 Badajoz;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
06 Badajoz;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
06 Badajoz;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
06 Badajoz;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
06 Badajoz;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
06 Badajoz;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
06 Badajoz;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;96,27
06 Badajoz;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
06 Badajoz;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
06 Badajoz;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
06 Badajoz;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;96,59
06 Badajoz;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
06 Badajoz;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
06 Badajoz;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
06 Badajoz;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;96,62
06 Badajoz;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
06 Badajoz;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
06 Badajoz;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
06 Badajoz;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
06 Badajoz;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
06 Badajoz;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
06 Badajoz;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;92,66
06 Badajoz;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
06 Badajoz;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
06 Badajoz;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
06 Badajoz;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;94,22
06 Badajoz;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
06 Badajoz;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
06 Badajoz;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
06 Badajoz;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
06 Badajoz;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
06 Badajoz;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
06 Badajoz;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;89,5
06 Badajoz;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
06 Badajoz;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
06 Badajoz;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
06 Badajoz;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;91,35
06 Badajoz;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
06 Badajoz;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
06 Badajoz;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
06 Badajoz;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
06 Badajoz;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
06 Badajoz;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
06 Badajoz;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;86,75
06 Badajoz;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
06 Badajoz;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
06 Badajoz;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
06 Badajoz;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;89,17
06 Badajoz;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
06 Badajoz;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
06 Badajoz;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
06 Badajoz;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
06 Badajoz;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
06 Badajoz;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
06 Badajoz;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
06 Badajoz;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
06 Badajoz;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
06 Badajoz;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QI;3.029
06 Badajoz;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
06 Badajoz;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
06 Badajoz;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
06 Badajoz;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QI;3.011
06 Badajoz;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
06 Badajoz;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
06 Badajoz;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
06 Badajoz;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QI;2.710
06 Badajoz;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
06 Badajoz;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
06 Badajoz;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2022QII;""
06 Badajoz;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2022QI;2.827
06 Badajoz;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
06 Badajoz;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
06 Badajoz;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2021QII;""
06 Badajoz;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2021QI;2.893
06 Badajoz;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
06 Badajoz;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
06 Badajoz;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2020QII;""
06 Badajoz;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2020QI;2.428
06 Badajoz;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
06 Badajoz;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
06 Badajoz;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2022QII;2.685
06 Badajoz;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2022QI;""
06 Badajoz;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
06 Badajoz;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
06 Badajoz;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2021QII;2.741
06 Badajoz;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2021QI;""
06 Badajoz;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
06 Badajoz;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
06 Badajoz;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2020QII;2.361
06 Badajoz;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2020QI;""
06 Badajoz;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
06 Badajoz;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QIII;2.560
06 Badajoz;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QII;""
06 Badajoz;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QI;""
06 Badajoz;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
06 Badajoz;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QIII;2.601
06 Badajoz;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QII;""
06 Badajoz;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QI;""
06 Badajoz;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
06 Badajoz;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QIII;2.246
06 Badajoz;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QII;""
06 Badajoz;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QI;""
06 Badajoz;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QIV;2.418
06 Badajoz;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
06 Badajoz;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QII;""
06 Badajoz;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QI;""
06 Badajoz;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QIV;2.477
06 Badajoz;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
06 Badajoz;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QII;""
06 Badajoz;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QI;""
06 Badajoz;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QIV;2.148
06 Badajoz;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
06 Badajoz;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QII;""
06 Badajoz;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QI;""
06 Badajoz;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
06 Badajoz;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
06 Badajoz;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
06 Badajoz;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
06 Badajoz;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
06 Badajoz;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
06 Badajoz;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
06 Badajoz;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
06 Badajoz;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
06 Badajoz;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
06 Badajoz;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
06 Badajoz;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
06 Badajoz;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
06 Badajoz;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
06 Badajoz;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
06 Badajoz;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;93,33
06 Badajoz;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
06 Badajoz;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
06 Badajoz;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
06 Badajoz;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;96,08
06 Badajoz;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
06 Badajoz;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
06 Badajoz;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
06 Badajoz;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;89,59
06 Badajoz;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
06 Badajoz;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
06 Badajoz;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;88,64
06 Badajoz;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
06 Badajoz;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
06 Badajoz;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
06 Badajoz;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;91,03
06 Badajoz;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
06 Badajoz;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
06 Badajoz;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
06 Badajoz;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;87,12
06 Badajoz;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
06 Badajoz;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
06 Badajoz;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;84,52
06 Badajoz;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
06 Badajoz;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
06 Badajoz;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
06 Badajoz;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;86,38
06 Badajoz;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
06 Badajoz;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
06 Badajoz;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
06 Badajoz;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;82,88
06 Badajoz;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
06 Badajoz;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
06 Badajoz;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;79,83
06 Badajoz;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
06 Badajoz;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
06 Badajoz;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
06 Badajoz;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;82,27
06 Badajoz;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
06 Badajoz;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
06 Badajoz;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
06 Badajoz;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;79,26
06 Badajoz;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
06 Badajoz;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
06 Badajoz;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
06 Badajoz;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
06 Badajoz;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
06 Badajoz;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
06 Badajoz;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QI;1.807
06 Badajoz;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
06 Badajoz;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
06 Badajoz;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
06 Badajoz;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QI;1.826
06 Badajoz;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
06 Badajoz;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
06 Badajoz;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
06 Badajoz;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QI;1.655
06 Badajoz;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
06 Badajoz;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
06 Badajoz;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2022QII;""
06 Badajoz;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2022QI;1.706
06 Badajoz;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
06 Badajoz;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
06 Badajoz;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2021QII;""
06 Badajoz;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2021QI;1.757
06 Badajoz;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
06 Badajoz;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
06 Badajoz;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2020QII;""
06 Badajoz;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2020QI;1.480
06 Badajoz;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
06 Badajoz;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
06 Badajoz;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2022QII;1.624
06 Badajoz;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2022QI;""
06 Badajoz;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
06 Badajoz;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
06 Badajoz;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2021QII;1.679
06 Badajoz;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2021QI;""
06 Badajoz;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
06 Badajoz;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
06 Badajoz;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2020QII;1.447
06 Badajoz;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2020QI;""
06 Badajoz;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
06 Badajoz;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QIII;1.548
06 Badajoz;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QII;""
06 Badajoz;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QI;""
06 Badajoz;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
06 Badajoz;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QIII;1.593
06 Badajoz;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QII;""
06 Badajoz;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QI;""
06 Badajoz;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
06 Badajoz;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QIII;1.397
06 Badajoz;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QII;""
06 Badajoz;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QI;""
06 Badajoz;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QIV;1.469
06 Badajoz;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
06 Badajoz;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QII;""
06 Badajoz;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QI;""
06 Badajoz;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QIV;1.524
06 Badajoz;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
06 Badajoz;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QII;""
06 Badajoz;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QI;""
06 Badajoz;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QIV;1.338
06 Badajoz;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
06 Badajoz;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QII;""
06 Badajoz;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QI;""
06 Badajoz;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
06 Badajoz;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
06 Badajoz;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
06 Badajoz;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
06 Badajoz;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
06 Badajoz;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
06 Badajoz;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
06 Badajoz;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
06 Badajoz;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
06 Badajoz;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
06 Badajoz;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
06 Badajoz;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
06 Badajoz;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
06 Badajoz;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
06 Badajoz;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
06 Badajoz;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;94,41
06 Badajoz;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
06 Badajoz;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
06 Badajoz;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
06 Badajoz;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;96,22
06 Badajoz;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
06 Badajoz;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
06 Badajoz;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
06 Badajoz;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;89,43
06 Badajoz;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
06 Badajoz;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
06 Badajoz;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;89,87
06 Badajoz;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
06 Badajoz;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
06 Badajoz;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
06 Badajoz;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;91,95
06 Badajoz;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
06 Badajoz;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
06 Badajoz;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
06 Badajoz;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;87,43
06 Badajoz;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
06 Badajoz;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
06 Badajoz;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;85,67
06 Badajoz;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
06 Badajoz;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
06 Badajoz;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
06 Badajoz;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;87,24
06 Badajoz;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
06 Badajoz;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
06 Badajoz;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
06 Badajoz;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;84,41
06 Badajoz;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
06 Badajoz;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
06 Badajoz;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;81,29
06 Badajoz;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
06 Badajoz;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
06 Badajoz;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
06 Badajoz;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;83,46
06 Badajoz;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
06 Badajoz;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
06 Badajoz;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
06 Badajoz;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;80,85
06 Badajoz;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
06 Badajoz;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
06 Badajoz;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
06 Badajoz;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
06 Badajoz;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
06 Badajoz;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
06 Badajoz;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QI;1.222
06 Badajoz;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
06 Badajoz;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
06 Badajoz;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
06 Badajoz;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QI;1.185
06 Badajoz;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
06 Badajoz;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
06 Badajoz;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
06 Badajoz;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QI;1.055
06 Badajoz;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
06 Badajoz;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
06 Badajoz;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2022QII;""
06 Badajoz;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2022QI;1.121
06 Badajoz;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
06 Badajoz;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
06 Badajoz;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2021QII;""
06 Badajoz;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2021QI;1.136
06 Badajoz;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
06 Badajoz;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
06 Badajoz;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2020QII;""
06 Badajoz;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2020QI;948
06 Badajoz;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
06 Badajoz;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
06 Badajoz;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2022QII;1.061
06 Badajoz;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2022QI;""
06 Badajoz;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
06 Badajoz;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
06 Badajoz;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2021QII;1.062
06 Badajoz;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2021QI;""
06 Badajoz;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
06 Badajoz;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
06 Badajoz;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2020QII;914
06 Badajoz;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2020QI;""
06 Badajoz;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
06 Badajoz;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QIII;1.012
06 Badajoz;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QII;""
06 Badajoz;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QI;""
06 Badajoz;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
06 Badajoz;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QIII;1.008
06 Badajoz;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QII;""
06 Badajoz;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QI;""
06 Badajoz;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
06 Badajoz;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QIII;849
06 Badajoz;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QII;""
06 Badajoz;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QI;""
06 Badajoz;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QIV;949
06 Badajoz;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
06 Badajoz;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QII;""
06 Badajoz;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QI;""
06 Badajoz;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QIV;953
06 Badajoz;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
06 Badajoz;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QII;""
06 Badajoz;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QI;""
06 Badajoz;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QIV;810
06 Badajoz;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
06 Badajoz;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QII;""
06 Badajoz;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QI;""
06 Badajoz;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
06 Badajoz;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
06 Badajoz;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
06 Badajoz;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
06 Badajoz;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
06 Badajoz;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
06 Badajoz;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
06 Badajoz;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
06 Badajoz;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
06 Badajoz;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
06 Badajoz;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
06 Badajoz;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
06 Badajoz;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
06 Badajoz;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
06 Badajoz;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
06 Badajoz;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;91,73
06 Badajoz;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
06 Badajoz;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
06 Badajoz;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
06 Badajoz;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;95,86
06 Badajoz;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
06 Badajoz;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
06 Badajoz;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
06 Badajoz;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;89,86
06 Badajoz;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
06 Badajoz;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
06 Badajoz;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;86,82
06 Badajoz;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
06 Badajoz;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
06 Badajoz;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
06 Badajoz;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;89,62
06 Badajoz;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
06 Badajoz;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
06 Badajoz;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
06 Badajoz;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;86,64
06 Badajoz;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
06 Badajoz;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
06 Badajoz;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;82,82
06 Badajoz;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
06 Badajoz;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
06 Badajoz;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
06 Badajoz;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;85,06
06 Badajoz;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
06 Badajoz;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
06 Badajoz;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
06 Badajoz;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;80,47
06 Badajoz;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
06 Badajoz;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
06 Badajoz;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;77,66
06 Badajoz;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
06 Badajoz;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
06 Badajoz;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
06 Badajoz;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;80,42
06 Badajoz;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
06 Badajoz;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
06 Badajoz;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
06 Badajoz;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;76,78
06 Badajoz;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
06 Badajoz;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
06 Badajoz;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
06 Badajoz;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
06 Badajoz;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
06 Badajoz;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QII;2.753
06 Badajoz;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
06 Badajoz;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
06 Badajoz;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
06 Badajoz;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QII;2.582
06 Badajoz;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
06 Badajoz;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
06 Badajoz;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
06 Badajoz;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QII;2.770
06 Badajoz;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
06 Badajoz;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
06 Badajoz;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
06 Badajoz;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2022QII;2.618
06 Badajoz;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2022QI;""
06 Badajoz;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
06 Badajoz;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
06 Badajoz;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2021QII;2.430
06 Badajoz;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2021QI;""
06 Badajoz;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
06 Badajoz;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
06 Badajoz;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2020QII;2.690
06 Badajoz;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2020QI;""
06 Badajoz;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
06 Badajoz;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2022QIII;2.508
06 Badajoz;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2022QII;""
06 Badajoz;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2022QI;""
06 Badajoz;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
06 Badajoz;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2021QIII;2.289
06 Badajoz;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2021QII;""
06 Badajoz;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2021QI;""
06 Badajoz;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
06 Badajoz;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2020QIII;2.560
06 Badajoz;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2020QII;""
06 Badajoz;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2020QI;""
06 Badajoz;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QIV;2.380
06 Badajoz;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
06 Badajoz;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QII;""
06 Badajoz;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QI;""
06 Badajoz;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QIV;2.167
06 Badajoz;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
06 Badajoz;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QII;""
06 Badajoz;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QI;""
06 Badajoz;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QIV;2.454
06 Badajoz;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
06 Badajoz;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QII;""
06 Badajoz;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QI;""
06 Badajoz;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
06 Badajoz;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
06 Badajoz;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QII;""
06 Badajoz;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QI;2.011
06 Badajoz;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
06 Badajoz;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
06 Badajoz;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QII;""
06 Badajoz;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QI;2.377
06 Badajoz;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
06 Badajoz;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
06 Badajoz;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QII;""
06 Badajoz;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QI;""
06 Badajoz;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
06 Badajoz;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
06 Badajoz;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
06 Badajoz;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
06 Badajoz;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
06 Badajoz;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
06 Badajoz;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
06 Badajoz;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
06 Badajoz;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
06 Badajoz;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
06 Badajoz;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
06 Badajoz;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
06 Badajoz;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
06 Badajoz;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
06 Badajoz;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;95,1
06 Badajoz;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
06 Badajoz;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
06 Badajoz;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
06 Badajoz;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;94,11
06 Badajoz;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
06 Badajoz;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
06 Badajoz;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
06 Badajoz;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;97,11
06 Badajoz;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
06 Badajoz;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
06 Badajoz;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;91,1
06 Badajoz;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
06 Badajoz;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
06 Badajoz;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
06 Badajoz;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;88,65
06 Badajoz;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
06 Badajoz;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
06 Badajoz;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
06 Badajoz;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;92,42
06 Badajoz;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
06 Badajoz;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
06 Badajoz;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;86,45
06 Badajoz;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
06 Badajoz;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
06 Badajoz;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
06 Badajoz;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;83,93
06 Badajoz;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
06 Badajoz;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
06 Badajoz;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
06 Badajoz;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;88,59
06 Badajoz;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
06 Badajoz;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
06 Badajoz;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
06 Badajoz;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
06 Badajoz;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
06 Badajoz;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
06 Badajoz;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;77,89
06 Badajoz;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
06 Badajoz;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
06 Badajoz;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
06 Badajoz;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;85,81
06 Badajoz;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
06 Badajoz;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
06 Badajoz;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
06 Badajoz;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
06 Badajoz;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
06 Badajoz;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
06 Badajoz;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QII;1.656
06 Badajoz;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
06 Badajoz;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
06 Badajoz;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
06 Badajoz;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QII;1.571
06 Badajoz;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
06 Badajoz;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
06 Badajoz;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
06 Badajoz;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QII;1.674
06 Badajoz;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
06 Badajoz;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
06 Badajoz;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
06 Badajoz;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2022QII;1.573
06 Badajoz;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2022QI;""
06 Badajoz;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
06 Badajoz;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
06 Badajoz;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2021QII;1.494
06 Badajoz;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2021QI;""
06 Badajoz;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
06 Badajoz;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
06 Badajoz;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2020QII;1.636
06 Badajoz;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2020QI;""
06 Badajoz;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
06 Badajoz;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2022QIII;1.505
06 Badajoz;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2022QII;""
06 Badajoz;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2022QI;""
06 Badajoz;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
06 Badajoz;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2021QIII;1.407
06 Badajoz;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2021QII;""
06 Badajoz;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2021QI;""
06 Badajoz;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
06 Badajoz;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2020QIII;1.578
06 Badajoz;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2020QII;""
06 Badajoz;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2020QI;""
06 Badajoz;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QIV;1.434
06 Badajoz;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
06 Badajoz;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QII;""
06 Badajoz;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QI;""
06 Badajoz;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QIV;1.336
06 Badajoz;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
06 Badajoz;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QII;""
06 Badajoz;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QI;""
06 Badajoz;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QIV;1.514
06 Badajoz;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
06 Badajoz;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QII;""
06 Badajoz;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QI;""
06 Badajoz;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
06 Badajoz;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
06 Badajoz;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QII;""
06 Badajoz;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QI;1.262
06 Badajoz;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
06 Badajoz;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
06 Badajoz;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QII;""
06 Badajoz;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QI;1.470
06 Badajoz;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
06 Badajoz;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
06 Badajoz;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QII;""
06 Badajoz;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QI;""
06 Badajoz;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
06 Badajoz;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
06 Badajoz;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
06 Badajoz;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
06 Badajoz;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
06 Badajoz;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
06 Badajoz;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
06 Badajoz;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
06 Badajoz;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
06 Badajoz;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
06 Badajoz;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
06 Badajoz;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
06 Badajoz;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
06 Badajoz;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
06 Badajoz;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;94,99
06 Badajoz;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
06 Badajoz;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
06 Badajoz;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
06 Badajoz;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;95,1
06 Badajoz;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
06 Badajoz;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
06 Badajoz;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
06 Badajoz;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;97,73
06 Badajoz;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
06 Badajoz;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
06 Badajoz;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;90,88
06 Badajoz;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
06 Badajoz;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
06 Badajoz;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
06 Badajoz;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;89,56
06 Badajoz;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
06 Badajoz;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
06 Badajoz;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
06 Badajoz;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;94,27
06 Badajoz;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
06 Badajoz;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
06 Badajoz;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;86,59
06 Badajoz;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
06 Badajoz;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
06 Badajoz;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
06 Badajoz;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;85,04
06 Badajoz;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
06 Badajoz;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
06 Badajoz;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
06 Badajoz;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;90,44
06 Badajoz;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
06 Badajoz;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
06 Badajoz;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
06 Badajoz;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
06 Badajoz;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
06 Badajoz;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
06 Badajoz;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;80,33
06 Badajoz;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
06 Badajoz;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
06 Badajoz;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
06 Badajoz;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;87,81
06 Badajoz;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
06 Badajoz;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
06 Badajoz;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
06 Badajoz;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
06 Badajoz;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
06 Badajoz;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
06 Badajoz;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QII;1.097
06 Badajoz;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
06 Badajoz;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
06 Badajoz;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
06 Badajoz;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QII;1.011
06 Badajoz;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
06 Badajoz;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
06 Badajoz;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
06 Badajoz;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QII;1.096
06 Badajoz;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
06 Badajoz;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
06 Badajoz;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
06 Badajoz;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2022QII;1.045
06 Badajoz;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2022QI;""
06 Badajoz;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
06 Badajoz;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
06 Badajoz;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2021QII;936
06 Badajoz;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2021QI;""
06 Badajoz;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
06 Badajoz;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
06 Badajoz;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2020QII;1.054
06 Badajoz;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2020QI;""
06 Badajoz;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
06 Badajoz;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2022QIII;1.003
06 Badajoz;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2022QII;""
06 Badajoz;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2022QI;""
06 Badajoz;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
06 Badajoz;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2021QIII;882
06 Badajoz;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2021QII;""
06 Badajoz;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2021QI;""
06 Badajoz;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
06 Badajoz;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2020QIII;982
06 Badajoz;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2020QII;""
06 Badajoz;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2020QI;""
06 Badajoz;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QIV;946
06 Badajoz;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
06 Badajoz;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QII;""
06 Badajoz;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QI;""
06 Badajoz;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QIV;831
06 Badajoz;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
06 Badajoz;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QII;""
06 Badajoz;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QI;""
06 Badajoz;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QIV;940
06 Badajoz;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
06 Badajoz;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QII;""
06 Badajoz;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QI;""
06 Badajoz;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
06 Badajoz;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
06 Badajoz;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QII;""
06 Badajoz;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QI;749
06 Badajoz;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
06 Badajoz;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
06 Badajoz;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QII;""
06 Badajoz;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QI;907
06 Badajoz;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
06 Badajoz;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
06 Badajoz;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QII;""
06 Badajoz;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QI;""
06 Badajoz;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
06 Badajoz;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
06 Badajoz;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
06 Badajoz;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
06 Badajoz;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
06 Badajoz;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
06 Badajoz;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
06 Badajoz;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
06 Badajoz;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
06 Badajoz;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
06 Badajoz;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
06 Badajoz;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
06 Badajoz;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
06 Badajoz;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
06 Badajoz;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;95,26
06 Badajoz;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
06 Badajoz;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
06 Badajoz;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
06 Badajoz;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;92,58
06 Badajoz;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
06 Badajoz;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
06 Badajoz;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
06 Badajoz;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;96,17
06 Badajoz;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
06 Badajoz;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
06 Badajoz;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;91,43
06 Badajoz;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
06 Badajoz;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
06 Badajoz;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
06 Badajoz;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;87,24
06 Badajoz;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
06 Badajoz;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
06 Badajoz;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
06 Badajoz;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;89,6
06 Badajoz;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
06 Badajoz;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
06 Badajoz;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;86,24
06 Badajoz;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
06 Badajoz;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
06 Badajoz;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
06 Badajoz;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;82,2
06 Badajoz;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
06 Badajoz;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
06 Badajoz;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
06 Badajoz;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;85,77
06 Badajoz;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
06 Badajoz;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
06 Badajoz;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
06 Badajoz;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
06 Badajoz;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
06 Badajoz;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
06 Badajoz;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;74,09
06 Badajoz;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
06 Badajoz;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
06 Badajoz;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
06 Badajoz;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;82,76
06 Badajoz;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
06 Badajoz;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
06 Badajoz;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
06 Badajoz;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
06 Badajoz;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
06 Badajoz;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QIII;2.818
06 Badajoz;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
06 Badajoz;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
06 Badajoz;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
06 Badajoz;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QIII;2.737
06 Badajoz;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
06 Badajoz;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
06 Badajoz;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
06 Badajoz;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QIII;2.855
06 Badajoz;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
06 Badajoz;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
06 Badajoz;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
06 Badajoz;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2022QIII;2.666
06 Badajoz;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2022QII;""
06 Badajoz;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2022QI;""
06 Badajoz;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
06 Badajoz;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2021QIII;2.557
06 Badajoz;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2021QII;""
06 Badajoz;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2021QI;""
06 Badajoz;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
06 Badajoz;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2020QIII;2.689
06 Badajoz;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2020QII;""
06 Badajoz;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2020QI;""
06 Badajoz;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2022QIV;2.519
06 Badajoz;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
06 Badajoz;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2022QII;""
06 Badajoz;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2022QI;""
06 Badajoz;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2021QIV;2.421
06 Badajoz;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
06 Badajoz;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2021QII;""
06 Badajoz;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2021QI;""
06 Badajoz;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2020QIV;2.572
06 Badajoz;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
06 Badajoz;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2020QII;""
06 Badajoz;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2020QI;""
06 Badajoz;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
06 Badajoz;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
06 Badajoz;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QII;""
06 Badajoz;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QI;2.253
06 Badajoz;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
06 Badajoz;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
06 Badajoz;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QII;""
06 Badajoz;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QI;2.490
06 Badajoz;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
06 Badajoz;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
06 Badajoz;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QII;""
06 Badajoz;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QI;""
06 Badajoz;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
06 Badajoz;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
06 Badajoz;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QII;2.139
06 Badajoz;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QI;""
06 Badajoz;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
06 Badajoz;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
06 Badajoz;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QII;2.366
06 Badajoz;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QI;""
06 Badajoz;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
06 Badajoz;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
06 Badajoz;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QII;""
06 Badajoz;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QI;""
06 Badajoz;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
06 Badajoz;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
06 Badajoz;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
06 Badajoz;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
06 Badajoz;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
06 Badajoz;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
06 Badajoz;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
06 Badajoz;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
06 Badajoz;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
06 Badajoz;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
06 Badajoz;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
06 Badajoz;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
06 Badajoz;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
06 Badajoz;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;94,61
06 Badajoz;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
06 Badajoz;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
06 Badajoz;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
06 Badajoz;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;93,42
06 Badajoz;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
06 Badajoz;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
06 Badajoz;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
06 Badajoz;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;94,19
06 Badajoz;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
06 Badajoz;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
06 Badajoz;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;89,39
06 Badajoz;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
06 Badajoz;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
06 Badajoz;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
06 Badajoz;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;88,45
06 Badajoz;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
06 Badajoz;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
06 Badajoz;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
06 Badajoz;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;90,09
06 Badajoz;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
06 Badajoz;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
06 Badajoz;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
06 Badajoz;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
06 Badajoz;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
06 Badajoz;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
06 Badajoz;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;82,32
06 Badajoz;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
06 Badajoz;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
06 Badajoz;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
06 Badajoz;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;87,22
06 Badajoz;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
06 Badajoz;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
06 Badajoz;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
06 Badajoz;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
06 Badajoz;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
06 Badajoz;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
06 Badajoz;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;78,15
06 Badajoz;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
06 Badajoz;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
06 Badajoz;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
06 Badajoz;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;82,87
06 Badajoz;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
06 Badajoz;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
06 Badajoz;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
06 Badajoz;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
06 Badajoz;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
06 Badajoz;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
06 Badajoz;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QIII;1.703
06 Badajoz;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
06 Badajoz;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
06 Badajoz;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
06 Badajoz;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QIII;1.664
06 Badajoz;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
06 Badajoz;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
06 Badajoz;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
06 Badajoz;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QIII;1.739
06 Badajoz;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
06 Badajoz;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
06 Badajoz;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
06 Badajoz;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2022QIII;1.611
06 Badajoz;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2022QII;""
06 Badajoz;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2022QI;""
06 Badajoz;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
06 Badajoz;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2021QIII;1.550
06 Badajoz;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2021QII;""
06 Badajoz;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2021QI;""
06 Badajoz;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
06 Badajoz;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2020QIII;1.660
06 Badajoz;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2020QII;""
06 Badajoz;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2020QI;""
06 Badajoz;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2022QIV;1.528
06 Badajoz;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
06 Badajoz;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2022QII;""
06 Badajoz;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2022QI;""
06 Badajoz;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2021QIV;1.469
06 Badajoz;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
06 Badajoz;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2021QII;""
06 Badajoz;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2021QI;""
06 Badajoz;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2020QIV;1.588
06 Badajoz;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
06 Badajoz;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2020QII;""
06 Badajoz;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2020QI;""
06 Badajoz;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
06 Badajoz;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
06 Badajoz;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QII;""
06 Badajoz;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QI;1.388
06 Badajoz;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
06 Badajoz;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
06 Badajoz;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QII;""
06 Badajoz;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QI;1.541
06 Badajoz;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
06 Badajoz;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
06 Badajoz;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QII;""
06 Badajoz;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QI;""
06 Badajoz;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
06 Badajoz;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
06 Badajoz;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QII;1.320
06 Badajoz;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QI;""
06 Badajoz;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
06 Badajoz;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
06 Badajoz;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QII;1.476
06 Badajoz;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QI;""
06 Badajoz;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
06 Badajoz;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
06 Badajoz;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QII;""
06 Badajoz;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QI;""
06 Badajoz;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
06 Badajoz;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
06 Badajoz;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
06 Badajoz;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
06 Badajoz;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
06 Badajoz;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
06 Badajoz;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
06 Badajoz;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
06 Badajoz;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
06 Badajoz;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
06 Badajoz;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
06 Badajoz;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
06 Badajoz;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
06 Badajoz;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;94,6
06 Badajoz;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
06 Badajoz;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
06 Badajoz;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
06 Badajoz;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;93,15
06 Badajoz;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
06 Badajoz;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
06 Badajoz;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
06 Badajoz;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;95,46
06 Badajoz;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
06 Badajoz;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
06 Badajoz;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;89,72
06 Badajoz;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
06 Badajoz;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
06 Badajoz;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
06 Badajoz;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;88,28
06 Badajoz;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
06 Badajoz;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
06 Badajoz;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
06 Badajoz;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;91,32
06 Badajoz;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
06 Badajoz;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
06 Badajoz;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
06 Badajoz;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
06 Badajoz;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
06 Badajoz;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
06 Badajoz;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;83,41
06 Badajoz;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
06 Badajoz;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
06 Badajoz;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
06 Badajoz;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;88,61
06 Badajoz;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
06 Badajoz;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
06 Badajoz;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
06 Badajoz;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
06 Badajoz;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
06 Badajoz;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
06 Badajoz;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;79,33
06 Badajoz;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
06 Badajoz;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
06 Badajoz;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
06 Badajoz;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;84,88
06 Badajoz;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
06 Badajoz;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
06 Badajoz;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
06 Badajoz;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
06 Badajoz;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
06 Badajoz;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
06 Badajoz;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QIII;1.115
06 Badajoz;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
06 Badajoz;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
06 Badajoz;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
06 Badajoz;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QIII;1.073
06 Badajoz;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
06 Badajoz;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
06 Badajoz;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
06 Badajoz;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QIII;1.116
06 Badajoz;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
06 Badajoz;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
06 Badajoz;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
06 Badajoz;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2022QIII;1.055
06 Badajoz;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2022QII;""
06 Badajoz;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2022QI;""
06 Badajoz;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
06 Badajoz;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2021QIII;1.007
06 Badajoz;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2021QII;""
06 Badajoz;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2021QI;""
06 Badajoz;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
06 Badajoz;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2020QIII;1.029
06 Badajoz;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2020QII;""
06 Badajoz;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2020QI;""
06 Badajoz;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2022QIV;991
06 Badajoz;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
06 Badajoz;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2022QII;""
06 Badajoz;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2022QI;""
06 Badajoz;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2021QIV;952
06 Badajoz;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
06 Badajoz;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2021QII;""
06 Badajoz;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2021QI;""
06 Badajoz;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2020QIV;984
06 Badajoz;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
06 Badajoz;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2020QII;""
06 Badajoz;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2020QI;""
06 Badajoz;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
06 Badajoz;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
06 Badajoz;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QII;""
06 Badajoz;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QI;865
06 Badajoz;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
06 Badajoz;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
06 Badajoz;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QII;""
06 Badajoz;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QI;949
06 Badajoz;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
06 Badajoz;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
06 Badajoz;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QII;""
06 Badajoz;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QI;""
06 Badajoz;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
06 Badajoz;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
06 Badajoz;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QII;819
06 Badajoz;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QI;""
06 Badajoz;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
06 Badajoz;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
06 Badajoz;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QII;890
06 Badajoz;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QI;""
06 Badajoz;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
06 Badajoz;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
06 Badajoz;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QII;""
06 Badajoz;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QI;""
06 Badajoz;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
06 Badajoz;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
06 Badajoz;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
06 Badajoz;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
06 Badajoz;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
06 Badajoz;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
06 Badajoz;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
06 Badajoz;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
06 Badajoz;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
06 Badajoz;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
06 Badajoz;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
06 Badajoz;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
06 Badajoz;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
06 Badajoz;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;94,62
06 Badajoz;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
06 Badajoz;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
06 Badajoz;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
06 Badajoz;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;93,85
06 Badajoz;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
06 Badajoz;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
06 Badajoz;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
06 Badajoz;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;92,2
06 Badajoz;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
06 Badajoz;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
06 Badajoz;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;88,88
06 Badajoz;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
06 Badajoz;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
06 Badajoz;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
06 Badajoz;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;88,72
06 Badajoz;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
06 Badajoz;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
06 Badajoz;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
06 Badajoz;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;88,17
06 Badajoz;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
06 Badajoz;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
06 Badajoz;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
06 Badajoz;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
06 Badajoz;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
06 Badajoz;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
06 Badajoz;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;80,62
06 Badajoz;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
06 Badajoz;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
06 Badajoz;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
06 Badajoz;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;85,04
06 Badajoz;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
06 Badajoz;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
06 Badajoz;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
06 Badajoz;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
06 Badajoz;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
06 Badajoz;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
06 Badajoz;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;76,33
06 Badajoz;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
06 Badajoz;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
06 Badajoz;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
06 Badajoz;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;79,75
06 Badajoz;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
06 Badajoz;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
06 Badajoz;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
06 Badajoz;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
06 Badajoz;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
06 Badajoz;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QIV;2.885
06 Badajoz;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
06 Badajoz;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
06 Badajoz;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
06 Badajoz;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QIV;2.850
06 Badajoz;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
06 Badajoz;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
06 Badajoz;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
06 Badajoz;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QIV;2.938
06 Badajoz;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
06 Badajoz;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
06 Badajoz;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
06 Badajoz;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2022QIV;2.723
06 Badajoz;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
06 Badajoz;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2022QII;""
06 Badajoz;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2022QI;""
06 Badajoz;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2021QIV;2.695
06 Badajoz;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
06 Badajoz;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2021QII;""
06 Badajoz;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2021QI;""
06 Badajoz;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2020QIV;2.789
06 Badajoz;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
06 Badajoz;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2020QII;""
06 Badajoz;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2020QI;""
06 Badajoz;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
06 Badajoz;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
06 Badajoz;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2022QII;""
06 Badajoz;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2022QI;2.518
06 Badajoz;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
06 Badajoz;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
06 Badajoz;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2021QII;""
06 Badajoz;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2021QI;2.691
06 Badajoz;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
06 Badajoz;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
06 Badajoz;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2020QII;""
06 Badajoz;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2020QI;""
06 Badajoz;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
06 Badajoz;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
06 Badajoz;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QII;2.397
06 Badajoz;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QI;""
06 Badajoz;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
06 Badajoz;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
06 Badajoz;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QII;2.555
06 Badajoz;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QI;""
06 Badajoz;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
06 Badajoz;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
06 Badajoz;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QII;""
06 Badajoz;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QI;""
06 Badajoz;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
06 Badajoz;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QIII;2.282
06 Badajoz;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QII;""
06 Badajoz;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QI;""
06 Badajoz;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
06 Badajoz;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QIII;2.427
06 Badajoz;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QII;""
06 Badajoz;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QI;""
06 Badajoz;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
06 Badajoz;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
06 Badajoz;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QII;""
06 Badajoz;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QI;""
06 Badajoz;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
06 Badajoz;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
06 Badajoz;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
06 Badajoz;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
06 Badajoz;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
06 Badajoz;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
06 Badajoz;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
06 Badajoz;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
06 Badajoz;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
06 Badajoz;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
06 Badajoz;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
06 Badajoz;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
06 Badajoz;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;94,38
06 Badajoz;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
06 Badajoz;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
06 Badajoz;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
06 Badajoz;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;94,56
06 Badajoz;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
06 Badajoz;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
06 Badajoz;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
06 Badajoz;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;94,93
06 Badajoz;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
06 Badajoz;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
06 Badajoz;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
06 Badajoz;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
06 Badajoz;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
06 Badajoz;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
06 Badajoz;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;88,35
06 Badajoz;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
06 Badajoz;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
06 Badajoz;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
06 Badajoz;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;91,59
06 Badajoz;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
06 Badajoz;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
06 Badajoz;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
06 Badajoz;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
06 Badajoz;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
06 Badajoz;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
06 Badajoz;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;84,11
06 Badajoz;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
06 Badajoz;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
06 Badajoz;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
06 Badajoz;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;86,96
06 Badajoz;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
06 Badajoz;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
06 Badajoz;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
06 Badajoz;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
06 Badajoz;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
06 Badajoz;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
06 Badajoz;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;80,07
06 Badajoz;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
06 Badajoz;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
06 Badajoz;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
06 Badajoz;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;82,61
06 Badajoz;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
06 Badajoz;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
06 Badajoz;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
06 Badajoz;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
06 Badajoz;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
06 Badajoz;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
06 Badajoz;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QIV;1.728
06 Badajoz;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
06 Badajoz;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
06 Badajoz;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
06 Badajoz;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QIV;1.703
06 Badajoz;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
06 Badajoz;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
06 Badajoz;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
06 Badajoz;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QIV;1.803
06 Badajoz;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
06 Badajoz;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
06 Badajoz;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
06 Badajoz;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2022QIV;1.637
06 Badajoz;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
06 Badajoz;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2022QII;""
06 Badajoz;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2022QI;""
06 Badajoz;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2021QIV;1.609
06 Badajoz;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
06 Badajoz;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2021QII;""
06 Badajoz;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2021QI;""
06 Badajoz;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2020QIV;1.714
06 Badajoz;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
06 Badajoz;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2020QII;""
06 Badajoz;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2020QI;""
06 Badajoz;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
06 Badajoz;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
06 Badajoz;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2022QII;""
06 Badajoz;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2022QI;1.524
06 Badajoz;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
06 Badajoz;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
06 Badajoz;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2021QII;""
06 Badajoz;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2021QI;1.659
06 Badajoz;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
06 Badajoz;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
06 Badajoz;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2020QII;""
06 Badajoz;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2020QI;""
06 Badajoz;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
06 Badajoz;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
06 Badajoz;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QII;1.454
06 Badajoz;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QI;""
06 Badajoz;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
06 Badajoz;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
06 Badajoz;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QII;1.587
06 Badajoz;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QI;""
06 Badajoz;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
06 Badajoz;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
06 Badajoz;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QII;""
06 Badajoz;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QI;""
06 Badajoz;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
06 Badajoz;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QIII;1.386
06 Badajoz;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QII;""
06 Badajoz;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QI;""
06 Badajoz;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
06 Badajoz;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QIII;1.509
06 Badajoz;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QII;""
06 Badajoz;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QI;""
06 Badajoz;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
06 Badajoz;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
06 Badajoz;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QII;""
06 Badajoz;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QI;""
06 Badajoz;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
06 Badajoz;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
06 Badajoz;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
06 Badajoz;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
06 Badajoz;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
06 Badajoz;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
06 Badajoz;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
06 Badajoz;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
06 Badajoz;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
06 Badajoz;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
06 Badajoz;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
06 Badajoz;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
06 Badajoz;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;94,73
06 Badajoz;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
06 Badajoz;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
06 Badajoz;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
06 Badajoz;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;94,48
06 Badajoz;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
06 Badajoz;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
06 Badajoz;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
06 Badajoz;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;95,06
06 Badajoz;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
06 Badajoz;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
06 Badajoz;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
06 Badajoz;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
06 Badajoz;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
06 Badajoz;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
06 Badajoz;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;89,49
06 Badajoz;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
06 Badajoz;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
06 Badajoz;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
06 Badajoz;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;92,01
06 Badajoz;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
06 Badajoz;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
06 Badajoz;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
06 Badajoz;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
06 Badajoz;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
06 Badajoz;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
06 Badajoz;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;85,38
06 Badajoz;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
06 Badajoz;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
06 Badajoz;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
06 Badajoz;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;88,02
06 Badajoz;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
06 Badajoz;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
06 Badajoz;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
06 Badajoz;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
06 Badajoz;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
06 Badajoz;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
06 Badajoz;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;81,39
06 Badajoz;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
06 Badajoz;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
06 Badajoz;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
06 Badajoz;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;83,69
06 Badajoz;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
06 Badajoz;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
06 Badajoz;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
06 Badajoz;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
06 Badajoz;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
06 Badajoz;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
06 Badajoz;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QIV;1.157
06 Badajoz;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
06 Badajoz;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
06 Badajoz;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
06 Badajoz;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QIV;1.147
06 Badajoz;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
06 Badajoz;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
06 Badajoz;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
06 Badajoz;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QIV;1.135
06 Badajoz;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
06 Badajoz;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
06 Badajoz;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
06 Badajoz;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2022QIV;1.086
06 Badajoz;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
06 Badajoz;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2022QII;""
06 Badajoz;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2022QI;""
06 Badajoz;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2021QIV;1.086
06 Badajoz;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
06 Badajoz;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2021QII;""
06 Badajoz;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2021QI;""
06 Badajoz;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2020QIV;1.075
06 Badajoz;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
06 Badajoz;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2020QII;""
06 Badajoz;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2020QI;""
06 Badajoz;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
06 Badajoz;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
06 Badajoz;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2022QII;""
06 Badajoz;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2022QI;994
06 Badajoz;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
06 Badajoz;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
06 Badajoz;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2021QII;""
06 Badajoz;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2021QI;1.032
06 Badajoz;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
06 Badajoz;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
06 Badajoz;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2020QII;""
06 Badajoz;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2020QI;""
06 Badajoz;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
06 Badajoz;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
06 Badajoz;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QII;943
06 Badajoz;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QI;""
06 Badajoz;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
06 Badajoz;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
06 Badajoz;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QII;968
06 Badajoz;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QI;""
06 Badajoz;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
06 Badajoz;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
06 Badajoz;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QII;""
06 Badajoz;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QI;""
06 Badajoz;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
06 Badajoz;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QIII;896
06 Badajoz;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QII;""
06 Badajoz;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QI;""
06 Badajoz;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
06 Badajoz;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QIII;918
06 Badajoz;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QII;""
06 Badajoz;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QI;""
06 Badajoz;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
06 Badajoz;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
06 Badajoz;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QII;""
06 Badajoz;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QI;""
06 Badajoz;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
06 Badajoz;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
06 Badajoz;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
06 Badajoz;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
06 Badajoz;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
06 Badajoz;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
06 Badajoz;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
06 Badajoz;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
06 Badajoz;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
06 Badajoz;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
06 Badajoz;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
06 Badajoz;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
06 Badajoz;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;93,86
06 Badajoz;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
06 Badajoz;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
06 Badajoz;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
06 Badajoz;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;94,68
06 Badajoz;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
06 Badajoz;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
06 Badajoz;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
06 Badajoz;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;94,71
06 Badajoz;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
06 Badajoz;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
06 Badajoz;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
06 Badajoz;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
06 Badajoz;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
06 Badajoz;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
06 Badajoz;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;86,66
06 Badajoz;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
06 Badajoz;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
06 Badajoz;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
06 Badajoz;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;90,93
06 Badajoz;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
06 Badajoz;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
06 Badajoz;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
06 Badajoz;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
06 Badajoz;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
06 Badajoz;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
06 Badajoz;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;82,21
06 Badajoz;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
06 Badajoz;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
06 Badajoz;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
06 Badajoz;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;85,29
06 Badajoz;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
06 Badajoz;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
06 Badajoz;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
06 Badajoz;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
06 Badajoz;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
06 Badajoz;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
06 Badajoz;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;78,12
06 Badajoz;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
06 Badajoz;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
06 Badajoz;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
06 Badajoz;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;80,88
06 Badajoz;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
06 Badajoz;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
06 Badajoz;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
06 Badajoz;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
06 Badajoz;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
06 Badajoz;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
06 Badajoz;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
06 Badajoz;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
06 Badajoz;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
06 Badajoz;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QI;8.356
06 Badajoz;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
06 Badajoz;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
06 Badajoz;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
06 Badajoz;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QI;8.424
06 Badajoz;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
06 Badajoz;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
06 Badajoz;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
06 Badajoz;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QI;8.412
06 Badajoz;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
06 Badajoz;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
06 Badajoz;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2022QII;""
06 Badajoz;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2022QI;8.065
06 Badajoz;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
06 Badajoz;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
06 Badajoz;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2021QII;""
06 Badajoz;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2021QI;8.215
06 Badajoz;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
06 Badajoz;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
06 Badajoz;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2020QII;""
06 Badajoz;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2020QI;7.826
06 Badajoz;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
06 Badajoz;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
06 Badajoz;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2022QII;7.813
06 Badajoz;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2022QI;""
06 Badajoz;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
06 Badajoz;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
06 Badajoz;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2021QII;7.998
06 Badajoz;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2021QI;""
06 Badajoz;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
06 Badajoz;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
06 Badajoz;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2020QII;7.675
06 Badajoz;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2020QI;""
06 Badajoz;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
06 Badajoz;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QIII;7.571
06 Badajoz;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QII;""
06 Badajoz;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QI;""
06 Badajoz;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
06 Badajoz;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QIII;7.817
06 Badajoz;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QII;""
06 Badajoz;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QI;""
06 Badajoz;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
06 Badajoz;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QIII;7.470
06 Badajoz;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QII;""
06 Badajoz;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QI;""
06 Badajoz;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QIV;7.351
06 Badajoz;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
06 Badajoz;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QII;""
06 Badajoz;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QI;""
06 Badajoz;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QIV;7.597
06 Badajoz;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
06 Badajoz;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QII;""
06 Badajoz;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QI;""
06 Badajoz;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QIV;7.255
06 Badajoz;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
06 Badajoz;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QII;""
06 Badajoz;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QI;""
06 Badajoz;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
06 Badajoz;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
06 Badajoz;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
06 Badajoz;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
06 Badajoz;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
06 Badajoz;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
06 Badajoz;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
06 Badajoz;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
06 Badajoz;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
06 Badajoz;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
06 Badajoz;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
06 Badajoz;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
06 Badajoz;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
06 Badajoz;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
06 Badajoz;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
06 Badajoz;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;96,52
06 Badajoz;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
06 Badajoz;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
06 Badajoz;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
06 Badajoz;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;97,52
06 Badajoz;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
06 Badajoz;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
06 Badajoz;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
06 Badajoz;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;93,03
06 Badajoz;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
06 Badajoz;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
06 Badajoz;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;93,5
06 Badajoz;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
06 Badajoz;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
06 Badajoz;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
06 Badajoz;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;94,94
06 Badajoz;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
06 Badajoz;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
06 Badajoz;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
06 Badajoz;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;91,24
06 Badajoz;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
06 Badajoz;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
06 Badajoz;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;90,61
06 Badajoz;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
06 Badajoz;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
06 Badajoz;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
06 Badajoz;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;92,79
06 Badajoz;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
06 Badajoz;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
06 Badajoz;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
06 Badajoz;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;88,8
06 Badajoz;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
06 Badajoz;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
06 Badajoz;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;87,97
06 Badajoz;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
06 Badajoz;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
06 Badajoz;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
06 Badajoz;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;90,18
06 Badajoz;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
06 Badajoz;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
06 Badajoz;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
06 Badajoz;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;86,25
06 Badajoz;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
06 Badajoz;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
06 Badajoz;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
06 Badajoz;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
06 Badajoz;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
06 Badajoz;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
06 Badajoz;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QI;5.053
06 Badajoz;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
06 Badajoz;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
06 Badajoz;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
06 Badajoz;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QI;5.132
06 Badajoz;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
06 Badajoz;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
06 Badajoz;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
06 Badajoz;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QI;5.110
06 Badajoz;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
06 Badajoz;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
06 Badajoz;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2022QII;""
06 Badajoz;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2022QI;4.909
06 Badajoz;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
06 Badajoz;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
06 Badajoz;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2021QII;""
06 Badajoz;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2021QI;5.031
06 Badajoz;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
06 Badajoz;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
06 Badajoz;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2020QII;""
06 Badajoz;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2020QI;4.795
06 Badajoz;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
06 Badajoz;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
06 Badajoz;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2022QII;4.773
06 Badajoz;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2022QI;""
06 Badajoz;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
06 Badajoz;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
06 Badajoz;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2021QII;4.913
06 Badajoz;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2021QI;""
06 Badajoz;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
06 Badajoz;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
06 Badajoz;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2020QII;4.697
06 Badajoz;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2020QI;""
06 Badajoz;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
06 Badajoz;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QIII;4.654
06 Badajoz;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QII;""
06 Badajoz;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QI;""
06 Badajoz;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
06 Badajoz;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QIII;4.814
06 Badajoz;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QII;""
06 Badajoz;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QI;""
06 Badajoz;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
06 Badajoz;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QIII;4.586
06 Badajoz;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QII;""
06 Badajoz;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QI;""
06 Badajoz;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QIV;4.530
06 Badajoz;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
06 Badajoz;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QII;""
06 Badajoz;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QI;""
06 Badajoz;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QIV;4.697
06 Badajoz;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
06 Badajoz;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QII;""
06 Badajoz;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QI;""
06 Badajoz;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QIV;4.460
06 Badajoz;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
06 Badajoz;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QII;""
06 Badajoz;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QI;""
06 Badajoz;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
06 Badajoz;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
06 Badajoz;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
06 Badajoz;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
06 Badajoz;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
06 Badajoz;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
06 Badajoz;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
06 Badajoz;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
06 Badajoz;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
06 Badajoz;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
06 Badajoz;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
06 Badajoz;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
06 Badajoz;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
06 Badajoz;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
06 Badajoz;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
06 Badajoz;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;97,15
06 Badajoz;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
06 Badajoz;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
06 Badajoz;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
06 Badajoz;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;98,03
06 Badajoz;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
06 Badajoz;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
06 Badajoz;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
06 Badajoz;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;93,84
06 Badajoz;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
06 Badajoz;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
06 Badajoz;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;94,46
06 Badajoz;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
06 Badajoz;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
06 Badajoz;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
06 Badajoz;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;95,73
06 Badajoz;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
06 Badajoz;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
06 Badajoz;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
06 Badajoz;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;91,92
06 Badajoz;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
06 Badajoz;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
06 Badajoz;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;92,1
06 Badajoz;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
06 Badajoz;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
06 Badajoz;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
06 Badajoz;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;93,8
06 Badajoz;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
06 Badajoz;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
06 Badajoz;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
06 Badajoz;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;89,75
06 Badajoz;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
06 Badajoz;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
06 Badajoz;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;89,65
06 Badajoz;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
06 Badajoz;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
06 Badajoz;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
06 Badajoz;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;91,52
06 Badajoz;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
06 Badajoz;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
06 Badajoz;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
06 Badajoz;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;87,28
06 Badajoz;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
06 Badajoz;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
06 Badajoz;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
06 Badajoz;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
06 Badajoz;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
06 Badajoz;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
06 Badajoz;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QI;3.303
06 Badajoz;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
06 Badajoz;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
06 Badajoz;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
06 Badajoz;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QI;3.292
06 Badajoz;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
06 Badajoz;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
06 Badajoz;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
06 Badajoz;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QI;3.302
06 Badajoz;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
06 Badajoz;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
06 Badajoz;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2022QII;""
06 Badajoz;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2022QI;3.156
06 Badajoz;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
06 Badajoz;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
06 Badajoz;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2021QII;""
06 Badajoz;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2021QI;3.184
06 Badajoz;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
06 Badajoz;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
06 Badajoz;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2020QII;""
06 Badajoz;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2020QI;3.031
06 Badajoz;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
06 Badajoz;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
06 Badajoz;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2022QII;3.040
06 Badajoz;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2022QI;""
06 Badajoz;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
06 Badajoz;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
06 Badajoz;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2021QII;3.085
06 Badajoz;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2021QI;""
06 Badajoz;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
06 Badajoz;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
06 Badajoz;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2020QII;2.978
06 Badajoz;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2020QI;""
06 Badajoz;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
06 Badajoz;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QIII;2.917
06 Badajoz;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QII;""
06 Badajoz;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QI;""
06 Badajoz;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
06 Badajoz;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QIII;3.003
06 Badajoz;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QII;""
06 Badajoz;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QI;""
06 Badajoz;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
06 Badajoz;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QIII;2.884
06 Badajoz;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QII;""
06 Badajoz;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QI;""
06 Badajoz;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QIV;2.821
06 Badajoz;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
06 Badajoz;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QII;""
06 Badajoz;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QI;""
06 Badajoz;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QIV;2.900
06 Badajoz;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
06 Badajoz;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QII;""
06 Badajoz;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QI;""
06 Badajoz;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QIV;2.795
06 Badajoz;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
06 Badajoz;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QII;""
06 Badajoz;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QI;""
06 Badajoz;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
06 Badajoz;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
06 Badajoz;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
06 Badajoz;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
06 Badajoz;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
06 Badajoz;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
06 Badajoz;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
06 Badajoz;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
06 Badajoz;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
06 Badajoz;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
06 Badajoz;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
06 Badajoz;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
06 Badajoz;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
06 Badajoz;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
06 Badajoz;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
06 Badajoz;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;95,55
06 Badajoz;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
06 Badajoz;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
06 Badajoz;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
06 Badajoz;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;96,72
06 Badajoz;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
06 Badajoz;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
06 Badajoz;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
06 Badajoz;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;91,79
06 Badajoz;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
06 Badajoz;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
06 Badajoz;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;92,04
06 Badajoz;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
06 Badajoz;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
06 Badajoz;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
06 Badajoz;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;93,71
06 Badajoz;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
06 Badajoz;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
06 Badajoz;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
06 Badajoz;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;90,19
06 Badajoz;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
06 Badajoz;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
06 Badajoz;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;88,31
06 Badajoz;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
06 Badajoz;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
06 Badajoz;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
06 Badajoz;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;91,22
06 Badajoz;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
06 Badajoz;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
06 Badajoz;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
06 Badajoz;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;87,34
06 Badajoz;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
06 Badajoz;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
06 Badajoz;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;85,41
06 Badajoz;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
06 Badajoz;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
06 Badajoz;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
06 Badajoz;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;88,09
06 Badajoz;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
06 Badajoz;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
06 Badajoz;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
06 Badajoz;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;84,65
06 Badajoz;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
06 Badajoz;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
06 Badajoz;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
06 Badajoz;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
06 Badajoz;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
06 Badajoz;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QII;8.154
06 Badajoz;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
06 Badajoz;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
06 Badajoz;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
06 Badajoz;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QII;7.948
06 Badajoz;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
06 Badajoz;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
06 Badajoz;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
06 Badajoz;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QII;8.292
06 Badajoz;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
06 Badajoz;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
06 Badajoz;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
06 Badajoz;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2022QII;7.875
06 Badajoz;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2022QI;""
06 Badajoz;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
06 Badajoz;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
06 Badajoz;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2021QII;7.703
06 Badajoz;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2021QI;""
06 Badajoz;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
06 Badajoz;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
06 Badajoz;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2020QII;8.130
06 Badajoz;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2020QI;""
06 Badajoz;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
06 Badajoz;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2022QIII;7.617
06 Badajoz;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2022QII;""
06 Badajoz;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2022QI;""
06 Badajoz;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
06 Badajoz;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2021QIII;7.514
06 Badajoz;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2021QII;""
06 Badajoz;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2021QI;""
06 Badajoz;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
06 Badajoz;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2020QIII;7.907
06 Badajoz;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2020QII;""
06 Badajoz;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2020QI;""
06 Badajoz;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QIV;7.380
06 Badajoz;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
06 Badajoz;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QII;""
06 Badajoz;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QI;""
06 Badajoz;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QIV;7.298
06 Badajoz;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
06 Badajoz;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QII;""
06 Badajoz;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QI;""
06 Badajoz;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QIV;7.675
06 Badajoz;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
06 Badajoz;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QII;""
06 Badajoz;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QI;""
06 Badajoz;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
06 Badajoz;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
06 Badajoz;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QII;""
06 Badajoz;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QI;7.047
06 Badajoz;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
06 Badajoz;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
06 Badajoz;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QII;""
06 Badajoz;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QI;7.518
06 Badajoz;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
06 Badajoz;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
06 Badajoz;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QII;""
06 Badajoz;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QI;""
06 Badajoz;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
06 Badajoz;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
06 Badajoz;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
06 Badajoz;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
06 Badajoz;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
06 Badajoz;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
06 Badajoz;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
06 Badajoz;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
06 Badajoz;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
06 Badajoz;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
06 Badajoz;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
06 Badajoz;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
06 Badajoz;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
06 Badajoz;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
06 Badajoz;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;96,58
06 Badajoz;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
06 Badajoz;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
06 Badajoz;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
06 Badajoz;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;96,92
06 Badajoz;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
06 Badajoz;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
06 Badajoz;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
06 Badajoz;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;98,05
06 Badajoz;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
06 Badajoz;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
06 Badajoz;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;93,41
06 Badajoz;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
06 Badajoz;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
06 Badajoz;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
06 Badajoz;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;94,54
06 Badajoz;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
06 Badajoz;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
06 Badajoz;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
06 Badajoz;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;95,36
06 Badajoz;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
06 Badajoz;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
06 Badajoz;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;90,51
06 Badajoz;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
06 Badajoz;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
06 Badajoz;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
06 Badajoz;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;91,82
06 Badajoz;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
06 Badajoz;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
06 Badajoz;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
06 Badajoz;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;92,56
06 Badajoz;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
06 Badajoz;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
06 Badajoz;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
06 Badajoz;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
06 Badajoz;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
06 Badajoz;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
06 Badajoz;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;88,66
06 Badajoz;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
06 Badajoz;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
06 Badajoz;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
06 Badajoz;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;90,67
06 Badajoz;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
06 Badajoz;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
06 Badajoz;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
06 Badajoz;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
06 Badajoz;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
06 Badajoz;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
06 Badajoz;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QII;4.873
06 Badajoz;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
06 Badajoz;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
06 Badajoz;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
06 Badajoz;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QII;4.853
06 Badajoz;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
06 Badajoz;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
06 Badajoz;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
06 Badajoz;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QII;5.049
06 Badajoz;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
06 Badajoz;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
06 Badajoz;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
06 Badajoz;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2022QII;4.723
06 Badajoz;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2022QI;""
06 Badajoz;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
06 Badajoz;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
06 Badajoz;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2021QII;4.720
06 Badajoz;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2021QI;""
06 Badajoz;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
06 Badajoz;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
06 Badajoz;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2020QII;4.943
06 Badajoz;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2020QI;""
06 Badajoz;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
06 Badajoz;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2022QIII;4.592
06 Badajoz;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2022QII;""
06 Badajoz;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2022QI;""
06 Badajoz;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
06 Badajoz;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2021QIII;4.610
06 Badajoz;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2021QII;""
06 Badajoz;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2021QI;""
06 Badajoz;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
06 Badajoz;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2020QIII;4.822
06 Badajoz;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2020QII;""
06 Badajoz;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2020QI;""
06 Badajoz;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QIV;4.460
06 Badajoz;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
06 Badajoz;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QII;""
06 Badajoz;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QI;""
06 Badajoz;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QIV;4.489
06 Badajoz;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
06 Badajoz;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QII;""
06 Badajoz;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QI;""
06 Badajoz;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QIV;4.686
06 Badajoz;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
06 Badajoz;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QII;""
06 Badajoz;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QI;""
06 Badajoz;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
06 Badajoz;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
06 Badajoz;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QII;""
06 Badajoz;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QI;4.365
06 Badajoz;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
06 Badajoz;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
06 Badajoz;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QII;""
06 Badajoz;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QI;4.616
06 Badajoz;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
06 Badajoz;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
06 Badajoz;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QII;""
06 Badajoz;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QI;""
06 Badajoz;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
06 Badajoz;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
06 Badajoz;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
06 Badajoz;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
06 Badajoz;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
06 Badajoz;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
06 Badajoz;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
06 Badajoz;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
06 Badajoz;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
06 Badajoz;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
06 Badajoz;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
06 Badajoz;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
06 Badajoz;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
06 Badajoz;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
06 Badajoz;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;96,92
06 Badajoz;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
06 Badajoz;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
06 Badajoz;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
06 Badajoz;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;97,26
06 Badajoz;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
06 Badajoz;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
06 Badajoz;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
06 Badajoz;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;97,9
06 Badajoz;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
06 Badajoz;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
06 Badajoz;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;94,23
06 Badajoz;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
06 Badajoz;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
06 Badajoz;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
06 Badajoz;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;94,99
06 Badajoz;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
06 Badajoz;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
06 Badajoz;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
06 Badajoz;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;95,5
06 Badajoz;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
06 Badajoz;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
06 Badajoz;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;91,52
06 Badajoz;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
06 Badajoz;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
06 Badajoz;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
06 Badajoz;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;92,5
06 Badajoz;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
06 Badajoz;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
06 Badajoz;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
06 Badajoz;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;92,81
06 Badajoz;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
06 Badajoz;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
06 Badajoz;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
06 Badajoz;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
06 Badajoz;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
06 Badajoz;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
06 Badajoz;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;89,94
06 Badajoz;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
06 Badajoz;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
06 Badajoz;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
06 Badajoz;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;91,42
06 Badajoz;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
06 Badajoz;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
06 Badajoz;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
06 Badajoz;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
06 Badajoz;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
06 Badajoz;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
06 Badajoz;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QII;3.281
06 Badajoz;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
06 Badajoz;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
06 Badajoz;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
06 Badajoz;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QII;3.095
06 Badajoz;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
06 Badajoz;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
06 Badajoz;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
06 Badajoz;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QII;3.243
06 Badajoz;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
06 Badajoz;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
06 Badajoz;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
06 Badajoz;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2022QII;3.152
06 Badajoz;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2022QI;""
06 Badajoz;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
06 Badajoz;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
06 Badajoz;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2021QII;2.983
06 Badajoz;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2021QI;""
06 Badajoz;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
06 Badajoz;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
06 Badajoz;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2020QII;3.187
06 Badajoz;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2020QI;""
06 Badajoz;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
06 Badajoz;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2022QIII;3.025
06 Badajoz;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2022QII;""
06 Badajoz;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2022QI;""
06 Badajoz;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
06 Badajoz;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2021QIII;2.904
06 Badajoz;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2021QII;""
06 Badajoz;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2021QI;""
06 Badajoz;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
06 Badajoz;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2020QIII;3.085
06 Badajoz;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2020QII;""
06 Badajoz;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2020QI;""
06 Badajoz;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QIV;2.920
06 Badajoz;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
06 Badajoz;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QII;""
06 Badajoz;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QI;""
06 Badajoz;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QIV;2.809
06 Badajoz;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
06 Badajoz;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QII;""
06 Badajoz;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QI;""
06 Badajoz;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QIV;2.989
06 Badajoz;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
06 Badajoz;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QII;""
06 Badajoz;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QI;""
06 Badajoz;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
06 Badajoz;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
06 Badajoz;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QII;""
06 Badajoz;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QI;2.682
06 Badajoz;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
06 Badajoz;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
06 Badajoz;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QII;""
06 Badajoz;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QI;2.902
06 Badajoz;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
06 Badajoz;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
06 Badajoz;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QII;""
06 Badajoz;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QI;""
06 Badajoz;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
06 Badajoz;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
06 Badajoz;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
06 Badajoz;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
06 Badajoz;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
06 Badajoz;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
06 Badajoz;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
06 Badajoz;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
06 Badajoz;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
06 Badajoz;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
06 Badajoz;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
06 Badajoz;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
06 Badajoz;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
06 Badajoz;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
06 Badajoz;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;96,07
06 Badajoz;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
06 Badajoz;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
06 Badajoz;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
06 Badajoz;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;96,38
06 Badajoz;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
06 Badajoz;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
06 Badajoz;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
06 Badajoz;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;98,27
06 Badajoz;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
06 Badajoz;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
06 Badajoz;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;92,2
06 Badajoz;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
06 Badajoz;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
06 Badajoz;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
06 Badajoz;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;93,83
06 Badajoz;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
06 Badajoz;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
06 Badajoz;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
06 Badajoz;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;95,13
06 Badajoz;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
06 Badajoz;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
06 Badajoz;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;89
06 Badajoz;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
06 Badajoz;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
06 Badajoz;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
06 Badajoz;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;90,76
06 Badajoz;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
06 Badajoz;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
06 Badajoz;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
06 Badajoz;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;92,17
06 Badajoz;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
06 Badajoz;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
06 Badajoz;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
06 Badajoz;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
06 Badajoz;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
06 Badajoz;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
06 Badajoz;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;86,66
06 Badajoz;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
06 Badajoz;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
06 Badajoz;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
06 Badajoz;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;89,49
06 Badajoz;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
06 Badajoz;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
06 Badajoz;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
06 Badajoz;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
06 Badajoz;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
06 Badajoz;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QIII;8.116
06 Badajoz;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
06 Badajoz;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
06 Badajoz;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
06 Badajoz;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QIII;8.109
06 Badajoz;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
06 Badajoz;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
06 Badajoz;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
06 Badajoz;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QIII;8.402
06 Badajoz;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
06 Badajoz;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
06 Badajoz;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
06 Badajoz;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2022QIII;7.815
06 Badajoz;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2022QII;""
06 Badajoz;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2022QI;""
06 Badajoz;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
06 Badajoz;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2021QIII;7.884
06 Badajoz;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2021QII;""
06 Badajoz;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2021QI;""
06 Badajoz;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
06 Badajoz;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2020QIII;8.149
06 Badajoz;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2020QII;""
06 Badajoz;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2020QI;""
06 Badajoz;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2022QIV;7.554
06 Badajoz;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
06 Badajoz;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2022QII;""
06 Badajoz;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2022QI;""
06 Badajoz;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2021QIV;7.646
06 Badajoz;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
06 Badajoz;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2021QII;""
06 Badajoz;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2021QI;""
06 Badajoz;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2020QIV;7.888
06 Badajoz;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
06 Badajoz;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2020QII;""
06 Badajoz;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2020QI;""
06 Badajoz;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
06 Badajoz;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
06 Badajoz;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QII;""
06 Badajoz;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QI;7.386
06 Badajoz;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
06 Badajoz;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
06 Badajoz;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QII;""
06 Badajoz;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QI;7.721
06 Badajoz;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
06 Badajoz;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
06 Badajoz;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QII;""
06 Badajoz;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QI;""
06 Badajoz;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
06 Badajoz;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
06 Badajoz;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QII;7.168
06 Badajoz;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QI;""
06 Badajoz;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
06 Badajoz;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
06 Badajoz;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QII;7.540
06 Badajoz;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QI;""
06 Badajoz;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
06 Badajoz;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
06 Badajoz;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QII;""
06 Badajoz;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QI;""
06 Badajoz;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
06 Badajoz;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
06 Badajoz;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
06 Badajoz;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
06 Badajoz;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
06 Badajoz;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
06 Badajoz;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
06 Badajoz;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
06 Badajoz;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
06 Badajoz;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
06 Badajoz;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
06 Badajoz;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
06 Badajoz;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
06 Badajoz;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;96,29
06 Badajoz;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
06 Badajoz;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
06 Badajoz;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
06 Badajoz;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;97,23
06 Badajoz;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
06 Badajoz;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
06 Badajoz;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
06 Badajoz;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;96,99
06 Badajoz;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
06 Badajoz;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
06 Badajoz;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;93,08
06 Badajoz;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
06 Badajoz;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
06 Badajoz;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
06 Badajoz;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;94,29
06 Badajoz;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
06 Badajoz;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
06 Badajoz;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
06 Badajoz;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;93,88
06 Badajoz;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
06 Badajoz;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
06 Badajoz;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
06 Badajoz;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
06 Badajoz;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
06 Badajoz;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
06 Badajoz;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;91,08
06 Badajoz;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
06 Badajoz;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
06 Badajoz;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
06 Badajoz;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;91,89
06 Badajoz;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
06 Badajoz;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
06 Badajoz;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
06 Badajoz;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
06 Badajoz;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
06 Badajoz;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
06 Badajoz;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;88,4
06 Badajoz;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
06 Badajoz;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
06 Badajoz;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
06 Badajoz;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;89,74
06 Badajoz;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
06 Badajoz;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
06 Badajoz;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
06 Badajoz;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
06 Badajoz;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
06 Badajoz;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
06 Badajoz;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QIII;4.862
06 Badajoz;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
06 Badajoz;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
06 Badajoz;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
06 Badajoz;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QIII;4.946
06 Badajoz;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
06 Badajoz;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
06 Badajoz;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
06 Badajoz;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QIII;5.127
06 Badajoz;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
06 Badajoz;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
06 Badajoz;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
06 Badajoz;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2022QIII;4.704
06 Badajoz;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2022QII;""
06 Badajoz;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2022QI;""
06 Badajoz;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
06 Badajoz;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2021QIII;4.818
06 Badajoz;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2021QII;""
06 Badajoz;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2021QI;""
06 Badajoz;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
06 Badajoz;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2020QIII;4.982
06 Badajoz;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2020QII;""
06 Badajoz;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2020QI;""
06 Badajoz;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2022QIV;4.555
06 Badajoz;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
06 Badajoz;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2022QII;""
06 Badajoz;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2022QI;""
06 Badajoz;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2021QIV;4.681
06 Badajoz;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
06 Badajoz;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2021QII;""
06 Badajoz;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2021QI;""
06 Badajoz;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2020QIV;4.819
06 Badajoz;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
06 Badajoz;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2020QII;""
06 Badajoz;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2020QI;""
06 Badajoz;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
06 Badajoz;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
06 Badajoz;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QII;""
06 Badajoz;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QI;4.552
06 Badajoz;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
06 Badajoz;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
06 Badajoz;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QII;""
06 Badajoz;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QI;4.740
06 Badajoz;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
06 Badajoz;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
06 Badajoz;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QII;""
06 Badajoz;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QI;""
06 Badajoz;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
06 Badajoz;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
06 Badajoz;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QII;4.434
06 Badajoz;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QI;""
06 Badajoz;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
06 Badajoz;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
06 Badajoz;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QII;4.644
06 Badajoz;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QI;""
06 Badajoz;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
06 Badajoz;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
06 Badajoz;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QII;""
06 Badajoz;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QI;""
06 Badajoz;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
06 Badajoz;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
06 Badajoz;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
06 Badajoz;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
06 Badajoz;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
06 Badajoz;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
06 Badajoz;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
06 Badajoz;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
06 Badajoz;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
06 Badajoz;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
06 Badajoz;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
06 Badajoz;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
06 Badajoz;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
06 Badajoz;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;96,75
06 Badajoz;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
06 Badajoz;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
06 Badajoz;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
06 Badajoz;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;97,41
06 Badajoz;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
06 Badajoz;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
06 Badajoz;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
06 Badajoz;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;97,17
06 Badajoz;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
06 Badajoz;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
06 Badajoz;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;93,69
06 Badajoz;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
06 Badajoz;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
06 Badajoz;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
06 Badajoz;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;94,64
06 Badajoz;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
06 Badajoz;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
06 Badajoz;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
06 Badajoz;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;93,99
06 Badajoz;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
06 Badajoz;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
06 Badajoz;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
06 Badajoz;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
06 Badajoz;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
06 Badajoz;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
06 Badajoz;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;92,03
06 Badajoz;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
06 Badajoz;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
06 Badajoz;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
06 Badajoz;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;92,45
06 Badajoz;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
06 Badajoz;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
06 Badajoz;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
06 Badajoz;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
06 Badajoz;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
06 Badajoz;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
06 Badajoz;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;89,65
06 Badajoz;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
06 Badajoz;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
06 Badajoz;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
06 Badajoz;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;90,58
06 Badajoz;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
06 Badajoz;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
06 Badajoz;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
06 Badajoz;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
06 Badajoz;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
06 Badajoz;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
06 Badajoz;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QIII;3.254
06 Badajoz;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
06 Badajoz;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
06 Badajoz;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
06 Badajoz;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QIII;3.163
06 Badajoz;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
06 Badajoz;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
06 Badajoz;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
06 Badajoz;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QIII;3.275
06 Badajoz;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
06 Badajoz;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
06 Badajoz;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
06 Badajoz;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2022QIII;3.111
06 Badajoz;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2022QII;""
06 Badajoz;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2022QI;""
06 Badajoz;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
06 Badajoz;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2021QIII;3.066
06 Badajoz;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2021QII;""
06 Badajoz;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2021QI;""
06 Badajoz;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
06 Badajoz;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2020QIII;3.167
06 Badajoz;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2020QII;""
06 Badajoz;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2020QI;""
06 Badajoz;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2022QIV;2.999
06 Badajoz;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
06 Badajoz;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2022QII;""
06 Badajoz;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2022QI;""
06 Badajoz;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2021QIV;2.965
06 Badajoz;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
06 Badajoz;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2021QII;""
06 Badajoz;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2021QI;""
06 Badajoz;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2020QIV;3.069
06 Badajoz;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
06 Badajoz;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2020QII;""
06 Badajoz;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2020QI;""
06 Badajoz;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
06 Badajoz;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
06 Badajoz;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QII;""
06 Badajoz;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QI;2.834
06 Badajoz;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
06 Badajoz;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
06 Badajoz;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QII;""
06 Badajoz;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QI;2.981
06 Badajoz;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
06 Badajoz;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
06 Badajoz;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QII;""
06 Badajoz;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QI;""
06 Badajoz;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
06 Badajoz;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
06 Badajoz;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QII;2.734
06 Badajoz;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QI;""
06 Badajoz;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
06 Badajoz;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
06 Badajoz;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QII;2.896
06 Badajoz;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QI;""
06 Badajoz;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
06 Badajoz;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
06 Badajoz;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QII;""
06 Badajoz;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QI;""
06 Badajoz;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
06 Badajoz;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
06 Badajoz;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
06 Badajoz;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
06 Badajoz;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
06 Badajoz;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
06 Badajoz;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
06 Badajoz;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
06 Badajoz;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
06 Badajoz;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
06 Badajoz;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
06 Badajoz;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
06 Badajoz;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
06 Badajoz;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;95,61
06 Badajoz;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
06 Badajoz;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
06 Badajoz;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
06 Badajoz;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;96,93
06 Badajoz;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
06 Badajoz;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
06 Badajoz;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
06 Badajoz;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;96,7
06 Badajoz;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
06 Badajoz;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
06 Badajoz;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;92,16
06 Badajoz;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
06 Badajoz;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
06 Badajoz;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
06 Badajoz;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;93,74
06 Badajoz;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
06 Badajoz;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
06 Badajoz;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
06 Badajoz;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;93,71
06 Badajoz;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
06 Badajoz;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
06 Badajoz;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
06 Badajoz;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
06 Badajoz;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
06 Badajoz;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
06 Badajoz;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;89,6
06 Badajoz;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
06 Badajoz;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
06 Badajoz;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
06 Badajoz;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;91,02
06 Badajoz;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
06 Badajoz;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
06 Badajoz;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
06 Badajoz;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
06 Badajoz;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
06 Badajoz;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
06 Badajoz;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;86,44
06 Badajoz;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
06 Badajoz;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
06 Badajoz;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
06 Badajoz;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;88,43
06 Badajoz;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
06 Badajoz;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
06 Badajoz;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
06 Badajoz;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
06 Badajoz;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
06 Badajoz;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QIV;8.079
06 Badajoz;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
06 Badajoz;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
06 Badajoz;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
06 Badajoz;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QIV;8.222
06 Badajoz;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
06 Badajoz;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
06 Badajoz;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
06 Badajoz;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QIV;8.444
06 Badajoz;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
06 Badajoz;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
06 Badajoz;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
06 Badajoz;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2022QIV;7.792
06 Badajoz;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
06 Badajoz;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2022QII;""
06 Badajoz;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2022QI;""
06 Badajoz;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2021QIV;7.955
06 Badajoz;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
06 Badajoz;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2021QII;""
06 Badajoz;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2021QI;""
06 Badajoz;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2020QIV;8.156
06 Badajoz;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
06 Badajoz;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2020QII;""
06 Badajoz;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2020QI;""
06 Badajoz;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
06 Badajoz;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
06 Badajoz;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2022QII;""
06 Badajoz;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2022QI;7.683
06 Badajoz;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
06 Badajoz;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
06 Badajoz;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2021QII;""
06 Badajoz;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2021QI;7.973
06 Badajoz;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
06 Badajoz;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
06 Badajoz;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2020QII;""
06 Badajoz;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2020QI;""
06 Badajoz;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
06 Badajoz;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
06 Badajoz;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QII;7.452
06 Badajoz;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QI;""
06 Badajoz;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
06 Badajoz;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
06 Badajoz;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QII;7.776
06 Badajoz;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QI;""
06 Badajoz;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
06 Badajoz;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
06 Badajoz;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QII;""
06 Badajoz;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QI;""
06 Badajoz;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
06 Badajoz;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QIII;7.230
06 Badajoz;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QII;""
06 Badajoz;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QI;""
06 Badajoz;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
06 Badajoz;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QIII;7.601
06 Badajoz;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QII;""
06 Badajoz;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QI;""
06 Badajoz;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
06 Badajoz;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
06 Badajoz;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QII;""
06 Badajoz;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QI;""
06 Badajoz;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
06 Badajoz;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
06 Badajoz;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
06 Badajoz;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
06 Badajoz;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
06 Badajoz;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
06 Badajoz;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
06 Badajoz;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
06 Badajoz;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
06 Badajoz;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
06 Badajoz;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
06 Badajoz;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
06 Badajoz;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;96,45
06 Badajoz;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
06 Badajoz;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
06 Badajoz;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
06 Badajoz;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;96,75
06 Badajoz;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
06 Badajoz;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
06 Badajoz;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
06 Badajoz;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;96,59
06 Badajoz;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
06 Badajoz;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
06 Badajoz;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
06 Badajoz;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
06 Badajoz;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
06 Badajoz;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
06 Badajoz;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;93,44
06 Badajoz;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
06 Badajoz;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
06 Badajoz;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
06 Badajoz;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;94,42
06 Badajoz;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
06 Badajoz;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
06 Badajoz;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
06 Badajoz;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
06 Badajoz;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
06 Badajoz;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
06 Badajoz;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;90,63
06 Badajoz;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
06 Badajoz;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
06 Badajoz;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
06 Badajoz;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;92,09
06 Badajoz;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
06 Badajoz;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
06 Badajoz;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
06 Badajoz;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
06 Badajoz;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
06 Badajoz;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
06 Badajoz;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;87,93
06 Badajoz;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
06 Badajoz;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
06 Badajoz;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
06 Badajoz;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;90,02
06 Badajoz;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
06 Badajoz;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
06 Badajoz;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
06 Badajoz;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
06 Badajoz;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
06 Badajoz;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
06 Badajoz;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QIV;4.846
06 Badajoz;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
06 Badajoz;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
06 Badajoz;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
06 Badajoz;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QIV;4.998
06 Badajoz;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
06 Badajoz;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
06 Badajoz;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
06 Badajoz;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QIV;5.162
06 Badajoz;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
06 Badajoz;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
06 Badajoz;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
06 Badajoz;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2022QIV;4.684
06 Badajoz;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
06 Badajoz;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2022QII;""
06 Badajoz;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2022QI;""
06 Badajoz;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2021QIV;4.841
06 Badajoz;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
06 Badajoz;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2021QII;""
06 Badajoz;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2021QI;""
06 Badajoz;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2020QIV;4.978
06 Badajoz;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
06 Badajoz;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2020QII;""
06 Badajoz;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2020QI;""
06 Badajoz;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
06 Badajoz;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
06 Badajoz;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2022QII;""
06 Badajoz;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2022QI;4.707
06 Badajoz;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
06 Badajoz;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
06 Badajoz;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2021QII;""
06 Badajoz;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2021QI;4.890
06 Badajoz;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
06 Badajoz;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
06 Badajoz;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2020QII;""
06 Badajoz;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2020QI;""
06 Badajoz;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
06 Badajoz;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
06 Badajoz;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QII;4.582
06 Badajoz;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QI;""
06 Badajoz;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
06 Badajoz;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
06 Badajoz;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QII;4.783
06 Badajoz;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QI;""
06 Badajoz;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
06 Badajoz;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
06 Badajoz;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QII;""
06 Badajoz;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QI;""
06 Badajoz;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
06 Badajoz;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QIII;4.474
06 Badajoz;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QII;""
06 Badajoz;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QI;""
06 Badajoz;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
06 Badajoz;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QIII;4.688
06 Badajoz;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QII;""
06 Badajoz;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QI;""
06 Badajoz;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
06 Badajoz;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
06 Badajoz;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QII;""
06 Badajoz;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QI;""
06 Badajoz;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
06 Badajoz;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
06 Badajoz;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
06 Badajoz;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
06 Badajoz;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
06 Badajoz;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
06 Badajoz;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
06 Badajoz;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
06 Badajoz;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
06 Badajoz;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
06 Badajoz;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
06 Badajoz;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
06 Badajoz;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;96,66
06 Badajoz;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
06 Badajoz;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
06 Badajoz;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
06 Badajoz;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;96,86
06 Badajoz;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
06 Badajoz;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
06 Badajoz;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
06 Badajoz;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;96,44
06 Badajoz;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
06 Badajoz;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
06 Badajoz;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
06 Badajoz;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
06 Badajoz;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
06 Badajoz;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
06 Badajoz;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;94,18
06 Badajoz;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
06 Badajoz;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
06 Badajoz;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
06 Badajoz;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;94,73
06 Badajoz;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
06 Badajoz;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
06 Badajoz;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
06 Badajoz;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
06 Badajoz;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
06 Badajoz;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
06 Badajoz;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;91,68
06 Badajoz;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
06 Badajoz;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
06 Badajoz;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
06 Badajoz;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;92,66
06 Badajoz;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
06 Badajoz;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
06 Badajoz;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
06 Badajoz;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
06 Badajoz;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
06 Badajoz;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
06 Badajoz;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;89,52
06 Badajoz;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
06 Badajoz;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
06 Badajoz;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
06 Badajoz;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;90,82
06 Badajoz;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
06 Badajoz;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
06 Badajoz;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
06 Badajoz;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
06 Badajoz;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
06 Badajoz;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
06 Badajoz;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QIV;3.233
06 Badajoz;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
06 Badajoz;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
06 Badajoz;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
06 Badajoz;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QIV;3.224
06 Badajoz;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
06 Badajoz;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
06 Badajoz;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
06 Badajoz;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QIV;3.282
06 Badajoz;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
06 Badajoz;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
06 Badajoz;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
06 Badajoz;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2022QIV;3.108
06 Badajoz;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
06 Badajoz;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2022QII;""
06 Badajoz;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2022QI;""
06 Badajoz;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2021QIV;3.114
06 Badajoz;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
06 Badajoz;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2021QII;""
06 Badajoz;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2021QI;""
06 Badajoz;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2020QIV;3.178
06 Badajoz;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
06 Badajoz;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2020QII;""
06 Badajoz;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2020QI;""
06 Badajoz;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
06 Badajoz;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
06 Badajoz;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2022QII;""
06 Badajoz;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2022QI;2.976
06 Badajoz;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
06 Badajoz;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
06 Badajoz;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2021QII;""
06 Badajoz;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2021QI;3.083
06 Badajoz;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
06 Badajoz;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
06 Badajoz;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2020QII;""
06 Badajoz;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2020QI;""
06 Badajoz;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
06 Badajoz;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
06 Badajoz;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QII;2.870
06 Badajoz;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QI;""
06 Badajoz;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
06 Badajoz;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
06 Badajoz;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QII;2.993
06 Badajoz;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QI;""
06 Badajoz;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
06 Badajoz;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
06 Badajoz;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QII;""
06 Badajoz;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QI;""
06 Badajoz;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
06 Badajoz;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QIII;2.756
06 Badajoz;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QII;""
06 Badajoz;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QI;""
06 Badajoz;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
06 Badajoz;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QIII;2.913
06 Badajoz;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QII;""
06 Badajoz;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QI;""
06 Badajoz;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
06 Badajoz;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
06 Badajoz;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QII;""
06 Badajoz;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QI;""
06 Badajoz;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
06 Badajoz;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
06 Badajoz;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
06 Badajoz;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
06 Badajoz;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
06 Badajoz;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
06 Badajoz;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
06 Badajoz;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
06 Badajoz;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
06 Badajoz;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
06 Badajoz;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
06 Badajoz;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
06 Badajoz;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;96,13
06 Badajoz;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
06 Badajoz;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
06 Badajoz;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
06 Badajoz;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;96,59
06 Badajoz;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
06 Badajoz;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
06 Badajoz;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
06 Badajoz;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;96,83
06 Badajoz;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
06 Badajoz;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
06 Badajoz;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
06 Badajoz;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
06 Badajoz;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
06 Badajoz;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
06 Badajoz;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;92,31
06 Badajoz;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
06 Badajoz;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
06 Badajoz;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
06 Badajoz;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;93,94
06 Badajoz;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
06 Badajoz;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
06 Badajoz;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
06 Badajoz;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
06 Badajoz;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
06 Badajoz;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
06 Badajoz;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;89,02
06 Badajoz;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
06 Badajoz;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
06 Badajoz;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
06 Badajoz;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;91,19
06 Badajoz;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
06 Badajoz;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
06 Badajoz;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
06 Badajoz;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
06 Badajoz;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
06 Badajoz;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
06 Badajoz;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;85,48
06 Badajoz;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
06 Badajoz;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
06 Badajoz;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
06 Badajoz;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;88,76
06 Badajoz;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
06 Badajoz;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
06 Badajoz;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
06 Badajoz;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
06 Badajoz;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
06 Badajoz;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
06 Badajoz;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
06 Badajoz;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
06 Badajoz;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
06 Badajoz;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QI;11.983
06 Badajoz;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
06 Badajoz;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
06 Badajoz;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
06 Badajoz;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QI;11.833
06 Badajoz;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
06 Badajoz;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
06 Badajoz;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
06 Badajoz;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QI;11.967
06 Badajoz;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
06 Badajoz;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
06 Badajoz;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2022QII;""
06 Badajoz;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2022QI;11.645
06 Badajoz;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
06 Badajoz;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
06 Badajoz;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2021QII;""
06 Badajoz;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2021QI;11.624
06 Badajoz;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
06 Badajoz;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
06 Badajoz;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2020QII;""
06 Badajoz;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2020QI;11.281
06 Badajoz;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
06 Badajoz;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
06 Badajoz;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2022QII;11.335
06 Badajoz;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2022QI;""
06 Badajoz;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
06 Badajoz;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
06 Badajoz;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2021QII;11.385
06 Badajoz;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2021QI;""
06 Badajoz;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
06 Badajoz;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
06 Badajoz;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2020QII;11.128
06 Badajoz;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2020QI;""
06 Badajoz;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
06 Badajoz;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QIII;11.098
06 Badajoz;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QII;""
06 Badajoz;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QI;""
06 Badajoz;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
06 Badajoz;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QIII;11.222
06 Badajoz;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QII;""
06 Badajoz;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QI;""
06 Badajoz;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
06 Badajoz;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QIII;10.937
06 Badajoz;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QII;""
06 Badajoz;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QI;""
06 Badajoz;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QIV;10.880
06 Badajoz;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
06 Badajoz;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QII;""
06 Badajoz;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QI;""
06 Badajoz;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QIV;10.991
06 Badajoz;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
06 Badajoz;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QII;""
06 Badajoz;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QI;""
06 Badajoz;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QIV;10.708
06 Badajoz;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
06 Badajoz;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QII;""
06 Badajoz;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QI;""
06 Badajoz;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
06 Badajoz;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
06 Badajoz;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
06 Badajoz;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
06 Badajoz;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
06 Badajoz;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
06 Badajoz;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
06 Badajoz;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
06 Badajoz;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
06 Badajoz;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
06 Badajoz;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
06 Badajoz;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
06 Badajoz;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
06 Badajoz;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
06 Badajoz;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
06 Badajoz;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;97,18
06 Badajoz;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
06 Badajoz;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
06 Badajoz;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
06 Badajoz;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;98,23
06 Badajoz;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
06 Badajoz;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
06 Badajoz;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
06 Badajoz;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;94,27
06 Badajoz;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
06 Badajoz;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
06 Badajoz;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;94,59
06 Badajoz;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
06 Badajoz;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
06 Badajoz;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
06 Badajoz;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;96,21
06 Badajoz;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
06 Badajoz;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
06 Badajoz;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
06 Badajoz;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;92,99
06 Badajoz;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
06 Badajoz;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
06 Badajoz;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;92,61
06 Badajoz;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
06 Badajoz;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
06 Badajoz;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
06 Badajoz;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;94,84
06 Badajoz;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
06 Badajoz;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
06 Badajoz;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
06 Badajoz;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;91,39
06 Badajoz;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
06 Badajoz;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
06 Badajoz;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;90,8
06 Badajoz;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
06 Badajoz;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
06 Badajoz;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
06 Badajoz;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;92,88
06 Badajoz;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
06 Badajoz;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
06 Badajoz;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
06 Badajoz;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;89,48
06 Badajoz;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
06 Badajoz;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
06 Badajoz;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
06 Badajoz;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
06 Badajoz;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
06 Badajoz;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
06 Badajoz;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QI;7.863
06 Badajoz;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
06 Badajoz;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
06 Badajoz;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
06 Badajoz;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QI;7.829
06 Badajoz;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
06 Badajoz;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
06 Badajoz;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
06 Badajoz;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QI;7.898
06 Badajoz;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
06 Badajoz;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
06 Badajoz;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2022QII;""
06 Badajoz;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2022QI;7.680
06 Badajoz;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
06 Badajoz;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
06 Badajoz;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2021QII;""
06 Badajoz;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2021QI;7.707
06 Badajoz;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
06 Badajoz;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
06 Badajoz;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2020QII;""
06 Badajoz;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2020QI;7.481
06 Badajoz;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
06 Badajoz;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
06 Badajoz;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2022QII;7.506
06 Badajoz;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2022QI;""
06 Badajoz;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
06 Badajoz;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
06 Badajoz;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2021QII;7.577
06 Badajoz;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2021QI;""
06 Badajoz;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
06 Badajoz;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
06 Badajoz;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2020QII;7.389
06 Badajoz;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2020QI;""
06 Badajoz;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
06 Badajoz;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QIII;7.368
06 Badajoz;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QII;""
06 Badajoz;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QI;""
06 Badajoz;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
06 Badajoz;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QIII;7.478
06 Badajoz;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QII;""
06 Badajoz;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QI;""
06 Badajoz;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
06 Badajoz;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QIII;7.288
06 Badajoz;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QII;""
06 Badajoz;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QI;""
06 Badajoz;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QIV;7.259
06 Badajoz;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
06 Badajoz;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QII;""
06 Badajoz;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QI;""
06 Badajoz;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QIV;7.348
06 Badajoz;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
06 Badajoz;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QII;""
06 Badajoz;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QI;""
06 Badajoz;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QIV;7.165
06 Badajoz;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
06 Badajoz;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QII;""
06 Badajoz;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QI;""
06 Badajoz;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
06 Badajoz;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
06 Badajoz;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
06 Badajoz;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
06 Badajoz;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
06 Badajoz;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
06 Badajoz;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
06 Badajoz;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
06 Badajoz;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
06 Badajoz;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
06 Badajoz;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
06 Badajoz;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
06 Badajoz;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
06 Badajoz;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
06 Badajoz;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
06 Badajoz;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;97,67
06 Badajoz;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
06 Badajoz;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
06 Badajoz;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
06 Badajoz;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;98,44
06 Badajoz;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
06 Badajoz;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
06 Badajoz;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
06 Badajoz;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;94,72
06 Badajoz;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
06 Badajoz;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
06 Badajoz;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;95,46
06 Badajoz;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
06 Badajoz;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
06 Badajoz;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
06 Badajoz;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;96,78
06 Badajoz;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
06 Badajoz;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
06 Badajoz;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
06 Badajoz;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;93,56
06 Badajoz;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
06 Badajoz;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
06 Badajoz;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;93,7
06 Badajoz;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
06 Badajoz;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
06 Badajoz;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
06 Badajoz;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;95,52
06 Badajoz;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
06 Badajoz;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
06 Badajoz;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
06 Badajoz;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;92,28
06 Badajoz;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
06 Badajoz;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
06 Badajoz;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;92,32
06 Badajoz;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
06 Badajoz;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
06 Badajoz;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
06 Badajoz;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;93,86
06 Badajoz;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
06 Badajoz;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
06 Badajoz;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
06 Badajoz;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;90,72
06 Badajoz;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
06 Badajoz;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
06 Badajoz;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
06 Badajoz;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
06 Badajoz;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
06 Badajoz;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
06 Badajoz;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QI;4.120
06 Badajoz;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
06 Badajoz;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
06 Badajoz;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
06 Badajoz;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QI;4.004
06 Badajoz;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
06 Badajoz;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
06 Badajoz;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
06 Badajoz;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QI;4.069
06 Badajoz;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
06 Badajoz;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
06 Badajoz;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2022QII;""
06 Badajoz;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2022QI;3.965
06 Badajoz;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
06 Badajoz;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
06 Badajoz;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2021QII;""
06 Badajoz;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2021QI;3.917
06 Badajoz;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
06 Badajoz;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
06 Badajoz;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2020QII;""
06 Badajoz;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2020QI;3.800
06 Badajoz;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
06 Badajoz;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
06 Badajoz;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2022QII;3.829
06 Badajoz;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2022QI;""
06 Badajoz;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
06 Badajoz;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
06 Badajoz;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2021QII;3.808
06 Badajoz;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2021QI;""
06 Badajoz;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
06 Badajoz;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
06 Badajoz;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2020QII;3.739
06 Badajoz;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2020QI;""
06 Badajoz;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
06 Badajoz;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QIII;3.730
06 Badajoz;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QII;""
06 Badajoz;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QI;""
06 Badajoz;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
06 Badajoz;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QIII;3.744
06 Badajoz;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QII;""
06 Badajoz;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QI;""
06 Badajoz;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
06 Badajoz;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QIII;3.649
06 Badajoz;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QII;""
06 Badajoz;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QI;""
06 Badajoz;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QIV;3.621
06 Badajoz;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
06 Badajoz;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QII;""
06 Badajoz;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QI;""
06 Badajoz;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QIV;3.643
06 Badajoz;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
06 Badajoz;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QII;""
06 Badajoz;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QI;""
06 Badajoz;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QIV;3.543
06 Badajoz;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
06 Badajoz;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QII;""
06 Badajoz;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QI;""
06 Badajoz;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
06 Badajoz;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
06 Badajoz;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
06 Badajoz;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
06 Badajoz;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
06 Badajoz;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
06 Badajoz;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
06 Badajoz;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
06 Badajoz;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
06 Badajoz;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
06 Badajoz;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
06 Badajoz;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
06 Badajoz;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
06 Badajoz;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
06 Badajoz;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
06 Badajoz;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;96,24
06 Badajoz;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
06 Badajoz;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
06 Badajoz;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
06 Badajoz;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;97,83
06 Badajoz;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
06 Badajoz;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
06 Badajoz;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
06 Badajoz;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;93,39
06 Badajoz;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
06 Badajoz;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
06 Badajoz;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;92,94
06 Badajoz;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
06 Badajoz;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
06 Badajoz;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
06 Badajoz;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;95,1
06 Badajoz;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
06 Badajoz;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
06 Badajoz;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
06 Badajoz;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;91,89
06 Badajoz;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
06 Badajoz;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
06 Badajoz;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;90,53
06 Badajoz;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
06 Badajoz;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
06 Badajoz;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
06 Badajoz;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;93,51
06 Badajoz;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
06 Badajoz;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
06 Badajoz;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
06 Badajoz;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;89,68
06 Badajoz;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
06 Badajoz;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
06 Badajoz;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;87,89
06 Badajoz;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
06 Badajoz;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
06 Badajoz;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
06 Badajoz;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;90,98
06 Badajoz;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
06 Badajoz;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
06 Badajoz;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
06 Badajoz;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;87,07
06 Badajoz;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
06 Badajoz;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
06 Badajoz;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
06 Badajoz;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
06 Badajoz;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
06 Badajoz;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QII;11.898
06 Badajoz;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
06 Badajoz;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
06 Badajoz;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
06 Badajoz;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QII;11.806
06 Badajoz;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
06 Badajoz;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
06 Badajoz;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
06 Badajoz;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QII;11.705
06 Badajoz;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
06 Badajoz;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
06 Badajoz;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
06 Badajoz;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2022QII;11.560
06 Badajoz;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2022QI;""
06 Badajoz;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
06 Badajoz;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
06 Badajoz;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2021QII;11.532
06 Badajoz;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2021QI;""
06 Badajoz;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
06 Badajoz;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
06 Badajoz;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2020QII;11.533
06 Badajoz;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2020QI;""
06 Badajoz;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
06 Badajoz;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2022QIII;11.297
06 Badajoz;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2022QII;""
06 Badajoz;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2022QI;""
06 Badajoz;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
06 Badajoz;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2021QIII;11.344
06 Badajoz;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2021QII;""
06 Badajoz;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2021QI;""
06 Badajoz;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
06 Badajoz;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2020QIII;11.327
06 Badajoz;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2020QII;""
06 Badajoz;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2020QI;""
06 Badajoz;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QIV;11.066
06 Badajoz;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
06 Badajoz;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QII;""
06 Badajoz;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QI;""
06 Badajoz;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QIV;11.083
06 Badajoz;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
06 Badajoz;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QII;""
06 Badajoz;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QI;""
06 Badajoz;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QIV;11.078
06 Badajoz;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
06 Badajoz;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QII;""
06 Badajoz;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QI;""
06 Badajoz;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
06 Badajoz;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
06 Badajoz;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QII;""
06 Badajoz;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QI;10.800
06 Badajoz;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
06 Badajoz;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
06 Badajoz;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QII;""
06 Badajoz;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QI;10.919
06 Badajoz;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
06 Badajoz;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
06 Badajoz;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QII;""
06 Badajoz;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QI;""
06 Badajoz;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
06 Badajoz;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
06 Badajoz;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
06 Badajoz;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
06 Badajoz;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
06 Badajoz;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
06 Badajoz;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
06 Badajoz;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
06 Badajoz;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
06 Badajoz;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
06 Badajoz;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
06 Badajoz;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
06 Badajoz;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
06 Badajoz;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
06 Badajoz;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;97,16
06 Badajoz;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
06 Badajoz;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
06 Badajoz;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
06 Badajoz;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;97,68
06 Badajoz;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
06 Badajoz;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
06 Badajoz;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
06 Badajoz;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;98,53
06 Badajoz;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
06 Badajoz;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
06 Badajoz;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;94,95
06 Badajoz;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
06 Badajoz;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
06 Badajoz;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
06 Badajoz;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;96,09
06 Badajoz;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
06 Badajoz;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
06 Badajoz;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
06 Badajoz;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;96,77
06 Badajoz;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
06 Badajoz;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
06 Badajoz;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;93,01
06 Badajoz;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
06 Badajoz;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
06 Badajoz;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
06 Badajoz;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;93,88
06 Badajoz;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
06 Badajoz;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
06 Badajoz;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
06 Badajoz;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;94,64
06 Badajoz;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
06 Badajoz;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
06 Badajoz;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
06 Badajoz;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
06 Badajoz;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
06 Badajoz;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
06 Badajoz;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;91,48
06 Badajoz;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
06 Badajoz;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
06 Badajoz;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
06 Badajoz;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;93,28
06 Badajoz;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
06 Badajoz;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
06 Badajoz;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
06 Badajoz;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
06 Badajoz;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
06 Badajoz;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
06 Badajoz;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QII;7.729
06 Badajoz;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
06 Badajoz;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
06 Badajoz;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
06 Badajoz;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QII;7.788
06 Badajoz;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
06 Badajoz;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
06 Badajoz;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
06 Badajoz;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QII;7.703
06 Badajoz;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
06 Badajoz;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
06 Badajoz;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
06 Badajoz;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2022QII;7.542
06 Badajoz;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2022QI;""
06 Badajoz;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
06 Badajoz;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
06 Badajoz;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2021QII;7.637
06 Badajoz;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2021QI;""
06 Badajoz;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
06 Badajoz;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
06 Badajoz;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2020QII;7.599
06 Badajoz;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2020QI;""
06 Badajoz;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
06 Badajoz;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2022QIII;7.386
06 Badajoz;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2022QII;""
06 Badajoz;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2022QI;""
06 Badajoz;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
06 Badajoz;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2021QIII;7.526
06 Badajoz;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2021QII;""
06 Badajoz;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2021QI;""
06 Badajoz;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
06 Badajoz;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2020QIII;7.486
06 Badajoz;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2020QII;""
06 Badajoz;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2020QI;""
06 Badajoz;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QIV;7.270
06 Badajoz;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
06 Badajoz;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QII;""
06 Badajoz;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QI;""
06 Badajoz;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QIV;7.378
06 Badajoz;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
06 Badajoz;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QII;""
06 Badajoz;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QI;""
06 Badajoz;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QIV;7.352
06 Badajoz;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
06 Badajoz;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QII;""
06 Badajoz;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QI;""
06 Badajoz;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
06 Badajoz;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
06 Badajoz;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QII;""
06 Badajoz;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QI;7.232
06 Badajoz;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
06 Badajoz;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
06 Badajoz;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QII;""
06 Badajoz;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QI;7.262
06 Badajoz;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
06 Badajoz;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
06 Badajoz;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QII;""
06 Badajoz;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QI;""
06 Badajoz;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
06 Badajoz;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
06 Badajoz;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
06 Badajoz;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
06 Badajoz;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
06 Badajoz;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
06 Badajoz;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
06 Badajoz;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
06 Badajoz;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
06 Badajoz;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
06 Badajoz;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
06 Badajoz;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
06 Badajoz;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
06 Badajoz;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
06 Badajoz;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;97,58
06 Badajoz;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
06 Badajoz;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
06 Badajoz;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
06 Badajoz;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;98,06
06 Badajoz;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
06 Badajoz;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
06 Badajoz;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
06 Badajoz;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;98,65
06 Badajoz;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
06 Badajoz;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
06 Badajoz;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;95,56
06 Badajoz;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
06 Badajoz;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
06 Badajoz;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
06 Badajoz;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;96,64
06 Badajoz;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
06 Badajoz;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
06 Badajoz;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
06 Badajoz;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;97,18
06 Badajoz;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
06 Badajoz;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
06 Badajoz;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;94,06
06 Badajoz;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
06 Badajoz;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
06 Badajoz;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
06 Badajoz;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;94,74
06 Badajoz;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
06 Badajoz;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
06 Badajoz;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
06 Badajoz;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;95,44
06 Badajoz;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
06 Badajoz;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
06 Badajoz;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
06 Badajoz;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
06 Badajoz;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
06 Badajoz;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
06 Badajoz;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;92,86
06 Badajoz;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
06 Badajoz;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
06 Badajoz;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
06 Badajoz;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;94,27
06 Badajoz;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
06 Badajoz;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
06 Badajoz;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
06 Badajoz;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
06 Badajoz;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
06 Badajoz;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
06 Badajoz;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QII;4.169
06 Badajoz;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
06 Badajoz;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
06 Badajoz;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
06 Badajoz;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QII;4.018
06 Badajoz;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
06 Badajoz;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
06 Badajoz;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
06 Badajoz;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QII;4.002
06 Badajoz;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
06 Badajoz;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
06 Badajoz;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
06 Badajoz;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2022QII;4.018
06 Badajoz;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2022QI;""
06 Badajoz;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
06 Badajoz;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
06 Badajoz;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2021QII;3.895
06 Badajoz;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2021QI;""
06 Badajoz;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
06 Badajoz;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
06 Badajoz;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2020QII;3.934
06 Badajoz;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2020QI;""
06 Badajoz;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
06 Badajoz;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2022QIII;3.911
06 Badajoz;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2022QII;""
06 Badajoz;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2022QI;""
06 Badajoz;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
06 Badajoz;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2021QIII;3.818
06 Badajoz;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2021QII;""
06 Badajoz;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2021QI;""
06 Badajoz;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
06 Badajoz;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2020QIII;3.841
06 Badajoz;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2020QII;""
06 Badajoz;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2020QI;""
06 Badajoz;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QIV;3.796
06 Badajoz;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
06 Badajoz;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QII;""
06 Badajoz;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QI;""
06 Badajoz;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QIV;3.705
06 Badajoz;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
06 Badajoz;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QII;""
06 Badajoz;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QI;""
06 Badajoz;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QIV;3.726
06 Badajoz;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
06 Badajoz;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QII;""
06 Badajoz;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QI;""
06 Badajoz;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
06 Badajoz;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
06 Badajoz;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QII;""
06 Badajoz;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QI;3.568
06 Badajoz;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
06 Badajoz;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
06 Badajoz;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QII;""
06 Badajoz;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QI;3.657
06 Badajoz;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
06 Badajoz;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
06 Badajoz;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QII;""
06 Badajoz;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QI;""
06 Badajoz;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
06 Badajoz;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
06 Badajoz;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
06 Badajoz;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
06 Badajoz;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
06 Badajoz;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
06 Badajoz;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
06 Badajoz;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
06 Badajoz;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
06 Badajoz;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
06 Badajoz;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
06 Badajoz;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
06 Badajoz;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
06 Badajoz;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
06 Badajoz;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;96,38
06 Badajoz;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
06 Badajoz;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
06 Badajoz;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
06 Badajoz;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;96,94
06 Badajoz;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
06 Badajoz;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
06 Badajoz;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
06 Badajoz;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;98,3
06 Badajoz;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
06 Badajoz;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
06 Badajoz;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;93,81
06 Badajoz;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
06 Badajoz;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
06 Badajoz;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
06 Badajoz;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;95,02
06 Badajoz;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
06 Badajoz;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
06 Badajoz;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
06 Badajoz;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;95,98
06 Badajoz;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
06 Badajoz;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
06 Badajoz;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;91,05
06 Badajoz;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
06 Badajoz;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
06 Badajoz;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
06 Badajoz;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;92,21
06 Badajoz;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
06 Badajoz;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
06 Badajoz;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
06 Badajoz;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;93,1
06 Badajoz;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
06 Badajoz;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
06 Badajoz;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
06 Badajoz;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
06 Badajoz;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
06 Badajoz;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
06 Badajoz;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;88,8
06 Badajoz;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
06 Badajoz;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
06 Badajoz;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
06 Badajoz;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;91,38
06 Badajoz;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
06 Badajoz;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
06 Badajoz;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
06 Badajoz;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
06 Badajoz;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
06 Badajoz;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QIII;11.812
06 Badajoz;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
06 Badajoz;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
06 Badajoz;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
06 Badajoz;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QIII;11.894
06 Badajoz;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
06 Badajoz;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
06 Badajoz;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
06 Badajoz;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QIII;11.854
06 Badajoz;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
06 Badajoz;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
06 Badajoz;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
06 Badajoz;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2022QIII;11.502
06 Badajoz;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2022QII;""
06 Badajoz;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2022QI;""
06 Badajoz;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
06 Badajoz;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2021QIII;11.673
06 Badajoz;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2021QII;""
06 Badajoz;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2021QI;""
06 Badajoz;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
06 Badajoz;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2020QIII;11.601
06 Badajoz;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2020QII;""
06 Badajoz;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2020QI;""
06 Badajoz;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2022QIV;11.233
06 Badajoz;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
06 Badajoz;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2022QII;""
06 Badajoz;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2022QI;""
06 Badajoz;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2021QIV;11.377
06 Badajoz;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
06 Badajoz;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2021QII;""
06 Badajoz;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2021QI;""
06 Badajoz;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2020QIV;11.315
06 Badajoz;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
06 Badajoz;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2020QII;""
06 Badajoz;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2020QI;""
06 Badajoz;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
06 Badajoz;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
06 Badajoz;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QII;""
06 Badajoz;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QI;11.085
06 Badajoz;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
06 Badajoz;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
06 Badajoz;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QII;""
06 Badajoz;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QI;11.148
06 Badajoz;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
06 Badajoz;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
06 Badajoz;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QII;""
06 Badajoz;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QI;""
06 Badajoz;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
06 Badajoz;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
06 Badajoz;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QII;10.819
06 Badajoz;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QI;""
06 Badajoz;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
06 Badajoz;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
06 Badajoz;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QII;10.949
06 Badajoz;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QI;""
06 Badajoz;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
06 Badajoz;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
06 Badajoz;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QII;""
06 Badajoz;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QI;""
06 Badajoz;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
06 Badajoz;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
06 Badajoz;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
06 Badajoz;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
06 Badajoz;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
06 Badajoz;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
06 Badajoz;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
06 Badajoz;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
06 Badajoz;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
06 Badajoz;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
06 Badajoz;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
06 Badajoz;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
06 Badajoz;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
06 Badajoz;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;97,38
06 Badajoz;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
06 Badajoz;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
06 Badajoz;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
06 Badajoz;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;98,14
06 Badajoz;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
06 Badajoz;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
06 Badajoz;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
06 Badajoz;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;97,87
06 Badajoz;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
06 Badajoz;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
06 Badajoz;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;95,1
06 Badajoz;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
06 Badajoz;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
06 Badajoz;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
06 Badajoz;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;95,65
06 Badajoz;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
06 Badajoz;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
06 Badajoz;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
06 Badajoz;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;95,45
06 Badajoz;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
06 Badajoz;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
06 Badajoz;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
06 Badajoz;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
06 Badajoz;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
06 Badajoz;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
06 Badajoz;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;93,2
06 Badajoz;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
06 Badajoz;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
06 Badajoz;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
06 Badajoz;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;94,04
06 Badajoz;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
06 Badajoz;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
06 Badajoz;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
06 Badajoz;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
06 Badajoz;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
06 Badajoz;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
06 Badajoz;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;90,96
06 Badajoz;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
06 Badajoz;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
06 Badajoz;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
06 Badajoz;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;92,37
06 Badajoz;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
06 Badajoz;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
06 Badajoz;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
06 Badajoz;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
06 Badajoz;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
06 Badajoz;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
06 Badajoz;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QIII;7.703
06 Badajoz;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
06 Badajoz;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
06 Badajoz;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
06 Badajoz;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QIII;7.858
06 Badajoz;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
06 Badajoz;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
06 Badajoz;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
06 Badajoz;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QIII;7.819
06 Badajoz;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
06 Badajoz;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
06 Badajoz;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
06 Badajoz;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2022QIII;7.517
06 Badajoz;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2022QII;""
06 Badajoz;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2022QI;""
06 Badajoz;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
06 Badajoz;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2021QIII;7.726
06 Badajoz;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2021QII;""
06 Badajoz;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2021QI;""
06 Badajoz;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
06 Badajoz;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2020QIII;7.673
06 Badajoz;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2020QII;""
06 Badajoz;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2020QI;""
06 Badajoz;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2022QIV;7.376
06 Badajoz;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
06 Badajoz;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2022QII;""
06 Badajoz;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2022QI;""
06 Badajoz;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2021QIV;7.547
06 Badajoz;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
06 Badajoz;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2021QII;""
06 Badajoz;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2021QI;""
06 Badajoz;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2020QIV;7.509
06 Badajoz;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
06 Badajoz;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2020QII;""
06 Badajoz;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2020QI;""
06 Badajoz;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
06 Badajoz;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
06 Badajoz;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QII;""
06 Badajoz;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QI;7.395
06 Badajoz;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
06 Badajoz;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
06 Badajoz;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QII;""
06 Badajoz;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QI;7.415
06 Badajoz;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
06 Badajoz;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
06 Badajoz;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QII;""
06 Badajoz;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QI;""
06 Badajoz;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
06 Badajoz;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
06 Badajoz;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QII;7.242
06 Badajoz;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QI;""
06 Badajoz;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
06 Badajoz;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
06 Badajoz;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QII;7.307
06 Badajoz;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QI;""
06 Badajoz;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
06 Badajoz;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
06 Badajoz;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QII;""
06 Badajoz;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QI;""
06 Badajoz;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
06 Badajoz;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
06 Badajoz;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
06 Badajoz;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
06 Badajoz;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
06 Badajoz;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
06 Badajoz;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
06 Badajoz;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
06 Badajoz;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
06 Badajoz;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
06 Badajoz;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
06 Badajoz;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
06 Badajoz;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
06 Badajoz;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;97,59
06 Badajoz;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
06 Badajoz;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
06 Badajoz;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
06 Badajoz;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;98,32
06 Badajoz;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
06 Badajoz;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
06 Badajoz;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
06 Badajoz;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;98,13
06 Badajoz;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
06 Badajoz;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
06 Badajoz;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;95,75
06 Badajoz;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
06 Badajoz;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
06 Badajoz;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
06 Badajoz;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;96,04
06 Badajoz;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
06 Badajoz;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
06 Badajoz;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
06 Badajoz;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;96,04
06 Badajoz;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
06 Badajoz;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
06 Badajoz;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
06 Badajoz;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
06 Badajoz;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
06 Badajoz;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
06 Badajoz;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;94,11
06 Badajoz;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
06 Badajoz;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
06 Badajoz;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
06 Badajoz;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;94,83
06 Badajoz;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
06 Badajoz;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
06 Badajoz;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
06 Badajoz;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
06 Badajoz;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
06 Badajoz;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
06 Badajoz;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;92,16
06 Badajoz;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
06 Badajoz;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
06 Badajoz;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
06 Badajoz;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;93,45
06 Badajoz;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
06 Badajoz;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
06 Badajoz;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
06 Badajoz;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
06 Badajoz;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
06 Badajoz;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
06 Badajoz;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QIII;4.109
06 Badajoz;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
06 Badajoz;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
06 Badajoz;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
06 Badajoz;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QIII;4.036
06 Badajoz;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
06 Badajoz;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
06 Badajoz;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
06 Badajoz;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QIII;4.035
06 Badajoz;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
06 Badajoz;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
06 Badajoz;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
06 Badajoz;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2022QIII;3.985
06 Badajoz;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2022QII;""
06 Badajoz;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2022QI;""
06 Badajoz;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
06 Badajoz;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2021QIII;3.947
06 Badajoz;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2021QII;""
06 Badajoz;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2021QI;""
06 Badajoz;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
06 Badajoz;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2020QIII;3.928
06 Badajoz;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2020QII;""
06 Badajoz;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2020QI;""
06 Badajoz;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2022QIV;3.857
06 Badajoz;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
06 Badajoz;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2022QII;""
06 Badajoz;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2022QI;""
06 Badajoz;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2021QIV;3.830
06 Badajoz;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
06 Badajoz;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2021QII;""
06 Badajoz;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2021QI;""
06 Badajoz;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2020QIV;3.806
06 Badajoz;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
06 Badajoz;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2020QII;""
06 Badajoz;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2020QI;""
06 Badajoz;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
06 Badajoz;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
06 Badajoz;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QII;""
06 Badajoz;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QI;3.690
06 Badajoz;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
06 Badajoz;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
06 Badajoz;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QII;""
06 Badajoz;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QI;3.733
06 Badajoz;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
06 Badajoz;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
06 Badajoz;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QII;""
06 Badajoz;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QI;""
06 Badajoz;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
06 Badajoz;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
06 Badajoz;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QII;3.577
06 Badajoz;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QI;""
06 Badajoz;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
06 Badajoz;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
06 Badajoz;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QII;3.642
06 Badajoz;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QI;""
06 Badajoz;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
06 Badajoz;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
06 Badajoz;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QII;""
06 Badajoz;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QI;""
06 Badajoz;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
06 Badajoz;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
06 Badajoz;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
06 Badajoz;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
06 Badajoz;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
06 Badajoz;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
06 Badajoz;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
06 Badajoz;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
06 Badajoz;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
06 Badajoz;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
06 Badajoz;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
06 Badajoz;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
06 Badajoz;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
06 Badajoz;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;96,98
06 Badajoz;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
06 Badajoz;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
06 Badajoz;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
06 Badajoz;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;97,79
06 Badajoz;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
06 Badajoz;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
06 Badajoz;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
06 Badajoz;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;97,35
06 Badajoz;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
06 Badajoz;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
06 Badajoz;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;93,87
06 Badajoz;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
06 Badajoz;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
06 Badajoz;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
06 Badajoz;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;94,9
06 Badajoz;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
06 Badajoz;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
06 Badajoz;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
06 Badajoz;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;94,32
06 Badajoz;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
06 Badajoz;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
06 Badajoz;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
06 Badajoz;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
06 Badajoz;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
06 Badajoz;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
06 Badajoz;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;91,43
06 Badajoz;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
06 Badajoz;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
06 Badajoz;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
06 Badajoz;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;92,52
06 Badajoz;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
06 Badajoz;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
06 Badajoz;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
06 Badajoz;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
06 Badajoz;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
06 Badajoz;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
06 Badajoz;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;88,63
06 Badajoz;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
06 Badajoz;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
06 Badajoz;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
06 Badajoz;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;90,26
06 Badajoz;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
06 Badajoz;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
06 Badajoz;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
06 Badajoz;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
06 Badajoz;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
06 Badajoz;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QIV;11.699
06 Badajoz;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
06 Badajoz;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
06 Badajoz;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
06 Badajoz;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QIV;11.970
06 Badajoz;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
06 Badajoz;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
06 Badajoz;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
06 Badajoz;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QIV;11.889
06 Badajoz;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
06 Badajoz;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
06 Badajoz;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
06 Badajoz;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2022QIV;11.410
06 Badajoz;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
06 Badajoz;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2022QII;""
06 Badajoz;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2022QI;""
06 Badajoz;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2021QIV;11.638
06 Badajoz;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
06 Badajoz;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2021QII;""
06 Badajoz;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2021QI;""
06 Badajoz;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2020QIV;11.561
06 Badajoz;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
06 Badajoz;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2020QII;""
06 Badajoz;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2020QI;""
06 Badajoz;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
06 Badajoz;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
06 Badajoz;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2022QII;""
06 Badajoz;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2022QI;11.335
06 Badajoz;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
06 Badajoz;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
06 Badajoz;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2021QII;""
06 Badajoz;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2021QI;11.379
06 Badajoz;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
06 Badajoz;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
06 Badajoz;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2020QII;""
06 Badajoz;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2020QI;""
06 Badajoz;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
06 Badajoz;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
06 Badajoz;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QII;11.050
06 Badajoz;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QI;""
06 Badajoz;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
06 Badajoz;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
06 Badajoz;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QII;11.161
06 Badajoz;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QI;""
06 Badajoz;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
06 Badajoz;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
06 Badajoz;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QII;""
06 Badajoz;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QI;""
06 Badajoz;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
06 Badajoz;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QIII;10.828
06 Badajoz;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QII;""
06 Badajoz;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QI;""
06 Badajoz;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
06 Badajoz;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QIII;11.010
06 Badajoz;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QII;""
06 Badajoz;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QI;""
06 Badajoz;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
06 Badajoz;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
06 Badajoz;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QII;""
06 Badajoz;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QI;""
06 Badajoz;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
06 Badajoz;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
06 Badajoz;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
06 Badajoz;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
06 Badajoz;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
06 Badajoz;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
06 Badajoz;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
06 Badajoz;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
06 Badajoz;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
06 Badajoz;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
06 Badajoz;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
06 Badajoz;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
06 Badajoz;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;97,53
06 Badajoz;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
06 Badajoz;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
06 Badajoz;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
06 Badajoz;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;97,23
06 Badajoz;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
06 Badajoz;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
06 Badajoz;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
06 Badajoz;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;97,24
06 Badajoz;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
06 Badajoz;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
06 Badajoz;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
06 Badajoz;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
06 Badajoz;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
06 Badajoz;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
06 Badajoz;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;94,7
06 Badajoz;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
06 Badajoz;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
06 Badajoz;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
06 Badajoz;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;95,71
06 Badajoz;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
06 Badajoz;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
06 Badajoz;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
06 Badajoz;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
06 Badajoz;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
06 Badajoz;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
06 Badajoz;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;92,31
06 Badajoz;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
06 Badajoz;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
06 Badajoz;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
06 Badajoz;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;93,88
06 Badajoz;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
06 Badajoz;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
06 Badajoz;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
06 Badajoz;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
06 Badajoz;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
06 Badajoz;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
06 Badajoz;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;90,46
06 Badajoz;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
06 Badajoz;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
06 Badajoz;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
06 Badajoz;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;92,61
06 Badajoz;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
06 Badajoz;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
06 Badajoz;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
06 Badajoz;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
06 Badajoz;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
06 Badajoz;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
06 Badajoz;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QIV;7.632
06 Badajoz;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
06 Badajoz;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
06 Badajoz;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
06 Badajoz;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QIV;7.883
06 Badajoz;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
06 Badajoz;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
06 Badajoz;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
06 Badajoz;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QIV;7.858
06 Badajoz;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
06 Badajoz;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
06 Badajoz;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
06 Badajoz;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2022QIV;7.479
06 Badajoz;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
06 Badajoz;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2022QII;""
06 Badajoz;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2022QI;""
06 Badajoz;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2021QIV;7.683
06 Badajoz;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
06 Badajoz;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2021QII;""
06 Badajoz;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2021QI;""
06 Badajoz;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2020QIV;7.665
06 Badajoz;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
06 Badajoz;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2020QII;""
06 Badajoz;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2020QI;""
06 Badajoz;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
06 Badajoz;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
06 Badajoz;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2022QII;""
06 Badajoz;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2022QI;7.523
06 Badajoz;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
06 Badajoz;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
06 Badajoz;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2021QII;""
06 Badajoz;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2021QI;7.559
06 Badajoz;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
06 Badajoz;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
06 Badajoz;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2020QII;""
06 Badajoz;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2020QI;""
06 Badajoz;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
06 Badajoz;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
06 Badajoz;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QII;7.360
06 Badajoz;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QI;""
06 Badajoz;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
06 Badajoz;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
06 Badajoz;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QII;7.441
06 Badajoz;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QI;""
06 Badajoz;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
06 Badajoz;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
06 Badajoz;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QII;""
06 Badajoz;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QI;""
06 Badajoz;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
06 Badajoz;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QIII;7.229
06 Badajoz;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QII;""
06 Badajoz;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QI;""
06 Badajoz;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
06 Badajoz;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QIII;7.350
06 Badajoz;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QII;""
06 Badajoz;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QI;""
06 Badajoz;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
06 Badajoz;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
06 Badajoz;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QII;""
06 Badajoz;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QI;""
06 Badajoz;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
06 Badajoz;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
06 Badajoz;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
06 Badajoz;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
06 Badajoz;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
06 Badajoz;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
06 Badajoz;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
06 Badajoz;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
06 Badajoz;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
06 Badajoz;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
06 Badajoz;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
06 Badajoz;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
06 Badajoz;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;98
06 Badajoz;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
06 Badajoz;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
06 Badajoz;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
06 Badajoz;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;97,46
06 Badajoz;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
06 Badajoz;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
06 Badajoz;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
06 Badajoz;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;97,54
06 Badajoz;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
06 Badajoz;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
06 Badajoz;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
06 Badajoz;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
06 Badajoz;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
06 Badajoz;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
06 Badajoz;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;95,43
06 Badajoz;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
06 Badajoz;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
06 Badajoz;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
06 Badajoz;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;96,19
06 Badajoz;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
06 Badajoz;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
06 Badajoz;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
06 Badajoz;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
06 Badajoz;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
06 Badajoz;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
06 Badajoz;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;93,37
06 Badajoz;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
06 Badajoz;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
06 Badajoz;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
06 Badajoz;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;94,69
06 Badajoz;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
06 Badajoz;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
06 Badajoz;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
06 Badajoz;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
06 Badajoz;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
06 Badajoz;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
06 Badajoz;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;91,7
06 Badajoz;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
06 Badajoz;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
06 Badajoz;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
06 Badajoz;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;93,54
06 Badajoz;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
06 Badajoz;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
06 Badajoz;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
06 Badajoz;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
06 Badajoz;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
06 Badajoz;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
06 Badajoz;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QIV;4.067
06 Badajoz;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
06 Badajoz;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
06 Badajoz;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
06 Badajoz;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QIV;4.087
06 Badajoz;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
06 Badajoz;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
06 Badajoz;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
06 Badajoz;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QIV;4.031
06 Badajoz;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
06 Badajoz;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
06 Badajoz;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
06 Badajoz;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2022QIV;3.931
06 Badajoz;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
06 Badajoz;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2022QII;""
06 Badajoz;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2022QI;""
06 Badajoz;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2021QIV;3.955
06 Badajoz;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
06 Badajoz;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2021QII;""
06 Badajoz;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2021QI;""
06 Badajoz;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2020QIV;3.896
06 Badajoz;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
06 Badajoz;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2020QII;""
06 Badajoz;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2020QI;""
06 Badajoz;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
06 Badajoz;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
06 Badajoz;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2022QII;""
06 Badajoz;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2022QI;3.812
06 Badajoz;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
06 Badajoz;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
06 Badajoz;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2021QII;""
06 Badajoz;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2021QI;3.820
06 Badajoz;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
06 Badajoz;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
06 Badajoz;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2020QII;""
06 Badajoz;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2020QI;""
06 Badajoz;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
06 Badajoz;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
06 Badajoz;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QII;3.690
06 Badajoz;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QI;""
06 Badajoz;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
06 Badajoz;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
06 Badajoz;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QII;3.720
06 Badajoz;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QI;""
06 Badajoz;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
06 Badajoz;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
06 Badajoz;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QII;""
06 Badajoz;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QI;""
06 Badajoz;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
06 Badajoz;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QIII;3.599
06 Badajoz;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QII;""
06 Badajoz;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QI;""
06 Badajoz;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
06 Badajoz;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QIII;3.660
06 Badajoz;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QII;""
06 Badajoz;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QI;""
06 Badajoz;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
06 Badajoz;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
06 Badajoz;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QII;""
06 Badajoz;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QI;""
06 Badajoz;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
06 Badajoz;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
06 Badajoz;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
06 Badajoz;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
06 Badajoz;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
06 Badajoz;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
06 Badajoz;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
06 Badajoz;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
06 Badajoz;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
06 Badajoz;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
06 Badajoz;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
06 Badajoz;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
06 Badajoz;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;96,66
06 Badajoz;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
06 Badajoz;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
06 Badajoz;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
06 Badajoz;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;96,77
06 Badajoz;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
06 Badajoz;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
06 Badajoz;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
06 Badajoz;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;96,65
06 Badajoz;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
06 Badajoz;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
06 Badajoz;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
06 Badajoz;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
06 Badajoz;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
06 Badajoz;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
06 Badajoz;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;93,27
06 Badajoz;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
06 Badajoz;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
06 Badajoz;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
06 Badajoz;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;94,77
06 Badajoz;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
06 Badajoz;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
06 Badajoz;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
06 Badajoz;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
06 Badajoz;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
06 Badajoz;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
06 Badajoz;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;90,29
06 Badajoz;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
06 Badajoz;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
06 Badajoz;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
06 Badajoz;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;92,28
06 Badajoz;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
06 Badajoz;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
06 Badajoz;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
06 Badajoz;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
06 Badajoz;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
06 Badajoz;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
06 Badajoz;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;88,06
06 Badajoz;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
06 Badajoz;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
06 Badajoz;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
06 Badajoz;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;90,8
06 Badajoz;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
06 Badajoz;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
06 Badajoz;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
06 Badajoz;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
06 Badajoz;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
06 Badajoz;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
06 Badajoz;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
06 Badajoz;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
06 Badajoz;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
06 Badajoz;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QI;11.005
06 Badajoz;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
06 Badajoz;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
06 Badajoz;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
06 Badajoz;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QI;10.777
06 Badajoz;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
06 Badajoz;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
06 Badajoz;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
06 Badajoz;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QI;11.035
06 Badajoz;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
06 Badajoz;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
06 Badajoz;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2022QII;""
06 Badajoz;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2022QI;10.772
06 Badajoz;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
06 Badajoz;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
06 Badajoz;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2021QII;""
06 Badajoz;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2021QI;10.617
06 Badajoz;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
06 Badajoz;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
06 Badajoz;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2020QII;""
06 Badajoz;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2020QI;10.522
06 Badajoz;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
06 Badajoz;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
06 Badajoz;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2022QII;10.565
06 Badajoz;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2022QI;""
06 Badajoz;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
06 Badajoz;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
06 Badajoz;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2021QII;10.441
06 Badajoz;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2021QI;""
06 Badajoz;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
06 Badajoz;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
06 Badajoz;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2020QII;10.412
06 Badajoz;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2020QI;""
06 Badajoz;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
06 Badajoz;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QIII;10.389
06 Badajoz;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QII;""
06 Badajoz;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QI;""
06 Badajoz;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
06 Badajoz;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QIII;10.303
06 Badajoz;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QII;""
06 Badajoz;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QI;""
06 Badajoz;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
06 Badajoz;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QIII;10.238
06 Badajoz;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QII;""
06 Badajoz;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QI;""
06 Badajoz;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QIV;10.213
06 Badajoz;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
06 Badajoz;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QII;""
06 Badajoz;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QI;""
06 Badajoz;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QIV;10.124
06 Badajoz;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
06 Badajoz;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QII;""
06 Badajoz;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QI;""
06 Badajoz;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QIV;10.051
06 Badajoz;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
06 Badajoz;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QII;""
06 Badajoz;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QI;""
06 Badajoz;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
06 Badajoz;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
06 Badajoz;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
06 Badajoz;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
06 Badajoz;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
06 Badajoz;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
06 Badajoz;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
06 Badajoz;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
06 Badajoz;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
06 Badajoz;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
06 Badajoz;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
06 Badajoz;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
06 Badajoz;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
06 Badajoz;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
06 Badajoz;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
06 Badajoz;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;97,88
06 Badajoz;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
06 Badajoz;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
06 Badajoz;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
06 Badajoz;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;98,52
06 Badajoz;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
06 Badajoz;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
06 Badajoz;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
06 Badajoz;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;95,35
06 Badajoz;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
06 Badajoz;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
06 Badajoz;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;96
06 Badajoz;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
06 Badajoz;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
06 Badajoz;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
06 Badajoz;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;96,88
06 Badajoz;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
06 Badajoz;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
06 Badajoz;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
06 Badajoz;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;94,35
06 Badajoz;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
06 Badajoz;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
06 Badajoz;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;94,4
06 Badajoz;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
06 Badajoz;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
06 Badajoz;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
06 Badajoz;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;95,6
06 Badajoz;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
06 Badajoz;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
06 Badajoz;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
06 Badajoz;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;92,78
06 Badajoz;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
06 Badajoz;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
06 Badajoz;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;92,8
06 Badajoz;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
06 Badajoz;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
06 Badajoz;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
06 Badajoz;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;93,94
06 Badajoz;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
06 Badajoz;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
06 Badajoz;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
06 Badajoz;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;91,08
06 Badajoz;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
06 Badajoz;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
06 Badajoz;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
06 Badajoz;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
06 Badajoz;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
06 Badajoz;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
06 Badajoz;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QI;7.429
06 Badajoz;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
06 Badajoz;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
06 Badajoz;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
06 Badajoz;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QI;7.316
06 Badajoz;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
06 Badajoz;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
06 Badajoz;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
06 Badajoz;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QI;7.517
06 Badajoz;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
06 Badajoz;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
06 Badajoz;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2022QII;""
06 Badajoz;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2022QI;7.290
06 Badajoz;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
06 Badajoz;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
06 Badajoz;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2021QII;""
06 Badajoz;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2021QI;7.218
06 Badajoz;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
06 Badajoz;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
06 Badajoz;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2020QII;""
06 Badajoz;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2020QI;7.181
06 Badajoz;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
06 Badajoz;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
06 Badajoz;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2022QII;7.177
06 Badajoz;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2022QI;""
06 Badajoz;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
06 Badajoz;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
06 Badajoz;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2021QII;7.115
06 Badajoz;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2021QI;""
06 Badajoz;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
06 Badajoz;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
06 Badajoz;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2020QII;7.112
06 Badajoz;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2020QI;""
06 Badajoz;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
06 Badajoz;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QIII;7.075
06 Badajoz;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QII;""
06 Badajoz;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QI;""
06 Badajoz;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
06 Badajoz;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QIII;7.033
06 Badajoz;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QII;""
06 Badajoz;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QI;""
06 Badajoz;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
06 Badajoz;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QIII;7.027
06 Badajoz;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QII;""
06 Badajoz;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QI;""
06 Badajoz;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QIV;6.969
06 Badajoz;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
06 Badajoz;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QII;""
06 Badajoz;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QI;""
06 Badajoz;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QIV;6.923
06 Badajoz;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
06 Badajoz;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QII;""
06 Badajoz;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QI;""
06 Badajoz;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QIV;6.906
06 Badajoz;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
06 Badajoz;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QII;""
06 Badajoz;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QI;""
06 Badajoz;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
06 Badajoz;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
06 Badajoz;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
06 Badajoz;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
06 Badajoz;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
06 Badajoz;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
06 Badajoz;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
06 Badajoz;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
06 Badajoz;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
06 Badajoz;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
06 Badajoz;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
06 Badajoz;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
06 Badajoz;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
06 Badajoz;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
06 Badajoz;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
06 Badajoz;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;98,13
06 Badajoz;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
06 Badajoz;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
06 Badajoz;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
06 Badajoz;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;98,66
06 Badajoz;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
06 Badajoz;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
06 Badajoz;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
06 Badajoz;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;95,53
06 Badajoz;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
06 Badajoz;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
06 Badajoz;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;96,61
06 Badajoz;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
06 Badajoz;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
06 Badajoz;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
06 Badajoz;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;97,25
06 Badajoz;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
06 Badajoz;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
06 Badajoz;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
06 Badajoz;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;94,61
06 Badajoz;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
06 Badajoz;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
06 Badajoz;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;95,23
06 Badajoz;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
06 Badajoz;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
06 Badajoz;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
06 Badajoz;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;96,13
06 Badajoz;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
06 Badajoz;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
06 Badajoz;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
06 Badajoz;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;93,48
06 Badajoz;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
06 Badajoz;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
06 Badajoz;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;93,81
06 Badajoz;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
06 Badajoz;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
06 Badajoz;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
06 Badajoz;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;94,63
06 Badajoz;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
06 Badajoz;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
06 Badajoz;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
06 Badajoz;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;91,87
06 Badajoz;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
06 Badajoz;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
06 Badajoz;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
06 Badajoz;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
06 Badajoz;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
06 Badajoz;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
06 Badajoz;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QI;3.576
06 Badajoz;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
06 Badajoz;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
06 Badajoz;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
06 Badajoz;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QI;3.461
06 Badajoz;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
06 Badajoz;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
06 Badajoz;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
06 Badajoz;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QI;3.518
06 Badajoz;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
06 Badajoz;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
06 Badajoz;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2022QII;""
06 Badajoz;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2022QI;3.482
06 Badajoz;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
06 Badajoz;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
06 Badajoz;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2021QII;""
06 Badajoz;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2021QI;3.399
06 Badajoz;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
06 Badajoz;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
06 Badajoz;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2020QII;""
06 Badajoz;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2020QI;3.341
06 Badajoz;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
06 Badajoz;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
06 Badajoz;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2022QII;3.388
06 Badajoz;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2022QI;""
06 Badajoz;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
06 Badajoz;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
06 Badajoz;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2021QII;3.326
06 Badajoz;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2021QI;""
06 Badajoz;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
06 Badajoz;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
06 Badajoz;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2020QII;3.300
06 Badajoz;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2020QI;""
06 Badajoz;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
06 Badajoz;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QIII;3.314
06 Badajoz;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QII;""
06 Badajoz;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QI;""
06 Badajoz;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
06 Badajoz;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QIII;3.270
06 Badajoz;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QII;""
06 Badajoz;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QI;""
06 Badajoz;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
06 Badajoz;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QIII;3.211
06 Badajoz;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QII;""
06 Badajoz;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QI;""
06 Badajoz;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QIV;3.244
06 Badajoz;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
06 Badajoz;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QII;""
06 Badajoz;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QI;""
06 Badajoz;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QIV;3.201
06 Badajoz;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
06 Badajoz;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QII;""
06 Badajoz;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QI;""
06 Badajoz;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QIV;3.145
06 Badajoz;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
06 Badajoz;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QII;""
06 Badajoz;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QI;""
06 Badajoz;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
06 Badajoz;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
06 Badajoz;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
06 Badajoz;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
06 Badajoz;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
06 Badajoz;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
06 Badajoz;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
06 Badajoz;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
06 Badajoz;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
06 Badajoz;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
06 Badajoz;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
06 Badajoz;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
06 Badajoz;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
06 Badajoz;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
06 Badajoz;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
06 Badajoz;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;97,37
06 Badajoz;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
06 Badajoz;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
06 Badajoz;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
06 Badajoz;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;98,21
06 Badajoz;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
06 Badajoz;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
06 Badajoz;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
06 Badajoz;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;94,97
06 Badajoz;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
06 Badajoz;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
06 Badajoz;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;94,74
06 Badajoz;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
06 Badajoz;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
06 Badajoz;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
06 Badajoz;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;96,1
06 Badajoz;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
06 Badajoz;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
06 Badajoz;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
06 Badajoz;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;93,8
06 Badajoz;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
06 Badajoz;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
06 Badajoz;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;92,67
06 Badajoz;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
06 Badajoz;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
06 Badajoz;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
06 Badajoz;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;94,48
06 Badajoz;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
06 Badajoz;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
06 Badajoz;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
06 Badajoz;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;91,27
06 Badajoz;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
06 Badajoz;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
06 Badajoz;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;90,72
06 Badajoz;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
06 Badajoz;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
06 Badajoz;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
06 Badajoz;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;92,49
06 Badajoz;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
06 Badajoz;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
06 Badajoz;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
06 Badajoz;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;89,4
06 Badajoz;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
06 Badajoz;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
06 Badajoz;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
06 Badajoz;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
06 Badajoz;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
06 Badajoz;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QII;11.288
06 Badajoz;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
06 Badajoz;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
06 Badajoz;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
06 Badajoz;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QII;11.074
06 Badajoz;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
06 Badajoz;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
06 Badajoz;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
06 Badajoz;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QII;10.845
06 Badajoz;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
06 Badajoz;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
06 Badajoz;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
06 Badajoz;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2022QII;11.049
06 Badajoz;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2022QI;""
06 Badajoz;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
06 Badajoz;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
06 Badajoz;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2021QII;10.865
06 Badajoz;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2021QI;""
06 Badajoz;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
06 Badajoz;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
06 Badajoz;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2020QII;10.727
06 Badajoz;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2020QI;""
06 Badajoz;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
06 Badajoz;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2022QIII;10.868
06 Badajoz;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2022QII;""
06 Badajoz;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2022QI;""
06 Badajoz;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
06 Badajoz;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2021QIII;10.720
06 Badajoz;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2021QII;""
06 Badajoz;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2021QI;""
06 Badajoz;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
06 Badajoz;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2020QIII;10.525
06 Badajoz;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2020QII;""
06 Badajoz;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2020QI;""
06 Badajoz;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QIV;10.676
06 Badajoz;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
06 Badajoz;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QII;""
06 Badajoz;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QI;""
06 Badajoz;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QIV;10.529
06 Badajoz;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
06 Badajoz;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QII;""
06 Badajoz;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QI;""
06 Badajoz;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QIV;10.332
06 Badajoz;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
06 Badajoz;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QII;""
06 Badajoz;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QI;""
06 Badajoz;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
06 Badajoz;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
06 Badajoz;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QII;""
06 Badajoz;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QI;10.330
06 Badajoz;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
06 Badajoz;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
06 Badajoz;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QII;""
06 Badajoz;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QI;10.204
06 Badajoz;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
06 Badajoz;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
06 Badajoz;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QII;""
06 Badajoz;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QI;""
06 Badajoz;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
06 Badajoz;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
06 Badajoz;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
06 Badajoz;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
06 Badajoz;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
06 Badajoz;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
06 Badajoz;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
06 Badajoz;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
06 Badajoz;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
06 Badajoz;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
06 Badajoz;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
06 Badajoz;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
06 Badajoz;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
06 Badajoz;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
06 Badajoz;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;97,88
06 Badajoz;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
06 Badajoz;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
06 Badajoz;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
06 Badajoz;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;98,11
06 Badajoz;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
06 Badajoz;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
06 Badajoz;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
06 Badajoz;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;98,91
06 Badajoz;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
06 Badajoz;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
06 Badajoz;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;96,28
06 Badajoz;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
06 Badajoz;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
06 Badajoz;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
06 Badajoz;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;96,8
06 Badajoz;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
06 Badajoz;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
06 Badajoz;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
06 Badajoz;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;97,05
06 Badajoz;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
06 Badajoz;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
06 Badajoz;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;94,58
06 Badajoz;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
06 Badajoz;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
06 Badajoz;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
06 Badajoz;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;95,08
06 Badajoz;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
06 Badajoz;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
06 Badajoz;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
06 Badajoz;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;95,27
06 Badajoz;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
06 Badajoz;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
06 Badajoz;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
06 Badajoz;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
06 Badajoz;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
06 Badajoz;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
06 Badajoz;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;93,28
06 Badajoz;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
06 Badajoz;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
06 Badajoz;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
06 Badajoz;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;94,09
06 Badajoz;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
06 Badajoz;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
06 Badajoz;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
06 Badajoz;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
06 Badajoz;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
06 Badajoz;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
06 Badajoz;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QII;7.614
06 Badajoz;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
06 Badajoz;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
06 Badajoz;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
06 Badajoz;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QII;7.492
06 Badajoz;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
06 Badajoz;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
06 Badajoz;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
06 Badajoz;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QII;7.358
06 Badajoz;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
06 Badajoz;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
06 Badajoz;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
06 Badajoz;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2022QII;7.477
06 Badajoz;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2022QI;""
06 Badajoz;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
06 Badajoz;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
06 Badajoz;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2021QII;7.361
06 Badajoz;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2021QI;""
06 Badajoz;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
06 Badajoz;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
06 Badajoz;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2020QII;7.284
06 Badajoz;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2020QI;""
06 Badajoz;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
06 Badajoz;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2022QIII;7.378
06 Badajoz;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2022QII;""
06 Badajoz;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2022QI;""
06 Badajoz;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
06 Badajoz;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2021QIII;7.273
06 Badajoz;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2021QII;""
06 Badajoz;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2021QI;""
06 Badajoz;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
06 Badajoz;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2020QIII;7.176
06 Badajoz;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2020QII;""
06 Badajoz;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2020QI;""
06 Badajoz;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QIV;7.261
06 Badajoz;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
06 Badajoz;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QII;""
06 Badajoz;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QI;""
06 Badajoz;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QIV;7.162
06 Badajoz;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
06 Badajoz;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QII;""
06 Badajoz;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QI;""
06 Badajoz;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QIV;7.050
06 Badajoz;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
06 Badajoz;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QII;""
06 Badajoz;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QI;""
06 Badajoz;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
06 Badajoz;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
06 Badajoz;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QII;""
06 Badajoz;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QI;7.049
06 Badajoz;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
06 Badajoz;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
06 Badajoz;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QII;""
06 Badajoz;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QI;6.979
06 Badajoz;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
06 Badajoz;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
06 Badajoz;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QII;""
06 Badajoz;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QI;""
06 Badajoz;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
06 Badajoz;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
06 Badajoz;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
06 Badajoz;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
06 Badajoz;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
06 Badajoz;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
06 Badajoz;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
06 Badajoz;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
06 Badajoz;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
06 Badajoz;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
06 Badajoz;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
06 Badajoz;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
06 Badajoz;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
06 Badajoz;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
06 Badajoz;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;98,2
06 Badajoz;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
06 Badajoz;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
06 Badajoz;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
06 Badajoz;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;98,25
06 Badajoz;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
06 Badajoz;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
06 Badajoz;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
06 Badajoz;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;98,99
06 Badajoz;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
06 Badajoz;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
06 Badajoz;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;96,9
06 Badajoz;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
06 Badajoz;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
06 Badajoz;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
06 Badajoz;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;97,08
06 Badajoz;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
06 Badajoz;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
06 Badajoz;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
06 Badajoz;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;97,53
06 Badajoz;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
06 Badajoz;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
06 Badajoz;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;95,36
06 Badajoz;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
06 Badajoz;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
06 Badajoz;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
06 Badajoz;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;95,6
06 Badajoz;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
06 Badajoz;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
06 Badajoz;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
06 Badajoz;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;95,81
06 Badajoz;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
06 Badajoz;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
06 Badajoz;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
06 Badajoz;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
06 Badajoz;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
06 Badajoz;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
06 Badajoz;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;94,09
06 Badajoz;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
06 Badajoz;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
06 Badajoz;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
06 Badajoz;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;94,85
06 Badajoz;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
06 Badajoz;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
06 Badajoz;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
06 Badajoz;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
06 Badajoz;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
06 Badajoz;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
06 Badajoz;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QII;3.674
06 Badajoz;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
06 Badajoz;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
06 Badajoz;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
06 Badajoz;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QII;3.582
06 Badajoz;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
06 Badajoz;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
06 Badajoz;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
06 Badajoz;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QII;3.487
06 Badajoz;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
06 Badajoz;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
06 Badajoz;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
06 Badajoz;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2022QII;3.572
06 Badajoz;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2022QI;""
06 Badajoz;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
06 Badajoz;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
06 Badajoz;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2021QII;3.504
06 Badajoz;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2021QI;""
06 Badajoz;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
06 Badajoz;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
06 Badajoz;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2020QII;3.443
06 Badajoz;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2020QI;""
06 Badajoz;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
06 Badajoz;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2022QIII;3.490
06 Badajoz;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2022QII;""
06 Badajoz;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2022QI;""
06 Badajoz;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
06 Badajoz;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2021QIII;3.447
06 Badajoz;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2021QII;""
06 Badajoz;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2021QI;""
06 Badajoz;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
06 Badajoz;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2020QIII;3.349
06 Badajoz;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2020QII;""
06 Badajoz;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2020QI;""
06 Badajoz;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QIV;3.415
06 Badajoz;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
06 Badajoz;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QII;""
06 Badajoz;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QI;""
06 Badajoz;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QIV;3.367
06 Badajoz;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
06 Badajoz;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QII;""
06 Badajoz;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QI;""
06 Badajoz;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QIV;3.282
06 Badajoz;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
06 Badajoz;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QII;""
06 Badajoz;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QI;""
06 Badajoz;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
06 Badajoz;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
06 Badajoz;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QII;""
06 Badajoz;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QI;3.281
06 Badajoz;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
06 Badajoz;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
06 Badajoz;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QII;""
06 Badajoz;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QI;3.225
06 Badajoz;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
06 Badajoz;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
06 Badajoz;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QII;""
06 Badajoz;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QI;""
06 Badajoz;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
06 Badajoz;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
06 Badajoz;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
06 Badajoz;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
06 Badajoz;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
06 Badajoz;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
06 Badajoz;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
06 Badajoz;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
06 Badajoz;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
06 Badajoz;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
06 Badajoz;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
06 Badajoz;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
06 Badajoz;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
06 Badajoz;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
06 Badajoz;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;97,22
06 Badajoz;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
06 Badajoz;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
06 Badajoz;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
06 Badajoz;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;97,82
06 Badajoz;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
06 Badajoz;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
06 Badajoz;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
06 Badajoz;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;98,74
06 Badajoz;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
06 Badajoz;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
06 Badajoz;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;94,99
06 Badajoz;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
06 Badajoz;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
06 Badajoz;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
06 Badajoz;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;96,23
06 Badajoz;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
06 Badajoz;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
06 Badajoz;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
06 Badajoz;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;96,04
06 Badajoz;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
06 Badajoz;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
06 Badajoz;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;92,95
06 Badajoz;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
06 Badajoz;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
06 Badajoz;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
06 Badajoz;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;94
06 Badajoz;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
06 Badajoz;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
06 Badajoz;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
06 Badajoz;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;94,12
06 Badajoz;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
06 Badajoz;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
06 Badajoz;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
06 Badajoz;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
06 Badajoz;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
06 Badajoz;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
06 Badajoz;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;91,6
06 Badajoz;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
06 Badajoz;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
06 Badajoz;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
06 Badajoz;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;92,49
06 Badajoz;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
06 Badajoz;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
06 Badajoz;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
06 Badajoz;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
06 Badajoz;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
06 Badajoz;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QIII;11.223
06 Badajoz;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
06 Badajoz;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
06 Badajoz;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
06 Badajoz;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QIII;11.095
06 Badajoz;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
06 Badajoz;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
06 Badajoz;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
06 Badajoz;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QIII;10.932
06 Badajoz;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
06 Badajoz;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
06 Badajoz;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
06 Badajoz;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2022QIII;11.004
06 Badajoz;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2022QII;""
06 Badajoz;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2022QI;""
06 Badajoz;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
06 Badajoz;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2021QIII;10.923
06 Badajoz;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2021QII;""
06 Badajoz;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2021QI;""
06 Badajoz;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
06 Badajoz;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2020QIII;10.693
06 Badajoz;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2020QII;""
06 Badajoz;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2020QI;""
06 Badajoz;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2022QIV;10.776
06 Badajoz;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
06 Badajoz;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2022QII;""
06 Badajoz;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2022QI;""
06 Badajoz;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2021QIV;10.704
06 Badajoz;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
06 Badajoz;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2021QII;""
06 Badajoz;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2021QI;""
06 Badajoz;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2020QIV;10.476
06 Badajoz;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
06 Badajoz;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2020QII;""
06 Badajoz;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2020QI;""
06 Badajoz;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
06 Badajoz;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
06 Badajoz;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QII;""
06 Badajoz;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QI;10.494
06 Badajoz;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
06 Badajoz;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
06 Badajoz;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QII;""
06 Badajoz;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QI;10.341
06 Badajoz;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
06 Badajoz;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
06 Badajoz;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QII;""
06 Badajoz;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QI;""
06 Badajoz;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
06 Badajoz;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
06 Badajoz;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QII;10.315
06 Badajoz;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QI;""
06 Badajoz;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
06 Badajoz;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
06 Badajoz;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QII;10.182
06 Badajoz;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QI;""
06 Badajoz;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
06 Badajoz;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
06 Badajoz;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QII;""
06 Badajoz;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QI;""
06 Badajoz;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
06 Badajoz;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
06 Badajoz;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
06 Badajoz;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
06 Badajoz;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
06 Badajoz;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
06 Badajoz;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
06 Badajoz;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
06 Badajoz;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
06 Badajoz;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
06 Badajoz;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
06 Badajoz;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
06 Badajoz;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
06 Badajoz;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;98,05
06 Badajoz;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
06 Badajoz;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
06 Badajoz;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
06 Badajoz;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;98,45
06 Badajoz;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
06 Badajoz;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
06 Badajoz;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
06 Badajoz;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;97,81
06 Badajoz;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
06 Badajoz;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
06 Badajoz;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;96,02
06 Badajoz;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
06 Badajoz;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
06 Badajoz;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
06 Badajoz;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;96,48
06 Badajoz;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
06 Badajoz;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
06 Badajoz;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
06 Badajoz;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;95,83
06 Badajoz;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
06 Badajoz;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
06 Badajoz;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
06 Badajoz;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
06 Badajoz;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
06 Badajoz;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
06 Badajoz;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;94,58
06 Badajoz;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
06 Badajoz;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
06 Badajoz;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
06 Badajoz;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;94,59
06 Badajoz;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
06 Badajoz;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
06 Badajoz;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
06 Badajoz;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
06 Badajoz;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
06 Badajoz;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
06 Badajoz;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;92,97
06 Badajoz;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
06 Badajoz;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
06 Badajoz;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
06 Badajoz;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;93,14
06 Badajoz;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
06 Badajoz;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
06 Badajoz;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
06 Badajoz;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
06 Badajoz;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
06 Badajoz;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
06 Badajoz;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QIII;7.588
06 Badajoz;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
06 Badajoz;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
06 Badajoz;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
06 Badajoz;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QIII;7.493
06 Badajoz;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
06 Badajoz;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
06 Badajoz;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
06 Badajoz;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QIII;7.434
06 Badajoz;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
06 Badajoz;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
06 Badajoz;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
06 Badajoz;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2022QIII;7.464
06 Badajoz;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2022QII;""
06 Badajoz;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2022QI;""
06 Badajoz;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
06 Badajoz;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2021QIII;7.384
06 Badajoz;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2021QII;""
06 Badajoz;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2021QI;""
06 Badajoz;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
06 Badajoz;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2020QIII;7.295
06 Badajoz;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2020QII;""
06 Badajoz;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2020QI;""
06 Badajoz;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2022QIV;7.319
06 Badajoz;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
06 Badajoz;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2022QII;""
06 Badajoz;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2022QI;""
06 Badajoz;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2021QIV;7.248
06 Badajoz;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
06 Badajoz;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2021QII;""
06 Badajoz;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2021QI;""
06 Badajoz;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2020QIV;7.152
06 Badajoz;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
06 Badajoz;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2020QII;""
06 Badajoz;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2020QI;""
06 Badajoz;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
06 Badajoz;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
06 Badajoz;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QII;""
06 Badajoz;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QI;7.127
06 Badajoz;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
06 Badajoz;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
06 Badajoz;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QII;""
06 Badajoz;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QI;7.075
06 Badajoz;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
06 Badajoz;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
06 Badajoz;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QII;""
06 Badajoz;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QI;""
06 Badajoz;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
06 Badajoz;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
06 Badajoz;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QII;7.031
06 Badajoz;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QI;""
06 Badajoz;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
06 Badajoz;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
06 Badajoz;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QII;6.983
06 Badajoz;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QI;""
06 Badajoz;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
06 Badajoz;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
06 Badajoz;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QII;""
06 Badajoz;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QI;""
06 Badajoz;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
06 Badajoz;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
06 Badajoz;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
06 Badajoz;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
06 Badajoz;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
06 Badajoz;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
06 Badajoz;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
06 Badajoz;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
06 Badajoz;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
06 Badajoz;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
06 Badajoz;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
06 Badajoz;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
06 Badajoz;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
06 Badajoz;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;98,37
06 Badajoz;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
06 Badajoz;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
06 Badajoz;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
06 Badajoz;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;98,55
06 Badajoz;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
06 Badajoz;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
06 Badajoz;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
06 Badajoz;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;98,13
06 Badajoz;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
06 Badajoz;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
06 Badajoz;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;96,45
06 Badajoz;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
06 Badajoz;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
06 Badajoz;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
06 Badajoz;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;96,73
06 Badajoz;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
06 Badajoz;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
06 Badajoz;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
06 Badajoz;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;96,21
06 Badajoz;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
06 Badajoz;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
06 Badajoz;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
06 Badajoz;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
06 Badajoz;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
06 Badajoz;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
06 Badajoz;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;95,12
06 Badajoz;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
06 Badajoz;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
06 Badajoz;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
06 Badajoz;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;95,17
06 Badajoz;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
06 Badajoz;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
06 Badajoz;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
06 Badajoz;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
06 Badajoz;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
06 Badajoz;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
06 Badajoz;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;93,83
06 Badajoz;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
06 Badajoz;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
06 Badajoz;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
06 Badajoz;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;93,93
06 Badajoz;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
06 Badajoz;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
06 Badajoz;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
06 Badajoz;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
06 Badajoz;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
06 Badajoz;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
06 Badajoz;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QIII;3.635
06 Badajoz;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
06 Badajoz;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
06 Badajoz;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
06 Badajoz;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QIII;3.602
06 Badajoz;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
06 Badajoz;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
06 Badajoz;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
06 Badajoz;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QIII;3.498
06 Badajoz;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
06 Badajoz;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
06 Badajoz;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
06 Badajoz;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2022QIII;3.540
06 Badajoz;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2022QII;""
06 Badajoz;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2022QI;""
06 Badajoz;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
06 Badajoz;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2021QIII;3.539
06 Badajoz;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2021QII;""
06 Badajoz;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2021QI;""
06 Badajoz;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
06 Badajoz;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2020QIII;3.398
06 Badajoz;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2020QII;""
06 Badajoz;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2020QI;""
06 Badajoz;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2022QIV;3.457
06 Badajoz;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
06 Badajoz;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2022QII;""
06 Badajoz;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2022QI;""
06 Badajoz;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2021QIV;3.456
06 Badajoz;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
06 Badajoz;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2021QII;""
06 Badajoz;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2021QI;""
06 Badajoz;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2020QIV;3.324
06 Badajoz;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
06 Badajoz;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2020QII;""
06 Badajoz;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2020QI;""
06 Badajoz;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
06 Badajoz;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
06 Badajoz;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QII;""
06 Badajoz;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QI;3.367
06 Badajoz;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
06 Badajoz;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
06 Badajoz;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QII;""
06 Badajoz;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QI;3.266
06 Badajoz;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
06 Badajoz;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
06 Badajoz;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QII;""
06 Badajoz;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QI;""
06 Badajoz;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
06 Badajoz;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
06 Badajoz;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QII;3.284
06 Badajoz;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QI;""
06 Badajoz;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
06 Badajoz;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
06 Badajoz;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QII;3.199
06 Badajoz;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QI;""
06 Badajoz;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
06 Badajoz;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
06 Badajoz;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QII;""
06 Badajoz;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QI;""
06 Badajoz;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
06 Badajoz;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
06 Badajoz;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
06 Badajoz;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
06 Badajoz;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
06 Badajoz;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
06 Badajoz;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
06 Badajoz;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
06 Badajoz;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
06 Badajoz;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
06 Badajoz;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
06 Badajoz;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
06 Badajoz;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
06 Badajoz;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;97,39
06 Badajoz;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
06 Badajoz;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
06 Badajoz;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
06 Badajoz;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;98,25
06 Badajoz;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
06 Badajoz;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
06 Badajoz;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
06 Badajoz;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;97,14
06 Badajoz;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
06 Badajoz;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
06 Badajoz;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;95,1
06 Badajoz;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
06 Badajoz;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
06 Badajoz;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
06 Badajoz;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;95,95
06 Badajoz;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
06 Badajoz;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
06 Badajoz;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
06 Badajoz;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;95,03
06 Badajoz;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
06 Badajoz;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
06 Badajoz;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
06 Badajoz;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
06 Badajoz;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
06 Badajoz;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
06 Badajoz;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;93,48
06 Badajoz;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
06 Badajoz;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
06 Badajoz;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
06 Badajoz;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;93,37
06 Badajoz;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
06 Badajoz;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
06 Badajoz;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
06 Badajoz;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
06 Badajoz;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
06 Badajoz;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
06 Badajoz;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;91,17
06 Badajoz;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
06 Badajoz;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
06 Badajoz;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
06 Badajoz;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;91,45
06 Badajoz;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
06 Badajoz;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
06 Badajoz;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
06 Badajoz;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
06 Badajoz;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
06 Badajoz;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QIV;11.164
06 Badajoz;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
06 Badajoz;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
06 Badajoz;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
06 Badajoz;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QIV;11.065
06 Badajoz;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
06 Badajoz;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
06 Badajoz;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
06 Badajoz;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QIV;10.886
06 Badajoz;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
06 Badajoz;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
06 Badajoz;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
06 Badajoz;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2022QIV;10.912
06 Badajoz;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
06 Badajoz;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2022QII;""
06 Badajoz;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2022QI;""
06 Badajoz;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2021QIV;10.826
06 Badajoz;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
06 Badajoz;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2021QII;""
06 Badajoz;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2021QI;""
06 Badajoz;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2020QIV;10.635
06 Badajoz;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
06 Badajoz;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2020QII;""
06 Badajoz;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2020QI;""
06 Badajoz;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
06 Badajoz;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
06 Badajoz;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2022QII;""
06 Badajoz;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2022QI;10.606
06 Badajoz;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
06 Badajoz;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
06 Badajoz;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2021QII;""
06 Badajoz;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2021QI;10.490
06 Badajoz;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
06 Badajoz;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
06 Badajoz;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2020QII;""
06 Badajoz;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2020QI;""
06 Badajoz;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
06 Badajoz;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
06 Badajoz;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QII;10.417
06 Badajoz;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QI;""
06 Badajoz;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
06 Badajoz;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
06 Badajoz;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QII;10.328
06 Badajoz;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QI;""
06 Badajoz;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
06 Badajoz;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
06 Badajoz;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QII;""
06 Badajoz;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QI;""
06 Badajoz;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
06 Badajoz;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QIII;10.249
06 Badajoz;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QII;""
06 Badajoz;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QI;""
06 Badajoz;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
06 Badajoz;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QIII;10.194
06 Badajoz;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QII;""
06 Badajoz;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QI;""
06 Badajoz;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
06 Badajoz;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
06 Badajoz;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QII;""
06 Badajoz;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QI;""
06 Badajoz;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
06 Badajoz;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
06 Badajoz;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
06 Badajoz;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
06 Badajoz;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
06 Badajoz;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
06 Badajoz;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
06 Badajoz;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
06 Badajoz;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
06 Badajoz;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
06 Badajoz;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
06 Badajoz;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
06 Badajoz;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;97,74
06 Badajoz;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
06 Badajoz;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
06 Badajoz;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
06 Badajoz;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;97,84
06 Badajoz;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
06 Badajoz;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
06 Badajoz;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
06 Badajoz;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;97,69
06 Badajoz;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
06 Badajoz;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
06 Badajoz;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
06 Badajoz;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
06 Badajoz;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
06 Badajoz;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
06 Badajoz;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;95,85
06 Badajoz;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
06 Badajoz;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
06 Badajoz;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
06 Badajoz;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;96,36
06 Badajoz;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
06 Badajoz;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
06 Badajoz;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
06 Badajoz;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
06 Badajoz;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
06 Badajoz;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
06 Badajoz;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;94,14
06 Badajoz;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
06 Badajoz;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
06 Badajoz;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
06 Badajoz;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;94,87
06 Badajoz;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
06 Badajoz;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
06 Badajoz;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
06 Badajoz;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
06 Badajoz;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
06 Badajoz;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
06 Badajoz;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;92,63
06 Badajoz;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
06 Badajoz;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
06 Badajoz;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
06 Badajoz;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;93,64
06 Badajoz;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
06 Badajoz;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
06 Badajoz;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
06 Badajoz;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
06 Badajoz;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
06 Badajoz;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
06 Badajoz;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QIV;7.564
06 Badajoz;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
06 Badajoz;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
06 Badajoz;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
06 Badajoz;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QIV;7.472
06 Badajoz;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
06 Badajoz;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
06 Badajoz;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
06 Badajoz;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QIV;7.407
06 Badajoz;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
06 Badajoz;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
06 Badajoz;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
06 Badajoz;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2022QIV;7.403
06 Badajoz;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
06 Badajoz;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2022QII;""
06 Badajoz;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2022QI;""
06 Badajoz;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2021QIV;7.324
06 Badajoz;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
06 Badajoz;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2021QII;""
06 Badajoz;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2021QI;""
06 Badajoz;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2020QIV;7.240
06 Badajoz;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
06 Badajoz;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2020QII;""
06 Badajoz;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2020QI;""
06 Badajoz;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
06 Badajoz;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
06 Badajoz;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2022QII;""
06 Badajoz;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2022QI;7.195
06 Badajoz;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
06 Badajoz;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
06 Badajoz;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2021QII;""
06 Badajoz;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2021QI;7.154
06 Badajoz;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
06 Badajoz;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
06 Badajoz;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2020QII;""
06 Badajoz;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2020QI;""
06 Badajoz;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
06 Badajoz;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
06 Badajoz;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QII;7.092
06 Badajoz;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QI;""
06 Badajoz;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
06 Badajoz;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
06 Badajoz;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QII;7.061
06 Badajoz;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QI;""
06 Badajoz;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
06 Badajoz;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
06 Badajoz;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QII;""
06 Badajoz;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QI;""
06 Badajoz;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
06 Badajoz;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QIII;6.997
06 Badajoz;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QII;""
06 Badajoz;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QI;""
06 Badajoz;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
06 Badajoz;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QIII;6.980
06 Badajoz;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QII;""
06 Badajoz;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QI;""
06 Badajoz;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
06 Badajoz;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
06 Badajoz;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QII;""
06 Badajoz;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QI;""
06 Badajoz;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
06 Badajoz;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
06 Badajoz;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
06 Badajoz;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
06 Badajoz;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
06 Badajoz;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
06 Badajoz;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
06 Badajoz;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
06 Badajoz;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
06 Badajoz;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
06 Badajoz;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
06 Badajoz;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
06 Badajoz;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;97,87
06 Badajoz;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
06 Badajoz;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
06 Badajoz;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
06 Badajoz;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;98,02
06 Badajoz;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
06 Badajoz;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
06 Badajoz;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
06 Badajoz;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;97,75
06 Badajoz;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
06 Badajoz;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
06 Badajoz;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
06 Badajoz;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
06 Badajoz;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
06 Badajoz;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
06 Badajoz;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;96,29
06 Badajoz;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
06 Badajoz;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
06 Badajoz;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
06 Badajoz;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;96,58
06 Badajoz;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
06 Badajoz;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
06 Badajoz;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
06 Badajoz;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
06 Badajoz;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
06 Badajoz;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
06 Badajoz;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;94,91
06 Badajoz;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
06 Badajoz;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
06 Badajoz;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
06 Badajoz;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;95,33
06 Badajoz;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
06 Badajoz;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
06 Badajoz;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
06 Badajoz;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
06 Badajoz;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
06 Badajoz;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
06 Badajoz;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;93,64
06 Badajoz;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
06 Badajoz;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
06 Badajoz;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
06 Badajoz;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;94,24
06 Badajoz;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
06 Badajoz;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
06 Badajoz;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
06 Badajoz;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
06 Badajoz;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
06 Badajoz;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
06 Badajoz;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QIV;3.600
06 Badajoz;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
06 Badajoz;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
06 Badajoz;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
06 Badajoz;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QIV;3.593
06 Badajoz;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
06 Badajoz;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
06 Badajoz;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
06 Badajoz;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QIV;3.479
06 Badajoz;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
06 Badajoz;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
06 Badajoz;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
06 Badajoz;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2022QIV;3.509
06 Badajoz;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
06 Badajoz;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2022QII;""
06 Badajoz;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2022QI;""
06 Badajoz;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2021QIV;3.502
06 Badajoz;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
06 Badajoz;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2021QII;""
06 Badajoz;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2021QI;""
06 Badajoz;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2020QIV;3.395
06 Badajoz;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
06 Badajoz;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2020QII;""
06 Badajoz;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2020QI;""
06 Badajoz;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
06 Badajoz;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
06 Badajoz;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2022QII;""
06 Badajoz;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2022QI;3.411
06 Badajoz;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
06 Badajoz;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
06 Badajoz;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2021QII;""
06 Badajoz;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2021QI;3.336
06 Badajoz;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
06 Badajoz;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
06 Badajoz;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2020QII;""
06 Badajoz;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2020QI;""
06 Badajoz;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
06 Badajoz;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
06 Badajoz;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QII;3.325
06 Badajoz;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QI;""
06 Badajoz;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
06 Badajoz;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
06 Badajoz;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QII;3.267
06 Badajoz;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QI;""
06 Badajoz;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
06 Badajoz;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
06 Badajoz;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QII;""
06 Badajoz;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QI;""
06 Badajoz;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
06 Badajoz;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QIII;3.252
06 Badajoz;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QII;""
06 Badajoz;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QI;""
06 Badajoz;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
06 Badajoz;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QIII;3.214
06 Badajoz;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QII;""
06 Badajoz;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QI;""
06 Badajoz;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
06 Badajoz;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
06 Badajoz;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QII;""
06 Badajoz;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QI;""
06 Badajoz;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
06 Badajoz;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
06 Badajoz;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
06 Badajoz;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
06 Badajoz;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
06 Badajoz;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
06 Badajoz;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
06 Badajoz;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
06 Badajoz;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
06 Badajoz;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
06 Badajoz;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
06 Badajoz;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
06 Badajoz;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;97,47
06 Badajoz;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
06 Badajoz;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
06 Badajoz;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
06 Badajoz;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;97,47
06 Badajoz;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
06 Badajoz;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
06 Badajoz;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
06 Badajoz;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;97,59
06 Badajoz;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
06 Badajoz;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
06 Badajoz;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
06 Badajoz;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
06 Badajoz;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
06 Badajoz;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
06 Badajoz;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;94,93
06 Badajoz;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
06 Badajoz;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
06 Badajoz;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
06 Badajoz;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;95,89
06 Badajoz;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
06 Badajoz;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
06 Badajoz;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
06 Badajoz;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
06 Badajoz;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
06 Badajoz;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
06 Badajoz;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;92,54
06 Badajoz;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
06 Badajoz;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
06 Badajoz;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
06 Badajoz;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;93,91
06 Badajoz;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
06 Badajoz;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
06 Badajoz;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
06 Badajoz;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
06 Badajoz;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
06 Badajoz;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
06 Badajoz;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;90,51
06 Badajoz;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
06 Badajoz;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
06 Badajoz;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
06 Badajoz;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;92,38
06 Badajoz;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
06 Badajoz;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
06 Badajoz;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
06 Badajoz;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
06 Badajoz;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
06 Badajoz;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
06 Badajoz;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
06 Badajoz;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
06 Badajoz;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
06 Badajoz;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QI;5.046
06 Badajoz;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
06 Badajoz;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
06 Badajoz;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
06 Badajoz;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QI;4.706
06 Badajoz;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
06 Badajoz;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
06 Badajoz;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
06 Badajoz;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QI;5.366
06 Badajoz;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
06 Badajoz;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
06 Badajoz;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2022QII;""
06 Badajoz;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2022QI;4.845
06 Badajoz;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
06 Badajoz;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
06 Badajoz;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2021QII;""
06 Badajoz;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2021QI;4.549
06 Badajoz;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
06 Badajoz;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
06 Badajoz;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2020QII;""
06 Badajoz;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2020QI;5.023
06 Badajoz;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
06 Badajoz;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
06 Badajoz;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2022QII;4.659
06 Badajoz;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2022QI;""
06 Badajoz;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
06 Badajoz;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
06 Badajoz;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2021QII;4.362
06 Badajoz;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2021QI;""
06 Badajoz;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
06 Badajoz;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
06 Badajoz;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2020QII;4.884
06 Badajoz;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2020QI;""
06 Badajoz;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
06 Badajoz;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QIII;4.497
06 Badajoz;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QII;""
06 Badajoz;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QI;""
06 Badajoz;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
06 Badajoz;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QIII;4.218
06 Badajoz;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QII;""
06 Badajoz;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QI;""
06 Badajoz;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
06 Badajoz;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QIII;4.694
06 Badajoz;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QII;""
06 Badajoz;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QI;""
06 Badajoz;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QIV;4.254
06 Badajoz;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
06 Badajoz;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QII;""
06 Badajoz;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QI;""
06 Badajoz;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QIV;4.034
06 Badajoz;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
06 Badajoz;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QII;""
06 Badajoz;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QI;""
06 Badajoz;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QIV;4.487
06 Badajoz;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
06 Badajoz;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QII;""
06 Badajoz;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QI;""
06 Badajoz;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
06 Badajoz;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
06 Badajoz;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
06 Badajoz;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
06 Badajoz;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
06 Badajoz;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
06 Badajoz;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
06 Badajoz;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
06 Badajoz;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
06 Badajoz;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
06 Badajoz;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
06 Badajoz;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
06 Badajoz;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
06 Badajoz;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
06 Badajoz;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
06 Badajoz;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;96,02
06 Badajoz;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
06 Badajoz;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
06 Badajoz;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
06 Badajoz;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;96,66
06 Badajoz;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
06 Badajoz;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
06 Badajoz;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
06 Badajoz;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;93,61
06 Badajoz;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
06 Badajoz;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
06 Badajoz;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;92,33
06 Badajoz;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
06 Badajoz;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
06 Badajoz;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
06 Badajoz;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;92,69
06 Badajoz;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
06 Badajoz;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
06 Badajoz;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
06 Badajoz;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;91,02
06 Badajoz;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
06 Badajoz;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
06 Badajoz;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;89,12
06 Badajoz;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
06 Badajoz;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
06 Badajoz;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
06 Badajoz;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;89,63
06 Badajoz;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
06 Badajoz;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
06 Badajoz;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
06 Badajoz;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;87,48
06 Badajoz;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
06 Badajoz;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
06 Badajoz;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;84,3
06 Badajoz;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
06 Badajoz;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
06 Badajoz;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
06 Badajoz;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;85,72
06 Badajoz;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
06 Badajoz;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
06 Badajoz;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
06 Badajoz;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;83,62
06 Badajoz;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
06 Badajoz;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
06 Badajoz;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
06 Badajoz;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
06 Badajoz;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
06 Badajoz;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
06 Badajoz;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QI;3.514
06 Badajoz;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
06 Badajoz;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
06 Badajoz;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
06 Badajoz;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QI;3.268
06 Badajoz;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
06 Badajoz;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
06 Badajoz;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
06 Badajoz;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QI;3.739
06 Badajoz;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
06 Badajoz;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
06 Badajoz;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2022QII;""
06 Badajoz;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2022QI;3.385
06 Badajoz;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
06 Badajoz;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
06 Badajoz;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2021QII;""
06 Badajoz;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2021QI;3.162
06 Badajoz;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
06 Badajoz;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
06 Badajoz;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2020QII;""
06 Badajoz;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2020QI;3.508
06 Badajoz;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
06 Badajoz;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
06 Badajoz;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2022QII;3.265
06 Badajoz;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2022QI;""
06 Badajoz;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
06 Badajoz;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
06 Badajoz;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2021QII;3.038
06 Badajoz;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2021QI;""
06 Badajoz;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
06 Badajoz;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
06 Badajoz;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2020QII;3.411
06 Badajoz;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2020QI;""
06 Badajoz;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
06 Badajoz;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QIII;3.155
06 Badajoz;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QII;""
06 Badajoz;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QI;""
06 Badajoz;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
06 Badajoz;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QIII;2.944
06 Badajoz;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QII;""
06 Badajoz;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QI;""
06 Badajoz;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
06 Badajoz;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QIII;3.282
06 Badajoz;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QII;""
06 Badajoz;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QI;""
06 Badajoz;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QIV;2.984
06 Badajoz;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
06 Badajoz;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QII;""
06 Badajoz;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QI;""
06 Badajoz;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QIV;2.819
06 Badajoz;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
06 Badajoz;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QII;""
06 Badajoz;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QI;""
06 Badajoz;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QIV;3.139
06 Badajoz;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
06 Badajoz;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QII;""
06 Badajoz;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QI;""
06 Badajoz;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
06 Badajoz;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
06 Badajoz;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
06 Badajoz;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
06 Badajoz;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
06 Badajoz;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
06 Badajoz;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
06 Badajoz;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
06 Badajoz;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
06 Badajoz;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
06 Badajoz;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
06 Badajoz;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
06 Badajoz;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
06 Badajoz;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
06 Badajoz;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
06 Badajoz;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;96,33
06 Badajoz;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
06 Badajoz;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
06 Badajoz;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
06 Badajoz;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;96,76
06 Badajoz;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
06 Badajoz;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
06 Badajoz;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
06 Badajoz;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;93,82
06 Badajoz;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
06 Badajoz;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
06 Badajoz;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;92,91
06 Badajoz;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
06 Badajoz;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
06 Badajoz;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
06 Badajoz;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;92,96
06 Badajoz;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
06 Badajoz;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
06 Badajoz;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
06 Badajoz;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;91,23
06 Badajoz;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
06 Badajoz;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
06 Badajoz;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;89,78
06 Badajoz;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
06 Badajoz;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
06 Badajoz;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
06 Badajoz;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;90,09
06 Badajoz;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
06 Badajoz;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
06 Badajoz;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
06 Badajoz;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;87,78
06 Badajoz;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
06 Badajoz;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
06 Badajoz;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;84,92
06 Badajoz;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
06 Badajoz;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
06 Badajoz;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
06 Badajoz;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;86,26
06 Badajoz;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
06 Badajoz;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
06 Badajoz;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
06 Badajoz;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;83,95
06 Badajoz;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
06 Badajoz;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
06 Badajoz;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
06 Badajoz;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
06 Badajoz;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
06 Badajoz;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
06 Badajoz;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QI;1.532
06 Badajoz;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
06 Badajoz;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
06 Badajoz;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
06 Badajoz;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QI;1.438
06 Badajoz;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
06 Badajoz;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
06 Badajoz;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
06 Badajoz;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QI;1.627
06 Badajoz;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
06 Badajoz;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
06 Badajoz;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2022QII;""
06 Badajoz;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2022QI;1.460
06 Badajoz;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
06 Badajoz;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
06 Badajoz;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2021QII;""
06 Badajoz;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2021QI;1.387
06 Badajoz;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
06 Badajoz;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
06 Badajoz;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2020QII;""
06 Badajoz;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2020QI;1.515
06 Badajoz;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
06 Badajoz;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
06 Badajoz;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2022QII;1.394
06 Badajoz;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2022QI;""
06 Badajoz;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
06 Badajoz;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
06 Badajoz;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2021QII;1.324
06 Badajoz;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2021QI;""
06 Badajoz;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
06 Badajoz;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
06 Badajoz;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2020QII;1.473
06 Badajoz;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2020QI;""
06 Badajoz;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
06 Badajoz;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QIII;1.342
06 Badajoz;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QII;""
06 Badajoz;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QI;""
06 Badajoz;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
06 Badajoz;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QIII;1.274
06 Badajoz;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QII;""
06 Badajoz;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QI;""
06 Badajoz;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
06 Badajoz;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QIII;1.412
06 Badajoz;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QII;""
06 Badajoz;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QI;""
06 Badajoz;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QIV;1.270
06 Badajoz;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
06 Badajoz;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QII;""
06 Badajoz;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QI;""
06 Badajoz;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QIV;1.215
06 Badajoz;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
06 Badajoz;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QII;""
06 Badajoz;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QI;""
06 Badajoz;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QIV;1.348
06 Badajoz;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
06 Badajoz;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QII;""
06 Badajoz;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QI;""
06 Badajoz;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
06 Badajoz;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
06 Badajoz;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
06 Badajoz;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
06 Badajoz;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
06 Badajoz;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
06 Badajoz;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
06 Badajoz;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
06 Badajoz;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
06 Badajoz;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
06 Badajoz;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
06 Badajoz;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
06 Badajoz;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
06 Badajoz;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
06 Badajoz;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
06 Badajoz;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;95,3
06 Badajoz;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
06 Badajoz;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
06 Badajoz;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
06 Badajoz;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;96,45
06 Badajoz;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
06 Badajoz;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
06 Badajoz;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
06 Badajoz;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;93,12
06 Badajoz;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
06 Badajoz;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
06 Badajoz;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;90,99
06 Badajoz;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
06 Badajoz;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
06 Badajoz;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
06 Badajoz;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;92,07
06 Badajoz;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
06 Badajoz;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
06 Badajoz;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
06 Badajoz;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;90,53
06 Badajoz;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
06 Badajoz;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
06 Badajoz;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;87,6
06 Badajoz;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
06 Badajoz;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
06 Badajoz;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
06 Badajoz;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;88,6
06 Badajoz;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
06 Badajoz;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
06 Badajoz;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
06 Badajoz;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;86,79
06 Badajoz;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
06 Badajoz;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
06 Badajoz;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;82,9
06 Badajoz;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
06 Badajoz;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
06 Badajoz;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
06 Badajoz;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;84,49
06 Badajoz;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
06 Badajoz;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
06 Badajoz;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
06 Badajoz;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;82,85
06 Badajoz;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
06 Badajoz;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
06 Badajoz;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
06 Badajoz;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
06 Badajoz;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
06 Badajoz;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QII;5.850
06 Badajoz;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
06 Badajoz;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
06 Badajoz;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
06 Badajoz;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QII;5.476
06 Badajoz;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
06 Badajoz;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
06 Badajoz;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
06 Badajoz;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QII;5.137
06 Badajoz;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
06 Badajoz;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
06 Badajoz;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
06 Badajoz;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2022QII;5.644
06 Badajoz;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2022QI;""
06 Badajoz;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
06 Badajoz;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
06 Badajoz;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2021QII;5.271
06 Badajoz;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2021QI;""
06 Badajoz;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
06 Badajoz;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
06 Badajoz;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2020QII;4.996
06 Badajoz;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2020QI;""
06 Badajoz;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
06 Badajoz;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2022QIII;5.456
06 Badajoz;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2022QII;""
06 Badajoz;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2022QI;""
06 Badajoz;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
06 Badajoz;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2021QIII;5.104
06 Badajoz;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2021QII;""
06 Badajoz;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2021QI;""
06 Badajoz;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
06 Badajoz;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2020QIII;4.784
06 Badajoz;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2020QII;""
06 Badajoz;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2020QI;""
06 Badajoz;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QIV;5.190
06 Badajoz;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
06 Badajoz;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QII;""
06 Badajoz;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QI;""
06 Badajoz;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QIV;4.895
06 Badajoz;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
06 Badajoz;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QII;""
06 Badajoz;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QI;""
06 Badajoz;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QIV;4.570
06 Badajoz;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
06 Badajoz;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QII;""
06 Badajoz;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QI;""
06 Badajoz;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
06 Badajoz;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
06 Badajoz;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QII;""
06 Badajoz;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QI;4.706
06 Badajoz;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
06 Badajoz;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
06 Badajoz;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QII;""
06 Badajoz;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QI;4.423
06 Badajoz;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
06 Badajoz;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
06 Badajoz;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QII;""
06 Badajoz;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QI;""
06 Badajoz;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
06 Badajoz;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
06 Badajoz;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
06 Badajoz;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
06 Badajoz;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
06 Badajoz;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
06 Badajoz;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
06 Badajoz;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
06 Badajoz;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
06 Badajoz;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
06 Badajoz;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
06 Badajoz;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
06 Badajoz;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
06 Badajoz;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
06 Badajoz;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;96,48
06 Badajoz;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
06 Badajoz;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
06 Badajoz;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
06 Badajoz;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;96,26
06 Badajoz;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
06 Badajoz;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
06 Badajoz;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
06 Badajoz;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;97,26
06 Badajoz;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
06 Badajoz;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
06 Badajoz;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;93,26
06 Badajoz;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
06 Badajoz;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
06 Badajoz;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
06 Badajoz;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;93,21
06 Badajoz;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
06 Badajoz;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
06 Badajoz;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
06 Badajoz;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;93,13
06 Badajoz;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
06 Badajoz;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
06 Badajoz;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;88,72
06 Badajoz;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
06 Badajoz;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
06 Badajoz;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
06 Badajoz;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;89,39
06 Badajoz;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
06 Badajoz;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
06 Badajoz;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
06 Badajoz;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;88,96
06 Badajoz;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
06 Badajoz;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
06 Badajoz;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
06 Badajoz;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
06 Badajoz;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
06 Badajoz;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
06 Badajoz;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;85,94
06 Badajoz;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
06 Badajoz;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
06 Badajoz;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
06 Badajoz;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;86,1
06 Badajoz;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
06 Badajoz;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
06 Badajoz;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
06 Badajoz;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
06 Badajoz;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
06 Badajoz;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
06 Badajoz;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QII;4.071
06 Badajoz;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
06 Badajoz;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
06 Badajoz;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
06 Badajoz;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QII;3.813
06 Badajoz;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
06 Badajoz;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
06 Badajoz;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
06 Badajoz;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QII;3.579
06 Badajoz;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
06 Badajoz;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
06 Badajoz;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
06 Badajoz;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2022QII;3.941
06 Badajoz;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2022QI;""
06 Badajoz;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
06 Badajoz;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
06 Badajoz;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2021QII;3.679
06 Badajoz;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2021QI;""
06 Badajoz;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
06 Badajoz;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
06 Badajoz;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2020QII;3.481
06 Badajoz;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2020QI;""
06 Badajoz;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
06 Badajoz;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2022QIII;3.813
06 Badajoz;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2022QII;""
06 Badajoz;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2022QI;""
06 Badajoz;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
06 Badajoz;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2021QIII;3.569
06 Badajoz;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2021QII;""
06 Badajoz;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2021QI;""
06 Badajoz;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
06 Badajoz;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2020QIII;3.335
06 Badajoz;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2020QII;""
06 Badajoz;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2020QI;""
06 Badajoz;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QIV;3.629
06 Badajoz;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
06 Badajoz;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QII;""
06 Badajoz;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QI;""
06 Badajoz;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QIV;3.426
06 Badajoz;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
06 Badajoz;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QII;""
06 Badajoz;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QI;""
06 Badajoz;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QIV;3.187
06 Badajoz;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
06 Badajoz;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QII;""
06 Badajoz;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QI;""
06 Badajoz;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
06 Badajoz;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
06 Badajoz;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QII;""
06 Badajoz;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QI;3.307
06 Badajoz;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
06 Badajoz;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
06 Badajoz;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QII;""
06 Badajoz;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QI;3.088
06 Badajoz;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
06 Badajoz;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
06 Badajoz;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QII;""
06 Badajoz;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QI;""
06 Badajoz;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
06 Badajoz;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
06 Badajoz;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
06 Badajoz;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
06 Badajoz;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
06 Badajoz;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
06 Badajoz;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
06 Badajoz;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
06 Badajoz;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
06 Badajoz;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
06 Badajoz;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
06 Badajoz;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
06 Badajoz;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
06 Badajoz;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
06 Badajoz;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;96,81
06 Badajoz;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
06 Badajoz;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
06 Badajoz;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
06 Badajoz;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;96,49
06 Badajoz;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
06 Badajoz;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
06 Badajoz;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
06 Badajoz;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;97,26
06 Badajoz;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
06 Badajoz;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
06 Badajoz;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;93,66
06 Badajoz;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
06 Badajoz;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
06 Badajoz;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
06 Badajoz;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;93,6
06 Badajoz;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
06 Badajoz;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
06 Badajoz;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
06 Badajoz;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;93,18
06 Badajoz;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
06 Badajoz;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
06 Badajoz;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;89,14
06 Badajoz;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
06 Badajoz;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
06 Badajoz;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
06 Badajoz;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;89,85
06 Badajoz;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
06 Badajoz;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
06 Badajoz;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
06 Badajoz;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;89,05
06 Badajoz;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
06 Badajoz;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
06 Badajoz;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
06 Badajoz;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
06 Badajoz;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
06 Badajoz;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
06 Badajoz;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;86,73
06 Badajoz;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
06 Badajoz;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
06 Badajoz;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
06 Badajoz;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;86,28
06 Badajoz;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
06 Badajoz;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
06 Badajoz;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
06 Badajoz;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
06 Badajoz;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
06 Badajoz;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
06 Badajoz;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QII;1.779
06 Badajoz;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
06 Badajoz;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
06 Badajoz;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
06 Badajoz;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QII;1.663
06 Badajoz;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
06 Badajoz;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
06 Badajoz;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
06 Badajoz;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QII;1.558
06 Badajoz;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
06 Badajoz;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
06 Badajoz;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
06 Badajoz;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2022QII;1.703
06 Badajoz;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2022QI;""
06 Badajoz;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
06 Badajoz;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
06 Badajoz;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2021QII;1.592
06 Badajoz;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2021QI;""
06 Badajoz;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
06 Badajoz;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
06 Badajoz;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2020QII;1.515
06 Badajoz;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2020QI;""
06 Badajoz;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
06 Badajoz;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2022QIII;1.643
06 Badajoz;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2022QII;""
06 Badajoz;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2022QI;""
06 Badajoz;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
06 Badajoz;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2021QIII;1.535
06 Badajoz;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2021QII;""
06 Badajoz;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2021QI;""
06 Badajoz;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
06 Badajoz;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2020QIII;1.449
06 Badajoz;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2020QII;""
06 Badajoz;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2020QI;""
06 Badajoz;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QIV;1.561
06 Badajoz;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
06 Badajoz;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QII;""
06 Badajoz;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QI;""
06 Badajoz;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QIV;1.469
06 Badajoz;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
06 Badajoz;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QII;""
06 Badajoz;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QI;""
06 Badajoz;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QIV;1.383
06 Badajoz;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
06 Badajoz;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QII;""
06 Badajoz;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QI;""
06 Badajoz;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
06 Badajoz;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
06 Badajoz;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QII;""
06 Badajoz;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QI;1.399
06 Badajoz;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
06 Badajoz;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
06 Badajoz;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QII;""
06 Badajoz;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QI;1.335
06 Badajoz;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
06 Badajoz;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
06 Badajoz;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QII;""
06 Badajoz;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QI;""
06 Badajoz;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
06 Badajoz;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
06 Badajoz;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
06 Badajoz;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
06 Badajoz;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
06 Badajoz;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
06 Badajoz;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
06 Badajoz;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
06 Badajoz;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
06 Badajoz;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
06 Badajoz;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
06 Badajoz;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
06 Badajoz;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
06 Badajoz;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
06 Badajoz;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;95,73
06 Badajoz;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
06 Badajoz;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
06 Badajoz;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
06 Badajoz;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;95,73
06 Badajoz;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
06 Badajoz;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
06 Badajoz;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
06 Badajoz;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;97,24
06 Badajoz;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
06 Badajoz;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
06 Badajoz;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;92,36
06 Badajoz;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
06 Badajoz;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
06 Badajoz;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
06 Badajoz;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;92,3
06 Badajoz;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
06 Badajoz;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
06 Badajoz;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
06 Badajoz;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;93
06 Badajoz;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
06 Badajoz;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
06 Badajoz;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;87,75
06 Badajoz;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
06 Badajoz;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
06 Badajoz;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
06 Badajoz;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;88,33
06 Badajoz;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
06 Badajoz;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
06 Badajoz;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
06 Badajoz;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;88,77
06 Badajoz;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
06 Badajoz;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
06 Badajoz;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
06 Badajoz;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
06 Badajoz;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
06 Badajoz;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
06 Badajoz;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;84,13
06 Badajoz;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
06 Badajoz;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
06 Badajoz;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
06 Badajoz;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;85,69
06 Badajoz;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
06 Badajoz;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
06 Badajoz;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
06 Badajoz;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
06 Badajoz;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
06 Badajoz;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QIII;5.705
06 Badajoz;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
06 Badajoz;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
06 Badajoz;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
06 Badajoz;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QIII;5.345
06 Badajoz;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
06 Badajoz;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
06 Badajoz;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
06 Badajoz;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QIII;5.060
06 Badajoz;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
06 Badajoz;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
06 Badajoz;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
06 Badajoz;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2022QIII;5.500
06 Badajoz;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2022QII;""
06 Badajoz;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2022QI;""
06 Badajoz;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
06 Badajoz;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2021QIII;5.169
06 Badajoz;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2021QII;""
06 Badajoz;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2021QI;""
06 Badajoz;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
06 Badajoz;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2020QIII;4.833
06 Badajoz;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2020QII;""
06 Badajoz;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2020QI;""
06 Badajoz;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2022QIV;5.224
06 Badajoz;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
06 Badajoz;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2022QII;""
06 Badajoz;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2022QI;""
06 Badajoz;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2021QIV;4.953
06 Badajoz;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
06 Badajoz;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2021QII;""
06 Badajoz;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2021QI;""
06 Badajoz;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2020QIV;4.612
06 Badajoz;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
06 Badajoz;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2020QII;""
06 Badajoz;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2020QI;""
06 Badajoz;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
06 Badajoz;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
06 Badajoz;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QII;""
06 Badajoz;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QI;4.762
06 Badajoz;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
06 Badajoz;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
06 Badajoz;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QII;""
06 Badajoz;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QI;4.463
06 Badajoz;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
06 Badajoz;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
06 Badajoz;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QII;""
06 Badajoz;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QI;""
06 Badajoz;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
06 Badajoz;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
06 Badajoz;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QII;4.582
06 Badajoz;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QI;""
06 Badajoz;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
06 Badajoz;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
06 Badajoz;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QII;4.286
06 Badajoz;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QI;""
06 Badajoz;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
06 Badajoz;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
06 Badajoz;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QII;""
06 Badajoz;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QI;""
06 Badajoz;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
06 Badajoz;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
06 Badajoz;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
06 Badajoz;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
06 Badajoz;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
06 Badajoz;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
06 Badajoz;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
06 Badajoz;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
06 Badajoz;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
06 Badajoz;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
06 Badajoz;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
06 Badajoz;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
06 Badajoz;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
06 Badajoz;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;96,41
06 Badajoz;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
06 Badajoz;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
06 Badajoz;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
06 Badajoz;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;96,71
06 Badajoz;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
06 Badajoz;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
06 Badajoz;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
06 Badajoz;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;95,51
06 Badajoz;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
06 Badajoz;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
06 Badajoz;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;91,57
06 Badajoz;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
06 Badajoz;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
06 Badajoz;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
06 Badajoz;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;92,67
06 Badajoz;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
06 Badajoz;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
06 Badajoz;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
06 Badajoz;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;91,15
06 Badajoz;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
06 Badajoz;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
06 Badajoz;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
06 Badajoz;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
06 Badajoz;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
06 Badajoz;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
06 Badajoz;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;89,09
06 Badajoz;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
06 Badajoz;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
06 Badajoz;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
06 Badajoz;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;88,2
06 Badajoz;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
06 Badajoz;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
06 Badajoz;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
06 Badajoz;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
06 Badajoz;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
06 Badajoz;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
06 Badajoz;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;85,72
06 Badajoz;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
06 Badajoz;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
06 Badajoz;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
06 Badajoz;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;84,7
06 Badajoz;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
06 Badajoz;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
06 Badajoz;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
06 Badajoz;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
06 Badajoz;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
06 Badajoz;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
06 Badajoz;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QIII;3.979
06 Badajoz;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
06 Badajoz;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
06 Badajoz;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
06 Badajoz;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QIII;3.732
06 Badajoz;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
06 Badajoz;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
06 Badajoz;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
06 Badajoz;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QIII;3.535
06 Badajoz;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
06 Badajoz;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
06 Badajoz;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
06 Badajoz;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2022QIII;3.837
06 Badajoz;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2022QII;""
06 Badajoz;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2022QI;""
06 Badajoz;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
06 Badajoz;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2021QIII;3.614
06 Badajoz;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2021QII;""
06 Badajoz;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2021QI;""
06 Badajoz;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
06 Badajoz;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2020QIII;3.374
06 Badajoz;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2020QII;""
06 Badajoz;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2020QI;""
06 Badajoz;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2022QIV;3.647
06 Badajoz;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
06 Badajoz;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2022QII;""
06 Badajoz;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2022QI;""
06 Badajoz;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2021QIV;3.464
06 Badajoz;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
06 Badajoz;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2021QII;""
06 Badajoz;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2021QI;""
06 Badajoz;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2020QIV;3.220
06 Badajoz;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
06 Badajoz;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2020QII;""
06 Badajoz;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2020QI;""
06 Badajoz;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
06 Badajoz;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
06 Badajoz;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QII;""
06 Badajoz;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QI;3.343
06 Badajoz;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
06 Badajoz;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
06 Badajoz;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QII;""
06 Badajoz;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QI;3.120
06 Badajoz;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
06 Badajoz;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
06 Badajoz;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QII;""
06 Badajoz;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QI;""
06 Badajoz;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
06 Badajoz;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
06 Badajoz;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QII;3.227
06 Badajoz;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QI;""
06 Badajoz;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
06 Badajoz;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
06 Badajoz;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QII;3.001
06 Badajoz;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QI;""
06 Badajoz;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
06 Badajoz;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
06 Badajoz;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QII;""
06 Badajoz;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QI;""
06 Badajoz;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
06 Badajoz;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
06 Badajoz;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
06 Badajoz;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
06 Badajoz;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
06 Badajoz;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
06 Badajoz;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
06 Badajoz;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
06 Badajoz;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
06 Badajoz;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
06 Badajoz;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
06 Badajoz;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
06 Badajoz;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
06 Badajoz;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;96,43
06 Badajoz;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
06 Badajoz;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
06 Badajoz;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
06 Badajoz;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;96,84
06 Badajoz;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
06 Badajoz;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
06 Badajoz;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
06 Badajoz;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;95,45
06 Badajoz;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
06 Badajoz;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
06 Badajoz;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;91,66
06 Badajoz;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
06 Badajoz;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
06 Badajoz;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
06 Badajoz;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;92,82
06 Badajoz;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
06 Badajoz;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
06 Badajoz;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
06 Badajoz;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;91,09
06 Badajoz;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
06 Badajoz;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
06 Badajoz;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
06 Badajoz;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
06 Badajoz;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
06 Badajoz;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
06 Badajoz;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;89,58
06 Badajoz;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
06 Badajoz;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
06 Badajoz;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
06 Badajoz;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;88,26
06 Badajoz;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
06 Badajoz;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
06 Badajoz;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
06 Badajoz;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
06 Badajoz;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
06 Badajoz;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
06 Badajoz;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;86,47
06 Badajoz;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
06 Badajoz;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
06 Badajoz;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
06 Badajoz;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;84,89
06 Badajoz;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
06 Badajoz;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
06 Badajoz;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
06 Badajoz;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
06 Badajoz;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
06 Badajoz;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
06 Badajoz;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QIII;1.726
06 Badajoz;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
06 Badajoz;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
06 Badajoz;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
06 Badajoz;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QIII;1.613
06 Badajoz;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
06 Badajoz;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
06 Badajoz;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
06 Badajoz;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QIII;1.525
06 Badajoz;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
06 Badajoz;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
06 Badajoz;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
06 Badajoz;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2022QIII;1.663
06 Badajoz;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2022QII;""
06 Badajoz;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2022QI;""
06 Badajoz;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
06 Badajoz;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2021QIII;1.555
06 Badajoz;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2021QII;""
06 Badajoz;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2021QI;""
06 Badajoz;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
06 Badajoz;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2020QIII;1.459
06 Badajoz;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2020QII;""
06 Badajoz;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2020QI;""
06 Badajoz;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2022QIV;1.577
06 Badajoz;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
06 Badajoz;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2022QII;""
06 Badajoz;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2022QI;""
06 Badajoz;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2021QIV;1.489
06 Badajoz;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
06 Badajoz;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2021QII;""
06 Badajoz;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2021QI;""
06 Badajoz;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2020QIV;1.392
06 Badajoz;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
06 Badajoz;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2020QII;""
06 Badajoz;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2020QI;""
06 Badajoz;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
06 Badajoz;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
06 Badajoz;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QII;""
06 Badajoz;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QI;1.419
06 Badajoz;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
06 Badajoz;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
06 Badajoz;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QII;""
06 Badajoz;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QI;1.343
06 Badajoz;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
06 Badajoz;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
06 Badajoz;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QII;""
06 Badajoz;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QI;""
06 Badajoz;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
06 Badajoz;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
06 Badajoz;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QII;1.355
06 Badajoz;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QI;""
06 Badajoz;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
06 Badajoz;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
06 Badajoz;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QII;1.285
06 Badajoz;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QI;""
06 Badajoz;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
06 Badajoz;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
06 Badajoz;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QII;""
06 Badajoz;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QI;""
06 Badajoz;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
06 Badajoz;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
06 Badajoz;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
06 Badajoz;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
06 Badajoz;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
06 Badajoz;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
06 Badajoz;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
06 Badajoz;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
06 Badajoz;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
06 Badajoz;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
06 Badajoz;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
06 Badajoz;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
06 Badajoz;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
06 Badajoz;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;96,35
06 Badajoz;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
06 Badajoz;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
06 Badajoz;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
06 Badajoz;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;96,4
06 Badajoz;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
06 Badajoz;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
06 Badajoz;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
06 Badajoz;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;95,67
06 Badajoz;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
06 Badajoz;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
06 Badajoz;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;91,37
06 Badajoz;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
06 Badajoz;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
06 Badajoz;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
06 Badajoz;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;92,31
06 Badajoz;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
06 Badajoz;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
06 Badajoz;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
06 Badajoz;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;91,28
06 Badajoz;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
06 Badajoz;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
06 Badajoz;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
06 Badajoz;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
06 Badajoz;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
06 Badajoz;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
06 Badajoz;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;87,97
06 Badajoz;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
06 Badajoz;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
06 Badajoz;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
06 Badajoz;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;88,07
06 Badajoz;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
06 Badajoz;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
06 Badajoz;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
06 Badajoz;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
06 Badajoz;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
06 Badajoz;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
06 Badajoz;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;84
06 Badajoz;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
06 Badajoz;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
06 Badajoz;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
06 Badajoz;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;84,26
06 Badajoz;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
06 Badajoz;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
06 Badajoz;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
06 Badajoz;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
06 Badajoz;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
06 Badajoz;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QIV;5.543
06 Badajoz;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
06 Badajoz;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
06 Badajoz;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
06 Badajoz;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QIV;5.229
06 Badajoz;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
06 Badajoz;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
06 Badajoz;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
06 Badajoz;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QIV;4.888
06 Badajoz;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
06 Badajoz;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
06 Badajoz;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
06 Badajoz;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2022QIV;5.259
06 Badajoz;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
06 Badajoz;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2022QII;""
06 Badajoz;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2022QI;""
06 Badajoz;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2021QIV;4.995
06 Badajoz;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
06 Badajoz;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2021QII;""
06 Badajoz;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2021QI;""
06 Badajoz;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2020QIV;4.657
06 Badajoz;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
06 Badajoz;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2020QII;""
06 Badajoz;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2020QI;""
06 Badajoz;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
06 Badajoz;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
06 Badajoz;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2022QII;""
06 Badajoz;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2022QI;4.799
06 Badajoz;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
06 Badajoz;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
06 Badajoz;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2021QII;""
06 Badajoz;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2021QI;4.506
06 Badajoz;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
06 Badajoz;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
06 Badajoz;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2020QII;""
06 Badajoz;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2020QI;""
06 Badajoz;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
06 Badajoz;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
06 Badajoz;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QII;4.615
06 Badajoz;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QI;""
06 Badajoz;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
06 Badajoz;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
06 Badajoz;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QII;4.323
06 Badajoz;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QI;""
06 Badajoz;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
06 Badajoz;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
06 Badajoz;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QII;""
06 Badajoz;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QI;""
06 Badajoz;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
06 Badajoz;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QIII;4.455
06 Badajoz;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QII;""
06 Badajoz;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QI;""
06 Badajoz;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
06 Badajoz;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QIII;4.181
06 Badajoz;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QII;""
06 Badajoz;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QI;""
06 Badajoz;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
06 Badajoz;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
06 Badajoz;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QII;""
06 Badajoz;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QI;""
06 Badajoz;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
06 Badajoz;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
06 Badajoz;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
06 Badajoz;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
06 Badajoz;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
06 Badajoz;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
06 Badajoz;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
06 Badajoz;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
06 Badajoz;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
06 Badajoz;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
06 Badajoz;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
06 Badajoz;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
06 Badajoz;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;94,88
06 Badajoz;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
06 Badajoz;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
06 Badajoz;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
06 Badajoz;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;95,52
06 Badajoz;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
06 Badajoz;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
06 Badajoz;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
06 Badajoz;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;95,27
06 Badajoz;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
06 Badajoz;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
06 Badajoz;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
06 Badajoz;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
06 Badajoz;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
06 Badajoz;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
06 Badajoz;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;91,78
06 Badajoz;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
06 Badajoz;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
06 Badajoz;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
06 Badajoz;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;92,18
06 Badajoz;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
06 Badajoz;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
06 Badajoz;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
06 Badajoz;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
06 Badajoz;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
06 Badajoz;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
06 Badajoz;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;88,26
06 Badajoz;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
06 Badajoz;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
06 Badajoz;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
06 Badajoz;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;88,44
06 Badajoz;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
06 Badajoz;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
06 Badajoz;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
06 Badajoz;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
06 Badajoz;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
06 Badajoz;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
06 Badajoz;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;85,2
06 Badajoz;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
06 Badajoz;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
06 Badajoz;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
06 Badajoz;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;85,54
06 Badajoz;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
06 Badajoz;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
06 Badajoz;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
06 Badajoz;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
06 Badajoz;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
06 Badajoz;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
06 Badajoz;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QIV;3.859
06 Badajoz;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
06 Badajoz;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
06 Badajoz;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
06 Badajoz;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QIV;3.646
06 Badajoz;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
06 Badajoz;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
06 Badajoz;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
06 Badajoz;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QIV;3.399
06 Badajoz;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
06 Badajoz;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
06 Badajoz;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
06 Badajoz;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2022QIV;3.664
06 Badajoz;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
06 Badajoz;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2022QII;""
06 Badajoz;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2022QI;""
06 Badajoz;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2021QIV;3.483
06 Badajoz;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
06 Badajoz;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2021QII;""
06 Badajoz;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2021QI;""
06 Badajoz;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2020QIV;3.238
06 Badajoz;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
06 Badajoz;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2020QII;""
06 Badajoz;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2020QI;""
06 Badajoz;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
06 Badajoz;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
06 Badajoz;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2022QII;""
06 Badajoz;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2022QI;3.359
06 Badajoz;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
06 Badajoz;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
06 Badajoz;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2021QII;""
06 Badajoz;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2021QI;3.137
06 Badajoz;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
06 Badajoz;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
06 Badajoz;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2020QII;""
06 Badajoz;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2020QI;""
06 Badajoz;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
06 Badajoz;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
06 Badajoz;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QII;3.240
06 Badajoz;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QI;""
06 Badajoz;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
06 Badajoz;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
06 Badajoz;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QII;3.016
06 Badajoz;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QI;""
06 Badajoz;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
06 Badajoz;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
06 Badajoz;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QII;""
06 Badajoz;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QI;""
06 Badajoz;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
06 Badajoz;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QIII;3.131
06 Badajoz;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QII;""
06 Badajoz;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QI;""
06 Badajoz;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
06 Badajoz;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QIII;2.923
06 Badajoz;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QII;""
06 Badajoz;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QI;""
06 Badajoz;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
06 Badajoz;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
06 Badajoz;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QII;""
06 Badajoz;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QI;""
06 Badajoz;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
06 Badajoz;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
06 Badajoz;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
06 Badajoz;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
06 Badajoz;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
06 Badajoz;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
06 Badajoz;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
06 Badajoz;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
06 Badajoz;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
06 Badajoz;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
06 Badajoz;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
06 Badajoz;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
06 Badajoz;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;94,95
06 Badajoz;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
06 Badajoz;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
06 Badajoz;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
06 Badajoz;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;95,53
06 Badajoz;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
06 Badajoz;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
06 Badajoz;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
06 Badajoz;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;95,26
06 Badajoz;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
06 Badajoz;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
06 Badajoz;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
06 Badajoz;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
06 Badajoz;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
06 Badajoz;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
06 Badajoz;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;92,13
06 Badajoz;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
06 Badajoz;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
06 Badajoz;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
06 Badajoz;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;92,29
06 Badajoz;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
06 Badajoz;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
06 Badajoz;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
06 Badajoz;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
06 Badajoz;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
06 Badajoz;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
06 Badajoz;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;88,86
06 Badajoz;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
06 Badajoz;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
06 Badajoz;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
06 Badajoz;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;88,73
06 Badajoz;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
06 Badajoz;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
06 Badajoz;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
06 Badajoz;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
06 Badajoz;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
06 Badajoz;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
06 Badajoz;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;85,87
06 Badajoz;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
06 Badajoz;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
06 Badajoz;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
06 Badajoz;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;86
06 Badajoz;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
06 Badajoz;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
06 Badajoz;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
06 Badajoz;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
06 Badajoz;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
06 Badajoz;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
06 Badajoz;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QIV;1.684
06 Badajoz;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
06 Badajoz;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
06 Badajoz;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
06 Badajoz;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QIV;1.583
06 Badajoz;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
06 Badajoz;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
06 Badajoz;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
06 Badajoz;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QIV;1.489
06 Badajoz;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
06 Badajoz;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
06 Badajoz;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
06 Badajoz;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2022QIV;1.595
06 Badajoz;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
06 Badajoz;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2022QII;""
06 Badajoz;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2022QI;""
06 Badajoz;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2021QIV;1.512
06 Badajoz;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
06 Badajoz;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2021QII;""
06 Badajoz;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2021QI;""
06 Badajoz;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2020QIV;1.419
06 Badajoz;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
06 Badajoz;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2020QII;""
06 Badajoz;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2020QI;""
06 Badajoz;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
06 Badajoz;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
06 Badajoz;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2022QII;""
06 Badajoz;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2022QI;1.440
06 Badajoz;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
06 Badajoz;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
06 Badajoz;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2021QII;""
06 Badajoz;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2021QI;1.369
06 Badajoz;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
06 Badajoz;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
06 Badajoz;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2020QII;""
06 Badajoz;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2020QI;""
06 Badajoz;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
06 Badajoz;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
06 Badajoz;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QII;1.375
06 Badajoz;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QI;""
06 Badajoz;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
06 Badajoz;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
06 Badajoz;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QII;1.307
06 Badajoz;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QI;""
06 Badajoz;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
06 Badajoz;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
06 Badajoz;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QII;""
06 Badajoz;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QI;""
06 Badajoz;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
06 Badajoz;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QIII;1.324
06 Badajoz;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QII;""
06 Badajoz;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QI;""
06 Badajoz;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
06 Badajoz;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QIII;1.258
06 Badajoz;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QII;""
06 Badajoz;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QI;""
06 Badajoz;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
06 Badajoz;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
06 Badajoz;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QII;""
06 Badajoz;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QI;""
06 Badajoz;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
06 Badajoz;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
06 Badajoz;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
06 Badajoz;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
06 Badajoz;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
06 Badajoz;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
06 Badajoz;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
06 Badajoz;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
06 Badajoz;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
06 Badajoz;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
06 Badajoz;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
06 Badajoz;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
06 Badajoz;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;94,71
06 Badajoz;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
06 Badajoz;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
06 Badajoz;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
06 Badajoz;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;95,51
06 Badajoz;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
06 Badajoz;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
06 Badajoz;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
06 Badajoz;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;95,3
06 Badajoz;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
06 Badajoz;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
06 Badajoz;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
06 Badajoz;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
06 Badajoz;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
06 Badajoz;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
06 Badajoz;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;90,97
06 Badajoz;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
06 Badajoz;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
06 Badajoz;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
06 Badajoz;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;91,94
06 Badajoz;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
06 Badajoz;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
06 Badajoz;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
06 Badajoz;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
06 Badajoz;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
06 Badajoz;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
06 Badajoz;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;86,86
06 Badajoz;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
06 Badajoz;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
06 Badajoz;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
06 Badajoz;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;87,78
06 Badajoz;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
06 Badajoz;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
06 Badajoz;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
06 Badajoz;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
06 Badajoz;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
06 Badajoz;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
06 Badajoz;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;83,64
06 Badajoz;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
06 Badajoz;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
06 Badajoz;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
06 Badajoz;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;84,49
06 Badajoz;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
06 Badajoz;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
06 Badajoz;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
06 Badajoz;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
06 Badajoz;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
06 Badajoz;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
07 Balears, Illes;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
07 Balears, Illes;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
07 Balears, Illes;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
07 Balears, Illes;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QI;88.063
07 Balears, Illes;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
07 Balears, Illes;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
07 Balears, Illes;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
07 Balears, Illes;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QI;85.651
07 Balears, Illes;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
07 Balears, Illes;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
07 Balears, Illes;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
07 Balears, Illes;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QI;88.568
07 Balears, Illes;All ages;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
07 Balears, Illes;All ages;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
07 Balears, Illes;All ages;Cohort January 1;Total;Survival in the first trimester;2022QII;""
07 Balears, Illes;All ages;Cohort January 1;Total;Survival in the first trimester;2022QI;84.955
07 Balears, Illes;All ages;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
07 Balears, Illes;All ages;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
07 Balears, Illes;All ages;Cohort January 1;Total;Survival in the first trimester;2021QII;""
07 Balears, Illes;All ages;Cohort January 1;Total;Survival in the first trimester;2021QI;82.911
07 Balears, Illes;All ages;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
07 Balears, Illes;All ages;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
07 Balears, Illes;All ages;Cohort January 1;Total;Survival in the first trimester;2020QII;""
07 Balears, Illes;All ages;Cohort January 1;Total;Survival in the first trimester;2020QI;81.734
07 Balears, Illes;All ages;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
07 Balears, Illes;All ages;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
07 Balears, Illes;All ages;Cohort January 1;Total;Survival in the second trimester;2022QII;82.073
07 Balears, Illes;All ages;Cohort January 1;Total;Survival in the second trimester;2022QI;""
07 Balears, Illes;All ages;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
07 Balears, Illes;All ages;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
07 Balears, Illes;All ages;Cohort January 1;Total;Survival in the second trimester;2021QII;80.462
07 Balears, Illes;All ages;Cohort January 1;Total;Survival in the second trimester;2021QI;""
07 Balears, Illes;All ages;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
07 Balears, Illes;All ages;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
07 Balears, Illes;All ages;Cohort January 1;Total;Survival in the second trimester;2020QII;79.679
07 Balears, Illes;All ages;Cohort January 1;Total;Survival in the second trimester;2020QI;""
07 Balears, Illes;All ages;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
07 Balears, Illes;All ages;Cohort January 1;Total;Survival in the third trimester;2022QIII;79.621
07 Balears, Illes;All ages;Cohort January 1;Total;Survival in the third trimester;2022QII;""
07 Balears, Illes;All ages;Cohort January 1;Total;Survival in the third trimester;2022QI;""
07 Balears, Illes;All ages;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
07 Balears, Illes;All ages;Cohort January 1;Total;Survival in the third trimester;2021QIII;78.166
07 Balears, Illes;All ages;Cohort January 1;Total;Survival in the third trimester;2021QII;""
07 Balears, Illes;All ages;Cohort January 1;Total;Survival in the third trimester;2021QI;""
07 Balears, Illes;All ages;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
07 Balears, Illes;All ages;Cohort January 1;Total;Survival in the third trimester;2020QIII;76.163
07 Balears, Illes;All ages;Cohort January 1;Total;Survival in the third trimester;2020QII;""
07 Balears, Illes;All ages;Cohort January 1;Total;Survival in the third trimester;2020QI;""
07 Balears, Illes;All ages;Cohort January 1;Total;Survival in the third trimester;2022QIV;76.180
07 Balears, Illes;All ages;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
07 Balears, Illes;All ages;Cohort January 1;Total;Survival in the third trimester;2022QII;""
07 Balears, Illes;All ages;Cohort January 1;Total;Survival in the third trimester;2022QI;""
07 Balears, Illes;All ages;Cohort January 1;Total;Survival in the third trimester;2021QIV;75.241
07 Balears, Illes;All ages;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
07 Balears, Illes;All ages;Cohort January 1;Total;Survival in the third trimester;2021QII;""
07 Balears, Illes;All ages;Cohort January 1;Total;Survival in the third trimester;2021QI;""
07 Balears, Illes;All ages;Cohort January 1;Total;Survival in the third trimester;2020QIV;73.298
07 Balears, Illes;All ages;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
07 Balears, Illes;All ages;Cohort January 1;Total;Survival in the third trimester;2020QII;""
07 Balears, Illes;All ages;Cohort January 1;Total;Survival in the third trimester;2020QI;""
07 Balears, Illes;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
07 Balears, Illes;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
07 Balears, Illes;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
07 Balears, Illes;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
07 Balears, Illes;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
07 Balears, Illes;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
07 Balears, Illes;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
07 Balears, Illes;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
07 Balears, Illes;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
07 Balears, Illes;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
07 Balears, Illes;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
07 Balears, Illes;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
07 Balears, Illes;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
07 Balears, Illes;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
07 Balears, Illes;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
07 Balears, Illes;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;96,47
07 Balears, Illes;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
07 Balears, Illes;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
07 Balears, Illes;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
07 Balears, Illes;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;96,8
07 Balears, Illes;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
07 Balears, Illes;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
07 Balears, Illes;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
07 Balears, Illes;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;92,28
07 Balears, Illes;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
07 Balears, Illes;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
07 Balears, Illes;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;93,2
07 Balears, Illes;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
07 Balears, Illes;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
07 Balears, Illes;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
07 Balears, Illes;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;93,94
07 Balears, Illes;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
07 Balears, Illes;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
07 Balears, Illes;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
07 Balears, Illes;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;89,96
07 Balears, Illes;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
07 Balears, Illes;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
07 Balears, Illes;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;90,41
07 Balears, Illes;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
07 Balears, Illes;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
07 Balears, Illes;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
07 Balears, Illes;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;91,26
07 Balears, Illes;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
07 Balears, Illes;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
07 Balears, Illes;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
07 Balears, Illes;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;85,99
07 Balears, Illes;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
07 Balears, Illes;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
07 Balears, Illes;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;86,51
07 Balears, Illes;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
07 Balears, Illes;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
07 Balears, Illes;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
07 Balears, Illes;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;87,85
07 Balears, Illes;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
07 Balears, Illes;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
07 Balears, Illes;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
07 Balears, Illes;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;82,76
07 Balears, Illes;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
07 Balears, Illes;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
07 Balears, Illes;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
07 Balears, Illes;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
07 Balears, Illes;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
07 Balears, Illes;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
07 Balears, Illes;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QI;56.860
07 Balears, Illes;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
07 Balears, Illes;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
07 Balears, Illes;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
07 Balears, Illes;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QI;55.547
07 Balears, Illes;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
07 Balears, Illes;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
07 Balears, Illes;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
07 Balears, Illes;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QI;57.271
07 Balears, Illes;All ages;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
07 Balears, Illes;All ages;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
07 Balears, Illes;All ages;Cohort January 1;Males;Survival in the first trimester;2022QII;""
07 Balears, Illes;All ages;Cohort January 1;Males;Survival in the first trimester;2022QI;54.974
07 Balears, Illes;All ages;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
07 Balears, Illes;All ages;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
07 Balears, Illes;All ages;Cohort January 1;Males;Survival in the first trimester;2021QII;""
07 Balears, Illes;All ages;Cohort January 1;Males;Survival in the first trimester;2021QI;53.804
07 Balears, Illes;All ages;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
07 Balears, Illes;All ages;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
07 Balears, Illes;All ages;Cohort January 1;Males;Survival in the first trimester;2020QII;""
07 Balears, Illes;All ages;Cohort January 1;Males;Survival in the first trimester;2020QI;53.216
07 Balears, Illes;All ages;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
07 Balears, Illes;All ages;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
07 Balears, Illes;All ages;Cohort January 1;Males;Survival in the second trimester;2022QII;53.228
07 Balears, Illes;All ages;Cohort January 1;Males;Survival in the second trimester;2022QI;""
07 Balears, Illes;All ages;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
07 Balears, Illes;All ages;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
07 Balears, Illes;All ages;Cohort January 1;Males;Survival in the second trimester;2021QII;52.318
07 Balears, Illes;All ages;Cohort January 1;Males;Survival in the second trimester;2021QI;""
07 Balears, Illes;All ages;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
07 Balears, Illes;All ages;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
07 Balears, Illes;All ages;Cohort January 1;Males;Survival in the second trimester;2020QII;51.964
07 Balears, Illes;All ages;Cohort January 1;Males;Survival in the second trimester;2020QI;""
07 Balears, Illes;All ages;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
07 Balears, Illes;All ages;Cohort January 1;Males;Survival in the third trimester;2022QIII;51.746
07 Balears, Illes;All ages;Cohort January 1;Males;Survival in the third trimester;2022QII;""
07 Balears, Illes;All ages;Cohort January 1;Males;Survival in the third trimester;2022QI;""
07 Balears, Illes;All ages;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
07 Balears, Illes;All ages;Cohort January 1;Males;Survival in the third trimester;2021QIII;50.906
07 Balears, Illes;All ages;Cohort January 1;Males;Survival in the third trimester;2021QII;""
07 Balears, Illes;All ages;Cohort January 1;Males;Survival in the third trimester;2021QI;""
07 Balears, Illes;All ages;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
07 Balears, Illes;All ages;Cohort January 1;Males;Survival in the third trimester;2020QIII;49.814
07 Balears, Illes;All ages;Cohort January 1;Males;Survival in the third trimester;2020QII;""
07 Balears, Illes;All ages;Cohort January 1;Males;Survival in the third trimester;2020QI;""
07 Balears, Illes;All ages;Cohort January 1;Males;Survival in the third trimester;2022QIV;49.697
07 Balears, Illes;All ages;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
07 Balears, Illes;All ages;Cohort January 1;Males;Survival in the third trimester;2022QII;""
07 Balears, Illes;All ages;Cohort January 1;Males;Survival in the third trimester;2022QI;""
07 Balears, Illes;All ages;Cohort January 1;Males;Survival in the third trimester;2021QIV;49.149
07 Balears, Illes;All ages;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
07 Balears, Illes;All ages;Cohort January 1;Males;Survival in the third trimester;2021QII;""
07 Balears, Illes;All ages;Cohort January 1;Males;Survival in the third trimester;2021QI;""
07 Balears, Illes;All ages;Cohort January 1;Males;Survival in the third trimester;2020QIV;48.003
07 Balears, Illes;All ages;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
07 Balears, Illes;All ages;Cohort January 1;Males;Survival in the third trimester;2020QII;""
07 Balears, Illes;All ages;Cohort January 1;Males;Survival in the third trimester;2020QI;""
07 Balears, Illes;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
07 Balears, Illes;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
07 Balears, Illes;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
07 Balears, Illes;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
07 Balears, Illes;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
07 Balears, Illes;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
07 Balears, Illes;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
07 Balears, Illes;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
07 Balears, Illes;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
07 Balears, Illes;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
07 Balears, Illes;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
07 Balears, Illes;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
07 Balears, Illes;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
07 Balears, Illes;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
07 Balears, Illes;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
07 Balears, Illes;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;96,68
07 Balears, Illes;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
07 Balears, Illes;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
07 Balears, Illes;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
07 Balears, Illes;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;96,86
07 Balears, Illes;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
07 Balears, Illes;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
07 Balears, Illes;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
07 Balears, Illes;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;92,92
07 Balears, Illes;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
07 Balears, Illes;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
07 Balears, Illes;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;93,61
07 Balears, Illes;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
07 Balears, Illes;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
07 Balears, Illes;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
07 Balears, Illes;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;94,19
07 Balears, Illes;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
07 Balears, Illes;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
07 Balears, Illes;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
07 Balears, Illes;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;90,73
07 Balears, Illes;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
07 Balears, Illes;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
07 Balears, Illes;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;91,01
07 Balears, Illes;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
07 Balears, Illes;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
07 Balears, Illes;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
07 Balears, Illes;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;91,64
07 Balears, Illes;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
07 Balears, Illes;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
07 Balears, Illes;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
07 Balears, Illes;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;86,98
07 Balears, Illes;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
07 Balears, Illes;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
07 Balears, Illes;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;87,4
07 Balears, Illes;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
07 Balears, Illes;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
07 Balears, Illes;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
07 Balears, Illes;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;88,48
07 Balears, Illes;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
07 Balears, Illes;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
07 Balears, Illes;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
07 Balears, Illes;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;83,82
07 Balears, Illes;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
07 Balears, Illes;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
07 Balears, Illes;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
07 Balears, Illes;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
07 Balears, Illes;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
07 Balears, Illes;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
07 Balears, Illes;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QI;31.203
07 Balears, Illes;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
07 Balears, Illes;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
07 Balears, Illes;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
07 Balears, Illes;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QI;30.104
07 Balears, Illes;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
07 Balears, Illes;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
07 Balears, Illes;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
07 Balears, Illes;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QI;31.297
07 Balears, Illes;All ages;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
07 Balears, Illes;All ages;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
07 Balears, Illes;All ages;Cohort January 1;Females;Survival in the first trimester;2022QII;""
07 Balears, Illes;All ages;Cohort January 1;Females;Survival in the first trimester;2022QI;29.981
07 Balears, Illes;All ages;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
07 Balears, Illes;All ages;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
07 Balears, Illes;All ages;Cohort January 1;Females;Survival in the first trimester;2021QII;""
07 Balears, Illes;All ages;Cohort January 1;Females;Survival in the first trimester;2021QI;29.107
07 Balears, Illes;All ages;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
07 Balears, Illes;All ages;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
07 Balears, Illes;All ages;Cohort January 1;Females;Survival in the first trimester;2020QII;""
07 Balears, Illes;All ages;Cohort January 1;Females;Survival in the first trimester;2020QI;28.518
07 Balears, Illes;All ages;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
07 Balears, Illes;All ages;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
07 Balears, Illes;All ages;Cohort January 1;Females;Survival in the second trimester;2022QII;28.845
07 Balears, Illes;All ages;Cohort January 1;Females;Survival in the second trimester;2022QI;""
07 Balears, Illes;All ages;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
07 Balears, Illes;All ages;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
07 Balears, Illes;All ages;Cohort January 1;Females;Survival in the second trimester;2021QII;28.144
07 Balears, Illes;All ages;Cohort January 1;Females;Survival in the second trimester;2021QI;""
07 Balears, Illes;All ages;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
07 Balears, Illes;All ages;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
07 Balears, Illes;All ages;Cohort January 1;Females;Survival in the second trimester;2020QII;27.715
07 Balears, Illes;All ages;Cohort January 1;Females;Survival in the second trimester;2020QI;""
07 Balears, Illes;All ages;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
07 Balears, Illes;All ages;Cohort January 1;Females;Survival in the third trimester;2022QIII;27.875
07 Balears, Illes;All ages;Cohort January 1;Females;Survival in the third trimester;2022QII;""
07 Balears, Illes;All ages;Cohort January 1;Females;Survival in the third trimester;2022QI;""
07 Balears, Illes;All ages;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
07 Balears, Illes;All ages;Cohort January 1;Females;Survival in the third trimester;2021QIII;27.260
07 Balears, Illes;All ages;Cohort January 1;Females;Survival in the third trimester;2021QII;""
07 Balears, Illes;All ages;Cohort January 1;Females;Survival in the third trimester;2021QI;""
07 Balears, Illes;All ages;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
07 Balears, Illes;All ages;Cohort January 1;Females;Survival in the third trimester;2020QIII;26.349
07 Balears, Illes;All ages;Cohort January 1;Females;Survival in the third trimester;2020QII;""
07 Balears, Illes;All ages;Cohort January 1;Females;Survival in the third trimester;2020QI;""
07 Balears, Illes;All ages;Cohort January 1;Females;Survival in the third trimester;2022QIV;26.483
07 Balears, Illes;All ages;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
07 Balears, Illes;All ages;Cohort January 1;Females;Survival in the third trimester;2022QII;""
07 Balears, Illes;All ages;Cohort January 1;Females;Survival in the third trimester;2022QI;""
07 Balears, Illes;All ages;Cohort January 1;Females;Survival in the third trimester;2021QIV;26.092
07 Balears, Illes;All ages;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
07 Balears, Illes;All ages;Cohort January 1;Females;Survival in the third trimester;2021QII;""
07 Balears, Illes;All ages;Cohort January 1;Females;Survival in the third trimester;2021QI;""
07 Balears, Illes;All ages;Cohort January 1;Females;Survival in the third trimester;2020QIV;25.295
07 Balears, Illes;All ages;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
07 Balears, Illes;All ages;Cohort January 1;Females;Survival in the third trimester;2020QII;""
07 Balears, Illes;All ages;Cohort January 1;Females;Survival in the third trimester;2020QI;""
07 Balears, Illes;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
07 Balears, Illes;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
07 Balears, Illes;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
07 Balears, Illes;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
07 Balears, Illes;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
07 Balears, Illes;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
07 Balears, Illes;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
07 Balears, Illes;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
07 Balears, Illes;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
07 Balears, Illes;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
07 Balears, Illes;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
07 Balears, Illes;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
07 Balears, Illes;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
07 Balears, Illes;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
07 Balears, Illes;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
07 Balears, Illes;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;96,08
07 Balears, Illes;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
07 Balears, Illes;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
07 Balears, Illes;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
07 Balears, Illes;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;96,69
07 Balears, Illes;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
07 Balears, Illes;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
07 Balears, Illes;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
07 Balears, Illes;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;91,12
07 Balears, Illes;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
07 Balears, Illes;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
07 Balears, Illes;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;92,44
07 Balears, Illes;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
07 Balears, Illes;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
07 Balears, Illes;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
07 Balears, Illes;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;93,49
07 Balears, Illes;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
07 Balears, Illes;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
07 Balears, Illes;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
07 Balears, Illes;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;88,55
07 Balears, Illes;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
07 Balears, Illes;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
07 Balears, Illes;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;89,33
07 Balears, Illes;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
07 Balears, Illes;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
07 Balears, Illes;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
07 Balears, Illes;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;90,55
07 Balears, Illes;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
07 Balears, Illes;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
07 Balears, Illes;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
07 Balears, Illes;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;84,19
07 Balears, Illes;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
07 Balears, Illes;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
07 Balears, Illes;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;84,87
07 Balears, Illes;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
07 Balears, Illes;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
07 Balears, Illes;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
07 Balears, Illes;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;86,67
07 Balears, Illes;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
07 Balears, Illes;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
07 Balears, Illes;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
07 Balears, Illes;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;80,82
07 Balears, Illes;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
07 Balears, Illes;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
07 Balears, Illes;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
07 Balears, Illes;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
07 Balears, Illes;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
07 Balears, Illes;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QII;89.950
07 Balears, Illes;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
07 Balears, Illes;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
07 Balears, Illes;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
07 Balears, Illes;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QII;86.819
07 Balears, Illes;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
07 Balears, Illes;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
07 Balears, Illes;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
07 Balears, Illes;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QII;86.846
07 Balears, Illes;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
07 Balears, Illes;All ages;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
07 Balears, Illes;All ages;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
07 Balears, Illes;All ages;Cohort April 1;Total;Survival in the first trimester;2022QII;86.655
07 Balears, Illes;All ages;Cohort April 1;Total;Survival in the first trimester;2022QI;""
07 Balears, Illes;All ages;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
07 Balears, Illes;All ages;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
07 Balears, Illes;All ages;Cohort April 1;Total;Survival in the first trimester;2021QII;83.983
07 Balears, Illes;All ages;Cohort April 1;Total;Survival in the first trimester;2021QI;""
07 Balears, Illes;All ages;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
07 Balears, Illes;All ages;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
07 Balears, Illes;All ages;Cohort April 1;Total;Survival in the first trimester;2020QII;84.489
07 Balears, Illes;All ages;Cohort April 1;Total;Survival in the first trimester;2020QI;""
07 Balears, Illes;All ages;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
07 Balears, Illes;All ages;Cohort April 1;Total;Survival in the second trimester;2022QIII;83.897
07 Balears, Illes;All ages;Cohort April 1;Total;Survival in the second trimester;2022QII;""
07 Balears, Illes;All ages;Cohort April 1;Total;Survival in the second trimester;2022QI;""
07 Balears, Illes;All ages;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
07 Balears, Illes;All ages;Cohort April 1;Total;Survival in the second trimester;2021QIII;81.437
07 Balears, Illes;All ages;Cohort April 1;Total;Survival in the second trimester;2021QII;""
07 Balears, Illes;All ages;Cohort April 1;Total;Survival in the second trimester;2021QI;""
07 Balears, Illes;All ages;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
07 Balears, Illes;All ages;Cohort April 1;Total;Survival in the second trimester;2020QIII;80.270
07 Balears, Illes;All ages;Cohort April 1;Total;Survival in the second trimester;2020QII;""
07 Balears, Illes;All ages;Cohort April 1;Total;Survival in the second trimester;2020QI;""
07 Balears, Illes;All ages;Cohort April 1;Total;Survival in the third trimester;2022QIV;79.331
07 Balears, Illes;All ages;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
07 Balears, Illes;All ages;Cohort April 1;Total;Survival in the third trimester;2022QII;""
07 Balears, Illes;All ages;Cohort April 1;Total;Survival in the third trimester;2022QI;""
07 Balears, Illes;All ages;Cohort April 1;Total;Survival in the third trimester;2021QIV;77.923
07 Balears, Illes;All ages;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
07 Balears, Illes;All ages;Cohort April 1;Total;Survival in the third trimester;2021QII;""
07 Balears, Illes;All ages;Cohort April 1;Total;Survival in the third trimester;2021QI;""
07 Balears, Illes;All ages;Cohort April 1;Total;Survival in the third trimester;2020QIV;76.833
07 Balears, Illes;All ages;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
07 Balears, Illes;All ages;Cohort April 1;Total;Survival in the third trimester;2020QII;""
07 Balears, Illes;All ages;Cohort April 1;Total;Survival in the third trimester;2020QI;""
07 Balears, Illes;All ages;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
07 Balears, Illes;All ages;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
07 Balears, Illes;All ages;Cohort April 1;Total;Survival in the third trimester;2022QII;""
07 Balears, Illes;All ages;Cohort April 1;Total;Survival in the third trimester;2022QI;75.697
07 Balears, Illes;All ages;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
07 Balears, Illes;All ages;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
07 Balears, Illes;All ages;Cohort April 1;Total;Survival in the third trimester;2021QII;""
07 Balears, Illes;All ages;Cohort April 1;Total;Survival in the third trimester;2021QI;74.858
07 Balears, Illes;All ages;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
07 Balears, Illes;All ages;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
07 Balears, Illes;All ages;Cohort April 1;Total;Survival in the third trimester;2020QII;""
07 Balears, Illes;All ages;Cohort April 1;Total;Survival in the third trimester;2020QI;""
07 Balears, Illes;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
07 Balears, Illes;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
07 Balears, Illes;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
07 Balears, Illes;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
07 Balears, Illes;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
07 Balears, Illes;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
07 Balears, Illes;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
07 Balears, Illes;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
07 Balears, Illes;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
07 Balears, Illes;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
07 Balears, Illes;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
07 Balears, Illes;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
07 Balears, Illes;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
07 Balears, Illes;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
07 Balears, Illes;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;96,34
07 Balears, Illes;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
07 Balears, Illes;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
07 Balears, Illes;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
07 Balears, Illes;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;96,73
07 Balears, Illes;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
07 Balears, Illes;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
07 Balears, Illes;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
07 Balears, Illes;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;97,29
07 Balears, Illes;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
07 Balears, Illes;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
07 Balears, Illes;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;93,27
07 Balears, Illes;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
07 Balears, Illes;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
07 Balears, Illes;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
07 Balears, Illes;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;93,8
07 Balears, Illes;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
07 Balears, Illes;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
07 Balears, Illes;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
07 Balears, Illes;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;92,43
07 Balears, Illes;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
07 Balears, Illes;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
07 Balears, Illes;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;88,19
07 Balears, Illes;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
07 Balears, Illes;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
07 Balears, Illes;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
07 Balears, Illes;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;89,75
07 Balears, Illes;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
07 Balears, Illes;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
07 Balears, Illes;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
07 Balears, Illes;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;88,47
07 Balears, Illes;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
07 Balears, Illes;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
07 Balears, Illes;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
07 Balears, Illes;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
07 Balears, Illes;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
07 Balears, Illes;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
07 Balears, Illes;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;87,19
07 Balears, Illes;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
07 Balears, Illes;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
07 Balears, Illes;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
07 Balears, Illes;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;86,2
07 Balears, Illes;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
07 Balears, Illes;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
07 Balears, Illes;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
07 Balears, Illes;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
07 Balears, Illes;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
07 Balears, Illes;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
07 Balears, Illes;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QII;57.972
07 Balears, Illes;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
07 Balears, Illes;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
07 Balears, Illes;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
07 Balears, Illes;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QII;56.303
07 Balears, Illes;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
07 Balears, Illes;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
07 Balears, Illes;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
07 Balears, Illes;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QII;56.415
07 Balears, Illes;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
07 Balears, Illes;All ages;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
07 Balears, Illes;All ages;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
07 Balears, Illes;All ages;Cohort April 1;Males;Survival in the first trimester;2022QII;55.941
07 Balears, Illes;All ages;Cohort April 1;Males;Survival in the first trimester;2022QI;""
07 Balears, Illes;All ages;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
07 Balears, Illes;All ages;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
07 Balears, Illes;All ages;Cohort April 1;Males;Survival in the first trimester;2021QII;54.553
07 Balears, Illes;All ages;Cohort April 1;Males;Survival in the first trimester;2021QI;""
07 Balears, Illes;All ages;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
07 Balears, Illes;All ages;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
07 Balears, Illes;All ages;Cohort April 1;Males;Survival in the first trimester;2020QII;54.954
07 Balears, Illes;All ages;Cohort April 1;Males;Survival in the first trimester;2020QI;""
07 Balears, Illes;All ages;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
07 Balears, Illes;All ages;Cohort April 1;Males;Survival in the second trimester;2022QIII;54.279
07 Balears, Illes;All ages;Cohort April 1;Males;Survival in the second trimester;2022QII;""
07 Balears, Illes;All ages;Cohort April 1;Males;Survival in the second trimester;2022QI;""
07 Balears, Illes;All ages;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
07 Balears, Illes;All ages;Cohort April 1;Males;Survival in the second trimester;2021QIII;52.961
07 Balears, Illes;All ages;Cohort April 1;Males;Survival in the second trimester;2021QII;""
07 Balears, Illes;All ages;Cohort April 1;Males;Survival in the second trimester;2021QI;""
07 Balears, Illes;All ages;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
07 Balears, Illes;All ages;Cohort April 1;Males;Survival in the second trimester;2020QIII;52.349
07 Balears, Illes;All ages;Cohort April 1;Males;Survival in the second trimester;2020QII;""
07 Balears, Illes;All ages;Cohort April 1;Males;Survival in the second trimester;2020QI;""
07 Balears, Illes;All ages;Cohort April 1;Males;Survival in the third trimester;2022QIV;51.573
07 Balears, Illes;All ages;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
07 Balears, Illes;All ages;Cohort April 1;Males;Survival in the third trimester;2022QII;""
07 Balears, Illes;All ages;Cohort April 1;Males;Survival in the third trimester;2022QI;""
07 Balears, Illes;All ages;Cohort April 1;Males;Survival in the third trimester;2021QIV;50.847
07 Balears, Illes;All ages;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
07 Balears, Illes;All ages;Cohort April 1;Males;Survival in the third trimester;2021QII;""
07 Balears, Illes;All ages;Cohort April 1;Males;Survival in the third trimester;2021QI;""
07 Balears, Illes;All ages;Cohort April 1;Males;Survival in the third trimester;2020QIV;50.201
07 Balears, Illes;All ages;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
07 Balears, Illes;All ages;Cohort April 1;Males;Survival in the third trimester;2020QII;""
07 Balears, Illes;All ages;Cohort April 1;Males;Survival in the third trimester;2020QI;""
07 Balears, Illes;All ages;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
07 Balears, Illes;All ages;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
07 Balears, Illes;All ages;Cohort April 1;Males;Survival in the third trimester;2022QII;""
07 Balears, Illes;All ages;Cohort April 1;Males;Survival in the third trimester;2022QI;49.503
07 Balears, Illes;All ages;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
07 Balears, Illes;All ages;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
07 Balears, Illes;All ages;Cohort April 1;Males;Survival in the third trimester;2021QII;""
07 Balears, Illes;All ages;Cohort April 1;Males;Survival in the third trimester;2021QI;48.930
07 Balears, Illes;All ages;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
07 Balears, Illes;All ages;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
07 Balears, Illes;All ages;Cohort April 1;Males;Survival in the third trimester;2020QII;""
07 Balears, Illes;All ages;Cohort April 1;Males;Survival in the third trimester;2020QI;""
07 Balears, Illes;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
07 Balears, Illes;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
07 Balears, Illes;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
07 Balears, Illes;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
07 Balears, Illes;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
07 Balears, Illes;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
07 Balears, Illes;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
07 Balears, Illes;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
07 Balears, Illes;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
07 Balears, Illes;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
07 Balears, Illes;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
07 Balears, Illes;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
07 Balears, Illes;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
07 Balears, Illes;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
07 Balears, Illes;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;96,5
07 Balears, Illes;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
07 Balears, Illes;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
07 Balears, Illes;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
07 Balears, Illes;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;96,89
07 Balears, Illes;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
07 Balears, Illes;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
07 Balears, Illes;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
07 Balears, Illes;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;97,41
07 Balears, Illes;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
07 Balears, Illes;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
07 Balears, Illes;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;93,63
07 Balears, Illes;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
07 Balears, Illes;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
07 Balears, Illes;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
07 Balears, Illes;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;94,06
07 Balears, Illes;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
07 Balears, Illes;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
07 Balears, Illes;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
07 Balears, Illes;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;92,79
07 Balears, Illes;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
07 Balears, Illes;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
07 Balears, Illes;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;88,96
07 Balears, Illes;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
07 Balears, Illes;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
07 Balears, Illes;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
07 Balears, Illes;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;90,31
07 Balears, Illes;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
07 Balears, Illes;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
07 Balears, Illes;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
07 Balears, Illes;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;88,99
07 Balears, Illes;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
07 Balears, Illes;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
07 Balears, Illes;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
07 Balears, Illes;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
07 Balears, Illes;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
07 Balears, Illes;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
07 Balears, Illes;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;87,92
07 Balears, Illes;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
07 Balears, Illes;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
07 Balears, Illes;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
07 Balears, Illes;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;86,73
07 Balears, Illes;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
07 Balears, Illes;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
07 Balears, Illes;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
07 Balears, Illes;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
07 Balears, Illes;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
07 Balears, Illes;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
07 Balears, Illes;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QII;31.978
07 Balears, Illes;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
07 Balears, Illes;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
07 Balears, Illes;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
07 Balears, Illes;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QII;30.516
07 Balears, Illes;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
07 Balears, Illes;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
07 Balears, Illes;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
07 Balears, Illes;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QII;30.431
07 Balears, Illes;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
07 Balears, Illes;All ages;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
07 Balears, Illes;All ages;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
07 Balears, Illes;All ages;Cohort April 1;Females;Survival in the first trimester;2022QII;30.714
07 Balears, Illes;All ages;Cohort April 1;Females;Survival in the first trimester;2022QI;""
07 Balears, Illes;All ages;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
07 Balears, Illes;All ages;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
07 Balears, Illes;All ages;Cohort April 1;Females;Survival in the first trimester;2021QII;29.430
07 Balears, Illes;All ages;Cohort April 1;Females;Survival in the first trimester;2021QI;""
07 Balears, Illes;All ages;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
07 Balears, Illes;All ages;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
07 Balears, Illes;All ages;Cohort April 1;Females;Survival in the first trimester;2020QII;29.535
07 Balears, Illes;All ages;Cohort April 1;Females;Survival in the first trimester;2020QI;""
07 Balears, Illes;All ages;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
07 Balears, Illes;All ages;Cohort April 1;Females;Survival in the second trimester;2022QIII;29.618
07 Balears, Illes;All ages;Cohort April 1;Females;Survival in the second trimester;2022QII;""
07 Balears, Illes;All ages;Cohort April 1;Females;Survival in the second trimester;2022QI;""
07 Balears, Illes;All ages;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
07 Balears, Illes;All ages;Cohort April 1;Females;Survival in the second trimester;2021QIII;28.476
07 Balears, Illes;All ages;Cohort April 1;Females;Survival in the second trimester;2021QII;""
07 Balears, Illes;All ages;Cohort April 1;Females;Survival in the second trimester;2021QI;""
07 Balears, Illes;All ages;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
07 Balears, Illes;All ages;Cohort April 1;Females;Survival in the second trimester;2020QIII;27.921
07 Balears, Illes;All ages;Cohort April 1;Females;Survival in the second trimester;2020QII;""
07 Balears, Illes;All ages;Cohort April 1;Females;Survival in the second trimester;2020QI;""
07 Balears, Illes;All ages;Cohort April 1;Females;Survival in the third trimester;2022QIV;27.758
07 Balears, Illes;All ages;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
07 Balears, Illes;All ages;Cohort April 1;Females;Survival in the third trimester;2022QII;""
07 Balears, Illes;All ages;Cohort April 1;Females;Survival in the third trimester;2022QI;""
07 Balears, Illes;All ages;Cohort April 1;Females;Survival in the third trimester;2021QIV;27.076
07 Balears, Illes;All ages;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
07 Balears, Illes;All ages;Cohort April 1;Females;Survival in the third trimester;2021QII;""
07 Balears, Illes;All ages;Cohort April 1;Females;Survival in the third trimester;2021QI;""
07 Balears, Illes;All ages;Cohort April 1;Females;Survival in the third trimester;2020QIV;26.632
07 Balears, Illes;All ages;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
07 Balears, Illes;All ages;Cohort April 1;Females;Survival in the third trimester;2020QII;""
07 Balears, Illes;All ages;Cohort April 1;Females;Survival in the third trimester;2020QI;""
07 Balears, Illes;All ages;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
07 Balears, Illes;All ages;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
07 Balears, Illes;All ages;Cohort April 1;Females;Survival in the third trimester;2022QII;""
07 Balears, Illes;All ages;Cohort April 1;Females;Survival in the third trimester;2022QI;26.194
07 Balears, Illes;All ages;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
07 Balears, Illes;All ages;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
07 Balears, Illes;All ages;Cohort April 1;Females;Survival in the third trimester;2021QII;""
07 Balears, Illes;All ages;Cohort April 1;Females;Survival in the third trimester;2021QI;25.928
07 Balears, Illes;All ages;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
07 Balears, Illes;All ages;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
07 Balears, Illes;All ages;Cohort April 1;Females;Survival in the third trimester;2020QII;""
07 Balears, Illes;All ages;Cohort April 1;Females;Survival in the third trimester;2020QI;""
07 Balears, Illes;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
07 Balears, Illes;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
07 Balears, Illes;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
07 Balears, Illes;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
07 Balears, Illes;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
07 Balears, Illes;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
07 Balears, Illes;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
07 Balears, Illes;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
07 Balears, Illes;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
07 Balears, Illes;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
07 Balears, Illes;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
07 Balears, Illes;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
07 Balears, Illes;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
07 Balears, Illes;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
07 Balears, Illes;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;96,05
07 Balears, Illes;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
07 Balears, Illes;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
07 Balears, Illes;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
07 Balears, Illes;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;96,44
07 Balears, Illes;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
07 Balears, Illes;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
07 Balears, Illes;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
07 Balears, Illes;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;97,06
07 Balears, Illes;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
07 Balears, Illes;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
07 Balears, Illes;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;92,62
07 Balears, Illes;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
07 Balears, Illes;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
07 Balears, Illes;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
07 Balears, Illes;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;93,31
07 Balears, Illes;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
07 Balears, Illes;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
07 Balears, Illes;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
07 Balears, Illes;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;91,75
07 Balears, Illes;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
07 Balears, Illes;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
07 Balears, Illes;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;86,8
07 Balears, Illes;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
07 Balears, Illes;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
07 Balears, Illes;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
07 Balears, Illes;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;88,73
07 Balears, Illes;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
07 Balears, Illes;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
07 Balears, Illes;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
07 Balears, Illes;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;87,52
07 Balears, Illes;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
07 Balears, Illes;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
07 Balears, Illes;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
07 Balears, Illes;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
07 Balears, Illes;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
07 Balears, Illes;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
07 Balears, Illes;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;85,84
07 Balears, Illes;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
07 Balears, Illes;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
07 Balears, Illes;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
07 Balears, Illes;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;85,2
07 Balears, Illes;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
07 Balears, Illes;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
07 Balears, Illes;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
07 Balears, Illes;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
07 Balears, Illes;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
07 Balears, Illes;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QIII;95.764
07 Balears, Illes;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
07 Balears, Illes;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
07 Balears, Illes;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
07 Balears, Illes;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QIII;91.877
07 Balears, Illes;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
07 Balears, Illes;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
07 Balears, Illes;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
07 Balears, Illes;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QIII;89.297
07 Balears, Illes;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
07 Balears, Illes;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
07 Balears, Illes;All ages;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
07 Balears, Illes;All ages;Cohort July 1;Total;Survival in the first trimester;2022QIII;91.535
07 Balears, Illes;All ages;Cohort July 1;Total;Survival in the first trimester;2022QII;""
07 Balears, Illes;All ages;Cohort July 1;Total;Survival in the first trimester;2022QI;""
07 Balears, Illes;All ages;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
07 Balears, Illes;All ages;Cohort July 1;Total;Survival in the first trimester;2021QIII;88.159
07 Balears, Illes;All ages;Cohort July 1;Total;Survival in the first trimester;2021QII;""
07 Balears, Illes;All ages;Cohort July 1;Total;Survival in the first trimester;2021QI;""
07 Balears, Illes;All ages;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
07 Balears, Illes;All ages;Cohort July 1;Total;Survival in the first trimester;2020QIII;83.861
07 Balears, Illes;All ages;Cohort July 1;Total;Survival in the first trimester;2020QII;""
07 Balears, Illes;All ages;Cohort July 1;Total;Survival in the first trimester;2020QI;""
07 Balears, Illes;All ages;Cohort July 1;Total;Survival in the second trimester;2022QIV;83.471
07 Balears, Illes;All ages;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
07 Balears, Illes;All ages;Cohort July 1;Total;Survival in the second trimester;2022QII;""
07 Balears, Illes;All ages;Cohort July 1;Total;Survival in the second trimester;2022QI;""
07 Balears, Illes;All ages;Cohort July 1;Total;Survival in the second trimester;2021QIV;81.786
07 Balears, Illes;All ages;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
07 Balears, Illes;All ages;Cohort July 1;Total;Survival in the second trimester;2021QII;""
07 Balears, Illes;All ages;Cohort July 1;Total;Survival in the second trimester;2021QI;""
07 Balears, Illes;All ages;Cohort July 1;Total;Survival in the second trimester;2020QIV;79.384
07 Balears, Illes;All ages;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
07 Balears, Illes;All ages;Cohort July 1;Total;Survival in the second trimester;2020QII;""
07 Balears, Illes;All ages;Cohort July 1;Total;Survival in the second trimester;2020QI;""
07 Balears, Illes;All ages;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
07 Balears, Illes;All ages;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
07 Balears, Illes;All ages;Cohort July 1;Total;Survival in the third trimester;2022QII;""
07 Balears, Illes;All ages;Cohort July 1;Total;Survival in the third trimester;2022QI;79.274
07 Balears, Illes;All ages;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
07 Balears, Illes;All ages;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
07 Balears, Illes;All ages;Cohort July 1;Total;Survival in the third trimester;2021QII;""
07 Balears, Illes;All ages;Cohort July 1;Total;Survival in the third trimester;2021QI;77.226
07 Balears, Illes;All ages;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
07 Balears, Illes;All ages;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
07 Balears, Illes;All ages;Cohort July 1;Total;Survival in the third trimester;2020QII;""
07 Balears, Illes;All ages;Cohort July 1;Total;Survival in the third trimester;2020QI;""
07 Balears, Illes;All ages;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
07 Balears, Illes;All ages;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
07 Balears, Illes;All ages;Cohort July 1;Total;Survival in the third trimester;2022QII;76.930
07 Balears, Illes;All ages;Cohort July 1;Total;Survival in the third trimester;2022QI;""
07 Balears, Illes;All ages;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
07 Balears, Illes;All ages;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
07 Balears, Illes;All ages;Cohort July 1;Total;Survival in the third trimester;2021QII;75.257
07 Balears, Illes;All ages;Cohort July 1;Total;Survival in the third trimester;2021QI;""
07 Balears, Illes;All ages;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
07 Balears, Illes;All ages;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
07 Balears, Illes;All ages;Cohort July 1;Total;Survival in the third trimester;2020QII;""
07 Balears, Illes;All ages;Cohort July 1;Total;Survival in the third trimester;2020QI;""
07 Balears, Illes;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
07 Balears, Illes;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
07 Balears, Illes;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
07 Balears, Illes;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
07 Balears, Illes;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
07 Balears, Illes;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
07 Balears, Illes;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
07 Balears, Illes;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
07 Balears, Illes;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
07 Balears, Illes;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
07 Balears, Illes;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
07 Balears, Illes;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
07 Balears, Illes;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
07 Balears, Illes;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;95,58
07 Balears, Illes;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
07 Balears, Illes;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
07 Balears, Illes;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
07 Balears, Illes;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;95,95
07 Balears, Illes;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
07 Balears, Illes;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
07 Balears, Illes;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
07 Balears, Illes;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;93,91
07 Balears, Illes;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
07 Balears, Illes;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
07 Balears, Illes;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;87,16
07 Balears, Illes;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
07 Balears, Illes;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
07 Balears, Illes;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
07 Balears, Illes;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;89,02
07 Balears, Illes;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
07 Balears, Illes;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
07 Balears, Illes;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
07 Balears, Illes;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;88,9
07 Balears, Illes;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
07 Balears, Illes;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
07 Balears, Illes;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
07 Balears, Illes;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
07 Balears, Illes;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
07 Balears, Illes;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
07 Balears, Illes;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;86,28
07 Balears, Illes;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
07 Balears, Illes;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
07 Balears, Illes;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
07 Balears, Illes;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;86,48
07 Balears, Illes;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
07 Balears, Illes;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
07 Balears, Illes;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
07 Balears, Illes;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
07 Balears, Illes;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
07 Balears, Illes;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
07 Balears, Illes;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;83,73
07 Balears, Illes;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
07 Balears, Illes;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
07 Balears, Illes;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
07 Balears, Illes;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;84,28
07 Balears, Illes;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
07 Balears, Illes;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
07 Balears, Illes;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
07 Balears, Illes;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
07 Balears, Illes;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
07 Balears, Illes;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
07 Balears, Illes;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QIII;61.057
07 Balears, Illes;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
07 Balears, Illes;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
07 Balears, Illes;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
07 Balears, Illes;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QIII;59.083
07 Balears, Illes;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
07 Balears, Illes;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
07 Balears, Illes;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
07 Balears, Illes;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QIII;57.947
07 Balears, Illes;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
07 Balears, Illes;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
07 Balears, Illes;All ages;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
07 Balears, Illes;All ages;Cohort July 1;Males;Survival in the first trimester;2022QIII;58.575
07 Balears, Illes;All ages;Cohort July 1;Males;Survival in the first trimester;2022QII;""
07 Balears, Illes;All ages;Cohort July 1;Males;Survival in the first trimester;2022QI;""
07 Balears, Illes;All ages;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
07 Balears, Illes;All ages;Cohort July 1;Males;Survival in the first trimester;2021QIII;56.818
07 Balears, Illes;All ages;Cohort July 1;Males;Survival in the first trimester;2021QII;""
07 Balears, Illes;All ages;Cohort July 1;Males;Survival in the first trimester;2021QI;""
07 Balears, Illes;All ages;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
07 Balears, Illes;All ages;Cohort July 1;Males;Survival in the first trimester;2020QIII;54.581
07 Balears, Illes;All ages;Cohort July 1;Males;Survival in the first trimester;2020QII;""
07 Balears, Illes;All ages;Cohort July 1;Males;Survival in the first trimester;2020QI;""
07 Balears, Illes;All ages;Cohort July 1;Males;Survival in the second trimester;2022QIV;53.953
07 Balears, Illes;All ages;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
07 Balears, Illes;All ages;Cohort July 1;Males;Survival in the second trimester;2022QII;""
07 Balears, Illes;All ages;Cohort July 1;Males;Survival in the second trimester;2022QI;""
07 Balears, Illes;All ages;Cohort July 1;Males;Survival in the second trimester;2021QIV;53.133
07 Balears, Illes;All ages;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
07 Balears, Illes;All ages;Cohort July 1;Males;Survival in the second trimester;2021QII;""
07 Balears, Illes;All ages;Cohort July 1;Males;Survival in the second trimester;2021QI;""
07 Balears, Illes;All ages;Cohort July 1;Males;Survival in the second trimester;2020QIV;51.825
07 Balears, Illes;All ages;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
07 Balears, Illes;All ages;Cohort July 1;Males;Survival in the second trimester;2020QII;""
07 Balears, Illes;All ages;Cohort July 1;Males;Survival in the second trimester;2020QI;""
07 Balears, Illes;All ages;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
07 Balears, Illes;All ages;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
07 Balears, Illes;All ages;Cohort July 1;Males;Survival in the third trimester;2022QII;""
07 Balears, Illes;All ages;Cohort July 1;Males;Survival in the third trimester;2022QI;51.623
07 Balears, Illes;All ages;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
07 Balears, Illes;All ages;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
07 Balears, Illes;All ages;Cohort July 1;Males;Survival in the third trimester;2021QII;""
07 Balears, Illes;All ages;Cohort July 1;Males;Survival in the third trimester;2021QI;50.432
07 Balears, Illes;All ages;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
07 Balears, Illes;All ages;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
07 Balears, Illes;All ages;Cohort July 1;Males;Survival in the third trimester;2020QII;""
07 Balears, Illes;All ages;Cohort July 1;Males;Survival in the third trimester;2020QI;""
07 Balears, Illes;All ages;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
07 Balears, Illes;All ages;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
07 Balears, Illes;All ages;Cohort July 1;Males;Survival in the third trimester;2022QII;50.193
07 Balears, Illes;All ages;Cohort July 1;Males;Survival in the third trimester;2022QI;""
07 Balears, Illes;All ages;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
07 Balears, Illes;All ages;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
07 Balears, Illes;All ages;Cohort July 1;Males;Survival in the third trimester;2021QII;49.237
07 Balears, Illes;All ages;Cohort July 1;Males;Survival in the third trimester;2021QI;""
07 Balears, Illes;All ages;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
07 Balears, Illes;All ages;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
07 Balears, Illes;All ages;Cohort July 1;Males;Survival in the third trimester;2020QII;""
07 Balears, Illes;All ages;Cohort July 1;Males;Survival in the third trimester;2020QI;""
07 Balears, Illes;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
07 Balears, Illes;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
07 Balears, Illes;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
07 Balears, Illes;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
07 Balears, Illes;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
07 Balears, Illes;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
07 Balears, Illes;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
07 Balears, Illes;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
07 Balears, Illes;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
07 Balears, Illes;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
07 Balears, Illes;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
07 Balears, Illes;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
07 Balears, Illes;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
07 Balears, Illes;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;95,93
07 Balears, Illes;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
07 Balears, Illes;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
07 Balears, Illes;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
07 Balears, Illes;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;96,17
07 Balears, Illes;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
07 Balears, Illes;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
07 Balears, Illes;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
07 Balears, Illes;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;94,19
07 Balears, Illes;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
07 Balears, Illes;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
07 Balears, Illes;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;88,36
07 Balears, Illes;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
07 Balears, Illes;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
07 Balears, Illes;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
07 Balears, Illes;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;89,93
07 Balears, Illes;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
07 Balears, Illes;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
07 Balears, Illes;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
07 Balears, Illes;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;89,44
07 Balears, Illes;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
07 Balears, Illes;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
07 Balears, Illes;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
07 Balears, Illes;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
07 Balears, Illes;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
07 Balears, Illes;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
07 Balears, Illes;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;87,37
07 Balears, Illes;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
07 Balears, Illes;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
07 Balears, Illes;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
07 Balears, Illes;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;87,03
07 Balears, Illes;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
07 Balears, Illes;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
07 Balears, Illes;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
07 Balears, Illes;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
07 Balears, Illes;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
07 Balears, Illes;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
07 Balears, Illes;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;84,95
07 Balears, Illes;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
07 Balears, Illes;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
07 Balears, Illes;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
07 Balears, Illes;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;84,97
07 Balears, Illes;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
07 Balears, Illes;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
07 Balears, Illes;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
07 Balears, Illes;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
07 Balears, Illes;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
07 Balears, Illes;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
07 Balears, Illes;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QIII;34.707
07 Balears, Illes;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
07 Balears, Illes;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
07 Balears, Illes;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
07 Balears, Illes;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QIII;32.794
07 Balears, Illes;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
07 Balears, Illes;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
07 Balears, Illes;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
07 Balears, Illes;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QIII;31.350
07 Balears, Illes;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
07 Balears, Illes;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
07 Balears, Illes;All ages;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
07 Balears, Illes;All ages;Cohort July 1;Females;Survival in the first trimester;2022QIII;32.960
07 Balears, Illes;All ages;Cohort July 1;Females;Survival in the first trimester;2022QII;""
07 Balears, Illes;All ages;Cohort July 1;Females;Survival in the first trimester;2022QI;""
07 Balears, Illes;All ages;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
07 Balears, Illes;All ages;Cohort July 1;Females;Survival in the first trimester;2021QIII;31.341
07 Balears, Illes;All ages;Cohort July 1;Females;Survival in the first trimester;2021QII;""
07 Balears, Illes;All ages;Cohort July 1;Females;Survival in the first trimester;2021QI;""
07 Balears, Illes;All ages;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
07 Balears, Illes;All ages;Cohort July 1;Females;Survival in the first trimester;2020QIII;29.280
07 Balears, Illes;All ages;Cohort July 1;Females;Survival in the first trimester;2020QII;""
07 Balears, Illes;All ages;Cohort July 1;Females;Survival in the first trimester;2020QI;""
07 Balears, Illes;All ages;Cohort July 1;Females;Survival in the second trimester;2022QIV;29.518
07 Balears, Illes;All ages;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
07 Balears, Illes;All ages;Cohort July 1;Females;Survival in the second trimester;2022QII;""
07 Balears, Illes;All ages;Cohort July 1;Females;Survival in the second trimester;2022QI;""
07 Balears, Illes;All ages;Cohort July 1;Females;Survival in the second trimester;2021QIV;28.653
07 Balears, Illes;All ages;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
07 Balears, Illes;All ages;Cohort July 1;Females;Survival in the second trimester;2021QII;""
07 Balears, Illes;All ages;Cohort July 1;Females;Survival in the second trimester;2021QI;""
07 Balears, Illes;All ages;Cohort July 1;Females;Survival in the second trimester;2020QIV;27.559
07 Balears, Illes;All ages;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
07 Balears, Illes;All ages;Cohort July 1;Females;Survival in the second trimester;2020QII;""
07 Balears, Illes;All ages;Cohort July 1;Females;Survival in the second trimester;2020QI;""
07 Balears, Illes;All ages;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
07 Balears, Illes;All ages;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
07 Balears, Illes;All ages;Cohort July 1;Females;Survival in the third trimester;2022QII;""
07 Balears, Illes;All ages;Cohort July 1;Females;Survival in the third trimester;2022QI;27.651
07 Balears, Illes;All ages;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
07 Balears, Illes;All ages;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
07 Balears, Illes;All ages;Cohort July 1;Females;Survival in the third trimester;2021QII;""
07 Balears, Illes;All ages;Cohort July 1;Females;Survival in the third trimester;2021QI;26.794
07 Balears, Illes;All ages;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
07 Balears, Illes;All ages;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
07 Balears, Illes;All ages;Cohort July 1;Females;Survival in the third trimester;2020QII;""
07 Balears, Illes;All ages;Cohort July 1;Females;Survival in the third trimester;2020QI;""
07 Balears, Illes;All ages;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
07 Balears, Illes;All ages;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
07 Balears, Illes;All ages;Cohort July 1;Females;Survival in the third trimester;2022QII;26.737
07 Balears, Illes;All ages;Cohort July 1;Females;Survival in the third trimester;2022QI;""
07 Balears, Illes;All ages;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
07 Balears, Illes;All ages;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
07 Balears, Illes;All ages;Cohort July 1;Females;Survival in the third trimester;2021QII;26.020
07 Balears, Illes;All ages;Cohort July 1;Females;Survival in the third trimester;2021QI;""
07 Balears, Illes;All ages;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
07 Balears, Illes;All ages;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
07 Balears, Illes;All ages;Cohort July 1;Females;Survival in the third trimester;2020QII;""
07 Balears, Illes;All ages;Cohort July 1;Females;Survival in the third trimester;2020QI;""
07 Balears, Illes;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
07 Balears, Illes;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
07 Balears, Illes;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
07 Balears, Illes;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
07 Balears, Illes;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
07 Balears, Illes;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
07 Balears, Illes;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
07 Balears, Illes;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
07 Balears, Illes;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
07 Balears, Illes;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
07 Balears, Illes;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
07 Balears, Illes;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
07 Balears, Illes;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
07 Balears, Illes;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;94,97
07 Balears, Illes;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
07 Balears, Illes;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
07 Balears, Illes;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
07 Balears, Illes;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;95,57
07 Balears, Illes;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
07 Balears, Illes;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
07 Balears, Illes;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
07 Balears, Illes;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;93,4
07 Balears, Illes;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
07 Balears, Illes;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
07 Balears, Illes;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;85,05
07 Balears, Illes;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
07 Balears, Illes;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
07 Balears, Illes;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
07 Balears, Illes;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;87,37
07 Balears, Illes;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
07 Balears, Illes;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
07 Balears, Illes;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
07 Balears, Illes;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;87,91
07 Balears, Illes;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
07 Balears, Illes;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
07 Balears, Illes;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
07 Balears, Illes;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
07 Balears, Illes;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
07 Balears, Illes;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
07 Balears, Illes;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;84,32
07 Balears, Illes;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
07 Balears, Illes;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
07 Balears, Illes;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
07 Balears, Illes;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;85,47
07 Balears, Illes;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
07 Balears, Illes;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
07 Balears, Illes;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
07 Balears, Illes;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
07 Balears, Illes;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
07 Balears, Illes;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
07 Balears, Illes;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;81,53
07 Balears, Illes;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
07 Balears, Illes;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
07 Balears, Illes;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
07 Balears, Illes;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;83
07 Balears, Illes;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
07 Balears, Illes;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
07 Balears, Illes;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
07 Balears, Illes;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
07 Balears, Illes;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
07 Balears, Illes;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QIV;94.892
07 Balears, Illes;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
07 Balears, Illes;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
07 Balears, Illes;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
07 Balears, Illes;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QIV;92.127
07 Balears, Illes;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
07 Balears, Illes;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
07 Balears, Illes;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
07 Balears, Illes;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QIV;88.207
07 Balears, Illes;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
07 Balears, Illes;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
07 Balears, Illes;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
07 Balears, Illes;All ages;Cohort October 1;Total;Survival in the first trimester;2022QIV;86.289
07 Balears, Illes;All ages;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
07 Balears, Illes;All ages;Cohort October 1;Total;Survival in the first trimester;2022QII;""
07 Balears, Illes;All ages;Cohort October 1;Total;Survival in the first trimester;2022QI;""
07 Balears, Illes;All ages;Cohort October 1;Total;Survival in the first trimester;2021QIV;84.757
07 Balears, Illes;All ages;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
07 Balears, Illes;All ages;Cohort October 1;Total;Survival in the first trimester;2021QII;""
07 Balears, Illes;All ages;Cohort October 1;Total;Survival in the first trimester;2021QI;""
07 Balears, Illes;All ages;Cohort October 1;Total;Survival in the first trimester;2020QIV;82.548
07 Balears, Illes;All ages;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
07 Balears, Illes;All ages;Cohort October 1;Total;Survival in the first trimester;2020QII;""
07 Balears, Illes;All ages;Cohort October 1;Total;Survival in the first trimester;2020QI;""
07 Balears, Illes;All ages;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
07 Balears, Illes;All ages;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
07 Balears, Illes;All ages;Cohort October 1;Total;Survival in the second trimester;2022QII;""
07 Balears, Illes;All ages;Cohort October 1;Total;Survival in the second trimester;2022QI;82.006
07 Balears, Illes;All ages;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
07 Balears, Illes;All ages;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
07 Balears, Illes;All ages;Cohort October 1;Total;Survival in the second trimester;2021QII;""
07 Balears, Illes;All ages;Cohort October 1;Total;Survival in the second trimester;2021QI;80.122
07 Balears, Illes;All ages;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
07 Balears, Illes;All ages;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
07 Balears, Illes;All ages;Cohort October 1;Total;Survival in the second trimester;2020QII;""
07 Balears, Illes;All ages;Cohort October 1;Total;Survival in the second trimester;2020QI;""
07 Balears, Illes;All ages;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
07 Balears, Illes;All ages;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
07 Balears, Illes;All ages;Cohort October 1;Total;Survival in the third trimester;2022QII;79.415
07 Balears, Illes;All ages;Cohort October 1;Total;Survival in the third trimester;2022QI;""
07 Balears, Illes;All ages;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
07 Balears, Illes;All ages;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
07 Balears, Illes;All ages;Cohort October 1;Total;Survival in the third trimester;2021QII;77.936
07 Balears, Illes;All ages;Cohort October 1;Total;Survival in the third trimester;2021QI;""
07 Balears, Illes;All ages;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
07 Balears, Illes;All ages;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
07 Balears, Illes;All ages;Cohort October 1;Total;Survival in the third trimester;2020QII;""
07 Balears, Illes;All ages;Cohort October 1;Total;Survival in the third trimester;2020QI;""
07 Balears, Illes;All ages;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
07 Balears, Illes;All ages;Cohort October 1;Total;Survival in the third trimester;2022QIII;77.182
07 Balears, Illes;All ages;Cohort October 1;Total;Survival in the third trimester;2022QII;""
07 Balears, Illes;All ages;Cohort October 1;Total;Survival in the third trimester;2022QI;""
07 Balears, Illes;All ages;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
07 Balears, Illes;All ages;Cohort October 1;Total;Survival in the third trimester;2021QIII;75.840
07 Balears, Illes;All ages;Cohort October 1;Total;Survival in the third trimester;2021QII;""
07 Balears, Illes;All ages;Cohort October 1;Total;Survival in the third trimester;2021QI;""
07 Balears, Illes;All ages;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
07 Balears, Illes;All ages;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
07 Balears, Illes;All ages;Cohort October 1;Total;Survival in the third trimester;2020QII;""
07 Balears, Illes;All ages;Cohort October 1;Total;Survival in the third trimester;2020QI;""
07 Balears, Illes;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
07 Balears, Illes;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
07 Balears, Illes;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
07 Balears, Illes;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
07 Balears, Illes;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
07 Balears, Illes;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
07 Balears, Illes;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
07 Balears, Illes;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
07 Balears, Illes;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
07 Balears, Illes;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
07 Balears, Illes;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
07 Balears, Illes;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
07 Balears, Illes;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;90,93
07 Balears, Illes;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
07 Balears, Illes;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
07 Balears, Illes;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
07 Balears, Illes;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;92
07 Balears, Illes;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
07 Balears, Illes;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
07 Balears, Illes;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
07 Balears, Illes;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;93,58
07 Balears, Illes;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
07 Balears, Illes;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
07 Balears, Illes;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
07 Balears, Illes;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
07 Balears, Illes;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
07 Balears, Illes;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
07 Balears, Illes;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;89,01
07 Balears, Illes;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
07 Balears, Illes;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
07 Balears, Illes;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
07 Balears, Illes;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;90,83
07 Balears, Illes;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
07 Balears, Illes;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
07 Balears, Illes;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
07 Balears, Illes;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
07 Balears, Illes;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
07 Balears, Illes;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
07 Balears, Illes;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;86,2
07 Balears, Illes;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
07 Balears, Illes;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
07 Balears, Illes;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
07 Balears, Illes;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;88,36
07 Balears, Illes;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
07 Balears, Illes;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
07 Balears, Illes;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
07 Balears, Illes;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
07 Balears, Illes;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
07 Balears, Illes;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
07 Balears, Illes;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;83,78
07 Balears, Illes;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
07 Balears, Illes;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
07 Balears, Illes;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
07 Balears, Illes;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;85,98
07 Balears, Illes;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
07 Balears, Illes;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
07 Balears, Illes;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
07 Balears, Illes;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
07 Balears, Illes;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
07 Balears, Illes;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
07 Balears, Illes;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QIV;60.503
07 Balears, Illes;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
07 Balears, Illes;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
07 Balears, Illes;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
07 Balears, Illes;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QIV;59.096
07 Balears, Illes;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
07 Balears, Illes;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
07 Balears, Illes;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
07 Balears, Illes;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QIV;57.090
07 Balears, Illes;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
07 Balears, Illes;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
07 Balears, Illes;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
07 Balears, Illes;All ages;Cohort October 1;Males;Survival in the first trimester;2022QIV;55.588
07 Balears, Illes;All ages;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
07 Balears, Illes;All ages;Cohort October 1;Males;Survival in the first trimester;2022QII;""
07 Balears, Illes;All ages;Cohort October 1;Males;Survival in the first trimester;2022QI;""
07 Balears, Illes;All ages;Cohort October 1;Males;Survival in the first trimester;2021QIV;54.855
07 Balears, Illes;All ages;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
07 Balears, Illes;All ages;Cohort October 1;Males;Survival in the first trimester;2021QII;""
07 Balears, Illes;All ages;Cohort October 1;Males;Survival in the first trimester;2021QI;""
07 Balears, Illes;All ages;Cohort October 1;Males;Survival in the first trimester;2020QIV;53.713
07 Balears, Illes;All ages;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
07 Balears, Illes;All ages;Cohort October 1;Males;Survival in the first trimester;2020QII;""
07 Balears, Illes;All ages;Cohort October 1;Males;Survival in the first trimester;2020QI;""
07 Balears, Illes;All ages;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
07 Balears, Illes;All ages;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
07 Balears, Illes;All ages;Cohort October 1;Males;Survival in the second trimester;2022QII;""
07 Balears, Illes;All ages;Cohort October 1;Males;Survival in the second trimester;2022QI;53.195
07 Balears, Illes;All ages;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
07 Balears, Illes;All ages;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
07 Balears, Illes;All ages;Cohort October 1;Males;Survival in the second trimester;2021QII;""
07 Balears, Illes;All ages;Cohort October 1;Males;Survival in the second trimester;2021QI;52.156
07 Balears, Illes;All ages;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
07 Balears, Illes;All ages;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
07 Balears, Illes;All ages;Cohort October 1;Males;Survival in the second trimester;2020QII;""
07 Balears, Illes;All ages;Cohort October 1;Males;Survival in the second trimester;2020QI;""
07 Balears, Illes;All ages;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
07 Balears, Illes;All ages;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
07 Balears, Illes;All ages;Cohort October 1;Males;Survival in the third trimester;2022QII;51.630
07 Balears, Illes;All ages;Cohort October 1;Males;Survival in the third trimester;2022QI;""
07 Balears, Illes;All ages;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
07 Balears, Illes;All ages;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
07 Balears, Illes;All ages;Cohort October 1;Males;Survival in the third trimester;2021QII;50.838
07 Balears, Illes;All ages;Cohort October 1;Males;Survival in the third trimester;2021QI;""
07 Balears, Illes;All ages;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
07 Balears, Illes;All ages;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
07 Balears, Illes;All ages;Cohort October 1;Males;Survival in the third trimester;2020QII;""
07 Balears, Illes;All ages;Cohort October 1;Males;Survival in the third trimester;2020QI;""
07 Balears, Illes;All ages;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
07 Balears, Illes;All ages;Cohort October 1;Males;Survival in the third trimester;2022QIII;50.280
07 Balears, Illes;All ages;Cohort October 1;Males;Survival in the third trimester;2022QII;""
07 Balears, Illes;All ages;Cohort October 1;Males;Survival in the third trimester;2022QI;""
07 Balears, Illes;All ages;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
07 Balears, Illes;All ages;Cohort October 1;Males;Survival in the third trimester;2021QIII;49.543
07 Balears, Illes;All ages;Cohort October 1;Males;Survival in the third trimester;2021QII;""
07 Balears, Illes;All ages;Cohort October 1;Males;Survival in the third trimester;2021QI;""
07 Balears, Illes;All ages;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
07 Balears, Illes;All ages;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
07 Balears, Illes;All ages;Cohort October 1;Males;Survival in the third trimester;2020QII;""
07 Balears, Illes;All ages;Cohort October 1;Males;Survival in the third trimester;2020QI;""
07 Balears, Illes;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
07 Balears, Illes;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
07 Balears, Illes;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
07 Balears, Illes;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
07 Balears, Illes;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
07 Balears, Illes;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
07 Balears, Illes;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
07 Balears, Illes;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
07 Balears, Illes;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
07 Balears, Illes;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
07 Balears, Illes;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
07 Balears, Illes;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
07 Balears, Illes;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;91,88
07 Balears, Illes;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
07 Balears, Illes;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
07 Balears, Illes;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
07 Balears, Illes;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;92,82
07 Balears, Illes;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
07 Balears, Illes;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
07 Balears, Illes;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
07 Balears, Illes;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;94,08
07 Balears, Illes;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
07 Balears, Illes;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
07 Balears, Illes;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
07 Balears, Illes;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
07 Balears, Illes;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
07 Balears, Illes;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
07 Balears, Illes;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;90,01
07 Balears, Illes;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
07 Balears, Illes;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
07 Balears, Illes;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
07 Balears, Illes;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;91,36
07 Balears, Illes;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
07 Balears, Illes;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
07 Balears, Illes;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
07 Balears, Illes;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
07 Balears, Illes;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
07 Balears, Illes;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
07 Balears, Illes;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;87,37
07 Balears, Illes;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
07 Balears, Illes;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
07 Balears, Illes;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
07 Balears, Illes;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;89,05
07 Balears, Illes;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
07 Balears, Illes;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
07 Balears, Illes;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
07 Balears, Illes;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
07 Balears, Illes;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
07 Balears, Illes;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
07 Balears, Illes;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;85,08
07 Balears, Illes;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
07 Balears, Illes;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
07 Balears, Illes;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
07 Balears, Illes;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;86,78
07 Balears, Illes;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
07 Balears, Illes;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
07 Balears, Illes;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
07 Balears, Illes;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
07 Balears, Illes;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
07 Balears, Illes;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
07 Balears, Illes;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QIV;34.389
07 Balears, Illes;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
07 Balears, Illes;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
07 Balears, Illes;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
07 Balears, Illes;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QIV;33.031
07 Balears, Illes;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
07 Balears, Illes;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
07 Balears, Illes;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
07 Balears, Illes;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QIV;31.117
07 Balears, Illes;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
07 Balears, Illes;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
07 Balears, Illes;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
07 Balears, Illes;All ages;Cohort October 1;Females;Survival in the first trimester;2022QIV;30.701
07 Balears, Illes;All ages;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
07 Balears, Illes;All ages;Cohort October 1;Females;Survival in the first trimester;2022QII;""
07 Balears, Illes;All ages;Cohort October 1;Females;Survival in the first trimester;2022QI;""
07 Balears, Illes;All ages;Cohort October 1;Females;Survival in the first trimester;2021QIV;29.902
07 Balears, Illes;All ages;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
07 Balears, Illes;All ages;Cohort October 1;Females;Survival in the first trimester;2021QII;""
07 Balears, Illes;All ages;Cohort October 1;Females;Survival in the first trimester;2021QI;""
07 Balears, Illes;All ages;Cohort October 1;Females;Survival in the first trimester;2020QIV;28.835
07 Balears, Illes;All ages;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
07 Balears, Illes;All ages;Cohort October 1;Females;Survival in the first trimester;2020QII;""
07 Balears, Illes;All ages;Cohort October 1;Females;Survival in the first trimester;2020QI;""
07 Balears, Illes;All ages;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
07 Balears, Illes;All ages;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
07 Balears, Illes;All ages;Cohort October 1;Females;Survival in the second trimester;2022QII;""
07 Balears, Illes;All ages;Cohort October 1;Females;Survival in the second trimester;2022QI;28.811
07 Balears, Illes;All ages;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
07 Balears, Illes;All ages;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
07 Balears, Illes;All ages;Cohort October 1;Females;Survival in the second trimester;2021QII;""
07 Balears, Illes;All ages;Cohort October 1;Females;Survival in the second trimester;2021QI;27.966
07 Balears, Illes;All ages;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
07 Balears, Illes;All ages;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
07 Balears, Illes;All ages;Cohort October 1;Females;Survival in the second trimester;2020QII;""
07 Balears, Illes;All ages;Cohort October 1;Females;Survival in the second trimester;2020QI;""
07 Balears, Illes;All ages;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
07 Balears, Illes;All ages;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
07 Balears, Illes;All ages;Cohort October 1;Females;Survival in the third trimester;2022QII;27.785
07 Balears, Illes;All ages;Cohort October 1;Females;Survival in the third trimester;2022QI;""
07 Balears, Illes;All ages;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
07 Balears, Illes;All ages;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
07 Balears, Illes;All ages;Cohort October 1;Females;Survival in the third trimester;2021QII;27.098
07 Balears, Illes;All ages;Cohort October 1;Females;Survival in the third trimester;2021QI;""
07 Balears, Illes;All ages;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
07 Balears, Illes;All ages;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
07 Balears, Illes;All ages;Cohort October 1;Females;Survival in the third trimester;2020QII;""
07 Balears, Illes;All ages;Cohort October 1;Females;Survival in the third trimester;2020QI;""
07 Balears, Illes;All ages;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
07 Balears, Illes;All ages;Cohort October 1;Females;Survival in the third trimester;2022QIII;26.902
07 Balears, Illes;All ages;Cohort October 1;Females;Survival in the third trimester;2022QII;""
07 Balears, Illes;All ages;Cohort October 1;Females;Survival in the third trimester;2022QI;""
07 Balears, Illes;All ages;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
07 Balears, Illes;All ages;Cohort October 1;Females;Survival in the third trimester;2021QIII;26.297
07 Balears, Illes;All ages;Cohort October 1;Females;Survival in the third trimester;2021QII;""
07 Balears, Illes;All ages;Cohort October 1;Females;Survival in the third trimester;2021QI;""
07 Balears, Illes;All ages;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
07 Balears, Illes;All ages;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
07 Balears, Illes;All ages;Cohort October 1;Females;Survival in the third trimester;2020QII;""
07 Balears, Illes;All ages;Cohort October 1;Females;Survival in the third trimester;2020QI;""
07 Balears, Illes;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
07 Balears, Illes;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
07 Balears, Illes;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
07 Balears, Illes;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
07 Balears, Illes;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
07 Balears, Illes;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
07 Balears, Illes;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
07 Balears, Illes;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
07 Balears, Illes;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
07 Balears, Illes;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
07 Balears, Illes;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
07 Balears, Illes;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
07 Balears, Illes;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;89,28
07 Balears, Illes;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
07 Balears, Illes;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
07 Balears, Illes;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
07 Balears, Illes;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;90,53
07 Balears, Illes;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
07 Balears, Illes;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
07 Balears, Illes;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
07 Balears, Illes;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;92,67
07 Balears, Illes;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
07 Balears, Illes;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
07 Balears, Illes;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
07 Balears, Illes;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
07 Balears, Illes;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
07 Balears, Illes;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
07 Balears, Illes;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;87,22
07 Balears, Illes;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
07 Balears, Illes;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
07 Balears, Illes;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
07 Balears, Illes;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;89,87
07 Balears, Illes;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
07 Balears, Illes;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
07 Balears, Illes;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
07 Balears, Illes;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
07 Balears, Illes;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
07 Balears, Illes;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
07 Balears, Illes;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;84,12
07 Balears, Illes;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
07 Balears, Illes;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
07 Balears, Illes;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
07 Balears, Illes;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;87,08
07 Balears, Illes;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
07 Balears, Illes;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
07 Balears, Illes;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
07 Balears, Illes;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
07 Balears, Illes;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
07 Balears, Illes;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
07 Balears, Illes;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;81,44
07 Balears, Illes;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
07 Balears, Illes;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
07 Balears, Illes;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
07 Balears, Illes;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;84,51
07 Balears, Illes;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
07 Balears, Illes;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
07 Balears, Illes;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
07 Balears, Illes;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
07 Balears, Illes;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
07 Balears, Illes;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QI;5.564
07 Balears, Illes;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QI;5.200
07 Balears, Illes;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QI;4.308
07 Balears, Illes;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2022QII;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2022QI;5.132
07 Balears, Illes;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2021QII;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2021QI;4.862
07 Balears, Illes;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2020QII;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2020QI;3.690
07 Balears, Illes;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2022QII;4.737
07 Balears, Illes;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2022QI;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2021QII;4.517
07 Balears, Illes;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2021QI;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2020QII;3.539
07 Balears, Illes;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2020QI;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QIII;4.444
07 Balears, Illes;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QII;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QI;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QIII;4.218
07 Balears, Illes;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QII;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QI;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QIII;3.291
07 Balears, Illes;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QII;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QI;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QIV;4.133
07 Balears, Illes;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QII;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QI;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QIV;3.940
07 Balears, Illes;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QII;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QI;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QIV;3.094
07 Balears, Illes;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QII;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QI;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
07 Balears, Illes;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
07 Balears, Illes;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
07 Balears, Illes;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;92,24
07 Balears, Illes;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;93,5
07 Balears, Illes;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;85,65
07 Balears, Illes;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;85,14
07 Balears, Illes;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;86,87
07 Balears, Illes;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;82,15
07 Balears, Illes;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;79,87
07 Balears, Illes;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;81,12
07 Balears, Illes;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;76,39
07 Balears, Illes;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;74,28
07 Balears, Illes;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;75,77
07 Balears, Illes;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;71,82
07 Balears, Illes;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QI;3.597
07 Balears, Illes;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QI;3.355
07 Balears, Illes;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QI;2.797
07 Balears, Illes;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2022QII;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2022QI;3.326
07 Balears, Illes;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2021QII;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2021QI;3.152
07 Balears, Illes;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2020QII;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2020QI;2.403
07 Balears, Illes;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2022QII;3.070
07 Balears, Illes;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2022QI;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2021QII;2.944
07 Balears, Illes;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2021QI;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2020QII;2.314
07 Balears, Illes;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2020QI;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QIII;2.889
07 Balears, Illes;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QII;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QI;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QIII;2.759
07 Balears, Illes;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QII;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QI;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QIII;2.154
07 Balears, Illes;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QII;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QI;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QIV;2.698
07 Balears, Illes;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QII;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QI;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QIV;2.609
07 Balears, Illes;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QII;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QI;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QIV;2.036
07 Balears, Illes;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QII;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QI;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
07 Balears, Illes;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
07 Balears, Illes;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
07 Balears, Illes;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;92,47
07 Balears, Illes;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;93,95
07 Balears, Illes;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;85,91
07 Balears, Illes;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;85,35
07 Balears, Illes;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;87,75
07 Balears, Illes;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;82,73
07 Balears, Illes;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;80,32
07 Balears, Illes;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;82,24
07 Balears, Illes;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;77,01
07 Balears, Illes;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;75,01
07 Balears, Illes;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;77,76
07 Balears, Illes;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;72,79
07 Balears, Illes;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QI;1.967
07 Balears, Illes;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QI;1.845
07 Balears, Illes;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QI;1.511
07 Balears, Illes;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2022QII;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2022QI;1.806
07 Balears, Illes;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2021QII;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2021QI;1.710
07 Balears, Illes;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2020QII;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2020QI;1.287
07 Balears, Illes;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2022QII;1.667
07 Balears, Illes;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2022QI;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2021QII;1.573
07 Balears, Illes;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2021QI;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2020QII;1.225
07 Balears, Illes;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2020QI;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QIII;1.555
07 Balears, Illes;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QII;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QI;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QIII;1.459
07 Balears, Illes;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QII;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QI;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QIII;1.137
07 Balears, Illes;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QII;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QI;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QIV;1.435
07 Balears, Illes;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QII;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QI;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QIV;1.331
07 Balears, Illes;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QII;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QI;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QIV;1.058
07 Balears, Illes;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QII;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QI;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
07 Balears, Illes;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
07 Balears, Illes;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
07 Balears, Illes;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;91,81
07 Balears, Illes;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;92,68
07 Balears, Illes;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;85,18
07 Balears, Illes;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;84,75
07 Balears, Illes;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;85,26
07 Balears, Illes;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;81,07
07 Balears, Illes;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;79,05
07 Balears, Illes;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;79,08
07 Balears, Illes;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;75,25
07 Balears, Illes;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;72,95
07 Balears, Illes;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;72,14
07 Balears, Illes;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;70,02
07 Balears, Illes;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QII;5.021
07 Balears, Illes;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QII;4.744
07 Balears, Illes;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QII;4.376
07 Balears, Illes;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2022QII;4.579
07 Balears, Illes;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2022QI;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2021QII;4.352
07 Balears, Illes;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2021QI;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2020QII;4.175
07 Balears, Illes;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2020QI;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2022QIII;4.261
07 Balears, Illes;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2022QII;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2022QI;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2021QIII;4.010
07 Balears, Illes;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2021QII;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2021QI;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2020QIII;3.870
07 Balears, Illes;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2020QII;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2020QI;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QIV;3.878
07 Balears, Illes;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QII;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QI;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QIV;3.693
07 Balears, Illes;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QII;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QI;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QIV;3.597
07 Balears, Illes;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QII;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QI;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QII;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QI;3.464
07 Balears, Illes;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QII;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QI;3.404
07 Balears, Illes;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QII;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QI;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
07 Balears, Illes;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
07 Balears, Illes;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
07 Balears, Illes;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;91,2
07 Balears, Illes;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;91,74
07 Balears, Illes;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;95,41
07 Balears, Illes;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;84,86
07 Balears, Illes;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;84,53
07 Balears, Illes;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;88,44
07 Balears, Illes;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;77,24
07 Balears, Illes;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;77,85
07 Balears, Illes;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;82,2
07 Balears, Illes;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;73,02
07 Balears, Illes;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;77,79
07 Balears, Illes;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QII;3.236
07 Balears, Illes;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QII;3.092
07 Balears, Illes;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QII;2.845
07 Balears, Illes;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2022QII;2.949
07 Balears, Illes;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2022QI;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2021QII;2.852
07 Balears, Illes;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2021QI;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2020QII;2.716
07 Balears, Illes;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2020QI;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2022QIII;2.759
07 Balears, Illes;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2022QII;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2022QI;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2021QIII;2.623
07 Balears, Illes;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2021QII;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2021QI;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2020QIII;2.512
07 Balears, Illes;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2020QII;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2020QI;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QIV;2.518
07 Balears, Illes;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QII;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QI;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QIV;2.441
07 Balears, Illes;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QII;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QI;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QIV;2.350
07 Balears, Illes;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QII;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QI;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QII;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QI;2.294
07 Balears, Illes;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QII;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QI;2.236
07 Balears, Illes;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QII;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QI;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
07 Balears, Illes;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
07 Balears, Illes;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
07 Balears, Illes;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;91,13
07 Balears, Illes;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;92,24
07 Balears, Illes;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;95,47
07 Balears, Illes;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;85,26
07 Balears, Illes;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;84,83
07 Balears, Illes;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;88,3
07 Balears, Illes;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;77,81
07 Balears, Illes;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;78,95
07 Balears, Illes;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;82,6
07 Balears, Illes;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;74,19
07 Balears, Illes;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;78,59
07 Balears, Illes;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QII;1.785
07 Balears, Illes;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QII;1.652
07 Balears, Illes;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QII;1.531
07 Balears, Illes;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2022QII;1.630
07 Balears, Illes;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2022QI;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2021QII;1.500
07 Balears, Illes;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2021QI;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2020QII;1.459
07 Balears, Illes;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2020QI;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2022QIII;1.502
07 Balears, Illes;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2022QII;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2022QI;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2021QIII;1.387
07 Balears, Illes;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2021QII;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2021QI;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2020QIII;1.358
07 Balears, Illes;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2020QII;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2020QI;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QIV;1.360
07 Balears, Illes;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QII;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QI;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QIV;1.252
07 Balears, Illes;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QII;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QI;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QIV;1.247
07 Balears, Illes;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QII;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QI;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QII;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QI;1.170
07 Balears, Illes;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QII;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QI;1.168
07 Balears, Illes;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QII;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QI;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
07 Balears, Illes;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
07 Balears, Illes;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
07 Balears, Illes;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;91,32
07 Balears, Illes;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;90,8
07 Balears, Illes;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;95,3
07 Balears, Illes;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;84,15
07 Balears, Illes;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;83,96
07 Balears, Illes;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;88,7
07 Balears, Illes;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;76,19
07 Balears, Illes;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;75,79
07 Balears, Illes;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;81,45
07 Balears, Illes;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;70,82
07 Balears, Illes;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;76,29
07 Balears, Illes;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QIII;5.820
07 Balears, Illes;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QIII;5.391
07 Balears, Illes;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QIII;4.817
07 Balears, Illes;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2022QIII;5.237
07 Balears, Illes;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2022QII;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2022QI;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2021QIII;4.811
07 Balears, Illes;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2021QII;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2021QI;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2020QIII;4.339
07 Balears, Illes;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2020QII;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2020QI;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2022QIV;4.590
07 Balears, Illes;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2022QII;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2022QI;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2021QIV;4.282
07 Balears, Illes;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2021QII;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2021QI;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2020QIV;3.976
07 Balears, Illes;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2020QII;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2020QI;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QII;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QI;4.000
07 Balears, Illes;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QII;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QI;3.753
07 Balears, Illes;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QII;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QI;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QII;3.720
07 Balears, Illes;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QI;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QII;3.534
07 Balears, Illes;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QI;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QII;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QI;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
07 Balears, Illes;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
07 Balears, Illes;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
07 Balears, Illes;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;89,98
07 Balears, Illes;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;89,24
07 Balears, Illes;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;90,08
07 Balears, Illes;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;78,87
07 Balears, Illes;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;79,43
07 Balears, Illes;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;82,54
07 Balears, Illes;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;74,2
07 Balears, Illes;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;77,91
07 Balears, Illes;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;69
07 Balears, Illes;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;73,37
07 Balears, Illes;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QIII;3.670
07 Balears, Illes;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QIII;3.486
07 Balears, Illes;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QIII;3.143
07 Balears, Illes;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2022QIII;3.328
07 Balears, Illes;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2022QII;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2022QI;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2021QIII;3.127
07 Balears, Illes;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2021QII;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2021QI;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2020QIII;2.823
07 Balears, Illes;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2020QII;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2020QI;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2022QIV;2.925
07 Balears, Illes;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2022QII;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2022QI;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2021QIV;2.817
07 Balears, Illes;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2021QII;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2021QI;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2020QIV;2.606
07 Balears, Illes;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2020QII;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2020QI;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QII;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QI;2.643
07 Balears, Illes;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QII;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QI;2.471
07 Balears, Illes;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QII;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QI;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QII;2.459
07 Balears, Illes;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QI;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QII;2.329
07 Balears, Illes;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QI;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QII;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QI;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
07 Balears, Illes;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
07 Balears, Illes;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
07 Balears, Illes;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;90,68
07 Balears, Illes;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;89,7
07 Balears, Illes;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;89,82
07 Balears, Illes;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;79,7
07 Balears, Illes;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;80,81
07 Balears, Illes;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;82,91
07 Balears, Illes;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;75,82
07 Balears, Illes;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;78,62
07 Balears, Illes;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;70,54
07 Balears, Illes;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;74,1
07 Balears, Illes;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QIII;2.150
07 Balears, Illes;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QIII;1.905
07 Balears, Illes;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QIII;1.674
07 Balears, Illes;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2022QIII;1.909
07 Balears, Illes;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2022QII;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2022QI;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2021QIII;1.684
07 Balears, Illes;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2021QII;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2021QI;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2020QIII;1.516
07 Balears, Illes;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2020QII;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2020QI;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2022QIV;1.665
07 Balears, Illes;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2022QII;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2022QI;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2021QIV;1.465
07 Balears, Illes;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2021QII;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2021QI;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2020QIV;1.370
07 Balears, Illes;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2020QII;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2020QI;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QII;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QI;1.357
07 Balears, Illes;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QII;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QI;1.282
07 Balears, Illes;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QII;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QI;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QII;1.261
07 Balears, Illes;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QI;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QII;1.205
07 Balears, Illes;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QI;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QII;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QI;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
07 Balears, Illes;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
07 Balears, Illes;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
07 Balears, Illes;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;88,79
07 Balears, Illes;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;88,4
07 Balears, Illes;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;90,56
07 Balears, Illes;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;77,44
07 Balears, Illes;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;76,9
07 Balears, Illes;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;81,84
07 Balears, Illes;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;71,23
07 Balears, Illes;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;76,58
07 Balears, Illes;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;66,19
07 Balears, Illes;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;71,98
07 Balears, Illes;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QIV;5.924
07 Balears, Illes;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QIV;5.543
07 Balears, Illes;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QIV;5.097
07 Balears, Illes;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2022QIV;5.157
07 Balears, Illes;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2022QII;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2022QI;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2021QIV;4.881
07 Balears, Illes;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2021QII;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2021QI;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2020QIV;4.591
07 Balears, Illes;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2020QII;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2020QI;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2022QII;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2022QI;4.545
07 Balears, Illes;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2021QII;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2021QI;4.313
07 Balears, Illes;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2020QII;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2020QI;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QII;4.203
07 Balears, Illes;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QI;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QII;4.032
07 Balears, Illes;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QI;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QII;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QI;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QIII;3.964
07 Balears, Illes;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QII;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QI;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QIII;3.774
07 Balears, Illes;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QII;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QI;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QII;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QI;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
07 Balears, Illes;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
07 Balears, Illes;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
07 Balears, Illes;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;87,05
07 Balears, Illes;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;88,06
07 Balears, Illes;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;90,07
07 Balears, Illes;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;82
07 Balears, Illes;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;84,62
07 Balears, Illes;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;75,83
07 Balears, Illes;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;79,11
07 Balears, Illes;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;71,51
07 Balears, Illes;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;74,04
07 Balears, Illes;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QIV;3.740
07 Balears, Illes;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QIV;3.556
07 Balears, Illes;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QIV;3.277
07 Balears, Illes;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2022QIV;3.269
07 Balears, Illes;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2022QII;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2022QI;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2021QIV;3.174
07 Balears, Illes;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2021QII;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2021QI;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2020QIV;2.980
07 Balears, Illes;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2020QII;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2020QI;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2022QII;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2022QI;2.964
07 Balears, Illes;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2021QII;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2021QI;2.814
07 Balears, Illes;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2020QII;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2020QI;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QII;2.745
07 Balears, Illes;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QI;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QII;2.642
07 Balears, Illes;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QI;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QII;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QI;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QIII;2.595
07 Balears, Illes;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QII;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QI;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QIII;2.483
07 Balears, Illes;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QII;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QI;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QII;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QI;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
07 Balears, Illes;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
07 Balears, Illes;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
07 Balears, Illes;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;87,41
07 Balears, Illes;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;89,26
07 Balears, Illes;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;90,94
07 Balears, Illes;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;83,35
07 Balears, Illes;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;85,87
07 Balears, Illes;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;77,19
07 Balears, Illes;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;80,62
07 Balears, Illes;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;72,98
07 Balears, Illes;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;75,77
07 Balears, Illes;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QIV;2.184
07 Balears, Illes;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QIV;1.987
07 Balears, Illes;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QIV;1.820
07 Balears, Illes;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2022QIV;1.888
07 Balears, Illes;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2022QII;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2022QI;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2021QIV;1.707
07 Balears, Illes;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2021QII;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2021QI;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2020QIV;1.611
07 Balears, Illes;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2020QII;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2020QI;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2022QII;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2022QI;1.581
07 Balears, Illes;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2021QII;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2021QI;1.499
07 Balears, Illes;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2020QII;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2020QI;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QII;1.458
07 Balears, Illes;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QI;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QII;1.390
07 Balears, Illes;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QI;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QII;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QI;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QIII;1.369
07 Balears, Illes;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QII;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QI;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QIII;1.291
07 Balears, Illes;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QII;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QI;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QII;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QI;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
07 Balears, Illes;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
07 Balears, Illes;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
07 Balears, Illes;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;86,45
07 Balears, Illes;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;85,91
07 Balears, Illes;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;88,52
07 Balears, Illes;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;79,57
07 Balears, Illes;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;82,36
07 Balears, Illes;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;73,38
07 Balears, Illes;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;76,37
07 Balears, Illes;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;68,9
07 Balears, Illes;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;70,93
07 Balears, Illes;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QI;16.659
07 Balears, Illes;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QI;16.551
07 Balears, Illes;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QI;16.405
07 Balears, Illes;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2022QII;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2022QI;15.930
07 Balears, Illes;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2021QII;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2021QI;15.910
07 Balears, Illes;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2020QII;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2020QI;14.823
07 Balears, Illes;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2022QII;15.269
07 Balears, Illes;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2022QI;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2021QII;15.345
07 Balears, Illes;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2021QI;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2020QII;14.345
07 Balears, Illes;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2020QI;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QIII;14.705
07 Balears, Illes;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QII;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QI;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QIII;14.833
07 Balears, Illes;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QII;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QI;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QIII;13.675
07 Balears, Illes;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QII;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QI;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QIV;13.920
07 Balears, Illes;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QII;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QI;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QIV;14.135
07 Balears, Illes;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QII;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QI;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QIV;13.081
07 Balears, Illes;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QII;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QI;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
07 Balears, Illes;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
07 Balears, Illes;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
07 Balears, Illes;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;95,62
07 Balears, Illes;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;96,13
07 Balears, Illes;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;90,36
07 Balears, Illes;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;91,66
07 Balears, Illes;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;92,71
07 Balears, Illes;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;87,44
07 Balears, Illes;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;88,27
07 Balears, Illes;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;89,62
07 Balears, Illes;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;83,36
07 Balears, Illes;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;83,56
07 Balears, Illes;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;85,4
07 Balears, Illes;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;79,74
07 Balears, Illes;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QI;10.374
07 Balears, Illes;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QI;10.393
07 Balears, Illes;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QI;10.242
07 Balears, Illes;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2022QII;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2022QI;9.945
07 Balears, Illes;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2021QII;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2021QI;9.998
07 Balears, Illes;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2020QII;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2020QI;9.369
07 Balears, Illes;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2022QII;9.562
07 Balears, Illes;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2022QI;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2021QII;9.672
07 Balears, Illes;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2021QI;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2020QII;9.105
07 Balears, Illes;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2020QI;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QIII;9.242
07 Balears, Illes;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QII;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QI;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QIII;9.391
07 Balears, Illes;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QII;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QI;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QIII;8.737
07 Balears, Illes;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QII;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QI;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QIV;8.808
07 Balears, Illes;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QII;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QI;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QIV;8.976
07 Balears, Illes;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QII;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QI;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QIV;8.370
07 Balears, Illes;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QII;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QI;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
07 Balears, Illes;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
07 Balears, Illes;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
07 Balears, Illes;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;95,86
07 Balears, Illes;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;96,2
07 Balears, Illes;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;91,48
07 Balears, Illes;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;92,17
07 Balears, Illes;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;93,06
07 Balears, Illes;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;88,9
07 Balears, Illes;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;89,09
07 Balears, Illes;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;90,36
07 Balears, Illes;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;85,31
07 Balears, Illes;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;84,9
07 Balears, Illes;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;86,37
07 Balears, Illes;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;81,72
07 Balears, Illes;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QI;6.285
07 Balears, Illes;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QI;6.158
07 Balears, Illes;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QI;6.163
07 Balears, Illes;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2022QII;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2022QI;5.985
07 Balears, Illes;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2021QII;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2021QI;5.912
07 Balears, Illes;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2020QII;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2020QI;5.454
07 Balears, Illes;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2022QII;5.707
07 Balears, Illes;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2022QI;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2021QII;5.673
07 Balears, Illes;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2021QI;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2020QII;5.240
07 Balears, Illes;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2020QI;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QIII;5.463
07 Balears, Illes;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QII;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QI;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QIII;5.442
07 Balears, Illes;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QII;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QI;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QIII;4.938
07 Balears, Illes;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QII;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QI;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QIV;5.112
07 Balears, Illes;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QII;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QI;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QIV;5.159
07 Balears, Illes;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QII;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QI;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QIV;4.711
07 Balears, Illes;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QII;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QI;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
07 Balears, Illes;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
07 Balears, Illes;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
07 Balears, Illes;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;95,23
07 Balears, Illes;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;96,01
07 Balears, Illes;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;88,5
07 Balears, Illes;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;90,8
07 Balears, Illes;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;92,12
07 Balears, Illes;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;85,02
07 Balears, Illes;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;86,92
07 Balears, Illes;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;88,37
07 Balears, Illes;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;80,12
07 Balears, Illes;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;81,34
07 Balears, Illes;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;83,78
07 Balears, Illes;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;76,44
07 Balears, Illes;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QII;15.998
07 Balears, Illes;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QII;15.647
07 Balears, Illes;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QII;16.177
07 Balears, Illes;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2022QII;15.272
07 Balears, Illes;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2022QI;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2021QII;15.014
07 Balears, Illes;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2021QI;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2020QII;15.614
07 Balears, Illes;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2020QI;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2022QIII;14.659
07 Balears, Illes;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2022QII;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2022QI;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2021QIII;14.460
07 Balears, Illes;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2021QII;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2021QI;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2020QIII;14.784
07 Balears, Illes;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2020QII;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2020QI;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QIV;13.691
07 Balears, Illes;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QII;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QI;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QIV;13.665
07 Balears, Illes;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QII;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QI;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QIV;14.069
07 Balears, Illes;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QII;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QI;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QII;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QI;13.161
07 Balears, Illes;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QII;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QI;13.630
07 Balears, Illes;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QII;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QI;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
07 Balears, Illes;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
07 Balears, Illes;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
07 Balears, Illes;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;95,46
07 Balears, Illes;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;95,95
07 Balears, Illes;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;96,52
07 Balears, Illes;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;91,63
07 Balears, Illes;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;92,41
07 Balears, Illes;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;91,39
07 Balears, Illes;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;85,58
07 Balears, Illes;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;87,33
07 Balears, Illes;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;86,97
07 Balears, Illes;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;84,11
07 Balears, Illes;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;84,26
07 Balears, Illes;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QII;9.912
07 Balears, Illes;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QII;9.779
07 Balears, Illes;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QII;10.148
07 Balears, Illes;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2022QII;9.477
07 Balears, Illes;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2022QI;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2021QII;9.404
07 Balears, Illes;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2021QI;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2020QII;9.831
07 Balears, Illes;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2020QI;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2022QIII;9.125
07 Balears, Illes;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2022QII;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2022QI;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2021QIII;9.102
07 Balears, Illes;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2021QII;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2021QI;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2020QIII;9.363
07 Balears, Illes;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2020QII;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2020QI;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QIV;8.587
07 Balears, Illes;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QII;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QI;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QIV;8.644
07 Balears, Illes;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QII;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QI;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QIV;8.931
07 Balears, Illes;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QII;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QI;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QII;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QI;8.351
07 Balears, Illes;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QII;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QI;8.657
07 Balears, Illes;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QII;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QI;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
07 Balears, Illes;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
07 Balears, Illes;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
07 Balears, Illes;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;95,61
07 Balears, Illes;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;96,17
07 Balears, Illes;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;96,88
07 Balears, Illes;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;92,06
07 Balears, Illes;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;93,08
07 Balears, Illes;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;92,26
07 Balears, Illes;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;86,63
07 Balears, Illes;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;88,39
07 Balears, Illes;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;88,01
07 Balears, Illes;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;85,4
07 Balears, Illes;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;85,31
07 Balears, Illes;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QII;6.086
07 Balears, Illes;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QII;5.868
07 Balears, Illes;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QII;6.029
07 Balears, Illes;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2022QII;5.795
07 Balears, Illes;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2022QI;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2021QII;5.610
07 Balears, Illes;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2021QI;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2020QII;5.783
07 Balears, Illes;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2020QI;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2022QIII;5.534
07 Balears, Illes;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2022QII;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2022QI;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2021QIII;5.358
07 Balears, Illes;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2021QII;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2021QI;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2020QIII;5.421
07 Balears, Illes;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2020QII;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2020QI;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QIV;5.104
07 Balears, Illes;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QII;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QI;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QIV;5.021
07 Balears, Illes;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QII;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QI;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QIV;5.138
07 Balears, Illes;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QII;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QI;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QII;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QI;4.810
07 Balears, Illes;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QII;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QI;4.973
07 Balears, Illes;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QII;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QI;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
07 Balears, Illes;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
07 Balears, Illes;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
07 Balears, Illes;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;95,22
07 Balears, Illes;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;95,6
07 Balears, Illes;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;95,92
07 Balears, Illes;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;90,93
07 Balears, Illes;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;91,31
07 Balears, Illes;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;89,92
07 Balears, Illes;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;83,86
07 Balears, Illes;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;85,57
07 Balears, Illes;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;85,22
07 Balears, Illes;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;81,97
07 Balears, Illes;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;82,48
07 Balears, Illes;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QIII;17.413
07 Balears, Illes;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QIII;16.897
07 Balears, Illes;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QIII;16.697
07 Balears, Illes;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2022QIII;16.493
07 Balears, Illes;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2022QII;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2022QI;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2021QIII;16.105
07 Balears, Illes;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2021QII;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2021QI;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2020QIII;15.631
07 Balears, Illes;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2020QII;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2020QI;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2022QIV;14.882
07 Balears, Illes;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2022QII;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2022QI;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2021QIV;14.798
07 Balears, Illes;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2021QII;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2021QI;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2020QIV;14.730
07 Balears, Illes;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2020QII;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2020QI;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QII;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QI;14.213
07 Balears, Illes;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QII;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QI;14.241
07 Balears, Illes;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QII;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QI;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QII;13.677
07 Balears, Illes;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QI;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QII;13.811
07 Balears, Illes;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QI;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QII;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QI;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
07 Balears, Illes;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
07 Balears, Illes;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
07 Balears, Illes;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;94,72
07 Balears, Illes;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;95,31
07 Balears, Illes;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;93,62
07 Balears, Illes;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;85,46
07 Balears, Illes;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;87,58
07 Balears, Illes;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;88,22
07 Balears, Illes;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;84,12
07 Balears, Illes;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;85,29
07 Balears, Illes;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;80,94
07 Balears, Illes;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;82,72
07 Balears, Illes;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QIII;10.666
07 Balears, Illes;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QIII;10.482
07 Balears, Illes;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QIII;10.499
07 Balears, Illes;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2022QIII;10.153
07 Balears, Illes;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2022QII;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2022QI;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2021QIII;10.041
07 Balears, Illes;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2021QII;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2021QI;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2020QIII;9.884
07 Balears, Illes;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2020QII;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2020QI;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2022QIV;9.264
07 Balears, Illes;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2022QII;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2022QI;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2021QIV;9.300
07 Balears, Illes;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2021QII;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2021QI;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2020QIV;9.339
07 Balears, Illes;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2020QII;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2020QI;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QII;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QI;8.958
07 Balears, Illes;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QII;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QI;9.028
07 Balears, Illes;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QII;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QI;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QII;8.645
07 Balears, Illes;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QI;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QII;8.786
07 Balears, Illes;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QI;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QII;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QI;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
07 Balears, Illes;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
07 Balears, Illes;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
07 Balears, Illes;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;95,19
07 Balears, Illes;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;95,79
07 Balears, Illes;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;94,14
07 Balears, Illes;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;86,86
07 Balears, Illes;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;88,72
07 Balears, Illes;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;88,95
07 Balears, Illes;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;85,46
07 Balears, Illes;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;85,99
07 Balears, Illes;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;82,47
07 Balears, Illes;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;83,68
07 Balears, Illes;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QIII;6.747
07 Balears, Illes;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QIII;6.415
07 Balears, Illes;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QIII;6.198
07 Balears, Illes;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2022QIII;6.340
07 Balears, Illes;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2022QII;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2022QI;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2021QIII;6.064
07 Balears, Illes;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2021QII;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2021QI;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2020QIII;5.747
07 Balears, Illes;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2020QII;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2020QI;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2022QIV;5.618
07 Balears, Illes;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2022QII;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2022QI;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2021QIV;5.498
07 Balears, Illes;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2021QII;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2021QI;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2020QIV;5.391
07 Balears, Illes;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2020QII;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2020QI;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QII;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QI;5.255
07 Balears, Illes;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QII;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QI;5.213
07 Balears, Illes;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QII;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QI;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QII;5.032
07 Balears, Illes;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QI;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QII;5.025
07 Balears, Illes;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QI;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QII;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QI;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
07 Balears, Illes;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
07 Balears, Illes;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
07 Balears, Illes;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;93,97
07 Balears, Illes;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;94,53
07 Balears, Illes;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;92,72
07 Balears, Illes;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;83,27
07 Balears, Illes;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;85,71
07 Balears, Illes;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;86,98
07 Balears, Illes;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;81,92
07 Balears, Illes;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;84,11
07 Balears, Illes;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;78,44
07 Balears, Illes;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;81,07
07 Balears, Illes;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QIV;17.441
07 Balears, Illes;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QIV;17.220
07 Balears, Illes;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QIV;16.788
07 Balears, Illes;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2022QIV;15.707
07 Balears, Illes;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2022QII;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2022QI;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2021QIV;15.693
07 Balears, Illes;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2021QII;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2021QI;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2020QIV;15.644
07 Balears, Illes;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2020QII;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2020QI;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2022QII;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2022QI;15.051
07 Balears, Illes;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2021QII;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2021QI;15.096
07 Balears, Illes;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2020QII;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2020QI;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QII;14.462
07 Balears, Illes;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QI;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QII;14.602
07 Balears, Illes;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QI;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QII;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QI;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QIII;13.957
07 Balears, Illes;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QII;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QI;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QIII;14.147
07 Balears, Illes;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QII;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QI;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QII;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QI;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
07 Balears, Illes;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
07 Balears, Illes;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
07 Balears, Illes;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;90,06
07 Balears, Illes;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;91,13
07 Balears, Illes;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;93,19
07 Balears, Illes;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;87,4
07 Balears, Illes;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;89,92
07 Balears, Illes;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;83,98
07 Balears, Illes;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;86,98
07 Balears, Illes;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;81,05
07 Balears, Illes;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;84,27
07 Balears, Illes;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QIV;10.654
07 Balears, Illes;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QIV;10.652
07 Balears, Illes;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QIV;10.559
07 Balears, Illes;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2022QIV;9.709
07 Balears, Illes;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2022QII;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2022QI;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2021QIV;9.798
07 Balears, Illes;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2021QII;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2021QI;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2020QIV;9.879
07 Balears, Illes;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2020QII;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2020QI;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2022QII;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2022QI;9.421
07 Balears, Illes;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2021QII;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2021QI;9.534
07 Balears, Illes;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2020QII;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2020QI;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QII;9.081
07 Balears, Illes;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QI;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QII;9.254
07 Balears, Illes;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QI;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QII;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QI;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QIII;8.794
07 Balears, Illes;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QII;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QI;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QIII;9.006
07 Balears, Illes;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QII;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QI;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QII;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QI;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
07 Balears, Illes;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
07 Balears, Illes;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
07 Balears, Illes;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;91,13
07 Balears, Illes;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;91,98
07 Balears, Illes;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;93,56
07 Balears, Illes;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;88,44
07 Balears, Illes;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;90,29
07 Balears, Illes;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;85,25
07 Balears, Illes;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;87,64
07 Balears, Illes;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;82,56
07 Balears, Illes;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;85,29
07 Balears, Illes;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QIV;6.787
07 Balears, Illes;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QIV;6.568
07 Balears, Illes;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QIV;6.229
07 Balears, Illes;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2022QIV;5.998
07 Balears, Illes;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2022QII;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2022QI;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2021QIV;5.895
07 Balears, Illes;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2021QII;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2021QI;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2020QIV;5.765
07 Balears, Illes;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2020QII;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2020QI;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2022QII;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2022QI;5.630
07 Balears, Illes;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2021QII;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2021QI;5.562
07 Balears, Illes;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2020QII;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2020QI;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QII;5.381
07 Balears, Illes;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QI;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QII;5.348
07 Balears, Illes;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QI;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QII;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QI;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QIII;5.163
07 Balears, Illes;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QII;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QI;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QIII;5.141
07 Balears, Illes;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QII;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QI;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QII;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QI;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
07 Balears, Illes;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
07 Balears, Illes;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
07 Balears, Illes;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;88,37
07 Balears, Illes;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;89,75
07 Balears, Illes;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;92,55
07 Balears, Illes;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;85,72
07 Balears, Illes;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;89,29
07 Balears, Illes;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;81,93
07 Balears, Illes;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;85,86
07 Balears, Illes;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;78,61
07 Balears, Illes;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;82,53
07 Balears, Illes;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QI;28.269
07 Balears, Illes;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QI;28.031
07 Balears, Illes;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QI;28.812
07 Balears, Illes;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2022QII;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2022QI;27.394
07 Balears, Illes;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2021QII;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2021QI;27.239
07 Balears, Illes;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2020QII;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2020QI;26.677
07 Balears, Illes;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2022QII;26.567
07 Balears, Illes;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2022QI;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2021QII;26.562
07 Balears, Illes;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2021QI;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2020QII;26.109
07 Balears, Illes;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2020QI;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QIII;25.884
07 Balears, Illes;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QII;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QI;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QIII;25.907
07 Balears, Illes;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QII;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QI;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QIII;25.094
07 Balears, Illes;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QII;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QI;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QIV;24.921
07 Balears, Illes;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QII;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QI;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QIV;25.041
07 Balears, Illes;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QII;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QI;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QIV;24.264
07 Balears, Illes;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QII;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QI;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
07 Balears, Illes;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
07 Balears, Illes;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
07 Balears, Illes;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;96,9
07 Balears, Illes;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;97,17
07 Balears, Illes;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;92,59
07 Balears, Illes;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;93,98
07 Balears, Illes;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;94,76
07 Balears, Illes;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;90,62
07 Balears, Illes;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;91,56
07 Balears, Illes;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;92,42
07 Balears, Illes;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;87,1
07 Balears, Illes;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;88,16
07 Balears, Illes;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;89,33
07 Balears, Illes;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;84,21
07 Balears, Illes;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QI;18.467
07 Balears, Illes;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QI;18.420
07 Balears, Illes;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QI;18.874
07 Balears, Illes;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2022QII;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2022QI;17.950
07 Balears, Illes;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2021QII;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2021QI;17.910
07 Balears, Illes;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2020QII;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2020QI;17.615
07 Balears, Illes;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2022QII;17.436
07 Balears, Illes;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2022QI;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2021QII;17.491
07 Balears, Illes;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2021QI;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2020QII;17.262
07 Balears, Illes;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2020QI;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QIII;17.002
07 Balears, Illes;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QII;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QI;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QIII;17.076
07 Balears, Illes;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QII;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QI;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QIII;16.644
07 Balears, Illes;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QII;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QI;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QIV;16.435
07 Balears, Illes;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QII;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QI;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QIV;16.555
07 Balears, Illes;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QII;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QI;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QIV;16.118
07 Balears, Illes;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QII;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QI;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
07 Balears, Illes;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
07 Balears, Illes;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
07 Balears, Illes;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;97,2
07 Balears, Illes;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;97,23
07 Balears, Illes;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;93,33
07 Balears, Illes;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;94,42
07 Balears, Illes;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;94,96
07 Balears, Illes;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;91,46
07 Balears, Illes;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;92,07
07 Balears, Illes;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;92,7
07 Balears, Illes;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;88,18
07 Balears, Illes;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;89
07 Balears, Illes;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;89,88
07 Balears, Illes;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;85,4
07 Balears, Illes;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QI;9.802
07 Balears, Illes;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QI;9.611
07 Balears, Illes;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QI;9.938
07 Balears, Illes;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2022QII;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2022QI;9.444
07 Balears, Illes;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2021QII;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2021QI;9.329
07 Balears, Illes;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2020QII;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2020QI;9.062
07 Balears, Illes;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2022QII;9.131
07 Balears, Illes;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2022QI;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2021QII;9.071
07 Balears, Illes;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2021QI;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2020QII;8.847
07 Balears, Illes;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2020QI;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QIII;8.882
07 Balears, Illes;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QII;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QI;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QIII;8.831
07 Balears, Illes;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QII;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QI;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QIII;8.450
07 Balears, Illes;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QII;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QI;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QIV;8.486
07 Balears, Illes;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QII;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QI;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QIV;8.486
07 Balears, Illes;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QII;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QI;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QIV;8.146
07 Balears, Illes;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QII;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QI;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
07 Balears, Illes;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
07 Balears, Illes;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
07 Balears, Illes;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;96,35
07 Balears, Illes;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;97,07
07 Balears, Illes;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;91,19
07 Balears, Illes;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;93,15
07 Balears, Illes;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;94,38
07 Balears, Illes;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;89,02
07 Balears, Illes;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;90,61
07 Balears, Illes;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;91,88
07 Balears, Illes;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;85,03
07 Balears, Illes;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;86,57
07 Balears, Illes;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;88,29
07 Balears, Illes;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;81,97
07 Balears, Illes;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QII;28.359
07 Balears, Illes;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QII;27.752
07 Balears, Illes;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QII;28.234
07 Balears, Illes;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2022QII;27.404
07 Balears, Illes;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2022QI;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2021QII;26.975
07 Balears, Illes;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2021QI;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2020QII;27.577
07 Balears, Illes;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2020QI;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2022QIII;26.623
07 Balears, Illes;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2022QII;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2022QI;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2021QIII;26.237
07 Balears, Illes;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2021QII;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2021QI;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2020QIII;26.362
07 Balears, Illes;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2020QII;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2020QI;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QIV;25.274
07 Balears, Illes;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QII;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QI;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QIV;25.190
07 Balears, Illes;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QII;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QI;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QIV;25.342
07 Balears, Illes;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QII;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QI;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QII;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QI;24.574
07 Balears, Illes;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QII;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QI;24.784
07 Balears, Illes;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QII;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QI;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
07 Balears, Illes;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
07 Balears, Illes;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
07 Balears, Illes;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;96,63
07 Balears, Illes;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;97,2
07 Balears, Illes;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;97,67
07 Balears, Illes;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;93,88
07 Balears, Illes;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;94,54
07 Balears, Illes;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;93,37
07 Balears, Illes;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;89,12
07 Balears, Illes;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;90,77
07 Balears, Illes;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;89,76
07 Balears, Illes;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;88,55
07 Balears, Illes;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;87,78
07 Balears, Illes;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QII;18.458
07 Balears, Illes;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QII;18.211
07 Balears, Illes;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QII;18.599
07 Balears, Illes;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2022QII;17.859
07 Balears, Illes;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2022QI;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2021QII;17.726
07 Balears, Illes;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2021QI;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2020QII;18.186
07 Balears, Illes;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2020QI;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2022QIII;17.379
07 Balears, Illes;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2022QII;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2022QI;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2021QIII;17.250
07 Balears, Illes;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2021QII;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2021QI;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2020QIII;17.440
07 Balears, Illes;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2020QII;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2020QI;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QIV;16.598
07 Balears, Illes;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QII;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QI;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QIV;16.615
07 Balears, Illes;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QII;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QI;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QIV;16.806
07 Balears, Illes;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QII;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QI;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QII;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QI;16.254
07 Balears, Illes;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QII;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QI;16.442
07 Balears, Illes;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QII;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QI;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
07 Balears, Illes;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
07 Balears, Illes;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
07 Balears, Illes;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;96,75
07 Balears, Illes;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;97,34
07 Balears, Illes;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;97,78
07 Balears, Illes;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;94,15
07 Balears, Illes;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;94,72
07 Balears, Illes;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;93,77
07 Balears, Illes;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;89,92
07 Balears, Illes;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;91,24
07 Balears, Illes;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;90,36
07 Balears, Illes;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;89,25
07 Balears, Illes;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;88,4
07 Balears, Illes;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QII;9.901
07 Balears, Illes;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QII;9.541
07 Balears, Illes;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QII;9.635
07 Balears, Illes;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2022QII;9.545
07 Balears, Illes;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2022QI;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2021QII;9.249
07 Balears, Illes;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2021QI;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2020QII;9.391
07 Balears, Illes;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2020QI;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2022QIII;9.244
07 Balears, Illes;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2022QII;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2022QI;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2021QIII;8.987
07 Balears, Illes;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2021QII;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2021QI;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2020QIII;8.922
07 Balears, Illes;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2020QII;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2020QI;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QIV;8.676
07 Balears, Illes;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QII;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QI;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QIV;8.575
07 Balears, Illes;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QII;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QI;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QIV;8.536
07 Balears, Illes;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QII;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QI;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QII;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QI;8.320
07 Balears, Illes;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QII;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QI;8.342
07 Balears, Illes;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QII;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QI;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
07 Balears, Illes;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
07 Balears, Illes;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
07 Balears, Illes;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;96,4
07 Balears, Illes;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;96,94
07 Balears, Illes;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;97,47
07 Balears, Illes;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;93,36
07 Balears, Illes;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;94,19
07 Balears, Illes;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;92,6
07 Balears, Illes;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;87,63
07 Balears, Illes;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;89,88
07 Balears, Illes;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;88,59
07 Balears, Illes;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;87,2
07 Balears, Illes;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;86,58
07 Balears, Illes;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QIII;30.158
07 Balears, Illes;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QIII;29.404
07 Balears, Illes;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QIII;29.090
07 Balears, Illes;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2022QIII;28.977
07 Balears, Illes;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2022QII;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2022QI;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2021QIII;28.334
07 Balears, Illes;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2021QII;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2021QI;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2020QIII;27.518
07 Balears, Illes;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2020QII;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2020QI;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2022QIV;26.547
07 Balears, Illes;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2022QII;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2022QI;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2021QIV;26.394
07 Balears, Illes;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2021QII;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2021QI;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2020QIV;26.182
07 Balears, Illes;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2020QII;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2020QI;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QII;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QI;25.690
07 Balears, Illes;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QII;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QI;25.570
07 Balears, Illes;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QII;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QI;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QII;25.017
07 Balears, Illes;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QI;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QII;25.014
07 Balears, Illes;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QI;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QII;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QI;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
07 Balears, Illes;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
07 Balears, Illes;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
07 Balears, Illes;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;96,08
07 Balears, Illes;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;96,36
07 Balears, Illes;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;94,6
07 Balears, Illes;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;88,03
07 Balears, Illes;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;89,76
07 Balears, Illes;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;90
07 Balears, Illes;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;87,37
07 Balears, Illes;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;87,9
07 Balears, Illes;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;85,08
07 Balears, Illes;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;85,99
07 Balears, Illes;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QIII;19.407
07 Balears, Illes;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QIII;19.119
07 Balears, Illes;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QIII;19.129
07 Balears, Illes;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2022QIII;18.707
07 Balears, Illes;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2022QII;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2022QI;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2021QIII;18.441
07 Balears, Illes;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2021QII;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2021QI;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2020QIII;18.159
07 Balears, Illes;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2020QII;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2020QI;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2022QIV;17.333
07 Balears, Illes;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2022QII;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2022QI;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2021QIV;17.326
07 Balears, Illes;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2021QII;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2021QI;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2020QIV;17.337
07 Balears, Illes;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2020QII;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2020QI;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QII;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QI;16.913
07 Balears, Illes;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QII;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QI;16.938
07 Balears, Illes;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QII;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QI;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QII;16.489
07 Balears, Illes;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QI;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QII;16.598
07 Balears, Illes;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QI;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QII;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QI;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
07 Balears, Illes;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
07 Balears, Illes;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
07 Balears, Illes;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;96,39
07 Balears, Illes;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;96,45
07 Balears, Illes;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;94,93
07 Balears, Illes;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;89,31
07 Balears, Illes;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;90,62
07 Balears, Illes;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;90,63
07 Balears, Illes;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;88,46
07 Balears, Illes;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;88,55
07 Balears, Illes;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;86,24
07 Balears, Illes;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;86,77
07 Balears, Illes;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QIII;10.751
07 Balears, Illes;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QIII;10.285
07 Balears, Illes;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QIII;9.961
07 Balears, Illes;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2022QIII;10.270
07 Balears, Illes;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2022QII;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2022QI;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2021QIII;9.893
07 Balears, Illes;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2021QII;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2021QI;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2020QIII;9.359
07 Balears, Illes;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2020QII;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2020QI;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2022QIV;9.214
07 Balears, Illes;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2022QII;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2022QI;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2021QIV;9.068
07 Balears, Illes;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2021QII;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2021QI;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2020QIV;8.845
07 Balears, Illes;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2020QII;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2020QI;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QII;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QI;8.777
07 Balears, Illes;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QII;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QI;8.632
07 Balears, Illes;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QII;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QI;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QII;8.528
07 Balears, Illes;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QI;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QII;8.416
07 Balears, Illes;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QI;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QII;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QI;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
07 Balears, Illes;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
07 Balears, Illes;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
07 Balears, Illes;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;95,53
07 Balears, Illes;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;96,19
07 Balears, Illes;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;93,96
07 Balears, Illes;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;85,7
07 Balears, Illes;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;88,17
07 Balears, Illes;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;88,8
07 Balears, Illes;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;85,34
07 Balears, Illes;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;86,66
07 Balears, Illes;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;82,92
07 Balears, Illes;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;84,49
07 Balears, Illes;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QIV;29.993
07 Balears, Illes;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QIV;29.493
07 Balears, Illes;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QIV;28.768
07 Balears, Illes;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2022QIV;27.404
07 Balears, Illes;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2022QII;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2022QI;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2021QIV;27.257
07 Balears, Illes;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2021QII;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2021QI;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2020QIV;27.077
07 Balears, Illes;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2020QII;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2020QI;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2022QII;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2022QI;26.482
07 Balears, Illes;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2021QII;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2021QI;26.384
07 Balears, Illes;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2020QII;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2020QI;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QII;25.743
07 Balears, Illes;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QI;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QII;25.780
07 Balears, Illes;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QI;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QII;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QI;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QIII;25.124
07 Balears, Illes;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QII;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QI;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QIII;25.186
07 Balears, Illes;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QII;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QI;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QII;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QI;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
07 Balears, Illes;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
07 Balears, Illes;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
07 Balears, Illes;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;91,37
07 Balears, Illes;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;92,42
07 Balears, Illes;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;94,12
07 Balears, Illes;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;89,79
07 Balears, Illes;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;91,71
07 Balears, Illes;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;87,29
07 Balears, Illes;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;89,61
07 Balears, Illes;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;85,19
07 Balears, Illes;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;87,55
07 Balears, Illes;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QIV;19.305
07 Balears, Illes;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QIV;19.135
07 Balears, Illes;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QIV;18.860
07 Balears, Illes;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2022QIV;17.840
07 Balears, Illes;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2022QII;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2022QI;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2021QIV;17.842
07 Balears, Illes;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2021QII;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2021QI;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2020QIV;17.855
07 Balears, Illes;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2020QII;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2020QI;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2022QII;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2022QI;17.388
07 Balears, Illes;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2021QII;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2021QI;17.404
07 Balears, Illes;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2020QII;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2020QI;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QII;16.925
07 Balears, Illes;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QI;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QII;17.037
07 Balears, Illes;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QI;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QII;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QI;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QIII;16.532
07 Balears, Illes;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QII;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QI;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QIII;16.663
07 Balears, Illes;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QII;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QI;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QII;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QI;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
07 Balears, Illes;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
07 Balears, Illes;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
07 Balears, Illes;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;92,41
07 Balears, Illes;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;93,24
07 Balears, Illes;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;94,67
07 Balears, Illes;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;90,87
07 Balears, Illes;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;92,28
07 Balears, Illes;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;88,45
07 Balears, Illes;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;90,33
07 Balears, Illes;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;86,4
07 Balears, Illes;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;88,35
07 Balears, Illes;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QIV;10.688
07 Balears, Illes;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QIV;10.358
07 Balears, Illes;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QIV;9.908
07 Balears, Illes;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2022QIV;9.564
07 Balears, Illes;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2022QII;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2022QI;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2021QIV;9.415
07 Balears, Illes;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2021QII;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2021QI;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2020QIV;9.222
07 Balears, Illes;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2020QII;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2020QI;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2022QII;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2022QI;9.094
07 Balears, Illes;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2021QII;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2021QI;8.980
07 Balears, Illes;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2020QII;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2020QI;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QII;8.818
07 Balears, Illes;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QI;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QII;8.743
07 Balears, Illes;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QI;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QII;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QI;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QIII;8.592
07 Balears, Illes;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QII;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QI;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QIII;8.523
07 Balears, Illes;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QII;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QI;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QII;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QI;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
07 Balears, Illes;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
07 Balears, Illes;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
07 Balears, Illes;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;89,48
07 Balears, Illes;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;90,9
07 Balears, Illes;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;93,08
07 Balears, Illes;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;87,8
07 Balears, Illes;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;90,63
07 Balears, Illes;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;85,13
07 Balears, Illes;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;88,24
07 Balears, Illes;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;82,95
07 Balears, Illes;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;86,02
07 Balears, Illes;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QI;25.111
07 Balears, Illes;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QI;24.023
07 Balears, Illes;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QI;25.095
07 Balears, Illes;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2022QII;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2022QI;24.501
07 Balears, Illes;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2021QII;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2021QI;23.520
07 Balears, Illes;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2020QII;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2020QI;23.632
07 Balears, Illes;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2022QII;23.949
07 Balears, Illes;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2022QI;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2021QII;23.082
07 Balears, Illes;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2021QI;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2020QII;23.215
07 Balears, Illes;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2020QI;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QIII;23.476
07 Balears, Illes;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QII;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QI;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QIII;22.633
07 Balears, Illes;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QII;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QI;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QIII;22.390
07 Balears, Illes;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QII;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QI;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QIV;22.776
07 Balears, Illes;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QII;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QI;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QIV;22.090
07 Balears, Illes;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QII;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QI;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QIV;21.786
07 Balears, Illes;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QII;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QI;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
07 Balears, Illes;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
07 Balears, Illes;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
07 Balears, Illes;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;97,57
07 Balears, Illes;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;97,91
07 Balears, Illes;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;94,17
07 Balears, Illes;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;95,37
07 Balears, Illes;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;96,08
07 Balears, Illes;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;92,51
07 Balears, Illes;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;93,49
07 Balears, Illes;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;94,21
07 Balears, Illes;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;89,22
07 Balears, Illes;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;90,7
07 Balears, Illes;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;91,95
07 Balears, Illes;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;86,81
07 Balears, Illes;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QI;16.358
07 Balears, Illes;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QI;15.716
07 Balears, Illes;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QI;16.370
07 Balears, Illes;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2022QII;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2022QI;15.989
07 Balears, Illes;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2021QII;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2021QI;15.391
07 Balears, Illes;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2020QII;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2020QI;15.489
07 Balears, Illes;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2022QII;15.669
07 Balears, Illes;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2022QI;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2021QII;15.121
07 Balears, Illes;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2021QI;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2020QII;15.227
07 Balears, Illes;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2020QI;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QIII;15.383
07 Balears, Illes;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QII;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QI;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QIII;14.842
07 Balears, Illes;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QII;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QI;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QIII;14.705
07 Balears, Illes;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QII;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QI;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QIV;14.963
07 Balears, Illes;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QII;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QI;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QIV;14.506
07 Balears, Illes;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QII;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QI;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QIV;14.319
07 Balears, Illes;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QII;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QI;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
07 Balears, Illes;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
07 Balears, Illes;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
07 Balears, Illes;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;97,74
07 Balears, Illes;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;97,93
07 Balears, Illes;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;94,62
07 Balears, Illes;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;95,79
07 Balears, Illes;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;96,21
07 Balears, Illes;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;93,02
07 Balears, Illes;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;94,04
07 Balears, Illes;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;94,44
07 Balears, Illes;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;89,83
07 Balears, Illes;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;91,47
07 Balears, Illes;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;92,3
07 Balears, Illes;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;87,47
07 Balears, Illes;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QI;8.753
07 Balears, Illes;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QI;8.307
07 Balears, Illes;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QI;8.725
07 Balears, Illes;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2022QII;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2022QI;8.512
07 Balears, Illes;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2021QII;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2021QI;8.129
07 Balears, Illes;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2020QII;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2020QI;8.143
07 Balears, Illes;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2022QII;8.280
07 Balears, Illes;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2022QI;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2021QII;7.961
07 Balears, Illes;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2021QI;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2020QII;7.988
07 Balears, Illes;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2020QI;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QIII;8.093
07 Balears, Illes;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QII;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QI;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QIII;7.791
07 Balears, Illes;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QII;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QI;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QIII;7.685
07 Balears, Illes;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QII;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QI;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QIV;7.813
07 Balears, Illes;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QII;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QI;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QIV;7.584
07 Balears, Illes;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QII;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QI;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QIV;7.467
07 Balears, Illes;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QII;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QI;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
07 Balears, Illes;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
07 Balears, Illes;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
07 Balears, Illes;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;97,25
07 Balears, Illes;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;97,86
07 Balears, Illes;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;93,33
07 Balears, Illes;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;94,6
07 Balears, Illes;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;95,83
07 Balears, Illes;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;91,55
07 Balears, Illes;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;92,46
07 Balears, Illes;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;93,79
07 Balears, Illes;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;88,08
07 Balears, Illes;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;89,26
07 Balears, Illes;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;91,3
07 Balears, Illes;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;85,58
07 Balears, Illes;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QII;26.373
07 Balears, Illes;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QII;25.182
07 Balears, Illes;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QII;24.687
07 Balears, Illes;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2022QII;25.717
07 Balears, Illes;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2022QI;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2021QII;24.640
07 Balears, Illes;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2021QI;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2020QII;24.221
07 Balears, Illes;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2020QI;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2022QIII;25.153
07 Balears, Illes;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2022QII;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2022QI;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2021QIII;24.155
07 Balears, Illes;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2021QII;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2021QI;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2020QIII;23.228
07 Balears, Illes;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2020QII;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2020QI;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QIV;24.159
07 Balears, Illes;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QII;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QI;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QIV;23.439
07 Balears, Illes;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QII;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QI;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QIV;22.500
07 Balears, Illes;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QII;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QI;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QII;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QI;22.977
07 Balears, Illes;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QII;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QI;22.130
07 Balears, Illes;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QII;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QI;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
07 Balears, Illes;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
07 Balears, Illes;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
07 Balears, Illes;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;97,51
07 Balears, Illes;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;97,85
07 Balears, Illes;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;98,11
07 Balears, Illes;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;95,37
07 Balears, Illes;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;95,92
07 Balears, Illes;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;94,09
07 Balears, Illes;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;91,61
07 Balears, Illes;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;93,08
07 Balears, Illes;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;91,14
07 Balears, Illes;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;91,24
07 Balears, Illes;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;89,64
07 Balears, Illes;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QII;17.160
07 Balears, Illes;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QII;16.476
07 Balears, Illes;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QII;16.165
07 Balears, Illes;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2022QII;16.765
07 Balears, Illes;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2022QI;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2021QII;16.134
07 Balears, Illes;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2021QI;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2020QII;15.868
07 Balears, Illes;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2020QI;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2022QIII;16.413
07 Balears, Illes;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2022QII;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2022QI;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2021QIII;15.829
07 Balears, Illes;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2021QII;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2021QI;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2020QIII;15.241
07 Balears, Illes;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2020QII;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2020QI;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QIV;15.829
07 Balears, Illes;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QII;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QI;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QIV;15.388
07 Balears, Illes;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QII;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QI;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QIV;14.780
07 Balears, Illes;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QII;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QI;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QII;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QI;15.114
07 Balears, Illes;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QII;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QI;14.536
07 Balears, Illes;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QII;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QI;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
07 Balears, Illes;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
07 Balears, Illes;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
07 Balears, Illes;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;97,7
07 Balears, Illes;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;97,92
07 Balears, Illes;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;98,16
07 Balears, Illes;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;95,65
07 Balears, Illes;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;96,07
07 Balears, Illes;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;94,28
07 Balears, Illes;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;92,24
07 Balears, Illes;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;93,4
07 Balears, Illes;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;91,43
07 Balears, Illes;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;91,73
07 Balears, Illes;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;89,92
07 Balears, Illes;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QII;9.213
07 Balears, Illes;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QII;8.706
07 Balears, Illes;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QII;8.522
07 Balears, Illes;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2022QII;8.952
07 Balears, Illes;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2022QI;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2021QII;8.506
07 Balears, Illes;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2021QI;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2020QII;8.353
07 Balears, Illes;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2020QI;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2022QIII;8.740
07 Balears, Illes;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2022QII;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2022QI;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2021QIII;8.326
07 Balears, Illes;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2021QII;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2021QI;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2020QIII;7.987
07 Balears, Illes;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2020QII;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2020QI;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QIV;8.330
07 Balears, Illes;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QII;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QI;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QIV;8.051
07 Balears, Illes;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QII;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QI;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QIV;7.720
07 Balears, Illes;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QII;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QI;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QII;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QI;7.863
07 Balears, Illes;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QII;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QI;7.594
07 Balears, Illes;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QII;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QI;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
07 Balears, Illes;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
07 Balears, Illes;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
07 Balears, Illes;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;97,17
07 Balears, Illes;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;97,7
07 Balears, Illes;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;98,02
07 Balears, Illes;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;94,87
07 Balears, Illes;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;95,64
07 Balears, Illes;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;93,72
07 Balears, Illes;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;90,42
07 Balears, Illes;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;92,48
07 Balears, Illes;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;90,59
07 Balears, Illes;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;90,32
07 Balears, Illes;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;89,11
07 Balears, Illes;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QIII;27.686
07 Balears, Illes;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QIII;26.332
07 Balears, Illes;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QIII;25.290
07 Balears, Illes;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2022QIII;26.813
07 Balears, Illes;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2022QII;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2022QI;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2021QIII;25.633
07 Balears, Illes;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2021QII;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2021QI;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2020QIII;24.009
07 Balears, Illes;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2020QII;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2020QI;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2022QIV;24.908
07 Balears, Illes;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2022QII;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2022QI;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2021QIV;24.143
07 Balears, Illes;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2021QII;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2021QI;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2020QIV;23.000
07 Balears, Illes;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2020QII;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2020QI;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QII;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QI;23.636
07 Balears, Illes;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QII;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QI;22.595
07 Balears, Illes;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QII;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QI;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QII;23.186
07 Balears, Illes;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QI;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QII;22.220
07 Balears, Illes;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QI;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QII;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QI;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
07 Balears, Illes;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
07 Balears, Illes;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
07 Balears, Illes;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;96,85
07 Balears, Illes;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;97,35
07 Balears, Illes;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;94,93
07 Balears, Illes;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;89,97
07 Balears, Illes;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;91,69
07 Balears, Illes;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;90,95
07 Balears, Illes;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;89,76
07 Balears, Illes;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;89,34
07 Balears, Illes;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;88,05
07 Balears, Illes;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;87,86
07 Balears, Illes;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QIII;17.850
07 Balears, Illes;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QIII;17.085
07 Balears, Illes;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QIII;16.526
07 Balears, Illes;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2022QIII;17.319
07 Balears, Illes;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2022QII;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2022QI;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2021QIII;16.659
07 Balears, Illes;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2021QII;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2021QI;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2020QIII;15.728
07 Balears, Illes;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2020QII;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2020QI;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2022QIV;16.258
07 Balears, Illes;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2022QII;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2022QI;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2021QIV;15.796
07 Balears, Illes;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2021QII;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2021QI;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2020QIV;15.108
07 Balears, Illes;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2020QII;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2020QI;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QII;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QI;15.497
07 Balears, Illes;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QII;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QI;14.843
07 Balears, Illes;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QII;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QI;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QII;15.236
07 Balears, Illes;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QI;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QII;14.610
07 Balears, Illes;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QI;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QII;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QI;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
07 Balears, Illes;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
07 Balears, Illes;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
07 Balears, Illes;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;97,03
07 Balears, Illes;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;97,51
07 Balears, Illes;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;95,17
07 Balears, Illes;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;91,08
07 Balears, Illes;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;92,46
07 Balears, Illes;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;91,42
07 Balears, Illes;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;90,71
07 Balears, Illes;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;89,82
07 Balears, Illes;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;89,18
07 Balears, Illes;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;88,41
07 Balears, Illes;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QIII;9.836
07 Balears, Illes;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QIII;9.247
07 Balears, Illes;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QIII;8.764
07 Balears, Illes;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2022QIII;9.494
07 Balears, Illes;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2022QII;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2022QI;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2021QIII;8.974
07 Balears, Illes;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2021QII;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2021QI;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2020QIII;8.281
07 Balears, Illes;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2020QII;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2020QI;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2022QIV;8.650
07 Balears, Illes;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2022QII;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2022QI;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2021QIV;8.347
07 Balears, Illes;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2021QII;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2021QI;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2020QIV;7.892
07 Balears, Illes;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2020QII;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2020QI;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QII;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QI;8.139
07 Balears, Illes;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QII;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QI;7.752
07 Balears, Illes;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QII;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QI;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QII;7.950
07 Balears, Illes;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QI;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QII;7.610
07 Balears, Illes;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QI;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QII;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QI;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
07 Balears, Illes;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
07 Balears, Illes;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
07 Balears, Illes;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;96,52
07 Balears, Illes;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;97,05
07 Balears, Illes;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;94,49
07 Balears, Illes;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;87,94
07 Balears, Illes;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;90,27
07 Balears, Illes;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;90,05
07 Balears, Illes;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;88,02
07 Balears, Illes;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;88,45
07 Balears, Illes;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;85,97
07 Balears, Illes;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;86,83
07 Balears, Illes;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QIV;27.352
07 Balears, Illes;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QIV;26.327
07 Balears, Illes;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QIV;24.843
07 Balears, Illes;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2022QIV;25.355
07 Balears, Illes;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2022QII;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2022QI;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2021QIV;24.610
07 Balears, Illes;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2021QII;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2021QI;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2020QIV;23.540
07 Balears, Illes;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2020QII;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2020QI;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2022QII;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2022QI;24.059
07 Balears, Illes;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2021QII;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2021QI;23.081
07 Balears, Illes;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2020QII;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2020QI;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QII;23.560
07 Balears, Illes;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QI;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QII;22.683
07 Balears, Illes;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QI;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QII;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QI;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QIII;23.115
07 Balears, Illes;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QII;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QI;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QIII;22.269
07 Balears, Illes;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QII;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QI;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QII;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QI;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
07 Balears, Illes;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
07 Balears, Illes;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
07 Balears, Illes;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;92,7
07 Balears, Illes;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;93,48
07 Balears, Illes;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;94,76
07 Balears, Illes;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;91,39
07 Balears, Illes;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;92,91
07 Balears, Illes;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;89,49
07 Balears, Illes;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;91,31
07 Balears, Illes;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;87,8
07 Balears, Illes;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;89,64
07 Balears, Illes;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QIV;17.631
07 Balears, Illes;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QIV;17.044
07 Balears, Illes;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QIV;16.190
07 Balears, Illes;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2022QIV;16.522
07 Balears, Illes;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2022QII;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2022QI;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2021QIV;16.062
07 Balears, Illes;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2021QII;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2021QI;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2020QIV;15.425
07 Balears, Illes;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2020QII;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2020QI;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2022QII;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2022QI;15.733
07 Balears, Illes;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2021QII;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2021QI;15.128
07 Balears, Illes;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2020QII;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2020QI;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QII;15.449
07 Balears, Illes;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QI;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QII;14.881
07 Balears, Illes;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QI;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QII;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QI;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QIII;15.182
07 Balears, Illes;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QII;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QI;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QIII;14.617
07 Balears, Illes;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QII;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QI;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QII;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QI;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
07 Balears, Illes;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
07 Balears, Illes;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
07 Balears, Illes;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;93,71
07 Balears, Illes;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;94,24
07 Balears, Illes;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;95,27
07 Balears, Illes;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;92,31
07 Balears, Illes;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;93,44
07 Balears, Illes;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;90,64
07 Balears, Illes;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;91,91
07 Balears, Illes;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;89,08
07 Balears, Illes;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;90,28
07 Balears, Illes;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QIV;9.721
07 Balears, Illes;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QIV;9.283
07 Balears, Illes;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QIV;8.653
07 Balears, Illes;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2022QIV;8.833
07 Balears, Illes;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2022QII;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2022QI;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2021QIV;8.548
07 Balears, Illes;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2021QII;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2021QI;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2020QIV;8.115
07 Balears, Illes;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2020QII;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2020QI;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2022QII;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2022QI;8.326
07 Balears, Illes;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2021QII;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2021QI;7.953
07 Balears, Illes;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2020QII;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2020QI;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QII;8.111
07 Balears, Illes;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QI;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QII;7.802
07 Balears, Illes;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QI;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QII;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QI;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QIII;7.933
07 Balears, Illes;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QII;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QI;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QIII;7.652
07 Balears, Illes;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QII;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QI;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QII;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QI;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
07 Balears, Illes;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
07 Balears, Illes;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
07 Balears, Illes;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;90,87
07 Balears, Illes;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;92,08
07 Balears, Illes;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;93,78
07 Balears, Illes;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;89,69
07 Balears, Illes;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;91,91
07 Balears, Illes;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;87,37
07 Balears, Illes;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;90,17
07 Balears, Illes;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;85,46
07 Balears, Illes;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;88,43
07 Balears, Illes;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
07 Balears, Illes;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
07 Balears, Illes;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
07 Balears, Illes;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
07 Balears, Illes;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QI;12.460
07 Balears, Illes;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
07 Balears, Illes;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
07 Balears, Illes;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
07 Balears, Illes;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QI;11.846
07 Balears, Illes;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
07 Balears, Illes;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
07 Balears, Illes;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
07 Balears, Illes;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QI;13.948
07 Balears, Illes;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
07 Balears, Illes;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
07 Balears, Illes;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2022QII;""
07 Balears, Illes;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2022QI;11.998
07 Balears, Illes;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
07 Balears, Illes;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
07 Balears, Illes;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2021QII;""
07 Balears, Illes;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2021QI;11.380
07 Balears, Illes;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
07 Balears, Illes;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
07 Balears, Illes;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2020QII;""
07 Balears, Illes;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2020QI;12.912
07 Balears, Illes;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
07 Balears, Illes;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
07 Balears, Illes;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2022QII;11.551
07 Balears, Illes;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2022QI;""
07 Balears, Illes;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
07 Balears, Illes;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
07 Balears, Illes;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2021QII;10.956
07 Balears, Illes;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2021QI;""
07 Balears, Illes;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
07 Balears, Illes;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
07 Balears, Illes;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2020QII;12.471
07 Balears, Illes;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2020QI;""
07 Balears, Illes;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
07 Balears, Illes;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QIII;11.112
07 Balears, Illes;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QII;""
07 Balears, Illes;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QI;""
07 Balears, Illes;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
07 Balears, Illes;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QIII;10.575
07 Balears, Illes;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QII;""
07 Balears, Illes;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QI;""
07 Balears, Illes;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
07 Balears, Illes;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QIII;11.713
07 Balears, Illes;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QII;""
07 Balears, Illes;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QI;""
07 Balears, Illes;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QIV;10.430
07 Balears, Illes;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
07 Balears, Illes;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QII;""
07 Balears, Illes;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QI;""
07 Balears, Illes;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QIV;10.035
07 Balears, Illes;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
07 Balears, Illes;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QII;""
07 Balears, Illes;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QI;""
07 Balears, Illes;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QIV;11.073
07 Balears, Illes;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
07 Balears, Illes;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QII;""
07 Balears, Illes;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QI;""
07 Balears, Illes;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
07 Balears, Illes;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
07 Balears, Illes;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
07 Balears, Illes;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
07 Balears, Illes;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
07 Balears, Illes;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
07 Balears, Illes;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
07 Balears, Illes;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
07 Balears, Illes;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
07 Balears, Illes;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
07 Balears, Illes;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
07 Balears, Illes;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
07 Balears, Illes;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
07 Balears, Illes;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
07 Balears, Illes;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
07 Balears, Illes;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;96,29
07 Balears, Illes;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
07 Balears, Illes;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
07 Balears, Illes;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
07 Balears, Illes;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;96,07
07 Balears, Illes;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
07 Balears, Illes;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
07 Balears, Illes;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
07 Balears, Illes;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;92,57
07 Balears, Illes;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
07 Balears, Illes;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
07 Balears, Illes;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;92,7
07 Balears, Illes;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
07 Balears, Illes;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
07 Balears, Illes;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
07 Balears, Illes;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;92,49
07 Balears, Illes;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
07 Balears, Illes;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
07 Balears, Illes;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
07 Balears, Illes;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;89,41
07 Balears, Illes;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
07 Balears, Illes;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
07 Balears, Illes;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;89,18
07 Balears, Illes;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
07 Balears, Illes;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
07 Balears, Illes;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
07 Balears, Illes;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;89,27
07 Balears, Illes;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
07 Balears, Illes;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
07 Balears, Illes;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
07 Balears, Illes;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;83,98
07 Balears, Illes;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
07 Balears, Illes;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
07 Balears, Illes;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;83,71
07 Balears, Illes;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
07 Balears, Illes;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
07 Balears, Illes;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
07 Balears, Illes;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;84,71
07 Balears, Illes;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
07 Balears, Illes;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
07 Balears, Illes;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
07 Balears, Illes;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;79,39
07 Balears, Illes;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
07 Balears, Illes;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
07 Balears, Illes;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
07 Balears, Illes;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
07 Balears, Illes;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
07 Balears, Illes;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
07 Balears, Illes;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QI;8.064
07 Balears, Illes;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
07 Balears, Illes;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
07 Balears, Illes;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
07 Balears, Illes;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QI;7.663
07 Balears, Illes;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
07 Balears, Illes;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
07 Balears, Illes;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
07 Balears, Illes;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QI;8.988
07 Balears, Illes;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
07 Balears, Illes;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
07 Balears, Illes;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2022QII;""
07 Balears, Illes;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2022QI;7.764
07 Balears, Illes;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
07 Balears, Illes;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
07 Balears, Illes;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2021QII;""
07 Balears, Illes;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2021QI;7.353
07 Balears, Illes;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
07 Balears, Illes;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
07 Balears, Illes;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2020QII;""
07 Balears, Illes;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2020QI;8.340
07 Balears, Illes;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
07 Balears, Illes;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
07 Balears, Illes;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2022QII;7.491
07 Balears, Illes;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2022QI;""
07 Balears, Illes;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
07 Balears, Illes;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
07 Balears, Illes;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2021QII;7.090
07 Balears, Illes;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2021QI;""
07 Balears, Illes;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
07 Balears, Illes;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
07 Balears, Illes;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2020QII;8.056
07 Balears, Illes;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2020QI;""
07 Balears, Illes;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
07 Balears, Illes;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QIII;7.230
07 Balears, Illes;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QII;""
07 Balears, Illes;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QI;""
07 Balears, Illes;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
07 Balears, Illes;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QIII;6.838
07 Balears, Illes;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QII;""
07 Balears, Illes;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QI;""
07 Balears, Illes;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
07 Balears, Illes;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QIII;7.574
07 Balears, Illes;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QII;""
07 Balears, Illes;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QI;""
07 Balears, Illes;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QIV;6.793
07 Balears, Illes;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
07 Balears, Illes;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QII;""
07 Balears, Illes;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QI;""
07 Balears, Illes;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QIV;6.503
07 Balears, Illes;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
07 Balears, Illes;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QII;""
07 Balears, Illes;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QI;""
07 Balears, Illes;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QIV;7.160
07 Balears, Illes;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
07 Balears, Illes;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QII;""
07 Balears, Illes;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QI;""
07 Balears, Illes;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
07 Balears, Illes;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
07 Balears, Illes;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
07 Balears, Illes;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
07 Balears, Illes;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
07 Balears, Illes;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
07 Balears, Illes;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
07 Balears, Illes;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
07 Balears, Illes;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
07 Balears, Illes;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
07 Balears, Illes;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
07 Balears, Illes;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
07 Balears, Illes;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
07 Balears, Illes;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
07 Balears, Illes;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
07 Balears, Illes;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;96,28
07 Balears, Illes;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
07 Balears, Illes;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
07 Balears, Illes;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
07 Balears, Illes;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;95,95
07 Balears, Illes;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
07 Balears, Illes;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
07 Balears, Illes;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
07 Balears, Illes;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;92,79
07 Balears, Illes;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
07 Balears, Illes;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
07 Balears, Illes;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;92,89
07 Balears, Illes;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
07 Balears, Illes;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
07 Balears, Illes;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
07 Balears, Illes;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;92,52
07 Balears, Illes;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
07 Balears, Illes;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
07 Balears, Illes;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
07 Balears, Illes;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;89,63
07 Balears, Illes;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
07 Balears, Illes;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
07 Balears, Illes;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;89,66
07 Balears, Illes;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
07 Balears, Illes;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
07 Balears, Illes;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
07 Balears, Illes;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;89,23
07 Balears, Illes;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
07 Balears, Illes;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
07 Balears, Illes;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
07 Balears, Illes;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;84,27
07 Balears, Illes;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
07 Balears, Illes;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
07 Balears, Illes;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;84,24
07 Balears, Illes;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
07 Balears, Illes;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
07 Balears, Illes;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
07 Balears, Illes;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;84,86
07 Balears, Illes;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
07 Balears, Illes;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
07 Balears, Illes;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
07 Balears, Illes;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;79,66
07 Balears, Illes;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
07 Balears, Illes;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
07 Balears, Illes;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
07 Balears, Illes;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
07 Balears, Illes;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
07 Balears, Illes;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
07 Balears, Illes;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QI;4.396
07 Balears, Illes;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
07 Balears, Illes;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
07 Balears, Illes;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
07 Balears, Illes;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QI;4.183
07 Balears, Illes;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
07 Balears, Illes;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
07 Balears, Illes;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
07 Balears, Illes;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QI;4.960
07 Balears, Illes;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
07 Balears, Illes;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
07 Balears, Illes;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2022QII;""
07 Balears, Illes;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2022QI;4.234
07 Balears, Illes;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
07 Balears, Illes;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
07 Balears, Illes;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2021QII;""
07 Balears, Illes;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2021QI;4.027
07 Balears, Illes;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
07 Balears, Illes;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
07 Balears, Illes;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2020QII;""
07 Balears, Illes;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2020QI;4.572
07 Balears, Illes;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
07 Balears, Illes;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
07 Balears, Illes;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2022QII;4.060
07 Balears, Illes;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2022QI;""
07 Balears, Illes;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
07 Balears, Illes;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
07 Balears, Illes;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2021QII;3.866
07 Balears, Illes;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2021QI;""
07 Balears, Illes;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
07 Balears, Illes;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
07 Balears, Illes;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2020QII;4.415
07 Balears, Illes;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2020QI;""
07 Balears, Illes;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
07 Balears, Illes;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QIII;3.882
07 Balears, Illes;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QII;""
07 Balears, Illes;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QI;""
07 Balears, Illes;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
07 Balears, Illes;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QIII;3.737
07 Balears, Illes;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QII;""
07 Balears, Illes;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QI;""
07 Balears, Illes;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
07 Balears, Illes;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QIII;4.139
07 Balears, Illes;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QII;""
07 Balears, Illes;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QI;""
07 Balears, Illes;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QIV;3.637
07 Balears, Illes;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
07 Balears, Illes;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QII;""
07 Balears, Illes;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QI;""
07 Balears, Illes;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QIV;3.532
07 Balears, Illes;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
07 Balears, Illes;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QII;""
07 Balears, Illes;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QI;""
07 Balears, Illes;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QIV;3.913
07 Balears, Illes;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
07 Balears, Illes;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QII;""
07 Balears, Illes;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QI;""
07 Balears, Illes;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
07 Balears, Illes;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
07 Balears, Illes;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
07 Balears, Illes;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
07 Balears, Illes;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
07 Balears, Illes;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
07 Balears, Illes;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
07 Balears, Illes;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
07 Balears, Illes;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
07 Balears, Illes;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
07 Balears, Illes;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
07 Balears, Illes;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
07 Balears, Illes;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
07 Balears, Illes;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
07 Balears, Illes;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
07 Balears, Illes;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;96,31
07 Balears, Illes;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
07 Balears, Illes;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
07 Balears, Illes;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
07 Balears, Illes;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;96,27
07 Balears, Illes;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
07 Balears, Illes;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
07 Balears, Illes;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
07 Balears, Illes;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;92,18
07 Balears, Illes;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
07 Balears, Illes;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
07 Balears, Illes;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;92,36
07 Balears, Illes;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
07 Balears, Illes;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
07 Balears, Illes;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
07 Balears, Illes;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;92,42
07 Balears, Illes;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
07 Balears, Illes;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
07 Balears, Illes;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
07 Balears, Illes;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;89,01
07 Balears, Illes;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
07 Balears, Illes;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
07 Balears, Illes;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;88,31
07 Balears, Illes;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
07 Balears, Illes;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
07 Balears, Illes;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
07 Balears, Illes;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;89,34
07 Balears, Illes;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
07 Balears, Illes;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
07 Balears, Illes;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
07 Balears, Illes;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;83,45
07 Balears, Illes;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
07 Balears, Illes;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
07 Balears, Illes;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;82,73
07 Balears, Illes;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
07 Balears, Illes;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
07 Balears, Illes;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
07 Balears, Illes;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;84,44
07 Balears, Illes;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
07 Balears, Illes;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
07 Balears, Illes;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
07 Balears, Illes;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;78,89
07 Balears, Illes;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
07 Balears, Illes;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
07 Balears, Illes;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
07 Balears, Illes;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
07 Balears, Illes;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
07 Balears, Illes;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QII;14.199
07 Balears, Illes;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
07 Balears, Illes;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
07 Balears, Illes;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
07 Balears, Illes;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QII;13.494
07 Balears, Illes;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
07 Balears, Illes;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
07 Balears, Illes;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
07 Balears, Illes;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QII;13.372
07 Balears, Illes;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
07 Balears, Illes;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
07 Balears, Illes;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
07 Balears, Illes;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2022QII;13.683
07 Balears, Illes;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2022QI;""
07 Balears, Illes;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
07 Balears, Illes;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
07 Balears, Illes;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2021QII;13.002
07 Balears, Illes;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2021QI;""
07 Balears, Illes;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
07 Balears, Illes;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
07 Balears, Illes;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2020QII;12.902
07 Balears, Illes;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2020QI;""
07 Balears, Illes;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
07 Balears, Illes;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2022QIII;13.201
07 Balears, Illes;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2022QII;""
07 Balears, Illes;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2022QI;""
07 Balears, Illes;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
07 Balears, Illes;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2021QIII;12.575
07 Balears, Illes;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2021QII;""
07 Balears, Illes;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2021QI;""
07 Balears, Illes;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
07 Balears, Illes;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2020QIII;12.026
07 Balears, Illes;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2020QII;""
07 Balears, Illes;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2020QI;""
07 Balears, Illes;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QIV;12.329
07 Balears, Illes;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
07 Balears, Illes;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QII;""
07 Balears, Illes;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QI;""
07 Balears, Illes;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QIV;11.936
07 Balears, Illes;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
07 Balears, Illes;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QII;""
07 Balears, Illes;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QI;""
07 Balears, Illes;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QIV;11.325
07 Balears, Illes;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
07 Balears, Illes;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QII;""
07 Balears, Illes;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QI;""
07 Balears, Illes;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
07 Balears, Illes;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
07 Balears, Illes;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QII;""
07 Balears, Illes;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QI;11.521
07 Balears, Illes;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
07 Balears, Illes;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
07 Balears, Illes;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QII;""
07 Balears, Illes;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QI;10.910
07 Balears, Illes;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
07 Balears, Illes;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
07 Balears, Illes;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QII;""
07 Balears, Illes;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QI;""
07 Balears, Illes;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
07 Balears, Illes;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
07 Balears, Illes;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
07 Balears, Illes;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
07 Balears, Illes;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
07 Balears, Illes;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
07 Balears, Illes;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
07 Balears, Illes;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
07 Balears, Illes;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
07 Balears, Illes;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
07 Balears, Illes;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
07 Balears, Illes;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
07 Balears, Illes;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
07 Balears, Illes;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
07 Balears, Illes;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;96,37
07 Balears, Illes;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
07 Balears, Illes;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
07 Balears, Illes;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
07 Balears, Illes;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;96,35
07 Balears, Illes;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
07 Balears, Illes;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
07 Balears, Illes;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
07 Balears, Illes;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;96,49
07 Balears, Illes;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
07 Balears, Illes;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
07 Balears, Illes;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;92,97
07 Balears, Illes;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
07 Balears, Illes;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
07 Balears, Illes;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
07 Balears, Illes;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;93,19
07 Balears, Illes;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
07 Balears, Illes;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
07 Balears, Illes;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
07 Balears, Illes;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;89,93
07 Balears, Illes;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
07 Balears, Illes;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
07 Balears, Illes;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;86,83
07 Balears, Illes;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
07 Balears, Illes;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
07 Balears, Illes;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
07 Balears, Illes;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;88,45
07 Balears, Illes;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
07 Balears, Illes;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
07 Balears, Illes;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
07 Balears, Illes;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;84,69
07 Balears, Illes;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
07 Balears, Illes;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
07 Balears, Illes;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
07 Balears, Illes;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
07 Balears, Illes;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
07 Balears, Illes;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
07 Balears, Illes;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;85,38
07 Balears, Illes;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
07 Balears, Illes;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
07 Balears, Illes;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
07 Balears, Illes;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;81,59
07 Balears, Illes;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
07 Balears, Illes;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
07 Balears, Illes;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
07 Balears, Illes;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
07 Balears, Illes;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
07 Balears, Illes;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
07 Balears, Illes;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QII;9.206
07 Balears, Illes;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
07 Balears, Illes;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
07 Balears, Illes;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
07 Balears, Illes;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QII;8.745
07 Balears, Illes;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
07 Balears, Illes;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
07 Balears, Illes;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
07 Balears, Illes;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QII;8.658
07 Balears, Illes;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
07 Balears, Illes;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
07 Balears, Illes;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
07 Balears, Illes;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2022QII;8.891
07 Balears, Illes;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2022QI;""
07 Balears, Illes;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
07 Balears, Illes;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
07 Balears, Illes;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2021QII;8.437
07 Balears, Illes;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2021QI;""
07 Balears, Illes;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
07 Balears, Illes;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
07 Balears, Illes;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2020QII;8.353
07 Balears, Illes;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2020QI;""
07 Balears, Illes;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
07 Balears, Illes;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2022QIII;8.603
07 Balears, Illes;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2022QII;""
07 Balears, Illes;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2022QI;""
07 Balears, Illes;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
07 Balears, Illes;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2021QIII;8.157
07 Balears, Illes;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2021QII;""
07 Balears, Illes;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2021QI;""
07 Balears, Illes;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
07 Balears, Illes;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2020QIII;7.793
07 Balears, Illes;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2020QII;""
07 Balears, Illes;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2020QI;""
07 Balears, Illes;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QIV;8.041
07 Balears, Illes;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
07 Balears, Illes;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QII;""
07 Balears, Illes;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QI;""
07 Balears, Illes;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QIV;7.759
07 Balears, Illes;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
07 Balears, Illes;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QII;""
07 Balears, Illes;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QI;""
07 Balears, Illes;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QIV;7.334
07 Balears, Illes;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
07 Balears, Illes;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QII;""
07 Balears, Illes;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QI;""
07 Balears, Illes;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
07 Balears, Illes;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
07 Balears, Illes;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QII;""
07 Balears, Illes;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QI;7.490
07 Balears, Illes;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
07 Balears, Illes;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
07 Balears, Illes;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QII;""
07 Balears, Illes;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QI;7.059
07 Balears, Illes;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
07 Balears, Illes;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
07 Balears, Illes;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QII;""
07 Balears, Illes;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QI;""
07 Balears, Illes;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
07 Balears, Illes;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
07 Balears, Illes;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
07 Balears, Illes;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
07 Balears, Illes;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
07 Balears, Illes;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
07 Balears, Illes;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
07 Balears, Illes;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
07 Balears, Illes;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
07 Balears, Illes;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
07 Balears, Illes;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
07 Balears, Illes;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
07 Balears, Illes;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
07 Balears, Illes;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
07 Balears, Illes;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;96,58
07 Balears, Illes;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
07 Balears, Illes;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
07 Balears, Illes;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
07 Balears, Illes;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;96,48
07 Balears, Illes;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
07 Balears, Illes;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
07 Balears, Illes;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
07 Balears, Illes;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;96,48
07 Balears, Illes;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
07 Balears, Illes;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
07 Balears, Illes;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;93,45
07 Balears, Illes;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
07 Balears, Illes;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
07 Balears, Illes;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
07 Balears, Illes;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;93,28
07 Balears, Illes;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
07 Balears, Illes;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
07 Balears, Illes;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
07 Balears, Illes;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;90,01
07 Balears, Illes;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
07 Balears, Illes;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
07 Balears, Illes;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;87,35
07 Balears, Illes;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
07 Balears, Illes;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
07 Balears, Illes;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
07 Balears, Illes;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;88,72
07 Balears, Illes;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
07 Balears, Illes;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
07 Balears, Illes;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
07 Balears, Illes;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;84,71
07 Balears, Illes;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
07 Balears, Illes;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
07 Balears, Illes;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
07 Balears, Illes;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
07 Balears, Illes;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
07 Balears, Illes;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
07 Balears, Illes;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;85,65
07 Balears, Illes;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
07 Balears, Illes;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
07 Balears, Illes;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
07 Balears, Illes;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;81,53
07 Balears, Illes;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
07 Balears, Illes;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
07 Balears, Illes;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
07 Balears, Illes;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
07 Balears, Illes;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
07 Balears, Illes;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
07 Balears, Illes;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QII;4.993
07 Balears, Illes;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
07 Balears, Illes;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
07 Balears, Illes;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
07 Balears, Illes;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QII;4.749
07 Balears, Illes;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
07 Balears, Illes;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
07 Balears, Illes;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
07 Balears, Illes;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QII;4.714
07 Balears, Illes;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
07 Balears, Illes;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
07 Balears, Illes;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
07 Balears, Illes;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2022QII;4.792
07 Balears, Illes;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2022QI;""
07 Balears, Illes;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
07 Balears, Illes;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
07 Balears, Illes;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2021QII;4.565
07 Balears, Illes;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2021QI;""
07 Balears, Illes;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
07 Balears, Illes;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
07 Balears, Illes;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2020QII;4.549
07 Balears, Illes;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2020QI;""
07 Balears, Illes;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
07 Balears, Illes;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2022QIII;4.598
07 Balears, Illes;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2022QII;""
07 Balears, Illes;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2022QI;""
07 Balears, Illes;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
07 Balears, Illes;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2021QIII;4.418
07 Balears, Illes;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2021QII;""
07 Balears, Illes;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2021QI;""
07 Balears, Illes;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
07 Balears, Illes;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2020QIII;4.233
07 Balears, Illes;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2020QII;""
07 Balears, Illes;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2020QI;""
07 Balears, Illes;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QIV;4.288
07 Balears, Illes;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
07 Balears, Illes;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QII;""
07 Balears, Illes;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QI;""
07 Balears, Illes;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QIV;4.177
07 Balears, Illes;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
07 Balears, Illes;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QII;""
07 Balears, Illes;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QI;""
07 Balears, Illes;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QIV;3.991
07 Balears, Illes;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
07 Balears, Illes;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QII;""
07 Balears, Illes;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QI;""
07 Balears, Illes;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
07 Balears, Illes;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
07 Balears, Illes;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QII;""
07 Balears, Illes;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QI;4.031
07 Balears, Illes;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
07 Balears, Illes;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
07 Balears, Illes;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QII;""
07 Balears, Illes;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QI;3.851
07 Balears, Illes;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
07 Balears, Illes;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
07 Balears, Illes;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QII;""
07 Balears, Illes;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QI;""
07 Balears, Illes;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
07 Balears, Illes;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
07 Balears, Illes;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
07 Balears, Illes;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
07 Balears, Illes;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
07 Balears, Illes;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
07 Balears, Illes;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
07 Balears, Illes;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
07 Balears, Illes;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
07 Balears, Illes;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
07 Balears, Illes;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
07 Balears, Illes;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
07 Balears, Illes;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
07 Balears, Illes;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
07 Balears, Illes;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;95,97
07 Balears, Illes;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
07 Balears, Illes;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
07 Balears, Illes;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
07 Balears, Illes;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;96,13
07 Balears, Illes;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
07 Balears, Illes;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
07 Balears, Illes;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
07 Balears, Illes;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;96,5
07 Balears, Illes;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
07 Balears, Illes;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
07 Balears, Illes;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;92,09
07 Balears, Illes;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
07 Balears, Illes;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
07 Balears, Illes;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
07 Balears, Illes;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;93,03
07 Balears, Illes;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
07 Balears, Illes;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
07 Balears, Illes;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
07 Balears, Illes;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;89,8
07 Balears, Illes;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
07 Balears, Illes;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
07 Balears, Illes;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;85,88
07 Balears, Illes;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
07 Balears, Illes;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
07 Balears, Illes;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
07 Balears, Illes;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;87,96
07 Balears, Illes;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
07 Balears, Illes;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
07 Balears, Illes;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
07 Balears, Illes;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;84,66
07 Balears, Illes;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
07 Balears, Illes;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
07 Balears, Illes;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
07 Balears, Illes;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
07 Balears, Illes;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
07 Balears, Illes;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
07 Balears, Illes;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;84,88
07 Balears, Illes;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
07 Balears, Illes;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
07 Balears, Illes;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
07 Balears, Illes;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;81,69
07 Balears, Illes;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
07 Balears, Illes;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
07 Balears, Illes;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
07 Balears, Illes;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
07 Balears, Illes;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
07 Balears, Illes;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QIII;14.687
07 Balears, Illes;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
07 Balears, Illes;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
07 Balears, Illes;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
07 Balears, Illes;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QIII;13.853
07 Balears, Illes;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
07 Balears, Illes;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
07 Balears, Illes;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
07 Balears, Illes;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QIII;13.403
07 Balears, Illes;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
07 Balears, Illes;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
07 Balears, Illes;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
07 Balears, Illes;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2022QIII;14.015
07 Balears, Illes;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2022QII;""
07 Balears, Illes;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2022QI;""
07 Balears, Illes;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
07 Balears, Illes;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2021QIII;13.276
07 Balears, Illes;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2021QII;""
07 Balears, Illes;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2021QI;""
07 Balears, Illes;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
07 Balears, Illes;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2020QIII;12.364
07 Balears, Illes;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2020QII;""
07 Balears, Illes;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2020QI;""
07 Balears, Illes;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2022QIV;12.544
07 Balears, Illes;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
07 Balears, Illes;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2022QII;""
07 Balears, Illes;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2022QI;""
07 Balears, Illes;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2021QIV;12.169
07 Balears, Illes;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
07 Balears, Illes;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2021QII;""
07 Balears, Illes;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2021QI;""
07 Balears, Illes;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2020QIV;11.496
07 Balears, Illes;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
07 Balears, Illes;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2020QII;""
07 Balears, Illes;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2020QI;""
07 Balears, Illes;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
07 Balears, Illes;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
07 Balears, Illes;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QII;""
07 Balears, Illes;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QI;11.735
07 Balears, Illes;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
07 Balears, Illes;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
07 Balears, Illes;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QII;""
07 Balears, Illes;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QI;11.067
07 Balears, Illes;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
07 Balears, Illes;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
07 Balears, Illes;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QII;""
07 Balears, Illes;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QI;""
07 Balears, Illes;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
07 Balears, Illes;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
07 Balears, Illes;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QII;11.330
07 Balears, Illes;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QI;""
07 Balears, Illes;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
07 Balears, Illes;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
07 Balears, Illes;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QII;10.678
07 Balears, Illes;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QI;""
07 Balears, Illes;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
07 Balears, Illes;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
07 Balears, Illes;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QII;""
07 Balears, Illes;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QI;""
07 Balears, Illes;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
07 Balears, Illes;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
07 Balears, Illes;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
07 Balears, Illes;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
07 Balears, Illes;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
07 Balears, Illes;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
07 Balears, Illes;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
07 Balears, Illes;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
07 Balears, Illes;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
07 Balears, Illes;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
07 Balears, Illes;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
07 Balears, Illes;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
07 Balears, Illes;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
07 Balears, Illes;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;95,42
07 Balears, Illes;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
07 Balears, Illes;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
07 Balears, Illes;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
07 Balears, Illes;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;95,83
07 Balears, Illes;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
07 Balears, Illes;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
07 Balears, Illes;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
07 Balears, Illes;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;92,25
07 Balears, Illes;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
07 Balears, Illes;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
07 Balears, Illes;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;85,41
07 Balears, Illes;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
07 Balears, Illes;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
07 Balears, Illes;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
07 Balears, Illes;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;87,84
07 Balears, Illes;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
07 Balears, Illes;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
07 Balears, Illes;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
07 Balears, Illes;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;85,77
07 Balears, Illes;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
07 Balears, Illes;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
07 Balears, Illes;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
07 Balears, Illes;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
07 Balears, Illes;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
07 Balears, Illes;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
07 Balears, Illes;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;84,71
07 Balears, Illes;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
07 Balears, Illes;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
07 Balears, Illes;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
07 Balears, Illes;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;82,57
07 Balears, Illes;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
07 Balears, Illes;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
07 Balears, Illes;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
07 Balears, Illes;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
07 Balears, Illes;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
07 Balears, Illes;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
07 Balears, Illes;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;81,79
07 Balears, Illes;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
07 Balears, Illes;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
07 Balears, Illes;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
07 Balears, Illes;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;79,67
07 Balears, Illes;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
07 Balears, Illes;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
07 Balears, Illes;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
07 Balears, Illes;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
07 Balears, Illes;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
07 Balears, Illes;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
07 Balears, Illes;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QIII;9.464
07 Balears, Illes;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
07 Balears, Illes;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
07 Balears, Illes;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
07 Balears, Illes;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QIII;8.911
07 Balears, Illes;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
07 Balears, Illes;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
07 Balears, Illes;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
07 Balears, Illes;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QIII;8.650
07 Balears, Illes;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
07 Balears, Illes;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
07 Balears, Illes;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
07 Balears, Illes;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2022QIII;9.068
07 Balears, Illes;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2022QII;""
07 Balears, Illes;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2022QI;""
07 Balears, Illes;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
07 Balears, Illes;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2021QIII;8.550
07 Balears, Illes;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2021QII;""
07 Balears, Illes;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2021QI;""
07 Balears, Illes;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
07 Balears, Illes;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2020QIII;7.987
07 Balears, Illes;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2020QII;""
07 Balears, Illes;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2020QI;""
07 Balears, Illes;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2022QIV;8.173
07 Balears, Illes;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
07 Balears, Illes;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2022QII;""
07 Balears, Illes;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2022QI;""
07 Balears, Illes;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2021QIV;7.894
07 Balears, Illes;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
07 Balears, Illes;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2021QII;""
07 Balears, Illes;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2021QI;""
07 Balears, Illes;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2020QIV;7.435
07 Balears, Illes;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
07 Balears, Illes;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2020QII;""
07 Balears, Illes;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2020QI;""
07 Balears, Illes;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
07 Balears, Illes;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
07 Balears, Illes;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QII;""
07 Balears, Illes;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QI;7.612
07 Balears, Illes;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
07 Balears, Illes;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
07 Balears, Illes;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QII;""
07 Balears, Illes;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QI;7.152
07 Balears, Illes;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
07 Balears, Illes;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
07 Balears, Illes;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QII;""
07 Balears, Illes;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QI;""
07 Balears, Illes;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
07 Balears, Illes;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
07 Balears, Illes;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QII;7.364
07 Balears, Illes;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QI;""
07 Balears, Illes;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
07 Balears, Illes;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
07 Balears, Illes;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QII;6.914
07 Balears, Illes;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QI;""
07 Balears, Illes;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
07 Balears, Illes;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
07 Balears, Illes;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QII;""
07 Balears, Illes;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QI;""
07 Balears, Illes;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
07 Balears, Illes;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
07 Balears, Illes;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
07 Balears, Illes;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
07 Balears, Illes;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
07 Balears, Illes;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
07 Balears, Illes;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
07 Balears, Illes;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
07 Balears, Illes;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
07 Balears, Illes;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
07 Balears, Illes;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
07 Balears, Illes;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
07 Balears, Illes;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
07 Balears, Illes;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;95,82
07 Balears, Illes;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
07 Balears, Illes;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
07 Balears, Illes;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
07 Balears, Illes;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;95,95
07 Balears, Illes;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
07 Balears, Illes;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
07 Balears, Illes;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
07 Balears, Illes;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;92,34
07 Balears, Illes;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
07 Balears, Illes;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
07 Balears, Illes;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;86,36
07 Balears, Illes;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
07 Balears, Illes;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
07 Balears, Illes;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
07 Balears, Illes;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;88,59
07 Balears, Illes;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
07 Balears, Illes;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
07 Balears, Illes;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
07 Balears, Illes;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;85,95
07 Balears, Illes;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
07 Balears, Illes;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
07 Balears, Illes;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
07 Balears, Illes;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
07 Balears, Illes;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
07 Balears, Illes;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
07 Balears, Illes;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;85,42
07 Balears, Illes;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
07 Balears, Illes;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
07 Balears, Illes;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
07 Balears, Illes;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;82,68
07 Balears, Illes;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
07 Balears, Illes;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
07 Balears, Illes;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
07 Balears, Illes;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
07 Balears, Illes;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
07 Balears, Illes;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
07 Balears, Illes;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;82,64
07 Balears, Illes;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
07 Balears, Illes;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
07 Balears, Illes;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
07 Balears, Illes;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;79,93
07 Balears, Illes;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
07 Balears, Illes;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
07 Balears, Illes;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
07 Balears, Illes;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
07 Balears, Illes;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
07 Balears, Illes;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
07 Balears, Illes;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QIII;5.223
07 Balears, Illes;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
07 Balears, Illes;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
07 Balears, Illes;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
07 Balears, Illes;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QIII;4.942
07 Balears, Illes;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
07 Balears, Illes;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
07 Balears, Illes;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
07 Balears, Illes;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QIII;4.753
07 Balears, Illes;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
07 Balears, Illes;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
07 Balears, Illes;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
07 Balears, Illes;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2022QIII;4.947
07 Balears, Illes;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2022QII;""
07 Balears, Illes;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2022QI;""
07 Balears, Illes;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
07 Balears, Illes;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2021QIII;4.726
07 Balears, Illes;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2021QII;""
07 Balears, Illes;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2021QI;""
07 Balears, Illes;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
07 Balears, Illes;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2020QIII;4.377
07 Balears, Illes;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2020QII;""
07 Balears, Illes;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2020QI;""
07 Balears, Illes;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2022QIV;4.371
07 Balears, Illes;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
07 Balears, Illes;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2022QII;""
07 Balears, Illes;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2022QI;""
07 Balears, Illes;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2021QIV;4.275
07 Balears, Illes;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
07 Balears, Illes;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2021QII;""
07 Balears, Illes;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2021QI;""
07 Balears, Illes;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2020QIV;4.061
07 Balears, Illes;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
07 Balears, Illes;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2020QII;""
07 Balears, Illes;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2020QI;""
07 Balears, Illes;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
07 Balears, Illes;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
07 Balears, Illes;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QII;""
07 Balears, Illes;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QI;4.123
07 Balears, Illes;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
07 Balears, Illes;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
07 Balears, Illes;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QII;""
07 Balears, Illes;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QI;3.915
07 Balears, Illes;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
07 Balears, Illes;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
07 Balears, Illes;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QII;""
07 Balears, Illes;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QI;""
07 Balears, Illes;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
07 Balears, Illes;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
07 Balears, Illes;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QII;3.966
07 Balears, Illes;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QI;""
07 Balears, Illes;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
07 Balears, Illes;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
07 Balears, Illes;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QII;3.764
07 Balears, Illes;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QI;""
07 Balears, Illes;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
07 Balears, Illes;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
07 Balears, Illes;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QII;""
07 Balears, Illes;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QI;""
07 Balears, Illes;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
07 Balears, Illes;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
07 Balears, Illes;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
07 Balears, Illes;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
07 Balears, Illes;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
07 Balears, Illes;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
07 Balears, Illes;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
07 Balears, Illes;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
07 Balears, Illes;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
07 Balears, Illes;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
07 Balears, Illes;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
07 Balears, Illes;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
07 Balears, Illes;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
07 Balears, Illes;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;94,72
07 Balears, Illes;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
07 Balears, Illes;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
07 Balears, Illes;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
07 Balears, Illes;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;95,63
07 Balears, Illes;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
07 Balears, Illes;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
07 Balears, Illes;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
07 Balears, Illes;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;92,09
07 Balears, Illes;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
07 Balears, Illes;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
07 Balears, Illes;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;83,69
07 Balears, Illes;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
07 Balears, Illes;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
07 Balears, Illes;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
07 Balears, Illes;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;86,5
07 Balears, Illes;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
07 Balears, Illes;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
07 Balears, Illes;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
07 Balears, Illes;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;85,44
07 Balears, Illes;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
07 Balears, Illes;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
07 Balears, Illes;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
07 Balears, Illes;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
07 Balears, Illes;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
07 Balears, Illes;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
07 Balears, Illes;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;83,43
07 Balears, Illes;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
07 Balears, Illes;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
07 Balears, Illes;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
07 Balears, Illes;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;82,37
07 Balears, Illes;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
07 Balears, Illes;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
07 Balears, Illes;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
07 Balears, Illes;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
07 Balears, Illes;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
07 Balears, Illes;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
07 Balears, Illes;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;80,25
07 Balears, Illes;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
07 Balears, Illes;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
07 Balears, Illes;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
07 Balears, Illes;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;79,19
07 Balears, Illes;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
07 Balears, Illes;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
07 Balears, Illes;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
07 Balears, Illes;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
07 Balears, Illes;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
07 Balears, Illes;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QIV;14.182
07 Balears, Illes;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
07 Balears, Illes;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
07 Balears, Illes;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
07 Balears, Illes;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QIV;13.544
07 Balears, Illes;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
07 Balears, Illes;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
07 Balears, Illes;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
07 Balears, Illes;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QIV;12.711
07 Balears, Illes;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
07 Balears, Illes;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
07 Balears, Illes;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
07 Balears, Illes;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2022QIV;12.666
07 Balears, Illes;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
07 Balears, Illes;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2022QII;""
07 Balears, Illes;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2022QI;""
07 Balears, Illes;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2021QIV;12.316
07 Balears, Illes;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
07 Balears, Illes;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2021QII;""
07 Balears, Illes;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2021QI;""
07 Balears, Illes;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2020QIV;11.696
07 Balears, Illes;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
07 Balears, Illes;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2020QII;""
07 Balears, Illes;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2020QI;""
07 Balears, Illes;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
07 Balears, Illes;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
07 Balears, Illes;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2022QII;""
07 Balears, Illes;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2022QI;11.869
07 Balears, Illes;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
07 Balears, Illes;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
07 Balears, Illes;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2021QII;""
07 Balears, Illes;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2021QI;11.248
07 Balears, Illes;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
07 Balears, Illes;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
07 Balears, Illes;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2020QII;""
07 Balears, Illes;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2020QI;""
07 Balears, Illes;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
07 Balears, Illes;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
07 Balears, Illes;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QII;11.447
07 Balears, Illes;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QI;""
07 Balears, Illes;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
07 Balears, Illes;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
07 Balears, Illes;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QII;10.839
07 Balears, Illes;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QI;""
07 Balears, Illes;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
07 Balears, Illes;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
07 Balears, Illes;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QII;""
07 Balears, Illes;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QI;""
07 Balears, Illes;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
07 Balears, Illes;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QIII;11.022
07 Balears, Illes;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QII;""
07 Balears, Illes;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QI;""
07 Balears, Illes;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
07 Balears, Illes;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QIII;10.464
07 Balears, Illes;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QII;""
07 Balears, Illes;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QI;""
07 Balears, Illes;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
07 Balears, Illes;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
07 Balears, Illes;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QII;""
07 Balears, Illes;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QI;""
07 Balears, Illes;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
07 Balears, Illes;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
07 Balears, Illes;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
07 Balears, Illes;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
07 Balears, Illes;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
07 Balears, Illes;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
07 Balears, Illes;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
07 Balears, Illes;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
07 Balears, Illes;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
07 Balears, Illes;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
07 Balears, Illes;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
07 Balears, Illes;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
07 Balears, Illes;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;89,31
07 Balears, Illes;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
07 Balears, Illes;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
07 Balears, Illes;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
07 Balears, Illes;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;90,93
07 Balears, Illes;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
07 Balears, Illes;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
07 Balears, Illes;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
07 Balears, Illes;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;92,01
07 Balears, Illes;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
07 Balears, Illes;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
07 Balears, Illes;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
07 Balears, Illes;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
07 Balears, Illes;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
07 Balears, Illes;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
07 Balears, Illes;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;87,63
07 Balears, Illes;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
07 Balears, Illes;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
07 Balears, Illes;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
07 Balears, Illes;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;88,49
07 Balears, Illes;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
07 Balears, Illes;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
07 Balears, Illes;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
07 Balears, Illes;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
07 Balears, Illes;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
07 Balears, Illes;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
07 Balears, Illes;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;84,52
07 Balears, Illes;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
07 Balears, Illes;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
07 Balears, Illes;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
07 Balears, Illes;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;85,27
07 Balears, Illes;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
07 Balears, Illes;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
07 Balears, Illes;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
07 Balears, Illes;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
07 Balears, Illes;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
07 Balears, Illes;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
07 Balears, Illes;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;81,38
07 Balears, Illes;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
07 Balears, Illes;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
07 Balears, Illes;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
07 Balears, Illes;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;82,32
07 Balears, Illes;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
07 Balears, Illes;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
07 Balears, Illes;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
07 Balears, Illes;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
07 Balears, Illes;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
07 Balears, Illes;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
07 Balears, Illes;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QIV;9.173
07 Balears, Illes;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
07 Balears, Illes;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
07 Balears, Illes;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
07 Balears, Illes;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QIV;8.709
07 Balears, Illes;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
07 Balears, Illes;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
07 Balears, Illes;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
07 Balears, Illes;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QIV;8.204
07 Balears, Illes;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
07 Balears, Illes;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
07 Balears, Illes;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
07 Balears, Illes;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2022QIV;8.248
07 Balears, Illes;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
07 Balears, Illes;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2022QII;""
07 Balears, Illes;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2022QI;""
07 Balears, Illes;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2021QIV;7.979
07 Balears, Illes;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
07 Balears, Illes;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2021QII;""
07 Balears, Illes;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2021QI;""
07 Balears, Illes;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2020QIV;7.574
07 Balears, Illes;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
07 Balears, Illes;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2020QII;""
07 Balears, Illes;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2020QI;""
07 Balears, Illes;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
07 Balears, Illes;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
07 Balears, Illes;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2022QII;""
07 Balears, Illes;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2022QI;7.689
07 Balears, Illes;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
07 Balears, Illes;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
07 Balears, Illes;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2021QII;""
07 Balears, Illes;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2021QI;7.276
07 Balears, Illes;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
07 Balears, Illes;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
07 Balears, Illes;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2020QII;""
07 Balears, Illes;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2020QI;""
07 Balears, Illes;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
07 Balears, Illes;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
07 Balears, Illes;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QII;7.430
07 Balears, Illes;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QI;""
07 Balears, Illes;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
07 Balears, Illes;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
07 Balears, Illes;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QII;7.024
07 Balears, Illes;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QI;""
07 Balears, Illes;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
07 Balears, Illes;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
07 Balears, Illes;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QII;""
07 Balears, Illes;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QI;""
07 Balears, Illes;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
07 Balears, Illes;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QIII;7.177
07 Balears, Illes;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QII;""
07 Balears, Illes;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QI;""
07 Balears, Illes;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
07 Balears, Illes;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QIII;6.774
07 Balears, Illes;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QII;""
07 Balears, Illes;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QI;""
07 Balears, Illes;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
07 Balears, Illes;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
07 Balears, Illes;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QII;""
07 Balears, Illes;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QI;""
07 Balears, Illes;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
07 Balears, Illes;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
07 Balears, Illes;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
07 Balears, Illes;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
07 Balears, Illes;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
07 Balears, Illes;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
07 Balears, Illes;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
07 Balears, Illes;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
07 Balears, Illes;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
07 Balears, Illes;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
07 Balears, Illes;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
07 Balears, Illes;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
07 Balears, Illes;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;89,92
07 Balears, Illes;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
07 Balears, Illes;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
07 Balears, Illes;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
07 Balears, Illes;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;91,62
07 Balears, Illes;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
07 Balears, Illes;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
07 Balears, Illes;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
07 Balears, Illes;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;92,32
07 Balears, Illes;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
07 Balears, Illes;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
07 Balears, Illes;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
07 Balears, Illes;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
07 Balears, Illes;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
07 Balears, Illes;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
07 Balears, Illes;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;88,29
07 Balears, Illes;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
07 Balears, Illes;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
07 Balears, Illes;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
07 Balears, Illes;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;88,69
07 Balears, Illes;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
07 Balears, Illes;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
07 Balears, Illes;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
07 Balears, Illes;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
07 Balears, Illes;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
07 Balears, Illes;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
07 Balears, Illes;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;85,31
07 Balears, Illes;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
07 Balears, Illes;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
07 Balears, Illes;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
07 Balears, Illes;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;85,62
07 Balears, Illes;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
07 Balears, Illes;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
07 Balears, Illes;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
07 Balears, Illes;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
07 Balears, Illes;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
07 Balears, Illes;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
07 Balears, Illes;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;82,41
07 Balears, Illes;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
07 Balears, Illes;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
07 Balears, Illes;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
07 Balears, Illes;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;82,57
07 Balears, Illes;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
07 Balears, Illes;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
07 Balears, Illes;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
07 Balears, Illes;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
07 Balears, Illes;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
07 Balears, Illes;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
07 Balears, Illes;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QIV;5.009
07 Balears, Illes;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
07 Balears, Illes;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
07 Balears, Illes;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
07 Balears, Illes;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QIV;4.835
07 Balears, Illes;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
07 Balears, Illes;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
07 Balears, Illes;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
07 Balears, Illes;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QIV;4.507
07 Balears, Illes;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
07 Balears, Illes;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
07 Balears, Illes;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
07 Balears, Illes;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2022QIV;4.418
07 Balears, Illes;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
07 Balears, Illes;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2022QII;""
07 Balears, Illes;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2022QI;""
07 Balears, Illes;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2021QIV;4.337
07 Balears, Illes;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
07 Balears, Illes;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2021QII;""
07 Balears, Illes;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2021QI;""
07 Balears, Illes;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2020QIV;4.122
07 Balears, Illes;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
07 Balears, Illes;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2020QII;""
07 Balears, Illes;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2020QI;""
07 Balears, Illes;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
07 Balears, Illes;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
07 Balears, Illes;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2022QII;""
07 Balears, Illes;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2022QI;4.180
07 Balears, Illes;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
07 Balears, Illes;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
07 Balears, Illes;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2021QII;""
07 Balears, Illes;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2021QI;3.972
07 Balears, Illes;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
07 Balears, Illes;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
07 Balears, Illes;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2020QII;""
07 Balears, Illes;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2020QI;""
07 Balears, Illes;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
07 Balears, Illes;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
07 Balears, Illes;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QII;4.017
07 Balears, Illes;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QI;""
07 Balears, Illes;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
07 Balears, Illes;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
07 Balears, Illes;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QII;3.815
07 Balears, Illes;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QI;""
07 Balears, Illes;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
07 Balears, Illes;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
07 Balears, Illes;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QII;""
07 Balears, Illes;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QI;""
07 Balears, Illes;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
07 Balears, Illes;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QIII;3.845
07 Balears, Illes;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QII;""
07 Balears, Illes;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QI;""
07 Balears, Illes;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
07 Balears, Illes;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QIII;3.690
07 Balears, Illes;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QII;""
07 Balears, Illes;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QI;""
07 Balears, Illes;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
07 Balears, Illes;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
07 Balears, Illes;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QII;""
07 Balears, Illes;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QI;""
07 Balears, Illes;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
07 Balears, Illes;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
07 Balears, Illes;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
07 Balears, Illes;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
07 Balears, Illes;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
07 Balears, Illes;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
07 Balears, Illes;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
07 Balears, Illes;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
07 Balears, Illes;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
07 Balears, Illes;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
07 Balears, Illes;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
07 Balears, Illes;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
07 Balears, Illes;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;88,2
07 Balears, Illes;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
07 Balears, Illes;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
07 Balears, Illes;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
07 Balears, Illes;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;89,7
07 Balears, Illes;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
07 Balears, Illes;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
07 Balears, Illes;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
07 Balears, Illes;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;91,46
07 Balears, Illes;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
07 Balears, Illes;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
07 Balears, Illes;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
07 Balears, Illes;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
07 Balears, Illes;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
07 Balears, Illes;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
07 Balears, Illes;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;86,45
07 Balears, Illes;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
07 Balears, Illes;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
07 Balears, Illes;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
07 Balears, Illes;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;88,13
07 Balears, Illes;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
07 Balears, Illes;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
07 Balears, Illes;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
07 Balears, Illes;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
07 Balears, Illes;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
07 Balears, Illes;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
07 Balears, Illes;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;83,08
07 Balears, Illes;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
07 Balears, Illes;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
07 Balears, Illes;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
07 Balears, Illes;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;84,65
07 Balears, Illes;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
07 Balears, Illes;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
07 Balears, Illes;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
07 Balears, Illes;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
07 Balears, Illes;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
07 Balears, Illes;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
07 Balears, Illes;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;79,52
07 Balears, Illes;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
07 Balears, Illes;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
07 Balears, Illes;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
07 Balears, Illes;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;81,87
07 Balears, Illes;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
07 Balears, Illes;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
07 Balears, Illes;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
07 Balears, Illes;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
07 Balears, Illes;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
07 Balears, Illes;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
08 Barcelona;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
08 Barcelona;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
08 Barcelona;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
08 Barcelona;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QI;395.020
08 Barcelona;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
08 Barcelona;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
08 Barcelona;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
08 Barcelona;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QI;387.275
08 Barcelona;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
08 Barcelona;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
08 Barcelona;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
08 Barcelona;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QI;390.831
08 Barcelona;All ages;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
08 Barcelona;All ages;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
08 Barcelona;All ages;Cohort January 1;Total;Survival in the first trimester;2022QII;""
08 Barcelona;All ages;Cohort January 1;Total;Survival in the first trimester;2022QI;380.096
08 Barcelona;All ages;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
08 Barcelona;All ages;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
08 Barcelona;All ages;Cohort January 1;Total;Survival in the first trimester;2021QII;""
08 Barcelona;All ages;Cohort January 1;Total;Survival in the first trimester;2021QI;376.162
08 Barcelona;All ages;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
08 Barcelona;All ages;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
08 Barcelona;All ages;Cohort January 1;Total;Survival in the first trimester;2020QII;""
08 Barcelona;All ages;Cohort January 1;Total;Survival in the first trimester;2020QI;366.294
08 Barcelona;All ages;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
08 Barcelona;All ages;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
08 Barcelona;All ages;Cohort January 1;Total;Survival in the second trimester;2022QII;366.515
08 Barcelona;All ages;Cohort January 1;Total;Survival in the second trimester;2022QI;""
08 Barcelona;All ages;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
08 Barcelona;All ages;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
08 Barcelona;All ages;Cohort January 1;Total;Survival in the second trimester;2021QII;364.559
08 Barcelona;All ages;Cohort January 1;Total;Survival in the second trimester;2021QI;""
08 Barcelona;All ages;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
08 Barcelona;All ages;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
08 Barcelona;All ages;Cohort January 1;Total;Survival in the second trimester;2020QII;358.511
08 Barcelona;All ages;Cohort January 1;Total;Survival in the second trimester;2020QI;""
08 Barcelona;All ages;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
08 Barcelona;All ages;Cohort January 1;Total;Survival in the third trimester;2022QIII;355.435
08 Barcelona;All ages;Cohort January 1;Total;Survival in the third trimester;2022QII;""
08 Barcelona;All ages;Cohort January 1;Total;Survival in the third trimester;2022QI;""
08 Barcelona;All ages;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
08 Barcelona;All ages;Cohort January 1;Total;Survival in the third trimester;2021QIII;354.206
08 Barcelona;All ages;Cohort January 1;Total;Survival in the third trimester;2021QII;""
08 Barcelona;All ages;Cohort January 1;Total;Survival in the third trimester;2021QI;""
08 Barcelona;All ages;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
08 Barcelona;All ages;Cohort January 1;Total;Survival in the third trimester;2020QIII;348.463
08 Barcelona;All ages;Cohort January 1;Total;Survival in the third trimester;2020QII;""
08 Barcelona;All ages;Cohort January 1;Total;Survival in the third trimester;2020QI;""
08 Barcelona;All ages;Cohort January 1;Total;Survival in the third trimester;2022QIV;342.675
08 Barcelona;All ages;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
08 Barcelona;All ages;Cohort January 1;Total;Survival in the third trimester;2022QII;""
08 Barcelona;All ages;Cohort January 1;Total;Survival in the third trimester;2022QI;""
08 Barcelona;All ages;Cohort January 1;Total;Survival in the third trimester;2021QIV;342.863
08 Barcelona;All ages;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
08 Barcelona;All ages;Cohort January 1;Total;Survival in the third trimester;2021QII;""
08 Barcelona;All ages;Cohort January 1;Total;Survival in the third trimester;2021QI;""
08 Barcelona;All ages;Cohort January 1;Total;Survival in the third trimester;2020QIV;338.202
08 Barcelona;All ages;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
08 Barcelona;All ages;Cohort January 1;Total;Survival in the third trimester;2020QII;""
08 Barcelona;All ages;Cohort January 1;Total;Survival in the third trimester;2020QI;""
08 Barcelona;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
08 Barcelona;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
08 Barcelona;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
08 Barcelona;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
08 Barcelona;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
08 Barcelona;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
08 Barcelona;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
08 Barcelona;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
08 Barcelona;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
08 Barcelona;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
08 Barcelona;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
08 Barcelona;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
08 Barcelona;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
08 Barcelona;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
08 Barcelona;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
08 Barcelona;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;96,22
08 Barcelona;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
08 Barcelona;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
08 Barcelona;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
08 Barcelona;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;97,13
08 Barcelona;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
08 Barcelona;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
08 Barcelona;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
08 Barcelona;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;93,72
08 Barcelona;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
08 Barcelona;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
08 Barcelona;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;92,78
08 Barcelona;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
08 Barcelona;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
08 Barcelona;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
08 Barcelona;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;94,13
08 Barcelona;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
08 Barcelona;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
08 Barcelona;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
08 Barcelona;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;91,73
08 Barcelona;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
08 Barcelona;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
08 Barcelona;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;89,98
08 Barcelona;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
08 Barcelona;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
08 Barcelona;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
08 Barcelona;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;91,46
08 Barcelona;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
08 Barcelona;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
08 Barcelona;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
08 Barcelona;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;89,16
08 Barcelona;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
08 Barcelona;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
08 Barcelona;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;86,75
08 Barcelona;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
08 Barcelona;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
08 Barcelona;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
08 Barcelona;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;88,53
08 Barcelona;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
08 Barcelona;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
08 Barcelona;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
08 Barcelona;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;86,53
08 Barcelona;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
08 Barcelona;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
08 Barcelona;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
08 Barcelona;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
08 Barcelona;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
08 Barcelona;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
08 Barcelona;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QI;250.232
08 Barcelona;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
08 Barcelona;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
08 Barcelona;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
08 Barcelona;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QI;247.583
08 Barcelona;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
08 Barcelona;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
08 Barcelona;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
08 Barcelona;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QI;249.369
08 Barcelona;All ages;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
08 Barcelona;All ages;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
08 Barcelona;All ages;Cohort January 1;Males;Survival in the first trimester;2022QII;""
08 Barcelona;All ages;Cohort January 1;Males;Survival in the first trimester;2022QI;241.098
08 Barcelona;All ages;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
08 Barcelona;All ages;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
08 Barcelona;All ages;Cohort January 1;Males;Survival in the first trimester;2021QII;""
08 Barcelona;All ages;Cohort January 1;Males;Survival in the first trimester;2021QI;240.595
08 Barcelona;All ages;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
08 Barcelona;All ages;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
08 Barcelona;All ages;Cohort January 1;Males;Survival in the first trimester;2020QII;""
08 Barcelona;All ages;Cohort January 1;Males;Survival in the first trimester;2020QI;234.754
08 Barcelona;All ages;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
08 Barcelona;All ages;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
08 Barcelona;All ages;Cohort January 1;Males;Survival in the second trimester;2022QII;233.027
08 Barcelona;All ages;Cohort January 1;Males;Survival in the second trimester;2022QI;""
08 Barcelona;All ages;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
08 Barcelona;All ages;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
08 Barcelona;All ages;Cohort January 1;Males;Survival in the second trimester;2021QII;233.424
08 Barcelona;All ages;Cohort January 1;Males;Survival in the second trimester;2021QI;""
08 Barcelona;All ages;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
08 Barcelona;All ages;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
08 Barcelona;All ages;Cohort January 1;Males;Survival in the second trimester;2020QII;230.236
08 Barcelona;All ages;Cohort January 1;Males;Survival in the second trimester;2020QI;""
08 Barcelona;All ages;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
08 Barcelona;All ages;Cohort January 1;Males;Survival in the third trimester;2022QIII;226.428
08 Barcelona;All ages;Cohort January 1;Males;Survival in the third trimester;2022QII;""
08 Barcelona;All ages;Cohort January 1;Males;Survival in the third trimester;2022QI;""
08 Barcelona;All ages;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
08 Barcelona;All ages;Cohort January 1;Males;Survival in the third trimester;2021QIII;226.961
08 Barcelona;All ages;Cohort January 1;Males;Survival in the third trimester;2021QII;""
08 Barcelona;All ages;Cohort January 1;Males;Survival in the third trimester;2021QI;""
08 Barcelona;All ages;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
08 Barcelona;All ages;Cohort January 1;Males;Survival in the third trimester;2020QIII;224.282
08 Barcelona;All ages;Cohort January 1;Males;Survival in the third trimester;2020QII;""
08 Barcelona;All ages;Cohort January 1;Males;Survival in the third trimester;2020QI;""
08 Barcelona;All ages;Cohort January 1;Males;Survival in the third trimester;2022QIV;218.595
08 Barcelona;All ages;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
08 Barcelona;All ages;Cohort January 1;Males;Survival in the third trimester;2022QII;""
08 Barcelona;All ages;Cohort January 1;Males;Survival in the third trimester;2022QI;""
08 Barcelona;All ages;Cohort January 1;Males;Survival in the third trimester;2021QIV;219.801
08 Barcelona;All ages;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
08 Barcelona;All ages;Cohort January 1;Males;Survival in the third trimester;2021QII;""
08 Barcelona;All ages;Cohort January 1;Males;Survival in the third trimester;2021QI;""
08 Barcelona;All ages;Cohort January 1;Males;Survival in the third trimester;2020QIV;218.025
08 Barcelona;All ages;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
08 Barcelona;All ages;Cohort January 1;Males;Survival in the third trimester;2020QII;""
08 Barcelona;All ages;Cohort January 1;Males;Survival in the third trimester;2020QI;""
08 Barcelona;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
08 Barcelona;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
08 Barcelona;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
08 Barcelona;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
08 Barcelona;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
08 Barcelona;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
08 Barcelona;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
08 Barcelona;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
08 Barcelona;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
08 Barcelona;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
08 Barcelona;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
08 Barcelona;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
08 Barcelona;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
08 Barcelona;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
08 Barcelona;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
08 Barcelona;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;96,35
08 Barcelona;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
08 Barcelona;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
08 Barcelona;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
08 Barcelona;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;97,18
08 Barcelona;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
08 Barcelona;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
08 Barcelona;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
08 Barcelona;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;94,14
08 Barcelona;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
08 Barcelona;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
08 Barcelona;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;93,12
08 Barcelona;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
08 Barcelona;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
08 Barcelona;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
08 Barcelona;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;94,28
08 Barcelona;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
08 Barcelona;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
08 Barcelona;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
08 Barcelona;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;92,33
08 Barcelona;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
08 Barcelona;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
08 Barcelona;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;90,49
08 Barcelona;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
08 Barcelona;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
08 Barcelona;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
08 Barcelona;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;91,67
08 Barcelona;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
08 Barcelona;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
08 Barcelona;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
08 Barcelona;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;89,94
08 Barcelona;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
08 Barcelona;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
08 Barcelona;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;87,36
08 Barcelona;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
08 Barcelona;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
08 Barcelona;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
08 Barcelona;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;88,78
08 Barcelona;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
08 Barcelona;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
08 Barcelona;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
08 Barcelona;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;87,43
08 Barcelona;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
08 Barcelona;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
08 Barcelona;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
08 Barcelona;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
08 Barcelona;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
08 Barcelona;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
08 Barcelona;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QI;144.788
08 Barcelona;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
08 Barcelona;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
08 Barcelona;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
08 Barcelona;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QI;139.692
08 Barcelona;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
08 Barcelona;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
08 Barcelona;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
08 Barcelona;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QI;141.462
08 Barcelona;All ages;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
08 Barcelona;All ages;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
08 Barcelona;All ages;Cohort January 1;Females;Survival in the first trimester;2022QII;""
08 Barcelona;All ages;Cohort January 1;Females;Survival in the first trimester;2022QI;138.998
08 Barcelona;All ages;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
08 Barcelona;All ages;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
08 Barcelona;All ages;Cohort January 1;Females;Survival in the first trimester;2021QII;""
08 Barcelona;All ages;Cohort January 1;Females;Survival in the first trimester;2021QI;135.567
08 Barcelona;All ages;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
08 Barcelona;All ages;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
08 Barcelona;All ages;Cohort January 1;Females;Survival in the first trimester;2020QII;""
08 Barcelona;All ages;Cohort January 1;Females;Survival in the first trimester;2020QI;131.540
08 Barcelona;All ages;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
08 Barcelona;All ages;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
08 Barcelona;All ages;Cohort January 1;Females;Survival in the second trimester;2022QII;133.488
08 Barcelona;All ages;Cohort January 1;Females;Survival in the second trimester;2022QI;""
08 Barcelona;All ages;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
08 Barcelona;All ages;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
08 Barcelona;All ages;Cohort January 1;Females;Survival in the second trimester;2021QII;131.135
08 Barcelona;All ages;Cohort January 1;Females;Survival in the second trimester;2021QI;""
08 Barcelona;All ages;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
08 Barcelona;All ages;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
08 Barcelona;All ages;Cohort January 1;Females;Survival in the second trimester;2020QII;128.275
08 Barcelona;All ages;Cohort January 1;Females;Survival in the second trimester;2020QI;""
08 Barcelona;All ages;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
08 Barcelona;All ages;Cohort January 1;Females;Survival in the third trimester;2022QIII;129.007
08 Barcelona;All ages;Cohort January 1;Females;Survival in the third trimester;2022QII;""
08 Barcelona;All ages;Cohort January 1;Females;Survival in the third trimester;2022QI;""
08 Barcelona;All ages;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
08 Barcelona;All ages;Cohort January 1;Females;Survival in the third trimester;2021QIII;127.245
08 Barcelona;All ages;Cohort January 1;Females;Survival in the third trimester;2021QII;""
08 Barcelona;All ages;Cohort January 1;Females;Survival in the third trimester;2021QI;""
08 Barcelona;All ages;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
08 Barcelona;All ages;Cohort January 1;Females;Survival in the third trimester;2020QIII;124.181
08 Barcelona;All ages;Cohort January 1;Females;Survival in the third trimester;2020QII;""
08 Barcelona;All ages;Cohort January 1;Females;Survival in the third trimester;2020QI;""
08 Barcelona;All ages;Cohort January 1;Females;Survival in the third trimester;2022QIV;124.080
08 Barcelona;All ages;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
08 Barcelona;All ages;Cohort January 1;Females;Survival in the third trimester;2022QII;""
08 Barcelona;All ages;Cohort January 1;Females;Survival in the third trimester;2022QI;""
08 Barcelona;All ages;Cohort January 1;Females;Survival in the third trimester;2021QIV;123.062
08 Barcelona;All ages;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
08 Barcelona;All ages;Cohort January 1;Females;Survival in the third trimester;2021QII;""
08 Barcelona;All ages;Cohort January 1;Females;Survival in the third trimester;2021QI;""
08 Barcelona;All ages;Cohort January 1;Females;Survival in the third trimester;2020QIV;120.177
08 Barcelona;All ages;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
08 Barcelona;All ages;Cohort January 1;Females;Survival in the third trimester;2020QII;""
08 Barcelona;All ages;Cohort January 1;Females;Survival in the third trimester;2020QI;""
08 Barcelona;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
08 Barcelona;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
08 Barcelona;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
08 Barcelona;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
08 Barcelona;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
08 Barcelona;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
08 Barcelona;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
08 Barcelona;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
08 Barcelona;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
08 Barcelona;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
08 Barcelona;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
08 Barcelona;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
08 Barcelona;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
08 Barcelona;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
08 Barcelona;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
08 Barcelona;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;96
08 Barcelona;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
08 Barcelona;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
08 Barcelona;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
08 Barcelona;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;97,05
08 Barcelona;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
08 Barcelona;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
08 Barcelona;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
08 Barcelona;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;92,99
08 Barcelona;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
08 Barcelona;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
08 Barcelona;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;92,2
08 Barcelona;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
08 Barcelona;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
08 Barcelona;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
08 Barcelona;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;93,87
08 Barcelona;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
08 Barcelona;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
08 Barcelona;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
08 Barcelona;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;90,68
08 Barcelona;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
08 Barcelona;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
08 Barcelona;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;89,1
08 Barcelona;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
08 Barcelona;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
08 Barcelona;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
08 Barcelona;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;91,09
08 Barcelona;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
08 Barcelona;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
08 Barcelona;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
08 Barcelona;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;87,78
08 Barcelona;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
08 Barcelona;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
08 Barcelona;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;85,7
08 Barcelona;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
08 Barcelona;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
08 Barcelona;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
08 Barcelona;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;88,1
08 Barcelona;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
08 Barcelona;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
08 Barcelona;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
08 Barcelona;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;84,95
08 Barcelona;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
08 Barcelona;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
08 Barcelona;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
08 Barcelona;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
08 Barcelona;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
08 Barcelona;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QII;396.216
08 Barcelona;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
08 Barcelona;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
08 Barcelona;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
08 Barcelona;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QII;392.258
08 Barcelona;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
08 Barcelona;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
08 Barcelona;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
08 Barcelona;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QII;384.574
08 Barcelona;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
08 Barcelona;All ages;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
08 Barcelona;All ages;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
08 Barcelona;All ages;Cohort April 1;Total;Survival in the first trimester;2022QII;381.000
08 Barcelona;All ages;Cohort April 1;Total;Survival in the first trimester;2022QI;""
08 Barcelona;All ages;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
08 Barcelona;All ages;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
08 Barcelona;All ages;Cohort April 1;Total;Survival in the first trimester;2021QII;378.916
08 Barcelona;All ages;Cohort April 1;Total;Survival in the first trimester;2021QI;""
08 Barcelona;All ages;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
08 Barcelona;All ages;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
08 Barcelona;All ages;Cohort April 1;Total;Survival in the first trimester;2020QII;375.603
08 Barcelona;All ages;Cohort April 1;Total;Survival in the first trimester;2020QI;""
08 Barcelona;All ages;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
08 Barcelona;All ages;Cohort April 1;Total;Survival in the second trimester;2022QIII;368.794
08 Barcelona;All ages;Cohort April 1;Total;Survival in the second trimester;2022QII;""
08 Barcelona;All ages;Cohort April 1;Total;Survival in the second trimester;2022QI;""
08 Barcelona;All ages;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
08 Barcelona;All ages;Cohort April 1;Total;Survival in the second trimester;2021QIII;367.343
08 Barcelona;All ages;Cohort April 1;Total;Survival in the second trimester;2021QII;""
08 Barcelona;All ages;Cohort April 1;Total;Survival in the second trimester;2021QI;""
08 Barcelona;All ages;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
08 Barcelona;All ages;Cohort April 1;Total;Survival in the second trimester;2020QIII;363.662
08 Barcelona;All ages;Cohort April 1;Total;Survival in the second trimester;2020QII;""
08 Barcelona;All ages;Cohort April 1;Total;Survival in the second trimester;2020QI;""
08 Barcelona;All ages;Cohort April 1;Total;Survival in the third trimester;2022QIV;354.886
08 Barcelona;All ages;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
08 Barcelona;All ages;Cohort April 1;Total;Survival in the third trimester;2022QII;""
08 Barcelona;All ages;Cohort April 1;Total;Survival in the third trimester;2022QI;""
08 Barcelona;All ages;Cohort April 1;Total;Survival in the third trimester;2021QIV;354.924
08 Barcelona;All ages;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
08 Barcelona;All ages;Cohort April 1;Total;Survival in the third trimester;2021QII;""
08 Barcelona;All ages;Cohort April 1;Total;Survival in the third trimester;2021QI;""
08 Barcelona;All ages;Cohort April 1;Total;Survival in the third trimester;2020QIV;352.268
08 Barcelona;All ages;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
08 Barcelona;All ages;Cohort April 1;Total;Survival in the third trimester;2020QII;""
08 Barcelona;All ages;Cohort April 1;Total;Survival in the third trimester;2020QI;""
08 Barcelona;All ages;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
08 Barcelona;All ages;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
08 Barcelona;All ages;Cohort April 1;Total;Survival in the third trimester;2022QII;""
08 Barcelona;All ages;Cohort April 1;Total;Survival in the third trimester;2022QI;343.763
08 Barcelona;All ages;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
08 Barcelona;All ages;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
08 Barcelona;All ages;Cohort April 1;Total;Survival in the third trimester;2021QII;""
08 Barcelona;All ages;Cohort April 1;Total;Survival in the third trimester;2021QI;343.970
08 Barcelona;All ages;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
08 Barcelona;All ages;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
08 Barcelona;All ages;Cohort April 1;Total;Survival in the third trimester;2020QII;""
08 Barcelona;All ages;Cohort April 1;Total;Survival in the third trimester;2020QI;""
08 Barcelona;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
08 Barcelona;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
08 Barcelona;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
08 Barcelona;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
08 Barcelona;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
08 Barcelona;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
08 Barcelona;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
08 Barcelona;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
08 Barcelona;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
08 Barcelona;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
08 Barcelona;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
08 Barcelona;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
08 Barcelona;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
08 Barcelona;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
08 Barcelona;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;96,16
08 Barcelona;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
08 Barcelona;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
08 Barcelona;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
08 Barcelona;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;96,6
08 Barcelona;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
08 Barcelona;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
08 Barcelona;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
08 Barcelona;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;97,67
08 Barcelona;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
08 Barcelona;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
08 Barcelona;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;93,08
08 Barcelona;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
08 Barcelona;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
08 Barcelona;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
08 Barcelona;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;93,65
08 Barcelona;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
08 Barcelona;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
08 Barcelona;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
08 Barcelona;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;94,56
08 Barcelona;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
08 Barcelona;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
08 Barcelona;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;89,57
08 Barcelona;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
08 Barcelona;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
08 Barcelona;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
08 Barcelona;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;90,48
08 Barcelona;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
08 Barcelona;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
08 Barcelona;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
08 Barcelona;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;91,6
08 Barcelona;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
08 Barcelona;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
08 Barcelona;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
08 Barcelona;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
08 Barcelona;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
08 Barcelona;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
08 Barcelona;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;87,64
08 Barcelona;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
08 Barcelona;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
08 Barcelona;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
08 Barcelona;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;89,44
08 Barcelona;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
08 Barcelona;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
08 Barcelona;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
08 Barcelona;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
08 Barcelona;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
08 Barcelona;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
08 Barcelona;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QII;250.676
08 Barcelona;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
08 Barcelona;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
08 Barcelona;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
08 Barcelona;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QII;250.298
08 Barcelona;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
08 Barcelona;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
08 Barcelona;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
08 Barcelona;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QII;245.864
08 Barcelona;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
08 Barcelona;All ages;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
08 Barcelona;All ages;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
08 Barcelona;All ages;Cohort April 1;Males;Survival in the first trimester;2022QII;241.588
08 Barcelona;All ages;Cohort April 1;Males;Survival in the first trimester;2022QI;""
08 Barcelona;All ages;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
08 Barcelona;All ages;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
08 Barcelona;All ages;Cohort April 1;Males;Survival in the first trimester;2021QII;241.973
08 Barcelona;All ages;Cohort April 1;Males;Survival in the first trimester;2021QI;""
08 Barcelona;All ages;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
08 Barcelona;All ages;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
08 Barcelona;All ages;Cohort April 1;Males;Survival in the first trimester;2020QII;240.600
08 Barcelona;All ages;Cohort April 1;Males;Survival in the first trimester;2020QI;""
08 Barcelona;All ages;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
08 Barcelona;All ages;Cohort April 1;Males;Survival in the second trimester;2022QIII;234.347
08 Barcelona;All ages;Cohort April 1;Males;Survival in the second trimester;2022QII;""
08 Barcelona;All ages;Cohort April 1;Males;Survival in the second trimester;2022QI;""
08 Barcelona;All ages;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
08 Barcelona;All ages;Cohort April 1;Males;Survival in the second trimester;2021QIII;234.734
08 Barcelona;All ages;Cohort April 1;Males;Survival in the second trimester;2021QII;""
08 Barcelona;All ages;Cohort April 1;Males;Survival in the second trimester;2021QI;""
08 Barcelona;All ages;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
08 Barcelona;All ages;Cohort April 1;Males;Survival in the second trimester;2020QIII;233.439
08 Barcelona;All ages;Cohort April 1;Males;Survival in the second trimester;2020QII;""
08 Barcelona;All ages;Cohort April 1;Males;Survival in the second trimester;2020QI;""
08 Barcelona;All ages;Cohort April 1;Males;Survival in the third trimester;2022QIV;225.832
08 Barcelona;All ages;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
08 Barcelona;All ages;Cohort April 1;Males;Survival in the third trimester;2022QII;""
08 Barcelona;All ages;Cohort April 1;Males;Survival in the third trimester;2022QI;""
08 Barcelona;All ages;Cohort April 1;Males;Survival in the third trimester;2021QIV;226.915
08 Barcelona;All ages;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
08 Barcelona;All ages;Cohort April 1;Males;Survival in the third trimester;2021QII;""
08 Barcelona;All ages;Cohort April 1;Males;Survival in the third trimester;2021QI;""
08 Barcelona;All ages;Cohort April 1;Males;Survival in the third trimester;2020QIV;226.508
08 Barcelona;All ages;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
08 Barcelona;All ages;Cohort April 1;Males;Survival in the third trimester;2020QII;""
08 Barcelona;All ages;Cohort April 1;Males;Survival in the third trimester;2020QI;""
08 Barcelona;All ages;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
08 Barcelona;All ages;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
08 Barcelona;All ages;Cohort April 1;Males;Survival in the third trimester;2022QII;""
08 Barcelona;All ages;Cohort April 1;Males;Survival in the third trimester;2022QI;220.028
08 Barcelona;All ages;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
08 Barcelona;All ages;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
08 Barcelona;All ages;Cohort April 1;Males;Survival in the third trimester;2021QII;""
08 Barcelona;All ages;Cohort April 1;Males;Survival in the third trimester;2021QI;221.309
08 Barcelona;All ages;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
08 Barcelona;All ages;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
08 Barcelona;All ages;Cohort April 1;Males;Survival in the third trimester;2020QII;""
08 Barcelona;All ages;Cohort April 1;Males;Survival in the third trimester;2020QI;""
08 Barcelona;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
08 Barcelona;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
08 Barcelona;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
08 Barcelona;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
08 Barcelona;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
08 Barcelona;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
08 Barcelona;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
08 Barcelona;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
08 Barcelona;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
08 Barcelona;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
08 Barcelona;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
08 Barcelona;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
08 Barcelona;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
08 Barcelona;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
08 Barcelona;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;96,37
08 Barcelona;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
08 Barcelona;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
08 Barcelona;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
08 Barcelona;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;96,67
08 Barcelona;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
08 Barcelona;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
08 Barcelona;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
08 Barcelona;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;97,86
08 Barcelona;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
08 Barcelona;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
08 Barcelona;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;93,49
08 Barcelona;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
08 Barcelona;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
08 Barcelona;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
08 Barcelona;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;93,78
08 Barcelona;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
08 Barcelona;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
08 Barcelona;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
08 Barcelona;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;94,95
08 Barcelona;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
08 Barcelona;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
08 Barcelona;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;90,09
08 Barcelona;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
08 Barcelona;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
08 Barcelona;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
08 Barcelona;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;90,66
08 Barcelona;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
08 Barcelona;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
08 Barcelona;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
08 Barcelona;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;92,13
08 Barcelona;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
08 Barcelona;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
08 Barcelona;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
08 Barcelona;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
08 Barcelona;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
08 Barcelona;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
08 Barcelona;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;87,91
08 Barcelona;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
08 Barcelona;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
08 Barcelona;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
08 Barcelona;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;90,01
08 Barcelona;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
08 Barcelona;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
08 Barcelona;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
08 Barcelona;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
08 Barcelona;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
08 Barcelona;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
08 Barcelona;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QII;145.540
08 Barcelona;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
08 Barcelona;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
08 Barcelona;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
08 Barcelona;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QII;141.960
08 Barcelona;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
08 Barcelona;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
08 Barcelona;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
08 Barcelona;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QII;138.710
08 Barcelona;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
08 Barcelona;All ages;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
08 Barcelona;All ages;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
08 Barcelona;All ages;Cohort April 1;Females;Survival in the first trimester;2022QII;139.412
08 Barcelona;All ages;Cohort April 1;Females;Survival in the first trimester;2022QI;""
08 Barcelona;All ages;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
08 Barcelona;All ages;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
08 Barcelona;All ages;Cohort April 1;Females;Survival in the first trimester;2021QII;136.943
08 Barcelona;All ages;Cohort April 1;Females;Survival in the first trimester;2021QI;""
08 Barcelona;All ages;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
08 Barcelona;All ages;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
08 Barcelona;All ages;Cohort April 1;Females;Survival in the first trimester;2020QII;135.003
08 Barcelona;All ages;Cohort April 1;Females;Survival in the first trimester;2020QI;""
08 Barcelona;All ages;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
08 Barcelona;All ages;Cohort April 1;Females;Survival in the second trimester;2022QIII;134.447
08 Barcelona;All ages;Cohort April 1;Females;Survival in the second trimester;2022QII;""
08 Barcelona;All ages;Cohort April 1;Females;Survival in the second trimester;2022QI;""
08 Barcelona;All ages;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
08 Barcelona;All ages;Cohort April 1;Females;Survival in the second trimester;2021QIII;132.609
08 Barcelona;All ages;Cohort April 1;Females;Survival in the second trimester;2021QII;""
08 Barcelona;All ages;Cohort April 1;Females;Survival in the second trimester;2021QI;""
08 Barcelona;All ages;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
08 Barcelona;All ages;Cohort April 1;Females;Survival in the second trimester;2020QIII;130.223
08 Barcelona;All ages;Cohort April 1;Females;Survival in the second trimester;2020QII;""
08 Barcelona;All ages;Cohort April 1;Females;Survival in the second trimester;2020QI;""
08 Barcelona;All ages;Cohort April 1;Females;Survival in the third trimester;2022QIV;129.054
08 Barcelona;All ages;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
08 Barcelona;All ages;Cohort April 1;Females;Survival in the third trimester;2022QII;""
08 Barcelona;All ages;Cohort April 1;Females;Survival in the third trimester;2022QI;""
08 Barcelona;All ages;Cohort April 1;Females;Survival in the third trimester;2021QIV;128.009
08 Barcelona;All ages;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
08 Barcelona;All ages;Cohort April 1;Females;Survival in the third trimester;2021QII;""
08 Barcelona;All ages;Cohort April 1;Females;Survival in the third trimester;2021QI;""
08 Barcelona;All ages;Cohort April 1;Females;Survival in the third trimester;2020QIV;125.760
08 Barcelona;All ages;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
08 Barcelona;All ages;Cohort April 1;Females;Survival in the third trimester;2020QII;""
08 Barcelona;All ages;Cohort April 1;Females;Survival in the third trimester;2020QI;""
08 Barcelona;All ages;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
08 Barcelona;All ages;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
08 Barcelona;All ages;Cohort April 1;Females;Survival in the third trimester;2022QII;""
08 Barcelona;All ages;Cohort April 1;Females;Survival in the third trimester;2022QI;123.735
08 Barcelona;All ages;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
08 Barcelona;All ages;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
08 Barcelona;All ages;Cohort April 1;Females;Survival in the third trimester;2021QII;""
08 Barcelona;All ages;Cohort April 1;Females;Survival in the third trimester;2021QI;122.661
08 Barcelona;All ages;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
08 Barcelona;All ages;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
08 Barcelona;All ages;Cohort April 1;Females;Survival in the third trimester;2020QII;""
08 Barcelona;All ages;Cohort April 1;Females;Survival in the third trimester;2020QI;""
08 Barcelona;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
08 Barcelona;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
08 Barcelona;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
08 Barcelona;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
08 Barcelona;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
08 Barcelona;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
08 Barcelona;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
08 Barcelona;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
08 Barcelona;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
08 Barcelona;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
08 Barcelona;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
08 Barcelona;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
08 Barcelona;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
08 Barcelona;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
08 Barcelona;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;95,79
08 Barcelona;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
08 Barcelona;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
08 Barcelona;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
08 Barcelona;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;96,47
08 Barcelona;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
08 Barcelona;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
08 Barcelona;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
08 Barcelona;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;97,33
08 Barcelona;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
08 Barcelona;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
08 Barcelona;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;92,38
08 Barcelona;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
08 Barcelona;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
08 Barcelona;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
08 Barcelona;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;93,41
08 Barcelona;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
08 Barcelona;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
08 Barcelona;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
08 Barcelona;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;93,88
08 Barcelona;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
08 Barcelona;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
08 Barcelona;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;88,67
08 Barcelona;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
08 Barcelona;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
08 Barcelona;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
08 Barcelona;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;90,17
08 Barcelona;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
08 Barcelona;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
08 Barcelona;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
08 Barcelona;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;90,66
08 Barcelona;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
08 Barcelona;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
08 Barcelona;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
08 Barcelona;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
08 Barcelona;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
08 Barcelona;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
08 Barcelona;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;87,16
08 Barcelona;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
08 Barcelona;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
08 Barcelona;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
08 Barcelona;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;88,43
08 Barcelona;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
08 Barcelona;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
08 Barcelona;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
08 Barcelona;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
08 Barcelona;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
08 Barcelona;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QIII;396.479
08 Barcelona;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
08 Barcelona;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
08 Barcelona;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
08 Barcelona;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QIII;394.866
08 Barcelona;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
08 Barcelona;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
08 Barcelona;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
08 Barcelona;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QIII;385.330
08 Barcelona;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
08 Barcelona;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
08 Barcelona;All ages;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
08 Barcelona;All ages;Cohort July 1;Total;Survival in the first trimester;2022QIII;382.407
08 Barcelona;All ages;Cohort July 1;Total;Survival in the first trimester;2022QII;""
08 Barcelona;All ages;Cohort July 1;Total;Survival in the first trimester;2022QI;""
08 Barcelona;All ages;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
08 Barcelona;All ages;Cohort July 1;Total;Survival in the first trimester;2021QIII;381.408
08 Barcelona;All ages;Cohort July 1;Total;Survival in the first trimester;2021QII;""
08 Barcelona;All ages;Cohort July 1;Total;Survival in the first trimester;2021QI;""
08 Barcelona;All ages;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
08 Barcelona;All ages;Cohort July 1;Total;Survival in the first trimester;2020QIII;372.092
08 Barcelona;All ages;Cohort July 1;Total;Survival in the first trimester;2020QII;""
08 Barcelona;All ages;Cohort July 1;Total;Survival in the first trimester;2020QI;""
08 Barcelona;All ages;Cohort July 1;Total;Survival in the second trimester;2022QIV;366.982
08 Barcelona;All ages;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
08 Barcelona;All ages;Cohort July 1;Total;Survival in the second trimester;2022QII;""
08 Barcelona;All ages;Cohort July 1;Total;Survival in the second trimester;2022QI;""
08 Barcelona;All ages;Cohort July 1;Total;Survival in the second trimester;2021QIV;367.606
08 Barcelona;All ages;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
08 Barcelona;All ages;Cohort July 1;Total;Survival in the second trimester;2021QII;""
08 Barcelona;All ages;Cohort July 1;Total;Survival in the second trimester;2021QI;""
08 Barcelona;All ages;Cohort July 1;Total;Survival in the second trimester;2020QIV;359.877
08 Barcelona;All ages;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
08 Barcelona;All ages;Cohort July 1;Total;Survival in the second trimester;2020QII;""
08 Barcelona;All ages;Cohort July 1;Total;Survival in the second trimester;2020QI;""
08 Barcelona;All ages;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
08 Barcelona;All ages;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
08 Barcelona;All ages;Cohort July 1;Total;Survival in the third trimester;2022QII;""
08 Barcelona;All ages;Cohort July 1;Total;Survival in the third trimester;2022QI;355.431
08 Barcelona;All ages;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
08 Barcelona;All ages;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
08 Barcelona;All ages;Cohort July 1;Total;Survival in the third trimester;2021QII;""
08 Barcelona;All ages;Cohort July 1;Total;Survival in the third trimester;2021QI;351.124
08 Barcelona;All ages;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
08 Barcelona;All ages;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
08 Barcelona;All ages;Cohort July 1;Total;Survival in the third trimester;2020QII;""
08 Barcelona;All ages;Cohort July 1;Total;Survival in the third trimester;2020QI;""
08 Barcelona;All ages;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
08 Barcelona;All ages;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
08 Barcelona;All ages;Cohort July 1;Total;Survival in the third trimester;2022QII;344.196
08 Barcelona;All ages;Cohort July 1;Total;Survival in the third trimester;2022QI;""
08 Barcelona;All ages;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
08 Barcelona;All ages;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
08 Barcelona;All ages;Cohort July 1;Total;Survival in the third trimester;2021QII;341.803
08 Barcelona;All ages;Cohort July 1;Total;Survival in the third trimester;2021QI;""
08 Barcelona;All ages;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
08 Barcelona;All ages;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
08 Barcelona;All ages;Cohort July 1;Total;Survival in the third trimester;2020QII;""
08 Barcelona;All ages;Cohort July 1;Total;Survival in the third trimester;2020QI;""
08 Barcelona;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
08 Barcelona;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
08 Barcelona;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
08 Barcelona;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
08 Barcelona;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
08 Barcelona;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
08 Barcelona;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
08 Barcelona;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
08 Barcelona;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
08 Barcelona;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
08 Barcelona;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
08 Barcelona;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
08 Barcelona;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
08 Barcelona;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;96,45
08 Barcelona;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
08 Barcelona;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
08 Barcelona;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
08 Barcelona;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;96,59
08 Barcelona;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
08 Barcelona;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
08 Barcelona;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
08 Barcelona;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;96,56
08 Barcelona;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
08 Barcelona;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
08 Barcelona;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;92,56
08 Barcelona;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
08 Barcelona;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
08 Barcelona;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
08 Barcelona;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;93,1
08 Barcelona;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
08 Barcelona;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
08 Barcelona;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
08 Barcelona;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;93,39
08 Barcelona;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
08 Barcelona;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
08 Barcelona;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
08 Barcelona;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
08 Barcelona;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
08 Barcelona;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
08 Barcelona;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;90,01
08 Barcelona;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
08 Barcelona;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
08 Barcelona;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
08 Barcelona;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;91,12
08 Barcelona;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
08 Barcelona;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
08 Barcelona;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
08 Barcelona;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
08 Barcelona;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
08 Barcelona;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
08 Barcelona;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;87,17
08 Barcelona;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
08 Barcelona;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
08 Barcelona;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
08 Barcelona;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;88,7
08 Barcelona;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
08 Barcelona;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
08 Barcelona;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
08 Barcelona;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
08 Barcelona;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
08 Barcelona;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
08 Barcelona;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QIII;250.693
08 Barcelona;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
08 Barcelona;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
08 Barcelona;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
08 Barcelona;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QIII;251.392
08 Barcelona;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
08 Barcelona;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
08 Barcelona;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
08 Barcelona;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QIII;246.744
08 Barcelona;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
08 Barcelona;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
08 Barcelona;All ages;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
08 Barcelona;All ages;Cohort July 1;Males;Survival in the first trimester;2022QIII;242.332
08 Barcelona;All ages;Cohort July 1;Males;Survival in the first trimester;2022QII;""
08 Barcelona;All ages;Cohort July 1;Males;Survival in the first trimester;2022QI;""
08 Barcelona;All ages;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
08 Barcelona;All ages;Cohort July 1;Males;Survival in the first trimester;2021QIII;242.971
08 Barcelona;All ages;Cohort July 1;Males;Survival in the first trimester;2021QII;""
08 Barcelona;All ages;Cohort July 1;Males;Survival in the first trimester;2021QI;""
08 Barcelona;All ages;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
08 Barcelona;All ages;Cohort July 1;Males;Survival in the first trimester;2020QIII;238.779
08 Barcelona;All ages;Cohort July 1;Males;Survival in the first trimester;2020QII;""
08 Barcelona;All ages;Cohort July 1;Males;Survival in the first trimester;2020QI;""
08 Barcelona;All ages;Cohort July 1;Males;Survival in the second trimester;2022QIV;232.916
08 Barcelona;All ages;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
08 Barcelona;All ages;Cohort July 1;Males;Survival in the second trimester;2022QII;""
08 Barcelona;All ages;Cohort July 1;Males;Survival in the second trimester;2022QI;""
08 Barcelona;All ages;Cohort July 1;Males;Survival in the second trimester;2021QIV;234.309
08 Barcelona;All ages;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
08 Barcelona;All ages;Cohort July 1;Males;Survival in the second trimester;2021QII;""
08 Barcelona;All ages;Cohort July 1;Males;Survival in the second trimester;2021QI;""
08 Barcelona;All ages;Cohort July 1;Males;Survival in the second trimester;2020QIV;231.314
08 Barcelona;All ages;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
08 Barcelona;All ages;Cohort July 1;Males;Survival in the second trimester;2020QII;""
08 Barcelona;All ages;Cohort July 1;Males;Survival in the second trimester;2020QI;""
08 Barcelona;All ages;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
08 Barcelona;All ages;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
08 Barcelona;All ages;Cohort July 1;Males;Survival in the third trimester;2022QII;""
08 Barcelona;All ages;Cohort July 1;Males;Survival in the third trimester;2022QI;226.823
08 Barcelona;All ages;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
08 Barcelona;All ages;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
08 Barcelona;All ages;Cohort July 1;Males;Survival in the third trimester;2021QII;""
08 Barcelona;All ages;Cohort July 1;Males;Survival in the third trimester;2021QI;225.820
08 Barcelona;All ages;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
08 Barcelona;All ages;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
08 Barcelona;All ages;Cohort July 1;Males;Survival in the third trimester;2020QII;""
08 Barcelona;All ages;Cohort July 1;Males;Survival in the third trimester;2020QI;""
08 Barcelona;All ages;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
08 Barcelona;All ages;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
08 Barcelona;All ages;Cohort July 1;Males;Survival in the third trimester;2022QII;220.079
08 Barcelona;All ages;Cohort July 1;Males;Survival in the third trimester;2022QI;""
08 Barcelona;All ages;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
08 Barcelona;All ages;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
08 Barcelona;All ages;Cohort July 1;Males;Survival in the third trimester;2021QII;220.049
08 Barcelona;All ages;Cohort July 1;Males;Survival in the third trimester;2021QI;""
08 Barcelona;All ages;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
08 Barcelona;All ages;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
08 Barcelona;All ages;Cohort July 1;Males;Survival in the third trimester;2020QII;""
08 Barcelona;All ages;Cohort July 1;Males;Survival in the third trimester;2020QI;""
08 Barcelona;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
08 Barcelona;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
08 Barcelona;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
08 Barcelona;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
08 Barcelona;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
08 Barcelona;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
08 Barcelona;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
08 Barcelona;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
08 Barcelona;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
08 Barcelona;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
08 Barcelona;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
08 Barcelona;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
08 Barcelona;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
08 Barcelona;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;96,66
08 Barcelona;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
08 Barcelona;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
08 Barcelona;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
08 Barcelona;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;96,65
08 Barcelona;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
08 Barcelona;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
08 Barcelona;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
08 Barcelona;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;96,77
08 Barcelona;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
08 Barcelona;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
08 Barcelona;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;92,91
08 Barcelona;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
08 Barcelona;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
08 Barcelona;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
08 Barcelona;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;93,2
08 Barcelona;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
08 Barcelona;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
08 Barcelona;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
08 Barcelona;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;93,75
08 Barcelona;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
08 Barcelona;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
08 Barcelona;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
08 Barcelona;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
08 Barcelona;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
08 Barcelona;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
08 Barcelona;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;90,23
08 Barcelona;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
08 Barcelona;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
08 Barcelona;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
08 Barcelona;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;91,52
08 Barcelona;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
08 Barcelona;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
08 Barcelona;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
08 Barcelona;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
08 Barcelona;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
08 Barcelona;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
08 Barcelona;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;87,54
08 Barcelona;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
08 Barcelona;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
08 Barcelona;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
08 Barcelona;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;89,18
08 Barcelona;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
08 Barcelona;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
08 Barcelona;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
08 Barcelona;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
08 Barcelona;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
08 Barcelona;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
08 Barcelona;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QIII;145.786
08 Barcelona;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
08 Barcelona;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
08 Barcelona;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
08 Barcelona;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QIII;143.474
08 Barcelona;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
08 Barcelona;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
08 Barcelona;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
08 Barcelona;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QIII;138.586
08 Barcelona;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
08 Barcelona;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
08 Barcelona;All ages;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
08 Barcelona;All ages;Cohort July 1;Females;Survival in the first trimester;2022QIII;140.075
08 Barcelona;All ages;Cohort July 1;Females;Survival in the first trimester;2022QII;""
08 Barcelona;All ages;Cohort July 1;Females;Survival in the first trimester;2022QI;""
08 Barcelona;All ages;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
08 Barcelona;All ages;Cohort July 1;Females;Survival in the first trimester;2021QIII;138.437
08 Barcelona;All ages;Cohort July 1;Females;Survival in the first trimester;2021QII;""
08 Barcelona;All ages;Cohort July 1;Females;Survival in the first trimester;2021QI;""
08 Barcelona;All ages;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
08 Barcelona;All ages;Cohort July 1;Females;Survival in the first trimester;2020QIII;133.313
08 Barcelona;All ages;Cohort July 1;Females;Survival in the first trimester;2020QII;""
08 Barcelona;All ages;Cohort July 1;Females;Survival in the first trimester;2020QI;""
08 Barcelona;All ages;Cohort July 1;Females;Survival in the second trimester;2022QIV;134.066
08 Barcelona;All ages;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
08 Barcelona;All ages;Cohort July 1;Females;Survival in the second trimester;2022QII;""
08 Barcelona;All ages;Cohort July 1;Females;Survival in the second trimester;2022QI;""
08 Barcelona;All ages;Cohort July 1;Females;Survival in the second trimester;2021QIV;133.297
08 Barcelona;All ages;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
08 Barcelona;All ages;Cohort July 1;Females;Survival in the second trimester;2021QII;""
08 Barcelona;All ages;Cohort July 1;Females;Survival in the second trimester;2021QI;""
08 Barcelona;All ages;Cohort July 1;Females;Survival in the second trimester;2020QIV;128.563
08 Barcelona;All ages;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
08 Barcelona;All ages;Cohort July 1;Females;Survival in the second trimester;2020QII;""
08 Barcelona;All ages;Cohort July 1;Females;Survival in the second trimester;2020QI;""
08 Barcelona;All ages;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
08 Barcelona;All ages;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
08 Barcelona;All ages;Cohort July 1;Females;Survival in the third trimester;2022QII;""
08 Barcelona;All ages;Cohort July 1;Females;Survival in the third trimester;2022QI;128.608
08 Barcelona;All ages;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
08 Barcelona;All ages;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
08 Barcelona;All ages;Cohort July 1;Females;Survival in the third trimester;2021QII;""
08 Barcelona;All ages;Cohort July 1;Females;Survival in the third trimester;2021QI;125.304
08 Barcelona;All ages;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
08 Barcelona;All ages;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
08 Barcelona;All ages;Cohort July 1;Females;Survival in the third trimester;2020QII;""
08 Barcelona;All ages;Cohort July 1;Females;Survival in the third trimester;2020QI;""
08 Barcelona;All ages;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
08 Barcelona;All ages;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
08 Barcelona;All ages;Cohort July 1;Females;Survival in the third trimester;2022QII;124.117
08 Barcelona;All ages;Cohort July 1;Females;Survival in the third trimester;2022QI;""
08 Barcelona;All ages;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
08 Barcelona;All ages;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
08 Barcelona;All ages;Cohort July 1;Females;Survival in the third trimester;2021QII;121.754
08 Barcelona;All ages;Cohort July 1;Females;Survival in the third trimester;2021QI;""
08 Barcelona;All ages;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
08 Barcelona;All ages;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
08 Barcelona;All ages;Cohort July 1;Females;Survival in the third trimester;2020QII;""
08 Barcelona;All ages;Cohort July 1;Females;Survival in the third trimester;2020QI;""
08 Barcelona;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
08 Barcelona;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
08 Barcelona;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
08 Barcelona;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
08 Barcelona;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
08 Barcelona;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
08 Barcelona;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
08 Barcelona;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
08 Barcelona;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
08 Barcelona;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
08 Barcelona;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
08 Barcelona;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
08 Barcelona;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
08 Barcelona;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;96,08
08 Barcelona;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
08 Barcelona;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
08 Barcelona;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
08 Barcelona;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;96,49
08 Barcelona;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
08 Barcelona;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
08 Barcelona;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
08 Barcelona;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;96,2
08 Barcelona;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
08 Barcelona;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
08 Barcelona;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;91,96
08 Barcelona;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
08 Barcelona;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
08 Barcelona;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
08 Barcelona;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;92,91
08 Barcelona;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
08 Barcelona;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
08 Barcelona;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
08 Barcelona;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;92,77
08 Barcelona;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
08 Barcelona;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
08 Barcelona;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
08 Barcelona;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
08 Barcelona;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
08 Barcelona;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
08 Barcelona;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;89,64
08 Barcelona;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
08 Barcelona;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
08 Barcelona;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
08 Barcelona;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;90,42
08 Barcelona;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
08 Barcelona;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
08 Barcelona;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
08 Barcelona;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
08 Barcelona;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
08 Barcelona;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
08 Barcelona;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;86,51
08 Barcelona;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
08 Barcelona;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
08 Barcelona;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
08 Barcelona;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;87,85
08 Barcelona;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
08 Barcelona;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
08 Barcelona;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
08 Barcelona;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
08 Barcelona;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
08 Barcelona;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QIV;395.116
08 Barcelona;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
08 Barcelona;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
08 Barcelona;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
08 Barcelona;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QIV;394.438
08 Barcelona;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
08 Barcelona;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
08 Barcelona;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
08 Barcelona;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QIV;385.473
08 Barcelona;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
08 Barcelona;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
08 Barcelona;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
08 Barcelona;All ages;Cohort October 1;Total;Survival in the first trimester;2022QIV;378.256
08 Barcelona;All ages;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
08 Barcelona;All ages;Cohort October 1;Total;Survival in the first trimester;2022QII;""
08 Barcelona;All ages;Cohort October 1;Total;Survival in the first trimester;2022QI;""
08 Barcelona;All ages;Cohort October 1;Total;Survival in the first trimester;2021QIV;379.248
08 Barcelona;All ages;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
08 Barcelona;All ages;Cohort October 1;Total;Survival in the first trimester;2021QII;""
08 Barcelona;All ages;Cohort October 1;Total;Survival in the first trimester;2021QI;""
08 Barcelona;All ages;Cohort October 1;Total;Survival in the first trimester;2020QIV;371.762
08 Barcelona;All ages;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
08 Barcelona;All ages;Cohort October 1;Total;Survival in the first trimester;2020QII;""
08 Barcelona;All ages;Cohort October 1;Total;Survival in the first trimester;2020QI;""
08 Barcelona;All ages;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
08 Barcelona;All ages;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
08 Barcelona;All ages;Cohort October 1;Total;Survival in the second trimester;2022QII;""
08 Barcelona;All ages;Cohort October 1;Total;Survival in the second trimester;2022QI;366.043
08 Barcelona;All ages;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
08 Barcelona;All ages;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
08 Barcelona;All ages;Cohort October 1;Total;Survival in the second trimester;2021QII;""
08 Barcelona;All ages;Cohort October 1;Total;Survival in the second trimester;2021QI;362.192
08 Barcelona;All ages;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
08 Barcelona;All ages;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
08 Barcelona;All ages;Cohort October 1;Total;Survival in the second trimester;2020QII;""
08 Barcelona;All ages;Cohort October 1;Total;Survival in the second trimester;2020QI;""
08 Barcelona;All ages;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
08 Barcelona;All ages;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
08 Barcelona;All ages;Cohort October 1;Total;Survival in the third trimester;2022QII;353.902
08 Barcelona;All ages;Cohort October 1;Total;Survival in the third trimester;2022QI;""
08 Barcelona;All ages;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
08 Barcelona;All ages;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
08 Barcelona;All ages;Cohort October 1;Total;Survival in the third trimester;2021QII;351.961
08 Barcelona;All ages;Cohort October 1;Total;Survival in the third trimester;2021QI;""
08 Barcelona;All ages;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
08 Barcelona;All ages;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
08 Barcelona;All ages;Cohort October 1;Total;Survival in the third trimester;2020QII;""
08 Barcelona;All ages;Cohort October 1;Total;Survival in the third trimester;2020QI;""
08 Barcelona;All ages;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
08 Barcelona;All ages;Cohort October 1;Total;Survival in the third trimester;2022QIII;343.796
08 Barcelona;All ages;Cohort October 1;Total;Survival in the third trimester;2022QII;""
08 Barcelona;All ages;Cohort October 1;Total;Survival in the third trimester;2022QI;""
08 Barcelona;All ages;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
08 Barcelona;All ages;Cohort October 1;Total;Survival in the third trimester;2021QIII;342.690
08 Barcelona;All ages;Cohort October 1;Total;Survival in the third trimester;2021QII;""
08 Barcelona;All ages;Cohort October 1;Total;Survival in the third trimester;2021QI;""
08 Barcelona;All ages;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
08 Barcelona;All ages;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
08 Barcelona;All ages;Cohort October 1;Total;Survival in the third trimester;2020QII;""
08 Barcelona;All ages;Cohort October 1;Total;Survival in the third trimester;2020QI;""
08 Barcelona;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
08 Barcelona;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
08 Barcelona;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
08 Barcelona;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
08 Barcelona;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
08 Barcelona;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
08 Barcelona;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
08 Barcelona;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
08 Barcelona;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
08 Barcelona;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
08 Barcelona;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
08 Barcelona;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
08 Barcelona;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;95,73
08 Barcelona;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
08 Barcelona;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
08 Barcelona;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
08 Barcelona;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;96,15
08 Barcelona;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
08 Barcelona;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
08 Barcelona;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
08 Barcelona;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;96,44
08 Barcelona;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
08 Barcelona;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
08 Barcelona;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
08 Barcelona;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
08 Barcelona;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
08 Barcelona;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
08 Barcelona;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;92,8
08 Barcelona;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
08 Barcelona;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
08 Barcelona;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
08 Barcelona;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;93,96
08 Barcelona;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
08 Barcelona;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
08 Barcelona;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
08 Barcelona;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
08 Barcelona;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
08 Barcelona;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
08 Barcelona;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;89,72
08 Barcelona;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
08 Barcelona;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
08 Barcelona;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
08 Barcelona;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;91,31
08 Barcelona;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
08 Barcelona;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
08 Barcelona;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
08 Barcelona;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
08 Barcelona;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
08 Barcelona;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
08 Barcelona;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;87,16
08 Barcelona;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
08 Barcelona;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
08 Barcelona;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
08 Barcelona;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;88,9
08 Barcelona;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
08 Barcelona;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
08 Barcelona;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
08 Barcelona;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
08 Barcelona;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
08 Barcelona;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
08 Barcelona;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QIV;249.758
08 Barcelona;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
08 Barcelona;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
08 Barcelona;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
08 Barcelona;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QIV;250.667
08 Barcelona;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
08 Barcelona;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
08 Barcelona;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
08 Barcelona;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QIV;246.843
08 Barcelona;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
08 Barcelona;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
08 Barcelona;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
08 Barcelona;All ages;Cohort October 1;Males;Survival in the first trimester;2022QIV;239.485
08 Barcelona;All ages;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
08 Barcelona;All ages;Cohort October 1;Males;Survival in the first trimester;2022QII;""
08 Barcelona;All ages;Cohort October 1;Males;Survival in the first trimester;2022QI;""
08 Barcelona;All ages;Cohort October 1;Males;Survival in the first trimester;2021QIV;241.150
08 Barcelona;All ages;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
08 Barcelona;All ages;Cohort October 1;Males;Survival in the first trimester;2021QII;""
08 Barcelona;All ages;Cohort October 1;Males;Survival in the first trimester;2021QI;""
08 Barcelona;All ages;Cohort October 1;Males;Survival in the first trimester;2020QIV;238.464
08 Barcelona;All ages;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
08 Barcelona;All ages;Cohort October 1;Males;Survival in the first trimester;2020QII;""
08 Barcelona;All ages;Cohort October 1;Males;Survival in the first trimester;2020QI;""
08 Barcelona;All ages;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
08 Barcelona;All ages;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
08 Barcelona;All ages;Cohort October 1;Males;Survival in the second trimester;2022QII;""
08 Barcelona;All ages;Cohort October 1;Males;Survival in the second trimester;2022QI;233.057
08 Barcelona;All ages;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
08 Barcelona;All ages;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
08 Barcelona;All ages;Cohort October 1;Males;Survival in the second trimester;2021QII;""
08 Barcelona;All ages;Cohort October 1;Males;Survival in the second trimester;2021QI;232.448
08 Barcelona;All ages;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
08 Barcelona;All ages;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
08 Barcelona;All ages;Cohort October 1;Males;Survival in the second trimester;2020QII;""
08 Barcelona;All ages;Cohort October 1;Males;Survival in the second trimester;2020QI;""
08 Barcelona;All ages;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
08 Barcelona;All ages;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
08 Barcelona;All ages;Cohort October 1;Males;Survival in the third trimester;2022QII;225.800
08 Barcelona;All ages;Cohort October 1;Males;Survival in the third trimester;2022QI;""
08 Barcelona;All ages;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
08 Barcelona;All ages;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
08 Barcelona;All ages;Cohort October 1;Males;Survival in the third trimester;2021QII;226.116
08 Barcelona;All ages;Cohort October 1;Males;Survival in the third trimester;2021QI;""
08 Barcelona;All ages;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
08 Barcelona;All ages;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
08 Barcelona;All ages;Cohort October 1;Males;Survival in the third trimester;2020QII;""
08 Barcelona;All ages;Cohort October 1;Males;Survival in the third trimester;2020QI;""
08 Barcelona;All ages;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
08 Barcelona;All ages;Cohort October 1;Males;Survival in the third trimester;2022QIII;219.747
08 Barcelona;All ages;Cohort October 1;Males;Survival in the third trimester;2022QII;""
08 Barcelona;All ages;Cohort October 1;Males;Survival in the third trimester;2022QI;""
08 Barcelona;All ages;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
08 Barcelona;All ages;Cohort October 1;Males;Survival in the third trimester;2021QIII;220.261
08 Barcelona;All ages;Cohort October 1;Males;Survival in the third trimester;2021QII;""
08 Barcelona;All ages;Cohort October 1;Males;Survival in the third trimester;2021QI;""
08 Barcelona;All ages;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
08 Barcelona;All ages;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
08 Barcelona;All ages;Cohort October 1;Males;Survival in the third trimester;2020QII;""
08 Barcelona;All ages;Cohort October 1;Males;Survival in the third trimester;2020QI;""
08 Barcelona;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
08 Barcelona;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
08 Barcelona;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
08 Barcelona;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
08 Barcelona;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
08 Barcelona;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
08 Barcelona;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
08 Barcelona;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
08 Barcelona;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
08 Barcelona;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
08 Barcelona;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
08 Barcelona;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
08 Barcelona;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;95,89
08 Barcelona;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
08 Barcelona;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
08 Barcelona;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
08 Barcelona;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;96,2
08 Barcelona;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
08 Barcelona;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
08 Barcelona;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
08 Barcelona;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;96,61
08 Barcelona;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
08 Barcelona;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
08 Barcelona;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
08 Barcelona;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
08 Barcelona;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
08 Barcelona;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
08 Barcelona;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;92,97
08 Barcelona;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
08 Barcelona;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
08 Barcelona;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
08 Barcelona;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;94,17
08 Barcelona;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
08 Barcelona;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
08 Barcelona;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
08 Barcelona;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
08 Barcelona;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
08 Barcelona;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
08 Barcelona;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;90,08
08 Barcelona;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
08 Barcelona;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
08 Barcelona;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
08 Barcelona;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;91,6
08 Barcelona;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
08 Barcelona;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
08 Barcelona;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
08 Barcelona;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
08 Barcelona;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
08 Barcelona;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
08 Barcelona;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;87,66
08 Barcelona;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
08 Barcelona;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
08 Barcelona;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
08 Barcelona;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;89,23
08 Barcelona;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
08 Barcelona;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
08 Barcelona;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
08 Barcelona;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
08 Barcelona;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
08 Barcelona;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
08 Barcelona;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QIV;145.358
08 Barcelona;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
08 Barcelona;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
08 Barcelona;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
08 Barcelona;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QIV;143.771
08 Barcelona;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
08 Barcelona;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
08 Barcelona;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
08 Barcelona;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QIV;138.630
08 Barcelona;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
08 Barcelona;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
08 Barcelona;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
08 Barcelona;All ages;Cohort October 1;Females;Survival in the first trimester;2022QIV;138.771
08 Barcelona;All ages;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
08 Barcelona;All ages;Cohort October 1;Females;Survival in the first trimester;2022QII;""
08 Barcelona;All ages;Cohort October 1;Females;Survival in the first trimester;2022QI;""
08 Barcelona;All ages;Cohort October 1;Females;Survival in the first trimester;2021QIV;138.098
08 Barcelona;All ages;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
08 Barcelona;All ages;Cohort October 1;Females;Survival in the first trimester;2021QII;""
08 Barcelona;All ages;Cohort October 1;Females;Survival in the first trimester;2021QI;""
08 Barcelona;All ages;Cohort October 1;Females;Survival in the first trimester;2020QIV;133.298
08 Barcelona;All ages;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
08 Barcelona;All ages;Cohort October 1;Females;Survival in the first trimester;2020QII;""
08 Barcelona;All ages;Cohort October 1;Females;Survival in the first trimester;2020QI;""
08 Barcelona;All ages;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
08 Barcelona;All ages;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
08 Barcelona;All ages;Cohort October 1;Females;Survival in the second trimester;2022QII;""
08 Barcelona;All ages;Cohort October 1;Females;Survival in the second trimester;2022QI;132.986
08 Barcelona;All ages;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
08 Barcelona;All ages;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
08 Barcelona;All ages;Cohort October 1;Females;Survival in the second trimester;2021QII;""
08 Barcelona;All ages;Cohort October 1;Females;Survival in the second trimester;2021QI;129.744
08 Barcelona;All ages;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
08 Barcelona;All ages;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
08 Barcelona;All ages;Cohort October 1;Females;Survival in the second trimester;2020QII;""
08 Barcelona;All ages;Cohort October 1;Females;Survival in the second trimester;2020QI;""
08 Barcelona;All ages;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
08 Barcelona;All ages;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
08 Barcelona;All ages;Cohort October 1;Females;Survival in the third trimester;2022QII;128.102
08 Barcelona;All ages;Cohort October 1;Females;Survival in the third trimester;2022QI;""
08 Barcelona;All ages;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
08 Barcelona;All ages;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
08 Barcelona;All ages;Cohort October 1;Females;Survival in the third trimester;2021QII;125.845
08 Barcelona;All ages;Cohort October 1;Females;Survival in the third trimester;2021QI;""
08 Barcelona;All ages;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
08 Barcelona;All ages;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
08 Barcelona;All ages;Cohort October 1;Females;Survival in the third trimester;2020QII;""
08 Barcelona;All ages;Cohort October 1;Females;Survival in the third trimester;2020QI;""
08 Barcelona;All ages;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
08 Barcelona;All ages;Cohort October 1;Females;Survival in the third trimester;2022QIII;124.049
08 Barcelona;All ages;Cohort October 1;Females;Survival in the third trimester;2022QII;""
08 Barcelona;All ages;Cohort October 1;Females;Survival in the third trimester;2022QI;""
08 Barcelona;All ages;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
08 Barcelona;All ages;Cohort October 1;Females;Survival in the third trimester;2021QIII;122.429
08 Barcelona;All ages;Cohort October 1;Females;Survival in the third trimester;2021QII;""
08 Barcelona;All ages;Cohort October 1;Females;Survival in the third trimester;2021QI;""
08 Barcelona;All ages;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
08 Barcelona;All ages;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
08 Barcelona;All ages;Cohort October 1;Females;Survival in the third trimester;2020QII;""
08 Barcelona;All ages;Cohort October 1;Females;Survival in the third trimester;2020QI;""
08 Barcelona;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
08 Barcelona;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
08 Barcelona;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
08 Barcelona;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
08 Barcelona;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
08 Barcelona;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
08 Barcelona;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
08 Barcelona;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
08 Barcelona;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
08 Barcelona;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
08 Barcelona;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
08 Barcelona;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
08 Barcelona;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;95,47
08 Barcelona;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
08 Barcelona;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
08 Barcelona;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
08 Barcelona;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;96,05
08 Barcelona;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
08 Barcelona;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
08 Barcelona;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
08 Barcelona;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;96,15
08 Barcelona;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
08 Barcelona;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
08 Barcelona;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
08 Barcelona;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
08 Barcelona;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
08 Barcelona;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
08 Barcelona;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;92,5
08 Barcelona;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
08 Barcelona;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
08 Barcelona;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
08 Barcelona;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;93,59
08 Barcelona;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
08 Barcelona;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
08 Barcelona;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
08 Barcelona;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
08 Barcelona;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
08 Barcelona;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
08 Barcelona;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;89,1
08 Barcelona;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
08 Barcelona;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
08 Barcelona;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
08 Barcelona;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;90,78
08 Barcelona;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
08 Barcelona;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
08 Barcelona;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
08 Barcelona;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
08 Barcelona;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
08 Barcelona;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
08 Barcelona;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;86,28
08 Barcelona;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
08 Barcelona;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
08 Barcelona;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
08 Barcelona;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;88,31
08 Barcelona;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
08 Barcelona;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
08 Barcelona;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
08 Barcelona;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
08 Barcelona;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
08 Barcelona;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
08 Barcelona;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
08 Barcelona;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
08 Barcelona;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
08 Barcelona;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QI;27.691
08 Barcelona;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
08 Barcelona;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
08 Barcelona;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
08 Barcelona;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QI;25.975
08 Barcelona;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
08 Barcelona;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
08 Barcelona;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
08 Barcelona;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QI;21.389
08 Barcelona;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
08 Barcelona;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
08 Barcelona;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2022QII;""
08 Barcelona;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2022QI;25.302
08 Barcelona;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
08 Barcelona;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
08 Barcelona;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2021QII;""
08 Barcelona;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2021QI;24.263
08 Barcelona;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
08 Barcelona;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
08 Barcelona;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2020QII;""
08 Barcelona;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2020QI;18.532
08 Barcelona;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
08 Barcelona;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
08 Barcelona;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2022QII;23.347
08 Barcelona;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2022QI;""
08 Barcelona;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
08 Barcelona;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
08 Barcelona;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2021QII;22.509
08 Barcelona;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2021QI;""
08 Barcelona;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
08 Barcelona;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
08 Barcelona;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2020QII;17.780
08 Barcelona;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2020QI;""
08 Barcelona;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
08 Barcelona;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QIII;21.691
08 Barcelona;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QII;""
08 Barcelona;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QI;""
08 Barcelona;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
08 Barcelona;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QIII;20.972
08 Barcelona;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QII;""
08 Barcelona;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QI;""
08 Barcelona;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
08 Barcelona;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QIII;16.643
08 Barcelona;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QII;""
08 Barcelona;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QI;""
08 Barcelona;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QIV;20.122
08 Barcelona;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
08 Barcelona;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QII;""
08 Barcelona;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QI;""
08 Barcelona;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QIV;19.493
08 Barcelona;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
08 Barcelona;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QII;""
08 Barcelona;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QI;""
08 Barcelona;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QIV;15.606
08 Barcelona;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
08 Barcelona;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QII;""
08 Barcelona;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QI;""
08 Barcelona;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
08 Barcelona;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
08 Barcelona;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
08 Barcelona;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
08 Barcelona;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
08 Barcelona;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
08 Barcelona;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
08 Barcelona;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
08 Barcelona;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
08 Barcelona;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
08 Barcelona;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
08 Barcelona;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
08 Barcelona;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
08 Barcelona;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
08 Barcelona;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
08 Barcelona;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;91,37
08 Barcelona;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
08 Barcelona;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
08 Barcelona;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
08 Barcelona;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;93,41
08 Barcelona;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
08 Barcelona;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
08 Barcelona;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
08 Barcelona;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;86,64
08 Barcelona;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
08 Barcelona;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
08 Barcelona;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;84,31
08 Barcelona;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
08 Barcelona;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
08 Barcelona;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
08 Barcelona;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;86,66
08 Barcelona;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
08 Barcelona;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
08 Barcelona;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
08 Barcelona;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;83,13
08 Barcelona;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
08 Barcelona;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
08 Barcelona;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;78,33
08 Barcelona;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
08 Barcelona;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
08 Barcelona;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
08 Barcelona;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;80,74
08 Barcelona;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
08 Barcelona;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
08 Barcelona;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
08 Barcelona;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;77,81
08 Barcelona;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
08 Barcelona;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
08 Barcelona;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;72,67
08 Barcelona;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
08 Barcelona;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
08 Barcelona;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
08 Barcelona;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;75,05
08 Barcelona;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
08 Barcelona;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
08 Barcelona;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
08 Barcelona;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;72,96
08 Barcelona;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
08 Barcelona;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
08 Barcelona;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
08 Barcelona;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
08 Barcelona;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
08 Barcelona;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
08 Barcelona;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QI;17.009
08 Barcelona;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
08 Barcelona;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
08 Barcelona;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
08 Barcelona;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QI;16.372
08 Barcelona;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
08 Barcelona;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
08 Barcelona;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
08 Barcelona;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QI;13.585
08 Barcelona;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
08 Barcelona;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
08 Barcelona;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2022QII;""
08 Barcelona;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2022QI;15.547
08 Barcelona;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
08 Barcelona;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
08 Barcelona;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2021QII;""
08 Barcelona;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2021QI;15.302
08 Barcelona;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
08 Barcelona;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
08 Barcelona;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2020QII;""
08 Barcelona;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2020QI;11.825
08 Barcelona;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
08 Barcelona;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
08 Barcelona;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2022QII;14.431
08 Barcelona;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2022QI;""
08 Barcelona;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
08 Barcelona;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
08 Barcelona;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2021QII;14.213
08 Barcelona;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2021QI;""
08 Barcelona;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
08 Barcelona;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
08 Barcelona;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2020QII;11.365
08 Barcelona;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2020QI;""
08 Barcelona;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
08 Barcelona;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QIII;13.436
08 Barcelona;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QII;""
08 Barcelona;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QI;""
08 Barcelona;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
08 Barcelona;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QIII;13.228
08 Barcelona;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QII;""
08 Barcelona;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QI;""
08 Barcelona;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
08 Barcelona;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QIII;10.681
08 Barcelona;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QII;""
08 Barcelona;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QI;""
08 Barcelona;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QIV;12.539
08 Barcelona;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
08 Barcelona;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QII;""
08 Barcelona;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QI;""
08 Barcelona;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QIV;12.295
08 Barcelona;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
08 Barcelona;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QII;""
08 Barcelona;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QI;""
08 Barcelona;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QIV;10.040
08 Barcelona;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
08 Barcelona;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QII;""
08 Barcelona;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QI;""
08 Barcelona;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
08 Barcelona;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
08 Barcelona;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
08 Barcelona;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
08 Barcelona;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
08 Barcelona;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
08 Barcelona;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
08 Barcelona;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
08 Barcelona;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
08 Barcelona;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
08 Barcelona;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
08 Barcelona;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
08 Barcelona;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
08 Barcelona;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
08 Barcelona;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
08 Barcelona;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;91,4
08 Barcelona;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
08 Barcelona;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
08 Barcelona;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
08 Barcelona;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;93,46
08 Barcelona;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
08 Barcelona;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
08 Barcelona;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
08 Barcelona;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;87,04
08 Barcelona;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
08 Barcelona;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
08 Barcelona;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;84,84
08 Barcelona;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
08 Barcelona;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
08 Barcelona;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
08 Barcelona;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;86,81
08 Barcelona;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
08 Barcelona;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
08 Barcelona;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
08 Barcelona;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;83,66
08 Barcelona;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
08 Barcelona;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
08 Barcelona;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;78,99
08 Barcelona;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
08 Barcelona;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
08 Barcelona;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
08 Barcelona;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;80,8
08 Barcelona;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
08 Barcelona;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
08 Barcelona;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
08 Barcelona;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;78,62
08 Barcelona;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
08 Barcelona;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
08 Barcelona;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;73,72
08 Barcelona;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
08 Barcelona;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
08 Barcelona;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
08 Barcelona;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;75,1
08 Barcelona;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
08 Barcelona;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
08 Barcelona;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
08 Barcelona;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;73,91
08 Barcelona;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
08 Barcelona;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
08 Barcelona;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
08 Barcelona;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
08 Barcelona;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
08 Barcelona;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
08 Barcelona;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QI;10.682
08 Barcelona;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
08 Barcelona;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
08 Barcelona;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
08 Barcelona;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QI;9.603
08 Barcelona;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
08 Barcelona;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
08 Barcelona;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
08 Barcelona;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QI;7.804
08 Barcelona;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
08 Barcelona;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
08 Barcelona;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2022QII;""
08 Barcelona;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2022QI;9.755
08 Barcelona;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
08 Barcelona;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
08 Barcelona;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2021QII;""
08 Barcelona;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2021QI;8.961
08 Barcelona;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
08 Barcelona;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
08 Barcelona;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2020QII;""
08 Barcelona;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2020QI;6.707
08 Barcelona;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
08 Barcelona;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
08 Barcelona;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2022QII;8.916
08 Barcelona;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2022QI;""
08 Barcelona;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
08 Barcelona;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
08 Barcelona;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2021QII;8.296
08 Barcelona;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2021QI;""
08 Barcelona;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
08 Barcelona;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
08 Barcelona;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2020QII;6.415
08 Barcelona;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2020QI;""
08 Barcelona;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
08 Barcelona;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QIII;8.255
08 Barcelona;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QII;""
08 Barcelona;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QI;""
08 Barcelona;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
08 Barcelona;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QIII;7.744
08 Barcelona;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QII;""
08 Barcelona;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QI;""
08 Barcelona;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
08 Barcelona;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QIII;5.962
08 Barcelona;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QII;""
08 Barcelona;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QI;""
08 Barcelona;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QIV;7.583
08 Barcelona;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
08 Barcelona;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QII;""
08 Barcelona;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QI;""
08 Barcelona;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QIV;7.198
08 Barcelona;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
08 Barcelona;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QII;""
08 Barcelona;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QI;""
08 Barcelona;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QIV;5.566
08 Barcelona;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
08 Barcelona;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QII;""
08 Barcelona;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QI;""
08 Barcelona;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
08 Barcelona;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
08 Barcelona;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
08 Barcelona;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
08 Barcelona;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
08 Barcelona;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
08 Barcelona;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
08 Barcelona;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
08 Barcelona;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
08 Barcelona;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
08 Barcelona;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
08 Barcelona;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
08 Barcelona;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
08 Barcelona;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
08 Barcelona;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
08 Barcelona;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;91,32
08 Barcelona;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
08 Barcelona;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
08 Barcelona;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
08 Barcelona;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;93,31
08 Barcelona;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
08 Barcelona;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
08 Barcelona;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
08 Barcelona;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;85,94
08 Barcelona;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
08 Barcelona;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
08 Barcelona;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;83,47
08 Barcelona;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
08 Barcelona;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
08 Barcelona;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
08 Barcelona;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;86,39
08 Barcelona;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
08 Barcelona;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
08 Barcelona;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
08 Barcelona;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;82,2
08 Barcelona;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
08 Barcelona;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
08 Barcelona;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;77,28
08 Barcelona;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
08 Barcelona;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
08 Barcelona;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
08 Barcelona;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;80,64
08 Barcelona;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
08 Barcelona;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
08 Barcelona;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
08 Barcelona;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;76,4
08 Barcelona;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
08 Barcelona;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
08 Barcelona;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;70,99
08 Barcelona;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
08 Barcelona;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
08 Barcelona;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
08 Barcelona;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;74,96
08 Barcelona;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
08 Barcelona;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
08 Barcelona;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
08 Barcelona;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;71,32
08 Barcelona;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
08 Barcelona;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
08 Barcelona;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
08 Barcelona;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
08 Barcelona;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
08 Barcelona;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QII;24.364
08 Barcelona;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
08 Barcelona;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
08 Barcelona;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
08 Barcelona;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QII;23.717
08 Barcelona;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
08 Barcelona;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
08 Barcelona;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
08 Barcelona;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QII;21.599
08 Barcelona;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
08 Barcelona;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
08 Barcelona;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
08 Barcelona;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2022QII;22.282
08 Barcelona;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2022QI;""
08 Barcelona;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
08 Barcelona;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
08 Barcelona;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2021QII;21.710
08 Barcelona;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2021QI;""
08 Barcelona;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
08 Barcelona;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
08 Barcelona;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2020QII;20.612
08 Barcelona;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2020QI;""
08 Barcelona;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
08 Barcelona;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2022QIII;20.596
08 Barcelona;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2022QII;""
08 Barcelona;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2022QI;""
08 Barcelona;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
08 Barcelona;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2021QIII;20.012
08 Barcelona;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2021QII;""
08 Barcelona;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2021QI;""
08 Barcelona;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
08 Barcelona;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2020QIII;19.178
08 Barcelona;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2020QII;""
08 Barcelona;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2020QI;""
08 Barcelona;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QIV;18.992
08 Barcelona;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
08 Barcelona;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QII;""
08 Barcelona;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QI;""
08 Barcelona;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QIV;18.431
08 Barcelona;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
08 Barcelona;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QII;""
08 Barcelona;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QI;""
08 Barcelona;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QIV;17.886
08 Barcelona;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
08 Barcelona;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QII;""
08 Barcelona;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QI;""
08 Barcelona;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
08 Barcelona;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
08 Barcelona;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QII;""
08 Barcelona;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QI;17.035
08 Barcelona;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
08 Barcelona;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
08 Barcelona;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QII;""
08 Barcelona;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QI;16.934
08 Barcelona;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
08 Barcelona;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
08 Barcelona;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QII;""
08 Barcelona;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QI;""
08 Barcelona;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
08 Barcelona;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
08 Barcelona;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
08 Barcelona;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
08 Barcelona;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
08 Barcelona;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
08 Barcelona;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
08 Barcelona;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
08 Barcelona;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
08 Barcelona;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
08 Barcelona;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
08 Barcelona;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
08 Barcelona;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
08 Barcelona;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
08 Barcelona;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;91,45
08 Barcelona;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
08 Barcelona;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
08 Barcelona;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
08 Barcelona;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;91,54
08 Barcelona;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
08 Barcelona;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
08 Barcelona;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
08 Barcelona;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;95,43
08 Barcelona;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
08 Barcelona;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
08 Barcelona;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;84,53
08 Barcelona;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
08 Barcelona;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
08 Barcelona;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
08 Barcelona;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;84,38
08 Barcelona;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
08 Barcelona;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
08 Barcelona;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
08 Barcelona;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;88,79
08 Barcelona;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
08 Barcelona;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
08 Barcelona;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;77,95
08 Barcelona;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
08 Barcelona;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
08 Barcelona;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
08 Barcelona;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;77,71
08 Barcelona;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
08 Barcelona;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
08 Barcelona;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
08 Barcelona;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;82,81
08 Barcelona;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
08 Barcelona;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
08 Barcelona;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
08 Barcelona;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
08 Barcelona;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
08 Barcelona;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
08 Barcelona;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;71,83
08 Barcelona;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
08 Barcelona;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
08 Barcelona;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
08 Barcelona;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;78,4
08 Barcelona;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
08 Barcelona;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
08 Barcelona;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
08 Barcelona;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
08 Barcelona;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
08 Barcelona;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
08 Barcelona;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QII;15.047
08 Barcelona;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
08 Barcelona;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
08 Barcelona;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
08 Barcelona;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QII;15.007
08 Barcelona;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
08 Barcelona;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
08 Barcelona;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
08 Barcelona;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QII;13.636
08 Barcelona;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
08 Barcelona;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
08 Barcelona;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
08 Barcelona;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2022QII;13.835
08 Barcelona;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2022QI;""
08 Barcelona;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
08 Barcelona;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
08 Barcelona;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2021QII;13.732
08 Barcelona;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2021QI;""
08 Barcelona;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
08 Barcelona;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
08 Barcelona;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2020QII;13.028
08 Barcelona;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2020QI;""
08 Barcelona;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
08 Barcelona;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2022QIII;12.816
08 Barcelona;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2022QII;""
08 Barcelona;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2022QI;""
08 Barcelona;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
08 Barcelona;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2021QIII;12.654
08 Barcelona;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2021QII;""
08 Barcelona;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2021QI;""
08 Barcelona;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
08 Barcelona;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2020QIII;12.181
08 Barcelona;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2020QII;""
08 Barcelona;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2020QI;""
08 Barcelona;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QIV;11.882
08 Barcelona;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
08 Barcelona;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QII;""
08 Barcelona;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QI;""
08 Barcelona;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QIV;11.662
08 Barcelona;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
08 Barcelona;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QII;""
08 Barcelona;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QI;""
08 Barcelona;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QIV;11.389
08 Barcelona;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
08 Barcelona;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QII;""
08 Barcelona;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QI;""
08 Barcelona;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
08 Barcelona;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
08 Barcelona;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QII;""
08 Barcelona;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QI;10.775
08 Barcelona;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
08 Barcelona;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
08 Barcelona;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QII;""
08 Barcelona;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QI;10.801
08 Barcelona;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
08 Barcelona;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
08 Barcelona;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QII;""
08 Barcelona;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QI;""
08 Barcelona;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
08 Barcelona;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
08 Barcelona;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
08 Barcelona;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
08 Barcelona;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
08 Barcelona;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
08 Barcelona;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
08 Barcelona;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
08 Barcelona;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
08 Barcelona;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
08 Barcelona;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
08 Barcelona;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
08 Barcelona;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
08 Barcelona;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
08 Barcelona;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;91,95
08 Barcelona;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
08 Barcelona;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
08 Barcelona;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
08 Barcelona;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;91,5
08 Barcelona;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
08 Barcelona;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
08 Barcelona;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
08 Barcelona;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;95,54
08 Barcelona;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
08 Barcelona;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
08 Barcelona;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;85,17
08 Barcelona;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
08 Barcelona;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
08 Barcelona;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
08 Barcelona;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;84,32
08 Barcelona;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
08 Barcelona;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
08 Barcelona;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
08 Barcelona;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;89,33
08 Barcelona;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
08 Barcelona;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
08 Barcelona;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;78,97
08 Barcelona;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
08 Barcelona;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
08 Barcelona;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
08 Barcelona;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;77,71
08 Barcelona;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
08 Barcelona;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
08 Barcelona;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
08 Barcelona;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;83,52
08 Barcelona;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
08 Barcelona;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
08 Barcelona;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
08 Barcelona;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
08 Barcelona;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
08 Barcelona;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
08 Barcelona;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;71,8
08 Barcelona;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
08 Barcelona;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
08 Barcelona;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
08 Barcelona;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;79,21
08 Barcelona;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
08 Barcelona;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
08 Barcelona;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
08 Barcelona;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
08 Barcelona;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
08 Barcelona;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
08 Barcelona;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QII;9.317
08 Barcelona;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
08 Barcelona;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
08 Barcelona;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
08 Barcelona;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QII;8.710
08 Barcelona;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
08 Barcelona;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
08 Barcelona;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
08 Barcelona;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QII;7.963
08 Barcelona;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
08 Barcelona;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
08 Barcelona;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
08 Barcelona;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2022QII;8.447
08 Barcelona;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2022QI;""
08 Barcelona;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
08 Barcelona;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
08 Barcelona;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2021QII;7.978
08 Barcelona;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2021QI;""
08 Barcelona;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
08 Barcelona;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
08 Barcelona;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2020QII;7.584
08 Barcelona;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2020QI;""
08 Barcelona;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
08 Barcelona;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2022QIII;7.780
08 Barcelona;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2022QII;""
08 Barcelona;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2022QI;""
08 Barcelona;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
08 Barcelona;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2021QIII;7.358
08 Barcelona;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2021QII;""
08 Barcelona;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2021QI;""
08 Barcelona;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
08 Barcelona;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2020QIII;6.997
08 Barcelona;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2020QII;""
08 Barcelona;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2020QI;""
08 Barcelona;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QIV;7.110
08 Barcelona;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
08 Barcelona;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QII;""
08 Barcelona;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QI;""
08 Barcelona;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QIV;6.769
08 Barcelona;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
08 Barcelona;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QII;""
08 Barcelona;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QI;""
08 Barcelona;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QIV;6.497
08 Barcelona;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
08 Barcelona;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QII;""
08 Barcelona;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QI;""
08 Barcelona;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
08 Barcelona;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
08 Barcelona;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QII;""
08 Barcelona;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QI;6.260
08 Barcelona;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
08 Barcelona;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
08 Barcelona;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QII;""
08 Barcelona;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QI;6.133
08 Barcelona;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
08 Barcelona;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
08 Barcelona;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QII;""
08 Barcelona;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QI;""
08 Barcelona;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
08 Barcelona;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
08 Barcelona;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
08 Barcelona;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
08 Barcelona;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
08 Barcelona;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
08 Barcelona;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
08 Barcelona;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
08 Barcelona;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
08 Barcelona;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
08 Barcelona;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
08 Barcelona;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
08 Barcelona;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
08 Barcelona;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
08 Barcelona;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;90,66
08 Barcelona;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
08 Barcelona;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
08 Barcelona;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
08 Barcelona;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;91,6
08 Barcelona;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
08 Barcelona;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
08 Barcelona;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
08 Barcelona;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;95,24
08 Barcelona;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
08 Barcelona;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
08 Barcelona;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;83,5
08 Barcelona;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
08 Barcelona;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
08 Barcelona;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
08 Barcelona;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;84,48
08 Barcelona;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
08 Barcelona;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
08 Barcelona;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
08 Barcelona;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;87,87
08 Barcelona;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
08 Barcelona;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
08 Barcelona;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;76,31
08 Barcelona;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
08 Barcelona;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
08 Barcelona;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
08 Barcelona;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;77,72
08 Barcelona;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
08 Barcelona;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
08 Barcelona;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
08 Barcelona;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;81,59
08 Barcelona;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
08 Barcelona;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
08 Barcelona;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
08 Barcelona;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
08 Barcelona;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
08 Barcelona;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
08 Barcelona;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;71,87
08 Barcelona;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
08 Barcelona;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
08 Barcelona;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
08 Barcelona;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;77,02
08 Barcelona;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
08 Barcelona;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
08 Barcelona;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
08 Barcelona;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
08 Barcelona;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
08 Barcelona;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QIII;25.494
08 Barcelona;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
08 Barcelona;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
08 Barcelona;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
08 Barcelona;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QIII;25.289
08 Barcelona;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
08 Barcelona;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
08 Barcelona;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
08 Barcelona;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QIII;22.537
08 Barcelona;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
08 Barcelona;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
08 Barcelona;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
08 Barcelona;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2022QIII;23.369
08 Barcelona;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2022QII;""
08 Barcelona;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2022QI;""
08 Barcelona;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
08 Barcelona;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2021QIII;23.119
08 Barcelona;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2021QII;""
08 Barcelona;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2021QI;""
08 Barcelona;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
08 Barcelona;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2020QIII;20.785
08 Barcelona;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2020QII;""
08 Barcelona;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2020QI;""
08 Barcelona;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2022QIV;21.447
08 Barcelona;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
08 Barcelona;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2022QII;""
08 Barcelona;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2022QI;""
08 Barcelona;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2021QIV;21.178
08 Barcelona;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
08 Barcelona;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2021QII;""
08 Barcelona;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2021QI;""
08 Barcelona;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2020QIV;19.306
08 Barcelona;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
08 Barcelona;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2020QII;""
08 Barcelona;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2020QI;""
08 Barcelona;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
08 Barcelona;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
08 Barcelona;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QII;""
08 Barcelona;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QI;19.513
08 Barcelona;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
08 Barcelona;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
08 Barcelona;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QII;""
08 Barcelona;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QI;18.235
08 Barcelona;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
08 Barcelona;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
08 Barcelona;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QII;""
08 Barcelona;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QI;""
08 Barcelona;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
08 Barcelona;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
08 Barcelona;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QII;18.163
08 Barcelona;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QI;""
08 Barcelona;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
08 Barcelona;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
08 Barcelona;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QII;17.148
08 Barcelona;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QI;""
08 Barcelona;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
08 Barcelona;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
08 Barcelona;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QII;""
08 Barcelona;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QI;""
08 Barcelona;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
08 Barcelona;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
08 Barcelona;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
08 Barcelona;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
08 Barcelona;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
08 Barcelona;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
08 Barcelona;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
08 Barcelona;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
08 Barcelona;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
08 Barcelona;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
08 Barcelona;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
08 Barcelona;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
08 Barcelona;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
08 Barcelona;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;91,66
08 Barcelona;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
08 Barcelona;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
08 Barcelona;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
08 Barcelona;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;91,42
08 Barcelona;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
08 Barcelona;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
08 Barcelona;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
08 Barcelona;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;92,23
08 Barcelona;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
08 Barcelona;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
08 Barcelona;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;84,13
08 Barcelona;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
08 Barcelona;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
08 Barcelona;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
08 Barcelona;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;83,74
08 Barcelona;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
08 Barcelona;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
08 Barcelona;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
08 Barcelona;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;85,66
08 Barcelona;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
08 Barcelona;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
08 Barcelona;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
08 Barcelona;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
08 Barcelona;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
08 Barcelona;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
08 Barcelona;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;77,16
08 Barcelona;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
08 Barcelona;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
08 Barcelona;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
08 Barcelona;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;80,91
08 Barcelona;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
08 Barcelona;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
08 Barcelona;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
08 Barcelona;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
08 Barcelona;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
08 Barcelona;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
08 Barcelona;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;71,82
08 Barcelona;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
08 Barcelona;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
08 Barcelona;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
08 Barcelona;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;76,09
08 Barcelona;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
08 Barcelona;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
08 Barcelona;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
08 Barcelona;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
08 Barcelona;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
08 Barcelona;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
08 Barcelona;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QIII;15.756
08 Barcelona;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
08 Barcelona;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
08 Barcelona;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
08 Barcelona;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QIII;15.858
08 Barcelona;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
08 Barcelona;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
08 Barcelona;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
08 Barcelona;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QIII;14.297
08 Barcelona;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
08 Barcelona;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
08 Barcelona;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
08 Barcelona;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2022QIII;14.481
08 Barcelona;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2022QII;""
08 Barcelona;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2022QI;""
08 Barcelona;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
08 Barcelona;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2021QIII;14.479
08 Barcelona;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2021QII;""
08 Barcelona;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2021QI;""
08 Barcelona;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
08 Barcelona;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2020QIII;13.248
08 Barcelona;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2020QII;""
08 Barcelona;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2020QI;""
08 Barcelona;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2022QIV;13.357
08 Barcelona;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
08 Barcelona;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2022QII;""
08 Barcelona;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2022QI;""
08 Barcelona;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2021QIV;13.274
08 Barcelona;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
08 Barcelona;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2021QII;""
08 Barcelona;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2021QI;""
08 Barcelona;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2020QIV;12.322
08 Barcelona;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
08 Barcelona;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2020QII;""
08 Barcelona;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2020QI;""
08 Barcelona;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
08 Barcelona;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
08 Barcelona;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QII;""
08 Barcelona;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QI;12.232
08 Barcelona;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
08 Barcelona;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
08 Barcelona;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QII;""
08 Barcelona;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QI;11.659
08 Barcelona;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
08 Barcelona;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
08 Barcelona;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QII;""
08 Barcelona;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QI;""
08 Barcelona;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
08 Barcelona;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
08 Barcelona;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QII;11.448
08 Barcelona;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QI;""
08 Barcelona;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
08 Barcelona;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
08 Barcelona;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QII;10.980
08 Barcelona;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QI;""
08 Barcelona;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
08 Barcelona;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
08 Barcelona;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QII;""
08 Barcelona;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QI;""
08 Barcelona;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
08 Barcelona;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
08 Barcelona;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
08 Barcelona;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
08 Barcelona;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
08 Barcelona;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
08 Barcelona;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
08 Barcelona;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
08 Barcelona;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
08 Barcelona;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
08 Barcelona;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
08 Barcelona;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
08 Barcelona;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
08 Barcelona;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;91,91
08 Barcelona;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
08 Barcelona;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
08 Barcelona;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
08 Barcelona;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;91,3
08 Barcelona;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
08 Barcelona;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
08 Barcelona;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
08 Barcelona;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;92,66
08 Barcelona;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
08 Barcelona;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
08 Barcelona;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;84,77
08 Barcelona;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
08 Barcelona;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
08 Barcelona;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
08 Barcelona;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;83,71
08 Barcelona;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
08 Barcelona;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
08 Barcelona;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
08 Barcelona;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;86,19
08 Barcelona;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
08 Barcelona;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
08 Barcelona;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
08 Barcelona;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
08 Barcelona;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
08 Barcelona;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
08 Barcelona;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;77,13
08 Barcelona;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
08 Barcelona;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
08 Barcelona;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
08 Barcelona;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;81,55
08 Barcelona;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
08 Barcelona;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
08 Barcelona;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
08 Barcelona;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
08 Barcelona;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
08 Barcelona;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
08 Barcelona;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;72,19
08 Barcelona;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
08 Barcelona;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
08 Barcelona;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
08 Barcelona;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;76,8
08 Barcelona;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
08 Barcelona;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
08 Barcelona;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
08 Barcelona;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
08 Barcelona;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
08 Barcelona;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
08 Barcelona;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QIII;9.738
08 Barcelona;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
08 Barcelona;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
08 Barcelona;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
08 Barcelona;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QIII;9.431
08 Barcelona;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
08 Barcelona;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
08 Barcelona;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
08 Barcelona;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QIII;8.240
08 Barcelona;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
08 Barcelona;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
08 Barcelona;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
08 Barcelona;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2022QIII;8.888
08 Barcelona;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2022QII;""
08 Barcelona;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2022QI;""
08 Barcelona;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
08 Barcelona;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2021QIII;8.640
08 Barcelona;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2021QII;""
08 Barcelona;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2021QI;""
08 Barcelona;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
08 Barcelona;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2020QIII;7.537
08 Barcelona;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2020QII;""
08 Barcelona;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2020QI;""
08 Barcelona;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2022QIV;8.090
08 Barcelona;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
08 Barcelona;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2022QII;""
08 Barcelona;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2022QI;""
08 Barcelona;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2021QIV;7.904
08 Barcelona;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
08 Barcelona;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2021QII;""
08 Barcelona;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2021QI;""
08 Barcelona;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2020QIV;6.984
08 Barcelona;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
08 Barcelona;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2020QII;""
08 Barcelona;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2020QI;""
08 Barcelona;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
08 Barcelona;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
08 Barcelona;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QII;""
08 Barcelona;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QI;7.281
08 Barcelona;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
08 Barcelona;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
08 Barcelona;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QII;""
08 Barcelona;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QI;6.576
08 Barcelona;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
08 Barcelona;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
08 Barcelona;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QII;""
08 Barcelona;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QI;""
08 Barcelona;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
08 Barcelona;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
08 Barcelona;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QII;6.715
08 Barcelona;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QI;""
08 Barcelona;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
08 Barcelona;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
08 Barcelona;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QII;6.168
08 Barcelona;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QI;""
08 Barcelona;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
08 Barcelona;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
08 Barcelona;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QII;""
08 Barcelona;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QI;""
08 Barcelona;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
08 Barcelona;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
08 Barcelona;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
08 Barcelona;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
08 Barcelona;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
08 Barcelona;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
08 Barcelona;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
08 Barcelona;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
08 Barcelona;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
08 Barcelona;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
08 Barcelona;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
08 Barcelona;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
08 Barcelona;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
08 Barcelona;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;91,27
08 Barcelona;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
08 Barcelona;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
08 Barcelona;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
08 Barcelona;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;91,61
08 Barcelona;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
08 Barcelona;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
08 Barcelona;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
08 Barcelona;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;91,47
08 Barcelona;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
08 Barcelona;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
08 Barcelona;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;83,08
08 Barcelona;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
08 Barcelona;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
08 Barcelona;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
08 Barcelona;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;83,81
08 Barcelona;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
08 Barcelona;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
08 Barcelona;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
08 Barcelona;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;84,76
08 Barcelona;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
08 Barcelona;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
08 Barcelona;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
08 Barcelona;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
08 Barcelona;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
08 Barcelona;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
08 Barcelona;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;77,2
08 Barcelona;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
08 Barcelona;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
08 Barcelona;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
08 Barcelona;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;79,81
08 Barcelona;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
08 Barcelona;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
08 Barcelona;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
08 Barcelona;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
08 Barcelona;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
08 Barcelona;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
08 Barcelona;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;71,2
08 Barcelona;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
08 Barcelona;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
08 Barcelona;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
08 Barcelona;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;74,85
08 Barcelona;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
08 Barcelona;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
08 Barcelona;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
08 Barcelona;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
08 Barcelona;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
08 Barcelona;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QIV;26.345
08 Barcelona;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
08 Barcelona;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
08 Barcelona;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
08 Barcelona;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QIV;26.178
08 Barcelona;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
08 Barcelona;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
08 Barcelona;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
08 Barcelona;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QIV;23.990
08 Barcelona;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
08 Barcelona;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
08 Barcelona;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
08 Barcelona;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2022QIV;24.069
08 Barcelona;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
08 Barcelona;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2022QII;""
08 Barcelona;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2022QI;""
08 Barcelona;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2021QIV;23.900
08 Barcelona;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
08 Barcelona;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2021QII;""
08 Barcelona;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2021QI;""
08 Barcelona;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2020QIV;22.157
08 Barcelona;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
08 Barcelona;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2020QII;""
08 Barcelona;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2020QI;""
08 Barcelona;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
08 Barcelona;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
08 Barcelona;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2022QII;""
08 Barcelona;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2022QI;21.957
08 Barcelona;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
08 Barcelona;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
08 Barcelona;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2021QII;""
08 Barcelona;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2021QI;20.866
08 Barcelona;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
08 Barcelona;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
08 Barcelona;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2020QII;""
08 Barcelona;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2020QI;""
08 Barcelona;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
08 Barcelona;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
08 Barcelona;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QII;20.367
08 Barcelona;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QI;""
08 Barcelona;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
08 Barcelona;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
08 Barcelona;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QII;19.520
08 Barcelona;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QI;""
08 Barcelona;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
08 Barcelona;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
08 Barcelona;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QII;""
08 Barcelona;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QI;""
08 Barcelona;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
08 Barcelona;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QIII;18.966
08 Barcelona;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QII;""
08 Barcelona;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QI;""
08 Barcelona;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
08 Barcelona;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QIII;18.294
08 Barcelona;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QII;""
08 Barcelona;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QI;""
08 Barcelona;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
08 Barcelona;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
08 Barcelona;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QII;""
08 Barcelona;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QI;""
08 Barcelona;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
08 Barcelona;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
08 Barcelona;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
08 Barcelona;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
08 Barcelona;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
08 Barcelona;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
08 Barcelona;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
08 Barcelona;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
08 Barcelona;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
08 Barcelona;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
08 Barcelona;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
08 Barcelona;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
08 Barcelona;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;91,36
08 Barcelona;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
08 Barcelona;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
08 Barcelona;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
08 Barcelona;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;91,3
08 Barcelona;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
08 Barcelona;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
08 Barcelona;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
08 Barcelona;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;92,36
08 Barcelona;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
08 Barcelona;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
08 Barcelona;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
08 Barcelona;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
08 Barcelona;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
08 Barcelona;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
08 Barcelona;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;83,88
08 Barcelona;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
08 Barcelona;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
08 Barcelona;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
08 Barcelona;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;86,98
08 Barcelona;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
08 Barcelona;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
08 Barcelona;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
08 Barcelona;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
08 Barcelona;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
08 Barcelona;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
08 Barcelona;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;77,8
08 Barcelona;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
08 Barcelona;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
08 Barcelona;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
08 Barcelona;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;81,37
08 Barcelona;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
08 Barcelona;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
08 Barcelona;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
08 Barcelona;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
08 Barcelona;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
08 Barcelona;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
08 Barcelona;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;72,45
08 Barcelona;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
08 Barcelona;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
08 Barcelona;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
08 Barcelona;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;76,26
08 Barcelona;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
08 Barcelona;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
08 Barcelona;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
08 Barcelona;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
08 Barcelona;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
08 Barcelona;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
08 Barcelona;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QIV;16.210
08 Barcelona;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
08 Barcelona;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
08 Barcelona;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
08 Barcelona;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QIV;16.244
08 Barcelona;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
08 Barcelona;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
08 Barcelona;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
08 Barcelona;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QIV;15.224
08 Barcelona;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
08 Barcelona;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
08 Barcelona;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
08 Barcelona;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2022QIV;14.880
08 Barcelona;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
08 Barcelona;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2022QII;""
08 Barcelona;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2022QI;""
08 Barcelona;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2021QIV;14.832
08 Barcelona;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
08 Barcelona;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2021QII;""
08 Barcelona;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2021QI;""
08 Barcelona;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2020QIV;14.074
08 Barcelona;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
08 Barcelona;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2020QII;""
08 Barcelona;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2020QI;""
08 Barcelona;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
08 Barcelona;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
08 Barcelona;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2022QII;""
08 Barcelona;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2022QI;13.636
08 Barcelona;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
08 Barcelona;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
08 Barcelona;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2021QII;""
08 Barcelona;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2021QI;13.280
08 Barcelona;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
08 Barcelona;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
08 Barcelona;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2020QII;""
08 Barcelona;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2020QI;""
08 Barcelona;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
08 Barcelona;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
08 Barcelona;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QII;12.730
08 Barcelona;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QI;""
08 Barcelona;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
08 Barcelona;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
08 Barcelona;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QII;12.438
08 Barcelona;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QI;""
08 Barcelona;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
08 Barcelona;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
08 Barcelona;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QII;""
08 Barcelona;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QI;""
08 Barcelona;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
08 Barcelona;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QIII;11.877
08 Barcelona;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QII;""
08 Barcelona;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QI;""
08 Barcelona;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
08 Barcelona;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QIII;11.632
08 Barcelona;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QII;""
08 Barcelona;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QI;""
08 Barcelona;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
08 Barcelona;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
08 Barcelona;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QII;""
08 Barcelona;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QI;""
08 Barcelona;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
08 Barcelona;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
08 Barcelona;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
08 Barcelona;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
08 Barcelona;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
08 Barcelona;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
08 Barcelona;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
08 Barcelona;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
08 Barcelona;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
08 Barcelona;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
08 Barcelona;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
08 Barcelona;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
08 Barcelona;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;91,8
08 Barcelona;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
08 Barcelona;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
08 Barcelona;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
08 Barcelona;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;91,31
08 Barcelona;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
08 Barcelona;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
08 Barcelona;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
08 Barcelona;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;92,45
08 Barcelona;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
08 Barcelona;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
08 Barcelona;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
08 Barcelona;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
08 Barcelona;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
08 Barcelona;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
08 Barcelona;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;83,94
08 Barcelona;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
08 Barcelona;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
08 Barcelona;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
08 Barcelona;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;87,23
08 Barcelona;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
08 Barcelona;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
08 Barcelona;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
08 Barcelona;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
08 Barcelona;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
08 Barcelona;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
08 Barcelona;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;78,37
08 Barcelona;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
08 Barcelona;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
08 Barcelona;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
08 Barcelona;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;81,7
08 Barcelona;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
08 Barcelona;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
08 Barcelona;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
08 Barcelona;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
08 Barcelona;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
08 Barcelona;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
08 Barcelona;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;73,12
08 Barcelona;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
08 Barcelona;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
08 Barcelona;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
08 Barcelona;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;76,41
08 Barcelona;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
08 Barcelona;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
08 Barcelona;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
08 Barcelona;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
08 Barcelona;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
08 Barcelona;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
08 Barcelona;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QIV;10.135
08 Barcelona;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
08 Barcelona;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
08 Barcelona;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
08 Barcelona;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QIV;9.934
08 Barcelona;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
08 Barcelona;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
08 Barcelona;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
08 Barcelona;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QIV;8.766
08 Barcelona;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
08 Barcelona;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
08 Barcelona;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
08 Barcelona;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2022QIV;9.189
08 Barcelona;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
08 Barcelona;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2022QII;""
08 Barcelona;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2022QI;""
08 Barcelona;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2021QIV;9.068
08 Barcelona;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
08 Barcelona;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2021QII;""
08 Barcelona;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2021QI;""
08 Barcelona;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2020QIV;8.083
08 Barcelona;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
08 Barcelona;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2020QII;""
08 Barcelona;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2020QI;""
08 Barcelona;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
08 Barcelona;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
08 Barcelona;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2022QII;""
08 Barcelona;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2022QI;8.321
08 Barcelona;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
08 Barcelona;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
08 Barcelona;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2021QII;""
08 Barcelona;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2021QI;7.586
08 Barcelona;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
08 Barcelona;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
08 Barcelona;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2020QII;""
08 Barcelona;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2020QI;""
08 Barcelona;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
08 Barcelona;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
08 Barcelona;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QII;7.637
08 Barcelona;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QI;""
08 Barcelona;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
08 Barcelona;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
08 Barcelona;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QII;7.082
08 Barcelona;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QI;""
08 Barcelona;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
08 Barcelona;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
08 Barcelona;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QII;""
08 Barcelona;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QI;""
08 Barcelona;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
08 Barcelona;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QIII;7.089
08 Barcelona;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QII;""
08 Barcelona;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QI;""
08 Barcelona;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
08 Barcelona;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QIII;6.662
08 Barcelona;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QII;""
08 Barcelona;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QI;""
08 Barcelona;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
08 Barcelona;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
08 Barcelona;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QII;""
08 Barcelona;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QI;""
08 Barcelona;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
08 Barcelona;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
08 Barcelona;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
08 Barcelona;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
08 Barcelona;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
08 Barcelona;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
08 Barcelona;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
08 Barcelona;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
08 Barcelona;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
08 Barcelona;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
08 Barcelona;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
08 Barcelona;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
08 Barcelona;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;90,67
08 Barcelona;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
08 Barcelona;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
08 Barcelona;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
08 Barcelona;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;91,28
08 Barcelona;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
08 Barcelona;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
08 Barcelona;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
08 Barcelona;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;92,21
08 Barcelona;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
08 Barcelona;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
08 Barcelona;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
08 Barcelona;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
08 Barcelona;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
08 Barcelona;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
08 Barcelona;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;83,76
08 Barcelona;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
08 Barcelona;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
08 Barcelona;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
08 Barcelona;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;86,54
08 Barcelona;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
08 Barcelona;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
08 Barcelona;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
08 Barcelona;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
08 Barcelona;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
08 Barcelona;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
08 Barcelona;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;76,88
08 Barcelona;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
08 Barcelona;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
08 Barcelona;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
08 Barcelona;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;80,79
08 Barcelona;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
08 Barcelona;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
08 Barcelona;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
08 Barcelona;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
08 Barcelona;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
08 Barcelona;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
08 Barcelona;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;71,36
08 Barcelona;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
08 Barcelona;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
08 Barcelona;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
08 Barcelona;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;76
08 Barcelona;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
08 Barcelona;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
08 Barcelona;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
08 Barcelona;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
08 Barcelona;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
08 Barcelona;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
08 Barcelona;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
08 Barcelona;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
08 Barcelona;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
08 Barcelona;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QI;70.719
08 Barcelona;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
08 Barcelona;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
08 Barcelona;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
08 Barcelona;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QI;70.918
08 Barcelona;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
08 Barcelona;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
08 Barcelona;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
08 Barcelona;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QI;68.647
08 Barcelona;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
08 Barcelona;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
08 Barcelona;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2022QII;""
08 Barcelona;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2022QI;67.153
08 Barcelona;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
08 Barcelona;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
08 Barcelona;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2021QII;""
08 Barcelona;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2021QI;68.316
08 Barcelona;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
08 Barcelona;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
08 Barcelona;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2020QII;""
08 Barcelona;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2020QI;62.890
08 Barcelona;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
08 Barcelona;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
08 Barcelona;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2022QII;63.993
08 Barcelona;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2022QI;""
08 Barcelona;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
08 Barcelona;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
08 Barcelona;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2021QII;65.504
08 Barcelona;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2021QI;""
08 Barcelona;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
08 Barcelona;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
08 Barcelona;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2020QII;61.170
08 Barcelona;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2020QI;""
08 Barcelona;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
08 Barcelona;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QIII;61.467
08 Barcelona;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QII;""
08 Barcelona;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QI;""
08 Barcelona;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
08 Barcelona;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QIII;63.028
08 Barcelona;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QII;""
08 Barcelona;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QI;""
08 Barcelona;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
08 Barcelona;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QIII;58.895
08 Barcelona;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QII;""
08 Barcelona;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QI;""
08 Barcelona;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QIV;58.726
08 Barcelona;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
08 Barcelona;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QII;""
08 Barcelona;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QI;""
08 Barcelona;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QIV;60.525
08 Barcelona;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
08 Barcelona;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QII;""
08 Barcelona;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QI;""
08 Barcelona;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QIV;56.779
08 Barcelona;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
08 Barcelona;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QII;""
08 Barcelona;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QI;""
08 Barcelona;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
08 Barcelona;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
08 Barcelona;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
08 Barcelona;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
08 Barcelona;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
08 Barcelona;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
08 Barcelona;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
08 Barcelona;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
08 Barcelona;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
08 Barcelona;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
08 Barcelona;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
08 Barcelona;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
08 Barcelona;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
08 Barcelona;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
08 Barcelona;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
08 Barcelona;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;94,96
08 Barcelona;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
08 Barcelona;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
08 Barcelona;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
08 Barcelona;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;96,33
08 Barcelona;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
08 Barcelona;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
08 Barcelona;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
08 Barcelona;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;91,61
08 Barcelona;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
08 Barcelona;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
08 Barcelona;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;90,49
08 Barcelona;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
08 Barcelona;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
08 Barcelona;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
08 Barcelona;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;92,37
08 Barcelona;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
08 Barcelona;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
08 Barcelona;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
08 Barcelona;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;89,11
08 Barcelona;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
08 Barcelona;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
08 Barcelona;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;86,92
08 Barcelona;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
08 Barcelona;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
08 Barcelona;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
08 Barcelona;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;88,87
08 Barcelona;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
08 Barcelona;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
08 Barcelona;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
08 Barcelona;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;85,79
08 Barcelona;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
08 Barcelona;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
08 Barcelona;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;83,04
08 Barcelona;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
08 Barcelona;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
08 Barcelona;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
08 Barcelona;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;85,35
08 Barcelona;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
08 Barcelona;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
08 Barcelona;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
08 Barcelona;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;82,71
08 Barcelona;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
08 Barcelona;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
08 Barcelona;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
08 Barcelona;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
08 Barcelona;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
08 Barcelona;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
08 Barcelona;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QI;42.695
08 Barcelona;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
08 Barcelona;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
08 Barcelona;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
08 Barcelona;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QI;43.460
08 Barcelona;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
08 Barcelona;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
08 Barcelona;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
08 Barcelona;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QI;41.925
08 Barcelona;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
08 Barcelona;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
08 Barcelona;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2022QII;""
08 Barcelona;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2022QI;40.619
08 Barcelona;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
08 Barcelona;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
08 Barcelona;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2021QII;""
08 Barcelona;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2021QI;41.888
08 Barcelona;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
08 Barcelona;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
08 Barcelona;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2020QII;""
08 Barcelona;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2020QI;38.692
08 Barcelona;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
08 Barcelona;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
08 Barcelona;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2022QII;38.821
08 Barcelona;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2022QI;""
08 Barcelona;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
08 Barcelona;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
08 Barcelona;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2021QII;40.142
08 Barcelona;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2021QI;""
08 Barcelona;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
08 Barcelona;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
08 Barcelona;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2020QII;37.756
08 Barcelona;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2020QI;""
08 Barcelona;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
08 Barcelona;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QIII;37.389
08 Barcelona;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QII;""
08 Barcelona;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QI;""
08 Barcelona;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
08 Barcelona;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QIII;38.682
08 Barcelona;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QII;""
08 Barcelona;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QI;""
08 Barcelona;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
08 Barcelona;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QIII;36.449
08 Barcelona;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QII;""
08 Barcelona;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QI;""
08 Barcelona;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QIV;35.736
08 Barcelona;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
08 Barcelona;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QII;""
08 Barcelona;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QI;""
08 Barcelona;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QIV;37.203
08 Barcelona;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
08 Barcelona;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QII;""
08 Barcelona;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QI;""
08 Barcelona;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QIV;35.203
08 Barcelona;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
08 Barcelona;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QII;""
08 Barcelona;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QI;""
08 Barcelona;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
08 Barcelona;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
08 Barcelona;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
08 Barcelona;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
08 Barcelona;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
08 Barcelona;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
08 Barcelona;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
08 Barcelona;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
08 Barcelona;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
08 Barcelona;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
08 Barcelona;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
08 Barcelona;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
08 Barcelona;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
08 Barcelona;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
08 Barcelona;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
08 Barcelona;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;95,14
08 Barcelona;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
08 Barcelona;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
08 Barcelona;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
08 Barcelona;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;96,38
08 Barcelona;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
08 Barcelona;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
08 Barcelona;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
08 Barcelona;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;92,29
08 Barcelona;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
08 Barcelona;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
08 Barcelona;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;90,93
08 Barcelona;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
08 Barcelona;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
08 Barcelona;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
08 Barcelona;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;92,37
08 Barcelona;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
08 Barcelona;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
08 Barcelona;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
08 Barcelona;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;90,06
08 Barcelona;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
08 Barcelona;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
08 Barcelona;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;87,57
08 Barcelona;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
08 Barcelona;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
08 Barcelona;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
08 Barcelona;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;89,01
08 Barcelona;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
08 Barcelona;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
08 Barcelona;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
08 Barcelona;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;86,94
08 Barcelona;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
08 Barcelona;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
08 Barcelona;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;83,7
08 Barcelona;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
08 Barcelona;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
08 Barcelona;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
08 Barcelona;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;85,6
08 Barcelona;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
08 Barcelona;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
08 Barcelona;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
08 Barcelona;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;83,97
08 Barcelona;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
08 Barcelona;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
08 Barcelona;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
08 Barcelona;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
08 Barcelona;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
08 Barcelona;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
08 Barcelona;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QI;28.024
08 Barcelona;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
08 Barcelona;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
08 Barcelona;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
08 Barcelona;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QI;27.458
08 Barcelona;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
08 Barcelona;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
08 Barcelona;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
08 Barcelona;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QI;26.722
08 Barcelona;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
08 Barcelona;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
08 Barcelona;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2022QII;""
08 Barcelona;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2022QI;26.534
08 Barcelona;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
08 Barcelona;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
08 Barcelona;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2021QII;""
08 Barcelona;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2021QI;26.428
08 Barcelona;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
08 Barcelona;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
08 Barcelona;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2020QII;""
08 Barcelona;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2020QI;24.198
08 Barcelona;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
08 Barcelona;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
08 Barcelona;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2022QII;25.172
08 Barcelona;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2022QI;""
08 Barcelona;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
08 Barcelona;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
08 Barcelona;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2021QII;25.362
08 Barcelona;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2021QI;""
08 Barcelona;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
08 Barcelona;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
08 Barcelona;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2020QII;23.414
08 Barcelona;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2020QI;""
08 Barcelona;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
08 Barcelona;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QIII;24.078
08 Barcelona;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QII;""
08 Barcelona;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QI;""
08 Barcelona;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
08 Barcelona;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QIII;24.346
08 Barcelona;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QII;""
08 Barcelona;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QI;""
08 Barcelona;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
08 Barcelona;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QIII;22.446
08 Barcelona;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QII;""
08 Barcelona;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QI;""
08 Barcelona;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QIV;22.990
08 Barcelona;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
08 Barcelona;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QII;""
08 Barcelona;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QI;""
08 Barcelona;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QIV;23.322
08 Barcelona;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
08 Barcelona;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QII;""
08 Barcelona;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QI;""
08 Barcelona;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QIV;21.576
08 Barcelona;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
08 Barcelona;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QII;""
08 Barcelona;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QI;""
08 Barcelona;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
08 Barcelona;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
08 Barcelona;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
08 Barcelona;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
08 Barcelona;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
08 Barcelona;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
08 Barcelona;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
08 Barcelona;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
08 Barcelona;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
08 Barcelona;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
08 Barcelona;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
08 Barcelona;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
08 Barcelona;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
08 Barcelona;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
08 Barcelona;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
08 Barcelona;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;94,68
08 Barcelona;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
08 Barcelona;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
08 Barcelona;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
08 Barcelona;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;96,25
08 Barcelona;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
08 Barcelona;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
08 Barcelona;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
08 Barcelona;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;90,55
08 Barcelona;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
08 Barcelona;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
08 Barcelona;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;89,82
08 Barcelona;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
08 Barcelona;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
08 Barcelona;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
08 Barcelona;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;92,37
08 Barcelona;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
08 Barcelona;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
08 Barcelona;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
08 Barcelona;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;87,62
08 Barcelona;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
08 Barcelona;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
08 Barcelona;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;85,92
08 Barcelona;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
08 Barcelona;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
08 Barcelona;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
08 Barcelona;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;88,67
08 Barcelona;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
08 Barcelona;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
08 Barcelona;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
08 Barcelona;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;84
08 Barcelona;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
08 Barcelona;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
08 Barcelona;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;82,04
08 Barcelona;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
08 Barcelona;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
08 Barcelona;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
08 Barcelona;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;84,94
08 Barcelona;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
08 Barcelona;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
08 Barcelona;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
08 Barcelona;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;80,74
08 Barcelona;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
08 Barcelona;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
08 Barcelona;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
08 Barcelona;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
08 Barcelona;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
08 Barcelona;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QII;67.243
08 Barcelona;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
08 Barcelona;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
08 Barcelona;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
08 Barcelona;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QII;67.758
08 Barcelona;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
08 Barcelona;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
08 Barcelona;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
08 Barcelona;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QII;67.858
08 Barcelona;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
08 Barcelona;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
08 Barcelona;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
08 Barcelona;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2022QII;63.698
08 Barcelona;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2022QI;""
08 Barcelona;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
08 Barcelona;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
08 Barcelona;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2021QII;64.538
08 Barcelona;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2021QI;""
08 Barcelona;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
08 Barcelona;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
08 Barcelona;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2020QII;65.833
08 Barcelona;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2020QI;""
08 Barcelona;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
08 Barcelona;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2022QIII;60.911
08 Barcelona;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2022QII;""
08 Barcelona;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2022QI;""
08 Barcelona;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
08 Barcelona;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2021QIII;61.800
08 Barcelona;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2021QII;""
08 Barcelona;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2021QI;""
08 Barcelona;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
08 Barcelona;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2020QIII;63.228
08 Barcelona;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2020QII;""
08 Barcelona;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2020QI;""
08 Barcelona;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QIV;57.872
08 Barcelona;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
08 Barcelona;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QII;""
08 Barcelona;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QI;""
08 Barcelona;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QIV;59.074
08 Barcelona;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
08 Barcelona;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QII;""
08 Barcelona;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QI;""
08 Barcelona;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QIV;60.769
08 Barcelona;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
08 Barcelona;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QII;""
08 Barcelona;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QI;""
08 Barcelona;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
08 Barcelona;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
08 Barcelona;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QII;""
08 Barcelona;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QI;56.596
08 Barcelona;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
08 Barcelona;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
08 Barcelona;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QII;""
08 Barcelona;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QI;58.934
08 Barcelona;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
08 Barcelona;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
08 Barcelona;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QII;""
08 Barcelona;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QI;""
08 Barcelona;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
08 Barcelona;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
08 Barcelona;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
08 Barcelona;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
08 Barcelona;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
08 Barcelona;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
08 Barcelona;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
08 Barcelona;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
08 Barcelona;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
08 Barcelona;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
08 Barcelona;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
08 Barcelona;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
08 Barcelona;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
08 Barcelona;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
08 Barcelona;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;94,73
08 Barcelona;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
08 Barcelona;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
08 Barcelona;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
08 Barcelona;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;95,25
08 Barcelona;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
08 Barcelona;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
08 Barcelona;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
08 Barcelona;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;97,02
08 Barcelona;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
08 Barcelona;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
08 Barcelona;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;90,58
08 Barcelona;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
08 Barcelona;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
08 Barcelona;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
08 Barcelona;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;91,21
08 Barcelona;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
08 Barcelona;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
08 Barcelona;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
08 Barcelona;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;93,18
08 Barcelona;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
08 Barcelona;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
08 Barcelona;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;86,06
08 Barcelona;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
08 Barcelona;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
08 Barcelona;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
08 Barcelona;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;87,18
08 Barcelona;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
08 Barcelona;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
08 Barcelona;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
08 Barcelona;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;89,55
08 Barcelona;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
08 Barcelona;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
08 Barcelona;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
08 Barcelona;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
08 Barcelona;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
08 Barcelona;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
08 Barcelona;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;83,53
08 Barcelona;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
08 Barcelona;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
08 Barcelona;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
08 Barcelona;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;86,85
08 Barcelona;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
08 Barcelona;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
08 Barcelona;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
08 Barcelona;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
08 Barcelona;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
08 Barcelona;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
08 Barcelona;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QII;40.242
08 Barcelona;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
08 Barcelona;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
08 Barcelona;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
08 Barcelona;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QII;41.175
08 Barcelona;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
08 Barcelona;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
08 Barcelona;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
08 Barcelona;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QII;41.542
08 Barcelona;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
08 Barcelona;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
08 Barcelona;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
08 Barcelona;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2022QII;38.204
08 Barcelona;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2022QI;""
08 Barcelona;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
08 Barcelona;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
08 Barcelona;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2021QII;39.168
08 Barcelona;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2021QI;""
08 Barcelona;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
08 Barcelona;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
08 Barcelona;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2020QII;40.437
08 Barcelona;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2020QI;""
08 Barcelona;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
08 Barcelona;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2022QIII;36.648
08 Barcelona;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2022QII;""
08 Barcelona;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2022QI;""
08 Barcelona;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
08 Barcelona;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2021QIII;37.533
08 Barcelona;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2021QII;""
08 Barcelona;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2021QI;""
08 Barcelona;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
08 Barcelona;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2020QIII;38.940
08 Barcelona;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2020QII;""
08 Barcelona;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2020QI;""
08 Barcelona;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QIV;34.865
08 Barcelona;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
08 Barcelona;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QII;""
08 Barcelona;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QI;""
08 Barcelona;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QIV;35.938
08 Barcelona;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
08 Barcelona;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QII;""
08 Barcelona;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QI;""
08 Barcelona;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QIV;37.499
08 Barcelona;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
08 Barcelona;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QII;""
08 Barcelona;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QI;""
08 Barcelona;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
08 Barcelona;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
08 Barcelona;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QII;""
08 Barcelona;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QI;34.473
08 Barcelona;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
08 Barcelona;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
08 Barcelona;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QII;""
08 Barcelona;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QI;36.400
08 Barcelona;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
08 Barcelona;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
08 Barcelona;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QII;""
08 Barcelona;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QI;""
08 Barcelona;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
08 Barcelona;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
08 Barcelona;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
08 Barcelona;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
08 Barcelona;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
08 Barcelona;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
08 Barcelona;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
08 Barcelona;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
08 Barcelona;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
08 Barcelona;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
08 Barcelona;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
08 Barcelona;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
08 Barcelona;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
08 Barcelona;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
08 Barcelona;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;94,94
08 Barcelona;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
08 Barcelona;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
08 Barcelona;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
08 Barcelona;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;95,13
08 Barcelona;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
08 Barcelona;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
08 Barcelona;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
08 Barcelona;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;97,34
08 Barcelona;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
08 Barcelona;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
08 Barcelona;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;91,07
08 Barcelona;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
08 Barcelona;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
08 Barcelona;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
08 Barcelona;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;91,15
08 Barcelona;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
08 Barcelona;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
08 Barcelona;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
08 Barcelona;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;93,74
08 Barcelona;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
08 Barcelona;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
08 Barcelona;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;86,64
08 Barcelona;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
08 Barcelona;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
08 Barcelona;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
08 Barcelona;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;87,28
08 Barcelona;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
08 Barcelona;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
08 Barcelona;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
08 Barcelona;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;90,27
08 Barcelona;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
08 Barcelona;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
08 Barcelona;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
08 Barcelona;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
08 Barcelona;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
08 Barcelona;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
08 Barcelona;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;83,72
08 Barcelona;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
08 Barcelona;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
08 Barcelona;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
08 Barcelona;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;87,62
08 Barcelona;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
08 Barcelona;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
08 Barcelona;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
08 Barcelona;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
08 Barcelona;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
08 Barcelona;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
08 Barcelona;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QII;27.001
08 Barcelona;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
08 Barcelona;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
08 Barcelona;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
08 Barcelona;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QII;26.583
08 Barcelona;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
08 Barcelona;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
08 Barcelona;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
08 Barcelona;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QII;26.316
08 Barcelona;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
08 Barcelona;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
08 Barcelona;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
08 Barcelona;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2022QII;25.494
08 Barcelona;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2022QI;""
08 Barcelona;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
08 Barcelona;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
08 Barcelona;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2021QII;25.370
08 Barcelona;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2021QI;""
08 Barcelona;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
08 Barcelona;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
08 Barcelona;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2020QII;25.396
08 Barcelona;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2020QI;""
08 Barcelona;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
08 Barcelona;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2022QIII;24.263
08 Barcelona;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2022QII;""
08 Barcelona;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2022QI;""
08 Barcelona;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
08 Barcelona;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2021QIII;24.267
08 Barcelona;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2021QII;""
08 Barcelona;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2021QI;""
08 Barcelona;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
08 Barcelona;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2020QIII;24.288
08 Barcelona;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2020QII;""
08 Barcelona;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2020QI;""
08 Barcelona;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QIV;23.007
08 Barcelona;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
08 Barcelona;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QII;""
08 Barcelona;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QI;""
08 Barcelona;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QIV;23.136
08 Barcelona;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
08 Barcelona;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QII;""
08 Barcelona;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QI;""
08 Barcelona;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QIV;23.270
08 Barcelona;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
08 Barcelona;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QII;""
08 Barcelona;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QI;""
08 Barcelona;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
08 Barcelona;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
08 Barcelona;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QII;""
08 Barcelona;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QI;22.123
08 Barcelona;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
08 Barcelona;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
08 Barcelona;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QII;""
08 Barcelona;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QI;22.534
08 Barcelona;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
08 Barcelona;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
08 Barcelona;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QII;""
08 Barcelona;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QI;""
08 Barcelona;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
08 Barcelona;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
08 Barcelona;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
08 Barcelona;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
08 Barcelona;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
08 Barcelona;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
08 Barcelona;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
08 Barcelona;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
08 Barcelona;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
08 Barcelona;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
08 Barcelona;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
08 Barcelona;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
08 Barcelona;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
08 Barcelona;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
08 Barcelona;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;94,42
08 Barcelona;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
08 Barcelona;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
08 Barcelona;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
08 Barcelona;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;95,44
08 Barcelona;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
08 Barcelona;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
08 Barcelona;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
08 Barcelona;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;96,5
08 Barcelona;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
08 Barcelona;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
08 Barcelona;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;89,86
08 Barcelona;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
08 Barcelona;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
08 Barcelona;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
08 Barcelona;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;91,29
08 Barcelona;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
08 Barcelona;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
08 Barcelona;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
08 Barcelona;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;92,29
08 Barcelona;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
08 Barcelona;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
08 Barcelona;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;85,21
08 Barcelona;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
08 Barcelona;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
08 Barcelona;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
08 Barcelona;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;87,03
08 Barcelona;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
08 Barcelona;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
08 Barcelona;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
08 Barcelona;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;88,43
08 Barcelona;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
08 Barcelona;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
08 Barcelona;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
08 Barcelona;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
08 Barcelona;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
08 Barcelona;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
08 Barcelona;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;83,22
08 Barcelona;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
08 Barcelona;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
08 Barcelona;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
08 Barcelona;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;85,63
08 Barcelona;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
08 Barcelona;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
08 Barcelona;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
08 Barcelona;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
08 Barcelona;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
08 Barcelona;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QIII;68.188
08 Barcelona;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
08 Barcelona;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
08 Barcelona;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
08 Barcelona;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QIII;69.072
08 Barcelona;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
08 Barcelona;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
08 Barcelona;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
08 Barcelona;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QIII;68.597
08 Barcelona;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
08 Barcelona;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
08 Barcelona;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
08 Barcelona;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2022QIII;64.930
08 Barcelona;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2022QII;""
08 Barcelona;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2022QI;""
08 Barcelona;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
08 Barcelona;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2021QIII;65.839
08 Barcelona;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2021QII;""
08 Barcelona;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2021QI;""
08 Barcelona;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
08 Barcelona;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2020QIII;65.672
08 Barcelona;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2020QII;""
08 Barcelona;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2020QI;""
08 Barcelona;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2022QIV;61.492
08 Barcelona;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
08 Barcelona;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2022QII;""
08 Barcelona;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2022QI;""
08 Barcelona;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2021QIV;62.758
08 Barcelona;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
08 Barcelona;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2021QII;""
08 Barcelona;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2021QI;""
08 Barcelona;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2020QIV;62.985
08 Barcelona;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
08 Barcelona;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2020QII;""
08 Barcelona;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2020QI;""
08 Barcelona;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
08 Barcelona;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
08 Barcelona;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QII;""
08 Barcelona;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QI;59.967
08 Barcelona;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
08 Barcelona;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
08 Barcelona;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QII;""
08 Barcelona;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QI;61.020
08 Barcelona;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
08 Barcelona;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
08 Barcelona;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QII;""
08 Barcelona;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QI;""
08 Barcelona;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
08 Barcelona;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
08 Barcelona;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QII;57.456
08 Barcelona;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QI;""
08 Barcelona;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
08 Barcelona;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
08 Barcelona;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QII;58.835
08 Barcelona;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QI;""
08 Barcelona;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
08 Barcelona;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
08 Barcelona;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QII;""
08 Barcelona;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QI;""
08 Barcelona;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
08 Barcelona;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
08 Barcelona;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
08 Barcelona;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
08 Barcelona;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
08 Barcelona;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
08 Barcelona;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
08 Barcelona;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
08 Barcelona;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
08 Barcelona;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
08 Barcelona;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
08 Barcelona;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
08 Barcelona;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
08 Barcelona;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;95,22
08 Barcelona;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
08 Barcelona;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
08 Barcelona;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
08 Barcelona;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;95,32
08 Barcelona;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
08 Barcelona;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
08 Barcelona;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
08 Barcelona;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;95,74
08 Barcelona;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
08 Barcelona;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
08 Barcelona;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;90,18
08 Barcelona;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
08 Barcelona;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
08 Barcelona;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
08 Barcelona;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;90,86
08 Barcelona;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
08 Barcelona;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
08 Barcelona;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
08 Barcelona;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;91,82
08 Barcelona;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
08 Barcelona;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
08 Barcelona;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
08 Barcelona;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
08 Barcelona;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
08 Barcelona;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
08 Barcelona;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;86,82
08 Barcelona;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
08 Barcelona;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
08 Barcelona;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
08 Barcelona;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;88,95
08 Barcelona;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
08 Barcelona;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
08 Barcelona;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
08 Barcelona;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
08 Barcelona;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
08 Barcelona;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
08 Barcelona;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;83,18
08 Barcelona;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
08 Barcelona;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
08 Barcelona;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
08 Barcelona;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;85,77
08 Barcelona;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
08 Barcelona;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
08 Barcelona;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
08 Barcelona;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
08 Barcelona;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
08 Barcelona;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
08 Barcelona;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QIII;40.797
08 Barcelona;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
08 Barcelona;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
08 Barcelona;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
08 Barcelona;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QIII;41.773
08 Barcelona;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
08 Barcelona;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
08 Barcelona;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
08 Barcelona;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QIII;42.109
08 Barcelona;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
08 Barcelona;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
08 Barcelona;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
08 Barcelona;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2022QIII;38.980
08 Barcelona;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2022QII;""
08 Barcelona;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2022QI;""
08 Barcelona;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
08 Barcelona;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2021QIII;39.853
08 Barcelona;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2021QII;""
08 Barcelona;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2021QI;""
08 Barcelona;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
08 Barcelona;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2020QIII;40.431
08 Barcelona;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2020QII;""
08 Barcelona;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2020QI;""
08 Barcelona;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2022QIV;36.971
08 Barcelona;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
08 Barcelona;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2022QII;""
08 Barcelona;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2022QI;""
08 Barcelona;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2021QIV;38.062
08 Barcelona;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
08 Barcelona;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2021QII;""
08 Barcelona;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2021QI;""
08 Barcelona;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2020QIV;38.854
08 Barcelona;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
08 Barcelona;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2020QII;""
08 Barcelona;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2020QI;""
08 Barcelona;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
08 Barcelona;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
08 Barcelona;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QII;""
08 Barcelona;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QI;36.426
08 Barcelona;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
08 Barcelona;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
08 Barcelona;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QII;""
08 Barcelona;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QI;37.671
08 Barcelona;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
08 Barcelona;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
08 Barcelona;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QII;""
08 Barcelona;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QI;""
08 Barcelona;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
08 Barcelona;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
08 Barcelona;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QII;34.986
08 Barcelona;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QI;""
08 Barcelona;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
08 Barcelona;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
08 Barcelona;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QII;36.313
08 Barcelona;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QI;""
08 Barcelona;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
08 Barcelona;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
08 Barcelona;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QII;""
08 Barcelona;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QI;""
08 Barcelona;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
08 Barcelona;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
08 Barcelona;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
08 Barcelona;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
08 Barcelona;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
08 Barcelona;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
08 Barcelona;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
08 Barcelona;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
08 Barcelona;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
08 Barcelona;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
08 Barcelona;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
08 Barcelona;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
08 Barcelona;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
08 Barcelona;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;95,55
08 Barcelona;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
08 Barcelona;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
08 Barcelona;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
08 Barcelona;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;95,4
08 Barcelona;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
08 Barcelona;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
08 Barcelona;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
08 Barcelona;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;96,02
08 Barcelona;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
08 Barcelona;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
08 Barcelona;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;90,62
08 Barcelona;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
08 Barcelona;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
08 Barcelona;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
08 Barcelona;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;91,12
08 Barcelona;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
08 Barcelona;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
08 Barcelona;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
08 Barcelona;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;92,27
08 Barcelona;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
08 Barcelona;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
08 Barcelona;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
08 Barcelona;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
08 Barcelona;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
08 Barcelona;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
08 Barcelona;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;87,2
08 Barcelona;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
08 Barcelona;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
08 Barcelona;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
08 Barcelona;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;89,46
08 Barcelona;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
08 Barcelona;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
08 Barcelona;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
08 Barcelona;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
08 Barcelona;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
08 Barcelona;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
08 Barcelona;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;83,75
08 Barcelona;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
08 Barcelona;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
08 Barcelona;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
08 Barcelona;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;86,24
08 Barcelona;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
08 Barcelona;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
08 Barcelona;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
08 Barcelona;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
08 Barcelona;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
08 Barcelona;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
08 Barcelona;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QIII;27.391
08 Barcelona;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
08 Barcelona;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
08 Barcelona;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
08 Barcelona;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QIII;27.299
08 Barcelona;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
08 Barcelona;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
08 Barcelona;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
08 Barcelona;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QIII;26.488
08 Barcelona;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
08 Barcelona;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
08 Barcelona;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
08 Barcelona;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2022QIII;25.950
08 Barcelona;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2022QII;""
08 Barcelona;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2022QI;""
08 Barcelona;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
08 Barcelona;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2021QIII;25.986
08 Barcelona;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2021QII;""
08 Barcelona;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2021QI;""
08 Barcelona;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
08 Barcelona;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2020QIII;25.241
08 Barcelona;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2020QII;""
08 Barcelona;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2020QI;""
08 Barcelona;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2022QIV;24.521
08 Barcelona;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
08 Barcelona;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2022QII;""
08 Barcelona;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2022QI;""
08 Barcelona;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2021QIV;24.696
08 Barcelona;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
08 Barcelona;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2021QII;""
08 Barcelona;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2021QI;""
08 Barcelona;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2020QIV;24.131
08 Barcelona;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
08 Barcelona;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2020QII;""
08 Barcelona;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2020QI;""
08 Barcelona;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
08 Barcelona;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
08 Barcelona;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QII;""
08 Barcelona;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QI;23.541
08 Barcelona;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
08 Barcelona;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
08 Barcelona;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QII;""
08 Barcelona;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QI;23.349
08 Barcelona;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
08 Barcelona;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
08 Barcelona;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QII;""
08 Barcelona;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QI;""
08 Barcelona;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
08 Barcelona;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
08 Barcelona;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QII;22.470
08 Barcelona;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QI;""
08 Barcelona;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
08 Barcelona;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
08 Barcelona;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QII;22.522
08 Barcelona;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QI;""
08 Barcelona;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
08 Barcelona;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
08 Barcelona;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QII;""
08 Barcelona;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QI;""
08 Barcelona;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
08 Barcelona;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
08 Barcelona;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
08 Barcelona;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
08 Barcelona;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
08 Barcelona;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
08 Barcelona;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
08 Barcelona;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
08 Barcelona;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
08 Barcelona;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
08 Barcelona;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
08 Barcelona;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
08 Barcelona;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
08 Barcelona;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;94,74
08 Barcelona;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
08 Barcelona;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
08 Barcelona;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
08 Barcelona;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;95,19
08 Barcelona;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
08 Barcelona;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
08 Barcelona;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
08 Barcelona;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;95,29
08 Barcelona;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
08 Barcelona;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
08 Barcelona;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;89,52
08 Barcelona;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
08 Barcelona;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
08 Barcelona;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
08 Barcelona;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;90,46
08 Barcelona;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
08 Barcelona;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
08 Barcelona;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
08 Barcelona;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;91,1
08 Barcelona;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
08 Barcelona;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
08 Barcelona;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
08 Barcelona;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
08 Barcelona;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
08 Barcelona;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
08 Barcelona;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;86,23
08 Barcelona;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
08 Barcelona;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
08 Barcelona;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
08 Barcelona;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;88,15
08 Barcelona;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
08 Barcelona;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
08 Barcelona;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
08 Barcelona;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
08 Barcelona;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
08 Barcelona;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
08 Barcelona;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;82,31
08 Barcelona;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
08 Barcelona;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
08 Barcelona;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
08 Barcelona;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;85,03
08 Barcelona;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
08 Barcelona;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
08 Barcelona;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
08 Barcelona;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
08 Barcelona;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
08 Barcelona;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QIV;68.624
08 Barcelona;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
08 Barcelona;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
08 Barcelona;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
08 Barcelona;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QIV;69.733
08 Barcelona;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
08 Barcelona;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
08 Barcelona;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
08 Barcelona;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QIV;69.534
08 Barcelona;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
08 Barcelona;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
08 Barcelona;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
08 Barcelona;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2022QIV;64.822
08 Barcelona;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
08 Barcelona;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2022QII;""
08 Barcelona;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2022QI;""
08 Barcelona;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2021QIV;66.288
08 Barcelona;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
08 Barcelona;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2021QII;""
08 Barcelona;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2021QI;""
08 Barcelona;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2020QIV;66.436
08 Barcelona;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
08 Barcelona;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2020QII;""
08 Barcelona;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2020QI;""
08 Barcelona;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
08 Barcelona;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
08 Barcelona;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2022QII;""
08 Barcelona;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2022QI;63.173
08 Barcelona;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
08 Barcelona;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
08 Barcelona;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2021QII;""
08 Barcelona;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2021QI;64.236
08 Barcelona;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
08 Barcelona;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
08 Barcelona;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2020QII;""
08 Barcelona;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2020QI;""
08 Barcelona;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
08 Barcelona;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
08 Barcelona;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QII;60.403
08 Barcelona;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QI;""
08 Barcelona;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
08 Barcelona;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
08 Barcelona;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QII;61.788
08 Barcelona;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QI;""
08 Barcelona;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
08 Barcelona;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
08 Barcelona;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QII;""
08 Barcelona;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QI;""
08 Barcelona;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
08 Barcelona;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QIII;58.149
08 Barcelona;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QII;""
08 Barcelona;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QI;""
08 Barcelona;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
08 Barcelona;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QIII;59.612
08 Barcelona;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QII;""
08 Barcelona;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QI;""
08 Barcelona;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
08 Barcelona;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
08 Barcelona;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QII;""
08 Barcelona;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QI;""
08 Barcelona;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
08 Barcelona;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
08 Barcelona;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
08 Barcelona;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
08 Barcelona;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
08 Barcelona;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
08 Barcelona;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
08 Barcelona;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
08 Barcelona;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
08 Barcelona;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
08 Barcelona;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
08 Barcelona;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
08 Barcelona;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;94,46
08 Barcelona;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
08 Barcelona;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
08 Barcelona;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
08 Barcelona;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;95,06
08 Barcelona;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
08 Barcelona;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
08 Barcelona;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
08 Barcelona;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;95,54
08 Barcelona;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
08 Barcelona;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
08 Barcelona;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
08 Barcelona;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
08 Barcelona;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
08 Barcelona;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
08 Barcelona;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;90,59
08 Barcelona;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
08 Barcelona;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
08 Barcelona;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
08 Barcelona;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;92,38
08 Barcelona;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
08 Barcelona;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
08 Barcelona;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
08 Barcelona;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
08 Barcelona;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
08 Barcelona;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
08 Barcelona;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;86,62
08 Barcelona;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
08 Barcelona;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
08 Barcelona;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
08 Barcelona;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;88,86
08 Barcelona;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
08 Barcelona;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
08 Barcelona;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
08 Barcelona;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
08 Barcelona;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
08 Barcelona;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
08 Barcelona;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;83,39
08 Barcelona;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
08 Barcelona;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
08 Barcelona;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
08 Barcelona;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;85,73
08 Barcelona;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
08 Barcelona;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
08 Barcelona;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
08 Barcelona;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
08 Barcelona;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
08 Barcelona;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
08 Barcelona;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QIV;41.130
08 Barcelona;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
08 Barcelona;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
08 Barcelona;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
08 Barcelona;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QIV;42.145
08 Barcelona;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
08 Barcelona;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
08 Barcelona;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
08 Barcelona;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QIV;42.694
08 Barcelona;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
08 Barcelona;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
08 Barcelona;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
08 Barcelona;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2022QIV;38.910
08 Barcelona;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
08 Barcelona;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2022QII;""
08 Barcelona;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2022QI;""
08 Barcelona;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2021QIV;40.154
08 Barcelona;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
08 Barcelona;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2021QII;""
08 Barcelona;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2021QI;""
08 Barcelona;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2020QIV;40.878
08 Barcelona;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
08 Barcelona;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2020QII;""
08 Barcelona;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2020QI;""
08 Barcelona;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
08 Barcelona;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
08 Barcelona;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2022QII;""
08 Barcelona;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2022QI;38.336
08 Barcelona;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
08 Barcelona;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
08 Barcelona;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2021QII;""
08 Barcelona;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2021QI;39.549
08 Barcelona;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
08 Barcelona;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
08 Barcelona;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2020QII;""
08 Barcelona;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2020QI;""
08 Barcelona;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
08 Barcelona;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
08 Barcelona;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QII;36.752
08 Barcelona;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QI;""
08 Barcelona;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
08 Barcelona;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
08 Barcelona;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QII;38.024
08 Barcelona;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QI;""
08 Barcelona;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
08 Barcelona;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
08 Barcelona;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QII;""
08 Barcelona;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QI;""
08 Barcelona;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
08 Barcelona;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QIII;35.466
08 Barcelona;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QII;""
08 Barcelona;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QI;""
08 Barcelona;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
08 Barcelona;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QIII;36.717
08 Barcelona;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QII;""
08 Barcelona;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QI;""
08 Barcelona;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
08 Barcelona;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
08 Barcelona;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QII;""
08 Barcelona;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QI;""
08 Barcelona;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
08 Barcelona;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
08 Barcelona;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
08 Barcelona;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
08 Barcelona;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
08 Barcelona;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
08 Barcelona;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
08 Barcelona;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
08 Barcelona;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
08 Barcelona;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
08 Barcelona;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
08 Barcelona;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
08 Barcelona;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;94,6
08 Barcelona;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
08 Barcelona;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
08 Barcelona;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
08 Barcelona;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;95,28
08 Barcelona;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
08 Barcelona;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
08 Barcelona;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
08 Barcelona;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;95,75
08 Barcelona;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
08 Barcelona;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
08 Barcelona;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
08 Barcelona;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
08 Barcelona;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
08 Barcelona;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
08 Barcelona;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;90,96
08 Barcelona;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
08 Barcelona;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
08 Barcelona;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
08 Barcelona;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;92,63
08 Barcelona;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
08 Barcelona;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
08 Barcelona;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
08 Barcelona;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
08 Barcelona;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
08 Barcelona;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
08 Barcelona;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;87,2
08 Barcelona;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
08 Barcelona;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
08 Barcelona;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
08 Barcelona;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;89,06
08 Barcelona;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
08 Barcelona;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
08 Barcelona;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
08 Barcelona;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
08 Barcelona;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
08 Barcelona;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
08 Barcelona;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;84,15
08 Barcelona;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
08 Barcelona;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
08 Barcelona;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
08 Barcelona;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;86
08 Barcelona;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
08 Barcelona;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
08 Barcelona;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
08 Barcelona;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
08 Barcelona;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
08 Barcelona;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
08 Barcelona;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QIV;27.494
08 Barcelona;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
08 Barcelona;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
08 Barcelona;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
08 Barcelona;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QIV;27.588
08 Barcelona;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
08 Barcelona;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
08 Barcelona;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
08 Barcelona;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QIV;26.840
08 Barcelona;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
08 Barcelona;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
08 Barcelona;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
08 Barcelona;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2022QIV;25.912
08 Barcelona;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
08 Barcelona;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2022QII;""
08 Barcelona;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2022QI;""
08 Barcelona;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2021QIV;26.134
08 Barcelona;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
08 Barcelona;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2021QII;""
08 Barcelona;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2021QI;""
08 Barcelona;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2020QIV;25.558
08 Barcelona;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
08 Barcelona;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2020QII;""
08 Barcelona;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2020QI;""
08 Barcelona;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
08 Barcelona;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
08 Barcelona;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2022QII;""
08 Barcelona;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2022QI;24.837
08 Barcelona;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
08 Barcelona;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
08 Barcelona;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2021QII;""
08 Barcelona;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2021QI;24.687
08 Barcelona;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
08 Barcelona;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
08 Barcelona;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2020QII;""
08 Barcelona;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2020QI;""
08 Barcelona;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
08 Barcelona;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
08 Barcelona;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QII;23.651
08 Barcelona;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QI;""
08 Barcelona;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
08 Barcelona;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
08 Barcelona;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QII;23.764
08 Barcelona;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QI;""
08 Barcelona;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
08 Barcelona;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
08 Barcelona;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QII;""
08 Barcelona;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QI;""
08 Barcelona;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
08 Barcelona;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QIII;22.683
08 Barcelona;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QII;""
08 Barcelona;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QI;""
08 Barcelona;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
08 Barcelona;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QIII;22.895
08 Barcelona;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QII;""
08 Barcelona;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QI;""
08 Barcelona;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
08 Barcelona;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
08 Barcelona;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QII;""
08 Barcelona;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QI;""
08 Barcelona;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
08 Barcelona;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
08 Barcelona;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
08 Barcelona;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
08 Barcelona;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
08 Barcelona;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
08 Barcelona;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
08 Barcelona;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
08 Barcelona;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
08 Barcelona;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
08 Barcelona;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
08 Barcelona;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
08 Barcelona;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;94,25
08 Barcelona;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
08 Barcelona;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
08 Barcelona;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
08 Barcelona;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;94,73
08 Barcelona;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
08 Barcelona;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
08 Barcelona;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
08 Barcelona;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;95,22
08 Barcelona;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
08 Barcelona;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
08 Barcelona;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
08 Barcelona;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
08 Barcelona;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
08 Barcelona;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
08 Barcelona;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;90,03
08 Barcelona;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
08 Barcelona;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
08 Barcelona;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
08 Barcelona;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;91,98
08 Barcelona;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
08 Barcelona;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
08 Barcelona;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
08 Barcelona;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
08 Barcelona;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
08 Barcelona;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
08 Barcelona;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;85,73
08 Barcelona;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
08 Barcelona;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
08 Barcelona;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
08 Barcelona;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;88,54
08 Barcelona;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
08 Barcelona;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
08 Barcelona;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
08 Barcelona;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
08 Barcelona;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
08 Barcelona;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
08 Barcelona;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;82,22
08 Barcelona;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
08 Barcelona;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
08 Barcelona;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
08 Barcelona;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;85,3
08 Barcelona;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
08 Barcelona;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
08 Barcelona;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
08 Barcelona;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
08 Barcelona;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
08 Barcelona;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
08 Barcelona;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
08 Barcelona;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
08 Barcelona;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
08 Barcelona;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QI;123.589
08 Barcelona;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
08 Barcelona;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
08 Barcelona;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
08 Barcelona;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QI;123.577
08 Barcelona;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
08 Barcelona;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
08 Barcelona;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
08 Barcelona;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QI;124.149
08 Barcelona;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
08 Barcelona;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
08 Barcelona;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2022QII;""
08 Barcelona;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2022QI;119.424
08 Barcelona;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
08 Barcelona;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
08 Barcelona;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2021QII;""
08 Barcelona;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2021QI;120.682
08 Barcelona;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
08 Barcelona;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
08 Barcelona;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2020QII;""
08 Barcelona;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2020QI;116.894
08 Barcelona;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
08 Barcelona;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
08 Barcelona;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2022QII;115.713
08 Barcelona;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2022QI;""
08 Barcelona;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
08 Barcelona;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
08 Barcelona;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2021QII;117.622
08 Barcelona;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2021QI;""
08 Barcelona;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
08 Barcelona;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
08 Barcelona;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2020QII;114.742
08 Barcelona;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2020QI;""
08 Barcelona;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
08 Barcelona;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QIII;112.812
08 Barcelona;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QII;""
08 Barcelona;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QI;""
08 Barcelona;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
08 Barcelona;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QIII;114.927
08 Barcelona;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QII;""
08 Barcelona;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QI;""
08 Barcelona;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
08 Barcelona;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QIII;112.006
08 Barcelona;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QII;""
08 Barcelona;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QI;""
08 Barcelona;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QIV;109.537
08 Barcelona;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
08 Barcelona;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QII;""
08 Barcelona;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QI;""
08 Barcelona;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QIV;111.888
08 Barcelona;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
08 Barcelona;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QII;""
08 Barcelona;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QI;""
08 Barcelona;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QIV;109.255
08 Barcelona;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
08 Barcelona;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QII;""
08 Barcelona;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QI;""
08 Barcelona;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
08 Barcelona;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
08 Barcelona;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
08 Barcelona;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
08 Barcelona;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
08 Barcelona;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
08 Barcelona;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
08 Barcelona;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
08 Barcelona;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
08 Barcelona;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
08 Barcelona;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
08 Barcelona;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
08 Barcelona;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
08 Barcelona;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
08 Barcelona;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
08 Barcelona;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;96,63
08 Barcelona;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
08 Barcelona;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
08 Barcelona;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
08 Barcelona;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;97,66
08 Barcelona;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
08 Barcelona;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
08 Barcelona;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
08 Barcelona;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;94,16
08 Barcelona;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
08 Barcelona;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
08 Barcelona;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;93,63
08 Barcelona;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
08 Barcelona;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
08 Barcelona;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
08 Barcelona;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;95,18
08 Barcelona;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
08 Barcelona;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
08 Barcelona;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
08 Barcelona;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;92,42
08 Barcelona;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
08 Barcelona;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
08 Barcelona;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;91,28
08 Barcelona;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
08 Barcelona;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
08 Barcelona;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
08 Barcelona;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;93
08 Barcelona;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
08 Barcelona;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
08 Barcelona;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
08 Barcelona;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;90,22
08 Barcelona;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
08 Barcelona;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
08 Barcelona;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;88,63
08 Barcelona;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
08 Barcelona;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
08 Barcelona;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
08 Barcelona;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;90,54
08 Barcelona;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
08 Barcelona;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
08 Barcelona;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
08 Barcelona;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;88
08 Barcelona;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
08 Barcelona;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
08 Barcelona;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
08 Barcelona;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
08 Barcelona;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
08 Barcelona;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
08 Barcelona;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QI;79.297
08 Barcelona;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
08 Barcelona;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
08 Barcelona;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
08 Barcelona;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QI;80.277
08 Barcelona;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
08 Barcelona;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
08 Barcelona;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
08 Barcelona;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QI;80.437
08 Barcelona;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
08 Barcelona;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
08 Barcelona;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2022QII;""
08 Barcelona;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2022QI;76.723
08 Barcelona;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
08 Barcelona;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
08 Barcelona;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2021QII;""
08 Barcelona;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2021QI;78.435
08 Barcelona;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
08 Barcelona;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
08 Barcelona;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2020QII;""
08 Barcelona;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2020QI;76.138
08 Barcelona;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
08 Barcelona;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
08 Barcelona;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2022QII;74.468
08 Barcelona;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2022QI;""
08 Barcelona;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
08 Barcelona;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
08 Barcelona;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2021QII;76.504
08 Barcelona;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2021QI;""
08 Barcelona;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
08 Barcelona;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
08 Barcelona;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2020QII;74.914
08 Barcelona;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2020QI;""
08 Barcelona;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
08 Barcelona;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QIII;72.742
08 Barcelona;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QII;""
08 Barcelona;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QI;""
08 Barcelona;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
08 Barcelona;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QIII;74.805
08 Barcelona;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QII;""
08 Barcelona;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QI;""
08 Barcelona;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
08 Barcelona;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QIII;73.278
08 Barcelona;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QII;""
08 Barcelona;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QI;""
08 Barcelona;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QIV;70.707
08 Barcelona;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
08 Barcelona;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QII;""
08 Barcelona;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QI;""
08 Barcelona;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QIV;72.804
08 Barcelona;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
08 Barcelona;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QII;""
08 Barcelona;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QI;""
08 Barcelona;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QIV;71.587
08 Barcelona;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
08 Barcelona;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QII;""
08 Barcelona;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QI;""
08 Barcelona;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
08 Barcelona;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
08 Barcelona;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
08 Barcelona;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
08 Barcelona;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
08 Barcelona;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
08 Barcelona;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
08 Barcelona;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
08 Barcelona;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
08 Barcelona;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
08 Barcelona;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
08 Barcelona;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
08 Barcelona;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
08 Barcelona;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
08 Barcelona;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
08 Barcelona;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;96,75
08 Barcelona;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
08 Barcelona;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
08 Barcelona;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
08 Barcelona;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;97,71
08 Barcelona;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
08 Barcelona;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
08 Barcelona;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
08 Barcelona;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;94,66
08 Barcelona;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
08 Barcelona;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
08 Barcelona;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;93,91
08 Barcelona;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
08 Barcelona;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
08 Barcelona;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
08 Barcelona;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;95,3
08 Barcelona;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
08 Barcelona;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
08 Barcelona;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
08 Barcelona;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;93,13
08 Barcelona;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
08 Barcelona;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
08 Barcelona;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;91,73
08 Barcelona;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
08 Barcelona;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
08 Barcelona;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
08 Barcelona;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;93,18
08 Barcelona;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
08 Barcelona;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
08 Barcelona;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
08 Barcelona;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;91,1
08 Barcelona;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
08 Barcelona;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
08 Barcelona;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;89,17
08 Barcelona;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
08 Barcelona;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
08 Barcelona;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
08 Barcelona;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;90,69
08 Barcelona;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
08 Barcelona;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
08 Barcelona;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
08 Barcelona;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;89
08 Barcelona;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
08 Barcelona;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
08 Barcelona;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
08 Barcelona;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
08 Barcelona;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
08 Barcelona;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
08 Barcelona;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QI;44.292
08 Barcelona;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
08 Barcelona;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
08 Barcelona;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
08 Barcelona;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QI;43.300
08 Barcelona;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
08 Barcelona;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
08 Barcelona;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
08 Barcelona;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QI;43.712
08 Barcelona;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
08 Barcelona;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
08 Barcelona;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2022QII;""
08 Barcelona;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2022QI;42.701
08 Barcelona;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
08 Barcelona;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
08 Barcelona;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2021QII;""
08 Barcelona;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2021QI;42.247
08 Barcelona;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
08 Barcelona;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
08 Barcelona;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2020QII;""
08 Barcelona;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2020QI;40.756
08 Barcelona;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
08 Barcelona;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
08 Barcelona;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2022QII;41.245
08 Barcelona;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2022QI;""
08 Barcelona;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
08 Barcelona;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
08 Barcelona;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2021QII;41.118
08 Barcelona;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2021QI;""
08 Barcelona;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
08 Barcelona;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
08 Barcelona;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2020QII;39.828
08 Barcelona;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2020QI;""
08 Barcelona;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
08 Barcelona;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QIII;40.070
08 Barcelona;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QII;""
08 Barcelona;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QI;""
08 Barcelona;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
08 Barcelona;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QIII;40.122
08 Barcelona;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QII;""
08 Barcelona;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QI;""
08 Barcelona;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
08 Barcelona;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QIII;38.728
08 Barcelona;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QII;""
08 Barcelona;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QI;""
08 Barcelona;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QIV;38.830
08 Barcelona;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
08 Barcelona;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QII;""
08 Barcelona;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QI;""
08 Barcelona;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QIV;39.084
08 Barcelona;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
08 Barcelona;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QII;""
08 Barcelona;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QI;""
08 Barcelona;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QIV;37.668
08 Barcelona;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
08 Barcelona;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QII;""
08 Barcelona;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QI;""
08 Barcelona;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
08 Barcelona;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
08 Barcelona;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
08 Barcelona;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
08 Barcelona;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
08 Barcelona;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
08 Barcelona;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
08 Barcelona;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
08 Barcelona;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
08 Barcelona;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
08 Barcelona;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
08 Barcelona;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
08 Barcelona;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
08 Barcelona;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
08 Barcelona;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
08 Barcelona;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;96,41
08 Barcelona;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
08 Barcelona;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
08 Barcelona;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
08 Barcelona;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;97,57
08 Barcelona;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
08 Barcelona;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
08 Barcelona;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
08 Barcelona;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;93,24
08 Barcelona;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
08 Barcelona;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
08 Barcelona;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;93,12
08 Barcelona;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
08 Barcelona;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
08 Barcelona;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
08 Barcelona;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;94,96
08 Barcelona;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
08 Barcelona;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
08 Barcelona;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
08 Barcelona;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;91,11
08 Barcelona;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
08 Barcelona;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
08 Barcelona;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;90,47
08 Barcelona;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
08 Barcelona;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
08 Barcelona;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
08 Barcelona;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;92,66
08 Barcelona;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
08 Barcelona;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
08 Barcelona;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
08 Barcelona;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;88,6
08 Barcelona;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
08 Barcelona;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
08 Barcelona;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;87,67
08 Barcelona;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
08 Barcelona;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
08 Barcelona;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
08 Barcelona;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;90,26
08 Barcelona;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
08 Barcelona;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
08 Barcelona;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
08 Barcelona;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;86,17
08 Barcelona;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
08 Barcelona;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
08 Barcelona;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
08 Barcelona;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
08 Barcelona;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
08 Barcelona;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QII;120.284
08 Barcelona;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
08 Barcelona;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
08 Barcelona;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
08 Barcelona;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QII;122.128
08 Barcelona;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
08 Barcelona;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
08 Barcelona;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
08 Barcelona;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QII;121.978
08 Barcelona;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
08 Barcelona;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
08 Barcelona;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
08 Barcelona;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2022QII;116.141
08 Barcelona;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2022QI;""
08 Barcelona;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
08 Barcelona;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
08 Barcelona;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2021QII;118.558
08 Barcelona;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2021QI;""
08 Barcelona;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
08 Barcelona;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
08 Barcelona;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2020QII;119.493
08 Barcelona;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2020QI;""
08 Barcelona;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
08 Barcelona;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2022QIII;112.902
08 Barcelona;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2022QII;""
08 Barcelona;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2022QI;""
08 Barcelona;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
08 Barcelona;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2021QIII;115.496
08 Barcelona;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2021QII;""
08 Barcelona;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2021QI;""
08 Barcelona;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
08 Barcelona;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2020QIII;116.402
08 Barcelona;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2020QII;""
08 Barcelona;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2020QI;""
08 Barcelona;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QIV;109.309
08 Barcelona;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
08 Barcelona;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QII;""
08 Barcelona;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QI;""
08 Barcelona;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QIV;112.152
08 Barcelona;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
08 Barcelona;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QII;""
08 Barcelona;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QI;""
08 Barcelona;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QIV;113.355
08 Barcelona;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
08 Barcelona;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QII;""
08 Barcelona;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QI;""
08 Barcelona;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
08 Barcelona;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
08 Barcelona;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QII;""
08 Barcelona;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QI;109.006
08 Barcelona;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
08 Barcelona;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
08 Barcelona;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QII;""
08 Barcelona;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QI;111.224
08 Barcelona;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
08 Barcelona;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
08 Barcelona;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QII;""
08 Barcelona;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QI;""
08 Barcelona;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
08 Barcelona;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
08 Barcelona;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
08 Barcelona;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
08 Barcelona;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
08 Barcelona;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
08 Barcelona;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
08 Barcelona;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
08 Barcelona;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
08 Barcelona;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
08 Barcelona;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
08 Barcelona;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
08 Barcelona;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
08 Barcelona;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
08 Barcelona;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;96,56
08 Barcelona;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
08 Barcelona;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
08 Barcelona;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
08 Barcelona;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;97,08
08 Barcelona;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
08 Barcelona;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
08 Barcelona;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
08 Barcelona;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;97,96
08 Barcelona;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
08 Barcelona;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
08 Barcelona;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;93,86
08 Barcelona;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
08 Barcelona;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
08 Barcelona;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
08 Barcelona;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;94,57
08 Barcelona;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
08 Barcelona;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
08 Barcelona;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
08 Barcelona;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;95,43
08 Barcelona;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
08 Barcelona;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
08 Barcelona;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;90,88
08 Barcelona;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
08 Barcelona;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
08 Barcelona;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
08 Barcelona;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;91,83
08 Barcelona;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
08 Barcelona;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
08 Barcelona;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
08 Barcelona;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;92,93
08 Barcelona;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
08 Barcelona;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
08 Barcelona;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
08 Barcelona;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
08 Barcelona;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
08 Barcelona;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
08 Barcelona;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;89,26
08 Barcelona;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
08 Barcelona;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
08 Barcelona;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
08 Barcelona;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;91,18
08 Barcelona;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
08 Barcelona;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
08 Barcelona;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
08 Barcelona;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
08 Barcelona;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
08 Barcelona;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
08 Barcelona;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QII;76.956
08 Barcelona;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
08 Barcelona;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
08 Barcelona;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
08 Barcelona;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QII;79.013
08 Barcelona;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
08 Barcelona;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
08 Barcelona;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
08 Barcelona;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QII;79.284
08 Barcelona;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
08 Barcelona;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
08 Barcelona;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
08 Barcelona;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2022QII;74.430
08 Barcelona;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2022QI;""
08 Barcelona;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
08 Barcelona;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
08 Barcelona;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2021QII;76.745
08 Barcelona;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2021QI;""
08 Barcelona;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
08 Barcelona;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
08 Barcelona;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2020QII;77.841
08 Barcelona;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2020QI;""
08 Barcelona;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
08 Barcelona;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2022QIII;72.507
08 Barcelona;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2022QII;""
08 Barcelona;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2022QI;""
08 Barcelona;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
08 Barcelona;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2021QIII;74.817
08 Barcelona;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2021QII;""
08 Barcelona;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2021QI;""
08 Barcelona;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
08 Barcelona;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2020QIII;75.981
08 Barcelona;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2020QII;""
08 Barcelona;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2020QI;""
08 Barcelona;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QIV;70.268
08 Barcelona;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
08 Barcelona;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QII;""
08 Barcelona;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QI;""
08 Barcelona;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QIV;72.613
08 Barcelona;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
08 Barcelona;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QII;""
08 Barcelona;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QI;""
08 Barcelona;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QIV;74.116
08 Barcelona;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
08 Barcelona;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QII;""
08 Barcelona;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QI;""
08 Barcelona;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
08 Barcelona;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
08 Barcelona;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QII;""
08 Barcelona;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QI;70.676
08 Barcelona;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
08 Barcelona;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
08 Barcelona;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QII;""
08 Barcelona;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QI;72.759
08 Barcelona;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
08 Barcelona;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
08 Barcelona;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QII;""
08 Barcelona;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QI;""
08 Barcelona;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
08 Barcelona;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
08 Barcelona;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
08 Barcelona;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
08 Barcelona;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
08 Barcelona;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
08 Barcelona;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
08 Barcelona;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
08 Barcelona;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
08 Barcelona;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
08 Barcelona;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
08 Barcelona;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
08 Barcelona;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
08 Barcelona;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
08 Barcelona;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;96,72
08 Barcelona;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
08 Barcelona;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
08 Barcelona;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
08 Barcelona;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;97,13
08 Barcelona;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
08 Barcelona;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
08 Barcelona;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
08 Barcelona;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;98,18
08 Barcelona;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
08 Barcelona;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
08 Barcelona;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;94,22
08 Barcelona;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
08 Barcelona;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
08 Barcelona;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
08 Barcelona;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;94,69
08 Barcelona;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
08 Barcelona;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
08 Barcelona;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
08 Barcelona;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;95,83
08 Barcelona;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
08 Barcelona;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
08 Barcelona;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;91,31
08 Barcelona;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
08 Barcelona;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
08 Barcelona;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
08 Barcelona;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;91,9
08 Barcelona;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
08 Barcelona;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
08 Barcelona;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
08 Barcelona;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;93,48
08 Barcelona;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
08 Barcelona;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
08 Barcelona;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
08 Barcelona;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
08 Barcelona;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
08 Barcelona;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
08 Barcelona;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;89,45
08 Barcelona;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
08 Barcelona;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
08 Barcelona;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
08 Barcelona;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;91,77
08 Barcelona;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
08 Barcelona;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
08 Barcelona;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
08 Barcelona;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
08 Barcelona;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
08 Barcelona;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
08 Barcelona;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QII;43.328
08 Barcelona;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
08 Barcelona;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
08 Barcelona;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
08 Barcelona;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QII;43.115
08 Barcelona;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
08 Barcelona;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
08 Barcelona;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
08 Barcelona;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QII;42.694
08 Barcelona;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
08 Barcelona;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
08 Barcelona;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
08 Barcelona;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2022QII;41.711
08 Barcelona;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2022QI;""
08 Barcelona;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
08 Barcelona;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
08 Barcelona;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2021QII;41.813
08 Barcelona;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2021QI;""
08 Barcelona;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
08 Barcelona;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
08 Barcelona;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2020QII;41.652
08 Barcelona;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2020QI;""
08 Barcelona;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
08 Barcelona;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2022QIII;40.395
08 Barcelona;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2022QII;""
08 Barcelona;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2022QI;""
08 Barcelona;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
08 Barcelona;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2021QIII;40.679
08 Barcelona;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2021QII;""
08 Barcelona;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2021QI;""
08 Barcelona;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
08 Barcelona;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2020QIII;40.421
08 Barcelona;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2020QII;""
08 Barcelona;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2020QI;""
08 Barcelona;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QIV;39.041
08 Barcelona;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
08 Barcelona;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QII;""
08 Barcelona;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QI;""
08 Barcelona;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QIV;39.539
08 Barcelona;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
08 Barcelona;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QII;""
08 Barcelona;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QI;""
08 Barcelona;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QIV;39.239
08 Barcelona;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
08 Barcelona;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QII;""
08 Barcelona;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QI;""
08 Barcelona;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
08 Barcelona;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
08 Barcelona;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QII;""
08 Barcelona;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QI;38.330
08 Barcelona;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
08 Barcelona;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
08 Barcelona;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QII;""
08 Barcelona;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QI;38.465
08 Barcelona;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
08 Barcelona;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
08 Barcelona;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QII;""
08 Barcelona;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QI;""
08 Barcelona;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
08 Barcelona;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
08 Barcelona;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
08 Barcelona;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
08 Barcelona;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
08 Barcelona;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
08 Barcelona;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
08 Barcelona;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
08 Barcelona;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
08 Barcelona;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
08 Barcelona;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
08 Barcelona;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
08 Barcelona;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
08 Barcelona;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
08 Barcelona;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;96,27
08 Barcelona;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
08 Barcelona;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
08 Barcelona;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
08 Barcelona;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;96,98
08 Barcelona;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
08 Barcelona;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
08 Barcelona;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
08 Barcelona;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;97,56
08 Barcelona;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
08 Barcelona;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
08 Barcelona;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;93,23
08 Barcelona;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
08 Barcelona;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
08 Barcelona;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
08 Barcelona;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;94,35
08 Barcelona;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
08 Barcelona;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
08 Barcelona;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
08 Barcelona;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;94,68
08 Barcelona;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
08 Barcelona;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
08 Barcelona;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;90,11
08 Barcelona;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
08 Barcelona;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
08 Barcelona;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
08 Barcelona;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;91,71
08 Barcelona;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
08 Barcelona;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
08 Barcelona;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
08 Barcelona;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;91,91
08 Barcelona;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
08 Barcelona;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
08 Barcelona;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
08 Barcelona;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
08 Barcelona;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
08 Barcelona;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
08 Barcelona;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;88,9
08 Barcelona;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
08 Barcelona;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
08 Barcelona;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
08 Barcelona;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;90,09
08 Barcelona;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
08 Barcelona;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
08 Barcelona;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
08 Barcelona;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
08 Barcelona;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
08 Barcelona;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QIII;120.649
08 Barcelona;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
08 Barcelona;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
08 Barcelona;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
08 Barcelona;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QIII;123.182
08 Barcelona;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
08 Barcelona;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
08 Barcelona;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
08 Barcelona;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QIII;122.497
08 Barcelona;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
08 Barcelona;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
08 Barcelona;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
08 Barcelona;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2022QIII;116.874
08 Barcelona;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2022QII;""
08 Barcelona;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2022QI;""
08 Barcelona;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
08 Barcelona;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2021QIII;119.592
08 Barcelona;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2021QII;""
08 Barcelona;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2021QI;""
08 Barcelona;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
08 Barcelona;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2020QIII;119.022
08 Barcelona;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2020QII;""
08 Barcelona;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2020QI;""
08 Barcelona;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2022QIV;112.841
08 Barcelona;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
08 Barcelona;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2022QII;""
08 Barcelona;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2022QI;""
08 Barcelona;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2021QIV;115.882
08 Barcelona;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
08 Barcelona;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2021QII;""
08 Barcelona;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2021QI;""
08 Barcelona;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2020QIV;115.745
08 Barcelona;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
08 Barcelona;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2020QII;""
08 Barcelona;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2020QI;""
08 Barcelona;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
08 Barcelona;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
08 Barcelona;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QII;""
08 Barcelona;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QI;112.467
08 Barcelona;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
08 Barcelona;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
08 Barcelona;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QII;""
08 Barcelona;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QI;113.484
08 Barcelona;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
08 Barcelona;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
08 Barcelona;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QII;""
08 Barcelona;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QI;""
08 Barcelona;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
08 Barcelona;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
08 Barcelona;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QII;109.398
08 Barcelona;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QI;""
08 Barcelona;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
08 Barcelona;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
08 Barcelona;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QII;111.030
08 Barcelona;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QI;""
08 Barcelona;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
08 Barcelona;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
08 Barcelona;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QII;""
08 Barcelona;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QI;""
08 Barcelona;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
08 Barcelona;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
08 Barcelona;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
08 Barcelona;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
08 Barcelona;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
08 Barcelona;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
08 Barcelona;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
08 Barcelona;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
08 Barcelona;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
08 Barcelona;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
08 Barcelona;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
08 Barcelona;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
08 Barcelona;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
08 Barcelona;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;96,87
08 Barcelona;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
08 Barcelona;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
08 Barcelona;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
08 Barcelona;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;97,09
08 Barcelona;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
08 Barcelona;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
08 Barcelona;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
08 Barcelona;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;97,16
08 Barcelona;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
08 Barcelona;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
08 Barcelona;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;93,53
08 Barcelona;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
08 Barcelona;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
08 Barcelona;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
08 Barcelona;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;94,07
08 Barcelona;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
08 Barcelona;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
08 Barcelona;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
08 Barcelona;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;94,49
08 Barcelona;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
08 Barcelona;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
08 Barcelona;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
08 Barcelona;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
08 Barcelona;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
08 Barcelona;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
08 Barcelona;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;91,3
08 Barcelona;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
08 Barcelona;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
08 Barcelona;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
08 Barcelona;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;92,64
08 Barcelona;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
08 Barcelona;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
08 Barcelona;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
08 Barcelona;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
08 Barcelona;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
08 Barcelona;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
08 Barcelona;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;88,81
08 Barcelona;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
08 Barcelona;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
08 Barcelona;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
08 Barcelona;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;90,64
08 Barcelona;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
08 Barcelona;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
08 Barcelona;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
08 Barcelona;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
08 Barcelona;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
08 Barcelona;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
08 Barcelona;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QIII;77.090
08 Barcelona;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
08 Barcelona;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
08 Barcelona;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
08 Barcelona;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QIII;79.509
08 Barcelona;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
08 Barcelona;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
08 Barcelona;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
08 Barcelona;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QIII;79.744
08 Barcelona;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
08 Barcelona;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
08 Barcelona;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
08 Barcelona;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2022QIII;74.834
08 Barcelona;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2022QII;""
08 Barcelona;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2022QI;""
08 Barcelona;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
08 Barcelona;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2021QIII;77.231
08 Barcelona;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2021QII;""
08 Barcelona;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2021QI;""
08 Barcelona;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
08 Barcelona;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2020QIII;77.637
08 Barcelona;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2020QII;""
08 Barcelona;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2020QI;""
08 Barcelona;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2022QIV;72.324
08 Barcelona;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
08 Barcelona;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2022QII;""
08 Barcelona;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2022QI;""
08 Barcelona;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2021QIV;74.791
08 Barcelona;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
08 Barcelona;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2021QII;""
08 Barcelona;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2021QI;""
08 Barcelona;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2020QIV;75.622
08 Barcelona;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
08 Barcelona;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2020QII;""
08 Barcelona;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2020QI;""
08 Barcelona;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
08 Barcelona;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
08 Barcelona;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QII;""
08 Barcelona;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QI;72.688
08 Barcelona;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
08 Barcelona;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
08 Barcelona;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QII;""
08 Barcelona;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QI;74.180
08 Barcelona;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
08 Barcelona;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
08 Barcelona;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QII;""
08 Barcelona;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QI;""
08 Barcelona;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
08 Barcelona;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
08 Barcelona;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QII;70.808
08 Barcelona;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QI;""
08 Barcelona;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
08 Barcelona;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
08 Barcelona;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QII;72.630
08 Barcelona;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QI;""
08 Barcelona;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
08 Barcelona;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
08 Barcelona;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QII;""
08 Barcelona;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QI;""
08 Barcelona;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
08 Barcelona;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
08 Barcelona;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
08 Barcelona;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
08 Barcelona;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
08 Barcelona;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
08 Barcelona;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
08 Barcelona;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
08 Barcelona;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
08 Barcelona;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
08 Barcelona;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
08 Barcelona;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
08 Barcelona;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
08 Barcelona;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;97,07
08 Barcelona;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
08 Barcelona;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
08 Barcelona;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
08 Barcelona;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;97,13
08 Barcelona;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
08 Barcelona;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
08 Barcelona;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
08 Barcelona;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;97,36
08 Barcelona;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
08 Barcelona;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
08 Barcelona;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;93,82
08 Barcelona;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
08 Barcelona;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
08 Barcelona;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
08 Barcelona;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;94,07
08 Barcelona;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
08 Barcelona;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
08 Barcelona;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
08 Barcelona;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;94,83
08 Barcelona;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
08 Barcelona;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
08 Barcelona;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
08 Barcelona;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
08 Barcelona;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
08 Barcelona;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
08 Barcelona;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;91,42
08 Barcelona;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
08 Barcelona;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
08 Barcelona;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
08 Barcelona;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;93,02
08 Barcelona;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
08 Barcelona;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
08 Barcelona;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
08 Barcelona;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
08 Barcelona;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
08 Barcelona;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
08 Barcelona;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;89,06
08 Barcelona;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
08 Barcelona;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
08 Barcelona;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
08 Barcelona;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;91,08
08 Barcelona;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
08 Barcelona;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
08 Barcelona;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
08 Barcelona;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
08 Barcelona;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
08 Barcelona;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
08 Barcelona;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QIII;43.559
08 Barcelona;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
08 Barcelona;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
08 Barcelona;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
08 Barcelona;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QIII;43.673
08 Barcelona;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
08 Barcelona;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
08 Barcelona;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
08 Barcelona;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QIII;42.753
08 Barcelona;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
08 Barcelona;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
08 Barcelona;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
08 Barcelona;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2022QIII;42.040
08 Barcelona;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2022QII;""
08 Barcelona;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2022QI;""
08 Barcelona;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
08 Barcelona;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2021QIII;42.361
08 Barcelona;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2021QII;""
08 Barcelona;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2021QI;""
08 Barcelona;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
08 Barcelona;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2020QIII;41.385
08 Barcelona;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2020QII;""
08 Barcelona;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2020QI;""
08 Barcelona;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2022QIV;40.517
08 Barcelona;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
08 Barcelona;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2022QII;""
08 Barcelona;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2022QI;""
08 Barcelona;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2021QIV;41.091
08 Barcelona;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
08 Barcelona;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2021QII;""
08 Barcelona;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2021QI;""
08 Barcelona;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2020QIV;40.123
08 Barcelona;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
08 Barcelona;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2020QII;""
08 Barcelona;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2020QI;""
08 Barcelona;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
08 Barcelona;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
08 Barcelona;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QII;""
08 Barcelona;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QI;39.779
08 Barcelona;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
08 Barcelona;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
08 Barcelona;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QII;""
08 Barcelona;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QI;39.304
08 Barcelona;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
08 Barcelona;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
08 Barcelona;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QII;""
08 Barcelona;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QI;""
08 Barcelona;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
08 Barcelona;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
08 Barcelona;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QII;38.590
08 Barcelona;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QI;""
08 Barcelona;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
08 Barcelona;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
08 Barcelona;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QII;38.400
08 Barcelona;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QI;""
08 Barcelona;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
08 Barcelona;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
08 Barcelona;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QII;""
08 Barcelona;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QI;""
08 Barcelona;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
08 Barcelona;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
08 Barcelona;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
08 Barcelona;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
08 Barcelona;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
08 Barcelona;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
08 Barcelona;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
08 Barcelona;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
08 Barcelona;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
08 Barcelona;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
08 Barcelona;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
08 Barcelona;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
08 Barcelona;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
08 Barcelona;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;96,51
08 Barcelona;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
08 Barcelona;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
08 Barcelona;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
08 Barcelona;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;97
08 Barcelona;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
08 Barcelona;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
08 Barcelona;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
08 Barcelona;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;96,8
08 Barcelona;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
08 Barcelona;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
08 Barcelona;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;93,02
08 Barcelona;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
08 Barcelona;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
08 Barcelona;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
08 Barcelona;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;94,09
08 Barcelona;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
08 Barcelona;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
08 Barcelona;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
08 Barcelona;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;93,85
08 Barcelona;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
08 Barcelona;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
08 Barcelona;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
08 Barcelona;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
08 Barcelona;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
08 Barcelona;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
08 Barcelona;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;91,08
08 Barcelona;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
08 Barcelona;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
08 Barcelona;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
08 Barcelona;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;91,93
08 Barcelona;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
08 Barcelona;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
08 Barcelona;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
08 Barcelona;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
08 Barcelona;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
08 Barcelona;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
08 Barcelona;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;88,36
08 Barcelona;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
08 Barcelona;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
08 Barcelona;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
08 Barcelona;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;89,82
08 Barcelona;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
08 Barcelona;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
08 Barcelona;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
08 Barcelona;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
08 Barcelona;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
08 Barcelona;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QIV;120.389
08 Barcelona;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
08 Barcelona;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
08 Barcelona;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
08 Barcelona;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QIV;123.234
08 Barcelona;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
08 Barcelona;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
08 Barcelona;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
08 Barcelona;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QIV;122.872
08 Barcelona;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
08 Barcelona;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
08 Barcelona;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
08 Barcelona;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2022QIV;115.944
08 Barcelona;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
08 Barcelona;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2022QII;""
08 Barcelona;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2022QI;""
08 Barcelona;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2021QIV;119.138
08 Barcelona;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
08 Barcelona;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2021QII;""
08 Barcelona;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2021QI;""
08 Barcelona;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2020QIV;119.178
08 Barcelona;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
08 Barcelona;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2020QII;""
08 Barcelona;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2020QI;""
08 Barcelona;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
08 Barcelona;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
08 Barcelona;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2022QII;""
08 Barcelona;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2022QI;115.459
08 Barcelona;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
08 Barcelona;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
08 Barcelona;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2021QII;""
08 Barcelona;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2021QI;116.699
08 Barcelona;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
08 Barcelona;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
08 Barcelona;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2020QII;""
08 Barcelona;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2020QI;""
08 Barcelona;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
08 Barcelona;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
08 Barcelona;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QII;112.153
08 Barcelona;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QI;""
08 Barcelona;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
08 Barcelona;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
08 Barcelona;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QII;114.011
08 Barcelona;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QI;""
08 Barcelona;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
08 Barcelona;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
08 Barcelona;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QII;""
08 Barcelona;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QI;""
08 Barcelona;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
08 Barcelona;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QIII;109.511
08 Barcelona;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QII;""
08 Barcelona;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QI;""
08 Barcelona;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
08 Barcelona;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QIII;111.585
08 Barcelona;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QII;""
08 Barcelona;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QI;""
08 Barcelona;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
08 Barcelona;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
08 Barcelona;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QII;""
08 Barcelona;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QI;""
08 Barcelona;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
08 Barcelona;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
08 Barcelona;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
08 Barcelona;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
08 Barcelona;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
08 Barcelona;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
08 Barcelona;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
08 Barcelona;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
08 Barcelona;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
08 Barcelona;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
08 Barcelona;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
08 Barcelona;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
08 Barcelona;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;96,31
08 Barcelona;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
08 Barcelona;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
08 Barcelona;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
08 Barcelona;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;96,68
08 Barcelona;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
08 Barcelona;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
08 Barcelona;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
08 Barcelona;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;96,99
08 Barcelona;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
08 Barcelona;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
08 Barcelona;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
08 Barcelona;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
08 Barcelona;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
08 Barcelona;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
08 Barcelona;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;93,69
08 Barcelona;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
08 Barcelona;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
08 Barcelona;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
08 Barcelona;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;94,98
08 Barcelona;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
08 Barcelona;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
08 Barcelona;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
08 Barcelona;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
08 Barcelona;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
08 Barcelona;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
08 Barcelona;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;91,01
08 Barcelona;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
08 Barcelona;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
08 Barcelona;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
08 Barcelona;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;92,79
08 Barcelona;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
08 Barcelona;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
08 Barcelona;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
08 Barcelona;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
08 Barcelona;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
08 Barcelona;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
08 Barcelona;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;88,86
08 Barcelona;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
08 Barcelona;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
08 Barcelona;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
08 Barcelona;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;90,81
08 Barcelona;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
08 Barcelona;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
08 Barcelona;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
08 Barcelona;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
08 Barcelona;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
08 Barcelona;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
08 Barcelona;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QIV;76.889
08 Barcelona;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
08 Barcelona;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
08 Barcelona;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
08 Barcelona;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QIV;79.441
08 Barcelona;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
08 Barcelona;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
08 Barcelona;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
08 Barcelona;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QIV;79.951
08 Barcelona;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
08 Barcelona;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
08 Barcelona;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
08 Barcelona;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2022QIV;74.130
08 Barcelona;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
08 Barcelona;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2022QII;""
08 Barcelona;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2022QI;""
08 Barcelona;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2021QIV;76.749
08 Barcelona;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
08 Barcelona;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2021QII;""
08 Barcelona;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2021QI;""
08 Barcelona;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2020QIV;77.689
08 Barcelona;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
08 Barcelona;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2020QII;""
08 Barcelona;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2020QI;""
08 Barcelona;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
08 Barcelona;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
08 Barcelona;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2022QII;""
08 Barcelona;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2022QI;74.473
08 Barcelona;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
08 Barcelona;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
08 Barcelona;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2021QII;""
08 Barcelona;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2021QI;76.104
08 Barcelona;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
08 Barcelona;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
08 Barcelona;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2020QII;""
08 Barcelona;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2020QI;""
08 Barcelona;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
08 Barcelona;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
08 Barcelona;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QII;72.447
08 Barcelona;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QI;""
08 Barcelona;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
08 Barcelona;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
08 Barcelona;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QII;74.411
08 Barcelona;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QI;""
08 Barcelona;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
08 Barcelona;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
08 Barcelona;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QII;""
08 Barcelona;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QI;""
08 Barcelona;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
08 Barcelona;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QIII;70.867
08 Barcelona;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QII;""
08 Barcelona;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QI;""
08 Barcelona;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
08 Barcelona;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QIII;72.865
08 Barcelona;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QII;""
08 Barcelona;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QI;""
08 Barcelona;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
08 Barcelona;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
08 Barcelona;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QII;""
08 Barcelona;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QI;""
08 Barcelona;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
08 Barcelona;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
08 Barcelona;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
08 Barcelona;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
08 Barcelona;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
08 Barcelona;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
08 Barcelona;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
08 Barcelona;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
08 Barcelona;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
08 Barcelona;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
08 Barcelona;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
08 Barcelona;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
08 Barcelona;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;96,41
08 Barcelona;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
08 Barcelona;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
08 Barcelona;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
08 Barcelona;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;96,61
08 Barcelona;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
08 Barcelona;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
08 Barcelona;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
08 Barcelona;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;97,17
08 Barcelona;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
08 Barcelona;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
08 Barcelona;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
08 Barcelona;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
08 Barcelona;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
08 Barcelona;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
08 Barcelona;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;93,75
08 Barcelona;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
08 Barcelona;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
08 Barcelona;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
08 Barcelona;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;95,19
08 Barcelona;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
08 Barcelona;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
08 Barcelona;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
08 Barcelona;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
08 Barcelona;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
08 Barcelona;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
08 Barcelona;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;91,2
08 Barcelona;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
08 Barcelona;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
08 Barcelona;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
08 Barcelona;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;93,07
08 Barcelona;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
08 Barcelona;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
08 Barcelona;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
08 Barcelona;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
08 Barcelona;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
08 Barcelona;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
08 Barcelona;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;89,21
08 Barcelona;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
08 Barcelona;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
08 Barcelona;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
08 Barcelona;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;91,14
08 Barcelona;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
08 Barcelona;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
08 Barcelona;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
08 Barcelona;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
08 Barcelona;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
08 Barcelona;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
08 Barcelona;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QIV;43.500
08 Barcelona;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
08 Barcelona;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
08 Barcelona;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
08 Barcelona;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QIV;43.793
08 Barcelona;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
08 Barcelona;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
08 Barcelona;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
08 Barcelona;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QIV;42.921
08 Barcelona;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
08 Barcelona;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
08 Barcelona;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
08 Barcelona;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2022QIV;41.814
08 Barcelona;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
08 Barcelona;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2022QII;""
08 Barcelona;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2022QI;""
08 Barcelona;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2021QIV;42.389
08 Barcelona;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
08 Barcelona;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2021QII;""
08 Barcelona;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2021QI;""
08 Barcelona;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2020QIV;41.489
08 Barcelona;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
08 Barcelona;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2020QII;""
08 Barcelona;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2020QI;""
08 Barcelona;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
08 Barcelona;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
08 Barcelona;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2022QII;""
08 Barcelona;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2022QI;40.986
08 Barcelona;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
08 Barcelona;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
08 Barcelona;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2021QII;""
08 Barcelona;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2021QI;40.595
08 Barcelona;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
08 Barcelona;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
08 Barcelona;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2020QII;""
08 Barcelona;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2020QI;""
08 Barcelona;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
08 Barcelona;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
08 Barcelona;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QII;39.706
08 Barcelona;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QI;""
08 Barcelona;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
08 Barcelona;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
08 Barcelona;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QII;39.600
08 Barcelona;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QI;""
08 Barcelona;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
08 Barcelona;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
08 Barcelona;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QII;""
08 Barcelona;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QI;""
08 Barcelona;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
08 Barcelona;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QIII;38.644
08 Barcelona;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QII;""
08 Barcelona;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QI;""
08 Barcelona;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
08 Barcelona;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QIII;38.720
08 Barcelona;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QII;""
08 Barcelona;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QI;""
08 Barcelona;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
08 Barcelona;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
08 Barcelona;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QII;""
08 Barcelona;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QI;""
08 Barcelona;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
08 Barcelona;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
08 Barcelona;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
08 Barcelona;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
08 Barcelona;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
08 Barcelona;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
08 Barcelona;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
08 Barcelona;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
08 Barcelona;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
08 Barcelona;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
08 Barcelona;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
08 Barcelona;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
08 Barcelona;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;96,12
08 Barcelona;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
08 Barcelona;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
08 Barcelona;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
08 Barcelona;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;96,79
08 Barcelona;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
08 Barcelona;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
08 Barcelona;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
08 Barcelona;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;96,66
08 Barcelona;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
08 Barcelona;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
08 Barcelona;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
08 Barcelona;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
08 Barcelona;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
08 Barcelona;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
08 Barcelona;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;93,59
08 Barcelona;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
08 Barcelona;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
08 Barcelona;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
08 Barcelona;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;94,58
08 Barcelona;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
08 Barcelona;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
08 Barcelona;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
08 Barcelona;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
08 Barcelona;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
08 Barcelona;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
08 Barcelona;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;90,67
08 Barcelona;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
08 Barcelona;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
08 Barcelona;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
08 Barcelona;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;92,26
08 Barcelona;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
08 Barcelona;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
08 Barcelona;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
08 Barcelona;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
08 Barcelona;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
08 Barcelona;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
08 Barcelona;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;88,24
08 Barcelona;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
08 Barcelona;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
08 Barcelona;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
08 Barcelona;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;90,21
08 Barcelona;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
08 Barcelona;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
08 Barcelona;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
08 Barcelona;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
08 Barcelona;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
08 Barcelona;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
08 Barcelona;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
08 Barcelona;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
08 Barcelona;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
08 Barcelona;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QI;114.164
08 Barcelona;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
08 Barcelona;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
08 Barcelona;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
08 Barcelona;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QI;110.795
08 Barcelona;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
08 Barcelona;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
08 Barcelona;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
08 Barcelona;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QI;112.898
08 Barcelona;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
08 Barcelona;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
08 Barcelona;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2022QII;""
08 Barcelona;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2022QI;111.580
08 Barcelona;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
08 Barcelona;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
08 Barcelona;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2021QII;""
08 Barcelona;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2021QI;108.798
08 Barcelona;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
08 Barcelona;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
08 Barcelona;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2020QII;""
08 Barcelona;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2020QI;108.042
08 Barcelona;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
08 Barcelona;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
08 Barcelona;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2022QII;109.034
08 Barcelona;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2022QI;""
08 Barcelona;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
08 Barcelona;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
08 Barcelona;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2021QII;106.769
08 Barcelona;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2021QI;""
08 Barcelona;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
08 Barcelona;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
08 Barcelona;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2020QII;106.602
08 Barcelona;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2020QI;""
08 Barcelona;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
08 Barcelona;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QIII;107.046
08 Barcelona;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QII;""
08 Barcelona;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QI;""
08 Barcelona;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
08 Barcelona;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QIII;104.989
08 Barcelona;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QII;""
08 Barcelona;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QI;""
08 Barcelona;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
08 Barcelona;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QIII;104.803
08 Barcelona;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QII;""
08 Barcelona;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QI;""
08 Barcelona;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QIV;104.781
08 Barcelona;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
08 Barcelona;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QII;""
08 Barcelona;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QI;""
08 Barcelona;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QIV;103.031
08 Barcelona;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
08 Barcelona;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QII;""
08 Barcelona;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QI;""
08 Barcelona;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QIV;102.959
08 Barcelona;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
08 Barcelona;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QII;""
08 Barcelona;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QI;""
08 Barcelona;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
08 Barcelona;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
08 Barcelona;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
08 Barcelona;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
08 Barcelona;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
08 Barcelona;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
08 Barcelona;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
08 Barcelona;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
08 Barcelona;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
08 Barcelona;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
08 Barcelona;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
08 Barcelona;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
08 Barcelona;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
08 Barcelona;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
08 Barcelona;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
08 Barcelona;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;97,74
08 Barcelona;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
08 Barcelona;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
08 Barcelona;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
08 Barcelona;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;98,2
08 Barcelona;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
08 Barcelona;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
08 Barcelona;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
08 Barcelona;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;95,7
08 Barcelona;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
08 Barcelona;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
08 Barcelona;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;95,51
08 Barcelona;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
08 Barcelona;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
08 Barcelona;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
08 Barcelona;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;96,37
08 Barcelona;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
08 Barcelona;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
08 Barcelona;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
08 Barcelona;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;94,42
08 Barcelona;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
08 Barcelona;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
08 Barcelona;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;93,77
08 Barcelona;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
08 Barcelona;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
08 Barcelona;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
08 Barcelona;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;94,76
08 Barcelona;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
08 Barcelona;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
08 Barcelona;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
08 Barcelona;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;92,83
08 Barcelona;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
08 Barcelona;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
08 Barcelona;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;91,78
08 Barcelona;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
08 Barcelona;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
08 Barcelona;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
08 Barcelona;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;92,99
08 Barcelona;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
08 Barcelona;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
08 Barcelona;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
08 Barcelona;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;91,2
08 Barcelona;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
08 Barcelona;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
08 Barcelona;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
08 Barcelona;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
08 Barcelona;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
08 Barcelona;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
08 Barcelona;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QI;73.358
08 Barcelona;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
08 Barcelona;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
08 Barcelona;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
08 Barcelona;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QI;71.408
08 Barcelona;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
08 Barcelona;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
08 Barcelona;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
08 Barcelona;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QI;72.599
08 Barcelona;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
08 Barcelona;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
08 Barcelona;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2022QII;""
08 Barcelona;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2022QI;71.743
08 Barcelona;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
08 Barcelona;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
08 Barcelona;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2021QII;""
08 Barcelona;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2021QI;70.132
08 Barcelona;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
08 Barcelona;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
08 Barcelona;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2020QII;""
08 Barcelona;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2020QI;69.656
08 Barcelona;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
08 Barcelona;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
08 Barcelona;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2022QII;70.214
08 Barcelona;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2022QI;""
08 Barcelona;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
08 Barcelona;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
08 Barcelona;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2021QII;68.926
08 Barcelona;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2021QI;""
08 Barcelona;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
08 Barcelona;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
08 Barcelona;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2020QII;68.816
08 Barcelona;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2020QI;""
08 Barcelona;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
08 Barcelona;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QIII;69.008
08 Barcelona;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QII;""
08 Barcelona;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QI;""
08 Barcelona;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
08 Barcelona;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QIII;67.786
08 Barcelona;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QII;""
08 Barcelona;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QI;""
08 Barcelona;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
08 Barcelona;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QIII;67.775
08 Barcelona;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QII;""
08 Barcelona;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QI;""
08 Barcelona;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QIV;67.667
08 Barcelona;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
08 Barcelona;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QII;""
08 Barcelona;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QI;""
08 Barcelona;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QIV;66.539
08 Barcelona;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
08 Barcelona;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QII;""
08 Barcelona;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QI;""
08 Barcelona;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QIV;66.657
08 Barcelona;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
08 Barcelona;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QII;""
08 Barcelona;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QI;""
08 Barcelona;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
08 Barcelona;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
08 Barcelona;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
08 Barcelona;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
08 Barcelona;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
08 Barcelona;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
08 Barcelona;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
08 Barcelona;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
08 Barcelona;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
08 Barcelona;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
08 Barcelona;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
08 Barcelona;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
08 Barcelona;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
08 Barcelona;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
08 Barcelona;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
08 Barcelona;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;97,8
08 Barcelona;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
08 Barcelona;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
08 Barcelona;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
08 Barcelona;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;98,21
08 Barcelona;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
08 Barcelona;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
08 Barcelona;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
08 Barcelona;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;95,95
08 Barcelona;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
08 Barcelona;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
08 Barcelona;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;95,71
08 Barcelona;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
08 Barcelona;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
08 Barcelona;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
08 Barcelona;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;96,52
08 Barcelona;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
08 Barcelona;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
08 Barcelona;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
08 Barcelona;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;94,79
08 Barcelona;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
08 Barcelona;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
08 Barcelona;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;94,07
08 Barcelona;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
08 Barcelona;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
08 Barcelona;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
08 Barcelona;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;94,93
08 Barcelona;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
08 Barcelona;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
08 Barcelona;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
08 Barcelona;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;93,36
08 Barcelona;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
08 Barcelona;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
08 Barcelona;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;92,24
08 Barcelona;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
08 Barcelona;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
08 Barcelona;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
08 Barcelona;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;93,18
08 Barcelona;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
08 Barcelona;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
08 Barcelona;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
08 Barcelona;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;91,82
08 Barcelona;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
08 Barcelona;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
08 Barcelona;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
08 Barcelona;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
08 Barcelona;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
08 Barcelona;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
08 Barcelona;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QI;40.806
08 Barcelona;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
08 Barcelona;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
08 Barcelona;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
08 Barcelona;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QI;39.387
08 Barcelona;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
08 Barcelona;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
08 Barcelona;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
08 Barcelona;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QI;40.299
08 Barcelona;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
08 Barcelona;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
08 Barcelona;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2022QII;""
08 Barcelona;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2022QI;39.837
08 Barcelona;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
08 Barcelona;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
08 Barcelona;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2021QII;""
08 Barcelona;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2021QI;38.666
08 Barcelona;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
08 Barcelona;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
08 Barcelona;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2020QII;""
08 Barcelona;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2020QI;38.386
08 Barcelona;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
08 Barcelona;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
08 Barcelona;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2022QII;38.820
08 Barcelona;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2022QI;""
08 Barcelona;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
08 Barcelona;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
08 Barcelona;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2021QII;37.843
08 Barcelona;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2021QI;""
08 Barcelona;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
08 Barcelona;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
08 Barcelona;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2020QII;37.786
08 Barcelona;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2020QI;""
08 Barcelona;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
08 Barcelona;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QIII;38.038
08 Barcelona;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QII;""
08 Barcelona;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QI;""
08 Barcelona;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
08 Barcelona;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QIII;37.203
08 Barcelona;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QII;""
08 Barcelona;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QI;""
08 Barcelona;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
08 Barcelona;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QIII;37.028
08 Barcelona;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QII;""
08 Barcelona;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QI;""
08 Barcelona;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QIV;37.114
08 Barcelona;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
08 Barcelona;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QII;""
08 Barcelona;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QI;""
08 Barcelona;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QIV;36.492
08 Barcelona;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
08 Barcelona;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QII;""
08 Barcelona;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QI;""
08 Barcelona;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QIV;36.302
08 Barcelona;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
08 Barcelona;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QII;""
08 Barcelona;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QI;""
08 Barcelona;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
08 Barcelona;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
08 Barcelona;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
08 Barcelona;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
08 Barcelona;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
08 Barcelona;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
08 Barcelona;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
08 Barcelona;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
08 Barcelona;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
08 Barcelona;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
08 Barcelona;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
08 Barcelona;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
08 Barcelona;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
08 Barcelona;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
08 Barcelona;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
08 Barcelona;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;97,63
08 Barcelona;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
08 Barcelona;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
08 Barcelona;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
08 Barcelona;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;98,17
08 Barcelona;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
08 Barcelona;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
08 Barcelona;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
08 Barcelona;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;95,25
08 Barcelona;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
08 Barcelona;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
08 Barcelona;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;95,13
08 Barcelona;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
08 Barcelona;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
08 Barcelona;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
08 Barcelona;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;96,08
08 Barcelona;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
08 Barcelona;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
08 Barcelona;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
08 Barcelona;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;93,76
08 Barcelona;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
08 Barcelona;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
08 Barcelona;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;93,22
08 Barcelona;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
08 Barcelona;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
08 Barcelona;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
08 Barcelona;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;94,46
08 Barcelona;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
08 Barcelona;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
08 Barcelona;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
08 Barcelona;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;91,88
08 Barcelona;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
08 Barcelona;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
08 Barcelona;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;90,95
08 Barcelona;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
08 Barcelona;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
08 Barcelona;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
08 Barcelona;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;92,65
08 Barcelona;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
08 Barcelona;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
08 Barcelona;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
08 Barcelona;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;90,08
08 Barcelona;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
08 Barcelona;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
08 Barcelona;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
08 Barcelona;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
08 Barcelona;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
08 Barcelona;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QII;117.493
08 Barcelona;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
08 Barcelona;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
08 Barcelona;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
08 Barcelona;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QII;114.693
08 Barcelona;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
08 Barcelona;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
08 Barcelona;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
08 Barcelona;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QII;111.432
08 Barcelona;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
08 Barcelona;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
08 Barcelona;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
08 Barcelona;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2022QII;114.505
08 Barcelona;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2022QI;""
08 Barcelona;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
08 Barcelona;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
08 Barcelona;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2021QII;112.332
08 Barcelona;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2021QI;""
08 Barcelona;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
08 Barcelona;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
08 Barcelona;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2020QII;109.782
08 Barcelona;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2020QI;""
08 Barcelona;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
08 Barcelona;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2022QIII;112.228
08 Barcelona;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2022QII;""
08 Barcelona;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2022QI;""
08 Barcelona;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
08 Barcelona;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2021QIII;110.314
08 Barcelona;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2021QII;""
08 Barcelona;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2021QI;""
08 Barcelona;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
08 Barcelona;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2020QIII;107.598
08 Barcelona;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2020QII;""
08 Barcelona;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2020QI;""
08 Barcelona;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QIV;109.696
08 Barcelona;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
08 Barcelona;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QII;""
08 Barcelona;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QI;""
08 Barcelona;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QIV;108.097
08 Barcelona;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
08 Barcelona;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QII;""
08 Barcelona;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QI;""
08 Barcelona;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QIV;105.593
08 Barcelona;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
08 Barcelona;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QII;""
08 Barcelona;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QI;""
08 Barcelona;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
08 Barcelona;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
08 Barcelona;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QII;""
08 Barcelona;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QI;106.011
08 Barcelona;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
08 Barcelona;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
08 Barcelona;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QII;""
08 Barcelona;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QI;104.003
08 Barcelona;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
08 Barcelona;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
08 Barcelona;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QII;""
08 Barcelona;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QI;""
08 Barcelona;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
08 Barcelona;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
08 Barcelona;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
08 Barcelona;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
08 Barcelona;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
08 Barcelona;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
08 Barcelona;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
08 Barcelona;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
08 Barcelona;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
08 Barcelona;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
08 Barcelona;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
08 Barcelona;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
08 Barcelona;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
08 Barcelona;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
08 Barcelona;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;97,46
08 Barcelona;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
08 Barcelona;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
08 Barcelona;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
08 Barcelona;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;97,94
08 Barcelona;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
08 Barcelona;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
08 Barcelona;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
08 Barcelona;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;98,52
08 Barcelona;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
08 Barcelona;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
08 Barcelona;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;95,52
08 Barcelona;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
08 Barcelona;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
08 Barcelona;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
08 Barcelona;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;96,18
08 Barcelona;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
08 Barcelona;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
08 Barcelona;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
08 Barcelona;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;96,56
08 Barcelona;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
08 Barcelona;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
08 Barcelona;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;93,36
08 Barcelona;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
08 Barcelona;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
08 Barcelona;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
08 Barcelona;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;94,25
08 Barcelona;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
08 Barcelona;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
08 Barcelona;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
08 Barcelona;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;94,76
08 Barcelona;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
08 Barcelona;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
08 Barcelona;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
08 Barcelona;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
08 Barcelona;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
08 Barcelona;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
08 Barcelona;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;92,43
08 Barcelona;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
08 Barcelona;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
08 Barcelona;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
08 Barcelona;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;93,33
08 Barcelona;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
08 Barcelona;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
08 Barcelona;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
08 Barcelona;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
08 Barcelona;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
08 Barcelona;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
08 Barcelona;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QII;75.393
08 Barcelona;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
08 Barcelona;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
08 Barcelona;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
08 Barcelona;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QII;73.940
08 Barcelona;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
08 Barcelona;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
08 Barcelona;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
08 Barcelona;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QII;71.779
08 Barcelona;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
08 Barcelona;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
08 Barcelona;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
08 Barcelona;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2022QII;73.609
08 Barcelona;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2022QI;""
08 Barcelona;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
08 Barcelona;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
08 Barcelona;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2021QII;72.509
08 Barcelona;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2021QI;""
08 Barcelona;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
08 Barcelona;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
08 Barcelona;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2020QII;70.805
08 Barcelona;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2020QI;""
08 Barcelona;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
08 Barcelona;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2022QIII;72.232
08 Barcelona;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2022QII;""
08 Barcelona;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2022QI;""
08 Barcelona;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
08 Barcelona;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2021QIII;71.207
08 Barcelona;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2021QII;""
08 Barcelona;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2021QI;""
08 Barcelona;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
08 Barcelona;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2020QIII;69.502
08 Barcelona;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2020QII;""
08 Barcelona;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2020QI;""
08 Barcelona;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QIV;70.724
08 Barcelona;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
08 Barcelona;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QII;""
08 Barcelona;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QI;""
08 Barcelona;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QIV;69.796
08 Barcelona;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
08 Barcelona;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QII;""
08 Barcelona;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QI;""
08 Barcelona;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QIV;68.280
08 Barcelona;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
08 Barcelona;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QII;""
08 Barcelona;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QI;""
08 Barcelona;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
08 Barcelona;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
08 Barcelona;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QII;""
08 Barcelona;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QI;68.495
08 Barcelona;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
08 Barcelona;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
08 Barcelona;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QII;""
08 Barcelona;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QI;67.273
08 Barcelona;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
08 Barcelona;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
08 Barcelona;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QII;""
08 Barcelona;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QI;""
08 Barcelona;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
08 Barcelona;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
08 Barcelona;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
08 Barcelona;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
08 Barcelona;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
08 Barcelona;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
08 Barcelona;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
08 Barcelona;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
08 Barcelona;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
08 Barcelona;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
08 Barcelona;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
08 Barcelona;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
08 Barcelona;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
08 Barcelona;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
08 Barcelona;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;97,63
08 Barcelona;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
08 Barcelona;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
08 Barcelona;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
08 Barcelona;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;98,06
08 Barcelona;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
08 Barcelona;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
08 Barcelona;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
08 Barcelona;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;98,64
08 Barcelona;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
08 Barcelona;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
08 Barcelona;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;95,81
08 Barcelona;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
08 Barcelona;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
08 Barcelona;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
08 Barcelona;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;96,3
08 Barcelona;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
08 Barcelona;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
08 Barcelona;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
08 Barcelona;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;96,83
08 Barcelona;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
08 Barcelona;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
08 Barcelona;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;93,81
08 Barcelona;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
08 Barcelona;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
08 Barcelona;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
08 Barcelona;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;94,4
08 Barcelona;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
08 Barcelona;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
08 Barcelona;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
08 Barcelona;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;95,13
08 Barcelona;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
08 Barcelona;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
08 Barcelona;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
08 Barcelona;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
08 Barcelona;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
08 Barcelona;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
08 Barcelona;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;92,64
08 Barcelona;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
08 Barcelona;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
08 Barcelona;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
08 Barcelona;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;93,72
08 Barcelona;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
08 Barcelona;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
08 Barcelona;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
08 Barcelona;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
08 Barcelona;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
08 Barcelona;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
08 Barcelona;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QII;42.100
08 Barcelona;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
08 Barcelona;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
08 Barcelona;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
08 Barcelona;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QII;40.753
08 Barcelona;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
08 Barcelona;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
08 Barcelona;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
08 Barcelona;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QII;39.653
08 Barcelona;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
08 Barcelona;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
08 Barcelona;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
08 Barcelona;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2022QII;40.896
08 Barcelona;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2022QI;""
08 Barcelona;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
08 Barcelona;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
08 Barcelona;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2021QII;39.823
08 Barcelona;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2021QI;""
08 Barcelona;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
08 Barcelona;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
08 Barcelona;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2020QII;38.977
08 Barcelona;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2020QI;""
08 Barcelona;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
08 Barcelona;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2022QIII;39.996
08 Barcelona;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2022QII;""
08 Barcelona;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2022QI;""
08 Barcelona;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
08 Barcelona;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2021QIII;39.107
08 Barcelona;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2021QII;""
08 Barcelona;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2021QI;""
08 Barcelona;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
08 Barcelona;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2020QIII;38.096
08 Barcelona;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2020QII;""
08 Barcelona;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2020QI;""
08 Barcelona;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QIV;38.972
08 Barcelona;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
08 Barcelona;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QII;""
08 Barcelona;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QI;""
08 Barcelona;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QIV;38.301
08 Barcelona;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
08 Barcelona;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QII;""
08 Barcelona;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QI;""
08 Barcelona;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QIV;37.313
08 Barcelona;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
08 Barcelona;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QII;""
08 Barcelona;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QI;""
08 Barcelona;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
08 Barcelona;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
08 Barcelona;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QII;""
08 Barcelona;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QI;37.516
08 Barcelona;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
08 Barcelona;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
08 Barcelona;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QII;""
08 Barcelona;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QI;36.730
08 Barcelona;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
08 Barcelona;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
08 Barcelona;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QII;""
08 Barcelona;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QI;""
08 Barcelona;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
08 Barcelona;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
08 Barcelona;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
08 Barcelona;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
08 Barcelona;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
08 Barcelona;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
08 Barcelona;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
08 Barcelona;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
08 Barcelona;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
08 Barcelona;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
08 Barcelona;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
08 Barcelona;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
08 Barcelona;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
08 Barcelona;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
08 Barcelona;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;97,14
08 Barcelona;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
08 Barcelona;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
08 Barcelona;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
08 Barcelona;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;97,72
08 Barcelona;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
08 Barcelona;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
08 Barcelona;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
08 Barcelona;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;98,3
08 Barcelona;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
08 Barcelona;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
08 Barcelona;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;95
08 Barcelona;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
08 Barcelona;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
08 Barcelona;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
08 Barcelona;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;95,96
08 Barcelona;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
08 Barcelona;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
08 Barcelona;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
08 Barcelona;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;96,07
08 Barcelona;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
08 Barcelona;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
08 Barcelona;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;92,57
08 Barcelona;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
08 Barcelona;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
08 Barcelona;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
08 Barcelona;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;93,98
08 Barcelona;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
08 Barcelona;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
08 Barcelona;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
08 Barcelona;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;94,1
08 Barcelona;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
08 Barcelona;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
08 Barcelona;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
08 Barcelona;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
08 Barcelona;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
08 Barcelona;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
08 Barcelona;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;92,06
08 Barcelona;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
08 Barcelona;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
08 Barcelona;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
08 Barcelona;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;92,63
08 Barcelona;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
08 Barcelona;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
08 Barcelona;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
08 Barcelona;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
08 Barcelona;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
08 Barcelona;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QIII;117.028
08 Barcelona;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
08 Barcelona;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
08 Barcelona;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
08 Barcelona;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QIII;114.818
08 Barcelona;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
08 Barcelona;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
08 Barcelona;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
08 Barcelona;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QIII;111.386
08 Barcelona;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
08 Barcelona;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
08 Barcelona;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
08 Barcelona;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2022QIII;114.440
08 Barcelona;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2022QII;""
08 Barcelona;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2022QI;""
08 Barcelona;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
08 Barcelona;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2021QIII;112.511
08 Barcelona;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2021QII;""
08 Barcelona;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2021QI;""
08 Barcelona;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
08 Barcelona;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2020QIII;108.998
08 Barcelona;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2020QII;""
08 Barcelona;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2020QI;""
08 Barcelona;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2022QIV;111.652
08 Barcelona;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
08 Barcelona;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2022QII;""
08 Barcelona;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2022QI;""
08 Barcelona;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2021QIV;110.062
08 Barcelona;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
08 Barcelona;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2021QII;""
08 Barcelona;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2021QI;""
08 Barcelona;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2020QIV;106.855
08 Barcelona;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
08 Barcelona;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2020QII;""
08 Barcelona;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2020QI;""
08 Barcelona;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
08 Barcelona;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
08 Barcelona;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QII;""
08 Barcelona;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QI;107.861
08 Barcelona;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
08 Barcelona;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
08 Barcelona;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QII;""
08 Barcelona;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QI;105.201
08 Barcelona;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
08 Barcelona;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
08 Barcelona;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QII;""
08 Barcelona;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QI;""
08 Barcelona;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
08 Barcelona;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
08 Barcelona;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QII;105.653
08 Barcelona;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QI;""
08 Barcelona;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
08 Barcelona;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
08 Barcelona;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QII;103.474
08 Barcelona;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QI;""
08 Barcelona;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
08 Barcelona;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
08 Barcelona;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QII;""
08 Barcelona;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QI;""
08 Barcelona;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
08 Barcelona;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
08 Barcelona;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
08 Barcelona;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
08 Barcelona;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
08 Barcelona;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
08 Barcelona;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
08 Barcelona;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
08 Barcelona;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
08 Barcelona;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
08 Barcelona;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
08 Barcelona;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
08 Barcelona;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
08 Barcelona;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;97,79
08 Barcelona;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
08 Barcelona;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
08 Barcelona;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
08 Barcelona;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;97,99
08 Barcelona;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
08 Barcelona;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
08 Barcelona;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
08 Barcelona;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;97,86
08 Barcelona;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
08 Barcelona;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
08 Barcelona;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;95,41
08 Barcelona;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
08 Barcelona;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
08 Barcelona;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
08 Barcelona;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;95,86
08 Barcelona;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
08 Barcelona;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
08 Barcelona;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
08 Barcelona;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;95,93
08 Barcelona;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
08 Barcelona;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
08 Barcelona;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
08 Barcelona;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
08 Barcelona;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
08 Barcelona;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
08 Barcelona;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;93,94
08 Barcelona;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
08 Barcelona;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
08 Barcelona;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
08 Barcelona;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;94,45
08 Barcelona;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
08 Barcelona;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
08 Barcelona;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
08 Barcelona;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
08 Barcelona;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
08 Barcelona;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
08 Barcelona;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;92,02
08 Barcelona;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
08 Barcelona;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
08 Barcelona;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
08 Barcelona;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;92,9
08 Barcelona;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
08 Barcelona;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
08 Barcelona;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
08 Barcelona;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
08 Barcelona;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
08 Barcelona;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
08 Barcelona;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QIII;75.115
08 Barcelona;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
08 Barcelona;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
08 Barcelona;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
08 Barcelona;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QIII;74.014
08 Barcelona;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
08 Barcelona;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
08 Barcelona;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
08 Barcelona;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QIII;71.834
08 Barcelona;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
08 Barcelona;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
08 Barcelona;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
08 Barcelona;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2022QIII;73.535
08 Barcelona;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2022QII;""
08 Barcelona;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2022QI;""
08 Barcelona;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
08 Barcelona;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2021QIII;72.527
08 Barcelona;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2021QII;""
08 Barcelona;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2021QI;""
08 Barcelona;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
08 Barcelona;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2020QIII;70.402
08 Barcelona;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2020QII;""
08 Barcelona;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2020QI;""
08 Barcelona;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2022QIV;71.873
08 Barcelona;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
08 Barcelona;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2022QII;""
08 Barcelona;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2022QI;""
08 Barcelona;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2021QIV;70.964
08 Barcelona;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
08 Barcelona;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2021QII;""
08 Barcelona;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2021QI;""
08 Barcelona;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2020QIV;69.089
08 Barcelona;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
08 Barcelona;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2020QII;""
08 Barcelona;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2020QI;""
08 Barcelona;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
08 Barcelona;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
08 Barcelona;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QII;""
08 Barcelona;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QI;69.585
08 Barcelona;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
08 Barcelona;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
08 Barcelona;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QII;""
08 Barcelona;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QI;68.041
08 Barcelona;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
08 Barcelona;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
08 Barcelona;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QII;""
08 Barcelona;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QI;""
08 Barcelona;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
08 Barcelona;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
08 Barcelona;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QII;68.248
08 Barcelona;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QI;""
08 Barcelona;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
08 Barcelona;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
08 Barcelona;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QII;67.008
08 Barcelona;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QI;""
08 Barcelona;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
08 Barcelona;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
08 Barcelona;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QII;""
08 Barcelona;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QI;""
08 Barcelona;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
08 Barcelona;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
08 Barcelona;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
08 Barcelona;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
08 Barcelona;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
08 Barcelona;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
08 Barcelona;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
08 Barcelona;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
08 Barcelona;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
08 Barcelona;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
08 Barcelona;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
08 Barcelona;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
08 Barcelona;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
08 Barcelona;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;97,9
08 Barcelona;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
08 Barcelona;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
08 Barcelona;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
08 Barcelona;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;97,99
08 Barcelona;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
08 Barcelona;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
08 Barcelona;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
08 Barcelona;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;98,01
08 Barcelona;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
08 Barcelona;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
08 Barcelona;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;95,68
08 Barcelona;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
08 Barcelona;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
08 Barcelona;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
08 Barcelona;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;95,88
08 Barcelona;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
08 Barcelona;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
08 Barcelona;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
08 Barcelona;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;96,18
08 Barcelona;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
08 Barcelona;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
08 Barcelona;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
08 Barcelona;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
08 Barcelona;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
08 Barcelona;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
08 Barcelona;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;94,02
08 Barcelona;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
08 Barcelona;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
08 Barcelona;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
08 Barcelona;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;94,72
08 Barcelona;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
08 Barcelona;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
08 Barcelona;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
08 Barcelona;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
08 Barcelona;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
08 Barcelona;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
08 Barcelona;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;92,21
08 Barcelona;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
08 Barcelona;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
08 Barcelona;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
08 Barcelona;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;93,28
08 Barcelona;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
08 Barcelona;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
08 Barcelona;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
08 Barcelona;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
08 Barcelona;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
08 Barcelona;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
08 Barcelona;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QIII;41.913
08 Barcelona;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
08 Barcelona;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
08 Barcelona;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
08 Barcelona;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QIII;40.804
08 Barcelona;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
08 Barcelona;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
08 Barcelona;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
08 Barcelona;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QIII;39.552
08 Barcelona;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
08 Barcelona;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
08 Barcelona;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
08 Barcelona;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2022QIII;40.905
08 Barcelona;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2022QII;""
08 Barcelona;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2022QI;""
08 Barcelona;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
08 Barcelona;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2021QIII;39.984
08 Barcelona;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2021QII;""
08 Barcelona;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2021QI;""
08 Barcelona;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
08 Barcelona;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2020QIII;38.596
08 Barcelona;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2020QII;""
08 Barcelona;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2020QI;""
08 Barcelona;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2022QIV;39.779
08 Barcelona;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
08 Barcelona;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2022QII;""
08 Barcelona;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2022QI;""
08 Barcelona;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2021QIV;39.098
08 Barcelona;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
08 Barcelona;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2021QII;""
08 Barcelona;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2021QI;""
08 Barcelona;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2020QIV;37.766
08 Barcelona;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
08 Barcelona;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2020QII;""
08 Barcelona;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2020QI;""
08 Barcelona;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
08 Barcelona;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
08 Barcelona;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QII;""
08 Barcelona;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QI;38.276
08 Barcelona;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
08 Barcelona;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
08 Barcelona;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QII;""
08 Barcelona;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QI;37.160
08 Barcelona;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
08 Barcelona;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
08 Barcelona;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QII;""
08 Barcelona;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QI;""
08 Barcelona;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
08 Barcelona;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
08 Barcelona;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QII;37.405
08 Barcelona;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QI;""
08 Barcelona;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
08 Barcelona;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
08 Barcelona;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QII;36.466
08 Barcelona;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QI;""
08 Barcelona;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
08 Barcelona;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
08 Barcelona;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QII;""
08 Barcelona;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QI;""
08 Barcelona;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
08 Barcelona;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
08 Barcelona;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
08 Barcelona;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
08 Barcelona;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
08 Barcelona;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
08 Barcelona;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
08 Barcelona;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
08 Barcelona;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
08 Barcelona;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
08 Barcelona;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
08 Barcelona;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
08 Barcelona;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
08 Barcelona;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;97,6
08 Barcelona;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
08 Barcelona;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
08 Barcelona;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
08 Barcelona;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;97,99
08 Barcelona;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
08 Barcelona;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
08 Barcelona;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
08 Barcelona;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;97,58
08 Barcelona;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
08 Barcelona;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
08 Barcelona;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;94,91
08 Barcelona;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
08 Barcelona;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
08 Barcelona;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
08 Barcelona;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;95,82
08 Barcelona;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
08 Barcelona;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
08 Barcelona;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
08 Barcelona;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;95,48
08 Barcelona;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
08 Barcelona;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
08 Barcelona;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
08 Barcelona;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
08 Barcelona;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
08 Barcelona;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
08 Barcelona;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;93,8
08 Barcelona;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
08 Barcelona;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
08 Barcelona;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
08 Barcelona;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;93,95
08 Barcelona;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
08 Barcelona;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
08 Barcelona;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
08 Barcelona;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
08 Barcelona;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
08 Barcelona;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
08 Barcelona;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;91,67
08 Barcelona;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
08 Barcelona;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
08 Barcelona;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
08 Barcelona;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;92,2
08 Barcelona;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
08 Barcelona;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
08 Barcelona;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
08 Barcelona;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
08 Barcelona;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
08 Barcelona;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QIV;116.374
08 Barcelona;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
08 Barcelona;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
08 Barcelona;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
08 Barcelona;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QIV;114.406
08 Barcelona;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
08 Barcelona;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
08 Barcelona;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
08 Barcelona;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QIV;110.904
08 Barcelona;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
08 Barcelona;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
08 Barcelona;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
08 Barcelona;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2022QIV;113.354
08 Barcelona;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
08 Barcelona;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2022QII;""
08 Barcelona;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2022QI;""
08 Barcelona;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2021QIV;111.738
08 Barcelona;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
08 Barcelona;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2021QII;""
08 Barcelona;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2021QI;""
08 Barcelona;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2020QIV;108.544
08 Barcelona;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
08 Barcelona;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2020QII;""
08 Barcelona;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2020QI;""
08 Barcelona;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
08 Barcelona;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
08 Barcelona;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2022QII;""
08 Barcelona;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2022QI;109.405
08 Barcelona;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
08 Barcelona;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
08 Barcelona;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2021QII;""
08 Barcelona;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2021QI;106.781
08 Barcelona;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
08 Barcelona;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
08 Barcelona;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2020QII;""
08 Barcelona;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2020QI;""
08 Barcelona;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
08 Barcelona;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
08 Barcelona;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QII;107.068
08 Barcelona;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QI;""
08 Barcelona;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
08 Barcelona;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
08 Barcelona;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QII;104.937
08 Barcelona;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QI;""
08 Barcelona;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
08 Barcelona;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
08 Barcelona;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QII;""
08 Barcelona;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QI;""
08 Barcelona;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
08 Barcelona;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QIII;105.231
08 Barcelona;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QII;""
08 Barcelona;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QI;""
08 Barcelona;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
08 Barcelona;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QIII;103.324
08 Barcelona;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QII;""
08 Barcelona;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QI;""
08 Barcelona;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
08 Barcelona;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
08 Barcelona;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QII;""
08 Barcelona;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QI;""
08 Barcelona;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
08 Barcelona;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
08 Barcelona;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
08 Barcelona;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
08 Barcelona;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
08 Barcelona;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
08 Barcelona;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
08 Barcelona;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
08 Barcelona;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
08 Barcelona;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
08 Barcelona;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
08 Barcelona;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
08 Barcelona;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;97,4
08 Barcelona;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
08 Barcelona;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
08 Barcelona;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
08 Barcelona;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;97,67
08 Barcelona;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
08 Barcelona;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
08 Barcelona;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
08 Barcelona;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;97,87
08 Barcelona;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
08 Barcelona;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
08 Barcelona;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
08 Barcelona;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
08 Barcelona;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
08 Barcelona;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
08 Barcelona;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;95,63
08 Barcelona;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
08 Barcelona;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
08 Barcelona;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
08 Barcelona;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;96,28
08 Barcelona;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
08 Barcelona;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
08 Barcelona;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
08 Barcelona;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
08 Barcelona;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
08 Barcelona;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
08 Barcelona;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;93,59
08 Barcelona;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
08 Barcelona;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
08 Barcelona;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
08 Barcelona;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;94,62
08 Barcelona;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
08 Barcelona;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
08 Barcelona;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
08 Barcelona;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
08 Barcelona;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
08 Barcelona;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
08 Barcelona;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;91,98
08 Barcelona;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
08 Barcelona;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
08 Barcelona;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
08 Barcelona;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;93,17
08 Barcelona;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
08 Barcelona;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
08 Barcelona;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
08 Barcelona;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
08 Barcelona;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
08 Barcelona;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
08 Barcelona;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QIV;74.676
08 Barcelona;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
08 Barcelona;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
08 Barcelona;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
08 Barcelona;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QIV;73.636
08 Barcelona;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
08 Barcelona;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
08 Barcelona;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
08 Barcelona;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QIV;71.548
08 Barcelona;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
08 Barcelona;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
08 Barcelona;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
08 Barcelona;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2022QIV;72.869
08 Barcelona;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
08 Barcelona;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2022QII;""
08 Barcelona;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2022QI;""
08 Barcelona;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2021QIV;71.934
08 Barcelona;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
08 Barcelona;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2021QII;""
08 Barcelona;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2021QI;""
08 Barcelona;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2020QIV;70.098
08 Barcelona;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
08 Barcelona;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2020QII;""
08 Barcelona;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2020QI;""
08 Barcelona;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
08 Barcelona;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
08 Barcelona;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2022QII;""
08 Barcelona;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2022QI;70.479
08 Barcelona;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
08 Barcelona;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
08 Barcelona;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2021QII;""
08 Barcelona;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2021QI;68.974
08 Barcelona;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
08 Barcelona;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
08 Barcelona;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2020QII;""
08 Barcelona;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2020QI;""
08 Barcelona;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
08 Barcelona;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
08 Barcelona;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QII;69.065
08 Barcelona;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QI;""
08 Barcelona;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
08 Barcelona;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
08 Barcelona;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QII;67.877
08 Barcelona;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QI;""
08 Barcelona;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
08 Barcelona;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
08 Barcelona;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QII;""
08 Barcelona;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QI;""
08 Barcelona;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
08 Barcelona;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QIII;67.946
08 Barcelona;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QII;""
08 Barcelona;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QI;""
08 Barcelona;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
08 Barcelona;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QIII;66.835
08 Barcelona;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QII;""
08 Barcelona;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QI;""
08 Barcelona;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
08 Barcelona;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
08 Barcelona;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QII;""
08 Barcelona;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QI;""
08 Barcelona;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
08 Barcelona;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
08 Barcelona;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
08 Barcelona;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
08 Barcelona;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
08 Barcelona;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
08 Barcelona;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
08 Barcelona;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
08 Barcelona;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
08 Barcelona;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
08 Barcelona;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
08 Barcelona;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
08 Barcelona;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;97,58
08 Barcelona;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
08 Barcelona;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
08 Barcelona;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
08 Barcelona;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;97,69
08 Barcelona;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
08 Barcelona;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
08 Barcelona;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
08 Barcelona;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;97,97
08 Barcelona;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
08 Barcelona;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
08 Barcelona;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
08 Barcelona;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
08 Barcelona;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
08 Barcelona;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
08 Barcelona;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;95,71
08 Barcelona;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
08 Barcelona;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
08 Barcelona;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
08 Barcelona;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;96,4
08 Barcelona;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
08 Barcelona;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
08 Barcelona;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
08 Barcelona;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
08 Barcelona;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
08 Barcelona;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
08 Barcelona;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;93,79
08 Barcelona;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
08 Barcelona;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
08 Barcelona;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
08 Barcelona;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;94,87
08 Barcelona;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
08 Barcelona;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
08 Barcelona;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
08 Barcelona;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
08 Barcelona;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
08 Barcelona;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
08 Barcelona;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;92,27
08 Barcelona;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
08 Barcelona;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
08 Barcelona;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
08 Barcelona;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;93,41
08 Barcelona;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
08 Barcelona;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
08 Barcelona;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
08 Barcelona;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
08 Barcelona;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
08 Barcelona;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
08 Barcelona;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QIV;41.698
08 Barcelona;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
08 Barcelona;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
08 Barcelona;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
08 Barcelona;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QIV;40.770
08 Barcelona;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
08 Barcelona;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
08 Barcelona;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
08 Barcelona;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QIV;39.356
08 Barcelona;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
08 Barcelona;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
08 Barcelona;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
08 Barcelona;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2022QIV;40.485
08 Barcelona;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
08 Barcelona;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2022QII;""
08 Barcelona;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2022QI;""
08 Barcelona;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2021QIV;39.804
08 Barcelona;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
08 Barcelona;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2021QII;""
08 Barcelona;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2021QI;""
08 Barcelona;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2020QIV;38.446
08 Barcelona;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
08 Barcelona;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2020QII;""
08 Barcelona;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2020QI;""
08 Barcelona;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
08 Barcelona;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
08 Barcelona;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2022QII;""
08 Barcelona;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2022QI;38.926
08 Barcelona;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
08 Barcelona;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
08 Barcelona;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2021QII;""
08 Barcelona;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2021QI;37.807
08 Barcelona;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
08 Barcelona;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
08 Barcelona;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2020QII;""
08 Barcelona;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2020QI;""
08 Barcelona;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
08 Barcelona;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
08 Barcelona;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QII;38.003
08 Barcelona;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QI;""
08 Barcelona;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
08 Barcelona;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
08 Barcelona;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QII;37.060
08 Barcelona;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QI;""
08 Barcelona;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
08 Barcelona;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
08 Barcelona;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QII;""
08 Barcelona;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QI;""
08 Barcelona;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
08 Barcelona;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QIII;37.285
08 Barcelona;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QII;""
08 Barcelona;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QI;""
08 Barcelona;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
08 Barcelona;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QIII;36.489
08 Barcelona;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QII;""
08 Barcelona;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QI;""
08 Barcelona;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
08 Barcelona;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
08 Barcelona;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QII;""
08 Barcelona;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QI;""
08 Barcelona;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
08 Barcelona;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
08 Barcelona;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
08 Barcelona;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
08 Barcelona;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
08 Barcelona;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
08 Barcelona;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
08 Barcelona;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
08 Barcelona;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
08 Barcelona;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
08 Barcelona;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
08 Barcelona;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
08 Barcelona;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;97,09
08 Barcelona;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
08 Barcelona;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
08 Barcelona;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
08 Barcelona;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;97,63
08 Barcelona;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
08 Barcelona;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
08 Barcelona;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
08 Barcelona;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;97,69
08 Barcelona;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
08 Barcelona;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
08 Barcelona;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
08 Barcelona;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
08 Barcelona;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
08 Barcelona;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
08 Barcelona;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;95,48
08 Barcelona;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
08 Barcelona;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
08 Barcelona;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
08 Barcelona;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;96,06
08 Barcelona;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
08 Barcelona;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
08 Barcelona;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
08 Barcelona;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
08 Barcelona;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
08 Barcelona;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
08 Barcelona;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;93,21
08 Barcelona;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
08 Barcelona;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
08 Barcelona;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
08 Barcelona;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;94,17
08 Barcelona;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
08 Barcelona;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
08 Barcelona;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
08 Barcelona;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
08 Barcelona;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
08 Barcelona;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
08 Barcelona;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;91,45
08 Barcelona;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
08 Barcelona;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
08 Barcelona;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
08 Barcelona;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;92,72
08 Barcelona;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
08 Barcelona;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
08 Barcelona;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
08 Barcelona;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
08 Barcelona;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
08 Barcelona;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
08 Barcelona;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
08 Barcelona;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
08 Barcelona;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
08 Barcelona;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QI;58.857
08 Barcelona;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
08 Barcelona;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
08 Barcelona;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
08 Barcelona;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QI;56.010
08 Barcelona;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
08 Barcelona;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
08 Barcelona;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
08 Barcelona;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QI;63.748
08 Barcelona;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
08 Barcelona;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
08 Barcelona;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2022QII;""
08 Barcelona;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2022QI;56.637
08 Barcelona;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
08 Barcelona;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
08 Barcelona;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2021QII;""
08 Barcelona;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2021QI;54.103
08 Barcelona;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
08 Barcelona;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
08 Barcelona;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2020QII;""
08 Barcelona;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2020QI;59.936
08 Barcelona;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
08 Barcelona;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
08 Barcelona;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2022QII;54.428
08 Barcelona;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2022QI;""
08 Barcelona;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
08 Barcelona;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
08 Barcelona;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2021QII;52.155
08 Barcelona;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2021QI;""
08 Barcelona;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
08 Barcelona;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
08 Barcelona;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2020QII;58.217
08 Barcelona;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2020QI;""
08 Barcelona;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
08 Barcelona;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QIII;52.419
08 Barcelona;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QII;""
08 Barcelona;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QI;""
08 Barcelona;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
08 Barcelona;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QIII;50.290
08 Barcelona;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QII;""
08 Barcelona;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QI;""
08 Barcelona;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
08 Barcelona;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QIII;56.116
08 Barcelona;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QII;""
08 Barcelona;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QI;""
08 Barcelona;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QIV;49.509
08 Barcelona;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
08 Barcelona;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QII;""
08 Barcelona;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QI;""
08 Barcelona;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QIV;47.926
08 Barcelona;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
08 Barcelona;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QII;""
08 Barcelona;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QI;""
08 Barcelona;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QIV;53.603
08 Barcelona;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
08 Barcelona;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QII;""
08 Barcelona;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QI;""
08 Barcelona;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
08 Barcelona;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
08 Barcelona;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
08 Barcelona;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
08 Barcelona;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
08 Barcelona;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
08 Barcelona;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
08 Barcelona;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
08 Barcelona;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
08 Barcelona;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
08 Barcelona;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
08 Barcelona;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
08 Barcelona;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
08 Barcelona;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
08 Barcelona;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
08 Barcelona;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;96,23
08 Barcelona;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
08 Barcelona;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
08 Barcelona;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
08 Barcelona;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;96,6
08 Barcelona;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
08 Barcelona;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
08 Barcelona;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
08 Barcelona;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;94,02
08 Barcelona;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
08 Barcelona;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
08 Barcelona;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;92,47
08 Barcelona;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
08 Barcelona;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
08 Barcelona;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
08 Barcelona;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;93,12
08 Barcelona;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
08 Barcelona;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
08 Barcelona;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
08 Barcelona;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;91,32
08 Barcelona;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
08 Barcelona;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
08 Barcelona;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;89,06
08 Barcelona;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
08 Barcelona;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
08 Barcelona;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
08 Barcelona;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;89,79
08 Barcelona;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
08 Barcelona;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
08 Barcelona;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
08 Barcelona;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;88,03
08 Barcelona;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
08 Barcelona;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
08 Barcelona;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;84,12
08 Barcelona;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
08 Barcelona;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
08 Barcelona;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
08 Barcelona;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;85,57
08 Barcelona;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
08 Barcelona;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
08 Barcelona;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
08 Barcelona;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;84,09
08 Barcelona;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
08 Barcelona;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
08 Barcelona;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
08 Barcelona;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
08 Barcelona;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
08 Barcelona;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
08 Barcelona;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QI;37.873
08 Barcelona;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
08 Barcelona;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
08 Barcelona;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
08 Barcelona;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QI;36.066
08 Barcelona;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
08 Barcelona;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
08 Barcelona;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
08 Barcelona;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QI;40.823
08 Barcelona;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
08 Barcelona;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
08 Barcelona;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2022QII;""
08 Barcelona;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2022QI;36.466
08 Barcelona;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
08 Barcelona;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
08 Barcelona;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2021QII;""
08 Barcelona;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2021QI;34.838
08 Barcelona;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
08 Barcelona;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
08 Barcelona;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2020QII;""
08 Barcelona;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2020QI;38.443
08 Barcelona;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
08 Barcelona;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
08 Barcelona;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2022QII;35.093
08 Barcelona;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2022QI;""
08 Barcelona;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
08 Barcelona;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
08 Barcelona;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2021QII;33.639
08 Barcelona;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2021QI;""
08 Barcelona;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
08 Barcelona;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
08 Barcelona;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2020QII;37.385
08 Barcelona;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2020QI;""
08 Barcelona;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
08 Barcelona;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QIII;33.853
08 Barcelona;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QII;""
08 Barcelona;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QI;""
08 Barcelona;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
08 Barcelona;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QIII;32.460
08 Barcelona;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QII;""
08 Barcelona;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QI;""
08 Barcelona;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
08 Barcelona;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QIII;36.099
08 Barcelona;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QII;""
08 Barcelona;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QI;""
08 Barcelona;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QIV;31.946
08 Barcelona;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
08 Barcelona;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QII;""
08 Barcelona;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QI;""
08 Barcelona;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QIV;30.960
08 Barcelona;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
08 Barcelona;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QII;""
08 Barcelona;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QI;""
08 Barcelona;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QIV;34.538
08 Barcelona;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
08 Barcelona;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QII;""
08 Barcelona;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QI;""
08 Barcelona;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
08 Barcelona;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
08 Barcelona;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
08 Barcelona;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
08 Barcelona;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
08 Barcelona;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
08 Barcelona;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
08 Barcelona;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
08 Barcelona;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
08 Barcelona;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
08 Barcelona;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
08 Barcelona;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
08 Barcelona;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
08 Barcelona;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
08 Barcelona;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
08 Barcelona;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;96,28
08 Barcelona;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
08 Barcelona;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
08 Barcelona;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
08 Barcelona;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;96,6
08 Barcelona;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
08 Barcelona;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
08 Barcelona;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
08 Barcelona;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;94,17
08 Barcelona;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
08 Barcelona;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
08 Barcelona;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;92,66
08 Barcelona;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
08 Barcelona;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
08 Barcelona;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
08 Barcelona;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;93,27
08 Barcelona;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
08 Barcelona;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
08 Barcelona;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
08 Barcelona;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;91,58
08 Barcelona;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
08 Barcelona;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
08 Barcelona;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;89,39
08 Barcelona;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
08 Barcelona;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
08 Barcelona;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
08 Barcelona;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;90
08 Barcelona;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
08 Barcelona;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
08 Barcelona;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
08 Barcelona;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;88,43
08 Barcelona;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
08 Barcelona;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
08 Barcelona;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;84,35
08 Barcelona;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
08 Barcelona;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
08 Barcelona;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
08 Barcelona;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;85,84
08 Barcelona;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
08 Barcelona;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
08 Barcelona;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
08 Barcelona;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;84,6
08 Barcelona;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
08 Barcelona;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
08 Barcelona;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
08 Barcelona;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
08 Barcelona;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
08 Barcelona;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
08 Barcelona;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QI;20.984
08 Barcelona;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
08 Barcelona;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
08 Barcelona;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
08 Barcelona;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QI;19.944
08 Barcelona;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
08 Barcelona;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
08 Barcelona;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
08 Barcelona;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QI;22.925
08 Barcelona;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
08 Barcelona;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
08 Barcelona;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2022QII;""
08 Barcelona;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2022QI;20.171
08 Barcelona;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
08 Barcelona;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
08 Barcelona;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2021QII;""
08 Barcelona;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2021QI;19.265
08 Barcelona;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
08 Barcelona;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
08 Barcelona;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2020QII;""
08 Barcelona;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2020QI;21.493
08 Barcelona;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
08 Barcelona;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
08 Barcelona;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2022QII;19.335
08 Barcelona;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2022QI;""
08 Barcelona;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
08 Barcelona;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
08 Barcelona;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2021QII;18.516
08 Barcelona;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2021QI;""
08 Barcelona;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
08 Barcelona;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
08 Barcelona;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2020QII;20.832
08 Barcelona;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2020QI;""
08 Barcelona;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
08 Barcelona;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QIII;18.566
08 Barcelona;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QII;""
08 Barcelona;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QI;""
08 Barcelona;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
08 Barcelona;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QIII;17.830
08 Barcelona;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QII;""
08 Barcelona;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QI;""
08 Barcelona;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
08 Barcelona;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QIII;20.017
08 Barcelona;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QII;""
08 Barcelona;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QI;""
08 Barcelona;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QIV;17.563
08 Barcelona;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
08 Barcelona;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QII;""
08 Barcelona;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QI;""
08 Barcelona;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QIV;16.966
08 Barcelona;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
08 Barcelona;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QII;""
08 Barcelona;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QI;""
08 Barcelona;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QIV;19.065
08 Barcelona;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
08 Barcelona;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QII;""
08 Barcelona;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QI;""
08 Barcelona;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
08 Barcelona;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
08 Barcelona;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
08 Barcelona;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
08 Barcelona;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
08 Barcelona;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
08 Barcelona;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
08 Barcelona;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
08 Barcelona;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
08 Barcelona;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
08 Barcelona;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
08 Barcelona;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
08 Barcelona;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
08 Barcelona;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
08 Barcelona;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
08 Barcelona;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;96,13
08 Barcelona;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
08 Barcelona;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
08 Barcelona;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
08 Barcelona;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;96,6
08 Barcelona;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
08 Barcelona;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
08 Barcelona;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
08 Barcelona;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;93,75
08 Barcelona;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
08 Barcelona;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
08 Barcelona;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;92,14
08 Barcelona;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
08 Barcelona;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
08 Barcelona;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
08 Barcelona;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;92,84
08 Barcelona;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
08 Barcelona;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
08 Barcelona;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
08 Barcelona;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;90,87
08 Barcelona;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
08 Barcelona;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
08 Barcelona;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;88,48
08 Barcelona;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
08 Barcelona;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
08 Barcelona;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
08 Barcelona;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;89,4
08 Barcelona;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
08 Barcelona;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
08 Barcelona;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
08 Barcelona;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;87,32
08 Barcelona;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
08 Barcelona;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
08 Barcelona;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;83,7
08 Barcelona;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
08 Barcelona;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
08 Barcelona;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
08 Barcelona;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;85,07
08 Barcelona;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
08 Barcelona;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
08 Barcelona;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
08 Barcelona;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;83,16
08 Barcelona;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
08 Barcelona;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
08 Barcelona;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
08 Barcelona;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
08 Barcelona;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
08 Barcelona;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QII;66.832
08 Barcelona;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
08 Barcelona;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
08 Barcelona;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
08 Barcelona;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QII;63.962
08 Barcelona;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
08 Barcelona;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
08 Barcelona;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
08 Barcelona;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QII;61.707
08 Barcelona;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
08 Barcelona;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
08 Barcelona;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
08 Barcelona;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2022QII;64.374
08 Barcelona;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2022QI;""
08 Barcelona;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
08 Barcelona;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
08 Barcelona;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2021QII;61.778
08 Barcelona;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2021QI;""
08 Barcelona;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
08 Barcelona;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
08 Barcelona;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2020QII;59.883
08 Barcelona;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2020QI;""
08 Barcelona;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
08 Barcelona;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2022QIII;62.157
08 Barcelona;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2022QII;""
08 Barcelona;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2022QI;""
08 Barcelona;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
08 Barcelona;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2021QIII;59.721
08 Barcelona;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2021QII;""
08 Barcelona;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2021QI;""
08 Barcelona;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
08 Barcelona;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2020QIII;57.256
08 Barcelona;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2020QII;""
08 Barcelona;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2020QI;""
08 Barcelona;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QIV;59.017
08 Barcelona;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
08 Barcelona;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QII;""
08 Barcelona;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QI;""
08 Barcelona;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QIV;57.170
08 Barcelona;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
08 Barcelona;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QII;""
08 Barcelona;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QI;""
08 Barcelona;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QIV;54.665
08 Barcelona;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
08 Barcelona;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QII;""
08 Barcelona;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QI;""
08 Barcelona;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
08 Barcelona;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
08 Barcelona;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QII;""
08 Barcelona;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QI;55.115
08 Barcelona;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
08 Barcelona;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
08 Barcelona;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QII;""
08 Barcelona;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QI;52.875
08 Barcelona;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
08 Barcelona;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
08 Barcelona;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QII;""
08 Barcelona;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QI;""
08 Barcelona;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
08 Barcelona;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
08 Barcelona;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
08 Barcelona;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
08 Barcelona;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
08 Barcelona;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
08 Barcelona;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
08 Barcelona;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
08 Barcelona;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
08 Barcelona;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
08 Barcelona;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
08 Barcelona;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
08 Barcelona;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
08 Barcelona;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
08 Barcelona;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;96,32
08 Barcelona;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
08 Barcelona;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
08 Barcelona;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
08 Barcelona;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;96,59
08 Barcelona;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
08 Barcelona;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
08 Barcelona;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
08 Barcelona;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;97,04
08 Barcelona;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
08 Barcelona;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
08 Barcelona;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;93
08 Barcelona;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
08 Barcelona;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
08 Barcelona;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
08 Barcelona;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;93,37
08 Barcelona;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
08 Barcelona;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
08 Barcelona;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
08 Barcelona;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;92,79
08 Barcelona;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
08 Barcelona;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
08 Barcelona;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;88,31
08 Barcelona;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
08 Barcelona;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
08 Barcelona;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
08 Barcelona;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;89,38
08 Barcelona;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
08 Barcelona;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
08 Barcelona;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
08 Barcelona;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;88,59
08 Barcelona;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
08 Barcelona;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
08 Barcelona;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
08 Barcelona;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
08 Barcelona;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
08 Barcelona;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
08 Barcelona;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;86,17
08 Barcelona;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
08 Barcelona;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
08 Barcelona;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
08 Barcelona;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;85,69
08 Barcelona;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
08 Barcelona;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
08 Barcelona;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
08 Barcelona;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
08 Barcelona;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
08 Barcelona;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
08 Barcelona;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QII;43.038
08 Barcelona;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
08 Barcelona;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
08 Barcelona;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
08 Barcelona;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QII;41.163
08 Barcelona;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
08 Barcelona;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
08 Barcelona;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
08 Barcelona;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QII;39.623
08 Barcelona;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
08 Barcelona;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
08 Barcelona;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
08 Barcelona;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2022QII;41.510
08 Barcelona;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2022QI;""
08 Barcelona;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
08 Barcelona;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
08 Barcelona;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2021QII;39.819
08 Barcelona;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2021QI;""
08 Barcelona;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
08 Barcelona;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
08 Barcelona;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2020QII;38.489
08 Barcelona;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2020QI;""
08 Barcelona;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
08 Barcelona;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2022QIII;40.144
08 Barcelona;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2022QII;""
08 Barcelona;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2022QI;""
08 Barcelona;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
08 Barcelona;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2021QIII;38.523
08 Barcelona;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2021QII;""
08 Barcelona;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2021QI;""
08 Barcelona;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
08 Barcelona;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2020QIII;36.835
08 Barcelona;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2020QII;""
08 Barcelona;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2020QI;""
08 Barcelona;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QIV;38.093
08 Barcelona;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
08 Barcelona;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QII;""
08 Barcelona;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QI;""
08 Barcelona;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QIV;36.906
08 Barcelona;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
08 Barcelona;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QII;""
08 Barcelona;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QI;""
08 Barcelona;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QIV;35.224
08 Barcelona;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
08 Barcelona;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QII;""
08 Barcelona;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QI;""
08 Barcelona;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
08 Barcelona;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
08 Barcelona;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QII;""
08 Barcelona;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QI;35.609
08 Barcelona;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
08 Barcelona;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
08 Barcelona;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QII;""
08 Barcelona;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QI;34.076
08 Barcelona;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
08 Barcelona;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
08 Barcelona;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QII;""
08 Barcelona;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QI;""
08 Barcelona;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
08 Barcelona;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
08 Barcelona;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
08 Barcelona;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
08 Barcelona;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
08 Barcelona;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
08 Barcelona;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
08 Barcelona;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
08 Barcelona;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
08 Barcelona;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
08 Barcelona;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
08 Barcelona;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
08 Barcelona;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
08 Barcelona;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
08 Barcelona;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;96,45
08 Barcelona;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
08 Barcelona;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
08 Barcelona;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
08 Barcelona;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;96,73
08 Barcelona;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
08 Barcelona;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
08 Barcelona;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
08 Barcelona;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;97,14
08 Barcelona;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
08 Barcelona;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
08 Barcelona;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;93,28
08 Barcelona;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
08 Barcelona;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
08 Barcelona;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
08 Barcelona;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;93,59
08 Barcelona;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
08 Barcelona;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
08 Barcelona;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
08 Barcelona;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;92,96
08 Barcelona;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
08 Barcelona;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
08 Barcelona;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;88,51
08 Barcelona;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
08 Barcelona;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
08 Barcelona;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
08 Barcelona;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;89,66
08 Barcelona;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
08 Barcelona;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
08 Barcelona;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
08 Barcelona;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;88,9
08 Barcelona;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
08 Barcelona;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
08 Barcelona;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
08 Barcelona;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
08 Barcelona;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
08 Barcelona;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
08 Barcelona;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;86,51
08 Barcelona;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
08 Barcelona;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
08 Barcelona;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
08 Barcelona;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;86
08 Barcelona;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
08 Barcelona;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
08 Barcelona;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
08 Barcelona;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
08 Barcelona;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
08 Barcelona;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
08 Barcelona;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QII;23.794
08 Barcelona;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
08 Barcelona;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
08 Barcelona;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
08 Barcelona;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QII;22.799
08 Barcelona;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
08 Barcelona;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
08 Barcelona;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
08 Barcelona;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QII;22.084
08 Barcelona;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
08 Barcelona;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
08 Barcelona;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
08 Barcelona;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2022QII;22.864
08 Barcelona;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2022QI;""
08 Barcelona;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
08 Barcelona;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
08 Barcelona;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2021QII;21.959
08 Barcelona;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2021QI;""
08 Barcelona;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
08 Barcelona;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
08 Barcelona;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2020QII;21.394
08 Barcelona;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2020QI;""
08 Barcelona;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
08 Barcelona;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2022QIII;22.013
08 Barcelona;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2022QII;""
08 Barcelona;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2022QI;""
08 Barcelona;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
08 Barcelona;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2021QIII;21.198
08 Barcelona;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2021QII;""
08 Barcelona;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2021QI;""
08 Barcelona;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
08 Barcelona;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2020QIII;20.421
08 Barcelona;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2020QII;""
08 Barcelona;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2020QI;""
08 Barcelona;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QIV;20.924
08 Barcelona;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
08 Barcelona;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QII;""
08 Barcelona;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QI;""
08 Barcelona;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QIV;20.264
08 Barcelona;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
08 Barcelona;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QII;""
08 Barcelona;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QI;""
08 Barcelona;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QIV;19.441
08 Barcelona;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
08 Barcelona;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QII;""
08 Barcelona;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QI;""
08 Barcelona;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
08 Barcelona;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
08 Barcelona;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QII;""
08 Barcelona;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QI;19.506
08 Barcelona;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
08 Barcelona;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
08 Barcelona;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QII;""
08 Barcelona;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QI;18.799
08 Barcelona;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
08 Barcelona;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
08 Barcelona;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QII;""
08 Barcelona;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QI;""
08 Barcelona;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
08 Barcelona;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
08 Barcelona;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
08 Barcelona;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
08 Barcelona;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
08 Barcelona;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
08 Barcelona;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
08 Barcelona;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
08 Barcelona;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
08 Barcelona;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
08 Barcelona;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
08 Barcelona;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
08 Barcelona;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
08 Barcelona;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
08 Barcelona;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;96,09
08 Barcelona;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
08 Barcelona;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
08 Barcelona;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
08 Barcelona;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;96,32
08 Barcelona;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
08 Barcelona;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
08 Barcelona;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
08 Barcelona;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;96,88
08 Barcelona;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
08 Barcelona;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
08 Barcelona;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;92,51
08 Barcelona;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
08 Barcelona;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
08 Barcelona;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
08 Barcelona;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;92,98
08 Barcelona;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
08 Barcelona;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
08 Barcelona;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
08 Barcelona;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;92,47
08 Barcelona;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
08 Barcelona;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
08 Barcelona;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;87,94
08 Barcelona;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
08 Barcelona;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
08 Barcelona;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
08 Barcelona;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;88,88
08 Barcelona;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
08 Barcelona;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
08 Barcelona;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
08 Barcelona;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;88,03
08 Barcelona;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
08 Barcelona;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
08 Barcelona;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
08 Barcelona;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
08 Barcelona;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
08 Barcelona;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
08 Barcelona;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;85,56
08 Barcelona;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
08 Barcelona;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
08 Barcelona;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
08 Barcelona;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;85,12
08 Barcelona;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
08 Barcelona;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
08 Barcelona;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
08 Barcelona;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
08 Barcelona;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
08 Barcelona;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QIII;65.120
08 Barcelona;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
08 Barcelona;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
08 Barcelona;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
08 Barcelona;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QIII;62.505
08 Barcelona;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
08 Barcelona;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
08 Barcelona;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
08 Barcelona;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QIII;60.313
08 Barcelona;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
08 Barcelona;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
08 Barcelona;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
08 Barcelona;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2022QIII;62.794
08 Barcelona;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2022QII;""
08 Barcelona;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2022QI;""
08 Barcelona;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
08 Barcelona;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2021QIII;60.347
08 Barcelona;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2021QII;""
08 Barcelona;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2021QI;""
08 Barcelona;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
08 Barcelona;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2020QIII;57.615
08 Barcelona;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2020QII;""
08 Barcelona;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2020QI;""
08 Barcelona;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2022QIV;59.550
08 Barcelona;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
08 Barcelona;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2022QII;""
08 Barcelona;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2022QI;""
08 Barcelona;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2021QIV;57.726
08 Barcelona;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
08 Barcelona;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2021QII;""
08 Barcelona;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2021QI;""
08 Barcelona;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2020QIV;54.986
08 Barcelona;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
08 Barcelona;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2020QII;""
08 Barcelona;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2020QI;""
08 Barcelona;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
08 Barcelona;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
08 Barcelona;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QII;""
08 Barcelona;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QI;55.623
08 Barcelona;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
08 Barcelona;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
08 Barcelona;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QII;""
08 Barcelona;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QI;53.184
08 Barcelona;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
08 Barcelona;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
08 Barcelona;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QII;""
08 Barcelona;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QI;""
08 Barcelona;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
08 Barcelona;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
08 Barcelona;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QII;53.526
08 Barcelona;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QI;""
08 Barcelona;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
08 Barcelona;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
08 Barcelona;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QII;51.316
08 Barcelona;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QI;""
08 Barcelona;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
08 Barcelona;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
08 Barcelona;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QII;""
08 Barcelona;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QI;""
08 Barcelona;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
08 Barcelona;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
08 Barcelona;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
08 Barcelona;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
08 Barcelona;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
08 Barcelona;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
08 Barcelona;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
08 Barcelona;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
08 Barcelona;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
08 Barcelona;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
08 Barcelona;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
08 Barcelona;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
08 Barcelona;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
08 Barcelona;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;96,43
08 Barcelona;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
08 Barcelona;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
08 Barcelona;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
08 Barcelona;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;96,55
08 Barcelona;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
08 Barcelona;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
08 Barcelona;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
08 Barcelona;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;95,53
08 Barcelona;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
08 Barcelona;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
08 Barcelona;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;91,45
08 Barcelona;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
08 Barcelona;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
08 Barcelona;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
08 Barcelona;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;92,35
08 Barcelona;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
08 Barcelona;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
08 Barcelona;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
08 Barcelona;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;91,17
08 Barcelona;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
08 Barcelona;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
08 Barcelona;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
08 Barcelona;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
08 Barcelona;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
08 Barcelona;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
08 Barcelona;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;88,99
08 Barcelona;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
08 Barcelona;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
08 Barcelona;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
08 Barcelona;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;88,18
08 Barcelona;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
08 Barcelona;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
08 Barcelona;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
08 Barcelona;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
08 Barcelona;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
08 Barcelona;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
08 Barcelona;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;85,63
08 Barcelona;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
08 Barcelona;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
08 Barcelona;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
08 Barcelona;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;85,08
08 Barcelona;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
08 Barcelona;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
08 Barcelona;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
08 Barcelona;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
08 Barcelona;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
08 Barcelona;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
08 Barcelona;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QIII;41.935
08 Barcelona;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
08 Barcelona;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
08 Barcelona;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
08 Barcelona;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QIII;40.238
08 Barcelona;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
08 Barcelona;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
08 Barcelona;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
08 Barcelona;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QIII;38.760
08 Barcelona;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
08 Barcelona;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
08 Barcelona;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
08 Barcelona;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2022QIII;40.502
08 Barcelona;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2022QII;""
08 Barcelona;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2022QI;""
08 Barcelona;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
08 Barcelona;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2021QIII;38.881
08 Barcelona;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2021QII;""
08 Barcelona;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2021QI;""
08 Barcelona;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
08 Barcelona;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2020QIII;37.061
08 Barcelona;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2020QII;""
08 Barcelona;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2020QI;""
08 Barcelona;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2022QIV;38.391
08 Barcelona;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
08 Barcelona;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2022QII;""
08 Barcelona;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2022QI;""
08 Barcelona;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2021QIV;37.218
08 Barcelona;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
08 Barcelona;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2021QII;""
08 Barcelona;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2021QI;""
08 Barcelona;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2020QIV;35.427
08 Barcelona;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
08 Barcelona;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2020QII;""
08 Barcelona;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2020QI;""
08 Barcelona;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
08 Barcelona;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
08 Barcelona;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QII;""
08 Barcelona;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QI;35.892
08 Barcelona;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
08 Barcelona;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
08 Barcelona;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QII;""
08 Barcelona;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QI;34.269
08 Barcelona;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
08 Barcelona;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
08 Barcelona;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QII;""
08 Barcelona;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QI;""
08 Barcelona;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
08 Barcelona;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
08 Barcelona;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QII;34.589
08 Barcelona;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QI;""
08 Barcelona;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
08 Barcelona;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
08 Barcelona;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QII;33.118
08 Barcelona;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QI;""
08 Barcelona;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
08 Barcelona;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
08 Barcelona;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QII;""
08 Barcelona;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QI;""
08 Barcelona;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
08 Barcelona;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
08 Barcelona;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
08 Barcelona;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
08 Barcelona;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
08 Barcelona;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
08 Barcelona;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
08 Barcelona;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
08 Barcelona;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
08 Barcelona;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
08 Barcelona;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
08 Barcelona;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
08 Barcelona;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
08 Barcelona;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;96,58
08 Barcelona;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
08 Barcelona;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
08 Barcelona;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
08 Barcelona;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;96,63
08 Barcelona;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
08 Barcelona;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
08 Barcelona;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
08 Barcelona;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;95,62
08 Barcelona;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
08 Barcelona;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
08 Barcelona;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;91,55
08 Barcelona;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
08 Barcelona;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
08 Barcelona;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
08 Barcelona;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;92,49
08 Barcelona;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
08 Barcelona;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
08 Barcelona;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
08 Barcelona;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;91,4
08 Barcelona;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
08 Barcelona;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
08 Barcelona;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
08 Barcelona;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
08 Barcelona;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
08 Barcelona;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
08 Barcelona;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;89,2
08 Barcelona;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
08 Barcelona;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
08 Barcelona;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
08 Barcelona;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;88,41
08 Barcelona;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
08 Barcelona;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
08 Barcelona;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
08 Barcelona;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
08 Barcelona;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
08 Barcelona;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
08 Barcelona;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;85,96
08 Barcelona;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
08 Barcelona;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
08 Barcelona;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
08 Barcelona;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;85,44
08 Barcelona;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
08 Barcelona;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
08 Barcelona;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
08 Barcelona;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
08 Barcelona;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
08 Barcelona;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
08 Barcelona;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QIII;23.185
08 Barcelona;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
08 Barcelona;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
08 Barcelona;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
08 Barcelona;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QIII;22.267
08 Barcelona;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
08 Barcelona;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
08 Barcelona;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
08 Barcelona;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QIII;21.553
08 Barcelona;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
08 Barcelona;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
08 Barcelona;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
08 Barcelona;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2022QIII;22.292
08 Barcelona;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2022QII;""
08 Barcelona;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2022QI;""
08 Barcelona;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
08 Barcelona;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2021QIII;21.466
08 Barcelona;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2021QII;""
08 Barcelona;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2021QI;""
08 Barcelona;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
08 Barcelona;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2020QIII;20.554
08 Barcelona;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2020QII;""
08 Barcelona;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2020QI;""
08 Barcelona;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2022QIV;21.159
08 Barcelona;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
08 Barcelona;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2022QII;""
08 Barcelona;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2022QI;""
08 Barcelona;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2021QIV;20.508
08 Barcelona;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
08 Barcelona;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2021QII;""
08 Barcelona;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2021QI;""
08 Barcelona;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2020QIV;19.559
08 Barcelona;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
08 Barcelona;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2020QII;""
08 Barcelona;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2020QI;""
08 Barcelona;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
08 Barcelona;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
08 Barcelona;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QII;""
08 Barcelona;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QI;19.731
08 Barcelona;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
08 Barcelona;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
08 Barcelona;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QII;""
08 Barcelona;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QI;18.915
08 Barcelona;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
08 Barcelona;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
08 Barcelona;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QII;""
08 Barcelona;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QI;""
08 Barcelona;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
08 Barcelona;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
08 Barcelona;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QII;18.937
08 Barcelona;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QI;""
08 Barcelona;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
08 Barcelona;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
08 Barcelona;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QII;18.198
08 Barcelona;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QI;""
08 Barcelona;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
08 Barcelona;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
08 Barcelona;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QII;""
08 Barcelona;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QI;""
08 Barcelona;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
08 Barcelona;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
08 Barcelona;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
08 Barcelona;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
08 Barcelona;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
08 Barcelona;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
08 Barcelona;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
08 Barcelona;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
08 Barcelona;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
08 Barcelona;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
08 Barcelona;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
08 Barcelona;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
08 Barcelona;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
08 Barcelona;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;96,15
08 Barcelona;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
08 Barcelona;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
08 Barcelona;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
08 Barcelona;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;96,4
08 Barcelona;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
08 Barcelona;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
08 Barcelona;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
08 Barcelona;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;95,36
08 Barcelona;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
08 Barcelona;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
08 Barcelona;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;91,26
08 Barcelona;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
08 Barcelona;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
08 Barcelona;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
08 Barcelona;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;92,1
08 Barcelona;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
08 Barcelona;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
08 Barcelona;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
08 Barcelona;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;90,75
08 Barcelona;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
08 Barcelona;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
08 Barcelona;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
08 Barcelona;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
08 Barcelona;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
08 Barcelona;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
08 Barcelona;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;88,61
08 Barcelona;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
08 Barcelona;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
08 Barcelona;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
08 Barcelona;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;87,76
08 Barcelona;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
08 Barcelona;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
08 Barcelona;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
08 Barcelona;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
08 Barcelona;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
08 Barcelona;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
08 Barcelona;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;85,05
08 Barcelona;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
08 Barcelona;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
08 Barcelona;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
08 Barcelona;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;84,43
08 Barcelona;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
08 Barcelona;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
08 Barcelona;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
08 Barcelona;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
08 Barcelona;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
08 Barcelona;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QIV;63.384
08 Barcelona;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
08 Barcelona;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
08 Barcelona;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
08 Barcelona;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QIV;60.887
08 Barcelona;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
08 Barcelona;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
08 Barcelona;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
08 Barcelona;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QIV;58.173
08 Barcelona;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
08 Barcelona;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
08 Barcelona;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
08 Barcelona;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2022QIV;60.067
08 Barcelona;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
08 Barcelona;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2022QII;""
08 Barcelona;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2022QI;""
08 Barcelona;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2021QIV;58.184
08 Barcelona;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
08 Barcelona;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2021QII;""
08 Barcelona;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2021QI;""
08 Barcelona;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2020QIV;55.447
08 Barcelona;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
08 Barcelona;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2020QII;""
08 Barcelona;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2020QI;""
08 Barcelona;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
08 Barcelona;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
08 Barcelona;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2022QII;""
08 Barcelona;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2022QI;56.049
08 Barcelona;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
08 Barcelona;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
08 Barcelona;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2021QII;""
08 Barcelona;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2021QI;53.610
08 Barcelona;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
08 Barcelona;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
08 Barcelona;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2020QII;""
08 Barcelona;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2020QI;""
08 Barcelona;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
08 Barcelona;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
08 Barcelona;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QII;53.911
08 Barcelona;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QI;""
08 Barcelona;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
08 Barcelona;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
08 Barcelona;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QII;51.705
08 Barcelona;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QI;""
08 Barcelona;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
08 Barcelona;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
08 Barcelona;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QII;""
08 Barcelona;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QI;""
08 Barcelona;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
08 Barcelona;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QIII;51.939
08 Barcelona;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QII;""
08 Barcelona;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QI;""
08 Barcelona;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
08 Barcelona;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QIII;49.875
08 Barcelona;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QII;""
08 Barcelona;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QI;""
08 Barcelona;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
08 Barcelona;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
08 Barcelona;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QII;""
08 Barcelona;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QI;""
08 Barcelona;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
08 Barcelona;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
08 Barcelona;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
08 Barcelona;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
08 Barcelona;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
08 Barcelona;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
08 Barcelona;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
08 Barcelona;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
08 Barcelona;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
08 Barcelona;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
08 Barcelona;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
08 Barcelona;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
08 Barcelona;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;94,77
08 Barcelona;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
08 Barcelona;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
08 Barcelona;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
08 Barcelona;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;95,56
08 Barcelona;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
08 Barcelona;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
08 Barcelona;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
08 Barcelona;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;95,31
08 Barcelona;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
08 Barcelona;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
08 Barcelona;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
08 Barcelona;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
08 Barcelona;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
08 Barcelona;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
08 Barcelona;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;92,05
08 Barcelona;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
08 Barcelona;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
08 Barcelona;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
08 Barcelona;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;92,16
08 Barcelona;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
08 Barcelona;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
08 Barcelona;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
08 Barcelona;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
08 Barcelona;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
08 Barcelona;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
08 Barcelona;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;88,54
08 Barcelona;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
08 Barcelona;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
08 Barcelona;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
08 Barcelona;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;88,88
08 Barcelona;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
08 Barcelona;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
08 Barcelona;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
08 Barcelona;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
08 Barcelona;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
08 Barcelona;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
08 Barcelona;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;85,3
08 Barcelona;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
08 Barcelona;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
08 Barcelona;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
08 Barcelona;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;85,74
08 Barcelona;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
08 Barcelona;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
08 Barcelona;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
08 Barcelona;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
08 Barcelona;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
08 Barcelona;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
08 Barcelona;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QIV;40.853
08 Barcelona;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
08 Barcelona;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
08 Barcelona;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
08 Barcelona;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QIV;39.201
08 Barcelona;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
08 Barcelona;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
08 Barcelona;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
08 Barcelona;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QIV;37.426
08 Barcelona;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
08 Barcelona;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
08 Barcelona;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
08 Barcelona;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2022QIV;38.696
08 Barcelona;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
08 Barcelona;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2022QII;""
08 Barcelona;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2022QI;""
08 Barcelona;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2021QIV;37.481
08 Barcelona;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
08 Barcelona;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2021QII;""
08 Barcelona;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2021QI;""
08 Barcelona;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2020QIV;35.725
08 Barcelona;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
08 Barcelona;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2020QII;""
08 Barcelona;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2020QI;""
08 Barcelona;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
08 Barcelona;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
08 Barcelona;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2022QII;""
08 Barcelona;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2022QI;36.133
08 Barcelona;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
08 Barcelona;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
08 Barcelona;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2021QII;""
08 Barcelona;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2021QI;34.541
08 Barcelona;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
08 Barcelona;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
08 Barcelona;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2020QII;""
08 Barcelona;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2020QI;""
08 Barcelona;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
08 Barcelona;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
08 Barcelona;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QII;34.806
08 Barcelona;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QI;""
08 Barcelona;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
08 Barcelona;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
08 Barcelona;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QII;33.366
08 Barcelona;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QI;""
08 Barcelona;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
08 Barcelona;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
08 Barcelona;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QII;""
08 Barcelona;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QI;""
08 Barcelona;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
08 Barcelona;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QIII;33.591
08 Barcelona;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QII;""
08 Barcelona;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QI;""
08 Barcelona;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
08 Barcelona;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QIII;32.212
08 Barcelona;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QII;""
08 Barcelona;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QI;""
08 Barcelona;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
08 Barcelona;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
08 Barcelona;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QII;""
08 Barcelona;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QI;""
08 Barcelona;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
08 Barcelona;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
08 Barcelona;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
08 Barcelona;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
08 Barcelona;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
08 Barcelona;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
08 Barcelona;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
08 Barcelona;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
08 Barcelona;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
08 Barcelona;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
08 Barcelona;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
08 Barcelona;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
08 Barcelona;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;94,72
08 Barcelona;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
08 Barcelona;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
08 Barcelona;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
08 Barcelona;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;95,61
08 Barcelona;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
08 Barcelona;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
08 Barcelona;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
08 Barcelona;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;95,46
08 Barcelona;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
08 Barcelona;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
08 Barcelona;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
08 Barcelona;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
08 Barcelona;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
08 Barcelona;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
08 Barcelona;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;92,17
08 Barcelona;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
08 Barcelona;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
08 Barcelona;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
08 Barcelona;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;92,29
08 Barcelona;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
08 Barcelona;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
08 Barcelona;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
08 Barcelona;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
08 Barcelona;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
08 Barcelona;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
08 Barcelona;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;88,79
08 Barcelona;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
08 Barcelona;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
08 Barcelona;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
08 Barcelona;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;89,15
08 Barcelona;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
08 Barcelona;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
08 Barcelona;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
08 Barcelona;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
08 Barcelona;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
08 Barcelona;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
08 Barcelona;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;85,69
08 Barcelona;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
08 Barcelona;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
08 Barcelona;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
08 Barcelona;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;86,07
08 Barcelona;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
08 Barcelona;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
08 Barcelona;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
08 Barcelona;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
08 Barcelona;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
08 Barcelona;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
08 Barcelona;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QIV;22.531
08 Barcelona;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
08 Barcelona;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
08 Barcelona;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
08 Barcelona;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QIV;21.686
08 Barcelona;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
08 Barcelona;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
08 Barcelona;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
08 Barcelona;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QIV;20.747
08 Barcelona;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
08 Barcelona;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
08 Barcelona;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
08 Barcelona;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2022QIV;21.371
08 Barcelona;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
08 Barcelona;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2022QII;""
08 Barcelona;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2022QI;""
08 Barcelona;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2021QIV;20.703
08 Barcelona;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
08 Barcelona;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2021QII;""
08 Barcelona;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2021QI;""
08 Barcelona;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2020QIV;19.722
08 Barcelona;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
08 Barcelona;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2020QII;""
08 Barcelona;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2020QI;""
08 Barcelona;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
08 Barcelona;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
08 Barcelona;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2022QII;""
08 Barcelona;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2022QI;19.916
08 Barcelona;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
08 Barcelona;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
08 Barcelona;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2021QII;""
08 Barcelona;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2021QI;19.069
08 Barcelona;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
08 Barcelona;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
08 Barcelona;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2020QII;""
08 Barcelona;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2020QI;""
08 Barcelona;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
08 Barcelona;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
08 Barcelona;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QII;19.105
08 Barcelona;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QI;""
08 Barcelona;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
08 Barcelona;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
08 Barcelona;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QII;18.339
08 Barcelona;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QI;""
08 Barcelona;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
08 Barcelona;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
08 Barcelona;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QII;""
08 Barcelona;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QI;""
08 Barcelona;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
08 Barcelona;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QIII;18.348
08 Barcelona;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QII;""
08 Barcelona;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QI;""
08 Barcelona;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
08 Barcelona;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QIII;17.663
08 Barcelona;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QII;""
08 Barcelona;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QI;""
08 Barcelona;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
08 Barcelona;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
08 Barcelona;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QII;""
08 Barcelona;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QI;""
08 Barcelona;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
08 Barcelona;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
08 Barcelona;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
08 Barcelona;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
08 Barcelona;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
08 Barcelona;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
08 Barcelona;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
08 Barcelona;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
08 Barcelona;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
08 Barcelona;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
08 Barcelona;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
08 Barcelona;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
08 Barcelona;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;94,85
08 Barcelona;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
08 Barcelona;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
08 Barcelona;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
08 Barcelona;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;95,47
08 Barcelona;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
08 Barcelona;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
08 Barcelona;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
08 Barcelona;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;95,06
08 Barcelona;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
08 Barcelona;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
08 Barcelona;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
08 Barcelona;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
08 Barcelona;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
08 Barcelona;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
08 Barcelona;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;91,84
08 Barcelona;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
08 Barcelona;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
08 Barcelona;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
08 Barcelona;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;91,91
08 Barcelona;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
08 Barcelona;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
08 Barcelona;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
08 Barcelona;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
08 Barcelona;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
08 Barcelona;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
08 Barcelona;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;88,1
08 Barcelona;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
08 Barcelona;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
08 Barcelona;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
08 Barcelona;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;88,39
08 Barcelona;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
08 Barcelona;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
08 Barcelona;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
08 Barcelona;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
08 Barcelona;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
08 Barcelona;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
08 Barcelona;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;84,61
08 Barcelona;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
08 Barcelona;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
08 Barcelona;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
08 Barcelona;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;85,14
08 Barcelona;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
08 Barcelona;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
08 Barcelona;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
08 Barcelona;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
08 Barcelona;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
08 Barcelona;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
48 Bizkaia;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
48 Bizkaia;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
48 Bizkaia;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
48 Bizkaia;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QI;80.798
48 Bizkaia;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
48 Bizkaia;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
48 Bizkaia;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
48 Bizkaia;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QI;80.860
48 Bizkaia;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
48 Bizkaia;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
48 Bizkaia;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
48 Bizkaia;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QI;81.989
48 Bizkaia;All ages;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
48 Bizkaia;All ages;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
48 Bizkaia;All ages;Cohort January 1;Total;Survival in the first trimester;2022QII;""
48 Bizkaia;All ages;Cohort January 1;Total;Survival in the first trimester;2022QI;78.404
48 Bizkaia;All ages;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
48 Bizkaia;All ages;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
48 Bizkaia;All ages;Cohort January 1;Total;Survival in the first trimester;2021QII;""
48 Bizkaia;All ages;Cohort January 1;Total;Survival in the first trimester;2021QI;78.967
48 Bizkaia;All ages;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
48 Bizkaia;All ages;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
48 Bizkaia;All ages;Cohort January 1;Total;Survival in the first trimester;2020QII;""
48 Bizkaia;All ages;Cohort January 1;Total;Survival in the first trimester;2020QI;78.174
48 Bizkaia;All ages;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
48 Bizkaia;All ages;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
48 Bizkaia;All ages;Cohort January 1;Total;Survival in the second trimester;2022QII;75.798
48 Bizkaia;All ages;Cohort January 1;Total;Survival in the second trimester;2022QI;""
48 Bizkaia;All ages;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
48 Bizkaia;All ages;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
48 Bizkaia;All ages;Cohort January 1;Total;Survival in the second trimester;2021QII;76.653
48 Bizkaia;All ages;Cohort January 1;Total;Survival in the second trimester;2021QI;""
48 Bizkaia;All ages;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
48 Bizkaia;All ages;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
48 Bizkaia;All ages;Cohort January 1;Total;Survival in the second trimester;2020QII;76.545
48 Bizkaia;All ages;Cohort January 1;Total;Survival in the second trimester;2020QI;""
48 Bizkaia;All ages;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
48 Bizkaia;All ages;Cohort January 1;Total;Survival in the third trimester;2022QIII;73.956
48 Bizkaia;All ages;Cohort January 1;Total;Survival in the third trimester;2022QII;""
48 Bizkaia;All ages;Cohort January 1;Total;Survival in the third trimester;2022QI;""
48 Bizkaia;All ages;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
48 Bizkaia;All ages;Cohort January 1;Total;Survival in the third trimester;2021QIII;74.867
48 Bizkaia;All ages;Cohort January 1;Total;Survival in the third trimester;2021QII;""
48 Bizkaia;All ages;Cohort January 1;Total;Survival in the third trimester;2021QI;""
48 Bizkaia;All ages;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
48 Bizkaia;All ages;Cohort January 1;Total;Survival in the third trimester;2020QIII;74.713
48 Bizkaia;All ages;Cohort January 1;Total;Survival in the third trimester;2020QII;""
48 Bizkaia;All ages;Cohort January 1;Total;Survival in the third trimester;2020QI;""
48 Bizkaia;All ages;Cohort January 1;Total;Survival in the third trimester;2022QIV;71.480
48 Bizkaia;All ages;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
48 Bizkaia;All ages;Cohort January 1;Total;Survival in the third trimester;2022QII;""
48 Bizkaia;All ages;Cohort January 1;Total;Survival in the third trimester;2022QI;""
48 Bizkaia;All ages;Cohort January 1;Total;Survival in the third trimester;2021QIV;72.875
48 Bizkaia;All ages;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
48 Bizkaia;All ages;Cohort January 1;Total;Survival in the third trimester;2021QII;""
48 Bizkaia;All ages;Cohort January 1;Total;Survival in the third trimester;2021QI;""
48 Bizkaia;All ages;Cohort January 1;Total;Survival in the third trimester;2020QIV;72.817
48 Bizkaia;All ages;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
48 Bizkaia;All ages;Cohort January 1;Total;Survival in the third trimester;2020QII;""
48 Bizkaia;All ages;Cohort January 1;Total;Survival in the third trimester;2020QI;""
48 Bizkaia;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
48 Bizkaia;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
48 Bizkaia;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
48 Bizkaia;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
48 Bizkaia;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
48 Bizkaia;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
48 Bizkaia;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
48 Bizkaia;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
48 Bizkaia;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
48 Bizkaia;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
48 Bizkaia;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
48 Bizkaia;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
48 Bizkaia;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
48 Bizkaia;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
48 Bizkaia;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
48 Bizkaia;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;97,04
48 Bizkaia;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
48 Bizkaia;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
48 Bizkaia;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
48 Bizkaia;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;97,66
48 Bizkaia;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
48 Bizkaia;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
48 Bizkaia;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
48 Bizkaia;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;95,35
48 Bizkaia;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
48 Bizkaia;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
48 Bizkaia;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;93,81
48 Bizkaia;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
48 Bizkaia;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
48 Bizkaia;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
48 Bizkaia;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;94,8
48 Bizkaia;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
48 Bizkaia;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
48 Bizkaia;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
48 Bizkaia;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;93,36
48 Bizkaia;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
48 Bizkaia;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
48 Bizkaia;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;91,53
48 Bizkaia;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
48 Bizkaia;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
48 Bizkaia;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
48 Bizkaia;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;92,59
48 Bizkaia;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
48 Bizkaia;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
48 Bizkaia;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
48 Bizkaia;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;91,13
48 Bizkaia;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
48 Bizkaia;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
48 Bizkaia;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;88,47
48 Bizkaia;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
48 Bizkaia;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
48 Bizkaia;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
48 Bizkaia;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;90,12
48 Bizkaia;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
48 Bizkaia;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
48 Bizkaia;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
48 Bizkaia;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;88,81
48 Bizkaia;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
48 Bizkaia;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
48 Bizkaia;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
48 Bizkaia;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
48 Bizkaia;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
48 Bizkaia;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
48 Bizkaia;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QI;47.910
48 Bizkaia;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
48 Bizkaia;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
48 Bizkaia;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
48 Bizkaia;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QI;48.320
48 Bizkaia;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
48 Bizkaia;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
48 Bizkaia;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
48 Bizkaia;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QI;48.962
48 Bizkaia;All ages;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
48 Bizkaia;All ages;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
48 Bizkaia;All ages;Cohort January 1;Males;Survival in the first trimester;2022QII;""
48 Bizkaia;All ages;Cohort January 1;Males;Survival in the first trimester;2022QI;46.429
48 Bizkaia;All ages;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
48 Bizkaia;All ages;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
48 Bizkaia;All ages;Cohort January 1;Males;Survival in the first trimester;2021QII;""
48 Bizkaia;All ages;Cohort January 1;Males;Survival in the first trimester;2021QI;47.152
48 Bizkaia;All ages;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
48 Bizkaia;All ages;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
48 Bizkaia;All ages;Cohort January 1;Males;Survival in the first trimester;2020QII;""
48 Bizkaia;All ages;Cohort January 1;Males;Survival in the first trimester;2020QI;46.696
48 Bizkaia;All ages;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
48 Bizkaia;All ages;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
48 Bizkaia;All ages;Cohort January 1;Males;Survival in the second trimester;2022QII;45.044
48 Bizkaia;All ages;Cohort January 1;Males;Survival in the second trimester;2022QI;""
48 Bizkaia;All ages;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
48 Bizkaia;All ages;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
48 Bizkaia;All ages;Cohort January 1;Males;Survival in the second trimester;2021QII;45.874
48 Bizkaia;All ages;Cohort January 1;Males;Survival in the second trimester;2021QI;""
48 Bizkaia;All ages;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
48 Bizkaia;All ages;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
48 Bizkaia;All ages;Cohort January 1;Males;Survival in the second trimester;2020QII;45.944
48 Bizkaia;All ages;Cohort January 1;Males;Survival in the second trimester;2020QI;""
48 Bizkaia;All ages;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
48 Bizkaia;All ages;Cohort January 1;Males;Survival in the third trimester;2022QIII;43.934
48 Bizkaia;All ages;Cohort January 1;Males;Survival in the third trimester;2022QII;""
48 Bizkaia;All ages;Cohort January 1;Males;Survival in the third trimester;2022QI;""
48 Bizkaia;All ages;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
48 Bizkaia;All ages;Cohort January 1;Males;Survival in the third trimester;2021QIII;44.811
48 Bizkaia;All ages;Cohort January 1;Males;Survival in the third trimester;2021QII;""
48 Bizkaia;All ages;Cohort January 1;Males;Survival in the third trimester;2021QI;""
48 Bizkaia;All ages;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
48 Bizkaia;All ages;Cohort January 1;Males;Survival in the third trimester;2020QIII;44.873
48 Bizkaia;All ages;Cohort January 1;Males;Survival in the third trimester;2020QII;""
48 Bizkaia;All ages;Cohort January 1;Males;Survival in the third trimester;2020QI;""
48 Bizkaia;All ages;Cohort January 1;Males;Survival in the third trimester;2022QIV;42.428
48 Bizkaia;All ages;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
48 Bizkaia;All ages;Cohort January 1;Males;Survival in the third trimester;2022QII;""
48 Bizkaia;All ages;Cohort January 1;Males;Survival in the third trimester;2022QI;""
48 Bizkaia;All ages;Cohort January 1;Males;Survival in the third trimester;2021QIV;43.544
48 Bizkaia;All ages;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
48 Bizkaia;All ages;Cohort January 1;Males;Survival in the third trimester;2021QII;""
48 Bizkaia;All ages;Cohort January 1;Males;Survival in the third trimester;2021QI;""
48 Bizkaia;All ages;Cohort January 1;Males;Survival in the third trimester;2020QIV;43.708
48 Bizkaia;All ages;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
48 Bizkaia;All ages;Cohort January 1;Males;Survival in the third trimester;2020QII;""
48 Bizkaia;All ages;Cohort January 1;Males;Survival in the third trimester;2020QI;""
48 Bizkaia;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
48 Bizkaia;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
48 Bizkaia;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
48 Bizkaia;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
48 Bizkaia;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
48 Bizkaia;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
48 Bizkaia;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
48 Bizkaia;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
48 Bizkaia;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
48 Bizkaia;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
48 Bizkaia;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
48 Bizkaia;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
48 Bizkaia;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
48 Bizkaia;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
48 Bizkaia;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
48 Bizkaia;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;96,91
48 Bizkaia;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
48 Bizkaia;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
48 Bizkaia;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
48 Bizkaia;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;97,58
48 Bizkaia;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
48 Bizkaia;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
48 Bizkaia;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
48 Bizkaia;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;95,37
48 Bizkaia;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
48 Bizkaia;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
48 Bizkaia;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;94,02
48 Bizkaia;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
48 Bizkaia;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
48 Bizkaia;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
48 Bizkaia;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;94,94
48 Bizkaia;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
48 Bizkaia;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
48 Bizkaia;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
48 Bizkaia;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;93,84
48 Bizkaia;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
48 Bizkaia;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
48 Bizkaia;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;91,7
48 Bizkaia;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
48 Bizkaia;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
48 Bizkaia;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
48 Bizkaia;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;92,74
48 Bizkaia;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
48 Bizkaia;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
48 Bizkaia;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
48 Bizkaia;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;91,65
48 Bizkaia;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
48 Bizkaia;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
48 Bizkaia;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;88,56
48 Bizkaia;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
48 Bizkaia;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
48 Bizkaia;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
48 Bizkaia;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;90,12
48 Bizkaia;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
48 Bizkaia;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
48 Bizkaia;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
48 Bizkaia;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;89,27
48 Bizkaia;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
48 Bizkaia;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
48 Bizkaia;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
48 Bizkaia;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
48 Bizkaia;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
48 Bizkaia;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
48 Bizkaia;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QI;32.888
48 Bizkaia;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
48 Bizkaia;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
48 Bizkaia;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
48 Bizkaia;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QI;32.540
48 Bizkaia;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
48 Bizkaia;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
48 Bizkaia;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
48 Bizkaia;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QI;33.027
48 Bizkaia;All ages;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
48 Bizkaia;All ages;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
48 Bizkaia;All ages;Cohort January 1;Females;Survival in the first trimester;2022QII;""
48 Bizkaia;All ages;Cohort January 1;Females;Survival in the first trimester;2022QI;31.975
48 Bizkaia;All ages;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
48 Bizkaia;All ages;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
48 Bizkaia;All ages;Cohort January 1;Females;Survival in the first trimester;2021QII;""
48 Bizkaia;All ages;Cohort January 1;Females;Survival in the first trimester;2021QI;31.815
48 Bizkaia;All ages;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
48 Bizkaia;All ages;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
48 Bizkaia;All ages;Cohort January 1;Females;Survival in the first trimester;2020QII;""
48 Bizkaia;All ages;Cohort January 1;Females;Survival in the first trimester;2020QI;31.478
48 Bizkaia;All ages;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
48 Bizkaia;All ages;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
48 Bizkaia;All ages;Cohort January 1;Females;Survival in the second trimester;2022QII;30.754
48 Bizkaia;All ages;Cohort January 1;Females;Survival in the second trimester;2022QI;""
48 Bizkaia;All ages;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
48 Bizkaia;All ages;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
48 Bizkaia;All ages;Cohort January 1;Females;Survival in the second trimester;2021QII;30.779
48 Bizkaia;All ages;Cohort January 1;Females;Survival in the second trimester;2021QI;""
48 Bizkaia;All ages;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
48 Bizkaia;All ages;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
48 Bizkaia;All ages;Cohort January 1;Females;Survival in the second trimester;2020QII;30.601
48 Bizkaia;All ages;Cohort January 1;Females;Survival in the second trimester;2020QI;""
48 Bizkaia;All ages;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
48 Bizkaia;All ages;Cohort January 1;Females;Survival in the third trimester;2022QIII;30.022
48 Bizkaia;All ages;Cohort January 1;Females;Survival in the third trimester;2022QII;""
48 Bizkaia;All ages;Cohort January 1;Females;Survival in the third trimester;2022QI;""
48 Bizkaia;All ages;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
48 Bizkaia;All ages;Cohort January 1;Females;Survival in the third trimester;2021QIII;30.056
48 Bizkaia;All ages;Cohort January 1;Females;Survival in the third trimester;2021QII;""
48 Bizkaia;All ages;Cohort January 1;Females;Survival in the third trimester;2021QI;""
48 Bizkaia;All ages;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
48 Bizkaia;All ages;Cohort January 1;Females;Survival in the third trimester;2020QIII;29.840
48 Bizkaia;All ages;Cohort January 1;Females;Survival in the third trimester;2020QII;""
48 Bizkaia;All ages;Cohort January 1;Females;Survival in the third trimester;2020QI;""
48 Bizkaia;All ages;Cohort January 1;Females;Survival in the third trimester;2022QIV;29.052
48 Bizkaia;All ages;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
48 Bizkaia;All ages;Cohort January 1;Females;Survival in the third trimester;2022QII;""
48 Bizkaia;All ages;Cohort January 1;Females;Survival in the third trimester;2022QI;""
48 Bizkaia;All ages;Cohort January 1;Females;Survival in the third trimester;2021QIV;29.331
48 Bizkaia;All ages;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
48 Bizkaia;All ages;Cohort January 1;Females;Survival in the third trimester;2021QII;""
48 Bizkaia;All ages;Cohort January 1;Females;Survival in the third trimester;2021QI;""
48 Bizkaia;All ages;Cohort January 1;Females;Survival in the third trimester;2020QIV;29.109
48 Bizkaia;All ages;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
48 Bizkaia;All ages;Cohort January 1;Females;Survival in the third trimester;2020QII;""
48 Bizkaia;All ages;Cohort January 1;Females;Survival in the third trimester;2020QI;""
48 Bizkaia;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
48 Bizkaia;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
48 Bizkaia;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
48 Bizkaia;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
48 Bizkaia;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
48 Bizkaia;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
48 Bizkaia;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
48 Bizkaia;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
48 Bizkaia;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
48 Bizkaia;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
48 Bizkaia;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
48 Bizkaia;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
48 Bizkaia;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
48 Bizkaia;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
48 Bizkaia;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
48 Bizkaia;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;97,22
48 Bizkaia;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
48 Bizkaia;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
48 Bizkaia;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
48 Bizkaia;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;97,77
48 Bizkaia;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
48 Bizkaia;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
48 Bizkaia;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
48 Bizkaia;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;95,31
48 Bizkaia;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
48 Bizkaia;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
48 Bizkaia;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;93,51
48 Bizkaia;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
48 Bizkaia;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
48 Bizkaia;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
48 Bizkaia;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;94,59
48 Bizkaia;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
48 Bizkaia;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
48 Bizkaia;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
48 Bizkaia;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;92,65
48 Bizkaia;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
48 Bizkaia;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
48 Bizkaia;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;91,29
48 Bizkaia;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
48 Bizkaia;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
48 Bizkaia;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
48 Bizkaia;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;92,37
48 Bizkaia;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
48 Bizkaia;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
48 Bizkaia;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
48 Bizkaia;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;90,35
48 Bizkaia;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
48 Bizkaia;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
48 Bizkaia;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;88,34
48 Bizkaia;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
48 Bizkaia;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
48 Bizkaia;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
48 Bizkaia;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;90,14
48 Bizkaia;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
48 Bizkaia;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
48 Bizkaia;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
48 Bizkaia;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;88,14
48 Bizkaia;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
48 Bizkaia;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
48 Bizkaia;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
48 Bizkaia;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
48 Bizkaia;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
48 Bizkaia;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QII;80.711
48 Bizkaia;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
48 Bizkaia;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
48 Bizkaia;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
48 Bizkaia;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QII;81.281
48 Bizkaia;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
48 Bizkaia;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
48 Bizkaia;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
48 Bizkaia;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QII;81.052
48 Bizkaia;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
48 Bizkaia;All ages;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
48 Bizkaia;All ages;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
48 Bizkaia;All ages;Cohort April 1;Total;Survival in the first trimester;2022QII;77.852
48 Bizkaia;All ages;Cohort April 1;Total;Survival in the first trimester;2022QI;""
48 Bizkaia;All ages;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
48 Bizkaia;All ages;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
48 Bizkaia;All ages;Cohort April 1;Total;Survival in the first trimester;2021QII;78.745
48 Bizkaia;All ages;Cohort April 1;Total;Survival in the first trimester;2021QI;""
48 Bizkaia;All ages;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
48 Bizkaia;All ages;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
48 Bizkaia;All ages;Cohort April 1;Total;Survival in the first trimester;2020QII;79.312
48 Bizkaia;All ages;Cohort April 1;Total;Survival in the first trimester;2020QI;""
48 Bizkaia;All ages;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
48 Bizkaia;All ages;Cohort April 1;Total;Survival in the second trimester;2022QIII;75.847
48 Bizkaia;All ages;Cohort April 1;Total;Survival in the second trimester;2022QII;""
48 Bizkaia;All ages;Cohort April 1;Total;Survival in the second trimester;2022QI;""
48 Bizkaia;All ages;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
48 Bizkaia;All ages;Cohort April 1;Total;Survival in the second trimester;2021QIII;76.788
48 Bizkaia;All ages;Cohort April 1;Total;Survival in the second trimester;2021QII;""
48 Bizkaia;All ages;Cohort April 1;Total;Survival in the second trimester;2021QI;""
48 Bizkaia;All ages;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
48 Bizkaia;All ages;Cohort April 1;Total;Survival in the second trimester;2020QIII;77.220
48 Bizkaia;All ages;Cohort April 1;Total;Survival in the second trimester;2020QII;""
48 Bizkaia;All ages;Cohort April 1;Total;Survival in the second trimester;2020QI;""
48 Bizkaia;All ages;Cohort April 1;Total;Survival in the third trimester;2022QIV;73.231
48 Bizkaia;All ages;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
48 Bizkaia;All ages;Cohort April 1;Total;Survival in the third trimester;2022QII;""
48 Bizkaia;All ages;Cohort April 1;Total;Survival in the third trimester;2022QI;""
48 Bizkaia;All ages;Cohort April 1;Total;Survival in the third trimester;2021QIV;74.656
48 Bizkaia;All ages;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
48 Bizkaia;All ages;Cohort April 1;Total;Survival in the third trimester;2021QII;""
48 Bizkaia;All ages;Cohort April 1;Total;Survival in the third trimester;2021QI;""
48 Bizkaia;All ages;Cohort April 1;Total;Survival in the third trimester;2020QIV;75.179
48 Bizkaia;All ages;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
48 Bizkaia;All ages;Cohort April 1;Total;Survival in the third trimester;2020QII;""
48 Bizkaia;All ages;Cohort April 1;Total;Survival in the third trimester;2020QI;""
48 Bizkaia;All ages;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
48 Bizkaia;All ages;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
48 Bizkaia;All ages;Cohort April 1;Total;Survival in the third trimester;2022QII;""
48 Bizkaia;All ages;Cohort April 1;Total;Survival in the third trimester;2022QI;72.750
48 Bizkaia;All ages;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
48 Bizkaia;All ages;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
48 Bizkaia;All ages;Cohort April 1;Total;Survival in the third trimester;2021QII;""
48 Bizkaia;All ages;Cohort April 1;Total;Survival in the third trimester;2021QI;73.663
48 Bizkaia;All ages;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
48 Bizkaia;All ages;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
48 Bizkaia;All ages;Cohort April 1;Total;Survival in the third trimester;2020QII;""
48 Bizkaia;All ages;Cohort April 1;Total;Survival in the third trimester;2020QI;""
48 Bizkaia;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
48 Bizkaia;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
48 Bizkaia;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
48 Bizkaia;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
48 Bizkaia;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
48 Bizkaia;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
48 Bizkaia;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
48 Bizkaia;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
48 Bizkaia;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
48 Bizkaia;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
48 Bizkaia;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
48 Bizkaia;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
48 Bizkaia;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
48 Bizkaia;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
48 Bizkaia;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;96,46
48 Bizkaia;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
48 Bizkaia;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
48 Bizkaia;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
48 Bizkaia;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;96,88
48 Bizkaia;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
48 Bizkaia;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
48 Bizkaia;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
48 Bizkaia;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;97,85
48 Bizkaia;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
48 Bizkaia;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
48 Bizkaia;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;93,97
48 Bizkaia;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
48 Bizkaia;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
48 Bizkaia;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
48 Bizkaia;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;94,47
48 Bizkaia;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
48 Bizkaia;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
48 Bizkaia;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
48 Bizkaia;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;95,27
48 Bizkaia;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
48 Bizkaia;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
48 Bizkaia;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;90,73
48 Bizkaia;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
48 Bizkaia;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
48 Bizkaia;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
48 Bizkaia;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;91,85
48 Bizkaia;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
48 Bizkaia;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
48 Bizkaia;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
48 Bizkaia;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;92,75
48 Bizkaia;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
48 Bizkaia;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
48 Bizkaia;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
48 Bizkaia;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
48 Bizkaia;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
48 Bizkaia;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
48 Bizkaia;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;89,5
48 Bizkaia;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
48 Bizkaia;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
48 Bizkaia;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
48 Bizkaia;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;90,88
48 Bizkaia;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
48 Bizkaia;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
48 Bizkaia;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
48 Bizkaia;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
48 Bizkaia;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
48 Bizkaia;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
48 Bizkaia;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QII;47.856
48 Bizkaia;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
48 Bizkaia;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
48 Bizkaia;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
48 Bizkaia;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QII;48.584
48 Bizkaia;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
48 Bizkaia;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
48 Bizkaia;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
48 Bizkaia;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QII;48.494
48 Bizkaia;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
48 Bizkaia;All ages;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
48 Bizkaia;All ages;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
48 Bizkaia;All ages;Cohort April 1;Males;Survival in the first trimester;2022QII;46.312
48 Bizkaia;All ages;Cohort April 1;Males;Survival in the first trimester;2022QI;""
48 Bizkaia;All ages;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
48 Bizkaia;All ages;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
48 Bizkaia;All ages;Cohort April 1;Males;Survival in the first trimester;2021QII;47.162
48 Bizkaia;All ages;Cohort April 1;Males;Survival in the first trimester;2021QI;""
48 Bizkaia;All ages;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
48 Bizkaia;All ages;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
48 Bizkaia;All ages;Cohort April 1;Males;Survival in the first trimester;2020QII;47.673
48 Bizkaia;All ages;Cohort April 1;Males;Survival in the first trimester;2020QI;""
48 Bizkaia;All ages;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
48 Bizkaia;All ages;Cohort April 1;Males;Survival in the second trimester;2022QIII;45.078
48 Bizkaia;All ages;Cohort April 1;Males;Survival in the second trimester;2022QII;""
48 Bizkaia;All ages;Cohort April 1;Males;Survival in the second trimester;2022QI;""
48 Bizkaia;All ages;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
48 Bizkaia;All ages;Cohort April 1;Males;Survival in the second trimester;2021QIII;45.983
48 Bizkaia;All ages;Cohort April 1;Males;Survival in the second trimester;2021QII;""
48 Bizkaia;All ages;Cohort April 1;Males;Survival in the second trimester;2021QI;""
48 Bizkaia;All ages;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
48 Bizkaia;All ages;Cohort April 1;Males;Survival in the second trimester;2020QIII;46.422
48 Bizkaia;All ages;Cohort April 1;Males;Survival in the second trimester;2020QII;""
48 Bizkaia;All ages;Cohort April 1;Males;Survival in the second trimester;2020QI;""
48 Bizkaia;All ages;Cohort April 1;Males;Survival in the third trimester;2022QIV;43.486
48 Bizkaia;All ages;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
48 Bizkaia;All ages;Cohort April 1;Males;Survival in the third trimester;2022QII;""
48 Bizkaia;All ages;Cohort April 1;Males;Survival in the third trimester;2022QI;""
48 Bizkaia;All ages;Cohort April 1;Males;Survival in the third trimester;2021QIV;44.620
48 Bizkaia;All ages;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
48 Bizkaia;All ages;Cohort April 1;Males;Survival in the third trimester;2021QII;""
48 Bizkaia;All ages;Cohort April 1;Males;Survival in the third trimester;2021QI;""
48 Bizkaia;All ages;Cohort April 1;Males;Survival in the third trimester;2020QIV;45.164
48 Bizkaia;All ages;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
48 Bizkaia;All ages;Cohort April 1;Males;Survival in the third trimester;2020QII;""
48 Bizkaia;All ages;Cohort April 1;Males;Survival in the third trimester;2020QI;""
48 Bizkaia;All ages;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
48 Bizkaia;All ages;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
48 Bizkaia;All ages;Cohort April 1;Males;Survival in the third trimester;2022QII;""
48 Bizkaia;All ages;Cohort April 1;Males;Survival in the third trimester;2022QI;43.458
48 Bizkaia;All ages;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
48 Bizkaia;All ages;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
48 Bizkaia;All ages;Cohort April 1;Males;Survival in the third trimester;2021QII;""
48 Bizkaia;All ages;Cohort April 1;Males;Survival in the third trimester;2021QI;44.217
48 Bizkaia;All ages;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
48 Bizkaia;All ages;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
48 Bizkaia;All ages;Cohort April 1;Males;Survival in the third trimester;2020QII;""
48 Bizkaia;All ages;Cohort April 1;Males;Survival in the third trimester;2020QI;""
48 Bizkaia;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
48 Bizkaia;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
48 Bizkaia;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
48 Bizkaia;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
48 Bizkaia;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
48 Bizkaia;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
48 Bizkaia;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
48 Bizkaia;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
48 Bizkaia;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
48 Bizkaia;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
48 Bizkaia;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
48 Bizkaia;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
48 Bizkaia;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
48 Bizkaia;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
48 Bizkaia;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;96,77
48 Bizkaia;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
48 Bizkaia;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
48 Bizkaia;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
48 Bizkaia;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;97,07
48 Bizkaia;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
48 Bizkaia;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
48 Bizkaia;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
48 Bizkaia;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;98,31
48 Bizkaia;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
48 Bizkaia;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
48 Bizkaia;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;94,2
48 Bizkaia;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
48 Bizkaia;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
48 Bizkaia;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
48 Bizkaia;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;94,65
48 Bizkaia;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
48 Bizkaia;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
48 Bizkaia;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
48 Bizkaia;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;95,73
48 Bizkaia;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
48 Bizkaia;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
48 Bizkaia;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;90,87
48 Bizkaia;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
48 Bizkaia;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
48 Bizkaia;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
48 Bizkaia;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;91,84
48 Bizkaia;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
48 Bizkaia;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
48 Bizkaia;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
48 Bizkaia;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;93,13
48 Bizkaia;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
48 Bizkaia;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
48 Bizkaia;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
48 Bizkaia;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
48 Bizkaia;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
48 Bizkaia;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
48 Bizkaia;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;89,45
48 Bizkaia;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
48 Bizkaia;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
48 Bizkaia;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
48 Bizkaia;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;91,18
48 Bizkaia;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
48 Bizkaia;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
48 Bizkaia;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
48 Bizkaia;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
48 Bizkaia;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
48 Bizkaia;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
48 Bizkaia;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QII;32.855
48 Bizkaia;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
48 Bizkaia;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
48 Bizkaia;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
48 Bizkaia;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QII;32.697
48 Bizkaia;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
48 Bizkaia;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
48 Bizkaia;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
48 Bizkaia;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QII;32.558
48 Bizkaia;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
48 Bizkaia;All ages;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
48 Bizkaia;All ages;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
48 Bizkaia;All ages;Cohort April 1;Females;Survival in the first trimester;2022QII;31.540
48 Bizkaia;All ages;Cohort April 1;Females;Survival in the first trimester;2022QI;""
48 Bizkaia;All ages;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
48 Bizkaia;All ages;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
48 Bizkaia;All ages;Cohort April 1;Females;Survival in the first trimester;2021QII;31.583
48 Bizkaia;All ages;Cohort April 1;Females;Survival in the first trimester;2021QI;""
48 Bizkaia;All ages;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
48 Bizkaia;All ages;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
48 Bizkaia;All ages;Cohort April 1;Females;Survival in the first trimester;2020QII;31.639
48 Bizkaia;All ages;Cohort April 1;Females;Survival in the first trimester;2020QI;""
48 Bizkaia;All ages;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
48 Bizkaia;All ages;Cohort April 1;Females;Survival in the second trimester;2022QIII;30.769
48 Bizkaia;All ages;Cohort April 1;Females;Survival in the second trimester;2022QII;""
48 Bizkaia;All ages;Cohort April 1;Females;Survival in the second trimester;2022QI;""
48 Bizkaia;All ages;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
48 Bizkaia;All ages;Cohort April 1;Females;Survival in the second trimester;2021QIII;30.805
48 Bizkaia;All ages;Cohort April 1;Females;Survival in the second trimester;2021QII;""
48 Bizkaia;All ages;Cohort April 1;Females;Survival in the second trimester;2021QI;""
48 Bizkaia;All ages;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
48 Bizkaia;All ages;Cohort April 1;Females;Survival in the second trimester;2020QIII;30.798
48 Bizkaia;All ages;Cohort April 1;Females;Survival in the second trimester;2020QII;""
48 Bizkaia;All ages;Cohort April 1;Females;Survival in the second trimester;2020QI;""
48 Bizkaia;All ages;Cohort April 1;Females;Survival in the third trimester;2022QIV;29.745
48 Bizkaia;All ages;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
48 Bizkaia;All ages;Cohort April 1;Females;Survival in the third trimester;2022QII;""
48 Bizkaia;All ages;Cohort April 1;Females;Survival in the third trimester;2022QI;""
48 Bizkaia;All ages;Cohort April 1;Females;Survival in the third trimester;2021QIV;30.036
48 Bizkaia;All ages;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
48 Bizkaia;All ages;Cohort April 1;Females;Survival in the third trimester;2021QII;""
48 Bizkaia;All ages;Cohort April 1;Females;Survival in the third trimester;2021QI;""
48 Bizkaia;All ages;Cohort April 1;Females;Survival in the third trimester;2020QIV;30.015
48 Bizkaia;All ages;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
48 Bizkaia;All ages;Cohort April 1;Females;Survival in the third trimester;2020QII;""
48 Bizkaia;All ages;Cohort April 1;Females;Survival in the third trimester;2020QI;""
48 Bizkaia;All ages;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
48 Bizkaia;All ages;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
48 Bizkaia;All ages;Cohort April 1;Females;Survival in the third trimester;2022QII;""
48 Bizkaia;All ages;Cohort April 1;Females;Survival in the third trimester;2022QI;29.292
48 Bizkaia;All ages;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
48 Bizkaia;All ages;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
48 Bizkaia;All ages;Cohort April 1;Females;Survival in the third trimester;2021QII;""
48 Bizkaia;All ages;Cohort April 1;Females;Survival in the third trimester;2021QI;29.446
48 Bizkaia;All ages;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
48 Bizkaia;All ages;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
48 Bizkaia;All ages;Cohort April 1;Females;Survival in the third trimester;2020QII;""
48 Bizkaia;All ages;Cohort April 1;Females;Survival in the third trimester;2020QI;""
48 Bizkaia;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
48 Bizkaia;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
48 Bizkaia;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
48 Bizkaia;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
48 Bizkaia;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
48 Bizkaia;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
48 Bizkaia;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
48 Bizkaia;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
48 Bizkaia;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
48 Bizkaia;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
48 Bizkaia;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
48 Bizkaia;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
48 Bizkaia;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
48 Bizkaia;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
48 Bizkaia;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;96
48 Bizkaia;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
48 Bizkaia;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
48 Bizkaia;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
48 Bizkaia;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;96,59
48 Bizkaia;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
48 Bizkaia;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
48 Bizkaia;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
48 Bizkaia;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;97,18
48 Bizkaia;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
48 Bizkaia;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
48 Bizkaia;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;93,65
48 Bizkaia;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
48 Bizkaia;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
48 Bizkaia;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
48 Bizkaia;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;94,21
48 Bizkaia;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
48 Bizkaia;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
48 Bizkaia;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
48 Bizkaia;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;94,59
48 Bizkaia;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
48 Bizkaia;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
48 Bizkaia;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;90,53
48 Bizkaia;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
48 Bizkaia;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
48 Bizkaia;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
48 Bizkaia;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;91,86
48 Bizkaia;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
48 Bizkaia;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
48 Bizkaia;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
48 Bizkaia;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;92,19
48 Bizkaia;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
48 Bizkaia;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
48 Bizkaia;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
48 Bizkaia;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
48 Bizkaia;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
48 Bizkaia;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
48 Bizkaia;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;89,59
48 Bizkaia;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
48 Bizkaia;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
48 Bizkaia;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
48 Bizkaia;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;90,44
48 Bizkaia;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
48 Bizkaia;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
48 Bizkaia;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
48 Bizkaia;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
48 Bizkaia;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
48 Bizkaia;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QIII;80.516
48 Bizkaia;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
48 Bizkaia;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
48 Bizkaia;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
48 Bizkaia;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QIII;80.927
48 Bizkaia;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
48 Bizkaia;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
48 Bizkaia;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
48 Bizkaia;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QIII;80.766
48 Bizkaia;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
48 Bizkaia;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
48 Bizkaia;All ages;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
48 Bizkaia;All ages;Cohort July 1;Total;Survival in the first trimester;2022QIII;78.231
48 Bizkaia;All ages;Cohort July 1;Total;Survival in the first trimester;2022QII;""
48 Bizkaia;All ages;Cohort July 1;Total;Survival in the first trimester;2022QI;""
48 Bizkaia;All ages;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
48 Bizkaia;All ages;Cohort July 1;Total;Survival in the first trimester;2021QIII;78.712
48 Bizkaia;All ages;Cohort July 1;Total;Survival in the first trimester;2021QII;""
48 Bizkaia;All ages;Cohort July 1;Total;Survival in the first trimester;2021QI;""
48 Bizkaia;All ages;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
48 Bizkaia;All ages;Cohort July 1;Total;Survival in the first trimester;2020QIII;78.477
48 Bizkaia;All ages;Cohort July 1;Total;Survival in the first trimester;2020QII;""
48 Bizkaia;All ages;Cohort July 1;Total;Survival in the first trimester;2020QI;""
48 Bizkaia;All ages;Cohort July 1;Total;Survival in the second trimester;2022QIV;75.424
48 Bizkaia;All ages;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
48 Bizkaia;All ages;Cohort July 1;Total;Survival in the second trimester;2022QII;""
48 Bizkaia;All ages;Cohort July 1;Total;Survival in the second trimester;2022QI;""
48 Bizkaia;All ages;Cohort July 1;Total;Survival in the second trimester;2021QIV;76.393
48 Bizkaia;All ages;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
48 Bizkaia;All ages;Cohort July 1;Total;Survival in the second trimester;2021QII;""
48 Bizkaia;All ages;Cohort July 1;Total;Survival in the second trimester;2021QI;""
48 Bizkaia;All ages;Cohort July 1;Total;Survival in the second trimester;2020QIV;76.340
48 Bizkaia;All ages;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
48 Bizkaia;All ages;Cohort July 1;Total;Survival in the second trimester;2020QII;""
48 Bizkaia;All ages;Cohort July 1;Total;Survival in the second trimester;2020QI;""
48 Bizkaia;All ages;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
48 Bizkaia;All ages;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
48 Bizkaia;All ages;Cohort July 1;Total;Survival in the third trimester;2022QII;""
48 Bizkaia;All ages;Cohort July 1;Total;Survival in the third trimester;2022QI;74.364
48 Bizkaia;All ages;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
48 Bizkaia;All ages;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
48 Bizkaia;All ages;Cohort July 1;Total;Survival in the third trimester;2021QII;""
48 Bizkaia;All ages;Cohort July 1;Total;Survival in the third trimester;2021QI;74.766
48 Bizkaia;All ages;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
48 Bizkaia;All ages;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
48 Bizkaia;All ages;Cohort July 1;Total;Survival in the third trimester;2020QII;""
48 Bizkaia;All ages;Cohort July 1;Total;Survival in the third trimester;2020QI;""
48 Bizkaia;All ages;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
48 Bizkaia;All ages;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
48 Bizkaia;All ages;Cohort July 1;Total;Survival in the third trimester;2022QII;72.319
48 Bizkaia;All ages;Cohort July 1;Total;Survival in the third trimester;2022QI;""
48 Bizkaia;All ages;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
48 Bizkaia;All ages;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
48 Bizkaia;All ages;Cohort July 1;Total;Survival in the third trimester;2021QII;73.013
48 Bizkaia;All ages;Cohort July 1;Total;Survival in the third trimester;2021QI;""
48 Bizkaia;All ages;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
48 Bizkaia;All ages;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
48 Bizkaia;All ages;Cohort July 1;Total;Survival in the third trimester;2020QII;""
48 Bizkaia;All ages;Cohort July 1;Total;Survival in the third trimester;2020QI;""
48 Bizkaia;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
48 Bizkaia;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
48 Bizkaia;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
48 Bizkaia;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
48 Bizkaia;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
48 Bizkaia;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
48 Bizkaia;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
48 Bizkaia;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
48 Bizkaia;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
48 Bizkaia;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
48 Bizkaia;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
48 Bizkaia;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
48 Bizkaia;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
48 Bizkaia;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;97,16
48 Bizkaia;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
48 Bizkaia;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
48 Bizkaia;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
48 Bizkaia;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;97,26
48 Bizkaia;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
48 Bizkaia;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
48 Bizkaia;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
48 Bizkaia;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;97,17
48 Bizkaia;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
48 Bizkaia;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
48 Bizkaia;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;93,68
48 Bizkaia;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
48 Bizkaia;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
48 Bizkaia;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
48 Bizkaia;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;94,4
48 Bizkaia;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
48 Bizkaia;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
48 Bizkaia;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
48 Bizkaia;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;94,52
48 Bizkaia;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
48 Bizkaia;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
48 Bizkaia;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
48 Bizkaia;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
48 Bizkaia;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
48 Bizkaia;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
48 Bizkaia;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;91,89
48 Bizkaia;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
48 Bizkaia;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
48 Bizkaia;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
48 Bizkaia;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;92,57
48 Bizkaia;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
48 Bizkaia;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
48 Bizkaia;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
48 Bizkaia;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
48 Bizkaia;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
48 Bizkaia;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
48 Bizkaia;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;89,36
48 Bizkaia;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
48 Bizkaia;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
48 Bizkaia;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
48 Bizkaia;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;90,4
48 Bizkaia;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
48 Bizkaia;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
48 Bizkaia;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
48 Bizkaia;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
48 Bizkaia;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
48 Bizkaia;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
48 Bizkaia;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QIII;47.866
48 Bizkaia;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
48 Bizkaia;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
48 Bizkaia;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
48 Bizkaia;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QIII;48.446
48 Bizkaia;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
48 Bizkaia;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
48 Bizkaia;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
48 Bizkaia;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QIII;48.613
48 Bizkaia;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
48 Bizkaia;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
48 Bizkaia;All ages;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
48 Bizkaia;All ages;Cohort July 1;Males;Survival in the first trimester;2022QIII;46.445
48 Bizkaia;All ages;Cohort July 1;Males;Survival in the first trimester;2022QII;""
48 Bizkaia;All ages;Cohort July 1;Males;Survival in the first trimester;2022QI;""
48 Bizkaia;All ages;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
48 Bizkaia;All ages;Cohort July 1;Males;Survival in the first trimester;2021QIII;47.094
48 Bizkaia;All ages;Cohort July 1;Males;Survival in the first trimester;2021QII;""
48 Bizkaia;All ages;Cohort July 1;Males;Survival in the first trimester;2021QI;""
48 Bizkaia;All ages;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
48 Bizkaia;All ages;Cohort July 1;Males;Survival in the first trimester;2020QIII;47.215
48 Bizkaia;All ages;Cohort July 1;Males;Survival in the first trimester;2020QII;""
48 Bizkaia;All ages;Cohort July 1;Males;Survival in the first trimester;2020QI;""
48 Bizkaia;All ages;Cohort July 1;Males;Survival in the second trimester;2022QIV;44.723
48 Bizkaia;All ages;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
48 Bizkaia;All ages;Cohort July 1;Males;Survival in the second trimester;2022QII;""
48 Bizkaia;All ages;Cohort July 1;Males;Survival in the second trimester;2022QI;""
48 Bizkaia;All ages;Cohort July 1;Males;Survival in the second trimester;2021QIV;45.608
48 Bizkaia;All ages;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
48 Bizkaia;All ages;Cohort July 1;Males;Survival in the second trimester;2021QII;""
48 Bizkaia;All ages;Cohort July 1;Males;Survival in the second trimester;2021QI;""
48 Bizkaia;All ages;Cohort July 1;Males;Survival in the second trimester;2020QIV;45.884
48 Bizkaia;All ages;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
48 Bizkaia;All ages;Cohort July 1;Males;Survival in the second trimester;2020QII;""
48 Bizkaia;All ages;Cohort July 1;Males;Survival in the second trimester;2020QI;""
48 Bizkaia;All ages;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
48 Bizkaia;All ages;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
48 Bizkaia;All ages;Cohort July 1;Males;Survival in the third trimester;2022QII;""
48 Bizkaia;All ages;Cohort July 1;Males;Survival in the third trimester;2022QI;44.366
48 Bizkaia;All ages;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
48 Bizkaia;All ages;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
48 Bizkaia;All ages;Cohort July 1;Males;Survival in the third trimester;2021QII;""
48 Bizkaia;All ages;Cohort July 1;Males;Survival in the third trimester;2021QI;44.909
48 Bizkaia;All ages;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
48 Bizkaia;All ages;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
48 Bizkaia;All ages;Cohort July 1;Males;Survival in the third trimester;2020QII;""
48 Bizkaia;All ages;Cohort July 1;Males;Survival in the third trimester;2020QI;""
48 Bizkaia;All ages;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
48 Bizkaia;All ages;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
48 Bizkaia;All ages;Cohort July 1;Males;Survival in the third trimester;2022QII;43.179
48 Bizkaia;All ages;Cohort July 1;Males;Survival in the third trimester;2022QI;""
48 Bizkaia;All ages;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
48 Bizkaia;All ages;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
48 Bizkaia;All ages;Cohort July 1;Males;Survival in the third trimester;2021QII;43.850
48 Bizkaia;All ages;Cohort July 1;Males;Survival in the third trimester;2021QI;""
48 Bizkaia;All ages;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
48 Bizkaia;All ages;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
48 Bizkaia;All ages;Cohort July 1;Males;Survival in the third trimester;2020QII;""
48 Bizkaia;All ages;Cohort July 1;Males;Survival in the third trimester;2020QI;""
48 Bizkaia;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
48 Bizkaia;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
48 Bizkaia;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
48 Bizkaia;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
48 Bizkaia;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
48 Bizkaia;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
48 Bizkaia;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
48 Bizkaia;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
48 Bizkaia;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
48 Bizkaia;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
48 Bizkaia;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
48 Bizkaia;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
48 Bizkaia;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
48 Bizkaia;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;97,03
48 Bizkaia;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
48 Bizkaia;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
48 Bizkaia;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
48 Bizkaia;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;97,21
48 Bizkaia;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
48 Bizkaia;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
48 Bizkaia;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
48 Bizkaia;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;97,12
48 Bizkaia;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
48 Bizkaia;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
48 Bizkaia;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;93,43
48 Bizkaia;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
48 Bizkaia;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
48 Bizkaia;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
48 Bizkaia;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;94,14
48 Bizkaia;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
48 Bizkaia;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
48 Bizkaia;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
48 Bizkaia;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;94,39
48 Bizkaia;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
48 Bizkaia;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
48 Bizkaia;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
48 Bizkaia;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
48 Bizkaia;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
48 Bizkaia;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
48 Bizkaia;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;91,58
48 Bizkaia;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
48 Bizkaia;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
48 Bizkaia;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
48 Bizkaia;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;92,38
48 Bizkaia;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
48 Bizkaia;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
48 Bizkaia;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
48 Bizkaia;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
48 Bizkaia;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
48 Bizkaia;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
48 Bizkaia;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;89,13
48 Bizkaia;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
48 Bizkaia;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
48 Bizkaia;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
48 Bizkaia;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;90,2
48 Bizkaia;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
48 Bizkaia;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
48 Bizkaia;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
48 Bizkaia;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
48 Bizkaia;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
48 Bizkaia;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
48 Bizkaia;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QIII;32.650
48 Bizkaia;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
48 Bizkaia;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
48 Bizkaia;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
48 Bizkaia;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QIII;32.481
48 Bizkaia;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
48 Bizkaia;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
48 Bizkaia;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
48 Bizkaia;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QIII;32.153
48 Bizkaia;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
48 Bizkaia;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
48 Bizkaia;All ages;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
48 Bizkaia;All ages;Cohort July 1;Females;Survival in the first trimester;2022QIII;31.786
48 Bizkaia;All ages;Cohort July 1;Females;Survival in the first trimester;2022QII;""
48 Bizkaia;All ages;Cohort July 1;Females;Survival in the first trimester;2022QI;""
48 Bizkaia;All ages;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
48 Bizkaia;All ages;Cohort July 1;Females;Survival in the first trimester;2021QIII;31.618
48 Bizkaia;All ages;Cohort July 1;Females;Survival in the first trimester;2021QII;""
48 Bizkaia;All ages;Cohort July 1;Females;Survival in the first trimester;2021QI;""
48 Bizkaia;All ages;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
48 Bizkaia;All ages;Cohort July 1;Females;Survival in the first trimester;2020QIII;31.262
48 Bizkaia;All ages;Cohort July 1;Females;Survival in the first trimester;2020QII;""
48 Bizkaia;All ages;Cohort July 1;Females;Survival in the first trimester;2020QI;""
48 Bizkaia;All ages;Cohort July 1;Females;Survival in the second trimester;2022QIV;30.701
48 Bizkaia;All ages;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
48 Bizkaia;All ages;Cohort July 1;Females;Survival in the second trimester;2022QII;""
48 Bizkaia;All ages;Cohort July 1;Females;Survival in the second trimester;2022QI;""
48 Bizkaia;All ages;Cohort July 1;Females;Survival in the second trimester;2021QIV;30.785
48 Bizkaia;All ages;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
48 Bizkaia;All ages;Cohort July 1;Females;Survival in the second trimester;2021QII;""
48 Bizkaia;All ages;Cohort July 1;Females;Survival in the second trimester;2021QI;""
48 Bizkaia;All ages;Cohort July 1;Females;Survival in the second trimester;2020QIV;30.456
48 Bizkaia;All ages;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
48 Bizkaia;All ages;Cohort July 1;Females;Survival in the second trimester;2020QII;""
48 Bizkaia;All ages;Cohort July 1;Females;Survival in the second trimester;2020QI;""
48 Bizkaia;All ages;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
48 Bizkaia;All ages;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
48 Bizkaia;All ages;Cohort July 1;Females;Survival in the third trimester;2022QII;""
48 Bizkaia;All ages;Cohort July 1;Females;Survival in the third trimester;2022QI;29.998
48 Bizkaia;All ages;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
48 Bizkaia;All ages;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
48 Bizkaia;All ages;Cohort July 1;Females;Survival in the third trimester;2021QII;""
48 Bizkaia;All ages;Cohort July 1;Females;Survival in the third trimester;2021QI;29.857
48 Bizkaia;All ages;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
48 Bizkaia;All ages;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
48 Bizkaia;All ages;Cohort July 1;Females;Survival in the third trimester;2020QII;""
48 Bizkaia;All ages;Cohort July 1;Females;Survival in the third trimester;2020QI;""
48 Bizkaia;All ages;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
48 Bizkaia;All ages;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
48 Bizkaia;All ages;Cohort July 1;Females;Survival in the third trimester;2022QII;29.140
48 Bizkaia;All ages;Cohort July 1;Females;Survival in the third trimester;2022QI;""
48 Bizkaia;All ages;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
48 Bizkaia;All ages;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
48 Bizkaia;All ages;Cohort July 1;Females;Survival in the third trimester;2021QII;29.163
48 Bizkaia;All ages;Cohort July 1;Females;Survival in the third trimester;2021QI;""
48 Bizkaia;All ages;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
48 Bizkaia;All ages;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
48 Bizkaia;All ages;Cohort July 1;Females;Survival in the third trimester;2020QII;""
48 Bizkaia;All ages;Cohort July 1;Females;Survival in the third trimester;2020QI;""
48 Bizkaia;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
48 Bizkaia;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
48 Bizkaia;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
48 Bizkaia;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
48 Bizkaia;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
48 Bizkaia;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
48 Bizkaia;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
48 Bizkaia;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
48 Bizkaia;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
48 Bizkaia;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
48 Bizkaia;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
48 Bizkaia;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
48 Bizkaia;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
48 Bizkaia;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;97,35
48 Bizkaia;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
48 Bizkaia;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
48 Bizkaia;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
48 Bizkaia;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;97,34
48 Bizkaia;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
48 Bizkaia;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
48 Bizkaia;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
48 Bizkaia;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;97,23
48 Bizkaia;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
48 Bizkaia;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
48 Bizkaia;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;94,03
48 Bizkaia;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
48 Bizkaia;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
48 Bizkaia;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
48 Bizkaia;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;94,78
48 Bizkaia;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
48 Bizkaia;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
48 Bizkaia;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
48 Bizkaia;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;94,72
48 Bizkaia;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
48 Bizkaia;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
48 Bizkaia;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
48 Bizkaia;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
48 Bizkaia;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
48 Bizkaia;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
48 Bizkaia;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;92,36
48 Bizkaia;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
48 Bizkaia;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
48 Bizkaia;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
48 Bizkaia;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;92,86
48 Bizkaia;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
48 Bizkaia;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
48 Bizkaia;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
48 Bizkaia;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
48 Bizkaia;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
48 Bizkaia;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
48 Bizkaia;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;89,71
48 Bizkaia;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
48 Bizkaia;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
48 Bizkaia;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
48 Bizkaia;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;90,7
48 Bizkaia;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
48 Bizkaia;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
48 Bizkaia;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
48 Bizkaia;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
48 Bizkaia;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
48 Bizkaia;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QIV;80.234
48 Bizkaia;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
48 Bizkaia;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
48 Bizkaia;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
48 Bizkaia;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QIV;80.749
48 Bizkaia;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
48 Bizkaia;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
48 Bizkaia;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
48 Bizkaia;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QIV;80.511
48 Bizkaia;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
48 Bizkaia;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
48 Bizkaia;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
48 Bizkaia;All ages;Cohort October 1;Total;Survival in the first trimester;2022QIV;77.254
48 Bizkaia;All ages;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
48 Bizkaia;All ages;Cohort October 1;Total;Survival in the first trimester;2022QII;""
48 Bizkaia;All ages;Cohort October 1;Total;Survival in the first trimester;2022QI;""
48 Bizkaia;All ages;Cohort October 1;Total;Survival in the first trimester;2021QIV;78.251
48 Bizkaia;All ages;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
48 Bizkaia;All ages;Cohort October 1;Total;Survival in the first trimester;2021QII;""
48 Bizkaia;All ages;Cohort October 1;Total;Survival in the first trimester;2021QI;""
48 Bizkaia;All ages;Cohort October 1;Total;Survival in the first trimester;2020QIV;78.167
48 Bizkaia;All ages;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
48 Bizkaia;All ages;Cohort October 1;Total;Survival in the first trimester;2020QII;""
48 Bizkaia;All ages;Cohort October 1;Total;Survival in the first trimester;2020QI;""
48 Bizkaia;All ages;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
48 Bizkaia;All ages;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
48 Bizkaia;All ages;Cohort October 1;Total;Survival in the second trimester;2022QII;""
48 Bizkaia;All ages;Cohort October 1;Total;Survival in the second trimester;2022QI;76.090
48 Bizkaia;All ages;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
48 Bizkaia;All ages;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
48 Bizkaia;All ages;Cohort October 1;Total;Survival in the second trimester;2021QII;""
48 Bizkaia;All ages;Cohort October 1;Total;Survival in the second trimester;2021QI;76.484
48 Bizkaia;All ages;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
48 Bizkaia;All ages;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
48 Bizkaia;All ages;Cohort October 1;Total;Survival in the second trimester;2020QII;""
48 Bizkaia;All ages;Cohort October 1;Total;Survival in the second trimester;2020QI;""
48 Bizkaia;All ages;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
48 Bizkaia;All ages;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
48 Bizkaia;All ages;Cohort October 1;Total;Survival in the third trimester;2022QII;73.881
48 Bizkaia;All ages;Cohort October 1;Total;Survival in the third trimester;2022QI;""
48 Bizkaia;All ages;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
48 Bizkaia;All ages;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
48 Bizkaia;All ages;Cohort October 1;Total;Survival in the third trimester;2021QII;74.561
48 Bizkaia;All ages;Cohort October 1;Total;Survival in the third trimester;2021QI;""
48 Bizkaia;All ages;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
48 Bizkaia;All ages;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
48 Bizkaia;All ages;Cohort October 1;Total;Survival in the third trimester;2020QII;""
48 Bizkaia;All ages;Cohort October 1;Total;Survival in the third trimester;2020QI;""
48 Bizkaia;All ages;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
48 Bizkaia;All ages;Cohort October 1;Total;Survival in the third trimester;2022QIII;72.185
48 Bizkaia;All ages;Cohort October 1;Total;Survival in the third trimester;2022QII;""
48 Bizkaia;All ages;Cohort October 1;Total;Survival in the third trimester;2022QI;""
48 Bizkaia;All ages;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
48 Bizkaia;All ages;Cohort October 1;Total;Survival in the third trimester;2021QIII;72.931
48 Bizkaia;All ages;Cohort October 1;Total;Survival in the third trimester;2021QII;""
48 Bizkaia;All ages;Cohort October 1;Total;Survival in the third trimester;2021QI;""
48 Bizkaia;All ages;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
48 Bizkaia;All ages;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
48 Bizkaia;All ages;Cohort October 1;Total;Survival in the third trimester;2020QII;""
48 Bizkaia;All ages;Cohort October 1;Total;Survival in the third trimester;2020QI;""
48 Bizkaia;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
48 Bizkaia;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
48 Bizkaia;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
48 Bizkaia;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
48 Bizkaia;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
48 Bizkaia;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
48 Bizkaia;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
48 Bizkaia;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
48 Bizkaia;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
48 Bizkaia;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
48 Bizkaia;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
48 Bizkaia;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
48 Bizkaia;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;96,29
48 Bizkaia;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
48 Bizkaia;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
48 Bizkaia;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
48 Bizkaia;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;96,91
48 Bizkaia;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
48 Bizkaia;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
48 Bizkaia;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
48 Bizkaia;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;97,09
48 Bizkaia;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
48 Bizkaia;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
48 Bizkaia;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
48 Bizkaia;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
48 Bizkaia;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
48 Bizkaia;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
48 Bizkaia;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;94,23
48 Bizkaia;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
48 Bizkaia;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
48 Bizkaia;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
48 Bizkaia;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;95
48 Bizkaia;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
48 Bizkaia;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
48 Bizkaia;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
48 Bizkaia;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
48 Bizkaia;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
48 Bizkaia;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
48 Bizkaia;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;91,49
48 Bizkaia;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
48 Bizkaia;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
48 Bizkaia;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
48 Bizkaia;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;92,61
48 Bizkaia;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
48 Bizkaia;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
48 Bizkaia;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
48 Bizkaia;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
48 Bizkaia;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
48 Bizkaia;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
48 Bizkaia;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;89,39
48 Bizkaia;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
48 Bizkaia;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
48 Bizkaia;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
48 Bizkaia;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;90,59
48 Bizkaia;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
48 Bizkaia;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
48 Bizkaia;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
48 Bizkaia;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
48 Bizkaia;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
48 Bizkaia;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
48 Bizkaia;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QIV;47.591
48 Bizkaia;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
48 Bizkaia;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
48 Bizkaia;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
48 Bizkaia;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QIV;48.212
48 Bizkaia;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
48 Bizkaia;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
48 Bizkaia;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
48 Bizkaia;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QIV;48.400
48 Bizkaia;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
48 Bizkaia;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
48 Bizkaia;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
48 Bizkaia;All ages;Cohort October 1;Males;Survival in the first trimester;2022QIV;45.757
48 Bizkaia;All ages;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
48 Bizkaia;All ages;Cohort October 1;Males;Survival in the first trimester;2022QII;""
48 Bizkaia;All ages;Cohort October 1;Males;Survival in the first trimester;2022QI;""
48 Bizkaia;All ages;Cohort October 1;Males;Survival in the first trimester;2021QIV;46.608
48 Bizkaia;All ages;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
48 Bizkaia;All ages;Cohort October 1;Males;Survival in the first trimester;2021QII;""
48 Bizkaia;All ages;Cohort October 1;Males;Survival in the first trimester;2021QI;""
48 Bizkaia;All ages;Cohort October 1;Males;Survival in the first trimester;2020QIV;46.924
48 Bizkaia;All ages;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
48 Bizkaia;All ages;Cohort October 1;Males;Survival in the first trimester;2020QII;""
48 Bizkaia;All ages;Cohort October 1;Males;Survival in the first trimester;2020QI;""
48 Bizkaia;All ages;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
48 Bizkaia;All ages;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
48 Bizkaia;All ages;Cohort October 1;Males;Survival in the second trimester;2022QII;""
48 Bizkaia;All ages;Cohort October 1;Males;Survival in the second trimester;2022QI;45.286
48 Bizkaia;All ages;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
48 Bizkaia;All ages;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
48 Bizkaia;All ages;Cohort October 1;Males;Survival in the second trimester;2021QII;""
48 Bizkaia;All ages;Cohort October 1;Males;Survival in the second trimester;2021QI;45.877
48 Bizkaia;All ages;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
48 Bizkaia;All ages;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
48 Bizkaia;All ages;Cohort October 1;Males;Survival in the second trimester;2020QII;""
48 Bizkaia;All ages;Cohort October 1;Males;Survival in the second trimester;2020QI;""
48 Bizkaia;All ages;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
48 Bizkaia;All ages;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
48 Bizkaia;All ages;Cohort October 1;Males;Survival in the third trimester;2022QII;44.027
48 Bizkaia;All ages;Cohort October 1;Males;Survival in the third trimester;2022QI;""
48 Bizkaia;All ages;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
48 Bizkaia;All ages;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
48 Bizkaia;All ages;Cohort October 1;Males;Survival in the third trimester;2021QII;44.739
48 Bizkaia;All ages;Cohort October 1;Males;Survival in the third trimester;2021QI;""
48 Bizkaia;All ages;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
48 Bizkaia;All ages;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
48 Bizkaia;All ages;Cohort October 1;Males;Survival in the third trimester;2020QII;""
48 Bizkaia;All ages;Cohort October 1;Males;Survival in the third trimester;2020QI;""
48 Bizkaia;All ages;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
48 Bizkaia;All ages;Cohort October 1;Males;Survival in the third trimester;2022QIII;42.999
48 Bizkaia;All ages;Cohort October 1;Males;Survival in the third trimester;2022QII;""
48 Bizkaia;All ages;Cohort October 1;Males;Survival in the third trimester;2022QI;""
48 Bizkaia;All ages;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
48 Bizkaia;All ages;Cohort October 1;Males;Survival in the third trimester;2021QIII;43.768
48 Bizkaia;All ages;Cohort October 1;Males;Survival in the third trimester;2021QII;""
48 Bizkaia;All ages;Cohort October 1;Males;Survival in the third trimester;2021QI;""
48 Bizkaia;All ages;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
48 Bizkaia;All ages;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
48 Bizkaia;All ages;Cohort October 1;Males;Survival in the third trimester;2020QII;""
48 Bizkaia;All ages;Cohort October 1;Males;Survival in the third trimester;2020QI;""
48 Bizkaia;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
48 Bizkaia;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
48 Bizkaia;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
48 Bizkaia;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
48 Bizkaia;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
48 Bizkaia;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
48 Bizkaia;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
48 Bizkaia;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
48 Bizkaia;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
48 Bizkaia;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
48 Bizkaia;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
48 Bizkaia;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
48 Bizkaia;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;96,15
48 Bizkaia;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
48 Bizkaia;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
48 Bizkaia;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
48 Bizkaia;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;96,67
48 Bizkaia;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
48 Bizkaia;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
48 Bizkaia;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
48 Bizkaia;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;96,95
48 Bizkaia;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
48 Bizkaia;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
48 Bizkaia;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
48 Bizkaia;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
48 Bizkaia;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
48 Bizkaia;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
48 Bizkaia;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;93,93
48 Bizkaia;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
48 Bizkaia;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
48 Bizkaia;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
48 Bizkaia;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;94,79
48 Bizkaia;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
48 Bizkaia;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
48 Bizkaia;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
48 Bizkaia;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
48 Bizkaia;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
48 Bizkaia;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
48 Bizkaia;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;91,32
48 Bizkaia;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
48 Bizkaia;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
48 Bizkaia;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
48 Bizkaia;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;92,44
48 Bizkaia;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
48 Bizkaia;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
48 Bizkaia;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
48 Bizkaia;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
48 Bizkaia;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
48 Bizkaia;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
48 Bizkaia;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;89,19
48 Bizkaia;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
48 Bizkaia;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
48 Bizkaia;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
48 Bizkaia;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;90,43
48 Bizkaia;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
48 Bizkaia;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
48 Bizkaia;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
48 Bizkaia;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
48 Bizkaia;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
48 Bizkaia;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
48 Bizkaia;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QIV;32.643
48 Bizkaia;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
48 Bizkaia;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
48 Bizkaia;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
48 Bizkaia;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QIV;32.537
48 Bizkaia;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
48 Bizkaia;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
48 Bizkaia;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
48 Bizkaia;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QIV;32.111
48 Bizkaia;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
48 Bizkaia;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
48 Bizkaia;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
48 Bizkaia;All ages;Cohort October 1;Females;Survival in the first trimester;2022QIV;31.497
48 Bizkaia;All ages;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
48 Bizkaia;All ages;Cohort October 1;Females;Survival in the first trimester;2022QII;""
48 Bizkaia;All ages;Cohort October 1;Females;Survival in the first trimester;2022QI;""
48 Bizkaia;All ages;Cohort October 1;Females;Survival in the first trimester;2021QIV;31.643
48 Bizkaia;All ages;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
48 Bizkaia;All ages;Cohort October 1;Females;Survival in the first trimester;2021QII;""
48 Bizkaia;All ages;Cohort October 1;Females;Survival in the first trimester;2021QI;""
48 Bizkaia;All ages;Cohort October 1;Females;Survival in the first trimester;2020QIV;31.243
48 Bizkaia;All ages;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
48 Bizkaia;All ages;Cohort October 1;Females;Survival in the first trimester;2020QII;""
48 Bizkaia;All ages;Cohort October 1;Females;Survival in the first trimester;2020QI;""
48 Bizkaia;All ages;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
48 Bizkaia;All ages;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
48 Bizkaia;All ages;Cohort October 1;Females;Survival in the second trimester;2022QII;""
48 Bizkaia;All ages;Cohort October 1;Females;Survival in the second trimester;2022QI;30.804
48 Bizkaia;All ages;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
48 Bizkaia;All ages;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
48 Bizkaia;All ages;Cohort October 1;Females;Survival in the second trimester;2021QII;""
48 Bizkaia;All ages;Cohort October 1;Females;Survival in the second trimester;2021QI;30.607
48 Bizkaia;All ages;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
48 Bizkaia;All ages;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
48 Bizkaia;All ages;Cohort October 1;Females;Survival in the second trimester;2020QII;""
48 Bizkaia;All ages;Cohort October 1;Females;Survival in the second trimester;2020QI;""
48 Bizkaia;All ages;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
48 Bizkaia;All ages;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
48 Bizkaia;All ages;Cohort October 1;Females;Survival in the third trimester;2022QII;29.854
48 Bizkaia;All ages;Cohort October 1;Females;Survival in the third trimester;2022QI;""
48 Bizkaia;All ages;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
48 Bizkaia;All ages;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
48 Bizkaia;All ages;Cohort October 1;Females;Survival in the third trimester;2021QII;29.822
48 Bizkaia;All ages;Cohort October 1;Females;Survival in the third trimester;2021QI;""
48 Bizkaia;All ages;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
48 Bizkaia;All ages;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
48 Bizkaia;All ages;Cohort October 1;Females;Survival in the third trimester;2020QII;""
48 Bizkaia;All ages;Cohort October 1;Females;Survival in the third trimester;2020QI;""
48 Bizkaia;All ages;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
48 Bizkaia;All ages;Cohort October 1;Females;Survival in the third trimester;2022QIII;29.186
48 Bizkaia;All ages;Cohort October 1;Females;Survival in the third trimester;2022QII;""
48 Bizkaia;All ages;Cohort October 1;Females;Survival in the third trimester;2022QI;""
48 Bizkaia;All ages;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
48 Bizkaia;All ages;Cohort October 1;Females;Survival in the third trimester;2021QIII;29.163
48 Bizkaia;All ages;Cohort October 1;Females;Survival in the third trimester;2021QII;""
48 Bizkaia;All ages;Cohort October 1;Females;Survival in the third trimester;2021QI;""
48 Bizkaia;All ages;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
48 Bizkaia;All ages;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
48 Bizkaia;All ages;Cohort October 1;Females;Survival in the third trimester;2020QII;""
48 Bizkaia;All ages;Cohort October 1;Females;Survival in the third trimester;2020QI;""
48 Bizkaia;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
48 Bizkaia;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
48 Bizkaia;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
48 Bizkaia;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
48 Bizkaia;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
48 Bizkaia;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
48 Bizkaia;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
48 Bizkaia;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
48 Bizkaia;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
48 Bizkaia;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
48 Bizkaia;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
48 Bizkaia;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
48 Bizkaia;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;96,49
48 Bizkaia;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
48 Bizkaia;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
48 Bizkaia;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
48 Bizkaia;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;97,25
48 Bizkaia;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
48 Bizkaia;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
48 Bizkaia;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
48 Bizkaia;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;97,3
48 Bizkaia;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
48 Bizkaia;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
48 Bizkaia;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
48 Bizkaia;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
48 Bizkaia;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
48 Bizkaia;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
48 Bizkaia;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;94,67
48 Bizkaia;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
48 Bizkaia;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
48 Bizkaia;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
48 Bizkaia;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;95,32
48 Bizkaia;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
48 Bizkaia;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
48 Bizkaia;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
48 Bizkaia;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
48 Bizkaia;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
48 Bizkaia;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
48 Bizkaia;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;91,75
48 Bizkaia;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
48 Bizkaia;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
48 Bizkaia;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
48 Bizkaia;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;92,87
48 Bizkaia;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
48 Bizkaia;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
48 Bizkaia;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
48 Bizkaia;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
48 Bizkaia;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
48 Bizkaia;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
48 Bizkaia;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;89,7
48 Bizkaia;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
48 Bizkaia;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
48 Bizkaia;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
48 Bizkaia;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;90,82
48 Bizkaia;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
48 Bizkaia;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
48 Bizkaia;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
48 Bizkaia;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
48 Bizkaia;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
48 Bizkaia;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
48 Bizkaia;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
48 Bizkaia;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
48 Bizkaia;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
48 Bizkaia;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QI;3.826
48 Bizkaia;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
48 Bizkaia;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
48 Bizkaia;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
48 Bizkaia;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QI;3.597
48 Bizkaia;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
48 Bizkaia;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
48 Bizkaia;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
48 Bizkaia;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QI;3.016
48 Bizkaia;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
48 Bizkaia;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
48 Bizkaia;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2022QII;""
48 Bizkaia;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2022QI;3.555
48 Bizkaia;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
48 Bizkaia;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
48 Bizkaia;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2021QII;""
48 Bizkaia;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2021QI;3.387
48 Bizkaia;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
48 Bizkaia;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
48 Bizkaia;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2020QII;""
48 Bizkaia;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2020QI;2.620
48 Bizkaia;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
48 Bizkaia;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
48 Bizkaia;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2022QII;3.303
48 Bizkaia;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2022QI;""
48 Bizkaia;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
48 Bizkaia;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
48 Bizkaia;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2021QII;3.164
48 Bizkaia;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2021QI;""
48 Bizkaia;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
48 Bizkaia;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
48 Bizkaia;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2020QII;2.520
48 Bizkaia;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2020QI;""
48 Bizkaia;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
48 Bizkaia;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QIII;3.075
48 Bizkaia;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QII;""
48 Bizkaia;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QI;""
48 Bizkaia;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
48 Bizkaia;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QIII;2.980
48 Bizkaia;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QII;""
48 Bizkaia;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QI;""
48 Bizkaia;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
48 Bizkaia;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QIII;2.374
48 Bizkaia;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QII;""
48 Bizkaia;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QI;""
48 Bizkaia;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QIV;2.824
48 Bizkaia;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
48 Bizkaia;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QII;""
48 Bizkaia;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QI;""
48 Bizkaia;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QIV;2.789
48 Bizkaia;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
48 Bizkaia;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QII;""
48 Bizkaia;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QI;""
48 Bizkaia;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QIV;2.237
48 Bizkaia;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
48 Bizkaia;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QII;""
48 Bizkaia;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QI;""
48 Bizkaia;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
48 Bizkaia;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
48 Bizkaia;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
48 Bizkaia;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
48 Bizkaia;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
48 Bizkaia;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
48 Bizkaia;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
48 Bizkaia;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
48 Bizkaia;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
48 Bizkaia;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
48 Bizkaia;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
48 Bizkaia;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
48 Bizkaia;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
48 Bizkaia;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
48 Bizkaia;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
48 Bizkaia;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;92,92
48 Bizkaia;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
48 Bizkaia;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
48 Bizkaia;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
48 Bizkaia;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;94,16
48 Bizkaia;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
48 Bizkaia;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
48 Bizkaia;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
48 Bizkaia;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;86,87
48 Bizkaia;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
48 Bizkaia;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
48 Bizkaia;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;86,33
48 Bizkaia;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
48 Bizkaia;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
48 Bizkaia;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
48 Bizkaia;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;87,96
48 Bizkaia;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
48 Bizkaia;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
48 Bizkaia;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
48 Bizkaia;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;83,55
48 Bizkaia;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
48 Bizkaia;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
48 Bizkaia;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;80,37
48 Bizkaia;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
48 Bizkaia;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
48 Bizkaia;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
48 Bizkaia;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;82,85
48 Bizkaia;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
48 Bizkaia;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
48 Bizkaia;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
48 Bizkaia;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;78,71
48 Bizkaia;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
48 Bizkaia;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
48 Bizkaia;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;73,81
48 Bizkaia;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
48 Bizkaia;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
48 Bizkaia;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
48 Bizkaia;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;77,54
48 Bizkaia;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
48 Bizkaia;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
48 Bizkaia;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
48 Bizkaia;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;74,17
48 Bizkaia;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
48 Bizkaia;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
48 Bizkaia;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
48 Bizkaia;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
48 Bizkaia;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
48 Bizkaia;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
48 Bizkaia;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QI;2.312
48 Bizkaia;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
48 Bizkaia;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
48 Bizkaia;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
48 Bizkaia;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QI;2.217
48 Bizkaia;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
48 Bizkaia;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
48 Bizkaia;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
48 Bizkaia;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QI;1.866
48 Bizkaia;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
48 Bizkaia;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
48 Bizkaia;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2022QII;""
48 Bizkaia;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2022QI;2.126
48 Bizkaia;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
48 Bizkaia;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
48 Bizkaia;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2021QII;""
48 Bizkaia;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2021QI;2.089
48 Bizkaia;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
48 Bizkaia;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
48 Bizkaia;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2020QII;""
48 Bizkaia;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2020QI;1.613
48 Bizkaia;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
48 Bizkaia;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
48 Bizkaia;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2022QII;1.963
48 Bizkaia;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2022QI;""
48 Bizkaia;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
48 Bizkaia;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
48 Bizkaia;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2021QII;1.940
48 Bizkaia;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2021QI;""
48 Bizkaia;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
48 Bizkaia;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
48 Bizkaia;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2020QII;1.548
48 Bizkaia;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2020QI;""
48 Bizkaia;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
48 Bizkaia;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QIII;1.827
48 Bizkaia;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QII;""
48 Bizkaia;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QI;""
48 Bizkaia;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
48 Bizkaia;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QIII;1.836
48 Bizkaia;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QII;""
48 Bizkaia;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QI;""
48 Bizkaia;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
48 Bizkaia;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QIII;1.451
48 Bizkaia;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QII;""
48 Bizkaia;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QI;""
48 Bizkaia;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QIV;1.677
48 Bizkaia;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
48 Bizkaia;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QII;""
48 Bizkaia;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QI;""
48 Bizkaia;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QIV;1.706
48 Bizkaia;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
48 Bizkaia;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QII;""
48 Bizkaia;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QI;""
48 Bizkaia;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QIV;1.371
48 Bizkaia;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
48 Bizkaia;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QII;""
48 Bizkaia;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QI;""
48 Bizkaia;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
48 Bizkaia;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
48 Bizkaia;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
48 Bizkaia;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
48 Bizkaia;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
48 Bizkaia;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
48 Bizkaia;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
48 Bizkaia;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
48 Bizkaia;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
48 Bizkaia;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
48 Bizkaia;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
48 Bizkaia;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
48 Bizkaia;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
48 Bizkaia;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
48 Bizkaia;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
48 Bizkaia;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;91,96
48 Bizkaia;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
48 Bizkaia;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
48 Bizkaia;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
48 Bizkaia;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;94,23
48 Bizkaia;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
48 Bizkaia;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
48 Bizkaia;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
48 Bizkaia;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;86,44
48 Bizkaia;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
48 Bizkaia;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
48 Bizkaia;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;84,9
48 Bizkaia;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
48 Bizkaia;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
48 Bizkaia;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
48 Bizkaia;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;87,51
48 Bizkaia;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
48 Bizkaia;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
48 Bizkaia;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
48 Bizkaia;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;82,96
48 Bizkaia;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
48 Bizkaia;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
48 Bizkaia;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;79,02
48 Bizkaia;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
48 Bizkaia;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
48 Bizkaia;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
48 Bizkaia;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;82,81
48 Bizkaia;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
48 Bizkaia;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
48 Bizkaia;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
48 Bizkaia;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;77,76
48 Bizkaia;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
48 Bizkaia;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
48 Bizkaia;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;72,53
48 Bizkaia;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
48 Bizkaia;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
48 Bizkaia;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
48 Bizkaia;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;76,95
48 Bizkaia;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
48 Bizkaia;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
48 Bizkaia;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
48 Bizkaia;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;73,47
48 Bizkaia;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
48 Bizkaia;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
48 Bizkaia;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
48 Bizkaia;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
48 Bizkaia;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
48 Bizkaia;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
48 Bizkaia;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QI;1.514
48 Bizkaia;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
48 Bizkaia;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
48 Bizkaia;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
48 Bizkaia;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QI;1.380
48 Bizkaia;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
48 Bizkaia;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
48 Bizkaia;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
48 Bizkaia;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QI;1.150
48 Bizkaia;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
48 Bizkaia;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
48 Bizkaia;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2022QII;""
48 Bizkaia;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2022QI;1.429
48 Bizkaia;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
48 Bizkaia;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
48 Bizkaia;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2021QII;""
48 Bizkaia;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2021QI;1.298
48 Bizkaia;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
48 Bizkaia;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
48 Bizkaia;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2020QII;""
48 Bizkaia;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2020QI;1.007
48 Bizkaia;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
48 Bizkaia;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
48 Bizkaia;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2022QII;1.340
48 Bizkaia;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2022QI;""
48 Bizkaia;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
48 Bizkaia;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
48 Bizkaia;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2021QII;1.224
48 Bizkaia;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2021QI;""
48 Bizkaia;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
48 Bizkaia;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
48 Bizkaia;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2020QII;972
48 Bizkaia;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2020QI;""
48 Bizkaia;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
48 Bizkaia;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QIII;1.248
48 Bizkaia;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QII;""
48 Bizkaia;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QI;""
48 Bizkaia;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
48 Bizkaia;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QIII;1.144
48 Bizkaia;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QII;""
48 Bizkaia;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QI;""
48 Bizkaia;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
48 Bizkaia;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QIII;923
48 Bizkaia;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QII;""
48 Bizkaia;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QI;""
48 Bizkaia;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QIV;1.147
48 Bizkaia;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
48 Bizkaia;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QII;""
48 Bizkaia;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QI;""
48 Bizkaia;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QIV;1.083
48 Bizkaia;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
48 Bizkaia;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QII;""
48 Bizkaia;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QI;""
48 Bizkaia;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QIV;866
48 Bizkaia;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
48 Bizkaia;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QII;""
48 Bizkaia;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QI;""
48 Bizkaia;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
48 Bizkaia;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
48 Bizkaia;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
48 Bizkaia;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
48 Bizkaia;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
48 Bizkaia;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
48 Bizkaia;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
48 Bizkaia;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
48 Bizkaia;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
48 Bizkaia;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
48 Bizkaia;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
48 Bizkaia;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
48 Bizkaia;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
48 Bizkaia;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
48 Bizkaia;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
48 Bizkaia;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;94,39
48 Bizkaia;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
48 Bizkaia;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
48 Bizkaia;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
48 Bizkaia;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;94,06
48 Bizkaia;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
48 Bizkaia;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
48 Bizkaia;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
48 Bizkaia;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;87,57
48 Bizkaia;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
48 Bizkaia;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
48 Bizkaia;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;88,51
48 Bizkaia;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
48 Bizkaia;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
48 Bizkaia;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
48 Bizkaia;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;88,7
48 Bizkaia;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
48 Bizkaia;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
48 Bizkaia;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
48 Bizkaia;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;84,52
48 Bizkaia;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
48 Bizkaia;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
48 Bizkaia;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;82,43
48 Bizkaia;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
48 Bizkaia;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
48 Bizkaia;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
48 Bizkaia;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;82,9
48 Bizkaia;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
48 Bizkaia;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
48 Bizkaia;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
48 Bizkaia;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;80,26
48 Bizkaia;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
48 Bizkaia;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
48 Bizkaia;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;75,76
48 Bizkaia;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
48 Bizkaia;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
48 Bizkaia;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
48 Bizkaia;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;78,48
48 Bizkaia;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
48 Bizkaia;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
48 Bizkaia;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
48 Bizkaia;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;75,3
48 Bizkaia;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
48 Bizkaia;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
48 Bizkaia;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
48 Bizkaia;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
48 Bizkaia;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
48 Bizkaia;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QII;3.394
48 Bizkaia;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
48 Bizkaia;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
48 Bizkaia;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
48 Bizkaia;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QII;3.226
48 Bizkaia;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
48 Bizkaia;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
48 Bizkaia;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
48 Bizkaia;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QII;3.020
48 Bizkaia;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
48 Bizkaia;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
48 Bizkaia;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
48 Bizkaia;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2022QII;3.131
48 Bizkaia;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2022QI;""
48 Bizkaia;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
48 Bizkaia;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
48 Bizkaia;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2021QII;2.985
48 Bizkaia;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2021QI;""
48 Bizkaia;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
48 Bizkaia;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
48 Bizkaia;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2020QII;2.902
48 Bizkaia;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2020QI;""
48 Bizkaia;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
48 Bizkaia;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2022QIII;2.891
48 Bizkaia;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2022QII;""
48 Bizkaia;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2022QI;""
48 Bizkaia;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
48 Bizkaia;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2021QIII;2.777
48 Bizkaia;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2021QII;""
48 Bizkaia;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2021QI;""
48 Bizkaia;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
48 Bizkaia;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2020QIII;2.728
48 Bizkaia;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2020QII;""
48 Bizkaia;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2020QI;""
48 Bizkaia;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QIV;2.645
48 Bizkaia;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
48 Bizkaia;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QII;""
48 Bizkaia;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QI;""
48 Bizkaia;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QIV;2.588
48 Bizkaia;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
48 Bizkaia;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QII;""
48 Bizkaia;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QI;""
48 Bizkaia;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QIV;2.560
48 Bizkaia;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
48 Bizkaia;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QII;""
48 Bizkaia;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QI;""
48 Bizkaia;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
48 Bizkaia;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
48 Bizkaia;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QII;""
48 Bizkaia;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QI;2.427
48 Bizkaia;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
48 Bizkaia;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
48 Bizkaia;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QII;""
48 Bizkaia;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QI;2.428
48 Bizkaia;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
48 Bizkaia;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
48 Bizkaia;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QII;""
48 Bizkaia;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QI;""
48 Bizkaia;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
48 Bizkaia;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
48 Bizkaia;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
48 Bizkaia;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
48 Bizkaia;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
48 Bizkaia;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
48 Bizkaia;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
48 Bizkaia;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
48 Bizkaia;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
48 Bizkaia;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
48 Bizkaia;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
48 Bizkaia;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
48 Bizkaia;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
48 Bizkaia;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
48 Bizkaia;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;92,25
48 Bizkaia;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
48 Bizkaia;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
48 Bizkaia;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
48 Bizkaia;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;92,53
48 Bizkaia;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
48 Bizkaia;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
48 Bizkaia;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
48 Bizkaia;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;96,09
48 Bizkaia;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
48 Bizkaia;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
48 Bizkaia;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;85,18
48 Bizkaia;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
48 Bizkaia;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
48 Bizkaia;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
48 Bizkaia;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;86,08
48 Bizkaia;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
48 Bizkaia;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
48 Bizkaia;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
48 Bizkaia;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;90,33
48 Bizkaia;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
48 Bizkaia;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
48 Bizkaia;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;77,93
48 Bizkaia;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
48 Bizkaia;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
48 Bizkaia;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
48 Bizkaia;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;80,22
48 Bizkaia;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
48 Bizkaia;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
48 Bizkaia;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
48 Bizkaia;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;84,77
48 Bizkaia;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
48 Bizkaia;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
48 Bizkaia;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
48 Bizkaia;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
48 Bizkaia;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
48 Bizkaia;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
48 Bizkaia;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;75,23
48 Bizkaia;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
48 Bizkaia;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
48 Bizkaia;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
48 Bizkaia;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;80,4
48 Bizkaia;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
48 Bizkaia;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
48 Bizkaia;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
48 Bizkaia;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
48 Bizkaia;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
48 Bizkaia;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
48 Bizkaia;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QII;2.068
48 Bizkaia;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
48 Bizkaia;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
48 Bizkaia;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
48 Bizkaia;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QII;2.009
48 Bizkaia;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
48 Bizkaia;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
48 Bizkaia;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
48 Bizkaia;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QII;1.884
48 Bizkaia;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
48 Bizkaia;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
48 Bizkaia;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
48 Bizkaia;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2022QII;1.897
48 Bizkaia;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2022QI;""
48 Bizkaia;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
48 Bizkaia;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
48 Bizkaia;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2021QII;1.848
48 Bizkaia;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2021QI;""
48 Bizkaia;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
48 Bizkaia;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
48 Bizkaia;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2020QII;1.805
48 Bizkaia;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2020QI;""
48 Bizkaia;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
48 Bizkaia;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2022QIII;1.744
48 Bizkaia;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2022QII;""
48 Bizkaia;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2022QI;""
48 Bizkaia;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
48 Bizkaia;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2021QIII;1.725
48 Bizkaia;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2021QII;""
48 Bizkaia;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2021QI;""
48 Bizkaia;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
48 Bizkaia;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2020QIII;1.691
48 Bizkaia;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2020QII;""
48 Bizkaia;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2020QI;""
48 Bizkaia;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QIV;1.599
48 Bizkaia;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
48 Bizkaia;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QII;""
48 Bizkaia;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QI;""
48 Bizkaia;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QIV;1.597
48 Bizkaia;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
48 Bizkaia;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QII;""
48 Bizkaia;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QI;""
48 Bizkaia;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QIV;1.592
48 Bizkaia;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
48 Bizkaia;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QII;""
48 Bizkaia;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QI;""
48 Bizkaia;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
48 Bizkaia;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
48 Bizkaia;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QII;""
48 Bizkaia;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QI;1.491
48 Bizkaia;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
48 Bizkaia;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
48 Bizkaia;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QII;""
48 Bizkaia;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QI;1.508
48 Bizkaia;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
48 Bizkaia;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
48 Bizkaia;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QII;""
48 Bizkaia;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QI;""
48 Bizkaia;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
48 Bizkaia;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
48 Bizkaia;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
48 Bizkaia;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
48 Bizkaia;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
48 Bizkaia;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
48 Bizkaia;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
48 Bizkaia;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
48 Bizkaia;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
48 Bizkaia;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
48 Bizkaia;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
48 Bizkaia;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
48 Bizkaia;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
48 Bizkaia;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
48 Bizkaia;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;91,73
48 Bizkaia;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
48 Bizkaia;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
48 Bizkaia;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
48 Bizkaia;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;91,99
48 Bizkaia;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
48 Bizkaia;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
48 Bizkaia;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
48 Bizkaia;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;95,81
48 Bizkaia;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
48 Bizkaia;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
48 Bizkaia;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;84,33
48 Bizkaia;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
48 Bizkaia;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
48 Bizkaia;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
48 Bizkaia;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;85,86
48 Bizkaia;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
48 Bizkaia;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
48 Bizkaia;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
48 Bizkaia;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;89,76
48 Bizkaia;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
48 Bizkaia;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
48 Bizkaia;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;77,32
48 Bizkaia;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
48 Bizkaia;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
48 Bizkaia;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
48 Bizkaia;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;79,49
48 Bizkaia;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
48 Bizkaia;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
48 Bizkaia;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
48 Bizkaia;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;84,5
48 Bizkaia;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
48 Bizkaia;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
48 Bizkaia;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
48 Bizkaia;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
48 Bizkaia;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
48 Bizkaia;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
48 Bizkaia;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;74,22
48 Bizkaia;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
48 Bizkaia;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
48 Bizkaia;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
48 Bizkaia;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;80,04
48 Bizkaia;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
48 Bizkaia;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
48 Bizkaia;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
48 Bizkaia;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
48 Bizkaia;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
48 Bizkaia;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
48 Bizkaia;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QII;1.326
48 Bizkaia;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
48 Bizkaia;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
48 Bizkaia;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
48 Bizkaia;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QII;1.217
48 Bizkaia;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
48 Bizkaia;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
48 Bizkaia;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
48 Bizkaia;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QII;1.136
48 Bizkaia;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
48 Bizkaia;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
48 Bizkaia;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
48 Bizkaia;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2022QII;1.234
48 Bizkaia;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2022QI;""
48 Bizkaia;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
48 Bizkaia;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
48 Bizkaia;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2021QII;1.137
48 Bizkaia;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2021QI;""
48 Bizkaia;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
48 Bizkaia;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
48 Bizkaia;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2020QII;1.097
48 Bizkaia;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2020QI;""
48 Bizkaia;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
48 Bizkaia;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2022QIII;1.147
48 Bizkaia;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2022QII;""
48 Bizkaia;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2022QI;""
48 Bizkaia;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
48 Bizkaia;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2021QIII;1.052
48 Bizkaia;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2021QII;""
48 Bizkaia;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2021QI;""
48 Bizkaia;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
48 Bizkaia;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2020QIII;1.037
48 Bizkaia;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2020QII;""
48 Bizkaia;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2020QI;""
48 Bizkaia;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QIV;1.046
48 Bizkaia;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
48 Bizkaia;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QII;""
48 Bizkaia;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QI;""
48 Bizkaia;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QIV;991
48 Bizkaia;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
48 Bizkaia;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QII;""
48 Bizkaia;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QI;""
48 Bizkaia;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QIV;968
48 Bizkaia;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
48 Bizkaia;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QII;""
48 Bizkaia;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QI;""
48 Bizkaia;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
48 Bizkaia;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
48 Bizkaia;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QII;""
48 Bizkaia;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QI;936
48 Bizkaia;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
48 Bizkaia;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
48 Bizkaia;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QII;""
48 Bizkaia;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QI;920
48 Bizkaia;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
48 Bizkaia;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
48 Bizkaia;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QII;""
48 Bizkaia;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QI;""
48 Bizkaia;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
48 Bizkaia;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
48 Bizkaia;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
48 Bizkaia;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
48 Bizkaia;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
48 Bizkaia;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
48 Bizkaia;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
48 Bizkaia;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
48 Bizkaia;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
48 Bizkaia;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
48 Bizkaia;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
48 Bizkaia;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
48 Bizkaia;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
48 Bizkaia;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
48 Bizkaia;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;93,06
48 Bizkaia;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
48 Bizkaia;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
48 Bizkaia;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
48 Bizkaia;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;93,43
48 Bizkaia;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
48 Bizkaia;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
48 Bizkaia;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
48 Bizkaia;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;96,57
48 Bizkaia;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
48 Bizkaia;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
48 Bizkaia;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;86,5
48 Bizkaia;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
48 Bizkaia;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
48 Bizkaia;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
48 Bizkaia;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;86,44
48 Bizkaia;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
48 Bizkaia;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
48 Bizkaia;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
48 Bizkaia;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;91,29
48 Bizkaia;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
48 Bizkaia;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
48 Bizkaia;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;78,88
48 Bizkaia;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
48 Bizkaia;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
48 Bizkaia;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
48 Bizkaia;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;81,43
48 Bizkaia;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
48 Bizkaia;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
48 Bizkaia;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
48 Bizkaia;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;85,21
48 Bizkaia;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
48 Bizkaia;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
48 Bizkaia;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
48 Bizkaia;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
48 Bizkaia;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
48 Bizkaia;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
48 Bizkaia;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;76,91
48 Bizkaia;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
48 Bizkaia;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
48 Bizkaia;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
48 Bizkaia;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;80,99
48 Bizkaia;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
48 Bizkaia;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
48 Bizkaia;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
48 Bizkaia;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
48 Bizkaia;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
48 Bizkaia;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QIII;3.751
48 Bizkaia;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
48 Bizkaia;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
48 Bizkaia;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
48 Bizkaia;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QIII;3.469
48 Bizkaia;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
48 Bizkaia;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
48 Bizkaia;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
48 Bizkaia;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QIII;3.136
48 Bizkaia;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
48 Bizkaia;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
48 Bizkaia;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
48 Bizkaia;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2022QIII;3.422
48 Bizkaia;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2022QII;""
48 Bizkaia;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2022QI;""
48 Bizkaia;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
48 Bizkaia;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2021QIII;3.185
48 Bizkaia;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2021QII;""
48 Bizkaia;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2021QI;""
48 Bizkaia;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
48 Bizkaia;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2020QIII;2.911
48 Bizkaia;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2020QII;""
48 Bizkaia;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2020QI;""
48 Bizkaia;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2022QIV;3.140
48 Bizkaia;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
48 Bizkaia;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2022QII;""
48 Bizkaia;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2022QI;""
48 Bizkaia;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2021QIV;2.945
48 Bizkaia;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
48 Bizkaia;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2021QII;""
48 Bizkaia;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2021QI;""
48 Bizkaia;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2020QIV;2.730
48 Bizkaia;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
48 Bizkaia;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2020QII;""
48 Bizkaia;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2020QI;""
48 Bizkaia;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
48 Bizkaia;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
48 Bizkaia;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QII;""
48 Bizkaia;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QI;2.751
48 Bizkaia;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
48 Bizkaia;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
48 Bizkaia;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QII;""
48 Bizkaia;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QI;2.583
48 Bizkaia;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
48 Bizkaia;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
48 Bizkaia;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QII;""
48 Bizkaia;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QI;""
48 Bizkaia;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
48 Bizkaia;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
48 Bizkaia;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QII;2.565
48 Bizkaia;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QI;""
48 Bizkaia;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
48 Bizkaia;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
48 Bizkaia;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QII;2.436
48 Bizkaia;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QI;""
48 Bizkaia;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
48 Bizkaia;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
48 Bizkaia;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QII;""
48 Bizkaia;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QI;""
48 Bizkaia;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
48 Bizkaia;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
48 Bizkaia;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
48 Bizkaia;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
48 Bizkaia;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
48 Bizkaia;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
48 Bizkaia;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
48 Bizkaia;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
48 Bizkaia;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
48 Bizkaia;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
48 Bizkaia;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
48 Bizkaia;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
48 Bizkaia;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
48 Bizkaia;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;91,23
48 Bizkaia;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
48 Bizkaia;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
48 Bizkaia;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
48 Bizkaia;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;91,81
48 Bizkaia;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
48 Bizkaia;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
48 Bizkaia;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
48 Bizkaia;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;92,83
48 Bizkaia;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
48 Bizkaia;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
48 Bizkaia;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;83,71
48 Bizkaia;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
48 Bizkaia;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
48 Bizkaia;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
48 Bizkaia;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;84,89
48 Bizkaia;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
48 Bizkaia;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
48 Bizkaia;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
48 Bizkaia;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;87,05
48 Bizkaia;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
48 Bizkaia;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
48 Bizkaia;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
48 Bizkaia;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
48 Bizkaia;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
48 Bizkaia;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
48 Bizkaia;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;79,3
48 Bizkaia;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
48 Bizkaia;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
48 Bizkaia;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
48 Bizkaia;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;82,37
48 Bizkaia;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
48 Bizkaia;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
48 Bizkaia;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
48 Bizkaia;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
48 Bizkaia;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
48 Bizkaia;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
48 Bizkaia;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;73,94
48 Bizkaia;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
48 Bizkaia;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
48 Bizkaia;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
48 Bizkaia;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;77,68
48 Bizkaia;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
48 Bizkaia;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
48 Bizkaia;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
48 Bizkaia;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
48 Bizkaia;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
48 Bizkaia;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
48 Bizkaia;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QIII;2.287
48 Bizkaia;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
48 Bizkaia;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
48 Bizkaia;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
48 Bizkaia;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QIII;2.135
48 Bizkaia;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
48 Bizkaia;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
48 Bizkaia;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
48 Bizkaia;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QIII;1.961
48 Bizkaia;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
48 Bizkaia;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
48 Bizkaia;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
48 Bizkaia;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2022QIII;2.068
48 Bizkaia;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2022QII;""
48 Bizkaia;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2022QI;""
48 Bizkaia;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
48 Bizkaia;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2021QIII;1.961
48 Bizkaia;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2021QII;""
48 Bizkaia;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2021QI;""
48 Bizkaia;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
48 Bizkaia;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2020QIII;1.810
48 Bizkaia;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2020QII;""
48 Bizkaia;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2020QI;""
48 Bizkaia;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2022QIV;1.897
48 Bizkaia;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
48 Bizkaia;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2022QII;""
48 Bizkaia;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2022QI;""
48 Bizkaia;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2021QIV;1.803
48 Bizkaia;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
48 Bizkaia;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2021QII;""
48 Bizkaia;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2021QI;""
48 Bizkaia;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2020QIV;1.699
48 Bizkaia;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
48 Bizkaia;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2020QII;""
48 Bizkaia;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2020QI;""
48 Bizkaia;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
48 Bizkaia;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
48 Bizkaia;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QII;""
48 Bizkaia;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QI;1.676
48 Bizkaia;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
48 Bizkaia;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
48 Bizkaia;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QII;""
48 Bizkaia;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QI;1.612
48 Bizkaia;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
48 Bizkaia;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
48 Bizkaia;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QII;""
48 Bizkaia;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QI;""
48 Bizkaia;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
48 Bizkaia;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
48 Bizkaia;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QII;1.552
48 Bizkaia;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QI;""
48 Bizkaia;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
48 Bizkaia;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
48 Bizkaia;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QII;1.513
48 Bizkaia;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QI;""
48 Bizkaia;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
48 Bizkaia;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
48 Bizkaia;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QII;""
48 Bizkaia;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QI;""
48 Bizkaia;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
48 Bizkaia;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
48 Bizkaia;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
48 Bizkaia;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
48 Bizkaia;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
48 Bizkaia;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
48 Bizkaia;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
48 Bizkaia;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
48 Bizkaia;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
48 Bizkaia;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
48 Bizkaia;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
48 Bizkaia;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
48 Bizkaia;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
48 Bizkaia;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;90,42
48 Bizkaia;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
48 Bizkaia;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
48 Bizkaia;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
48 Bizkaia;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;91,85
48 Bizkaia;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
48 Bizkaia;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
48 Bizkaia;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
48 Bizkaia;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;92,3
48 Bizkaia;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
48 Bizkaia;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
48 Bizkaia;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;82,95
48 Bizkaia;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
48 Bizkaia;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
48 Bizkaia;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
48 Bizkaia;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;84,45
48 Bizkaia;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
48 Bizkaia;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
48 Bizkaia;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
48 Bizkaia;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;86,64
48 Bizkaia;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
48 Bizkaia;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
48 Bizkaia;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
48 Bizkaia;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
48 Bizkaia;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
48 Bizkaia;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
48 Bizkaia;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;78,5
48 Bizkaia;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
48 Bizkaia;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
48 Bizkaia;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
48 Bizkaia;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;82,2
48 Bizkaia;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
48 Bizkaia;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
48 Bizkaia;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
48 Bizkaia;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
48 Bizkaia;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
48 Bizkaia;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
48 Bizkaia;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;72,69
48 Bizkaia;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
48 Bizkaia;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
48 Bizkaia;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
48 Bizkaia;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;77,15
48 Bizkaia;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
48 Bizkaia;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
48 Bizkaia;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
48 Bizkaia;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
48 Bizkaia;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
48 Bizkaia;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
48 Bizkaia;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QIII;1.464
48 Bizkaia;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
48 Bizkaia;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
48 Bizkaia;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
48 Bizkaia;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QIII;1.334
48 Bizkaia;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
48 Bizkaia;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
48 Bizkaia;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
48 Bizkaia;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QIII;1.175
48 Bizkaia;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
48 Bizkaia;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
48 Bizkaia;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
48 Bizkaia;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2022QIII;1.354
48 Bizkaia;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2022QII;""
48 Bizkaia;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2022QI;""
48 Bizkaia;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
48 Bizkaia;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2021QIII;1.224
48 Bizkaia;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2021QII;""
48 Bizkaia;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2021QI;""
48 Bizkaia;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
48 Bizkaia;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2020QIII;1.101
48 Bizkaia;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2020QII;""
48 Bizkaia;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2020QI;""
48 Bizkaia;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2022QIV;1.243
48 Bizkaia;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
48 Bizkaia;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2022QII;""
48 Bizkaia;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2022QI;""
48 Bizkaia;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2021QIV;1.142
48 Bizkaia;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
48 Bizkaia;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2021QII;""
48 Bizkaia;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2021QI;""
48 Bizkaia;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2020QIV;1.031
48 Bizkaia;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
48 Bizkaia;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2020QII;""
48 Bizkaia;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2020QI;""
48 Bizkaia;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
48 Bizkaia;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
48 Bizkaia;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QII;""
48 Bizkaia;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QI;1.075
48 Bizkaia;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
48 Bizkaia;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
48 Bizkaia;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QII;""
48 Bizkaia;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QI;971
48 Bizkaia;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
48 Bizkaia;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
48 Bizkaia;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QII;""
48 Bizkaia;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QI;""
48 Bizkaia;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
48 Bizkaia;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
48 Bizkaia;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QII;1.013
48 Bizkaia;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QI;""
48 Bizkaia;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
48 Bizkaia;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
48 Bizkaia;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QII;923
48 Bizkaia;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QI;""
48 Bizkaia;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
48 Bizkaia;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
48 Bizkaia;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QII;""
48 Bizkaia;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QI;""
48 Bizkaia;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
48 Bizkaia;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
48 Bizkaia;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
48 Bizkaia;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
48 Bizkaia;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
48 Bizkaia;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
48 Bizkaia;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
48 Bizkaia;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
48 Bizkaia;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
48 Bizkaia;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
48 Bizkaia;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
48 Bizkaia;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
48 Bizkaia;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
48 Bizkaia;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;92,49
48 Bizkaia;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
48 Bizkaia;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
48 Bizkaia;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
48 Bizkaia;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;91,75
48 Bizkaia;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
48 Bizkaia;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
48 Bizkaia;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
48 Bizkaia;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;93,7
48 Bizkaia;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
48 Bizkaia;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
48 Bizkaia;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;84,9
48 Bizkaia;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
48 Bizkaia;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
48 Bizkaia;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
48 Bizkaia;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;85,61
48 Bizkaia;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
48 Bizkaia;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
48 Bizkaia;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
48 Bizkaia;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;87,74
48 Bizkaia;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
48 Bizkaia;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
48 Bizkaia;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
48 Bizkaia;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
48 Bizkaia;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
48 Bizkaia;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
48 Bizkaia;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;80,58
48 Bizkaia;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
48 Bizkaia;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
48 Bizkaia;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
48 Bizkaia;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;82,64
48 Bizkaia;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
48 Bizkaia;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
48 Bizkaia;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
48 Bizkaia;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
48 Bizkaia;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
48 Bizkaia;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
48 Bizkaia;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;75,94
48 Bizkaia;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
48 Bizkaia;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
48 Bizkaia;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
48 Bizkaia;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;78,55
48 Bizkaia;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
48 Bizkaia;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
48 Bizkaia;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
48 Bizkaia;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
48 Bizkaia;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
48 Bizkaia;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QIV;3.870
48 Bizkaia;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
48 Bizkaia;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
48 Bizkaia;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
48 Bizkaia;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QIV;3.602
48 Bizkaia;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
48 Bizkaia;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
48 Bizkaia;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
48 Bizkaia;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QIV;3.317
48 Bizkaia;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
48 Bizkaia;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
48 Bizkaia;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
48 Bizkaia;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2022QIV;3.552
48 Bizkaia;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
48 Bizkaia;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2022QII;""
48 Bizkaia;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2022QI;""
48 Bizkaia;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2021QIV;3.327
48 Bizkaia;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
48 Bizkaia;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2021QII;""
48 Bizkaia;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2021QI;""
48 Bizkaia;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2020QIV;3.086
48 Bizkaia;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
48 Bizkaia;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2020QII;""
48 Bizkaia;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2020QI;""
48 Bizkaia;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
48 Bizkaia;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
48 Bizkaia;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2022QII;""
48 Bizkaia;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2022QI;3.105
48 Bizkaia;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
48 Bizkaia;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
48 Bizkaia;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2021QII;""
48 Bizkaia;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2021QI;2.919
48 Bizkaia;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
48 Bizkaia;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
48 Bizkaia;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2020QII;""
48 Bizkaia;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2020QI;""
48 Bizkaia;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
48 Bizkaia;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
48 Bizkaia;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QII;2.898
48 Bizkaia;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QI;""
48 Bizkaia;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
48 Bizkaia;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
48 Bizkaia;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QII;2.737
48 Bizkaia;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QI;""
48 Bizkaia;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
48 Bizkaia;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
48 Bizkaia;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QII;""
48 Bizkaia;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QI;""
48 Bizkaia;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
48 Bizkaia;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QIII;2.707
48 Bizkaia;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QII;""
48 Bizkaia;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QI;""
48 Bizkaia;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
48 Bizkaia;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QIII;2.591
48 Bizkaia;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QII;""
48 Bizkaia;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QI;""
48 Bizkaia;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
48 Bizkaia;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
48 Bizkaia;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QII;""
48 Bizkaia;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QI;""
48 Bizkaia;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
48 Bizkaia;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
48 Bizkaia;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
48 Bizkaia;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
48 Bizkaia;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
48 Bizkaia;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
48 Bizkaia;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
48 Bizkaia;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
48 Bizkaia;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
48 Bizkaia;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
48 Bizkaia;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
48 Bizkaia;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
48 Bizkaia;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;91,78
48 Bizkaia;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
48 Bizkaia;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
48 Bizkaia;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
48 Bizkaia;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;92,37
48 Bizkaia;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
48 Bizkaia;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
48 Bizkaia;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
48 Bizkaia;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;93,04
48 Bizkaia;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
48 Bizkaia;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
48 Bizkaia;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
48 Bizkaia;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
48 Bizkaia;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
48 Bizkaia;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
48 Bizkaia;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;86,2
48 Bizkaia;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
48 Bizkaia;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
48 Bizkaia;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
48 Bizkaia;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;88
48 Bizkaia;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
48 Bizkaia;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
48 Bizkaia;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
48 Bizkaia;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
48 Bizkaia;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
48 Bizkaia;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
48 Bizkaia;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;80,46
48 Bizkaia;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
48 Bizkaia;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
48 Bizkaia;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
48 Bizkaia;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;82,51
48 Bizkaia;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
48 Bizkaia;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
48 Bizkaia;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
48 Bizkaia;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
48 Bizkaia;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
48 Bizkaia;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
48 Bizkaia;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;75,15
48 Bizkaia;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
48 Bizkaia;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
48 Bizkaia;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
48 Bizkaia;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;78,11
48 Bizkaia;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
48 Bizkaia;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
48 Bizkaia;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
48 Bizkaia;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
48 Bizkaia;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
48 Bizkaia;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
48 Bizkaia;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QIV;2.347
48 Bizkaia;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
48 Bizkaia;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
48 Bizkaia;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
48 Bizkaia;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QIV;2.215
48 Bizkaia;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
48 Bizkaia;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
48 Bizkaia;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
48 Bizkaia;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QIV;2.064
48 Bizkaia;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
48 Bizkaia;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
48 Bizkaia;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
48 Bizkaia;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2022QIV;2.150
48 Bizkaia;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
48 Bizkaia;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2022QII;""
48 Bizkaia;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2022QI;""
48 Bizkaia;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2021QIV;2.030
48 Bizkaia;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
48 Bizkaia;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2021QII;""
48 Bizkaia;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2021QI;""
48 Bizkaia;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2020QIV;1.918
48 Bizkaia;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
48 Bizkaia;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2020QII;""
48 Bizkaia;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2020QI;""
48 Bizkaia;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
48 Bizkaia;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
48 Bizkaia;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2022QII;""
48 Bizkaia;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2022QI;1.884
48 Bizkaia;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
48 Bizkaia;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
48 Bizkaia;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2021QII;""
48 Bizkaia;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2021QI;1.819
48 Bizkaia;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
48 Bizkaia;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
48 Bizkaia;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2020QII;""
48 Bizkaia;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2020QI;""
48 Bizkaia;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
48 Bizkaia;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
48 Bizkaia;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QII;1.747
48 Bizkaia;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QI;""
48 Bizkaia;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
48 Bizkaia;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
48 Bizkaia;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QII;1.698
48 Bizkaia;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QI;""
48 Bizkaia;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
48 Bizkaia;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
48 Bizkaia;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QII;""
48 Bizkaia;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QI;""
48 Bizkaia;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
48 Bizkaia;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QIII;1.630
48 Bizkaia;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QII;""
48 Bizkaia;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QI;""
48 Bizkaia;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
48 Bizkaia;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QIII;1.614
48 Bizkaia;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QII;""
48 Bizkaia;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QI;""
48 Bizkaia;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
48 Bizkaia;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
48 Bizkaia;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QII;""
48 Bizkaia;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QI;""
48 Bizkaia;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
48 Bizkaia;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
48 Bizkaia;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
48 Bizkaia;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
48 Bizkaia;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
48 Bizkaia;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
48 Bizkaia;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
48 Bizkaia;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
48 Bizkaia;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
48 Bizkaia;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
48 Bizkaia;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
48 Bizkaia;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
48 Bizkaia;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;91,61
48 Bizkaia;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
48 Bizkaia;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
48 Bizkaia;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
48 Bizkaia;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;91,65
48 Bizkaia;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
48 Bizkaia;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
48 Bizkaia;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
48 Bizkaia;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;92,93
48 Bizkaia;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
48 Bizkaia;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
48 Bizkaia;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
48 Bizkaia;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
48 Bizkaia;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
48 Bizkaia;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
48 Bizkaia;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;85,06
48 Bizkaia;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
48 Bizkaia;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
48 Bizkaia;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
48 Bizkaia;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;88,13
48 Bizkaia;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
48 Bizkaia;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
48 Bizkaia;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
48 Bizkaia;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
48 Bizkaia;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
48 Bizkaia;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
48 Bizkaia;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;78,87
48 Bizkaia;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
48 Bizkaia;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
48 Bizkaia;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
48 Bizkaia;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;82,27
48 Bizkaia;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
48 Bizkaia;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
48 Bizkaia;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
48 Bizkaia;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
48 Bizkaia;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
48 Bizkaia;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
48 Bizkaia;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;73,59
48 Bizkaia;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
48 Bizkaia;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
48 Bizkaia;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
48 Bizkaia;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;78,2
48 Bizkaia;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
48 Bizkaia;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
48 Bizkaia;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
48 Bizkaia;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
48 Bizkaia;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
48 Bizkaia;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
48 Bizkaia;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QIV;1.523
48 Bizkaia;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
48 Bizkaia;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
48 Bizkaia;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
48 Bizkaia;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QIV;1.387
48 Bizkaia;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
48 Bizkaia;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
48 Bizkaia;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
48 Bizkaia;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QIV;1.253
48 Bizkaia;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
48 Bizkaia;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
48 Bizkaia;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
48 Bizkaia;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2022QIV;1.402
48 Bizkaia;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
48 Bizkaia;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2022QII;""
48 Bizkaia;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2022QI;""
48 Bizkaia;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2021QIV;1.297
48 Bizkaia;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
48 Bizkaia;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2021QII;""
48 Bizkaia;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2021QI;""
48 Bizkaia;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2020QIV;1.168
48 Bizkaia;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
48 Bizkaia;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2020QII;""
48 Bizkaia;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2020QI;""
48 Bizkaia;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
48 Bizkaia;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
48 Bizkaia;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2022QII;""
48 Bizkaia;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2022QI;1.221
48 Bizkaia;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
48 Bizkaia;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
48 Bizkaia;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2021QII;""
48 Bizkaia;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2021QI;1.100
48 Bizkaia;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
48 Bizkaia;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
48 Bizkaia;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2020QII;""
48 Bizkaia;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2020QI;""
48 Bizkaia;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
48 Bizkaia;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
48 Bizkaia;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QII;1.151
48 Bizkaia;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QI;""
48 Bizkaia;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
48 Bizkaia;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
48 Bizkaia;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QII;1.039
48 Bizkaia;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QI;""
48 Bizkaia;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
48 Bizkaia;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
48 Bizkaia;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QII;""
48 Bizkaia;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QI;""
48 Bizkaia;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
48 Bizkaia;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QIII;1.077
48 Bizkaia;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QII;""
48 Bizkaia;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QI;""
48 Bizkaia;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
48 Bizkaia;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QIII;977
48 Bizkaia;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QII;""
48 Bizkaia;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QI;""
48 Bizkaia;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
48 Bizkaia;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
48 Bizkaia;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QII;""
48 Bizkaia;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QI;""
48 Bizkaia;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
48 Bizkaia;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
48 Bizkaia;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
48 Bizkaia;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
48 Bizkaia;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
48 Bizkaia;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
48 Bizkaia;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
48 Bizkaia;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
48 Bizkaia;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
48 Bizkaia;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
48 Bizkaia;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
48 Bizkaia;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
48 Bizkaia;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;92,06
48 Bizkaia;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
48 Bizkaia;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
48 Bizkaia;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
48 Bizkaia;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;93,51
48 Bizkaia;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
48 Bizkaia;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
48 Bizkaia;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
48 Bizkaia;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;93,22
48 Bizkaia;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
48 Bizkaia;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
48 Bizkaia;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
48 Bizkaia;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
48 Bizkaia;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
48 Bizkaia;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
48 Bizkaia;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;88,03
48 Bizkaia;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
48 Bizkaia;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
48 Bizkaia;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
48 Bizkaia;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;87,79
48 Bizkaia;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
48 Bizkaia;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
48 Bizkaia;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
48 Bizkaia;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
48 Bizkaia;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
48 Bizkaia;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
48 Bizkaia;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;82,98
48 Bizkaia;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
48 Bizkaia;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
48 Bizkaia;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
48 Bizkaia;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;82,92
48 Bizkaia;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
48 Bizkaia;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
48 Bizkaia;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
48 Bizkaia;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
48 Bizkaia;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
48 Bizkaia;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
48 Bizkaia;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;77,65
48 Bizkaia;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
48 Bizkaia;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
48 Bizkaia;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
48 Bizkaia;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;77,97
48 Bizkaia;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
48 Bizkaia;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
48 Bizkaia;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
48 Bizkaia;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
48 Bizkaia;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
48 Bizkaia;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
48 Bizkaia;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
48 Bizkaia;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
48 Bizkaia;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
48 Bizkaia;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QI;12.397
48 Bizkaia;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
48 Bizkaia;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
48 Bizkaia;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
48 Bizkaia;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QI;12.840
48 Bizkaia;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
48 Bizkaia;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
48 Bizkaia;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
48 Bizkaia;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QI;12.376
48 Bizkaia;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
48 Bizkaia;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
48 Bizkaia;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2022QII;""
48 Bizkaia;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2022QI;11.875
48 Bizkaia;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
48 Bizkaia;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
48 Bizkaia;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2021QII;""
48 Bizkaia;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2021QI;12.443
48 Bizkaia;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
48 Bizkaia;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
48 Bizkaia;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2020QII;""
48 Bizkaia;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2020QI;11.586
48 Bizkaia;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
48 Bizkaia;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
48 Bizkaia;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2022QII;11.310
48 Bizkaia;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2022QI;""
48 Bizkaia;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
48 Bizkaia;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
48 Bizkaia;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2021QII;11.950
48 Bizkaia;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2021QI;""
48 Bizkaia;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
48 Bizkaia;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
48 Bizkaia;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2020QII;11.259
48 Bizkaia;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2020QI;""
48 Bizkaia;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
48 Bizkaia;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QIII;10.960
48 Bizkaia;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QII;""
48 Bizkaia;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QI;""
48 Bizkaia;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
48 Bizkaia;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QIII;11.579
48 Bizkaia;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QII;""
48 Bizkaia;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QI;""
48 Bizkaia;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
48 Bizkaia;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QIII;10.896
48 Bizkaia;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QII;""
48 Bizkaia;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QI;""
48 Bizkaia;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QIV;10.555
48 Bizkaia;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
48 Bizkaia;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QII;""
48 Bizkaia;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QI;""
48 Bizkaia;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QIV;11.185
48 Bizkaia;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
48 Bizkaia;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QII;""
48 Bizkaia;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QI;""
48 Bizkaia;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QIV;10.577
48 Bizkaia;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
48 Bizkaia;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QII;""
48 Bizkaia;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QI;""
48 Bizkaia;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
48 Bizkaia;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
48 Bizkaia;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
48 Bizkaia;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
48 Bizkaia;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
48 Bizkaia;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
48 Bizkaia;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
48 Bizkaia;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
48 Bizkaia;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
48 Bizkaia;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
48 Bizkaia;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
48 Bizkaia;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
48 Bizkaia;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
48 Bizkaia;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
48 Bizkaia;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
48 Bizkaia;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;95,79
48 Bizkaia;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
48 Bizkaia;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
48 Bizkaia;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
48 Bizkaia;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;96,91
48 Bizkaia;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
48 Bizkaia;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
48 Bizkaia;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
48 Bizkaia;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;93,62
48 Bizkaia;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
48 Bizkaia;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
48 Bizkaia;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;91,23
48 Bizkaia;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
48 Bizkaia;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
48 Bizkaia;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
48 Bizkaia;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;93,07
48 Bizkaia;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
48 Bizkaia;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
48 Bizkaia;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
48 Bizkaia;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;90,97
48 Bizkaia;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
48 Bizkaia;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
48 Bizkaia;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;88,41
48 Bizkaia;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
48 Bizkaia;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
48 Bizkaia;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
48 Bizkaia;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;90,18
48 Bizkaia;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
48 Bizkaia;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
48 Bizkaia;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
48 Bizkaia;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;88,04
48 Bizkaia;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
48 Bizkaia;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
48 Bizkaia;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;85,14
48 Bizkaia;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
48 Bizkaia;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
48 Bizkaia;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
48 Bizkaia;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;87,11
48 Bizkaia;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
48 Bizkaia;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
48 Bizkaia;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
48 Bizkaia;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;85,46
48 Bizkaia;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
48 Bizkaia;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
48 Bizkaia;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
48 Bizkaia;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
48 Bizkaia;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
48 Bizkaia;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
48 Bizkaia;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QI;7.117
48 Bizkaia;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
48 Bizkaia;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
48 Bizkaia;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
48 Bizkaia;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QI;7.451
48 Bizkaia;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
48 Bizkaia;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
48 Bizkaia;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
48 Bizkaia;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QI;7.129
48 Bizkaia;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
48 Bizkaia;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
48 Bizkaia;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2022QII;""
48 Bizkaia;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2022QI;6.804
48 Bizkaia;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
48 Bizkaia;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
48 Bizkaia;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2021QII;""
48 Bizkaia;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2021QI;7.210
48 Bizkaia;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
48 Bizkaia;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
48 Bizkaia;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2020QII;""
48 Bizkaia;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2020QI;6.687
48 Bizkaia;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
48 Bizkaia;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
48 Bizkaia;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2022QII;6.512
48 Bizkaia;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2022QI;""
48 Bizkaia;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
48 Bizkaia;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
48 Bizkaia;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2021QII;6.945
48 Bizkaia;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2021QI;""
48 Bizkaia;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
48 Bizkaia;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
48 Bizkaia;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2020QII;6.544
48 Bizkaia;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2020QI;""
48 Bizkaia;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
48 Bizkaia;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QIII;6.301
48 Bizkaia;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QII;""
48 Bizkaia;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QI;""
48 Bizkaia;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
48 Bizkaia;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QIII;6.725
48 Bizkaia;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QII;""
48 Bizkaia;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QI;""
48 Bizkaia;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
48 Bizkaia;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QIII;6.325
48 Bizkaia;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QII;""
48 Bizkaia;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QI;""
48 Bizkaia;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QIV;6.064
48 Bizkaia;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
48 Bizkaia;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QII;""
48 Bizkaia;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QI;""
48 Bizkaia;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QIV;6.480
48 Bizkaia;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
48 Bizkaia;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QII;""
48 Bizkaia;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QI;""
48 Bizkaia;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QIV;6.137
48 Bizkaia;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
48 Bizkaia;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QII;""
48 Bizkaia;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QI;""
48 Bizkaia;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
48 Bizkaia;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
48 Bizkaia;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
48 Bizkaia;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
48 Bizkaia;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
48 Bizkaia;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
48 Bizkaia;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
48 Bizkaia;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
48 Bizkaia;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
48 Bizkaia;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
48 Bizkaia;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
48 Bizkaia;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
48 Bizkaia;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
48 Bizkaia;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
48 Bizkaia;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
48 Bizkaia;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;95,6
48 Bizkaia;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
48 Bizkaia;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
48 Bizkaia;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
48 Bizkaia;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;96,77
48 Bizkaia;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
48 Bizkaia;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
48 Bizkaia;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
48 Bizkaia;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;93,8
48 Bizkaia;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
48 Bizkaia;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
48 Bizkaia;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;91,5
48 Bizkaia;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
48 Bizkaia;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
48 Bizkaia;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
48 Bizkaia;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;93,21
48 Bizkaia;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
48 Bizkaia;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
48 Bizkaia;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
48 Bizkaia;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;91,79
48 Bizkaia;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
48 Bizkaia;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
48 Bizkaia;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;88,53
48 Bizkaia;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
48 Bizkaia;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
48 Bizkaia;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
48 Bizkaia;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;90,26
48 Bizkaia;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
48 Bizkaia;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
48 Bizkaia;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
48 Bizkaia;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;88,72
48 Bizkaia;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
48 Bizkaia;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
48 Bizkaia;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;85,2
48 Bizkaia;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
48 Bizkaia;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
48 Bizkaia;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
48 Bizkaia;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;86,97
48 Bizkaia;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
48 Bizkaia;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
48 Bizkaia;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
48 Bizkaia;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;86,09
48 Bizkaia;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
48 Bizkaia;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
48 Bizkaia;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
48 Bizkaia;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
48 Bizkaia;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
48 Bizkaia;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
48 Bizkaia;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QI;5.280
48 Bizkaia;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
48 Bizkaia;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
48 Bizkaia;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
48 Bizkaia;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QI;5.389
48 Bizkaia;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
48 Bizkaia;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
48 Bizkaia;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
48 Bizkaia;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QI;5.247
48 Bizkaia;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
48 Bizkaia;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
48 Bizkaia;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2022QII;""
48 Bizkaia;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2022QI;5.071
48 Bizkaia;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
48 Bizkaia;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
48 Bizkaia;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2021QII;""
48 Bizkaia;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2021QI;5.233
48 Bizkaia;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
48 Bizkaia;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
48 Bizkaia;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2020QII;""
48 Bizkaia;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2020QI;4.899
48 Bizkaia;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
48 Bizkaia;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
48 Bizkaia;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2022QII;4.798
48 Bizkaia;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2022QI;""
48 Bizkaia;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
48 Bizkaia;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
48 Bizkaia;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2021QII;5.005
48 Bizkaia;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2021QI;""
48 Bizkaia;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
48 Bizkaia;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
48 Bizkaia;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2020QII;4.715
48 Bizkaia;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2020QI;""
48 Bizkaia;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
48 Bizkaia;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QIII;4.659
48 Bizkaia;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QII;""
48 Bizkaia;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QI;""
48 Bizkaia;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
48 Bizkaia;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QIII;4.854
48 Bizkaia;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QII;""
48 Bizkaia;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QI;""
48 Bizkaia;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
48 Bizkaia;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QIII;4.571
48 Bizkaia;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QII;""
48 Bizkaia;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QI;""
48 Bizkaia;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QIV;4.491
48 Bizkaia;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
48 Bizkaia;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QII;""
48 Bizkaia;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QI;""
48 Bizkaia;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QIV;4.705
48 Bizkaia;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
48 Bizkaia;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QII;""
48 Bizkaia;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QI;""
48 Bizkaia;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QIV;4.440
48 Bizkaia;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
48 Bizkaia;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QII;""
48 Bizkaia;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QI;""
48 Bizkaia;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
48 Bizkaia;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
48 Bizkaia;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
48 Bizkaia;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
48 Bizkaia;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
48 Bizkaia;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
48 Bizkaia;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
48 Bizkaia;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
48 Bizkaia;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
48 Bizkaia;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
48 Bizkaia;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
48 Bizkaia;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
48 Bizkaia;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
48 Bizkaia;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
48 Bizkaia;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
48 Bizkaia;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;96,04
48 Bizkaia;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
48 Bizkaia;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
48 Bizkaia;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
48 Bizkaia;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;97,11
48 Bizkaia;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
48 Bizkaia;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
48 Bizkaia;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
48 Bizkaia;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;93,37
48 Bizkaia;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
48 Bizkaia;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
48 Bizkaia;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;90,87
48 Bizkaia;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
48 Bizkaia;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
48 Bizkaia;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
48 Bizkaia;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;92,87
48 Bizkaia;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
48 Bizkaia;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
48 Bizkaia;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
48 Bizkaia;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;89,86
48 Bizkaia;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
48 Bizkaia;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
48 Bizkaia;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;88,24
48 Bizkaia;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
48 Bizkaia;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
48 Bizkaia;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
48 Bizkaia;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;90,07
48 Bizkaia;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
48 Bizkaia;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
48 Bizkaia;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
48 Bizkaia;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;87,12
48 Bizkaia;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
48 Bizkaia;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
48 Bizkaia;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;85,06
48 Bizkaia;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
48 Bizkaia;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
48 Bizkaia;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
48 Bizkaia;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;87,31
48 Bizkaia;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
48 Bizkaia;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
48 Bizkaia;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
48 Bizkaia;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;84,62
48 Bizkaia;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
48 Bizkaia;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
48 Bizkaia;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
48 Bizkaia;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
48 Bizkaia;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
48 Bizkaia;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QII;11.529
48 Bizkaia;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
48 Bizkaia;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
48 Bizkaia;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
48 Bizkaia;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QII;11.972
48 Bizkaia;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
48 Bizkaia;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
48 Bizkaia;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
48 Bizkaia;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QII;12.320
48 Bizkaia;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
48 Bizkaia;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
48 Bizkaia;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
48 Bizkaia;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2022QII;10.917
48 Bizkaia;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2022QI;""
48 Bizkaia;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
48 Bizkaia;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
48 Bizkaia;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2021QII;11.462
48 Bizkaia;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2021QI;""
48 Bizkaia;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
48 Bizkaia;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
48 Bizkaia;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2020QII;11.964
48 Bizkaia;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2020QI;""
48 Bizkaia;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
48 Bizkaia;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2022QIII;10.550
48 Bizkaia;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2022QII;""
48 Bizkaia;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2022QI;""
48 Bizkaia;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
48 Bizkaia;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2021QIII;11.058
48 Bizkaia;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2021QII;""
48 Bizkaia;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2021QI;""
48 Bizkaia;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
48 Bizkaia;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2020QIII;11.555
48 Bizkaia;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2020QII;""
48 Bizkaia;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2020QI;""
48 Bizkaia;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QIV;10.104
48 Bizkaia;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
48 Bizkaia;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QII;""
48 Bizkaia;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QI;""
48 Bizkaia;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QIV;10.637
48 Bizkaia;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
48 Bizkaia;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QII;""
48 Bizkaia;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QI;""
48 Bizkaia;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QIV;11.185
48 Bizkaia;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
48 Bizkaia;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QII;""
48 Bizkaia;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QI;""
48 Bizkaia;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
48 Bizkaia;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
48 Bizkaia;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QII;""
48 Bizkaia;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QI;10.239
48 Bizkaia;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
48 Bizkaia;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
48 Bizkaia;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QII;""
48 Bizkaia;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QI;10.886
48 Bizkaia;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
48 Bizkaia;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
48 Bizkaia;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QII;""
48 Bizkaia;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QI;""
48 Bizkaia;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
48 Bizkaia;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
48 Bizkaia;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
48 Bizkaia;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
48 Bizkaia;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
48 Bizkaia;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
48 Bizkaia;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
48 Bizkaia;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
48 Bizkaia;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
48 Bizkaia;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
48 Bizkaia;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
48 Bizkaia;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
48 Bizkaia;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
48 Bizkaia;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
48 Bizkaia;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;94,69
48 Bizkaia;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
48 Bizkaia;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
48 Bizkaia;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
48 Bizkaia;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;95,74
48 Bizkaia;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
48 Bizkaia;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
48 Bizkaia;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
48 Bizkaia;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;97,11
48 Bizkaia;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
48 Bizkaia;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
48 Bizkaia;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;91,51
48 Bizkaia;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
48 Bizkaia;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
48 Bizkaia;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
48 Bizkaia;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;92,37
48 Bizkaia;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
48 Bizkaia;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
48 Bizkaia;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
48 Bizkaia;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;93,79
48 Bizkaia;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
48 Bizkaia;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
48 Bizkaia;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;87,64
48 Bizkaia;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
48 Bizkaia;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
48 Bizkaia;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
48 Bizkaia;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;88,85
48 Bizkaia;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
48 Bizkaia;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
48 Bizkaia;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
48 Bizkaia;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;90,79
48 Bizkaia;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
48 Bizkaia;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
48 Bizkaia;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
48 Bizkaia;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
48 Bizkaia;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
48 Bizkaia;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
48 Bizkaia;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;85,52
48 Bizkaia;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
48 Bizkaia;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
48 Bizkaia;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
48 Bizkaia;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;88,36
48 Bizkaia;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
48 Bizkaia;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
48 Bizkaia;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
48 Bizkaia;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
48 Bizkaia;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
48 Bizkaia;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
48 Bizkaia;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QII;6.609
48 Bizkaia;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
48 Bizkaia;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
48 Bizkaia;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
48 Bizkaia;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QII;6.971
48 Bizkaia;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
48 Bizkaia;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
48 Bizkaia;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
48 Bizkaia;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QII;7.141
48 Bizkaia;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
48 Bizkaia;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
48 Bizkaia;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
48 Bizkaia;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2022QII;6.283
48 Bizkaia;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2022QI;""
48 Bizkaia;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
48 Bizkaia;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
48 Bizkaia;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2021QII;6.682
48 Bizkaia;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2021QI;""
48 Bizkaia;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
48 Bizkaia;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
48 Bizkaia;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2020QII;6.978
48 Bizkaia;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2020QI;""
48 Bizkaia;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
48 Bizkaia;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2022QIII;6.061
48 Bizkaia;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2022QII;""
48 Bizkaia;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2022QI;""
48 Bizkaia;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
48 Bizkaia;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2021QIII;6.437
48 Bizkaia;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2021QII;""
48 Bizkaia;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2021QI;""
48 Bizkaia;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
48 Bizkaia;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2020QIII;6.729
48 Bizkaia;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2020QII;""
48 Bizkaia;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2020QI;""
48 Bizkaia;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QIV;5.799
48 Bizkaia;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
48 Bizkaia;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QII;""
48 Bizkaia;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QI;""
48 Bizkaia;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QIV;6.177
48 Bizkaia;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
48 Bizkaia;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QII;""
48 Bizkaia;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QI;""
48 Bizkaia;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QIV;6.507
48 Bizkaia;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
48 Bizkaia;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QII;""
48 Bizkaia;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QI;""
48 Bizkaia;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
48 Bizkaia;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
48 Bizkaia;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QII;""
48 Bizkaia;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QI;5.934
48 Bizkaia;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
48 Bizkaia;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
48 Bizkaia;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QII;""
48 Bizkaia;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QI;6.330
48 Bizkaia;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
48 Bizkaia;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
48 Bizkaia;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QII;""
48 Bizkaia;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QI;""
48 Bizkaia;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
48 Bizkaia;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
48 Bizkaia;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
48 Bizkaia;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
48 Bizkaia;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
48 Bizkaia;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
48 Bizkaia;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
48 Bizkaia;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
48 Bizkaia;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
48 Bizkaia;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
48 Bizkaia;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
48 Bizkaia;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
48 Bizkaia;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
48 Bizkaia;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
48 Bizkaia;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;95,07
48 Bizkaia;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
48 Bizkaia;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
48 Bizkaia;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
48 Bizkaia;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;95,85
48 Bizkaia;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
48 Bizkaia;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
48 Bizkaia;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
48 Bizkaia;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;97,72
48 Bizkaia;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
48 Bizkaia;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
48 Bizkaia;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;91,71
48 Bizkaia;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
48 Bizkaia;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
48 Bizkaia;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
48 Bizkaia;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;92,34
48 Bizkaia;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
48 Bizkaia;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
48 Bizkaia;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
48 Bizkaia;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;94,23
48 Bizkaia;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
48 Bizkaia;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
48 Bizkaia;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;87,74
48 Bizkaia;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
48 Bizkaia;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
48 Bizkaia;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
48 Bizkaia;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;88,61
48 Bizkaia;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
48 Bizkaia;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
48 Bizkaia;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
48 Bizkaia;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;91,12
48 Bizkaia;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
48 Bizkaia;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
48 Bizkaia;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
48 Bizkaia;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
48 Bizkaia;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
48 Bizkaia;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
48 Bizkaia;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;85,12
48 Bizkaia;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
48 Bizkaia;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
48 Bizkaia;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
48 Bizkaia;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;88,64
48 Bizkaia;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
48 Bizkaia;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
48 Bizkaia;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
48 Bizkaia;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
48 Bizkaia;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
48 Bizkaia;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
48 Bizkaia;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QII;4.920
48 Bizkaia;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
48 Bizkaia;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
48 Bizkaia;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
48 Bizkaia;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QII;5.001
48 Bizkaia;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
48 Bizkaia;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
48 Bizkaia;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
48 Bizkaia;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QII;5.179
48 Bizkaia;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
48 Bizkaia;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
48 Bizkaia;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
48 Bizkaia;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2022QII;4.634
48 Bizkaia;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2022QI;""
48 Bizkaia;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
48 Bizkaia;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
48 Bizkaia;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2021QII;4.780
48 Bizkaia;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2021QI;""
48 Bizkaia;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
48 Bizkaia;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
48 Bizkaia;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2020QII;4.986
48 Bizkaia;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2020QI;""
48 Bizkaia;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
48 Bizkaia;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2022QIII;4.489
48 Bizkaia;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2022QII;""
48 Bizkaia;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2022QI;""
48 Bizkaia;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
48 Bizkaia;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2021QIII;4.621
48 Bizkaia;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2021QII;""
48 Bizkaia;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2021QI;""
48 Bizkaia;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
48 Bizkaia;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2020QIII;4.826
48 Bizkaia;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2020QII;""
48 Bizkaia;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2020QI;""
48 Bizkaia;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QIV;4.305
48 Bizkaia;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
48 Bizkaia;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QII;""
48 Bizkaia;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QI;""
48 Bizkaia;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QIV;4.460
48 Bizkaia;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
48 Bizkaia;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QII;""
48 Bizkaia;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QI;""
48 Bizkaia;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QIV;4.678
48 Bizkaia;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
48 Bizkaia;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QII;""
48 Bizkaia;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QI;""
48 Bizkaia;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
48 Bizkaia;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
48 Bizkaia;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QII;""
48 Bizkaia;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QI;4.305
48 Bizkaia;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
48 Bizkaia;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
48 Bizkaia;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QII;""
48 Bizkaia;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QI;4.556
48 Bizkaia;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
48 Bizkaia;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
48 Bizkaia;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QII;""
48 Bizkaia;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QI;""
48 Bizkaia;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
48 Bizkaia;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
48 Bizkaia;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
48 Bizkaia;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
48 Bizkaia;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
48 Bizkaia;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
48 Bizkaia;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
48 Bizkaia;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
48 Bizkaia;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
48 Bizkaia;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
48 Bizkaia;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
48 Bizkaia;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
48 Bizkaia;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
48 Bizkaia;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
48 Bizkaia;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;94,19
48 Bizkaia;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
48 Bizkaia;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
48 Bizkaia;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
48 Bizkaia;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;95,58
48 Bizkaia;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
48 Bizkaia;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
48 Bizkaia;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
48 Bizkaia;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;96,27
48 Bizkaia;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
48 Bizkaia;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
48 Bizkaia;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;91,24
48 Bizkaia;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
48 Bizkaia;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
48 Bizkaia;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
48 Bizkaia;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;92,4
48 Bizkaia;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
48 Bizkaia;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
48 Bizkaia;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
48 Bizkaia;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;93,18
48 Bizkaia;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
48 Bizkaia;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
48 Bizkaia;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;87,5
48 Bizkaia;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
48 Bizkaia;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
48 Bizkaia;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
48 Bizkaia;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;89,18
48 Bizkaia;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
48 Bizkaia;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
48 Bizkaia;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
48 Bizkaia;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;90,33
48 Bizkaia;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
48 Bizkaia;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
48 Bizkaia;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
48 Bizkaia;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
48 Bizkaia;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
48 Bizkaia;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
48 Bizkaia;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;86,08
48 Bizkaia;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
48 Bizkaia;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
48 Bizkaia;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
48 Bizkaia;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;87,97
48 Bizkaia;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
48 Bizkaia;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
48 Bizkaia;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
48 Bizkaia;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
48 Bizkaia;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
48 Bizkaia;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QIII;11.680
48 Bizkaia;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
48 Bizkaia;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
48 Bizkaia;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
48 Bizkaia;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QIII;12.071
48 Bizkaia;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
48 Bizkaia;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
48 Bizkaia;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
48 Bizkaia;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QIII;12.366
48 Bizkaia;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
48 Bizkaia;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
48 Bizkaia;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
48 Bizkaia;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2022QIII;11.258
48 Bizkaia;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2022QII;""
48 Bizkaia;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2022QI;""
48 Bizkaia;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
48 Bizkaia;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2021QIII;11.610
48 Bizkaia;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2021QII;""
48 Bizkaia;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2021QI;""
48 Bizkaia;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
48 Bizkaia;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2020QIII;11.907
48 Bizkaia;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2020QII;""
48 Bizkaia;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2020QI;""
48 Bizkaia;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2022QIV;10.760
48 Bizkaia;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
48 Bizkaia;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2022QII;""
48 Bizkaia;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2022QI;""
48 Bizkaia;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2021QIV;11.148
48 Bizkaia;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
48 Bizkaia;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2021QII;""
48 Bizkaia;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2021QI;""
48 Bizkaia;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2020QIV;11.507
48 Bizkaia;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
48 Bizkaia;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2020QII;""
48 Bizkaia;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2020QI;""
48 Bizkaia;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
48 Bizkaia;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
48 Bizkaia;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QII;""
48 Bizkaia;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QI;10.719
48 Bizkaia;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
48 Bizkaia;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
48 Bizkaia;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QII;""
48 Bizkaia;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QI;11.194
48 Bizkaia;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
48 Bizkaia;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
48 Bizkaia;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QII;""
48 Bizkaia;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QI;""
48 Bizkaia;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
48 Bizkaia;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
48 Bizkaia;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QII;10.294
48 Bizkaia;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QI;""
48 Bizkaia;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
48 Bizkaia;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
48 Bizkaia;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QII;10.858
48 Bizkaia;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QI;""
48 Bizkaia;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
48 Bizkaia;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
48 Bizkaia;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QII;""
48 Bizkaia;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QI;""
48 Bizkaia;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
48 Bizkaia;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
48 Bizkaia;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
48 Bizkaia;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
48 Bizkaia;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
48 Bizkaia;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
48 Bizkaia;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
48 Bizkaia;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
48 Bizkaia;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
48 Bizkaia;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
48 Bizkaia;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
48 Bizkaia;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
48 Bizkaia;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
48 Bizkaia;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;96,39
48 Bizkaia;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
48 Bizkaia;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
48 Bizkaia;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
48 Bizkaia;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;96,18
48 Bizkaia;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
48 Bizkaia;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
48 Bizkaia;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
48 Bizkaia;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;96,29
48 Bizkaia;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
48 Bizkaia;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
48 Bizkaia;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;92,12
48 Bizkaia;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
48 Bizkaia;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
48 Bizkaia;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
48 Bizkaia;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;92,35
48 Bizkaia;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
48 Bizkaia;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
48 Bizkaia;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
48 Bizkaia;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;93,05
48 Bizkaia;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
48 Bizkaia;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
48 Bizkaia;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
48 Bizkaia;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
48 Bizkaia;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
48 Bizkaia;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
48 Bizkaia;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;88,8
48 Bizkaia;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
48 Bizkaia;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
48 Bizkaia;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
48 Bizkaia;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;90,52
48 Bizkaia;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
48 Bizkaia;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
48 Bizkaia;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
48 Bizkaia;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
48 Bizkaia;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
48 Bizkaia;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
48 Bizkaia;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;85,28
48 Bizkaia;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
48 Bizkaia;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
48 Bizkaia;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
48 Bizkaia;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;87,81
48 Bizkaia;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
48 Bizkaia;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
48 Bizkaia;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
48 Bizkaia;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
48 Bizkaia;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
48 Bizkaia;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
48 Bizkaia;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QIII;6.733
48 Bizkaia;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
48 Bizkaia;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
48 Bizkaia;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
48 Bizkaia;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QIII;7.034
48 Bizkaia;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
48 Bizkaia;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
48 Bizkaia;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
48 Bizkaia;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QIII;7.240
48 Bizkaia;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
48 Bizkaia;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
48 Bizkaia;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
48 Bizkaia;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2022QIII;6.478
48 Bizkaia;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2022QII;""
48 Bizkaia;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2022QI;""
48 Bizkaia;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
48 Bizkaia;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2021QIII;6.754
48 Bizkaia;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2021QII;""
48 Bizkaia;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2021QI;""
48 Bizkaia;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
48 Bizkaia;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2020QIII;6.953
48 Bizkaia;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2020QII;""
48 Bizkaia;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2020QI;""
48 Bizkaia;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2022QIV;6.182
48 Bizkaia;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
48 Bizkaia;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2022QII;""
48 Bizkaia;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2022QI;""
48 Bizkaia;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2021QIV;6.467
48 Bizkaia;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
48 Bizkaia;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2021QII;""
48 Bizkaia;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2021QI;""
48 Bizkaia;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2020QIV;6.709
48 Bizkaia;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
48 Bizkaia;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2020QII;""
48 Bizkaia;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2020QI;""
48 Bizkaia;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
48 Bizkaia;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
48 Bizkaia;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QII;""
48 Bizkaia;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QI;6.208
48 Bizkaia;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
48 Bizkaia;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
48 Bizkaia;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QII;""
48 Bizkaia;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QI;6.521
48 Bizkaia;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
48 Bizkaia;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
48 Bizkaia;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QII;""
48 Bizkaia;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QI;""
48 Bizkaia;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
48 Bizkaia;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
48 Bizkaia;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QII;5.968
48 Bizkaia;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QI;""
48 Bizkaia;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
48 Bizkaia;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
48 Bizkaia;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QII;6.327
48 Bizkaia;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QI;""
48 Bizkaia;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
48 Bizkaia;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
48 Bizkaia;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QII;""
48 Bizkaia;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QI;""
48 Bizkaia;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
48 Bizkaia;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
48 Bizkaia;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
48 Bizkaia;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
48 Bizkaia;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
48 Bizkaia;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
48 Bizkaia;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
48 Bizkaia;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
48 Bizkaia;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
48 Bizkaia;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
48 Bizkaia;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
48 Bizkaia;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
48 Bizkaia;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
48 Bizkaia;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;96,21
48 Bizkaia;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
48 Bizkaia;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
48 Bizkaia;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
48 Bizkaia;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;96,02
48 Bizkaia;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
48 Bizkaia;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
48 Bizkaia;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
48 Bizkaia;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;96,04
48 Bizkaia;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
48 Bizkaia;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
48 Bizkaia;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;91,82
48 Bizkaia;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
48 Bizkaia;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
48 Bizkaia;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
48 Bizkaia;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;91,94
48 Bizkaia;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
48 Bizkaia;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
48 Bizkaia;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
48 Bizkaia;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;92,67
48 Bizkaia;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
48 Bizkaia;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
48 Bizkaia;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
48 Bizkaia;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
48 Bizkaia;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
48 Bizkaia;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
48 Bizkaia;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;88,26
48 Bizkaia;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
48 Bizkaia;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
48 Bizkaia;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
48 Bizkaia;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;90,07
48 Bizkaia;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
48 Bizkaia;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
48 Bizkaia;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
48 Bizkaia;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
48 Bizkaia;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
48 Bizkaia;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
48 Bizkaia;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;84,85
48 Bizkaia;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
48 Bizkaia;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
48 Bizkaia;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
48 Bizkaia;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;87,39
48 Bizkaia;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
48 Bizkaia;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
48 Bizkaia;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
48 Bizkaia;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
48 Bizkaia;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
48 Bizkaia;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
48 Bizkaia;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QIII;4.947
48 Bizkaia;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
48 Bizkaia;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
48 Bizkaia;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
48 Bizkaia;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QIII;5.037
48 Bizkaia;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
48 Bizkaia;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
48 Bizkaia;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
48 Bizkaia;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QIII;5.126
48 Bizkaia;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
48 Bizkaia;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
48 Bizkaia;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
48 Bizkaia;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2022QIII;4.780
48 Bizkaia;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2022QII;""
48 Bizkaia;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2022QI;""
48 Bizkaia;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
48 Bizkaia;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2021QIII;4.856
48 Bizkaia;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2021QII;""
48 Bizkaia;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2021QI;""
48 Bizkaia;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
48 Bizkaia;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2020QIII;4.954
48 Bizkaia;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2020QII;""
48 Bizkaia;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2020QI;""
48 Bizkaia;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2022QIV;4.578
48 Bizkaia;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
48 Bizkaia;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2022QII;""
48 Bizkaia;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2022QI;""
48 Bizkaia;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2021QIV;4.681
48 Bizkaia;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
48 Bizkaia;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2021QII;""
48 Bizkaia;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2021QI;""
48 Bizkaia;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2020QIV;4.798
48 Bizkaia;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
48 Bizkaia;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2020QII;""
48 Bizkaia;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2020QI;""
48 Bizkaia;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
48 Bizkaia;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
48 Bizkaia;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QII;""
48 Bizkaia;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QI;4.511
48 Bizkaia;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
48 Bizkaia;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
48 Bizkaia;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QII;""
48 Bizkaia;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QI;4.673
48 Bizkaia;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
48 Bizkaia;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
48 Bizkaia;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QII;""
48 Bizkaia;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QI;""
48 Bizkaia;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
48 Bizkaia;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
48 Bizkaia;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QII;4.326
48 Bizkaia;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QI;""
48 Bizkaia;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
48 Bizkaia;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
48 Bizkaia;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QII;4.531
48 Bizkaia;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QI;""
48 Bizkaia;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
48 Bizkaia;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
48 Bizkaia;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QII;""
48 Bizkaia;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QI;""
48 Bizkaia;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
48 Bizkaia;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
48 Bizkaia;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
48 Bizkaia;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
48 Bizkaia;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
48 Bizkaia;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
48 Bizkaia;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
48 Bizkaia;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
48 Bizkaia;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
48 Bizkaia;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
48 Bizkaia;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
48 Bizkaia;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
48 Bizkaia;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
48 Bizkaia;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;96,62
48 Bizkaia;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
48 Bizkaia;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
48 Bizkaia;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
48 Bizkaia;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;96,41
48 Bizkaia;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
48 Bizkaia;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
48 Bizkaia;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
48 Bizkaia;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;96,64
48 Bizkaia;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
48 Bizkaia;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
48 Bizkaia;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;92,54
48 Bizkaia;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
48 Bizkaia;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
48 Bizkaia;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
48 Bizkaia;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;92,93
48 Bizkaia;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
48 Bizkaia;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
48 Bizkaia;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
48 Bizkaia;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;93,6
48 Bizkaia;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
48 Bizkaia;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
48 Bizkaia;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
48 Bizkaia;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
48 Bizkaia;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
48 Bizkaia;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
48 Bizkaia;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;89,56
48 Bizkaia;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
48 Bizkaia;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
48 Bizkaia;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
48 Bizkaia;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;91,16
48 Bizkaia;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
48 Bizkaia;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
48 Bizkaia;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
48 Bizkaia;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
48 Bizkaia;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
48 Bizkaia;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
48 Bizkaia;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;85,88
48 Bizkaia;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
48 Bizkaia;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
48 Bizkaia;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
48 Bizkaia;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;88,39
48 Bizkaia;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
48 Bizkaia;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
48 Bizkaia;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
48 Bizkaia;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
48 Bizkaia;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
48 Bizkaia;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QIV;11.801
48 Bizkaia;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
48 Bizkaia;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
48 Bizkaia;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
48 Bizkaia;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QIV;12.169
48 Bizkaia;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
48 Bizkaia;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
48 Bizkaia;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
48 Bizkaia;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QIV;12.509
48 Bizkaia;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
48 Bizkaia;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
48 Bizkaia;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
48 Bizkaia;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2022QIV;11.258
48 Bizkaia;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
48 Bizkaia;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2022QII;""
48 Bizkaia;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2022QI;""
48 Bizkaia;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2021QIV;11.667
48 Bizkaia;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
48 Bizkaia;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2021QII;""
48 Bizkaia;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2021QI;""
48 Bizkaia;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2020QIV;12.051
48 Bizkaia;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
48 Bizkaia;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2020QII;""
48 Bizkaia;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2020QI;""
48 Bizkaia;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
48 Bizkaia;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
48 Bizkaia;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2022QII;""
48 Bizkaia;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2022QI;11.199
48 Bizkaia;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
48 Bizkaia;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
48 Bizkaia;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2021QII;""
48 Bizkaia;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2021QI;11.707
48 Bizkaia;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
48 Bizkaia;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
48 Bizkaia;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2020QII;""
48 Bizkaia;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2020QI;""
48 Bizkaia;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
48 Bizkaia;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
48 Bizkaia;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QII;10.733
48 Bizkaia;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QI;""
48 Bizkaia;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
48 Bizkaia;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
48 Bizkaia;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QII;11.324
48 Bizkaia;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QI;""
48 Bizkaia;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
48 Bizkaia;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
48 Bizkaia;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QII;""
48 Bizkaia;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QI;""
48 Bizkaia;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
48 Bizkaia;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QIII;10.417
48 Bizkaia;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QII;""
48 Bizkaia;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QI;""
48 Bizkaia;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
48 Bizkaia;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QIII;11.004
48 Bizkaia;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QII;""
48 Bizkaia;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QI;""
48 Bizkaia;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
48 Bizkaia;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
48 Bizkaia;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QII;""
48 Bizkaia;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QI;""
48 Bizkaia;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
48 Bizkaia;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
48 Bizkaia;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
48 Bizkaia;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
48 Bizkaia;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
48 Bizkaia;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
48 Bizkaia;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
48 Bizkaia;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
48 Bizkaia;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
48 Bizkaia;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
48 Bizkaia;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
48 Bizkaia;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
48 Bizkaia;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;95,4
48 Bizkaia;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
48 Bizkaia;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
48 Bizkaia;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
48 Bizkaia;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;95,87
48 Bizkaia;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
48 Bizkaia;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
48 Bizkaia;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
48 Bizkaia;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;96,34
48 Bizkaia;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
48 Bizkaia;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
48 Bizkaia;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
48 Bizkaia;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
48 Bizkaia;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
48 Bizkaia;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
48 Bizkaia;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;92,03
48 Bizkaia;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
48 Bizkaia;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
48 Bizkaia;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
48 Bizkaia;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;93,59
48 Bizkaia;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
48 Bizkaia;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
48 Bizkaia;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
48 Bizkaia;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
48 Bizkaia;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
48 Bizkaia;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
48 Bizkaia;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;88,2
48 Bizkaia;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
48 Bizkaia;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
48 Bizkaia;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
48 Bizkaia;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;90,53
48 Bizkaia;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
48 Bizkaia;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
48 Bizkaia;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
48 Bizkaia;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
48 Bizkaia;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
48 Bizkaia;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
48 Bizkaia;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;85,6
48 Bizkaia;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
48 Bizkaia;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
48 Bizkaia;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
48 Bizkaia;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;87,97
48 Bizkaia;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
48 Bizkaia;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
48 Bizkaia;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
48 Bizkaia;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
48 Bizkaia;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
48 Bizkaia;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
48 Bizkaia;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QIV;6.799
48 Bizkaia;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
48 Bizkaia;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
48 Bizkaia;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
48 Bizkaia;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QIV;7.054
48 Bizkaia;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
48 Bizkaia;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
48 Bizkaia;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
48 Bizkaia;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QIV;7.331
48 Bizkaia;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
48 Bizkaia;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
48 Bizkaia;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
48 Bizkaia;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2022QIV;6.473
48 Bizkaia;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
48 Bizkaia;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2022QII;""
48 Bizkaia;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2022QI;""
48 Bizkaia;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2021QIV;6.742
48 Bizkaia;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
48 Bizkaia;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2021QII;""
48 Bizkaia;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2021QI;""
48 Bizkaia;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2020QIV;7.048
48 Bizkaia;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
48 Bizkaia;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2020QII;""
48 Bizkaia;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2020QI;""
48 Bizkaia;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
48 Bizkaia;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
48 Bizkaia;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2022QII;""
48 Bizkaia;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2022QI;6.463
48 Bizkaia;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
48 Bizkaia;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
48 Bizkaia;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2021QII;""
48 Bizkaia;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2021QI;6.838
48 Bizkaia;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
48 Bizkaia;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
48 Bizkaia;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2020QII;""
48 Bizkaia;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2020QI;""
48 Bizkaia;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
48 Bizkaia;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
48 Bizkaia;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QII;6.199
48 Bizkaia;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QI;""
48 Bizkaia;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
48 Bizkaia;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
48 Bizkaia;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QII;6.618
48 Bizkaia;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QI;""
48 Bizkaia;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
48 Bizkaia;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
48 Bizkaia;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QII;""
48 Bizkaia;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QI;""
48 Bizkaia;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
48 Bizkaia;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QIII;6.013
48 Bizkaia;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QII;""
48 Bizkaia;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QI;""
48 Bizkaia;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
48 Bizkaia;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QIII;6.431
48 Bizkaia;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QII;""
48 Bizkaia;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QI;""
48 Bizkaia;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
48 Bizkaia;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
48 Bizkaia;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QII;""
48 Bizkaia;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QI;""
48 Bizkaia;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
48 Bizkaia;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
48 Bizkaia;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
48 Bizkaia;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
48 Bizkaia;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
48 Bizkaia;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
48 Bizkaia;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
48 Bizkaia;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
48 Bizkaia;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
48 Bizkaia;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
48 Bizkaia;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
48 Bizkaia;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
48 Bizkaia;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;95,21
48 Bizkaia;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
48 Bizkaia;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
48 Bizkaia;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
48 Bizkaia;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;95,58
48 Bizkaia;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
48 Bizkaia;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
48 Bizkaia;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
48 Bizkaia;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;96,14
48 Bizkaia;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
48 Bizkaia;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
48 Bizkaia;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
48 Bizkaia;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
48 Bizkaia;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
48 Bizkaia;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
48 Bizkaia;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;91,62
48 Bizkaia;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
48 Bizkaia;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
48 Bizkaia;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
48 Bizkaia;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;93,28
48 Bizkaia;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
48 Bizkaia;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
48 Bizkaia;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
48 Bizkaia;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
48 Bizkaia;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
48 Bizkaia;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
48 Bizkaia;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;87,88
48 Bizkaia;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
48 Bizkaia;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
48 Bizkaia;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
48 Bizkaia;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;90,27
48 Bizkaia;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
48 Bizkaia;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
48 Bizkaia;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
48 Bizkaia;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
48 Bizkaia;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
48 Bizkaia;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
48 Bizkaia;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;85,24
48 Bizkaia;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
48 Bizkaia;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
48 Bizkaia;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
48 Bizkaia;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;87,72
48 Bizkaia;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
48 Bizkaia;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
48 Bizkaia;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
48 Bizkaia;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
48 Bizkaia;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
48 Bizkaia;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
48 Bizkaia;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QIV;5.002
48 Bizkaia;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
48 Bizkaia;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
48 Bizkaia;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
48 Bizkaia;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QIV;5.115
48 Bizkaia;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
48 Bizkaia;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
48 Bizkaia;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
48 Bizkaia;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QIV;5.178
48 Bizkaia;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
48 Bizkaia;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
48 Bizkaia;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
48 Bizkaia;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2022QIV;4.785
48 Bizkaia;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
48 Bizkaia;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2022QII;""
48 Bizkaia;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2022QI;""
48 Bizkaia;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2021QIV;4.925
48 Bizkaia;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
48 Bizkaia;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2021QII;""
48 Bizkaia;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2021QI;""
48 Bizkaia;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2020QIV;5.003
48 Bizkaia;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
48 Bizkaia;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2020QII;""
48 Bizkaia;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2020QI;""
48 Bizkaia;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
48 Bizkaia;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
48 Bizkaia;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2022QII;""
48 Bizkaia;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2022QI;4.736
48 Bizkaia;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
48 Bizkaia;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
48 Bizkaia;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2021QII;""
48 Bizkaia;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2021QI;4.869
48 Bizkaia;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
48 Bizkaia;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
48 Bizkaia;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2020QII;""
48 Bizkaia;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2020QI;""
48 Bizkaia;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
48 Bizkaia;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
48 Bizkaia;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QII;4.534
48 Bizkaia;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QI;""
48 Bizkaia;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
48 Bizkaia;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
48 Bizkaia;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QII;4.706
48 Bizkaia;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QI;""
48 Bizkaia;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
48 Bizkaia;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
48 Bizkaia;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QII;""
48 Bizkaia;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QI;""
48 Bizkaia;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
48 Bizkaia;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QIII;4.404
48 Bizkaia;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QII;""
48 Bizkaia;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QI;""
48 Bizkaia;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
48 Bizkaia;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QIII;4.573
48 Bizkaia;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QII;""
48 Bizkaia;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QI;""
48 Bizkaia;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
48 Bizkaia;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
48 Bizkaia;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QII;""
48 Bizkaia;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QI;""
48 Bizkaia;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
48 Bizkaia;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
48 Bizkaia;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
48 Bizkaia;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
48 Bizkaia;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
48 Bizkaia;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
48 Bizkaia;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
48 Bizkaia;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
48 Bizkaia;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
48 Bizkaia;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
48 Bizkaia;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
48 Bizkaia;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
48 Bizkaia;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;95,66
48 Bizkaia;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
48 Bizkaia;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
48 Bizkaia;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
48 Bizkaia;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;96,29
48 Bizkaia;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
48 Bizkaia;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
48 Bizkaia;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
48 Bizkaia;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;96,62
48 Bizkaia;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
48 Bizkaia;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
48 Bizkaia;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
48 Bizkaia;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
48 Bizkaia;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
48 Bizkaia;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
48 Bizkaia;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;92,59
48 Bizkaia;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
48 Bizkaia;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
48 Bizkaia;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
48 Bizkaia;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;94,03
48 Bizkaia;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
48 Bizkaia;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
48 Bizkaia;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
48 Bizkaia;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
48 Bizkaia;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
48 Bizkaia;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
48 Bizkaia;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;88,64
48 Bizkaia;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
48 Bizkaia;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
48 Bizkaia;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
48 Bizkaia;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;90,88
48 Bizkaia;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
48 Bizkaia;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
48 Bizkaia;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
48 Bizkaia;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
48 Bizkaia;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
48 Bizkaia;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
48 Bizkaia;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;86,1
48 Bizkaia;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
48 Bizkaia;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
48 Bizkaia;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
48 Bizkaia;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;88,32
48 Bizkaia;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
48 Bizkaia;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
48 Bizkaia;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
48 Bizkaia;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
48 Bizkaia;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
48 Bizkaia;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
48 Bizkaia;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
48 Bizkaia;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
48 Bizkaia;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
48 Bizkaia;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QI;25.615
48 Bizkaia;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
48 Bizkaia;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
48 Bizkaia;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
48 Bizkaia;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QI;26.584
48 Bizkaia;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
48 Bizkaia;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
48 Bizkaia;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
48 Bizkaia;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QI;26.599
48 Bizkaia;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
48 Bizkaia;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
48 Bizkaia;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2022QII;""
48 Bizkaia;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2022QI;24.961
48 Bizkaia;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
48 Bizkaia;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
48 Bizkaia;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2021QII;""
48 Bizkaia;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2021QI;26.116
48 Bizkaia;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
48 Bizkaia;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
48 Bizkaia;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2020QII;""
48 Bizkaia;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2020QI;25.523
48 Bizkaia;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
48 Bizkaia;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
48 Bizkaia;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2022QII;24.169
48 Bizkaia;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2022QI;""
48 Bizkaia;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
48 Bizkaia;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
48 Bizkaia;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2021QII;25.424
48 Bizkaia;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2021QI;""
48 Bizkaia;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
48 Bizkaia;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
48 Bizkaia;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2020QII;24.990
48 Bizkaia;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2020QI;""
48 Bizkaia;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
48 Bizkaia;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QIII;23.662
48 Bizkaia;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QII;""
48 Bizkaia;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QI;""
48 Bizkaia;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
48 Bizkaia;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QIII;24.963
48 Bizkaia;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QII;""
48 Bizkaia;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QI;""
48 Bizkaia;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
48 Bizkaia;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QIII;24.554
48 Bizkaia;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QII;""
48 Bizkaia;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QI;""
48 Bizkaia;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QIV;23.088
48 Bizkaia;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
48 Bizkaia;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QII;""
48 Bizkaia;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QI;""
48 Bizkaia;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QIV;24.492
48 Bizkaia;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
48 Bizkaia;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QII;""
48 Bizkaia;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QI;""
48 Bizkaia;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QIV;24.033
48 Bizkaia;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
48 Bizkaia;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QII;""
48 Bizkaia;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QI;""
48 Bizkaia;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
48 Bizkaia;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
48 Bizkaia;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
48 Bizkaia;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
48 Bizkaia;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
48 Bizkaia;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
48 Bizkaia;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
48 Bizkaia;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
48 Bizkaia;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
48 Bizkaia;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
48 Bizkaia;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
48 Bizkaia;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
48 Bizkaia;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
48 Bizkaia;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
48 Bizkaia;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
48 Bizkaia;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;97,45
48 Bizkaia;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
48 Bizkaia;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
48 Bizkaia;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
48 Bizkaia;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;98,24
48 Bizkaia;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
48 Bizkaia;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
48 Bizkaia;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
48 Bizkaia;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;95,95
48 Bizkaia;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
48 Bizkaia;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
48 Bizkaia;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;94,35
48 Bizkaia;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
48 Bizkaia;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
48 Bizkaia;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
48 Bizkaia;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;95,64
48 Bizkaia;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
48 Bizkaia;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
48 Bizkaia;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
48 Bizkaia;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;93,95
48 Bizkaia;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
48 Bizkaia;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
48 Bizkaia;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;92,38
48 Bizkaia;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
48 Bizkaia;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
48 Bizkaia;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
48 Bizkaia;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;93,9
48 Bizkaia;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
48 Bizkaia;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
48 Bizkaia;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
48 Bizkaia;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;92,31
48 Bizkaia;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
48 Bizkaia;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
48 Bizkaia;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;90,13
48 Bizkaia;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
48 Bizkaia;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
48 Bizkaia;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
48 Bizkaia;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;92,13
48 Bizkaia;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
48 Bizkaia;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
48 Bizkaia;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
48 Bizkaia;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;90,35
48 Bizkaia;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
48 Bizkaia;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
48 Bizkaia;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
48 Bizkaia;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
48 Bizkaia;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
48 Bizkaia;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
48 Bizkaia;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QI;14.558
48 Bizkaia;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
48 Bizkaia;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
48 Bizkaia;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
48 Bizkaia;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QI;15.187
48 Bizkaia;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
48 Bizkaia;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
48 Bizkaia;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
48 Bizkaia;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QI;15.152
48 Bizkaia;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
48 Bizkaia;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
48 Bizkaia;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2022QII;""
48 Bizkaia;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2022QI;14.158
48 Bizkaia;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
48 Bizkaia;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
48 Bizkaia;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2021QII;""
48 Bizkaia;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2021QI;14.896
48 Bizkaia;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
48 Bizkaia;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
48 Bizkaia;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2020QII;""
48 Bizkaia;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2020QI;14.529
48 Bizkaia;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
48 Bizkaia;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
48 Bizkaia;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2022QII;13.791
48 Bizkaia;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2022QI;""
48 Bizkaia;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
48 Bizkaia;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
48 Bizkaia;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2021QII;14.558
48 Bizkaia;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2021QI;""
48 Bizkaia;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
48 Bizkaia;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
48 Bizkaia;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2020QII;14.350
48 Bizkaia;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2020QI;""
48 Bizkaia;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
48 Bizkaia;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QIII;13.510
48 Bizkaia;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QII;""
48 Bizkaia;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QI;""
48 Bizkaia;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
48 Bizkaia;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QIII;14.276
48 Bizkaia;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QII;""
48 Bizkaia;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QI;""
48 Bizkaia;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
48 Bizkaia;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QIII;14.109
48 Bizkaia;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QII;""
48 Bizkaia;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QI;""
48 Bizkaia;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QIV;13.172
48 Bizkaia;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
48 Bizkaia;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QII;""
48 Bizkaia;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QI;""
48 Bizkaia;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QIV;13.979
48 Bizkaia;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
48 Bizkaia;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QII;""
48 Bizkaia;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QI;""
48 Bizkaia;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QIV;13.800
48 Bizkaia;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
48 Bizkaia;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QII;""
48 Bizkaia;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QI;""
48 Bizkaia;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
48 Bizkaia;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
48 Bizkaia;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
48 Bizkaia;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
48 Bizkaia;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
48 Bizkaia;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
48 Bizkaia;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
48 Bizkaia;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
48 Bizkaia;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
48 Bizkaia;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
48 Bizkaia;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
48 Bizkaia;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
48 Bizkaia;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
48 Bizkaia;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
48 Bizkaia;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
48 Bizkaia;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;97,25
48 Bizkaia;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
48 Bizkaia;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
48 Bizkaia;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
48 Bizkaia;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;98,08
48 Bizkaia;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
48 Bizkaia;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
48 Bizkaia;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
48 Bizkaia;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;95,89
48 Bizkaia;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
48 Bizkaia;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
48 Bizkaia;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;94,73
48 Bizkaia;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
48 Bizkaia;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
48 Bizkaia;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
48 Bizkaia;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;95,86
48 Bizkaia;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
48 Bizkaia;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
48 Bizkaia;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
48 Bizkaia;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;94,71
48 Bizkaia;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
48 Bizkaia;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
48 Bizkaia;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;92,8
48 Bizkaia;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
48 Bizkaia;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
48 Bizkaia;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
48 Bizkaia;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;94
48 Bizkaia;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
48 Bizkaia;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
48 Bizkaia;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
48 Bizkaia;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;93,12
48 Bizkaia;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
48 Bizkaia;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
48 Bizkaia;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;90,48
48 Bizkaia;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
48 Bizkaia;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
48 Bizkaia;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
48 Bizkaia;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;92,05
48 Bizkaia;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
48 Bizkaia;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
48 Bizkaia;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
48 Bizkaia;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;91,08
48 Bizkaia;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
48 Bizkaia;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
48 Bizkaia;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
48 Bizkaia;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
48 Bizkaia;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
48 Bizkaia;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
48 Bizkaia;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QI;11.057
48 Bizkaia;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
48 Bizkaia;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
48 Bizkaia;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
48 Bizkaia;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QI;11.397
48 Bizkaia;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
48 Bizkaia;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
48 Bizkaia;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
48 Bizkaia;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QI;11.447
48 Bizkaia;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
48 Bizkaia;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
48 Bizkaia;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2022QII;""
48 Bizkaia;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2022QI;10.803
48 Bizkaia;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
48 Bizkaia;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
48 Bizkaia;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2021QII;""
48 Bizkaia;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2021QI;11.220
48 Bizkaia;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
48 Bizkaia;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
48 Bizkaia;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2020QII;""
48 Bizkaia;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2020QI;10.994
48 Bizkaia;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
48 Bizkaia;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
48 Bizkaia;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2022QII;10.378
48 Bizkaia;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2022QI;""
48 Bizkaia;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
48 Bizkaia;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
48 Bizkaia;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2021QII;10.866
48 Bizkaia;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2021QI;""
48 Bizkaia;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
48 Bizkaia;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
48 Bizkaia;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2020QII;10.640
48 Bizkaia;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2020QI;""
48 Bizkaia;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
48 Bizkaia;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QIII;10.152
48 Bizkaia;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QII;""
48 Bizkaia;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QI;""
48 Bizkaia;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
48 Bizkaia;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QIII;10.687
48 Bizkaia;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QII;""
48 Bizkaia;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QI;""
48 Bizkaia;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
48 Bizkaia;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QIII;10.445
48 Bizkaia;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QII;""
48 Bizkaia;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QI;""
48 Bizkaia;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QIV;9.916
48 Bizkaia;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
48 Bizkaia;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QII;""
48 Bizkaia;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QI;""
48 Bizkaia;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QIV;10.513
48 Bizkaia;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
48 Bizkaia;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QII;""
48 Bizkaia;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QI;""
48 Bizkaia;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QIV;10.233
48 Bizkaia;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
48 Bizkaia;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QII;""
48 Bizkaia;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QI;""
48 Bizkaia;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
48 Bizkaia;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
48 Bizkaia;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
48 Bizkaia;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
48 Bizkaia;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
48 Bizkaia;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
48 Bizkaia;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
48 Bizkaia;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
48 Bizkaia;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
48 Bizkaia;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
48 Bizkaia;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
48 Bizkaia;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
48 Bizkaia;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
48 Bizkaia;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
48 Bizkaia;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
48 Bizkaia;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;97,7
48 Bizkaia;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
48 Bizkaia;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
48 Bizkaia;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
48 Bizkaia;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;98,45
48 Bizkaia;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
48 Bizkaia;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
48 Bizkaia;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
48 Bizkaia;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;96,04
48 Bizkaia;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
48 Bizkaia;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
48 Bizkaia;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;93,86
48 Bizkaia;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
48 Bizkaia;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
48 Bizkaia;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
48 Bizkaia;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;95,34
48 Bizkaia;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
48 Bizkaia;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
48 Bizkaia;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
48 Bizkaia;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;92,95
48 Bizkaia;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
48 Bizkaia;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
48 Bizkaia;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;91,82
48 Bizkaia;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
48 Bizkaia;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
48 Bizkaia;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
48 Bizkaia;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;93,77
48 Bizkaia;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
48 Bizkaia;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
48 Bizkaia;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
48 Bizkaia;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;91,25
48 Bizkaia;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
48 Bizkaia;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
48 Bizkaia;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;89,68
48 Bizkaia;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
48 Bizkaia;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
48 Bizkaia;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
48 Bizkaia;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;92,24
48 Bizkaia;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
48 Bizkaia;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
48 Bizkaia;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
48 Bizkaia;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;89,39
48 Bizkaia;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
48 Bizkaia;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
48 Bizkaia;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
48 Bizkaia;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
48 Bizkaia;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
48 Bizkaia;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QII;24.376
48 Bizkaia;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
48 Bizkaia;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
48 Bizkaia;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
48 Bizkaia;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QII;25.543
48 Bizkaia;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
48 Bizkaia;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
48 Bizkaia;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
48 Bizkaia;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QII;26.343
48 Bizkaia;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
48 Bizkaia;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
48 Bizkaia;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
48 Bizkaia;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2022QII;23.508
48 Bizkaia;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2022QI;""
48 Bizkaia;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
48 Bizkaia;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
48 Bizkaia;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2021QII;24.777
48 Bizkaia;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2021QI;""
48 Bizkaia;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
48 Bizkaia;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
48 Bizkaia;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2020QII;25.778
48 Bizkaia;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2020QI;""
48 Bizkaia;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
48 Bizkaia;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2022QIII;22.948
48 Bizkaia;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2022QII;""
48 Bizkaia;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2022QI;""
48 Bizkaia;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
48 Bizkaia;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2021QIII;24.281
48 Bizkaia;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2021QII;""
48 Bizkaia;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2021QI;""
48 Bizkaia;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
48 Bizkaia;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2020QIII;25.295
48 Bizkaia;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2020QII;""
48 Bizkaia;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2020QI;""
48 Bizkaia;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QIV;22.352
48 Bizkaia;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
48 Bizkaia;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QII;""
48 Bizkaia;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QI;""
48 Bizkaia;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QIV;23.756
48 Bizkaia;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
48 Bizkaia;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QII;""
48 Bizkaia;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QI;""
48 Bizkaia;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QIV;24.742
48 Bizkaia;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
48 Bizkaia;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QII;""
48 Bizkaia;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QI;""
48 Bizkaia;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
48 Bizkaia;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
48 Bizkaia;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QII;""
48 Bizkaia;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QI;23.252
48 Bizkaia;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
48 Bizkaia;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
48 Bizkaia;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QII;""
48 Bizkaia;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QI;24.397
48 Bizkaia;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
48 Bizkaia;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
48 Bizkaia;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QII;""
48 Bizkaia;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QI;""
48 Bizkaia;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
48 Bizkaia;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
48 Bizkaia;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
48 Bizkaia;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
48 Bizkaia;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
48 Bizkaia;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
48 Bizkaia;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
48 Bizkaia;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
48 Bizkaia;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
48 Bizkaia;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
48 Bizkaia;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
48 Bizkaia;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
48 Bizkaia;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
48 Bizkaia;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
48 Bizkaia;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;96,44
48 Bizkaia;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
48 Bizkaia;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
48 Bizkaia;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
48 Bizkaia;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;97
48 Bizkaia;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
48 Bizkaia;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
48 Bizkaia;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
48 Bizkaia;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;97,86
48 Bizkaia;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
48 Bizkaia;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
48 Bizkaia;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;94,14
48 Bizkaia;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
48 Bizkaia;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
48 Bizkaia;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
48 Bizkaia;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;95,06
48 Bizkaia;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
48 Bizkaia;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
48 Bizkaia;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
48 Bizkaia;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;96,02
48 Bizkaia;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
48 Bizkaia;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
48 Bizkaia;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;91,7
48 Bizkaia;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
48 Bizkaia;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
48 Bizkaia;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
48 Bizkaia;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;93
48 Bizkaia;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
48 Bizkaia;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
48 Bizkaia;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
48 Bizkaia;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;93,92
48 Bizkaia;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
48 Bizkaia;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
48 Bizkaia;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
48 Bizkaia;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
48 Bizkaia;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
48 Bizkaia;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
48 Bizkaia;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;91,03
48 Bizkaia;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
48 Bizkaia;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
48 Bizkaia;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
48 Bizkaia;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;92,61
48 Bizkaia;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
48 Bizkaia;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
48 Bizkaia;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
48 Bizkaia;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
48 Bizkaia;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
48 Bizkaia;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
48 Bizkaia;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QII;13.875
48 Bizkaia;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
48 Bizkaia;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
48 Bizkaia;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
48 Bizkaia;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QII;14.643
48 Bizkaia;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
48 Bizkaia;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
48 Bizkaia;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
48 Bizkaia;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QII;15.037
48 Bizkaia;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
48 Bizkaia;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
48 Bizkaia;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
48 Bizkaia;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2022QII;13.462
48 Bizkaia;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2022QI;""
48 Bizkaia;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
48 Bizkaia;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
48 Bizkaia;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2021QII;14.258
48 Bizkaia;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2021QI;""
48 Bizkaia;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
48 Bizkaia;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
48 Bizkaia;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2020QII;14.838
48 Bizkaia;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2020QI;""
48 Bizkaia;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
48 Bizkaia;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2022QIII;13.145
48 Bizkaia;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2022QII;""
48 Bizkaia;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2022QI;""
48 Bizkaia;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
48 Bizkaia;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2021QIII;13.947
48 Bizkaia;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2021QII;""
48 Bizkaia;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2021QI;""
48 Bizkaia;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
48 Bizkaia;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2020QIII;14.564
48 Bizkaia;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2020QII;""
48 Bizkaia;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2020QI;""
48 Bizkaia;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QIV;12.787
48 Bizkaia;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
48 Bizkaia;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QII;""
48 Bizkaia;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QI;""
48 Bizkaia;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QIV;13.607
48 Bizkaia;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
48 Bizkaia;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QII;""
48 Bizkaia;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QI;""
48 Bizkaia;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QIV;14.236
48 Bizkaia;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
48 Bizkaia;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QII;""
48 Bizkaia;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QI;""
48 Bizkaia;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
48 Bizkaia;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
48 Bizkaia;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QII;""
48 Bizkaia;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QI;13.312
48 Bizkaia;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
48 Bizkaia;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
48 Bizkaia;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QII;""
48 Bizkaia;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QI;14.018
48 Bizkaia;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
48 Bizkaia;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
48 Bizkaia;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QII;""
48 Bizkaia;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QI;""
48 Bizkaia;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
48 Bizkaia;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
48 Bizkaia;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
48 Bizkaia;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
48 Bizkaia;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
48 Bizkaia;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
48 Bizkaia;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
48 Bizkaia;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
48 Bizkaia;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
48 Bizkaia;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
48 Bizkaia;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
48 Bizkaia;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
48 Bizkaia;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
48 Bizkaia;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
48 Bizkaia;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;97,02
48 Bizkaia;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
48 Bizkaia;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
48 Bizkaia;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
48 Bizkaia;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;97,37
48 Bizkaia;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
48 Bizkaia;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
48 Bizkaia;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
48 Bizkaia;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;98,68
48 Bizkaia;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
48 Bizkaia;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
48 Bizkaia;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;94,74
48 Bizkaia;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
48 Bizkaia;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
48 Bizkaia;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
48 Bizkaia;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;95,25
48 Bizkaia;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
48 Bizkaia;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
48 Bizkaia;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
48 Bizkaia;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;96,85
48 Bizkaia;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
48 Bizkaia;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
48 Bizkaia;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;92,16
48 Bizkaia;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
48 Bizkaia;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
48 Bizkaia;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
48 Bizkaia;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;92,92
48 Bizkaia;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
48 Bizkaia;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
48 Bizkaia;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
48 Bizkaia;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;94,67
48 Bizkaia;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
48 Bizkaia;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
48 Bizkaia;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
48 Bizkaia;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
48 Bizkaia;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
48 Bizkaia;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
48 Bizkaia;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;90,91
48 Bizkaia;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
48 Bizkaia;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
48 Bizkaia;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
48 Bizkaia;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;93,22
48 Bizkaia;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
48 Bizkaia;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
48 Bizkaia;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
48 Bizkaia;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
48 Bizkaia;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
48 Bizkaia;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
48 Bizkaia;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QII;10.501
48 Bizkaia;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
48 Bizkaia;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
48 Bizkaia;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
48 Bizkaia;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QII;10.900
48 Bizkaia;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
48 Bizkaia;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
48 Bizkaia;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
48 Bizkaia;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QII;11.306
48 Bizkaia;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
48 Bizkaia;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
48 Bizkaia;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
48 Bizkaia;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2022QII;10.046
48 Bizkaia;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2022QI;""
48 Bizkaia;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
48 Bizkaia;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
48 Bizkaia;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2021QII;10.519
48 Bizkaia;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2021QI;""
48 Bizkaia;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
48 Bizkaia;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
48 Bizkaia;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2020QII;10.940
48 Bizkaia;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2020QI;""
48 Bizkaia;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
48 Bizkaia;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2022QIII;9.803
48 Bizkaia;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2022QII;""
48 Bizkaia;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2022QI;""
48 Bizkaia;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
48 Bizkaia;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2021QIII;10.334
48 Bizkaia;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2021QII;""
48 Bizkaia;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2021QI;""
48 Bizkaia;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
48 Bizkaia;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2020QIII;10.731
48 Bizkaia;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2020QII;""
48 Bizkaia;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2020QI;""
48 Bizkaia;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QIV;9.565
48 Bizkaia;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
48 Bizkaia;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QII;""
48 Bizkaia;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QI;""
48 Bizkaia;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QIV;10.149
48 Bizkaia;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
48 Bizkaia;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QII;""
48 Bizkaia;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QI;""
48 Bizkaia;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QIV;10.506
48 Bizkaia;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
48 Bizkaia;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QII;""
48 Bizkaia;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QI;""
48 Bizkaia;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
48 Bizkaia;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
48 Bizkaia;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QII;""
48 Bizkaia;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QI;9.940
48 Bizkaia;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
48 Bizkaia;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
48 Bizkaia;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QII;""
48 Bizkaia;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QI;10.379
48 Bizkaia;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
48 Bizkaia;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
48 Bizkaia;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QII;""
48 Bizkaia;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QI;""
48 Bizkaia;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
48 Bizkaia;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
48 Bizkaia;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
48 Bizkaia;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
48 Bizkaia;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
48 Bizkaia;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
48 Bizkaia;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
48 Bizkaia;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
48 Bizkaia;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
48 Bizkaia;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
48 Bizkaia;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
48 Bizkaia;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
48 Bizkaia;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
48 Bizkaia;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
48 Bizkaia;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;95,67
48 Bizkaia;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
48 Bizkaia;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
48 Bizkaia;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
48 Bizkaia;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;96,5
48 Bizkaia;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
48 Bizkaia;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
48 Bizkaia;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
48 Bizkaia;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;96,76
48 Bizkaia;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
48 Bizkaia;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
48 Bizkaia;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;93,35
48 Bizkaia;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
48 Bizkaia;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
48 Bizkaia;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
48 Bizkaia;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;94,81
48 Bizkaia;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
48 Bizkaia;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
48 Bizkaia;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
48 Bizkaia;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;94,91
48 Bizkaia;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
48 Bizkaia;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
48 Bizkaia;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;91,09
48 Bizkaia;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
48 Bizkaia;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
48 Bizkaia;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
48 Bizkaia;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;93,11
48 Bizkaia;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
48 Bizkaia;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
48 Bizkaia;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
48 Bizkaia;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;92,92
48 Bizkaia;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
48 Bizkaia;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
48 Bizkaia;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
48 Bizkaia;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
48 Bizkaia;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
48 Bizkaia;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
48 Bizkaia;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;91,19
48 Bizkaia;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
48 Bizkaia;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
48 Bizkaia;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
48 Bizkaia;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;91,8
48 Bizkaia;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
48 Bizkaia;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
48 Bizkaia;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
48 Bizkaia;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
48 Bizkaia;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
48 Bizkaia;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QIII;24.241
48 Bizkaia;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
48 Bizkaia;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
48 Bizkaia;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
48 Bizkaia;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QIII;25.426
48 Bizkaia;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
48 Bizkaia;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
48 Bizkaia;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
48 Bizkaia;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QIII;26.249
48 Bizkaia;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
48 Bizkaia;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
48 Bizkaia;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
48 Bizkaia;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2022QIII;23.614
48 Bizkaia;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2022QII;""
48 Bizkaia;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2022QI;""
48 Bizkaia;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
48 Bizkaia;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2021QIII;24.864
48 Bizkaia;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2021QII;""
48 Bizkaia;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2021QI;""
48 Bizkaia;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
48 Bizkaia;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2020QIII;25.721
48 Bizkaia;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2020QII;""
48 Bizkaia;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2020QI;""
48 Bizkaia;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2022QIV;22.955
48 Bizkaia;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
48 Bizkaia;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2022QII;""
48 Bizkaia;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2022QI;""
48 Bizkaia;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2021QIV;24.288
48 Bizkaia;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
48 Bizkaia;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2021QII;""
48 Bizkaia;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2021QI;""
48 Bizkaia;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2020QIV;25.137
48 Bizkaia;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
48 Bizkaia;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2020QII;""
48 Bizkaia;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2020QI;""
48 Bizkaia;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
48 Bizkaia;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
48 Bizkaia;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QII;""
48 Bizkaia;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QI;23.743
48 Bizkaia;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
48 Bizkaia;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
48 Bizkaia;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QII;""
48 Bizkaia;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QI;24.773
48 Bizkaia;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
48 Bizkaia;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
48 Bizkaia;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QII;""
48 Bizkaia;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QI;""
48 Bizkaia;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
48 Bizkaia;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
48 Bizkaia;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QII;23.158
48 Bizkaia;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QI;""
48 Bizkaia;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
48 Bizkaia;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
48 Bizkaia;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QII;24.291
48 Bizkaia;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QI;""
48 Bizkaia;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
48 Bizkaia;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
48 Bizkaia;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QII;""
48 Bizkaia;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QI;""
48 Bizkaia;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
48 Bizkaia;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
48 Bizkaia;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
48 Bizkaia;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
48 Bizkaia;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
48 Bizkaia;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
48 Bizkaia;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
48 Bizkaia;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
48 Bizkaia;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
48 Bizkaia;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
48 Bizkaia;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
48 Bizkaia;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
48 Bizkaia;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
48 Bizkaia;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;97,41
48 Bizkaia;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
48 Bizkaia;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
48 Bizkaia;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
48 Bizkaia;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;97,79
48 Bizkaia;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
48 Bizkaia;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
48 Bizkaia;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
48 Bizkaia;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;97,99
48 Bizkaia;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
48 Bizkaia;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
48 Bizkaia;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;94,69
48 Bizkaia;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
48 Bizkaia;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
48 Bizkaia;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
48 Bizkaia;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;95,52
48 Bizkaia;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
48 Bizkaia;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
48 Bizkaia;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
48 Bizkaia;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;95,76
48 Bizkaia;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
48 Bizkaia;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
48 Bizkaia;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
48 Bizkaia;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
48 Bizkaia;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
48 Bizkaia;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
48 Bizkaia;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;93,38
48 Bizkaia;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
48 Bizkaia;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
48 Bizkaia;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
48 Bizkaia;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;94,38
48 Bizkaia;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
48 Bizkaia;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
48 Bizkaia;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
48 Bizkaia;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
48 Bizkaia;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
48 Bizkaia;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
48 Bizkaia;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;91,08
48 Bizkaia;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
48 Bizkaia;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
48 Bizkaia;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
48 Bizkaia;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;92,54
48 Bizkaia;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
48 Bizkaia;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
48 Bizkaia;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
48 Bizkaia;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
48 Bizkaia;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
48 Bizkaia;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
48 Bizkaia;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QIII;13.874
48 Bizkaia;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
48 Bizkaia;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
48 Bizkaia;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
48 Bizkaia;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QIII;14.647
48 Bizkaia;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
48 Bizkaia;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
48 Bizkaia;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
48 Bizkaia;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QIII;15.136
48 Bizkaia;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
48 Bizkaia;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
48 Bizkaia;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
48 Bizkaia;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2022QIII;13.513
48 Bizkaia;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2022QII;""
48 Bizkaia;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2022QI;""
48 Bizkaia;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
48 Bizkaia;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2021QIII;14.286
48 Bizkaia;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2021QII;""
48 Bizkaia;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2021QI;""
48 Bizkaia;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
48 Bizkaia;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2020QIII;14.827
48 Bizkaia;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2020QII;""
48 Bizkaia;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2020QI;""
48 Bizkaia;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2022QIV;13.113
48 Bizkaia;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
48 Bizkaia;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2022QII;""
48 Bizkaia;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2022QI;""
48 Bizkaia;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2021QIV;13.911
48 Bizkaia;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
48 Bizkaia;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2021QII;""
48 Bizkaia;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2021QI;""
48 Bizkaia;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2020QIV;14.478
48 Bizkaia;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
48 Bizkaia;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2020QII;""
48 Bizkaia;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2020QI;""
48 Bizkaia;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
48 Bizkaia;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
48 Bizkaia;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QII;""
48 Bizkaia;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QI;13.584
48 Bizkaia;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
48 Bizkaia;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
48 Bizkaia;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QII;""
48 Bizkaia;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QI;14.250
48 Bizkaia;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
48 Bizkaia;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
48 Bizkaia;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QII;""
48 Bizkaia;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QI;""
48 Bizkaia;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
48 Bizkaia;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
48 Bizkaia;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QII;13.264
48 Bizkaia;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QI;""
48 Bizkaia;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
48 Bizkaia;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
48 Bizkaia;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QII;13.966
48 Bizkaia;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QI;""
48 Bizkaia;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
48 Bizkaia;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
48 Bizkaia;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QII;""
48 Bizkaia;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QI;""
48 Bizkaia;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
48 Bizkaia;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
48 Bizkaia;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
48 Bizkaia;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
48 Bizkaia;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
48 Bizkaia;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
48 Bizkaia;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
48 Bizkaia;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
48 Bizkaia;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
48 Bizkaia;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
48 Bizkaia;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
48 Bizkaia;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
48 Bizkaia;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
48 Bizkaia;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;97,4
48 Bizkaia;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
48 Bizkaia;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
48 Bizkaia;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
48 Bizkaia;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;97,54
48 Bizkaia;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
48 Bizkaia;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
48 Bizkaia;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
48 Bizkaia;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;97,96
48 Bizkaia;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
48 Bizkaia;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
48 Bizkaia;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;94,51
48 Bizkaia;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
48 Bizkaia;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
48 Bizkaia;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
48 Bizkaia;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;94,98
48 Bizkaia;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
48 Bizkaia;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
48 Bizkaia;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
48 Bizkaia;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;95,65
48 Bizkaia;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
48 Bizkaia;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
48 Bizkaia;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
48 Bizkaia;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
48 Bizkaia;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
48 Bizkaia;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
48 Bizkaia;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;92,74
48 Bizkaia;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
48 Bizkaia;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
48 Bizkaia;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
48 Bizkaia;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;94,15
48 Bizkaia;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
48 Bizkaia;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
48 Bizkaia;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
48 Bizkaia;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
48 Bizkaia;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
48 Bizkaia;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
48 Bizkaia;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;90,56
48 Bizkaia;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
48 Bizkaia;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
48 Bizkaia;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
48 Bizkaia;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;92,27
48 Bizkaia;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
48 Bizkaia;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
48 Bizkaia;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
48 Bizkaia;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
48 Bizkaia;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
48 Bizkaia;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
48 Bizkaia;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QIII;10.367
48 Bizkaia;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
48 Bizkaia;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
48 Bizkaia;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
48 Bizkaia;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QIII;10.779
48 Bizkaia;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
48 Bizkaia;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
48 Bizkaia;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
48 Bizkaia;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QIII;11.113
48 Bizkaia;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
48 Bizkaia;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
48 Bizkaia;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
48 Bizkaia;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2022QIII;10.101
48 Bizkaia;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2022QII;""
48 Bizkaia;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2022QI;""
48 Bizkaia;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
48 Bizkaia;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2021QIII;10.578
48 Bizkaia;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2021QII;""
48 Bizkaia;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2021QI;""
48 Bizkaia;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
48 Bizkaia;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2020QIII;10.894
48 Bizkaia;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2020QII;""
48 Bizkaia;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2020QI;""
48 Bizkaia;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2022QIV;9.842
48 Bizkaia;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
48 Bizkaia;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2022QII;""
48 Bizkaia;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2022QI;""
48 Bizkaia;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2021QIV;10.377
48 Bizkaia;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
48 Bizkaia;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2021QII;""
48 Bizkaia;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2021QI;""
48 Bizkaia;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2020QIV;10.659
48 Bizkaia;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
48 Bizkaia;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2020QII;""
48 Bizkaia;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2020QI;""
48 Bizkaia;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
48 Bizkaia;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
48 Bizkaia;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QII;""
48 Bizkaia;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QI;10.159
48 Bizkaia;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
48 Bizkaia;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
48 Bizkaia;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QII;""
48 Bizkaia;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QI;10.523
48 Bizkaia;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
48 Bizkaia;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
48 Bizkaia;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QII;""
48 Bizkaia;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QI;""
48 Bizkaia;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
48 Bizkaia;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
48 Bizkaia;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QII;9.894
48 Bizkaia;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QI;""
48 Bizkaia;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
48 Bizkaia;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
48 Bizkaia;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QII;10.325
48 Bizkaia;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QI;""
48 Bizkaia;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
48 Bizkaia;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
48 Bizkaia;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QII;""
48 Bizkaia;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QI;""
48 Bizkaia;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
48 Bizkaia;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
48 Bizkaia;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
48 Bizkaia;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
48 Bizkaia;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
48 Bizkaia;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
48 Bizkaia;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
48 Bizkaia;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
48 Bizkaia;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
48 Bizkaia;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
48 Bizkaia;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
48 Bizkaia;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
48 Bizkaia;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
48 Bizkaia;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;97,43
48 Bizkaia;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
48 Bizkaia;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
48 Bizkaia;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
48 Bizkaia;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;98,14
48 Bizkaia;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
48 Bizkaia;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
48 Bizkaia;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
48 Bizkaia;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;98,03
48 Bizkaia;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
48 Bizkaia;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
48 Bizkaia;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;94,94
48 Bizkaia;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
48 Bizkaia;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
48 Bizkaia;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
48 Bizkaia;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;96,27
48 Bizkaia;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
48 Bizkaia;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
48 Bizkaia;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
48 Bizkaia;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;95,91
48 Bizkaia;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
48 Bizkaia;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
48 Bizkaia;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
48 Bizkaia;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
48 Bizkaia;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
48 Bizkaia;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
48 Bizkaia;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;94,25
48 Bizkaia;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
48 Bizkaia;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
48 Bizkaia;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
48 Bizkaia;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;94,69
48 Bizkaia;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
48 Bizkaia;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
48 Bizkaia;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
48 Bizkaia;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
48 Bizkaia;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
48 Bizkaia;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
48 Bizkaia;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;91,79
48 Bizkaia;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
48 Bizkaia;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
48 Bizkaia;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
48 Bizkaia;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;92,91
48 Bizkaia;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
48 Bizkaia;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
48 Bizkaia;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
48 Bizkaia;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
48 Bizkaia;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
48 Bizkaia;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QIV;24.197
48 Bizkaia;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
48 Bizkaia;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
48 Bizkaia;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
48 Bizkaia;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QIV;25.476
48 Bizkaia;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
48 Bizkaia;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
48 Bizkaia;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
48 Bizkaia;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QIV;26.339
48 Bizkaia;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
48 Bizkaia;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
48 Bizkaia;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
48 Bizkaia;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2022QIV;23.486
48 Bizkaia;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
48 Bizkaia;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2022QII;""
48 Bizkaia;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2022QI;""
48 Bizkaia;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2021QIV;24.845
48 Bizkaia;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
48 Bizkaia;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2021QII;""
48 Bizkaia;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2021QI;""
48 Bizkaia;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2020QIV;25.695
48 Bizkaia;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
48 Bizkaia;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2020QII;""
48 Bizkaia;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2020QI;""
48 Bizkaia;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
48 Bizkaia;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
48 Bizkaia;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2022QII;""
48 Bizkaia;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2022QI;24.266
48 Bizkaia;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
48 Bizkaia;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
48 Bizkaia;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2021QII;""
48 Bizkaia;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2021QI;25.298
48 Bizkaia;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
48 Bizkaia;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
48 Bizkaia;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2020QII;""
48 Bizkaia;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2020QI;""
48 Bizkaia;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
48 Bizkaia;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
48 Bizkaia;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QII;23.622
48 Bizkaia;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QI;""
48 Bizkaia;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
48 Bizkaia;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
48 Bizkaia;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QII;24.759
48 Bizkaia;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QI;""
48 Bizkaia;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
48 Bizkaia;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
48 Bizkaia;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QII;""
48 Bizkaia;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QI;""
48 Bizkaia;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
48 Bizkaia;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QIII;23.157
48 Bizkaia;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QII;""
48 Bizkaia;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QI;""
48 Bizkaia;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
48 Bizkaia;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QIII;24.346
48 Bizkaia;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QII;""
48 Bizkaia;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QI;""
48 Bizkaia;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
48 Bizkaia;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
48 Bizkaia;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QII;""
48 Bizkaia;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QI;""
48 Bizkaia;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
48 Bizkaia;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
48 Bizkaia;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
48 Bizkaia;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
48 Bizkaia;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
48 Bizkaia;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
48 Bizkaia;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
48 Bizkaia;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
48 Bizkaia;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
48 Bizkaia;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
48 Bizkaia;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
48 Bizkaia;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
48 Bizkaia;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;97,06
48 Bizkaia;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
48 Bizkaia;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
48 Bizkaia;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
48 Bizkaia;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;97,52
48 Bizkaia;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
48 Bizkaia;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
48 Bizkaia;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
48 Bizkaia;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;97,55
48 Bizkaia;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
48 Bizkaia;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
48 Bizkaia;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
48 Bizkaia;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
48 Bizkaia;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
48 Bizkaia;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
48 Bizkaia;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;95,25
48 Bizkaia;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
48 Bizkaia;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
48 Bizkaia;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
48 Bizkaia;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;96,05
48 Bizkaia;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
48 Bizkaia;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
48 Bizkaia;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
48 Bizkaia;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
48 Bizkaia;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
48 Bizkaia;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
48 Bizkaia;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;92,72
48 Bizkaia;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
48 Bizkaia;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
48 Bizkaia;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
48 Bizkaia;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;94
48 Bizkaia;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
48 Bizkaia;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
48 Bizkaia;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
48 Bizkaia;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
48 Bizkaia;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
48 Bizkaia;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
48 Bizkaia;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;90,9
48 Bizkaia;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
48 Bizkaia;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
48 Bizkaia;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
48 Bizkaia;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;92,43
48 Bizkaia;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
48 Bizkaia;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
48 Bizkaia;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
48 Bizkaia;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
48 Bizkaia;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
48 Bizkaia;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
48 Bizkaia;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QIV;13.811
48 Bizkaia;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
48 Bizkaia;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
48 Bizkaia;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
48 Bizkaia;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QIV;14.608
48 Bizkaia;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
48 Bizkaia;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
48 Bizkaia;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
48 Bizkaia;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QIV;15.163
48 Bizkaia;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
48 Bizkaia;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
48 Bizkaia;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
48 Bizkaia;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2022QIV;13.378
48 Bizkaia;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
48 Bizkaia;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2022QII;""
48 Bizkaia;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2022QI;""
48 Bizkaia;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2021QIV;14.197
48 Bizkaia;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
48 Bizkaia;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2021QII;""
48 Bizkaia;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2021QI;""
48 Bizkaia;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2020QIV;14.768
48 Bizkaia;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
48 Bizkaia;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2020QII;""
48 Bizkaia;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2020QI;""
48 Bizkaia;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
48 Bizkaia;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
48 Bizkaia;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2022QII;""
48 Bizkaia;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2022QI;13.846
48 Bizkaia;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
48 Bizkaia;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
48 Bizkaia;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2021QII;""
48 Bizkaia;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2021QI;14.515
48 Bizkaia;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
48 Bizkaia;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
48 Bizkaia;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2020QII;""
48 Bizkaia;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2020QI;""
48 Bizkaia;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
48 Bizkaia;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
48 Bizkaia;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QII;13.512
48 Bizkaia;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QI;""
48 Bizkaia;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
48 Bizkaia;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
48 Bizkaia;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QII;14.212
48 Bizkaia;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QI;""
48 Bizkaia;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
48 Bizkaia;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
48 Bizkaia;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QII;""
48 Bizkaia;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QI;""
48 Bizkaia;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
48 Bizkaia;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QIII;13.251
48 Bizkaia;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QII;""
48 Bizkaia;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QI;""
48 Bizkaia;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
48 Bizkaia;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QIII;13.961
48 Bizkaia;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QII;""
48 Bizkaia;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QI;""
48 Bizkaia;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
48 Bizkaia;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
48 Bizkaia;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QII;""
48 Bizkaia;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QI;""
48 Bizkaia;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
48 Bizkaia;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
48 Bizkaia;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
48 Bizkaia;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
48 Bizkaia;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
48 Bizkaia;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
48 Bizkaia;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
48 Bizkaia;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
48 Bizkaia;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
48 Bizkaia;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
48 Bizkaia;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
48 Bizkaia;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
48 Bizkaia;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;96,86
48 Bizkaia;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
48 Bizkaia;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
48 Bizkaia;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
48 Bizkaia;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;97,19
48 Bizkaia;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
48 Bizkaia;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
48 Bizkaia;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
48 Bizkaia;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;97,39
48 Bizkaia;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
48 Bizkaia;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
48 Bizkaia;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
48 Bizkaia;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
48 Bizkaia;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
48 Bizkaia;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
48 Bizkaia;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;94,78
48 Bizkaia;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
48 Bizkaia;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
48 Bizkaia;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
48 Bizkaia;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;95,73
48 Bizkaia;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
48 Bizkaia;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
48 Bizkaia;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
48 Bizkaia;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
48 Bizkaia;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
48 Bizkaia;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
48 Bizkaia;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;92,5
48 Bizkaia;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
48 Bizkaia;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
48 Bizkaia;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
48 Bizkaia;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;93,73
48 Bizkaia;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
48 Bizkaia;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
48 Bizkaia;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
48 Bizkaia;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
48 Bizkaia;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
48 Bizkaia;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
48 Bizkaia;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;90,71
48 Bizkaia;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
48 Bizkaia;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
48 Bizkaia;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
48 Bizkaia;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;92,07
48 Bizkaia;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
48 Bizkaia;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
48 Bizkaia;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
48 Bizkaia;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
48 Bizkaia;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
48 Bizkaia;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
48 Bizkaia;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QIV;10.386
48 Bizkaia;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
48 Bizkaia;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
48 Bizkaia;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
48 Bizkaia;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QIV;10.868
48 Bizkaia;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
48 Bizkaia;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
48 Bizkaia;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
48 Bizkaia;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QIV;11.176
48 Bizkaia;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
48 Bizkaia;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
48 Bizkaia;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
48 Bizkaia;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2022QIV;10.108
48 Bizkaia;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
48 Bizkaia;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2022QII;""
48 Bizkaia;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2022QI;""
48 Bizkaia;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2021QIV;10.648
48 Bizkaia;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
48 Bizkaia;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2021QII;""
48 Bizkaia;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2021QI;""
48 Bizkaia;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2020QIV;10.927
48 Bizkaia;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
48 Bizkaia;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2020QII;""
48 Bizkaia;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2020QI;""
48 Bizkaia;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
48 Bizkaia;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
48 Bizkaia;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2022QII;""
48 Bizkaia;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2022QI;10.420
48 Bizkaia;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
48 Bizkaia;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
48 Bizkaia;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2021QII;""
48 Bizkaia;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2021QI;10.783
48 Bizkaia;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
48 Bizkaia;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
48 Bizkaia;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2020QII;""
48 Bizkaia;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2020QI;""
48 Bizkaia;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
48 Bizkaia;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
48 Bizkaia;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QII;10.110
48 Bizkaia;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QI;""
48 Bizkaia;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
48 Bizkaia;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
48 Bizkaia;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QII;10.547
48 Bizkaia;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QI;""
48 Bizkaia;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
48 Bizkaia;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
48 Bizkaia;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QII;""
48 Bizkaia;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QI;""
48 Bizkaia;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
48 Bizkaia;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QIII;9.906
48 Bizkaia;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QII;""
48 Bizkaia;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QI;""
48 Bizkaia;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
48 Bizkaia;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QIII;10.385
48 Bizkaia;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QII;""
48 Bizkaia;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QI;""
48 Bizkaia;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
48 Bizkaia;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
48 Bizkaia;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QII;""
48 Bizkaia;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QI;""
48 Bizkaia;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
48 Bizkaia;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
48 Bizkaia;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
48 Bizkaia;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
48 Bizkaia;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
48 Bizkaia;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
48 Bizkaia;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
48 Bizkaia;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
48 Bizkaia;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
48 Bizkaia;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
48 Bizkaia;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
48 Bizkaia;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
48 Bizkaia;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;97,32
48 Bizkaia;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
48 Bizkaia;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
48 Bizkaia;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
48 Bizkaia;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;97,98
48 Bizkaia;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
48 Bizkaia;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
48 Bizkaia;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
48 Bizkaia;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;97,77
48 Bizkaia;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
48 Bizkaia;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
48 Bizkaia;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
48 Bizkaia;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
48 Bizkaia;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
48 Bizkaia;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
48 Bizkaia;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;95,88
48 Bizkaia;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
48 Bizkaia;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
48 Bizkaia;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
48 Bizkaia;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;96,48
48 Bizkaia;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
48 Bizkaia;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
48 Bizkaia;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
48 Bizkaia;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
48 Bizkaia;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
48 Bizkaia;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
48 Bizkaia;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;93,03
48 Bizkaia;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
48 Bizkaia;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
48 Bizkaia;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
48 Bizkaia;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;94,37
48 Bizkaia;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
48 Bizkaia;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
48 Bizkaia;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
48 Bizkaia;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
48 Bizkaia;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
48 Bizkaia;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
48 Bizkaia;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;91,15
48 Bizkaia;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
48 Bizkaia;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
48 Bizkaia;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
48 Bizkaia;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;92,92
48 Bizkaia;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
48 Bizkaia;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
48 Bizkaia;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
48 Bizkaia;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
48 Bizkaia;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
48 Bizkaia;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
48 Bizkaia;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
48 Bizkaia;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
48 Bizkaia;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
48 Bizkaia;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QI;27.108
48 Bizkaia;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
48 Bizkaia;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
48 Bizkaia;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
48 Bizkaia;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QI;26.542
48 Bizkaia;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
48 Bizkaia;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
48 Bizkaia;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
48 Bizkaia;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QI;26.979
48 Bizkaia;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
48 Bizkaia;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
48 Bizkaia;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2022QII;""
48 Bizkaia;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2022QI;26.628
48 Bizkaia;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
48 Bizkaia;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
48 Bizkaia;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2021QII;""
48 Bizkaia;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2021QI;26.175
48 Bizkaia;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
48 Bizkaia;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
48 Bizkaia;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2020QII;""
48 Bizkaia;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2020QI;26.155
48 Bizkaia;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
48 Bizkaia;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
48 Bizkaia;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2022QII;26.090
48 Bizkaia;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2022QI;""
48 Bizkaia;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
48 Bizkaia;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
48 Bizkaia;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2021QII;25.766
48 Bizkaia;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2021QI;""
48 Bizkaia;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
48 Bizkaia;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
48 Bizkaia;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2020QII;25.833
48 Bizkaia;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2020QI;""
48 Bizkaia;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
48 Bizkaia;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QIII;25.722
48 Bizkaia;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QII;""
48 Bizkaia;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QI;""
48 Bizkaia;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
48 Bizkaia;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QIII;25.398
48 Bizkaia;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QII;""
48 Bizkaia;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QI;""
48 Bizkaia;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
48 Bizkaia;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QIII;25.481
48 Bizkaia;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QII;""
48 Bizkaia;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QI;""
48 Bizkaia;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QIV;25.225
48 Bizkaia;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
48 Bizkaia;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QII;""
48 Bizkaia;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QI;""
48 Bizkaia;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QIV;24.982
48 Bizkaia;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
48 Bizkaia;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QII;""
48 Bizkaia;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QI;""
48 Bizkaia;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QIV;25.129
48 Bizkaia;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
48 Bizkaia;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QII;""
48 Bizkaia;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QI;""
48 Bizkaia;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
48 Bizkaia;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
48 Bizkaia;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
48 Bizkaia;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
48 Bizkaia;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
48 Bizkaia;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
48 Bizkaia;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
48 Bizkaia;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
48 Bizkaia;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
48 Bizkaia;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
48 Bizkaia;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
48 Bizkaia;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
48 Bizkaia;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
48 Bizkaia;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
48 Bizkaia;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
48 Bizkaia;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;98,23
48 Bizkaia;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
48 Bizkaia;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
48 Bizkaia;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
48 Bizkaia;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;98,62
48 Bizkaia;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
48 Bizkaia;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
48 Bizkaia;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
48 Bizkaia;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;96,95
48 Bizkaia;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
48 Bizkaia;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
48 Bizkaia;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;96,24
48 Bizkaia;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
48 Bizkaia;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
48 Bizkaia;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
48 Bizkaia;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;97,08
48 Bizkaia;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
48 Bizkaia;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
48 Bizkaia;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
48 Bizkaia;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;95,75
48 Bizkaia;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
48 Bizkaia;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
48 Bizkaia;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;94,89
48 Bizkaia;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
48 Bizkaia;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
48 Bizkaia;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
48 Bizkaia;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;95,69
48 Bizkaia;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
48 Bizkaia;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
48 Bizkaia;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
48 Bizkaia;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;94,45
48 Bizkaia;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
48 Bizkaia;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
48 Bizkaia;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;93,05
48 Bizkaia;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
48 Bizkaia;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
48 Bizkaia;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
48 Bizkaia;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;94,12
48 Bizkaia;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
48 Bizkaia;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
48 Bizkaia;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
48 Bizkaia;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;93,14
48 Bizkaia;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
48 Bizkaia;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
48 Bizkaia;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
48 Bizkaia;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
48 Bizkaia;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
48 Bizkaia;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
48 Bizkaia;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QI;16.221
48 Bizkaia;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
48 Bizkaia;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
48 Bizkaia;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
48 Bizkaia;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QI;16.081
48 Bizkaia;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
48 Bizkaia;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
48 Bizkaia;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
48 Bizkaia;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QI;16.332
48 Bizkaia;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
48 Bizkaia;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
48 Bizkaia;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2022QII;""
48 Bizkaia;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2022QI;15.934
48 Bizkaia;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
48 Bizkaia;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
48 Bizkaia;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2021QII;""
48 Bizkaia;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2021QI;15.866
48 Bizkaia;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
48 Bizkaia;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
48 Bizkaia;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2020QII;""
48 Bizkaia;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2020QI;15.861
48 Bizkaia;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
48 Bizkaia;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
48 Bizkaia;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2022QII;15.655
48 Bizkaia;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2022QI;""
48 Bizkaia;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
48 Bizkaia;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
48 Bizkaia;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2021QII;15.658
48 Bizkaia;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2021QI;""
48 Bizkaia;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
48 Bizkaia;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
48 Bizkaia;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2020QII;15.700
48 Bizkaia;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2020QI;""
48 Bizkaia;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
48 Bizkaia;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QIII;15.445
48 Bizkaia;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QII;""
48 Bizkaia;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QI;""
48 Bizkaia;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
48 Bizkaia;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QIII;15.461
48 Bizkaia;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QII;""
48 Bizkaia;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QI;""
48 Bizkaia;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
48 Bizkaia;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QIII;15.509
48 Bizkaia;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QII;""
48 Bizkaia;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QI;""
48 Bizkaia;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QIV;15.153
48 Bizkaia;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
48 Bizkaia;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QII;""
48 Bizkaia;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QI;""
48 Bizkaia;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QIV;15.223
48 Bizkaia;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
48 Bizkaia;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QII;""
48 Bizkaia;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QI;""
48 Bizkaia;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QIV;15.297
48 Bizkaia;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
48 Bizkaia;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QII;""
48 Bizkaia;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QI;""
48 Bizkaia;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
48 Bizkaia;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
48 Bizkaia;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
48 Bizkaia;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
48 Bizkaia;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
48 Bizkaia;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
48 Bizkaia;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
48 Bizkaia;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
48 Bizkaia;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
48 Bizkaia;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
48 Bizkaia;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
48 Bizkaia;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
48 Bizkaia;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
48 Bizkaia;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
48 Bizkaia;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
48 Bizkaia;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;98,23
48 Bizkaia;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
48 Bizkaia;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
48 Bizkaia;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
48 Bizkaia;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;98,66
48 Bizkaia;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
48 Bizkaia;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
48 Bizkaia;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
48 Bizkaia;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;97,12
48 Bizkaia;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
48 Bizkaia;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
48 Bizkaia;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;96,51
48 Bizkaia;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
48 Bizkaia;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
48 Bizkaia;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
48 Bizkaia;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;97,37
48 Bizkaia;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
48 Bizkaia;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
48 Bizkaia;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
48 Bizkaia;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;96,13
48 Bizkaia;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
48 Bizkaia;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
48 Bizkaia;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;95,22
48 Bizkaia;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
48 Bizkaia;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
48 Bizkaia;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
48 Bizkaia;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;96,14
48 Bizkaia;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
48 Bizkaia;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
48 Bizkaia;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
48 Bizkaia;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;94,96
48 Bizkaia;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
48 Bizkaia;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
48 Bizkaia;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;93,42
48 Bizkaia;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
48 Bizkaia;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
48 Bizkaia;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
48 Bizkaia;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;94,66
48 Bizkaia;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
48 Bizkaia;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
48 Bizkaia;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
48 Bizkaia;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;93,66
48 Bizkaia;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
48 Bizkaia;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
48 Bizkaia;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
48 Bizkaia;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
48 Bizkaia;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
48 Bizkaia;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
48 Bizkaia;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QI;10.887
48 Bizkaia;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
48 Bizkaia;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
48 Bizkaia;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
48 Bizkaia;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QI;10.461
48 Bizkaia;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
48 Bizkaia;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
48 Bizkaia;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
48 Bizkaia;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QI;10.647
48 Bizkaia;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
48 Bizkaia;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
48 Bizkaia;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2022QII;""
48 Bizkaia;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2022QI;10.694
48 Bizkaia;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
48 Bizkaia;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
48 Bizkaia;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2021QII;""
48 Bizkaia;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2021QI;10.309
48 Bizkaia;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
48 Bizkaia;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
48 Bizkaia;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2020QII;""
48 Bizkaia;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2020QI;10.294
48 Bizkaia;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
48 Bizkaia;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
48 Bizkaia;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2022QII;10.435
48 Bizkaia;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2022QI;""
48 Bizkaia;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
48 Bizkaia;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
48 Bizkaia;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2021QII;10.108
48 Bizkaia;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2021QI;""
48 Bizkaia;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
48 Bizkaia;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
48 Bizkaia;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2020QII;10.133
48 Bizkaia;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2020QI;""
48 Bizkaia;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
48 Bizkaia;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QIII;10.277
48 Bizkaia;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QII;""
48 Bizkaia;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QI;""
48 Bizkaia;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
48 Bizkaia;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QIII;9.937
48 Bizkaia;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QII;""
48 Bizkaia;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QI;""
48 Bizkaia;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
48 Bizkaia;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QIII;9.972
48 Bizkaia;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QII;""
48 Bizkaia;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QI;""
48 Bizkaia;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QIV;10.072
48 Bizkaia;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
48 Bizkaia;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QII;""
48 Bizkaia;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QI;""
48 Bizkaia;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QIV;9.759
48 Bizkaia;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
48 Bizkaia;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QII;""
48 Bizkaia;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QI;""
48 Bizkaia;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QIV;9.832
48 Bizkaia;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
48 Bizkaia;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QII;""
48 Bizkaia;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QI;""
48 Bizkaia;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
48 Bizkaia;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
48 Bizkaia;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
48 Bizkaia;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
48 Bizkaia;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
48 Bizkaia;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
48 Bizkaia;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
48 Bizkaia;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
48 Bizkaia;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
48 Bizkaia;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
48 Bizkaia;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
48 Bizkaia;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
48 Bizkaia;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
48 Bizkaia;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
48 Bizkaia;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
48 Bizkaia;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;98,23
48 Bizkaia;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
48 Bizkaia;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
48 Bizkaia;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
48 Bizkaia;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;98,55
48 Bizkaia;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
48 Bizkaia;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
48 Bizkaia;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
48 Bizkaia;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;96,68
48 Bizkaia;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
48 Bizkaia;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
48 Bizkaia;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;95,85
48 Bizkaia;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
48 Bizkaia;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
48 Bizkaia;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
48 Bizkaia;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;96,63
48 Bizkaia;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
48 Bizkaia;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
48 Bizkaia;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
48 Bizkaia;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;95,17
48 Bizkaia;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
48 Bizkaia;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
48 Bizkaia;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;94,4
48 Bizkaia;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
48 Bizkaia;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
48 Bizkaia;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
48 Bizkaia;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;94,99
48 Bizkaia;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
48 Bizkaia;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
48 Bizkaia;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
48 Bizkaia;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;93,66
48 Bizkaia;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
48 Bizkaia;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
48 Bizkaia;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;92,51
48 Bizkaia;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
48 Bizkaia;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
48 Bizkaia;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
48 Bizkaia;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;93,29
48 Bizkaia;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
48 Bizkaia;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
48 Bizkaia;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
48 Bizkaia;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;92,35
48 Bizkaia;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
48 Bizkaia;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
48 Bizkaia;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
48 Bizkaia;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
48 Bizkaia;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
48 Bizkaia;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QII;27.703
48 Bizkaia;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
48 Bizkaia;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
48 Bizkaia;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
48 Bizkaia;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QII;27.361
48 Bizkaia;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
48 Bizkaia;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
48 Bizkaia;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
48 Bizkaia;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QII;26.798
48 Bizkaia;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
48 Bizkaia;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
48 Bizkaia;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
48 Bizkaia;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2022QII;27.105
48 Bizkaia;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2022QI;""
48 Bizkaia;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
48 Bizkaia;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
48 Bizkaia;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2021QII;26.887
48 Bizkaia;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2021QI;""
48 Bizkaia;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
48 Bizkaia;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
48 Bizkaia;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2020QII;26.450
48 Bizkaia;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2020QI;""
48 Bizkaia;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
48 Bizkaia;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2022QIII;26.686
48 Bizkaia;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2022QII;""
48 Bizkaia;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2022QI;""
48 Bizkaia;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
48 Bizkaia;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2021QIII;26.486
48 Bizkaia;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2021QII;""
48 Bizkaia;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2021QI;""
48 Bizkaia;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
48 Bizkaia;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2020QIII;26.020
48 Bizkaia;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2020QII;""
48 Bizkaia;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2020QI;""
48 Bizkaia;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QIV;26.175
48 Bizkaia;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
48 Bizkaia;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QII;""
48 Bizkaia;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QI;""
48 Bizkaia;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QIV;26.069
48 Bizkaia;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
48 Bizkaia;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QII;""
48 Bizkaia;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QI;""
48 Bizkaia;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QIV;25.647
48 Bizkaia;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
48 Bizkaia;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QII;""
48 Bizkaia;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QI;""
48 Bizkaia;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
48 Bizkaia;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
48 Bizkaia;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QII;""
48 Bizkaia;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QI;25.669
48 Bizkaia;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
48 Bizkaia;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
48 Bizkaia;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QII;""
48 Bizkaia;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QI;25.342
48 Bizkaia;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
48 Bizkaia;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
48 Bizkaia;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QII;""
48 Bizkaia;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QI;""
48 Bizkaia;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
48 Bizkaia;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
48 Bizkaia;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
48 Bizkaia;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
48 Bizkaia;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
48 Bizkaia;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
48 Bizkaia;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
48 Bizkaia;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
48 Bizkaia;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
48 Bizkaia;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
48 Bizkaia;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
48 Bizkaia;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
48 Bizkaia;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
48 Bizkaia;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
48 Bizkaia;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;97,84
48 Bizkaia;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
48 Bizkaia;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
48 Bizkaia;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
48 Bizkaia;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;98,27
48 Bizkaia;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
48 Bizkaia;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
48 Bizkaia;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
48 Bizkaia;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;98,7
48 Bizkaia;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
48 Bizkaia;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
48 Bizkaia;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;96,33
48 Bizkaia;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
48 Bizkaia;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
48 Bizkaia;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
48 Bizkaia;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;96,8
48 Bizkaia;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
48 Bizkaia;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
48 Bizkaia;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
48 Bizkaia;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;97,1
48 Bizkaia;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
48 Bizkaia;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
48 Bizkaia;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;94,48
48 Bizkaia;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
48 Bizkaia;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
48 Bizkaia;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
48 Bizkaia;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;95,28
48 Bizkaia;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
48 Bizkaia;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
48 Bizkaia;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
48 Bizkaia;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;95,7
48 Bizkaia;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
48 Bizkaia;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
48 Bizkaia;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
48 Bizkaia;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
48 Bizkaia;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
48 Bizkaia;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
48 Bizkaia;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;93,82
48 Bizkaia;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
48 Bizkaia;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
48 Bizkaia;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
48 Bizkaia;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;94,57
48 Bizkaia;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
48 Bizkaia;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
48 Bizkaia;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
48 Bizkaia;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
48 Bizkaia;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
48 Bizkaia;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
48 Bizkaia;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QII;16.397
48 Bizkaia;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
48 Bizkaia;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
48 Bizkaia;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
48 Bizkaia;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QII;16.379
48 Bizkaia;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
48 Bizkaia;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
48 Bizkaia;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
48 Bizkaia;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QII;16.243
48 Bizkaia;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
48 Bizkaia;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
48 Bizkaia;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
48 Bizkaia;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2022QII;16.084
48 Bizkaia;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2022QI;""
48 Bizkaia;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
48 Bizkaia;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
48 Bizkaia;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2021QII;16.132
48 Bizkaia;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2021QI;""
48 Bizkaia;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
48 Bizkaia;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
48 Bizkaia;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2020QII;16.071
48 Bizkaia;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2020QI;""
48 Bizkaia;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
48 Bizkaia;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2022QIII;15.833
48 Bizkaia;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2022QII;""
48 Bizkaia;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2022QI;""
48 Bizkaia;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
48 Bizkaia;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2021QIII;15.920
48 Bizkaia;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2021QII;""
48 Bizkaia;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2021QI;""
48 Bizkaia;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
48 Bizkaia;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2020QIII;15.825
48 Bizkaia;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2020QII;""
48 Bizkaia;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2020QI;""
48 Bizkaia;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QIV;15.541
48 Bizkaia;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
48 Bizkaia;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QII;""
48 Bizkaia;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QI;""
48 Bizkaia;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QIV;15.669
48 Bizkaia;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
48 Bizkaia;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QII;""
48 Bizkaia;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QI;""
48 Bizkaia;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QIV;15.598
48 Bizkaia;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
48 Bizkaia;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QII;""
48 Bizkaia;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QI;""
48 Bizkaia;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
48 Bizkaia;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
48 Bizkaia;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QII;""
48 Bizkaia;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QI;15.433
48 Bizkaia;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
48 Bizkaia;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
48 Bizkaia;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QII;""
48 Bizkaia;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QI;15.416
48 Bizkaia;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
48 Bizkaia;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
48 Bizkaia;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QII;""
48 Bizkaia;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QI;""
48 Bizkaia;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
48 Bizkaia;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
48 Bizkaia;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
48 Bizkaia;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
48 Bizkaia;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
48 Bizkaia;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
48 Bizkaia;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
48 Bizkaia;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
48 Bizkaia;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
48 Bizkaia;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
48 Bizkaia;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
48 Bizkaia;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
48 Bizkaia;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
48 Bizkaia;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
48 Bizkaia;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;98,09
48 Bizkaia;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
48 Bizkaia;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
48 Bizkaia;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
48 Bizkaia;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;98,49
48 Bizkaia;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
48 Bizkaia;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
48 Bizkaia;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
48 Bizkaia;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;98,94
48 Bizkaia;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
48 Bizkaia;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
48 Bizkaia;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;96,56
48 Bizkaia;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
48 Bizkaia;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
48 Bizkaia;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
48 Bizkaia;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;97,2
48 Bizkaia;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
48 Bizkaia;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
48 Bizkaia;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
48 Bizkaia;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;97,43
48 Bizkaia;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
48 Bizkaia;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
48 Bizkaia;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;94,78
48 Bizkaia;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
48 Bizkaia;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
48 Bizkaia;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
48 Bizkaia;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;95,67
48 Bizkaia;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
48 Bizkaia;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
48 Bizkaia;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
48 Bizkaia;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;96,03
48 Bizkaia;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
48 Bizkaia;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
48 Bizkaia;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
48 Bizkaia;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
48 Bizkaia;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
48 Bizkaia;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
48 Bizkaia;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;94,22
48 Bizkaia;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
48 Bizkaia;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
48 Bizkaia;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
48 Bizkaia;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;94,91
48 Bizkaia;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
48 Bizkaia;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
48 Bizkaia;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
48 Bizkaia;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
48 Bizkaia;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
48 Bizkaia;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
48 Bizkaia;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QII;11.306
48 Bizkaia;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
48 Bizkaia;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
48 Bizkaia;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
48 Bizkaia;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QII;10.982
48 Bizkaia;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
48 Bizkaia;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
48 Bizkaia;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
48 Bizkaia;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QII;10.555
48 Bizkaia;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
48 Bizkaia;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
48 Bizkaia;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
48 Bizkaia;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2022QII;11.021
48 Bizkaia;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2022QI;""
48 Bizkaia;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
48 Bizkaia;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
48 Bizkaia;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2021QII;10.755
48 Bizkaia;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2021QI;""
48 Bizkaia;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
48 Bizkaia;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
48 Bizkaia;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2020QII;10.379
48 Bizkaia;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2020QI;""
48 Bizkaia;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
48 Bizkaia;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2022QIII;10.853
48 Bizkaia;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2022QII;""
48 Bizkaia;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2022QI;""
48 Bizkaia;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
48 Bizkaia;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2021QIII;10.566
48 Bizkaia;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2021QII;""
48 Bizkaia;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2021QI;""
48 Bizkaia;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
48 Bizkaia;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2020QIII;10.195
48 Bizkaia;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2020QII;""
48 Bizkaia;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2020QI;""
48 Bizkaia;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QIV;10.634
48 Bizkaia;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
48 Bizkaia;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QII;""
48 Bizkaia;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QI;""
48 Bizkaia;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QIV;10.400
48 Bizkaia;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
48 Bizkaia;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QII;""
48 Bizkaia;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QI;""
48 Bizkaia;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QIV;10.049
48 Bizkaia;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
48 Bizkaia;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QII;""
48 Bizkaia;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QI;""
48 Bizkaia;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
48 Bizkaia;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
48 Bizkaia;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QII;""
48 Bizkaia;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QI;10.236
48 Bizkaia;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
48 Bizkaia;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
48 Bizkaia;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QII;""
48 Bizkaia;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QI;9.926
48 Bizkaia;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
48 Bizkaia;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
48 Bizkaia;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QII;""
48 Bizkaia;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QI;""
48 Bizkaia;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
48 Bizkaia;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
48 Bizkaia;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
48 Bizkaia;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
48 Bizkaia;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
48 Bizkaia;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
48 Bizkaia;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
48 Bizkaia;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
48 Bizkaia;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
48 Bizkaia;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
48 Bizkaia;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
48 Bizkaia;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
48 Bizkaia;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
48 Bizkaia;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
48 Bizkaia;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;97,48
48 Bizkaia;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
48 Bizkaia;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
48 Bizkaia;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
48 Bizkaia;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;97,93
48 Bizkaia;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
48 Bizkaia;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
48 Bizkaia;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
48 Bizkaia;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;98,33
48 Bizkaia;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
48 Bizkaia;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
48 Bizkaia;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;95,99
48 Bizkaia;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
48 Bizkaia;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
48 Bizkaia;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
48 Bizkaia;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;96,21
48 Bizkaia;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
48 Bizkaia;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
48 Bizkaia;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
48 Bizkaia;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;96,59
48 Bizkaia;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
48 Bizkaia;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
48 Bizkaia;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;94,06
48 Bizkaia;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
48 Bizkaia;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
48 Bizkaia;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
48 Bizkaia;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;94,7
48 Bizkaia;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
48 Bizkaia;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
48 Bizkaia;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
48 Bizkaia;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;95,21
48 Bizkaia;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
48 Bizkaia;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
48 Bizkaia;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
48 Bizkaia;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
48 Bizkaia;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
48 Bizkaia;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
48 Bizkaia;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;93,21
48 Bizkaia;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
48 Bizkaia;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
48 Bizkaia;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
48 Bizkaia;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;94,04
48 Bizkaia;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
48 Bizkaia;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
48 Bizkaia;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
48 Bizkaia;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
48 Bizkaia;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
48 Bizkaia;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QIII;27.527
48 Bizkaia;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
48 Bizkaia;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
48 Bizkaia;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
48 Bizkaia;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QIII;27.232
48 Bizkaia;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
48 Bizkaia;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
48 Bizkaia;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
48 Bizkaia;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QIII;26.724
48 Bizkaia;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
48 Bizkaia;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
48 Bizkaia;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
48 Bizkaia;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2022QIII;27.063
48 Bizkaia;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2022QII;""
48 Bizkaia;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2022QI;""
48 Bizkaia;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
48 Bizkaia;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2021QIII;26.787
48 Bizkaia;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2021QII;""
48 Bizkaia;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2021QI;""
48 Bizkaia;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
48 Bizkaia;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2020QIII;26.257
48 Bizkaia;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2020QII;""
48 Bizkaia;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2020QI;""
48 Bizkaia;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2022QIV;26.522
48 Bizkaia;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
48 Bizkaia;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2022QII;""
48 Bizkaia;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2022QI;""
48 Bizkaia;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2021QIV;26.338
48 Bizkaia;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
48 Bizkaia;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2021QII;""
48 Bizkaia;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2021QI;""
48 Bizkaia;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2020QIV;25.864
48 Bizkaia;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
48 Bizkaia;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2020QII;""
48 Bizkaia;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2020QI;""
48 Bizkaia;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
48 Bizkaia;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
48 Bizkaia;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QII;""
48 Bizkaia;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QI;25.925
48 Bizkaia;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
48 Bizkaia;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
48 Bizkaia;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QII;""
48 Bizkaia;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QI;25.551
48 Bizkaia;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
48 Bizkaia;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
48 Bizkaia;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QII;""
48 Bizkaia;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QI;""
48 Bizkaia;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
48 Bizkaia;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
48 Bizkaia;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QII;25.506
48 Bizkaia;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QI;""
48 Bizkaia;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
48 Bizkaia;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
48 Bizkaia;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QII;25.236
48 Bizkaia;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QI;""
48 Bizkaia;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
48 Bizkaia;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
48 Bizkaia;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QII;""
48 Bizkaia;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QI;""
48 Bizkaia;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
48 Bizkaia;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
48 Bizkaia;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
48 Bizkaia;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
48 Bizkaia;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
48 Bizkaia;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
48 Bizkaia;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
48 Bizkaia;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
48 Bizkaia;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
48 Bizkaia;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
48 Bizkaia;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
48 Bizkaia;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
48 Bizkaia;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
48 Bizkaia;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;98,31
48 Bizkaia;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
48 Bizkaia;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
48 Bizkaia;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
48 Bizkaia;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;98,37
48 Bizkaia;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
48 Bizkaia;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
48 Bizkaia;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
48 Bizkaia;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;98,25
48 Bizkaia;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
48 Bizkaia;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
48 Bizkaia;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;96,35
48 Bizkaia;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
48 Bizkaia;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
48 Bizkaia;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
48 Bizkaia;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;96,72
48 Bizkaia;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
48 Bizkaia;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
48 Bizkaia;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
48 Bizkaia;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;96,78
48 Bizkaia;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
48 Bizkaia;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
48 Bizkaia;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
48 Bizkaia;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
48 Bizkaia;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
48 Bizkaia;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
48 Bizkaia;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;95,2
48 Bizkaia;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
48 Bizkaia;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
48 Bizkaia;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
48 Bizkaia;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;95,61
48 Bizkaia;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
48 Bizkaia;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
48 Bizkaia;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
48 Bizkaia;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
48 Bizkaia;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
48 Bizkaia;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
48 Bizkaia;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;93,66
48 Bizkaia;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
48 Bizkaia;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
48 Bizkaia;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
48 Bizkaia;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;94,43
48 Bizkaia;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
48 Bizkaia;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
48 Bizkaia;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
48 Bizkaia;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
48 Bizkaia;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
48 Bizkaia;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
48 Bizkaia;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QIII;16.314
48 Bizkaia;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
48 Bizkaia;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
48 Bizkaia;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
48 Bizkaia;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QIII;16.335
48 Bizkaia;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
48 Bizkaia;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
48 Bizkaia;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
48 Bizkaia;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QIII;16.245
48 Bizkaia;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
48 Bizkaia;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
48 Bizkaia;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
48 Bizkaia;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2022QIII;16.035
48 Bizkaia;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2022QII;""
48 Bizkaia;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2022QI;""
48 Bizkaia;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
48 Bizkaia;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2021QIII;16.092
48 Bizkaia;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2021QII;""
48 Bizkaia;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2021QI;""
48 Bizkaia;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
48 Bizkaia;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2020QIII;15.972
48 Bizkaia;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2020QII;""
48 Bizkaia;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2020QI;""
48 Bizkaia;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2022QIV;15.723
48 Bizkaia;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
48 Bizkaia;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2022QII;""
48 Bizkaia;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2022QI;""
48 Bizkaia;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2021QIV;15.819
48 Bizkaia;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
48 Bizkaia;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2021QII;""
48 Bizkaia;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2021QI;""
48 Bizkaia;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2020QIV;15.729
48 Bizkaia;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
48 Bizkaia;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2020QII;""
48 Bizkaia;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2020QI;""
48 Bizkaia;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
48 Bizkaia;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
48 Bizkaia;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QII;""
48 Bizkaia;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QI;15.575
48 Bizkaia;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
48 Bizkaia;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
48 Bizkaia;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QII;""
48 Bizkaia;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QI;15.543
48 Bizkaia;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
48 Bizkaia;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
48 Bizkaia;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QII;""
48 Bizkaia;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QI;""
48 Bizkaia;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
48 Bizkaia;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
48 Bizkaia;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QII;15.338
48 Bizkaia;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QI;""
48 Bizkaia;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
48 Bizkaia;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
48 Bizkaia;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QII;15.367
48 Bizkaia;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QI;""
48 Bizkaia;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
48 Bizkaia;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
48 Bizkaia;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QII;""
48 Bizkaia;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QI;""
48 Bizkaia;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
48 Bizkaia;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
48 Bizkaia;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
48 Bizkaia;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
48 Bizkaia;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
48 Bizkaia;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
48 Bizkaia;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
48 Bizkaia;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
48 Bizkaia;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
48 Bizkaia;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
48 Bizkaia;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
48 Bizkaia;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
48 Bizkaia;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
48 Bizkaia;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;98,29
48 Bizkaia;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
48 Bizkaia;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
48 Bizkaia;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
48 Bizkaia;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;98,51
48 Bizkaia;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
48 Bizkaia;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
48 Bizkaia;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
48 Bizkaia;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;98,32
48 Bizkaia;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
48 Bizkaia;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
48 Bizkaia;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;96,38
48 Bizkaia;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
48 Bizkaia;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
48 Bizkaia;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
48 Bizkaia;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;96,84
48 Bizkaia;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
48 Bizkaia;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
48 Bizkaia;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
48 Bizkaia;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;96,82
48 Bizkaia;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
48 Bizkaia;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
48 Bizkaia;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
48 Bizkaia;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
48 Bizkaia;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
48 Bizkaia;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
48 Bizkaia;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;95,35
48 Bizkaia;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
48 Bizkaia;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
48 Bizkaia;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
48 Bizkaia;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;95,68
48 Bizkaia;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
48 Bizkaia;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
48 Bizkaia;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
48 Bizkaia;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
48 Bizkaia;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
48 Bizkaia;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
48 Bizkaia;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;93,9
48 Bizkaia;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
48 Bizkaia;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
48 Bizkaia;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
48 Bizkaia;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;94,6
48 Bizkaia;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
48 Bizkaia;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
48 Bizkaia;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
48 Bizkaia;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
48 Bizkaia;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
48 Bizkaia;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
48 Bizkaia;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QIII;11.213
48 Bizkaia;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
48 Bizkaia;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
48 Bizkaia;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
48 Bizkaia;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QIII;10.897
48 Bizkaia;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
48 Bizkaia;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
48 Bizkaia;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
48 Bizkaia;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QIII;10.479
48 Bizkaia;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
48 Bizkaia;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
48 Bizkaia;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
48 Bizkaia;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2022QIII;11.028
48 Bizkaia;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2022QII;""
48 Bizkaia;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2022QI;""
48 Bizkaia;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
48 Bizkaia;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2021QIII;10.695
48 Bizkaia;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2021QII;""
48 Bizkaia;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2021QI;""
48 Bizkaia;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
48 Bizkaia;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2020QIII;10.285
48 Bizkaia;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2020QII;""
48 Bizkaia;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2020QI;""
48 Bizkaia;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2022QIV;10.799
48 Bizkaia;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
48 Bizkaia;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2022QII;""
48 Bizkaia;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2022QI;""
48 Bizkaia;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2021QIV;10.519
48 Bizkaia;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
48 Bizkaia;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2021QII;""
48 Bizkaia;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2021QI;""
48 Bizkaia;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2020QIV;10.135
48 Bizkaia;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
48 Bizkaia;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2020QII;""
48 Bizkaia;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2020QI;""
48 Bizkaia;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
48 Bizkaia;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
48 Bizkaia;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QII;""
48 Bizkaia;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QI;10.350
48 Bizkaia;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
48 Bizkaia;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
48 Bizkaia;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QII;""
48 Bizkaia;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QI;10.008
48 Bizkaia;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
48 Bizkaia;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
48 Bizkaia;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QII;""
48 Bizkaia;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QI;""
48 Bizkaia;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
48 Bizkaia;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
48 Bizkaia;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QII;10.168
48 Bizkaia;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QI;""
48 Bizkaia;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
48 Bizkaia;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
48 Bizkaia;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QII;9.869
48 Bizkaia;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QI;""
48 Bizkaia;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
48 Bizkaia;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
48 Bizkaia;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QII;""
48 Bizkaia;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QI;""
48 Bizkaia;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
48 Bizkaia;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
48 Bizkaia;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
48 Bizkaia;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
48 Bizkaia;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
48 Bizkaia;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
48 Bizkaia;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
48 Bizkaia;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
48 Bizkaia;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
48 Bizkaia;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
48 Bizkaia;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
48 Bizkaia;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
48 Bizkaia;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
48 Bizkaia;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;98,35
48 Bizkaia;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
48 Bizkaia;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
48 Bizkaia;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
48 Bizkaia;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;98,15
48 Bizkaia;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
48 Bizkaia;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
48 Bizkaia;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
48 Bizkaia;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;98,15
48 Bizkaia;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
48 Bizkaia;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
48 Bizkaia;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;96,31
48 Bizkaia;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
48 Bizkaia;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
48 Bizkaia;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
48 Bizkaia;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;96,53
48 Bizkaia;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
48 Bizkaia;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
48 Bizkaia;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
48 Bizkaia;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;96,72
48 Bizkaia;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
48 Bizkaia;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
48 Bizkaia;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
48 Bizkaia;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
48 Bizkaia;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
48 Bizkaia;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
48 Bizkaia;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;94,98
48 Bizkaia;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
48 Bizkaia;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
48 Bizkaia;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
48 Bizkaia;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;95,51
48 Bizkaia;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
48 Bizkaia;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
48 Bizkaia;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
48 Bizkaia;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
48 Bizkaia;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
48 Bizkaia;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
48 Bizkaia;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;93,31
48 Bizkaia;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
48 Bizkaia;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
48 Bizkaia;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
48 Bizkaia;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;94,18
48 Bizkaia;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
48 Bizkaia;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
48 Bizkaia;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
48 Bizkaia;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
48 Bizkaia;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
48 Bizkaia;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QIV;27.413
48 Bizkaia;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
48 Bizkaia;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
48 Bizkaia;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
48 Bizkaia;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QIV;27.168
48 Bizkaia;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
48 Bizkaia;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
48 Bizkaia;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
48 Bizkaia;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QIV;26.577
48 Bizkaia;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
48 Bizkaia;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
48 Bizkaia;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
48 Bizkaia;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2022QIV;26.841
48 Bizkaia;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
48 Bizkaia;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2022QII;""
48 Bizkaia;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2022QI;""
48 Bizkaia;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2021QIV;26.678
48 Bizkaia;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
48 Bizkaia;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2021QII;""
48 Bizkaia;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2021QI;""
48 Bizkaia;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2020QIV;26.151
48 Bizkaia;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
48 Bizkaia;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2020QII;""
48 Bizkaia;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2020QI;""
48 Bizkaia;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
48 Bizkaia;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
48 Bizkaia;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2022QII;""
48 Bizkaia;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2022QI;26.239
48 Bizkaia;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
48 Bizkaia;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
48 Bizkaia;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2021QII;""
48 Bizkaia;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2021QI;25.819
48 Bizkaia;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
48 Bizkaia;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
48 Bizkaia;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2020QII;""
48 Bizkaia;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2020QI;""
48 Bizkaia;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
48 Bizkaia;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
48 Bizkaia;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QII;25.783
48 Bizkaia;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QI;""
48 Bizkaia;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
48 Bizkaia;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
48 Bizkaia;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QII;25.478
48 Bizkaia;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QI;""
48 Bizkaia;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
48 Bizkaia;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
48 Bizkaia;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QII;""
48 Bizkaia;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QI;""
48 Bizkaia;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
48 Bizkaia;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QIII;25.446
48 Bizkaia;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QII;""
48 Bizkaia;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QI;""
48 Bizkaia;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
48 Bizkaia;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QIII;25.127
48 Bizkaia;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QII;""
48 Bizkaia;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QI;""
48 Bizkaia;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
48 Bizkaia;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
48 Bizkaia;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QII;""
48 Bizkaia;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QI;""
48 Bizkaia;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
48 Bizkaia;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
48 Bizkaia;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
48 Bizkaia;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
48 Bizkaia;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
48 Bizkaia;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
48 Bizkaia;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
48 Bizkaia;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
48 Bizkaia;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
48 Bizkaia;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
48 Bizkaia;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
48 Bizkaia;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
48 Bizkaia;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;97,91
48 Bizkaia;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
48 Bizkaia;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
48 Bizkaia;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
48 Bizkaia;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;98,2
48 Bizkaia;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
48 Bizkaia;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
48 Bizkaia;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
48 Bizkaia;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;98,4
48 Bizkaia;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
48 Bizkaia;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
48 Bizkaia;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
48 Bizkaia;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
48 Bizkaia;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
48 Bizkaia;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
48 Bizkaia;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;96,58
48 Bizkaia;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
48 Bizkaia;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
48 Bizkaia;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
48 Bizkaia;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;97,15
48 Bizkaia;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
48 Bizkaia;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
48 Bizkaia;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
48 Bizkaia;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
48 Bizkaia;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
48 Bizkaia;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
48 Bizkaia;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;94,9
48 Bizkaia;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
48 Bizkaia;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
48 Bizkaia;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
48 Bizkaia;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;95,86
48 Bizkaia;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
48 Bizkaia;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
48 Bizkaia;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
48 Bizkaia;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
48 Bizkaia;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
48 Bizkaia;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
48 Bizkaia;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;93,66
48 Bizkaia;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
48 Bizkaia;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
48 Bizkaia;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
48 Bizkaia;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;94,54
48 Bizkaia;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
48 Bizkaia;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
48 Bizkaia;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
48 Bizkaia;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
48 Bizkaia;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
48 Bizkaia;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
48 Bizkaia;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QIV;16.235
48 Bizkaia;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
48 Bizkaia;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
48 Bizkaia;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
48 Bizkaia;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QIV;16.297
48 Bizkaia;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
48 Bizkaia;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
48 Bizkaia;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
48 Bizkaia;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QIV;16.138
48 Bizkaia;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
48 Bizkaia;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
48 Bizkaia;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
48 Bizkaia;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2022QIV;15.907
48 Bizkaia;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
48 Bizkaia;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2022QII;""
48 Bizkaia;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2022QI;""
48 Bizkaia;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2021QIV;15.998
48 Bizkaia;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
48 Bizkaia;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2021QII;""
48 Bizkaia;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2021QI;""
48 Bizkaia;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2020QIV;15.873
48 Bizkaia;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
48 Bizkaia;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2020QII;""
48 Bizkaia;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2020QI;""
48 Bizkaia;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
48 Bizkaia;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
48 Bizkaia;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2022QII;""
48 Bizkaia;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2022QI;15.739
48 Bizkaia;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
48 Bizkaia;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
48 Bizkaia;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2021QII;""
48 Bizkaia;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2021QI;15.678
48 Bizkaia;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
48 Bizkaia;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
48 Bizkaia;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2020QII;""
48 Bizkaia;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2020QI;""
48 Bizkaia;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
48 Bizkaia;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
48 Bizkaia;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QII;15.487
48 Bizkaia;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QI;""
48 Bizkaia;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
48 Bizkaia;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
48 Bizkaia;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QII;15.492
48 Bizkaia;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QI;""
48 Bizkaia;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
48 Bizkaia;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
48 Bizkaia;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QII;""
48 Bizkaia;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QI;""
48 Bizkaia;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
48 Bizkaia;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QIII;15.294
48 Bizkaia;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QII;""
48 Bizkaia;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QI;""
48 Bizkaia;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
48 Bizkaia;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QIII;15.303
48 Bizkaia;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QII;""
48 Bizkaia;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QI;""
48 Bizkaia;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
48 Bizkaia;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
48 Bizkaia;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QII;""
48 Bizkaia;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QI;""
48 Bizkaia;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
48 Bizkaia;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
48 Bizkaia;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
48 Bizkaia;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
48 Bizkaia;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
48 Bizkaia;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
48 Bizkaia;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
48 Bizkaia;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
48 Bizkaia;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
48 Bizkaia;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
48 Bizkaia;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
48 Bizkaia;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
48 Bizkaia;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;97,98
48 Bizkaia;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
48 Bizkaia;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
48 Bizkaia;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
48 Bizkaia;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;98,17
48 Bizkaia;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
48 Bizkaia;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
48 Bizkaia;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
48 Bizkaia;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;98,36
48 Bizkaia;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
48 Bizkaia;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
48 Bizkaia;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
48 Bizkaia;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
48 Bizkaia;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
48 Bizkaia;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
48 Bizkaia;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;96,58
48 Bizkaia;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
48 Bizkaia;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
48 Bizkaia;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
48 Bizkaia;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;97,15
48 Bizkaia;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
48 Bizkaia;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
48 Bizkaia;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
48 Bizkaia;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
48 Bizkaia;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
48 Bizkaia;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
48 Bizkaia;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;95,03
48 Bizkaia;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
48 Bizkaia;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
48 Bizkaia;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
48 Bizkaia;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;96
48 Bizkaia;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
48 Bizkaia;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
48 Bizkaia;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
48 Bizkaia;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
48 Bizkaia;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
48 Bizkaia;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
48 Bizkaia;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;93,85
48 Bizkaia;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
48 Bizkaia;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
48 Bizkaia;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
48 Bizkaia;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;94,83
48 Bizkaia;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
48 Bizkaia;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
48 Bizkaia;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
48 Bizkaia;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
48 Bizkaia;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
48 Bizkaia;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
48 Bizkaia;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QIV;11.178
48 Bizkaia;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
48 Bizkaia;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
48 Bizkaia;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
48 Bizkaia;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QIV;10.871
48 Bizkaia;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
48 Bizkaia;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
48 Bizkaia;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
48 Bizkaia;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QIV;10.439
48 Bizkaia;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
48 Bizkaia;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
48 Bizkaia;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
48 Bizkaia;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2022QIV;10.934
48 Bizkaia;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
48 Bizkaia;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2022QII;""
48 Bizkaia;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2022QI;""
48 Bizkaia;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2021QIV;10.680
48 Bizkaia;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
48 Bizkaia;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2021QII;""
48 Bizkaia;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2021QI;""
48 Bizkaia;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2020QIV;10.278
48 Bizkaia;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
48 Bizkaia;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2020QII;""
48 Bizkaia;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2020QI;""
48 Bizkaia;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
48 Bizkaia;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
48 Bizkaia;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2022QII;""
48 Bizkaia;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2022QI;10.500
48 Bizkaia;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
48 Bizkaia;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
48 Bizkaia;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2021QII;""
48 Bizkaia;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2021QI;10.141
48 Bizkaia;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
48 Bizkaia;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
48 Bizkaia;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2020QII;""
48 Bizkaia;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2020QI;""
48 Bizkaia;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
48 Bizkaia;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
48 Bizkaia;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QII;10.296
48 Bizkaia;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QI;""
48 Bizkaia;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
48 Bizkaia;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
48 Bizkaia;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QII;9.986
48 Bizkaia;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QI;""
48 Bizkaia;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
48 Bizkaia;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
48 Bizkaia;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QII;""
48 Bizkaia;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QI;""
48 Bizkaia;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
48 Bizkaia;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QIII;10.152
48 Bizkaia;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QII;""
48 Bizkaia;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QI;""
48 Bizkaia;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
48 Bizkaia;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QIII;9.824
48 Bizkaia;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QII;""
48 Bizkaia;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QI;""
48 Bizkaia;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
48 Bizkaia;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
48 Bizkaia;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QII;""
48 Bizkaia;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QI;""
48 Bizkaia;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
48 Bizkaia;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
48 Bizkaia;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
48 Bizkaia;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
48 Bizkaia;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
48 Bizkaia;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
48 Bizkaia;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
48 Bizkaia;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
48 Bizkaia;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
48 Bizkaia;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
48 Bizkaia;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
48 Bizkaia;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
48 Bizkaia;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;97,82
48 Bizkaia;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
48 Bizkaia;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
48 Bizkaia;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
48 Bizkaia;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;98,24
48 Bizkaia;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
48 Bizkaia;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
48 Bizkaia;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
48 Bizkaia;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;98,46
48 Bizkaia;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
48 Bizkaia;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
48 Bizkaia;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
48 Bizkaia;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
48 Bizkaia;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
48 Bizkaia;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
48 Bizkaia;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;96,59
48 Bizkaia;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
48 Bizkaia;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
48 Bizkaia;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
48 Bizkaia;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;97,15
48 Bizkaia;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
48 Bizkaia;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
48 Bizkaia;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
48 Bizkaia;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
48 Bizkaia;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
48 Bizkaia;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
48 Bizkaia;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;94,71
48 Bizkaia;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
48 Bizkaia;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
48 Bizkaia;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
48 Bizkaia;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;95,66
48 Bizkaia;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
48 Bizkaia;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
48 Bizkaia;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
48 Bizkaia;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
48 Bizkaia;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
48 Bizkaia;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
48 Bizkaia;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;93,39
48 Bizkaia;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
48 Bizkaia;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
48 Bizkaia;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
48 Bizkaia;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;94,11
48 Bizkaia;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
48 Bizkaia;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
48 Bizkaia;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
48 Bizkaia;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
48 Bizkaia;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
48 Bizkaia;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
48 Bizkaia;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
48 Bizkaia;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
48 Bizkaia;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
48 Bizkaia;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QI;11.852
48 Bizkaia;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
48 Bizkaia;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
48 Bizkaia;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
48 Bizkaia;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QI;11.297
48 Bizkaia;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
48 Bizkaia;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
48 Bizkaia;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
48 Bizkaia;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QI;13.019
48 Bizkaia;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
48 Bizkaia;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
48 Bizkaia;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2022QII;""
48 Bizkaia;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2022QI;11.385
48 Bizkaia;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
48 Bizkaia;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
48 Bizkaia;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2021QII;""
48 Bizkaia;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2021QI;10.846
48 Bizkaia;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
48 Bizkaia;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
48 Bizkaia;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2020QII;""
48 Bizkaia;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2020QI;12.290
48 Bizkaia;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
48 Bizkaia;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
48 Bizkaia;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2022QII;10.926
48 Bizkaia;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2022QI;""
48 Bizkaia;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
48 Bizkaia;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
48 Bizkaia;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2021QII;10.349
48 Bizkaia;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2021QI;""
48 Bizkaia;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
48 Bizkaia;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
48 Bizkaia;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2020QII;11.943
48 Bizkaia;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2020QI;""
48 Bizkaia;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
48 Bizkaia;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QIII;10.537
48 Bizkaia;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QII;""
48 Bizkaia;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QI;""
48 Bizkaia;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
48 Bizkaia;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QIII;9.947
48 Bizkaia;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QII;""
48 Bizkaia;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QI;""
48 Bizkaia;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
48 Bizkaia;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QIII;11.408
48 Bizkaia;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QII;""
48 Bizkaia;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QI;""
48 Bizkaia;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QIV;9.788
48 Bizkaia;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
48 Bizkaia;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QII;""
48 Bizkaia;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QI;""
48 Bizkaia;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QIV;9.427
48 Bizkaia;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
48 Bizkaia;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QII;""
48 Bizkaia;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QI;""
48 Bizkaia;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QIV;10.841
48 Bizkaia;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
48 Bizkaia;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QII;""
48 Bizkaia;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QI;""
48 Bizkaia;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
48 Bizkaia;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
48 Bizkaia;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
48 Bizkaia;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
48 Bizkaia;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
48 Bizkaia;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
48 Bizkaia;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
48 Bizkaia;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
48 Bizkaia;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
48 Bizkaia;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
48 Bizkaia;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
48 Bizkaia;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
48 Bizkaia;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
48 Bizkaia;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
48 Bizkaia;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
48 Bizkaia;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;96,06
48 Bizkaia;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
48 Bizkaia;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
48 Bizkaia;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
48 Bizkaia;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;96,01
48 Bizkaia;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
48 Bizkaia;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
48 Bizkaia;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
48 Bizkaia;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;94,4
48 Bizkaia;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
48 Bizkaia;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
48 Bizkaia;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;92,19
48 Bizkaia;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
48 Bizkaia;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
48 Bizkaia;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
48 Bizkaia;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;91,61
48 Bizkaia;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
48 Bizkaia;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
48 Bizkaia;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
48 Bizkaia;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;91,74
48 Bizkaia;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
48 Bizkaia;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
48 Bizkaia;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;88,9
48 Bizkaia;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
48 Bizkaia;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
48 Bizkaia;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
48 Bizkaia;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;88,05
48 Bizkaia;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
48 Bizkaia;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
48 Bizkaia;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
48 Bizkaia;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;87,63
48 Bizkaia;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
48 Bizkaia;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
48 Bizkaia;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;82,59
48 Bizkaia;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
48 Bizkaia;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
48 Bizkaia;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
48 Bizkaia;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;83,45
48 Bizkaia;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
48 Bizkaia;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
48 Bizkaia;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
48 Bizkaia;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;83,27
48 Bizkaia;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
48 Bizkaia;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
48 Bizkaia;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
48 Bizkaia;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
48 Bizkaia;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
48 Bizkaia;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
48 Bizkaia;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QI;7.702
48 Bizkaia;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
48 Bizkaia;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
48 Bizkaia;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
48 Bizkaia;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QI;7.384
48 Bizkaia;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
48 Bizkaia;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
48 Bizkaia;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
48 Bizkaia;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QI;8.483
48 Bizkaia;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
48 Bizkaia;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
48 Bizkaia;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2022QII;""
48 Bizkaia;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2022QI;7.407
48 Bizkaia;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
48 Bizkaia;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
48 Bizkaia;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2021QII;""
48 Bizkaia;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2021QI;7.091
48 Bizkaia;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
48 Bizkaia;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
48 Bizkaia;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2020QII;""
48 Bizkaia;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2020QI;8.006
48 Bizkaia;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
48 Bizkaia;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
48 Bizkaia;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2022QII;7.123
48 Bizkaia;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2022QI;""
48 Bizkaia;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
48 Bizkaia;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
48 Bizkaia;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2021QII;6.773
48 Bizkaia;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2021QI;""
48 Bizkaia;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
48 Bizkaia;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
48 Bizkaia;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2020QII;7.802
48 Bizkaia;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2020QI;""
48 Bizkaia;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
48 Bizkaia;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QIII;6.851
48 Bizkaia;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QII;""
48 Bizkaia;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QI;""
48 Bizkaia;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
48 Bizkaia;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QIII;6.513
48 Bizkaia;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QII;""
48 Bizkaia;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QI;""
48 Bizkaia;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
48 Bizkaia;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QIII;7.479
48 Bizkaia;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QII;""
48 Bizkaia;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QI;""
48 Bizkaia;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QIV;6.362
48 Bizkaia;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
48 Bizkaia;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QII;""
48 Bizkaia;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QI;""
48 Bizkaia;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QIV;6.156
48 Bizkaia;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
48 Bizkaia;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QII;""
48 Bizkaia;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QI;""
48 Bizkaia;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QIV;7.103
48 Bizkaia;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
48 Bizkaia;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QII;""
48 Bizkaia;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QI;""
48 Bizkaia;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
48 Bizkaia;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
48 Bizkaia;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
48 Bizkaia;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
48 Bizkaia;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
48 Bizkaia;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
48 Bizkaia;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
48 Bizkaia;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
48 Bizkaia;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
48 Bizkaia;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
48 Bizkaia;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
48 Bizkaia;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
48 Bizkaia;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
48 Bizkaia;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
48 Bizkaia;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
48 Bizkaia;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;96,17
48 Bizkaia;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
48 Bizkaia;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
48 Bizkaia;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
48 Bizkaia;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;96,03
48 Bizkaia;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
48 Bizkaia;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
48 Bizkaia;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
48 Bizkaia;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;94,38
48 Bizkaia;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
48 Bizkaia;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
48 Bizkaia;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;92,48
48 Bizkaia;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
48 Bizkaia;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
48 Bizkaia;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
48 Bizkaia;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;91,73
48 Bizkaia;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
48 Bizkaia;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
48 Bizkaia;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
48 Bizkaia;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;91,97
48 Bizkaia;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
48 Bizkaia;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
48 Bizkaia;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;88,95
48 Bizkaia;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
48 Bizkaia;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
48 Bizkaia;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
48 Bizkaia;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;88,2
48 Bizkaia;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
48 Bizkaia;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
48 Bizkaia;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
48 Bizkaia;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;88,16
48 Bizkaia;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
48 Bizkaia;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
48 Bizkaia;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;82,6
48 Bizkaia;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
48 Bizkaia;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
48 Bizkaia;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
48 Bizkaia;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;83,37
48 Bizkaia;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
48 Bizkaia;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
48 Bizkaia;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
48 Bizkaia;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;83,73
48 Bizkaia;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
48 Bizkaia;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
48 Bizkaia;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
48 Bizkaia;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
48 Bizkaia;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
48 Bizkaia;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
48 Bizkaia;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QI;4.150
48 Bizkaia;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
48 Bizkaia;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
48 Bizkaia;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
48 Bizkaia;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QI;3.913
48 Bizkaia;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
48 Bizkaia;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
48 Bizkaia;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
48 Bizkaia;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QI;4.536
48 Bizkaia;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
48 Bizkaia;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
48 Bizkaia;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2022QII;""
48 Bizkaia;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2022QI;3.978
48 Bizkaia;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
48 Bizkaia;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
48 Bizkaia;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2021QII;""
48 Bizkaia;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2021QI;3.755
48 Bizkaia;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
48 Bizkaia;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
48 Bizkaia;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2020QII;""
48 Bizkaia;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2020QI;4.284
48 Bizkaia;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
48 Bizkaia;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
48 Bizkaia;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2022QII;3.803
48 Bizkaia;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2022QI;""
48 Bizkaia;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
48 Bizkaia;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
48 Bizkaia;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2021QII;3.576
48 Bizkaia;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2021QI;""
48 Bizkaia;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
48 Bizkaia;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
48 Bizkaia;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2020QII;4.141
48 Bizkaia;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2020QI;""
48 Bizkaia;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
48 Bizkaia;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QIII;3.686
48 Bizkaia;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QII;""
48 Bizkaia;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QI;""
48 Bizkaia;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
48 Bizkaia;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QIII;3.434
48 Bizkaia;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QII;""
48 Bizkaia;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QI;""
48 Bizkaia;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
48 Bizkaia;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QIII;3.929
48 Bizkaia;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QII;""
48 Bizkaia;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QI;""
48 Bizkaia;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QIV;3.426
48 Bizkaia;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
48 Bizkaia;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QII;""
48 Bizkaia;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QI;""
48 Bizkaia;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QIV;3.271
48 Bizkaia;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
48 Bizkaia;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QII;""
48 Bizkaia;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QI;""
48 Bizkaia;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QIV;3.738
48 Bizkaia;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
48 Bizkaia;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QII;""
48 Bizkaia;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QI;""
48 Bizkaia;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
48 Bizkaia;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
48 Bizkaia;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
48 Bizkaia;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
48 Bizkaia;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
48 Bizkaia;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
48 Bizkaia;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
48 Bizkaia;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
48 Bizkaia;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
48 Bizkaia;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
48 Bizkaia;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
48 Bizkaia;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
48 Bizkaia;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
48 Bizkaia;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
48 Bizkaia;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
48 Bizkaia;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;95,86
48 Bizkaia;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
48 Bizkaia;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
48 Bizkaia;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
48 Bizkaia;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;95,96
48 Bizkaia;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
48 Bizkaia;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
48 Bizkaia;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
48 Bizkaia;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;94,44
48 Bizkaia;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
48 Bizkaia;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
48 Bizkaia;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;91,64
48 Bizkaia;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
48 Bizkaia;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
48 Bizkaia;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
48 Bizkaia;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;91,39
48 Bizkaia;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
48 Bizkaia;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
48 Bizkaia;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
48 Bizkaia;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;91,29
48 Bizkaia;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
48 Bizkaia;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
48 Bizkaia;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;88,82
48 Bizkaia;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
48 Bizkaia;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
48 Bizkaia;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
48 Bizkaia;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;87,76
48 Bizkaia;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
48 Bizkaia;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
48 Bizkaia;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
48 Bizkaia;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;86,62
48 Bizkaia;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
48 Bizkaia;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
48 Bizkaia;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;82,55
48 Bizkaia;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
48 Bizkaia;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
48 Bizkaia;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
48 Bizkaia;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;83,59
48 Bizkaia;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
48 Bizkaia;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
48 Bizkaia;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
48 Bizkaia;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;82,41
48 Bizkaia;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
48 Bizkaia;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
48 Bizkaia;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
48 Bizkaia;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
48 Bizkaia;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
48 Bizkaia;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QII;13.709
48 Bizkaia;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
48 Bizkaia;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
48 Bizkaia;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
48 Bizkaia;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QII;13.179
48 Bizkaia;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
48 Bizkaia;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
48 Bizkaia;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
48 Bizkaia;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QII;12.571
48 Bizkaia;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
48 Bizkaia;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
48 Bizkaia;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
48 Bizkaia;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2022QII;13.191
48 Bizkaia;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2022QI;""
48 Bizkaia;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
48 Bizkaia;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
48 Bizkaia;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2021QII;12.634
48 Bizkaia;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2021QI;""
48 Bizkaia;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
48 Bizkaia;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
48 Bizkaia;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2020QII;12.218
48 Bizkaia;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2020QI;""
48 Bizkaia;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
48 Bizkaia;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2022QIII;12.772
48 Bizkaia;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2022QII;""
48 Bizkaia;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2022QI;""
48 Bizkaia;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
48 Bizkaia;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2021QIII;12.186
48 Bizkaia;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2021QII;""
48 Bizkaia;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2021QI;""
48 Bizkaia;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
48 Bizkaia;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2020QIII;11.622
48 Bizkaia;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2020QII;""
48 Bizkaia;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2020QI;""
48 Bizkaia;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QIV;11.955
48 Bizkaia;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
48 Bizkaia;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QII;""
48 Bizkaia;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QI;""
48 Bizkaia;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QIV;11.606
48 Bizkaia;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
48 Bizkaia;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QII;""
48 Bizkaia;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QI;""
48 Bizkaia;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QIV;11.045
48 Bizkaia;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
48 Bizkaia;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QII;""
48 Bizkaia;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QI;""
48 Bizkaia;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
48 Bizkaia;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
48 Bizkaia;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QII;""
48 Bizkaia;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QI;11.163
48 Bizkaia;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
48 Bizkaia;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
48 Bizkaia;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QII;""
48 Bizkaia;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QI;10.610
48 Bizkaia;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
48 Bizkaia;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
48 Bizkaia;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QII;""
48 Bizkaia;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QI;""
48 Bizkaia;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
48 Bizkaia;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
48 Bizkaia;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
48 Bizkaia;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
48 Bizkaia;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
48 Bizkaia;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
48 Bizkaia;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
48 Bizkaia;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
48 Bizkaia;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
48 Bizkaia;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
48 Bizkaia;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
48 Bizkaia;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
48 Bizkaia;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
48 Bizkaia;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
48 Bizkaia;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;96,22
48 Bizkaia;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
48 Bizkaia;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
48 Bizkaia;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
48 Bizkaia;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;95,86
48 Bizkaia;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
48 Bizkaia;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
48 Bizkaia;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
48 Bizkaia;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;97,19
48 Bizkaia;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
48 Bizkaia;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
48 Bizkaia;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;93,17
48 Bizkaia;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
48 Bizkaia;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
48 Bizkaia;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
48 Bizkaia;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;92,47
48 Bizkaia;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
48 Bizkaia;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
48 Bizkaia;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
48 Bizkaia;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;92,45
48 Bizkaia;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
48 Bizkaia;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
48 Bizkaia;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;87,21
48 Bizkaia;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
48 Bizkaia;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
48 Bizkaia;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
48 Bizkaia;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;88,06
48 Bizkaia;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
48 Bizkaia;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
48 Bizkaia;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
48 Bizkaia;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;87,86
48 Bizkaia;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
48 Bizkaia;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
48 Bizkaia;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
48 Bizkaia;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
48 Bizkaia;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
48 Bizkaia;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
48 Bizkaia;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;84,7
48 Bizkaia;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
48 Bizkaia;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
48 Bizkaia;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
48 Bizkaia;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;84,4
48 Bizkaia;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
48 Bizkaia;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
48 Bizkaia;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
48 Bizkaia;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
48 Bizkaia;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
48 Bizkaia;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
48 Bizkaia;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QII;8.907
48 Bizkaia;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
48 Bizkaia;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
48 Bizkaia;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
48 Bizkaia;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QII;8.582
48 Bizkaia;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
48 Bizkaia;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
48 Bizkaia;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
48 Bizkaia;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QII;8.189
48 Bizkaia;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
48 Bizkaia;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
48 Bizkaia;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
48 Bizkaia;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2022QII;8.586
48 Bizkaia;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2022QI;""
48 Bizkaia;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
48 Bizkaia;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
48 Bizkaia;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2021QII;8.242
48 Bizkaia;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2021QI;""
48 Bizkaia;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
48 Bizkaia;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
48 Bizkaia;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2020QII;7.981
48 Bizkaia;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2020QI;""
48 Bizkaia;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
48 Bizkaia;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2022QIII;8.295
48 Bizkaia;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2022QII;""
48 Bizkaia;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2022QI;""
48 Bizkaia;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
48 Bizkaia;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2021QIII;7.954
48 Bizkaia;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2021QII;""
48 Bizkaia;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2021QI;""
48 Bizkaia;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
48 Bizkaia;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2020QIII;7.613
48 Bizkaia;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2020QII;""
48 Bizkaia;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2020QI;""
48 Bizkaia;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QIV;7.760
48 Bizkaia;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
48 Bizkaia;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QII;""
48 Bizkaia;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QI;""
48 Bizkaia;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QIV;7.570
48 Bizkaia;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
48 Bizkaia;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QII;""
48 Bizkaia;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QI;""
48 Bizkaia;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QIV;7.231
48 Bizkaia;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
48 Bizkaia;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QII;""
48 Bizkaia;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QI;""
48 Bizkaia;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
48 Bizkaia;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
48 Bizkaia;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QII;""
48 Bizkaia;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QI;7.288
48 Bizkaia;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
48 Bizkaia;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
48 Bizkaia;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QII;""
48 Bizkaia;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QI;6.945
48 Bizkaia;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
48 Bizkaia;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
48 Bizkaia;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QII;""
48 Bizkaia;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QI;""
48 Bizkaia;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
48 Bizkaia;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
48 Bizkaia;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
48 Bizkaia;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
48 Bizkaia;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
48 Bizkaia;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
48 Bizkaia;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
48 Bizkaia;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
48 Bizkaia;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
48 Bizkaia;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
48 Bizkaia;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
48 Bizkaia;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
48 Bizkaia;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
48 Bizkaia;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
48 Bizkaia;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;96,4
48 Bizkaia;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
48 Bizkaia;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
48 Bizkaia;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
48 Bizkaia;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;96,04
48 Bizkaia;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
48 Bizkaia;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
48 Bizkaia;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
48 Bizkaia;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;97,46
48 Bizkaia;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
48 Bizkaia;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
48 Bizkaia;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;93,13
48 Bizkaia;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
48 Bizkaia;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
48 Bizkaia;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
48 Bizkaia;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;92,68
48 Bizkaia;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
48 Bizkaia;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
48 Bizkaia;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
48 Bizkaia;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;92,97
48 Bizkaia;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
48 Bizkaia;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
48 Bizkaia;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;87,12
48 Bizkaia;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
48 Bizkaia;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
48 Bizkaia;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
48 Bizkaia;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;88,21
48 Bizkaia;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
48 Bizkaia;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
48 Bizkaia;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
48 Bizkaia;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;88,3
48 Bizkaia;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
48 Bizkaia;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
48 Bizkaia;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
48 Bizkaia;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
48 Bizkaia;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
48 Bizkaia;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
48 Bizkaia;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;84,92
48 Bizkaia;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
48 Bizkaia;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
48 Bizkaia;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
48 Bizkaia;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;84,81
48 Bizkaia;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
48 Bizkaia;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
48 Bizkaia;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
48 Bizkaia;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
48 Bizkaia;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
48 Bizkaia;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
48 Bizkaia;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QII;4.802
48 Bizkaia;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
48 Bizkaia;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
48 Bizkaia;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
48 Bizkaia;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QII;4.597
48 Bizkaia;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
48 Bizkaia;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
48 Bizkaia;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
48 Bizkaia;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QII;4.382
48 Bizkaia;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
48 Bizkaia;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
48 Bizkaia;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
48 Bizkaia;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2022QII;4.605
48 Bizkaia;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2022QI;""
48 Bizkaia;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
48 Bizkaia;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
48 Bizkaia;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2021QII;4.392
48 Bizkaia;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2021QI;""
48 Bizkaia;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
48 Bizkaia;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
48 Bizkaia;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2020QII;4.237
48 Bizkaia;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2020QI;""
48 Bizkaia;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
48 Bizkaia;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2022QIII;4.477
48 Bizkaia;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2022QII;""
48 Bizkaia;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2022QI;""
48 Bizkaia;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
48 Bizkaia;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2021QIII;4.232
48 Bizkaia;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2021QII;""
48 Bizkaia;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2021QI;""
48 Bizkaia;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
48 Bizkaia;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2020QIII;4.009
48 Bizkaia;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2020QII;""
48 Bizkaia;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2020QI;""
48 Bizkaia;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QIV;4.195
48 Bizkaia;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
48 Bizkaia;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QII;""
48 Bizkaia;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QI;""
48 Bizkaia;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QIV;4.036
48 Bizkaia;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
48 Bizkaia;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QII;""
48 Bizkaia;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QI;""
48 Bizkaia;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QIV;3.814
48 Bizkaia;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
48 Bizkaia;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QII;""
48 Bizkaia;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QI;""
48 Bizkaia;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
48 Bizkaia;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
48 Bizkaia;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QII;""
48 Bizkaia;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QI;3.875
48 Bizkaia;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
48 Bizkaia;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
48 Bizkaia;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QII;""
48 Bizkaia;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QI;3.665
48 Bizkaia;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
48 Bizkaia;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
48 Bizkaia;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QII;""
48 Bizkaia;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QI;""
48 Bizkaia;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
48 Bizkaia;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
48 Bizkaia;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
48 Bizkaia;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
48 Bizkaia;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
48 Bizkaia;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
48 Bizkaia;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
48 Bizkaia;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
48 Bizkaia;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
48 Bizkaia;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
48 Bizkaia;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
48 Bizkaia;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
48 Bizkaia;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
48 Bizkaia;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
48 Bizkaia;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;95,9
48 Bizkaia;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
48 Bizkaia;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
48 Bizkaia;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
48 Bizkaia;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;95,54
48 Bizkaia;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
48 Bizkaia;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
48 Bizkaia;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
48 Bizkaia;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;96,69
48 Bizkaia;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
48 Bizkaia;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
48 Bizkaia;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;93,23
48 Bizkaia;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
48 Bizkaia;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
48 Bizkaia;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
48 Bizkaia;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;92,06
48 Bizkaia;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
48 Bizkaia;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
48 Bizkaia;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
48 Bizkaia;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;91,49
48 Bizkaia;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
48 Bizkaia;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
48 Bizkaia;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;87,36
48 Bizkaia;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
48 Bizkaia;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
48 Bizkaia;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
48 Bizkaia;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;87,8
48 Bizkaia;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
48 Bizkaia;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
48 Bizkaia;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
48 Bizkaia;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;87,04
48 Bizkaia;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
48 Bizkaia;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
48 Bizkaia;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
48 Bizkaia;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
48 Bizkaia;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
48 Bizkaia;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
48 Bizkaia;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;84,29
48 Bizkaia;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
48 Bizkaia;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
48 Bizkaia;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
48 Bizkaia;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;83,64
48 Bizkaia;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
48 Bizkaia;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
48 Bizkaia;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
48 Bizkaia;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
48 Bizkaia;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
48 Bizkaia;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QIII;13.317
48 Bizkaia;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
48 Bizkaia;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
48 Bizkaia;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
48 Bizkaia;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QIII;12.729
48 Bizkaia;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
48 Bizkaia;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
48 Bizkaia;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
48 Bizkaia;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QIII;12.291
48 Bizkaia;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
48 Bizkaia;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
48 Bizkaia;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
48 Bizkaia;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2022QIII;12.874
48 Bizkaia;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2022QII;""
48 Bizkaia;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2022QI;""
48 Bizkaia;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
48 Bizkaia;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2021QIII;12.266
48 Bizkaia;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2021QII;""
48 Bizkaia;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2021QI;""
48 Bizkaia;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
48 Bizkaia;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2020QIII;11.681
48 Bizkaia;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2020QII;""
48 Bizkaia;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2020QI;""
48 Bizkaia;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2022QIV;12.047
48 Bizkaia;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
48 Bizkaia;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2022QII;""
48 Bizkaia;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2022QI;""
48 Bizkaia;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2021QIV;11.674
48 Bizkaia;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
48 Bizkaia;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2021QII;""
48 Bizkaia;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2021QI;""
48 Bizkaia;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2020QIV;11.102
48 Bizkaia;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
48 Bizkaia;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2020QII;""
48 Bizkaia;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2020QI;""
48 Bizkaia;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
48 Bizkaia;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
48 Bizkaia;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QII;""
48 Bizkaia;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QI;11.226
48 Bizkaia;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
48 Bizkaia;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
48 Bizkaia;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QII;""
48 Bizkaia;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QI;10.665
48 Bizkaia;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
48 Bizkaia;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
48 Bizkaia;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QII;""
48 Bizkaia;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QI;""
48 Bizkaia;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
48 Bizkaia;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
48 Bizkaia;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QII;10.796
48 Bizkaia;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QI;""
48 Bizkaia;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
48 Bizkaia;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
48 Bizkaia;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QII;10.192
48 Bizkaia;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QI;""
48 Bizkaia;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
48 Bizkaia;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
48 Bizkaia;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QII;""
48 Bizkaia;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QI;""
48 Bizkaia;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
48 Bizkaia;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
48 Bizkaia;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
48 Bizkaia;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
48 Bizkaia;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
48 Bizkaia;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
48 Bizkaia;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
48 Bizkaia;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
48 Bizkaia;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
48 Bizkaia;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
48 Bizkaia;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
48 Bizkaia;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
48 Bizkaia;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
48 Bizkaia;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;96,67
48 Bizkaia;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
48 Bizkaia;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
48 Bizkaia;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
48 Bizkaia;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;96,36
48 Bizkaia;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
48 Bizkaia;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
48 Bizkaia;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
48 Bizkaia;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;95,04
48 Bizkaia;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
48 Bizkaia;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
48 Bizkaia;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;90,46
48 Bizkaia;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
48 Bizkaia;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
48 Bizkaia;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
48 Bizkaia;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;91,71
48 Bizkaia;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
48 Bizkaia;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
48 Bizkaia;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
48 Bizkaia;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;90,33
48 Bizkaia;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
48 Bizkaia;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
48 Bizkaia;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
48 Bizkaia;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
48 Bizkaia;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
48 Bizkaia;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
48 Bizkaia;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;88,19
48 Bizkaia;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
48 Bizkaia;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
48 Bizkaia;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
48 Bizkaia;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;86,77
48 Bizkaia;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
48 Bizkaia;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
48 Bizkaia;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
48 Bizkaia;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
48 Bizkaia;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
48 Bizkaia;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
48 Bizkaia;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;84,81
48 Bizkaia;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
48 Bizkaia;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
48 Bizkaia;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
48 Bizkaia;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;82,92
48 Bizkaia;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
48 Bizkaia;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
48 Bizkaia;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
48 Bizkaia;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
48 Bizkaia;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
48 Bizkaia;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
48 Bizkaia;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QIII;8.658
48 Bizkaia;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
48 Bizkaia;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
48 Bizkaia;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
48 Bizkaia;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QIII;8.295
48 Bizkaia;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
48 Bizkaia;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
48 Bizkaia;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
48 Bizkaia;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QIII;8.031
48 Bizkaia;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
48 Bizkaia;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
48 Bizkaia;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
48 Bizkaia;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2022QIII;8.351
48 Bizkaia;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2022QII;""
48 Bizkaia;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2022QI;""
48 Bizkaia;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
48 Bizkaia;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2021QIII;8.001
48 Bizkaia;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2021QII;""
48 Bizkaia;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2021QI;""
48 Bizkaia;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
48 Bizkaia;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2020QIII;7.653
48 Bizkaia;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2020QII;""
48 Bizkaia;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2020QI;""
48 Bizkaia;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2022QIV;7.808
48 Bizkaia;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
48 Bizkaia;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2022QII;""
48 Bizkaia;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2022QI;""
48 Bizkaia;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2021QIV;7.608
48 Bizkaia;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
48 Bizkaia;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2021QII;""
48 Bizkaia;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2021QI;""
48 Bizkaia;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2020QIV;7.269
48 Bizkaia;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
48 Bizkaia;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2020QII;""
48 Bizkaia;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2020QI;""
48 Bizkaia;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
48 Bizkaia;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
48 Bizkaia;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QII;""
48 Bizkaia;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QI;7.323
48 Bizkaia;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
48 Bizkaia;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
48 Bizkaia;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QII;""
48 Bizkaia;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QI;6.983
48 Bizkaia;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
48 Bizkaia;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
48 Bizkaia;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QII;""
48 Bizkaia;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QI;""
48 Bizkaia;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
48 Bizkaia;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
48 Bizkaia;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QII;7.057
48 Bizkaia;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QI;""
48 Bizkaia;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
48 Bizkaia;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
48 Bizkaia;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QII;6.677
48 Bizkaia;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QI;""
48 Bizkaia;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
48 Bizkaia;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
48 Bizkaia;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QII;""
48 Bizkaia;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QI;""
48 Bizkaia;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
48 Bizkaia;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
48 Bizkaia;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
48 Bizkaia;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
48 Bizkaia;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
48 Bizkaia;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
48 Bizkaia;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
48 Bizkaia;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
48 Bizkaia;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
48 Bizkaia;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
48 Bizkaia;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
48 Bizkaia;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
48 Bizkaia;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
48 Bizkaia;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;96,45
48 Bizkaia;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
48 Bizkaia;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
48 Bizkaia;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
48 Bizkaia;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;96,46
48 Bizkaia;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
48 Bizkaia;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
48 Bizkaia;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
48 Bizkaia;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;95,29
48 Bizkaia;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
48 Bizkaia;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
48 Bizkaia;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;90,18
48 Bizkaia;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
48 Bizkaia;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
48 Bizkaia;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
48 Bizkaia;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;91,72
48 Bizkaia;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
48 Bizkaia;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
48 Bizkaia;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
48 Bizkaia;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;90,51
48 Bizkaia;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
48 Bizkaia;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
48 Bizkaia;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
48 Bizkaia;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
48 Bizkaia;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
48 Bizkaia;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
48 Bizkaia;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;88,28
48 Bizkaia;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
48 Bizkaia;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
48 Bizkaia;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
48 Bizkaia;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;86,95
48 Bizkaia;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
48 Bizkaia;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
48 Bizkaia;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
48 Bizkaia;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
48 Bizkaia;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
48 Bizkaia;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
48 Bizkaia;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;85,08
48 Bizkaia;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
48 Bizkaia;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
48 Bizkaia;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
48 Bizkaia;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;83,14
48 Bizkaia;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
48 Bizkaia;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
48 Bizkaia;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
48 Bizkaia;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
48 Bizkaia;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
48 Bizkaia;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
48 Bizkaia;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QIII;4.659
48 Bizkaia;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
48 Bizkaia;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
48 Bizkaia;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
48 Bizkaia;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QIII;4.434
48 Bizkaia;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
48 Bizkaia;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
48 Bizkaia;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
48 Bizkaia;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QIII;4.260
48 Bizkaia;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
48 Bizkaia;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
48 Bizkaia;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
48 Bizkaia;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2022QIII;4.523
48 Bizkaia;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2022QII;""
48 Bizkaia;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2022QI;""
48 Bizkaia;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
48 Bizkaia;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2021QIII;4.265
48 Bizkaia;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2021QII;""
48 Bizkaia;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2021QI;""
48 Bizkaia;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
48 Bizkaia;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2020QIII;4.028
48 Bizkaia;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2020QII;""
48 Bizkaia;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2020QI;""
48 Bizkaia;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2022QIV;4.239
48 Bizkaia;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
48 Bizkaia;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2022QII;""
48 Bizkaia;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2022QI;""
48 Bizkaia;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2021QIV;4.066
48 Bizkaia;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
48 Bizkaia;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2021QII;""
48 Bizkaia;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2021QI;""
48 Bizkaia;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2020QIV;3.833
48 Bizkaia;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
48 Bizkaia;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2020QII;""
48 Bizkaia;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2020QI;""
48 Bizkaia;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
48 Bizkaia;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
48 Bizkaia;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QII;""
48 Bizkaia;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QI;3.903
48 Bizkaia;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
48 Bizkaia;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
48 Bizkaia;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QII;""
48 Bizkaia;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QI;3.682
48 Bizkaia;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
48 Bizkaia;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
48 Bizkaia;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QII;""
48 Bizkaia;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QI;""
48 Bizkaia;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
48 Bizkaia;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
48 Bizkaia;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QII;3.739
48 Bizkaia;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QI;""
48 Bizkaia;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
48 Bizkaia;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
48 Bizkaia;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QII;3.515
48 Bizkaia;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QI;""
48 Bizkaia;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
48 Bizkaia;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
48 Bizkaia;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QII;""
48 Bizkaia;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QI;""
48 Bizkaia;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
48 Bizkaia;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
48 Bizkaia;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
48 Bizkaia;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
48 Bizkaia;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
48 Bizkaia;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
48 Bizkaia;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
48 Bizkaia;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
48 Bizkaia;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
48 Bizkaia;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
48 Bizkaia;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
48 Bizkaia;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
48 Bizkaia;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
48 Bizkaia;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;97,08
48 Bizkaia;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
48 Bizkaia;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
48 Bizkaia;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
48 Bizkaia;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;96,19
48 Bizkaia;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
48 Bizkaia;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
48 Bizkaia;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
48 Bizkaia;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;94,55
48 Bizkaia;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
48 Bizkaia;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
48 Bizkaia;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;90,99
48 Bizkaia;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
48 Bizkaia;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
48 Bizkaia;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
48 Bizkaia;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;91,7
48 Bizkaia;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
48 Bizkaia;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
48 Bizkaia;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
48 Bizkaia;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;89,98
48 Bizkaia;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
48 Bizkaia;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
48 Bizkaia;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
48 Bizkaia;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
48 Bizkaia;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
48 Bizkaia;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
48 Bizkaia;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;88,02
48 Bizkaia;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
48 Bizkaia;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
48 Bizkaia;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
48 Bizkaia;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;86,43
48 Bizkaia;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
48 Bizkaia;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
48 Bizkaia;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
48 Bizkaia;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
48 Bizkaia;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
48 Bizkaia;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
48 Bizkaia;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;84,33
48 Bizkaia;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
48 Bizkaia;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
48 Bizkaia;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
48 Bizkaia;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;82,51
48 Bizkaia;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
48 Bizkaia;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
48 Bizkaia;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
48 Bizkaia;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
48 Bizkaia;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
48 Bizkaia;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QIV;12.953
48 Bizkaia;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
48 Bizkaia;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
48 Bizkaia;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
48 Bizkaia;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QIV;12.334
48 Bizkaia;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
48 Bizkaia;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
48 Bizkaia;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
48 Bizkaia;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QIV;11.769
48 Bizkaia;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
48 Bizkaia;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
48 Bizkaia;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
48 Bizkaia;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2022QIV;12.117
48 Bizkaia;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
48 Bizkaia;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2022QII;""
48 Bizkaia;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2022QI;""
48 Bizkaia;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2021QIV;11.734
48 Bizkaia;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
48 Bizkaia;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2021QII;""
48 Bizkaia;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2021QI;""
48 Bizkaia;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2020QIV;11.184
48 Bizkaia;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
48 Bizkaia;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2020QII;""
48 Bizkaia;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2020QI;""
48 Bizkaia;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
48 Bizkaia;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
48 Bizkaia;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2022QII;""
48 Bizkaia;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2022QI;11.281
48 Bizkaia;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
48 Bizkaia;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
48 Bizkaia;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2021QII;""
48 Bizkaia;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2021QI;10.741
48 Bizkaia;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
48 Bizkaia;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
48 Bizkaia;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2020QII;""
48 Bizkaia;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2020QI;""
48 Bizkaia;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
48 Bizkaia;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
48 Bizkaia;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QII;10.845
48 Bizkaia;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QI;""
48 Bizkaia;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
48 Bizkaia;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
48 Bizkaia;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QII;10.263
48 Bizkaia;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QI;""
48 Bizkaia;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
48 Bizkaia;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
48 Bizkaia;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QII;""
48 Bizkaia;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QI;""
48 Bizkaia;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
48 Bizkaia;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QIII;10.458
48 Bizkaia;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QII;""
48 Bizkaia;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QI;""
48 Bizkaia;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
48 Bizkaia;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QIII;9.863
48 Bizkaia;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QII;""
48 Bizkaia;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QI;""
48 Bizkaia;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
48 Bizkaia;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
48 Bizkaia;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QII;""
48 Bizkaia;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QI;""
48 Bizkaia;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
48 Bizkaia;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
48 Bizkaia;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
48 Bizkaia;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
48 Bizkaia;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
48 Bizkaia;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
48 Bizkaia;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
48 Bizkaia;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
48 Bizkaia;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
48 Bizkaia;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
48 Bizkaia;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
48 Bizkaia;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
48 Bizkaia;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;93,55
48 Bizkaia;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
48 Bizkaia;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
48 Bizkaia;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
48 Bizkaia;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;95,14
48 Bizkaia;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
48 Bizkaia;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
48 Bizkaia;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
48 Bizkaia;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;95,03
48 Bizkaia;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
48 Bizkaia;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
48 Bizkaia;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
48 Bizkaia;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
48 Bizkaia;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
48 Bizkaia;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
48 Bizkaia;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;91,46
48 Bizkaia;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
48 Bizkaia;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
48 Bizkaia;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
48 Bizkaia;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;91,27
48 Bizkaia;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
48 Bizkaia;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
48 Bizkaia;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
48 Bizkaia;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
48 Bizkaia;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
48 Bizkaia;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
48 Bizkaia;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;87,93
48 Bizkaia;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
48 Bizkaia;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
48 Bizkaia;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
48 Bizkaia;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;87,2
48 Bizkaia;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
48 Bizkaia;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
48 Bizkaia;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
48 Bizkaia;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
48 Bizkaia;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
48 Bizkaia;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
48 Bizkaia;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;84,79
48 Bizkaia;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
48 Bizkaia;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
48 Bizkaia;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
48 Bizkaia;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;83,8
48 Bizkaia;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
48 Bizkaia;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
48 Bizkaia;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
48 Bizkaia;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
48 Bizkaia;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
48 Bizkaia;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
48 Bizkaia;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QIV;8.399
48 Bizkaia;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
48 Bizkaia;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
48 Bizkaia;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
48 Bizkaia;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QIV;8.038
48 Bizkaia;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
48 Bizkaia;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
48 Bizkaia;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
48 Bizkaia;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QIV;7.704
48 Bizkaia;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
48 Bizkaia;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
48 Bizkaia;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
48 Bizkaia;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2022QIV;7.849
48 Bizkaia;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
48 Bizkaia;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2022QII;""
48 Bizkaia;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2022QI;""
48 Bizkaia;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2021QIV;7.641
48 Bizkaia;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
48 Bizkaia;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2021QII;""
48 Bizkaia;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2021QI;""
48 Bizkaia;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2020QIV;7.317
48 Bizkaia;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
48 Bizkaia;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2020QII;""
48 Bizkaia;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2020QI;""
48 Bizkaia;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
48 Bizkaia;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
48 Bizkaia;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2022QII;""
48 Bizkaia;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2022QI;7.354
48 Bizkaia;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
48 Bizkaia;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
48 Bizkaia;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2021QII;""
48 Bizkaia;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2021QI;7.027
48 Bizkaia;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
48 Bizkaia;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
48 Bizkaia;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2020QII;""
48 Bizkaia;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2020QI;""
48 Bizkaia;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
48 Bizkaia;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
48 Bizkaia;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QII;7.082
48 Bizkaia;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QI;""
48 Bizkaia;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
48 Bizkaia;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
48 Bizkaia;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QII;6.719
48 Bizkaia;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QI;""
48 Bizkaia;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
48 Bizkaia;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
48 Bizkaia;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QII;""
48 Bizkaia;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QI;""
48 Bizkaia;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
48 Bizkaia;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QIII;6.811
48 Bizkaia;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QII;""
48 Bizkaia;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QI;""
48 Bizkaia;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
48 Bizkaia;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QIII;6.459
48 Bizkaia;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QII;""
48 Bizkaia;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QI;""
48 Bizkaia;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
48 Bizkaia;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
48 Bizkaia;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QII;""
48 Bizkaia;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QI;""
48 Bizkaia;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
48 Bizkaia;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
48 Bizkaia;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
48 Bizkaia;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
48 Bizkaia;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
48 Bizkaia;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
48 Bizkaia;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
48 Bizkaia;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
48 Bizkaia;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
48 Bizkaia;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
48 Bizkaia;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
48 Bizkaia;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
48 Bizkaia;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;93,45
48 Bizkaia;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
48 Bizkaia;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
48 Bizkaia;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
48 Bizkaia;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;95,06
48 Bizkaia;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
48 Bizkaia;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
48 Bizkaia;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
48 Bizkaia;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;94,98
48 Bizkaia;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
48 Bizkaia;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
48 Bizkaia;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
48 Bizkaia;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
48 Bizkaia;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
48 Bizkaia;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
48 Bizkaia;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;91,49
48 Bizkaia;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
48 Bizkaia;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
48 Bizkaia;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
48 Bizkaia;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;91,21
48 Bizkaia;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
48 Bizkaia;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
48 Bizkaia;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
48 Bizkaia;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
48 Bizkaia;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
48 Bizkaia;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
48 Bizkaia;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;88,11
48 Bizkaia;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
48 Bizkaia;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
48 Bizkaia;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
48 Bizkaia;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;87,21
48 Bizkaia;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
48 Bizkaia;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
48 Bizkaia;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
48 Bizkaia;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
48 Bizkaia;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
48 Bizkaia;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
48 Bizkaia;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;84,74
48 Bizkaia;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
48 Bizkaia;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
48 Bizkaia;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
48 Bizkaia;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;83,84
48 Bizkaia;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
48 Bizkaia;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
48 Bizkaia;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
48 Bizkaia;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
48 Bizkaia;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
48 Bizkaia;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
48 Bizkaia;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QIV;4.554
48 Bizkaia;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
48 Bizkaia;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
48 Bizkaia;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
48 Bizkaia;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QIV;4.296
48 Bizkaia;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
48 Bizkaia;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
48 Bizkaia;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
48 Bizkaia;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QIV;4.065
48 Bizkaia;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
48 Bizkaia;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
48 Bizkaia;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
48 Bizkaia;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2022QIV;4.268
48 Bizkaia;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
48 Bizkaia;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2022QII;""
48 Bizkaia;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2022QI;""
48 Bizkaia;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2021QIV;4.093
48 Bizkaia;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
48 Bizkaia;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2021QII;""
48 Bizkaia;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2021QI;""
48 Bizkaia;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2020QIV;3.867
48 Bizkaia;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
48 Bizkaia;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2020QII;""
48 Bizkaia;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2020QI;""
48 Bizkaia;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
48 Bizkaia;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
48 Bizkaia;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2022QII;""
48 Bizkaia;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2022QI;3.927
48 Bizkaia;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
48 Bizkaia;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
48 Bizkaia;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2021QII;""
48 Bizkaia;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2021QI;3.714
48 Bizkaia;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
48 Bizkaia;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
48 Bizkaia;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2020QII;""
48 Bizkaia;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2020QI;""
48 Bizkaia;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
48 Bizkaia;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
48 Bizkaia;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QII;3.763
48 Bizkaia;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QI;""
48 Bizkaia;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
48 Bizkaia;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
48 Bizkaia;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QII;3.544
48 Bizkaia;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QI;""
48 Bizkaia;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
48 Bizkaia;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
48 Bizkaia;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QII;""
48 Bizkaia;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QI;""
48 Bizkaia;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
48 Bizkaia;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QIII;3.647
48 Bizkaia;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QII;""
48 Bizkaia;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QI;""
48 Bizkaia;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
48 Bizkaia;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QIII;3.404
48 Bizkaia;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QII;""
48 Bizkaia;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QI;""
48 Bizkaia;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
48 Bizkaia;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
48 Bizkaia;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QII;""
48 Bizkaia;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QI;""
48 Bizkaia;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
48 Bizkaia;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
48 Bizkaia;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
48 Bizkaia;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
48 Bizkaia;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
48 Bizkaia;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
48 Bizkaia;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
48 Bizkaia;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
48 Bizkaia;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
48 Bizkaia;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
48 Bizkaia;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
48 Bizkaia;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
48 Bizkaia;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;93,72
48 Bizkaia;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
48 Bizkaia;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
48 Bizkaia;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
48 Bizkaia;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;95,27
48 Bizkaia;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
48 Bizkaia;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
48 Bizkaia;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
48 Bizkaia;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;95,13
48 Bizkaia;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
48 Bizkaia;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
48 Bizkaia;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
48 Bizkaia;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
48 Bizkaia;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
48 Bizkaia;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
48 Bizkaia;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;91,41
48 Bizkaia;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
48 Bizkaia;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
48 Bizkaia;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
48 Bizkaia;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;91,37
48 Bizkaia;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
48 Bizkaia;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
48 Bizkaia;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
48 Bizkaia;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
48 Bizkaia;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
48 Bizkaia;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
48 Bizkaia;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;87,59
48 Bizkaia;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
48 Bizkaia;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
48 Bizkaia;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
48 Bizkaia;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;87,18
48 Bizkaia;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
48 Bizkaia;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
48 Bizkaia;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
48 Bizkaia;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
48 Bizkaia;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
48 Bizkaia;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
48 Bizkaia;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;84,89
48 Bizkaia;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
48 Bizkaia;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
48 Bizkaia;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
48 Bizkaia;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;83,74
48 Bizkaia;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
48 Bizkaia;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
48 Bizkaia;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
48 Bizkaia;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
48 Bizkaia;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
48 Bizkaia;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
09 Burgos;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
09 Burgos;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
09 Burgos;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
09 Burgos;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QI;21.759
09 Burgos;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
09 Burgos;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
09 Burgos;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
09 Burgos;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QI;21.707
09 Burgos;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
09 Burgos;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
09 Burgos;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
09 Burgos;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QI;22.267
09 Burgos;All ages;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
09 Burgos;All ages;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
09 Burgos;All ages;Cohort January 1;Total;Survival in the first trimester;2022QII;""
09 Burgos;All ages;Cohort January 1;Total;Survival in the first trimester;2022QI;21.178
09 Burgos;All ages;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
09 Burgos;All ages;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
09 Burgos;All ages;Cohort January 1;Total;Survival in the first trimester;2021QII;""
09 Burgos;All ages;Cohort January 1;Total;Survival in the first trimester;2021QI;21.233
09 Burgos;All ages;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
09 Burgos;All ages;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
09 Burgos;All ages;Cohort January 1;Total;Survival in the first trimester;2020QII;""
09 Burgos;All ages;Cohort January 1;Total;Survival in the first trimester;2020QI;21.143
09 Burgos;All ages;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
09 Burgos;All ages;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
09 Burgos;All ages;Cohort January 1;Total;Survival in the second trimester;2022QII;20.623
09 Burgos;All ages;Cohort January 1;Total;Survival in the second trimester;2022QI;""
09 Burgos;All ages;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
09 Burgos;All ages;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
09 Burgos;All ages;Cohort January 1;Total;Survival in the second trimester;2021QII;20.686
09 Burgos;All ages;Cohort January 1;Total;Survival in the second trimester;2021QI;""
09 Burgos;All ages;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
09 Burgos;All ages;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
09 Burgos;All ages;Cohort January 1;Total;Survival in the second trimester;2020QII;20.788
09 Burgos;All ages;Cohort January 1;Total;Survival in the second trimester;2020QI;""
09 Burgos;All ages;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
09 Burgos;All ages;Cohort January 1;Total;Survival in the third trimester;2022QIII;20.144
09 Burgos;All ages;Cohort January 1;Total;Survival in the third trimester;2022QII;""
09 Burgos;All ages;Cohort January 1;Total;Survival in the third trimester;2022QI;""
09 Burgos;All ages;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
09 Burgos;All ages;Cohort January 1;Total;Survival in the third trimester;2021QIII;20.252
09 Burgos;All ages;Cohort January 1;Total;Survival in the third trimester;2021QII;""
09 Burgos;All ages;Cohort January 1;Total;Survival in the third trimester;2021QI;""
09 Burgos;All ages;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
09 Burgos;All ages;Cohort January 1;Total;Survival in the third trimester;2020QIII;20.317
09 Burgos;All ages;Cohort January 1;Total;Survival in the third trimester;2020QII;""
09 Burgos;All ages;Cohort January 1;Total;Survival in the third trimester;2020QI;""
09 Burgos;All ages;Cohort January 1;Total;Survival in the third trimester;2022QIV;19.534
09 Burgos;All ages;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
09 Burgos;All ages;Cohort January 1;Total;Survival in the third trimester;2022QII;""
09 Burgos;All ages;Cohort January 1;Total;Survival in the third trimester;2022QI;""
09 Burgos;All ages;Cohort January 1;Total;Survival in the third trimester;2021QIV;19.698
09 Burgos;All ages;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
09 Burgos;All ages;Cohort January 1;Total;Survival in the third trimester;2021QII;""
09 Burgos;All ages;Cohort January 1;Total;Survival in the third trimester;2021QI;""
09 Burgos;All ages;Cohort January 1;Total;Survival in the third trimester;2020QIV;19.841
09 Burgos;All ages;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
09 Burgos;All ages;Cohort January 1;Total;Survival in the third trimester;2020QII;""
09 Burgos;All ages;Cohort January 1;Total;Survival in the third trimester;2020QI;""
09 Burgos;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
09 Burgos;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
09 Burgos;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
09 Burgos;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
09 Burgos;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
09 Burgos;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
09 Burgos;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
09 Burgos;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
09 Burgos;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
09 Burgos;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
09 Burgos;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
09 Burgos;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
09 Burgos;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
09 Burgos;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
09 Burgos;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
09 Burgos;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;97,33
09 Burgos;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
09 Burgos;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
09 Burgos;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
09 Burgos;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;97,82
09 Burgos;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
09 Burgos;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
09 Burgos;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
09 Burgos;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;94,95
09 Burgos;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
09 Burgos;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
09 Burgos;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;94,78
09 Burgos;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
09 Burgos;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
09 Burgos;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
09 Burgos;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;95,3
09 Burgos;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
09 Burgos;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
09 Burgos;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
09 Burgos;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;93,36
09 Burgos;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
09 Burgos;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
09 Burgos;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;92,58
09 Burgos;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
09 Burgos;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
09 Burgos;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
09 Burgos;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;93,3
09 Burgos;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
09 Burgos;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
09 Burgos;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
09 Burgos;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;91,24
09 Burgos;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
09 Burgos;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
09 Burgos;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;89,77
09 Burgos;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
09 Burgos;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
09 Burgos;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
09 Burgos;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;90,74
09 Burgos;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
09 Burgos;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
09 Burgos;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
09 Burgos;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;89,1
09 Burgos;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
09 Burgos;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
09 Burgos;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
09 Burgos;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
09 Burgos;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
09 Burgos;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
09 Burgos;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QI;13.568
09 Burgos;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
09 Burgos;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
09 Burgos;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
09 Burgos;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QI;13.654
09 Burgos;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
09 Burgos;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
09 Burgos;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
09 Burgos;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QI;14.015
09 Burgos;All ages;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
09 Burgos;All ages;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
09 Burgos;All ages;Cohort January 1;Males;Survival in the first trimester;2022QII;""
09 Burgos;All ages;Cohort January 1;Males;Survival in the first trimester;2022QI;13.218
09 Burgos;All ages;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
09 Burgos;All ages;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
09 Burgos;All ages;Cohort January 1;Males;Survival in the first trimester;2021QII;""
09 Burgos;All ages;Cohort January 1;Males;Survival in the first trimester;2021QI;13.371
09 Burgos;All ages;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
09 Burgos;All ages;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
09 Burgos;All ages;Cohort January 1;Males;Survival in the first trimester;2020QII;""
09 Burgos;All ages;Cohort January 1;Males;Survival in the first trimester;2020QI;13.336
09 Burgos;All ages;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
09 Burgos;All ages;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
09 Burgos;All ages;Cohort January 1;Males;Survival in the second trimester;2022QII;12.915
09 Burgos;All ages;Cohort January 1;Males;Survival in the second trimester;2022QI;""
09 Burgos;All ages;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
09 Burgos;All ages;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
09 Burgos;All ages;Cohort January 1;Males;Survival in the second trimester;2021QII;13.043
09 Burgos;All ages;Cohort January 1;Males;Survival in the second trimester;2021QI;""
09 Burgos;All ages;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
09 Burgos;All ages;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
09 Burgos;All ages;Cohort January 1;Males;Survival in the second trimester;2020QII;13.146
09 Burgos;All ages;Cohort January 1;Males;Survival in the second trimester;2020QI;""
09 Burgos;All ages;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
09 Burgos;All ages;Cohort January 1;Males;Survival in the third trimester;2022QIII;12.658
09 Burgos;All ages;Cohort January 1;Males;Survival in the third trimester;2022QII;""
09 Burgos;All ages;Cohort January 1;Males;Survival in the third trimester;2022QI;""
09 Burgos;All ages;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
09 Burgos;All ages;Cohort January 1;Males;Survival in the third trimester;2021QIII;12.770
09 Burgos;All ages;Cohort January 1;Males;Survival in the third trimester;2021QII;""
09 Burgos;All ages;Cohort January 1;Males;Survival in the third trimester;2021QI;""
09 Burgos;All ages;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
09 Burgos;All ages;Cohort January 1;Males;Survival in the third trimester;2020QIII;12.872
09 Burgos;All ages;Cohort January 1;Males;Survival in the third trimester;2020QII;""
09 Burgos;All ages;Cohort January 1;Males;Survival in the third trimester;2020QI;""
09 Burgos;All ages;Cohort January 1;Males;Survival in the third trimester;2022QIV;12.295
09 Burgos;All ages;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
09 Burgos;All ages;Cohort January 1;Males;Survival in the third trimester;2022QII;""
09 Burgos;All ages;Cohort January 1;Males;Survival in the third trimester;2022QI;""
09 Burgos;All ages;Cohort January 1;Males;Survival in the third trimester;2021QIV;12.440
09 Burgos;All ages;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
09 Burgos;All ages;Cohort January 1;Males;Survival in the third trimester;2021QII;""
09 Burgos;All ages;Cohort January 1;Males;Survival in the third trimester;2021QI;""
09 Burgos;All ages;Cohort January 1;Males;Survival in the third trimester;2020QIV;12.588
09 Burgos;All ages;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
09 Burgos;All ages;Cohort January 1;Males;Survival in the third trimester;2020QII;""
09 Burgos;All ages;Cohort January 1;Males;Survival in the third trimester;2020QI;""
09 Burgos;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
09 Burgos;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
09 Burgos;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
09 Burgos;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
09 Burgos;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
09 Burgos;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
09 Burgos;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
09 Burgos;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
09 Burgos;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
09 Burgos;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
09 Burgos;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
09 Burgos;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
09 Burgos;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
09 Burgos;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
09 Burgos;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
09 Burgos;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;97,42
09 Burgos;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
09 Burgos;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
09 Burgos;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
09 Burgos;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;97,93
09 Burgos;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
09 Burgos;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
09 Burgos;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
09 Burgos;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;95,16
09 Burgos;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
09 Burgos;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
09 Burgos;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;95,19
09 Burgos;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
09 Burgos;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
09 Burgos;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
09 Burgos;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;95,53
09 Burgos;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
09 Burgos;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
09 Burgos;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
09 Burgos;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;93,8
09 Burgos;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
09 Burgos;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
09 Burgos;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;93,29
09 Burgos;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
09 Burgos;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
09 Burgos;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
09 Burgos;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;93,53
09 Burgos;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
09 Burgos;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
09 Burgos;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
09 Burgos;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;91,84
09 Burgos;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
09 Burgos;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
09 Burgos;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;90,62
09 Burgos;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
09 Burgos;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
09 Burgos;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
09 Burgos;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;91,11
09 Burgos;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
09 Burgos;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
09 Burgos;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
09 Burgos;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;89,82
09 Burgos;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
09 Burgos;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
09 Burgos;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
09 Burgos;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
09 Burgos;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
09 Burgos;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
09 Burgos;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QI;8.191
09 Burgos;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
09 Burgos;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
09 Burgos;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
09 Burgos;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QI;8.053
09 Burgos;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
09 Burgos;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
09 Burgos;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
09 Burgos;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QI;8.252
09 Burgos;All ages;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
09 Burgos;All ages;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
09 Burgos;All ages;Cohort January 1;Females;Survival in the first trimester;2022QII;""
09 Burgos;All ages;Cohort January 1;Females;Survival in the first trimester;2022QI;7.960
09 Burgos;All ages;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
09 Burgos;All ages;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
09 Burgos;All ages;Cohort January 1;Females;Survival in the first trimester;2021QII;""
09 Burgos;All ages;Cohort January 1;Females;Survival in the first trimester;2021QI;7.862
09 Burgos;All ages;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
09 Burgos;All ages;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
09 Burgos;All ages;Cohort January 1;Females;Survival in the first trimester;2020QII;""
09 Burgos;All ages;Cohort January 1;Females;Survival in the first trimester;2020QI;7.807
09 Burgos;All ages;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
09 Burgos;All ages;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
09 Burgos;All ages;Cohort January 1;Females;Survival in the second trimester;2022QII;7.708
09 Burgos;All ages;Cohort January 1;Females;Survival in the second trimester;2022QI;""
09 Burgos;All ages;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
09 Burgos;All ages;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
09 Burgos;All ages;Cohort January 1;Females;Survival in the second trimester;2021QII;7.643
09 Burgos;All ages;Cohort January 1;Females;Survival in the second trimester;2021QI;""
09 Burgos;All ages;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
09 Burgos;All ages;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
09 Burgos;All ages;Cohort January 1;Females;Survival in the second trimester;2020QII;7.642
09 Burgos;All ages;Cohort January 1;Females;Survival in the second trimester;2020QI;""
09 Burgos;All ages;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
09 Burgos;All ages;Cohort January 1;Females;Survival in the third trimester;2022QIII;7.486
09 Burgos;All ages;Cohort January 1;Females;Survival in the third trimester;2022QII;""
09 Burgos;All ages;Cohort January 1;Females;Survival in the third trimester;2022QI;""
09 Burgos;All ages;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
09 Burgos;All ages;Cohort January 1;Females;Survival in the third trimester;2021QIII;7.482
09 Burgos;All ages;Cohort January 1;Females;Survival in the third trimester;2021QII;""
09 Burgos;All ages;Cohort January 1;Females;Survival in the third trimester;2021QI;""
09 Burgos;All ages;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
09 Burgos;All ages;Cohort January 1;Females;Survival in the third trimester;2020QIII;7.445
09 Burgos;All ages;Cohort January 1;Females;Survival in the third trimester;2020QII;""
09 Burgos;All ages;Cohort January 1;Females;Survival in the third trimester;2020QI;""
09 Burgos;All ages;Cohort January 1;Females;Survival in the third trimester;2022QIV;7.239
09 Burgos;All ages;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
09 Burgos;All ages;Cohort January 1;Females;Survival in the third trimester;2022QII;""
09 Burgos;All ages;Cohort January 1;Females;Survival in the third trimester;2022QI;""
09 Burgos;All ages;Cohort January 1;Females;Survival in the third trimester;2021QIV;7.258
09 Burgos;All ages;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
09 Burgos;All ages;Cohort January 1;Females;Survival in the third trimester;2021QII;""
09 Burgos;All ages;Cohort January 1;Females;Survival in the third trimester;2021QI;""
09 Burgos;All ages;Cohort January 1;Females;Survival in the third trimester;2020QIV;7.253
09 Burgos;All ages;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
09 Burgos;All ages;Cohort January 1;Females;Survival in the third trimester;2020QII;""
09 Burgos;All ages;Cohort January 1;Females;Survival in the third trimester;2020QI;""
09 Burgos;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
09 Burgos;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
09 Burgos;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
09 Burgos;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
09 Burgos;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
09 Burgos;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
09 Burgos;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
09 Burgos;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
09 Burgos;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
09 Burgos;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
09 Burgos;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
09 Burgos;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
09 Burgos;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
09 Burgos;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
09 Burgos;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
09 Burgos;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;97,18
09 Burgos;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
09 Burgos;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
09 Burgos;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
09 Burgos;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;97,63
09 Burgos;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
09 Burgos;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
09 Burgos;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
09 Burgos;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;94,61
09 Burgos;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
09 Burgos;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
09 Burgos;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;94,1
09 Burgos;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
09 Burgos;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
09 Burgos;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
09 Burgos;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;94,91
09 Burgos;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
09 Burgos;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
09 Burgos;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
09 Burgos;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;92,61
09 Burgos;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
09 Burgos;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
09 Burgos;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;91,39
09 Burgos;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
09 Burgos;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
09 Burgos;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
09 Burgos;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;92,91
09 Burgos;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
09 Burgos;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
09 Burgos;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
09 Burgos;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;90,22
09 Burgos;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
09 Burgos;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
09 Burgos;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;88,38
09 Burgos;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
09 Burgos;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
09 Burgos;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
09 Burgos;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;90,13
09 Burgos;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
09 Burgos;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
09 Burgos;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
09 Burgos;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;87,89
09 Burgos;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
09 Burgos;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
09 Burgos;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
09 Burgos;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
09 Burgos;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
09 Burgos;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QII;21.754
09 Burgos;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
09 Burgos;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
09 Burgos;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
09 Burgos;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QII;21.782
09 Burgos;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
09 Burgos;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
09 Burgos;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
09 Burgos;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QII;21.867
09 Burgos;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
09 Burgos;All ages;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
09 Burgos;All ages;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
09 Burgos;All ages;Cohort April 1;Total;Survival in the first trimester;2022QII;21.126
09 Burgos;All ages;Cohort April 1;Total;Survival in the first trimester;2022QI;""
09 Burgos;All ages;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
09 Burgos;All ages;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
09 Burgos;All ages;Cohort April 1;Total;Survival in the first trimester;2021QII;21.176
09 Burgos;All ages;Cohort April 1;Total;Survival in the first trimester;2021QI;""
09 Burgos;All ages;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
09 Burgos;All ages;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
09 Burgos;All ages;Cohort April 1;Total;Survival in the first trimester;2020QII;21.466
09 Burgos;All ages;Cohort April 1;Total;Survival in the first trimester;2020QI;""
09 Burgos;All ages;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
09 Burgos;All ages;Cohort April 1;Total;Survival in the second trimester;2022QIII;20.611
09 Burgos;All ages;Cohort April 1;Total;Survival in the second trimester;2022QII;""
09 Burgos;All ages;Cohort April 1;Total;Survival in the second trimester;2022QI;""
09 Burgos;All ages;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
09 Burgos;All ages;Cohort April 1;Total;Survival in the second trimester;2021QIII;20.701
09 Burgos;All ages;Cohort April 1;Total;Survival in the second trimester;2021QII;""
09 Burgos;All ages;Cohort April 1;Total;Survival in the second trimester;2021QI;""
09 Burgos;All ages;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
09 Burgos;All ages;Cohort April 1;Total;Survival in the second trimester;2020QIII;20.909
09 Burgos;All ages;Cohort April 1;Total;Survival in the second trimester;2020QII;""
09 Burgos;All ages;Cohort April 1;Total;Survival in the second trimester;2020QI;""
09 Burgos;All ages;Cohort April 1;Total;Survival in the third trimester;2022QIV;19.960
09 Burgos;All ages;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
09 Burgos;All ages;Cohort April 1;Total;Survival in the third trimester;2022QII;""
09 Burgos;All ages;Cohort April 1;Total;Survival in the third trimester;2022QI;""
09 Burgos;All ages;Cohort April 1;Total;Survival in the third trimester;2021QIV;20.098
09 Burgos;All ages;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
09 Burgos;All ages;Cohort April 1;Total;Survival in the third trimester;2021QII;""
09 Burgos;All ages;Cohort April 1;Total;Survival in the third trimester;2021QI;""
09 Burgos;All ages;Cohort April 1;Total;Survival in the third trimester;2020QIV;20.386
09 Burgos;All ages;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
09 Burgos;All ages;Cohort April 1;Total;Survival in the third trimester;2020QII;""
09 Burgos;All ages;Cohort April 1;Total;Survival in the third trimester;2020QI;""
09 Burgos;All ages;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
09 Burgos;All ages;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
09 Burgos;All ages;Cohort April 1;Total;Survival in the third trimester;2022QII;""
09 Burgos;All ages;Cohort April 1;Total;Survival in the third trimester;2022QI;19.667
09 Burgos;All ages;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
09 Burgos;All ages;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
09 Burgos;All ages;Cohort April 1;Total;Survival in the third trimester;2021QII;""
09 Burgos;All ages;Cohort April 1;Total;Survival in the third trimester;2021QI;20.028
09 Burgos;All ages;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
09 Burgos;All ages;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
09 Burgos;All ages;Cohort April 1;Total;Survival in the third trimester;2020QII;""
09 Burgos;All ages;Cohort April 1;Total;Survival in the third trimester;2020QI;""
09 Burgos;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
09 Burgos;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
09 Burgos;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
09 Burgos;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
09 Burgos;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
09 Burgos;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
09 Burgos;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
09 Burgos;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
09 Burgos;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
09 Burgos;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
09 Burgos;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
09 Burgos;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
09 Burgos;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
09 Burgos;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
09 Burgos;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;97,11
09 Burgos;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
09 Burgos;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
09 Burgos;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
09 Burgos;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;97,22
09 Burgos;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
09 Burgos;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
09 Burgos;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
09 Burgos;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;98,17
09 Burgos;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
09 Burgos;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
09 Burgos;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;94,75
09 Burgos;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
09 Burgos;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
09 Burgos;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
09 Burgos;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;95,04
09 Burgos;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
09 Burgos;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
09 Burgos;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
09 Burgos;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;95,62
09 Burgos;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
09 Burgos;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
09 Burgos;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;91,75
09 Burgos;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
09 Burgos;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
09 Burgos;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
09 Burgos;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;92,27
09 Burgos;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
09 Burgos;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
09 Burgos;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
09 Burgos;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;93,23
09 Burgos;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
09 Burgos;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
09 Burgos;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
09 Burgos;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
09 Burgos;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
09 Burgos;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
09 Burgos;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;90,29
09 Burgos;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
09 Burgos;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
09 Burgos;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
09 Burgos;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;91,59
09 Burgos;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
09 Burgos;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
09 Burgos;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
09 Burgos;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
09 Burgos;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
09 Burgos;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
09 Burgos;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QII;13.543
09 Burgos;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
09 Burgos;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
09 Burgos;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
09 Burgos;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QII;13.704
09 Burgos;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
09 Burgos;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
09 Burgos;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
09 Burgos;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QII;13.754
09 Burgos;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
09 Burgos;All ages;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
09 Burgos;All ages;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
09 Burgos;All ages;Cohort April 1;Males;Survival in the first trimester;2022QII;13.192
09 Burgos;All ages;Cohort April 1;Males;Survival in the first trimester;2022QI;""
09 Burgos;All ages;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
09 Burgos;All ages;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
09 Burgos;All ages;Cohort April 1;Males;Survival in the first trimester;2021QII;13.337
09 Burgos;All ages;Cohort April 1;Males;Survival in the first trimester;2021QI;""
09 Burgos;All ages;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
09 Burgos;All ages;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
09 Burgos;All ages;Cohort April 1;Males;Survival in the first trimester;2020QII;13.532
09 Burgos;All ages;Cohort April 1;Males;Survival in the first trimester;2020QI;""
09 Burgos;All ages;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
09 Burgos;All ages;Cohort April 1;Males;Survival in the second trimester;2022QIII;12.911
09 Burgos;All ages;Cohort April 1;Males;Survival in the second trimester;2022QII;""
09 Burgos;All ages;Cohort April 1;Males;Survival in the second trimester;2022QI;""
09 Burgos;All ages;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
09 Burgos;All ages;Cohort April 1;Males;Survival in the second trimester;2021QIII;13.037
09 Burgos;All ages;Cohort April 1;Males;Survival in the second trimester;2021QII;""
09 Burgos;All ages;Cohort April 1;Males;Survival in the second trimester;2021QI;""
09 Burgos;All ages;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
09 Burgos;All ages;Cohort April 1;Males;Survival in the second trimester;2020QIII;13.198
09 Burgos;All ages;Cohort April 1;Males;Survival in the second trimester;2020QII;""
09 Burgos;All ages;Cohort April 1;Males;Survival in the second trimester;2020QI;""
09 Burgos;All ages;Cohort April 1;Males;Survival in the third trimester;2022QIV;12.526
09 Burgos;All ages;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
09 Burgos;All ages;Cohort April 1;Males;Survival in the third trimester;2022QII;""
09 Burgos;All ages;Cohort April 1;Males;Survival in the third trimester;2022QI;""
09 Burgos;All ages;Cohort April 1;Males;Survival in the third trimester;2021QIV;12.672
09 Burgos;All ages;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
09 Burgos;All ages;Cohort April 1;Males;Survival in the third trimester;2021QII;""
09 Burgos;All ages;Cohort April 1;Males;Survival in the third trimester;2021QI;""
09 Burgos;All ages;Cohort April 1;Males;Survival in the third trimester;2020QIV;12.886
09 Burgos;All ages;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
09 Burgos;All ages;Cohort April 1;Males;Survival in the third trimester;2020QII;""
09 Burgos;All ages;Cohort April 1;Males;Survival in the third trimester;2020QI;""
09 Burgos;All ages;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
09 Burgos;All ages;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
09 Burgos;All ages;Cohort April 1;Males;Survival in the third trimester;2022QII;""
09 Burgos;All ages;Cohort April 1;Males;Survival in the third trimester;2022QI;12.411
09 Burgos;All ages;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
09 Burgos;All ages;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
09 Burgos;All ages;Cohort April 1;Males;Survival in the third trimester;2021QII;""
09 Burgos;All ages;Cohort April 1;Males;Survival in the third trimester;2021QI;12.664
09 Burgos;All ages;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
09 Burgos;All ages;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
09 Burgos;All ages;Cohort April 1;Males;Survival in the third trimester;2020QII;""
09 Burgos;All ages;Cohort April 1;Males;Survival in the third trimester;2020QI;""
09 Burgos;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
09 Burgos;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
09 Burgos;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
09 Burgos;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
09 Burgos;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
09 Burgos;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
09 Burgos;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
09 Burgos;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
09 Burgos;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
09 Burgos;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
09 Burgos;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
09 Burgos;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
09 Burgos;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
09 Burgos;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
09 Burgos;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;97,41
09 Burgos;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
09 Burgos;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
09 Burgos;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
09 Burgos;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;97,32
09 Burgos;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
09 Burgos;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
09 Burgos;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
09 Burgos;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;98,39
09 Burgos;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
09 Burgos;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
09 Burgos;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;95,33
09 Burgos;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
09 Burgos;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
09 Burgos;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
09 Burgos;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;95,13
09 Burgos;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
09 Burgos;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
09 Burgos;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
09 Burgos;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;95,96
09 Burgos;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
09 Burgos;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
09 Burgos;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;92,49
09 Burgos;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
09 Burgos;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
09 Burgos;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
09 Burgos;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;92,47
09 Burgos;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
09 Burgos;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
09 Burgos;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
09 Burgos;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;93,69
09 Burgos;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
09 Burgos;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
09 Burgos;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
09 Burgos;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
09 Burgos;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
09 Burgos;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
09 Burgos;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;90,56
09 Burgos;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
09 Burgos;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
09 Burgos;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
09 Burgos;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;92,08
09 Burgos;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
09 Burgos;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
09 Burgos;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
09 Burgos;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
09 Burgos;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
09 Burgos;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
09 Burgos;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QII;8.211
09 Burgos;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
09 Burgos;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
09 Burgos;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
09 Burgos;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QII;8.078
09 Burgos;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
09 Burgos;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
09 Burgos;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
09 Burgos;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QII;8.113
09 Burgos;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
09 Burgos;All ages;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
09 Burgos;All ages;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
09 Burgos;All ages;Cohort April 1;Females;Survival in the first trimester;2022QII;7.934
09 Burgos;All ages;Cohort April 1;Females;Survival in the first trimester;2022QI;""
09 Burgos;All ages;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
09 Burgos;All ages;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
09 Burgos;All ages;Cohort April 1;Females;Survival in the first trimester;2021QII;7.839
09 Burgos;All ages;Cohort April 1;Females;Survival in the first trimester;2021QI;""
09 Burgos;All ages;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
09 Burgos;All ages;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
09 Burgos;All ages;Cohort April 1;Females;Survival in the first trimester;2020QII;7.934
09 Burgos;All ages;Cohort April 1;Females;Survival in the first trimester;2020QI;""
09 Burgos;All ages;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
09 Burgos;All ages;Cohort April 1;Females;Survival in the second trimester;2022QIII;7.700
09 Burgos;All ages;Cohort April 1;Females;Survival in the second trimester;2022QII;""
09 Burgos;All ages;Cohort April 1;Females;Survival in the second trimester;2022QI;""
09 Burgos;All ages;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
09 Burgos;All ages;Cohort April 1;Females;Survival in the second trimester;2021QIII;7.664
09 Burgos;All ages;Cohort April 1;Females;Survival in the second trimester;2021QII;""
09 Burgos;All ages;Cohort April 1;Females;Survival in the second trimester;2021QI;""
09 Burgos;All ages;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
09 Burgos;All ages;Cohort April 1;Females;Survival in the second trimester;2020QIII;7.711
09 Burgos;All ages;Cohort April 1;Females;Survival in the second trimester;2020QII;""
09 Burgos;All ages;Cohort April 1;Females;Survival in the second trimester;2020QI;""
09 Burgos;All ages;Cohort April 1;Females;Survival in the third trimester;2022QIV;7.434
09 Burgos;All ages;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
09 Burgos;All ages;Cohort April 1;Females;Survival in the third trimester;2022QII;""
09 Burgos;All ages;Cohort April 1;Females;Survival in the third trimester;2022QI;""
09 Burgos;All ages;Cohort April 1;Females;Survival in the third trimester;2021QIV;7.426
09 Burgos;All ages;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
09 Burgos;All ages;Cohort April 1;Females;Survival in the third trimester;2021QII;""
09 Burgos;All ages;Cohort April 1;Females;Survival in the third trimester;2021QI;""
09 Burgos;All ages;Cohort April 1;Females;Survival in the third trimester;2020QIV;7.500
09 Burgos;All ages;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
09 Burgos;All ages;Cohort April 1;Females;Survival in the third trimester;2020QII;""
09 Burgos;All ages;Cohort April 1;Females;Survival in the third trimester;2020QI;""
09 Burgos;All ages;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
09 Burgos;All ages;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
09 Burgos;All ages;Cohort April 1;Females;Survival in the third trimester;2022QII;""
09 Burgos;All ages;Cohort April 1;Females;Survival in the third trimester;2022QI;7.256
09 Burgos;All ages;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
09 Burgos;All ages;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
09 Burgos;All ages;Cohort April 1;Females;Survival in the third trimester;2021QII;""
09 Burgos;All ages;Cohort April 1;Females;Survival in the third trimester;2021QI;7.364
09 Burgos;All ages;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
09 Burgos;All ages;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
09 Burgos;All ages;Cohort April 1;Females;Survival in the third trimester;2020QII;""
09 Burgos;All ages;Cohort April 1;Females;Survival in the third trimester;2020QI;""
09 Burgos;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
09 Burgos;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
09 Burgos;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
09 Burgos;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
09 Burgos;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
09 Burgos;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
09 Burgos;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
09 Burgos;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
09 Burgos;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
09 Burgos;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
09 Burgos;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
09 Burgos;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
09 Burgos;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
09 Burgos;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
09 Burgos;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;96,63
09 Burgos;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
09 Burgos;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
09 Burgos;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
09 Burgos;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;97,04
09 Burgos;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
09 Burgos;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
09 Burgos;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
09 Burgos;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;97,79
09 Burgos;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
09 Burgos;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
09 Burgos;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;93,78
09 Burgos;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
09 Burgos;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
09 Burgos;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
09 Burgos;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;94,87
09 Burgos;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
09 Burgos;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
09 Burgos;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
09 Burgos;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;95,04
09 Burgos;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
09 Burgos;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
09 Burgos;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;90,54
09 Burgos;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
09 Burgos;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
09 Burgos;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
09 Burgos;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;91,93
09 Burgos;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
09 Burgos;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
09 Burgos;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
09 Burgos;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;92,44
09 Burgos;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
09 Burgos;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
09 Burgos;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
09 Burgos;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
09 Burgos;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
09 Burgos;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
09 Burgos;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;89,82
09 Burgos;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
09 Burgos;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
09 Burgos;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
09 Burgos;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;90,77
09 Burgos;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
09 Burgos;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
09 Burgos;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
09 Burgos;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
09 Burgos;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
09 Burgos;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QIII;21.832
09 Burgos;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
09 Burgos;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
09 Burgos;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
09 Burgos;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QIII;21.854
09 Burgos;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
09 Burgos;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
09 Burgos;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
09 Burgos;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QIII;21.898
09 Burgos;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
09 Burgos;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
09 Burgos;All ages;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
09 Burgos;All ages;Cohort July 1;Total;Survival in the first trimester;2022QIII;21.200
09 Burgos;All ages;Cohort July 1;Total;Survival in the first trimester;2022QII;""
09 Burgos;All ages;Cohort July 1;Total;Survival in the first trimester;2022QI;""
09 Burgos;All ages;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
09 Burgos;All ages;Cohort July 1;Total;Survival in the first trimester;2021QIII;21.281
09 Burgos;All ages;Cohort July 1;Total;Survival in the first trimester;2021QII;""
09 Burgos;All ages;Cohort July 1;Total;Survival in the first trimester;2021QI;""
09 Burgos;All ages;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
09 Burgos;All ages;Cohort July 1;Total;Survival in the first trimester;2020QIII;21.252
09 Burgos;All ages;Cohort July 1;Total;Survival in the first trimester;2020QII;""
09 Burgos;All ages;Cohort July 1;Total;Survival in the first trimester;2020QI;""
09 Burgos;All ages;Cohort July 1;Total;Survival in the second trimester;2022QIV;20.476
09 Burgos;All ages;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
09 Burgos;All ages;Cohort July 1;Total;Survival in the second trimester;2022QII;""
09 Burgos;All ages;Cohort July 1;Total;Survival in the second trimester;2022QI;""
09 Burgos;All ages;Cohort July 1;Total;Survival in the second trimester;2021QIV;20.633
09 Burgos;All ages;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
09 Burgos;All ages;Cohort July 1;Total;Survival in the second trimester;2021QII;""
09 Burgos;All ages;Cohort July 1;Total;Survival in the second trimester;2021QI;""
09 Burgos;All ages;Cohort July 1;Total;Survival in the second trimester;2020QIV;20.676
09 Burgos;All ages;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
09 Burgos;All ages;Cohort July 1;Total;Survival in the second trimester;2020QII;""
09 Burgos;All ages;Cohort July 1;Total;Survival in the second trimester;2020QI;""
09 Burgos;All ages;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
09 Burgos;All ages;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
09 Burgos;All ages;Cohort July 1;Total;Survival in the third trimester;2022QII;""
09 Burgos;All ages;Cohort July 1;Total;Survival in the third trimester;2022QI;20.156
09 Burgos;All ages;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
09 Burgos;All ages;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
09 Burgos;All ages;Cohort July 1;Total;Survival in the third trimester;2021QII;""
09 Burgos;All ages;Cohort July 1;Total;Survival in the third trimester;2021QI;20.299
09 Burgos;All ages;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
09 Burgos;All ages;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
09 Burgos;All ages;Cohort July 1;Total;Survival in the third trimester;2020QII;""
09 Burgos;All ages;Cohort July 1;Total;Survival in the third trimester;2020QI;""
09 Burgos;All ages;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
09 Burgos;All ages;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
09 Burgos;All ages;Cohort July 1;Total;Survival in the third trimester;2022QII;19.703
09 Burgos;All ages;Cohort July 1;Total;Survival in the third trimester;2022QI;""
09 Burgos;All ages;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
09 Burgos;All ages;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
09 Burgos;All ages;Cohort July 1;Total;Survival in the third trimester;2021QII;19.866
09 Burgos;All ages;Cohort July 1;Total;Survival in the third trimester;2021QI;""
09 Burgos;All ages;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
09 Burgos;All ages;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
09 Burgos;All ages;Cohort July 1;Total;Survival in the third trimester;2020QII;""
09 Burgos;All ages;Cohort July 1;Total;Survival in the third trimester;2020QI;""
09 Burgos;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
09 Burgos;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
09 Burgos;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
09 Burgos;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
09 Burgos;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
09 Burgos;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
09 Burgos;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
09 Burgos;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
09 Burgos;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
09 Burgos;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
09 Burgos;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
09 Burgos;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
09 Burgos;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
09 Burgos;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;97,11
09 Burgos;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
09 Burgos;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
09 Burgos;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
09 Burgos;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;97,38
09 Burgos;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
09 Burgos;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
09 Burgos;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
09 Burgos;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;97,05
09 Burgos;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
09 Burgos;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
09 Burgos;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;93,79
09 Burgos;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
09 Burgos;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
09 Burgos;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
09 Burgos;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;94,41
09 Burgos;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
09 Burgos;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
09 Burgos;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
09 Burgos;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;94,42
09 Burgos;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
09 Burgos;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
09 Burgos;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
09 Burgos;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
09 Burgos;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
09 Burgos;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
09 Burgos;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;92,23
09 Burgos;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
09 Burgos;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
09 Burgos;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
09 Burgos;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;92,7
09 Burgos;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
09 Burgos;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
09 Burgos;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
09 Burgos;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
09 Burgos;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
09 Burgos;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
09 Burgos;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;90,16
09 Burgos;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
09 Burgos;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
09 Burgos;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
09 Burgos;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;90,72
09 Burgos;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
09 Burgos;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
09 Burgos;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
09 Burgos;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
09 Burgos;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
09 Burgos;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
09 Burgos;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QIII;13.572
09 Burgos;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
09 Burgos;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
09 Burgos;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
09 Burgos;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QIII;13.741
09 Burgos;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
09 Burgos;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
09 Burgos;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
09 Burgos;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QIII;13.817
09 Burgos;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
09 Burgos;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
09 Burgos;All ages;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
09 Burgos;All ages;Cohort July 1;Males;Survival in the first trimester;2022QIII;13.223
09 Burgos;All ages;Cohort July 1;Males;Survival in the first trimester;2022QII;""
09 Burgos;All ages;Cohort July 1;Males;Survival in the first trimester;2022QI;""
09 Burgos;All ages;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
09 Burgos;All ages;Cohort July 1;Males;Survival in the first trimester;2021QIII;13.380
09 Burgos;All ages;Cohort July 1;Males;Survival in the first trimester;2021QII;""
09 Burgos;All ages;Cohort July 1;Males;Survival in the first trimester;2021QI;""
09 Burgos;All ages;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
09 Burgos;All ages;Cohort July 1;Males;Survival in the first trimester;2020QIII;13.422
09 Burgos;All ages;Cohort July 1;Males;Survival in the first trimester;2020QII;""
09 Burgos;All ages;Cohort July 1;Males;Survival in the first trimester;2020QI;""
09 Burgos;All ages;Cohort July 1;Males;Survival in the second trimester;2022QIV;12.788
09 Burgos;All ages;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
09 Burgos;All ages;Cohort July 1;Males;Survival in the second trimester;2022QII;""
09 Burgos;All ages;Cohort July 1;Males;Survival in the second trimester;2022QI;""
09 Burgos;All ages;Cohort July 1;Males;Survival in the second trimester;2021QIV;12.985
09 Burgos;All ages;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
09 Burgos;All ages;Cohort July 1;Males;Survival in the second trimester;2021QII;""
09 Burgos;All ages;Cohort July 1;Males;Survival in the second trimester;2021QI;""
09 Burgos;All ages;Cohort July 1;Males;Survival in the second trimester;2020QIV;13.071
09 Burgos;All ages;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
09 Burgos;All ages;Cohort July 1;Males;Survival in the second trimester;2020QII;""
09 Burgos;All ages;Cohort July 1;Males;Survival in the second trimester;2020QI;""
09 Burgos;All ages;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
09 Burgos;All ages;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
09 Burgos;All ages;Cohort July 1;Males;Survival in the third trimester;2022QII;""
09 Burgos;All ages;Cohort July 1;Males;Survival in the third trimester;2022QI;12.695
09 Burgos;All ages;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
09 Burgos;All ages;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
09 Burgos;All ages;Cohort July 1;Males;Survival in the third trimester;2021QII;""
09 Burgos;All ages;Cohort July 1;Males;Survival in the third trimester;2021QI;12.837
09 Burgos;All ages;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
09 Burgos;All ages;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
09 Burgos;All ages;Cohort July 1;Males;Survival in the third trimester;2020QII;""
09 Burgos;All ages;Cohort July 1;Males;Survival in the third trimester;2020QI;""
09 Burgos;All ages;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
09 Burgos;All ages;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
09 Burgos;All ages;Cohort July 1;Males;Survival in the third trimester;2022QII;12.437
09 Burgos;All ages;Cohort July 1;Males;Survival in the third trimester;2022QI;""
09 Burgos;All ages;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
09 Burgos;All ages;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
09 Burgos;All ages;Cohort July 1;Males;Survival in the third trimester;2021QII;12.571
09 Burgos;All ages;Cohort July 1;Males;Survival in the third trimester;2021QI;""
09 Burgos;All ages;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
09 Burgos;All ages;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
09 Burgos;All ages;Cohort July 1;Males;Survival in the third trimester;2020QII;""
09 Burgos;All ages;Cohort July 1;Males;Survival in the third trimester;2020QI;""
09 Burgos;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
09 Burgos;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
09 Burgos;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
09 Burgos;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
09 Burgos;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
09 Burgos;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
09 Burgos;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
09 Burgos;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
09 Burgos;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
09 Burgos;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
09 Burgos;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
09 Burgos;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
09 Burgos;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
09 Burgos;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;97,43
09 Burgos;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
09 Burgos;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
09 Burgos;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
09 Burgos;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;97,37
09 Burgos;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
09 Burgos;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
09 Burgos;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
09 Burgos;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;97,14
09 Burgos;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
09 Burgos;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
09 Burgos;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;94,22
09 Burgos;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
09 Burgos;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
09 Burgos;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
09 Burgos;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;94,5
09 Burgos;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
09 Burgos;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
09 Burgos;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
09 Burgos;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;94,6
09 Burgos;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
09 Burgos;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
09 Burgos;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
09 Burgos;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
09 Burgos;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
09 Burgos;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
09 Burgos;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;92,39
09 Burgos;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
09 Burgos;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
09 Burgos;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
09 Burgos;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;92,91
09 Burgos;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
09 Burgos;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
09 Burgos;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
09 Burgos;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
09 Burgos;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
09 Burgos;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
09 Burgos;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;90,51
09 Burgos;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
09 Burgos;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
09 Burgos;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
09 Burgos;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;90,98
09 Burgos;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
09 Burgos;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
09 Burgos;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
09 Burgos;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
09 Burgos;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
09 Burgos;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
09 Burgos;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QIII;8.260
09 Burgos;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
09 Burgos;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
09 Burgos;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
09 Burgos;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QIII;8.113
09 Burgos;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
09 Burgos;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
09 Burgos;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
09 Burgos;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QIII;8.081
09 Burgos;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
09 Burgos;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
09 Burgos;All ages;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
09 Burgos;All ages;Cohort July 1;Females;Survival in the first trimester;2022QIII;7.977
09 Burgos;All ages;Cohort July 1;Females;Survival in the first trimester;2022QII;""
09 Burgos;All ages;Cohort July 1;Females;Survival in the first trimester;2022QI;""
09 Burgos;All ages;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
09 Burgos;All ages;Cohort July 1;Females;Survival in the first trimester;2021QIII;7.901
09 Burgos;All ages;Cohort July 1;Females;Survival in the first trimester;2021QII;""
09 Burgos;All ages;Cohort July 1;Females;Survival in the first trimester;2021QI;""
09 Burgos;All ages;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
09 Burgos;All ages;Cohort July 1;Females;Survival in the first trimester;2020QIII;7.830
09 Burgos;All ages;Cohort July 1;Females;Survival in the first trimester;2020QII;""
09 Burgos;All ages;Cohort July 1;Females;Survival in the first trimester;2020QI;""
09 Burgos;All ages;Cohort July 1;Females;Survival in the second trimester;2022QIV;7.688
09 Burgos;All ages;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
09 Burgos;All ages;Cohort July 1;Females;Survival in the second trimester;2022QII;""
09 Burgos;All ages;Cohort July 1;Females;Survival in the second trimester;2022QI;""
09 Burgos;All ages;Cohort July 1;Females;Survival in the second trimester;2021QIV;7.648
09 Burgos;All ages;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
09 Burgos;All ages;Cohort July 1;Females;Survival in the second trimester;2021QII;""
09 Burgos;All ages;Cohort July 1;Females;Survival in the second trimester;2021QI;""
09 Burgos;All ages;Cohort July 1;Females;Survival in the second trimester;2020QIV;7.605
09 Burgos;All ages;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
09 Burgos;All ages;Cohort July 1;Females;Survival in the second trimester;2020QII;""
09 Burgos;All ages;Cohort July 1;Females;Survival in the second trimester;2020QI;""
09 Burgos;All ages;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
09 Burgos;All ages;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
09 Burgos;All ages;Cohort July 1;Females;Survival in the third trimester;2022QII;""
09 Burgos;All ages;Cohort July 1;Females;Survival in the third trimester;2022QI;7.461
09 Burgos;All ages;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
09 Burgos;All ages;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
09 Burgos;All ages;Cohort July 1;Females;Survival in the third trimester;2021QII;""
09 Burgos;All ages;Cohort July 1;Females;Survival in the third trimester;2021QI;7.462
09 Burgos;All ages;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
09 Burgos;All ages;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
09 Burgos;All ages;Cohort July 1;Females;Survival in the third trimester;2020QII;""
09 Burgos;All ages;Cohort July 1;Females;Survival in the third trimester;2020QI;""
09 Burgos;All ages;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
09 Burgos;All ages;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
09 Burgos;All ages;Cohort July 1;Females;Survival in the third trimester;2022QII;7.266
09 Burgos;All ages;Cohort July 1;Females;Survival in the third trimester;2022QI;""
09 Burgos;All ages;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
09 Burgos;All ages;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
09 Burgos;All ages;Cohort July 1;Females;Survival in the third trimester;2021QII;7.295
09 Burgos;All ages;Cohort July 1;Females;Survival in the third trimester;2021QI;""
09 Burgos;All ages;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
09 Burgos;All ages;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
09 Burgos;All ages;Cohort July 1;Females;Survival in the third trimester;2020QII;""
09 Burgos;All ages;Cohort July 1;Females;Survival in the third trimester;2020QI;""
09 Burgos;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
09 Burgos;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
09 Burgos;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
09 Burgos;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
09 Burgos;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
09 Burgos;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
09 Burgos;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
09 Burgos;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
09 Burgos;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
09 Burgos;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
09 Burgos;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
09 Burgos;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
09 Burgos;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
09 Burgos;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;96,57
09 Burgos;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
09 Burgos;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
09 Burgos;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
09 Burgos;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;97,39
09 Burgos;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
09 Burgos;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
09 Burgos;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
09 Burgos;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;96,89
09 Burgos;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
09 Burgos;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
09 Burgos;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;93,08
09 Burgos;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
09 Burgos;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
09 Burgos;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
09 Burgos;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;94,27
09 Burgos;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
09 Burgos;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
09 Burgos;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
09 Burgos;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;94,11
09 Burgos;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
09 Burgos;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
09 Burgos;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
09 Burgos;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
09 Burgos;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
09 Burgos;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
09 Burgos;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;91,96
09 Burgos;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
09 Burgos;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
09 Burgos;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
09 Burgos;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;92,34
09 Burgos;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
09 Burgos;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
09 Burgos;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
09 Burgos;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
09 Burgos;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
09 Burgos;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
09 Burgos;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;89,56
09 Burgos;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
09 Burgos;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
09 Burgos;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
09 Burgos;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;90,27
09 Burgos;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
09 Burgos;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
09 Burgos;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
09 Burgos;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
09 Burgos;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
09 Burgos;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QIV;21.714
09 Burgos;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
09 Burgos;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
09 Burgos;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
09 Burgos;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QIV;21.902
09 Burgos;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
09 Burgos;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
09 Burgos;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
09 Burgos;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QIV;21.841
09 Burgos;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
09 Burgos;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
09 Burgos;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
09 Burgos;All ages;Cohort October 1;Total;Survival in the first trimester;2022QIV;20.914
09 Burgos;All ages;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
09 Burgos;All ages;Cohort October 1;Total;Survival in the first trimester;2022QII;""
09 Burgos;All ages;Cohort October 1;Total;Survival in the first trimester;2022QI;""
09 Burgos;All ages;Cohort October 1;Total;Survival in the first trimester;2021QIV;21.164
09 Burgos;All ages;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
09 Burgos;All ages;Cohort October 1;Total;Survival in the first trimester;2021QII;""
09 Burgos;All ages;Cohort October 1;Total;Survival in the first trimester;2021QI;""
09 Burgos;All ages;Cohort October 1;Total;Survival in the first trimester;2020QIV;21.179
09 Burgos;All ages;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
09 Burgos;All ages;Cohort October 1;Total;Survival in the first trimester;2020QII;""
09 Burgos;All ages;Cohort October 1;Total;Survival in the first trimester;2020QI;""
09 Burgos;All ages;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
09 Burgos;All ages;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
09 Burgos;All ages;Cohort October 1;Total;Survival in the second trimester;2022QII;""
09 Burgos;All ages;Cohort October 1;Total;Survival in the second trimester;2022QI;20.651
09 Burgos;All ages;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
09 Burgos;All ages;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
09 Burgos;All ages;Cohort October 1;Total;Survival in the second trimester;2021QII;""
09 Burgos;All ages;Cohort October 1;Total;Survival in the second trimester;2021QI;20.762
09 Burgos;All ages;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
09 Burgos;All ages;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
09 Burgos;All ages;Cohort October 1;Total;Survival in the second trimester;2020QII;""
09 Burgos;All ages;Cohort October 1;Total;Survival in the second trimester;2020QI;""
09 Burgos;All ages;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
09 Burgos;All ages;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
09 Burgos;All ages;Cohort October 1;Total;Survival in the third trimester;2022QII;20.156
09 Burgos;All ages;Cohort October 1;Total;Survival in the third trimester;2022QI;""
09 Burgos;All ages;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
09 Burgos;All ages;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
09 Burgos;All ages;Cohort October 1;Total;Survival in the third trimester;2021QII;20.295
09 Burgos;All ages;Cohort October 1;Total;Survival in the third trimester;2021QI;""
09 Burgos;All ages;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
09 Burgos;All ages;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
09 Burgos;All ages;Cohort October 1;Total;Survival in the third trimester;2020QII;""
09 Burgos;All ages;Cohort October 1;Total;Survival in the third trimester;2020QI;""
09 Burgos;All ages;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
09 Burgos;All ages;Cohort October 1;Total;Survival in the third trimester;2022QIII;19.712
09 Burgos;All ages;Cohort October 1;Total;Survival in the third trimester;2022QII;""
09 Burgos;All ages;Cohort October 1;Total;Survival in the third trimester;2022QI;""
09 Burgos;All ages;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
09 Burgos;All ages;Cohort October 1;Total;Survival in the third trimester;2021QIII;19.893
09 Burgos;All ages;Cohort October 1;Total;Survival in the third trimester;2021QII;""
09 Burgos;All ages;Cohort October 1;Total;Survival in the third trimester;2021QI;""
09 Burgos;All ages;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
09 Burgos;All ages;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
09 Burgos;All ages;Cohort October 1;Total;Survival in the third trimester;2020QII;""
09 Burgos;All ages;Cohort October 1;Total;Survival in the third trimester;2020QI;""
09 Burgos;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
09 Burgos;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
09 Burgos;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
09 Burgos;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
09 Burgos;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
09 Burgos;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
09 Burgos;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
09 Burgos;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
09 Burgos;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
09 Burgos;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
09 Burgos;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
09 Burgos;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
09 Burgos;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;96,32
09 Burgos;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
09 Burgos;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
09 Burgos;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
09 Burgos;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;96,63
09 Burgos;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
09 Burgos;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
09 Burgos;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
09 Burgos;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;96,97
09 Burgos;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
09 Burgos;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
09 Burgos;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
09 Burgos;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
09 Burgos;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
09 Burgos;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
09 Burgos;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;94,29
09 Burgos;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
09 Burgos;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
09 Burgos;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
09 Burgos;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;95,06
09 Burgos;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
09 Burgos;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
09 Burgos;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
09 Burgos;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
09 Burgos;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
09 Burgos;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
09 Burgos;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;92,03
09 Burgos;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
09 Burgos;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
09 Burgos;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
09 Burgos;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;92,92
09 Burgos;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
09 Burgos;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
09 Burgos;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
09 Burgos;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
09 Burgos;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
09 Burgos;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
09 Burgos;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;90
09 Burgos;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
09 Burgos;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
09 Burgos;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
09 Burgos;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;91,08
09 Burgos;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
09 Burgos;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
09 Burgos;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
09 Burgos;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
09 Burgos;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
09 Burgos;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
09 Burgos;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QIV;13.506
09 Burgos;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
09 Burgos;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
09 Burgos;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
09 Burgos;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QIV;13.724
09 Burgos;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
09 Burgos;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
09 Burgos;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
09 Burgos;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QIV;13.760
09 Burgos;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
09 Burgos;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
09 Burgos;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
09 Burgos;All ages;Cohort October 1;Males;Survival in the first trimester;2022QIV;13.018
09 Burgos;All ages;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
09 Burgos;All ages;Cohort October 1;Males;Survival in the first trimester;2022QII;""
09 Burgos;All ages;Cohort October 1;Males;Survival in the first trimester;2022QI;""
09 Burgos;All ages;Cohort October 1;Males;Survival in the first trimester;2021QIV;13.277
09 Burgos;All ages;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
09 Burgos;All ages;Cohort October 1;Males;Survival in the first trimester;2021QII;""
09 Burgos;All ages;Cohort October 1;Males;Survival in the first trimester;2021QI;""
09 Burgos;All ages;Cohort October 1;Males;Survival in the first trimester;2020QIV;13.353
09 Burgos;All ages;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
09 Burgos;All ages;Cohort October 1;Males;Survival in the first trimester;2020QII;""
09 Burgos;All ages;Cohort October 1;Males;Survival in the first trimester;2020QI;""
09 Burgos;All ages;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
09 Burgos;All ages;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
09 Burgos;All ages;Cohort October 1;Males;Survival in the second trimester;2022QII;""
09 Burgos;All ages;Cohort October 1;Males;Survival in the second trimester;2022QI;12.966
09 Burgos;All ages;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
09 Burgos;All ages;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
09 Burgos;All ages;Cohort October 1;Males;Survival in the second trimester;2021QII;""
09 Burgos;All ages;Cohort October 1;Males;Survival in the second trimester;2021QI;13.103
09 Burgos;All ages;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
09 Burgos;All ages;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
09 Burgos;All ages;Cohort October 1;Males;Survival in the second trimester;2020QII;""
09 Burgos;All ages;Cohort October 1;Males;Survival in the second trimester;2020QI;""
09 Burgos;All ages;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
09 Burgos;All ages;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
09 Burgos;All ages;Cohort October 1;Males;Survival in the third trimester;2022QII;12.687
09 Burgos;All ages;Cohort October 1;Males;Survival in the third trimester;2022QI;""
09 Burgos;All ages;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
09 Burgos;All ages;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
09 Burgos;All ages;Cohort October 1;Males;Survival in the third trimester;2021QII;12.818
09 Burgos;All ages;Cohort October 1;Males;Survival in the third trimester;2021QI;""
09 Burgos;All ages;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
09 Burgos;All ages;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
09 Burgos;All ages;Cohort October 1;Males;Survival in the third trimester;2020QII;""
09 Burgos;All ages;Cohort October 1;Males;Survival in the third trimester;2020QI;""
09 Burgos;All ages;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
09 Burgos;All ages;Cohort October 1;Males;Survival in the third trimester;2022QIII;12.443
09 Burgos;All ages;Cohort October 1;Males;Survival in the third trimester;2022QII;""
09 Burgos;All ages;Cohort October 1;Males;Survival in the third trimester;2022QI;""
09 Burgos;All ages;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
09 Burgos;All ages;Cohort October 1;Males;Survival in the third trimester;2021QIII;12.564
09 Burgos;All ages;Cohort October 1;Males;Survival in the third trimester;2021QII;""
09 Burgos;All ages;Cohort October 1;Males;Survival in the third trimester;2021QI;""
09 Burgos;All ages;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
09 Burgos;All ages;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
09 Burgos;All ages;Cohort October 1;Males;Survival in the third trimester;2020QII;""
09 Burgos;All ages;Cohort October 1;Males;Survival in the third trimester;2020QI;""
09 Burgos;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
09 Burgos;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
09 Burgos;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
09 Burgos;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
09 Burgos;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
09 Burgos;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
09 Burgos;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
09 Burgos;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
09 Burgos;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
09 Burgos;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
09 Burgos;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
09 Burgos;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
09 Burgos;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;96,39
09 Burgos;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
09 Burgos;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
09 Burgos;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
09 Burgos;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;96,74
09 Burgos;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
09 Burgos;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
09 Burgos;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
09 Burgos;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;97,04
09 Burgos;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
09 Burgos;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
09 Burgos;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
09 Burgos;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
09 Burgos;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
09 Burgos;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
09 Burgos;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;94,48
09 Burgos;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
09 Burgos;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
09 Burgos;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
09 Burgos;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;95,23
09 Burgos;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
09 Burgos;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
09 Burgos;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
09 Burgos;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
09 Burgos;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
09 Burgos;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
09 Burgos;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;92,44
09 Burgos;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
09 Burgos;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
09 Burgos;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
09 Burgos;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;93,15
09 Burgos;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
09 Burgos;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
09 Burgos;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
09 Burgos;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
09 Burgos;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
09 Burgos;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
09 Burgos;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;90,67
09 Burgos;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
09 Burgos;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
09 Burgos;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
09 Burgos;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;91,31
09 Burgos;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
09 Burgos;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
09 Burgos;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
09 Burgos;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
09 Burgos;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
09 Burgos;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
09 Burgos;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QIV;8.208
09 Burgos;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
09 Burgos;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
09 Burgos;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
09 Burgos;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QIV;8.178
09 Burgos;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
09 Burgos;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
09 Burgos;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
09 Burgos;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QIV;8.081
09 Burgos;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
09 Burgos;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
09 Burgos;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
09 Burgos;All ages;Cohort October 1;Females;Survival in the first trimester;2022QIV;7.896
09 Burgos;All ages;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
09 Burgos;All ages;Cohort October 1;Females;Survival in the first trimester;2022QII;""
09 Burgos;All ages;Cohort October 1;Females;Survival in the first trimester;2022QI;""
09 Burgos;All ages;Cohort October 1;Females;Survival in the first trimester;2021QIV;7.887
09 Burgos;All ages;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
09 Burgos;All ages;Cohort October 1;Females;Survival in the first trimester;2021QII;""
09 Burgos;All ages;Cohort October 1;Females;Survival in the first trimester;2021QI;""
09 Burgos;All ages;Cohort October 1;Females;Survival in the first trimester;2020QIV;7.826
09 Burgos;All ages;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
09 Burgos;All ages;Cohort October 1;Females;Survival in the first trimester;2020QII;""
09 Burgos;All ages;Cohort October 1;Females;Survival in the first trimester;2020QI;""
09 Burgos;All ages;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
09 Burgos;All ages;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
09 Burgos;All ages;Cohort October 1;Females;Survival in the second trimester;2022QII;""
09 Burgos;All ages;Cohort October 1;Females;Survival in the second trimester;2022QI;7.685
09 Burgos;All ages;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
09 Burgos;All ages;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
09 Burgos;All ages;Cohort October 1;Females;Survival in the second trimester;2021QII;""
09 Burgos;All ages;Cohort October 1;Females;Survival in the second trimester;2021QI;7.659
09 Burgos;All ages;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
09 Burgos;All ages;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
09 Burgos;All ages;Cohort October 1;Females;Survival in the second trimester;2020QII;""
09 Burgos;All ages;Cohort October 1;Females;Survival in the second trimester;2020QI;""
09 Burgos;All ages;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
09 Burgos;All ages;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
09 Burgos;All ages;Cohort October 1;Females;Survival in the third trimester;2022QII;7.469
09 Burgos;All ages;Cohort October 1;Females;Survival in the third trimester;2022QI;""
09 Burgos;All ages;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
09 Burgos;All ages;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
09 Burgos;All ages;Cohort October 1;Females;Survival in the third trimester;2021QII;7.477
09 Burgos;All ages;Cohort October 1;Females;Survival in the third trimester;2021QI;""
09 Burgos;All ages;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
09 Burgos;All ages;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
09 Burgos;All ages;Cohort October 1;Females;Survival in the third trimester;2020QII;""
09 Burgos;All ages;Cohort October 1;Females;Survival in the third trimester;2020QI;""
09 Burgos;All ages;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
09 Burgos;All ages;Cohort October 1;Females;Survival in the third trimester;2022QIII;7.269
09 Burgos;All ages;Cohort October 1;Females;Survival in the third trimester;2022QII;""
09 Burgos;All ages;Cohort October 1;Females;Survival in the third trimester;2022QI;""
09 Burgos;All ages;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
09 Burgos;All ages;Cohort October 1;Females;Survival in the third trimester;2021QIII;7.329
09 Burgos;All ages;Cohort October 1;Females;Survival in the third trimester;2021QII;""
09 Burgos;All ages;Cohort October 1;Females;Survival in the third trimester;2021QI;""
09 Burgos;All ages;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
09 Burgos;All ages;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
09 Burgos;All ages;Cohort October 1;Females;Survival in the third trimester;2020QII;""
09 Burgos;All ages;Cohort October 1;Females;Survival in the third trimester;2020QI;""
09 Burgos;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
09 Burgos;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
09 Burgos;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
09 Burgos;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
09 Burgos;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
09 Burgos;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
09 Burgos;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
09 Burgos;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
09 Burgos;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
09 Burgos;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
09 Burgos;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
09 Burgos;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
09 Burgos;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;96,2
09 Burgos;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
09 Burgos;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
09 Burgos;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
09 Burgos;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;96,44
09 Burgos;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
09 Burgos;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
09 Burgos;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
09 Burgos;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;96,84
09 Burgos;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
09 Burgos;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
09 Burgos;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
09 Burgos;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
09 Burgos;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
09 Burgos;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
09 Burgos;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;93,97
09 Burgos;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
09 Burgos;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
09 Burgos;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
09 Burgos;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;94,78
09 Burgos;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
09 Burgos;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
09 Burgos;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
09 Burgos;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
09 Burgos;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
09 Burgos;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
09 Burgos;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;91,33
09 Burgos;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
09 Burgos;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
09 Burgos;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
09 Burgos;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;92,53
09 Burgos;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
09 Burgos;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
09 Burgos;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
09 Burgos;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
09 Burgos;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
09 Burgos;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
09 Burgos;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;88,88
09 Burgos;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
09 Burgos;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
09 Burgos;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
09 Burgos;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;90,69
09 Burgos;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
09 Burgos;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
09 Burgos;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
09 Burgos;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
09 Burgos;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
09 Burgos;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
09 Burgos;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
09 Burgos;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
09 Burgos;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
09 Burgos;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QI;1.053
09 Burgos;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
09 Burgos;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
09 Burgos;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
09 Burgos;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QI;1.012
09 Burgos;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
09 Burgos;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
09 Burgos;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
09 Burgos;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QI;840
09 Burgos;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
09 Burgos;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
09 Burgos;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2022QII;""
09 Burgos;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2022QI;984
09 Burgos;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
09 Burgos;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
09 Burgos;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2021QII;""
09 Burgos;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2021QI;941
09 Burgos;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
09 Burgos;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
09 Burgos;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2020QII;""
09 Burgos;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2020QI;726
09 Burgos;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
09 Burgos;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
09 Burgos;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2022QII;920
09 Burgos;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2022QI;""
09 Burgos;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
09 Burgos;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
09 Burgos;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2021QII;871
09 Burgos;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2021QI;""
09 Burgos;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
09 Burgos;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
09 Burgos;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2020QII;693
09 Burgos;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2020QI;""
09 Burgos;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
09 Burgos;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QIII;863
09 Burgos;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QII;""
09 Burgos;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QI;""
09 Burgos;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
09 Burgos;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QIII;826
09 Burgos;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QII;""
09 Burgos;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QI;""
09 Burgos;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
09 Burgos;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QIII;650
09 Burgos;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QII;""
09 Burgos;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QI;""
09 Burgos;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QIV;820
09 Burgos;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
09 Burgos;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QII;""
09 Burgos;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QI;""
09 Burgos;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QIV;780
09 Burgos;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
09 Burgos;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QII;""
09 Burgos;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QI;""
09 Burgos;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QIV;626
09 Burgos;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
09 Burgos;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QII;""
09 Burgos;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QI;""
09 Burgos;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
09 Burgos;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
09 Burgos;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
09 Burgos;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
09 Burgos;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
09 Burgos;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
09 Burgos;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
09 Burgos;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
09 Burgos;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
09 Burgos;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
09 Burgos;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
09 Burgos;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
09 Burgos;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
09 Burgos;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
09 Burgos;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
09 Burgos;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;93,45
09 Burgos;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
09 Burgos;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
09 Burgos;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
09 Burgos;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;92,98
09 Burgos;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
09 Burgos;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
09 Burgos;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
09 Burgos;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;86,43
09 Burgos;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
09 Burgos;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
09 Burgos;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;87,37
09 Burgos;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
09 Burgos;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
09 Burgos;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
09 Burgos;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;86,07
09 Burgos;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
09 Burgos;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
09 Burgos;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
09 Burgos;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;82,5
09 Burgos;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
09 Burgos;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
09 Burgos;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;81,96
09 Burgos;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
09 Burgos;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
09 Burgos;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
09 Burgos;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;81,62
09 Burgos;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
09 Burgos;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
09 Burgos;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
09 Burgos;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;77,38
09 Burgos;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
09 Burgos;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
09 Burgos;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;77,87
09 Burgos;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
09 Burgos;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
09 Burgos;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
09 Burgos;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;77,08
09 Burgos;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
09 Burgos;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
09 Burgos;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
09 Burgos;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;74,52
09 Burgos;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
09 Burgos;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
09 Burgos;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
09 Burgos;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
09 Burgos;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
09 Burgos;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
09 Burgos;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QI;632
09 Burgos;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
09 Burgos;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
09 Burgos;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
09 Burgos;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QI;602
09 Burgos;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
09 Burgos;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
09 Burgos;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
09 Burgos;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QI;504
09 Burgos;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
09 Burgos;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
09 Burgos;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2022QII;""
09 Burgos;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2022QI;592
09 Burgos;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
09 Burgos;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
09 Burgos;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2021QII;""
09 Burgos;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2021QI;564
09 Burgos;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
09 Burgos;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
09 Burgos;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2020QII;""
09 Burgos;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2020QI;435
09 Burgos;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
09 Burgos;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
09 Burgos;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2022QII;554
09 Burgos;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2022QI;""
09 Burgos;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
09 Burgos;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
09 Burgos;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2021QII;521
09 Burgos;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2021QI;""
09 Burgos;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
09 Burgos;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
09 Burgos;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2020QII;420
09 Burgos;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2020QI;""
09 Burgos;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
09 Burgos;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QIII;521
09 Burgos;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QII;""
09 Burgos;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QI;""
09 Burgos;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
09 Burgos;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QIII;491
09 Burgos;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QII;""
09 Burgos;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QI;""
09 Burgos;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
09 Burgos;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QIII;391
09 Burgos;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QII;""
09 Burgos;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QI;""
09 Burgos;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QIV;499
09 Burgos;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
09 Burgos;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QII;""
09 Burgos;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QI;""
09 Burgos;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QIV;467
09 Burgos;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
09 Burgos;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QII;""
09 Burgos;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QI;""
09 Burgos;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QIV;379
09 Burgos;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
09 Burgos;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QII;""
09 Burgos;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QI;""
09 Burgos;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
09 Burgos;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
09 Burgos;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
09 Burgos;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
09 Burgos;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
09 Burgos;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
09 Burgos;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
09 Burgos;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
09 Burgos;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
09 Burgos;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
09 Burgos;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
09 Burgos;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
09 Burgos;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
09 Burgos;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
09 Burgos;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
09 Burgos;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;93,67
09 Burgos;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
09 Burgos;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
09 Burgos;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
09 Burgos;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;93,69
09 Burgos;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
09 Burgos;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
09 Burgos;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
09 Burgos;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;86,31
09 Burgos;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
09 Burgos;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
09 Burgos;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;87,66
09 Burgos;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
09 Burgos;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
09 Burgos;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
09 Burgos;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;86,54
09 Burgos;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
09 Burgos;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
09 Burgos;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
09 Burgos;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;83,33
09 Burgos;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
09 Burgos;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
09 Burgos;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;82,44
09 Burgos;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
09 Burgos;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
09 Burgos;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
09 Burgos;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;81,56
09 Burgos;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
09 Burgos;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
09 Burgos;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
09 Burgos;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;77,58
09 Burgos;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
09 Burgos;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
09 Burgos;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;78,96
09 Burgos;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
09 Burgos;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
09 Burgos;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
09 Burgos;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;77,57
09 Burgos;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
09 Burgos;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
09 Burgos;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
09 Burgos;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;75,2
09 Burgos;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
09 Burgos;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
09 Burgos;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
09 Burgos;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
09 Burgos;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
09 Burgos;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
09 Burgos;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QI;421
09 Burgos;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
09 Burgos;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
09 Burgos;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
09 Burgos;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QI;410
09 Burgos;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
09 Burgos;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
09 Burgos;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
09 Burgos;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QI;336
09 Burgos;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
09 Burgos;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
09 Burgos;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2022QII;""
09 Burgos;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2022QI;392
09 Burgos;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
09 Burgos;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
09 Burgos;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2021QII;""
09 Burgos;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2021QI;377
09 Burgos;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
09 Burgos;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
09 Burgos;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2020QII;""
09 Burgos;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2020QI;291
09 Burgos;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
09 Burgos;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
09 Burgos;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2022QII;366
09 Burgos;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2022QI;""
09 Burgos;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
09 Burgos;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
09 Burgos;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2021QII;350
09 Burgos;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2021QI;""
09 Burgos;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
09 Burgos;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
09 Burgos;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2020QII;273
09 Burgos;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2020QI;""
09 Burgos;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
09 Burgos;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QIII;342
09 Burgos;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QII;""
09 Burgos;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QI;""
09 Burgos;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
09 Burgos;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QIII;335
09 Burgos;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QII;""
09 Burgos;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QI;""
09 Burgos;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
09 Burgos;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QIII;259
09 Burgos;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QII;""
09 Burgos;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QI;""
09 Burgos;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QIV;321
09 Burgos;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
09 Burgos;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QII;""
09 Burgos;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QI;""
09 Burgos;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QIV;313
09 Burgos;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
09 Burgos;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QII;""
09 Burgos;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QI;""
09 Burgos;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QIV;247
09 Burgos;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
09 Burgos;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QII;""
09 Burgos;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QI;""
09 Burgos;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
09 Burgos;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
09 Burgos;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
09 Burgos;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
09 Burgos;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
09 Burgos;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
09 Burgos;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
09 Burgos;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
09 Burgos;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
09 Burgos;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
09 Burgos;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
09 Burgos;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
09 Burgos;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
09 Burgos;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
09 Burgos;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
09 Burgos;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;93,11
09 Burgos;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
09 Burgos;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
09 Burgos;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
09 Burgos;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;91,95
09 Burgos;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
09 Burgos;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
09 Burgos;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
09 Burgos;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;86,61
09 Burgos;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
09 Burgos;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
09 Burgos;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;86,94
09 Burgos;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
09 Burgos;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
09 Burgos;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
09 Burgos;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;85,37
09 Burgos;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
09 Burgos;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
09 Burgos;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
09 Burgos;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;81,25
09 Burgos;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
09 Burgos;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
09 Burgos;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;81,24
09 Burgos;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
09 Burgos;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
09 Burgos;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
09 Burgos;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;81,71
09 Burgos;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
09 Burgos;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
09 Burgos;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
09 Burgos;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;77,08
09 Burgos;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
09 Burgos;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
09 Burgos;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;76,25
09 Burgos;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
09 Burgos;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
09 Burgos;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
09 Burgos;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;76,34
09 Burgos;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
09 Burgos;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
09 Burgos;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
09 Burgos;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;73,51
09 Burgos;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
09 Burgos;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
09 Burgos;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
09 Burgos;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
09 Burgos;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
09 Burgos;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QII;916
09 Burgos;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
09 Burgos;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
09 Burgos;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
09 Burgos;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QII;899
09 Burgos;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
09 Burgos;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
09 Burgos;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
09 Burgos;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QII;846
09 Burgos;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
09 Burgos;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
09 Burgos;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
09 Burgos;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2022QII;827
09 Burgos;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2022QI;""
09 Burgos;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
09 Burgos;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
09 Burgos;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2021QII;818
09 Burgos;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2021QI;""
09 Burgos;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
09 Burgos;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
09 Burgos;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2020QII;807
09 Burgos;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2020QI;""
09 Burgos;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
09 Burgos;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2022QIII;769
09 Burgos;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2022QII;""
09 Burgos;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2022QI;""
09 Burgos;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
09 Burgos;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2021QIII;759
09 Burgos;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2021QII;""
09 Burgos;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2021QI;""
09 Burgos;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
09 Burgos;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2020QIII;746
09 Burgos;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2020QII;""
09 Burgos;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2020QI;""
09 Burgos;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QIV;721
09 Burgos;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
09 Burgos;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QII;""
09 Burgos;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QI;""
09 Burgos;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QIV;714
09 Burgos;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
09 Burgos;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QII;""
09 Burgos;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QI;""
09 Burgos;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QIV;712
09 Burgos;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
09 Burgos;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QII;""
09 Burgos;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QI;""
09 Burgos;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
09 Burgos;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
09 Burgos;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QII;""
09 Burgos;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QI;674
09 Burgos;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
09 Burgos;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
09 Burgos;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QII;""
09 Burgos;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QI;680
09 Burgos;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
09 Burgos;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
09 Burgos;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QII;""
09 Burgos;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QI;""
09 Burgos;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
09 Burgos;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
09 Burgos;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
09 Burgos;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
09 Burgos;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
09 Burgos;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
09 Burgos;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
09 Burgos;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
09 Burgos;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
09 Burgos;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
09 Burgos;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
09 Burgos;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
09 Burgos;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
09 Burgos;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
09 Burgos;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;90,28
09 Burgos;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
09 Burgos;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
09 Burgos;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
09 Burgos;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;90,99
09 Burgos;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
09 Burgos;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
09 Burgos;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
09 Burgos;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;95,39
09 Burgos;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
09 Burgos;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
09 Burgos;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;83,95
09 Burgos;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
09 Burgos;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
09 Burgos;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
09 Burgos;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;84,43
09 Burgos;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
09 Burgos;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
09 Burgos;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
09 Burgos;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;88,18
09 Burgos;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
09 Burgos;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
09 Burgos;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;78,71
09 Burgos;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
09 Burgos;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
09 Burgos;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
09 Burgos;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;79,42
09 Burgos;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
09 Burgos;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
09 Burgos;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
09 Burgos;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;84,16
09 Burgos;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
09 Burgos;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
09 Burgos;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
09 Burgos;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
09 Burgos;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
09 Burgos;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
09 Burgos;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;74,97
09 Burgos;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
09 Burgos;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
09 Burgos;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
09 Burgos;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;80,38
09 Burgos;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
09 Burgos;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
09 Burgos;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
09 Burgos;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
09 Burgos;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
09 Burgos;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
09 Burgos;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QII;554
09 Burgos;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
09 Burgos;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
09 Burgos;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
09 Burgos;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QII;557
09 Burgos;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
09 Burgos;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
09 Burgos;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
09 Burgos;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QII;511
09 Burgos;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
09 Burgos;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
09 Burgos;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
09 Burgos;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2022QII;499
09 Burgos;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2022QI;""
09 Burgos;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
09 Burgos;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
09 Burgos;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2021QII;504
09 Burgos;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2021QI;""
09 Burgos;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
09 Burgos;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
09 Burgos;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2020QII;491
09 Burgos;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2020QI;""
09 Burgos;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
09 Burgos;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2022QIII;465
09 Burgos;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2022QII;""
09 Burgos;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2022QI;""
09 Burgos;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
09 Burgos;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2021QIII;465
09 Burgos;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2021QII;""
09 Burgos;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2021QI;""
09 Burgos;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
09 Burgos;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2020QIII;449
09 Burgos;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2020QII;""
09 Burgos;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2020QI;""
09 Burgos;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QIV;443
09 Burgos;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
09 Burgos;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QII;""
09 Burgos;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QI;""
09 Burgos;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QIV;438
09 Burgos;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
09 Burgos;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QII;""
09 Burgos;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QI;""
09 Burgos;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QIV;429
09 Burgos;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
09 Burgos;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QII;""
09 Burgos;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QI;""
09 Burgos;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
09 Burgos;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
09 Burgos;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QII;""
09 Burgos;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QI;416
09 Burgos;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
09 Burgos;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
09 Burgos;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QII;""
09 Burgos;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QI;405
09 Burgos;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
09 Burgos;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
09 Burgos;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QII;""
09 Burgos;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QI;""
09 Burgos;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
09 Burgos;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
09 Burgos;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
09 Burgos;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
09 Burgos;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
09 Burgos;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
09 Burgos;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
09 Burgos;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
09 Burgos;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
09 Burgos;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
09 Burgos;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
09 Burgos;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
09 Burgos;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
09 Burgos;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
09 Burgos;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;90,07
09 Burgos;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
09 Burgos;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
09 Burgos;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
09 Burgos;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;90,48
09 Burgos;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
09 Burgos;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
09 Burgos;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
09 Burgos;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;96,09
09 Burgos;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
09 Burgos;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
09 Burgos;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;83,94
09 Burgos;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
09 Burgos;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
09 Burgos;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
09 Burgos;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;83,48
09 Burgos;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
09 Burgos;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
09 Burgos;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
09 Burgos;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;87,87
09 Burgos;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
09 Burgos;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
09 Burgos;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;79,96
09 Burgos;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
09 Burgos;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
09 Burgos;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
09 Burgos;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;78,64
09 Burgos;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
09 Burgos;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
09 Burgos;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
09 Burgos;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;83,95
09 Burgos;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
09 Burgos;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
09 Burgos;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
09 Burgos;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
09 Burgos;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
09 Burgos;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
09 Burgos;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;74,69
09 Burgos;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
09 Burgos;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
09 Burgos;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
09 Burgos;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;79,26
09 Burgos;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
09 Burgos;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
09 Burgos;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
09 Burgos;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
09 Burgos;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
09 Burgos;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
09 Burgos;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QII;362
09 Burgos;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
09 Burgos;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
09 Burgos;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
09 Burgos;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QII;342
09 Burgos;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
09 Burgos;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
09 Burgos;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
09 Burgos;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QII;335
09 Burgos;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
09 Burgos;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
09 Burgos;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
09 Burgos;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2022QII;328
09 Burgos;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2022QI;""
09 Burgos;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
09 Burgos;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
09 Burgos;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2021QII;314
09 Burgos;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2021QI;""
09 Burgos;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
09 Burgos;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
09 Burgos;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2020QII;316
09 Burgos;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2020QI;""
09 Burgos;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
09 Burgos;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2022QIII;304
09 Burgos;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2022QII;""
09 Burgos;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2022QI;""
09 Burgos;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
09 Burgos;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2021QIII;294
09 Burgos;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2021QII;""
09 Burgos;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2021QI;""
09 Burgos;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
09 Burgos;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2020QIII;297
09 Burgos;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2020QII;""
09 Burgos;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2020QI;""
09 Burgos;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QIV;278
09 Burgos;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
09 Burgos;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QII;""
09 Burgos;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QI;""
09 Burgos;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QIV;276
09 Burgos;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
09 Burgos;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QII;""
09 Burgos;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QI;""
09 Burgos;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QIV;283
09 Burgos;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
09 Burgos;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QII;""
09 Burgos;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QI;""
09 Burgos;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
09 Burgos;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
09 Burgos;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QII;""
09 Burgos;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QI;258
09 Burgos;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
09 Burgos;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
09 Burgos;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QII;""
09 Burgos;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QI;275
09 Burgos;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
09 Burgos;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
09 Burgos;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QII;""
09 Burgos;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QI;""
09 Burgos;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
09 Burgos;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
09 Burgos;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
09 Burgos;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
09 Burgos;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
09 Burgos;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
09 Burgos;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
09 Burgos;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
09 Burgos;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
09 Burgos;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
09 Burgos;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
09 Burgos;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
09 Burgos;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
09 Burgos;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
09 Burgos;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;90,61
09 Burgos;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
09 Burgos;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
09 Burgos;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
09 Burgos;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;91,81
09 Burgos;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
09 Burgos;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
09 Burgos;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
09 Burgos;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;94,33
09 Burgos;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
09 Burgos;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
09 Burgos;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;83,98
09 Burgos;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
09 Burgos;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
09 Burgos;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
09 Burgos;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;85,96
09 Burgos;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
09 Burgos;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
09 Burgos;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
09 Burgos;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;88,66
09 Burgos;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
09 Burgos;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
09 Burgos;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;76,8
09 Burgos;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
09 Burgos;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
09 Burgos;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
09 Burgos;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;80,7
09 Burgos;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
09 Burgos;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
09 Burgos;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
09 Burgos;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;84,48
09 Burgos;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
09 Burgos;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
09 Burgos;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
09 Burgos;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
09 Burgos;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
09 Burgos;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
09 Burgos;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;75,44
09 Burgos;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
09 Burgos;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
09 Burgos;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
09 Burgos;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;82,09
09 Burgos;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
09 Burgos;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
09 Burgos;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
09 Burgos;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
09 Burgos;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
09 Burgos;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QIII;992
09 Burgos;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
09 Burgos;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
09 Burgos;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
09 Burgos;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QIII;966
09 Burgos;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
09 Burgos;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
09 Burgos;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
09 Burgos;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QIII;910
09 Burgos;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
09 Burgos;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
09 Burgos;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
09 Burgos;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2022QIII;893
09 Burgos;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2022QII;""
09 Burgos;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2022QI;""
09 Burgos;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
09 Burgos;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2021QIII;869
09 Burgos;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2021QII;""
09 Burgos;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2021QI;""
09 Burgos;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
09 Burgos;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2020QIII;816
09 Burgos;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2020QII;""
09 Burgos;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2020QI;""
09 Burgos;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2022QIV;832
09 Burgos;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
09 Burgos;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2022QII;""
09 Burgos;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2022QI;""
09 Burgos;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2021QIV;816
09 Burgos;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
09 Burgos;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2021QII;""
09 Burgos;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2021QI;""
09 Burgos;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2020QIV;772
09 Burgos;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
09 Burgos;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2020QII;""
09 Burgos;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2020QI;""
09 Burgos;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
09 Burgos;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
09 Burgos;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QII;""
09 Burgos;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QI;768
09 Burgos;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
09 Burgos;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
09 Burgos;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QII;""
09 Burgos;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QI;733
09 Burgos;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
09 Burgos;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
09 Burgos;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QII;""
09 Burgos;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QI;""
09 Burgos;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
09 Burgos;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
09 Burgos;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QII;725
09 Burgos;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QI;""
09 Burgos;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
09 Burgos;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
09 Burgos;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QII;693
09 Burgos;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QI;""
09 Burgos;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
09 Burgos;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
09 Burgos;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QII;""
09 Burgos;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QI;""
09 Burgos;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
09 Burgos;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
09 Burgos;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
09 Burgos;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
09 Burgos;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
09 Burgos;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
09 Burgos;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
09 Burgos;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
09 Burgos;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
09 Burgos;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
09 Burgos;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
09 Burgos;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
09 Burgos;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
09 Burgos;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;90,02
09 Burgos;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
09 Burgos;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
09 Burgos;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
09 Burgos;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;89,96
09 Burgos;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
09 Burgos;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
09 Burgos;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
09 Burgos;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;89,67
09 Burgos;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
09 Burgos;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
09 Burgos;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;83,87
09 Burgos;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
09 Burgos;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
09 Burgos;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
09 Burgos;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;84,47
09 Burgos;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
09 Burgos;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
09 Burgos;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
09 Burgos;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;84,84
09 Burgos;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
09 Burgos;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
09 Burgos;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
09 Burgos;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
09 Burgos;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
09 Burgos;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
09 Burgos;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;79,5
09 Burgos;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
09 Burgos;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
09 Burgos;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
09 Burgos;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;80,55
09 Burgos;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
09 Burgos;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
09 Burgos;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
09 Burgos;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
09 Burgos;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
09 Burgos;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
09 Burgos;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;75,05
09 Burgos;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
09 Burgos;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
09 Burgos;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
09 Burgos;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;76,15
09 Burgos;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
09 Burgos;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
09 Burgos;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
09 Burgos;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
09 Burgos;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
09 Burgos;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
09 Burgos;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QIII;599
09 Burgos;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
09 Burgos;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
09 Burgos;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
09 Burgos;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QIII;597
09 Burgos;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
09 Burgos;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
09 Burgos;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
09 Burgos;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QIII;558
09 Burgos;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
09 Burgos;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
09 Burgos;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
09 Burgos;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2022QIII;543
09 Burgos;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2022QII;""
09 Burgos;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2022QI;""
09 Burgos;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
09 Burgos;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2021QIII;531
09 Burgos;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2021QII;""
09 Burgos;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2021QI;""
09 Burgos;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
09 Burgos;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2020QIII;491
09 Burgos;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2020QII;""
09 Burgos;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2020QI;""
09 Burgos;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2022QIV;511
09 Burgos;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
09 Burgos;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2022QII;""
09 Burgos;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2022QI;""
09 Burgos;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2021QIV;499
09 Burgos;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
09 Burgos;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2021QII;""
09 Burgos;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2021QI;""
09 Burgos;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2020QIV;467
09 Burgos;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
09 Burgos;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2020QII;""
09 Burgos;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2020QI;""
09 Burgos;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
09 Burgos;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
09 Burgos;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QII;""
09 Burgos;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QI;470
09 Burgos;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
09 Burgos;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
09 Burgos;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QII;""
09 Burgos;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QI;439
09 Burgos;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
09 Burgos;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
09 Burgos;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QII;""
09 Burgos;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QI;""
09 Burgos;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
09 Burgos;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
09 Burgos;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QII;446
09 Burgos;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QI;""
09 Burgos;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
09 Burgos;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
09 Burgos;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QII;414
09 Burgos;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QI;""
09 Burgos;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
09 Burgos;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
09 Burgos;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QII;""
09 Burgos;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QI;""
09 Burgos;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
09 Burgos;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
09 Burgos;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
09 Burgos;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
09 Burgos;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
09 Burgos;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
09 Burgos;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
09 Burgos;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
09 Burgos;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
09 Burgos;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
09 Burgos;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
09 Burgos;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
09 Burgos;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
09 Burgos;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;90,65
09 Burgos;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
09 Burgos;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
09 Burgos;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
09 Burgos;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;88,94
09 Burgos;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
09 Burgos;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
09 Burgos;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
09 Burgos;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;87,99
09 Burgos;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
09 Burgos;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
09 Burgos;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;85,31
09 Burgos;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
09 Burgos;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
09 Burgos;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
09 Burgos;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;83,58
09 Burgos;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
09 Burgos;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
09 Burgos;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
09 Burgos;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;83,69
09 Burgos;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
09 Burgos;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
09 Burgos;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
09 Burgos;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
09 Burgos;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
09 Burgos;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
09 Burgos;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;78,73
09 Burgos;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
09 Burgos;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
09 Burgos;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
09 Burgos;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;78,67
09 Burgos;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
09 Burgos;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
09 Burgos;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
09 Burgos;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
09 Burgos;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
09 Burgos;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
09 Burgos;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;74,71
09 Burgos;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
09 Burgos;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
09 Burgos;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
09 Burgos;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;74,19
09 Burgos;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
09 Burgos;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
09 Burgos;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
09 Burgos;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
09 Burgos;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
09 Burgos;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
09 Burgos;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QIII;393
09 Burgos;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
09 Burgos;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
09 Burgos;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
09 Burgos;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QIII;369
09 Burgos;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
09 Burgos;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
09 Burgos;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
09 Burgos;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QIII;352
09 Burgos;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
09 Burgos;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
09 Burgos;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
09 Burgos;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2022QIII;350
09 Burgos;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2022QII;""
09 Burgos;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2022QI;""
09 Burgos;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
09 Burgos;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2021QIII;338
09 Burgos;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2021QII;""
09 Burgos;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2021QI;""
09 Burgos;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
09 Burgos;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2020QIII;325
09 Burgos;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2020QII;""
09 Burgos;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2020QI;""
09 Burgos;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2022QIV;321
09 Burgos;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
09 Burgos;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2022QII;""
09 Burgos;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2022QI;""
09 Burgos;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2021QIV;317
09 Burgos;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
09 Burgos;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2021QII;""
09 Burgos;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2021QI;""
09 Burgos;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2020QIV;305
09 Burgos;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
09 Burgos;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2020QII;""
09 Burgos;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2020QI;""
09 Burgos;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
09 Burgos;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
09 Burgos;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QII;""
09 Burgos;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QI;298
09 Burgos;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
09 Burgos;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
09 Burgos;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QII;""
09 Burgos;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QI;294
09 Burgos;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
09 Burgos;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
09 Burgos;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QII;""
09 Burgos;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QI;""
09 Burgos;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
09 Burgos;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
09 Burgos;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QII;279
09 Burgos;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QI;""
09 Burgos;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
09 Burgos;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
09 Burgos;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QII;279
09 Burgos;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QI;""
09 Burgos;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
09 Burgos;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
09 Burgos;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QII;""
09 Burgos;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QI;""
09 Burgos;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
09 Burgos;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
09 Burgos;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
09 Burgos;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
09 Burgos;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
09 Burgos;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
09 Burgos;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
09 Burgos;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
09 Burgos;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
09 Burgos;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
09 Burgos;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
09 Burgos;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
09 Burgos;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
09 Burgos;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;89,06
09 Burgos;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
09 Burgos;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
09 Burgos;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
09 Burgos;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;91,6
09 Burgos;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
09 Burgos;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
09 Burgos;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
09 Burgos;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;92,33
09 Burgos;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
09 Burgos;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
09 Burgos;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;81,68
09 Burgos;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
09 Burgos;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
09 Burgos;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
09 Burgos;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;85,91
09 Burgos;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
09 Burgos;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
09 Burgos;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
09 Burgos;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;86,65
09 Burgos;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
09 Burgos;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
09 Burgos;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
09 Burgos;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
09 Burgos;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
09 Burgos;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
09 Burgos;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;80,76
09 Burgos;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
09 Burgos;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
09 Burgos;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
09 Burgos;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;83,52
09 Burgos;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
09 Burgos;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
09 Burgos;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
09 Burgos;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
09 Burgos;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
09 Burgos;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
09 Burgos;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;75,61
09 Burgos;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
09 Burgos;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
09 Burgos;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
09 Burgos;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;79,26
09 Burgos;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
09 Burgos;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
09 Burgos;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
09 Burgos;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
09 Burgos;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
09 Burgos;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QIV;1.009
09 Burgos;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
09 Burgos;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
09 Burgos;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
09 Burgos;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QIV;1.012
09 Burgos;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
09 Burgos;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
09 Burgos;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
09 Burgos;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QIV;958
09 Burgos;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
09 Burgos;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
09 Burgos;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
09 Burgos;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2022QIV;927
09 Burgos;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
09 Burgos;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2022QII;""
09 Burgos;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2022QI;""
09 Burgos;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2021QIV;932
09 Burgos;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
09 Burgos;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2021QII;""
09 Burgos;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2021QI;""
09 Burgos;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2020QIV;887
09 Burgos;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
09 Burgos;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2020QII;""
09 Burgos;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2020QI;""
09 Burgos;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
09 Burgos;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
09 Burgos;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2022QII;""
09 Burgos;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2022QI;878
09 Burgos;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
09 Burgos;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
09 Burgos;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2021QII;""
09 Burgos;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2021QI;836
09 Burgos;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
09 Burgos;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
09 Burgos;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2020QII;""
09 Burgos;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2020QI;""
09 Burgos;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
09 Burgos;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
09 Burgos;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QII;829
09 Burgos;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QI;""
09 Burgos;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
09 Burgos;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
09 Burgos;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QII;785
09 Burgos;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QI;""
09 Burgos;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
09 Burgos;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
09 Burgos;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QII;""
09 Burgos;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QI;""
09 Burgos;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
09 Burgos;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QIII;779
09 Burgos;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QII;""
09 Burgos;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QI;""
09 Burgos;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
09 Burgos;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QIII;746
09 Burgos;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QII;""
09 Burgos;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QI;""
09 Burgos;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
09 Burgos;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
09 Burgos;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QII;""
09 Burgos;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QI;""
09 Burgos;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
09 Burgos;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
09 Burgos;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
09 Burgos;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
09 Burgos;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
09 Burgos;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
09 Burgos;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
09 Burgos;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
09 Burgos;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
09 Burgos;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
09 Burgos;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
09 Burgos;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
09 Burgos;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;91,87
09 Burgos;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
09 Burgos;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
09 Burgos;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
09 Burgos;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;92,09
09 Burgos;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
09 Burgos;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
09 Burgos;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
09 Burgos;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;92,59
09 Burgos;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
09 Burgos;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
09 Burgos;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
09 Burgos;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
09 Burgos;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
09 Burgos;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
09 Burgos;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;86,76
09 Burgos;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
09 Burgos;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
09 Burgos;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
09 Burgos;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;87,27
09 Burgos;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
09 Burgos;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
09 Burgos;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
09 Burgos;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
09 Burgos;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
09 Burgos;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
09 Burgos;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;81,92
09 Burgos;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
09 Burgos;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
09 Burgos;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
09 Burgos;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;81,94
09 Burgos;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
09 Burgos;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
09 Burgos;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
09 Burgos;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
09 Burgos;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
09 Burgos;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
09 Burgos;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;76,98
09 Burgos;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
09 Burgos;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
09 Burgos;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
09 Burgos;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;77,87
09 Burgos;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
09 Burgos;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
09 Burgos;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
09 Burgos;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
09 Burgos;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
09 Burgos;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
09 Burgos;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QIV;611
09 Burgos;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
09 Burgos;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
09 Burgos;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
09 Burgos;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QIV;615
09 Burgos;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
09 Burgos;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
09 Burgos;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
09 Burgos;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QIV;572
09 Burgos;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
09 Burgos;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
09 Burgos;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
09 Burgos;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2022QIV;563
09 Burgos;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
09 Burgos;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2022QII;""
09 Burgos;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2022QI;""
09 Burgos;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2021QIV;570
09 Burgos;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
09 Burgos;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2021QII;""
09 Burgos;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2021QI;""
09 Burgos;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2020QIV;530
09 Burgos;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
09 Burgos;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2020QII;""
09 Burgos;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2020QI;""
09 Burgos;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
09 Burgos;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
09 Burgos;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2022QII;""
09 Burgos;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2022QI;539
09 Burgos;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
09 Burgos;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
09 Burgos;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2021QII;""
09 Burgos;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2021QI;499
09 Burgos;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
09 Burgos;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
09 Burgos;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2020QII;""
09 Burgos;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2020QI;""
09 Burgos;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
09 Burgos;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
09 Burgos;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QII;511
09 Burgos;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QI;""
09 Burgos;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
09 Burgos;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
09 Burgos;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QII;468
09 Burgos;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QI;""
09 Burgos;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
09 Burgos;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
09 Burgos;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QII;""
09 Burgos;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QI;""
09 Burgos;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
09 Burgos;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QIII;481
09 Burgos;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QII;""
09 Burgos;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QI;""
09 Burgos;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
09 Burgos;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QIII;442
09 Burgos;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QII;""
09 Burgos;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QI;""
09 Burgos;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
09 Burgos;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
09 Burgos;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QII;""
09 Burgos;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QI;""
09 Burgos;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
09 Burgos;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
09 Burgos;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
09 Burgos;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
09 Burgos;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
09 Burgos;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
09 Burgos;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
09 Burgos;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
09 Burgos;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
09 Burgos;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
09 Burgos;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
09 Burgos;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
09 Burgos;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;92,14
09 Burgos;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
09 Burgos;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
09 Burgos;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
09 Burgos;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;92,68
09 Burgos;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
09 Burgos;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
09 Burgos;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
09 Burgos;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;92,66
09 Burgos;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
09 Burgos;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
09 Burgos;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
09 Burgos;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
09 Burgos;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
09 Burgos;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
09 Burgos;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;87,64
09 Burgos;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
09 Burgos;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
09 Burgos;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
09 Burgos;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;87,24
09 Burgos;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
09 Burgos;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
09 Burgos;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
09 Burgos;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
09 Burgos;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
09 Burgos;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
09 Burgos;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;83,09
09 Burgos;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
09 Burgos;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
09 Burgos;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
09 Burgos;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;81,82
09 Burgos;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
09 Burgos;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
09 Burgos;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
09 Burgos;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
09 Burgos;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
09 Burgos;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
09 Burgos;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;78,21
09 Burgos;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
09 Burgos;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
09 Burgos;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
09 Burgos;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;77,27
09 Burgos;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
09 Burgos;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
09 Burgos;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
09 Burgos;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
09 Burgos;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
09 Burgos;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
09 Burgos;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QIV;398
09 Burgos;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
09 Burgos;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
09 Burgos;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
09 Burgos;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QIV;397
09 Burgos;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
09 Burgos;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
09 Burgos;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
09 Burgos;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QIV;386
09 Burgos;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
09 Burgos;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
09 Burgos;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
09 Burgos;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2022QIV;364
09 Burgos;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
09 Burgos;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2022QII;""
09 Burgos;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2022QI;""
09 Burgos;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2021QIV;362
09 Burgos;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
09 Burgos;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2021QII;""
09 Burgos;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2021QI;""
09 Burgos;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2020QIV;357
09 Burgos;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
09 Burgos;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2020QII;""
09 Burgos;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2020QI;""
09 Burgos;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
09 Burgos;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
09 Burgos;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2022QII;""
09 Burgos;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2022QI;339
09 Burgos;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
09 Burgos;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
09 Burgos;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2021QII;""
09 Burgos;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2021QI;337
09 Burgos;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
09 Burgos;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
09 Burgos;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2020QII;""
09 Burgos;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2020QI;""
09 Burgos;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
09 Burgos;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
09 Burgos;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QII;318
09 Burgos;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QI;""
09 Burgos;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
09 Burgos;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
09 Burgos;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QII;317
09 Burgos;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QI;""
09 Burgos;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
09 Burgos;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
09 Burgos;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QII;""
09 Burgos;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QI;""
09 Burgos;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
09 Burgos;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QIII;298
09 Burgos;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QII;""
09 Burgos;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QI;""
09 Burgos;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
09 Burgos;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QIII;304
09 Burgos;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QII;""
09 Burgos;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QI;""
09 Burgos;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
09 Burgos;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
09 Burgos;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QII;""
09 Burgos;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QI;""
09 Burgos;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
09 Burgos;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
09 Burgos;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
09 Burgos;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
09 Burgos;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
09 Burgos;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
09 Burgos;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
09 Burgos;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
09 Burgos;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
09 Burgos;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
09 Burgos;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
09 Burgos;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
09 Burgos;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;91,46
09 Burgos;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
09 Burgos;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
09 Burgos;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
09 Burgos;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;91,18
09 Burgos;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
09 Burgos;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
09 Burgos;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
09 Burgos;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;92,49
09 Burgos;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
09 Burgos;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
09 Burgos;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
09 Burgos;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
09 Burgos;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
09 Burgos;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
09 Burgos;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;85,39
09 Burgos;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
09 Burgos;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
09 Burgos;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
09 Burgos;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;87,31
09 Burgos;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
09 Burgos;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
09 Burgos;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
09 Burgos;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
09 Burgos;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
09 Burgos;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
09 Burgos;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;80,1
09 Burgos;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
09 Burgos;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
09 Burgos;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
09 Burgos;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;82,12
09 Burgos;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
09 Burgos;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
09 Burgos;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
09 Burgos;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
09 Burgos;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
09 Burgos;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
09 Burgos;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;75,06
09 Burgos;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
09 Burgos;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
09 Burgos;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
09 Burgos;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;78,76
09 Burgos;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
09 Burgos;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
09 Burgos;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
09 Burgos;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
09 Burgos;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
09 Burgos;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
09 Burgos;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
09 Burgos;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
09 Burgos;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
09 Burgos;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QI;3.448
09 Burgos;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
09 Burgos;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
09 Burgos;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
09 Burgos;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QI;3.483
09 Burgos;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
09 Burgos;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
09 Burgos;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
09 Burgos;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QI;3.406
09 Burgos;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
09 Burgos;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
09 Burgos;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2022QII;""
09 Burgos;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2022QI;3.341
09 Burgos;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
09 Burgos;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
09 Burgos;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2021QII;""
09 Burgos;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2021QI;3.386
09 Burgos;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
09 Burgos;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
09 Burgos;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2020QII;""
09 Burgos;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2020QI;3.206
09 Burgos;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
09 Burgos;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
09 Burgos;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2022QII;3.220
09 Burgos;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2022QI;""
09 Burgos;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
09 Burgos;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
09 Burgos;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2021QII;3.280
09 Burgos;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2021QI;""
09 Burgos;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
09 Burgos;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
09 Burgos;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2020QII;3.139
09 Burgos;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2020QI;""
09 Burgos;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
09 Burgos;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QIII;3.123
09 Burgos;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QII;""
09 Burgos;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QI;""
09 Burgos;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
09 Burgos;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QIII;3.198
09 Burgos;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QII;""
09 Burgos;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QI;""
09 Burgos;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
09 Burgos;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QIII;3.057
09 Burgos;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QII;""
09 Burgos;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QI;""
09 Burgos;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QIV;3.038
09 Burgos;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
09 Burgos;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QII;""
09 Burgos;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QI;""
09 Burgos;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QIV;3.113
09 Burgos;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
09 Burgos;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QII;""
09 Burgos;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QI;""
09 Burgos;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QIV;2.976
09 Burgos;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
09 Burgos;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QII;""
09 Burgos;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QI;""
09 Burgos;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
09 Burgos;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
09 Burgos;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
09 Burgos;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
09 Burgos;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
09 Burgos;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
09 Burgos;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
09 Burgos;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
09 Burgos;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
09 Burgos;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
09 Burgos;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
09 Burgos;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
09 Burgos;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
09 Burgos;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
09 Burgos;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
09 Burgos;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;96,9
09 Burgos;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
09 Burgos;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
09 Burgos;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
09 Burgos;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;97,22
09 Burgos;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
09 Burgos;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
09 Burgos;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
09 Burgos;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;94,13
09 Burgos;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
09 Burgos;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
09 Burgos;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;93,39
09 Burgos;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
09 Burgos;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
09 Burgos;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
09 Burgos;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;94,17
09 Burgos;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
09 Burgos;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
09 Burgos;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
09 Burgos;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;92,16
09 Burgos;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
09 Burgos;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
09 Burgos;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;90,57
09 Burgos;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
09 Burgos;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
09 Burgos;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
09 Burgos;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;91,82
09 Burgos;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
09 Burgos;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
09 Burgos;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
09 Burgos;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;89,75
09 Burgos;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
09 Burgos;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
09 Burgos;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;88,11
09 Burgos;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
09 Burgos;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
09 Burgos;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
09 Burgos;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;89,38
09 Burgos;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
09 Burgos;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
09 Burgos;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
09 Burgos;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;87,38
09 Burgos;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
09 Burgos;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
09 Burgos;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
09 Burgos;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
09 Burgos;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
09 Burgos;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
09 Burgos;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QI;1.935
09 Burgos;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
09 Burgos;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
09 Burgos;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
09 Burgos;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QI;2.004
09 Burgos;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
09 Burgos;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
09 Burgos;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
09 Burgos;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QI;1.975
09 Burgos;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
09 Burgos;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
09 Burgos;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2022QII;""
09 Burgos;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2022QI;1.890
09 Burgos;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
09 Burgos;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
09 Burgos;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2021QII;""
09 Burgos;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2021QI;1.949
09 Burgos;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
09 Burgos;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
09 Burgos;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2020QII;""
09 Burgos;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2020QI;1.851
09 Burgos;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
09 Burgos;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
09 Burgos;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2022QII;1.833
09 Burgos;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2022QI;""
09 Burgos;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
09 Burgos;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
09 Burgos;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2021QII;1.889
09 Burgos;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2021QI;""
09 Burgos;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
09 Burgos;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
09 Burgos;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2020QII;1.822
09 Burgos;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2020QI;""
09 Burgos;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
09 Burgos;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QIII;1.791
09 Burgos;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QII;""
09 Burgos;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QI;""
09 Burgos;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
09 Burgos;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QIII;1.846
09 Burgos;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QII;""
09 Burgos;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QI;""
09 Burgos;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
09 Burgos;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QIII;1.779
09 Burgos;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QII;""
09 Burgos;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QI;""
09 Burgos;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QIV;1.747
09 Burgos;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
09 Burgos;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QII;""
09 Burgos;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QI;""
09 Burgos;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QIV;1.792
09 Burgos;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
09 Burgos;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QII;""
09 Burgos;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QI;""
09 Burgos;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QIV;1.732
09 Burgos;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
09 Burgos;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QII;""
09 Burgos;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QI;""
09 Burgos;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
09 Burgos;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
09 Burgos;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
09 Burgos;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
09 Burgos;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
09 Burgos;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
09 Burgos;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
09 Burgos;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
09 Burgos;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
09 Burgos;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
09 Burgos;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
09 Burgos;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
09 Burgos;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
09 Burgos;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
09 Burgos;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
09 Burgos;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;97,67
09 Burgos;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
09 Burgos;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
09 Burgos;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
09 Burgos;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;97,26
09 Burgos;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
09 Burgos;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
09 Burgos;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
09 Burgos;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;93,72
09 Burgos;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
09 Burgos;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
09 Burgos;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;94,73
09 Burgos;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
09 Burgos;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
09 Burgos;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
09 Burgos;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;94,26
09 Burgos;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
09 Burgos;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
09 Burgos;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
09 Burgos;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;92,25
09 Burgos;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
09 Burgos;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
09 Burgos;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;92,56
09 Burgos;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
09 Burgos;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
09 Burgos;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
09 Burgos;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;92,12
09 Burgos;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
09 Burgos;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
09 Burgos;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
09 Burgos;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;90,08
09 Burgos;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
09 Burgos;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
09 Burgos;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;90,28
09 Burgos;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
09 Burgos;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
09 Burgos;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
09 Burgos;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;89,42
09 Burgos;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
09 Burgos;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
09 Burgos;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
09 Burgos;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;87,7
09 Burgos;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
09 Burgos;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
09 Burgos;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
09 Burgos;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
09 Burgos;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
09 Burgos;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
09 Burgos;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QI;1.513
09 Burgos;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
09 Burgos;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
09 Burgos;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
09 Burgos;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QI;1.479
09 Burgos;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
09 Burgos;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
09 Burgos;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
09 Burgos;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QI;1.431
09 Burgos;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
09 Burgos;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
09 Burgos;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2022QII;""
09 Burgos;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2022QI;1.451
09 Burgos;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
09 Burgos;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
09 Burgos;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2021QII;""
09 Burgos;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2021QI;1.437
09 Burgos;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
09 Burgos;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
09 Burgos;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2020QII;""
09 Burgos;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2020QI;1.355
09 Burgos;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
09 Burgos;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
09 Burgos;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2022QII;1.387
09 Burgos;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2022QI;""
09 Burgos;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
09 Burgos;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
09 Burgos;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2021QII;1.391
09 Burgos;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2021QI;""
09 Burgos;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
09 Burgos;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
09 Burgos;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2020QII;1.317
09 Burgos;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2020QI;""
09 Burgos;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
09 Burgos;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QIII;1.332
09 Burgos;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QII;""
09 Burgos;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QI;""
09 Burgos;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
09 Burgos;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QIII;1.352
09 Burgos;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QII;""
09 Burgos;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QI;""
09 Burgos;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
09 Burgos;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QIII;1.278
09 Burgos;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QII;""
09 Burgos;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QI;""
09 Burgos;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QIV;1.291
09 Burgos;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
09 Burgos;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QII;""
09 Burgos;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QI;""
09 Burgos;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QIV;1.321
09 Burgos;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
09 Burgos;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QII;""
09 Burgos;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QI;""
09 Burgos;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QIV;1.244
09 Burgos;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
09 Burgos;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QII;""
09 Burgos;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QI;""
09 Burgos;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
09 Burgos;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
09 Burgos;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
09 Burgos;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
09 Burgos;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
09 Burgos;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
09 Burgos;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
09 Burgos;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
09 Burgos;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
09 Burgos;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
09 Burgos;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
09 Burgos;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
09 Burgos;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
09 Burgos;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
09 Burgos;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
09 Burgos;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;95,9
09 Burgos;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
09 Burgos;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
09 Burgos;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
09 Burgos;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;97,16
09 Burgos;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
09 Burgos;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
09 Burgos;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
09 Burgos;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;94,69
09 Burgos;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
09 Burgos;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
09 Burgos;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;91,67
09 Burgos;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
09 Burgos;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
09 Burgos;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
09 Burgos;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;94,05
09 Burgos;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
09 Burgos;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
09 Burgos;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
09 Burgos;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;92,03
09 Burgos;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
09 Burgos;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
09 Burgos;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;88,04
09 Burgos;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
09 Burgos;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
09 Burgos;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
09 Burgos;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;91,41
09 Burgos;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
09 Burgos;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
09 Burgos;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
09 Burgos;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;89,31
09 Burgos;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
09 Burgos;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
09 Burgos;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;85,33
09 Burgos;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
09 Burgos;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
09 Burgos;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
09 Burgos;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;89,32
09 Burgos;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
09 Burgos;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
09 Burgos;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
09 Burgos;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;86,93
09 Burgos;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
09 Burgos;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
09 Burgos;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
09 Burgos;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
09 Burgos;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
09 Burgos;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QII;3.196
09 Burgos;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
09 Burgos;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
09 Burgos;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
09 Burgos;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QII;3.243
09 Burgos;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
09 Burgos;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
09 Burgos;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
09 Burgos;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QII;3.377
09 Burgos;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
09 Burgos;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
09 Burgos;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
09 Burgos;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2022QII;3.069
09 Burgos;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2022QI;""
09 Burgos;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
09 Burgos;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
09 Burgos;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2021QII;3.132
09 Burgos;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2021QI;""
09 Burgos;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
09 Burgos;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
09 Burgos;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2020QII;3.300
09 Burgos;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2020QI;""
09 Burgos;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
09 Burgos;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2022QIII;2.972
09 Burgos;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2022QII;""
09 Burgos;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2022QI;""
09 Burgos;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
09 Burgos;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2021QIII;3.045
09 Burgos;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2021QII;""
09 Burgos;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2021QI;""
09 Burgos;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
09 Burgos;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2020QIII;3.205
09 Burgos;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2020QII;""
09 Burgos;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2020QI;""
09 Burgos;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QIV;2.883
09 Burgos;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
09 Burgos;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QII;""
09 Burgos;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QI;""
09 Burgos;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QIV;2.957
09 Burgos;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
09 Burgos;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QII;""
09 Burgos;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QI;""
09 Burgos;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QIV;3.118
09 Burgos;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
09 Burgos;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QII;""
09 Burgos;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QI;""
09 Burgos;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
09 Burgos;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
09 Burgos;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QII;""
09 Burgos;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QI;2.892
09 Burgos;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
09 Burgos;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
09 Burgos;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QII;""
09 Burgos;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QI;3.055
09 Burgos;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
09 Burgos;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
09 Burgos;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QII;""
09 Burgos;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QI;""
09 Burgos;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
09 Burgos;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
09 Burgos;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
09 Burgos;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
09 Burgos;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
09 Burgos;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
09 Burgos;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
09 Burgos;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
09 Burgos;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
09 Burgos;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
09 Burgos;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
09 Burgos;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
09 Burgos;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
09 Burgos;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
09 Burgos;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;96,03
09 Burgos;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
09 Burgos;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
09 Burgos;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
09 Burgos;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;96,58
09 Burgos;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
09 Burgos;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
09 Burgos;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
09 Burgos;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;97,72
09 Burgos;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
09 Burgos;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
09 Burgos;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;92,99
09 Burgos;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
09 Burgos;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
09 Burgos;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
09 Burgos;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;93,89
09 Burgos;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
09 Burgos;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
09 Burgos;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
09 Burgos;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;94,91
09 Burgos;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
09 Burgos;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
09 Burgos;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;90,21
09 Burgos;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
09 Burgos;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
09 Burgos;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
09 Burgos;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;91,18
09 Burgos;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
09 Burgos;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
09 Burgos;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
09 Burgos;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;92,33
09 Burgos;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
09 Burgos;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
09 Burgos;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
09 Burgos;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
09 Burgos;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
09 Burgos;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
09 Burgos;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;89,18
09 Burgos;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
09 Burgos;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
09 Burgos;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
09 Burgos;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;90,46
09 Burgos;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
09 Burgos;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
09 Burgos;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
09 Burgos;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
09 Burgos;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
09 Burgos;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
09 Burgos;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QII;1.812
09 Burgos;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
09 Burgos;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
09 Burgos;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
09 Burgos;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QII;1.857
09 Burgos;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
09 Burgos;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
09 Burgos;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
09 Burgos;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QII;1.944
09 Burgos;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
09 Burgos;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
09 Burgos;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
09 Burgos;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2022QII;1.748
09 Burgos;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2022QI;""
09 Burgos;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
09 Burgos;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
09 Burgos;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2021QII;1.795
09 Burgos;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2021QI;""
09 Burgos;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
09 Burgos;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
09 Burgos;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2020QII;1.908
09 Burgos;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2020QI;""
09 Burgos;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
09 Burgos;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2022QIII;1.702
09 Burgos;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2022QII;""
09 Burgos;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2022QI;""
09 Burgos;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
09 Burgos;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2021QIII;1.748
09 Burgos;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2021QII;""
09 Burgos;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2021QI;""
09 Burgos;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
09 Burgos;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2020QIII;1.857
09 Burgos;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2020QII;""
09 Burgos;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2020QI;""
09 Burgos;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QIV;1.654
09 Burgos;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
09 Burgos;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QII;""
09 Burgos;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QI;""
09 Burgos;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QIV;1.691
09 Burgos;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
09 Burgos;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QII;""
09 Burgos;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QI;""
09 Burgos;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QIV;1.807
09 Burgos;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
09 Burgos;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QII;""
09 Burgos;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QI;""
09 Burgos;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
09 Burgos;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
09 Burgos;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QII;""
09 Burgos;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QI;1.662
09 Burgos;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
09 Burgos;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
09 Burgos;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QII;""
09 Burgos;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QI;1.771
09 Burgos;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
09 Burgos;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
09 Burgos;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QII;""
09 Burgos;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QI;""
09 Burgos;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
09 Burgos;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
09 Burgos;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
09 Burgos;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
09 Burgos;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
09 Burgos;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
09 Burgos;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
09 Burgos;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
09 Burgos;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
09 Burgos;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
09 Burgos;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
09 Burgos;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
09 Burgos;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
09 Burgos;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
09 Burgos;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;96,47
09 Burgos;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
09 Burgos;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
09 Burgos;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
09 Burgos;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;96,66
09 Burgos;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
09 Burgos;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
09 Burgos;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
09 Burgos;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;98,15
09 Burgos;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
09 Burgos;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
09 Burgos;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;93,93
09 Burgos;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
09 Burgos;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
09 Burgos;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
09 Burgos;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;94,13
09 Burgos;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
09 Burgos;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
09 Burgos;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
09 Burgos;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;95,52
09 Burgos;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
09 Burgos;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
09 Burgos;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;91,28
09 Burgos;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
09 Burgos;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
09 Burgos;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
09 Burgos;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;91,06
09 Burgos;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
09 Burgos;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
09 Burgos;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
09 Burgos;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;92,95
09 Burgos;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
09 Burgos;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
09 Burgos;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
09 Burgos;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
09 Burgos;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
09 Burgos;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
09 Burgos;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;89,5
09 Burgos;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
09 Burgos;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
09 Burgos;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
09 Burgos;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;91,1
09 Burgos;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
09 Burgos;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
09 Burgos;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
09 Burgos;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
09 Burgos;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
09 Burgos;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
09 Burgos;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QII;1.384
09 Burgos;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
09 Burgos;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
09 Burgos;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
09 Burgos;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QII;1.386
09 Burgos;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
09 Burgos;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
09 Burgos;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
09 Burgos;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QII;1.433
09 Burgos;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
09 Burgos;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
09 Burgos;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
09 Burgos;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2022QII;1.321
09 Burgos;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2022QI;""
09 Burgos;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
09 Burgos;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
09 Burgos;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2021QII;1.337
09 Burgos;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2021QI;""
09 Burgos;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
09 Burgos;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
09 Burgos;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2020QII;1.392
09 Burgos;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2020QI;""
09 Burgos;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
09 Burgos;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2022QIII;1.270
09 Burgos;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2022QII;""
09 Burgos;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2022QI;""
09 Burgos;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
09 Burgos;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2021QIII;1.297
09 Burgos;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2021QII;""
09 Burgos;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2021QI;""
09 Burgos;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
09 Burgos;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2020QIII;1.348
09 Burgos;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2020QII;""
09 Burgos;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2020QI;""
09 Burgos;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QIV;1.229
09 Burgos;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
09 Burgos;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QII;""
09 Burgos;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QI;""
09 Burgos;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QIV;1.266
09 Burgos;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
09 Burgos;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QII;""
09 Burgos;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QI;""
09 Burgos;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QIV;1.311
09 Burgos;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
09 Burgos;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QII;""
09 Burgos;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QI;""
09 Burgos;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
09 Burgos;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
09 Burgos;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QII;""
09 Burgos;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QI;1.230
09 Burgos;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
09 Burgos;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
09 Burgos;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QII;""
09 Burgos;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QI;1.284
09 Burgos;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
09 Burgos;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
09 Burgos;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QII;""
09 Burgos;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QI;""
09 Burgos;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
09 Burgos;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
09 Burgos;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
09 Burgos;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
09 Burgos;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
09 Burgos;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
09 Burgos;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
09 Burgos;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
09 Burgos;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
09 Burgos;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
09 Burgos;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
09 Burgos;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
09 Burgos;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
09 Burgos;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
09 Burgos;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;95,45
09 Burgos;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
09 Burgos;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
09 Burgos;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
09 Burgos;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;96,46
09 Burgos;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
09 Burgos;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
09 Burgos;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
09 Burgos;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;97,14
09 Burgos;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
09 Burgos;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
09 Burgos;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;91,76
09 Burgos;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
09 Burgos;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
09 Burgos;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
09 Burgos;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;93,58
09 Burgos;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
09 Burgos;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
09 Burgos;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
09 Burgos;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;94,07
09 Burgos;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
09 Burgos;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
09 Burgos;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;88,8
09 Burgos;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
09 Burgos;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
09 Burgos;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
09 Burgos;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;91,34
09 Burgos;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
09 Burgos;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
09 Burgos;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
09 Burgos;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;91,49
09 Burgos;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
09 Burgos;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
09 Burgos;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
09 Burgos;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
09 Burgos;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
09 Burgos;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
09 Burgos;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;88,74
09 Burgos;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
09 Burgos;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
09 Burgos;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
09 Burgos;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;89,6
09 Burgos;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
09 Burgos;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
09 Burgos;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
09 Burgos;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
09 Burgos;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
09 Burgos;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QIII;3.246
09 Burgos;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
09 Burgos;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
09 Burgos;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
09 Burgos;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QIII;3.316
09 Burgos;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
09 Burgos;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
09 Burgos;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
09 Burgos;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QIII;3.401
09 Burgos;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
09 Burgos;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
09 Burgos;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
09 Burgos;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2022QIII;3.130
09 Burgos;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2022QII;""
09 Burgos;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2022QI;""
09 Burgos;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
09 Burgos;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2021QIII;3.209
09 Burgos;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2021QII;""
09 Burgos;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2021QI;""
09 Burgos;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
09 Burgos;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2020QIII;3.292
09 Burgos;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2020QII;""
09 Burgos;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2020QI;""
09 Burgos;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2022QIV;3.014
09 Burgos;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
09 Burgos;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2022QII;""
09 Burgos;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2022QI;""
09 Burgos;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2021QIV;3.112
09 Burgos;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
09 Burgos;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2021QII;""
09 Burgos;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2021QI;""
09 Burgos;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2020QIV;3.197
09 Burgos;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
09 Burgos;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2020QII;""
09 Burgos;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2020QI;""
09 Burgos;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
09 Burgos;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
09 Burgos;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QII;""
09 Burgos;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QI;3.035
09 Burgos;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
09 Burgos;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
09 Burgos;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QII;""
09 Burgos;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QI;3.131
09 Burgos;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
09 Burgos;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
09 Burgos;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QII;""
09 Burgos;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QI;""
09 Burgos;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
09 Burgos;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
09 Burgos;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QII;2.944
09 Burgos;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QI;""
09 Burgos;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
09 Burgos;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
09 Burgos;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QII;3.052
09 Burgos;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QI;""
09 Burgos;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
09 Burgos;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
09 Burgos;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QII;""
09 Burgos;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QI;""
09 Burgos;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
09 Burgos;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
09 Burgos;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
09 Burgos;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
09 Burgos;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
09 Burgos;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
09 Burgos;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
09 Burgos;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
09 Burgos;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
09 Burgos;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
09 Burgos;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
09 Burgos;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
09 Burgos;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
09 Burgos;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;96,43
09 Burgos;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
09 Burgos;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
09 Burgos;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
09 Burgos;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;96,77
09 Burgos;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
09 Burgos;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
09 Burgos;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
09 Burgos;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;96,8
09 Burgos;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
09 Burgos;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
09 Burgos;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;92,85
09 Burgos;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
09 Burgos;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
09 Burgos;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
09 Burgos;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;93,85
09 Burgos;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
09 Burgos;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
09 Burgos;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
09 Burgos;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;94
09 Burgos;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
09 Burgos;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
09 Burgos;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
09 Burgos;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
09 Burgos;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
09 Burgos;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
09 Burgos;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;91,53
09 Burgos;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
09 Burgos;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
09 Burgos;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
09 Burgos;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;92,06
09 Burgos;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
09 Burgos;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
09 Burgos;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
09 Burgos;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
09 Burgos;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
09 Burgos;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
09 Burgos;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;88,78
09 Burgos;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
09 Burgos;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
09 Burgos;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
09 Burgos;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;89,74
09 Burgos;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
09 Burgos;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
09 Burgos;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
09 Burgos;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
09 Burgos;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
09 Burgos;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
09 Burgos;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QIII;1.837
09 Burgos;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
09 Burgos;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
09 Burgos;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
09 Burgos;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QIII;1.899
09 Burgos;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
09 Burgos;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
09 Burgos;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
09 Burgos;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QIII;1.972
09 Burgos;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
09 Burgos;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
09 Burgos;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
09 Burgos;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2022QIII;1.779
09 Burgos;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2022QII;""
09 Burgos;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2022QI;""
09 Burgos;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
09 Burgos;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2021QIII;1.840
09 Burgos;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2021QII;""
09 Burgos;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2021QI;""
09 Burgos;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
09 Burgos;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2020QIII;1.911
09 Burgos;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2020QII;""
09 Burgos;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2020QI;""
09 Burgos;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2022QIV;1.712
09 Burgos;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
09 Burgos;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2022QII;""
09 Burgos;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2022QI;""
09 Burgos;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2021QIV;1.778
09 Burgos;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
09 Burgos;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2021QII;""
09 Burgos;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2021QI;""
09 Burgos;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2020QIV;1.853
09 Burgos;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
09 Burgos;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2020QII;""
09 Burgos;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2020QI;""
09 Burgos;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
09 Burgos;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
09 Burgos;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QII;""
09 Burgos;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QI;1.746
09 Burgos;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
09 Burgos;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
09 Burgos;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QII;""
09 Burgos;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QI;1.815
09 Burgos;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
09 Burgos;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
09 Burgos;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QII;""
09 Burgos;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QI;""
09 Burgos;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
09 Burgos;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
09 Burgos;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QII;1.700
09 Burgos;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QI;""
09 Burgos;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
09 Burgos;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
09 Burgos;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QII;1.768
09 Burgos;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QI;""
09 Burgos;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
09 Burgos;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
09 Burgos;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QII;""
09 Burgos;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QI;""
09 Burgos;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
09 Burgos;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
09 Burgos;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
09 Burgos;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
09 Burgos;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
09 Burgos;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
09 Burgos;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
09 Burgos;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
09 Burgos;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
09 Burgos;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
09 Burgos;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
09 Burgos;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
09 Burgos;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
09 Burgos;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;96,84
09 Burgos;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
09 Burgos;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
09 Burgos;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
09 Burgos;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;96,89
09 Burgos;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
09 Burgos;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
09 Burgos;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
09 Burgos;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;96,91
09 Burgos;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
09 Burgos;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
09 Burgos;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;93,2
09 Burgos;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
09 Burgos;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
09 Burgos;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
09 Burgos;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;93,63
09 Burgos;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
09 Burgos;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
09 Burgos;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
09 Burgos;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;93,97
09 Burgos;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
09 Burgos;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
09 Burgos;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
09 Burgos;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
09 Burgos;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
09 Burgos;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
09 Burgos;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;91,94
09 Burgos;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
09 Burgos;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
09 Burgos;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
09 Burgos;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;92,04
09 Burgos;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
09 Burgos;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
09 Burgos;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
09 Burgos;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
09 Burgos;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
09 Burgos;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
09 Burgos;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;89,52
09 Burgos;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
09 Burgos;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
09 Burgos;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
09 Burgos;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;89,66
09 Burgos;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
09 Burgos;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
09 Burgos;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
09 Burgos;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
09 Burgos;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
09 Burgos;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
09 Burgos;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QIII;1.409
09 Burgos;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
09 Burgos;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
09 Burgos;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
09 Burgos;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QIII;1.417
09 Burgos;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
09 Burgos;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
09 Burgos;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
09 Burgos;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QIII;1.429
09 Burgos;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
09 Burgos;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
09 Burgos;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
09 Burgos;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2022QIII;1.351
09 Burgos;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2022QII;""
09 Burgos;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2022QI;""
09 Burgos;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
09 Burgos;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2021QIII;1.369
09 Burgos;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2021QII;""
09 Burgos;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2021QI;""
09 Burgos;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
09 Burgos;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2020QIII;1.381
09 Burgos;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2020QII;""
09 Burgos;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2020QI;""
09 Burgos;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2022QIV;1.302
09 Burgos;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
09 Burgos;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2022QII;""
09 Burgos;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2022QI;""
09 Burgos;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2021QIV;1.334
09 Burgos;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
09 Burgos;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2021QII;""
09 Burgos;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2021QI;""
09 Burgos;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2020QIV;1.344
09 Burgos;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
09 Burgos;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2020QII;""
09 Burgos;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2020QI;""
09 Burgos;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
09 Burgos;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
09 Burgos;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QII;""
09 Burgos;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QI;1.289
09 Burgos;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
09 Burgos;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
09 Burgos;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QII;""
09 Burgos;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QI;1.316
09 Burgos;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
09 Burgos;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
09 Burgos;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QII;""
09 Burgos;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QI;""
09 Burgos;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
09 Burgos;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
09 Burgos;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QII;1.244
09 Burgos;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QI;""
09 Burgos;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
09 Burgos;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
09 Burgos;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QII;1.284
09 Burgos;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QI;""
09 Burgos;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
09 Burgos;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
09 Burgos;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QII;""
09 Burgos;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QI;""
09 Burgos;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
09 Burgos;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
09 Burgos;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
09 Burgos;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
09 Burgos;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
09 Burgos;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
09 Burgos;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
09 Burgos;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
09 Burgos;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
09 Burgos;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
09 Burgos;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
09 Burgos;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
09 Burgos;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
09 Burgos;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;95,88
09 Burgos;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
09 Burgos;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
09 Burgos;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
09 Burgos;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;96,61
09 Burgos;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
09 Burgos;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
09 Burgos;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
09 Burgos;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;96,64
09 Burgos;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
09 Burgos;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
09 Burgos;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;92,41
09 Burgos;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
09 Burgos;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
09 Burgos;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
09 Burgos;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;94,14
09 Burgos;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
09 Burgos;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
09 Burgos;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
09 Burgos;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;94,05
09 Burgos;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
09 Burgos;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
09 Burgos;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
09 Burgos;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
09 Burgos;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
09 Burgos;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
09 Burgos;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;90,97
09 Burgos;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
09 Burgos;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
09 Burgos;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
09 Burgos;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;92,09
09 Burgos;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
09 Burgos;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
09 Burgos;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
09 Burgos;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
09 Burgos;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
09 Burgos;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
09 Burgos;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;87,79
09 Burgos;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
09 Burgos;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
09 Burgos;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
09 Burgos;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;89,85
09 Burgos;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
09 Burgos;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
09 Burgos;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
09 Burgos;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
09 Burgos;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
09 Burgos;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QIV;3.271
09 Burgos;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
09 Burgos;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
09 Burgos;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
09 Burgos;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QIV;3.390
09 Burgos;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
09 Burgos;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
09 Burgos;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
09 Burgos;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QIV;3.441
09 Burgos;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
09 Burgos;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
09 Burgos;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
09 Burgos;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2022QIV;3.137
09 Burgos;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
09 Burgos;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2022QII;""
09 Burgos;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2022QI;""
09 Burgos;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2021QIV;3.273
09 Burgos;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
09 Burgos;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2021QII;""
09 Burgos;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2021QI;""
09 Burgos;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2020QIV;3.332
09 Burgos;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
09 Burgos;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2020QII;""
09 Burgos;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2020QI;""
09 Burgos;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
09 Burgos;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
09 Burgos;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2022QII;""
09 Burgos;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2022QI;3.182
09 Burgos;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
09 Burgos;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
09 Burgos;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2021QII;""
09 Burgos;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2021QI;3.252
09 Burgos;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
09 Burgos;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
09 Burgos;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2020QII;""
09 Burgos;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2020QI;""
09 Burgos;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
09 Burgos;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
09 Burgos;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QII;3.076
09 Burgos;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QI;""
09 Burgos;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
09 Burgos;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
09 Burgos;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QII;3.166
09 Burgos;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QI;""
09 Burgos;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
09 Burgos;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
09 Burgos;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QII;""
09 Burgos;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QI;""
09 Burgos;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
09 Burgos;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QIII;2.988
09 Burgos;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QII;""
09 Burgos;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QI;""
09 Burgos;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
09 Burgos;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QIII;3.093
09 Burgos;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QII;""
09 Burgos;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QI;""
09 Burgos;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
09 Burgos;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
09 Burgos;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QII;""
09 Burgos;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QI;""
09 Burgos;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
09 Burgos;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
09 Burgos;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
09 Burgos;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
09 Burgos;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
09 Burgos;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
09 Burgos;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
09 Burgos;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
09 Burgos;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
09 Burgos;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
09 Burgos;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
09 Burgos;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
09 Burgos;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;95,9
09 Burgos;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
09 Burgos;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
09 Burgos;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
09 Burgos;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;96,55
09 Burgos;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
09 Burgos;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
09 Burgos;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
09 Burgos;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;96,83
09 Burgos;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
09 Burgos;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
09 Burgos;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
09 Burgos;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
09 Burgos;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
09 Burgos;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
09 Burgos;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;93,86
09 Burgos;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
09 Burgos;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
09 Burgos;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
09 Burgos;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;94,51
09 Burgos;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
09 Burgos;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
09 Burgos;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
09 Burgos;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
09 Burgos;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
09 Burgos;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
09 Burgos;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;90,74
09 Burgos;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
09 Burgos;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
09 Burgos;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
09 Burgos;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;92,01
09 Burgos;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
09 Burgos;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
09 Burgos;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
09 Burgos;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
09 Burgos;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
09 Burgos;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
09 Burgos;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;88,14
09 Burgos;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
09 Burgos;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
09 Burgos;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
09 Burgos;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;89,89
09 Burgos;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
09 Burgos;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
09 Burgos;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
09 Burgos;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
09 Burgos;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
09 Burgos;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
09 Burgos;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QIV;1.851
09 Burgos;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
09 Burgos;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
09 Burgos;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
09 Burgos;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QIV;1.933
09 Burgos;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
09 Burgos;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
09 Burgos;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
09 Burgos;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QIV;1.983
09 Burgos;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
09 Burgos;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
09 Burgos;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
09 Burgos;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2022QIV;1.773
09 Burgos;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
09 Burgos;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2022QII;""
09 Burgos;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2022QI;""
09 Burgos;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2021QIV;1.858
09 Burgos;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
09 Burgos;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2021QII;""
09 Burgos;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2021QI;""
09 Burgos;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2020QIV;1.917
09 Burgos;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
09 Burgos;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2020QII;""
09 Burgos;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2020QI;""
09 Burgos;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
09 Burgos;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
09 Burgos;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2022QII;""
09 Burgos;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2022QI;1.819
09 Burgos;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
09 Burgos;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
09 Burgos;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2021QII;""
09 Burgos;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2021QI;1.874
09 Burgos;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
09 Burgos;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
09 Burgos;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2020QII;""
09 Burgos;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2020QI;""
09 Burgos;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
09 Burgos;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
09 Burgos;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QII;1.765
09 Burgos;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QI;""
09 Burgos;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
09 Burgos;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
09 Burgos;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QII;1.824
09 Burgos;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QI;""
09 Burgos;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
09 Burgos;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
09 Burgos;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QII;""
09 Burgos;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QI;""
09 Burgos;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
09 Burgos;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QIII;1.726
09 Burgos;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QII;""
09 Burgos;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QI;""
09 Burgos;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
09 Burgos;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QIII;1.786
09 Burgos;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QII;""
09 Burgos;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QI;""
09 Burgos;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
09 Burgos;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
09 Burgos;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QII;""
09 Burgos;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QI;""
09 Burgos;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
09 Burgos;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
09 Burgos;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
09 Burgos;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
09 Burgos;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
09 Burgos;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
09 Burgos;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
09 Burgos;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
09 Burgos;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
09 Burgos;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
09 Burgos;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
09 Burgos;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
09 Burgos;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;95,79
09 Burgos;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
09 Burgos;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
09 Burgos;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
09 Burgos;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;96,12
09 Burgos;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
09 Burgos;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
09 Burgos;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
09 Burgos;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;96,67
09 Burgos;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
09 Burgos;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
09 Burgos;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
09 Burgos;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
09 Burgos;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
09 Burgos;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
09 Burgos;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;94,1
09 Burgos;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
09 Burgos;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
09 Burgos;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
09 Burgos;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;94,5
09 Burgos;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
09 Burgos;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
09 Burgos;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
09 Burgos;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
09 Burgos;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
09 Burgos;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
09 Burgos;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;91,31
09 Burgos;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
09 Burgos;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
09 Burgos;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
09 Burgos;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;91,98
09 Burgos;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
09 Burgos;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
09 Burgos;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
09 Burgos;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
09 Burgos;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
09 Burgos;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
09 Burgos;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;89,29
09 Burgos;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
09 Burgos;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
09 Burgos;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
09 Burgos;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;90,07
09 Burgos;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
09 Burgos;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
09 Burgos;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
09 Burgos;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
09 Burgos;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
09 Burgos;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
09 Burgos;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QIV;1.420
09 Burgos;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
09 Burgos;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
09 Burgos;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
09 Burgos;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QIV;1.457
09 Burgos;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
09 Burgos;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
09 Burgos;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
09 Burgos;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QIV;1.458
09 Burgos;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
09 Burgos;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
09 Burgos;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
09 Burgos;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2022QIV;1.364
09 Burgos;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
09 Burgos;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2022QII;""
09 Burgos;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2022QI;""
09 Burgos;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2021QIV;1.415
09 Burgos;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
09 Burgos;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2021QII;""
09 Burgos;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2021QI;""
09 Burgos;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2020QIV;1.415
09 Burgos;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
09 Burgos;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2020QII;""
09 Burgos;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2020QI;""
09 Burgos;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
09 Burgos;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
09 Burgos;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2022QII;""
09 Burgos;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2022QI;1.363
09 Burgos;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
09 Burgos;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
09 Burgos;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2021QII;""
09 Burgos;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2021QI;1.378
09 Burgos;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
09 Burgos;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
09 Burgos;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2020QII;""
09 Burgos;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2020QI;""
09 Burgos;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
09 Burgos;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
09 Burgos;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QII;1.311
09 Burgos;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QI;""
09 Burgos;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
09 Burgos;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
09 Burgos;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QII;1.342
09 Burgos;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QI;""
09 Burgos;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
09 Burgos;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
09 Burgos;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QII;""
09 Burgos;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QI;""
09 Burgos;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
09 Burgos;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QIII;1.262
09 Burgos;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QII;""
09 Burgos;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QI;""
09 Burgos;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
09 Burgos;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QIII;1.307
09 Burgos;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QII;""
09 Burgos;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QI;""
09 Burgos;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
09 Burgos;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
09 Burgos;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QII;""
09 Burgos;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QI;""
09 Burgos;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
09 Burgos;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
09 Burgos;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
09 Burgos;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
09 Burgos;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
09 Burgos;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
09 Burgos;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
09 Burgos;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
09 Burgos;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
09 Burgos;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
09 Burgos;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
09 Burgos;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
09 Burgos;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;96,06
09 Burgos;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
09 Burgos;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
09 Burgos;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
09 Burgos;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;97,12
09 Burgos;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
09 Burgos;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
09 Burgos;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
09 Burgos;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;97,05
09 Burgos;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
09 Burgos;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
09 Burgos;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
09 Burgos;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
09 Burgos;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
09 Burgos;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
09 Burgos;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;93,55
09 Burgos;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
09 Burgos;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
09 Burgos;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
09 Burgos;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;94,51
09 Burgos;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
09 Burgos;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
09 Burgos;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
09 Burgos;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
09 Burgos;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
09 Burgos;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
09 Burgos;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;89,98
09 Burgos;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
09 Burgos;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
09 Burgos;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
09 Burgos;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;92,04
09 Burgos;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
09 Burgos;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
09 Burgos;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
09 Burgos;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
09 Burgos;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
09 Burgos;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
09 Burgos;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;86,62
09 Burgos;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
09 Burgos;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
09 Burgos;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
09 Burgos;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;89,64
09 Burgos;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
09 Burgos;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
09 Burgos;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
09 Burgos;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
09 Burgos;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
09 Burgos;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
09 Burgos;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
09 Burgos;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
09 Burgos;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
09 Burgos;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QI;6.317
09 Burgos;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
09 Burgos;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
09 Burgos;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
09 Burgos;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QI;6.436
09 Burgos;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
09 Burgos;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
09 Burgos;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
09 Burgos;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QI;6.491
09 Burgos;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
09 Burgos;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
09 Burgos;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2022QII;""
09 Burgos;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2022QI;6.163
09 Burgos;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
09 Burgos;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
09 Burgos;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2021QII;""
09 Burgos;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2021QI;6.336
09 Burgos;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
09 Burgos;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
09 Burgos;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2020QII;""
09 Burgos;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2020QI;6.226
09 Burgos;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
09 Burgos;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
09 Burgos;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2022QII;6.025
09 Burgos;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2022QI;""
09 Burgos;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
09 Burgos;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
09 Burgos;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2021QII;6.197
09 Burgos;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2021QI;""
09 Burgos;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
09 Burgos;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
09 Burgos;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2020QII;6.131
09 Burgos;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2020QI;""
09 Burgos;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
09 Burgos;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QIII;5.923
09 Burgos;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QII;""
09 Burgos;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QI;""
09 Burgos;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
09 Burgos;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QIII;6.096
09 Burgos;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QII;""
09 Burgos;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QI;""
09 Burgos;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
09 Burgos;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QIII;6.033
09 Burgos;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QII;""
09 Burgos;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QI;""
09 Burgos;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QIV;5.802
09 Burgos;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
09 Burgos;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QII;""
09 Burgos;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QI;""
09 Burgos;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QIV;5.982
09 Burgos;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
09 Burgos;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QII;""
09 Burgos;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QI;""
09 Burgos;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QIV;5.934
09 Burgos;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
09 Burgos;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QII;""
09 Burgos;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QI;""
09 Burgos;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
09 Burgos;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
09 Burgos;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
09 Burgos;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
09 Burgos;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
09 Burgos;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
09 Burgos;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
09 Burgos;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
09 Burgos;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
09 Burgos;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
09 Burgos;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
09 Burgos;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
09 Burgos;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
09 Burgos;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
09 Burgos;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
09 Burgos;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;97,56
09 Burgos;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
09 Burgos;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
09 Burgos;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
09 Burgos;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;98,45
09 Burgos;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
09 Burgos;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
09 Burgos;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
09 Burgos;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;95,92
09 Burgos;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
09 Burgos;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
09 Burgos;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;95,38
09 Burgos;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
09 Burgos;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
09 Burgos;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
09 Burgos;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;96,29
09 Burgos;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
09 Burgos;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
09 Burgos;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
09 Burgos;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;94,45
09 Burgos;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
09 Burgos;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
09 Burgos;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;93,76
09 Burgos;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
09 Burgos;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
09 Burgos;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
09 Burgos;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;94,72
09 Burgos;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
09 Burgos;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
09 Burgos;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
09 Burgos;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;92,94
09 Burgos;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
09 Burgos;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
09 Burgos;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;91,85
09 Burgos;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
09 Burgos;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
09 Burgos;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
09 Burgos;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;92,95
09 Burgos;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
09 Burgos;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
09 Burgos;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
09 Burgos;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;91,42
09 Burgos;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
09 Burgos;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
09 Burgos;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
09 Burgos;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
09 Burgos;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
09 Burgos;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
09 Burgos;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QI;3.894
09 Burgos;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
09 Burgos;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
09 Burgos;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
09 Burgos;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QI;4.030
09 Burgos;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
09 Burgos;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
09 Burgos;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
09 Burgos;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QI;4.050
09 Burgos;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
09 Burgos;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
09 Burgos;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2022QII;""
09 Burgos;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2022QI;3.798
09 Burgos;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
09 Burgos;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
09 Burgos;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2021QII;""
09 Burgos;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2021QI;3.974
09 Burgos;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
09 Burgos;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
09 Burgos;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2020QII;""
09 Burgos;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2020QI;3.905
09 Burgos;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
09 Burgos;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
09 Burgos;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2022QII;3.728
09 Burgos;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2022QI;""
09 Burgos;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
09 Burgos;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
09 Burgos;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2021QII;3.891
09 Burgos;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2021QI;""
09 Burgos;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
09 Burgos;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
09 Burgos;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2020QII;3.860
09 Burgos;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2020QI;""
09 Burgos;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
09 Burgos;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QIII;3.679
09 Burgos;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QII;""
09 Burgos;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QI;""
09 Burgos;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
09 Burgos;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QIII;3.829
09 Burgos;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QII;""
09 Burgos;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QI;""
09 Burgos;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
09 Burgos;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QIII;3.803
09 Burgos;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QII;""
09 Burgos;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QI;""
09 Burgos;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QIV;3.611
09 Burgos;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
09 Burgos;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QII;""
09 Burgos;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QI;""
09 Burgos;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QIV;3.768
09 Burgos;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
09 Burgos;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QII;""
09 Burgos;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QI;""
09 Burgos;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QIV;3.744
09 Burgos;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
09 Burgos;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QII;""
09 Burgos;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QI;""
09 Burgos;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
09 Burgos;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
09 Burgos;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
09 Burgos;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
09 Burgos;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
09 Burgos;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
09 Burgos;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
09 Burgos;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
09 Burgos;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
09 Burgos;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
09 Burgos;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
09 Burgos;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
09 Burgos;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
09 Burgos;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
09 Burgos;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
09 Burgos;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;97,53
09 Burgos;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
09 Burgos;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
09 Burgos;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
09 Burgos;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;98,61
09 Burgos;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
09 Burgos;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
09 Burgos;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
09 Burgos;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;96,42
09 Burgos;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
09 Burgos;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
09 Burgos;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;95,74
09 Burgos;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
09 Burgos;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
09 Burgos;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
09 Burgos;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;96,55
09 Burgos;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
09 Burgos;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
09 Burgos;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
09 Burgos;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;95,31
09 Burgos;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
09 Burgos;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
09 Burgos;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;94,48
09 Burgos;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
09 Burgos;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
09 Burgos;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
09 Burgos;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;95,01
09 Burgos;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
09 Burgos;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
09 Burgos;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
09 Burgos;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;93,9
09 Burgos;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
09 Burgos;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
09 Burgos;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;92,73
09 Burgos;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
09 Burgos;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
09 Burgos;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
09 Burgos;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;93,5
09 Burgos;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
09 Burgos;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
09 Burgos;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
09 Burgos;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;92,44
09 Burgos;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
09 Burgos;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
09 Burgos;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
09 Burgos;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
09 Burgos;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
09 Burgos;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
09 Burgos;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QI;2.423
09 Burgos;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
09 Burgos;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
09 Burgos;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
09 Burgos;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QI;2.406
09 Burgos;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
09 Burgos;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
09 Burgos;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
09 Burgos;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QI;2.441
09 Burgos;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
09 Burgos;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
09 Burgos;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2022QII;""
09 Burgos;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2022QI;2.365
09 Burgos;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
09 Burgos;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
09 Burgos;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2021QII;""
09 Burgos;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2021QI;2.362
09 Burgos;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
09 Burgos;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
09 Burgos;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2020QII;""
09 Burgos;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2020QI;2.321
09 Burgos;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
09 Burgos;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
09 Burgos;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2022QII;2.297
09 Burgos;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2022QI;""
09 Burgos;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
09 Burgos;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
09 Burgos;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2021QII;2.306
09 Burgos;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2021QI;""
09 Burgos;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
09 Burgos;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
09 Burgos;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2020QII;2.271
09 Burgos;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2020QI;""
09 Burgos;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
09 Burgos;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QIII;2.244
09 Burgos;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QII;""
09 Burgos;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QI;""
09 Burgos;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
09 Burgos;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QIII;2.267
09 Burgos;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QII;""
09 Burgos;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QI;""
09 Burgos;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
09 Burgos;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QIII;2.230
09 Burgos;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QII;""
09 Burgos;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QI;""
09 Burgos;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QIV;2.191
09 Burgos;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
09 Burgos;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QII;""
09 Burgos;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QI;""
09 Burgos;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QIV;2.214
09 Burgos;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
09 Burgos;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QII;""
09 Burgos;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QI;""
09 Burgos;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QIV;2.190
09 Burgos;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
09 Burgos;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QII;""
09 Burgos;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QI;""
09 Burgos;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
09 Burgos;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
09 Burgos;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
09 Burgos;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
09 Burgos;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
09 Burgos;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
09 Burgos;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
09 Burgos;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
09 Burgos;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
09 Burgos;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
09 Burgos;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
09 Burgos;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
09 Burgos;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
09 Burgos;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
09 Burgos;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
09 Burgos;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;97,61
09 Burgos;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
09 Burgos;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
09 Burgos;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
09 Burgos;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;98,17
09 Burgos;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
09 Burgos;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
09 Burgos;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
09 Burgos;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;95,08
09 Burgos;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
09 Burgos;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
09 Burgos;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;94,8
09 Burgos;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
09 Burgos;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
09 Burgos;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
09 Burgos;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;95,84
09 Burgos;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
09 Burgos;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
09 Burgos;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
09 Burgos;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;93,04
09 Burgos;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
09 Burgos;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
09 Burgos;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;92,61
09 Burgos;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
09 Burgos;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
09 Burgos;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
09 Burgos;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;94,22
09 Burgos;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
09 Burgos;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
09 Burgos;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
09 Burgos;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;91,36
09 Burgos;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
09 Burgos;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
09 Burgos;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;90,43
09 Burgos;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
09 Burgos;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
09 Burgos;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
09 Burgos;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;92,02
09 Burgos;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
09 Burgos;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
09 Burgos;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
09 Burgos;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;89,72
09 Burgos;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
09 Burgos;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
09 Burgos;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
09 Burgos;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
09 Burgos;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
09 Burgos;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QII;6.106
09 Burgos;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
09 Burgos;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
09 Burgos;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
09 Burgos;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QII;6.236
09 Burgos;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
09 Burgos;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
09 Burgos;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
09 Burgos;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QII;6.429
09 Burgos;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
09 Burgos;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
09 Burgos;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
09 Burgos;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2022QII;5.952
09 Burgos;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2022QI;""
09 Burgos;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
09 Burgos;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
09 Burgos;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2021QII;6.077
09 Burgos;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2021QI;""
09 Burgos;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
09 Burgos;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
09 Burgos;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2020QII;6.316
09 Burgos;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2020QI;""
09 Burgos;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
09 Burgos;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2022QIII;5.831
09 Burgos;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2022QII;""
09 Burgos;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2022QI;""
09 Burgos;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
09 Burgos;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2021QIII;5.969
09 Burgos;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2021QII;""
09 Burgos;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2021QI;""
09 Burgos;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
09 Burgos;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2020QIII;6.206
09 Burgos;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2020QII;""
09 Burgos;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2020QI;""
09 Burgos;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QIV;5.710
09 Burgos;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
09 Burgos;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QII;""
09 Burgos;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QI;""
09 Burgos;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QIV;5.833
09 Burgos;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
09 Burgos;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QII;""
09 Burgos;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QI;""
09 Burgos;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QIV;6.090
09 Burgos;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
09 Burgos;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QII;""
09 Burgos;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QI;""
09 Burgos;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
09 Burgos;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
09 Burgos;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QII;""
09 Burgos;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QI;5.722
09 Burgos;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
09 Burgos;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
09 Burgos;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QII;""
09 Burgos;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QI;6.011
09 Burgos;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
09 Burgos;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
09 Burgos;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QII;""
09 Burgos;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QI;""
09 Burgos;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
09 Burgos;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
09 Burgos;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
09 Burgos;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
09 Burgos;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
09 Burgos;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
09 Burgos;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
09 Burgos;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
09 Burgos;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
09 Burgos;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
09 Burgos;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
09 Burgos;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
09 Burgos;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
09 Burgos;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
09 Burgos;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;97,48
09 Burgos;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
09 Burgos;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
09 Burgos;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
09 Burgos;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;97,45
09 Burgos;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
09 Burgos;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
09 Burgos;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
09 Burgos;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;98,24
09 Burgos;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
09 Burgos;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
09 Burgos;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;95,5
09 Burgos;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
09 Burgos;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
09 Burgos;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
09 Burgos;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;95,72
09 Burgos;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
09 Burgos;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
09 Burgos;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
09 Burgos;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;96,53
09 Burgos;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
09 Burgos;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
09 Burgos;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;93,51
09 Burgos;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
09 Burgos;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
09 Burgos;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
09 Burgos;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;93,54
09 Burgos;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
09 Burgos;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
09 Burgos;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
09 Burgos;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;94,73
09 Burgos;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
09 Burgos;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
09 Burgos;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
09 Burgos;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
09 Burgos;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
09 Burgos;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
09 Burgos;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;91,76
09 Burgos;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
09 Burgos;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
09 Burgos;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
09 Burgos;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;93,5
09 Burgos;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
09 Burgos;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
09 Burgos;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
09 Burgos;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
09 Burgos;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
09 Burgos;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
09 Burgos;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QII;3.753
09 Burgos;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
09 Burgos;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
09 Burgos;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
09 Burgos;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QII;3.879
09 Burgos;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
09 Burgos;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
09 Burgos;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
09 Burgos;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QII;4.016
09 Burgos;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
09 Burgos;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
09 Burgos;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
09 Burgos;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2022QII;3.674
09 Burgos;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2022QI;""
09 Burgos;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
09 Burgos;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
09 Burgos;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2021QII;3.783
09 Burgos;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2021QI;""
09 Burgos;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
09 Burgos;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
09 Burgos;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2020QII;3.960
09 Burgos;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2020QI;""
09 Burgos;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
09 Burgos;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2022QIII;3.613
09 Burgos;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2022QII;""
09 Burgos;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2022QI;""
09 Burgos;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
09 Burgos;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2021QIII;3.717
09 Burgos;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2021QII;""
09 Burgos;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2021QI;""
09 Burgos;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
09 Burgos;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2020QIII;3.895
09 Burgos;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2020QII;""
09 Burgos;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2020QI;""
09 Burgos;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QIV;3.541
09 Burgos;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
09 Burgos;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QII;""
09 Burgos;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QI;""
09 Burgos;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QIV;3.640
09 Burgos;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
09 Burgos;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QII;""
09 Burgos;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QI;""
09 Burgos;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QIV;3.826
09 Burgos;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
09 Burgos;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QII;""
09 Burgos;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QI;""
09 Burgos;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
09 Burgos;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
09 Burgos;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QII;""
09 Burgos;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QI;3.573
09 Burgos;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
09 Burgos;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
09 Burgos;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QII;""
09 Burgos;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QI;3.784
09 Burgos;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
09 Burgos;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
09 Burgos;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QII;""
09 Burgos;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QI;""
09 Burgos;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
09 Burgos;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
09 Burgos;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
09 Burgos;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
09 Burgos;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
09 Burgos;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
09 Burgos;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
09 Burgos;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
09 Burgos;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
09 Burgos;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
09 Burgos;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
09 Burgos;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
09 Burgos;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
09 Burgos;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
09 Burgos;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;97,9
09 Burgos;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
09 Burgos;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
09 Burgos;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
09 Burgos;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;97,53
09 Burgos;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
09 Burgos;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
09 Burgos;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
09 Burgos;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;98,61
09 Burgos;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
09 Burgos;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
09 Burgos;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;96,27
09 Burgos;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
09 Burgos;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
09 Burgos;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
09 Burgos;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;95,82
09 Burgos;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
09 Burgos;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
09 Burgos;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
09 Burgos;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;96,99
09 Burgos;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
09 Burgos;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
09 Burgos;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;94,35
09 Burgos;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
09 Burgos;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
09 Burgos;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
09 Burgos;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;93,84
09 Burgos;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
09 Burgos;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
09 Burgos;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
09 Burgos;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;95,27
09 Burgos;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
09 Burgos;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
09 Burgos;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
09 Burgos;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
09 Burgos;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
09 Burgos;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
09 Burgos;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;92,11
09 Burgos;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
09 Burgos;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
09 Burgos;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
09 Burgos;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;94,22
09 Burgos;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
09 Burgos;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
09 Burgos;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
09 Burgos;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
09 Burgos;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
09 Burgos;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
09 Burgos;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QII;2.353
09 Burgos;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
09 Burgos;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
09 Burgos;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
09 Burgos;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QII;2.357
09 Burgos;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
09 Burgos;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
09 Burgos;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
09 Burgos;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QII;2.413
09 Burgos;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
09 Burgos;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
09 Burgos;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
09 Burgos;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2022QII;2.278
09 Burgos;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2022QI;""
09 Burgos;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
09 Burgos;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
09 Burgos;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2021QII;2.294
09 Burgos;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2021QI;""
09 Burgos;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
09 Burgos;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
09 Burgos;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2020QII;2.356
09 Burgos;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2020QI;""
09 Burgos;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
09 Burgos;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2022QIII;2.218
09 Burgos;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2022QII;""
09 Burgos;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2022QI;""
09 Burgos;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
09 Burgos;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2021QIII;2.252
09 Burgos;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2021QII;""
09 Burgos;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2021QI;""
09 Burgos;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
09 Burgos;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2020QIII;2.311
09 Burgos;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2020QII;""
09 Burgos;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2020QI;""
09 Burgos;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QIV;2.169
09 Burgos;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
09 Burgos;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QII;""
09 Burgos;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QI;""
09 Burgos;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QIV;2.193
09 Burgos;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
09 Burgos;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QII;""
09 Burgos;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QI;""
09 Burgos;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QIV;2.264
09 Burgos;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
09 Burgos;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QII;""
09 Burgos;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QI;""
09 Burgos;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
09 Burgos;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
09 Burgos;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QII;""
09 Burgos;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QI;2.149
09 Burgos;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
09 Burgos;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
09 Burgos;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QII;""
09 Burgos;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QI;2.227
09 Burgos;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
09 Burgos;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
09 Burgos;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QII;""
09 Burgos;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QI;""
09 Burgos;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
09 Burgos;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
09 Burgos;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
09 Burgos;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
09 Burgos;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
09 Burgos;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
09 Burgos;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
09 Burgos;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
09 Burgos;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
09 Burgos;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
09 Burgos;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
09 Burgos;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
09 Burgos;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
09 Burgos;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
09 Burgos;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;96,81
09 Burgos;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
09 Burgos;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
09 Burgos;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
09 Burgos;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;97,33
09 Burgos;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
09 Burgos;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
09 Burgos;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
09 Burgos;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;97,64
09 Burgos;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
09 Burgos;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
09 Burgos;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;94,26
09 Burgos;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
09 Burgos;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
09 Burgos;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
09 Burgos;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;95,55
09 Burgos;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
09 Burgos;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
09 Burgos;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
09 Burgos;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;95,77
09 Burgos;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
09 Burgos;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
09 Burgos;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;92,18
09 Burgos;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
09 Burgos;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
09 Burgos;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
09 Burgos;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;93,04
09 Burgos;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
09 Burgos;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
09 Burgos;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
09 Burgos;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;93,83
09 Burgos;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
09 Burgos;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
09 Burgos;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
09 Burgos;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
09 Burgos;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
09 Burgos;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
09 Burgos;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;91,18
09 Burgos;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
09 Burgos;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
09 Burgos;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
09 Burgos;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;92,29
09 Burgos;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
09 Burgos;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
09 Burgos;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
09 Burgos;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
09 Burgos;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
09 Burgos;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QIII;6.148
09 Burgos;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
09 Burgos;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
09 Burgos;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
09 Burgos;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QIII;6.274
09 Burgos;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
09 Burgos;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
09 Burgos;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
09 Burgos;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QIII;6.415
09 Burgos;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
09 Burgos;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
09 Burgos;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
09 Burgos;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2022QIII;5.998
09 Burgos;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2022QII;""
09 Burgos;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2022QI;""
09 Burgos;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
09 Burgos;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2021QIII;6.147
09 Burgos;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2021QII;""
09 Burgos;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2021QI;""
09 Burgos;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
09 Burgos;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2020QIII;6.284
09 Burgos;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2020QII;""
09 Burgos;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2020QI;""
09 Burgos;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2022QIV;5.861
09 Burgos;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
09 Burgos;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2022QII;""
09 Burgos;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2022QI;""
09 Burgos;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2021QIV;5.999
09 Burgos;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
09 Burgos;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2021QII;""
09 Burgos;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2021QI;""
09 Burgos;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2020QIV;6.152
09 Burgos;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
09 Burgos;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2020QII;""
09 Burgos;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2020QI;""
09 Burgos;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
09 Burgos;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
09 Burgos;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QII;""
09 Burgos;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QI;5.873
09 Burgos;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
09 Burgos;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
09 Burgos;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QII;""
09 Burgos;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QI;6.067
09 Burgos;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
09 Burgos;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
09 Burgos;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QII;""
09 Burgos;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QI;""
09 Burgos;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
09 Burgos;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
09 Burgos;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QII;5.759
09 Burgos;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QI;""
09 Burgos;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
09 Burgos;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
09 Burgos;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QII;5.961
09 Burgos;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QI;""
09 Burgos;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
09 Burgos;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
09 Burgos;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QII;""
09 Burgos;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QI;""
09 Burgos;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
09 Burgos;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
09 Burgos;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
09 Burgos;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
09 Burgos;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
09 Burgos;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
09 Burgos;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
09 Burgos;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
09 Burgos;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
09 Burgos;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
09 Burgos;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
09 Burgos;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
09 Burgos;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
09 Burgos;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;97,56
09 Burgos;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
09 Burgos;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
09 Burgos;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
09 Burgos;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;97,98
09 Burgos;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
09 Burgos;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
09 Burgos;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
09 Burgos;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;97,96
09 Burgos;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
09 Burgos;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
09 Burgos;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;95,33
09 Burgos;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
09 Burgos;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
09 Burgos;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
09 Burgos;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;95,62
09 Burgos;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
09 Burgos;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
09 Burgos;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
09 Burgos;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;95,9
09 Burgos;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
09 Burgos;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
09 Burgos;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
09 Burgos;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
09 Burgos;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
09 Burgos;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
09 Burgos;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;93,61
09 Burgos;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
09 Burgos;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
09 Burgos;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
09 Burgos;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;94,58
09 Burgos;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
09 Burgos;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
09 Burgos;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
09 Burgos;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
09 Burgos;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
09 Burgos;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
09 Burgos;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;91,79
09 Burgos;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
09 Burgos;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
09 Burgos;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
09 Burgos;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;92,92
09 Burgos;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
09 Burgos;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
09 Burgos;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
09 Burgos;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
09 Burgos;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
09 Burgos;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
09 Burgos;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QIII;3.769
09 Burgos;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
09 Burgos;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
09 Burgos;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
09 Burgos;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QIII;3.896
09 Burgos;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
09 Burgos;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
09 Burgos;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
09 Burgos;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QIII;4.026
09 Burgos;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
09 Burgos;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
09 Burgos;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
09 Burgos;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2022QIII;3.690
09 Burgos;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2022QII;""
09 Burgos;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2022QI;""
09 Burgos;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
09 Burgos;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2021QIII;3.819
09 Burgos;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2021QII;""
09 Burgos;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2021QI;""
09 Burgos;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
09 Burgos;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2020QIII;3.948
09 Burgos;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2020QII;""
09 Burgos;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2020QI;""
09 Burgos;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2022QIV;3.608
09 Burgos;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
09 Burgos;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2022QII;""
09 Burgos;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2022QI;""
09 Burgos;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2021QIV;3.735
09 Burgos;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
09 Burgos;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2021QII;""
09 Burgos;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2021QI;""
09 Burgos;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2020QIV;3.868
09 Burgos;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
09 Burgos;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2020QII;""
09 Burgos;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2020QI;""
09 Burgos;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
09 Burgos;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
09 Burgos;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QII;""
09 Burgos;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QI;3.656
09 Burgos;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
09 Burgos;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
09 Burgos;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QII;""
09 Burgos;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QI;3.822
09 Burgos;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
09 Burgos;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
09 Burgos;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QII;""
09 Burgos;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QI;""
09 Burgos;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
09 Burgos;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
09 Burgos;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QII;3.593
09 Burgos;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QI;""
09 Burgos;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
09 Burgos;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
09 Burgos;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QII;3.758
09 Burgos;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QI;""
09 Burgos;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
09 Burgos;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
09 Burgos;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QII;""
09 Burgos;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QI;""
09 Burgos;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
09 Burgos;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
09 Burgos;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
09 Burgos;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
09 Burgos;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
09 Burgos;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
09 Burgos;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
09 Burgos;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
09 Burgos;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
09 Burgos;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
09 Burgos;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
09 Burgos;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
09 Burgos;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
09 Burgos;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;97,9
09 Burgos;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
09 Burgos;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
09 Burgos;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
09 Burgos;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;98,02
09 Burgos;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
09 Burgos;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
09 Burgos;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
09 Burgos;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;98,06
09 Burgos;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
09 Burgos;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
09 Burgos;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;95,73
09 Burgos;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
09 Burgos;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
09 Burgos;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
09 Burgos;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;95,87
09 Burgos;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
09 Burgos;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
09 Burgos;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
09 Burgos;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;96,08
09 Burgos;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
09 Burgos;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
09 Burgos;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
09 Burgos;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
09 Burgos;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
09 Burgos;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
09 Burgos;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;93,84
09 Burgos;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
09 Burgos;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
09 Burgos;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
09 Burgos;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;94,93
09 Burgos;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
09 Burgos;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
09 Burgos;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
09 Burgos;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
09 Burgos;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
09 Burgos;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
09 Burgos;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;92,22
09 Burgos;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
09 Burgos;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
09 Burgos;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
09 Burgos;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;93,34
09 Burgos;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
09 Burgos;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
09 Burgos;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
09 Burgos;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
09 Burgos;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
09 Burgos;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
09 Burgos;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QIII;2.379
09 Burgos;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
09 Burgos;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
09 Burgos;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
09 Burgos;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QIII;2.378
09 Burgos;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
09 Burgos;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
09 Burgos;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
09 Burgos;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QIII;2.389
09 Burgos;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
09 Burgos;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
09 Burgos;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
09 Burgos;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2022QIII;2.308
09 Burgos;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2022QII;""
09 Burgos;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2022QI;""
09 Burgos;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
09 Burgos;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2021QIII;2.328
09 Burgos;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2021QII;""
09 Burgos;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2021QI;""
09 Burgos;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
09 Burgos;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2020QIII;2.336
09 Burgos;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2020QII;""
09 Burgos;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2020QI;""
09 Burgos;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2022QIV;2.253
09 Burgos;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
09 Burgos;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2022QII;""
09 Burgos;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2022QI;""
09 Burgos;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2021QIV;2.264
09 Burgos;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
09 Burgos;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2021QII;""
09 Burgos;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2021QI;""
09 Burgos;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2020QIV;2.284
09 Burgos;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
09 Burgos;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2020QII;""
09 Burgos;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2020QI;""
09 Burgos;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
09 Burgos;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
09 Burgos;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QII;""
09 Burgos;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QI;2.217
09 Burgos;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
09 Burgos;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
09 Burgos;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QII;""
09 Burgos;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QI;2.245
09 Burgos;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
09 Burgos;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
09 Burgos;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QII;""
09 Burgos;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QI;""
09 Burgos;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
09 Burgos;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
09 Burgos;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QII;2.166
09 Burgos;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QI;""
09 Burgos;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
09 Burgos;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
09 Burgos;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QII;2.203
09 Burgos;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QI;""
09 Burgos;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
09 Burgos;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
09 Burgos;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QII;""
09 Burgos;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QI;""
09 Burgos;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
09 Burgos;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
09 Burgos;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
09 Burgos;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
09 Burgos;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
09 Burgos;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
09 Burgos;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
09 Burgos;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
09 Burgos;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
09 Burgos;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
09 Burgos;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
09 Burgos;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
09 Burgos;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
09 Burgos;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;97,02
09 Burgos;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
09 Burgos;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
09 Burgos;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
09 Burgos;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;97,9
09 Burgos;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
09 Burgos;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
09 Burgos;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
09 Burgos;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;97,78
09 Burgos;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
09 Burgos;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
09 Burgos;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;94,7
09 Burgos;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
09 Burgos;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
09 Burgos;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
09 Burgos;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;95,21
09 Burgos;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
09 Burgos;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
09 Burgos;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
09 Burgos;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;95,6
09 Burgos;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
09 Burgos;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
09 Burgos;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
09 Burgos;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
09 Burgos;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
09 Burgos;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
09 Burgos;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;93,23
09 Burgos;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
09 Burgos;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
09 Burgos;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
09 Burgos;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;93,97
09 Burgos;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
09 Burgos;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
09 Burgos;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
09 Burgos;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
09 Burgos;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
09 Burgos;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
09 Burgos;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;91,08
09 Burgos;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
09 Burgos;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
09 Burgos;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
09 Burgos;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;92,21
09 Burgos;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
09 Burgos;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
09 Burgos;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
09 Burgos;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
09 Burgos;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
09 Burgos;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QIV;6.145
09 Burgos;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
09 Burgos;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
09 Burgos;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
09 Burgos;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QIV;6.310
09 Burgos;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
09 Burgos;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
09 Burgos;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
09 Burgos;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QIV;6.445
09 Burgos;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
09 Burgos;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
09 Burgos;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
09 Burgos;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2022QIV;5.987
09 Burgos;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
09 Burgos;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2022QII;""
09 Burgos;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2022QI;""
09 Burgos;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2021QIV;6.138
09 Burgos;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
09 Burgos;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2021QII;""
09 Burgos;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2021QI;""
09 Burgos;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2020QIV;6.291
09 Burgos;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
09 Burgos;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2020QII;""
09 Burgos;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2020QI;""
09 Burgos;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
09 Burgos;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
09 Burgos;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2022QII;""
09 Burgos;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2022QI;6.005
09 Burgos;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
09 Burgos;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
09 Burgos;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2021QII;""
09 Burgos;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2021QI;6.199
09 Burgos;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
09 Burgos;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
09 Burgos;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2020QII;""
09 Burgos;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2020QI;""
09 Burgos;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
09 Burgos;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
09 Burgos;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QII;5.880
09 Burgos;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QI;""
09 Burgos;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
09 Burgos;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
09 Burgos;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QII;6.083
09 Burgos;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QI;""
09 Burgos;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
09 Burgos;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
09 Burgos;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QII;""
09 Burgos;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QI;""
09 Burgos;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
09 Burgos;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QIII;5.787
09 Burgos;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QII;""
09 Burgos;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QI;""
09 Burgos;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
09 Burgos;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QIII;5.993
09 Burgos;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QII;""
09 Burgos;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QI;""
09 Burgos;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
09 Burgos;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
09 Burgos;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QII;""
09 Burgos;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QI;""
09 Burgos;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
09 Burgos;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
09 Burgos;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
09 Burgos;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
09 Burgos;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
09 Burgos;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
09 Burgos;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
09 Burgos;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
09 Burgos;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
09 Burgos;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
09 Burgos;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
09 Burgos;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
09 Burgos;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;97,43
09 Burgos;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
09 Burgos;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
09 Burgos;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
09 Burgos;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;97,27
09 Burgos;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
09 Burgos;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
09 Burgos;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
09 Burgos;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;97,61
09 Burgos;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
09 Burgos;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
09 Burgos;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
09 Burgos;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
09 Burgos;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
09 Burgos;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
09 Burgos;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;95,17
09 Burgos;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
09 Burgos;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
09 Burgos;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
09 Burgos;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;96,18
09 Burgos;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
09 Burgos;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
09 Burgos;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
09 Burgos;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
09 Burgos;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
09 Burgos;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
09 Burgos;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;93,19
09 Burgos;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
09 Burgos;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
09 Burgos;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
09 Burgos;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;94,38
09 Burgos;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
09 Burgos;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
09 Burgos;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
09 Burgos;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
09 Burgos;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
09 Burgos;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
09 Burgos;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;91,71
09 Burgos;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
09 Burgos;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
09 Burgos;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
09 Burgos;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;92,99
09 Burgos;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
09 Burgos;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
09 Burgos;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
09 Burgos;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
09 Burgos;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
09 Burgos;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
09 Burgos;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QIV;3.769
09 Burgos;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
09 Burgos;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
09 Burgos;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
09 Burgos;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QIV;3.901
09 Burgos;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
09 Burgos;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
09 Burgos;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
09 Burgos;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QIV;4.042
09 Burgos;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
09 Burgos;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
09 Burgos;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
09 Burgos;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2022QIV;3.674
09 Burgos;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
09 Burgos;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2022QII;""
09 Burgos;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2022QI;""
09 Burgos;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2021QIV;3.807
09 Burgos;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
09 Burgos;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2021QII;""
09 Burgos;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2021QI;""
09 Burgos;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2020QIV;3.946
09 Burgos;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
09 Burgos;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2020QII;""
09 Burgos;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2020QI;""
09 Burgos;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
09 Burgos;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
09 Burgos;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2022QII;""
09 Burgos;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2022QI;3.723
09 Burgos;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
09 Burgos;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
09 Burgos;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2021QII;""
09 Burgos;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2021QI;3.896
09 Burgos;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
09 Burgos;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
09 Burgos;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2020QII;""
09 Burgos;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2020QI;""
09 Burgos;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
09 Burgos;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
09 Burgos;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QII;3.656
09 Burgos;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QI;""
09 Burgos;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
09 Burgos;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
09 Burgos;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QII;3.826
09 Burgos;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QI;""
09 Burgos;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
09 Burgos;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
09 Burgos;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QII;""
09 Burgos;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QI;""
09 Burgos;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
09 Burgos;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QIII;3.609
09 Burgos;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QII;""
09 Burgos;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QI;""
09 Burgos;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
09 Burgos;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QIII;3.772
09 Burgos;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QII;""
09 Burgos;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QI;""
09 Burgos;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
09 Burgos;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
09 Burgos;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QII;""
09 Burgos;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QI;""
09 Burgos;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
09 Burgos;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
09 Burgos;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
09 Burgos;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
09 Burgos;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
09 Burgos;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
09 Burgos;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
09 Burgos;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
09 Burgos;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
09 Burgos;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
09 Burgos;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
09 Burgos;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
09 Burgos;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;97,48
09 Burgos;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
09 Burgos;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
09 Burgos;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
09 Burgos;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;97,59
09 Burgos;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
09 Burgos;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
09 Burgos;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
09 Burgos;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;97,62
09 Burgos;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
09 Burgos;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
09 Burgos;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
09 Burgos;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
09 Burgos;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
09 Burgos;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
09 Burgos;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;95,44
09 Burgos;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
09 Burgos;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
09 Burgos;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
09 Burgos;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;96,39
09 Burgos;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
09 Burgos;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
09 Burgos;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
09 Burgos;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
09 Burgos;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
09 Burgos;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
09 Burgos;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;93,72
09 Burgos;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
09 Burgos;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
09 Burgos;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
09 Burgos;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;94,66
09 Burgos;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
09 Burgos;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
09 Burgos;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
09 Burgos;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
09 Burgos;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
09 Burgos;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
09 Burgos;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;92,51
09 Burgos;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
09 Burgos;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
09 Burgos;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
09 Burgos;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;93,32
09 Burgos;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
09 Burgos;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
09 Burgos;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
09 Burgos;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
09 Burgos;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
09 Burgos;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
09 Burgos;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QIV;2.376
09 Burgos;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
09 Burgos;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
09 Burgos;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
09 Burgos;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QIV;2.409
09 Burgos;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
09 Burgos;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
09 Burgos;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
09 Burgos;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QIV;2.403
09 Burgos;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
09 Burgos;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
09 Burgos;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
09 Burgos;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2022QIV;2.313
09 Burgos;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
09 Burgos;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2022QII;""
09 Burgos;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2022QI;""
09 Burgos;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2021QIV;2.331
09 Burgos;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
09 Burgos;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2021QII;""
09 Burgos;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2021QI;""
09 Burgos;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2020QIV;2.345
09 Burgos;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
09 Burgos;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2020QII;""
09 Burgos;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2020QI;""
09 Burgos;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
09 Burgos;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
09 Burgos;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2022QII;""
09 Burgos;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2022QI;2.282
09 Burgos;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
09 Burgos;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
09 Burgos;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2021QII;""
09 Burgos;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2021QI;2.303
09 Burgos;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
09 Burgos;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
09 Burgos;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2020QII;""
09 Burgos;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2020QI;""
09 Burgos;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
09 Burgos;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
09 Burgos;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QII;2.224
09 Burgos;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QI;""
09 Burgos;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
09 Burgos;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
09 Burgos;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QII;2.257
09 Burgos;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QI;""
09 Burgos;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
09 Burgos;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
09 Burgos;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QII;""
09 Burgos;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QI;""
09 Burgos;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
09 Burgos;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QIII;2.178
09 Burgos;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QII;""
09 Burgos;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QI;""
09 Burgos;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
09 Burgos;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QIII;2.221
09 Burgos;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QII;""
09 Burgos;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QI;""
09 Burgos;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
09 Burgos;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
09 Burgos;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QII;""
09 Burgos;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QI;""
09 Burgos;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
09 Burgos;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
09 Burgos;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
09 Burgos;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
09 Burgos;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
09 Burgos;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
09 Burgos;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
09 Burgos;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
09 Burgos;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
09 Burgos;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
09 Burgos;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
09 Burgos;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
09 Burgos;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;97,35
09 Burgos;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
09 Burgos;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
09 Burgos;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
09 Burgos;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;96,76
09 Burgos;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
09 Burgos;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
09 Burgos;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
09 Burgos;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;97,59
09 Burgos;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
09 Burgos;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
09 Burgos;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
09 Burgos;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
09 Burgos;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
09 Burgos;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
09 Burgos;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;94,73
09 Burgos;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
09 Burgos;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
09 Burgos;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
09 Burgos;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;95,84
09 Burgos;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
09 Burgos;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
09 Burgos;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
09 Burgos;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
09 Burgos;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
09 Burgos;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
09 Burgos;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;92,32
09 Burgos;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
09 Burgos;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
09 Burgos;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
09 Burgos;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;93,92
09 Burgos;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
09 Burgos;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
09 Burgos;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
09 Burgos;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
09 Burgos;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
09 Burgos;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
09 Burgos;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;90,41
09 Burgos;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
09 Burgos;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
09 Burgos;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
09 Burgos;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;92,43
09 Burgos;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
09 Burgos;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
09 Burgos;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
09 Burgos;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
09 Burgos;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
09 Burgos;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
09 Burgos;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
09 Burgos;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
09 Burgos;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
09 Burgos;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QI;6.979
09 Burgos;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
09 Burgos;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
09 Burgos;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
09 Burgos;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QI;6.962
09 Burgos;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
09 Burgos;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
09 Burgos;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
09 Burgos;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QI;7.123
09 Burgos;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
09 Burgos;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
09 Burgos;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2022QII;""
09 Burgos;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2022QI;6.870
09 Burgos;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
09 Burgos;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
09 Burgos;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2021QII;""
09 Burgos;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2021QI;6.872
09 Burgos;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
09 Burgos;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
09 Burgos;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2020QII;""
09 Burgos;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2020QI;6.843
09 Burgos;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
09 Burgos;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
09 Burgos;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2022QII;6.765
09 Burgos;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2022QI;""
09 Burgos;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
09 Burgos;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
09 Burgos;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2021QII;6.777
09 Burgos;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2021QI;""
09 Burgos;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
09 Burgos;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
09 Burgos;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2020QII;6.771
09 Burgos;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2020QI;""
09 Burgos;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
09 Burgos;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QIII;6.676
09 Burgos;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QII;""
09 Burgos;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QI;""
09 Burgos;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
09 Burgos;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QIII;6.712
09 Burgos;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QII;""
09 Burgos;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QI;""
09 Burgos;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
09 Burgos;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QIII;6.677
09 Burgos;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QII;""
09 Burgos;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QI;""
09 Burgos;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QIV;6.579
09 Burgos;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
09 Burgos;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QII;""
09 Burgos;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QI;""
09 Burgos;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QIV;6.604
09 Burgos;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
09 Burgos;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QII;""
09 Burgos;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QI;""
09 Burgos;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QIV;6.597
09 Burgos;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
09 Burgos;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QII;""
09 Burgos;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QI;""
09 Burgos;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
09 Burgos;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
09 Burgos;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
09 Burgos;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
09 Burgos;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
09 Burgos;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
09 Burgos;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
09 Burgos;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
09 Burgos;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
09 Burgos;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
09 Burgos;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
09 Burgos;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
09 Burgos;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
09 Burgos;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
09 Burgos;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
09 Burgos;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;98,44
09 Burgos;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
09 Burgos;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
09 Burgos;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
09 Burgos;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;98,71
09 Burgos;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
09 Burgos;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
09 Burgos;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
09 Burgos;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;96,07
09 Burgos;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
09 Burgos;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
09 Burgos;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;96,93
09 Burgos;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
09 Burgos;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
09 Burgos;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
09 Burgos;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;97,34
09 Burgos;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
09 Burgos;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
09 Burgos;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
09 Burgos;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;95,06
09 Burgos;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
09 Burgos;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
09 Burgos;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;95,66
09 Burgos;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
09 Burgos;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
09 Burgos;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
09 Burgos;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;96,41
09 Burgos;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
09 Burgos;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
09 Burgos;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
09 Burgos;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;93,74
09 Burgos;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
09 Burgos;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
09 Burgos;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;94,27
09 Burgos;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
09 Burgos;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
09 Burgos;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
09 Burgos;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;94,86
09 Burgos;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
09 Burgos;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
09 Burgos;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
09 Burgos;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;92,62
09 Burgos;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
09 Burgos;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
09 Burgos;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
09 Burgos;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
09 Burgos;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
09 Burgos;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
09 Burgos;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QI;4.467
09 Burgos;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
09 Burgos;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
09 Burgos;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
09 Burgos;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QI;4.449
09 Burgos;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
09 Burgos;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
09 Burgos;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
09 Burgos;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QI;4.529
09 Burgos;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
09 Burgos;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
09 Burgos;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2022QII;""
09 Burgos;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2022QI;4.394
09 Burgos;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
09 Burgos;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
09 Burgos;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2021QII;""
09 Burgos;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2021QI;4.397
09 Burgos;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
09 Burgos;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
09 Burgos;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2020QII;""
09 Burgos;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2020QI;4.362
09 Burgos;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
09 Burgos;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
09 Burgos;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2022QII;4.330
09 Burgos;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2022QI;""
09 Burgos;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
09 Burgos;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
09 Burgos;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2021QII;4.337
09 Burgos;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2021QI;""
09 Burgos;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
09 Burgos;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
09 Burgos;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2020QII;4.321
09 Burgos;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2020QI;""
09 Burgos;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
09 Burgos;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QIII;4.280
09 Burgos;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QII;""
09 Burgos;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QI;""
09 Burgos;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
09 Burgos;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QIII;4.300
09 Burgos;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QII;""
09 Burgos;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QI;""
09 Burgos;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
09 Burgos;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QIII;4.270
09 Burgos;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QII;""
09 Burgos;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QI;""
09 Burgos;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QIV;4.220
09 Burgos;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
09 Burgos;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QII;""
09 Burgos;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QI;""
09 Burgos;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QIV;4.243
09 Burgos;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
09 Burgos;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QII;""
09 Burgos;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QI;""
09 Burgos;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QIV;4.228
09 Burgos;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
09 Burgos;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QII;""
09 Burgos;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QI;""
09 Burgos;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
09 Burgos;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
09 Burgos;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
09 Burgos;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
09 Burgos;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
09 Burgos;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
09 Burgos;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
09 Burgos;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
09 Burgos;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
09 Burgos;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
09 Burgos;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
09 Burgos;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
09 Burgos;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
09 Burgos;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
09 Burgos;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
09 Burgos;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;98,37
09 Burgos;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
09 Burgos;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
09 Burgos;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
09 Burgos;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;98,83
09 Burgos;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
09 Burgos;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
09 Burgos;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
09 Burgos;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;96,31
09 Burgos;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
09 Burgos;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
09 Burgos;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;96,93
09 Burgos;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
09 Burgos;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
09 Burgos;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
09 Burgos;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;97,48
09 Burgos;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
09 Burgos;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
09 Burgos;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
09 Burgos;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;95,41
09 Burgos;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
09 Burgos;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
09 Burgos;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;95,81
09 Burgos;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
09 Burgos;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
09 Burgos;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
09 Burgos;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;96,65
09 Burgos;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
09 Burgos;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
09 Burgos;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
09 Burgos;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;94,28
09 Burgos;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
09 Burgos;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
09 Burgos;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;94,47
09 Burgos;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
09 Burgos;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
09 Burgos;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
09 Burgos;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;95,37
09 Burgos;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
09 Burgos;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
09 Burgos;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
09 Burgos;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;93,35
09 Burgos;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
09 Burgos;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
09 Burgos;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
09 Burgos;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
09 Burgos;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
09 Burgos;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
09 Burgos;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QI;2.512
09 Burgos;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
09 Burgos;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
09 Burgos;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
09 Burgos;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QI;2.513
09 Burgos;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
09 Burgos;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
09 Burgos;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
09 Burgos;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QI;2.594
09 Burgos;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
09 Burgos;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
09 Burgos;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2022QII;""
09 Burgos;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2022QI;2.476
09 Burgos;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
09 Burgos;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
09 Burgos;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2021QII;""
09 Burgos;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2021QI;2.475
09 Burgos;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
09 Burgos;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
09 Burgos;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2020QII;""
09 Burgos;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2020QI;2.481
09 Burgos;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
09 Burgos;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
09 Burgos;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2022QII;2.435
09 Burgos;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2022QI;""
09 Burgos;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
09 Burgos;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
09 Burgos;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2021QII;2.440
09 Burgos;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2021QI;""
09 Burgos;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
09 Burgos;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
09 Burgos;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2020QII;2.450
09 Burgos;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2020QI;""
09 Burgos;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
09 Burgos;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QIII;2.396
09 Burgos;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QII;""
09 Burgos;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QI;""
09 Burgos;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
09 Burgos;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QIII;2.412
09 Burgos;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QII;""
09 Burgos;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QI;""
09 Burgos;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
09 Burgos;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QIII;2.407
09 Burgos;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QII;""
09 Burgos;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QI;""
09 Burgos;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QIV;2.359
09 Burgos;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
09 Burgos;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QII;""
09 Burgos;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QI;""
09 Burgos;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QIV;2.361
09 Burgos;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
09 Burgos;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QII;""
09 Burgos;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QI;""
09 Burgos;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QIV;2.369
09 Burgos;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
09 Burgos;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QII;""
09 Burgos;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QI;""
09 Burgos;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
09 Burgos;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
09 Burgos;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
09 Burgos;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
09 Burgos;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
09 Burgos;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
09 Burgos;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
09 Burgos;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
09 Burgos;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
09 Burgos;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
09 Burgos;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
09 Burgos;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
09 Burgos;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
09 Burgos;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
09 Burgos;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
09 Burgos;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;98,57
09 Burgos;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
09 Burgos;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
09 Burgos;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
09 Burgos;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;98,49
09 Burgos;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
09 Burgos;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
09 Burgos;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
09 Burgos;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;95,64
09 Burgos;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
09 Burgos;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
09 Burgos;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;96,93
09 Burgos;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
09 Burgos;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
09 Burgos;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
09 Burgos;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;97,1
09 Burgos;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
09 Burgos;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
09 Burgos;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
09 Burgos;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;94,45
09 Burgos;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
09 Burgos;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
09 Burgos;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;95,38
09 Burgos;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
09 Burgos;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
09 Burgos;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
09 Burgos;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;95,98
09 Burgos;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
09 Burgos;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
09 Burgos;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
09 Burgos;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;92,79
09 Burgos;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
09 Burgos;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
09 Burgos;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;93,91
09 Burgos;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
09 Burgos;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
09 Burgos;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
09 Burgos;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;93,95
09 Burgos;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
09 Burgos;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
09 Burgos;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
09 Burgos;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;91,33
09 Burgos;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
09 Burgos;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
09 Burgos;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
09 Burgos;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
09 Burgos;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
09 Burgos;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QII;7.034
09 Burgos;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
09 Burgos;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
09 Burgos;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
09 Burgos;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QII;7.017
09 Burgos;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
09 Burgos;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
09 Burgos;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
09 Burgos;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QII;7.002
09 Burgos;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
09 Burgos;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
09 Burgos;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
09 Burgos;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2022QII;6.921
09 Burgos;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2022QI;""
09 Burgos;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
09 Burgos;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
09 Burgos;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2021QII;6.912
09 Burgos;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2021QI;""
09 Burgos;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
09 Burgos;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
09 Burgos;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2020QII;6.920
09 Burgos;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2020QI;""
09 Burgos;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
09 Burgos;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2022QIII;6.825
09 Burgos;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2022QII;""
09 Burgos;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2022QI;""
09 Burgos;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
09 Burgos;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2021QIII;6.838
09 Burgos;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2021QII;""
09 Burgos;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2021QI;""
09 Burgos;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
09 Burgos;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2020QIII;6.807
09 Burgos;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2020QII;""
09 Burgos;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2020QI;""
09 Burgos;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QIV;6.711
09 Burgos;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
09 Burgos;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QII;""
09 Burgos;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QI;""
09 Burgos;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QIV;6.716
09 Burgos;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
09 Burgos;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QII;""
09 Burgos;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QI;""
09 Burgos;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QIV;6.719
09 Burgos;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
09 Burgos;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QII;""
09 Burgos;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QI;""
09 Burgos;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
09 Burgos;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
09 Burgos;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QII;""
09 Burgos;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QI;6.629
09 Burgos;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
09 Burgos;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
09 Burgos;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QII;""
09 Burgos;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QI;6.643
09 Burgos;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
09 Burgos;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
09 Burgos;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QII;""
09 Burgos;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QI;""
09 Burgos;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
09 Burgos;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
09 Burgos;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
09 Burgos;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
09 Burgos;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
09 Burgos;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
09 Burgos;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
09 Burgos;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
09 Burgos;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
09 Burgos;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
09 Burgos;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
09 Burgos;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
09 Burgos;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
09 Burgos;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
09 Burgos;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;98,39
09 Burgos;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
09 Burgos;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
09 Burgos;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
09 Burgos;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;98,5
09 Burgos;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
09 Burgos;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
09 Burgos;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
09 Burgos;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;98,83
09 Burgos;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
09 Burgos;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
09 Burgos;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;97,03
09 Burgos;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
09 Burgos;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
09 Burgos;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
09 Burgos;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;97,45
09 Burgos;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
09 Burgos;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
09 Burgos;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
09 Burgos;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;97,22
09 Burgos;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
09 Burgos;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
09 Burgos;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;95,41
09 Burgos;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
09 Burgos;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
09 Burgos;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
09 Burgos;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;95,71
09 Burgos;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
09 Burgos;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
09 Burgos;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
09 Burgos;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;95,96
09 Burgos;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
09 Burgos;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
09 Burgos;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
09 Burgos;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
09 Burgos;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
09 Burgos;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
09 Burgos;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;94,47
09 Burgos;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
09 Burgos;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
09 Burgos;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
09 Burgos;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;94,87
09 Burgos;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
09 Burgos;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
09 Burgos;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
09 Burgos;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
09 Burgos;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
09 Burgos;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
09 Burgos;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QII;4.440
09 Burgos;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
09 Burgos;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
09 Burgos;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
09 Burgos;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QII;4.480
09 Burgos;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
09 Burgos;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
09 Burgos;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
09 Burgos;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QII;4.460
09 Burgos;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
09 Burgos;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
09 Burgos;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
09 Burgos;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2022QII;4.372
09 Burgos;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2022QI;""
09 Burgos;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
09 Burgos;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
09 Burgos;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2021QII;4.413
09 Burgos;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2021QI;""
09 Burgos;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
09 Burgos;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
09 Burgos;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2020QII;4.410
09 Burgos;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2020QI;""
09 Burgos;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
09 Burgos;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2022QIII;4.321
09 Burgos;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2022QII;""
09 Burgos;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2022QI;""
09 Burgos;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
09 Burgos;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2021QIII;4.369
09 Burgos;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2021QII;""
09 Burgos;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2021QI;""
09 Burgos;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
09 Burgos;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2020QIII;4.345
09 Burgos;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2020QII;""
09 Burgos;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2020QI;""
09 Burgos;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QIV;4.255
09 Burgos;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
09 Burgos;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QII;""
09 Burgos;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QI;""
09 Burgos;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QIV;4.304
09 Burgos;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
09 Burgos;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QII;""
09 Burgos;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QI;""
09 Burgos;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QIV;4.298
09 Burgos;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
09 Burgos;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QII;""
09 Burgos;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QI;""
09 Burgos;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
09 Burgos;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
09 Burgos;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QII;""
09 Burgos;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QI;4.250
09 Burgos;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
09 Burgos;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
09 Burgos;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QII;""
09 Burgos;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QI;4.254
09 Burgos;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
09 Burgos;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
09 Burgos;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QII;""
09 Burgos;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QI;""
09 Burgos;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
09 Burgos;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
09 Burgos;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
09 Burgos;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
09 Burgos;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
09 Burgos;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
09 Burgos;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
09 Burgos;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
09 Burgos;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
09 Burgos;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
09 Burgos;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
09 Burgos;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
09 Burgos;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
09 Burgos;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
09 Burgos;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;98,47
09 Burgos;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
09 Burgos;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
09 Burgos;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
09 Burgos;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;98,5
09 Burgos;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
09 Burgos;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
09 Burgos;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
09 Burgos;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;98,88
09 Burgos;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
09 Burgos;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
09 Burgos;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;97,32
09 Burgos;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
09 Burgos;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
09 Burgos;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
09 Burgos;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;97,52
09 Burgos;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
09 Burgos;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
09 Burgos;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
09 Burgos;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;97,42
09 Burgos;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
09 Burgos;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
09 Burgos;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;95,83
09 Burgos;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
09 Burgos;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
09 Burgos;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
09 Burgos;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;96,07
09 Burgos;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
09 Burgos;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
09 Burgos;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
09 Burgos;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;96,37
09 Burgos;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
09 Burgos;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
09 Burgos;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
09 Burgos;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
09 Burgos;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
09 Burgos;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
09 Burgos;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;94,87
09 Burgos;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
09 Burgos;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
09 Burgos;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
09 Burgos;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;95,38
09 Burgos;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
09 Burgos;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
09 Burgos;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
09 Burgos;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
09 Burgos;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
09 Burgos;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
09 Burgos;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QII;2.594
09 Burgos;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
09 Burgos;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
09 Burgos;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
09 Burgos;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QII;2.537
09 Burgos;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
09 Burgos;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
09 Burgos;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
09 Burgos;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QII;2.542
09 Burgos;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
09 Burgos;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
09 Burgos;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
09 Burgos;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2022QII;2.549
09 Burgos;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2022QI;""
09 Burgos;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
09 Burgos;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
09 Burgos;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2021QII;2.499
09 Burgos;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2021QI;""
09 Burgos;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
09 Burgos;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
09 Burgos;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2020QII;2.510
09 Burgos;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2020QI;""
09 Burgos;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
09 Burgos;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2022QIII;2.504
09 Burgos;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2022QII;""
09 Burgos;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2022QI;""
09 Burgos;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
09 Burgos;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2021QIII;2.469
09 Burgos;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2021QII;""
09 Burgos;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2021QI;""
09 Burgos;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
09 Burgos;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2020QIII;2.462
09 Burgos;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2020QII;""
09 Burgos;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2020QI;""
09 Burgos;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QIV;2.456
09 Burgos;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
09 Burgos;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QII;""
09 Burgos;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QI;""
09 Burgos;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QIV;2.412
09 Burgos;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
09 Burgos;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QII;""
09 Burgos;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QI;""
09 Burgos;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QIV;2.421
09 Burgos;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
09 Burgos;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QII;""
09 Burgos;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QI;""
09 Burgos;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
09 Burgos;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
09 Burgos;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QII;""
09 Burgos;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QI;2.379
09 Burgos;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
09 Burgos;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
09 Burgos;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QII;""
09 Burgos;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QI;2.389
09 Burgos;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
09 Burgos;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
09 Burgos;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QII;""
09 Burgos;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QI;""
09 Burgos;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
09 Burgos;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
09 Burgos;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
09 Burgos;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
09 Burgos;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
09 Burgos;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
09 Burgos;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
09 Burgos;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
09 Burgos;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
09 Burgos;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
09 Burgos;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
09 Burgos;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
09 Burgos;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
09 Burgos;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
09 Burgos;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;98,27
09 Burgos;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
09 Burgos;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
09 Burgos;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
09 Burgos;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;98,5
09 Burgos;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
09 Burgos;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
09 Burgos;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
09 Burgos;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;98,74
09 Burgos;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
09 Burgos;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
09 Burgos;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;96,53
09 Burgos;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
09 Burgos;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
09 Burgos;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
09 Burgos;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;97,32
09 Burgos;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
09 Burgos;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
09 Burgos;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
09 Burgos;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;96,85
09 Burgos;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
09 Burgos;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
09 Burgos;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;94,68
09 Burgos;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
09 Burgos;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
09 Burgos;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
09 Burgos;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;95,07
09 Burgos;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
09 Burgos;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
09 Burgos;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
09 Burgos;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;95,24
09 Burgos;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
09 Burgos;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
09 Burgos;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
09 Burgos;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
09 Burgos;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
09 Burgos;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
09 Burgos;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;93,77
09 Burgos;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
09 Burgos;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
09 Burgos;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
09 Burgos;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;93,98
09 Burgos;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
09 Burgos;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
09 Burgos;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
09 Burgos;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
09 Burgos;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
09 Burgos;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QIII;7.051
09 Burgos;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
09 Burgos;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
09 Burgos;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
09 Burgos;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QIII;7.032
09 Burgos;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
09 Burgos;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
09 Burgos;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
09 Burgos;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QIII;7.022
09 Burgos;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
09 Burgos;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
09 Burgos;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
09 Burgos;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2022QIII;6.936
09 Burgos;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2022QII;""
09 Burgos;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2022QI;""
09 Burgos;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
09 Burgos;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2021QIII;6.943
09 Burgos;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2021QII;""
09 Burgos;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2021QI;""
09 Burgos;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
09 Burgos;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2020QIII;6.894
09 Burgos;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2020QII;""
09 Burgos;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2020QI;""
09 Burgos;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2022QIV;6.811
09 Burgos;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
09 Burgos;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2022QII;""
09 Burgos;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2022QI;""
09 Burgos;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2021QIV;6.807
09 Burgos;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
09 Burgos;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2021QII;""
09 Burgos;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2021QI;""
09 Burgos;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2020QIV;6.791
09 Burgos;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
09 Burgos;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2020QII;""
09 Burgos;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2020QI;""
09 Burgos;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
09 Burgos;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
09 Burgos;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QII;""
09 Burgos;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QI;6.713
09 Burgos;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
09 Burgos;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
09 Burgos;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QII;""
09 Burgos;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QI;6.712
09 Burgos;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
09 Burgos;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
09 Burgos;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QII;""
09 Burgos;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QI;""
09 Burgos;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
09 Burgos;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
09 Burgos;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QII;6.626
09 Burgos;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QI;""
09 Burgos;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
09 Burgos;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
09 Burgos;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QII;6.635
09 Burgos;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QI;""
09 Burgos;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
09 Burgos;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
09 Burgos;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QII;""
09 Burgos;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QI;""
09 Burgos;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
09 Burgos;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
09 Burgos;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
09 Burgos;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
09 Burgos;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
09 Burgos;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
09 Burgos;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
09 Burgos;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
09 Burgos;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
09 Burgos;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
09 Burgos;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
09 Burgos;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
09 Burgos;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
09 Burgos;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;98,37
09 Burgos;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
09 Burgos;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
09 Burgos;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
09 Burgos;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;98,73
09 Burgos;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
09 Burgos;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
09 Burgos;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
09 Burgos;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;98,18
09 Burgos;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
09 Burgos;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
09 Burgos;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;96,6
09 Burgos;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
09 Burgos;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
09 Burgos;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
09 Burgos;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;96,8
09 Burgos;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
09 Burgos;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
09 Burgos;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
09 Burgos;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;96,71
09 Burgos;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
09 Burgos;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
09 Burgos;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
09 Burgos;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
09 Burgos;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
09 Burgos;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
09 Burgos;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;95,46
09 Burgos;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
09 Burgos;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
09 Burgos;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
09 Burgos;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;95,59
09 Burgos;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
09 Burgos;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
09 Burgos;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
09 Burgos;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
09 Burgos;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
09 Burgos;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
09 Burgos;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;94,23
09 Burgos;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
09 Burgos;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
09 Burgos;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
09 Burgos;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;94,49
09 Burgos;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
09 Burgos;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
09 Burgos;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
09 Burgos;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
09 Burgos;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
09 Burgos;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
09 Burgos;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QIII;4.445
09 Burgos;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
09 Burgos;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
09 Burgos;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
09 Burgos;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QIII;4.493
09 Burgos;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
09 Burgos;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
09 Burgos;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
09 Burgos;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QIII;4.482
09 Burgos;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
09 Burgos;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
09 Burgos;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
09 Burgos;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2022QIII;4.384
09 Burgos;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2022QII;""
09 Burgos;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2022QI;""
09 Burgos;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
09 Burgos;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2021QIII;4.441
09 Burgos;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2021QII;""
09 Burgos;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2021QI;""
09 Burgos;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
09 Burgos;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2020QIII;4.408
09 Burgos;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2020QII;""
09 Burgos;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2020QI;""
09 Burgos;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2022QIV;4.310
09 Burgos;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
09 Burgos;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2022QII;""
09 Burgos;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2022QI;""
09 Burgos;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2021QIV;4.365
09 Burgos;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
09 Burgos;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2021QII;""
09 Burgos;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2021QI;""
09 Burgos;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2020QIV;4.349
09 Burgos;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
09 Burgos;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2020QII;""
09 Burgos;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2020QI;""
09 Burgos;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
09 Burgos;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
09 Burgos;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QII;""
09 Burgos;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QI;4.305
09 Burgos;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
09 Burgos;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
09 Burgos;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QII;""
09 Burgos;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QI;4.303
09 Burgos;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
09 Burgos;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
09 Burgos;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QII;""
09 Burgos;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QI;""
09 Burgos;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
09 Burgos;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
09 Burgos;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QII;4.252
09 Burgos;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QI;""
09 Burgos;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
09 Burgos;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
09 Burgos;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QII;4.253
09 Burgos;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QI;""
09 Burgos;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
09 Burgos;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
09 Burgos;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QII;""
09 Burgos;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QI;""
09 Burgos;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
09 Burgos;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
09 Burgos;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
09 Burgos;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
09 Burgos;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
09 Burgos;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
09 Burgos;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
09 Burgos;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
09 Burgos;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
09 Burgos;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
09 Burgos;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
09 Burgos;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
09 Burgos;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
09 Burgos;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;98,63
09 Burgos;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
09 Burgos;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
09 Burgos;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
09 Burgos;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;98,84
09 Burgos;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
09 Burgos;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
09 Burgos;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
09 Burgos;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;98,35
09 Burgos;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
09 Burgos;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
09 Burgos;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;96,96
09 Burgos;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
09 Burgos;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
09 Burgos;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
09 Burgos;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;97,15
09 Burgos;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
09 Burgos;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
09 Burgos;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
09 Burgos;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;97,03
09 Burgos;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
09 Burgos;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
09 Burgos;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
09 Burgos;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
09 Burgos;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
09 Burgos;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
09 Burgos;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;95,82
09 Burgos;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
09 Burgos;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
09 Burgos;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
09 Burgos;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;96,01
09 Burgos;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
09 Burgos;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
09 Burgos;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
09 Burgos;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
09 Burgos;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
09 Burgos;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
09 Burgos;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;94,64
09 Burgos;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
09 Burgos;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
09 Burgos;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
09 Burgos;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;94,89
09 Burgos;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
09 Burgos;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
09 Burgos;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
09 Burgos;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
09 Burgos;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
09 Burgos;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
09 Burgos;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QIII;2.606
09 Burgos;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
09 Burgos;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
09 Burgos;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
09 Burgos;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QIII;2.539
09 Burgos;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
09 Burgos;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
09 Burgos;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
09 Burgos;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QIII;2.540
09 Burgos;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
09 Burgos;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
09 Burgos;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
09 Burgos;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2022QIII;2.552
09 Burgos;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2022QII;""
09 Burgos;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2022QI;""
09 Burgos;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
09 Burgos;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2021QIII;2.502
09 Burgos;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2021QII;""
09 Burgos;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2021QI;""
09 Burgos;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
09 Burgos;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2020QIII;2.486
09 Burgos;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2020QII;""
09 Burgos;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2020QI;""
09 Burgos;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2022QIV;2.501
09 Burgos;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
09 Burgos;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2022QII;""
09 Burgos;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2022QI;""
09 Burgos;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2021QIV;2.442
09 Burgos;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
09 Burgos;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2021QII;""
09 Burgos;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2021QI;""
09 Burgos;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2020QIV;2.442
09 Burgos;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
09 Burgos;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2020QII;""
09 Burgos;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2020QI;""
09 Burgos;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
09 Burgos;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
09 Burgos;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QII;""
09 Burgos;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QI;2.408
09 Burgos;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
09 Burgos;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
09 Burgos;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QII;""
09 Burgos;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QI;2.409
09 Burgos;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
09 Burgos;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
09 Burgos;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QII;""
09 Burgos;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QI;""
09 Burgos;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
09 Burgos;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
09 Burgos;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QII;2.374
09 Burgos;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QI;""
09 Burgos;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
09 Burgos;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
09 Burgos;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QII;2.382
09 Burgos;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QI;""
09 Burgos;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
09 Burgos;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
09 Burgos;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QII;""
09 Burgos;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QI;""
09 Burgos;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
09 Burgos;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
09 Burgos;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
09 Burgos;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
09 Burgos;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
09 Burgos;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
09 Burgos;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
09 Burgos;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
09 Burgos;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
09 Burgos;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
09 Burgos;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
09 Burgos;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
09 Burgos;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
09 Burgos;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;97,93
09 Burgos;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
09 Burgos;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
09 Burgos;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
09 Burgos;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;98,54
09 Burgos;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
09 Burgos;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
09 Burgos;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
09 Burgos;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;97,87
09 Burgos;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
09 Burgos;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
09 Burgos;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;95,97
09 Burgos;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
09 Burgos;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
09 Burgos;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
09 Burgos;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;96,18
09 Burgos;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
09 Burgos;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
09 Burgos;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
09 Burgos;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;96,14
09 Burgos;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
09 Burgos;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
09 Burgos;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
09 Burgos;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
09 Burgos;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
09 Burgos;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
09 Burgos;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;94,84
09 Burgos;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
09 Burgos;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
09 Burgos;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
09 Burgos;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;94,84
09 Burgos;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
09 Burgos;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
09 Burgos;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
09 Burgos;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
09 Burgos;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
09 Burgos;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
09 Burgos;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;93,5
09 Burgos;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
09 Burgos;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
09 Burgos;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
09 Burgos;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;93,78
09 Burgos;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
09 Burgos;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
09 Burgos;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
09 Burgos;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
09 Burgos;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
09 Burgos;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QIV;7.020
09 Burgos;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
09 Burgos;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
09 Burgos;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
09 Burgos;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QIV;7.042
09 Burgos;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
09 Burgos;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
09 Burgos;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
09 Burgos;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QIV;6.995
09 Burgos;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
09 Burgos;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
09 Burgos;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
09 Burgos;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2022QIV;6.885
09 Burgos;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
09 Burgos;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2022QII;""
09 Burgos;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2022QI;""
09 Burgos;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2021QIV;6.894
09 Burgos;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
09 Burgos;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2021QII;""
09 Burgos;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2021QI;""
09 Burgos;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2020QIV;6.877
09 Burgos;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
09 Burgos;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2020QII;""
09 Burgos;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2020QI;""
09 Burgos;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
09 Burgos;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
09 Burgos;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2022QII;""
09 Burgos;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2022QI;6.796
09 Burgos;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
09 Burgos;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
09 Burgos;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2021QII;""
09 Burgos;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2021QI;6.795
09 Burgos;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
09 Burgos;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
09 Burgos;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2020QII;""
09 Burgos;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2020QI;""
09 Burgos;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
09 Burgos;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
09 Burgos;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QII;6.702
09 Burgos;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QI;""
09 Burgos;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
09 Burgos;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
09 Burgos;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QII;6.714
09 Burgos;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QI;""
09 Burgos;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
09 Burgos;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
09 Burgos;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QII;""
09 Burgos;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QI;""
09 Burgos;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
09 Burgos;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QIII;6.621
09 Burgos;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QII;""
09 Burgos;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QI;""
09 Burgos;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
09 Burgos;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QIII;6.652
09 Burgos;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QII;""
09 Burgos;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QI;""
09 Burgos;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
09 Burgos;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
09 Burgos;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QII;""
09 Burgos;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QI;""
09 Burgos;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
09 Burgos;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
09 Burgos;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
09 Burgos;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
09 Burgos;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
09 Burgos;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
09 Burgos;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
09 Burgos;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
09 Burgos;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
09 Burgos;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
09 Burgos;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
09 Burgos;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
09 Burgos;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;98,08
09 Burgos;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
09 Burgos;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
09 Burgos;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
09 Burgos;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;97,9
09 Burgos;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
09 Burgos;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
09 Burgos;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
09 Burgos;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;98,31
09 Burgos;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
09 Burgos;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
09 Burgos;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
09 Burgos;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
09 Burgos;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
09 Burgos;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
09 Burgos;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;96,51
09 Burgos;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
09 Burgos;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
09 Burgos;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
09 Burgos;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;97,14
09 Burgos;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
09 Burgos;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
09 Burgos;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
09 Burgos;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
09 Burgos;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
09 Burgos;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
09 Burgos;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;95,17
09 Burgos;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
09 Burgos;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
09 Burgos;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
09 Burgos;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;95,98
09 Burgos;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
09 Burgos;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
09 Burgos;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
09 Burgos;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
09 Burgos;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
09 Burgos;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
09 Burgos;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;94,02
09 Burgos;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
09 Burgos;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
09 Burgos;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
09 Burgos;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;95,1
09 Burgos;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
09 Burgos;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
09 Burgos;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
09 Burgos;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
09 Burgos;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
09 Burgos;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
09 Burgos;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QIV;4.432
09 Burgos;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
09 Burgos;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
09 Burgos;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
09 Burgos;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QIV;4.505
09 Burgos;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
09 Burgos;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
09 Burgos;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
09 Burgos;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QIV;4.471
09 Burgos;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
09 Burgos;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
09 Burgos;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
09 Burgos;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2022QIV;4.350
09 Burgos;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
09 Burgos;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2022QII;""
09 Burgos;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2022QI;""
09 Burgos;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2021QIV;4.419
09 Burgos;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
09 Burgos;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2021QII;""
09 Burgos;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2021QI;""
09 Burgos;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2020QIV;4.404
09 Burgos;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
09 Burgos;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2020QII;""
09 Burgos;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2020QI;""
09 Burgos;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
09 Burgos;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
09 Burgos;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2022QII;""
09 Burgos;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2022QI;4.355
09 Burgos;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
09 Burgos;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
09 Burgos;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2021QII;""
09 Burgos;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2021QI;4.357
09 Burgos;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
09 Burgos;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
09 Burgos;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2020QII;""
09 Burgos;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2020QI;""
09 Burgos;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
09 Burgos;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
09 Burgos;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QII;4.297
09 Burgos;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QI;""
09 Burgos;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
09 Burgos;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
09 Burgos;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QII;4.305
09 Burgos;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QI;""
09 Burgos;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
09 Burgos;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
09 Burgos;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QII;""
09 Burgos;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QI;""
09 Burgos;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
09 Burgos;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QIII;4.251
09 Burgos;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QII;""
09 Burgos;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QI;""
09 Burgos;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
09 Burgos;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QIII;4.269
09 Burgos;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QII;""
09 Burgos;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QI;""
09 Burgos;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
09 Burgos;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
09 Burgos;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QII;""
09 Burgos;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QI;""
09 Burgos;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
09 Burgos;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
09 Burgos;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
09 Burgos;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
09 Burgos;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
09 Burgos;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
09 Burgos;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
09 Burgos;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
09 Burgos;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
09 Burgos;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
09 Burgos;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
09 Burgos;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
09 Burgos;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;98,15
09 Burgos;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
09 Burgos;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
09 Burgos;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
09 Burgos;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;98,09
09 Burgos;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
09 Burgos;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
09 Burgos;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
09 Burgos;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;98,5
09 Burgos;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
09 Burgos;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
09 Burgos;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
09 Burgos;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
09 Burgos;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
09 Burgos;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
09 Burgos;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;96,67
09 Burgos;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
09 Burgos;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
09 Burgos;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
09 Burgos;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;97,45
09 Burgos;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
09 Burgos;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
09 Burgos;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
09 Burgos;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
09 Burgos;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
09 Burgos;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
09 Burgos;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;95,38
09 Burgos;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
09 Burgos;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
09 Burgos;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
09 Burgos;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;96,29
09 Burgos;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
09 Burgos;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
09 Burgos;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
09 Burgos;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
09 Burgos;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
09 Burgos;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
09 Burgos;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;94,36
09 Burgos;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
09 Burgos;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
09 Burgos;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
09 Burgos;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;95,48
09 Burgos;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
09 Burgos;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
09 Burgos;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
09 Burgos;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
09 Burgos;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
09 Burgos;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
09 Burgos;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QIV;2.588
09 Burgos;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
09 Burgos;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
09 Burgos;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
09 Burgos;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QIV;2.537
09 Burgos;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
09 Burgos;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
09 Burgos;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
09 Burgos;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QIV;2.524
09 Burgos;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
09 Burgos;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
09 Burgos;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
09 Burgos;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2022QIV;2.535
09 Burgos;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
09 Burgos;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2022QII;""
09 Burgos;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2022QI;""
09 Burgos;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2021QIV;2.475
09 Burgos;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
09 Burgos;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2021QII;""
09 Burgos;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2021QI;""
09 Burgos;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2020QIV;2.473
09 Burgos;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
09 Burgos;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2020QII;""
09 Burgos;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2020QI;""
09 Burgos;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
09 Burgos;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
09 Burgos;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2022QII;""
09 Burgos;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2022QI;2.441
09 Burgos;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
09 Burgos;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
09 Burgos;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2021QII;""
09 Burgos;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2021QI;2.438
09 Burgos;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
09 Burgos;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
09 Burgos;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2020QII;""
09 Burgos;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2020QI;""
09 Burgos;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
09 Burgos;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
09 Burgos;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QII;2.405
09 Burgos;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QI;""
09 Burgos;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
09 Burgos;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
09 Burgos;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QII;2.409
09 Burgos;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QI;""
09 Burgos;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
09 Burgos;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
09 Burgos;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QII;""
09 Burgos;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QI;""
09 Burgos;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
09 Burgos;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QIII;2.370
09 Burgos;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QII;""
09 Burgos;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QI;""
09 Burgos;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
09 Burgos;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QIII;2.383
09 Burgos;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QII;""
09 Burgos;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QI;""
09 Burgos;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
09 Burgos;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
09 Burgos;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QII;""
09 Burgos;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QI;""
09 Burgos;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
09 Burgos;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
09 Burgos;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
09 Burgos;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
09 Burgos;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
09 Burgos;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
09 Burgos;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
09 Burgos;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
09 Burgos;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
09 Burgos;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
09 Burgos;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
09 Burgos;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
09 Burgos;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;97,95
09 Burgos;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
09 Burgos;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
09 Burgos;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
09 Burgos;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;97,56
09 Burgos;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
09 Burgos;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
09 Burgos;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
09 Burgos;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;97,98
09 Burgos;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
09 Burgos;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
09 Burgos;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
09 Burgos;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
09 Burgos;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
09 Burgos;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
09 Burgos;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;96,22
09 Burgos;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
09 Burgos;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
09 Burgos;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
09 Burgos;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;96,59
09 Burgos;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
09 Burgos;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
09 Burgos;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
09 Burgos;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
09 Burgos;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
09 Burgos;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
09 Burgos;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;94,8
09 Burgos;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
09 Burgos;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
09 Burgos;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
09 Burgos;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;95,44
09 Burgos;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
09 Burgos;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
09 Burgos;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
09 Burgos;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
09 Burgos;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
09 Burgos;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
09 Burgos;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;93,42
09 Burgos;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
09 Burgos;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
09 Burgos;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
09 Burgos;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;94,41
09 Burgos;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
09 Burgos;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
09 Burgos;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
09 Burgos;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
09 Burgos;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
09 Burgos;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
09 Burgos;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
09 Burgos;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
09 Burgos;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
09 Burgos;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QI;3.962
09 Burgos;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
09 Burgos;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
09 Burgos;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
09 Burgos;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QI;3.814
09 Burgos;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
09 Burgos;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
09 Burgos;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
09 Burgos;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QI;4.407
09 Burgos;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
09 Burgos;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
09 Burgos;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2022QII;""
09 Burgos;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2022QI;3.820
09 Burgos;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
09 Burgos;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
09 Burgos;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2021QII;""
09 Burgos;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2021QI;3.698
09 Burgos;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
09 Burgos;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
09 Burgos;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2020QII;""
09 Burgos;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2020QI;4.142
09 Burgos;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
09 Burgos;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
09 Burgos;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2022QII;3.693
09 Burgos;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2022QI;""
09 Burgos;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
09 Burgos;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
09 Burgos;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2021QII;3.561
09 Burgos;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2021QI;""
09 Burgos;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
09 Burgos;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
09 Burgos;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2020QII;4.054
09 Burgos;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2020QI;""
09 Burgos;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
09 Burgos;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QIII;3.559
09 Burgos;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QII;""
09 Burgos;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QI;""
09 Burgos;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
09 Burgos;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QIII;3.420
09 Burgos;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QII;""
09 Burgos;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QI;""
09 Burgos;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
09 Burgos;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QIII;3.900
09 Burgos;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QII;""
09 Burgos;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QI;""
09 Burgos;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QIV;3.295
09 Burgos;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
09 Burgos;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QII;""
09 Burgos;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QI;""
09 Burgos;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QIV;3.219
09 Burgos;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
09 Burgos;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QII;""
09 Burgos;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QI;""
09 Burgos;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QIV;3.708
09 Burgos;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
09 Burgos;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QII;""
09 Burgos;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QI;""
09 Burgos;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
09 Burgos;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
09 Burgos;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
09 Burgos;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
09 Burgos;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
09 Burgos;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
09 Burgos;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
09 Burgos;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
09 Burgos;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
09 Burgos;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
09 Burgos;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
09 Burgos;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
09 Burgos;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
09 Burgos;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
09 Burgos;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
09 Burgos;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;96,42
09 Burgos;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
09 Burgos;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
09 Burgos;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
09 Burgos;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;96,96
09 Burgos;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
09 Burgos;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
09 Burgos;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
09 Burgos;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;93,99
09 Burgos;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
09 Burgos;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
09 Burgos;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;93,21
09 Burgos;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
09 Burgos;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
09 Burgos;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
09 Burgos;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;93,37
09 Burgos;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
09 Burgos;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
09 Burgos;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
09 Burgos;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;91,99
09 Burgos;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
09 Burgos;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
09 Burgos;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;89,83
09 Burgos;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
09 Burgos;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
09 Burgos;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
09 Burgos;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;89,67
09 Burgos;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
09 Burgos;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
09 Burgos;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
09 Burgos;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;88,5
09 Burgos;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
09 Burgos;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
09 Burgos;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;83,17
09 Burgos;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
09 Burgos;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
09 Burgos;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
09 Burgos;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;84,4
09 Burgos;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
09 Burgos;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
09 Burgos;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
09 Burgos;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;84,14
09 Burgos;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
09 Burgos;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
09 Burgos;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
09 Burgos;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
09 Burgos;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
09 Burgos;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
09 Burgos;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QI;2.640
09 Burgos;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
09 Burgos;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
09 Burgos;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
09 Burgos;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QI;2.569
09 Burgos;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
09 Burgos;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
09 Burgos;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
09 Burgos;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QI;2.957
09 Burgos;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
09 Burgos;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
09 Burgos;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2022QII;""
09 Burgos;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2022QI;2.544
09 Burgos;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
09 Burgos;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
09 Burgos;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2021QII;""
09 Burgos;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2021QI;2.487
09 Burgos;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
09 Burgos;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
09 Burgos;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2020QII;""
09 Burgos;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2020QI;2.783
09 Burgos;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
09 Burgos;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
09 Burgos;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2022QII;2.470
09 Burgos;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2022QI;""
09 Burgos;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
09 Burgos;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
09 Burgos;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2021QII;2.405
09 Burgos;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2021QI;""
09 Burgos;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
09 Burgos;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
09 Burgos;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2020QII;2.723
09 Burgos;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2020QI;""
09 Burgos;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
09 Burgos;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QIII;2.387
09 Burgos;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QII;""
09 Burgos;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QI;""
09 Burgos;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
09 Burgos;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QIII;2.304
09 Burgos;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QII;""
09 Burgos;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QI;""
09 Burgos;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
09 Burgos;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QIII;2.629
09 Burgos;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QII;""
09 Burgos;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QI;""
09 Burgos;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QIV;2.218
09 Burgos;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
09 Burgos;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QII;""
09 Burgos;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QI;""
09 Burgos;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QIV;2.170
09 Burgos;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
09 Burgos;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QII;""
09 Burgos;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QI;""
09 Burgos;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QIV;2.505
09 Burgos;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
09 Burgos;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QII;""
09 Burgos;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QI;""
09 Burgos;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
09 Burgos;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
09 Burgos;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
09 Burgos;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
09 Burgos;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
09 Burgos;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
09 Burgos;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
09 Burgos;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
09 Burgos;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
09 Burgos;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
09 Burgos;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
09 Burgos;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
09 Burgos;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
09 Burgos;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
09 Burgos;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
09 Burgos;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;96,36
09 Burgos;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
09 Burgos;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
09 Burgos;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
09 Burgos;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;96,81
09 Burgos;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
09 Burgos;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
09 Burgos;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
09 Burgos;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;94,12
09 Burgos;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
09 Burgos;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
09 Burgos;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;93,56
09 Burgos;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
09 Burgos;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
09 Burgos;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
09 Burgos;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;93,62
09 Burgos;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
09 Burgos;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
09 Burgos;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
09 Burgos;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;92,09
09 Burgos;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
09 Burgos;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
09 Burgos;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;90,42
09 Burgos;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
09 Burgos;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
09 Burgos;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
09 Burgos;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;89,68
09 Burgos;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
09 Burgos;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
09 Burgos;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
09 Burgos;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;88,91
09 Burgos;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
09 Burgos;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
09 Burgos;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;84,02
09 Burgos;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
09 Burgos;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
09 Burgos;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
09 Burgos;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;84,47
09 Burgos;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
09 Burgos;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
09 Burgos;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
09 Burgos;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;84,71
09 Burgos;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
09 Burgos;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
09 Burgos;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
09 Burgos;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
09 Burgos;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
09 Burgos;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
09 Burgos;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QI;1.322
09 Burgos;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
09 Burgos;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
09 Burgos;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
09 Burgos;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QI;1.245
09 Burgos;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
09 Burgos;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
09 Burgos;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
09 Burgos;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QI;1.450
09 Burgos;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
09 Burgos;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
09 Burgos;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2022QII;""
09 Burgos;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2022QI;1.276
09 Burgos;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
09 Burgos;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
09 Burgos;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2021QII;""
09 Burgos;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2021QI;1.211
09 Burgos;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
09 Burgos;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
09 Burgos;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2020QII;""
09 Burgos;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2020QI;1.359
09 Burgos;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
09 Burgos;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
09 Burgos;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2022QII;1.223
09 Burgos;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2022QI;""
09 Burgos;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
09 Burgos;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
09 Burgos;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2021QII;1.156
09 Burgos;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2021QI;""
09 Burgos;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
09 Burgos;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
09 Burgos;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2020QII;1.331
09 Burgos;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2020QI;""
09 Burgos;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
09 Burgos;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QIII;1.172
09 Burgos;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QII;""
09 Burgos;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QI;""
09 Burgos;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
09 Burgos;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QIII;1.116
09 Burgos;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QII;""
09 Burgos;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QI;""
09 Burgos;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
09 Burgos;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QIII;1.271
09 Burgos;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QII;""
09 Burgos;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QI;""
09 Burgos;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QIV;1.077
09 Burgos;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
09 Burgos;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QII;""
09 Burgos;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QI;""
09 Burgos;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QIV;1.049
09 Burgos;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
09 Burgos;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QII;""
09 Burgos;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QI;""
09 Burgos;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QIV;1.203
09 Burgos;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
09 Burgos;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QII;""
09 Burgos;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QI;""
09 Burgos;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
09 Burgos;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
09 Burgos;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
09 Burgos;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
09 Burgos;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
09 Burgos;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
09 Burgos;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
09 Burgos;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
09 Burgos;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
09 Burgos;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
09 Burgos;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
09 Burgos;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
09 Burgos;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
09 Burgos;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
09 Burgos;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
09 Burgos;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;96,52
09 Burgos;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
09 Burgos;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
09 Burgos;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
09 Burgos;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;97,27
09 Burgos;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
09 Burgos;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
09 Burgos;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
09 Burgos;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;93,72
09 Burgos;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
09 Burgos;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
09 Burgos;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;92,51
09 Burgos;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
09 Burgos;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
09 Burgos;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
09 Burgos;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;92,85
09 Burgos;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
09 Burgos;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
09 Burgos;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
09 Burgos;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;91,79
09 Burgos;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
09 Burgos;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
09 Burgos;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;88,65
09 Burgos;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
09 Burgos;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
09 Burgos;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
09 Burgos;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;89,64
09 Burgos;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
09 Burgos;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
09 Burgos;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
09 Burgos;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;87,66
09 Burgos;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
09 Burgos;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
09 Burgos;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;81,47
09 Burgos;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
09 Burgos;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
09 Burgos;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
09 Burgos;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;84,26
09 Burgos;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
09 Burgos;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
09 Burgos;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
09 Burgos;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;82,97
09 Burgos;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
09 Burgos;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
09 Burgos;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
09 Burgos;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
09 Burgos;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
09 Burgos;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QII;4.502
09 Burgos;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
09 Burgos;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
09 Burgos;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
09 Burgos;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QII;4.387
09 Burgos;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
09 Burgos;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
09 Burgos;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
09 Burgos;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QII;4.213
09 Burgos;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
09 Burgos;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
09 Burgos;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
09 Burgos;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2022QII;4.357
09 Burgos;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2022QI;""
09 Burgos;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
09 Burgos;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
09 Burgos;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2021QII;4.237
09 Burgos;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2021QI;""
09 Burgos;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
09 Burgos;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
09 Burgos;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2020QII;4.123
09 Burgos;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2020QI;""
09 Burgos;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
09 Burgos;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2022QIII;4.214
09 Burgos;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2022QII;""
09 Burgos;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2022QI;""
09 Burgos;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
09 Burgos;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2021QIII;4.090
09 Burgos;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2021QII;""
09 Burgos;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2021QI;""
09 Burgos;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
09 Burgos;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2020QIII;3.945
09 Burgos;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2020QII;""
09 Burgos;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2020QI;""
09 Burgos;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QIV;3.935
09 Burgos;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
09 Burgos;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QII;""
09 Burgos;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QI;""
09 Burgos;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QIV;3.878
09 Burgos;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
09 Burgos;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QII;""
09 Burgos;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QI;""
09 Burgos;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QIV;3.747
09 Burgos;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
09 Burgos;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QII;""
09 Burgos;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QI;""
09 Burgos;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
09 Burgos;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
09 Burgos;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QII;""
09 Burgos;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QI;3.750
09 Burgos;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
09 Burgos;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
09 Burgos;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QII;""
09 Burgos;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QI;3.639
09 Burgos;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
09 Burgos;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
09 Burgos;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QII;""
09 Burgos;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QI;""
09 Burgos;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
09 Burgos;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
09 Burgos;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
09 Burgos;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
09 Burgos;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
09 Burgos;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
09 Burgos;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
09 Burgos;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
09 Burgos;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
09 Burgos;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
09 Burgos;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
09 Burgos;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
09 Burgos;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
09 Burgos;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
09 Burgos;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;96,78
09 Burgos;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
09 Burgos;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
09 Burgos;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
09 Burgos;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;96,58
09 Burgos;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
09 Burgos;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
09 Burgos;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
09 Burgos;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;97,86
09 Burgos;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
09 Burgos;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
09 Burgos;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;93,6
09 Burgos;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
09 Burgos;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
09 Burgos;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
09 Burgos;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;93,23
09 Burgos;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
09 Burgos;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
09 Burgos;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
09 Burgos;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;93,64
09 Burgos;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
09 Burgos;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
09 Burgos;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;87,41
09 Burgos;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
09 Burgos;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
09 Burgos;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
09 Burgos;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;88,4
09 Burgos;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
09 Burgos;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
09 Burgos;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
09 Burgos;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;88,94
09 Burgos;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
09 Burgos;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
09 Burgos;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
09 Burgos;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
09 Burgos;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
09 Burgos;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
09 Burgos;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;85,48
09 Burgos;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
09 Burgos;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
09 Burgos;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
09 Burgos;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;86,38
09 Burgos;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
09 Burgos;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
09 Burgos;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
09 Burgos;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
09 Burgos;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
09 Burgos;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
09 Burgos;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QII;2.984
09 Burgos;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
09 Burgos;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
09 Burgos;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
09 Burgos;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QII;2.931
09 Burgos;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
09 Burgos;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
09 Burgos;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
09 Burgos;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QII;2.823
09 Burgos;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
09 Burgos;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
09 Burgos;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
09 Burgos;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2022QII;2.899
09 Burgos;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2022QI;""
09 Burgos;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
09 Burgos;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
09 Burgos;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2021QII;2.842
09 Burgos;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2021QI;""
09 Burgos;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
09 Burgos;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
09 Burgos;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2020QII;2.763
09 Burgos;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2020QI;""
09 Burgos;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
09 Burgos;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2022QIII;2.810
09 Burgos;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2022QII;""
09 Burgos;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2022QI;""
09 Burgos;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
09 Burgos;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2021QIII;2.738
09 Burgos;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2021QII;""
09 Burgos;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2021QI;""
09 Burgos;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
09 Burgos;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2020QIII;2.652
09 Burgos;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2020QII;""
09 Burgos;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2020QI;""
09 Burgos;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QIV;2.633
09 Burgos;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
09 Burgos;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QII;""
09 Burgos;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QI;""
09 Burgos;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QIV;2.599
09 Burgos;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
09 Burgos;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QII;""
09 Burgos;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QI;""
09 Burgos;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QIV;2.526
09 Burgos;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
09 Burgos;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QII;""
09 Burgos;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QI;""
09 Burgos;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
09 Burgos;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
09 Burgos;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QII;""
09 Burgos;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QI;2.510
09 Burgos;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
09 Burgos;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
09 Burgos;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QII;""
09 Burgos;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QI;2.450
09 Burgos;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
09 Burgos;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
09 Burgos;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QII;""
09 Burgos;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QI;""
09 Burgos;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
09 Burgos;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
09 Burgos;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
09 Burgos;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
09 Burgos;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
09 Burgos;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
09 Burgos;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
09 Burgos;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
09 Burgos;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
09 Burgos;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
09 Burgos;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
09 Burgos;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
09 Burgos;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
09 Burgos;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
09 Burgos;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;97,15
09 Burgos;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
09 Burgos;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
09 Burgos;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
09 Burgos;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;96,96
09 Burgos;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
09 Burgos;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
09 Burgos;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
09 Burgos;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;97,87
09 Burgos;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
09 Burgos;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
09 Burgos;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;94,17
09 Burgos;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
09 Burgos;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
09 Burgos;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
09 Burgos;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;93,42
09 Burgos;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
09 Burgos;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
09 Burgos;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
09 Burgos;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;93,94
09 Burgos;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
09 Burgos;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
09 Burgos;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;88,24
09 Burgos;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
09 Burgos;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
09 Burgos;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
09 Burgos;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;88,67
09 Burgos;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
09 Burgos;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
09 Burgos;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
09 Burgos;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;89,48
09 Burgos;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
09 Burgos;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
09 Burgos;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
09 Burgos;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
09 Burgos;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
09 Burgos;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
09 Burgos;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;85,64
09 Burgos;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
09 Burgos;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
09 Burgos;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
09 Burgos;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;86,79
09 Burgos;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
09 Burgos;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
09 Burgos;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
09 Burgos;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
09 Burgos;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
09 Burgos;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
09 Burgos;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QII;1.518
09 Burgos;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
09 Burgos;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
09 Burgos;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
09 Burgos;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QII;1.456
09 Burgos;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
09 Burgos;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
09 Burgos;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
09 Burgos;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QII;1.390
09 Burgos;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
09 Burgos;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
09 Burgos;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
09 Burgos;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2022QII;1.458
09 Burgos;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2022QI;""
09 Burgos;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
09 Burgos;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
09 Burgos;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2021QII;1.395
09 Burgos;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2021QI;""
09 Burgos;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
09 Burgos;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
09 Burgos;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2020QII;1.360
09 Burgos;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2020QI;""
09 Burgos;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
09 Burgos;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2022QIII;1.404
09 Burgos;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2022QII;""
09 Burgos;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2022QI;""
09 Burgos;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
09 Burgos;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2021QIII;1.352
09 Burgos;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2021QII;""
09 Burgos;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2021QI;""
09 Burgos;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
09 Burgos;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2020QIII;1.293
09 Burgos;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2020QII;""
09 Burgos;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2020QI;""
09 Burgos;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QIV;1.302
09 Burgos;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
09 Burgos;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QII;""
09 Burgos;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QI;""
09 Burgos;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QIV;1.279
09 Burgos;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
09 Burgos;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QII;""
09 Burgos;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QI;""
09 Burgos;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QIV;1.221
09 Burgos;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
09 Burgos;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QII;""
09 Burgos;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QI;""
09 Burgos;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
09 Burgos;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
09 Burgos;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QII;""
09 Burgos;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QI;1.240
09 Burgos;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
09 Burgos;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
09 Burgos;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QII;""
09 Burgos;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QI;1.189
09 Burgos;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
09 Burgos;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
09 Burgos;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QII;""
09 Burgos;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QI;""
09 Burgos;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
09 Burgos;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
09 Burgos;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
09 Burgos;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
09 Burgos;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
09 Burgos;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
09 Burgos;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
09 Burgos;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
09 Burgos;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
09 Burgos;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
09 Burgos;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
09 Burgos;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
09 Burgos;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
09 Burgos;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
09 Burgos;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;96,05
09 Burgos;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
09 Burgos;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
09 Burgos;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
09 Burgos;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;95,81
09 Burgos;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
09 Burgos;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
09 Burgos;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
09 Burgos;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;97,84
09 Burgos;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
09 Burgos;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
09 Burgos;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;92,49
09 Burgos;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
09 Burgos;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
09 Burgos;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
09 Burgos;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;92,86
09 Burgos;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
09 Burgos;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
09 Burgos;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
09 Burgos;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;93,02
09 Burgos;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
09 Burgos;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
09 Burgos;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;85,77
09 Burgos;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
09 Burgos;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
09 Burgos;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
09 Burgos;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;87,84
09 Burgos;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
09 Burgos;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
09 Burgos;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
09 Burgos;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;87,84
09 Burgos;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
09 Burgos;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
09 Burgos;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
09 Burgos;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
09 Burgos;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
09 Burgos;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
09 Burgos;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;85,16
09 Burgos;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
09 Burgos;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
09 Burgos;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
09 Burgos;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;85,54
09 Burgos;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
09 Burgos;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
09 Burgos;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
09 Burgos;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
09 Burgos;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
09 Burgos;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QIII;4.395
09 Burgos;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
09 Burgos;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
09 Burgos;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
09 Burgos;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QIII;4.266
09 Burgos;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
09 Burgos;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
09 Burgos;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
09 Burgos;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QIII;4.150
09 Burgos;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
09 Burgos;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
09 Burgos;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
09 Burgos;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2022QIII;4.243
09 Burgos;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2022QII;""
09 Burgos;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2022QI;""
09 Burgos;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
09 Burgos;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2021QIII;4.113
09 Burgos;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2021QII;""
09 Burgos;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2021QI;""
09 Burgos;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
09 Burgos;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2020QIII;3.966
09 Burgos;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2020QII;""
09 Burgos;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2020QI;""
09 Burgos;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2022QIV;3.958
09 Burgos;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
09 Burgos;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2022QII;""
09 Burgos;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2022QI;""
09 Burgos;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2021QIV;3.899
09 Burgos;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
09 Burgos;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2021QII;""
09 Burgos;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2021QI;""
09 Burgos;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2020QIV;3.764
09 Burgos;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
09 Burgos;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2020QII;""
09 Burgos;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2020QI;""
09 Burgos;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
09 Burgos;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
09 Burgos;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QII;""
09 Burgos;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QI;3.767
09 Burgos;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
09 Burgos;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
09 Burgos;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QII;""
09 Burgos;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QI;3.656
09 Burgos;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
09 Burgos;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
09 Burgos;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QII;""
09 Burgos;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QI;""
09 Burgos;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
09 Burgos;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
09 Burgos;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QII;3.649
09 Burgos;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QI;""
09 Burgos;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
09 Burgos;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
09 Burgos;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QII;3.525
09 Burgos;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QI;""
09 Burgos;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
09 Burgos;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
09 Burgos;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QII;""
09 Burgos;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QI;""
09 Burgos;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
09 Burgos;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
09 Burgos;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
09 Burgos;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
09 Burgos;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
09 Burgos;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
09 Burgos;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
09 Burgos;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
09 Burgos;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
09 Burgos;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
09 Burgos;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
09 Burgos;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
09 Burgos;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
09 Burgos;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;96,54
09 Burgos;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
09 Burgos;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
09 Burgos;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
09 Burgos;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;96,41
09 Burgos;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
09 Burgos;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
09 Burgos;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
09 Burgos;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;95,57
09 Burgos;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
09 Burgos;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
09 Burgos;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;90,06
09 Burgos;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
09 Burgos;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
09 Burgos;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
09 Burgos;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;91,4
09 Burgos;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
09 Burgos;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
09 Burgos;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
09 Burgos;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;90,7
09 Burgos;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
09 Burgos;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
09 Burgos;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
09 Burgos;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
09 Burgos;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
09 Burgos;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
09 Burgos;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;88,3
09 Burgos;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
09 Burgos;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
09 Burgos;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
09 Burgos;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;88,1
09 Burgos;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
09 Burgos;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
09 Burgos;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
09 Burgos;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
09 Burgos;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
09 Burgos;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
09 Burgos;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;85,54
09 Burgos;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
09 Burgos;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
09 Burgos;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
09 Burgos;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;84,94
09 Burgos;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
09 Burgos;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
09 Burgos;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
09 Burgos;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
09 Burgos;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
09 Burgos;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
09 Burgos;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QIII;2.922
09 Burgos;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
09 Burgos;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
09 Burgos;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
09 Burgos;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QIII;2.856
09 Burgos;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
09 Burgos;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
09 Burgos;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
09 Burgos;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QIII;2.779
09 Burgos;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
09 Burgos;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
09 Burgos;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
09 Burgos;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2022QIII;2.827
09 Burgos;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2022QII;""
09 Burgos;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2022QI;""
09 Burgos;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
09 Burgos;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2021QIII;2.749
09 Burgos;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2021QII;""
09 Burgos;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2021QI;""
09 Burgos;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
09 Burgos;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2020QIII;2.664
09 Burgos;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2020QII;""
09 Burgos;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2020QI;""
09 Burgos;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2022QIV;2.647
09 Burgos;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
09 Burgos;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2022QII;""
09 Burgos;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2022QI;""
09 Burgos;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2021QIV;2.608
09 Burgos;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
09 Burgos;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2021QII;""
09 Burgos;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2021QI;""
09 Burgos;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2020QIV;2.534
09 Burgos;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
09 Burgos;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2020QII;""
09 Burgos;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2020QI;""
09 Burgos;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
09 Burgos;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
09 Burgos;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QII;""
09 Burgos;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QI;2.518
09 Burgos;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
09 Burgos;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
09 Burgos;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QII;""
09 Burgos;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QI;2.458
09 Burgos;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
09 Burgos;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
09 Burgos;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QII;""
09 Burgos;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QI;""
09 Burgos;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
09 Burgos;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
09 Burgos;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QII;2.446
09 Burgos;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QI;""
09 Burgos;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
09 Burgos;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
09 Burgos;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QII;2.378
09 Burgos;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QI;""
09 Burgos;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
09 Burgos;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
09 Burgos;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QII;""
09 Burgos;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QI;""
09 Burgos;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
09 Burgos;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
09 Burgos;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
09 Burgos;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
09 Burgos;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
09 Burgos;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
09 Burgos;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
09 Burgos;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
09 Burgos;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
09 Burgos;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
09 Burgos;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
09 Burgos;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
09 Burgos;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
09 Burgos;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;96,75
09 Burgos;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
09 Burgos;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
09 Burgos;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
09 Burgos;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;96,25
09 Burgos;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
09 Burgos;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
09 Burgos;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
09 Burgos;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;95,86
09 Burgos;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
09 Burgos;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
09 Burgos;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;90,59
09 Burgos;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
09 Burgos;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
09 Burgos;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
09 Burgos;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;91,32
09 Burgos;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
09 Burgos;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
09 Burgos;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
09 Burgos;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;91,18
09 Burgos;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
09 Burgos;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
09 Burgos;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
09 Burgos;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
09 Burgos;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
09 Burgos;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
09 Burgos;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;88,17
09 Burgos;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
09 Burgos;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
09 Burgos;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
09 Burgos;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;88,45
09 Burgos;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
09 Burgos;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
09 Burgos;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
09 Burgos;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
09 Burgos;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
09 Burgos;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
09 Burgos;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;85,64
09 Burgos;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
09 Burgos;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
09 Burgos;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
09 Burgos;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;85,57
09 Burgos;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
09 Burgos;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
09 Burgos;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
09 Burgos;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
09 Burgos;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
09 Burgos;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
09 Burgos;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QIII;1.473
09 Burgos;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
09 Burgos;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
09 Burgos;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
09 Burgos;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QIII;1.410
09 Burgos;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
09 Burgos;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
09 Burgos;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
09 Burgos;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QIII;1.371
09 Burgos;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
09 Burgos;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
09 Burgos;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
09 Burgos;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2022QIII;1.416
09 Burgos;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2022QII;""
09 Burgos;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2022QI;""
09 Burgos;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
09 Burgos;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2021QIII;1.364
09 Burgos;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2021QII;""
09 Burgos;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2021QI;""
09 Burgos;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
09 Burgos;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2020QIII;1.302
09 Burgos;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2020QII;""
09 Burgos;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2020QI;""
09 Burgos;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2022QIV;1.311
09 Burgos;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
09 Burgos;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2022QII;""
09 Burgos;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2022QI;""
09 Burgos;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2021QIV;1.291
09 Burgos;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
09 Burgos;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2021QII;""
09 Burgos;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2021QI;""
09 Burgos;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2020QIV;1.230
09 Burgos;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
09 Burgos;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2020QII;""
09 Burgos;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2020QI;""
09 Burgos;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
09 Burgos;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
09 Burgos;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QII;""
09 Burgos;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QI;1.249
09 Burgos;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
09 Burgos;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
09 Burgos;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QII;""
09 Burgos;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QI;1.198
09 Burgos;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
09 Burgos;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
09 Burgos;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QII;""
09 Burgos;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QI;""
09 Burgos;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
09 Burgos;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
09 Burgos;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QII;1.203
09 Burgos;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QI;""
09 Burgos;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
09 Burgos;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
09 Burgos;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QII;1.147
09 Burgos;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QI;""
09 Burgos;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
09 Burgos;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
09 Burgos;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QII;""
09 Burgos;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QI;""
09 Burgos;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
09 Burgos;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
09 Burgos;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
09 Burgos;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
09 Burgos;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
09 Burgos;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
09 Burgos;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
09 Burgos;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
09 Burgos;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
09 Burgos;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
09 Burgos;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
09 Burgos;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
09 Burgos;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
09 Burgos;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;96,13
09 Burgos;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
09 Burgos;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
09 Burgos;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
09 Burgos;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;96,74
09 Burgos;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
09 Burgos;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
09 Burgos;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
09 Burgos;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;94,97
09 Burgos;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
09 Burgos;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
09 Burgos;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;89
09 Burgos;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
09 Burgos;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
09 Burgos;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
09 Burgos;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;91,56
09 Burgos;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
09 Burgos;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
09 Burgos;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
09 Burgos;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;89,72
09 Burgos;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
09 Burgos;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
09 Burgos;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
09 Burgos;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
09 Burgos;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
09 Burgos;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
09 Burgos;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;88,58
09 Burgos;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
09 Burgos;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
09 Burgos;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
09 Burgos;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;87,38
09 Burgos;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
09 Burgos;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
09 Burgos;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
09 Burgos;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
09 Burgos;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
09 Burgos;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
09 Burgos;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;85,32
09 Burgos;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
09 Burgos;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
09 Burgos;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
09 Burgos;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;83,66
09 Burgos;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
09 Burgos;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
09 Burgos;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
09 Burgos;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
09 Burgos;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
09 Burgos;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QIV;4.269
09 Burgos;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
09 Burgos;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
09 Burgos;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
09 Burgos;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QIV;4.148
09 Burgos;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
09 Burgos;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
09 Burgos;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
09 Burgos;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QIV;4.002
09 Burgos;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
09 Burgos;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
09 Burgos;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
09 Burgos;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2022QIV;3.978
09 Burgos;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
09 Burgos;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2022QII;""
09 Burgos;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2022QI;""
09 Burgos;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2021QIV;3.927
09 Burgos;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
09 Burgos;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2021QII;""
09 Burgos;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2021QI;""
09 Burgos;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2020QIV;3.792
09 Burgos;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
09 Burgos;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2020QII;""
09 Burgos;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2020QI;""
09 Burgos;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
09 Burgos;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
09 Burgos;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2022QII;""
09 Burgos;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2022QI;3.790
09 Burgos;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
09 Burgos;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
09 Burgos;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2021QII;""
09 Burgos;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2021QI;3.680
09 Burgos;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
09 Burgos;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
09 Burgos;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2020QII;""
09 Burgos;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2020QI;""
09 Burgos;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
09 Burgos;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
09 Burgos;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QII;3.669
09 Burgos;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QI;""
09 Burgos;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
09 Burgos;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
09 Burgos;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QII;3.547
09 Burgos;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QI;""
09 Burgos;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
09 Burgos;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
09 Burgos;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QII;""
09 Burgos;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QI;""
09 Burgos;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
09 Burgos;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QIII;3.537
09 Burgos;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QII;""
09 Burgos;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QI;""
09 Burgos;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
09 Burgos;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QIII;3.409
09 Burgos;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QII;""
09 Burgos;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QI;""
09 Burgos;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
09 Burgos;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
09 Burgos;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QII;""
09 Burgos;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QI;""
09 Burgos;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
09 Burgos;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
09 Burgos;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
09 Burgos;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
09 Burgos;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
09 Burgos;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
09 Burgos;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
09 Burgos;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
09 Burgos;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
09 Burgos;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
09 Burgos;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
09 Burgos;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
09 Burgos;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;93,18
09 Burgos;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
09 Burgos;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
09 Burgos;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
09 Burgos;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;94,67
09 Burgos;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
09 Burgos;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
09 Burgos;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
09 Burgos;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;94,75
09 Burgos;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
09 Burgos;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
09 Burgos;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
09 Burgos;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
09 Burgos;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
09 Burgos;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
09 Burgos;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;91,37
09 Burgos;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
09 Burgos;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
09 Burgos;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
09 Burgos;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;91,95
09 Burgos;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
09 Burgos;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
09 Burgos;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
09 Burgos;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
09 Burgos;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
09 Burgos;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
09 Burgos;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;88,45
09 Burgos;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
09 Burgos;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
09 Burgos;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
09 Burgos;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;88,63
09 Burgos;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
09 Burgos;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
09 Burgos;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
09 Burgos;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
09 Burgos;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
09 Burgos;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
09 Burgos;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;85,27
09 Burgos;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
09 Burgos;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
09 Burgos;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
09 Burgos;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;85,18
09 Burgos;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
09 Burgos;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
09 Burgos;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
09 Burgos;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
09 Burgos;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
09 Burgos;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
09 Burgos;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QIV;2.843
09 Burgos;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
09 Burgos;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
09 Burgos;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
09 Burgos;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QIV;2.770
09 Burgos;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
09 Burgos;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
09 Burgos;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
09 Burgos;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QIV;2.692
09 Burgos;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
09 Burgos;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
09 Burgos;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
09 Burgos;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2022QIV;2.658
09 Burgos;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
09 Burgos;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2022QII;""
09 Burgos;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2022QI;""
09 Burgos;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2021QIV;2.623
09 Burgos;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
09 Burgos;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2021QII;""
09 Burgos;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2021QI;""
09 Burgos;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2020QIV;2.556
09 Burgos;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
09 Burgos;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2020QII;""
09 Burgos;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2020QI;""
09 Burgos;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
09 Burgos;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
09 Burgos;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2022QII;""
09 Burgos;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2022QI;2.530
09 Burgos;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
09 Burgos;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
09 Burgos;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2021QII;""
09 Burgos;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2021QI;2.477
09 Burgos;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
09 Burgos;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
09 Burgos;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2020QII;""
09 Burgos;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2020QI;""
09 Burgos;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
09 Burgos;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
09 Burgos;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QII;2.458
09 Burgos;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QI;""
09 Burgos;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
09 Burgos;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
09 Burgos;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QII;2.395
09 Burgos;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QI;""
09 Burgos;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
09 Burgos;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
09 Burgos;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QII;""
09 Burgos;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QI;""
09 Burgos;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
09 Burgos;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QIII;2.376
09 Burgos;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QII;""
09 Burgos;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QI;""
09 Burgos;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
09 Burgos;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QIII;2.295
09 Burgos;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QII;""
09 Burgos;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QI;""
09 Burgos;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
09 Burgos;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
09 Burgos;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QII;""
09 Burgos;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QI;""
09 Burgos;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
09 Burgos;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
09 Burgos;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
09 Burgos;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
09 Burgos;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
09 Burgos;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
09 Burgos;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
09 Burgos;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
09 Burgos;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
09 Burgos;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
09 Burgos;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
09 Burgos;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
09 Burgos;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;93,49
09 Burgos;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
09 Burgos;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
09 Burgos;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
09 Burgos;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;94,69
09 Burgos;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
09 Burgos;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
09 Burgos;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
09 Burgos;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;94,95
09 Burgos;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
09 Burgos;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
09 Burgos;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
09 Burgos;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
09 Burgos;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
09 Burgos;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
09 Burgos;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;91,34
09 Burgos;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
09 Burgos;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
09 Burgos;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
09 Burgos;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;92,01
09 Burgos;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
09 Burgos;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
09 Burgos;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
09 Burgos;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
09 Burgos;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
09 Burgos;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
09 Burgos;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;88,74
09 Burgos;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
09 Burgos;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
09 Burgos;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
09 Burgos;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;88,97
09 Burgos;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
09 Burgos;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
09 Burgos;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
09 Burgos;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
09 Burgos;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
09 Burgos;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
09 Burgos;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;85,78
09 Burgos;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
09 Burgos;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
09 Burgos;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
09 Burgos;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;85,25
09 Burgos;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
09 Burgos;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
09 Burgos;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
09 Burgos;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
09 Burgos;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
09 Burgos;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
09 Burgos;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QIV;1.426
09 Burgos;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
09 Burgos;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
09 Burgos;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
09 Burgos;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QIV;1.378
09 Burgos;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
09 Burgos;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
09 Burgos;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
09 Burgos;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QIV;1.310
09 Burgos;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
09 Burgos;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
09 Burgos;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
09 Burgos;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2022QIV;1.320
09 Burgos;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
09 Burgos;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2022QII;""
09 Burgos;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2022QI;""
09 Burgos;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2021QIV;1.304
09 Burgos;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
09 Burgos;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2021QII;""
09 Burgos;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2021QI;""
09 Burgos;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2020QIV;1.236
09 Burgos;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
09 Burgos;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2020QII;""
09 Burgos;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2020QI;""
09 Burgos;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
09 Burgos;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
09 Burgos;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2022QII;""
09 Burgos;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2022QI;1.260
09 Burgos;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
09 Burgos;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
09 Burgos;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2021QII;""
09 Burgos;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2021QI;1.203
09 Burgos;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
09 Burgos;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
09 Burgos;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2020QII;""
09 Burgos;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2020QI;""
09 Burgos;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
09 Burgos;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
09 Burgos;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QII;1.211
09 Burgos;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QI;""
09 Burgos;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
09 Burgos;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
09 Burgos;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QII;1.152
09 Burgos;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QI;""
09 Burgos;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
09 Burgos;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
09 Burgos;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QII;""
09 Burgos;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QI;""
09 Burgos;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
09 Burgos;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QIII;1.161
09 Burgos;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QII;""
09 Burgos;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QI;""
09 Burgos;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
09 Burgos;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QIII;1.114
09 Burgos;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QII;""
09 Burgos;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QI;""
09 Burgos;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
09 Burgos;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
09 Burgos;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QII;""
09 Burgos;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QI;""
09 Burgos;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
09 Burgos;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
09 Burgos;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
09 Burgos;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
09 Burgos;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
09 Burgos;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
09 Burgos;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
09 Burgos;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
09 Burgos;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
09 Burgos;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
09 Burgos;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
09 Burgos;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
09 Burgos;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;92,57
09 Burgos;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
09 Burgos;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
09 Burgos;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
09 Burgos;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;94,63
09 Burgos;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
09 Burgos;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
09 Burgos;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
09 Burgos;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;94,35
09 Burgos;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
09 Burgos;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
09 Burgos;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
09 Burgos;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
09 Burgos;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
09 Burgos;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
09 Burgos;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;91,44
09 Burgos;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
09 Burgos;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
09 Burgos;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
09 Burgos;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;91,83
09 Burgos;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
09 Burgos;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
09 Burgos;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
09 Burgos;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
09 Burgos;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
09 Burgos;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
09 Burgos;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;87,88
09 Burgos;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
09 Burgos;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
09 Burgos;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
09 Burgos;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;87,94
09 Burgos;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
09 Burgos;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
09 Burgos;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
09 Burgos;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
09 Burgos;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
09 Burgos;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
09 Burgos;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;84,25
09 Burgos;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
09 Burgos;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
09 Burgos;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
09 Burgos;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;85,04
09 Burgos;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
09 Burgos;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
09 Burgos;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
09 Burgos;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
09 Burgos;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
09 Burgos;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
10 Cáceres;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
10 Cáceres;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
10 Cáceres;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
10 Cáceres;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QI;24.788
10 Cáceres;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
10 Cáceres;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
10 Cáceres;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
10 Cáceres;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QI;24.502
10 Cáceres;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
10 Cáceres;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
10 Cáceres;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
10 Cáceres;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QI;24.977
10 Cáceres;All ages;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
10 Cáceres;All ages;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
10 Cáceres;All ages;Cohort January 1;Total;Survival in the first trimester;2022QII;""
10 Cáceres;All ages;Cohort January 1;Total;Survival in the first trimester;2022QI;23.992
10 Cáceres;All ages;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
10 Cáceres;All ages;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
10 Cáceres;All ages;Cohort January 1;Total;Survival in the first trimester;2021QII;""
10 Cáceres;All ages;Cohort January 1;Total;Survival in the first trimester;2021QI;23.905
10 Cáceres;All ages;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
10 Cáceres;All ages;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
10 Cáceres;All ages;Cohort January 1;Total;Survival in the first trimester;2020QII;""
10 Cáceres;All ages;Cohort January 1;Total;Survival in the first trimester;2020QI;23.602
10 Cáceres;All ages;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
10 Cáceres;All ages;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
10 Cáceres;All ages;Cohort January 1;Total;Survival in the second trimester;2022QII;23.249
10 Cáceres;All ages;Cohort January 1;Total;Survival in the second trimester;2022QI;""
10 Cáceres;All ages;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
10 Cáceres;All ages;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
10 Cáceres;All ages;Cohort January 1;Total;Survival in the second trimester;2021QII;23.347
10 Cáceres;All ages;Cohort January 1;Total;Survival in the second trimester;2021QI;""
10 Cáceres;All ages;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
10 Cáceres;All ages;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
10 Cáceres;All ages;Cohort January 1;Total;Survival in the second trimester;2020QII;23.175
10 Cáceres;All ages;Cohort January 1;Total;Survival in the second trimester;2020QI;""
10 Cáceres;All ages;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
10 Cáceres;All ages;Cohort January 1;Total;Survival in the third trimester;2022QIII;22.616
10 Cáceres;All ages;Cohort January 1;Total;Survival in the third trimester;2022QII;""
10 Cáceres;All ages;Cohort January 1;Total;Survival in the third trimester;2022QI;""
10 Cáceres;All ages;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
10 Cáceres;All ages;Cohort January 1;Total;Survival in the third trimester;2021QIII;22.830
10 Cáceres;All ages;Cohort January 1;Total;Survival in the third trimester;2021QII;""
10 Cáceres;All ages;Cohort January 1;Total;Survival in the third trimester;2021QI;""
10 Cáceres;All ages;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
10 Cáceres;All ages;Cohort January 1;Total;Survival in the third trimester;2020QIII;22.647
10 Cáceres;All ages;Cohort January 1;Total;Survival in the third trimester;2020QII;""
10 Cáceres;All ages;Cohort January 1;Total;Survival in the third trimester;2020QI;""
10 Cáceres;All ages;Cohort January 1;Total;Survival in the third trimester;2022QIV;21.950
10 Cáceres;All ages;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
10 Cáceres;All ages;Cohort January 1;Total;Survival in the third trimester;2022QII;""
10 Cáceres;All ages;Cohort January 1;Total;Survival in the third trimester;2022QI;""
10 Cáceres;All ages;Cohort January 1;Total;Survival in the third trimester;2021QIV;22.294
10 Cáceres;All ages;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
10 Cáceres;All ages;Cohort January 1;Total;Survival in the third trimester;2021QII;""
10 Cáceres;All ages;Cohort January 1;Total;Survival in the third trimester;2021QI;""
10 Cáceres;All ages;Cohort January 1;Total;Survival in the third trimester;2020QIV;22.111
10 Cáceres;All ages;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
10 Cáceres;All ages;Cohort January 1;Total;Survival in the third trimester;2020QII;""
10 Cáceres;All ages;Cohort January 1;Total;Survival in the third trimester;2020QI;""
10 Cáceres;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
10 Cáceres;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
10 Cáceres;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
10 Cáceres;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
10 Cáceres;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
10 Cáceres;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
10 Cáceres;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
10 Cáceres;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
10 Cáceres;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
10 Cáceres;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
10 Cáceres;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
10 Cáceres;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
10 Cáceres;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
10 Cáceres;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
10 Cáceres;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
10 Cáceres;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;96,79
10 Cáceres;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
10 Cáceres;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
10 Cáceres;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
10 Cáceres;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;97,56
10 Cáceres;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
10 Cáceres;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
10 Cáceres;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
10 Cáceres;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;94,49
10 Cáceres;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
10 Cáceres;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
10 Cáceres;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;93,79
10 Cáceres;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
10 Cáceres;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
10 Cáceres;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
10 Cáceres;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;95,29
10 Cáceres;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
10 Cáceres;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
10 Cáceres;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
10 Cáceres;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;92,79
10 Cáceres;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
10 Cáceres;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
10 Cáceres;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;91,24
10 Cáceres;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
10 Cáceres;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
10 Cáceres;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
10 Cáceres;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;93,18
10 Cáceres;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
10 Cáceres;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
10 Cáceres;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
10 Cáceres;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;90,67
10 Cáceres;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
10 Cáceres;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
10 Cáceres;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;88,55
10 Cáceres;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
10 Cáceres;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
10 Cáceres;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
10 Cáceres;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;90,99
10 Cáceres;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
10 Cáceres;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
10 Cáceres;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
10 Cáceres;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;88,53
10 Cáceres;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
10 Cáceres;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
10 Cáceres;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
10 Cáceres;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
10 Cáceres;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
10 Cáceres;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
10 Cáceres;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QI;15.776
10 Cáceres;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
10 Cáceres;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
10 Cáceres;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
10 Cáceres;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QI;15.632
10 Cáceres;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
10 Cáceres;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
10 Cáceres;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
10 Cáceres;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QI;15.976
10 Cáceres;All ages;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
10 Cáceres;All ages;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
10 Cáceres;All ages;Cohort January 1;Males;Survival in the first trimester;2022QII;""
10 Cáceres;All ages;Cohort January 1;Males;Survival in the first trimester;2022QI;15.296
10 Cáceres;All ages;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
10 Cáceres;All ages;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
10 Cáceres;All ages;Cohort January 1;Males;Survival in the first trimester;2021QII;""
10 Cáceres;All ages;Cohort January 1;Males;Survival in the first trimester;2021QI;15.295
10 Cáceres;All ages;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
10 Cáceres;All ages;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
10 Cáceres;All ages;Cohort January 1;Males;Survival in the first trimester;2020QII;""
10 Cáceres;All ages;Cohort January 1;Males;Survival in the first trimester;2020QI;15.092
10 Cáceres;All ages;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
10 Cáceres;All ages;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
10 Cáceres;All ages;Cohort January 1;Males;Survival in the second trimester;2022QII;14.885
10 Cáceres;All ages;Cohort January 1;Males;Survival in the second trimester;2022QI;""
10 Cáceres;All ages;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
10 Cáceres;All ages;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
10 Cáceres;All ages;Cohort January 1;Males;Survival in the second trimester;2021QII;14.983
10 Cáceres;All ages;Cohort January 1;Males;Survival in the second trimester;2021QI;""
10 Cáceres;All ages;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
10 Cáceres;All ages;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
10 Cáceres;All ages;Cohort January 1;Males;Survival in the second trimester;2020QII;14.828
10 Cáceres;All ages;Cohort January 1;Males;Survival in the second trimester;2020QI;""
10 Cáceres;All ages;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
10 Cáceres;All ages;Cohort January 1;Males;Survival in the third trimester;2022QIII;14.528
10 Cáceres;All ages;Cohort January 1;Males;Survival in the third trimester;2022QII;""
10 Cáceres;All ages;Cohort January 1;Males;Survival in the third trimester;2022QI;""
10 Cáceres;All ages;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
10 Cáceres;All ages;Cohort January 1;Males;Survival in the third trimester;2021QIII;14.677
10 Cáceres;All ages;Cohort January 1;Males;Survival in the third trimester;2021QII;""
10 Cáceres;All ages;Cohort January 1;Males;Survival in the third trimester;2021QI;""
10 Cáceres;All ages;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
10 Cáceres;All ages;Cohort January 1;Males;Survival in the third trimester;2020QIII;14.529
10 Cáceres;All ages;Cohort January 1;Males;Survival in the third trimester;2020QII;""
10 Cáceres;All ages;Cohort January 1;Males;Survival in the third trimester;2020QI;""
10 Cáceres;All ages;Cohort January 1;Males;Survival in the third trimester;2022QIV;14.111
10 Cáceres;All ages;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
10 Cáceres;All ages;Cohort January 1;Males;Survival in the third trimester;2022QII;""
10 Cáceres;All ages;Cohort January 1;Males;Survival in the third trimester;2022QI;""
10 Cáceres;All ages;Cohort January 1;Males;Survival in the third trimester;2021QIV;14.382
10 Cáceres;All ages;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
10 Cáceres;All ages;Cohort January 1;Males;Survival in the third trimester;2021QII;""
10 Cáceres;All ages;Cohort January 1;Males;Survival in the third trimester;2021QI;""
10 Cáceres;All ages;Cohort January 1;Males;Survival in the third trimester;2020QIV;14.212
10 Cáceres;All ages;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
10 Cáceres;All ages;Cohort January 1;Males;Survival in the third trimester;2020QII;""
10 Cáceres;All ages;Cohort January 1;Males;Survival in the third trimester;2020QI;""
10 Cáceres;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
10 Cáceres;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
10 Cáceres;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
10 Cáceres;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
10 Cáceres;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
10 Cáceres;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
10 Cáceres;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
10 Cáceres;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
10 Cáceres;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
10 Cáceres;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
10 Cáceres;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
10 Cáceres;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
10 Cáceres;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
10 Cáceres;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
10 Cáceres;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
10 Cáceres;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;96,96
10 Cáceres;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
10 Cáceres;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
10 Cáceres;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
10 Cáceres;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;97,84
10 Cáceres;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
10 Cáceres;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
10 Cáceres;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
10 Cáceres;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;94,47
10 Cáceres;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
10 Cáceres;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
10 Cáceres;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;94,35
10 Cáceres;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
10 Cáceres;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
10 Cáceres;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
10 Cáceres;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;95,85
10 Cáceres;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
10 Cáceres;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
10 Cáceres;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
10 Cáceres;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;92,81
10 Cáceres;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
10 Cáceres;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
10 Cáceres;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;92,09
10 Cáceres;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
10 Cáceres;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
10 Cáceres;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
10 Cáceres;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;93,89
10 Cáceres;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
10 Cáceres;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
10 Cáceres;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
10 Cáceres;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;90,94
10 Cáceres;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
10 Cáceres;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
10 Cáceres;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;89,45
10 Cáceres;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
10 Cáceres;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
10 Cáceres;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
10 Cáceres;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;92
10 Cáceres;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
10 Cáceres;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
10 Cáceres;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
10 Cáceres;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;88,96
10 Cáceres;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
10 Cáceres;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
10 Cáceres;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
10 Cáceres;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
10 Cáceres;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
10 Cáceres;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
10 Cáceres;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QI;9.012
10 Cáceres;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
10 Cáceres;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
10 Cáceres;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
10 Cáceres;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QI;8.870
10 Cáceres;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
10 Cáceres;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
10 Cáceres;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
10 Cáceres;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QI;9.001
10 Cáceres;All ages;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
10 Cáceres;All ages;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
10 Cáceres;All ages;Cohort January 1;Females;Survival in the first trimester;2022QII;""
10 Cáceres;All ages;Cohort January 1;Females;Survival in the first trimester;2022QI;8.696
10 Cáceres;All ages;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
10 Cáceres;All ages;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
10 Cáceres;All ages;Cohort January 1;Females;Survival in the first trimester;2021QII;""
10 Cáceres;All ages;Cohort January 1;Females;Survival in the first trimester;2021QI;8.610
10 Cáceres;All ages;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
10 Cáceres;All ages;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
10 Cáceres;All ages;Cohort January 1;Females;Survival in the first trimester;2020QII;""
10 Cáceres;All ages;Cohort January 1;Females;Survival in the first trimester;2020QI;8.510
10 Cáceres;All ages;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
10 Cáceres;All ages;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
10 Cáceres;All ages;Cohort January 1;Females;Survival in the second trimester;2022QII;8.364
10 Cáceres;All ages;Cohort January 1;Females;Survival in the second trimester;2022QI;""
10 Cáceres;All ages;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
10 Cáceres;All ages;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
10 Cáceres;All ages;Cohort January 1;Females;Survival in the second trimester;2021QII;8.364
10 Cáceres;All ages;Cohort January 1;Females;Survival in the second trimester;2021QI;""
10 Cáceres;All ages;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
10 Cáceres;All ages;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
10 Cáceres;All ages;Cohort January 1;Females;Survival in the second trimester;2020QII;8.347
10 Cáceres;All ages;Cohort January 1;Females;Survival in the second trimester;2020QI;""
10 Cáceres;All ages;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
10 Cáceres;All ages;Cohort January 1;Females;Survival in the third trimester;2022QIII;8.088
10 Cáceres;All ages;Cohort January 1;Females;Survival in the third trimester;2022QII;""
10 Cáceres;All ages;Cohort January 1;Females;Survival in the third trimester;2022QI;""
10 Cáceres;All ages;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
10 Cáceres;All ages;Cohort January 1;Females;Survival in the third trimester;2021QIII;8.153
10 Cáceres;All ages;Cohort January 1;Females;Survival in the third trimester;2021QII;""
10 Cáceres;All ages;Cohort January 1;Females;Survival in the third trimester;2021QI;""
10 Cáceres;All ages;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
10 Cáceres;All ages;Cohort January 1;Females;Survival in the third trimester;2020QIII;8.118
10 Cáceres;All ages;Cohort January 1;Females;Survival in the third trimester;2020QII;""
10 Cáceres;All ages;Cohort January 1;Females;Survival in the third trimester;2020QI;""
10 Cáceres;All ages;Cohort January 1;Females;Survival in the third trimester;2022QIV;7.839
10 Cáceres;All ages;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
10 Cáceres;All ages;Cohort January 1;Females;Survival in the third trimester;2022QII;""
10 Cáceres;All ages;Cohort January 1;Females;Survival in the third trimester;2022QI;""
10 Cáceres;All ages;Cohort January 1;Females;Survival in the third trimester;2021QIV;7.912
10 Cáceres;All ages;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
10 Cáceres;All ages;Cohort January 1;Females;Survival in the third trimester;2021QII;""
10 Cáceres;All ages;Cohort January 1;Females;Survival in the third trimester;2021QI;""
10 Cáceres;All ages;Cohort January 1;Females;Survival in the third trimester;2020QIV;7.899
10 Cáceres;All ages;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
10 Cáceres;All ages;Cohort January 1;Females;Survival in the third trimester;2020QII;""
10 Cáceres;All ages;Cohort January 1;Females;Survival in the third trimester;2020QI;""
10 Cáceres;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
10 Cáceres;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
10 Cáceres;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
10 Cáceres;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
10 Cáceres;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
10 Cáceres;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
10 Cáceres;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
10 Cáceres;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
10 Cáceres;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
10 Cáceres;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
10 Cáceres;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
10 Cáceres;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
10 Cáceres;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
10 Cáceres;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
10 Cáceres;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
10 Cáceres;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;96,49
10 Cáceres;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
10 Cáceres;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
10 Cáceres;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
10 Cáceres;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;97,07
10 Cáceres;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
10 Cáceres;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
10 Cáceres;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
10 Cáceres;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;94,55
10 Cáceres;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
10 Cáceres;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
10 Cáceres;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;92,81
10 Cáceres;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
10 Cáceres;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
10 Cáceres;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
10 Cáceres;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;94,3
10 Cáceres;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
10 Cáceres;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
10 Cáceres;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
10 Cáceres;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;92,73
10 Cáceres;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
10 Cáceres;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
10 Cáceres;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;89,75
10 Cáceres;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
10 Cáceres;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
10 Cáceres;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
10 Cáceres;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;91,92
10 Cáceres;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
10 Cáceres;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
10 Cáceres;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
10 Cáceres;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;90,19
10 Cáceres;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
10 Cáceres;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
10 Cáceres;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;86,98
10 Cáceres;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
10 Cáceres;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
10 Cáceres;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
10 Cáceres;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;89,2
10 Cáceres;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
10 Cáceres;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
10 Cáceres;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
10 Cáceres;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;87,76
10 Cáceres;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
10 Cáceres;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
10 Cáceres;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
10 Cáceres;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
10 Cáceres;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
10 Cáceres;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QII;25.053
10 Cáceres;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
10 Cáceres;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
10 Cáceres;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
10 Cáceres;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QII;24.567
10 Cáceres;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
10 Cáceres;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
10 Cáceres;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
10 Cáceres;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QII;24.594
10 Cáceres;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
10 Cáceres;All ages;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
10 Cáceres;All ages;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
10 Cáceres;All ages;Cohort April 1;Total;Survival in the first trimester;2022QII;24.246
10 Cáceres;All ages;Cohort April 1;Total;Survival in the first trimester;2022QI;""
10 Cáceres;All ages;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
10 Cáceres;All ages;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
10 Cáceres;All ages;Cohort April 1;Total;Survival in the first trimester;2021QII;23.946
10 Cáceres;All ages;Cohort April 1;Total;Survival in the first trimester;2021QI;""
10 Cáceres;All ages;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
10 Cáceres;All ages;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
10 Cáceres;All ages;Cohort April 1;Total;Survival in the first trimester;2020QII;24.139
10 Cáceres;All ages;Cohort April 1;Total;Survival in the first trimester;2020QI;""
10 Cáceres;All ages;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
10 Cáceres;All ages;Cohort April 1;Total;Survival in the second trimester;2022QIII;23.553
10 Cáceres;All ages;Cohort April 1;Total;Survival in the second trimester;2022QII;""
10 Cáceres;All ages;Cohort April 1;Total;Survival in the second trimester;2022QI;""
10 Cáceres;All ages;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
10 Cáceres;All ages;Cohort April 1;Total;Survival in the second trimester;2021QIII;23.374
10 Cáceres;All ages;Cohort April 1;Total;Survival in the second trimester;2021QII;""
10 Cáceres;All ages;Cohort April 1;Total;Survival in the second trimester;2021QI;""
10 Cáceres;All ages;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
10 Cáceres;All ages;Cohort April 1;Total;Survival in the second trimester;2020QIII;23.552
10 Cáceres;All ages;Cohort April 1;Total;Survival in the second trimester;2020QII;""
10 Cáceres;All ages;Cohort April 1;Total;Survival in the second trimester;2020QI;""
10 Cáceres;All ages;Cohort April 1;Total;Survival in the third trimester;2022QIV;22.856
10 Cáceres;All ages;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
10 Cáceres;All ages;Cohort April 1;Total;Survival in the third trimester;2022QII;""
10 Cáceres;All ages;Cohort April 1;Total;Survival in the third trimester;2022QI;""
10 Cáceres;All ages;Cohort April 1;Total;Survival in the third trimester;2021QIV;22.802
10 Cáceres;All ages;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
10 Cáceres;All ages;Cohort April 1;Total;Survival in the third trimester;2021QII;""
10 Cáceres;All ages;Cohort April 1;Total;Survival in the third trimester;2021QI;""
10 Cáceres;All ages;Cohort April 1;Total;Survival in the third trimester;2020QIV;22.982
10 Cáceres;All ages;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
10 Cáceres;All ages;Cohort April 1;Total;Survival in the third trimester;2020QII;""
10 Cáceres;All ages;Cohort April 1;Total;Survival in the third trimester;2020QI;""
10 Cáceres;All ages;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
10 Cáceres;All ages;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
10 Cáceres;All ages;Cohort April 1;Total;Survival in the third trimester;2022QII;""
10 Cáceres;All ages;Cohort April 1;Total;Survival in the third trimester;2022QI;22.124
10 Cáceres;All ages;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
10 Cáceres;All ages;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
10 Cáceres;All ages;Cohort April 1;Total;Survival in the third trimester;2021QII;""
10 Cáceres;All ages;Cohort April 1;Total;Survival in the third trimester;2021QI;22.485
10 Cáceres;All ages;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
10 Cáceres;All ages;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
10 Cáceres;All ages;Cohort April 1;Total;Survival in the third trimester;2020QII;""
10 Cáceres;All ages;Cohort April 1;Total;Survival in the third trimester;2020QI;""
10 Cáceres;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
10 Cáceres;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
10 Cáceres;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
10 Cáceres;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
10 Cáceres;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
10 Cáceres;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
10 Cáceres;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
10 Cáceres;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
10 Cáceres;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
10 Cáceres;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
10 Cáceres;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
10 Cáceres;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
10 Cáceres;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
10 Cáceres;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
10 Cáceres;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;96,78
10 Cáceres;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
10 Cáceres;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
10 Cáceres;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
10 Cáceres;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;97,47
10 Cáceres;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
10 Cáceres;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
10 Cáceres;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
10 Cáceres;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;98,15
10 Cáceres;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
10 Cáceres;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
10 Cáceres;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;94,01
10 Cáceres;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
10 Cáceres;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
10 Cáceres;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
10 Cáceres;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;95,14
10 Cáceres;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
10 Cáceres;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
10 Cáceres;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
10 Cáceres;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;95,76
10 Cáceres;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
10 Cáceres;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
10 Cáceres;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;91,23
10 Cáceres;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
10 Cáceres;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
10 Cáceres;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
10 Cáceres;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;92,82
10 Cáceres;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
10 Cáceres;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
10 Cáceres;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
10 Cáceres;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;93,45
10 Cáceres;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
10 Cáceres;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
10 Cáceres;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
10 Cáceres;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
10 Cáceres;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
10 Cáceres;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
10 Cáceres;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;90,06
10 Cáceres;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
10 Cáceres;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
10 Cáceres;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
10 Cáceres;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;91,42
10 Cáceres;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
10 Cáceres;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
10 Cáceres;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
10 Cáceres;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
10 Cáceres;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
10 Cáceres;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
10 Cáceres;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QII;15.809
10 Cáceres;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
10 Cáceres;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
10 Cáceres;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
10 Cáceres;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QII;15.693
10 Cáceres;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
10 Cáceres;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
10 Cáceres;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
10 Cáceres;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QII;15.640
10 Cáceres;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
10 Cáceres;All ages;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
10 Cáceres;All ages;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
10 Cáceres;All ages;Cohort April 1;Males;Survival in the first trimester;2022QII;15.356
10 Cáceres;All ages;Cohort April 1;Males;Survival in the first trimester;2022QI;""
10 Cáceres;All ages;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
10 Cáceres;All ages;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
10 Cáceres;All ages;Cohort April 1;Males;Survival in the first trimester;2021QII;15.342
10 Cáceres;All ages;Cohort April 1;Males;Survival in the first trimester;2021QI;""
10 Cáceres;All ages;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
10 Cáceres;All ages;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
10 Cáceres;All ages;Cohort April 1;Males;Survival in the first trimester;2020QII;15.363
10 Cáceres;All ages;Cohort April 1;Males;Survival in the first trimester;2020QI;""
10 Cáceres;All ages;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
10 Cáceres;All ages;Cohort April 1;Males;Survival in the second trimester;2022QIII;14.959
10 Cáceres;All ages;Cohort April 1;Males;Survival in the second trimester;2022QII;""
10 Cáceres;All ages;Cohort April 1;Males;Survival in the second trimester;2022QI;""
10 Cáceres;All ages;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
10 Cáceres;All ages;Cohort April 1;Males;Survival in the second trimester;2021QIII;15.005
10 Cáceres;All ages;Cohort April 1;Males;Survival in the second trimester;2021QII;""
10 Cáceres;All ages;Cohort April 1;Males;Survival in the second trimester;2021QI;""
10 Cáceres;All ages;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
10 Cáceres;All ages;Cohort April 1;Males;Survival in the second trimester;2020QIII;15.030
10 Cáceres;All ages;Cohort April 1;Males;Survival in the second trimester;2020QII;""
10 Cáceres;All ages;Cohort April 1;Males;Survival in the second trimester;2020QI;""
10 Cáceres;All ages;Cohort April 1;Males;Survival in the third trimester;2022QIV;14.527
10 Cáceres;All ages;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
10 Cáceres;All ages;Cohort April 1;Males;Survival in the third trimester;2022QII;""
10 Cáceres;All ages;Cohort April 1;Males;Survival in the third trimester;2022QI;""
10 Cáceres;All ages;Cohort April 1;Males;Survival in the third trimester;2021QIV;14.691
10 Cáceres;All ages;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
10 Cáceres;All ages;Cohort April 1;Males;Survival in the third trimester;2021QII;""
10 Cáceres;All ages;Cohort April 1;Males;Survival in the third trimester;2021QI;""
10 Cáceres;All ages;Cohort April 1;Males;Survival in the third trimester;2020QIV;14.691
10 Cáceres;All ages;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
10 Cáceres;All ages;Cohort April 1;Males;Survival in the third trimester;2020QII;""
10 Cáceres;All ages;Cohort April 1;Males;Survival in the third trimester;2020QI;""
10 Cáceres;All ages;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
10 Cáceres;All ages;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
10 Cáceres;All ages;Cohort April 1;Males;Survival in the third trimester;2022QII;""
10 Cáceres;All ages;Cohort April 1;Males;Survival in the third trimester;2022QI;14.293
10 Cáceres;All ages;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
10 Cáceres;All ages;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
10 Cáceres;All ages;Cohort April 1;Males;Survival in the third trimester;2021QII;""
10 Cáceres;All ages;Cohort April 1;Males;Survival in the third trimester;2021QI;14.420
10 Cáceres;All ages;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
10 Cáceres;All ages;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
10 Cáceres;All ages;Cohort April 1;Males;Survival in the third trimester;2020QII;""
10 Cáceres;All ages;Cohort April 1;Males;Survival in the third trimester;2020QI;""
10 Cáceres;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
10 Cáceres;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
10 Cáceres;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
10 Cáceres;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
10 Cáceres;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
10 Cáceres;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
10 Cáceres;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
10 Cáceres;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
10 Cáceres;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
10 Cáceres;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
10 Cáceres;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
10 Cáceres;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
10 Cáceres;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
10 Cáceres;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
10 Cáceres;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;97,13
10 Cáceres;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
10 Cáceres;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
10 Cáceres;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
10 Cáceres;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;97,76
10 Cáceres;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
10 Cáceres;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
10 Cáceres;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
10 Cáceres;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;98,23
10 Cáceres;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
10 Cáceres;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
10 Cáceres;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;94,62
10 Cáceres;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
10 Cáceres;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
10 Cáceres;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
10 Cáceres;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;95,62
10 Cáceres;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
10 Cáceres;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
10 Cáceres;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
10 Cáceres;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;96,1
10 Cáceres;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
10 Cáceres;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
10 Cáceres;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;91,89
10 Cáceres;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
10 Cáceres;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
10 Cáceres;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
10 Cáceres;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;93,61
10 Cáceres;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
10 Cáceres;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
10 Cáceres;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
10 Cáceres;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;93,93
10 Cáceres;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
10 Cáceres;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
10 Cáceres;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
10 Cáceres;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
10 Cáceres;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
10 Cáceres;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
10 Cáceres;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;91,08
10 Cáceres;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
10 Cáceres;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
10 Cáceres;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
10 Cáceres;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;92,2
10 Cáceres;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
10 Cáceres;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
10 Cáceres;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
10 Cáceres;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
10 Cáceres;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
10 Cáceres;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
10 Cáceres;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QII;9.244
10 Cáceres;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
10 Cáceres;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
10 Cáceres;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
10 Cáceres;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QII;8.874
10 Cáceres;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
10 Cáceres;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
10 Cáceres;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
10 Cáceres;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QII;8.954
10 Cáceres;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
10 Cáceres;All ages;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
10 Cáceres;All ages;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
10 Cáceres;All ages;Cohort April 1;Females;Survival in the first trimester;2022QII;8.890
10 Cáceres;All ages;Cohort April 1;Females;Survival in the first trimester;2022QI;""
10 Cáceres;All ages;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
10 Cáceres;All ages;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
10 Cáceres;All ages;Cohort April 1;Females;Survival in the first trimester;2021QII;8.604
10 Cáceres;All ages;Cohort April 1;Females;Survival in the first trimester;2021QI;""
10 Cáceres;All ages;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
10 Cáceres;All ages;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
10 Cáceres;All ages;Cohort April 1;Females;Survival in the first trimester;2020QII;8.776
10 Cáceres;All ages;Cohort April 1;Females;Survival in the first trimester;2020QI;""
10 Cáceres;All ages;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
10 Cáceres;All ages;Cohort April 1;Females;Survival in the second trimester;2022QIII;8.594
10 Cáceres;All ages;Cohort April 1;Females;Survival in the second trimester;2022QII;""
10 Cáceres;All ages;Cohort April 1;Females;Survival in the second trimester;2022QI;""
10 Cáceres;All ages;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
10 Cáceres;All ages;Cohort April 1;Females;Survival in the second trimester;2021QIII;8.369
10 Cáceres;All ages;Cohort April 1;Females;Survival in the second trimester;2021QII;""
10 Cáceres;All ages;Cohort April 1;Females;Survival in the second trimester;2021QI;""
10 Cáceres;All ages;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
10 Cáceres;All ages;Cohort April 1;Females;Survival in the second trimester;2020QIII;8.522
10 Cáceres;All ages;Cohort April 1;Females;Survival in the second trimester;2020QII;""
10 Cáceres;All ages;Cohort April 1;Females;Survival in the second trimester;2020QI;""
10 Cáceres;All ages;Cohort April 1;Females;Survival in the third trimester;2022QIV;8.329
10 Cáceres;All ages;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
10 Cáceres;All ages;Cohort April 1;Females;Survival in the third trimester;2022QII;""
10 Cáceres;All ages;Cohort April 1;Females;Survival in the third trimester;2022QI;""
10 Cáceres;All ages;Cohort April 1;Females;Survival in the third trimester;2021QIV;8.111
10 Cáceres;All ages;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
10 Cáceres;All ages;Cohort April 1;Females;Survival in the third trimester;2021QII;""
10 Cáceres;All ages;Cohort April 1;Females;Survival in the third trimester;2021QI;""
10 Cáceres;All ages;Cohort April 1;Females;Survival in the third trimester;2020QIV;8.291
10 Cáceres;All ages;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
10 Cáceres;All ages;Cohort April 1;Females;Survival in the third trimester;2020QII;""
10 Cáceres;All ages;Cohort April 1;Females;Survival in the third trimester;2020QI;""
10 Cáceres;All ages;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
10 Cáceres;All ages;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
10 Cáceres;All ages;Cohort April 1;Females;Survival in the third trimester;2022QII;""
10 Cáceres;All ages;Cohort April 1;Females;Survival in the third trimester;2022QI;7.831
10 Cáceres;All ages;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
10 Cáceres;All ages;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
10 Cáceres;All ages;Cohort April 1;Females;Survival in the third trimester;2021QII;""
10 Cáceres;All ages;Cohort April 1;Females;Survival in the third trimester;2021QI;8.065
10 Cáceres;All ages;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
10 Cáceres;All ages;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
10 Cáceres;All ages;Cohort April 1;Females;Survival in the third trimester;2020QII;""
10 Cáceres;All ages;Cohort April 1;Females;Survival in the third trimester;2020QI;""
10 Cáceres;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
10 Cáceres;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
10 Cáceres;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
10 Cáceres;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
10 Cáceres;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
10 Cáceres;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
10 Cáceres;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
10 Cáceres;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
10 Cáceres;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
10 Cáceres;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
10 Cáceres;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
10 Cáceres;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
10 Cáceres;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
10 Cáceres;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
10 Cáceres;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;96,17
10 Cáceres;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
10 Cáceres;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
10 Cáceres;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
10 Cáceres;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;96,96
10 Cáceres;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
10 Cáceres;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
10 Cáceres;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
10 Cáceres;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;98,01
10 Cáceres;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
10 Cáceres;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
10 Cáceres;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;92,97
10 Cáceres;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
10 Cáceres;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
10 Cáceres;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
10 Cáceres;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;94,31
10 Cáceres;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
10 Cáceres;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
10 Cáceres;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
10 Cáceres;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;95,18
10 Cáceres;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
10 Cáceres;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
10 Cáceres;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;90,1
10 Cáceres;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
10 Cáceres;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
10 Cáceres;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
10 Cáceres;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;91,4
10 Cáceres;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
10 Cáceres;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
10 Cáceres;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
10 Cáceres;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;92,6
10 Cáceres;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
10 Cáceres;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
10 Cáceres;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
10 Cáceres;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
10 Cáceres;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
10 Cáceres;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
10 Cáceres;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;88,25
10 Cáceres;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
10 Cáceres;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
10 Cáceres;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
10 Cáceres;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;90,07
10 Cáceres;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
10 Cáceres;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
10 Cáceres;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
10 Cáceres;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
10 Cáceres;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
10 Cáceres;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QIII;24.846
10 Cáceres;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
10 Cáceres;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
10 Cáceres;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
10 Cáceres;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QIII;24.778
10 Cáceres;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
10 Cáceres;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
10 Cáceres;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
10 Cáceres;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QIII;24.705
10 Cáceres;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
10 Cáceres;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
10 Cáceres;All ages;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
10 Cáceres;All ages;Cohort July 1;Total;Survival in the first trimester;2022QIII;24.008
10 Cáceres;All ages;Cohort July 1;Total;Survival in the first trimester;2022QII;""
10 Cáceres;All ages;Cohort July 1;Total;Survival in the first trimester;2022QI;""
10 Cáceres;All ages;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
10 Cáceres;All ages;Cohort July 1;Total;Survival in the first trimester;2021QIII;24.078
10 Cáceres;All ages;Cohort July 1;Total;Survival in the first trimester;2021QII;""
10 Cáceres;All ages;Cohort July 1;Total;Survival in the first trimester;2021QI;""
10 Cáceres;All ages;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
10 Cáceres;All ages;Cohort July 1;Total;Survival in the first trimester;2020QIII;24.001
10 Cáceres;All ages;Cohort July 1;Total;Survival in the first trimester;2020QII;""
10 Cáceres;All ages;Cohort July 1;Total;Survival in the first trimester;2020QI;""
10 Cáceres;All ages;Cohort July 1;Total;Survival in the second trimester;2022QIV;23.239
10 Cáceres;All ages;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
10 Cáceres;All ages;Cohort July 1;Total;Survival in the second trimester;2022QII;""
10 Cáceres;All ages;Cohort July 1;Total;Survival in the second trimester;2022QI;""
10 Cáceres;All ages;Cohort July 1;Total;Survival in the second trimester;2021QIV;23.444
10 Cáceres;All ages;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
10 Cáceres;All ages;Cohort July 1;Total;Survival in the second trimester;2021QII;""
10 Cáceres;All ages;Cohort July 1;Total;Survival in the second trimester;2021QI;""
10 Cáceres;All ages;Cohort July 1;Total;Survival in the second trimester;2020QIV;23.371
10 Cáceres;All ages;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
10 Cáceres;All ages;Cohort July 1;Total;Survival in the second trimester;2020QII;""
10 Cáceres;All ages;Cohort July 1;Total;Survival in the second trimester;2020QI;""
10 Cáceres;All ages;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
10 Cáceres;All ages;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
10 Cáceres;All ages;Cohort July 1;Total;Survival in the third trimester;2022QII;""
10 Cáceres;All ages;Cohort July 1;Total;Survival in the third trimester;2022QI;22.740
10 Cáceres;All ages;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
10 Cáceres;All ages;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
10 Cáceres;All ages;Cohort July 1;Total;Survival in the third trimester;2021QII;""
10 Cáceres;All ages;Cohort July 1;Total;Survival in the third trimester;2021QI;22.860
10 Cáceres;All ages;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
10 Cáceres;All ages;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
10 Cáceres;All ages;Cohort July 1;Total;Survival in the third trimester;2020QII;""
10 Cáceres;All ages;Cohort July 1;Total;Survival in the third trimester;2020QI;""
10 Cáceres;All ages;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
10 Cáceres;All ages;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
10 Cáceres;All ages;Cohort July 1;Total;Survival in the third trimester;2022QII;22.071
10 Cáceres;All ages;Cohort July 1;Total;Survival in the third trimester;2022QI;""
10 Cáceres;All ages;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
10 Cáceres;All ages;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
10 Cáceres;All ages;Cohort July 1;Total;Survival in the third trimester;2021QII;22.376
10 Cáceres;All ages;Cohort July 1;Total;Survival in the third trimester;2021QI;""
10 Cáceres;All ages;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
10 Cáceres;All ages;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
10 Cáceres;All ages;Cohort July 1;Total;Survival in the third trimester;2020QII;""
10 Cáceres;All ages;Cohort July 1;Total;Survival in the third trimester;2020QI;""
10 Cáceres;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
10 Cáceres;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
10 Cáceres;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
10 Cáceres;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
10 Cáceres;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
10 Cáceres;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
10 Cáceres;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
10 Cáceres;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
10 Cáceres;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
10 Cáceres;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
10 Cáceres;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
10 Cáceres;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
10 Cáceres;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
10 Cáceres;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;96,63
10 Cáceres;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
10 Cáceres;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
10 Cáceres;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
10 Cáceres;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;97,17
10 Cáceres;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
10 Cáceres;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
10 Cáceres;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
10 Cáceres;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;97,15
10 Cáceres;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
10 Cáceres;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
10 Cáceres;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;93,53
10 Cáceres;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
10 Cáceres;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
10 Cáceres;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
10 Cáceres;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;94,62
10 Cáceres;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
10 Cáceres;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
10 Cáceres;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
10 Cáceres;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;94,6
10 Cáceres;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
10 Cáceres;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
10 Cáceres;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
10 Cáceres;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
10 Cáceres;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
10 Cáceres;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
10 Cáceres;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;91,77
10 Cáceres;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
10 Cáceres;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
10 Cáceres;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
10 Cáceres;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;92,53
10 Cáceres;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
10 Cáceres;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
10 Cáceres;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
10 Cáceres;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
10 Cáceres;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
10 Cáceres;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
10 Cáceres;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;89,07
10 Cáceres;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
10 Cáceres;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
10 Cáceres;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
10 Cáceres;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;90,57
10 Cáceres;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
10 Cáceres;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
10 Cáceres;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
10 Cáceres;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
10 Cáceres;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
10 Cáceres;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
10 Cáceres;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QIII;15.728
10 Cáceres;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
10 Cáceres;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
10 Cáceres;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
10 Cáceres;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QIII;15.819
10 Cáceres;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
10 Cáceres;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
10 Cáceres;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
10 Cáceres;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QIII;15.757
10 Cáceres;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
10 Cáceres;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
10 Cáceres;All ages;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
10 Cáceres;All ages;Cohort July 1;Males;Survival in the first trimester;2022QIII;15.245
10 Cáceres;All ages;Cohort July 1;Males;Survival in the first trimester;2022QII;""
10 Cáceres;All ages;Cohort July 1;Males;Survival in the first trimester;2022QI;""
10 Cáceres;All ages;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
10 Cáceres;All ages;Cohort July 1;Males;Survival in the first trimester;2021QIII;15.404
10 Cáceres;All ages;Cohort July 1;Males;Survival in the first trimester;2021QII;""
10 Cáceres;All ages;Cohort July 1;Males;Survival in the first trimester;2021QI;""
10 Cáceres;All ages;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
10 Cáceres;All ages;Cohort July 1;Males;Survival in the first trimester;2020QIII;15.348
10 Cáceres;All ages;Cohort July 1;Males;Survival in the first trimester;2020QII;""
10 Cáceres;All ages;Cohort July 1;Males;Survival in the first trimester;2020QI;""
10 Cáceres;All ages;Cohort July 1;Males;Survival in the second trimester;2022QIV;14.759
10 Cáceres;All ages;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
10 Cáceres;All ages;Cohort July 1;Males;Survival in the second trimester;2022QII;""
10 Cáceres;All ages;Cohort July 1;Males;Survival in the second trimester;2022QI;""
10 Cáceres;All ages;Cohort July 1;Males;Survival in the second trimester;2021QIV;15.044
10 Cáceres;All ages;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
10 Cáceres;All ages;Cohort July 1;Males;Survival in the second trimester;2021QII;""
10 Cáceres;All ages;Cohort July 1;Males;Survival in the second trimester;2021QI;""
10 Cáceres;All ages;Cohort July 1;Males;Survival in the second trimester;2020QIV;14.959
10 Cáceres;All ages;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
10 Cáceres;All ages;Cohort July 1;Males;Survival in the second trimester;2020QII;""
10 Cáceres;All ages;Cohort July 1;Males;Survival in the second trimester;2020QI;""
10 Cáceres;All ages;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
10 Cáceres;All ages;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
10 Cáceres;All ages;Cohort July 1;Males;Survival in the third trimester;2022QII;""
10 Cáceres;All ages;Cohort July 1;Males;Survival in the third trimester;2022QI;14.629
10 Cáceres;All ages;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
10 Cáceres;All ages;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
10 Cáceres;All ages;Cohort July 1;Males;Survival in the third trimester;2021QII;""
10 Cáceres;All ages;Cohort July 1;Males;Survival in the third trimester;2021QI;14.679
10 Cáceres;All ages;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
10 Cáceres;All ages;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
10 Cáceres;All ages;Cohort July 1;Males;Survival in the third trimester;2020QII;""
10 Cáceres;All ages;Cohort July 1;Males;Survival in the third trimester;2020QI;""
10 Cáceres;All ages;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
10 Cáceres;All ages;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
10 Cáceres;All ages;Cohort July 1;Males;Survival in the third trimester;2022QII;14.254
10 Cáceres;All ages;Cohort July 1;Males;Survival in the third trimester;2022QI;""
10 Cáceres;All ages;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
10 Cáceres;All ages;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
10 Cáceres;All ages;Cohort July 1;Males;Survival in the third trimester;2021QII;14.417
10 Cáceres;All ages;Cohort July 1;Males;Survival in the third trimester;2021QI;""
10 Cáceres;All ages;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
10 Cáceres;All ages;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
10 Cáceres;All ages;Cohort July 1;Males;Survival in the third trimester;2020QII;""
10 Cáceres;All ages;Cohort July 1;Males;Survival in the third trimester;2020QI;""
10 Cáceres;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
10 Cáceres;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
10 Cáceres;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
10 Cáceres;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
10 Cáceres;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
10 Cáceres;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
10 Cáceres;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
10 Cáceres;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
10 Cáceres;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
10 Cáceres;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
10 Cáceres;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
10 Cáceres;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
10 Cáceres;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
10 Cáceres;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;96,93
10 Cáceres;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
10 Cáceres;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
10 Cáceres;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
10 Cáceres;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;97,38
10 Cáceres;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
10 Cáceres;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
10 Cáceres;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
10 Cáceres;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;97,4
10 Cáceres;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
10 Cáceres;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
10 Cáceres;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;93,84
10 Cáceres;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
10 Cáceres;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
10 Cáceres;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
10 Cáceres;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;95,1
10 Cáceres;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
10 Cáceres;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
10 Cáceres;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
10 Cáceres;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;94,94
10 Cáceres;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
10 Cáceres;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
10 Cáceres;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
10 Cáceres;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
10 Cáceres;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
10 Cáceres;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
10 Cáceres;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;92,48
10 Cáceres;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
10 Cáceres;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
10 Cáceres;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
10 Cáceres;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;93,16
10 Cáceres;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
10 Cáceres;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
10 Cáceres;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
10 Cáceres;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
10 Cáceres;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
10 Cáceres;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
10 Cáceres;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;90,11
10 Cáceres;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
10 Cáceres;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
10 Cáceres;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
10 Cáceres;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;91,5
10 Cáceres;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
10 Cáceres;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
10 Cáceres;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
10 Cáceres;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
10 Cáceres;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
10 Cáceres;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
10 Cáceres;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QIII;9.118
10 Cáceres;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
10 Cáceres;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
10 Cáceres;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
10 Cáceres;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QIII;8.959
10 Cáceres;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
10 Cáceres;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
10 Cáceres;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
10 Cáceres;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QIII;8.948
10 Cáceres;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
10 Cáceres;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
10 Cáceres;All ages;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
10 Cáceres;All ages;Cohort July 1;Females;Survival in the first trimester;2022QIII;8.763
10 Cáceres;All ages;Cohort July 1;Females;Survival in the first trimester;2022QII;""
10 Cáceres;All ages;Cohort July 1;Females;Survival in the first trimester;2022QI;""
10 Cáceres;All ages;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
10 Cáceres;All ages;Cohort July 1;Females;Survival in the first trimester;2021QIII;8.674
10 Cáceres;All ages;Cohort July 1;Females;Survival in the first trimester;2021QII;""
10 Cáceres;All ages;Cohort July 1;Females;Survival in the first trimester;2021QI;""
10 Cáceres;All ages;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
10 Cáceres;All ages;Cohort July 1;Females;Survival in the first trimester;2020QIII;8.653
10 Cáceres;All ages;Cohort July 1;Females;Survival in the first trimester;2020QII;""
10 Cáceres;All ages;Cohort July 1;Females;Survival in the first trimester;2020QI;""
10 Cáceres;All ages;Cohort July 1;Females;Survival in the second trimester;2022QIV;8.480
10 Cáceres;All ages;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
10 Cáceres;All ages;Cohort July 1;Females;Survival in the second trimester;2022QII;""
10 Cáceres;All ages;Cohort July 1;Females;Survival in the second trimester;2022QI;""
10 Cáceres;All ages;Cohort July 1;Females;Survival in the second trimester;2021QIV;8.400
10 Cáceres;All ages;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
10 Cáceres;All ages;Cohort July 1;Females;Survival in the second trimester;2021QII;""
10 Cáceres;All ages;Cohort July 1;Females;Survival in the second trimester;2021QI;""
10 Cáceres;All ages;Cohort July 1;Females;Survival in the second trimester;2020QIV;8.412
10 Cáceres;All ages;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
10 Cáceres;All ages;Cohort July 1;Females;Survival in the second trimester;2020QII;""
10 Cáceres;All ages;Cohort July 1;Females;Survival in the second trimester;2020QI;""
10 Cáceres;All ages;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
10 Cáceres;All ages;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
10 Cáceres;All ages;Cohort July 1;Females;Survival in the third trimester;2022QII;""
10 Cáceres;All ages;Cohort July 1;Females;Survival in the third trimester;2022QI;8.111
10 Cáceres;All ages;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
10 Cáceres;All ages;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
10 Cáceres;All ages;Cohort July 1;Females;Survival in the third trimester;2021QII;""
10 Cáceres;All ages;Cohort July 1;Females;Survival in the third trimester;2021QI;8.181
10 Cáceres;All ages;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
10 Cáceres;All ages;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
10 Cáceres;All ages;Cohort July 1;Females;Survival in the third trimester;2020QII;""
10 Cáceres;All ages;Cohort July 1;Females;Survival in the third trimester;2020QI;""
10 Cáceres;All ages;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
10 Cáceres;All ages;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
10 Cáceres;All ages;Cohort July 1;Females;Survival in the third trimester;2022QII;7.817
10 Cáceres;All ages;Cohort July 1;Females;Survival in the third trimester;2022QI;""
10 Cáceres;All ages;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
10 Cáceres;All ages;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
10 Cáceres;All ages;Cohort July 1;Females;Survival in the third trimester;2021QII;7.959
10 Cáceres;All ages;Cohort July 1;Females;Survival in the third trimester;2021QI;""
10 Cáceres;All ages;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
10 Cáceres;All ages;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
10 Cáceres;All ages;Cohort July 1;Females;Survival in the third trimester;2020QII;""
10 Cáceres;All ages;Cohort July 1;Females;Survival in the third trimester;2020QI;""
10 Cáceres;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
10 Cáceres;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
10 Cáceres;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
10 Cáceres;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
10 Cáceres;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
10 Cáceres;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
10 Cáceres;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
10 Cáceres;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
10 Cáceres;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
10 Cáceres;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
10 Cáceres;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
10 Cáceres;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
10 Cáceres;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
10 Cáceres;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;96,11
10 Cáceres;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
10 Cáceres;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
10 Cáceres;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
10 Cáceres;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;96,82
10 Cáceres;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
10 Cáceres;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
10 Cáceres;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
10 Cáceres;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;96,7
10 Cáceres;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
10 Cáceres;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
10 Cáceres;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;93
10 Cáceres;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
10 Cáceres;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
10 Cáceres;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
10 Cáceres;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;93,76
10 Cáceres;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
10 Cáceres;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
10 Cáceres;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
10 Cáceres;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;94,01
10 Cáceres;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
10 Cáceres;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
10 Cáceres;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
10 Cáceres;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
10 Cáceres;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
10 Cáceres;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
10 Cáceres;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;90,53
10 Cáceres;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
10 Cáceres;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
10 Cáceres;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
10 Cáceres;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;91,43
10 Cáceres;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
10 Cáceres;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
10 Cáceres;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
10 Cáceres;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
10 Cáceres;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
10 Cáceres;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
10 Cáceres;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;87,25
10 Cáceres;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
10 Cáceres;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
10 Cáceres;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
10 Cáceres;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;88,95
10 Cáceres;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
10 Cáceres;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
10 Cáceres;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
10 Cáceres;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
10 Cáceres;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
10 Cáceres;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QIV;24.547
10 Cáceres;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
10 Cáceres;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
10 Cáceres;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
10 Cáceres;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QIV;24.748
10 Cáceres;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
10 Cáceres;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
10 Cáceres;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
10 Cáceres;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QIV;24.642
10 Cáceres;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
10 Cáceres;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
10 Cáceres;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
10 Cáceres;All ages;Cohort October 1;Total;Survival in the first trimester;2022QIV;23.708
10 Cáceres;All ages;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
10 Cáceres;All ages;Cohort October 1;Total;Survival in the first trimester;2022QII;""
10 Cáceres;All ages;Cohort October 1;Total;Survival in the first trimester;2022QI;""
10 Cáceres;All ages;Cohort October 1;Total;Survival in the first trimester;2021QIV;24.044
10 Cáceres;All ages;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
10 Cáceres;All ages;Cohort October 1;Total;Survival in the first trimester;2021QII;""
10 Cáceres;All ages;Cohort October 1;Total;Survival in the first trimester;2021QI;""
10 Cáceres;All ages;Cohort October 1;Total;Survival in the first trimester;2020QIV;23.935
10 Cáceres;All ages;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
10 Cáceres;All ages;Cohort October 1;Total;Survival in the first trimester;2020QII;""
10 Cáceres;All ages;Cohort October 1;Total;Survival in the first trimester;2020QI;""
10 Cáceres;All ages;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
10 Cáceres;All ages;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
10 Cáceres;All ages;Cohort October 1;Total;Survival in the second trimester;2022QII;""
10 Cáceres;All ages;Cohort October 1;Total;Survival in the second trimester;2022QI;23.311
10 Cáceres;All ages;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
10 Cáceres;All ages;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
10 Cáceres;All ages;Cohort October 1;Total;Survival in the second trimester;2021QII;""
10 Cáceres;All ages;Cohort October 1;Total;Survival in the second trimester;2021QI;23.386
10 Cáceres;All ages;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
10 Cáceres;All ages;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
10 Cáceres;All ages;Cohort October 1;Total;Survival in the second trimester;2020QII;""
10 Cáceres;All ages;Cohort October 1;Total;Survival in the second trimester;2020QI;""
10 Cáceres;All ages;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
10 Cáceres;All ages;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
10 Cáceres;All ages;Cohort October 1;Total;Survival in the third trimester;2022QII;22.616
10 Cáceres;All ages;Cohort October 1;Total;Survival in the third trimester;2022QI;""
10 Cáceres;All ages;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
10 Cáceres;All ages;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
10 Cáceres;All ages;Cohort October 1;Total;Survival in the third trimester;2021QII;22.880
10 Cáceres;All ages;Cohort October 1;Total;Survival in the third trimester;2021QI;""
10 Cáceres;All ages;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
10 Cáceres;All ages;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
10 Cáceres;All ages;Cohort October 1;Total;Survival in the third trimester;2020QII;""
10 Cáceres;All ages;Cohort October 1;Total;Survival in the third trimester;2020QI;""
10 Cáceres;All ages;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
10 Cáceres;All ages;Cohort October 1;Total;Survival in the third trimester;2022QIII;22.007
10 Cáceres;All ages;Cohort October 1;Total;Survival in the third trimester;2022QII;""
10 Cáceres;All ages;Cohort October 1;Total;Survival in the third trimester;2022QI;""
10 Cáceres;All ages;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
10 Cáceres;All ages;Cohort October 1;Total;Survival in the third trimester;2021QIII;22.389
10 Cáceres;All ages;Cohort October 1;Total;Survival in the third trimester;2021QII;""
10 Cáceres;All ages;Cohort October 1;Total;Survival in the third trimester;2021QI;""
10 Cáceres;All ages;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
10 Cáceres;All ages;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
10 Cáceres;All ages;Cohort October 1;Total;Survival in the third trimester;2020QII;""
10 Cáceres;All ages;Cohort October 1;Total;Survival in the third trimester;2020QI;""
10 Cáceres;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
10 Cáceres;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
10 Cáceres;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
10 Cáceres;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
10 Cáceres;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
10 Cáceres;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
10 Cáceres;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
10 Cáceres;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
10 Cáceres;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
10 Cáceres;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
10 Cáceres;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
10 Cáceres;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
10 Cáceres;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;96,58
10 Cáceres;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
10 Cáceres;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
10 Cáceres;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
10 Cáceres;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;97,16
10 Cáceres;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
10 Cáceres;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
10 Cáceres;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
10 Cáceres;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;97,13
10 Cáceres;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
10 Cáceres;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
10 Cáceres;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
10 Cáceres;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
10 Cáceres;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
10 Cáceres;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
10 Cáceres;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;94,19
10 Cáceres;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
10 Cáceres;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
10 Cáceres;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
10 Cáceres;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;94,9
10 Cáceres;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
10 Cáceres;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
10 Cáceres;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
10 Cáceres;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
10 Cáceres;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
10 Cáceres;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
10 Cáceres;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;91,39
10 Cáceres;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
10 Cáceres;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
10 Cáceres;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
10 Cáceres;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;92,85
10 Cáceres;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
10 Cáceres;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
10 Cáceres;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
10 Cáceres;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
10 Cáceres;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
10 Cáceres;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
10 Cáceres;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;88,92
10 Cáceres;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
10 Cáceres;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
10 Cáceres;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
10 Cáceres;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;90,86
10 Cáceres;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
10 Cáceres;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
10 Cáceres;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
10 Cáceres;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
10 Cáceres;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
10 Cáceres;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
10 Cáceres;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QIV;15.564
10 Cáceres;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
10 Cáceres;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
10 Cáceres;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
10 Cáceres;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QIV;15.777
10 Cáceres;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
10 Cáceres;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
10 Cáceres;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
10 Cáceres;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QIV;15.752
10 Cáceres;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
10 Cáceres;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
10 Cáceres;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
10 Cáceres;All ages;Cohort October 1;Males;Survival in the first trimester;2022QIV;15.028
10 Cáceres;All ages;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
10 Cáceres;All ages;Cohort October 1;Males;Survival in the first trimester;2022QII;""
10 Cáceres;All ages;Cohort October 1;Males;Survival in the first trimester;2022QI;""
10 Cáceres;All ages;Cohort October 1;Males;Survival in the first trimester;2021QIV;15.370
10 Cáceres;All ages;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
10 Cáceres;All ages;Cohort October 1;Males;Survival in the first trimester;2021QII;""
10 Cáceres;All ages;Cohort October 1;Males;Survival in the first trimester;2021QI;""
10 Cáceres;All ages;Cohort October 1;Males;Survival in the first trimester;2020QIV;15.307
10 Cáceres;All ages;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
10 Cáceres;All ages;Cohort October 1;Males;Survival in the first trimester;2020QII;""
10 Cáceres;All ages;Cohort October 1;Males;Survival in the first trimester;2020QI;""
10 Cáceres;All ages;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
10 Cáceres;All ages;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
10 Cáceres;All ages;Cohort October 1;Males;Survival in the second trimester;2022QII;""
10 Cáceres;All ages;Cohort October 1;Males;Survival in the second trimester;2022QI;14.936
10 Cáceres;All ages;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
10 Cáceres;All ages;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
10 Cáceres;All ages;Cohort October 1;Males;Survival in the second trimester;2021QII;""
10 Cáceres;All ages;Cohort October 1;Males;Survival in the second trimester;2021QI;14.998
10 Cáceres;All ages;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
10 Cáceres;All ages;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
10 Cáceres;All ages;Cohort October 1;Males;Survival in the second trimester;2020QII;""
10 Cáceres;All ages;Cohort October 1;Males;Survival in the second trimester;2020QI;""
10 Cáceres;All ages;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
10 Cáceres;All ages;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
10 Cáceres;All ages;Cohort October 1;Males;Survival in the third trimester;2022QII;14.550
10 Cáceres;All ages;Cohort October 1;Males;Survival in the third trimester;2022QI;""
10 Cáceres;All ages;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
10 Cáceres;All ages;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
10 Cáceres;All ages;Cohort October 1;Males;Survival in the third trimester;2021QII;14.720
10 Cáceres;All ages;Cohort October 1;Males;Survival in the third trimester;2021QI;""
10 Cáceres;All ages;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
10 Cáceres;All ages;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
10 Cáceres;All ages;Cohort October 1;Males;Survival in the third trimester;2020QII;""
10 Cáceres;All ages;Cohort October 1;Males;Survival in the third trimester;2020QI;""
10 Cáceres;All ages;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
10 Cáceres;All ages;Cohort October 1;Males;Survival in the third trimester;2022QIII;14.207
10 Cáceres;All ages;Cohort October 1;Males;Survival in the third trimester;2022QII;""
10 Cáceres;All ages;Cohort October 1;Males;Survival in the third trimester;2022QI;""
10 Cáceres;All ages;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
10 Cáceres;All ages;Cohort October 1;Males;Survival in the third trimester;2021QIII;14.434
10 Cáceres;All ages;Cohort October 1;Males;Survival in the third trimester;2021QII;""
10 Cáceres;All ages;Cohort October 1;Males;Survival in the third trimester;2021QI;""
10 Cáceres;All ages;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
10 Cáceres;All ages;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
10 Cáceres;All ages;Cohort October 1;Males;Survival in the third trimester;2020QII;""
10 Cáceres;All ages;Cohort October 1;Males;Survival in the third trimester;2020QI;""
10 Cáceres;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
10 Cáceres;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
10 Cáceres;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
10 Cáceres;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
10 Cáceres;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
10 Cáceres;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
10 Cáceres;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
10 Cáceres;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
10 Cáceres;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
10 Cáceres;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
10 Cáceres;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
10 Cáceres;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
10 Cáceres;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;96,56
10 Cáceres;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
10 Cáceres;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
10 Cáceres;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
10 Cáceres;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;97,42
10 Cáceres;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
10 Cáceres;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
10 Cáceres;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
10 Cáceres;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;97,17
10 Cáceres;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
10 Cáceres;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
10 Cáceres;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
10 Cáceres;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
10 Cáceres;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
10 Cáceres;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
10 Cáceres;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;94,67
10 Cáceres;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
10 Cáceres;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
10 Cáceres;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
10 Cáceres;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;95,21
10 Cáceres;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
10 Cáceres;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
10 Cáceres;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
10 Cáceres;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
10 Cáceres;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
10 Cáceres;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
10 Cáceres;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;92,22
10 Cáceres;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
10 Cáceres;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
10 Cáceres;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
10 Cáceres;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;93,45
10 Cáceres;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
10 Cáceres;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
10 Cáceres;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
10 Cáceres;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
10 Cáceres;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
10 Cáceres;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
10 Cáceres;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;90,05
10 Cáceres;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
10 Cáceres;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
10 Cáceres;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
10 Cáceres;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;91,63
10 Cáceres;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
10 Cáceres;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
10 Cáceres;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
10 Cáceres;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
10 Cáceres;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
10 Cáceres;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
10 Cáceres;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QIV;8.983
10 Cáceres;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
10 Cáceres;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
10 Cáceres;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
10 Cáceres;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QIV;8.971
10 Cáceres;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
10 Cáceres;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
10 Cáceres;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
10 Cáceres;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QIV;8.890
10 Cáceres;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
10 Cáceres;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
10 Cáceres;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
10 Cáceres;All ages;Cohort October 1;Females;Survival in the first trimester;2022QIV;8.680
10 Cáceres;All ages;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
10 Cáceres;All ages;Cohort October 1;Females;Survival in the first trimester;2022QII;""
10 Cáceres;All ages;Cohort October 1;Females;Survival in the first trimester;2022QI;""
10 Cáceres;All ages;Cohort October 1;Females;Survival in the first trimester;2021QIV;8.674
10 Cáceres;All ages;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
10 Cáceres;All ages;Cohort October 1;Females;Survival in the first trimester;2021QII;""
10 Cáceres;All ages;Cohort October 1;Females;Survival in the first trimester;2021QI;""
10 Cáceres;All ages;Cohort October 1;Females;Survival in the first trimester;2020QIV;8.628
10 Cáceres;All ages;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
10 Cáceres;All ages;Cohort October 1;Females;Survival in the first trimester;2020QII;""
10 Cáceres;All ages;Cohort October 1;Females;Survival in the first trimester;2020QI;""
10 Cáceres;All ages;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
10 Cáceres;All ages;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
10 Cáceres;All ages;Cohort October 1;Females;Survival in the second trimester;2022QII;""
10 Cáceres;All ages;Cohort October 1;Females;Survival in the second trimester;2022QI;8.375
10 Cáceres;All ages;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
10 Cáceres;All ages;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
10 Cáceres;All ages;Cohort October 1;Females;Survival in the second trimester;2021QII;""
10 Cáceres;All ages;Cohort October 1;Females;Survival in the second trimester;2021QI;8.388
10 Cáceres;All ages;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
10 Cáceres;All ages;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
10 Cáceres;All ages;Cohort October 1;Females;Survival in the second trimester;2020QII;""
10 Cáceres;All ages;Cohort October 1;Females;Survival in the second trimester;2020QI;""
10 Cáceres;All ages;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
10 Cáceres;All ages;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
10 Cáceres;All ages;Cohort October 1;Females;Survival in the third trimester;2022QII;8.066
10 Cáceres;All ages;Cohort October 1;Females;Survival in the third trimester;2022QI;""
10 Cáceres;All ages;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
10 Cáceres;All ages;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
10 Cáceres;All ages;Cohort October 1;Females;Survival in the third trimester;2021QII;8.160
10 Cáceres;All ages;Cohort October 1;Females;Survival in the third trimester;2021QI;""
10 Cáceres;All ages;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
10 Cáceres;All ages;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
10 Cáceres;All ages;Cohort October 1;Females;Survival in the third trimester;2020QII;""
10 Cáceres;All ages;Cohort October 1;Females;Survival in the third trimester;2020QI;""
10 Cáceres;All ages;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
10 Cáceres;All ages;Cohort October 1;Females;Survival in the third trimester;2022QIII;7.800
10 Cáceres;All ages;Cohort October 1;Females;Survival in the third trimester;2022QII;""
10 Cáceres;All ages;Cohort October 1;Females;Survival in the third trimester;2022QI;""
10 Cáceres;All ages;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
10 Cáceres;All ages;Cohort October 1;Females;Survival in the third trimester;2021QIII;7.955
10 Cáceres;All ages;Cohort October 1;Females;Survival in the third trimester;2021QII;""
10 Cáceres;All ages;Cohort October 1;Females;Survival in the third trimester;2021QI;""
10 Cáceres;All ages;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
10 Cáceres;All ages;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
10 Cáceres;All ages;Cohort October 1;Females;Survival in the third trimester;2020QII;""
10 Cáceres;All ages;Cohort October 1;Females;Survival in the third trimester;2020QI;""
10 Cáceres;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
10 Cáceres;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
10 Cáceres;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
10 Cáceres;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
10 Cáceres;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
10 Cáceres;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
10 Cáceres;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
10 Cáceres;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
10 Cáceres;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
10 Cáceres;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
10 Cáceres;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
10 Cáceres;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
10 Cáceres;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;96,63
10 Cáceres;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
10 Cáceres;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
10 Cáceres;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
10 Cáceres;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;96,69
10 Cáceres;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
10 Cáceres;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
10 Cáceres;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
10 Cáceres;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;97,05
10 Cáceres;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
10 Cáceres;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
10 Cáceres;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
10 Cáceres;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
10 Cáceres;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
10 Cáceres;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
10 Cáceres;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;93,36
10 Cáceres;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
10 Cáceres;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
10 Cáceres;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
10 Cáceres;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;94,35
10 Cáceres;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
10 Cáceres;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
10 Cáceres;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
10 Cáceres;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
10 Cáceres;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
10 Cáceres;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
10 Cáceres;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;89,91
10 Cáceres;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
10 Cáceres;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
10 Cáceres;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
10 Cáceres;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;91,79
10 Cáceres;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
10 Cáceres;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
10 Cáceres;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
10 Cáceres;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
10 Cáceres;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
10 Cáceres;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
10 Cáceres;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;86,95
10 Cáceres;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
10 Cáceres;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
10 Cáceres;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
10 Cáceres;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;89,48
10 Cáceres;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
10 Cáceres;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
10 Cáceres;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
10 Cáceres;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
10 Cáceres;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
10 Cáceres;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
10 Cáceres;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
10 Cáceres;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
10 Cáceres;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
10 Cáceres;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QI;1.654
10 Cáceres;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
10 Cáceres;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
10 Cáceres;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
10 Cáceres;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QI;1.643
10 Cáceres;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
10 Cáceres;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
10 Cáceres;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
10 Cáceres;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QI;1.465
10 Cáceres;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
10 Cáceres;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
10 Cáceres;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2022QII;""
10 Cáceres;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2022QI;1.523
10 Cáceres;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
10 Cáceres;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
10 Cáceres;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2021QII;""
10 Cáceres;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2021QI;1.562
10 Cáceres;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
10 Cáceres;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
10 Cáceres;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2020QII;""
10 Cáceres;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2020QI;1.318
10 Cáceres;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
10 Cáceres;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
10 Cáceres;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2022QII;1.443
10 Cáceres;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2022QI;""
10 Cáceres;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
10 Cáceres;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
10 Cáceres;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2021QII;1.479
10 Cáceres;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2021QI;""
10 Cáceres;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
10 Cáceres;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
10 Cáceres;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2020QII;1.270
10 Cáceres;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2020QI;""
10 Cáceres;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
10 Cáceres;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QIII;1.365
10 Cáceres;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QII;""
10 Cáceres;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QI;""
10 Cáceres;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
10 Cáceres;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QIII;1.409
10 Cáceres;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QII;""
10 Cáceres;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QI;""
10 Cáceres;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
10 Cáceres;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QIII;1.218
10 Cáceres;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QII;""
10 Cáceres;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QI;""
10 Cáceres;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QIV;1.311
10 Cáceres;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
10 Cáceres;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QII;""
10 Cáceres;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QI;""
10 Cáceres;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QIV;1.328
10 Cáceres;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
10 Cáceres;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QII;""
10 Cáceres;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QI;""
10 Cáceres;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QIV;1.163
10 Cáceres;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
10 Cáceres;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QII;""
10 Cáceres;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QI;""
10 Cáceres;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
10 Cáceres;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
10 Cáceres;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
10 Cáceres;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
10 Cáceres;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
10 Cáceres;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
10 Cáceres;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
10 Cáceres;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
10 Cáceres;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
10 Cáceres;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
10 Cáceres;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
10 Cáceres;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
10 Cáceres;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
10 Cáceres;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
10 Cáceres;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
10 Cáceres;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;92,08
10 Cáceres;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
10 Cáceres;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
10 Cáceres;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
10 Cáceres;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;95,07
10 Cáceres;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
10 Cáceres;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
10 Cáceres;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
10 Cáceres;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;89,97
10 Cáceres;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
10 Cáceres;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
10 Cáceres;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;87,24
10 Cáceres;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
10 Cáceres;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
10 Cáceres;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
10 Cáceres;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;90,02
10 Cáceres;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
10 Cáceres;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
10 Cáceres;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
10 Cáceres;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;86,69
10 Cáceres;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
10 Cáceres;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
10 Cáceres;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;82,53
10 Cáceres;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
10 Cáceres;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
10 Cáceres;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
10 Cáceres;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;85,76
10 Cáceres;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
10 Cáceres;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
10 Cáceres;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
10 Cáceres;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;83,14
10 Cáceres;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
10 Cáceres;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
10 Cáceres;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;79,26
10 Cáceres;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
10 Cáceres;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
10 Cáceres;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
10 Cáceres;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;80,83
10 Cáceres;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
10 Cáceres;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
10 Cáceres;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
10 Cáceres;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;79,39
10 Cáceres;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
10 Cáceres;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
10 Cáceres;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
10 Cáceres;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
10 Cáceres;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
10 Cáceres;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
10 Cáceres;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QI;981
10 Cáceres;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
10 Cáceres;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
10 Cáceres;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
10 Cáceres;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QI;983
10 Cáceres;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
10 Cáceres;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
10 Cáceres;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
10 Cáceres;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QI;886
10 Cáceres;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
10 Cáceres;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
10 Cáceres;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2022QII;""
10 Cáceres;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2022QI;908
10 Cáceres;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
10 Cáceres;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
10 Cáceres;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2021QII;""
10 Cáceres;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2021QI;938
10 Cáceres;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
10 Cáceres;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
10 Cáceres;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2020QII;""
10 Cáceres;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2020QI;794
10 Cáceres;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
10 Cáceres;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
10 Cáceres;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2022QII;858
10 Cáceres;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2022QI;""
10 Cáceres;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
10 Cáceres;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
10 Cáceres;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2021QII;886
10 Cáceres;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2021QI;""
10 Cáceres;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
10 Cáceres;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
10 Cáceres;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2020QII;767
10 Cáceres;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2020QI;""
10 Cáceres;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
10 Cáceres;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QIII;813
10 Cáceres;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QII;""
10 Cáceres;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QI;""
10 Cáceres;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
10 Cáceres;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QIII;845
10 Cáceres;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QII;""
10 Cáceres;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QI;""
10 Cáceres;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
10 Cáceres;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QIII;735
10 Cáceres;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QII;""
10 Cáceres;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QI;""
10 Cáceres;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QIV;780
10 Cáceres;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
10 Cáceres;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QII;""
10 Cáceres;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QI;""
10 Cáceres;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QIV;802
10 Cáceres;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
10 Cáceres;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QII;""
10 Cáceres;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QI;""
10 Cáceres;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QIV;704
10 Cáceres;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
10 Cáceres;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QII;""
10 Cáceres;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QI;""
10 Cáceres;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
10 Cáceres;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
10 Cáceres;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
10 Cáceres;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
10 Cáceres;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
10 Cáceres;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
10 Cáceres;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
10 Cáceres;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
10 Cáceres;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
10 Cáceres;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
10 Cáceres;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
10 Cáceres;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
10 Cáceres;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
10 Cáceres;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
10 Cáceres;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
10 Cáceres;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;92,56
10 Cáceres;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
10 Cáceres;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
10 Cáceres;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
10 Cáceres;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;95,42
10 Cáceres;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
10 Cáceres;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
10 Cáceres;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
10 Cáceres;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;89,62
10 Cáceres;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
10 Cáceres;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
10 Cáceres;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;87,46
10 Cáceres;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
10 Cáceres;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
10 Cáceres;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
10 Cáceres;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;90,13
10 Cáceres;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
10 Cáceres;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
10 Cáceres;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
10 Cáceres;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;86,57
10 Cáceres;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
10 Cáceres;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
10 Cáceres;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;82,87
10 Cáceres;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
10 Cáceres;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
10 Cáceres;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
10 Cáceres;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;85,96
10 Cáceres;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
10 Cáceres;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
10 Cáceres;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
10 Cáceres;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;82,96
10 Cáceres;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
10 Cáceres;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
10 Cáceres;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;79,51
10 Cáceres;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
10 Cáceres;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
10 Cáceres;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
10 Cáceres;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;81,59
10 Cáceres;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
10 Cáceres;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
10 Cáceres;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
10 Cáceres;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;79,46
10 Cáceres;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
10 Cáceres;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
10 Cáceres;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
10 Cáceres;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
10 Cáceres;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
10 Cáceres;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
10 Cáceres;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QI;673
10 Cáceres;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
10 Cáceres;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
10 Cáceres;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
10 Cáceres;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QI;660
10 Cáceres;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
10 Cáceres;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
10 Cáceres;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
10 Cáceres;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QI;579
10 Cáceres;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
10 Cáceres;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
10 Cáceres;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2022QII;""
10 Cáceres;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2022QI;615
10 Cáceres;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
10 Cáceres;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
10 Cáceres;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2021QII;""
10 Cáceres;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2021QI;624
10 Cáceres;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
10 Cáceres;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
10 Cáceres;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2020QII;""
10 Cáceres;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2020QI;524
10 Cáceres;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
10 Cáceres;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
10 Cáceres;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2022QII;585
10 Cáceres;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2022QI;""
10 Cáceres;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
10 Cáceres;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
10 Cáceres;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2021QII;593
10 Cáceres;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2021QI;""
10 Cáceres;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
10 Cáceres;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
10 Cáceres;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2020QII;503
10 Cáceres;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2020QI;""
10 Cáceres;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
10 Cáceres;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QIII;552
10 Cáceres;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QII;""
10 Cáceres;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QI;""
10 Cáceres;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
10 Cáceres;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QIII;564
10 Cáceres;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QII;""
10 Cáceres;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QI;""
10 Cáceres;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
10 Cáceres;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QIII;483
10 Cáceres;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QII;""
10 Cáceres;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QI;""
10 Cáceres;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QIV;531
10 Cáceres;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
10 Cáceres;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QII;""
10 Cáceres;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QI;""
10 Cáceres;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QIV;526
10 Cáceres;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
10 Cáceres;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QII;""
10 Cáceres;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QI;""
10 Cáceres;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QIV;459
10 Cáceres;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
10 Cáceres;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QII;""
10 Cáceres;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QI;""
10 Cáceres;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
10 Cáceres;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
10 Cáceres;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
10 Cáceres;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
10 Cáceres;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
10 Cáceres;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
10 Cáceres;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
10 Cáceres;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
10 Cáceres;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
10 Cáceres;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
10 Cáceres;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
10 Cáceres;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
10 Cáceres;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
10 Cáceres;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
10 Cáceres;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
10 Cáceres;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;91,38
10 Cáceres;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
10 Cáceres;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
10 Cáceres;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
10 Cáceres;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;94,55
10 Cáceres;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
10 Cáceres;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
10 Cáceres;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
10 Cáceres;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;90,5
10 Cáceres;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
10 Cáceres;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
10 Cáceres;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;86,92
10 Cáceres;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
10 Cáceres;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
10 Cáceres;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
10 Cáceres;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;89,85
10 Cáceres;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
10 Cáceres;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
10 Cáceres;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
10 Cáceres;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;86,87
10 Cáceres;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
10 Cáceres;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
10 Cáceres;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;82,02
10 Cáceres;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
10 Cáceres;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
10 Cáceres;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
10 Cáceres;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;85,45
10 Cáceres;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
10 Cáceres;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
10 Cáceres;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
10 Cáceres;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;83,42
10 Cáceres;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
10 Cáceres;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
10 Cáceres;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;78,9
10 Cáceres;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
10 Cáceres;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
10 Cáceres;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
10 Cáceres;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;79,7
10 Cáceres;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
10 Cáceres;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
10 Cáceres;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
10 Cáceres;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;79,27
10 Cáceres;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
10 Cáceres;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
10 Cáceres;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
10 Cáceres;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
10 Cáceres;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
10 Cáceres;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QII;1.490
10 Cáceres;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
10 Cáceres;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
10 Cáceres;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
10 Cáceres;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QII;1.408
10 Cáceres;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
10 Cáceres;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
10 Cáceres;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
10 Cáceres;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QII;1.502
10 Cáceres;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
10 Cáceres;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
10 Cáceres;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
10 Cáceres;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2022QII;1.403
10 Cáceres;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2022QI;""
10 Cáceres;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
10 Cáceres;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
10 Cáceres;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2021QII;1.324
10 Cáceres;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2021QI;""
10 Cáceres;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
10 Cáceres;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
10 Cáceres;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2020QII;1.446
10 Cáceres;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2020QI;""
10 Cáceres;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
10 Cáceres;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2022QIII;1.323
10 Cáceres;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2022QII;""
10 Cáceres;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2022QI;""
10 Cáceres;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
10 Cáceres;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2021QIII;1.248
10 Cáceres;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2021QII;""
10 Cáceres;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2021QI;""
10 Cáceres;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
10 Cáceres;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2020QIII;1.386
10 Cáceres;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2020QII;""
10 Cáceres;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2020QI;""
10 Cáceres;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QIV;1.271
10 Cáceres;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
10 Cáceres;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QII;""
10 Cáceres;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QI;""
10 Cáceres;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QIV;1.170
10 Cáceres;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
10 Cáceres;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QII;""
10 Cáceres;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QI;""
10 Cáceres;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QIV;1.323
10 Cáceres;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
10 Cáceres;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QII;""
10 Cáceres;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QI;""
10 Cáceres;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
10 Cáceres;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
10 Cáceres;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QII;""
10 Cáceres;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QI;1.066
10 Cáceres;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
10 Cáceres;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
10 Cáceres;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QII;""
10 Cáceres;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QI;1.264
10 Cáceres;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
10 Cáceres;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
10 Cáceres;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QII;""
10 Cáceres;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QI;""
10 Cáceres;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
10 Cáceres;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
10 Cáceres;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
10 Cáceres;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
10 Cáceres;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
10 Cáceres;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
10 Cáceres;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
10 Cáceres;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
10 Cáceres;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
10 Cáceres;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
10 Cáceres;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
10 Cáceres;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
10 Cáceres;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
10 Cáceres;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
10 Cáceres;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;94,16
10 Cáceres;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
10 Cáceres;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
10 Cáceres;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
10 Cáceres;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;94,03
10 Cáceres;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
10 Cáceres;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
10 Cáceres;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
10 Cáceres;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;96,27
10 Cáceres;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
10 Cáceres;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
10 Cáceres;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;88,79
10 Cáceres;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
10 Cáceres;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
10 Cáceres;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
10 Cáceres;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;88,64
10 Cáceres;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
10 Cáceres;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
10 Cáceres;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
10 Cáceres;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;92,28
10 Cáceres;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
10 Cáceres;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
10 Cáceres;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;85,3
10 Cáceres;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
10 Cáceres;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
10 Cáceres;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
10 Cáceres;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;83,1
10 Cáceres;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
10 Cáceres;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
10 Cáceres;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
10 Cáceres;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;88,08
10 Cáceres;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
10 Cáceres;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
10 Cáceres;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
10 Cáceres;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
10 Cáceres;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
10 Cáceres;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
10 Cáceres;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;75,71
10 Cáceres;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
10 Cáceres;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
10 Cáceres;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
10 Cáceres;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;84,15
10 Cáceres;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
10 Cáceres;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
10 Cáceres;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
10 Cáceres;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
10 Cáceres;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
10 Cáceres;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
10 Cáceres;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QII;904
10 Cáceres;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
10 Cáceres;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
10 Cáceres;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
10 Cáceres;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QII;844
10 Cáceres;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
10 Cáceres;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
10 Cáceres;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
10 Cáceres;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QII;900
10 Cáceres;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
10 Cáceres;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
10 Cáceres;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
10 Cáceres;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2022QII;845
10 Cáceres;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2022QI;""
10 Cáceres;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
10 Cáceres;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
10 Cáceres;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2021QII;786
10 Cáceres;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2021QI;""
10 Cáceres;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
10 Cáceres;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
10 Cáceres;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2020QII;868
10 Cáceres;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2020QI;""
10 Cáceres;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
10 Cáceres;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2022QIII;794
10 Cáceres;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2022QII;""
10 Cáceres;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2022QI;""
10 Cáceres;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
10 Cáceres;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2021QIII;744
10 Cáceres;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2021QII;""
10 Cáceres;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2021QI;""
10 Cáceres;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
10 Cáceres;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2020QIII;832
10 Cáceres;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2020QII;""
10 Cáceres;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2020QI;""
10 Cáceres;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QIV;763
10 Cáceres;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
10 Cáceres;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QII;""
10 Cáceres;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QI;""
10 Cáceres;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QIV;704
10 Cáceres;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
10 Cáceres;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QII;""
10 Cáceres;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QI;""
10 Cáceres;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QIV;796
10 Cáceres;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
10 Cáceres;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QII;""
10 Cáceres;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QI;""
10 Cáceres;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
10 Cáceres;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
10 Cáceres;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QII;""
10 Cáceres;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QI;647
10 Cáceres;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
10 Cáceres;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
10 Cáceres;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QII;""
10 Cáceres;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QI;767
10 Cáceres;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
10 Cáceres;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
10 Cáceres;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QII;""
10 Cáceres;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QI;""
10 Cáceres;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
10 Cáceres;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
10 Cáceres;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
10 Cáceres;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
10 Cáceres;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
10 Cáceres;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
10 Cáceres;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
10 Cáceres;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
10 Cáceres;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
10 Cáceres;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
10 Cáceres;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
10 Cáceres;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
10 Cáceres;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
10 Cáceres;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
10 Cáceres;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;93,47
10 Cáceres;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
10 Cáceres;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
10 Cáceres;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
10 Cáceres;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;93,13
10 Cáceres;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
10 Cáceres;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
10 Cáceres;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
10 Cáceres;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;96,44
10 Cáceres;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
10 Cáceres;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
10 Cáceres;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;87,83
10 Cáceres;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
10 Cáceres;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
10 Cáceres;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
10 Cáceres;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;88,15
10 Cáceres;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
10 Cáceres;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
10 Cáceres;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
10 Cáceres;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;92,44
10 Cáceres;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
10 Cáceres;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
10 Cáceres;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;84,4
10 Cáceres;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
10 Cáceres;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
10 Cáceres;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
10 Cáceres;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;83,41
10 Cáceres;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
10 Cáceres;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
10 Cáceres;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
10 Cáceres;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;88,44
10 Cáceres;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
10 Cáceres;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
10 Cáceres;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
10 Cáceres;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
10 Cáceres;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
10 Cáceres;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
10 Cáceres;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;76,66
10 Cáceres;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
10 Cáceres;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
10 Cáceres;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
10 Cáceres;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;85,22
10 Cáceres;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
10 Cáceres;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
10 Cáceres;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
10 Cáceres;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
10 Cáceres;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
10 Cáceres;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
10 Cáceres;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QII;586
10 Cáceres;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
10 Cáceres;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
10 Cáceres;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
10 Cáceres;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QII;564
10 Cáceres;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
10 Cáceres;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
10 Cáceres;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
10 Cáceres;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QII;602
10 Cáceres;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
10 Cáceres;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
10 Cáceres;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
10 Cáceres;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2022QII;558
10 Cáceres;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2022QI;""
10 Cáceres;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
10 Cáceres;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
10 Cáceres;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2021QII;538
10 Cáceres;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2021QI;""
10 Cáceres;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
10 Cáceres;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
10 Cáceres;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2020QII;578
10 Cáceres;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2020QI;""
10 Cáceres;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
10 Cáceres;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2022QIII;529
10 Cáceres;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2022QII;""
10 Cáceres;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2022QI;""
10 Cáceres;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
10 Cáceres;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2021QIII;504
10 Cáceres;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2021QII;""
10 Cáceres;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2021QI;""
10 Cáceres;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
10 Cáceres;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2020QIII;554
10 Cáceres;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2020QII;""
10 Cáceres;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2020QI;""
10 Cáceres;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QIV;508
10 Cáceres;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
10 Cáceres;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QII;""
10 Cáceres;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QI;""
10 Cáceres;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QIV;466
10 Cáceres;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
10 Cáceres;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QII;""
10 Cáceres;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QI;""
10 Cáceres;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QIV;527
10 Cáceres;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
10 Cáceres;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QII;""
10 Cáceres;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QI;""
10 Cáceres;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
10 Cáceres;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
10 Cáceres;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QII;""
10 Cáceres;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QI;419
10 Cáceres;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
10 Cáceres;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
10 Cáceres;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QII;""
10 Cáceres;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QI;497
10 Cáceres;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
10 Cáceres;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
10 Cáceres;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QII;""
10 Cáceres;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QI;""
10 Cáceres;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
10 Cáceres;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
10 Cáceres;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
10 Cáceres;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
10 Cáceres;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
10 Cáceres;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
10 Cáceres;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
10 Cáceres;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
10 Cáceres;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
10 Cáceres;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
10 Cáceres;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
10 Cáceres;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
10 Cáceres;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
10 Cáceres;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
10 Cáceres;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;95,22
10 Cáceres;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
10 Cáceres;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
10 Cáceres;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
10 Cáceres;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;95,39
10 Cáceres;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
10 Cáceres;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
10 Cáceres;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
10 Cáceres;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;96,01
10 Cáceres;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
10 Cáceres;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
10 Cáceres;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;90,27
10 Cáceres;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
10 Cáceres;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
10 Cáceres;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
10 Cáceres;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;89,36
10 Cáceres;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
10 Cáceres;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
10 Cáceres;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
10 Cáceres;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;92,03
10 Cáceres;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
10 Cáceres;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
10 Cáceres;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;86,69
10 Cáceres;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
10 Cáceres;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
10 Cáceres;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
10 Cáceres;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;82,62
10 Cáceres;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
10 Cáceres;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
10 Cáceres;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
10 Cáceres;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;87,54
10 Cáceres;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
10 Cáceres;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
10 Cáceres;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
10 Cáceres;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
10 Cáceres;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
10 Cáceres;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
10 Cáceres;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;74,29
10 Cáceres;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
10 Cáceres;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
10 Cáceres;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
10 Cáceres;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;82,56
10 Cáceres;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
10 Cáceres;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
10 Cáceres;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
10 Cáceres;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
10 Cáceres;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
10 Cáceres;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QIII;1.553
10 Cáceres;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
10 Cáceres;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
10 Cáceres;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
10 Cáceres;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QIII;1.504
10 Cáceres;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
10 Cáceres;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
10 Cáceres;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
10 Cáceres;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QIII;1.554
10 Cáceres;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
10 Cáceres;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
10 Cáceres;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
10 Cáceres;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2022QIII;1.430
10 Cáceres;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2022QII;""
10 Cáceres;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2022QI;""
10 Cáceres;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
10 Cáceres;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2021QIII;1.398
10 Cáceres;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2021QII;""
10 Cáceres;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2021QI;""
10 Cáceres;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
10 Cáceres;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2020QIII;1.463
10 Cáceres;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2020QII;""
10 Cáceres;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2020QI;""
10 Cáceres;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2022QIV;1.361
10 Cáceres;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
10 Cáceres;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2022QII;""
10 Cáceres;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2022QI;""
10 Cáceres;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2021QIV;1.310
10 Cáceres;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
10 Cáceres;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2021QII;""
10 Cáceres;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2021QI;""
10 Cáceres;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2020QIV;1.392
10 Cáceres;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
10 Cáceres;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2020QII;""
10 Cáceres;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2020QI;""
10 Cáceres;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
10 Cáceres;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
10 Cáceres;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QII;""
10 Cáceres;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QI;1.202
10 Cáceres;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
10 Cáceres;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
10 Cáceres;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QII;""
10 Cáceres;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QI;1.332
10 Cáceres;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
10 Cáceres;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
10 Cáceres;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QII;""
10 Cáceres;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QI;""
10 Cáceres;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
10 Cáceres;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
10 Cáceres;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QII;1.136
10 Cáceres;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QI;""
10 Cáceres;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
10 Cáceres;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
10 Cáceres;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QII;1.272
10 Cáceres;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QI;""
10 Cáceres;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
10 Cáceres;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
10 Cáceres;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QII;""
10 Cáceres;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QI;""
10 Cáceres;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
10 Cáceres;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
10 Cáceres;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
10 Cáceres;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
10 Cáceres;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
10 Cáceres;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
10 Cáceres;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
10 Cáceres;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
10 Cáceres;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
10 Cáceres;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
10 Cáceres;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
10 Cáceres;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
10 Cáceres;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
10 Cáceres;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;92,08
10 Cáceres;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
10 Cáceres;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
10 Cáceres;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
10 Cáceres;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;92,95
10 Cáceres;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
10 Cáceres;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
10 Cáceres;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
10 Cáceres;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;94,14
10 Cáceres;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
10 Cáceres;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
10 Cáceres;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;87,64
10 Cáceres;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
10 Cáceres;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
10 Cáceres;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
10 Cáceres;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;87,1
10 Cáceres;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
10 Cáceres;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
10 Cáceres;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
10 Cáceres;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;89,58
10 Cáceres;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
10 Cáceres;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
10 Cáceres;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
10 Cáceres;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
10 Cáceres;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
10 Cáceres;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
10 Cáceres;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;79,92
10 Cáceres;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
10 Cáceres;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
10 Cáceres;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
10 Cáceres;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;85,71
10 Cáceres;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
10 Cáceres;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
10 Cáceres;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
10 Cáceres;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
10 Cáceres;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
10 Cáceres;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
10 Cáceres;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;75,53
10 Cáceres;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
10 Cáceres;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
10 Cáceres;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
10 Cáceres;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;81,85
10 Cáceres;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
10 Cáceres;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
10 Cáceres;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
10 Cáceres;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
10 Cáceres;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
10 Cáceres;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
10 Cáceres;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QIII;934
10 Cáceres;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
10 Cáceres;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
10 Cáceres;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
10 Cáceres;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QIII;898
10 Cáceres;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
10 Cáceres;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
10 Cáceres;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
10 Cáceres;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QIII;937
10 Cáceres;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
10 Cáceres;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
10 Cáceres;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
10 Cáceres;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2022QIII;857
10 Cáceres;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2022QII;""
10 Cáceres;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2022QI;""
10 Cáceres;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
10 Cáceres;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2021QIII;836
10 Cáceres;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2021QII;""
10 Cáceres;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2021QI;""
10 Cáceres;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
10 Cáceres;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2020QIII;877
10 Cáceres;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2020QII;""
10 Cáceres;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2020QI;""
10 Cáceres;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2022QIV;814
10 Cáceres;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
10 Cáceres;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2022QII;""
10 Cáceres;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2022QI;""
10 Cáceres;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2021QIV;789
10 Cáceres;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
10 Cáceres;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2021QII;""
10 Cáceres;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2021QI;""
10 Cáceres;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2020QIV;834
10 Cáceres;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
10 Cáceres;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2020QII;""
10 Cáceres;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2020QI;""
10 Cáceres;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
10 Cáceres;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
10 Cáceres;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QII;""
10 Cáceres;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QI;730
10 Cáceres;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
10 Cáceres;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
10 Cáceres;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QII;""
10 Cáceres;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QI;805
10 Cáceres;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
10 Cáceres;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
10 Cáceres;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QII;""
10 Cáceres;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QI;""
10 Cáceres;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
10 Cáceres;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
10 Cáceres;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QII;689
10 Cáceres;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QI;""
10 Cáceres;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
10 Cáceres;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
10 Cáceres;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QII;772
10 Cáceres;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QI;""
10 Cáceres;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
10 Cáceres;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
10 Cáceres;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QII;""
10 Cáceres;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QI;""
10 Cáceres;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
10 Cáceres;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
10 Cáceres;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
10 Cáceres;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
10 Cáceres;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
10 Cáceres;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
10 Cáceres;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
10 Cáceres;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
10 Cáceres;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
10 Cáceres;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
10 Cáceres;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
10 Cáceres;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
10 Cáceres;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
10 Cáceres;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;91,76
10 Cáceres;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
10 Cáceres;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
10 Cáceres;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
10 Cáceres;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;93,1
10 Cáceres;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
10 Cáceres;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
10 Cáceres;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
10 Cáceres;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;93,6
10 Cáceres;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
10 Cáceres;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
10 Cáceres;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;87,15
10 Cáceres;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
10 Cáceres;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
10 Cáceres;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
10 Cáceres;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;87,86
10 Cáceres;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
10 Cáceres;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
10 Cáceres;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
10 Cáceres;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;89,01
10 Cáceres;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
10 Cáceres;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
10 Cáceres;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
10 Cáceres;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
10 Cáceres;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
10 Cáceres;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
10 Cáceres;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;81,29
10 Cáceres;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
10 Cáceres;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
10 Cáceres;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
10 Cáceres;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;85,91
10 Cáceres;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
10 Cáceres;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
10 Cáceres;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
10 Cáceres;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
10 Cáceres;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
10 Cáceres;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
10 Cáceres;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;76,73
10 Cáceres;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
10 Cáceres;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
10 Cáceres;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
10 Cáceres;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;82,39
10 Cáceres;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
10 Cáceres;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
10 Cáceres;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
10 Cáceres;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
10 Cáceres;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
10 Cáceres;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
10 Cáceres;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QIII;619
10 Cáceres;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
10 Cáceres;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
10 Cáceres;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
10 Cáceres;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QIII;606
10 Cáceres;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
10 Cáceres;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
10 Cáceres;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
10 Cáceres;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QIII;617
10 Cáceres;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
10 Cáceres;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
10 Cáceres;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
10 Cáceres;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2022QIII;573
10 Cáceres;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2022QII;""
10 Cáceres;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2022QI;""
10 Cáceres;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
10 Cáceres;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2021QIII;562
10 Cáceres;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2021QII;""
10 Cáceres;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2021QI;""
10 Cáceres;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
10 Cáceres;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2020QIII;586
10 Cáceres;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2020QII;""
10 Cáceres;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2020QI;""
10 Cáceres;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2022QIV;547
10 Cáceres;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
10 Cáceres;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2022QII;""
10 Cáceres;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2022QI;""
10 Cáceres;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2021QIV;521
10 Cáceres;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
10 Cáceres;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2021QII;""
10 Cáceres;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2021QI;""
10 Cáceres;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2020QIV;558
10 Cáceres;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
10 Cáceres;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2020QII;""
10 Cáceres;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2020QI;""
10 Cáceres;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
10 Cáceres;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
10 Cáceres;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QII;""
10 Cáceres;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QI;472
10 Cáceres;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
10 Cáceres;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
10 Cáceres;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QII;""
10 Cáceres;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QI;527
10 Cáceres;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
10 Cáceres;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
10 Cáceres;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QII;""
10 Cáceres;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QI;""
10 Cáceres;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
10 Cáceres;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
10 Cáceres;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QII;447
10 Cáceres;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QI;""
10 Cáceres;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
10 Cáceres;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
10 Cáceres;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QII;500
10 Cáceres;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QI;""
10 Cáceres;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
10 Cáceres;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
10 Cáceres;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QII;""
10 Cáceres;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QI;""
10 Cáceres;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
10 Cáceres;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
10 Cáceres;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
10 Cáceres;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
10 Cáceres;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
10 Cáceres;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
10 Cáceres;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
10 Cáceres;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
10 Cáceres;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
10 Cáceres;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
10 Cáceres;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
10 Cáceres;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
10 Cáceres;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
10 Cáceres;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;92,57
10 Cáceres;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
10 Cáceres;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
10 Cáceres;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
10 Cáceres;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;92,74
10 Cáceres;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
10 Cáceres;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
10 Cáceres;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
10 Cáceres;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;94,98
10 Cáceres;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
10 Cáceres;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
10 Cáceres;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;88,37
10 Cáceres;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
10 Cáceres;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
10 Cáceres;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
10 Cáceres;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;85,97
10 Cáceres;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
10 Cáceres;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
10 Cáceres;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
10 Cáceres;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;90,44
10 Cáceres;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
10 Cáceres;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
10 Cáceres;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
10 Cáceres;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
10 Cáceres;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
10 Cáceres;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
10 Cáceres;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;77,89
10 Cáceres;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
10 Cáceres;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
10 Cáceres;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
10 Cáceres;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;85,41
10 Cáceres;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
10 Cáceres;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
10 Cáceres;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
10 Cáceres;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
10 Cáceres;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
10 Cáceres;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
10 Cáceres;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;73,76
10 Cáceres;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
10 Cáceres;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
10 Cáceres;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
10 Cáceres;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;81,04
10 Cáceres;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
10 Cáceres;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
10 Cáceres;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
10 Cáceres;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
10 Cáceres;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
10 Cáceres;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QIV;1.563
10 Cáceres;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
10 Cáceres;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
10 Cáceres;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
10 Cáceres;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QIV;1.572
10 Cáceres;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
10 Cáceres;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
10 Cáceres;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
10 Cáceres;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QIV;1.593
10 Cáceres;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
10 Cáceres;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
10 Cáceres;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
10 Cáceres;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2022QIV;1.472
10 Cáceres;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
10 Cáceres;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2022QII;""
10 Cáceres;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2022QI;""
10 Cáceres;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2021QIV;1.470
10 Cáceres;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
10 Cáceres;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2021QII;""
10 Cáceres;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2021QI;""
10 Cáceres;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2020QIV;1.509
10 Cáceres;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
10 Cáceres;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2020QII;""
10 Cáceres;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2020QI;""
10 Cáceres;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
10 Cáceres;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
10 Cáceres;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2022QII;""
10 Cáceres;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2022QI;1.355
10 Cáceres;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
10 Cáceres;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
10 Cáceres;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2021QII;""
10 Cáceres;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2021QI;1.442
10 Cáceres;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
10 Cáceres;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
10 Cáceres;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2020QII;""
10 Cáceres;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2020QI;""
10 Cáceres;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
10 Cáceres;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
10 Cáceres;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QII;1.282
10 Cáceres;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QI;""
10 Cáceres;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
10 Cáceres;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
10 Cáceres;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QII;1.375
10 Cáceres;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QI;""
10 Cáceres;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
10 Cáceres;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
10 Cáceres;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QII;""
10 Cáceres;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QI;""
10 Cáceres;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
10 Cáceres;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QIII;1.211
10 Cáceres;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QII;""
10 Cáceres;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QI;""
10 Cáceres;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
10 Cáceres;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QIII;1.309
10 Cáceres;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QII;""
10 Cáceres;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QI;""
10 Cáceres;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
10 Cáceres;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
10 Cáceres;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QII;""
10 Cáceres;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QI;""
10 Cáceres;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
10 Cáceres;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
10 Cáceres;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
10 Cáceres;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
10 Cáceres;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
10 Cáceres;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
10 Cáceres;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
10 Cáceres;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
10 Cáceres;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
10 Cáceres;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
10 Cáceres;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
10 Cáceres;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
10 Cáceres;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;94,18
10 Cáceres;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
10 Cáceres;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
10 Cáceres;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
10 Cáceres;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;93,51
10 Cáceres;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
10 Cáceres;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
10 Cáceres;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
10 Cáceres;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;94,73
10 Cáceres;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
10 Cáceres;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
10 Cáceres;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
10 Cáceres;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
10 Cáceres;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
10 Cáceres;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
10 Cáceres;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;86,2
10 Cáceres;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
10 Cáceres;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
10 Cáceres;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
10 Cáceres;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;90,52
10 Cáceres;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
10 Cáceres;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
10 Cáceres;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
10 Cáceres;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
10 Cáceres;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
10 Cáceres;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
10 Cáceres;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;81,55
10 Cáceres;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
10 Cáceres;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
10 Cáceres;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
10 Cáceres;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;86,32
10 Cáceres;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
10 Cáceres;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
10 Cáceres;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
10 Cáceres;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
10 Cáceres;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
10 Cáceres;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
10 Cáceres;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;77,04
10 Cáceres;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
10 Cáceres;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
10 Cáceres;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
10 Cáceres;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;82,17
10 Cáceres;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
10 Cáceres;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
10 Cáceres;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
10 Cáceres;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
10 Cáceres;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
10 Cáceres;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
10 Cáceres;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QIV;947
10 Cáceres;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
10 Cáceres;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
10 Cáceres;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
10 Cáceres;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QIV;930
10 Cáceres;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
10 Cáceres;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
10 Cáceres;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
10 Cáceres;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QIV;953
10 Cáceres;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
10 Cáceres;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
10 Cáceres;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
10 Cáceres;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2022QIV;885
10 Cáceres;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
10 Cáceres;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2022QII;""
10 Cáceres;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2022QI;""
10 Cáceres;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2021QIV;873
10 Cáceres;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
10 Cáceres;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2021QII;""
10 Cáceres;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2021QI;""
10 Cáceres;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2020QIV;902
10 Cáceres;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
10 Cáceres;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2020QII;""
10 Cáceres;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2020QI;""
10 Cáceres;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
10 Cáceres;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
10 Cáceres;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2022QII;""
10 Cáceres;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2022QI;810
10 Cáceres;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
10 Cáceres;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
10 Cáceres;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2021QII;""
10 Cáceres;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2021QI;869
10 Cáceres;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
10 Cáceres;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
10 Cáceres;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2020QII;""
10 Cáceres;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2020QI;""
10 Cáceres;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
10 Cáceres;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
10 Cáceres;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QII;766
10 Cáceres;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QI;""
10 Cáceres;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
10 Cáceres;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
10 Cáceres;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QII;831
10 Cáceres;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QI;""
10 Cáceres;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
10 Cáceres;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
10 Cáceres;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QII;""
10 Cáceres;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QI;""
10 Cáceres;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
10 Cáceres;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QIII;727
10 Cáceres;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QII;""
10 Cáceres;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QI;""
10 Cáceres;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
10 Cáceres;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QIII;793
10 Cáceres;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QII;""
10 Cáceres;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QI;""
10 Cáceres;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
10 Cáceres;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
10 Cáceres;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QII;""
10 Cáceres;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QI;""
10 Cáceres;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
10 Cáceres;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
10 Cáceres;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
10 Cáceres;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
10 Cáceres;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
10 Cáceres;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
10 Cáceres;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
10 Cáceres;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
10 Cáceres;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
10 Cáceres;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
10 Cáceres;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
10 Cáceres;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
10 Cáceres;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;93,45
10 Cáceres;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
10 Cáceres;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
10 Cáceres;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
10 Cáceres;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;93,87
10 Cáceres;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
10 Cáceres;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
10 Cáceres;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
10 Cáceres;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;94,65
10 Cáceres;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
10 Cáceres;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
10 Cáceres;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
10 Cáceres;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
10 Cáceres;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
10 Cáceres;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
10 Cáceres;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;87,1
10 Cáceres;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
10 Cáceres;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
10 Cáceres;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
10 Cáceres;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;91,19
10 Cáceres;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
10 Cáceres;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
10 Cáceres;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
10 Cáceres;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
10 Cáceres;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
10 Cáceres;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
10 Cáceres;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;82,37
10 Cáceres;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
10 Cáceres;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
10 Cáceres;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
10 Cáceres;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;87,2
10 Cáceres;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
10 Cáceres;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
10 Cáceres;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
10 Cáceres;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
10 Cáceres;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
10 Cáceres;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
10 Cáceres;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;78,17
10 Cáceres;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
10 Cáceres;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
10 Cáceres;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
10 Cáceres;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;83,21
10 Cáceres;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
10 Cáceres;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
10 Cáceres;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
10 Cáceres;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
10 Cáceres;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
10 Cáceres;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
10 Cáceres;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QIV;616
10 Cáceres;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
10 Cáceres;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
10 Cáceres;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
10 Cáceres;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QIV;642
10 Cáceres;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
10 Cáceres;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
10 Cáceres;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
10 Cáceres;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QIV;640
10 Cáceres;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
10 Cáceres;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
10 Cáceres;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
10 Cáceres;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2022QIV;587
10 Cáceres;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
10 Cáceres;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2022QII;""
10 Cáceres;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2022QI;""
10 Cáceres;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2021QIV;597
10 Cáceres;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
10 Cáceres;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2021QII;""
10 Cáceres;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2021QI;""
10 Cáceres;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2020QIV;607
10 Cáceres;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
10 Cáceres;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2020QII;""
10 Cáceres;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2020QI;""
10 Cáceres;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
10 Cáceres;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
10 Cáceres;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2022QII;""
10 Cáceres;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2022QI;545
10 Cáceres;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
10 Cáceres;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
10 Cáceres;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2021QII;""
10 Cáceres;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2021QI;573
10 Cáceres;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
10 Cáceres;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
10 Cáceres;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2020QII;""
10 Cáceres;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2020QI;""
10 Cáceres;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
10 Cáceres;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
10 Cáceres;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QII;516
10 Cáceres;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QI;""
10 Cáceres;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
10 Cáceres;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
10 Cáceres;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QII;544
10 Cáceres;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QI;""
10 Cáceres;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
10 Cáceres;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
10 Cáceres;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QII;""
10 Cáceres;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QI;""
10 Cáceres;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
10 Cáceres;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QIII;484
10 Cáceres;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QII;""
10 Cáceres;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QI;""
10 Cáceres;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
10 Cáceres;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QIII;516
10 Cáceres;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QII;""
10 Cáceres;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QI;""
10 Cáceres;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
10 Cáceres;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
10 Cáceres;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QII;""
10 Cáceres;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QI;""
10 Cáceres;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
10 Cáceres;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
10 Cáceres;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
10 Cáceres;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
10 Cáceres;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
10 Cáceres;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
10 Cáceres;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
10 Cáceres;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
10 Cáceres;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
10 Cáceres;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
10 Cáceres;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
10 Cáceres;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
10 Cáceres;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;95,29
10 Cáceres;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
10 Cáceres;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
10 Cáceres;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
10 Cáceres;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;92,99
10 Cáceres;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
10 Cáceres;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
10 Cáceres;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
10 Cáceres;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;94,84
10 Cáceres;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
10 Cáceres;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
10 Cáceres;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
10 Cáceres;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
10 Cáceres;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
10 Cáceres;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
10 Cáceres;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;84,89
10 Cáceres;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
10 Cáceres;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
10 Cáceres;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
10 Cáceres;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;89,53
10 Cáceres;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
10 Cáceres;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
10 Cáceres;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
10 Cáceres;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
10 Cáceres;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
10 Cáceres;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
10 Cáceres;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;80,37
10 Cáceres;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
10 Cáceres;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
10 Cáceres;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
10 Cáceres;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;85
10 Cáceres;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
10 Cáceres;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
10 Cáceres;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
10 Cáceres;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
10 Cáceres;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
10 Cáceres;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
10 Cáceres;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;75,39
10 Cáceres;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
10 Cáceres;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
10 Cáceres;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
10 Cáceres;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;80,63
10 Cáceres;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
10 Cáceres;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
10 Cáceres;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
10 Cáceres;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
10 Cáceres;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
10 Cáceres;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
10 Cáceres;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
10 Cáceres;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
10 Cáceres;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
10 Cáceres;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QI;4.837
10 Cáceres;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
10 Cáceres;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
10 Cáceres;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
10 Cáceres;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QI;4.922
10 Cáceres;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
10 Cáceres;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
10 Cáceres;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
10 Cáceres;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QI;4.885
10 Cáceres;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
10 Cáceres;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
10 Cáceres;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2022QII;""
10 Cáceres;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2022QI;4.668
10 Cáceres;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
10 Cáceres;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
10 Cáceres;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2021QII;""
10 Cáceres;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2021QI;4.781
10 Cáceres;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
10 Cáceres;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
10 Cáceres;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2020QII;""
10 Cáceres;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2020QI;4.579
10 Cáceres;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
10 Cáceres;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
10 Cáceres;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2022QII;4.518
10 Cáceres;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2022QI;""
10 Cáceres;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
10 Cáceres;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
10 Cáceres;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2021QII;4.643
10 Cáceres;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2021QI;""
10 Cáceres;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
10 Cáceres;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
10 Cáceres;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2020QII;4.488
10 Cáceres;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2020QI;""
10 Cáceres;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
10 Cáceres;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QIII;4.358
10 Cáceres;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QII;""
10 Cáceres;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QI;""
10 Cáceres;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
10 Cáceres;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QIII;4.498
10 Cáceres;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QII;""
10 Cáceres;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QI;""
10 Cáceres;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
10 Cáceres;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QIII;4.376
10 Cáceres;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QII;""
10 Cáceres;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QI;""
10 Cáceres;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QIV;4.224
10 Cáceres;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
10 Cáceres;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QII;""
10 Cáceres;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QI;""
10 Cáceres;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QIV;4.392
10 Cáceres;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
10 Cáceres;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QII;""
10 Cáceres;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QI;""
10 Cáceres;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QIV;4.246
10 Cáceres;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
10 Cáceres;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QII;""
10 Cáceres;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QI;""
10 Cáceres;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
10 Cáceres;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
10 Cáceres;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
10 Cáceres;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
10 Cáceres;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
10 Cáceres;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
10 Cáceres;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
10 Cáceres;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
10 Cáceres;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
10 Cáceres;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
10 Cáceres;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
10 Cáceres;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
10 Cáceres;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
10 Cáceres;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
10 Cáceres;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
10 Cáceres;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;96,51
10 Cáceres;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
10 Cáceres;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
10 Cáceres;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
10 Cáceres;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;97,14
10 Cáceres;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
10 Cáceres;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
10 Cáceres;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
10 Cáceres;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;93,74
10 Cáceres;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
10 Cáceres;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
10 Cáceres;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;93,41
10 Cáceres;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
10 Cáceres;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
10 Cáceres;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
10 Cáceres;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;94,33
10 Cáceres;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
10 Cáceres;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
10 Cáceres;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
10 Cáceres;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;91,87
10 Cáceres;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
10 Cáceres;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
10 Cáceres;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;90,1
10 Cáceres;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
10 Cáceres;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
10 Cáceres;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
10 Cáceres;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;91,39
10 Cáceres;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
10 Cáceres;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
10 Cáceres;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
10 Cáceres;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;89,58
10 Cáceres;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
10 Cáceres;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
10 Cáceres;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;87,33
10 Cáceres;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
10 Cáceres;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
10 Cáceres;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
10 Cáceres;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;89,23
10 Cáceres;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
10 Cáceres;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
10 Cáceres;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
10 Cáceres;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;86,92
10 Cáceres;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
10 Cáceres;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
10 Cáceres;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
10 Cáceres;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
10 Cáceres;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
10 Cáceres;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
10 Cáceres;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QI;2.913
10 Cáceres;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
10 Cáceres;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
10 Cáceres;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
10 Cáceres;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QI;2.993
10 Cáceres;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
10 Cáceres;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
10 Cáceres;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
10 Cáceres;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QI;2.948
10 Cáceres;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
10 Cáceres;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
10 Cáceres;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2022QII;""
10 Cáceres;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2022QI;2.813
10 Cáceres;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
10 Cáceres;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
10 Cáceres;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2021QII;""
10 Cáceres;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2021QI;2.928
10 Cáceres;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
10 Cáceres;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
10 Cáceres;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2020QII;""
10 Cáceres;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2020QI;2.764
10 Cáceres;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
10 Cáceres;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
10 Cáceres;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2022QII;2.737
10 Cáceres;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2022QI;""
10 Cáceres;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
10 Cáceres;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
10 Cáceres;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2021QII;2.855
10 Cáceres;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2021QI;""
10 Cáceres;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
10 Cáceres;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
10 Cáceres;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2020QII;2.720
10 Cáceres;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2020QI;""
10 Cáceres;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
10 Cáceres;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QIII;2.651
10 Cáceres;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QII;""
10 Cáceres;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QI;""
10 Cáceres;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
10 Cáceres;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QIII;2.784
10 Cáceres;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QII;""
10 Cáceres;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QI;""
10 Cáceres;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
10 Cáceres;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QIII;2.664
10 Cáceres;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QII;""
10 Cáceres;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QI;""
10 Cáceres;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QIV;2.574
10 Cáceres;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
10 Cáceres;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QII;""
10 Cáceres;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QI;""
10 Cáceres;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QIV;2.726
10 Cáceres;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
10 Cáceres;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QII;""
10 Cáceres;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QI;""
10 Cáceres;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QIV;2.591
10 Cáceres;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
10 Cáceres;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QII;""
10 Cáceres;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QI;""
10 Cáceres;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
10 Cáceres;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
10 Cáceres;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
10 Cáceres;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
10 Cáceres;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
10 Cáceres;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
10 Cáceres;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
10 Cáceres;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
10 Cáceres;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
10 Cáceres;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
10 Cáceres;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
10 Cáceres;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
10 Cáceres;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
10 Cáceres;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
10 Cáceres;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
10 Cáceres;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;96,57
10 Cáceres;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
10 Cáceres;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
10 Cáceres;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
10 Cáceres;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;97,83
10 Cáceres;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
10 Cáceres;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
10 Cáceres;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
10 Cáceres;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;93,76
10 Cáceres;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
10 Cáceres;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
10 Cáceres;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;93,96
10 Cáceres;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
10 Cáceres;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
10 Cáceres;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
10 Cáceres;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;95,39
10 Cáceres;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
10 Cáceres;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
10 Cáceres;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
10 Cáceres;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;92,27
10 Cáceres;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
10 Cáceres;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
10 Cáceres;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;91,01
10 Cáceres;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
10 Cáceres;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
10 Cáceres;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
10 Cáceres;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;93,02
10 Cáceres;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
10 Cáceres;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
10 Cáceres;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
10 Cáceres;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;90,37
10 Cáceres;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
10 Cáceres;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
10 Cáceres;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;88,36
10 Cáceres;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
10 Cáceres;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
10 Cáceres;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
10 Cáceres;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;91,08
10 Cáceres;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
10 Cáceres;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
10 Cáceres;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
10 Cáceres;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;87,89
10 Cáceres;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
10 Cáceres;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
10 Cáceres;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
10 Cáceres;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
10 Cáceres;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
10 Cáceres;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
10 Cáceres;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QI;1.924
10 Cáceres;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
10 Cáceres;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
10 Cáceres;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
10 Cáceres;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QI;1.929
10 Cáceres;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
10 Cáceres;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
10 Cáceres;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
10 Cáceres;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QI;1.937
10 Cáceres;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
10 Cáceres;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
10 Cáceres;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2022QII;""
10 Cáceres;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2022QI;1.855
10 Cáceres;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
10 Cáceres;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
10 Cáceres;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2021QII;""
10 Cáceres;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2021QI;1.853
10 Cáceres;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
10 Cáceres;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
10 Cáceres;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2020QII;""
10 Cáceres;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2020QI;1.815
10 Cáceres;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
10 Cáceres;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
10 Cáceres;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2022QII;1.781
10 Cáceres;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2022QI;""
10 Cáceres;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
10 Cáceres;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
10 Cáceres;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2021QII;1.788
10 Cáceres;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2021QI;""
10 Cáceres;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
10 Cáceres;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
10 Cáceres;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2020QII;1.768
10 Cáceres;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2020QI;""
10 Cáceres;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
10 Cáceres;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QIII;1.707
10 Cáceres;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QII;""
10 Cáceres;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QI;""
10 Cáceres;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
10 Cáceres;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QIII;1.714
10 Cáceres;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QII;""
10 Cáceres;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QI;""
10 Cáceres;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
10 Cáceres;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QIII;1.712
10 Cáceres;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QII;""
10 Cáceres;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QI;""
10 Cáceres;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QIV;1.650
10 Cáceres;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
10 Cáceres;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QII;""
10 Cáceres;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QI;""
10 Cáceres;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QIV;1.666
10 Cáceres;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
10 Cáceres;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QII;""
10 Cáceres;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QI;""
10 Cáceres;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QIV;1.655
10 Cáceres;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
10 Cáceres;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QII;""
10 Cáceres;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QI;""
10 Cáceres;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
10 Cáceres;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
10 Cáceres;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
10 Cáceres;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
10 Cáceres;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
10 Cáceres;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
10 Cáceres;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
10 Cáceres;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
10 Cáceres;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
10 Cáceres;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
10 Cáceres;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
10 Cáceres;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
10 Cáceres;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
10 Cáceres;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
10 Cáceres;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
10 Cáceres;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;96,41
10 Cáceres;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
10 Cáceres;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
10 Cáceres;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
10 Cáceres;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;96,06
10 Cáceres;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
10 Cáceres;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
10 Cáceres;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
10 Cáceres;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;93,7
10 Cáceres;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
10 Cáceres;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
10 Cáceres;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;92,57
10 Cáceres;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
10 Cáceres;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
10 Cáceres;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
10 Cáceres;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;92,69
10 Cáceres;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
10 Cáceres;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
10 Cáceres;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
10 Cáceres;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;91,28
10 Cáceres;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
10 Cáceres;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
10 Cáceres;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;88,72
10 Cáceres;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
10 Cáceres;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
10 Cáceres;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
10 Cáceres;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;88,85
10 Cáceres;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
10 Cáceres;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
10 Cáceres;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
10 Cáceres;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;88,38
10 Cáceres;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
10 Cáceres;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
10 Cáceres;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;85,76
10 Cáceres;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
10 Cáceres;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
10 Cáceres;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
10 Cáceres;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;86,37
10 Cáceres;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
10 Cáceres;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
10 Cáceres;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
10 Cáceres;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;85,44
10 Cáceres;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
10 Cáceres;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
10 Cáceres;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
10 Cáceres;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
10 Cáceres;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
10 Cáceres;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QII;4.676
10 Cáceres;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
10 Cáceres;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
10 Cáceres;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
10 Cáceres;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QII;4.667
10 Cáceres;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
10 Cáceres;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
10 Cáceres;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
10 Cáceres;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QII;4.828
10 Cáceres;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
10 Cáceres;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
10 Cáceres;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
10 Cáceres;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2022QII;4.516
10 Cáceres;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2022QI;""
10 Cáceres;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
10 Cáceres;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
10 Cáceres;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2021QII;4.513
10 Cáceres;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2021QI;""
10 Cáceres;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
10 Cáceres;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
10 Cáceres;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2020QII;4.730
10 Cáceres;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2020QI;""
10 Cáceres;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
10 Cáceres;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2022QIII;4.345
10 Cáceres;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2022QII;""
10 Cáceres;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2022QI;""
10 Cáceres;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
10 Cáceres;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2021QIII;4.362
10 Cáceres;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2021QII;""
10 Cáceres;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2021QI;""
10 Cáceres;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
10 Cáceres;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2020QIII;4.608
10 Cáceres;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2020QII;""
10 Cáceres;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2020QI;""
10 Cáceres;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QIV;4.203
10 Cáceres;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
10 Cáceres;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QII;""
10 Cáceres;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QI;""
10 Cáceres;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QIV;4.238
10 Cáceres;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
10 Cáceres;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QII;""
10 Cáceres;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QI;""
10 Cáceres;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QIV;4.470
10 Cáceres;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
10 Cáceres;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QII;""
10 Cáceres;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QI;""
10 Cáceres;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
10 Cáceres;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
10 Cáceres;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QII;""
10 Cáceres;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QI;4.101
10 Cáceres;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
10 Cáceres;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
10 Cáceres;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QII;""
10 Cáceres;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QI;4.357
10 Cáceres;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
10 Cáceres;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
10 Cáceres;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QII;""
10 Cáceres;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QI;""
10 Cáceres;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
10 Cáceres;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
10 Cáceres;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
10 Cáceres;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
10 Cáceres;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
10 Cáceres;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
10 Cáceres;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
10 Cáceres;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
10 Cáceres;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
10 Cáceres;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
10 Cáceres;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
10 Cáceres;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
10 Cáceres;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
10 Cáceres;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
10 Cáceres;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;96,58
10 Cáceres;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
10 Cáceres;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
10 Cáceres;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
10 Cáceres;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;96,7
10 Cáceres;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
10 Cáceres;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
10 Cáceres;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
10 Cáceres;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;97,97
10 Cáceres;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
10 Cáceres;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
10 Cáceres;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;92,92
10 Cáceres;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
10 Cáceres;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
10 Cáceres;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
10 Cáceres;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;93,46
10 Cáceres;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
10 Cáceres;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
10 Cáceres;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
10 Cáceres;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;95,44
10 Cáceres;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
10 Cáceres;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
10 Cáceres;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;89,88
10 Cáceres;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
10 Cáceres;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
10 Cáceres;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
10 Cáceres;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;90,81
10 Cáceres;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
10 Cáceres;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
10 Cáceres;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
10 Cáceres;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;92,58
10 Cáceres;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
10 Cáceres;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
10 Cáceres;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
10 Cáceres;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
10 Cáceres;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
10 Cáceres;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
10 Cáceres;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;87,87
10 Cáceres;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
10 Cáceres;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
10 Cáceres;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
10 Cáceres;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;90,24
10 Cáceres;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
10 Cáceres;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
10 Cáceres;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
10 Cáceres;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
10 Cáceres;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
10 Cáceres;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
10 Cáceres;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QII;2.735
10 Cáceres;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
10 Cáceres;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
10 Cáceres;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
10 Cáceres;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QII;2.835
10 Cáceres;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
10 Cáceres;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
10 Cáceres;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
10 Cáceres;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QII;2.900
10 Cáceres;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
10 Cáceres;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
10 Cáceres;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
10 Cáceres;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2022QII;2.654
10 Cáceres;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2022QI;""
10 Cáceres;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
10 Cáceres;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
10 Cáceres;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2021QII;2.755
10 Cáceres;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2021QI;""
10 Cáceres;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
10 Cáceres;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
10 Cáceres;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2020QII;2.852
10 Cáceres;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2020QI;""
10 Cáceres;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
10 Cáceres;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2022QIII;2.564
10 Cáceres;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2022QII;""
10 Cáceres;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2022QI;""
10 Cáceres;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
10 Cáceres;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2021QIII;2.678
10 Cáceres;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2021QII;""
10 Cáceres;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2021QI;""
10 Cáceres;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
10 Cáceres;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2020QIII;2.792
10 Cáceres;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2020QII;""
10 Cáceres;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2020QI;""
10 Cáceres;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QIV;2.482
10 Cáceres;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
10 Cáceres;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QII;""
10 Cáceres;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QI;""
10 Cáceres;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QIV;2.609
10 Cáceres;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
10 Cáceres;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QII;""
10 Cáceres;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QI;""
10 Cáceres;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QIV;2.714
10 Cáceres;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
10 Cáceres;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QII;""
10 Cáceres;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QI;""
10 Cáceres;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
10 Cáceres;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
10 Cáceres;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QII;""
10 Cáceres;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QI;2.529
10 Cáceres;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
10 Cáceres;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
10 Cáceres;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QII;""
10 Cáceres;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QI;2.666
10 Cáceres;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
10 Cáceres;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
10 Cáceres;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QII;""
10 Cáceres;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QI;""
10 Cáceres;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
10 Cáceres;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
10 Cáceres;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
10 Cáceres;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
10 Cáceres;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
10 Cáceres;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
10 Cáceres;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
10 Cáceres;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
10 Cáceres;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
10 Cáceres;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
10 Cáceres;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
10 Cáceres;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
10 Cáceres;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
10 Cáceres;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
10 Cáceres;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;97,04
10 Cáceres;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
10 Cáceres;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
10 Cáceres;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
10 Cáceres;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;97,18
10 Cáceres;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
10 Cáceres;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
10 Cáceres;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
10 Cáceres;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;98,34
10 Cáceres;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
10 Cáceres;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
10 Cáceres;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;93,75
10 Cáceres;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
10 Cáceres;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
10 Cáceres;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
10 Cáceres;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;94,46
10 Cáceres;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
10 Cáceres;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
10 Cáceres;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
10 Cáceres;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;96,28
10 Cáceres;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
10 Cáceres;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
10 Cáceres;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;90,75
10 Cáceres;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
10 Cáceres;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
10 Cáceres;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
10 Cáceres;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;92,03
10 Cáceres;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
10 Cáceres;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
10 Cáceres;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
10 Cáceres;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;93,59
10 Cáceres;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
10 Cáceres;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
10 Cáceres;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
10 Cáceres;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
10 Cáceres;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
10 Cáceres;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
10 Cáceres;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;89,21
10 Cáceres;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
10 Cáceres;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
10 Cáceres;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
10 Cáceres;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;91,93
10 Cáceres;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
10 Cáceres;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
10 Cáceres;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
10 Cáceres;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
10 Cáceres;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
10 Cáceres;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
10 Cáceres;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QII;1.941
10 Cáceres;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
10 Cáceres;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
10 Cáceres;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
10 Cáceres;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QII;1.832
10 Cáceres;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
10 Cáceres;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
10 Cáceres;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
10 Cáceres;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QII;1.928
10 Cáceres;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
10 Cáceres;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
10 Cáceres;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
10 Cáceres;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2022QII;1.862
10 Cáceres;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2022QI;""
10 Cáceres;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
10 Cáceres;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
10 Cáceres;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2021QII;1.758
10 Cáceres;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2021QI;""
10 Cáceres;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
10 Cáceres;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
10 Cáceres;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2020QII;1.878
10 Cáceres;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2020QI;""
10 Cáceres;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
10 Cáceres;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2022QIII;1.781
10 Cáceres;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2022QII;""
10 Cáceres;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2022QI;""
10 Cáceres;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
10 Cáceres;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2021QIII;1.684
10 Cáceres;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2021QII;""
10 Cáceres;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2021QI;""
10 Cáceres;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
10 Cáceres;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2020QIII;1.816
10 Cáceres;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2020QII;""
10 Cáceres;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2020QI;""
10 Cáceres;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QIV;1.721
10 Cáceres;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
10 Cáceres;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QII;""
10 Cáceres;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QI;""
10 Cáceres;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QIV;1.629
10 Cáceres;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
10 Cáceres;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QII;""
10 Cáceres;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QI;""
10 Cáceres;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QIV;1.756
10 Cáceres;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
10 Cáceres;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QII;""
10 Cáceres;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QI;""
10 Cáceres;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
10 Cáceres;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
10 Cáceres;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QII;""
10 Cáceres;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QI;1.572
10 Cáceres;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
10 Cáceres;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
10 Cáceres;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QII;""
10 Cáceres;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QI;1.691
10 Cáceres;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
10 Cáceres;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
10 Cáceres;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QII;""
10 Cáceres;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QI;""
10 Cáceres;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
10 Cáceres;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
10 Cáceres;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
10 Cáceres;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
10 Cáceres;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
10 Cáceres;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
10 Cáceres;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
10 Cáceres;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
10 Cáceres;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
10 Cáceres;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
10 Cáceres;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
10 Cáceres;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
10 Cáceres;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
10 Cáceres;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
10 Cáceres;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;95,93
10 Cáceres;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
10 Cáceres;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
10 Cáceres;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
10 Cáceres;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;95,96
10 Cáceres;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
10 Cáceres;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
10 Cáceres;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
10 Cáceres;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;97,41
10 Cáceres;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
10 Cáceres;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
10 Cáceres;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;91,76
10 Cáceres;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
10 Cáceres;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
10 Cáceres;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
10 Cáceres;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;91,92
10 Cáceres;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
10 Cáceres;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
10 Cáceres;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
10 Cáceres;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;94,19
10 Cáceres;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
10 Cáceres;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
10 Cáceres;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;88,67
10 Cáceres;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
10 Cáceres;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
10 Cáceres;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
10 Cáceres;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;88,92
10 Cáceres;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
10 Cáceres;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
10 Cáceres;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
10 Cáceres;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;91,08
10 Cáceres;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
10 Cáceres;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
10 Cáceres;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
10 Cáceres;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
10 Cáceres;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
10 Cáceres;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
10 Cáceres;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;85,81
10 Cáceres;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
10 Cáceres;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
10 Cáceres;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
10 Cáceres;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;87,71
10 Cáceres;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
10 Cáceres;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
10 Cáceres;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
10 Cáceres;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
10 Cáceres;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
10 Cáceres;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QIII;4.686
10 Cáceres;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
10 Cáceres;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
10 Cáceres;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
10 Cáceres;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QIII;4.760
10 Cáceres;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
10 Cáceres;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
10 Cáceres;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
10 Cáceres;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QIII;4.876
10 Cáceres;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
10 Cáceres;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
10 Cáceres;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
10 Cáceres;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2022QIII;4.486
10 Cáceres;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2022QII;""
10 Cáceres;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2022QI;""
10 Cáceres;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
10 Cáceres;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2021QIII;4.583
10 Cáceres;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2021QII;""
10 Cáceres;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2021QI;""
10 Cáceres;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
10 Cáceres;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2020QIII;4.729
10 Cáceres;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2020QII;""
10 Cáceres;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2020QI;""
10 Cáceres;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2022QIV;4.331
10 Cáceres;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
10 Cáceres;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2022QII;""
10 Cáceres;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2022QI;""
10 Cáceres;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2021QIV;4.440
10 Cáceres;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
10 Cáceres;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2021QII;""
10 Cáceres;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2021QI;""
10 Cáceres;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2020QIV;4.571
10 Cáceres;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
10 Cáceres;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2020QII;""
10 Cáceres;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2020QI;""
10 Cáceres;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
10 Cáceres;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
10 Cáceres;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QII;""
10 Cáceres;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QI;4.296
10 Cáceres;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
10 Cáceres;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
10 Cáceres;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QII;""
10 Cáceres;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QI;4.454
10 Cáceres;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
10 Cáceres;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
10 Cáceres;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QII;""
10 Cáceres;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QI;""
10 Cáceres;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
10 Cáceres;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
10 Cáceres;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QII;4.161
10 Cáceres;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QI;""
10 Cáceres;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
10 Cáceres;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
10 Cáceres;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QII;4.335
10 Cáceres;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QI;""
10 Cáceres;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
10 Cáceres;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
10 Cáceres;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QII;""
10 Cáceres;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QI;""
10 Cáceres;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
10 Cáceres;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
10 Cáceres;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
10 Cáceres;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
10 Cáceres;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
10 Cáceres;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
10 Cáceres;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
10 Cáceres;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
10 Cáceres;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
10 Cáceres;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
10 Cáceres;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
10 Cáceres;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
10 Cáceres;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
10 Cáceres;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;95,73
10 Cáceres;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
10 Cáceres;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
10 Cáceres;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
10 Cáceres;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;96,28
10 Cáceres;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
10 Cáceres;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
10 Cáceres;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
10 Cáceres;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;96,99
10 Cáceres;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
10 Cáceres;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
10 Cáceres;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;92,42
10 Cáceres;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
10 Cáceres;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
10 Cáceres;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
10 Cáceres;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;93,28
10 Cáceres;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
10 Cáceres;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
10 Cáceres;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
10 Cáceres;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;93,74
10 Cáceres;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
10 Cáceres;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
10 Cáceres;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
10 Cáceres;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
10 Cáceres;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
10 Cáceres;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
10 Cáceres;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;90,25
10 Cáceres;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
10 Cáceres;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
10 Cáceres;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
10 Cáceres;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;91,35
10 Cáceres;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
10 Cáceres;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
10 Cáceres;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
10 Cáceres;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
10 Cáceres;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
10 Cáceres;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
10 Cáceres;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;87,42
10 Cáceres;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
10 Cáceres;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
10 Cáceres;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
10 Cáceres;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;88,9
10 Cáceres;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
10 Cáceres;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
10 Cáceres;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
10 Cáceres;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
10 Cáceres;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
10 Cáceres;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
10 Cáceres;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QIII;2.760
10 Cáceres;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
10 Cáceres;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
10 Cáceres;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
10 Cáceres;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QIII;2.887
10 Cáceres;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
10 Cáceres;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
10 Cáceres;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
10 Cáceres;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QIII;2.952
10 Cáceres;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
10 Cáceres;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
10 Cáceres;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
10 Cáceres;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2022QIII;2.653
10 Cáceres;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2022QII;""
10 Cáceres;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2022QI;""
10 Cáceres;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
10 Cáceres;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2021QIII;2.794
10 Cáceres;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2021QII;""
10 Cáceres;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2021QI;""
10 Cáceres;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
10 Cáceres;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2020QIII;2.879
10 Cáceres;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2020QII;""
10 Cáceres;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2020QI;""
10 Cáceres;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2022QIV;2.564
10 Cáceres;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
10 Cáceres;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2022QII;""
10 Cáceres;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2022QI;""
10 Cáceres;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2021QIV;2.712
10 Cáceres;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
10 Cáceres;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2021QII;""
10 Cáceres;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2021QI;""
10 Cáceres;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2020QIV;2.785
10 Cáceres;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
10 Cáceres;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2020QII;""
10 Cáceres;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2020QI;""
10 Cáceres;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
10 Cáceres;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
10 Cáceres;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QII;""
10 Cáceres;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QI;2.627
10 Cáceres;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
10 Cáceres;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
10 Cáceres;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QII;""
10 Cáceres;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QI;2.734
10 Cáceres;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
10 Cáceres;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
10 Cáceres;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QII;""
10 Cáceres;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QI;""
10 Cáceres;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
10 Cáceres;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
10 Cáceres;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QII;2.557
10 Cáceres;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QI;""
10 Cáceres;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
10 Cáceres;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
10 Cáceres;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QII;2.674
10 Cáceres;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QI;""
10 Cáceres;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
10 Cáceres;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
10 Cáceres;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QII;""
10 Cáceres;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QI;""
10 Cáceres;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
10 Cáceres;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
10 Cáceres;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
10 Cáceres;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
10 Cáceres;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
10 Cáceres;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
10 Cáceres;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
10 Cáceres;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
10 Cáceres;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
10 Cáceres;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
10 Cáceres;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
10 Cáceres;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
10 Cáceres;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
10 Cáceres;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;96,12
10 Cáceres;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
10 Cáceres;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
10 Cáceres;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
10 Cáceres;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;96,78
10 Cáceres;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
10 Cáceres;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
10 Cáceres;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
10 Cáceres;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;97,53
10 Cáceres;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
10 Cáceres;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
10 Cáceres;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;92,9
10 Cáceres;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
10 Cáceres;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
10 Cáceres;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
10 Cáceres;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;93,94
10 Cáceres;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
10 Cáceres;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
10 Cáceres;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
10 Cáceres;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;94,34
10 Cáceres;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
10 Cáceres;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
10 Cáceres;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
10 Cáceres;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
10 Cáceres;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
10 Cáceres;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
10 Cáceres;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;90,99
10 Cáceres;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
10 Cáceres;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
10 Cáceres;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
10 Cáceres;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;92,62
10 Cáceres;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
10 Cáceres;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
10 Cáceres;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
10 Cáceres;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
10 Cáceres;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
10 Cáceres;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
10 Cáceres;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;88,57
10 Cáceres;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
10 Cáceres;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
10 Cáceres;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
10 Cáceres;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;90,58
10 Cáceres;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
10 Cáceres;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
10 Cáceres;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
10 Cáceres;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
10 Cáceres;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
10 Cáceres;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
10 Cáceres;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QIII;1.926
10 Cáceres;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
10 Cáceres;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
10 Cáceres;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
10 Cáceres;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QIII;1.873
10 Cáceres;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
10 Cáceres;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
10 Cáceres;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
10 Cáceres;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QIII;1.924
10 Cáceres;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
10 Cáceres;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
10 Cáceres;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
10 Cáceres;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2022QIII;1.833
10 Cáceres;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2022QII;""
10 Cáceres;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2022QI;""
10 Cáceres;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
10 Cáceres;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2021QIII;1.789
10 Cáceres;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2021QII;""
10 Cáceres;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2021QI;""
10 Cáceres;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
10 Cáceres;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2020QIII;1.850
10 Cáceres;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2020QII;""
10 Cáceres;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2020QI;""
10 Cáceres;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2022QIV;1.767
10 Cáceres;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
10 Cáceres;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2022QII;""
10 Cáceres;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2022QI;""
10 Cáceres;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2021QIV;1.728
10 Cáceres;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
10 Cáceres;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2021QII;""
10 Cáceres;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2021QI;""
10 Cáceres;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2020QIV;1.786
10 Cáceres;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
10 Cáceres;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2020QII;""
10 Cáceres;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2020QI;""
10 Cáceres;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
10 Cáceres;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
10 Cáceres;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QII;""
10 Cáceres;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QI;1.669
10 Cáceres;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
10 Cáceres;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
10 Cáceres;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QII;""
10 Cáceres;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QI;1.720
10 Cáceres;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
10 Cáceres;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
10 Cáceres;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QII;""
10 Cáceres;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QI;""
10 Cáceres;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
10 Cáceres;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
10 Cáceres;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QII;1.604
10 Cáceres;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QI;""
10 Cáceres;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
10 Cáceres;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
10 Cáceres;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QII;1.661
10 Cáceres;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QI;""
10 Cáceres;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
10 Cáceres;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
10 Cáceres;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QII;""
10 Cáceres;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QI;""
10 Cáceres;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
10 Cáceres;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
10 Cáceres;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
10 Cáceres;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
10 Cáceres;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
10 Cáceres;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
10 Cáceres;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
10 Cáceres;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
10 Cáceres;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
10 Cáceres;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
10 Cáceres;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
10 Cáceres;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
10 Cáceres;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
10 Cáceres;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;95,17
10 Cáceres;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
10 Cáceres;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
10 Cáceres;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
10 Cáceres;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;95,52
10 Cáceres;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
10 Cáceres;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
10 Cáceres;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
10 Cáceres;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;96,15
10 Cáceres;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
10 Cáceres;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
10 Cáceres;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;91,74
10 Cáceres;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
10 Cáceres;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
10 Cáceres;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
10 Cáceres;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;92,26
10 Cáceres;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
10 Cáceres;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
10 Cáceres;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
10 Cáceres;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;92,83
10 Cáceres;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
10 Cáceres;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
10 Cáceres;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
10 Cáceres;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
10 Cáceres;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
10 Cáceres;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
10 Cáceres;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;89,11
10 Cáceres;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
10 Cáceres;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
10 Cáceres;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
10 Cáceres;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;89,4
10 Cáceres;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
10 Cáceres;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
10 Cáceres;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
10 Cáceres;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
10 Cáceres;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
10 Cáceres;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
10 Cáceres;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;85,64
10 Cáceres;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
10 Cáceres;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
10 Cáceres;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
10 Cáceres;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;86,33
10 Cáceres;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
10 Cáceres;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
10 Cáceres;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
10 Cáceres;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
10 Cáceres;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
10 Cáceres;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QIV;4.632
10 Cáceres;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
10 Cáceres;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
10 Cáceres;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
10 Cáceres;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QIV;4.769
10 Cáceres;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
10 Cáceres;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
10 Cáceres;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
10 Cáceres;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QIV;4.914
10 Cáceres;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
10 Cáceres;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
10 Cáceres;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
10 Cáceres;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2022QIV;4.462
10 Cáceres;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
10 Cáceres;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2022QII;""
10 Cáceres;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2022QI;""
10 Cáceres;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2021QIV;4.599
10 Cáceres;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
10 Cáceres;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2021QII;""
10 Cáceres;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2021QI;""
10 Cáceres;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2020QIV;4.738
10 Cáceres;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
10 Cáceres;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2020QII;""
10 Cáceres;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2020QI;""
10 Cáceres;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
10 Cáceres;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
10 Cáceres;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2022QII;""
10 Cáceres;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2022QI;4.443
10 Cáceres;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
10 Cáceres;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
10 Cáceres;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2021QII;""
10 Cáceres;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2021QI;4.609
10 Cáceres;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
10 Cáceres;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
10 Cáceres;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2020QII;""
10 Cáceres;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2020QI;""
10 Cáceres;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
10 Cáceres;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
10 Cáceres;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QII;4.306
10 Cáceres;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QI;""
10 Cáceres;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
10 Cáceres;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
10 Cáceres;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QII;4.483
10 Cáceres;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QI;""
10 Cáceres;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
10 Cáceres;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
10 Cáceres;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QII;""
10 Cáceres;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QI;""
10 Cáceres;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
10 Cáceres;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QIII;4.151
10 Cáceres;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QII;""
10 Cáceres;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QI;""
10 Cáceres;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
10 Cáceres;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QIII;4.350
10 Cáceres;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QII;""
10 Cáceres;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QI;""
10 Cáceres;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
10 Cáceres;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
10 Cáceres;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QII;""
10 Cáceres;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QI;""
10 Cáceres;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
10 Cáceres;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
10 Cáceres;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
10 Cáceres;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
10 Cáceres;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
10 Cáceres;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
10 Cáceres;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
10 Cáceres;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
10 Cáceres;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
10 Cáceres;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
10 Cáceres;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
10 Cáceres;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
10 Cáceres;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;96,33
10 Cáceres;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
10 Cáceres;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
10 Cáceres;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
10 Cáceres;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;96,44
10 Cáceres;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
10 Cáceres;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
10 Cáceres;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
10 Cáceres;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;96,42
10 Cáceres;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
10 Cáceres;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
10 Cáceres;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
10 Cáceres;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
10 Cáceres;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
10 Cáceres;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
10 Cáceres;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;93,16
10 Cáceres;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
10 Cáceres;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
10 Cáceres;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
10 Cáceres;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;93,79
10 Cáceres;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
10 Cáceres;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
10 Cáceres;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
10 Cáceres;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
10 Cáceres;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
10 Cáceres;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
10 Cáceres;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;90,29
10 Cáceres;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
10 Cáceres;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
10 Cáceres;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
10 Cáceres;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;91,23
10 Cáceres;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
10 Cáceres;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
10 Cáceres;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
10 Cáceres;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
10 Cáceres;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
10 Cáceres;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
10 Cáceres;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;87,04
10 Cáceres;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
10 Cáceres;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
10 Cáceres;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
10 Cáceres;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;88,52
10 Cáceres;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
10 Cáceres;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
10 Cáceres;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
10 Cáceres;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
10 Cáceres;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
10 Cáceres;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
10 Cáceres;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QIV;2.737
10 Cáceres;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
10 Cáceres;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
10 Cáceres;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
10 Cáceres;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QIV;2.903
10 Cáceres;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
10 Cáceres;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
10 Cáceres;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
10 Cáceres;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QIV;3.002
10 Cáceres;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
10 Cáceres;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
10 Cáceres;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
10 Cáceres;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2022QIV;2.640
10 Cáceres;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
10 Cáceres;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2022QII;""
10 Cáceres;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2022QI;""
10 Cáceres;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2021QIV;2.802
10 Cáceres;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
10 Cáceres;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2021QII;""
10 Cáceres;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2021QI;""
10 Cáceres;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2020QIV;2.896
10 Cáceres;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
10 Cáceres;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2020QII;""
10 Cáceres;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2020QI;""
10 Cáceres;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
10 Cáceres;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
10 Cáceres;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2022QII;""
10 Cáceres;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2022QI;2.711
10 Cáceres;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
10 Cáceres;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
10 Cáceres;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2021QII;""
10 Cáceres;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2021QI;2.833
10 Cáceres;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
10 Cáceres;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
10 Cáceres;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2020QII;""
10 Cáceres;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2020QI;""
10 Cáceres;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
10 Cáceres;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
10 Cáceres;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QII;2.640
10 Cáceres;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QI;""
10 Cáceres;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
10 Cáceres;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
10 Cáceres;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QII;2.768
10 Cáceres;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QI;""
10 Cáceres;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
10 Cáceres;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
10 Cáceres;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QII;""
10 Cáceres;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QI;""
10 Cáceres;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
10 Cáceres;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QIII;2.555
10 Cáceres;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QII;""
10 Cáceres;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QI;""
10 Cáceres;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
10 Cáceres;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QIII;2.706
10 Cáceres;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QII;""
10 Cáceres;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QI;""
10 Cáceres;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
10 Cáceres;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
10 Cáceres;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QII;""
10 Cáceres;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QI;""
10 Cáceres;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
10 Cáceres;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
10 Cáceres;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
10 Cáceres;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
10 Cáceres;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
10 Cáceres;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
10 Cáceres;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
10 Cáceres;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
10 Cáceres;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
10 Cáceres;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
10 Cáceres;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
10 Cáceres;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
10 Cáceres;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;96,46
10 Cáceres;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
10 Cáceres;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
10 Cáceres;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
10 Cáceres;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;96,52
10 Cáceres;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
10 Cáceres;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
10 Cáceres;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
10 Cáceres;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;96,47
10 Cáceres;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
10 Cáceres;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
10 Cáceres;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
10 Cáceres;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
10 Cáceres;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
10 Cáceres;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
10 Cáceres;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;93,39
10 Cáceres;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
10 Cáceres;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
10 Cáceres;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
10 Cáceres;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;94,37
10 Cáceres;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
10 Cáceres;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
10 Cáceres;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
10 Cáceres;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
10 Cáceres;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
10 Cáceres;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
10 Cáceres;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;90,94
10 Cáceres;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
10 Cáceres;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
10 Cáceres;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
10 Cáceres;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;92,21
10 Cáceres;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
10 Cáceres;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
10 Cáceres;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
10 Cáceres;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
10 Cáceres;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
10 Cáceres;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
10 Cáceres;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;88,01
10 Cáceres;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
10 Cáceres;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
10 Cáceres;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
10 Cáceres;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;90,14
10 Cáceres;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
10 Cáceres;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
10 Cáceres;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
10 Cáceres;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
10 Cáceres;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
10 Cáceres;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
10 Cáceres;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QIV;1.895
10 Cáceres;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
10 Cáceres;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
10 Cáceres;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
10 Cáceres;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QIV;1.866
10 Cáceres;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
10 Cáceres;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
10 Cáceres;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
10 Cáceres;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QIV;1.912
10 Cáceres;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
10 Cáceres;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
10 Cáceres;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
10 Cáceres;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2022QIV;1.822
10 Cáceres;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
10 Cáceres;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2022QII;""
10 Cáceres;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2022QI;""
10 Cáceres;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2021QIV;1.797
10 Cáceres;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
10 Cáceres;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2021QII;""
10 Cáceres;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2021QI;""
10 Cáceres;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2020QIV;1.842
10 Cáceres;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
10 Cáceres;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2020QII;""
10 Cáceres;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2020QI;""
10 Cáceres;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
10 Cáceres;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
10 Cáceres;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2022QII;""
10 Cáceres;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2022QI;1.732
10 Cáceres;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
10 Cáceres;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
10 Cáceres;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2021QII;""
10 Cáceres;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2021QI;1.776
10 Cáceres;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
10 Cáceres;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
10 Cáceres;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2020QII;""
10 Cáceres;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2020QI;""
10 Cáceres;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
10 Cáceres;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
10 Cáceres;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QII;1.666
10 Cáceres;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QI;""
10 Cáceres;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
10 Cáceres;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
10 Cáceres;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QII;1.715
10 Cáceres;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QI;""
10 Cáceres;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
10 Cáceres;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
10 Cáceres;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QII;""
10 Cáceres;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QI;""
10 Cáceres;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
10 Cáceres;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QIII;1.596
10 Cáceres;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QII;""
10 Cáceres;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QI;""
10 Cáceres;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
10 Cáceres;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QIII;1.644
10 Cáceres;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QII;""
10 Cáceres;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QI;""
10 Cáceres;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
10 Cáceres;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
10 Cáceres;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QII;""
10 Cáceres;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QI;""
10 Cáceres;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
10 Cáceres;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
10 Cáceres;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
10 Cáceres;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
10 Cáceres;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
10 Cáceres;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
10 Cáceres;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
10 Cáceres;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
10 Cáceres;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
10 Cáceres;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
10 Cáceres;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
10 Cáceres;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
10 Cáceres;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;96,15
10 Cáceres;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
10 Cáceres;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
10 Cáceres;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
10 Cáceres;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;96,3
10 Cáceres;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
10 Cáceres;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
10 Cáceres;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
10 Cáceres;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;96,34
10 Cáceres;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
10 Cáceres;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
10 Cáceres;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
10 Cáceres;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
10 Cáceres;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
10 Cáceres;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
10 Cáceres;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;92,82
10 Cáceres;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
10 Cáceres;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
10 Cáceres;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
10 Cáceres;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;92,89
10 Cáceres;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
10 Cáceres;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
10 Cáceres;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
10 Cáceres;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
10 Cáceres;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
10 Cáceres;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
10 Cáceres;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;89,28
10 Cáceres;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
10 Cáceres;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
10 Cáceres;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
10 Cáceres;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;89,7
10 Cáceres;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
10 Cáceres;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
10 Cáceres;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
10 Cáceres;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
10 Cáceres;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
10 Cáceres;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
10 Cáceres;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;85,53
10 Cáceres;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
10 Cáceres;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
10 Cáceres;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
10 Cáceres;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;85,98
10 Cáceres;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
10 Cáceres;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
10 Cáceres;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
10 Cáceres;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
10 Cáceres;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
10 Cáceres;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
10 Cáceres;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
10 Cáceres;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
10 Cáceres;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
10 Cáceres;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QI;7.412
10 Cáceres;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
10 Cáceres;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
10 Cáceres;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
10 Cáceres;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QI;7.433
10 Cáceres;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
10 Cáceres;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
10 Cáceres;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
10 Cáceres;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QI;7.470
10 Cáceres;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
10 Cáceres;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
10 Cáceres;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2022QII;""
10 Cáceres;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2022QI;7.221
10 Cáceres;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
10 Cáceres;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
10 Cáceres;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2021QII;""
10 Cáceres;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2021QI;7.297
10 Cáceres;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
10 Cáceres;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
10 Cáceres;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2020QII;""
10 Cáceres;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2020QI;7.101
10 Cáceres;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
10 Cáceres;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
10 Cáceres;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2022QII;7.019
10 Cáceres;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2022QI;""
10 Cáceres;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
10 Cáceres;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
10 Cáceres;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2021QII;7.172
10 Cáceres;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2021QI;""
10 Cáceres;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
10 Cáceres;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
10 Cáceres;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2020QII;7.012
10 Cáceres;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2020QI;""
10 Cáceres;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
10 Cáceres;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QIII;6.871
10 Cáceres;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QII;""
10 Cáceres;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QI;""
10 Cáceres;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
10 Cáceres;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QIII;7.069
10 Cáceres;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QII;""
10 Cáceres;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QI;""
10 Cáceres;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
10 Cáceres;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QIII;6.881
10 Cáceres;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QII;""
10 Cáceres;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QI;""
10 Cáceres;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QIV;6.704
10 Cáceres;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
10 Cáceres;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QII;""
10 Cáceres;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QI;""
10 Cáceres;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QIV;6.954
10 Cáceres;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
10 Cáceres;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QII;""
10 Cáceres;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QI;""
10 Cáceres;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QIV;6.759
10 Cáceres;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
10 Cáceres;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QII;""
10 Cáceres;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QI;""
10 Cáceres;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
10 Cáceres;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
10 Cáceres;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
10 Cáceres;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
10 Cáceres;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
10 Cáceres;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
10 Cáceres;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
10 Cáceres;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
10 Cáceres;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
10 Cáceres;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
10 Cáceres;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
10 Cáceres;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
10 Cáceres;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
10 Cáceres;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
10 Cáceres;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
10 Cáceres;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;97,42
10 Cáceres;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
10 Cáceres;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
10 Cáceres;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
10 Cáceres;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;98,17
10 Cáceres;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
10 Cáceres;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
10 Cáceres;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
10 Cáceres;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;95,06
10 Cáceres;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
10 Cáceres;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
10 Cáceres;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;94,7
10 Cáceres;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
10 Cáceres;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
10 Cáceres;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
10 Cáceres;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;96,49
10 Cáceres;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
10 Cáceres;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
10 Cáceres;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
10 Cáceres;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;93,87
10 Cáceres;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
10 Cáceres;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
10 Cáceres;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;92,7
10 Cáceres;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
10 Cáceres;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
10 Cáceres;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
10 Cáceres;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;95,1
10 Cáceres;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
10 Cáceres;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
10 Cáceres;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
10 Cáceres;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;92,12
10 Cáceres;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
10 Cáceres;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
10 Cáceres;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;90,45
10 Cáceres;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
10 Cáceres;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
10 Cáceres;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
10 Cáceres;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;93,56
10 Cáceres;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
10 Cáceres;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
10 Cáceres;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
10 Cáceres;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;90,48
10 Cáceres;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
10 Cáceres;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
10 Cáceres;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
10 Cáceres;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
10 Cáceres;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
10 Cáceres;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
10 Cáceres;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QI;4.785
10 Cáceres;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
10 Cáceres;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
10 Cáceres;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
10 Cáceres;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QI;4.801
10 Cáceres;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
10 Cáceres;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
10 Cáceres;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
10 Cáceres;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QI;4.845
10 Cáceres;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
10 Cáceres;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
10 Cáceres;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2022QII;""
10 Cáceres;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2022QI;4.669
10 Cáceres;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
10 Cáceres;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
10 Cáceres;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2021QII;""
10 Cáceres;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2021QI;4.721
10 Cáceres;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
10 Cáceres;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
10 Cáceres;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2020QII;""
10 Cáceres;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2020QI;4.601
10 Cáceres;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
10 Cáceres;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
10 Cáceres;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2022QII;4.566
10 Cáceres;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2022QI;""
10 Cáceres;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
10 Cáceres;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
10 Cáceres;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2021QII;4.652
10 Cáceres;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2021QI;""
10 Cáceres;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
10 Cáceres;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
10 Cáceres;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2020QII;4.548
10 Cáceres;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2020QI;""
10 Cáceres;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
10 Cáceres;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QIII;4.484
10 Cáceres;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QII;""
10 Cáceres;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QI;""
10 Cáceres;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
10 Cáceres;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QIII;4.589
10 Cáceres;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QII;""
10 Cáceres;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QI;""
10 Cáceres;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
10 Cáceres;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QIII;4.478
10 Cáceres;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QII;""
10 Cáceres;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QI;""
10 Cáceres;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QIV;4.384
10 Cáceres;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
10 Cáceres;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QII;""
10 Cáceres;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QI;""
10 Cáceres;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QIV;4.532
10 Cáceres;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
10 Cáceres;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QII;""
10 Cáceres;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QI;""
10 Cáceres;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QIV;4.403
10 Cáceres;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
10 Cáceres;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QII;""
10 Cáceres;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QI;""
10 Cáceres;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
10 Cáceres;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
10 Cáceres;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
10 Cáceres;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
10 Cáceres;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
10 Cáceres;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
10 Cáceres;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
10 Cáceres;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
10 Cáceres;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
10 Cáceres;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
10 Cáceres;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
10 Cáceres;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
10 Cáceres;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
10 Cáceres;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
10 Cáceres;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
10 Cáceres;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;97,58
10 Cáceres;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
10 Cáceres;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
10 Cáceres;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
10 Cáceres;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;98,33
10 Cáceres;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
10 Cáceres;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
10 Cáceres;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
10 Cáceres;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;94,96
10 Cáceres;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
10 Cáceres;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
10 Cáceres;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;95,42
10 Cáceres;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
10 Cáceres;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
10 Cáceres;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
10 Cáceres;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;96,9
10 Cáceres;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
10 Cáceres;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
10 Cáceres;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
10 Cáceres;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;93,87
10 Cáceres;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
10 Cáceres;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
10 Cáceres;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;93,71
10 Cáceres;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
10 Cáceres;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
10 Cáceres;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
10 Cáceres;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;95,58
10 Cáceres;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
10 Cáceres;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
10 Cáceres;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
10 Cáceres;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;92,43
10 Cáceres;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
10 Cáceres;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
10 Cáceres;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;91,62
10 Cáceres;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
10 Cáceres;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
10 Cáceres;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
10 Cáceres;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;94,4
10 Cáceres;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
10 Cáceres;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
10 Cáceres;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
10 Cáceres;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;90,88
10 Cáceres;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
10 Cáceres;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
10 Cáceres;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
10 Cáceres;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
10 Cáceres;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
10 Cáceres;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
10 Cáceres;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QI;2.627
10 Cáceres;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
10 Cáceres;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
10 Cáceres;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
10 Cáceres;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QI;2.632
10 Cáceres;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
10 Cáceres;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
10 Cáceres;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
10 Cáceres;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QI;2.625
10 Cáceres;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
10 Cáceres;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
10 Cáceres;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2022QII;""
10 Cáceres;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2022QI;2.552
10 Cáceres;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
10 Cáceres;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
10 Cáceres;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2021QII;""
10 Cáceres;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2021QI;2.576
10 Cáceres;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
10 Cáceres;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
10 Cáceres;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2020QII;""
10 Cáceres;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2020QI;2.500
10 Cáceres;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
10 Cáceres;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
10 Cáceres;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2022QII;2.453
10 Cáceres;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2022QI;""
10 Cáceres;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
10 Cáceres;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
10 Cáceres;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2021QII;2.520
10 Cáceres;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2021QI;""
10 Cáceres;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
10 Cáceres;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
10 Cáceres;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2020QII;2.464
10 Cáceres;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2020QI;""
10 Cáceres;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
10 Cáceres;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QIII;2.387
10 Cáceres;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QII;""
10 Cáceres;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QI;""
10 Cáceres;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
10 Cáceres;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QIII;2.480
10 Cáceres;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QII;""
10 Cáceres;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QI;""
10 Cáceres;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
10 Cáceres;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QIII;2.403
10 Cáceres;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QII;""
10 Cáceres;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QI;""
10 Cáceres;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QIV;2.320
10 Cáceres;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
10 Cáceres;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QII;""
10 Cáceres;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QI;""
10 Cáceres;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QIV;2.422
10 Cáceres;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
10 Cáceres;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QII;""
10 Cáceres;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QI;""
10 Cáceres;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QIV;2.356
10 Cáceres;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
10 Cáceres;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QII;""
10 Cáceres;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QI;""
10 Cáceres;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
10 Cáceres;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
10 Cáceres;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
10 Cáceres;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
10 Cáceres;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
10 Cáceres;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
10 Cáceres;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
10 Cáceres;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
10 Cáceres;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
10 Cáceres;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
10 Cáceres;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
10 Cáceres;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
10 Cáceres;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
10 Cáceres;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
10 Cáceres;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
10 Cáceres;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;97,15
10 Cáceres;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
10 Cáceres;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
10 Cáceres;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
10 Cáceres;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;97,87
10 Cáceres;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
10 Cáceres;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
10 Cáceres;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
10 Cáceres;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;95,24
10 Cáceres;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
10 Cáceres;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
10 Cáceres;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;93,38
10 Cáceres;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
10 Cáceres;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
10 Cáceres;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
10 Cáceres;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;95,74
10 Cáceres;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
10 Cáceres;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
10 Cáceres;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
10 Cáceres;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;93,87
10 Cáceres;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
10 Cáceres;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
10 Cáceres;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;90,86
10 Cáceres;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
10 Cáceres;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
10 Cáceres;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
10 Cáceres;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;94,22
10 Cáceres;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
10 Cáceres;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
10 Cáceres;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
10 Cáceres;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;91,54
10 Cáceres;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
10 Cáceres;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
10 Cáceres;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;88,31
10 Cáceres;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
10 Cáceres;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
10 Cáceres;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
10 Cáceres;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;92,02
10 Cáceres;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
10 Cáceres;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
10 Cáceres;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
10 Cáceres;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;89,75
10 Cáceres;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
10 Cáceres;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
10 Cáceres;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
10 Cáceres;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
10 Cáceres;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
10 Cáceres;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QII;7.366
10 Cáceres;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
10 Cáceres;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
10 Cáceres;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
10 Cáceres;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QII;7.304
10 Cáceres;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
10 Cáceres;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
10 Cáceres;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
10 Cáceres;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QII;7.377
10 Cáceres;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
10 Cáceres;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
10 Cáceres;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
10 Cáceres;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2022QII;7.150
10 Cáceres;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2022QI;""
10 Cáceres;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
10 Cáceres;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
10 Cáceres;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2021QII;7.158
10 Cáceres;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2021QI;""
10 Cáceres;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
10 Cáceres;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
10 Cáceres;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2020QII;7.283
10 Cáceres;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2020QI;""
10 Cáceres;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
10 Cáceres;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2022QIII;6.986
10 Cáceres;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2022QII;""
10 Cáceres;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2022QI;""
10 Cáceres;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
10 Cáceres;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2021QIII;7.034
10 Cáceres;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2021QII;""
10 Cáceres;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2021QI;""
10 Cáceres;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
10 Cáceres;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2020QIII;7.144
10 Cáceres;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2020QII;""
10 Cáceres;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2020QI;""
10 Cáceres;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QIV;6.819
10 Cáceres;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
10 Cáceres;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QII;""
10 Cáceres;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QI;""
10 Cáceres;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QIV;6.914
10 Cáceres;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
10 Cáceres;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QII;""
10 Cáceres;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QI;""
10 Cáceres;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QIV;7.011
10 Cáceres;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
10 Cáceres;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QII;""
10 Cáceres;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QI;""
10 Cáceres;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
10 Cáceres;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
10 Cáceres;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QII;""
10 Cáceres;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QI;6.759
10 Cáceres;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
10 Cáceres;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
10 Cáceres;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QII;""
10 Cáceres;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QI;6.905
10 Cáceres;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
10 Cáceres;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
10 Cáceres;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QII;""
10 Cáceres;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QI;""
10 Cáceres;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
10 Cáceres;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
10 Cáceres;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
10 Cáceres;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
10 Cáceres;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
10 Cáceres;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
10 Cáceres;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
10 Cáceres;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
10 Cáceres;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
10 Cáceres;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
10 Cáceres;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
10 Cáceres;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
10 Cáceres;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
10 Cáceres;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
10 Cáceres;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;97,07
10 Cáceres;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
10 Cáceres;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
10 Cáceres;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
10 Cáceres;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;98
10 Cáceres;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
10 Cáceres;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
10 Cáceres;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
10 Cáceres;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;98,73
10 Cáceres;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
10 Cáceres;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
10 Cáceres;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;94,84
10 Cáceres;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
10 Cáceres;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
10 Cáceres;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
10 Cáceres;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;96,3
10 Cáceres;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
10 Cáceres;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
10 Cáceres;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
10 Cáceres;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;96,84
10 Cáceres;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
10 Cáceres;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
10 Cáceres;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;92,57
10 Cáceres;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
10 Cáceres;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
10 Cáceres;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
10 Cáceres;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;94,66
10 Cáceres;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
10 Cáceres;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
10 Cáceres;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
10 Cáceres;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;95,04
10 Cáceres;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
10 Cáceres;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
10 Cáceres;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
10 Cáceres;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
10 Cáceres;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
10 Cáceres;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
10 Cáceres;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;92,54
10 Cáceres;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
10 Cáceres;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
10 Cáceres;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
10 Cáceres;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;93,6
10 Cáceres;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
10 Cáceres;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
10 Cáceres;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
10 Cáceres;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
10 Cáceres;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
10 Cáceres;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
10 Cáceres;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QII;4.704
10 Cáceres;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
10 Cáceres;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
10 Cáceres;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
10 Cáceres;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QII;4.721
10 Cáceres;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
10 Cáceres;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
10 Cáceres;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
10 Cáceres;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QII;4.750
10 Cáceres;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
10 Cáceres;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
10 Cáceres;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
10 Cáceres;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2022QII;4.591
10 Cáceres;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2022QI;""
10 Cáceres;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
10 Cáceres;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
10 Cáceres;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2021QII;4.641
10 Cáceres;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2021QI;""
10 Cáceres;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
10 Cáceres;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
10 Cáceres;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2020QII;4.696
10 Cáceres;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2020QI;""
10 Cáceres;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
10 Cáceres;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2022QIII;4.496
10 Cáceres;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2022QII;""
10 Cáceres;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2022QI;""
10 Cáceres;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
10 Cáceres;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2021QIII;4.568
10 Cáceres;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2021QII;""
10 Cáceres;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2021QI;""
10 Cáceres;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
10 Cáceres;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2020QIII;4.619
10 Cáceres;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2020QII;""
10 Cáceres;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2020QI;""
10 Cáceres;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QIV;4.395
10 Cáceres;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
10 Cáceres;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QII;""
10 Cáceres;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QI;""
10 Cáceres;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QIV;4.509
10 Cáceres;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
10 Cáceres;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QII;""
10 Cáceres;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QI;""
10 Cáceres;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QIV;4.537
10 Cáceres;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
10 Cáceres;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QII;""
10 Cáceres;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QI;""
10 Cáceres;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
10 Cáceres;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
10 Cáceres;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QII;""
10 Cáceres;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QI;4.420
10 Cáceres;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
10 Cáceres;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
10 Cáceres;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QII;""
10 Cáceres;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QI;4.480
10 Cáceres;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
10 Cáceres;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
10 Cáceres;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QII;""
10 Cáceres;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QI;""
10 Cáceres;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
10 Cáceres;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
10 Cáceres;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
10 Cáceres;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
10 Cáceres;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
10 Cáceres;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
10 Cáceres;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
10 Cáceres;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
10 Cáceres;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
10 Cáceres;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
10 Cáceres;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
10 Cáceres;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
10 Cáceres;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
10 Cáceres;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
10 Cáceres;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;97,6
10 Cáceres;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
10 Cáceres;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
10 Cáceres;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
10 Cáceres;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;98,31
10 Cáceres;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
10 Cáceres;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
10 Cáceres;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
10 Cáceres;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;98,86
10 Cáceres;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
10 Cáceres;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
10 Cáceres;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;95,58
10 Cáceres;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
10 Cáceres;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
10 Cáceres;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
10 Cáceres;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;96,76
10 Cáceres;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
10 Cáceres;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
10 Cáceres;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
10 Cáceres;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;97,24
10 Cáceres;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
10 Cáceres;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
10 Cáceres;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;93,43
10 Cáceres;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
10 Cáceres;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
10 Cáceres;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
10 Cáceres;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;95,51
10 Cáceres;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
10 Cáceres;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
10 Cáceres;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
10 Cáceres;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;95,52
10 Cáceres;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
10 Cáceres;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
10 Cáceres;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
10 Cáceres;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
10 Cáceres;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
10 Cáceres;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
10 Cáceres;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;93,62
10 Cáceres;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
10 Cáceres;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
10 Cáceres;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
10 Cáceres;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;94,32
10 Cáceres;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
10 Cáceres;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
10 Cáceres;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
10 Cáceres;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
10 Cáceres;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
10 Cáceres;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
10 Cáceres;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QII;2.662
10 Cáceres;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
10 Cáceres;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
10 Cáceres;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
10 Cáceres;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QII;2.583
10 Cáceres;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
10 Cáceres;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
10 Cáceres;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
10 Cáceres;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QII;2.627
10 Cáceres;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
10 Cáceres;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
10 Cáceres;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
10 Cáceres;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2022QII;2.559
10 Cáceres;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2022QI;""
10 Cáceres;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
10 Cáceres;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
10 Cáceres;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2021QII;2.517
10 Cáceres;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2021QI;""
10 Cáceres;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
10 Cáceres;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
10 Cáceres;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2020QII;2.587
10 Cáceres;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2020QI;""
10 Cáceres;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
10 Cáceres;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2022QIII;2.490
10 Cáceres;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2022QII;""
10 Cáceres;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2022QI;""
10 Cáceres;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
10 Cáceres;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2021QIII;2.466
10 Cáceres;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2021QII;""
10 Cáceres;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2021QI;""
10 Cáceres;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
10 Cáceres;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2020QIII;2.525
10 Cáceres;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2020QII;""
10 Cáceres;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2020QI;""
10 Cáceres;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QIV;2.424
10 Cáceres;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
10 Cáceres;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QII;""
10 Cáceres;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QI;""
10 Cáceres;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QIV;2.405
10 Cáceres;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
10 Cáceres;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QII;""
10 Cáceres;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QI;""
10 Cáceres;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QIV;2.474
10 Cáceres;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
10 Cáceres;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QII;""
10 Cáceres;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QI;""
10 Cáceres;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
10 Cáceres;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
10 Cáceres;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QII;""
10 Cáceres;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QI;2.339
10 Cáceres;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
10 Cáceres;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
10 Cáceres;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QII;""
10 Cáceres;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QI;2.425
10 Cáceres;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
10 Cáceres;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
10 Cáceres;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QII;""
10 Cáceres;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QI;""
10 Cáceres;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
10 Cáceres;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
10 Cáceres;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
10 Cáceres;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
10 Cáceres;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
10 Cáceres;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
10 Cáceres;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
10 Cáceres;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
10 Cáceres;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
10 Cáceres;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
10 Cáceres;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
10 Cáceres;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
10 Cáceres;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
10 Cáceres;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
10 Cáceres;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;96,13
10 Cáceres;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
10 Cáceres;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
10 Cáceres;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
10 Cáceres;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;97,44
10 Cáceres;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
10 Cáceres;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
10 Cáceres;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
10 Cáceres;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;98,48
10 Cáceres;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
10 Cáceres;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
10 Cáceres;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;93,54
10 Cáceres;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
10 Cáceres;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
10 Cáceres;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
10 Cáceres;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;95,47
10 Cáceres;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
10 Cáceres;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
10 Cáceres;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
10 Cáceres;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;96,12
10 Cáceres;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
10 Cáceres;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
10 Cáceres;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;91,06
10 Cáceres;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
10 Cáceres;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
10 Cáceres;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
10 Cáceres;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;93,11
10 Cáceres;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
10 Cáceres;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
10 Cáceres;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
10 Cáceres;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;94,18
10 Cáceres;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
10 Cáceres;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
10 Cáceres;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
10 Cáceres;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
10 Cáceres;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
10 Cáceres;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
10 Cáceres;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;90,55
10 Cáceres;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
10 Cáceres;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
10 Cáceres;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
10 Cáceres;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;92,31
10 Cáceres;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
10 Cáceres;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
10 Cáceres;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
10 Cáceres;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
10 Cáceres;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
10 Cáceres;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QIII;7.279
10 Cáceres;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
10 Cáceres;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
10 Cáceres;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
10 Cáceres;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QIII;7.362
10 Cáceres;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
10 Cáceres;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
10 Cáceres;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
10 Cáceres;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QIII;7.444
10 Cáceres;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
10 Cáceres;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
10 Cáceres;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
10 Cáceres;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2022QIII;7.088
10 Cáceres;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2022QII;""
10 Cáceres;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2022QI;""
10 Cáceres;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
10 Cáceres;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2021QIII;7.207
10 Cáceres;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2021QII;""
10 Cáceres;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2021QI;""
10 Cáceres;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
10 Cáceres;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2020QIII;7.283
10 Cáceres;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2020QII;""
10 Cáceres;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2020QI;""
10 Cáceres;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2022QIV;6.903
10 Cáceres;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
10 Cáceres;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2022QII;""
10 Cáceres;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2022QI;""
10 Cáceres;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2021QIV;7.073
10 Cáceres;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
10 Cáceres;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2021QII;""
10 Cáceres;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2021QI;""
10 Cáceres;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2020QIV;7.135
10 Cáceres;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
10 Cáceres;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2020QII;""
10 Cáceres;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2020QI;""
10 Cáceres;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
10 Cáceres;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
10 Cáceres;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QII;""
10 Cáceres;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QI;6.910
10 Cáceres;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
10 Cáceres;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
10 Cáceres;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QII;""
10 Cáceres;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QI;7.024
10 Cáceres;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
10 Cáceres;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
10 Cáceres;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QII;""
10 Cáceres;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QI;""
10 Cáceres;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
10 Cáceres;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
10 Cáceres;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QII;6.731
10 Cáceres;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QI;""
10 Cáceres;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
10 Cáceres;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
10 Cáceres;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QII;6.918
10 Cáceres;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QI;""
10 Cáceres;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
10 Cáceres;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
10 Cáceres;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QII;""
10 Cáceres;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QI;""
10 Cáceres;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
10 Cáceres;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
10 Cáceres;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
10 Cáceres;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
10 Cáceres;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
10 Cáceres;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
10 Cáceres;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
10 Cáceres;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
10 Cáceres;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
10 Cáceres;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
10 Cáceres;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
10 Cáceres;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
10 Cáceres;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
10 Cáceres;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;97,38
10 Cáceres;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
10 Cáceres;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
10 Cáceres;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
10 Cáceres;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;97,89
10 Cáceres;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
10 Cáceres;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
10 Cáceres;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
10 Cáceres;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;97,84
10 Cáceres;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
10 Cáceres;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
10 Cáceres;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;94,83
10 Cáceres;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
10 Cáceres;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
10 Cáceres;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
10 Cáceres;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;96,07
10 Cáceres;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
10 Cáceres;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
10 Cáceres;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
10 Cáceres;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;95,85
10 Cáceres;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
10 Cáceres;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
10 Cáceres;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
10 Cáceres;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
10 Cáceres;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
10 Cáceres;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
10 Cáceres;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;93,86
10 Cáceres;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
10 Cáceres;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
10 Cáceres;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
10 Cáceres;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;94,36
10 Cáceres;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
10 Cáceres;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
10 Cáceres;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
10 Cáceres;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
10 Cáceres;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
10 Cáceres;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
10 Cáceres;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;91,43
10 Cáceres;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
10 Cáceres;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
10 Cáceres;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
10 Cáceres;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;92,93
10 Cáceres;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
10 Cáceres;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
10 Cáceres;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
10 Cáceres;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
10 Cáceres;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
10 Cáceres;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
10 Cáceres;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QIII;4.671
10 Cáceres;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
10 Cáceres;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
10 Cáceres;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
10 Cáceres;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QIII;4.760
10 Cáceres;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
10 Cáceres;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
10 Cáceres;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
10 Cáceres;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QIII;4.809
10 Cáceres;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
10 Cáceres;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
10 Cáceres;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
10 Cáceres;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2022QIII;4.560
10 Cáceres;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2022QII;""
10 Cáceres;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2022QI;""
10 Cáceres;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
10 Cáceres;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2021QIII;4.669
10 Cáceres;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2021QII;""
10 Cáceres;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2021QI;""
10 Cáceres;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
10 Cáceres;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2020QIII;4.720
10 Cáceres;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2020QII;""
10 Cáceres;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2020QI;""
10 Cáceres;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2022QIV;4.444
10 Cáceres;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
10 Cáceres;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2022QII;""
10 Cáceres;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2022QI;""
10 Cáceres;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2021QIV;4.598
10 Cáceres;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
10 Cáceres;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2021QII;""
10 Cáceres;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2021QI;""
10 Cáceres;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2020QIV;4.625
10 Cáceres;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
10 Cáceres;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2020QII;""
10 Cáceres;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2020QI;""
10 Cáceres;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
10 Cáceres;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
10 Cáceres;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QII;""
10 Cáceres;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QI;4.505
10 Cáceres;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
10 Cáceres;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
10 Cáceres;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QII;""
10 Cáceres;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QI;4.564
10 Cáceres;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
10 Cáceres;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
10 Cáceres;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QII;""
10 Cáceres;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QI;""
10 Cáceres;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
10 Cáceres;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
10 Cáceres;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QII;4.412
10 Cáceres;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QI;""
10 Cáceres;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
10 Cáceres;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
10 Cáceres;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QII;4.506
10 Cáceres;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QI;""
10 Cáceres;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
10 Cáceres;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
10 Cáceres;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QII;""
10 Cáceres;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QI;""
10 Cáceres;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
10 Cáceres;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
10 Cáceres;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
10 Cáceres;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
10 Cáceres;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
10 Cáceres;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
10 Cáceres;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
10 Cáceres;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
10 Cáceres;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
10 Cáceres;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
10 Cáceres;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
10 Cáceres;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
10 Cáceres;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
10 Cáceres;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;97,62
10 Cáceres;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
10 Cáceres;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
10 Cáceres;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
10 Cáceres;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;98,09
10 Cáceres;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
10 Cáceres;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
10 Cáceres;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
10 Cáceres;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;98,15
10 Cáceres;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
10 Cáceres;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
10 Cáceres;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;95,14
10 Cáceres;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
10 Cáceres;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
10 Cáceres;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
10 Cáceres;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;96,6
10 Cáceres;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
10 Cáceres;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
10 Cáceres;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
10 Cáceres;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;96,17
10 Cáceres;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
10 Cáceres;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
10 Cáceres;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
10 Cáceres;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
10 Cáceres;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
10 Cáceres;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
10 Cáceres;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;94,64
10 Cáceres;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
10 Cáceres;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
10 Cáceres;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
10 Cáceres;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;94,91
10 Cáceres;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
10 Cáceres;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
10 Cáceres;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
10 Cáceres;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
10 Cáceres;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
10 Cáceres;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
10 Cáceres;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;92,69
10 Cáceres;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
10 Cáceres;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
10 Cáceres;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
10 Cáceres;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;93,7
10 Cáceres;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
10 Cáceres;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
10 Cáceres;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
10 Cáceres;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
10 Cáceres;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
10 Cáceres;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
10 Cáceres;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QIII;2.608
10 Cáceres;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
10 Cáceres;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
10 Cáceres;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
10 Cáceres;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QIII;2.602
10 Cáceres;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
10 Cáceres;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
10 Cáceres;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
10 Cáceres;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QIII;2.635
10 Cáceres;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
10 Cáceres;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
10 Cáceres;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
10 Cáceres;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2022QIII;2.528
10 Cáceres;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2022QII;""
10 Cáceres;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2022QI;""
10 Cáceres;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
10 Cáceres;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2021QIII;2.538
10 Cáceres;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2021QII;""
10 Cáceres;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2021QI;""
10 Cáceres;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
10 Cáceres;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2020QIII;2.563
10 Cáceres;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2020QII;""
10 Cáceres;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2020QI;""
10 Cáceres;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2022QIV;2.459
10 Cáceres;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
10 Cáceres;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2022QII;""
10 Cáceres;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2022QI;""
10 Cáceres;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2021QIV;2.475
10 Cáceres;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
10 Cáceres;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2021QII;""
10 Cáceres;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2021QI;""
10 Cáceres;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2020QIV;2.510
10 Cáceres;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
10 Cáceres;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2020QII;""
10 Cáceres;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2020QI;""
10 Cáceres;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
10 Cáceres;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
10 Cáceres;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QII;""
10 Cáceres;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QI;2.405
10 Cáceres;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
10 Cáceres;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
10 Cáceres;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QII;""
10 Cáceres;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QI;2.460
10 Cáceres;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
10 Cáceres;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
10 Cáceres;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QII;""
10 Cáceres;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QI;""
10 Cáceres;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
10 Cáceres;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
10 Cáceres;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QII;2.319
10 Cáceres;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QI;""
10 Cáceres;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
10 Cáceres;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
10 Cáceres;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QII;2.412
10 Cáceres;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QI;""
10 Cáceres;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
10 Cáceres;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
10 Cáceres;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QII;""
10 Cáceres;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QI;""
10 Cáceres;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
10 Cáceres;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
10 Cáceres;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
10 Cáceres;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
10 Cáceres;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
10 Cáceres;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
10 Cáceres;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
10 Cáceres;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
10 Cáceres;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
10 Cáceres;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
10 Cáceres;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
10 Cáceres;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
10 Cáceres;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
10 Cáceres;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;96,93
10 Cáceres;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
10 Cáceres;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
10 Cáceres;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
10 Cáceres;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;97,54
10 Cáceres;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
10 Cáceres;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
10 Cáceres;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
10 Cáceres;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;97,27
10 Cáceres;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
10 Cáceres;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
10 Cáceres;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;94,29
10 Cáceres;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
10 Cáceres;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
10 Cáceres;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
10 Cáceres;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;95,12
10 Cáceres;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
10 Cáceres;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
10 Cáceres;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
10 Cáceres;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;95,26
10 Cáceres;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
10 Cáceres;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
10 Cáceres;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
10 Cáceres;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
10 Cáceres;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
10 Cáceres;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
10 Cáceres;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;92,43
10 Cáceres;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
10 Cáceres;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
10 Cáceres;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
10 Cáceres;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;93,36
10 Cáceres;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
10 Cáceres;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
10 Cáceres;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
10 Cáceres;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
10 Cáceres;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
10 Cáceres;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
10 Cáceres;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;89,12
10 Cáceres;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
10 Cáceres;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
10 Cáceres;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
10 Cáceres;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;91,54
10 Cáceres;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
10 Cáceres;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
10 Cáceres;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
10 Cáceres;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
10 Cáceres;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
10 Cáceres;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QIV;7.242
10 Cáceres;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
10 Cáceres;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
10 Cáceres;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
10 Cáceres;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QIV;7.381
10 Cáceres;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
10 Cáceres;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
10 Cáceres;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
10 Cáceres;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QIV;7.467
10 Cáceres;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
10 Cáceres;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
10 Cáceres;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
10 Cáceres;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2022QIV;7.035
10 Cáceres;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
10 Cáceres;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2022QII;""
10 Cáceres;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2022QI;""
10 Cáceres;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2021QIV;7.235
10 Cáceres;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
10 Cáceres;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2021QII;""
10 Cáceres;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2021QI;""
10 Cáceres;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2020QIV;7.293
10 Cáceres;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
10 Cáceres;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2020QII;""
10 Cáceres;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2020QI;""
10 Cáceres;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
10 Cáceres;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
10 Cáceres;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2022QII;""
10 Cáceres;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2022QI;7.064
10 Cáceres;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
10 Cáceres;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
10 Cáceres;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2021QII;""
10 Cáceres;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2021QI;7.171
10 Cáceres;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
10 Cáceres;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
10 Cáceres;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2020QII;""
10 Cáceres;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2020QI;""
10 Cáceres;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
10 Cáceres;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
10 Cáceres;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QII;6.874
10 Cáceres;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QI;""
10 Cáceres;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
10 Cáceres;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
10 Cáceres;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QII;7.061
10 Cáceres;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QI;""
10 Cáceres;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
10 Cáceres;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
10 Cáceres;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QII;""
10 Cáceres;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QI;""
10 Cáceres;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
10 Cáceres;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QIII;6.731
10 Cáceres;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QII;""
10 Cáceres;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QI;""
10 Cáceres;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
10 Cáceres;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QIII;6.960
10 Cáceres;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QII;""
10 Cáceres;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QI;""
10 Cáceres;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
10 Cáceres;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
10 Cáceres;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QII;""
10 Cáceres;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QI;""
10 Cáceres;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
10 Cáceres;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
10 Cáceres;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
10 Cáceres;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
10 Cáceres;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
10 Cáceres;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
10 Cáceres;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
10 Cáceres;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
10 Cáceres;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
10 Cáceres;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
10 Cáceres;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
10 Cáceres;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
10 Cáceres;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;97,14
10 Cáceres;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
10 Cáceres;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
10 Cáceres;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
10 Cáceres;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;98,02
10 Cáceres;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
10 Cáceres;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
10 Cáceres;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
10 Cáceres;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;97,67
10 Cáceres;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
10 Cáceres;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
10 Cáceres;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
10 Cáceres;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
10 Cáceres;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
10 Cáceres;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
10 Cáceres;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;95,71
10 Cáceres;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
10 Cáceres;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
10 Cáceres;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
10 Cáceres;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;96,04
10 Cáceres;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
10 Cáceres;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
10 Cáceres;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
10 Cáceres;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
10 Cáceres;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
10 Cáceres;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
10 Cáceres;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;93,13
10 Cáceres;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
10 Cáceres;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
10 Cáceres;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
10 Cáceres;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;94,56
10 Cáceres;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
10 Cáceres;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
10 Cáceres;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
10 Cáceres;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
10 Cáceres;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
10 Cáceres;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
10 Cáceres;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;91,19
10 Cáceres;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
10 Cáceres;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
10 Cáceres;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
10 Cáceres;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;93,21
10 Cáceres;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
10 Cáceres;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
10 Cáceres;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
10 Cáceres;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
10 Cáceres;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
10 Cáceres;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
10 Cáceres;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QIV;4.645
10 Cáceres;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
10 Cáceres;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
10 Cáceres;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
10 Cáceres;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QIV;4.762
10 Cáceres;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
10 Cáceres;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
10 Cáceres;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
10 Cáceres;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QIV;4.830
10 Cáceres;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
10 Cáceres;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
10 Cáceres;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
10 Cáceres;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2022QIV;4.515
10 Cáceres;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
10 Cáceres;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2022QII;""
10 Cáceres;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2022QI;""
10 Cáceres;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2021QIV;4.683
10 Cáceres;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
10 Cáceres;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2021QII;""
10 Cáceres;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2021QI;""
10 Cáceres;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2020QIV;4.715
10 Cáceres;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
10 Cáceres;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2020QII;""
10 Cáceres;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2020QI;""
10 Cáceres;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
10 Cáceres;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
10 Cáceres;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2022QII;""
10 Cáceres;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2022QI;4.582
10 Cáceres;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
10 Cáceres;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
10 Cáceres;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2021QII;""
10 Cáceres;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2021QI;4.646
10 Cáceres;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
10 Cáceres;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
10 Cáceres;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2020QII;""
10 Cáceres;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2020QI;""
10 Cáceres;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
10 Cáceres;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
10 Cáceres;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QII;4.485
10 Cáceres;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QI;""
10 Cáceres;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
10 Cáceres;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
10 Cáceres;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QII;4.585
10 Cáceres;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QI;""
10 Cáceres;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
10 Cáceres;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
10 Cáceres;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QII;""
10 Cáceres;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QI;""
10 Cáceres;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
10 Cáceres;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QIII;4.407
10 Cáceres;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QII;""
10 Cáceres;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QI;""
10 Cáceres;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
10 Cáceres;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QIII;4.523
10 Cáceres;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QII;""
10 Cáceres;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QI;""
10 Cáceres;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
10 Cáceres;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
10 Cáceres;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QII;""
10 Cáceres;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QI;""
10 Cáceres;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
10 Cáceres;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
10 Cáceres;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
10 Cáceres;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
10 Cáceres;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
10 Cáceres;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
10 Cáceres;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
10 Cáceres;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
10 Cáceres;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
10 Cáceres;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
10 Cáceres;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
10 Cáceres;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
10 Cáceres;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;97,2
10 Cáceres;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
10 Cáceres;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
10 Cáceres;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
10 Cáceres;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;98,34
10 Cáceres;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
10 Cáceres;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
10 Cáceres;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
10 Cáceres;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;97,62
10 Cáceres;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
10 Cáceres;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
10 Cáceres;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
10 Cáceres;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
10 Cáceres;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
10 Cáceres;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
10 Cáceres;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;96,22
10 Cáceres;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
10 Cáceres;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
10 Cáceres;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
10 Cáceres;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;96,19
10 Cáceres;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
10 Cáceres;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
10 Cáceres;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
10 Cáceres;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
10 Cáceres;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
10 Cáceres;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
10 Cáceres;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;94,18
10 Cáceres;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
10 Cáceres;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
10 Cáceres;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
10 Cáceres;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;94,93
10 Cáceres;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
10 Cáceres;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
10 Cáceres;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
10 Cáceres;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
10 Cáceres;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
10 Cáceres;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
10 Cáceres;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;92,55
10 Cáceres;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
10 Cáceres;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
10 Cáceres;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
10 Cáceres;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;93,64
10 Cáceres;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
10 Cáceres;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
10 Cáceres;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
10 Cáceres;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
10 Cáceres;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
10 Cáceres;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
10 Cáceres;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QIV;2.597
10 Cáceres;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
10 Cáceres;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
10 Cáceres;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
10 Cáceres;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QIV;2.619
10 Cáceres;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
10 Cáceres;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
10 Cáceres;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
10 Cáceres;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QIV;2.637
10 Cáceres;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
10 Cáceres;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
10 Cáceres;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
10 Cáceres;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2022QIV;2.520
10 Cáceres;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
10 Cáceres;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2022QII;""
10 Cáceres;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2022QI;""
10 Cáceres;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2021QIV;2.552
10 Cáceres;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
10 Cáceres;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2021QII;""
10 Cáceres;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2021QI;""
10 Cáceres;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2020QIV;2.578
10 Cáceres;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
10 Cáceres;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2020QII;""
10 Cáceres;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2020QI;""
10 Cáceres;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
10 Cáceres;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
10 Cáceres;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2022QII;""
10 Cáceres;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2022QI;2.482
10 Cáceres;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
10 Cáceres;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
10 Cáceres;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2021QII;""
10 Cáceres;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2021QI;2.525
10 Cáceres;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
10 Cáceres;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
10 Cáceres;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2020QII;""
10 Cáceres;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2020QI;""
10 Cáceres;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
10 Cáceres;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
10 Cáceres;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QII;2.389
10 Cáceres;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QI;""
10 Cáceres;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
10 Cáceres;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
10 Cáceres;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QII;2.476
10 Cáceres;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QI;""
10 Cáceres;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
10 Cáceres;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
10 Cáceres;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QII;""
10 Cáceres;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QI;""
10 Cáceres;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
10 Cáceres;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QIII;2.324
10 Cáceres;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QII;""
10 Cáceres;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QI;""
10 Cáceres;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
10 Cáceres;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QIII;2.437
10 Cáceres;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QII;""
10 Cáceres;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QI;""
10 Cáceres;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
10 Cáceres;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
10 Cáceres;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QII;""
10 Cáceres;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QI;""
10 Cáceres;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
10 Cáceres;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
10 Cáceres;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
10 Cáceres;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
10 Cáceres;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
10 Cáceres;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
10 Cáceres;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
10 Cáceres;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
10 Cáceres;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
10 Cáceres;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
10 Cáceres;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
10 Cáceres;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
10 Cáceres;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;97,04
10 Cáceres;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
10 Cáceres;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
10 Cáceres;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
10 Cáceres;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;97,44
10 Cáceres;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
10 Cáceres;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
10 Cáceres;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
10 Cáceres;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;97,76
10 Cáceres;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
10 Cáceres;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
10 Cáceres;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
10 Cáceres;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
10 Cáceres;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
10 Cáceres;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
10 Cáceres;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;94,77
10 Cáceres;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
10 Cáceres;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
10 Cáceres;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
10 Cáceres;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;95,75
10 Cáceres;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
10 Cáceres;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
10 Cáceres;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
10 Cáceres;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
10 Cáceres;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
10 Cáceres;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
10 Cáceres;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;91,22
10 Cáceres;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
10 Cáceres;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
10 Cáceres;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
10 Cáceres;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;93,89
10 Cáceres;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
10 Cáceres;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
10 Cáceres;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
10 Cáceres;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
10 Cáceres;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
10 Cáceres;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
10 Cáceres;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;88,74
10 Cáceres;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
10 Cáceres;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
10 Cáceres;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
10 Cáceres;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;92,42
10 Cáceres;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
10 Cáceres;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
10 Cáceres;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
10 Cáceres;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
10 Cáceres;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
10 Cáceres;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
10 Cáceres;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
10 Cáceres;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
10 Cáceres;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
10 Cáceres;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QI;7.431
10 Cáceres;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
10 Cáceres;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
10 Cáceres;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
10 Cáceres;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QI;7.241
10 Cáceres;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
10 Cáceres;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
10 Cáceres;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
10 Cáceres;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QI;7.421
10 Cáceres;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
10 Cáceres;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
10 Cáceres;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2022QII;""
10 Cáceres;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2022QI;7.277
10 Cáceres;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
10 Cáceres;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
10 Cáceres;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2021QII;""
10 Cáceres;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2021QI;7.126
10 Cáceres;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
10 Cáceres;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
10 Cáceres;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2020QII;""
10 Cáceres;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2020QI;7.110
10 Cáceres;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
10 Cáceres;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
10 Cáceres;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2022QII;7.117
10 Cáceres;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2022QI;""
10 Cáceres;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
10 Cáceres;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
10 Cáceres;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2021QII;7.023
10 Cáceres;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2021QI;""
10 Cáceres;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
10 Cáceres;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
10 Cáceres;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2020QII;7.021
10 Cáceres;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2020QI;""
10 Cáceres;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
10 Cáceres;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QIII;6.990
10 Cáceres;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QII;""
10 Cáceres;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QI;""
10 Cáceres;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
10 Cáceres;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QIII;6.935
10 Cáceres;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QII;""
10 Cáceres;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QI;""
10 Cáceres;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
10 Cáceres;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QIII;6.921
10 Cáceres;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QII;""
10 Cáceres;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QI;""
10 Cáceres;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QIV;6.872
10 Cáceres;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
10 Cáceres;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QII;""
10 Cáceres;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QI;""
10 Cáceres;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QIV;6.832
10 Cáceres;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
10 Cáceres;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QII;""
10 Cáceres;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QI;""
10 Cáceres;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QIV;6.812
10 Cáceres;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
10 Cáceres;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QII;""
10 Cáceres;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QI;""
10 Cáceres;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
10 Cáceres;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
10 Cáceres;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
10 Cáceres;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
10 Cáceres;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
10 Cáceres;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
10 Cáceres;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
10 Cáceres;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
10 Cáceres;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
10 Cáceres;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
10 Cáceres;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
10 Cáceres;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
10 Cáceres;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
10 Cáceres;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
10 Cáceres;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
10 Cáceres;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;97,93
10 Cáceres;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
10 Cáceres;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
10 Cáceres;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
10 Cáceres;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;98,41
10 Cáceres;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
10 Cáceres;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
10 Cáceres;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
10 Cáceres;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;95,81
10 Cáceres;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
10 Cáceres;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
10 Cáceres;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;95,77
10 Cáceres;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
10 Cáceres;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
10 Cáceres;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
10 Cáceres;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;96,99
10 Cáceres;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
10 Cáceres;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
10 Cáceres;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
10 Cáceres;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;94,61
10 Cáceres;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
10 Cáceres;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
10 Cáceres;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;94,07
10 Cáceres;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
10 Cáceres;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
10 Cáceres;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
10 Cáceres;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;95,77
10 Cáceres;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
10 Cáceres;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
10 Cáceres;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
10 Cáceres;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;93,26
10 Cáceres;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
10 Cáceres;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
10 Cáceres;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;92,48
10 Cáceres;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
10 Cáceres;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
10 Cáceres;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
10 Cáceres;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;94,35
10 Cáceres;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
10 Cáceres;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
10 Cáceres;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
10 Cáceres;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;91,79
10 Cáceres;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
10 Cáceres;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
10 Cáceres;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
10 Cáceres;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
10 Cáceres;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
10 Cáceres;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
10 Cáceres;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QI;4.842
10 Cáceres;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
10 Cáceres;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
10 Cáceres;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
10 Cáceres;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QI;4.732
10 Cáceres;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
10 Cáceres;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
10 Cáceres;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
10 Cáceres;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QI;4.853
10 Cáceres;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
10 Cáceres;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
10 Cáceres;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2022QII;""
10 Cáceres;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2022QI;4.745
10 Cáceres;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
10 Cáceres;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
10 Cáceres;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2021QII;""
10 Cáceres;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2021QI;4.669
10 Cáceres;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
10 Cáceres;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
10 Cáceres;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2020QII;""
10 Cáceres;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2020QI;4.649
10 Cáceres;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
10 Cáceres;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
10 Cáceres;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2022QII;4.657
10 Cáceres;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2022QI;""
10 Cáceres;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
10 Cáceres;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
10 Cáceres;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2021QII;4.613
10 Cáceres;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2021QI;""
10 Cáceres;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
10 Cáceres;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
10 Cáceres;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2020QII;4.591
10 Cáceres;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2020QI;""
10 Cáceres;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
10 Cáceres;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QIII;4.583
10 Cáceres;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QII;""
10 Cáceres;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QI;""
10 Cáceres;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
10 Cáceres;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QIII;4.563
10 Cáceres;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QII;""
10 Cáceres;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QI;""
10 Cáceres;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
10 Cáceres;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QIII;4.538
10 Cáceres;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QII;""
10 Cáceres;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QI;""
10 Cáceres;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QIV;4.507
10 Cáceres;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
10 Cáceres;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QII;""
10 Cáceres;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QI;""
10 Cáceres;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QIV;4.505
10 Cáceres;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
10 Cáceres;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QII;""
10 Cáceres;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QI;""
10 Cáceres;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QIV;4.472
10 Cáceres;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
10 Cáceres;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QII;""
10 Cáceres;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QI;""
10 Cáceres;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
10 Cáceres;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
10 Cáceres;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
10 Cáceres;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
10 Cáceres;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
10 Cáceres;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
10 Cáceres;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
10 Cáceres;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
10 Cáceres;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
10 Cáceres;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
10 Cáceres;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
10 Cáceres;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
10 Cáceres;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
10 Cáceres;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
10 Cáceres;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
10 Cáceres;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;98
10 Cáceres;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
10 Cáceres;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
10 Cáceres;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
10 Cáceres;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;98,67
10 Cáceres;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
10 Cáceres;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
10 Cáceres;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
10 Cáceres;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;95,8
10 Cáceres;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
10 Cáceres;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
10 Cáceres;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;96,18
10 Cáceres;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
10 Cáceres;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
10 Cáceres;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
10 Cáceres;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;97,49
10 Cáceres;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
10 Cáceres;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
10 Cáceres;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
10 Cáceres;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;94,6
10 Cáceres;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
10 Cáceres;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
10 Cáceres;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;94,65
10 Cáceres;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
10 Cáceres;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
10 Cáceres;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
10 Cáceres;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;96,43
10 Cáceres;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
10 Cáceres;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
10 Cáceres;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
10 Cáceres;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;93,51
10 Cáceres;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
10 Cáceres;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
10 Cáceres;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;93,08
10 Cáceres;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
10 Cáceres;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
10 Cáceres;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
10 Cáceres;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;95,2
10 Cáceres;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
10 Cáceres;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
10 Cáceres;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
10 Cáceres;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;92,15
10 Cáceres;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
10 Cáceres;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
10 Cáceres;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
10 Cáceres;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
10 Cáceres;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
10 Cáceres;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
10 Cáceres;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QI;2.589
10 Cáceres;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
10 Cáceres;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
10 Cáceres;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
10 Cáceres;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QI;2.509
10 Cáceres;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
10 Cáceres;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
10 Cáceres;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
10 Cáceres;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QI;2.568
10 Cáceres;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
10 Cáceres;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
10 Cáceres;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2022QII;""
10 Cáceres;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2022QI;2.532
10 Cáceres;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
10 Cáceres;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
10 Cáceres;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2021QII;""
10 Cáceres;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2021QI;2.457
10 Cáceres;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
10 Cáceres;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
10 Cáceres;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2020QII;""
10 Cáceres;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2020QI;2.461
10 Cáceres;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
10 Cáceres;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
10 Cáceres;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2022QII;2.460
10 Cáceres;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2022QI;""
10 Cáceres;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
10 Cáceres;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
10 Cáceres;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2021QII;2.410
10 Cáceres;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2021QI;""
10 Cáceres;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
10 Cáceres;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
10 Cáceres;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2020QII;2.430
10 Cáceres;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2020QI;""
10 Cáceres;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
10 Cáceres;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QIII;2.407
10 Cáceres;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QII;""
10 Cáceres;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QI;""
10 Cáceres;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
10 Cáceres;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QIII;2.372
10 Cáceres;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QII;""
10 Cáceres;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QI;""
10 Cáceres;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
10 Cáceres;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QIII;2.383
10 Cáceres;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QII;""
10 Cáceres;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QI;""
10 Cáceres;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QIV;2.365
10 Cáceres;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
10 Cáceres;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QII;""
10 Cáceres;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QI;""
10 Cáceres;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QIV;2.327
10 Cáceres;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
10 Cáceres;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QII;""
10 Cáceres;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QI;""
10 Cáceres;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QIV;2.340
10 Cáceres;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
10 Cáceres;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QII;""
10 Cáceres;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QI;""
10 Cáceres;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
10 Cáceres;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
10 Cáceres;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
10 Cáceres;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
10 Cáceres;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
10 Cáceres;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
10 Cáceres;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
10 Cáceres;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
10 Cáceres;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
10 Cáceres;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
10 Cáceres;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
10 Cáceres;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
10 Cáceres;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
10 Cáceres;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
10 Cáceres;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
10 Cáceres;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;97,8
10 Cáceres;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
10 Cáceres;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
10 Cáceres;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
10 Cáceres;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;97,93
10 Cáceres;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
10 Cáceres;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
10 Cáceres;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
10 Cáceres;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;95,83
10 Cáceres;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
10 Cáceres;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
10 Cáceres;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;95,02
10 Cáceres;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
10 Cáceres;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
10 Cáceres;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
10 Cáceres;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;96,05
10 Cáceres;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
10 Cáceres;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
10 Cáceres;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
10 Cáceres;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;94,63
10 Cáceres;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
10 Cáceres;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
10 Cáceres;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;92,97
10 Cáceres;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
10 Cáceres;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
10 Cáceres;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
10 Cáceres;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;94,54
10 Cáceres;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
10 Cáceres;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
10 Cáceres;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
10 Cáceres;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;92,8
10 Cáceres;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
10 Cáceres;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
10 Cáceres;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;91,35
10 Cáceres;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
10 Cáceres;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
10 Cáceres;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
10 Cáceres;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;92,75
10 Cáceres;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
10 Cáceres;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
10 Cáceres;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
10 Cáceres;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;91,12
10 Cáceres;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
10 Cáceres;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
10 Cáceres;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
10 Cáceres;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
10 Cáceres;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
10 Cáceres;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QII;7.551
10 Cáceres;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
10 Cáceres;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
10 Cáceres;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
10 Cáceres;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QII;7.418
10 Cáceres;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
10 Cáceres;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
10 Cáceres;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
10 Cáceres;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QII;7.317
10 Cáceres;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
10 Cáceres;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
10 Cáceres;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
10 Cáceres;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2022QII;7.373
10 Cáceres;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2022QI;""
10 Cáceres;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
10 Cáceres;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
10 Cáceres;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2021QII;7.302
10 Cáceres;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2021QI;""
10 Cáceres;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
10 Cáceres;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
10 Cáceres;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2020QII;7.222
10 Cáceres;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2020QI;""
10 Cáceres;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
10 Cáceres;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2022QIII;7.229
10 Cáceres;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2022QII;""
10 Cáceres;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2022QI;""
10 Cáceres;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
10 Cáceres;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2021QIII;7.206
10 Cáceres;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2021QII;""
10 Cáceres;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2021QI;""
10 Cáceres;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
10 Cáceres;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2020QIII;7.103
10 Cáceres;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2020QII;""
10 Cáceres;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2020QI;""
10 Cáceres;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QIV;7.102
10 Cáceres;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
10 Cáceres;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QII;""
10 Cáceres;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QI;""
10 Cáceres;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QIV;7.100
10 Cáceres;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
10 Cáceres;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QII;""
10 Cáceres;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QI;""
10 Cáceres;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QIV;6.991
10 Cáceres;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
10 Cáceres;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QII;""
10 Cáceres;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QI;""
10 Cáceres;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
10 Cáceres;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
10 Cáceres;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QII;""
10 Cáceres;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QI;6.959
10 Cáceres;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
10 Cáceres;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
10 Cáceres;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QII;""
10 Cáceres;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QI;6.890
10 Cáceres;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
10 Cáceres;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
10 Cáceres;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QII;""
10 Cáceres;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QI;""
10 Cáceres;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
10 Cáceres;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
10 Cáceres;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
10 Cáceres;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
10 Cáceres;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
10 Cáceres;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
10 Cáceres;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
10 Cáceres;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
10 Cáceres;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
10 Cáceres;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
10 Cáceres;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
10 Cáceres;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
10 Cáceres;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
10 Cáceres;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
10 Cáceres;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;97,64
10 Cáceres;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
10 Cáceres;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
10 Cáceres;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
10 Cáceres;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;98,44
10 Cáceres;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
10 Cáceres;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
10 Cáceres;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
10 Cáceres;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;98,7
10 Cáceres;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
10 Cáceres;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
10 Cáceres;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;95,74
10 Cáceres;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
10 Cáceres;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
10 Cáceres;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
10 Cáceres;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;97,14
10 Cáceres;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
10 Cáceres;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
10 Cáceres;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
10 Cáceres;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;97,08
10 Cáceres;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
10 Cáceres;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
10 Cáceres;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;94,05
10 Cáceres;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
10 Cáceres;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
10 Cáceres;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
10 Cáceres;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;95,71
10 Cáceres;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
10 Cáceres;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
10 Cáceres;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
10 Cáceres;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;95,54
10 Cáceres;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
10 Cáceres;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
10 Cáceres;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
10 Cáceres;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
10 Cáceres;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
10 Cáceres;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
10 Cáceres;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;93,81
10 Cáceres;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
10 Cáceres;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
10 Cáceres;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
10 Cáceres;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;94,16
10 Cáceres;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
10 Cáceres;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
10 Cáceres;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
10 Cáceres;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
10 Cáceres;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
10 Cáceres;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
10 Cáceres;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QII;4.884
10 Cáceres;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
10 Cáceres;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
10 Cáceres;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
10 Cáceres;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QII;4.843
10 Cáceres;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
10 Cáceres;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
10 Cáceres;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
10 Cáceres;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QII;4.761
10 Cáceres;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
10 Cáceres;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
10 Cáceres;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
10 Cáceres;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2022QII;4.787
10 Cáceres;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2022QI;""
10 Cáceres;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
10 Cáceres;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
10 Cáceres;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2021QII;4.776
10 Cáceres;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2021QI;""
10 Cáceres;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
10 Cáceres;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
10 Cáceres;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2020QII;4.701
10 Cáceres;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2020QI;""
10 Cáceres;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
10 Cáceres;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2022QIII;4.704
10 Cáceres;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2022QII;""
10 Cáceres;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2022QI;""
10 Cáceres;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
10 Cáceres;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2021QIII;4.721
10 Cáceres;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2021QII;""
10 Cáceres;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2021QI;""
10 Cáceres;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
10 Cáceres;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2020QIII;4.638
10 Cáceres;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2020QII;""
10 Cáceres;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2020QI;""
10 Cáceres;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QIV;4.625
10 Cáceres;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
10 Cáceres;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QII;""
10 Cáceres;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QI;""
10 Cáceres;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QIV;4.660
10 Cáceres;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
10 Cáceres;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QII;""
10 Cáceres;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QI;""
10 Cáceres;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QIV;4.570
10 Cáceres;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
10 Cáceres;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QII;""
10 Cáceres;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QI;""
10 Cáceres;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
10 Cáceres;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
10 Cáceres;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QII;""
10 Cáceres;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QI;4.574
10 Cáceres;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
10 Cáceres;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
10 Cáceres;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QII;""
10 Cáceres;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QI;4.514
10 Cáceres;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
10 Cáceres;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
10 Cáceres;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QII;""
10 Cáceres;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QI;""
10 Cáceres;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
10 Cáceres;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
10 Cáceres;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
10 Cáceres;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
10 Cáceres;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
10 Cáceres;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
10 Cáceres;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
10 Cáceres;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
10 Cáceres;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
10 Cáceres;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
10 Cáceres;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
10 Cáceres;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
10 Cáceres;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
10 Cáceres;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
10 Cáceres;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;98,01
10 Cáceres;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
10 Cáceres;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
10 Cáceres;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
10 Cáceres;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;98,62
10 Cáceres;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
10 Cáceres;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
10 Cáceres;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
10 Cáceres;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;98,74
10 Cáceres;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
10 Cáceres;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
10 Cáceres;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;96,31
10 Cáceres;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
10 Cáceres;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
10 Cáceres;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
10 Cáceres;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;97,48
10 Cáceres;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
10 Cáceres;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
10 Cáceres;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
10 Cáceres;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;97,42
10 Cáceres;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
10 Cáceres;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
10 Cáceres;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;94,7
10 Cáceres;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
10 Cáceres;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
10 Cáceres;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
10 Cáceres;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;96,22
10 Cáceres;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
10 Cáceres;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
10 Cáceres;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
10 Cáceres;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;95,99
10 Cáceres;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
10 Cáceres;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
10 Cáceres;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
10 Cáceres;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
10 Cáceres;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
10 Cáceres;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
10 Cáceres;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;94,45
10 Cáceres;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
10 Cáceres;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
10 Cáceres;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
10 Cáceres;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;94,81
10 Cáceres;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
10 Cáceres;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
10 Cáceres;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
10 Cáceres;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
10 Cáceres;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
10 Cáceres;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
10 Cáceres;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QII;2.667
10 Cáceres;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
10 Cáceres;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
10 Cáceres;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
10 Cáceres;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QII;2.575
10 Cáceres;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
10 Cáceres;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
10 Cáceres;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
10 Cáceres;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QII;2.556
10 Cáceres;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
10 Cáceres;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
10 Cáceres;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
10 Cáceres;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2022QII;2.586
10 Cáceres;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2022QI;""
10 Cáceres;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
10 Cáceres;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
10 Cáceres;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2021QII;2.526
10 Cáceres;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2021QI;""
10 Cáceres;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
10 Cáceres;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
10 Cáceres;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2020QII;2.521
10 Cáceres;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2020QI;""
10 Cáceres;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
10 Cáceres;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2022QIII;2.525
10 Cáceres;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2022QII;""
10 Cáceres;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2022QI;""
10 Cáceres;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
10 Cáceres;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2021QIII;2.485
10 Cáceres;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2021QII;""
10 Cáceres;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2021QI;""
10 Cáceres;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
10 Cáceres;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2020QIII;2.465
10 Cáceres;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2020QII;""
10 Cáceres;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2020QI;""
10 Cáceres;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QIV;2.477
10 Cáceres;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
10 Cáceres;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QII;""
10 Cáceres;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QI;""
10 Cáceres;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QIV;2.440
10 Cáceres;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
10 Cáceres;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QII;""
10 Cáceres;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QI;""
10 Cáceres;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QIV;2.421
10 Cáceres;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
10 Cáceres;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QII;""
10 Cáceres;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QI;""
10 Cáceres;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
10 Cáceres;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
10 Cáceres;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QII;""
10 Cáceres;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QI;2.385
10 Cáceres;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
10 Cáceres;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
10 Cáceres;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QII;""
10 Cáceres;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QI;2.376
10 Cáceres;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
10 Cáceres;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
10 Cáceres;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QII;""
10 Cáceres;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QI;""
10 Cáceres;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
10 Cáceres;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
10 Cáceres;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
10 Cáceres;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
10 Cáceres;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
10 Cáceres;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
10 Cáceres;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
10 Cáceres;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
10 Cáceres;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
10 Cáceres;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
10 Cáceres;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
10 Cáceres;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
10 Cáceres;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
10 Cáceres;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
10 Cáceres;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;96,96
10 Cáceres;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
10 Cáceres;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
10 Cáceres;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
10 Cáceres;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;98,1
10 Cáceres;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
10 Cáceres;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
10 Cáceres;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
10 Cáceres;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;98,63
10 Cáceres;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
10 Cáceres;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
10 Cáceres;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;94,68
10 Cáceres;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
10 Cáceres;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
10 Cáceres;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
10 Cáceres;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;96,5
10 Cáceres;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
10 Cáceres;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
10 Cáceres;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
10 Cáceres;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;96,44
10 Cáceres;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
10 Cáceres;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
10 Cáceres;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;92,88
10 Cáceres;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
10 Cáceres;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
10 Cáceres;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
10 Cáceres;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;94,76
10 Cáceres;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
10 Cáceres;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
10 Cáceres;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
10 Cáceres;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;94,72
10 Cáceres;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
10 Cáceres;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
10 Cáceres;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
10 Cáceres;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
10 Cáceres;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
10 Cáceres;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
10 Cáceres;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;92,62
10 Cáceres;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
10 Cáceres;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
10 Cáceres;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
10 Cáceres;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;92,96
10 Cáceres;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
10 Cáceres;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
10 Cáceres;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
10 Cáceres;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
10 Cáceres;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
10 Cáceres;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QIII;7.466
10 Cáceres;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
10 Cáceres;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
10 Cáceres;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
10 Cáceres;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QIII;7.460
10 Cáceres;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
10 Cáceres;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
10 Cáceres;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
10 Cáceres;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QIII;7.339
10 Cáceres;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
10 Cáceres;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
10 Cáceres;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
10 Cáceres;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2022QIII;7.297
10 Cáceres;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2022QII;""
10 Cáceres;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2022QI;""
10 Cáceres;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
10 Cáceres;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2021QIII;7.337
10 Cáceres;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2021QII;""
10 Cáceres;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2021QI;""
10 Cáceres;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
10 Cáceres;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2020QIII;7.194
10 Cáceres;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2020QII;""
10 Cáceres;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2020QI;""
10 Cáceres;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2022QIV;7.157
10 Cáceres;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
10 Cáceres;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2022QII;""
10 Cáceres;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2022QI;""
10 Cáceres;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2021QIV;7.216
10 Cáceres;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
10 Cáceres;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2021QII;""
10 Cáceres;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2021QI;""
10 Cáceres;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2020QIV;7.068
10 Cáceres;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
10 Cáceres;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2020QII;""
10 Cáceres;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2020QI;""
10 Cáceres;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
10 Cáceres;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
10 Cáceres;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QII;""
10 Cáceres;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QI;7.072
10 Cáceres;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
10 Cáceres;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
10 Cáceres;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QII;""
10 Cáceres;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QI;6.964
10 Cáceres;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
10 Cáceres;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
10 Cáceres;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QII;""
10 Cáceres;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QI;""
10 Cáceres;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
10 Cáceres;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
10 Cáceres;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QII;6.927
10 Cáceres;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QI;""
10 Cáceres;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
10 Cáceres;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
10 Cáceres;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QII;6.871
10 Cáceres;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QI;""
10 Cáceres;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
10 Cáceres;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
10 Cáceres;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QII;""
10 Cáceres;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QI;""
10 Cáceres;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
10 Cáceres;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
10 Cáceres;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
10 Cáceres;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
10 Cáceres;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
10 Cáceres;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
10 Cáceres;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
10 Cáceres;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
10 Cáceres;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
10 Cáceres;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
10 Cáceres;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
10 Cáceres;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
10 Cáceres;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
10 Cáceres;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;97,74
10 Cáceres;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
10 Cáceres;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
10 Cáceres;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
10 Cáceres;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;98,35
10 Cáceres;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
10 Cáceres;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
10 Cáceres;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
10 Cáceres;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;98,02
10 Cáceres;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
10 Cáceres;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
10 Cáceres;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;95,86
10 Cáceres;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
10 Cáceres;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
10 Cáceres;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
10 Cáceres;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;96,73
10 Cáceres;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
10 Cáceres;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
10 Cáceres;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
10 Cáceres;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;96,31
10 Cáceres;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
10 Cáceres;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
10 Cáceres;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
10 Cáceres;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
10 Cáceres;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
10 Cáceres;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
10 Cáceres;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;94,8
10 Cáceres;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
10 Cáceres;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
10 Cáceres;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
10 Cáceres;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;94,89
10 Cáceres;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
10 Cáceres;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
10 Cáceres;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
10 Cáceres;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
10 Cáceres;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
10 Cáceres;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
10 Cáceres;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;92,86
10 Cáceres;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
10 Cáceres;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
10 Cáceres;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
10 Cáceres;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;93,62
10 Cáceres;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
10 Cáceres;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
10 Cáceres;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
10 Cáceres;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
10 Cáceres;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
10 Cáceres;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
10 Cáceres;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QIII;4.849
10 Cáceres;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
10 Cáceres;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
10 Cáceres;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
10 Cáceres;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QIII;4.863
10 Cáceres;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
10 Cáceres;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
10 Cáceres;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
10 Cáceres;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QIII;4.790
10 Cáceres;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
10 Cáceres;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
10 Cáceres;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
10 Cáceres;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2022QIII;4.748
10 Cáceres;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2022QII;""
10 Cáceres;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2022QI;""
10 Cáceres;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
10 Cáceres;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2021QIII;4.792
10 Cáceres;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2021QII;""
10 Cáceres;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2021QI;""
10 Cáceres;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
10 Cáceres;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2020QIII;4.709
10 Cáceres;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2020QII;""
10 Cáceres;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2020QI;""
10 Cáceres;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2022QIV;4.658
10 Cáceres;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
10 Cáceres;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2022QII;""
10 Cáceres;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2022QI;""
10 Cáceres;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2021QIV;4.721
10 Cáceres;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
10 Cáceres;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2021QII;""
10 Cáceres;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2021QI;""
10 Cáceres;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2020QIV;4.629
10 Cáceres;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
10 Cáceres;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2020QII;""
10 Cáceres;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2020QI;""
10 Cáceres;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
10 Cáceres;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
10 Cáceres;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QII;""
10 Cáceres;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QI;4.632
10 Cáceres;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
10 Cáceres;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
10 Cáceres;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QII;""
10 Cáceres;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QI;4.571
10 Cáceres;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
10 Cáceres;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
10 Cáceres;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QII;""
10 Cáceres;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QI;""
10 Cáceres;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
10 Cáceres;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
10 Cáceres;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QII;4.550
10 Cáceres;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QI;""
10 Cáceres;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
10 Cáceres;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
10 Cáceres;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QII;4.521
10 Cáceres;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QI;""
10 Cáceres;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
10 Cáceres;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
10 Cáceres;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QII;""
10 Cáceres;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QI;""
10 Cáceres;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
10 Cáceres;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
10 Cáceres;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
10 Cáceres;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
10 Cáceres;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
10 Cáceres;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
10 Cáceres;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
10 Cáceres;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
10 Cáceres;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
10 Cáceres;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
10 Cáceres;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
10 Cáceres;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
10 Cáceres;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
10 Cáceres;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;97,92
10 Cáceres;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
10 Cáceres;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
10 Cáceres;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
10 Cáceres;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;98,54
10 Cáceres;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
10 Cáceres;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
10 Cáceres;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
10 Cáceres;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;98,31
10 Cáceres;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
10 Cáceres;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
10 Cáceres;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;96,06
10 Cáceres;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
10 Cáceres;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
10 Cáceres;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
10 Cáceres;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;97,08
10 Cáceres;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
10 Cáceres;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
10 Cáceres;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
10 Cáceres;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;96,64
10 Cáceres;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
10 Cáceres;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
10 Cáceres;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
10 Cáceres;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
10 Cáceres;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
10 Cáceres;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
10 Cáceres;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;95,25
10 Cáceres;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
10 Cáceres;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
10 Cáceres;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
10 Cáceres;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;95,43
10 Cáceres;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
10 Cáceres;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
10 Cáceres;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
10 Cáceres;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
10 Cáceres;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
10 Cáceres;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
10 Cáceres;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;93,56
10 Cáceres;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
10 Cáceres;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
10 Cáceres;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
10 Cáceres;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;94,38
10 Cáceres;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
10 Cáceres;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
10 Cáceres;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
10 Cáceres;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
10 Cáceres;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
10 Cáceres;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
10 Cáceres;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QIII;2.617
10 Cáceres;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
10 Cáceres;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
10 Cáceres;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
10 Cáceres;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QIII;2.597
10 Cáceres;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
10 Cáceres;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
10 Cáceres;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
10 Cáceres;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QIII;2.549
10 Cáceres;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
10 Cáceres;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
10 Cáceres;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
10 Cáceres;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2022QIII;2.549
10 Cáceres;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2022QII;""
10 Cáceres;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2022QI;""
10 Cáceres;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
10 Cáceres;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2021QIII;2.545
10 Cáceres;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2021QII;""
10 Cáceres;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2021QI;""
10 Cáceres;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
10 Cáceres;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2020QIII;2.485
10 Cáceres;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2020QII;""
10 Cáceres;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2020QI;""
10 Cáceres;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2022QIV;2.499
10 Cáceres;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
10 Cáceres;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2022QII;""
10 Cáceres;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2022QI;""
10 Cáceres;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2021QIV;2.495
10 Cáceres;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
10 Cáceres;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2021QII;""
10 Cáceres;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2021QI;""
10 Cáceres;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2020QIV;2.439
10 Cáceres;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
10 Cáceres;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2020QII;""
10 Cáceres;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2020QI;""
10 Cáceres;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
10 Cáceres;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
10 Cáceres;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QII;""
10 Cáceres;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QI;2.440
10 Cáceres;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
10 Cáceres;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
10 Cáceres;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QII;""
10 Cáceres;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QI;2.393
10 Cáceres;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
10 Cáceres;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
10 Cáceres;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QII;""
10 Cáceres;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QI;""
10 Cáceres;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
10 Cáceres;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
10 Cáceres;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QII;2.377
10 Cáceres;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QI;""
10 Cáceres;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
10 Cáceres;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
10 Cáceres;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QII;2.350
10 Cáceres;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QI;""
10 Cáceres;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
10 Cáceres;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
10 Cáceres;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QII;""
10 Cáceres;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QI;""
10 Cáceres;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
10 Cáceres;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
10 Cáceres;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
10 Cáceres;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
10 Cáceres;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
10 Cáceres;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
10 Cáceres;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
10 Cáceres;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
10 Cáceres;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
10 Cáceres;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
10 Cáceres;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
10 Cáceres;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
10 Cáceres;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
10 Cáceres;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;97,4
10 Cáceres;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
10 Cáceres;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
10 Cáceres;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
10 Cáceres;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;98
10 Cáceres;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
10 Cáceres;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
10 Cáceres;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
10 Cáceres;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;97,49
10 Cáceres;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
10 Cáceres;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
10 Cáceres;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;95,49
10 Cáceres;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
10 Cáceres;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
10 Cáceres;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
10 Cáceres;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;96,07
10 Cáceres;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
10 Cáceres;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
10 Cáceres;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
10 Cáceres;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;95,68
10 Cáceres;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
10 Cáceres;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
10 Cáceres;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
10 Cáceres;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
10 Cáceres;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
10 Cáceres;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
10 Cáceres;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;93,95
10 Cáceres;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
10 Cáceres;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
10 Cáceres;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
10 Cáceres;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;93,88
10 Cáceres;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
10 Cáceres;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
10 Cáceres;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
10 Cáceres;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
10 Cáceres;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
10 Cáceres;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
10 Cáceres;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;91,53
10 Cáceres;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
10 Cáceres;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
10 Cáceres;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
10 Cáceres;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;92,19
10 Cáceres;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
10 Cáceres;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
10 Cáceres;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
10 Cáceres;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
10 Cáceres;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
10 Cáceres;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QIV;7.369
10 Cáceres;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
10 Cáceres;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
10 Cáceres;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
10 Cáceres;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QIV;7.444
10 Cáceres;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
10 Cáceres;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
10 Cáceres;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
10 Cáceres;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QIV;7.303
10 Cáceres;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
10 Cáceres;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
10 Cáceres;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
10 Cáceres;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2022QIV;7.224
10 Cáceres;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
10 Cáceres;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2022QII;""
10 Cáceres;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2022QI;""
10 Cáceres;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2021QIV;7.313
10 Cáceres;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
10 Cáceres;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2021QII;""
10 Cáceres;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2021QI;""
10 Cáceres;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2020QIV;7.165
10 Cáceres;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
10 Cáceres;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2020QII;""
10 Cáceres;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2020QI;""
10 Cáceres;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
10 Cáceres;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
10 Cáceres;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2022QII;""
10 Cáceres;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2022QI;7.168
10 Cáceres;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
10 Cáceres;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
10 Cáceres;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2021QII;""
10 Cáceres;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2021QI;7.055
10 Cáceres;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
10 Cáceres;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
10 Cáceres;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2020QII;""
10 Cáceres;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2020QI;""
10 Cáceres;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
10 Cáceres;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
10 Cáceres;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QII;7.019
10 Cáceres;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QI;""
10 Cáceres;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
10 Cáceres;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
10 Cáceres;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QII;6.959
10 Cáceres;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QI;""
10 Cáceres;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
10 Cáceres;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
10 Cáceres;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QII;""
10 Cáceres;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QI;""
10 Cáceres;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
10 Cáceres;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QIII;6.897
10 Cáceres;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QII;""
10 Cáceres;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QI;""
10 Cáceres;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
10 Cáceres;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QIII;6.875
10 Cáceres;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QII;""
10 Cáceres;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QI;""
10 Cáceres;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
10 Cáceres;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
10 Cáceres;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QII;""
10 Cáceres;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QI;""
10 Cáceres;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
10 Cáceres;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
10 Cáceres;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
10 Cáceres;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
10 Cáceres;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
10 Cáceres;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
10 Cáceres;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
10 Cáceres;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
10 Cáceres;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
10 Cáceres;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
10 Cáceres;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
10 Cáceres;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
10 Cáceres;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;98,03
10 Cáceres;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
10 Cáceres;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
10 Cáceres;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
10 Cáceres;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;98,24
10 Cáceres;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
10 Cáceres;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
10 Cáceres;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
10 Cáceres;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;98,11
10 Cáceres;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
10 Cáceres;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
10 Cáceres;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
10 Cáceres;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
10 Cáceres;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
10 Cáceres;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
10 Cáceres;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;96,29
10 Cáceres;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
10 Cáceres;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
10 Cáceres;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
10 Cáceres;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;96,6
10 Cáceres;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
10 Cáceres;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
10 Cáceres;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
10 Cáceres;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
10 Cáceres;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
10 Cáceres;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
10 Cáceres;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;94,29
10 Cáceres;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
10 Cáceres;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
10 Cáceres;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
10 Cáceres;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;95,29
10 Cáceres;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
10 Cáceres;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
10 Cáceres;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
10 Cáceres;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
10 Cáceres;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
10 Cáceres;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
10 Cáceres;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;92,65
10 Cáceres;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
10 Cáceres;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
10 Cáceres;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
10 Cáceres;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;94,14
10 Cáceres;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
10 Cáceres;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
10 Cáceres;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
10 Cáceres;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
10 Cáceres;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
10 Cáceres;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
10 Cáceres;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QIV;4.787
10 Cáceres;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
10 Cáceres;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
10 Cáceres;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
10 Cáceres;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QIV;4.851
10 Cáceres;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
10 Cáceres;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
10 Cáceres;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
10 Cáceres;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QIV;4.783
10 Cáceres;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
10 Cáceres;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
10 Cáceres;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
10 Cáceres;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2022QIV;4.692
10 Cáceres;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
10 Cáceres;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2022QII;""
10 Cáceres;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2022QI;""
10 Cáceres;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2021QIV;4.774
10 Cáceres;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
10 Cáceres;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2021QII;""
10 Cáceres;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2021QI;""
10 Cáceres;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2020QIV;4.693
10 Cáceres;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
10 Cáceres;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2020QII;""
10 Cáceres;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2020QI;""
10 Cáceres;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
10 Cáceres;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
10 Cáceres;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2022QII;""
10 Cáceres;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2022QI;4.685
10 Cáceres;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
10 Cáceres;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
10 Cáceres;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2021QII;""
10 Cáceres;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2021QI;4.631
10 Cáceres;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
10 Cáceres;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
10 Cáceres;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2020QII;""
10 Cáceres;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2020QI;""
10 Cáceres;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
10 Cáceres;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
10 Cáceres;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QII;4.602
10 Cáceres;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QI;""
10 Cáceres;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
10 Cáceres;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
10 Cáceres;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QII;4.578
10 Cáceres;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QI;""
10 Cáceres;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
10 Cáceres;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
10 Cáceres;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QII;""
10 Cáceres;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QI;""
10 Cáceres;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
10 Cáceres;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QIII;4.530
10 Cáceres;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QII;""
10 Cáceres;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QI;""
10 Cáceres;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
10 Cáceres;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QIII;4.531
10 Cáceres;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QII;""
10 Cáceres;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QI;""
10 Cáceres;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
10 Cáceres;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
10 Cáceres;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QII;""
10 Cáceres;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QI;""
10 Cáceres;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
10 Cáceres;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
10 Cáceres;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
10 Cáceres;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
10 Cáceres;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
10 Cáceres;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
10 Cáceres;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
10 Cáceres;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
10 Cáceres;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
10 Cáceres;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
10 Cáceres;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
10 Cáceres;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
10 Cáceres;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;98,02
10 Cáceres;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
10 Cáceres;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
10 Cáceres;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
10 Cáceres;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;98,41
10 Cáceres;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
10 Cáceres;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
10 Cáceres;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
10 Cáceres;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;98,12
10 Cáceres;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
10 Cáceres;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
10 Cáceres;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
10 Cáceres;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
10 Cáceres;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
10 Cáceres;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
10 Cáceres;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;96,58
10 Cáceres;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
10 Cáceres;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
10 Cáceres;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
10 Cáceres;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;96,82
10 Cáceres;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
10 Cáceres;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
10 Cáceres;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
10 Cáceres;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
10 Cáceres;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
10 Cáceres;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
10 Cáceres;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;94,87
10 Cáceres;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
10 Cáceres;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
10 Cáceres;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
10 Cáceres;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;95,71
10 Cáceres;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
10 Cáceres;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
10 Cáceres;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
10 Cáceres;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
10 Cáceres;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
10 Cáceres;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
10 Cáceres;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;93,38
10 Cáceres;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
10 Cáceres;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
10 Cáceres;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
10 Cáceres;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;94,73
10 Cáceres;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
10 Cáceres;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
10 Cáceres;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
10 Cáceres;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
10 Cáceres;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
10 Cáceres;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
10 Cáceres;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QIV;2.582
10 Cáceres;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
10 Cáceres;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
10 Cáceres;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
10 Cáceres;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QIV;2.593
10 Cáceres;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
10 Cáceres;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
10 Cáceres;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
10 Cáceres;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QIV;2.520
10 Cáceres;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
10 Cáceres;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
10 Cáceres;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
10 Cáceres;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2022QIV;2.532
10 Cáceres;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
10 Cáceres;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2022QII;""
10 Cáceres;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2022QI;""
10 Cáceres;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2021QIV;2.539
10 Cáceres;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
10 Cáceres;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2021QII;""
10 Cáceres;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2021QI;""
10 Cáceres;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2020QIV;2.472
10 Cáceres;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
10 Cáceres;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2020QII;""
10 Cáceres;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2020QI;""
10 Cáceres;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
10 Cáceres;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
10 Cáceres;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2022QII;""
10 Cáceres;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2022QI;2.483
10 Cáceres;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
10 Cáceres;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
10 Cáceres;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2021QII;""
10 Cáceres;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2021QI;2.424
10 Cáceres;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
10 Cáceres;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
10 Cáceres;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2020QII;""
10 Cáceres;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2020QI;""
10 Cáceres;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
10 Cáceres;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
10 Cáceres;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QII;2.417
10 Cáceres;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QI;""
10 Cáceres;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
10 Cáceres;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
10 Cáceres;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QII;2.381
10 Cáceres;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QI;""
10 Cáceres;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
10 Cáceres;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
10 Cáceres;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QII;""
10 Cáceres;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QI;""
10 Cáceres;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
10 Cáceres;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QIII;2.367
10 Cáceres;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QII;""
10 Cáceres;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QI;""
10 Cáceres;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
10 Cáceres;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QIII;2.344
10 Cáceres;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QII;""
10 Cáceres;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QI;""
10 Cáceres;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
10 Cáceres;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
10 Cáceres;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QII;""
10 Cáceres;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QI;""
10 Cáceres;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
10 Cáceres;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
10 Cáceres;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
10 Cáceres;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
10 Cáceres;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
10 Cáceres;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
10 Cáceres;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
10 Cáceres;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
10 Cáceres;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
10 Cáceres;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
10 Cáceres;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
10 Cáceres;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
10 Cáceres;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;98,06
10 Cáceres;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
10 Cáceres;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
10 Cáceres;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
10 Cáceres;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;97,92
10 Cáceres;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
10 Cáceres;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
10 Cáceres;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
10 Cáceres;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;98,1
10 Cáceres;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
10 Cáceres;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
10 Cáceres;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
10 Cáceres;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
10 Cáceres;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
10 Cáceres;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
10 Cáceres;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;95,76
10 Cáceres;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
10 Cáceres;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
10 Cáceres;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
10 Cáceres;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;96,19
10 Cáceres;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
10 Cáceres;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
10 Cáceres;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
10 Cáceres;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
10 Cáceres;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
10 Cáceres;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
10 Cáceres;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;93,21
10 Cáceres;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
10 Cáceres;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
10 Cáceres;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
10 Cáceres;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;94,48
10 Cáceres;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
10 Cáceres;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
10 Cáceres;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
10 Cáceres;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
10 Cáceres;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
10 Cáceres;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
10 Cáceres;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;91,28
10 Cáceres;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
10 Cáceres;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
10 Cáceres;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
10 Cáceres;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;93,02
10 Cáceres;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
10 Cáceres;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
10 Cáceres;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
10 Cáceres;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
10 Cáceres;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
10 Cáceres;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
10 Cáceres;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
10 Cáceres;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
10 Cáceres;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
10 Cáceres;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QI;3.454
10 Cáceres;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
10 Cáceres;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
10 Cáceres;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
10 Cáceres;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QI;3.263
10 Cáceres;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
10 Cáceres;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
10 Cáceres;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
10 Cáceres;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QI;3.736
10 Cáceres;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
10 Cáceres;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
10 Cáceres;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2022QII;""
10 Cáceres;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2022QI;3.303
10 Cáceres;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
10 Cáceres;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
10 Cáceres;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2021QII;""
10 Cáceres;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2021QI;3.139
10 Cáceres;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
10 Cáceres;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
10 Cáceres;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2020QII;""
10 Cáceres;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2020QI;3.494
10 Cáceres;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
10 Cáceres;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
10 Cáceres;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2022QII;3.152
10 Cáceres;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2022QI;""
10 Cáceres;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
10 Cáceres;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
10 Cáceres;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2021QII;3.030
10 Cáceres;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2021QI;""
10 Cáceres;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
10 Cáceres;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
10 Cáceres;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2020QII;3.384
10 Cáceres;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2020QI;""
10 Cáceres;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
10 Cáceres;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QIII;3.032
10 Cáceres;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QII;""
10 Cáceres;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QI;""
10 Cáceres;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
10 Cáceres;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QIII;2.919
10 Cáceres;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QII;""
10 Cáceres;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QI;""
10 Cáceres;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
10 Cáceres;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QIII;3.251
10 Cáceres;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QII;""
10 Cáceres;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QI;""
10 Cáceres;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QIV;2.839
10 Cáceres;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
10 Cáceres;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QII;""
10 Cáceres;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QI;""
10 Cáceres;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QIV;2.788
10 Cáceres;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
10 Cáceres;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QII;""
10 Cáceres;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QI;""
10 Cáceres;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QIV;3.131
10 Cáceres;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
10 Cáceres;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QII;""
10 Cáceres;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QI;""
10 Cáceres;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
10 Cáceres;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
10 Cáceres;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
10 Cáceres;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
10 Cáceres;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
10 Cáceres;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
10 Cáceres;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
10 Cáceres;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
10 Cáceres;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
10 Cáceres;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
10 Cáceres;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
10 Cáceres;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
10 Cáceres;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
10 Cáceres;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
10 Cáceres;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
10 Cáceres;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;95,63
10 Cáceres;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
10 Cáceres;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
10 Cáceres;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
10 Cáceres;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;96,2
10 Cáceres;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
10 Cáceres;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
10 Cáceres;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
10 Cáceres;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;93,52
10 Cáceres;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
10 Cáceres;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
10 Cáceres;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;91,26
10 Cáceres;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
10 Cáceres;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
10 Cáceres;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
10 Cáceres;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;92,86
10 Cáceres;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
10 Cáceres;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
10 Cáceres;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
10 Cáceres;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;90,58
10 Cáceres;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
10 Cáceres;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
10 Cáceres;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;87,78
10 Cáceres;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
10 Cáceres;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
10 Cáceres;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
10 Cáceres;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;89,46
10 Cáceres;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
10 Cáceres;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
10 Cáceres;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
10 Cáceres;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;87,02
10 Cáceres;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
10 Cáceres;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
10 Cáceres;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;82,19
10 Cáceres;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
10 Cáceres;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
10 Cáceres;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
10 Cáceres;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;85,44
10 Cáceres;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
10 Cáceres;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
10 Cáceres;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
10 Cáceres;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;83,81
10 Cáceres;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
10 Cáceres;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
10 Cáceres;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
10 Cáceres;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
10 Cáceres;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
10 Cáceres;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
10 Cáceres;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QI;2.255
10 Cáceres;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
10 Cáceres;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
10 Cáceres;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
10 Cáceres;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QI;2.123
10 Cáceres;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
10 Cáceres;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
10 Cáceres;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
10 Cáceres;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QI;2.444
10 Cáceres;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
10 Cáceres;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
10 Cáceres;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2022QII;""
10 Cáceres;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2022QI;2.161
10 Cáceres;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
10 Cáceres;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
10 Cáceres;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2021QII;""
10 Cáceres;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2021QI;2.039
10 Cáceres;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
10 Cáceres;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
10 Cáceres;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2020QII;""
10 Cáceres;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2020QI;2.284
10 Cáceres;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
10 Cáceres;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
10 Cáceres;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2022QII;2.067
10 Cáceres;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2022QI;""
10 Cáceres;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
10 Cáceres;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
10 Cáceres;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2021QII;1.977
10 Cáceres;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2021QI;""
10 Cáceres;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
10 Cáceres;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
10 Cáceres;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2020QII;2.202
10 Cáceres;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2020QI;""
10 Cáceres;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
10 Cáceres;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QIII;1.997
10 Cáceres;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QII;""
10 Cáceres;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QI;""
10 Cáceres;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
10 Cáceres;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QIII;1.896
10 Cáceres;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QII;""
10 Cáceres;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QI;""
10 Cáceres;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
10 Cáceres;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QIII;2.114
10 Cáceres;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QII;""
10 Cáceres;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QI;""
10 Cáceres;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QIV;1.866
10 Cáceres;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
10 Cáceres;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QII;""
10 Cáceres;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QI;""
10 Cáceres;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QIV;1.817
10 Cáceres;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
10 Cáceres;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QII;""
10 Cáceres;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QI;""
10 Cáceres;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QIV;2.042
10 Cáceres;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
10 Cáceres;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QII;""
10 Cáceres;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QI;""
10 Cáceres;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
10 Cáceres;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
10 Cáceres;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
10 Cáceres;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
10 Cáceres;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
10 Cáceres;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
10 Cáceres;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
10 Cáceres;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
10 Cáceres;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
10 Cáceres;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
10 Cáceres;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
10 Cáceres;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
10 Cáceres;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
10 Cáceres;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
10 Cáceres;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
10 Cáceres;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;95,83
10 Cáceres;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
10 Cáceres;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
10 Cáceres;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
10 Cáceres;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;96,04
10 Cáceres;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
10 Cáceres;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
10 Cáceres;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
10 Cáceres;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;93,45
10 Cáceres;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
10 Cáceres;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
10 Cáceres;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;91,66
10 Cáceres;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
10 Cáceres;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
10 Cáceres;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
10 Cáceres;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;93,12
10 Cáceres;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
10 Cáceres;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
10 Cáceres;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
10 Cáceres;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;90,1
10 Cáceres;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
10 Cáceres;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
10 Cáceres;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;88,56
10 Cáceres;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
10 Cáceres;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
10 Cáceres;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
10 Cáceres;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;89,31
10 Cáceres;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
10 Cáceres;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
10 Cáceres;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
10 Cáceres;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;86,5
10 Cáceres;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
10 Cáceres;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
10 Cáceres;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;82,75
10 Cáceres;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
10 Cáceres;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
10 Cáceres;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
10 Cáceres;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;85,59
10 Cáceres;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
10 Cáceres;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
10 Cáceres;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
10 Cáceres;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;83,55
10 Cáceres;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
10 Cáceres;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
10 Cáceres;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
10 Cáceres;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
10 Cáceres;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
10 Cáceres;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
10 Cáceres;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QI;1.199
10 Cáceres;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
10 Cáceres;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
10 Cáceres;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
10 Cáceres;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QI;1.140
10 Cáceres;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
10 Cáceres;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
10 Cáceres;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
10 Cáceres;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QI;1.292
10 Cáceres;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
10 Cáceres;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
10 Cáceres;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2022QII;""
10 Cáceres;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2022QI;1.142
10 Cáceres;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
10 Cáceres;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
10 Cáceres;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2021QII;""
10 Cáceres;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2021QI;1.100
10 Cáceres;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
10 Cáceres;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
10 Cáceres;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2020QII;""
10 Cáceres;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2020QI;1.210
10 Cáceres;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
10 Cáceres;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
10 Cáceres;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2022QII;1.085
10 Cáceres;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2022QI;""
10 Cáceres;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
10 Cáceres;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
10 Cáceres;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2021QII;1.053
10 Cáceres;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2021QI;""
10 Cáceres;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
10 Cáceres;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
10 Cáceres;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2020QII;1.182
10 Cáceres;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2020QI;""
10 Cáceres;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
10 Cáceres;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QIII;1.035
10 Cáceres;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QII;""
10 Cáceres;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QI;""
10 Cáceres;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
10 Cáceres;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QIII;1.023
10 Cáceres;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QII;""
10 Cáceres;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QI;""
10 Cáceres;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
10 Cáceres;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QIII;1.137
10 Cáceres;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QII;""
10 Cáceres;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QI;""
10 Cáceres;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QIV;973
10 Cáceres;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
10 Cáceres;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QII;""
10 Cáceres;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QI;""
10 Cáceres;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QIV;971
10 Cáceres;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
10 Cáceres;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QII;""
10 Cáceres;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QI;""
10 Cáceres;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QIV;1.089
10 Cáceres;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
10 Cáceres;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QII;""
10 Cáceres;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QI;""
10 Cáceres;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
10 Cáceres;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
10 Cáceres;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
10 Cáceres;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
10 Cáceres;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
10 Cáceres;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
10 Cáceres;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
10 Cáceres;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
10 Cáceres;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
10 Cáceres;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
10 Cáceres;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
10 Cáceres;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
10 Cáceres;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
10 Cáceres;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
10 Cáceres;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
10 Cáceres;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;95,25
10 Cáceres;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
10 Cáceres;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
10 Cáceres;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
10 Cáceres;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;96,49
10 Cáceres;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
10 Cáceres;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
10 Cáceres;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
10 Cáceres;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;93,65
10 Cáceres;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
10 Cáceres;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
10 Cáceres;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;90,49
10 Cáceres;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
10 Cáceres;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
10 Cáceres;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
10 Cáceres;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;92,37
10 Cáceres;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
10 Cáceres;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
10 Cáceres;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
10 Cáceres;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;91,49
10 Cáceres;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
10 Cáceres;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
10 Cáceres;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;86,32
10 Cáceres;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
10 Cáceres;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
10 Cáceres;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
10 Cáceres;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;89,74
10 Cáceres;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
10 Cáceres;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
10 Cáceres;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
10 Cáceres;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;88
10 Cáceres;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
10 Cáceres;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
10 Cáceres;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;81,15
10 Cáceres;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
10 Cáceres;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
10 Cáceres;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
10 Cáceres;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;85,18
10 Cáceres;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
10 Cáceres;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
10 Cáceres;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
10 Cáceres;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;84,29
10 Cáceres;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
10 Cáceres;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
10 Cáceres;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
10 Cáceres;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
10 Cáceres;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
10 Cáceres;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QII;3.970
10 Cáceres;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
10 Cáceres;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
10 Cáceres;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
10 Cáceres;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QII;3.770
10 Cáceres;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
10 Cáceres;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
10 Cáceres;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
10 Cáceres;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QII;3.570
10 Cáceres;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
10 Cáceres;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
10 Cáceres;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
10 Cáceres;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2022QII;3.804
10 Cáceres;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2022QI;""
10 Cáceres;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
10 Cáceres;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
10 Cáceres;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2021QII;3.649
10 Cáceres;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2021QI;""
10 Cáceres;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
10 Cáceres;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
10 Cáceres;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2020QII;3.458
10 Cáceres;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2020QI;""
10 Cáceres;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
10 Cáceres;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2022QIII;3.670
10 Cáceres;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2022QII;""
10 Cáceres;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2022QI;""
10 Cáceres;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
10 Cáceres;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2021QIII;3.524
10 Cáceres;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2021QII;""
10 Cáceres;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2021QI;""
10 Cáceres;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
10 Cáceres;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2020QIII;3.311
10 Cáceres;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2020QII;""
10 Cáceres;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2020QI;""
10 Cáceres;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QIV;3.461
10 Cáceres;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
10 Cáceres;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QII;""
10 Cáceres;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QI;""
10 Cáceres;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QIV;3.380
10 Cáceres;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
10 Cáceres;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QII;""
10 Cáceres;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QI;""
10 Cáceres;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QIV;3.187
10 Cáceres;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
10 Cáceres;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QII;""
10 Cáceres;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QI;""
10 Cáceres;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
10 Cáceres;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
10 Cáceres;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QII;""
10 Cáceres;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QI;3.239
10 Cáceres;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
10 Cáceres;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
10 Cáceres;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QII;""
10 Cáceres;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QI;3.069
10 Cáceres;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
10 Cáceres;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
10 Cáceres;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QII;""
10 Cáceres;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QI;""
10 Cáceres;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
10 Cáceres;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
10 Cáceres;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
10 Cáceres;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
10 Cáceres;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
10 Cáceres;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
10 Cáceres;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
10 Cáceres;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
10 Cáceres;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
10 Cáceres;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
10 Cáceres;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
10 Cáceres;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
10 Cáceres;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
10 Cáceres;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
10 Cáceres;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;95,82
10 Cáceres;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
10 Cáceres;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
10 Cáceres;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
10 Cáceres;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;96,79
10 Cáceres;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
10 Cáceres;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
10 Cáceres;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
10 Cáceres;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;96,86
10 Cáceres;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
10 Cáceres;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
10 Cáceres;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;92,44
10 Cáceres;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
10 Cáceres;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
10 Cáceres;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
10 Cáceres;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;93,47
10 Cáceres;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
10 Cáceres;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
10 Cáceres;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
10 Cáceres;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;92,75
10 Cáceres;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
10 Cáceres;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
10 Cáceres;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;87,18
10 Cáceres;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
10 Cáceres;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
10 Cáceres;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
10 Cáceres;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;89,66
10 Cáceres;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
10 Cáceres;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
10 Cáceres;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
10 Cáceres;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;89,27
10 Cáceres;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
10 Cáceres;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
10 Cáceres;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
10 Cáceres;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
10 Cáceres;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
10 Cáceres;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
10 Cáceres;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;85,92
10 Cáceres;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
10 Cáceres;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
10 Cáceres;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
10 Cáceres;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;85,97
10 Cáceres;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
10 Cáceres;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
10 Cáceres;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
10 Cáceres;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
10 Cáceres;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
10 Cáceres;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
10 Cáceres;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QII;2.582
10 Cáceres;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
10 Cáceres;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
10 Cáceres;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
10 Cáceres;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QII;2.450
10 Cáceres;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
10 Cáceres;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
10 Cáceres;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
10 Cáceres;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QII;2.329
10 Cáceres;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
10 Cáceres;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
10 Cáceres;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
10 Cáceres;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2022QII;2.479
10 Cáceres;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2022QI;""
10 Cáceres;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
10 Cáceres;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
10 Cáceres;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2021QII;2.384
10 Cáceres;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2021QI;""
10 Cáceres;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
10 Cáceres;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
10 Cáceres;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2020QII;2.246
10 Cáceres;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2020QI;""
10 Cáceres;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
10 Cáceres;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2022QIII;2.401
10 Cáceres;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2022QII;""
10 Cáceres;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2022QI;""
10 Cáceres;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
10 Cáceres;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2021QIII;2.294
10 Cáceres;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2021QII;""
10 Cáceres;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2021QI;""
10 Cáceres;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
10 Cáceres;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2020QIII;2.149
10 Cáceres;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2020QII;""
10 Cáceres;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2020QI;""
10 Cáceres;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QIV;2.262
10 Cáceres;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
10 Cáceres;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QII;""
10 Cáceres;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QI;""
10 Cáceres;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QIV;2.209
10 Cáceres;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
10 Cáceres;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QII;""
10 Cáceres;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QI;""
10 Cáceres;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QIV;2.074
10 Cáceres;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
10 Cáceres;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QII;""
10 Cáceres;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QI;""
10 Cáceres;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
10 Cáceres;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
10 Cáceres;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QII;""
10 Cáceres;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QI;2.123
10 Cáceres;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
10 Cáceres;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
10 Cáceres;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QII;""
10 Cáceres;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QI;1.993
10 Cáceres;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
10 Cáceres;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
10 Cáceres;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QII;""
10 Cáceres;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QI;""
10 Cáceres;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
10 Cáceres;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
10 Cáceres;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
10 Cáceres;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
10 Cáceres;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
10 Cáceres;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
10 Cáceres;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
10 Cáceres;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
10 Cáceres;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
10 Cáceres;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
10 Cáceres;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
10 Cáceres;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
10 Cáceres;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
10 Cáceres;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
10 Cáceres;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;96,01
10 Cáceres;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
10 Cáceres;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
10 Cáceres;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
10 Cáceres;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;97,31
10 Cáceres;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
10 Cáceres;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
10 Cáceres;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
10 Cáceres;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;96,44
10 Cáceres;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
10 Cáceres;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
10 Cáceres;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;92,99
10 Cáceres;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
10 Cáceres;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
10 Cáceres;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
10 Cáceres;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;93,63
10 Cáceres;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
10 Cáceres;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
10 Cáceres;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
10 Cáceres;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;92,27
10 Cáceres;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
10 Cáceres;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
10 Cáceres;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;87,61
10 Cáceres;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
10 Cáceres;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
10 Cáceres;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
10 Cáceres;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;90,16
10 Cáceres;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
10 Cáceres;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
10 Cáceres;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
10 Cáceres;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;89,05
10 Cáceres;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
10 Cáceres;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
10 Cáceres;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
10 Cáceres;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
10 Cáceres;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
10 Cáceres;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
10 Cáceres;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;86,65
10 Cáceres;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
10 Cáceres;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
10 Cáceres;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
10 Cáceres;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;85,57
10 Cáceres;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
10 Cáceres;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
10 Cáceres;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
10 Cáceres;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
10 Cáceres;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
10 Cáceres;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
10 Cáceres;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QII;1.388
10 Cáceres;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
10 Cáceres;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
10 Cáceres;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
10 Cáceres;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QII;1.320
10 Cáceres;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
10 Cáceres;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
10 Cáceres;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
10 Cáceres;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QII;1.241
10 Cáceres;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
10 Cáceres;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
10 Cáceres;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
10 Cáceres;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2022QII;1.325
10 Cáceres;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2022QI;""
10 Cáceres;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
10 Cáceres;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
10 Cáceres;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2021QII;1.265
10 Cáceres;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2021QI;""
10 Cáceres;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
10 Cáceres;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
10 Cáceres;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2020QII;1.212
10 Cáceres;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2020QI;""
10 Cáceres;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
10 Cáceres;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2022QIII;1.269
10 Cáceres;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2022QII;""
10 Cáceres;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2022QI;""
10 Cáceres;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
10 Cáceres;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2021QIII;1.230
10 Cáceres;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2021QII;""
10 Cáceres;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2021QI;""
10 Cáceres;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
10 Cáceres;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2020QIII;1.162
10 Cáceres;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2020QII;""
10 Cáceres;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2020QI;""
10 Cáceres;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QIV;1.199
10 Cáceres;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
10 Cáceres;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QII;""
10 Cáceres;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QI;""
10 Cáceres;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QIV;1.171
10 Cáceres;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
10 Cáceres;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QII;""
10 Cáceres;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QI;""
10 Cáceres;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QIV;1.113
10 Cáceres;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
10 Cáceres;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QII;""
10 Cáceres;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QI;""
10 Cáceres;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
10 Cáceres;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
10 Cáceres;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QII;""
10 Cáceres;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QI;1.116
10 Cáceres;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
10 Cáceres;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
10 Cáceres;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QII;""
10 Cáceres;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QI;1.076
10 Cáceres;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
10 Cáceres;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
10 Cáceres;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QII;""
10 Cáceres;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QI;""
10 Cáceres;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
10 Cáceres;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
10 Cáceres;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
10 Cáceres;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
10 Cáceres;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
10 Cáceres;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
10 Cáceres;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
10 Cáceres;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
10 Cáceres;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
10 Cáceres;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
10 Cáceres;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
10 Cáceres;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
10 Cáceres;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
10 Cáceres;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
10 Cáceres;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;95,46
10 Cáceres;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
10 Cáceres;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
10 Cáceres;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
10 Cáceres;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;95,83
10 Cáceres;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
10 Cáceres;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
10 Cáceres;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
10 Cáceres;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;97,66
10 Cáceres;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
10 Cáceres;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
10 Cáceres;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;91,43
10 Cáceres;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
10 Cáceres;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
10 Cáceres;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
10 Cáceres;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;93,18
10 Cáceres;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
10 Cáceres;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
10 Cáceres;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
10 Cáceres;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;93,63
10 Cáceres;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
10 Cáceres;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
10 Cáceres;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;86,38
10 Cáceres;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
10 Cáceres;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
10 Cáceres;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
10 Cáceres;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;88,71
10 Cáceres;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
10 Cáceres;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
10 Cáceres;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
10 Cáceres;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;89,69
10 Cáceres;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
10 Cáceres;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
10 Cáceres;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
10 Cáceres;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
10 Cáceres;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
10 Cáceres;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
10 Cáceres;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;84,55
10 Cáceres;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
10 Cáceres;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
10 Cáceres;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
10 Cáceres;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;86,7
10 Cáceres;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
10 Cáceres;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
10 Cáceres;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
10 Cáceres;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
10 Cáceres;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
10 Cáceres;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QIII;3.862
10 Cáceres;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
10 Cáceres;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
10 Cáceres;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
10 Cáceres;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QIII;3.692
10 Cáceres;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
10 Cáceres;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
10 Cáceres;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
10 Cáceres;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QIII;3.492
10 Cáceres;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
10 Cáceres;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
10 Cáceres;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
10 Cáceres;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2022QIII;3.707
10 Cáceres;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2022QII;""
10 Cáceres;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2022QI;""
10 Cáceres;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
10 Cáceres;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2021QIII;3.553
10 Cáceres;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2021QII;""
10 Cáceres;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2021QI;""
10 Cáceres;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
10 Cáceres;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2020QIII;3.332
10 Cáceres;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2020QII;""
10 Cáceres;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2020QI;""
10 Cáceres;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2022QIV;3.487
10 Cáceres;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
10 Cáceres;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2022QII;""
10 Cáceres;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2022QI;""
10 Cáceres;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2021QIV;3.405
10 Cáceres;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
10 Cáceres;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2021QII;""
10 Cáceres;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2021QI;""
10 Cáceres;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2020QIV;3.205
10 Cáceres;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
10 Cáceres;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2020QII;""
10 Cáceres;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2020QI;""
10 Cáceres;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
10 Cáceres;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
10 Cáceres;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QII;""
10 Cáceres;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QI;3.260
10 Cáceres;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
10 Cáceres;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
10 Cáceres;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QII;""
10 Cáceres;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QI;3.086
10 Cáceres;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
10 Cáceres;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
10 Cáceres;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QII;""
10 Cáceres;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QI;""
10 Cáceres;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
10 Cáceres;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
10 Cáceres;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QII;3.116
10 Cáceres;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QI;""
10 Cáceres;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
10 Cáceres;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
10 Cáceres;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QII;2.980
10 Cáceres;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QI;""
10 Cáceres;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
10 Cáceres;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
10 Cáceres;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QII;""
10 Cáceres;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QI;""
10 Cáceres;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
10 Cáceres;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
10 Cáceres;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
10 Cáceres;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
10 Cáceres;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
10 Cáceres;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
10 Cáceres;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
10 Cáceres;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
10 Cáceres;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
10 Cáceres;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
10 Cáceres;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
10 Cáceres;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
10 Cáceres;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
10 Cáceres;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;95,99
10 Cáceres;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
10 Cáceres;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
10 Cáceres;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
10 Cáceres;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;96,24
10 Cáceres;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
10 Cáceres;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
10 Cáceres;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
10 Cáceres;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;95,42
10 Cáceres;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
10 Cáceres;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
10 Cáceres;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;90,29
10 Cáceres;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
10 Cáceres;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
10 Cáceres;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
10 Cáceres;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;92,23
10 Cáceres;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
10 Cáceres;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
10 Cáceres;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
10 Cáceres;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;91,78
10 Cáceres;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
10 Cáceres;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
10 Cáceres;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
10 Cáceres;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
10 Cáceres;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
10 Cáceres;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
10 Cáceres;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;88,3
10 Cáceres;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
10 Cáceres;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
10 Cáceres;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
10 Cáceres;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;88,37
10 Cáceres;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
10 Cáceres;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
10 Cáceres;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
10 Cáceres;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
10 Cáceres;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
10 Cáceres;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
10 Cáceres;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;84,4
10 Cáceres;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
10 Cáceres;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
10 Cáceres;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
10 Cáceres;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;85,34
10 Cáceres;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
10 Cáceres;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
10 Cáceres;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
10 Cáceres;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
10 Cáceres;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
10 Cáceres;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
10 Cáceres;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QIII;2.514
10 Cáceres;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
10 Cáceres;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
10 Cáceres;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
10 Cáceres;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QIII;2.411
10 Cáceres;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
10 Cáceres;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
10 Cáceres;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
10 Cáceres;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QIII;2.269
10 Cáceres;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
10 Cáceres;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
10 Cáceres;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
10 Cáceres;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2022QIII;2.427
10 Cáceres;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2022QII;""
10 Cáceres;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2022QI;""
10 Cáceres;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
10 Cáceres;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2021QIII;2.313
10 Cáceres;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2021QII;""
10 Cáceres;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2021QI;""
10 Cáceres;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
10 Cáceres;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2020QIII;2.163
10 Cáceres;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2020QII;""
10 Cáceres;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2020QI;""
10 Cáceres;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2022QIV;2.279
10 Cáceres;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
10 Cáceres;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2022QII;""
10 Cáceres;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2022QI;""
10 Cáceres;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2021QIV;2.224
10 Cáceres;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
10 Cáceres;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2021QII;""
10 Cáceres;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2021QI;""
10 Cáceres;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2020QIV;2.086
10 Cáceres;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
10 Cáceres;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2020QII;""
10 Cáceres;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2020QI;""
10 Cáceres;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
10 Cáceres;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
10 Cáceres;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QII;""
10 Cáceres;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QI;2.135
10 Cáceres;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
10 Cáceres;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
10 Cáceres;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QII;""
10 Cáceres;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QI;2.005
10 Cáceres;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
10 Cáceres;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
10 Cáceres;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QII;""
10 Cáceres;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QI;""
10 Cáceres;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
10 Cáceres;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
10 Cáceres;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QII;2.046
10 Cáceres;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QI;""
10 Cáceres;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
10 Cáceres;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
10 Cáceres;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QII;1.944
10 Cáceres;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QI;""
10 Cáceres;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
10 Cáceres;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
10 Cáceres;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QII;""
10 Cáceres;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QI;""
10 Cáceres;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
10 Cáceres;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
10 Cáceres;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
10 Cáceres;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
10 Cáceres;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
10 Cáceres;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
10 Cáceres;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
10 Cáceres;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
10 Cáceres;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
10 Cáceres;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
10 Cáceres;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
10 Cáceres;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
10 Cáceres;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
10 Cáceres;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;96,54
10 Cáceres;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
10 Cáceres;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
10 Cáceres;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
10 Cáceres;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;95,94
10 Cáceres;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
10 Cáceres;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
10 Cáceres;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
10 Cáceres;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;95,33
10 Cáceres;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
10 Cáceres;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
10 Cáceres;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;90,65
10 Cáceres;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
10 Cáceres;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
10 Cáceres;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
10 Cáceres;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;92,24
10 Cáceres;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
10 Cáceres;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
10 Cáceres;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
10 Cáceres;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;91,93
10 Cáceres;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
10 Cáceres;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
10 Cáceres;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
10 Cáceres;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
10 Cáceres;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
10 Cáceres;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
10 Cáceres;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;88,55
10 Cáceres;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
10 Cáceres;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
10 Cáceres;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
10 Cáceres;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;88,36
10 Cáceres;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
10 Cáceres;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
10 Cáceres;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
10 Cáceres;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
10 Cáceres;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
10 Cáceres;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
10 Cáceres;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;84,86
10 Cáceres;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
10 Cáceres;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
10 Cáceres;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
10 Cáceres;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;85,68
10 Cáceres;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
10 Cáceres;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
10 Cáceres;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
10 Cáceres;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
10 Cáceres;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
10 Cáceres;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
10 Cáceres;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QIII;1.348
10 Cáceres;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
10 Cáceres;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
10 Cáceres;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
10 Cáceres;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QIII;1.281
10 Cáceres;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
10 Cáceres;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
10 Cáceres;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
10 Cáceres;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QIII;1.223
10 Cáceres;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
10 Cáceres;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
10 Cáceres;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
10 Cáceres;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2022QIII;1.280
10 Cáceres;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2022QII;""
10 Cáceres;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2022QI;""
10 Cáceres;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
10 Cáceres;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2021QIII;1.240
10 Cáceres;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2021QII;""
10 Cáceres;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2021QI;""
10 Cáceres;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
10 Cáceres;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2020QIII;1.169
10 Cáceres;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2020QII;""
10 Cáceres;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2020QI;""
10 Cáceres;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2022QIV;1.208
10 Cáceres;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
10 Cáceres;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2022QII;""
10 Cáceres;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2022QI;""
10 Cáceres;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2021QIV;1.181
10 Cáceres;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
10 Cáceres;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2021QII;""
10 Cáceres;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2021QI;""
10 Cáceres;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2020QIV;1.119
10 Cáceres;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
10 Cáceres;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2020QII;""
10 Cáceres;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2020QI;""
10 Cáceres;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
10 Cáceres;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
10 Cáceres;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QII;""
10 Cáceres;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QI;1.125
10 Cáceres;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
10 Cáceres;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
10 Cáceres;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QII;""
10 Cáceres;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QI;1.081
10 Cáceres;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
10 Cáceres;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
10 Cáceres;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QII;""
10 Cáceres;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QI;""
10 Cáceres;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
10 Cáceres;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
10 Cáceres;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QII;1.070
10 Cáceres;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QI;""
10 Cáceres;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
10 Cáceres;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
10 Cáceres;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QII;1.036
10 Cáceres;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QI;""
10 Cáceres;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
10 Cáceres;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
10 Cáceres;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QII;""
10 Cáceres;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QI;""
10 Cáceres;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
10 Cáceres;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
10 Cáceres;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
10 Cáceres;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
10 Cáceres;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
10 Cáceres;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
10 Cáceres;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
10 Cáceres;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
10 Cáceres;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
10 Cáceres;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
10 Cáceres;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
10 Cáceres;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
10 Cáceres;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
10 Cáceres;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;94,96
10 Cáceres;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
10 Cáceres;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
10 Cáceres;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
10 Cáceres;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;96,8
10 Cáceres;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
10 Cáceres;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
10 Cáceres;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
10 Cáceres;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;95,58
10 Cáceres;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
10 Cáceres;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
10 Cáceres;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;89,61
10 Cáceres;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
10 Cáceres;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
10 Cáceres;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
10 Cáceres;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;92,19
10 Cáceres;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
10 Cáceres;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
10 Cáceres;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
10 Cáceres;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;91,5
10 Cáceres;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
10 Cáceres;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
10 Cáceres;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
10 Cáceres;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
10 Cáceres;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
10 Cáceres;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
10 Cáceres;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;87,82
10 Cáceres;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
10 Cáceres;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
10 Cáceres;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
10 Cáceres;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;88,39
10 Cáceres;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
10 Cáceres;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
10 Cáceres;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
10 Cáceres;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
10 Cáceres;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
10 Cáceres;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
10 Cáceres;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;83,53
10 Cáceres;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
10 Cáceres;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
10 Cáceres;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
10 Cáceres;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;84,71
10 Cáceres;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
10 Cáceres;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
10 Cáceres;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
10 Cáceres;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
10 Cáceres;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
10 Cáceres;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QIV;3.741
10 Cáceres;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
10 Cáceres;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
10 Cáceres;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
10 Cáceres;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QIV;3.582
10 Cáceres;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
10 Cáceres;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
10 Cáceres;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
10 Cáceres;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QIV;3.365
10 Cáceres;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
10 Cáceres;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
10 Cáceres;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
10 Cáceres;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2022QIV;3.515
10 Cáceres;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
10 Cáceres;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2022QII;""
10 Cáceres;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2022QI;""
10 Cáceres;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2021QIV;3.427
10 Cáceres;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
10 Cáceres;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2021QII;""
10 Cáceres;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2021QI;""
10 Cáceres;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2020QIV;3.230
10 Cáceres;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
10 Cáceres;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2020QII;""
10 Cáceres;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2020QI;""
10 Cáceres;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
10 Cáceres;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
10 Cáceres;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2022QII;""
10 Cáceres;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2022QI;3.281
10 Cáceres;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
10 Cáceres;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
10 Cáceres;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2021QII;""
10 Cáceres;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2021QI;3.109
10 Cáceres;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
10 Cáceres;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
10 Cáceres;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2020QII;""
10 Cáceres;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2020QI;""
10 Cáceres;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
10 Cáceres;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
10 Cáceres;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QII;3.135
10 Cáceres;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QI;""
10 Cáceres;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
10 Cáceres;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
10 Cáceres;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QII;3.002
10 Cáceres;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QI;""
10 Cáceres;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
10 Cáceres;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
10 Cáceres;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QII;""
10 Cáceres;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QI;""
10 Cáceres;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
10 Cáceres;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QIII;3.017
10 Cáceres;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QII;""
10 Cáceres;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QI;""
10 Cáceres;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
10 Cáceres;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QIII;2.895
10 Cáceres;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QII;""
10 Cáceres;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QI;""
10 Cáceres;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
10 Cáceres;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
10 Cáceres;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QII;""
10 Cáceres;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QI;""
10 Cáceres;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
10 Cáceres;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
10 Cáceres;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
10 Cáceres;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
10 Cáceres;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
10 Cáceres;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
10 Cáceres;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
10 Cáceres;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
10 Cáceres;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
10 Cáceres;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
10 Cáceres;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
10 Cáceres;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
10 Cáceres;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;93,96
10 Cáceres;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
10 Cáceres;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
10 Cáceres;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
10 Cáceres;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;95,67
10 Cáceres;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
10 Cáceres;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
10 Cáceres;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
10 Cáceres;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;95,99
10 Cáceres;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
10 Cáceres;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
10 Cáceres;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
10 Cáceres;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
10 Cáceres;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
10 Cáceres;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
10 Cáceres;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;91,6
10 Cáceres;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
10 Cáceres;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
10 Cáceres;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
10 Cáceres;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;92,39
10 Cáceres;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
10 Cáceres;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
10 Cáceres;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
10 Cáceres;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
10 Cáceres;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
10 Cáceres;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
10 Cáceres;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;87,52
10 Cáceres;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
10 Cáceres;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
10 Cáceres;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
10 Cáceres;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;89,21
10 Cáceres;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
10 Cáceres;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
10 Cáceres;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
10 Cáceres;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
10 Cáceres;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
10 Cáceres;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
10 Cáceres;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;84,23
10 Cáceres;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
10 Cáceres;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
10 Cáceres;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
10 Cáceres;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;86,03
10 Cáceres;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
10 Cáceres;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
10 Cáceres;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
10 Cáceres;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
10 Cáceres;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
10 Cáceres;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
10 Cáceres;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QIV;2.448
10 Cáceres;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
10 Cáceres;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
10 Cáceres;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
10 Cáceres;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QIV;2.331
10 Cáceres;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
10 Cáceres;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
10 Cáceres;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
10 Cáceres;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QIV;2.184
10 Cáceres;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
10 Cáceres;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
10 Cáceres;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
10 Cáceres;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2022QIV;2.296
10 Cáceres;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
10 Cáceres;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2022QII;""
10 Cáceres;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2022QI;""
10 Cáceres;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2021QIV;2.238
10 Cáceres;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
10 Cáceres;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2021QII;""
10 Cáceres;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2021QI;""
10 Cáceres;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2020QIV;2.101
10 Cáceres;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
10 Cáceres;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2020QII;""
10 Cáceres;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2020QI;""
10 Cáceres;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
10 Cáceres;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
10 Cáceres;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2022QII;""
10 Cáceres;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2022QI;2.148
10 Cáceres;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
10 Cáceres;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
10 Cáceres;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2021QII;""
10 Cáceres;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2021QI;2.019
10 Cáceres;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
10 Cáceres;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
10 Cáceres;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2020QII;""
10 Cáceres;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2020QI;""
10 Cáceres;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
10 Cáceres;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
10 Cáceres;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QII;2.057
10 Cáceres;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QI;""
10 Cáceres;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
10 Cáceres;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
10 Cáceres;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QII;1.958
10 Cáceres;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QI;""
10 Cáceres;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
10 Cáceres;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
10 Cáceres;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QII;""
10 Cáceres;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QI;""
10 Cáceres;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
10 Cáceres;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QIII;1.988
10 Cáceres;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QII;""
10 Cáceres;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QI;""
10 Cáceres;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
10 Cáceres;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QIII;1.881
10 Cáceres;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QII;""
10 Cáceres;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QI;""
10 Cáceres;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
10 Cáceres;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
10 Cáceres;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QII;""
10 Cáceres;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QI;""
10 Cáceres;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
10 Cáceres;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
10 Cáceres;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
10 Cáceres;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
10 Cáceres;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
10 Cáceres;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
10 Cáceres;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
10 Cáceres;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
10 Cáceres;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
10 Cáceres;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
10 Cáceres;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
10 Cáceres;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
10 Cáceres;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;93,79
10 Cáceres;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
10 Cáceres;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
10 Cáceres;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
10 Cáceres;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;96,01
10 Cáceres;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
10 Cáceres;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
10 Cáceres;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
10 Cáceres;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;96,2
10 Cáceres;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
10 Cáceres;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
10 Cáceres;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
10 Cáceres;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
10 Cáceres;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
10 Cáceres;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
10 Cáceres;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;92,15
10 Cáceres;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
10 Cáceres;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
10 Cáceres;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
10 Cáceres;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;92,45
10 Cáceres;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
10 Cáceres;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
10 Cáceres;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
10 Cáceres;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
10 Cáceres;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
10 Cáceres;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
10 Cáceres;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;88,25
10 Cáceres;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
10 Cáceres;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
10 Cáceres;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
10 Cáceres;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;89,65
10 Cáceres;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
10 Cáceres;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
10 Cáceres;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
10 Cáceres;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
10 Cáceres;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
10 Cáceres;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
10 Cáceres;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;85,29
10 Cáceres;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
10 Cáceres;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
10 Cáceres;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
10 Cáceres;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;86,13
10 Cáceres;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
10 Cáceres;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
10 Cáceres;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
10 Cáceres;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
10 Cáceres;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
10 Cáceres;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
10 Cáceres;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QIV;1.293
10 Cáceres;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
10 Cáceres;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
10 Cáceres;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
10 Cáceres;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QIV;1.251
10 Cáceres;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
10 Cáceres;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
10 Cáceres;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
10 Cáceres;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QIV;1.181
10 Cáceres;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
10 Cáceres;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
10 Cáceres;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
10 Cáceres;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2022QIV;1.219
10 Cáceres;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
10 Cáceres;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2022QII;""
10 Cáceres;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2022QI;""
10 Cáceres;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2021QIV;1.189
10 Cáceres;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
10 Cáceres;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2021QII;""
10 Cáceres;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2021QI;""
10 Cáceres;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2020QIV;1.129
10 Cáceres;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
10 Cáceres;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2020QII;""
10 Cáceres;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2020QI;""
10 Cáceres;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
10 Cáceres;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
10 Cáceres;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2022QII;""
10 Cáceres;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2022QI;1.133
10 Cáceres;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
10 Cáceres;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
10 Cáceres;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2021QII;""
10 Cáceres;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2021QI;1.090
10 Cáceres;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
10 Cáceres;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
10 Cáceres;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2020QII;""
10 Cáceres;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2020QI;""
10 Cáceres;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
10 Cáceres;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
10 Cáceres;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QII;1.078
10 Cáceres;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QI;""
10 Cáceres;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
10 Cáceres;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
10 Cáceres;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QII;1.044
10 Cáceres;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QI;""
10 Cáceres;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
10 Cáceres;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
10 Cáceres;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QII;""
10 Cáceres;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QI;""
10 Cáceres;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
10 Cáceres;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QIII;1.029
10 Cáceres;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QII;""
10 Cáceres;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QI;""
10 Cáceres;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
10 Cáceres;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QIII;1.014
10 Cáceres;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QII;""
10 Cáceres;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QI;""
10 Cáceres;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
10 Cáceres;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
10 Cáceres;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QII;""
10 Cáceres;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QI;""
10 Cáceres;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
10 Cáceres;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
10 Cáceres;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
10 Cáceres;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
10 Cáceres;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
10 Cáceres;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
10 Cáceres;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
10 Cáceres;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
10 Cáceres;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
10 Cáceres;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
10 Cáceres;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
10 Cáceres;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
10 Cáceres;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;94,28
10 Cáceres;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
10 Cáceres;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
10 Cáceres;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
10 Cáceres;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;95,04
10 Cáceres;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
10 Cáceres;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
10 Cáceres;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
10 Cáceres;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;95,6
10 Cáceres;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
10 Cáceres;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
10 Cáceres;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
10 Cáceres;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
10 Cáceres;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
10 Cáceres;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
10 Cáceres;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;90,57
10 Cáceres;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
10 Cáceres;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
10 Cáceres;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
10 Cáceres;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;92,29
10 Cáceres;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
10 Cáceres;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
10 Cáceres;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
10 Cáceres;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
10 Cáceres;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
10 Cáceres;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
10 Cáceres;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;86,17
10 Cáceres;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
10 Cáceres;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
10 Cáceres;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
10 Cáceres;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;88,4
10 Cáceres;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
10 Cáceres;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
10 Cáceres;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
10 Cáceres;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
10 Cáceres;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
10 Cáceres;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
10 Cáceres;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;82,25
10 Cáceres;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
10 Cáceres;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
10 Cáceres;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
10 Cáceres;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;85,86
10 Cáceres;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
10 Cáceres;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
10 Cáceres;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
10 Cáceres;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
10 Cáceres;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
10 Cáceres;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
11 Cádiz;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
11 Cádiz;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
11 Cádiz;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
11 Cádiz;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QI;60.167
11 Cádiz;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
11 Cádiz;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
11 Cádiz;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
11 Cádiz;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QI;58.445
11 Cádiz;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
11 Cádiz;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
11 Cádiz;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
11 Cádiz;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QI;58.110
11 Cádiz;All ages;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
11 Cádiz;All ages;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
11 Cádiz;All ages;Cohort January 1;Total;Survival in the first trimester;2022QII;""
11 Cádiz;All ages;Cohort January 1;Total;Survival in the first trimester;2022QI;57.899
11 Cádiz;All ages;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
11 Cádiz;All ages;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
11 Cádiz;All ages;Cohort January 1;Total;Survival in the first trimester;2021QII;""
11 Cádiz;All ages;Cohort January 1;Total;Survival in the first trimester;2021QI;56.696
11 Cádiz;All ages;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
11 Cádiz;All ages;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
11 Cádiz;All ages;Cohort January 1;Total;Survival in the first trimester;2020QII;""
11 Cádiz;All ages;Cohort January 1;Total;Survival in the first trimester;2020QI;53.635
11 Cádiz;All ages;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
11 Cádiz;All ages;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
11 Cádiz;All ages;Cohort January 1;Total;Survival in the second trimester;2022QII;55.754
11 Cádiz;All ages;Cohort January 1;Total;Survival in the second trimester;2022QI;""
11 Cádiz;All ages;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
11 Cádiz;All ages;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
11 Cádiz;All ages;Cohort January 1;Total;Survival in the second trimester;2021QII;54.909
11 Cádiz;All ages;Cohort January 1;Total;Survival in the second trimester;2021QI;""
11 Cádiz;All ages;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
11 Cádiz;All ages;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
11 Cádiz;All ages;Cohort January 1;Total;Survival in the second trimester;2020QII;52.495
11 Cádiz;All ages;Cohort January 1;Total;Survival in the second trimester;2020QI;""
11 Cádiz;All ages;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
11 Cádiz;All ages;Cohort January 1;Total;Survival in the third trimester;2022QIII;54.012
11 Cádiz;All ages;Cohort January 1;Total;Survival in the third trimester;2022QII;""
11 Cádiz;All ages;Cohort January 1;Total;Survival in the third trimester;2022QI;""
11 Cádiz;All ages;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
11 Cádiz;All ages;Cohort January 1;Total;Survival in the third trimester;2021QIII;53.353
11 Cádiz;All ages;Cohort January 1;Total;Survival in the third trimester;2021QII;""
11 Cádiz;All ages;Cohort January 1;Total;Survival in the third trimester;2021QI;""
11 Cádiz;All ages;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
11 Cádiz;All ages;Cohort January 1;Total;Survival in the third trimester;2020QIII;51.016
11 Cádiz;All ages;Cohort January 1;Total;Survival in the third trimester;2020QII;""
11 Cádiz;All ages;Cohort January 1;Total;Survival in the third trimester;2020QI;""
11 Cádiz;All ages;Cohort January 1;Total;Survival in the third trimester;2022QIV;52.174
11 Cádiz;All ages;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
11 Cádiz;All ages;Cohort January 1;Total;Survival in the third trimester;2022QII;""
11 Cádiz;All ages;Cohort January 1;Total;Survival in the third trimester;2022QI;""
11 Cádiz;All ages;Cohort January 1;Total;Survival in the third trimester;2021QIV;51.722
11 Cádiz;All ages;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
11 Cádiz;All ages;Cohort January 1;Total;Survival in the third trimester;2021QII;""
11 Cádiz;All ages;Cohort January 1;Total;Survival in the third trimester;2021QI;""
11 Cádiz;All ages;Cohort January 1;Total;Survival in the third trimester;2020QIV;49.559
11 Cádiz;All ages;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
11 Cádiz;All ages;Cohort January 1;Total;Survival in the third trimester;2020QII;""
11 Cádiz;All ages;Cohort January 1;Total;Survival in the third trimester;2020QI;""
11 Cádiz;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
11 Cádiz;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
11 Cádiz;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
11 Cádiz;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
11 Cádiz;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
11 Cádiz;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
11 Cádiz;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
11 Cádiz;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
11 Cádiz;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
11 Cádiz;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
11 Cádiz;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
11 Cádiz;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
11 Cádiz;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
11 Cádiz;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
11 Cádiz;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
11 Cádiz;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;96,23
11 Cádiz;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
11 Cádiz;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
11 Cádiz;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
11 Cádiz;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;97,01
11 Cádiz;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
11 Cádiz;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
11 Cádiz;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
11 Cádiz;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;92,3
11 Cádiz;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
11 Cádiz;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
11 Cádiz;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;92,67
11 Cádiz;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
11 Cádiz;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
11 Cádiz;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
11 Cádiz;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;93,95
11 Cádiz;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
11 Cádiz;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
11 Cádiz;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
11 Cádiz;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;90,34
11 Cádiz;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
11 Cádiz;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
11 Cádiz;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;89,77
11 Cádiz;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
11 Cádiz;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
11 Cádiz;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
11 Cádiz;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;91,29
11 Cádiz;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
11 Cádiz;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
11 Cádiz;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
11 Cádiz;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;87,79
11 Cádiz;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
11 Cádiz;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
11 Cádiz;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;86,72
11 Cádiz;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
11 Cádiz;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
11 Cádiz;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
11 Cádiz;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;88,5
11 Cádiz;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
11 Cádiz;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
11 Cádiz;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
11 Cádiz;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;85,28
11 Cádiz;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
11 Cádiz;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
11 Cádiz;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
11 Cádiz;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
11 Cádiz;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
11 Cádiz;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
11 Cádiz;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QI;38.201
11 Cádiz;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
11 Cádiz;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
11 Cádiz;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
11 Cádiz;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QI;37.399
11 Cádiz;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
11 Cádiz;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
11 Cádiz;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
11 Cádiz;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QI;37.123
11 Cádiz;All ages;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
11 Cádiz;All ages;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
11 Cádiz;All ages;Cohort January 1;Males;Survival in the first trimester;2022QII;""
11 Cádiz;All ages;Cohort January 1;Males;Survival in the first trimester;2022QI;36.922
11 Cádiz;All ages;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
11 Cádiz;All ages;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
11 Cádiz;All ages;Cohort January 1;Males;Survival in the first trimester;2021QII;""
11 Cádiz;All ages;Cohort January 1;Males;Survival in the first trimester;2021QI;36.363
11 Cádiz;All ages;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
11 Cádiz;All ages;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
11 Cádiz;All ages;Cohort January 1;Males;Survival in the first trimester;2020QII;""
11 Cádiz;All ages;Cohort January 1;Males;Survival in the first trimester;2020QI;34.493
11 Cádiz;All ages;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
11 Cádiz;All ages;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
11 Cádiz;All ages;Cohort January 1;Males;Survival in the second trimester;2022QII;35.723
11 Cádiz;All ages;Cohort January 1;Males;Survival in the second trimester;2022QI;""
11 Cádiz;All ages;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
11 Cádiz;All ages;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
11 Cádiz;All ages;Cohort January 1;Males;Survival in the second trimester;2021QII;35.352
11 Cádiz;All ages;Cohort January 1;Males;Survival in the second trimester;2021QI;""
11 Cádiz;All ages;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
11 Cádiz;All ages;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
11 Cádiz;All ages;Cohort January 1;Males;Survival in the second trimester;2020QII;33.815
11 Cádiz;All ages;Cohort January 1;Males;Survival in the second trimester;2020QI;""
11 Cádiz;All ages;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
11 Cádiz;All ages;Cohort January 1;Males;Survival in the third trimester;2022QIII;34.725
11 Cádiz;All ages;Cohort January 1;Males;Survival in the third trimester;2022QII;""
11 Cádiz;All ages;Cohort January 1;Males;Survival in the third trimester;2022QI;""
11 Cádiz;All ages;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
11 Cádiz;All ages;Cohort January 1;Males;Survival in the third trimester;2021QIII;34.411
11 Cádiz;All ages;Cohort January 1;Males;Survival in the third trimester;2021QII;""
11 Cádiz;All ages;Cohort January 1;Males;Survival in the third trimester;2021QI;""
11 Cádiz;All ages;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
11 Cádiz;All ages;Cohort January 1;Males;Survival in the third trimester;2020QIII;32.993
11 Cádiz;All ages;Cohort January 1;Males;Survival in the third trimester;2020QII;""
11 Cádiz;All ages;Cohort January 1;Males;Survival in the third trimester;2020QI;""
11 Cádiz;All ages;Cohort January 1;Males;Survival in the third trimester;2022QIV;33.659
11 Cádiz;All ages;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
11 Cádiz;All ages;Cohort January 1;Males;Survival in the third trimester;2022QII;""
11 Cádiz;All ages;Cohort January 1;Males;Survival in the third trimester;2022QI;""
11 Cádiz;All ages;Cohort January 1;Males;Survival in the third trimester;2021QIV;33.432
11 Cádiz;All ages;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
11 Cádiz;All ages;Cohort January 1;Males;Survival in the third trimester;2021QII;""
11 Cádiz;All ages;Cohort January 1;Males;Survival in the third trimester;2021QI;""
11 Cádiz;All ages;Cohort January 1;Males;Survival in the third trimester;2020QIV;32.136
11 Cádiz;All ages;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
11 Cádiz;All ages;Cohort January 1;Males;Survival in the third trimester;2020QII;""
11 Cádiz;All ages;Cohort January 1;Males;Survival in the third trimester;2020QI;""
11 Cádiz;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
11 Cádiz;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
11 Cádiz;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
11 Cádiz;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
11 Cádiz;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
11 Cádiz;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
11 Cádiz;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
11 Cádiz;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
11 Cádiz;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
11 Cádiz;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
11 Cádiz;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
11 Cádiz;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
11 Cádiz;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
11 Cádiz;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
11 Cádiz;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
11 Cádiz;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;96,65
11 Cádiz;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
11 Cádiz;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
11 Cádiz;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
11 Cádiz;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;97,23
11 Cádiz;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
11 Cádiz;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
11 Cádiz;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
11 Cádiz;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;92,92
11 Cádiz;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
11 Cádiz;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
11 Cádiz;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;93,51
11 Cádiz;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
11 Cádiz;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
11 Cádiz;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
11 Cádiz;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;94,53
11 Cádiz;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
11 Cádiz;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
11 Cádiz;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
11 Cádiz;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;91,09
11 Cádiz;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
11 Cádiz;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
11 Cádiz;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;90,9
11 Cádiz;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
11 Cádiz;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
11 Cádiz;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
11 Cádiz;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;92,01
11 Cádiz;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
11 Cádiz;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
11 Cádiz;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
11 Cádiz;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;88,87
11 Cádiz;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
11 Cádiz;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
11 Cádiz;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;88,11
11 Cádiz;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
11 Cádiz;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
11 Cádiz;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
11 Cádiz;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;89,39
11 Cádiz;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
11 Cádiz;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
11 Cádiz;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
11 Cádiz;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;86,57
11 Cádiz;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
11 Cádiz;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
11 Cádiz;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
11 Cádiz;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
11 Cádiz;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
11 Cádiz;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
11 Cádiz;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QI;21.966
11 Cádiz;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
11 Cádiz;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
11 Cádiz;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
11 Cádiz;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QI;21.046
11 Cádiz;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
11 Cádiz;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
11 Cádiz;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
11 Cádiz;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QI;20.987
11 Cádiz;All ages;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
11 Cádiz;All ages;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
11 Cádiz;All ages;Cohort January 1;Females;Survival in the first trimester;2022QII;""
11 Cádiz;All ages;Cohort January 1;Females;Survival in the first trimester;2022QI;20.977
11 Cádiz;All ages;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
11 Cádiz;All ages;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
11 Cádiz;All ages;Cohort January 1;Females;Survival in the first trimester;2021QII;""
11 Cádiz;All ages;Cohort January 1;Females;Survival in the first trimester;2021QI;20.333
11 Cádiz;All ages;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
11 Cádiz;All ages;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
11 Cádiz;All ages;Cohort January 1;Females;Survival in the first trimester;2020QII;""
11 Cádiz;All ages;Cohort January 1;Females;Survival in the first trimester;2020QI;19.142
11 Cádiz;All ages;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
11 Cádiz;All ages;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
11 Cádiz;All ages;Cohort January 1;Females;Survival in the second trimester;2022QII;20.031
11 Cádiz;All ages;Cohort January 1;Females;Survival in the second trimester;2022QI;""
11 Cádiz;All ages;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
11 Cádiz;All ages;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
11 Cádiz;All ages;Cohort January 1;Females;Survival in the second trimester;2021QII;19.557
11 Cádiz;All ages;Cohort January 1;Females;Survival in the second trimester;2021QI;""
11 Cádiz;All ages;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
11 Cádiz;All ages;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
11 Cádiz;All ages;Cohort January 1;Females;Survival in the second trimester;2020QII;18.680
11 Cádiz;All ages;Cohort January 1;Females;Survival in the second trimester;2020QI;""
11 Cádiz;All ages;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
11 Cádiz;All ages;Cohort January 1;Females;Survival in the third trimester;2022QIII;19.287
11 Cádiz;All ages;Cohort January 1;Females;Survival in the third trimester;2022QII;""
11 Cádiz;All ages;Cohort January 1;Females;Survival in the third trimester;2022QI;""
11 Cádiz;All ages;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
11 Cádiz;All ages;Cohort January 1;Females;Survival in the third trimester;2021QIII;18.942
11 Cádiz;All ages;Cohort January 1;Females;Survival in the third trimester;2021QII;""
11 Cádiz;All ages;Cohort January 1;Females;Survival in the third trimester;2021QI;""
11 Cádiz;All ages;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
11 Cádiz;All ages;Cohort January 1;Females;Survival in the third trimester;2020QIII;18.023
11 Cádiz;All ages;Cohort January 1;Females;Survival in the third trimester;2020QII;""
11 Cádiz;All ages;Cohort January 1;Females;Survival in the third trimester;2020QI;""
11 Cádiz;All ages;Cohort January 1;Females;Survival in the third trimester;2022QIV;18.515
11 Cádiz;All ages;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
11 Cádiz;All ages;Cohort January 1;Females;Survival in the third trimester;2022QII;""
11 Cádiz;All ages;Cohort January 1;Females;Survival in the third trimester;2022QI;""
11 Cádiz;All ages;Cohort January 1;Females;Survival in the third trimester;2021QIV;18.290
11 Cádiz;All ages;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
11 Cádiz;All ages;Cohort January 1;Females;Survival in the third trimester;2021QII;""
11 Cádiz;All ages;Cohort January 1;Females;Survival in the third trimester;2021QI;""
11 Cádiz;All ages;Cohort January 1;Females;Survival in the third trimester;2020QIV;17.423
11 Cádiz;All ages;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
11 Cádiz;All ages;Cohort January 1;Females;Survival in the third trimester;2020QII;""
11 Cádiz;All ages;Cohort January 1;Females;Survival in the third trimester;2020QI;""
11 Cádiz;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
11 Cádiz;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
11 Cádiz;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
11 Cádiz;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
11 Cádiz;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
11 Cádiz;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
11 Cádiz;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
11 Cádiz;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
11 Cádiz;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
11 Cádiz;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
11 Cádiz;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
11 Cádiz;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
11 Cádiz;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
11 Cádiz;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
11 Cádiz;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
11 Cádiz;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;95,5
11 Cádiz;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
11 Cádiz;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
11 Cádiz;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
11 Cádiz;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;96,61
11 Cádiz;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
11 Cádiz;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
11 Cádiz;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
11 Cádiz;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;91,21
11 Cádiz;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
11 Cádiz;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
11 Cádiz;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;91,19
11 Cádiz;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
11 Cádiz;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
11 Cádiz;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
11 Cádiz;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;92,93
11 Cádiz;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
11 Cádiz;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
11 Cádiz;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
11 Cádiz;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;89,01
11 Cádiz;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
11 Cádiz;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
11 Cádiz;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;87,8
11 Cádiz;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
11 Cádiz;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
11 Cádiz;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
11 Cádiz;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;90
11 Cádiz;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
11 Cádiz;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
11 Cádiz;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
11 Cádiz;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;85,88
11 Cádiz;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
11 Cádiz;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
11 Cádiz;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;84,29
11 Cádiz;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
11 Cádiz;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
11 Cádiz;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
11 Cádiz;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;86,9
11 Cádiz;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
11 Cádiz;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
11 Cádiz;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
11 Cádiz;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;83,02
11 Cádiz;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
11 Cádiz;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
11 Cádiz;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
11 Cádiz;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
11 Cádiz;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
11 Cádiz;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QII;60.544
11 Cádiz;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
11 Cádiz;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
11 Cádiz;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
11 Cádiz;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QII;59.152
11 Cádiz;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
11 Cádiz;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
11 Cádiz;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
11 Cádiz;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QII;56.627
11 Cádiz;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
11 Cádiz;All ages;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
11 Cádiz;All ages;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
11 Cádiz;All ages;Cohort April 1;Total;Survival in the first trimester;2022QII;58.150
11 Cádiz;All ages;Cohort April 1;Total;Survival in the first trimester;2022QI;""
11 Cádiz;All ages;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
11 Cádiz;All ages;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
11 Cádiz;All ages;Cohort April 1;Total;Survival in the first trimester;2021QII;57.104
11 Cádiz;All ages;Cohort April 1;Total;Survival in the first trimester;2021QI;""
11 Cádiz;All ages;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
11 Cádiz;All ages;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
11 Cádiz;All ages;Cohort April 1;Total;Survival in the first trimester;2020QII;55.343
11 Cádiz;All ages;Cohort April 1;Total;Survival in the first trimester;2020QI;""
11 Cádiz;All ages;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
11 Cádiz;All ages;Cohort April 1;Total;Survival in the second trimester;2022QIII;56.197
11 Cádiz;All ages;Cohort April 1;Total;Survival in the second trimester;2022QII;""
11 Cádiz;All ages;Cohort April 1;Total;Survival in the second trimester;2022QI;""
11 Cádiz;All ages;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
11 Cádiz;All ages;Cohort April 1;Total;Survival in the second trimester;2021QIII;55.311
11 Cádiz;All ages;Cohort April 1;Total;Survival in the second trimester;2021QII;""
11 Cádiz;All ages;Cohort April 1;Total;Survival in the second trimester;2021QI;""
11 Cádiz;All ages;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
11 Cádiz;All ages;Cohort April 1;Total;Survival in the second trimester;2020QIII;53.624
11 Cádiz;All ages;Cohort April 1;Total;Survival in the second trimester;2020QII;""
11 Cádiz;All ages;Cohort April 1;Total;Survival in the second trimester;2020QI;""
11 Cádiz;All ages;Cohort April 1;Total;Survival in the third trimester;2022QIV;54.122
11 Cádiz;All ages;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
11 Cádiz;All ages;Cohort April 1;Total;Survival in the third trimester;2022QII;""
11 Cádiz;All ages;Cohort April 1;Total;Survival in the third trimester;2022QI;""
11 Cádiz;All ages;Cohort April 1;Total;Survival in the third trimester;2021QIV;53.433
11 Cádiz;All ages;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
11 Cádiz;All ages;Cohort April 1;Total;Survival in the third trimester;2021QII;""
11 Cádiz;All ages;Cohort April 1;Total;Survival in the third trimester;2021QI;""
11 Cádiz;All ages;Cohort April 1;Total;Survival in the third trimester;2020QIV;51.962
11 Cádiz;All ages;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
11 Cádiz;All ages;Cohort April 1;Total;Survival in the third trimester;2020QII;""
11 Cádiz;All ages;Cohort April 1;Total;Survival in the third trimester;2020QI;""
11 Cádiz;All ages;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
11 Cádiz;All ages;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
11 Cádiz;All ages;Cohort April 1;Total;Survival in the third trimester;2022QII;""
11 Cádiz;All ages;Cohort April 1;Total;Survival in the third trimester;2022QI;51.776
11 Cádiz;All ages;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
11 Cádiz;All ages;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
11 Cádiz;All ages;Cohort April 1;Total;Survival in the third trimester;2021QII;""
11 Cádiz;All ages;Cohort April 1;Total;Survival in the third trimester;2021QI;50.769
11 Cádiz;All ages;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
11 Cádiz;All ages;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
11 Cádiz;All ages;Cohort April 1;Total;Survival in the third trimester;2020QII;""
11 Cádiz;All ages;Cohort April 1;Total;Survival in the third trimester;2020QI;""
11 Cádiz;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
11 Cádiz;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
11 Cádiz;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
11 Cádiz;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
11 Cádiz;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
11 Cádiz;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
11 Cádiz;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
11 Cádiz;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
11 Cádiz;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
11 Cádiz;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
11 Cádiz;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
11 Cádiz;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
11 Cádiz;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
11 Cádiz;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
11 Cádiz;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;96,05
11 Cádiz;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
11 Cádiz;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
11 Cádiz;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
11 Cádiz;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;96,54
11 Cádiz;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
11 Cádiz;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
11 Cádiz;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
11 Cádiz;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;97,73
11 Cádiz;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
11 Cádiz;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
11 Cádiz;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;92,82
11 Cádiz;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
11 Cádiz;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
11 Cádiz;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
11 Cádiz;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;93,51
11 Cádiz;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
11 Cádiz;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
11 Cádiz;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
11 Cádiz;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;94,7
11 Cádiz;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
11 Cádiz;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
11 Cádiz;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;89,39
11 Cádiz;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
11 Cádiz;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
11 Cádiz;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
11 Cádiz;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;90,33
11 Cádiz;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
11 Cádiz;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
11 Cádiz;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
11 Cádiz;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;91,76
11 Cádiz;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
11 Cádiz;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
11 Cádiz;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
11 Cádiz;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
11 Cádiz;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
11 Cádiz;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
11 Cádiz;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;87,53
11 Cádiz;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
11 Cádiz;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
11 Cádiz;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
11 Cádiz;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;89,66
11 Cádiz;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
11 Cádiz;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
11 Cádiz;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
11 Cádiz;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
11 Cádiz;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
11 Cádiz;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
11 Cádiz;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QII;38.476
11 Cádiz;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
11 Cádiz;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
11 Cádiz;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
11 Cádiz;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QII;37.836
11 Cádiz;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
11 Cádiz;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
11 Cádiz;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
11 Cádiz;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QII;36.244
11 Cádiz;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
11 Cádiz;All ages;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
11 Cádiz;All ages;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
11 Cádiz;All ages;Cohort April 1;Males;Survival in the first trimester;2022QII;37.127
11 Cádiz;All ages;Cohort April 1;Males;Survival in the first trimester;2022QI;""
11 Cádiz;All ages;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
11 Cádiz;All ages;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
11 Cádiz;All ages;Cohort April 1;Males;Survival in the first trimester;2021QII;36.659
11 Cádiz;All ages;Cohort April 1;Males;Survival in the first trimester;2021QI;""
11 Cádiz;All ages;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
11 Cádiz;All ages;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
11 Cádiz;All ages;Cohort April 1;Males;Survival in the first trimester;2020QII;35.481
11 Cádiz;All ages;Cohort April 1;Males;Survival in the first trimester;2020QI;""
11 Cádiz;All ages;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
11 Cádiz;All ages;Cohort April 1;Males;Survival in the second trimester;2022QIII;35.997
11 Cádiz;All ages;Cohort April 1;Males;Survival in the second trimester;2022QII;""
11 Cádiz;All ages;Cohort April 1;Males;Survival in the second trimester;2022QI;""
11 Cádiz;All ages;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
11 Cádiz;All ages;Cohort April 1;Males;Survival in the second trimester;2021QIII;35.568
11 Cádiz;All ages;Cohort April 1;Males;Survival in the second trimester;2021QII;""
11 Cádiz;All ages;Cohort April 1;Males;Survival in the second trimester;2021QI;""
11 Cádiz;All ages;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
11 Cádiz;All ages;Cohort April 1;Males;Survival in the second trimester;2020QIII;34.524
11 Cádiz;All ages;Cohort April 1;Males;Survival in the second trimester;2020QII;""
11 Cádiz;All ages;Cohort April 1;Males;Survival in the second trimester;2020QI;""
11 Cádiz;All ages;Cohort April 1;Males;Survival in the third trimester;2022QIV;34.801
11 Cádiz;All ages;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
11 Cádiz;All ages;Cohort April 1;Males;Survival in the third trimester;2022QII;""
11 Cádiz;All ages;Cohort April 1;Males;Survival in the third trimester;2022QI;""
11 Cádiz;All ages;Cohort April 1;Males;Survival in the third trimester;2021QIV;34.445
11 Cádiz;All ages;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
11 Cádiz;All ages;Cohort April 1;Males;Survival in the third trimester;2021QII;""
11 Cádiz;All ages;Cohort April 1;Males;Survival in the third trimester;2021QI;""
11 Cádiz;All ages;Cohort April 1;Males;Survival in the third trimester;2020QIV;33.553
11 Cádiz;All ages;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
11 Cádiz;All ages;Cohort April 1;Males;Survival in the third trimester;2020QII;""
11 Cádiz;All ages;Cohort April 1;Males;Survival in the third trimester;2020QI;""
11 Cádiz;All ages;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
11 Cádiz;All ages;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
11 Cádiz;All ages;Cohort April 1;Males;Survival in the third trimester;2022QII;""
11 Cádiz;All ages;Cohort April 1;Males;Survival in the third trimester;2022QI;33.530
11 Cádiz;All ages;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
11 Cádiz;All ages;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
11 Cádiz;All ages;Cohort April 1;Males;Survival in the third trimester;2021QII;""
11 Cádiz;All ages;Cohort April 1;Males;Survival in the third trimester;2021QI;32.842
11 Cádiz;All ages;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
11 Cádiz;All ages;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
11 Cádiz;All ages;Cohort April 1;Males;Survival in the third trimester;2020QII;""
11 Cádiz;All ages;Cohort April 1;Males;Survival in the third trimester;2020QI;""
11 Cádiz;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
11 Cádiz;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
11 Cádiz;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
11 Cádiz;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
11 Cádiz;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
11 Cádiz;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
11 Cádiz;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
11 Cádiz;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
11 Cádiz;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
11 Cádiz;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
11 Cádiz;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
11 Cádiz;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
11 Cádiz;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
11 Cádiz;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
11 Cádiz;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;96,49
11 Cádiz;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
11 Cádiz;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
11 Cádiz;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
11 Cádiz;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;96,89
11 Cádiz;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
11 Cádiz;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
11 Cádiz;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
11 Cádiz;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;97,89
11 Cádiz;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
11 Cádiz;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
11 Cádiz;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;93,56
11 Cádiz;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
11 Cádiz;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
11 Cádiz;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
11 Cádiz;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;94,01
11 Cádiz;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
11 Cádiz;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
11 Cádiz;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
11 Cádiz;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;95,25
11 Cádiz;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
11 Cádiz;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
11 Cádiz;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;90,45
11 Cádiz;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
11 Cádiz;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
11 Cádiz;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
11 Cádiz;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;91,04
11 Cádiz;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
11 Cádiz;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
11 Cádiz;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
11 Cádiz;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;92,58
11 Cádiz;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
11 Cádiz;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
11 Cádiz;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
11 Cádiz;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
11 Cádiz;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
11 Cádiz;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
11 Cádiz;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;88,62
11 Cádiz;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
11 Cádiz;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
11 Cádiz;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
11 Cádiz;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;90,61
11 Cádiz;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
11 Cádiz;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
11 Cádiz;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
11 Cádiz;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
11 Cádiz;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
11 Cádiz;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
11 Cádiz;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QII;22.068
11 Cádiz;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
11 Cádiz;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
11 Cádiz;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
11 Cádiz;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QII;21.316
11 Cádiz;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
11 Cádiz;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
11 Cádiz;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
11 Cádiz;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QII;20.383
11 Cádiz;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
11 Cádiz;All ages;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
11 Cádiz;All ages;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
11 Cádiz;All ages;Cohort April 1;Females;Survival in the first trimester;2022QII;21.023
11 Cádiz;All ages;Cohort April 1;Females;Survival in the first trimester;2022QI;""
11 Cádiz;All ages;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
11 Cádiz;All ages;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
11 Cádiz;All ages;Cohort April 1;Females;Survival in the first trimester;2021QII;20.445
11 Cádiz;All ages;Cohort April 1;Females;Survival in the first trimester;2021QI;""
11 Cádiz;All ages;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
11 Cádiz;All ages;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
11 Cádiz;All ages;Cohort April 1;Females;Survival in the first trimester;2020QII;19.862
11 Cádiz;All ages;Cohort April 1;Females;Survival in the first trimester;2020QI;""
11 Cádiz;All ages;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
11 Cádiz;All ages;Cohort April 1;Females;Survival in the second trimester;2022QIII;20.200
11 Cádiz;All ages;Cohort April 1;Females;Survival in the second trimester;2022QII;""
11 Cádiz;All ages;Cohort April 1;Females;Survival in the second trimester;2022QI;""
11 Cádiz;All ages;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
11 Cádiz;All ages;Cohort April 1;Females;Survival in the second trimester;2021QIII;19.743
11 Cádiz;All ages;Cohort April 1;Females;Survival in the second trimester;2021QII;""
11 Cádiz;All ages;Cohort April 1;Females;Survival in the second trimester;2021QI;""
11 Cádiz;All ages;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
11 Cádiz;All ages;Cohort April 1;Females;Survival in the second trimester;2020QIII;19.100
11 Cádiz;All ages;Cohort April 1;Females;Survival in the second trimester;2020QII;""
11 Cádiz;All ages;Cohort April 1;Females;Survival in the second trimester;2020QI;""
11 Cádiz;All ages;Cohort April 1;Females;Survival in the third trimester;2022QIV;19.321
11 Cádiz;All ages;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
11 Cádiz;All ages;Cohort April 1;Females;Survival in the third trimester;2022QII;""
11 Cádiz;All ages;Cohort April 1;Females;Survival in the third trimester;2022QI;""
11 Cádiz;All ages;Cohort April 1;Females;Survival in the third trimester;2021QIV;18.988
11 Cádiz;All ages;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
11 Cádiz;All ages;Cohort April 1;Females;Survival in the third trimester;2021QII;""
11 Cádiz;All ages;Cohort April 1;Females;Survival in the third trimester;2021QI;""
11 Cádiz;All ages;Cohort April 1;Females;Survival in the third trimester;2020QIV;18.409
11 Cádiz;All ages;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
11 Cádiz;All ages;Cohort April 1;Females;Survival in the third trimester;2020QII;""
11 Cádiz;All ages;Cohort April 1;Females;Survival in the third trimester;2020QI;""
11 Cádiz;All ages;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
11 Cádiz;All ages;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
11 Cádiz;All ages;Cohort April 1;Females;Survival in the third trimester;2022QII;""
11 Cádiz;All ages;Cohort April 1;Females;Survival in the third trimester;2022QI;18.246
11 Cádiz;All ages;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
11 Cádiz;All ages;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
11 Cádiz;All ages;Cohort April 1;Females;Survival in the third trimester;2021QII;""
11 Cádiz;All ages;Cohort April 1;Females;Survival in the third trimester;2021QI;17.927
11 Cádiz;All ages;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
11 Cádiz;All ages;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
11 Cádiz;All ages;Cohort April 1;Females;Survival in the third trimester;2020QII;""
11 Cádiz;All ages;Cohort April 1;Females;Survival in the third trimester;2020QI;""
11 Cádiz;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
11 Cádiz;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
11 Cádiz;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
11 Cádiz;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
11 Cádiz;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
11 Cádiz;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
11 Cádiz;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
11 Cádiz;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
11 Cádiz;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
11 Cádiz;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
11 Cádiz;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
11 Cádiz;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
11 Cádiz;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
11 Cádiz;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
11 Cádiz;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;95,26
11 Cádiz;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
11 Cádiz;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
11 Cádiz;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
11 Cádiz;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;95,91
11 Cádiz;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
11 Cádiz;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
11 Cádiz;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
11 Cádiz;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;97,44
11 Cádiz;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
11 Cádiz;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
11 Cádiz;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;91,54
11 Cádiz;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
11 Cádiz;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
11 Cádiz;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
11 Cádiz;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;92,62
11 Cádiz;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
11 Cádiz;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
11 Cádiz;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
11 Cádiz;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;93,71
11 Cádiz;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
11 Cádiz;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
11 Cádiz;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;87,55
11 Cádiz;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
11 Cádiz;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
11 Cádiz;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
11 Cádiz;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;89,08
11 Cádiz;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
11 Cádiz;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
11 Cádiz;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
11 Cádiz;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;90,32
11 Cádiz;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
11 Cádiz;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
11 Cádiz;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
11 Cádiz;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
11 Cádiz;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
11 Cádiz;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
11 Cádiz;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;85,6
11 Cádiz;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
11 Cádiz;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
11 Cádiz;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
11 Cádiz;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;87,95
11 Cádiz;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
11 Cádiz;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
11 Cádiz;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
11 Cádiz;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
11 Cádiz;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
11 Cádiz;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QIII;61.434
11 Cádiz;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
11 Cádiz;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
11 Cádiz;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
11 Cádiz;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QIII;60.536
11 Cádiz;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
11 Cádiz;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
11 Cádiz;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
11 Cádiz;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QIII;58.129
11 Cádiz;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
11 Cádiz;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
11 Cádiz;All ages;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
11 Cádiz;All ages;Cohort July 1;Total;Survival in the first trimester;2022QIII;58.788
11 Cádiz;All ages;Cohort July 1;Total;Survival in the first trimester;2022QII;""
11 Cádiz;All ages;Cohort July 1;Total;Survival in the first trimester;2022QI;""
11 Cádiz;All ages;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
11 Cádiz;All ages;Cohort July 1;Total;Survival in the first trimester;2021QIII;58.085
11 Cádiz;All ages;Cohort July 1;Total;Survival in the first trimester;2021QII;""
11 Cádiz;All ages;Cohort July 1;Total;Survival in the first trimester;2021QI;""
11 Cádiz;All ages;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
11 Cádiz;All ages;Cohort July 1;Total;Survival in the first trimester;2020QIII;55.837
11 Cádiz;All ages;Cohort July 1;Total;Survival in the first trimester;2020QII;""
11 Cádiz;All ages;Cohort July 1;Total;Survival in the first trimester;2020QI;""
11 Cádiz;All ages;Cohort July 1;Total;Survival in the second trimester;2022QIV;56.278
11 Cádiz;All ages;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
11 Cádiz;All ages;Cohort July 1;Total;Survival in the second trimester;2022QII;""
11 Cádiz;All ages;Cohort July 1;Total;Survival in the second trimester;2022QI;""
11 Cádiz;All ages;Cohort July 1;Total;Survival in the second trimester;2021QIV;55.767
11 Cádiz;All ages;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
11 Cádiz;All ages;Cohort July 1;Total;Survival in the second trimester;2021QII;""
11 Cádiz;All ages;Cohort July 1;Total;Survival in the second trimester;2021QI;""
11 Cádiz;All ages;Cohort July 1;Total;Survival in the second trimester;2020QIV;53.851
11 Cádiz;All ages;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
11 Cádiz;All ages;Cohort July 1;Total;Survival in the second trimester;2020QII;""
11 Cádiz;All ages;Cohort July 1;Total;Survival in the second trimester;2020QI;""
11 Cádiz;All ages;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
11 Cádiz;All ages;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
11 Cádiz;All ages;Cohort July 1;Total;Survival in the third trimester;2022QII;""
11 Cádiz;All ages;Cohort July 1;Total;Survival in the third trimester;2022QI;53.940
11 Cádiz;All ages;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
11 Cádiz;All ages;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
11 Cádiz;All ages;Cohort July 1;Total;Survival in the third trimester;2021QII;""
11 Cádiz;All ages;Cohort July 1;Total;Survival in the third trimester;2021QI;52.545
11 Cádiz;All ages;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
11 Cádiz;All ages;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
11 Cádiz;All ages;Cohort July 1;Total;Survival in the third trimester;2020QII;""
11 Cádiz;All ages;Cohort July 1;Total;Survival in the third trimester;2020QI;""
11 Cádiz;All ages;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
11 Cádiz;All ages;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
11 Cádiz;All ages;Cohort July 1;Total;Survival in the third trimester;2022QII;52.198
11 Cádiz;All ages;Cohort July 1;Total;Survival in the third trimester;2022QI;""
11 Cádiz;All ages;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
11 Cádiz;All ages;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
11 Cádiz;All ages;Cohort July 1;Total;Survival in the third trimester;2021QII;51.185
11 Cádiz;All ages;Cohort July 1;Total;Survival in the third trimester;2021QI;""
11 Cádiz;All ages;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
11 Cádiz;All ages;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
11 Cádiz;All ages;Cohort July 1;Total;Survival in the third trimester;2020QII;""
11 Cádiz;All ages;Cohort July 1;Total;Survival in the third trimester;2020QI;""
11 Cádiz;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
11 Cádiz;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
11 Cádiz;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
11 Cádiz;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
11 Cádiz;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
11 Cádiz;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
11 Cádiz;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
11 Cádiz;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
11 Cádiz;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
11 Cádiz;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
11 Cádiz;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
11 Cádiz;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
11 Cádiz;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
11 Cádiz;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;95,69
11 Cádiz;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
11 Cádiz;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
11 Cádiz;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
11 Cádiz;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;95,95
11 Cádiz;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
11 Cádiz;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
11 Cádiz;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
11 Cádiz;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;96,06
11 Cádiz;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
11 Cádiz;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
11 Cádiz;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;91,61
11 Cádiz;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
11 Cádiz;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
11 Cádiz;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
11 Cádiz;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;92,12
11 Cádiz;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
11 Cádiz;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
11 Cádiz;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
11 Cádiz;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;92,64
11 Cádiz;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
11 Cádiz;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
11 Cádiz;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
11 Cádiz;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
11 Cádiz;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
11 Cádiz;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
11 Cádiz;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;89,1
11 Cádiz;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
11 Cádiz;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
11 Cádiz;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
11 Cádiz;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;90,39
11 Cádiz;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
11 Cádiz;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
11 Cádiz;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
11 Cádiz;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
11 Cádiz;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
11 Cádiz;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
11 Cádiz;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;86,23
11 Cádiz;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
11 Cádiz;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
11 Cádiz;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
11 Cádiz;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;88,05
11 Cádiz;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
11 Cádiz;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
11 Cádiz;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
11 Cádiz;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
11 Cádiz;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
11 Cádiz;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
11 Cádiz;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QIII;38.944
11 Cádiz;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
11 Cádiz;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
11 Cádiz;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
11 Cádiz;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QIII;38.579
11 Cádiz;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
11 Cádiz;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
11 Cádiz;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
11 Cádiz;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QIII;37.217
11 Cádiz;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
11 Cádiz;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
11 Cádiz;All ages;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
11 Cádiz;All ages;Cohort July 1;Males;Survival in the first trimester;2022QIII;37.451
11 Cádiz;All ages;Cohort July 1;Males;Survival in the first trimester;2022QII;""
11 Cádiz;All ages;Cohort July 1;Males;Survival in the first trimester;2022QI;""
11 Cádiz;All ages;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
11 Cádiz;All ages;Cohort July 1;Males;Survival in the first trimester;2021QIII;37.118
11 Cádiz;All ages;Cohort July 1;Males;Survival in the first trimester;2021QII;""
11 Cádiz;All ages;Cohort July 1;Males;Survival in the first trimester;2021QI;""
11 Cádiz;All ages;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
11 Cádiz;All ages;Cohort July 1;Males;Survival in the first trimester;2020QIII;35.938
11 Cádiz;All ages;Cohort July 1;Males;Survival in the first trimester;2020QII;""
11 Cádiz;All ages;Cohort July 1;Males;Survival in the first trimester;2020QI;""
11 Cádiz;All ages;Cohort July 1;Males;Survival in the second trimester;2022QIV;36.008
11 Cádiz;All ages;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
11 Cádiz;All ages;Cohort July 1;Males;Survival in the second trimester;2022QII;""
11 Cádiz;All ages;Cohort July 1;Males;Survival in the second trimester;2022QI;""
11 Cádiz;All ages;Cohort July 1;Males;Survival in the second trimester;2021QIV;35.764
11 Cádiz;All ages;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
11 Cádiz;All ages;Cohort July 1;Males;Survival in the second trimester;2021QII;""
11 Cádiz;All ages;Cohort July 1;Males;Survival in the second trimester;2021QI;""
11 Cádiz;All ages;Cohort July 1;Males;Survival in the second trimester;2020QIV;34.763
11 Cádiz;All ages;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
11 Cádiz;All ages;Cohort July 1;Males;Survival in the second trimester;2020QII;""
11 Cádiz;All ages;Cohort July 1;Males;Survival in the second trimester;2020QI;""
11 Cádiz;All ages;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
11 Cádiz;All ages;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
11 Cádiz;All ages;Cohort July 1;Males;Survival in the third trimester;2022QII;""
11 Cádiz;All ages;Cohort July 1;Males;Survival in the third trimester;2022QI;34.749
11 Cádiz;All ages;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
11 Cádiz;All ages;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
11 Cádiz;All ages;Cohort July 1;Males;Survival in the third trimester;2021QII;""
11 Cádiz;All ages;Cohort July 1;Males;Survival in the third trimester;2021QI;33.981
11 Cádiz;All ages;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
11 Cádiz;All ages;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
11 Cádiz;All ages;Cohort July 1;Males;Survival in the third trimester;2020QII;""
11 Cádiz;All ages;Cohort July 1;Males;Survival in the third trimester;2020QI;""
11 Cádiz;All ages;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
11 Cádiz;All ages;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
11 Cádiz;All ages;Cohort July 1;Males;Survival in the third trimester;2022QII;33.782
11 Cádiz;All ages;Cohort July 1;Males;Survival in the third trimester;2022QI;""
11 Cádiz;All ages;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
11 Cádiz;All ages;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
11 Cádiz;All ages;Cohort July 1;Males;Survival in the third trimester;2021QII;33.211
11 Cádiz;All ages;Cohort July 1;Males;Survival in the third trimester;2021QI;""
11 Cádiz;All ages;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
11 Cádiz;All ages;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
11 Cádiz;All ages;Cohort July 1;Males;Survival in the third trimester;2020QII;""
11 Cádiz;All ages;Cohort July 1;Males;Survival in the third trimester;2020QI;""
11 Cádiz;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
11 Cádiz;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
11 Cádiz;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
11 Cádiz;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
11 Cádiz;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
11 Cádiz;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
11 Cádiz;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
11 Cádiz;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
11 Cádiz;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
11 Cádiz;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
11 Cádiz;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
11 Cádiz;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
11 Cádiz;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
11 Cádiz;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;96,17
11 Cádiz;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
11 Cádiz;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
11 Cádiz;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
11 Cádiz;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;96,21
11 Cádiz;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
11 Cádiz;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
11 Cádiz;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
11 Cádiz;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;96,56
11 Cádiz;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
11 Cádiz;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
11 Cádiz;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;92,46
11 Cádiz;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
11 Cádiz;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
11 Cádiz;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
11 Cádiz;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;92,7
11 Cádiz;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
11 Cádiz;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
11 Cádiz;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
11 Cádiz;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;93,41
11 Cádiz;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
11 Cádiz;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
11 Cádiz;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
11 Cádiz;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
11 Cádiz;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
11 Cádiz;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
11 Cádiz;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;90,07
11 Cádiz;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
11 Cádiz;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
11 Cádiz;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
11 Cádiz;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;91,31
11 Cádiz;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
11 Cádiz;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
11 Cádiz;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
11 Cádiz;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
11 Cádiz;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
11 Cádiz;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
11 Cádiz;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;87,57
11 Cádiz;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
11 Cádiz;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
11 Cádiz;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
11 Cádiz;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;89,24
11 Cádiz;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
11 Cádiz;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
11 Cádiz;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
11 Cádiz;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
11 Cádiz;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
11 Cádiz;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
11 Cádiz;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QIII;22.490
11 Cádiz;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
11 Cádiz;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
11 Cádiz;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
11 Cádiz;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QIII;21.957
11 Cádiz;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
11 Cádiz;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
11 Cádiz;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
11 Cádiz;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QIII;20.912
11 Cádiz;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
11 Cádiz;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
11 Cádiz;All ages;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
11 Cádiz;All ages;Cohort July 1;Females;Survival in the first trimester;2022QIII;21.337
11 Cádiz;All ages;Cohort July 1;Females;Survival in the first trimester;2022QII;""
11 Cádiz;All ages;Cohort July 1;Females;Survival in the first trimester;2022QI;""
11 Cádiz;All ages;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
11 Cádiz;All ages;Cohort July 1;Females;Survival in the first trimester;2021QIII;20.967
11 Cádiz;All ages;Cohort July 1;Females;Survival in the first trimester;2021QII;""
11 Cádiz;All ages;Cohort July 1;Females;Survival in the first trimester;2021QI;""
11 Cádiz;All ages;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
11 Cádiz;All ages;Cohort July 1;Females;Survival in the first trimester;2020QIII;19.899
11 Cádiz;All ages;Cohort July 1;Females;Survival in the first trimester;2020QII;""
11 Cádiz;All ages;Cohort July 1;Females;Survival in the first trimester;2020QI;""
11 Cádiz;All ages;Cohort July 1;Females;Survival in the second trimester;2022QIV;20.270
11 Cádiz;All ages;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
11 Cádiz;All ages;Cohort July 1;Females;Survival in the second trimester;2022QII;""
11 Cádiz;All ages;Cohort July 1;Females;Survival in the second trimester;2022QI;""
11 Cádiz;All ages;Cohort July 1;Females;Survival in the second trimester;2021QIV;20.003
11 Cádiz;All ages;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
11 Cádiz;All ages;Cohort July 1;Females;Survival in the second trimester;2021QII;""
11 Cádiz;All ages;Cohort July 1;Females;Survival in the second trimester;2021QI;""
11 Cádiz;All ages;Cohort July 1;Females;Survival in the second trimester;2020QIV;19.088
11 Cádiz;All ages;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
11 Cádiz;All ages;Cohort July 1;Females;Survival in the second trimester;2020QII;""
11 Cádiz;All ages;Cohort July 1;Females;Survival in the second trimester;2020QI;""
11 Cádiz;All ages;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
11 Cádiz;All ages;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
11 Cádiz;All ages;Cohort July 1;Females;Survival in the third trimester;2022QII;""
11 Cádiz;All ages;Cohort July 1;Females;Survival in the third trimester;2022QI;19.191
11 Cádiz;All ages;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
11 Cádiz;All ages;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
11 Cádiz;All ages;Cohort July 1;Females;Survival in the third trimester;2021QII;""
11 Cádiz;All ages;Cohort July 1;Females;Survival in the third trimester;2021QI;18.564
11 Cádiz;All ages;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
11 Cádiz;All ages;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
11 Cádiz;All ages;Cohort July 1;Females;Survival in the third trimester;2020QII;""
11 Cádiz;All ages;Cohort July 1;Females;Survival in the third trimester;2020QI;""
11 Cádiz;All ages;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
11 Cádiz;All ages;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
11 Cádiz;All ages;Cohort July 1;Females;Survival in the third trimester;2022QII;18.416
11 Cádiz;All ages;Cohort July 1;Females;Survival in the third trimester;2022QI;""
11 Cádiz;All ages;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
11 Cádiz;All ages;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
11 Cádiz;All ages;Cohort July 1;Females;Survival in the third trimester;2021QII;17.974
11 Cádiz;All ages;Cohort July 1;Females;Survival in the third trimester;2021QI;""
11 Cádiz;All ages;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
11 Cádiz;All ages;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
11 Cádiz;All ages;Cohort July 1;Females;Survival in the third trimester;2020QII;""
11 Cádiz;All ages;Cohort July 1;Females;Survival in the third trimester;2020QI;""
11 Cádiz;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
11 Cádiz;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
11 Cádiz;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
11 Cádiz;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
11 Cádiz;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
11 Cádiz;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
11 Cádiz;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
11 Cádiz;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
11 Cádiz;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
11 Cádiz;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
11 Cádiz;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
11 Cádiz;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
11 Cádiz;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
11 Cádiz;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;94,87
11 Cádiz;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
11 Cádiz;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
11 Cádiz;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
11 Cádiz;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;95,49
11 Cádiz;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
11 Cádiz;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
11 Cádiz;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
11 Cádiz;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;95,16
11 Cádiz;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
11 Cádiz;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
11 Cádiz;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;90,13
11 Cádiz;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
11 Cádiz;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
11 Cádiz;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
11 Cádiz;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;91,1
11 Cádiz;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
11 Cádiz;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
11 Cádiz;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
11 Cádiz;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;91,28
11 Cádiz;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
11 Cádiz;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
11 Cádiz;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
11 Cádiz;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
11 Cádiz;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
11 Cádiz;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
11 Cádiz;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;87,4
11 Cádiz;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
11 Cádiz;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
11 Cádiz;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
11 Cádiz;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;88,77
11 Cádiz;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
11 Cádiz;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
11 Cádiz;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
11 Cádiz;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
11 Cádiz;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
11 Cádiz;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
11 Cádiz;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;83,87
11 Cádiz;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
11 Cádiz;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
11 Cádiz;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
11 Cádiz;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;85,95
11 Cádiz;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
11 Cádiz;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
11 Cádiz;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
11 Cádiz;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
11 Cádiz;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
11 Cádiz;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QIV;61.138
11 Cádiz;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
11 Cádiz;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
11 Cádiz;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
11 Cádiz;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QIV;60.395
11 Cádiz;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
11 Cádiz;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
11 Cádiz;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
11 Cádiz;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QIV;58.353
11 Cádiz;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
11 Cádiz;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
11 Cádiz;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
11 Cádiz;All ages;Cohort October 1;Total;Survival in the first trimester;2022QIV;58.323
11 Cádiz;All ages;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
11 Cádiz;All ages;Cohort October 1;Total;Survival in the first trimester;2022QII;""
11 Cádiz;All ages;Cohort October 1;Total;Survival in the first trimester;2022QI;""
11 Cádiz;All ages;Cohort October 1;Total;Survival in the first trimester;2021QIV;57.786
11 Cádiz;All ages;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
11 Cádiz;All ages;Cohort October 1;Total;Survival in the first trimester;2021QII;""
11 Cádiz;All ages;Cohort October 1;Total;Survival in the first trimester;2021QI;""
11 Cádiz;All ages;Cohort October 1;Total;Survival in the first trimester;2020QIV;56.032
11 Cádiz;All ages;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
11 Cádiz;All ages;Cohort October 1;Total;Survival in the first trimester;2020QII;""
11 Cádiz;All ages;Cohort October 1;Total;Survival in the first trimester;2020QI;""
11 Cádiz;All ages;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
11 Cádiz;All ages;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
11 Cádiz;All ages;Cohort October 1;Total;Survival in the second trimester;2022QII;""
11 Cádiz;All ages;Cohort October 1;Total;Survival in the second trimester;2022QI;55.772
11 Cádiz;All ages;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
11 Cádiz;All ages;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
11 Cádiz;All ages;Cohort October 1;Total;Survival in the second trimester;2021QII;""
11 Cádiz;All ages;Cohort October 1;Total;Survival in the second trimester;2021QI;54.578
11 Cádiz;All ages;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
11 Cádiz;All ages;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
11 Cádiz;All ages;Cohort October 1;Total;Survival in the second trimester;2020QII;""
11 Cádiz;All ages;Cohort October 1;Total;Survival in the second trimester;2020QI;""
11 Cádiz;All ages;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
11 Cádiz;All ages;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
11 Cádiz;All ages;Cohort October 1;Total;Survival in the third trimester;2022QII;53.857
11 Cádiz;All ages;Cohort October 1;Total;Survival in the third trimester;2022QI;""
11 Cádiz;All ages;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
11 Cádiz;All ages;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
11 Cádiz;All ages;Cohort October 1;Total;Survival in the third trimester;2021QII;53.042
11 Cádiz;All ages;Cohort October 1;Total;Survival in the third trimester;2021QI;""
11 Cádiz;All ages;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
11 Cádiz;All ages;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
11 Cádiz;All ages;Cohort October 1;Total;Survival in the third trimester;2020QII;""
11 Cádiz;All ages;Cohort October 1;Total;Survival in the third trimester;2020QI;""
11 Cádiz;All ages;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
11 Cádiz;All ages;Cohort October 1;Total;Survival in the third trimester;2022QIII;52.254
11 Cádiz;All ages;Cohort October 1;Total;Survival in the third trimester;2022QII;""
11 Cádiz;All ages;Cohort October 1;Total;Survival in the third trimester;2022QI;""
11 Cádiz;All ages;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
11 Cádiz;All ages;Cohort October 1;Total;Survival in the third trimester;2021QIII;51.654
11 Cádiz;All ages;Cohort October 1;Total;Survival in the third trimester;2021QII;""
11 Cádiz;All ages;Cohort October 1;Total;Survival in the third trimester;2021QI;""
11 Cádiz;All ages;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
11 Cádiz;All ages;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
11 Cádiz;All ages;Cohort October 1;Total;Survival in the third trimester;2020QII;""
11 Cádiz;All ages;Cohort October 1;Total;Survival in the third trimester;2020QI;""
11 Cádiz;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
11 Cádiz;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
11 Cádiz;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
11 Cádiz;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
11 Cádiz;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
11 Cádiz;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
11 Cádiz;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
11 Cádiz;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
11 Cádiz;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
11 Cádiz;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
11 Cádiz;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
11 Cádiz;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
11 Cádiz;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;95,4
11 Cádiz;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
11 Cádiz;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
11 Cádiz;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
11 Cádiz;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;95,68
11 Cádiz;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
11 Cádiz;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
11 Cádiz;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
11 Cádiz;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;96,02
11 Cádiz;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
11 Cádiz;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
11 Cádiz;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
11 Cádiz;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
11 Cádiz;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
11 Cádiz;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
11 Cádiz;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;92,35
11 Cádiz;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
11 Cádiz;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
11 Cádiz;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
11 Cádiz;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;93,53
11 Cádiz;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
11 Cádiz;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
11 Cádiz;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
11 Cádiz;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
11 Cádiz;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
11 Cádiz;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
11 Cádiz;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;89,17
11 Cádiz;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
11 Cádiz;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
11 Cádiz;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
11 Cádiz;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;90,9
11 Cádiz;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
11 Cádiz;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
11 Cádiz;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
11 Cádiz;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
11 Cádiz;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
11 Cádiz;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
11 Cádiz;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;86,52
11 Cádiz;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
11 Cádiz;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
11 Cádiz;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
11 Cádiz;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;88,52
11 Cádiz;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
11 Cádiz;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
11 Cádiz;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
11 Cádiz;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
11 Cádiz;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
11 Cádiz;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
11 Cádiz;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QIV;38.714
11 Cádiz;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
11 Cádiz;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
11 Cádiz;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
11 Cádiz;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QIV;38.405
11 Cádiz;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
11 Cádiz;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
11 Cádiz;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
11 Cádiz;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QIV;37.388
11 Cádiz;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
11 Cádiz;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
11 Cádiz;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
11 Cádiz;All ages;Cohort October 1;Males;Survival in the first trimester;2022QIV;37.085
11 Cádiz;All ages;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
11 Cádiz;All ages;Cohort October 1;Males;Survival in the first trimester;2022QII;""
11 Cádiz;All ages;Cohort October 1;Males;Survival in the first trimester;2022QI;""
11 Cádiz;All ages;Cohort October 1;Males;Survival in the first trimester;2021QIV;36.873
11 Cádiz;All ages;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
11 Cádiz;All ages;Cohort October 1;Males;Survival in the first trimester;2021QII;""
11 Cádiz;All ages;Cohort October 1;Males;Survival in the first trimester;2021QI;""
11 Cádiz;All ages;Cohort October 1;Males;Survival in the first trimester;2020QIV;36.012
11 Cádiz;All ages;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
11 Cádiz;All ages;Cohort October 1;Males;Survival in the first trimester;2020QII;""
11 Cádiz;All ages;Cohort October 1;Males;Survival in the first trimester;2020QI;""
11 Cádiz;All ages;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
11 Cádiz;All ages;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
11 Cádiz;All ages;Cohort October 1;Males;Survival in the second trimester;2022QII;""
11 Cádiz;All ages;Cohort October 1;Males;Survival in the second trimester;2022QI;35.747
11 Cádiz;All ages;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
11 Cádiz;All ages;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
11 Cádiz;All ages;Cohort October 1;Males;Survival in the second trimester;2021QII;""
11 Cádiz;All ages;Cohort October 1;Males;Survival in the second trimester;2021QI;35.147
11 Cádiz;All ages;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
11 Cádiz;All ages;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
11 Cádiz;All ages;Cohort October 1;Males;Survival in the second trimester;2020QII;""
11 Cádiz;All ages;Cohort October 1;Males;Survival in the second trimester;2020QI;""
11 Cádiz;All ages;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
11 Cádiz;All ages;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
11 Cádiz;All ages;Cohort October 1;Males;Survival in the third trimester;2022QII;34.685
11 Cádiz;All ages;Cohort October 1;Males;Survival in the third trimester;2022QI;""
11 Cádiz;All ages;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
11 Cádiz;All ages;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
11 Cádiz;All ages;Cohort October 1;Males;Survival in the third trimester;2021QII;34.278
11 Cádiz;All ages;Cohort October 1;Males;Survival in the third trimester;2021QI;""
11 Cádiz;All ages;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
11 Cádiz;All ages;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
11 Cádiz;All ages;Cohort October 1;Males;Survival in the third trimester;2020QII;""
11 Cádiz;All ages;Cohort October 1;Males;Survival in the third trimester;2020QI;""
11 Cádiz;All ages;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
11 Cádiz;All ages;Cohort October 1;Males;Survival in the third trimester;2022QIII;33.768
11 Cádiz;All ages;Cohort October 1;Males;Survival in the third trimester;2022QII;""
11 Cádiz;All ages;Cohort October 1;Males;Survival in the third trimester;2022QI;""
11 Cádiz;All ages;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
11 Cádiz;All ages;Cohort October 1;Males;Survival in the third trimester;2021QIII;33.442
11 Cádiz;All ages;Cohort October 1;Males;Survival in the third trimester;2021QII;""
11 Cádiz;All ages;Cohort October 1;Males;Survival in the third trimester;2021QI;""
11 Cádiz;All ages;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
11 Cádiz;All ages;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
11 Cádiz;All ages;Cohort October 1;Males;Survival in the third trimester;2020QII;""
11 Cádiz;All ages;Cohort October 1;Males;Survival in the third trimester;2020QI;""
11 Cádiz;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
11 Cádiz;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
11 Cádiz;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
11 Cádiz;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
11 Cádiz;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
11 Cádiz;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
11 Cádiz;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
11 Cádiz;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
11 Cádiz;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
11 Cádiz;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
11 Cádiz;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
11 Cádiz;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
11 Cádiz;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;95,79
11 Cádiz;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
11 Cádiz;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
11 Cádiz;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
11 Cádiz;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;96,01
11 Cádiz;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
11 Cádiz;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
11 Cádiz;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
11 Cádiz;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;96,32
11 Cádiz;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
11 Cádiz;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
11 Cádiz;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
11 Cádiz;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
11 Cádiz;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
11 Cádiz;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
11 Cádiz;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;93,08
11 Cádiz;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
11 Cádiz;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
11 Cádiz;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
11 Cádiz;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;94,01
11 Cádiz;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
11 Cádiz;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
11 Cádiz;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
11 Cádiz;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
11 Cádiz;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
11 Cádiz;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
11 Cádiz;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;90,31
11 Cádiz;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
11 Cádiz;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
11 Cádiz;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
11 Cádiz;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;91,68
11 Cádiz;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
11 Cádiz;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
11 Cádiz;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
11 Cádiz;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
11 Cádiz;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
11 Cádiz;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
11 Cádiz;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;87,93
11 Cádiz;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
11 Cádiz;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
11 Cádiz;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
11 Cádiz;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;89,45
11 Cádiz;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
11 Cádiz;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
11 Cádiz;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
11 Cádiz;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
11 Cádiz;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
11 Cádiz;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
11 Cádiz;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QIV;22.424
11 Cádiz;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
11 Cádiz;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
11 Cádiz;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
11 Cádiz;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QIV;21.990
11 Cádiz;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
11 Cádiz;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
11 Cádiz;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
11 Cádiz;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QIV;20.965
11 Cádiz;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
11 Cádiz;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
11 Cádiz;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
11 Cádiz;All ages;Cohort October 1;Females;Survival in the first trimester;2022QIV;21.238
11 Cádiz;All ages;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
11 Cádiz;All ages;Cohort October 1;Females;Survival in the first trimester;2022QII;""
11 Cádiz;All ages;Cohort October 1;Females;Survival in the first trimester;2022QI;""
11 Cádiz;All ages;Cohort October 1;Females;Survival in the first trimester;2021QIV;20.913
11 Cádiz;All ages;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
11 Cádiz;All ages;Cohort October 1;Females;Survival in the first trimester;2021QII;""
11 Cádiz;All ages;Cohort October 1;Females;Survival in the first trimester;2021QI;""
11 Cádiz;All ages;Cohort October 1;Females;Survival in the first trimester;2020QIV;20.020
11 Cádiz;All ages;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
11 Cádiz;All ages;Cohort October 1;Females;Survival in the first trimester;2020QII;""
11 Cádiz;All ages;Cohort October 1;Females;Survival in the first trimester;2020QI;""
11 Cádiz;All ages;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
11 Cádiz;All ages;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
11 Cádiz;All ages;Cohort October 1;Females;Survival in the second trimester;2022QII;""
11 Cádiz;All ages;Cohort October 1;Females;Survival in the second trimester;2022QI;20.025
11 Cádiz;All ages;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
11 Cádiz;All ages;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
11 Cádiz;All ages;Cohort October 1;Females;Survival in the second trimester;2021QII;""
11 Cádiz;All ages;Cohort October 1;Females;Survival in the second trimester;2021QI;19.431
11 Cádiz;All ages;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
11 Cádiz;All ages;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
11 Cádiz;All ages;Cohort October 1;Females;Survival in the second trimester;2020QII;""
11 Cádiz;All ages;Cohort October 1;Females;Survival in the second trimester;2020QI;""
11 Cádiz;All ages;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
11 Cádiz;All ages;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
11 Cádiz;All ages;Cohort October 1;Females;Survival in the third trimester;2022QII;19.172
11 Cádiz;All ages;Cohort October 1;Females;Survival in the third trimester;2022QI;""
11 Cádiz;All ages;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
11 Cádiz;All ages;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
11 Cádiz;All ages;Cohort October 1;Females;Survival in the third trimester;2021QII;18.764
11 Cádiz;All ages;Cohort October 1;Females;Survival in the third trimester;2021QI;""
11 Cádiz;All ages;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
11 Cádiz;All ages;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
11 Cádiz;All ages;Cohort October 1;Females;Survival in the third trimester;2020QII;""
11 Cádiz;All ages;Cohort October 1;Females;Survival in the third trimester;2020QI;""
11 Cádiz;All ages;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
11 Cádiz;All ages;Cohort October 1;Females;Survival in the third trimester;2022QIII;18.486
11 Cádiz;All ages;Cohort October 1;Females;Survival in the third trimester;2022QII;""
11 Cádiz;All ages;Cohort October 1;Females;Survival in the third trimester;2022QI;""
11 Cádiz;All ages;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
11 Cádiz;All ages;Cohort October 1;Females;Survival in the third trimester;2021QIII;18.212
11 Cádiz;All ages;Cohort October 1;Females;Survival in the third trimester;2021QII;""
11 Cádiz;All ages;Cohort October 1;Females;Survival in the third trimester;2021QI;""
11 Cádiz;All ages;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
11 Cádiz;All ages;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
11 Cádiz;All ages;Cohort October 1;Females;Survival in the third trimester;2020QII;""
11 Cádiz;All ages;Cohort October 1;Females;Survival in the third trimester;2020QI;""
11 Cádiz;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
11 Cádiz;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
11 Cádiz;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
11 Cádiz;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
11 Cádiz;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
11 Cádiz;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
11 Cádiz;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
11 Cádiz;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
11 Cádiz;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
11 Cádiz;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
11 Cádiz;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
11 Cádiz;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
11 Cádiz;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;94,71
11 Cádiz;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
11 Cádiz;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
11 Cádiz;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
11 Cádiz;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;95,1
11 Cádiz;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
11 Cádiz;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
11 Cádiz;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
11 Cádiz;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;95,49
11 Cádiz;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
11 Cádiz;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
11 Cádiz;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
11 Cádiz;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
11 Cádiz;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
11 Cádiz;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
11 Cádiz;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;91,06
11 Cádiz;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
11 Cádiz;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
11 Cádiz;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
11 Cádiz;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;92,68
11 Cádiz;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
11 Cádiz;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
11 Cádiz;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
11 Cádiz;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
11 Cádiz;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
11 Cádiz;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
11 Cádiz;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;87,19
11 Cádiz;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
11 Cádiz;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
11 Cádiz;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
11 Cádiz;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;89,5
11 Cádiz;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
11 Cádiz;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
11 Cádiz;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
11 Cádiz;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
11 Cádiz;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
11 Cádiz;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
11 Cádiz;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;84,07
11 Cádiz;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
11 Cádiz;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
11 Cádiz;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
11 Cádiz;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;86,87
11 Cádiz;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
11 Cádiz;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
11 Cádiz;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
11 Cádiz;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
11 Cádiz;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
11 Cádiz;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
11 Cádiz;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
11 Cádiz;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
11 Cádiz;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
11 Cádiz;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QI;4.508
11 Cádiz;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
11 Cádiz;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
11 Cádiz;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
11 Cádiz;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QI;4.408
11 Cádiz;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
11 Cádiz;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
11 Cádiz;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
11 Cádiz;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QI;3.435
11 Cádiz;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
11 Cádiz;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
11 Cádiz;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2022QII;""
11 Cádiz;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2022QI;4.127
11 Cádiz;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
11 Cádiz;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
11 Cádiz;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2021QII;""
11 Cádiz;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2021QI;4.107
11 Cádiz;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
11 Cádiz;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
11 Cádiz;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2020QII;""
11 Cádiz;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2020QI;2.961
11 Cádiz;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
11 Cádiz;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
11 Cádiz;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2022QII;3.805
11 Cádiz;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2022QI;""
11 Cádiz;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
11 Cádiz;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
11 Cádiz;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2021QII;3.816
11 Cádiz;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2021QI;""
11 Cádiz;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
11 Cádiz;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
11 Cádiz;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2020QII;2.871
11 Cádiz;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2020QI;""
11 Cádiz;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
11 Cádiz;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QIII;3.551
11 Cádiz;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QII;""
11 Cádiz;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QI;""
11 Cádiz;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
11 Cádiz;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QIII;3.555
11 Cádiz;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QII;""
11 Cádiz;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QI;""
11 Cádiz;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
11 Cádiz;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QIII;2.709
11 Cádiz;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QII;""
11 Cádiz;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QI;""
11 Cádiz;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QIV;3.332
11 Cádiz;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
11 Cádiz;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QII;""
11 Cádiz;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QI;""
11 Cádiz;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QIV;3.330
11 Cádiz;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
11 Cádiz;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QII;""
11 Cádiz;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QI;""
11 Cádiz;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QIV;2.584
11 Cádiz;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
11 Cádiz;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QII;""
11 Cádiz;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QI;""
11 Cádiz;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
11 Cádiz;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
11 Cádiz;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
11 Cádiz;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
11 Cádiz;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
11 Cádiz;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
11 Cádiz;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
11 Cádiz;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
11 Cádiz;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
11 Cádiz;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
11 Cádiz;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
11 Cádiz;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
11 Cádiz;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
11 Cádiz;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
11 Cádiz;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
11 Cádiz;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;91,55
11 Cádiz;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
11 Cádiz;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
11 Cádiz;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
11 Cádiz;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;93,17
11 Cádiz;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
11 Cádiz;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
11 Cádiz;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
11 Cádiz;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;86,2
11 Cádiz;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
11 Cádiz;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
11 Cádiz;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;84,41
11 Cádiz;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
11 Cádiz;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
11 Cádiz;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
11 Cádiz;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;86,57
11 Cádiz;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
11 Cádiz;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
11 Cádiz;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
11 Cádiz;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;83,58
11 Cádiz;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
11 Cádiz;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
11 Cádiz;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;78,77
11 Cádiz;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
11 Cádiz;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
11 Cádiz;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
11 Cádiz;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;80,65
11 Cádiz;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
11 Cádiz;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
11 Cádiz;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
11 Cádiz;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;78,86
11 Cádiz;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
11 Cádiz;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
11 Cádiz;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;73,91
11 Cádiz;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
11 Cádiz;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
11 Cádiz;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
11 Cádiz;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;75,54
11 Cádiz;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
11 Cádiz;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
11 Cádiz;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
11 Cádiz;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;75,23
11 Cádiz;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
11 Cádiz;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
11 Cádiz;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
11 Cádiz;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
11 Cádiz;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
11 Cádiz;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
11 Cádiz;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QI;2.637
11 Cádiz;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
11 Cádiz;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
11 Cádiz;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
11 Cádiz;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QI;2.632
11 Cádiz;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
11 Cádiz;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
11 Cádiz;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
11 Cádiz;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QI;2.037
11 Cádiz;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
11 Cádiz;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
11 Cádiz;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2022QII;""
11 Cádiz;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2022QI;2.445
11 Cádiz;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
11 Cádiz;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
11 Cádiz;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2021QII;""
11 Cádiz;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2021QI;2.456
11 Cádiz;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
11 Cádiz;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
11 Cádiz;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2020QII;""
11 Cádiz;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2020QI;1.755
11 Cádiz;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
11 Cádiz;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
11 Cádiz;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2022QII;2.261
11 Cádiz;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2022QI;""
11 Cádiz;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
11 Cádiz;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
11 Cádiz;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2021QII;2.268
11 Cádiz;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2021QI;""
11 Cádiz;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
11 Cádiz;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
11 Cádiz;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2020QII;1.708
11 Cádiz;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2020QI;""
11 Cádiz;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
11 Cádiz;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QIII;2.129
11 Cádiz;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QII;""
11 Cádiz;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QI;""
11 Cádiz;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
11 Cádiz;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QIII;2.106
11 Cádiz;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QII;""
11 Cádiz;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QI;""
11 Cádiz;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
11 Cádiz;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QIII;1.627
11 Cádiz;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QII;""
11 Cádiz;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QI;""
11 Cádiz;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QIV;2.003
11 Cádiz;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
11 Cádiz;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QII;""
11 Cádiz;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QI;""
11 Cádiz;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QIV;1.976
11 Cádiz;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
11 Cádiz;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QII;""
11 Cádiz;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QI;""
11 Cádiz;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QIV;1.554
11 Cádiz;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
11 Cádiz;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QII;""
11 Cádiz;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QI;""
11 Cádiz;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
11 Cádiz;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
11 Cádiz;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
11 Cádiz;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
11 Cádiz;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
11 Cádiz;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
11 Cádiz;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
11 Cádiz;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
11 Cádiz;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
11 Cádiz;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
11 Cádiz;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
11 Cádiz;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
11 Cádiz;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
11 Cádiz;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
11 Cádiz;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
11 Cádiz;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;92,72
11 Cádiz;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
11 Cádiz;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
11 Cádiz;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
11 Cádiz;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;93,31
11 Cádiz;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
11 Cádiz;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
11 Cádiz;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
11 Cádiz;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;86,16
11 Cádiz;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
11 Cádiz;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
11 Cádiz;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;85,74
11 Cádiz;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
11 Cádiz;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
11 Cádiz;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
11 Cádiz;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;86,17
11 Cádiz;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
11 Cádiz;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
11 Cádiz;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
11 Cádiz;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;83,85
11 Cádiz;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
11 Cádiz;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
11 Cádiz;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;80,74
11 Cádiz;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
11 Cádiz;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
11 Cádiz;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
11 Cádiz;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;80,02
11 Cádiz;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
11 Cádiz;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
11 Cádiz;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
11 Cádiz;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;79,87
11 Cádiz;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
11 Cádiz;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
11 Cádiz;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;75,96
11 Cádiz;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
11 Cádiz;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
11 Cádiz;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
11 Cádiz;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;75,08
11 Cádiz;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
11 Cádiz;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
11 Cádiz;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
11 Cádiz;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;76,29
11 Cádiz;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
11 Cádiz;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
11 Cádiz;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
11 Cádiz;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
11 Cádiz;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
11 Cádiz;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
11 Cádiz;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QI;1.871
11 Cádiz;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
11 Cádiz;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
11 Cádiz;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
11 Cádiz;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QI;1.776
11 Cádiz;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
11 Cádiz;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
11 Cádiz;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
11 Cádiz;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QI;1.398
11 Cádiz;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
11 Cádiz;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
11 Cádiz;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2022QII;""
11 Cádiz;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2022QI;1.682
11 Cádiz;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
11 Cádiz;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
11 Cádiz;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2021QII;""
11 Cádiz;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2021QI;1.651
11 Cádiz;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
11 Cádiz;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
11 Cádiz;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2020QII;""
11 Cádiz;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2020QI;1.206
11 Cádiz;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
11 Cádiz;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
11 Cádiz;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2022QII;1.544
11 Cádiz;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2022QI;""
11 Cádiz;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
11 Cádiz;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
11 Cádiz;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2021QII;1.548
11 Cádiz;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2021QI;""
11 Cádiz;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
11 Cádiz;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
11 Cádiz;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2020QII;1.163
11 Cádiz;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2020QI;""
11 Cádiz;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
11 Cádiz;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QIII;1.422
11 Cádiz;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QII;""
11 Cádiz;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QI;""
11 Cádiz;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
11 Cádiz;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QIII;1.449
11 Cádiz;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QII;""
11 Cádiz;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QI;""
11 Cádiz;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
11 Cádiz;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QIII;1.082
11 Cádiz;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QII;""
11 Cádiz;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QI;""
11 Cádiz;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QIV;1.329
11 Cádiz;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
11 Cádiz;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QII;""
11 Cádiz;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QI;""
11 Cádiz;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QIV;1.354
11 Cádiz;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
11 Cádiz;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QII;""
11 Cádiz;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QI;""
11 Cádiz;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QIV;1.030
11 Cádiz;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
11 Cádiz;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QII;""
11 Cádiz;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QI;""
11 Cádiz;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
11 Cádiz;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
11 Cádiz;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
11 Cádiz;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
11 Cádiz;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
11 Cádiz;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
11 Cádiz;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
11 Cádiz;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
11 Cádiz;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
11 Cádiz;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
11 Cádiz;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
11 Cádiz;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
11 Cádiz;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
11 Cádiz;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
11 Cádiz;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
11 Cádiz;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;89,9
11 Cádiz;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
11 Cádiz;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
11 Cádiz;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
11 Cádiz;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;92,96
11 Cádiz;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
11 Cádiz;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
11 Cádiz;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
11 Cádiz;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;86,27
11 Cádiz;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
11 Cádiz;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
11 Cádiz;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;82,52
11 Cádiz;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
11 Cádiz;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
11 Cádiz;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
11 Cádiz;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;87,16
11 Cádiz;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
11 Cádiz;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
11 Cádiz;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
11 Cádiz;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;83,19
11 Cádiz;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
11 Cádiz;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
11 Cádiz;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;76
11 Cádiz;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
11 Cádiz;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
11 Cádiz;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
11 Cádiz;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;81,59
11 Cádiz;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
11 Cádiz;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
11 Cádiz;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
11 Cádiz;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;77,4
11 Cádiz;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
11 Cádiz;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
11 Cádiz;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;71,03
11 Cádiz;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
11 Cádiz;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
11 Cádiz;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
11 Cádiz;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;76,24
11 Cádiz;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
11 Cádiz;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
11 Cádiz;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
11 Cádiz;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;73,68
11 Cádiz;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
11 Cádiz;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
11 Cádiz;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
11 Cádiz;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
11 Cádiz;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
11 Cádiz;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QII;3.893
11 Cádiz;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
11 Cádiz;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
11 Cádiz;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
11 Cádiz;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QII;3.902
11 Cádiz;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
11 Cádiz;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
11 Cádiz;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
11 Cádiz;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QII;3.501
11 Cádiz;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
11 Cádiz;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
11 Cádiz;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
11 Cádiz;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2022QII;3.554
11 Cádiz;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2022QI;""
11 Cádiz;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
11 Cádiz;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
11 Cádiz;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2021QII;3.552
11 Cádiz;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2021QI;""
11 Cádiz;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
11 Cádiz;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
11 Cádiz;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2020QII;3.381
11 Cádiz;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2020QI;""
11 Cádiz;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
11 Cádiz;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2022QIII;3.286
11 Cádiz;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2022QII;""
11 Cádiz;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2022QI;""
11 Cádiz;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
11 Cádiz;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2021QIII;3.242
11 Cádiz;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2021QII;""
11 Cádiz;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2021QI;""
11 Cádiz;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
11 Cádiz;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2020QIII;3.169
11 Cádiz;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2020QII;""
11 Cádiz;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2020QI;""
11 Cádiz;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QIV;3.071
11 Cádiz;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
11 Cádiz;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QII;""
11 Cádiz;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QI;""
11 Cádiz;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QIV;3.018
11 Cádiz;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
11 Cádiz;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QII;""
11 Cádiz;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QI;""
11 Cádiz;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QIV;3.008
11 Cádiz;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
11 Cádiz;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QII;""
11 Cádiz;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QI;""
11 Cádiz;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
11 Cádiz;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
11 Cádiz;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QII;""
11 Cádiz;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QI;2.799
11 Cádiz;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
11 Cádiz;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
11 Cádiz;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QII;""
11 Cádiz;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QI;2.869
11 Cádiz;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
11 Cádiz;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
11 Cádiz;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QII;""
11 Cádiz;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QI;""
11 Cádiz;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
11 Cádiz;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
11 Cádiz;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
11 Cádiz;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
11 Cádiz;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
11 Cádiz;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
11 Cádiz;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
11 Cádiz;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
11 Cádiz;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
11 Cádiz;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
11 Cádiz;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
11 Cádiz;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
11 Cádiz;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
11 Cádiz;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
11 Cádiz;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;91,29
11 Cádiz;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
11 Cádiz;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
11 Cádiz;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
11 Cádiz;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;91,03
11 Cádiz;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
11 Cádiz;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
11 Cádiz;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
11 Cádiz;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;96,57
11 Cádiz;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
11 Cádiz;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
11 Cádiz;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;84,41
11 Cádiz;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
11 Cádiz;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
11 Cádiz;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
11 Cádiz;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;83,09
11 Cádiz;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
11 Cádiz;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
11 Cádiz;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
11 Cádiz;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;90,52
11 Cádiz;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
11 Cádiz;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
11 Cádiz;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;78,89
11 Cádiz;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
11 Cádiz;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
11 Cádiz;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
11 Cádiz;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;77,34
11 Cádiz;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
11 Cádiz;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
11 Cádiz;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
11 Cádiz;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;85,92
11 Cádiz;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
11 Cádiz;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
11 Cádiz;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
11 Cádiz;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
11 Cádiz;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
11 Cádiz;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
11 Cádiz;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;71,73
11 Cádiz;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
11 Cádiz;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
11 Cádiz;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
11 Cádiz;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;81,95
11 Cádiz;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
11 Cádiz;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
11 Cádiz;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
11 Cádiz;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
11 Cádiz;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
11 Cádiz;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
11 Cádiz;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QII;2.328
11 Cádiz;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
11 Cádiz;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
11 Cádiz;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
11 Cádiz;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QII;2.369
11 Cádiz;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
11 Cádiz;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
11 Cádiz;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
11 Cádiz;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QII;2.073
11 Cádiz;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
11 Cádiz;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
11 Cádiz;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
11 Cádiz;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2022QII;2.121
11 Cádiz;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2022QI;""
11 Cádiz;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
11 Cádiz;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
11 Cádiz;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2021QII;2.139
11 Cádiz;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2021QI;""
11 Cádiz;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
11 Cádiz;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
11 Cádiz;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2020QII;2.011
11 Cádiz;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2020QI;""
11 Cádiz;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
11 Cádiz;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2022QIII;1.980
11 Cádiz;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2022QII;""
11 Cádiz;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2022QI;""
11 Cádiz;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
11 Cádiz;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2021QIII;1.940
11 Cádiz;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2021QII;""
11 Cádiz;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2021QI;""
11 Cádiz;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
11 Cádiz;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2020QIII;1.905
11 Cádiz;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2020QII;""
11 Cádiz;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2020QI;""
11 Cádiz;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QIV;1.848
11 Cádiz;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
11 Cádiz;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QII;""
11 Cádiz;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QI;""
11 Cádiz;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QIV;1.809
11 Cádiz;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
11 Cádiz;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QII;""
11 Cádiz;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QI;""
11 Cádiz;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QIV;1.813
11 Cádiz;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
11 Cádiz;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QII;""
11 Cádiz;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QI;""
11 Cádiz;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
11 Cádiz;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
11 Cádiz;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QII;""
11 Cádiz;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QI;1.710
11 Cádiz;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
11 Cádiz;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
11 Cádiz;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QII;""
11 Cádiz;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QI;1.728
11 Cádiz;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
11 Cádiz;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
11 Cádiz;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QII;""
11 Cádiz;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QI;""
11 Cádiz;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
11 Cádiz;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
11 Cádiz;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
11 Cádiz;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
11 Cádiz;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
11 Cádiz;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
11 Cádiz;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
11 Cádiz;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
11 Cádiz;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
11 Cádiz;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
11 Cádiz;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
11 Cádiz;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
11 Cádiz;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
11 Cádiz;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
11 Cádiz;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;91,11
11 Cádiz;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
11 Cádiz;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
11 Cádiz;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
11 Cádiz;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;90,29
11 Cádiz;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
11 Cádiz;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
11 Cádiz;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
11 Cádiz;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;97,01
11 Cádiz;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
11 Cádiz;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
11 Cádiz;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;85,05
11 Cádiz;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
11 Cádiz;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
11 Cádiz;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
11 Cádiz;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;81,89
11 Cádiz;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
11 Cádiz;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
11 Cádiz;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
11 Cádiz;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;91,9
11 Cádiz;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
11 Cádiz;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
11 Cádiz;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;79,38
11 Cádiz;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
11 Cádiz;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
11 Cádiz;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
11 Cádiz;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;76,36
11 Cádiz;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
11 Cádiz;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
11 Cádiz;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
11 Cádiz;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;87,46
11 Cádiz;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
11 Cádiz;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
11 Cádiz;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
11 Cádiz;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
11 Cádiz;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
11 Cádiz;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
11 Cádiz;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;72,18
11 Cádiz;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
11 Cádiz;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
11 Cádiz;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
11 Cádiz;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;83,36
11 Cádiz;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
11 Cádiz;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
11 Cádiz;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
11 Cádiz;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
11 Cádiz;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
11 Cádiz;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
11 Cádiz;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QII;1.565
11 Cádiz;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
11 Cádiz;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
11 Cádiz;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
11 Cádiz;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QII;1.533
11 Cádiz;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
11 Cádiz;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
11 Cádiz;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
11 Cádiz;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QII;1.428
11 Cádiz;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
11 Cádiz;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
11 Cádiz;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
11 Cádiz;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2022QII;1.433
11 Cádiz;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2022QI;""
11 Cádiz;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
11 Cádiz;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
11 Cádiz;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2021QII;1.413
11 Cádiz;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2021QI;""
11 Cádiz;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
11 Cádiz;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
11 Cádiz;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2020QII;1.370
11 Cádiz;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2020QI;""
11 Cádiz;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
11 Cádiz;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2022QIII;1.306
11 Cádiz;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2022QII;""
11 Cádiz;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2022QI;""
11 Cádiz;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
11 Cádiz;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2021QIII;1.302
11 Cádiz;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2021QII;""
11 Cádiz;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2021QI;""
11 Cádiz;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
11 Cádiz;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2020QIII;1.264
11 Cádiz;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2020QII;""
11 Cádiz;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2020QI;""
11 Cádiz;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QIV;1.223
11 Cádiz;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
11 Cádiz;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QII;""
11 Cádiz;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QI;""
11 Cádiz;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QIV;1.209
11 Cádiz;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
11 Cádiz;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QII;""
11 Cádiz;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QI;""
11 Cádiz;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QIV;1.195
11 Cádiz;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
11 Cádiz;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QII;""
11 Cádiz;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QI;""
11 Cádiz;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
11 Cádiz;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
11 Cádiz;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QII;""
11 Cádiz;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QI;1.089
11 Cádiz;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
11 Cádiz;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
11 Cádiz;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QII;""
11 Cádiz;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QI;1.141
11 Cádiz;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
11 Cádiz;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
11 Cádiz;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QII;""
11 Cádiz;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QI;""
11 Cádiz;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
11 Cádiz;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
11 Cádiz;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
11 Cádiz;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
11 Cádiz;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
11 Cádiz;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
11 Cádiz;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
11 Cádiz;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
11 Cádiz;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
11 Cádiz;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
11 Cádiz;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
11 Cádiz;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
11 Cádiz;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
11 Cádiz;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
11 Cádiz;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;91,57
11 Cádiz;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
11 Cádiz;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
11 Cádiz;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
11 Cádiz;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;92,17
11 Cádiz;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
11 Cádiz;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
11 Cádiz;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
11 Cádiz;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;95,94
11 Cádiz;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
11 Cádiz;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
11 Cádiz;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;83,45
11 Cádiz;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
11 Cádiz;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
11 Cádiz;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
11 Cádiz;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;84,93
11 Cádiz;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
11 Cádiz;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
11 Cádiz;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
11 Cádiz;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;88,52
11 Cádiz;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
11 Cádiz;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
11 Cádiz;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;78,15
11 Cádiz;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
11 Cádiz;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
11 Cádiz;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
11 Cádiz;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;78,86
11 Cádiz;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
11 Cádiz;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
11 Cádiz;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
11 Cádiz;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;83,68
11 Cádiz;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
11 Cádiz;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
11 Cádiz;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
11 Cádiz;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
11 Cádiz;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
11 Cádiz;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
11 Cádiz;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;71,04
11 Cádiz;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
11 Cádiz;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
11 Cádiz;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
11 Cádiz;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;79,9
11 Cádiz;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
11 Cádiz;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
11 Cádiz;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
11 Cádiz;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
11 Cádiz;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
11 Cádiz;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QIII;4.169
11 Cádiz;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
11 Cádiz;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
11 Cádiz;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
11 Cádiz;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QIII;4.234
11 Cádiz;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
11 Cádiz;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
11 Cádiz;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
11 Cádiz;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QIII;3.838
11 Cádiz;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
11 Cádiz;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
11 Cádiz;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
11 Cádiz;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2022QIII;3.769
11 Cádiz;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2022QII;""
11 Cádiz;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2022QI;""
11 Cádiz;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
11 Cádiz;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2021QIII;3.771
11 Cádiz;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2021QII;""
11 Cádiz;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2021QI;""
11 Cádiz;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
11 Cádiz;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2020QIII;3.516
11 Cádiz;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2020QII;""
11 Cádiz;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2020QI;""
11 Cádiz;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2022QIV;3.490
11 Cádiz;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
11 Cádiz;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2022QII;""
11 Cádiz;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2022QI;""
11 Cádiz;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2021QIV;3.489
11 Cádiz;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
11 Cádiz;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2021QII;""
11 Cádiz;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2021QI;""
11 Cádiz;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2020QIV;3.308
11 Cádiz;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
11 Cádiz;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2020QII;""
11 Cádiz;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2020QI;""
11 Cádiz;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
11 Cádiz;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
11 Cádiz;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QII;""
11 Cádiz;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QI;3.224
11 Cádiz;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
11 Cádiz;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
11 Cádiz;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QII;""
11 Cádiz;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QI;3.146
11 Cádiz;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
11 Cádiz;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
11 Cádiz;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QII;""
11 Cádiz;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QI;""
11 Cádiz;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
11 Cádiz;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
11 Cádiz;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QII;2.995
11 Cádiz;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QI;""
11 Cádiz;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
11 Cádiz;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
11 Cádiz;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QII;2.975
11 Cádiz;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QI;""
11 Cádiz;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
11 Cádiz;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
11 Cádiz;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QII;""
11 Cádiz;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QI;""
11 Cádiz;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
11 Cádiz;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
11 Cádiz;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
11 Cádiz;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
11 Cádiz;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
11 Cádiz;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
11 Cádiz;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
11 Cádiz;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
11 Cádiz;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
11 Cádiz;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
11 Cádiz;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
11 Cádiz;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
11 Cádiz;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
11 Cádiz;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;90,41
11 Cádiz;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
11 Cádiz;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
11 Cádiz;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
11 Cádiz;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;89,06
11 Cádiz;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
11 Cádiz;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
11 Cádiz;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
11 Cádiz;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;91,61
11 Cádiz;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
11 Cádiz;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
11 Cádiz;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;83,71
11 Cádiz;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
11 Cádiz;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
11 Cádiz;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
11 Cádiz;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;82,4
11 Cádiz;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
11 Cádiz;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
11 Cádiz;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
11 Cádiz;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;86,19
11 Cádiz;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
11 Cádiz;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
11 Cádiz;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
11 Cádiz;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
11 Cádiz;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
11 Cádiz;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
11 Cádiz;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;76,15
11 Cádiz;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
11 Cádiz;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
11 Cádiz;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
11 Cádiz;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;81,97
11 Cádiz;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
11 Cádiz;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
11 Cádiz;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
11 Cádiz;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
11 Cádiz;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
11 Cádiz;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
11 Cádiz;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;70,74
11 Cádiz;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
11 Cádiz;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
11 Cádiz;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
11 Cádiz;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;77,51
11 Cádiz;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
11 Cádiz;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
11 Cádiz;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
11 Cádiz;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
11 Cádiz;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
11 Cádiz;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
11 Cádiz;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QIII;2.484
11 Cádiz;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
11 Cádiz;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
11 Cádiz;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
11 Cádiz;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QIII;2.512
11 Cádiz;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
11 Cádiz;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
11 Cádiz;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
11 Cádiz;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QIII;2.304
11 Cádiz;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
11 Cádiz;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
11 Cádiz;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
11 Cádiz;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2022QIII;2.266
11 Cádiz;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2022QII;""
11 Cádiz;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2022QI;""
11 Cádiz;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
11 Cádiz;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2021QIII;2.226
11 Cádiz;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2021QII;""
11 Cádiz;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2021QI;""
11 Cádiz;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
11 Cádiz;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2020QIII;2.136
11 Cádiz;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2020QII;""
11 Cádiz;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2020QI;""
11 Cádiz;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2022QIV;2.090
11 Cádiz;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
11 Cádiz;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2022QII;""
11 Cádiz;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2022QI;""
11 Cádiz;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2021QIV;2.067
11 Cádiz;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
11 Cádiz;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2021QII;""
11 Cádiz;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2021QI;""
11 Cádiz;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2020QIV;2.015
11 Cádiz;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
11 Cádiz;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2020QII;""
11 Cádiz;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2020QI;""
11 Cádiz;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
11 Cádiz;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
11 Cádiz;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QII;""
11 Cádiz;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QI;1.940
11 Cádiz;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
11 Cádiz;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
11 Cádiz;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QII;""
11 Cádiz;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QI;1.916
11 Cádiz;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
11 Cádiz;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
11 Cádiz;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QII;""
11 Cádiz;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QI;""
11 Cádiz;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
11 Cádiz;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
11 Cádiz;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QII;1.815
11 Cádiz;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QI;""
11 Cádiz;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
11 Cádiz;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
11 Cádiz;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QII;1.808
11 Cádiz;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QI;""
11 Cádiz;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
11 Cádiz;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
11 Cádiz;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QII;""
11 Cádiz;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QI;""
11 Cádiz;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
11 Cádiz;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
11 Cádiz;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
11 Cádiz;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
11 Cádiz;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
11 Cádiz;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
11 Cádiz;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
11 Cádiz;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
11 Cádiz;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
11 Cádiz;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
11 Cádiz;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
11 Cádiz;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
11 Cádiz;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
11 Cádiz;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;91,22
11 Cádiz;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
11 Cádiz;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
11 Cádiz;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
11 Cádiz;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;88,61
11 Cádiz;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
11 Cádiz;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
11 Cádiz;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
11 Cádiz;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;92,71
11 Cádiz;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
11 Cádiz;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
11 Cádiz;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;84,14
11 Cádiz;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
11 Cádiz;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
11 Cádiz;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
11 Cádiz;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;82,29
11 Cádiz;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
11 Cádiz;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
11 Cádiz;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
11 Cádiz;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;87,46
11 Cádiz;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
11 Cádiz;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
11 Cádiz;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
11 Cádiz;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
11 Cádiz;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
11 Cádiz;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
11 Cádiz;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;77,23
11 Cádiz;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
11 Cádiz;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
11 Cádiz;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
11 Cádiz;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;83,16
11 Cádiz;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
11 Cádiz;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
11 Cádiz;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
11 Cádiz;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
11 Cádiz;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
11 Cádiz;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
11 Cádiz;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;72,25
11 Cádiz;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
11 Cádiz;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
11 Cádiz;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
11 Cádiz;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;78,47
11 Cádiz;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
11 Cádiz;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
11 Cádiz;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
11 Cádiz;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
11 Cádiz;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
11 Cádiz;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
11 Cádiz;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QIII;1.685
11 Cádiz;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
11 Cádiz;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
11 Cádiz;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
11 Cádiz;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QIII;1.722
11 Cádiz;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
11 Cádiz;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
11 Cádiz;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
11 Cádiz;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QIII;1.534
11 Cádiz;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
11 Cádiz;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
11 Cádiz;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
11 Cádiz;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2022QIII;1.503
11 Cádiz;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2022QII;""
11 Cádiz;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2022QI;""
11 Cádiz;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
11 Cádiz;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2021QIII;1.545
11 Cádiz;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2021QII;""
11 Cádiz;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2021QI;""
11 Cádiz;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
11 Cádiz;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2020QIII;1.380
11 Cádiz;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2020QII;""
11 Cádiz;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2020QI;""
11 Cádiz;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2022QIV;1.400
11 Cádiz;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
11 Cádiz;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2022QII;""
11 Cádiz;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2022QI;""
11 Cádiz;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2021QIV;1.422
11 Cádiz;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
11 Cádiz;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2021QII;""
11 Cádiz;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2021QI;""
11 Cádiz;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2020QIV;1.293
11 Cádiz;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
11 Cádiz;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2020QII;""
11 Cádiz;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2020QI;""
11 Cádiz;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
11 Cádiz;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
11 Cádiz;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QII;""
11 Cádiz;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QI;1.284
11 Cádiz;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
11 Cádiz;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
11 Cádiz;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QII;""
11 Cádiz;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QI;1.230
11 Cádiz;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
11 Cádiz;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
11 Cádiz;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QII;""
11 Cádiz;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QI;""
11 Cádiz;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
11 Cádiz;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
11 Cádiz;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QII;1.180
11 Cádiz;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QI;""
11 Cádiz;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
11 Cádiz;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
11 Cádiz;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QII;1.167
11 Cádiz;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QI;""
11 Cádiz;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
11 Cádiz;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
11 Cádiz;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QII;""
11 Cádiz;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QI;""
11 Cádiz;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
11 Cádiz;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
11 Cádiz;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
11 Cádiz;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
11 Cádiz;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
11 Cádiz;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
11 Cádiz;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
11 Cádiz;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
11 Cádiz;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
11 Cádiz;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
11 Cádiz;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
11 Cádiz;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
11 Cádiz;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
11 Cádiz;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;89,2
11 Cádiz;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
11 Cádiz;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
11 Cádiz;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
11 Cádiz;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;89,72
11 Cádiz;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
11 Cádiz;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
11 Cádiz;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
11 Cádiz;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;89,96
11 Cádiz;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
11 Cádiz;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
11 Cádiz;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;83,09
11 Cádiz;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
11 Cádiz;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
11 Cádiz;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
11 Cádiz;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;82,58
11 Cádiz;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
11 Cádiz;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
11 Cádiz;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
11 Cádiz;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;84,29
11 Cádiz;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
11 Cádiz;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
11 Cádiz;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
11 Cádiz;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
11 Cádiz;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
11 Cádiz;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
11 Cádiz;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;74,56
11 Cádiz;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
11 Cádiz;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
11 Cádiz;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
11 Cádiz;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;80,18
11 Cádiz;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
11 Cádiz;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
11 Cádiz;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
11 Cádiz;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
11 Cádiz;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
11 Cádiz;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
11 Cádiz;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;68,52
11 Cádiz;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
11 Cádiz;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
11 Cádiz;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
11 Cádiz;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;76,08
11 Cádiz;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
11 Cádiz;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
11 Cádiz;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
11 Cádiz;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
11 Cádiz;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
11 Cádiz;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QIV;4.314
11 Cádiz;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
11 Cádiz;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
11 Cádiz;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
11 Cádiz;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QIV;4.351
11 Cádiz;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
11 Cádiz;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
11 Cádiz;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
11 Cádiz;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QIV;4.087
11 Cádiz;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
11 Cádiz;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
11 Cádiz;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
11 Cádiz;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2022QIV;3.971
11 Cádiz;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
11 Cádiz;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2022QII;""
11 Cádiz;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2022QI;""
11 Cádiz;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2021QIV;3.998
11 Cádiz;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
11 Cádiz;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2021QII;""
11 Cádiz;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2021QI;""
11 Cádiz;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2020QIV;3.803
11 Cádiz;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
11 Cádiz;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2020QII;""
11 Cádiz;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2020QI;""
11 Cádiz;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
11 Cádiz;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
11 Cádiz;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2022QII;""
11 Cádiz;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2022QI;3.678
11 Cádiz;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
11 Cádiz;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
11 Cádiz;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2021QII;""
11 Cádiz;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2021QI;3.600
11 Cádiz;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
11 Cádiz;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
11 Cádiz;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2020QII;""
11 Cádiz;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2020QI;""
11 Cádiz;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
11 Cádiz;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
11 Cádiz;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QII;3.405
11 Cádiz;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QI;""
11 Cádiz;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
11 Cádiz;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
11 Cádiz;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QII;3.380
11 Cádiz;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QI;""
11 Cádiz;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
11 Cádiz;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
11 Cádiz;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QII;""
11 Cádiz;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QI;""
11 Cádiz;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
11 Cádiz;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QIII;3.188
11 Cádiz;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QII;""
11 Cádiz;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QI;""
11 Cádiz;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
11 Cádiz;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QIII;3.169
11 Cádiz;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QII;""
11 Cádiz;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QI;""
11 Cádiz;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
11 Cádiz;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
11 Cádiz;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QII;""
11 Cádiz;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QI;""
11 Cádiz;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
11 Cádiz;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
11 Cádiz;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
11 Cádiz;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
11 Cádiz;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
11 Cádiz;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
11 Cádiz;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
11 Cádiz;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
11 Cádiz;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
11 Cádiz;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
11 Cádiz;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
11 Cádiz;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
11 Cádiz;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;92,05
11 Cádiz;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
11 Cádiz;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
11 Cádiz;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
11 Cádiz;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;91,89
11 Cádiz;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
11 Cádiz;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
11 Cádiz;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
11 Cádiz;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;93,05
11 Cádiz;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
11 Cádiz;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
11 Cádiz;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
11 Cádiz;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
11 Cádiz;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
11 Cádiz;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
11 Cádiz;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;84,53
11 Cádiz;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
11 Cádiz;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
11 Cádiz;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
11 Cádiz;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;88,08
11 Cádiz;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
11 Cádiz;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
11 Cádiz;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
11 Cádiz;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
11 Cádiz;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
11 Cádiz;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
11 Cádiz;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;78,26
11 Cádiz;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
11 Cádiz;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
11 Cádiz;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
11 Cádiz;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;82,7
11 Cádiz;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
11 Cádiz;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
11 Cádiz;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
11 Cádiz;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
11 Cádiz;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
11 Cádiz;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
11 Cádiz;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;73,27
11 Cádiz;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
11 Cádiz;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
11 Cádiz;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
11 Cádiz;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;77,54
11 Cádiz;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
11 Cádiz;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
11 Cádiz;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
11 Cádiz;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
11 Cádiz;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
11 Cádiz;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
11 Cádiz;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QIV;2.556
11 Cádiz;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
11 Cádiz;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
11 Cádiz;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
11 Cádiz;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QIV;2.556
11 Cádiz;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
11 Cádiz;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
11 Cádiz;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
11 Cádiz;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QIV;2.453
11 Cádiz;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
11 Cádiz;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
11 Cádiz;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
11 Cádiz;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2022QIV;2.339
11 Cádiz;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
11 Cádiz;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2022QII;""
11 Cádiz;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2022QI;""
11 Cádiz;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2021QIV;2.353
11 Cádiz;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
11 Cádiz;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2021QII;""
11 Cádiz;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2021QI;""
11 Cádiz;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2020QIV;2.284
11 Cádiz;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
11 Cádiz;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2020QII;""
11 Cádiz;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2020QI;""
11 Cádiz;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
11 Cádiz;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
11 Cádiz;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2022QII;""
11 Cádiz;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2022QI;2.196
11 Cádiz;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
11 Cádiz;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
11 Cádiz;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2021QII;""
11 Cádiz;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2021QI;2.166
11 Cádiz;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
11 Cádiz;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
11 Cádiz;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2020QII;""
11 Cádiz;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2020QI;""
11 Cádiz;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
11 Cádiz;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
11 Cádiz;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QII;2.044
11 Cádiz;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QI;""
11 Cádiz;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
11 Cádiz;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
11 Cádiz;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QII;2.025
11 Cádiz;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QI;""
11 Cádiz;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
11 Cádiz;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
11 Cádiz;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QII;""
11 Cádiz;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QI;""
11 Cádiz;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
11 Cádiz;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QIII;1.928
11 Cádiz;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QII;""
11 Cádiz;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QI;""
11 Cádiz;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
11 Cádiz;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QIII;1.892
11 Cádiz;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QII;""
11 Cádiz;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QI;""
11 Cádiz;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
11 Cádiz;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
11 Cádiz;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QII;""
11 Cádiz;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QI;""
11 Cádiz;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
11 Cádiz;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
11 Cádiz;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
11 Cádiz;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
11 Cádiz;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
11 Cádiz;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
11 Cádiz;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
11 Cádiz;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
11 Cádiz;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
11 Cádiz;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
11 Cádiz;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
11 Cádiz;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
11 Cádiz;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;91,51
11 Cádiz;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
11 Cádiz;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
11 Cádiz;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
11 Cádiz;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;92,06
11 Cádiz;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
11 Cádiz;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
11 Cádiz;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
11 Cádiz;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;93,11
11 Cádiz;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
11 Cádiz;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
11 Cádiz;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
11 Cádiz;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
11 Cádiz;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
11 Cádiz;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
11 Cádiz;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;85,92
11 Cádiz;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
11 Cádiz;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
11 Cádiz;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
11 Cádiz;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;88,3
11 Cádiz;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
11 Cádiz;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
11 Cádiz;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
11 Cádiz;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
11 Cádiz;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
11 Cádiz;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
11 Cádiz;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;79,97
11 Cádiz;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
11 Cádiz;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
11 Cádiz;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
11 Cádiz;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;82,55
11 Cádiz;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
11 Cádiz;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
11 Cádiz;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
11 Cádiz;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
11 Cádiz;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
11 Cádiz;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
11 Cádiz;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;75,43
11 Cádiz;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
11 Cádiz;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
11 Cádiz;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
11 Cádiz;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;77,13
11 Cádiz;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
11 Cádiz;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
11 Cádiz;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
11 Cádiz;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
11 Cádiz;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
11 Cádiz;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
11 Cádiz;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QIV;1.758
11 Cádiz;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
11 Cádiz;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
11 Cádiz;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
11 Cádiz;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QIV;1.795
11 Cádiz;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
11 Cádiz;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
11 Cádiz;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
11 Cádiz;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QIV;1.634
11 Cádiz;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
11 Cádiz;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
11 Cádiz;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
11 Cádiz;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2022QIV;1.632
11 Cádiz;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
11 Cádiz;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2022QII;""
11 Cádiz;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2022QI;""
11 Cádiz;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2021QIV;1.645
11 Cádiz;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
11 Cádiz;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2021QII;""
11 Cádiz;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2021QI;""
11 Cádiz;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2020QIV;1.519
11 Cádiz;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
11 Cádiz;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2020QII;""
11 Cádiz;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2020QI;""
11 Cádiz;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
11 Cádiz;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
11 Cádiz;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2022QII;""
11 Cádiz;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2022QI;1.482
11 Cádiz;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
11 Cádiz;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
11 Cádiz;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2021QII;""
11 Cádiz;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2021QI;1.434
11 Cádiz;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
11 Cádiz;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
11 Cádiz;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2020QII;""
11 Cádiz;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2020QI;""
11 Cádiz;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
11 Cádiz;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
11 Cádiz;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QII;1.361
11 Cádiz;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QI;""
11 Cádiz;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
11 Cádiz;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
11 Cádiz;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QII;1.355
11 Cádiz;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QI;""
11 Cádiz;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
11 Cádiz;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
11 Cádiz;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QII;""
11 Cádiz;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QI;""
11 Cádiz;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
11 Cádiz;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QIII;1.260
11 Cádiz;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QII;""
11 Cádiz;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QI;""
11 Cádiz;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
11 Cádiz;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QIII;1.277
11 Cádiz;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QII;""
11 Cádiz;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QI;""
11 Cádiz;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
11 Cádiz;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
11 Cádiz;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QII;""
11 Cádiz;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QI;""
11 Cádiz;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
11 Cádiz;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
11 Cádiz;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
11 Cádiz;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
11 Cádiz;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
11 Cádiz;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
11 Cádiz;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
11 Cádiz;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
11 Cádiz;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
11 Cádiz;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
11 Cádiz;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
11 Cádiz;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
11 Cádiz;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;92,83
11 Cádiz;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
11 Cádiz;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
11 Cádiz;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
11 Cádiz;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;91,64
11 Cádiz;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
11 Cádiz;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
11 Cádiz;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
11 Cádiz;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;92,96
11 Cádiz;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
11 Cádiz;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
11 Cádiz;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
11 Cádiz;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
11 Cádiz;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
11 Cádiz;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
11 Cádiz;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;82,56
11 Cádiz;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
11 Cádiz;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
11 Cádiz;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
11 Cádiz;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;87,76
11 Cádiz;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
11 Cádiz;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
11 Cádiz;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
11 Cádiz;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
11 Cádiz;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
11 Cádiz;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
11 Cádiz;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;75,82
11 Cádiz;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
11 Cádiz;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
11 Cádiz;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
11 Cádiz;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;82,93
11 Cádiz;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
11 Cádiz;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
11 Cádiz;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
11 Cádiz;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
11 Cádiz;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
11 Cádiz;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
11 Cádiz;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;70,19
11 Cádiz;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
11 Cádiz;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
11 Cádiz;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
11 Cádiz;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;78,15
11 Cádiz;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
11 Cádiz;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
11 Cádiz;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
11 Cádiz;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
11 Cádiz;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
11 Cádiz;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
11 Cádiz;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
11 Cádiz;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
11 Cádiz;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
11 Cádiz;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QI;12.655
11 Cádiz;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
11 Cádiz;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
11 Cádiz;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
11 Cádiz;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QI;12.518
11 Cádiz;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
11 Cádiz;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
11 Cádiz;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
11 Cádiz;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QI;12.086
11 Cádiz;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
11 Cádiz;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
11 Cádiz;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2022QII;""
11 Cádiz;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2022QI;12.077
11 Cádiz;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
11 Cádiz;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
11 Cádiz;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2021QII;""
11 Cádiz;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2021QI;12.070
11 Cádiz;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
11 Cádiz;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
11 Cádiz;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2020QII;""
11 Cádiz;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2020QI;10.983
11 Cádiz;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
11 Cádiz;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
11 Cádiz;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2022QII;11.555
11 Cádiz;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2022QI;""
11 Cádiz;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
11 Cádiz;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
11 Cádiz;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2021QII;11.654
11 Cádiz;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2021QI;""
11 Cádiz;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
11 Cádiz;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
11 Cádiz;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2020QII;10.734
11 Cádiz;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2020QI;""
11 Cádiz;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
11 Cádiz;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QIII;11.103
11 Cádiz;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QII;""
11 Cádiz;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QI;""
11 Cádiz;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
11 Cádiz;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QIII;11.249
11 Cádiz;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QII;""
11 Cádiz;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QI;""
11 Cádiz;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
11 Cádiz;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QIII;10.318
11 Cádiz;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QII;""
11 Cádiz;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QI;""
11 Cádiz;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QIV;10.663
11 Cádiz;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
11 Cádiz;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QII;""
11 Cádiz;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QI;""
11 Cádiz;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QIV;10.842
11 Cádiz;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
11 Cádiz;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QII;""
11 Cádiz;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QI;""
11 Cádiz;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QIV;9.970
11 Cádiz;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
11 Cádiz;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QII;""
11 Cádiz;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QI;""
11 Cádiz;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
11 Cádiz;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
11 Cádiz;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
11 Cádiz;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
11 Cádiz;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
11 Cádiz;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
11 Cádiz;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
11 Cádiz;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
11 Cádiz;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
11 Cádiz;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
11 Cádiz;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
11 Cádiz;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
11 Cádiz;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
11 Cádiz;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
11 Cádiz;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
11 Cádiz;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;95,43
11 Cádiz;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
11 Cádiz;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
11 Cádiz;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
11 Cádiz;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;96,42
11 Cádiz;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
11 Cádiz;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
11 Cádiz;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
11 Cádiz;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;90,87
11 Cádiz;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
11 Cádiz;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
11 Cádiz;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;91,31
11 Cádiz;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
11 Cádiz;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
11 Cádiz;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
11 Cádiz;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;93,1
11 Cádiz;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
11 Cádiz;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
11 Cádiz;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
11 Cádiz;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;88,81
11 Cádiz;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
11 Cádiz;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
11 Cádiz;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;87,74
11 Cádiz;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
11 Cádiz;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
11 Cádiz;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
11 Cádiz;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;89,86
11 Cádiz;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
11 Cádiz;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
11 Cádiz;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
11 Cádiz;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;85,37
11 Cádiz;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
11 Cádiz;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
11 Cádiz;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;84,26
11 Cádiz;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
11 Cádiz;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
11 Cádiz;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
11 Cádiz;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;86,61
11 Cádiz;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
11 Cádiz;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
11 Cádiz;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
11 Cádiz;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;82,49
11 Cádiz;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
11 Cádiz;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
11 Cádiz;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
11 Cádiz;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
11 Cádiz;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
11 Cádiz;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
11 Cádiz;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QI;7.366
11 Cádiz;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
11 Cádiz;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
11 Cádiz;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
11 Cádiz;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QI;7.385
11 Cádiz;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
11 Cádiz;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
11 Cádiz;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
11 Cádiz;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QI;7.071
11 Cádiz;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
11 Cádiz;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
11 Cádiz;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2022QII;""
11 Cádiz;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2022QI;7.055
11 Cádiz;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
11 Cádiz;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
11 Cádiz;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2021QII;""
11 Cádiz;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2021QI;7.132
11 Cádiz;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
11 Cádiz;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
11 Cádiz;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2020QII;""
11 Cádiz;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2020QI;6.445
11 Cádiz;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
11 Cádiz;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
11 Cádiz;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2022QII;6.788
11 Cádiz;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2022QI;""
11 Cádiz;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
11 Cádiz;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
11 Cádiz;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2021QII;6.909
11 Cádiz;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2021QI;""
11 Cádiz;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
11 Cádiz;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
11 Cádiz;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2020QII;6.311
11 Cádiz;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2020QI;""
11 Cádiz;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
11 Cádiz;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QIII;6.551
11 Cádiz;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QII;""
11 Cádiz;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QI;""
11 Cádiz;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
11 Cádiz;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QIII;6.663
11 Cádiz;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QII;""
11 Cádiz;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QI;""
11 Cádiz;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
11 Cádiz;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QIII;6.093
11 Cádiz;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QII;""
11 Cádiz;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QI;""
11 Cádiz;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QIV;6.314
11 Cádiz;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
11 Cádiz;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QII;""
11 Cádiz;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QI;""
11 Cádiz;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QIV;6.432
11 Cádiz;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
11 Cádiz;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QII;""
11 Cádiz;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QI;""
11 Cádiz;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QIV;5.908
11 Cádiz;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
11 Cádiz;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QII;""
11 Cádiz;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QI;""
11 Cádiz;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
11 Cádiz;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
11 Cádiz;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
11 Cádiz;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
11 Cádiz;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
11 Cádiz;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
11 Cádiz;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
11 Cádiz;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
11 Cádiz;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
11 Cádiz;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
11 Cádiz;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
11 Cádiz;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
11 Cádiz;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
11 Cádiz;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
11 Cádiz;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
11 Cádiz;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;95,78
11 Cádiz;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
11 Cádiz;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
11 Cádiz;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
11 Cádiz;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;96,57
11 Cádiz;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
11 Cádiz;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
11 Cádiz;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
11 Cádiz;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;91,15
11 Cádiz;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
11 Cádiz;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
11 Cádiz;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;92,15
11 Cádiz;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
11 Cádiz;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
11 Cádiz;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
11 Cádiz;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;93,55
11 Cádiz;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
11 Cádiz;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
11 Cádiz;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
11 Cádiz;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;89,25
11 Cádiz;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
11 Cádiz;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
11 Cádiz;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;88,94
11 Cádiz;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
11 Cádiz;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
11 Cádiz;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
11 Cádiz;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;90,22
11 Cádiz;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
11 Cádiz;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
11 Cádiz;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
11 Cádiz;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;86,17
11 Cádiz;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
11 Cádiz;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
11 Cádiz;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;85,72
11 Cádiz;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
11 Cádiz;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
11 Cádiz;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
11 Cádiz;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;87,1
11 Cádiz;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
11 Cádiz;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
11 Cádiz;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
11 Cádiz;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;83,55
11 Cádiz;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
11 Cádiz;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
11 Cádiz;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
11 Cádiz;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
11 Cádiz;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
11 Cádiz;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
11 Cádiz;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QI;5.289
11 Cádiz;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
11 Cádiz;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
11 Cádiz;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
11 Cádiz;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QI;5.133
11 Cádiz;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
11 Cádiz;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
11 Cádiz;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
11 Cádiz;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QI;5.015
11 Cádiz;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
11 Cádiz;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
11 Cádiz;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2022QII;""
11 Cádiz;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2022QI;5.022
11 Cádiz;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
11 Cádiz;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
11 Cádiz;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2021QII;""
11 Cádiz;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2021QI;4.938
11 Cádiz;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
11 Cádiz;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
11 Cádiz;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2020QII;""
11 Cádiz;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2020QI;4.538
11 Cádiz;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
11 Cádiz;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
11 Cádiz;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2022QII;4.767
11 Cádiz;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2022QI;""
11 Cádiz;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
11 Cádiz;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
11 Cádiz;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2021QII;4.745
11 Cádiz;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2021QI;""
11 Cádiz;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
11 Cádiz;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
11 Cádiz;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2020QII;4.423
11 Cádiz;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2020QI;""
11 Cádiz;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
11 Cádiz;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QIII;4.552
11 Cádiz;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QII;""
11 Cádiz;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QI;""
11 Cádiz;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
11 Cádiz;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QIII;4.586
11 Cádiz;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QII;""
11 Cádiz;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QI;""
11 Cádiz;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
11 Cádiz;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QIII;4.225
11 Cádiz;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QII;""
11 Cádiz;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QI;""
11 Cádiz;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QIV;4.349
11 Cádiz;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
11 Cádiz;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QII;""
11 Cádiz;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QI;""
11 Cádiz;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QIV;4.410
11 Cádiz;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
11 Cádiz;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QII;""
11 Cádiz;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QI;""
11 Cádiz;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QIV;4.062
11 Cádiz;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
11 Cádiz;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QII;""
11 Cádiz;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QI;""
11 Cádiz;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
11 Cádiz;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
11 Cádiz;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
11 Cádiz;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
11 Cádiz;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
11 Cádiz;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
11 Cádiz;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
11 Cádiz;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
11 Cádiz;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
11 Cádiz;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
11 Cádiz;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
11 Cádiz;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
11 Cádiz;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
11 Cádiz;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
11 Cádiz;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
11 Cádiz;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;94,95
11 Cádiz;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
11 Cádiz;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
11 Cádiz;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
11 Cádiz;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;96,2
11 Cádiz;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
11 Cádiz;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
11 Cádiz;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
11 Cádiz;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;90,49
11 Cádiz;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
11 Cádiz;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
11 Cádiz;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;90,13
11 Cádiz;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
11 Cádiz;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
11 Cádiz;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
11 Cádiz;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;92,44
11 Cádiz;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
11 Cádiz;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
11 Cádiz;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
11 Cádiz;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;88,2
11 Cádiz;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
11 Cádiz;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
11 Cádiz;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;86,07
11 Cádiz;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
11 Cádiz;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
11 Cádiz;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
11 Cádiz;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;89,34
11 Cádiz;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
11 Cádiz;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
11 Cádiz;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
11 Cádiz;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;84,25
11 Cádiz;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
11 Cádiz;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
11 Cádiz;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;82,23
11 Cádiz;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
11 Cádiz;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
11 Cádiz;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
11 Cádiz;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;85,91
11 Cádiz;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
11 Cádiz;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
11 Cádiz;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
11 Cádiz;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;81
11 Cádiz;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
11 Cádiz;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
11 Cádiz;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
11 Cádiz;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
11 Cádiz;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
11 Cádiz;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QII;11.994
11 Cádiz;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
11 Cádiz;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
11 Cádiz;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
11 Cádiz;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QII;11.944
11 Cádiz;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
11 Cádiz;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
11 Cádiz;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
11 Cádiz;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QII;11.858
11 Cádiz;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
11 Cádiz;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
11 Cádiz;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
11 Cádiz;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2022QII;11.430
11 Cádiz;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2022QI;""
11 Cádiz;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
11 Cádiz;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
11 Cádiz;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2021QII;11.475
11 Cádiz;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2021QI;""
11 Cádiz;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
11 Cádiz;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
11 Cádiz;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2020QII;11.569
11 Cádiz;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2020QI;""
11 Cádiz;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
11 Cádiz;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2022QIII;10.947
11 Cádiz;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2022QII;""
11 Cádiz;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2022QI;""
11 Cádiz;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
11 Cádiz;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2021QIII;11.045
11 Cádiz;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2021QII;""
11 Cádiz;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2021QI;""
11 Cádiz;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
11 Cádiz;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2020QIII;11.094
11 Cádiz;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2020QII;""
11 Cádiz;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2020QI;""
11 Cádiz;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QIV;10.463
11 Cádiz;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
11 Cádiz;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QII;""
11 Cádiz;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QI;""
11 Cádiz;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QIV;10.583
11 Cádiz;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
11 Cádiz;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QII;""
11 Cádiz;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QI;""
11 Cádiz;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QIV;10.685
11 Cádiz;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
11 Cádiz;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QII;""
11 Cádiz;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QI;""
11 Cádiz;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
11 Cádiz;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
11 Cádiz;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QII;""
11 Cádiz;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QI;10.179
11 Cádiz;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
11 Cádiz;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
11 Cádiz;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QII;""
11 Cádiz;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QI;10.386
11 Cádiz;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
11 Cádiz;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
11 Cádiz;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QII;""
11 Cádiz;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QI;""
11 Cádiz;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
11 Cádiz;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
11 Cádiz;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
11 Cádiz;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
11 Cádiz;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
11 Cádiz;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
11 Cádiz;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
11 Cádiz;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
11 Cádiz;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
11 Cádiz;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
11 Cádiz;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
11 Cádiz;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
11 Cádiz;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
11 Cádiz;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
11 Cádiz;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;95,3
11 Cádiz;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
11 Cádiz;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
11 Cádiz;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
11 Cádiz;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;96,07
11 Cádiz;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
11 Cádiz;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
11 Cádiz;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
11 Cádiz;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;97,56
11 Cádiz;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
11 Cádiz;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
11 Cádiz;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;91,27
11 Cádiz;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
11 Cádiz;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
11 Cádiz;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
11 Cádiz;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;92,47
11 Cádiz;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
11 Cádiz;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
11 Cádiz;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
11 Cádiz;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;93,56
11 Cádiz;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
11 Cádiz;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
11 Cádiz;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;87,24
11 Cádiz;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
11 Cádiz;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
11 Cádiz;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
11 Cádiz;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;88,61
11 Cádiz;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
11 Cádiz;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
11 Cádiz;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
11 Cádiz;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;90,11
11 Cádiz;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
11 Cádiz;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
11 Cádiz;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
11 Cádiz;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
11 Cádiz;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
11 Cádiz;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
11 Cádiz;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;85,22
11 Cádiz;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
11 Cádiz;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
11 Cádiz;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
11 Cádiz;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;87,59
11 Cádiz;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
11 Cádiz;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
11 Cádiz;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
11 Cádiz;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
11 Cádiz;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
11 Cádiz;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
11 Cádiz;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QII;6.922
11 Cádiz;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
11 Cádiz;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
11 Cádiz;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
11 Cádiz;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QII;6.992
11 Cádiz;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
11 Cádiz;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
11 Cádiz;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
11 Cádiz;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QII;6.946
11 Cádiz;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
11 Cádiz;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
11 Cádiz;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
11 Cádiz;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2022QII;6.641
11 Cádiz;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2022QI;""
11 Cádiz;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
11 Cádiz;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
11 Cádiz;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2021QII;6.739
11 Cádiz;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2021QI;""
11 Cádiz;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
11 Cádiz;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
11 Cádiz;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2020QII;6.790
11 Cádiz;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2020QI;""
11 Cádiz;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
11 Cádiz;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2022QIII;6.383
11 Cádiz;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2022QII;""
11 Cádiz;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2022QI;""
11 Cádiz;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
11 Cádiz;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2021QIII;6.473
11 Cádiz;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2021QII;""
11 Cádiz;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2021QI;""
11 Cádiz;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
11 Cádiz;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2020QIII;6.538
11 Cádiz;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2020QII;""
11 Cádiz;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2020QI;""
11 Cádiz;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QIV;6.136
11 Cádiz;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
11 Cádiz;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QII;""
11 Cádiz;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QI;""
11 Cádiz;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QIV;6.211
11 Cádiz;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
11 Cádiz;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QII;""
11 Cádiz;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QI;""
11 Cádiz;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QIV;6.320
11 Cádiz;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
11 Cádiz;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QII;""
11 Cádiz;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QI;""
11 Cádiz;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
11 Cádiz;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
11 Cádiz;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QII;""
11 Cádiz;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QI;6.003
11 Cádiz;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
11 Cádiz;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
11 Cádiz;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QII;""
11 Cádiz;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QI;6.154
11 Cádiz;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
11 Cádiz;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
11 Cádiz;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QII;""
11 Cádiz;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QI;""
11 Cádiz;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
11 Cádiz;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
11 Cádiz;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
11 Cádiz;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
11 Cádiz;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
11 Cádiz;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
11 Cádiz;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
11 Cádiz;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
11 Cádiz;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
11 Cádiz;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
11 Cádiz;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
11 Cádiz;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
11 Cádiz;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
11 Cádiz;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
11 Cádiz;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;95,94
11 Cádiz;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
11 Cádiz;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
11 Cádiz;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
11 Cádiz;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;96,38
11 Cádiz;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
11 Cádiz;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
11 Cádiz;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
11 Cádiz;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;97,75
11 Cádiz;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
11 Cádiz;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
11 Cádiz;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;92,21
11 Cádiz;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
11 Cádiz;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
11 Cádiz;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
11 Cádiz;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;92,58
11 Cádiz;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
11 Cádiz;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
11 Cádiz;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
11 Cádiz;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;94,13
11 Cádiz;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
11 Cádiz;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
11 Cádiz;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;88,64
11 Cádiz;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
11 Cádiz;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
11 Cádiz;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
11 Cádiz;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;88,83
11 Cádiz;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
11 Cádiz;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
11 Cádiz;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
11 Cádiz;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;90,99
11 Cádiz;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
11 Cádiz;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
11 Cádiz;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
11 Cádiz;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
11 Cádiz;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
11 Cádiz;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
11 Cádiz;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;85,86
11 Cádiz;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
11 Cádiz;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
11 Cádiz;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
11 Cádiz;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;88,6
11 Cádiz;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
11 Cádiz;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
11 Cádiz;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
11 Cádiz;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
11 Cádiz;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
11 Cádiz;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
11 Cádiz;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QII;5.072
11 Cádiz;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
11 Cádiz;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
11 Cádiz;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
11 Cádiz;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QII;4.952
11 Cádiz;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
11 Cádiz;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
11 Cádiz;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
11 Cádiz;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QII;4.912
11 Cádiz;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
11 Cádiz;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
11 Cádiz;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
11 Cádiz;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2022QII;4.789
11 Cádiz;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2022QI;""
11 Cádiz;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
11 Cádiz;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
11 Cádiz;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2021QII;4.736
11 Cádiz;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2021QI;""
11 Cádiz;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
11 Cádiz;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
11 Cádiz;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2020QII;4.779
11 Cádiz;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2020QI;""
11 Cádiz;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
11 Cádiz;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2022QIII;4.564
11 Cádiz;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2022QII;""
11 Cádiz;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2022QI;""
11 Cádiz;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
11 Cádiz;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2021QIII;4.572
11 Cádiz;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2021QII;""
11 Cádiz;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2021QI;""
11 Cádiz;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
11 Cádiz;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2020QIII;4.556
11 Cádiz;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2020QII;""
11 Cádiz;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2020QI;""
11 Cádiz;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QIV;4.327
11 Cádiz;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
11 Cádiz;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QII;""
11 Cádiz;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QI;""
11 Cádiz;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QIV;4.372
11 Cádiz;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
11 Cádiz;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QII;""
11 Cádiz;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QI;""
11 Cádiz;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QIV;4.365
11 Cádiz;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
11 Cádiz;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QII;""
11 Cádiz;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QI;""
11 Cádiz;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
11 Cádiz;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
11 Cádiz;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QII;""
11 Cádiz;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QI;4.176
11 Cádiz;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
11 Cádiz;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
11 Cádiz;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QII;""
11 Cádiz;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QI;4.232
11 Cádiz;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
11 Cádiz;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
11 Cádiz;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QII;""
11 Cádiz;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QI;""
11 Cádiz;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
11 Cádiz;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
11 Cádiz;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
11 Cádiz;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
11 Cádiz;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
11 Cádiz;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
11 Cádiz;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
11 Cádiz;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
11 Cádiz;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
11 Cádiz;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
11 Cádiz;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
11 Cádiz;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
11 Cádiz;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
11 Cádiz;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
11 Cádiz;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;94,42
11 Cádiz;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
11 Cádiz;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
11 Cádiz;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
11 Cádiz;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;95,64
11 Cádiz;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
11 Cádiz;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
11 Cádiz;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
11 Cádiz;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;97,29
11 Cádiz;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
11 Cádiz;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
11 Cádiz;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;89,98
11 Cádiz;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
11 Cádiz;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
11 Cádiz;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
11 Cádiz;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;92,33
11 Cádiz;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
11 Cádiz;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
11 Cádiz;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
11 Cádiz;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;92,75
11 Cádiz;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
11 Cádiz;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
11 Cádiz;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;85,31
11 Cádiz;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
11 Cádiz;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
11 Cádiz;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
11 Cádiz;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;88,29
11 Cádiz;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
11 Cádiz;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
11 Cádiz;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
11 Cádiz;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;88,86
11 Cádiz;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
11 Cádiz;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
11 Cádiz;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
11 Cádiz;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
11 Cádiz;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
11 Cádiz;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
11 Cádiz;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;84,33
11 Cádiz;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
11 Cádiz;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
11 Cádiz;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
11 Cádiz;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;86,16
11 Cádiz;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
11 Cádiz;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
11 Cádiz;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
11 Cádiz;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
11 Cádiz;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
11 Cádiz;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QIII;12.315
11 Cádiz;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
11 Cádiz;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
11 Cádiz;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
11 Cádiz;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QIII;12.424
11 Cádiz;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
11 Cádiz;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
11 Cádiz;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
11 Cádiz;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QIII;12.293
11 Cádiz;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
11 Cádiz;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
11 Cádiz;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
11 Cádiz;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2022QIII;11.694
11 Cádiz;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2022QII;""
11 Cádiz;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2022QI;""
11 Cádiz;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
11 Cádiz;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2021QIII;11.853
11 Cádiz;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2021QII;""
11 Cádiz;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2021QI;""
11 Cádiz;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
11 Cádiz;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2020QIII;11.692
11 Cádiz;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2020QII;""
11 Cádiz;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2020QI;""
11 Cádiz;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2022QIV;11.116
11 Cádiz;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
11 Cádiz;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2022QII;""
11 Cádiz;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2022QI;""
11 Cádiz;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2021QIV;11.296
11 Cádiz;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
11 Cádiz;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2021QII;""
11 Cádiz;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2021QI;""
11 Cádiz;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2020QIV;11.203
11 Cádiz;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
11 Cádiz;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2020QII;""
11 Cádiz;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2020QI;""
11 Cádiz;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
11 Cádiz;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
11 Cádiz;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QII;""
11 Cádiz;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QI;10.847
11 Cádiz;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
11 Cádiz;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
11 Cádiz;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QII;""
11 Cádiz;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QI;10.879
11 Cádiz;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
11 Cádiz;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
11 Cádiz;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QII;""
11 Cádiz;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QI;""
11 Cádiz;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
11 Cádiz;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
11 Cádiz;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QII;10.422
11 Cádiz;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QI;""
11 Cádiz;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
11 Cádiz;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
11 Cádiz;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QII;10.565
11 Cádiz;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QI;""
11 Cádiz;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
11 Cádiz;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
11 Cádiz;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QII;""
11 Cádiz;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QI;""
11 Cádiz;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
11 Cádiz;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
11 Cádiz;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
11 Cádiz;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
11 Cádiz;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
11 Cádiz;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
11 Cádiz;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
11 Cádiz;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
11 Cádiz;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
11 Cádiz;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
11 Cádiz;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
11 Cádiz;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
11 Cádiz;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
11 Cádiz;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;94,96
11 Cádiz;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
11 Cádiz;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
11 Cádiz;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
11 Cádiz;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;95,4
11 Cádiz;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
11 Cádiz;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
11 Cádiz;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
11 Cádiz;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;95,11
11 Cádiz;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
11 Cádiz;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
11 Cádiz;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;90,26
11 Cádiz;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
11 Cádiz;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
11 Cádiz;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
11 Cádiz;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;90,92
11 Cádiz;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
11 Cádiz;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
11 Cádiz;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
11 Cádiz;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;91,13
11 Cádiz;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
11 Cádiz;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
11 Cádiz;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
11 Cádiz;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
11 Cádiz;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
11 Cádiz;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
11 Cádiz;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;87,31
11 Cádiz;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
11 Cádiz;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
11 Cádiz;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
11 Cádiz;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;88,5
11 Cádiz;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
11 Cádiz;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
11 Cádiz;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
11 Cádiz;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
11 Cádiz;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
11 Cádiz;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
11 Cádiz;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;83,89
11 Cádiz;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
11 Cádiz;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
11 Cádiz;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
11 Cádiz;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;85,94
11 Cádiz;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
11 Cádiz;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
11 Cádiz;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
11 Cádiz;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
11 Cádiz;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
11 Cádiz;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
11 Cádiz;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QIII;7.139
11 Cádiz;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
11 Cádiz;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
11 Cádiz;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
11 Cádiz;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QIII;7.270
11 Cádiz;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
11 Cádiz;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
11 Cádiz;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
11 Cádiz;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QIII;7.220
11 Cádiz;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
11 Cádiz;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
11 Cádiz;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
11 Cádiz;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2022QIII;6.807
11 Cádiz;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2022QII;""
11 Cádiz;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2022QI;""
11 Cádiz;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
11 Cádiz;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2021QIII;6.925
11 Cádiz;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2021QII;""
11 Cádiz;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2021QI;""
11 Cádiz;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
11 Cádiz;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2020QIII;6.897
11 Cádiz;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2020QII;""
11 Cádiz;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2020QI;""
11 Cádiz;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2022QIV;6.506
11 Cádiz;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
11 Cádiz;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2022QII;""
11 Cádiz;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2022QI;""
11 Cádiz;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2021QIV;6.618
11 Cádiz;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
11 Cádiz;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2021QII;""
11 Cádiz;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2021QI;""
11 Cádiz;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2020QIV;6.630
11 Cádiz;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
11 Cádiz;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2020QII;""
11 Cádiz;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2020QI;""
11 Cádiz;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
11 Cádiz;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
11 Cádiz;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QII;""
11 Cádiz;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QI;6.385
11 Cádiz;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
11 Cádiz;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
11 Cádiz;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QII;""
11 Cádiz;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QI;6.452
11 Cádiz;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
11 Cádiz;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
11 Cádiz;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QII;""
11 Cádiz;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QI;""
11 Cádiz;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
11 Cádiz;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
11 Cádiz;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QII;6.174
11 Cádiz;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QI;""
11 Cádiz;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
11 Cádiz;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
11 Cádiz;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QII;6.285
11 Cádiz;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QI;""
11 Cádiz;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
11 Cádiz;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
11 Cádiz;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QII;""
11 Cádiz;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QI;""
11 Cádiz;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
11 Cádiz;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
11 Cádiz;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
11 Cádiz;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
11 Cádiz;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
11 Cádiz;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
11 Cádiz;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
11 Cádiz;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
11 Cádiz;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
11 Cádiz;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
11 Cádiz;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
11 Cádiz;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
11 Cádiz;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
11 Cádiz;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;95,35
11 Cádiz;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
11 Cádiz;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
11 Cádiz;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
11 Cádiz;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;95,25
11 Cádiz;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
11 Cádiz;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
11 Cádiz;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
11 Cádiz;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;95,53
11 Cádiz;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
11 Cádiz;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
11 Cádiz;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;91,13
11 Cádiz;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
11 Cádiz;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
11 Cádiz;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
11 Cádiz;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;91,03
11 Cádiz;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
11 Cádiz;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
11 Cádiz;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
11 Cádiz;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;91,83
11 Cádiz;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
11 Cádiz;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
11 Cádiz;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
11 Cádiz;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
11 Cádiz;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
11 Cádiz;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
11 Cádiz;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;87,83
11 Cádiz;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
11 Cádiz;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
11 Cádiz;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
11 Cádiz;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;89,36
11 Cádiz;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
11 Cádiz;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
11 Cádiz;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
11 Cádiz;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
11 Cádiz;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
11 Cádiz;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
11 Cádiz;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;84,92
11 Cádiz;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
11 Cádiz;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
11 Cádiz;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
11 Cádiz;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;87,05
11 Cádiz;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
11 Cádiz;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
11 Cádiz;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
11 Cádiz;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
11 Cádiz;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
11 Cádiz;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
11 Cádiz;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QIII;5.176
11 Cádiz;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
11 Cádiz;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
11 Cádiz;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
11 Cádiz;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QIII;5.154
11 Cádiz;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
11 Cádiz;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
11 Cádiz;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
11 Cádiz;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QIII;5.073
11 Cádiz;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
11 Cádiz;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
11 Cádiz;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
11 Cádiz;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2022QIII;4.887
11 Cádiz;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2022QII;""
11 Cádiz;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2022QI;""
11 Cádiz;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
11 Cádiz;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2021QIII;4.928
11 Cádiz;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2021QII;""
11 Cádiz;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2021QI;""
11 Cádiz;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
11 Cádiz;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2020QIII;4.795
11 Cádiz;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2020QII;""
11 Cádiz;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2020QI;""
11 Cádiz;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2022QIV;4.610
11 Cádiz;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
11 Cádiz;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2022QII;""
11 Cádiz;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2022QI;""
11 Cádiz;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2021QIV;4.678
11 Cádiz;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
11 Cádiz;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2021QII;""
11 Cádiz;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2021QI;""
11 Cádiz;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2020QIV;4.573
11 Cádiz;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
11 Cádiz;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2020QII;""
11 Cádiz;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2020QI;""
11 Cádiz;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
11 Cádiz;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
11 Cádiz;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QII;""
11 Cádiz;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QI;4.462
11 Cádiz;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
11 Cádiz;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
11 Cádiz;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QII;""
11 Cádiz;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QI;4.427
11 Cádiz;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
11 Cádiz;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
11 Cádiz;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QII;""
11 Cádiz;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QI;""
11 Cádiz;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
11 Cádiz;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
11 Cádiz;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QII;4.248
11 Cádiz;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QI;""
11 Cádiz;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
11 Cádiz;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
11 Cádiz;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QII;4.280
11 Cádiz;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QI;""
11 Cádiz;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
11 Cádiz;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
11 Cádiz;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QII;""
11 Cádiz;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QI;""
11 Cádiz;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
11 Cádiz;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
11 Cádiz;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
11 Cádiz;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
11 Cádiz;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
11 Cádiz;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
11 Cádiz;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
11 Cádiz;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
11 Cádiz;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
11 Cádiz;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
11 Cádiz;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
11 Cádiz;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
11 Cádiz;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
11 Cádiz;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;94,42
11 Cádiz;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
11 Cádiz;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
11 Cádiz;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
11 Cádiz;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;95,62
11 Cádiz;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
11 Cádiz;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
11 Cádiz;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
11 Cádiz;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;94,52
11 Cádiz;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
11 Cádiz;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
11 Cádiz;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;89,06
11 Cádiz;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
11 Cádiz;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
11 Cádiz;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
11 Cádiz;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;90,76
11 Cádiz;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
11 Cádiz;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
11 Cádiz;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
11 Cádiz;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;90,14
11 Cádiz;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
11 Cádiz;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
11 Cádiz;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
11 Cádiz;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
11 Cádiz;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
11 Cádiz;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
11 Cádiz;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;86,57
11 Cádiz;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
11 Cádiz;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
11 Cádiz;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
11 Cádiz;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;87,27
11 Cádiz;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
11 Cádiz;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
11 Cádiz;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
11 Cádiz;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
11 Cádiz;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
11 Cádiz;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
11 Cádiz;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;82,42
11 Cádiz;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
11 Cádiz;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
11 Cádiz;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
11 Cádiz;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;84,37
11 Cádiz;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
11 Cádiz;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
11 Cádiz;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
11 Cádiz;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
11 Cádiz;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
11 Cádiz;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QIV;12.365
11 Cádiz;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
11 Cádiz;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
11 Cádiz;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
11 Cádiz;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QIV;12.546
11 Cádiz;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
11 Cádiz;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
11 Cádiz;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
11 Cádiz;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QIV;12.381
11 Cádiz;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
11 Cádiz;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
11 Cádiz;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
11 Cádiz;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2022QIV;11.711
11 Cádiz;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
11 Cádiz;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2022QII;""
11 Cádiz;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2022QI;""
11 Cádiz;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2021QIV;11.907
11 Cádiz;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
11 Cádiz;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2021QII;""
11 Cádiz;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2021QI;""
11 Cádiz;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2020QIV;11.817
11 Cádiz;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
11 Cádiz;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2020QII;""
11 Cádiz;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2020QI;""
11 Cádiz;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
11 Cádiz;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
11 Cádiz;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2022QII;""
11 Cádiz;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2022QI;11.404
11 Cádiz;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
11 Cádiz;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
11 Cádiz;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2021QII;""
11 Cádiz;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2021QI;11.450
11 Cádiz;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
11 Cádiz;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
11 Cádiz;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2020QII;""
11 Cádiz;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2020QI;""
11 Cádiz;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
11 Cádiz;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
11 Cádiz;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QII;10.932
11 Cádiz;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QI;""
11 Cádiz;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
11 Cádiz;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
11 Cádiz;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QII;11.093
11 Cádiz;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QI;""
11 Cádiz;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
11 Cádiz;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
11 Cádiz;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QII;""
11 Cádiz;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QI;""
11 Cádiz;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
11 Cádiz;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QIII;10.513
11 Cádiz;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QII;""
11 Cádiz;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QI;""
11 Cádiz;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
11 Cádiz;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QIII;10.740
11 Cádiz;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QII;""
11 Cádiz;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QI;""
11 Cádiz;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
11 Cádiz;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
11 Cádiz;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QII;""
11 Cádiz;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QI;""
11 Cádiz;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
11 Cádiz;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
11 Cádiz;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
11 Cádiz;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
11 Cádiz;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
11 Cádiz;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
11 Cádiz;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
11 Cádiz;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
11 Cádiz;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
11 Cádiz;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
11 Cádiz;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
11 Cádiz;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
11 Cádiz;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;94,71
11 Cádiz;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
11 Cádiz;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
11 Cádiz;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
11 Cádiz;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;94,91
11 Cádiz;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
11 Cádiz;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
11 Cádiz;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
11 Cádiz;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;95,44
11 Cádiz;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
11 Cádiz;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
11 Cádiz;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
11 Cádiz;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
11 Cádiz;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
11 Cádiz;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
11 Cádiz;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;90,9
11 Cádiz;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
11 Cádiz;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
11 Cádiz;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
11 Cádiz;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;92,48
11 Cádiz;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
11 Cádiz;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
11 Cádiz;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
11 Cádiz;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
11 Cádiz;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
11 Cádiz;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
11 Cádiz;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;87,14
11 Cádiz;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
11 Cádiz;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
11 Cádiz;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
11 Cádiz;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;89,6
11 Cádiz;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
11 Cádiz;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
11 Cádiz;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
11 Cádiz;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
11 Cádiz;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
11 Cádiz;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
11 Cádiz;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;83,8
11 Cádiz;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
11 Cádiz;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
11 Cádiz;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
11 Cádiz;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;86,75
11 Cádiz;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
11 Cádiz;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
11 Cádiz;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
11 Cádiz;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
11 Cádiz;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
11 Cádiz;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
11 Cádiz;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QIV;7.161
11 Cádiz;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
11 Cádiz;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
11 Cádiz;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
11 Cádiz;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QIV;7.310
11 Cádiz;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
11 Cádiz;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
11 Cádiz;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
11 Cádiz;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QIV;7.294
11 Cádiz;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
11 Cádiz;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
11 Cádiz;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
11 Cádiz;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2022QIV;6.814
11 Cádiz;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
11 Cádiz;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2022QII;""
11 Cádiz;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2022QI;""
11 Cádiz;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2021QIV;6.954
11 Cádiz;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
11 Cádiz;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2021QII;""
11 Cádiz;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2021QI;""
11 Cádiz;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2020QIV;6.984
11 Cádiz;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
11 Cádiz;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2020QII;""
11 Cádiz;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2020QI;""
11 Cádiz;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
11 Cádiz;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
11 Cádiz;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2022QII;""
11 Cádiz;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2022QI;6.690
11 Cádiz;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
11 Cádiz;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
11 Cádiz;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2021QII;""
11 Cádiz;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2021QI;6.779
11 Cádiz;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
11 Cádiz;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
11 Cádiz;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2020QII;""
11 Cádiz;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2020QI;""
11 Cádiz;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
11 Cádiz;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
11 Cádiz;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QII;6.451
11 Cádiz;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QI;""
11 Cádiz;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
11 Cádiz;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
11 Cádiz;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QII;6.586
11 Cádiz;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QI;""
11 Cádiz;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
11 Cádiz;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
11 Cádiz;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QII;""
11 Cádiz;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QI;""
11 Cádiz;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
11 Cádiz;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QIII;6.232
11 Cádiz;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QII;""
11 Cádiz;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QI;""
11 Cádiz;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
11 Cádiz;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QIII;6.372
11 Cádiz;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QII;""
11 Cádiz;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QI;""
11 Cádiz;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
11 Cádiz;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
11 Cádiz;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QII;""
11 Cádiz;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QI;""
11 Cádiz;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
11 Cádiz;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
11 Cádiz;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
11 Cádiz;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
11 Cádiz;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
11 Cádiz;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
11 Cádiz;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
11 Cádiz;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
11 Cádiz;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
11 Cádiz;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
11 Cádiz;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
11 Cádiz;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
11 Cádiz;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;95,15
11 Cádiz;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
11 Cádiz;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
11 Cádiz;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
11 Cádiz;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;95,13
11 Cádiz;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
11 Cádiz;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
11 Cádiz;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
11 Cádiz;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;95,75
11 Cádiz;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
11 Cádiz;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
11 Cádiz;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
11 Cádiz;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
11 Cádiz;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
11 Cádiz;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
11 Cádiz;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;91,52
11 Cádiz;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
11 Cádiz;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
11 Cádiz;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
11 Cádiz;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;92,94
11 Cádiz;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
11 Cádiz;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
11 Cádiz;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
11 Cádiz;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
11 Cádiz;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
11 Cádiz;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
11 Cádiz;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;88,25
11 Cádiz;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
11 Cádiz;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
11 Cádiz;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
11 Cádiz;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;90,29
11 Cádiz;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
11 Cádiz;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
11 Cádiz;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
11 Cádiz;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
11 Cádiz;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
11 Cádiz;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
11 Cádiz;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;85,25
11 Cádiz;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
11 Cádiz;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
11 Cádiz;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
11 Cádiz;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;87,36
11 Cádiz;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
11 Cádiz;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
11 Cádiz;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
11 Cádiz;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
11 Cádiz;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
11 Cádiz;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
11 Cádiz;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QIV;5.204
11 Cádiz;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
11 Cádiz;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
11 Cádiz;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
11 Cádiz;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QIV;5.236
11 Cádiz;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
11 Cádiz;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
11 Cádiz;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
11 Cádiz;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QIV;5.087
11 Cádiz;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
11 Cádiz;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
11 Cádiz;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
11 Cádiz;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2022QIV;4.897
11 Cádiz;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
11 Cádiz;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2022QII;""
11 Cádiz;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2022QI;""
11 Cádiz;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2021QIV;4.953
11 Cádiz;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
11 Cádiz;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2021QII;""
11 Cádiz;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2021QI;""
11 Cádiz;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2020QIV;4.833
11 Cádiz;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
11 Cádiz;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2020QII;""
11 Cádiz;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2020QI;""
11 Cádiz;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
11 Cádiz;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
11 Cádiz;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2022QII;""
11 Cádiz;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2022QI;4.714
11 Cádiz;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
11 Cádiz;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
11 Cádiz;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2021QII;""
11 Cádiz;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2021QI;4.671
11 Cádiz;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
11 Cádiz;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
11 Cádiz;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2020QII;""
11 Cádiz;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2020QI;""
11 Cádiz;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
11 Cádiz;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
11 Cádiz;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QII;4.481
11 Cádiz;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QI;""
11 Cádiz;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
11 Cádiz;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
11 Cádiz;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QII;4.507
11 Cádiz;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QI;""
11 Cádiz;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
11 Cádiz;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
11 Cádiz;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QII;""
11 Cádiz;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QI;""
11 Cádiz;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
11 Cádiz;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QIII;4.281
11 Cádiz;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QII;""
11 Cádiz;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QI;""
11 Cádiz;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
11 Cádiz;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QIII;4.368
11 Cádiz;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QII;""
11 Cádiz;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QI;""
11 Cádiz;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
11 Cádiz;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
11 Cádiz;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QII;""
11 Cádiz;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QI;""
11 Cádiz;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
11 Cádiz;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
11 Cádiz;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
11 Cádiz;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
11 Cádiz;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
11 Cádiz;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
11 Cádiz;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
11 Cádiz;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
11 Cádiz;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
11 Cádiz;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
11 Cádiz;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
11 Cádiz;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
11 Cádiz;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;94,1
11 Cádiz;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
11 Cádiz;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
11 Cádiz;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
11 Cádiz;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;94,6
11 Cádiz;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
11 Cádiz;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
11 Cádiz;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
11 Cádiz;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;95,01
11 Cádiz;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
11 Cádiz;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
11 Cádiz;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
11 Cádiz;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
11 Cádiz;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
11 Cádiz;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
11 Cádiz;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;90,03
11 Cádiz;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
11 Cádiz;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
11 Cádiz;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
11 Cádiz;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;91,82
11 Cádiz;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
11 Cádiz;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
11 Cádiz;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
11 Cádiz;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
11 Cádiz;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
11 Cádiz;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
11 Cádiz;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;85,58
11 Cádiz;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
11 Cádiz;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
11 Cádiz;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
11 Cádiz;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;88,6
11 Cádiz;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
11 Cádiz;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
11 Cádiz;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
11 Cádiz;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
11 Cádiz;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
11 Cádiz;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
11 Cádiz;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;81,76
11 Cádiz;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
11 Cádiz;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
11 Cádiz;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
11 Cádiz;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;85,87
11 Cádiz;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
11 Cádiz;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
11 Cádiz;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
11 Cádiz;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
11 Cádiz;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
11 Cádiz;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
11 Cádiz;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
11 Cádiz;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
11 Cádiz;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
11 Cádiz;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QI;19.372
11 Cádiz;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
11 Cádiz;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
11 Cádiz;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
11 Cádiz;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QI;19.077
11 Cádiz;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
11 Cádiz;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
11 Cádiz;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
11 Cádiz;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QI;18.991
11 Cádiz;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
11 Cádiz;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
11 Cádiz;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2022QII;""
11 Cádiz;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2022QI;18.737
11 Cádiz;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
11 Cádiz;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
11 Cádiz;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2021QII;""
11 Cádiz;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2021QI;18.639
11 Cádiz;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
11 Cádiz;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
11 Cádiz;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2020QII;""
11 Cádiz;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2020QI;17.606
11 Cádiz;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
11 Cádiz;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
11 Cádiz;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2022QII;18.138
11 Cádiz;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2022QI;""
11 Cádiz;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
11 Cádiz;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
11 Cádiz;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2021QII;18.157
11 Cádiz;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2021QI;""
11 Cádiz;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
11 Cádiz;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
11 Cádiz;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2020QII;17.263
11 Cádiz;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2020QI;""
11 Cádiz;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
11 Cádiz;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QIII;17.654
11 Cádiz;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QII;""
11 Cádiz;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QI;""
11 Cádiz;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
11 Cádiz;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QIII;17.745
11 Cádiz;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QII;""
11 Cádiz;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QI;""
11 Cádiz;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
11 Cádiz;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QIII;16.850
11 Cádiz;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QII;""
11 Cádiz;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QI;""
11 Cádiz;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QIV;17.159
11 Cádiz;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
11 Cádiz;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QII;""
11 Cádiz;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QI;""
11 Cádiz;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QIV;17.303
11 Cádiz;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
11 Cádiz;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QII;""
11 Cádiz;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QI;""
11 Cádiz;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QIV;16.427
11 Cádiz;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
11 Cádiz;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QII;""
11 Cádiz;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QI;""
11 Cádiz;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
11 Cádiz;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
11 Cádiz;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
11 Cádiz;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
11 Cádiz;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
11 Cádiz;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
11 Cádiz;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
11 Cádiz;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
11 Cádiz;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
11 Cádiz;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
11 Cádiz;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
11 Cádiz;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
11 Cádiz;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
11 Cádiz;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
11 Cádiz;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
11 Cádiz;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;96,72
11 Cádiz;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
11 Cádiz;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
11 Cádiz;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
11 Cádiz;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;97,7
11 Cádiz;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
11 Cádiz;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
11 Cádiz;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
11 Cádiz;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;92,71
11 Cádiz;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
11 Cádiz;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
11 Cádiz;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;93,63
11 Cádiz;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
11 Cádiz;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
11 Cádiz;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
11 Cádiz;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;95,18
11 Cádiz;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
11 Cádiz;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
11 Cádiz;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
11 Cádiz;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;90,9
11 Cádiz;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
11 Cádiz;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
11 Cádiz;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;91,13
11 Cádiz;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
11 Cádiz;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
11 Cádiz;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
11 Cádiz;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;93,02
11 Cádiz;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
11 Cádiz;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
11 Cádiz;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
11 Cádiz;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;88,73
11 Cádiz;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
11 Cádiz;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
11 Cádiz;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;88,58
11 Cádiz;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
11 Cádiz;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
11 Cádiz;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
11 Cádiz;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;90,7
11 Cádiz;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
11 Cádiz;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
11 Cádiz;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
11 Cádiz;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;86,5
11 Cádiz;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
11 Cádiz;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
11 Cádiz;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
11 Cádiz;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
11 Cádiz;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
11 Cádiz;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
11 Cádiz;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QI;12.343
11 Cádiz;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
11 Cádiz;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
11 Cádiz;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
11 Cádiz;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QI;12.251
11 Cádiz;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
11 Cádiz;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
11 Cádiz;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
11 Cádiz;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QI;12.153
11 Cádiz;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
11 Cádiz;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
11 Cádiz;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2022QII;""
11 Cádiz;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2022QI;11.972
11 Cádiz;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
11 Cádiz;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
11 Cádiz;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2021QII;""
11 Cádiz;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2021QI;12.016
11 Cádiz;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
11 Cádiz;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
11 Cádiz;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2020QII;""
11 Cádiz;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2020QI;11.345
11 Cádiz;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
11 Cádiz;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
11 Cádiz;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2022QII;11.643
11 Cádiz;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2022QI;""
11 Cádiz;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
11 Cádiz;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
11 Cádiz;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2021QII;11.767
11 Cádiz;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2021QI;""
11 Cádiz;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
11 Cádiz;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
11 Cádiz;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2020QII;11.157
11 Cádiz;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2020QI;""
11 Cádiz;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
11 Cádiz;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QIII;11.364
11 Cádiz;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QII;""
11 Cádiz;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QI;""
11 Cádiz;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
11 Cádiz;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QIII;11.525
11 Cádiz;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QII;""
11 Cádiz;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QI;""
11 Cádiz;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
11 Cádiz;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QIII;10.932
11 Cádiz;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QII;""
11 Cádiz;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QI;""
11 Cádiz;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QIV;11.090
11 Cádiz;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
11 Cádiz;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QII;""
11 Cádiz;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QI;""
11 Cádiz;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QIV;11.262
11 Cádiz;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
11 Cádiz;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QII;""
11 Cádiz;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QI;""
11 Cádiz;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QIV;10.682
11 Cádiz;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
11 Cádiz;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QII;""
11 Cádiz;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QI;""
11 Cádiz;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
11 Cádiz;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
11 Cádiz;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
11 Cádiz;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
11 Cádiz;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
11 Cádiz;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
11 Cádiz;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
11 Cádiz;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
11 Cádiz;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
11 Cádiz;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
11 Cádiz;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
11 Cádiz;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
11 Cádiz;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
11 Cádiz;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
11 Cádiz;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
11 Cádiz;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;96,99
11 Cádiz;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
11 Cádiz;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
11 Cádiz;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
11 Cádiz;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;98,08
11 Cádiz;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
11 Cádiz;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
11 Cádiz;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
11 Cádiz;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;93,35
11 Cádiz;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
11 Cádiz;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
11 Cádiz;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;94,33
11 Cádiz;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
11 Cádiz;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
11 Cádiz;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
11 Cádiz;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;96,05
11 Cádiz;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
11 Cádiz;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
11 Cádiz;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
11 Cádiz;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;91,8
11 Cádiz;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
11 Cádiz;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
11 Cádiz;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;92,07
11 Cádiz;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
11 Cádiz;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
11 Cádiz;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
11 Cádiz;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;94,07
11 Cádiz;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
11 Cádiz;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
11 Cádiz;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
11 Cádiz;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;89,95
11 Cádiz;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
11 Cádiz;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
11 Cádiz;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;89,85
11 Cádiz;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
11 Cádiz;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
11 Cádiz;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
11 Cádiz;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;91,93
11 Cádiz;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
11 Cádiz;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
11 Cádiz;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
11 Cádiz;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;87,9
11 Cádiz;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
11 Cádiz;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
11 Cádiz;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
11 Cádiz;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
11 Cádiz;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
11 Cádiz;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
11 Cádiz;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QI;7.029
11 Cádiz;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
11 Cádiz;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
11 Cádiz;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
11 Cádiz;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QI;6.826
11 Cádiz;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
11 Cádiz;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
11 Cádiz;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
11 Cádiz;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QI;6.838
11 Cádiz;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
11 Cádiz;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
11 Cádiz;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2022QII;""
11 Cádiz;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2022QI;6.765
11 Cádiz;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
11 Cádiz;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
11 Cádiz;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2021QII;""
11 Cádiz;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2021QI;6.623
11 Cádiz;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
11 Cádiz;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
11 Cádiz;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2020QII;""
11 Cádiz;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2020QI;6.261
11 Cádiz;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
11 Cádiz;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
11 Cádiz;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2022QII;6.495
11 Cádiz;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2022QI;""
11 Cádiz;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
11 Cádiz;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
11 Cádiz;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2021QII;6.390
11 Cádiz;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2021QI;""
11 Cádiz;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
11 Cádiz;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
11 Cádiz;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2020QII;6.106
11 Cádiz;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2020QI;""
11 Cádiz;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
11 Cádiz;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QIII;6.290
11 Cádiz;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QII;""
11 Cádiz;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QI;""
11 Cádiz;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
11 Cádiz;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QIII;6.220
11 Cádiz;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QII;""
11 Cádiz;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QI;""
11 Cádiz;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
11 Cádiz;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QIII;5.918
11 Cádiz;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QII;""
11 Cádiz;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QI;""
11 Cádiz;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QIV;6.069
11 Cádiz;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
11 Cádiz;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QII;""
11 Cádiz;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QI;""
11 Cádiz;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QIV;6.041
11 Cádiz;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
11 Cádiz;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QII;""
11 Cádiz;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QI;""
11 Cádiz;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QIV;5.745
11 Cádiz;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
11 Cádiz;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QII;""
11 Cádiz;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QI;""
11 Cádiz;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
11 Cádiz;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
11 Cádiz;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
11 Cádiz;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
11 Cádiz;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
11 Cádiz;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
11 Cádiz;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
11 Cádiz;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
11 Cádiz;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
11 Cádiz;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
11 Cádiz;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
11 Cádiz;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
11 Cádiz;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
11 Cádiz;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
11 Cádiz;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
11 Cádiz;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;96,24
11 Cádiz;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
11 Cádiz;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
11 Cádiz;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
11 Cádiz;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;97,03
11 Cádiz;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
11 Cádiz;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
11 Cádiz;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
11 Cádiz;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;91,56
11 Cádiz;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
11 Cádiz;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
11 Cádiz;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;92,4
11 Cádiz;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
11 Cádiz;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
11 Cádiz;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
11 Cádiz;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;93,61
11 Cádiz;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
11 Cádiz;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
11 Cádiz;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
11 Cádiz;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;89,3
11 Cádiz;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
11 Cádiz;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
11 Cádiz;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;89,49
11 Cádiz;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
11 Cádiz;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
11 Cádiz;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
11 Cádiz;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;91,12
11 Cádiz;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
11 Cádiz;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
11 Cádiz;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
11 Cádiz;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;86,55
11 Cádiz;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
11 Cádiz;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
11 Cádiz;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;86,34
11 Cádiz;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
11 Cádiz;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
11 Cádiz;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
11 Cádiz;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;88,5
11 Cádiz;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
11 Cádiz;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
11 Cádiz;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
11 Cádiz;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;84,02
11 Cádiz;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
11 Cádiz;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
11 Cádiz;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
11 Cádiz;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
11 Cádiz;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
11 Cádiz;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QII;19.288
11 Cádiz;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
11 Cádiz;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
11 Cádiz;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
11 Cádiz;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QII;19.051
11 Cádiz;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
11 Cádiz;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
11 Cádiz;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
11 Cádiz;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QII;18.512
11 Cádiz;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
11 Cádiz;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
11 Cádiz;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
11 Cádiz;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2022QII;18.605
11 Cádiz;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2022QI;""
11 Cádiz;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
11 Cádiz;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
11 Cádiz;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2021QII;18.496
11 Cádiz;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2021QI;""
11 Cádiz;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
11 Cádiz;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
11 Cádiz;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2020QII;18.128
11 Cádiz;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2020QI;""
11 Cádiz;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
11 Cádiz;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2022QIII;18.043
11 Cádiz;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2022QII;""
11 Cádiz;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2022QI;""
11 Cádiz;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
11 Cádiz;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2021QIII;17.995
11 Cádiz;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2021QII;""
11 Cádiz;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2021QI;""
11 Cádiz;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
11 Cádiz;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2020QIII;17.649
11 Cádiz;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2020QII;""
11 Cádiz;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2020QI;""
11 Cádiz;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QIV;17.444
11 Cádiz;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
11 Cádiz;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QII;""
11 Cádiz;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QI;""
11 Cádiz;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QIV;17.454
11 Cádiz;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
11 Cádiz;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QII;""
11 Cádiz;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QI;""
11 Cádiz;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QIV;17.164
11 Cádiz;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
11 Cádiz;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QII;""
11 Cádiz;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QI;""
11 Cádiz;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
11 Cádiz;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
11 Cádiz;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QII;""
11 Cádiz;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QI;17.002
11 Cádiz;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
11 Cádiz;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
11 Cádiz;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QII;""
11 Cádiz;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QI;16.870
11 Cádiz;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
11 Cádiz;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
11 Cádiz;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QII;""
11 Cádiz;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QI;""
11 Cádiz;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
11 Cádiz;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
11 Cádiz;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
11 Cádiz;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
11 Cádiz;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
11 Cádiz;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
11 Cádiz;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
11 Cádiz;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
11 Cádiz;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
11 Cádiz;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
11 Cádiz;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
11 Cádiz;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
11 Cádiz;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
11 Cádiz;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
11 Cádiz;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;96,46
11 Cádiz;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
11 Cádiz;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
11 Cádiz;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
11 Cádiz;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;97,09
11 Cádiz;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
11 Cádiz;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
11 Cádiz;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
11 Cádiz;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;97,93
11 Cádiz;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
11 Cádiz;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
11 Cádiz;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;93,55
11 Cádiz;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
11 Cádiz;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
11 Cádiz;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
11 Cádiz;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;94,46
11 Cádiz;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
11 Cádiz;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
11 Cádiz;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
11 Cádiz;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;95,34
11 Cádiz;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
11 Cádiz;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
11 Cádiz;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;90,44
11 Cádiz;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
11 Cádiz;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
11 Cádiz;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
11 Cádiz;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;91,62
11 Cádiz;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
11 Cádiz;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
11 Cádiz;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
11 Cádiz;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;92,72
11 Cádiz;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
11 Cádiz;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
11 Cádiz;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
11 Cádiz;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
11 Cádiz;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
11 Cádiz;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
11 Cádiz;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;89,24
11 Cádiz;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
11 Cádiz;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
11 Cádiz;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
11 Cádiz;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;91,13
11 Cádiz;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
11 Cádiz;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
11 Cádiz;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
11 Cádiz;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
11 Cádiz;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
11 Cádiz;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
11 Cádiz;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QII;12.224
11 Cádiz;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
11 Cádiz;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
11 Cádiz;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
11 Cádiz;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QII;12.173
11 Cádiz;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
11 Cádiz;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
11 Cádiz;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
11 Cádiz;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QII;11.870
11 Cádiz;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
11 Cádiz;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
11 Cádiz;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
11 Cádiz;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2022QII;11.843
11 Cádiz;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2022QI;""
11 Cádiz;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
11 Cádiz;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
11 Cádiz;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2021QII;11.878
11 Cádiz;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2021QI;""
11 Cádiz;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
11 Cádiz;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
11 Cádiz;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2020QII;11.656
11 Cádiz;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2020QI;""
11 Cádiz;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
11 Cádiz;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2022QIII;11.512
11 Cádiz;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2022QII;""
11 Cádiz;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2022QI;""
11 Cádiz;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
11 Cádiz;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2021QIII;11.588
11 Cádiz;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2021QII;""
11 Cádiz;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2021QI;""
11 Cádiz;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
11 Cádiz;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2020QIII;11.398
11 Cádiz;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2020QII;""
11 Cádiz;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2020QI;""
11 Cádiz;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QIV;11.179
11 Cádiz;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
11 Cádiz;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QII;""
11 Cádiz;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QI;""
11 Cádiz;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QIV;11.273
11 Cádiz;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
11 Cádiz;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QII;""
11 Cádiz;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QI;""
11 Cádiz;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QIV;11.116
11 Cádiz;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
11 Cádiz;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QII;""
11 Cádiz;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QI;""
11 Cádiz;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
11 Cádiz;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
11 Cádiz;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QII;""
11 Cádiz;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QI;11.017
11 Cádiz;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
11 Cádiz;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
11 Cádiz;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QII;""
11 Cádiz;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QI;10.964
11 Cádiz;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
11 Cádiz;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
11 Cádiz;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QII;""
11 Cádiz;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QI;""
11 Cádiz;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
11 Cádiz;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
11 Cádiz;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
11 Cádiz;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
11 Cádiz;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
11 Cádiz;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
11 Cádiz;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
11 Cádiz;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
11 Cádiz;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
11 Cádiz;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
11 Cádiz;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
11 Cádiz;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
11 Cádiz;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
11 Cádiz;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
11 Cádiz;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;96,88
11 Cádiz;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
11 Cádiz;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
11 Cádiz;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
11 Cádiz;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;97,58
11 Cádiz;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
11 Cádiz;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
11 Cádiz;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
11 Cádiz;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;98,2
11 Cádiz;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
11 Cádiz;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
11 Cádiz;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;94,18
11 Cádiz;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
11 Cádiz;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
11 Cádiz;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
11 Cádiz;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;95,19
11 Cádiz;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
11 Cádiz;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
11 Cádiz;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
11 Cádiz;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;96,02
11 Cádiz;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
11 Cádiz;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
11 Cádiz;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;91,45
11 Cádiz;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
11 Cádiz;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
11 Cádiz;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
11 Cádiz;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;92,61
11 Cádiz;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
11 Cádiz;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
11 Cádiz;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
11 Cádiz;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;93,65
11 Cádiz;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
11 Cádiz;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
11 Cádiz;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
11 Cádiz;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
11 Cádiz;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
11 Cádiz;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
11 Cádiz;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;90,5
11 Cádiz;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
11 Cádiz;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
11 Cádiz;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
11 Cádiz;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;92,37
11 Cádiz;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
11 Cádiz;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
11 Cádiz;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
11 Cádiz;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
11 Cádiz;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
11 Cádiz;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
11 Cádiz;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QII;7.064
11 Cádiz;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
11 Cádiz;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
11 Cádiz;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
11 Cádiz;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QII;6.878
11 Cádiz;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
11 Cádiz;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
11 Cádiz;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
11 Cádiz;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QII;6.642
11 Cádiz;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
11 Cádiz;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
11 Cádiz;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
11 Cádiz;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2022QII;6.762
11 Cádiz;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2022QI;""
11 Cádiz;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
11 Cádiz;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
11 Cádiz;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2021QII;6.618
11 Cádiz;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2021QI;""
11 Cádiz;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
11 Cádiz;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
11 Cádiz;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2020QII;6.472
11 Cádiz;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2020QI;""
11 Cádiz;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
11 Cádiz;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2022QIII;6.531
11 Cádiz;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2022QII;""
11 Cádiz;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2022QI;""
11 Cádiz;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
11 Cádiz;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2021QIII;6.407
11 Cádiz;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2021QII;""
11 Cádiz;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2021QI;""
11 Cádiz;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
11 Cádiz;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2020QIII;6.251
11 Cádiz;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2020QII;""
11 Cádiz;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2020QI;""
11 Cádiz;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QIV;6.265
11 Cádiz;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
11 Cádiz;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QII;""
11 Cádiz;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QI;""
11 Cádiz;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QIV;6.181
11 Cádiz;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
11 Cádiz;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QII;""
11 Cádiz;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QI;""
11 Cádiz;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QIV;6.048
11 Cádiz;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
11 Cádiz;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QII;""
11 Cádiz;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QI;""
11 Cádiz;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
11 Cádiz;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
11 Cádiz;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QII;""
11 Cádiz;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QI;5.985
11 Cádiz;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
11 Cádiz;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
11 Cádiz;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QII;""
11 Cádiz;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QI;5.906
11 Cádiz;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
11 Cádiz;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
11 Cádiz;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QII;""
11 Cádiz;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QI;""
11 Cádiz;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
11 Cádiz;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
11 Cádiz;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
11 Cádiz;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
11 Cádiz;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
11 Cádiz;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
11 Cádiz;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
11 Cádiz;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
11 Cádiz;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
11 Cádiz;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
11 Cádiz;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
11 Cádiz;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
11 Cádiz;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
11 Cádiz;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
11 Cádiz;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;95,72
11 Cádiz;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
11 Cádiz;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
11 Cádiz;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
11 Cádiz;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;96,22
11 Cádiz;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
11 Cádiz;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
11 Cádiz;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
11 Cádiz;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;97,44
11 Cádiz;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
11 Cádiz;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
11 Cádiz;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;92,45
11 Cádiz;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
11 Cádiz;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
11 Cádiz;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
11 Cádiz;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;93,15
11 Cádiz;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
11 Cádiz;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
11 Cádiz;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
11 Cádiz;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;94,11
11 Cádiz;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
11 Cádiz;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
11 Cádiz;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;88,69
11 Cádiz;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
11 Cádiz;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
11 Cádiz;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
11 Cádiz;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;89,87
11 Cádiz;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
11 Cádiz;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
11 Cádiz;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
11 Cádiz;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;91,06
11 Cádiz;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
11 Cádiz;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
11 Cádiz;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
11 Cádiz;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
11 Cádiz;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
11 Cádiz;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
11 Cádiz;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;87,02
11 Cádiz;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
11 Cádiz;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
11 Cádiz;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
11 Cádiz;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;88,92
11 Cádiz;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
11 Cádiz;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
11 Cádiz;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
11 Cádiz;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
11 Cádiz;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
11 Cádiz;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QIII;19.571
11 Cádiz;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
11 Cádiz;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
11 Cádiz;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
11 Cádiz;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QIII;19.531
11 Cádiz;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
11 Cádiz;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
11 Cádiz;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
11 Cádiz;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QIII;19.042
11 Cádiz;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
11 Cádiz;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
11 Cádiz;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
11 Cádiz;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2022QIII;18.794
11 Cádiz;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2022QII;""
11 Cádiz;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2022QI;""
11 Cádiz;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
11 Cádiz;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2021QIII;18.829
11 Cádiz;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2021QII;""
11 Cádiz;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2021QI;""
11 Cádiz;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
11 Cádiz;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2020QIII;18.384
11 Cádiz;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2020QII;""
11 Cádiz;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2020QI;""
11 Cádiz;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2022QIV;18.064
11 Cádiz;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
11 Cádiz;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2022QII;""
11 Cádiz;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2022QI;""
11 Cádiz;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2021QIV;18.144
11 Cádiz;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
11 Cádiz;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2021QII;""
11 Cádiz;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2021QI;""
11 Cádiz;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2020QIV;17.795
11 Cádiz;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
11 Cádiz;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2020QII;""
11 Cádiz;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2020QI;""
11 Cádiz;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
11 Cádiz;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
11 Cádiz;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QII;""
11 Cádiz;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QI;17.639
11 Cádiz;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
11 Cádiz;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
11 Cádiz;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QII;""
11 Cádiz;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QI;17.466
11 Cádiz;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
11 Cádiz;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
11 Cádiz;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QII;""
11 Cádiz;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QI;""
11 Cádiz;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
11 Cádiz;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
11 Cádiz;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QII;17.154
11 Cádiz;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QI;""
11 Cádiz;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
11 Cádiz;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
11 Cádiz;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QII;17.096
11 Cádiz;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QI;""
11 Cádiz;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
11 Cádiz;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
11 Cádiz;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QII;""
11 Cádiz;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QI;""
11 Cádiz;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
11 Cádiz;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
11 Cádiz;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
11 Cádiz;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
11 Cádiz;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
11 Cádiz;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
11 Cádiz;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
11 Cádiz;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
11 Cádiz;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
11 Cádiz;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
11 Cádiz;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
11 Cádiz;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
11 Cádiz;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
11 Cádiz;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;96,03
11 Cádiz;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
11 Cádiz;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
11 Cádiz;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
11 Cádiz;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;96,41
11 Cádiz;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
11 Cádiz;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
11 Cádiz;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
11 Cádiz;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;96,54
11 Cádiz;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
11 Cádiz;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
11 Cádiz;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;92,3
11 Cádiz;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
11 Cádiz;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
11 Cádiz;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
11 Cádiz;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;92,9
11 Cádiz;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
11 Cádiz;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
11 Cádiz;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
11 Cádiz;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;93,45
11 Cádiz;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
11 Cádiz;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
11 Cádiz;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
11 Cádiz;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
11 Cádiz;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
11 Cádiz;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
11 Cádiz;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;90,31
11 Cádiz;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
11 Cádiz;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
11 Cádiz;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
11 Cádiz;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;91,72
11 Cádiz;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
11 Cádiz;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
11 Cádiz;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
11 Cádiz;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
11 Cádiz;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
11 Cádiz;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
11 Cádiz;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;87,83
11 Cádiz;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
11 Cádiz;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
11 Cádiz;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
11 Cádiz;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;89,78
11 Cádiz;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
11 Cádiz;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
11 Cádiz;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
11 Cádiz;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
11 Cádiz;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
11 Cádiz;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
11 Cádiz;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QIII;12.362
11 Cádiz;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
11 Cádiz;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
11 Cádiz;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
11 Cádiz;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QIII;12.456
11 Cádiz;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
11 Cádiz;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
11 Cádiz;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
11 Cádiz;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QIII;12.218
11 Cádiz;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
11 Cádiz;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
11 Cádiz;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
11 Cádiz;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2022QIII;11.928
11 Cádiz;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2022QII;""
11 Cádiz;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2022QI;""
11 Cádiz;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
11 Cádiz;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2021QIII;12.055
11 Cádiz;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2021QII;""
11 Cádiz;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2021QI;""
11 Cádiz;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
11 Cádiz;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2020QIII;11.861
11 Cádiz;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2020QII;""
11 Cádiz;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2020QI;""
11 Cádiz;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2022QIV;11.529
11 Cádiz;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
11 Cádiz;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2022QII;""
11 Cádiz;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2022QI;""
11 Cádiz;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2021QIV;11.669
11 Cádiz;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
11 Cádiz;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2021QII;""
11 Cádiz;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2021QI;""
11 Cádiz;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2020QIV;11.518
11 Cádiz;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
11 Cádiz;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2020QII;""
11 Cádiz;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2020QI;""
11 Cádiz;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
11 Cádiz;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
11 Cádiz;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QII;""
11 Cádiz;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QI;11.383
11 Cádiz;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
11 Cádiz;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
11 Cádiz;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QII;""
11 Cádiz;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QI;11.343
11 Cádiz;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
11 Cádiz;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
11 Cádiz;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QII;""
11 Cádiz;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QI;""
11 Cádiz;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
11 Cádiz;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
11 Cádiz;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QII;11.113
11 Cádiz;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QI;""
11 Cádiz;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
11 Cádiz;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
11 Cádiz;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QII;11.145
11 Cádiz;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QI;""
11 Cádiz;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
11 Cádiz;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
11 Cádiz;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QII;""
11 Cádiz;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QI;""
11 Cádiz;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
11 Cádiz;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
11 Cádiz;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
11 Cádiz;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
11 Cádiz;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
11 Cádiz;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
11 Cádiz;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
11 Cádiz;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
11 Cádiz;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
11 Cádiz;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
11 Cádiz;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
11 Cádiz;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
11 Cádiz;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
11 Cádiz;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;96,49
11 Cádiz;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
11 Cádiz;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
11 Cádiz;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
11 Cádiz;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;96,78
11 Cádiz;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
11 Cádiz;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
11 Cádiz;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
11 Cádiz;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;97,08
11 Cádiz;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
11 Cádiz;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
11 Cádiz;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;93,26
11 Cádiz;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
11 Cádiz;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
11 Cádiz;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
11 Cádiz;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;93,68
11 Cádiz;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
11 Cádiz;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
11 Cádiz;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
11 Cádiz;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;94,27
11 Cádiz;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
11 Cádiz;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
11 Cádiz;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
11 Cádiz;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
11 Cádiz;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
11 Cádiz;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
11 Cádiz;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;91,39
11 Cádiz;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
11 Cádiz;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
11 Cádiz;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
11 Cádiz;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;92,84
11 Cádiz;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
11 Cádiz;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
11 Cádiz;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
11 Cádiz;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
11 Cádiz;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
11 Cádiz;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
11 Cádiz;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;89,22
11 Cádiz;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
11 Cádiz;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
11 Cádiz;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
11 Cádiz;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;91,22
11 Cádiz;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
11 Cádiz;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
11 Cádiz;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
11 Cádiz;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
11 Cádiz;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
11 Cádiz;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
11 Cádiz;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QIII;7.209
11 Cádiz;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
11 Cádiz;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
11 Cádiz;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
11 Cádiz;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QIII;7.075
11 Cádiz;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
11 Cádiz;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
11 Cádiz;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
11 Cádiz;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QIII;6.824
11 Cádiz;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
11 Cádiz;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
11 Cádiz;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
11 Cádiz;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2022QIII;6.866
11 Cádiz;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2022QII;""
11 Cádiz;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2022QI;""
11 Cádiz;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
11 Cádiz;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2021QIII;6.774
11 Cádiz;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2021QII;""
11 Cádiz;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2021QI;""
11 Cádiz;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
11 Cádiz;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2020QIII;6.523
11 Cádiz;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2020QII;""
11 Cádiz;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2020QI;""
11 Cádiz;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2022QIV;6.535
11 Cádiz;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
11 Cádiz;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2022QII;""
11 Cádiz;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2022QI;""
11 Cádiz;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2021QIV;6.475
11 Cádiz;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
11 Cádiz;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2021QII;""
11 Cádiz;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2021QI;""
11 Cádiz;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2020QIV;6.277
11 Cádiz;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
11 Cádiz;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2020QII;""
11 Cádiz;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2020QI;""
11 Cádiz;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
11 Cádiz;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
11 Cádiz;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QII;""
11 Cádiz;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QI;6.256
11 Cádiz;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
11 Cádiz;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
11 Cádiz;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QII;""
11 Cádiz;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QI;6.123
11 Cádiz;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
11 Cádiz;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
11 Cádiz;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QII;""
11 Cádiz;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QI;""
11 Cádiz;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
11 Cádiz;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
11 Cádiz;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QII;6.041
11 Cádiz;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QI;""
11 Cádiz;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
11 Cádiz;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
11 Cádiz;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QII;5.951
11 Cádiz;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QI;""
11 Cádiz;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
11 Cádiz;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
11 Cádiz;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QII;""
11 Cádiz;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QI;""
11 Cádiz;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
11 Cádiz;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
11 Cádiz;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
11 Cádiz;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
11 Cádiz;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
11 Cádiz;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
11 Cádiz;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
11 Cádiz;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
11 Cádiz;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
11 Cádiz;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
11 Cádiz;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
11 Cádiz;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
11 Cádiz;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
11 Cádiz;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;95,24
11 Cádiz;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
11 Cádiz;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
11 Cádiz;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
11 Cádiz;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;95,75
11 Cádiz;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
11 Cádiz;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
11 Cádiz;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
11 Cádiz;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;95,59
11 Cádiz;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
11 Cádiz;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
11 Cádiz;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;90,65
11 Cádiz;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
11 Cádiz;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
11 Cádiz;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
11 Cádiz;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;91,52
11 Cádiz;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
11 Cádiz;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
11 Cádiz;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
11 Cádiz;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;91,98
11 Cádiz;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
11 Cádiz;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
11 Cádiz;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
11 Cádiz;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
11 Cádiz;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
11 Cádiz;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
11 Cádiz;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;88,42
11 Cádiz;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
11 Cádiz;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
11 Cádiz;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
11 Cádiz;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;89,73
11 Cádiz;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
11 Cádiz;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
11 Cádiz;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
11 Cádiz;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
11 Cádiz;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
11 Cádiz;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
11 Cádiz;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;85,39
11 Cádiz;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
11 Cádiz;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
11 Cádiz;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
11 Cádiz;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;87,21
11 Cádiz;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
11 Cádiz;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
11 Cádiz;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
11 Cádiz;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
11 Cádiz;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
11 Cádiz;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QIV;19.446
11 Cádiz;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
11 Cádiz;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
11 Cádiz;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
11 Cádiz;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QIV;19.453
11 Cádiz;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
11 Cádiz;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
11 Cádiz;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
11 Cádiz;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QIV;19.076
11 Cádiz;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
11 Cádiz;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
11 Cádiz;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
11 Cádiz;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2022QIV;18.626
11 Cádiz;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
11 Cádiz;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2022QII;""
11 Cádiz;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2022QI;""
11 Cádiz;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2021QIV;18.701
11 Cádiz;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
11 Cádiz;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2021QII;""
11 Cádiz;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2021QI;""
11 Cádiz;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2020QIV;18.401
11 Cádiz;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
11 Cádiz;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2020QII;""
11 Cádiz;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2020QI;""
11 Cádiz;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
11 Cádiz;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
11 Cádiz;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2022QII;""
11 Cádiz;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2022QI;18.140
11 Cádiz;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
11 Cádiz;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
11 Cádiz;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2021QII;""
11 Cádiz;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2021QI;18.035
11 Cádiz;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
11 Cádiz;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
11 Cádiz;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2020QII;""
11 Cádiz;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2020QI;""
11 Cádiz;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
11 Cádiz;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
11 Cádiz;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QII;17.606
11 Cádiz;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QI;""
11 Cádiz;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
11 Cádiz;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
11 Cádiz;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QII;17.617
11 Cádiz;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QI;""
11 Cádiz;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
11 Cádiz;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
11 Cádiz;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QII;""
11 Cádiz;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QI;""
11 Cádiz;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
11 Cádiz;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QIII;17.165
11 Cádiz;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QII;""
11 Cádiz;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QI;""
11 Cádiz;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
11 Cádiz;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QIII;17.241
11 Cádiz;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QII;""
11 Cádiz;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QI;""
11 Cádiz;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
11 Cádiz;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
11 Cádiz;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QII;""
11 Cádiz;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QI;""
11 Cádiz;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
11 Cádiz;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
11 Cádiz;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
11 Cádiz;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
11 Cádiz;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
11 Cádiz;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
11 Cádiz;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
11 Cádiz;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
11 Cádiz;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
11 Cádiz;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
11 Cádiz;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
11 Cádiz;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
11 Cádiz;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;95,78
11 Cádiz;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
11 Cádiz;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
11 Cádiz;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
11 Cádiz;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;96,13
11 Cádiz;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
11 Cádiz;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
11 Cádiz;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
11 Cádiz;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;96,46
11 Cádiz;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
11 Cádiz;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
11 Cádiz;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
11 Cádiz;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
11 Cádiz;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
11 Cádiz;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
11 Cádiz;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;93,25
11 Cádiz;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
11 Cádiz;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
11 Cádiz;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
11 Cádiz;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;94,54
11 Cádiz;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
11 Cádiz;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
11 Cádiz;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
11 Cádiz;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
11 Cádiz;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
11 Cádiz;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
11 Cádiz;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;90,51
11 Cádiz;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
11 Cádiz;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
11 Cádiz;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
11 Cádiz;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;92,35
11 Cádiz;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
11 Cádiz;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
11 Cádiz;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
11 Cádiz;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
11 Cádiz;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
11 Cádiz;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
11 Cádiz;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;88,24
11 Cádiz;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
11 Cádiz;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
11 Cádiz;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
11 Cádiz;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;90,38
11 Cádiz;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
11 Cádiz;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
11 Cádiz;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
11 Cádiz;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
11 Cádiz;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
11 Cádiz;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
11 Cádiz;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QIV;12.280
11 Cádiz;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
11 Cádiz;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
11 Cádiz;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
11 Cádiz;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QIV;12.386
11 Cádiz;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
11 Cádiz;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
11 Cádiz;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
11 Cádiz;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QIV;12.258
11 Cádiz;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
11 Cádiz;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
11 Cádiz;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
11 Cádiz;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2022QIV;11.827
11 Cádiz;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
11 Cádiz;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2022QII;""
11 Cádiz;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2022QI;""
11 Cádiz;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2021QIV;11.957
11 Cádiz;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
11 Cádiz;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2021QII;""
11 Cádiz;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2021QI;""
11 Cádiz;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2020QIV;11.864
11 Cádiz;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
11 Cádiz;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2020QII;""
11 Cádiz;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2020QI;""
11 Cádiz;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
11 Cádiz;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
11 Cádiz;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2022QII;""
11 Cádiz;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2022QI;11.633
11 Cádiz;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
11 Cádiz;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
11 Cádiz;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2021QII;""
11 Cádiz;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2021QI;11.668
11 Cádiz;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
11 Cádiz;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
11 Cádiz;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2020QII;""
11 Cádiz;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2020QI;""
11 Cádiz;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
11 Cádiz;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
11 Cádiz;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QII;11.343
11 Cádiz;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QI;""
11 Cádiz;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
11 Cádiz;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
11 Cádiz;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QII;11.446
11 Cádiz;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QI;""
11 Cádiz;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
11 Cádiz;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
11 Cádiz;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QII;""
11 Cádiz;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QI;""
11 Cádiz;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
11 Cádiz;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QIII;11.093
11 Cádiz;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QII;""
11 Cádiz;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QI;""
11 Cádiz;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
11 Cádiz;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QIII;11.227
11 Cádiz;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QII;""
11 Cádiz;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QI;""
11 Cádiz;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
11 Cádiz;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
11 Cádiz;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QII;""
11 Cádiz;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QI;""
11 Cádiz;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
11 Cádiz;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
11 Cádiz;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
11 Cádiz;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
11 Cádiz;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
11 Cádiz;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
11 Cádiz;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
11 Cádiz;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
11 Cádiz;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
11 Cádiz;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
11 Cádiz;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
11 Cádiz;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
11 Cádiz;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;96,31
11 Cádiz;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
11 Cádiz;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
11 Cádiz;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
11 Cádiz;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;96,54
11 Cádiz;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
11 Cádiz;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
11 Cádiz;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
11 Cádiz;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;96,79
11 Cádiz;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
11 Cádiz;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
11 Cádiz;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
11 Cádiz;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
11 Cádiz;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
11 Cádiz;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
11 Cádiz;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;93,92
11 Cádiz;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
11 Cádiz;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
11 Cádiz;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
11 Cádiz;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;95,19
11 Cádiz;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
11 Cádiz;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
11 Cádiz;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
11 Cádiz;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
11 Cádiz;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
11 Cádiz;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
11 Cádiz;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;91,58
11 Cádiz;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
11 Cádiz;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
11 Cádiz;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
11 Cádiz;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;93,38
11 Cádiz;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
11 Cádiz;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
11 Cádiz;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
11 Cádiz;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
11 Cádiz;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
11 Cádiz;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
11 Cádiz;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;89,56
11 Cádiz;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
11 Cádiz;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
11 Cádiz;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
11 Cádiz;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;91,59
11 Cádiz;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
11 Cádiz;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
11 Cádiz;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
11 Cádiz;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
11 Cádiz;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
11 Cádiz;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
11 Cádiz;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QIV;7.166
11 Cádiz;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
11 Cádiz;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
11 Cádiz;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
11 Cádiz;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QIV;7.067
11 Cádiz;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
11 Cádiz;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
11 Cádiz;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
11 Cádiz;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QIV;6.818
11 Cádiz;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
11 Cádiz;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
11 Cádiz;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
11 Cádiz;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2022QIV;6.799
11 Cádiz;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
11 Cádiz;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2022QII;""
11 Cádiz;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2022QI;""
11 Cádiz;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2021QIV;6.744
11 Cádiz;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
11 Cádiz;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2021QII;""
11 Cádiz;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2021QI;""
11 Cádiz;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2020QIV;6.537
11 Cádiz;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
11 Cádiz;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2020QII;""
11 Cádiz;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2020QI;""
11 Cádiz;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
11 Cádiz;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
11 Cádiz;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2022QII;""
11 Cádiz;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2022QI;6.507
11 Cádiz;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
11 Cádiz;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
11 Cádiz;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2021QII;""
11 Cádiz;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2021QI;6.367
11 Cádiz;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
11 Cádiz;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
11 Cádiz;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2020QII;""
11 Cádiz;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2020QI;""
11 Cádiz;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
11 Cádiz;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
11 Cádiz;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QII;6.263
11 Cádiz;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QI;""
11 Cádiz;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
11 Cádiz;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
11 Cádiz;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QII;6.171
11 Cádiz;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QI;""
11 Cádiz;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
11 Cádiz;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
11 Cádiz;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QII;""
11 Cádiz;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QI;""
11 Cádiz;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
11 Cádiz;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QIII;6.072
11 Cádiz;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QII;""
11 Cádiz;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QI;""
11 Cádiz;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
11 Cádiz;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QIII;6.014
11 Cádiz;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QII;""
11 Cádiz;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QI;""
11 Cádiz;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
11 Cádiz;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
11 Cádiz;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QII;""
11 Cádiz;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QI;""
11 Cádiz;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
11 Cádiz;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
11 Cádiz;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
11 Cádiz;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
11 Cádiz;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
11 Cádiz;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
11 Cádiz;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
11 Cádiz;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
11 Cádiz;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
11 Cádiz;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
11 Cádiz;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
11 Cádiz;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
11 Cádiz;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;94,88
11 Cádiz;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
11 Cádiz;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
11 Cádiz;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
11 Cádiz;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;95,43
11 Cádiz;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
11 Cádiz;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
11 Cádiz;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
11 Cádiz;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;95,88
11 Cádiz;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
11 Cádiz;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
11 Cádiz;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
11 Cádiz;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
11 Cádiz;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
11 Cádiz;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
11 Cádiz;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;92,08
11 Cádiz;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
11 Cádiz;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
11 Cádiz;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
11 Cádiz;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;93,39
11 Cádiz;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
11 Cádiz;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
11 Cádiz;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
11 Cádiz;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
11 Cádiz;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
11 Cádiz;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
11 Cádiz;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;88,62
11 Cádiz;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
11 Cádiz;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
11 Cádiz;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
11 Cádiz;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;90,51
11 Cádiz;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
11 Cádiz;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
11 Cádiz;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
11 Cádiz;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
11 Cádiz;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
11 Cádiz;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
11 Cádiz;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;85,92
11 Cádiz;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
11 Cádiz;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
11 Cádiz;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
11 Cádiz;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;88,21
11 Cádiz;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
11 Cádiz;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
11 Cádiz;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
11 Cádiz;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
11 Cádiz;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
11 Cádiz;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
11 Cádiz;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
11 Cádiz;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
11 Cádiz;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
11 Cádiz;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QI;16.699
11 Cádiz;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
11 Cádiz;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
11 Cádiz;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
11 Cádiz;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QI;15.898
11 Cádiz;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
11 Cádiz;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
11 Cádiz;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
11 Cádiz;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QI;16.211
11 Cádiz;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
11 Cádiz;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
11 Cádiz;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2022QII;""
11 Cádiz;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2022QI;16.271
11 Cádiz;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
11 Cádiz;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
11 Cádiz;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2021QII;""
11 Cádiz;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2021QI;15.603
11 Cádiz;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
11 Cádiz;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
11 Cádiz;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2020QII;""
11 Cádiz;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2020QI;15.233
11 Cádiz;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
11 Cádiz;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
11 Cádiz;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2022QII;15.827
11 Cádiz;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2022QI;""
11 Cádiz;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
11 Cádiz;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
11 Cádiz;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2021QII;15.245
11 Cádiz;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2021QI;""
11 Cádiz;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
11 Cádiz;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
11 Cádiz;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2020QII;14.987
11 Cádiz;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2020QI;""
11 Cádiz;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
11 Cádiz;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QIII;15.508
11 Cádiz;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QII;""
11 Cádiz;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QI;""
11 Cádiz;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
11 Cádiz;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QIII;14.985
11 Cádiz;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QII;""
11 Cádiz;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QI;""
11 Cádiz;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
11 Cádiz;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QIII;14.738
11 Cádiz;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QII;""
11 Cádiz;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QI;""
11 Cádiz;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QIV;15.134
11 Cádiz;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
11 Cádiz;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QII;""
11 Cádiz;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QI;""
11 Cádiz;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QIV;14.705
11 Cádiz;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
11 Cádiz;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QII;""
11 Cádiz;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QI;""
11 Cádiz;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QIV;14.435
11 Cádiz;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
11 Cádiz;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QII;""
11 Cádiz;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QI;""
11 Cádiz;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
11 Cádiz;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
11 Cádiz;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
11 Cádiz;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
11 Cádiz;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
11 Cádiz;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
11 Cádiz;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
11 Cádiz;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
11 Cádiz;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
11 Cádiz;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
11 Cádiz;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
11 Cádiz;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
11 Cádiz;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
11 Cádiz;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
11 Cádiz;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
11 Cádiz;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;97,44
11 Cádiz;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
11 Cádiz;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
11 Cádiz;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
11 Cádiz;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;98,14
11 Cádiz;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
11 Cádiz;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
11 Cádiz;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
11 Cádiz;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;93,97
11 Cádiz;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
11 Cádiz;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
11 Cádiz;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;94,78
11 Cádiz;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
11 Cádiz;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
11 Cádiz;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
11 Cádiz;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;95,89
11 Cádiz;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
11 Cádiz;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
11 Cádiz;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
11 Cádiz;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;92,45
11 Cádiz;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
11 Cádiz;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
11 Cádiz;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;92,87
11 Cádiz;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
11 Cádiz;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
11 Cádiz;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
11 Cádiz;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;94,26
11 Cádiz;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
11 Cádiz;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
11 Cádiz;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
11 Cádiz;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;90,91
11 Cádiz;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
11 Cádiz;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
11 Cádiz;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;90,63
11 Cádiz;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
11 Cádiz;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
11 Cádiz;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
11 Cádiz;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;92,5
11 Cádiz;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
11 Cádiz;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
11 Cádiz;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
11 Cádiz;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;89,04
11 Cádiz;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
11 Cádiz;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
11 Cádiz;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
11 Cádiz;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
11 Cádiz;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
11 Cádiz;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
11 Cádiz;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QI;11.116
11 Cádiz;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
11 Cádiz;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
11 Cádiz;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
11 Cádiz;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QI;10.684
11 Cádiz;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
11 Cádiz;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
11 Cádiz;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
11 Cádiz;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QI;10.878
11 Cádiz;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
11 Cádiz;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
11 Cádiz;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2022QII;""
11 Cádiz;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2022QI;10.868
11 Cádiz;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
11 Cádiz;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
11 Cádiz;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2021QII;""
11 Cádiz;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2021QI;10.498
11 Cádiz;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
11 Cádiz;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
11 Cádiz;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2020QII;""
11 Cádiz;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2020QI;10.295
11 Cádiz;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
11 Cádiz;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
11 Cádiz;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2022QII;10.629
11 Cádiz;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2022QI;""
11 Cádiz;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
11 Cádiz;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
11 Cádiz;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2021QII;10.290
11 Cádiz;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2021QI;""
11 Cádiz;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
11 Cádiz;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
11 Cádiz;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2020QII;10.130
11 Cádiz;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2020QI;""
11 Cádiz;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
11 Cádiz;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QIII;10.436
11 Cádiz;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QII;""
11 Cádiz;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QI;""
11 Cádiz;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
11 Cádiz;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QIII;10.121
11 Cádiz;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QII;""
11 Cádiz;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QI;""
11 Cádiz;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
11 Cádiz;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QIII;9.977
11 Cádiz;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QII;""
11 Cádiz;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QI;""
11 Cádiz;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QIV;10.213
11 Cádiz;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
11 Cádiz;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QII;""
11 Cádiz;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QI;""
11 Cádiz;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QIV;9.950
11 Cádiz;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
11 Cádiz;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QII;""
11 Cádiz;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QI;""
11 Cádiz;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QIV;9.795
11 Cádiz;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
11 Cádiz;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QII;""
11 Cádiz;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QI;""
11 Cádiz;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
11 Cádiz;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
11 Cádiz;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
11 Cádiz;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
11 Cádiz;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
11 Cádiz;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
11 Cádiz;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
11 Cádiz;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
11 Cádiz;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
11 Cádiz;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
11 Cádiz;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
11 Cádiz;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
11 Cádiz;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
11 Cádiz;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
11 Cádiz;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
11 Cádiz;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;97,77
11 Cádiz;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
11 Cádiz;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
11 Cádiz;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
11 Cádiz;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;98,26
11 Cádiz;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
11 Cádiz;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
11 Cádiz;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
11 Cádiz;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;94,64
11 Cádiz;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
11 Cádiz;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
11 Cádiz;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;95,62
11 Cádiz;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
11 Cádiz;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
11 Cádiz;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
11 Cádiz;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;96,31
11 Cádiz;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
11 Cádiz;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
11 Cádiz;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
11 Cádiz;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;93,12
11 Cádiz;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
11 Cádiz;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
11 Cádiz;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;93,88
11 Cádiz;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
11 Cádiz;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
11 Cádiz;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
11 Cádiz;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;94,73
11 Cádiz;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
11 Cádiz;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
11 Cádiz;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
11 Cádiz;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;91,72
11 Cádiz;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
11 Cádiz;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
11 Cádiz;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;91,88
11 Cádiz;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
11 Cádiz;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
11 Cádiz;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
11 Cádiz;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;93,13
11 Cádiz;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
11 Cádiz;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
11 Cádiz;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
11 Cádiz;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;90,04
11 Cádiz;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
11 Cádiz;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
11 Cádiz;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
11 Cádiz;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
11 Cádiz;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
11 Cádiz;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
11 Cádiz;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QI;5.583
11 Cádiz;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
11 Cádiz;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
11 Cádiz;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
11 Cádiz;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QI;5.214
11 Cádiz;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
11 Cádiz;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
11 Cádiz;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
11 Cádiz;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QI;5.333
11 Cádiz;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
11 Cádiz;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
11 Cádiz;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2022QII;""
11 Cádiz;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2022QI;5.403
11 Cádiz;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
11 Cádiz;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
11 Cádiz;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2021QII;""
11 Cádiz;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2021QI;5.105
11 Cádiz;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
11 Cádiz;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
11 Cádiz;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2020QII;""
11 Cádiz;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2020QI;4.938
11 Cádiz;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
11 Cádiz;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
11 Cádiz;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2022QII;5.198
11 Cádiz;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2022QI;""
11 Cádiz;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
11 Cádiz;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
11 Cádiz;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2021QII;4.955
11 Cádiz;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2021QI;""
11 Cádiz;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
11 Cádiz;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
11 Cádiz;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2020QII;4.857
11 Cádiz;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2020QI;""
11 Cádiz;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
11 Cádiz;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QIII;5.072
11 Cádiz;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QII;""
11 Cádiz;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QI;""
11 Cádiz;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
11 Cádiz;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QIII;4.864
11 Cádiz;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QII;""
11 Cádiz;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QI;""
11 Cádiz;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
11 Cádiz;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QIII;4.761
11 Cádiz;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QII;""
11 Cádiz;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QI;""
11 Cádiz;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QIV;4.921
11 Cádiz;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
11 Cádiz;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QII;""
11 Cádiz;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QI;""
11 Cádiz;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QIV;4.755
11 Cádiz;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
11 Cádiz;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QII;""
11 Cádiz;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QI;""
11 Cádiz;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QIV;4.640
11 Cádiz;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
11 Cádiz;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QII;""
11 Cádiz;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QI;""
11 Cádiz;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
11 Cádiz;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
11 Cádiz;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
11 Cádiz;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
11 Cádiz;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
11 Cádiz;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
11 Cádiz;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
11 Cádiz;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
11 Cádiz;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
11 Cádiz;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
11 Cádiz;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
11 Cádiz;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
11 Cádiz;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
11 Cádiz;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
11 Cádiz;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
11 Cádiz;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;96,78
11 Cádiz;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
11 Cádiz;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
11 Cádiz;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
11 Cádiz;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;97,91
11 Cádiz;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
11 Cádiz;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
11 Cádiz;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
11 Cádiz;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;92,59
11 Cádiz;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
11 Cádiz;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
11 Cádiz;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;93,1
11 Cádiz;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
11 Cádiz;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
11 Cádiz;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
11 Cádiz;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;95,03
11 Cádiz;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
11 Cádiz;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
11 Cádiz;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
11 Cádiz;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;91,07
11 Cádiz;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
11 Cádiz;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
11 Cádiz;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;90,85
11 Cádiz;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
11 Cádiz;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
11 Cádiz;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
11 Cádiz;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;93,29
11 Cádiz;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
11 Cádiz;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
11 Cádiz;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
11 Cádiz;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;89,27
11 Cádiz;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
11 Cádiz;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
11 Cádiz;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;88,14
11 Cádiz;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
11 Cádiz;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
11 Cádiz;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
11 Cádiz;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;91,2
11 Cádiz;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
11 Cádiz;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
11 Cádiz;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
11 Cádiz;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;87,01
11 Cádiz;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
11 Cádiz;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
11 Cádiz;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
11 Cádiz;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
11 Cádiz;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
11 Cádiz;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QII;17.397
11 Cádiz;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
11 Cádiz;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
11 Cádiz;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
11 Cádiz;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QII;16.781
11 Cádiz;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
11 Cádiz;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
11 Cádiz;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
11 Cádiz;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QII;15.734
11 Cádiz;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
11 Cádiz;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
11 Cádiz;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
11 Cádiz;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2022QII;16.883
11 Cádiz;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2022QI;""
11 Cádiz;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
11 Cádiz;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
11 Cádiz;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2021QII;16.377
11 Cádiz;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2021QI;""
11 Cádiz;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
11 Cádiz;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
11 Cádiz;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2020QII;15.460
11 Cádiz;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2020QI;""
11 Cádiz;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
11 Cádiz;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2022QIII;16.505
11 Cádiz;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2022QII;""
11 Cádiz;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2022QI;""
11 Cádiz;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
11 Cádiz;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2021QIII;16.062
11 Cádiz;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2021QII;""
11 Cádiz;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2021QI;""
11 Cádiz;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
11 Cádiz;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2020QIII;15.174
11 Cádiz;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2020QII;""
11 Cádiz;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2020QI;""
11 Cádiz;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QIV;16.076
11 Cádiz;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
11 Cádiz;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QII;""
11 Cádiz;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QI;""
11 Cádiz;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QIV;15.722
11 Cádiz;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
11 Cádiz;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QII;""
11 Cádiz;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QI;""
11 Cádiz;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QIV;14.832
11 Cádiz;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
11 Cádiz;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QII;""
11 Cádiz;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QI;""
11 Cádiz;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
11 Cádiz;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
11 Cádiz;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QII;""
11 Cádiz;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QI;15.361
11 Cádiz;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
11 Cádiz;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
11 Cádiz;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QII;""
11 Cádiz;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QI;14.619
11 Cádiz;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
11 Cádiz;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
11 Cádiz;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QII;""
11 Cádiz;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QI;""
11 Cádiz;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
11 Cádiz;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
11 Cádiz;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
11 Cádiz;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
11 Cádiz;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
11 Cádiz;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
11 Cádiz;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
11 Cádiz;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
11 Cádiz;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
11 Cádiz;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
11 Cádiz;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
11 Cádiz;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
11 Cádiz;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
11 Cádiz;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
11 Cádiz;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;97,05
11 Cádiz;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
11 Cádiz;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
11 Cádiz;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
11 Cádiz;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;97,59
11 Cádiz;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
11 Cádiz;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
11 Cádiz;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
11 Cádiz;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;98,26
11 Cádiz;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
11 Cádiz;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
11 Cádiz;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;94,87
11 Cádiz;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
11 Cádiz;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
11 Cádiz;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
11 Cádiz;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;95,72
11 Cádiz;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
11 Cádiz;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
11 Cádiz;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
11 Cádiz;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;96,44
11 Cádiz;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
11 Cádiz;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
11 Cádiz;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;92,41
11 Cádiz;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
11 Cádiz;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
11 Cádiz;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
11 Cádiz;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;93,69
11 Cádiz;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
11 Cádiz;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
11 Cádiz;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
11 Cádiz;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;94,27
11 Cádiz;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
11 Cádiz;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
11 Cádiz;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
11 Cádiz;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
11 Cádiz;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
11 Cádiz;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
11 Cádiz;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;91,54
11 Cádiz;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
11 Cádiz;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
11 Cádiz;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
11 Cádiz;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;92,91
11 Cádiz;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
11 Cádiz;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
11 Cádiz;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
11 Cádiz;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
11 Cádiz;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
11 Cádiz;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
11 Cádiz;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QII;11.573
11 Cádiz;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
11 Cádiz;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
11 Cádiz;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
11 Cádiz;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QII;11.204
11 Cádiz;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
11 Cádiz;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
11 Cádiz;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
11 Cádiz;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QII;10.593
11 Cádiz;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
11 Cádiz;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
11 Cádiz;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
11 Cádiz;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2022QII;11.291
11 Cádiz;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2022QI;""
11 Cádiz;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
11 Cádiz;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
11 Cádiz;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2021QII;10.972
11 Cádiz;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2021QI;""
11 Cádiz;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
11 Cádiz;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
11 Cádiz;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2020QII;10.410
11 Cádiz;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2020QI;""
11 Cádiz;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
11 Cádiz;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2022QIII;11.065
11 Cádiz;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2022QII;""
11 Cádiz;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2022QI;""
11 Cádiz;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
11 Cádiz;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2021QIII;10.771
11 Cádiz;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2021QII;""
11 Cádiz;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2021QI;""
11 Cádiz;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
11 Cádiz;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2020QIII;10.234
11 Cádiz;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2020QII;""
11 Cádiz;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2020QI;""
11 Cádiz;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QIV;10.808
11 Cádiz;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
11 Cádiz;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QII;""
11 Cádiz;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QI;""
11 Cádiz;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QIV;10.567
11 Cádiz;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
11 Cádiz;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QII;""
11 Cádiz;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QI;""
11 Cádiz;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QIV;10.026
11 Cádiz;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
11 Cádiz;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QII;""
11 Cádiz;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QI;""
11 Cádiz;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
11 Cádiz;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
11 Cádiz;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QII;""
11 Cádiz;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QI;10.358
11 Cádiz;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
11 Cádiz;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
11 Cádiz;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QII;""
11 Cádiz;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QI;9.889
11 Cádiz;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
11 Cádiz;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
11 Cádiz;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QII;""
11 Cádiz;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QI;""
11 Cádiz;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
11 Cádiz;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
11 Cádiz;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
11 Cádiz;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
11 Cádiz;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
11 Cádiz;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
11 Cádiz;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
11 Cádiz;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
11 Cádiz;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
11 Cádiz;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
11 Cádiz;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
11 Cádiz;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
11 Cádiz;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
11 Cádiz;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
11 Cádiz;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;97,56
11 Cádiz;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
11 Cádiz;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
11 Cádiz;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
11 Cádiz;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;97,93
11 Cádiz;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
11 Cádiz;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
11 Cádiz;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
11 Cádiz;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;98,27
11 Cádiz;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
11 Cádiz;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
11 Cádiz;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;95,61
11 Cádiz;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
11 Cádiz;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
11 Cádiz;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
11 Cádiz;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;96,14
11 Cádiz;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
11 Cádiz;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
11 Cádiz;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
11 Cádiz;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;96,61
11 Cádiz;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
11 Cádiz;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
11 Cádiz;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;93,39
11 Cádiz;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
11 Cádiz;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
11 Cádiz;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
11 Cádiz;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;94,31
11 Cádiz;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
11 Cádiz;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
11 Cádiz;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
11 Cádiz;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;94,65
11 Cádiz;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
11 Cádiz;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
11 Cádiz;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
11 Cádiz;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
11 Cádiz;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
11 Cádiz;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
11 Cádiz;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;92,45
11 Cádiz;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
11 Cádiz;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
11 Cádiz;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
11 Cádiz;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;93,35
11 Cádiz;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
11 Cádiz;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
11 Cádiz;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
11 Cádiz;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
11 Cádiz;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
11 Cádiz;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
11 Cádiz;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QII;5.824
11 Cádiz;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
11 Cádiz;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
11 Cádiz;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
11 Cádiz;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QII;5.577
11 Cádiz;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
11 Cádiz;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
11 Cádiz;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
11 Cádiz;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QII;5.141
11 Cádiz;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
11 Cádiz;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
11 Cádiz;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
11 Cádiz;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2022QII;5.592
11 Cádiz;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2022QI;""
11 Cádiz;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
11 Cádiz;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
11 Cádiz;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2021QII;5.405
11 Cádiz;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2021QI;""
11 Cádiz;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
11 Cádiz;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
11 Cádiz;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2020QII;5.050
11 Cádiz;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2020QI;""
11 Cádiz;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
11 Cádiz;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2022QIII;5.440
11 Cádiz;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2022QII;""
11 Cádiz;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2022QI;""
11 Cádiz;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
11 Cádiz;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2021QIII;5.291
11 Cádiz;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2021QII;""
11 Cádiz;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2021QI;""
11 Cádiz;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
11 Cádiz;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2020QIII;4.940
11 Cádiz;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2020QII;""
11 Cádiz;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2020QI;""
11 Cádiz;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QIV;5.268
11 Cádiz;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
11 Cádiz;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QII;""
11 Cádiz;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QI;""
11 Cádiz;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QIV;5.155
11 Cádiz;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
11 Cádiz;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QII;""
11 Cádiz;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QI;""
11 Cádiz;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QIV;4.806
11 Cádiz;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
11 Cádiz;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QII;""
11 Cádiz;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QI;""
11 Cádiz;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
11 Cádiz;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
11 Cádiz;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QII;""
11 Cádiz;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QI;5.003
11 Cádiz;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
11 Cádiz;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
11 Cádiz;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QII;""
11 Cádiz;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QI;4.730
11 Cádiz;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
11 Cádiz;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
11 Cádiz;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QII;""
11 Cádiz;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QI;""
11 Cádiz;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
11 Cádiz;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
11 Cádiz;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
11 Cádiz;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
11 Cádiz;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
11 Cádiz;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
11 Cádiz;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
11 Cádiz;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
11 Cádiz;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
11 Cádiz;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
11 Cádiz;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
11 Cádiz;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
11 Cádiz;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
11 Cádiz;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
11 Cádiz;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;96,02
11 Cádiz;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
11 Cádiz;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
11 Cádiz;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
11 Cádiz;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;96,92
11 Cádiz;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
11 Cádiz;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
11 Cádiz;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
11 Cádiz;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;98,23
11 Cádiz;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
11 Cádiz;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
11 Cádiz;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;93,41
11 Cádiz;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
11 Cádiz;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
11 Cádiz;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
11 Cádiz;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;94,87
11 Cádiz;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
11 Cádiz;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
11 Cádiz;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
11 Cádiz;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;96,09
11 Cádiz;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
11 Cádiz;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
11 Cádiz;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;90,45
11 Cádiz;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
11 Cádiz;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
11 Cádiz;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
11 Cádiz;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;92,43
11 Cádiz;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
11 Cádiz;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
11 Cádiz;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
11 Cádiz;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;93,48
11 Cádiz;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
11 Cádiz;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
11 Cádiz;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
11 Cádiz;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
11 Cádiz;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
11 Cádiz;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
11 Cádiz;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;89,71
11 Cádiz;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
11 Cádiz;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
11 Cádiz;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
11 Cádiz;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;92,01
11 Cádiz;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
11 Cádiz;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
11 Cádiz;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
11 Cádiz;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
11 Cádiz;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
11 Cádiz;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QIII;17.509
11 Cádiz;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
11 Cádiz;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
11 Cádiz;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
11 Cádiz;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QIII;16.955
11 Cádiz;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
11 Cádiz;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
11 Cádiz;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
11 Cádiz;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QIII;15.999
11 Cádiz;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
11 Cádiz;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
11 Cádiz;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
11 Cádiz;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2022QIII;16.985
11 Cádiz;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2022QII;""
11 Cádiz;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2022QI;""
11 Cádiz;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
11 Cádiz;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2021QIII;16.539
11 Cádiz;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2021QII;""
11 Cádiz;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2021QI;""
11 Cádiz;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
11 Cádiz;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2020QIII;15.604
11 Cádiz;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2020QII;""
11 Cádiz;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2020QI;""
11 Cádiz;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2022QIV;16.456
11 Cádiz;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
11 Cádiz;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2022QII;""
11 Cádiz;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2022QI;""
11 Cádiz;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2021QIV;16.094
11 Cádiz;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
11 Cádiz;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2021QII;""
11 Cádiz;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2021QI;""
11 Cádiz;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2020QIV;15.193
11 Cádiz;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
11 Cádiz;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2020QII;""
11 Cádiz;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2020QI;""
11 Cádiz;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
11 Cádiz;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
11 Cádiz;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QII;""
11 Cádiz;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QI;15.715
11 Cádiz;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
11 Cádiz;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
11 Cádiz;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QII;""
11 Cádiz;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QI;14.957
11 Cádiz;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
11 Cádiz;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
11 Cádiz;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QII;""
11 Cádiz;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QI;""
11 Cádiz;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
11 Cádiz;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
11 Cádiz;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QII;15.347
11 Cádiz;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QI;""
11 Cádiz;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
11 Cádiz;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
11 Cádiz;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QII;14.669
11 Cádiz;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QI;""
11 Cádiz;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
11 Cádiz;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
11 Cádiz;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QII;""
11 Cádiz;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QI;""
11 Cádiz;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
11 Cádiz;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
11 Cádiz;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
11 Cádiz;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
11 Cádiz;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
11 Cádiz;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
11 Cádiz;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
11 Cádiz;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
11 Cádiz;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
11 Cádiz;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
11 Cádiz;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
11 Cádiz;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
11 Cádiz;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
11 Cádiz;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;97,01
11 Cádiz;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
11 Cádiz;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
11 Cádiz;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
11 Cádiz;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;97,55
11 Cádiz;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
11 Cádiz;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
11 Cádiz;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
11 Cádiz;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;97,53
11 Cádiz;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
11 Cádiz;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
11 Cádiz;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;93,99
11 Cádiz;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
11 Cádiz;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
11 Cádiz;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
11 Cádiz;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;94,92
11 Cádiz;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
11 Cádiz;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
11 Cádiz;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
11 Cádiz;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;94,96
11 Cádiz;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
11 Cádiz;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
11 Cádiz;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
11 Cádiz;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
11 Cádiz;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
11 Cádiz;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
11 Cádiz;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;92,69
11 Cádiz;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
11 Cádiz;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
11 Cádiz;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
11 Cádiz;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;93,49
11 Cádiz;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
11 Cádiz;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
11 Cádiz;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
11 Cádiz;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
11 Cádiz;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
11 Cádiz;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
11 Cádiz;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;90,52
11 Cádiz;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
11 Cádiz;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
11 Cádiz;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
11 Cádiz;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;91,69
11 Cádiz;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
11 Cádiz;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
11 Cádiz;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
11 Cádiz;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
11 Cádiz;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
11 Cádiz;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
11 Cádiz;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QIII;11.619
11 Cádiz;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
11 Cádiz;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
11 Cádiz;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
11 Cádiz;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QIII;11.305
11 Cádiz;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
11 Cádiz;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
11 Cádiz;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
11 Cádiz;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QIII;10.769
11 Cádiz;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
11 Cádiz;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
11 Cádiz;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
11 Cádiz;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2022QIII;11.316
11 Cádiz;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2022QII;""
11 Cádiz;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2022QI;""
11 Cádiz;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
11 Cádiz;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2021QIII;11.043
11 Cádiz;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2021QII;""
11 Cádiz;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2021QI;""
11 Cádiz;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
11 Cádiz;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2020QIII;10.529
11 Cádiz;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2020QII;""
11 Cádiz;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2020QI;""
11 Cádiz;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2022QIV;11.005
11 Cádiz;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
11 Cádiz;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2022QII;""
11 Cádiz;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2022QI;""
11 Cádiz;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2021QIV;10.776
11 Cádiz;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
11 Cádiz;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2021QII;""
11 Cádiz;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2021QI;""
11 Cádiz;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2020QIV;10.273
11 Cádiz;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
11 Cádiz;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2020QII;""
11 Cádiz;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2020QI;""
11 Cádiz;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
11 Cádiz;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
11 Cádiz;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QII;""
11 Cádiz;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QI;10.553
11 Cádiz;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
11 Cádiz;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
11 Cádiz;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QII;""
11 Cádiz;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QI;10.120
11 Cádiz;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
11 Cádiz;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
11 Cádiz;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QII;""
11 Cádiz;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QI;""
11 Cádiz;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
11 Cádiz;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
11 Cádiz;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QII;10.356
11 Cádiz;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QI;""
11 Cádiz;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
11 Cádiz;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
11 Cádiz;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QII;9.952
11 Cádiz;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QI;""
11 Cádiz;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
11 Cádiz;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
11 Cádiz;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QII;""
11 Cádiz;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QI;""
11 Cádiz;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
11 Cádiz;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
11 Cádiz;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
11 Cádiz;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
11 Cádiz;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
11 Cádiz;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
11 Cádiz;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
11 Cádiz;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
11 Cádiz;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
11 Cádiz;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
11 Cádiz;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
11 Cádiz;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
11 Cádiz;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
11 Cádiz;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;97,39
11 Cádiz;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
11 Cádiz;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
11 Cádiz;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
11 Cádiz;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;97,68
11 Cádiz;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
11 Cádiz;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
11 Cádiz;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
11 Cádiz;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;97,77
11 Cádiz;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
11 Cádiz;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
11 Cádiz;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;94,72
11 Cádiz;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
11 Cádiz;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
11 Cádiz;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
11 Cádiz;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;95,32
11 Cádiz;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
11 Cádiz;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
11 Cádiz;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
11 Cádiz;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;95,39
11 Cádiz;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
11 Cádiz;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
11 Cádiz;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
11 Cádiz;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
11 Cádiz;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
11 Cádiz;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
11 Cádiz;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;93,35
11 Cádiz;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
11 Cádiz;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
11 Cádiz;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
11 Cádiz;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;93,97
11 Cádiz;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
11 Cádiz;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
11 Cádiz;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
11 Cádiz;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
11 Cádiz;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
11 Cádiz;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
11 Cádiz;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;91,61
11 Cádiz;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
11 Cádiz;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
11 Cádiz;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
11 Cádiz;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;92,41
11 Cádiz;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
11 Cádiz;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
11 Cádiz;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
11 Cádiz;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
11 Cádiz;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
11 Cádiz;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
11 Cádiz;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QIII;5.890
11 Cádiz;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
11 Cádiz;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
11 Cádiz;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
11 Cádiz;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QIII;5.650
11 Cádiz;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
11 Cádiz;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
11 Cádiz;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
11 Cádiz;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QIII;5.230
11 Cádiz;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
11 Cádiz;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
11 Cádiz;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
11 Cádiz;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2022QIII;5.669
11 Cádiz;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2022QII;""
11 Cádiz;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2022QI;""
11 Cádiz;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
11 Cádiz;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2021QIII;5.496
11 Cádiz;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2021QII;""
11 Cádiz;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2021QI;""
11 Cádiz;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
11 Cádiz;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2020QIII;5.075
11 Cádiz;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2020QII;""
11 Cádiz;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2020QI;""
11 Cádiz;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2022QIV;5.451
11 Cádiz;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
11 Cádiz;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2022QII;""
11 Cádiz;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2022QI;""
11 Cádiz;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2021QIV;5.318
11 Cádiz;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
11 Cádiz;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2021QII;""
11 Cádiz;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2021QI;""
11 Cádiz;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2020QIV;4.920
11 Cádiz;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
11 Cádiz;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2020QII;""
11 Cádiz;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2020QI;""
11 Cádiz;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
11 Cádiz;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
11 Cádiz;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QII;""
11 Cádiz;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QI;5.162
11 Cádiz;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
11 Cádiz;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
11 Cádiz;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QII;""
11 Cádiz;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QI;4.837
11 Cádiz;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
11 Cádiz;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
11 Cádiz;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QII;""
11 Cádiz;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QI;""
11 Cádiz;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
11 Cádiz;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
11 Cádiz;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QII;4.991
11 Cádiz;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QI;""
11 Cádiz;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
11 Cádiz;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
11 Cádiz;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QII;4.717
11 Cádiz;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QI;""
11 Cádiz;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
11 Cádiz;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
11 Cádiz;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QII;""
11 Cádiz;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QI;""
11 Cádiz;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
11 Cádiz;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
11 Cádiz;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
11 Cádiz;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
11 Cádiz;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
11 Cádiz;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
11 Cádiz;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
11 Cádiz;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
11 Cádiz;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
11 Cádiz;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
11 Cádiz;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
11 Cádiz;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
11 Cádiz;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
11 Cádiz;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;96,25
11 Cádiz;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
11 Cádiz;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
11 Cádiz;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
11 Cádiz;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;97,27
11 Cádiz;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
11 Cádiz;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
11 Cádiz;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
11 Cádiz;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;97,04
11 Cádiz;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
11 Cádiz;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
11 Cádiz;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;92,55
11 Cádiz;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
11 Cádiz;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
11 Cádiz;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
11 Cádiz;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;94,12
11 Cádiz;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
11 Cádiz;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
11 Cádiz;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
11 Cádiz;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;94,07
11 Cádiz;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
11 Cádiz;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
11 Cádiz;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
11 Cádiz;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
11 Cádiz;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
11 Cádiz;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
11 Cádiz;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;91,36
11 Cádiz;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
11 Cádiz;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
11 Cádiz;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
11 Cádiz;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;92,49
11 Cádiz;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
11 Cádiz;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
11 Cádiz;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
11 Cádiz;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
11 Cádiz;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
11 Cádiz;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
11 Cádiz;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;88,34
11 Cádiz;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
11 Cádiz;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
11 Cádiz;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
11 Cádiz;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;90,19
11 Cádiz;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
11 Cádiz;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
11 Cádiz;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
11 Cádiz;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
11 Cádiz;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
11 Cádiz;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QIV;17.348
11 Cádiz;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
11 Cádiz;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
11 Cádiz;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
11 Cádiz;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QIV;16.854
11 Cádiz;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
11 Cádiz;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
11 Cádiz;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
11 Cádiz;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QIV;16.047
11 Cádiz;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
11 Cádiz;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
11 Cádiz;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
11 Cádiz;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2022QIV;16.768
11 Cádiz;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
11 Cádiz;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2022QII;""
11 Cádiz;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2022QI;""
11 Cádiz;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2021QIV;16.358
11 Cádiz;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
11 Cádiz;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2021QII;""
11 Cádiz;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2021QI;""
11 Cádiz;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2020QIV;15.556
11 Cádiz;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
11 Cádiz;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2020QII;""
11 Cádiz;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2020QI;""
11 Cádiz;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
11 Cádiz;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
11 Cádiz;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2022QII;""
11 Cádiz;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2022QI;15.962
11 Cádiz;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
11 Cádiz;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
11 Cádiz;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2021QII;""
11 Cádiz;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2021QI;15.297
11 Cádiz;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
11 Cádiz;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
11 Cádiz;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2020QII;""
11 Cádiz;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2020QI;""
11 Cádiz;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
11 Cádiz;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
11 Cádiz;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QII;15.567
11 Cádiz;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QI;""
11 Cádiz;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
11 Cádiz;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
11 Cádiz;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QII;14.985
11 Cádiz;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QI;""
11 Cádiz;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
11 Cádiz;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
11 Cádiz;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QII;""
11 Cádiz;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QI;""
11 Cádiz;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
11 Cádiz;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QIII;15.266
11 Cádiz;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QII;""
11 Cádiz;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QI;""
11 Cádiz;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
11 Cádiz;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QIII;14.746
11 Cádiz;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QII;""
11 Cádiz;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QI;""
11 Cádiz;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
11 Cádiz;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
11 Cádiz;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QII;""
11 Cádiz;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QI;""
11 Cádiz;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
11 Cádiz;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
11 Cádiz;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
11 Cádiz;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
11 Cádiz;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
11 Cádiz;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
11 Cádiz;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
11 Cádiz;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
11 Cádiz;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
11 Cádiz;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
11 Cádiz;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
11 Cádiz;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
11 Cádiz;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;96,66
11 Cádiz;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
11 Cádiz;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
11 Cádiz;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
11 Cádiz;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;97,06
11 Cádiz;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
11 Cádiz;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
11 Cádiz;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
11 Cádiz;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;96,94
11 Cádiz;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
11 Cádiz;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
11 Cádiz;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
11 Cádiz;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
11 Cádiz;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
11 Cádiz;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
11 Cádiz;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;94,71
11 Cádiz;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
11 Cádiz;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
11 Cádiz;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
11 Cádiz;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;95,33
11 Cádiz;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
11 Cádiz;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
11 Cádiz;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
11 Cádiz;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
11 Cádiz;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
11 Cádiz;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
11 Cádiz;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;92,36
11 Cádiz;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
11 Cádiz;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
11 Cádiz;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
11 Cádiz;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;93,38
11 Cádiz;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
11 Cádiz;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
11 Cádiz;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
11 Cádiz;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
11 Cádiz;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
11 Cádiz;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
11 Cádiz;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;90,58
11 Cádiz;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
11 Cádiz;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
11 Cádiz;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
11 Cádiz;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;91,89
11 Cádiz;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
11 Cádiz;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
11 Cádiz;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
11 Cádiz;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
11 Cádiz;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
11 Cádiz;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
11 Cádiz;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QIV;11.518
11 Cádiz;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
11 Cádiz;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
11 Cádiz;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
11 Cádiz;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QIV;11.229
11 Cádiz;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
11 Cádiz;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
11 Cádiz;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
11 Cádiz;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QIV;10.795
11 Cádiz;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
11 Cádiz;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
11 Cádiz;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
11 Cádiz;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2022QIV;11.178
11 Cádiz;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
11 Cádiz;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2022QII;""
11 Cádiz;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2022QI;""
11 Cádiz;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2021QIV;10.935
11 Cádiz;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
11 Cádiz;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2021QII;""
11 Cádiz;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2021QI;""
11 Cádiz;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2020QIV;10.491
11 Cádiz;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
11 Cádiz;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2020QII;""
11 Cádiz;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2020QI;""
11 Cádiz;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
11 Cádiz;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
11 Cádiz;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2022QII;""
11 Cádiz;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2022QI;10.703
11 Cádiz;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
11 Cádiz;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
11 Cádiz;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2021QII;""
11 Cádiz;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2021QI;10.326
11 Cádiz;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
11 Cádiz;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
11 Cádiz;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2020QII;""
11 Cádiz;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2020QI;""
11 Cádiz;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
11 Cádiz;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
11 Cádiz;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QII;10.490
11 Cádiz;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QI;""
11 Cádiz;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
11 Cádiz;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
11 Cádiz;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QII;10.147
11 Cádiz;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QI;""
11 Cádiz;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
11 Cádiz;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
11 Cádiz;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QII;""
11 Cádiz;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QI;""
11 Cádiz;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
11 Cádiz;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QIII;10.307
11 Cádiz;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QII;""
11 Cádiz;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QI;""
11 Cádiz;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
11 Cádiz;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QIII;9.995
11 Cádiz;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QII;""
11 Cádiz;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QI;""
11 Cádiz;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
11 Cádiz;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
11 Cádiz;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QII;""
11 Cádiz;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QI;""
11 Cádiz;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
11 Cádiz;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
11 Cádiz;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
11 Cádiz;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
11 Cádiz;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
11 Cádiz;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
11 Cádiz;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
11 Cádiz;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
11 Cádiz;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
11 Cádiz;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
11 Cádiz;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
11 Cádiz;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
11 Cádiz;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;97,05
11 Cádiz;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
11 Cádiz;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
11 Cádiz;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
11 Cádiz;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;97,38
11 Cádiz;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
11 Cádiz;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
11 Cádiz;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
11 Cádiz;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;97,18
11 Cádiz;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
11 Cádiz;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
11 Cádiz;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
11 Cádiz;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
11 Cádiz;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
11 Cádiz;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
11 Cádiz;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;95,32
11 Cádiz;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
11 Cádiz;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
11 Cádiz;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
11 Cádiz;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;95,66
11 Cádiz;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
11 Cádiz;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
11 Cádiz;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
11 Cádiz;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
11 Cádiz;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
11 Cádiz;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
11 Cádiz;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;93,42
11 Cádiz;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
11 Cádiz;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
11 Cádiz;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
11 Cádiz;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;94
11 Cádiz;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
11 Cádiz;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
11 Cádiz;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
11 Cádiz;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
11 Cádiz;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
11 Cádiz;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
11 Cádiz;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;91,79
11 Cádiz;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
11 Cádiz;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
11 Cádiz;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
11 Cádiz;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;92,59
11 Cádiz;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
11 Cádiz;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
11 Cádiz;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
11 Cádiz;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
11 Cádiz;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
11 Cádiz;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
11 Cádiz;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QIV;5.830
11 Cádiz;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
11 Cádiz;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
11 Cádiz;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
11 Cádiz;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QIV;5.625
11 Cádiz;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
11 Cádiz;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
11 Cádiz;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
11 Cádiz;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QIV;5.252
11 Cádiz;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
11 Cádiz;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
11 Cádiz;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
11 Cádiz;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2022QIV;5.590
11 Cádiz;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
11 Cádiz;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2022QII;""
11 Cádiz;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2022QI;""
11 Cádiz;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2021QIV;5.423
11 Cádiz;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
11 Cádiz;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2021QII;""
11 Cádiz;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2021QI;""
11 Cádiz;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2020QIV;5.065
11 Cádiz;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
11 Cádiz;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2020QII;""
11 Cádiz;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2020QI;""
11 Cádiz;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
11 Cádiz;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
11 Cádiz;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2022QII;""
11 Cádiz;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2022QI;5.259
11 Cádiz;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
11 Cádiz;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
11 Cádiz;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2021QII;""
11 Cádiz;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2021QI;4.971
11 Cádiz;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
11 Cádiz;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
11 Cádiz;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2020QII;""
11 Cádiz;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2020QI;""
11 Cádiz;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
11 Cádiz;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
11 Cádiz;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QII;5.077
11 Cádiz;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QI;""
11 Cádiz;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
11 Cádiz;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
11 Cádiz;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QII;4.838
11 Cádiz;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QI;""
11 Cádiz;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
11 Cádiz;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
11 Cádiz;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QII;""
11 Cádiz;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QI;""
11 Cádiz;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
11 Cádiz;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QIII;4.959
11 Cádiz;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QII;""
11 Cádiz;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QI;""
11 Cádiz;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
11 Cádiz;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QIII;4.751
11 Cádiz;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QII;""
11 Cádiz;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QI;""
11 Cádiz;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
11 Cádiz;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
11 Cádiz;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QII;""
11 Cádiz;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QI;""
11 Cádiz;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
11 Cádiz;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
11 Cádiz;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
11 Cádiz;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
11 Cádiz;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
11 Cádiz;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
11 Cádiz;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
11 Cádiz;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
11 Cádiz;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
11 Cádiz;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
11 Cádiz;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
11 Cádiz;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
11 Cádiz;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;95,88
11 Cádiz;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
11 Cádiz;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
11 Cádiz;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
11 Cádiz;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;96,41
11 Cádiz;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
11 Cádiz;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
11 Cádiz;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
11 Cádiz;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;96,44
11 Cádiz;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
11 Cádiz;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
11 Cádiz;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
11 Cádiz;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
11 Cádiz;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
11 Cádiz;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
11 Cádiz;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;93,49
11 Cádiz;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
11 Cádiz;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
11 Cádiz;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
11 Cádiz;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;94,65
11 Cádiz;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
11 Cádiz;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
11 Cádiz;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
11 Cádiz;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
11 Cádiz;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
11 Cádiz;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
11 Cádiz;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;90,26
11 Cádiz;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
11 Cádiz;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
11 Cádiz;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
11 Cádiz;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;92,12
11 Cádiz;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
11 Cádiz;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
11 Cádiz;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
11 Cádiz;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
11 Cádiz;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
11 Cádiz;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
11 Cádiz;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;88,16
11 Cádiz;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
11 Cádiz;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
11 Cádiz;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
11 Cádiz;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;90,46
11 Cádiz;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
11 Cádiz;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
11 Cádiz;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
11 Cádiz;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
11 Cádiz;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
11 Cádiz;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
11 Cádiz;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
11 Cádiz;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
11 Cádiz;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
11 Cádiz;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QI;6.933
11 Cádiz;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
11 Cádiz;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
11 Cádiz;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
11 Cádiz;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QI;6.544
11 Cádiz;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
11 Cádiz;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
11 Cádiz;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
11 Cádiz;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QI;7.387
11 Cádiz;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
11 Cádiz;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
11 Cádiz;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2022QII;""
11 Cádiz;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2022QI;6.687
11 Cádiz;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
11 Cádiz;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
11 Cádiz;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2021QII;""
11 Cádiz;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2021QI;6.277
11 Cádiz;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
11 Cádiz;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
11 Cádiz;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2020QII;""
11 Cádiz;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2020QI;6.852
11 Cádiz;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
11 Cádiz;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
11 Cádiz;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2022QII;6.429
11 Cádiz;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2022QI;""
11 Cádiz;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
11 Cádiz;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
11 Cádiz;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2021QII;6.037
11 Cádiz;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2021QI;""
11 Cádiz;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
11 Cádiz;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
11 Cádiz;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2020QII;6.640
11 Cádiz;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2020QI;""
11 Cádiz;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
11 Cádiz;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QIII;6.196
11 Cádiz;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QII;""
11 Cádiz;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QI;""
11 Cádiz;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
11 Cádiz;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QIII;5.819
11 Cádiz;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QII;""
11 Cádiz;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QI;""
11 Cádiz;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
11 Cádiz;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QIII;6.401
11 Cádiz;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QII;""
11 Cádiz;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QI;""
11 Cádiz;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QIV;5.886
11 Cádiz;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
11 Cádiz;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QII;""
11 Cádiz;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QI;""
11 Cádiz;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QIV;5.542
11 Cádiz;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
11 Cádiz;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QII;""
11 Cádiz;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QI;""
11 Cádiz;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QIV;6.143
11 Cádiz;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
11 Cádiz;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QII;""
11 Cádiz;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QI;""
11 Cádiz;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
11 Cádiz;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
11 Cádiz;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
11 Cádiz;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
11 Cádiz;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
11 Cádiz;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
11 Cádiz;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
11 Cádiz;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
11 Cádiz;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
11 Cádiz;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
11 Cádiz;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
11 Cádiz;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
11 Cádiz;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
11 Cádiz;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
11 Cádiz;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
11 Cádiz;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;96,45
11 Cádiz;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
11 Cádiz;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
11 Cádiz;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
11 Cádiz;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;95,92
11 Cádiz;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
11 Cádiz;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
11 Cádiz;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
11 Cádiz;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;92,76
11 Cádiz;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
11 Cádiz;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
11 Cádiz;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;92,73
11 Cádiz;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
11 Cádiz;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
11 Cádiz;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
11 Cádiz;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;92,25
11 Cádiz;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
11 Cádiz;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
11 Cádiz;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
11 Cádiz;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;89,89
11 Cádiz;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
11 Cádiz;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
11 Cádiz;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;89,37
11 Cádiz;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
11 Cádiz;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
11 Cádiz;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
11 Cádiz;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;88,92
11 Cádiz;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
11 Cádiz;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
11 Cádiz;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
11 Cádiz;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;86,65
11 Cádiz;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
11 Cádiz;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
11 Cádiz;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;84,9
11 Cádiz;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
11 Cádiz;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
11 Cádiz;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
11 Cádiz;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;84,69
11 Cádiz;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
11 Cádiz;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
11 Cádiz;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
11 Cádiz;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;83,16
11 Cádiz;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
11 Cádiz;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
11 Cádiz;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
11 Cádiz;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
11 Cádiz;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
11 Cádiz;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
11 Cádiz;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QI;4.739
11 Cádiz;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
11 Cádiz;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
11 Cádiz;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
11 Cádiz;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QI;4.447
11 Cádiz;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
11 Cádiz;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
11 Cádiz;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
11 Cádiz;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QI;4.984
11 Cádiz;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
11 Cádiz;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
11 Cádiz;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2022QII;""
11 Cádiz;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2022QI;4.582
11 Cádiz;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
11 Cádiz;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
11 Cádiz;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2021QII;""
11 Cádiz;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2021QI;4.261
11 Cádiz;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
11 Cádiz;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
11 Cádiz;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2020QII;""
11 Cádiz;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2020QI;4.653
11 Cádiz;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
11 Cádiz;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
11 Cádiz;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2022QII;4.402
11 Cádiz;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2022QI;""
11 Cádiz;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
11 Cádiz;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
11 Cádiz;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2021QII;4.118
11 Cádiz;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2021QI;""
11 Cádiz;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
11 Cádiz;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
11 Cádiz;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2020QII;4.509
11 Cádiz;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2020QI;""
11 Cádiz;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
11 Cádiz;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QIII;4.245
11 Cádiz;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QII;""
11 Cádiz;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QI;""
11 Cádiz;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
11 Cádiz;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QIII;3.996
11 Cádiz;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QII;""
11 Cádiz;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QI;""
11 Cádiz;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
11 Cádiz;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QIII;4.364
11 Cádiz;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QII;""
11 Cádiz;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QI;""
11 Cádiz;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QIV;4.039
11 Cádiz;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
11 Cádiz;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QII;""
11 Cádiz;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QI;""
11 Cádiz;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QIV;3.812
11 Cádiz;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
11 Cádiz;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QII;""
11 Cádiz;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QI;""
11 Cádiz;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QIV;4.197
11 Cádiz;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
11 Cádiz;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QII;""
11 Cádiz;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QI;""
11 Cádiz;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
11 Cádiz;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
11 Cádiz;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
11 Cádiz;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
11 Cádiz;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
11 Cádiz;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
11 Cádiz;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
11 Cádiz;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
11 Cádiz;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
11 Cádiz;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
11 Cádiz;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
11 Cádiz;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
11 Cádiz;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
11 Cádiz;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
11 Cádiz;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
11 Cádiz;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;96,69
11 Cádiz;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
11 Cádiz;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
11 Cádiz;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
11 Cádiz;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;95,82
11 Cádiz;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
11 Cádiz;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
11 Cádiz;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
11 Cádiz;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;93,36
11 Cádiz;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
11 Cádiz;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
11 Cádiz;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;92,89
11 Cádiz;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
11 Cádiz;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
11 Cádiz;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
11 Cádiz;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;92,6
11 Cádiz;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
11 Cádiz;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
11 Cádiz;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
11 Cádiz;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;90,47
11 Cádiz;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
11 Cádiz;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
11 Cádiz;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;89,58
11 Cádiz;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
11 Cádiz;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
11 Cádiz;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
11 Cádiz;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;89,86
11 Cádiz;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
11 Cádiz;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
11 Cádiz;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
11 Cádiz;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;87,56
11 Cádiz;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
11 Cádiz;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
11 Cádiz;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;85,23
11 Cádiz;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
11 Cádiz;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
11 Cádiz;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
11 Cádiz;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;85,72
11 Cádiz;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
11 Cádiz;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
11 Cádiz;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
11 Cádiz;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;84,21
11 Cádiz;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
11 Cádiz;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
11 Cádiz;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
11 Cádiz;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
11 Cádiz;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
11 Cádiz;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
11 Cádiz;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QI;2.194
11 Cádiz;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
11 Cádiz;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
11 Cádiz;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
11 Cádiz;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QI;2.097
11 Cádiz;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
11 Cádiz;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
11 Cádiz;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
11 Cádiz;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QI;2.403
11 Cádiz;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
11 Cádiz;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
11 Cádiz;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2022QII;""
11 Cádiz;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2022QI;2.105
11 Cádiz;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
11 Cádiz;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
11 Cádiz;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2021QII;""
11 Cádiz;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2021QI;2.016
11 Cádiz;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
11 Cádiz;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
11 Cádiz;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2020QII;""
11 Cádiz;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2020QI;2.199
11 Cádiz;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
11 Cádiz;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
11 Cádiz;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2022QII;2.027
11 Cádiz;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2022QI;""
11 Cádiz;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
11 Cádiz;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
11 Cádiz;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2021QII;1.919
11 Cádiz;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2021QI;""
11 Cádiz;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
11 Cádiz;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
11 Cádiz;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2020QII;2.131
11 Cádiz;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2020QI;""
11 Cádiz;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
11 Cádiz;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QIII;1.951
11 Cádiz;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QII;""
11 Cádiz;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QI;""
11 Cádiz;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
11 Cádiz;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QIII;1.823
11 Cádiz;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QII;""
11 Cádiz;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QI;""
11 Cádiz;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
11 Cádiz;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QIII;2.037
11 Cádiz;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QII;""
11 Cádiz;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QI;""
11 Cádiz;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QIV;1.847
11 Cádiz;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
11 Cádiz;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QII;""
11 Cádiz;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QI;""
11 Cádiz;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QIV;1.730
11 Cádiz;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
11 Cádiz;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QII;""
11 Cádiz;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QI;""
11 Cádiz;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QIV;1.946
11 Cádiz;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
11 Cádiz;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QII;""
11 Cádiz;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QI;""
11 Cádiz;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
11 Cádiz;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
11 Cádiz;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
11 Cádiz;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
11 Cádiz;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
11 Cádiz;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
11 Cádiz;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
11 Cádiz;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
11 Cádiz;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
11 Cádiz;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
11 Cádiz;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
11 Cádiz;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
11 Cádiz;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
11 Cádiz;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
11 Cádiz;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
11 Cádiz;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;95,94
11 Cádiz;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
11 Cádiz;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
11 Cádiz;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
11 Cádiz;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;96,14
11 Cádiz;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
11 Cádiz;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
11 Cádiz;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
11 Cádiz;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;91,51
11 Cádiz;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
11 Cádiz;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
11 Cádiz;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;92,39
11 Cádiz;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
11 Cádiz;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
11 Cádiz;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
11 Cádiz;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;91,51
11 Cádiz;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
11 Cádiz;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
11 Cádiz;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
11 Cádiz;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;88,68
11 Cádiz;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
11 Cádiz;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
11 Cádiz;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;88,92
11 Cádiz;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
11 Cádiz;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
11 Cádiz;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
11 Cádiz;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;86,93
11 Cádiz;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
11 Cádiz;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
11 Cádiz;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
11 Cádiz;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;84,77
11 Cádiz;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
11 Cádiz;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
11 Cádiz;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;84,18
11 Cádiz;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
11 Cádiz;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
11 Cádiz;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
11 Cádiz;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;82,5
11 Cádiz;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
11 Cádiz;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
11 Cádiz;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
11 Cádiz;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;80,98
11 Cádiz;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
11 Cádiz;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
11 Cádiz;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
11 Cádiz;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
11 Cádiz;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
11 Cádiz;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QII;7.972
11 Cádiz;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
11 Cádiz;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
11 Cádiz;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
11 Cádiz;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QII;7.474
11 Cádiz;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
11 Cádiz;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
11 Cádiz;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
11 Cádiz;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QII;7.022
11 Cádiz;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
11 Cádiz;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
11 Cádiz;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
11 Cádiz;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2022QII;7.678
11 Cádiz;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2022QI;""
11 Cádiz;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
11 Cádiz;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
11 Cádiz;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2021QII;7.204
11 Cádiz;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2021QI;""
11 Cádiz;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
11 Cádiz;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
11 Cádiz;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2020QII;6.805
11 Cádiz;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2020QI;""
11 Cádiz;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
11 Cádiz;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2022QIII;7.416
11 Cádiz;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2022QII;""
11 Cádiz;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2022QI;""
11 Cádiz;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
11 Cádiz;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2021QIII;6.967
11 Cádiz;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2021QII;""
11 Cádiz;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2021QI;""
11 Cádiz;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
11 Cádiz;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2020QIII;6.538
11 Cádiz;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2020QII;""
11 Cádiz;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2020QI;""
11 Cádiz;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QIV;7.068
11 Cádiz;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
11 Cádiz;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QII;""
11 Cádiz;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QI;""
11 Cádiz;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QIV;6.656
11 Cádiz;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
11 Cádiz;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QII;""
11 Cádiz;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QI;""
11 Cádiz;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QIV;6.273
11 Cádiz;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
11 Cádiz;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QII;""
11 Cádiz;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QI;""
11 Cádiz;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
11 Cádiz;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
11 Cádiz;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QII;""
11 Cádiz;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QI;6.435
11 Cádiz;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
11 Cádiz;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
11 Cádiz;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QII;""
11 Cádiz;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QI;6.025
11 Cádiz;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
11 Cádiz;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
11 Cádiz;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QII;""
11 Cádiz;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QI;""
11 Cádiz;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
11 Cádiz;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
11 Cádiz;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
11 Cádiz;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
11 Cádiz;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
11 Cádiz;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
11 Cádiz;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
11 Cádiz;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
11 Cádiz;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
11 Cádiz;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
11 Cádiz;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
11 Cádiz;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
11 Cádiz;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
11 Cádiz;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
11 Cádiz;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;96,31
11 Cádiz;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
11 Cádiz;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
11 Cádiz;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
11 Cádiz;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;96,39
11 Cádiz;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
11 Cádiz;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
11 Cádiz;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
11 Cádiz;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;96,91
11 Cádiz;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
11 Cádiz;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
11 Cádiz;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;93,03
11 Cádiz;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
11 Cádiz;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
11 Cádiz;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
11 Cádiz;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;93,22
11 Cádiz;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
11 Cádiz;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
11 Cádiz;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
11 Cádiz;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;93,11
11 Cádiz;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
11 Cádiz;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
11 Cádiz;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;88,66
11 Cádiz;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
11 Cádiz;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
11 Cádiz;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
11 Cádiz;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;89,06
11 Cádiz;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
11 Cádiz;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
11 Cádiz;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
11 Cádiz;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;89,33
11 Cádiz;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
11 Cádiz;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
11 Cádiz;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
11 Cádiz;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
11 Cádiz;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
11 Cádiz;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
11 Cádiz;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;86,1
11 Cádiz;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
11 Cádiz;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
11 Cádiz;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
11 Cádiz;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;85,8
11 Cádiz;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
11 Cádiz;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
11 Cádiz;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
11 Cádiz;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
11 Cádiz;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
11 Cádiz;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
11 Cádiz;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QII;5.429
11 Cádiz;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
11 Cádiz;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
11 Cádiz;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
11 Cádiz;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QII;5.098
11 Cádiz;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
11 Cádiz;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
11 Cádiz;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
11 Cádiz;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QII;4.762
11 Cádiz;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
11 Cádiz;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
11 Cádiz;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
11 Cádiz;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2022QII;5.231
11 Cádiz;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2022QI;""
11 Cádiz;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
11 Cádiz;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
11 Cádiz;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2021QII;4.931
11 Cádiz;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2021QI;""
11 Cádiz;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
11 Cádiz;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
11 Cádiz;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2020QII;4.614
11 Cádiz;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2020QI;""
11 Cádiz;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
11 Cádiz;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2022QIII;5.057
11 Cádiz;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2022QII;""
11 Cádiz;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2022QI;""
11 Cádiz;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
11 Cádiz;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2021QIII;4.796
11 Cádiz;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2021QII;""
11 Cádiz;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2021QI;""
11 Cádiz;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
11 Cádiz;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2020QIII;4.449
11 Cádiz;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2020QII;""
11 Cádiz;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2020QI;""
11 Cádiz;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QIV;4.830
11 Cádiz;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
11 Cádiz;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QII;""
11 Cádiz;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QI;""
11 Cádiz;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QIV;4.585
11 Cádiz;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
11 Cádiz;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QII;""
11 Cádiz;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QI;""
11 Cádiz;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QIV;4.278
11 Cádiz;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
11 Cádiz;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QII;""
11 Cádiz;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QI;""
11 Cádiz;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
11 Cádiz;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
11 Cádiz;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QII;""
11 Cádiz;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QI;4.442
11 Cádiz;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
11 Cádiz;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
11 Cádiz;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QII;""
11 Cádiz;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QI;4.107
11 Cádiz;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
11 Cádiz;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
11 Cádiz;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QII;""
11 Cádiz;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QI;""
11 Cádiz;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
11 Cádiz;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
11 Cádiz;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
11 Cádiz;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
11 Cádiz;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
11 Cádiz;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
11 Cádiz;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
11 Cádiz;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
11 Cádiz;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
11 Cádiz;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
11 Cádiz;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
11 Cádiz;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
11 Cádiz;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
11 Cádiz;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
11 Cádiz;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;96,35
11 Cádiz;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
11 Cádiz;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
11 Cádiz;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
11 Cádiz;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;96,72
11 Cádiz;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
11 Cádiz;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
11 Cádiz;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
11 Cádiz;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;96,89
11 Cádiz;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
11 Cádiz;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
11 Cádiz;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;93,15
11 Cádiz;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
11 Cádiz;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
11 Cádiz;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
11 Cádiz;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;94,08
11 Cádiz;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
11 Cádiz;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
11 Cádiz;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
11 Cádiz;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;93,43
11 Cádiz;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
11 Cádiz;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
11 Cádiz;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;88,97
11 Cádiz;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
11 Cádiz;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
11 Cádiz;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
11 Cádiz;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;89,94
11 Cádiz;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
11 Cádiz;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
11 Cádiz;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
11 Cádiz;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;89,84
11 Cádiz;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
11 Cádiz;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
11 Cádiz;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
11 Cádiz;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
11 Cádiz;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
11 Cádiz;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
11 Cádiz;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;87,13
11 Cádiz;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
11 Cádiz;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
11 Cádiz;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
11 Cádiz;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;86,25
11 Cádiz;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
11 Cádiz;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
11 Cádiz;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
11 Cádiz;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
11 Cádiz;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
11 Cádiz;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
11 Cádiz;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QII;2.543
11 Cádiz;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
11 Cádiz;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
11 Cádiz;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
11 Cádiz;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QII;2.376
11 Cádiz;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
11 Cádiz;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
11 Cádiz;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
11 Cádiz;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QII;2.260
11 Cádiz;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
11 Cádiz;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
11 Cádiz;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
11 Cádiz;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2022QII;2.447
11 Cádiz;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2022QI;""
11 Cádiz;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
11 Cádiz;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
11 Cádiz;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2021QII;2.273
11 Cádiz;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2021QI;""
11 Cádiz;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
11 Cádiz;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
11 Cádiz;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2020QII;2.191
11 Cádiz;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2020QI;""
11 Cádiz;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
11 Cádiz;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2022QIII;2.359
11 Cádiz;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2022QII;""
11 Cádiz;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2022QI;""
11 Cádiz;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
11 Cádiz;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2021QIII;2.171
11 Cádiz;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2021QII;""
11 Cádiz;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2021QI;""
11 Cádiz;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
11 Cádiz;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2020QIII;2.089
11 Cádiz;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2020QII;""
11 Cádiz;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2020QI;""
11 Cádiz;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QIV;2.238
11 Cádiz;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
11 Cádiz;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QII;""
11 Cádiz;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QI;""
11 Cádiz;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QIV;2.071
11 Cádiz;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
11 Cádiz;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QII;""
11 Cádiz;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QI;""
11 Cádiz;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QIV;1.995
11 Cádiz;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
11 Cádiz;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QII;""
11 Cádiz;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QI;""
11 Cádiz;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
11 Cádiz;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
11 Cádiz;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QII;""
11 Cádiz;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QI;1.993
11 Cádiz;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
11 Cádiz;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
11 Cádiz;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QII;""
11 Cádiz;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QI;1.918
11 Cádiz;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
11 Cádiz;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
11 Cádiz;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QII;""
11 Cádiz;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QI;""
11 Cádiz;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
11 Cádiz;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
11 Cádiz;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
11 Cádiz;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
11 Cádiz;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
11 Cádiz;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
11 Cádiz;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
11 Cádiz;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
11 Cádiz;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
11 Cádiz;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
11 Cádiz;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
11 Cádiz;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
11 Cádiz;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
11 Cádiz;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
11 Cádiz;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;96,22
11 Cádiz;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
11 Cádiz;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
11 Cádiz;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
11 Cádiz;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;95,66
11 Cádiz;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
11 Cádiz;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
11 Cádiz;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
11 Cádiz;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;96,95
11 Cádiz;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
11 Cádiz;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
11 Cádiz;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;92,76
11 Cádiz;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
11 Cádiz;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
11 Cádiz;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
11 Cádiz;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;91,37
11 Cádiz;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
11 Cádiz;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
11 Cádiz;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
11 Cádiz;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;92,43
11 Cádiz;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
11 Cádiz;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
11 Cádiz;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;88,01
11 Cádiz;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
11 Cádiz;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
11 Cádiz;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
11 Cádiz;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;87,16
11 Cádiz;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
11 Cádiz;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
11 Cádiz;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
11 Cádiz;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;88,27
11 Cádiz;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
11 Cádiz;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
11 Cádiz;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
11 Cádiz;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
11 Cádiz;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
11 Cádiz;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
11 Cádiz;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;83,88
11 Cádiz;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
11 Cádiz;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
11 Cádiz;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
11 Cádiz;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;84,87
11 Cádiz;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
11 Cádiz;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
11 Cádiz;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
11 Cádiz;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
11 Cádiz;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
11 Cádiz;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QIII;7.870
11 Cádiz;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
11 Cádiz;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
11 Cádiz;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
11 Cádiz;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QIII;7.392
11 Cádiz;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
11 Cádiz;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
11 Cádiz;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
11 Cádiz;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QIII;6.957
11 Cádiz;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
11 Cádiz;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
11 Cádiz;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
11 Cádiz;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2022QIII;7.546
11 Cádiz;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2022QII;""
11 Cádiz;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2022QI;""
11 Cádiz;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
11 Cádiz;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2021QIII;7.093
11 Cádiz;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2021QII;""
11 Cádiz;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2021QI;""
11 Cádiz;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
11 Cádiz;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2020QIII;6.641
11 Cádiz;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2020QII;""
11 Cádiz;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2020QI;""
11 Cádiz;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2022QIV;7.152
11 Cádiz;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
11 Cádiz;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2022QII;""
11 Cádiz;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2022QI;""
11 Cádiz;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2021QIV;6.744
11 Cádiz;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
11 Cádiz;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2021QII;""
11 Cádiz;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2021QI;""
11 Cádiz;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2020QIV;6.352
11 Cádiz;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
11 Cádiz;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2020QII;""
11 Cádiz;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2020QI;""
11 Cádiz;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
11 Cádiz;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
11 Cádiz;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QII;""
11 Cádiz;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QI;6.515
11 Cádiz;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
11 Cádiz;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
11 Cádiz;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QII;""
11 Cádiz;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QI;6.097
11 Cádiz;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
11 Cádiz;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
11 Cádiz;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QII;""
11 Cádiz;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QI;""
11 Cádiz;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
11 Cádiz;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
11 Cádiz;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QII;6.280
11 Cádiz;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QI;""
11 Cádiz;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
11 Cádiz;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
11 Cádiz;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QII;5.880
11 Cádiz;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QI;""
11 Cádiz;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
11 Cádiz;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
11 Cádiz;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QII;""
11 Cádiz;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QI;""
11 Cádiz;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
11 Cádiz;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
11 Cádiz;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
11 Cádiz;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
11 Cádiz;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
11 Cádiz;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
11 Cádiz;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
11 Cádiz;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
11 Cádiz;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
11 Cádiz;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
11 Cádiz;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
11 Cádiz;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
11 Cádiz;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
11 Cádiz;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;95,88
11 Cádiz;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
11 Cádiz;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
11 Cádiz;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
11 Cádiz;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;95,96
11 Cádiz;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
11 Cádiz;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
11 Cádiz;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
11 Cádiz;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;95,46
11 Cádiz;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
11 Cádiz;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
11 Cádiz;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;90,88
11 Cádiz;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
11 Cádiz;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
11 Cádiz;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
11 Cádiz;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;91,23
11 Cádiz;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
11 Cádiz;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
11 Cádiz;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
11 Cádiz;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;91,3
11 Cádiz;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
11 Cádiz;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
11 Cádiz;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
11 Cádiz;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
11 Cádiz;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
11 Cádiz;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
11 Cádiz;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;88,14
11 Cádiz;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
11 Cádiz;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
11 Cádiz;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
11 Cádiz;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;87,64
11 Cádiz;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
11 Cádiz;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
11 Cádiz;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
11 Cádiz;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
11 Cádiz;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
11 Cádiz;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
11 Cádiz;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;84,96
11 Cádiz;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
11 Cádiz;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
11 Cádiz;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
11 Cádiz;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;84,52
11 Cádiz;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
11 Cádiz;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
11 Cádiz;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
11 Cádiz;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
11 Cádiz;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
11 Cádiz;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
11 Cádiz;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QIII;5.340
11 Cádiz;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
11 Cádiz;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
11 Cádiz;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
11 Cádiz;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QIII;5.036
11 Cádiz;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
11 Cádiz;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
11 Cádiz;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
11 Cádiz;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QIII;4.706
11 Cádiz;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
11 Cádiz;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
11 Cádiz;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
11 Cádiz;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2022QIII;5.134
11 Cádiz;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2022QII;""
11 Cádiz;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2022QI;""
11 Cádiz;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
11 Cádiz;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2021QIII;4.869
11 Cádiz;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2021QII;""
11 Cádiz;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2021QI;""
11 Cádiz;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
11 Cádiz;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2020QIII;4.515
11 Cádiz;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2020QII;""
11 Cádiz;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2020QI;""
11 Cádiz;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2022QIV;4.878
11 Cádiz;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
11 Cádiz;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2022QII;""
11 Cádiz;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2022QI;""
11 Cádiz;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2021QIV;4.634
11 Cádiz;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
11 Cádiz;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2021QII;""
11 Cádiz;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2021QI;""
11 Cádiz;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2020QIV;4.327
11 Cádiz;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
11 Cádiz;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2020QII;""
11 Cádiz;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2020QI;""
11 Cádiz;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
11 Cádiz;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
11 Cádiz;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QII;""
11 Cádiz;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QI;4.488
11 Cádiz;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
11 Cádiz;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
11 Cádiz;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QII;""
11 Cádiz;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QI;4.150
11 Cádiz;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
11 Cádiz;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
11 Cádiz;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QII;""
11 Cádiz;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QI;""
11 Cádiz;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
11 Cádiz;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
11 Cádiz;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QII;4.324
11 Cádiz;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QI;""
11 Cádiz;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
11 Cádiz;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
11 Cádiz;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QII;4.021
11 Cádiz;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QI;""
11 Cádiz;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
11 Cádiz;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
11 Cádiz;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QII;""
11 Cádiz;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QI;""
11 Cádiz;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
11 Cádiz;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
11 Cádiz;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
11 Cádiz;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
11 Cádiz;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
11 Cádiz;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
11 Cádiz;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
11 Cádiz;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
11 Cádiz;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
11 Cádiz;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
11 Cádiz;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
11 Cádiz;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
11 Cádiz;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
11 Cádiz;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;96,14
11 Cádiz;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
11 Cádiz;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
11 Cádiz;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
11 Cádiz;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;96,68
11 Cádiz;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
11 Cádiz;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
11 Cádiz;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
11 Cádiz;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;95,94
11 Cádiz;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
11 Cádiz;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
11 Cádiz;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;91,35
11 Cádiz;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
11 Cádiz;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
11 Cádiz;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
11 Cádiz;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;92,02
11 Cádiz;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
11 Cádiz;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
11 Cádiz;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
11 Cádiz;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;91,95
11 Cádiz;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
11 Cádiz;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
11 Cádiz;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
11 Cádiz;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
11 Cádiz;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
11 Cádiz;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
11 Cádiz;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;89,12
11 Cádiz;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
11 Cádiz;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
11 Cádiz;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
11 Cádiz;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;88,19
11 Cádiz;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
11 Cádiz;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
11 Cádiz;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
11 Cádiz;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
11 Cádiz;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
11 Cádiz;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
11 Cádiz;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;85,86
11 Cádiz;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
11 Cádiz;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
11 Cádiz;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
11 Cádiz;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;85,44
11 Cádiz;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
11 Cádiz;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
11 Cádiz;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
11 Cádiz;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
11 Cádiz;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
11 Cádiz;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
11 Cádiz;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QIII;2.530
11 Cádiz;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
11 Cádiz;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
11 Cádiz;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
11 Cádiz;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QIII;2.356
11 Cádiz;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
11 Cádiz;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
11 Cádiz;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
11 Cádiz;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QIII;2.251
11 Cádiz;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
11 Cádiz;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
11 Cádiz;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
11 Cádiz;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2022QIII;2.412
11 Cádiz;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2022QII;""
11 Cádiz;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2022QI;""
11 Cádiz;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
11 Cádiz;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2021QIII;2.224
11 Cádiz;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2021QII;""
11 Cádiz;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2021QI;""
11 Cádiz;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
11 Cádiz;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2020QIII;2.126
11 Cádiz;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2020QII;""
11 Cádiz;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2020QI;""
11 Cádiz;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2022QIV;2.274
11 Cádiz;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
11 Cádiz;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2022QII;""
11 Cádiz;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2022QI;""
11 Cádiz;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2021QIV;2.110
11 Cádiz;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
11 Cádiz;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2021QII;""
11 Cádiz;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2021QI;""
11 Cádiz;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2020QIV;2.025
11 Cádiz;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
11 Cádiz;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2020QII;""
11 Cádiz;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2020QI;""
11 Cádiz;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
11 Cádiz;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
11 Cádiz;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QII;""
11 Cádiz;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QI;2.027
11 Cádiz;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
11 Cádiz;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
11 Cádiz;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QII;""
11 Cádiz;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QI;1.947
11 Cádiz;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
11 Cádiz;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
11 Cádiz;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QII;""
11 Cádiz;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QI;""
11 Cádiz;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
11 Cádiz;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
11 Cádiz;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QII;1.956
11 Cádiz;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QI;""
11 Cádiz;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
11 Cádiz;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
11 Cádiz;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QII;1.859
11 Cádiz;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QI;""
11 Cádiz;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
11 Cádiz;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
11 Cádiz;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QII;""
11 Cádiz;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QI;""
11 Cádiz;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
11 Cádiz;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
11 Cádiz;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
11 Cádiz;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
11 Cádiz;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
11 Cádiz;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
11 Cádiz;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
11 Cádiz;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
11 Cádiz;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
11 Cádiz;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
11 Cádiz;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
11 Cádiz;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
11 Cádiz;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
11 Cádiz;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;95,34
11 Cádiz;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
11 Cádiz;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
11 Cádiz;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
11 Cádiz;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;94,4
11 Cádiz;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
11 Cádiz;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
11 Cádiz;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
11 Cádiz;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;94,45
11 Cádiz;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
11 Cádiz;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
11 Cádiz;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;89,88
11 Cádiz;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
11 Cádiz;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
11 Cádiz;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
11 Cádiz;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;89,56
11 Cádiz;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
11 Cádiz;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
11 Cádiz;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
11 Cádiz;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;89,96
11 Cádiz;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
11 Cádiz;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
11 Cádiz;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
11 Cádiz;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
11 Cádiz;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
11 Cádiz;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
11 Cádiz;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;86,04
11 Cádiz;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
11 Cádiz;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
11 Cádiz;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
11 Cádiz;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;86,49
11 Cádiz;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
11 Cádiz;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
11 Cádiz;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
11 Cádiz;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
11 Cádiz;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
11 Cádiz;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
11 Cádiz;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;83,02
11 Cádiz;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
11 Cádiz;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
11 Cádiz;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
11 Cádiz;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;82,59
11 Cádiz;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
11 Cádiz;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
11 Cádiz;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
11 Cádiz;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
11 Cádiz;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
11 Cádiz;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QIV;7.665
11 Cádiz;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
11 Cádiz;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
11 Cádiz;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
11 Cádiz;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QIV;7.191
11 Cádiz;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
11 Cádiz;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
11 Cádiz;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
11 Cádiz;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QIV;6.762
11 Cádiz;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
11 Cádiz;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
11 Cádiz;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
11 Cádiz;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2022QIV;7.247
11 Cádiz;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
11 Cádiz;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2022QII;""
11 Cádiz;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2022QI;""
11 Cádiz;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2021QIV;6.822
11 Cádiz;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
11 Cádiz;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2021QII;""
11 Cádiz;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2021QI;""
11 Cádiz;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2020QIV;6.455
11 Cádiz;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
11 Cádiz;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2020QII;""
11 Cádiz;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2020QI;""
11 Cádiz;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
11 Cádiz;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
11 Cádiz;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2022QII;""
11 Cádiz;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2022QI;6.588
11 Cádiz;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
11 Cádiz;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
11 Cádiz;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2021QII;""
11 Cádiz;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2021QI;6.196
11 Cádiz;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
11 Cádiz;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
11 Cádiz;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2020QII;""
11 Cádiz;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2020QI;""
11 Cádiz;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
11 Cádiz;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
11 Cádiz;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QII;6.347
11 Cádiz;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QI;""
11 Cádiz;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
11 Cádiz;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
11 Cádiz;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QII;5.967
11 Cádiz;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QI;""
11 Cádiz;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
11 Cádiz;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
11 Cádiz;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QII;""
11 Cádiz;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QI;""
11 Cádiz;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
11 Cádiz;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QIII;6.122
11 Cádiz;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QII;""
11 Cádiz;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QI;""
11 Cádiz;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
11 Cádiz;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QIII;5.758
11 Cádiz;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QII;""
11 Cádiz;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QI;""
11 Cádiz;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
11 Cádiz;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
11 Cádiz;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QII;""
11 Cádiz;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QI;""
11 Cádiz;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
11 Cádiz;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
11 Cádiz;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
11 Cádiz;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
11 Cádiz;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
11 Cádiz;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
11 Cádiz;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
11 Cádiz;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
11 Cádiz;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
11 Cádiz;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
11 Cádiz;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
11 Cádiz;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
11 Cádiz;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;94,55
11 Cádiz;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
11 Cádiz;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
11 Cádiz;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
11 Cádiz;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;94,87
11 Cádiz;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
11 Cádiz;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
11 Cádiz;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
11 Cádiz;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;95,46
11 Cádiz;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
11 Cádiz;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
11 Cádiz;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
11 Cádiz;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
11 Cádiz;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
11 Cádiz;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
11 Cádiz;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;91,61
11 Cádiz;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
11 Cádiz;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
11 Cádiz;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
11 Cádiz;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;91,63
11 Cádiz;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
11 Cádiz;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
11 Cádiz;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
11 Cádiz;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
11 Cádiz;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
11 Cádiz;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
11 Cádiz;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;88,26
11 Cádiz;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
11 Cádiz;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
11 Cádiz;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
11 Cádiz;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;88,24
11 Cádiz;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
11 Cádiz;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
11 Cádiz;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
11 Cádiz;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
11 Cádiz;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
11 Cádiz;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
11 Cádiz;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;85,13
11 Cádiz;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
11 Cádiz;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
11 Cádiz;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
11 Cádiz;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;85,15
11 Cádiz;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
11 Cádiz;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
11 Cádiz;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
11 Cádiz;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
11 Cádiz;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
11 Cádiz;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
11 Cádiz;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QIV;5.199
11 Cádiz;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
11 Cádiz;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
11 Cádiz;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
11 Cádiz;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QIV;4.924
11 Cádiz;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
11 Cádiz;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
11 Cádiz;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
11 Cádiz;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QIV;4.588
11 Cádiz;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
11 Cádiz;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
11 Cádiz;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
11 Cádiz;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2022QIV;4.927
11 Cádiz;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
11 Cádiz;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2022QII;""
11 Cádiz;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2022QI;""
11 Cádiz;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2021QIV;4.674
11 Cádiz;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
11 Cádiz;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2021QII;""
11 Cádiz;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2021QI;""
11 Cádiz;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2020QIV;4.389
11 Cádiz;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
11 Cádiz;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2020QII;""
11 Cádiz;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2020QI;""
11 Cádiz;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
11 Cádiz;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
11 Cádiz;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2022QII;""
11 Cádiz;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2022QI;4.525
11 Cádiz;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
11 Cádiz;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
11 Cádiz;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2021QII;""
11 Cádiz;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2021QI;4.208
11 Cádiz;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
11 Cádiz;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
11 Cádiz;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2020QII;""
11 Cádiz;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2020QI;""
11 Cádiz;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
11 Cádiz;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
11 Cádiz;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QII;4.357
11 Cádiz;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QI;""
11 Cádiz;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
11 Cádiz;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
11 Cádiz;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QII;4.074
11 Cádiz;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QI;""
11 Cádiz;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
11 Cádiz;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
11 Cádiz;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QII;""
11 Cádiz;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QI;""
11 Cádiz;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
11 Cádiz;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QIII;4.208
11 Cádiz;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QII;""
11 Cádiz;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QI;""
11 Cádiz;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
11 Cádiz;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QIII;3.956
11 Cádiz;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QII;""
11 Cádiz;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QI;""
11 Cádiz;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
11 Cádiz;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
11 Cádiz;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QII;""
11 Cádiz;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QI;""
11 Cádiz;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
11 Cádiz;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
11 Cádiz;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
11 Cádiz;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
11 Cádiz;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
11 Cádiz;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
11 Cádiz;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
11 Cádiz;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
11 Cádiz;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
11 Cádiz;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
11 Cádiz;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
11 Cádiz;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
11 Cádiz;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;94,77
11 Cádiz;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
11 Cádiz;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
11 Cádiz;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
11 Cádiz;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;94,92
11 Cádiz;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
11 Cádiz;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
11 Cádiz;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
11 Cádiz;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;95,66
11 Cádiz;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
11 Cádiz;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
11 Cádiz;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
11 Cádiz;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
11 Cádiz;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
11 Cádiz;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
11 Cádiz;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;91,9
11 Cádiz;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
11 Cádiz;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
11 Cádiz;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
11 Cádiz;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;91,72
11 Cádiz;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
11 Cádiz;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
11 Cádiz;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
11 Cádiz;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
11 Cádiz;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
11 Cádiz;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
11 Cádiz;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;88,48
11 Cádiz;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
11 Cádiz;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
11 Cádiz;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
11 Cádiz;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;88,8
11 Cádiz;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
11 Cádiz;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
11 Cádiz;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
11 Cádiz;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
11 Cádiz;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
11 Cádiz;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
11 Cádiz;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;85,46
11 Cádiz;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
11 Cádiz;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
11 Cádiz;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
11 Cádiz;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;86,22
11 Cádiz;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
11 Cádiz;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
11 Cádiz;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
11 Cádiz;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
11 Cádiz;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
11 Cádiz;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
11 Cádiz;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QIV;2.466
11 Cádiz;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
11 Cádiz;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
11 Cádiz;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
11 Cádiz;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QIV;2.267
11 Cádiz;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
11 Cádiz;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
11 Cádiz;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
11 Cádiz;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QIV;2.174
11 Cádiz;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
11 Cádiz;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
11 Cádiz;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
11 Cádiz;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2022QIV;2.320
11 Cádiz;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
11 Cádiz;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2022QII;""
11 Cádiz;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2022QI;""
11 Cádiz;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2021QIV;2.148
11 Cádiz;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
11 Cádiz;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2021QII;""
11 Cádiz;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2021QI;""
11 Cádiz;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2020QIV;2.066
11 Cádiz;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
11 Cádiz;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2020QII;""
11 Cádiz;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2020QI;""
11 Cádiz;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
11 Cádiz;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
11 Cádiz;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2022QII;""
11 Cádiz;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2022QI;2.063
11 Cádiz;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
11 Cádiz;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
11 Cádiz;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2021QII;""
11 Cádiz;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2021QI;1.988
11 Cádiz;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
11 Cádiz;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
11 Cádiz;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2020QII;""
11 Cádiz;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2020QI;""
11 Cádiz;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
11 Cádiz;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
11 Cádiz;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QII;1.990
11 Cádiz;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QI;""
11 Cádiz;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
11 Cádiz;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
11 Cádiz;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QII;1.893
11 Cádiz;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QI;""
11 Cádiz;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
11 Cádiz;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
11 Cádiz;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QII;""
11 Cádiz;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QI;""
11 Cádiz;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
11 Cádiz;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QIII;1.914
11 Cádiz;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QII;""
11 Cádiz;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QI;""
11 Cádiz;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
11 Cádiz;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QIII;1.802
11 Cádiz;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QII;""
11 Cádiz;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QI;""
11 Cádiz;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
11 Cádiz;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
11 Cádiz;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QII;""
11 Cádiz;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QI;""
11 Cádiz;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
11 Cádiz;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
11 Cádiz;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
11 Cádiz;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
11 Cádiz;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
11 Cádiz;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
11 Cádiz;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
11 Cádiz;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
11 Cádiz;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
11 Cádiz;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
11 Cádiz;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
11 Cádiz;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
11 Cádiz;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;94,08
11 Cádiz;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
11 Cádiz;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
11 Cádiz;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
11 Cádiz;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;94,75
11 Cádiz;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
11 Cádiz;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
11 Cádiz;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
11 Cádiz;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;95,03
11 Cádiz;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
11 Cádiz;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
11 Cádiz;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
11 Cádiz;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
11 Cádiz;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
11 Cádiz;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
11 Cádiz;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;91
11 Cádiz;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
11 Cádiz;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
11 Cádiz;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
11 Cádiz;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;91,44
11 Cádiz;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
11 Cádiz;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
11 Cádiz;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
11 Cádiz;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
11 Cádiz;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
11 Cádiz;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
11 Cádiz;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;87,78
11 Cádiz;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
11 Cádiz;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
11 Cádiz;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
11 Cádiz;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;87,07
11 Cádiz;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
11 Cádiz;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
11 Cádiz;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
11 Cádiz;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
11 Cádiz;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
11 Cádiz;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
11 Cádiz;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;84,43
11 Cádiz;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
11 Cádiz;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
11 Cádiz;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
11 Cádiz;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;82,89
11 Cádiz;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
11 Cádiz;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
11 Cádiz;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
11 Cádiz;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
11 Cádiz;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
11 Cádiz;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
39 Cantabria;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
39 Cantabria;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
39 Cantabria;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
39 Cantabria;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QI;36.852
39 Cantabria;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
39 Cantabria;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
39 Cantabria;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
39 Cantabria;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QI;36.407
39 Cantabria;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
39 Cantabria;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
39 Cantabria;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
39 Cantabria;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QI;36.854
39 Cantabria;All ages;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
39 Cantabria;All ages;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
39 Cantabria;All ages;Cohort January 1;Total;Survival in the first trimester;2022QII;""
39 Cantabria;All ages;Cohort January 1;Total;Survival in the first trimester;2022QI;35.892
39 Cantabria;All ages;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
39 Cantabria;All ages;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
39 Cantabria;All ages;Cohort January 1;Total;Survival in the first trimester;2021QII;""
39 Cantabria;All ages;Cohort January 1;Total;Survival in the first trimester;2021QI;35.662
39 Cantabria;All ages;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
39 Cantabria;All ages;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
39 Cantabria;All ages;Cohort January 1;Total;Survival in the first trimester;2020QII;""
39 Cantabria;All ages;Cohort January 1;Total;Survival in the first trimester;2020QI;35.021
39 Cantabria;All ages;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
39 Cantabria;All ages;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
39 Cantabria;All ages;Cohort January 1;Total;Survival in the second trimester;2022QII;34.981
39 Cantabria;All ages;Cohort January 1;Total;Survival in the second trimester;2022QI;""
39 Cantabria;All ages;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
39 Cantabria;All ages;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
39 Cantabria;All ages;Cohort January 1;Total;Survival in the second trimester;2021QII;34.907
39 Cantabria;All ages;Cohort January 1;Total;Survival in the second trimester;2021QI;""
39 Cantabria;All ages;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
39 Cantabria;All ages;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
39 Cantabria;All ages;Cohort January 1;Total;Survival in the second trimester;2020QII;34.413
39 Cantabria;All ages;Cohort January 1;Total;Survival in the second trimester;2020QI;""
39 Cantabria;All ages;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
39 Cantabria;All ages;Cohort January 1;Total;Survival in the third trimester;2022QIII;34.293
39 Cantabria;All ages;Cohort January 1;Total;Survival in the third trimester;2022QII;""
39 Cantabria;All ages;Cohort January 1;Total;Survival in the third trimester;2022QI;""
39 Cantabria;All ages;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
39 Cantabria;All ages;Cohort January 1;Total;Survival in the third trimester;2021QIII;34.209
39 Cantabria;All ages;Cohort January 1;Total;Survival in the third trimester;2021QII;""
39 Cantabria;All ages;Cohort January 1;Total;Survival in the third trimester;2021QI;""
39 Cantabria;All ages;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
39 Cantabria;All ages;Cohort January 1;Total;Survival in the third trimester;2020QIII;33.748
39 Cantabria;All ages;Cohort January 1;Total;Survival in the third trimester;2020QII;""
39 Cantabria;All ages;Cohort January 1;Total;Survival in the third trimester;2020QI;""
39 Cantabria;All ages;Cohort January 1;Total;Survival in the third trimester;2022QIV;33.346
39 Cantabria;All ages;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
39 Cantabria;All ages;Cohort January 1;Total;Survival in the third trimester;2022QII;""
39 Cantabria;All ages;Cohort January 1;Total;Survival in the third trimester;2022QI;""
39 Cantabria;All ages;Cohort January 1;Total;Survival in the third trimester;2021QIV;33.431
39 Cantabria;All ages;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
39 Cantabria;All ages;Cohort January 1;Total;Survival in the third trimester;2021QII;""
39 Cantabria;All ages;Cohort January 1;Total;Survival in the third trimester;2021QI;""
39 Cantabria;All ages;Cohort January 1;Total;Survival in the third trimester;2020QIV;32.958
39 Cantabria;All ages;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
39 Cantabria;All ages;Cohort January 1;Total;Survival in the third trimester;2020QII;""
39 Cantabria;All ages;Cohort January 1;Total;Survival in the third trimester;2020QI;""
39 Cantabria;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
39 Cantabria;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
39 Cantabria;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
39 Cantabria;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
39 Cantabria;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
39 Cantabria;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
39 Cantabria;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
39 Cantabria;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
39 Cantabria;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
39 Cantabria;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
39 Cantabria;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
39 Cantabria;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
39 Cantabria;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
39 Cantabria;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
39 Cantabria;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
39 Cantabria;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;97,39
39 Cantabria;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
39 Cantabria;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
39 Cantabria;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
39 Cantabria;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;97,95
39 Cantabria;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
39 Cantabria;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
39 Cantabria;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
39 Cantabria;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;95,03
39 Cantabria;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
39 Cantabria;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
39 Cantabria;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;94,92
39 Cantabria;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
39 Cantabria;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
39 Cantabria;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
39 Cantabria;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;95,88
39 Cantabria;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
39 Cantabria;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
39 Cantabria;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
39 Cantabria;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;93,38
39 Cantabria;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
39 Cantabria;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
39 Cantabria;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;93,06
39 Cantabria;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
39 Cantabria;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
39 Cantabria;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
39 Cantabria;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;93,96
39 Cantabria;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
39 Cantabria;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
39 Cantabria;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
39 Cantabria;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;91,57
39 Cantabria;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
39 Cantabria;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
39 Cantabria;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;90,49
39 Cantabria;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
39 Cantabria;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
39 Cantabria;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
39 Cantabria;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;91,83
39 Cantabria;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
39 Cantabria;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
39 Cantabria;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
39 Cantabria;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;89,43
39 Cantabria;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
39 Cantabria;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
39 Cantabria;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
39 Cantabria;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
39 Cantabria;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
39 Cantabria;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
39 Cantabria;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QI;22.940
39 Cantabria;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
39 Cantabria;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
39 Cantabria;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
39 Cantabria;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QI;22.770
39 Cantabria;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
39 Cantabria;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
39 Cantabria;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
39 Cantabria;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QI;23.067
39 Cantabria;All ages;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
39 Cantabria;All ages;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
39 Cantabria;All ages;Cohort January 1;Males;Survival in the first trimester;2022QII;""
39 Cantabria;All ages;Cohort January 1;Males;Survival in the first trimester;2022QI;22.367
39 Cantabria;All ages;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
39 Cantabria;All ages;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
39 Cantabria;All ages;Cohort January 1;Males;Survival in the first trimester;2021QII;""
39 Cantabria;All ages;Cohort January 1;Males;Survival in the first trimester;2021QI;22.298
39 Cantabria;All ages;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
39 Cantabria;All ages;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
39 Cantabria;All ages;Cohort January 1;Males;Survival in the first trimester;2020QII;""
39 Cantabria;All ages;Cohort January 1;Males;Survival in the first trimester;2020QI;21.928
39 Cantabria;All ages;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
39 Cantabria;All ages;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
39 Cantabria;All ages;Cohort January 1;Males;Survival in the second trimester;2022QII;21.843
39 Cantabria;All ages;Cohort January 1;Males;Survival in the second trimester;2022QI;""
39 Cantabria;All ages;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
39 Cantabria;All ages;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
39 Cantabria;All ages;Cohort January 1;Males;Survival in the second trimester;2021QII;21.868
39 Cantabria;All ages;Cohort January 1;Males;Survival in the second trimester;2021QI;""
39 Cantabria;All ages;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
39 Cantabria;All ages;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
39 Cantabria;All ages;Cohort January 1;Males;Survival in the second trimester;2020QII;21.591
39 Cantabria;All ages;Cohort January 1;Males;Survival in the second trimester;2020QI;""
39 Cantabria;All ages;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
39 Cantabria;All ages;Cohort January 1;Males;Survival in the third trimester;2022QIII;21.433
39 Cantabria;All ages;Cohort January 1;Males;Survival in the third trimester;2022QII;""
39 Cantabria;All ages;Cohort January 1;Males;Survival in the third trimester;2022QI;""
39 Cantabria;All ages;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
39 Cantabria;All ages;Cohort January 1;Males;Survival in the third trimester;2021QIII;21.438
39 Cantabria;All ages;Cohort January 1;Males;Survival in the third trimester;2021QII;""
39 Cantabria;All ages;Cohort January 1;Males;Survival in the third trimester;2021QI;""
39 Cantabria;All ages;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
39 Cantabria;All ages;Cohort January 1;Males;Survival in the third trimester;2020QIII;21.193
39 Cantabria;All ages;Cohort January 1;Males;Survival in the third trimester;2020QII;""
39 Cantabria;All ages;Cohort January 1;Males;Survival in the third trimester;2020QI;""
39 Cantabria;All ages;Cohort January 1;Males;Survival in the third trimester;2022QIV;20.829
39 Cantabria;All ages;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
39 Cantabria;All ages;Cohort January 1;Males;Survival in the third trimester;2022QII;""
39 Cantabria;All ages;Cohort January 1;Males;Survival in the third trimester;2022QI;""
39 Cantabria;All ages;Cohort January 1;Males;Survival in the third trimester;2021QIV;20.952
39 Cantabria;All ages;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
39 Cantabria;All ages;Cohort January 1;Males;Survival in the third trimester;2021QII;""
39 Cantabria;All ages;Cohort January 1;Males;Survival in the third trimester;2021QI;""
39 Cantabria;All ages;Cohort January 1;Males;Survival in the third trimester;2020QIV;20.719
39 Cantabria;All ages;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
39 Cantabria;All ages;Cohort January 1;Males;Survival in the third trimester;2020QII;""
39 Cantabria;All ages;Cohort January 1;Males;Survival in the third trimester;2020QI;""
39 Cantabria;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
39 Cantabria;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
39 Cantabria;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
39 Cantabria;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
39 Cantabria;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
39 Cantabria;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
39 Cantabria;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
39 Cantabria;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
39 Cantabria;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
39 Cantabria;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
39 Cantabria;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
39 Cantabria;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
39 Cantabria;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
39 Cantabria;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
39 Cantabria;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
39 Cantabria;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;97,5
39 Cantabria;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
39 Cantabria;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
39 Cantabria;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
39 Cantabria;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;97,93
39 Cantabria;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
39 Cantabria;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
39 Cantabria;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
39 Cantabria;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;95,06
39 Cantabria;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
39 Cantabria;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
39 Cantabria;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;95,22
39 Cantabria;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
39 Cantabria;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
39 Cantabria;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
39 Cantabria;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;96,04
39 Cantabria;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
39 Cantabria;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
39 Cantabria;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
39 Cantabria;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;93,6
39 Cantabria;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
39 Cantabria;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
39 Cantabria;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;93,43
39 Cantabria;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
39 Cantabria;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
39 Cantabria;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
39 Cantabria;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;94,15
39 Cantabria;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
39 Cantabria;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
39 Cantabria;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
39 Cantabria;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;91,88
39 Cantabria;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
39 Cantabria;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
39 Cantabria;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;90,8
39 Cantabria;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
39 Cantabria;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
39 Cantabria;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
39 Cantabria;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;92,02
39 Cantabria;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
39 Cantabria;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
39 Cantabria;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
39 Cantabria;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;89,82
39 Cantabria;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
39 Cantabria;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
39 Cantabria;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
39 Cantabria;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
39 Cantabria;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
39 Cantabria;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
39 Cantabria;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QI;13.912
39 Cantabria;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
39 Cantabria;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
39 Cantabria;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
39 Cantabria;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QI;13.637
39 Cantabria;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
39 Cantabria;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
39 Cantabria;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
39 Cantabria;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QI;13.787
39 Cantabria;All ages;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
39 Cantabria;All ages;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
39 Cantabria;All ages;Cohort January 1;Females;Survival in the first trimester;2022QII;""
39 Cantabria;All ages;Cohort January 1;Females;Survival in the first trimester;2022QI;13.525
39 Cantabria;All ages;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
39 Cantabria;All ages;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
39 Cantabria;All ages;Cohort January 1;Females;Survival in the first trimester;2021QII;""
39 Cantabria;All ages;Cohort January 1;Females;Survival in the first trimester;2021QI;13.364
39 Cantabria;All ages;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
39 Cantabria;All ages;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
39 Cantabria;All ages;Cohort January 1;Females;Survival in the first trimester;2020QII;""
39 Cantabria;All ages;Cohort January 1;Females;Survival in the first trimester;2020QI;13.093
39 Cantabria;All ages;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
39 Cantabria;All ages;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
39 Cantabria;All ages;Cohort January 1;Females;Survival in the second trimester;2022QII;13.138
39 Cantabria;All ages;Cohort January 1;Females;Survival in the second trimester;2022QI;""
39 Cantabria;All ages;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
39 Cantabria;All ages;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
39 Cantabria;All ages;Cohort January 1;Females;Survival in the second trimester;2021QII;13.039
39 Cantabria;All ages;Cohort January 1;Females;Survival in the second trimester;2021QI;""
39 Cantabria;All ages;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
39 Cantabria;All ages;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
39 Cantabria;All ages;Cohort January 1;Females;Survival in the second trimester;2020QII;12.822
39 Cantabria;All ages;Cohort January 1;Females;Survival in the second trimester;2020QI;""
39 Cantabria;All ages;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
39 Cantabria;All ages;Cohort January 1;Females;Survival in the third trimester;2022QIII;12.860
39 Cantabria;All ages;Cohort January 1;Females;Survival in the third trimester;2022QII;""
39 Cantabria;All ages;Cohort January 1;Females;Survival in the third trimester;2022QI;""
39 Cantabria;All ages;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
39 Cantabria;All ages;Cohort January 1;Females;Survival in the third trimester;2021QIII;12.771
39 Cantabria;All ages;Cohort January 1;Females;Survival in the third trimester;2021QII;""
39 Cantabria;All ages;Cohort January 1;Females;Survival in the third trimester;2021QI;""
39 Cantabria;All ages;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
39 Cantabria;All ages;Cohort January 1;Females;Survival in the third trimester;2020QIII;12.555
39 Cantabria;All ages;Cohort January 1;Females;Survival in the third trimester;2020QII;""
39 Cantabria;All ages;Cohort January 1;Females;Survival in the third trimester;2020QI;""
39 Cantabria;All ages;Cohort January 1;Females;Survival in the third trimester;2022QIV;12.517
39 Cantabria;All ages;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
39 Cantabria;All ages;Cohort January 1;Females;Survival in the third trimester;2022QII;""
39 Cantabria;All ages;Cohort January 1;Females;Survival in the third trimester;2022QI;""
39 Cantabria;All ages;Cohort January 1;Females;Survival in the third trimester;2021QIV;12.479
39 Cantabria;All ages;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
39 Cantabria;All ages;Cohort January 1;Females;Survival in the third trimester;2021QII;""
39 Cantabria;All ages;Cohort January 1;Females;Survival in the third trimester;2021QI;""
39 Cantabria;All ages;Cohort January 1;Females;Survival in the third trimester;2020QIV;12.239
39 Cantabria;All ages;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
39 Cantabria;All ages;Cohort January 1;Females;Survival in the third trimester;2020QII;""
39 Cantabria;All ages;Cohort January 1;Females;Survival in the third trimester;2020QI;""
39 Cantabria;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
39 Cantabria;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
39 Cantabria;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
39 Cantabria;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
39 Cantabria;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
39 Cantabria;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
39 Cantabria;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
39 Cantabria;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
39 Cantabria;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
39 Cantabria;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
39 Cantabria;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
39 Cantabria;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
39 Cantabria;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
39 Cantabria;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
39 Cantabria;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
39 Cantabria;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;97,22
39 Cantabria;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
39 Cantabria;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
39 Cantabria;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
39 Cantabria;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;98
39 Cantabria;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
39 Cantabria;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
39 Cantabria;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
39 Cantabria;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;94,97
39 Cantabria;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
39 Cantabria;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
39 Cantabria;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;94,44
39 Cantabria;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
39 Cantabria;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
39 Cantabria;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
39 Cantabria;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;95,61
39 Cantabria;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
39 Cantabria;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
39 Cantabria;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
39 Cantabria;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;93
39 Cantabria;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
39 Cantabria;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
39 Cantabria;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;92,44
39 Cantabria;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
39 Cantabria;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
39 Cantabria;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
39 Cantabria;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;93,65
39 Cantabria;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
39 Cantabria;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
39 Cantabria;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
39 Cantabria;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;91,06
39 Cantabria;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
39 Cantabria;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
39 Cantabria;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;89,97
39 Cantabria;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
39 Cantabria;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
39 Cantabria;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
39 Cantabria;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;91,51
39 Cantabria;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
39 Cantabria;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
39 Cantabria;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
39 Cantabria;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;88,77
39 Cantabria;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
39 Cantabria;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
39 Cantabria;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
39 Cantabria;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
39 Cantabria;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
39 Cantabria;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QII;36.949
39 Cantabria;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
39 Cantabria;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
39 Cantabria;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
39 Cantabria;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QII;36.645
39 Cantabria;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
39 Cantabria;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
39 Cantabria;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
39 Cantabria;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QII;36.196
39 Cantabria;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
39 Cantabria;All ages;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
39 Cantabria;All ages;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
39 Cantabria;All ages;Cohort April 1;Total;Survival in the first trimester;2022QII;35.959
39 Cantabria;All ages;Cohort April 1;Total;Survival in the first trimester;2022QI;""
39 Cantabria;All ages;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
39 Cantabria;All ages;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
39 Cantabria;All ages;Cohort April 1;Total;Survival in the first trimester;2021QII;35.788
39 Cantabria;All ages;Cohort April 1;Total;Survival in the first trimester;2021QI;""
39 Cantabria;All ages;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
39 Cantabria;All ages;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
39 Cantabria;All ages;Cohort April 1;Total;Survival in the first trimester;2020QII;35.538
39 Cantabria;All ages;Cohort April 1;Total;Survival in the first trimester;2020QI;""
39 Cantabria;All ages;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
39 Cantabria;All ages;Cohort April 1;Total;Survival in the second trimester;2022QIII;35.208
39 Cantabria;All ages;Cohort April 1;Total;Survival in the second trimester;2022QII;""
39 Cantabria;All ages;Cohort April 1;Total;Survival in the second trimester;2022QI;""
39 Cantabria;All ages;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
39 Cantabria;All ages;Cohort April 1;Total;Survival in the second trimester;2021QIII;35.040
39 Cantabria;All ages;Cohort April 1;Total;Survival in the second trimester;2021QII;""
39 Cantabria;All ages;Cohort April 1;Total;Survival in the second trimester;2021QI;""
39 Cantabria;All ages;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
39 Cantabria;All ages;Cohort April 1;Total;Survival in the second trimester;2020QIII;34.772
39 Cantabria;All ages;Cohort April 1;Total;Survival in the second trimester;2020QII;""
39 Cantabria;All ages;Cohort April 1;Total;Survival in the second trimester;2020QI;""
39 Cantabria;All ages;Cohort April 1;Total;Survival in the third trimester;2022QIV;34.181
39 Cantabria;All ages;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
39 Cantabria;All ages;Cohort April 1;Total;Survival in the third trimester;2022QII;""
39 Cantabria;All ages;Cohort April 1;Total;Survival in the third trimester;2022QI;""
39 Cantabria;All ages;Cohort April 1;Total;Survival in the third trimester;2021QIV;34.204
39 Cantabria;All ages;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
39 Cantabria;All ages;Cohort April 1;Total;Survival in the third trimester;2021QII;""
39 Cantabria;All ages;Cohort April 1;Total;Survival in the third trimester;2021QI;""
39 Cantabria;All ages;Cohort April 1;Total;Survival in the third trimester;2020QIV;33.929
39 Cantabria;All ages;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
39 Cantabria;All ages;Cohort April 1;Total;Survival in the third trimester;2020QII;""
39 Cantabria;All ages;Cohort April 1;Total;Survival in the third trimester;2020QI;""
39 Cantabria;All ages;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
39 Cantabria;All ages;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
39 Cantabria;All ages;Cohort April 1;Total;Survival in the third trimester;2022QII;""
39 Cantabria;All ages;Cohort April 1;Total;Survival in the third trimester;2022QI;33.420
39 Cantabria;All ages;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
39 Cantabria;All ages;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
39 Cantabria;All ages;Cohort April 1;Total;Survival in the third trimester;2021QII;""
39 Cantabria;All ages;Cohort April 1;Total;Survival in the third trimester;2021QI;33.345
39 Cantabria;All ages;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
39 Cantabria;All ages;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
39 Cantabria;All ages;Cohort April 1;Total;Survival in the third trimester;2020QII;""
39 Cantabria;All ages;Cohort April 1;Total;Survival in the third trimester;2020QI;""
39 Cantabria;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
39 Cantabria;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
39 Cantabria;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
39 Cantabria;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
39 Cantabria;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
39 Cantabria;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
39 Cantabria;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
39 Cantabria;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
39 Cantabria;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
39 Cantabria;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
39 Cantabria;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
39 Cantabria;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
39 Cantabria;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
39 Cantabria;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
39 Cantabria;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;97,32
39 Cantabria;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
39 Cantabria;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
39 Cantabria;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
39 Cantabria;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;97,66
39 Cantabria;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
39 Cantabria;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
39 Cantabria;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
39 Cantabria;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;98,18
39 Cantabria;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
39 Cantabria;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
39 Cantabria;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;95,29
39 Cantabria;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
39 Cantabria;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
39 Cantabria;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
39 Cantabria;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;95,62
39 Cantabria;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
39 Cantabria;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
39 Cantabria;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
39 Cantabria;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;96,07
39 Cantabria;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
39 Cantabria;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
39 Cantabria;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;92,51
39 Cantabria;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
39 Cantabria;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
39 Cantabria;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
39 Cantabria;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;93,34
39 Cantabria;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
39 Cantabria;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
39 Cantabria;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
39 Cantabria;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;93,74
39 Cantabria;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
39 Cantabria;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
39 Cantabria;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
39 Cantabria;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
39 Cantabria;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
39 Cantabria;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
39 Cantabria;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;91,2
39 Cantabria;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
39 Cantabria;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
39 Cantabria;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
39 Cantabria;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;92,12
39 Cantabria;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
39 Cantabria;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
39 Cantabria;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
39 Cantabria;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
39 Cantabria;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
39 Cantabria;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
39 Cantabria;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QII;23.000
39 Cantabria;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
39 Cantabria;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
39 Cantabria;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
39 Cantabria;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QII;22.900
39 Cantabria;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
39 Cantabria;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
39 Cantabria;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
39 Cantabria;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QII;22.634
39 Cantabria;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
39 Cantabria;All ages;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
39 Cantabria;All ages;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
39 Cantabria;All ages;Cohort April 1;Males;Survival in the first trimester;2022QII;22.422
39 Cantabria;All ages;Cohort April 1;Males;Survival in the first trimester;2022QI;""
39 Cantabria;All ages;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
39 Cantabria;All ages;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
39 Cantabria;All ages;Cohort April 1;Males;Survival in the first trimester;2021QII;22.403
39 Cantabria;All ages;Cohort April 1;Males;Survival in the first trimester;2021QI;""
39 Cantabria;All ages;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
39 Cantabria;All ages;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
39 Cantabria;All ages;Cohort April 1;Males;Survival in the first trimester;2020QII;22.262
39 Cantabria;All ages;Cohort April 1;Males;Survival in the first trimester;2020QI;""
39 Cantabria;All ages;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
39 Cantabria;All ages;Cohort April 1;Males;Survival in the second trimester;2022QIII;21.973
39 Cantabria;All ages;Cohort April 1;Males;Survival in the second trimester;2022QII;""
39 Cantabria;All ages;Cohort April 1;Males;Survival in the second trimester;2022QI;""
39 Cantabria;All ages;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
39 Cantabria;All ages;Cohort April 1;Males;Survival in the second trimester;2021QIII;21.937
39 Cantabria;All ages;Cohort April 1;Males;Survival in the second trimester;2021QII;""
39 Cantabria;All ages;Cohort April 1;Males;Survival in the second trimester;2021QI;""
39 Cantabria;All ages;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
39 Cantabria;All ages;Cohort April 1;Males;Survival in the second trimester;2020QIII;21.787
39 Cantabria;All ages;Cohort April 1;Males;Survival in the second trimester;2020QII;""
39 Cantabria;All ages;Cohort April 1;Males;Survival in the second trimester;2020QI;""
39 Cantabria;All ages;Cohort April 1;Males;Survival in the third trimester;2022QIV;21.322
39 Cantabria;All ages;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
39 Cantabria;All ages;Cohort April 1;Males;Survival in the third trimester;2022QII;""
39 Cantabria;All ages;Cohort April 1;Males;Survival in the third trimester;2022QI;""
39 Cantabria;All ages;Cohort April 1;Males;Survival in the third trimester;2021QIV;21.415
39 Cantabria;All ages;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
39 Cantabria;All ages;Cohort April 1;Males;Survival in the third trimester;2021QII;""
39 Cantabria;All ages;Cohort April 1;Males;Survival in the third trimester;2021QI;""
39 Cantabria;All ages;Cohort April 1;Males;Survival in the third trimester;2020QIV;21.286
39 Cantabria;All ages;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
39 Cantabria;All ages;Cohort April 1;Males;Survival in the third trimester;2020QII;""
39 Cantabria;All ages;Cohort April 1;Males;Survival in the third trimester;2020QI;""
39 Cantabria;All ages;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
39 Cantabria;All ages;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
39 Cantabria;All ages;Cohort April 1;Males;Survival in the third trimester;2022QII;""
39 Cantabria;All ages;Cohort April 1;Males;Survival in the third trimester;2022QI;20.958
39 Cantabria;All ages;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
39 Cantabria;All ages;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
39 Cantabria;All ages;Cohort April 1;Males;Survival in the third trimester;2021QII;""
39 Cantabria;All ages;Cohort April 1;Males;Survival in the third trimester;2021QI;20.925
39 Cantabria;All ages;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
39 Cantabria;All ages;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
39 Cantabria;All ages;Cohort April 1;Males;Survival in the third trimester;2020QII;""
39 Cantabria;All ages;Cohort April 1;Males;Survival in the third trimester;2020QI;""
39 Cantabria;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
39 Cantabria;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
39 Cantabria;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
39 Cantabria;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
39 Cantabria;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
39 Cantabria;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
39 Cantabria;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
39 Cantabria;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
39 Cantabria;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
39 Cantabria;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
39 Cantabria;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
39 Cantabria;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
39 Cantabria;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
39 Cantabria;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
39 Cantabria;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;97,49
39 Cantabria;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
39 Cantabria;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
39 Cantabria;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
39 Cantabria;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;97,83
39 Cantabria;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
39 Cantabria;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
39 Cantabria;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
39 Cantabria;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;98,36
39 Cantabria;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
39 Cantabria;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
39 Cantabria;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;95,53
39 Cantabria;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
39 Cantabria;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
39 Cantabria;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
39 Cantabria;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;95,79
39 Cantabria;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
39 Cantabria;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
39 Cantabria;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
39 Cantabria;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;96,26
39 Cantabria;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
39 Cantabria;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
39 Cantabria;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;92,7
39 Cantabria;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
39 Cantabria;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
39 Cantabria;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
39 Cantabria;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;93,52
39 Cantabria;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
39 Cantabria;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
39 Cantabria;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
39 Cantabria;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;94,04
39 Cantabria;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
39 Cantabria;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
39 Cantabria;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
39 Cantabria;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
39 Cantabria;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
39 Cantabria;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
39 Cantabria;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;91,52
39 Cantabria;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
39 Cantabria;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
39 Cantabria;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
39 Cantabria;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;92,45
39 Cantabria;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
39 Cantabria;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
39 Cantabria;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
39 Cantabria;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
39 Cantabria;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
39 Cantabria;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
39 Cantabria;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QII;13.949
39 Cantabria;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
39 Cantabria;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
39 Cantabria;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
39 Cantabria;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QII;13.745
39 Cantabria;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
39 Cantabria;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
39 Cantabria;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
39 Cantabria;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QII;13.562
39 Cantabria;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
39 Cantabria;All ages;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
39 Cantabria;All ages;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
39 Cantabria;All ages;Cohort April 1;Females;Survival in the first trimester;2022QII;13.537
39 Cantabria;All ages;Cohort April 1;Females;Survival in the first trimester;2022QI;""
39 Cantabria;All ages;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
39 Cantabria;All ages;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
39 Cantabria;All ages;Cohort April 1;Females;Survival in the first trimester;2021QII;13.385
39 Cantabria;All ages;Cohort April 1;Females;Survival in the first trimester;2021QI;""
39 Cantabria;All ages;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
39 Cantabria;All ages;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
39 Cantabria;All ages;Cohort April 1;Females;Survival in the first trimester;2020QII;13.276
39 Cantabria;All ages;Cohort April 1;Females;Survival in the first trimester;2020QI;""
39 Cantabria;All ages;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
39 Cantabria;All ages;Cohort April 1;Females;Survival in the second trimester;2022QIII;13.235
39 Cantabria;All ages;Cohort April 1;Females;Survival in the second trimester;2022QII;""
39 Cantabria;All ages;Cohort April 1;Females;Survival in the second trimester;2022QI;""
39 Cantabria;All ages;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
39 Cantabria;All ages;Cohort April 1;Females;Survival in the second trimester;2021QIII;13.103
39 Cantabria;All ages;Cohort April 1;Females;Survival in the second trimester;2021QII;""
39 Cantabria;All ages;Cohort April 1;Females;Survival in the second trimester;2021QI;""
39 Cantabria;All ages;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
39 Cantabria;All ages;Cohort April 1;Females;Survival in the second trimester;2020QIII;12.985
39 Cantabria;All ages;Cohort April 1;Females;Survival in the second trimester;2020QII;""
39 Cantabria;All ages;Cohort April 1;Females;Survival in the second trimester;2020QI;""
39 Cantabria;All ages;Cohort April 1;Females;Survival in the third trimester;2022QIV;12.859
39 Cantabria;All ages;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
39 Cantabria;All ages;Cohort April 1;Females;Survival in the third trimester;2022QII;""
39 Cantabria;All ages;Cohort April 1;Females;Survival in the third trimester;2022QI;""
39 Cantabria;All ages;Cohort April 1;Females;Survival in the third trimester;2021QIV;12.789
39 Cantabria;All ages;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
39 Cantabria;All ages;Cohort April 1;Females;Survival in the third trimester;2021QII;""
39 Cantabria;All ages;Cohort April 1;Females;Survival in the third trimester;2021QI;""
39 Cantabria;All ages;Cohort April 1;Females;Survival in the third trimester;2020QIV;12.643
39 Cantabria;All ages;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
39 Cantabria;All ages;Cohort April 1;Females;Survival in the third trimester;2020QII;""
39 Cantabria;All ages;Cohort April 1;Females;Survival in the third trimester;2020QI;""
39 Cantabria;All ages;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
39 Cantabria;All ages;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
39 Cantabria;All ages;Cohort April 1;Females;Survival in the third trimester;2022QII;""
39 Cantabria;All ages;Cohort April 1;Females;Survival in the third trimester;2022QI;12.462
39 Cantabria;All ages;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
39 Cantabria;All ages;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
39 Cantabria;All ages;Cohort April 1;Females;Survival in the third trimester;2021QII;""
39 Cantabria;All ages;Cohort April 1;Females;Survival in the third trimester;2021QI;12.420
39 Cantabria;All ages;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
39 Cantabria;All ages;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
39 Cantabria;All ages;Cohort April 1;Females;Survival in the third trimester;2020QII;""
39 Cantabria;All ages;Cohort April 1;Females;Survival in the third trimester;2020QI;""
39 Cantabria;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
39 Cantabria;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
39 Cantabria;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
39 Cantabria;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
39 Cantabria;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
39 Cantabria;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
39 Cantabria;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
39 Cantabria;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
39 Cantabria;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
39 Cantabria;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
39 Cantabria;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
39 Cantabria;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
39 Cantabria;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
39 Cantabria;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
39 Cantabria;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;97,05
39 Cantabria;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
39 Cantabria;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
39 Cantabria;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
39 Cantabria;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;97,38
39 Cantabria;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
39 Cantabria;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
39 Cantabria;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
39 Cantabria;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;97,89
39 Cantabria;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
39 Cantabria;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
39 Cantabria;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;94,88
39 Cantabria;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
39 Cantabria;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
39 Cantabria;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
39 Cantabria;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;95,33
39 Cantabria;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
39 Cantabria;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
39 Cantabria;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
39 Cantabria;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;95,75
39 Cantabria;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
39 Cantabria;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
39 Cantabria;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;92,19
39 Cantabria;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
39 Cantabria;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
39 Cantabria;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
39 Cantabria;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;93,04
39 Cantabria;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
39 Cantabria;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
39 Cantabria;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
39 Cantabria;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;93,22
39 Cantabria;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
39 Cantabria;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
39 Cantabria;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
39 Cantabria;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
39 Cantabria;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
39 Cantabria;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
39 Cantabria;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;90,67
39 Cantabria;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
39 Cantabria;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
39 Cantabria;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
39 Cantabria;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;91,58
39 Cantabria;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
39 Cantabria;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
39 Cantabria;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
39 Cantabria;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
39 Cantabria;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
39 Cantabria;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QIII;37.238
39 Cantabria;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
39 Cantabria;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
39 Cantabria;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
39 Cantabria;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QIII;37.080
39 Cantabria;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
39 Cantabria;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
39 Cantabria;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
39 Cantabria;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QIII;36.501
39 Cantabria;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
39 Cantabria;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
39 Cantabria;All ages;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
39 Cantabria;All ages;Cohort July 1;Total;Survival in the first trimester;2022QIII;36.225
39 Cantabria;All ages;Cohort July 1;Total;Survival in the first trimester;2022QII;""
39 Cantabria;All ages;Cohort July 1;Total;Survival in the first trimester;2022QI;""
39 Cantabria;All ages;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
39 Cantabria;All ages;Cohort July 1;Total;Survival in the first trimester;2021QIII;36.125
39 Cantabria;All ages;Cohort July 1;Total;Survival in the first trimester;2021QII;""
39 Cantabria;All ages;Cohort July 1;Total;Survival in the first trimester;2021QI;""
39 Cantabria;All ages;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
39 Cantabria;All ages;Cohort July 1;Total;Survival in the first trimester;2020QIII;35.564
39 Cantabria;All ages;Cohort July 1;Total;Survival in the first trimester;2020QII;""
39 Cantabria;All ages;Cohort July 1;Total;Survival in the first trimester;2020QI;""
39 Cantabria;All ages;Cohort July 1;Total;Survival in the second trimester;2022QIV;35.062
39 Cantabria;All ages;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
39 Cantabria;All ages;Cohort July 1;Total;Survival in the second trimester;2022QII;""
39 Cantabria;All ages;Cohort July 1;Total;Survival in the second trimester;2022QI;""
39 Cantabria;All ages;Cohort July 1;Total;Survival in the second trimester;2021QIV;35.142
39 Cantabria;All ages;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
39 Cantabria;All ages;Cohort July 1;Total;Survival in the second trimester;2021QII;""
39 Cantabria;All ages;Cohort July 1;Total;Survival in the second trimester;2021QI;""
39 Cantabria;All ages;Cohort July 1;Total;Survival in the second trimester;2020QIV;34.621
39 Cantabria;All ages;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
39 Cantabria;All ages;Cohort July 1;Total;Survival in the second trimester;2020QII;""
39 Cantabria;All ages;Cohort July 1;Total;Survival in the second trimester;2020QI;""
39 Cantabria;All ages;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
39 Cantabria;All ages;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
39 Cantabria;All ages;Cohort July 1;Total;Survival in the third trimester;2022QII;""
39 Cantabria;All ages;Cohort July 1;Total;Survival in the third trimester;2022QI;34.299
39 Cantabria;All ages;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
39 Cantabria;All ages;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
39 Cantabria;All ages;Cohort July 1;Total;Survival in the third trimester;2021QII;""
39 Cantabria;All ages;Cohort July 1;Total;Survival in the third trimester;2021QI;34.001
39 Cantabria;All ages;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
39 Cantabria;All ages;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
39 Cantabria;All ages;Cohort July 1;Total;Survival in the third trimester;2020QII;""
39 Cantabria;All ages;Cohort July 1;Total;Survival in the third trimester;2020QI;""
39 Cantabria;All ages;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
39 Cantabria;All ages;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
39 Cantabria;All ages;Cohort July 1;Total;Survival in the third trimester;2022QII;33.533
39 Cantabria;All ages;Cohort July 1;Total;Survival in the third trimester;2022QI;""
39 Cantabria;All ages;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
39 Cantabria;All ages;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
39 Cantabria;All ages;Cohort July 1;Total;Survival in the third trimester;2021QII;33.355
39 Cantabria;All ages;Cohort July 1;Total;Survival in the third trimester;2021QI;""
39 Cantabria;All ages;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
39 Cantabria;All ages;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
39 Cantabria;All ages;Cohort July 1;Total;Survival in the third trimester;2020QII;""
39 Cantabria;All ages;Cohort July 1;Total;Survival in the third trimester;2020QI;""
39 Cantabria;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
39 Cantabria;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
39 Cantabria;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
39 Cantabria;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
39 Cantabria;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
39 Cantabria;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
39 Cantabria;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
39 Cantabria;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
39 Cantabria;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
39 Cantabria;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
39 Cantabria;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
39 Cantabria;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
39 Cantabria;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
39 Cantabria;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;97,28
39 Cantabria;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
39 Cantabria;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
39 Cantabria;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
39 Cantabria;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;97,42
39 Cantabria;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
39 Cantabria;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
39 Cantabria;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
39 Cantabria;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;97,43
39 Cantabria;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
39 Cantabria;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
39 Cantabria;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;94,16
39 Cantabria;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
39 Cantabria;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
39 Cantabria;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
39 Cantabria;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;94,77
39 Cantabria;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
39 Cantabria;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
39 Cantabria;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
39 Cantabria;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;94,85
39 Cantabria;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
39 Cantabria;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
39 Cantabria;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
39 Cantabria;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
39 Cantabria;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
39 Cantabria;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
39 Cantabria;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;92,5
39 Cantabria;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
39 Cantabria;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
39 Cantabria;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
39 Cantabria;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;93,15
39 Cantabria;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
39 Cantabria;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
39 Cantabria;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
39 Cantabria;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
39 Cantabria;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
39 Cantabria;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
39 Cantabria;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;90,43
39 Cantabria;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
39 Cantabria;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
39 Cantabria;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
39 Cantabria;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;91,38
39 Cantabria;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
39 Cantabria;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
39 Cantabria;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
39 Cantabria;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
39 Cantabria;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
39 Cantabria;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
39 Cantabria;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QIII;23.165
39 Cantabria;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
39 Cantabria;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
39 Cantabria;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
39 Cantabria;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QIII;23.188
39 Cantabria;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
39 Cantabria;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
39 Cantabria;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
39 Cantabria;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QIII;22.860
39 Cantabria;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
39 Cantabria;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
39 Cantabria;All ages;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
39 Cantabria;All ages;Cohort July 1;Males;Survival in the first trimester;2022QIII;22.573
39 Cantabria;All ages;Cohort July 1;Males;Survival in the first trimester;2022QII;""
39 Cantabria;All ages;Cohort July 1;Males;Survival in the first trimester;2022QI;""
39 Cantabria;All ages;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
39 Cantabria;All ages;Cohort July 1;Males;Survival in the first trimester;2021QIII;22.603
39 Cantabria;All ages;Cohort July 1;Males;Survival in the first trimester;2021QII;""
39 Cantabria;All ages;Cohort July 1;Males;Survival in the first trimester;2021QI;""
39 Cantabria;All ages;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
39 Cantabria;All ages;Cohort July 1;Males;Survival in the first trimester;2020QIII;22.284
39 Cantabria;All ages;Cohort July 1;Males;Survival in the first trimester;2020QII;""
39 Cantabria;All ages;Cohort July 1;Males;Survival in the first trimester;2020QI;""
39 Cantabria;All ages;Cohort July 1;Males;Survival in the second trimester;2022QIV;21.849
39 Cantabria;All ages;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
39 Cantabria;All ages;Cohort July 1;Males;Survival in the second trimester;2022QII;""
39 Cantabria;All ages;Cohort July 1;Males;Survival in the second trimester;2022QI;""
39 Cantabria;All ages;Cohort July 1;Males;Survival in the second trimester;2021QIV;22.004
39 Cantabria;All ages;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
39 Cantabria;All ages;Cohort July 1;Males;Survival in the second trimester;2021QII;""
39 Cantabria;All ages;Cohort July 1;Males;Survival in the second trimester;2021QI;""
39 Cantabria;All ages;Cohort July 1;Males;Survival in the second trimester;2020QIV;21.722
39 Cantabria;All ages;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
39 Cantabria;All ages;Cohort July 1;Males;Survival in the second trimester;2020QII;""
39 Cantabria;All ages;Cohort July 1;Males;Survival in the second trimester;2020QI;""
39 Cantabria;All ages;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
39 Cantabria;All ages;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
39 Cantabria;All ages;Cohort July 1;Males;Survival in the third trimester;2022QII;""
39 Cantabria;All ages;Cohort July 1;Males;Survival in the third trimester;2022QI;21.508
39 Cantabria;All ages;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
39 Cantabria;All ages;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
39 Cantabria;All ages;Cohort July 1;Males;Survival in the third trimester;2021QII;""
39 Cantabria;All ages;Cohort July 1;Males;Survival in the third trimester;2021QI;21.339
39 Cantabria;All ages;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
39 Cantabria;All ages;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
39 Cantabria;All ages;Cohort July 1;Males;Survival in the third trimester;2020QII;""
39 Cantabria;All ages;Cohort July 1;Males;Survival in the third trimester;2020QI;""
39 Cantabria;All ages;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
39 Cantabria;All ages;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
39 Cantabria;All ages;Cohort July 1;Males;Survival in the third trimester;2022QII;21.052
39 Cantabria;All ages;Cohort July 1;Males;Survival in the third trimester;2022QI;""
39 Cantabria;All ages;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
39 Cantabria;All ages;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
39 Cantabria;All ages;Cohort July 1;Males;Survival in the third trimester;2021QII;20.970
39 Cantabria;All ages;Cohort July 1;Males;Survival in the third trimester;2021QI;""
39 Cantabria;All ages;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
39 Cantabria;All ages;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
39 Cantabria;All ages;Cohort July 1;Males;Survival in the third trimester;2020QII;""
39 Cantabria;All ages;Cohort July 1;Males;Survival in the third trimester;2020QI;""
39 Cantabria;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
39 Cantabria;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
39 Cantabria;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
39 Cantabria;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
39 Cantabria;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
39 Cantabria;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
39 Cantabria;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
39 Cantabria;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
39 Cantabria;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
39 Cantabria;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
39 Cantabria;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
39 Cantabria;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
39 Cantabria;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
39 Cantabria;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;97,44
39 Cantabria;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
39 Cantabria;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
39 Cantabria;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
39 Cantabria;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;97,48
39 Cantabria;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
39 Cantabria;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
39 Cantabria;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
39 Cantabria;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;97,48
39 Cantabria;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
39 Cantabria;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
39 Cantabria;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;94,32
39 Cantabria;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
39 Cantabria;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
39 Cantabria;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
39 Cantabria;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;94,89
39 Cantabria;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
39 Cantabria;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
39 Cantabria;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
39 Cantabria;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;95,02
39 Cantabria;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
39 Cantabria;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
39 Cantabria;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
39 Cantabria;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
39 Cantabria;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
39 Cantabria;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
39 Cantabria;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;92,75
39 Cantabria;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
39 Cantabria;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
39 Cantabria;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
39 Cantabria;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;93,35
39 Cantabria;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
39 Cantabria;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
39 Cantabria;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
39 Cantabria;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
39 Cantabria;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
39 Cantabria;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
39 Cantabria;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;90,79
39 Cantabria;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
39 Cantabria;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
39 Cantabria;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
39 Cantabria;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;91,73
39 Cantabria;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
39 Cantabria;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
39 Cantabria;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
39 Cantabria;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
39 Cantabria;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
39 Cantabria;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
39 Cantabria;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QIII;14.073
39 Cantabria;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
39 Cantabria;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
39 Cantabria;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
39 Cantabria;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QIII;13.892
39 Cantabria;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
39 Cantabria;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
39 Cantabria;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
39 Cantabria;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QIII;13.641
39 Cantabria;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
39 Cantabria;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
39 Cantabria;All ages;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
39 Cantabria;All ages;Cohort July 1;Females;Survival in the first trimester;2022QIII;13.652
39 Cantabria;All ages;Cohort July 1;Females;Survival in the first trimester;2022QII;""
39 Cantabria;All ages;Cohort July 1;Females;Survival in the first trimester;2022QI;""
39 Cantabria;All ages;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
39 Cantabria;All ages;Cohort July 1;Females;Survival in the first trimester;2021QIII;13.522
39 Cantabria;All ages;Cohort July 1;Females;Survival in the first trimester;2021QII;""
39 Cantabria;All ages;Cohort July 1;Females;Survival in the first trimester;2021QI;""
39 Cantabria;All ages;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
39 Cantabria;All ages;Cohort July 1;Females;Survival in the first trimester;2020QIII;13.280
39 Cantabria;All ages;Cohort July 1;Females;Survival in the first trimester;2020QII;""
39 Cantabria;All ages;Cohort July 1;Females;Survival in the first trimester;2020QI;""
39 Cantabria;All ages;Cohort July 1;Females;Survival in the second trimester;2022QIV;13.213
39 Cantabria;All ages;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
39 Cantabria;All ages;Cohort July 1;Females;Survival in the second trimester;2022QII;""
39 Cantabria;All ages;Cohort July 1;Females;Survival in the second trimester;2022QI;""
39 Cantabria;All ages;Cohort July 1;Females;Survival in the second trimester;2021QIV;13.138
39 Cantabria;All ages;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
39 Cantabria;All ages;Cohort July 1;Females;Survival in the second trimester;2021QII;""
39 Cantabria;All ages;Cohort July 1;Females;Survival in the second trimester;2021QI;""
39 Cantabria;All ages;Cohort July 1;Females;Survival in the second trimester;2020QIV;12.899
39 Cantabria;All ages;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
39 Cantabria;All ages;Cohort July 1;Females;Survival in the second trimester;2020QII;""
39 Cantabria;All ages;Cohort July 1;Females;Survival in the second trimester;2020QI;""
39 Cantabria;All ages;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
39 Cantabria;All ages;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
39 Cantabria;All ages;Cohort July 1;Females;Survival in the third trimester;2022QII;""
39 Cantabria;All ages;Cohort July 1;Females;Survival in the third trimester;2022QI;12.791
39 Cantabria;All ages;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
39 Cantabria;All ages;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
39 Cantabria;All ages;Cohort July 1;Females;Survival in the third trimester;2021QII;""
39 Cantabria;All ages;Cohort July 1;Females;Survival in the third trimester;2021QI;12.662
39 Cantabria;All ages;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
39 Cantabria;All ages;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
39 Cantabria;All ages;Cohort July 1;Females;Survival in the third trimester;2020QII;""
39 Cantabria;All ages;Cohort July 1;Females;Survival in the third trimester;2020QI;""
39 Cantabria;All ages;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
39 Cantabria;All ages;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
39 Cantabria;All ages;Cohort July 1;Females;Survival in the third trimester;2022QII;12.481
39 Cantabria;All ages;Cohort July 1;Females;Survival in the third trimester;2022QI;""
39 Cantabria;All ages;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
39 Cantabria;All ages;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
39 Cantabria;All ages;Cohort July 1;Females;Survival in the third trimester;2021QII;12.385
39 Cantabria;All ages;Cohort July 1;Females;Survival in the third trimester;2021QI;""
39 Cantabria;All ages;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
39 Cantabria;All ages;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
39 Cantabria;All ages;Cohort July 1;Females;Survival in the third trimester;2020QII;""
39 Cantabria;All ages;Cohort July 1;Females;Survival in the third trimester;2020QI;""
39 Cantabria;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
39 Cantabria;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
39 Cantabria;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
39 Cantabria;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
39 Cantabria;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
39 Cantabria;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
39 Cantabria;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
39 Cantabria;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
39 Cantabria;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
39 Cantabria;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
39 Cantabria;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
39 Cantabria;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
39 Cantabria;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
39 Cantabria;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;97,01
39 Cantabria;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
39 Cantabria;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
39 Cantabria;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
39 Cantabria;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;97,34
39 Cantabria;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
39 Cantabria;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
39 Cantabria;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
39 Cantabria;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;97,35
39 Cantabria;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
39 Cantabria;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
39 Cantabria;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;93,89
39 Cantabria;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
39 Cantabria;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
39 Cantabria;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
39 Cantabria;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;94,57
39 Cantabria;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
39 Cantabria;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
39 Cantabria;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
39 Cantabria;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;94,56
39 Cantabria;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
39 Cantabria;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
39 Cantabria;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
39 Cantabria;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
39 Cantabria;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
39 Cantabria;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
39 Cantabria;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;92,07
39 Cantabria;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
39 Cantabria;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
39 Cantabria;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
39 Cantabria;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;92,82
39 Cantabria;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
39 Cantabria;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
39 Cantabria;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
39 Cantabria;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
39 Cantabria;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
39 Cantabria;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
39 Cantabria;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;89,84
39 Cantabria;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
39 Cantabria;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
39 Cantabria;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
39 Cantabria;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;90,79
39 Cantabria;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
39 Cantabria;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
39 Cantabria;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
39 Cantabria;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
39 Cantabria;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
39 Cantabria;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QIV;37.084
39 Cantabria;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
39 Cantabria;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
39 Cantabria;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
39 Cantabria;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QIV;37.027
39 Cantabria;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
39 Cantabria;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
39 Cantabria;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
39 Cantabria;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QIV;36.568
39 Cantabria;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
39 Cantabria;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
39 Cantabria;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
39 Cantabria;All ages;Cohort October 1;Total;Survival in the first trimester;2022QIV;35.816
39 Cantabria;All ages;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
39 Cantabria;All ages;Cohort October 1;Total;Survival in the first trimester;2022QII;""
39 Cantabria;All ages;Cohort October 1;Total;Survival in the first trimester;2022QI;""
39 Cantabria;All ages;Cohort October 1;Total;Survival in the first trimester;2021QIV;35.907
39 Cantabria;All ages;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
39 Cantabria;All ages;Cohort October 1;Total;Survival in the first trimester;2021QII;""
39 Cantabria;All ages;Cohort October 1;Total;Survival in the first trimester;2021QI;""
39 Cantabria;All ages;Cohort October 1;Total;Survival in the first trimester;2020QIV;35.491
39 Cantabria;All ages;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
39 Cantabria;All ages;Cohort October 1;Total;Survival in the first trimester;2020QII;""
39 Cantabria;All ages;Cohort October 1;Total;Survival in the first trimester;2020QI;""
39 Cantabria;All ages;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
39 Cantabria;All ages;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
39 Cantabria;All ages;Cohort October 1;Total;Survival in the second trimester;2022QII;""
39 Cantabria;All ages;Cohort October 1;Total;Survival in the second trimester;2022QI;35.017
39 Cantabria;All ages;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
39 Cantabria;All ages;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
39 Cantabria;All ages;Cohort October 1;Total;Survival in the second trimester;2021QII;""
39 Cantabria;All ages;Cohort October 1;Total;Survival in the second trimester;2021QI;34.828
39 Cantabria;All ages;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
39 Cantabria;All ages;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
39 Cantabria;All ages;Cohort October 1;Total;Survival in the second trimester;2020QII;""
39 Cantabria;All ages;Cohort October 1;Total;Survival in the second trimester;2020QI;""
39 Cantabria;All ages;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
39 Cantabria;All ages;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
39 Cantabria;All ages;Cohort October 1;Total;Survival in the third trimester;2022QII;34.195
39 Cantabria;All ages;Cohort October 1;Total;Survival in the third trimester;2022QI;""
39 Cantabria;All ages;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
39 Cantabria;All ages;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
39 Cantabria;All ages;Cohort October 1;Total;Survival in the third trimester;2021QII;34.138
39 Cantabria;All ages;Cohort October 1;Total;Survival in the third trimester;2021QI;""
39 Cantabria;All ages;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
39 Cantabria;All ages;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
39 Cantabria;All ages;Cohort October 1;Total;Survival in the third trimester;2020QII;""
39 Cantabria;All ages;Cohort October 1;Total;Survival in the third trimester;2020QI;""
39 Cantabria;All ages;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
39 Cantabria;All ages;Cohort October 1;Total;Survival in the third trimester;2022QIII;33.563
39 Cantabria;All ages;Cohort October 1;Total;Survival in the third trimester;2022QII;""
39 Cantabria;All ages;Cohort October 1;Total;Survival in the third trimester;2022QI;""
39 Cantabria;All ages;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
39 Cantabria;All ages;Cohort October 1;Total;Survival in the third trimester;2021QIII;33.485
39 Cantabria;All ages;Cohort October 1;Total;Survival in the third trimester;2021QII;""
39 Cantabria;All ages;Cohort October 1;Total;Survival in the third trimester;2021QI;""
39 Cantabria;All ages;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
39 Cantabria;All ages;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
39 Cantabria;All ages;Cohort October 1;Total;Survival in the third trimester;2020QII;""
39 Cantabria;All ages;Cohort October 1;Total;Survival in the third trimester;2020QI;""
39 Cantabria;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
39 Cantabria;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
39 Cantabria;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
39 Cantabria;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
39 Cantabria;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
39 Cantabria;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
39 Cantabria;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
39 Cantabria;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
39 Cantabria;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
39 Cantabria;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
39 Cantabria;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
39 Cantabria;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
39 Cantabria;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;96,58
39 Cantabria;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
39 Cantabria;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
39 Cantabria;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
39 Cantabria;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;96,98
39 Cantabria;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
39 Cantabria;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
39 Cantabria;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
39 Cantabria;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;97,05
39 Cantabria;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
39 Cantabria;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
39 Cantabria;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
39 Cantabria;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
39 Cantabria;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
39 Cantabria;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
39 Cantabria;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;94,57
39 Cantabria;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
39 Cantabria;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
39 Cantabria;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
39 Cantabria;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;95,24
39 Cantabria;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
39 Cantabria;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
39 Cantabria;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
39 Cantabria;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
39 Cantabria;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
39 Cantabria;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
39 Cantabria;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;92,35
39 Cantabria;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
39 Cantabria;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
39 Cantabria;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
39 Cantabria;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;93,35
39 Cantabria;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
39 Cantabria;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
39 Cantabria;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
39 Cantabria;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
39 Cantabria;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
39 Cantabria;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
39 Cantabria;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;90,64
39 Cantabria;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
39 Cantabria;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
39 Cantabria;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
39 Cantabria;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;91,57
39 Cantabria;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
39 Cantabria;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
39 Cantabria;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
39 Cantabria;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
39 Cantabria;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
39 Cantabria;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
39 Cantabria;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QIV;23.040
39 Cantabria;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
39 Cantabria;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
39 Cantabria;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
39 Cantabria;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QIV;23.110
39 Cantabria;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
39 Cantabria;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
39 Cantabria;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
39 Cantabria;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QIV;22.844
39 Cantabria;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
39 Cantabria;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
39 Cantabria;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
39 Cantabria;All ages;Cohort October 1;Males;Survival in the first trimester;2022QIV;22.251
39 Cantabria;All ages;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
39 Cantabria;All ages;Cohort October 1;Males;Survival in the first trimester;2022QII;""
39 Cantabria;All ages;Cohort October 1;Males;Survival in the first trimester;2022QI;""
39 Cantabria;All ages;Cohort October 1;Males;Survival in the first trimester;2021QIV;22.429
39 Cantabria;All ages;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
39 Cantabria;All ages;Cohort October 1;Males;Survival in the first trimester;2021QII;""
39 Cantabria;All ages;Cohort October 1;Males;Survival in the first trimester;2021QI;""
39 Cantabria;All ages;Cohort October 1;Males;Survival in the first trimester;2020QIV;22.212
39 Cantabria;All ages;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
39 Cantabria;All ages;Cohort October 1;Males;Survival in the first trimester;2020QII;""
39 Cantabria;All ages;Cohort October 1;Males;Survival in the first trimester;2020QI;""
39 Cantabria;All ages;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
39 Cantabria;All ages;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
39 Cantabria;All ages;Cohort October 1;Males;Survival in the second trimester;2022QII;""
39 Cantabria;All ages;Cohort October 1;Males;Survival in the second trimester;2022QI;21.904
39 Cantabria;All ages;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
39 Cantabria;All ages;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
39 Cantabria;All ages;Cohort October 1;Males;Survival in the second trimester;2021QII;""
39 Cantabria;All ages;Cohort October 1;Males;Survival in the second trimester;2021QI;21.801
39 Cantabria;All ages;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
39 Cantabria;All ages;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
39 Cantabria;All ages;Cohort October 1;Males;Survival in the second trimester;2020QII;""
39 Cantabria;All ages;Cohort October 1;Males;Survival in the second trimester;2020QI;""
39 Cantabria;All ages;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
39 Cantabria;All ages;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
39 Cantabria;All ages;Cohort October 1;Males;Survival in the third trimester;2022QII;21.424
39 Cantabria;All ages;Cohort October 1;Males;Survival in the third trimester;2022QI;""
39 Cantabria;All ages;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
39 Cantabria;All ages;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
39 Cantabria;All ages;Cohort October 1;Males;Survival in the third trimester;2021QII;21.414
39 Cantabria;All ages;Cohort October 1;Males;Survival in the third trimester;2021QI;""
39 Cantabria;All ages;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
39 Cantabria;All ages;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
39 Cantabria;All ages;Cohort October 1;Males;Survival in the third trimester;2020QII;""
39 Cantabria;All ages;Cohort October 1;Males;Survival in the third trimester;2020QI;""
39 Cantabria;All ages;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
39 Cantabria;All ages;Cohort October 1;Males;Survival in the third trimester;2022QIII;21.045
39 Cantabria;All ages;Cohort October 1;Males;Survival in the third trimester;2022QII;""
39 Cantabria;All ages;Cohort October 1;Males;Survival in the third trimester;2022QI;""
39 Cantabria;All ages;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
39 Cantabria;All ages;Cohort October 1;Males;Survival in the third trimester;2021QIII;21.018
39 Cantabria;All ages;Cohort October 1;Males;Survival in the third trimester;2021QII;""
39 Cantabria;All ages;Cohort October 1;Males;Survival in the third trimester;2021QI;""
39 Cantabria;All ages;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
39 Cantabria;All ages;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
39 Cantabria;All ages;Cohort October 1;Males;Survival in the third trimester;2020QII;""
39 Cantabria;All ages;Cohort October 1;Males;Survival in the third trimester;2020QI;""
39 Cantabria;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
39 Cantabria;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
39 Cantabria;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
39 Cantabria;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
39 Cantabria;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
39 Cantabria;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
39 Cantabria;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
39 Cantabria;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
39 Cantabria;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
39 Cantabria;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
39 Cantabria;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
39 Cantabria;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
39 Cantabria;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;96,58
39 Cantabria;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
39 Cantabria;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
39 Cantabria;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
39 Cantabria;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;97,05
39 Cantabria;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
39 Cantabria;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
39 Cantabria;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
39 Cantabria;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;97,23
39 Cantabria;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
39 Cantabria;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
39 Cantabria;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
39 Cantabria;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
39 Cantabria;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
39 Cantabria;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
39 Cantabria;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;94,78
39 Cantabria;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
39 Cantabria;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
39 Cantabria;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
39 Cantabria;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;95,43
39 Cantabria;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
39 Cantabria;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
39 Cantabria;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
39 Cantabria;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
39 Cantabria;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
39 Cantabria;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
39 Cantabria;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;92,7
39 Cantabria;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
39 Cantabria;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
39 Cantabria;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
39 Cantabria;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;93,74
39 Cantabria;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
39 Cantabria;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
39 Cantabria;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
39 Cantabria;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
39 Cantabria;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
39 Cantabria;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
39 Cantabria;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;91,06
39 Cantabria;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
39 Cantabria;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
39 Cantabria;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
39 Cantabria;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;92,01
39 Cantabria;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
39 Cantabria;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
39 Cantabria;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
39 Cantabria;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
39 Cantabria;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
39 Cantabria;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
39 Cantabria;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QIV;14.044
39 Cantabria;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
39 Cantabria;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
39 Cantabria;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
39 Cantabria;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QIV;13.917
39 Cantabria;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
39 Cantabria;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
39 Cantabria;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
39 Cantabria;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QIV;13.724
39 Cantabria;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
39 Cantabria;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
39 Cantabria;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
39 Cantabria;All ages;Cohort October 1;Females;Survival in the first trimester;2022QIV;13.565
39 Cantabria;All ages;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
39 Cantabria;All ages;Cohort October 1;Females;Survival in the first trimester;2022QII;""
39 Cantabria;All ages;Cohort October 1;Females;Survival in the first trimester;2022QI;""
39 Cantabria;All ages;Cohort October 1;Females;Survival in the first trimester;2021QIV;13.478
39 Cantabria;All ages;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
39 Cantabria;All ages;Cohort October 1;Females;Survival in the first trimester;2021QII;""
39 Cantabria;All ages;Cohort October 1;Females;Survival in the first trimester;2021QI;""
39 Cantabria;All ages;Cohort October 1;Females;Survival in the first trimester;2020QIV;13.279
39 Cantabria;All ages;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
39 Cantabria;All ages;Cohort October 1;Females;Survival in the first trimester;2020QII;""
39 Cantabria;All ages;Cohort October 1;Females;Survival in the first trimester;2020QI;""
39 Cantabria;All ages;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
39 Cantabria;All ages;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
39 Cantabria;All ages;Cohort October 1;Females;Survival in the second trimester;2022QII;""
39 Cantabria;All ages;Cohort October 1;Females;Survival in the second trimester;2022QI;13.113
39 Cantabria;All ages;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
39 Cantabria;All ages;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
39 Cantabria;All ages;Cohort October 1;Females;Survival in the second trimester;2021QII;""
39 Cantabria;All ages;Cohort October 1;Females;Survival in the second trimester;2021QI;13.027
39 Cantabria;All ages;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
39 Cantabria;All ages;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
39 Cantabria;All ages;Cohort October 1;Females;Survival in the second trimester;2020QII;""
39 Cantabria;All ages;Cohort October 1;Females;Survival in the second trimester;2020QI;""
39 Cantabria;All ages;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
39 Cantabria;All ages;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
39 Cantabria;All ages;Cohort October 1;Females;Survival in the third trimester;2022QII;12.771
39 Cantabria;All ages;Cohort October 1;Females;Survival in the third trimester;2022QI;""
39 Cantabria;All ages;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
39 Cantabria;All ages;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
39 Cantabria;All ages;Cohort October 1;Females;Survival in the third trimester;2021QII;12.724
39 Cantabria;All ages;Cohort October 1;Females;Survival in the third trimester;2021QI;""
39 Cantabria;All ages;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
39 Cantabria;All ages;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
39 Cantabria;All ages;Cohort October 1;Females;Survival in the third trimester;2020QII;""
39 Cantabria;All ages;Cohort October 1;Females;Survival in the third trimester;2020QI;""
39 Cantabria;All ages;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
39 Cantabria;All ages;Cohort October 1;Females;Survival in the third trimester;2022QIII;12.518
39 Cantabria;All ages;Cohort October 1;Females;Survival in the third trimester;2022QII;""
39 Cantabria;All ages;Cohort October 1;Females;Survival in the third trimester;2022QI;""
39 Cantabria;All ages;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
39 Cantabria;All ages;Cohort October 1;Females;Survival in the third trimester;2021QIII;12.467
39 Cantabria;All ages;Cohort October 1;Females;Survival in the third trimester;2021QII;""
39 Cantabria;All ages;Cohort October 1;Females;Survival in the third trimester;2021QI;""
39 Cantabria;All ages;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
39 Cantabria;All ages;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
39 Cantabria;All ages;Cohort October 1;Females;Survival in the third trimester;2020QII;""
39 Cantabria;All ages;Cohort October 1;Females;Survival in the third trimester;2020QI;""
39 Cantabria;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
39 Cantabria;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
39 Cantabria;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
39 Cantabria;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
39 Cantabria;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
39 Cantabria;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
39 Cantabria;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
39 Cantabria;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
39 Cantabria;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
39 Cantabria;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
39 Cantabria;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
39 Cantabria;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
39 Cantabria;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;96,59
39 Cantabria;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
39 Cantabria;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
39 Cantabria;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
39 Cantabria;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;96,85
39 Cantabria;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
39 Cantabria;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
39 Cantabria;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
39 Cantabria;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;96,76
39 Cantabria;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
39 Cantabria;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
39 Cantabria;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
39 Cantabria;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
39 Cantabria;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
39 Cantabria;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
39 Cantabria;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;94,22
39 Cantabria;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
39 Cantabria;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
39 Cantabria;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
39 Cantabria;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;94,92
39 Cantabria;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
39 Cantabria;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
39 Cantabria;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
39 Cantabria;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
39 Cantabria;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
39 Cantabria;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
39 Cantabria;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;91,77
39 Cantabria;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
39 Cantabria;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
39 Cantabria;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
39 Cantabria;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;92,71
39 Cantabria;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
39 Cantabria;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
39 Cantabria;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
39 Cantabria;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
39 Cantabria;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
39 Cantabria;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
39 Cantabria;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;89,95
39 Cantabria;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
39 Cantabria;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
39 Cantabria;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
39 Cantabria;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;90,84
39 Cantabria;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
39 Cantabria;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
39 Cantabria;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
39 Cantabria;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
39 Cantabria;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
39 Cantabria;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
39 Cantabria;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
39 Cantabria;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
39 Cantabria;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
39 Cantabria;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QI;1.800
39 Cantabria;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
39 Cantabria;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
39 Cantabria;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
39 Cantabria;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QI;1.730
39 Cantabria;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
39 Cantabria;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
39 Cantabria;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
39 Cantabria;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QI;1.450
39 Cantabria;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
39 Cantabria;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
39 Cantabria;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2022QII;""
39 Cantabria;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2022QI;1.699
39 Cantabria;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
39 Cantabria;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
39 Cantabria;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2021QII;""
39 Cantabria;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2021QI;1.650
39 Cantabria;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
39 Cantabria;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
39 Cantabria;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2020QII;""
39 Cantabria;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2020QI;1.305
39 Cantabria;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
39 Cantabria;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
39 Cantabria;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2022QII;1.622
39 Cantabria;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2022QI;""
39 Cantabria;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
39 Cantabria;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
39 Cantabria;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2021QII;1.584
39 Cantabria;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2021QI;""
39 Cantabria;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
39 Cantabria;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
39 Cantabria;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2020QII;1.260
39 Cantabria;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2020QI;""
39 Cantabria;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
39 Cantabria;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QIII;1.546
39 Cantabria;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QII;""
39 Cantabria;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QI;""
39 Cantabria;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
39 Cantabria;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QIII;1.523
39 Cantabria;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QII;""
39 Cantabria;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QI;""
39 Cantabria;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
39 Cantabria;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QIII;1.209
39 Cantabria;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QII;""
39 Cantabria;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QI;""
39 Cantabria;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QIV;1.464
39 Cantabria;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
39 Cantabria;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QII;""
39 Cantabria;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QI;""
39 Cantabria;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QIV;1.462
39 Cantabria;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
39 Cantabria;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QII;""
39 Cantabria;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QI;""
39 Cantabria;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QIV;1.159
39 Cantabria;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
39 Cantabria;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QII;""
39 Cantabria;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QI;""
39 Cantabria;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
39 Cantabria;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
39 Cantabria;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
39 Cantabria;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
39 Cantabria;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
39 Cantabria;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
39 Cantabria;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
39 Cantabria;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
39 Cantabria;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
39 Cantabria;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
39 Cantabria;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
39 Cantabria;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
39 Cantabria;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
39 Cantabria;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
39 Cantabria;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
39 Cantabria;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;94,39
39 Cantabria;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
39 Cantabria;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
39 Cantabria;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
39 Cantabria;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;95,38
39 Cantabria;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
39 Cantabria;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
39 Cantabria;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
39 Cantabria;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;90
39 Cantabria;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
39 Cantabria;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
39 Cantabria;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;90,11
39 Cantabria;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
39 Cantabria;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
39 Cantabria;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
39 Cantabria;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;91,56
39 Cantabria;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
39 Cantabria;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
39 Cantabria;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
39 Cantabria;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;86,9
39 Cantabria;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
39 Cantabria;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
39 Cantabria;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;85,89
39 Cantabria;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
39 Cantabria;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
39 Cantabria;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
39 Cantabria;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;88,03
39 Cantabria;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
39 Cantabria;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
39 Cantabria;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
39 Cantabria;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;83,38
39 Cantabria;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
39 Cantabria;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
39 Cantabria;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;81,33
39 Cantabria;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
39 Cantabria;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
39 Cantabria;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
39 Cantabria;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;84,51
39 Cantabria;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
39 Cantabria;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
39 Cantabria;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
39 Cantabria;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;79,93
39 Cantabria;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
39 Cantabria;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
39 Cantabria;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
39 Cantabria;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
39 Cantabria;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
39 Cantabria;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
39 Cantabria;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QI;1.123
39 Cantabria;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
39 Cantabria;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
39 Cantabria;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
39 Cantabria;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QI;1.080
39 Cantabria;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
39 Cantabria;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
39 Cantabria;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
39 Cantabria;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QI;897
39 Cantabria;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
39 Cantabria;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
39 Cantabria;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2022QII;""
39 Cantabria;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2022QI;1.058
39 Cantabria;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
39 Cantabria;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
39 Cantabria;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2021QII;""
39 Cantabria;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2021QI;1.022
39 Cantabria;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
39 Cantabria;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
39 Cantabria;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2020QII;""
39 Cantabria;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2020QI;807
39 Cantabria;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
39 Cantabria;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
39 Cantabria;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2022QII;1.007
39 Cantabria;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2022QI;""
39 Cantabria;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
39 Cantabria;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
39 Cantabria;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2021QII;979
39 Cantabria;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2021QI;""
39 Cantabria;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
39 Cantabria;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
39 Cantabria;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2020QII;779
39 Cantabria;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2020QI;""
39 Cantabria;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
39 Cantabria;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QIII;968
39 Cantabria;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QII;""
39 Cantabria;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QI;""
39 Cantabria;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
39 Cantabria;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QIII;941
39 Cantabria;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QII;""
39 Cantabria;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QI;""
39 Cantabria;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
39 Cantabria;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QIII;747
39 Cantabria;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QII;""
39 Cantabria;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QI;""
39 Cantabria;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QIV;911
39 Cantabria;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
39 Cantabria;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QII;""
39 Cantabria;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QI;""
39 Cantabria;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QIV;907
39 Cantabria;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
39 Cantabria;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QII;""
39 Cantabria;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QI;""
39 Cantabria;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QIV;715
39 Cantabria;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
39 Cantabria;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QII;""
39 Cantabria;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QI;""
39 Cantabria;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
39 Cantabria;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
39 Cantabria;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
39 Cantabria;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
39 Cantabria;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
39 Cantabria;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
39 Cantabria;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
39 Cantabria;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
39 Cantabria;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
39 Cantabria;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
39 Cantabria;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
39 Cantabria;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
39 Cantabria;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
39 Cantabria;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
39 Cantabria;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
39 Cantabria;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;94,21
39 Cantabria;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
39 Cantabria;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
39 Cantabria;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
39 Cantabria;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;94,63
39 Cantabria;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
39 Cantabria;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
39 Cantabria;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
39 Cantabria;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;89,97
39 Cantabria;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
39 Cantabria;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
39 Cantabria;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;89,67
39 Cantabria;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
39 Cantabria;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
39 Cantabria;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
39 Cantabria;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;90,65
39 Cantabria;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
39 Cantabria;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
39 Cantabria;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
39 Cantabria;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;86,85
39 Cantabria;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
39 Cantabria;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
39 Cantabria;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;86,2
39 Cantabria;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
39 Cantabria;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
39 Cantabria;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
39 Cantabria;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;87,13
39 Cantabria;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
39 Cantabria;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
39 Cantabria;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
39 Cantabria;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;83,28
39 Cantabria;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
39 Cantabria;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
39 Cantabria;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;81,12
39 Cantabria;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
39 Cantabria;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
39 Cantabria;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
39 Cantabria;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;83,98
39 Cantabria;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
39 Cantabria;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
39 Cantabria;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
39 Cantabria;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;79,71
39 Cantabria;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
39 Cantabria;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
39 Cantabria;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
39 Cantabria;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
39 Cantabria;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
39 Cantabria;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
39 Cantabria;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QI;677
39 Cantabria;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
39 Cantabria;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
39 Cantabria;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
39 Cantabria;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QI;650
39 Cantabria;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
39 Cantabria;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
39 Cantabria;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
39 Cantabria;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QI;553
39 Cantabria;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
39 Cantabria;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
39 Cantabria;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2022QII;""
39 Cantabria;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2022QI;641
39 Cantabria;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
39 Cantabria;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
39 Cantabria;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2021QII;""
39 Cantabria;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2021QI;628
39 Cantabria;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
39 Cantabria;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
39 Cantabria;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2020QII;""
39 Cantabria;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2020QI;498
39 Cantabria;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
39 Cantabria;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
39 Cantabria;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2022QII;615
39 Cantabria;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2022QI;""
39 Cantabria;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
39 Cantabria;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
39 Cantabria;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2021QII;605
39 Cantabria;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2021QI;""
39 Cantabria;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
39 Cantabria;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
39 Cantabria;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2020QII;481
39 Cantabria;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2020QI;""
39 Cantabria;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
39 Cantabria;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QIII;578
39 Cantabria;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QII;""
39 Cantabria;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QI;""
39 Cantabria;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
39 Cantabria;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QIII;582
39 Cantabria;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QII;""
39 Cantabria;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QI;""
39 Cantabria;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
39 Cantabria;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QIII;462
39 Cantabria;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QII;""
39 Cantabria;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QI;""
39 Cantabria;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QIV;553
39 Cantabria;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
39 Cantabria;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QII;""
39 Cantabria;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QI;""
39 Cantabria;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QIV;555
39 Cantabria;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
39 Cantabria;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QII;""
39 Cantabria;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QI;""
39 Cantabria;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QIV;444
39 Cantabria;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
39 Cantabria;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QII;""
39 Cantabria;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QI;""
39 Cantabria;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
39 Cantabria;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
39 Cantabria;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
39 Cantabria;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
39 Cantabria;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
39 Cantabria;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
39 Cantabria;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
39 Cantabria;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
39 Cantabria;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
39 Cantabria;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
39 Cantabria;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
39 Cantabria;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
39 Cantabria;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
39 Cantabria;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
39 Cantabria;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
39 Cantabria;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;94,68
39 Cantabria;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
39 Cantabria;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
39 Cantabria;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
39 Cantabria;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;96,62
39 Cantabria;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
39 Cantabria;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
39 Cantabria;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
39 Cantabria;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;90,05
39 Cantabria;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
39 Cantabria;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
39 Cantabria;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;90,84
39 Cantabria;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
39 Cantabria;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
39 Cantabria;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
39 Cantabria;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;93,08
39 Cantabria;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
39 Cantabria;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
39 Cantabria;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
39 Cantabria;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;86,98
39 Cantabria;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
39 Cantabria;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
39 Cantabria;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;85,38
39 Cantabria;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
39 Cantabria;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
39 Cantabria;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
39 Cantabria;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;89,54
39 Cantabria;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
39 Cantabria;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
39 Cantabria;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
39 Cantabria;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;83,54
39 Cantabria;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
39 Cantabria;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
39 Cantabria;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;81,68
39 Cantabria;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
39 Cantabria;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
39 Cantabria;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
39 Cantabria;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;85,38
39 Cantabria;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
39 Cantabria;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
39 Cantabria;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
39 Cantabria;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;80,29
39 Cantabria;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
39 Cantabria;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
39 Cantabria;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
39 Cantabria;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
39 Cantabria;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
39 Cantabria;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QII;1.577
39 Cantabria;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
39 Cantabria;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
39 Cantabria;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
39 Cantabria;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QII;1.506
39 Cantabria;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
39 Cantabria;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
39 Cantabria;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
39 Cantabria;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QII;1.474
39 Cantabria;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
39 Cantabria;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
39 Cantabria;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
39 Cantabria;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2022QII;1.496
39 Cantabria;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2022QI;""
39 Cantabria;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
39 Cantabria;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
39 Cantabria;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2021QII;1.418
39 Cantabria;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2021QI;""
39 Cantabria;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
39 Cantabria;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
39 Cantabria;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2020QII;1.421
39 Cantabria;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2020QI;""
39 Cantabria;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
39 Cantabria;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2022QIII;1.420
39 Cantabria;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2022QII;""
39 Cantabria;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2022QI;""
39 Cantabria;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
39 Cantabria;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2021QIII;1.357
39 Cantabria;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2021QII;""
39 Cantabria;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2021QI;""
39 Cantabria;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
39 Cantabria;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2020QIII;1.360
39 Cantabria;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2020QII;""
39 Cantabria;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2020QI;""
39 Cantabria;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QIV;1.329
39 Cantabria;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
39 Cantabria;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QII;""
39 Cantabria;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QI;""
39 Cantabria;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QIV;1.297
39 Cantabria;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
39 Cantabria;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QII;""
39 Cantabria;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QI;""
39 Cantabria;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QIV;1.301
39 Cantabria;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
39 Cantabria;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QII;""
39 Cantabria;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QI;""
39 Cantabria;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
39 Cantabria;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
39 Cantabria;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QII;""
39 Cantabria;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QI;1.234
39 Cantabria;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
39 Cantabria;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
39 Cantabria;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QII;""
39 Cantabria;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QI;1.252
39 Cantabria;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
39 Cantabria;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
39 Cantabria;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QII;""
39 Cantabria;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QI;""
39 Cantabria;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
39 Cantabria;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
39 Cantabria;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
39 Cantabria;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
39 Cantabria;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
39 Cantabria;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
39 Cantabria;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
39 Cantabria;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
39 Cantabria;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
39 Cantabria;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
39 Cantabria;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
39 Cantabria;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
39 Cantabria;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
39 Cantabria;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
39 Cantabria;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;94,86
39 Cantabria;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
39 Cantabria;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
39 Cantabria;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
39 Cantabria;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;94,16
39 Cantabria;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
39 Cantabria;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
39 Cantabria;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
39 Cantabria;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;96,4
39 Cantabria;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
39 Cantabria;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
39 Cantabria;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;90,04
39 Cantabria;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
39 Cantabria;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
39 Cantabria;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
39 Cantabria;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;90,11
39 Cantabria;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
39 Cantabria;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
39 Cantabria;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
39 Cantabria;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;92,27
39 Cantabria;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
39 Cantabria;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
39 Cantabria;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;84,27
39 Cantabria;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
39 Cantabria;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
39 Cantabria;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
39 Cantabria;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;86,12
39 Cantabria;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
39 Cantabria;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
39 Cantabria;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
39 Cantabria;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;88,26
39 Cantabria;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
39 Cantabria;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
39 Cantabria;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
39 Cantabria;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
39 Cantabria;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
39 Cantabria;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
39 Cantabria;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;81,94
39 Cantabria;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
39 Cantabria;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
39 Cantabria;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
39 Cantabria;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;84,94
39 Cantabria;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
39 Cantabria;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
39 Cantabria;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
39 Cantabria;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
39 Cantabria;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
39 Cantabria;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
39 Cantabria;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QII;983
39 Cantabria;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
39 Cantabria;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
39 Cantabria;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
39 Cantabria;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QII;941
39 Cantabria;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
39 Cantabria;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
39 Cantabria;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
39 Cantabria;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QII;907
39 Cantabria;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
39 Cantabria;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
39 Cantabria;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
39 Cantabria;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2022QII;931
39 Cantabria;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2022QI;""
39 Cantabria;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
39 Cantabria;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
39 Cantabria;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2021QII;879
39 Cantabria;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2021QI;""
39 Cantabria;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
39 Cantabria;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
39 Cantabria;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2020QII;873
39 Cantabria;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2020QI;""
39 Cantabria;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
39 Cantabria;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2022QIII;890
39 Cantabria;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2022QII;""
39 Cantabria;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2022QI;""
39 Cantabria;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
39 Cantabria;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2021QIII;838
39 Cantabria;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2021QII;""
39 Cantabria;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2021QI;""
39 Cantabria;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
39 Cantabria;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2020QIII;834
39 Cantabria;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2020QII;""
39 Cantabria;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2020QI;""
39 Cantabria;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QIV;831
39 Cantabria;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
39 Cantabria;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QII;""
39 Cantabria;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QI;""
39 Cantabria;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QIV;802
39 Cantabria;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
39 Cantabria;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QII;""
39 Cantabria;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QI;""
39 Cantabria;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QIV;796
39 Cantabria;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
39 Cantabria;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QII;""
39 Cantabria;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QI;""
39 Cantabria;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
39 Cantabria;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
39 Cantabria;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QII;""
39 Cantabria;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QI;760
39 Cantabria;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
39 Cantabria;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
39 Cantabria;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QII;""
39 Cantabria;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QI;762
39 Cantabria;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
39 Cantabria;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
39 Cantabria;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QII;""
39 Cantabria;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QI;""
39 Cantabria;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
39 Cantabria;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
39 Cantabria;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
39 Cantabria;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
39 Cantabria;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
39 Cantabria;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
39 Cantabria;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
39 Cantabria;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
39 Cantabria;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
39 Cantabria;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
39 Cantabria;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
39 Cantabria;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
39 Cantabria;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
39 Cantabria;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
39 Cantabria;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;94,71
39 Cantabria;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
39 Cantabria;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
39 Cantabria;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
39 Cantabria;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;93,41
39 Cantabria;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
39 Cantabria;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
39 Cantabria;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
39 Cantabria;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;96,25
39 Cantabria;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
39 Cantabria;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
39 Cantabria;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;90,54
39 Cantabria;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
39 Cantabria;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
39 Cantabria;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
39 Cantabria;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;89,05
39 Cantabria;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
39 Cantabria;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
39 Cantabria;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
39 Cantabria;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;91,95
39 Cantabria;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
39 Cantabria;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
39 Cantabria;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;84,54
39 Cantabria;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
39 Cantabria;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
39 Cantabria;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
39 Cantabria;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;85,23
39 Cantabria;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
39 Cantabria;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
39 Cantabria;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
39 Cantabria;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;87,76
39 Cantabria;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
39 Cantabria;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
39 Cantabria;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
39 Cantabria;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
39 Cantabria;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
39 Cantabria;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
39 Cantabria;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;80,77
39 Cantabria;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
39 Cantabria;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
39 Cantabria;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
39 Cantabria;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;84,01
39 Cantabria;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
39 Cantabria;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
39 Cantabria;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
39 Cantabria;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
39 Cantabria;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
39 Cantabria;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
39 Cantabria;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QII;594
39 Cantabria;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
39 Cantabria;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
39 Cantabria;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
39 Cantabria;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QII;565
39 Cantabria;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
39 Cantabria;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
39 Cantabria;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
39 Cantabria;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QII;567
39 Cantabria;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
39 Cantabria;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
39 Cantabria;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
39 Cantabria;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2022QII;565
39 Cantabria;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2022QI;""
39 Cantabria;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
39 Cantabria;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
39 Cantabria;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2021QII;539
39 Cantabria;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2021QI;""
39 Cantabria;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
39 Cantabria;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
39 Cantabria;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2020QII;548
39 Cantabria;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2020QI;""
39 Cantabria;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
39 Cantabria;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2022QIII;530
39 Cantabria;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2022QII;""
39 Cantabria;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2022QI;""
39 Cantabria;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
39 Cantabria;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2021QIII;519
39 Cantabria;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2021QII;""
39 Cantabria;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2021QI;""
39 Cantabria;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
39 Cantabria;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2020QIII;526
39 Cantabria;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2020QII;""
39 Cantabria;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2020QI;""
39 Cantabria;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QIV;498
39 Cantabria;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
39 Cantabria;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QII;""
39 Cantabria;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QI;""
39 Cantabria;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QIV;495
39 Cantabria;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
39 Cantabria;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QII;""
39 Cantabria;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QI;""
39 Cantabria;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QIV;505
39 Cantabria;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
39 Cantabria;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QII;""
39 Cantabria;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QI;""
39 Cantabria;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
39 Cantabria;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
39 Cantabria;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QII;""
39 Cantabria;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QI;474
39 Cantabria;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
39 Cantabria;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
39 Cantabria;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QII;""
39 Cantabria;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QI;490
39 Cantabria;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
39 Cantabria;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
39 Cantabria;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QII;""
39 Cantabria;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QI;""
39 Cantabria;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
39 Cantabria;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
39 Cantabria;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
39 Cantabria;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
39 Cantabria;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
39 Cantabria;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
39 Cantabria;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
39 Cantabria;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
39 Cantabria;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
39 Cantabria;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
39 Cantabria;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
39 Cantabria;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
39 Cantabria;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
39 Cantabria;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
39 Cantabria;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;95,12
39 Cantabria;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
39 Cantabria;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
39 Cantabria;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
39 Cantabria;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;95,4
39 Cantabria;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
39 Cantabria;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
39 Cantabria;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
39 Cantabria;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;96,65
39 Cantabria;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
39 Cantabria;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
39 Cantabria;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;89,23
39 Cantabria;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
39 Cantabria;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
39 Cantabria;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
39 Cantabria;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;91,86
39 Cantabria;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
39 Cantabria;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
39 Cantabria;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
39 Cantabria;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;92,77
39 Cantabria;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
39 Cantabria;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
39 Cantabria;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;83,84
39 Cantabria;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
39 Cantabria;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
39 Cantabria;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
39 Cantabria;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;87,61
39 Cantabria;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
39 Cantabria;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
39 Cantabria;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
39 Cantabria;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;89,07
39 Cantabria;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
39 Cantabria;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
39 Cantabria;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
39 Cantabria;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
39 Cantabria;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
39 Cantabria;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
39 Cantabria;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;83,89
39 Cantabria;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
39 Cantabria;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
39 Cantabria;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
39 Cantabria;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;86,42
39 Cantabria;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
39 Cantabria;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
39 Cantabria;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
39 Cantabria;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
39 Cantabria;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
39 Cantabria;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QIII;1.704
39 Cantabria;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
39 Cantabria;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
39 Cantabria;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
39 Cantabria;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QIII;1.638
39 Cantabria;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
39 Cantabria;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
39 Cantabria;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
39 Cantabria;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QIII;1.556
39 Cantabria;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
39 Cantabria;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
39 Cantabria;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
39 Cantabria;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2022QIII;1.591
39 Cantabria;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2022QII;""
39 Cantabria;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2022QI;""
39 Cantabria;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
39 Cantabria;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2021QIII;1.533
39 Cantabria;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2021QII;""
39 Cantabria;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2021QI;""
39 Cantabria;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
39 Cantabria;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2020QIII;1.461
39 Cantabria;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2020QII;""
39 Cantabria;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2020QI;""
39 Cantabria;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2022QIV;1.482
39 Cantabria;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
39 Cantabria;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2022QII;""
39 Cantabria;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2022QI;""
39 Cantabria;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2021QIV;1.458
39 Cantabria;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
39 Cantabria;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2021QII;""
39 Cantabria;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2021QI;""
39 Cantabria;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2020QIV;1.391
39 Cantabria;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
39 Cantabria;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2020QII;""
39 Cantabria;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2020QI;""
39 Cantabria;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
39 Cantabria;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
39 Cantabria;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QII;""
39 Cantabria;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QI;1.383
39 Cantabria;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
39 Cantabria;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
39 Cantabria;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QII;""
39 Cantabria;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QI;1.334
39 Cantabria;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
39 Cantabria;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
39 Cantabria;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QII;""
39 Cantabria;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QI;""
39 Cantabria;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
39 Cantabria;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
39 Cantabria;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QII;1.325
39 Cantabria;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QI;""
39 Cantabria;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
39 Cantabria;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
39 Cantabria;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QII;1.294
39 Cantabria;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QI;""
39 Cantabria;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
39 Cantabria;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
39 Cantabria;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QII;""
39 Cantabria;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QI;""
39 Cantabria;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
39 Cantabria;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
39 Cantabria;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
39 Cantabria;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
39 Cantabria;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
39 Cantabria;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
39 Cantabria;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
39 Cantabria;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
39 Cantabria;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
39 Cantabria;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
39 Cantabria;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
39 Cantabria;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
39 Cantabria;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
39 Cantabria;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;93,37
39 Cantabria;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
39 Cantabria;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
39 Cantabria;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
39 Cantabria;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;93,59
39 Cantabria;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
39 Cantabria;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
39 Cantabria;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
39 Cantabria;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;93,89
39 Cantabria;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
39 Cantabria;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
39 Cantabria;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;86,97
39 Cantabria;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
39 Cantabria;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
39 Cantabria;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
39 Cantabria;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;89,01
39 Cantabria;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
39 Cantabria;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
39 Cantabria;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
39 Cantabria;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;89,4
39 Cantabria;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
39 Cantabria;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
39 Cantabria;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
39 Cantabria;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
39 Cantabria;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
39 Cantabria;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
39 Cantabria;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;84,43
39 Cantabria;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
39 Cantabria;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
39 Cantabria;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
39 Cantabria;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;85,73
39 Cantabria;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
39 Cantabria;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
39 Cantabria;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
39 Cantabria;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
39 Cantabria;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
39 Cantabria;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
39 Cantabria;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;80,89
39 Cantabria;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
39 Cantabria;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
39 Cantabria;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
39 Cantabria;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;83,16
39 Cantabria;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
39 Cantabria;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
39 Cantabria;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
39 Cantabria;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
39 Cantabria;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
39 Cantabria;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
39 Cantabria;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QIII;1.061
39 Cantabria;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
39 Cantabria;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
39 Cantabria;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
39 Cantabria;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QIII;1.030
39 Cantabria;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
39 Cantabria;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
39 Cantabria;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
39 Cantabria;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QIII;965
39 Cantabria;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
39 Cantabria;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
39 Cantabria;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
39 Cantabria;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2022QIII;995
39 Cantabria;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2022QII;""
39 Cantabria;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2022QI;""
39 Cantabria;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
39 Cantabria;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2021QIII;958
39 Cantabria;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2021QII;""
39 Cantabria;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2021QI;""
39 Cantabria;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
39 Cantabria;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2020QIII;900
39 Cantabria;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2020QII;""
39 Cantabria;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2020QI;""
39 Cantabria;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2022QIV;923
39 Cantabria;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
39 Cantabria;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2022QII;""
39 Cantabria;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2022QI;""
39 Cantabria;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2021QIV;915
39 Cantabria;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
39 Cantabria;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2021QII;""
39 Cantabria;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2021QI;""
39 Cantabria;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2020QIV;855
39 Cantabria;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
39 Cantabria;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2020QII;""
39 Cantabria;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2020QI;""
39 Cantabria;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
39 Cantabria;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
39 Cantabria;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QII;""
39 Cantabria;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QI;868
39 Cantabria;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
39 Cantabria;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
39 Cantabria;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QII;""
39 Cantabria;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QI;815
39 Cantabria;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
39 Cantabria;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
39 Cantabria;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QII;""
39 Cantabria;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QI;""
39 Cantabria;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
39 Cantabria;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
39 Cantabria;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QII;828
39 Cantabria;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QI;""
39 Cantabria;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
39 Cantabria;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
39 Cantabria;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QII;789
39 Cantabria;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QI;""
39 Cantabria;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
39 Cantabria;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
39 Cantabria;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QII;""
39 Cantabria;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QI;""
39 Cantabria;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
39 Cantabria;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
39 Cantabria;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
39 Cantabria;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
39 Cantabria;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
39 Cantabria;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
39 Cantabria;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
39 Cantabria;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
39 Cantabria;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
39 Cantabria;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
39 Cantabria;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
39 Cantabria;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
39 Cantabria;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
39 Cantabria;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;93,78
39 Cantabria;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
39 Cantabria;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
39 Cantabria;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
39 Cantabria;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;93,01
39 Cantabria;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
39 Cantabria;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
39 Cantabria;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
39 Cantabria;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;93,26
39 Cantabria;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
39 Cantabria;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
39 Cantabria;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;86,99
39 Cantabria;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
39 Cantabria;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
39 Cantabria;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
39 Cantabria;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;88,83
39 Cantabria;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
39 Cantabria;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
39 Cantabria;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
39 Cantabria;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;88,6
39 Cantabria;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
39 Cantabria;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
39 Cantabria;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
39 Cantabria;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
39 Cantabria;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
39 Cantabria;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
39 Cantabria;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;84,27
39 Cantabria;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
39 Cantabria;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
39 Cantabria;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
39 Cantabria;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;84,46
39 Cantabria;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
39 Cantabria;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
39 Cantabria;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
39 Cantabria;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
39 Cantabria;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
39 Cantabria;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
39 Cantabria;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;80,39
39 Cantabria;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
39 Cantabria;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
39 Cantabria;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
39 Cantabria;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;81,76
39 Cantabria;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
39 Cantabria;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
39 Cantabria;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
39 Cantabria;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
39 Cantabria;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
39 Cantabria;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
39 Cantabria;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QIII;643
39 Cantabria;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
39 Cantabria;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
39 Cantabria;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
39 Cantabria;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QIII;608
39 Cantabria;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
39 Cantabria;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
39 Cantabria;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
39 Cantabria;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QIII;591
39 Cantabria;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
39 Cantabria;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
39 Cantabria;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
39 Cantabria;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2022QIII;596
39 Cantabria;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2022QII;""
39 Cantabria;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2022QI;""
39 Cantabria;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
39 Cantabria;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2021QIII;575
39 Cantabria;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2021QII;""
39 Cantabria;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2021QI;""
39 Cantabria;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
39 Cantabria;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2020QIII;561
39 Cantabria;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2020QII;""
39 Cantabria;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2020QI;""
39 Cantabria;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2022QIV;559
39 Cantabria;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
39 Cantabria;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2022QII;""
39 Cantabria;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2022QI;""
39 Cantabria;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2021QIV;543
39 Cantabria;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
39 Cantabria;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2021QII;""
39 Cantabria;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2021QI;""
39 Cantabria;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2020QIV;536
39 Cantabria;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
39 Cantabria;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2020QII;""
39 Cantabria;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2020QI;""
39 Cantabria;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
39 Cantabria;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
39 Cantabria;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QII;""
39 Cantabria;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QI;515
39 Cantabria;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
39 Cantabria;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
39 Cantabria;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QII;""
39 Cantabria;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QI;519
39 Cantabria;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
39 Cantabria;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
39 Cantabria;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QII;""
39 Cantabria;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QI;""
39 Cantabria;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
39 Cantabria;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
39 Cantabria;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QII;497
39 Cantabria;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QI;""
39 Cantabria;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
39 Cantabria;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
39 Cantabria;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QII;505
39 Cantabria;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QI;""
39 Cantabria;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
39 Cantabria;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
39 Cantabria;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QII;""
39 Cantabria;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QI;""
39 Cantabria;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
39 Cantabria;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
39 Cantabria;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
39 Cantabria;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
39 Cantabria;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
39 Cantabria;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
39 Cantabria;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
39 Cantabria;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
39 Cantabria;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
39 Cantabria;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
39 Cantabria;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
39 Cantabria;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
39 Cantabria;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
39 Cantabria;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;92,69
39 Cantabria;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
39 Cantabria;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
39 Cantabria;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
39 Cantabria;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;94,57
39 Cantabria;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
39 Cantabria;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
39 Cantabria;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
39 Cantabria;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;94,92
39 Cantabria;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
39 Cantabria;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
39 Cantabria;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;86,94
39 Cantabria;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
39 Cantabria;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
39 Cantabria;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
39 Cantabria;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;89,31
39 Cantabria;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
39 Cantabria;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
39 Cantabria;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
39 Cantabria;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;90,69
39 Cantabria;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
39 Cantabria;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
39 Cantabria;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
39 Cantabria;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
39 Cantabria;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
39 Cantabria;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
39 Cantabria;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;84,7
39 Cantabria;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
39 Cantabria;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
39 Cantabria;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
39 Cantabria;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;87,82
39 Cantabria;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
39 Cantabria;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
39 Cantabria;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
39 Cantabria;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
39 Cantabria;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
39 Cantabria;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
39 Cantabria;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;81,74
39 Cantabria;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
39 Cantabria;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
39 Cantabria;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
39 Cantabria;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;85,45
39 Cantabria;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
39 Cantabria;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
39 Cantabria;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
39 Cantabria;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
39 Cantabria;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
39 Cantabria;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QIV;1.769
39 Cantabria;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
39 Cantabria;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
39 Cantabria;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
39 Cantabria;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QIV;1.713
39 Cantabria;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
39 Cantabria;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
39 Cantabria;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
39 Cantabria;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QIV;1.649
39 Cantabria;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
39 Cantabria;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
39 Cantabria;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
39 Cantabria;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2022QIV;1.640
39 Cantabria;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
39 Cantabria;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2022QII;""
39 Cantabria;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2022QI;""
39 Cantabria;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2021QIV;1.609
39 Cantabria;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
39 Cantabria;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2021QII;""
39 Cantabria;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2021QI;""
39 Cantabria;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2020QIV;1.555
39 Cantabria;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
39 Cantabria;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2020QII;""
39 Cantabria;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2020QI;""
39 Cantabria;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
39 Cantabria;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
39 Cantabria;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2022QII;""
39 Cantabria;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2022QI;1.523
39 Cantabria;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
39 Cantabria;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
39 Cantabria;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2021QII;""
39 Cantabria;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2021QI;1.489
39 Cantabria;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
39 Cantabria;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
39 Cantabria;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2020QII;""
39 Cantabria;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2020QI;""
39 Cantabria;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
39 Cantabria;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
39 Cantabria;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QII;1.456
39 Cantabria;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QI;""
39 Cantabria;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
39 Cantabria;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
39 Cantabria;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QII;1.443
39 Cantabria;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QI;""
39 Cantabria;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
39 Cantabria;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
39 Cantabria;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QII;""
39 Cantabria;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QI;""
39 Cantabria;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
39 Cantabria;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QIII;1.387
39 Cantabria;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QII;""
39 Cantabria;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QI;""
39 Cantabria;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
39 Cantabria;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QIII;1.390
39 Cantabria;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QII;""
39 Cantabria;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QI;""
39 Cantabria;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
39 Cantabria;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
39 Cantabria;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QII;""
39 Cantabria;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QI;""
39 Cantabria;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
39 Cantabria;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
39 Cantabria;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
39 Cantabria;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
39 Cantabria;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
39 Cantabria;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
39 Cantabria;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
39 Cantabria;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
39 Cantabria;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
39 Cantabria;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
39 Cantabria;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
39 Cantabria;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
39 Cantabria;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;92,71
39 Cantabria;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
39 Cantabria;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
39 Cantabria;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
39 Cantabria;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;93,93
39 Cantabria;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
39 Cantabria;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
39 Cantabria;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
39 Cantabria;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;94,3
39 Cantabria;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
39 Cantabria;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
39 Cantabria;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
39 Cantabria;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
39 Cantabria;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
39 Cantabria;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
39 Cantabria;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;88,91
39 Cantabria;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
39 Cantabria;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
39 Cantabria;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
39 Cantabria;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;90,3
39 Cantabria;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
39 Cantabria;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
39 Cantabria;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
39 Cantabria;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
39 Cantabria;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
39 Cantabria;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
39 Cantabria;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;85
39 Cantabria;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
39 Cantabria;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
39 Cantabria;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
39 Cantabria;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;87,51
39 Cantabria;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
39 Cantabria;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
39 Cantabria;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
39 Cantabria;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
39 Cantabria;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
39 Cantabria;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
39 Cantabria;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;80,97
39 Cantabria;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
39 Cantabria;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
39 Cantabria;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
39 Cantabria;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;84,29
39 Cantabria;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
39 Cantabria;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
39 Cantabria;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
39 Cantabria;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
39 Cantabria;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
39 Cantabria;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
39 Cantabria;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QIV;1.101
39 Cantabria;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
39 Cantabria;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
39 Cantabria;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
39 Cantabria;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QIV;1.061
39 Cantabria;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
39 Cantabria;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
39 Cantabria;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
39 Cantabria;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QIV;1.023
39 Cantabria;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
39 Cantabria;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
39 Cantabria;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
39 Cantabria;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2022QIV;1.016
39 Cantabria;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
39 Cantabria;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2022QII;""
39 Cantabria;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2022QI;""
39 Cantabria;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2021QIV;1.000
39 Cantabria;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
39 Cantabria;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2021QII;""
39 Cantabria;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2021QI;""
39 Cantabria;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2020QIV;962
39 Cantabria;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
39 Cantabria;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2020QII;""
39 Cantabria;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2020QI;""
39 Cantabria;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
39 Cantabria;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
39 Cantabria;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2022QII;""
39 Cantabria;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2022QI;947
39 Cantabria;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
39 Cantabria;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
39 Cantabria;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2021QII;""
39 Cantabria;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2021QI;916
39 Cantabria;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
39 Cantabria;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
39 Cantabria;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2020QII;""
39 Cantabria;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2020QI;""
39 Cantabria;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
39 Cantabria;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
39 Cantabria;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QII;901
39 Cantabria;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QI;""
39 Cantabria;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
39 Cantabria;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
39 Cantabria;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QII;887
39 Cantabria;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QI;""
39 Cantabria;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
39 Cantabria;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
39 Cantabria;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QII;""
39 Cantabria;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QI;""
39 Cantabria;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
39 Cantabria;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QIII;867
39 Cantabria;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QII;""
39 Cantabria;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QI;""
39 Cantabria;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
39 Cantabria;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QIII;855
39 Cantabria;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QII;""
39 Cantabria;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QI;""
39 Cantabria;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
39 Cantabria;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
39 Cantabria;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QII;""
39 Cantabria;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QI;""
39 Cantabria;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
39 Cantabria;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
39 Cantabria;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
39 Cantabria;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
39 Cantabria;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
39 Cantabria;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
39 Cantabria;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
39 Cantabria;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
39 Cantabria;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
39 Cantabria;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
39 Cantabria;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
39 Cantabria;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
39 Cantabria;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;92,28
39 Cantabria;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
39 Cantabria;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
39 Cantabria;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
39 Cantabria;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;94,25
39 Cantabria;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
39 Cantabria;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
39 Cantabria;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
39 Cantabria;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;94,04
39 Cantabria;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
39 Cantabria;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
39 Cantabria;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
39 Cantabria;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
39 Cantabria;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
39 Cantabria;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
39 Cantabria;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;89,26
39 Cantabria;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
39 Cantabria;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
39 Cantabria;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
39 Cantabria;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;89,54
39 Cantabria;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
39 Cantabria;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
39 Cantabria;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
39 Cantabria;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
39 Cantabria;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
39 Cantabria;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
39 Cantabria;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;84,92
39 Cantabria;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
39 Cantabria;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
39 Cantabria;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
39 Cantabria;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;86,71
39 Cantabria;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
39 Cantabria;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
39 Cantabria;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
39 Cantabria;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
39 Cantabria;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
39 Cantabria;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
39 Cantabria;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;81,72
39 Cantabria;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
39 Cantabria;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
39 Cantabria;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
39 Cantabria;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;83,58
39 Cantabria;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
39 Cantabria;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
39 Cantabria;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
39 Cantabria;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
39 Cantabria;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
39 Cantabria;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
39 Cantabria;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QIV;668
39 Cantabria;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
39 Cantabria;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
39 Cantabria;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
39 Cantabria;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QIV;652
39 Cantabria;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
39 Cantabria;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
39 Cantabria;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
39 Cantabria;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QIV;626
39 Cantabria;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
39 Cantabria;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
39 Cantabria;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
39 Cantabria;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2022QIV;624
39 Cantabria;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
39 Cantabria;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2022QII;""
39 Cantabria;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2022QI;""
39 Cantabria;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2021QIV;609
39 Cantabria;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
39 Cantabria;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2021QII;""
39 Cantabria;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2021QI;""
39 Cantabria;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2020QIV;593
39 Cantabria;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
39 Cantabria;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2020QII;""
39 Cantabria;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2020QI;""
39 Cantabria;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
39 Cantabria;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
39 Cantabria;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2022QII;""
39 Cantabria;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2022QI;576
39 Cantabria;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
39 Cantabria;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
39 Cantabria;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2021QII;""
39 Cantabria;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2021QI;573
39 Cantabria;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
39 Cantabria;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
39 Cantabria;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2020QII;""
39 Cantabria;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2020QI;""
39 Cantabria;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
39 Cantabria;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
39 Cantabria;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QII;555
39 Cantabria;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QI;""
39 Cantabria;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
39 Cantabria;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
39 Cantabria;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QII;556
39 Cantabria;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QI;""
39 Cantabria;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
39 Cantabria;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
39 Cantabria;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QII;""
39 Cantabria;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QI;""
39 Cantabria;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
39 Cantabria;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QIII;520
39 Cantabria;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QII;""
39 Cantabria;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QI;""
39 Cantabria;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
39 Cantabria;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QIII;535
39 Cantabria;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QII;""
39 Cantabria;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QI;""
39 Cantabria;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
39 Cantabria;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
39 Cantabria;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QII;""
39 Cantabria;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QI;""
39 Cantabria;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
39 Cantabria;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
39 Cantabria;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
39 Cantabria;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
39 Cantabria;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
39 Cantabria;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
39 Cantabria;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
39 Cantabria;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
39 Cantabria;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
39 Cantabria;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
39 Cantabria;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
39 Cantabria;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
39 Cantabria;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;93,41
39 Cantabria;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
39 Cantabria;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
39 Cantabria;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
39 Cantabria;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;93,4
39 Cantabria;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
39 Cantabria;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
39 Cantabria;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
39 Cantabria;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;94,73
39 Cantabria;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
39 Cantabria;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
39 Cantabria;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
39 Cantabria;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
39 Cantabria;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
39 Cantabria;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
39 Cantabria;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;88,34
39 Cantabria;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
39 Cantabria;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
39 Cantabria;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
39 Cantabria;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;91,53
39 Cantabria;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
39 Cantabria;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
39 Cantabria;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
39 Cantabria;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
39 Cantabria;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
39 Cantabria;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
39 Cantabria;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;85,12
39 Cantabria;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
39 Cantabria;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
39 Cantabria;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
39 Cantabria;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;88,82
39 Cantabria;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
39 Cantabria;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
39 Cantabria;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
39 Cantabria;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
39 Cantabria;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
39 Cantabria;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
39 Cantabria;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;79,75
39 Cantabria;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
39 Cantabria;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
39 Cantabria;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
39 Cantabria;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;85,46
39 Cantabria;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
39 Cantabria;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
39 Cantabria;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
39 Cantabria;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
39 Cantabria;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
39 Cantabria;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
39 Cantabria;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
39 Cantabria;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
39 Cantabria;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
39 Cantabria;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QI;6.062
39 Cantabria;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
39 Cantabria;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
39 Cantabria;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
39 Cantabria;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QI;6.240
39 Cantabria;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
39 Cantabria;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
39 Cantabria;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
39 Cantabria;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QI;6.044
39 Cantabria;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
39 Cantabria;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
39 Cantabria;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2022QII;""
39 Cantabria;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2022QI;5.886
39 Cantabria;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
39 Cantabria;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
39 Cantabria;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2021QII;""
39 Cantabria;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2021QI;6.087
39 Cantabria;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
39 Cantabria;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
39 Cantabria;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2020QII;""
39 Cantabria;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2020QI;5.700
39 Cantabria;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
39 Cantabria;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
39 Cantabria;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2022QII;5.692
39 Cantabria;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2022QI;""
39 Cantabria;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
39 Cantabria;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
39 Cantabria;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2021QII;5.933
39 Cantabria;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2021QI;""
39 Cantabria;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
39 Cantabria;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
39 Cantabria;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2020QII;5.582
39 Cantabria;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2020QI;""
39 Cantabria;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
39 Cantabria;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QIII;5.563
39 Cantabria;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QII;""
39 Cantabria;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QI;""
39 Cantabria;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
39 Cantabria;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QIII;5.794
39 Cantabria;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QII;""
39 Cantabria;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QI;""
39 Cantabria;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
39 Cantabria;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QIII;5.468
39 Cantabria;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QII;""
39 Cantabria;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QI;""
39 Cantabria;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QIV;5.387
39 Cantabria;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
39 Cantabria;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QII;""
39 Cantabria;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QI;""
39 Cantabria;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QIV;5.646
39 Cantabria;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
39 Cantabria;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QII;""
39 Cantabria;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QI;""
39 Cantabria;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QIV;5.324
39 Cantabria;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
39 Cantabria;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QII;""
39 Cantabria;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QI;""
39 Cantabria;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
39 Cantabria;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
39 Cantabria;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
39 Cantabria;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
39 Cantabria;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
39 Cantabria;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
39 Cantabria;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
39 Cantabria;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
39 Cantabria;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
39 Cantabria;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
39 Cantabria;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
39 Cantabria;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
39 Cantabria;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
39 Cantabria;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
39 Cantabria;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
39 Cantabria;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;97,1
39 Cantabria;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
39 Cantabria;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
39 Cantabria;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
39 Cantabria;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;97,55
39 Cantabria;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
39 Cantabria;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
39 Cantabria;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
39 Cantabria;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;94,31
39 Cantabria;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
39 Cantabria;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
39 Cantabria;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;93,9
39 Cantabria;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
39 Cantabria;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
39 Cantabria;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
39 Cantabria;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;95,08
39 Cantabria;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
39 Cantabria;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
39 Cantabria;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
39 Cantabria;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;92,36
39 Cantabria;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
39 Cantabria;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
39 Cantabria;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;91,77
39 Cantabria;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
39 Cantabria;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
39 Cantabria;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
39 Cantabria;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;92,85
39 Cantabria;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
39 Cantabria;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
39 Cantabria;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
39 Cantabria;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;90,47
39 Cantabria;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
39 Cantabria;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
39 Cantabria;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;88,87
39 Cantabria;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
39 Cantabria;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
39 Cantabria;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
39 Cantabria;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;90,48
39 Cantabria;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
39 Cantabria;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
39 Cantabria;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
39 Cantabria;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;88,09
39 Cantabria;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
39 Cantabria;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
39 Cantabria;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
39 Cantabria;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
39 Cantabria;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
39 Cantabria;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
39 Cantabria;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QI;3.595
39 Cantabria;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
39 Cantabria;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
39 Cantabria;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
39 Cantabria;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QI;3.743
39 Cantabria;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
39 Cantabria;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
39 Cantabria;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
39 Cantabria;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QI;3.633
39 Cantabria;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
39 Cantabria;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
39 Cantabria;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2022QII;""
39 Cantabria;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2022QI;3.493
39 Cantabria;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
39 Cantabria;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
39 Cantabria;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2021QII;""
39 Cantabria;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2021QI;3.651
39 Cantabria;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
39 Cantabria;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
39 Cantabria;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2020QII;""
39 Cantabria;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2020QI;3.423
39 Cantabria;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
39 Cantabria;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
39 Cantabria;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2022QII;3.388
39 Cantabria;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2022QI;""
39 Cantabria;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
39 Cantabria;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
39 Cantabria;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2021QII;3.560
39 Cantabria;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2021QI;""
39 Cantabria;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
39 Cantabria;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
39 Cantabria;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2020QII;3.354
39 Cantabria;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2020QI;""
39 Cantabria;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
39 Cantabria;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QIII;3.319
39 Cantabria;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QII;""
39 Cantabria;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QI;""
39 Cantabria;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
39 Cantabria;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QIII;3.474
39 Cantabria;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QII;""
39 Cantabria;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QI;""
39 Cantabria;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
39 Cantabria;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QIII;3.294
39 Cantabria;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QII;""
39 Cantabria;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QI;""
39 Cantabria;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QIV;3.210
39 Cantabria;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
39 Cantabria;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QII;""
39 Cantabria;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QI;""
39 Cantabria;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QIV;3.389
39 Cantabria;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
39 Cantabria;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QII;""
39 Cantabria;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QI;""
39 Cantabria;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QIV;3.217
39 Cantabria;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
39 Cantabria;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QII;""
39 Cantabria;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QI;""
39 Cantabria;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
39 Cantabria;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
39 Cantabria;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
39 Cantabria;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
39 Cantabria;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
39 Cantabria;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
39 Cantabria;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
39 Cantabria;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
39 Cantabria;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
39 Cantabria;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
39 Cantabria;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
39 Cantabria;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
39 Cantabria;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
39 Cantabria;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
39 Cantabria;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
39 Cantabria;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;97,16
39 Cantabria;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
39 Cantabria;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
39 Cantabria;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
39 Cantabria;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;97,54
39 Cantabria;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
39 Cantabria;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
39 Cantabria;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
39 Cantabria;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;94,22
39 Cantabria;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
39 Cantabria;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
39 Cantabria;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;94,24
39 Cantabria;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
39 Cantabria;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
39 Cantabria;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
39 Cantabria;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;95,11
39 Cantabria;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
39 Cantabria;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
39 Cantabria;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
39 Cantabria;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;92,32
39 Cantabria;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
39 Cantabria;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
39 Cantabria;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;92,32
39 Cantabria;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
39 Cantabria;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
39 Cantabria;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
39 Cantabria;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;92,81
39 Cantabria;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
39 Cantabria;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
39 Cantabria;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
39 Cantabria;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;90,67
39 Cantabria;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
39 Cantabria;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
39 Cantabria;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;89,29
39 Cantabria;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
39 Cantabria;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
39 Cantabria;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
39 Cantabria;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;90,54
39 Cantabria;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
39 Cantabria;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
39 Cantabria;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
39 Cantabria;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;88,55
39 Cantabria;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
39 Cantabria;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
39 Cantabria;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
39 Cantabria;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
39 Cantabria;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
39 Cantabria;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
39 Cantabria;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QI;2.467
39 Cantabria;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
39 Cantabria;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
39 Cantabria;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
39 Cantabria;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QI;2.497
39 Cantabria;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
39 Cantabria;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
39 Cantabria;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
39 Cantabria;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QI;2.411
39 Cantabria;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
39 Cantabria;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
39 Cantabria;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2022QII;""
39 Cantabria;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2022QI;2.393
39 Cantabria;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
39 Cantabria;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
39 Cantabria;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2021QII;""
39 Cantabria;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2021QI;2.436
39 Cantabria;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
39 Cantabria;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
39 Cantabria;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2020QII;""
39 Cantabria;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2020QI;2.277
39 Cantabria;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
39 Cantabria;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
39 Cantabria;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2022QII;2.304
39 Cantabria;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2022QI;""
39 Cantabria;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
39 Cantabria;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
39 Cantabria;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2021QII;2.373
39 Cantabria;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2021QI;""
39 Cantabria;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
39 Cantabria;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
39 Cantabria;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2020QII;2.228
39 Cantabria;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2020QI;""
39 Cantabria;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
39 Cantabria;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QIII;2.244
39 Cantabria;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QII;""
39 Cantabria;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QI;""
39 Cantabria;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
39 Cantabria;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QIII;2.320
39 Cantabria;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QII;""
39 Cantabria;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QI;""
39 Cantabria;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
39 Cantabria;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QIII;2.174
39 Cantabria;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QII;""
39 Cantabria;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QI;""
39 Cantabria;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QIV;2.177
39 Cantabria;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
39 Cantabria;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QII;""
39 Cantabria;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QI;""
39 Cantabria;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QIV;2.257
39 Cantabria;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
39 Cantabria;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QII;""
39 Cantabria;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QI;""
39 Cantabria;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QIV;2.107
39 Cantabria;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
39 Cantabria;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QII;""
39 Cantabria;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QI;""
39 Cantabria;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
39 Cantabria;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
39 Cantabria;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
39 Cantabria;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
39 Cantabria;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
39 Cantabria;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
39 Cantabria;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
39 Cantabria;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
39 Cantabria;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
39 Cantabria;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
39 Cantabria;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
39 Cantabria;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
39 Cantabria;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
39 Cantabria;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
39 Cantabria;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
39 Cantabria;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;97
39 Cantabria;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
39 Cantabria;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
39 Cantabria;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
39 Cantabria;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;97,56
39 Cantabria;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
39 Cantabria;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
39 Cantabria;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
39 Cantabria;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;94,44
39 Cantabria;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
39 Cantabria;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
39 Cantabria;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;93,39
39 Cantabria;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
39 Cantabria;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
39 Cantabria;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
39 Cantabria;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;95,03
39 Cantabria;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
39 Cantabria;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
39 Cantabria;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
39 Cantabria;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;92,41
39 Cantabria;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
39 Cantabria;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
39 Cantabria;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;90,96
39 Cantabria;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
39 Cantabria;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
39 Cantabria;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
39 Cantabria;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;92,91
39 Cantabria;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
39 Cantabria;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
39 Cantabria;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
39 Cantabria;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;90,17
39 Cantabria;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
39 Cantabria;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
39 Cantabria;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;88,24
39 Cantabria;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
39 Cantabria;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
39 Cantabria;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
39 Cantabria;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;90,39
39 Cantabria;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
39 Cantabria;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
39 Cantabria;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
39 Cantabria;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;87,39
39 Cantabria;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
39 Cantabria;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
39 Cantabria;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
39 Cantabria;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
39 Cantabria;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
39 Cantabria;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QII;5.603
39 Cantabria;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
39 Cantabria;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
39 Cantabria;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
39 Cantabria;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QII;5.796
39 Cantabria;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
39 Cantabria;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
39 Cantabria;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
39 Cantabria;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QII;5.968
39 Cantabria;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
39 Cantabria;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
39 Cantabria;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
39 Cantabria;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2022QII;5.409
39 Cantabria;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2022QI;""
39 Cantabria;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
39 Cantabria;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
39 Cantabria;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2021QII;5.633
39 Cantabria;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2021QI;""
39 Cantabria;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
39 Cantabria;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
39 Cantabria;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2020QII;5.837
39 Cantabria;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2020QI;""
39 Cantabria;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
39 Cantabria;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2022QIII;5.267
39 Cantabria;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2022QII;""
39 Cantabria;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2022QI;""
39 Cantabria;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
39 Cantabria;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2021QIII;5.484
39 Cantabria;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2021QII;""
39 Cantabria;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2021QI;""
39 Cantabria;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
39 Cantabria;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2020QIII;5.712
39 Cantabria;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2020QII;""
39 Cantabria;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2020QI;""
39 Cantabria;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QIV;5.093
39 Cantabria;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
39 Cantabria;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QII;""
39 Cantabria;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QI;""
39 Cantabria;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QIV;5.329
39 Cantabria;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
39 Cantabria;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QII;""
39 Cantabria;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QI;""
39 Cantabria;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QIV;5.558
39 Cantabria;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
39 Cantabria;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QII;""
39 Cantabria;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QI;""
39 Cantabria;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
39 Cantabria;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
39 Cantabria;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QII;""
39 Cantabria;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QI;5.192
39 Cantabria;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
39 Cantabria;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
39 Cantabria;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QII;""
39 Cantabria;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QI;5.442
39 Cantabria;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
39 Cantabria;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
39 Cantabria;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QII;""
39 Cantabria;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QI;""
39 Cantabria;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
39 Cantabria;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
39 Cantabria;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
39 Cantabria;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
39 Cantabria;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
39 Cantabria;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
39 Cantabria;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
39 Cantabria;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
39 Cantabria;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
39 Cantabria;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
39 Cantabria;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
39 Cantabria;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
39 Cantabria;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
39 Cantabria;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
39 Cantabria;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;96,54
39 Cantabria;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
39 Cantabria;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
39 Cantabria;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
39 Cantabria;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;97,19
39 Cantabria;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
39 Cantabria;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
39 Cantabria;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
39 Cantabria;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;97,8
39 Cantabria;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
39 Cantabria;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
39 Cantabria;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;94
39 Cantabria;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
39 Cantabria;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
39 Cantabria;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
39 Cantabria;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;94,62
39 Cantabria;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
39 Cantabria;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
39 Cantabria;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
39 Cantabria;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;95,71
39 Cantabria;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
39 Cantabria;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
39 Cantabria;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;90,9
39 Cantabria;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
39 Cantabria;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
39 Cantabria;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
39 Cantabria;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;91,94
39 Cantabria;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
39 Cantabria;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
39 Cantabria;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
39 Cantabria;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;93,13
39 Cantabria;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
39 Cantabria;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
39 Cantabria;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
39 Cantabria;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
39 Cantabria;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
39 Cantabria;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
39 Cantabria;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;89,58
39 Cantabria;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
39 Cantabria;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
39 Cantabria;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
39 Cantabria;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;91,19
39 Cantabria;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
39 Cantabria;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
39 Cantabria;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
39 Cantabria;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
39 Cantabria;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
39 Cantabria;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
39 Cantabria;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QII;3.303
39 Cantabria;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
39 Cantabria;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
39 Cantabria;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
39 Cantabria;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QII;3.453
39 Cantabria;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
39 Cantabria;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
39 Cantabria;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
39 Cantabria;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QII;3.581
39 Cantabria;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
39 Cantabria;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
39 Cantabria;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
39 Cantabria;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2022QII;3.191
39 Cantabria;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2022QI;""
39 Cantabria;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
39 Cantabria;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
39 Cantabria;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2021QII;3.360
39 Cantabria;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2021QI;""
39 Cantabria;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
39 Cantabria;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
39 Cantabria;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2020QII;3.504
39 Cantabria;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2020QI;""
39 Cantabria;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
39 Cantabria;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2022QIII;3.108
39 Cantabria;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2022QII;""
39 Cantabria;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2022QI;""
39 Cantabria;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
39 Cantabria;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2021QIII;3.270
39 Cantabria;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2021QII;""
39 Cantabria;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2021QI;""
39 Cantabria;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
39 Cantabria;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2020QIII;3.437
39 Cantabria;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2020QII;""
39 Cantabria;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2020QI;""
39 Cantabria;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QIV;2.996
39 Cantabria;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
39 Cantabria;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QII;""
39 Cantabria;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QI;""
39 Cantabria;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QIV;3.182
39 Cantabria;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
39 Cantabria;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QII;""
39 Cantabria;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QI;""
39 Cantabria;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QIV;3.354
39 Cantabria;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
39 Cantabria;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QII;""
39 Cantabria;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QI;""
39 Cantabria;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
39 Cantabria;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
39 Cantabria;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QII;""
39 Cantabria;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QI;3.110
39 Cantabria;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
39 Cantabria;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
39 Cantabria;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QII;""
39 Cantabria;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QI;3.289
39 Cantabria;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
39 Cantabria;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
39 Cantabria;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QII;""
39 Cantabria;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QI;""
39 Cantabria;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
39 Cantabria;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
39 Cantabria;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
39 Cantabria;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
39 Cantabria;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
39 Cantabria;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
39 Cantabria;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
39 Cantabria;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
39 Cantabria;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
39 Cantabria;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
39 Cantabria;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
39 Cantabria;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
39 Cantabria;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
39 Cantabria;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
39 Cantabria;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;96,61
39 Cantabria;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
39 Cantabria;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
39 Cantabria;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
39 Cantabria;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;97,31
39 Cantabria;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
39 Cantabria;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
39 Cantabria;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
39 Cantabria;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;97,85
39 Cantabria;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
39 Cantabria;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
39 Cantabria;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;94,1
39 Cantabria;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
39 Cantabria;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
39 Cantabria;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
39 Cantabria;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;94,7
39 Cantabria;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
39 Cantabria;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
39 Cantabria;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
39 Cantabria;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;95,98
39 Cantabria;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
39 Cantabria;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
39 Cantabria;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;90,71
39 Cantabria;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
39 Cantabria;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
39 Cantabria;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
39 Cantabria;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;92,15
39 Cantabria;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
39 Cantabria;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
39 Cantabria;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
39 Cantabria;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;93,66
39 Cantabria;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
39 Cantabria;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
39 Cantabria;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
39 Cantabria;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
39 Cantabria;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
39 Cantabria;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
39 Cantabria;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;90,07
39 Cantabria;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
39 Cantabria;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
39 Cantabria;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
39 Cantabria;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;91,85
39 Cantabria;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
39 Cantabria;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
39 Cantabria;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
39 Cantabria;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
39 Cantabria;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
39 Cantabria;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
39 Cantabria;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QII;2.300
39 Cantabria;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
39 Cantabria;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
39 Cantabria;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
39 Cantabria;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QII;2.343
39 Cantabria;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
39 Cantabria;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
39 Cantabria;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
39 Cantabria;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QII;2.387
39 Cantabria;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
39 Cantabria;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
39 Cantabria;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
39 Cantabria;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2022QII;2.218
39 Cantabria;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2022QI;""
39 Cantabria;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
39 Cantabria;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
39 Cantabria;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2021QII;2.273
39 Cantabria;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2021QI;""
39 Cantabria;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
39 Cantabria;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
39 Cantabria;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2020QII;2.333
39 Cantabria;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2020QI;""
39 Cantabria;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
39 Cantabria;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2022QIII;2.159
39 Cantabria;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2022QII;""
39 Cantabria;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2022QI;""
39 Cantabria;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
39 Cantabria;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2021QIII;2.214
39 Cantabria;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2021QII;""
39 Cantabria;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2021QI;""
39 Cantabria;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
39 Cantabria;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2020QIII;2.275
39 Cantabria;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2020QII;""
39 Cantabria;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2020QI;""
39 Cantabria;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QIV;2.097
39 Cantabria;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
39 Cantabria;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QII;""
39 Cantabria;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QI;""
39 Cantabria;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QIV;2.147
39 Cantabria;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
39 Cantabria;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QII;""
39 Cantabria;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QI;""
39 Cantabria;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QIV;2.204
39 Cantabria;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
39 Cantabria;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QII;""
39 Cantabria;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QI;""
39 Cantabria;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
39 Cantabria;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
39 Cantabria;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QII;""
39 Cantabria;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QI;2.082
39 Cantabria;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
39 Cantabria;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
39 Cantabria;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QII;""
39 Cantabria;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QI;2.153
39 Cantabria;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
39 Cantabria;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
39 Cantabria;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QII;""
39 Cantabria;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QI;""
39 Cantabria;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
39 Cantabria;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
39 Cantabria;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
39 Cantabria;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
39 Cantabria;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
39 Cantabria;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
39 Cantabria;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
39 Cantabria;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
39 Cantabria;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
39 Cantabria;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
39 Cantabria;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
39 Cantabria;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
39 Cantabria;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
39 Cantabria;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
39 Cantabria;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;96,43
39 Cantabria;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
39 Cantabria;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
39 Cantabria;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
39 Cantabria;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;97,01
39 Cantabria;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
39 Cantabria;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
39 Cantabria;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
39 Cantabria;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;97,74
39 Cantabria;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
39 Cantabria;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
39 Cantabria;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;93,87
39 Cantabria;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
39 Cantabria;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
39 Cantabria;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
39 Cantabria;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;94,49
39 Cantabria;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
39 Cantabria;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
39 Cantabria;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
39 Cantabria;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;95,31
39 Cantabria;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
39 Cantabria;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
39 Cantabria;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;91,17
39 Cantabria;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
39 Cantabria;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
39 Cantabria;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
39 Cantabria;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;91,63
39 Cantabria;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
39 Cantabria;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
39 Cantabria;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
39 Cantabria;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;92,33
39 Cantabria;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
39 Cantabria;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
39 Cantabria;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
39 Cantabria;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
39 Cantabria;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
39 Cantabria;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
39 Cantabria;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;88,86
39 Cantabria;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
39 Cantabria;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
39 Cantabria;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
39 Cantabria;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;90,2
39 Cantabria;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
39 Cantabria;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
39 Cantabria;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
39 Cantabria;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
39 Cantabria;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
39 Cantabria;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QIII;5.715
39 Cantabria;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
39 Cantabria;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
39 Cantabria;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
39 Cantabria;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QIII;5.948
39 Cantabria;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
39 Cantabria;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
39 Cantabria;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
39 Cantabria;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QIII;6.069
39 Cantabria;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
39 Cantabria;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
39 Cantabria;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
39 Cantabria;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2022QIII;5.538
39 Cantabria;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2022QII;""
39 Cantabria;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2022QI;""
39 Cantabria;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
39 Cantabria;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2021QIII;5.776
39 Cantabria;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2021QII;""
39 Cantabria;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2021QI;""
39 Cantabria;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
39 Cantabria;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2020QIII;5.908
39 Cantabria;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2020QII;""
39 Cantabria;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2020QI;""
39 Cantabria;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2022QIV;5.340
39 Cantabria;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
39 Cantabria;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2022QII;""
39 Cantabria;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2022QI;""
39 Cantabria;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2021QIV;5.597
39 Cantabria;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
39 Cantabria;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2021QII;""
39 Cantabria;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2021QI;""
39 Cantabria;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2020QIV;5.740
39 Cantabria;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
39 Cantabria;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2020QII;""
39 Cantabria;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2020QI;""
39 Cantabria;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
39 Cantabria;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
39 Cantabria;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QII;""
39 Cantabria;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QI;5.444
39 Cantabria;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
39 Cantabria;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
39 Cantabria;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QII;""
39 Cantabria;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QI;5.613
39 Cantabria;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
39 Cantabria;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
39 Cantabria;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QII;""
39 Cantabria;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QI;""
39 Cantabria;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
39 Cantabria;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
39 Cantabria;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QII;5.282
39 Cantabria;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QI;""
39 Cantabria;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
39 Cantabria;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
39 Cantabria;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QII;5.488
39 Cantabria;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QI;""
39 Cantabria;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
39 Cantabria;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
39 Cantabria;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QII;""
39 Cantabria;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QI;""
39 Cantabria;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
39 Cantabria;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
39 Cantabria;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
39 Cantabria;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
39 Cantabria;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
39 Cantabria;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
39 Cantabria;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
39 Cantabria;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
39 Cantabria;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
39 Cantabria;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
39 Cantabria;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
39 Cantabria;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
39 Cantabria;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
39 Cantabria;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;96,9
39 Cantabria;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
39 Cantabria;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
39 Cantabria;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
39 Cantabria;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;97,11
39 Cantabria;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
39 Cantabria;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
39 Cantabria;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
39 Cantabria;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;97,35
39 Cantabria;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
39 Cantabria;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
39 Cantabria;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;93,44
39 Cantabria;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
39 Cantabria;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
39 Cantabria;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
39 Cantabria;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;94,1
39 Cantabria;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
39 Cantabria;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
39 Cantabria;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
39 Cantabria;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;94,58
39 Cantabria;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
39 Cantabria;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
39 Cantabria;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
39 Cantabria;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
39 Cantabria;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
39 Cantabria;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
39 Cantabria;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;91,53
39 Cantabria;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
39 Cantabria;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
39 Cantabria;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
39 Cantabria;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;92,49
39 Cantabria;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
39 Cantabria;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
39 Cantabria;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
39 Cantabria;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
39 Cantabria;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
39 Cantabria;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
39 Cantabria;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;88,8
39 Cantabria;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
39 Cantabria;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
39 Cantabria;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
39 Cantabria;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;90,43
39 Cantabria;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
39 Cantabria;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
39 Cantabria;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
39 Cantabria;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
39 Cantabria;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
39 Cantabria;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
39 Cantabria;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QIII;3.372
39 Cantabria;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
39 Cantabria;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
39 Cantabria;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
39 Cantabria;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QIII;3.544
39 Cantabria;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
39 Cantabria;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
39 Cantabria;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
39 Cantabria;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QIII;3.643
39 Cantabria;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
39 Cantabria;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
39 Cantabria;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
39 Cantabria;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2022QIII;3.267
39 Cantabria;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2022QII;""
39 Cantabria;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2022QI;""
39 Cantabria;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
39 Cantabria;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2021QIII;3.439
39 Cantabria;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2021QII;""
39 Cantabria;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2021QI;""
39 Cantabria;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
39 Cantabria;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2020QIII;3.554
39 Cantabria;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2020QII;""
39 Cantabria;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2020QI;""
39 Cantabria;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2022QIV;3.143
39 Cantabria;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
39 Cantabria;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2022QII;""
39 Cantabria;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2022QI;""
39 Cantabria;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2021QIV;3.339
39 Cantabria;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
39 Cantabria;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2021QII;""
39 Cantabria;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2021QI;""
39 Cantabria;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2020QIV;3.461
39 Cantabria;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
39 Cantabria;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2020QII;""
39 Cantabria;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2020QI;""
39 Cantabria;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
39 Cantabria;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
39 Cantabria;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QII;""
39 Cantabria;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QI;3.254
39 Cantabria;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
39 Cantabria;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
39 Cantabria;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QII;""
39 Cantabria;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QI;3.389
39 Cantabria;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
39 Cantabria;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
39 Cantabria;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QII;""
39 Cantabria;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QI;""
39 Cantabria;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
39 Cantabria;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
39 Cantabria;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QII;3.163
39 Cantabria;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QI;""
39 Cantabria;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
39 Cantabria;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
39 Cantabria;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QII;3.313
39 Cantabria;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QI;""
39 Cantabria;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
39 Cantabria;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
39 Cantabria;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QII;""
39 Cantabria;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QI;""
39 Cantabria;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
39 Cantabria;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
39 Cantabria;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
39 Cantabria;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
39 Cantabria;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
39 Cantabria;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
39 Cantabria;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
39 Cantabria;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
39 Cantabria;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
39 Cantabria;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
39 Cantabria;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
39 Cantabria;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
39 Cantabria;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
39 Cantabria;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;96,89
39 Cantabria;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
39 Cantabria;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
39 Cantabria;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
39 Cantabria;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;97,04
39 Cantabria;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
39 Cantabria;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
39 Cantabria;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
39 Cantabria;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;97,56
39 Cantabria;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
39 Cantabria;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
39 Cantabria;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;93,21
39 Cantabria;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
39 Cantabria;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
39 Cantabria;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
39 Cantabria;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;94,22
39 Cantabria;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
39 Cantabria;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
39 Cantabria;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
39 Cantabria;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;95
39 Cantabria;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
39 Cantabria;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
39 Cantabria;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
39 Cantabria;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
39 Cantabria;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
39 Cantabria;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
39 Cantabria;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;91,82
39 Cantabria;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
39 Cantabria;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
39 Cantabria;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
39 Cantabria;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;93,03
39 Cantabria;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
39 Cantabria;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
39 Cantabria;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
39 Cantabria;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
39 Cantabria;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
39 Cantabria;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
39 Cantabria;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;89,25
39 Cantabria;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
39 Cantabria;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
39 Cantabria;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
39 Cantabria;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;90,94
39 Cantabria;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
39 Cantabria;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
39 Cantabria;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
39 Cantabria;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
39 Cantabria;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
39 Cantabria;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
39 Cantabria;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QIII;2.343
39 Cantabria;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
39 Cantabria;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
39 Cantabria;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
39 Cantabria;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QIII;2.404
39 Cantabria;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
39 Cantabria;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
39 Cantabria;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
39 Cantabria;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QIII;2.426
39 Cantabria;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
39 Cantabria;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
39 Cantabria;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
39 Cantabria;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2022QIII;2.271
39 Cantabria;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2022QII;""
39 Cantabria;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2022QI;""
39 Cantabria;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
39 Cantabria;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2021QIII;2.337
39 Cantabria;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2021QII;""
39 Cantabria;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2021QI;""
39 Cantabria;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
39 Cantabria;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2020QIII;2.354
39 Cantabria;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2020QII;""
39 Cantabria;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2020QI;""
39 Cantabria;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2022QIV;2.197
39 Cantabria;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
39 Cantabria;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2022QII;""
39 Cantabria;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2022QI;""
39 Cantabria;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2021QIV;2.258
39 Cantabria;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
39 Cantabria;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2021QII;""
39 Cantabria;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2021QI;""
39 Cantabria;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2020QIV;2.279
39 Cantabria;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
39 Cantabria;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2020QII;""
39 Cantabria;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2020QI;""
39 Cantabria;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
39 Cantabria;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
39 Cantabria;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QII;""
39 Cantabria;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QI;2.190
39 Cantabria;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
39 Cantabria;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
39 Cantabria;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QII;""
39 Cantabria;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QI;2.224
39 Cantabria;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
39 Cantabria;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
39 Cantabria;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QII;""
39 Cantabria;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QI;""
39 Cantabria;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
39 Cantabria;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
39 Cantabria;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QII;2.119
39 Cantabria;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QI;""
39 Cantabria;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
39 Cantabria;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
39 Cantabria;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QII;2.175
39 Cantabria;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QI;""
39 Cantabria;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
39 Cantabria;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
39 Cantabria;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QII;""
39 Cantabria;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QI;""
39 Cantabria;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
39 Cantabria;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
39 Cantabria;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
39 Cantabria;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
39 Cantabria;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
39 Cantabria;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
39 Cantabria;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
39 Cantabria;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
39 Cantabria;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
39 Cantabria;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
39 Cantabria;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
39 Cantabria;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
39 Cantabria;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
39 Cantabria;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;96,93
39 Cantabria;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
39 Cantabria;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
39 Cantabria;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
39 Cantabria;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;97,21
39 Cantabria;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
39 Cantabria;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
39 Cantabria;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
39 Cantabria;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;97,03
39 Cantabria;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
39 Cantabria;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
39 Cantabria;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;93,77
39 Cantabria;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
39 Cantabria;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
39 Cantabria;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
39 Cantabria;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;93,93
39 Cantabria;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
39 Cantabria;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
39 Cantabria;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
39 Cantabria;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;93,94
39 Cantabria;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
39 Cantabria;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
39 Cantabria;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
39 Cantabria;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
39 Cantabria;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
39 Cantabria;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
39 Cantabria;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;91,1
39 Cantabria;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
39 Cantabria;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
39 Cantabria;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
39 Cantabria;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;91,67
39 Cantabria;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
39 Cantabria;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
39 Cantabria;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
39 Cantabria;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
39 Cantabria;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
39 Cantabria;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
39 Cantabria;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;88,14
39 Cantabria;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
39 Cantabria;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
39 Cantabria;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
39 Cantabria;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;89,65
39 Cantabria;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
39 Cantabria;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
39 Cantabria;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
39 Cantabria;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
39 Cantabria;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
39 Cantabria;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QIV;5.762
39 Cantabria;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
39 Cantabria;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
39 Cantabria;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
39 Cantabria;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QIV;6.019
39 Cantabria;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
39 Cantabria;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
39 Cantabria;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
39 Cantabria;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QIV;6.171
39 Cantabria;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
39 Cantabria;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
39 Cantabria;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
39 Cantabria;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2022QIV;5.543
39 Cantabria;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
39 Cantabria;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2022QII;""
39 Cantabria;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2022QI;""
39 Cantabria;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2021QIV;5.815
39 Cantabria;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
39 Cantabria;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2021QII;""
39 Cantabria;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2021QI;""
39 Cantabria;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2020QIV;5.984
39 Cantabria;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
39 Cantabria;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2020QII;""
39 Cantabria;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2020QI;""
39 Cantabria;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
39 Cantabria;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
39 Cantabria;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2022QII;""
39 Cantabria;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2022QI;5.655
39 Cantabria;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
39 Cantabria;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
39 Cantabria;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2021QII;""
39 Cantabria;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2021QI;5.849
39 Cantabria;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
39 Cantabria;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
39 Cantabria;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2020QII;""
39 Cantabria;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2020QI;""
39 Cantabria;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
39 Cantabria;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
39 Cantabria;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QII;5.479
39 Cantabria;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QI;""
39 Cantabria;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
39 Cantabria;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
39 Cantabria;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QII;5.710
39 Cantabria;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QI;""
39 Cantabria;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
39 Cantabria;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
39 Cantabria;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QII;""
39 Cantabria;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QI;""
39 Cantabria;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
39 Cantabria;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QIII;5.366
39 Cantabria;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QII;""
39 Cantabria;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QI;""
39 Cantabria;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
39 Cantabria;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QIII;5.587
39 Cantabria;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QII;""
39 Cantabria;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QI;""
39 Cantabria;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
39 Cantabria;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
39 Cantabria;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QII;""
39 Cantabria;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QI;""
39 Cantabria;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
39 Cantabria;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
39 Cantabria;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
39 Cantabria;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
39 Cantabria;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
39 Cantabria;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
39 Cantabria;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
39 Cantabria;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
39 Cantabria;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
39 Cantabria;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
39 Cantabria;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
39 Cantabria;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
39 Cantabria;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;96,2
39 Cantabria;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
39 Cantabria;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
39 Cantabria;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
39 Cantabria;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;96,61
39 Cantabria;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
39 Cantabria;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
39 Cantabria;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
39 Cantabria;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;96,97
39 Cantabria;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
39 Cantabria;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
39 Cantabria;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
39 Cantabria;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
39 Cantabria;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
39 Cantabria;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
39 Cantabria;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;93,95
39 Cantabria;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
39 Cantabria;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
39 Cantabria;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
39 Cantabria;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;94,78
39 Cantabria;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
39 Cantabria;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
39 Cantabria;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
39 Cantabria;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
39 Cantabria;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
39 Cantabria;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
39 Cantabria;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;91,03
39 Cantabria;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
39 Cantabria;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
39 Cantabria;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
39 Cantabria;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;92,53
39 Cantabria;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
39 Cantabria;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
39 Cantabria;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
39 Cantabria;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
39 Cantabria;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
39 Cantabria;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
39 Cantabria;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;89,15
39 Cantabria;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
39 Cantabria;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
39 Cantabria;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
39 Cantabria;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;90,54
39 Cantabria;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
39 Cantabria;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
39 Cantabria;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
39 Cantabria;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
39 Cantabria;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
39 Cantabria;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
39 Cantabria;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QIV;3.390
39 Cantabria;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
39 Cantabria;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
39 Cantabria;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
39 Cantabria;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QIV;3.588
39 Cantabria;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
39 Cantabria;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
39 Cantabria;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
39 Cantabria;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QIV;3.687
39 Cantabria;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
39 Cantabria;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
39 Cantabria;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
39 Cantabria;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2022QIV;3.258
39 Cantabria;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
39 Cantabria;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2022QII;""
39 Cantabria;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2022QI;""
39 Cantabria;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2021QIV;3.470
39 Cantabria;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
39 Cantabria;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2021QII;""
39 Cantabria;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2021QI;""
39 Cantabria;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2020QIV;3.586
39 Cantabria;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
39 Cantabria;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2020QII;""
39 Cantabria;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2020QI;""
39 Cantabria;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
39 Cantabria;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
39 Cantabria;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2022QII;""
39 Cantabria;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2022QI;3.380
39 Cantabria;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
39 Cantabria;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
39 Cantabria;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2021QII;""
39 Cantabria;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2021QI;3.508
39 Cantabria;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
39 Cantabria;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
39 Cantabria;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2020QII;""
39 Cantabria;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2020QI;""
39 Cantabria;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
39 Cantabria;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
39 Cantabria;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QII;3.283
39 Cantabria;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QI;""
39 Cantabria;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
39 Cantabria;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
39 Cantabria;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QII;3.428
39 Cantabria;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QI;""
39 Cantabria;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
39 Cantabria;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
39 Cantabria;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QII;""
39 Cantabria;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QI;""
39 Cantabria;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
39 Cantabria;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QIII;3.221
39 Cantabria;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QII;""
39 Cantabria;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QI;""
39 Cantabria;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
39 Cantabria;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QIII;3.351
39 Cantabria;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QII;""
39 Cantabria;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QI;""
39 Cantabria;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
39 Cantabria;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
39 Cantabria;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QII;""
39 Cantabria;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QI;""
39 Cantabria;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
39 Cantabria;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
39 Cantabria;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
39 Cantabria;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
39 Cantabria;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
39 Cantabria;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
39 Cantabria;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
39 Cantabria;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
39 Cantabria;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
39 Cantabria;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
39 Cantabria;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
39 Cantabria;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
39 Cantabria;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;96,11
39 Cantabria;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
39 Cantabria;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
39 Cantabria;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
39 Cantabria;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;96,71
39 Cantabria;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
39 Cantabria;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
39 Cantabria;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
39 Cantabria;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;97,26
39 Cantabria;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
39 Cantabria;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
39 Cantabria;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
39 Cantabria;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
39 Cantabria;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
39 Cantabria;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
39 Cantabria;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;94,2
39 Cantabria;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
39 Cantabria;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
39 Cantabria;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
39 Cantabria;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;95,15
39 Cantabria;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
39 Cantabria;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
39 Cantabria;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
39 Cantabria;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
39 Cantabria;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
39 Cantabria;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
39 Cantabria;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;91,5
39 Cantabria;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
39 Cantabria;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
39 Cantabria;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
39 Cantabria;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;92,98
39 Cantabria;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
39 Cantabria;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
39 Cantabria;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
39 Cantabria;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
39 Cantabria;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
39 Cantabria;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
39 Cantabria;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;89,77
39 Cantabria;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
39 Cantabria;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
39 Cantabria;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
39 Cantabria;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;90,89
39 Cantabria;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
39 Cantabria;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
39 Cantabria;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
39 Cantabria;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
39 Cantabria;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
39 Cantabria;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
39 Cantabria;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QIV;2.372
39 Cantabria;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
39 Cantabria;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
39 Cantabria;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
39 Cantabria;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QIV;2.431
39 Cantabria;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
39 Cantabria;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
39 Cantabria;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
39 Cantabria;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QIV;2.484
39 Cantabria;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
39 Cantabria;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
39 Cantabria;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
39 Cantabria;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2022QIV;2.285
39 Cantabria;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
39 Cantabria;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2022QII;""
39 Cantabria;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2022QI;""
39 Cantabria;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2021QIV;2.345
39 Cantabria;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
39 Cantabria;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2021QII;""
39 Cantabria;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2021QI;""
39 Cantabria;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2020QIV;2.398
39 Cantabria;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
39 Cantabria;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2020QII;""
39 Cantabria;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2020QI;""
39 Cantabria;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
39 Cantabria;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
39 Cantabria;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2022QII;""
39 Cantabria;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2022QI;2.275
39 Cantabria;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
39 Cantabria;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
39 Cantabria;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2021QII;""
39 Cantabria;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2021QI;2.341
39 Cantabria;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
39 Cantabria;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
39 Cantabria;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2020QII;""
39 Cantabria;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2020QI;""
39 Cantabria;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
39 Cantabria;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
39 Cantabria;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QII;2.196
39 Cantabria;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QI;""
39 Cantabria;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
39 Cantabria;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
39 Cantabria;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QII;2.282
39 Cantabria;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QI;""
39 Cantabria;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
39 Cantabria;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
39 Cantabria;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QII;""
39 Cantabria;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QI;""
39 Cantabria;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
39 Cantabria;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QIII;2.145
39 Cantabria;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QII;""
39 Cantabria;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QI;""
39 Cantabria;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
39 Cantabria;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QIII;2.236
39 Cantabria;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QII;""
39 Cantabria;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QI;""
39 Cantabria;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
39 Cantabria;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
39 Cantabria;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QII;""
39 Cantabria;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QI;""
39 Cantabria;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
39 Cantabria;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
39 Cantabria;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
39 Cantabria;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
39 Cantabria;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
39 Cantabria;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
39 Cantabria;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
39 Cantabria;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
39 Cantabria;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
39 Cantabria;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
39 Cantabria;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
39 Cantabria;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
39 Cantabria;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;96,33
39 Cantabria;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
39 Cantabria;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
39 Cantabria;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
39 Cantabria;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;96,46
39 Cantabria;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
39 Cantabria;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
39 Cantabria;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
39 Cantabria;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;96,54
39 Cantabria;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
39 Cantabria;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
39 Cantabria;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
39 Cantabria;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
39 Cantabria;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
39 Cantabria;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
39 Cantabria;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;93,58
39 Cantabria;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
39 Cantabria;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
39 Cantabria;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
39 Cantabria;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;94,24
39 Cantabria;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
39 Cantabria;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
39 Cantabria;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
39 Cantabria;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
39 Cantabria;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
39 Cantabria;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
39 Cantabria;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;90,33
39 Cantabria;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
39 Cantabria;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
39 Cantabria;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
39 Cantabria;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;91,87
39 Cantabria;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
39 Cantabria;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
39 Cantabria;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
39 Cantabria;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
39 Cantabria;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
39 Cantabria;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
39 Cantabria;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;88,24
39 Cantabria;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
39 Cantabria;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
39 Cantabria;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
39 Cantabria;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;90,02
39 Cantabria;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
39 Cantabria;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
39 Cantabria;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
39 Cantabria;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
39 Cantabria;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
39 Cantabria;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
39 Cantabria;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
39 Cantabria;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
39 Cantabria;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
39 Cantabria;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QI;11.647
39 Cantabria;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
39 Cantabria;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
39 Cantabria;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
39 Cantabria;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QI;11.592
39 Cantabria;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
39 Cantabria;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
39 Cantabria;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
39 Cantabria;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QI;11.617
39 Cantabria;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
39 Cantabria;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
39 Cantabria;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2022QII;""
39 Cantabria;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2022QI;11.386
39 Cantabria;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
39 Cantabria;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
39 Cantabria;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2021QII;""
39 Cantabria;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2021QI;11.383
39 Cantabria;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
39 Cantabria;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
39 Cantabria;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2020QII;""
39 Cantabria;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2020QI;11.065
39 Cantabria;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
39 Cantabria;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
39 Cantabria;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2022QII;11.119
39 Cantabria;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2022QI;""
39 Cantabria;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
39 Cantabria;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
39 Cantabria;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2021QII;11.204
39 Cantabria;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2021QI;""
39 Cantabria;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
39 Cantabria;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
39 Cantabria;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2020QII;10.904
39 Cantabria;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2020QI;""
39 Cantabria;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
39 Cantabria;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QIII;10.959
39 Cantabria;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QII;""
39 Cantabria;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QI;""
39 Cantabria;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
39 Cantabria;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QIII;11.031
39 Cantabria;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QII;""
39 Cantabria;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QI;""
39 Cantabria;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
39 Cantabria;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QIII;10.727
39 Cantabria;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QII;""
39 Cantabria;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QI;""
39 Cantabria;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QIV;10.748
39 Cantabria;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
39 Cantabria;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QII;""
39 Cantabria;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QI;""
39 Cantabria;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QIV;10.840
39 Cantabria;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
39 Cantabria;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QII;""
39 Cantabria;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QI;""
39 Cantabria;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QIV;10.545
39 Cantabria;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
39 Cantabria;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QII;""
39 Cantabria;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QI;""
39 Cantabria;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
39 Cantabria;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
39 Cantabria;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
39 Cantabria;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
39 Cantabria;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
39 Cantabria;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
39 Cantabria;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
39 Cantabria;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
39 Cantabria;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
39 Cantabria;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
39 Cantabria;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
39 Cantabria;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
39 Cantabria;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
39 Cantabria;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
39 Cantabria;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
39 Cantabria;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;97,76
39 Cantabria;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
39 Cantabria;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
39 Cantabria;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
39 Cantabria;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;98,2
39 Cantabria;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
39 Cantabria;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
39 Cantabria;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
39 Cantabria;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;95,25
39 Cantabria;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
39 Cantabria;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
39 Cantabria;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;95,47
39 Cantabria;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
39 Cantabria;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
39 Cantabria;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
39 Cantabria;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;96,65
39 Cantabria;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
39 Cantabria;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
39 Cantabria;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
39 Cantabria;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;93,86
39 Cantabria;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
39 Cantabria;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
39 Cantabria;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;94,09
39 Cantabria;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
39 Cantabria;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
39 Cantabria;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
39 Cantabria;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;95,16
39 Cantabria;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
39 Cantabria;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
39 Cantabria;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
39 Cantabria;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;92,34
39 Cantabria;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
39 Cantabria;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
39 Cantabria;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;92,28
39 Cantabria;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
39 Cantabria;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
39 Cantabria;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
39 Cantabria;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;93,51
39 Cantabria;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
39 Cantabria;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
39 Cantabria;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
39 Cantabria;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;90,77
39 Cantabria;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
39 Cantabria;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
39 Cantabria;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
39 Cantabria;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
39 Cantabria;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
39 Cantabria;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
39 Cantabria;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QI;7.315
39 Cantabria;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
39 Cantabria;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
39 Cantabria;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
39 Cantabria;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QI;7.327
39 Cantabria;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
39 Cantabria;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
39 Cantabria;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
39 Cantabria;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QI;7.357
39 Cantabria;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
39 Cantabria;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
39 Cantabria;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2022QII;""
39 Cantabria;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2022QI;7.163
39 Cantabria;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
39 Cantabria;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
39 Cantabria;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2021QII;""
39 Cantabria;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2021QI;7.198
39 Cantabria;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
39 Cantabria;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
39 Cantabria;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2020QII;""
39 Cantabria;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2020QI;7.001
39 Cantabria;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
39 Cantabria;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
39 Cantabria;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2022QII;7.012
39 Cantabria;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2022QI;""
39 Cantabria;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
39 Cantabria;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
39 Cantabria;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2021QII;7.103
39 Cantabria;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2021QI;""
39 Cantabria;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
39 Cantabria;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
39 Cantabria;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2020QII;6.908
39 Cantabria;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2020QI;""
39 Cantabria;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
39 Cantabria;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QIII;6.915
39 Cantabria;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QII;""
39 Cantabria;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QI;""
39 Cantabria;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
39 Cantabria;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QIII;6.999
39 Cantabria;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QII;""
39 Cantabria;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QI;""
39 Cantabria;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
39 Cantabria;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QIII;6.800
39 Cantabria;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QII;""
39 Cantabria;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QI;""
39 Cantabria;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QIV;6.785
39 Cantabria;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
39 Cantabria;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QII;""
39 Cantabria;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QI;""
39 Cantabria;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QIV;6.883
39 Cantabria;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
39 Cantabria;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QII;""
39 Cantabria;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QI;""
39 Cantabria;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QIV;6.692
39 Cantabria;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
39 Cantabria;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QII;""
39 Cantabria;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QI;""
39 Cantabria;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
39 Cantabria;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
39 Cantabria;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
39 Cantabria;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
39 Cantabria;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
39 Cantabria;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
39 Cantabria;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
39 Cantabria;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
39 Cantabria;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
39 Cantabria;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
39 Cantabria;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
39 Cantabria;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
39 Cantabria;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
39 Cantabria;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
39 Cantabria;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
39 Cantabria;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;97,92
39 Cantabria;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
39 Cantabria;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
39 Cantabria;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
39 Cantabria;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;98,24
39 Cantabria;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
39 Cantabria;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
39 Cantabria;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
39 Cantabria;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;95,16
39 Cantabria;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
39 Cantabria;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
39 Cantabria;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;95,86
39 Cantabria;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
39 Cantabria;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
39 Cantabria;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
39 Cantabria;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;96,94
39 Cantabria;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
39 Cantabria;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
39 Cantabria;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
39 Cantabria;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;93,9
39 Cantabria;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
39 Cantabria;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
39 Cantabria;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;94,53
39 Cantabria;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
39 Cantabria;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
39 Cantabria;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
39 Cantabria;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;95,52
39 Cantabria;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
39 Cantabria;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
39 Cantabria;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
39 Cantabria;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;92,43
39 Cantabria;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
39 Cantabria;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
39 Cantabria;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;92,75
39 Cantabria;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
39 Cantabria;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
39 Cantabria;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
39 Cantabria;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;93,94
39 Cantabria;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
39 Cantabria;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
39 Cantabria;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
39 Cantabria;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;90,96
39 Cantabria;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
39 Cantabria;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
39 Cantabria;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
39 Cantabria;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
39 Cantabria;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
39 Cantabria;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
39 Cantabria;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QI;4.332
39 Cantabria;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
39 Cantabria;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
39 Cantabria;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
39 Cantabria;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QI;4.265
39 Cantabria;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
39 Cantabria;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
39 Cantabria;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
39 Cantabria;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QI;4.260
39 Cantabria;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
39 Cantabria;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
39 Cantabria;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2022QII;""
39 Cantabria;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2022QI;4.223
39 Cantabria;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
39 Cantabria;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
39 Cantabria;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2021QII;""
39 Cantabria;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2021QI;4.185
39 Cantabria;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
39 Cantabria;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
39 Cantabria;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2020QII;""
39 Cantabria;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2020QI;4.064
39 Cantabria;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
39 Cantabria;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
39 Cantabria;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2022QII;4.107
39 Cantabria;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2022QI;""
39 Cantabria;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
39 Cantabria;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
39 Cantabria;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2021QII;4.101
39 Cantabria;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2021QI;""
39 Cantabria;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
39 Cantabria;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
39 Cantabria;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2020QII;3.996
39 Cantabria;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2020QI;""
39 Cantabria;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
39 Cantabria;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QIII;4.044
39 Cantabria;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QII;""
39 Cantabria;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QI;""
39 Cantabria;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
39 Cantabria;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QIII;4.032
39 Cantabria;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QII;""
39 Cantabria;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QI;""
39 Cantabria;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
39 Cantabria;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QIII;3.927
39 Cantabria;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QII;""
39 Cantabria;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QI;""
39 Cantabria;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QIV;3.963
39 Cantabria;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
39 Cantabria;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QII;""
39 Cantabria;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QI;""
39 Cantabria;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QIV;3.957
39 Cantabria;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
39 Cantabria;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QII;""
39 Cantabria;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QI;""
39 Cantabria;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QIV;3.853
39 Cantabria;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
39 Cantabria;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QII;""
39 Cantabria;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QI;""
39 Cantabria;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
39 Cantabria;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
39 Cantabria;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
39 Cantabria;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
39 Cantabria;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
39 Cantabria;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
39 Cantabria;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
39 Cantabria;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
39 Cantabria;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
39 Cantabria;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
39 Cantabria;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
39 Cantabria;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
39 Cantabria;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
39 Cantabria;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
39 Cantabria;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
39 Cantabria;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;97,48
39 Cantabria;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
39 Cantabria;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
39 Cantabria;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
39 Cantabria;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;98,12
39 Cantabria;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
39 Cantabria;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
39 Cantabria;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
39 Cantabria;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;95,4
39 Cantabria;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
39 Cantabria;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
39 Cantabria;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;94,81
39 Cantabria;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
39 Cantabria;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
39 Cantabria;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
39 Cantabria;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;96,15
39 Cantabria;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
39 Cantabria;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
39 Cantabria;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
39 Cantabria;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;93,8
39 Cantabria;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
39 Cantabria;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
39 Cantabria;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;93,35
39 Cantabria;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
39 Cantabria;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
39 Cantabria;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
39 Cantabria;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;94,54
39 Cantabria;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
39 Cantabria;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
39 Cantabria;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
39 Cantabria;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;92,18
39 Cantabria;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
39 Cantabria;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
39 Cantabria;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;91,48
39 Cantabria;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
39 Cantabria;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
39 Cantabria;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
39 Cantabria;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;92,78
39 Cantabria;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
39 Cantabria;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
39 Cantabria;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
39 Cantabria;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;90,45
39 Cantabria;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
39 Cantabria;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
39 Cantabria;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
39 Cantabria;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
39 Cantabria;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
39 Cantabria;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QII;11.384
39 Cantabria;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
39 Cantabria;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
39 Cantabria;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
39 Cantabria;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QII;11.447
39 Cantabria;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
39 Cantabria;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
39 Cantabria;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
39 Cantabria;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QII;11.403
39 Cantabria;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
39 Cantabria;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
39 Cantabria;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
39 Cantabria;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2022QII;11.096
39 Cantabria;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2022QI;""
39 Cantabria;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
39 Cantabria;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
39 Cantabria;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2021QII;11.248
39 Cantabria;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2021QI;""
39 Cantabria;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
39 Cantabria;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
39 Cantabria;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2020QII;11.228
39 Cantabria;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2020QI;""
39 Cantabria;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
39 Cantabria;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2022QIII;10.931
39 Cantabria;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2022QII;""
39 Cantabria;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2022QI;""
39 Cantabria;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
39 Cantabria;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2021QIII;11.063
39 Cantabria;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2021QII;""
39 Cantabria;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2021QI;""
39 Cantabria;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
39 Cantabria;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2020QIII;11.034
39 Cantabria;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2020QII;""
39 Cantabria;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2020QI;""
39 Cantabria;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QIV;10.692
39 Cantabria;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
39 Cantabria;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QII;""
39 Cantabria;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QI;""
39 Cantabria;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QIV;10.848
39 Cantabria;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
39 Cantabria;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QII;""
39 Cantabria;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QI;""
39 Cantabria;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QIV;10.837
39 Cantabria;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
39 Cantabria;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QII;""
39 Cantabria;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QI;""
39 Cantabria;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
39 Cantabria;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
39 Cantabria;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QII;""
39 Cantabria;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QI;10.634
39 Cantabria;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
39 Cantabria;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
39 Cantabria;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QII;""
39 Cantabria;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QI;10.676
39 Cantabria;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
39 Cantabria;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
39 Cantabria;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QII;""
39 Cantabria;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QI;""
39 Cantabria;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
39 Cantabria;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
39 Cantabria;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
39 Cantabria;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
39 Cantabria;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
39 Cantabria;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
39 Cantabria;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
39 Cantabria;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
39 Cantabria;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
39 Cantabria;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
39 Cantabria;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
39 Cantabria;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
39 Cantabria;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
39 Cantabria;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
39 Cantabria;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;97,47
39 Cantabria;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
39 Cantabria;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
39 Cantabria;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
39 Cantabria;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;98,26
39 Cantabria;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
39 Cantabria;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
39 Cantabria;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
39 Cantabria;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;98,47
39 Cantabria;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
39 Cantabria;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
39 Cantabria;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;96,02
39 Cantabria;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
39 Cantabria;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
39 Cantabria;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
39 Cantabria;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;96,65
39 Cantabria;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
39 Cantabria;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
39 Cantabria;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
39 Cantabria;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;96,76
39 Cantabria;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
39 Cantabria;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
39 Cantabria;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;93,92
39 Cantabria;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
39 Cantabria;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
39 Cantabria;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
39 Cantabria;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;94,77
39 Cantabria;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
39 Cantabria;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
39 Cantabria;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
39 Cantabria;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;95,04
39 Cantabria;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
39 Cantabria;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
39 Cantabria;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
39 Cantabria;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
39 Cantabria;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
39 Cantabria;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
39 Cantabria;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;92,9
39 Cantabria;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
39 Cantabria;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
39 Cantabria;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
39 Cantabria;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;93,62
39 Cantabria;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
39 Cantabria;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
39 Cantabria;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
39 Cantabria;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
39 Cantabria;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
39 Cantabria;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
39 Cantabria;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QII;7.157
39 Cantabria;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
39 Cantabria;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
39 Cantabria;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
39 Cantabria;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QII;7.219
39 Cantabria;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
39 Cantabria;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
39 Cantabria;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
39 Cantabria;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QII;7.198
39 Cantabria;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
39 Cantabria;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
39 Cantabria;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
39 Cantabria;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2022QII;6.993
39 Cantabria;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2022QI;""
39 Cantabria;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
39 Cantabria;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
39 Cantabria;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2021QII;7.108
39 Cantabria;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2021QI;""
39 Cantabria;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
39 Cantabria;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
39 Cantabria;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2020QII;7.095
39 Cantabria;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2020QI;""
39 Cantabria;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
39 Cantabria;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2022QIII;6.897
39 Cantabria;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2022QII;""
39 Cantabria;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2022QI;""
39 Cantabria;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
39 Cantabria;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2021QIII;6.990
39 Cantabria;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2021QII;""
39 Cantabria;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2021QI;""
39 Cantabria;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
39 Cantabria;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2020QIII;6.977
39 Cantabria;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2020QII;""
39 Cantabria;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2020QI;""
39 Cantabria;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QIV;6.748
39 Cantabria;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
39 Cantabria;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QII;""
39 Cantabria;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QI;""
39 Cantabria;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QIV;6.857
39 Cantabria;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
39 Cantabria;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QII;""
39 Cantabria;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QI;""
39 Cantabria;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QIV;6.862
39 Cantabria;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
39 Cantabria;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QII;""
39 Cantabria;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QI;""
39 Cantabria;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
39 Cantabria;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
39 Cantabria;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QII;""
39 Cantabria;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QI;6.736
39 Cantabria;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
39 Cantabria;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
39 Cantabria;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QII;""
39 Cantabria;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QI;6.764
39 Cantabria;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
39 Cantabria;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
39 Cantabria;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QII;""
39 Cantabria;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QI;""
39 Cantabria;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
39 Cantabria;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
39 Cantabria;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
39 Cantabria;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
39 Cantabria;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
39 Cantabria;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
39 Cantabria;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
39 Cantabria;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
39 Cantabria;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
39 Cantabria;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
39 Cantabria;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
39 Cantabria;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
39 Cantabria;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
39 Cantabria;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
39 Cantabria;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;97,71
39 Cantabria;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
39 Cantabria;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
39 Cantabria;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
39 Cantabria;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;98,46
39 Cantabria;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
39 Cantabria;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
39 Cantabria;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
39 Cantabria;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;98,57
39 Cantabria;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
39 Cantabria;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
39 Cantabria;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;96,37
39 Cantabria;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
39 Cantabria;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
39 Cantabria;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
39 Cantabria;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;96,83
39 Cantabria;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
39 Cantabria;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
39 Cantabria;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
39 Cantabria;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;96,93
39 Cantabria;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
39 Cantabria;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
39 Cantabria;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;94,29
39 Cantabria;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
39 Cantabria;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
39 Cantabria;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
39 Cantabria;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;94,99
39 Cantabria;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
39 Cantabria;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
39 Cantabria;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
39 Cantabria;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;95,33
39 Cantabria;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
39 Cantabria;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
39 Cantabria;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
39 Cantabria;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
39 Cantabria;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
39 Cantabria;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
39 Cantabria;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;93,31
39 Cantabria;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
39 Cantabria;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
39 Cantabria;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
39 Cantabria;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;93,97
39 Cantabria;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
39 Cantabria;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
39 Cantabria;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
39 Cantabria;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
39 Cantabria;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
39 Cantabria;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
39 Cantabria;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QII;4.227
39 Cantabria;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
39 Cantabria;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
39 Cantabria;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
39 Cantabria;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QII;4.228
39 Cantabria;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
39 Cantabria;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
39 Cantabria;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
39 Cantabria;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QII;4.205
39 Cantabria;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
39 Cantabria;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
39 Cantabria;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
39 Cantabria;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2022QII;4.103
39 Cantabria;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2022QI;""
39 Cantabria;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
39 Cantabria;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
39 Cantabria;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2021QII;4.140
39 Cantabria;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2021QI;""
39 Cantabria;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
39 Cantabria;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
39 Cantabria;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2020QII;4.133
39 Cantabria;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2020QI;""
39 Cantabria;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
39 Cantabria;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2022QIII;4.034
39 Cantabria;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2022QII;""
39 Cantabria;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2022QI;""
39 Cantabria;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
39 Cantabria;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2021QIII;4.073
39 Cantabria;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2021QII;""
39 Cantabria;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2021QI;""
39 Cantabria;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
39 Cantabria;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2020QIII;4.057
39 Cantabria;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2020QII;""
39 Cantabria;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2020QI;""
39 Cantabria;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QIV;3.944
39 Cantabria;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
39 Cantabria;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QII;""
39 Cantabria;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QI;""
39 Cantabria;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QIV;3.991
39 Cantabria;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
39 Cantabria;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QII;""
39 Cantabria;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QI;""
39 Cantabria;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QIV;3.975
39 Cantabria;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
39 Cantabria;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QII;""
39 Cantabria;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QI;""
39 Cantabria;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
39 Cantabria;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
39 Cantabria;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QII;""
39 Cantabria;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QI;3.898
39 Cantabria;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
39 Cantabria;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
39 Cantabria;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QII;""
39 Cantabria;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QI;3.912
39 Cantabria;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
39 Cantabria;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
39 Cantabria;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QII;""
39 Cantabria;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QI;""
39 Cantabria;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
39 Cantabria;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
39 Cantabria;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
39 Cantabria;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
39 Cantabria;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
39 Cantabria;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
39 Cantabria;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
39 Cantabria;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
39 Cantabria;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
39 Cantabria;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
39 Cantabria;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
39 Cantabria;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
39 Cantabria;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
39 Cantabria;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
39 Cantabria;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;97,07
39 Cantabria;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
39 Cantabria;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
39 Cantabria;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
39 Cantabria;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;97,92
39 Cantabria;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
39 Cantabria;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
39 Cantabria;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
39 Cantabria;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;98,29
39 Cantabria;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
39 Cantabria;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
39 Cantabria;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;95,43
39 Cantabria;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
39 Cantabria;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
39 Cantabria;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
39 Cantabria;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;96,33
39 Cantabria;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
39 Cantabria;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
39 Cantabria;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
39 Cantabria;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;96,48
39 Cantabria;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
39 Cantabria;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
39 Cantabria;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;93,3
39 Cantabria;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
39 Cantabria;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
39 Cantabria;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
39 Cantabria;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;94,39
39 Cantabria;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
39 Cantabria;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
39 Cantabria;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
39 Cantabria;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;94,53
39 Cantabria;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
39 Cantabria;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
39 Cantabria;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
39 Cantabria;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
39 Cantabria;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
39 Cantabria;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
39 Cantabria;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;92,19
39 Cantabria;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
39 Cantabria;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
39 Cantabria;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
39 Cantabria;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;93,03
39 Cantabria;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
39 Cantabria;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
39 Cantabria;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
39 Cantabria;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
39 Cantabria;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
39 Cantabria;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QIII;11.499
39 Cantabria;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
39 Cantabria;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
39 Cantabria;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
39 Cantabria;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QIII;11.653
39 Cantabria;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
39 Cantabria;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
39 Cantabria;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
39 Cantabria;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QIII;11.548
39 Cantabria;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
39 Cantabria;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
39 Cantabria;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
39 Cantabria;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2022QIII;11.249
39 Cantabria;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2022QII;""
39 Cantabria;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2022QI;""
39 Cantabria;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
39 Cantabria;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2021QIII;11.409
39 Cantabria;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2021QII;""
39 Cantabria;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2021QI;""
39 Cantabria;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
39 Cantabria;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2020QIII;11.309
39 Cantabria;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2020QII;""
39 Cantabria;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2020QI;""
39 Cantabria;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2022QIV;10.968
39 Cantabria;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
39 Cantabria;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2022QII;""
39 Cantabria;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2022QI;""
39 Cantabria;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2021QIV;11.149
39 Cantabria;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
39 Cantabria;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2021QII;""
39 Cantabria;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2021QI;""
39 Cantabria;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2020QIV;11.075
39 Cantabria;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
39 Cantabria;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2020QII;""
39 Cantabria;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2020QI;""
39 Cantabria;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
39 Cantabria;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
39 Cantabria;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QII;""
39 Cantabria;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QI;10.912
39 Cantabria;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
39 Cantabria;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
39 Cantabria;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QII;""
39 Cantabria;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QI;10.903
39 Cantabria;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
39 Cantabria;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
39 Cantabria;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QII;""
39 Cantabria;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QI;""
39 Cantabria;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
39 Cantabria;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
39 Cantabria;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QII;10.697
39 Cantabria;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QI;""
39 Cantabria;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
39 Cantabria;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
39 Cantabria;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QII;10.746
39 Cantabria;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QI;""
39 Cantabria;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
39 Cantabria;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
39 Cantabria;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QII;""
39 Cantabria;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QI;""
39 Cantabria;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
39 Cantabria;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
39 Cantabria;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
39 Cantabria;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
39 Cantabria;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
39 Cantabria;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
39 Cantabria;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
39 Cantabria;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
39 Cantabria;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
39 Cantabria;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
39 Cantabria;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
39 Cantabria;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
39 Cantabria;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
39 Cantabria;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;97,83
39 Cantabria;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
39 Cantabria;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
39 Cantabria;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
39 Cantabria;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;97,91
39 Cantabria;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
39 Cantabria;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
39 Cantabria;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
39 Cantabria;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;97,93
39 Cantabria;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
39 Cantabria;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
39 Cantabria;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;95,38
39 Cantabria;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
39 Cantabria;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
39 Cantabria;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
39 Cantabria;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;95,67
39 Cantabria;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
39 Cantabria;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
39 Cantabria;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
39 Cantabria;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;95,9
39 Cantabria;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
39 Cantabria;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
39 Cantabria;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
39 Cantabria;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
39 Cantabria;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
39 Cantabria;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
39 Cantabria;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;93,64
39 Cantabria;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
39 Cantabria;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
39 Cantabria;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
39 Cantabria;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;94,41
39 Cantabria;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
39 Cantabria;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
39 Cantabria;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
39 Cantabria;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
39 Cantabria;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
39 Cantabria;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
39 Cantabria;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;91,8
39 Cantabria;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
39 Cantabria;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
39 Cantabria;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
39 Cantabria;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;93,06
39 Cantabria;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
39 Cantabria;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
39 Cantabria;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
39 Cantabria;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
39 Cantabria;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
39 Cantabria;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
39 Cantabria;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QIII;7.235
39 Cantabria;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
39 Cantabria;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
39 Cantabria;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
39 Cantabria;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QIII;7.354
39 Cantabria;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
39 Cantabria;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
39 Cantabria;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
39 Cantabria;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QIII;7.289
39 Cantabria;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
39 Cantabria;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
39 Cantabria;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
39 Cantabria;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2022QIII;7.094
39 Cantabria;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2022QII;""
39 Cantabria;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2022QI;""
39 Cantabria;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
39 Cantabria;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2021QIII;7.209
39 Cantabria;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2021QII;""
39 Cantabria;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2021QI;""
39 Cantabria;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
39 Cantabria;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2020QIII;7.151
39 Cantabria;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2020QII;""
39 Cantabria;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2020QI;""
39 Cantabria;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2022QIV;6.921
39 Cantabria;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
39 Cantabria;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2022QII;""
39 Cantabria;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2022QI;""
39 Cantabria;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2021QIV;7.049
39 Cantabria;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
39 Cantabria;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2021QII;""
39 Cantabria;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2021QI;""
39 Cantabria;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2020QIV;7.015
39 Cantabria;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
39 Cantabria;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2020QII;""
39 Cantabria;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2020QI;""
39 Cantabria;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
39 Cantabria;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
39 Cantabria;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QII;""
39 Cantabria;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QI;6.912
39 Cantabria;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
39 Cantabria;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
39 Cantabria;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QII;""
39 Cantabria;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QI;6.910
39 Cantabria;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
39 Cantabria;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
39 Cantabria;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QII;""
39 Cantabria;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QI;""
39 Cantabria;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
39 Cantabria;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
39 Cantabria;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QII;6.792
39 Cantabria;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QI;""
39 Cantabria;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
39 Cantabria;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
39 Cantabria;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QII;6.830
39 Cantabria;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QI;""
39 Cantabria;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
39 Cantabria;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
39 Cantabria;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QII;""
39 Cantabria;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QI;""
39 Cantabria;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
39 Cantabria;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
39 Cantabria;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
39 Cantabria;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
39 Cantabria;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
39 Cantabria;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
39 Cantabria;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
39 Cantabria;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
39 Cantabria;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
39 Cantabria;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
39 Cantabria;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
39 Cantabria;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
39 Cantabria;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
39 Cantabria;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;98,05
39 Cantabria;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
39 Cantabria;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
39 Cantabria;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
39 Cantabria;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;98,03
39 Cantabria;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
39 Cantabria;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
39 Cantabria;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
39 Cantabria;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;98,11
39 Cantabria;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
39 Cantabria;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
39 Cantabria;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;95,66
39 Cantabria;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
39 Cantabria;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
39 Cantabria;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
39 Cantabria;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;95,85
39 Cantabria;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
39 Cantabria;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
39 Cantabria;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
39 Cantabria;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;96,24
39 Cantabria;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
39 Cantabria;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
39 Cantabria;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
39 Cantabria;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
39 Cantabria;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
39 Cantabria;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
39 Cantabria;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;93,99
39 Cantabria;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
39 Cantabria;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
39 Cantabria;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
39 Cantabria;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;94,8
39 Cantabria;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
39 Cantabria;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
39 Cantabria;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
39 Cantabria;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
39 Cantabria;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
39 Cantabria;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
39 Cantabria;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;92,36
39 Cantabria;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
39 Cantabria;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
39 Cantabria;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
39 Cantabria;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;93,7
39 Cantabria;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
39 Cantabria;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
39 Cantabria;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
39 Cantabria;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
39 Cantabria;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
39 Cantabria;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
39 Cantabria;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QIII;4.264
39 Cantabria;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
39 Cantabria;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
39 Cantabria;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
39 Cantabria;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QIII;4.299
39 Cantabria;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
39 Cantabria;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
39 Cantabria;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
39 Cantabria;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QIII;4.259
39 Cantabria;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
39 Cantabria;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
39 Cantabria;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
39 Cantabria;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2022QIII;4.155
39 Cantabria;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2022QII;""
39 Cantabria;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2022QI;""
39 Cantabria;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
39 Cantabria;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2021QIII;4.200
39 Cantabria;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2021QII;""
39 Cantabria;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2021QI;""
39 Cantabria;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
39 Cantabria;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2020QIII;4.158
39 Cantabria;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2020QII;""
39 Cantabria;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2020QI;""
39 Cantabria;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2022QIV;4.047
39 Cantabria;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
39 Cantabria;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2022QII;""
39 Cantabria;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2022QI;""
39 Cantabria;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2021QIV;4.100
39 Cantabria;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
39 Cantabria;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2021QII;""
39 Cantabria;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2021QI;""
39 Cantabria;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2020QIV;4.060
39 Cantabria;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
39 Cantabria;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2020QII;""
39 Cantabria;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2020QI;""
39 Cantabria;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
39 Cantabria;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
39 Cantabria;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QII;""
39 Cantabria;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QI;4.000
39 Cantabria;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
39 Cantabria;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
39 Cantabria;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QII;""
39 Cantabria;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QI;3.993
39 Cantabria;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
39 Cantabria;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
39 Cantabria;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QII;""
39 Cantabria;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QI;""
39 Cantabria;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
39 Cantabria;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
39 Cantabria;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QII;3.905
39 Cantabria;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QI;""
39 Cantabria;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
39 Cantabria;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
39 Cantabria;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QII;3.916
39 Cantabria;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QI;""
39 Cantabria;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
39 Cantabria;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
39 Cantabria;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QII;""
39 Cantabria;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QI;""
39 Cantabria;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
39 Cantabria;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
39 Cantabria;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
39 Cantabria;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
39 Cantabria;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
39 Cantabria;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
39 Cantabria;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
39 Cantabria;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
39 Cantabria;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
39 Cantabria;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
39 Cantabria;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
39 Cantabria;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
39 Cantabria;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
39 Cantabria;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;97,44
39 Cantabria;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
39 Cantabria;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
39 Cantabria;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
39 Cantabria;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;97,7
39 Cantabria;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
39 Cantabria;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
39 Cantabria;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
39 Cantabria;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;97,63
39 Cantabria;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
39 Cantabria;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
39 Cantabria;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;94,91
39 Cantabria;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
39 Cantabria;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
39 Cantabria;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
39 Cantabria;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;95,37
39 Cantabria;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
39 Cantabria;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
39 Cantabria;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
39 Cantabria;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;95,33
39 Cantabria;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
39 Cantabria;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
39 Cantabria;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
39 Cantabria;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
39 Cantabria;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
39 Cantabria;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
39 Cantabria;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;93,04
39 Cantabria;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
39 Cantabria;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
39 Cantabria;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
39 Cantabria;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;93,75
39 Cantabria;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
39 Cantabria;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
39 Cantabria;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
39 Cantabria;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
39 Cantabria;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
39 Cantabria;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
39 Cantabria;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;90,84
39 Cantabria;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
39 Cantabria;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
39 Cantabria;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
39 Cantabria;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;91,95
39 Cantabria;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
39 Cantabria;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
39 Cantabria;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
39 Cantabria;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
39 Cantabria;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
39 Cantabria;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QIV;11.499
39 Cantabria;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
39 Cantabria;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
39 Cantabria;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
39 Cantabria;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QIV;11.669
39 Cantabria;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
39 Cantabria;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
39 Cantabria;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
39 Cantabria;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QIV;11.582
39 Cantabria;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
39 Cantabria;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
39 Cantabria;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
39 Cantabria;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2022QIV;11.184
39 Cantabria;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
39 Cantabria;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2022QII;""
39 Cantabria;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2022QI;""
39 Cantabria;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2021QIV;11.366
39 Cantabria;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
39 Cantabria;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2021QII;""
39 Cantabria;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2021QI;""
39 Cantabria;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2020QIV;11.308
39 Cantabria;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
39 Cantabria;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2020QII;""
39 Cantabria;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2020QI;""
39 Cantabria;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
39 Cantabria;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
39 Cantabria;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2022QII;""
39 Cantabria;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2022QI;11.121
39 Cantabria;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
39 Cantabria;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
39 Cantabria;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2021QII;""
39 Cantabria;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2021QI;11.125
39 Cantabria;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
39 Cantabria;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
39 Cantabria;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2020QII;""
39 Cantabria;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2020QI;""
39 Cantabria;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
39 Cantabria;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
39 Cantabria;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QII;10.888
39 Cantabria;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QI;""
39 Cantabria;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
39 Cantabria;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
39 Cantabria;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QII;10.962
39 Cantabria;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QI;""
39 Cantabria;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
39 Cantabria;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
39 Cantabria;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QII;""
39 Cantabria;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QI;""
39 Cantabria;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
39 Cantabria;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QIII;10.742
39 Cantabria;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QII;""
39 Cantabria;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QI;""
39 Cantabria;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
39 Cantabria;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QIII;10.801
39 Cantabria;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QII;""
39 Cantabria;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QI;""
39 Cantabria;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
39 Cantabria;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
39 Cantabria;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QII;""
39 Cantabria;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QI;""
39 Cantabria;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
39 Cantabria;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
39 Cantabria;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
39 Cantabria;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
39 Cantabria;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
39 Cantabria;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
39 Cantabria;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
39 Cantabria;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
39 Cantabria;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
39 Cantabria;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
39 Cantabria;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
39 Cantabria;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
39 Cantabria;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;97,26
39 Cantabria;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
39 Cantabria;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
39 Cantabria;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
39 Cantabria;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;97,4
39 Cantabria;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
39 Cantabria;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
39 Cantabria;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
39 Cantabria;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;97,63
39 Cantabria;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
39 Cantabria;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
39 Cantabria;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
39 Cantabria;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
39 Cantabria;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
39 Cantabria;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
39 Cantabria;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;95,3
39 Cantabria;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
39 Cantabria;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
39 Cantabria;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
39 Cantabria;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;96,05
39 Cantabria;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
39 Cantabria;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
39 Cantabria;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
39 Cantabria;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
39 Cantabria;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
39 Cantabria;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
39 Cantabria;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;93,31
39 Cantabria;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
39 Cantabria;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
39 Cantabria;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
39 Cantabria;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;94,65
39 Cantabria;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
39 Cantabria;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
39 Cantabria;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
39 Cantabria;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
39 Cantabria;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
39 Cantabria;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
39 Cantabria;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;92,06
39 Cantabria;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
39 Cantabria;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
39 Cantabria;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
39 Cantabria;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;93,26
39 Cantabria;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
39 Cantabria;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
39 Cantabria;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
39 Cantabria;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
39 Cantabria;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
39 Cantabria;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
39 Cantabria;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QIV;7.225
39 Cantabria;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
39 Cantabria;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
39 Cantabria;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
39 Cantabria;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QIV;7.353
39 Cantabria;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
39 Cantabria;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
39 Cantabria;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
39 Cantabria;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QIV;7.319
39 Cantabria;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
39 Cantabria;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
39 Cantabria;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
39 Cantabria;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2022QIV;7.025
39 Cantabria;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
39 Cantabria;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2022QII;""
39 Cantabria;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2022QI;""
39 Cantabria;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2021QIV;7.168
39 Cantabria;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
39 Cantabria;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2021QII;""
39 Cantabria;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2021QI;""
39 Cantabria;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2020QIV;7.158
39 Cantabria;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
39 Cantabria;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2020QII;""
39 Cantabria;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2020QI;""
39 Cantabria;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
39 Cantabria;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
39 Cantabria;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2022QII;""
39 Cantabria;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2022QI;7.025
39 Cantabria;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
39 Cantabria;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
39 Cantabria;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2021QII;""
39 Cantabria;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2021QI;7.047
39 Cantabria;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
39 Cantabria;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
39 Cantabria;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2020QII;""
39 Cantabria;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2020QI;""
39 Cantabria;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
39 Cantabria;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
39 Cantabria;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QII;6.897
39 Cantabria;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QI;""
39 Cantabria;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
39 Cantabria;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
39 Cantabria;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QII;6.962
39 Cantabria;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QI;""
39 Cantabria;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
39 Cantabria;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
39 Cantabria;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QII;""
39 Cantabria;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QI;""
39 Cantabria;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
39 Cantabria;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QIII;6.808
39 Cantabria;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QII;""
39 Cantabria;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QI;""
39 Cantabria;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
39 Cantabria;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QIII;6.868
39 Cantabria;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QII;""
39 Cantabria;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QI;""
39 Cantabria;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
39 Cantabria;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
39 Cantabria;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QII;""
39 Cantabria;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QI;""
39 Cantabria;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
39 Cantabria;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
39 Cantabria;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
39 Cantabria;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
39 Cantabria;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
39 Cantabria;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
39 Cantabria;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
39 Cantabria;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
39 Cantabria;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
39 Cantabria;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
39 Cantabria;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
39 Cantabria;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
39 Cantabria;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;97,23
39 Cantabria;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
39 Cantabria;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
39 Cantabria;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
39 Cantabria;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;97,48
39 Cantabria;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
39 Cantabria;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
39 Cantabria;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
39 Cantabria;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;97,8
39 Cantabria;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
39 Cantabria;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
39 Cantabria;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
39 Cantabria;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
39 Cantabria;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
39 Cantabria;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
39 Cantabria;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;95,54
39 Cantabria;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
39 Cantabria;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
39 Cantabria;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
39 Cantabria;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;96,28
39 Cantabria;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
39 Cantabria;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
39 Cantabria;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
39 Cantabria;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
39 Cantabria;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
39 Cantabria;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
39 Cantabria;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;93,8
39 Cantabria;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
39 Cantabria;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
39 Cantabria;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
39 Cantabria;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;95,12
39 Cantabria;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
39 Cantabria;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
39 Cantabria;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
39 Cantabria;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
39 Cantabria;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
39 Cantabria;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
39 Cantabria;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;92,59
39 Cantabria;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
39 Cantabria;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
39 Cantabria;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
39 Cantabria;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;93,84
39 Cantabria;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
39 Cantabria;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
39 Cantabria;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
39 Cantabria;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
39 Cantabria;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
39 Cantabria;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
39 Cantabria;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QIV;4.274
39 Cantabria;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
39 Cantabria;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
39 Cantabria;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
39 Cantabria;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QIV;4.316
39 Cantabria;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
39 Cantabria;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
39 Cantabria;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
39 Cantabria;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QIV;4.263
39 Cantabria;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
39 Cantabria;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
39 Cantabria;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
39 Cantabria;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2022QIV;4.159
39 Cantabria;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
39 Cantabria;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2022QII;""
39 Cantabria;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2022QI;""
39 Cantabria;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2021QIV;4.198
39 Cantabria;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
39 Cantabria;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2021QII;""
39 Cantabria;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2021QI;""
39 Cantabria;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2020QIV;4.150
39 Cantabria;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
39 Cantabria;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2020QII;""
39 Cantabria;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2020QI;""
39 Cantabria;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
39 Cantabria;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
39 Cantabria;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2022QII;""
39 Cantabria;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2022QI;4.096
39 Cantabria;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
39 Cantabria;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
39 Cantabria;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2021QII;""
39 Cantabria;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2021QI;4.078
39 Cantabria;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
39 Cantabria;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
39 Cantabria;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2020QII;""
39 Cantabria;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2020QI;""
39 Cantabria;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
39 Cantabria;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
39 Cantabria;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QII;3.991
39 Cantabria;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QI;""
39 Cantabria;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
39 Cantabria;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
39 Cantabria;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QII;4.000
39 Cantabria;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QI;""
39 Cantabria;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
39 Cantabria;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
39 Cantabria;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QII;""
39 Cantabria;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QI;""
39 Cantabria;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
39 Cantabria;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QIII;3.934
39 Cantabria;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QII;""
39 Cantabria;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QI;""
39 Cantabria;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
39 Cantabria;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QIII;3.933
39 Cantabria;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QII;""
39 Cantabria;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QI;""
39 Cantabria;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
39 Cantabria;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
39 Cantabria;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QII;""
39 Cantabria;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QI;""
39 Cantabria;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
39 Cantabria;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
39 Cantabria;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
39 Cantabria;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
39 Cantabria;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
39 Cantabria;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
39 Cantabria;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
39 Cantabria;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
39 Cantabria;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
39 Cantabria;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
39 Cantabria;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
39 Cantabria;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
39 Cantabria;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;97,31
39 Cantabria;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
39 Cantabria;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
39 Cantabria;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
39 Cantabria;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;97,27
39 Cantabria;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
39 Cantabria;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
39 Cantabria;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
39 Cantabria;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;97,35
39 Cantabria;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
39 Cantabria;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
39 Cantabria;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
39 Cantabria;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
39 Cantabria;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
39 Cantabria;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
39 Cantabria;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;94,9
39 Cantabria;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
39 Cantabria;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
39 Cantabria;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
39 Cantabria;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;95,66
39 Cantabria;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
39 Cantabria;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
39 Cantabria;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
39 Cantabria;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
39 Cantabria;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
39 Cantabria;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
39 Cantabria;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;92,47
39 Cantabria;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
39 Cantabria;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
39 Cantabria;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
39 Cantabria;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;93,83
39 Cantabria;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
39 Cantabria;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
39 Cantabria;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
39 Cantabria;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
39 Cantabria;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
39 Cantabria;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
39 Cantabria;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;91,15
39 Cantabria;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
39 Cantabria;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
39 Cantabria;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
39 Cantabria;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;92,26
39 Cantabria;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
39 Cantabria;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
39 Cantabria;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
39 Cantabria;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
39 Cantabria;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
39 Cantabria;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
39 Cantabria;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
39 Cantabria;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
39 Cantabria;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
39 Cantabria;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QI;11.507
39 Cantabria;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
39 Cantabria;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
39 Cantabria;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
39 Cantabria;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QI;11.292
39 Cantabria;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
39 Cantabria;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
39 Cantabria;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
39 Cantabria;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QI;11.423
39 Cantabria;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
39 Cantabria;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
39 Cantabria;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2022QII;""
39 Cantabria;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2022QI;11.298
39 Cantabria;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
39 Cantabria;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
39 Cantabria;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2021QII;""
39 Cantabria;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2021QI;11.160
39 Cantabria;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
39 Cantabria;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
39 Cantabria;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2020QII;""
39 Cantabria;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2020QI;10.988
39 Cantabria;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
39 Cantabria;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
39 Cantabria;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2022QII;11.129
39 Cantabria;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2022QI;""
39 Cantabria;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
39 Cantabria;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
39 Cantabria;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2021QII;11.012
39 Cantabria;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2021QI;""
39 Cantabria;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
39 Cantabria;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
39 Cantabria;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2020QII;10.871
39 Cantabria;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2020QI;""
39 Cantabria;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
39 Cantabria;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QIII;10.969
39 Cantabria;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QII;""
39 Cantabria;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QI;""
39 Cantabria;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
39 Cantabria;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QIII;10.867
39 Cantabria;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QII;""
39 Cantabria;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QI;""
39 Cantabria;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
39 Cantabria;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QIII;10.744
39 Cantabria;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QII;""
39 Cantabria;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QI;""
39 Cantabria;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QIV;10.791
39 Cantabria;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
39 Cantabria;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QII;""
39 Cantabria;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QI;""
39 Cantabria;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QIV;10.720
39 Cantabria;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
39 Cantabria;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QII;""
39 Cantabria;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QI;""
39 Cantabria;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QIV;10.594
39 Cantabria;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
39 Cantabria;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QII;""
39 Cantabria;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QI;""
39 Cantabria;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
39 Cantabria;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
39 Cantabria;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
39 Cantabria;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
39 Cantabria;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
39 Cantabria;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
39 Cantabria;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
39 Cantabria;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
39 Cantabria;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
39 Cantabria;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
39 Cantabria;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
39 Cantabria;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
39 Cantabria;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
39 Cantabria;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
39 Cantabria;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
39 Cantabria;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;98,18
39 Cantabria;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
39 Cantabria;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
39 Cantabria;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
39 Cantabria;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;98,83
39 Cantabria;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
39 Cantabria;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
39 Cantabria;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
39 Cantabria;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;96,19
39 Cantabria;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
39 Cantabria;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
39 Cantabria;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;96,72
39 Cantabria;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
39 Cantabria;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
39 Cantabria;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
39 Cantabria;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;97,52
39 Cantabria;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
39 Cantabria;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
39 Cantabria;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
39 Cantabria;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;95,17
39 Cantabria;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
39 Cantabria;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
39 Cantabria;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;95,32
39 Cantabria;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
39 Cantabria;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
39 Cantabria;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
39 Cantabria;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;96,24
39 Cantabria;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
39 Cantabria;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
39 Cantabria;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
39 Cantabria;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;94,06
39 Cantabria;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
39 Cantabria;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
39 Cantabria;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;93,78
39 Cantabria;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
39 Cantabria;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
39 Cantabria;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
39 Cantabria;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;94,93
39 Cantabria;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
39 Cantabria;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
39 Cantabria;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
39 Cantabria;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;92,74
39 Cantabria;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
39 Cantabria;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
39 Cantabria;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
39 Cantabria;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
39 Cantabria;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
39 Cantabria;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
39 Cantabria;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QI;7.205
39 Cantabria;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
39 Cantabria;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
39 Cantabria;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
39 Cantabria;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QI;7.098
39 Cantabria;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
39 Cantabria;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
39 Cantabria;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
39 Cantabria;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QI;7.186
39 Cantabria;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
39 Cantabria;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
39 Cantabria;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2022QII;""
39 Cantabria;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2022QI;7.089
39 Cantabria;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
39 Cantabria;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
39 Cantabria;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2021QII;""
39 Cantabria;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2021QI;7.017
39 Cantabria;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
39 Cantabria;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
39 Cantabria;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2020QII;""
39 Cantabria;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2020QI;6.919
39 Cantabria;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
39 Cantabria;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
39 Cantabria;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2022QII;6.998
39 Cantabria;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2022QI;""
39 Cantabria;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
39 Cantabria;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
39 Cantabria;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2021QII;6.941
39 Cantabria;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2021QI;""
39 Cantabria;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
39 Cantabria;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
39 Cantabria;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2020QII;6.863
39 Cantabria;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2020QI;""
39 Cantabria;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
39 Cantabria;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QIII;6.904
39 Cantabria;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QII;""
39 Cantabria;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QI;""
39 Cantabria;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
39 Cantabria;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QIII;6.850
39 Cantabria;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QII;""
39 Cantabria;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QI;""
39 Cantabria;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
39 Cantabria;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QIII;6.795
39 Cantabria;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QII;""
39 Cantabria;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QI;""
39 Cantabria;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QIV;6.800
39 Cantabria;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
39 Cantabria;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QII;""
39 Cantabria;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QI;""
39 Cantabria;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QIV;6.751
39 Cantabria;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
39 Cantabria;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QII;""
39 Cantabria;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QI;""
39 Cantabria;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QIV;6.701
39 Cantabria;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
39 Cantabria;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QII;""
39 Cantabria;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QI;""
39 Cantabria;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
39 Cantabria;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
39 Cantabria;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
39 Cantabria;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
39 Cantabria;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
39 Cantabria;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
39 Cantabria;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
39 Cantabria;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
39 Cantabria;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
39 Cantabria;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
39 Cantabria;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
39 Cantabria;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
39 Cantabria;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
39 Cantabria;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
39 Cantabria;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
39 Cantabria;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;98,39
39 Cantabria;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
39 Cantabria;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
39 Cantabria;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
39 Cantabria;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;98,86
39 Cantabria;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
39 Cantabria;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
39 Cantabria;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
39 Cantabria;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;96,28
39 Cantabria;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
39 Cantabria;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
39 Cantabria;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;97,13
39 Cantabria;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
39 Cantabria;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
39 Cantabria;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
39 Cantabria;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;97,79
39 Cantabria;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
39 Cantabria;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
39 Cantabria;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
39 Cantabria;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;95,51
39 Cantabria;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
39 Cantabria;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
39 Cantabria;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;95,82
39 Cantabria;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
39 Cantabria;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
39 Cantabria;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
39 Cantabria;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;96,51
39 Cantabria;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
39 Cantabria;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
39 Cantabria;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
39 Cantabria;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;94,56
39 Cantabria;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
39 Cantabria;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
39 Cantabria;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;94,38
39 Cantabria;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
39 Cantabria;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
39 Cantabria;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
39 Cantabria;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;95,11
39 Cantabria;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
39 Cantabria;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
39 Cantabria;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
39 Cantabria;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;93,25
39 Cantabria;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
39 Cantabria;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
39 Cantabria;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
39 Cantabria;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
39 Cantabria;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
39 Cantabria;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
39 Cantabria;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QI;4.302
39 Cantabria;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
39 Cantabria;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
39 Cantabria;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
39 Cantabria;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QI;4.194
39 Cantabria;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
39 Cantabria;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
39 Cantabria;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
39 Cantabria;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QI;4.237
39 Cantabria;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
39 Cantabria;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
39 Cantabria;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2022QII;""
39 Cantabria;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2022QI;4.209
39 Cantabria;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
39 Cantabria;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
39 Cantabria;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2021QII;""
39 Cantabria;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2021QI;4.143
39 Cantabria;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
39 Cantabria;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
39 Cantabria;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2020QII;""
39 Cantabria;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2020QI;4.069
39 Cantabria;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
39 Cantabria;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
39 Cantabria;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2022QII;4.131
39 Cantabria;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2022QI;""
39 Cantabria;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
39 Cantabria;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
39 Cantabria;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2021QII;4.071
39 Cantabria;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2021QI;""
39 Cantabria;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
39 Cantabria;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
39 Cantabria;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2020QII;4.008
39 Cantabria;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2020QI;""
39 Cantabria;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
39 Cantabria;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QIII;4.065
39 Cantabria;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QII;""
39 Cantabria;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QI;""
39 Cantabria;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
39 Cantabria;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QIII;4.017
39 Cantabria;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QII;""
39 Cantabria;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QI;""
39 Cantabria;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
39 Cantabria;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QIII;3.949
39 Cantabria;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QII;""
39 Cantabria;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QI;""
39 Cantabria;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QIV;3.991
39 Cantabria;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
39 Cantabria;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QII;""
39 Cantabria;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QI;""
39 Cantabria;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QIV;3.969
39 Cantabria;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
39 Cantabria;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QII;""
39 Cantabria;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QI;""
39 Cantabria;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QIV;3.893
39 Cantabria;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
39 Cantabria;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QII;""
39 Cantabria;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QI;""
39 Cantabria;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
39 Cantabria;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
39 Cantabria;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
39 Cantabria;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
39 Cantabria;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
39 Cantabria;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
39 Cantabria;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
39 Cantabria;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
39 Cantabria;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
39 Cantabria;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
39 Cantabria;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
39 Cantabria;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
39 Cantabria;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
39 Cantabria;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
39 Cantabria;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
39 Cantabria;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;97,84
39 Cantabria;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
39 Cantabria;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
39 Cantabria;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
39 Cantabria;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;98,78
39 Cantabria;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
39 Cantabria;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
39 Cantabria;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
39 Cantabria;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;96,03
39 Cantabria;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
39 Cantabria;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
39 Cantabria;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;96,03
39 Cantabria;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
39 Cantabria;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
39 Cantabria;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
39 Cantabria;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;97,07
39 Cantabria;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
39 Cantabria;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
39 Cantabria;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
39 Cantabria;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;94,6
39 Cantabria;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
39 Cantabria;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
39 Cantabria;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;94,49
39 Cantabria;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
39 Cantabria;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
39 Cantabria;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
39 Cantabria;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;95,78
39 Cantabria;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
39 Cantabria;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
39 Cantabria;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
39 Cantabria;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;93,2
39 Cantabria;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
39 Cantabria;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
39 Cantabria;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;92,77
39 Cantabria;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
39 Cantabria;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
39 Cantabria;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
39 Cantabria;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;94,64
39 Cantabria;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
39 Cantabria;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
39 Cantabria;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
39 Cantabria;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;91,88
39 Cantabria;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
39 Cantabria;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
39 Cantabria;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
39 Cantabria;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
39 Cantabria;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
39 Cantabria;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QII;11.732
39 Cantabria;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
39 Cantabria;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
39 Cantabria;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
39 Cantabria;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QII;11.520
39 Cantabria;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
39 Cantabria;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
39 Cantabria;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
39 Cantabria;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QII;11.277
39 Cantabria;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
39 Cantabria;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
39 Cantabria;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
39 Cantabria;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2022QII;11.530
39 Cantabria;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2022QI;""
39 Cantabria;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
39 Cantabria;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
39 Cantabria;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2021QII;11.336
39 Cantabria;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2021QI;""
39 Cantabria;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
39 Cantabria;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
39 Cantabria;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2020QII;11.153
39 Cantabria;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2020QI;""
39 Cantabria;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
39 Cantabria;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2022QIII;11.352
39 Cantabria;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2022QII;""
39 Cantabria;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2022QI;""
39 Cantabria;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
39 Cantabria;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2021QIII;11.178
39 Cantabria;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2021QII;""
39 Cantabria;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2021QI;""
39 Cantabria;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
39 Cantabria;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2020QIII;10.988
39 Cantabria;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2020QII;""
39 Cantabria;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2020QI;""
39 Cantabria;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QIV;11.148
39 Cantabria;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
39 Cantabria;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QII;""
39 Cantabria;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QI;""
39 Cantabria;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QIV;11.023
39 Cantabria;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
39 Cantabria;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QII;""
39 Cantabria;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QI;""
39 Cantabria;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QIV;10.822
39 Cantabria;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
39 Cantabria;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QII;""
39 Cantabria;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QI;""
39 Cantabria;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
39 Cantabria;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
39 Cantabria;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QII;""
39 Cantabria;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QI;10.853
39 Cantabria;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
39 Cantabria;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
39 Cantabria;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QII;""
39 Cantabria;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QI;10.725
39 Cantabria;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
39 Cantabria;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
39 Cantabria;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QII;""
39 Cantabria;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QI;""
39 Cantabria;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
39 Cantabria;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
39 Cantabria;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
39 Cantabria;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
39 Cantabria;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
39 Cantabria;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
39 Cantabria;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
39 Cantabria;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
39 Cantabria;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
39 Cantabria;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
39 Cantabria;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
39 Cantabria;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
39 Cantabria;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
39 Cantabria;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
39 Cantabria;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;98,28
39 Cantabria;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
39 Cantabria;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
39 Cantabria;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
39 Cantabria;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;98,4
39 Cantabria;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
39 Cantabria;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
39 Cantabria;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
39 Cantabria;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;98,9
39 Cantabria;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
39 Cantabria;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
39 Cantabria;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;96,76
39 Cantabria;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
39 Cantabria;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
39 Cantabria;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
39 Cantabria;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;97,03
39 Cantabria;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
39 Cantabria;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
39 Cantabria;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
39 Cantabria;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;97,44
39 Cantabria;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
39 Cantabria;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
39 Cantabria;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;95,02
39 Cantabria;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
39 Cantabria;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
39 Cantabria;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
39 Cantabria;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;95,69
39 Cantabria;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
39 Cantabria;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
39 Cantabria;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
39 Cantabria;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;95,97
39 Cantabria;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
39 Cantabria;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
39 Cantabria;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
39 Cantabria;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
39 Cantabria;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
39 Cantabria;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
39 Cantabria;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;94,21
39 Cantabria;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
39 Cantabria;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
39 Cantabria;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
39 Cantabria;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;95,11
39 Cantabria;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
39 Cantabria;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
39 Cantabria;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
39 Cantabria;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
39 Cantabria;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
39 Cantabria;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
39 Cantabria;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QII;7.340
39 Cantabria;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
39 Cantabria;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
39 Cantabria;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
39 Cantabria;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QII;7.237
39 Cantabria;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
39 Cantabria;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
39 Cantabria;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
39 Cantabria;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QII;7.094
39 Cantabria;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
39 Cantabria;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
39 Cantabria;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
39 Cantabria;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2022QII;7.230
39 Cantabria;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2022QI;""
39 Cantabria;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
39 Cantabria;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
39 Cantabria;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2021QII;7.142
39 Cantabria;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2021QI;""
39 Cantabria;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
39 Cantabria;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
39 Cantabria;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2020QII;7.033
39 Cantabria;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2020QI;""
39 Cantabria;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
39 Cantabria;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2022QIII;7.128
39 Cantabria;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2022QII;""
39 Cantabria;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2022QI;""
39 Cantabria;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
39 Cantabria;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2021QIII;7.047
39 Cantabria;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2021QII;""
39 Cantabria;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2021QI;""
39 Cantabria;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
39 Cantabria;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2020QIII;6.934
39 Cantabria;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2020QII;""
39 Cantabria;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2020QI;""
39 Cantabria;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QIV;7.015
39 Cantabria;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
39 Cantabria;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QII;""
39 Cantabria;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QI;""
39 Cantabria;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QIV;6.946
39 Cantabria;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
39 Cantabria;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QII;""
39 Cantabria;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QI;""
39 Cantabria;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QIV;6.833
39 Cantabria;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
39 Cantabria;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QII;""
39 Cantabria;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QI;""
39 Cantabria;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
39 Cantabria;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
39 Cantabria;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QII;""
39 Cantabria;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QI;6.852
39 Cantabria;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
39 Cantabria;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
39 Cantabria;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QII;""
39 Cantabria;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QI;6.773
39 Cantabria;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
39 Cantabria;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
39 Cantabria;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QII;""
39 Cantabria;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QI;""
39 Cantabria;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
39 Cantabria;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
39 Cantabria;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
39 Cantabria;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
39 Cantabria;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
39 Cantabria;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
39 Cantabria;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
39 Cantabria;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
39 Cantabria;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
39 Cantabria;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
39 Cantabria;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
39 Cantabria;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
39 Cantabria;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
39 Cantabria;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
39 Cantabria;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;98,5
39 Cantabria;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
39 Cantabria;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
39 Cantabria;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
39 Cantabria;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;98,69
39 Cantabria;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
39 Cantabria;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
39 Cantabria;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
39 Cantabria;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;99,14
39 Cantabria;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
39 Cantabria;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
39 Cantabria;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;97,11
39 Cantabria;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
39 Cantabria;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
39 Cantabria;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
39 Cantabria;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;97,37
39 Cantabria;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
39 Cantabria;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
39 Cantabria;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
39 Cantabria;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;97,74
39 Cantabria;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
39 Cantabria;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
39 Cantabria;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;95,57
39 Cantabria;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
39 Cantabria;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
39 Cantabria;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
39 Cantabria;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;95,98
39 Cantabria;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
39 Cantabria;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
39 Cantabria;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
39 Cantabria;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;96,32
39 Cantabria;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
39 Cantabria;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
39 Cantabria;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
39 Cantabria;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
39 Cantabria;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
39 Cantabria;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
39 Cantabria;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;94,68
39 Cantabria;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
39 Cantabria;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
39 Cantabria;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
39 Cantabria;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;95,48
39 Cantabria;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
39 Cantabria;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
39 Cantabria;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
39 Cantabria;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
39 Cantabria;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
39 Cantabria;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
39 Cantabria;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QII;4.392
39 Cantabria;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
39 Cantabria;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
39 Cantabria;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
39 Cantabria;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QII;4.283
39 Cantabria;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
39 Cantabria;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
39 Cantabria;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
39 Cantabria;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QII;4.183
39 Cantabria;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
39 Cantabria;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
39 Cantabria;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
39 Cantabria;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2022QII;4.300
39 Cantabria;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2022QI;""
39 Cantabria;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
39 Cantabria;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
39 Cantabria;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2021QII;4.194
39 Cantabria;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2021QI;""
39 Cantabria;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
39 Cantabria;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
39 Cantabria;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2020QII;4.120
39 Cantabria;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2020QI;""
39 Cantabria;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
39 Cantabria;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2022QIII;4.224
39 Cantabria;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2022QII;""
39 Cantabria;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2022QI;""
39 Cantabria;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
39 Cantabria;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2021QIII;4.131
39 Cantabria;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2021QII;""
39 Cantabria;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2021QI;""
39 Cantabria;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
39 Cantabria;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2020QIII;4.054
39 Cantabria;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2020QII;""
39 Cantabria;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2020QI;""
39 Cantabria;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QIV;4.133
39 Cantabria;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
39 Cantabria;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QII;""
39 Cantabria;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QI;""
39 Cantabria;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QIV;4.077
39 Cantabria;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
39 Cantabria;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QII;""
39 Cantabria;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QI;""
39 Cantabria;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QIV;3.989
39 Cantabria;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
39 Cantabria;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QII;""
39 Cantabria;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QI;""
39 Cantabria;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
39 Cantabria;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
39 Cantabria;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QII;""
39 Cantabria;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QI;4.001
39 Cantabria;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
39 Cantabria;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
39 Cantabria;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QII;""
39 Cantabria;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QI;3.952
39 Cantabria;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
39 Cantabria;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
39 Cantabria;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QII;""
39 Cantabria;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QI;""
39 Cantabria;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
39 Cantabria;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
39 Cantabria;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
39 Cantabria;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
39 Cantabria;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
39 Cantabria;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
39 Cantabria;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
39 Cantabria;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
39 Cantabria;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
39 Cantabria;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
39 Cantabria;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
39 Cantabria;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
39 Cantabria;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
39 Cantabria;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
39 Cantabria;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;97,91
39 Cantabria;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
39 Cantabria;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
39 Cantabria;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
39 Cantabria;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;97,92
39 Cantabria;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
39 Cantabria;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
39 Cantabria;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
39 Cantabria;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;98,49
39 Cantabria;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
39 Cantabria;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
39 Cantabria;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;96,17
39 Cantabria;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
39 Cantabria;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
39 Cantabria;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
39 Cantabria;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;96,45
39 Cantabria;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
39 Cantabria;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
39 Cantabria;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
39 Cantabria;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;96,92
39 Cantabria;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
39 Cantabria;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
39 Cantabria;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;94,1
39 Cantabria;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
39 Cantabria;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
39 Cantabria;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
39 Cantabria;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;95,19
39 Cantabria;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
39 Cantabria;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
39 Cantabria;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
39 Cantabria;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;95,36
39 Cantabria;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
39 Cantabria;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
39 Cantabria;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
39 Cantabria;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
39 Cantabria;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
39 Cantabria;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
39 Cantabria;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;93,42
39 Cantabria;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
39 Cantabria;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
39 Cantabria;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
39 Cantabria;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;94,48
39 Cantabria;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
39 Cantabria;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
39 Cantabria;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
39 Cantabria;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
39 Cantabria;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
39 Cantabria;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QIII;11.782
39 Cantabria;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
39 Cantabria;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
39 Cantabria;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
39 Cantabria;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QIII;11.579
39 Cantabria;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
39 Cantabria;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
39 Cantabria;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
39 Cantabria;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QIII;11.356
39 Cantabria;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
39 Cantabria;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
39 Cantabria;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
39 Cantabria;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2022QIII;11.545
39 Cantabria;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2022QII;""
39 Cantabria;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2022QI;""
39 Cantabria;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
39 Cantabria;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2021QIII;11.374
39 Cantabria;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2021QII;""
39 Cantabria;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2021QI;""
39 Cantabria;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
39 Cantabria;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2020QIII;11.153
39 Cantabria;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2020QII;""
39 Cantabria;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2020QI;""
39 Cantabria;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2022QIV;11.306
39 Cantabria;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
39 Cantabria;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2022QII;""
39 Cantabria;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2022QI;""
39 Cantabria;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2021QIV;11.178
39 Cantabria;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
39 Cantabria;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2021QII;""
39 Cantabria;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2021QI;""
39 Cantabria;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2020QIV;10.964
39 Cantabria;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
39 Cantabria;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2020QII;""
39 Cantabria;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2020QI;""
39 Cantabria;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
39 Cantabria;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
39 Cantabria;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QII;""
39 Cantabria;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QI;11.004
39 Cantabria;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
39 Cantabria;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
39 Cantabria;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QII;""
39 Cantabria;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QI;10.862
39 Cantabria;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
39 Cantabria;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
39 Cantabria;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QII;""
39 Cantabria;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QI;""
39 Cantabria;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
39 Cantabria;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
39 Cantabria;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QII;10.867
39 Cantabria;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QI;""
39 Cantabria;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
39 Cantabria;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
39 Cantabria;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QII;10.733
39 Cantabria;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QI;""
39 Cantabria;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
39 Cantabria;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
39 Cantabria;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QII;""
39 Cantabria;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QI;""
39 Cantabria;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
39 Cantabria;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
39 Cantabria;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
39 Cantabria;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
39 Cantabria;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
39 Cantabria;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
39 Cantabria;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
39 Cantabria;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
39 Cantabria;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
39 Cantabria;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
39 Cantabria;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
39 Cantabria;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
39 Cantabria;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
39 Cantabria;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;97,99
39 Cantabria;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
39 Cantabria;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
39 Cantabria;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
39 Cantabria;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;98,23
39 Cantabria;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
39 Cantabria;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
39 Cantabria;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
39 Cantabria;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;98,21
39 Cantabria;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
39 Cantabria;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
39 Cantabria;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;95,96
39 Cantabria;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
39 Cantabria;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
39 Cantabria;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
39 Cantabria;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;96,54
39 Cantabria;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
39 Cantabria;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
39 Cantabria;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
39 Cantabria;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;96,55
39 Cantabria;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
39 Cantabria;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
39 Cantabria;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
39 Cantabria;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
39 Cantabria;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
39 Cantabria;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
39 Cantabria;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;95,03
39 Cantabria;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
39 Cantabria;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
39 Cantabria;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
39 Cantabria;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;95,65
39 Cantabria;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
39 Cantabria;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
39 Cantabria;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
39 Cantabria;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
39 Cantabria;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
39 Cantabria;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
39 Cantabria;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;93,85
39 Cantabria;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
39 Cantabria;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
39 Cantabria;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
39 Cantabria;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;94,51
39 Cantabria;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
39 Cantabria;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
39 Cantabria;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
39 Cantabria;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
39 Cantabria;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
39 Cantabria;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
39 Cantabria;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QIII;7.359
39 Cantabria;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
39 Cantabria;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
39 Cantabria;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
39 Cantabria;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QIII;7.283
39 Cantabria;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
39 Cantabria;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
39 Cantabria;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
39 Cantabria;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QIII;7.157
39 Cantabria;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
39 Cantabria;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
39 Cantabria;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
39 Cantabria;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2022QIII;7.230
39 Cantabria;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2022QII;""
39 Cantabria;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2022QI;""
39 Cantabria;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
39 Cantabria;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2021QIII;7.160
39 Cantabria;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2021QII;""
39 Cantabria;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2021QI;""
39 Cantabria;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
39 Cantabria;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2020QIII;7.039
39 Cantabria;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2020QII;""
39 Cantabria;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2020QI;""
39 Cantabria;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2022QIV;7.102
39 Cantabria;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
39 Cantabria;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2022QII;""
39 Cantabria;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2022QI;""
39 Cantabria;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2021QIV;7.040
39 Cantabria;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
39 Cantabria;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2021QII;""
39 Cantabria;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2021QI;""
39 Cantabria;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2020QIV;6.925
39 Cantabria;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
39 Cantabria;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2020QII;""
39 Cantabria;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2020QI;""
39 Cantabria;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
39 Cantabria;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
39 Cantabria;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QII;""
39 Cantabria;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QI;6.944
39 Cantabria;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
39 Cantabria;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
39 Cantabria;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QII;""
39 Cantabria;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QI;6.863
39 Cantabria;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
39 Cantabria;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
39 Cantabria;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QII;""
39 Cantabria;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QI;""
39 Cantabria;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
39 Cantabria;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
39 Cantabria;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QII;6.863
39 Cantabria;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QI;""
39 Cantabria;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
39 Cantabria;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
39 Cantabria;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QII;6.795
39 Cantabria;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QI;""
39 Cantabria;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
39 Cantabria;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
39 Cantabria;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QII;""
39 Cantabria;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QI;""
39 Cantabria;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
39 Cantabria;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
39 Cantabria;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
39 Cantabria;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
39 Cantabria;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
39 Cantabria;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
39 Cantabria;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
39 Cantabria;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
39 Cantabria;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
39 Cantabria;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
39 Cantabria;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
39 Cantabria;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
39 Cantabria;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
39 Cantabria;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;98,25
39 Cantabria;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
39 Cantabria;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
39 Cantabria;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
39 Cantabria;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;98,31
39 Cantabria;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
39 Cantabria;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
39 Cantabria;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
39 Cantabria;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;98,35
39 Cantabria;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
39 Cantabria;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
39 Cantabria;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;96,51
39 Cantabria;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
39 Cantabria;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
39 Cantabria;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
39 Cantabria;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;96,66
39 Cantabria;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
39 Cantabria;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
39 Cantabria;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
39 Cantabria;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;96,76
39 Cantabria;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
39 Cantabria;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
39 Cantabria;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
39 Cantabria;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
39 Cantabria;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
39 Cantabria;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
39 Cantabria;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;95,35
39 Cantabria;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
39 Cantabria;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
39 Cantabria;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
39 Cantabria;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;95,89
39 Cantabria;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
39 Cantabria;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
39 Cantabria;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
39 Cantabria;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
39 Cantabria;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
39 Cantabria;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
39 Cantabria;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;94,23
39 Cantabria;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
39 Cantabria;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
39 Cantabria;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
39 Cantabria;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;94,94
39 Cantabria;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
39 Cantabria;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
39 Cantabria;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
39 Cantabria;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
39 Cantabria;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
39 Cantabria;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
39 Cantabria;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QIII;4.423
39 Cantabria;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
39 Cantabria;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
39 Cantabria;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
39 Cantabria;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QIII;4.296
39 Cantabria;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
39 Cantabria;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
39 Cantabria;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
39 Cantabria;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QIII;4.199
39 Cantabria;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
39 Cantabria;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
39 Cantabria;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
39 Cantabria;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2022QIII;4.315
39 Cantabria;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2022QII;""
39 Cantabria;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2022QI;""
39 Cantabria;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
39 Cantabria;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2021QIII;4.214
39 Cantabria;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2021QII;""
39 Cantabria;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2021QI;""
39 Cantabria;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
39 Cantabria;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2020QIII;4.114
39 Cantabria;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2020QII;""
39 Cantabria;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2020QI;""
39 Cantabria;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2022QIV;4.204
39 Cantabria;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
39 Cantabria;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2022QII;""
39 Cantabria;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2022QI;""
39 Cantabria;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2021QIV;4.138
39 Cantabria;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
39 Cantabria;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2021QII;""
39 Cantabria;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2021QI;""
39 Cantabria;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2020QIV;4.039
39 Cantabria;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
39 Cantabria;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2020QII;""
39 Cantabria;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2020QI;""
39 Cantabria;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
39 Cantabria;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
39 Cantabria;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QII;""
39 Cantabria;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QI;4.060
39 Cantabria;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
39 Cantabria;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
39 Cantabria;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QII;""
39 Cantabria;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QI;3.999
39 Cantabria;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
39 Cantabria;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
39 Cantabria;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QII;""
39 Cantabria;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QI;""
39 Cantabria;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
39 Cantabria;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
39 Cantabria;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QII;4.004
39 Cantabria;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QI;""
39 Cantabria;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
39 Cantabria;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
39 Cantabria;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QII;3.938
39 Cantabria;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QI;""
39 Cantabria;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
39 Cantabria;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
39 Cantabria;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QII;""
39 Cantabria;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QI;""
39 Cantabria;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
39 Cantabria;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
39 Cantabria;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
39 Cantabria;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
39 Cantabria;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
39 Cantabria;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
39 Cantabria;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
39 Cantabria;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
39 Cantabria;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
39 Cantabria;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
39 Cantabria;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
39 Cantabria;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
39 Cantabria;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
39 Cantabria;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;97,56
39 Cantabria;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
39 Cantabria;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
39 Cantabria;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
39 Cantabria;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;98,09
39 Cantabria;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
39 Cantabria;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
39 Cantabria;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
39 Cantabria;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;97,98
39 Cantabria;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
39 Cantabria;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
39 Cantabria;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;95,05
39 Cantabria;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
39 Cantabria;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
39 Cantabria;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
39 Cantabria;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;96,32
39 Cantabria;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
39 Cantabria;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
39 Cantabria;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
39 Cantabria;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;96,19
39 Cantabria;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
39 Cantabria;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
39 Cantabria;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
39 Cantabria;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
39 Cantabria;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
39 Cantabria;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
39 Cantabria;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;94,51
39 Cantabria;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
39 Cantabria;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
39 Cantabria;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
39 Cantabria;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;95,24
39 Cantabria;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
39 Cantabria;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
39 Cantabria;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
39 Cantabria;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
39 Cantabria;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
39 Cantabria;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
39 Cantabria;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;93,2
39 Cantabria;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
39 Cantabria;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
39 Cantabria;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
39 Cantabria;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;93,78
39 Cantabria;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
39 Cantabria;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
39 Cantabria;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
39 Cantabria;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
39 Cantabria;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
39 Cantabria;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QIV;11.699
39 Cantabria;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
39 Cantabria;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
39 Cantabria;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
39 Cantabria;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QIV;11.546
39 Cantabria;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
39 Cantabria;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
39 Cantabria;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
39 Cantabria;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QIV;11.368
39 Cantabria;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
39 Cantabria;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
39 Cantabria;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
39 Cantabria;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2022QIV;11.437
39 Cantabria;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
39 Cantabria;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2022QII;""
39 Cantabria;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2022QI;""
39 Cantabria;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2021QIV;11.321
39 Cantabria;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
39 Cantabria;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2021QII;""
39 Cantabria;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2021QI;""
39 Cantabria;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2020QIV;11.139
39 Cantabria;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
39 Cantabria;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2020QII;""
39 Cantabria;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2020QI;""
39 Cantabria;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
39 Cantabria;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
39 Cantabria;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2022QII;""
39 Cantabria;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2022QI;11.129
39 Cantabria;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
39 Cantabria;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
39 Cantabria;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2021QII;""
39 Cantabria;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2021QI;11.025
39 Cantabria;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
39 Cantabria;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
39 Cantabria;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2020QII;""
39 Cantabria;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2020QI;""
39 Cantabria;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
39 Cantabria;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
39 Cantabria;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QII;10.983
39 Cantabria;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QI;""
39 Cantabria;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
39 Cantabria;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
39 Cantabria;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QII;10.885
39 Cantabria;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QI;""
39 Cantabria;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
39 Cantabria;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
39 Cantabria;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QII;""
39 Cantabria;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QI;""
39 Cantabria;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
39 Cantabria;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QIII;10.838
39 Cantabria;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QII;""
39 Cantabria;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QI;""
39 Cantabria;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
39 Cantabria;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QIII;10.744
39 Cantabria;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QII;""
39 Cantabria;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QI;""
39 Cantabria;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
39 Cantabria;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
39 Cantabria;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QII;""
39 Cantabria;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QI;""
39 Cantabria;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
39 Cantabria;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
39 Cantabria;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
39 Cantabria;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
39 Cantabria;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
39 Cantabria;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
39 Cantabria;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
39 Cantabria;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
39 Cantabria;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
39 Cantabria;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
39 Cantabria;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
39 Cantabria;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
39 Cantabria;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;97,76
39 Cantabria;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
39 Cantabria;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
39 Cantabria;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
39 Cantabria;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;98,05
39 Cantabria;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
39 Cantabria;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
39 Cantabria;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
39 Cantabria;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;97,99
39 Cantabria;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
39 Cantabria;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
39 Cantabria;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
39 Cantabria;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
39 Cantabria;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
39 Cantabria;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
39 Cantabria;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;96,39
39 Cantabria;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
39 Cantabria;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
39 Cantabria;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
39 Cantabria;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;96,98
39 Cantabria;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
39 Cantabria;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
39 Cantabria;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
39 Cantabria;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
39 Cantabria;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
39 Cantabria;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
39 Cantabria;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;95,12
39 Cantabria;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
39 Cantabria;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
39 Cantabria;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
39 Cantabria;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;95,75
39 Cantabria;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
39 Cantabria;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
39 Cantabria;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
39 Cantabria;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
39 Cantabria;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
39 Cantabria;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
39 Cantabria;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;93,87
39 Cantabria;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
39 Cantabria;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
39 Cantabria;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
39 Cantabria;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;94,51
39 Cantabria;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
39 Cantabria;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
39 Cantabria;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
39 Cantabria;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
39 Cantabria;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
39 Cantabria;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
39 Cantabria;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QIV;7.308
39 Cantabria;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
39 Cantabria;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
39 Cantabria;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
39 Cantabria;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QIV;7.243
39 Cantabria;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
39 Cantabria;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
39 Cantabria;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
39 Cantabria;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QIV;7.144
39 Cantabria;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
39 Cantabria;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
39 Cantabria;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
39 Cantabria;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2022QIV;7.169
39 Cantabria;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
39 Cantabria;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2022QII;""
39 Cantabria;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2022QI;""
39 Cantabria;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2021QIV;7.110
39 Cantabria;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
39 Cantabria;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2021QII;""
39 Cantabria;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2021QI;""
39 Cantabria;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2020QIV;7.016
39 Cantabria;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
39 Cantabria;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2020QII;""
39 Cantabria;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2020QI;""
39 Cantabria;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
39 Cantabria;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
39 Cantabria;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2022QII;""
39 Cantabria;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2022QI;7.004
39 Cantabria;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
39 Cantabria;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
39 Cantabria;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2021QII;""
39 Cantabria;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2021QI;6.947
39 Cantabria;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
39 Cantabria;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
39 Cantabria;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2020QII;""
39 Cantabria;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2020QI;""
39 Cantabria;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
39 Cantabria;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
39 Cantabria;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QII;6.920
39 Cantabria;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QI;""
39 Cantabria;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
39 Cantabria;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
39 Cantabria;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QII;6.875
39 Cantabria;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QI;""
39 Cantabria;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
39 Cantabria;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
39 Cantabria;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QII;""
39 Cantabria;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QI;""
39 Cantabria;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
39 Cantabria;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QIII;6.834
39 Cantabria;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QII;""
39 Cantabria;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QI;""
39 Cantabria;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
39 Cantabria;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QIII;6.788
39 Cantabria;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QII;""
39 Cantabria;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QI;""
39 Cantabria;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
39 Cantabria;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
39 Cantabria;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QII;""
39 Cantabria;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QI;""
39 Cantabria;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
39 Cantabria;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
39 Cantabria;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
39 Cantabria;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
39 Cantabria;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
39 Cantabria;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
39 Cantabria;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
39 Cantabria;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
39 Cantabria;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
39 Cantabria;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
39 Cantabria;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
39 Cantabria;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
39 Cantabria;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;98,1
39 Cantabria;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
39 Cantabria;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
39 Cantabria;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
39 Cantabria;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;98,16
39 Cantabria;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
39 Cantabria;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
39 Cantabria;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
39 Cantabria;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;98,21
39 Cantabria;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
39 Cantabria;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
39 Cantabria;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
39 Cantabria;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
39 Cantabria;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
39 Cantabria;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
39 Cantabria;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;96,7
39 Cantabria;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
39 Cantabria;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
39 Cantabria;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
39 Cantabria;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;97,24
39 Cantabria;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
39 Cantabria;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
39 Cantabria;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
39 Cantabria;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
39 Cantabria;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
39 Cantabria;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
39 Cantabria;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;95,54
39 Cantabria;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
39 Cantabria;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
39 Cantabria;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
39 Cantabria;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;96,23
39 Cantabria;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
39 Cantabria;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
39 Cantabria;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
39 Cantabria;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
39 Cantabria;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
39 Cantabria;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
39 Cantabria;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;94,35
39 Cantabria;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
39 Cantabria;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
39 Cantabria;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
39 Cantabria;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;95,02
39 Cantabria;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
39 Cantabria;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
39 Cantabria;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
39 Cantabria;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
39 Cantabria;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
39 Cantabria;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
39 Cantabria;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QIV;4.391
39 Cantabria;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
39 Cantabria;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
39 Cantabria;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
39 Cantabria;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QIV;4.303
39 Cantabria;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
39 Cantabria;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
39 Cantabria;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
39 Cantabria;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QIV;4.224
39 Cantabria;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
39 Cantabria;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
39 Cantabria;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
39 Cantabria;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2022QIV;4.268
39 Cantabria;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
39 Cantabria;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2022QII;""
39 Cantabria;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2022QI;""
39 Cantabria;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2021QIV;4.211
39 Cantabria;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
39 Cantabria;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2021QII;""
39 Cantabria;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2021QI;""
39 Cantabria;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2020QIV;4.123
39 Cantabria;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
39 Cantabria;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2020QII;""
39 Cantabria;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2020QI;""
39 Cantabria;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
39 Cantabria;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
39 Cantabria;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2022QII;""
39 Cantabria;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2022QI;4.125
39 Cantabria;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
39 Cantabria;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
39 Cantabria;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2021QII;""
39 Cantabria;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2021QI;4.078
39 Cantabria;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
39 Cantabria;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
39 Cantabria;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2020QII;""
39 Cantabria;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2020QI;""
39 Cantabria;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
39 Cantabria;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
39 Cantabria;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QII;4.063
39 Cantabria;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QI;""
39 Cantabria;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
39 Cantabria;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
39 Cantabria;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QII;4.010
39 Cantabria;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QI;""
39 Cantabria;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
39 Cantabria;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
39 Cantabria;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QII;""
39 Cantabria;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QI;""
39 Cantabria;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
39 Cantabria;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QIII;4.004
39 Cantabria;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QII;""
39 Cantabria;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QI;""
39 Cantabria;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
39 Cantabria;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QIII;3.956
39 Cantabria;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QII;""
39 Cantabria;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QI;""
39 Cantabria;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
39 Cantabria;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
39 Cantabria;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QII;""
39 Cantabria;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QI;""
39 Cantabria;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
39 Cantabria;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
39 Cantabria;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
39 Cantabria;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
39 Cantabria;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
39 Cantabria;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
39 Cantabria;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
39 Cantabria;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
39 Cantabria;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
39 Cantabria;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
39 Cantabria;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
39 Cantabria;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
39 Cantabria;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;97,2
39 Cantabria;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
39 Cantabria;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
39 Cantabria;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
39 Cantabria;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;97,86
39 Cantabria;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
39 Cantabria;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
39 Cantabria;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
39 Cantabria;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;97,61
39 Cantabria;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
39 Cantabria;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
39 Cantabria;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
39 Cantabria;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
39 Cantabria;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
39 Cantabria;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
39 Cantabria;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;95,86
39 Cantabria;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
39 Cantabria;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
39 Cantabria;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
39 Cantabria;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;96,54
39 Cantabria;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
39 Cantabria;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
39 Cantabria;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
39 Cantabria;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
39 Cantabria;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
39 Cantabria;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
39 Cantabria;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;94,42
39 Cantabria;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
39 Cantabria;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
39 Cantabria;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
39 Cantabria;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;94,93
39 Cantabria;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
39 Cantabria;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
39 Cantabria;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
39 Cantabria;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
39 Cantabria;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
39 Cantabria;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
39 Cantabria;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;93,05
39 Cantabria;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
39 Cantabria;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
39 Cantabria;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
39 Cantabria;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;93,66
39 Cantabria;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
39 Cantabria;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
39 Cantabria;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
39 Cantabria;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
39 Cantabria;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
39 Cantabria;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
39 Cantabria;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
39 Cantabria;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
39 Cantabria;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
39 Cantabria;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QI;5.836
39 Cantabria;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
39 Cantabria;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
39 Cantabria;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
39 Cantabria;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QI;5.553
39 Cantabria;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
39 Cantabria;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
39 Cantabria;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
39 Cantabria;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QI;6.320
39 Cantabria;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
39 Cantabria;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
39 Cantabria;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2022QII;""
39 Cantabria;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2022QI;5.623
39 Cantabria;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
39 Cantabria;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
39 Cantabria;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2021QII;""
39 Cantabria;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2021QI;5.382
39 Cantabria;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
39 Cantabria;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
39 Cantabria;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2020QII;""
39 Cantabria;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2020QI;5.963
39 Cantabria;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
39 Cantabria;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
39 Cantabria;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2022QII;5.419
39 Cantabria;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2022QI;""
39 Cantabria;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
39 Cantabria;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
39 Cantabria;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2021QII;5.174
39 Cantabria;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2021QI;""
39 Cantabria;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
39 Cantabria;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
39 Cantabria;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2020QII;5.796
39 Cantabria;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2020QI;""
39 Cantabria;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
39 Cantabria;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QIII;5.256
39 Cantabria;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QII;""
39 Cantabria;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QI;""
39 Cantabria;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
39 Cantabria;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QIII;4.994
39 Cantabria;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QII;""
39 Cantabria;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QI;""
39 Cantabria;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
39 Cantabria;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QIII;5.600
39 Cantabria;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QII;""
39 Cantabria;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QI;""
39 Cantabria;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QIV;4.956
39 Cantabria;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
39 Cantabria;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QII;""
39 Cantabria;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QI;""
39 Cantabria;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QIV;4.763
39 Cantabria;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
39 Cantabria;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QII;""
39 Cantabria;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QI;""
39 Cantabria;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QIV;5.336
39 Cantabria;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
39 Cantabria;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QII;""
39 Cantabria;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QI;""
39 Cantabria;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
39 Cantabria;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
39 Cantabria;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
39 Cantabria;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
39 Cantabria;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
39 Cantabria;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
39 Cantabria;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
39 Cantabria;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
39 Cantabria;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
39 Cantabria;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
39 Cantabria;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
39 Cantabria;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
39 Cantabria;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
39 Cantabria;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
39 Cantabria;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
39 Cantabria;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;96,35
39 Cantabria;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
39 Cantabria;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
39 Cantabria;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
39 Cantabria;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;96,92
39 Cantabria;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
39 Cantabria;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
39 Cantabria;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
39 Cantabria;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;94,35
39 Cantabria;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
39 Cantabria;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
39 Cantabria;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;92,85
39 Cantabria;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
39 Cantabria;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
39 Cantabria;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
39 Cantabria;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;93,17
39 Cantabria;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
39 Cantabria;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
39 Cantabria;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
39 Cantabria;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;91,71
39 Cantabria;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
39 Cantabria;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
39 Cantabria;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;90,06
39 Cantabria;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
39 Cantabria;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
39 Cantabria;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
39 Cantabria;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;89,93
39 Cantabria;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
39 Cantabria;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
39 Cantabria;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
39 Cantabria;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;88,61
39 Cantabria;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
39 Cantabria;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
39 Cantabria;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;84,92
39 Cantabria;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
39 Cantabria;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
39 Cantabria;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
39 Cantabria;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;85,77
39 Cantabria;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
39 Cantabria;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
39 Cantabria;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
39 Cantabria;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;84,43
39 Cantabria;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
39 Cantabria;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
39 Cantabria;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
39 Cantabria;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
39 Cantabria;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
39 Cantabria;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
39 Cantabria;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QI;3.702
39 Cantabria;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
39 Cantabria;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
39 Cantabria;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
39 Cantabria;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QI;3.522
39 Cantabria;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
39 Cantabria;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
39 Cantabria;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
39 Cantabria;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QI;3.994
39 Cantabria;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
39 Cantabria;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
39 Cantabria;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2022QII;""
39 Cantabria;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2022QI;3.564
39 Cantabria;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
39 Cantabria;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
39 Cantabria;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2021QII;""
39 Cantabria;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2021QI;3.410
39 Cantabria;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
39 Cantabria;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
39 Cantabria;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2020QII;""
39 Cantabria;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2020QI;3.778
39 Cantabria;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
39 Cantabria;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
39 Cantabria;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2022QII;3.438
39 Cantabria;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2022QI;""
39 Cantabria;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
39 Cantabria;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
39 Cantabria;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2021QII;3.285
39 Cantabria;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2021QI;""
39 Cantabria;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
39 Cantabria;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
39 Cantabria;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2020QII;3.687
39 Cantabria;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2020QI;""
39 Cantabria;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
39 Cantabria;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QIII;3.327
39 Cantabria;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QII;""
39 Cantabria;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QI;""
39 Cantabria;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
39 Cantabria;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QIII;3.174
39 Cantabria;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QII;""
39 Cantabria;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QI;""
39 Cantabria;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
39 Cantabria;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QIII;3.557
39 Cantabria;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QII;""
39 Cantabria;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QI;""
39 Cantabria;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QIV;3.123
39 Cantabria;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
39 Cantabria;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QII;""
39 Cantabria;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QI;""
39 Cantabria;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QIV;3.022
39 Cantabria;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
39 Cantabria;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QII;""
39 Cantabria;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QI;""
39 Cantabria;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QIV;3.394
39 Cantabria;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
39 Cantabria;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QII;""
39 Cantabria;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QI;""
39 Cantabria;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
39 Cantabria;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
39 Cantabria;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
39 Cantabria;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
39 Cantabria;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
39 Cantabria;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
39 Cantabria;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
39 Cantabria;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
39 Cantabria;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
39 Cantabria;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
39 Cantabria;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
39 Cantabria;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
39 Cantabria;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
39 Cantabria;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
39 Cantabria;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
39 Cantabria;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;96,27
39 Cantabria;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
39 Cantabria;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
39 Cantabria;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
39 Cantabria;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;96,82
39 Cantabria;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
39 Cantabria;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
39 Cantabria;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
39 Cantabria;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;94,59
39 Cantabria;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
39 Cantabria;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
39 Cantabria;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;92,87
39 Cantabria;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
39 Cantabria;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
39 Cantabria;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
39 Cantabria;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;93,27
39 Cantabria;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
39 Cantabria;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
39 Cantabria;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
39 Cantabria;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;92,31
39 Cantabria;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
39 Cantabria;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
39 Cantabria;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;89,87
39 Cantabria;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
39 Cantabria;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
39 Cantabria;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
39 Cantabria;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;90,12
39 Cantabria;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
39 Cantabria;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
39 Cantabria;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
39 Cantabria;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;89,06
39 Cantabria;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
39 Cantabria;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
39 Cantabria;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;84,36
39 Cantabria;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
39 Cantabria;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
39 Cantabria;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
39 Cantabria;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;85,8
39 Cantabria;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
39 Cantabria;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
39 Cantabria;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
39 Cantabria;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;84,98
39 Cantabria;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
39 Cantabria;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
39 Cantabria;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
39 Cantabria;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
39 Cantabria;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
39 Cantabria;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
39 Cantabria;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QI;2.134
39 Cantabria;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
39 Cantabria;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
39 Cantabria;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
39 Cantabria;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QI;2.031
39 Cantabria;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
39 Cantabria;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
39 Cantabria;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
39 Cantabria;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QI;2.326
39 Cantabria;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
39 Cantabria;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
39 Cantabria;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2022QII;""
39 Cantabria;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2022QI;2.059
39 Cantabria;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
39 Cantabria;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
39 Cantabria;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2021QII;""
39 Cantabria;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2021QI;1.972
39 Cantabria;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
39 Cantabria;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
39 Cantabria;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2020QII;""
39 Cantabria;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2020QI;2.185
39 Cantabria;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
39 Cantabria;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
39 Cantabria;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2022QII;1.981
39 Cantabria;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2022QI;""
39 Cantabria;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
39 Cantabria;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
39 Cantabria;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2021QII;1.889
39 Cantabria;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2021QI;""
39 Cantabria;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
39 Cantabria;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
39 Cantabria;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2020QII;2.109
39 Cantabria;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2020QI;""
39 Cantabria;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
39 Cantabria;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QIII;1.929
39 Cantabria;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QII;""
39 Cantabria;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QI;""
39 Cantabria;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
39 Cantabria;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QIII;1.820
39 Cantabria;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QII;""
39 Cantabria;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QI;""
39 Cantabria;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
39 Cantabria;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QIII;2.043
39 Cantabria;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QII;""
39 Cantabria;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QI;""
39 Cantabria;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QIV;1.833
39 Cantabria;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
39 Cantabria;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QII;""
39 Cantabria;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QI;""
39 Cantabria;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QIV;1.741
39 Cantabria;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
39 Cantabria;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QII;""
39 Cantabria;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QI;""
39 Cantabria;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QIV;1.942
39 Cantabria;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
39 Cantabria;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QII;""
39 Cantabria;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QI;""
39 Cantabria;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
39 Cantabria;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
39 Cantabria;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
39 Cantabria;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
39 Cantabria;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
39 Cantabria;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
39 Cantabria;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
39 Cantabria;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
39 Cantabria;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
39 Cantabria;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
39 Cantabria;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
39 Cantabria;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
39 Cantabria;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
39 Cantabria;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
39 Cantabria;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
39 Cantabria;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;96,49
39 Cantabria;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
39 Cantabria;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
39 Cantabria;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
39 Cantabria;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;97,1
39 Cantabria;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
39 Cantabria;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
39 Cantabria;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
39 Cantabria;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;93,94
39 Cantabria;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
39 Cantabria;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
39 Cantabria;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;92,83
39 Cantabria;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
39 Cantabria;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
39 Cantabria;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
39 Cantabria;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;93,01
39 Cantabria;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
39 Cantabria;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
39 Cantabria;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
39 Cantabria;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;90,67
39 Cantabria;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
39 Cantabria;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
39 Cantabria;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;90,39
39 Cantabria;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
39 Cantabria;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
39 Cantabria;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
39 Cantabria;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;89,61
39 Cantabria;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
39 Cantabria;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
39 Cantabria;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
39 Cantabria;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;87,83
39 Cantabria;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
39 Cantabria;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
39 Cantabria;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;85,9
39 Cantabria;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
39 Cantabria;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
39 Cantabria;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
39 Cantabria;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;85,72
39 Cantabria;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
39 Cantabria;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
39 Cantabria;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
39 Cantabria;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;83,49
39 Cantabria;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
39 Cantabria;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
39 Cantabria;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
39 Cantabria;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
39 Cantabria;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
39 Cantabria;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QII;6.653
39 Cantabria;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
39 Cantabria;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
39 Cantabria;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
39 Cantabria;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QII;6.376
39 Cantabria;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
39 Cantabria;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
39 Cantabria;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
39 Cantabria;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QII;6.074
39 Cantabria;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
39 Cantabria;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
39 Cantabria;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
39 Cantabria;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2022QII;6.428
39 Cantabria;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2022QI;""
39 Cantabria;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
39 Cantabria;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
39 Cantabria;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2021QII;6.153
39 Cantabria;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2021QI;""
39 Cantabria;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
39 Cantabria;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
39 Cantabria;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2020QII;5.899
39 Cantabria;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2020QI;""
39 Cantabria;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
39 Cantabria;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2022QIII;6.238
39 Cantabria;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2022QII;""
39 Cantabria;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2022QI;""
39 Cantabria;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
39 Cantabria;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2021QIII;5.958
39 Cantabria;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2021QII;""
39 Cantabria;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2021QI;""
39 Cantabria;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
39 Cantabria;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2020QIII;5.678
39 Cantabria;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2020QII;""
39 Cantabria;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2020QI;""
39 Cantabria;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QIV;5.919
39 Cantabria;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
39 Cantabria;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QII;""
39 Cantabria;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QI;""
39 Cantabria;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QIV;5.707
39 Cantabria;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
39 Cantabria;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QII;""
39 Cantabria;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QI;""
39 Cantabria;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QIV;5.411
39 Cantabria;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
39 Cantabria;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QII;""
39 Cantabria;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QI;""
39 Cantabria;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
39 Cantabria;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
39 Cantabria;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QII;""
39 Cantabria;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QI;5.507
39 Cantabria;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
39 Cantabria;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
39 Cantabria;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QII;""
39 Cantabria;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QI;5.250
39 Cantabria;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
39 Cantabria;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
39 Cantabria;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QII;""
39 Cantabria;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QI;""
39 Cantabria;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
39 Cantabria;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
39 Cantabria;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
39 Cantabria;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
39 Cantabria;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
39 Cantabria;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
39 Cantabria;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
39 Cantabria;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
39 Cantabria;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
39 Cantabria;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
39 Cantabria;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
39 Cantabria;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
39 Cantabria;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
39 Cantabria;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
39 Cantabria;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;96,62
39 Cantabria;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
39 Cantabria;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
39 Cantabria;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
39 Cantabria;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;96,5
39 Cantabria;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
39 Cantabria;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
39 Cantabria;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
39 Cantabria;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;97,12
39 Cantabria;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
39 Cantabria;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
39 Cantabria;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;93,76
39 Cantabria;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
39 Cantabria;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
39 Cantabria;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
39 Cantabria;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;93,44
39 Cantabria;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
39 Cantabria;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
39 Cantabria;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
39 Cantabria;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;93,48
39 Cantabria;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
39 Cantabria;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
39 Cantabria;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;88,97
39 Cantabria;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
39 Cantabria;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
39 Cantabria;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
39 Cantabria;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;89,51
39 Cantabria;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
39 Cantabria;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
39 Cantabria;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
39 Cantabria;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;89,08
39 Cantabria;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
39 Cantabria;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
39 Cantabria;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
39 Cantabria;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
39 Cantabria;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
39 Cantabria;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
39 Cantabria;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;86,37
39 Cantabria;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
39 Cantabria;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
39 Cantabria;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
39 Cantabria;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;86,43
39 Cantabria;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
39 Cantabria;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
39 Cantabria;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
39 Cantabria;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
39 Cantabria;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
39 Cantabria;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
39 Cantabria;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QII;4.217
39 Cantabria;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
39 Cantabria;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
39 Cantabria;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
39 Cantabria;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QII;4.050
39 Cantabria;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
39 Cantabria;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
39 Cantabria;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
39 Cantabria;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QII;3.854
39 Cantabria;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
39 Cantabria;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
39 Cantabria;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
39 Cantabria;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2022QII;4.077
39 Cantabria;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2022QI;""
39 Cantabria;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
39 Cantabria;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
39 Cantabria;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2021QII;3.914
39 Cantabria;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2021QI;""
39 Cantabria;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
39 Cantabria;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
39 Cantabria;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2020QII;3.757
39 Cantabria;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2020QI;""
39 Cantabria;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
39 Cantabria;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2022QIII;3.950
39 Cantabria;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2022QII;""
39 Cantabria;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2022QI;""
39 Cantabria;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
39 Cantabria;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2021QIII;3.792
39 Cantabria;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2021QII;""
39 Cantabria;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2021QI;""
39 Cantabria;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
39 Cantabria;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2020QIII;3.605
39 Cantabria;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2020QII;""
39 Cantabria;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2020QI;""
39 Cantabria;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QIV;3.732
39 Cantabria;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
39 Cantabria;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QII;""
39 Cantabria;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QI;""
39 Cantabria;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QIV;3.628
39 Cantabria;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
39 Cantabria;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QII;""
39 Cantabria;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QI;""
39 Cantabria;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QIV;3.441
39 Cantabria;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
39 Cantabria;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QII;""
39 Cantabria;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QI;""
39 Cantabria;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
39 Cantabria;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
39 Cantabria;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QII;""
39 Cantabria;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QI;3.500
39 Cantabria;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
39 Cantabria;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
39 Cantabria;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QII;""
39 Cantabria;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QI;3.337
39 Cantabria;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
39 Cantabria;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
39 Cantabria;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QII;""
39 Cantabria;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QI;""
39 Cantabria;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
39 Cantabria;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
39 Cantabria;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
39 Cantabria;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
39 Cantabria;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
39 Cantabria;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
39 Cantabria;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
39 Cantabria;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
39 Cantabria;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
39 Cantabria;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
39 Cantabria;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
39 Cantabria;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
39 Cantabria;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
39 Cantabria;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
39 Cantabria;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;96,68
39 Cantabria;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
39 Cantabria;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
39 Cantabria;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
39 Cantabria;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;96,64
39 Cantabria;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
39 Cantabria;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
39 Cantabria;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
39 Cantabria;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;97,48
39 Cantabria;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
39 Cantabria;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
39 Cantabria;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;93,67
39 Cantabria;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
39 Cantabria;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
39 Cantabria;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
39 Cantabria;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;93,63
39 Cantabria;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
39 Cantabria;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
39 Cantabria;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
39 Cantabria;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;93,54
39 Cantabria;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
39 Cantabria;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
39 Cantabria;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;88,5
39 Cantabria;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
39 Cantabria;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
39 Cantabria;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
39 Cantabria;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;89,58
39 Cantabria;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
39 Cantabria;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
39 Cantabria;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
39 Cantabria;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;89,28
39 Cantabria;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
39 Cantabria;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
39 Cantabria;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
39 Cantabria;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
39 Cantabria;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
39 Cantabria;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
39 Cantabria;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;86,42
39 Cantabria;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
39 Cantabria;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
39 Cantabria;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
39 Cantabria;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;86,59
39 Cantabria;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
39 Cantabria;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
39 Cantabria;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
39 Cantabria;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
39 Cantabria;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
39 Cantabria;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
39 Cantabria;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QII;2.436
39 Cantabria;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
39 Cantabria;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
39 Cantabria;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
39 Cantabria;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QII;2.326
39 Cantabria;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
39 Cantabria;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
39 Cantabria;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
39 Cantabria;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QII;2.220
39 Cantabria;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
39 Cantabria;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
39 Cantabria;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
39 Cantabria;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2022QII;2.351
39 Cantabria;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2022QI;""
39 Cantabria;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
39 Cantabria;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
39 Cantabria;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2021QII;2.239
39 Cantabria;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2021QI;""
39 Cantabria;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
39 Cantabria;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
39 Cantabria;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2020QII;2.142
39 Cantabria;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2020QI;""
39 Cantabria;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
39 Cantabria;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2022QIII;2.288
39 Cantabria;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2022QII;""
39 Cantabria;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2022QI;""
39 Cantabria;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
39 Cantabria;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2021QIII;2.166
39 Cantabria;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2021QII;""
39 Cantabria;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2021QI;""
39 Cantabria;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
39 Cantabria;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2020QIII;2.073
39 Cantabria;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2020QII;""
39 Cantabria;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2020QI;""
39 Cantabria;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QIV;2.187
39 Cantabria;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
39 Cantabria;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QII;""
39 Cantabria;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QI;""
39 Cantabria;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QIV;2.079
39 Cantabria;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
39 Cantabria;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QII;""
39 Cantabria;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QI;""
39 Cantabria;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QIV;1.970
39 Cantabria;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
39 Cantabria;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QII;""
39 Cantabria;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QI;""
39 Cantabria;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
39 Cantabria;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
39 Cantabria;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QII;""
39 Cantabria;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QI;2.007
39 Cantabria;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
39 Cantabria;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
39 Cantabria;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QII;""
39 Cantabria;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QI;1.913
39 Cantabria;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
39 Cantabria;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
39 Cantabria;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QII;""
39 Cantabria;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QI;""
39 Cantabria;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
39 Cantabria;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
39 Cantabria;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
39 Cantabria;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
39 Cantabria;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
39 Cantabria;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
39 Cantabria;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
39 Cantabria;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
39 Cantabria;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
39 Cantabria;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
39 Cantabria;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
39 Cantabria;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
39 Cantabria;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
39 Cantabria;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
39 Cantabria;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;96,51
39 Cantabria;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
39 Cantabria;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
39 Cantabria;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
39 Cantabria;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;96,26
39 Cantabria;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
39 Cantabria;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
39 Cantabria;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
39 Cantabria;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;96,49
39 Cantabria;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
39 Cantabria;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
39 Cantabria;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;93,92
39 Cantabria;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
39 Cantabria;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
39 Cantabria;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
39 Cantabria;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;93,12
39 Cantabria;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
39 Cantabria;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
39 Cantabria;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
39 Cantabria;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;93,38
39 Cantabria;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
39 Cantabria;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
39 Cantabria;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;89,78
39 Cantabria;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
39 Cantabria;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
39 Cantabria;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
39 Cantabria;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;89,38
39 Cantabria;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
39 Cantabria;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
39 Cantabria;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
39 Cantabria;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;88,74
39 Cantabria;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
39 Cantabria;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
39 Cantabria;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
39 Cantabria;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
39 Cantabria;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
39 Cantabria;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
39 Cantabria;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;86,29
39 Cantabria;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
39 Cantabria;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
39 Cantabria;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
39 Cantabria;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;86,17
39 Cantabria;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
39 Cantabria;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
39 Cantabria;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
39 Cantabria;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
39 Cantabria;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
39 Cantabria;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QIII;6.538
39 Cantabria;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
39 Cantabria;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
39 Cantabria;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
39 Cantabria;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QIII;6.262
39 Cantabria;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
39 Cantabria;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
39 Cantabria;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
39 Cantabria;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QIII;5.972
39 Cantabria;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
39 Cantabria;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
39 Cantabria;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
39 Cantabria;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2022QIII;6.302
39 Cantabria;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2022QII;""
39 Cantabria;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2022QI;""
39 Cantabria;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
39 Cantabria;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2021QIII;6.033
39 Cantabria;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2021QII;""
39 Cantabria;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2021QI;""
39 Cantabria;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
39 Cantabria;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2020QIII;5.733
39 Cantabria;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2020QII;""
39 Cantabria;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2020QI;""
39 Cantabria;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2022QIV;5.966
39 Cantabria;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
39 Cantabria;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2022QII;""
39 Cantabria;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2022QI;""
39 Cantabria;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2021QIV;5.760
39 Cantabria;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
39 Cantabria;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2021QII;""
39 Cantabria;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2021QI;""
39 Cantabria;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2020QIV;5.451
39 Cantabria;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
39 Cantabria;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2020QII;""
39 Cantabria;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2020QI;""
39 Cantabria;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
39 Cantabria;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
39 Cantabria;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QII;""
39 Cantabria;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QI;5.556
39 Cantabria;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
39 Cantabria;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
39 Cantabria;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QII;""
39 Cantabria;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QI;5.289
39 Cantabria;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
39 Cantabria;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
39 Cantabria;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QII;""
39 Cantabria;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QI;""
39 Cantabria;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
39 Cantabria;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
39 Cantabria;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QII;5.362
39 Cantabria;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QI;""
39 Cantabria;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
39 Cantabria;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
39 Cantabria;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QII;5.094
39 Cantabria;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QI;""
39 Cantabria;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
39 Cantabria;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
39 Cantabria;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QII;""
39 Cantabria;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QI;""
39 Cantabria;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
39 Cantabria;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
39 Cantabria;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
39 Cantabria;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
39 Cantabria;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
39 Cantabria;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
39 Cantabria;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
39 Cantabria;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
39 Cantabria;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
39 Cantabria;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
39 Cantabria;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
39 Cantabria;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
39 Cantabria;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
39 Cantabria;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;96,39
39 Cantabria;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
39 Cantabria;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
39 Cantabria;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
39 Cantabria;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;96,34
39 Cantabria;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
39 Cantabria;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
39 Cantabria;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
39 Cantabria;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;96
39 Cantabria;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
39 Cantabria;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
39 Cantabria;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;91,25
39 Cantabria;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
39 Cantabria;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
39 Cantabria;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
39 Cantabria;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;91,98
39 Cantabria;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
39 Cantabria;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
39 Cantabria;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
39 Cantabria;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;91,28
39 Cantabria;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
39 Cantabria;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
39 Cantabria;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
39 Cantabria;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
39 Cantabria;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
39 Cantabria;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
39 Cantabria;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;88,73
39 Cantabria;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
39 Cantabria;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
39 Cantabria;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
39 Cantabria;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;88,56
39 Cantabria;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
39 Cantabria;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
39 Cantabria;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
39 Cantabria;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
39 Cantabria;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
39 Cantabria;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
39 Cantabria;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;85,63
39 Cantabria;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
39 Cantabria;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
39 Cantabria;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
39 Cantabria;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;85,3
39 Cantabria;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
39 Cantabria;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
39 Cantabria;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
39 Cantabria;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
39 Cantabria;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
39 Cantabria;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
39 Cantabria;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QIII;4.138
39 Cantabria;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
39 Cantabria;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
39 Cantabria;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
39 Cantabria;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QIII;3.977
39 Cantabria;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
39 Cantabria;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
39 Cantabria;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
39 Cantabria;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QIII;3.806
39 Cantabria;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
39 Cantabria;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
39 Cantabria;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
39 Cantabria;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2022QIII;3.987
39 Cantabria;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2022QII;""
39 Cantabria;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2022QI;""
39 Cantabria;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
39 Cantabria;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2021QIII;3.837
39 Cantabria;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2021QII;""
39 Cantabria;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2021QI;""
39 Cantabria;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
39 Cantabria;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2020QIII;3.640
39 Cantabria;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2020QII;""
39 Cantabria;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2020QI;""
39 Cantabria;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2022QIV;3.760
39 Cantabria;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
39 Cantabria;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2022QII;""
39 Cantabria;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2022QI;""
39 Cantabria;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2021QIV;3.661
39 Cantabria;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
39 Cantabria;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2021QII;""
39 Cantabria;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2021QI;""
39 Cantabria;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2020QIV;3.466
39 Cantabria;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
39 Cantabria;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2020QII;""
39 Cantabria;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2020QI;""
39 Cantabria;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
39 Cantabria;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
39 Cantabria;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QII;""
39 Cantabria;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QI;3.530
39 Cantabria;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
39 Cantabria;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
39 Cantabria;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QII;""
39 Cantabria;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QI;3.362
39 Cantabria;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
39 Cantabria;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
39 Cantabria;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QII;""
39 Cantabria;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QI;""
39 Cantabria;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
39 Cantabria;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
39 Cantabria;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QII;3.406
39 Cantabria;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QI;""
39 Cantabria;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
39 Cantabria;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
39 Cantabria;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QII;3.243
39 Cantabria;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QI;""
39 Cantabria;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
39 Cantabria;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
39 Cantabria;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QII;""
39 Cantabria;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QI;""
39 Cantabria;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
39 Cantabria;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
39 Cantabria;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
39 Cantabria;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
39 Cantabria;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
39 Cantabria;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
39 Cantabria;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
39 Cantabria;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
39 Cantabria;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
39 Cantabria;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
39 Cantabria;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
39 Cantabria;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
39 Cantabria;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
39 Cantabria;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;96,35
39 Cantabria;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
39 Cantabria;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
39 Cantabria;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
39 Cantabria;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;96,48
39 Cantabria;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
39 Cantabria;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
39 Cantabria;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
39 Cantabria;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;95,64
39 Cantabria;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
39 Cantabria;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
39 Cantabria;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;90,87
39 Cantabria;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
39 Cantabria;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
39 Cantabria;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
39 Cantabria;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;92,05
39 Cantabria;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
39 Cantabria;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
39 Cantabria;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
39 Cantabria;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;91,07
39 Cantabria;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
39 Cantabria;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
39 Cantabria;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
39 Cantabria;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
39 Cantabria;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
39 Cantabria;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
39 Cantabria;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;88,76
39 Cantabria;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
39 Cantabria;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
39 Cantabria;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
39 Cantabria;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;88,33
39 Cantabria;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
39 Cantabria;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
39 Cantabria;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
39 Cantabria;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
39 Cantabria;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
39 Cantabria;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
39 Cantabria;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;85,64
39 Cantabria;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
39 Cantabria;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
39 Cantabria;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
39 Cantabria;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;85,21
39 Cantabria;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
39 Cantabria;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
39 Cantabria;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
39 Cantabria;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
39 Cantabria;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
39 Cantabria;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
39 Cantabria;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QIII;2.400
39 Cantabria;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
39 Cantabria;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
39 Cantabria;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
39 Cantabria;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QIII;2.285
39 Cantabria;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
39 Cantabria;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
39 Cantabria;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
39 Cantabria;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QIII;2.166
39 Cantabria;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
39 Cantabria;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
39 Cantabria;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
39 Cantabria;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2022QIII;2.315
39 Cantabria;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2022QII;""
39 Cantabria;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2022QI;""
39 Cantabria;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
39 Cantabria;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2021QIII;2.196
39 Cantabria;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2021QII;""
39 Cantabria;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2021QI;""
39 Cantabria;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
39 Cantabria;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2020QIII;2.093
39 Cantabria;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2020QII;""
39 Cantabria;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2020QI;""
39 Cantabria;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2022QIV;2.206
39 Cantabria;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
39 Cantabria;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2022QII;""
39 Cantabria;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2022QI;""
39 Cantabria;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2021QIV;2.099
39 Cantabria;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
39 Cantabria;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2021QII;""
39 Cantabria;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2021QI;""
39 Cantabria;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2020QIV;1.985
39 Cantabria;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
39 Cantabria;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2020QII;""
39 Cantabria;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2020QI;""
39 Cantabria;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
39 Cantabria;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
39 Cantabria;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QII;""
39 Cantabria;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QI;2.026
39 Cantabria;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
39 Cantabria;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
39 Cantabria;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QII;""
39 Cantabria;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QI;1.927
39 Cantabria;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
39 Cantabria;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
39 Cantabria;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QII;""
39 Cantabria;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QI;""
39 Cantabria;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
39 Cantabria;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
39 Cantabria;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QII;1.956
39 Cantabria;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QI;""
39 Cantabria;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
39 Cantabria;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
39 Cantabria;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QII;1.851
39 Cantabria;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QI;""
39 Cantabria;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
39 Cantabria;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
39 Cantabria;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QII;""
39 Cantabria;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QI;""
39 Cantabria;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
39 Cantabria;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
39 Cantabria;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
39 Cantabria;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
39 Cantabria;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
39 Cantabria;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
39 Cantabria;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
39 Cantabria;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
39 Cantabria;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
39 Cantabria;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
39 Cantabria;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
39 Cantabria;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
39 Cantabria;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
39 Cantabria;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;96,46
39 Cantabria;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
39 Cantabria;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
39 Cantabria;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
39 Cantabria;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;96,11
39 Cantabria;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
39 Cantabria;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
39 Cantabria;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
39 Cantabria;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;96,63
39 Cantabria;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
39 Cantabria;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
39 Cantabria;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;91,92
39 Cantabria;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
39 Cantabria;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
39 Cantabria;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
39 Cantabria;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;91,86
39 Cantabria;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
39 Cantabria;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
39 Cantabria;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
39 Cantabria;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;91,64
39 Cantabria;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
39 Cantabria;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
39 Cantabria;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
39 Cantabria;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
39 Cantabria;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
39 Cantabria;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
39 Cantabria;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;88,67
39 Cantabria;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
39 Cantabria;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
39 Cantabria;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
39 Cantabria;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;88,97
39 Cantabria;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
39 Cantabria;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
39 Cantabria;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
39 Cantabria;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
39 Cantabria;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
39 Cantabria;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
39 Cantabria;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;85,6
39 Cantabria;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
39 Cantabria;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
39 Cantabria;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
39 Cantabria;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;85,46
39 Cantabria;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
39 Cantabria;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
39 Cantabria;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
39 Cantabria;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
39 Cantabria;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
39 Cantabria;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QIV;6.355
39 Cantabria;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
39 Cantabria;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
39 Cantabria;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
39 Cantabria;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QIV;6.080
39 Cantabria;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
39 Cantabria;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
39 Cantabria;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
39 Cantabria;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QIV;5.798
39 Cantabria;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
39 Cantabria;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
39 Cantabria;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
39 Cantabria;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2022QIV;6.012
39 Cantabria;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
39 Cantabria;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2022QII;""
39 Cantabria;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2022QI;""
39 Cantabria;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2021QIV;5.796
39 Cantabria;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
39 Cantabria;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2021QII;""
39 Cantabria;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2021QI;""
39 Cantabria;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2020QIV;5.505
39 Cantabria;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
39 Cantabria;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2020QII;""
39 Cantabria;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2020QI;""
39 Cantabria;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
39 Cantabria;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
39 Cantabria;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2022QII;""
39 Cantabria;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2022QI;5.589
39 Cantabria;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
39 Cantabria;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
39 Cantabria;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2021QII;""
39 Cantabria;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2021QI;5.340
39 Cantabria;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
39 Cantabria;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
39 Cantabria;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2020QII;""
39 Cantabria;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2020QI;""
39 Cantabria;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
39 Cantabria;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
39 Cantabria;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QII;5.389
39 Cantabria;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QI;""
39 Cantabria;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
39 Cantabria;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
39 Cantabria;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QII;5.138
39 Cantabria;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QI;""
39 Cantabria;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
39 Cantabria;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
39 Cantabria;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QII;""
39 Cantabria;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QI;""
39 Cantabria;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
39 Cantabria;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QIII;5.230
39 Cantabria;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QII;""
39 Cantabria;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QI;""
39 Cantabria;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
39 Cantabria;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QIII;4.963
39 Cantabria;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QII;""
39 Cantabria;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QI;""
39 Cantabria;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
39 Cantabria;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
39 Cantabria;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QII;""
39 Cantabria;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QI;""
39 Cantabria;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
39 Cantabria;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
39 Cantabria;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
39 Cantabria;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
39 Cantabria;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
39 Cantabria;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
39 Cantabria;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
39 Cantabria;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
39 Cantabria;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
39 Cantabria;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
39 Cantabria;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
39 Cantabria;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
39 Cantabria;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;94,6
39 Cantabria;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
39 Cantabria;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
39 Cantabria;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
39 Cantabria;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;95,33
39 Cantabria;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
39 Cantabria;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
39 Cantabria;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
39 Cantabria;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;94,95
39 Cantabria;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
39 Cantabria;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
39 Cantabria;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
39 Cantabria;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
39 Cantabria;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
39 Cantabria;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
39 Cantabria;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;91,92
39 Cantabria;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
39 Cantabria;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
39 Cantabria;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
39 Cantabria;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;92,1
39 Cantabria;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
39 Cantabria;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
39 Cantabria;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
39 Cantabria;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
39 Cantabria;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
39 Cantabria;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
39 Cantabria;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;88,63
39 Cantabria;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
39 Cantabria;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
39 Cantabria;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
39 Cantabria;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;88,62
39 Cantabria;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
39 Cantabria;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
39 Cantabria;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
39 Cantabria;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
39 Cantabria;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
39 Cantabria;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
39 Cantabria;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;86,02
39 Cantabria;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
39 Cantabria;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
39 Cantabria;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
39 Cantabria;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;85,6
39 Cantabria;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
39 Cantabria;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
39 Cantabria;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
39 Cantabria;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
39 Cantabria;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
39 Cantabria;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
39 Cantabria;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QIV;4.016
39 Cantabria;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
39 Cantabria;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
39 Cantabria;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
39 Cantabria;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QIV;3.865
39 Cantabria;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
39 Cantabria;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
39 Cantabria;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
39 Cantabria;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QIV;3.671
39 Cantabria;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
39 Cantabria;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
39 Cantabria;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
39 Cantabria;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2022QIV;3.783
39 Cantabria;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
39 Cantabria;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2022QII;""
39 Cantabria;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2022QI;""
39 Cantabria;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2021QIV;3.681
39 Cantabria;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
39 Cantabria;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2021QII;""
39 Cantabria;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2021QI;""
39 Cantabria;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2020QIV;3.490
39 Cantabria;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
39 Cantabria;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2020QII;""
39 Cantabria;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2020QI;""
39 Cantabria;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
39 Cantabria;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
39 Cantabria;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2022QII;""
39 Cantabria;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2022QI;3.548
39 Cantabria;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
39 Cantabria;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
39 Cantabria;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2021QII;""
39 Cantabria;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2021QI;3.383
39 Cantabria;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
39 Cantabria;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
39 Cantabria;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2020QII;""
39 Cantabria;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2020QI;""
39 Cantabria;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
39 Cantabria;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
39 Cantabria;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QII;3.423
39 Cantabria;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QI;""
39 Cantabria;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
39 Cantabria;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
39 Cantabria;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QII;3.262
39 Cantabria;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QI;""
39 Cantabria;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
39 Cantabria;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
39 Cantabria;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QII;""
39 Cantabria;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QI;""
39 Cantabria;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
39 Cantabria;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QIII;3.315
39 Cantabria;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QII;""
39 Cantabria;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QI;""
39 Cantabria;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
39 Cantabria;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QIII;3.156
39 Cantabria;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QII;""
39 Cantabria;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QI;""
39 Cantabria;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
39 Cantabria;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
39 Cantabria;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QII;""
39 Cantabria;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QI;""
39 Cantabria;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
39 Cantabria;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
39 Cantabria;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
39 Cantabria;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
39 Cantabria;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
39 Cantabria;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
39 Cantabria;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
39 Cantabria;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
39 Cantabria;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
39 Cantabria;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
39 Cantabria;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
39 Cantabria;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
39 Cantabria;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;94,2
39 Cantabria;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
39 Cantabria;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
39 Cantabria;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
39 Cantabria;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;95,24
39 Cantabria;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
39 Cantabria;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
39 Cantabria;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
39 Cantabria;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;95,07
39 Cantabria;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
39 Cantabria;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
39 Cantabria;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
39 Cantabria;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
39 Cantabria;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
39 Cantabria;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
39 Cantabria;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;91,8
39 Cantabria;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
39 Cantabria;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
39 Cantabria;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
39 Cantabria;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;92,15
39 Cantabria;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
39 Cantabria;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
39 Cantabria;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
39 Cantabria;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
39 Cantabria;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
39 Cantabria;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
39 Cantabria;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;88,56
39 Cantabria;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
39 Cantabria;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
39 Cantabria;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
39 Cantabria;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;88,86
39 Cantabria;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
39 Cantabria;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
39 Cantabria;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
39 Cantabria;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
39 Cantabria;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
39 Cantabria;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
39 Cantabria;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;85,77
39 Cantabria;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
39 Cantabria;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
39 Cantabria;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
39 Cantabria;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;85,97
39 Cantabria;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
39 Cantabria;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
39 Cantabria;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
39 Cantabria;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
39 Cantabria;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
39 Cantabria;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
39 Cantabria;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QIV;2.339
39 Cantabria;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
39 Cantabria;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
39 Cantabria;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
39 Cantabria;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QIV;2.215
39 Cantabria;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
39 Cantabria;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
39 Cantabria;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
39 Cantabria;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QIV;2.127
39 Cantabria;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
39 Cantabria;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
39 Cantabria;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
39 Cantabria;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2022QIV;2.229
39 Cantabria;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
39 Cantabria;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2022QII;""
39 Cantabria;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2022QI;""
39 Cantabria;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2021QIV;2.115
39 Cantabria;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
39 Cantabria;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2021QII;""
39 Cantabria;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2021QI;""
39 Cantabria;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2020QIV;2.015
39 Cantabria;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
39 Cantabria;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2020QII;""
39 Cantabria;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2020QI;""
39 Cantabria;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
39 Cantabria;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
39 Cantabria;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2022QII;""
39 Cantabria;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2022QI;2.041
39 Cantabria;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
39 Cantabria;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
39 Cantabria;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2021QII;""
39 Cantabria;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2021QI;1.957
39 Cantabria;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
39 Cantabria;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
39 Cantabria;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2020QII;""
39 Cantabria;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2020QI;""
39 Cantabria;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
39 Cantabria;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
39 Cantabria;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QII;1.966
39 Cantabria;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QI;""
39 Cantabria;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
39 Cantabria;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
39 Cantabria;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QII;1.876
39 Cantabria;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QI;""
39 Cantabria;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
39 Cantabria;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
39 Cantabria;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QII;""
39 Cantabria;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QI;""
39 Cantabria;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
39 Cantabria;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QIII;1.915
39 Cantabria;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QII;""
39 Cantabria;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QI;""
39 Cantabria;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
39 Cantabria;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QIII;1.807
39 Cantabria;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QII;""
39 Cantabria;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QI;""
39 Cantabria;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
39 Cantabria;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
39 Cantabria;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QII;""
39 Cantabria;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QI;""
39 Cantabria;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
39 Cantabria;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
39 Cantabria;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
39 Cantabria;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
39 Cantabria;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
39 Cantabria;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
39 Cantabria;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
39 Cantabria;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
39 Cantabria;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
39 Cantabria;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
39 Cantabria;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
39 Cantabria;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
39 Cantabria;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;95,3
39 Cantabria;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
39 Cantabria;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
39 Cantabria;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
39 Cantabria;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;95,49
39 Cantabria;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
39 Cantabria;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
39 Cantabria;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
39 Cantabria;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;94,73
39 Cantabria;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
39 Cantabria;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
39 Cantabria;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
39 Cantabria;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
39 Cantabria;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
39 Cantabria;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
39 Cantabria;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;92,14
39 Cantabria;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
39 Cantabria;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
39 Cantabria;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
39 Cantabria;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;92,01
39 Cantabria;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
39 Cantabria;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
39 Cantabria;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
39 Cantabria;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
39 Cantabria;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
39 Cantabria;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
39 Cantabria;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;88,76
39 Cantabria;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
39 Cantabria;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
39 Cantabria;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
39 Cantabria;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;88,2
39 Cantabria;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
39 Cantabria;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
39 Cantabria;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
39 Cantabria;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
39 Cantabria;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
39 Cantabria;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
39 Cantabria;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;86,46
39 Cantabria;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
39 Cantabria;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
39 Cantabria;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
39 Cantabria;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;84,96
39 Cantabria;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
39 Cantabria;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
39 Cantabria;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
39 Cantabria;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
39 Cantabria;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
39 Cantabria;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
12 Castellón/Castelló;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
12 Castellón/Castelló;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
12 Castellón/Castelló;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
12 Castellón/Castelló;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QI;37.640
12 Castellón/Castelló;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
12 Castellón/Castelló;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
12 Castellón/Castelló;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
12 Castellón/Castelló;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QI;37.034
12 Castellón/Castelló;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
12 Castellón/Castelló;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
12 Castellón/Castelló;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
12 Castellón/Castelló;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QI;37.747
12 Castellón/Castelló;All ages;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
12 Castellón/Castelló;All ages;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
12 Castellón/Castelló;All ages;Cohort January 1;Total;Survival in the first trimester;2022QII;""
12 Castellón/Castelló;All ages;Cohort January 1;Total;Survival in the first trimester;2022QI;36.503
12 Castellón/Castelló;All ages;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
12 Castellón/Castelló;All ages;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
12 Castellón/Castelló;All ages;Cohort January 1;Total;Survival in the first trimester;2021QII;""
12 Castellón/Castelló;All ages;Cohort January 1;Total;Survival in the first trimester;2021QI;36.056
12 Castellón/Castelló;All ages;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
12 Castellón/Castelló;All ages;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
12 Castellón/Castelló;All ages;Cohort January 1;Total;Survival in the first trimester;2020QII;""
12 Castellón/Castelló;All ages;Cohort January 1;Total;Survival in the first trimester;2020QI;35.457
12 Castellón/Castelló;All ages;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
12 Castellón/Castelló;All ages;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
12 Castellón/Castelló;All ages;Cohort January 1;Total;Survival in the second trimester;2022QII;35.318
12 Castellón/Castelló;All ages;Cohort January 1;Total;Survival in the second trimester;2022QI;""
12 Castellón/Castelló;All ages;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
12 Castellón/Castelló;All ages;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
12 Castellón/Castelló;All ages;Cohort January 1;Total;Survival in the second trimester;2021QII;35.030
12 Castellón/Castelló;All ages;Cohort January 1;Total;Survival in the second trimester;2021QI;""
12 Castellón/Castelló;All ages;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
12 Castellón/Castelló;All ages;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
12 Castellón/Castelló;All ages;Cohort January 1;Total;Survival in the second trimester;2020QII;34.693
12 Castellón/Castelló;All ages;Cohort January 1;Total;Survival in the second trimester;2020QI;""
12 Castellón/Castelló;All ages;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
12 Castellón/Castelló;All ages;Cohort January 1;Total;Survival in the third trimester;2022QIII;34.346
12 Castellón/Castelló;All ages;Cohort January 1;Total;Survival in the third trimester;2022QII;""
12 Castellón/Castelló;All ages;Cohort January 1;Total;Survival in the third trimester;2022QI;""
12 Castellón/Castelló;All ages;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
12 Castellón/Castelló;All ages;Cohort January 1;Total;Survival in the third trimester;2021QIII;34.177
12 Castellón/Castelló;All ages;Cohort January 1;Total;Survival in the third trimester;2021QII;""
12 Castellón/Castelló;All ages;Cohort January 1;Total;Survival in the third trimester;2021QI;""
12 Castellón/Castelló;All ages;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
12 Castellón/Castelló;All ages;Cohort January 1;Total;Survival in the third trimester;2020QIII;33.742
12 Castellón/Castelló;All ages;Cohort January 1;Total;Survival in the third trimester;2020QII;""
12 Castellón/Castelló;All ages;Cohort January 1;Total;Survival in the third trimester;2020QI;""
12 Castellón/Castelló;All ages;Cohort January 1;Total;Survival in the third trimester;2022QIV;33.237
12 Castellón/Castelló;All ages;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
12 Castellón/Castelló;All ages;Cohort January 1;Total;Survival in the third trimester;2022QII;""
12 Castellón/Castelló;All ages;Cohort January 1;Total;Survival in the third trimester;2022QI;""
12 Castellón/Castelló;All ages;Cohort January 1;Total;Survival in the third trimester;2021QIV;33.206
12 Castellón/Castelló;All ages;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
12 Castellón/Castelló;All ages;Cohort January 1;Total;Survival in the third trimester;2021QII;""
12 Castellón/Castelló;All ages;Cohort January 1;Total;Survival in the third trimester;2021QI;""
12 Castellón/Castelló;All ages;Cohort January 1;Total;Survival in the third trimester;2020QIV;32.723
12 Castellón/Castelló;All ages;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
12 Castellón/Castelló;All ages;Cohort January 1;Total;Survival in the third trimester;2020QII;""
12 Castellón/Castelló;All ages;Cohort January 1;Total;Survival in the third trimester;2020QI;""
12 Castellón/Castelló;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
12 Castellón/Castelló;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
12 Castellón/Castelló;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
12 Castellón/Castelló;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
12 Castellón/Castelló;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
12 Castellón/Castelló;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
12 Castellón/Castelló;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
12 Castellón/Castelló;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
12 Castellón/Castelló;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
12 Castellón/Castelló;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
12 Castellón/Castelló;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
12 Castellón/Castelló;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
12 Castellón/Castelló;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
12 Castellón/Castelló;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
12 Castellón/Castelló;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
12 Castellón/Castelló;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;96,98
12 Castellón/Castelló;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
12 Castellón/Castelló;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
12 Castellón/Castelló;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
12 Castellón/Castelló;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;97,36
12 Castellón/Castelló;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
12 Castellón/Castelló;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
12 Castellón/Castelló;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
12 Castellón/Castelló;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;93,93
12 Castellón/Castelló;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
12 Castellón/Castelló;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
12 Castellón/Castelló;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;93,83
12 Castellón/Castelló;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
12 Castellón/Castelló;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
12 Castellón/Castelló;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
12 Castellón/Castelló;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;94,59
12 Castellón/Castelló;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
12 Castellón/Castelló;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
12 Castellón/Castelló;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
12 Castellón/Castelló;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;91,91
12 Castellón/Castelló;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
12 Castellón/Castelló;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
12 Castellón/Castelló;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;91,25
12 Castellón/Castelló;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
12 Castellón/Castelló;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
12 Castellón/Castelló;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
12 Castellón/Castelló;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;92,29
12 Castellón/Castelló;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
12 Castellón/Castelló;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
12 Castellón/Castelló;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
12 Castellón/Castelló;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;89,39
12 Castellón/Castelló;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
12 Castellón/Castelló;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
12 Castellón/Castelló;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;88,3
12 Castellón/Castelló;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
12 Castellón/Castelló;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
12 Castellón/Castelló;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
12 Castellón/Castelló;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;89,66
12 Castellón/Castelló;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
12 Castellón/Castelló;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
12 Castellón/Castelló;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
12 Castellón/Castelló;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;86,69
12 Castellón/Castelló;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
12 Castellón/Castelló;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
12 Castellón/Castelló;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
12 Castellón/Castelló;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
12 Castellón/Castelló;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
12 Castellón/Castelló;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
12 Castellón/Castelló;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QI;22.985
12 Castellón/Castelló;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
12 Castellón/Castelló;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
12 Castellón/Castelló;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
12 Castellón/Castelló;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QI;22.687
12 Castellón/Castelló;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
12 Castellón/Castelló;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
12 Castellón/Castelló;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
12 Castellón/Castelló;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QI;23.099
12 Castellón/Castelló;All ages;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
12 Castellón/Castelló;All ages;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
12 Castellón/Castelló;All ages;Cohort January 1;Males;Survival in the first trimester;2022QII;""
12 Castellón/Castelló;All ages;Cohort January 1;Males;Survival in the first trimester;2022QI;22.342
12 Castellón/Castelló;All ages;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
12 Castellón/Castelló;All ages;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
12 Castellón/Castelló;All ages;Cohort January 1;Males;Survival in the first trimester;2021QII;""
12 Castellón/Castelló;All ages;Cohort January 1;Males;Survival in the first trimester;2021QI;22.081
12 Castellón/Castelló;All ages;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
12 Castellón/Castelló;All ages;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
12 Castellón/Castelló;All ages;Cohort January 1;Males;Survival in the first trimester;2020QII;""
12 Castellón/Castelló;All ages;Cohort January 1;Males;Survival in the first trimester;2020QI;21.827
12 Castellón/Castelló;All ages;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
12 Castellón/Castelló;All ages;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
12 Castellón/Castelló;All ages;Cohort January 1;Males;Survival in the second trimester;2022QII;21.704
12 Castellón/Castelló;All ages;Cohort January 1;Males;Survival in the second trimester;2022QI;""
12 Castellón/Castelló;All ages;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
12 Castellón/Castelló;All ages;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
12 Castellón/Castelló;All ages;Cohort January 1;Males;Survival in the second trimester;2021QII;21.504
12 Castellón/Castelló;All ages;Cohort January 1;Males;Survival in the second trimester;2021QI;""
12 Castellón/Castelló;All ages;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
12 Castellón/Castelló;All ages;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
12 Castellón/Castelló;All ages;Cohort January 1;Males;Survival in the second trimester;2020QII;21.384
12 Castellón/Castelló;All ages;Cohort January 1;Males;Survival in the second trimester;2020QI;""
12 Castellón/Castelló;All ages;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
12 Castellón/Castelló;All ages;Cohort January 1;Males;Survival in the third trimester;2022QIII;21.179
12 Castellón/Castelló;All ages;Cohort January 1;Males;Survival in the third trimester;2022QII;""
12 Castellón/Castelló;All ages;Cohort January 1;Males;Survival in the third trimester;2022QI;""
12 Castellón/Castelló;All ages;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
12 Castellón/Castelló;All ages;Cohort January 1;Males;Survival in the third trimester;2021QIII;21.017
12 Castellón/Castelló;All ages;Cohort January 1;Males;Survival in the third trimester;2021QII;""
12 Castellón/Castelló;All ages;Cohort January 1;Males;Survival in the third trimester;2021QI;""
12 Castellón/Castelló;All ages;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
12 Castellón/Castelló;All ages;Cohort January 1;Males;Survival in the third trimester;2020QIII;20.824
12 Castellón/Castelló;All ages;Cohort January 1;Males;Survival in the third trimester;2020QII;""
12 Castellón/Castelló;All ages;Cohort January 1;Males;Survival in the third trimester;2020QI;""
12 Castellón/Castelló;All ages;Cohort January 1;Males;Survival in the third trimester;2022QIV;20.524
12 Castellón/Castelló;All ages;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
12 Castellón/Castelló;All ages;Cohort January 1;Males;Survival in the third trimester;2022QII;""
12 Castellón/Castelló;All ages;Cohort January 1;Males;Survival in the third trimester;2022QI;""
12 Castellón/Castelló;All ages;Cohort January 1;Males;Survival in the third trimester;2021QIV;20.469
12 Castellón/Castelló;All ages;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
12 Castellón/Castelló;All ages;Cohort January 1;Males;Survival in the third trimester;2021QII;""
12 Castellón/Castelló;All ages;Cohort January 1;Males;Survival in the third trimester;2021QI;""
12 Castellón/Castelló;All ages;Cohort January 1;Males;Survival in the third trimester;2020QIV;20.243
12 Castellón/Castelló;All ages;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
12 Castellón/Castelló;All ages;Cohort January 1;Males;Survival in the third trimester;2020QII;""
12 Castellón/Castelló;All ages;Cohort January 1;Males;Survival in the third trimester;2020QI;""
12 Castellón/Castelló;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
12 Castellón/Castelló;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
12 Castellón/Castelló;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
12 Castellón/Castelló;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
12 Castellón/Castelló;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
12 Castellón/Castelló;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
12 Castellón/Castelló;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
12 Castellón/Castelló;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
12 Castellón/Castelló;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
12 Castellón/Castelló;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
12 Castellón/Castelló;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
12 Castellón/Castelló;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
12 Castellón/Castelló;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
12 Castellón/Castelló;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
12 Castellón/Castelló;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
12 Castellón/Castelló;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;97,2
12 Castellón/Castelló;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
12 Castellón/Castelló;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
12 Castellón/Castelló;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
12 Castellón/Castelló;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;97,33
12 Castellón/Castelló;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
12 Castellón/Castelló;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
12 Castellón/Castelló;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
12 Castellón/Castelló;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;94,49
12 Castellón/Castelló;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
12 Castellón/Castelló;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
12 Castellón/Castelló;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;94,43
12 Castellón/Castelló;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
12 Castellón/Castelló;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
12 Castellón/Castelló;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
12 Castellón/Castelló;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;94,79
12 Castellón/Castelló;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
12 Castellón/Castelló;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
12 Castellón/Castelló;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
12 Castellón/Castelló;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;92,58
12 Castellón/Castelló;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
12 Castellón/Castelló;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
12 Castellón/Castelló;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;92,14
12 Castellón/Castelló;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
12 Castellón/Castelló;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
12 Castellón/Castelló;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
12 Castellón/Castelló;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;92,64
12 Castellón/Castelló;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
12 Castellón/Castelló;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
12 Castellón/Castelló;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
12 Castellón/Castelló;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;90,15
12 Castellón/Castelló;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
12 Castellón/Castelló;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
12 Castellón/Castelló;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;89,29
12 Castellón/Castelló;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
12 Castellón/Castelló;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
12 Castellón/Castelló;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
12 Castellón/Castelló;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;90,22
12 Castellón/Castelló;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
12 Castellón/Castelló;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
12 Castellón/Castelló;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
12 Castellón/Castelló;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;87,64
12 Castellón/Castelló;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
12 Castellón/Castelló;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
12 Castellón/Castelló;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
12 Castellón/Castelló;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
12 Castellón/Castelló;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
12 Castellón/Castelló;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
12 Castellón/Castelló;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QI;14.655
12 Castellón/Castelló;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
12 Castellón/Castelló;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
12 Castellón/Castelló;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
12 Castellón/Castelló;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QI;14.347
12 Castellón/Castelló;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
12 Castellón/Castelló;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
12 Castellón/Castelló;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
12 Castellón/Castelló;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QI;14.648
12 Castellón/Castelló;All ages;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
12 Castellón/Castelló;All ages;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
12 Castellón/Castelló;All ages;Cohort January 1;Females;Survival in the first trimester;2022QII;""
12 Castellón/Castelló;All ages;Cohort January 1;Females;Survival in the first trimester;2022QI;14.161
12 Castellón/Castelló;All ages;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
12 Castellón/Castelló;All ages;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
12 Castellón/Castelló;All ages;Cohort January 1;Females;Survival in the first trimester;2021QII;""
12 Castellón/Castelló;All ages;Cohort January 1;Females;Survival in the first trimester;2021QI;13.975
12 Castellón/Castelló;All ages;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
12 Castellón/Castelló;All ages;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
12 Castellón/Castelló;All ages;Cohort January 1;Females;Survival in the first trimester;2020QII;""
12 Castellón/Castelló;All ages;Cohort January 1;Females;Survival in the first trimester;2020QI;13.630
12 Castellón/Castelló;All ages;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
12 Castellón/Castelló;All ages;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
12 Castellón/Castelló;All ages;Cohort January 1;Females;Survival in the second trimester;2022QII;13.614
12 Castellón/Castelló;All ages;Cohort January 1;Females;Survival in the second trimester;2022QI;""
12 Castellón/Castelló;All ages;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
12 Castellón/Castelló;All ages;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
12 Castellón/Castelló;All ages;Cohort January 1;Females;Survival in the second trimester;2021QII;13.526
12 Castellón/Castelló;All ages;Cohort January 1;Females;Survival in the second trimester;2021QI;""
12 Castellón/Castelló;All ages;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
12 Castellón/Castelló;All ages;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
12 Castellón/Castelló;All ages;Cohort January 1;Females;Survival in the second trimester;2020QII;13.309
12 Castellón/Castelló;All ages;Cohort January 1;Females;Survival in the second trimester;2020QI;""
12 Castellón/Castelló;All ages;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
12 Castellón/Castelló;All ages;Cohort January 1;Females;Survival in the third trimester;2022QIII;13.167
12 Castellón/Castelló;All ages;Cohort January 1;Females;Survival in the third trimester;2022QII;""
12 Castellón/Castelló;All ages;Cohort January 1;Females;Survival in the third trimester;2022QI;""
12 Castellón/Castelló;All ages;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
12 Castellón/Castelló;All ages;Cohort January 1;Females;Survival in the third trimester;2021QIII;13.160
12 Castellón/Castelló;All ages;Cohort January 1;Females;Survival in the third trimester;2021QII;""
12 Castellón/Castelló;All ages;Cohort January 1;Females;Survival in the third trimester;2021QI;""
12 Castellón/Castelló;All ages;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
12 Castellón/Castelló;All ages;Cohort January 1;Females;Survival in the third trimester;2020QIII;12.918
12 Castellón/Castelló;All ages;Cohort January 1;Females;Survival in the third trimester;2020QII;""
12 Castellón/Castelló;All ages;Cohort January 1;Females;Survival in the third trimester;2020QI;""
12 Castellón/Castelló;All ages;Cohort January 1;Females;Survival in the third trimester;2022QIV;12.713
12 Castellón/Castelló;All ages;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
12 Castellón/Castelló;All ages;Cohort January 1;Females;Survival in the third trimester;2022QII;""
12 Castellón/Castelló;All ages;Cohort January 1;Females;Survival in the third trimester;2022QI;""
12 Castellón/Castelló;All ages;Cohort January 1;Females;Survival in the third trimester;2021QIV;12.737
12 Castellón/Castelló;All ages;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
12 Castellón/Castelló;All ages;Cohort January 1;Females;Survival in the third trimester;2021QII;""
12 Castellón/Castelló;All ages;Cohort January 1;Females;Survival in the third trimester;2021QI;""
12 Castellón/Castelló;All ages;Cohort January 1;Females;Survival in the third trimester;2020QIV;12.480
12 Castellón/Castelló;All ages;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
12 Castellón/Castelló;All ages;Cohort January 1;Females;Survival in the third trimester;2020QII;""
12 Castellón/Castelló;All ages;Cohort January 1;Females;Survival in the third trimester;2020QI;""
12 Castellón/Castelló;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
12 Castellón/Castelló;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
12 Castellón/Castelló;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
12 Castellón/Castelló;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
12 Castellón/Castelló;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
12 Castellón/Castelló;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
12 Castellón/Castelló;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
12 Castellón/Castelló;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
12 Castellón/Castelló;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
12 Castellón/Castelló;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
12 Castellón/Castelló;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
12 Castellón/Castelló;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
12 Castellón/Castelló;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
12 Castellón/Castelló;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
12 Castellón/Castelló;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
12 Castellón/Castelló;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;96,63
12 Castellón/Castelló;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
12 Castellón/Castelló;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
12 Castellón/Castelló;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
12 Castellón/Castelló;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;97,41
12 Castellón/Castelló;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
12 Castellón/Castelló;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
12 Castellón/Castelló;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
12 Castellón/Castelló;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;93,05
12 Castellón/Castelló;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
12 Castellón/Castelló;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
12 Castellón/Castelló;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;92,9
12 Castellón/Castelló;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
12 Castellón/Castelló;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
12 Castellón/Castelló;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
12 Castellón/Castelló;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;94,28
12 Castellón/Castelló;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
12 Castellón/Castelló;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
12 Castellón/Castelló;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
12 Castellón/Castelló;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;90,86
12 Castellón/Castelló;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
12 Castellón/Castelló;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
12 Castellón/Castelló;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;89,85
12 Castellón/Castelló;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
12 Castellón/Castelló;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
12 Castellón/Castelló;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
12 Castellón/Castelló;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;91,73
12 Castellón/Castelló;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
12 Castellón/Castelló;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
12 Castellón/Castelló;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
12 Castellón/Castelló;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;88,19
12 Castellón/Castelló;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
12 Castellón/Castelló;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
12 Castellón/Castelló;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;86,75
12 Castellón/Castelló;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
12 Castellón/Castelló;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
12 Castellón/Castelló;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
12 Castellón/Castelló;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;88,78
12 Castellón/Castelló;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
12 Castellón/Castelló;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
12 Castellón/Castelló;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
12 Castellón/Castelló;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;85,2
12 Castellón/Castelló;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
12 Castellón/Castelló;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
12 Castellón/Castelló;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
12 Castellón/Castelló;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
12 Castellón/Castelló;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
12 Castellón/Castelló;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QII;37.876
12 Castellón/Castelló;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
12 Castellón/Castelló;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
12 Castellón/Castelló;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
12 Castellón/Castelló;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QII;37.390
12 Castellón/Castelló;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
12 Castellón/Castelló;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
12 Castellón/Castelló;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
12 Castellón/Castelló;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QII;36.983
12 Castellón/Castelló;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
12 Castellón/Castelló;All ages;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
12 Castellón/Castelló;All ages;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
12 Castellón/Castelló;All ages;Cohort April 1;Total;Survival in the first trimester;2022QII;36.573
12 Castellón/Castelló;All ages;Cohort April 1;Total;Survival in the first trimester;2022QI;""
12 Castellón/Castelló;All ages;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
12 Castellón/Castelló;All ages;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
12 Castellón/Castelló;All ages;Cohort April 1;Total;Survival in the first trimester;2021QII;36.266
12 Castellón/Castelló;All ages;Cohort April 1;Total;Survival in the first trimester;2021QI;""
12 Castellón/Castelló;All ages;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
12 Castellón/Castelló;All ages;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
12 Castellón/Castelló;All ages;Cohort April 1;Total;Survival in the first trimester;2020QII;36.157
12 Castellón/Castelló;All ages;Cohort April 1;Total;Survival in the first trimester;2020QI;""
12 Castellón/Castelló;All ages;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
12 Castellón/Castelló;All ages;Cohort April 1;Total;Survival in the second trimester;2022QIII;35.495
12 Castellón/Castelló;All ages;Cohort April 1;Total;Survival in the second trimester;2022QII;""
12 Castellón/Castelló;All ages;Cohort April 1;Total;Survival in the second trimester;2022QI;""
12 Castellón/Castelló;All ages;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
12 Castellón/Castelló;All ages;Cohort April 1;Total;Survival in the second trimester;2021QIII;35.321
12 Castellón/Castelló;All ages;Cohort April 1;Total;Survival in the second trimester;2021QII;""
12 Castellón/Castelló;All ages;Cohort April 1;Total;Survival in the second trimester;2021QI;""
12 Castellón/Castelló;All ages;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
12 Castellón/Castelló;All ages;Cohort April 1;Total;Survival in the second trimester;2020QIII;35.058
12 Castellón/Castelló;All ages;Cohort April 1;Total;Survival in the second trimester;2020QII;""
12 Castellón/Castelló;All ages;Cohort April 1;Total;Survival in the second trimester;2020QI;""
12 Castellón/Castelló;All ages;Cohort April 1;Total;Survival in the third trimester;2022QIV;34.245
12 Castellón/Castelló;All ages;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
12 Castellón/Castelló;All ages;Cohort April 1;Total;Survival in the third trimester;2022QII;""
12 Castellón/Castelló;All ages;Cohort April 1;Total;Survival in the third trimester;2022QI;""
12 Castellón/Castelló;All ages;Cohort April 1;Total;Survival in the third trimester;2021QIV;34.208
12 Castellón/Castelló;All ages;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
12 Castellón/Castelló;All ages;Cohort April 1;Total;Survival in the third trimester;2021QII;""
12 Castellón/Castelló;All ages;Cohort April 1;Total;Survival in the third trimester;2021QI;""
12 Castellón/Castelló;All ages;Cohort April 1;Total;Survival in the third trimester;2020QIV;33.914
12 Castellón/Castelló;All ages;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
12 Castellón/Castelló;All ages;Cohort April 1;Total;Survival in the third trimester;2020QII;""
12 Castellón/Castelló;All ages;Cohort April 1;Total;Survival in the third trimester;2020QI;""
12 Castellón/Castelló;All ages;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
12 Castellón/Castelló;All ages;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
12 Castellón/Castelló;All ages;Cohort April 1;Total;Survival in the third trimester;2022QII;""
12 Castellón/Castelló;All ages;Cohort April 1;Total;Survival in the third trimester;2022QI;33.379
12 Castellón/Castelló;All ages;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
12 Castellón/Castelló;All ages;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
12 Castellón/Castelló;All ages;Cohort April 1;Total;Survival in the third trimester;2021QII;""
12 Castellón/Castelló;All ages;Cohort April 1;Total;Survival in the third trimester;2021QI;33.221
12 Castellón/Castelló;All ages;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
12 Castellón/Castelló;All ages;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
12 Castellón/Castelló;All ages;Cohort April 1;Total;Survival in the third trimester;2020QII;""
12 Castellón/Castelló;All ages;Cohort April 1;Total;Survival in the third trimester;2020QI;""
12 Castellón/Castelló;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
12 Castellón/Castelló;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
12 Castellón/Castelló;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
12 Castellón/Castelló;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
12 Castellón/Castelló;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
12 Castellón/Castelló;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
12 Castellón/Castelló;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
12 Castellón/Castelló;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
12 Castellón/Castelló;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
12 Castellón/Castelló;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
12 Castellón/Castelló;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
12 Castellón/Castelló;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
12 Castellón/Castelló;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
12 Castellón/Castelló;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
12 Castellón/Castelló;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;96,56
12 Castellón/Castelló;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
12 Castellón/Castelló;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
12 Castellón/Castelló;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
12 Castellón/Castelló;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;96,99
12 Castellón/Castelló;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
12 Castellón/Castelló;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
12 Castellón/Castelló;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
12 Castellón/Castelló;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;97,77
12 Castellón/Castelló;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
12 Castellón/Castelló;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
12 Castellón/Castelló;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;93,71
12 Castellón/Castelló;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
12 Castellón/Castelló;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
12 Castellón/Castelló;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
12 Castellón/Castelló;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;94,47
12 Castellón/Castelló;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
12 Castellón/Castelló;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
12 Castellón/Castelló;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
12 Castellón/Castelló;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;94,79
12 Castellón/Castelló;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
12 Castellón/Castelló;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
12 Castellón/Castelló;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;90,41
12 Castellón/Castelló;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
12 Castellón/Castelló;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
12 Castellón/Castelló;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
12 Castellón/Castelló;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;91,49
12 Castellón/Castelló;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
12 Castellón/Castelló;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
12 Castellón/Castelló;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
12 Castellón/Castelló;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;91,7
12 Castellón/Castelló;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
12 Castellón/Castelló;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
12 Castellón/Castelló;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
12 Castellón/Castelló;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
12 Castellón/Castelló;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
12 Castellón/Castelló;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
12 Castellón/Castelló;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;89,27
12 Castellón/Castelló;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
12 Castellón/Castelló;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
12 Castellón/Castelló;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
12 Castellón/Castelló;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;89,83
12 Castellón/Castelló;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
12 Castellón/Castelló;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
12 Castellón/Castelló;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
12 Castellón/Castelló;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
12 Castellón/Castelló;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
12 Castellón/Castelló;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
12 Castellón/Castelló;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QII;23.113
12 Castellón/Castelló;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
12 Castellón/Castelló;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
12 Castellón/Castelló;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
12 Castellón/Castelló;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QII;22.866
12 Castellón/Castelló;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
12 Castellón/Castelló;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
12 Castellón/Castelló;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
12 Castellón/Castelló;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QII;22.641
12 Castellón/Castelló;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
12 Castellón/Castelló;All ages;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
12 Castellón/Castelló;All ages;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
12 Castellón/Castelló;All ages;Cohort April 1;Males;Survival in the first trimester;2022QII;22.409
12 Castellón/Castelló;All ages;Cohort April 1;Males;Survival in the first trimester;2022QI;""
12 Castellón/Castelló;All ages;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
12 Castellón/Castelló;All ages;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
12 Castellón/Castelló;All ages;Cohort April 1;Males;Survival in the first trimester;2021QII;22.224
12 Castellón/Castelló;All ages;Cohort April 1;Males;Survival in the first trimester;2021QI;""
12 Castellón/Castelló;All ages;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
12 Castellón/Castelló;All ages;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
12 Castellón/Castelló;All ages;Cohort April 1;Males;Survival in the first trimester;2020QII;22.158
12 Castellón/Castelló;All ages;Cohort April 1;Males;Survival in the first trimester;2020QI;""
12 Castellón/Castelló;All ages;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
12 Castellón/Castelló;All ages;Cohort April 1;Males;Survival in the second trimester;2022QIII;21.821
12 Castellón/Castelló;All ages;Cohort April 1;Males;Survival in the second trimester;2022QII;""
12 Castellón/Castelló;All ages;Cohort April 1;Males;Survival in the second trimester;2022QI;""
12 Castellón/Castelló;All ages;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
12 Castellón/Castelló;All ages;Cohort April 1;Males;Survival in the second trimester;2021QIII;21.673
12 Castellón/Castelló;All ages;Cohort April 1;Males;Survival in the second trimester;2021QII;""
12 Castellón/Castelló;All ages;Cohort April 1;Males;Survival in the second trimester;2021QI;""
12 Castellón/Castelló;All ages;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
12 Castellón/Castelló;All ages;Cohort April 1;Males;Survival in the second trimester;2020QIII;21.516
12 Castellón/Castelló;All ages;Cohort April 1;Males;Survival in the second trimester;2020QII;""
12 Castellón/Castelló;All ages;Cohort April 1;Males;Survival in the second trimester;2020QI;""
12 Castellón/Castelló;All ages;Cohort April 1;Males;Survival in the third trimester;2022QIV;21.090
12 Castellón/Castelló;All ages;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
12 Castellón/Castelló;All ages;Cohort April 1;Males;Survival in the third trimester;2022QII;""
12 Castellón/Castelló;All ages;Cohort April 1;Males;Survival in the third trimester;2022QI;""
12 Castellón/Castelló;All ages;Cohort April 1;Males;Survival in the third trimester;2021QIV;21.047
12 Castellón/Castelló;All ages;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
12 Castellón/Castelló;All ages;Cohort April 1;Males;Survival in the third trimester;2021QII;""
12 Castellón/Castelló;All ages;Cohort April 1;Males;Survival in the third trimester;2021QI;""
12 Castellón/Castelló;All ages;Cohort April 1;Males;Survival in the third trimester;2020QIV;20.866
12 Castellón/Castelló;All ages;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
12 Castellón/Castelló;All ages;Cohort April 1;Males;Survival in the third trimester;2020QII;""
12 Castellón/Castelló;All ages;Cohort April 1;Males;Survival in the third trimester;2020QI;""
12 Castellón/Castelló;All ages;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
12 Castellón/Castelló;All ages;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
12 Castellón/Castelló;All ages;Cohort April 1;Males;Survival in the third trimester;2022QII;""
12 Castellón/Castelló;All ages;Cohort April 1;Males;Survival in the third trimester;2022QI;20.572
12 Castellón/Castelló;All ages;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
12 Castellón/Castelló;All ages;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
12 Castellón/Castelló;All ages;Cohort April 1;Males;Survival in the third trimester;2021QII;""
12 Castellón/Castelló;All ages;Cohort April 1;Males;Survival in the third trimester;2021QI;20.458
12 Castellón/Castelló;All ages;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
12 Castellón/Castelló;All ages;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
12 Castellón/Castelló;All ages;Cohort April 1;Males;Survival in the third trimester;2020QII;""
12 Castellón/Castelló;All ages;Cohort April 1;Males;Survival in the third trimester;2020QI;""
12 Castellón/Castelló;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
12 Castellón/Castelló;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
12 Castellón/Castelló;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
12 Castellón/Castelló;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
12 Castellón/Castelló;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
12 Castellón/Castelló;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
12 Castellón/Castelló;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
12 Castellón/Castelló;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
12 Castellón/Castelló;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
12 Castellón/Castelló;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
12 Castellón/Castelló;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
12 Castellón/Castelló;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
12 Castellón/Castelló;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
12 Castellón/Castelló;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
12 Castellón/Castelló;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;96,95
12 Castellón/Castelló;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
12 Castellón/Castelló;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
12 Castellón/Castelló;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
12 Castellón/Castelló;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;97,19
12 Castellón/Castelló;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
12 Castellón/Castelló;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
12 Castellón/Castelló;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
12 Castellón/Castelló;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;97,87
12 Castellón/Castelló;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
12 Castellón/Castelló;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
12 Castellón/Castelló;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;94,41
12 Castellón/Castelló;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
12 Castellón/Castelló;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
12 Castellón/Castelló;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
12 Castellón/Castelló;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;94,78
12 Castellón/Castelló;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
12 Castellón/Castelló;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
12 Castellón/Castelló;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
12 Castellón/Castelló;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;95,03
12 Castellón/Castelló;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
12 Castellón/Castelló;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
12 Castellón/Castelló;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;91,25
12 Castellón/Castelló;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
12 Castellón/Castelló;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
12 Castellón/Castelló;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
12 Castellón/Castelló;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;92,04
12 Castellón/Castelló;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
12 Castellón/Castelló;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
12 Castellón/Castelló;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
12 Castellón/Castelló;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;92,16
12 Castellón/Castelló;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
12 Castellón/Castelló;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
12 Castellón/Castelló;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
12 Castellón/Castelló;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
12 Castellón/Castelló;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
12 Castellón/Castelló;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
12 Castellón/Castelló;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;89,97
12 Castellón/Castelló;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
12 Castellón/Castelló;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
12 Castellón/Castelló;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
12 Castellón/Castelló;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;90,36
12 Castellón/Castelló;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
12 Castellón/Castelló;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
12 Castellón/Castelló;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
12 Castellón/Castelló;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
12 Castellón/Castelló;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
12 Castellón/Castelló;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
12 Castellón/Castelló;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QII;14.763
12 Castellón/Castelló;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
12 Castellón/Castelló;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
12 Castellón/Castelló;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
12 Castellón/Castelló;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QII;14.524
12 Castellón/Castelló;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
12 Castellón/Castelló;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
12 Castellón/Castelló;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
12 Castellón/Castelló;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QII;14.342
12 Castellón/Castelló;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
12 Castellón/Castelló;All ages;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
12 Castellón/Castelló;All ages;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
12 Castellón/Castelló;All ages;Cohort April 1;Females;Survival in the first trimester;2022QII;14.164
12 Castellón/Castelló;All ages;Cohort April 1;Females;Survival in the first trimester;2022QI;""
12 Castellón/Castelló;All ages;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
12 Castellón/Castelló;All ages;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
12 Castellón/Castelló;All ages;Cohort April 1;Females;Survival in the first trimester;2021QII;14.042
12 Castellón/Castelló;All ages;Cohort April 1;Females;Survival in the first trimester;2021QI;""
12 Castellón/Castelló;All ages;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
12 Castellón/Castelló;All ages;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
12 Castellón/Castelló;All ages;Cohort April 1;Females;Survival in the first trimester;2020QII;13.999
12 Castellón/Castelló;All ages;Cohort April 1;Females;Survival in the first trimester;2020QI;""
12 Castellón/Castelló;All ages;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
12 Castellón/Castelló;All ages;Cohort April 1;Females;Survival in the second trimester;2022QIII;13.674
12 Castellón/Castelló;All ages;Cohort April 1;Females;Survival in the second trimester;2022QII;""
12 Castellón/Castelló;All ages;Cohort April 1;Females;Survival in the second trimester;2022QI;""
12 Castellón/Castelló;All ages;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
12 Castellón/Castelló;All ages;Cohort April 1;Females;Survival in the second trimester;2021QIII;13.648
12 Castellón/Castelló;All ages;Cohort April 1;Females;Survival in the second trimester;2021QII;""
12 Castellón/Castelló;All ages;Cohort April 1;Females;Survival in the second trimester;2021QI;""
12 Castellón/Castelló;All ages;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
12 Castellón/Castelló;All ages;Cohort April 1;Females;Survival in the second trimester;2020QIII;13.542
12 Castellón/Castelló;All ages;Cohort April 1;Females;Survival in the second trimester;2020QII;""
12 Castellón/Castelló;All ages;Cohort April 1;Females;Survival in the second trimester;2020QI;""
12 Castellón/Castelló;All ages;Cohort April 1;Females;Survival in the third trimester;2022QIV;13.155
12 Castellón/Castelló;All ages;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
12 Castellón/Castelló;All ages;Cohort April 1;Females;Survival in the third trimester;2022QII;""
12 Castellón/Castelló;All ages;Cohort April 1;Females;Survival in the third trimester;2022QI;""
12 Castellón/Castelló;All ages;Cohort April 1;Females;Survival in the third trimester;2021QIV;13.161
12 Castellón/Castelló;All ages;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
12 Castellón/Castelló;All ages;Cohort April 1;Females;Survival in the third trimester;2021QII;""
12 Castellón/Castelló;All ages;Cohort April 1;Females;Survival in the third trimester;2021QI;""
12 Castellón/Castelló;All ages;Cohort April 1;Females;Survival in the third trimester;2020QIV;13.048
12 Castellón/Castelló;All ages;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
12 Castellón/Castelló;All ages;Cohort April 1;Females;Survival in the third trimester;2020QII;""
12 Castellón/Castelló;All ages;Cohort April 1;Females;Survival in the third trimester;2020QI;""
12 Castellón/Castelló;All ages;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
12 Castellón/Castelló;All ages;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
12 Castellón/Castelló;All ages;Cohort April 1;Females;Survival in the third trimester;2022QII;""
12 Castellón/Castelló;All ages;Cohort April 1;Females;Survival in the third trimester;2022QI;12.807
12 Castellón/Castelló;All ages;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
12 Castellón/Castelló;All ages;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
12 Castellón/Castelló;All ages;Cohort April 1;Females;Survival in the third trimester;2021QII;""
12 Castellón/Castelló;All ages;Cohort April 1;Females;Survival in the third trimester;2021QI;12.763
12 Castellón/Castelló;All ages;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
12 Castellón/Castelló;All ages;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
12 Castellón/Castelló;All ages;Cohort April 1;Females;Survival in the third trimester;2020QII;""
12 Castellón/Castelló;All ages;Cohort April 1;Females;Survival in the third trimester;2020QI;""
12 Castellón/Castelló;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
12 Castellón/Castelló;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
12 Castellón/Castelló;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
12 Castellón/Castelló;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
12 Castellón/Castelló;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
12 Castellón/Castelló;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
12 Castellón/Castelló;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
12 Castellón/Castelló;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
12 Castellón/Castelló;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
12 Castellón/Castelló;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
12 Castellón/Castelló;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
12 Castellón/Castelló;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
12 Castellón/Castelló;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
12 Castellón/Castelló;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
12 Castellón/Castelló;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;95,94
12 Castellón/Castelló;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
12 Castellón/Castelló;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
12 Castellón/Castelló;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
12 Castellón/Castelló;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;96,68
12 Castellón/Castelló;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
12 Castellón/Castelló;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
12 Castellón/Castelló;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
12 Castellón/Castelló;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;97,61
12 Castellón/Castelló;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
12 Castellón/Castelló;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
12 Castellón/Castelló;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;92,62
12 Castellón/Castelló;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
12 Castellón/Castelló;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
12 Castellón/Castelló;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
12 Castellón/Castelló;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;93,97
12 Castellón/Castelló;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
12 Castellón/Castelló;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
12 Castellón/Castelló;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
12 Castellón/Castelló;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;94,42
12 Castellón/Castelló;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
12 Castellón/Castelló;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
12 Castellón/Castelló;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;89,11
12 Castellón/Castelló;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
12 Castellón/Castelló;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
12 Castellón/Castelló;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
12 Castellón/Castelló;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;90,62
12 Castellón/Castelló;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
12 Castellón/Castelló;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
12 Castellón/Castelló;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
12 Castellón/Castelló;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;90,98
12 Castellón/Castelló;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
12 Castellón/Castelló;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
12 Castellón/Castelló;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
12 Castellón/Castelló;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
12 Castellón/Castelló;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
12 Castellón/Castelló;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
12 Castellón/Castelló;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;88,18
12 Castellón/Castelló;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
12 Castellón/Castelló;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
12 Castellón/Castelló;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
12 Castellón/Castelló;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;88,99
12 Castellón/Castelló;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
12 Castellón/Castelló;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
12 Castellón/Castelló;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
12 Castellón/Castelló;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
12 Castellón/Castelló;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
12 Castellón/Castelló;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QIII;38.153
12 Castellón/Castelló;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
12 Castellón/Castelló;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
12 Castellón/Castelló;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
12 Castellón/Castelló;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QIII;37.973
12 Castellón/Castelló;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
12 Castellón/Castelló;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
12 Castellón/Castelló;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
12 Castellón/Castelló;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QIII;37.381
12 Castellón/Castelló;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
12 Castellón/Castelló;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
12 Castellón/Castelló;All ages;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
12 Castellón/Castelló;All ages;Cohort July 1;Total;Survival in the first trimester;2022QIII;36.687
12 Castellón/Castelló;All ages;Cohort July 1;Total;Survival in the first trimester;2022QII;""
12 Castellón/Castelló;All ages;Cohort July 1;Total;Survival in the first trimester;2022QI;""
12 Castellón/Castelló;All ages;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
12 Castellón/Castelló;All ages;Cohort July 1;Total;Survival in the first trimester;2021QIII;36.689
12 Castellón/Castelló;All ages;Cohort July 1;Total;Survival in the first trimester;2021QII;""
12 Castellón/Castelló;All ages;Cohort July 1;Total;Survival in the first trimester;2021QI;""
12 Castellón/Castelló;All ages;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
12 Castellón/Castelló;All ages;Cohort July 1;Total;Survival in the first trimester;2020QIII;36.000
12 Castellón/Castelló;All ages;Cohort July 1;Total;Survival in the first trimester;2020QII;""
12 Castellón/Castelló;All ages;Cohort July 1;Total;Survival in the first trimester;2020QI;""
12 Castellón/Castelló;All ages;Cohort July 1;Total;Survival in the second trimester;2022QIV;35.201
12 Castellón/Castelló;All ages;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
12 Castellón/Castelló;All ages;Cohort July 1;Total;Survival in the second trimester;2022QII;""
12 Castellón/Castelló;All ages;Cohort July 1;Total;Survival in the second trimester;2022QI;""
12 Castellón/Castelló;All ages;Cohort July 1;Total;Survival in the second trimester;2021QIV;35.335
12 Castellón/Castelló;All ages;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
12 Castellón/Castelló;All ages;Cohort July 1;Total;Survival in the second trimester;2021QII;""
12 Castellón/Castelló;All ages;Cohort July 1;Total;Survival in the second trimester;2021QI;""
12 Castellón/Castelló;All ages;Cohort July 1;Total;Survival in the second trimester;2020QIV;34.692
12 Castellón/Castelló;All ages;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
12 Castellón/Castelló;All ages;Cohort July 1;Total;Survival in the second trimester;2020QII;""
12 Castellón/Castelló;All ages;Cohort July 1;Total;Survival in the second trimester;2020QI;""
12 Castellón/Castelló;All ages;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
12 Castellón/Castelló;All ages;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
12 Castellón/Castelló;All ages;Cohort July 1;Total;Survival in the third trimester;2022QII;""
12 Castellón/Castelló;All ages;Cohort July 1;Total;Survival in the third trimester;2022QI;34.414
12 Castellón/Castelló;All ages;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
12 Castellón/Castelló;All ages;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
12 Castellón/Castelló;All ages;Cohort July 1;Total;Survival in the third trimester;2021QII;""
12 Castellón/Castelló;All ages;Cohort July 1;Total;Survival in the third trimester;2021QI;33.946
12 Castellón/Castelló;All ages;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
12 Castellón/Castelló;All ages;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
12 Castellón/Castelló;All ages;Cohort July 1;Total;Survival in the third trimester;2020QII;""
12 Castellón/Castelló;All ages;Cohort July 1;Total;Survival in the third trimester;2020QI;""
12 Castellón/Castelló;All ages;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
12 Castellón/Castelló;All ages;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
12 Castellón/Castelló;All ages;Cohort July 1;Total;Survival in the third trimester;2022QII;33.478
12 Castellón/Castelló;All ages;Cohort July 1;Total;Survival in the third trimester;2022QI;""
12 Castellón/Castelló;All ages;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
12 Castellón/Castelló;All ages;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
12 Castellón/Castelló;All ages;Cohort July 1;Total;Survival in the third trimester;2021QII;33.140
12 Castellón/Castelló;All ages;Cohort July 1;Total;Survival in the third trimester;2021QI;""
12 Castellón/Castelló;All ages;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
12 Castellón/Castelló;All ages;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
12 Castellón/Castelló;All ages;Cohort July 1;Total;Survival in the third trimester;2020QII;""
12 Castellón/Castelló;All ages;Cohort July 1;Total;Survival in the third trimester;2020QI;""
12 Castellón/Castelló;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
12 Castellón/Castelló;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
12 Castellón/Castelló;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
12 Castellón/Castelló;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
12 Castellón/Castelló;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
12 Castellón/Castelló;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
12 Castellón/Castelló;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
12 Castellón/Castelló;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
12 Castellón/Castelló;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
12 Castellón/Castelló;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
12 Castellón/Castelló;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
12 Castellón/Castelló;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
12 Castellón/Castelló;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
12 Castellón/Castelló;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;96,16
12 Castellón/Castelló;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
12 Castellón/Castelló;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
12 Castellón/Castelló;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
12 Castellón/Castelló;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;96,62
12 Castellón/Castelló;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
12 Castellón/Castelló;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
12 Castellón/Castelló;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
12 Castellón/Castelló;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;96,31
12 Castellón/Castelló;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
12 Castellón/Castelló;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
12 Castellón/Castelló;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;92,26
12 Castellón/Castelló;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
12 Castellón/Castelló;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
12 Castellón/Castelló;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
12 Castellón/Castelló;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;93,05
12 Castellón/Castelló;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
12 Castellón/Castelló;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
12 Castellón/Castelló;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
12 Castellón/Castelló;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;92,81
12 Castellón/Castelló;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
12 Castellón/Castelló;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
12 Castellón/Castelló;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
12 Castellón/Castelló;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
12 Castellón/Castelló;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
12 Castellón/Castelló;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
12 Castellón/Castelló;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;90,63
12 Castellón/Castelló;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
12 Castellón/Castelló;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
12 Castellón/Castelló;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
12 Castellón/Castelló;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;90,81
12 Castellón/Castelló;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
12 Castellón/Castelló;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
12 Castellón/Castelló;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
12 Castellón/Castelló;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
12 Castellón/Castelló;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
12 Castellón/Castelló;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
12 Castellón/Castelló;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;88,16
12 Castellón/Castelló;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
12 Castellón/Castelló;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
12 Castellón/Castelló;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
12 Castellón/Castelló;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;88,65
12 Castellón/Castelló;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
12 Castellón/Castelló;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
12 Castellón/Castelló;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
12 Castellón/Castelló;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
12 Castellón/Castelló;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
12 Castellón/Castelló;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
12 Castellón/Castelló;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QIII;23.263
12 Castellón/Castelló;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
12 Castellón/Castelló;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
12 Castellón/Castelló;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
12 Castellón/Castelló;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QIII;23.133
12 Castellón/Castelló;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
12 Castellón/Castelló;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
12 Castellón/Castelló;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
12 Castellón/Castelló;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QIII;22.857
12 Castellón/Castelló;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
12 Castellón/Castelló;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
12 Castellón/Castelló;All ages;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
12 Castellón/Castelló;All ages;Cohort July 1;Males;Survival in the first trimester;2022QIII;22.469
12 Castellón/Castelló;All ages;Cohort July 1;Males;Survival in the first trimester;2022QII;""
12 Castellón/Castelló;All ages;Cohort July 1;Males;Survival in the first trimester;2022QI;""
12 Castellón/Castelló;All ages;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
12 Castellón/Castelló;All ages;Cohort July 1;Males;Survival in the first trimester;2021QIII;22.406
12 Castellón/Castelló;All ages;Cohort July 1;Males;Survival in the first trimester;2021QII;""
12 Castellón/Castelló;All ages;Cohort July 1;Males;Survival in the first trimester;2021QI;""
12 Castellón/Castelló;All ages;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
12 Castellón/Castelló;All ages;Cohort July 1;Males;Survival in the first trimester;2020QIII;22.052
12 Castellón/Castelló;All ages;Cohort July 1;Males;Survival in the first trimester;2020QII;""
12 Castellón/Castelló;All ages;Cohort July 1;Males;Survival in the first trimester;2020QI;""
12 Castellón/Castelló;All ages;Cohort July 1;Males;Survival in the second trimester;2022QIV;21.622
12 Castellón/Castelló;All ages;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
12 Castellón/Castelló;All ages;Cohort July 1;Males;Survival in the second trimester;2022QII;""
12 Castellón/Castelló;All ages;Cohort July 1;Males;Survival in the second trimester;2022QI;""
12 Castellón/Castelló;All ages;Cohort July 1;Males;Survival in the second trimester;2021QIV;21.659
12 Castellón/Castelló;All ages;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
12 Castellón/Castelló;All ages;Cohort July 1;Males;Survival in the second trimester;2021QII;""
12 Castellón/Castelló;All ages;Cohort July 1;Males;Survival in the second trimester;2021QI;""
12 Castellón/Castelló;All ages;Cohort July 1;Males;Survival in the second trimester;2020QIV;21.319
12 Castellón/Castelló;All ages;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
12 Castellón/Castelló;All ages;Cohort July 1;Males;Survival in the second trimester;2020QII;""
12 Castellón/Castelló;All ages;Cohort July 1;Males;Survival in the second trimester;2020QI;""
12 Castellón/Castelló;All ages;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
12 Castellón/Castelló;All ages;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
12 Castellón/Castelló;All ages;Cohort July 1;Males;Survival in the third trimester;2022QII;""
12 Castellón/Castelló;All ages;Cohort July 1;Males;Survival in the third trimester;2022QI;21.137
12 Castellón/Castelló;All ages;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
12 Castellón/Castelló;All ages;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
12 Castellón/Castelló;All ages;Cohort July 1;Males;Survival in the third trimester;2021QII;""
12 Castellón/Castelló;All ages;Cohort July 1;Males;Survival in the third trimester;2021QI;20.880
12 Castellón/Castelló;All ages;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
12 Castellón/Castelló;All ages;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
12 Castellón/Castelló;All ages;Cohort July 1;Males;Survival in the third trimester;2020QII;""
12 Castellón/Castelló;All ages;Cohort July 1;Males;Survival in the third trimester;2020QI;""
12 Castellón/Castelló;All ages;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
12 Castellón/Castelló;All ages;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
12 Castellón/Castelló;All ages;Cohort July 1;Males;Survival in the third trimester;2022QII;20.627
12 Castellón/Castelló;All ages;Cohort July 1;Males;Survival in the third trimester;2022QI;""
12 Castellón/Castelló;All ages;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
12 Castellón/Castelló;All ages;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
12 Castellón/Castelló;All ages;Cohort July 1;Males;Survival in the third trimester;2021QII;20.444
12 Castellón/Castelló;All ages;Cohort July 1;Males;Survival in the third trimester;2021QI;""
12 Castellón/Castelló;All ages;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
12 Castellón/Castelló;All ages;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
12 Castellón/Castelló;All ages;Cohort July 1;Males;Survival in the third trimester;2020QII;""
12 Castellón/Castelló;All ages;Cohort July 1;Males;Survival in the third trimester;2020QI;""
12 Castellón/Castelló;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
12 Castellón/Castelló;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
12 Castellón/Castelló;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
12 Castellón/Castelló;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
12 Castellón/Castelló;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
12 Castellón/Castelló;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
12 Castellón/Castelló;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
12 Castellón/Castelló;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
12 Castellón/Castelló;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
12 Castellón/Castelló;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
12 Castellón/Castelló;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
12 Castellón/Castelló;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
12 Castellón/Castelló;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
12 Castellón/Castelló;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;96,59
12 Castellón/Castelló;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
12 Castellón/Castelló;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
12 Castellón/Castelló;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
12 Castellón/Castelló;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;96,86
12 Castellón/Castelló;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
12 Castellón/Castelló;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
12 Castellón/Castelló;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
12 Castellón/Castelló;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;96,48
12 Castellón/Castelló;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
12 Castellón/Castelló;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
12 Castellón/Castelló;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;92,95
12 Castellón/Castelló;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
12 Castellón/Castelló;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
12 Castellón/Castelló;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
12 Castellón/Castelló;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;93,63
12 Castellón/Castelló;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
12 Castellón/Castelló;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
12 Castellón/Castelló;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
12 Castellón/Castelló;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;93,27
12 Castellón/Castelló;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
12 Castellón/Castelló;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
12 Castellón/Castelló;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
12 Castellón/Castelló;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
12 Castellón/Castelló;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
12 Castellón/Castelló;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
12 Castellón/Castelló;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;91,37
12 Castellón/Castelló;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
12 Castellón/Castelló;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
12 Castellón/Castelló;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
12 Castellón/Castelló;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;91,35
12 Castellón/Castelló;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
12 Castellón/Castelló;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
12 Castellón/Castelló;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
12 Castellón/Castelló;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
12 Castellón/Castelló;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
12 Castellón/Castelló;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
12 Castellón/Castelló;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;89,17
12 Castellón/Castelló;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
12 Castellón/Castelló;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
12 Castellón/Castelló;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
12 Castellón/Castelló;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;89,44
12 Castellón/Castelló;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
12 Castellón/Castelló;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
12 Castellón/Castelló;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
12 Castellón/Castelló;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
12 Castellón/Castelló;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
12 Castellón/Castelló;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
12 Castellón/Castelló;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QIII;14.890
12 Castellón/Castelló;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
12 Castellón/Castelló;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
12 Castellón/Castelló;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
12 Castellón/Castelló;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QIII;14.840
12 Castellón/Castelló;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
12 Castellón/Castelló;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
12 Castellón/Castelló;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
12 Castellón/Castelló;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QIII;14.524
12 Castellón/Castelló;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
12 Castellón/Castelló;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
12 Castellón/Castelló;All ages;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
12 Castellón/Castelló;All ages;Cohort July 1;Females;Survival in the first trimester;2022QIII;14.218
12 Castellón/Castelló;All ages;Cohort July 1;Females;Survival in the first trimester;2022QII;""
12 Castellón/Castelló;All ages;Cohort July 1;Females;Survival in the first trimester;2022QI;""
12 Castellón/Castelló;All ages;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
12 Castellón/Castelló;All ages;Cohort July 1;Females;Survival in the first trimester;2021QIII;14.283
12 Castellón/Castelló;All ages;Cohort July 1;Females;Survival in the first trimester;2021QII;""
12 Castellón/Castelló;All ages;Cohort July 1;Females;Survival in the first trimester;2021QI;""
12 Castellón/Castelló;All ages;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
12 Castellón/Castelló;All ages;Cohort July 1;Females;Survival in the first trimester;2020QIII;13.948
12 Castellón/Castelló;All ages;Cohort July 1;Females;Survival in the first trimester;2020QII;""
12 Castellón/Castelló;All ages;Cohort July 1;Females;Survival in the first trimester;2020QI;""
12 Castellón/Castelló;All ages;Cohort July 1;Females;Survival in the second trimester;2022QIV;13.579
12 Castellón/Castelló;All ages;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
12 Castellón/Castelló;All ages;Cohort July 1;Females;Survival in the second trimester;2022QII;""
12 Castellón/Castelló;All ages;Cohort July 1;Females;Survival in the second trimester;2022QI;""
12 Castellón/Castelló;All ages;Cohort July 1;Females;Survival in the second trimester;2021QIV;13.676
12 Castellón/Castelló;All ages;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
12 Castellón/Castelló;All ages;Cohort July 1;Females;Survival in the second trimester;2021QII;""
12 Castellón/Castelló;All ages;Cohort July 1;Females;Survival in the second trimester;2021QI;""
12 Castellón/Castelló;All ages;Cohort July 1;Females;Survival in the second trimester;2020QIV;13.373
12 Castellón/Castelló;All ages;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
12 Castellón/Castelló;All ages;Cohort July 1;Females;Survival in the second trimester;2020QII;""
12 Castellón/Castelló;All ages;Cohort July 1;Females;Survival in the second trimester;2020QI;""
12 Castellón/Castelló;All ages;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
12 Castellón/Castelló;All ages;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
12 Castellón/Castelló;All ages;Cohort July 1;Females;Survival in the third trimester;2022QII;""
12 Castellón/Castelló;All ages;Cohort July 1;Females;Survival in the third trimester;2022QI;13.277
12 Castellón/Castelló;All ages;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
12 Castellón/Castelló;All ages;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
12 Castellón/Castelló;All ages;Cohort July 1;Females;Survival in the third trimester;2021QII;""
12 Castellón/Castelló;All ages;Cohort July 1;Females;Survival in the third trimester;2021QI;13.066
12 Castellón/Castelló;All ages;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
12 Castellón/Castelló;All ages;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
12 Castellón/Castelló;All ages;Cohort July 1;Females;Survival in the third trimester;2020QII;""
12 Castellón/Castelló;All ages;Cohort July 1;Females;Survival in the third trimester;2020QI;""
12 Castellón/Castelló;All ages;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
12 Castellón/Castelló;All ages;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
12 Castellón/Castelló;All ages;Cohort July 1;Females;Survival in the third trimester;2022QII;12.851
12 Castellón/Castelló;All ages;Cohort July 1;Females;Survival in the third trimester;2022QI;""
12 Castellón/Castelló;All ages;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
12 Castellón/Castelló;All ages;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
12 Castellón/Castelló;All ages;Cohort July 1;Females;Survival in the third trimester;2021QII;12.696
12 Castellón/Castelló;All ages;Cohort July 1;Females;Survival in the third trimester;2021QI;""
12 Castellón/Castelló;All ages;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
12 Castellón/Castelló;All ages;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
12 Castellón/Castelló;All ages;Cohort July 1;Females;Survival in the third trimester;2020QII;""
12 Castellón/Castelló;All ages;Cohort July 1;Females;Survival in the third trimester;2020QI;""
12 Castellón/Castelló;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
12 Castellón/Castelló;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
12 Castellón/Castelló;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
12 Castellón/Castelló;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
12 Castellón/Castelló;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
12 Castellón/Castelló;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
12 Castellón/Castelló;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
12 Castellón/Castelló;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
12 Castellón/Castelló;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
12 Castellón/Castelló;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
12 Castellón/Castelló;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
12 Castellón/Castelló;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
12 Castellón/Castelló;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
12 Castellón/Castelló;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;95,49
12 Castellón/Castelló;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
12 Castellón/Castelló;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
12 Castellón/Castelló;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
12 Castellón/Castelló;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;96,25
12 Castellón/Castelló;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
12 Castellón/Castelló;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
12 Castellón/Castelló;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
12 Castellón/Castelló;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;96,03
12 Castellón/Castelló;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
12 Castellón/Castelló;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
12 Castellón/Castelló;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;91,2
12 Castellón/Castelló;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
12 Castellón/Castelló;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
12 Castellón/Castelló;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
12 Castellón/Castelló;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;92,16
12 Castellón/Castelló;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
12 Castellón/Castelló;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
12 Castellón/Castelló;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
12 Castellón/Castelló;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;92,08
12 Castellón/Castelló;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
12 Castellón/Castelló;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
12 Castellón/Castelló;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
12 Castellón/Castelló;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
12 Castellón/Castelló;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
12 Castellón/Castelló;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
12 Castellón/Castelló;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;89,47
12 Castellón/Castelló;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
12 Castellón/Castelló;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
12 Castellón/Castelló;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
12 Castellón/Castelló;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;89,96
12 Castellón/Castelló;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
12 Castellón/Castelló;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
12 Castellón/Castelló;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
12 Castellón/Castelló;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
12 Castellón/Castelló;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
12 Castellón/Castelló;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
12 Castellón/Castelló;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;86,6
12 Castellón/Castelló;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
12 Castellón/Castelló;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
12 Castellón/Castelló;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
12 Castellón/Castelló;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;87,41
12 Castellón/Castelló;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
12 Castellón/Castelló;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
12 Castellón/Castelló;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
12 Castellón/Castelló;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
12 Castellón/Castelló;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
12 Castellón/Castelló;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QIV;37.770
12 Castellón/Castelló;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
12 Castellón/Castelló;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
12 Castellón/Castelló;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
12 Castellón/Castelló;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QIV;37.808
12 Castellón/Castelló;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
12 Castellón/Castelló;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
12 Castellón/Castelló;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
12 Castellón/Castelló;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QIV;37.246
12 Castellón/Castelló;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
12 Castellón/Castelló;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
12 Castellón/Castelló;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
12 Castellón/Castelló;All ages;Cohort October 1;Total;Survival in the first trimester;2022QIV;36.162
12 Castellón/Castelló;All ages;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
12 Castellón/Castelló;All ages;Cohort October 1;Total;Survival in the first trimester;2022QII;""
12 Castellón/Castelló;All ages;Cohort October 1;Total;Survival in the first trimester;2022QI;""
12 Castellón/Castelló;All ages;Cohort October 1;Total;Survival in the first trimester;2021QIV;36.317
12 Castellón/Castelló;All ages;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
12 Castellón/Castelló;All ages;Cohort October 1;Total;Survival in the first trimester;2021QII;""
12 Castellón/Castelló;All ages;Cohort October 1;Total;Survival in the first trimester;2021QI;""
12 Castellón/Castelló;All ages;Cohort October 1;Total;Survival in the first trimester;2020QIV;35.751
12 Castellón/Castelló;All ages;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
12 Castellón/Castelló;All ages;Cohort October 1;Total;Survival in the first trimester;2020QII;""
12 Castellón/Castelló;All ages;Cohort October 1;Total;Survival in the first trimester;2020QI;""
12 Castellón/Castelló;All ages;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
12 Castellón/Castelló;All ages;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
12 Castellón/Castelló;All ages;Cohort October 1;Total;Survival in the second trimester;2022QII;""
12 Castellón/Castelló;All ages;Cohort October 1;Total;Survival in the second trimester;2022QI;35.346
12 Castellón/Castelló;All ages;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
12 Castellón/Castelló;All ages;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
12 Castellón/Castelló;All ages;Cohort October 1;Total;Survival in the second trimester;2021QII;""
12 Castellón/Castelló;All ages;Cohort October 1;Total;Survival in the second trimester;2021QI;34.924
12 Castellón/Castelló;All ages;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
12 Castellón/Castelló;All ages;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
12 Castellón/Castelló;All ages;Cohort October 1;Total;Survival in the second trimester;2020QII;""
12 Castellón/Castelló;All ages;Cohort October 1;Total;Survival in the second trimester;2020QI;""
12 Castellón/Castelló;All ages;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
12 Castellón/Castelló;All ages;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
12 Castellón/Castelló;All ages;Cohort October 1;Total;Survival in the third trimester;2022QII;34.306
12 Castellón/Castelló;All ages;Cohort October 1;Total;Survival in the third trimester;2022QI;""
12 Castellón/Castelló;All ages;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
12 Castellón/Castelló;All ages;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
12 Castellón/Castelló;All ages;Cohort October 1;Total;Survival in the third trimester;2021QII;34.024
12 Castellón/Castelló;All ages;Cohort October 1;Total;Survival in the third trimester;2021QI;""
12 Castellón/Castelló;All ages;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
12 Castellón/Castelló;All ages;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
12 Castellón/Castelló;All ages;Cohort October 1;Total;Survival in the third trimester;2020QII;""
12 Castellón/Castelló;All ages;Cohort October 1;Total;Survival in the third trimester;2020QI;""
12 Castellón/Castelló;All ages;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
12 Castellón/Castelló;All ages;Cohort October 1;Total;Survival in the third trimester;2022QIII;33.409
12 Castellón/Castelló;All ages;Cohort October 1;Total;Survival in the third trimester;2022QII;""
12 Castellón/Castelló;All ages;Cohort October 1;Total;Survival in the third trimester;2022QI;""
12 Castellón/Castelló;All ages;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
12 Castellón/Castelló;All ages;Cohort October 1;Total;Survival in the third trimester;2021QIII;33.259
12 Castellón/Castelló;All ages;Cohort October 1;Total;Survival in the third trimester;2021QII;""
12 Castellón/Castelló;All ages;Cohort October 1;Total;Survival in the third trimester;2021QI;""
12 Castellón/Castelló;All ages;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
12 Castellón/Castelló;All ages;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
12 Castellón/Castelló;All ages;Cohort October 1;Total;Survival in the third trimester;2020QII;""
12 Castellón/Castelló;All ages;Cohort October 1;Total;Survival in the third trimester;2020QI;""
12 Castellón/Castelló;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
12 Castellón/Castelló;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
12 Castellón/Castelló;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
12 Castellón/Castelló;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
12 Castellón/Castelló;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
12 Castellón/Castelló;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
12 Castellón/Castelló;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
12 Castellón/Castelló;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
12 Castellón/Castelló;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
12 Castellón/Castelló;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
12 Castellón/Castelló;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
12 Castellón/Castelló;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
12 Castellón/Castelló;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;95,74
12 Castellón/Castelló;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
12 Castellón/Castelló;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
12 Castellón/Castelló;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
12 Castellón/Castelló;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;96,06
12 Castellón/Castelló;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
12 Castellón/Castelló;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
12 Castellón/Castelló;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
12 Castellón/Castelló;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;95,99
12 Castellón/Castelló;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
12 Castellón/Castelló;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
12 Castellón/Castelló;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
12 Castellón/Castelló;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
12 Castellón/Castelló;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
12 Castellón/Castelló;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
12 Castellón/Castelló;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;93,49
12 Castellón/Castelló;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
12 Castellón/Castelló;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
12 Castellón/Castelló;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
12 Castellón/Castelló;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;93,77
12 Castellón/Castelló;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
12 Castellón/Castelló;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
12 Castellón/Castelló;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
12 Castellón/Castelló;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
12 Castellón/Castelló;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
12 Castellón/Castelló;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
12 Castellón/Castelló;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;90,74
12 Castellón/Castelló;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
12 Castellón/Castelló;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
12 Castellón/Castelló;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
12 Castellón/Castelló;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;91,35
12 Castellón/Castelló;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
12 Castellón/Castelló;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
12 Castellón/Castelló;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
12 Castellón/Castelló;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
12 Castellón/Castelló;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
12 Castellón/Castelló;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
12 Castellón/Castelló;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;88,36
12 Castellón/Castelló;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
12 Castellón/Castelló;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
12 Castellón/Castelló;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
12 Castellón/Castelló;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;89,3
12 Castellón/Castelló;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
12 Castellón/Castelló;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
12 Castellón/Castelló;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
12 Castellón/Castelló;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
12 Castellón/Castelló;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
12 Castellón/Castelló;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
12 Castellón/Castelló;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QIV;23.061
12 Castellón/Castelló;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
12 Castellón/Castelló;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
12 Castellón/Castelló;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
12 Castellón/Castelló;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QIV;23.038
12 Castellón/Castelló;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
12 Castellón/Castelló;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
12 Castellón/Castelló;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
12 Castellón/Castelló;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QIV;22.745
12 Castellón/Castelló;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
12 Castellón/Castelló;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
12 Castellón/Castelló;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
12 Castellón/Castelló;All ages;Cohort October 1;Males;Survival in the first trimester;2022QIV;22.140
12 Castellón/Castelló;All ages;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
12 Castellón/Castelló;All ages;Cohort October 1;Males;Survival in the first trimester;2022QII;""
12 Castellón/Castelló;All ages;Cohort October 1;Males;Survival in the first trimester;2022QI;""
12 Castellón/Castelló;All ages;Cohort October 1;Males;Survival in the first trimester;2021QIV;22.212
12 Castellón/Castelló;All ages;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
12 Castellón/Castelló;All ages;Cohort October 1;Males;Survival in the first trimester;2021QII;""
12 Castellón/Castelló;All ages;Cohort October 1;Males;Survival in the first trimester;2021QI;""
12 Castellón/Castelló;All ages;Cohort October 1;Males;Survival in the first trimester;2020QIV;21.919
12 Castellón/Castelló;All ages;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
12 Castellón/Castelló;All ages;Cohort October 1;Males;Survival in the first trimester;2020QII;""
12 Castellón/Castelló;All ages;Cohort October 1;Males;Survival in the first trimester;2020QI;""
12 Castellón/Castelló;All ages;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
12 Castellón/Castelló;All ages;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
12 Castellón/Castelló;All ages;Cohort October 1;Males;Survival in the second trimester;2022QII;""
12 Castellón/Castelló;All ages;Cohort October 1;Males;Survival in the second trimester;2022QI;21.662
12 Castellón/Castelló;All ages;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
12 Castellón/Castelló;All ages;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
12 Castellón/Castelló;All ages;Cohort October 1;Males;Survival in the second trimester;2021QII;""
12 Castellón/Castelló;All ages;Cohort October 1;Males;Survival in the second trimester;2021QI;21.426
12 Castellón/Castelló;All ages;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
12 Castellón/Castelló;All ages;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
12 Castellón/Castelló;All ages;Cohort October 1;Males;Survival in the second trimester;2020QII;""
12 Castellón/Castelló;All ages;Cohort October 1;Males;Survival in the second trimester;2020QI;""
12 Castellón/Castelló;All ages;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
12 Castellón/Castelló;All ages;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
12 Castellón/Castelló;All ages;Cohort October 1;Males;Survival in the third trimester;2022QII;21.101
12 Castellón/Castelló;All ages;Cohort October 1;Males;Survival in the third trimester;2022QI;""
12 Castellón/Castelló;All ages;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
12 Castellón/Castelló;All ages;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
12 Castellón/Castelló;All ages;Cohort October 1;Males;Survival in the third trimester;2021QII;20.934
12 Castellón/Castelló;All ages;Cohort October 1;Males;Survival in the third trimester;2021QI;""
12 Castellón/Castelló;All ages;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
12 Castellón/Castelló;All ages;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
12 Castellón/Castelló;All ages;Cohort October 1;Males;Survival in the third trimester;2020QII;""
12 Castellón/Castelló;All ages;Cohort October 1;Males;Survival in the third trimester;2020QI;""
12 Castellón/Castelló;All ages;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
12 Castellón/Castelló;All ages;Cohort October 1;Males;Survival in the third trimester;2022QIII;20.618
12 Castellón/Castelló;All ages;Cohort October 1;Males;Survival in the third trimester;2022QII;""
12 Castellón/Castelló;All ages;Cohort October 1;Males;Survival in the third trimester;2022QI;""
12 Castellón/Castelló;All ages;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
12 Castellón/Castelló;All ages;Cohort October 1;Males;Survival in the third trimester;2021QIII;20.500
12 Castellón/Castelló;All ages;Cohort October 1;Males;Survival in the third trimester;2021QII;""
12 Castellón/Castelló;All ages;Cohort October 1;Males;Survival in the third trimester;2021QI;""
12 Castellón/Castelló;All ages;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
12 Castellón/Castelló;All ages;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
12 Castellón/Castelló;All ages;Cohort October 1;Males;Survival in the third trimester;2020QII;""
12 Castellón/Castelló;All ages;Cohort October 1;Males;Survival in the third trimester;2020QI;""
12 Castellón/Castelló;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
12 Castellón/Castelló;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
12 Castellón/Castelló;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
12 Castellón/Castelló;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
12 Castellón/Castelló;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
12 Castellón/Castelló;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
12 Castellón/Castelló;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
12 Castellón/Castelló;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
12 Castellón/Castelló;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
12 Castellón/Castelló;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
12 Castellón/Castelló;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
12 Castellón/Castelló;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
12 Castellón/Castelló;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;96,01
12 Castellón/Castelló;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
12 Castellón/Castelló;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
12 Castellón/Castelló;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
12 Castellón/Castelló;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;96,41
12 Castellón/Castelló;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
12 Castellón/Castelló;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
12 Castellón/Castelló;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
12 Castellón/Castelló;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;96,37
12 Castellón/Castelló;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
12 Castellón/Castelló;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
12 Castellón/Castelló;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
12 Castellón/Castelló;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
12 Castellón/Castelló;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
12 Castellón/Castelló;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
12 Castellón/Castelló;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;94,03
12 Castellón/Castelló;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
12 Castellón/Castelló;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
12 Castellón/Castelló;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
12 Castellón/Castelló;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;94,2
12 Castellón/Castelló;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
12 Castellón/Castelló;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
12 Castellón/Castelló;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
12 Castellón/Castelló;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
12 Castellón/Castelló;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
12 Castellón/Castelló;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
12 Castellón/Castelló;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;91,59
12 Castellón/Castelló;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
12 Castellón/Castelló;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
12 Castellón/Castelló;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
12 Castellón/Castelló;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;92,04
12 Castellón/Castelló;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
12 Castellón/Castelló;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
12 Castellón/Castelló;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
12 Castellón/Castelló;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
12 Castellón/Castelló;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
12 Castellón/Castelló;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
12 Castellón/Castelló;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;89,5
12 Castellón/Castelló;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
12 Castellón/Castelló;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
12 Castellón/Castelló;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
12 Castellón/Castelló;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;90,13
12 Castellón/Castelló;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
12 Castellón/Castelló;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
12 Castellón/Castelló;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
12 Castellón/Castelló;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
12 Castellón/Castelló;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
12 Castellón/Castelló;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
12 Castellón/Castelló;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QIV;14.709
12 Castellón/Castelló;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
12 Castellón/Castelló;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
12 Castellón/Castelló;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
12 Castellón/Castelló;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QIV;14.770
12 Castellón/Castelló;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
12 Castellón/Castelló;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
12 Castellón/Castelló;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
12 Castellón/Castelló;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QIV;14.501
12 Castellón/Castelló;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
12 Castellón/Castelló;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
12 Castellón/Castelló;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
12 Castellón/Castelló;All ages;Cohort October 1;Females;Survival in the first trimester;2022QIV;14.022
12 Castellón/Castelló;All ages;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
12 Castellón/Castelló;All ages;Cohort October 1;Females;Survival in the first trimester;2022QII;""
12 Castellón/Castelló;All ages;Cohort October 1;Females;Survival in the first trimester;2022QI;""
12 Castellón/Castelló;All ages;Cohort October 1;Females;Survival in the first trimester;2021QIV;14.105
12 Castellón/Castelló;All ages;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
12 Castellón/Castelló;All ages;Cohort October 1;Females;Survival in the first trimester;2021QII;""
12 Castellón/Castelló;All ages;Cohort October 1;Females;Survival in the first trimester;2021QI;""
12 Castellón/Castelló;All ages;Cohort October 1;Females;Survival in the first trimester;2020QIV;13.832
12 Castellón/Castelló;All ages;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
12 Castellón/Castelló;All ages;Cohort October 1;Females;Survival in the first trimester;2020QII;""
12 Castellón/Castelló;All ages;Cohort October 1;Females;Survival in the first trimester;2020QI;""
12 Castellón/Castelló;All ages;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
12 Castellón/Castelló;All ages;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
12 Castellón/Castelló;All ages;Cohort October 1;Females;Survival in the second trimester;2022QII;""
12 Castellón/Castelló;All ages;Cohort October 1;Females;Survival in the second trimester;2022QI;13.684
12 Castellón/Castelló;All ages;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
12 Castellón/Castelló;All ages;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
12 Castellón/Castelló;All ages;Cohort October 1;Females;Survival in the second trimester;2021QII;""
12 Castellón/Castelló;All ages;Cohort October 1;Females;Survival in the second trimester;2021QI;13.498
12 Castellón/Castelló;All ages;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
12 Castellón/Castelló;All ages;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
12 Castellón/Castelló;All ages;Cohort October 1;Females;Survival in the second trimester;2020QII;""
12 Castellón/Castelló;All ages;Cohort October 1;Females;Survival in the second trimester;2020QI;""
12 Castellón/Castelló;All ages;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
12 Castellón/Castelló;All ages;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
12 Castellón/Castelló;All ages;Cohort October 1;Females;Survival in the third trimester;2022QII;13.205
12 Castellón/Castelló;All ages;Cohort October 1;Females;Survival in the third trimester;2022QI;""
12 Castellón/Castelló;All ages;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
12 Castellón/Castelló;All ages;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
12 Castellón/Castelló;All ages;Cohort October 1;Females;Survival in the third trimester;2021QII;13.090
12 Castellón/Castelló;All ages;Cohort October 1;Females;Survival in the third trimester;2021QI;""
12 Castellón/Castelló;All ages;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
12 Castellón/Castelló;All ages;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
12 Castellón/Castelló;All ages;Cohort October 1;Females;Survival in the third trimester;2020QII;""
12 Castellón/Castelló;All ages;Cohort October 1;Females;Survival in the third trimester;2020QI;""
12 Castellón/Castelló;All ages;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
12 Castellón/Castelló;All ages;Cohort October 1;Females;Survival in the third trimester;2022QIII;12.791
12 Castellón/Castelló;All ages;Cohort October 1;Females;Survival in the third trimester;2022QII;""
12 Castellón/Castelló;All ages;Cohort October 1;Females;Survival in the third trimester;2022QI;""
12 Castellón/Castelló;All ages;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
12 Castellón/Castelló;All ages;Cohort October 1;Females;Survival in the third trimester;2021QIII;12.759
12 Castellón/Castelló;All ages;Cohort October 1;Females;Survival in the third trimester;2021QII;""
12 Castellón/Castelló;All ages;Cohort October 1;Females;Survival in the third trimester;2021QI;""
12 Castellón/Castelló;All ages;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
12 Castellón/Castelló;All ages;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
12 Castellón/Castelló;All ages;Cohort October 1;Females;Survival in the third trimester;2020QII;""
12 Castellón/Castelló;All ages;Cohort October 1;Females;Survival in the third trimester;2020QI;""
12 Castellón/Castelló;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
12 Castellón/Castelló;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
12 Castellón/Castelló;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
12 Castellón/Castelló;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
12 Castellón/Castelló;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
12 Castellón/Castelló;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
12 Castellón/Castelló;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
12 Castellón/Castelló;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
12 Castellón/Castelló;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
12 Castellón/Castelló;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
12 Castellón/Castelló;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
12 Castellón/Castelló;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
12 Castellón/Castelló;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;95,33
12 Castellón/Castelló;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
12 Castellón/Castelló;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
12 Castellón/Castelló;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
12 Castellón/Castelló;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;95,5
12 Castellón/Castelló;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
12 Castellón/Castelló;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
12 Castellón/Castelló;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
12 Castellón/Castelló;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;95,39
12 Castellón/Castelló;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
12 Castellón/Castelló;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
12 Castellón/Castelló;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
12 Castellón/Castelló;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
12 Castellón/Castelló;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
12 Castellón/Castelló;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
12 Castellón/Castelló;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;92,65
12 Castellón/Castelló;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
12 Castellón/Castelló;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
12 Castellón/Castelló;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
12 Castellón/Castelló;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;93,08
12 Castellón/Castelló;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
12 Castellón/Castelló;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
12 Castellón/Castelló;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
12 Castellón/Castelló;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
12 Castellón/Castelló;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
12 Castellón/Castelló;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
12 Castellón/Castelló;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;89,4
12 Castellón/Castelló;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
12 Castellón/Castelló;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
12 Castellón/Castelló;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
12 Castellón/Castelló;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;90,27
12 Castellón/Castelló;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
12 Castellón/Castelló;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
12 Castellón/Castelló;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
12 Castellón/Castelló;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
12 Castellón/Castelló;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
12 Castellón/Castelló;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
12 Castellón/Castelló;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;86,6
12 Castellón/Castelló;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
12 Castellón/Castelló;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
12 Castellón/Castelló;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
12 Castellón/Castelló;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;87,99
12 Castellón/Castelló;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
12 Castellón/Castelló;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
12 Castellón/Castelló;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
12 Castellón/Castelló;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
12 Castellón/Castelló;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
12 Castellón/Castelló;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QI;2.343
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QI;2.234
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QI;1.846
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2022QII;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2022QI;2.190
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2021QII;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2021QI;2.110
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2020QII;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2020QI;1.598
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2022QII;2.038
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2022QI;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2021QII;1.997
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2021QI;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2020QII;1.539
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2020QI;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QIII;1.916
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QII;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QI;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QIII;1.859
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QII;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QI;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QIII;1.458
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QII;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QI;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QIV;1.818
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QII;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QI;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QIV;1.752
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QII;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QI;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QIV;1.378
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QII;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QI;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;93,47
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;94,45
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;86,57
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;86,98
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;89,39
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;83,37
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;81,78
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;83,21
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;78,98
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;77,59
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;78,42
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;74,65
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QI;1.428
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QI;1.353
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QI;1.122
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2022QII;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2022QI;1.346
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2021QII;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2021QI;1.266
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2020QII;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2020QI;975
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2022QII;1.262
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2022QI;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2021QII;1.202
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2021QI;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2020QII;942
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2020QI;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QIII;1.193
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QII;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QI;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QIII;1.135
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QII;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QI;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QIII;903
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QII;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QI;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QIV;1.139
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QII;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QI;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QIV;1.073
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QII;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QI;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QIV;861
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QII;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QI;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;94,26
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;93,57
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;86,9
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;88,38
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;88,84
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;83,96
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;83,54
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;83,89
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;80,48
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;79,76
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;79,31
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;76,74
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QI;915
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QI;881
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QI;724
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2022QII;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2022QI;844
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2021QII;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2021QI;844
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2020QII;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2020QI;623
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2022QII;776
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2022QI;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2021QII;795
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2021QI;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2020QII;597
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2020QI;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QIII;723
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QII;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QI;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QIII;724
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QII;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QI;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QIII;555
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QII;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QI;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QIV;679
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QII;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QI;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QIV;679
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QII;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QI;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QIV;517
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QII;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QI;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;92,24
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;95,8
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;86,05
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;84,81
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;90,24
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;82,46
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;79,02
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;82,18
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;76,66
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;74,21
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;77,07
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;71,41
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QII;2.080
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QII;1.962
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QII;1.875
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2022QII;1.929
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2022QI;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2021QII;1.839
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2021QI;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2020QII;1.798
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2020QI;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2022QIII;1.800
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2022QII;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2022QI;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2021QIII;1.698
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2021QII;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2021QI;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2020QIII;1.682
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2020QII;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2020QI;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QIV;1.691
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QII;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QI;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QIV;1.589
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QII;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QI;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QIV;1.574
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QII;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QI;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QII;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QI;1.502
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QII;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QI;1.507
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QII;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QI;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;92,74
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;93,73
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;95,89
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;86,54
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;86,54
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;89,71
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;81,3
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;80,99
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;83,95
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;76,55
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;80,37
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QII;1.271
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QII;1.205
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QII;1.123
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2022QII;1.188
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2022QI;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2021QII;1.132
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2021QI;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2020QII;1.079
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2020QI;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2022QIII;1.112
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2022QII;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2022QI;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2021QIII;1.061
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2021QII;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2021QI;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2020QIII;1.025
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2020QII;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2020QI;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QIV;1.050
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QII;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QI;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QIV;1.000
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QII;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QI;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QIV;967
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QII;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QI;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QII;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QI;950
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QII;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QI;922
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QII;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QI;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;93,47
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;93,94
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;96,08
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;87,49
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;88,05
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;91,27
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;82,61
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;82,99
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;86,11
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;78,84
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;82,1
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QII;809
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QII;757
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QII;752
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2022QII;741
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2022QI;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2021QII;707
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2021QI;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2020QII;719
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2020QI;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2022QIII;688
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2022QII;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2022QI;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2021QIII;637
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2021QII;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2021QI;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2020QIII;657
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2020QII;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2020QI;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QIV;641
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QII;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QI;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QIV;589
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QII;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QI;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QIV;607
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QII;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QI;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QII;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QI;552
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QII;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QI;585
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QII;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QI;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;91,59
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;93,39
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;95,61
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;85,04
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;84,15
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;87,37
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;79,23
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;77,81
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;80,72
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;72,92
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;77,79
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QIII;2.197
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QIII;2.209
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QIII;2.050
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2022QIII;2.005
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2022QII;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2022QI;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2021QIII;1.989
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2021QII;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2021QI;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2020QIII;1.860
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2020QII;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2020QI;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2022QIV;1.867
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2022QII;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2022QI;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2021QIV;1.839
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2021QII;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2021QI;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2020QIV;1.729
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2020QII;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2020QI;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QII;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QI;1.732
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QII;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QI;1.648
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QII;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QI;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QII;1.625
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QI;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QII;1.574
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QI;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QII;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QI;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;91,26
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;90,04
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;90,73
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;84,98
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;83,25
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;84,34
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;78,41
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;80,39
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;73,56
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;76,78
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QIII;1.343
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QIII;1.339
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QIII;1.234
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2022QIII;1.231
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2022QII;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2022QI;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2021QIII;1.218
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2021QII;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2021QI;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2020QIII;1.130
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2020QII;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2020QI;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2022QIV;1.156
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2022QII;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2022QI;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2021QIV;1.136
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2021QII;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2021QI;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2020QIV;1.061
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2020QII;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2020QI;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QII;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QI;1.078
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QII;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QI;1.004
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QII;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QI;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QII;1.018
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QI;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QII;963
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QI;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QII;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QI;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;91,66
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;90,96
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;91,57
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;86,08
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;84,84
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;85,98
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;80,51
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;81,36
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;76,03
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;78,04
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QIII;854
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QIII;870
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QIII;816
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2022QIII;774
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2022QII;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2022QI;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2021QIII;771
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2021QII;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2021QI;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2020QIII;730
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2020QII;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2020QI;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2022QIV;711
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2022QII;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2022QI;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2021QIV;703
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2021QII;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2021QI;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2020QIV;668
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2020QII;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2020QI;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QII;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QI;654
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QII;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QI;644
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QII;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QI;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QII;607
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QI;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QII;611
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QI;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QII;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QI;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;90,63
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;88,62
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;89,46
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;83,26
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;80,8
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;81,86
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;75,17
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;78,92
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;69,77
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;74,88
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QIV;2.224
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QIV;2.243
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QIV;2.124
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2022QIV;2.061
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2022QII;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2022QI;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2021QIV;2.054
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2021QII;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2021QI;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2020QIV;1.953
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2020QII;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2020QI;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2022QII;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2022QI;1.935
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2021QII;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2021QI;1.851
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2020QII;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2020QI;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QII;1.810
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QI;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QII;1.762
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QI;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QII;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QI;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QIII;1.705
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QII;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QI;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QIII;1.648
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QII;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QI;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QII;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QI;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;92,67
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;91,57
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;91,95
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;86,27
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;87,15
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;80,7
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;82,96
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;76,01
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;77,59
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QIV;1.361
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QIV;1.359
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QIV;1.283
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2022QIV;1.272
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2022QII;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2022QI;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2021QIV;1.256
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2021QII;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2021QI;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2020QIV;1.190
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2020QII;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2020QI;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2022QII;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2022QI;1.193
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2021QII;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2021QI;1.120
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2020QII;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2020QI;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QII;1.125
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QI;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QII;1.071
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QI;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QII;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QI;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QIII;1.063
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QII;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QI;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QIII;1.019
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QII;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QI;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QII;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QI;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;93,46
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;92,42
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;92,75
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;87,79
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;87,3
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;82,78
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;83,48
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;78,22
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;79,42
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QIV;863
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QIV;884
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QIV;841
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2022QIV;789
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2022QII;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2022QI;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2021QIV;798
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2021QII;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2021QI;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2020QIV;763
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2020QII;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2020QI;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2022QII;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2022QI;742
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2021QII;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2021QI;731
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2020QII;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2020QI;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QII;685
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QI;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QII;691
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QI;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QII;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QI;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QIII;642
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QII;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QI;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QIII;629
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QII;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QI;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QII;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QI;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;91,43
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;90,27
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;90,73
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;83,94
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;86,92
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;77,49
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;82,16
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;72,62
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;74,79
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QI;6.662
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QI;6.711
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QI;6.557
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2022QII;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2022QI;6.394
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2021QII;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2021QI;6.508
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2020QII;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2020QI;6.085
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2022QII;6.132
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2022QI;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2021QII;6.279
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2021QI;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2020QII;5.953
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2020QI;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QIII;5.931
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QII;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QI;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QIII;6.103
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QII;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QI;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QIII;5.754
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QII;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QI;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QIV;5.718
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QII;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QI;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QIV;5.919
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QII;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QI;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QIV;5.546
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QII;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QI;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;95,98
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;96,98
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;92,8
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;92,04
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;93,56
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;90,79
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;89,03
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;90,94
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;87,75
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;85,83
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;88,2
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;84,58
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QI;3.816
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QI;3.932
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QI;3.839
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2022QII;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2022QI;3.677
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2021QII;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2021QI;3.815
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2020QII;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2020QI;3.600
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2022QII;3.556
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2022QI;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2021QII;3.688
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2021QI;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2020QII;3.531
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2020QI;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QIII;3.445
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QII;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QI;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QIII;3.585
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QII;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QI;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QIII;3.412
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QII;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QI;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QIV;3.339
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QII;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QI;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QIV;3.486
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QII;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QI;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QIV;3.304
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QII;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QI;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;96,36
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;97,02
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;93,77
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;93,19
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;93,79
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;91,98
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;90,28
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;91,17
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;88,88
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;87,5
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;88,66
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;86,06
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QI;2.846
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QI;2.779
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QI;2.718
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2022QII;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2022QI;2.717
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2021QII;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2021QI;2.693
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2020QII;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2020QI;2.485
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2022QII;2.576
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2022QI;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2021QII;2.591
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2021QI;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2020QII;2.422
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2020QI;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QIII;2.486
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QII;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QI;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QIII;2.518
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QII;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QI;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QIII;2.342
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QII;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QI;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QIV;2.379
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QII;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QI;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QIV;2.433
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QII;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QI;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QIV;2.242
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QII;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QI;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;95,47
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;96,91
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;91,43
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;90,51
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;93,23
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;89,11
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;87,35
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;90,61
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;86,17
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;83,59
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;87,55
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;82,49
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QII;6.228
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QII;6.393
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QII;6.508
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2022QII;5.959
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2022QI;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2021QII;6.148
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2021QI;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2020QII;6.361
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2020QI;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2022QIII;5.743
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2022QII;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2022QI;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2021QIII;5.953
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2021QII;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2021QI;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2020QIII;6.131
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2020QII;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2020QI;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QIV;5.519
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QII;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QI;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QIV;5.740
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QII;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QI;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QIV;5.892
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QII;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QI;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QII;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QI;5.556
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QII;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QI;5.753
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QII;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QI;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;95,68
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;96,17
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;97,74
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;92,21
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;93,12
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;94,21
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;88,62
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;89,79
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;90,53
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;86,91
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;88,4
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QII;3.540
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QII;3.718
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QII;3.811
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2022QII;3.415
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2022QI;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2021QII;3.582
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2021QI;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2020QII;3.734
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2020QI;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2022QIII;3.299
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2022QII;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2022QI;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2021QIII;3.463
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2021QII;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2021QI;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2020QIII;3.601
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2020QII;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2020QI;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QIV;3.192
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QII;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QI;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QIV;3.339
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QII;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QI;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QIV;3.476
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QII;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QI;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QII;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QI;3.243
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QII;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QI;3.399
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QII;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QI;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;96,47
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;96,34
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;97,98
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;93,19
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;93,14
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;94,49
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;90,17
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;89,81
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;91,21
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;87,22
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;89,19
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QII;2.688
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QII;2.675
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QII;2.697
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2022QII;2.544
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2022QI;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2021QII;2.566
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2021QI;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2020QII;2.627
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2020QI;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2022QIII;2.444
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2022QII;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2022QI;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2021QIII;2.490
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2021QII;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2021QI;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2020QIII;2.530
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2020QII;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2020QI;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QIV;2.327
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QII;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QI;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QIV;2.401
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QII;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QI;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QIV;2.416
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QII;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QI;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QII;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QI;2.313
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QII;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QI;2.354
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QII;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QI;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;94,64
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;95,93
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;97,4
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;90,92
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;93,08
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;93,81
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;86,57
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;89,76
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;89,58
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;86,47
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;87,28
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QIII;6.350
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QIII;6.571
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QIII;6.662
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2022QIII;6.060
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2022QII;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2022QI;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2021QIII;6.305
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2021QII;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2021QI;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2020QIII;6.371
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2020QII;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2020QI;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2022QIV;5.784
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2022QII;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2022QI;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2021QIV;6.037
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2021QII;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2021QI;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2020QIV;6.095
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2020QII;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2020QI;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QII;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QI;5.821
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QII;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QI;5.948
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QII;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QI;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QII;5.620
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QI;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QII;5.776
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QI;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QII;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QI;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;95,43
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;95,95
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;95,63
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;91,09
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;91,87
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;91,49
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;88,59
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;89,28
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;85,53
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;86,7
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QIII;3.607
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QIII;3.802
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QIII;3.902
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2022QIII;3.453
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2022QII;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2022QI;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2021QIII;3.642
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2021QII;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2021QI;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2020QIII;3.734
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2020QII;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2020QI;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2022QIV;3.320
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2022QII;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2022QI;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2021QIV;3.490
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2021QII;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2021QI;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2020QIV;3.590
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2020QII;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2020QI;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QII;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QI;3.378
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QII;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QI;3.510
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QII;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QI;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QII;3.285
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QI;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QII;3.419
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QI;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QII;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QI;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;95,73
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;95,79
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;95,69
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;92,04
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;91,79
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;92
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;88,85
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;89,95
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;86,4
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;87,62
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QIII;2.743
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QIII;2.769
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QIII;2.760
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2022QIII;2.607
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2022QII;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2022QI;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2021QIII;2.663
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2021QII;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2021QI;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2020QIII;2.637
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2020QII;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2020QI;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2022QIV;2.464
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2022QII;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2022QI;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2021QIV;2.547
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2021QII;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2021QI;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2020QIV;2.505
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2020QII;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2020QI;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QII;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QI;2.443
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QII;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QI;2.438
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QII;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QI;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QII;2.335
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QI;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QII;2.357
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QI;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QII;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QI;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;95,04
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;96,17
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;95,54
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;89,83
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;91,98
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;90,76
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;88,23
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;88,33
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;84,33
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;85,4
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QIV;6.370
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QIV;6.610
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QIV;6.674
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2022QIV;6.063
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2022QII;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2022QI;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2021QIV;6.316
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2021QII;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2021QI;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2020QIV;6.364
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2020QII;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2020QI;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2022QII;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2022QI;6.085
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2021QII;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2021QI;6.200
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2020QII;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2020QI;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QII;5.856
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QI;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QII;6.005
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QI;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QII;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QI;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QIII;5.677
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QII;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QI;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QIII;5.853
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QII;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QI;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QII;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QI;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;95,18
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;95,55
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;95,36
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;92,06
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;92,9
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;88,59
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;89,98
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;85,89
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;87,7
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QIV;3.611
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QIV;3.799
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QIV;3.891
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2022QIV;3.459
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2022QII;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2022QI;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2021QIV;3.634
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2021QII;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2021QI;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2020QIV;3.730
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2020QII;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2020QI;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2022QII;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2022QI;3.513
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2021QII;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2021QI;3.640
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2020QII;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2020QI;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QII;3.407
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QI;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QII;3.536
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QI;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QII;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QI;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QIII;3.308
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QII;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QI;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QIII;3.446
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QII;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QI;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QII;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QI;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;95,79
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;95,66
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;95,86
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;92,47
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;93,55
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;89,68
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;90,88
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;87,08
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;88,56
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QIV;2.759
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QIV;2.811
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QIV;2.783
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2022QIV;2.604
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2022QII;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2022QI;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2021QIV;2.682
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2021QII;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2021QI;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2020QIV;2.634
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2020QII;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2020QI;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2022QII;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2022QI;2.572
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2021QII;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2021QI;2.560
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2020QII;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2020QI;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QII;2.449
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QI;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QII;2.469
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QI;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QII;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QI;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QIII;2.369
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QII;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QI;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QIII;2.407
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QII;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QI;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QII;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QI;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;94,38
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;95,41
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;94,65
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;91,5
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;91,99
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;87,12
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;88,72
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;84,28
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;86,49
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QI;12.215
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QI;12.235
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QI;12.361
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2022QII;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2022QI;11.889
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2021QII;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2021QI;11.965
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2020QII;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2020QI;11.673
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2022QII;11.566
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2022QI;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2021QII;11.681
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2021QI;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2020QII;11.433
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2020QI;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QIII;11.319
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QII;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QI;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QIII;11.491
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QII;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QI;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QIII;11.166
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QII;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QI;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QIV;11.048
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QII;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QI;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QIV;11.207
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QII;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QI;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QIV;10.913
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QII;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QI;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;97,33
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;97,79
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;94,43
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;94,69
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;95,47
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;92,49
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;92,66
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;93,92
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;90,33
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;90,45
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;91,6
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;88,29
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QI;7.529
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QI;7.599
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QI;7.661
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2022QII;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2022QI;7.339
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2021QII;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2021QI;7.423
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2020QII;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2020QI;7.279
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2022QII;7.159
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2022QI;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2021QII;7.273
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2021QI;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2020QII;7.136
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2020QI;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QIII;7.031
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QII;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QI;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QIII;7.158
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QII;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QI;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QIII;6.974
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QII;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QI;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QIV;6.879
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QII;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QI;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QIV;6.988
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QII;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QI;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QIV;6.822
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QII;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QI;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;97,48
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;97,68
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;95,01
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;95,09
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;95,71
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;93,15
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;93,39
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;94,2
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;91,03
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;91,37
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;91,96
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;89,05
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QI;4.686
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QI;4.636
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QI;4.700
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2022QII;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2022QI;4.550
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2021QII;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2021QI;4.542
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2020QII;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2020QI;4.394
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2022QII;4.407
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2022QI;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2021QII;4.408
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2021QI;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2020QII;4.297
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2020QI;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QIII;4.288
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QII;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QI;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QIII;4.333
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QII;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QI;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QIII;4.192
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QII;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QI;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QIV;4.169
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QII;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QI;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QIV;4.219
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QII;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QI;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QIV;4.091
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QII;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QI;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;97,1
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;97,97
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;93,49
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;94,05
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;95,08
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;91,43
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;91,51
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;93,46
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;89,19
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;88,97
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;91,01
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;87,04
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QII;11.978
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QII;12.015
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QII;12.113
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2022QII;11.612
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2022QI;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2021QII;11.701
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2021QI;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2020QII;11.857
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2020QI;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2022QIII;11.338
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2022QII;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2022QI;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2021QIII;11.485
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2021QII;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2021QI;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2020QIII;11.561
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2020QII;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2020QI;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QIV;11.013
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QII;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QI;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QIV;11.173
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QII;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QI;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QIV;11.274
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QII;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QI;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QII;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QI;10.930
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QII;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QI;11.095
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QII;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QI;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;96,94
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;97,39
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;97,89
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;94,66
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;95,59
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;95,44
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;91,94
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;92,99
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;93,07
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;90,97
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;91,6
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QII;7.358
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QII;7.381
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QII;7.522
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2022QII;7.157
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2022QI;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2021QII;7.204
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2021QI;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2020QII;7.368
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2020QI;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2022QIII;7.014
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2022QII;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2022QI;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2021QIII;7.074
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2021QII;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2021QI;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2020QIII;7.187
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2020QII;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2020QI;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QIV;6.836
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QII;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QI;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QIV;6.901
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QII;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QI;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QIV;7.016
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QII;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QI;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QII;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QI;6.762
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QII;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QI;6.906
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QII;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QI;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;97,27
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;97,6
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;97,95
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;95,32
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;95,84
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;95,55
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;92,91
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;93,5
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;93,27
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;91,61
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;91,81
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QII;4.620
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QII;4.634
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QII;4.591
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2022QII;4.455
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2022QI;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2021QII;4.497
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2021QI;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2020QII;4.489
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2020QI;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2022QIII;4.324
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2022QII;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2022QI;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2021QIII;4.411
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2021QII;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2021QI;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2020QIII;4.374
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2020QII;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2020QI;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QIV;4.177
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QII;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QI;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QIV;4.272
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QII;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QI;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QIV;4.258
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QII;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QI;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QII;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QI;4.168
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QII;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QI;4.189
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QII;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QI;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;96,43
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;97,04
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;97,78
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;93,59
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;95,19
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;95,27
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;90,41
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;92,19
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;92,75
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;89,94
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;91,24
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QIII;12.093
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QIII;12.180
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QIII;12.210
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2022QIII;11.715
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2022QII;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2022QI;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2021QIII;11.889
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2021QII;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2021QI;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2020QIII;11.847
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2020QII;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2020QI;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2022QIV;11.319
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2022QII;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2022QI;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2021QIV;11.494
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2021QII;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2021QI;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2020QIV;11.510
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2020QII;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2020QI;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QII;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QI;11.228
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QII;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QI;11.318
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QII;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QI;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QII;10.986
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QI;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QII;11.105
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QI;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QII;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QI;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;96,87
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;97,61
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;97,03
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;93,6
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;94,37
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;94,27
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;92,18
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;92,69
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;90,2
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;90,95
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QIII;7.430
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QIII;7.470
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QIII;7.575
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2022QIII;7.225
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2022QII;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2022QI;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2021QIII;7.306
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2021QII;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2021QI;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2020QIII;7.354
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2020QII;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2020QI;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2022QIV;7.007
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2022QII;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2022QI;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2021QIV;7.090
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2021QII;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2021QI;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2020QIV;7.158
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2020QII;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2020QI;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QII;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QI;6.937
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QII;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QI;7.040
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QII;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QI;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QII;6.800
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QI;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QII;6.933
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QI;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QII;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QI;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;97,24
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;97,8
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;97,08
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;94,31
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;94,91
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;94,5
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;92,86
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;92,94
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;91,03
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;91,52
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QIII;4.663
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QIII;4.710
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QIII;4.635
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2022QIII;4.490
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2022QII;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2022QI;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2021QIII;4.583
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2021QII;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2021QI;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2020QIII;4.493
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2020QII;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2020QI;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2022QIV;4.312
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2022QII;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2022QI;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2021QIV;4.404
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2021QII;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2021QI;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2020QIV;4.352
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2020QII;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2020QI;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QII;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QI;4.291
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QII;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QI;4.278
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QII;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QI;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QII;4.186
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QI;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QII;4.172
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QI;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QII;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QI;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;96,29
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;97,3
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;96,94
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;92,47
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;93,5
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;93,89
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;91,1
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;92,3
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;88,87
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;90,01
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QIV;12.038
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QIV;12.223
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QIV;12.234
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2022QIV;11.608
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2022QII;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2022QI;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2021QIV;11.785
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2021QII;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2021QI;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2020QIV;11.836
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2020QII;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2020QI;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2022QII;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2022QI;11.507
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2021QII;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2021QI;11.618
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2020QII;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2020QI;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QII;11.231
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QI;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QII;11.374
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QI;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QII;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QI;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QIII;11.004
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QII;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QI;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QIII;11.206
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QII;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QI;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QII;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QI;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;96,43
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;96,42
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;96,75
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;94,14
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;94,96
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;91,88
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;92,97
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;90,03
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;91,6
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QIV;7.407
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QIV;7.506
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QIV;7.568
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2022QIV;7.166
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2022QII;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2022QI;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2021QIV;7.260
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2021QII;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2021QI;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2020QIV;7.347
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2020QII;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2020QI;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2022QII;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2022QI;7.099
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2021QII;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2021QI;7.211
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2020QII;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2020QI;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QII;6.945
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QI;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QII;7.085
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QI;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QII;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QI;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QIII;6.828
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QII;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QI;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QIII;6.987
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QII;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QI;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QII;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QI;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;96,75
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;96,72
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;97,08
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;94,58
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;95,28
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;92,53
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;93,62
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;90,97
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;92,32
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QIV;4.631
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QIV;4.717
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QIV;4.666
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2022QIV;4.442
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2022QII;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2022QI;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2021QIV;4.525
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2021QII;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2021QI;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2020QIV;4.489
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2020QII;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2020QI;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2022QII;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2022QI;4.408
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2021QII;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2021QI;4.407
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2020QII;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2020QI;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QII;4.286
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QI;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QII;4.289
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QI;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QII;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QI;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QIII;4.176
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QII;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QI;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QIII;4.219
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QII;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QI;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QII;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QI;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;95,92
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;95,93
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;96,21
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;93,45
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;94,45
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;90,86
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;91,92
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;88,53
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;90,42
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QI;11.154
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QI;10.878
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QI;11.176
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2022QII;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2022QI;10.939
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2021QII;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2021QI;10.680
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2020QII;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2020QI;10.695
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2022QII;10.691
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2022QI;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2021QII;10.491
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2021QI;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2020QII;10.528
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2020QI;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QIII;10.492
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QII;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QI;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QIII;10.313
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QII;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QI;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QIII;10.333
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QII;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QI;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QIV;10.284
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QII;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QI;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QIV;10.131
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QII;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QI;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QIV;10.138
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QII;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QI;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;98,07
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;98,18
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;95,7
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;95,85
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;96,44
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;94,2
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;94,06
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;94,81
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;92,46
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;92,2
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;93,13
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;90,71
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QI;6.903
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QI;6.683
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QI;6.862
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2022QII;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2022QI;6.789
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2021QII;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2021QI;6.568
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2020QII;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2020QI;6.597
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2022QII;6.654
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2022QI;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2021QII;6.466
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2021QI;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2020QII;6.500
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2020QI;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QIII;6.546
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QII;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QI;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QIII;6.360
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QII;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QI;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QIII;6.377
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QII;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QI;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QIV;6.427
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QII;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QI;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QIV;6.267
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QII;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QI;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QIV;6.263
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QII;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QI;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;98,35
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;98,28
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;96,14
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;96,39
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;96,75
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;94,72
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;94,83
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;95,17
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;92,93
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;93,1
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;93,78
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;91,27
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QI;4.251
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QI;4.195
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QI;4.314
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2022QII;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2022QI;4.150
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2021QII;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2021QI;4.112
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2020QII;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2020QI;4.098
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2022QII;4.037
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2022QI;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2021QII;4.025
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2021QI;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2020QII;4.028
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2020QI;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QIII;3.946
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QII;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QI;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QIII;3.953
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QII;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QI;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QIII;3.956
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QII;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QI;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QIV;3.857
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QII;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QI;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QIV;3.864
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QII;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QI;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QIV;3.875
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QII;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QI;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;97,62
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;98,02
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;94,99
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;94,97
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;95,95
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;93,37
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;92,83
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;94,23
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;91,7
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;90,73
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;92,11
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;89,82
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QII;11.526
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QII;11.244
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QII;10.982
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2022QII;11.238
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2022QI;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2021QII;11.027
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2021QI;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2020QII;10.804
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2020QI;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2022QIII;11.002
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2022QII;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2022QI;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2021QIII;10.828
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2021QII;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2021QI;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2020QIII;10.575
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2020QII;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2020QI;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QIV;10.762
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QII;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QI;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QIV;10.588
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QII;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QI;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QIV;10.355
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QII;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QI;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QII;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QI;10.427
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QII;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QI;10.212
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QII;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QI;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;97,5
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;98,07
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;98,38
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;95,45
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;96,3
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;96,29
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;93,37
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;94,17
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;94,29
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;92,73
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;92,99
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QII;7.135
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QII;6.952
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QII;6.755
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2022QII;6.978
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2022QI;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2021QII;6.836
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2021QI;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2020QII;6.650
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2020QI;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2022QIII;6.845
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2022QII;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2022QI;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2021QIII;6.714
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2021QII;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2021QI;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2020QIII;6.505
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2020QII;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2020QI;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QIV;6.705
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QII;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QI;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QIV;6.582
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QII;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QI;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QIV;6.379
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QII;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QI;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QII;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QI;6.496
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QII;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QI;6.301
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QII;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QI;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;97,8
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;98,33
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;98,45
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;95,94
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;96,58
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;96,3
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;93,97
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;94,68
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;94,43
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;93,44
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;93,28
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QII;4.391
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QII;4.292
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QII;4.227
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2022QII;4.260
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2022QI;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2021QII;4.191
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2021QI;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2020QII;4.154
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2020QI;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2022QIII;4.157
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2022QII;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2022QI;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2021QIII;4.114
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2021QII;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2021QI;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2020QIII;4.070
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2020QII;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2020QI;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QIV;4.057
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QII;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QI;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QIV;4.006
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QII;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QI;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QIV;3.976
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QII;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QI;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QII;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QI;3.931
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QII;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QI;3.911
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QII;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QI;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;97,02
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;97,65
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;98,27
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;94,67
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;95,85
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;96,29
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;92,39
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;93,34
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;94,06
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;91,59
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;92,52
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QIII;11.543
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QIII;11.346
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QIII;11.049
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2022QIII;11.211
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2022QII;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2022QI;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2021QIII;11.071
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2021QII;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2021QI;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2020QIII;10.760
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2020QII;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2020QI;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2022QIV;10.920
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2022QII;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2022QI;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2021QIV;10.792
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2021QII;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2021QI;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2020QIV;10.505
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2020QII;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2020QI;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QII;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QI;10.618
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QII;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QI;10.346
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QII;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QI;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QII;10.420
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QI;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QII;10.199
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QI;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QII;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QI;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;97,12
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;97,58
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;97,38
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;94,6
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;95,12
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;95,08
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;93,58
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;93,64
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;91,84
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;92,31
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QIII;7.137
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QIII;6.998
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QIII;6.786
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2022QIII;6.958
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2022QII;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2022QI;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2021QIII;6.841
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2021QII;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2021QI;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2020QIII;6.610
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2020QII;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2020QI;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2022QIV;6.797
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2022QII;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2022QI;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2021QIV;6.688
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2021QII;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2021QI;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2020QIV;6.465
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2020QII;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2020QI;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QII;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QI;6.597
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QII;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QI;6.380
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QII;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QI;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QII;6.486
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QI;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QII;6.307
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QI;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QII;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QI;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;97,49
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;97,76
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;97,41
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;95,24
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;95,57
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;95,27
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;94,27
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;94,02
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;92,68
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;92,94
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QIII;4.406
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QIII;4.348
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QIII;4.263
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2022QIII;4.253
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2022QII;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2022QI;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2021QIII;4.230
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2021QII;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2021QI;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2020QIII;4.150
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2020QII;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2020QI;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2022QIV;4.123
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2022QII;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2022QI;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2021QIV;4.104
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2021QII;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2021QI;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2020QIV;4.040
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2020QII;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2020QI;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QII;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QI;4.021
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QII;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QI;3.966
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QII;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QI;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QII;3.934
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QI;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QII;3.892
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QI;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QII;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QI;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;96,53
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;97,29
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;97,35
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;93,58
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;94,39
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;94,77
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;92,48
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;93,03
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;90,48
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;91,3
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QIV;11.388
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QIV;11.251
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QIV;10.979
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2022QIV;11.074
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2022QII;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2022QI;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2021QIV;10.957
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2021QII;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2021QI;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2020QIV;10.686
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2020QII;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2020QI;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2022QII;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2022QI;10.773
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2021QII;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2021QI;10.514
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2020QII;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2020QI;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QII;10.555
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QI;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QII;10.347
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QI;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QII;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QI;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QIII;10.371
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QII;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QI;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QIII;10.183
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QII;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QI;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QII;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QI;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;97,24
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;97,39
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;97,33
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;95,75
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;95,76
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;93,81
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;94,24
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;92,18
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;92,75
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QIV;7.052
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QIV;6.950
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QIV;6.734
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2022QIV;6.877
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2022QII;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2022QI;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2021QIV;6.787
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2021QII;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2021QI;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2020QIV;6.570
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2020QII;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2020QI;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2022QII;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2022QI;6.691
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2021QII;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2021QI;6.474
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2020QII;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2020QI;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QII;6.570
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QI;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QII;6.389
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QI;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QII;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QI;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QIII;6.473
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QII;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QI;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QIII;6.290
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QII;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QI;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QII;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QI;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;97,52
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;97,65
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;97,56
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;96,27
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;96,14
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;94,53
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;94,88
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;93,14
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;93,41
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QIV;4.336
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QIV;4.301
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QIV;4.245
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2022QIV;4.197
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2022QII;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2022QI;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2021QIV;4.170
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2021QII;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2021QI;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2020QIV;4.116
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2020QII;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2020QI;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2022QII;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2022QI;4.082
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2021QII;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2021QI;4.040
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2020QII;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2020QI;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QII;3.985
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QI;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QII;3.958
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QI;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QII;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QI;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QIII;3.898
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QII;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QI;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QIII;3.893
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QII;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QI;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QII;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QI;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;96,79
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;96,95
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;96,96
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;94,91
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;95,17
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;92,65
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;93,24
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;90,63
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;91,71
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QI;5.266
12 Castellón/Castelló;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QI;4.976
12 Castellón/Castelló;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QI;5.807
12 Castellón/Castelló;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2022QII;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2022QI;5.091
12 Castellón/Castelló;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2021QII;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2021QI;4.793
12 Castellón/Castelló;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2020QII;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2020QI;5.406
12 Castellón/Castelló;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2022QII;4.891
12 Castellón/Castelló;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2022QI;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2021QII;4.582
12 Castellón/Castelló;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2021QI;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2020QII;5.240
12 Castellón/Castelló;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2020QI;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QIII;4.688
12 Castellón/Castelló;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QII;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QI;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QIII;4.411
12 Castellón/Castelló;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QII;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QI;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QIII;5.031
12 Castellón/Castelló;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QII;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QI;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QIV;4.369
12 Castellón/Castelló;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QII;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QI;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QIV;4.197
12 Castellón/Castelló;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QII;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QI;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QIV;4.748
12 Castellón/Castelló;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QII;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QI;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
12 Castellón/Castelló;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
12 Castellón/Castelló;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
12 Castellón/Castelló;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;96,68
12 Castellón/Castelló;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;96,32
12 Castellón/Castelló;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;93,09
12 Castellón/Castelló;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;92,88
12 Castellón/Castelló;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;92,08
12 Castellón/Castelló;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;90,24
12 Castellón/Castelló;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;89,02
12 Castellón/Castelló;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;88,65
12 Castellón/Castelló;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;86,64
12 Castellón/Castelló;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;82,97
12 Castellón/Castelló;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;84,34
12 Castellón/Castelló;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;81,76
12 Castellón/Castelló;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QI;3.309
12 Castellón/Castelló;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QI;3.120
12 Castellón/Castelló;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QI;3.615
12 Castellón/Castelló;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2022QII;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2022QI;3.191
12 Castellón/Castelló;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2021QII;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2021QI;3.009
12 Castellón/Castelló;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2020QII;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2020QI;3.376
12 Castellón/Castelló;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2022QII;3.073
12 Castellón/Castelló;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2022QI;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2021QII;2.875
12 Castellón/Castelló;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2021QI;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2020QII;3.275
12 Castellón/Castelló;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2020QI;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QIII;2.964
12 Castellón/Castelló;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QII;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QI;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QIII;2.779
12 Castellón/Castelló;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QII;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QI;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QIII;3.158
12 Castellón/Castelló;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QII;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QI;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QIV;2.740
12 Castellón/Castelló;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QII;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QI;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QIV;2.655
12 Castellón/Castelló;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QII;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QI;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QIV;2.993
12 Castellón/Castelló;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QII;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QI;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
12 Castellón/Castelló;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
12 Castellón/Castelló;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
12 Castellón/Castelló;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;96,43
12 Castellón/Castelló;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;96,44
12 Castellón/Castelló;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;93,39
12 Castellón/Castelló;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;92,87
12 Castellón/Castelló;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;92,15
12 Castellón/Castelló;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;90,59
12 Castellón/Castelló;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;89,57
12 Castellón/Castelló;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;89,07
12 Castellón/Castelló;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;87,36
12 Castellón/Castelló;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;82,8
12 Castellón/Castelló;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;85,1
12 Castellón/Castelló;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;82,79
12 Castellón/Castelló;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QI;1.957
12 Castellón/Castelló;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QI;1.856
12 Castellón/Castelló;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QI;2.192
12 Castellón/Castelló;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2022QII;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2022QI;1.900
12 Castellón/Castelló;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2021QII;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2021QI;1.784
12 Castellón/Castelló;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2020QII;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2020QI;2.030
12 Castellón/Castelló;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2022QII;1.818
12 Castellón/Castelló;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2022QI;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2021QII;1.707
12 Castellón/Castelló;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2021QI;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2020QII;1.965
12 Castellón/Castelló;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2020QI;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QIII;1.724
12 Castellón/Castelló;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QII;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QI;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QIII;1.632
12 Castellón/Castelló;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QII;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QI;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QIII;1.873
12 Castellón/Castelló;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QII;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QI;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QIV;1.629
12 Castellón/Castelló;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QII;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QI;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QIV;1.542
12 Castellón/Castelló;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QII;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QI;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QIV;1.755
12 Castellón/Castelló;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QII;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QI;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
12 Castellón/Castelló;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
12 Castellón/Castelló;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
12 Castellón/Castelló;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;97,09
12 Castellón/Castelló;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;96,12
12 Castellón/Castelló;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;92,61
12 Castellón/Castelló;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;92,9
12 Castellón/Castelló;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;91,97
12 Castellón/Castelló;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;89,64
12 Castellón/Castelló;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;88,09
12 Castellón/Castelló;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;87,93
12 Castellón/Castelló;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;85,45
12 Castellón/Castelló;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;83,24
12 Castellón/Castelló;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;83,08
12 Castellón/Castelló;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;80,06
12 Castellón/Castelló;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QII;6.064
12 Castellón/Castelló;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QII;5.776
12 Castellón/Castelló;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QII;5.505
12 Castellón/Castelló;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2022QII;5.835
12 Castellón/Castelló;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2022QI;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2021QII;5.551
12 Castellón/Castelló;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2021QI;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2020QII;5.337
12 Castellón/Castelló;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2020QI;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2022QIII;5.612
12 Castellón/Castelló;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2022QII;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2022QI;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2021QIII;5.357
12 Castellón/Castelló;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2021QII;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2021QI;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2020QIII;5.109
12 Castellón/Castelló;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2020QII;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2020QI;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QIV;5.260
12 Castellón/Castelló;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QII;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QI;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QIV;5.118
12 Castellón/Castelló;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QII;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QI;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QIV;4.819
12 Castellón/Castelló;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QII;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QI;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QII;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QI;4.964
12 Castellón/Castelló;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QII;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QI;4.654
12 Castellón/Castelló;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QII;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QI;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
12 Castellón/Castelló;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
12 Castellón/Castelló;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
12 Castellón/Castelló;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;96,22
12 Castellón/Castelló;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;96,1
12 Castellón/Castelló;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;96,95
12 Castellón/Castelló;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;92,55
12 Castellón/Castelló;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;92,75
12 Castellón/Castelló;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;92,81
12 Castellón/Castelló;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;86,74
12 Castellón/Castelló;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;88,61
12 Castellón/Castelló;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;87,54
12 Castellón/Castelló;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;85,94
12 Castellón/Castelló;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;84,54
12 Castellón/Castelló;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QII;3.809
12 Castellón/Castelló;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QII;3.610
12 Castellón/Castelló;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QII;3.430
12 Castellón/Castelló;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2022QII;3.671
12 Castellón/Castelló;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2022QI;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2021QII;3.470
12 Castellón/Castelló;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2021QI;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2020QII;3.327
12 Castellón/Castelló;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2020QI;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2022QIII;3.551
12 Castellón/Castelló;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2022QII;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2022QI;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2021QIII;3.361
12 Castellón/Castelló;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2021QII;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2021QI;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2020QIII;3.198
12 Castellón/Castelló;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2020QII;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2020QI;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QIV;3.307
12 Castellón/Castelló;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QII;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QI;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QIV;3.225
12 Castellón/Castelló;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QII;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QI;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QIV;3.028
12 Castellón/Castelló;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QII;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QI;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QII;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QI;3.121
12 Castellón/Castelló;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QII;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QI;2.930
12 Castellón/Castelló;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QII;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QI;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
12 Castellón/Castelló;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
12 Castellón/Castelló;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
12 Castellón/Castelló;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;96,38
12 Castellón/Castelló;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;96,12
12 Castellón/Castelló;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;97
12 Castellón/Castelló;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;93,23
12 Castellón/Castelló;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;93,1
12 Castellón/Castelló;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;93,24
12 Castellón/Castelló;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;86,82
12 Castellón/Castelló;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;89,34
12 Castellón/Castelló;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;88,28
12 Castellón/Castelló;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;86,45
12 Castellón/Castelló;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;85,42
12 Castellón/Castelló;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QII;2.255
12 Castellón/Castelló;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QII;2.166
12 Castellón/Castelló;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QII;2.075
12 Castellón/Castelló;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2022QII;2.164
12 Castellón/Castelló;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2022QI;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2021QII;2.081
12 Castellón/Castelló;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2021QI;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2020QII;2.010
12 Castellón/Castelló;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2020QI;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2022QIII;2.061
12 Castellón/Castelló;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2022QII;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2022QI;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2021QIII;1.996
12 Castellón/Castelló;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2021QII;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2021QI;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2020QIII;1.911
12 Castellón/Castelló;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2020QII;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2020QI;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QIV;1.953
12 Castellón/Castelló;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QII;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QI;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QIV;1.893
12 Castellón/Castelló;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QII;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QI;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QIV;1.791
12 Castellón/Castelló;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QII;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QI;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QII;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QI;1.843
12 Castellón/Castelló;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QII;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QI;1.724
12 Castellón/Castelló;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QII;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QI;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
12 Castellón/Castelló;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
12 Castellón/Castelló;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
12 Castellón/Castelló;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;95,96
12 Castellón/Castelló;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;96,08
12 Castellón/Castelló;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;96,87
12 Castellón/Castelló;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;91,4
12 Castellón/Castelló;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;92,15
12 Castellón/Castelló;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;92,1
12 Castellón/Castelló;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;86,61
12 Castellón/Castelló;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;87,4
12 Castellón/Castelló;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;86,31
12 Castellón/Castelló;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;85,09
12 Castellón/Castelló;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;83,08
12 Castellón/Castelló;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QIII;5.970
12 Castellón/Castelló;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QIII;5.667
12 Castellón/Castelló;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QIII;5.410
12 Castellón/Castelló;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2022QIII;5.696
12 Castellón/Castelló;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2022QII;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2022QI;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2021QIII;5.435
12 Castellón/Castelló;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2021QII;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2021QI;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2020QIII;5.162
12 Castellón/Castelló;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2020QII;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2020QI;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2022QIV;5.311
12 Castellón/Castelló;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2022QII;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2022QI;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2021QIV;5.173
12 Castellón/Castelló;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2021QII;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2021QI;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2020QIV;4.853
12 Castellón/Castelló;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2020QII;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2020QI;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QII;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QI;5.015
12 Castellón/Castelló;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QII;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QI;4.686
12 Castellón/Castelló;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QII;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QI;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QII;4.827
12 Castellón/Castelló;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QI;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QII;4.486
12 Castellón/Castelló;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QI;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QII;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QI;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
12 Castellón/Castelló;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
12 Castellón/Castelló;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
12 Castellón/Castelló;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;95,41
12 Castellón/Castelló;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;95,91
12 Castellón/Castelló;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;95,42
12 Castellón/Castelló;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;88,96
12 Castellón/Castelló;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;91,28
12 Castellón/Castelló;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;89,7
12 Castellón/Castelló;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;88,49
12 Castellón/Castelló;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;86,62
12 Castellón/Castelló;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;85,18
12 Castellón/Castelló;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;82,92
12 Castellón/Castelló;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QIII;3.746
12 Castellón/Castelló;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QIII;3.524
12 Castellón/Castelló;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QIII;3.360
12 Castellón/Castelló;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2022QIII;3.602
12 Castellón/Castelló;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2022QII;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2022QI;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2021QIII;3.399
12 Castellón/Castelló;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2021QII;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2021QI;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2020QIII;3.224
12 Castellón/Castelló;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2020QII;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2020QI;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2022QIV;3.342
12 Castellón/Castelló;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2022QII;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2022QI;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2021QIV;3.255
12 Castellón/Castelló;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2021QII;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2021QI;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2020QIV;3.045
12 Castellón/Castelló;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2020QII;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2020QI;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QII;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QI;3.147
12 Castellón/Castelló;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QII;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QI;2.946
12 Castellón/Castelló;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QII;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QI;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QII;3.038
12 Castellón/Castelló;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QI;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QII;2.822
12 Castellón/Castelló;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QI;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QII;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QI;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
12 Castellón/Castelló;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
12 Castellón/Castelló;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
12 Castellón/Castelló;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;96,16
12 Castellón/Castelló;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;96,45
12 Castellón/Castelló;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;95,95
12 Castellón/Castelló;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;89,22
12 Castellón/Castelló;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;92,37
12 Castellón/Castelló;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;90,63
12 Castellón/Castelló;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;89,3
12 Castellón/Castelló;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;87,68
12 Castellón/Castelló;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;86,21
12 Castellón/Castelló;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;83,99
12 Castellón/Castelló;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QIII;2.224
12 Castellón/Castelló;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QIII;2.143
12 Castellón/Castelló;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QIII;2.050
12 Castellón/Castelló;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2022QIII;2.094
12 Castellón/Castelló;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2022QII;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2022QI;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2021QIII;2.036
12 Castellón/Castelló;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2021QII;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2021QI;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2020QIII;1.938
12 Castellón/Castelló;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2020QII;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2020QI;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2022QIV;1.969
12 Castellón/Castelló;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2022QII;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2022QI;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2021QIV;1.918
12 Castellón/Castelló;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2021QII;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2021QI;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2020QIV;1.808
12 Castellón/Castelló;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2020QII;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2020QI;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QII;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QI;1.868
12 Castellón/Castelló;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QII;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QI;1.740
12 Castellón/Castelló;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QII;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QI;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QII;1.789
12 Castellón/Castelló;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QI;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QII;1.664
12 Castellón/Castelló;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QI;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QII;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QI;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
12 Castellón/Castelló;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
12 Castellón/Castelló;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
12 Castellón/Castelló;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;94,15
12 Castellón/Castelló;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;95,01
12 Castellón/Castelló;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;94,54
12 Castellón/Castelló;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;88,53
12 Castellón/Castelló;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;89,5
12 Castellón/Castelló;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;88,2
12 Castellón/Castelló;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;87,17
12 Castellón/Castelló;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;84,88
12 Castellón/Castelló;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;83,48
12 Castellón/Castelló;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;81,17
12 Castellón/Castelló;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QIV;5.750
12 Castellón/Castelló;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QIV;5.481
12 Castellón/Castelló;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QIV;5.235
12 Castellón/Castelló;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2022QIV;5.356
12 Castellón/Castelló;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2022QII;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2022QI;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2021QIV;5.205
12 Castellón/Castelló;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2021QII;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2021QI;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2020QIV;4.912
12 Castellón/Castelló;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2020QII;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2020QI;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2022QII;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2022QI;5.046
12 Castellón/Castelló;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2021QII;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2021QI;4.741
12 Castellón/Castelló;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2020QII;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2020QI;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QII;4.854
12 Castellón/Castelló;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QI;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QII;4.536
12 Castellón/Castelló;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QI;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QII;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QI;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QIII;4.652
12 Castellón/Castelló;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QII;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QI;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QIII;4.369
12 Castellón/Castelló;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QII;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QI;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QII;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QI;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
12 Castellón/Castelló;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
12 Castellón/Castelló;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
12 Castellón/Castelló;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;93,15
12 Castellón/Castelló;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;94,96
12 Castellón/Castelló;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;93,83
12 Castellón/Castelló;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;92,06
12 Castellón/Castelló;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;90,56
12 Castellón/Castelló;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;88,56
12 Castellón/Castelló;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;86,65
12 Castellón/Castelló;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;84,88
12 Castellón/Castelló;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;83,46
12 Castellón/Castelló;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QIV;3.630
12 Castellón/Castelló;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QIV;3.424
12 Castellón/Castelló;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QIV;3.269
12 Castellón/Castelló;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2022QIV;3.366
12 Castellón/Castelló;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2022QII;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2022QI;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2021QIV;3.275
12 Castellón/Castelló;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2021QII;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2021QI;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2020QIV;3.082
12 Castellón/Castelló;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2020QII;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2020QI;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2022QII;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2022QI;3.166
12 Castellón/Castelló;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2021QII;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2021QI;2.981
12 Castellón/Castelló;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2020QII;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2020QI;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QII;3.054
12 Castellón/Castelló;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QI;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QII;2.853
12 Castellón/Castelló;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QI;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QII;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QI;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QIII;2.946
12 Castellón/Castelló;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QII;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QI;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QIII;2.758
12 Castellón/Castelló;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QII;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QI;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QII;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QI;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
12 Castellón/Castelló;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
12 Castellón/Castelló;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
12 Castellón/Castelló;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;92,73
12 Castellón/Castelló;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;95,65
12 Castellón/Castelló;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;94,28
12 Castellón/Castelló;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;92,46
12 Castellón/Castelló;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;91,19
12 Castellón/Castelló;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;89,19
12 Castellón/Castelló;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;87,27
12 Castellón/Castelló;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;86,04
12 Castellón/Castelló;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;84,37
12 Castellón/Castelló;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QIV;2.120
12 Castellón/Castelló;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QIV;2.057
12 Castellón/Castelló;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QIV;1.966
12 Castellón/Castelló;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2022QIV;1.990
12 Castellón/Castelló;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2022QII;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2022QI;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2021QIV;1.930
12 Castellón/Castelló;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2021QII;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2021QI;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2020QIV;1.830
12 Castellón/Castelló;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2020QII;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2020QI;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2022QII;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2022QI;1.880
12 Castellón/Castelló;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2021QII;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2021QI;1.760
12 Castellón/Castelló;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2020QII;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2020QI;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QII;1.800
12 Castellón/Castelló;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QI;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QII;1.683
12 Castellón/Castelló;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QI;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QII;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QI;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QIII;1.706
12 Castellón/Castelló;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QII;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QI;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QIII;1.611
12 Castellón/Castelló;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QII;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QI;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QII;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QI;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
12 Castellón/Castelló;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
12 Castellón/Castelló;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
12 Castellón/Castelló;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;93,87
12 Castellón/Castelló;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;93,83
12 Castellón/Castelló;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;93,08
12 Castellón/Castelló;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;91,4
12 Castellón/Castelló;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;89,52
12 Castellón/Castelló;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;87,51
12 Castellón/Castelló;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;85,61
12 Castellón/Castelló;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;82,94
12 Castellón/Castelló;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;81,94
12 Castellón/Castelló;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
13 Ciudad Real;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
13 Ciudad Real;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
13 Ciudad Real;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
13 Ciudad Real;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QI;28.807
13 Ciudad Real;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
13 Ciudad Real;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
13 Ciudad Real;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
13 Ciudad Real;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QI;28.330
13 Ciudad Real;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
13 Ciudad Real;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
13 Ciudad Real;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
13 Ciudad Real;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QI;28.765
13 Ciudad Real;All ages;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
13 Ciudad Real;All ages;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
13 Ciudad Real;All ages;Cohort January 1;Total;Survival in the first trimester;2022QII;""
13 Ciudad Real;All ages;Cohort January 1;Total;Survival in the first trimester;2022QI;27.949
13 Ciudad Real;All ages;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
13 Ciudad Real;All ages;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
13 Ciudad Real;All ages;Cohort January 1;Total;Survival in the first trimester;2021QII;""
13 Ciudad Real;All ages;Cohort January 1;Total;Survival in the first trimester;2021QI;27.746
13 Ciudad Real;All ages;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
13 Ciudad Real;All ages;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
13 Ciudad Real;All ages;Cohort January 1;Total;Survival in the first trimester;2020QII;""
13 Ciudad Real;All ages;Cohort January 1;Total;Survival in the first trimester;2020QI;26.970
13 Ciudad Real;All ages;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
13 Ciudad Real;All ages;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
13 Ciudad Real;All ages;Cohort January 1;Total;Survival in the second trimester;2022QII;27.114
13 Ciudad Real;All ages;Cohort January 1;Total;Survival in the second trimester;2022QI;""
13 Ciudad Real;All ages;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
13 Ciudad Real;All ages;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
13 Ciudad Real;All ages;Cohort January 1;Total;Survival in the second trimester;2021QII;27.143
13 Ciudad Real;All ages;Cohort January 1;Total;Survival in the second trimester;2021QI;""
13 Ciudad Real;All ages;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
13 Ciudad Real;All ages;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
13 Ciudad Real;All ages;Cohort January 1;Total;Survival in the second trimester;2020QII;26.429
13 Ciudad Real;All ages;Cohort January 1;Total;Survival in the second trimester;2020QI;""
13 Ciudad Real;All ages;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
13 Ciudad Real;All ages;Cohort January 1;Total;Survival in the third trimester;2022QIII;26.442
13 Ciudad Real;All ages;Cohort January 1;Total;Survival in the third trimester;2022QII;""
13 Ciudad Real;All ages;Cohort January 1;Total;Survival in the third trimester;2022QI;""
13 Ciudad Real;All ages;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
13 Ciudad Real;All ages;Cohort January 1;Total;Survival in the third trimester;2021QIII;26.574
13 Ciudad Real;All ages;Cohort January 1;Total;Survival in the third trimester;2021QII;""
13 Ciudad Real;All ages;Cohort January 1;Total;Survival in the third trimester;2021QI;""
13 Ciudad Real;All ages;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
13 Ciudad Real;All ages;Cohort January 1;Total;Survival in the third trimester;2020QIII;25.884
13 Ciudad Real;All ages;Cohort January 1;Total;Survival in the third trimester;2020QII;""
13 Ciudad Real;All ages;Cohort January 1;Total;Survival in the third trimester;2020QI;""
13 Ciudad Real;All ages;Cohort January 1;Total;Survival in the third trimester;2022QIV;25.685
13 Ciudad Real;All ages;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
13 Ciudad Real;All ages;Cohort January 1;Total;Survival in the third trimester;2022QII;""
13 Ciudad Real;All ages;Cohort January 1;Total;Survival in the third trimester;2022QI;""
13 Ciudad Real;All ages;Cohort January 1;Total;Survival in the third trimester;2021QIV;25.957
13 Ciudad Real;All ages;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
13 Ciudad Real;All ages;Cohort January 1;Total;Survival in the third trimester;2021QII;""
13 Ciudad Real;All ages;Cohort January 1;Total;Survival in the third trimester;2021QI;""
13 Ciudad Real;All ages;Cohort January 1;Total;Survival in the third trimester;2020QIV;25.299
13 Ciudad Real;All ages;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
13 Ciudad Real;All ages;Cohort January 1;Total;Survival in the third trimester;2020QII;""
13 Ciudad Real;All ages;Cohort January 1;Total;Survival in the third trimester;2020QI;""
13 Ciudad Real;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
13 Ciudad Real;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
13 Ciudad Real;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
13 Ciudad Real;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
13 Ciudad Real;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
13 Ciudad Real;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
13 Ciudad Real;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
13 Ciudad Real;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
13 Ciudad Real;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
13 Ciudad Real;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
13 Ciudad Real;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
13 Ciudad Real;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
13 Ciudad Real;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
13 Ciudad Real;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
13 Ciudad Real;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
13 Ciudad Real;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;97,02
13 Ciudad Real;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
13 Ciudad Real;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
13 Ciudad Real;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
13 Ciudad Real;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;97,94
13 Ciudad Real;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
13 Ciudad Real;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
13 Ciudad Real;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
13 Ciudad Real;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;93,76
13 Ciudad Real;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
13 Ciudad Real;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
13 Ciudad Real;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;94,12
13 Ciudad Real;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
13 Ciudad Real;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
13 Ciudad Real;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
13 Ciudad Real;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;95,81
13 Ciudad Real;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
13 Ciudad Real;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
13 Ciudad Real;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
13 Ciudad Real;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;91,88
13 Ciudad Real;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
13 Ciudad Real;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
13 Ciudad Real;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;91,79
13 Ciudad Real;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
13 Ciudad Real;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
13 Ciudad Real;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
13 Ciudad Real;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;93,8
13 Ciudad Real;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
13 Ciudad Real;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
13 Ciudad Real;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
13 Ciudad Real;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;89,98
13 Ciudad Real;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
13 Ciudad Real;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
13 Ciudad Real;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;89,16
13 Ciudad Real;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
13 Ciudad Real;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
13 Ciudad Real;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
13 Ciudad Real;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;91,62
13 Ciudad Real;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
13 Ciudad Real;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
13 Ciudad Real;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
13 Ciudad Real;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;87,95
13 Ciudad Real;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
13 Ciudad Real;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
13 Ciudad Real;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
13 Ciudad Real;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
13 Ciudad Real;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
13 Ciudad Real;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
13 Ciudad Real;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QI;18.905
13 Ciudad Real;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
13 Ciudad Real;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
13 Ciudad Real;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
13 Ciudad Real;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QI;18.744
13 Ciudad Real;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
13 Ciudad Real;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
13 Ciudad Real;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
13 Ciudad Real;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QI;19.099
13 Ciudad Real;All ages;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
13 Ciudad Real;All ages;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
13 Ciudad Real;All ages;Cohort January 1;Males;Survival in the first trimester;2022QII;""
13 Ciudad Real;All ages;Cohort January 1;Males;Survival in the first trimester;2022QI;18.395
13 Ciudad Real;All ages;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
13 Ciudad Real;All ages;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
13 Ciudad Real;All ages;Cohort January 1;Males;Survival in the first trimester;2021QII;""
13 Ciudad Real;All ages;Cohort January 1;Males;Survival in the first trimester;2021QI;18.383
13 Ciudad Real;All ages;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
13 Ciudad Real;All ages;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
13 Ciudad Real;All ages;Cohort January 1;Males;Survival in the first trimester;2020QII;""
13 Ciudad Real;All ages;Cohort January 1;Males;Survival in the first trimester;2020QI;17.988
13 Ciudad Real;All ages;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
13 Ciudad Real;All ages;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
13 Ciudad Real;All ages;Cohort January 1;Males;Survival in the second trimester;2022QII;17.912
13 Ciudad Real;All ages;Cohort January 1;Males;Survival in the second trimester;2022QI;""
13 Ciudad Real;All ages;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
13 Ciudad Real;All ages;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
13 Ciudad Real;All ages;Cohort January 1;Males;Survival in the second trimester;2021QII;18.016
13 Ciudad Real;All ages;Cohort January 1;Males;Survival in the second trimester;2021QI;""
13 Ciudad Real;All ages;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
13 Ciudad Real;All ages;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
13 Ciudad Real;All ages;Cohort January 1;Males;Survival in the second trimester;2020QII;17.652
13 Ciudad Real;All ages;Cohort January 1;Males;Survival in the second trimester;2020QI;""
13 Ciudad Real;All ages;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
13 Ciudad Real;All ages;Cohort January 1;Males;Survival in the third trimester;2022QIII;17.506
13 Ciudad Real;All ages;Cohort January 1;Males;Survival in the third trimester;2022QII;""
13 Ciudad Real;All ages;Cohort January 1;Males;Survival in the third trimester;2022QI;""
13 Ciudad Real;All ages;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
13 Ciudad Real;All ages;Cohort January 1;Males;Survival in the third trimester;2021QIII;17.684
13 Ciudad Real;All ages;Cohort January 1;Males;Survival in the third trimester;2021QII;""
13 Ciudad Real;All ages;Cohort January 1;Males;Survival in the third trimester;2021QI;""
13 Ciudad Real;All ages;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
13 Ciudad Real;All ages;Cohort January 1;Males;Survival in the third trimester;2020QIII;17.346
13 Ciudad Real;All ages;Cohort January 1;Males;Survival in the third trimester;2020QII;""
13 Ciudad Real;All ages;Cohort January 1;Males;Survival in the third trimester;2020QI;""
13 Ciudad Real;All ages;Cohort January 1;Males;Survival in the third trimester;2022QIV;17.039
13 Ciudad Real;All ages;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
13 Ciudad Real;All ages;Cohort January 1;Males;Survival in the third trimester;2022QII;""
13 Ciudad Real;All ages;Cohort January 1;Males;Survival in the third trimester;2022QI;""
13 Ciudad Real;All ages;Cohort January 1;Males;Survival in the third trimester;2021QIV;17.290
13 Ciudad Real;All ages;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
13 Ciudad Real;All ages;Cohort January 1;Males;Survival in the third trimester;2021QII;""
13 Ciudad Real;All ages;Cohort January 1;Males;Survival in the third trimester;2021QI;""
13 Ciudad Real;All ages;Cohort January 1;Males;Survival in the third trimester;2020QIV;16.986
13 Ciudad Real;All ages;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
13 Ciudad Real;All ages;Cohort January 1;Males;Survival in the third trimester;2020QII;""
13 Ciudad Real;All ages;Cohort January 1;Males;Survival in the third trimester;2020QI;""
13 Ciudad Real;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
13 Ciudad Real;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
13 Ciudad Real;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
13 Ciudad Real;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
13 Ciudad Real;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
13 Ciudad Real;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
13 Ciudad Real;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
13 Ciudad Real;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
13 Ciudad Real;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
13 Ciudad Real;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
13 Ciudad Real;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
13 Ciudad Real;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
13 Ciudad Real;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
13 Ciudad Real;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
13 Ciudad Real;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
13 Ciudad Real;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;97,3
13 Ciudad Real;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
13 Ciudad Real;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
13 Ciudad Real;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
13 Ciudad Real;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;98,07
13 Ciudad Real;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
13 Ciudad Real;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
13 Ciudad Real;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
13 Ciudad Real;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;94,18
13 Ciudad Real;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
13 Ciudad Real;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
13 Ciudad Real;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;94,75
13 Ciudad Real;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
13 Ciudad Real;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
13 Ciudad Real;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
13 Ciudad Real;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;96,12
13 Ciudad Real;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
13 Ciudad Real;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
13 Ciudad Real;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
13 Ciudad Real;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;92,42
13 Ciudad Real;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
13 Ciudad Real;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
13 Ciudad Real;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;92,6
13 Ciudad Real;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
13 Ciudad Real;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
13 Ciudad Real;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
13 Ciudad Real;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;94,34
13 Ciudad Real;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
13 Ciudad Real;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
13 Ciudad Real;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
13 Ciudad Real;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;90,82
13 Ciudad Real;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
13 Ciudad Real;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
13 Ciudad Real;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;90,13
13 Ciudad Real;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
13 Ciudad Real;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
13 Ciudad Real;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
13 Ciudad Real;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;92,24
13 Ciudad Real;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
13 Ciudad Real;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
13 Ciudad Real;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
13 Ciudad Real;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;88,94
13 Ciudad Real;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
13 Ciudad Real;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
13 Ciudad Real;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
13 Ciudad Real;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
13 Ciudad Real;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
13 Ciudad Real;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
13 Ciudad Real;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QI;9.902
13 Ciudad Real;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
13 Ciudad Real;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
13 Ciudad Real;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
13 Ciudad Real;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QI;9.586
13 Ciudad Real;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
13 Ciudad Real;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
13 Ciudad Real;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
13 Ciudad Real;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QI;9.666
13 Ciudad Real;All ages;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
13 Ciudad Real;All ages;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
13 Ciudad Real;All ages;Cohort January 1;Females;Survival in the first trimester;2022QII;""
13 Ciudad Real;All ages;Cohort January 1;Females;Survival in the first trimester;2022QI;9.554
13 Ciudad Real;All ages;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
13 Ciudad Real;All ages;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
13 Ciudad Real;All ages;Cohort January 1;Females;Survival in the first trimester;2021QII;""
13 Ciudad Real;All ages;Cohort January 1;Females;Survival in the first trimester;2021QI;9.363
13 Ciudad Real;All ages;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
13 Ciudad Real;All ages;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
13 Ciudad Real;All ages;Cohort January 1;Females;Survival in the first trimester;2020QII;""
13 Ciudad Real;All ages;Cohort January 1;Females;Survival in the first trimester;2020QI;8.982
13 Ciudad Real;All ages;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
13 Ciudad Real;All ages;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
13 Ciudad Real;All ages;Cohort January 1;Females;Survival in the second trimester;2022QII;9.202
13 Ciudad Real;All ages;Cohort January 1;Females;Survival in the second trimester;2022QI;""
13 Ciudad Real;All ages;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
13 Ciudad Real;All ages;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
13 Ciudad Real;All ages;Cohort January 1;Females;Survival in the second trimester;2021QII;9.127
13 Ciudad Real;All ages;Cohort January 1;Females;Survival in the second trimester;2021QI;""
13 Ciudad Real;All ages;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
13 Ciudad Real;All ages;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
13 Ciudad Real;All ages;Cohort January 1;Females;Survival in the second trimester;2020QII;8.777
13 Ciudad Real;All ages;Cohort January 1;Females;Survival in the second trimester;2020QI;""
13 Ciudad Real;All ages;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
13 Ciudad Real;All ages;Cohort January 1;Females;Survival in the third trimester;2022QIII;8.936
13 Ciudad Real;All ages;Cohort January 1;Females;Survival in the third trimester;2022QII;""
13 Ciudad Real;All ages;Cohort January 1;Females;Survival in the third trimester;2022QI;""
13 Ciudad Real;All ages;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
13 Ciudad Real;All ages;Cohort January 1;Females;Survival in the third trimester;2021QIII;8.890
13 Ciudad Real;All ages;Cohort January 1;Females;Survival in the third trimester;2021QII;""
13 Ciudad Real;All ages;Cohort January 1;Females;Survival in the third trimester;2021QI;""
13 Ciudad Real;All ages;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
13 Ciudad Real;All ages;Cohort January 1;Females;Survival in the third trimester;2020QIII;8.538
13 Ciudad Real;All ages;Cohort January 1;Females;Survival in the third trimester;2020QII;""
13 Ciudad Real;All ages;Cohort January 1;Females;Survival in the third trimester;2020QI;""
13 Ciudad Real;All ages;Cohort January 1;Females;Survival in the third trimester;2022QIV;8.646
13 Ciudad Real;All ages;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
13 Ciudad Real;All ages;Cohort January 1;Females;Survival in the third trimester;2022QII;""
13 Ciudad Real;All ages;Cohort January 1;Females;Survival in the third trimester;2022QI;""
13 Ciudad Real;All ages;Cohort January 1;Females;Survival in the third trimester;2021QIV;8.667
13 Ciudad Real;All ages;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
13 Ciudad Real;All ages;Cohort January 1;Females;Survival in the third trimester;2021QII;""
13 Ciudad Real;All ages;Cohort January 1;Females;Survival in the third trimester;2021QI;""
13 Ciudad Real;All ages;Cohort January 1;Females;Survival in the third trimester;2020QIV;8.313
13 Ciudad Real;All ages;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
13 Ciudad Real;All ages;Cohort January 1;Females;Survival in the third trimester;2020QII;""
13 Ciudad Real;All ages;Cohort January 1;Females;Survival in the third trimester;2020QI;""
13 Ciudad Real;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
13 Ciudad Real;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
13 Ciudad Real;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
13 Ciudad Real;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
13 Ciudad Real;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
13 Ciudad Real;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
13 Ciudad Real;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
13 Ciudad Real;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
13 Ciudad Real;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
13 Ciudad Real;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
13 Ciudad Real;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
13 Ciudad Real;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
13 Ciudad Real;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
13 Ciudad Real;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
13 Ciudad Real;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
13 Ciudad Real;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;96,49
13 Ciudad Real;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
13 Ciudad Real;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
13 Ciudad Real;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
13 Ciudad Real;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;97,67
13 Ciudad Real;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
13 Ciudad Real;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
13 Ciudad Real;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
13 Ciudad Real;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;92,92
13 Ciudad Real;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
13 Ciudad Real;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
13 Ciudad Real;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;92,93
13 Ciudad Real;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
13 Ciudad Real;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
13 Ciudad Real;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
13 Ciudad Real;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;95,21
13 Ciudad Real;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
13 Ciudad Real;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
13 Ciudad Real;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
13 Ciudad Real;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;90,8
13 Ciudad Real;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
13 Ciudad Real;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
13 Ciudad Real;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;90,24
13 Ciudad Real;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
13 Ciudad Real;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
13 Ciudad Real;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
13 Ciudad Real;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;92,74
13 Ciudad Real;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
13 Ciudad Real;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
13 Ciudad Real;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
13 Ciudad Real;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;88,33
13 Ciudad Real;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
13 Ciudad Real;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
13 Ciudad Real;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;87,32
13 Ciudad Real;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
13 Ciudad Real;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
13 Ciudad Real;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
13 Ciudad Real;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;90,41
13 Ciudad Real;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
13 Ciudad Real;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
13 Ciudad Real;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
13 Ciudad Real;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;86
13 Ciudad Real;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
13 Ciudad Real;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
13 Ciudad Real;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
13 Ciudad Real;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
13 Ciudad Real;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
13 Ciudad Real;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QII;28.811
13 Ciudad Real;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
13 Ciudad Real;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
13 Ciudad Real;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
13 Ciudad Real;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QII;28.617
13 Ciudad Real;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
13 Ciudad Real;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
13 Ciudad Real;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
13 Ciudad Real;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QII;27.997
13 Ciudad Real;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
13 Ciudad Real;All ages;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
13 Ciudad Real;All ages;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
13 Ciudad Real;All ages;Cohort April 1;Total;Survival in the first trimester;2022QII;27.890
13 Ciudad Real;All ages;Cohort April 1;Total;Survival in the first trimester;2022QI;""
13 Ciudad Real;All ages;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
13 Ciudad Real;All ages;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
13 Ciudad Real;All ages;Cohort April 1;Total;Survival in the first trimester;2021QII;27.929
13 Ciudad Real;All ages;Cohort April 1;Total;Survival in the first trimester;2021QI;""
13 Ciudad Real;All ages;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
13 Ciudad Real;All ages;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
13 Ciudad Real;All ages;Cohort April 1;Total;Survival in the first trimester;2020QII;27.406
13 Ciudad Real;All ages;Cohort April 1;Total;Survival in the first trimester;2020QI;""
13 Ciudad Real;All ages;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
13 Ciudad Real;All ages;Cohort April 1;Total;Survival in the second trimester;2022QIII;27.157
13 Ciudad Real;All ages;Cohort April 1;Total;Survival in the second trimester;2022QII;""
13 Ciudad Real;All ages;Cohort April 1;Total;Survival in the second trimester;2022QI;""
13 Ciudad Real;All ages;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
13 Ciudad Real;All ages;Cohort April 1;Total;Survival in the second trimester;2021QIII;27.305
13 Ciudad Real;All ages;Cohort April 1;Total;Survival in the second trimester;2021QII;""
13 Ciudad Real;All ages;Cohort April 1;Total;Survival in the second trimester;2021QI;""
13 Ciudad Real;All ages;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
13 Ciudad Real;All ages;Cohort April 1;Total;Survival in the second trimester;2020QIII;26.760
13 Ciudad Real;All ages;Cohort April 1;Total;Survival in the second trimester;2020QII;""
13 Ciudad Real;All ages;Cohort April 1;Total;Survival in the second trimester;2020QI;""
13 Ciudad Real;All ages;Cohort April 1;Total;Survival in the third trimester;2022QIV;26.345
13 Ciudad Real;All ages;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
13 Ciudad Real;All ages;Cohort April 1;Total;Survival in the third trimester;2022QII;""
13 Ciudad Real;All ages;Cohort April 1;Total;Survival in the third trimester;2022QI;""
13 Ciudad Real;All ages;Cohort April 1;Total;Survival in the third trimester;2021QIV;26.614
13 Ciudad Real;All ages;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
13 Ciudad Real;All ages;Cohort April 1;Total;Survival in the third trimester;2021QII;""
13 Ciudad Real;All ages;Cohort April 1;Total;Survival in the third trimester;2021QI;""
13 Ciudad Real;All ages;Cohort April 1;Total;Survival in the third trimester;2020QIV;26.132
13 Ciudad Real;All ages;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
13 Ciudad Real;All ages;Cohort April 1;Total;Survival in the third trimester;2020QII;""
13 Ciudad Real;All ages;Cohort April 1;Total;Survival in the third trimester;2020QI;""
13 Ciudad Real;All ages;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
13 Ciudad Real;All ages;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
13 Ciudad Real;All ages;Cohort April 1;Total;Survival in the third trimester;2022QII;""
13 Ciudad Real;All ages;Cohort April 1;Total;Survival in the third trimester;2022QI;25.950
13 Ciudad Real;All ages;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
13 Ciudad Real;All ages;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
13 Ciudad Real;All ages;Cohort April 1;Total;Survival in the third trimester;2021QII;""
13 Ciudad Real;All ages;Cohort April 1;Total;Survival in the third trimester;2021QI;25.703
13 Ciudad Real;All ages;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
13 Ciudad Real;All ages;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
13 Ciudad Real;All ages;Cohort April 1;Total;Survival in the third trimester;2020QII;""
13 Ciudad Real;All ages;Cohort April 1;Total;Survival in the third trimester;2020QI;""
13 Ciudad Real;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
13 Ciudad Real;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
13 Ciudad Real;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
13 Ciudad Real;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
13 Ciudad Real;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
13 Ciudad Real;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
13 Ciudad Real;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
13 Ciudad Real;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
13 Ciudad Real;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
13 Ciudad Real;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
13 Ciudad Real;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
13 Ciudad Real;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
13 Ciudad Real;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
13 Ciudad Real;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
13 Ciudad Real;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;96,8
13 Ciudad Real;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
13 Ciudad Real;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
13 Ciudad Real;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
13 Ciudad Real;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;97,6
13 Ciudad Real;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
13 Ciudad Real;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
13 Ciudad Real;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
13 Ciudad Real;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;97,89
13 Ciudad Real;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
13 Ciudad Real;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
13 Ciudad Real;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;94,26
13 Ciudad Real;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
13 Ciudad Real;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
13 Ciudad Real;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
13 Ciudad Real;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;95,42
13 Ciudad Real;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
13 Ciudad Real;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
13 Ciudad Real;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
13 Ciudad Real;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;95,58
13 Ciudad Real;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
13 Ciudad Real;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
13 Ciudad Real;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;91,44
13 Ciudad Real;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
13 Ciudad Real;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
13 Ciudad Real;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
13 Ciudad Real;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;93
13 Ciudad Real;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
13 Ciudad Real;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
13 Ciudad Real;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
13 Ciudad Real;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;93,34
13 Ciudad Real;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
13 Ciudad Real;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
13 Ciudad Real;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
13 Ciudad Real;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
13 Ciudad Real;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
13 Ciudad Real;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
13 Ciudad Real;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;90,68
13 Ciudad Real;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
13 Ciudad Real;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
13 Ciudad Real;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
13 Ciudad Real;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;91,81
13 Ciudad Real;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
13 Ciudad Real;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
13 Ciudad Real;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
13 Ciudad Real;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
13 Ciudad Real;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
13 Ciudad Real;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
13 Ciudad Real;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QII;18.880
13 Ciudad Real;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
13 Ciudad Real;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
13 Ciudad Real;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
13 Ciudad Real;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QII;18.923
13 Ciudad Real;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
13 Ciudad Real;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
13 Ciudad Real;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
13 Ciudad Real;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QII;18.619
13 Ciudad Real;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
13 Ciudad Real;All ages;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
13 Ciudad Real;All ages;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
13 Ciudad Real;All ages;Cohort April 1;Males;Survival in the first trimester;2022QII;18.349
13 Ciudad Real;All ages;Cohort April 1;Males;Survival in the first trimester;2022QI;""
13 Ciudad Real;All ages;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
13 Ciudad Real;All ages;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
13 Ciudad Real;All ages;Cohort April 1;Males;Survival in the first trimester;2021QII;18.497
13 Ciudad Real;All ages;Cohort April 1;Males;Survival in the first trimester;2021QI;""
13 Ciudad Real;All ages;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
13 Ciudad Real;All ages;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
13 Ciudad Real;All ages;Cohort April 1;Males;Survival in the first trimester;2020QII;18.247
13 Ciudad Real;All ages;Cohort April 1;Males;Survival in the first trimester;2020QI;""
13 Ciudad Real;All ages;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
13 Ciudad Real;All ages;Cohort April 1;Males;Survival in the second trimester;2022QIII;17.901
13 Ciudad Real;All ages;Cohort April 1;Males;Survival in the second trimester;2022QII;""
13 Ciudad Real;All ages;Cohort April 1;Males;Survival in the second trimester;2022QI;""
13 Ciudad Real;All ages;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
13 Ciudad Real;All ages;Cohort April 1;Males;Survival in the second trimester;2021QIII;18.127
13 Ciudad Real;All ages;Cohort April 1;Males;Survival in the second trimester;2021QII;""
13 Ciudad Real;All ages;Cohort April 1;Males;Survival in the second trimester;2021QI;""
13 Ciudad Real;All ages;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
13 Ciudad Real;All ages;Cohort April 1;Males;Survival in the second trimester;2020QIII;17.867
13 Ciudad Real;All ages;Cohort April 1;Males;Survival in the second trimester;2020QII;""
13 Ciudad Real;All ages;Cohort April 1;Males;Survival in the second trimester;2020QI;""
13 Ciudad Real;All ages;Cohort April 1;Males;Survival in the third trimester;2022QIV;17.401
13 Ciudad Real;All ages;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
13 Ciudad Real;All ages;Cohort April 1;Males;Survival in the third trimester;2022QII;""
13 Ciudad Real;All ages;Cohort April 1;Males;Survival in the third trimester;2022QI;""
13 Ciudad Real;All ages;Cohort April 1;Males;Survival in the third trimester;2021QIV;17.680
13 Ciudad Real;All ages;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
13 Ciudad Real;All ages;Cohort April 1;Males;Survival in the third trimester;2021QII;""
13 Ciudad Real;All ages;Cohort April 1;Males;Survival in the third trimester;2021QI;""
13 Ciudad Real;All ages;Cohort April 1;Males;Survival in the third trimester;2020QIV;17.472
13 Ciudad Real;All ages;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
13 Ciudad Real;All ages;Cohort April 1;Males;Survival in the third trimester;2020QII;""
13 Ciudad Real;All ages;Cohort April 1;Males;Survival in the third trimester;2020QI;""
13 Ciudad Real;All ages;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
13 Ciudad Real;All ages;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
13 Ciudad Real;All ages;Cohort April 1;Males;Survival in the third trimester;2022QII;""
13 Ciudad Real;All ages;Cohort April 1;Males;Survival in the third trimester;2022QI;17.287
13 Ciudad Real;All ages;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
13 Ciudad Real;All ages;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
13 Ciudad Real;All ages;Cohort April 1;Males;Survival in the third trimester;2021QII;""
13 Ciudad Real;All ages;Cohort April 1;Males;Survival in the third trimester;2021QI;17.208
13 Ciudad Real;All ages;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
13 Ciudad Real;All ages;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
13 Ciudad Real;All ages;Cohort April 1;Males;Survival in the third trimester;2020QII;""
13 Ciudad Real;All ages;Cohort April 1;Males;Survival in the third trimester;2020QI;""
13 Ciudad Real;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
13 Ciudad Real;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
13 Ciudad Real;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
13 Ciudad Real;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
13 Ciudad Real;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
13 Ciudad Real;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
13 Ciudad Real;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
13 Ciudad Real;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
13 Ciudad Real;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
13 Ciudad Real;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
13 Ciudad Real;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
13 Ciudad Real;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
13 Ciudad Real;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
13 Ciudad Real;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
13 Ciudad Real;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;97,19
13 Ciudad Real;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
13 Ciudad Real;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
13 Ciudad Real;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
13 Ciudad Real;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;97,75
13 Ciudad Real;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
13 Ciudad Real;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
13 Ciudad Real;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
13 Ciudad Real;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;98
13 Ciudad Real;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
13 Ciudad Real;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
13 Ciudad Real;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;94,81
13 Ciudad Real;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
13 Ciudad Real;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
13 Ciudad Real;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
13 Ciudad Real;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;95,79
13 Ciudad Real;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
13 Ciudad Real;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
13 Ciudad Real;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
13 Ciudad Real;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;95,96
13 Ciudad Real;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
13 Ciudad Real;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
13 Ciudad Real;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;92,17
13 Ciudad Real;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
13 Ciudad Real;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
13 Ciudad Real;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
13 Ciudad Real;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;93,43
13 Ciudad Real;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
13 Ciudad Real;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
13 Ciudad Real;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
13 Ciudad Real;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;93,84
13 Ciudad Real;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
13 Ciudad Real;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
13 Ciudad Real;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
13 Ciudad Real;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
13 Ciudad Real;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
13 Ciudad Real;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
13 Ciudad Real;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;91,35
13 Ciudad Real;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
13 Ciudad Real;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
13 Ciudad Real;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
13 Ciudad Real;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;92,42
13 Ciudad Real;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
13 Ciudad Real;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
13 Ciudad Real;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
13 Ciudad Real;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
13 Ciudad Real;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
13 Ciudad Real;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
13 Ciudad Real;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QII;9.931
13 Ciudad Real;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
13 Ciudad Real;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
13 Ciudad Real;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
13 Ciudad Real;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QII;9.694
13 Ciudad Real;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
13 Ciudad Real;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
13 Ciudad Real;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
13 Ciudad Real;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QII;9.378
13 Ciudad Real;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
13 Ciudad Real;All ages;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
13 Ciudad Real;All ages;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
13 Ciudad Real;All ages;Cohort April 1;Females;Survival in the first trimester;2022QII;9.541
13 Ciudad Real;All ages;Cohort April 1;Females;Survival in the first trimester;2022QI;""
13 Ciudad Real;All ages;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
13 Ciudad Real;All ages;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
13 Ciudad Real;All ages;Cohort April 1;Females;Survival in the first trimester;2021QII;9.432
13 Ciudad Real;All ages;Cohort April 1;Females;Survival in the first trimester;2021QI;""
13 Ciudad Real;All ages;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
13 Ciudad Real;All ages;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
13 Ciudad Real;All ages;Cohort April 1;Females;Survival in the first trimester;2020QII;9.159
13 Ciudad Real;All ages;Cohort April 1;Females;Survival in the first trimester;2020QI;""
13 Ciudad Real;All ages;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
13 Ciudad Real;All ages;Cohort April 1;Females;Survival in the second trimester;2022QIII;9.256
13 Ciudad Real;All ages;Cohort April 1;Females;Survival in the second trimester;2022QII;""
13 Ciudad Real;All ages;Cohort April 1;Females;Survival in the second trimester;2022QI;""
13 Ciudad Real;All ages;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
13 Ciudad Real;All ages;Cohort April 1;Females;Survival in the second trimester;2021QIII;9.178
13 Ciudad Real;All ages;Cohort April 1;Females;Survival in the second trimester;2021QII;""
13 Ciudad Real;All ages;Cohort April 1;Females;Survival in the second trimester;2021QI;""
13 Ciudad Real;All ages;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
13 Ciudad Real;All ages;Cohort April 1;Females;Survival in the second trimester;2020QIII;8.893
13 Ciudad Real;All ages;Cohort April 1;Females;Survival in the second trimester;2020QII;""
13 Ciudad Real;All ages;Cohort April 1;Females;Survival in the second trimester;2020QI;""
13 Ciudad Real;All ages;Cohort April 1;Females;Survival in the third trimester;2022QIV;8.944
13 Ciudad Real;All ages;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
13 Ciudad Real;All ages;Cohort April 1;Females;Survival in the third trimester;2022QII;""
13 Ciudad Real;All ages;Cohort April 1;Females;Survival in the third trimester;2022QI;""
13 Ciudad Real;All ages;Cohort April 1;Females;Survival in the third trimester;2021QIV;8.934
13 Ciudad Real;All ages;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
13 Ciudad Real;All ages;Cohort April 1;Females;Survival in the third trimester;2021QII;""
13 Ciudad Real;All ages;Cohort April 1;Females;Survival in the third trimester;2021QI;""
13 Ciudad Real;All ages;Cohort April 1;Females;Survival in the third trimester;2020QIV;8.660
13 Ciudad Real;All ages;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
13 Ciudad Real;All ages;Cohort April 1;Females;Survival in the third trimester;2020QII;""
13 Ciudad Real;All ages;Cohort April 1;Females;Survival in the third trimester;2020QI;""
13 Ciudad Real;All ages;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
13 Ciudad Real;All ages;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
13 Ciudad Real;All ages;Cohort April 1;Females;Survival in the third trimester;2022QII;""
13 Ciudad Real;All ages;Cohort April 1;Females;Survival in the third trimester;2022QI;8.663
13 Ciudad Real;All ages;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
13 Ciudad Real;All ages;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
13 Ciudad Real;All ages;Cohort April 1;Females;Survival in the third trimester;2021QII;""
13 Ciudad Real;All ages;Cohort April 1;Females;Survival in the third trimester;2021QI;8.495
13 Ciudad Real;All ages;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
13 Ciudad Real;All ages;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
13 Ciudad Real;All ages;Cohort April 1;Females;Survival in the third trimester;2020QII;""
13 Ciudad Real;All ages;Cohort April 1;Females;Survival in the third trimester;2020QI;""
13 Ciudad Real;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
13 Ciudad Real;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
13 Ciudad Real;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
13 Ciudad Real;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
13 Ciudad Real;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
13 Ciudad Real;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
13 Ciudad Real;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
13 Ciudad Real;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
13 Ciudad Real;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
13 Ciudad Real;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
13 Ciudad Real;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
13 Ciudad Real;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
13 Ciudad Real;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
13 Ciudad Real;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
13 Ciudad Real;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;96,07
13 Ciudad Real;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
13 Ciudad Real;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
13 Ciudad Real;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
13 Ciudad Real;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;97,3
13 Ciudad Real;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
13 Ciudad Real;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
13 Ciudad Real;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
13 Ciudad Real;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;97,66
13 Ciudad Real;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
13 Ciudad Real;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
13 Ciudad Real;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;93,2
13 Ciudad Real;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
13 Ciudad Real;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
13 Ciudad Real;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
13 Ciudad Real;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;94,68
13 Ciudad Real;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
13 Ciudad Real;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
13 Ciudad Real;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
13 Ciudad Real;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;94,83
13 Ciudad Real;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
13 Ciudad Real;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
13 Ciudad Real;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;90,06
13 Ciudad Real;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
13 Ciudad Real;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
13 Ciudad Real;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
13 Ciudad Real;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;92,16
13 Ciudad Real;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
13 Ciudad Real;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
13 Ciudad Real;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
13 Ciudad Real;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;92,34
13 Ciudad Real;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
13 Ciudad Real;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
13 Ciudad Real;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
13 Ciudad Real;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
13 Ciudad Real;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
13 Ciudad Real;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
13 Ciudad Real;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;89,36
13 Ciudad Real;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
13 Ciudad Real;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
13 Ciudad Real;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
13 Ciudad Real;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;90,58
13 Ciudad Real;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
13 Ciudad Real;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
13 Ciudad Real;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
13 Ciudad Real;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
13 Ciudad Real;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
13 Ciudad Real;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QIII;28.958
13 Ciudad Real;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
13 Ciudad Real;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
13 Ciudad Real;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
13 Ciudad Real;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QIII;28.940
13 Ciudad Real;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
13 Ciudad Real;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
13 Ciudad Real;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
13 Ciudad Real;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QIII;28.358
13 Ciudad Real;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
13 Ciudad Real;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
13 Ciudad Real;All ages;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
13 Ciudad Real;All ages;Cohort July 1;Total;Survival in the first trimester;2022QIII;28.001
13 Ciudad Real;All ages;Cohort July 1;Total;Survival in the first trimester;2022QII;""
13 Ciudad Real;All ages;Cohort July 1;Total;Survival in the first trimester;2022QI;""
13 Ciudad Real;All ages;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
13 Ciudad Real;All ages;Cohort July 1;Total;Survival in the first trimester;2021QIII;28.126
13 Ciudad Real;All ages;Cohort July 1;Total;Survival in the first trimester;2021QII;""
13 Ciudad Real;All ages;Cohort July 1;Total;Survival in the first trimester;2021QI;""
13 Ciudad Real;All ages;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
13 Ciudad Real;All ages;Cohort July 1;Total;Survival in the first trimester;2020QIII;27.554
13 Ciudad Real;All ages;Cohort July 1;Total;Survival in the first trimester;2020QII;""
13 Ciudad Real;All ages;Cohort July 1;Total;Survival in the first trimester;2020QI;""
13 Ciudad Real;All ages;Cohort July 1;Total;Survival in the second trimester;2022QIV;27.094
13 Ciudad Real;All ages;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
13 Ciudad Real;All ages;Cohort July 1;Total;Survival in the second trimester;2022QII;""
13 Ciudad Real;All ages;Cohort July 1;Total;Survival in the second trimester;2022QI;""
13 Ciudad Real;All ages;Cohort July 1;Total;Survival in the second trimester;2021QIV;27.326
13 Ciudad Real;All ages;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
13 Ciudad Real;All ages;Cohort July 1;Total;Survival in the second trimester;2021QII;""
13 Ciudad Real;All ages;Cohort July 1;Total;Survival in the second trimester;2021QI;""
13 Ciudad Real;All ages;Cohort July 1;Total;Survival in the second trimester;2020QIV;26.820
13 Ciudad Real;All ages;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
13 Ciudad Real;All ages;Cohort July 1;Total;Survival in the second trimester;2020QII;""
13 Ciudad Real;All ages;Cohort July 1;Total;Survival in the second trimester;2020QI;""
13 Ciudad Real;All ages;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
13 Ciudad Real;All ages;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
13 Ciudad Real;All ages;Cohort July 1;Total;Survival in the third trimester;2022QII;""
13 Ciudad Real;All ages;Cohort July 1;Total;Survival in the third trimester;2022QI;26.613
13 Ciudad Real;All ages;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
13 Ciudad Real;All ages;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
13 Ciudad Real;All ages;Cohort July 1;Total;Survival in the third trimester;2021QII;""
13 Ciudad Real;All ages;Cohort July 1;Total;Survival in the third trimester;2021QI;26.357
13 Ciudad Real;All ages;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
13 Ciudad Real;All ages;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
13 Ciudad Real;All ages;Cohort July 1;Total;Survival in the third trimester;2020QII;""
13 Ciudad Real;All ages;Cohort July 1;Total;Survival in the third trimester;2020QI;""
13 Ciudad Real;All ages;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
13 Ciudad Real;All ages;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
13 Ciudad Real;All ages;Cohort July 1;Total;Survival in the third trimester;2022QII;25.917
13 Ciudad Real;All ages;Cohort July 1;Total;Survival in the third trimester;2022QI;""
13 Ciudad Real;All ages;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
13 Ciudad Real;All ages;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
13 Ciudad Real;All ages;Cohort July 1;Total;Survival in the third trimester;2021QII;25.854
13 Ciudad Real;All ages;Cohort July 1;Total;Survival in the third trimester;2021QI;""
13 Ciudad Real;All ages;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
13 Ciudad Real;All ages;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
13 Ciudad Real;All ages;Cohort July 1;Total;Survival in the third trimester;2020QII;""
13 Ciudad Real;All ages;Cohort July 1;Total;Survival in the third trimester;2020QI;""
13 Ciudad Real;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
13 Ciudad Real;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
13 Ciudad Real;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
13 Ciudad Real;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
13 Ciudad Real;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
13 Ciudad Real;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
13 Ciudad Real;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
13 Ciudad Real;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
13 Ciudad Real;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
13 Ciudad Real;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
13 Ciudad Real;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
13 Ciudad Real;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
13 Ciudad Real;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
13 Ciudad Real;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;96,7
13 Ciudad Real;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
13 Ciudad Real;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
13 Ciudad Real;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
13 Ciudad Real;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;97,19
13 Ciudad Real;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
13 Ciudad Real;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
13 Ciudad Real;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
13 Ciudad Real;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;97,16
13 Ciudad Real;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
13 Ciudad Real;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
13 Ciudad Real;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;93,56
13 Ciudad Real;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
13 Ciudad Real;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
13 Ciudad Real;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
13 Ciudad Real;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;94,42
13 Ciudad Real;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
13 Ciudad Real;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
13 Ciudad Real;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
13 Ciudad Real;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;94,58
13 Ciudad Real;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
13 Ciudad Real;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
13 Ciudad Real;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
13 Ciudad Real;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
13 Ciudad Real;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
13 Ciudad Real;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
13 Ciudad Real;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;91,96
13 Ciudad Real;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
13 Ciudad Real;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
13 Ciudad Real;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
13 Ciudad Real;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;92,94
13 Ciudad Real;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
13 Ciudad Real;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
13 Ciudad Real;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
13 Ciudad Real;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
13 Ciudad Real;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
13 Ciudad Real;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
13 Ciudad Real;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;89,55
13 Ciudad Real;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
13 Ciudad Real;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
13 Ciudad Real;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
13 Ciudad Real;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;91,17
13 Ciudad Real;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
13 Ciudad Real;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
13 Ciudad Real;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
13 Ciudad Real;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
13 Ciudad Real;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
13 Ciudad Real;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
13 Ciudad Real;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QIII;18.961
13 Ciudad Real;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
13 Ciudad Real;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
13 Ciudad Real;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
13 Ciudad Real;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QIII;19.112
13 Ciudad Real;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
13 Ciudad Real;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
13 Ciudad Real;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
13 Ciudad Real;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QIII;18.862
13 Ciudad Real;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
13 Ciudad Real;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
13 Ciudad Real;All ages;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
13 Ciudad Real;All ages;Cohort July 1;Males;Survival in the first trimester;2022QIII;18.386
13 Ciudad Real;All ages;Cohort July 1;Males;Survival in the first trimester;2022QII;""
13 Ciudad Real;All ages;Cohort July 1;Males;Survival in the first trimester;2022QI;""
13 Ciudad Real;All ages;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
13 Ciudad Real;All ages;Cohort July 1;Males;Survival in the first trimester;2021QIII;18.626
13 Ciudad Real;All ages;Cohort July 1;Males;Survival in the first trimester;2021QII;""
13 Ciudad Real;All ages;Cohort July 1;Males;Survival in the first trimester;2021QI;""
13 Ciudad Real;All ages;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
13 Ciudad Real;All ages;Cohort July 1;Males;Survival in the first trimester;2020QIII;18.376
13 Ciudad Real;All ages;Cohort July 1;Males;Survival in the first trimester;2020QII;""
13 Ciudad Real;All ages;Cohort July 1;Males;Survival in the first trimester;2020QI;""
13 Ciudad Real;All ages;Cohort July 1;Males;Survival in the second trimester;2022QIV;17.827
13 Ciudad Real;All ages;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
13 Ciudad Real;All ages;Cohort July 1;Males;Survival in the second trimester;2022QII;""
13 Ciudad Real;All ages;Cohort July 1;Males;Survival in the second trimester;2022QI;""
13 Ciudad Real;All ages;Cohort July 1;Males;Survival in the second trimester;2021QIV;18.120
13 Ciudad Real;All ages;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
13 Ciudad Real;All ages;Cohort July 1;Males;Survival in the second trimester;2021QII;""
13 Ciudad Real;All ages;Cohort July 1;Males;Survival in the second trimester;2021QI;""
13 Ciudad Real;All ages;Cohort July 1;Males;Survival in the second trimester;2020QIV;17.906
13 Ciudad Real;All ages;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
13 Ciudad Real;All ages;Cohort July 1;Males;Survival in the second trimester;2020QII;""
13 Ciudad Real;All ages;Cohort July 1;Males;Survival in the second trimester;2020QI;""
13 Ciudad Real;All ages;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
13 Ciudad Real;All ages;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
13 Ciudad Real;All ages;Cohort July 1;Males;Survival in the third trimester;2022QII;""
13 Ciudad Real;All ages;Cohort July 1;Males;Survival in the third trimester;2022QI;17.697
13 Ciudad Real;All ages;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
13 Ciudad Real;All ages;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
13 Ciudad Real;All ages;Cohort July 1;Males;Survival in the third trimester;2021QII;""
13 Ciudad Real;All ages;Cohort July 1;Males;Survival in the third trimester;2021QI;17.619
13 Ciudad Real;All ages;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
13 Ciudad Real;All ages;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
13 Ciudad Real;All ages;Cohort July 1;Males;Survival in the third trimester;2020QII;""
13 Ciudad Real;All ages;Cohort July 1;Males;Survival in the third trimester;2020QI;""
13 Ciudad Real;All ages;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
13 Ciudad Real;All ages;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
13 Ciudad Real;All ages;Cohort July 1;Males;Survival in the third trimester;2022QII;17.285
13 Ciudad Real;All ages;Cohort July 1;Males;Survival in the third trimester;2022QI;""
13 Ciudad Real;All ages;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
13 Ciudad Real;All ages;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
13 Ciudad Real;All ages;Cohort July 1;Males;Survival in the third trimester;2021QII;17.311
13 Ciudad Real;All ages;Cohort July 1;Males;Survival in the third trimester;2021QI;""
13 Ciudad Real;All ages;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
13 Ciudad Real;All ages;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
13 Ciudad Real;All ages;Cohort July 1;Males;Survival in the third trimester;2020QII;""
13 Ciudad Real;All ages;Cohort July 1;Males;Survival in the third trimester;2020QI;""
13 Ciudad Real;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
13 Ciudad Real;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
13 Ciudad Real;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
13 Ciudad Real;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
13 Ciudad Real;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
13 Ciudad Real;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
13 Ciudad Real;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
13 Ciudad Real;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
13 Ciudad Real;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
13 Ciudad Real;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
13 Ciudad Real;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
13 Ciudad Real;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
13 Ciudad Real;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
13 Ciudad Real;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;96,97
13 Ciudad Real;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
13 Ciudad Real;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
13 Ciudad Real;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
13 Ciudad Real;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;97,46
13 Ciudad Real;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
13 Ciudad Real;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
13 Ciudad Real;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
13 Ciudad Real;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;97,42
13 Ciudad Real;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
13 Ciudad Real;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
13 Ciudad Real;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;94,02
13 Ciudad Real;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
13 Ciudad Real;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
13 Ciudad Real;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
13 Ciudad Real;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;94,81
13 Ciudad Real;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
13 Ciudad Real;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
13 Ciudad Real;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
13 Ciudad Real;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;94,93
13 Ciudad Real;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
13 Ciudad Real;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
13 Ciudad Real;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
13 Ciudad Real;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
13 Ciudad Real;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
13 Ciudad Real;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
13 Ciudad Real;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;92,6
13 Ciudad Real;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
13 Ciudad Real;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
13 Ciudad Real;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
13 Ciudad Real;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;93,41
13 Ciudad Real;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
13 Ciudad Real;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
13 Ciudad Real;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
13 Ciudad Real;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
13 Ciudad Real;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
13 Ciudad Real;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
13 Ciudad Real;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;90,44
13 Ciudad Real;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
13 Ciudad Real;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
13 Ciudad Real;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
13 Ciudad Real;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;91,78
13 Ciudad Real;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
13 Ciudad Real;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
13 Ciudad Real;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
13 Ciudad Real;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
13 Ciudad Real;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
13 Ciudad Real;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
13 Ciudad Real;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QIII;9.997
13 Ciudad Real;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
13 Ciudad Real;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
13 Ciudad Real;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
13 Ciudad Real;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QIII;9.828
13 Ciudad Real;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
13 Ciudad Real;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
13 Ciudad Real;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
13 Ciudad Real;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QIII;9.496
13 Ciudad Real;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
13 Ciudad Real;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
13 Ciudad Real;All ages;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
13 Ciudad Real;All ages;Cohort July 1;Females;Survival in the first trimester;2022QIII;9.615
13 Ciudad Real;All ages;Cohort July 1;Females;Survival in the first trimester;2022QII;""
13 Ciudad Real;All ages;Cohort July 1;Females;Survival in the first trimester;2022QI;""
13 Ciudad Real;All ages;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
13 Ciudad Real;All ages;Cohort July 1;Females;Survival in the first trimester;2021QIII;9.500
13 Ciudad Real;All ages;Cohort July 1;Females;Survival in the first trimester;2021QII;""
13 Ciudad Real;All ages;Cohort July 1;Females;Survival in the first trimester;2021QI;""
13 Ciudad Real;All ages;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
13 Ciudad Real;All ages;Cohort July 1;Females;Survival in the first trimester;2020QIII;9.178
13 Ciudad Real;All ages;Cohort July 1;Females;Survival in the first trimester;2020QII;""
13 Ciudad Real;All ages;Cohort July 1;Females;Survival in the first trimester;2020QI;""
13 Ciudad Real;All ages;Cohort July 1;Females;Survival in the second trimester;2022QIV;9.267
13 Ciudad Real;All ages;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
13 Ciudad Real;All ages;Cohort July 1;Females;Survival in the second trimester;2022QII;""
13 Ciudad Real;All ages;Cohort July 1;Females;Survival in the second trimester;2022QI;""
13 Ciudad Real;All ages;Cohort July 1;Females;Survival in the second trimester;2021QIV;9.206
13 Ciudad Real;All ages;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
13 Ciudad Real;All ages;Cohort July 1;Females;Survival in the second trimester;2021QII;""
13 Ciudad Real;All ages;Cohort July 1;Females;Survival in the second trimester;2021QI;""
13 Ciudad Real;All ages;Cohort July 1;Females;Survival in the second trimester;2020QIV;8.914
13 Ciudad Real;All ages;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
13 Ciudad Real;All ages;Cohort July 1;Females;Survival in the second trimester;2020QII;""
13 Ciudad Real;All ages;Cohort July 1;Females;Survival in the second trimester;2020QI;""
13 Ciudad Real;All ages;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
13 Ciudad Real;All ages;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
13 Ciudad Real;All ages;Cohort July 1;Females;Survival in the third trimester;2022QII;""
13 Ciudad Real;All ages;Cohort July 1;Females;Survival in the third trimester;2022QI;8.916
13 Ciudad Real;All ages;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
13 Ciudad Real;All ages;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
13 Ciudad Real;All ages;Cohort July 1;Females;Survival in the third trimester;2021QII;""
13 Ciudad Real;All ages;Cohort July 1;Females;Survival in the third trimester;2021QI;8.738
13 Ciudad Real;All ages;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
13 Ciudad Real;All ages;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
13 Ciudad Real;All ages;Cohort July 1;Females;Survival in the third trimester;2020QII;""
13 Ciudad Real;All ages;Cohort July 1;Females;Survival in the third trimester;2020QI;""
13 Ciudad Real;All ages;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
13 Ciudad Real;All ages;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
13 Ciudad Real;All ages;Cohort July 1;Females;Survival in the third trimester;2022QII;8.632
13 Ciudad Real;All ages;Cohort July 1;Females;Survival in the third trimester;2022QI;""
13 Ciudad Real;All ages;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
13 Ciudad Real;All ages;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
13 Ciudad Real;All ages;Cohort July 1;Females;Survival in the third trimester;2021QII;8.543
13 Ciudad Real;All ages;Cohort July 1;Females;Survival in the third trimester;2021QI;""
13 Ciudad Real;All ages;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
13 Ciudad Real;All ages;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
13 Ciudad Real;All ages;Cohort July 1;Females;Survival in the third trimester;2020QII;""
13 Ciudad Real;All ages;Cohort July 1;Females;Survival in the third trimester;2020QI;""
13 Ciudad Real;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
13 Ciudad Real;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
13 Ciudad Real;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
13 Ciudad Real;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
13 Ciudad Real;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
13 Ciudad Real;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
13 Ciudad Real;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
13 Ciudad Real;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
13 Ciudad Real;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
13 Ciudad Real;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
13 Ciudad Real;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
13 Ciudad Real;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
13 Ciudad Real;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
13 Ciudad Real;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;96,18
13 Ciudad Real;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
13 Ciudad Real;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
13 Ciudad Real;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
13 Ciudad Real;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;96,66
13 Ciudad Real;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
13 Ciudad Real;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
13 Ciudad Real;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
13 Ciudad Real;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;96,65
13 Ciudad Real;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
13 Ciudad Real;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
13 Ciudad Real;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;92,7
13 Ciudad Real;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
13 Ciudad Real;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
13 Ciudad Real;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
13 Ciudad Real;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;93,67
13 Ciudad Real;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
13 Ciudad Real;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
13 Ciudad Real;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
13 Ciudad Real;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;93,87
13 Ciudad Real;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
13 Ciudad Real;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
13 Ciudad Real;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
13 Ciudad Real;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
13 Ciudad Real;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
13 Ciudad Real;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
13 Ciudad Real;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;90,72
13 Ciudad Real;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
13 Ciudad Real;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
13 Ciudad Real;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
13 Ciudad Real;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;92,02
13 Ciudad Real;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
13 Ciudad Real;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
13 Ciudad Real;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
13 Ciudad Real;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
13 Ciudad Real;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
13 Ciudad Real;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
13 Ciudad Real;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;87,83
13 Ciudad Real;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
13 Ciudad Real;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
13 Ciudad Real;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
13 Ciudad Real;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;89,96
13 Ciudad Real;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
13 Ciudad Real;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
13 Ciudad Real;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
13 Ciudad Real;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
13 Ciudad Real;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
13 Ciudad Real;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QIV;28.677
13 Ciudad Real;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
13 Ciudad Real;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
13 Ciudad Real;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
13 Ciudad Real;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QIV;28.882
13 Ciudad Real;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
13 Ciudad Real;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
13 Ciudad Real;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
13 Ciudad Real;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QIV;28.432
13 Ciudad Real;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
13 Ciudad Real;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
13 Ciudad Real;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
13 Ciudad Real;All ages;Cohort October 1;Total;Survival in the first trimester;2022QIV;27.661
13 Ciudad Real;All ages;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
13 Ciudad Real;All ages;Cohort October 1;Total;Survival in the first trimester;2022QII;""
13 Ciudad Real;All ages;Cohort October 1;Total;Survival in the first trimester;2022QI;""
13 Ciudad Real;All ages;Cohort October 1;Total;Survival in the first trimester;2021QIV;27.985
13 Ciudad Real;All ages;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
13 Ciudad Real;All ages;Cohort October 1;Total;Survival in the first trimester;2021QII;""
13 Ciudad Real;All ages;Cohort October 1;Total;Survival in the first trimester;2021QI;""
13 Ciudad Real;All ages;Cohort October 1;Total;Survival in the first trimester;2020QIV;27.578
13 Ciudad Real;All ages;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
13 Ciudad Real;All ages;Cohort October 1;Total;Survival in the first trimester;2020QII;""
13 Ciudad Real;All ages;Cohort October 1;Total;Survival in the first trimester;2020QI;""
13 Ciudad Real;All ages;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
13 Ciudad Real;All ages;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
13 Ciudad Real;All ages;Cohort October 1;Total;Survival in the second trimester;2022QII;""
13 Ciudad Real;All ages;Cohort October 1;Total;Survival in the second trimester;2022QI;27.221
13 Ciudad Real;All ages;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
13 Ciudad Real;All ages;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
13 Ciudad Real;All ages;Cohort October 1;Total;Survival in the second trimester;2021QII;""
13 Ciudad Real;All ages;Cohort October 1;Total;Survival in the second trimester;2021QI;27.062
13 Ciudad Real;All ages;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
13 Ciudad Real;All ages;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
13 Ciudad Real;All ages;Cohort October 1;Total;Survival in the second trimester;2020QII;""
13 Ciudad Real;All ages;Cohort October 1;Total;Survival in the second trimester;2020QI;""
13 Ciudad Real;All ages;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
13 Ciudad Real;All ages;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
13 Ciudad Real;All ages;Cohort October 1;Total;Survival in the third trimester;2022QII;26.469
13 Ciudad Real;All ages;Cohort October 1;Total;Survival in the third trimester;2022QI;""
13 Ciudad Real;All ages;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
13 Ciudad Real;All ages;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
13 Ciudad Real;All ages;Cohort October 1;Total;Survival in the third trimester;2021QII;26.517
13 Ciudad Real;All ages;Cohort October 1;Total;Survival in the third trimester;2021QI;""
13 Ciudad Real;All ages;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
13 Ciudad Real;All ages;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
13 Ciudad Real;All ages;Cohort October 1;Total;Survival in the third trimester;2020QII;""
13 Ciudad Real;All ages;Cohort October 1;Total;Survival in the third trimester;2020QI;""
13 Ciudad Real;All ages;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
13 Ciudad Real;All ages;Cohort October 1;Total;Survival in the third trimester;2022QIII;25.844
13 Ciudad Real;All ages;Cohort October 1;Total;Survival in the third trimester;2022QII;""
13 Ciudad Real;All ages;Cohort October 1;Total;Survival in the third trimester;2022QI;""
13 Ciudad Real;All ages;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
13 Ciudad Real;All ages;Cohort October 1;Total;Survival in the third trimester;2021QIII;25.985
13 Ciudad Real;All ages;Cohort October 1;Total;Survival in the third trimester;2021QII;""
13 Ciudad Real;All ages;Cohort October 1;Total;Survival in the third trimester;2021QI;""
13 Ciudad Real;All ages;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
13 Ciudad Real;All ages;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
13 Ciudad Real;All ages;Cohort October 1;Total;Survival in the third trimester;2020QII;""
13 Ciudad Real;All ages;Cohort October 1;Total;Survival in the third trimester;2020QI;""
13 Ciudad Real;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
13 Ciudad Real;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
13 Ciudad Real;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
13 Ciudad Real;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
13 Ciudad Real;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
13 Ciudad Real;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
13 Ciudad Real;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
13 Ciudad Real;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
13 Ciudad Real;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
13 Ciudad Real;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
13 Ciudad Real;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
13 Ciudad Real;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
13 Ciudad Real;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;96,46
13 Ciudad Real;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
13 Ciudad Real;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
13 Ciudad Real;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
13 Ciudad Real;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;96,89
13 Ciudad Real;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
13 Ciudad Real;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
13 Ciudad Real;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
13 Ciudad Real;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;97
13 Ciudad Real;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
13 Ciudad Real;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
13 Ciudad Real;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
13 Ciudad Real;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
13 Ciudad Real;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
13 Ciudad Real;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
13 Ciudad Real;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;94,25
13 Ciudad Real;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
13 Ciudad Real;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
13 Ciudad Real;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
13 Ciudad Real;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;95,18
13 Ciudad Real;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
13 Ciudad Real;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
13 Ciudad Real;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
13 Ciudad Real;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
13 Ciudad Real;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
13 Ciudad Real;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
13 Ciudad Real;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;91,65
13 Ciudad Real;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
13 Ciudad Real;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
13 Ciudad Real;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
13 Ciudad Real;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;93,26
13 Ciudad Real;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
13 Ciudad Real;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
13 Ciudad Real;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
13 Ciudad Real;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
13 Ciudad Real;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
13 Ciudad Real;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
13 Ciudad Real;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;89,48
13 Ciudad Real;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
13 Ciudad Real;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
13 Ciudad Real;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
13 Ciudad Real;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;91,39
13 Ciudad Real;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
13 Ciudad Real;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
13 Ciudad Real;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
13 Ciudad Real;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
13 Ciudad Real;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
13 Ciudad Real;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
13 Ciudad Real;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QIV;18.767
13 Ciudad Real;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
13 Ciudad Real;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
13 Ciudad Real;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
13 Ciudad Real;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QIV;19.058
13 Ciudad Real;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
13 Ciudad Real;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
13 Ciudad Real;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
13 Ciudad Real;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QIV;18.881
13 Ciudad Real;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
13 Ciudad Real;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
13 Ciudad Real;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
13 Ciudad Real;All ages;Cohort October 1;Males;Survival in the first trimester;2022QIV;18.134
13 Ciudad Real;All ages;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
13 Ciudad Real;All ages;Cohort October 1;Males;Survival in the first trimester;2022QII;""
13 Ciudad Real;All ages;Cohort October 1;Males;Survival in the first trimester;2022QI;""
13 Ciudad Real;All ages;Cohort October 1;Males;Survival in the first trimester;2021QIV;18.489
13 Ciudad Real;All ages;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
13 Ciudad Real;All ages;Cohort October 1;Males;Survival in the first trimester;2021QII;""
13 Ciudad Real;All ages;Cohort October 1;Males;Survival in the first trimester;2021QI;""
13 Ciudad Real;All ages;Cohort October 1;Males;Survival in the first trimester;2020QIV;18.324
13 Ciudad Real;All ages;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
13 Ciudad Real;All ages;Cohort October 1;Males;Survival in the first trimester;2020QII;""
13 Ciudad Real;All ages;Cohort October 1;Males;Survival in the first trimester;2020QI;""
13 Ciudad Real;All ages;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
13 Ciudad Real;All ages;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
13 Ciudad Real;All ages;Cohort October 1;Males;Survival in the second trimester;2022QII;""
13 Ciudad Real;All ages;Cohort October 1;Males;Survival in the second trimester;2022QI;18.033
13 Ciudad Real;All ages;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
13 Ciudad Real;All ages;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
13 Ciudad Real;All ages;Cohort October 1;Males;Survival in the second trimester;2021QII;""
13 Ciudad Real;All ages;Cohort October 1;Males;Survival in the second trimester;2021QI;18.006
13 Ciudad Real;All ages;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
13 Ciudad Real;All ages;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
13 Ciudad Real;All ages;Cohort October 1;Males;Survival in the second trimester;2020QII;""
13 Ciudad Real;All ages;Cohort October 1;Males;Survival in the second trimester;2020QI;""
13 Ciudad Real;All ages;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
13 Ciudad Real;All ages;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
13 Ciudad Real;All ages;Cohort October 1;Males;Survival in the third trimester;2022QII;17.592
13 Ciudad Real;All ages;Cohort October 1;Males;Survival in the third trimester;2022QI;""
13 Ciudad Real;All ages;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
13 Ciudad Real;All ages;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
13 Ciudad Real;All ages;Cohort October 1;Males;Survival in the third trimester;2021QII;17.670
13 Ciudad Real;All ages;Cohort October 1;Males;Survival in the third trimester;2021QI;""
13 Ciudad Real;All ages;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
13 Ciudad Real;All ages;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
13 Ciudad Real;All ages;Cohort October 1;Males;Survival in the third trimester;2020QII;""
13 Ciudad Real;All ages;Cohort October 1;Males;Survival in the third trimester;2020QI;""
13 Ciudad Real;All ages;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
13 Ciudad Real;All ages;Cohort October 1;Males;Survival in the third trimester;2022QIII;17.212
13 Ciudad Real;All ages;Cohort October 1;Males;Survival in the third trimester;2022QII;""
13 Ciudad Real;All ages;Cohort October 1;Males;Survival in the third trimester;2022QI;""
13 Ciudad Real;All ages;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
13 Ciudad Real;All ages;Cohort October 1;Males;Survival in the third trimester;2021QIII;17.362
13 Ciudad Real;All ages;Cohort October 1;Males;Survival in the third trimester;2021QII;""
13 Ciudad Real;All ages;Cohort October 1;Males;Survival in the third trimester;2021QI;""
13 Ciudad Real;All ages;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
13 Ciudad Real;All ages;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
13 Ciudad Real;All ages;Cohort October 1;Males;Survival in the third trimester;2020QII;""
13 Ciudad Real;All ages;Cohort October 1;Males;Survival in the third trimester;2020QI;""
13 Ciudad Real;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
13 Ciudad Real;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
13 Ciudad Real;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
13 Ciudad Real;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
13 Ciudad Real;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
13 Ciudad Real;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
13 Ciudad Real;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
13 Ciudad Real;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
13 Ciudad Real;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
13 Ciudad Real;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
13 Ciudad Real;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
13 Ciudad Real;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
13 Ciudad Real;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;96,63
13 Ciudad Real;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
13 Ciudad Real;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
13 Ciudad Real;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
13 Ciudad Real;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;97,01
13 Ciudad Real;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
13 Ciudad Real;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
13 Ciudad Real;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
13 Ciudad Real;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;97,05
13 Ciudad Real;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
13 Ciudad Real;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
13 Ciudad Real;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
13 Ciudad Real;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
13 Ciudad Real;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
13 Ciudad Real;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
13 Ciudad Real;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;94,62
13 Ciudad Real;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
13 Ciudad Real;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
13 Ciudad Real;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
13 Ciudad Real;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;95,37
13 Ciudad Real;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
13 Ciudad Real;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
13 Ciudad Real;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
13 Ciudad Real;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
13 Ciudad Real;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
13 Ciudad Real;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
13 Ciudad Real;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;92,31
13 Ciudad Real;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
13 Ciudad Real;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
13 Ciudad Real;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
13 Ciudad Real;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;93,59
13 Ciudad Real;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
13 Ciudad Real;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
13 Ciudad Real;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
13 Ciudad Real;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
13 Ciudad Real;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
13 Ciudad Real;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
13 Ciudad Real;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;90,31
13 Ciudad Real;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
13 Ciudad Real;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
13 Ciudad Real;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
13 Ciudad Real;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;91,95
13 Ciudad Real;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
13 Ciudad Real;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
13 Ciudad Real;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
13 Ciudad Real;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
13 Ciudad Real;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
13 Ciudad Real;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
13 Ciudad Real;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QIV;9.910
13 Ciudad Real;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
13 Ciudad Real;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
13 Ciudad Real;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
13 Ciudad Real;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QIV;9.824
13 Ciudad Real;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
13 Ciudad Real;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
13 Ciudad Real;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
13 Ciudad Real;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QIV;9.551
13 Ciudad Real;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
13 Ciudad Real;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
13 Ciudad Real;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
13 Ciudad Real;All ages;Cohort October 1;Females;Survival in the first trimester;2022QIV;9.527
13 Ciudad Real;All ages;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
13 Ciudad Real;All ages;Cohort October 1;Females;Survival in the first trimester;2022QII;""
13 Ciudad Real;All ages;Cohort October 1;Females;Survival in the first trimester;2022QI;""
13 Ciudad Real;All ages;Cohort October 1;Females;Survival in the first trimester;2021QIV;9.496
13 Ciudad Real;All ages;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
13 Ciudad Real;All ages;Cohort October 1;Females;Survival in the first trimester;2021QII;""
13 Ciudad Real;All ages;Cohort October 1;Females;Survival in the first trimester;2021QI;""
13 Ciudad Real;All ages;Cohort October 1;Females;Survival in the first trimester;2020QIV;9.254
13 Ciudad Real;All ages;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
13 Ciudad Real;All ages;Cohort October 1;Females;Survival in the first trimester;2020QII;""
13 Ciudad Real;All ages;Cohort October 1;Females;Survival in the first trimester;2020QI;""
13 Ciudad Real;All ages;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
13 Ciudad Real;All ages;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
13 Ciudad Real;All ages;Cohort October 1;Females;Survival in the second trimester;2022QII;""
13 Ciudad Real;All ages;Cohort October 1;Females;Survival in the second trimester;2022QI;9.188
13 Ciudad Real;All ages;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
13 Ciudad Real;All ages;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
13 Ciudad Real;All ages;Cohort October 1;Females;Survival in the second trimester;2021QII;""
13 Ciudad Real;All ages;Cohort October 1;Females;Survival in the second trimester;2021QI;9.056
13 Ciudad Real;All ages;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
13 Ciudad Real;All ages;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
13 Ciudad Real;All ages;Cohort October 1;Females;Survival in the second trimester;2020QII;""
13 Ciudad Real;All ages;Cohort October 1;Females;Survival in the second trimester;2020QI;""
13 Ciudad Real;All ages;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
13 Ciudad Real;All ages;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
13 Ciudad Real;All ages;Cohort October 1;Females;Survival in the third trimester;2022QII;8.877
13 Ciudad Real;All ages;Cohort October 1;Females;Survival in the third trimester;2022QI;""
13 Ciudad Real;All ages;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
13 Ciudad Real;All ages;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
13 Ciudad Real;All ages;Cohort October 1;Females;Survival in the third trimester;2021QII;8.847
13 Ciudad Real;All ages;Cohort October 1;Females;Survival in the third trimester;2021QI;""
13 Ciudad Real;All ages;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
13 Ciudad Real;All ages;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
13 Ciudad Real;All ages;Cohort October 1;Females;Survival in the third trimester;2020QII;""
13 Ciudad Real;All ages;Cohort October 1;Females;Survival in the third trimester;2020QI;""
13 Ciudad Real;All ages;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
13 Ciudad Real;All ages;Cohort October 1;Females;Survival in the third trimester;2022QIII;8.632
13 Ciudad Real;All ages;Cohort October 1;Females;Survival in the third trimester;2022QII;""
13 Ciudad Real;All ages;Cohort October 1;Females;Survival in the third trimester;2022QI;""
13 Ciudad Real;All ages;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
13 Ciudad Real;All ages;Cohort October 1;Females;Survival in the third trimester;2021QIII;8.623
13 Ciudad Real;All ages;Cohort October 1;Females;Survival in the third trimester;2021QII;""
13 Ciudad Real;All ages;Cohort October 1;Females;Survival in the third trimester;2021QI;""
13 Ciudad Real;All ages;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
13 Ciudad Real;All ages;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
13 Ciudad Real;All ages;Cohort October 1;Females;Survival in the third trimester;2020QII;""
13 Ciudad Real;All ages;Cohort October 1;Females;Survival in the third trimester;2020QI;""
13 Ciudad Real;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
13 Ciudad Real;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
13 Ciudad Real;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
13 Ciudad Real;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
13 Ciudad Real;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
13 Ciudad Real;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
13 Ciudad Real;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
13 Ciudad Real;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
13 Ciudad Real;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
13 Ciudad Real;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
13 Ciudad Real;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
13 Ciudad Real;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
13 Ciudad Real;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;96,14
13 Ciudad Real;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
13 Ciudad Real;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
13 Ciudad Real;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
13 Ciudad Real;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;96,66
13 Ciudad Real;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
13 Ciudad Real;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
13 Ciudad Real;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
13 Ciudad Real;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;96,89
13 Ciudad Real;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
13 Ciudad Real;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
13 Ciudad Real;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
13 Ciudad Real;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
13 Ciudad Real;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
13 Ciudad Real;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
13 Ciudad Real;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;93,53
13 Ciudad Real;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
13 Ciudad Real;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
13 Ciudad Real;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
13 Ciudad Real;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;94,82
13 Ciudad Real;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
13 Ciudad Real;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
13 Ciudad Real;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
13 Ciudad Real;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
13 Ciudad Real;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
13 Ciudad Real;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
13 Ciudad Real;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;90,36
13 Ciudad Real;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
13 Ciudad Real;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
13 Ciudad Real;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
13 Ciudad Real;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;92,63
13 Ciudad Real;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
13 Ciudad Real;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
13 Ciudad Real;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
13 Ciudad Real;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
13 Ciudad Real;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
13 Ciudad Real;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
13 Ciudad Real;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;87,87
13 Ciudad Real;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
13 Ciudad Real;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
13 Ciudad Real;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
13 Ciudad Real;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;90,28
13 Ciudad Real;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
13 Ciudad Real;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
13 Ciudad Real;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
13 Ciudad Real;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
13 Ciudad Real;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
13 Ciudad Real;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QI;1.991
13 Ciudad Real;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QI;1.947
13 Ciudad Real;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QI;1.680
13 Ciudad Real;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2022QII;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2022QI;1.854
13 Ciudad Real;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2021QII;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2021QI;1.867
13 Ciudad Real;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2020QII;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2020QI;1.487
13 Ciudad Real;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2022QII;1.745
13 Ciudad Real;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2022QI;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2021QII;1.786
13 Ciudad Real;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2021QI;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2020QII;1.441
13 Ciudad Real;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2020QI;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QIII;1.659
13 Ciudad Real;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QII;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QI;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QIII;1.694
13 Ciudad Real;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QII;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QI;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QIII;1.392
13 Ciudad Real;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QII;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QI;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QIV;1.583
13 Ciudad Real;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QII;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QI;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QIV;1.629
13 Ciudad Real;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QII;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QI;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QIV;1.331
13 Ciudad Real;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QII;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QI;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
13 Ciudad Real;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
13 Ciudad Real;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
13 Ciudad Real;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;93,12
13 Ciudad Real;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;95,89
13 Ciudad Real;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;88,51
13 Ciudad Real;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;87,64
13 Ciudad Real;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;91,73
13 Ciudad Real;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;85,77
13 Ciudad Real;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;83,32
13 Ciudad Real;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;87,01
13 Ciudad Real;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;82,86
13 Ciudad Real;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;79,51
13 Ciudad Real;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;83,67
13 Ciudad Real;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;79,23
13 Ciudad Real;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QI;1.249
13 Ciudad Real;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QI;1.226
13 Ciudad Real;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QI;1.057
13 Ciudad Real;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2022QII;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2022QI;1.164
13 Ciudad Real;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2021QII;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2021QI;1.171
13 Ciudad Real;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2020QII;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2020QI;951
13 Ciudad Real;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2022QII;1.102
13 Ciudad Real;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2022QI;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2021QII;1.117
13 Ciudad Real;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2021QI;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2020QII;918
13 Ciudad Real;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2020QI;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QIII;1.049
13 Ciudad Real;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QII;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QI;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QIII;1.066
13 Ciudad Real;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QII;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QI;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QIII;894
13 Ciudad Real;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QII;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QI;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QIV;1.008
13 Ciudad Real;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QII;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QI;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QIV;1.024
13 Ciudad Real;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QII;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QI;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QIV;854
13 Ciudad Real;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QII;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QI;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
13 Ciudad Real;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
13 Ciudad Real;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
13 Ciudad Real;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;93,19
13 Ciudad Real;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;95,51
13 Ciudad Real;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;89,97
13 Ciudad Real;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;88,23
13 Ciudad Real;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;91,11
13 Ciudad Real;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;86,85
13 Ciudad Real;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;83,99
13 Ciudad Real;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;86,95
13 Ciudad Real;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;84,58
13 Ciudad Real;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;80,7
13 Ciudad Real;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;83,52
13 Ciudad Real;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;80,79
13 Ciudad Real;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QI;742
13 Ciudad Real;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QI;721
13 Ciudad Real;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QI;623
13 Ciudad Real;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2022QII;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2022QI;690
13 Ciudad Real;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2021QII;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2021QI;696
13 Ciudad Real;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2020QII;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2020QI;536
13 Ciudad Real;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2022QII;643
13 Ciudad Real;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2022QI;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2021QII;669
13 Ciudad Real;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2021QI;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2020QII;523
13 Ciudad Real;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2020QI;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QIII;610
13 Ciudad Real;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QII;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QI;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QIII;628
13 Ciudad Real;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QII;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QI;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QIII;498
13 Ciudad Real;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QII;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QI;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QIV;575
13 Ciudad Real;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QII;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QI;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QIV;605
13 Ciudad Real;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QII;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QI;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QIV;477
13 Ciudad Real;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QII;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QI;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
13 Ciudad Real;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
13 Ciudad Real;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
13 Ciudad Real;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;92,99
13 Ciudad Real;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;96,53
13 Ciudad Real;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;86,04
13 Ciudad Real;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;86,66
13 Ciudad Real;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;92,79
13 Ciudad Real;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;83,95
13 Ciudad Real;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;82,21
13 Ciudad Real;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;87,1
13 Ciudad Real;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;79,94
13 Ciudad Real;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;77,49
13 Ciudad Real;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;83,91
13 Ciudad Real;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;76,57
13 Ciudad Real;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QII;1.721
13 Ciudad Real;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QII;1.693
13 Ciudad Real;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QII;1.688
13 Ciudad Real;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2022QII;1.609
13 Ciudad Real;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2022QI;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2021QII;1.617
13 Ciudad Real;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2021QI;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2020QII;1.626
13 Ciudad Real;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2020QI;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2022QIII;1.522
13 Ciudad Real;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2022QII;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2022QI;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2021QIII;1.526
13 Ciudad Real;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2021QII;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2021QI;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2020QIII;1.562
13 Ciudad Real;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2020QII;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2020QI;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QIV;1.447
13 Ciudad Real;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QII;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QI;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QIV;1.458
13 Ciudad Real;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QII;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QI;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QIV;1.488
13 Ciudad Real;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QII;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QI;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QII;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QI;1.373
13 Ciudad Real;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QII;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QI;1.448
13 Ciudad Real;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QII;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QI;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
13 Ciudad Real;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
13 Ciudad Real;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
13 Ciudad Real;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;93,49
13 Ciudad Real;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;95,51
13 Ciudad Real;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;96,33
13 Ciudad Real;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;88,44
13 Ciudad Real;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;90,14
13 Ciudad Real;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;92,54
13 Ciudad Real;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;84,08
13 Ciudad Real;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;86,12
13 Ciudad Real;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;88,15
13 Ciudad Real;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;81,1
13 Ciudad Real;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;85,78
13 Ciudad Real;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QII;1.070
13 Ciudad Real;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QII;1.071
13 Ciudad Real;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QII;1.077
13 Ciudad Real;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2022QII;1.014
13 Ciudad Real;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2022QI;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2021QII;1.024
13 Ciudad Real;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2021QI;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2020QII;1.036
13 Ciudad Real;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2020QI;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2022QIII;960
13 Ciudad Real;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2022QII;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2022QI;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2021QIII;972
13 Ciudad Real;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2021QII;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2021QI;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2020QIII;1.000
13 Ciudad Real;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2020QII;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2020QI;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QIV;917
13 Ciudad Real;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QII;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QI;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QIV;928
13 Ciudad Real;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QII;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QI;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QIV;951
13 Ciudad Real;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QII;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QI;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QII;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QI;879
13 Ciudad Real;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QII;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QI;925
13 Ciudad Real;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QII;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QI;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
13 Ciudad Real;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
13 Ciudad Real;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
13 Ciudad Real;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;94,77
13 Ciudad Real;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;95,61
13 Ciudad Real;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;96,19
13 Ciudad Real;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;89,72
13 Ciudad Real;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;90,76
13 Ciudad Real;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;92,85
13 Ciudad Real;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;85,7
13 Ciudad Real;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;86,65
13 Ciudad Real;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;88,3
13 Ciudad Real;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;82,07
13 Ciudad Real;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;85,89
13 Ciudad Real;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QII;651
13 Ciudad Real;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QII;622
13 Ciudad Real;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QII;611
13 Ciudad Real;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2022QII;595
13 Ciudad Real;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2022QI;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2021QII;593
13 Ciudad Real;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2021QI;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2020QII;590
13 Ciudad Real;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2020QI;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2022QIII;562
13 Ciudad Real;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2022QII;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2022QI;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2021QIII;554
13 Ciudad Real;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2021QII;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2021QI;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2020QIII;562
13 Ciudad Real;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2020QII;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2020QI;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QIV;530
13 Ciudad Real;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QII;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QI;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QIV;530
13 Ciudad Real;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QII;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QI;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QIV;537
13 Ciudad Real;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QII;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QI;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QII;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QI;494
13 Ciudad Real;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QII;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QI;523
13 Ciudad Real;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QII;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QI;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
13 Ciudad Real;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
13 Ciudad Real;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
13 Ciudad Real;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;91,4
13 Ciudad Real;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;95,34
13 Ciudad Real;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;96,56
13 Ciudad Real;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;86,33
13 Ciudad Real;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;89,07
13 Ciudad Real;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;91,98
13 Ciudad Real;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;81,41
13 Ciudad Real;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;85,21
13 Ciudad Real;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;87,89
13 Ciudad Real;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;79,42
13 Ciudad Real;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;85,6
13 Ciudad Real;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QIII;1.853
13 Ciudad Real;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QIII;1.856
13 Ciudad Real;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QIII;1.771
13 Ciudad Real;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2022QIII;1.700
13 Ciudad Real;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2022QII;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2022QI;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2021QIII;1.717
13 Ciudad Real;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2021QII;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2021QI;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2020QIII;1.673
13 Ciudad Real;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2020QII;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2020QI;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2022QIV;1.609
13 Ciudad Real;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2022QII;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2022QI;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2021QIV;1.620
13 Ciudad Real;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2021QII;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2021QI;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2020QIV;1.582
13 Ciudad Real;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2020QII;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2020QI;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QII;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QI;1.526
13 Ciudad Real;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QII;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QI;1.535
13 Ciudad Real;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QII;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QI;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QII;1.452
13 Ciudad Real;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QI;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QII;1.474
13 Ciudad Real;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QI;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QII;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QI;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
13 Ciudad Real;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
13 Ciudad Real;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
13 Ciudad Real;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;91,74
13 Ciudad Real;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;92,51
13 Ciudad Real;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;94,47
13 Ciudad Real;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;86,83
13 Ciudad Real;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;87,28
13 Ciudad Real;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;89,33
13 Ciudad Real;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;82,22
13 Ciudad Real;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;86,67
13 Ciudad Real;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;78,23
13 Ciudad Real;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;83,23
13 Ciudad Real;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QIII;1.149
13 Ciudad Real;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QIII;1.175
13 Ciudad Real;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QIII;1.131
13 Ciudad Real;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2022QIII;1.057
13 Ciudad Real;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2022QII;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2022QI;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2021QIII;1.091
13 Ciudad Real;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2021QII;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2021QI;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2020QIII;1.071
13 Ciudad Real;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2020QII;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2020QI;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2022QIV;1.006
13 Ciudad Real;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2022QII;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2022QI;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2021QIV;1.032
13 Ciudad Real;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2021QII;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2021QI;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2020QIV;1.010
13 Ciudad Real;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2020QII;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2020QI;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QII;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QI;975
13 Ciudad Real;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QII;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QI;980
13 Ciudad Real;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QII;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QI;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QII;935
13 Ciudad Real;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QI;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QII;940
13 Ciudad Real;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QI;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QII;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QI;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
13 Ciudad Real;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
13 Ciudad Real;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
13 Ciudad Real;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;91,99
13 Ciudad Real;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;92,85
13 Ciudad Real;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;94,69
13 Ciudad Real;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;87,55
13 Ciudad Real;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;87,83
13 Ciudad Real;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;89,3
13 Ciudad Real;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;82,98
13 Ciudad Real;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;86,65
13 Ciudad Real;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;79,57
13 Ciudad Real;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;83,11
13 Ciudad Real;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QIII;704
13 Ciudad Real;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QIII;681
13 Ciudad Real;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QIII;640
13 Ciudad Real;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2022QIII;643
13 Ciudad Real;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2022QII;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2022QI;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2021QIII;626
13 Ciudad Real;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2021QII;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2021QI;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2020QIII;602
13 Ciudad Real;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2020QII;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2020QI;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2022QIV;603
13 Ciudad Real;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2022QII;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2022QI;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2021QIV;588
13 Ciudad Real;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2021QII;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2021QI;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2020QIV;572
13 Ciudad Real;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2020QII;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2020QI;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QII;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QI;551
13 Ciudad Real;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QII;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QI;555
13 Ciudad Real;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QII;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QI;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QII;517
13 Ciudad Real;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QI;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QII;534
13 Ciudad Real;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QI;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QII;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QI;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
13 Ciudad Real;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
13 Ciudad Real;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
13 Ciudad Real;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;91,34
13 Ciudad Real;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;91,92
13 Ciudad Real;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;94,06
13 Ciudad Real;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;85,65
13 Ciudad Real;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;86,34
13 Ciudad Real;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;89,38
13 Ciudad Real;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;80,91
13 Ciudad Real;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;86,72
13 Ciudad Real;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;75,92
13 Ciudad Real;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;83,44
13 Ciudad Real;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QIV;1.870
13 Ciudad Real;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QIV;1.902
13 Ciudad Real;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QIV;1.867
13 Ciudad Real;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2022QIV;1.757
13 Ciudad Real;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2022QII;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2022QI;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2021QIV;1.787
13 Ciudad Real;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2021QII;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2021QI;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2020QIV;1.758
13 Ciudad Real;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2020QII;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2020QI;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2022QII;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2022QI;1.679
13 Ciudad Real;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2021QII;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2021QI;1.699
13 Ciudad Real;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2020QII;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2020QI;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QII;1.592
13 Ciudad Real;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QI;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QII;1.629
13 Ciudad Real;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QI;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QII;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QI;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QIII;1.514
13 Ciudad Real;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QII;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QI;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QIII;1.549
13 Ciudad Real;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QII;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QI;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QII;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QI;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
13 Ciudad Real;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
13 Ciudad Real;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
13 Ciudad Real;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;93,96
13 Ciudad Real;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;93,95
13 Ciudad Real;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;94,16
13 Ciudad Real;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;88,28
13 Ciudad Real;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;91
13 Ciudad Real;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;83,7
13 Ciudad Real;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;87,25
13 Ciudad Real;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;79,6
13 Ciudad Real;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;82,97
13 Ciudad Real;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QIV;1.153
13 Ciudad Real;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QIV;1.208
13 Ciudad Real;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QIV;1.184
13 Ciudad Real;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2022QIV;1.090
13 Ciudad Real;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2022QII;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2022QI;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2021QIV;1.137
13 Ciudad Real;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2021QII;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2021QI;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2020QIV;1.111
13 Ciudad Real;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2020QII;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2020QI;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2022QII;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2022QI;1.070
13 Ciudad Real;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2021QII;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2021QI;1.072
13 Ciudad Real;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2020QII;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2020QI;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QII;1.023
13 Ciudad Real;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QI;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QII;1.023
13 Ciudad Real;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QI;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QII;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QI;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QIII;975
13 Ciudad Real;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QII;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QI;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QIII;978
13 Ciudad Real;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QII;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QI;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QII;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QI;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
13 Ciudad Real;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
13 Ciudad Real;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
13 Ciudad Real;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;94,54
13 Ciudad Real;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;94,12
13 Ciudad Real;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;93,83
13 Ciudad Real;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;88,58
13 Ciudad Real;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;90,54
13 Ciudad Real;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;84,69
13 Ciudad Real;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;86,4
13 Ciudad Real;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;80,71
13 Ciudad Real;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;82,6
13 Ciudad Real;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QIV;717
13 Ciudad Real;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QIV;694
13 Ciudad Real;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QIV;683
13 Ciudad Real;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2022QIV;667
13 Ciudad Real;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2022QII;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2022QI;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2021QIV;650
13 Ciudad Real;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2021QII;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2021QI;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2020QIV;647
13 Ciudad Real;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2020QII;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2020QI;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2022QII;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2022QI;609
13 Ciudad Real;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2021QII;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2021QI;627
13 Ciudad Real;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2020QII;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2020QI;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QII;569
13 Ciudad Real;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QI;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QII;606
13 Ciudad Real;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QI;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QII;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QI;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QIII;539
13 Ciudad Real;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QII;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QI;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QIII;571
13 Ciudad Real;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QII;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QI;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QII;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QI;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
13 Ciudad Real;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
13 Ciudad Real;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
13 Ciudad Real;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;93,03
13 Ciudad Real;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;93,66
13 Ciudad Real;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;94,73
13 Ciudad Real;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;87,75
13 Ciudad Real;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;91,8
13 Ciudad Real;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;81,99
13 Ciudad Real;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;88,73
13 Ciudad Real;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;77,67
13 Ciudad Real;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;83,6
13 Ciudad Real;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QI;5.571
13 Ciudad Real;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QI;5.580
13 Ciudad Real;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QI;5.551
13 Ciudad Real;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2022QII;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2022QI;5.351
13 Ciudad Real;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2021QII;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2021QI;5.449
13 Ciudad Real;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2020QII;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2020QI;5.136
13 Ciudad Real;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2022QII;5.160
13 Ciudad Real;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2022QI;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2021QII;5.308
13 Ciudad Real;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2021QI;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2020QII;5.012
13 Ciudad Real;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2020QI;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QIII;5.011
13 Ciudad Real;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QII;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QI;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QIII;5.192
13 Ciudad Real;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QII;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QI;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QIII;4.881
13 Ciudad Real;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QII;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QI;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QIV;4.831
13 Ciudad Real;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QII;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QI;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QIV;5.057
13 Ciudad Real;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QII;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QI;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QIV;4.759
13 Ciudad Real;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QII;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QI;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
13 Ciudad Real;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
13 Ciudad Real;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
13 Ciudad Real;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;96,05
13 Ciudad Real;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;97,65
13 Ciudad Real;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;92,52
13 Ciudad Real;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;92,62
13 Ciudad Real;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;95,13
13 Ciudad Real;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;90,29
13 Ciudad Real;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;89,95
13 Ciudad Real;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;93,05
13 Ciudad Real;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;87,93
13 Ciudad Real;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;86,72
13 Ciudad Real;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;90,63
13 Ciudad Real;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;85,73
13 Ciudad Real;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QI;3.407
13 Ciudad Real;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QI;3.482
13 Ciudad Real;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QI;3.473
13 Ciudad Real;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2022QII;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2022QI;3.295
13 Ciudad Real;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2021QII;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2021QI;3.410
13 Ciudad Real;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2020QII;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2020QI;3.227
13 Ciudad Real;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2022QII;3.185
13 Ciudad Real;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2022QI;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2021QII;3.319
13 Ciudad Real;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2021QI;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2020QII;3.153
13 Ciudad Real;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2020QI;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QIII;3.104
13 Ciudad Real;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QII;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QI;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QIII;3.253
13 Ciudad Real;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QII;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QI;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QIII;3.083
13 Ciudad Real;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QII;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QI;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QIV;2.997
13 Ciudad Real;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QII;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QI;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QIV;3.168
13 Ciudad Real;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QII;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QI;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QIV;3.012
13 Ciudad Real;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QII;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QI;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
13 Ciudad Real;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
13 Ciudad Real;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
13 Ciudad Real;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;96,71
13 Ciudad Real;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;97,93
13 Ciudad Real;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;92,92
13 Ciudad Real;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;93,48
13 Ciudad Real;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;95,32
13 Ciudad Real;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;90,79
13 Ciudad Real;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;91,11
13 Ciudad Real;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;93,42
13 Ciudad Real;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;88,77
13 Ciudad Real;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;87,97
13 Ciudad Real;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;90,98
13 Ciudad Real;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;86,73
13 Ciudad Real;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QI;2.164
13 Ciudad Real;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QI;2.098
13 Ciudad Real;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QI;2.078
13 Ciudad Real;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2022QII;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2022QI;2.056
13 Ciudad Real;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2021QII;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2021QI;2.039
13 Ciudad Real;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2020QII;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2020QI;1.909
13 Ciudad Real;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2022QII;1.975
13 Ciudad Real;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2022QI;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2021QII;1.989
13 Ciudad Real;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2021QI;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2020QII;1.859
13 Ciudad Real;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2020QI;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QIII;1.907
13 Ciudad Real;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QII;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QI;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QIII;1.939
13 Ciudad Real;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QII;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QI;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QIII;1.798
13 Ciudad Real;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QII;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QI;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QIV;1.834
13 Ciudad Real;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QII;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QI;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QIV;1.889
13 Ciudad Real;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QII;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QI;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QIV;1.747
13 Ciudad Real;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QII;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QI;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
13 Ciudad Real;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
13 Ciudad Real;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
13 Ciudad Real;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;95,01
13 Ciudad Real;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;97,19
13 Ciudad Real;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;91,87
13 Ciudad Real;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;91,27
13 Ciudad Real;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;94,8
13 Ciudad Real;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;89,46
13 Ciudad Real;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;88,12
13 Ciudad Real;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;92,42
13 Ciudad Real;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;86,53
13 Ciudad Real;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;84,75
13 Ciudad Real;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;90,04
13 Ciudad Real;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;84,07
13 Ciudad Real;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QII;5.272
13 Ciudad Real;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QII;5.348
13 Ciudad Real;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QII;5.381
13 Ciudad Real;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2022QII;5.059
13 Ciudad Real;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2022QI;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2021QII;5.179
13 Ciudad Real;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2021QI;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2020QII;5.247
13 Ciudad Real;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2020QI;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2022QIII;4.898
13 Ciudad Real;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2022QII;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2022QI;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2021QIII;5.049
13 Ciudad Real;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2021QII;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2021QI;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2020QIII;5.093
13 Ciudad Real;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2020QII;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2020QI;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QIV;4.710
13 Ciudad Real;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QII;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QI;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QIV;4.896
13 Ciudad Real;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QII;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QI;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QIV;4.964
13 Ciudad Real;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QII;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QI;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QII;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QI;4.737
13 Ciudad Real;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QII;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QI;4.865
13 Ciudad Real;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QII;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QI;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
13 Ciudad Real;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
13 Ciudad Real;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
13 Ciudad Real;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;95,96
13 Ciudad Real;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;96,84
13 Ciudad Real;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;97,51
13 Ciudad Real;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;92,91
13 Ciudad Real;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;94,41
13 Ciudad Real;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;94,65
13 Ciudad Real;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;89,34
13 Ciudad Real;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;91,55
13 Ciudad Real;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;92,25
13 Ciudad Real;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;88,58
13 Ciudad Real;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;90,41
13 Ciudad Real;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QII;3.204
13 Ciudad Real;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QII;3.307
13 Ciudad Real;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QII;3.373
13 Ciudad Real;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2022QII;3.080
13 Ciudad Real;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2022QI;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2021QII;3.194
13 Ciudad Real;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2021QI;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2020QII;3.291
13 Ciudad Real;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2020QI;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2022QIII;2.994
13 Ciudad Real;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2022QII;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2022QI;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2021QIII;3.123
13 Ciudad Real;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2021QII;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2021QI;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2020QIII;3.209
13 Ciudad Real;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2020QII;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2020QI;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QIV;2.883
13 Ciudad Real;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QII;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QI;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QIV;3.024
13 Ciudad Real;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QII;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QI;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QIV;3.132
13 Ciudad Real;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QII;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QI;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QII;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QI;2.941
13 Ciudad Real;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QII;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QI;3.079
13 Ciudad Real;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QII;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QI;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
13 Ciudad Real;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
13 Ciudad Real;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
13 Ciudad Real;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;96,13
13 Ciudad Real;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;96,58
13 Ciudad Real;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;97,57
13 Ciudad Real;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;93,45
13 Ciudad Real;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;94,44
13 Ciudad Real;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;95,14
13 Ciudad Real;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;89,98
13 Ciudad Real;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;91,44
13 Ciudad Real;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;92,86
13 Ciudad Real;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;88,93
13 Ciudad Real;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;91,28
13 Ciudad Real;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QII;2.068
13 Ciudad Real;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QII;2.041
13 Ciudad Real;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QII;2.008
13 Ciudad Real;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2022QII;1.979
13 Ciudad Real;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2022QI;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2021QII;1.985
13 Ciudad Real;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2021QI;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2020QII;1.956
13 Ciudad Real;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2020QI;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2022QIII;1.904
13 Ciudad Real;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2022QII;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2022QI;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2021QIII;1.926
13 Ciudad Real;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2021QII;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2021QI;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2020QIII;1.884
13 Ciudad Real;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2020QII;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2020QI;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QIV;1.827
13 Ciudad Real;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QII;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QI;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QIV;1.872
13 Ciudad Real;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QII;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QI;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QIV;1.832
13 Ciudad Real;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QII;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QI;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QII;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QI;1.796
13 Ciudad Real;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QII;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QI;1.786
13 Ciudad Real;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QII;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QI;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
13 Ciudad Real;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
13 Ciudad Real;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
13 Ciudad Real;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;95,7
13 Ciudad Real;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;97,26
13 Ciudad Real;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;97,41
13 Ciudad Real;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;92,07
13 Ciudad Real;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;94,37
13 Ciudad Real;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;93,82
13 Ciudad Real;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;88,35
13 Ciudad Real;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;91,72
13 Ciudad Real;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;91,24
13 Ciudad Real;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;88
13 Ciudad Real;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;88,94
13 Ciudad Real;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QIII;5.336
13 Ciudad Real;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QIII;5.459
13 Ciudad Real;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QIII;5.482
13 Ciudad Real;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2022QIII;5.136
13 Ciudad Real;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2022QII;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2022QI;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2021QIII;5.288
13 Ciudad Real;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2021QII;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2021QI;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2020QIII;5.297
13 Ciudad Real;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2020QII;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2020QI;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2022QIV;4.924
13 Ciudad Real;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2022QII;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2022QI;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2021QIV;5.117
13 Ciudad Real;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2021QII;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2021QI;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2020QIV;5.140
13 Ciudad Real;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2020QII;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2020QI;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QII;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QI;4.944
13 Ciudad Real;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QII;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QI;5.036
13 Ciudad Real;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QII;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QI;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QII;4.783
13 Ciudad Real;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QI;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QII;4.925
13 Ciudad Real;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QI;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QII;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QI;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
13 Ciudad Real;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
13 Ciudad Real;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
13 Ciudad Real;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;96,25
13 Ciudad Real;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;96,87
13 Ciudad Real;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;96,63
13 Ciudad Real;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;92,28
13 Ciudad Real;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;93,74
13 Ciudad Real;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;93,76
13 Ciudad Real;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;90,57
13 Ciudad Real;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;91,86
13 Ciudad Real;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;87,62
13 Ciudad Real;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;89,84
13 Ciudad Real;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QIII;3.243
13 Ciudad Real;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QIII;3.361
13 Ciudad Real;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QIII;3.441
13 Ciudad Real;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2022QIII;3.136
13 Ciudad Real;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2022QII;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2022QI;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2021QIII;3.266
13 Ciudad Real;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2021QII;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2021QI;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2020QIII;3.339
13 Ciudad Real;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2020QII;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2020QI;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2022QIV;3.010
13 Ciudad Real;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2022QII;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2022QI;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2021QIV;3.159
13 Ciudad Real;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2021QII;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2021QI;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2020QIV;3.242
13 Ciudad Real;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2020QII;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2020QI;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QII;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QI;3.071
13 Ciudad Real;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QII;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QI;3.185
13 Ciudad Real;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QII;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QI;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QII;2.977
13 Ciudad Real;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QI;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QII;3.110
13 Ciudad Real;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QI;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QII;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QI;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
13 Ciudad Real;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
13 Ciudad Real;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
13 Ciudad Real;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;96,7
13 Ciudad Real;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;97,17
13 Ciudad Real;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;97,04
13 Ciudad Real;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;92,82
13 Ciudad Real;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;93,99
13 Ciudad Real;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;94,22
13 Ciudad Real;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;91,37
13 Ciudad Real;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;92,56
13 Ciudad Real;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;88,57
13 Ciudad Real;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;90,38
13 Ciudad Real;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QIII;2.093
13 Ciudad Real;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QIII;2.098
13 Ciudad Real;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QIII;2.041
13 Ciudad Real;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2022QIII;2.000
13 Ciudad Real;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2022QII;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2022QI;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2021QIII;2.022
13 Ciudad Real;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2021QII;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2021QI;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2020QIII;1.958
13 Ciudad Real;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2020QII;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2020QI;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2022QIV;1.914
13 Ciudad Real;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2022QII;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2022QI;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2021QIV;1.958
13 Ciudad Real;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2021QII;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2021QI;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2020QIV;1.898
13 Ciudad Real;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2020QII;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2020QI;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QII;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QI;1.873
13 Ciudad Real;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QII;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QI;1.851
13 Ciudad Real;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QII;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QI;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QII;1.806
13 Ciudad Real;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QI;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QII;1.815
13 Ciudad Real;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QI;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QII;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QI;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
13 Ciudad Real;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
13 Ciudad Real;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
13 Ciudad Real;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;95,56
13 Ciudad Real;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;96,38
13 Ciudad Real;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;95,93
13 Ciudad Real;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;91,45
13 Ciudad Real;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;93,33
13 Ciudad Real;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;92,99
13 Ciudad Real;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;89,28
13 Ciudad Real;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;90,69
13 Ciudad Real;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;86,08
13 Ciudad Real;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;88,93
13 Ciudad Real;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QIV;5.318
13 Ciudad Real;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QIV;5.505
13 Ciudad Real;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QIV;5.565
13 Ciudad Real;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2022QIV;5.086
13 Ciudad Real;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2022QII;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2022QI;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2021QIV;5.315
13 Ciudad Real;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2021QII;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2021QI;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2020QIV;5.375
13 Ciudad Real;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2020QII;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2020QI;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2022QII;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2022QI;5.123
13 Ciudad Real;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2021QII;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2021QI;5.254
13 Ciudad Real;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2020QII;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2020QI;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QII;4.948
13 Ciudad Real;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QI;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QII;5.130
13 Ciudad Real;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QI;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QII;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QI;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QIII;4.815
13 Ciudad Real;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QII;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QI;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QIII;5.023
13 Ciudad Real;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QII;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QI;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QII;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QI;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
13 Ciudad Real;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
13 Ciudad Real;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
13 Ciudad Real;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;95,64
13 Ciudad Real;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;96,55
13 Ciudad Real;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;96,59
13 Ciudad Real;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;93,06
13 Ciudad Real;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;94,41
13 Ciudad Real;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;89,88
13 Ciudad Real;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;92,18
13 Ciudad Real;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;87,47
13 Ciudad Real;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;90,26
13 Ciudad Real;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QIV;3.243
13 Ciudad Real;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QIV;3.393
13 Ciudad Real;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QIV;3.494
13 Ciudad Real;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2022QIV;3.101
13 Ciudad Real;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2022QII;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2022QI;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2021QIV;3.273
13 Ciudad Real;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2021QII;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2021QI;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2020QIV;3.374
13 Ciudad Real;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2020QII;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2020QI;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2022QII;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2022QI;3.175
13 Ciudad Real;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2021QII;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2021QI;3.308
13 Ciudad Real;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2020QII;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2020QI;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QII;3.074
13 Ciudad Real;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QI;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QII;3.226
13 Ciudad Real;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QI;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QII;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QI;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QIII;3.000
13 Ciudad Real;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QII;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QI;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QIII;3.168
13 Ciudad Real;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QII;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QI;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QII;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QI;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
13 Ciudad Real;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
13 Ciudad Real;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
13 Ciudad Real;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;95,62
13 Ciudad Real;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;96,46
13 Ciudad Real;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;96,57
13 Ciudad Real;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;93,58
13 Ciudad Real;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;94,68
13 Ciudad Real;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;90,6
13 Ciudad Real;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;92,33
13 Ciudad Real;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;88,42
13 Ciudad Real;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;90,67
13 Ciudad Real;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QIV;2.075
13 Ciudad Real;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QIV;2.112
13 Ciudad Real;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QIV;2.071
13 Ciudad Real;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2022QIV;1.985
13 Ciudad Real;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2022QII;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2022QI;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2021QIV;2.042
13 Ciudad Real;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2021QII;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2021QI;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2020QIV;2.001
13 Ciudad Real;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2020QII;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2020QI;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2022QII;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2022QI;1.948
13 Ciudad Real;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2021QII;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2021QI;1.946
13 Ciudad Real;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2020QII;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2020QI;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QII;1.874
13 Ciudad Real;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QI;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QII;1.904
13 Ciudad Real;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QI;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QII;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QI;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QIII;1.815
13 Ciudad Real;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QII;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QI;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QIII;1.855
13 Ciudad Real;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QII;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QI;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QII;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QI;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
13 Ciudad Real;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
13 Ciudad Real;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
13 Ciudad Real;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;95,66
13 Ciudad Real;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;96,69
13 Ciudad Real;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;96,62
13 Ciudad Real;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;92,23
13 Ciudad Real;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;93,96
13 Ciudad Real;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;88,73
13 Ciudad Real;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;91,94
13 Ciudad Real;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;85,94
13 Ciudad Real;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;89,57
13 Ciudad Real;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QI;8.502
13 Ciudad Real;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QI;8.441
13 Ciudad Real;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QI;8.470
13 Ciudad Real;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2022QII;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2022QI;8.314
13 Ciudad Real;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2021QII;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2021QI;8.300
13 Ciudad Real;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2020QII;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2020QI;7.959
13 Ciudad Real;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2022QII;8.093
13 Ciudad Real;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2022QI;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2021QII;8.163
13 Ciudad Real;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2021QI;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2020QII;7.827
13 Ciudad Real;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2020QI;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QIII;7.930
13 Ciudad Real;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QII;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QI;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QIII;8.027
13 Ciudad Real;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QII;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QI;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QIII;7.706
13 Ciudad Real;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QII;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QI;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QIV;7.799
13 Ciudad Real;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QII;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QI;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QIV;7.887
13 Ciudad Real;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QII;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QI;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QIV;7.579
13 Ciudad Real;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QII;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QI;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
13 Ciudad Real;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
13 Ciudad Real;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
13 Ciudad Real;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;97,79
13 Ciudad Real;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;98,33
13 Ciudad Real;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;93,97
13 Ciudad Real;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;95,19
13 Ciudad Real;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;96,71
13 Ciudad Real;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;92,41
13 Ciudad Real;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;93,27
13 Ciudad Real;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;95,1
13 Ciudad Real;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;90,98
13 Ciudad Real;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;91,73
13 Ciudad Real;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;93,44
13 Ciudad Real;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;89,48
13 Ciudad Real;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QI;5.562
13 Ciudad Real;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QI;5.550
13 Ciudad Real;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QI;5.617
13 Ciudad Real;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2022QII;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2022QI;5.452
13 Ciudad Real;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2021QII;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2021QI;5.469
13 Ciudad Real;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2020QII;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2020QI;5.295
13 Ciudad Real;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2022QII;5.335
13 Ciudad Real;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2022QI;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2021QII;5.406
13 Ciudad Real;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2021QI;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2020QII;5.214
13 Ciudad Real;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2020QI;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QIII;5.243
13 Ciudad Real;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QII;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QI;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QIII;5.327
13 Ciudad Real;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QII;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QI;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QIII;5.140
13 Ciudad Real;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QII;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QI;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QIV;5.171
13 Ciudad Real;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QII;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QI;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QIV;5.242
13 Ciudad Real;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QII;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QI;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QIV;5.061
13 Ciudad Real;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QII;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QI;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
13 Ciudad Real;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
13 Ciudad Real;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
13 Ciudad Real;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;98,02
13 Ciudad Real;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;98,54
13 Ciudad Real;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;94,27
13 Ciudad Real;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;95,92
13 Ciudad Real;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;97,41
13 Ciudad Real;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;92,83
13 Ciudad Real;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;94,26
13 Ciudad Real;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;95,98
13 Ciudad Real;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;91,51
13 Ciudad Real;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;92,97
13 Ciudad Real;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;94,45
13 Ciudad Real;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;90,1
13 Ciudad Real;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QI;2.940
13 Ciudad Real;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QI;2.891
13 Ciudad Real;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QI;2.853
13 Ciudad Real;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2022QII;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2022QI;2.862
13 Ciudad Real;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2021QII;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2021QI;2.831
13 Ciudad Real;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2020QII;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2020QI;2.664
13 Ciudad Real;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2022QII;2.758
13 Ciudad Real;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2022QI;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2021QII;2.757
13 Ciudad Real;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2021QI;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2020QII;2.613
13 Ciudad Real;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2020QI;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QIII;2.687
13 Ciudad Real;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QII;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QI;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QIII;2.700
13 Ciudad Real;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QII;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QI;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QIII;2.566
13 Ciudad Real;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QII;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QI;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QIV;2.628
13 Ciudad Real;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QII;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QI;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QIV;2.645
13 Ciudad Real;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QII;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QI;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QIV;2.518
13 Ciudad Real;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QII;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QI;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
13 Ciudad Real;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
13 Ciudad Real;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
13 Ciudad Real;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;97,35
13 Ciudad Real;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;97,92
13 Ciudad Real;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;93,38
13 Ciudad Real;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;93,81
13 Ciudad Real;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;95,36
13 Ciudad Real;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;91,59
13 Ciudad Real;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;91,39
13 Ciudad Real;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;93,39
13 Ciudad Real;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;89,94
13 Ciudad Real;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;89,39
13 Ciudad Real;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;91,49
13 Ciudad Real;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;88,26
13 Ciudad Real;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QII;8.305
13 Ciudad Real;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QII;8.421
13 Ciudad Real;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QII;8.233
13 Ciudad Real;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2022QII;8.063
13 Ciudad Real;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2022QI;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2021QII;8.255
13 Ciudad Real;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2021QI;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2020QII;8.089
13 Ciudad Real;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2020QI;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2022QIII;7.890
13 Ciudad Real;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2022QII;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2022QI;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2021QIII;8.105
13 Ciudad Real;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2021QII;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2021QI;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2020QIII;7.953
13 Ciudad Real;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2020QII;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2020QI;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QIV;7.741
13 Ciudad Real;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QII;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QI;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QIV;7.946
13 Ciudad Real;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QII;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QI;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QIV;7.819
13 Ciudad Real;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QII;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QI;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QII;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QI;7.789
13 Ciudad Real;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QII;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QI;7.716
13 Ciudad Real;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QII;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QI;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
13 Ciudad Real;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
13 Ciudad Real;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
13 Ciudad Real;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;97,09
13 Ciudad Real;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;98,03
13 Ciudad Real;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;98,25
13 Ciudad Real;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;95
13 Ciudad Real;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;96,25
13 Ciudad Real;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;96,6
13 Ciudad Real;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;93,21
13 Ciudad Real;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;94,36
13 Ciudad Real;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;94,97
13 Ciudad Real;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;92,49
13 Ciudad Real;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;93,72
13 Ciudad Real;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QII;5.432
13 Ciudad Real;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QII;5.546
13 Ciudad Real;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QII;5.458
13 Ciudad Real;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2022QII;5.307
13 Ciudad Real;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2022QI;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2021QII;5.458
13 Ciudad Real;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2021QI;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2020QII;5.368
13 Ciudad Real;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2020QI;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2022QIII;5.207
13 Ciudad Real;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2022QII;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2022QI;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2021QIII;5.365
13 Ciudad Real;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2021QII;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2021QI;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2020QIII;5.282
13 Ciudad Real;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2020QII;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2020QI;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QIV;5.122
13 Ciudad Real;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QII;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QI;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QIV;5.267
13 Ciudad Real;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QII;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QI;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QIV;5.197
13 Ciudad Real;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QII;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QI;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QII;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QI;5.174
13 Ciudad Real;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QII;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QI;5.139
13 Ciudad Real;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QII;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QI;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
13 Ciudad Real;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
13 Ciudad Real;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
13 Ciudad Real;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;97,7
13 Ciudad Real;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;98,41
13 Ciudad Real;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;98,35
13 Ciudad Real;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;95,86
13 Ciudad Real;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;96,74
13 Ciudad Real;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;96,78
13 Ciudad Real;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;94,29
13 Ciudad Real;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;94,97
13 Ciudad Real;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;95,22
13 Ciudad Real;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;93,29
13 Ciudad Real;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;94,16
13 Ciudad Real;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QII;2.873
13 Ciudad Real;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QII;2.875
13 Ciudad Real;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QII;2.775
13 Ciudad Real;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2022QII;2.756
13 Ciudad Real;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2022QI;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2021QII;2.797
13 Ciudad Real;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2021QI;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2020QII;2.721
13 Ciudad Real;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2020QI;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2022QIII;2.683
13 Ciudad Real;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2022QII;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2022QI;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2021QIII;2.740
13 Ciudad Real;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2021QII;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2021QI;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2020QIII;2.671
13 Ciudad Real;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2020QII;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2020QI;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QIV;2.619
13 Ciudad Real;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QII;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QI;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QIV;2.679
13 Ciudad Real;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QII;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QI;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QIV;2.622
13 Ciudad Real;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QII;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QI;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QII;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QI;2.615
13 Ciudad Real;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QII;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QI;2.577
13 Ciudad Real;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QII;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QI;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
13 Ciudad Real;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
13 Ciudad Real;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
13 Ciudad Real;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;95,93
13 Ciudad Real;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;97,29
13 Ciudad Real;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;98,05
13 Ciudad Real;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;93,39
13 Ciudad Real;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;95,3
13 Ciudad Real;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;96,25
13 Ciudad Real;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;91,16
13 Ciudad Real;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;93,18
13 Ciudad Real;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;94,49
13 Ciudad Real;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;90,96
13 Ciudad Real;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;92,86
13 Ciudad Real;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QIII;8.355
13 Ciudad Real;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QIII;8.503
13 Ciudad Real;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QIII;8.389
13 Ciudad Real;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2022QIII;8.133
13 Ciudad Real;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2022QII;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2022QI;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2021QIII;8.317
13 Ciudad Real;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2021QII;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2021QI;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2020QIII;8.222
13 Ciudad Real;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2020QII;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2020QI;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2022QIV;7.960
13 Ciudad Real;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2022QII;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2022QI;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2021QIV;8.139
13 Ciudad Real;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2021QII;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2021QI;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2020QIV;8.055
13 Ciudad Real;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2020QII;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2020QI;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QII;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QI;7.969
13 Ciudad Real;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QII;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QI;7.941
13 Ciudad Real;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QII;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QI;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QII;7.789
13 Ciudad Real;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QI;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QII;7.832
13 Ciudad Real;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QI;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QII;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QI;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
13 Ciudad Real;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
13 Ciudad Real;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
13 Ciudad Real;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;97,34
13 Ciudad Real;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;97,81
13 Ciudad Real;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;98,01
13 Ciudad Real;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;95,27
13 Ciudad Real;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;95,72
13 Ciudad Real;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;96,02
13 Ciudad Real;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;93,72
13 Ciudad Real;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;94,66
13 Ciudad Real;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;91,6
13 Ciudad Real;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;93,36
13 Ciudad Real;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QIII;5.477
13 Ciudad Real;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QIII;5.598
13 Ciudad Real;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QIII;5.571
13 Ciudad Real;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2022QIII;5.345
13 Ciudad Real;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2022QII;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2022QI;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2021QIII;5.487
13 Ciudad Real;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2021QII;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2021QI;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2020QIII;5.463
13 Ciudad Real;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2020QII;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2020QI;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2022QIV;5.244
13 Ciudad Real;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2022QII;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2022QI;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2021QIV;5.383
13 Ciudad Real;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2021QII;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2021QI;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2020QIV;5.352
13 Ciudad Real;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2020QII;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2020QI;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QII;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QI;5.282
13 Ciudad Real;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QII;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QI;5.285
13 Ciudad Real;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QII;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QI;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QII;5.187
13 Ciudad Real;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QI;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QII;5.237
13 Ciudad Real;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QI;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QII;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QI;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
13 Ciudad Real;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
13 Ciudad Real;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
13 Ciudad Real;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;97,59
13 Ciudad Real;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;98,02
13 Ciudad Real;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;98,06
13 Ciudad Real;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;95,75
13 Ciudad Real;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;96,16
13 Ciudad Real;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;96,07
13 Ciudad Real;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;94,36
13 Ciudad Real;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;94,87
13 Ciudad Real;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;92,66
13 Ciudad Real;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;94
13 Ciudad Real;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QIII;2.878
13 Ciudad Real;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QIII;2.905
13 Ciudad Real;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QIII;2.818
13 Ciudad Real;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2022QIII;2.788
13 Ciudad Real;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2022QII;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2022QI;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2021QIII;2.830
13 Ciudad Real;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2021QII;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2021QI;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2020QIII;2.759
13 Ciudad Real;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2020QII;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2020QI;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2022QIV;2.716
13 Ciudad Real;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2022QII;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2022QI;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2021QIV;2.756
13 Ciudad Real;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2021QII;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2021QI;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2020QIV;2.703
13 Ciudad Real;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2020QII;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2020QI;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QII;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QI;2.687
13 Ciudad Real;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QII;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QI;2.656
13 Ciudad Real;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QII;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QI;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QII;2.602
13 Ciudad Real;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QI;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QII;2.595
13 Ciudad Real;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QI;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QII;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QI;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
13 Ciudad Real;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
13 Ciudad Real;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
13 Ciudad Real;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;96,87
13 Ciudad Real;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;97,42
13 Ciudad Real;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;97,91
13 Ciudad Real;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;94,37
13 Ciudad Real;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;94,87
13 Ciudad Real;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;95,92
13 Ciudad Real;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;92,5
13 Ciudad Real;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;94,25
13 Ciudad Real;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;89,57
13 Ciudad Real;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;92,09
13 Ciudad Real;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QIV;8.295
13 Ciudad Real;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QIV;8.504
13 Ciudad Real;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QIV;8.431
13 Ciudad Real;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2022QIV;8.097
13 Ciudad Real;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2022QII;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2022QI;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2021QIV;8.297
13 Ciudad Real;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2021QII;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2021QI;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2020QIV;8.238
13 Ciudad Real;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2020QII;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2020QI;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2022QII;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2022QI;8.123
13 Ciudad Real;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2021QII;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2021QI;8.114
13 Ciudad Real;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2020QII;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2020QI;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QII;7.926
13 Ciudad Real;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QI;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QII;7.994
13 Ciudad Real;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QI;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QII;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QI;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QIII;7.774
13 Ciudad Real;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QII;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QI;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QIII;7.865
13 Ciudad Real;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QII;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QI;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QII;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QI;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
13 Ciudad Real;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
13 Ciudad Real;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
13 Ciudad Real;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;97,61
13 Ciudad Real;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;97,57
13 Ciudad Real;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;97,71
13 Ciudad Real;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;95,52
13 Ciudad Real;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;96,24
13 Ciudad Real;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;93,2
13 Ciudad Real;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;94,82
13 Ciudad Real;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;91,42
13 Ciudad Real;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;93,29
13 Ciudad Real;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QIV;5.434
13 Ciudad Real;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QIV;5.590
13 Ciudad Real;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QIV;5.577
13 Ciudad Real;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2022QIV;5.317
13 Ciudad Real;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2022QII;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2022QI;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2021QIV;5.468
13 Ciudad Real;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2021QII;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2021QI;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2020QIV;5.450
13 Ciudad Real;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2020QII;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2020QI;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2022QII;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2022QI;5.365
13 Ciudad Real;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2021QII;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2021QI;5.378
13 Ciudad Real;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2020QII;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2020QI;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QII;5.259
13 Ciudad Real;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QI;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QII;5.323
13 Ciudad Real;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QI;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QII;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QI;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QIII;5.172
13 Ciudad Real;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QII;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QI;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QIII;5.249
13 Ciudad Real;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QII;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QI;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QII;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QI;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
13 Ciudad Real;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
13 Ciudad Real;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
13 Ciudad Real;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;97,85
13 Ciudad Real;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;97,82
13 Ciudad Real;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;97,72
13 Ciudad Real;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;95,97
13 Ciudad Real;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;96,43
13 Ciudad Real;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;94,08
13 Ciudad Real;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;95,45
13 Ciudad Real;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;92,52
13 Ciudad Real;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;94,12
13 Ciudad Real;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QIV;2.861
13 Ciudad Real;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QIV;2.914
13 Ciudad Real;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QIV;2.854
13 Ciudad Real;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2022QIV;2.780
13 Ciudad Real;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2022QII;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2022QI;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2021QIV;2.829
13 Ciudad Real;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2021QII;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2021QI;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2020QIV;2.788
13 Ciudad Real;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2020QII;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2020QI;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2022QII;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2022QI;2.758
13 Ciudad Real;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2021QII;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2021QI;2.736
13 Ciudad Real;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2020QII;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2020QI;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QII;2.667
13 Ciudad Real;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QI;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QII;2.671
13 Ciudad Real;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QI;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QII;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QI;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QIII;2.602
13 Ciudad Real;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QII;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QI;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QIII;2.616
13 Ciudad Real;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QII;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QI;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QII;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QI;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
13 Ciudad Real;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
13 Ciudad Real;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
13 Ciudad Real;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;97,17
13 Ciudad Real;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;97,08
13 Ciudad Real;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;97,69
13 Ciudad Real;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;94,65
13 Ciudad Real;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;95,87
13 Ciudad Real;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;91,52
13 Ciudad Real;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;93,59
13 Ciudad Real;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;89,29
13 Ciudad Real;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;91,66
13 Ciudad Real;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QI;8.576
13 Ciudad Real;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QI;8.556
13 Ciudad Real;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QI;8.721
13 Ciudad Real;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2022QII;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2022QI;8.398
13 Ciudad Real;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2021QII;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2021QI;8.444
13 Ciudad Real;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2020QII;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2020QI;8.316
13 Ciudad Real;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2022QII;8.247
13 Ciudad Real;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2022QI;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2021QII;8.316
13 Ciudad Real;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2021QI;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2020QII;8.192
13 Ciudad Real;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2020QI;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QIII;8.120
13 Ciudad Real;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QII;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QI;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QIII;8.208
13 Ciudad Real;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QII;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QI;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QIII;8.090
13 Ciudad Real;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QII;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QI;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QIV;7.973
13 Ciudad Real;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QII;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QI;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QIV;8.095
13 Ciudad Real;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QII;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QI;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QIV;7.980
13 Ciudad Real;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QII;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QI;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
13 Ciudad Real;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
13 Ciudad Real;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
13 Ciudad Real;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;97,92
13 Ciudad Real;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;98,69
13 Ciudad Real;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;95,36
13 Ciudad Real;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;96,16
13 Ciudad Real;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;97,19
13 Ciudad Real;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;93,93
13 Ciudad Real;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;94,68
13 Ciudad Real;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;95,93
13 Ciudad Real;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;92,76
13 Ciudad Real;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;92,97
13 Ciudad Real;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;94,61
13 Ciudad Real;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;91,5
13 Ciudad Real;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QI;5.825
13 Ciudad Real;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QI;5.870
13 Ciudad Real;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QI;5.976
13 Ciudad Real;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2022QII;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2022QI;5.717
13 Ciudad Real;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2021QII;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2021QI;5.800
13 Ciudad Real;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2020QII;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2020QI;5.726
13 Ciudad Real;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2022QII;5.634
13 Ciudad Real;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2022QI;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2021QII;5.717
13 Ciudad Real;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2021QI;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2020QII;5.650
13 Ciudad Real;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2020QI;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QIII;5.547
13 Ciudad Real;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QII;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QI;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QIII;5.653
13 Ciudad Real;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QII;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QI;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QIII;5.597
13 Ciudad Real;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QII;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QI;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QIV;5.456
13 Ciudad Real;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QII;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QI;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QIV;5.581
13 Ciudad Real;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QII;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QI;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QIV;5.534
13 Ciudad Real;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QII;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QI;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
13 Ciudad Real;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
13 Ciudad Real;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
13 Ciudad Real;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;98,15
13 Ciudad Real;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;98,81
13 Ciudad Real;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;95,82
13 Ciudad Real;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;96,72
13 Ciudad Real;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;97,39
13 Ciudad Real;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;94,54
13 Ciudad Real;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;95,23
13 Ciudad Real;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;96,3
13 Ciudad Real;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;93,66
13 Ciudad Real;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;93,67
13 Ciudad Real;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;95,08
13 Ciudad Real;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;92,6
13 Ciudad Real;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QI;2.751
13 Ciudad Real;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QI;2.686
13 Ciudad Real;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QI;2.745
13 Ciudad Real;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2022QII;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2022QI;2.681
13 Ciudad Real;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2021QII;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2021QI;2.644
13 Ciudad Real;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2020QII;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2020QI;2.590
13 Ciudad Real;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2022QII;2.613
13 Ciudad Real;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2022QI;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2021QII;2.599
13 Ciudad Real;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2021QI;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2020QII;2.542
13 Ciudad Real;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2020QI;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QIII;2.573
13 Ciudad Real;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QII;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QI;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QIII;2.555
13 Ciudad Real;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QII;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QI;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QIII;2.493
13 Ciudad Real;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QII;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QI;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QIV;2.517
13 Ciudad Real;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QII;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QI;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QIV;2.514
13 Ciudad Real;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QII;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QI;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QIV;2.446
13 Ciudad Real;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QII;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QI;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
13 Ciudad Real;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
13 Ciudad Real;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
13 Ciudad Real;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;97,46
13 Ciudad Real;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;98,44
13 Ciudad Real;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;94,35
13 Ciudad Real;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;94,98
13 Ciudad Real;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;96,76
13 Ciudad Real;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;92,6
13 Ciudad Real;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;93,53
13 Ciudad Real;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;95,12
13 Ciudad Real;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;90,82
13 Ciudad Real;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;91,49
13 Ciudad Real;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;93,6
13 Ciudad Real;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;89,11
13 Ciudad Real;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QII;8.714
13 Ciudad Real;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QII;8.655
13 Ciudad Real;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QII;8.540
13 Ciudad Real;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2022QII;8.542
13 Ciudad Real;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2022QI;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2021QII;8.516
13 Ciudad Real;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2021QI;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2020QII;8.410
13 Ciudad Real;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2020QI;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2022QIII;8.390
13 Ciudad Real;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2022QII;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2022QI;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2021QIII;8.390
13 Ciudad Real;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2021QII;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2021QI;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2020QIII;8.282
13 Ciudad Real;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2020QII;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2020QI;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QIV;8.234
13 Ciudad Real;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QII;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QI;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QIV;8.260
13 Ciudad Real;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QII;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QI;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QIV;8.161
13 Ciudad Real;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QII;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QI;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QII;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QI;8.117
13 Ciudad Real;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QII;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QI;8.083
13 Ciudad Real;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QII;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QI;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
13 Ciudad Real;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
13 Ciudad Real;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
13 Ciudad Real;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;98,03
13 Ciudad Real;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;98,39
13 Ciudad Real;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;98,48
13 Ciudad Real;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;96,28
13 Ciudad Real;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;96,94
13 Ciudad Real;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;96,98
13 Ciudad Real;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;94,49
13 Ciudad Real;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;95,44
13 Ciudad Real;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;95,56
13 Ciudad Real;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;93,78
13 Ciudad Real;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;94,65
13 Ciudad Real;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QII;5.869
13 Ciudad Real;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QII;5.911
13 Ciudad Real;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QII;5.868
13 Ciudad Real;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2022QII;5.764
13 Ciudad Real;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2022QI;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2021QII;5.823
13 Ciudad Real;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2021QI;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2020QII;5.787
13 Ciudad Real;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2020QI;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2022QIII;5.659
13 Ciudad Real;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2022QII;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2022QI;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2021QIII;5.746
13 Ciudad Real;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2021QII;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2021QI;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2020QIII;5.711
13 Ciudad Real;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2020QII;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2020QI;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QIV;5.564
13 Ciudad Real;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QII;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QI;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QIV;5.658
13 Ciudad Real;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QII;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QI;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QIV;5.638
13 Ciudad Real;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QII;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QI;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QII;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QI;5.576
13 Ciudad Real;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QII;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QI;5.587
13 Ciudad Real;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QII;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QI;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
13 Ciudad Real;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
13 Ciudad Real;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
13 Ciudad Real;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;98,21
13 Ciudad Real;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;98,51
13 Ciudad Real;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;98,62
13 Ciudad Real;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;96,42
13 Ciudad Real;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;97,21
13 Ciudad Real;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;97,32
13 Ciudad Real;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;94,8
13 Ciudad Real;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;95,72
13 Ciudad Real;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;96,08
13 Ciudad Real;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;94,33
13 Ciudad Real;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;95,21
13 Ciudad Real;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QII;2.845
13 Ciudad Real;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QII;2.744
13 Ciudad Real;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QII;2.672
13 Ciudad Real;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2022QII;2.778
13 Ciudad Real;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2022QI;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2021QII;2.693
13 Ciudad Real;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2021QI;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2020QII;2.623
13 Ciudad Real;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2020QI;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2022QIII;2.731
13 Ciudad Real;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2022QII;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2022QI;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2021QIII;2.644
13 Ciudad Real;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2021QII;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2021QI;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2020QIII;2.571
13 Ciudad Real;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2020QII;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2020QI;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QIV;2.670
13 Ciudad Real;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QII;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QI;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QIV;2.602
13 Ciudad Real;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QII;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QI;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QIV;2.523
13 Ciudad Real;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QII;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QI;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QII;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QI;2.541
13 Ciudad Real;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QII;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QI;2.496
13 Ciudad Real;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QII;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QI;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
13 Ciudad Real;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
13 Ciudad Real;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
13 Ciudad Real;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;97,64
13 Ciudad Real;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;98,14
13 Ciudad Real;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;98,17
13 Ciudad Real;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;95,99
13 Ciudad Real;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;96,36
13 Ciudad Real;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;96,22
13 Ciudad Real;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;93,85
13 Ciudad Real;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;94,83
13 Ciudad Real;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;94,42
13 Ciudad Real;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;92,6
13 Ciudad Real;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;93,41
13 Ciudad Real;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QIII;8.745
13 Ciudad Real;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QIII;8.688
13 Ciudad Real;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QIII;8.619
13 Ciudad Real;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2022QIII;8.538
13 Ciudad Real;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2022QII;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2022QI;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2021QIII;8.518
13 Ciudad Real;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2021QII;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2021QI;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2020QIII;8.451
13 Ciudad Real;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2020QII;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2020QI;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2022QIV;8.358
13 Ciudad Real;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2022QII;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2022QI;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2021QIV;8.358
13 Ciudad Real;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2021QII;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2021QI;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2020QIV;8.310
13 Ciudad Real;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2020QII;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2020QI;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QII;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QI;8.205
13 Ciudad Real;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QII;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QI;8.222
13 Ciudad Real;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QII;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QI;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QII;8.078
13 Ciudad Real;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QI;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QII;8.112
13 Ciudad Real;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QI;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QII;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QI;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
13 Ciudad Real;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
13 Ciudad Real;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
13 Ciudad Real;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;97,63
13 Ciudad Real;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;98,04
13 Ciudad Real;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;98,05
13 Ciudad Real;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;95,57
13 Ciudad Real;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;96,2
13 Ciudad Real;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;96,41
13 Ciudad Real;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;94,44
13 Ciudad Real;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;95,39
13 Ciudad Real;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;92,98
13 Ciudad Real;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;94,12
13 Ciudad Real;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QIII;5.882
13 Ciudad Real;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QIII;5.933
13 Ciudad Real;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QIII;5.916
13 Ciudad Real;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2022QIII;5.748
13 Ciudad Real;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2022QII;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2022QI;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2021QIII;5.829
13 Ciudad Real;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2021QII;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2021QI;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2020QIII;5.814
13 Ciudad Real;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2020QII;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2020QI;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2022QIV;5.637
13 Ciudad Real;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2022QII;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2022QI;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2021QIV;5.720
13 Ciudad Real;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2021QII;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2021QI;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2020QIV;5.728
13 Ciudad Real;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2020QII;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2020QI;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QII;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QI;5.630
13 Ciudad Real;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QII;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QI;5.672
13 Ciudad Real;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QII;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QI;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QII;5.553
13 Ciudad Real;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QI;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QII;5.601
13 Ciudad Real;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QI;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QII;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QI;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
13 Ciudad Real;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
13 Ciudad Real;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
13 Ciudad Real;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;97,72
13 Ciudad Real;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;98,25
13 Ciudad Real;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;98,28
13 Ciudad Real;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;95,83
13 Ciudad Real;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;96,41
13 Ciudad Real;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;96,82
13 Ciudad Real;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;94,89
13 Ciudad Real;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;95,88
13 Ciudad Real;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;93,6
13 Ciudad Real;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;94,68
13 Ciudad Real;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QIII;2.863
13 Ciudad Real;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QIII;2.755
13 Ciudad Real;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QIII;2.703
13 Ciudad Real;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2022QIII;2.790
13 Ciudad Real;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2022QII;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2022QI;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2021QIII;2.689
13 Ciudad Real;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2021QII;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2021QI;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2020QIII;2.637
13 Ciudad Real;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2020QII;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2020QI;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2022QIV;2.721
13 Ciudad Real;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2022QII;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2022QI;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2021QIV;2.638
13 Ciudad Real;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2021QII;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2021QI;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2020QIV;2.582
13 Ciudad Real;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2020QII;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2020QI;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QII;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QI;2.575
13 Ciudad Real;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QII;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QI;2.550
13 Ciudad Real;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QII;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QI;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QII;2.525
13 Ciudad Real;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QI;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QII;2.511
13 Ciudad Real;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QI;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QII;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QI;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
13 Ciudad Real;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
13 Ciudad Real;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
13 Ciudad Real;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;97,45
13 Ciudad Real;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;97,6
13 Ciudad Real;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;97,56
13 Ciudad Real;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;95,04
13 Ciudad Real;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;95,75
13 Ciudad Real;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;95,52
13 Ciudad Real;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;93,47
13 Ciudad Real;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;94,34
13 Ciudad Real;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;91,65
13 Ciudad Real;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;92,9
13 Ciudad Real;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QIV;8.657
13 Ciudad Real;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QIV;8.638
13 Ciudad Real;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QIV;8.610
13 Ciudad Real;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2022QIV;8.450
13 Ciudad Real;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2022QII;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2022QI;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2021QIV;8.459
13 Ciudad Real;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2021QII;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2021QI;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2020QIV;8.440
13 Ciudad Real;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2020QII;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2020QI;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2022QII;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2022QI;8.296
13 Ciudad Real;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2021QII;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2021QI;8.343
13 Ciudad Real;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2020QII;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2020QI;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QII;8.160
13 Ciudad Real;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QI;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QII;8.225
13 Ciudad Real;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QI;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QII;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QI;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QIII;8.043
13 Ciudad Real;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QII;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QI;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QIII;8.123
13 Ciudad Real;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QII;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QI;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QII;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QI;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
13 Ciudad Real;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
13 Ciudad Real;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
13 Ciudad Real;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;97,61
13 Ciudad Real;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;97,93
13 Ciudad Real;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;98,03
13 Ciudad Real;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;96,04
13 Ciudad Real;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;96,9
13 Ciudad Real;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;94,47
13 Ciudad Real;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;95,53
13 Ciudad Real;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;93,11
13 Ciudad Real;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;94,34
13 Ciudad Real;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QIV;5.812
13 Ciudad Real;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QIV;5.891
13 Ciudad Real;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QIV;5.907
13 Ciudad Real;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2022QIV;5.681
13 Ciudad Real;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2022QII;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2022QI;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2021QIV;5.771
13 Ciudad Real;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2021QII;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2021QI;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2020QIV;5.796
13 Ciudad Real;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2020QII;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2020QI;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2022QII;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2022QI;5.673
13 Ciudad Real;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2021QII;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2021QI;5.735
13 Ciudad Real;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2020QII;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2020QI;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QII;5.594
13 Ciudad Real;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QI;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QII;5.659
13 Ciudad Real;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QI;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QII;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QI;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QIII;5.514
13 Ciudad Real;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QII;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QI;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QIII;5.599
13 Ciudad Real;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QII;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QI;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QII;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QI;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
13 Ciudad Real;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
13 Ciudad Real;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
13 Ciudad Real;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;97,75
13 Ciudad Real;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;97,96
13 Ciudad Real;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;98,12
13 Ciudad Real;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;96,3
13 Ciudad Real;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;97,09
13 Ciudad Real;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;94,96
13 Ciudad Real;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;95,8
13 Ciudad Real;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;93,6
13 Ciudad Real;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;94,79
13 Ciudad Real;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QIV;2.845
13 Ciudad Real;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QIV;2.747
13 Ciudad Real;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QIV;2.703
13 Ciudad Real;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2022QIV;2.769
13 Ciudad Real;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2022QII;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2022QI;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2021QIV;2.688
13 Ciudad Real;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2021QII;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2021QI;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2020QIV;2.644
13 Ciudad Real;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2020QII;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2020QI;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2022QII;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2022QI;2.623
13 Ciudad Real;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2021QII;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2021QI;2.608
13 Ciudad Real;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2020QII;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2020QI;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QII;2.566
13 Ciudad Real;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QI;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QII;2.566
13 Ciudad Real;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QI;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QII;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QI;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QIII;2.529
13 Ciudad Real;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QII;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QI;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QIII;2.524
13 Ciudad Real;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QII;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QI;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QII;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QI;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
13 Ciudad Real;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
13 Ciudad Real;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
13 Ciudad Real;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;97,33
13 Ciudad Real;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;97,85
13 Ciudad Real;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;97,82
13 Ciudad Real;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;95,49
13 Ciudad Real;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;96,49
13 Ciudad Real;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;93,41
13 Ciudad Real;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;94,93
13 Ciudad Real;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;92,06
13 Ciudad Real;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;93,38
13 Ciudad Real;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
13 Ciudad Real;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
13 Ciudad Real;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
13 Ciudad Real;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
13 Ciudad Real;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QI;4.167
13 Ciudad Real;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
13 Ciudad Real;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
13 Ciudad Real;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
13 Ciudad Real;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QI;3.806
13 Ciudad Real;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
13 Ciudad Real;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
13 Ciudad Real;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
13 Ciudad Real;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QI;4.343
13 Ciudad Real;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
13 Ciudad Real;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
13 Ciudad Real;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2022QII;""
13 Ciudad Real;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2022QI;4.032
13 Ciudad Real;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
13 Ciudad Real;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
13 Ciudad Real;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2021QII;""
13 Ciudad Real;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2021QI;3.686
13 Ciudad Real;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
13 Ciudad Real;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
13 Ciudad Real;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2020QII;""
13 Ciudad Real;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2020QI;4.072
13 Ciudad Real;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
13 Ciudad Real;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
13 Ciudad Real;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2022QII;3.869
13 Ciudad Real;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2022QI;""
13 Ciudad Real;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
13 Ciudad Real;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
13 Ciudad Real;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2021QII;3.570
13 Ciudad Real;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2021QI;""
13 Ciudad Real;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
13 Ciudad Real;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
13 Ciudad Real;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2020QII;3.957
13 Ciudad Real;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2020QI;""
13 Ciudad Real;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
13 Ciudad Real;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QIII;3.722
13 Ciudad Real;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QII;""
13 Ciudad Real;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QI;""
13 Ciudad Real;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
13 Ciudad Real;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QIII;3.453
13 Ciudad Real;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QII;""
13 Ciudad Real;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QI;""
13 Ciudad Real;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
13 Ciudad Real;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QIII;3.815
13 Ciudad Real;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QII;""
13 Ciudad Real;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QI;""
13 Ciudad Real;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QIV;3.499
13 Ciudad Real;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
13 Ciudad Real;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QII;""
13 Ciudad Real;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QI;""
13 Ciudad Real;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QIV;3.289
13 Ciudad Real;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
13 Ciudad Real;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QII;""
13 Ciudad Real;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QI;""
13 Ciudad Real;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QIV;3.650
13 Ciudad Real;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
13 Ciudad Real;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QII;""
13 Ciudad Real;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QI;""
13 Ciudad Real;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
13 Ciudad Real;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
13 Ciudad Real;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
13 Ciudad Real;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
13 Ciudad Real;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
13 Ciudad Real;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
13 Ciudad Real;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
13 Ciudad Real;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
13 Ciudad Real;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
13 Ciudad Real;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
13 Ciudad Real;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
13 Ciudad Real;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
13 Ciudad Real;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
13 Ciudad Real;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
13 Ciudad Real;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
13 Ciudad Real;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;96,76
13 Ciudad Real;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
13 Ciudad Real;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
13 Ciudad Real;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
13 Ciudad Real;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;96,85
13 Ciudad Real;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
13 Ciudad Real;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
13 Ciudad Real;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
13 Ciudad Real;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;93,76
13 Ciudad Real;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
13 Ciudad Real;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
13 Ciudad Real;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;92,85
13 Ciudad Real;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
13 Ciudad Real;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
13 Ciudad Real;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
13 Ciudad Real;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;93,8
13 Ciudad Real;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
13 Ciudad Real;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
13 Ciudad Real;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
13 Ciudad Real;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;91,11
13 Ciudad Real;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
13 Ciudad Real;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
13 Ciudad Real;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;89,32
13 Ciudad Real;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
13 Ciudad Real;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
13 Ciudad Real;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
13 Ciudad Real;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;90,73
13 Ciudad Real;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
13 Ciudad Real;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
13 Ciudad Real;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
13 Ciudad Real;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;87,84
13 Ciudad Real;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
13 Ciudad Real;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
13 Ciudad Real;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;83,97
13 Ciudad Real;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
13 Ciudad Real;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
13 Ciudad Real;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
13 Ciudad Real;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;86,42
13 Ciudad Real;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
13 Ciudad Real;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
13 Ciudad Real;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
13 Ciudad Real;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;84,04
13 Ciudad Real;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
13 Ciudad Real;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
13 Ciudad Real;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
13 Ciudad Real;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
13 Ciudad Real;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
13 Ciudad Real;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
13 Ciudad Real;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QI;2.862
13 Ciudad Real;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
13 Ciudad Real;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
13 Ciudad Real;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
13 Ciudad Real;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QI;2.616
13 Ciudad Real;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
13 Ciudad Real;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
13 Ciudad Real;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
13 Ciudad Real;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QI;2.976
13 Ciudad Real;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
13 Ciudad Real;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
13 Ciudad Real;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2022QII;""
13 Ciudad Real;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2022QI;2.767
13 Ciudad Real;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
13 Ciudad Real;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
13 Ciudad Real;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2021QII;""
13 Ciudad Real;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2021QI;2.533
13 Ciudad Real;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
13 Ciudad Real;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
13 Ciudad Real;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2020QII;""
13 Ciudad Real;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2020QI;2.789
13 Ciudad Real;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
13 Ciudad Real;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
13 Ciudad Real;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2022QII;2.656
13 Ciudad Real;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2022QI;""
13 Ciudad Real;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
13 Ciudad Real;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
13 Ciudad Real;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2021QII;2.457
13 Ciudad Real;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2021QI;""
13 Ciudad Real;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
13 Ciudad Real;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
13 Ciudad Real;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2020QII;2.717
13 Ciudad Real;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2020QI;""
13 Ciudad Real;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
13 Ciudad Real;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QIII;2.563
13 Ciudad Real;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QII;""
13 Ciudad Real;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QI;""
13 Ciudad Real;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
13 Ciudad Real;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QIII;2.385
13 Ciudad Real;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QII;""
13 Ciudad Real;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QI;""
13 Ciudad Real;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
13 Ciudad Real;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QIII;2.632
13 Ciudad Real;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QII;""
13 Ciudad Real;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QI;""
13 Ciudad Real;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QIV;2.407
13 Ciudad Real;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
13 Ciudad Real;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QII;""
13 Ciudad Real;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QI;""
13 Ciudad Real;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QIV;2.275
13 Ciudad Real;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
13 Ciudad Real;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QII;""
13 Ciudad Real;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QI;""
13 Ciudad Real;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QIV;2.525
13 Ciudad Real;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
13 Ciudad Real;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QII;""
13 Ciudad Real;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QI;""
13 Ciudad Real;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
13 Ciudad Real;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
13 Ciudad Real;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
13 Ciudad Real;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
13 Ciudad Real;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
13 Ciudad Real;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
13 Ciudad Real;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
13 Ciudad Real;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
13 Ciudad Real;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
13 Ciudad Real;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
13 Ciudad Real;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
13 Ciudad Real;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
13 Ciudad Real;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
13 Ciudad Real;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
13 Ciudad Real;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
13 Ciudad Real;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;96,68
13 Ciudad Real;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
13 Ciudad Real;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
13 Ciudad Real;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
13 Ciudad Real;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;96,83
13 Ciudad Real;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
13 Ciudad Real;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
13 Ciudad Real;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
13 Ciudad Real;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;93,72
13 Ciudad Real;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
13 Ciudad Real;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
13 Ciudad Real;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;92,8
13 Ciudad Real;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
13 Ciudad Real;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
13 Ciudad Real;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
13 Ciudad Real;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;93,92
13 Ciudad Real;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
13 Ciudad Real;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
13 Ciudad Real;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
13 Ciudad Real;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;91,3
13 Ciudad Real;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
13 Ciudad Real;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
13 Ciudad Real;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;89,55
13 Ciudad Real;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
13 Ciudad Real;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
13 Ciudad Real;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
13 Ciudad Real;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;91,17
13 Ciudad Real;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
13 Ciudad Real;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
13 Ciudad Real;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
13 Ciudad Real;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;88,44
13 Ciudad Real;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
13 Ciudad Real;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
13 Ciudad Real;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;84,1
13 Ciudad Real;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
13 Ciudad Real;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
13 Ciudad Real;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
13 Ciudad Real;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;86,96
13 Ciudad Real;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
13 Ciudad Real;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
13 Ciudad Real;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
13 Ciudad Real;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;84,85
13 Ciudad Real;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
13 Ciudad Real;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
13 Ciudad Real;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
13 Ciudad Real;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
13 Ciudad Real;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
13 Ciudad Real;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
13 Ciudad Real;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QI;1.305
13 Ciudad Real;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
13 Ciudad Real;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
13 Ciudad Real;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
13 Ciudad Real;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QI;1.190
13 Ciudad Real;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
13 Ciudad Real;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
13 Ciudad Real;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
13 Ciudad Real;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QI;1.367
13 Ciudad Real;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
13 Ciudad Real;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
13 Ciudad Real;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2022QII;""
13 Ciudad Real;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2022QI;1.265
13 Ciudad Real;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
13 Ciudad Real;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
13 Ciudad Real;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2021QII;""
13 Ciudad Real;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2021QI;1.153
13 Ciudad Real;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
13 Ciudad Real;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
13 Ciudad Real;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2020QII;""
13 Ciudad Real;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2020QI;1.283
13 Ciudad Real;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
13 Ciudad Real;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
13 Ciudad Real;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2022QII;1.213
13 Ciudad Real;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2022QI;""
13 Ciudad Real;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
13 Ciudad Real;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
13 Ciudad Real;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2021QII;1.113
13 Ciudad Real;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2021QI;""
13 Ciudad Real;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
13 Ciudad Real;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
13 Ciudad Real;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2020QII;1.240
13 Ciudad Real;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2020QI;""
13 Ciudad Real;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
13 Ciudad Real;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QIII;1.159
13 Ciudad Real;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QII;""
13 Ciudad Real;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QI;""
13 Ciudad Real;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
13 Ciudad Real;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QIII;1.068
13 Ciudad Real;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QII;""
13 Ciudad Real;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QI;""
13 Ciudad Real;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
13 Ciudad Real;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QIII;1.183
13 Ciudad Real;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QII;""
13 Ciudad Real;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QI;""
13 Ciudad Real;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QIV;1.092
13 Ciudad Real;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
13 Ciudad Real;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QII;""
13 Ciudad Real;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QI;""
13 Ciudad Real;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QIV;1.014
13 Ciudad Real;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
13 Ciudad Real;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QII;""
13 Ciudad Real;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QI;""
13 Ciudad Real;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QIV;1.125
13 Ciudad Real;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
13 Ciudad Real;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QII;""
13 Ciudad Real;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QI;""
13 Ciudad Real;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
13 Ciudad Real;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
13 Ciudad Real;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
13 Ciudad Real;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
13 Ciudad Real;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
13 Ciudad Real;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
13 Ciudad Real;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
13 Ciudad Real;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
13 Ciudad Real;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
13 Ciudad Real;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
13 Ciudad Real;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
13 Ciudad Real;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
13 Ciudad Real;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
13 Ciudad Real;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
13 Ciudad Real;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
13 Ciudad Real;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;96,93
13 Ciudad Real;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
13 Ciudad Real;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
13 Ciudad Real;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
13 Ciudad Real;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;96,89
13 Ciudad Real;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
13 Ciudad Real;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
13 Ciudad Real;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
13 Ciudad Real;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;93,86
13 Ciudad Real;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
13 Ciudad Real;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
13 Ciudad Real;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;92,95
13 Ciudad Real;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
13 Ciudad Real;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
13 Ciudad Real;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
13 Ciudad Real;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;93,53
13 Ciudad Real;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
13 Ciudad Real;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
13 Ciudad Real;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
13 Ciudad Real;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;90,71
13 Ciudad Real;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
13 Ciudad Real;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
13 Ciudad Real;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;88,81
13 Ciudad Real;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
13 Ciudad Real;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
13 Ciudad Real;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
13 Ciudad Real;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;89,75
13 Ciudad Real;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
13 Ciudad Real;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
13 Ciudad Real;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
13 Ciudad Real;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;86,54
13 Ciudad Real;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
13 Ciudad Real;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
13 Ciudad Real;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;83,68
13 Ciudad Real;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
13 Ciudad Real;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
13 Ciudad Real;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
13 Ciudad Real;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;85,21
13 Ciudad Real;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
13 Ciudad Real;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
13 Ciudad Real;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
13 Ciudad Real;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;82,3
13 Ciudad Real;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
13 Ciudad Real;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
13 Ciudad Real;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
13 Ciudad Real;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
13 Ciudad Real;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
13 Ciudad Real;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QII;4.799
13 Ciudad Real;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
13 Ciudad Real;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
13 Ciudad Real;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
13 Ciudad Real;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QII;4.500
13 Ciudad Real;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
13 Ciudad Real;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
13 Ciudad Real;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
13 Ciudad Real;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QII;4.155
13 Ciudad Real;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
13 Ciudad Real;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
13 Ciudad Real;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
13 Ciudad Real;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2022QII;4.617
13 Ciudad Real;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2022QI;""
13 Ciudad Real;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
13 Ciudad Real;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
13 Ciudad Real;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2021QII;4.362
13 Ciudad Real;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2021QI;""
13 Ciudad Real;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
13 Ciudad Real;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
13 Ciudad Real;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2020QII;4.034
13 Ciudad Real;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2020QI;""
13 Ciudad Real;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
13 Ciudad Real;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2022QIII;4.457
13 Ciudad Real;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2022QII;""
13 Ciudad Real;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2022QI;""
13 Ciudad Real;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
13 Ciudad Real;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2021QIII;4.235
13 Ciudad Real;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2021QII;""
13 Ciudad Real;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2021QI;""
13 Ciudad Real;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
13 Ciudad Real;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2020QIII;3.870
13 Ciudad Real;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2020QII;""
13 Ciudad Real;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2020QI;""
13 Ciudad Real;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QIV;4.213
13 Ciudad Real;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
13 Ciudad Real;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QII;""
13 Ciudad Real;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QI;""
13 Ciudad Real;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QIV;4.054
13 Ciudad Real;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
13 Ciudad Real;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QII;""
13 Ciudad Real;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QI;""
13 Ciudad Real;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QIV;3.700
13 Ciudad Real;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
13 Ciudad Real;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QII;""
13 Ciudad Real;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QI;""
13 Ciudad Real;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
13 Ciudad Real;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
13 Ciudad Real;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QII;""
13 Ciudad Real;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QI;3.934
13 Ciudad Real;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
13 Ciudad Real;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
13 Ciudad Real;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QII;""
13 Ciudad Real;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QI;3.591
13 Ciudad Real;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
13 Ciudad Real;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
13 Ciudad Real;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QII;""
13 Ciudad Real;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QI;""
13 Ciudad Real;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
13 Ciudad Real;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
13 Ciudad Real;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
13 Ciudad Real;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
13 Ciudad Real;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
13 Ciudad Real;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
13 Ciudad Real;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
13 Ciudad Real;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
13 Ciudad Real;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
13 Ciudad Real;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
13 Ciudad Real;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
13 Ciudad Real;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
13 Ciudad Real;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
13 Ciudad Real;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
13 Ciudad Real;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;96,21
13 Ciudad Real;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
13 Ciudad Real;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
13 Ciudad Real;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
13 Ciudad Real;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;96,93
13 Ciudad Real;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
13 Ciudad Real;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
13 Ciudad Real;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
13 Ciudad Real;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;97,09
13 Ciudad Real;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
13 Ciudad Real;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
13 Ciudad Real;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;92,87
13 Ciudad Real;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
13 Ciudad Real;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
13 Ciudad Real;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
13 Ciudad Real;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;94,11
13 Ciudad Real;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
13 Ciudad Real;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
13 Ciudad Real;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
13 Ciudad Real;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;93,14
13 Ciudad Real;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
13 Ciudad Real;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
13 Ciudad Real;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;87,79
13 Ciudad Real;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
13 Ciudad Real;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
13 Ciudad Real;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
13 Ciudad Real;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;90,09
13 Ciudad Real;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
13 Ciudad Real;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
13 Ciudad Real;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
13 Ciudad Real;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;89,05
13 Ciudad Real;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
13 Ciudad Real;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
13 Ciudad Real;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
13 Ciudad Real;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
13 Ciudad Real;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
13 Ciudad Real;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
13 Ciudad Real;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;87,42
13 Ciudad Real;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
13 Ciudad Real;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
13 Ciudad Real;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
13 Ciudad Real;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;86,43
13 Ciudad Real;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
13 Ciudad Real;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
13 Ciudad Real;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
13 Ciudad Real;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
13 Ciudad Real;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
13 Ciudad Real;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
13 Ciudad Real;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QII;3.305
13 Ciudad Real;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
13 Ciudad Real;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
13 Ciudad Real;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
13 Ciudad Real;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QII;3.088
13 Ciudad Real;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
13 Ciudad Real;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
13 Ciudad Real;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
13 Ciudad Real;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QII;2.843
13 Ciudad Real;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
13 Ciudad Real;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
13 Ciudad Real;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
13 Ciudad Real;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2022QII;3.184
13 Ciudad Real;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2022QI;""
13 Ciudad Real;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
13 Ciudad Real;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
13 Ciudad Real;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2021QII;2.998
13 Ciudad Real;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2021QI;""
13 Ciudad Real;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
13 Ciudad Real;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
13 Ciudad Real;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2020QII;2.765
13 Ciudad Real;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2020QI;""
13 Ciudad Real;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
13 Ciudad Real;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2022QIII;3.081
13 Ciudad Real;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2022QII;""
13 Ciudad Real;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2022QI;""
13 Ciudad Real;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
13 Ciudad Real;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2021QIII;2.921
13 Ciudad Real;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2021QII;""
13 Ciudad Real;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2021QI;""
13 Ciudad Real;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
13 Ciudad Real;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2020QIII;2.665
13 Ciudad Real;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2020QII;""
13 Ciudad Real;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2020QI;""
13 Ciudad Real;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QIV;2.915
13 Ciudad Real;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
13 Ciudad Real;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QII;""
13 Ciudad Real;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QI;""
13 Ciudad Real;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QIV;2.803
13 Ciudad Real;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
13 Ciudad Real;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QII;""
13 Ciudad Real;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QI;""
13 Ciudad Real;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QIV;2.554
13 Ciudad Real;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
13 Ciudad Real;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QII;""
13 Ciudad Real;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QI;""
13 Ciudad Real;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
13 Ciudad Real;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
13 Ciudad Real;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QII;""
13 Ciudad Real;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QI;2.717
13 Ciudad Real;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
13 Ciudad Real;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
13 Ciudad Real;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QII;""
13 Ciudad Real;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QI;2.478
13 Ciudad Real;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
13 Ciudad Real;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
13 Ciudad Real;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QII;""
13 Ciudad Real;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QI;""
13 Ciudad Real;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
13 Ciudad Real;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
13 Ciudad Real;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
13 Ciudad Real;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
13 Ciudad Real;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
13 Ciudad Real;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
13 Ciudad Real;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
13 Ciudad Real;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
13 Ciudad Real;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
13 Ciudad Real;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
13 Ciudad Real;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
13 Ciudad Real;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
13 Ciudad Real;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
13 Ciudad Real;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
13 Ciudad Real;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;96,34
13 Ciudad Real;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
13 Ciudad Real;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
13 Ciudad Real;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
13 Ciudad Real;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;97,09
13 Ciudad Real;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
13 Ciudad Real;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
13 Ciudad Real;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
13 Ciudad Real;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;97,26
13 Ciudad Real;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
13 Ciudad Real;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
13 Ciudad Real;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;93,22
13 Ciudad Real;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
13 Ciudad Real;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
13 Ciudad Real;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
13 Ciudad Real;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;94,59
13 Ciudad Real;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
13 Ciudad Real;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
13 Ciudad Real;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
13 Ciudad Real;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;93,74
13 Ciudad Real;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
13 Ciudad Real;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
13 Ciudad Real;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;88,2
13 Ciudad Real;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
13 Ciudad Real;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
13 Ciudad Real;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
13 Ciudad Real;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;90,77
13 Ciudad Real;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
13 Ciudad Real;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
13 Ciudad Real;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
13 Ciudad Real;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;89,83
13 Ciudad Real;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
13 Ciudad Real;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
13 Ciudad Real;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
13 Ciudad Real;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
13 Ciudad Real;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
13 Ciudad Real;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
13 Ciudad Real;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;87,99
13 Ciudad Real;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
13 Ciudad Real;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
13 Ciudad Real;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
13 Ciudad Real;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;87,16
13 Ciudad Real;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
13 Ciudad Real;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
13 Ciudad Real;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
13 Ciudad Real;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
13 Ciudad Real;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
13 Ciudad Real;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
13 Ciudad Real;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QII;1.494
13 Ciudad Real;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
13 Ciudad Real;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
13 Ciudad Real;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
13 Ciudad Real;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QII;1.412
13 Ciudad Real;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
13 Ciudad Real;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
13 Ciudad Real;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
13 Ciudad Real;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QII;1.312
13 Ciudad Real;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
13 Ciudad Real;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
13 Ciudad Real;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
13 Ciudad Real;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2022QII;1.433
13 Ciudad Real;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2022QI;""
13 Ciudad Real;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
13 Ciudad Real;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
13 Ciudad Real;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2021QII;1.364
13 Ciudad Real;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2021QI;""
13 Ciudad Real;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
13 Ciudad Real;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
13 Ciudad Real;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2020QII;1.269
13 Ciudad Real;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2020QI;""
13 Ciudad Real;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
13 Ciudad Real;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2022QIII;1.376
13 Ciudad Real;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2022QII;""
13 Ciudad Real;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2022QI;""
13 Ciudad Real;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
13 Ciudad Real;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2021QIII;1.314
13 Ciudad Real;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2021QII;""
13 Ciudad Real;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2021QI;""
13 Ciudad Real;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
13 Ciudad Real;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2020QIII;1.205
13 Ciudad Real;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2020QII;""
13 Ciudad Real;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2020QI;""
13 Ciudad Real;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QIV;1.298
13 Ciudad Real;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
13 Ciudad Real;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QII;""
13 Ciudad Real;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QI;""
13 Ciudad Real;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QIV;1.251
13 Ciudad Real;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
13 Ciudad Real;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QII;""
13 Ciudad Real;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QI;""
13 Ciudad Real;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QIV;1.146
13 Ciudad Real;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
13 Ciudad Real;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QII;""
13 Ciudad Real;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QI;""
13 Ciudad Real;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
13 Ciudad Real;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
13 Ciudad Real;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QII;""
13 Ciudad Real;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QI;1.217
13 Ciudad Real;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
13 Ciudad Real;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
13 Ciudad Real;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QII;""
13 Ciudad Real;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QI;1.113
13 Ciudad Real;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
13 Ciudad Real;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
13 Ciudad Real;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QII;""
13 Ciudad Real;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QI;""
13 Ciudad Real;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
13 Ciudad Real;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
13 Ciudad Real;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
13 Ciudad Real;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
13 Ciudad Real;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
13 Ciudad Real;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
13 Ciudad Real;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
13 Ciudad Real;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
13 Ciudad Real;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
13 Ciudad Real;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
13 Ciudad Real;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
13 Ciudad Real;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
13 Ciudad Real;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
13 Ciudad Real;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
13 Ciudad Real;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;95,92
13 Ciudad Real;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
13 Ciudad Real;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
13 Ciudad Real;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
13 Ciudad Real;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;96,6
13 Ciudad Real;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
13 Ciudad Real;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
13 Ciudad Real;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
13 Ciudad Real;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;96,72
13 Ciudad Real;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
13 Ciudad Real;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
13 Ciudad Real;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;92,1
13 Ciudad Real;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
13 Ciudad Real;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
13 Ciudad Real;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
13 Ciudad Real;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;93,06
13 Ciudad Real;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
13 Ciudad Real;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
13 Ciudad Real;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
13 Ciudad Real;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;91,84
13 Ciudad Real;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
13 Ciudad Real;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
13 Ciudad Real;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;86,88
13 Ciudad Real;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
13 Ciudad Real;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
13 Ciudad Real;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
13 Ciudad Real;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;88,6
13 Ciudad Real;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
13 Ciudad Real;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
13 Ciudad Real;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
13 Ciudad Real;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;87,35
13 Ciudad Real;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
13 Ciudad Real;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
13 Ciudad Real;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
13 Ciudad Real;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
13 Ciudad Real;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
13 Ciudad Real;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
13 Ciudad Real;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;86,19
13 Ciudad Real;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
13 Ciudad Real;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
13 Ciudad Real;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
13 Ciudad Real;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;84,83
13 Ciudad Real;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
13 Ciudad Real;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
13 Ciudad Real;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
13 Ciudad Real;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
13 Ciudad Real;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
13 Ciudad Real;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QIII;4.669
13 Ciudad Real;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
13 Ciudad Real;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
13 Ciudad Real;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
13 Ciudad Real;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QIII;4.434
13 Ciudad Real;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
13 Ciudad Real;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
13 Ciudad Real;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
13 Ciudad Real;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QIII;4.097
13 Ciudad Real;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
13 Ciudad Real;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
13 Ciudad Real;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
13 Ciudad Real;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2022QIII;4.494
13 Ciudad Real;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2022QII;""
13 Ciudad Real;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2022QI;""
13 Ciudad Real;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
13 Ciudad Real;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2021QIII;4.286
13 Ciudad Real;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2021QII;""
13 Ciudad Real;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2021QI;""
13 Ciudad Real;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
13 Ciudad Real;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2020QIII;3.911
13 Ciudad Real;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2020QII;""
13 Ciudad Real;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2020QI;""
13 Ciudad Real;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2022QIV;4.243
13 Ciudad Real;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
13 Ciudad Real;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2022QII;""
13 Ciudad Real;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2022QI;""
13 Ciudad Real;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2021QIV;4.092
13 Ciudad Real;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
13 Ciudad Real;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2021QII;""
13 Ciudad Real;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2021QI;""
13 Ciudad Real;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2020QIV;3.733
13 Ciudad Real;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
13 Ciudad Real;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2020QII;""
13 Ciudad Real;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2020QI;""
13 Ciudad Real;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
13 Ciudad Real;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
13 Ciudad Real;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QII;""
13 Ciudad Real;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QI;3.969
13 Ciudad Real;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
13 Ciudad Real;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
13 Ciudad Real;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QII;""
13 Ciudad Real;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QI;3.623
13 Ciudad Real;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
13 Ciudad Real;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
13 Ciudad Real;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QII;""
13 Ciudad Real;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QI;""
13 Ciudad Real;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
13 Ciudad Real;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
13 Ciudad Real;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QII;3.815
13 Ciudad Real;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QI;""
13 Ciudad Real;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
13 Ciudad Real;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
13 Ciudad Real;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QII;3.511
13 Ciudad Real;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QI;""
13 Ciudad Real;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
13 Ciudad Real;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
13 Ciudad Real;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QII;""
13 Ciudad Real;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QI;""
13 Ciudad Real;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
13 Ciudad Real;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
13 Ciudad Real;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
13 Ciudad Real;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
13 Ciudad Real;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
13 Ciudad Real;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
13 Ciudad Real;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
13 Ciudad Real;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
13 Ciudad Real;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
13 Ciudad Real;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
13 Ciudad Real;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
13 Ciudad Real;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
13 Ciudad Real;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
13 Ciudad Real;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;96,25
13 Ciudad Real;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
13 Ciudad Real;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
13 Ciudad Real;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
13 Ciudad Real;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;96,66
13 Ciudad Real;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
13 Ciudad Real;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
13 Ciudad Real;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
13 Ciudad Real;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;95,46
13 Ciudad Real;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
13 Ciudad Real;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
13 Ciudad Real;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;90,88
13 Ciudad Real;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
13 Ciudad Real;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
13 Ciudad Real;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
13 Ciudad Real;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;92,29
13 Ciudad Real;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
13 Ciudad Real;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
13 Ciudad Real;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
13 Ciudad Real;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;91,12
13 Ciudad Real;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
13 Ciudad Real;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
13 Ciudad Real;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
13 Ciudad Real;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
13 Ciudad Real;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
13 Ciudad Real;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
13 Ciudad Real;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;89,51
13 Ciudad Real;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
13 Ciudad Real;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
13 Ciudad Real;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
13 Ciudad Real;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;88,43
13 Ciudad Real;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
13 Ciudad Real;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
13 Ciudad Real;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
13 Ciudad Real;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
13 Ciudad Real;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
13 Ciudad Real;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
13 Ciudad Real;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;86,04
13 Ciudad Real;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
13 Ciudad Real;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
13 Ciudad Real;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
13 Ciudad Real;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;85,7
13 Ciudad Real;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
13 Ciudad Real;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
13 Ciudad Real;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
13 Ciudad Real;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
13 Ciudad Real;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
13 Ciudad Real;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
13 Ciudad Real;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QIII;3.210
13 Ciudad Real;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
13 Ciudad Real;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
13 Ciudad Real;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
13 Ciudad Real;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QIII;3.045
13 Ciudad Real;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
13 Ciudad Real;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
13 Ciudad Real;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
13 Ciudad Real;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QIII;2.803
13 Ciudad Real;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
13 Ciudad Real;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
13 Ciudad Real;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
13 Ciudad Real;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2022QIII;3.100
13 Ciudad Real;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2022QII;""
13 Ciudad Real;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2022QI;""
13 Ciudad Real;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
13 Ciudad Real;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2021QIII;2.953
13 Ciudad Real;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2021QII;""
13 Ciudad Real;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2021QI;""
13 Ciudad Real;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
13 Ciudad Real;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2020QIII;2.689
13 Ciudad Real;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2020QII;""
13 Ciudad Real;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2020QI;""
13 Ciudad Real;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2022QIV;2.930
13 Ciudad Real;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
13 Ciudad Real;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2022QII;""
13 Ciudad Real;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2022QI;""
13 Ciudad Real;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2021QIV;2.826
13 Ciudad Real;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
13 Ciudad Real;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2021QII;""
13 Ciudad Real;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2021QI;""
13 Ciudad Real;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2020QIV;2.574
13 Ciudad Real;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
13 Ciudad Real;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2020QII;""
13 Ciudad Real;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2020QI;""
13 Ciudad Real;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
13 Ciudad Real;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
13 Ciudad Real;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QII;""
13 Ciudad Real;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QI;2.739
13 Ciudad Real;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
13 Ciudad Real;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
13 Ciudad Real;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QII;""
13 Ciudad Real;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QI;2.497
13 Ciudad Real;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
13 Ciudad Real;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
13 Ciudad Real;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QII;""
13 Ciudad Real;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QI;""
13 Ciudad Real;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
13 Ciudad Real;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
13 Ciudad Real;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QII;2.633
13 Ciudad Real;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QI;""
13 Ciudad Real;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
13 Ciudad Real;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
13 Ciudad Real;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QII;2.423
13 Ciudad Real;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QI;""
13 Ciudad Real;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
13 Ciudad Real;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
13 Ciudad Real;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QII;""
13 Ciudad Real;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QI;""
13 Ciudad Real;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
13 Ciudad Real;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
13 Ciudad Real;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
13 Ciudad Real;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
13 Ciudad Real;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
13 Ciudad Real;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
13 Ciudad Real;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
13 Ciudad Real;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
13 Ciudad Real;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
13 Ciudad Real;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
13 Ciudad Real;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
13 Ciudad Real;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
13 Ciudad Real;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
13 Ciudad Real;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;96,57
13 Ciudad Real;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
13 Ciudad Real;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
13 Ciudad Real;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
13 Ciudad Real;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;96,98
13 Ciudad Real;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
13 Ciudad Real;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
13 Ciudad Real;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
13 Ciudad Real;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;95,93
13 Ciudad Real;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
13 Ciudad Real;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
13 Ciudad Real;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;91,28
13 Ciudad Real;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
13 Ciudad Real;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
13 Ciudad Real;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
13 Ciudad Real;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;92,81
13 Ciudad Real;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
13 Ciudad Real;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
13 Ciudad Real;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
13 Ciudad Real;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;91,83
13 Ciudad Real;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
13 Ciudad Real;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
13 Ciudad Real;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
13 Ciudad Real;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
13 Ciudad Real;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
13 Ciudad Real;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
13 Ciudad Real;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;89,95
13 Ciudad Real;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
13 Ciudad Real;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
13 Ciudad Real;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
13 Ciudad Real;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;89,08
13 Ciudad Real;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
13 Ciudad Real;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
13 Ciudad Real;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
13 Ciudad Real;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
13 Ciudad Real;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
13 Ciudad Real;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
13 Ciudad Real;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;86,47
13 Ciudad Real;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
13 Ciudad Real;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
13 Ciudad Real;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
13 Ciudad Real;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;86,44
13 Ciudad Real;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
13 Ciudad Real;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
13 Ciudad Real;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
13 Ciudad Real;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
13 Ciudad Real;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
13 Ciudad Real;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
13 Ciudad Real;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QIII;1.459
13 Ciudad Real;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
13 Ciudad Real;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
13 Ciudad Real;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
13 Ciudad Real;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QIII;1.389
13 Ciudad Real;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
13 Ciudad Real;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
13 Ciudad Real;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
13 Ciudad Real;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QIII;1.294
13 Ciudad Real;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
13 Ciudad Real;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
13 Ciudad Real;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
13 Ciudad Real;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2022QIII;1.394
13 Ciudad Real;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2022QII;""
13 Ciudad Real;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2022QI;""
13 Ciudad Real;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
13 Ciudad Real;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2021QIII;1.333
13 Ciudad Real;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2021QII;""
13 Ciudad Real;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2021QI;""
13 Ciudad Real;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
13 Ciudad Real;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2020QIII;1.222
13 Ciudad Real;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2020QII;""
13 Ciudad Real;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2020QI;""
13 Ciudad Real;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2022QIV;1.313
13 Ciudad Real;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
13 Ciudad Real;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2022QII;""
13 Ciudad Real;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2022QI;""
13 Ciudad Real;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2021QIV;1.266
13 Ciudad Real;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
13 Ciudad Real;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2021QII;""
13 Ciudad Real;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2021QI;""
13 Ciudad Real;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2020QIV;1.159
13 Ciudad Real;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
13 Ciudad Real;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2020QII;""
13 Ciudad Real;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2020QI;""
13 Ciudad Real;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
13 Ciudad Real;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
13 Ciudad Real;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QII;""
13 Ciudad Real;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QI;1.230
13 Ciudad Real;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
13 Ciudad Real;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
13 Ciudad Real;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QII;""
13 Ciudad Real;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QI;1.126
13 Ciudad Real;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
13 Ciudad Real;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
13 Ciudad Real;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QII;""
13 Ciudad Real;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QI;""
13 Ciudad Real;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
13 Ciudad Real;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
13 Ciudad Real;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QII;1.182
13 Ciudad Real;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QI;""
13 Ciudad Real;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
13 Ciudad Real;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
13 Ciudad Real;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QII;1.088
13 Ciudad Real;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QI;""
13 Ciudad Real;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
13 Ciudad Real;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
13 Ciudad Real;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QII;""
13 Ciudad Real;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QI;""
13 Ciudad Real;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
13 Ciudad Real;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
13 Ciudad Real;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
13 Ciudad Real;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
13 Ciudad Real;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
13 Ciudad Real;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
13 Ciudad Real;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
13 Ciudad Real;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
13 Ciudad Real;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
13 Ciudad Real;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
13 Ciudad Real;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
13 Ciudad Real;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
13 Ciudad Real;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
13 Ciudad Real;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;95,54
13 Ciudad Real;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
13 Ciudad Real;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
13 Ciudad Real;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
13 Ciudad Real;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;95,97
13 Ciudad Real;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
13 Ciudad Real;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
13 Ciudad Real;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
13 Ciudad Real;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;94,44
13 Ciudad Real;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
13 Ciudad Real;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
13 Ciudad Real;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;89,99
13 Ciudad Real;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
13 Ciudad Real;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
13 Ciudad Real;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
13 Ciudad Real;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;91,14
13 Ciudad Real;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
13 Ciudad Real;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
13 Ciudad Real;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
13 Ciudad Real;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;89,57
13 Ciudad Real;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
13 Ciudad Real;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
13 Ciudad Real;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
13 Ciudad Real;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
13 Ciudad Real;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
13 Ciudad Real;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
13 Ciudad Real;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;88,55
13 Ciudad Real;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
13 Ciudad Real;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
13 Ciudad Real;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
13 Ciudad Real;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;87,02
13 Ciudad Real;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
13 Ciudad Real;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
13 Ciudad Real;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
13 Ciudad Real;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
13 Ciudad Real;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
13 Ciudad Real;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
13 Ciudad Real;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;85,1
13 Ciudad Real;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
13 Ciudad Real;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
13 Ciudad Real;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
13 Ciudad Real;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;84,08
13 Ciudad Real;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
13 Ciudad Real;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
13 Ciudad Real;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
13 Ciudad Real;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
13 Ciudad Real;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
13 Ciudad Real;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QIV;4.537
13 Ciudad Real;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
13 Ciudad Real;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
13 Ciudad Real;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
13 Ciudad Real;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QIV;4.333
13 Ciudad Real;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
13 Ciudad Real;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
13 Ciudad Real;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
13 Ciudad Real;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QIV;3.959
13 Ciudad Real;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
13 Ciudad Real;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
13 Ciudad Real;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
13 Ciudad Real;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2022QIV;4.271
13 Ciudad Real;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
13 Ciudad Real;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2022QII;""
13 Ciudad Real;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2022QI;""
13 Ciudad Real;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2021QIV;4.127
13 Ciudad Real;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
13 Ciudad Real;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2021QII;""
13 Ciudad Real;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2021QI;""
13 Ciudad Real;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2020QIV;3.767
13 Ciudad Real;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
13 Ciudad Real;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2020QII;""
13 Ciudad Real;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2020QI;""
13 Ciudad Real;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
13 Ciudad Real;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
13 Ciudad Real;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2022QII;""
13 Ciudad Real;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2022QI;4.000
13 Ciudad Real;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
13 Ciudad Real;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
13 Ciudad Real;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2021QII;""
13 Ciudad Real;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2021QI;3.652
13 Ciudad Real;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
13 Ciudad Real;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
13 Ciudad Real;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2020QII;""
13 Ciudad Real;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2020QI;""
13 Ciudad Real;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
13 Ciudad Real;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
13 Ciudad Real;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QII;3.843
13 Ciudad Real;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QI;""
13 Ciudad Real;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
13 Ciudad Real;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
13 Ciudad Real;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QII;3.539
13 Ciudad Real;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QI;""
13 Ciudad Real;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
13 Ciudad Real;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
13 Ciudad Real;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QII;""
13 Ciudad Real;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QI;""
13 Ciudad Real;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
13 Ciudad Real;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QIII;3.698
13 Ciudad Real;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QII;""
13 Ciudad Real;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QI;""
13 Ciudad Real;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
13 Ciudad Real;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QIII;3.425
13 Ciudad Real;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QII;""
13 Ciudad Real;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QI;""
13 Ciudad Real;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
13 Ciudad Real;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
13 Ciudad Real;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QII;""
13 Ciudad Real;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QI;""
13 Ciudad Real;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
13 Ciudad Real;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
13 Ciudad Real;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
13 Ciudad Real;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
13 Ciudad Real;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
13 Ciudad Real;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
13 Ciudad Real;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
13 Ciudad Real;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
13 Ciudad Real;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
13 Ciudad Real;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
13 Ciudad Real;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
13 Ciudad Real;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
13 Ciudad Real;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;94,14
13 Ciudad Real;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
13 Ciudad Real;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
13 Ciudad Real;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
13 Ciudad Real;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;95,25
13 Ciudad Real;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
13 Ciudad Real;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
13 Ciudad Real;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
13 Ciudad Real;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;95,15
13 Ciudad Real;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
13 Ciudad Real;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
13 Ciudad Real;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
13 Ciudad Real;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
13 Ciudad Real;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
13 Ciudad Real;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
13 Ciudad Real;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;92,31
13 Ciudad Real;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
13 Ciudad Real;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
13 Ciudad Real;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
13 Ciudad Real;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;92,25
13 Ciudad Real;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
13 Ciudad Real;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
13 Ciudad Real;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
13 Ciudad Real;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
13 Ciudad Real;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
13 Ciudad Real;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
13 Ciudad Real;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;88,69
13 Ciudad Real;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
13 Ciudad Real;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
13 Ciudad Real;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
13 Ciudad Real;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;89,39
13 Ciudad Real;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
13 Ciudad Real;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
13 Ciudad Real;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
13 Ciudad Real;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
13 Ciudad Real;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
13 Ciudad Real;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
13 Ciudad Real;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;85,35
13 Ciudad Real;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
13 Ciudad Real;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
13 Ciudad Real;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
13 Ciudad Real;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;86,51
13 Ciudad Real;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
13 Ciudad Real;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
13 Ciudad Real;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
13 Ciudad Real;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
13 Ciudad Real;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
13 Ciudad Real;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
13 Ciudad Real;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QIV;3.125
13 Ciudad Real;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
13 Ciudad Real;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
13 Ciudad Real;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
13 Ciudad Real;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QIV;2.976
13 Ciudad Real;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
13 Ciudad Real;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
13 Ciudad Real;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
13 Ciudad Real;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QIV;2.719
13 Ciudad Real;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
13 Ciudad Real;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
13 Ciudad Real;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
13 Ciudad Real;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2022QIV;2.945
13 Ciudad Real;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
13 Ciudad Real;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2022QII;""
13 Ciudad Real;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2022QI;""
13 Ciudad Real;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2021QIV;2.840
13 Ciudad Real;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
13 Ciudad Real;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2021QII;""
13 Ciudad Real;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2021QI;""
13 Ciudad Real;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2020QIV;2.593
13 Ciudad Real;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
13 Ciudad Real;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2020QII;""
13 Ciudad Real;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2020QI;""
13 Ciudad Real;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
13 Ciudad Real;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
13 Ciudad Real;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2022QII;""
13 Ciudad Real;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2022QI;2.750
13 Ciudad Real;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
13 Ciudad Real;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
13 Ciudad Real;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2021QII;""
13 Ciudad Real;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2021QI;2.513
13 Ciudad Real;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
13 Ciudad Real;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
13 Ciudad Real;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2020QII;""
13 Ciudad Real;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2020QI;""
13 Ciudad Real;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
13 Ciudad Real;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
13 Ciudad Real;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QII;2.642
13 Ciudad Real;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QI;""
13 Ciudad Real;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
13 Ciudad Real;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
13 Ciudad Real;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QII;2.439
13 Ciudad Real;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QI;""
13 Ciudad Real;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
13 Ciudad Real;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
13 Ciudad Real;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QII;""
13 Ciudad Real;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QI;""
13 Ciudad Real;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
13 Ciudad Real;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QIII;2.551
13 Ciudad Real;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QII;""
13 Ciudad Real;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QI;""
13 Ciudad Real;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
13 Ciudad Real;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QIII;2.368
13 Ciudad Real;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QII;""
13 Ciudad Real;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QI;""
13 Ciudad Real;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
13 Ciudad Real;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
13 Ciudad Real;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QII;""
13 Ciudad Real;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QI;""
13 Ciudad Real;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
13 Ciudad Real;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
13 Ciudad Real;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
13 Ciudad Real;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
13 Ciudad Real;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
13 Ciudad Real;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
13 Ciudad Real;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
13 Ciudad Real;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
13 Ciudad Real;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
13 Ciudad Real;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
13 Ciudad Real;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
13 Ciudad Real;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
13 Ciudad Real;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;94,24
13 Ciudad Real;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
13 Ciudad Real;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
13 Ciudad Real;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
13 Ciudad Real;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;95,43
13 Ciudad Real;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
13 Ciudad Real;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
13 Ciudad Real;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
13 Ciudad Real;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;95,37
13 Ciudad Real;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
13 Ciudad Real;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
13 Ciudad Real;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
13 Ciudad Real;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
13 Ciudad Real;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
13 Ciudad Real;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
13 Ciudad Real;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;92,41
13 Ciudad Real;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
13 Ciudad Real;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
13 Ciudad Real;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
13 Ciudad Real;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;92,42
13 Ciudad Real;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
13 Ciudad Real;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
13 Ciudad Real;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
13 Ciudad Real;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
13 Ciudad Real;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
13 Ciudad Real;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
13 Ciudad Real;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;88,78
13 Ciudad Real;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
13 Ciudad Real;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
13 Ciudad Real;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
13 Ciudad Real;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;89,7
13 Ciudad Real;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
13 Ciudad Real;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
13 Ciudad Real;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
13 Ciudad Real;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
13 Ciudad Real;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
13 Ciudad Real;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
13 Ciudad Real;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;85,72
13 Ciudad Real;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
13 Ciudad Real;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
13 Ciudad Real;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
13 Ciudad Real;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;87,09
13 Ciudad Real;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
13 Ciudad Real;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
13 Ciudad Real;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
13 Ciudad Real;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
13 Ciudad Real;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
13 Ciudad Real;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
13 Ciudad Real;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QIV;1.412
13 Ciudad Real;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
13 Ciudad Real;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
13 Ciudad Real;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
13 Ciudad Real;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QIV;1.357
13 Ciudad Real;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
13 Ciudad Real;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
13 Ciudad Real;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
13 Ciudad Real;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QIV;1.240
13 Ciudad Real;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
13 Ciudad Real;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
13 Ciudad Real;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
13 Ciudad Real;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2022QIV;1.326
13 Ciudad Real;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
13 Ciudad Real;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2022QII;""
13 Ciudad Real;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2022QI;""
13 Ciudad Real;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2021QIV;1.287
13 Ciudad Real;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
13 Ciudad Real;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2021QII;""
13 Ciudad Real;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2021QI;""
13 Ciudad Real;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2020QIV;1.174
13 Ciudad Real;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
13 Ciudad Real;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2020QII;""
13 Ciudad Real;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2020QI;""
13 Ciudad Real;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
13 Ciudad Real;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
13 Ciudad Real;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2022QII;""
13 Ciudad Real;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2022QI;1.250
13 Ciudad Real;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
13 Ciudad Real;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
13 Ciudad Real;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2021QII;""
13 Ciudad Real;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2021QI;1.139
13 Ciudad Real;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
13 Ciudad Real;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
13 Ciudad Real;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2020QII;""
13 Ciudad Real;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2020QI;""
13 Ciudad Real;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
13 Ciudad Real;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
13 Ciudad Real;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QII;1.201
13 Ciudad Real;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QI;""
13 Ciudad Real;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
13 Ciudad Real;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
13 Ciudad Real;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QII;1.100
13 Ciudad Real;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QI;""
13 Ciudad Real;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
13 Ciudad Real;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
13 Ciudad Real;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QII;""
13 Ciudad Real;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QI;""
13 Ciudad Real;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
13 Ciudad Real;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QIII;1.147
13 Ciudad Real;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QII;""
13 Ciudad Real;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QI;""
13 Ciudad Real;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
13 Ciudad Real;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QIII;1.057
13 Ciudad Real;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QII;""
13 Ciudad Real;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QI;""
13 Ciudad Real;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
13 Ciudad Real;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
13 Ciudad Real;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QII;""
13 Ciudad Real;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QI;""
13 Ciudad Real;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
13 Ciudad Real;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
13 Ciudad Real;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
13 Ciudad Real;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
13 Ciudad Real;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
13 Ciudad Real;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
13 Ciudad Real;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
13 Ciudad Real;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
13 Ciudad Real;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
13 Ciudad Real;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
13 Ciudad Real;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
13 Ciudad Real;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
13 Ciudad Real;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;93,91
13 Ciudad Real;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
13 Ciudad Real;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
13 Ciudad Real;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
13 Ciudad Real;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;94,84
13 Ciudad Real;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
13 Ciudad Real;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
13 Ciudad Real;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
13 Ciudad Real;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;94,68
13 Ciudad Real;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
13 Ciudad Real;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
13 Ciudad Real;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
13 Ciudad Real;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
13 Ciudad Real;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
13 Ciudad Real;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
13 Ciudad Real;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;92,11
13 Ciudad Real;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
13 Ciudad Real;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
13 Ciudad Real;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
13 Ciudad Real;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;91,85
13 Ciudad Real;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
13 Ciudad Real;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
13 Ciudad Real;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
13 Ciudad Real;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
13 Ciudad Real;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
13 Ciudad Real;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
13 Ciudad Real;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;88,5
13 Ciudad Real;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
13 Ciudad Real;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
13 Ciudad Real;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
13 Ciudad Real;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;88,71
13 Ciudad Real;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
13 Ciudad Real;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
13 Ciudad Real;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
13 Ciudad Real;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
13 Ciudad Real;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
13 Ciudad Real;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
13 Ciudad Real;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;84,52
13 Ciudad Real;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
13 Ciudad Real;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
13 Ciudad Real;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
13 Ciudad Real;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;85,24
13 Ciudad Real;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
13 Ciudad Real;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
13 Ciudad Real;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
13 Ciudad Real;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
13 Ciudad Real;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
13 Ciudad Real;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
14 Córdoba;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
14 Córdoba;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
14 Córdoba;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
14 Córdoba;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QI;46.582
14 Córdoba;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
14 Córdoba;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
14 Córdoba;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
14 Córdoba;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QI;45.713
14 Córdoba;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
14 Córdoba;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
14 Córdoba;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
14 Córdoba;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QI;45.850
14 Córdoba;All ages;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
14 Córdoba;All ages;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
14 Córdoba;All ages;Cohort January 1;Total;Survival in the first trimester;2022QII;""
14 Córdoba;All ages;Cohort January 1;Total;Survival in the first trimester;2022QI;45.239
14 Córdoba;All ages;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
14 Córdoba;All ages;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
14 Córdoba;All ages;Cohort January 1;Total;Survival in the first trimester;2021QII;""
14 Córdoba;All ages;Cohort January 1;Total;Survival in the first trimester;2021QI;44.630
14 Córdoba;All ages;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
14 Córdoba;All ages;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
14 Córdoba;All ages;Cohort January 1;Total;Survival in the first trimester;2020QII;""
14 Córdoba;All ages;Cohort January 1;Total;Survival in the first trimester;2020QI;42.946
14 Córdoba;All ages;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
14 Córdoba;All ages;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
14 Córdoba;All ages;Cohort January 1;Total;Survival in the second trimester;2022QII;43.887
14 Córdoba;All ages;Cohort January 1;Total;Survival in the second trimester;2022QI;""
14 Córdoba;All ages;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
14 Córdoba;All ages;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
14 Córdoba;All ages;Cohort January 1;Total;Survival in the second trimester;2021QII;43.562
14 Córdoba;All ages;Cohort January 1;Total;Survival in the second trimester;2021QI;""
14 Córdoba;All ages;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
14 Córdoba;All ages;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
14 Córdoba;All ages;Cohort January 1;Total;Survival in the second trimester;2020QII;42.179
14 Córdoba;All ages;Cohort January 1;Total;Survival in the second trimester;2020QI;""
14 Córdoba;All ages;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
14 Córdoba;All ages;Cohort January 1;Total;Survival in the third trimester;2022QIII;42.718
14 Córdoba;All ages;Cohort January 1;Total;Survival in the third trimester;2022QII;""
14 Córdoba;All ages;Cohort January 1;Total;Survival in the third trimester;2022QI;""
14 Córdoba;All ages;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
14 Córdoba;All ages;Cohort January 1;Total;Survival in the third trimester;2021QIII;42.584
14 Córdoba;All ages;Cohort January 1;Total;Survival in the third trimester;2021QII;""
14 Córdoba;All ages;Cohort January 1;Total;Survival in the third trimester;2021QI;""
14 Córdoba;All ages;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
14 Córdoba;All ages;Cohort January 1;Total;Survival in the third trimester;2020QIII;41.208
14 Córdoba;All ages;Cohort January 1;Total;Survival in the third trimester;2020QII;""
14 Córdoba;All ages;Cohort January 1;Total;Survival in the third trimester;2020QI;""
14 Córdoba;All ages;Cohort January 1;Total;Survival in the third trimester;2022QIV;41.423
14 Córdoba;All ages;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
14 Córdoba;All ages;Cohort January 1;Total;Survival in the third trimester;2022QII;""
14 Córdoba;All ages;Cohort January 1;Total;Survival in the third trimester;2022QI;""
14 Córdoba;All ages;Cohort January 1;Total;Survival in the third trimester;2021QIV;41.563
14 Córdoba;All ages;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
14 Córdoba;All ages;Cohort January 1;Total;Survival in the third trimester;2021QII;""
14 Córdoba;All ages;Cohort January 1;Total;Survival in the third trimester;2021QI;""
14 Córdoba;All ages;Cohort January 1;Total;Survival in the third trimester;2020QIV;40.223
14 Córdoba;All ages;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
14 Córdoba;All ages;Cohort January 1;Total;Survival in the third trimester;2020QII;""
14 Córdoba;All ages;Cohort January 1;Total;Survival in the third trimester;2020QI;""
14 Córdoba;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
14 Córdoba;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
14 Córdoba;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
14 Córdoba;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
14 Córdoba;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
14 Córdoba;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
14 Córdoba;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
14 Córdoba;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
14 Córdoba;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
14 Córdoba;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
14 Córdoba;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
14 Córdoba;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
14 Córdoba;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
14 Córdoba;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
14 Córdoba;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
14 Córdoba;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;97,12
14 Córdoba;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
14 Córdoba;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
14 Córdoba;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
14 Córdoba;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;97,63
14 Córdoba;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
14 Córdoba;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
14 Córdoba;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
14 Córdoba;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;93,67
14 Córdoba;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
14 Córdoba;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
14 Córdoba;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;94,21
14 Córdoba;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
14 Córdoba;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
14 Córdoba;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
14 Córdoba;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;95,29
14 Córdoba;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
14 Córdoba;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
14 Córdoba;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
14 Córdoba;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;91,99
14 Córdoba;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
14 Córdoba;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
14 Córdoba;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;91,7
14 Córdoba;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
14 Córdoba;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
14 Córdoba;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
14 Córdoba;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;93,16
14 Córdoba;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
14 Córdoba;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
14 Córdoba;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
14 Córdoba;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;89,88
14 Córdoba;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
14 Córdoba;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
14 Córdoba;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;88,92
14 Córdoba;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
14 Córdoba;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
14 Córdoba;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
14 Córdoba;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;90,92
14 Córdoba;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
14 Córdoba;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
14 Córdoba;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
14 Córdoba;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;87,73
14 Córdoba;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
14 Córdoba;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
14 Córdoba;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
14 Córdoba;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
14 Córdoba;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
14 Córdoba;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
14 Córdoba;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QI;30.201
14 Córdoba;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
14 Córdoba;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
14 Córdoba;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
14 Córdoba;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QI;29.901
14 Córdoba;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
14 Córdoba;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
14 Córdoba;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
14 Córdoba;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QI;30.098
14 Córdoba;All ages;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
14 Córdoba;All ages;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
14 Córdoba;All ages;Cohort January 1;Males;Survival in the first trimester;2022QII;""
14 Córdoba;All ages;Cohort January 1;Males;Survival in the first trimester;2022QI;29.392
14 Córdoba;All ages;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
14 Córdoba;All ages;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
14 Córdoba;All ages;Cohort January 1;Males;Survival in the first trimester;2021QII;""
14 Córdoba;All ages;Cohort January 1;Males;Survival in the first trimester;2021QI;29.212
14 Córdoba;All ages;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
14 Córdoba;All ages;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
14 Córdoba;All ages;Cohort January 1;Males;Survival in the first trimester;2020QII;""
14 Córdoba;All ages;Cohort January 1;Males;Survival in the first trimester;2020QI;28.314
14 Córdoba;All ages;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
14 Córdoba;All ages;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
14 Córdoba;All ages;Cohort January 1;Males;Survival in the second trimester;2022QII;28.625
14 Córdoba;All ages;Cohort January 1;Males;Survival in the second trimester;2022QI;""
14 Córdoba;All ages;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
14 Córdoba;All ages;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
14 Córdoba;All ages;Cohort January 1;Males;Survival in the second trimester;2021QII;28.553
14 Córdoba;All ages;Cohort January 1;Males;Survival in the second trimester;2021QI;""
14 Córdoba;All ages;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
14 Córdoba;All ages;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
14 Córdoba;All ages;Cohort January 1;Males;Survival in the second trimester;2020QII;27.851
14 Córdoba;All ages;Cohort January 1;Males;Survival in the second trimester;2020QI;""
14 Córdoba;All ages;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
14 Córdoba;All ages;Cohort January 1;Males;Survival in the third trimester;2022QIII;27.940
14 Córdoba;All ages;Cohort January 1;Males;Survival in the third trimester;2022QII;""
14 Córdoba;All ages;Cohort January 1;Males;Survival in the third trimester;2022QI;""
14 Córdoba;All ages;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
14 Córdoba;All ages;Cohort January 1;Males;Survival in the third trimester;2021QIII;27.970
14 Córdoba;All ages;Cohort January 1;Males;Survival in the third trimester;2021QII;""
14 Córdoba;All ages;Cohort January 1;Males;Survival in the third trimester;2021QI;""
14 Córdoba;All ages;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
14 Córdoba;All ages;Cohort January 1;Males;Survival in the third trimester;2020QIII;27.275
14 Córdoba;All ages;Cohort January 1;Males;Survival in the third trimester;2020QII;""
14 Córdoba;All ages;Cohort January 1;Males;Survival in the third trimester;2020QI;""
14 Córdoba;All ages;Cohort January 1;Males;Survival in the third trimester;2022QIV;27.173
14 Córdoba;All ages;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
14 Córdoba;All ages;Cohort January 1;Males;Survival in the third trimester;2022QII;""
14 Córdoba;All ages;Cohort January 1;Males;Survival in the third trimester;2022QI;""
14 Córdoba;All ages;Cohort January 1;Males;Survival in the third trimester;2021QIV;27.318
14 Córdoba;All ages;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
14 Córdoba;All ages;Cohort January 1;Males;Survival in the third trimester;2021QII;""
14 Córdoba;All ages;Cohort January 1;Males;Survival in the third trimester;2021QI;""
14 Córdoba;All ages;Cohort January 1;Males;Survival in the third trimester;2020QIV;26.657
14 Córdoba;All ages;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
14 Córdoba;All ages;Cohort January 1;Males;Survival in the third trimester;2020QII;""
14 Córdoba;All ages;Cohort January 1;Males;Survival in the third trimester;2020QI;""
14 Córdoba;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
14 Córdoba;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
14 Córdoba;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
14 Córdoba;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
14 Córdoba;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
14 Córdoba;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
14 Córdoba;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
14 Córdoba;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
14 Córdoba;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
14 Córdoba;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
14 Córdoba;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
14 Córdoba;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
14 Córdoba;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
14 Córdoba;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
14 Córdoba;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
14 Córdoba;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;97,32
14 Córdoba;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
14 Córdoba;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
14 Córdoba;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
14 Córdoba;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;97,7
14 Córdoba;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
14 Córdoba;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
14 Córdoba;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
14 Córdoba;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;94,07
14 Córdoba;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
14 Córdoba;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
14 Córdoba;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;94,78
14 Córdoba;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
14 Córdoba;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
14 Córdoba;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
14 Córdoba;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;95,49
14 Córdoba;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
14 Córdoba;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
14 Córdoba;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
14 Córdoba;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;92,53
14 Córdoba;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
14 Córdoba;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
14 Córdoba;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;92,51
14 Córdoba;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
14 Córdoba;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
14 Córdoba;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
14 Córdoba;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;93,54
14 Córdoba;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
14 Córdoba;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
14 Córdoba;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
14 Córdoba;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;90,62
14 Córdoba;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
14 Córdoba;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
14 Córdoba;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;89,97
14 Córdoba;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
14 Córdoba;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
14 Córdoba;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
14 Córdoba;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;91,36
14 Córdoba;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
14 Córdoba;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
14 Córdoba;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
14 Córdoba;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;88,57
14 Córdoba;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
14 Córdoba;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
14 Córdoba;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
14 Córdoba;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
14 Córdoba;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
14 Córdoba;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
14 Córdoba;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QI;16.381
14 Córdoba;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
14 Córdoba;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
14 Córdoba;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
14 Córdoba;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QI;15.812
14 Córdoba;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
14 Córdoba;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
14 Córdoba;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
14 Córdoba;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QI;15.752
14 Córdoba;All ages;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
14 Córdoba;All ages;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
14 Córdoba;All ages;Cohort January 1;Females;Survival in the first trimester;2022QII;""
14 Córdoba;All ages;Cohort January 1;Females;Survival in the first trimester;2022QI;15.847
14 Córdoba;All ages;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
14 Córdoba;All ages;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
14 Córdoba;All ages;Cohort January 1;Females;Survival in the first trimester;2021QII;""
14 Córdoba;All ages;Cohort January 1;Females;Survival in the first trimester;2021QI;15.418
14 Córdoba;All ages;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
14 Córdoba;All ages;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
14 Córdoba;All ages;Cohort January 1;Females;Survival in the first trimester;2020QII;""
14 Córdoba;All ages;Cohort January 1;Females;Survival in the first trimester;2020QI;14.632
14 Córdoba;All ages;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
14 Córdoba;All ages;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
14 Córdoba;All ages;Cohort January 1;Females;Survival in the second trimester;2022QII;15.262
14 Córdoba;All ages;Cohort January 1;Females;Survival in the second trimester;2022QI;""
14 Córdoba;All ages;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
14 Córdoba;All ages;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
14 Córdoba;All ages;Cohort January 1;Females;Survival in the second trimester;2021QII;15.009
14 Córdoba;All ages;Cohort January 1;Females;Survival in the second trimester;2021QI;""
14 Córdoba;All ages;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
14 Córdoba;All ages;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
14 Córdoba;All ages;Cohort January 1;Females;Survival in the second trimester;2020QII;14.328
14 Córdoba;All ages;Cohort January 1;Females;Survival in the second trimester;2020QI;""
14 Córdoba;All ages;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
14 Córdoba;All ages;Cohort January 1;Females;Survival in the third trimester;2022QIII;14.778
14 Córdoba;All ages;Cohort January 1;Females;Survival in the third trimester;2022QII;""
14 Córdoba;All ages;Cohort January 1;Females;Survival in the third trimester;2022QI;""
14 Córdoba;All ages;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
14 Córdoba;All ages;Cohort January 1;Females;Survival in the third trimester;2021QIII;14.614
14 Córdoba;All ages;Cohort January 1;Females;Survival in the third trimester;2021QII;""
14 Córdoba;All ages;Cohort January 1;Females;Survival in the third trimester;2021QI;""
14 Córdoba;All ages;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
14 Córdoba;All ages;Cohort January 1;Females;Survival in the third trimester;2020QIII;13.933
14 Córdoba;All ages;Cohort January 1;Females;Survival in the third trimester;2020QII;""
14 Córdoba;All ages;Cohort January 1;Females;Survival in the third trimester;2020QI;""
14 Córdoba;All ages;Cohort January 1;Females;Survival in the third trimester;2022QIV;14.250
14 Córdoba;All ages;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
14 Córdoba;All ages;Cohort January 1;Females;Survival in the third trimester;2022QII;""
14 Córdoba;All ages;Cohort January 1;Females;Survival in the third trimester;2022QI;""
14 Córdoba;All ages;Cohort January 1;Females;Survival in the third trimester;2021QIV;14.245
14 Córdoba;All ages;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
14 Córdoba;All ages;Cohort January 1;Females;Survival in the third trimester;2021QII;""
14 Córdoba;All ages;Cohort January 1;Females;Survival in the third trimester;2021QI;""
14 Córdoba;All ages;Cohort January 1;Females;Survival in the third trimester;2020QIV;13.566
14 Córdoba;All ages;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
14 Córdoba;All ages;Cohort January 1;Females;Survival in the third trimester;2020QII;""
14 Córdoba;All ages;Cohort January 1;Females;Survival in the third trimester;2020QI;""
14 Córdoba;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
14 Córdoba;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
14 Córdoba;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
14 Córdoba;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
14 Córdoba;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
14 Córdoba;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
14 Córdoba;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
14 Córdoba;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
14 Córdoba;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
14 Córdoba;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
14 Córdoba;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
14 Córdoba;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
14 Córdoba;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
14 Córdoba;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
14 Córdoba;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
14 Córdoba;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;96,74
14 Córdoba;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
14 Córdoba;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
14 Córdoba;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
14 Córdoba;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;97,51
14 Córdoba;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
14 Córdoba;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
14 Córdoba;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
14 Córdoba;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;92,89
14 Córdoba;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
14 Córdoba;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
14 Córdoba;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;93,17
14 Córdoba;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
14 Córdoba;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
14 Córdoba;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
14 Córdoba;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;94,92
14 Córdoba;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
14 Córdoba;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
14 Córdoba;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
14 Córdoba;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;90,96
14 Córdoba;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
14 Córdoba;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
14 Córdoba;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;90,21
14 Córdoba;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
14 Córdoba;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
14 Córdoba;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
14 Córdoba;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;92,42
14 Córdoba;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
14 Córdoba;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
14 Córdoba;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
14 Córdoba;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;88,45
14 Córdoba;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
14 Córdoba;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
14 Córdoba;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;86,99
14 Córdoba;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
14 Córdoba;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
14 Córdoba;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
14 Córdoba;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;90,09
14 Córdoba;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
14 Córdoba;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
14 Córdoba;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
14 Córdoba;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;86,12
14 Córdoba;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
14 Córdoba;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
14 Córdoba;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
14 Córdoba;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
14 Córdoba;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
14 Córdoba;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QII;46.693
14 Córdoba;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
14 Córdoba;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
14 Córdoba;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
14 Córdoba;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QII;46.153
14 Córdoba;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
14 Córdoba;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
14 Córdoba;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
14 Córdoba;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QII;44.823
14 Córdoba;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
14 Córdoba;All ages;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
14 Córdoba;All ages;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
14 Córdoba;All ages;Cohort April 1;Total;Survival in the first trimester;2022QII;45.169
14 Córdoba;All ages;Cohort April 1;Total;Survival in the first trimester;2022QI;""
14 Córdoba;All ages;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
14 Córdoba;All ages;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
14 Córdoba;All ages;Cohort April 1;Total;Survival in the first trimester;2021QII;44.909
14 Córdoba;All ages;Cohort April 1;Total;Survival in the first trimester;2021QI;""
14 Córdoba;All ages;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
14 Córdoba;All ages;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
14 Córdoba;All ages;Cohort April 1;Total;Survival in the first trimester;2020QII;43.952
14 Córdoba;All ages;Cohort April 1;Total;Survival in the first trimester;2020QI;""
14 Córdoba;All ages;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
14 Córdoba;All ages;Cohort April 1;Total;Survival in the second trimester;2022QIII;43.910
14 Córdoba;All ages;Cohort April 1;Total;Survival in the second trimester;2022QII;""
14 Córdoba;All ages;Cohort April 1;Total;Survival in the second trimester;2022QI;""
14 Córdoba;All ages;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
14 Córdoba;All ages;Cohort April 1;Total;Survival in the second trimester;2021QIII;43.818
14 Córdoba;All ages;Cohort April 1;Total;Survival in the second trimester;2021QII;""
14 Córdoba;All ages;Cohort April 1;Total;Survival in the second trimester;2021QI;""
14 Córdoba;All ages;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
14 Córdoba;All ages;Cohort April 1;Total;Survival in the second trimester;2020QIII;42.823
14 Córdoba;All ages;Cohort April 1;Total;Survival in the second trimester;2020QII;""
14 Córdoba;All ages;Cohort April 1;Total;Survival in the second trimester;2020QI;""
14 Córdoba;All ages;Cohort April 1;Total;Survival in the third trimester;2022QIV;42.519
14 Córdoba;All ages;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
14 Córdoba;All ages;Cohort April 1;Total;Survival in the third trimester;2022QII;""
14 Córdoba;All ages;Cohort April 1;Total;Survival in the third trimester;2022QI;""
14 Córdoba;All ages;Cohort April 1;Total;Survival in the third trimester;2021QIV;42.714
14 Córdoba;All ages;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
14 Córdoba;All ages;Cohort April 1;Total;Survival in the third trimester;2021QII;""
14 Córdoba;All ages;Cohort April 1;Total;Survival in the third trimester;2021QI;""
14 Córdoba;All ages;Cohort April 1;Total;Survival in the third trimester;2020QIV;41.741
14 Córdoba;All ages;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
14 Córdoba;All ages;Cohort April 1;Total;Survival in the third trimester;2020QII;""
14 Córdoba;All ages;Cohort April 1;Total;Survival in the third trimester;2020QI;""
14 Córdoba;All ages;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
14 Córdoba;All ages;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
14 Córdoba;All ages;Cohort April 1;Total;Survival in the third trimester;2022QII;""
14 Córdoba;All ages;Cohort April 1;Total;Survival in the third trimester;2022QI;41.679
14 Córdoba;All ages;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
14 Córdoba;All ages;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
14 Córdoba;All ages;Cohort April 1;Total;Survival in the third trimester;2021QII;""
14 Córdoba;All ages;Cohort April 1;Total;Survival in the third trimester;2021QI;40.979
14 Córdoba;All ages;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
14 Córdoba;All ages;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
14 Córdoba;All ages;Cohort April 1;Total;Survival in the third trimester;2020QII;""
14 Córdoba;All ages;Cohort April 1;Total;Survival in the third trimester;2020QI;""
14 Córdoba;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
14 Córdoba;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
14 Córdoba;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
14 Córdoba;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
14 Córdoba;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
14 Córdoba;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
14 Córdoba;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
14 Córdoba;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
14 Córdoba;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
14 Córdoba;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
14 Córdoba;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
14 Córdoba;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
14 Córdoba;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
14 Córdoba;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
14 Córdoba;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;96,74
14 Córdoba;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
14 Córdoba;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
14 Córdoba;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
14 Córdoba;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;97,3
14 Córdoba;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
14 Córdoba;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
14 Córdoba;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
14 Córdoba;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;98,06
14 Córdoba;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
14 Córdoba;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
14 Córdoba;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;94,04
14 Córdoba;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
14 Córdoba;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
14 Córdoba;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
14 Córdoba;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;94,94
14 Córdoba;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
14 Córdoba;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
14 Córdoba;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
14 Córdoba;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;95,54
14 Córdoba;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
14 Córdoba;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
14 Córdoba;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;91,06
14 Córdoba;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
14 Córdoba;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
14 Córdoba;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
14 Córdoba;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;92,55
14 Córdoba;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
14 Córdoba;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
14 Córdoba;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
14 Córdoba;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;93,12
14 Córdoba;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
14 Córdoba;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
14 Córdoba;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
14 Córdoba;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
14 Córdoba;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
14 Córdoba;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
14 Córdoba;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;90,31
14 Córdoba;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
14 Córdoba;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
14 Córdoba;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
14 Córdoba;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;91,42
14 Córdoba;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
14 Córdoba;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
14 Córdoba;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
14 Córdoba;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
14 Córdoba;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
14 Córdoba;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
14 Córdoba;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QII;30.258
14 Córdoba;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
14 Córdoba;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
14 Córdoba;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
14 Córdoba;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QII;30.143
14 Córdoba;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
14 Córdoba;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
14 Córdoba;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
14 Córdoba;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QII;29.399
14 Córdoba;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
14 Córdoba;All ages;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
14 Córdoba;All ages;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
14 Córdoba;All ages;Cohort April 1;Males;Survival in the first trimester;2022QII;29.395
14 Córdoba;All ages;Cohort April 1;Males;Survival in the first trimester;2022QI;""
14 Córdoba;All ages;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
14 Córdoba;All ages;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
14 Córdoba;All ages;Cohort April 1;Males;Survival in the first trimester;2021QII;29.375
14 Córdoba;All ages;Cohort April 1;Males;Survival in the first trimester;2021QI;""
14 Córdoba;All ages;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
14 Córdoba;All ages;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
14 Córdoba;All ages;Cohort April 1;Males;Survival in the first trimester;2020QII;28.878
14 Córdoba;All ages;Cohort April 1;Males;Survival in the first trimester;2020QI;""
14 Córdoba;All ages;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
14 Córdoba;All ages;Cohort April 1;Males;Survival in the second trimester;2022QIII;28.651
14 Córdoba;All ages;Cohort April 1;Males;Survival in the second trimester;2022QII;""
14 Córdoba;All ages;Cohort April 1;Males;Survival in the second trimester;2022QI;""
14 Córdoba;All ages;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
14 Córdoba;All ages;Cohort April 1;Males;Survival in the second trimester;2021QIII;28.718
14 Córdoba;All ages;Cohort April 1;Males;Survival in the second trimester;2021QII;""
14 Córdoba;All ages;Cohort April 1;Males;Survival in the second trimester;2021QI;""
14 Córdoba;All ages;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
14 Córdoba;All ages;Cohort April 1;Males;Survival in the second trimester;2020QIII;28.195
14 Córdoba;All ages;Cohort April 1;Males;Survival in the second trimester;2020QII;""
14 Córdoba;All ages;Cohort April 1;Males;Survival in the second trimester;2020QI;""
14 Córdoba;All ages;Cohort April 1;Males;Survival in the third trimester;2022QIV;27.820
14 Córdoba;All ages;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
14 Córdoba;All ages;Cohort April 1;Males;Survival in the third trimester;2022QII;""
14 Córdoba;All ages;Cohort April 1;Males;Survival in the third trimester;2022QI;""
14 Córdoba;All ages;Cohort April 1;Males;Survival in the third trimester;2021QIV;28.014
14 Córdoba;All ages;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
14 Córdoba;All ages;Cohort April 1;Males;Survival in the third trimester;2021QII;""
14 Córdoba;All ages;Cohort April 1;Males;Survival in the third trimester;2021QI;""
14 Córdoba;All ages;Cohort April 1;Males;Survival in the third trimester;2020QIV;27.524
14 Córdoba;All ages;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
14 Córdoba;All ages;Cohort April 1;Males;Survival in the third trimester;2020QII;""
14 Córdoba;All ages;Cohort April 1;Males;Survival in the third trimester;2020QI;""
14 Córdoba;All ages;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
14 Córdoba;All ages;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
14 Córdoba;All ages;Cohort April 1;Males;Survival in the third trimester;2022QII;""
14 Córdoba;All ages;Cohort April 1;Males;Survival in the third trimester;2022QI;27.401
14 Córdoba;All ages;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
14 Córdoba;All ages;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
14 Córdoba;All ages;Cohort April 1;Males;Survival in the third trimester;2021QII;""
14 Córdoba;All ages;Cohort April 1;Males;Survival in the third trimester;2021QI;27.044
14 Córdoba;All ages;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
14 Córdoba;All ages;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
14 Córdoba;All ages;Cohort April 1;Males;Survival in the third trimester;2020QII;""
14 Córdoba;All ages;Cohort April 1;Males;Survival in the third trimester;2020QI;""
14 Córdoba;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
14 Córdoba;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
14 Córdoba;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
14 Córdoba;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
14 Córdoba;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
14 Córdoba;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
14 Córdoba;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
14 Córdoba;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
14 Córdoba;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
14 Córdoba;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
14 Córdoba;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
14 Córdoba;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
14 Córdoba;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
14 Córdoba;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
14 Córdoba;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;97,15
14 Córdoba;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
14 Córdoba;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
14 Córdoba;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
14 Córdoba;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;97,45
14 Córdoba;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
14 Córdoba;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
14 Córdoba;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
14 Córdoba;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;98,23
14 Córdoba;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
14 Córdoba;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
14 Córdoba;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;94,69
14 Córdoba;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
14 Córdoba;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
14 Córdoba;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
14 Córdoba;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;95,27
14 Córdoba;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
14 Córdoba;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
14 Córdoba;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
14 Córdoba;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;95,9
14 Córdoba;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
14 Córdoba;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
14 Córdoba;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;91,94
14 Córdoba;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
14 Córdoba;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
14 Córdoba;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
14 Córdoba;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;92,94
14 Córdoba;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
14 Córdoba;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
14 Córdoba;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
14 Córdoba;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;93,62
14 Córdoba;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
14 Córdoba;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
14 Córdoba;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
14 Córdoba;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
14 Córdoba;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
14 Córdoba;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
14 Córdoba;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;90,9
14 Córdoba;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
14 Córdoba;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
14 Córdoba;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
14 Córdoba;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;91,99
14 Córdoba;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
14 Córdoba;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
14 Córdoba;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
14 Córdoba;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
14 Córdoba;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
14 Córdoba;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
14 Córdoba;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QII;16.435
14 Córdoba;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
14 Córdoba;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
14 Córdoba;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
14 Córdoba;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QII;16.010
14 Córdoba;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
14 Córdoba;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
14 Córdoba;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
14 Córdoba;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QII;15.424
14 Córdoba;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
14 Córdoba;All ages;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
14 Córdoba;All ages;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
14 Córdoba;All ages;Cohort April 1;Females;Survival in the first trimester;2022QII;15.774
14 Córdoba;All ages;Cohort April 1;Females;Survival in the first trimester;2022QI;""
14 Córdoba;All ages;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
14 Córdoba;All ages;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
14 Córdoba;All ages;Cohort April 1;Females;Survival in the first trimester;2021QII;15.534
14 Córdoba;All ages;Cohort April 1;Females;Survival in the first trimester;2021QI;""
14 Córdoba;All ages;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
14 Córdoba;All ages;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
14 Córdoba;All ages;Cohort April 1;Females;Survival in the first trimester;2020QII;15.074
14 Córdoba;All ages;Cohort April 1;Females;Survival in the first trimester;2020QI;""
14 Córdoba;All ages;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
14 Córdoba;All ages;Cohort April 1;Females;Survival in the second trimester;2022QIII;15.259
14 Córdoba;All ages;Cohort April 1;Females;Survival in the second trimester;2022QII;""
14 Córdoba;All ages;Cohort April 1;Females;Survival in the second trimester;2022QI;""
14 Córdoba;All ages;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
14 Córdoba;All ages;Cohort April 1;Females;Survival in the second trimester;2021QIII;15.100
14 Córdoba;All ages;Cohort April 1;Females;Survival in the second trimester;2021QII;""
14 Córdoba;All ages;Cohort April 1;Females;Survival in the second trimester;2021QI;""
14 Córdoba;All ages;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
14 Córdoba;All ages;Cohort April 1;Females;Survival in the second trimester;2020QIII;14.628
14 Córdoba;All ages;Cohort April 1;Females;Survival in the second trimester;2020QII;""
14 Córdoba;All ages;Cohort April 1;Females;Survival in the second trimester;2020QI;""
14 Córdoba;All ages;Cohort April 1;Females;Survival in the third trimester;2022QIV;14.699
14 Córdoba;All ages;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
14 Córdoba;All ages;Cohort April 1;Females;Survival in the third trimester;2022QII;""
14 Córdoba;All ages;Cohort April 1;Females;Survival in the third trimester;2022QI;""
14 Córdoba;All ages;Cohort April 1;Females;Survival in the third trimester;2021QIV;14.700
14 Córdoba;All ages;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
14 Córdoba;All ages;Cohort April 1;Females;Survival in the third trimester;2021QII;""
14 Córdoba;All ages;Cohort April 1;Females;Survival in the third trimester;2021QI;""
14 Córdoba;All ages;Cohort April 1;Females;Survival in the third trimester;2020QIV;14.217
14 Córdoba;All ages;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
14 Córdoba;All ages;Cohort April 1;Females;Survival in the third trimester;2020QII;""
14 Córdoba;All ages;Cohort April 1;Females;Survival in the third trimester;2020QI;""
14 Córdoba;All ages;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
14 Córdoba;All ages;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
14 Córdoba;All ages;Cohort April 1;Females;Survival in the third trimester;2022QII;""
14 Córdoba;All ages;Cohort April 1;Females;Survival in the third trimester;2022QI;14.278
14 Córdoba;All ages;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
14 Córdoba;All ages;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
14 Córdoba;All ages;Cohort April 1;Females;Survival in the third trimester;2021QII;""
14 Córdoba;All ages;Cohort April 1;Females;Survival in the third trimester;2021QI;13.935
14 Córdoba;All ages;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
14 Córdoba;All ages;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
14 Córdoba;All ages;Cohort April 1;Females;Survival in the third trimester;2020QII;""
14 Córdoba;All ages;Cohort April 1;Females;Survival in the third trimester;2020QI;""
14 Córdoba;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
14 Córdoba;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
14 Córdoba;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
14 Córdoba;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
14 Córdoba;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
14 Córdoba;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
14 Córdoba;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
14 Córdoba;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
14 Córdoba;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
14 Córdoba;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
14 Córdoba;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
14 Córdoba;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
14 Córdoba;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
14 Córdoba;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
14 Córdoba;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;95,98
14 Córdoba;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
14 Córdoba;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
14 Córdoba;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
14 Córdoba;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;97,03
14 Córdoba;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
14 Córdoba;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
14 Córdoba;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
14 Córdoba;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;97,73
14 Córdoba;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
14 Córdoba;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
14 Córdoba;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;92,84
14 Córdoba;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
14 Córdoba;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
14 Córdoba;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
14 Córdoba;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;94,32
14 Córdoba;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
14 Córdoba;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
14 Córdoba;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
14 Córdoba;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;94,84
14 Córdoba;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
14 Córdoba;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
14 Córdoba;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;89,44
14 Córdoba;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
14 Córdoba;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
14 Córdoba;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
14 Córdoba;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;91,82
14 Córdoba;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
14 Córdoba;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
14 Córdoba;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
14 Córdoba;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;92,17
14 Córdoba;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
14 Córdoba;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
14 Córdoba;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
14 Córdoba;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
14 Córdoba;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
14 Córdoba;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
14 Córdoba;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;89,18
14 Córdoba;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
14 Córdoba;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
14 Córdoba;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
14 Córdoba;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;90,35
14 Córdoba;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
14 Córdoba;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
14 Córdoba;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
14 Córdoba;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
14 Córdoba;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
14 Córdoba;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QIII;46.810
14 Córdoba;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
14 Córdoba;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
14 Córdoba;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
14 Córdoba;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QIII;46.766
14 Córdoba;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
14 Córdoba;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
14 Córdoba;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
14 Córdoba;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QIII;45.498
14 Córdoba;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
14 Córdoba;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
14 Córdoba;All ages;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
14 Córdoba;All ages;Cohort July 1;Total;Survival in the first trimester;2022QIII;45.266
14 Córdoba;All ages;Cohort July 1;Total;Survival in the first trimester;2022QII;""
14 Córdoba;All ages;Cohort July 1;Total;Survival in the first trimester;2022QI;""
14 Córdoba;All ages;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
14 Córdoba;All ages;Cohort July 1;Total;Survival in the first trimester;2021QIII;45.407
14 Córdoba;All ages;Cohort July 1;Total;Survival in the first trimester;2021QII;""
14 Córdoba;All ages;Cohort July 1;Total;Survival in the first trimester;2021QI;""
14 Córdoba;All ages;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
14 Córdoba;All ages;Cohort July 1;Total;Survival in the first trimester;2020QIII;44.135
14 Córdoba;All ages;Cohort July 1;Total;Survival in the first trimester;2020QII;""
14 Córdoba;All ages;Cohort July 1;Total;Survival in the first trimester;2020QI;""
14 Córdoba;All ages;Cohort July 1;Total;Survival in the second trimester;2022QIV;43.688
14 Córdoba;All ages;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
14 Córdoba;All ages;Cohort July 1;Total;Survival in the second trimester;2022QII;""
14 Córdoba;All ages;Cohort July 1;Total;Survival in the second trimester;2022QI;""
14 Córdoba;All ages;Cohort July 1;Total;Survival in the second trimester;2021QIV;44.099
14 Córdoba;All ages;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
14 Córdoba;All ages;Cohort July 1;Total;Survival in the second trimester;2021QII;""
14 Córdoba;All ages;Cohort July 1;Total;Survival in the second trimester;2021QI;""
14 Córdoba;All ages;Cohort July 1;Total;Survival in the second trimester;2020QIV;42.907
14 Córdoba;All ages;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
14 Córdoba;All ages;Cohort July 1;Total;Survival in the second trimester;2020QII;""
14 Córdoba;All ages;Cohort July 1;Total;Survival in the second trimester;2020QI;""
14 Córdoba;All ages;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
14 Córdoba;All ages;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
14 Córdoba;All ages;Cohort July 1;Total;Survival in the third trimester;2022QII;""
14 Córdoba;All ages;Cohort July 1;Total;Survival in the third trimester;2022QI;42.990
14 Córdoba;All ages;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
14 Córdoba;All ages;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
14 Córdoba;All ages;Cohort July 1;Total;Survival in the third trimester;2021QII;""
14 Córdoba;All ages;Cohort July 1;Total;Survival in the third trimester;2021QI;42.083
14 Córdoba;All ages;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
14 Córdoba;All ages;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
14 Córdoba;All ages;Cohort July 1;Total;Survival in the third trimester;2020QII;""
14 Córdoba;All ages;Cohort July 1;Total;Survival in the third trimester;2020QI;""
14 Córdoba;All ages;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
14 Córdoba;All ages;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
14 Córdoba;All ages;Cohort July 1;Total;Survival in the third trimester;2022QII;41.838
14 Córdoba;All ages;Cohort July 1;Total;Survival in the third trimester;2022QI;""
14 Córdoba;All ages;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
14 Córdoba;All ages;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
14 Córdoba;All ages;Cohort July 1;Total;Survival in the third trimester;2021QII;41.241
14 Córdoba;All ages;Cohort July 1;Total;Survival in the third trimester;2021QI;""
14 Córdoba;All ages;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
14 Córdoba;All ages;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
14 Córdoba;All ages;Cohort July 1;Total;Survival in the third trimester;2020QII;""
14 Córdoba;All ages;Cohort July 1;Total;Survival in the third trimester;2020QI;""
14 Córdoba;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
14 Córdoba;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
14 Córdoba;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
14 Córdoba;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
14 Córdoba;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
14 Córdoba;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
14 Córdoba;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
14 Córdoba;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
14 Córdoba;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
14 Córdoba;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
14 Córdoba;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
14 Córdoba;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
14 Córdoba;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
14 Córdoba;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;96,7
14 Córdoba;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
14 Córdoba;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
14 Córdoba;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
14 Córdoba;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;97,09
14 Córdoba;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
14 Córdoba;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
14 Córdoba;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
14 Córdoba;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;97
14 Córdoba;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
14 Córdoba;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
14 Córdoba;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;93,33
14 Córdoba;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
14 Córdoba;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
14 Córdoba;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
14 Córdoba;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;94,3
14 Córdoba;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
14 Córdoba;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
14 Córdoba;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
14 Córdoba;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;94,31
14 Córdoba;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
14 Córdoba;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
14 Córdoba;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
14 Córdoba;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
14 Córdoba;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
14 Córdoba;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
14 Córdoba;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;91,93
14 Córdoba;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
14 Córdoba;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
14 Córdoba;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
14 Córdoba;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;92,49
14 Córdoba;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
14 Córdoba;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
14 Córdoba;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
14 Córdoba;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
14 Córdoba;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
14 Córdoba;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
14 Córdoba;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;89,46
14 Córdoba;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
14 Córdoba;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
14 Córdoba;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
14 Córdoba;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;90,64
14 Córdoba;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
14 Córdoba;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
14 Córdoba;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
14 Córdoba;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
14 Córdoba;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
14 Córdoba;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
14 Córdoba;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QIII;30.395
14 Córdoba;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
14 Córdoba;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
14 Córdoba;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
14 Córdoba;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QIII;30.527
14 Córdoba;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
14 Córdoba;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
14 Córdoba;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
14 Córdoba;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QIII;29.900
14 Córdoba;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
14 Córdoba;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
14 Córdoba;All ages;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
14 Córdoba;All ages;Cohort July 1;Males;Survival in the first trimester;2022QIII;29.468
14 Córdoba;All ages;Cohort July 1;Males;Survival in the first trimester;2022QII;""
14 Córdoba;All ages;Cohort July 1;Males;Survival in the first trimester;2022QI;""
14 Córdoba;All ages;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
14 Córdoba;All ages;Cohort July 1;Males;Survival in the first trimester;2021QIII;29.691
14 Córdoba;All ages;Cohort July 1;Males;Survival in the first trimester;2021QII;""
14 Córdoba;All ages;Cohort July 1;Males;Survival in the first trimester;2021QI;""
14 Córdoba;All ages;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
14 Córdoba;All ages;Cohort July 1;Males;Survival in the first trimester;2020QIII;29.051
14 Córdoba;All ages;Cohort July 1;Males;Survival in the first trimester;2020QII;""
14 Córdoba;All ages;Cohort July 1;Males;Survival in the first trimester;2020QI;""
14 Córdoba;All ages;Cohort July 1;Males;Survival in the second trimester;2022QIV;28.502
14 Córdoba;All ages;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
14 Córdoba;All ages;Cohort July 1;Males;Survival in the second trimester;2022QII;""
14 Córdoba;All ages;Cohort July 1;Males;Survival in the second trimester;2022QI;""
14 Córdoba;All ages;Cohort July 1;Males;Survival in the second trimester;2021QIV;28.827
14 Córdoba;All ages;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
14 Córdoba;All ages;Cohort July 1;Males;Survival in the second trimester;2021QII;""
14 Córdoba;All ages;Cohort July 1;Males;Survival in the second trimester;2021QI;""
14 Córdoba;All ages;Cohort July 1;Males;Survival in the second trimester;2020QIV;28.261
14 Córdoba;All ages;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
14 Córdoba;All ages;Cohort July 1;Males;Survival in the second trimester;2020QII;""
14 Córdoba;All ages;Cohort July 1;Males;Survival in the second trimester;2020QI;""
14 Córdoba;All ages;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
14 Córdoba;All ages;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
14 Córdoba;All ages;Cohort July 1;Males;Survival in the third trimester;2022QII;""
14 Córdoba;All ages;Cohort July 1;Males;Survival in the third trimester;2022QI;28.167
14 Córdoba;All ages;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
14 Córdoba;All ages;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
14 Córdoba;All ages;Cohort July 1;Males;Survival in the third trimester;2021QII;""
14 Córdoba;All ages;Cohort July 1;Males;Survival in the third trimester;2021QI;27.739
14 Córdoba;All ages;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
14 Córdoba;All ages;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
14 Córdoba;All ages;Cohort July 1;Males;Survival in the third trimester;2020QII;""
14 Córdoba;All ages;Cohort July 1;Males;Survival in the third trimester;2020QI;""
14 Córdoba;All ages;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
14 Córdoba;All ages;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
14 Córdoba;All ages;Cohort July 1;Males;Survival in the third trimester;2022QII;27.511
14 Córdoba;All ages;Cohort July 1;Males;Survival in the third trimester;2022QI;""
14 Córdoba;All ages;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
14 Córdoba;All ages;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
14 Córdoba;All ages;Cohort July 1;Males;Survival in the third trimester;2021QII;27.213
14 Córdoba;All ages;Cohort July 1;Males;Survival in the third trimester;2021QI;""
14 Córdoba;All ages;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
14 Córdoba;All ages;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
14 Córdoba;All ages;Cohort July 1;Males;Survival in the third trimester;2020QII;""
14 Córdoba;All ages;Cohort July 1;Males;Survival in the third trimester;2020QI;""
14 Córdoba;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
14 Córdoba;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
14 Córdoba;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
14 Córdoba;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
14 Córdoba;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
14 Córdoba;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
14 Córdoba;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
14 Córdoba;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
14 Córdoba;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
14 Córdoba;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
14 Córdoba;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
14 Córdoba;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
14 Córdoba;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
14 Córdoba;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;96,95
14 Córdoba;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
14 Córdoba;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
14 Córdoba;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
14 Córdoba;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;97,26
14 Córdoba;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
14 Córdoba;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
14 Córdoba;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
14 Córdoba;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;97,16
14 Córdoba;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
14 Córdoba;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
14 Córdoba;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;93,77
14 Córdoba;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
14 Córdoba;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
14 Córdoba;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
14 Córdoba;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;94,43
14 Córdoba;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
14 Córdoba;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
14 Córdoba;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
14 Córdoba;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;94,52
14 Córdoba;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
14 Córdoba;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
14 Córdoba;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
14 Córdoba;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
14 Córdoba;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
14 Córdoba;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
14 Córdoba;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;92,27
14 Córdoba;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
14 Córdoba;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
14 Córdoba;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
14 Córdoba;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;92,77
14 Córdoba;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
14 Córdoba;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
14 Córdoba;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
14 Córdoba;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
14 Córdoba;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
14 Córdoba;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
14 Córdoba;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;90,12
14 Córdoba;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
14 Córdoba;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
14 Córdoba;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
14 Córdoba;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;91,01
14 Córdoba;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
14 Córdoba;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
14 Córdoba;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
14 Córdoba;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
14 Córdoba;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
14 Córdoba;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
14 Córdoba;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QIII;16.415
14 Córdoba;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
14 Córdoba;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
14 Córdoba;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
14 Córdoba;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QIII;16.239
14 Córdoba;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
14 Córdoba;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
14 Córdoba;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
14 Córdoba;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QIII;15.598
14 Córdoba;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
14 Córdoba;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
14 Córdoba;All ages;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
14 Córdoba;All ages;Cohort July 1;Females;Survival in the first trimester;2022QIII;15.798
14 Córdoba;All ages;Cohort July 1;Females;Survival in the first trimester;2022QII;""
14 Córdoba;All ages;Cohort July 1;Females;Survival in the first trimester;2022QI;""
14 Córdoba;All ages;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
14 Córdoba;All ages;Cohort July 1;Females;Survival in the first trimester;2021QIII;15.716
14 Córdoba;All ages;Cohort July 1;Females;Survival in the first trimester;2021QII;""
14 Córdoba;All ages;Cohort July 1;Females;Survival in the first trimester;2021QI;""
14 Córdoba;All ages;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
14 Córdoba;All ages;Cohort July 1;Females;Survival in the first trimester;2020QIII;15.084
14 Córdoba;All ages;Cohort July 1;Females;Survival in the first trimester;2020QII;""
14 Córdoba;All ages;Cohort July 1;Females;Survival in the first trimester;2020QI;""
14 Córdoba;All ages;Cohort July 1;Females;Survival in the second trimester;2022QIV;15.186
14 Córdoba;All ages;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
14 Córdoba;All ages;Cohort July 1;Females;Survival in the second trimester;2022QII;""
14 Córdoba;All ages;Cohort July 1;Females;Survival in the second trimester;2022QI;""
14 Córdoba;All ages;Cohort July 1;Females;Survival in the second trimester;2021QIV;15.272
14 Córdoba;All ages;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
14 Córdoba;All ages;Cohort July 1;Females;Survival in the second trimester;2021QII;""
14 Córdoba;All ages;Cohort July 1;Females;Survival in the second trimester;2021QI;""
14 Córdoba;All ages;Cohort July 1;Females;Survival in the second trimester;2020QIV;14.646
14 Córdoba;All ages;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
14 Córdoba;All ages;Cohort July 1;Females;Survival in the second trimester;2020QII;""
14 Córdoba;All ages;Cohort July 1;Females;Survival in the second trimester;2020QI;""
14 Córdoba;All ages;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
14 Córdoba;All ages;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
14 Córdoba;All ages;Cohort July 1;Females;Survival in the third trimester;2022QII;""
14 Córdoba;All ages;Cohort July 1;Females;Survival in the third trimester;2022QI;14.823
14 Córdoba;All ages;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
14 Córdoba;All ages;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
14 Córdoba;All ages;Cohort July 1;Females;Survival in the third trimester;2021QII;""
14 Córdoba;All ages;Cohort July 1;Females;Survival in the third trimester;2021QI;14.344
14 Córdoba;All ages;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
14 Córdoba;All ages;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
14 Córdoba;All ages;Cohort July 1;Females;Survival in the third trimester;2020QII;""
14 Córdoba;All ages;Cohort July 1;Females;Survival in the third trimester;2020QI;""
14 Córdoba;All ages;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
14 Córdoba;All ages;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
14 Córdoba;All ages;Cohort July 1;Females;Survival in the third trimester;2022QII;14.327
14 Córdoba;All ages;Cohort July 1;Females;Survival in the third trimester;2022QI;""
14 Córdoba;All ages;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
14 Córdoba;All ages;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
14 Córdoba;All ages;Cohort July 1;Females;Survival in the third trimester;2021QII;14.028
14 Córdoba;All ages;Cohort July 1;Females;Survival in the third trimester;2021QI;""
14 Córdoba;All ages;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
14 Córdoba;All ages;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
14 Córdoba;All ages;Cohort July 1;Females;Survival in the third trimester;2020QII;""
14 Córdoba;All ages;Cohort July 1;Females;Survival in the third trimester;2020QI;""
14 Córdoba;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
14 Córdoba;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
14 Córdoba;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
14 Córdoba;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
14 Córdoba;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
14 Córdoba;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
14 Córdoba;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
14 Córdoba;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
14 Córdoba;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
14 Córdoba;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
14 Córdoba;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
14 Córdoba;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
14 Córdoba;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
14 Córdoba;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;96,24
14 Córdoba;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
14 Córdoba;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
14 Córdoba;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
14 Córdoba;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;96,78
14 Córdoba;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
14 Córdoba;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
14 Córdoba;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
14 Córdoba;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;96,7
14 Córdoba;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
14 Córdoba;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
14 Córdoba;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;92,51
14 Córdoba;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
14 Córdoba;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
14 Córdoba;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
14 Córdoba;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;94,05
14 Córdoba;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
14 Córdoba;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
14 Córdoba;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
14 Córdoba;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;93,9
14 Córdoba;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
14 Córdoba;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
14 Córdoba;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
14 Córdoba;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
14 Córdoba;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
14 Córdoba;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
14 Córdoba;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;91,28
14 Córdoba;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
14 Córdoba;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
14 Córdoba;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
14 Córdoba;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;91,96
14 Córdoba;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
14 Córdoba;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
14 Córdoba;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
14 Córdoba;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
14 Córdoba;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
14 Córdoba;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
14 Córdoba;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;88,23
14 Córdoba;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
14 Córdoba;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
14 Córdoba;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
14 Córdoba;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;89,93
14 Córdoba;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
14 Córdoba;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
14 Córdoba;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
14 Córdoba;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
14 Córdoba;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
14 Córdoba;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QIV;46.616
14 Córdoba;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
14 Córdoba;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
14 Córdoba;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
14 Córdoba;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QIV;46.675
14 Córdoba;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
14 Córdoba;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
14 Córdoba;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
14 Córdoba;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QIV;45.618
14 Córdoba;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
14 Córdoba;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
14 Córdoba;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
14 Córdoba;All ages;Cohort October 1;Total;Survival in the first trimester;2022QIV;44.857
14 Córdoba;All ages;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
14 Córdoba;All ages;Cohort October 1;Total;Survival in the first trimester;2022QII;""
14 Córdoba;All ages;Cohort October 1;Total;Survival in the first trimester;2022QI;""
14 Córdoba;All ages;Cohort October 1;Total;Survival in the first trimester;2021QIV;45.184
14 Córdoba;All ages;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
14 Córdoba;All ages;Cohort October 1;Total;Survival in the first trimester;2021QII;""
14 Córdoba;All ages;Cohort October 1;Total;Survival in the first trimester;2021QI;""
14 Córdoba;All ages;Cohort October 1;Total;Survival in the first trimester;2020QIV;44.213
14 Córdoba;All ages;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
14 Córdoba;All ages;Cohort October 1;Total;Survival in the first trimester;2020QII;""
14 Córdoba;All ages;Cohort October 1;Total;Survival in the first trimester;2020QI;""
14 Córdoba;All ages;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
14 Córdoba;All ages;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
14 Córdoba;All ages;Cohort October 1;Total;Survival in the second trimester;2022QII;""
14 Córdoba;All ages;Cohort October 1;Total;Survival in the second trimester;2022QI;44.007
14 Córdoba;All ages;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
14 Córdoba;All ages;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
14 Córdoba;All ages;Cohort October 1;Total;Survival in the second trimester;2021QII;""
14 Córdoba;All ages;Cohort October 1;Total;Survival in the second trimester;2021QI;43.292
14 Córdoba;All ages;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
14 Córdoba;All ages;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
14 Córdoba;All ages;Cohort October 1;Total;Survival in the second trimester;2020QII;""
14 Córdoba;All ages;Cohort October 1;Total;Survival in the second trimester;2020QI;""
14 Córdoba;All ages;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
14 Córdoba;All ages;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
14 Córdoba;All ages;Cohort October 1;Total;Survival in the third trimester;2022QII;42.788
14 Córdoba;All ages;Cohort October 1;Total;Survival in the third trimester;2022QI;""
14 Córdoba;All ages;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
14 Córdoba;All ages;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
14 Córdoba;All ages;Cohort October 1;Total;Survival in the third trimester;2021QII;42.354
14 Córdoba;All ages;Cohort October 1;Total;Survival in the third trimester;2021QI;""
14 Córdoba;All ages;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
14 Córdoba;All ages;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
14 Córdoba;All ages;Cohort October 1;Total;Survival in the third trimester;2020QII;""
14 Córdoba;All ages;Cohort October 1;Total;Survival in the third trimester;2020QI;""
14 Córdoba;All ages;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
14 Córdoba;All ages;Cohort October 1;Total;Survival in the third trimester;2022QIII;41.682
14 Córdoba;All ages;Cohort October 1;Total;Survival in the third trimester;2022QII;""
14 Córdoba;All ages;Cohort October 1;Total;Survival in the third trimester;2022QI;""
14 Córdoba;All ages;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
14 Córdoba;All ages;Cohort October 1;Total;Survival in the third trimester;2021QIII;41.469
14 Córdoba;All ages;Cohort October 1;Total;Survival in the third trimester;2021QII;""
14 Córdoba;All ages;Cohort October 1;Total;Survival in the third trimester;2021QI;""
14 Córdoba;All ages;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
14 Córdoba;All ages;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
14 Córdoba;All ages;Cohort October 1;Total;Survival in the third trimester;2020QII;""
14 Córdoba;All ages;Cohort October 1;Total;Survival in the third trimester;2020QI;""
14 Córdoba;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
14 Córdoba;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
14 Córdoba;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
14 Córdoba;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
14 Córdoba;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
14 Córdoba;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
14 Córdoba;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
14 Córdoba;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
14 Córdoba;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
14 Córdoba;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
14 Córdoba;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
14 Córdoba;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
14 Córdoba;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;96,23
14 Córdoba;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
14 Córdoba;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
14 Córdoba;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
14 Córdoba;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;96,81
14 Córdoba;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
14 Córdoba;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
14 Córdoba;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
14 Córdoba;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;96,92
14 Córdoba;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
14 Córdoba;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
14 Córdoba;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
14 Córdoba;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
14 Córdoba;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
14 Córdoba;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
14 Córdoba;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;94,28
14 Córdoba;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
14 Córdoba;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
14 Córdoba;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
14 Córdoba;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;94,9
14 Córdoba;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
14 Córdoba;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
14 Córdoba;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
14 Córdoba;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
14 Córdoba;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
14 Córdoba;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
14 Córdoba;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;91,67
14 Córdoba;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
14 Córdoba;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
14 Córdoba;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
14 Córdoba;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;92,84
14 Córdoba;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
14 Córdoba;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
14 Córdoba;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
14 Córdoba;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
14 Córdoba;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
14 Córdoba;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
14 Córdoba;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;89,3
14 Córdoba;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
14 Córdoba;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
14 Córdoba;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
14 Córdoba;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;90,9
14 Córdoba;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
14 Córdoba;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
14 Córdoba;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
14 Córdoba;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
14 Córdoba;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
14 Córdoba;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
14 Córdoba;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QIV;30.235
14 Córdoba;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
14 Córdoba;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
14 Córdoba;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
14 Córdoba;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QIV;30.441
14 Córdoba;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
14 Córdoba;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
14 Córdoba;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
14 Córdoba;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QIV;29.919
14 Córdoba;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
14 Córdoba;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
14 Córdoba;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
14 Córdoba;All ages;Cohort October 1;Males;Survival in the first trimester;2022QIV;29.148
14 Córdoba;All ages;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
14 Córdoba;All ages;Cohort October 1;Males;Survival in the first trimester;2022QII;""
14 Córdoba;All ages;Cohort October 1;Males;Survival in the first trimester;2022QI;""
14 Córdoba;All ages;Cohort October 1;Males;Survival in the first trimester;2021QIV;29.444
14 Córdoba;All ages;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
14 Córdoba;All ages;Cohort October 1;Males;Survival in the first trimester;2021QII;""
14 Córdoba;All ages;Cohort October 1;Males;Survival in the first trimester;2021QI;""
14 Córdoba;All ages;Cohort October 1;Males;Survival in the first trimester;2020QIV;29.014
14 Córdoba;All ages;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
14 Córdoba;All ages;Cohort October 1;Males;Survival in the first trimester;2020QII;""
14 Córdoba;All ages;Cohort October 1;Males;Survival in the first trimester;2020QI;""
14 Córdoba;All ages;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
14 Córdoba;All ages;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
14 Córdoba;All ages;Cohort October 1;Males;Survival in the second trimester;2022QII;""
14 Córdoba;All ages;Cohort October 1;Males;Survival in the second trimester;2022QI;28.740
14 Córdoba;All ages;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
14 Córdoba;All ages;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
14 Córdoba;All ages;Cohort October 1;Males;Survival in the second trimester;2021QII;""
14 Córdoba;All ages;Cohort October 1;Males;Survival in the second trimester;2021QI;28.432
14 Córdoba;All ages;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
14 Córdoba;All ages;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
14 Córdoba;All ages;Cohort October 1;Males;Survival in the second trimester;2020QII;""
14 Córdoba;All ages;Cohort October 1;Males;Survival in the second trimester;2020QI;""
14 Córdoba;All ages;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
14 Córdoba;All ages;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
14 Córdoba;All ages;Cohort October 1;Males;Survival in the third trimester;2022QII;28.048
14 Córdoba;All ages;Cohort October 1;Males;Survival in the third trimester;2022QI;""
14 Córdoba;All ages;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
14 Córdoba;All ages;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
14 Córdoba;All ages;Cohort October 1;Males;Survival in the third trimester;2021QII;27.849
14 Córdoba;All ages;Cohort October 1;Males;Survival in the third trimester;2021QI;""
14 Córdoba;All ages;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
14 Córdoba;All ages;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
14 Córdoba;All ages;Cohort October 1;Males;Survival in the third trimester;2020QII;""
14 Córdoba;All ages;Cohort October 1;Males;Survival in the third trimester;2020QI;""
14 Córdoba;All ages;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
14 Córdoba;All ages;Cohort October 1;Males;Survival in the third trimester;2022QIII;27.398
14 Córdoba;All ages;Cohort October 1;Males;Survival in the third trimester;2022QII;""
14 Córdoba;All ages;Cohort October 1;Males;Survival in the third trimester;2022QI;""
14 Córdoba;All ages;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
14 Córdoba;All ages;Cohort October 1;Males;Survival in the third trimester;2021QIII;27.319
14 Córdoba;All ages;Cohort October 1;Males;Survival in the third trimester;2021QII;""
14 Córdoba;All ages;Cohort October 1;Males;Survival in the third trimester;2021QI;""
14 Córdoba;All ages;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
14 Córdoba;All ages;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
14 Córdoba;All ages;Cohort October 1;Males;Survival in the third trimester;2020QII;""
14 Córdoba;All ages;Cohort October 1;Males;Survival in the third trimester;2020QI;""
14 Córdoba;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
14 Córdoba;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
14 Córdoba;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
14 Córdoba;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
14 Córdoba;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
14 Córdoba;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
14 Córdoba;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
14 Córdoba;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
14 Córdoba;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
14 Córdoba;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
14 Córdoba;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
14 Córdoba;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
14 Córdoba;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;96,4
14 Córdoba;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
14 Córdoba;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
14 Córdoba;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
14 Córdoba;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;96,72
14 Córdoba;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
14 Córdoba;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
14 Córdoba;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
14 Córdoba;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;96,98
14 Córdoba;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
14 Córdoba;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
14 Córdoba;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
14 Córdoba;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
14 Córdoba;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
14 Córdoba;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
14 Córdoba;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;94,41
14 Córdoba;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
14 Córdoba;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
14 Córdoba;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
14 Córdoba;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;95,03
14 Córdoba;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
14 Córdoba;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
14 Córdoba;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
14 Córdoba;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
14 Córdoba;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
14 Córdoba;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
14 Córdoba;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;92,14
14 Córdoba;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
14 Córdoba;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
14 Córdoba;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
14 Córdoba;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;93,08
14 Córdoba;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
14 Córdoba;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
14 Córdoba;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
14 Córdoba;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
14 Córdoba;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
14 Córdoba;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
14 Córdoba;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;90
14 Córdoba;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
14 Córdoba;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
14 Córdoba;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
14 Córdoba;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;91,31
14 Córdoba;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
14 Córdoba;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
14 Córdoba;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
14 Córdoba;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
14 Córdoba;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
14 Córdoba;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
14 Córdoba;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QIV;16.381
14 Córdoba;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
14 Córdoba;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
14 Córdoba;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
14 Córdoba;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QIV;16.234
14 Córdoba;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
14 Córdoba;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
14 Córdoba;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
14 Córdoba;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QIV;15.699
14 Córdoba;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
14 Córdoba;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
14 Córdoba;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
14 Córdoba;All ages;Cohort October 1;Females;Survival in the first trimester;2022QIV;15.709
14 Córdoba;All ages;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
14 Córdoba;All ages;Cohort October 1;Females;Survival in the first trimester;2022QII;""
14 Córdoba;All ages;Cohort October 1;Females;Survival in the first trimester;2022QI;""
14 Córdoba;All ages;Cohort October 1;Females;Survival in the first trimester;2021QIV;15.740
14 Córdoba;All ages;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
14 Córdoba;All ages;Cohort October 1;Females;Survival in the first trimester;2021QII;""
14 Córdoba;All ages;Cohort October 1;Females;Survival in the first trimester;2021QI;""
14 Córdoba;All ages;Cohort October 1;Females;Survival in the first trimester;2020QIV;15.199
14 Córdoba;All ages;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
14 Córdoba;All ages;Cohort October 1;Females;Survival in the first trimester;2020QII;""
14 Córdoba;All ages;Cohort October 1;Females;Survival in the first trimester;2020QI;""
14 Córdoba;All ages;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
14 Córdoba;All ages;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
14 Córdoba;All ages;Cohort October 1;Females;Survival in the second trimester;2022QII;""
14 Córdoba;All ages;Cohort October 1;Females;Survival in the second trimester;2022QI;15.267
14 Córdoba;All ages;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
14 Córdoba;All ages;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
14 Córdoba;All ages;Cohort October 1;Females;Survival in the second trimester;2021QII;""
14 Córdoba;All ages;Cohort October 1;Females;Survival in the second trimester;2021QI;14.860
14 Córdoba;All ages;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
14 Córdoba;All ages;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
14 Córdoba;All ages;Cohort October 1;Females;Survival in the second trimester;2020QII;""
14 Córdoba;All ages;Cohort October 1;Females;Survival in the second trimester;2020QI;""
14 Córdoba;All ages;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
14 Córdoba;All ages;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
14 Córdoba;All ages;Cohort October 1;Females;Survival in the third trimester;2022QII;14.740
14 Córdoba;All ages;Cohort October 1;Females;Survival in the third trimester;2022QI;""
14 Córdoba;All ages;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
14 Córdoba;All ages;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
14 Córdoba;All ages;Cohort October 1;Females;Survival in the third trimester;2021QII;14.505
14 Córdoba;All ages;Cohort October 1;Females;Survival in the third trimester;2021QI;""
14 Córdoba;All ages;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
14 Córdoba;All ages;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
14 Córdoba;All ages;Cohort October 1;Females;Survival in the third trimester;2020QII;""
14 Córdoba;All ages;Cohort October 1;Females;Survival in the third trimester;2020QI;""
14 Córdoba;All ages;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
14 Córdoba;All ages;Cohort October 1;Females;Survival in the third trimester;2022QIII;14.284
14 Córdoba;All ages;Cohort October 1;Females;Survival in the third trimester;2022QII;""
14 Córdoba;All ages;Cohort October 1;Females;Survival in the third trimester;2022QI;""
14 Córdoba;All ages;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
14 Córdoba;All ages;Cohort October 1;Females;Survival in the third trimester;2021QIII;14.150
14 Córdoba;All ages;Cohort October 1;Females;Survival in the third trimester;2021QII;""
14 Córdoba;All ages;Cohort October 1;Females;Survival in the third trimester;2021QI;""
14 Córdoba;All ages;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
14 Córdoba;All ages;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
14 Córdoba;All ages;Cohort October 1;Females;Survival in the third trimester;2020QII;""
14 Córdoba;All ages;Cohort October 1;Females;Survival in the third trimester;2020QI;""
14 Córdoba;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
14 Córdoba;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
14 Córdoba;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
14 Córdoba;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
14 Córdoba;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
14 Córdoba;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
14 Córdoba;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
14 Córdoba;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
14 Córdoba;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
14 Córdoba;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
14 Córdoba;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
14 Córdoba;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
14 Córdoba;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;95,9
14 Córdoba;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
14 Córdoba;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
14 Córdoba;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
14 Córdoba;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;96,96
14 Córdoba;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
14 Córdoba;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
14 Córdoba;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
14 Córdoba;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;96,82
14 Córdoba;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
14 Córdoba;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
14 Córdoba;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
14 Córdoba;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
14 Córdoba;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
14 Córdoba;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
14 Córdoba;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;94,04
14 Córdoba;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
14 Córdoba;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
14 Córdoba;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
14 Córdoba;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;94,66
14 Córdoba;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
14 Córdoba;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
14 Córdoba;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
14 Córdoba;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
14 Córdoba;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
14 Córdoba;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
14 Córdoba;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;90,8
14 Córdoba;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
14 Córdoba;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
14 Córdoba;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
14 Córdoba;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;92,39
14 Córdoba;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
14 Córdoba;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
14 Córdoba;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
14 Córdoba;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
14 Córdoba;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
14 Córdoba;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
14 Córdoba;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;87,99
14 Córdoba;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
14 Córdoba;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
14 Córdoba;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
14 Córdoba;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;90,13
14 Córdoba;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
14 Córdoba;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
14 Córdoba;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
14 Córdoba;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
14 Córdoba;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
14 Córdoba;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
14 Córdoba;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
14 Córdoba;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
14 Córdoba;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
14 Córdoba;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QI;3.344
14 Córdoba;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
14 Córdoba;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
14 Córdoba;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
14 Córdoba;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QI;3.265
14 Córdoba;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
14 Córdoba;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
14 Córdoba;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
14 Córdoba;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QI;2.608
14 Córdoba;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
14 Córdoba;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
14 Córdoba;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2022QII;""
14 Córdoba;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2022QI;3.134
14 Córdoba;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
14 Córdoba;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
14 Córdoba;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2021QII;""
14 Córdoba;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2021QI;3.084
14 Córdoba;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
14 Córdoba;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
14 Córdoba;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2020QII;""
14 Córdoba;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2020QI;2.333
14 Córdoba;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
14 Córdoba;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
14 Córdoba;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2022QII;2.956
14 Córdoba;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2022QI;""
14 Córdoba;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
14 Córdoba;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
14 Córdoba;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2021QII;2.925
14 Córdoba;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2021QI;""
14 Córdoba;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
14 Córdoba;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
14 Córdoba;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2020QII;2.262
14 Córdoba;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2020QI;""
14 Córdoba;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
14 Córdoba;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QIII;2.769
14 Córdoba;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QII;""
14 Córdoba;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QI;""
14 Córdoba;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
14 Córdoba;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QIII;2.783
14 Córdoba;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QII;""
14 Córdoba;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QI;""
14 Córdoba;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
14 Córdoba;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QIII;2.168
14 Córdoba;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QII;""
14 Córdoba;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QI;""
14 Córdoba;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QIV;2.616
14 Córdoba;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
14 Córdoba;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QII;""
14 Córdoba;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QI;""
14 Córdoba;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QIV;2.640
14 Córdoba;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
14 Córdoba;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QII;""
14 Córdoba;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QI;""
14 Córdoba;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QIV;2.076
14 Córdoba;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
14 Córdoba;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QII;""
14 Córdoba;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QI;""
14 Córdoba;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
14 Córdoba;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
14 Córdoba;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
14 Córdoba;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
14 Córdoba;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
14 Córdoba;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
14 Córdoba;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
14 Córdoba;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
14 Córdoba;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
14 Córdoba;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
14 Córdoba;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
14 Córdoba;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
14 Córdoba;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
14 Córdoba;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
14 Córdoba;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
14 Córdoba;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;93,72
14 Córdoba;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
14 Córdoba;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
14 Córdoba;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
14 Córdoba;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;94,46
14 Córdoba;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
14 Córdoba;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
14 Córdoba;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
14 Córdoba;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;89,46
14 Córdoba;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
14 Córdoba;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
14 Córdoba;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;88,4
14 Córdoba;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
14 Córdoba;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
14 Córdoba;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
14 Córdoba;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;89,59
14 Córdoba;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
14 Córdoba;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
14 Córdoba;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
14 Córdoba;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;86,73
14 Córdoba;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
14 Córdoba;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
14 Córdoba;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;82,81
14 Córdoba;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
14 Córdoba;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
14 Córdoba;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
14 Córdoba;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;85,24
14 Córdoba;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
14 Córdoba;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
14 Córdoba;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
14 Córdoba;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;83,13
14 Córdoba;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
14 Córdoba;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
14 Córdoba;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;78,23
14 Córdoba;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
14 Córdoba;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
14 Córdoba;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
14 Córdoba;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;80,86
14 Córdoba;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
14 Córdoba;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
14 Córdoba;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
14 Córdoba;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;79,6
14 Córdoba;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
14 Córdoba;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
14 Córdoba;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
14 Córdoba;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
14 Córdoba;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
14 Córdoba;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
14 Córdoba;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QI;2.008
14 Córdoba;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
14 Córdoba;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
14 Córdoba;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
14 Córdoba;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QI;1.977
14 Córdoba;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
14 Córdoba;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
14 Córdoba;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
14 Córdoba;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QI;1.592
14 Córdoba;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
14 Córdoba;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
14 Córdoba;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2022QII;""
14 Córdoba;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2022QI;1.889
14 Córdoba;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
14 Córdoba;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
14 Córdoba;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2021QII;""
14 Córdoba;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2021QI;1.862
14 Córdoba;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
14 Córdoba;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
14 Córdoba;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2020QII;""
14 Córdoba;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2020QI;1.444
14 Córdoba;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
14 Córdoba;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
14 Córdoba;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2022QII;1.791
14 Córdoba;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2022QI;""
14 Córdoba;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
14 Córdoba;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
14 Córdoba;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2021QII;1.765
14 Córdoba;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2021QI;""
14 Córdoba;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
14 Córdoba;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
14 Córdoba;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2020QII;1.403
14 Córdoba;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2020QI;""
14 Córdoba;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
14 Córdoba;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QIII;1.669
14 Córdoba;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QII;""
14 Córdoba;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QI;""
14 Córdoba;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
14 Córdoba;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QIII;1.686
14 Córdoba;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QII;""
14 Córdoba;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QI;""
14 Córdoba;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
14 Córdoba;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QIII;1.353
14 Córdoba;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QII;""
14 Córdoba;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QI;""
14 Córdoba;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QIV;1.579
14 Córdoba;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
14 Córdoba;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QII;""
14 Córdoba;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QI;""
14 Córdoba;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QIV;1.605
14 Córdoba;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
14 Córdoba;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QII;""
14 Córdoba;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QI;""
14 Córdoba;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QIV;1.300
14 Córdoba;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
14 Córdoba;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QII;""
14 Córdoba;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QI;""
14 Córdoba;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
14 Córdoba;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
14 Córdoba;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
14 Córdoba;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
14 Córdoba;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
14 Córdoba;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
14 Córdoba;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
14 Córdoba;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
14 Córdoba;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
14 Córdoba;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
14 Córdoba;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
14 Córdoba;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
14 Córdoba;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
14 Córdoba;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
14 Córdoba;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
14 Córdoba;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;94,07
14 Córdoba;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
14 Córdoba;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
14 Córdoba;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
14 Córdoba;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;94,18
14 Córdoba;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
14 Córdoba;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
14 Córdoba;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
14 Córdoba;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;90,7
14 Córdoba;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
14 Córdoba;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
14 Córdoba;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;89,19
14 Córdoba;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
14 Córdoba;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
14 Córdoba;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
14 Córdoba;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;89,28
14 Córdoba;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
14 Córdoba;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
14 Córdoba;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
14 Córdoba;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;88,13
14 Córdoba;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
14 Córdoba;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
14 Córdoba;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;83,12
14 Córdoba;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
14 Córdoba;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
14 Córdoba;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
14 Córdoba;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;85,28
14 Córdoba;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
14 Córdoba;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
14 Córdoba;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
14 Córdoba;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;84,99
14 Córdoba;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
14 Córdoba;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
14 Córdoba;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;78,64
14 Córdoba;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
14 Córdoba;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
14 Córdoba;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
14 Córdoba;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;81,18
14 Córdoba;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
14 Córdoba;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
14 Córdoba;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
14 Córdoba;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;81,66
14 Córdoba;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
14 Córdoba;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
14 Córdoba;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
14 Córdoba;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
14 Córdoba;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
14 Córdoba;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
14 Córdoba;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QI;1.336
14 Córdoba;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
14 Córdoba;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
14 Córdoba;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
14 Córdoba;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QI;1.288
14 Córdoba;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
14 Córdoba;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
14 Córdoba;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
14 Córdoba;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QI;1.016
14 Córdoba;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
14 Córdoba;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
14 Córdoba;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2022QII;""
14 Córdoba;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2022QI;1.245
14 Córdoba;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
14 Córdoba;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
14 Córdoba;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2021QII;""
14 Córdoba;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2021QI;1.222
14 Córdoba;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
14 Córdoba;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
14 Córdoba;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2020QII;""
14 Córdoba;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2020QI;889
14 Córdoba;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
14 Córdoba;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
14 Córdoba;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2022QII;1.165
14 Córdoba;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2022QI;""
14 Córdoba;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
14 Córdoba;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
14 Córdoba;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2021QII;1.160
14 Córdoba;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2021QI;""
14 Córdoba;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
14 Córdoba;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
14 Córdoba;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2020QII;859
14 Córdoba;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2020QI;""
14 Córdoba;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
14 Córdoba;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QIII;1.100
14 Córdoba;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QII;""
14 Córdoba;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QI;""
14 Córdoba;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
14 Córdoba;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QIII;1.097
14 Córdoba;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QII;""
14 Córdoba;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QI;""
14 Córdoba;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
14 Córdoba;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QIII;815
14 Córdoba;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QII;""
14 Córdoba;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QI;""
14 Córdoba;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QIV;1.037
14 Córdoba;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
14 Córdoba;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QII;""
14 Córdoba;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QI;""
14 Córdoba;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QIV;1.035
14 Córdoba;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
14 Córdoba;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QII;""
14 Córdoba;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QI;""
14 Córdoba;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QIV;776
14 Córdoba;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
14 Córdoba;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QII;""
14 Córdoba;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QI;""
14 Córdoba;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
14 Córdoba;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
14 Córdoba;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
14 Córdoba;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
14 Córdoba;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
14 Córdoba;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
14 Córdoba;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
14 Córdoba;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
14 Córdoba;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
14 Córdoba;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
14 Córdoba;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
14 Córdoba;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
14 Córdoba;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
14 Córdoba;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
14 Córdoba;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
14 Córdoba;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;93,19
14 Córdoba;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
14 Córdoba;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
14 Córdoba;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
14 Córdoba;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;94,88
14 Córdoba;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
14 Córdoba;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
14 Córdoba;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
14 Córdoba;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;87,5
14 Córdoba;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
14 Córdoba;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
14 Córdoba;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;87,2
14 Córdoba;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
14 Córdoba;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
14 Córdoba;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
14 Córdoba;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;90,06
14 Córdoba;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
14 Córdoba;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
14 Córdoba;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
14 Córdoba;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;84,55
14 Córdoba;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
14 Córdoba;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
14 Córdoba;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;82,34
14 Córdoba;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
14 Córdoba;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
14 Córdoba;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
14 Córdoba;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;85,17
14 Córdoba;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
14 Córdoba;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
14 Córdoba;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
14 Córdoba;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;80,22
14 Córdoba;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
14 Córdoba;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
14 Córdoba;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;77,62
14 Córdoba;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
14 Córdoba;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
14 Córdoba;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
14 Córdoba;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;80,36
14 Córdoba;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
14 Córdoba;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
14 Córdoba;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
14 Córdoba;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;76,38
14 Córdoba;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
14 Córdoba;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
14 Córdoba;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
14 Córdoba;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
14 Córdoba;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
14 Córdoba;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QII;2.874
14 Córdoba;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
14 Córdoba;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
14 Córdoba;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
14 Córdoba;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QII;2.895
14 Córdoba;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
14 Córdoba;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
14 Córdoba;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
14 Córdoba;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QII;2.728
14 Córdoba;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
14 Córdoba;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
14 Córdoba;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
14 Córdoba;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2022QII;2.689
14 Córdoba;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2022QI;""
14 Córdoba;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
14 Córdoba;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
14 Córdoba;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2021QII;2.704
14 Córdoba;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2021QI;""
14 Córdoba;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
14 Córdoba;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
14 Córdoba;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2020QII;2.631
14 Córdoba;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2020QI;""
14 Córdoba;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
14 Córdoba;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2022QIII;2.516
14 Córdoba;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2022QII;""
14 Córdoba;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2022QI;""
14 Córdoba;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
14 Córdoba;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2021QIII;2.556
14 Córdoba;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2021QII;""
14 Córdoba;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2021QI;""
14 Córdoba;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
14 Córdoba;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2020QIII;2.500
14 Córdoba;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2020QII;""
14 Córdoba;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2020QI;""
14 Córdoba;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QIV;2.372
14 Córdoba;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
14 Córdoba;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QII;""
14 Córdoba;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QI;""
14 Córdoba;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QIV;2.415
14 Córdoba;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
14 Córdoba;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QII;""
14 Córdoba;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QI;""
14 Córdoba;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QIV;2.387
14 Córdoba;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
14 Córdoba;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QII;""
14 Córdoba;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QI;""
14 Córdoba;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
14 Córdoba;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
14 Córdoba;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QII;""
14 Córdoba;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QI;2.281
14 Córdoba;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
14 Córdoba;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
14 Córdoba;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QII;""
14 Córdoba;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QI;2.292
14 Córdoba;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
14 Córdoba;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
14 Córdoba;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QII;""
14 Córdoba;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QI;""
14 Córdoba;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
14 Córdoba;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
14 Córdoba;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
14 Córdoba;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
14 Córdoba;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
14 Córdoba;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
14 Córdoba;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
14 Córdoba;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
14 Córdoba;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
14 Córdoba;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
14 Córdoba;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
14 Córdoba;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
14 Córdoba;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
14 Córdoba;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
14 Córdoba;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;93,56
14 Córdoba;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
14 Córdoba;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
14 Córdoba;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
14 Córdoba;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;93,4
14 Córdoba;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
14 Córdoba;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
14 Córdoba;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
14 Córdoba;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;96,44
14 Córdoba;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
14 Córdoba;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
14 Córdoba;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;87,54
14 Córdoba;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
14 Córdoba;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
14 Córdoba;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
14 Córdoba;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;88,29
14 Córdoba;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
14 Córdoba;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
14 Córdoba;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
14 Córdoba;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;91,64
14 Córdoba;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
14 Córdoba;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
14 Córdoba;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;82,53
14 Córdoba;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
14 Córdoba;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
14 Córdoba;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
14 Córdoba;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;83,42
14 Córdoba;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
14 Córdoba;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
14 Córdoba;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
14 Córdoba;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;87,5
14 Córdoba;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
14 Córdoba;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
14 Córdoba;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
14 Córdoba;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
14 Córdoba;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
14 Córdoba;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
14 Córdoba;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;78,79
14 Córdoba;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
14 Córdoba;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
14 Córdoba;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
14 Córdoba;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;84,02
14 Córdoba;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
14 Córdoba;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
14 Córdoba;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
14 Córdoba;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
14 Córdoba;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
14 Córdoba;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
14 Córdoba;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QII;1.753
14 Córdoba;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
14 Córdoba;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
14 Córdoba;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
14 Córdoba;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QII;1.763
14 Córdoba;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
14 Córdoba;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
14 Córdoba;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
14 Córdoba;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QII;1.656
14 Córdoba;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
14 Córdoba;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
14 Córdoba;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
14 Córdoba;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2022QII;1.645
14 Córdoba;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2022QI;""
14 Córdoba;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
14 Córdoba;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
14 Córdoba;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2021QII;1.647
14 Córdoba;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2021QI;""
14 Córdoba;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
14 Córdoba;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
14 Córdoba;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2020QII;1.601
14 Córdoba;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2020QI;""
14 Córdoba;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
14 Córdoba;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2022QIII;1.535
14 Córdoba;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2022QII;""
14 Córdoba;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2022QI;""
14 Córdoba;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
14 Córdoba;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2021QIII;1.558
14 Córdoba;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2021QII;""
14 Córdoba;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2021QI;""
14 Córdoba;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
14 Córdoba;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2020QIII;1.526
14 Córdoba;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2020QII;""
14 Córdoba;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2020QI;""
14 Córdoba;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QIV;1.449
14 Córdoba;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
14 Córdoba;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QII;""
14 Córdoba;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QI;""
14 Córdoba;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QIV;1.479
14 Córdoba;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
14 Córdoba;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QII;""
14 Córdoba;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QI;""
14 Córdoba;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QIV;1.465
14 Córdoba;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
14 Córdoba;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QII;""
14 Córdoba;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QI;""
14 Córdoba;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
14 Córdoba;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
14 Córdoba;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QII;""
14 Córdoba;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QI;1.410
14 Córdoba;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
14 Córdoba;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
14 Córdoba;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QII;""
14 Córdoba;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QI;1.407
14 Córdoba;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
14 Córdoba;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
14 Córdoba;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QII;""
14 Córdoba;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QI;""
14 Córdoba;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
14 Córdoba;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
14 Córdoba;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
14 Córdoba;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
14 Córdoba;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
14 Córdoba;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
14 Córdoba;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
14 Córdoba;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
14 Córdoba;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
14 Córdoba;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
14 Córdoba;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
14 Córdoba;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
14 Córdoba;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
14 Córdoba;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
14 Córdoba;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;93,84
14 Córdoba;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
14 Córdoba;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
14 Córdoba;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
14 Córdoba;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;93,42
14 Córdoba;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
14 Córdoba;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
14 Córdoba;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
14 Córdoba;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;96,68
14 Córdoba;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
14 Córdoba;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
14 Córdoba;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;87,56
14 Córdoba;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
14 Córdoba;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
14 Córdoba;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
14 Córdoba;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;88,37
14 Córdoba;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
14 Córdoba;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
14 Córdoba;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
14 Córdoba;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;92,15
14 Córdoba;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
14 Córdoba;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
14 Córdoba;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;82,66
14 Córdoba;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
14 Córdoba;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
14 Córdoba;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
14 Córdoba;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;83,89
14 Córdoba;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
14 Córdoba;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
14 Córdoba;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
14 Córdoba;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;88,47
14 Córdoba;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
14 Córdoba;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
14 Córdoba;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
14 Córdoba;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
14 Córdoba;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
14 Córdoba;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
14 Córdoba;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;79,98
14 Córdoba;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
14 Córdoba;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
14 Córdoba;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
14 Córdoba;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;84,96
14 Córdoba;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
14 Córdoba;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
14 Córdoba;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
14 Córdoba;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
14 Córdoba;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
14 Córdoba;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
14 Córdoba;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QII;1.121
14 Córdoba;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
14 Córdoba;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
14 Córdoba;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
14 Córdoba;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QII;1.132
14 Córdoba;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
14 Córdoba;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
14 Córdoba;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
14 Córdoba;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QII;1.072
14 Córdoba;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
14 Córdoba;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
14 Córdoba;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
14 Córdoba;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2022QII;1.044
14 Córdoba;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2022QI;""
14 Córdoba;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
14 Córdoba;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
14 Córdoba;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2021QII;1.057
14 Córdoba;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2021QI;""
14 Córdoba;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
14 Córdoba;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
14 Córdoba;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2020QII;1.030
14 Córdoba;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2020QI;""
14 Córdoba;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
14 Córdoba;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2022QIII;981
14 Córdoba;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2022QII;""
14 Córdoba;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2022QI;""
14 Córdoba;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
14 Córdoba;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2021QIII;998
14 Córdoba;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2021QII;""
14 Córdoba;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2021QI;""
14 Córdoba;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
14 Córdoba;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2020QIII;974
14 Córdoba;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2020QII;""
14 Córdoba;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2020QI;""
14 Córdoba;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QIV;923
14 Córdoba;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
14 Córdoba;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QII;""
14 Córdoba;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QI;""
14 Córdoba;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QIV;936
14 Córdoba;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
14 Córdoba;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QII;""
14 Córdoba;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QI;""
14 Córdoba;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QIV;922
14 Córdoba;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
14 Córdoba;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QII;""
14 Córdoba;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QI;""
14 Córdoba;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
14 Córdoba;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
14 Córdoba;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QII;""
14 Córdoba;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QI;871
14 Córdoba;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
14 Córdoba;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
14 Córdoba;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QII;""
14 Córdoba;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QI;885
14 Córdoba;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
14 Córdoba;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
14 Córdoba;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QII;""
14 Córdoba;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QI;""
14 Córdoba;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
14 Córdoba;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
14 Córdoba;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
14 Córdoba;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
14 Córdoba;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
14 Córdoba;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
14 Córdoba;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
14 Córdoba;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
14 Córdoba;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
14 Córdoba;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
14 Córdoba;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
14 Córdoba;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
14 Córdoba;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
14 Córdoba;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
14 Córdoba;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;93,13
14 Córdoba;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
14 Córdoba;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
14 Córdoba;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
14 Córdoba;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;93,37
14 Córdoba;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
14 Córdoba;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
14 Córdoba;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
14 Córdoba;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;96,08
14 Córdoba;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
14 Córdoba;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
14 Córdoba;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;87,51
14 Córdoba;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
14 Córdoba;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
14 Córdoba;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
14 Córdoba;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;88,16
14 Córdoba;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
14 Córdoba;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
14 Córdoba;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
14 Córdoba;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;90,86
14 Córdoba;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
14 Córdoba;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
14 Córdoba;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;82,34
14 Córdoba;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
14 Córdoba;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
14 Córdoba;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
14 Córdoba;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;82,69
14 Córdoba;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
14 Córdoba;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
14 Córdoba;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
14 Córdoba;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;86,01
14 Córdoba;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
14 Córdoba;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
14 Córdoba;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
14 Córdoba;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
14 Córdoba;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
14 Córdoba;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
14 Córdoba;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;76,94
14 Córdoba;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
14 Córdoba;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
14 Córdoba;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
14 Córdoba;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;82,56
14 Córdoba;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
14 Córdoba;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
14 Córdoba;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
14 Córdoba;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
14 Córdoba;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
14 Córdoba;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QIII;3.044
14 Córdoba;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
14 Córdoba;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
14 Córdoba;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
14 Córdoba;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QIII;3.125
14 Córdoba;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
14 Córdoba;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
14 Córdoba;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
14 Córdoba;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QIII;2.898
14 Córdoba;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
14 Córdoba;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
14 Córdoba;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
14 Córdoba;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2022QIII;2.807
14 Córdoba;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2022QII;""
14 Córdoba;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2022QI;""
14 Córdoba;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
14 Córdoba;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2021QIII;2.910
14 Córdoba;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2021QII;""
14 Córdoba;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2021QI;""
14 Córdoba;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
14 Córdoba;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2020QIII;2.712
14 Córdoba;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2020QII;""
14 Córdoba;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2020QI;""
14 Córdoba;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2022QIV;2.639
14 Córdoba;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
14 Córdoba;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2022QII;""
14 Córdoba;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2022QI;""
14 Córdoba;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2021QIV;2.743
14 Córdoba;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
14 Córdoba;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2021QII;""
14 Córdoba;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2021QI;""
14 Córdoba;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2020QIV;2.581
14 Córdoba;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
14 Córdoba;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2020QII;""
14 Córdoba;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2020QI;""
14 Córdoba;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
14 Córdoba;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
14 Córdoba;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QII;""
14 Córdoba;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QI;2.587
14 Córdoba;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
14 Córdoba;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
14 Córdoba;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QII;""
14 Córdoba;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QI;2.464
14 Córdoba;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
14 Córdoba;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
14 Córdoba;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QII;""
14 Córdoba;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QI;""
14 Córdoba;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
14 Córdoba;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
14 Córdoba;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QII;2.453
14 Córdoba;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QI;""
14 Córdoba;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
14 Córdoba;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
14 Córdoba;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QII;2.365
14 Córdoba;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QI;""
14 Córdoba;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
14 Córdoba;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
14 Córdoba;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QII;""
14 Córdoba;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QI;""
14 Córdoba;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
14 Córdoba;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
14 Córdoba;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
14 Córdoba;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
14 Córdoba;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
14 Córdoba;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
14 Córdoba;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
14 Córdoba;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
14 Córdoba;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
14 Córdoba;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
14 Córdoba;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
14 Córdoba;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
14 Córdoba;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
14 Córdoba;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;92,21
14 Córdoba;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
14 Córdoba;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
14 Córdoba;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
14 Córdoba;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;93,12
14 Córdoba;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
14 Córdoba;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
14 Córdoba;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
14 Córdoba;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;93,58
14 Córdoba;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
14 Córdoba;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
14 Córdoba;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;86,7
14 Córdoba;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
14 Córdoba;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
14 Córdoba;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
14 Córdoba;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;87,78
14 Córdoba;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
14 Córdoba;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
14 Córdoba;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
14 Córdoba;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;89,06
14 Córdoba;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
14 Córdoba;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
14 Córdoba;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
14 Córdoba;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
14 Córdoba;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
14 Córdoba;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
14 Córdoba;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;82,78
14 Córdoba;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
14 Córdoba;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
14 Córdoba;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
14 Córdoba;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;85,02
14 Córdoba;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
14 Córdoba;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
14 Córdoba;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
14 Córdoba;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
14 Córdoba;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
14 Córdoba;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
14 Córdoba;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;78,5
14 Córdoba;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
14 Córdoba;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
14 Córdoba;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
14 Córdoba;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;81,61
14 Córdoba;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
14 Córdoba;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
14 Córdoba;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
14 Córdoba;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
14 Córdoba;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
14 Córdoba;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
14 Córdoba;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QIII;1.870
14 Córdoba;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
14 Córdoba;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
14 Córdoba;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
14 Córdoba;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QIII;1.905
14 Córdoba;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
14 Córdoba;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
14 Córdoba;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
14 Córdoba;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QIII;1.759
14 Córdoba;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
14 Córdoba;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
14 Córdoba;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
14 Córdoba;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2022QIII;1.714
14 Córdoba;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2022QII;""
14 Córdoba;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2022QI;""
14 Córdoba;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
14 Córdoba;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2021QIII;1.766
14 Córdoba;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2021QII;""
14 Córdoba;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2021QI;""
14 Córdoba;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
14 Córdoba;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2020QIII;1.651
14 Córdoba;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2020QII;""
14 Córdoba;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2020QI;""
14 Córdoba;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2022QIV;1.610
14 Córdoba;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
14 Córdoba;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2022QII;""
14 Córdoba;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2022QI;""
14 Córdoba;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2021QIV;1.672
14 Córdoba;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
14 Córdoba;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2021QII;""
14 Córdoba;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2021QI;""
14 Córdoba;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2020QIV;1.579
14 Córdoba;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
14 Córdoba;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2020QII;""
14 Córdoba;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2020QI;""
14 Córdoba;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
14 Córdoba;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
14 Córdoba;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QII;""
14 Córdoba;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QI;1.589
14 Córdoba;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
14 Córdoba;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
14 Córdoba;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QII;""
14 Córdoba;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QI;1.505
14 Córdoba;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
14 Córdoba;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
14 Córdoba;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QII;""
14 Córdoba;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QI;""
14 Córdoba;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
14 Córdoba;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
14 Córdoba;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QII;1.520
14 Córdoba;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QI;""
14 Córdoba;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
14 Córdoba;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
14 Córdoba;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QII;1.445
14 Córdoba;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QI;""
14 Córdoba;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
14 Córdoba;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
14 Córdoba;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QII;""
14 Córdoba;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QI;""
14 Córdoba;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
14 Córdoba;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
14 Córdoba;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
14 Córdoba;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
14 Córdoba;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
14 Córdoba;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
14 Córdoba;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
14 Córdoba;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
14 Córdoba;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
14 Córdoba;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
14 Córdoba;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
14 Córdoba;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
14 Córdoba;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
14 Córdoba;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;91,66
14 Córdoba;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
14 Córdoba;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
14 Córdoba;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
14 Córdoba;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;92,7
14 Córdoba;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
14 Córdoba;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
14 Córdoba;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
14 Córdoba;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;93,86
14 Córdoba;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
14 Córdoba;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
14 Córdoba;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;86,1
14 Córdoba;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
14 Córdoba;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
14 Córdoba;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
14 Córdoba;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;87,77
14 Córdoba;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
14 Córdoba;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
14 Córdoba;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
14 Córdoba;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;89,77
14 Córdoba;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
14 Córdoba;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
14 Córdoba;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
14 Córdoba;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
14 Córdoba;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
14 Córdoba;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
14 Córdoba;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;83,41
14 Córdoba;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
14 Córdoba;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
14 Córdoba;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
14 Córdoba;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;85,56
14 Córdoba;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
14 Córdoba;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
14 Córdoba;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
14 Córdoba;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
14 Córdoba;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
14 Córdoba;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
14 Córdoba;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;79,79
14 Córdoba;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
14 Córdoba;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
14 Córdoba;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
14 Córdoba;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;82,15
14 Córdoba;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
14 Córdoba;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
14 Córdoba;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
14 Córdoba;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
14 Córdoba;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
14 Córdoba;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
14 Córdoba;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QIII;1.174
14 Córdoba;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
14 Córdoba;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
14 Córdoba;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
14 Córdoba;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QIII;1.220
14 Córdoba;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
14 Córdoba;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
14 Córdoba;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
14 Córdoba;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QIII;1.139
14 Córdoba;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
14 Córdoba;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
14 Córdoba;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
14 Córdoba;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2022QIII;1.093
14 Córdoba;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2022QII;""
14 Córdoba;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2022QI;""
14 Córdoba;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
14 Córdoba;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2021QIII;1.144
14 Córdoba;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2021QII;""
14 Córdoba;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2021QI;""
14 Córdoba;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
14 Córdoba;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2020QIII;1.061
14 Córdoba;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2020QII;""
14 Córdoba;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2020QI;""
14 Córdoba;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2022QIV;1.029
14 Córdoba;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
14 Córdoba;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2022QII;""
14 Córdoba;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2022QI;""
14 Córdoba;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2021QIV;1.071
14 Córdoba;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
14 Córdoba;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2021QII;""
14 Córdoba;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2021QI;""
14 Córdoba;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2020QIV;1.002
14 Córdoba;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
14 Córdoba;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2020QII;""
14 Córdoba;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2020QI;""
14 Córdoba;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
14 Córdoba;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
14 Córdoba;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QII;""
14 Córdoba;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QI;998
14 Córdoba;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
14 Córdoba;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
14 Córdoba;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QII;""
14 Córdoba;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QI;959
14 Córdoba;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
14 Córdoba;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
14 Córdoba;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QII;""
14 Córdoba;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QI;""
14 Córdoba;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
14 Córdoba;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
14 Córdoba;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QII;933
14 Córdoba;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QI;""
14 Córdoba;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
14 Córdoba;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
14 Córdoba;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QII;920
14 Córdoba;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QI;""
14 Córdoba;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
14 Córdoba;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
14 Córdoba;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QII;""
14 Córdoba;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QI;""
14 Córdoba;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
14 Córdoba;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
14 Córdoba;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
14 Córdoba;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
14 Córdoba;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
14 Córdoba;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
14 Córdoba;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
14 Córdoba;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
14 Córdoba;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
14 Córdoba;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
14 Córdoba;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
14 Córdoba;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
14 Córdoba;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
14 Córdoba;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;93,1
14 Córdoba;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
14 Córdoba;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
14 Córdoba;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
14 Córdoba;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;93,77
14 Córdoba;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
14 Córdoba;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
14 Córdoba;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
14 Córdoba;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;93,15
14 Córdoba;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
14 Córdoba;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
14 Córdoba;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;87,65
14 Córdoba;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
14 Córdoba;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
14 Córdoba;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
14 Córdoba;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;87,79
14 Córdoba;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
14 Córdoba;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
14 Córdoba;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
14 Córdoba;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;87,97
14 Córdoba;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
14 Córdoba;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
14 Córdoba;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
14 Córdoba;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
14 Córdoba;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
14 Córdoba;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
14 Córdoba;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;81,8
14 Córdoba;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
14 Córdoba;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
14 Córdoba;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
14 Córdoba;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;84,2
14 Córdoba;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
14 Córdoba;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
14 Córdoba;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
14 Córdoba;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
14 Córdoba;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
14 Córdoba;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
14 Córdoba;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;76,48
14 Córdoba;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
14 Córdoba;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
14 Córdoba;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
14 Córdoba;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;80,77
14 Córdoba;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
14 Córdoba;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
14 Córdoba;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
14 Córdoba;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
14 Córdoba;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
14 Córdoba;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QIV;3.133
14 Córdoba;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
14 Córdoba;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
14 Córdoba;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
14 Córdoba;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QIV;3.224
14 Córdoba;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
14 Córdoba;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
14 Córdoba;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
14 Córdoba;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QIV;3.061
14 Córdoba;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
14 Córdoba;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
14 Córdoba;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
14 Córdoba;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2022QIV;2.925
14 Córdoba;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
14 Córdoba;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2022QII;""
14 Córdoba;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2022QI;""
14 Córdoba;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2021QIV;3.020
14 Córdoba;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
14 Córdoba;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2021QII;""
14 Córdoba;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2021QI;""
14 Córdoba;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2020QIV;2.883
14 Córdoba;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
14 Córdoba;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2020QII;""
14 Córdoba;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2020QI;""
14 Córdoba;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
14 Córdoba;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
14 Córdoba;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2022QII;""
14 Córdoba;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2022QI;2.857
14 Córdoba;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
14 Córdoba;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
14 Córdoba;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2021QII;""
14 Córdoba;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2021QI;2.741
14 Córdoba;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
14 Córdoba;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
14 Córdoba;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2020QII;""
14 Córdoba;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2020QI;""
14 Córdoba;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
14 Córdoba;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
14 Córdoba;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QII;2.706
14 Córdoba;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QI;""
14 Córdoba;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
14 Córdoba;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
14 Córdoba;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QII;2.613
14 Córdoba;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QI;""
14 Córdoba;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
14 Córdoba;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
14 Córdoba;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QII;""
14 Córdoba;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QI;""
14 Córdoba;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
14 Córdoba;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QIII;2.538
14 Córdoba;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QII;""
14 Córdoba;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QI;""
14 Córdoba;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
14 Córdoba;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QIII;2.500
14 Córdoba;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QII;""
14 Córdoba;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QI;""
14 Córdoba;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
14 Córdoba;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
14 Córdoba;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QII;""
14 Córdoba;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QI;""
14 Córdoba;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
14 Córdoba;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
14 Córdoba;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
14 Córdoba;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
14 Córdoba;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
14 Córdoba;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
14 Córdoba;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
14 Córdoba;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
14 Córdoba;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
14 Córdoba;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
14 Córdoba;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
14 Córdoba;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
14 Córdoba;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;93,36
14 Córdoba;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
14 Córdoba;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
14 Córdoba;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
14 Córdoba;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;93,67
14 Córdoba;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
14 Córdoba;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
14 Córdoba;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
14 Córdoba;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;94,18
14 Córdoba;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
14 Córdoba;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
14 Córdoba;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
14 Córdoba;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
14 Córdoba;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
14 Córdoba;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
14 Córdoba;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;88,62
14 Córdoba;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
14 Córdoba;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
14 Córdoba;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
14 Córdoba;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;89,55
14 Córdoba;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
14 Córdoba;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
14 Córdoba;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
14 Córdoba;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
14 Córdoba;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
14 Córdoba;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
14 Córdoba;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;83,93
14 Córdoba;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
14 Córdoba;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
14 Córdoba;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
14 Córdoba;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;85,36
14 Córdoba;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
14 Córdoba;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
14 Córdoba;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
14 Córdoba;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
14 Córdoba;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
14 Córdoba;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
14 Córdoba;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;78,72
14 Córdoba;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
14 Córdoba;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
14 Córdoba;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
14 Córdoba;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;81,67
14 Córdoba;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
14 Córdoba;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
14 Córdoba;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
14 Córdoba;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
14 Córdoba;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
14 Córdoba;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
14 Córdoba;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QIV;1.892
14 Córdoba;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
14 Córdoba;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
14 Córdoba;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
14 Córdoba;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QIV;1.941
14 Córdoba;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
14 Córdoba;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
14 Córdoba;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
14 Córdoba;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QIV;1.858
14 Córdoba;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
14 Córdoba;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
14 Córdoba;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
14 Córdoba;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2022QIV;1.765
14 Córdoba;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
14 Córdoba;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2022QII;""
14 Córdoba;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2022QI;""
14 Córdoba;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2021QIV;1.822
14 Córdoba;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
14 Córdoba;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2021QII;""
14 Córdoba;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2021QI;""
14 Córdoba;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2020QIV;1.752
14 Córdoba;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
14 Córdoba;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2020QII;""
14 Córdoba;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2020QI;""
14 Córdoba;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
14 Córdoba;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
14 Córdoba;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2022QII;""
14 Córdoba;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2022QI;1.735
14 Córdoba;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
14 Córdoba;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
14 Córdoba;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2021QII;""
14 Córdoba;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2021QI;1.664
14 Córdoba;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
14 Córdoba;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
14 Córdoba;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2020QII;""
14 Córdoba;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2020QI;""
14 Córdoba;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
14 Córdoba;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
14 Córdoba;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QII;1.657
14 Córdoba;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QI;""
14 Córdoba;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
14 Córdoba;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
14 Córdoba;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QII;1.585
14 Córdoba;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QI;""
14 Córdoba;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
14 Córdoba;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
14 Córdoba;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QII;""
14 Córdoba;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QI;""
14 Córdoba;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
14 Córdoba;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QIII;1.549
14 Córdoba;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QII;""
14 Córdoba;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QI;""
14 Córdoba;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
14 Córdoba;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QIII;1.520
14 Córdoba;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QII;""
14 Córdoba;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QI;""
14 Córdoba;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
14 Córdoba;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
14 Córdoba;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QII;""
14 Córdoba;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QI;""
14 Córdoba;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
14 Córdoba;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
14 Córdoba;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
14 Córdoba;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
14 Córdoba;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
14 Córdoba;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
14 Córdoba;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
14 Córdoba;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
14 Córdoba;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
14 Córdoba;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
14 Córdoba;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
14 Córdoba;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
14 Córdoba;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;93,29
14 Córdoba;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
14 Córdoba;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
14 Córdoba;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
14 Córdoba;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;93,87
14 Córdoba;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
14 Córdoba;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
14 Córdoba;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
14 Córdoba;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;94,29
14 Córdoba;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
14 Córdoba;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
14 Córdoba;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
14 Córdoba;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
14 Córdoba;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
14 Córdoba;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
14 Córdoba;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;89,39
14 Córdoba;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
14 Córdoba;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
14 Córdoba;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
14 Córdoba;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;89,56
14 Córdoba;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
14 Córdoba;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
14 Córdoba;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
14 Córdoba;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
14 Córdoba;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
14 Córdoba;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
14 Córdoba;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;85,37
14 Córdoba;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
14 Córdoba;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
14 Córdoba;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
14 Córdoba;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;85,31
14 Córdoba;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
14 Córdoba;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
14 Córdoba;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
14 Córdoba;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
14 Córdoba;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
14 Córdoba;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
14 Córdoba;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;79,8
14 Córdoba;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
14 Córdoba;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
14 Córdoba;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
14 Córdoba;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;81,81
14 Córdoba;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
14 Córdoba;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
14 Córdoba;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
14 Córdoba;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
14 Córdoba;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
14 Córdoba;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
14 Córdoba;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QIV;1.241
14 Córdoba;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
14 Córdoba;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
14 Córdoba;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
14 Córdoba;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QIV;1.283
14 Córdoba;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
14 Córdoba;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
14 Córdoba;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
14 Córdoba;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QIV;1.203
14 Córdoba;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
14 Córdoba;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
14 Córdoba;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
14 Córdoba;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2022QIV;1.160
14 Córdoba;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
14 Córdoba;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2022QII;""
14 Córdoba;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2022QI;""
14 Córdoba;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2021QIV;1.198
14 Córdoba;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
14 Córdoba;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2021QII;""
14 Córdoba;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2021QI;""
14 Córdoba;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2020QIV;1.131
14 Córdoba;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
14 Córdoba;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2020QII;""
14 Córdoba;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2020QI;""
14 Córdoba;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
14 Córdoba;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
14 Córdoba;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2022QII;""
14 Córdoba;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2022QI;1.122
14 Córdoba;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
14 Córdoba;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
14 Córdoba;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2021QII;""
14 Córdoba;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2021QI;1.077
14 Córdoba;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
14 Córdoba;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
14 Córdoba;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2020QII;""
14 Córdoba;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2020QI;""
14 Córdoba;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
14 Córdoba;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
14 Córdoba;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QII;1.049
14 Córdoba;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QI;""
14 Córdoba;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
14 Córdoba;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
14 Córdoba;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QII;1.028
14 Córdoba;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QI;""
14 Córdoba;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
14 Córdoba;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
14 Córdoba;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QII;""
14 Córdoba;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QI;""
14 Córdoba;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
14 Córdoba;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QIII;989
14 Córdoba;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QII;""
14 Córdoba;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QI;""
14 Córdoba;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
14 Córdoba;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QIII;980
14 Córdoba;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QII;""
14 Córdoba;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QI;""
14 Córdoba;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
14 Córdoba;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
14 Córdoba;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QII;""
14 Córdoba;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QI;""
14 Córdoba;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
14 Córdoba;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
14 Córdoba;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
14 Córdoba;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
14 Córdoba;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
14 Córdoba;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
14 Córdoba;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
14 Córdoba;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
14 Córdoba;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
14 Córdoba;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
14 Córdoba;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
14 Córdoba;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
14 Córdoba;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;93,47
14 Córdoba;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
14 Córdoba;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
14 Córdoba;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
14 Córdoba;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;93,37
14 Córdoba;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
14 Córdoba;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
14 Córdoba;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
14 Córdoba;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;94,01
14 Córdoba;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
14 Córdoba;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
14 Córdoba;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
14 Córdoba;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
14 Córdoba;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
14 Córdoba;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
14 Córdoba;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;87,45
14 Córdoba;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
14 Córdoba;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
14 Córdoba;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
14 Córdoba;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;89,53
14 Córdoba;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
14 Córdoba;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
14 Córdoba;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
14 Córdoba;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
14 Córdoba;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
14 Córdoba;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
14 Córdoba;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;81,76
14 Córdoba;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
14 Córdoba;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
14 Córdoba;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
14 Córdoba;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;85,45
14 Córdoba;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
14 Córdoba;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
14 Córdoba;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
14 Córdoba;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
14 Córdoba;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
14 Córdoba;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
14 Córdoba;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;77,08
14 Córdoba;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
14 Córdoba;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
14 Córdoba;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
14 Córdoba;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;81,46
14 Córdoba;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
14 Córdoba;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
14 Córdoba;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
14 Córdoba;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
14 Córdoba;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
14 Córdoba;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
14 Córdoba;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
14 Córdoba;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
14 Córdoba;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
14 Córdoba;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QI;9.128
14 Córdoba;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
14 Córdoba;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
14 Córdoba;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
14 Córdoba;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QI;9.194
14 Córdoba;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
14 Córdoba;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
14 Córdoba;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
14 Córdoba;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QI;8.909
14 Córdoba;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
14 Córdoba;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
14 Córdoba;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2022QII;""
14 Córdoba;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2022QI;8.794
14 Córdoba;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
14 Córdoba;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
14 Córdoba;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2021QII;""
14 Córdoba;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2021QI;8.945
14 Córdoba;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
14 Córdoba;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
14 Córdoba;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2020QII;""
14 Córdoba;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2020QI;8.224
14 Córdoba;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
14 Córdoba;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
14 Córdoba;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2022QII;8.476
14 Córdoba;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2022QI;""
14 Córdoba;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
14 Córdoba;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
14 Córdoba;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2021QII;8.713
14 Córdoba;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2021QI;""
14 Córdoba;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
14 Córdoba;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
14 Córdoba;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2020QII;8.058
14 Córdoba;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2020QI;""
14 Córdoba;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
14 Córdoba;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QIII;8.208
14 Córdoba;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QII;""
14 Córdoba;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QI;""
14 Córdoba;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
14 Córdoba;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QIII;8.479
14 Córdoba;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QII;""
14 Córdoba;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QI;""
14 Córdoba;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
14 Córdoba;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QIII;7.837
14 Córdoba;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QII;""
14 Córdoba;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QI;""
14 Córdoba;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QIV;7.949
14 Córdoba;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
14 Córdoba;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QII;""
14 Córdoba;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QI;""
14 Córdoba;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QIV;8.253
14 Córdoba;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
14 Córdoba;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QII;""
14 Córdoba;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QI;""
14 Córdoba;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QIV;7.619
14 Córdoba;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
14 Córdoba;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QII;""
14 Córdoba;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QI;""
14 Córdoba;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
14 Córdoba;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
14 Córdoba;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
14 Córdoba;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
14 Córdoba;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
14 Córdoba;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
14 Córdoba;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
14 Córdoba;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
14 Córdoba;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
14 Córdoba;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
14 Córdoba;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
14 Córdoba;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
14 Córdoba;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
14 Córdoba;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
14 Córdoba;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
14 Córdoba;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;96,34
14 Córdoba;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
14 Córdoba;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
14 Córdoba;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
14 Córdoba;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;97,29
14 Córdoba;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
14 Córdoba;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
14 Córdoba;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
14 Córdoba;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;92,31
14 Córdoba;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
14 Córdoba;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
14 Córdoba;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;92,86
14 Córdoba;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
14 Córdoba;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
14 Córdoba;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
14 Córdoba;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;94,77
14 Córdoba;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
14 Córdoba;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
14 Córdoba;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
14 Córdoba;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;90,45
14 Córdoba;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
14 Córdoba;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
14 Córdoba;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;89,92
14 Córdoba;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
14 Córdoba;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
14 Córdoba;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
14 Córdoba;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;92,22
14 Córdoba;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
14 Córdoba;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
14 Córdoba;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
14 Córdoba;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;87,97
14 Córdoba;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
14 Córdoba;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
14 Córdoba;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;87,08
14 Córdoba;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
14 Córdoba;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
14 Córdoba;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
14 Córdoba;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;89,77
14 Córdoba;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
14 Córdoba;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
14 Córdoba;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
14 Córdoba;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;85,52
14 Córdoba;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
14 Córdoba;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
14 Córdoba;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
14 Córdoba;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
14 Córdoba;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
14 Córdoba;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
14 Córdoba;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QI;5.435
14 Córdoba;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
14 Córdoba;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
14 Córdoba;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
14 Córdoba;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QI;5.573
14 Córdoba;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
14 Córdoba;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
14 Córdoba;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
14 Córdoba;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QI;5.405
14 Córdoba;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
14 Córdoba;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
14 Córdoba;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2022QII;""
14 Córdoba;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2022QI;5.239
14 Córdoba;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
14 Córdoba;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
14 Córdoba;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2021QII;""
14 Córdoba;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2021QI;5.431
14 Córdoba;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
14 Córdoba;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
14 Córdoba;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2020QII;""
14 Córdoba;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2020QI;5.011
14 Córdoba;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
14 Córdoba;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
14 Córdoba;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2022QII;5.076
14 Córdoba;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2022QI;""
14 Córdoba;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
14 Córdoba;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
14 Córdoba;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2021QII;5.289
14 Córdoba;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2021QI;""
14 Córdoba;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
14 Córdoba;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
14 Córdoba;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2020QII;4.921
14 Córdoba;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2020QI;""
14 Córdoba;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
14 Córdoba;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QIII;4.930
14 Córdoba;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QII;""
14 Córdoba;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QI;""
14 Córdoba;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
14 Córdoba;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QIII;5.163
14 Córdoba;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QII;""
14 Córdoba;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QI;""
14 Córdoba;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
14 Córdoba;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QIII;4.802
14 Córdoba;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QII;""
14 Córdoba;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QI;""
14 Córdoba;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QIV;4.791
14 Córdoba;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
14 Córdoba;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QII;""
14 Córdoba;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QI;""
14 Córdoba;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QIV;5.027
14 Córdoba;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
14 Córdoba;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QII;""
14 Córdoba;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QI;""
14 Córdoba;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QIV;4.675
14 Córdoba;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
14 Córdoba;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QII;""
14 Córdoba;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QI;""
14 Córdoba;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
14 Córdoba;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
14 Córdoba;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
14 Córdoba;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
14 Córdoba;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
14 Córdoba;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
14 Córdoba;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
14 Córdoba;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
14 Córdoba;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
14 Córdoba;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
14 Córdoba;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
14 Córdoba;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
14 Córdoba;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
14 Córdoba;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
14 Córdoba;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
14 Córdoba;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;96,39
14 Córdoba;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
14 Córdoba;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
14 Córdoba;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
14 Córdoba;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;97,45
14 Córdoba;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
14 Córdoba;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
14 Córdoba;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
14 Córdoba;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;92,71
14 Córdoba;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
14 Córdoba;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
14 Córdoba;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;93,39
14 Córdoba;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
14 Córdoba;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
14 Córdoba;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
14 Córdoba;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;94,9
14 Córdoba;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
14 Córdoba;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
14 Córdoba;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
14 Córdoba;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;91,05
14 Córdoba;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
14 Córdoba;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
14 Córdoba;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;90,71
14 Córdoba;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
14 Córdoba;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
14 Córdoba;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
14 Córdoba;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;92,64
14 Córdoba;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
14 Córdoba;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
14 Córdoba;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
14 Córdoba;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;88,84
14 Córdoba;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
14 Córdoba;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
14 Córdoba;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;88,15
14 Córdoba;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
14 Córdoba;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
14 Córdoba;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
14 Córdoba;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;90,2
14 Córdoba;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
14 Córdoba;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
14 Córdoba;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
14 Córdoba;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;86,49
14 Córdoba;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
14 Córdoba;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
14 Córdoba;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
14 Córdoba;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
14 Córdoba;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
14 Córdoba;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
14 Córdoba;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QI;3.693
14 Córdoba;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
14 Córdoba;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
14 Córdoba;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
14 Córdoba;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QI;3.621
14 Córdoba;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
14 Córdoba;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
14 Córdoba;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
14 Córdoba;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QI;3.504
14 Córdoba;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
14 Córdoba;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
14 Córdoba;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2022QII;""
14 Córdoba;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2022QI;3.555
14 Córdoba;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
14 Córdoba;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
14 Córdoba;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2021QII;""
14 Córdoba;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2021QI;3.514
14 Córdoba;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
14 Córdoba;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
14 Córdoba;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2020QII;""
14 Córdoba;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2020QI;3.213
14 Córdoba;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
14 Córdoba;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
14 Córdoba;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2022QII;3.400
14 Córdoba;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2022QI;""
14 Córdoba;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
14 Córdoba;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
14 Córdoba;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2021QII;3.424
14 Córdoba;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2021QI;""
14 Córdoba;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
14 Córdoba;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
14 Córdoba;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2020QII;3.137
14 Córdoba;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2020QI;""
14 Córdoba;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
14 Córdoba;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QIII;3.278
14 Córdoba;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QII;""
14 Córdoba;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QI;""
14 Córdoba;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
14 Córdoba;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QIII;3.316
14 Córdoba;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QII;""
14 Córdoba;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QI;""
14 Córdoba;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
14 Córdoba;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QIII;3.035
14 Córdoba;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QII;""
14 Córdoba;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QI;""
14 Córdoba;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QIV;3.158
14 Córdoba;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
14 Córdoba;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QII;""
14 Córdoba;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QI;""
14 Córdoba;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QIV;3.226
14 Córdoba;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
14 Córdoba;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QII;""
14 Córdoba;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QI;""
14 Córdoba;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QIV;2.944
14 Córdoba;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
14 Córdoba;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QII;""
14 Córdoba;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QI;""
14 Córdoba;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
14 Córdoba;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
14 Córdoba;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
14 Córdoba;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
14 Córdoba;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
14 Córdoba;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
14 Córdoba;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
14 Córdoba;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
14 Córdoba;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
14 Córdoba;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
14 Córdoba;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
14 Córdoba;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
14 Córdoba;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
14 Córdoba;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
14 Córdoba;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
14 Córdoba;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;96,26
14 Córdoba;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
14 Córdoba;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
14 Córdoba;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
14 Córdoba;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;97,05
14 Córdoba;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
14 Córdoba;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
14 Córdoba;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
14 Córdoba;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;91,7
14 Córdoba;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
14 Córdoba;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
14 Córdoba;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;92,07
14 Córdoba;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
14 Córdoba;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
14 Córdoba;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
14 Córdoba;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;94,56
14 Córdoba;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
14 Córdoba;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
14 Córdoba;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
14 Córdoba;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;89,53
14 Córdoba;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
14 Córdoba;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
14 Córdoba;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;88,76
14 Córdoba;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
14 Córdoba;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
14 Córdoba;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
14 Córdoba;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;91,58
14 Córdoba;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
14 Córdoba;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
14 Córdoba;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
14 Córdoba;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;86,62
14 Córdoba;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
14 Córdoba;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
14 Córdoba;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;85,51
14 Córdoba;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
14 Córdoba;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
14 Córdoba;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
14 Córdoba;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;89,09
14 Córdoba;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
14 Córdoba;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
14 Córdoba;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
14 Córdoba;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;84,02
14 Córdoba;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
14 Córdoba;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
14 Córdoba;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
14 Córdoba;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
14 Córdoba;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
14 Córdoba;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QII;8.653
14 Córdoba;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
14 Córdoba;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
14 Córdoba;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
14 Córdoba;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QII;8.759
14 Córdoba;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
14 Córdoba;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
14 Córdoba;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
14 Córdoba;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QII;8.733
14 Córdoba;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
14 Córdoba;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
14 Córdoba;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
14 Córdoba;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2022QII;8.300
14 Córdoba;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2022QI;""
14 Córdoba;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
14 Córdoba;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
14 Córdoba;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2021QII;8.495
14 Córdoba;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2021QI;""
14 Córdoba;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
14 Córdoba;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
14 Córdoba;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2020QII;8.543
14 Córdoba;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2020QI;""
14 Córdoba;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
14 Córdoba;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2022QIII;8.011
14 Córdoba;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2022QII;""
14 Córdoba;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2022QI;""
14 Córdoba;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
14 Córdoba;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2021QIII;8.231
14 Córdoba;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2021QII;""
14 Córdoba;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2021QI;""
14 Córdoba;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
14 Córdoba;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2020QIII;8.301
14 Córdoba;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2020QII;""
14 Córdoba;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2020QI;""
14 Córdoba;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QIV;7.721
14 Córdoba;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
14 Córdoba;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QII;""
14 Córdoba;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QI;""
14 Córdoba;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QIV;7.995
14 Córdoba;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
14 Córdoba;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QII;""
14 Córdoba;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QI;""
14 Córdoba;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QIV;8.056
14 Córdoba;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
14 Córdoba;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QII;""
14 Córdoba;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QI;""
14 Córdoba;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
14 Córdoba;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
14 Córdoba;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QII;""
14 Córdoba;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QI;7.747
14 Córdoba;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
14 Córdoba;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
14 Córdoba;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QII;""
14 Córdoba;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QI;7.892
14 Córdoba;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
14 Córdoba;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
14 Córdoba;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QII;""
14 Córdoba;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QI;""
14 Córdoba;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
14 Córdoba;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
14 Córdoba;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
14 Córdoba;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
14 Córdoba;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
14 Córdoba;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
14 Córdoba;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
14 Córdoba;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
14 Córdoba;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
14 Córdoba;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
14 Córdoba;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
14 Córdoba;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
14 Córdoba;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
14 Córdoba;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
14 Córdoba;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;95,92
14 Córdoba;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
14 Córdoba;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
14 Córdoba;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
14 Córdoba;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;96,99
14 Córdoba;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
14 Córdoba;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
14 Córdoba;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
14 Córdoba;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;97,82
14 Córdoba;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
14 Córdoba;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
14 Córdoba;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;92,58
14 Córdoba;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
14 Córdoba;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
14 Córdoba;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
14 Córdoba;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;93,97
14 Córdoba;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
14 Córdoba;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
14 Córdoba;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
14 Córdoba;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;95,05
14 Córdoba;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
14 Córdoba;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
14 Córdoba;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;89,23
14 Córdoba;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
14 Córdoba;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
14 Córdoba;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
14 Córdoba;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;91,28
14 Córdoba;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
14 Córdoba;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
14 Córdoba;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
14 Córdoba;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;92,25
14 Córdoba;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
14 Córdoba;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
14 Córdoba;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
14 Córdoba;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
14 Córdoba;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
14 Córdoba;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
14 Córdoba;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;88,45
14 Córdoba;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
14 Córdoba;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
14 Córdoba;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
14 Córdoba;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;90,37
14 Córdoba;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
14 Córdoba;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
14 Córdoba;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
14 Córdoba;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
14 Córdoba;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
14 Córdoba;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
14 Córdoba;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QII;5.116
14 Córdoba;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
14 Córdoba;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
14 Córdoba;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
14 Córdoba;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QII;5.265
14 Córdoba;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
14 Córdoba;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
14 Córdoba;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
14 Córdoba;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QII;5.294
14 Córdoba;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
14 Córdoba;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
14 Córdoba;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
14 Córdoba;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2022QII;4.933
14 Córdoba;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2022QI;""
14 Córdoba;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
14 Córdoba;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
14 Córdoba;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2021QII;5.100
14 Córdoba;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2021QI;""
14 Córdoba;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
14 Córdoba;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
14 Córdoba;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2020QII;5.191
14 Córdoba;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2020QI;""
14 Córdoba;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
14 Córdoba;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2022QIII;4.766
14 Córdoba;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2022QII;""
14 Córdoba;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2022QI;""
14 Córdoba;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
14 Córdoba;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2021QIII;4.955
14 Córdoba;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2021QII;""
14 Córdoba;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2021QI;""
14 Córdoba;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
14 Córdoba;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2020QIII;5.063
14 Córdoba;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2020QII;""
14 Córdoba;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2020QI;""
14 Córdoba;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QIV;4.611
14 Córdoba;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
14 Córdoba;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QII;""
14 Córdoba;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QI;""
14 Córdoba;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QIV;4.811
14 Córdoba;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
14 Córdoba;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QII;""
14 Córdoba;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QI;""
14 Córdoba;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QIV;4.919
14 Córdoba;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
14 Córdoba;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QII;""
14 Córdoba;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QI;""
14 Córdoba;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
14 Córdoba;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
14 Córdoba;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QII;""
14 Córdoba;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QI;4.667
14 Córdoba;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
14 Córdoba;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
14 Córdoba;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QII;""
14 Córdoba;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QI;4.827
14 Córdoba;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
14 Córdoba;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
14 Córdoba;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QII;""
14 Córdoba;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QI;""
14 Córdoba;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
14 Córdoba;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
14 Córdoba;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
14 Córdoba;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
14 Córdoba;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
14 Córdoba;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
14 Córdoba;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
14 Córdoba;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
14 Córdoba;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
14 Córdoba;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
14 Córdoba;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
14 Córdoba;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
14 Córdoba;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
14 Córdoba;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
14 Córdoba;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;96,42
14 Córdoba;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
14 Córdoba;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
14 Córdoba;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
14 Córdoba;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;96,87
14 Córdoba;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
14 Córdoba;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
14 Córdoba;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
14 Córdoba;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;98,05
14 Córdoba;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
14 Córdoba;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
14 Córdoba;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;93,16
14 Córdoba;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
14 Córdoba;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
14 Córdoba;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
14 Córdoba;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;94,11
14 Córdoba;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
14 Córdoba;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
14 Córdoba;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
14 Córdoba;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;95,64
14 Córdoba;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
14 Córdoba;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
14 Córdoba;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;90,13
14 Córdoba;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
14 Córdoba;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
14 Córdoba;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
14 Córdoba;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;91,38
14 Córdoba;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
14 Córdoba;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
14 Córdoba;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
14 Córdoba;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;92,92
14 Córdoba;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
14 Córdoba;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
14 Córdoba;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
14 Córdoba;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
14 Córdoba;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
14 Córdoba;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
14 Córdoba;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;88,64
14 Córdoba;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
14 Córdoba;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
14 Córdoba;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
14 Córdoba;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;91,18
14 Córdoba;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
14 Córdoba;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
14 Córdoba;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
14 Córdoba;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
14 Córdoba;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
14 Córdoba;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
14 Córdoba;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QII;3.537
14 Córdoba;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
14 Córdoba;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
14 Córdoba;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
14 Córdoba;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QII;3.494
14 Córdoba;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
14 Córdoba;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
14 Córdoba;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
14 Córdoba;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QII;3.439
14 Córdoba;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
14 Córdoba;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
14 Córdoba;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
14 Córdoba;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2022QII;3.367
14 Córdoba;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2022QI;""
14 Córdoba;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
14 Córdoba;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
14 Córdoba;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2021QII;3.395
14 Córdoba;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2021QI;""
14 Córdoba;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
14 Córdoba;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
14 Córdoba;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2020QII;3.352
14 Córdoba;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2020QI;""
14 Córdoba;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
14 Córdoba;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2022QIII;3.245
14 Córdoba;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2022QII;""
14 Córdoba;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2022QI;""
14 Córdoba;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
14 Córdoba;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2021QIII;3.276
14 Córdoba;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2021QII;""
14 Córdoba;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2021QI;""
14 Córdoba;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
14 Córdoba;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2020QIII;3.238
14 Córdoba;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2020QII;""
14 Córdoba;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2020QI;""
14 Córdoba;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QIV;3.110
14 Córdoba;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
14 Córdoba;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QII;""
14 Córdoba;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QI;""
14 Córdoba;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QIV;3.184
14 Córdoba;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
14 Córdoba;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QII;""
14 Córdoba;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QI;""
14 Córdoba;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QIV;3.137
14 Córdoba;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
14 Córdoba;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QII;""
14 Córdoba;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QI;""
14 Córdoba;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
14 Córdoba;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
14 Córdoba;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QII;""
14 Córdoba;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QI;3.080
14 Córdoba;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
14 Córdoba;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
14 Córdoba;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QII;""
14 Córdoba;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QI;3.065
14 Córdoba;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
14 Córdoba;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
14 Córdoba;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QII;""
14 Córdoba;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QI;""
14 Córdoba;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
14 Córdoba;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
14 Córdoba;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
14 Córdoba;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
14 Córdoba;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
14 Córdoba;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
14 Córdoba;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
14 Córdoba;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
14 Córdoba;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
14 Córdoba;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
14 Córdoba;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
14 Córdoba;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
14 Córdoba;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
14 Córdoba;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
14 Córdoba;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;95,19
14 Córdoba;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
14 Córdoba;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
14 Córdoba;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
14 Córdoba;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;97,17
14 Córdoba;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
14 Córdoba;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
14 Córdoba;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
14 Córdoba;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;97,47
14 Córdoba;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
14 Córdoba;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
14 Córdoba;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;91,74
14 Córdoba;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
14 Córdoba;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
14 Córdoba;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
14 Córdoba;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;93,76
14 Córdoba;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
14 Córdoba;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
14 Córdoba;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
14 Córdoba;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;94,16
14 Córdoba;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
14 Córdoba;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
14 Córdoba;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;87,93
14 Córdoba;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
14 Córdoba;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
14 Córdoba;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
14 Córdoba;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;91,13
14 Córdoba;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
14 Córdoba;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
14 Córdoba;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
14 Córdoba;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;91,22
14 Córdoba;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
14 Córdoba;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
14 Córdoba;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
14 Córdoba;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
14 Córdoba;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
14 Córdoba;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
14 Córdoba;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;88,15
14 Córdoba;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
14 Córdoba;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
14 Córdoba;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
14 Córdoba;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;89,12
14 Córdoba;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
14 Córdoba;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
14 Córdoba;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
14 Córdoba;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
14 Córdoba;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
14 Córdoba;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QIII;8.787
14 Córdoba;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
14 Córdoba;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
14 Córdoba;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
14 Córdoba;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QIII;9.014
14 Córdoba;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
14 Córdoba;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
14 Córdoba;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
14 Córdoba;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QIII;8.945
14 Córdoba;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
14 Córdoba;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
14 Córdoba;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
14 Córdoba;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2022QIII;8.427
14 Córdoba;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2022QII;""
14 Córdoba;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2022QI;""
14 Córdoba;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
14 Córdoba;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2021QIII;8.680
14 Córdoba;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2021QII;""
14 Córdoba;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2021QI;""
14 Córdoba;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
14 Córdoba;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2020QIII;8.651
14 Córdoba;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2020QII;""
14 Córdoba;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2020QI;""
14 Córdoba;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2022QIV;8.092
14 Córdoba;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
14 Córdoba;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2022QII;""
14 Córdoba;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2022QI;""
14 Córdoba;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2021QIV;8.404
14 Córdoba;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
14 Córdoba;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2021QII;""
14 Córdoba;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2021QI;""
14 Córdoba;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2020QIV;8.384
14 Córdoba;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
14 Córdoba;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2020QII;""
14 Córdoba;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2020QI;""
14 Córdoba;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
14 Córdoba;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
14 Córdoba;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QII;""
14 Córdoba;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QI;8.136
14 Córdoba;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
14 Córdoba;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
14 Córdoba;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QII;""
14 Córdoba;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QI;8.207
14 Córdoba;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
14 Córdoba;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
14 Córdoba;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QII;""
14 Córdoba;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QI;""
14 Córdoba;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
14 Córdoba;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
14 Córdoba;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QII;7.880
14 Córdoba;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QI;""
14 Córdoba;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
14 Córdoba;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
14 Córdoba;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QII;8.035
14 Córdoba;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QI;""
14 Córdoba;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
14 Córdoba;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
14 Córdoba;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QII;""
14 Córdoba;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QI;""
14 Córdoba;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
14 Córdoba;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
14 Córdoba;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
14 Córdoba;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
14 Córdoba;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
14 Córdoba;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
14 Córdoba;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
14 Córdoba;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
14 Córdoba;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
14 Córdoba;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
14 Córdoba;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
14 Córdoba;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
14 Córdoba;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
14 Córdoba;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;95,9
14 Córdoba;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
14 Córdoba;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
14 Córdoba;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
14 Córdoba;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;96,29
14 Córdoba;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
14 Córdoba;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
14 Córdoba;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
14 Córdoba;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;96,71
14 Córdoba;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
14 Córdoba;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
14 Córdoba;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;92,09
14 Córdoba;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
14 Córdoba;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
14 Córdoba;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
14 Córdoba;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;93,23
14 Córdoba;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
14 Córdoba;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
14 Córdoba;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
14 Córdoba;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;93,73
14 Córdoba;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
14 Córdoba;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
14 Córdoba;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
14 Córdoba;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
14 Córdoba;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
14 Córdoba;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
14 Córdoba;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;90,26
14 Córdoba;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
14 Córdoba;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
14 Córdoba;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
14 Córdoba;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;91,75
14 Córdoba;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
14 Córdoba;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
14 Córdoba;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
14 Córdoba;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
14 Córdoba;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
14 Córdoba;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
14 Córdoba;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;87,42
14 Córdoba;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
14 Córdoba;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
14 Córdoba;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
14 Córdoba;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;89,83
14 Córdoba;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
14 Córdoba;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
14 Córdoba;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
14 Córdoba;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
14 Córdoba;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
14 Córdoba;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
14 Córdoba;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QIII;5.213
14 Córdoba;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
14 Córdoba;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
14 Córdoba;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
14 Córdoba;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QIII;5.415
14 Córdoba;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
14 Córdoba;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
14 Córdoba;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
14 Córdoba;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QIII;5.441
14 Córdoba;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
14 Córdoba;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
14 Córdoba;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
14 Córdoba;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2022QIII;5.002
14 Córdoba;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2022QII;""
14 Córdoba;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2022QI;""
14 Córdoba;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
14 Córdoba;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2021QIII;5.224
14 Córdoba;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2021QII;""
14 Córdoba;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2021QI;""
14 Córdoba;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
14 Córdoba;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2020QIII;5.276
14 Córdoba;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2020QII;""
14 Córdoba;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2020QI;""
14 Córdoba;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2022QIV;4.820
14 Córdoba;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
14 Córdoba;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2022QII;""
14 Córdoba;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2022QI;""
14 Córdoba;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2021QIV;5.049
14 Córdoba;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
14 Córdoba;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2021QII;""
14 Córdoba;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2021QI;""
14 Córdoba;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2020QIV;5.114
14 Córdoba;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
14 Córdoba;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2020QII;""
14 Córdoba;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2020QI;""
14 Córdoba;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
14 Córdoba;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
14 Córdoba;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QII;""
14 Córdoba;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QI;4.894
14 Córdoba;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
14 Córdoba;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
14 Córdoba;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QII;""
14 Córdoba;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QI;5.013
14 Córdoba;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
14 Córdoba;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
14 Córdoba;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QII;""
14 Córdoba;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QI;""
14 Córdoba;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
14 Córdoba;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
14 Córdoba;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QII;4.766
14 Córdoba;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QI;""
14 Córdoba;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
14 Córdoba;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
14 Córdoba;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QII;4.909
14 Córdoba;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QI;""
14 Córdoba;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
14 Córdoba;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
14 Córdoba;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QII;""
14 Córdoba;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QI;""
14 Córdoba;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
14 Córdoba;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
14 Córdoba;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
14 Córdoba;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
14 Córdoba;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
14 Córdoba;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
14 Córdoba;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
14 Córdoba;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
14 Córdoba;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
14 Córdoba;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
14 Córdoba;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
14 Córdoba;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
14 Córdoba;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
14 Córdoba;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;95,95
14 Córdoba;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
14 Córdoba;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
14 Córdoba;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
14 Córdoba;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;96,47
14 Córdoba;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
14 Córdoba;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
14 Córdoba;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
14 Córdoba;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;96,97
14 Córdoba;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
14 Córdoba;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
14 Córdoba;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;92,46
14 Córdoba;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
14 Córdoba;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
14 Córdoba;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
14 Córdoba;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;93,24
14 Córdoba;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
14 Córdoba;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
14 Córdoba;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
14 Córdoba;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;93,99
14 Córdoba;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
14 Córdoba;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
14 Córdoba;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
14 Córdoba;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
14 Córdoba;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
14 Córdoba;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
14 Córdoba;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;90,38
14 Córdoba;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
14 Córdoba;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
14 Córdoba;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
14 Córdoba;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;92,13
14 Córdoba;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
14 Córdoba;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
14 Córdoba;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
14 Córdoba;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
14 Córdoba;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
14 Córdoba;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
14 Córdoba;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;88,01
14 Córdoba;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
14 Córdoba;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
14 Córdoba;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
14 Córdoba;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;90,22
14 Córdoba;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
14 Córdoba;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
14 Córdoba;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
14 Córdoba;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
14 Córdoba;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
14 Córdoba;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
14 Córdoba;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QIII;3.574
14 Córdoba;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
14 Córdoba;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
14 Córdoba;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
14 Córdoba;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QIII;3.599
14 Córdoba;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
14 Córdoba;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
14 Córdoba;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
14 Córdoba;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QIII;3.504
14 Córdoba;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
14 Córdoba;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
14 Córdoba;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
14 Córdoba;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2022QIII;3.425
14 Córdoba;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2022QII;""
14 Córdoba;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2022QI;""
14 Córdoba;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
14 Córdoba;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2021QIII;3.456
14 Córdoba;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2021QII;""
14 Córdoba;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2021QI;""
14 Córdoba;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
14 Córdoba;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2020QIII;3.375
14 Córdoba;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2020QII;""
14 Córdoba;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2020QI;""
14 Córdoba;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2022QIV;3.272
14 Córdoba;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
14 Córdoba;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2022QII;""
14 Córdoba;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2022QI;""
14 Córdoba;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2021QIV;3.355
14 Córdoba;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
14 Córdoba;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2021QII;""
14 Córdoba;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2021QI;""
14 Córdoba;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2020QIV;3.270
14 Córdoba;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
14 Córdoba;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2020QII;""
14 Córdoba;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2020QI;""
14 Córdoba;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
14 Córdoba;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
14 Córdoba;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QII;""
14 Córdoba;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QI;3.242
14 Córdoba;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
14 Córdoba;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
14 Córdoba;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QII;""
14 Córdoba;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QI;3.194
14 Córdoba;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
14 Córdoba;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
14 Córdoba;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QII;""
14 Córdoba;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QI;""
14 Córdoba;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
14 Córdoba;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
14 Córdoba;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QII;3.114
14 Córdoba;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QI;""
14 Córdoba;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
14 Córdoba;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
14 Córdoba;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QII;3.126
14 Córdoba;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QI;""
14 Córdoba;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
14 Córdoba;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
14 Córdoba;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QII;""
14 Córdoba;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QI;""
14 Córdoba;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
14 Córdoba;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
14 Córdoba;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
14 Córdoba;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
14 Córdoba;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
14 Córdoba;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
14 Córdoba;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
14 Córdoba;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
14 Córdoba;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
14 Córdoba;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
14 Córdoba;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
14 Córdoba;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
14 Córdoba;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
14 Córdoba;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;95,83
14 Córdoba;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
14 Córdoba;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
14 Córdoba;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
14 Córdoba;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;96,03
14 Córdoba;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
14 Córdoba;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
14 Córdoba;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
14 Córdoba;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;96,32
14 Córdoba;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
14 Córdoba;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
14 Córdoba;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;91,55
14 Córdoba;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
14 Córdoba;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
14 Córdoba;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
14 Córdoba;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;93,22
14 Córdoba;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
14 Córdoba;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
14 Córdoba;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
14 Córdoba;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;93,32
14 Córdoba;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
14 Córdoba;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
14 Córdoba;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
14 Córdoba;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
14 Córdoba;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
14 Córdoba;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
14 Córdoba;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;90,08
14 Córdoba;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
14 Córdoba;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
14 Córdoba;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
14 Córdoba;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;91,15
14 Córdoba;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
14 Córdoba;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
14 Córdoba;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
14 Córdoba;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
14 Córdoba;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
14 Córdoba;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
14 Córdoba;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;86,52
14 Córdoba;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
14 Córdoba;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
14 Córdoba;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
14 Córdoba;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;89,21
14 Córdoba;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
14 Córdoba;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
14 Córdoba;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
14 Córdoba;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
14 Córdoba;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
14 Córdoba;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QIV;8.805
14 Córdoba;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
14 Córdoba;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
14 Córdoba;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
14 Córdoba;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QIV;9.046
14 Córdoba;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
14 Córdoba;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
14 Córdoba;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
14 Córdoba;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QIV;9.075
14 Córdoba;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
14 Córdoba;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
14 Córdoba;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
14 Córdoba;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2022QIV;8.433
14 Córdoba;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
14 Córdoba;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2022QII;""
14 Córdoba;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2022QI;""
14 Córdoba;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2021QIV;8.727
14 Córdoba;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
14 Córdoba;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2021QII;""
14 Córdoba;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2021QI;""
14 Córdoba;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2020QIV;8.773
14 Córdoba;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
14 Córdoba;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2020QII;""
14 Córdoba;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2020QI;""
14 Córdoba;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
14 Córdoba;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
14 Córdoba;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2022QII;""
14 Córdoba;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2022QI;8.439
14 Córdoba;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
14 Córdoba;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
14 Córdoba;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2021QII;""
14 Córdoba;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2021QI;8.563
14 Córdoba;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
14 Córdoba;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
14 Córdoba;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2020QII;""
14 Córdoba;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2020QI;""
14 Córdoba;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
14 Córdoba;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
14 Córdoba;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QII;8.158
14 Córdoba;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QI;""
14 Córdoba;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
14 Córdoba;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
14 Córdoba;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QII;8.365
14 Córdoba;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QI;""
14 Córdoba;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
14 Córdoba;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
14 Córdoba;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QII;""
14 Córdoba;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QI;""
14 Córdoba;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
14 Córdoba;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QIII;7.910
14 Córdoba;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QII;""
14 Córdoba;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QI;""
14 Córdoba;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
14 Córdoba;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QIII;8.161
14 Córdoba;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QII;""
14 Córdoba;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QI;""
14 Córdoba;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
14 Córdoba;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
14 Córdoba;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QII;""
14 Córdoba;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QI;""
14 Córdoba;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
14 Córdoba;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
14 Córdoba;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
14 Córdoba;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
14 Córdoba;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
14 Córdoba;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
14 Córdoba;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
14 Córdoba;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
14 Córdoba;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
14 Córdoba;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
14 Córdoba;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
14 Córdoba;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
14 Córdoba;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;95,78
14 Córdoba;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
14 Córdoba;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
14 Córdoba;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
14 Córdoba;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;96,47
14 Córdoba;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
14 Córdoba;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
14 Córdoba;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
14 Córdoba;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;96,67
14 Córdoba;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
14 Córdoba;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
14 Córdoba;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
14 Córdoba;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
14 Córdoba;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
14 Córdoba;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
14 Córdoba;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;93,29
14 Córdoba;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
14 Córdoba;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
14 Córdoba;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
14 Córdoba;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;94,36
14 Córdoba;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
14 Córdoba;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
14 Córdoba;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
14 Córdoba;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
14 Córdoba;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
14 Córdoba;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
14 Córdoba;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;90,18
14 Córdoba;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
14 Córdoba;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
14 Córdoba;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
14 Córdoba;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;92,18
14 Córdoba;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
14 Córdoba;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
14 Córdoba;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
14 Córdoba;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
14 Córdoba;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
14 Córdoba;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
14 Córdoba;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;87,44
14 Córdoba;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
14 Córdoba;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
14 Córdoba;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
14 Córdoba;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;89,93
14 Córdoba;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
14 Córdoba;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
14 Córdoba;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
14 Córdoba;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
14 Córdoba;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
14 Córdoba;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
14 Córdoba;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QIV;5.234
14 Córdoba;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
14 Córdoba;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
14 Córdoba;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
14 Córdoba;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QIV;5.428
14 Córdoba;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
14 Córdoba;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
14 Córdoba;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
14 Córdoba;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QIV;5.518
14 Córdoba;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
14 Córdoba;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
14 Córdoba;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
14 Córdoba;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2022QIV;5.023
14 Córdoba;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
14 Córdoba;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2022QII;""
14 Córdoba;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2022QI;""
14 Córdoba;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2021QIV;5.223
14 Córdoba;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
14 Córdoba;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2021QII;""
14 Córdoba;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2021QI;""
14 Córdoba;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2020QIV;5.336
14 Córdoba;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
14 Córdoba;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2020QII;""
14 Córdoba;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2020QI;""
14 Córdoba;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
14 Córdoba;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
14 Córdoba;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2022QII;""
14 Córdoba;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2022QI;5.056
14 Córdoba;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
14 Córdoba;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
14 Córdoba;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2021QII;""
14 Córdoba;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2021QI;5.217
14 Córdoba;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
14 Córdoba;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
14 Córdoba;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2020QII;""
14 Córdoba;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2020QI;""
14 Córdoba;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
14 Córdoba;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
14 Córdoba;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QII;4.914
14 Córdoba;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QI;""
14 Córdoba;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
14 Córdoba;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
14 Córdoba;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QII;5.096
14 Córdoba;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QI;""
14 Córdoba;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
14 Córdoba;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
14 Córdoba;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QII;""
14 Córdoba;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QI;""
14 Córdoba;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
14 Córdoba;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QIII;4.775
14 Córdoba;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QII;""
14 Córdoba;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QI;""
14 Córdoba;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
14 Córdoba;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QIII;4.985
14 Córdoba;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QII;""
14 Córdoba;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QI;""
14 Córdoba;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
14 Córdoba;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
14 Córdoba;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QII;""
14 Córdoba;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QI;""
14 Córdoba;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
14 Córdoba;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
14 Córdoba;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
14 Córdoba;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
14 Córdoba;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
14 Córdoba;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
14 Córdoba;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
14 Córdoba;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
14 Córdoba;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
14 Córdoba;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
14 Córdoba;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
14 Córdoba;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
14 Córdoba;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;95,97
14 Córdoba;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
14 Córdoba;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
14 Córdoba;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
14 Córdoba;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;96,22
14 Córdoba;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
14 Córdoba;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
14 Córdoba;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
14 Córdoba;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;96,7
14 Córdoba;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
14 Córdoba;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
14 Córdoba;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
14 Córdoba;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
14 Córdoba;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
14 Córdoba;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
14 Córdoba;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;93,15
14 Córdoba;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
14 Córdoba;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
14 Córdoba;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
14 Córdoba;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;94,55
14 Córdoba;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
14 Córdoba;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
14 Córdoba;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
14 Córdoba;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
14 Córdoba;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
14 Córdoba;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
14 Córdoba;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;90,53
14 Córdoba;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
14 Córdoba;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
14 Córdoba;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
14 Córdoba;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;92,35
14 Córdoba;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
14 Córdoba;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
14 Córdoba;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
14 Córdoba;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
14 Córdoba;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
14 Córdoba;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
14 Córdoba;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;87,97
14 Córdoba;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
14 Córdoba;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
14 Córdoba;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
14 Córdoba;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;90,34
14 Córdoba;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
14 Córdoba;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
14 Córdoba;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
14 Córdoba;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
14 Córdoba;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
14 Córdoba;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
14 Córdoba;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QIV;3.571
14 Córdoba;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
14 Córdoba;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
14 Córdoba;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
14 Córdoba;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QIV;3.618
14 Córdoba;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
14 Córdoba;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
14 Córdoba;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
14 Córdoba;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QIV;3.557
14 Córdoba;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
14 Córdoba;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
14 Córdoba;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
14 Córdoba;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2022QIV;3.410
14 Córdoba;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
14 Córdoba;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2022QII;""
14 Córdoba;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2022QI;""
14 Córdoba;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2021QIV;3.504
14 Córdoba;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
14 Córdoba;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2021QII;""
14 Córdoba;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2021QI;""
14 Córdoba;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2020QIV;3.437
14 Córdoba;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
14 Córdoba;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2020QII;""
14 Córdoba;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2020QI;""
14 Córdoba;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
14 Córdoba;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
14 Córdoba;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2022QII;""
14 Córdoba;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2022QI;3.383
14 Córdoba;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
14 Córdoba;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
14 Córdoba;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2021QII;""
14 Córdoba;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2021QI;3.346
14 Córdoba;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
14 Córdoba;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
14 Córdoba;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2020QII;""
14 Córdoba;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2020QI;""
14 Córdoba;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
14 Córdoba;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
14 Córdoba;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QII;3.244
14 Córdoba;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QI;""
14 Córdoba;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
14 Córdoba;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
14 Córdoba;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QII;3.269
14 Córdoba;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QI;""
14 Córdoba;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
14 Córdoba;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
14 Córdoba;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QII;""
14 Córdoba;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QI;""
14 Córdoba;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
14 Córdoba;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QIII;3.135
14 Córdoba;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QII;""
14 Córdoba;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QI;""
14 Córdoba;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
14 Córdoba;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QIII;3.176
14 Córdoba;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QII;""
14 Córdoba;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QI;""
14 Córdoba;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
14 Córdoba;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
14 Córdoba;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QII;""
14 Córdoba;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QI;""
14 Córdoba;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
14 Córdoba;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
14 Córdoba;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
14 Córdoba;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
14 Córdoba;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
14 Córdoba;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
14 Córdoba;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
14 Córdoba;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
14 Córdoba;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
14 Córdoba;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
14 Córdoba;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
14 Córdoba;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
14 Córdoba;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;95,49
14 Córdoba;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
14 Córdoba;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
14 Córdoba;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
14 Córdoba;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;96,85
14 Córdoba;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
14 Córdoba;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
14 Córdoba;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
14 Córdoba;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;96,63
14 Córdoba;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
14 Córdoba;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
14 Córdoba;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
14 Córdoba;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
14 Córdoba;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
14 Córdoba;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
14 Córdoba;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;93,5
14 Córdoba;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
14 Córdoba;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
14 Córdoba;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
14 Córdoba;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;94,07
14 Córdoba;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
14 Córdoba;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
14 Córdoba;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
14 Córdoba;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
14 Córdoba;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
14 Córdoba;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
14 Córdoba;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;89,66
14 Córdoba;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
14 Córdoba;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
14 Córdoba;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
14 Córdoba;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;91,9
14 Córdoba;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
14 Córdoba;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
14 Córdoba;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
14 Córdoba;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
14 Córdoba;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
14 Córdoba;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
14 Córdoba;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;86,65
14 Córdoba;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
14 Córdoba;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
14 Córdoba;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
14 Córdoba;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;89,29
14 Córdoba;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
14 Córdoba;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
14 Córdoba;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
14 Córdoba;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
14 Córdoba;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
14 Córdoba;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
14 Córdoba;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
14 Córdoba;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
14 Córdoba;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
14 Córdoba;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QI;14.157
14 Córdoba;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
14 Córdoba;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
14 Córdoba;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
14 Córdoba;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QI;14.107
14 Córdoba;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
14 Córdoba;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
14 Córdoba;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
14 Córdoba;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QI;14.109
14 Córdoba;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
14 Córdoba;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
14 Córdoba;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2022QII;""
14 Córdoba;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2022QI;13.827
14 Córdoba;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
14 Córdoba;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
14 Córdoba;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2021QII;""
14 Córdoba;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2021QI;13.860
14 Córdoba;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
14 Córdoba;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
14 Córdoba;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2020QII;""
14 Córdoba;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2020QI;13.260
14 Córdoba;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
14 Córdoba;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
14 Córdoba;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2022QII;13.485
14 Córdoba;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2022QI;""
14 Córdoba;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
14 Córdoba;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
14 Córdoba;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2021QII;13.589
14 Córdoba;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2021QI;""
14 Córdoba;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
14 Córdoba;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
14 Córdoba;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2020QII;13.071
14 Córdoba;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2020QI;""
14 Córdoba;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
14 Córdoba;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QIII;13.209
14 Córdoba;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QII;""
14 Córdoba;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QI;""
14 Córdoba;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
14 Córdoba;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QIII;13.366
14 Córdoba;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QII;""
14 Córdoba;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QI;""
14 Córdoba;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
14 Córdoba;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QIII;12.824
14 Córdoba;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QII;""
14 Córdoba;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QI;""
14 Córdoba;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QIV;12.909
14 Córdoba;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
14 Córdoba;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QII;""
14 Córdoba;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QI;""
14 Córdoba;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QIV;13.132
14 Córdoba;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
14 Córdoba;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QII;""
14 Córdoba;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QI;""
14 Córdoba;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QIV;12.608
14 Córdoba;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
14 Córdoba;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QII;""
14 Córdoba;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QI;""
14 Córdoba;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
14 Córdoba;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
14 Córdoba;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
14 Córdoba;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
14 Córdoba;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
14 Córdoba;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
14 Córdoba;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
14 Córdoba;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
14 Córdoba;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
14 Córdoba;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
14 Córdoba;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
14 Córdoba;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
14 Córdoba;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
14 Córdoba;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
14 Córdoba;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
14 Córdoba;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;97,67
14 Córdoba;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
14 Córdoba;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
14 Córdoba;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
14 Córdoba;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;98,25
14 Córdoba;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
14 Córdoba;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
14 Córdoba;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
14 Córdoba;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;93,98
14 Córdoba;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
14 Córdoba;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
14 Córdoba;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;95,25
14 Córdoba;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
14 Córdoba;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
14 Córdoba;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
14 Córdoba;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;96,33
14 Córdoba;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
14 Córdoba;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
14 Córdoba;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
14 Córdoba;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;92,64
14 Córdoba;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
14 Córdoba;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
14 Córdoba;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;93,3
14 Córdoba;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
14 Córdoba;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
14 Córdoba;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
14 Córdoba;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;94,75
14 Córdoba;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
14 Córdoba;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
14 Córdoba;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
14 Córdoba;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;90,89
14 Córdoba;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
14 Córdoba;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
14 Córdoba;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;91,18
14 Córdoba;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
14 Córdoba;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
14 Córdoba;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
14 Córdoba;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;93,09
14 Córdoba;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
14 Córdoba;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
14 Córdoba;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
14 Córdoba;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;89,36
14 Córdoba;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
14 Córdoba;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
14 Córdoba;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
14 Córdoba;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
14 Córdoba;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
14 Córdoba;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
14 Córdoba;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QI;9.327
14 Córdoba;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
14 Córdoba;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
14 Córdoba;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
14 Córdoba;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QI;9.332
14 Córdoba;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
14 Córdoba;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
14 Córdoba;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
14 Córdoba;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QI;9.331
14 Córdoba;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
14 Córdoba;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
14 Córdoba;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2022QII;""
14 Córdoba;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2022QI;9.123
14 Córdoba;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
14 Córdoba;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
14 Córdoba;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2021QII;""
14 Córdoba;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2021QI;9.180
14 Córdoba;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
14 Córdoba;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
14 Córdoba;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2020QII;""
14 Córdoba;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2020QI;8.814
14 Córdoba;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
14 Córdoba;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
14 Córdoba;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2022QII;8.928
14 Córdoba;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2022QI;""
14 Córdoba;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
14 Córdoba;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
14 Córdoba;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2021QII;9.021
14 Córdoba;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2021QI;""
14 Córdoba;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
14 Córdoba;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
14 Córdoba;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2020QII;8.704
14 Córdoba;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2020QI;""
14 Córdoba;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
14 Córdoba;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QIII;8.786
14 Córdoba;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QII;""
14 Córdoba;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QI;""
14 Córdoba;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
14 Córdoba;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QIII;8.898
14 Córdoba;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QII;""
14 Córdoba;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QI;""
14 Córdoba;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
14 Córdoba;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QIII;8.560
14 Córdoba;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QII;""
14 Córdoba;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QI;""
14 Córdoba;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QIV;8.612
14 Córdoba;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
14 Córdoba;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QII;""
14 Córdoba;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QI;""
14 Córdoba;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QIV;8.756
14 Córdoba;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
14 Córdoba;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QII;""
14 Córdoba;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QI;""
14 Córdoba;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QIV;8.428
14 Córdoba;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
14 Córdoba;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QII;""
14 Córdoba;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QI;""
14 Córdoba;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
14 Córdoba;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
14 Córdoba;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
14 Córdoba;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
14 Córdoba;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
14 Córdoba;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
14 Córdoba;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
14 Córdoba;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
14 Córdoba;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
14 Córdoba;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
14 Córdoba;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
14 Córdoba;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
14 Córdoba;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
14 Córdoba;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
14 Córdoba;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
14 Córdoba;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;97,81
14 Córdoba;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
14 Córdoba;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
14 Córdoba;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
14 Córdoba;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;98,37
14 Córdoba;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
14 Córdoba;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
14 Córdoba;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
14 Córdoba;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;94,46
14 Córdoba;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
14 Córdoba;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
14 Córdoba;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;95,72
14 Córdoba;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
14 Córdoba;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
14 Córdoba;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
14 Córdoba;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;96,67
14 Córdoba;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
14 Córdoba;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
14 Córdoba;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
14 Córdoba;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;93,28
14 Córdoba;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
14 Córdoba;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
14 Córdoba;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;94,2
14 Córdoba;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
14 Córdoba;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
14 Córdoba;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
14 Córdoba;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;95,35
14 Córdoba;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
14 Córdoba;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
14 Córdoba;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
14 Córdoba;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;91,74
14 Córdoba;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
14 Córdoba;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
14 Córdoba;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;92,33
14 Córdoba;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
14 Córdoba;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
14 Córdoba;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
14 Córdoba;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;93,83
14 Córdoba;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
14 Córdoba;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
14 Córdoba;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
14 Córdoba;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;90,32
14 Córdoba;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
14 Córdoba;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
14 Córdoba;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
14 Córdoba;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
14 Córdoba;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
14 Córdoba;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
14 Córdoba;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QI;4.830
14 Córdoba;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
14 Córdoba;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
14 Córdoba;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
14 Córdoba;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QI;4.775
14 Córdoba;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
14 Córdoba;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
14 Córdoba;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
14 Córdoba;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QI;4.778
14 Córdoba;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
14 Córdoba;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
14 Córdoba;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2022QII;""
14 Córdoba;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2022QI;4.704
14 Córdoba;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
14 Córdoba;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
14 Córdoba;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2021QII;""
14 Córdoba;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2021QI;4.680
14 Córdoba;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
14 Córdoba;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
14 Córdoba;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2020QII;""
14 Córdoba;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2020QI;4.446
14 Córdoba;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
14 Córdoba;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
14 Córdoba;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2022QII;4.557
14 Córdoba;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2022QI;""
14 Córdoba;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
14 Córdoba;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
14 Córdoba;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2021QII;4.568
14 Córdoba;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2021QI;""
14 Córdoba;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
14 Córdoba;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
14 Córdoba;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2020QII;4.367
14 Córdoba;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2020QI;""
14 Córdoba;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
14 Córdoba;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QIII;4.423
14 Córdoba;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QII;""
14 Córdoba;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QI;""
14 Córdoba;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
14 Córdoba;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QIII;4.468
14 Córdoba;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QII;""
14 Córdoba;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QI;""
14 Córdoba;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
14 Córdoba;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QIII;4.264
14 Córdoba;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QII;""
14 Córdoba;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QI;""
14 Córdoba;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QIV;4.297
14 Córdoba;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
14 Córdoba;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QII;""
14 Córdoba;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QI;""
14 Córdoba;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QIV;4.376
14 Córdoba;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
14 Córdoba;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QII;""
14 Córdoba;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QI;""
14 Córdoba;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QIV;4.180
14 Córdoba;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
14 Córdoba;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QII;""
14 Córdoba;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QI;""
14 Córdoba;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
14 Córdoba;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
14 Córdoba;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
14 Córdoba;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
14 Córdoba;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
14 Córdoba;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
14 Córdoba;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
14 Córdoba;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
14 Córdoba;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
14 Córdoba;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
14 Córdoba;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
14 Córdoba;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
14 Córdoba;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
14 Córdoba;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
14 Córdoba;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
14 Córdoba;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;97,39
14 Córdoba;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
14 Córdoba;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
14 Córdoba;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
14 Córdoba;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;98,01
14 Córdoba;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
14 Córdoba;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
14 Córdoba;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
14 Córdoba;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;93,05
14 Córdoba;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
14 Córdoba;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
14 Córdoba;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;94,35
14 Córdoba;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
14 Córdoba;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
14 Córdoba;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
14 Córdoba;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;95,66
14 Córdoba;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
14 Córdoba;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
14 Córdoba;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
14 Córdoba;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;91,4
14 Córdoba;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
14 Córdoba;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
14 Córdoba;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;91,57
14 Córdoba;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
14 Córdoba;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
14 Córdoba;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
14 Córdoba;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;93,57
14 Córdoba;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
14 Córdoba;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
14 Córdoba;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
14 Córdoba;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;89,24
14 Córdoba;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
14 Córdoba;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
14 Córdoba;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;88,96
14 Córdoba;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
14 Córdoba;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
14 Córdoba;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
14 Córdoba;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;91,64
14 Córdoba;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
14 Córdoba;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
14 Córdoba;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
14 Córdoba;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;87,48
14 Córdoba;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
14 Córdoba;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
14 Córdoba;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
14 Córdoba;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
14 Córdoba;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
14 Córdoba;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QII;13.851
14 Córdoba;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
14 Córdoba;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
14 Córdoba;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
14 Córdoba;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QII;13.985
14 Córdoba;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
14 Córdoba;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
14 Córdoba;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
14 Córdoba;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QII;13.754
14 Córdoba;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
14 Córdoba;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
14 Córdoba;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
14 Córdoba;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2022QII;13.470
14 Córdoba;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2022QI;""
14 Córdoba;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
14 Córdoba;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
14 Córdoba;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2021QII;13.665
14 Córdoba;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2021QI;""
14 Córdoba;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
14 Córdoba;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
14 Córdoba;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2020QII;13.542
14 Córdoba;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2020QI;""
14 Córdoba;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
14 Córdoba;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2022QIII;13.154
14 Córdoba;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2022QII;""
14 Córdoba;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2022QI;""
14 Córdoba;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
14 Córdoba;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2021QIII;13.408
14 Córdoba;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2021QII;""
14 Córdoba;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2021QI;""
14 Córdoba;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
14 Córdoba;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2020QIII;13.262
14 Córdoba;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2020QII;""
14 Córdoba;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2020QI;""
14 Córdoba;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QIV;12.830
14 Córdoba;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
14 Córdoba;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QII;""
14 Córdoba;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QI;""
14 Córdoba;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QIV;13.149
14 Córdoba;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
14 Córdoba;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QII;""
14 Córdoba;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QI;""
14 Córdoba;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QIV;13.018
14 Córdoba;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
14 Córdoba;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QII;""
14 Córdoba;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QI;""
14 Córdoba;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
14 Córdoba;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
14 Córdoba;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QII;""
14 Córdoba;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QI;12.902
14 Córdoba;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
14 Córdoba;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
14 Córdoba;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QII;""
14 Córdoba;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QI;12.840
14 Córdoba;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
14 Córdoba;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
14 Córdoba;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QII;""
14 Córdoba;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QI;""
14 Córdoba;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
14 Córdoba;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
14 Córdoba;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
14 Córdoba;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
14 Córdoba;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
14 Córdoba;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
14 Córdoba;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
14 Córdoba;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
14 Córdoba;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
14 Córdoba;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
14 Córdoba;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
14 Córdoba;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
14 Córdoba;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
14 Córdoba;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
14 Córdoba;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;97,25
14 Córdoba;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
14 Córdoba;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
14 Córdoba;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
14 Córdoba;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;97,71
14 Córdoba;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
14 Córdoba;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
14 Córdoba;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
14 Córdoba;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;98,46
14 Córdoba;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
14 Córdoba;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
14 Córdoba;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;94,97
14 Córdoba;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
14 Córdoba;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
14 Córdoba;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
14 Córdoba;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;95,87
14 Córdoba;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
14 Córdoba;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
14 Córdoba;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
14 Córdoba;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;96,42
14 Córdoba;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
14 Córdoba;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
14 Córdoba;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;92,63
14 Córdoba;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
14 Córdoba;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
14 Córdoba;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
14 Córdoba;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;94,02
14 Córdoba;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
14 Córdoba;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
14 Córdoba;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
14 Córdoba;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;94,65
14 Córdoba;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
14 Córdoba;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
14 Córdoba;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
14 Córdoba;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
14 Córdoba;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
14 Córdoba;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
14 Córdoba;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;92,26
14 Córdoba;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
14 Córdoba;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
14 Córdoba;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
14 Córdoba;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;93,35
14 Córdoba;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
14 Córdoba;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
14 Córdoba;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
14 Córdoba;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
14 Córdoba;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
14 Córdoba;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
14 Córdoba;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QII;9.042
14 Córdoba;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
14 Córdoba;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
14 Córdoba;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
14 Córdoba;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QII;9.221
14 Córdoba;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
14 Córdoba;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
14 Córdoba;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
14 Córdoba;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QII;9.097
14 Córdoba;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
14 Córdoba;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
14 Córdoba;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
14 Córdoba;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2022QII;8.835
14 Córdoba;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2022QI;""
14 Córdoba;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
14 Córdoba;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
14 Córdoba;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2021QII;9.030
14 Córdoba;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2021QI;""
14 Córdoba;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
14 Córdoba;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
14 Córdoba;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2020QII;8.975
14 Córdoba;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2020QI;""
14 Córdoba;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
14 Córdoba;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2022QIII;8.669
14 Córdoba;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2022QII;""
14 Córdoba;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2022QI;""
14 Córdoba;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
14 Córdoba;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2021QIII;8.887
14 Córdoba;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2021QII;""
14 Córdoba;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2021QI;""
14 Córdoba;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
14 Córdoba;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2020QIII;8.809
14 Córdoba;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2020QII;""
14 Córdoba;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2020QI;""
14 Córdoba;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QIV;8.476
14 Córdoba;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
14 Córdoba;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QII;""
14 Córdoba;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QI;""
14 Córdoba;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QIV;8.730
14 Córdoba;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
14 Córdoba;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QII;""
14 Córdoba;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QI;""
14 Córdoba;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QIV;8.662
14 Córdoba;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
14 Córdoba;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QII;""
14 Córdoba;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QI;""
14 Córdoba;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
14 Córdoba;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
14 Córdoba;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QII;""
14 Córdoba;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QI;8.581
14 Córdoba;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
14 Córdoba;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
14 Córdoba;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QII;""
14 Córdoba;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QI;8.552
14 Córdoba;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
14 Córdoba;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
14 Córdoba;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QII;""
14 Córdoba;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QI;""
14 Córdoba;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
14 Córdoba;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
14 Córdoba;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
14 Córdoba;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
14 Córdoba;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
14 Córdoba;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
14 Córdoba;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
14 Córdoba;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
14 Córdoba;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
14 Córdoba;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
14 Córdoba;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
14 Córdoba;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
14 Córdoba;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
14 Córdoba;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
14 Córdoba;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;97,71
14 Córdoba;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
14 Córdoba;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
14 Córdoba;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
14 Córdoba;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;97,93
14 Córdoba;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
14 Córdoba;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
14 Córdoba;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
14 Córdoba;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;98,66
14 Córdoba;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
14 Córdoba;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
14 Córdoba;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;95,87
14 Córdoba;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
14 Córdoba;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
14 Córdoba;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
14 Córdoba;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;96,38
14 Córdoba;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
14 Córdoba;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
14 Córdoba;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
14 Córdoba;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;96,83
14 Córdoba;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
14 Córdoba;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
14 Córdoba;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;93,74
14 Córdoba;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
14 Córdoba;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
14 Córdoba;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
14 Córdoba;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;94,68
14 Córdoba;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
14 Córdoba;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
14 Córdoba;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
14 Córdoba;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;95,22
14 Córdoba;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
14 Córdoba;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
14 Córdoba;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
14 Córdoba;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
14 Córdoba;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
14 Córdoba;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
14 Córdoba;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;93,06
14 Córdoba;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
14 Córdoba;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
14 Córdoba;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
14 Córdoba;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;94,01
14 Córdoba;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
14 Córdoba;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
14 Córdoba;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
14 Córdoba;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
14 Córdoba;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
14 Córdoba;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
14 Córdoba;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QII;4.809
14 Córdoba;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
14 Córdoba;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
14 Córdoba;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
14 Córdoba;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QII;4.764
14 Córdoba;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
14 Córdoba;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
14 Córdoba;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
14 Córdoba;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QII;4.657
14 Córdoba;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
14 Córdoba;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
14 Córdoba;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
14 Córdoba;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2022QII;4.635
14 Córdoba;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2022QI;""
14 Córdoba;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
14 Córdoba;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
14 Córdoba;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2021QII;4.635
14 Córdoba;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2021QI;""
14 Córdoba;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
14 Córdoba;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
14 Córdoba;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2020QII;4.567
14 Córdoba;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2020QI;""
14 Córdoba;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
14 Córdoba;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2022QIII;4.485
14 Córdoba;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2022QII;""
14 Córdoba;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2022QI;""
14 Córdoba;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
14 Córdoba;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2021QIII;4.521
14 Córdoba;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2021QII;""
14 Córdoba;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2021QI;""
14 Córdoba;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
14 Córdoba;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2020QIII;4.453
14 Córdoba;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2020QII;""
14 Córdoba;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2020QI;""
14 Córdoba;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QIV;4.354
14 Córdoba;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
14 Córdoba;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QII;""
14 Córdoba;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QI;""
14 Córdoba;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QIV;4.419
14 Córdoba;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
14 Córdoba;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QII;""
14 Córdoba;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QI;""
14 Córdoba;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QIV;4.356
14 Córdoba;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
14 Córdoba;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QII;""
14 Córdoba;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QI;""
14 Córdoba;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
14 Córdoba;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
14 Córdoba;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QII;""
14 Córdoba;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QI;4.321
14 Córdoba;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
14 Córdoba;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
14 Córdoba;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QII;""
14 Córdoba;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QI;4.288
14 Córdoba;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
14 Córdoba;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
14 Córdoba;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QII;""
14 Córdoba;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QI;""
14 Córdoba;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
14 Córdoba;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
14 Córdoba;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
14 Córdoba;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
14 Córdoba;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
14 Córdoba;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
14 Córdoba;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
14 Córdoba;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
14 Córdoba;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
14 Córdoba;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
14 Córdoba;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
14 Córdoba;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
14 Córdoba;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
14 Córdoba;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
14 Córdoba;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;96,38
14 Córdoba;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
14 Córdoba;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
14 Córdoba;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
14 Córdoba;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;97,29
14 Córdoba;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
14 Córdoba;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
14 Córdoba;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
14 Córdoba;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;98,07
14 Córdoba;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
14 Córdoba;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
14 Córdoba;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;93,26
14 Córdoba;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
14 Córdoba;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
14 Córdoba;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
14 Córdoba;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;94,9
14 Córdoba;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
14 Córdoba;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
14 Córdoba;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
14 Córdoba;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;95,62
14 Córdoba;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
14 Córdoba;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
14 Córdoba;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;90,54
14 Córdoba;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
14 Córdoba;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
14 Córdoba;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
14 Córdoba;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;92,76
14 Córdoba;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
14 Córdoba;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
14 Córdoba;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
14 Córdoba;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;93,54
14 Córdoba;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
14 Córdoba;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
14 Córdoba;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
14 Córdoba;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
14 Córdoba;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
14 Córdoba;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
14 Córdoba;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;90,7
14 Córdoba;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
14 Córdoba;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
14 Córdoba;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
14 Córdoba;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;92,08
14 Córdoba;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
14 Córdoba;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
14 Córdoba;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
14 Córdoba;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
14 Córdoba;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
14 Córdoba;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QIII;13.883
14 Córdoba;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
14 Córdoba;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
14 Córdoba;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
14 Córdoba;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QIII;14.153
14 Córdoba;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
14 Córdoba;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
14 Córdoba;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
14 Córdoba;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QIII;14.016
14 Córdoba;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
14 Córdoba;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
14 Córdoba;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
14 Córdoba;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2022QIII;13.499
14 Córdoba;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2022QII;""
14 Córdoba;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2022QI;""
14 Córdoba;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
14 Córdoba;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2021QIII;13.837
14 Córdoba;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2021QII;""
14 Córdoba;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2021QI;""
14 Córdoba;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
14 Córdoba;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2020QIII;13.681
14 Córdoba;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2020QII;""
14 Córdoba;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2020QI;""
14 Córdoba;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2022QIV;13.122
14 Córdoba;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
14 Córdoba;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2022QII;""
14 Córdoba;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2022QI;""
14 Córdoba;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2021QIV;13.496
14 Córdoba;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
14 Córdoba;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2021QII;""
14 Córdoba;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2021QI;""
14 Córdoba;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2020QIV;13.391
14 Córdoba;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
14 Córdoba;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2020QII;""
14 Córdoba;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2020QI;""
14 Córdoba;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
14 Córdoba;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
14 Córdoba;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QII;""
14 Córdoba;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QI;13.225
14 Córdoba;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
14 Córdoba;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
14 Córdoba;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QII;""
14 Córdoba;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QI;13.199
14 Córdoba;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
14 Córdoba;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
14 Córdoba;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QII;""
14 Córdoba;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QI;""
14 Córdoba;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
14 Córdoba;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
14 Córdoba;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QII;12.931
14 Córdoba;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QI;""
14 Córdoba;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
14 Córdoba;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
14 Córdoba;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QII;12.989
14 Córdoba;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QI;""
14 Córdoba;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
14 Córdoba;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
14 Córdoba;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QII;""
14 Córdoba;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QI;""
14 Córdoba;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
14 Córdoba;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
14 Córdoba;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
14 Córdoba;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
14 Córdoba;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
14 Córdoba;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
14 Córdoba;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
14 Córdoba;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
14 Córdoba;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
14 Córdoba;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
14 Córdoba;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
14 Córdoba;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
14 Córdoba;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
14 Córdoba;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;97,23
14 Córdoba;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
14 Córdoba;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
14 Córdoba;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
14 Córdoba;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;97,77
14 Córdoba;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
14 Córdoba;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
14 Córdoba;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
14 Córdoba;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;97,61
14 Córdoba;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
14 Córdoba;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
14 Córdoba;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;94,52
14 Córdoba;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
14 Córdoba;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
14 Córdoba;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
14 Córdoba;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;95,36
14 Córdoba;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
14 Córdoba;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
14 Córdoba;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
14 Córdoba;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;95,54
14 Córdoba;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
14 Córdoba;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
14 Córdoba;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
14 Córdoba;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
14 Córdoba;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
14 Córdoba;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
14 Córdoba;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;93,44
14 Córdoba;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
14 Córdoba;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
14 Córdoba;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
14 Córdoba;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;94,17
14 Córdoba;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
14 Córdoba;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
14 Córdoba;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
14 Córdoba;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
14 Córdoba;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
14 Córdoba;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
14 Córdoba;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;91,37
14 Córdoba;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
14 Córdoba;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
14 Córdoba;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
14 Córdoba;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;92,67
14 Córdoba;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
14 Córdoba;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
14 Córdoba;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
14 Córdoba;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
14 Córdoba;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
14 Córdoba;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
14 Córdoba;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QIII;9.086
14 Córdoba;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
14 Córdoba;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
14 Córdoba;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
14 Córdoba;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QIII;9.350
14 Córdoba;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
14 Córdoba;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
14 Córdoba;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
14 Córdoba;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QIII;9.303
14 Córdoba;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
14 Córdoba;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
14 Córdoba;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
14 Córdoba;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2022QIII;8.877
14 Córdoba;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2022QII;""
14 Córdoba;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2022QI;""
14 Córdoba;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
14 Córdoba;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2021QIII;9.173
14 Córdoba;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2021QII;""
14 Córdoba;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2021QI;""
14 Córdoba;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
14 Córdoba;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2020QIII;9.094
14 Córdoba;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2020QII;""
14 Córdoba;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2020QI;""
14 Córdoba;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2022QIV;8.646
14 Córdoba;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
14 Córdoba;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2022QII;""
14 Córdoba;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2022QI;""
14 Córdoba;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2021QIV;8.947
14 Córdoba;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
14 Córdoba;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2021QII;""
14 Córdoba;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2021QI;""
14 Córdoba;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2020QIV;8.911
14 Córdoba;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
14 Córdoba;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2020QII;""
14 Córdoba;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2020QI;""
14 Córdoba;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
14 Córdoba;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
14 Córdoba;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QII;""
14 Córdoba;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QI;8.783
14 Córdoba;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
14 Córdoba;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
14 Córdoba;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QII;""
14 Córdoba;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QI;8.793
14 Córdoba;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
14 Córdoba;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
14 Córdoba;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QII;""
14 Córdoba;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QI;""
14 Córdoba;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
14 Córdoba;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
14 Córdoba;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QII;8.609
14 Córdoba;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QI;""
14 Córdoba;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
14 Córdoba;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
14 Córdoba;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QII;8.670
14 Córdoba;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QI;""
14 Córdoba;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
14 Córdoba;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
14 Córdoba;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QII;""
14 Córdoba;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QI;""
14 Córdoba;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
14 Córdoba;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
14 Córdoba;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
14 Córdoba;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
14 Córdoba;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
14 Córdoba;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
14 Córdoba;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
14 Córdoba;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
14 Córdoba;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
14 Córdoba;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
14 Córdoba;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
14 Córdoba;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
14 Córdoba;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
14 Córdoba;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;97,7
14 Córdoba;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
14 Córdoba;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
14 Córdoba;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
14 Córdoba;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;98,11
14 Córdoba;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
14 Córdoba;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
14 Córdoba;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
14 Córdoba;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;97,75
14 Córdoba;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
14 Córdoba;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
14 Córdoba;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;95,16
14 Córdoba;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
14 Córdoba;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
14 Córdoba;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
14 Córdoba;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;95,69
14 Córdoba;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
14 Córdoba;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
14 Córdoba;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
14 Córdoba;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;95,79
14 Córdoba;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
14 Córdoba;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
14 Córdoba;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
14 Córdoba;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
14 Córdoba;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
14 Córdoba;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
14 Córdoba;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;93,94
14 Córdoba;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
14 Córdoba;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
14 Córdoba;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
14 Córdoba;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;94,52
14 Córdoba;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
14 Córdoba;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
14 Córdoba;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
14 Córdoba;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
14 Córdoba;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
14 Córdoba;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
14 Córdoba;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;92,07
14 Córdoba;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
14 Córdoba;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
14 Córdoba;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
14 Córdoba;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;93,2
14 Córdoba;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
14 Córdoba;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
14 Córdoba;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
14 Córdoba;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
14 Córdoba;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
14 Córdoba;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
14 Córdoba;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QIII;4.797
14 Córdoba;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
14 Córdoba;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
14 Córdoba;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
14 Córdoba;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QIII;4.803
14 Córdoba;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
14 Córdoba;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
14 Córdoba;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
14 Córdoba;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QIII;4.713
14 Córdoba;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
14 Córdoba;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
14 Córdoba;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
14 Córdoba;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2022QIII;4.622
14 Córdoba;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2022QII;""
14 Córdoba;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2022QI;""
14 Córdoba;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
14 Córdoba;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2021QIII;4.664
14 Córdoba;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2021QII;""
14 Córdoba;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2021QI;""
14 Córdoba;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
14 Córdoba;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2020QIII;4.587
14 Córdoba;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2020QII;""
14 Córdoba;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2020QI;""
14 Córdoba;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2022QIV;4.476
14 Córdoba;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
14 Córdoba;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2022QII;""
14 Córdoba;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2022QI;""
14 Córdoba;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2021QIV;4.549
14 Córdoba;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
14 Córdoba;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2021QII;""
14 Córdoba;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2021QI;""
14 Córdoba;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2020QIV;4.480
14 Córdoba;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
14 Córdoba;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2020QII;""
14 Córdoba;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2020QI;""
14 Córdoba;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
14 Córdoba;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
14 Córdoba;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QII;""
14 Córdoba;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QI;4.442
14 Córdoba;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
14 Córdoba;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
14 Córdoba;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QII;""
14 Córdoba;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QI;4.406
14 Córdoba;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
14 Córdoba;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
14 Córdoba;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QII;""
14 Córdoba;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QI;""
14 Córdoba;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
14 Córdoba;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
14 Córdoba;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QII;4.322
14 Córdoba;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QI;""
14 Córdoba;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
14 Córdoba;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
14 Córdoba;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QII;4.319
14 Córdoba;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QI;""
14 Córdoba;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
14 Córdoba;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
14 Córdoba;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QII;""
14 Córdoba;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QI;""
14 Córdoba;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
14 Córdoba;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
14 Córdoba;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
14 Córdoba;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
14 Córdoba;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
14 Córdoba;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
14 Córdoba;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
14 Córdoba;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
14 Córdoba;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
14 Córdoba;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
14 Córdoba;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
14 Córdoba;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
14 Córdoba;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
14 Córdoba;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;96,35
14 Córdoba;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
14 Córdoba;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
14 Córdoba;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
14 Córdoba;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;97,11
14 Córdoba;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
14 Córdoba;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
14 Córdoba;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
14 Córdoba;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;97,33
14 Córdoba;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
14 Córdoba;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
14 Córdoba;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;93,31
14 Córdoba;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
14 Córdoba;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
14 Córdoba;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
14 Córdoba;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;94,71
14 Córdoba;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
14 Córdoba;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
14 Córdoba;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
14 Córdoba;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;95,06
14 Córdoba;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
14 Córdoba;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
14 Córdoba;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
14 Córdoba;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
14 Córdoba;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
14 Córdoba;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
14 Córdoba;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;92,48
14 Córdoba;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
14 Córdoba;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
14 Córdoba;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
14 Córdoba;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;93,49
14 Córdoba;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
14 Córdoba;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
14 Córdoba;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
14 Córdoba;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
14 Córdoba;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
14 Córdoba;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
14 Córdoba;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;89,99
14 Córdoba;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
14 Córdoba;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
14 Córdoba;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
14 Córdoba;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;91,64
14 Córdoba;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
14 Córdoba;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
14 Córdoba;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
14 Córdoba;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
14 Córdoba;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
14 Córdoba;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QIV;13.861
14 Córdoba;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
14 Córdoba;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
14 Córdoba;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
14 Córdoba;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QIV;14.160
14 Córdoba;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
14 Córdoba;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
14 Córdoba;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
14 Córdoba;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QIV;14.074
14 Córdoba;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
14 Córdoba;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
14 Córdoba;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
14 Córdoba;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2022QIV;13.438
14 Córdoba;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
14 Córdoba;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2022QII;""
14 Córdoba;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2022QI;""
14 Córdoba;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2021QIV;13.776
14 Córdoba;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
14 Córdoba;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2021QII;""
14 Córdoba;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2021QI;""
14 Córdoba;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2020QIV;13.743
14 Córdoba;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
14 Córdoba;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2020QII;""
14 Córdoba;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2020QI;""
14 Córdoba;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
14 Córdoba;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
14 Córdoba;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2022QII;""
14 Córdoba;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2022QI;13.484
14 Córdoba;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
14 Córdoba;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
14 Córdoba;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2021QII;""
14 Córdoba;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2021QI;13.531
14 Córdoba;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
14 Córdoba;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
14 Córdoba;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2020QII;""
14 Córdoba;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2020QI;""
14 Córdoba;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
14 Córdoba;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
14 Córdoba;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QII;13.175
14 Córdoba;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QI;""
14 Córdoba;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
14 Córdoba;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
14 Córdoba;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QII;13.294
14 Córdoba;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QI;""
14 Córdoba;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
14 Córdoba;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
14 Córdoba;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QII;""
14 Córdoba;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QI;""
14 Córdoba;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
14 Córdoba;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QIII;12.909
14 Córdoba;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QII;""
14 Córdoba;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QI;""
14 Córdoba;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
14 Córdoba;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QIII;13.089
14 Córdoba;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QII;""
14 Córdoba;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QI;""
14 Córdoba;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
14 Córdoba;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
14 Córdoba;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QII;""
14 Córdoba;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QI;""
14 Córdoba;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
14 Córdoba;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
14 Córdoba;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
14 Córdoba;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
14 Córdoba;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
14 Córdoba;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
14 Córdoba;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
14 Córdoba;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
14 Córdoba;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
14 Córdoba;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
14 Córdoba;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
14 Córdoba;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
14 Córdoba;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;96,95
14 Córdoba;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
14 Córdoba;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
14 Córdoba;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
14 Córdoba;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;97,29
14 Córdoba;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
14 Córdoba;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
14 Córdoba;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
14 Córdoba;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;97,65
14 Córdoba;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
14 Córdoba;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
14 Córdoba;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
14 Córdoba;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
14 Córdoba;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
14 Córdoba;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
14 Córdoba;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;95,23
14 Córdoba;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
14 Córdoba;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
14 Córdoba;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
14 Córdoba;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;96,14
14 Córdoba;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
14 Córdoba;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
14 Córdoba;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
14 Córdoba;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
14 Córdoba;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
14 Córdoba;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
14 Córdoba;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;93,04
14 Córdoba;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
14 Córdoba;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
14 Córdoba;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
14 Córdoba;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;94,46
14 Córdoba;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
14 Córdoba;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
14 Córdoba;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
14 Córdoba;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
14 Córdoba;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
14 Córdoba;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
14 Córdoba;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;91,17
14 Córdoba;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
14 Córdoba;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
14 Córdoba;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
14 Córdoba;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;93
14 Córdoba;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
14 Córdoba;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
14 Córdoba;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
14 Córdoba;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
14 Córdoba;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
14 Córdoba;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
14 Córdoba;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QIV;9.078
14 Córdoba;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
14 Córdoba;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
14 Córdoba;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
14 Córdoba;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QIV;9.377
14 Córdoba;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
14 Córdoba;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
14 Córdoba;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
14 Córdoba;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QIV;9.323
14 Córdoba;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
14 Córdoba;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
14 Córdoba;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
14 Córdoba;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2022QIV;8.816
14 Córdoba;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
14 Córdoba;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2022QII;""
14 Córdoba;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2022QI;""
14 Córdoba;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2021QIV;9.122
14 Córdoba;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
14 Córdoba;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2021QII;""
14 Córdoba;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2021QI;""
14 Córdoba;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2020QIV;9.115
14 Córdoba;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
14 Córdoba;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2020QII;""
14 Córdoba;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2020QI;""
14 Córdoba;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
14 Córdoba;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
14 Córdoba;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2022QII;""
14 Córdoba;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2022QI;8.941
14 Córdoba;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
14 Córdoba;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
14 Córdoba;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2021QII;""
14 Córdoba;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2021QI;8.983
14 Córdoba;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
14 Córdoba;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
14 Córdoba;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2020QII;""
14 Córdoba;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2020QI;""
14 Córdoba;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
14 Córdoba;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
14 Córdoba;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QII;8.760
14 Córdoba;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QI;""
14 Córdoba;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
14 Córdoba;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
14 Córdoba;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QII;8.844
14 Córdoba;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QI;""
14 Córdoba;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
14 Córdoba;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
14 Córdoba;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QII;""
14 Córdoba;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QI;""
14 Córdoba;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
14 Córdoba;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QIII;8.625
14 Córdoba;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QII;""
14 Córdoba;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QI;""
14 Córdoba;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
14 Córdoba;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QIII;8.733
14 Córdoba;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QII;""
14 Córdoba;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QI;""
14 Córdoba;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
14 Córdoba;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
14 Córdoba;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QII;""
14 Córdoba;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QI;""
14 Córdoba;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
14 Córdoba;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
14 Córdoba;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
14 Córdoba;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
14 Córdoba;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
14 Córdoba;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
14 Córdoba;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
14 Córdoba;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
14 Córdoba;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
14 Córdoba;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
14 Córdoba;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
14 Córdoba;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
14 Córdoba;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;97,11
14 Córdoba;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
14 Córdoba;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
14 Córdoba;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
14 Córdoba;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;97,28
14 Córdoba;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
14 Córdoba;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
14 Córdoba;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
14 Córdoba;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;97,77
14 Córdoba;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
14 Córdoba;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
14 Córdoba;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
14 Córdoba;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
14 Córdoba;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
14 Córdoba;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
14 Córdoba;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;95,35
14 Córdoba;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
14 Córdoba;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
14 Córdoba;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
14 Córdoba;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;96,35
14 Córdoba;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
14 Córdoba;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
14 Córdoba;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
14 Córdoba;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
14 Córdoba;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
14 Córdoba;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
14 Córdoba;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;93,42
14 Córdoba;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
14 Córdoba;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
14 Córdoba;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
14 Córdoba;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;94,86
14 Córdoba;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
14 Córdoba;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
14 Córdoba;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
14 Córdoba;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
14 Córdoba;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
14 Córdoba;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
14 Córdoba;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;91,98
14 Córdoba;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
14 Córdoba;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
14 Córdoba;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
14 Córdoba;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;93,67
14 Córdoba;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
14 Córdoba;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
14 Córdoba;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
14 Córdoba;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
14 Córdoba;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
14 Córdoba;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
14 Córdoba;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QIV;4.783
14 Córdoba;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
14 Córdoba;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
14 Córdoba;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
14 Córdoba;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QIV;4.783
14 Córdoba;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
14 Córdoba;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
14 Córdoba;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
14 Córdoba;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QIV;4.751
14 Córdoba;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
14 Córdoba;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
14 Córdoba;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
14 Córdoba;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2022QIV;4.622
14 Córdoba;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
14 Córdoba;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2022QII;""
14 Córdoba;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2022QI;""
14 Córdoba;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2021QIV;4.654
14 Córdoba;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
14 Córdoba;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2021QII;""
14 Córdoba;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2021QI;""
14 Córdoba;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2020QIV;4.628
14 Córdoba;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
14 Córdoba;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2020QII;""
14 Córdoba;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2020QI;""
14 Córdoba;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
14 Córdoba;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
14 Córdoba;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2022QII;""
14 Córdoba;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2022QI;4.543
14 Córdoba;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
14 Córdoba;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
14 Córdoba;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2021QII;""
14 Córdoba;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2021QI;4.548
14 Córdoba;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
14 Córdoba;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
14 Córdoba;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2020QII;""
14 Córdoba;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2020QI;""
14 Córdoba;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
14 Córdoba;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
14 Córdoba;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QII;4.415
14 Córdoba;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QI;""
14 Córdoba;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
14 Córdoba;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
14 Córdoba;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QII;4.450
14 Córdoba;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QI;""
14 Córdoba;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
14 Córdoba;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
14 Córdoba;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QII;""
14 Córdoba;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QI;""
14 Córdoba;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
14 Córdoba;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QIII;4.284
14 Córdoba;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QII;""
14 Córdoba;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QI;""
14 Córdoba;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
14 Córdoba;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QIII;4.356
14 Córdoba;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QII;""
14 Córdoba;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QI;""
14 Córdoba;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
14 Córdoba;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
14 Córdoba;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QII;""
14 Córdoba;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QI;""
14 Córdoba;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
14 Córdoba;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
14 Córdoba;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
14 Córdoba;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
14 Córdoba;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
14 Córdoba;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
14 Córdoba;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
14 Córdoba;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
14 Córdoba;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
14 Córdoba;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
14 Córdoba;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
14 Córdoba;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
14 Córdoba;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;96,63
14 Córdoba;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
14 Córdoba;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
14 Córdoba;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
14 Córdoba;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;97,3
14 Córdoba;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
14 Córdoba;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
14 Córdoba;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
14 Córdoba;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;97,41
14 Córdoba;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
14 Córdoba;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
14 Córdoba;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
14 Córdoba;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
14 Córdoba;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
14 Córdoba;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
14 Córdoba;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;94,98
14 Córdoba;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
14 Córdoba;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
14 Córdoba;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
14 Córdoba;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;95,73
14 Córdoba;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
14 Córdoba;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
14 Córdoba;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
14 Córdoba;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
14 Córdoba;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
14 Córdoba;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
14 Córdoba;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;92,31
14 Córdoba;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
14 Córdoba;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
14 Córdoba;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
14 Córdoba;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;93,66
14 Córdoba;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
14 Córdoba;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
14 Córdoba;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
14 Córdoba;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
14 Córdoba;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
14 Córdoba;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
14 Córdoba;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;89,57
14 Córdoba;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
14 Córdoba;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
14 Córdoba;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
14 Córdoba;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;91,69
14 Córdoba;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
14 Córdoba;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
14 Córdoba;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
14 Córdoba;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
14 Córdoba;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
14 Córdoba;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
14 Córdoba;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
14 Córdoba;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
14 Córdoba;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
14 Córdoba;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QI;13.947
14 Córdoba;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
14 Córdoba;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
14 Córdoba;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
14 Córdoba;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QI;13.593
14 Córdoba;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
14 Córdoba;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
14 Córdoba;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
14 Córdoba;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QI;13.804
14 Córdoba;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
14 Córdoba;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
14 Córdoba;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2022QII;""
14 Córdoba;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2022QI;13.691
14 Córdoba;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
14 Córdoba;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
14 Córdoba;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2021QII;""
14 Córdoba;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2021QI;13.373
14 Córdoba;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
14 Córdoba;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
14 Córdoba;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2020QII;""
14 Córdoba;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2020QI;13.153
14 Córdoba;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
14 Córdoba;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
14 Córdoba;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2022QII;13.406
14 Córdoba;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2022QI;""
14 Córdoba;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
14 Córdoba;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
14 Córdoba;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2021QII;13.189
14 Córdoba;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2021QI;""
14 Córdoba;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
14 Córdoba;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
14 Córdoba;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2020QII;13.009
14 Córdoba;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2020QI;""
14 Córdoba;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
14 Córdoba;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QIII;13.201
14 Córdoba;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QII;""
14 Córdoba;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QI;""
14 Córdoba;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
14 Córdoba;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QIII;13.019
14 Córdoba;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QII;""
14 Córdoba;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QI;""
14 Córdoba;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
14 Córdoba;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QIII;12.835
14 Córdoba;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QII;""
14 Córdoba;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QI;""
14 Córdoba;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QIV;12.946
14 Córdoba;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
14 Córdoba;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QII;""
14 Córdoba;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QI;""
14 Córdoba;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QIV;12.826
14 Córdoba;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
14 Córdoba;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QII;""
14 Córdoba;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QI;""
14 Córdoba;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QIV;12.643
14 Córdoba;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
14 Córdoba;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QII;""
14 Córdoba;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QI;""
14 Córdoba;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
14 Córdoba;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
14 Córdoba;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
14 Córdoba;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
14 Córdoba;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
14 Córdoba;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
14 Córdoba;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
14 Córdoba;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
14 Córdoba;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
14 Córdoba;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
14 Córdoba;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
14 Córdoba;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
14 Córdoba;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
14 Córdoba;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
14 Córdoba;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
14 Córdoba;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;98,16
14 Córdoba;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
14 Córdoba;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
14 Córdoba;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
14 Córdoba;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;98,38
14 Córdoba;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
14 Córdoba;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
14 Córdoba;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
14 Córdoba;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;95,28
14 Córdoba;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
14 Córdoba;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
14 Córdoba;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;96,12
14 Córdoba;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
14 Córdoba;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
14 Córdoba;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
14 Córdoba;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;97,03
14 Córdoba;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
14 Córdoba;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
14 Córdoba;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
14 Córdoba;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;94,24
14 Córdoba;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
14 Córdoba;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
14 Córdoba;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;94,65
14 Córdoba;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
14 Córdoba;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
14 Córdoba;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
14 Córdoba;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;95,78
14 Córdoba;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
14 Córdoba;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
14 Córdoba;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
14 Córdoba;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;92,98
14 Córdoba;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
14 Córdoba;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
14 Córdoba;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;92,82
14 Córdoba;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
14 Córdoba;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
14 Córdoba;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
14 Córdoba;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;94,36
14 Córdoba;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
14 Córdoba;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
14 Córdoba;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
14 Córdoba;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;91,59
14 Córdoba;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
14 Córdoba;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
14 Córdoba;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
14 Córdoba;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
14 Córdoba;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
14 Córdoba;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
14 Córdoba;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QI;9.391
14 Córdoba;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
14 Córdoba;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
14 Córdoba;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
14 Córdoba;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QI;9.242
14 Córdoba;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
14 Córdoba;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
14 Córdoba;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
14 Córdoba;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QI;9.419
14 Córdoba;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
14 Córdoba;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
14 Córdoba;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2022QII;""
14 Córdoba;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2022QI;9.236
14 Córdoba;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
14 Córdoba;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
14 Córdoba;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2021QII;""
14 Córdoba;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2021QI;9.101
14 Córdoba;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
14 Córdoba;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
14 Córdoba;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2020QII;""
14 Córdoba;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2020QI;8.981
14 Córdoba;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
14 Córdoba;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
14 Córdoba;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2022QII;9.069
14 Córdoba;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2022QI;""
14 Córdoba;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
14 Córdoba;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
14 Córdoba;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2021QII;8.983
14 Córdoba;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2021QI;""
14 Córdoba;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
14 Córdoba;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
14 Córdoba;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2020QII;8.888
14 Córdoba;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2020QI;""
14 Córdoba;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
14 Córdoba;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QIII;8.940
14 Córdoba;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QII;""
14 Córdoba;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QI;""
14 Córdoba;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
14 Córdoba;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QIII;8.877
14 Córdoba;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QII;""
14 Córdoba;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QI;""
14 Córdoba;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
14 Córdoba;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QIII;8.779
14 Córdoba;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QII;""
14 Córdoba;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QI;""
14 Córdoba;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QIV;8.785
14 Córdoba;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
14 Córdoba;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QII;""
14 Córdoba;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QI;""
14 Córdoba;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QIV;8.743
14 Córdoba;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
14 Córdoba;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QII;""
14 Córdoba;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QI;""
14 Córdoba;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QIV;8.656
14 Córdoba;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
14 Córdoba;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QII;""
14 Córdoba;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QI;""
14 Córdoba;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
14 Córdoba;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
14 Córdoba;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
14 Córdoba;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
14 Córdoba;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
14 Córdoba;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
14 Córdoba;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
14 Córdoba;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
14 Córdoba;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
14 Córdoba;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
14 Córdoba;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
14 Córdoba;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
14 Córdoba;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
14 Córdoba;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
14 Córdoba;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
14 Córdoba;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;98,35
14 Córdoba;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
14 Córdoba;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
14 Córdoba;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
14 Córdoba;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;98,47
14 Córdoba;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
14 Córdoba;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
14 Córdoba;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
14 Córdoba;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;95,35
14 Córdoba;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
14 Córdoba;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
14 Córdoba;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;96,57
14 Córdoba;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
14 Córdoba;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
14 Córdoba;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
14 Córdoba;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;97,2
14 Córdoba;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
14 Córdoba;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
14 Córdoba;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
14 Córdoba;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;94,36
14 Córdoba;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
14 Córdoba;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
14 Córdoba;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;95,2
14 Córdoba;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
14 Córdoba;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
14 Córdoba;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
14 Córdoba;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;96,05
14 Córdoba;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
14 Córdoba;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
14 Córdoba;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
14 Córdoba;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;93,21
14 Córdoba;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
14 Córdoba;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
14 Córdoba;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;93,55
14 Córdoba;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
14 Córdoba;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
14 Córdoba;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
14 Córdoba;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;94,6
14 Córdoba;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
14 Córdoba;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
14 Córdoba;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
14 Córdoba;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;91,9
14 Córdoba;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
14 Córdoba;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
14 Córdoba;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
14 Córdoba;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
14 Córdoba;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
14 Córdoba;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
14 Córdoba;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QI;4.556
14 Córdoba;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
14 Córdoba;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
14 Córdoba;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
14 Córdoba;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QI;4.351
14 Córdoba;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
14 Córdoba;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
14 Córdoba;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
14 Córdoba;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QI;4.385
14 Córdoba;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
14 Córdoba;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
14 Córdoba;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2022QII;""
14 Córdoba;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2022QI;4.455
14 Córdoba;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
14 Córdoba;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
14 Córdoba;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2021QII;""
14 Córdoba;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2021QI;4.272
14 Córdoba;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
14 Córdoba;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
14 Córdoba;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2020QII;""
14 Córdoba;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2020QI;4.172
14 Córdoba;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
14 Córdoba;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
14 Córdoba;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2022QII;4.337
14 Córdoba;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2022QI;""
14 Córdoba;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
14 Córdoba;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
14 Córdoba;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2021QII;4.206
14 Córdoba;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2021QI;""
14 Córdoba;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
14 Córdoba;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
14 Córdoba;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2020QII;4.121
14 Córdoba;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2020QI;""
14 Córdoba;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
14 Córdoba;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QIII;4.261
14 Córdoba;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QII;""
14 Córdoba;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QI;""
14 Córdoba;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
14 Córdoba;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QIII;4.142
14 Córdoba;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QII;""
14 Córdoba;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QI;""
14 Córdoba;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
14 Córdoba;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QIII;4.056
14 Córdoba;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QII;""
14 Córdoba;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QI;""
14 Córdoba;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QIV;4.161
14 Córdoba;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
14 Córdoba;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QII;""
14 Córdoba;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QI;""
14 Córdoba;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QIV;4.083
14 Córdoba;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
14 Córdoba;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QII;""
14 Córdoba;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QI;""
14 Córdoba;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QIV;3.987
14 Córdoba;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
14 Córdoba;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QII;""
14 Córdoba;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QI;""
14 Córdoba;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
14 Córdoba;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
14 Córdoba;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
14 Córdoba;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
14 Córdoba;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
14 Córdoba;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
14 Córdoba;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
14 Córdoba;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
14 Córdoba;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
14 Córdoba;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
14 Córdoba;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
14 Córdoba;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
14 Córdoba;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
14 Córdoba;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
14 Córdoba;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
14 Córdoba;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;97,78
14 Córdoba;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
14 Córdoba;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
14 Córdoba;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
14 Córdoba;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;98,18
14 Córdoba;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
14 Córdoba;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
14 Córdoba;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
14 Córdoba;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;95,14
14 Córdoba;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
14 Córdoba;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
14 Córdoba;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;95,19
14 Córdoba;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
14 Córdoba;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
14 Córdoba;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
14 Córdoba;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;96,67
14 Córdoba;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
14 Córdoba;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
14 Córdoba;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
14 Córdoba;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;93,98
14 Córdoba;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
14 Córdoba;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
14 Córdoba;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;93,53
14 Córdoba;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
14 Córdoba;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
14 Córdoba;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
14 Córdoba;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;95,2
14 Córdoba;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
14 Córdoba;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
14 Córdoba;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
14 Córdoba;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;92,5
14 Córdoba;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
14 Córdoba;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
14 Córdoba;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;91,33
14 Córdoba;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
14 Córdoba;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
14 Córdoba;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
14 Córdoba;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;93,84
14 Córdoba;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
14 Córdoba;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
14 Córdoba;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
14 Córdoba;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;90,92
14 Córdoba;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
14 Córdoba;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
14 Córdoba;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
14 Córdoba;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
14 Córdoba;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
14 Córdoba;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QII;14.304
14 Córdoba;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
14 Córdoba;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
14 Córdoba;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
14 Córdoba;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QII;13.982
14 Córdoba;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
14 Córdoba;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
14 Córdoba;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
14 Córdoba;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QII;13.502
14 Córdoba;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
14 Córdoba;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
14 Córdoba;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
14 Córdoba;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2022QII;13.962
14 Córdoba;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2022QI;""
14 Córdoba;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
14 Córdoba;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
14 Córdoba;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2021QII;13.760
14 Córdoba;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2021QI;""
14 Córdoba;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
14 Córdoba;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
14 Córdoba;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2020QII;13.331
14 Córdoba;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2020QI;""
14 Córdoba;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
14 Córdoba;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2022QIII;13.740
14 Córdoba;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2022QII;""
14 Córdoba;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2022QI;""
14 Córdoba;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
14 Córdoba;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2021QIII;13.553
14 Córdoba;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2021QII;""
14 Córdoba;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2021QI;""
14 Córdoba;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
14 Córdoba;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2020QIII;13.121
14 Córdoba;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2020QII;""
14 Córdoba;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2020QI;""
14 Córdoba;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QIV;13.462
14 Córdoba;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
14 Córdoba;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QII;""
14 Córdoba;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QI;""
14 Córdoba;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QIV;13.330
14 Córdoba;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
14 Córdoba;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QII;""
14 Córdoba;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QI;""
14 Córdoba;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QIV;12.913
14 Córdoba;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
14 Córdoba;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QII;""
14 Córdoba;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QI;""
14 Córdoba;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
14 Córdoba;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
14 Córdoba;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QII;""
14 Córdoba;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QI;13.121
14 Córdoba;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
14 Córdoba;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
14 Córdoba;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QII;""
14 Córdoba;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QI;12.751
14 Córdoba;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
14 Córdoba;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
14 Córdoba;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QII;""
14 Córdoba;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QI;""
14 Córdoba;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
14 Córdoba;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
14 Córdoba;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
14 Córdoba;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
14 Córdoba;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
14 Córdoba;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
14 Córdoba;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
14 Córdoba;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
14 Córdoba;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
14 Córdoba;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
14 Córdoba;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
14 Córdoba;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
14 Córdoba;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
14 Córdoba;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
14 Córdoba;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;97,61
14 Córdoba;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
14 Córdoba;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
14 Córdoba;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
14 Córdoba;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;98,41
14 Córdoba;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
14 Córdoba;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
14 Córdoba;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
14 Córdoba;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;98,73
14 Córdoba;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
14 Córdoba;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
14 Córdoba;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;96,06
14 Córdoba;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
14 Córdoba;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
14 Córdoba;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
14 Córdoba;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;96,93
14 Córdoba;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
14 Córdoba;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
14 Córdoba;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
14 Córdoba;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;97,18
14 Córdoba;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
14 Córdoba;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
14 Córdoba;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;94,11
14 Córdoba;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
14 Córdoba;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
14 Córdoba;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
14 Córdoba;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;95,34
14 Córdoba;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
14 Córdoba;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
14 Córdoba;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
14 Córdoba;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;95,64
14 Córdoba;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
14 Córdoba;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
14 Córdoba;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
14 Córdoba;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
14 Córdoba;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
14 Córdoba;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
14 Córdoba;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;93,84
14 Córdoba;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
14 Córdoba;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
14 Córdoba;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
14 Córdoba;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;94,44
14 Córdoba;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
14 Córdoba;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
14 Córdoba;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
14 Córdoba;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
14 Córdoba;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
14 Córdoba;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
14 Córdoba;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QII;9.603
14 Córdoba;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
14 Córdoba;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
14 Córdoba;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
14 Córdoba;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QII;9.462
14 Córdoba;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
14 Córdoba;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
14 Córdoba;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
14 Córdoba;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QII;9.195
14 Córdoba;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
14 Córdoba;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
14 Córdoba;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
14 Córdoba;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2022QII;9.397
14 Córdoba;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2022QI;""
14 Córdoba;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
14 Córdoba;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
14 Córdoba;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2021QII;9.324
14 Córdoba;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2021QI;""
14 Córdoba;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
14 Córdoba;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
14 Córdoba;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2020QII;9.086
14 Córdoba;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2020QI;""
14 Córdoba;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
14 Córdoba;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2022QIII;9.257
14 Córdoba;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2022QII;""
14 Córdoba;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2022QI;""
14 Córdoba;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
14 Córdoba;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2021QIII;9.197
14 Córdoba;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2021QII;""
14 Córdoba;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2021QI;""
14 Córdoba;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
14 Córdoba;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2020QIII;8.948
14 Córdoba;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2020QII;""
14 Córdoba;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2020QI;""
14 Córdoba;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QIV;9.084
14 Córdoba;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
14 Córdoba;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QII;""
14 Córdoba;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QI;""
14 Córdoba;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QIV;9.047
14 Córdoba;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
14 Córdoba;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QII;""
14 Córdoba;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QI;""
14 Córdoba;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QIV;8.814
14 Córdoba;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
14 Córdoba;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QII;""
14 Córdoba;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QI;""
14 Córdoba;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
14 Córdoba;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
14 Córdoba;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QII;""
14 Córdoba;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QI;8.922
14 Córdoba;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
14 Córdoba;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
14 Córdoba;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QII;""
14 Córdoba;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QI;8.715
14 Córdoba;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
14 Córdoba;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
14 Córdoba;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QII;""
14 Córdoba;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QI;""
14 Córdoba;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
14 Córdoba;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
14 Córdoba;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
14 Córdoba;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
14 Córdoba;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
14 Córdoba;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
14 Córdoba;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
14 Córdoba;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
14 Córdoba;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
14 Córdoba;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
14 Córdoba;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
14 Córdoba;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
14 Córdoba;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
14 Córdoba;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
14 Córdoba;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;97,85
14 Córdoba;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
14 Córdoba;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
14 Córdoba;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
14 Córdoba;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;98,54
14 Córdoba;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
14 Córdoba;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
14 Córdoba;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
14 Córdoba;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;98,81
14 Córdoba;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
14 Córdoba;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
14 Córdoba;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;96,4
14 Córdoba;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
14 Córdoba;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
14 Córdoba;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
14 Córdoba;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;97,2
14 Córdoba;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
14 Córdoba;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
14 Córdoba;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
14 Córdoba;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;97,31
14 Córdoba;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
14 Córdoba;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
14 Córdoba;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;94,6
14 Córdoba;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
14 Córdoba;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
14 Córdoba;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
14 Córdoba;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;95,61
14 Córdoba;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
14 Córdoba;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
14 Córdoba;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
14 Córdoba;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;95,86
14 Córdoba;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
14 Córdoba;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
14 Córdoba;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
14 Córdoba;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
14 Córdoba;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
14 Córdoba;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
14 Córdoba;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;94,29
14 Córdoba;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
14 Córdoba;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
14 Córdoba;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
14 Córdoba;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;94,78
14 Córdoba;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
14 Córdoba;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
14 Córdoba;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
14 Córdoba;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
14 Córdoba;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
14 Córdoba;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
14 Córdoba;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QII;4.701
14 Córdoba;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
14 Córdoba;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
14 Córdoba;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
14 Córdoba;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QII;4.520
14 Córdoba;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
14 Córdoba;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
14 Córdoba;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
14 Córdoba;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QII;4.307
14 Córdoba;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
14 Córdoba;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
14 Córdoba;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
14 Córdoba;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2022QII;4.565
14 Córdoba;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2022QI;""
14 Córdoba;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
14 Córdoba;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
14 Córdoba;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2021QII;4.436
14 Córdoba;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2021QI;""
14 Córdoba;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
14 Córdoba;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
14 Córdoba;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2020QII;4.245
14 Córdoba;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2020QI;""
14 Córdoba;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
14 Córdoba;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2022QIII;4.483
14 Córdoba;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2022QII;""
14 Córdoba;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2022QI;""
14 Córdoba;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
14 Córdoba;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2021QIII;4.356
14 Córdoba;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2021QII;""
14 Córdoba;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2021QI;""
14 Córdoba;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
14 Córdoba;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2020QIII;4.173
14 Córdoba;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2020QII;""
14 Córdoba;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2020QI;""
14 Córdoba;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QIV;4.378
14 Córdoba;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
14 Córdoba;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QII;""
14 Córdoba;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QI;""
14 Córdoba;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QIV;4.283
14 Córdoba;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
14 Córdoba;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QII;""
14 Córdoba;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QI;""
14 Córdoba;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QIV;4.099
14 Córdoba;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
14 Córdoba;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QII;""
14 Córdoba;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QI;""
14 Córdoba;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
14 Córdoba;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
14 Córdoba;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QII;""
14 Córdoba;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QI;4.199
14 Córdoba;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
14 Córdoba;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
14 Córdoba;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QII;""
14 Córdoba;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QI;4.036
14 Córdoba;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
14 Córdoba;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
14 Córdoba;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QII;""
14 Córdoba;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QI;""
14 Córdoba;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
14 Córdoba;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
14 Córdoba;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
14 Córdoba;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
14 Córdoba;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
14 Córdoba;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
14 Córdoba;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
14 Córdoba;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
14 Córdoba;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
14 Córdoba;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
14 Córdoba;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
14 Córdoba;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
14 Córdoba;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
14 Córdoba;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
14 Córdoba;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;97,11
14 Córdoba;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
14 Córdoba;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
14 Córdoba;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
14 Córdoba;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;98,14
14 Córdoba;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
14 Córdoba;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
14 Córdoba;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
14 Córdoba;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;98,56
14 Córdoba;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
14 Córdoba;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
14 Córdoba;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;95,36
14 Córdoba;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
14 Córdoba;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
14 Córdoba;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
14 Córdoba;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;96,37
14 Córdoba;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
14 Córdoba;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
14 Córdoba;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
14 Córdoba;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;96,89
14 Córdoba;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
14 Córdoba;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
14 Córdoba;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;93,13
14 Córdoba;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
14 Córdoba;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
14 Córdoba;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
14 Córdoba;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;94,76
14 Córdoba;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
14 Córdoba;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
14 Córdoba;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
14 Córdoba;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;95,17
14 Córdoba;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
14 Córdoba;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
14 Córdoba;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
14 Córdoba;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
14 Córdoba;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
14 Córdoba;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
14 Córdoba;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;92,9
14 Córdoba;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
14 Córdoba;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
14 Córdoba;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
14 Córdoba;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;93,71
14 Córdoba;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
14 Córdoba;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
14 Córdoba;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
14 Córdoba;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
14 Córdoba;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
14 Córdoba;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QIII;14.252
14 Córdoba;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
14 Córdoba;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
14 Córdoba;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
14 Córdoba;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QIII;14.073
14 Córdoba;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
14 Córdoba;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
14 Córdoba;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
14 Córdoba;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QIII;13.641
14 Córdoba;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
14 Córdoba;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
14 Córdoba;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
14 Córdoba;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2022QIII;13.967
14 Córdoba;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2022QII;""
14 Córdoba;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2022QI;""
14 Córdoba;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
14 Córdoba;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2021QIII;13.808
14 Córdoba;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2021QII;""
14 Córdoba;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2021QI;""
14 Córdoba;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
14 Córdoba;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2020QIII;13.376
14 Córdoba;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2020QII;""
14 Córdoba;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2020QI;""
14 Córdoba;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2022QIV;13.638
14 Córdoba;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
14 Córdoba;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2022QII;""
14 Córdoba;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2022QI;""
14 Córdoba;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2021QIV;13.551
14 Córdoba;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
14 Córdoba;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2021QII;""
14 Córdoba;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2021QI;""
14 Córdoba;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2020QIV;13.124
14 Córdoba;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
14 Córdoba;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2020QII;""
14 Córdoba;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2020QI;""
14 Córdoba;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
14 Córdoba;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
14 Córdoba;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QII;""
14 Córdoba;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QI;13.339
14 Córdoba;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
14 Córdoba;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
14 Córdoba;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QII;""
14 Córdoba;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QI;12.953
14 Córdoba;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
14 Córdoba;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
14 Córdoba;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QII;""
14 Córdoba;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QI;""
14 Córdoba;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
14 Córdoba;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
14 Córdoba;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QII;13.088
14 Córdoba;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QI;""
14 Córdoba;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
14 Córdoba;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
14 Córdoba;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QII;12.799
14 Córdoba;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QI;""
14 Córdoba;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
14 Córdoba;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
14 Córdoba;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QII;""
14 Córdoba;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QI;""
14 Córdoba;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
14 Córdoba;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
14 Córdoba;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
14 Córdoba;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
14 Córdoba;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
14 Córdoba;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
14 Córdoba;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
14 Córdoba;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
14 Córdoba;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
14 Córdoba;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
14 Córdoba;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
14 Córdoba;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
14 Córdoba;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
14 Córdoba;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;98
14 Córdoba;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
14 Córdoba;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
14 Córdoba;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
14 Córdoba;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;98,12
14 Córdoba;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
14 Córdoba;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
14 Córdoba;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
14 Córdoba;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;98,06
14 Córdoba;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
14 Córdoba;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
14 Córdoba;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;95,69
14 Córdoba;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
14 Córdoba;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
14 Córdoba;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
14 Córdoba;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;96,29
14 Córdoba;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
14 Córdoba;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
14 Córdoba;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
14 Córdoba;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;96,21
14 Córdoba;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
14 Córdoba;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
14 Córdoba;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
14 Córdoba;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
14 Córdoba;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
14 Córdoba;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
14 Córdoba;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;94,78
14 Córdoba;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
14 Córdoba;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
14 Córdoba;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
14 Córdoba;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;94,96
14 Córdoba;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
14 Córdoba;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
14 Córdoba;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
14 Córdoba;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
14 Córdoba;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
14 Córdoba;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
14 Córdoba;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;93
14 Córdoba;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
14 Córdoba;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
14 Córdoba;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
14 Córdoba;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;93,83
14 Córdoba;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
14 Córdoba;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
14 Córdoba;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
14 Córdoba;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
14 Córdoba;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
14 Córdoba;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
14 Córdoba;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QIII;9.576
14 Córdoba;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
14 Córdoba;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
14 Córdoba;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
14 Córdoba;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QIII;9.513
14 Córdoba;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
14 Córdoba;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
14 Córdoba;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
14 Córdoba;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QIII;9.305
14 Córdoba;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
14 Córdoba;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
14 Córdoba;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
14 Córdoba;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2022QIII;9.396
14 Córdoba;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2022QII;""
14 Córdoba;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2022QI;""
14 Córdoba;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
14 Córdoba;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2021QIII;9.346
14 Córdoba;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2021QII;""
14 Córdoba;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2021QI;""
14 Córdoba;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
14 Córdoba;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2020QIII;9.128
14 Córdoba;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2020QII;""
14 Córdoba;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2020QI;""
14 Córdoba;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2022QIV;9.184
14 Córdoba;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
14 Córdoba;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2022QII;""
14 Córdoba;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2022QI;""
14 Córdoba;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2021QIV;9.167
14 Córdoba;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
14 Córdoba;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2021QII;""
14 Córdoba;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2021QI;""
14 Córdoba;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2020QIV;8.955
14 Córdoba;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
14 Córdoba;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2020QII;""
14 Córdoba;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2020QI;""
14 Córdoba;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
14 Córdoba;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
14 Córdoba;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QII;""
14 Córdoba;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QI;9.039
14 Córdoba;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
14 Córdoba;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
14 Córdoba;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QII;""
14 Córdoba;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QI;8.851
14 Córdoba;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
14 Córdoba;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
14 Córdoba;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QII;""
14 Córdoba;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QI;""
14 Córdoba;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
14 Córdoba;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
14 Córdoba;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QII;8.891
14 Córdoba;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QI;""
14 Córdoba;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
14 Córdoba;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
14 Córdoba;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QII;8.747
14 Córdoba;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QI;""
14 Córdoba;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
14 Córdoba;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
14 Córdoba;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QII;""
14 Córdoba;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QI;""
14 Córdoba;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
14 Córdoba;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
14 Córdoba;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
14 Córdoba;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
14 Córdoba;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
14 Córdoba;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
14 Córdoba;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
14 Córdoba;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
14 Córdoba;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
14 Córdoba;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
14 Córdoba;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
14 Córdoba;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
14 Córdoba;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
14 Córdoba;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;98,12
14 Córdoba;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
14 Córdoba;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
14 Córdoba;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
14 Córdoba;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;98,24
14 Córdoba;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
14 Córdoba;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
14 Córdoba;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
14 Córdoba;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;98,1
14 Córdoba;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
14 Córdoba;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
14 Córdoba;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;95,91
14 Córdoba;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
14 Córdoba;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
14 Córdoba;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
14 Córdoba;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;96,36
14 Córdoba;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
14 Córdoba;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
14 Córdoba;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
14 Córdoba;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;96,24
14 Córdoba;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
14 Córdoba;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
14 Córdoba;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
14 Córdoba;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
14 Córdoba;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
14 Córdoba;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
14 Córdoba;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;95,02
14 Córdoba;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
14 Córdoba;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
14 Córdoba;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
14 Córdoba;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;95,12
14 Córdoba;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
14 Córdoba;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
14 Córdoba;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
14 Córdoba;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
14 Córdoba;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
14 Córdoba;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
14 Córdoba;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;93,46
14 Córdoba;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
14 Córdoba;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
14 Córdoba;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
14 Córdoba;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;94
14 Córdoba;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
14 Córdoba;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
14 Córdoba;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
14 Córdoba;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
14 Córdoba;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
14 Córdoba;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
14 Córdoba;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QIII;4.676
14 Córdoba;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
14 Córdoba;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
14 Córdoba;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
14 Córdoba;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QIII;4.560
14 Córdoba;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
14 Córdoba;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
14 Córdoba;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
14 Córdoba;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QIII;4.336
14 Córdoba;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
14 Córdoba;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
14 Córdoba;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
14 Córdoba;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2022QIII;4.571
14 Córdoba;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2022QII;""
14 Córdoba;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2022QI;""
14 Córdoba;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
14 Córdoba;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2021QIII;4.462
14 Córdoba;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2021QII;""
14 Córdoba;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2021QI;""
14 Córdoba;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
14 Córdoba;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2020QIII;4.248
14 Córdoba;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2020QII;""
14 Córdoba;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2020QI;""
14 Córdoba;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2022QIV;4.454
14 Córdoba;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
14 Córdoba;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2022QII;""
14 Córdoba;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2022QI;""
14 Córdoba;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2021QIV;4.384
14 Córdoba;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
14 Córdoba;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2021QII;""
14 Córdoba;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2021QI;""
14 Córdoba;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2020QIV;4.169
14 Córdoba;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
14 Córdoba;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2020QII;""
14 Córdoba;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2020QI;""
14 Córdoba;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
14 Córdoba;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
14 Córdoba;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QII;""
14 Córdoba;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QI;4.300
14 Córdoba;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
14 Córdoba;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
14 Córdoba;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QII;""
14 Córdoba;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QI;4.102
14 Córdoba;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
14 Córdoba;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
14 Córdoba;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QII;""
14 Córdoba;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QI;""
14 Córdoba;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
14 Córdoba;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
14 Córdoba;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QII;4.197
14 Córdoba;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QI;""
14 Córdoba;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
14 Córdoba;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
14 Córdoba;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QII;4.052
14 Córdoba;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QI;""
14 Córdoba;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
14 Córdoba;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
14 Córdoba;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QII;""
14 Córdoba;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QI;""
14 Córdoba;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
14 Córdoba;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
14 Córdoba;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
14 Córdoba;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
14 Córdoba;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
14 Córdoba;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
14 Córdoba;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
14 Córdoba;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
14 Córdoba;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
14 Córdoba;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
14 Córdoba;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
14 Córdoba;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
14 Córdoba;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
14 Córdoba;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;97,75
14 Córdoba;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
14 Córdoba;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
14 Córdoba;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
14 Córdoba;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;97,85
14 Córdoba;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
14 Córdoba;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
14 Córdoba;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
14 Córdoba;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;97,97
14 Córdoba;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
14 Córdoba;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
14 Córdoba;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;95,25
14 Córdoba;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
14 Córdoba;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
14 Córdoba;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
14 Córdoba;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;96,14
14 Córdoba;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
14 Córdoba;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
14 Córdoba;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
14 Córdoba;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;96,15
14 Córdoba;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
14 Córdoba;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
14 Córdoba;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
14 Córdoba;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
14 Córdoba;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
14 Córdoba;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
14 Córdoba;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;94,3
14 Córdoba;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
14 Córdoba;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
14 Córdoba;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
14 Córdoba;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;94,6
14 Córdoba;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
14 Córdoba;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
14 Córdoba;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
14 Córdoba;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
14 Córdoba;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
14 Córdoba;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
14 Córdoba;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;92,04
14 Córdoba;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
14 Córdoba;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
14 Córdoba;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
14 Córdoba;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;93,45
14 Córdoba;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
14 Córdoba;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
14 Córdoba;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
14 Córdoba;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
14 Córdoba;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
14 Córdoba;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QIV;14.185
14 Córdoba;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
14 Córdoba;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
14 Córdoba;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
14 Córdoba;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QIV;14.017
14 Córdoba;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
14 Córdoba;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
14 Córdoba;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
14 Córdoba;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QIV;13.630
14 Córdoba;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
14 Córdoba;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
14 Córdoba;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
14 Córdoba;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2022QIV;13.815
14 Córdoba;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
14 Córdoba;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2022QII;""
14 Córdoba;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2022QI;""
14 Córdoba;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2021QIV;13.712
14 Córdoba;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
14 Córdoba;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2021QII;""
14 Córdoba;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2021QI;""
14 Córdoba;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2020QIV;13.333
14 Córdoba;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
14 Córdoba;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2020QII;""
14 Córdoba;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2020QI;""
14 Córdoba;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
14 Córdoba;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
14 Córdoba;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2022QII;""
14 Córdoba;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2022QI;13.484
14 Córdoba;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
14 Córdoba;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
14 Córdoba;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2021QII;""
14 Córdoba;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2021QI;13.149
14 Córdoba;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
14 Córdoba;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
14 Córdoba;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2020QII;""
14 Córdoba;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2020QI;""
14 Córdoba;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
14 Córdoba;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
14 Córdoba;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QII;13.226
14 Córdoba;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QI;""
14 Córdoba;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
14 Córdoba;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
14 Córdoba;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QII;12.987
14 Córdoba;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QI;""
14 Córdoba;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
14 Córdoba;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
14 Córdoba;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QII;""
14 Córdoba;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QI;""
14 Córdoba;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
14 Córdoba;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QIII;13.034
14 Córdoba;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QII;""
14 Córdoba;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QI;""
14 Córdoba;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
14 Córdoba;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QIII;12.830
14 Córdoba;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QII;""
14 Córdoba;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QI;""
14 Córdoba;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
14 Córdoba;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
14 Córdoba;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QII;""
14 Córdoba;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QI;""
14 Córdoba;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
14 Córdoba;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
14 Córdoba;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
14 Córdoba;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
14 Córdoba;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
14 Córdoba;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
14 Córdoba;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
14 Córdoba;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
14 Córdoba;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
14 Córdoba;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
14 Córdoba;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
14 Córdoba;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
14 Córdoba;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;97,39
14 Córdoba;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
14 Córdoba;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
14 Córdoba;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
14 Córdoba;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;97,82
14 Córdoba;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
14 Córdoba;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
14 Córdoba;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
14 Córdoba;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;97,82
14 Córdoba;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
14 Córdoba;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
14 Córdoba;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
14 Córdoba;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
14 Córdoba;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
14 Córdoba;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
14 Córdoba;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;96,2
14 Córdoba;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
14 Córdoba;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
14 Córdoba;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
14 Córdoba;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;96,47
14 Córdoba;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
14 Córdoba;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
14 Córdoba;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
14 Córdoba;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
14 Córdoba;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
14 Córdoba;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
14 Córdoba;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;94,36
14 Córdoba;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
14 Córdoba;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
14 Córdoba;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
14 Córdoba;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;95,28
14 Córdoba;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
14 Córdoba;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
14 Córdoba;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
14 Córdoba;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
14 Córdoba;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
14 Córdoba;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
14 Córdoba;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;92,99
14 Córdoba;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
14 Córdoba;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
14 Córdoba;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
14 Córdoba;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;94,13
14 Córdoba;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
14 Córdoba;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
14 Córdoba;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
14 Córdoba;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
14 Córdoba;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
14 Córdoba;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
14 Córdoba;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QIV;9.510
14 Córdoba;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
14 Córdoba;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
14 Córdoba;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
14 Córdoba;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QIV;9.480
14 Córdoba;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
14 Córdoba;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
14 Córdoba;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
14 Córdoba;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QIV;9.279
14 Córdoba;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
14 Córdoba;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
14 Córdoba;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
14 Córdoba;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2022QIV;9.272
14 Córdoba;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
14 Córdoba;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2022QII;""
14 Córdoba;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2022QI;""
14 Córdoba;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2021QIV;9.263
14 Córdoba;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
14 Córdoba;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2021QII;""
14 Córdoba;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2021QI;""
14 Córdoba;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2020QIV;9.075
14 Córdoba;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
14 Córdoba;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2020QII;""
14 Córdoba;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2020QI;""
14 Córdoba;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
14 Córdoba;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
14 Córdoba;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2022QII;""
14 Córdoba;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2022QI;9.125
14 Córdoba;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
14 Córdoba;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
14 Córdoba;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2021QII;""
14 Córdoba;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2021QI;8.962
14 Córdoba;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
14 Córdoba;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
14 Córdoba;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2020QII;""
14 Córdoba;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2020QI;""
14 Córdoba;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
14 Córdoba;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
14 Córdoba;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QII;8.972
14 Córdoba;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QI;""
14 Córdoba;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
14 Córdoba;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
14 Córdoba;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QII;8.855
14 Córdoba;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QI;""
14 Córdoba;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
14 Córdoba;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
14 Córdoba;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QII;""
14 Córdoba;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QI;""
14 Córdoba;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
14 Córdoba;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QIII;8.850
14 Córdoba;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QII;""
14 Córdoba;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QI;""
14 Córdoba;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
14 Córdoba;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QIII;8.761
14 Córdoba;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QII;""
14 Córdoba;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QI;""
14 Córdoba;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
14 Córdoba;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
14 Córdoba;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QII;""
14 Córdoba;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QI;""
14 Córdoba;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
14 Córdoba;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
14 Córdoba;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
14 Córdoba;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
14 Córdoba;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
14 Córdoba;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
14 Córdoba;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
14 Córdoba;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
14 Córdoba;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
14 Córdoba;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
14 Córdoba;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
14 Córdoba;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
14 Córdoba;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;97,5
14 Córdoba;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
14 Córdoba;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
14 Córdoba;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
14 Córdoba;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;97,71
14 Córdoba;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
14 Córdoba;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
14 Córdoba;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
14 Córdoba;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;97,8
14 Córdoba;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
14 Córdoba;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
14 Córdoba;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
14 Córdoba;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
14 Córdoba;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
14 Córdoba;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
14 Córdoba;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;96,26
14 Córdoba;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
14 Córdoba;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
14 Córdoba;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
14 Córdoba;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;96,58
14 Córdoba;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
14 Córdoba;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
14 Córdoba;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
14 Córdoba;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
14 Córdoba;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
14 Córdoba;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
14 Córdoba;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;94,64
14 Córdoba;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
14 Córdoba;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
14 Córdoba;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
14 Córdoba;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;95,43
14 Córdoba;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
14 Córdoba;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
14 Córdoba;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
14 Córdoba;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
14 Córdoba;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
14 Córdoba;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
14 Córdoba;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;93,35
14 Córdoba;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
14 Córdoba;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
14 Córdoba;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
14 Córdoba;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;94,42
14 Córdoba;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
14 Córdoba;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
14 Córdoba;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
14 Córdoba;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
14 Córdoba;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
14 Córdoba;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
14 Córdoba;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QIV;4.675
14 Córdoba;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
14 Córdoba;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
14 Córdoba;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
14 Córdoba;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QIV;4.537
14 Córdoba;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
14 Córdoba;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
14 Córdoba;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
14 Córdoba;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QIV;4.351
14 Córdoba;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
14 Córdoba;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
14 Córdoba;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
14 Córdoba;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2022QIV;4.543
14 Córdoba;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
14 Córdoba;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2022QII;""
14 Córdoba;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2022QI;""
14 Córdoba;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2021QIV;4.449
14 Córdoba;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
14 Córdoba;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2021QII;""
14 Córdoba;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2021QI;""
14 Córdoba;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2020QIV;4.258
14 Córdoba;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
14 Córdoba;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2020QII;""
14 Córdoba;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2020QI;""
14 Córdoba;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
14 Córdoba;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
14 Córdoba;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2022QII;""
14 Córdoba;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2022QI;4.359
14 Córdoba;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
14 Córdoba;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
14 Córdoba;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2021QII;""
14 Córdoba;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2021QI;4.187
14 Córdoba;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
14 Córdoba;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
14 Córdoba;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2020QII;""
14 Córdoba;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2020QI;""
14 Córdoba;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
14 Córdoba;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
14 Córdoba;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QII;4.254
14 Córdoba;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QI;""
14 Córdoba;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
14 Córdoba;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
14 Córdoba;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QII;4.132
14 Córdoba;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QI;""
14 Córdoba;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
14 Córdoba;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
14 Córdoba;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QII;""
14 Córdoba;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QI;""
14 Córdoba;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
14 Córdoba;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QIII;4.184
14 Córdoba;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QII;""
14 Córdoba;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QI;""
14 Córdoba;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
14 Córdoba;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QIII;4.069
14 Córdoba;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QII;""
14 Córdoba;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QI;""
14 Córdoba;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
14 Córdoba;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
14 Córdoba;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QII;""
14 Córdoba;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QI;""
14 Córdoba;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
14 Córdoba;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
14 Córdoba;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
14 Córdoba;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
14 Córdoba;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
14 Córdoba;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
14 Córdoba;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
14 Córdoba;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
14 Córdoba;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
14 Córdoba;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
14 Córdoba;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
14 Córdoba;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
14 Córdoba;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;97,18
14 Córdoba;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
14 Córdoba;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
14 Córdoba;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
14 Córdoba;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;98,06
14 Córdoba;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
14 Córdoba;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
14 Córdoba;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
14 Córdoba;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;97,86
14 Córdoba;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
14 Córdoba;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
14 Córdoba;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
14 Córdoba;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
14 Córdoba;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
14 Córdoba;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
14 Córdoba;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;96,08
14 Córdoba;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
14 Córdoba;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
14 Córdoba;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
14 Córdoba;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;96,23
14 Córdoba;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
14 Córdoba;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
14 Córdoba;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
14 Córdoba;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
14 Córdoba;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
14 Córdoba;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
14 Córdoba;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;93,76
14 Córdoba;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
14 Córdoba;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
14 Córdoba;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
14 Córdoba;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;94,97
14 Córdoba;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
14 Córdoba;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
14 Córdoba;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
14 Córdoba;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
14 Córdoba;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
14 Córdoba;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
14 Córdoba;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;92,22
14 Córdoba;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
14 Córdoba;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
14 Córdoba;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
14 Córdoba;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;93,52
14 Córdoba;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
14 Córdoba;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
14 Córdoba;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
14 Córdoba;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
14 Córdoba;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
14 Córdoba;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
14 Córdoba;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
14 Córdoba;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
14 Córdoba;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
14 Córdoba;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QI;6.006
14 Córdoba;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
14 Córdoba;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
14 Córdoba;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
14 Córdoba;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QI;5.554
14 Córdoba;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
14 Córdoba;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
14 Córdoba;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
14 Córdoba;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QI;6.420
14 Córdoba;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
14 Córdoba;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
14 Córdoba;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2022QII;""
14 Córdoba;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2022QI;5.793
14 Córdoba;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
14 Córdoba;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
14 Córdoba;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2021QII;""
14 Córdoba;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2021QI;5.368
14 Córdoba;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
14 Córdoba;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
14 Córdoba;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2020QII;""
14 Córdoba;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2020QI;5.976
14 Córdoba;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
14 Córdoba;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
14 Córdoba;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2022QII;5.564
14 Córdoba;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2022QI;""
14 Córdoba;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
14 Córdoba;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
14 Córdoba;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2021QII;5.146
14 Córdoba;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2021QI;""
14 Córdoba;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
14 Córdoba;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
14 Córdoba;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2020QII;5.779
14 Córdoba;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2020QI;""
14 Córdoba;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
14 Córdoba;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QIII;5.331
14 Córdoba;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QII;""
14 Córdoba;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QI;""
14 Córdoba;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
14 Córdoba;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QIII;4.937
14 Córdoba;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QII;""
14 Córdoba;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QI;""
14 Córdoba;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
14 Córdoba;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QIII;5.544
14 Córdoba;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QII;""
14 Córdoba;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QI;""
14 Córdoba;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QIV;5.003
14 Córdoba;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
14 Córdoba;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QII;""
14 Córdoba;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QI;""
14 Córdoba;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QIV;4.712
14 Córdoba;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
14 Córdoba;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QII;""
14 Córdoba;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QI;""
14 Córdoba;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QIV;5.277
14 Córdoba;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
14 Córdoba;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QII;""
14 Córdoba;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QI;""
14 Córdoba;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
14 Córdoba;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
14 Córdoba;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
14 Córdoba;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
14 Córdoba;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
14 Córdoba;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
14 Córdoba;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
14 Córdoba;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
14 Córdoba;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
14 Córdoba;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
14 Córdoba;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
14 Córdoba;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
14 Córdoba;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
14 Córdoba;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
14 Córdoba;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
14 Córdoba;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;96,45
14 Córdoba;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
14 Córdoba;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
14 Córdoba;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
14 Córdoba;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;96,65
14 Córdoba;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
14 Córdoba;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
14 Córdoba;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
14 Córdoba;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;93,08
14 Córdoba;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
14 Córdoba;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
14 Córdoba;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;92,64
14 Córdoba;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
14 Córdoba;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
14 Córdoba;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
14 Córdoba;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;92,65
14 Córdoba;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
14 Córdoba;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
14 Córdoba;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
14 Córdoba;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;90,02
14 Córdoba;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
14 Córdoba;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
14 Córdoba;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;88,76
14 Córdoba;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
14 Córdoba;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
14 Córdoba;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
14 Córdoba;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;88,89
14 Córdoba;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
14 Córdoba;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
14 Córdoba;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
14 Córdoba;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;86,36
14 Córdoba;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
14 Córdoba;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
14 Córdoba;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;83,3
14 Córdoba;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
14 Córdoba;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
14 Córdoba;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
14 Córdoba;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;84,84
14 Córdoba;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
14 Córdoba;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
14 Córdoba;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
14 Córdoba;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;82,2
14 Córdoba;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
14 Córdoba;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
14 Córdoba;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
14 Córdoba;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
14 Córdoba;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
14 Córdoba;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
14 Córdoba;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QI;4.040
14 Córdoba;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
14 Córdoba;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
14 Córdoba;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
14 Córdoba;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QI;3.777
14 Córdoba;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
14 Córdoba;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
14 Córdoba;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
14 Córdoba;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QI;4.351
14 Córdoba;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
14 Córdoba;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
14 Córdoba;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2022QII;""
14 Córdoba;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2022QI;3.905
14 Córdoba;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
14 Córdoba;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
14 Córdoba;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2021QII;""
14 Córdoba;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2021QI;3.638
14 Córdoba;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
14 Córdoba;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
14 Córdoba;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2020QII;""
14 Córdoba;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2020QI;4.064
14 Córdoba;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
14 Córdoba;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
14 Córdoba;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2022QII;3.761
14 Córdoba;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2022QI;""
14 Córdoba;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
14 Córdoba;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
14 Córdoba;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2021QII;3.495
14 Córdoba;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2021QI;""
14 Córdoba;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
14 Córdoba;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
14 Córdoba;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2020QII;3.935
14 Córdoba;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2020QI;""
14 Córdoba;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
14 Córdoba;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QIII;3.615
14 Córdoba;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QII;""
14 Córdoba;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QI;""
14 Córdoba;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
14 Córdoba;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QIII;3.346
14 Córdoba;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QII;""
14 Córdoba;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QI;""
14 Córdoba;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
14 Córdoba;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QIII;3.781
14 Córdoba;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QII;""
14 Córdoba;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QI;""
14 Córdoba;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QIV;3.406
14 Córdoba;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
14 Córdoba;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QII;""
14 Córdoba;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QI;""
14 Córdoba;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QIV;3.187
14 Córdoba;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
14 Córdoba;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QII;""
14 Córdoba;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QI;""
14 Córdoba;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QIV;3.598
14 Córdoba;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
14 Córdoba;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QII;""
14 Córdoba;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QI;""
14 Córdoba;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
14 Córdoba;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
14 Córdoba;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
14 Córdoba;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
14 Córdoba;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
14 Córdoba;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
14 Córdoba;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
14 Córdoba;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
14 Córdoba;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
14 Córdoba;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
14 Córdoba;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
14 Córdoba;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
14 Córdoba;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
14 Córdoba;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
14 Córdoba;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
14 Córdoba;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;96,66
14 Córdoba;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
14 Córdoba;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
14 Córdoba;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
14 Córdoba;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;96,32
14 Córdoba;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
14 Córdoba;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
14 Córdoba;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
14 Córdoba;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;93,4
14 Córdoba;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
14 Córdoba;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
14 Córdoba;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;93,09
14 Córdoba;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
14 Córdoba;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
14 Córdoba;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
14 Córdoba;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;92,53
14 Córdoba;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
14 Córdoba;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
14 Córdoba;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
14 Córdoba;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;90,44
14 Córdoba;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
14 Córdoba;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
14 Córdoba;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;89,48
14 Córdoba;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
14 Córdoba;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
14 Córdoba;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
14 Córdoba;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;88,59
14 Córdoba;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
14 Córdoba;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
14 Córdoba;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
14 Córdoba;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;86,9
14 Córdoba;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
14 Córdoba;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
14 Córdoba;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;84,31
14 Córdoba;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
14 Córdoba;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
14 Córdoba;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
14 Córdoba;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;84,38
14 Córdoba;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
14 Córdoba;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
14 Córdoba;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
14 Córdoba;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;82,69
14 Córdoba;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
14 Córdoba;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
14 Córdoba;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
14 Córdoba;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
14 Córdoba;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
14 Córdoba;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
14 Córdoba;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QI;1.966
14 Córdoba;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
14 Córdoba;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
14 Córdoba;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
14 Córdoba;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QI;1.777
14 Córdoba;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
14 Córdoba;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
14 Córdoba;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
14 Córdoba;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QI;2.069
14 Córdoba;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
14 Córdoba;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
14 Córdoba;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2022QII;""
14 Córdoba;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2022QI;1.888
14 Córdoba;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
14 Córdoba;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
14 Córdoba;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2021QII;""
14 Córdoba;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2021QI;1.730
14 Córdoba;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
14 Córdoba;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
14 Córdoba;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2020QII;""
14 Córdoba;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2020QI;1.912
14 Córdoba;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
14 Córdoba;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
14 Córdoba;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2022QII;1.803
14 Córdoba;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2022QI;""
14 Córdoba;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
14 Córdoba;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
14 Córdoba;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2021QII;1.651
14 Córdoba;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2021QI;""
14 Córdoba;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
14 Córdoba;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
14 Córdoba;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2020QII;1.844
14 Córdoba;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2020QI;""
14 Córdoba;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
14 Córdoba;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QIII;1.716
14 Córdoba;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QII;""
14 Córdoba;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QI;""
14 Córdoba;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
14 Córdoba;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QIII;1.591
14 Córdoba;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QII;""
14 Córdoba;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QI;""
14 Córdoba;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
14 Córdoba;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QIII;1.763
14 Córdoba;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QII;""
14 Córdoba;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QI;""
14 Córdoba;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QIV;1.597
14 Córdoba;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
14 Córdoba;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QII;""
14 Córdoba;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QI;""
14 Córdoba;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QIV;1.525
14 Córdoba;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
14 Córdoba;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QII;""
14 Córdoba;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QI;""
14 Córdoba;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QIV;1.679
14 Córdoba;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
14 Córdoba;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QII;""
14 Córdoba;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QI;""
14 Córdoba;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
14 Córdoba;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
14 Córdoba;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
14 Córdoba;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
14 Córdoba;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
14 Córdoba;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
14 Córdoba;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
14 Córdoba;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
14 Córdoba;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
14 Córdoba;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
14 Córdoba;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
14 Córdoba;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
14 Córdoba;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
14 Córdoba;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
14 Córdoba;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
14 Córdoba;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;96,03
14 Córdoba;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
14 Córdoba;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
14 Córdoba;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
14 Córdoba;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;97,36
14 Córdoba;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
14 Córdoba;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
14 Córdoba;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
14 Córdoba;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;92,41
14 Córdoba;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
14 Córdoba;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
14 Córdoba;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;91,71
14 Córdoba;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
14 Córdoba;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
14 Córdoba;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
14 Córdoba;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;92,91
14 Córdoba;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
14 Córdoba;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
14 Córdoba;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
14 Córdoba;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;89,13
14 Córdoba;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
14 Córdoba;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
14 Córdoba;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;87,28
14 Córdoba;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
14 Córdoba;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
14 Córdoba;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
14 Córdoba;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;89,53
14 Córdoba;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
14 Córdoba;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
14 Córdoba;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
14 Córdoba;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;85,21
14 Córdoba;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
14 Córdoba;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
14 Córdoba;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;81,23
14 Córdoba;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
14 Córdoba;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
14 Córdoba;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
14 Córdoba;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;85,82
14 Córdoba;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
14 Córdoba;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
14 Córdoba;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
14 Córdoba;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;81,15
14 Córdoba;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
14 Córdoba;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
14 Córdoba;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
14 Córdoba;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
14 Córdoba;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
14 Córdoba;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QII;7.011
14 Córdoba;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
14 Córdoba;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
14 Córdoba;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
14 Córdoba;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QII;6.532
14 Córdoba;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
14 Córdoba;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
14 Córdoba;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
14 Córdoba;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QII;6.106
14 Córdoba;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
14 Córdoba;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
14 Córdoba;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
14 Córdoba;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2022QII;6.748
14 Córdoba;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2022QI;""
14 Córdoba;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
14 Córdoba;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
14 Córdoba;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2021QII;6.285
14 Córdoba;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2021QI;""
14 Córdoba;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
14 Córdoba;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
14 Córdoba;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2020QII;5.905
14 Córdoba;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2020QI;""
14 Córdoba;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
14 Córdoba;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2022QIII;6.489
14 Córdoba;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2022QII;""
14 Córdoba;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2022QI;""
14 Córdoba;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
14 Córdoba;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2021QIII;6.070
14 Córdoba;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2021QII;""
14 Córdoba;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2021QI;""
14 Córdoba;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
14 Córdoba;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2020QIII;5.639
14 Córdoba;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2020QII;""
14 Córdoba;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2020QI;""
14 Córdoba;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QIV;6.134
14 Córdoba;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
14 Córdoba;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QII;""
14 Córdoba;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QI;""
14 Córdoba;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QIV;5.825
14 Córdoba;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
14 Córdoba;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QII;""
14 Córdoba;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QI;""
14 Córdoba;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QIV;5.367
14 Córdoba;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
14 Córdoba;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QII;""
14 Córdoba;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QI;""
14 Córdoba;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
14 Córdoba;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
14 Córdoba;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QII;""
14 Córdoba;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QI;5.628
14 Córdoba;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
14 Córdoba;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
14 Córdoba;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QII;""
14 Córdoba;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QI;5.204
14 Córdoba;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
14 Córdoba;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
14 Córdoba;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QII;""
14 Córdoba;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QI;""
14 Córdoba;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
14 Córdoba;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
14 Córdoba;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
14 Córdoba;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
14 Córdoba;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
14 Córdoba;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
14 Córdoba;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
14 Córdoba;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
14 Córdoba;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
14 Córdoba;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
14 Córdoba;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
14 Córdoba;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
14 Córdoba;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
14 Córdoba;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
14 Córdoba;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;96,25
14 Córdoba;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
14 Córdoba;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
14 Córdoba;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
14 Córdoba;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;96,22
14 Córdoba;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
14 Córdoba;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
14 Córdoba;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
14 Córdoba;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;96,71
14 Córdoba;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
14 Córdoba;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
14 Córdoba;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;92,55
14 Córdoba;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
14 Córdoba;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
14 Córdoba;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
14 Córdoba;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;92,93
14 Córdoba;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
14 Córdoba;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
14 Córdoba;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
14 Córdoba;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;92,35
14 Córdoba;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
14 Córdoba;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
14 Córdoba;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;87,49
14 Córdoba;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
14 Córdoba;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
14 Córdoba;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
14 Córdoba;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;89,18
14 Córdoba;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
14 Córdoba;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
14 Córdoba;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
14 Córdoba;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;87,9
14 Córdoba;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
14 Córdoba;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
14 Córdoba;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
14 Córdoba;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
14 Córdoba;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
14 Córdoba;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
14 Córdoba;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;86,16
14 Córdoba;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
14 Córdoba;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
14 Córdoba;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
14 Córdoba;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;85,23
14 Córdoba;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
14 Córdoba;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
14 Córdoba;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
14 Córdoba;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
14 Córdoba;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
14 Córdoba;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
14 Córdoba;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QII;4.744
14 Córdoba;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
14 Córdoba;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
14 Córdoba;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
14 Córdoba;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QII;4.432
14 Córdoba;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
14 Córdoba;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
14 Córdoba;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
14 Córdoba;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QII;4.157
14 Córdoba;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
14 Córdoba;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
14 Córdoba;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
14 Córdoba;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2022QII;4.585
14 Córdoba;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2022QI;""
14 Córdoba;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
14 Córdoba;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
14 Córdoba;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2021QII;4.274
14 Córdoba;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2021QI;""
14 Córdoba;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
14 Córdoba;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
14 Córdoba;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2020QII;4.025
14 Córdoba;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2020QI;""
14 Córdoba;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
14 Córdoba;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2022QIII;4.424
14 Córdoba;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2022QII;""
14 Córdoba;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2022QI;""
14 Córdoba;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
14 Córdoba;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2021QIII;4.121
14 Córdoba;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2021QII;""
14 Córdoba;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2021QI;""
14 Córdoba;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
14 Córdoba;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2020QIII;3.849
14 Córdoba;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2020QII;""
14 Córdoba;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2020QI;""
14 Córdoba;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QIV;4.200
14 Córdoba;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
14 Córdoba;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QII;""
14 Córdoba;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QI;""
14 Córdoba;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QIV;3.947
14 Córdoba;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
14 Córdoba;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QII;""
14 Córdoba;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QI;""
14 Córdoba;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QIV;3.664
14 Córdoba;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
14 Córdoba;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QII;""
14 Córdoba;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QI;""
14 Córdoba;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
14 Córdoba;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
14 Córdoba;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QII;""
14 Córdoba;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QI;3.821
14 Córdoba;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
14 Córdoba;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
14 Córdoba;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QII;""
14 Córdoba;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QI;3.543
14 Córdoba;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
14 Córdoba;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
14 Córdoba;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QII;""
14 Córdoba;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QI;""
14 Córdoba;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
14 Córdoba;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
14 Córdoba;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
14 Córdoba;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
14 Córdoba;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
14 Córdoba;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
14 Córdoba;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
14 Córdoba;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
14 Córdoba;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
14 Córdoba;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
14 Córdoba;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
14 Córdoba;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
14 Córdoba;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
14 Córdoba;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
14 Córdoba;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;96,65
14 Córdoba;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
14 Córdoba;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
14 Córdoba;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
14 Córdoba;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;96,44
14 Córdoba;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
14 Córdoba;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
14 Córdoba;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
14 Córdoba;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;96,82
14 Córdoba;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
14 Córdoba;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
14 Córdoba;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;93,25
14 Córdoba;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
14 Córdoba;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
14 Córdoba;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
14 Córdoba;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;92,98
14 Córdoba;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
14 Córdoba;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
14 Córdoba;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
14 Córdoba;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;92,59
14 Córdoba;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
14 Córdoba;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
14 Córdoba;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;88,53
14 Córdoba;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
14 Córdoba;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
14 Córdoba;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
14 Córdoba;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;89,06
14 Córdoba;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
14 Córdoba;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
14 Córdoba;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
14 Córdoba;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;88,14
14 Córdoba;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
14 Córdoba;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
14 Córdoba;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
14 Córdoba;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
14 Córdoba;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
14 Córdoba;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
14 Córdoba;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;86,21
14 Córdoba;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
14 Córdoba;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
14 Córdoba;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
14 Córdoba;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;85,23
14 Córdoba;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
14 Córdoba;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
14 Córdoba;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
14 Córdoba;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
14 Córdoba;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
14 Córdoba;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
14 Córdoba;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QII;2.267
14 Córdoba;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
14 Córdoba;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
14 Córdoba;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
14 Córdoba;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QII;2.100
14 Córdoba;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
14 Córdoba;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
14 Córdoba;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
14 Córdoba;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QII;1.949
14 Córdoba;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
14 Córdoba;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
14 Córdoba;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
14 Córdoba;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2022QII;2.163
14 Córdoba;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2022QI;""
14 Córdoba;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
14 Córdoba;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
14 Córdoba;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2021QII;2.011
14 Córdoba;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2021QI;""
14 Córdoba;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
14 Córdoba;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
14 Córdoba;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2020QII;1.880
14 Córdoba;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2020QI;""
14 Córdoba;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
14 Córdoba;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2022QIII;2.065
14 Córdoba;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2022QII;""
14 Córdoba;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2022QI;""
14 Córdoba;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
14 Córdoba;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2021QIII;1.949
14 Córdoba;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2021QII;""
14 Córdoba;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2021QI;""
14 Córdoba;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
14 Córdoba;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2020QIII;1.790
14 Córdoba;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2020QII;""
14 Córdoba;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2020QI;""
14 Córdoba;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QIV;1.934
14 Córdoba;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
14 Córdoba;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QII;""
14 Córdoba;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QI;""
14 Córdoba;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QIV;1.878
14 Córdoba;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
14 Córdoba;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QII;""
14 Córdoba;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QI;""
14 Córdoba;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QIV;1.703
14 Córdoba;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
14 Córdoba;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QII;""
14 Córdoba;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QI;""
14 Córdoba;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
14 Córdoba;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
14 Córdoba;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QII;""
14 Córdoba;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QI;1.807
14 Córdoba;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
14 Córdoba;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
14 Córdoba;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QII;""
14 Córdoba;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QI;1.661
14 Córdoba;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
14 Córdoba;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
14 Córdoba;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QII;""
14 Córdoba;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QI;""
14 Córdoba;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
14 Córdoba;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
14 Córdoba;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
14 Córdoba;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
14 Córdoba;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
14 Córdoba;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
14 Córdoba;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
14 Córdoba;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
14 Córdoba;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
14 Córdoba;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
14 Córdoba;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
14 Córdoba;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
14 Córdoba;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
14 Córdoba;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
14 Córdoba;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;95,41
14 Córdoba;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
14 Córdoba;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
14 Córdoba;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
14 Córdoba;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;95,76
14 Córdoba;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
14 Córdoba;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
14 Córdoba;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
14 Córdoba;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;96,46
14 Córdoba;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
14 Córdoba;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
14 Córdoba;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;91,09
14 Córdoba;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
14 Córdoba;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
14 Córdoba;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
14 Córdoba;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;92,81
14 Córdoba;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
14 Córdoba;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
14 Córdoba;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
14 Córdoba;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;91,84
14 Córdoba;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
14 Córdoba;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
14 Córdoba;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;85,31
14 Córdoba;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
14 Córdoba;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
14 Córdoba;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
14 Córdoba;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;89,43
14 Córdoba;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
14 Córdoba;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
14 Córdoba;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
14 Córdoba;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;87,38
14 Córdoba;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
14 Córdoba;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
14 Córdoba;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
14 Córdoba;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
14 Córdoba;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
14 Córdoba;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
14 Córdoba;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;86,05
14 Córdoba;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
14 Córdoba;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
14 Córdoba;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
14 Córdoba;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;85,22
14 Córdoba;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
14 Córdoba;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
14 Córdoba;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
14 Córdoba;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
14 Córdoba;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
14 Córdoba;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QIII;6.844
14 Córdoba;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
14 Córdoba;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
14 Córdoba;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
14 Córdoba;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QIII;6.401
14 Córdoba;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
14 Córdoba;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
14 Córdoba;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
14 Córdoba;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QIII;5.998
14 Córdoba;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
14 Córdoba;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
14 Córdoba;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
14 Córdoba;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2022QIII;6.566
14 Córdoba;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2022QII;""
14 Córdoba;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2022QI;""
14 Córdoba;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
14 Córdoba;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2021QIII;6.172
14 Córdoba;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2021QII;""
14 Córdoba;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2021QI;""
14 Córdoba;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
14 Córdoba;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2020QIII;5.715
14 Córdoba;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2020QII;""
14 Córdoba;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2020QI;""
14 Córdoba;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2022QIV;6.197
14 Córdoba;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
14 Córdoba;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2022QII;""
14 Córdoba;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2022QI;""
14 Córdoba;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2021QIV;5.905
14 Córdoba;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
14 Córdoba;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2021QII;""
14 Córdoba;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2021QI;""
14 Córdoba;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2020QIV;5.427
14 Córdoba;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
14 Córdoba;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2020QII;""
14 Córdoba;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2020QI;""
14 Córdoba;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
14 Córdoba;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
14 Córdoba;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QII;""
14 Córdoba;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QI;5.703
14 Córdoba;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
14 Córdoba;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
14 Córdoba;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QII;""
14 Córdoba;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QI;5.260
14 Córdoba;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
14 Córdoba;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
14 Córdoba;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QII;""
14 Córdoba;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QI;""
14 Córdoba;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
14 Córdoba;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
14 Córdoba;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QII;5.486
14 Córdoba;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QI;""
14 Córdoba;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
14 Córdoba;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
14 Córdoba;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QII;5.053
14 Córdoba;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QI;""
14 Córdoba;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
14 Córdoba;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
14 Córdoba;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QII;""
14 Córdoba;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QI;""
14 Córdoba;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
14 Córdoba;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
14 Córdoba;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
14 Córdoba;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
14 Córdoba;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
14 Córdoba;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
14 Córdoba;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
14 Córdoba;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
14 Córdoba;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
14 Córdoba;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
14 Córdoba;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
14 Córdoba;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
14 Córdoba;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
14 Córdoba;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;95,94
14 Córdoba;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
14 Córdoba;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
14 Córdoba;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
14 Córdoba;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;96,42
14 Córdoba;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
14 Córdoba;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
14 Córdoba;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
14 Córdoba;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;95,28
14 Córdoba;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
14 Córdoba;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
14 Córdoba;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;90,55
14 Córdoba;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
14 Córdoba;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
14 Córdoba;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
14 Córdoba;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;92,25
14 Córdoba;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
14 Córdoba;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
14 Córdoba;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
14 Córdoba;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;90,48
14 Córdoba;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
14 Córdoba;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
14 Córdoba;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
14 Córdoba;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
14 Córdoba;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
14 Córdoba;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
14 Córdoba;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;89,1
14 Córdoba;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
14 Córdoba;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
14 Córdoba;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
14 Córdoba;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;87,7
14 Córdoba;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
14 Córdoba;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
14 Córdoba;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
14 Córdoba;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
14 Córdoba;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
14 Córdoba;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
14 Córdoba;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;85,71
14 Córdoba;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
14 Córdoba;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
14 Córdoba;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
14 Córdoba;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;84,24
14 Córdoba;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
14 Córdoba;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
14 Córdoba;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
14 Córdoba;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
14 Córdoba;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
14 Córdoba;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
14 Córdoba;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QIII;4.650
14 Córdoba;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
14 Córdoba;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
14 Córdoba;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
14 Córdoba;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QIII;4.344
14 Córdoba;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
14 Córdoba;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
14 Córdoba;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
14 Córdoba;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QIII;4.092
14 Córdoba;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
14 Córdoba;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
14 Córdoba;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
14 Córdoba;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2022QIII;4.479
14 Córdoba;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2022QII;""
14 Córdoba;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2022QI;""
14 Córdoba;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
14 Córdoba;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2021QIII;4.182
14 Córdoba;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2021QII;""
14 Córdoba;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2021QI;""
14 Córdoba;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
14 Córdoba;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2020QIII;3.902
14 Córdoba;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2020QII;""
14 Córdoba;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2020QI;""
14 Córdoba;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2022QIV;4.242
14 Córdoba;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
14 Córdoba;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2022QII;""
14 Córdoba;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2022QI;""
14 Córdoba;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2021QIV;3.992
14 Córdoba;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
14 Córdoba;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2021QII;""
14 Córdoba;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2021QI;""
14 Córdoba;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2020QIV;3.702
14 Córdoba;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
14 Córdoba;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2020QII;""
14 Córdoba;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2020QI;""
14 Córdoba;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
14 Córdoba;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
14 Córdoba;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QII;""
14 Córdoba;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QI;3.862
14 Córdoba;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
14 Córdoba;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
14 Córdoba;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QII;""
14 Córdoba;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QI;3.577
14 Córdoba;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
14 Córdoba;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
14 Córdoba;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QII;""
14 Córdoba;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QI;""
14 Córdoba;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
14 Córdoba;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
14 Córdoba;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QII;3.725
14 Córdoba;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QI;""
14 Córdoba;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
14 Córdoba;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
14 Córdoba;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QII;3.442
14 Córdoba;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QI;""
14 Córdoba;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
14 Córdoba;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
14 Córdoba;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QII;""
14 Córdoba;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QI;""
14 Córdoba;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
14 Córdoba;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
14 Córdoba;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
14 Córdoba;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
14 Córdoba;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
14 Córdoba;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
14 Córdoba;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
14 Córdoba;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
14 Córdoba;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
14 Córdoba;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
14 Córdoba;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
14 Córdoba;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
14 Córdoba;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
14 Córdoba;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;96,32
14 Córdoba;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
14 Córdoba;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
14 Córdoba;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
14 Córdoba;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;96,27
14 Córdoba;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
14 Córdoba;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
14 Córdoba;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
14 Córdoba;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;95,36
14 Córdoba;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
14 Córdoba;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
14 Córdoba;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;91,23
14 Córdoba;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
14 Córdoba;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
14 Córdoba;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
14 Córdoba;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;91,9
14 Córdoba;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
14 Córdoba;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
14 Córdoba;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
14 Córdoba;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;90,47
14 Córdoba;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
14 Córdoba;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
14 Córdoba;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
14 Córdoba;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
14 Córdoba;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
14 Córdoba;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
14 Córdoba;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;88,9
14 Córdoba;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
14 Córdoba;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
14 Córdoba;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
14 Córdoba;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;87,41
14 Córdoba;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
14 Córdoba;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
14 Córdoba;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
14 Córdoba;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
14 Córdoba;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
14 Córdoba;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
14 Córdoba;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;85,75
14 Córdoba;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
14 Córdoba;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
14 Córdoba;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
14 Córdoba;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;84,12
14 Córdoba;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
14 Córdoba;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
14 Córdoba;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
14 Córdoba;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
14 Córdoba;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
14 Córdoba;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
14 Córdoba;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QIII;2.194
14 Córdoba;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
14 Córdoba;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
14 Córdoba;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
14 Córdoba;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QIII;2.057
14 Córdoba;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
14 Córdoba;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
14 Córdoba;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
14 Córdoba;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QIII;1.906
14 Córdoba;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
14 Córdoba;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
14 Córdoba;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
14 Córdoba;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2022QIII;2.087
14 Córdoba;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2022QII;""
14 Córdoba;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2022QI;""
14 Córdoba;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
14 Córdoba;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2021QIII;1.990
14 Córdoba;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2021QII;""
14 Córdoba;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2021QI;""
14 Córdoba;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
14 Córdoba;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2020QIII;1.813
14 Córdoba;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2020QII;""
14 Córdoba;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2020QI;""
14 Córdoba;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2022QIV;1.955
14 Córdoba;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
14 Córdoba;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2022QII;""
14 Córdoba;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2022QI;""
14 Córdoba;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2021QIV;1.913
14 Córdoba;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
14 Córdoba;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2021QII;""
14 Córdoba;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2021QI;""
14 Córdoba;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2020QIV;1.725
14 Córdoba;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
14 Córdoba;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2020QII;""
14 Córdoba;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2020QI;""
14 Córdoba;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
14 Córdoba;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
14 Córdoba;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QII;""
14 Córdoba;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QI;1.841
14 Córdoba;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
14 Córdoba;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
14 Córdoba;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QII;""
14 Córdoba;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QI;1.683
14 Córdoba;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
14 Córdoba;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
14 Córdoba;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QII;""
14 Córdoba;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QI;""
14 Córdoba;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
14 Córdoba;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
14 Córdoba;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QII;1.761
14 Córdoba;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QI;""
14 Córdoba;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
14 Córdoba;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
14 Córdoba;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QII;1.611
14 Córdoba;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QI;""
14 Córdoba;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
14 Córdoba;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
14 Córdoba;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QII;""
14 Córdoba;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QI;""
14 Córdoba;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
14 Córdoba;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
14 Córdoba;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
14 Córdoba;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
14 Córdoba;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
14 Córdoba;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
14 Córdoba;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
14 Córdoba;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
14 Córdoba;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
14 Córdoba;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
14 Córdoba;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
14 Córdoba;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
14 Córdoba;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
14 Córdoba;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;95,12
14 Córdoba;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
14 Córdoba;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
14 Córdoba;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
14 Córdoba;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;96,74
14 Córdoba;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
14 Córdoba;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
14 Córdoba;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
14 Córdoba;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;95,12
14 Córdoba;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
14 Córdoba;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
14 Córdoba;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;89,11
14 Córdoba;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
14 Córdoba;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
14 Córdoba;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
14 Córdoba;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;93
14 Córdoba;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
14 Córdoba;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
14 Córdoba;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
14 Córdoba;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;90,5
14 Córdoba;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
14 Córdoba;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
14 Córdoba;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
14 Córdoba;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
14 Córdoba;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
14 Córdoba;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
14 Córdoba;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;89,5
14 Córdoba;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
14 Córdoba;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
14 Córdoba;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
14 Córdoba;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;88,3
14 Córdoba;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
14 Córdoba;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
14 Córdoba;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
14 Córdoba;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
14 Córdoba;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
14 Córdoba;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
14 Córdoba;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;85,61
14 Córdoba;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
14 Córdoba;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
14 Córdoba;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
14 Córdoba;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;84,52
14 Córdoba;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
14 Córdoba;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
14 Córdoba;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
14 Córdoba;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
14 Córdoba;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
14 Córdoba;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QIV;6.632
14 Córdoba;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
14 Córdoba;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
14 Córdoba;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
14 Córdoba;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QIV;6.228
14 Córdoba;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
14 Córdoba;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
14 Córdoba;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
14 Córdoba;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QIV;5.778
14 Córdoba;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
14 Córdoba;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
14 Córdoba;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
14 Córdoba;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2022QIV;6.246
14 Córdoba;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
14 Córdoba;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2022QII;""
14 Córdoba;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2022QI;""
14 Córdoba;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2021QIV;5.949
14 Córdoba;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
14 Córdoba;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2021QII;""
14 Córdoba;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2021QI;""
14 Córdoba;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2020QIV;5.481
14 Córdoba;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
14 Córdoba;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2020QII;""
14 Córdoba;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2020QI;""
14 Córdoba;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
14 Córdoba;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
14 Córdoba;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2022QII;""
14 Córdoba;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2022QI;5.743
14 Córdoba;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
14 Córdoba;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
14 Córdoba;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2021QII;""
14 Córdoba;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2021QI;5.308
14 Córdoba;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
14 Córdoba;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
14 Córdoba;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2020QII;""
14 Córdoba;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2020QI;""
14 Córdoba;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
14 Córdoba;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
14 Córdoba;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QII;5.523
14 Córdoba;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QI;""
14 Córdoba;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
14 Córdoba;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
14 Córdoba;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QII;5.095
14 Córdoba;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QI;""
14 Córdoba;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
14 Córdoba;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
14 Córdoba;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QII;""
14 Córdoba;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QI;""
14 Córdoba;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
14 Córdoba;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QIII;5.291
14 Córdoba;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QII;""
14 Córdoba;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QI;""
14 Córdoba;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
14 Córdoba;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QIII;4.889
14 Córdoba;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QII;""
14 Córdoba;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QI;""
14 Córdoba;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
14 Córdoba;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
14 Córdoba;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QII;""
14 Córdoba;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QI;""
14 Córdoba;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
14 Córdoba;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
14 Córdoba;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
14 Córdoba;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
14 Córdoba;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
14 Córdoba;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
14 Córdoba;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
14 Córdoba;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
14 Córdoba;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
14 Córdoba;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
14 Córdoba;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
14 Córdoba;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
14 Córdoba;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;94,18
14 Córdoba;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
14 Córdoba;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
14 Córdoba;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
14 Córdoba;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;95,52
14 Córdoba;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
14 Córdoba;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
14 Córdoba;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
14 Córdoba;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;94,86
14 Córdoba;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
14 Córdoba;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
14 Córdoba;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
14 Córdoba;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
14 Córdoba;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
14 Córdoba;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
14 Córdoba;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;92,21
14 Córdoba;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
14 Córdoba;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
14 Córdoba;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
14 Córdoba;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;91,87
14 Córdoba;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
14 Córdoba;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
14 Córdoba;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
14 Córdoba;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
14 Córdoba;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
14 Córdoba;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
14 Córdoba;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;88,68
14 Córdoba;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
14 Córdoba;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
14 Córdoba;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
14 Córdoba;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;88,18
14 Córdoba;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
14 Córdoba;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
14 Córdoba;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
14 Córdoba;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
14 Córdoba;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
14 Córdoba;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
14 Córdoba;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;84,96
14 Córdoba;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
14 Córdoba;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
14 Córdoba;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
14 Córdoba;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;84,61
14 Córdoba;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
14 Córdoba;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
14 Córdoba;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
14 Córdoba;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
14 Córdoba;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
14 Córdoba;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
14 Córdoba;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QIV;4.521
14 Córdoba;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
14 Córdoba;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
14 Córdoba;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
14 Córdoba;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QIV;4.215
14 Córdoba;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
14 Córdoba;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
14 Córdoba;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
14 Córdoba;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QIV;3.941
14 Córdoba;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
14 Córdoba;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
14 Córdoba;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
14 Córdoba;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2022QIV;4.272
14 Córdoba;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
14 Córdoba;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2022QII;""
14 Córdoba;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2022QI;""
14 Córdoba;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2021QIV;4.014
14 Córdoba;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
14 Córdoba;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2021QII;""
14 Córdoba;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2021QI;""
14 Córdoba;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2020QIV;3.736
14 Córdoba;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
14 Córdoba;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2020QII;""
14 Córdoba;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2020QI;""
14 Córdoba;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
14 Córdoba;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
14 Córdoba;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2022QII;""
14 Córdoba;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2022QI;3.883
14 Córdoba;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
14 Córdoba;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
14 Córdoba;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2021QII;""
14 Córdoba;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2021QI;3.606
14 Córdoba;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
14 Córdoba;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
14 Córdoba;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2020QII;""
14 Córdoba;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2020QI;""
14 Córdoba;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
14 Córdoba;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
14 Córdoba;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QII;3.745
14 Córdoba;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QI;""
14 Córdoba;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
14 Córdoba;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
14 Córdoba;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QII;3.469
14 Córdoba;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QI;""
14 Córdoba;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
14 Córdoba;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
14 Córdoba;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QII;""
14 Córdoba;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QI;""
14 Córdoba;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
14 Córdoba;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QIII;3.599
14 Córdoba;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QII;""
14 Córdoba;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QI;""
14 Córdoba;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
14 Córdoba;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QIII;3.320
14 Córdoba;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QII;""
14 Córdoba;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QI;""
14 Córdoba;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
14 Córdoba;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
14 Córdoba;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QII;""
14 Córdoba;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QI;""
14 Córdoba;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
14 Córdoba;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
14 Córdoba;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
14 Córdoba;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
14 Córdoba;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
14 Córdoba;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
14 Córdoba;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
14 Córdoba;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
14 Córdoba;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
14 Córdoba;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
14 Córdoba;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
14 Córdoba;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
14 Córdoba;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;94,49
14 Córdoba;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
14 Córdoba;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
14 Córdoba;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
14 Córdoba;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;95,23
14 Córdoba;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
14 Córdoba;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
14 Córdoba;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
14 Córdoba;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;94,8
14 Córdoba;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
14 Córdoba;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
14 Córdoba;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
14 Córdoba;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
14 Córdoba;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
14 Córdoba;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
14 Córdoba;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;92,12
14 Córdoba;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
14 Córdoba;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
14 Córdoba;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
14 Córdoba;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;91,5
14 Córdoba;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
14 Córdoba;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
14 Córdoba;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
14 Córdoba;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
14 Córdoba;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
14 Córdoba;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
14 Córdoba;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;88,85
14 Córdoba;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
14 Córdoba;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
14 Córdoba;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
14 Córdoba;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;88,02
14 Córdoba;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
14 Córdoba;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
14 Córdoba;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
14 Córdoba;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
14 Córdoba;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
14 Córdoba;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
14 Córdoba;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;85,39
14 Córdoba;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
14 Córdoba;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
14 Córdoba;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
14 Córdoba;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;84,24
14 Córdoba;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
14 Córdoba;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
14 Córdoba;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
14 Córdoba;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
14 Córdoba;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
14 Córdoba;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
14 Córdoba;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QIV;2.111
14 Córdoba;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
14 Córdoba;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
14 Córdoba;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
14 Córdoba;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QIV;2.013
14 Córdoba;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
14 Córdoba;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
14 Córdoba;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
14 Córdoba;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QIV;1.837
14 Córdoba;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
14 Córdoba;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
14 Córdoba;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
14 Córdoba;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2022QIV;1.974
14 Córdoba;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
14 Córdoba;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2022QII;""
14 Córdoba;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2022QI;""
14 Córdoba;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2021QIV;1.935
14 Córdoba;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
14 Córdoba;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2021QII;""
14 Córdoba;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2021QI;""
14 Córdoba;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2020QIV;1.745
14 Córdoba;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
14 Córdoba;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2020QII;""
14 Córdoba;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2020QI;""
14 Córdoba;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
14 Córdoba;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
14 Córdoba;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2022QII;""
14 Córdoba;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2022QI;1.860
14 Córdoba;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
14 Córdoba;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
14 Córdoba;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2021QII;""
14 Córdoba;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2021QI;1.702
14 Córdoba;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
14 Córdoba;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
14 Córdoba;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2020QII;""
14 Córdoba;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2020QI;""
14 Córdoba;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
14 Córdoba;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
14 Córdoba;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QII;1.778
14 Córdoba;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QI;""
14 Córdoba;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
14 Córdoba;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
14 Córdoba;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QII;1.626
14 Córdoba;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QI;""
14 Córdoba;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
14 Córdoba;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
14 Córdoba;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QII;""
14 Córdoba;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QI;""
14 Córdoba;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
14 Córdoba;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QIII;1.692
14 Córdoba;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QII;""
14 Córdoba;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QI;""
14 Córdoba;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
14 Córdoba;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QIII;1.569
14 Córdoba;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QII;""
14 Córdoba;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QI;""
14 Córdoba;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
14 Córdoba;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
14 Córdoba;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QII;""
14 Córdoba;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QI;""
14 Córdoba;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
14 Córdoba;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
14 Córdoba;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
14 Córdoba;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
14 Córdoba;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
14 Córdoba;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
14 Córdoba;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
14 Córdoba;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
14 Córdoba;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
14 Córdoba;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
14 Córdoba;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
14 Córdoba;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
14 Córdoba;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;93,51
14 Córdoba;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
14 Córdoba;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
14 Córdoba;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
14 Córdoba;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;96,13
14 Córdoba;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
14 Córdoba;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
14 Córdoba;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
14 Córdoba;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;94,99
14 Córdoba;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
14 Córdoba;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
14 Córdoba;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
14 Córdoba;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
14 Córdoba;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
14 Córdoba;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
14 Córdoba;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;92,4
14 Córdoba;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
14 Córdoba;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
14 Córdoba;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
14 Córdoba;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;92,65
14 Córdoba;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
14 Córdoba;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
14 Córdoba;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
14 Córdoba;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
14 Córdoba;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
14 Córdoba;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
14 Córdoba;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;88,33
14 Córdoba;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
14 Córdoba;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
14 Córdoba;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
14 Córdoba;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;88,51
14 Córdoba;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
14 Córdoba;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
14 Córdoba;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
14 Córdoba;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
14 Córdoba;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
14 Córdoba;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
14 Córdoba;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;84,05
14 Córdoba;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
14 Córdoba;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
14 Córdoba;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
14 Córdoba;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;85,41
14 Córdoba;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
14 Córdoba;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
14 Córdoba;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
14 Córdoba;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
14 Córdoba;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
14 Córdoba;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
15 Coruña, A;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
15 Coruña, A;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
15 Coruña, A;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
15 Coruña, A;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QI;74.868
15 Coruña, A;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
15 Coruña, A;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
15 Coruña, A;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
15 Coruña, A;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QI;73.927
15 Coruña, A;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
15 Coruña, A;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
15 Coruña, A;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
15 Coruña, A;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QI;75.276
15 Coruña, A;All ages;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
15 Coruña, A;All ages;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
15 Coruña, A;All ages;Cohort January 1;Total;Survival in the first trimester;2022QII;""
15 Coruña, A;All ages;Cohort January 1;Total;Survival in the first trimester;2022QI;72.780
15 Coruña, A;All ages;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
15 Coruña, A;All ages;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
15 Coruña, A;All ages;Cohort January 1;Total;Survival in the first trimester;2021QII;""
15 Coruña, A;All ages;Cohort January 1;Total;Survival in the first trimester;2021QI;72.373
15 Coruña, A;All ages;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
15 Coruña, A;All ages;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
15 Coruña, A;All ages;Cohort January 1;Total;Survival in the first trimester;2020QII;""
15 Coruña, A;All ages;Cohort January 1;Total;Survival in the first trimester;2020QI;71.602
15 Coruña, A;All ages;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
15 Coruña, A;All ages;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
15 Coruña, A;All ages;Cohort January 1;Total;Survival in the second trimester;2022QII;70.824
15 Coruña, A;All ages;Cohort January 1;Total;Survival in the second trimester;2022QI;""
15 Coruña, A;All ages;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
15 Coruña, A;All ages;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
15 Coruña, A;All ages;Cohort January 1;Total;Survival in the second trimester;2021QII;70.768
15 Coruña, A;All ages;Cohort January 1;Total;Survival in the second trimester;2021QI;""
15 Coruña, A;All ages;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
15 Coruña, A;All ages;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
15 Coruña, A;All ages;Cohort January 1;Total;Survival in the second trimester;2020QII;70.069
15 Coruña, A;All ages;Cohort January 1;Total;Survival in the second trimester;2020QI;""
15 Coruña, A;All ages;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
15 Coruña, A;All ages;Cohort January 1;Total;Survival in the third trimester;2022QIII;69.093
15 Coruña, A;All ages;Cohort January 1;Total;Survival in the third trimester;2022QII;""
15 Coruña, A;All ages;Cohort January 1;Total;Survival in the third trimester;2022QI;""
15 Coruña, A;All ages;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
15 Coruña, A;All ages;Cohort January 1;Total;Survival in the third trimester;2021QIII;69.304
15 Coruña, A;All ages;Cohort January 1;Total;Survival in the third trimester;2021QII;""
15 Coruña, A;All ages;Cohort January 1;Total;Survival in the third trimester;2021QI;""
15 Coruña, A;All ages;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
15 Coruña, A;All ages;Cohort January 1;Total;Survival in the third trimester;2020QIII;68.523
15 Coruña, A;All ages;Cohort January 1;Total;Survival in the third trimester;2020QII;""
15 Coruña, A;All ages;Cohort January 1;Total;Survival in the third trimester;2020QI;""
15 Coruña, A;All ages;Cohort January 1;Total;Survival in the third trimester;2022QIV;67.066
15 Coruña, A;All ages;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
15 Coruña, A;All ages;Cohort January 1;Total;Survival in the third trimester;2022QII;""
15 Coruña, A;All ages;Cohort January 1;Total;Survival in the third trimester;2022QI;""
15 Coruña, A;All ages;Cohort January 1;Total;Survival in the third trimester;2021QIV;67.602
15 Coruña, A;All ages;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
15 Coruña, A;All ages;Cohort January 1;Total;Survival in the third trimester;2021QII;""
15 Coruña, A;All ages;Cohort January 1;Total;Survival in the third trimester;2021QI;""
15 Coruña, A;All ages;Cohort January 1;Total;Survival in the third trimester;2020QIV;66.880
15 Coruña, A;All ages;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
15 Coruña, A;All ages;Cohort January 1;Total;Survival in the third trimester;2020QII;""
15 Coruña, A;All ages;Cohort January 1;Total;Survival in the third trimester;2020QI;""
15 Coruña, A;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
15 Coruña, A;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
15 Coruña, A;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
15 Coruña, A;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
15 Coruña, A;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
15 Coruña, A;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
15 Coruña, A;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
15 Coruña, A;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
15 Coruña, A;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
15 Coruña, A;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
15 Coruña, A;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
15 Coruña, A;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
15 Coruña, A;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
15 Coruña, A;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
15 Coruña, A;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
15 Coruña, A;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;97,21
15 Coruña, A;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
15 Coruña, A;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
15 Coruña, A;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
15 Coruña, A;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;97,9
15 Coruña, A;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
15 Coruña, A;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
15 Coruña, A;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
15 Coruña, A;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;95,12
15 Coruña, A;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
15 Coruña, A;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
15 Coruña, A;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;94,6
15 Coruña, A;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
15 Coruña, A;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
15 Coruña, A;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
15 Coruña, A;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;95,73
15 Coruña, A;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
15 Coruña, A;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
15 Coruña, A;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
15 Coruña, A;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;93,08
15 Coruña, A;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
15 Coruña, A;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
15 Coruña, A;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;92,29
15 Coruña, A;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
15 Coruña, A;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
15 Coruña, A;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
15 Coruña, A;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;93,75
15 Coruña, A;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
15 Coruña, A;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
15 Coruña, A;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
15 Coruña, A;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;91,03
15 Coruña, A;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
15 Coruña, A;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
15 Coruña, A;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;89,58
15 Coruña, A;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
15 Coruña, A;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
15 Coruña, A;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
15 Coruña, A;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;91,44
15 Coruña, A;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
15 Coruña, A;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
15 Coruña, A;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
15 Coruña, A;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;88,85
15 Coruña, A;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
15 Coruña, A;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
15 Coruña, A;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
15 Coruña, A;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
15 Coruña, A;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
15 Coruña, A;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
15 Coruña, A;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QI;44.789
15 Coruña, A;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
15 Coruña, A;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
15 Coruña, A;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
15 Coruña, A;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QI;44.365
15 Coruña, A;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
15 Coruña, A;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
15 Coruña, A;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
15 Coruña, A;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QI;44.873
15 Coruña, A;All ages;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
15 Coruña, A;All ages;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
15 Coruña, A;All ages;Cohort January 1;Males;Survival in the first trimester;2022QII;""
15 Coruña, A;All ages;Cohort January 1;Males;Survival in the first trimester;2022QI;43.610
15 Coruña, A;All ages;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
15 Coruña, A;All ages;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
15 Coruña, A;All ages;Cohort January 1;Males;Survival in the first trimester;2021QII;""
15 Coruña, A;All ages;Cohort January 1;Males;Survival in the first trimester;2021QI;43.444
15 Coruña, A;All ages;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
15 Coruña, A;All ages;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
15 Coruña, A;All ages;Cohort January 1;Males;Survival in the first trimester;2020QII;""
15 Coruña, A;All ages;Cohort January 1;Males;Survival in the first trimester;2020QI;42.766
15 Coruña, A;All ages;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
15 Coruña, A;All ages;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
15 Coruña, A;All ages;Cohort January 1;Males;Survival in the second trimester;2022QII;42.542
15 Coruña, A;All ages;Cohort January 1;Males;Survival in the second trimester;2022QI;""
15 Coruña, A;All ages;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
15 Coruña, A;All ages;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
15 Coruña, A;All ages;Cohort January 1;Males;Survival in the second trimester;2021QII;42.552
15 Coruña, A;All ages;Cohort January 1;Males;Survival in the second trimester;2021QI;""
15 Coruña, A;All ages;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
15 Coruña, A;All ages;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
15 Coruña, A;All ages;Cohort January 1;Males;Survival in the second trimester;2020QII;42.076
15 Coruña, A;All ages;Cohort January 1;Males;Survival in the second trimester;2020QI;""
15 Coruña, A;All ages;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
15 Coruña, A;All ages;Cohort January 1;Males;Survival in the third trimester;2022QIII;41.583
15 Coruña, A;All ages;Cohort January 1;Males;Survival in the third trimester;2022QII;""
15 Coruña, A;All ages;Cohort January 1;Males;Survival in the third trimester;2022QI;""
15 Coruña, A;All ages;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
15 Coruña, A;All ages;Cohort January 1;Males;Survival in the third trimester;2021QIII;41.735
15 Coruña, A;All ages;Cohort January 1;Males;Survival in the third trimester;2021QII;""
15 Coruña, A;All ages;Cohort January 1;Males;Survival in the third trimester;2021QI;""
15 Coruña, A;All ages;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
15 Coruña, A;All ages;Cohort January 1;Males;Survival in the third trimester;2020QIII;41.275
15 Coruña, A;All ages;Cohort January 1;Males;Survival in the third trimester;2020QII;""
15 Coruña, A;All ages;Cohort January 1;Males;Survival in the third trimester;2020QI;""
15 Coruña, A;All ages;Cohort January 1;Males;Survival in the third trimester;2022QIV;40.429
15 Coruña, A;All ages;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
15 Coruña, A;All ages;Cohort January 1;Males;Survival in the third trimester;2022QII;""
15 Coruña, A;All ages;Cohort January 1;Males;Survival in the third trimester;2022QI;""
15 Coruña, A;All ages;Cohort January 1;Males;Survival in the third trimester;2021QIV;40.750
15 Coruña, A;All ages;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
15 Coruña, A;All ages;Cohort January 1;Males;Survival in the third trimester;2021QII;""
15 Coruña, A;All ages;Cohort January 1;Males;Survival in the third trimester;2021QI;""
15 Coruña, A;All ages;Cohort January 1;Males;Survival in the third trimester;2020QIV;40.367
15 Coruña, A;All ages;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
15 Coruña, A;All ages;Cohort January 1;Males;Survival in the third trimester;2020QII;""
15 Coruña, A;All ages;Cohort January 1;Males;Survival in the third trimester;2020QI;""
15 Coruña, A;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
15 Coruña, A;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
15 Coruña, A;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
15 Coruña, A;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
15 Coruña, A;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
15 Coruña, A;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
15 Coruña, A;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
15 Coruña, A;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
15 Coruña, A;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
15 Coruña, A;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
15 Coruña, A;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
15 Coruña, A;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
15 Coruña, A;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
15 Coruña, A;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
15 Coruña, A;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
15 Coruña, A;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;97,37
15 Coruña, A;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
15 Coruña, A;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
15 Coruña, A;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
15 Coruña, A;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;97,92
15 Coruña, A;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
15 Coruña, A;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
15 Coruña, A;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
15 Coruña, A;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;95,3
15 Coruña, A;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
15 Coruña, A;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
15 Coruña, A;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;94,98
15 Coruña, A;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
15 Coruña, A;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
15 Coruña, A;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
15 Coruña, A;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;95,91
15 Coruña, A;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
15 Coruña, A;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
15 Coruña, A;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
15 Coruña, A;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;93,77
15 Coruña, A;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
15 Coruña, A;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
15 Coruña, A;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;92,84
15 Coruña, A;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
15 Coruña, A;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
15 Coruña, A;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
15 Coruña, A;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;94,07
15 Coruña, A;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
15 Coruña, A;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
15 Coruña, A;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
15 Coruña, A;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;91,98
15 Coruña, A;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
15 Coruña, A;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
15 Coruña, A;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;90,27
15 Coruña, A;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
15 Coruña, A;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
15 Coruña, A;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
15 Coruña, A;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;91,85
15 Coruña, A;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
15 Coruña, A;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
15 Coruña, A;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
15 Coruña, A;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;89,96
15 Coruña, A;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
15 Coruña, A;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
15 Coruña, A;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
15 Coruña, A;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
15 Coruña, A;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
15 Coruña, A;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
15 Coruña, A;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QI;30.079
15 Coruña, A;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
15 Coruña, A;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
15 Coruña, A;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
15 Coruña, A;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QI;29.562
15 Coruña, A;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
15 Coruña, A;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
15 Coruña, A;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
15 Coruña, A;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QI;30.403
15 Coruña, A;All ages;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
15 Coruña, A;All ages;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
15 Coruña, A;All ages;Cohort January 1;Females;Survival in the first trimester;2022QII;""
15 Coruña, A;All ages;Cohort January 1;Females;Survival in the first trimester;2022QI;29.170
15 Coruña, A;All ages;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
15 Coruña, A;All ages;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
15 Coruña, A;All ages;Cohort January 1;Females;Survival in the first trimester;2021QII;""
15 Coruña, A;All ages;Cohort January 1;Females;Survival in the first trimester;2021QI;28.929
15 Coruña, A;All ages;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
15 Coruña, A;All ages;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
15 Coruña, A;All ages;Cohort January 1;Females;Survival in the first trimester;2020QII;""
15 Coruña, A;All ages;Cohort January 1;Females;Survival in the first trimester;2020QI;28.836
15 Coruña, A;All ages;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
15 Coruña, A;All ages;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
15 Coruña, A;All ages;Cohort January 1;Females;Survival in the second trimester;2022QII;28.282
15 Coruña, A;All ages;Cohort January 1;Females;Survival in the second trimester;2022QI;""
15 Coruña, A;All ages;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
15 Coruña, A;All ages;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
15 Coruña, A;All ages;Cohort January 1;Females;Survival in the second trimester;2021QII;28.216
15 Coruña, A;All ages;Cohort January 1;Females;Survival in the second trimester;2021QI;""
15 Coruña, A;All ages;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
15 Coruña, A;All ages;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
15 Coruña, A;All ages;Cohort January 1;Females;Survival in the second trimester;2020QII;27.993
15 Coruña, A;All ages;Cohort January 1;Females;Survival in the second trimester;2020QI;""
15 Coruña, A;All ages;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
15 Coruña, A;All ages;Cohort January 1;Females;Survival in the third trimester;2022QIII;27.510
15 Coruña, A;All ages;Cohort January 1;Females;Survival in the third trimester;2022QII;""
15 Coruña, A;All ages;Cohort January 1;Females;Survival in the third trimester;2022QI;""
15 Coruña, A;All ages;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
15 Coruña, A;All ages;Cohort January 1;Females;Survival in the third trimester;2021QIII;27.569
15 Coruña, A;All ages;Cohort January 1;Females;Survival in the third trimester;2021QII;""
15 Coruña, A;All ages;Cohort January 1;Females;Survival in the third trimester;2021QI;""
15 Coruña, A;All ages;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
15 Coruña, A;All ages;Cohort January 1;Females;Survival in the third trimester;2020QIII;27.248
15 Coruña, A;All ages;Cohort January 1;Females;Survival in the third trimester;2020QII;""
15 Coruña, A;All ages;Cohort January 1;Females;Survival in the third trimester;2020QI;""
15 Coruña, A;All ages;Cohort January 1;Females;Survival in the third trimester;2022QIV;26.637
15 Coruña, A;All ages;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
15 Coruña, A;All ages;Cohort January 1;Females;Survival in the third trimester;2022QII;""
15 Coruña, A;All ages;Cohort January 1;Females;Survival in the third trimester;2022QI;""
15 Coruña, A;All ages;Cohort January 1;Females;Survival in the third trimester;2021QIV;26.852
15 Coruña, A;All ages;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
15 Coruña, A;All ages;Cohort January 1;Females;Survival in the third trimester;2021QII;""
15 Coruña, A;All ages;Cohort January 1;Females;Survival in the third trimester;2021QI;""
15 Coruña, A;All ages;Cohort January 1;Females;Survival in the third trimester;2020QIV;26.513
15 Coruña, A;All ages;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
15 Coruña, A;All ages;Cohort January 1;Females;Survival in the third trimester;2020QII;""
15 Coruña, A;All ages;Cohort January 1;Females;Survival in the third trimester;2020QI;""
15 Coruña, A;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
15 Coruña, A;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
15 Coruña, A;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
15 Coruña, A;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
15 Coruña, A;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
15 Coruña, A;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
15 Coruña, A;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
15 Coruña, A;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
15 Coruña, A;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
15 Coruña, A;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
15 Coruña, A;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
15 Coruña, A;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
15 Coruña, A;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
15 Coruña, A;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
15 Coruña, A;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
15 Coruña, A;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;96,98
15 Coruña, A;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
15 Coruña, A;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
15 Coruña, A;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
15 Coruña, A;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;97,86
15 Coruña, A;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
15 Coruña, A;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
15 Coruña, A;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
15 Coruña, A;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;94,85
15 Coruña, A;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
15 Coruña, A;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
15 Coruña, A;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;94,03
15 Coruña, A;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
15 Coruña, A;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
15 Coruña, A;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
15 Coruña, A;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;95,45
15 Coruña, A;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
15 Coruña, A;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
15 Coruña, A;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
15 Coruña, A;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;92,07
15 Coruña, A;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
15 Coruña, A;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
15 Coruña, A;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;91,46
15 Coruña, A;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
15 Coruña, A;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
15 Coruña, A;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
15 Coruña, A;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;93,26
15 Coruña, A;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
15 Coruña, A;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
15 Coruña, A;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
15 Coruña, A;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;89,62
15 Coruña, A;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
15 Coruña, A;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
15 Coruña, A;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;88,56
15 Coruña, A;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
15 Coruña, A;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
15 Coruña, A;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
15 Coruña, A;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;90,83
15 Coruña, A;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
15 Coruña, A;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
15 Coruña, A;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
15 Coruña, A;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;87,21
15 Coruña, A;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
15 Coruña, A;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
15 Coruña, A;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
15 Coruña, A;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
15 Coruña, A;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
15 Coruña, A;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QII;74.794
15 Coruña, A;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
15 Coruña, A;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
15 Coruña, A;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
15 Coruña, A;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QII;74.440
15 Coruña, A;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
15 Coruña, A;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
15 Coruña, A;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
15 Coruña, A;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QII;74.086
15 Coruña, A;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
15 Coruña, A;All ages;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
15 Coruña, A;All ages;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
15 Coruña, A;All ages;Cohort April 1;Total;Survival in the first trimester;2022QII;72.687
15 Coruña, A;All ages;Cohort April 1;Total;Survival in the first trimester;2022QI;""
15 Coruña, A;All ages;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
15 Coruña, A;All ages;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
15 Coruña, A;All ages;Cohort April 1;Total;Survival in the first trimester;2021QII;72.636
15 Coruña, A;All ages;Cohort April 1;Total;Survival in the first trimester;2021QI;""
15 Coruña, A;All ages;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
15 Coruña, A;All ages;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
15 Coruña, A;All ages;Cohort April 1;Total;Survival in the first trimester;2020QII;72.437
15 Coruña, A;All ages;Cohort April 1;Total;Survival in the first trimester;2020QI;""
15 Coruña, A;All ages;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
15 Coruña, A;All ages;Cohort April 1;Total;Survival in the second trimester;2022QIII;70.845
15 Coruña, A;All ages;Cohort April 1;Total;Survival in the second trimester;2022QII;""
15 Coruña, A;All ages;Cohort April 1;Total;Survival in the second trimester;2022QI;""
15 Coruña, A;All ages;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
15 Coruña, A;All ages;Cohort April 1;Total;Survival in the second trimester;2021QIII;71.047
15 Coruña, A;All ages;Cohort April 1;Total;Survival in the second trimester;2021QII;""
15 Coruña, A;All ages;Cohort April 1;Total;Survival in the second trimester;2021QI;""
15 Coruña, A;All ages;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
15 Coruña, A;All ages;Cohort April 1;Total;Survival in the second trimester;2020QIII;70.643
15 Coruña, A;All ages;Cohort April 1;Total;Survival in the second trimester;2020QII;""
15 Coruña, A;All ages;Cohort April 1;Total;Survival in the second trimester;2020QI;""
15 Coruña, A;All ages;Cohort April 1;Total;Survival in the third trimester;2022QIV;68.707
15 Coruña, A;All ages;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
15 Coruña, A;All ages;Cohort April 1;Total;Survival in the third trimester;2022QII;""
15 Coruña, A;All ages;Cohort April 1;Total;Survival in the third trimester;2022QI;""
15 Coruña, A;All ages;Cohort April 1;Total;Survival in the third trimester;2021QIV;69.230
15 Coruña, A;All ages;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
15 Coruña, A;All ages;Cohort April 1;Total;Survival in the third trimester;2021QII;""
15 Coruña, A;All ages;Cohort April 1;Total;Survival in the third trimester;2021QI;""
15 Coruña, A;All ages;Cohort April 1;Total;Survival in the third trimester;2020QIV;68.884
15 Coruña, A;All ages;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
15 Coruña, A;All ages;Cohort April 1;Total;Survival in the third trimester;2020QII;""
15 Coruña, A;All ages;Cohort April 1;Total;Survival in the third trimester;2020QI;""
15 Coruña, A;All ages;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
15 Coruña, A;All ages;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
15 Coruña, A;All ages;Cohort April 1;Total;Survival in the third trimester;2022QII;""
15 Coruña, A;All ages;Cohort April 1;Total;Survival in the third trimester;2022QI;67.548
15 Coruña, A;All ages;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
15 Coruña, A;All ages;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
15 Coruña, A;All ages;Cohort April 1;Total;Survival in the third trimester;2021QII;""
15 Coruña, A;All ages;Cohort April 1;Total;Survival in the third trimester;2021QI;67.680
15 Coruña, A;All ages;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
15 Coruña, A;All ages;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
15 Coruña, A;All ages;Cohort April 1;Total;Survival in the third trimester;2020QII;""
15 Coruña, A;All ages;Cohort April 1;Total;Survival in the third trimester;2020QI;""
15 Coruña, A;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
15 Coruña, A;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
15 Coruña, A;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
15 Coruña, A;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
15 Coruña, A;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
15 Coruña, A;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
15 Coruña, A;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
15 Coruña, A;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
15 Coruña, A;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
15 Coruña, A;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
15 Coruña, A;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
15 Coruña, A;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
15 Coruña, A;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
15 Coruña, A;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
15 Coruña, A;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;97,18
15 Coruña, A;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
15 Coruña, A;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
15 Coruña, A;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
15 Coruña, A;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;97,58
15 Coruña, A;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
15 Coruña, A;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
15 Coruña, A;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
15 Coruña, A;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;97,77
15 Coruña, A;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
15 Coruña, A;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
15 Coruña, A;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;94,72
15 Coruña, A;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
15 Coruña, A;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
15 Coruña, A;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
15 Coruña, A;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;95,44
15 Coruña, A;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
15 Coruña, A;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
15 Coruña, A;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
15 Coruña, A;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;95,35
15 Coruña, A;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
15 Coruña, A;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
15 Coruña, A;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;91,86
15 Coruña, A;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
15 Coruña, A;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
15 Coruña, A;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
15 Coruña, A;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;93
15 Coruña, A;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
15 Coruña, A;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
15 Coruña, A;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
15 Coruña, A;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;92,98
15 Coruña, A;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
15 Coruña, A;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
15 Coruña, A;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
15 Coruña, A;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
15 Coruña, A;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
15 Coruña, A;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
15 Coruña, A;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;90,74
15 Coruña, A;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
15 Coruña, A;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
15 Coruña, A;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
15 Coruña, A;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;91,35
15 Coruña, A;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
15 Coruña, A;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
15 Coruña, A;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
15 Coruña, A;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
15 Coruña, A;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
15 Coruña, A;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
15 Coruña, A;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QII;44.689
15 Coruña, A;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
15 Coruña, A;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
15 Coruña, A;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
15 Coruña, A;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QII;44.676
15 Coruña, A;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
15 Coruña, A;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
15 Coruña, A;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
15 Coruña, A;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QII;44.167
15 Coruña, A;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
15 Coruña, A;All ages;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
15 Coruña, A;All ages;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
15 Coruña, A;All ages;Cohort April 1;Males;Survival in the first trimester;2022QII;43.528
15 Coruña, A;All ages;Cohort April 1;Males;Survival in the first trimester;2022QI;""
15 Coruña, A;All ages;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
15 Coruña, A;All ages;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
15 Coruña, A;All ages;Cohort April 1;Males;Survival in the first trimester;2021QII;43.653
15 Coruña, A;All ages;Cohort April 1;Males;Survival in the first trimester;2021QI;""
15 Coruña, A;All ages;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
15 Coruña, A;All ages;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
15 Coruña, A;All ages;Cohort April 1;Males;Survival in the first trimester;2020QII;43.416
15 Coruña, A;All ages;Cohort April 1;Males;Survival in the first trimester;2020QI;""
15 Coruña, A;All ages;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
15 Coruña, A;All ages;Cohort April 1;Males;Survival in the second trimester;2022QIII;42.509
15 Coruña, A;All ages;Cohort April 1;Males;Survival in the second trimester;2022QII;""
15 Coruña, A;All ages;Cohort April 1;Males;Survival in the second trimester;2022QI;""
15 Coruña, A;All ages;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
15 Coruña, A;All ages;Cohort April 1;Males;Survival in the second trimester;2021QIII;42.750
15 Coruña, A;All ages;Cohort April 1;Males;Survival in the second trimester;2021QII;""
15 Coruña, A;All ages;Cohort April 1;Males;Survival in the second trimester;2021QI;""
15 Coruña, A;All ages;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
15 Coruña, A;All ages;Cohort April 1;Males;Survival in the second trimester;2020QIII;42.449
15 Coruña, A;All ages;Cohort April 1;Males;Survival in the second trimester;2020QII;""
15 Coruña, A;All ages;Cohort April 1;Males;Survival in the second trimester;2020QI;""
15 Coruña, A;All ages;Cohort April 1;Males;Survival in the third trimester;2022QIV;41.292
15 Coruña, A;All ages;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
15 Coruña, A;All ages;Cohort April 1;Males;Survival in the third trimester;2022QII;""
15 Coruña, A;All ages;Cohort April 1;Males;Survival in the third trimester;2022QI;""
15 Coruña, A;All ages;Cohort April 1;Males;Survival in the third trimester;2021QIV;41.698
15 Coruña, A;All ages;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
15 Coruña, A;All ages;Cohort April 1;Males;Survival in the third trimester;2021QII;""
15 Coruña, A;All ages;Cohort April 1;Males;Survival in the third trimester;2021QI;""
15 Coruña, A;All ages;Cohort April 1;Males;Survival in the third trimester;2020QIV;41.478
15 Coruña, A;All ages;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
15 Coruña, A;All ages;Cohort April 1;Males;Survival in the third trimester;2020QII;""
15 Coruña, A;All ages;Cohort April 1;Males;Survival in the third trimester;2020QI;""
15 Coruña, A;All ages;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
15 Coruña, A;All ages;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
15 Coruña, A;All ages;Cohort April 1;Males;Survival in the third trimester;2022QII;""
15 Coruña, A;All ages;Cohort April 1;Males;Survival in the third trimester;2022QI;40.759
15 Coruña, A;All ages;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
15 Coruña, A;All ages;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
15 Coruña, A;All ages;Cohort April 1;Males;Survival in the third trimester;2021QII;""
15 Coruña, A;All ages;Cohort April 1;Males;Survival in the third trimester;2021QI;40.768
15 Coruña, A;All ages;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
15 Coruña, A;All ages;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
15 Coruña, A;All ages;Cohort April 1;Males;Survival in the third trimester;2020QII;""
15 Coruña, A;All ages;Cohort April 1;Males;Survival in the third trimester;2020QI;""
15 Coruña, A;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
15 Coruña, A;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
15 Coruña, A;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
15 Coruña, A;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
15 Coruña, A;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
15 Coruña, A;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
15 Coruña, A;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
15 Coruña, A;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
15 Coruña, A;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
15 Coruña, A;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
15 Coruña, A;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
15 Coruña, A;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
15 Coruña, A;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
15 Coruña, A;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
15 Coruña, A;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;97,4
15 Coruña, A;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
15 Coruña, A;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
15 Coruña, A;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
15 Coruña, A;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;97,71
15 Coruña, A;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
15 Coruña, A;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
15 Coruña, A;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
15 Coruña, A;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;98,3
15 Coruña, A;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
15 Coruña, A;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
15 Coruña, A;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;95,12
15 Coruña, A;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
15 Coruña, A;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
15 Coruña, A;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
15 Coruña, A;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;95,69
15 Coruña, A;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
15 Coruña, A;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
15 Coruña, A;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
15 Coruña, A;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;96,11
15 Coruña, A;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
15 Coruña, A;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
15 Coruña, A;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;92,4
15 Coruña, A;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
15 Coruña, A;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
15 Coruña, A;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
15 Coruña, A;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;93,33
15 Coruña, A;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
15 Coruña, A;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
15 Coruña, A;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
15 Coruña, A;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;93,91
15 Coruña, A;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
15 Coruña, A;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
15 Coruña, A;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
15 Coruña, A;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
15 Coruña, A;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
15 Coruña, A;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
15 Coruña, A;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;91,23
15 Coruña, A;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
15 Coruña, A;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
15 Coruña, A;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
15 Coruña, A;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;92,3
15 Coruña, A;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
15 Coruña, A;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
15 Coruña, A;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
15 Coruña, A;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
15 Coruña, A;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
15 Coruña, A;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
15 Coruña, A;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QII;30.105
15 Coruña, A;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
15 Coruña, A;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
15 Coruña, A;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
15 Coruña, A;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QII;29.764
15 Coruña, A;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
15 Coruña, A;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
15 Coruña, A;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
15 Coruña, A;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QII;29.919
15 Coruña, A;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
15 Coruña, A;All ages;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
15 Coruña, A;All ages;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
15 Coruña, A;All ages;Cohort April 1;Females;Survival in the first trimester;2022QII;29.159
15 Coruña, A;All ages;Cohort April 1;Females;Survival in the first trimester;2022QI;""
15 Coruña, A;All ages;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
15 Coruña, A;All ages;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
15 Coruña, A;All ages;Cohort April 1;Females;Survival in the first trimester;2021QII;28.983
15 Coruña, A;All ages;Cohort April 1;Females;Survival in the first trimester;2021QI;""
15 Coruña, A;All ages;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
15 Coruña, A;All ages;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
15 Coruña, A;All ages;Cohort April 1;Females;Survival in the first trimester;2020QII;29.021
15 Coruña, A;All ages;Cohort April 1;Females;Survival in the first trimester;2020QI;""
15 Coruña, A;All ages;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
15 Coruña, A;All ages;Cohort April 1;Females;Survival in the second trimester;2022QIII;28.336
15 Coruña, A;All ages;Cohort April 1;Females;Survival in the second trimester;2022QII;""
15 Coruña, A;All ages;Cohort April 1;Females;Survival in the second trimester;2022QI;""
15 Coruña, A;All ages;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
15 Coruña, A;All ages;Cohort April 1;Females;Survival in the second trimester;2021QIII;28.297
15 Coruña, A;All ages;Cohort April 1;Females;Survival in the second trimester;2021QII;""
15 Coruña, A;All ages;Cohort April 1;Females;Survival in the second trimester;2021QI;""
15 Coruña, A;All ages;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
15 Coruña, A;All ages;Cohort April 1;Females;Survival in the second trimester;2020QIII;28.194
15 Coruña, A;All ages;Cohort April 1;Females;Survival in the second trimester;2020QII;""
15 Coruña, A;All ages;Cohort April 1;Females;Survival in the second trimester;2020QI;""
15 Coruña, A;All ages;Cohort April 1;Females;Survival in the third trimester;2022QIV;27.415
15 Coruña, A;All ages;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
15 Coruña, A;All ages;Cohort April 1;Females;Survival in the third trimester;2022QII;""
15 Coruña, A;All ages;Cohort April 1;Females;Survival in the third trimester;2022QI;""
15 Coruña, A;All ages;Cohort April 1;Females;Survival in the third trimester;2021QIV;27.532
15 Coruña, A;All ages;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
15 Coruña, A;All ages;Cohort April 1;Females;Survival in the third trimester;2021QII;""
15 Coruña, A;All ages;Cohort April 1;Females;Survival in the third trimester;2021QI;""
15 Coruña, A;All ages;Cohort April 1;Females;Survival in the third trimester;2020QIV;27.406
15 Coruña, A;All ages;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
15 Coruña, A;All ages;Cohort April 1;Females;Survival in the third trimester;2020QII;""
15 Coruña, A;All ages;Cohort April 1;Females;Survival in the third trimester;2020QI;""
15 Coruña, A;All ages;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
15 Coruña, A;All ages;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
15 Coruña, A;All ages;Cohort April 1;Females;Survival in the third trimester;2022QII;""
15 Coruña, A;All ages;Cohort April 1;Females;Survival in the third trimester;2022QI;26.789
15 Coruña, A;All ages;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
15 Coruña, A;All ages;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
15 Coruña, A;All ages;Cohort April 1;Females;Survival in the third trimester;2021QII;""
15 Coruña, A;All ages;Cohort April 1;Females;Survival in the third trimester;2021QI;26.912
15 Coruña, A;All ages;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
15 Coruña, A;All ages;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
15 Coruña, A;All ages;Cohort April 1;Females;Survival in the third trimester;2020QII;""
15 Coruña, A;All ages;Cohort April 1;Females;Survival in the third trimester;2020QI;""
15 Coruña, A;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
15 Coruña, A;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
15 Coruña, A;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
15 Coruña, A;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
15 Coruña, A;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
15 Coruña, A;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
15 Coruña, A;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
15 Coruña, A;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
15 Coruña, A;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
15 Coruña, A;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
15 Coruña, A;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
15 Coruña, A;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
15 Coruña, A;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
15 Coruña, A;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
15 Coruña, A;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;96,86
15 Coruña, A;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
15 Coruña, A;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
15 Coruña, A;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
15 Coruña, A;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;97,38
15 Coruña, A;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
15 Coruña, A;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
15 Coruña, A;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
15 Coruña, A;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;97
15 Coruña, A;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
15 Coruña, A;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
15 Coruña, A;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;94,12
15 Coruña, A;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
15 Coruña, A;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
15 Coruña, A;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
15 Coruña, A;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;95,07
15 Coruña, A;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
15 Coruña, A;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
15 Coruña, A;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
15 Coruña, A;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;94,23
15 Coruña, A;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
15 Coruña, A;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
15 Coruña, A;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;91,06
15 Coruña, A;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
15 Coruña, A;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
15 Coruña, A;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
15 Coruña, A;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;92,5
15 Coruña, A;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
15 Coruña, A;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
15 Coruña, A;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
15 Coruña, A;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;91,6
15 Coruña, A;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
15 Coruña, A;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
15 Coruña, A;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
15 Coruña, A;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
15 Coruña, A;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
15 Coruña, A;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
15 Coruña, A;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;90
15 Coruña, A;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
15 Coruña, A;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
15 Coruña, A;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
15 Coruña, A;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;89,95
15 Coruña, A;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
15 Coruña, A;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
15 Coruña, A;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
15 Coruña, A;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
15 Coruña, A;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
15 Coruña, A;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QIII;74.953
15 Coruña, A;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
15 Coruña, A;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
15 Coruña, A;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
15 Coruña, A;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QIII;74.867
15 Coruña, A;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
15 Coruña, A;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
15 Coruña, A;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
15 Coruña, A;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QIII;73.933
15 Coruña, A;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
15 Coruña, A;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
15 Coruña, A;All ages;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
15 Coruña, A;All ages;Cohort July 1;Total;Survival in the first trimester;2022QIII;72.778
15 Coruña, A;All ages;Cohort July 1;Total;Survival in the first trimester;2022QII;""
15 Coruña, A;All ages;Cohort July 1;Total;Survival in the first trimester;2022QI;""
15 Coruña, A;All ages;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
15 Coruña, A;All ages;Cohort July 1;Total;Survival in the first trimester;2021QIII;73.018
15 Coruña, A;All ages;Cohort July 1;Total;Survival in the first trimester;2021QII;""
15 Coruña, A;All ages;Cohort July 1;Total;Survival in the first trimester;2021QI;""
15 Coruña, A;All ages;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
15 Coruña, A;All ages;Cohort July 1;Total;Survival in the first trimester;2020QIII;71.903
15 Coruña, A;All ages;Cohort July 1;Total;Survival in the first trimester;2020QII;""
15 Coruña, A;All ages;Cohort July 1;Total;Survival in the first trimester;2020QI;""
15 Coruña, A;All ages;Cohort July 1;Total;Survival in the second trimester;2022QIV;70.429
15 Coruña, A;All ages;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
15 Coruña, A;All ages;Cohort July 1;Total;Survival in the second trimester;2022QII;""
15 Coruña, A;All ages;Cohort July 1;Total;Survival in the second trimester;2022QI;""
15 Coruña, A;All ages;Cohort July 1;Total;Survival in the second trimester;2021QIV;71.024
15 Coruña, A;All ages;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
15 Coruña, A;All ages;Cohort July 1;Total;Survival in the second trimester;2021QII;""
15 Coruña, A;All ages;Cohort July 1;Total;Survival in the second trimester;2021QI;""
15 Coruña, A;All ages;Cohort July 1;Total;Survival in the second trimester;2020QIV;70.025
15 Coruña, A;All ages;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
15 Coruña, A;All ages;Cohort July 1;Total;Survival in the second trimester;2020QII;""
15 Coruña, A;All ages;Cohort July 1;Total;Survival in the second trimester;2020QI;""
15 Coruña, A;All ages;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
15 Coruña, A;All ages;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
15 Coruña, A;All ages;Cohort July 1;Total;Survival in the third trimester;2022QII;""
15 Coruña, A;All ages;Cohort July 1;Total;Survival in the third trimester;2022QI;69.242
15 Coruña, A;All ages;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
15 Coruña, A;All ages;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
15 Coruña, A;All ages;Cohort July 1;Total;Survival in the third trimester;2021QII;""
15 Coruña, A;All ages;Cohort July 1;Total;Survival in the third trimester;2021QI;68.769
15 Coruña, A;All ages;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
15 Coruña, A;All ages;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
15 Coruña, A;All ages;Cohort July 1;Total;Survival in the third trimester;2020QII;""
15 Coruña, A;All ages;Cohort July 1;Total;Survival in the third trimester;2020QI;""
15 Coruña, A;All ages;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
15 Coruña, A;All ages;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
15 Coruña, A;All ages;Cohort July 1;Total;Survival in the third trimester;2022QII;67.558
15 Coruña, A;All ages;Cohort July 1;Total;Survival in the third trimester;2022QI;""
15 Coruña, A;All ages;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
15 Coruña, A;All ages;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
15 Coruña, A;All ages;Cohort July 1;Total;Survival in the third trimester;2021QII;67.447
15 Coruña, A;All ages;Cohort July 1;Total;Survival in the third trimester;2021QI;""
15 Coruña, A;All ages;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
15 Coruña, A;All ages;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
15 Coruña, A;All ages;Cohort July 1;Total;Survival in the third trimester;2020QII;""
15 Coruña, A;All ages;Cohort July 1;Total;Survival in the third trimester;2020QI;""
15 Coruña, A;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
15 Coruña, A;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
15 Coruña, A;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
15 Coruña, A;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
15 Coruña, A;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
15 Coruña, A;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
15 Coruña, A;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
15 Coruña, A;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
15 Coruña, A;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
15 Coruña, A;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
15 Coruña, A;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
15 Coruña, A;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
15 Coruña, A;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
15 Coruña, A;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;97,1
15 Coruña, A;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
15 Coruña, A;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
15 Coruña, A;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
15 Coruña, A;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;97,53
15 Coruña, A;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
15 Coruña, A;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
15 Coruña, A;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
15 Coruña, A;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;97,25
15 Coruña, A;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
15 Coruña, A;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
15 Coruña, A;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;93,96
15 Coruña, A;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
15 Coruña, A;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
15 Coruña, A;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
15 Coruña, A;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;94,87
15 Coruña, A;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
15 Coruña, A;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
15 Coruña, A;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
15 Coruña, A;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;94,71
15 Coruña, A;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
15 Coruña, A;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
15 Coruña, A;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
15 Coruña, A;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
15 Coruña, A;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
15 Coruña, A;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
15 Coruña, A;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;92,49
15 Coruña, A;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
15 Coruña, A;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
15 Coruña, A;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
15 Coruña, A;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;93,02
15 Coruña, A;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
15 Coruña, A;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
15 Coruña, A;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
15 Coruña, A;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
15 Coruña, A;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
15 Coruña, A;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
15 Coruña, A;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;90,24
15 Coruña, A;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
15 Coruña, A;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
15 Coruña, A;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
15 Coruña, A;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;91,23
15 Coruña, A;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
15 Coruña, A;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
15 Coruña, A;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
15 Coruña, A;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
15 Coruña, A;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
15 Coruña, A;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
15 Coruña, A;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QIII;44.740
15 Coruña, A;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
15 Coruña, A;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
15 Coruña, A;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
15 Coruña, A;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QIII;44.941
15 Coruña, A;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
15 Coruña, A;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
15 Coruña, A;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
15 Coruña, A;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QIII;44.343
15 Coruña, A;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
15 Coruña, A;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
15 Coruña, A;All ages;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
15 Coruña, A;All ages;Cohort July 1;Males;Survival in the first trimester;2022QIII;43.538
15 Coruña, A;All ages;Cohort July 1;Males;Survival in the first trimester;2022QII;""
15 Coruña, A;All ages;Cohort July 1;Males;Survival in the first trimester;2022QI;""
15 Coruña, A;All ages;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
15 Coruña, A;All ages;Cohort July 1;Males;Survival in the first trimester;2021QIII;43.882
15 Coruña, A;All ages;Cohort July 1;Males;Survival in the first trimester;2021QII;""
15 Coruña, A;All ages;Cohort July 1;Males;Survival in the first trimester;2021QI;""
15 Coruña, A;All ages;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
15 Coruña, A;All ages;Cohort July 1;Males;Survival in the first trimester;2020QIII;43.228
15 Coruña, A;All ages;Cohort July 1;Males;Survival in the first trimester;2020QII;""
15 Coruña, A;All ages;Cohort July 1;Males;Survival in the first trimester;2020QI;""
15 Coruña, A;All ages;Cohort July 1;Males;Survival in the second trimester;2022QIV;42.195
15 Coruña, A;All ages;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
15 Coruña, A;All ages;Cohort July 1;Males;Survival in the second trimester;2022QII;""
15 Coruña, A;All ages;Cohort July 1;Males;Survival in the second trimester;2022QI;""
15 Coruña, A;All ages;Cohort July 1;Males;Survival in the second trimester;2021QIV;42.734
15 Coruña, A;All ages;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
15 Coruña, A;All ages;Cohort July 1;Males;Survival in the second trimester;2021QII;""
15 Coruña, A;All ages;Cohort July 1;Males;Survival in the second trimester;2021QI;""
15 Coruña, A;All ages;Cohort July 1;Males;Survival in the second trimester;2020QIV;42.180
15 Coruña, A;All ages;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
15 Coruña, A;All ages;Cohort July 1;Males;Survival in the second trimester;2020QII;""
15 Coruña, A;All ages;Cohort July 1;Males;Survival in the second trimester;2020QI;""
15 Coruña, A;All ages;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
15 Coruña, A;All ages;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
15 Coruña, A;All ages;Cohort July 1;Males;Survival in the third trimester;2022QII;""
15 Coruña, A;All ages;Cohort July 1;Males;Survival in the third trimester;2022QI;41.725
15 Coruña, A;All ages;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
15 Coruña, A;All ages;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
15 Coruña, A;All ages;Cohort July 1;Males;Survival in the third trimester;2021QII;""
15 Coruña, A;All ages;Cohort July 1;Males;Survival in the third trimester;2021QI;41.437
15 Coruña, A;All ages;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
15 Coruña, A;All ages;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
15 Coruña, A;All ages;Cohort July 1;Males;Survival in the third trimester;2020QII;""
15 Coruña, A;All ages;Cohort July 1;Males;Survival in the third trimester;2020QI;""
15 Coruña, A;All ages;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
15 Coruña, A;All ages;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
15 Coruña, A;All ages;Cohort July 1;Males;Survival in the third trimester;2022QII;40.790
15 Coruña, A;All ages;Cohort July 1;Males;Survival in the third trimester;2022QI;""
15 Coruña, A;All ages;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
15 Coruña, A;All ages;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
15 Coruña, A;All ages;Cohort July 1;Males;Survival in the third trimester;2021QII;40.690
15 Coruña, A;All ages;Cohort July 1;Males;Survival in the third trimester;2021QI;""
15 Coruña, A;All ages;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
15 Coruña, A;All ages;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
15 Coruña, A;All ages;Cohort July 1;Males;Survival in the third trimester;2020QII;""
15 Coruña, A;All ages;Cohort July 1;Males;Survival in the third trimester;2020QI;""
15 Coruña, A;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
15 Coruña, A;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
15 Coruña, A;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
15 Coruña, A;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
15 Coruña, A;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
15 Coruña, A;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
15 Coruña, A;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
15 Coruña, A;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
15 Coruña, A;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
15 Coruña, A;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
15 Coruña, A;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
15 Coruña, A;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
15 Coruña, A;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
15 Coruña, A;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;97,31
15 Coruña, A;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
15 Coruña, A;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
15 Coruña, A;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
15 Coruña, A;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;97,64
15 Coruña, A;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
15 Coruña, A;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
15 Coruña, A;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
15 Coruña, A;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;97,49
15 Coruña, A;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
15 Coruña, A;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
15 Coruña, A;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;94,31
15 Coruña, A;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
15 Coruña, A;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
15 Coruña, A;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
15 Coruña, A;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;95,09
15 Coruña, A;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
15 Coruña, A;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
15 Coruña, A;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
15 Coruña, A;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;95,12
15 Coruña, A;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
15 Coruña, A;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
15 Coruña, A;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
15 Coruña, A;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
15 Coruña, A;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
15 Coruña, A;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
15 Coruña, A;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;92,84
15 Coruña, A;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
15 Coruña, A;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
15 Coruña, A;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
15 Coruña, A;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;93,45
15 Coruña, A;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
15 Coruña, A;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
15 Coruña, A;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
15 Coruña, A;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
15 Coruña, A;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
15 Coruña, A;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
15 Coruña, A;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;90,76
15 Coruña, A;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
15 Coruña, A;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
15 Coruña, A;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
15 Coruña, A;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;91,76
15 Coruña, A;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
15 Coruña, A;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
15 Coruña, A;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
15 Coruña, A;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
15 Coruña, A;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
15 Coruña, A;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
15 Coruña, A;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QIII;30.213
15 Coruña, A;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
15 Coruña, A;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
15 Coruña, A;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
15 Coruña, A;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QIII;29.926
15 Coruña, A;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
15 Coruña, A;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
15 Coruña, A;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
15 Coruña, A;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QIII;29.590
15 Coruña, A;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
15 Coruña, A;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
15 Coruña, A;All ages;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
15 Coruña, A;All ages;Cohort July 1;Females;Survival in the first trimester;2022QIII;29.240
15 Coruña, A;All ages;Cohort July 1;Females;Survival in the first trimester;2022QII;""
15 Coruña, A;All ages;Cohort July 1;Females;Survival in the first trimester;2022QI;""
15 Coruña, A;All ages;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
15 Coruña, A;All ages;Cohort July 1;Females;Survival in the first trimester;2021QIII;29.136
15 Coruña, A;All ages;Cohort July 1;Females;Survival in the first trimester;2021QII;""
15 Coruña, A;All ages;Cohort July 1;Females;Survival in the first trimester;2021QI;""
15 Coruña, A;All ages;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
15 Coruña, A;All ages;Cohort July 1;Females;Survival in the first trimester;2020QIII;28.675
15 Coruña, A;All ages;Cohort July 1;Females;Survival in the first trimester;2020QII;""
15 Coruña, A;All ages;Cohort July 1;Females;Survival in the first trimester;2020QI;""
15 Coruña, A;All ages;Cohort July 1;Females;Survival in the second trimester;2022QIV;28.234
15 Coruña, A;All ages;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
15 Coruña, A;All ages;Cohort July 1;Females;Survival in the second trimester;2022QII;""
15 Coruña, A;All ages;Cohort July 1;Females;Survival in the second trimester;2022QI;""
15 Coruña, A;All ages;Cohort July 1;Females;Survival in the second trimester;2021QIV;28.290
15 Coruña, A;All ages;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
15 Coruña, A;All ages;Cohort July 1;Females;Survival in the second trimester;2021QII;""
15 Coruña, A;All ages;Cohort July 1;Females;Survival in the second trimester;2021QI;""
15 Coruña, A;All ages;Cohort July 1;Females;Survival in the second trimester;2020QIV;27.845
15 Coruña, A;All ages;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
15 Coruña, A;All ages;Cohort July 1;Females;Survival in the second trimester;2020QII;""
15 Coruña, A;All ages;Cohort July 1;Females;Survival in the second trimester;2020QI;""
15 Coruña, A;All ages;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
15 Coruña, A;All ages;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
15 Coruña, A;All ages;Cohort July 1;Females;Survival in the third trimester;2022QII;""
15 Coruña, A;All ages;Cohort July 1;Females;Survival in the third trimester;2022QI;27.517
15 Coruña, A;All ages;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
15 Coruña, A;All ages;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
15 Coruña, A;All ages;Cohort July 1;Females;Survival in the third trimester;2021QII;""
15 Coruña, A;All ages;Cohort July 1;Females;Survival in the third trimester;2021QI;27.332
15 Coruña, A;All ages;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
15 Coruña, A;All ages;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
15 Coruña, A;All ages;Cohort July 1;Females;Survival in the third trimester;2020QII;""
15 Coruña, A;All ages;Cohort July 1;Females;Survival in the third trimester;2020QI;""
15 Coruña, A;All ages;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
15 Coruña, A;All ages;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
15 Coruña, A;All ages;Cohort July 1;Females;Survival in the third trimester;2022QII;26.768
15 Coruña, A;All ages;Cohort July 1;Females;Survival in the third trimester;2022QI;""
15 Coruña, A;All ages;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
15 Coruña, A;All ages;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
15 Coruña, A;All ages;Cohort July 1;Females;Survival in the third trimester;2021QII;26.757
15 Coruña, A;All ages;Cohort July 1;Females;Survival in the third trimester;2021QI;""
15 Coruña, A;All ages;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
15 Coruña, A;All ages;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
15 Coruña, A;All ages;Cohort July 1;Females;Survival in the third trimester;2020QII;""
15 Coruña, A;All ages;Cohort July 1;Females;Survival in the third trimester;2020QI;""
15 Coruña, A;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
15 Coruña, A;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
15 Coruña, A;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
15 Coruña, A;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
15 Coruña, A;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
15 Coruña, A;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
15 Coruña, A;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
15 Coruña, A;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
15 Coruña, A;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
15 Coruña, A;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
15 Coruña, A;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
15 Coruña, A;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
15 Coruña, A;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
15 Coruña, A;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;96,78
15 Coruña, A;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
15 Coruña, A;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
15 Coruña, A;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
15 Coruña, A;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;97,36
15 Coruña, A;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
15 Coruña, A;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
15 Coruña, A;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
15 Coruña, A;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;96,91
15 Coruña, A;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
15 Coruña, A;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
15 Coruña, A;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;93,45
15 Coruña, A;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
15 Coruña, A;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
15 Coruña, A;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
15 Coruña, A;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;94,53
15 Coruña, A;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
15 Coruña, A;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
15 Coruña, A;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
15 Coruña, A;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;94,1
15 Coruña, A;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
15 Coruña, A;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
15 Coruña, A;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
15 Coruña, A;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
15 Coruña, A;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
15 Coruña, A;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
15 Coruña, A;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;91,95
15 Coruña, A;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
15 Coruña, A;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
15 Coruña, A;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
15 Coruña, A;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;92,37
15 Coruña, A;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
15 Coruña, A;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
15 Coruña, A;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
15 Coruña, A;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
15 Coruña, A;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
15 Coruña, A;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
15 Coruña, A;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;89,45
15 Coruña, A;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
15 Coruña, A;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
15 Coruña, A;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
15 Coruña, A;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;90,43
15 Coruña, A;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
15 Coruña, A;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
15 Coruña, A;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
15 Coruña, A;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
15 Coruña, A;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
15 Coruña, A;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QIV;74.455
15 Coruña, A;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
15 Coruña, A;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
15 Coruña, A;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
15 Coruña, A;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QIV;75.086
15 Coruña, A;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
15 Coruña, A;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
15 Coruña, A;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
15 Coruña, A;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QIV;73.905
15 Coruña, A;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
15 Coruña, A;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
15 Coruña, A;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
15 Coruña, A;All ages;Cohort October 1;Total;Survival in the first trimester;2022QIV;71.894
15 Coruña, A;All ages;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
15 Coruña, A;All ages;Cohort October 1;Total;Survival in the first trimester;2022QII;""
15 Coruña, A;All ages;Cohort October 1;Total;Survival in the first trimester;2022QI;""
15 Coruña, A;All ages;Cohort October 1;Total;Survival in the first trimester;2021QIV;72.855
15 Coruña, A;All ages;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
15 Coruña, A;All ages;Cohort October 1;Total;Survival in the first trimester;2021QII;""
15 Coruña, A;All ages;Cohort October 1;Total;Survival in the first trimester;2021QI;""
15 Coruña, A;All ages;Cohort October 1;Total;Survival in the first trimester;2020QIV;71.826
15 Coruña, A;All ages;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
15 Coruña, A;All ages;Cohort October 1;Total;Survival in the first trimester;2020QII;""
15 Coruña, A;All ages;Cohort October 1;Total;Survival in the first trimester;2020QI;""
15 Coruña, A;All ages;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
15 Coruña, A;All ages;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
15 Coruña, A;All ages;Cohort October 1;Total;Survival in the second trimester;2022QII;""
15 Coruña, A;All ages;Cohort October 1;Total;Survival in the second trimester;2022QI;70.959
15 Coruña, A;All ages;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
15 Coruña, A;All ages;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
15 Coruña, A;All ages;Cohort October 1;Total;Survival in the second trimester;2021QII;""
15 Coruña, A;All ages;Cohort October 1;Total;Survival in the second trimester;2021QI;70.441
15 Coruña, A;All ages;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
15 Coruña, A;All ages;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
15 Coruña, A;All ages;Cohort October 1;Total;Survival in the second trimester;2020QII;""
15 Coruña, A;All ages;Cohort October 1;Total;Survival in the second trimester;2020QI;""
15 Coruña, A;All ages;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
15 Coruña, A;All ages;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
15 Coruña, A;All ages;Cohort October 1;Total;Survival in the third trimester;2022QII;69.158
15 Coruña, A;All ages;Cohort October 1;Total;Survival in the third trimester;2022QI;""
15 Coruña, A;All ages;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
15 Coruña, A;All ages;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
15 Coruña, A;All ages;Cohort October 1;Total;Survival in the third trimester;2021QII;68.989
15 Coruña, A;All ages;Cohort October 1;Total;Survival in the third trimester;2021QI;""
15 Coruña, A;All ages;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
15 Coruña, A;All ages;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
15 Coruña, A;All ages;Cohort October 1;Total;Survival in the third trimester;2020QII;""
15 Coruña, A;All ages;Cohort October 1;Total;Survival in the third trimester;2020QI;""
15 Coruña, A;All ages;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
15 Coruña, A;All ages;Cohort October 1;Total;Survival in the third trimester;2022QIII;67.523
15 Coruña, A;All ages;Cohort October 1;Total;Survival in the third trimester;2022QII;""
15 Coruña, A;All ages;Cohort October 1;Total;Survival in the third trimester;2022QI;""
15 Coruña, A;All ages;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
15 Coruña, A;All ages;Cohort October 1;Total;Survival in the third trimester;2021QIII;67.628
15 Coruña, A;All ages;Cohort October 1;Total;Survival in the third trimester;2021QII;""
15 Coruña, A;All ages;Cohort October 1;Total;Survival in the third trimester;2021QI;""
15 Coruña, A;All ages;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
15 Coruña, A;All ages;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
15 Coruña, A;All ages;Cohort October 1;Total;Survival in the third trimester;2020QII;""
15 Coruña, A;All ages;Cohort October 1;Total;Survival in the third trimester;2020QI;""
15 Coruña, A;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
15 Coruña, A;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
15 Coruña, A;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
15 Coruña, A;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
15 Coruña, A;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
15 Coruña, A;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
15 Coruña, A;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
15 Coruña, A;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
15 Coruña, A;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
15 Coruña, A;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
15 Coruña, A;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
15 Coruña, A;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
15 Coruña, A;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;96,56
15 Coruña, A;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
15 Coruña, A;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
15 Coruña, A;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
15 Coruña, A;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;97,03
15 Coruña, A;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
15 Coruña, A;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
15 Coruña, A;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
15 Coruña, A;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;97,19
15 Coruña, A;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
15 Coruña, A;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
15 Coruña, A;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
15 Coruña, A;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
15 Coruña, A;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
15 Coruña, A;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
15 Coruña, A;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;94,5
15 Coruña, A;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
15 Coruña, A;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
15 Coruña, A;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
15 Coruña, A;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;95,31
15 Coruña, A;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
15 Coruña, A;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
15 Coruña, A;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
15 Coruña, A;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
15 Coruña, A;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
15 Coruña, A;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
15 Coruña, A;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;92,11
15 Coruña, A;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
15 Coruña, A;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
15 Coruña, A;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
15 Coruña, A;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;93,35
15 Coruña, A;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
15 Coruña, A;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
15 Coruña, A;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
15 Coruña, A;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
15 Coruña, A;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
15 Coruña, A;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
15 Coruña, A;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;89,93
15 Coruña, A;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
15 Coruña, A;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
15 Coruña, A;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
15 Coruña, A;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;91,51
15 Coruña, A;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
15 Coruña, A;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
15 Coruña, A;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
15 Coruña, A;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
15 Coruña, A;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
15 Coruña, A;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
15 Coruña, A;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QIV;44.472
15 Coruña, A;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
15 Coruña, A;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
15 Coruña, A;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
15 Coruña, A;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QIV;45.021
15 Coruña, A;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
15 Coruña, A;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
15 Coruña, A;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
15 Coruña, A;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QIV;44.375
15 Coruña, A;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
15 Coruña, A;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
15 Coruña, A;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
15 Coruña, A;All ages;Cohort October 1;Males;Survival in the first trimester;2022QIV;43.012
15 Coruña, A;All ages;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
15 Coruña, A;All ages;Cohort October 1;Males;Survival in the first trimester;2022QII;""
15 Coruña, A;All ages;Cohort October 1;Males;Survival in the first trimester;2022QI;""
15 Coruña, A;All ages;Cohort October 1;Males;Survival in the first trimester;2021QIV;43.739
15 Coruña, A;All ages;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
15 Coruña, A;All ages;Cohort October 1;Males;Survival in the first trimester;2021QII;""
15 Coruña, A;All ages;Cohort October 1;Males;Survival in the first trimester;2021QI;""
15 Coruña, A;All ages;Cohort October 1;Males;Survival in the first trimester;2020QIV;43.205
15 Coruña, A;All ages;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
15 Coruña, A;All ages;Cohort October 1;Males;Survival in the first trimester;2020QII;""
15 Coruña, A;All ages;Cohort October 1;Males;Survival in the first trimester;2020QI;""
15 Coruña, A;All ages;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
15 Coruña, A;All ages;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
15 Coruña, A;All ages;Cohort October 1;Males;Survival in the second trimester;2022QII;""
15 Coruña, A;All ages;Cohort October 1;Males;Survival in the second trimester;2022QI;42.666
15 Coruña, A;All ages;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
15 Coruña, A;All ages;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
15 Coruña, A;All ages;Cohort October 1;Males;Survival in the second trimester;2021QII;""
15 Coruña, A;All ages;Cohort October 1;Males;Survival in the second trimester;2021QI;42.385
15 Coruña, A;All ages;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
15 Coruña, A;All ages;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
15 Coruña, A;All ages;Cohort October 1;Males;Survival in the second trimester;2020QII;""
15 Coruña, A;All ages;Cohort October 1;Males;Survival in the second trimester;2020QI;""
15 Coruña, A;All ages;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
15 Coruña, A;All ages;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
15 Coruña, A;All ages;Cohort October 1;Males;Survival in the third trimester;2022QII;41.671
15 Coruña, A;All ages;Cohort October 1;Males;Survival in the third trimester;2022QI;""
15 Coruña, A;All ages;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
15 Coruña, A;All ages;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
15 Coruña, A;All ages;Cohort October 1;Males;Survival in the third trimester;2021QII;41.570
15 Coruña, A;All ages;Cohort October 1;Males;Survival in the third trimester;2021QI;""
15 Coruña, A;All ages;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
15 Coruña, A;All ages;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
15 Coruña, A;All ages;Cohort October 1;Males;Survival in the third trimester;2020QII;""
15 Coruña, A;All ages;Cohort October 1;Males;Survival in the third trimester;2020QI;""
15 Coruña, A;All ages;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
15 Coruña, A;All ages;Cohort October 1;Males;Survival in the third trimester;2022QIII;40.762
15 Coruña, A;All ages;Cohort October 1;Males;Survival in the third trimester;2022QII;""
15 Coruña, A;All ages;Cohort October 1;Males;Survival in the third trimester;2022QI;""
15 Coruña, A;All ages;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
15 Coruña, A;All ages;Cohort October 1;Males;Survival in the third trimester;2021QIII;40.807
15 Coruña, A;All ages;Cohort October 1;Males;Survival in the third trimester;2021QII;""
15 Coruña, A;All ages;Cohort October 1;Males;Survival in the third trimester;2021QI;""
15 Coruña, A;All ages;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
15 Coruña, A;All ages;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
15 Coruña, A;All ages;Cohort October 1;Males;Survival in the third trimester;2020QII;""
15 Coruña, A;All ages;Cohort October 1;Males;Survival in the third trimester;2020QI;""
15 Coruña, A;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
15 Coruña, A;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
15 Coruña, A;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
15 Coruña, A;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
15 Coruña, A;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
15 Coruña, A;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
15 Coruña, A;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
15 Coruña, A;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
15 Coruña, A;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
15 Coruña, A;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
15 Coruña, A;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
15 Coruña, A;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
15 Coruña, A;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;96,72
15 Coruña, A;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
15 Coruña, A;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
15 Coruña, A;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
15 Coruña, A;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;97,15
15 Coruña, A;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
15 Coruña, A;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
15 Coruña, A;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
15 Coruña, A;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;97,36
15 Coruña, A;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
15 Coruña, A;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
15 Coruña, A;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
15 Coruña, A;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
15 Coruña, A;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
15 Coruña, A;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
15 Coruña, A;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;94,77
15 Coruña, A;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
15 Coruña, A;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
15 Coruña, A;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
15 Coruña, A;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;95,52
15 Coruña, A;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
15 Coruña, A;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
15 Coruña, A;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
15 Coruña, A;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
15 Coruña, A;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
15 Coruña, A;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
15 Coruña, A;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;92,56
15 Coruña, A;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
15 Coruña, A;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
15 Coruña, A;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
15 Coruña, A;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;93,68
15 Coruña, A;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
15 Coruña, A;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
15 Coruña, A;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
15 Coruña, A;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
15 Coruña, A;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
15 Coruña, A;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
15 Coruña, A;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;90,54
15 Coruña, A;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
15 Coruña, A;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
15 Coruña, A;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
15 Coruña, A;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;91,96
15 Coruña, A;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
15 Coruña, A;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
15 Coruña, A;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
15 Coruña, A;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
15 Coruña, A;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
15 Coruña, A;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
15 Coruña, A;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QIV;29.983
15 Coruña, A;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
15 Coruña, A;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
15 Coruña, A;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
15 Coruña, A;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QIV;30.065
15 Coruña, A;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
15 Coruña, A;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
15 Coruña, A;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
15 Coruña, A;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QIV;29.530
15 Coruña, A;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
15 Coruña, A;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
15 Coruña, A;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
15 Coruña, A;All ages;Cohort October 1;Females;Survival in the first trimester;2022QIV;28.882
15 Coruña, A;All ages;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
15 Coruña, A;All ages;Cohort October 1;Females;Survival in the first trimester;2022QII;""
15 Coruña, A;All ages;Cohort October 1;Females;Survival in the first trimester;2022QI;""
15 Coruña, A;All ages;Cohort October 1;Females;Survival in the first trimester;2021QIV;29.116
15 Coruña, A;All ages;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
15 Coruña, A;All ages;Cohort October 1;Females;Survival in the first trimester;2021QII;""
15 Coruña, A;All ages;Cohort October 1;Females;Survival in the first trimester;2021QI;""
15 Coruña, A;All ages;Cohort October 1;Females;Survival in the first trimester;2020QIV;28.621
15 Coruña, A;All ages;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
15 Coruña, A;All ages;Cohort October 1;Females;Survival in the first trimester;2020QII;""
15 Coruña, A;All ages;Cohort October 1;Females;Survival in the first trimester;2020QI;""
15 Coruña, A;All ages;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
15 Coruña, A;All ages;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
15 Coruña, A;All ages;Cohort October 1;Females;Survival in the second trimester;2022QII;""
15 Coruña, A;All ages;Cohort October 1;Females;Survival in the second trimester;2022QI;28.293
15 Coruña, A;All ages;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
15 Coruña, A;All ages;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
15 Coruña, A;All ages;Cohort October 1;Females;Survival in the second trimester;2021QII;""
15 Coruña, A;All ages;Cohort October 1;Females;Survival in the second trimester;2021QI;28.056
15 Coruña, A;All ages;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
15 Coruña, A;All ages;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
15 Coruña, A;All ages;Cohort October 1;Females;Survival in the second trimester;2020QII;""
15 Coruña, A;All ages;Cohort October 1;Females;Survival in the second trimester;2020QI;""
15 Coruña, A;All ages;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
15 Coruña, A;All ages;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
15 Coruña, A;All ages;Cohort October 1;Females;Survival in the third trimester;2022QII;27.487
15 Coruña, A;All ages;Cohort October 1;Females;Survival in the third trimester;2022QI;""
15 Coruña, A;All ages;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
15 Coruña, A;All ages;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
15 Coruña, A;All ages;Cohort October 1;Females;Survival in the third trimester;2021QII;27.419
15 Coruña, A;All ages;Cohort October 1;Females;Survival in the third trimester;2021QI;""
15 Coruña, A;All ages;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
15 Coruña, A;All ages;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
15 Coruña, A;All ages;Cohort October 1;Females;Survival in the third trimester;2020QII;""
15 Coruña, A;All ages;Cohort October 1;Females;Survival in the third trimester;2020QI;""
15 Coruña, A;All ages;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
15 Coruña, A;All ages;Cohort October 1;Females;Survival in the third trimester;2022QIII;26.761
15 Coruña, A;All ages;Cohort October 1;Females;Survival in the third trimester;2022QII;""
15 Coruña, A;All ages;Cohort October 1;Females;Survival in the third trimester;2022QI;""
15 Coruña, A;All ages;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
15 Coruña, A;All ages;Cohort October 1;Females;Survival in the third trimester;2021QIII;26.821
15 Coruña, A;All ages;Cohort October 1;Females;Survival in the third trimester;2021QII;""
15 Coruña, A;All ages;Cohort October 1;Females;Survival in the third trimester;2021QI;""
15 Coruña, A;All ages;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
15 Coruña, A;All ages;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
15 Coruña, A;All ages;Cohort October 1;Females;Survival in the third trimester;2020QII;""
15 Coruña, A;All ages;Cohort October 1;Females;Survival in the third trimester;2020QI;""
15 Coruña, A;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
15 Coruña, A;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
15 Coruña, A;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
15 Coruña, A;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
15 Coruña, A;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
15 Coruña, A;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
15 Coruña, A;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
15 Coruña, A;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
15 Coruña, A;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
15 Coruña, A;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
15 Coruña, A;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
15 Coruña, A;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
15 Coruña, A;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;96,33
15 Coruña, A;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
15 Coruña, A;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
15 Coruña, A;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
15 Coruña, A;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;96,84
15 Coruña, A;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
15 Coruña, A;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
15 Coruña, A;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
15 Coruña, A;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;96,92
15 Coruña, A;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
15 Coruña, A;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
15 Coruña, A;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
15 Coruña, A;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
15 Coruña, A;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
15 Coruña, A;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
15 Coruña, A;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;94,11
15 Coruña, A;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
15 Coruña, A;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
15 Coruña, A;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
15 Coruña, A;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;95,01
15 Coruña, A;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
15 Coruña, A;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
15 Coruña, A;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
15 Coruña, A;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
15 Coruña, A;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
15 Coruña, A;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
15 Coruña, A;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;91,43
15 Coruña, A;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
15 Coruña, A;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
15 Coruña, A;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
15 Coruña, A;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;92,85
15 Coruña, A;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
15 Coruña, A;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
15 Coruña, A;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
15 Coruña, A;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
15 Coruña, A;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
15 Coruña, A;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
15 Coruña, A;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;89,01
15 Coruña, A;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
15 Coruña, A;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
15 Coruña, A;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
15 Coruña, A;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;90,83
15 Coruña, A;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
15 Coruña, A;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
15 Coruña, A;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
15 Coruña, A;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
15 Coruña, A;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
15 Coruña, A;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
15 Coruña, A;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
15 Coruña, A;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
15 Coruña, A;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
15 Coruña, A;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QI;3.710
15 Coruña, A;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
15 Coruña, A;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
15 Coruña, A;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
15 Coruña, A;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QI;3.634
15 Coruña, A;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
15 Coruña, A;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
15 Coruña, A;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
15 Coruña, A;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QI;2.975
15 Coruña, A;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
15 Coruña, A;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
15 Coruña, A;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2022QII;""
15 Coruña, A;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2022QI;3.469
15 Coruña, A;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
15 Coruña, A;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
15 Coruña, A;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2021QII;""
15 Coruña, A;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2021QI;3.442
15 Coruña, A;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
15 Coruña, A;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
15 Coruña, A;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2020QII;""
15 Coruña, A;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2020QI;2.640
15 Coruña, A;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
15 Coruña, A;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
15 Coruña, A;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2022QII;3.240
15 Coruña, A;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2022QI;""
15 Coruña, A;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
15 Coruña, A;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
15 Coruña, A;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2021QII;3.261
15 Coruña, A;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2021QI;""
15 Coruña, A;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
15 Coruña, A;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
15 Coruña, A;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2020QII;2.546
15 Coruña, A;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2020QI;""
15 Coruña, A;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
15 Coruña, A;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QIII;3.020
15 Coruña, A;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QII;""
15 Coruña, A;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QI;""
15 Coruña, A;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
15 Coruña, A;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QIII;3.074
15 Coruña, A;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QII;""
15 Coruña, A;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QI;""
15 Coruña, A;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
15 Coruña, A;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QIII;2.428
15 Coruña, A;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QII;""
15 Coruña, A;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QI;""
15 Coruña, A;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QIV;2.855
15 Coruña, A;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
15 Coruña, A;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QII;""
15 Coruña, A;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QI;""
15 Coruña, A;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QIV;2.924
15 Coruña, A;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
15 Coruña, A;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QII;""
15 Coruña, A;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QI;""
15 Coruña, A;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QIV;2.305
15 Coruña, A;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
15 Coruña, A;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QII;""
15 Coruña, A;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QI;""
15 Coruña, A;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
15 Coruña, A;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
15 Coruña, A;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
15 Coruña, A;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
15 Coruña, A;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
15 Coruña, A;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
15 Coruña, A;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
15 Coruña, A;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
15 Coruña, A;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
15 Coruña, A;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
15 Coruña, A;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
15 Coruña, A;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
15 Coruña, A;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
15 Coruña, A;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
15 Coruña, A;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
15 Coruña, A;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;93,5
15 Coruña, A;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
15 Coruña, A;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
15 Coruña, A;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
15 Coruña, A;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;94,72
15 Coruña, A;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
15 Coruña, A;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
15 Coruña, A;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
15 Coruña, A;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;88,74
15 Coruña, A;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
15 Coruña, A;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
15 Coruña, A;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;87,33
15 Coruña, A;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
15 Coruña, A;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
15 Coruña, A;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
15 Coruña, A;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;89,74
15 Coruña, A;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
15 Coruña, A;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
15 Coruña, A;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
15 Coruña, A;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;85,58
15 Coruña, A;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
15 Coruña, A;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
15 Coruña, A;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;81,4
15 Coruña, A;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
15 Coruña, A;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
15 Coruña, A;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
15 Coruña, A;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;84,59
15 Coruña, A;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
15 Coruña, A;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
15 Coruña, A;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
15 Coruña, A;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;81,61
15 Coruña, A;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
15 Coruña, A;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
15 Coruña, A;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;76,95
15 Coruña, A;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
15 Coruña, A;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
15 Coruña, A;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
15 Coruña, A;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;80,46
15 Coruña, A;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
15 Coruña, A;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
15 Coruña, A;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
15 Coruña, A;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;77,48
15 Coruña, A;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
15 Coruña, A;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
15 Coruña, A;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
15 Coruña, A;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
15 Coruña, A;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
15 Coruña, A;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
15 Coruña, A;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QI;2.200
15 Coruña, A;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
15 Coruña, A;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
15 Coruña, A;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
15 Coruña, A;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QI;2.189
15 Coruña, A;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
15 Coruña, A;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
15 Coruña, A;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
15 Coruña, A;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QI;1.789
15 Coruña, A;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
15 Coruña, A;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
15 Coruña, A;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2022QII;""
15 Coruña, A;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2022QI;2.059
15 Coruña, A;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
15 Coruña, A;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
15 Coruña, A;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2021QII;""
15 Coruña, A;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2021QI;2.071
15 Coruña, A;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
15 Coruña, A;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
15 Coruña, A;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2020QII;""
15 Coruña, A;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2020QI;1.604
15 Coruña, A;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
15 Coruña, A;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
15 Coruña, A;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2022QII;1.924
15 Coruña, A;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2022QI;""
15 Coruña, A;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
15 Coruña, A;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
15 Coruña, A;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2021QII;1.970
15 Coruña, A;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2021QI;""
15 Coruña, A;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
15 Coruña, A;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
15 Coruña, A;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2020QII;1.551
15 Coruña, A;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2020QI;""
15 Coruña, A;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
15 Coruña, A;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QIII;1.813
15 Coruña, A;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QII;""
15 Coruña, A;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QI;""
15 Coruña, A;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
15 Coruña, A;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QIII;1.862
15 Coruña, A;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QII;""
15 Coruña, A;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QI;""
15 Coruña, A;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
15 Coruña, A;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QIII;1.484
15 Coruña, A;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QII;""
15 Coruña, A;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QI;""
15 Coruña, A;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QIV;1.726
15 Coruña, A;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
15 Coruña, A;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QII;""
15 Coruña, A;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QI;""
15 Coruña, A;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QIV;1.774
15 Coruña, A;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
15 Coruña, A;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QII;""
15 Coruña, A;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QI;""
15 Coruña, A;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QIV;1.416
15 Coruña, A;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
15 Coruña, A;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QII;""
15 Coruña, A;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QI;""
15 Coruña, A;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
15 Coruña, A;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
15 Coruña, A;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
15 Coruña, A;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
15 Coruña, A;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
15 Coruña, A;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
15 Coruña, A;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
15 Coruña, A;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
15 Coruña, A;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
15 Coruña, A;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
15 Coruña, A;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
15 Coruña, A;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
15 Coruña, A;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
15 Coruña, A;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
15 Coruña, A;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
15 Coruña, A;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;93,59
15 Coruña, A;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
15 Coruña, A;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
15 Coruña, A;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
15 Coruña, A;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;94,61
15 Coruña, A;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
15 Coruña, A;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
15 Coruña, A;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
15 Coruña, A;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;89,66
15 Coruña, A;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
15 Coruña, A;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
15 Coruña, A;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;87,45
15 Coruña, A;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
15 Coruña, A;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
15 Coruña, A;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
15 Coruña, A;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;90
15 Coruña, A;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
15 Coruña, A;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
15 Coruña, A;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
15 Coruña, A;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;86,7
15 Coruña, A;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
15 Coruña, A;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
15 Coruña, A;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;82,41
15 Coruña, A;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
15 Coruña, A;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
15 Coruña, A;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
15 Coruña, A;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;85,06
15 Coruña, A;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
15 Coruña, A;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
15 Coruña, A;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
15 Coruña, A;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;82,95
15 Coruña, A;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
15 Coruña, A;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
15 Coruña, A;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;78,45
15 Coruña, A;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
15 Coruña, A;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
15 Coruña, A;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
15 Coruña, A;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;81,04
15 Coruña, A;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
15 Coruña, A;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
15 Coruña, A;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
15 Coruña, A;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;79,15
15 Coruña, A;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
15 Coruña, A;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
15 Coruña, A;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
15 Coruña, A;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
15 Coruña, A;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
15 Coruña, A;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
15 Coruña, A;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QI;1.510
15 Coruña, A;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
15 Coruña, A;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
15 Coruña, A;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
15 Coruña, A;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QI;1.445
15 Coruña, A;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
15 Coruña, A;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
15 Coruña, A;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
15 Coruña, A;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QI;1.186
15 Coruña, A;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
15 Coruña, A;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
15 Coruña, A;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2022QII;""
15 Coruña, A;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2022QI;1.410
15 Coruña, A;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
15 Coruña, A;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
15 Coruña, A;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2021QII;""
15 Coruña, A;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2021QI;1.371
15 Coruña, A;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
15 Coruña, A;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
15 Coruña, A;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2020QII;""
15 Coruña, A;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2020QI;1.036
15 Coruña, A;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
15 Coruña, A;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
15 Coruña, A;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2022QII;1.316
15 Coruña, A;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2022QI;""
15 Coruña, A;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
15 Coruña, A;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
15 Coruña, A;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2021QII;1.291
15 Coruña, A;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2021QI;""
15 Coruña, A;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
15 Coruña, A;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
15 Coruña, A;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2020QII;995
15 Coruña, A;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2020QI;""
15 Coruña, A;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
15 Coruña, A;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QIII;1.207
15 Coruña, A;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QII;""
15 Coruña, A;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QI;""
15 Coruña, A;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
15 Coruña, A;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QIII;1.212
15 Coruña, A;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QII;""
15 Coruña, A;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QI;""
15 Coruña, A;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
15 Coruña, A;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QIII;944
15 Coruña, A;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QII;""
15 Coruña, A;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QI;""
15 Coruña, A;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QIV;1.129
15 Coruña, A;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
15 Coruña, A;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QII;""
15 Coruña, A;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QI;""
15 Coruña, A;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QIV;1.150
15 Coruña, A;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
15 Coruña, A;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QII;""
15 Coruña, A;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QI;""
15 Coruña, A;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QIV;889
15 Coruña, A;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
15 Coruña, A;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QII;""
15 Coruña, A;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QI;""
15 Coruña, A;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
15 Coruña, A;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
15 Coruña, A;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
15 Coruña, A;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
15 Coruña, A;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
15 Coruña, A;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
15 Coruña, A;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
15 Coruña, A;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
15 Coruña, A;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
15 Coruña, A;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
15 Coruña, A;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
15 Coruña, A;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
15 Coruña, A;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
15 Coruña, A;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
15 Coruña, A;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
15 Coruña, A;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;93,38
15 Coruña, A;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
15 Coruña, A;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
15 Coruña, A;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
15 Coruña, A;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;94,88
15 Coruña, A;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
15 Coruña, A;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
15 Coruña, A;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
15 Coruña, A;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;87,35
15 Coruña, A;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
15 Coruña, A;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
15 Coruña, A;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;87,15
15 Coruña, A;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
15 Coruña, A;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
15 Coruña, A;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
15 Coruña, A;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;89,34
15 Coruña, A;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
15 Coruña, A;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
15 Coruña, A;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
15 Coruña, A;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;83,9
15 Coruña, A;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
15 Coruña, A;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
15 Coruña, A;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;79,93
15 Coruña, A;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
15 Coruña, A;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
15 Coruña, A;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
15 Coruña, A;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;83,88
15 Coruña, A;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
15 Coruña, A;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
15 Coruña, A;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
15 Coruña, A;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;79,6
15 Coruña, A;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
15 Coruña, A;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
15 Coruña, A;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;74,77
15 Coruña, A;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
15 Coruña, A;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
15 Coruña, A;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
15 Coruña, A;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;79,58
15 Coruña, A;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
15 Coruña, A;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
15 Coruña, A;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
15 Coruña, A;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;74,96
15 Coruña, A;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
15 Coruña, A;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
15 Coruña, A;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
15 Coruña, A;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
15 Coruña, A;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
15 Coruña, A;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QII;3.139
15 Coruña, A;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
15 Coruña, A;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
15 Coruña, A;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
15 Coruña, A;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QII;3.156
15 Coruña, A;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
15 Coruña, A;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
15 Coruña, A;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
15 Coruña, A;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QII;3.021
15 Coruña, A;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
15 Coruña, A;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
15 Coruña, A;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
15 Coruña, A;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2022QII;2.908
15 Coruña, A;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2022QI;""
15 Coruña, A;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
15 Coruña, A;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
15 Coruña, A;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2021QII;2.944
15 Coruña, A;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2021QI;""
15 Coruña, A;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
15 Coruña, A;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
15 Coruña, A;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2020QII;2.908
15 Coruña, A;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2020QI;""
15 Coruña, A;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
15 Coruña, A;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2022QIII;2.694
15 Coruña, A;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2022QII;""
15 Coruña, A;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2022QI;""
15 Coruña, A;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
15 Coruña, A;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2021QIII;2.739
15 Coruña, A;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2021QII;""
15 Coruña, A;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2021QI;""
15 Coruña, A;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
15 Coruña, A;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2020QIII;2.756
15 Coruña, A;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2020QII;""
15 Coruña, A;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2020QI;""
15 Coruña, A;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QIV;2.534
15 Coruña, A;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
15 Coruña, A;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QII;""
15 Coruña, A;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QI;""
15 Coruña, A;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QIV;2.590
15 Coruña, A;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
15 Coruña, A;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QII;""
15 Coruña, A;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QI;""
15 Coruña, A;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QIV;2.611
15 Coruña, A;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
15 Coruña, A;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QII;""
15 Coruña, A;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QI;""
15 Coruña, A;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
15 Coruña, A;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
15 Coruña, A;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QII;""
15 Coruña, A;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QI;2.458
15 Coruña, A;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
15 Coruña, A;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
15 Coruña, A;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QII;""
15 Coruña, A;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QI;2.514
15 Coruña, A;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
15 Coruña, A;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
15 Coruña, A;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QII;""
15 Coruña, A;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QI;""
15 Coruña, A;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
15 Coruña, A;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
15 Coruña, A;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
15 Coruña, A;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
15 Coruña, A;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
15 Coruña, A;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
15 Coruña, A;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
15 Coruña, A;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
15 Coruña, A;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
15 Coruña, A;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
15 Coruña, A;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
15 Coruña, A;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
15 Coruña, A;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
15 Coruña, A;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
15 Coruña, A;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;92,64
15 Coruña, A;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
15 Coruña, A;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
15 Coruña, A;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
15 Coruña, A;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;93,28
15 Coruña, A;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
15 Coruña, A;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
15 Coruña, A;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
15 Coruña, A;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;96,26
15 Coruña, A;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
15 Coruña, A;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
15 Coruña, A;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;85,82
15 Coruña, A;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
15 Coruña, A;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
15 Coruña, A;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
15 Coruña, A;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;86,79
15 Coruña, A;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
15 Coruña, A;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
15 Coruña, A;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
15 Coruña, A;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;91,23
15 Coruña, A;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
15 Coruña, A;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
15 Coruña, A;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;80,73
15 Coruña, A;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
15 Coruña, A;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
15 Coruña, A;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
15 Coruña, A;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;82,07
15 Coruña, A;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
15 Coruña, A;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
15 Coruña, A;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
15 Coruña, A;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;86,43
15 Coruña, A;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
15 Coruña, A;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
15 Coruña, A;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
15 Coruña, A;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
15 Coruña, A;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
15 Coruña, A;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
15 Coruña, A;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;77,88
15 Coruña, A;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
15 Coruña, A;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
15 Coruña, A;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
15 Coruña, A;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;83,22
15 Coruña, A;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
15 Coruña, A;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
15 Coruña, A;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
15 Coruña, A;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
15 Coruña, A;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
15 Coruña, A;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
15 Coruña, A;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QII;1.853
15 Coruña, A;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
15 Coruña, A;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
15 Coruña, A;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
15 Coruña, A;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QII;1.931
15 Coruña, A;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
15 Coruña, A;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
15 Coruña, A;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
15 Coruña, A;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QII;1.811
15 Coruña, A;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
15 Coruña, A;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
15 Coruña, A;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
15 Coruña, A;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2022QII;1.714
15 Coruña, A;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2022QI;""
15 Coruña, A;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
15 Coruña, A;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
15 Coruña, A;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2021QII;1.802
15 Coruña, A;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2021QI;""
15 Coruña, A;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
15 Coruña, A;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
15 Coruña, A;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2020QII;1.751
15 Coruña, A;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2020QI;""
15 Coruña, A;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
15 Coruña, A;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2022QIII;1.605
15 Coruña, A;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2022QII;""
15 Coruña, A;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2022QI;""
15 Coruña, A;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
15 Coruña, A;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2021QIII;1.679
15 Coruña, A;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2021QII;""
15 Coruña, A;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2021QI;""
15 Coruña, A;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
15 Coruña, A;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2020QIII;1.662
15 Coruña, A;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2020QII;""
15 Coruña, A;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2020QI;""
15 Coruña, A;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QIV;1.517
15 Coruña, A;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
15 Coruña, A;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QII;""
15 Coruña, A;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QI;""
15 Coruña, A;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QIV;1.594
15 Coruña, A;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
15 Coruña, A;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QII;""
15 Coruña, A;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QI;""
15 Coruña, A;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QIV;1.581
15 Coruña, A;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
15 Coruña, A;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QII;""
15 Coruña, A;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QI;""
15 Coruña, A;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
15 Coruña, A;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
15 Coruña, A;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QII;""
15 Coruña, A;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QI;1.516
15 Coruña, A;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
15 Coruña, A;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
15 Coruña, A;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QII;""
15 Coruña, A;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QI;1.521
15 Coruña, A;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
15 Coruña, A;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
15 Coruña, A;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QII;""
15 Coruña, A;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QI;""
15 Coruña, A;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
15 Coruña, A;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
15 Coruña, A;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
15 Coruña, A;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
15 Coruña, A;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
15 Coruña, A;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
15 Coruña, A;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
15 Coruña, A;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
15 Coruña, A;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
15 Coruña, A;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
15 Coruña, A;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
15 Coruña, A;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
15 Coruña, A;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
15 Coruña, A;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
15 Coruña, A;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;92,5
15 Coruña, A;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
15 Coruña, A;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
15 Coruña, A;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
15 Coruña, A;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;93,32
15 Coruña, A;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
15 Coruña, A;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
15 Coruña, A;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
15 Coruña, A;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;96,69
15 Coruña, A;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
15 Coruña, A;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
15 Coruña, A;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;86,62
15 Coruña, A;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
15 Coruña, A;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
15 Coruña, A;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
15 Coruña, A;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;86,95
15 Coruña, A;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
15 Coruña, A;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
15 Coruña, A;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
15 Coruña, A;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;91,77
15 Coruña, A;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
15 Coruña, A;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
15 Coruña, A;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;81,87
15 Coruña, A;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
15 Coruña, A;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
15 Coruña, A;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
15 Coruña, A;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;82,55
15 Coruña, A;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
15 Coruña, A;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
15 Coruña, A;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
15 Coruña, A;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;87,3
15 Coruña, A;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
15 Coruña, A;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
15 Coruña, A;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
15 Coruña, A;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
15 Coruña, A;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
15 Coruña, A;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
15 Coruña, A;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;78,51
15 Coruña, A;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
15 Coruña, A;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
15 Coruña, A;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
15 Coruña, A;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;83,99
15 Coruña, A;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
15 Coruña, A;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
15 Coruña, A;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
15 Coruña, A;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
15 Coruña, A;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
15 Coruña, A;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
15 Coruña, A;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QII;1.286
15 Coruña, A;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
15 Coruña, A;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
15 Coruña, A;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
15 Coruña, A;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QII;1.225
15 Coruña, A;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
15 Coruña, A;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
15 Coruña, A;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
15 Coruña, A;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QII;1.210
15 Coruña, A;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
15 Coruña, A;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
15 Coruña, A;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
15 Coruña, A;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2022QII;1.194
15 Coruña, A;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2022QI;""
15 Coruña, A;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
15 Coruña, A;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
15 Coruña, A;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2021QII;1.142
15 Coruña, A;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2021QI;""
15 Coruña, A;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
15 Coruña, A;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
15 Coruña, A;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2020QII;1.157
15 Coruña, A;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2020QI;""
15 Coruña, A;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
15 Coruña, A;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2022QIII;1.089
15 Coruña, A;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2022QII;""
15 Coruña, A;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2022QI;""
15 Coruña, A;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
15 Coruña, A;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2021QIII;1.060
15 Coruña, A;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2021QII;""
15 Coruña, A;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2021QI;""
15 Coruña, A;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
15 Coruña, A;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2020QIII;1.094
15 Coruña, A;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2020QII;""
15 Coruña, A;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2020QI;""
15 Coruña, A;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QIV;1.017
15 Coruña, A;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
15 Coruña, A;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QII;""
15 Coruña, A;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QI;""
15 Coruña, A;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QIV;996
15 Coruña, A;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
15 Coruña, A;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QII;""
15 Coruña, A;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QI;""
15 Coruña, A;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QIV;1.030
15 Coruña, A;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
15 Coruña, A;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QII;""
15 Coruña, A;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QI;""
15 Coruña, A;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
15 Coruña, A;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
15 Coruña, A;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QII;""
15 Coruña, A;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QI;942
15 Coruña, A;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
15 Coruña, A;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
15 Coruña, A;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QII;""
15 Coruña, A;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QI;993
15 Coruña, A;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
15 Coruña, A;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
15 Coruña, A;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QII;""
15 Coruña, A;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QI;""
15 Coruña, A;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
15 Coruña, A;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
15 Coruña, A;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
15 Coruña, A;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
15 Coruña, A;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
15 Coruña, A;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
15 Coruña, A;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
15 Coruña, A;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
15 Coruña, A;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
15 Coruña, A;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
15 Coruña, A;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
15 Coruña, A;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
15 Coruña, A;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
15 Coruña, A;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
15 Coruña, A;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;92,85
15 Coruña, A;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
15 Coruña, A;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
15 Coruña, A;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
15 Coruña, A;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;93,22
15 Coruña, A;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
15 Coruña, A;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
15 Coruña, A;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
15 Coruña, A;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;95,62
15 Coruña, A;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
15 Coruña, A;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
15 Coruña, A;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;84,68
15 Coruña, A;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
15 Coruña, A;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
15 Coruña, A;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
15 Coruña, A;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;86,53
15 Coruña, A;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
15 Coruña, A;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
15 Coruña, A;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
15 Coruña, A;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;90,41
15 Coruña, A;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
15 Coruña, A;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
15 Coruña, A;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;79,08
15 Coruña, A;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
15 Coruña, A;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
15 Coruña, A;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
15 Coruña, A;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;81,31
15 Coruña, A;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
15 Coruña, A;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
15 Coruña, A;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
15 Coruña, A;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;85,12
15 Coruña, A;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
15 Coruña, A;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
15 Coruña, A;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
15 Coruña, A;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
15 Coruña, A;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
15 Coruña, A;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
15 Coruña, A;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;76,9
15 Coruña, A;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
15 Coruña, A;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
15 Coruña, A;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
15 Coruña, A;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;82,07
15 Coruña, A;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
15 Coruña, A;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
15 Coruña, A;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
15 Coruña, A;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
15 Coruña, A;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
15 Coruña, A;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QIII;3.349
15 Coruña, A;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
15 Coruña, A;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
15 Coruña, A;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
15 Coruña, A;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QIII;3.357
15 Coruña, A;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
15 Coruña, A;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
15 Coruña, A;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
15 Coruña, A;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QIII;3.168
15 Coruña, A;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
15 Coruña, A;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
15 Coruña, A;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
15 Coruña, A;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2022QIII;3.054
15 Coruña, A;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2022QII;""
15 Coruña, A;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2022QI;""
15 Coruña, A;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
15 Coruña, A;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2021QIII;3.091
15 Coruña, A;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2021QII;""
15 Coruña, A;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2021QI;""
15 Coruña, A;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
15 Coruña, A;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2020QIII;2.962
15 Coruña, A;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2020QII;""
15 Coruña, A;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2020QI;""
15 Coruña, A;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2022QIV;2.859
15 Coruña, A;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
15 Coruña, A;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2022QII;""
15 Coruña, A;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2022QI;""
15 Coruña, A;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2021QIV;2.909
15 Coruña, A;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
15 Coruña, A;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2021QII;""
15 Coruña, A;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2021QI;""
15 Coruña, A;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2020QIV;2.787
15 Coruña, A;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
15 Coruña, A;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2020QII;""
15 Coruña, A;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2020QI;""
15 Coruña, A;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
15 Coruña, A;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
15 Coruña, A;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QII;""
15 Coruña, A;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QI;2.754
15 Coruña, A;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
15 Coruña, A;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
15 Coruña, A;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QII;""
15 Coruña, A;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QI;2.676
15 Coruña, A;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
15 Coruña, A;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
15 Coruña, A;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QII;""
15 Coruña, A;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QI;""
15 Coruña, A;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
15 Coruña, A;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
15 Coruña, A;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QII;2.578
15 Coruña, A;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QI;""
15 Coruña, A;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
15 Coruña, A;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
15 Coruña, A;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QII;2.568
15 Coruña, A;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QI;""
15 Coruña, A;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
15 Coruña, A;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
15 Coruña, A;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QII;""
15 Coruña, A;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QI;""
15 Coruña, A;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
15 Coruña, A;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
15 Coruña, A;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
15 Coruña, A;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
15 Coruña, A;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
15 Coruña, A;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
15 Coruña, A;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
15 Coruña, A;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
15 Coruña, A;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
15 Coruña, A;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
15 Coruña, A;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
15 Coruña, A;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
15 Coruña, A;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
15 Coruña, A;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;91,19
15 Coruña, A;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
15 Coruña, A;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
15 Coruña, A;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
15 Coruña, A;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;92,08
15 Coruña, A;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
15 Coruña, A;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
15 Coruña, A;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
15 Coruña, A;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;93,5
15 Coruña, A;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
15 Coruña, A;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
15 Coruña, A;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;85,37
15 Coruña, A;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
15 Coruña, A;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
15 Coruña, A;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
15 Coruña, A;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;86,65
15 Coruña, A;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
15 Coruña, A;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
15 Coruña, A;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
15 Coruña, A;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;87,97
15 Coruña, A;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
15 Coruña, A;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
15 Coruña, A;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
15 Coruña, A;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
15 Coruña, A;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
15 Coruña, A;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
15 Coruña, A;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;82,04
15 Coruña, A;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
15 Coruña, A;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
15 Coruña, A;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
15 Coruña, A;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;84,47
15 Coruña, A;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
15 Coruña, A;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
15 Coruña, A;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
15 Coruña, A;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
15 Coruña, A;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
15 Coruña, A;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
15 Coruña, A;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;76,79
15 Coruña, A;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
15 Coruña, A;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
15 Coruña, A;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
15 Coruña, A;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;81,06
15 Coruña, A;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
15 Coruña, A;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
15 Coruña, A;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
15 Coruña, A;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
15 Coruña, A;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
15 Coruña, A;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
15 Coruña, A;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QIII;1.966
15 Coruña, A;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
15 Coruña, A;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
15 Coruña, A;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
15 Coruña, A;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QIII;2.043
15 Coruña, A;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
15 Coruña, A;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
15 Coruña, A;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
15 Coruña, A;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QIII;1.910
15 Coruña, A;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
15 Coruña, A;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
15 Coruña, A;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
15 Coruña, A;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2022QIII;1.810
15 Coruña, A;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2022QII;""
15 Coruña, A;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2022QI;""
15 Coruña, A;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
15 Coruña, A;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2021QIII;1.886
15 Coruña, A;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2021QII;""
15 Coruña, A;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2021QI;""
15 Coruña, A;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
15 Coruña, A;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2020QIII;1.789
15 Coruña, A;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2020QII;""
15 Coruña, A;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2020QI;""
15 Coruña, A;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2022QIV;1.702
15 Coruña, A;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
15 Coruña, A;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2022QII;""
15 Coruña, A;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2022QI;""
15 Coruña, A;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2021QIV;1.783
15 Coruña, A;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
15 Coruña, A;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2021QII;""
15 Coruña, A;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2021QI;""
15 Coruña, A;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2020QIV;1.692
15 Coruña, A;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
15 Coruña, A;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2020QII;""
15 Coruña, A;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2020QI;""
15 Coruña, A;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
15 Coruña, A;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
15 Coruña, A;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QII;""
15 Coruña, A;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QI;1.690
15 Coruña, A;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
15 Coruña, A;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
15 Coruña, A;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QII;""
15 Coruña, A;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QI;1.625
15 Coruña, A;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
15 Coruña, A;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
15 Coruña, A;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QII;""
15 Coruña, A;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QI;""
15 Coruña, A;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
15 Coruña, A;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
15 Coruña, A;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QII;1.589
15 Coruña, A;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QI;""
15 Coruña, A;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
15 Coruña, A;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
15 Coruña, A;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QII;1.562
15 Coruña, A;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QI;""
15 Coruña, A;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
15 Coruña, A;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
15 Coruña, A;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QII;""
15 Coruña, A;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QI;""
15 Coruña, A;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
15 Coruña, A;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
15 Coruña, A;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
15 Coruña, A;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
15 Coruña, A;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
15 Coruña, A;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
15 Coruña, A;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
15 Coruña, A;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
15 Coruña, A;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
15 Coruña, A;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
15 Coruña, A;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
15 Coruña, A;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
15 Coruña, A;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
15 Coruña, A;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;92,07
15 Coruña, A;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
15 Coruña, A;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
15 Coruña, A;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
15 Coruña, A;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;92,32
15 Coruña, A;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
15 Coruña, A;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
15 Coruña, A;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
15 Coruña, A;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;93,66
15 Coruña, A;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
15 Coruña, A;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
15 Coruña, A;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;86,57
15 Coruña, A;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
15 Coruña, A;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
15 Coruña, A;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
15 Coruña, A;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;87,27
15 Coruña, A;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
15 Coruña, A;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
15 Coruña, A;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
15 Coruña, A;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;88,59
15 Coruña, A;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
15 Coruña, A;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
15 Coruña, A;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
15 Coruña, A;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
15 Coruña, A;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
15 Coruña, A;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
15 Coruña, A;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;82,72
15 Coruña, A;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
15 Coruña, A;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
15 Coruña, A;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
15 Coruña, A;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;85,08
15 Coruña, A;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
15 Coruña, A;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
15 Coruña, A;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
15 Coruña, A;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
15 Coruña, A;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
15 Coruña, A;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
15 Coruña, A;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;77,78
15 Coruña, A;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
15 Coruña, A;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
15 Coruña, A;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
15 Coruña, A;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;81,78
15 Coruña, A;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
15 Coruña, A;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
15 Coruña, A;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
15 Coruña, A;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
15 Coruña, A;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
15 Coruña, A;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
15 Coruña, A;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QIII;1.383
15 Coruña, A;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
15 Coruña, A;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
15 Coruña, A;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
15 Coruña, A;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QIII;1.314
15 Coruña, A;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
15 Coruña, A;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
15 Coruña, A;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
15 Coruña, A;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QIII;1.258
15 Coruña, A;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
15 Coruña, A;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
15 Coruña, A;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
15 Coruña, A;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2022QIII;1.244
15 Coruña, A;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2022QII;""
15 Coruña, A;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2022QI;""
15 Coruña, A;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
15 Coruña, A;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2021QIII;1.205
15 Coruña, A;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2021QII;""
15 Coruña, A;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2021QI;""
15 Coruña, A;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
15 Coruña, A;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2020QIII;1.173
15 Coruña, A;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2020QII;""
15 Coruña, A;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2020QI;""
15 Coruña, A;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2022QIV;1.157
15 Coruña, A;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
15 Coruña, A;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2022QII;""
15 Coruña, A;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2022QI;""
15 Coruña, A;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2021QIV;1.126
15 Coruña, A;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
15 Coruña, A;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2021QII;""
15 Coruña, A;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2021QI;""
15 Coruña, A;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2020QIV;1.095
15 Coruña, A;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
15 Coruña, A;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2020QII;""
15 Coruña, A;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2020QI;""
15 Coruña, A;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
15 Coruña, A;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
15 Coruña, A;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QII;""
15 Coruña, A;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QI;1.064
15 Coruña, A;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
15 Coruña, A;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
15 Coruña, A;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QII;""
15 Coruña, A;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QI;1.051
15 Coruña, A;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
15 Coruña, A;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
15 Coruña, A;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QII;""
15 Coruña, A;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QI;""
15 Coruña, A;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
15 Coruña, A;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
15 Coruña, A;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QII;989
15 Coruña, A;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QI;""
15 Coruña, A;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
15 Coruña, A;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
15 Coruña, A;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QII;1.006
15 Coruña, A;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QI;""
15 Coruña, A;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
15 Coruña, A;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
15 Coruña, A;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QII;""
15 Coruña, A;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QI;""
15 Coruña, A;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
15 Coruña, A;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
15 Coruña, A;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
15 Coruña, A;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
15 Coruña, A;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
15 Coruña, A;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
15 Coruña, A;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
15 Coruña, A;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
15 Coruña, A;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
15 Coruña, A;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
15 Coruña, A;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
15 Coruña, A;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
15 Coruña, A;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
15 Coruña, A;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;89,95
15 Coruña, A;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
15 Coruña, A;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
15 Coruña, A;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
15 Coruña, A;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;91,7
15 Coruña, A;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
15 Coruña, A;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
15 Coruña, A;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
15 Coruña, A;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;93,24
15 Coruña, A;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
15 Coruña, A;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
15 Coruña, A;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;83,66
15 Coruña, A;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
15 Coruña, A;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
15 Coruña, A;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
15 Coruña, A;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;85,69
15 Coruña, A;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
15 Coruña, A;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
15 Coruña, A;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
15 Coruña, A;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;87,04
15 Coruña, A;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
15 Coruña, A;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
15 Coruña, A;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
15 Coruña, A;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
15 Coruña, A;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
15 Coruña, A;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
15 Coruña, A;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;80,97
15 Coruña, A;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
15 Coruña, A;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
15 Coruña, A;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
15 Coruña, A;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;83,55
15 Coruña, A;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
15 Coruña, A;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
15 Coruña, A;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
15 Coruña, A;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
15 Coruña, A;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
15 Coruña, A;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
15 Coruña, A;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;75,27
15 Coruña, A;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
15 Coruña, A;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
15 Coruña, A;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
15 Coruña, A;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;79,97
15 Coruña, A;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
15 Coruña, A;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
15 Coruña, A;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
15 Coruña, A;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
15 Coruña, A;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
15 Coruña, A;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QIV;3.365
15 Coruña, A;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
15 Coruña, A;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
15 Coruña, A;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
15 Coruña, A;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QIV;3.530
15 Coruña, A;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
15 Coruña, A;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
15 Coruña, A;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
15 Coruña, A;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QIV;3.410
15 Coruña, A;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
15 Coruña, A;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
15 Coruña, A;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
15 Coruña, A;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2022QIV;3.120
15 Coruña, A;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
15 Coruña, A;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2022QII;""
15 Coruña, A;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2022QI;""
15 Coruña, A;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2021QIV;3.286
15 Coruña, A;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
15 Coruña, A;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2021QII;""
15 Coruña, A;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2021QI;""
15 Coruña, A;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2020QIV;3.188
15 Coruña, A;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
15 Coruña, A;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2020QII;""
15 Coruña, A;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2020QI;""
15 Coruña, A;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
15 Coruña, A;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
15 Coruña, A;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2022QII;""
15 Coruña, A;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2022QI;3.095
15 Coruña, A;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
15 Coruña, A;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
15 Coruña, A;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2021QII;""
15 Coruña, A;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2021QI;3.039
15 Coruña, A;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
15 Coruña, A;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
15 Coruña, A;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2020QII;""
15 Coruña, A;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2020QI;""
15 Coruña, A;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
15 Coruña, A;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
15 Coruña, A;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QII;2.902
15 Coruña, A;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QI;""
15 Coruña, A;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
15 Coruña, A;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
15 Coruña, A;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QII;2.893
15 Coruña, A;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QI;""
15 Coruña, A;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
15 Coruña, A;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
15 Coruña, A;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QII;""
15 Coruña, A;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QI;""
15 Coruña, A;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
15 Coruña, A;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QIII;2.712
15 Coruña, A;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QII;""
15 Coruña, A;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QI;""
15 Coruña, A;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
15 Coruña, A;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QIII;2.730
15 Coruña, A;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QII;""
15 Coruña, A;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QI;""
15 Coruña, A;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
15 Coruña, A;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
15 Coruña, A;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QII;""
15 Coruña, A;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QI;""
15 Coruña, A;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
15 Coruña, A;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
15 Coruña, A;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
15 Coruña, A;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
15 Coruña, A;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
15 Coruña, A;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
15 Coruña, A;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
15 Coruña, A;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
15 Coruña, A;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
15 Coruña, A;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
15 Coruña, A;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
15 Coruña, A;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
15 Coruña, A;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;92,72
15 Coruña, A;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
15 Coruña, A;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
15 Coruña, A;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
15 Coruña, A;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;93,09
15 Coruña, A;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
15 Coruña, A;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
15 Coruña, A;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
15 Coruña, A;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;93,49
15 Coruña, A;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
15 Coruña, A;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
15 Coruña, A;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
15 Coruña, A;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
15 Coruña, A;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
15 Coruña, A;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
15 Coruña, A;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;87,68
15 Coruña, A;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
15 Coruña, A;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
15 Coruña, A;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
15 Coruña, A;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;89,12
15 Coruña, A;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
15 Coruña, A;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
15 Coruña, A;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
15 Coruña, A;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
15 Coruña, A;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
15 Coruña, A;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
15 Coruña, A;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;82,21
15 Coruña, A;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
15 Coruña, A;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
15 Coruña, A;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
15 Coruña, A;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;84,84
15 Coruña, A;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
15 Coruña, A;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
15 Coruña, A;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
15 Coruña, A;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
15 Coruña, A;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
15 Coruña, A;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
15 Coruña, A;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;76,83
15 Coruña, A;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
15 Coruña, A;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
15 Coruña, A;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
15 Coruña, A;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;80,06
15 Coruña, A;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
15 Coruña, A;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
15 Coruña, A;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
15 Coruña, A;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
15 Coruña, A;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
15 Coruña, A;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
15 Coruña, A;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QIV;1.981
15 Coruña, A;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
15 Coruña, A;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
15 Coruña, A;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
15 Coruña, A;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QIV;2.111
15 Coruña, A;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
15 Coruña, A;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
15 Coruña, A;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
15 Coruña, A;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QIV;2.047
15 Coruña, A;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
15 Coruña, A;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
15 Coruña, A;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
15 Coruña, A;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2022QIV;1.847
15 Coruña, A;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
15 Coruña, A;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2022QII;""
15 Coruña, A;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2022QI;""
15 Coruña, A;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2021QIV;1.972
15 Coruña, A;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
15 Coruña, A;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2021QII;""
15 Coruña, A;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2021QI;""
15 Coruña, A;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2020QIV;1.928
15 Coruña, A;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
15 Coruña, A;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2020QII;""
15 Coruña, A;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2020QI;""
15 Coruña, A;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
15 Coruña, A;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
15 Coruña, A;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2022QII;""
15 Coruña, A;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2022QI;1.858
15 Coruña, A;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
15 Coruña, A;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
15 Coruña, A;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2021QII;""
15 Coruña, A;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2021QI;1.835
15 Coruña, A;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
15 Coruña, A;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
15 Coruña, A;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2020QII;""
15 Coruña, A;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2020QI;""
15 Coruña, A;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
15 Coruña, A;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
15 Coruña, A;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QII;1.744
15 Coruña, A;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QI;""
15 Coruña, A;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
15 Coruña, A;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
15 Coruña, A;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QII;1.753
15 Coruña, A;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QI;""
15 Coruña, A;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
15 Coruña, A;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
15 Coruña, A;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QII;""
15 Coruña, A;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QI;""
15 Coruña, A;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
15 Coruña, A;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QIII;1.650
15 Coruña, A;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QII;""
15 Coruña, A;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QI;""
15 Coruña, A;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
15 Coruña, A;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QIII;1.660
15 Coruña, A;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QII;""
15 Coruña, A;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QI;""
15 Coruña, A;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
15 Coruña, A;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
15 Coruña, A;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QII;""
15 Coruña, A;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QI;""
15 Coruña, A;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
15 Coruña, A;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
15 Coruña, A;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
15 Coruña, A;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
15 Coruña, A;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
15 Coruña, A;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
15 Coruña, A;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
15 Coruña, A;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
15 Coruña, A;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
15 Coruña, A;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
15 Coruña, A;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
15 Coruña, A;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
15 Coruña, A;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;93,24
15 Coruña, A;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
15 Coruña, A;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
15 Coruña, A;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
15 Coruña, A;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;93,42
15 Coruña, A;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
15 Coruña, A;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
15 Coruña, A;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
15 Coruña, A;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;94,19
15 Coruña, A;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
15 Coruña, A;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
15 Coruña, A;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
15 Coruña, A;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
15 Coruña, A;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
15 Coruña, A;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
15 Coruña, A;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;88,02
15 Coruña, A;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
15 Coruña, A;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
15 Coruña, A;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
15 Coruña, A;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;89,64
15 Coruña, A;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
15 Coruña, A;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
15 Coruña, A;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
15 Coruña, A;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
15 Coruña, A;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
15 Coruña, A;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
15 Coruña, A;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;82,61
15 Coruña, A;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
15 Coruña, A;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
15 Coruña, A;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
15 Coruña, A;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;85,64
15 Coruña, A;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
15 Coruña, A;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
15 Coruña, A;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
15 Coruña, A;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
15 Coruña, A;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
15 Coruña, A;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
15 Coruña, A;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;78,16
15 Coruña, A;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
15 Coruña, A;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
15 Coruña, A;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
15 Coruña, A;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;81,09
15 Coruña, A;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
15 Coruña, A;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
15 Coruña, A;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
15 Coruña, A;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
15 Coruña, A;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
15 Coruña, A;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
15 Coruña, A;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QIV;1.384
15 Coruña, A;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
15 Coruña, A;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
15 Coruña, A;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
15 Coruña, A;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QIV;1.419
15 Coruña, A;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
15 Coruña, A;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
15 Coruña, A;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
15 Coruña, A;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QIV;1.363
15 Coruña, A;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
15 Coruña, A;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
15 Coruña, A;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
15 Coruña, A;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2022QIV;1.273
15 Coruña, A;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
15 Coruña, A;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2022QII;""
15 Coruña, A;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2022QI;""
15 Coruña, A;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2021QIV;1.314
15 Coruña, A;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
15 Coruña, A;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2021QII;""
15 Coruña, A;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2021QI;""
15 Coruña, A;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2020QIV;1.260
15 Coruña, A;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
15 Coruña, A;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2020QII;""
15 Coruña, A;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2020QI;""
15 Coruña, A;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
15 Coruña, A;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
15 Coruña, A;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2022QII;""
15 Coruña, A;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2022QI;1.237
15 Coruña, A;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
15 Coruña, A;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
15 Coruña, A;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2021QII;""
15 Coruña, A;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2021QI;1.204
15 Coruña, A;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
15 Coruña, A;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
15 Coruña, A;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2020QII;""
15 Coruña, A;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2020QI;""
15 Coruña, A;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
15 Coruña, A;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
15 Coruña, A;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QII;1.158
15 Coruña, A;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QI;""
15 Coruña, A;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
15 Coruña, A;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
15 Coruña, A;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QII;1.140
15 Coruña, A;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QI;""
15 Coruña, A;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
15 Coruña, A;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
15 Coruña, A;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QII;""
15 Coruña, A;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QI;""
15 Coruña, A;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
15 Coruña, A;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QIII;1.062
15 Coruña, A;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QII;""
15 Coruña, A;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QI;""
15 Coruña, A;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
15 Coruña, A;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QIII;1.070
15 Coruña, A;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QII;""
15 Coruña, A;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QI;""
15 Coruña, A;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
15 Coruña, A;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
15 Coruña, A;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QII;""
15 Coruña, A;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QI;""
15 Coruña, A;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
15 Coruña, A;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
15 Coruña, A;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
15 Coruña, A;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
15 Coruña, A;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
15 Coruña, A;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
15 Coruña, A;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
15 Coruña, A;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
15 Coruña, A;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
15 Coruña, A;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
15 Coruña, A;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
15 Coruña, A;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
15 Coruña, A;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;91,98
15 Coruña, A;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
15 Coruña, A;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
15 Coruña, A;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
15 Coruña, A;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;92,6
15 Coruña, A;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
15 Coruña, A;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
15 Coruña, A;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
15 Coruña, A;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;92,44
15 Coruña, A;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
15 Coruña, A;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
15 Coruña, A;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
15 Coruña, A;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
15 Coruña, A;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
15 Coruña, A;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
15 Coruña, A;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;87,17
15 Coruña, A;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
15 Coruña, A;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
15 Coruña, A;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
15 Coruña, A;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;88,33
15 Coruña, A;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
15 Coruña, A;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
15 Coruña, A;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
15 Coruña, A;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
15 Coruña, A;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
15 Coruña, A;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
15 Coruña, A;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;81,61
15 Coruña, A;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
15 Coruña, A;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
15 Coruña, A;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
15 Coruña, A;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;83,64
15 Coruña, A;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
15 Coruña, A;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
15 Coruña, A;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
15 Coruña, A;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
15 Coruña, A;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
15 Coruña, A;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
15 Coruña, A;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;74,84
15 Coruña, A;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
15 Coruña, A;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
15 Coruña, A;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
15 Coruña, A;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;78,5
15 Coruña, A;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
15 Coruña, A;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
15 Coruña, A;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
15 Coruña, A;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
15 Coruña, A;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
15 Coruña, A;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
15 Coruña, A;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
15 Coruña, A;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
15 Coruña, A;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
15 Coruña, A;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QI;12.844
15 Coruña, A;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
15 Coruña, A;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
15 Coruña, A;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
15 Coruña, A;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QI;13.242
15 Coruña, A;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
15 Coruña, A;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
15 Coruña, A;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
15 Coruña, A;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QI;12.871
15 Coruña, A;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
15 Coruña, A;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
15 Coruña, A;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2022QII;""
15 Coruña, A;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2022QI;12.420
15 Coruña, A;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
15 Coruña, A;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
15 Coruña, A;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2021QII;""
15 Coruña, A;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2021QI;12.897
15 Coruña, A;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
15 Coruña, A;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
15 Coruña, A;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2020QII;""
15 Coruña, A;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2020QI;12.113
15 Coruña, A;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
15 Coruña, A;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
15 Coruña, A;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2022QII;12.006
15 Coruña, A;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2022QI;""
15 Coruña, A;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
15 Coruña, A;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
15 Coruña, A;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2021QII;12.580
15 Coruña, A;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2021QI;""
15 Coruña, A;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
15 Coruña, A;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
15 Coruña, A;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2020QII;11.853
15 Coruña, A;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2020QI;""
15 Coruña, A;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
15 Coruña, A;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QIII;11.652
15 Coruña, A;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QII;""
15 Coruña, A;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QI;""
15 Coruña, A;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
15 Coruña, A;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QIII;12.281
15 Coruña, A;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QII;""
15 Coruña, A;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QI;""
15 Coruña, A;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
15 Coruña, A;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QIII;11.552
15 Coruña, A;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QII;""
15 Coruña, A;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QI;""
15 Coruña, A;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QIV;11.279
15 Coruña, A;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
15 Coruña, A;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QII;""
15 Coruña, A;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QI;""
15 Coruña, A;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QIV;11.945
15 Coruña, A;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
15 Coruña, A;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QII;""
15 Coruña, A;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QI;""
15 Coruña, A;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QIV;11.257
15 Coruña, A;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
15 Coruña, A;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QII;""
15 Coruña, A;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QI;""
15 Coruña, A;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
15 Coruña, A;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
15 Coruña, A;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
15 Coruña, A;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
15 Coruña, A;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
15 Coruña, A;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
15 Coruña, A;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
15 Coruña, A;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
15 Coruña, A;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
15 Coruña, A;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
15 Coruña, A;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
15 Coruña, A;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
15 Coruña, A;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
15 Coruña, A;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
15 Coruña, A;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
15 Coruña, A;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;96,7
15 Coruña, A;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
15 Coruña, A;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
15 Coruña, A;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
15 Coruña, A;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;97,39
15 Coruña, A;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
15 Coruña, A;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
15 Coruña, A;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
15 Coruña, A;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;94,11
15 Coruña, A;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
15 Coruña, A;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
15 Coruña, A;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;93,48
15 Coruña, A;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
15 Coruña, A;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
15 Coruña, A;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
15 Coruña, A;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;95
15 Coruña, A;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
15 Coruña, A;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
15 Coruña, A;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
15 Coruña, A;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;92,09
15 Coruña, A;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
15 Coruña, A;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
15 Coruña, A;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;90,72
15 Coruña, A;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
15 Coruña, A;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
15 Coruña, A;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
15 Coruña, A;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;92,74
15 Coruña, A;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
15 Coruña, A;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
15 Coruña, A;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
15 Coruña, A;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;89,75
15 Coruña, A;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
15 Coruña, A;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
15 Coruña, A;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;87,82
15 Coruña, A;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
15 Coruña, A;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
15 Coruña, A;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
15 Coruña, A;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;90,21
15 Coruña, A;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
15 Coruña, A;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
15 Coruña, A;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
15 Coruña, A;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;87,46
15 Coruña, A;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
15 Coruña, A;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
15 Coruña, A;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
15 Coruña, A;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
15 Coruña, A;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
15 Coruña, A;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
15 Coruña, A;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QI;7.444
15 Coruña, A;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
15 Coruña, A;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
15 Coruña, A;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
15 Coruña, A;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QI;7.702
15 Coruña, A;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
15 Coruña, A;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
15 Coruña, A;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
15 Coruña, A;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QI;7.431
15 Coruña, A;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
15 Coruña, A;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
15 Coruña, A;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2022QII;""
15 Coruña, A;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2022QI;7.201
15 Coruña, A;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
15 Coruña, A;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
15 Coruña, A;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2021QII;""
15 Coruña, A;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2021QI;7.517
15 Coruña, A;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
15 Coruña, A;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
15 Coruña, A;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2020QII;""
15 Coruña, A;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2020QI;7.023
15 Coruña, A;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
15 Coruña, A;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
15 Coruña, A;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2022QII;6.979
15 Coruña, A;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2022QI;""
15 Coruña, A;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
15 Coruña, A;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
15 Coruña, A;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2021QII;7.353
15 Coruña, A;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2021QI;""
15 Coruña, A;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
15 Coruña, A;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
15 Coruña, A;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2020QII;6.891
15 Coruña, A;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2020QI;""
15 Coruña, A;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
15 Coruña, A;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QIII;6.777
15 Coruña, A;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QII;""
15 Coruña, A;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QI;""
15 Coruña, A;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
15 Coruña, A;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QIII;7.196
15 Coruña, A;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QII;""
15 Coruña, A;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QI;""
15 Coruña, A;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
15 Coruña, A;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QIII;6.753
15 Coruña, A;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QII;""
15 Coruña, A;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QI;""
15 Coruña, A;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QIV;6.567
15 Coruña, A;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
15 Coruña, A;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QII;""
15 Coruña, A;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QI;""
15 Coruña, A;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QIV;7.004
15 Coruña, A;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
15 Coruña, A;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QII;""
15 Coruña, A;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QI;""
15 Coruña, A;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QIV;6.598
15 Coruña, A;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
15 Coruña, A;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QII;""
15 Coruña, A;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QI;""
15 Coruña, A;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
15 Coruña, A;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
15 Coruña, A;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
15 Coruña, A;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
15 Coruña, A;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
15 Coruña, A;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
15 Coruña, A;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
15 Coruña, A;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
15 Coruña, A;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
15 Coruña, A;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
15 Coruña, A;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
15 Coruña, A;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
15 Coruña, A;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
15 Coruña, A;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
15 Coruña, A;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
15 Coruña, A;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;96,74
15 Coruña, A;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
15 Coruña, A;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
15 Coruña, A;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
15 Coruña, A;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;97,6
15 Coruña, A;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
15 Coruña, A;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
15 Coruña, A;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
15 Coruña, A;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;94,51
15 Coruña, A;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
15 Coruña, A;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
15 Coruña, A;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;93,75
15 Coruña, A;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
15 Coruña, A;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
15 Coruña, A;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
15 Coruña, A;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;95,47
15 Coruña, A;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
15 Coruña, A;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
15 Coruña, A;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
15 Coruña, A;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;92,73
15 Coruña, A;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
15 Coruña, A;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
15 Coruña, A;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;91,04
15 Coruña, A;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
15 Coruña, A;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
15 Coruña, A;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
15 Coruña, A;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;93,43
15 Coruña, A;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
15 Coruña, A;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
15 Coruña, A;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
15 Coruña, A;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;90,88
15 Coruña, A;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
15 Coruña, A;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
15 Coruña, A;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;88,22
15 Coruña, A;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
15 Coruña, A;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
15 Coruña, A;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
15 Coruña, A;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;90,94
15 Coruña, A;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
15 Coruña, A;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
15 Coruña, A;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
15 Coruña, A;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;88,79
15 Coruña, A;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
15 Coruña, A;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
15 Coruña, A;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
15 Coruña, A;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
15 Coruña, A;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
15 Coruña, A;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
15 Coruña, A;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QI;5.400
15 Coruña, A;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
15 Coruña, A;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
15 Coruña, A;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
15 Coruña, A;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QI;5.540
15 Coruña, A;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
15 Coruña, A;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
15 Coruña, A;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
15 Coruña, A;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QI;5.440
15 Coruña, A;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
15 Coruña, A;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
15 Coruña, A;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2022QII;""
15 Coruña, A;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2022QI;5.219
15 Coruña, A;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
15 Coruña, A;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
15 Coruña, A;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2021QII;""
15 Coruña, A;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2021QI;5.380
15 Coruña, A;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
15 Coruña, A;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
15 Coruña, A;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2020QII;""
15 Coruña, A;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2020QI;5.090
15 Coruña, A;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
15 Coruña, A;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
15 Coruña, A;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2022QII;5.027
15 Coruña, A;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2022QI;""
15 Coruña, A;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
15 Coruña, A;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
15 Coruña, A;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2021QII;5.227
15 Coruña, A;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2021QI;""
15 Coruña, A;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
15 Coruña, A;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
15 Coruña, A;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2020QII;4.962
15 Coruña, A;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2020QI;""
15 Coruña, A;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
15 Coruña, A;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QIII;4.875
15 Coruña, A;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QII;""
15 Coruña, A;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QI;""
15 Coruña, A;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
15 Coruña, A;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QIII;5.085
15 Coruña, A;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QII;""
15 Coruña, A;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QI;""
15 Coruña, A;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
15 Coruña, A;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QIII;4.799
15 Coruña, A;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QII;""
15 Coruña, A;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QI;""
15 Coruña, A;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QIV;4.712
15 Coruña, A;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
15 Coruña, A;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QII;""
15 Coruña, A;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QI;""
15 Coruña, A;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QIV;4.941
15 Coruña, A;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
15 Coruña, A;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QII;""
15 Coruña, A;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QI;""
15 Coruña, A;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QIV;4.659
15 Coruña, A;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
15 Coruña, A;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QII;""
15 Coruña, A;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QI;""
15 Coruña, A;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
15 Coruña, A;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
15 Coruña, A;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
15 Coruña, A;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
15 Coruña, A;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
15 Coruña, A;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
15 Coruña, A;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
15 Coruña, A;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
15 Coruña, A;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
15 Coruña, A;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
15 Coruña, A;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
15 Coruña, A;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
15 Coruña, A;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
15 Coruña, A;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
15 Coruña, A;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
15 Coruña, A;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;96,65
15 Coruña, A;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
15 Coruña, A;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
15 Coruña, A;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
15 Coruña, A;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;97,11
15 Coruña, A;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
15 Coruña, A;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
15 Coruña, A;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
15 Coruña, A;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;93,57
15 Coruña, A;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
15 Coruña, A;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
15 Coruña, A;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;93,09
15 Coruña, A;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
15 Coruña, A;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
15 Coruña, A;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
15 Coruña, A;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;94,35
15 Coruña, A;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
15 Coruña, A;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
15 Coruña, A;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
15 Coruña, A;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;91,21
15 Coruña, A;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
15 Coruña, A;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
15 Coruña, A;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;90,28
15 Coruña, A;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
15 Coruña, A;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
15 Coruña, A;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
15 Coruña, A;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;91,79
15 Coruña, A;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
15 Coruña, A;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
15 Coruña, A;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
15 Coruña, A;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;88,22
15 Coruña, A;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
15 Coruña, A;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
15 Coruña, A;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;87,26
15 Coruña, A;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
15 Coruña, A;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
15 Coruña, A;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
15 Coruña, A;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;89,19
15 Coruña, A;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
15 Coruña, A;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
15 Coruña, A;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
15 Coruña, A;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;85,64
15 Coruña, A;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
15 Coruña, A;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
15 Coruña, A;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
15 Coruña, A;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
15 Coruña, A;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
15 Coruña, A;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QII;11.833
15 Coruña, A;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
15 Coruña, A;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
15 Coruña, A;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
15 Coruña, A;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QII;12.258
15 Coruña, A;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
15 Coruña, A;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
15 Coruña, A;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
15 Coruña, A;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QII;12.755
15 Coruña, A;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
15 Coruña, A;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
15 Coruña, A;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
15 Coruña, A;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2022QII;11.394
15 Coruña, A;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2022QI;""
15 Coruña, A;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
15 Coruña, A;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
15 Coruña, A;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2021QII;11.907
15 Coruña, A;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2021QI;""
15 Coruña, A;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
15 Coruña, A;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
15 Coruña, A;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2020QII;12.463
15 Coruña, A;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2020QI;""
15 Coruña, A;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
15 Coruña, A;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2022QIII;11.027
15 Coruña, A;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2022QII;""
15 Coruña, A;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2022QI;""
15 Coruña, A;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
15 Coruña, A;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2021QIII;11.580
15 Coruña, A;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2021QII;""
15 Coruña, A;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2021QI;""
15 Coruña, A;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
15 Coruña, A;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2020QIII;12.125
15 Coruña, A;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2020QII;""
15 Coruña, A;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2020QI;""
15 Coruña, A;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QIV;10.650
15 Coruña, A;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
15 Coruña, A;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QII;""
15 Coruña, A;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QI;""
15 Coruña, A;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QIV;11.224
15 Coruña, A;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
15 Coruña, A;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QII;""
15 Coruña, A;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QI;""
15 Coruña, A;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QIV;11.797
15 Coruña, A;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
15 Coruña, A;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QII;""
15 Coruña, A;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QI;""
15 Coruña, A;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
15 Coruña, A;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
15 Coruña, A;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QII;""
15 Coruña, A;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QI;10.899
15 Coruña, A;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
15 Coruña, A;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
15 Coruña, A;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QII;""
15 Coruña, A;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QI;11.541
15 Coruña, A;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
15 Coruña, A;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
15 Coruña, A;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QII;""
15 Coruña, A;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QI;""
15 Coruña, A;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
15 Coruña, A;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
15 Coruña, A;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
15 Coruña, A;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
15 Coruña, A;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
15 Coruña, A;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
15 Coruña, A;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
15 Coruña, A;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
15 Coruña, A;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
15 Coruña, A;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
15 Coruña, A;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
15 Coruña, A;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
15 Coruña, A;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
15 Coruña, A;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
15 Coruña, A;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;96,29
15 Coruña, A;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
15 Coruña, A;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
15 Coruña, A;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
15 Coruña, A;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;97,14
15 Coruña, A;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
15 Coruña, A;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
15 Coruña, A;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
15 Coruña, A;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;97,71
15 Coruña, A;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
15 Coruña, A;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
15 Coruña, A;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;93,19
15 Coruña, A;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
15 Coruña, A;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
15 Coruña, A;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
15 Coruña, A;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;94,47
15 Coruña, A;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
15 Coruña, A;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
15 Coruña, A;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
15 Coruña, A;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;95,06
15 Coruña, A;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
15 Coruña, A;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
15 Coruña, A;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;90
15 Coruña, A;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
15 Coruña, A;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
15 Coruña, A;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
15 Coruña, A;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;91,56
15 Coruña, A;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
15 Coruña, A;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
15 Coruña, A;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
15 Coruña, A;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;92,49
15 Coruña, A;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
15 Coruña, A;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
15 Coruña, A;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
15 Coruña, A;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
15 Coruña, A;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
15 Coruña, A;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
15 Coruña, A;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;88,91
15 Coruña, A;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
15 Coruña, A;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
15 Coruña, A;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
15 Coruña, A;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;90,48
15 Coruña, A;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
15 Coruña, A;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
15 Coruña, A;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
15 Coruña, A;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
15 Coruña, A;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
15 Coruña, A;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
15 Coruña, A;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QII;6.840
15 Coruña, A;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
15 Coruña, A;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
15 Coruña, A;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
15 Coruña, A;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QII;7.115
15 Coruña, A;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
15 Coruña, A;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
15 Coruña, A;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
15 Coruña, A;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QII;7.376
15 Coruña, A;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
15 Coruña, A;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
15 Coruña, A;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
15 Coruña, A;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2022QII;6.595
15 Coruña, A;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2022QI;""
15 Coruña, A;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
15 Coruña, A;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
15 Coruña, A;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2021QII;6.925
15 Coruña, A;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2021QI;""
15 Coruña, A;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
15 Coruña, A;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
15 Coruña, A;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2020QII;7.224
15 Coruña, A;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2020QI;""
15 Coruña, A;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
15 Coruña, A;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2022QIII;6.388
15 Coruña, A;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2022QII;""
15 Coruña, A;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2022QI;""
15 Coruña, A;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
15 Coruña, A;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2021QIII;6.746
15 Coruña, A;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2021QII;""
15 Coruña, A;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2021QI;""
15 Coruña, A;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
15 Coruña, A;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2020QIII;7.069
15 Coruña, A;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2020QII;""
15 Coruña, A;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2020QI;""
15 Coruña, A;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QIV;6.180
15 Coruña, A;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
15 Coruña, A;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QII;""
15 Coruña, A;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QI;""
15 Coruña, A;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QIV;6.542
15 Coruña, A;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
15 Coruña, A;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QII;""
15 Coruña, A;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QI;""
15 Coruña, A;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QIV;6.897
15 Coruña, A;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
15 Coruña, A;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QII;""
15 Coruña, A;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QI;""
15 Coruña, A;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
15 Coruña, A;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
15 Coruña, A;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QII;""
15 Coruña, A;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QI;6.359
15 Coruña, A;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
15 Coruña, A;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
15 Coruña, A;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QII;""
15 Coruña, A;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QI;6.759
15 Coruña, A;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
15 Coruña, A;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
15 Coruña, A;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QII;""
15 Coruña, A;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QI;""
15 Coruña, A;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
15 Coruña, A;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
15 Coruña, A;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
15 Coruña, A;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
15 Coruña, A;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
15 Coruña, A;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
15 Coruña, A;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
15 Coruña, A;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
15 Coruña, A;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
15 Coruña, A;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
15 Coruña, A;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
15 Coruña, A;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
15 Coruña, A;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
15 Coruña, A;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
15 Coruña, A;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;96,42
15 Coruña, A;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
15 Coruña, A;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
15 Coruña, A;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
15 Coruña, A;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;97,33
15 Coruña, A;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
15 Coruña, A;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
15 Coruña, A;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
15 Coruña, A;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;97,94
15 Coruña, A;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
15 Coruña, A;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
15 Coruña, A;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;93,39
15 Coruña, A;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
15 Coruña, A;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
15 Coruña, A;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
15 Coruña, A;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;94,81
15 Coruña, A;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
15 Coruña, A;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
15 Coruña, A;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
15 Coruña, A;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;95,84
15 Coruña, A;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
15 Coruña, A;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
15 Coruña, A;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;90,35
15 Coruña, A;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
15 Coruña, A;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
15 Coruña, A;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
15 Coruña, A;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;91,95
15 Coruña, A;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
15 Coruña, A;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
15 Coruña, A;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
15 Coruña, A;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;93,51
15 Coruña, A;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
15 Coruña, A;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
15 Coruña, A;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
15 Coruña, A;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
15 Coruña, A;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
15 Coruña, A;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
15 Coruña, A;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;89,37
15 Coruña, A;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
15 Coruña, A;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
15 Coruña, A;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
15 Coruña, A;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;91,64
15 Coruña, A;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
15 Coruña, A;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
15 Coruña, A;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
15 Coruña, A;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
15 Coruña, A;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
15 Coruña, A;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
15 Coruña, A;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QII;4.993
15 Coruña, A;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
15 Coruña, A;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
15 Coruña, A;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
15 Coruña, A;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QII;5.143
15 Coruña, A;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
15 Coruña, A;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
15 Coruña, A;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
15 Coruña, A;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QII;5.379
15 Coruña, A;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
15 Coruña, A;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
15 Coruña, A;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
15 Coruña, A;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2022QII;4.799
15 Coruña, A;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2022QI;""
15 Coruña, A;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
15 Coruña, A;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
15 Coruña, A;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2021QII;4.982
15 Coruña, A;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2021QI;""
15 Coruña, A;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
15 Coruña, A;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
15 Coruña, A;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2020QII;5.239
15 Coruña, A;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2020QI;""
15 Coruña, A;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
15 Coruña, A;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2022QIII;4.639
15 Coruña, A;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2022QII;""
15 Coruña, A;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2022QI;""
15 Coruña, A;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
15 Coruña, A;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2021QIII;4.834
15 Coruña, A;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2021QII;""
15 Coruña, A;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2021QI;""
15 Coruña, A;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
15 Coruña, A;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2020QIII;5.056
15 Coruña, A;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2020QII;""
15 Coruña, A;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2020QI;""
15 Coruña, A;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QIV;4.470
15 Coruña, A;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
15 Coruña, A;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QII;""
15 Coruña, A;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QI;""
15 Coruña, A;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QIV;4.682
15 Coruña, A;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
15 Coruña, A;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QII;""
15 Coruña, A;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QI;""
15 Coruña, A;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QIV;4.900
15 Coruña, A;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
15 Coruña, A;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QII;""
15 Coruña, A;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QI;""
15 Coruña, A;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
15 Coruña, A;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
15 Coruña, A;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QII;""
15 Coruña, A;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QI;4.540
15 Coruña, A;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
15 Coruña, A;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
15 Coruña, A;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QII;""
15 Coruña, A;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QI;4.782
15 Coruña, A;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
15 Coruña, A;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
15 Coruña, A;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QII;""
15 Coruña, A;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QI;""
15 Coruña, A;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
15 Coruña, A;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
15 Coruña, A;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
15 Coruña, A;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
15 Coruña, A;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
15 Coruña, A;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
15 Coruña, A;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
15 Coruña, A;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
15 Coruña, A;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
15 Coruña, A;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
15 Coruña, A;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
15 Coruña, A;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
15 Coruña, A;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
15 Coruña, A;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
15 Coruña, A;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;96,11
15 Coruña, A;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
15 Coruña, A;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
15 Coruña, A;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
15 Coruña, A;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;96,87
15 Coruña, A;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
15 Coruña, A;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
15 Coruña, A;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
15 Coruña, A;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;97,4
15 Coruña, A;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
15 Coruña, A;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
15 Coruña, A;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;92,91
15 Coruña, A;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
15 Coruña, A;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
15 Coruña, A;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
15 Coruña, A;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;93,99
15 Coruña, A;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
15 Coruña, A;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
15 Coruña, A;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
15 Coruña, A;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;94
15 Coruña, A;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
15 Coruña, A;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
15 Coruña, A;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;89,53
15 Coruña, A;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
15 Coruña, A;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
15 Coruña, A;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
15 Coruña, A;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;91,04
15 Coruña, A;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
15 Coruña, A;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
15 Coruña, A;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
15 Coruña, A;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;91,09
15 Coruña, A;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
15 Coruña, A;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
15 Coruña, A;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
15 Coruña, A;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
15 Coruña, A;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
15 Coruña, A;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
15 Coruña, A;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;88,28
15 Coruña, A;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
15 Coruña, A;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
15 Coruña, A;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
15 Coruña, A;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;88,9
15 Coruña, A;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
15 Coruña, A;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
15 Coruña, A;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
15 Coruña, A;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
15 Coruña, A;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
15 Coruña, A;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QIII;12.002
15 Coruña, A;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
15 Coruña, A;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
15 Coruña, A;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
15 Coruña, A;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QIII;12.538
15 Coruña, A;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
15 Coruña, A;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
15 Coruña, A;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
15 Coruña, A;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QIII;12.870
15 Coruña, A;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
15 Coruña, A;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
15 Coruña, A;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
15 Coruña, A;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2022QIII;11.572
15 Coruña, A;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2022QII;""
15 Coruña, A;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2022QI;""
15 Coruña, A;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
15 Coruña, A;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2021QIII;12.161
15 Coruña, A;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2021QII;""
15 Coruña, A;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2021QI;""
15 Coruña, A;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
15 Coruña, A;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2020QIII;12.488
15 Coruña, A;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2020QII;""
15 Coruña, A;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2020QI;""
15 Coruña, A;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2022QIV;11.161
15 Coruña, A;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
15 Coruña, A;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2022QII;""
15 Coruña, A;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2022QI;""
15 Coruña, A;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2021QIV;11.760
15 Coruña, A;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
15 Coruña, A;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2021QII;""
15 Coruña, A;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2021QI;""
15 Coruña, A;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2020QIV;12.136
15 Coruña, A;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
15 Coruña, A;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2020QII;""
15 Coruña, A;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2020QI;""
15 Coruña, A;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
15 Coruña, A;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
15 Coruña, A;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QII;""
15 Coruña, A;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QI;11.403
15 Coruña, A;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
15 Coruña, A;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
15 Coruña, A;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QII;""
15 Coruña, A;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QI;11.864
15 Coruña, A;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
15 Coruña, A;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
15 Coruña, A;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QII;""
15 Coruña, A;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QI;""
15 Coruña, A;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
15 Coruña, A;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
15 Coruña, A;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QII;11.059
15 Coruña, A;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QI;""
15 Coruña, A;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
15 Coruña, A;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
15 Coruña, A;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QII;11.614
15 Coruña, A;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QI;""
15 Coruña, A;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
15 Coruña, A;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
15 Coruña, A;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QII;""
15 Coruña, A;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QI;""
15 Coruña, A;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
15 Coruña, A;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
15 Coruña, A;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
15 Coruña, A;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
15 Coruña, A;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
15 Coruña, A;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
15 Coruña, A;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
15 Coruña, A;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
15 Coruña, A;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
15 Coruña, A;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
15 Coruña, A;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
15 Coruña, A;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
15 Coruña, A;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
15 Coruña, A;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;96,42
15 Coruña, A;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
15 Coruña, A;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
15 Coruña, A;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
15 Coruña, A;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;96,99
15 Coruña, A;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
15 Coruña, A;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
15 Coruña, A;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
15 Coruña, A;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;97,03
15 Coruña, A;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
15 Coruña, A;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
15 Coruña, A;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;92,99
15 Coruña, A;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
15 Coruña, A;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
15 Coruña, A;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
15 Coruña, A;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;93,79
15 Coruña, A;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
15 Coruña, A;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
15 Coruña, A;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
15 Coruña, A;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;94,3
15 Coruña, A;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
15 Coruña, A;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
15 Coruña, A;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
15 Coruña, A;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
15 Coruña, A;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
15 Coruña, A;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
15 Coruña, A;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;90,95
15 Coruña, A;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
15 Coruña, A;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
15 Coruña, A;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
15 Coruña, A;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;92,18
15 Coruña, A;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
15 Coruña, A;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
15 Coruña, A;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
15 Coruña, A;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
15 Coruña, A;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
15 Coruña, A;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
15 Coruña, A;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;88,2
15 Coruña, A;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
15 Coruña, A;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
15 Coruña, A;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
15 Coruña, A;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;90,24
15 Coruña, A;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
15 Coruña, A;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
15 Coruña, A;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
15 Coruña, A;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
15 Coruña, A;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
15 Coruña, A;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
15 Coruña, A;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QIII;6.912
15 Coruña, A;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
15 Coruña, A;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
15 Coruña, A;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
15 Coruña, A;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QIII;7.295
15 Coruña, A;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
15 Coruña, A;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
15 Coruña, A;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
15 Coruña, A;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QIII;7.482
15 Coruña, A;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
15 Coruña, A;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
15 Coruña, A;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
15 Coruña, A;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2022QIII;6.673
15 Coruña, A;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2022QII;""
15 Coruña, A;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2022QI;""
15 Coruña, A;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
15 Coruña, A;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2021QIII;7.086
15 Coruña, A;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2021QII;""
15 Coruña, A;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2021QI;""
15 Coruña, A;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
15 Coruña, A;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2020QIII;7.295
15 Coruña, A;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2020QII;""
15 Coruña, A;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2020QI;""
15 Coruña, A;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2022QIV;6.445
15 Coruña, A;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
15 Coruña, A;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2022QII;""
15 Coruña, A;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2022QI;""
15 Coruña, A;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2021QIV;6.859
15 Coruña, A;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
15 Coruña, A;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2021QII;""
15 Coruña, A;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2021QI;""
15 Coruña, A;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2020QIV;7.106
15 Coruña, A;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
15 Coruña, A;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2020QII;""
15 Coruña, A;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2020QI;""
15 Coruña, A;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
15 Coruña, A;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
15 Coruña, A;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QII;""
15 Coruña, A;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QI;6.653
15 Coruña, A;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
15 Coruña, A;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
15 Coruña, A;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QII;""
15 Coruña, A;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QI;6.954
15 Coruña, A;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
15 Coruña, A;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
15 Coruña, A;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QII;""
15 Coruña, A;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QI;""
15 Coruña, A;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
15 Coruña, A;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
15 Coruña, A;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QII;6.465
15 Coruña, A;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QI;""
15 Coruña, A;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
15 Coruña, A;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
15 Coruña, A;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QII;6.827
15 Coruña, A;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QI;""
15 Coruña, A;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
15 Coruña, A;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
15 Coruña, A;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QII;""
15 Coruña, A;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QI;""
15 Coruña, A;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
15 Coruña, A;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
15 Coruña, A;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
15 Coruña, A;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
15 Coruña, A;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
15 Coruña, A;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
15 Coruña, A;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
15 Coruña, A;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
15 Coruña, A;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
15 Coruña, A;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
15 Coruña, A;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
15 Coruña, A;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
15 Coruña, A;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
15 Coruña, A;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;96,54
15 Coruña, A;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
15 Coruña, A;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
15 Coruña, A;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
15 Coruña, A;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;97,14
15 Coruña, A;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
15 Coruña, A;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
15 Coruña, A;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
15 Coruña, A;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;97,5
15 Coruña, A;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
15 Coruña, A;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
15 Coruña, A;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;93,24
15 Coruña, A;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
15 Coruña, A;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
15 Coruña, A;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
15 Coruña, A;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;94,02
15 Coruña, A;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
15 Coruña, A;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
15 Coruña, A;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
15 Coruña, A;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;94,97
15 Coruña, A;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
15 Coruña, A;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
15 Coruña, A;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
15 Coruña, A;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
15 Coruña, A;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
15 Coruña, A;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
15 Coruña, A;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;91,2
15 Coruña, A;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
15 Coruña, A;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
15 Coruña, A;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
15 Coruña, A;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;92,94
15 Coruña, A;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
15 Coruña, A;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
15 Coruña, A;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
15 Coruña, A;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
15 Coruña, A;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
15 Coruña, A;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
15 Coruña, A;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;88,62
15 Coruña, A;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
15 Coruña, A;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
15 Coruña, A;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
15 Coruña, A;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;91,25
15 Coruña, A;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
15 Coruña, A;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
15 Coruña, A;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
15 Coruña, A;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
15 Coruña, A;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
15 Coruña, A;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
15 Coruña, A;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QIII;5.090
15 Coruña, A;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
15 Coruña, A;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
15 Coruña, A;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
15 Coruña, A;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QIII;5.243
15 Coruña, A;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
15 Coruña, A;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
15 Coruña, A;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
15 Coruña, A;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QIII;5.388
15 Coruña, A;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
15 Coruña, A;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
15 Coruña, A;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
15 Coruña, A;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2022QIII;4.899
15 Coruña, A;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2022QII;""
15 Coruña, A;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2022QI;""
15 Coruña, A;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
15 Coruña, A;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2021QIII;5.075
15 Coruña, A;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2021QII;""
15 Coruña, A;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2021QI;""
15 Coruña, A;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
15 Coruña, A;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2020QIII;5.193
15 Coruña, A;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2020QII;""
15 Coruña, A;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2020QI;""
15 Coruña, A;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2022QIV;4.716
15 Coruña, A;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
15 Coruña, A;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2022QII;""
15 Coruña, A;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2022QI;""
15 Coruña, A;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2021QIV;4.901
15 Coruña, A;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
15 Coruña, A;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2021QII;""
15 Coruña, A;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2021QI;""
15 Coruña, A;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2020QIV;5.030
15 Coruña, A;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
15 Coruña, A;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2020QII;""
15 Coruña, A;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2020QI;""
15 Coruña, A;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
15 Coruña, A;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
15 Coruña, A;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QII;""
15 Coruña, A;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QI;4.750
15 Coruña, A;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
15 Coruña, A;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
15 Coruña, A;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QII;""
15 Coruña, A;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QI;4.910
15 Coruña, A;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
15 Coruña, A;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
15 Coruña, A;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QII;""
15 Coruña, A;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QI;""
15 Coruña, A;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
15 Coruña, A;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
15 Coruña, A;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QII;4.594
15 Coruña, A;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QI;""
15 Coruña, A;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
15 Coruña, A;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
15 Coruña, A;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QII;4.787
15 Coruña, A;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QI;""
15 Coruña, A;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
15 Coruña, A;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
15 Coruña, A;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QII;""
15 Coruña, A;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QI;""
15 Coruña, A;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
15 Coruña, A;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
15 Coruña, A;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
15 Coruña, A;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
15 Coruña, A;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
15 Coruña, A;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
15 Coruña, A;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
15 Coruña, A;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
15 Coruña, A;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
15 Coruña, A;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
15 Coruña, A;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
15 Coruña, A;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
15 Coruña, A;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
15 Coruña, A;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;96,25
15 Coruña, A;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
15 Coruña, A;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
15 Coruña, A;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
15 Coruña, A;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;96,8
15 Coruña, A;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
15 Coruña, A;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
15 Coruña, A;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
15 Coruña, A;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;96,38
15 Coruña, A;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
15 Coruña, A;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
15 Coruña, A;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;92,65
15 Coruña, A;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
15 Coruña, A;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
15 Coruña, A;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
15 Coruña, A;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;93,48
15 Coruña, A;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
15 Coruña, A;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
15 Coruña, A;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
15 Coruña, A;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;93,36
15 Coruña, A;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
15 Coruña, A;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
15 Coruña, A;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
15 Coruña, A;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
15 Coruña, A;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
15 Coruña, A;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
15 Coruña, A;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;90,6
15 Coruña, A;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
15 Coruña, A;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
15 Coruña, A;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
15 Coruña, A;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;91,13
15 Coruña, A;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
15 Coruña, A;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
15 Coruña, A;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
15 Coruña, A;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
15 Coruña, A;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
15 Coruña, A;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
15 Coruña, A;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;87,62
15 Coruña, A;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
15 Coruña, A;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
15 Coruña, A;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
15 Coruña, A;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;88,85
15 Coruña, A;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
15 Coruña, A;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
15 Coruña, A;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
15 Coruña, A;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
15 Coruña, A;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
15 Coruña, A;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QIV;12.006
15 Coruña, A;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
15 Coruña, A;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
15 Coruña, A;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
15 Coruña, A;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QIV;12.722
15 Coruña, A;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
15 Coruña, A;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
15 Coruña, A;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
15 Coruña, A;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QIV;13.025
15 Coruña, A;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
15 Coruña, A;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
15 Coruña, A;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
15 Coruña, A;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2022QIV;11.552
15 Coruña, A;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
15 Coruña, A;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2022QII;""
15 Coruña, A;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2022QI;""
15 Coruña, A;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2021QIV;12.268
15 Coruña, A;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
15 Coruña, A;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2021QII;""
15 Coruña, A;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2021QI;""
15 Coruña, A;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2020QIV;12.629
15 Coruña, A;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
15 Coruña, A;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2020QII;""
15 Coruña, A;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2020QI;""
15 Coruña, A;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
15 Coruña, A;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
15 Coruña, A;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2022QII;""
15 Coruña, A;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2022QI;11.884
15 Coruña, A;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
15 Coruña, A;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
15 Coruña, A;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2021QII;""
15 Coruña, A;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2021QI;12.330
15 Coruña, A;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
15 Coruña, A;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
15 Coruña, A;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2020QII;""
15 Coruña, A;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2020QI;""
15 Coruña, A;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
15 Coruña, A;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
15 Coruña, A;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QII;11.509
15 Coruña, A;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QI;""
15 Coruña, A;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
15 Coruña, A;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
15 Coruña, A;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QII;12.056
15 Coruña, A;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QI;""
15 Coruña, A;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
15 Coruña, A;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
15 Coruña, A;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QII;""
15 Coruña, A;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QI;""
15 Coruña, A;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
15 Coruña, A;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QIII;11.184
15 Coruña, A;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QII;""
15 Coruña, A;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QI;""
15 Coruña, A;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
15 Coruña, A;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QIII;11.786
15 Coruña, A;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QII;""
15 Coruña, A;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QI;""
15 Coruña, A;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
15 Coruña, A;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
15 Coruña, A;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QII;""
15 Coruña, A;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QI;""
15 Coruña, A;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
15 Coruña, A;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
15 Coruña, A;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
15 Coruña, A;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
15 Coruña, A;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
15 Coruña, A;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
15 Coruña, A;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
15 Coruña, A;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
15 Coruña, A;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
15 Coruña, A;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
15 Coruña, A;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
15 Coruña, A;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
15 Coruña, A;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;96,22
15 Coruña, A;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
15 Coruña, A;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
15 Coruña, A;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
15 Coruña, A;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;96,43
15 Coruña, A;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
15 Coruña, A;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
15 Coruña, A;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
15 Coruña, A;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;96,96
15 Coruña, A;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
15 Coruña, A;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
15 Coruña, A;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
15 Coruña, A;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
15 Coruña, A;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
15 Coruña, A;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
15 Coruña, A;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;93,41
15 Coruña, A;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
15 Coruña, A;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
15 Coruña, A;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
15 Coruña, A;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;94,66
15 Coruña, A;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
15 Coruña, A;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
15 Coruña, A;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
15 Coruña, A;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
15 Coruña, A;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
15 Coruña, A;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
15 Coruña, A;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;90,47
15 Coruña, A;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
15 Coruña, A;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
15 Coruña, A;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
15 Coruña, A;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;92,56
15 Coruña, A;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
15 Coruña, A;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
15 Coruña, A;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
15 Coruña, A;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
15 Coruña, A;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
15 Coruña, A;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
15 Coruña, A;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;87,91
15 Coruña, A;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
15 Coruña, A;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
15 Coruña, A;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
15 Coruña, A;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;90,49
15 Coruña, A;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
15 Coruña, A;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
15 Coruña, A;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
15 Coruña, A;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
15 Coruña, A;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
15 Coruña, A;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
15 Coruña, A;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QIV;6.912
15 Coruña, A;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
15 Coruña, A;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
15 Coruña, A;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
15 Coruña, A;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QIV;7.413
15 Coruña, A;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
15 Coruña, A;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
15 Coruña, A;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
15 Coruña, A;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QIV;7.600
15 Coruña, A;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
15 Coruña, A;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
15 Coruña, A;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
15 Coruña, A;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2022QIV;6.657
15 Coruña, A;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
15 Coruña, A;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2022QII;""
15 Coruña, A;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2022QI;""
15 Coruña, A;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2021QIV;7.153
15 Coruña, A;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
15 Coruña, A;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2021QII;""
15 Coruña, A;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2021QI;""
15 Coruña, A;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2020QIV;7.381
15 Coruña, A;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
15 Coruña, A;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2020QII;""
15 Coruña, A;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2020QI;""
15 Coruña, A;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
15 Coruña, A;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
15 Coruña, A;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2022QII;""
15 Coruña, A;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2022QI;6.931
15 Coruña, A;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
15 Coruña, A;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
15 Coruña, A;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2021QII;""
15 Coruña, A;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2021QI;7.219
15 Coruña, A;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
15 Coruña, A;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
15 Coruña, A;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2020QII;""
15 Coruña, A;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2020QI;""
15 Coruña, A;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
15 Coruña, A;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
15 Coruña, A;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QII;6.728
15 Coruña, A;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QI;""
15 Coruña, A;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
15 Coruña, A;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
15 Coruña, A;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QII;7.077
15 Coruña, A;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QI;""
15 Coruña, A;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
15 Coruña, A;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
15 Coruña, A;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QII;""
15 Coruña, A;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QI;""
15 Coruña, A;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
15 Coruña, A;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QIII;6.541
15 Coruña, A;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QII;""
15 Coruña, A;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QI;""
15 Coruña, A;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
15 Coruña, A;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QIII;6.932
15 Coruña, A;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QII;""
15 Coruña, A;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QI;""
15 Coruña, A;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
15 Coruña, A;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
15 Coruña, A;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QII;""
15 Coruña, A;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QI;""
15 Coruña, A;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
15 Coruña, A;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
15 Coruña, A;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
15 Coruña, A;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
15 Coruña, A;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
15 Coruña, A;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
15 Coruña, A;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
15 Coruña, A;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
15 Coruña, A;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
15 Coruña, A;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
15 Coruña, A;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
15 Coruña, A;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
15 Coruña, A;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;96,31
15 Coruña, A;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
15 Coruña, A;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
15 Coruña, A;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
15 Coruña, A;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;96,49
15 Coruña, A;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
15 Coruña, A;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
15 Coruña, A;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
15 Coruña, A;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;97,12
15 Coruña, A;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
15 Coruña, A;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
15 Coruña, A;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
15 Coruña, A;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
15 Coruña, A;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
15 Coruña, A;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
15 Coruña, A;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;93,5
15 Coruña, A;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
15 Coruña, A;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
15 Coruña, A;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
15 Coruña, A;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;94,99
15 Coruña, A;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
15 Coruña, A;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
15 Coruña, A;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
15 Coruña, A;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
15 Coruña, A;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
15 Coruña, A;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
15 Coruña, A;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;90,76
15 Coruña, A;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
15 Coruña, A;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
15 Coruña, A;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
15 Coruña, A;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;93,12
15 Coruña, A;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
15 Coruña, A;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
15 Coruña, A;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
15 Coruña, A;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
15 Coruña, A;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
15 Coruña, A;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
15 Coruña, A;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;88,24
15 Coruña, A;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
15 Coruña, A;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
15 Coruña, A;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
15 Coruña, A;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;91,21
15 Coruña, A;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
15 Coruña, A;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
15 Coruña, A;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
15 Coruña, A;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
15 Coruña, A;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
15 Coruña, A;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
15 Coruña, A;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QIV;5.094
15 Coruña, A;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
15 Coruña, A;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
15 Coruña, A;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
15 Coruña, A;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QIV;5.309
15 Coruña, A;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
15 Coruña, A;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
15 Coruña, A;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
15 Coruña, A;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QIV;5.425
15 Coruña, A;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
15 Coruña, A;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
15 Coruña, A;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
15 Coruña, A;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2022QIV;4.895
15 Coruña, A;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
15 Coruña, A;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2022QII;""
15 Coruña, A;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2022QI;""
15 Coruña, A;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2021QIV;5.115
15 Coruña, A;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
15 Coruña, A;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2021QII;""
15 Coruña, A;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2021QI;""
15 Coruña, A;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2020QIV;5.248
15 Coruña, A;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
15 Coruña, A;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2020QII;""
15 Coruña, A;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2020QI;""
15 Coruña, A;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
15 Coruña, A;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
15 Coruña, A;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2022QII;""
15 Coruña, A;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2022QI;4.953
15 Coruña, A;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
15 Coruña, A;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
15 Coruña, A;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2021QII;""
15 Coruña, A;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2021QI;5.111
15 Coruña, A;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
15 Coruña, A;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
15 Coruña, A;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2020QII;""
15 Coruña, A;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2020QI;""
15 Coruña, A;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
15 Coruña, A;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
15 Coruña, A;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QII;4.781
15 Coruña, A;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QI;""
15 Coruña, A;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
15 Coruña, A;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
15 Coruña, A;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QII;4.979
15 Coruña, A;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QI;""
15 Coruña, A;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
15 Coruña, A;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
15 Coruña, A;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QII;""
15 Coruña, A;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QI;""
15 Coruña, A;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
15 Coruña, A;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QIII;4.643
15 Coruña, A;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QII;""
15 Coruña, A;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QI;""
15 Coruña, A;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
15 Coruña, A;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QIII;4.854
15 Coruña, A;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QII;""
15 Coruña, A;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QI;""
15 Coruña, A;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
15 Coruña, A;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
15 Coruña, A;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QII;""
15 Coruña, A;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QI;""
15 Coruña, A;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
15 Coruña, A;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
15 Coruña, A;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
15 Coruña, A;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
15 Coruña, A;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
15 Coruña, A;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
15 Coruña, A;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
15 Coruña, A;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
15 Coruña, A;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
15 Coruña, A;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
15 Coruña, A;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
15 Coruña, A;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
15 Coruña, A;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;96,09
15 Coruña, A;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
15 Coruña, A;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
15 Coruña, A;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
15 Coruña, A;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;96,35
15 Coruña, A;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
15 Coruña, A;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
15 Coruña, A;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
15 Coruña, A;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;96,74
15 Coruña, A;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
15 Coruña, A;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
15 Coruña, A;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
15 Coruña, A;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
15 Coruña, A;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
15 Coruña, A;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
15 Coruña, A;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;93,29
15 Coruña, A;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
15 Coruña, A;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
15 Coruña, A;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
15 Coruña, A;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;94,21
15 Coruña, A;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
15 Coruña, A;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
15 Coruña, A;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
15 Coruña, A;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
15 Coruña, A;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
15 Coruña, A;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
15 Coruña, A;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;90,05
15 Coruña, A;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
15 Coruña, A;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
15 Coruña, A;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
15 Coruña, A;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;91,78
15 Coruña, A;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
15 Coruña, A;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
15 Coruña, A;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
15 Coruña, A;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
15 Coruña, A;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
15 Coruña, A;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
15 Coruña, A;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;87,46
15 Coruña, A;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
15 Coruña, A;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
15 Coruña, A;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
15 Coruña, A;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;89,47
15 Coruña, A;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
15 Coruña, A;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
15 Coruña, A;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
15 Coruña, A;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
15 Coruña, A;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
15 Coruña, A;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
15 Coruña, A;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
15 Coruña, A;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
15 Coruña, A;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
15 Coruña, A;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QI;24.340
15 Coruña, A;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
15 Coruña, A;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
15 Coruña, A;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
15 Coruña, A;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QI;24.182
15 Coruña, A;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
15 Coruña, A;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
15 Coruña, A;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
15 Coruña, A;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QI;24.260
15 Coruña, A;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
15 Coruña, A;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
15 Coruña, A;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2022QII;""
15 Coruña, A;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2022QI;23.744
15 Coruña, A;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
15 Coruña, A;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
15 Coruña, A;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2021QII;""
15 Coruña, A;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2021QI;23.768
15 Coruña, A;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
15 Coruña, A;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
15 Coruña, A;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2020QII;""
15 Coruña, A;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2020QI;23.162
15 Coruña, A;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
15 Coruña, A;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
15 Coruña, A;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2022QII;23.208
15 Coruña, A;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2022QI;""
15 Coruña, A;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
15 Coruña, A;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
15 Coruña, A;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2021QII;23.325
15 Coruña, A;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2021QI;""
15 Coruña, A;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
15 Coruña, A;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
15 Coruña, A;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2020QII;22.806
15 Coruña, A;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2020QI;""
15 Coruña, A;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
15 Coruña, A;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QIII;22.789
15 Coruña, A;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QII;""
15 Coruña, A;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QI;""
15 Coruña, A;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
15 Coruña, A;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QIII;22.977
15 Coruña, A;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QII;""
15 Coruña, A;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QI;""
15 Coruña, A;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
15 Coruña, A;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QIII;22.403
15 Coruña, A;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QII;""
15 Coruña, A;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QI;""
15 Coruña, A;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QIV;22.306
15 Coruña, A;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
15 Coruña, A;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QII;""
15 Coruña, A;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QI;""
15 Coruña, A;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QIV;22.549
15 Coruña, A;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
15 Coruña, A;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QII;""
15 Coruña, A;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QI;""
15 Coruña, A;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QIV;22.022
15 Coruña, A;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
15 Coruña, A;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QII;""
15 Coruña, A;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QI;""
15 Coruña, A;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
15 Coruña, A;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
15 Coruña, A;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
15 Coruña, A;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
15 Coruña, A;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
15 Coruña, A;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
15 Coruña, A;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
15 Coruña, A;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
15 Coruña, A;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
15 Coruña, A;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
15 Coruña, A;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
15 Coruña, A;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
15 Coruña, A;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
15 Coruña, A;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
15 Coruña, A;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
15 Coruña, A;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;97,55
15 Coruña, A;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
15 Coruña, A;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
15 Coruña, A;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
15 Coruña, A;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;98,29
15 Coruña, A;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
15 Coruña, A;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
15 Coruña, A;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
15 Coruña, A;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;95,47
15 Coruña, A;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
15 Coruña, A;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
15 Coruña, A;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;95,35
15 Coruña, A;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
15 Coruña, A;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
15 Coruña, A;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
15 Coruña, A;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;96,46
15 Coruña, A;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
15 Coruña, A;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
15 Coruña, A;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
15 Coruña, A;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;94,01
15 Coruña, A;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
15 Coruña, A;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
15 Coruña, A;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;93,63
15 Coruña, A;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
15 Coruña, A;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
15 Coruña, A;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
15 Coruña, A;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;95,02
15 Coruña, A;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
15 Coruña, A;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
15 Coruña, A;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
15 Coruña, A;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;92,35
15 Coruña, A;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
15 Coruña, A;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
15 Coruña, A;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;91,64
15 Coruña, A;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
15 Coruña, A;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
15 Coruña, A;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
15 Coruña, A;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;93,25
15 Coruña, A;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
15 Coruña, A;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
15 Coruña, A;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
15 Coruña, A;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;90,77
15 Coruña, A;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
15 Coruña, A;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
15 Coruña, A;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
15 Coruña, A;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
15 Coruña, A;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
15 Coruña, A;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
15 Coruña, A;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QI;14.729
15 Coruña, A;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
15 Coruña, A;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
15 Coruña, A;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
15 Coruña, A;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QI;14.605
15 Coruña, A;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
15 Coruña, A;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
15 Coruña, A;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
15 Coruña, A;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QI;14.581
15 Coruña, A;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
15 Coruña, A;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
15 Coruña, A;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2022QII;""
15 Coruña, A;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2022QI;14.422
15 Coruña, A;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
15 Coruña, A;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
15 Coruña, A;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2021QII;""
15 Coruña, A;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2021QI;14.376
15 Coruña, A;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
15 Coruña, A;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
15 Coruña, A;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2020QII;""
15 Coruña, A;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2020QI;13.961
15 Coruña, A;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
15 Coruña, A;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
15 Coruña, A;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2022QII;14.148
15 Coruña, A;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2022QI;""
15 Coruña, A;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
15 Coruña, A;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
15 Coruña, A;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2021QII;14.146
15 Coruña, A;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2021QI;""
15 Coruña, A;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
15 Coruña, A;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
15 Coruña, A;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2020QII;13.791
15 Coruña, A;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2020QI;""
15 Coruña, A;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
15 Coruña, A;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QIII;13.931
15 Coruña, A;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QII;""
15 Coruña, A;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QI;""
15 Coruña, A;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
15 Coruña, A;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QIII;13.956
15 Coruña, A;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QII;""
15 Coruña, A;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QI;""
15 Coruña, A;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
15 Coruña, A;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QIII;13.590
15 Coruña, A;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QII;""
15 Coruña, A;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QI;""
15 Coruña, A;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QIV;13.656
15 Coruña, A;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
15 Coruña, A;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QII;""
15 Coruña, A;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QI;""
15 Coruña, A;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QIV;13.722
15 Coruña, A;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
15 Coruña, A;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QII;""
15 Coruña, A;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QI;""
15 Coruña, A;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QIV;13.390
15 Coruña, A;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
15 Coruña, A;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QII;""
15 Coruña, A;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QI;""
15 Coruña, A;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
15 Coruña, A;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
15 Coruña, A;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
15 Coruña, A;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
15 Coruña, A;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
15 Coruña, A;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
15 Coruña, A;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
15 Coruña, A;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
15 Coruña, A;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
15 Coruña, A;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
15 Coruña, A;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
15 Coruña, A;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
15 Coruña, A;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
15 Coruña, A;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
15 Coruña, A;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
15 Coruña, A;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;97,92
15 Coruña, A;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
15 Coruña, A;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
15 Coruña, A;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
15 Coruña, A;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;98,43
15 Coruña, A;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
15 Coruña, A;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
15 Coruña, A;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
15 Coruña, A;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;95,75
15 Coruña, A;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
15 Coruña, A;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
15 Coruña, A;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;96,06
15 Coruña, A;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
15 Coruña, A;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
15 Coruña, A;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
15 Coruña, A;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;96,86
15 Coruña, A;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
15 Coruña, A;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
15 Coruña, A;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
15 Coruña, A;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;94,58
15 Coruña, A;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
15 Coruña, A;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
15 Coruña, A;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;94,58
15 Coruña, A;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
15 Coruña, A;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
15 Coruña, A;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
15 Coruña, A;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;95,56
15 Coruña, A;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
15 Coruña, A;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
15 Coruña, A;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
15 Coruña, A;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;93,2
15 Coruña, A;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
15 Coruña, A;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
15 Coruña, A;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;92,72
15 Coruña, A;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
15 Coruña, A;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
15 Coruña, A;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
15 Coruña, A;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;93,95
15 Coruña, A;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
15 Coruña, A;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
15 Coruña, A;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
15 Coruña, A;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;91,83
15 Coruña, A;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
15 Coruña, A;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
15 Coruña, A;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
15 Coruña, A;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
15 Coruña, A;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
15 Coruña, A;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
15 Coruña, A;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QI;9.611
15 Coruña, A;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
15 Coruña, A;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
15 Coruña, A;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
15 Coruña, A;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QI;9.577
15 Coruña, A;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
15 Coruña, A;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
15 Coruña, A;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
15 Coruña, A;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QI;9.679
15 Coruña, A;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
15 Coruña, A;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
15 Coruña, A;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2022QII;""
15 Coruña, A;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2022QI;9.322
15 Coruña, A;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
15 Coruña, A;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
15 Coruña, A;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2021QII;""
15 Coruña, A;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2021QI;9.392
15 Coruña, A;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
15 Coruña, A;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
15 Coruña, A;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2020QII;""
15 Coruña, A;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2020QI;9.201
15 Coruña, A;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
15 Coruña, A;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
15 Coruña, A;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2022QII;9.060
15 Coruña, A;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2022QI;""
15 Coruña, A;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
15 Coruña, A;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
15 Coruña, A;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2021QII;9.179
15 Coruña, A;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2021QI;""
15 Coruña, A;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
15 Coruña, A;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
15 Coruña, A;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2020QII;9.015
15 Coruña, A;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2020QI;""
15 Coruña, A;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
15 Coruña, A;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QIII;8.858
15 Coruña, A;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QII;""
15 Coruña, A;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QI;""
15 Coruña, A;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
15 Coruña, A;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QIII;9.021
15 Coruña, A;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QII;""
15 Coruña, A;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QI;""
15 Coruña, A;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
15 Coruña, A;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QIII;8.813
15 Coruña, A;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QII;""
15 Coruña, A;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QI;""
15 Coruña, A;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QIV;8.650
15 Coruña, A;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
15 Coruña, A;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QII;""
15 Coruña, A;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QI;""
15 Coruña, A;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QIV;8.827
15 Coruña, A;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
15 Coruña, A;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QII;""
15 Coruña, A;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QI;""
15 Coruña, A;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QIV;8.632
15 Coruña, A;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
15 Coruña, A;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QII;""
15 Coruña, A;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QI;""
15 Coruña, A;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
15 Coruña, A;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
15 Coruña, A;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
15 Coruña, A;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
15 Coruña, A;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
15 Coruña, A;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
15 Coruña, A;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
15 Coruña, A;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
15 Coruña, A;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
15 Coruña, A;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
15 Coruña, A;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
15 Coruña, A;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
15 Coruña, A;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
15 Coruña, A;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
15 Coruña, A;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
15 Coruña, A;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;96,99
15 Coruña, A;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
15 Coruña, A;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
15 Coruña, A;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
15 Coruña, A;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;98,07
15 Coruña, A;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
15 Coruña, A;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
15 Coruña, A;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
15 Coruña, A;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;95,06
15 Coruña, A;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
15 Coruña, A;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
15 Coruña, A;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;94,27
15 Coruña, A;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
15 Coruña, A;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
15 Coruña, A;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
15 Coruña, A;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;95,84
15 Coruña, A;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
15 Coruña, A;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
15 Coruña, A;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
15 Coruña, A;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;93,14
15 Coruña, A;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
15 Coruña, A;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
15 Coruña, A;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;92,17
15 Coruña, A;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
15 Coruña, A;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
15 Coruña, A;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
15 Coruña, A;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;94,19
15 Coruña, A;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
15 Coruña, A;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
15 Coruña, A;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
15 Coruña, A;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;91,05
15 Coruña, A;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
15 Coruña, A;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
15 Coruña, A;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;90
15 Coruña, A;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
15 Coruña, A;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
15 Coruña, A;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
15 Coruña, A;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;92,17
15 Coruña, A;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
15 Coruña, A;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
15 Coruña, A;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
15 Coruña, A;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;89,18
15 Coruña, A;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
15 Coruña, A;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
15 Coruña, A;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
15 Coruña, A;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
15 Coruña, A;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
15 Coruña, A;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QII;23.823
15 Coruña, A;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
15 Coruña, A;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
15 Coruña, A;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
15 Coruña, A;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QII;23.964
15 Coruña, A;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
15 Coruña, A;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
15 Coruña, A;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
15 Coruña, A;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QII;23.925
15 Coruña, A;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
15 Coruña, A;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
15 Coruña, A;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
15 Coruña, A;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2022QII;23.235
15 Coruña, A;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2022QI;""
15 Coruña, A;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
15 Coruña, A;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
15 Coruña, A;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2021QII;23.477
15 Coruña, A;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2021QI;""
15 Coruña, A;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
15 Coruña, A;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
15 Coruña, A;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2020QII;23.531
15 Coruña, A;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2020QI;""
15 Coruña, A;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
15 Coruña, A;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2022QIII;22.781
15 Coruña, A;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2022QII;""
15 Coruña, A;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2022QI;""
15 Coruña, A;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
15 Coruña, A;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2021QIII;23.098
15 Coruña, A;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2021QII;""
15 Coruña, A;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2021QI;""
15 Coruña, A;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
15 Coruña, A;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2020QIII;23.065
15 Coruña, A;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2020QII;""
15 Coruña, A;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2020QI;""
15 Coruña, A;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QIV;22.265
15 Coruña, A;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
15 Coruña, A;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QII;""
15 Coruña, A;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QI;""
15 Coruña, A;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QIV;22.639
15 Coruña, A;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
15 Coruña, A;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QII;""
15 Coruña, A;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QI;""
15 Coruña, A;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QIV;22.649
15 Coruña, A;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
15 Coruña, A;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QII;""
15 Coruña, A;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QI;""
15 Coruña, A;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
15 Coruña, A;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
15 Coruña, A;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QII;""
15 Coruña, A;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QI;22.155
15 Coruña, A;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
15 Coruña, A;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
15 Coruña, A;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QII;""
15 Coruña, A;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QI;22.330
15 Coruña, A;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
15 Coruña, A;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
15 Coruña, A;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QII;""
15 Coruña, A;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QI;""
15 Coruña, A;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
15 Coruña, A;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
15 Coruña, A;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
15 Coruña, A;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
15 Coruña, A;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
15 Coruña, A;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
15 Coruña, A;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
15 Coruña, A;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
15 Coruña, A;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
15 Coruña, A;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
15 Coruña, A;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
15 Coruña, A;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
15 Coruña, A;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
15 Coruña, A;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
15 Coruña, A;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;97,53
15 Coruña, A;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
15 Coruña, A;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
15 Coruña, A;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
15 Coruña, A;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;97,97
15 Coruña, A;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
15 Coruña, A;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
15 Coruña, A;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
15 Coruña, A;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;98,35
15 Coruña, A;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
15 Coruña, A;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
15 Coruña, A;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;95,63
15 Coruña, A;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
15 Coruña, A;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
15 Coruña, A;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
15 Coruña, A;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;96,39
15 Coruña, A;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
15 Coruña, A;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
15 Coruña, A;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
15 Coruña, A;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;96,41
15 Coruña, A;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
15 Coruña, A;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
15 Coruña, A;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;93,46
15 Coruña, A;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
15 Coruña, A;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
15 Coruña, A;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
15 Coruña, A;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;94,47
15 Coruña, A;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
15 Coruña, A;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
15 Coruña, A;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
15 Coruña, A;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;94,67
15 Coruña, A;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
15 Coruña, A;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
15 Coruña, A;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
15 Coruña, A;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
15 Coruña, A;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
15 Coruña, A;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
15 Coruña, A;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;92,45
15 Coruña, A;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
15 Coruña, A;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
15 Coruña, A;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
15 Coruña, A;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;93,33
15 Coruña, A;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
15 Coruña, A;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
15 Coruña, A;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
15 Coruña, A;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
15 Coruña, A;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
15 Coruña, A;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
15 Coruña, A;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QII;14.346
15 Coruña, A;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
15 Coruña, A;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
15 Coruña, A;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
15 Coruña, A;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QII;14.531
15 Coruña, A;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
15 Coruña, A;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
15 Coruña, A;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
15 Coruña, A;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QII;14.395
15 Coruña, A;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
15 Coruña, A;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
15 Coruña, A;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
15 Coruña, A;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2022QII;14.046
15 Coruña, A;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2022QI;""
15 Coruña, A;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
15 Coruña, A;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
15 Coruña, A;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2021QII;14.279
15 Coruña, A;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2021QI;""
15 Coruña, A;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
15 Coruña, A;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
15 Coruña, A;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2020QII;14.204
15 Coruña, A;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2020QI;""
15 Coruña, A;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
15 Coruña, A;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2022QIII;13.807
15 Coruña, A;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2022QII;""
15 Coruña, A;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2022QI;""
15 Coruña, A;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
15 Coruña, A;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2021QIII;14.067
15 Coruña, A;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2021QII;""
15 Coruña, A;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2021QI;""
15 Coruña, A;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
15 Coruña, A;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2020QIII;13.963
15 Coruña, A;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2020QII;""
15 Coruña, A;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2020QI;""
15 Coruña, A;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QIV;13.517
15 Coruña, A;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
15 Coruña, A;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QII;""
15 Coruña, A;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QI;""
15 Coruña, A;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QIV;13.807
15 Coruña, A;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
15 Coruña, A;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QII;""
15 Coruña, A;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QI;""
15 Coruña, A;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QIV;13.743
15 Coruña, A;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
15 Coruña, A;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QII;""
15 Coruña, A;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QI;""
15 Coruña, A;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
15 Coruña, A;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
15 Coruña, A;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QII;""
15 Coruña, A;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QI;13.562
15 Coruña, A;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
15 Coruña, A;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
15 Coruña, A;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QII;""
15 Coruña, A;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QI;13.569
15 Coruña, A;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
15 Coruña, A;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
15 Coruña, A;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QII;""
15 Coruña, A;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QI;""
15 Coruña, A;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
15 Coruña, A;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
15 Coruña, A;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
15 Coruña, A;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
15 Coruña, A;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
15 Coruña, A;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
15 Coruña, A;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
15 Coruña, A;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
15 Coruña, A;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
15 Coruña, A;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
15 Coruña, A;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
15 Coruña, A;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
15 Coruña, A;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
15 Coruña, A;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
15 Coruña, A;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;97,91
15 Coruña, A;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
15 Coruña, A;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
15 Coruña, A;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
15 Coruña, A;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;98,27
15 Coruña, A;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
15 Coruña, A;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
15 Coruña, A;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
15 Coruña, A;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;98,67
15 Coruña, A;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
15 Coruña, A;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
15 Coruña, A;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;96,24
15 Coruña, A;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
15 Coruña, A;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
15 Coruña, A;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
15 Coruña, A;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;96,81
15 Coruña, A;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
15 Coruña, A;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
15 Coruña, A;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
15 Coruña, A;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;97
15 Coruña, A;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
15 Coruña, A;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
15 Coruña, A;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;94,22
15 Coruña, A;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
15 Coruña, A;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
15 Coruña, A;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
15 Coruña, A;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;95,02
15 Coruña, A;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
15 Coruña, A;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
15 Coruña, A;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
15 Coruña, A;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;95,47
15 Coruña, A;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
15 Coruña, A;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
15 Coruña, A;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
15 Coruña, A;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
15 Coruña, A;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
15 Coruña, A;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
15 Coruña, A;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;93,33
15 Coruña, A;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
15 Coruña, A;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
15 Coruña, A;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
15 Coruña, A;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;94,26
15 Coruña, A;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
15 Coruña, A;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
15 Coruña, A;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
15 Coruña, A;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
15 Coruña, A;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
15 Coruña, A;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
15 Coruña, A;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QII;9.477
15 Coruña, A;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
15 Coruña, A;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
15 Coruña, A;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
15 Coruña, A;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QII;9.433
15 Coruña, A;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
15 Coruña, A;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
15 Coruña, A;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
15 Coruña, A;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QII;9.530
15 Coruña, A;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
15 Coruña, A;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
15 Coruña, A;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
15 Coruña, A;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2022QII;9.189
15 Coruña, A;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2022QI;""
15 Coruña, A;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
15 Coruña, A;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
15 Coruña, A;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2021QII;9.198
15 Coruña, A;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2021QI;""
15 Coruña, A;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
15 Coruña, A;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
15 Coruña, A;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2020QII;9.327
15 Coruña, A;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2020QI;""
15 Coruña, A;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
15 Coruña, A;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2022QIII;8.974
15 Coruña, A;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2022QII;""
15 Coruña, A;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2022QI;""
15 Coruña, A;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
15 Coruña, A;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2021QIII;9.031
15 Coruña, A;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2021QII;""
15 Coruña, A;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2021QI;""
15 Coruña, A;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
15 Coruña, A;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2020QIII;9.102
15 Coruña, A;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2020QII;""
15 Coruña, A;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2020QI;""
15 Coruña, A;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QIV;8.748
15 Coruña, A;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
15 Coruña, A;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QII;""
15 Coruña, A;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QI;""
15 Coruña, A;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QIV;8.832
15 Coruña, A;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
15 Coruña, A;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QII;""
15 Coruña, A;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QI;""
15 Coruña, A;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QIV;8.906
15 Coruña, A;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
15 Coruña, A;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QII;""
15 Coruña, A;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QI;""
15 Coruña, A;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
15 Coruña, A;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
15 Coruña, A;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QII;""
15 Coruña, A;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QI;8.593
15 Coruña, A;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
15 Coruña, A;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
15 Coruña, A;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QII;""
15 Coruña, A;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QI;8.761
15 Coruña, A;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
15 Coruña, A;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
15 Coruña, A;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QII;""
15 Coruña, A;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QI;""
15 Coruña, A;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
15 Coruña, A;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
15 Coruña, A;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
15 Coruña, A;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
15 Coruña, A;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
15 Coruña, A;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
15 Coruña, A;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
15 Coruña, A;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
15 Coruña, A;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
15 Coruña, A;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
15 Coruña, A;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
15 Coruña, A;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
15 Coruña, A;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
15 Coruña, A;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
15 Coruña, A;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;96,96
15 Coruña, A;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
15 Coruña, A;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
15 Coruña, A;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
15 Coruña, A;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;97,51
15 Coruña, A;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
15 Coruña, A;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
15 Coruña, A;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
15 Coruña, A;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;97,87
15 Coruña, A;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
15 Coruña, A;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
15 Coruña, A;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;94,69
15 Coruña, A;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
15 Coruña, A;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
15 Coruña, A;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
15 Coruña, A;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;95,74
15 Coruña, A;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
15 Coruña, A;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
15 Coruña, A;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
15 Coruña, A;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;95,51
15 Coruña, A;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
15 Coruña, A;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
15 Coruña, A;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;92,31
15 Coruña, A;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
15 Coruña, A;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
15 Coruña, A;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
15 Coruña, A;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;93,63
15 Coruña, A;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
15 Coruña, A;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
15 Coruña, A;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
15 Coruña, A;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;93,45
15 Coruña, A;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
15 Coruña, A;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
15 Coruña, A;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
15 Coruña, A;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
15 Coruña, A;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
15 Coruña, A;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
15 Coruña, A;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;91,1
15 Coruña, A;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
15 Coruña, A;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
15 Coruña, A;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
15 Coruña, A;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;91,93
15 Coruña, A;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
15 Coruña, A;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
15 Coruña, A;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
15 Coruña, A;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
15 Coruña, A;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
15 Coruña, A;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QIII;23.894
15 Coruña, A;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
15 Coruña, A;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
15 Coruña, A;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
15 Coruña, A;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QIII;24.148
15 Coruña, A;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
15 Coruña, A;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
15 Coruña, A;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
15 Coruña, A;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QIII;23.994
15 Coruña, A;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
15 Coruña, A;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
15 Coruña, A;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
15 Coruña, A;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2022QIII;23.350
15 Coruña, A;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2022QII;""
15 Coruña, A;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2022QI;""
15 Coruña, A;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
15 Coruña, A;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2021QIII;23.703
15 Coruña, A;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2021QII;""
15 Coruña, A;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2021QI;""
15 Coruña, A;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
15 Coruña, A;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2020QIII;23.468
15 Coruña, A;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2020QII;""
15 Coruña, A;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2020QI;""
15 Coruña, A;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2022QIV;22.765
15 Coruña, A;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
15 Coruña, A;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2022QII;""
15 Coruña, A;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2022QI;""
15 Coruña, A;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2021QIV;23.187
15 Coruña, A;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
15 Coruña, A;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2021QII;""
15 Coruña, A;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2021QI;""
15 Coruña, A;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2020QIV;23.020
15 Coruña, A;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
15 Coruña, A;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2020QII;""
15 Coruña, A;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2020QI;""
15 Coruña, A;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
15 Coruña, A;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
15 Coruña, A;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QII;""
15 Coruña, A;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QI;22.679
15 Coruña, A;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
15 Coruña, A;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
15 Coruña, A;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QII;""
15 Coruña, A;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QI;22.690
15 Coruña, A;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
15 Coruña, A;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
15 Coruña, A;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QII;""
15 Coruña, A;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QI;""
15 Coruña, A;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
15 Coruña, A;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
15 Coruña, A;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QII;22.220
15 Coruña, A;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QI;""
15 Coruña, A;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
15 Coruña, A;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
15 Coruña, A;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QII;22.336
15 Coruña, A;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QI;""
15 Coruña, A;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
15 Coruña, A;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
15 Coruña, A;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QII;""
15 Coruña, A;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QI;""
15 Coruña, A;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
15 Coruña, A;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
15 Coruña, A;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
15 Coruña, A;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
15 Coruña, A;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
15 Coruña, A;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
15 Coruña, A;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
15 Coruña, A;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
15 Coruña, A;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
15 Coruña, A;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
15 Coruña, A;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
15 Coruña, A;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
15 Coruña, A;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
15 Coruña, A;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;97,72
15 Coruña, A;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
15 Coruña, A;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
15 Coruña, A;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
15 Coruña, A;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;98,16
15 Coruña, A;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
15 Coruña, A;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
15 Coruña, A;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
15 Coruña, A;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;97,81
15 Coruña, A;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
15 Coruña, A;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
15 Coruña, A;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;95,27
15 Coruña, A;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
15 Coruña, A;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
15 Coruña, A;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
15 Coruña, A;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;96,02
15 Coruña, A;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
15 Coruña, A;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
15 Coruña, A;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
15 Coruña, A;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;95,94
15 Coruña, A;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
15 Coruña, A;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
15 Coruña, A;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
15 Coruña, A;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
15 Coruña, A;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
15 Coruña, A;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
15 Coruña, A;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;93,92
15 Coruña, A;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
15 Coruña, A;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
15 Coruña, A;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
15 Coruña, A;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;94,57
15 Coruña, A;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
15 Coruña, A;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
15 Coruña, A;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
15 Coruña, A;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
15 Coruña, A;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
15 Coruña, A;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
15 Coruña, A;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;92,02
15 Coruña, A;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
15 Coruña, A;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
15 Coruña, A;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
15 Coruña, A;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;93,09
15 Coruña, A;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
15 Coruña, A;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
15 Coruña, A;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
15 Coruña, A;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
15 Coruña, A;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
15 Coruña, A;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
15 Coruña, A;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QIII;14.402
15 Coruña, A;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
15 Coruña, A;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
15 Coruña, A;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
15 Coruña, A;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QIII;14.672
15 Coruña, A;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
15 Coruña, A;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
15 Coruña, A;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
15 Coruña, A;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QIII;14.484
15 Coruña, A;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
15 Coruña, A;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
15 Coruña, A;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
15 Coruña, A;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2022QIII;14.106
15 Coruña, A;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2022QII;""
15 Coruña, A;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2022QI;""
15 Coruña, A;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
15 Coruña, A;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2021QIII;14.415
15 Coruña, A;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2021QII;""
15 Coruña, A;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2021QI;""
15 Coruña, A;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
15 Coruña, A;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2020QIII;14.203
15 Coruña, A;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2020QII;""
15 Coruña, A;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2020QI;""
15 Coruña, A;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2022QIV;13.773
15 Coruña, A;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
15 Coruña, A;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2022QII;""
15 Coruña, A;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2022QI;""
15 Coruña, A;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2021QIV;14.124
15 Coruña, A;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
15 Coruña, A;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2021QII;""
15 Coruña, A;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2021QI;""
15 Coruña, A;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2020QIV;13.961
15 Coruña, A;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
15 Coruña, A;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2020QII;""
15 Coruña, A;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2020QI;""
15 Coruña, A;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
15 Coruña, A;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
15 Coruña, A;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QII;""
15 Coruña, A;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QI;13.863
15 Coruña, A;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
15 Coruña, A;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
15 Coruña, A;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QII;""
15 Coruña, A;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QI;13.784
15 Coruña, A;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
15 Coruña, A;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
15 Coruña, A;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QII;""
15 Coruña, A;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QI;""
15 Coruña, A;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
15 Coruña, A;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
15 Coruña, A;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QII;13.623
15 Coruña, A;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QI;""
15 Coruña, A;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
15 Coruña, A;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
15 Coruña, A;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QII;13.598
15 Coruña, A;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QI;""
15 Coruña, A;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
15 Coruña, A;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
15 Coruña, A;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QII;""
15 Coruña, A;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QI;""
15 Coruña, A;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
15 Coruña, A;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
15 Coruña, A;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
15 Coruña, A;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
15 Coruña, A;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
15 Coruña, A;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
15 Coruña, A;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
15 Coruña, A;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
15 Coruña, A;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
15 Coruña, A;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
15 Coruña, A;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
15 Coruña, A;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
15 Coruña, A;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
15 Coruña, A;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;97,94
15 Coruña, A;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
15 Coruña, A;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
15 Coruña, A;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
15 Coruña, A;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;98,25
15 Coruña, A;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
15 Coruña, A;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
15 Coruña, A;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
15 Coruña, A;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;98,06
15 Coruña, A;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
15 Coruña, A;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
15 Coruña, A;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;95,63
15 Coruña, A;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
15 Coruña, A;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
15 Coruña, A;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
15 Coruña, A;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;96,26
15 Coruña, A;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
15 Coruña, A;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
15 Coruña, A;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
15 Coruña, A;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;96,39
15 Coruña, A;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
15 Coruña, A;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
15 Coruña, A;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
15 Coruña, A;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
15 Coruña, A;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
15 Coruña, A;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
15 Coruña, A;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;94,49
15 Coruña, A;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
15 Coruña, A;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
15 Coruña, A;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
15 Coruña, A;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;95,17
15 Coruña, A;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
15 Coruña, A;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
15 Coruña, A;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
15 Coruña, A;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
15 Coruña, A;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
15 Coruña, A;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
15 Coruña, A;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;92,85
15 Coruña, A;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
15 Coruña, A;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
15 Coruña, A;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
15 Coruña, A;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;93,88
15 Coruña, A;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
15 Coruña, A;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
15 Coruña, A;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
15 Coruña, A;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
15 Coruña, A;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
15 Coruña, A;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
15 Coruña, A;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QIII;9.492
15 Coruña, A;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
15 Coruña, A;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
15 Coruña, A;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
15 Coruña, A;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QIII;9.476
15 Coruña, A;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
15 Coruña, A;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
15 Coruña, A;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
15 Coruña, A;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QIII;9.510
15 Coruña, A;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
15 Coruña, A;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
15 Coruña, A;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
15 Coruña, A;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2022QIII;9.244
15 Coruña, A;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2022QII;""
15 Coruña, A;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2022QI;""
15 Coruña, A;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
15 Coruña, A;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2021QIII;9.288
15 Coruña, A;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2021QII;""
15 Coruña, A;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2021QI;""
15 Coruña, A;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
15 Coruña, A;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2020QIII;9.265
15 Coruña, A;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2020QII;""
15 Coruña, A;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2020QI;""
15 Coruña, A;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2022QIV;8.992
15 Coruña, A;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
15 Coruña, A;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2022QII;""
15 Coruña, A;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2022QI;""
15 Coruña, A;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2021QIV;9.063
15 Coruña, A;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
15 Coruña, A;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2021QII;""
15 Coruña, A;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2021QI;""
15 Coruña, A;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2020QIV;9.059
15 Coruña, A;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
15 Coruña, A;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2020QII;""
15 Coruña, A;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2020QI;""
15 Coruña, A;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
15 Coruña, A;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
15 Coruña, A;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QII;""
15 Coruña, A;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QI;8.816
15 Coruña, A;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
15 Coruña, A;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
15 Coruña, A;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QII;""
15 Coruña, A;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QI;8.906
15 Coruña, A;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
15 Coruña, A;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
15 Coruña, A;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QII;""
15 Coruña, A;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QI;""
15 Coruña, A;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
15 Coruña, A;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
15 Coruña, A;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QII;8.597
15 Coruña, A;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QI;""
15 Coruña, A;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
15 Coruña, A;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
15 Coruña, A;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QII;8.738
15 Coruña, A;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QI;""
15 Coruña, A;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
15 Coruña, A;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
15 Coruña, A;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QII;""
15 Coruña, A;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QI;""
15 Coruña, A;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
15 Coruña, A;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
15 Coruña, A;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
15 Coruña, A;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
15 Coruña, A;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
15 Coruña, A;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
15 Coruña, A;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
15 Coruña, A;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
15 Coruña, A;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
15 Coruña, A;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
15 Coruña, A;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
15 Coruña, A;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
15 Coruña, A;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
15 Coruña, A;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;97,39
15 Coruña, A;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
15 Coruña, A;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
15 Coruña, A;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
15 Coruña, A;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;98,02
15 Coruña, A;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
15 Coruña, A;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
15 Coruña, A;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
15 Coruña, A;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;97,42
15 Coruña, A;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
15 Coruña, A;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
15 Coruña, A;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;94,73
15 Coruña, A;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
15 Coruña, A;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
15 Coruña, A;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
15 Coruña, A;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;95,64
15 Coruña, A;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
15 Coruña, A;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
15 Coruña, A;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
15 Coruña, A;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;95,26
15 Coruña, A;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
15 Coruña, A;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
15 Coruña, A;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
15 Coruña, A;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
15 Coruña, A;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
15 Coruña, A;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
15 Coruña, A;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;93,04
15 Coruña, A;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
15 Coruña, A;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
15 Coruña, A;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
15 Coruña, A;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;93,65
15 Coruña, A;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
15 Coruña, A;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
15 Coruña, A;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
15 Coruña, A;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
15 Coruña, A;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
15 Coruña, A;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
15 Coruña, A;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;90,72
15 Coruña, A;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
15 Coruña, A;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
15 Coruña, A;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
15 Coruña, A;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;91,88
15 Coruña, A;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
15 Coruña, A;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
15 Coruña, A;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
15 Coruña, A;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
15 Coruña, A;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
15 Coruña, A;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QIV;23.873
15 Coruña, A;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
15 Coruña, A;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
15 Coruña, A;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
15 Coruña, A;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QIV;24.341
15 Coruña, A;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
15 Coruña, A;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
15 Coruña, A;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
15 Coruña, A;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QIV;24.082
15 Coruña, A;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
15 Coruña, A;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
15 Coruña, A;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
15 Coruña, A;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2022QIV;23.234
15 Coruña, A;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
15 Coruña, A;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2022QII;""
15 Coruña, A;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2022QI;""
15 Coruña, A;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2021QIV;23.762
15 Coruña, A;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
15 Coruña, A;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2021QII;""
15 Coruña, A;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2021QI;""
15 Coruña, A;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2020QIV;23.563
15 Coruña, A;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
15 Coruña, A;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2020QII;""
15 Coruña, A;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2020QI;""
15 Coruña, A;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
15 Coruña, A;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
15 Coruña, A;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2022QII;""
15 Coruña, A;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2022QI;23.221
15 Coruña, A;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
15 Coruña, A;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
15 Coruña, A;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2021QII;""
15 Coruña, A;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2021QI;23.196
15 Coruña, A;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
15 Coruña, A;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
15 Coruña, A;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2020QII;""
15 Coruña, A;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2020QI;""
15 Coruña, A;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
15 Coruña, A;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
15 Coruña, A;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QII;22.724
15 Coruña, A;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QI;""
15 Coruña, A;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
15 Coruña, A;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
15 Coruña, A;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QII;22.799
15 Coruña, A;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QI;""
15 Coruña, A;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
15 Coruña, A;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
15 Coruña, A;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QII;""
15 Coruña, A;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QI;""
15 Coruña, A;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
15 Coruña, A;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QIII;22.326
15 Coruña, A;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QII;""
15 Coruña, A;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QI;""
15 Coruña, A;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
15 Coruña, A;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QIII;22.480
15 Coruña, A;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QII;""
15 Coruña, A;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QI;""
15 Coruña, A;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
15 Coruña, A;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
15 Coruña, A;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QII;""
15 Coruña, A;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QI;""
15 Coruña, A;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
15 Coruña, A;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
15 Coruña, A;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
15 Coruña, A;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
15 Coruña, A;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
15 Coruña, A;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
15 Coruña, A;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
15 Coruña, A;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
15 Coruña, A;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
15 Coruña, A;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
15 Coruña, A;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
15 Coruña, A;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
15 Coruña, A;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;97,32
15 Coruña, A;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
15 Coruña, A;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
15 Coruña, A;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
15 Coruña, A;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;97,62
15 Coruña, A;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
15 Coruña, A;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
15 Coruña, A;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
15 Coruña, A;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;97,84
15 Coruña, A;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
15 Coruña, A;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
15 Coruña, A;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
15 Coruña, A;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
15 Coruña, A;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
15 Coruña, A;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
15 Coruña, A;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;95,4
15 Coruña, A;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
15 Coruña, A;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
15 Coruña, A;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
15 Coruña, A;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;96,32
15 Coruña, A;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
15 Coruña, A;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
15 Coruña, A;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
15 Coruña, A;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
15 Coruña, A;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
15 Coruña, A;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
15 Coruña, A;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;93,36
15 Coruña, A;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
15 Coruña, A;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
15 Coruña, A;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
15 Coruña, A;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;94,67
15 Coruña, A;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
15 Coruña, A;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
15 Coruña, A;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
15 Coruña, A;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
15 Coruña, A;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
15 Coruña, A;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
15 Coruña, A;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;91,72
15 Coruña, A;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
15 Coruña, A;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
15 Coruña, A;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
15 Coruña, A;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;93,35
15 Coruña, A;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
15 Coruña, A;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
15 Coruña, A;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
15 Coruña, A;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
15 Coruña, A;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
15 Coruña, A;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
15 Coruña, A;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QIV;14.396
15 Coruña, A;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
15 Coruña, A;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
15 Coruña, A;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
15 Coruña, A;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QIV;14.763
15 Coruña, A;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
15 Coruña, A;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
15 Coruña, A;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
15 Coruña, A;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QIV;14.564
15 Coruña, A;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
15 Coruña, A;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
15 Coruña, A;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
15 Coruña, A;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2022QIV;14.035
15 Coruña, A;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
15 Coruña, A;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2022QII;""
15 Coruña, A;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2022QI;""
15 Coruña, A;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2021QIV;14.436
15 Coruña, A;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
15 Coruña, A;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2021QII;""
15 Coruña, A;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2021QI;""
15 Coruña, A;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2020QIV;14.274
15 Coruña, A;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
15 Coruña, A;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2020QII;""
15 Coruña, A;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2020QI;""
15 Coruña, A;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
15 Coruña, A;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
15 Coruña, A;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2022QII;""
15 Coruña, A;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2022QI;14.158
15 Coruña, A;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
15 Coruña, A;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
15 Coruña, A;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2021QII;""
15 Coruña, A;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2021QI;14.075
15 Coruña, A;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
15 Coruña, A;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
15 Coruña, A;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2020QII;""
15 Coruña, A;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2020QI;""
15 Coruña, A;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
15 Coruña, A;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
15 Coruña, A;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QII;13.901
15 Coruña, A;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QI;""
15 Coruña, A;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
15 Coruña, A;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
15 Coruña, A;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QII;13.868
15 Coruña, A;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QI;""
15 Coruña, A;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
15 Coruña, A;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
15 Coruña, A;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QII;""
15 Coruña, A;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QI;""
15 Coruña, A;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
15 Coruña, A;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QIII;13.693
15 Coruña, A;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QII;""
15 Coruña, A;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QI;""
15 Coruña, A;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
15 Coruña, A;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QIII;13.696
15 Coruña, A;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QII;""
15 Coruña, A;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QI;""
15 Coruña, A;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
15 Coruña, A;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
15 Coruña, A;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QII;""
15 Coruña, A;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QI;""
15 Coruña, A;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
15 Coruña, A;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
15 Coruña, A;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
15 Coruña, A;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
15 Coruña, A;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
15 Coruña, A;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
15 Coruña, A;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
15 Coruña, A;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
15 Coruña, A;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
15 Coruña, A;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
15 Coruña, A;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
15 Coruña, A;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
15 Coruña, A;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;97,49
15 Coruña, A;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
15 Coruña, A;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
15 Coruña, A;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
15 Coruña, A;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;97,79
15 Coruña, A;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
15 Coruña, A;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
15 Coruña, A;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
15 Coruña, A;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;98,01
15 Coruña, A;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
15 Coruña, A;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
15 Coruña, A;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
15 Coruña, A;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
15 Coruña, A;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
15 Coruña, A;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
15 Coruña, A;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;95,9
15 Coruña, A;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
15 Coruña, A;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
15 Coruña, A;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
15 Coruña, A;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;96,64
15 Coruña, A;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
15 Coruña, A;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
15 Coruña, A;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
15 Coruña, A;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
15 Coruña, A;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
15 Coruña, A;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
15 Coruña, A;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;94,16
15 Coruña, A;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
15 Coruña, A;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
15 Coruña, A;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
15 Coruña, A;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;95,22
15 Coruña, A;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
15 Coruña, A;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
15 Coruña, A;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
15 Coruña, A;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
15 Coruña, A;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
15 Coruña, A;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
15 Coruña, A;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;92,75
15 Coruña, A;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
15 Coruña, A;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
15 Coruña, A;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
15 Coruña, A;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;94,04
15 Coruña, A;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
15 Coruña, A;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
15 Coruña, A;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
15 Coruña, A;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
15 Coruña, A;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
15 Coruña, A;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
15 Coruña, A;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QIV;9.477
15 Coruña, A;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
15 Coruña, A;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
15 Coruña, A;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
15 Coruña, A;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QIV;9.578
15 Coruña, A;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
15 Coruña, A;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
15 Coruña, A;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
15 Coruña, A;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QIV;9.518
15 Coruña, A;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
15 Coruña, A;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
15 Coruña, A;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
15 Coruña, A;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2022QIV;9.199
15 Coruña, A;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
15 Coruña, A;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2022QII;""
15 Coruña, A;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2022QI;""
15 Coruña, A;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2021QIV;9.326
15 Coruña, A;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
15 Coruña, A;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2021QII;""
15 Coruña, A;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2021QI;""
15 Coruña, A;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2020QIV;9.289
15 Coruña, A;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
15 Coruña, A;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2020QII;""
15 Coruña, A;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2020QI;""
15 Coruña, A;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
15 Coruña, A;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
15 Coruña, A;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2022QII;""
15 Coruña, A;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2022QI;9.063
15 Coruña, A;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
15 Coruña, A;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
15 Coruña, A;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2021QII;""
15 Coruña, A;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2021QI;9.121
15 Coruña, A;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
15 Coruña, A;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
15 Coruña, A;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2020QII;""
15 Coruña, A;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2020QI;""
15 Coruña, A;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
15 Coruña, A;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
15 Coruña, A;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QII;8.823
15 Coruña, A;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QI;""
15 Coruña, A;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
15 Coruña, A;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
15 Coruña, A;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QII;8.931
15 Coruña, A;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QI;""
15 Coruña, A;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
15 Coruña, A;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
15 Coruña, A;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QII;""
15 Coruña, A;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QI;""
15 Coruña, A;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
15 Coruña, A;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QIII;8.633
15 Coruña, A;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QII;""
15 Coruña, A;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QI;""
15 Coruña, A;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
15 Coruña, A;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QIII;8.784
15 Coruña, A;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QII;""
15 Coruña, A;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QI;""
15 Coruña, A;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
15 Coruña, A;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
15 Coruña, A;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QII;""
15 Coruña, A;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QI;""
15 Coruña, A;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
15 Coruña, A;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
15 Coruña, A;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
15 Coruña, A;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
15 Coruña, A;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
15 Coruña, A;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
15 Coruña, A;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
15 Coruña, A;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
15 Coruña, A;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
15 Coruña, A;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
15 Coruña, A;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
15 Coruña, A;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
15 Coruña, A;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;97,07
15 Coruña, A;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
15 Coruña, A;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
15 Coruña, A;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
15 Coruña, A;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;97,37
15 Coruña, A;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
15 Coruña, A;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
15 Coruña, A;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
15 Coruña, A;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;97,59
15 Coruña, A;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
15 Coruña, A;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
15 Coruña, A;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
15 Coruña, A;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
15 Coruña, A;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
15 Coruña, A;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
15 Coruña, A;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;94,62
15 Coruña, A;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
15 Coruña, A;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
15 Coruña, A;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
15 Coruña, A;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;95,83
15 Coruña, A;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
15 Coruña, A;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
15 Coruña, A;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
15 Coruña, A;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
15 Coruña, A;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
15 Coruña, A;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
15 Coruña, A;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;92,12
15 Coruña, A;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
15 Coruña, A;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
15 Coruña, A;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
15 Coruña, A;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;93,83
15 Coruña, A;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
15 Coruña, A;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
15 Coruña, A;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
15 Coruña, A;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
15 Coruña, A;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
15 Coruña, A;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
15 Coruña, A;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;90,13
15 Coruña, A;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
15 Coruña, A;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
15 Coruña, A;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
15 Coruña, A;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;92,29
15 Coruña, A;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
15 Coruña, A;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
15 Coruña, A;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
15 Coruña, A;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
15 Coruña, A;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
15 Coruña, A;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
15 Coruña, A;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
15 Coruña, A;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
15 Coruña, A;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
15 Coruña, A;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QI;22.262
15 Coruña, A;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
15 Coruña, A;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
15 Coruña, A;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
15 Coruña, A;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QI;21.695
15 Coruña, A;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
15 Coruña, A;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
15 Coruña, A;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
15 Coruña, A;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QI;22.241
15 Coruña, A;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
15 Coruña, A;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
15 Coruña, A;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2022QII;""
15 Coruña, A;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2022QI;21.845
15 Coruña, A;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
15 Coruña, A;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
15 Coruña, A;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2021QII;""
15 Coruña, A;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2021QI;21.428
15 Coruña, A;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
15 Coruña, A;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
15 Coruña, A;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2020QII;""
15 Coruña, A;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2020QI;21.471
15 Coruña, A;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
15 Coruña, A;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
15 Coruña, A;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2022QII;21.449
15 Coruña, A;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2022QI;""
15 Coruña, A;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
15 Coruña, A;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
15 Coruña, A;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2021QII;21.117
15 Coruña, A;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2021QI;""
15 Coruña, A;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
15 Coruña, A;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
15 Coruña, A;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2020QII;21.104
15 Coruña, A;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2020QI;""
15 Coruña, A;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
15 Coruña, A;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QIII;21.087
15 Coruña, A;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QII;""
15 Coruña, A;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QI;""
15 Coruña, A;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
15 Coruña, A;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QIII;20.840
15 Coruña, A;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QII;""
15 Coruña, A;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QI;""
15 Coruña, A;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
15 Coruña, A;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QIII;20.794
15 Coruña, A;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QII;""
15 Coruña, A;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QI;""
15 Coruña, A;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QIV;20.699
15 Coruña, A;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
15 Coruña, A;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QII;""
15 Coruña, A;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QI;""
15 Coruña, A;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QIV;20.543
15 Coruña, A;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
15 Coruña, A;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QII;""
15 Coruña, A;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QI;""
15 Coruña, A;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QIV;20.475
15 Coruña, A;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
15 Coruña, A;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QII;""
15 Coruña, A;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QI;""
15 Coruña, A;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
15 Coruña, A;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
15 Coruña, A;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
15 Coruña, A;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
15 Coruña, A;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
15 Coruña, A;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
15 Coruña, A;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
15 Coruña, A;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
15 Coruña, A;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
15 Coruña, A;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
15 Coruña, A;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
15 Coruña, A;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
15 Coruña, A;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
15 Coruña, A;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
15 Coruña, A;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
15 Coruña, A;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;98,13
15 Coruña, A;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
15 Coruña, A;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
15 Coruña, A;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
15 Coruña, A;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;98,77
15 Coruña, A;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
15 Coruña, A;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
15 Coruña, A;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
15 Coruña, A;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;96,54
15 Coruña, A;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
15 Coruña, A;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
15 Coruña, A;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;96,35
15 Coruña, A;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
15 Coruña, A;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
15 Coruña, A;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
15 Coruña, A;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;97,34
15 Coruña, A;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
15 Coruña, A;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
15 Coruña, A;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
15 Coruña, A;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;94,89
15 Coruña, A;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
15 Coruña, A;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
15 Coruña, A;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;94,72
15 Coruña, A;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
15 Coruña, A;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
15 Coruña, A;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
15 Coruña, A;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;96,06
15 Coruña, A;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
15 Coruña, A;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
15 Coruña, A;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
15 Coruña, A;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;93,49
15 Coruña, A;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
15 Coruña, A;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
15 Coruña, A;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;92,98
15 Coruña, A;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
15 Coruña, A;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
15 Coruña, A;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
15 Coruña, A;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;94,69
15 Coruña, A;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
15 Coruña, A;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
15 Coruña, A;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
15 Coruña, A;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;92,06
15 Coruña, A;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
15 Coruña, A;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
15 Coruña, A;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
15 Coruña, A;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
15 Coruña, A;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
15 Coruña, A;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
15 Coruña, A;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QI;13.321
15 Coruña, A;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
15 Coruña, A;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
15 Coruña, A;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
15 Coruña, A;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QI;13.089
15 Coruña, A;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
15 Coruña, A;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
15 Coruña, A;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
15 Coruña, A;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QI;13.320
15 Coruña, A;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
15 Coruña, A;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
15 Coruña, A;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2022QII;""
15 Coruña, A;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2022QI;13.068
15 Coruña, A;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
15 Coruña, A;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
15 Coruña, A;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2021QII;""
15 Coruña, A;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2021QI;12.918
15 Coruña, A;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
15 Coruña, A;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
15 Coruña, A;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2020QII;""
15 Coruña, A;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2020QI;12.869
15 Coruña, A;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
15 Coruña, A;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
15 Coruña, A;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2022QII;12.853
15 Coruña, A;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2022QI;""
15 Coruña, A;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
15 Coruña, A;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
15 Coruña, A;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2021QII;12.742
15 Coruña, A;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2021QI;""
15 Coruña, A;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
15 Coruña, A;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
15 Coruña, A;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2020QII;12.725
15 Coruña, A;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2020QI;""
15 Coruña, A;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
15 Coruña, A;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QIII;12.655
15 Coruña, A;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QII;""
15 Coruña, A;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QI;""
15 Coruña, A;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
15 Coruña, A;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QIII;12.582
15 Coruña, A;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QII;""
15 Coruña, A;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QI;""
15 Coruña, A;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
15 Coruña, A;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QIII;12.565
15 Coruña, A;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QII;""
15 Coruña, A;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QI;""
15 Coruña, A;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QIV;12.453
15 Coruña, A;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
15 Coruña, A;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QII;""
15 Coruña, A;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QI;""
15 Coruña, A;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QIV;12.399
15 Coruña, A;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
15 Coruña, A;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QII;""
15 Coruña, A;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QI;""
15 Coruña, A;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QIV;12.376
15 Coruña, A;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
15 Coruña, A;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QII;""
15 Coruña, A;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QI;""
15 Coruña, A;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
15 Coruña, A;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
15 Coruña, A;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
15 Coruña, A;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
15 Coruña, A;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
15 Coruña, A;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
15 Coruña, A;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
15 Coruña, A;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
15 Coruña, A;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
15 Coruña, A;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
15 Coruña, A;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
15 Coruña, A;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
15 Coruña, A;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
15 Coruña, A;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
15 Coruña, A;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
15 Coruña, A;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;98,1
15 Coruña, A;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
15 Coruña, A;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
15 Coruña, A;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
15 Coruña, A;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;98,69
15 Coruña, A;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
15 Coruña, A;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
15 Coruña, A;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
15 Coruña, A;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;96,61
15 Coruña, A;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
15 Coruña, A;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
15 Coruña, A;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;96,49
15 Coruña, A;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
15 Coruña, A;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
15 Coruña, A;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
15 Coruña, A;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;97,35
15 Coruña, A;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
15 Coruña, A;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
15 Coruña, A;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
15 Coruña, A;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;95,53
15 Coruña, A;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
15 Coruña, A;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
15 Coruña, A;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;95
15 Coruña, A;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
15 Coruña, A;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
15 Coruña, A;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
15 Coruña, A;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;96,13
15 Coruña, A;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
15 Coruña, A;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
15 Coruña, A;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
15 Coruña, A;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;94,33
15 Coruña, A;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
15 Coruña, A;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
15 Coruña, A;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;93,48
15 Coruña, A;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
15 Coruña, A;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
15 Coruña, A;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
15 Coruña, A;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;94,73
15 Coruña, A;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
15 Coruña, A;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
15 Coruña, A;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
15 Coruña, A;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;92,91
15 Coruña, A;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
15 Coruña, A;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
15 Coruña, A;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
15 Coruña, A;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
15 Coruña, A;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
15 Coruña, A;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
15 Coruña, A;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QI;8.941
15 Coruña, A;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
15 Coruña, A;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
15 Coruña, A;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
15 Coruña, A;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QI;8.606
15 Coruña, A;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
15 Coruña, A;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
15 Coruña, A;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
15 Coruña, A;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QI;8.921
15 Coruña, A;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
15 Coruña, A;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
15 Coruña, A;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2022QII;""
15 Coruña, A;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2022QI;8.777
15 Coruña, A;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
15 Coruña, A;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
15 Coruña, A;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2021QII;""
15 Coruña, A;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2021QI;8.510
15 Coruña, A;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
15 Coruña, A;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
15 Coruña, A;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2020QII;""
15 Coruña, A;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2020QI;8.602
15 Coruña, A;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
15 Coruña, A;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
15 Coruña, A;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2022QII;8.596
15 Coruña, A;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2022QI;""
15 Coruña, A;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
15 Coruña, A;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
15 Coruña, A;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2021QII;8.375
15 Coruña, A;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2021QI;""
15 Coruña, A;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
15 Coruña, A;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
15 Coruña, A;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2020QII;8.379
15 Coruña, A;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2020QI;""
15 Coruña, A;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
15 Coruña, A;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QIII;8.432
15 Coruña, A;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QII;""
15 Coruña, A;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QI;""
15 Coruña, A;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
15 Coruña, A;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QIII;8.258
15 Coruña, A;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QII;""
15 Coruña, A;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QI;""
15 Coruña, A;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
15 Coruña, A;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QIII;8.229
15 Coruña, A;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QII;""
15 Coruña, A;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QI;""
15 Coruña, A;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QIV;8.246
15 Coruña, A;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
15 Coruña, A;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QII;""
15 Coruña, A;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QI;""
15 Coruña, A;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QIV;8.144
15 Coruña, A;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
15 Coruña, A;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QII;""
15 Coruña, A;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QI;""
15 Coruña, A;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QIV;8.099
15 Coruña, A;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
15 Coruña, A;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QII;""
15 Coruña, A;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QI;""
15 Coruña, A;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
15 Coruña, A;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
15 Coruña, A;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
15 Coruña, A;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
15 Coruña, A;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
15 Coruña, A;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
15 Coruña, A;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
15 Coruña, A;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
15 Coruña, A;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
15 Coruña, A;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
15 Coruña, A;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
15 Coruña, A;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
15 Coruña, A;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
15 Coruña, A;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
15 Coruña, A;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
15 Coruña, A;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;98,17
15 Coruña, A;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
15 Coruña, A;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
15 Coruña, A;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
15 Coruña, A;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;98,88
15 Coruña, A;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
15 Coruña, A;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
15 Coruña, A;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
15 Coruña, A;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;96,42
15 Coruña, A;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
15 Coruña, A;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
15 Coruña, A;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;96,14
15 Coruña, A;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
15 Coruña, A;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
15 Coruña, A;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
15 Coruña, A;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;97,32
15 Coruña, A;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
15 Coruña, A;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
15 Coruña, A;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
15 Coruña, A;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;93,92
15 Coruña, A;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
15 Coruña, A;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
15 Coruña, A;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;94,31
15 Coruña, A;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
15 Coruña, A;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
15 Coruña, A;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
15 Coruña, A;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;95,96
15 Coruña, A;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
15 Coruña, A;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
15 Coruña, A;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
15 Coruña, A;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;92,24
15 Coruña, A;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
15 Coruña, A;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
15 Coruña, A;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;92,23
15 Coruña, A;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
15 Coruña, A;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
15 Coruña, A;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
15 Coruña, A;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;94,63
15 Coruña, A;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
15 Coruña, A;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
15 Coruña, A;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
15 Coruña, A;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;90,79
15 Coruña, A;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
15 Coruña, A;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
15 Coruña, A;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
15 Coruña, A;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
15 Coruña, A;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
15 Coruña, A;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QII;22.730
15 Coruña, A;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
15 Coruña, A;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
15 Coruña, A;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
15 Coruña, A;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QII;22.296
15 Coruña, A;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
15 Coruña, A;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
15 Coruña, A;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
15 Coruña, A;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QII;21.970
15 Coruña, A;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
15 Coruña, A;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
15 Coruña, A;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
15 Coruña, A;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2022QII;22.303
15 Coruña, A;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2022QI;""
15 Coruña, A;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
15 Coruña, A;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
15 Coruña, A;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2021QII;21.943
15 Coruña, A;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2021QI;""
15 Coruña, A;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
15 Coruña, A;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
15 Coruña, A;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2020QII;21.586
15 Coruña, A;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2020QI;""
15 Coruña, A;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
15 Coruña, A;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2022QIII;21.911
15 Coruña, A;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2022QII;""
15 Coruña, A;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2022QI;""
15 Coruña, A;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
15 Coruña, A;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2021QIII;21.649
15 Coruña, A;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2021QII;""
15 Coruña, A;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2021QI;""
15 Coruña, A;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
15 Coruña, A;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2020QIII;21.218
15 Coruña, A;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2020QII;""
15 Coruña, A;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2020QI;""
15 Coruña, A;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QIV;21.482
15 Coruña, A;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
15 Coruña, A;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QII;""
15 Coruña, A;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QI;""
15 Coruña, A;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QIV;21.321
15 Coruña, A;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
15 Coruña, A;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QII;""
15 Coruña, A;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QI;""
15 Coruña, A;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QIV;20.879
15 Coruña, A;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
15 Coruña, A;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QII;""
15 Coruña, A;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QI;""
15 Coruña, A;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
15 Coruña, A;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
15 Coruña, A;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QII;""
15 Coruña, A;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QI;20.970
15 Coruña, A;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
15 Coruña, A;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
15 Coruña, A;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QII;""
15 Coruña, A;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QI;20.661
15 Coruña, A;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
15 Coruña, A;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
15 Coruña, A;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QII;""
15 Coruña, A;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QI;""
15 Coruña, A;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
15 Coruña, A;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
15 Coruña, A;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
15 Coruña, A;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
15 Coruña, A;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
15 Coruña, A;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
15 Coruña, A;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
15 Coruña, A;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
15 Coruña, A;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
15 Coruña, A;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
15 Coruña, A;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
15 Coruña, A;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
15 Coruña, A;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
15 Coruña, A;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
15 Coruña, A;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;98,12
15 Coruña, A;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
15 Coruña, A;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
15 Coruña, A;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
15 Coruña, A;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;98,42
15 Coruña, A;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
15 Coruña, A;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
15 Coruña, A;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
15 Coruña, A;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;98,25
15 Coruña, A;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
15 Coruña, A;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
15 Coruña, A;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;96,4
15 Coruña, A;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
15 Coruña, A;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
15 Coruña, A;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
15 Coruña, A;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;97,1
15 Coruña, A;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
15 Coruña, A;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
15 Coruña, A;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
15 Coruña, A;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;96,58
15 Coruña, A;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
15 Coruña, A;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
15 Coruña, A;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;94,51
15 Coruña, A;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
15 Coruña, A;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
15 Coruña, A;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
15 Coruña, A;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;95,63
15 Coruña, A;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
15 Coruña, A;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
15 Coruña, A;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
15 Coruña, A;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;95,03
15 Coruña, A;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
15 Coruña, A;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
15 Coruña, A;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
15 Coruña, A;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
15 Coruña, A;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
15 Coruña, A;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
15 Coruña, A;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;94,05
15 Coruña, A;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
15 Coruña, A;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
15 Coruña, A;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
15 Coruña, A;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;94,04
15 Coruña, A;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
15 Coruña, A;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
15 Coruña, A;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
15 Coruña, A;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
15 Coruña, A;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
15 Coruña, A;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
15 Coruña, A;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QII;13.599
15 Coruña, A;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
15 Coruña, A;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
15 Coruña, A;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
15 Coruña, A;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QII;13.361
15 Coruña, A;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
15 Coruña, A;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
15 Coruña, A;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
15 Coruña, A;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QII;13.154
15 Coruña, A;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
15 Coruña, A;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
15 Coruña, A;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
15 Coruña, A;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2022QII;13.370
15 Coruña, A;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2022QI;""
15 Coruña, A;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
15 Coruña, A;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
15 Coruña, A;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2021QII;13.157
15 Coruña, A;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2021QI;""
15 Coruña, A;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
15 Coruña, A;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
15 Coruña, A;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2020QII;13.002
15 Coruña, A;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2020QI;""
15 Coruña, A;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
15 Coruña, A;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2022QIII;13.156
15 Coruña, A;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2022QII;""
15 Coruña, A;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2022QI;""
15 Coruña, A;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
15 Coruña, A;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2021QIII;12.993
15 Coruña, A;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2021QII;""
15 Coruña, A;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2021QI;""
15 Coruña, A;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
15 Coruña, A;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2020QIII;12.797
15 Coruña, A;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2020QII;""
15 Coruña, A;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2020QI;""
15 Coruña, A;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QIV;12.928
15 Coruña, A;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
15 Coruña, A;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QII;""
15 Coruña, A;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QI;""
15 Coruña, A;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QIV;12.798
15 Coruña, A;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
15 Coruña, A;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QII;""
15 Coruña, A;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QI;""
15 Coruña, A;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QIV;12.596
15 Coruña, A;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
15 Coruña, A;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QII;""
15 Coruña, A;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QI;""
15 Coruña, A;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
15 Coruña, A;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
15 Coruña, A;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QII;""
15 Coruña, A;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QI;12.591
15 Coruña, A;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
15 Coruña, A;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
15 Coruña, A;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QII;""
15 Coruña, A;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QI;12.460
15 Coruña, A;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
15 Coruña, A;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
15 Coruña, A;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QII;""
15 Coruña, A;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QI;""
15 Coruña, A;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
15 Coruña, A;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
15 Coruña, A;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
15 Coruña, A;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
15 Coruña, A;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
15 Coruña, A;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
15 Coruña, A;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
15 Coruña, A;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
15 Coruña, A;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
15 Coruña, A;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
15 Coruña, A;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
15 Coruña, A;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
15 Coruña, A;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
15 Coruña, A;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
15 Coruña, A;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;98,32
15 Coruña, A;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
15 Coruña, A;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
15 Coruña, A;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
15 Coruña, A;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;98,47
15 Coruña, A;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
15 Coruña, A;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
15 Coruña, A;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
15 Coruña, A;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;98,84
15 Coruña, A;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
15 Coruña, A;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
15 Coruña, A;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;96,74
15 Coruña, A;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
15 Coruña, A;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
15 Coruña, A;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
15 Coruña, A;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;97,25
15 Coruña, A;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
15 Coruña, A;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
15 Coruña, A;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
15 Coruña, A;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;97,29
15 Coruña, A;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
15 Coruña, A;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
15 Coruña, A;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;95,07
15 Coruña, A;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
15 Coruña, A;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
15 Coruña, A;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
15 Coruña, A;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;95,79
15 Coruña, A;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
15 Coruña, A;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
15 Coruña, A;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
15 Coruña, A;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;95,76
15 Coruña, A;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
15 Coruña, A;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
15 Coruña, A;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
15 Coruña, A;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
15 Coruña, A;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
15 Coruña, A;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
15 Coruña, A;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;94,24
15 Coruña, A;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
15 Coruña, A;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
15 Coruña, A;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
15 Coruña, A;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;94,72
15 Coruña, A;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
15 Coruña, A;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
15 Coruña, A;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
15 Coruña, A;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
15 Coruña, A;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
15 Coruña, A;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
15 Coruña, A;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QII;9.131
15 Coruña, A;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
15 Coruña, A;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
15 Coruña, A;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
15 Coruña, A;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QII;8.935
15 Coruña, A;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
15 Coruña, A;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
15 Coruña, A;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
15 Coruña, A;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QII;8.816
15 Coruña, A;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
15 Coruña, A;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
15 Coruña, A;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
15 Coruña, A;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2022QII;8.933
15 Coruña, A;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2022QI;""
15 Coruña, A;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
15 Coruña, A;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
15 Coruña, A;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2021QII;8.786
15 Coruña, A;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2021QI;""
15 Coruña, A;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
15 Coruña, A;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
15 Coruña, A;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2020QII;8.584
15 Coruña, A;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2020QI;""
15 Coruña, A;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
15 Coruña, A;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2022QIII;8.755
15 Coruña, A;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2022QII;""
15 Coruña, A;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2022QI;""
15 Coruña, A;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
15 Coruña, A;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2021QIII;8.656
15 Coruña, A;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2021QII;""
15 Coruña, A;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2021QI;""
15 Coruña, A;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
15 Coruña, A;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2020QIII;8.421
15 Coruña, A;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2020QII;""
15 Coruña, A;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2020QI;""
15 Coruña, A;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QIV;8.554
15 Coruña, A;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
15 Coruña, A;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QII;""
15 Coruña, A;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QI;""
15 Coruña, A;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QIV;8.523
15 Coruña, A;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
15 Coruña, A;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QII;""
15 Coruña, A;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QI;""
15 Coruña, A;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QIV;8.283
15 Coruña, A;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
15 Coruña, A;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QII;""
15 Coruña, A;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QI;""
15 Coruña, A;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
15 Coruña, A;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
15 Coruña, A;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QII;""
15 Coruña, A;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QI;8.379
15 Coruña, A;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
15 Coruña, A;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
15 Coruña, A;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QII;""
15 Coruña, A;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QI;8.201
15 Coruña, A;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
15 Coruña, A;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
15 Coruña, A;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QII;""
15 Coruña, A;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QI;""
15 Coruña, A;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
15 Coruña, A;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
15 Coruña, A;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
15 Coruña, A;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
15 Coruña, A;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
15 Coruña, A;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
15 Coruña, A;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
15 Coruña, A;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
15 Coruña, A;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
15 Coruña, A;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
15 Coruña, A;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
15 Coruña, A;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
15 Coruña, A;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
15 Coruña, A;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
15 Coruña, A;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;97,83
15 Coruña, A;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
15 Coruña, A;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
15 Coruña, A;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
15 Coruña, A;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;98,33
15 Coruña, A;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
15 Coruña, A;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
15 Coruña, A;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
15 Coruña, A;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;97,37
15 Coruña, A;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
15 Coruña, A;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
15 Coruña, A;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;95,88
15 Coruña, A;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
15 Coruña, A;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
15 Coruña, A;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
15 Coruña, A;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;96,88
15 Coruña, A;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
15 Coruña, A;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
15 Coruña, A;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
15 Coruña, A;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;95,52
15 Coruña, A;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
15 Coruña, A;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
15 Coruña, A;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;93,68
15 Coruña, A;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
15 Coruña, A;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
15 Coruña, A;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
15 Coruña, A;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;95,39
15 Coruña, A;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
15 Coruña, A;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
15 Coruña, A;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
15 Coruña, A;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;93,95
15 Coruña, A;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
15 Coruña, A;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
15 Coruña, A;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
15 Coruña, A;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
15 Coruña, A;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
15 Coruña, A;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
15 Coruña, A;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;93,78
15 Coruña, A;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
15 Coruña, A;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
15 Coruña, A;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
15 Coruña, A;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;93,02
15 Coruña, A;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
15 Coruña, A;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
15 Coruña, A;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
15 Coruña, A;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
15 Coruña, A;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
15 Coruña, A;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QIII;22.729
15 Coruña, A;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
15 Coruña, A;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
15 Coruña, A;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
15 Coruña, A;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QIII;22.336
15 Coruña, A;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
15 Coruña, A;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
15 Coruña, A;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
15 Coruña, A;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QIII;21.868
15 Coruña, A;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
15 Coruña, A;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
15 Coruña, A;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
15 Coruña, A;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2022QIII;22.277
15 Coruña, A;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2022QII;""
15 Coruña, A;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2022QI;""
15 Coruña, A;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
15 Coruña, A;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2021QIII;21.982
15 Coruña, A;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2021QII;""
15 Coruña, A;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2021QI;""
15 Coruña, A;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
15 Coruña, A;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2020QIII;21.446
15 Coruña, A;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2020QII;""
15 Coruña, A;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2020QI;""
15 Coruña, A;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2022QIV;21.795
15 Coruña, A;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
15 Coruña, A;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2022QII;""
15 Coruña, A;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2022QI;""
15 Coruña, A;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2021QIV;21.627
15 Coruña, A;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
15 Coruña, A;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2021QII;""
15 Coruña, A;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2021QI;""
15 Coruña, A;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2020QIV;21.083
15 Coruña, A;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
15 Coruña, A;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2020QII;""
15 Coruña, A;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2020QI;""
15 Coruña, A;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
15 Coruña, A;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
15 Coruña, A;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QII;""
15 Coruña, A;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QI;21.258
15 Coruña, A;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
15 Coruña, A;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
15 Coruña, A;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QII;""
15 Coruña, A;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QI;20.856
15 Coruña, A;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
15 Coruña, A;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
15 Coruña, A;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QII;""
15 Coruña, A;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QI;""
15 Coruña, A;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
15 Coruña, A;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
15 Coruña, A;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QII;20.924
15 Coruña, A;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QI;""
15 Coruña, A;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
15 Coruña, A;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
15 Coruña, A;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QII;20.587
15 Coruña, A;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QI;""
15 Coruña, A;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
15 Coruña, A;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
15 Coruña, A;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QII;""
15 Coruña, A;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QI;""
15 Coruña, A;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
15 Coruña, A;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
15 Coruña, A;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
15 Coruña, A;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
15 Coruña, A;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
15 Coruña, A;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
15 Coruña, A;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
15 Coruña, A;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
15 Coruña, A;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
15 Coruña, A;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
15 Coruña, A;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
15 Coruña, A;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
15 Coruña, A;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
15 Coruña, A;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;98,01
15 Coruña, A;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
15 Coruña, A;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
15 Coruña, A;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
15 Coruña, A;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;98,42
15 Coruña, A;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
15 Coruña, A;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
15 Coruña, A;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
15 Coruña, A;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;98,07
15 Coruña, A;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
15 Coruña, A;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
15 Coruña, A;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;95,89
15 Coruña, A;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
15 Coruña, A;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
15 Coruña, A;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
15 Coruña, A;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;96,83
15 Coruña, A;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
15 Coruña, A;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
15 Coruña, A;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
15 Coruña, A;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;96,41
15 Coruña, A;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
15 Coruña, A;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
15 Coruña, A;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
15 Coruña, A;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
15 Coruña, A;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
15 Coruña, A;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
15 Coruña, A;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;95,17
15 Coruña, A;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
15 Coruña, A;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
15 Coruña, A;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
15 Coruña, A;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;95,37
15 Coruña, A;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
15 Coruña, A;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
15 Coruña, A;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
15 Coruña, A;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
15 Coruña, A;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
15 Coruña, A;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
15 Coruña, A;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;93,68
15 Coruña, A;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
15 Coruña, A;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
15 Coruña, A;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
15 Coruña, A;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;94,14
15 Coruña, A;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
15 Coruña, A;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
15 Coruña, A;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
15 Coruña, A;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
15 Coruña, A;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
15 Coruña, A;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
15 Coruña, A;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QIII;13.590
15 Coruña, A;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
15 Coruña, A;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
15 Coruña, A;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
15 Coruña, A;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QIII;13.372
15 Coruña, A;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
15 Coruña, A;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
15 Coruña, A;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
15 Coruña, A;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QIII;13.187
15 Coruña, A;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
15 Coruña, A;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
15 Coruña, A;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
15 Coruña, A;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2022QIII;13.345
15 Coruña, A;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2022QII;""
15 Coruña, A;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2022QI;""
15 Coruña, A;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
15 Coruña, A;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2021QIII;13.173
15 Coruña, A;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2021QII;""
15 Coruña, A;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2021QI;""
15 Coruña, A;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
15 Coruña, A;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2020QIII;12.950
15 Coruña, A;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2020QII;""
15 Coruña, A;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2020QI;""
15 Coruña, A;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2022QIV;13.084
15 Coruña, A;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
15 Coruña, A;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2022QII;""
15 Coruña, A;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2022QI;""
15 Coruña, A;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2021QIV;12.962
15 Coruña, A;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
15 Coruña, A;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2021QII;""
15 Coruña, A;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2021QI;""
15 Coruña, A;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2020QIV;12.733
15 Coruña, A;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
15 Coruña, A;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2020QII;""
15 Coruña, A;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2020QI;""
15 Coruña, A;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
15 Coruña, A;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
15 Coruña, A;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QII;""
15 Coruña, A;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QI;12.742
15 Coruña, A;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
15 Coruña, A;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
15 Coruña, A;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QII;""
15 Coruña, A;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QI;12.590
15 Coruña, A;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
15 Coruña, A;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
15 Coruña, A;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QII;""
15 Coruña, A;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QI;""
15 Coruña, A;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
15 Coruña, A;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
15 Coruña, A;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QII;12.552
15 Coruña, A;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QI;""
15 Coruña, A;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
15 Coruña, A;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
15 Coruña, A;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QII;12.434
15 Coruña, A;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QI;""
15 Coruña, A;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
15 Coruña, A;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
15 Coruña, A;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QII;""
15 Coruña, A;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QI;""
15 Coruña, A;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
15 Coruña, A;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
15 Coruña, A;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
15 Coruña, A;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
15 Coruña, A;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
15 Coruña, A;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
15 Coruña, A;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
15 Coruña, A;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
15 Coruña, A;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
15 Coruña, A;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
15 Coruña, A;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
15 Coruña, A;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
15 Coruña, A;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
15 Coruña, A;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;98,2
15 Coruña, A;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
15 Coruña, A;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
15 Coruña, A;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
15 Coruña, A;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;98,51
15 Coruña, A;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
15 Coruña, A;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
15 Coruña, A;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
15 Coruña, A;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;98,2
15 Coruña, A;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
15 Coruña, A;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
15 Coruña, A;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;96,28
15 Coruña, A;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
15 Coruña, A;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
15 Coruña, A;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
15 Coruña, A;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;96,93
15 Coruña, A;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
15 Coruña, A;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
15 Coruña, A;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
15 Coruña, A;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;96,56
15 Coruña, A;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
15 Coruña, A;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
15 Coruña, A;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
15 Coruña, A;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
15 Coruña, A;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
15 Coruña, A;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
15 Coruña, A;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;95,29
15 Coruña, A;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
15 Coruña, A;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
15 Coruña, A;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
15 Coruña, A;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;95,47
15 Coruña, A;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
15 Coruña, A;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
15 Coruña, A;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
15 Coruña, A;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
15 Coruña, A;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
15 Coruña, A;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
15 Coruña, A;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;93,87
15 Coruña, A;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
15 Coruña, A;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
15 Coruña, A;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
15 Coruña, A;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;94,29
15 Coruña, A;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
15 Coruña, A;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
15 Coruña, A;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
15 Coruña, A;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
15 Coruña, A;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
15 Coruña, A;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
15 Coruña, A;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QIII;9.139
15 Coruña, A;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
15 Coruña, A;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
15 Coruña, A;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
15 Coruña, A;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QIII;8.964
15 Coruña, A;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
15 Coruña, A;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
15 Coruña, A;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
15 Coruña, A;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QIII;8.681
15 Coruña, A;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
15 Coruña, A;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
15 Coruña, A;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
15 Coruña, A;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2022QIII;8.932
15 Coruña, A;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2022QII;""
15 Coruña, A;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2022QI;""
15 Coruña, A;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
15 Coruña, A;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2021QIII;8.809
15 Coruña, A;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2021QII;""
15 Coruña, A;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2021QI;""
15 Coruña, A;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
15 Coruña, A;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2020QIII;8.496
15 Coruña, A;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2020QII;""
15 Coruña, A;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2020QI;""
15 Coruña, A;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2022QIV;8.711
15 Coruña, A;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
15 Coruña, A;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2022QII;""
15 Coruña, A;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2022QI;""
15 Coruña, A;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2021QIV;8.665
15 Coruña, A;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
15 Coruña, A;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2021QII;""
15 Coruña, A;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2021QI;""
15 Coruña, A;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2020QIV;8.350
15 Coruña, A;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
15 Coruña, A;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2020QII;""
15 Coruña, A;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2020QI;""
15 Coruña, A;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
15 Coruña, A;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
15 Coruña, A;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QII;""
15 Coruña, A;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QI;8.516
15 Coruña, A;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
15 Coruña, A;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
15 Coruña, A;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QII;""
15 Coruña, A;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QI;8.266
15 Coruña, A;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
15 Coruña, A;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
15 Coruña, A;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QII;""
15 Coruña, A;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QI;""
15 Coruña, A;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
15 Coruña, A;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
15 Coruña, A;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QII;8.372
15 Coruña, A;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QI;""
15 Coruña, A;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
15 Coruña, A;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
15 Coruña, A;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QII;8.153
15 Coruña, A;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QI;""
15 Coruña, A;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
15 Coruña, A;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
15 Coruña, A;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QII;""
15 Coruña, A;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QI;""
15 Coruña, A;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
15 Coruña, A;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
15 Coruña, A;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
15 Coruña, A;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
15 Coruña, A;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
15 Coruña, A;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
15 Coruña, A;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
15 Coruña, A;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
15 Coruña, A;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
15 Coruña, A;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
15 Coruña, A;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
15 Coruña, A;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
15 Coruña, A;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
15 Coruña, A;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;97,73
15 Coruña, A;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
15 Coruña, A;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
15 Coruña, A;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
15 Coruña, A;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;98,27
15 Coruña, A;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
15 Coruña, A;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
15 Coruña, A;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
15 Coruña, A;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;97,87
15 Coruña, A;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
15 Coruña, A;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
15 Coruña, A;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;95,32
15 Coruña, A;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
15 Coruña, A;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
15 Coruña, A;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
15 Coruña, A;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;96,66
15 Coruña, A;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
15 Coruña, A;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
15 Coruña, A;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
15 Coruña, A;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;96,19
15 Coruña, A;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
15 Coruña, A;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
15 Coruña, A;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
15 Coruña, A;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
15 Coruña, A;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
15 Coruña, A;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
15 Coruña, A;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;95
15 Coruña, A;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
15 Coruña, A;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
15 Coruña, A;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
15 Coruña, A;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;95,22
15 Coruña, A;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
15 Coruña, A;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
15 Coruña, A;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
15 Coruña, A;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
15 Coruña, A;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
15 Coruña, A;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
15 Coruña, A;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;93,4
15 Coruña, A;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
15 Coruña, A;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
15 Coruña, A;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
15 Coruña, A;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;93,92
15 Coruña, A;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
15 Coruña, A;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
15 Coruña, A;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
15 Coruña, A;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
15 Coruña, A;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
15 Coruña, A;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QIV;22.591
15 Coruña, A;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
15 Coruña, A;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
15 Coruña, A;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
15 Coruña, A;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QIV;22.307
15 Coruña, A;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
15 Coruña, A;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
15 Coruña, A;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
15 Coruña, A;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QIV;21.764
15 Coruña, A;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
15 Coruña, A;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
15 Coruña, A;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
15 Coruña, A;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2022QIV;22.068
15 Coruña, A;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
15 Coruña, A;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2022QII;""
15 Coruña, A;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2022QI;""
15 Coruña, A;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2021QIV;21.919
15 Coruña, A;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
15 Coruña, A;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2021QII;""
15 Coruña, A;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2021QI;""
15 Coruña, A;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2020QIV;21.373
15 Coruña, A;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
15 Coruña, A;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2020QII;""
15 Coruña, A;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2020QI;""
15 Coruña, A;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
15 Coruña, A;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
15 Coruña, A;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2022QII;""
15 Coruña, A;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2022QI;21.538
15 Coruña, A;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
15 Coruña, A;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
15 Coruña, A;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2021QII;""
15 Coruña, A;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2021QI;21.125
15 Coruña, A;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
15 Coruña, A;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
15 Coruña, A;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2020QII;""
15 Coruña, A;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2020QI;""
15 Coruña, A;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
15 Coruña, A;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
15 Coruña, A;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QII;21.176
15 Coruña, A;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QI;""
15 Coruña, A;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
15 Coruña, A;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
15 Coruña, A;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QII;20.834
15 Coruña, A;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QI;""
15 Coruña, A;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
15 Coruña, A;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
15 Coruña, A;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QII;""
15 Coruña, A;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QI;""
15 Coruña, A;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
15 Coruña, A;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QIII;20.825
15 Coruña, A;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QII;""
15 Coruña, A;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QI;""
15 Coruña, A;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
15 Coruña, A;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QIII;20.570
15 Coruña, A;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QII;""
15 Coruña, A;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QI;""
15 Coruña, A;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
15 Coruña, A;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
15 Coruña, A;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QII;""
15 Coruña, A;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QI;""
15 Coruña, A;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
15 Coruña, A;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
15 Coruña, A;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
15 Coruña, A;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
15 Coruña, A;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
15 Coruña, A;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
15 Coruña, A;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
15 Coruña, A;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
15 Coruña, A;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
15 Coruña, A;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
15 Coruña, A;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
15 Coruña, A;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
15 Coruña, A;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;97,68
15 Coruña, A;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
15 Coruña, A;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
15 Coruña, A;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
15 Coruña, A;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;98,26
15 Coruña, A;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
15 Coruña, A;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
15 Coruña, A;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
15 Coruña, A;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;98,2
15 Coruña, A;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
15 Coruña, A;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
15 Coruña, A;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
15 Coruña, A;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
15 Coruña, A;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
15 Coruña, A;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
15 Coruña, A;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;96,55
15 Coruña, A;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
15 Coruña, A;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
15 Coruña, A;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
15 Coruña, A;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;97,06
15 Coruña, A;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
15 Coruña, A;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
15 Coruña, A;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
15 Coruña, A;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
15 Coruña, A;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
15 Coruña, A;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
15 Coruña, A;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;94,93
15 Coruña, A;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
15 Coruña, A;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
15 Coruña, A;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
15 Coruña, A;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;95,73
15 Coruña, A;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
15 Coruña, A;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
15 Coruña, A;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
15 Coruña, A;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
15 Coruña, A;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
15 Coruña, A;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
15 Coruña, A;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;93,36
15 Coruña, A;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
15 Coruña, A;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
15 Coruña, A;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
15 Coruña, A;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;94,51
15 Coruña, A;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
15 Coruña, A;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
15 Coruña, A;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
15 Coruña, A;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
15 Coruña, A;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
15 Coruña, A;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
15 Coruña, A;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QIV;13.528
15 Coruña, A;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
15 Coruña, A;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
15 Coruña, A;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
15 Coruña, A;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QIV;13.353
15 Coruña, A;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
15 Coruña, A;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
15 Coruña, A;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
15 Coruña, A;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QIV;13.138
15 Coruña, A;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
15 Coruña, A;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
15 Coruña, A;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
15 Coruña, A;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2022QIV;13.241
15 Coruña, A;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
15 Coruña, A;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2022QII;""
15 Coruña, A;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2022QI;""
15 Coruña, A;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2021QIV;13.126
15 Coruña, A;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
15 Coruña, A;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2021QII;""
15 Coruña, A;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2021QI;""
15 Coruña, A;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2020QIV;12.905
15 Coruña, A;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
15 Coruña, A;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2020QII;""
15 Coruña, A;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2020QI;""
15 Coruña, A;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
15 Coruña, A;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
15 Coruña, A;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2022QII;""
15 Coruña, A;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2022QI;12.899
15 Coruña, A;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
15 Coruña, A;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
15 Coruña, A;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2021QII;""
15 Coruña, A;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2021QI;12.747
15 Coruña, A;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
15 Coruña, A;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
15 Coruña, A;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2020QII;""
15 Coruña, A;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2020QI;""
15 Coruña, A;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
15 Coruña, A;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
15 Coruña, A;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QII;12.696
15 Coruña, A;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QI;""
15 Coruña, A;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
15 Coruña, A;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
15 Coruña, A;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QII;12.580
15 Coruña, A;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QI;""
15 Coruña, A;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
15 Coruña, A;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
15 Coruña, A;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QII;""
15 Coruña, A;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QI;""
15 Coruña, A;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
15 Coruña, A;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QIII;12.504
15 Coruña, A;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QII;""
15 Coruña, A;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QI;""
15 Coruña, A;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
15 Coruña, A;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QIII;12.425
15 Coruña, A;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QII;""
15 Coruña, A;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QI;""
15 Coruña, A;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
15 Coruña, A;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
15 Coruña, A;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QII;""
15 Coruña, A;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QI;""
15 Coruña, A;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
15 Coruña, A;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
15 Coruña, A;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
15 Coruña, A;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
15 Coruña, A;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
15 Coruña, A;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
15 Coruña, A;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
15 Coruña, A;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
15 Coruña, A;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
15 Coruña, A;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
15 Coruña, A;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
15 Coruña, A;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
15 Coruña, A;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;97,88
15 Coruña, A;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
15 Coruña, A;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
15 Coruña, A;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
15 Coruña, A;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;98,3
15 Coruña, A;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
15 Coruña, A;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
15 Coruña, A;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
15 Coruña, A;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;98,23
15 Coruña, A;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
15 Coruña, A;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
15 Coruña, A;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
15 Coruña, A;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
15 Coruña, A;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
15 Coruña, A;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
15 Coruña, A;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;96,6
15 Coruña, A;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
15 Coruña, A;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
15 Coruña, A;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
15 Coruña, A;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;97,02
15 Coruña, A;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
15 Coruña, A;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
15 Coruña, A;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
15 Coruña, A;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
15 Coruña, A;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
15 Coruña, A;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
15 Coruña, A;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;95,08
15 Coruña, A;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
15 Coruña, A;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
15 Coruña, A;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
15 Coruña, A;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;95,75
15 Coruña, A;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
15 Coruña, A;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
15 Coruña, A;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
15 Coruña, A;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
15 Coruña, A;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
15 Coruña, A;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
15 Coruña, A;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;93,64
15 Coruña, A;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
15 Coruña, A;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
15 Coruña, A;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
15 Coruña, A;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;94,57
15 Coruña, A;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
15 Coruña, A;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
15 Coruña, A;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
15 Coruña, A;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
15 Coruña, A;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
15 Coruña, A;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
15 Coruña, A;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QIV;9.063
15 Coruña, A;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
15 Coruña, A;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
15 Coruña, A;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
15 Coruña, A;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QIV;8.954
15 Coruña, A;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
15 Coruña, A;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
15 Coruña, A;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
15 Coruña, A;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QIV;8.626
15 Coruña, A;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
15 Coruña, A;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
15 Coruña, A;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
15 Coruña, A;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2022QIV;8.827
15 Coruña, A;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
15 Coruña, A;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2022QII;""
15 Coruña, A;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2022QI;""
15 Coruña, A;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2021QIV;8.793
15 Coruña, A;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
15 Coruña, A;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2021QII;""
15 Coruña, A;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2021QI;""
15 Coruña, A;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2020QIV;8.468
15 Coruña, A;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
15 Coruña, A;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2020QII;""
15 Coruña, A;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2020QI;""
15 Coruña, A;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
15 Coruña, A;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
15 Coruña, A;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2022QII;""
15 Coruña, A;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2022QI;8.639
15 Coruña, A;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
15 Coruña, A;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
15 Coruña, A;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2021QII;""
15 Coruña, A;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2021QI;8.378
15 Coruña, A;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
15 Coruña, A;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
15 Coruña, A;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2020QII;""
15 Coruña, A;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2020QI;""
15 Coruña, A;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
15 Coruña, A;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
15 Coruña, A;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QII;8.480
15 Coruña, A;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QI;""
15 Coruña, A;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
15 Coruña, A;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
15 Coruña, A;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QII;8.254
15 Coruña, A;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QI;""
15 Coruña, A;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
15 Coruña, A;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
15 Coruña, A;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QII;""
15 Coruña, A;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QI;""
15 Coruña, A;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
15 Coruña, A;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QIII;8.321
15 Coruña, A;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QII;""
15 Coruña, A;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QI;""
15 Coruña, A;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
15 Coruña, A;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QIII;8.145
15 Coruña, A;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QII;""
15 Coruña, A;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QI;""
15 Coruña, A;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
15 Coruña, A;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
15 Coruña, A;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QII;""
15 Coruña, A;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QI;""
15 Coruña, A;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
15 Coruña, A;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
15 Coruña, A;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
15 Coruña, A;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
15 Coruña, A;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
15 Coruña, A;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
15 Coruña, A;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
15 Coruña, A;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
15 Coruña, A;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
15 Coruña, A;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
15 Coruña, A;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
15 Coruña, A;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
15 Coruña, A;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;97,4
15 Coruña, A;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
15 Coruña, A;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
15 Coruña, A;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
15 Coruña, A;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;98,2
15 Coruña, A;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
15 Coruña, A;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
15 Coruña, A;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
15 Coruña, A;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;98,17
15 Coruña, A;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
15 Coruña, A;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
15 Coruña, A;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
15 Coruña, A;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
15 Coruña, A;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
15 Coruña, A;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
15 Coruña, A;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;96,48
15 Coruña, A;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
15 Coruña, A;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
15 Coruña, A;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
15 Coruña, A;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;97,12
15 Coruña, A;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
15 Coruña, A;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
15 Coruña, A;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
15 Coruña, A;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
15 Coruña, A;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
15 Coruña, A;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
15 Coruña, A;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;94,71
15 Coruña, A;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
15 Coruña, A;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
15 Coruña, A;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
15 Coruña, A;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;95,69
15 Coruña, A;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
15 Coruña, A;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
15 Coruña, A;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
15 Coruña, A;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
15 Coruña, A;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
15 Coruña, A;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
15 Coruña, A;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;92,93
15 Coruña, A;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
15 Coruña, A;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
15 Coruña, A;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
15 Coruña, A;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;94,42
15 Coruña, A;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
15 Coruña, A;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
15 Coruña, A;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
15 Coruña, A;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
15 Coruña, A;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
15 Coruña, A;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
15 Coruña, A;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
15 Coruña, A;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
15 Coruña, A;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
15 Coruña, A;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QI;11.712
15 Coruña, A;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
15 Coruña, A;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
15 Coruña, A;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
15 Coruña, A;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QI;11.174
15 Coruña, A;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
15 Coruña, A;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
15 Coruña, A;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
15 Coruña, A;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QI;12.929
15 Coruña, A;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
15 Coruña, A;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
15 Coruña, A;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2022QII;""
15 Coruña, A;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2022QI;11.302
15 Coruña, A;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
15 Coruña, A;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
15 Coruña, A;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2021QII;""
15 Coruña, A;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2021QI;10.838
15 Coruña, A;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
15 Coruña, A;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
15 Coruña, A;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2020QII;""
15 Coruña, A;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2020QI;12.216
15 Coruña, A;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
15 Coruña, A;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
15 Coruña, A;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2022QII;10.921
15 Coruña, A;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2022QI;""
15 Coruña, A;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
15 Coruña, A;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
15 Coruña, A;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2021QII;10.485
15 Coruña, A;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2021QI;""
15 Coruña, A;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
15 Coruña, A;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
15 Coruña, A;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2020QII;11.760
15 Coruña, A;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2020QI;""
15 Coruña, A;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
15 Coruña, A;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QIII;10.545
15 Coruña, A;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QII;""
15 Coruña, A;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QI;""
15 Coruña, A;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
15 Coruña, A;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QIII;10.132
15 Coruña, A;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QII;""
15 Coruña, A;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QI;""
15 Coruña, A;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
15 Coruña, A;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QIII;11.346
15 Coruña, A;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QII;""
15 Coruña, A;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QI;""
15 Coruña, A;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QIV;9.927
15 Coruña, A;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
15 Coruña, A;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QII;""
15 Coruña, A;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QI;""
15 Coruña, A;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QIV;9.641
15 Coruña, A;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
15 Coruña, A;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QII;""
15 Coruña, A;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QI;""
15 Coruña, A;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QIV;10.821
15 Coruña, A;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
15 Coruña, A;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QII;""
15 Coruña, A;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QI;""
15 Coruña, A;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
15 Coruña, A;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
15 Coruña, A;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
15 Coruña, A;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
15 Coruña, A;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
15 Coruña, A;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
15 Coruña, A;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
15 Coruña, A;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
15 Coruña, A;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
15 Coruña, A;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
15 Coruña, A;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
15 Coruña, A;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
15 Coruña, A;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
15 Coruña, A;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
15 Coruña, A;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
15 Coruña, A;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;96,5
15 Coruña, A;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
15 Coruña, A;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
15 Coruña, A;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
15 Coruña, A;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;96,99
15 Coruña, A;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
15 Coruña, A;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
15 Coruña, A;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
15 Coruña, A;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;94,49
15 Coruña, A;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
15 Coruña, A;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
15 Coruña, A;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;93,25
15 Coruña, A;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
15 Coruña, A;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
15 Coruña, A;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
15 Coruña, A;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;93,83
15 Coruña, A;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
15 Coruña, A;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
15 Coruña, A;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
15 Coruña, A;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;90,96
15 Coruña, A;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
15 Coruña, A;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
15 Coruña, A;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;90,04
15 Coruña, A;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
15 Coruña, A;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
15 Coruña, A;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
15 Coruña, A;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;90,67
15 Coruña, A;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
15 Coruña, A;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
15 Coruña, A;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
15 Coruña, A;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;87,76
15 Coruña, A;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
15 Coruña, A;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
15 Coruña, A;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;84,76
15 Coruña, A;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
15 Coruña, A;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
15 Coruña, A;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
15 Coruña, A;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;86,28
15 Coruña, A;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
15 Coruña, A;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
15 Coruña, A;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
15 Coruña, A;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;83,7
15 Coruña, A;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
15 Coruña, A;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
15 Coruña, A;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
15 Coruña, A;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
15 Coruña, A;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
15 Coruña, A;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
15 Coruña, A;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QI;7.095
15 Coruña, A;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
15 Coruña, A;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
15 Coruña, A;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
15 Coruña, A;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QI;6.780
15 Coruña, A;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
15 Coruña, A;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
15 Coruña, A;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
15 Coruña, A;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QI;7.752
15 Coruña, A;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
15 Coruña, A;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
15 Coruña, A;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2022QII;""
15 Coruña, A;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2022QI;6.860
15 Coruña, A;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
15 Coruña, A;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
15 Coruña, A;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2021QII;""
15 Coruña, A;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2021QI;6.562
15 Coruña, A;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
15 Coruña, A;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
15 Coruña, A;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2020QII;""
15 Coruña, A;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2020QI;7.309
15 Coruña, A;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
15 Coruña, A;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
15 Coruña, A;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2022QII;6.638
15 Coruña, A;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2022QI;""
15 Coruña, A;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
15 Coruña, A;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
15 Coruña, A;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2021QII;6.341
15 Coruña, A;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2021QI;""
15 Coruña, A;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
15 Coruña, A;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
15 Coruña, A;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2020QII;7.118
15 Coruña, A;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2020QI;""
15 Coruña, A;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
15 Coruña, A;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QIII;6.407
15 Coruña, A;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QII;""
15 Coruña, A;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QI;""
15 Coruña, A;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
15 Coruña, A;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QIII;6.139
15 Coruña, A;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QII;""
15 Coruña, A;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QI;""
15 Coruña, A;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
15 Coruña, A;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QIII;6.883
15 Coruña, A;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QII;""
15 Coruña, A;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QI;""
15 Coruña, A;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QIV;6.027
15 Coruña, A;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
15 Coruña, A;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QII;""
15 Coruña, A;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QI;""
15 Coruña, A;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QIV;5.851
15 Coruña, A;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
15 Coruña, A;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QII;""
15 Coruña, A;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QI;""
15 Coruña, A;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QIV;6.587
15 Coruña, A;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
15 Coruña, A;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QII;""
15 Coruña, A;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QI;""
15 Coruña, A;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
15 Coruña, A;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
15 Coruña, A;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
15 Coruña, A;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
15 Coruña, A;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
15 Coruña, A;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
15 Coruña, A;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
15 Coruña, A;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
15 Coruña, A;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
15 Coruña, A;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
15 Coruña, A;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
15 Coruña, A;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
15 Coruña, A;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
15 Coruña, A;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
15 Coruña, A;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
15 Coruña, A;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;96,69
15 Coruña, A;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
15 Coruña, A;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
15 Coruña, A;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
15 Coruña, A;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;96,78
15 Coruña, A;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
15 Coruña, A;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
15 Coruña, A;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
15 Coruña, A;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;94,29
15 Coruña, A;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
15 Coruña, A;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
15 Coruña, A;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;93,56
15 Coruña, A;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
15 Coruña, A;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
15 Coruña, A;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
15 Coruña, A;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;93,53
15 Coruña, A;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
15 Coruña, A;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
15 Coruña, A;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
15 Coruña, A;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;91,82
15 Coruña, A;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
15 Coruña, A;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
15 Coruña, A;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;90,3
15 Coruña, A;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
15 Coruña, A;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
15 Coruña, A;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
15 Coruña, A;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;90,55
15 Coruña, A;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
15 Coruña, A;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
15 Coruña, A;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
15 Coruña, A;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;88,79
15 Coruña, A;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
15 Coruña, A;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
15 Coruña, A;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;84,95
15 Coruña, A;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
15 Coruña, A;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
15 Coruña, A;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
15 Coruña, A;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;86,3
15 Coruña, A;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
15 Coruña, A;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
15 Coruña, A;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
15 Coruña, A;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;84,97
15 Coruña, A;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
15 Coruña, A;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
15 Coruña, A;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
15 Coruña, A;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
15 Coruña, A;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
15 Coruña, A;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
15 Coruña, A;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QI;4.617
15 Coruña, A;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
15 Coruña, A;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
15 Coruña, A;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
15 Coruña, A;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QI;4.394
15 Coruña, A;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
15 Coruña, A;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
15 Coruña, A;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
15 Coruña, A;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QI;5.177
15 Coruña, A;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
15 Coruña, A;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
15 Coruña, A;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2022QII;""
15 Coruña, A;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2022QI;4.442
15 Coruña, A;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
15 Coruña, A;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
15 Coruña, A;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2021QII;""
15 Coruña, A;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2021QI;4.276
15 Coruña, A;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
15 Coruña, A;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
15 Coruña, A;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2020QII;""
15 Coruña, A;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2020QI;4.907
15 Coruña, A;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
15 Coruña, A;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
15 Coruña, A;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2022QII;4.283
15 Coruña, A;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2022QI;""
15 Coruña, A;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
15 Coruña, A;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
15 Coruña, A;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2021QII;4.144
15 Coruña, A;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2021QI;""
15 Coruña, A;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
15 Coruña, A;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
15 Coruña, A;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2020QII;4.642
15 Coruña, A;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2020QI;""
15 Coruña, A;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
15 Coruña, A;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QIII;4.138
15 Coruña, A;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QII;""
15 Coruña, A;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QI;""
15 Coruña, A;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
15 Coruña, A;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QIII;3.993
15 Coruña, A;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QII;""
15 Coruña, A;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QI;""
15 Coruña, A;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
15 Coruña, A;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QIII;4.463
15 Coruña, A;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QII;""
15 Coruña, A;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QI;""
15 Coruña, A;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QIV;3.900
15 Coruña, A;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
15 Coruña, A;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QII;""
15 Coruña, A;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QI;""
15 Coruña, A;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QIV;3.790
15 Coruña, A;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
15 Coruña, A;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QII;""
15 Coruña, A;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QI;""
15 Coruña, A;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QIV;4.234
15 Coruña, A;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
15 Coruña, A;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QII;""
15 Coruña, A;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QI;""
15 Coruña, A;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
15 Coruña, A;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
15 Coruña, A;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
15 Coruña, A;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
15 Coruña, A;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
15 Coruña, A;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
15 Coruña, A;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
15 Coruña, A;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
15 Coruña, A;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
15 Coruña, A;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
15 Coruña, A;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
15 Coruña, A;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
15 Coruña, A;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
15 Coruña, A;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
15 Coruña, A;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
15 Coruña, A;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;96,21
15 Coruña, A;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
15 Coruña, A;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
15 Coruña, A;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
15 Coruña, A;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;97,31
15 Coruña, A;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
15 Coruña, A;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
15 Coruña, A;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
15 Coruña, A;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;94,78
15 Coruña, A;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
15 Coruña, A;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
15 Coruña, A;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;92,77
15 Coruña, A;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
15 Coruña, A;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
15 Coruña, A;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
15 Coruña, A;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;94,31
15 Coruña, A;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
15 Coruña, A;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
15 Coruña, A;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
15 Coruña, A;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;89,67
15 Coruña, A;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
15 Coruña, A;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
15 Coruña, A;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;89,63
15 Coruña, A;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
15 Coruña, A;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
15 Coruña, A;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
15 Coruña, A;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;90,87
15 Coruña, A;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
15 Coruña, A;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
15 Coruña, A;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
15 Coruña, A;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;86,21
15 Coruña, A;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
15 Coruña, A;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
15 Coruña, A;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;84,47
15 Coruña, A;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
15 Coruña, A;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
15 Coruña, A;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
15 Coruña, A;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;86,25
15 Coruña, A;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
15 Coruña, A;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
15 Coruña, A;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
15 Coruña, A;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;81,78
15 Coruña, A;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
15 Coruña, A;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
15 Coruña, A;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
15 Coruña, A;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
15 Coruña, A;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
15 Coruña, A;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QII;13.269
15 Coruña, A;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
15 Coruña, A;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
15 Coruña, A;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
15 Coruña, A;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QII;12.766
15 Coruña, A;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
15 Coruña, A;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
15 Coruña, A;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
15 Coruña, A;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QII;12.415
15 Coruña, A;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
15 Coruña, A;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
15 Coruña, A;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
15 Coruña, A;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2022QII;12.847
15 Coruña, A;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2022QI;""
15 Coruña, A;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
15 Coruña, A;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
15 Coruña, A;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2021QII;12.365
15 Coruña, A;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2021QI;""
15 Coruña, A;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
15 Coruña, A;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
15 Coruña, A;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2020QII;11.949
15 Coruña, A;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2020QI;""
15 Coruña, A;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
15 Coruña, A;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2022QIII;12.432
15 Coruña, A;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2022QII;""
15 Coruña, A;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2022QI;""
15 Coruña, A;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
15 Coruña, A;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2021QIII;11.981
15 Coruña, A;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2021QII;""
15 Coruña, A;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2021QI;""
15 Coruña, A;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
15 Coruña, A;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2020QIII;11.479
15 Coruña, A;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2020QII;""
15 Coruña, A;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2020QI;""
15 Coruña, A;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QIV;11.776
15 Coruña, A;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
15 Coruña, A;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QII;""
15 Coruña, A;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QI;""
15 Coruña, A;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QIV;11.456
15 Coruña, A;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
15 Coruña, A;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QII;""
15 Coruña, A;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QI;""
15 Coruña, A;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QIV;10.948
15 Coruña, A;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
15 Coruña, A;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QII;""
15 Coruña, A;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QI;""
15 Coruña, A;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
15 Coruña, A;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
15 Coruña, A;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QII;""
15 Coruña, A;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QI;11.066
15 Coruña, A;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
15 Coruña, A;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
15 Coruña, A;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QII;""
15 Coruña, A;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QI;10.634
15 Coruña, A;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
15 Coruña, A;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
15 Coruña, A;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QII;""
15 Coruña, A;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QI;""
15 Coruña, A;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
15 Coruña, A;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
15 Coruña, A;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
15 Coruña, A;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
15 Coruña, A;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
15 Coruña, A;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
15 Coruña, A;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
15 Coruña, A;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
15 Coruña, A;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
15 Coruña, A;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
15 Coruña, A;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
15 Coruña, A;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
15 Coruña, A;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
15 Coruña, A;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
15 Coruña, A;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;96,82
15 Coruña, A;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
15 Coruña, A;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
15 Coruña, A;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
15 Coruña, A;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;96,86
15 Coruña, A;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
15 Coruña, A;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
15 Coruña, A;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
15 Coruña, A;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;96,25
15 Coruña, A;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
15 Coruña, A;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
15 Coruña, A;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;93,69
15 Coruña, A;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
15 Coruña, A;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
15 Coruña, A;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
15 Coruña, A;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;93,85
15 Coruña, A;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
15 Coruña, A;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
15 Coruña, A;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
15 Coruña, A;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;92,46
15 Coruña, A;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
15 Coruña, A;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
15 Coruña, A;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;88,75
15 Coruña, A;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
15 Coruña, A;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
15 Coruña, A;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
15 Coruña, A;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;89,74
15 Coruña, A;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
15 Coruña, A;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
15 Coruña, A;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
15 Coruña, A;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;88,18
15 Coruña, A;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
15 Coruña, A;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
15 Coruña, A;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
15 Coruña, A;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
15 Coruña, A;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
15 Coruña, A;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
15 Coruña, A;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;86,68
15 Coruña, A;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
15 Coruña, A;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
15 Coruña, A;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
15 Coruña, A;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;85,65
15 Coruña, A;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
15 Coruña, A;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
15 Coruña, A;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
15 Coruña, A;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
15 Coruña, A;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
15 Coruña, A;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
15 Coruña, A;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QII;8.051
15 Coruña, A;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
15 Coruña, A;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
15 Coruña, A;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
15 Coruña, A;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QII;7.738
15 Coruña, A;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
15 Coruña, A;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
15 Coruña, A;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
15 Coruña, A;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QII;7.431
15 Coruña, A;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
15 Coruña, A;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
15 Coruña, A;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
15 Coruña, A;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2022QII;7.803
15 Coruña, A;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2022QI;""
15 Coruña, A;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
15 Coruña, A;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
15 Coruña, A;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2021QII;7.490
15 Coruña, A;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2021QI;""
15 Coruña, A;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
15 Coruña, A;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
15 Coruña, A;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2020QII;7.235
15 Coruña, A;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2020QI;""
15 Coruña, A;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
15 Coruña, A;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2022QIII;7.553
15 Coruña, A;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2022QII;""
15 Coruña, A;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2022QI;""
15 Coruña, A;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
15 Coruña, A;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2021QIII;7.265
15 Coruña, A;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2021QII;""
15 Coruña, A;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2021QI;""
15 Coruña, A;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
15 Coruña, A;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2020QIII;6.958
15 Coruña, A;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2020QII;""
15 Coruña, A;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2020QI;""
15 Coruña, A;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QIV;7.150
15 Coruña, A;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
15 Coruña, A;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QII;""
15 Coruña, A;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QI;""
15 Coruña, A;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QIV;6.957
15 Coruña, A;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
15 Coruña, A;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QII;""
15 Coruña, A;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QI;""
15 Coruña, A;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QIV;6.661
15 Coruña, A;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
15 Coruña, A;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QII;""
15 Coruña, A;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QI;""
15 Coruña, A;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
15 Coruña, A;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
15 Coruña, A;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QII;""
15 Coruña, A;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QI;6.731
15 Coruña, A;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
15 Coruña, A;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
15 Coruña, A;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QII;""
15 Coruña, A;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QI;6.459
15 Coruña, A;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
15 Coruña, A;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
15 Coruña, A;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QII;""
15 Coruña, A;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QI;""
15 Coruña, A;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
15 Coruña, A;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
15 Coruña, A;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
15 Coruña, A;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
15 Coruña, A;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
15 Coruña, A;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
15 Coruña, A;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
15 Coruña, A;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
15 Coruña, A;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
15 Coruña, A;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
15 Coruña, A;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
15 Coruña, A;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
15 Coruña, A;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
15 Coruña, A;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
15 Coruña, A;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;96,92
15 Coruña, A;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
15 Coruña, A;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
15 Coruña, A;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
15 Coruña, A;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;96,8
15 Coruña, A;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
15 Coruña, A;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
15 Coruña, A;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
15 Coruña, A;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;97,36
15 Coruña, A;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
15 Coruña, A;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
15 Coruña, A;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;93,81
15 Coruña, A;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
15 Coruña, A;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
15 Coruña, A;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
15 Coruña, A;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;93,89
15 Coruña, A;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
15 Coruña, A;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
15 Coruña, A;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
15 Coruña, A;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;93,63
15 Coruña, A;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
15 Coruña, A;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
15 Coruña, A;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;88,81
15 Coruña, A;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
15 Coruña, A;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
15 Coruña, A;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
15 Coruña, A;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;89,91
15 Coruña, A;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
15 Coruña, A;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
15 Coruña, A;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
15 Coruña, A;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;89,64
15 Coruña, A;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
15 Coruña, A;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
15 Coruña, A;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
15 Coruña, A;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
15 Coruña, A;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
15 Coruña, A;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
15 Coruña, A;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;86,99
15 Coruña, A;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
15 Coruña, A;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
15 Coruña, A;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
15 Coruña, A;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;86,92
15 Coruña, A;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
15 Coruña, A;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
15 Coruña, A;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
15 Coruña, A;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
15 Coruña, A;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
15 Coruña, A;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
15 Coruña, A;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QII;5.218
15 Coruña, A;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
15 Coruña, A;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
15 Coruña, A;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
15 Coruña, A;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QII;5.028
15 Coruña, A;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
15 Coruña, A;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
15 Coruña, A;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
15 Coruña, A;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QII;4.984
15 Coruña, A;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
15 Coruña, A;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
15 Coruña, A;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
15 Coruña, A;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2022QII;5.044
15 Coruña, A;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2022QI;""
15 Coruña, A;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
15 Coruña, A;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
15 Coruña, A;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2021QII;4.875
15 Coruña, A;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2021QI;""
15 Coruña, A;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
15 Coruña, A;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
15 Coruña, A;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2020QII;4.714
15 Coruña, A;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2020QI;""
15 Coruña, A;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
15 Coruña, A;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2022QIII;4.879
15 Coruña, A;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2022QII;""
15 Coruña, A;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2022QI;""
15 Coruña, A;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
15 Coruña, A;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2021QIII;4.716
15 Coruña, A;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2021QII;""
15 Coruña, A;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2021QI;""
15 Coruña, A;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
15 Coruña, A;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2020QIII;4.521
15 Coruña, A;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2020QII;""
15 Coruña, A;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2020QI;""
15 Coruña, A;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QIV;4.626
15 Coruña, A;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
15 Coruña, A;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QII;""
15 Coruña, A;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QI;""
15 Coruña, A;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QIV;4.499
15 Coruña, A;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
15 Coruña, A;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QII;""
15 Coruña, A;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QI;""
15 Coruña, A;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QIV;4.287
15 Coruña, A;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
15 Coruña, A;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QII;""
15 Coruña, A;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QI;""
15 Coruña, A;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
15 Coruña, A;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
15 Coruña, A;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QII;""
15 Coruña, A;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QI;4.335
15 Coruña, A;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
15 Coruña, A;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
15 Coruña, A;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QII;""
15 Coruña, A;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QI;4.175
15 Coruña, A;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
15 Coruña, A;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
15 Coruña, A;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QII;""
15 Coruña, A;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QI;""
15 Coruña, A;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
15 Coruña, A;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
15 Coruña, A;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
15 Coruña, A;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
15 Coruña, A;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
15 Coruña, A;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
15 Coruña, A;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
15 Coruña, A;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
15 Coruña, A;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
15 Coruña, A;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
15 Coruña, A;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
15 Coruña, A;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
15 Coruña, A;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
15 Coruña, A;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
15 Coruña, A;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;96,67
15 Coruña, A;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
15 Coruña, A;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
15 Coruña, A;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
15 Coruña, A;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;96,96
15 Coruña, A;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
15 Coruña, A;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
15 Coruña, A;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
15 Coruña, A;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;94,58
15 Coruña, A;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
15 Coruña, A;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
15 Coruña, A;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;93,5
15 Coruña, A;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
15 Coruña, A;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
15 Coruña, A;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
15 Coruña, A;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;93,79
15 Coruña, A;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
15 Coruña, A;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
15 Coruña, A;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
15 Coruña, A;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;90,71
15 Coruña, A;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
15 Coruña, A;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
15 Coruña, A;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;88,65
15 Coruña, A;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
15 Coruña, A;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
15 Coruña, A;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
15 Coruña, A;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;89,48
15 Coruña, A;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
15 Coruña, A;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
15 Coruña, A;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
15 Coruña, A;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;86,02
15 Coruña, A;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
15 Coruña, A;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
15 Coruña, A;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
15 Coruña, A;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
15 Coruña, A;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
15 Coruña, A;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
15 Coruña, A;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;86,22
15 Coruña, A;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
15 Coruña, A;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
15 Coruña, A;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
15 Coruña, A;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;83,77
15 Coruña, A;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
15 Coruña, A;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
15 Coruña, A;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
15 Coruña, A;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
15 Coruña, A;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
15 Coruña, A;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QIII;12.979
15 Coruña, A;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
15 Coruña, A;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
15 Coruña, A;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
15 Coruña, A;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QIII;12.488
15 Coruña, A;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
15 Coruña, A;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
15 Coruña, A;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
15 Coruña, A;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QIII;12.033
15 Coruña, A;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
15 Coruña, A;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
15 Coruña, A;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
15 Coruña, A;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2022QIII;12.525
15 Coruña, A;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2022QII;""
15 Coruña, A;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2022QI;""
15 Coruña, A;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
15 Coruña, A;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2021QIII;12.081
15 Coruña, A;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2021QII;""
15 Coruña, A;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2021QI;""
15 Coruña, A;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
15 Coruña, A;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2020QIII;11.539
15 Coruña, A;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2020QII;""
15 Coruña, A;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2020QI;""
15 Coruña, A;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2022QIV;11.849
15 Coruña, A;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
15 Coruña, A;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2022QII;""
15 Coruña, A;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2022QI;""
15 Coruña, A;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2021QIV;11.541
15 Coruña, A;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
15 Coruña, A;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2021QII;""
15 Coruña, A;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2021QI;""
15 Coruña, A;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2020QIV;10.999
15 Coruña, A;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
15 Coruña, A;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2020QII;""
15 Coruña, A;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2020QI;""
15 Coruña, A;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
15 Coruña, A;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
15 Coruña, A;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QII;""
15 Coruña, A;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QI;11.148
15 Coruña, A;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
15 Coruña, A;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
15 Coruña, A;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QII;""
15 Coruña, A;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QI;10.683
15 Coruña, A;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
15 Coruña, A;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
15 Coruña, A;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QII;""
15 Coruña, A;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QI;""
15 Coruña, A;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
15 Coruña, A;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
15 Coruña, A;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QII;10.777
15 Coruña, A;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QI;""
15 Coruña, A;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
15 Coruña, A;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
15 Coruña, A;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QII;10.342
15 Coruña, A;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QI;""
15 Coruña, A;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
15 Coruña, A;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
15 Coruña, A;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QII;""
15 Coruña, A;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QI;""
15 Coruña, A;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
15 Coruña, A;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
15 Coruña, A;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
15 Coruña, A;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
15 Coruña, A;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
15 Coruña, A;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
15 Coruña, A;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
15 Coruña, A;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
15 Coruña, A;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
15 Coruña, A;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
15 Coruña, A;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
15 Coruña, A;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
15 Coruña, A;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
15 Coruña, A;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;96,5
15 Coruña, A;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
15 Coruña, A;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
15 Coruña, A;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
15 Coruña, A;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;96,74
15 Coruña, A;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
15 Coruña, A;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
15 Coruña, A;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
15 Coruña, A;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;95,89
15 Coruña, A;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
15 Coruña, A;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
15 Coruña, A;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;91,29
15 Coruña, A;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
15 Coruña, A;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
15 Coruña, A;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
15 Coruña, A;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;92,42
15 Coruña, A;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
15 Coruña, A;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
15 Coruña, A;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
15 Coruña, A;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;91,41
15 Coruña, A;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
15 Coruña, A;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
15 Coruña, A;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
15 Coruña, A;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
15 Coruña, A;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
15 Coruña, A;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
15 Coruña, A;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;89,27
15 Coruña, A;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
15 Coruña, A;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
15 Coruña, A;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
15 Coruña, A;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;88,78
15 Coruña, A;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
15 Coruña, A;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
15 Coruña, A;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
15 Coruña, A;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
15 Coruña, A;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
15 Coruña, A;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
15 Coruña, A;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;86,3
15 Coruña, A;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
15 Coruña, A;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
15 Coruña, A;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
15 Coruña, A;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;85,95
15 Coruña, A;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
15 Coruña, A;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
15 Coruña, A;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
15 Coruña, A;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
15 Coruña, A;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
15 Coruña, A;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
15 Coruña, A;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QIII;7.870
15 Coruña, A;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
15 Coruña, A;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
15 Coruña, A;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
15 Coruña, A;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QIII;7.559
15 Coruña, A;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
15 Coruña, A;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
15 Coruña, A;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
15 Coruña, A;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QIII;7.280
15 Coruña, A;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
15 Coruña, A;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
15 Coruña, A;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
15 Coruña, A;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2022QIII;7.604
15 Coruña, A;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2022QII;""
15 Coruña, A;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2022QI;""
15 Coruña, A;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
15 Coruña, A;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2021QIII;7.322
15 Coruña, A;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2021QII;""
15 Coruña, A;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2021QI;""
15 Coruña, A;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
15 Coruña, A;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2020QIII;6.991
15 Coruña, A;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2020QII;""
15 Coruña, A;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2020QI;""
15 Coruña, A;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2022QIV;7.191
15 Coruña, A;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
15 Coruña, A;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2022QII;""
15 Coruña, A;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2022QI;""
15 Coruña, A;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2021QIV;7.006
15 Coruña, A;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
15 Coruña, A;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2021QII;""
15 Coruña, A;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2021QI;""
15 Coruña, A;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2020QIV;6.688
15 Coruña, A;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
15 Coruña, A;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2020QII;""
15 Coruña, A;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2020QI;""
15 Coruña, A;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
15 Coruña, A;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
15 Coruña, A;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QII;""
15 Coruña, A;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QI;6.777
15 Coruña, A;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
15 Coruña, A;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
15 Coruña, A;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QII;""
15 Coruña, A;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QI;6.484
15 Coruña, A;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
15 Coruña, A;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
15 Coruña, A;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QII;""
15 Coruña, A;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QI;""
15 Coruña, A;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
15 Coruña, A;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
15 Coruña, A;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QII;6.561
15 Coruña, A;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QI;""
15 Coruña, A;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
15 Coruña, A;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
15 Coruña, A;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QII;6.269
15 Coruña, A;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QI;""
15 Coruña, A;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
15 Coruña, A;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
15 Coruña, A;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QII;""
15 Coruña, A;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QI;""
15 Coruña, A;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
15 Coruña, A;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
15 Coruña, A;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
15 Coruña, A;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
15 Coruña, A;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
15 Coruña, A;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
15 Coruña, A;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
15 Coruña, A;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
15 Coruña, A;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
15 Coruña, A;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
15 Coruña, A;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
15 Coruña, A;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
15 Coruña, A;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
15 Coruña, A;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;96,62
15 Coruña, A;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
15 Coruña, A;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
15 Coruña, A;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
15 Coruña, A;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;96,86
15 Coruña, A;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
15 Coruña, A;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
15 Coruña, A;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
15 Coruña, A;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;96,03
15 Coruña, A;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
15 Coruña, A;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
15 Coruña, A;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;91,37
15 Coruña, A;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
15 Coruña, A;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
15 Coruña, A;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
15 Coruña, A;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;92,68
15 Coruña, A;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
15 Coruña, A;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
15 Coruña, A;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
15 Coruña, A;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;91,87
15 Coruña, A;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
15 Coruña, A;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
15 Coruña, A;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
15 Coruña, A;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
15 Coruña, A;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
15 Coruña, A;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
15 Coruña, A;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;89,65
15 Coruña, A;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
15 Coruña, A;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
15 Coruña, A;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
15 Coruña, A;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;89,07
15 Coruña, A;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
15 Coruña, A;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
15 Coruña, A;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
15 Coruña, A;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
15 Coruña, A;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
15 Coruña, A;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
15 Coruña, A;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;86,8
15 Coruña, A;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
15 Coruña, A;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
15 Coruña, A;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
15 Coruña, A;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;86,11
15 Coruña, A;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
15 Coruña, A;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
15 Coruña, A;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
15 Coruña, A;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
15 Coruña, A;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
15 Coruña, A;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
15 Coruña, A;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QIII;5.109
15 Coruña, A;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
15 Coruña, A;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
15 Coruña, A;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
15 Coruña, A;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QIII;4.929
15 Coruña, A;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
15 Coruña, A;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
15 Coruña, A;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
15 Coruña, A;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QIII;4.753
15 Coruña, A;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
15 Coruña, A;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
15 Coruña, A;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
15 Coruña, A;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2022QIII;4.921
15 Coruña, A;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2022QII;""
15 Coruña, A;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2022QI;""
15 Coruña, A;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
15 Coruña, A;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2021QIII;4.759
15 Coruña, A;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2021QII;""
15 Coruña, A;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2021QI;""
15 Coruña, A;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
15 Coruña, A;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2020QIII;4.548
15 Coruña, A;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2020QII;""
15 Coruña, A;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2020QI;""
15 Coruña, A;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2022QIV;4.658
15 Coruña, A;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
15 Coruña, A;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2022QII;""
15 Coruña, A;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2022QI;""
15 Coruña, A;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2021QIV;4.535
15 Coruña, A;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
15 Coruña, A;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2021QII;""
15 Coruña, A;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2021QI;""
15 Coruña, A;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2020QIV;4.311
15 Coruña, A;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
15 Coruña, A;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2020QII;""
15 Coruña, A;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2020QI;""
15 Coruña, A;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
15 Coruña, A;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
15 Coruña, A;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QII;""
15 Coruña, A;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QI;4.371
15 Coruña, A;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
15 Coruña, A;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
15 Coruña, A;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QII;""
15 Coruña, A;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QI;4.199
15 Coruña, A;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
15 Coruña, A;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
15 Coruña, A;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QII;""
15 Coruña, A;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QI;""
15 Coruña, A;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
15 Coruña, A;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
15 Coruña, A;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QII;4.216
15 Coruña, A;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QI;""
15 Coruña, A;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
15 Coruña, A;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
15 Coruña, A;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QII;4.073
15 Coruña, A;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QI;""
15 Coruña, A;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
15 Coruña, A;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
15 Coruña, A;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QII;""
15 Coruña, A;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QI;""
15 Coruña, A;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
15 Coruña, A;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
15 Coruña, A;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
15 Coruña, A;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
15 Coruña, A;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
15 Coruña, A;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
15 Coruña, A;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
15 Coruña, A;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
15 Coruña, A;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
15 Coruña, A;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
15 Coruña, A;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
15 Coruña, A;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
15 Coruña, A;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
15 Coruña, A;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;96,32
15 Coruña, A;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
15 Coruña, A;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
15 Coruña, A;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
15 Coruña, A;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;96,55
15 Coruña, A;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
15 Coruña, A;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
15 Coruña, A;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
15 Coruña, A;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;95,69
15 Coruña, A;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
15 Coruña, A;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
15 Coruña, A;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;91,17
15 Coruña, A;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
15 Coruña, A;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
15 Coruña, A;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
15 Coruña, A;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;92,01
15 Coruña, A;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
15 Coruña, A;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
15 Coruña, A;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
15 Coruña, A;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;90,7
15 Coruña, A;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
15 Coruña, A;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
15 Coruña, A;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
15 Coruña, A;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
15 Coruña, A;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
15 Coruña, A;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
15 Coruña, A;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;88,68
15 Coruña, A;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
15 Coruña, A;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
15 Coruña, A;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
15 Coruña, A;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;88,34
15 Coruña, A;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
15 Coruña, A;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
15 Coruña, A;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
15 Coruña, A;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
15 Coruña, A;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
15 Coruña, A;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
15 Coruña, A;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;85,53
15 Coruña, A;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
15 Coruña, A;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
15 Coruña, A;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
15 Coruña, A;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;85,69
15 Coruña, A;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
15 Coruña, A;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
15 Coruña, A;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
15 Coruña, A;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
15 Coruña, A;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
15 Coruña, A;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QIV;12.620
15 Coruña, A;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
15 Coruña, A;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
15 Coruña, A;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
15 Coruña, A;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QIV;12.186
15 Coruña, A;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
15 Coruña, A;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
15 Coruña, A;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
15 Coruña, A;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QIV;11.624
15 Coruña, A;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
15 Coruña, A;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
15 Coruña, A;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
15 Coruña, A;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2022QIV;11.920
15 Coruña, A;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
15 Coruña, A;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2022QII;""
15 Coruña, A;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2022QI;""
15 Coruña, A;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2021QIV;11.620
15 Coruña, A;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
15 Coruña, A;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2021QII;""
15 Coruña, A;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2021QI;""
15 Coruña, A;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2020QIV;11.073
15 Coruña, A;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
15 Coruña, A;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2020QII;""
15 Coruña, A;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2020QI;""
15 Coruña, A;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
15 Coruña, A;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
15 Coruña, A;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2022QII;""
15 Coruña, A;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2022QI;11.221
15 Coruña, A;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
15 Coruña, A;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
15 Coruña, A;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2021QII;""
15 Coruña, A;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2021QI;10.751
15 Coruña, A;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
15 Coruña, A;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
15 Coruña, A;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2020QII;""
15 Coruña, A;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2020QI;""
15 Coruña, A;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
15 Coruña, A;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
15 Coruña, A;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QII;10.847
15 Coruña, A;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QI;""
15 Coruña, A;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
15 Coruña, A;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
15 Coruña, A;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QII;10.407
15 Coruña, A;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QI;""
15 Coruña, A;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
15 Coruña, A;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
15 Coruña, A;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QII;""
15 Coruña, A;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QI;""
15 Coruña, A;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
15 Coruña, A;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QIII;10.476
15 Coruña, A;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QII;""
15 Coruña, A;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QI;""
15 Coruña, A;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
15 Coruña, A;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QIII;10.062
15 Coruña, A;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QII;""
15 Coruña, A;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QI;""
15 Coruña, A;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
15 Coruña, A;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
15 Coruña, A;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QII;""
15 Coruña, A;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QI;""
15 Coruña, A;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
15 Coruña, A;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
15 Coruña, A;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
15 Coruña, A;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
15 Coruña, A;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
15 Coruña, A;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
15 Coruña, A;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
15 Coruña, A;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
15 Coruña, A;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
15 Coruña, A;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
15 Coruña, A;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
15 Coruña, A;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
15 Coruña, A;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;94,45
15 Coruña, A;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
15 Coruña, A;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
15 Coruña, A;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
15 Coruña, A;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;95,36
15 Coruña, A;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
15 Coruña, A;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
15 Coruña, A;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
15 Coruña, A;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;95,26
15 Coruña, A;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
15 Coruña, A;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
15 Coruña, A;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
15 Coruña, A;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
15 Coruña, A;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
15 Coruña, A;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
15 Coruña, A;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;92,08
15 Coruña, A;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
15 Coruña, A;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
15 Coruña, A;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
15 Coruña, A;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;92,49
15 Coruña, A;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
15 Coruña, A;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
15 Coruña, A;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
15 Coruña, A;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
15 Coruña, A;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
15 Coruña, A;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
15 Coruña, A;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;89,01
15 Coruña, A;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
15 Coruña, A;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
15 Coruña, A;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
15 Coruña, A;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;89,53
15 Coruña, A;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
15 Coruña, A;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
15 Coruña, A;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
15 Coruña, A;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
15 Coruña, A;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
15 Coruña, A;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
15 Coruña, A;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;85,97
15 Coruña, A;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
15 Coruña, A;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
15 Coruña, A;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
15 Coruña, A;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;86,56
15 Coruña, A;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
15 Coruña, A;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
15 Coruña, A;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
15 Coruña, A;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
15 Coruña, A;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
15 Coruña, A;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
15 Coruña, A;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QIV;7.655
15 Coruña, A;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
15 Coruña, A;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
15 Coruña, A;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
15 Coruña, A;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QIV;7.381
15 Coruña, A;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
15 Coruña, A;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
15 Coruña, A;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
15 Coruña, A;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QIV;7.026
15 Coruña, A;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
15 Coruña, A;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
15 Coruña, A;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
15 Coruña, A;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2022QIV;7.232
15 Coruña, A;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
15 Coruña, A;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2022QII;""
15 Coruña, A;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2022QI;""
15 Coruña, A;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2021QIV;7.052
15 Coruña, A;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
15 Coruña, A;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2021QII;""
15 Coruña, A;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2021QI;""
15 Coruña, A;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2020QIV;6.717
15 Coruña, A;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
15 Coruña, A;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2020QII;""
15 Coruña, A;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2020QI;""
15 Coruña, A;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
15 Coruña, A;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
15 Coruña, A;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2022QII;""
15 Coruña, A;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2022QI;6.820
15 Coruña, A;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
15 Coruña, A;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
15 Coruña, A;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2021QII;""
15 Coruña, A;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2021QI;6.509
15 Coruña, A;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
15 Coruña, A;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
15 Coruña, A;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2020QII;""
15 Coruña, A;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2020QI;""
15 Coruña, A;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
15 Coruña, A;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
15 Coruña, A;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QII;6.602
15 Coruña, A;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QI;""
15 Coruña, A;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
15 Coruña, A;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
15 Coruña, A;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QII;6.292
15 Coruña, A;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QI;""
15 Coruña, A;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
15 Coruña, A;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
15 Coruña, A;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QII;""
15 Coruña, A;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QI;""
15 Coruña, A;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
15 Coruña, A;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QIII;6.374
15 Coruña, A;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QII;""
15 Coruña, A;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QI;""
15 Coruña, A;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
15 Coruña, A;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QIII;6.094
15 Coruña, A;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QII;""
15 Coruña, A;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QI;""
15 Coruña, A;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
15 Coruña, A;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
15 Coruña, A;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QII;""
15 Coruña, A;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QI;""
15 Coruña, A;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
15 Coruña, A;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
15 Coruña, A;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
15 Coruña, A;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
15 Coruña, A;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
15 Coruña, A;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
15 Coruña, A;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
15 Coruña, A;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
15 Coruña, A;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
15 Coruña, A;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
15 Coruña, A;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
15 Coruña, A;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
15 Coruña, A;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;94,47
15 Coruña, A;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
15 Coruña, A;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
15 Coruña, A;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
15 Coruña, A;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;95,54
15 Coruña, A;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
15 Coruña, A;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
15 Coruña, A;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
15 Coruña, A;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;95,6
15 Coruña, A;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
15 Coruña, A;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
15 Coruña, A;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
15 Coruña, A;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
15 Coruña, A;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
15 Coruña, A;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
15 Coruña, A;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;92,4
15 Coruña, A;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
15 Coruña, A;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
15 Coruña, A;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
15 Coruña, A;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;92,64
15 Coruña, A;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
15 Coruña, A;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
15 Coruña, A;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
15 Coruña, A;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
15 Coruña, A;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
15 Coruña, A;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
15 Coruña, A;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;89,45
15 Coruña, A;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
15 Coruña, A;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
15 Coruña, A;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
15 Coruña, A;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;89,55
15 Coruña, A;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
15 Coruña, A;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
15 Coruña, A;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
15 Coruña, A;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
15 Coruña, A;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
15 Coruña, A;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
15 Coruña, A;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;86,36
15 Coruña, A;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
15 Coruña, A;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
15 Coruña, A;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
15 Coruña, A;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;86,73
15 Coruña, A;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
15 Coruña, A;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
15 Coruña, A;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
15 Coruña, A;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
15 Coruña, A;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
15 Coruña, A;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
15 Coruña, A;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QIV;4.965
15 Coruña, A;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
15 Coruña, A;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
15 Coruña, A;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
15 Coruña, A;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QIV;4.805
15 Coruña, A;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
15 Coruña, A;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
15 Coruña, A;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
15 Coruña, A;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QIV;4.598
15 Coruña, A;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
15 Coruña, A;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
15 Coruña, A;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
15 Coruña, A;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2022QIV;4.688
15 Coruña, A;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
15 Coruña, A;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2022QII;""
15 Coruña, A;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2022QI;""
15 Coruña, A;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2021QIV;4.568
15 Coruña, A;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
15 Coruña, A;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2021QII;""
15 Coruña, A;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2021QI;""
15 Coruña, A;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2020QIV;4.356
15 Coruña, A;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
15 Coruña, A;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2020QII;""
15 Coruña, A;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2020QI;""
15 Coruña, A;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
15 Coruña, A;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
15 Coruña, A;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2022QII;""
15 Coruña, A;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2022QI;4.401
15 Coruña, A;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
15 Coruña, A;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
15 Coruña, A;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2021QII;""
15 Coruña, A;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2021QI;4.242
15 Coruña, A;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
15 Coruña, A;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
15 Coruña, A;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2020QII;""
15 Coruña, A;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2020QI;""
15 Coruña, A;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
15 Coruña, A;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
15 Coruña, A;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QII;4.245
15 Coruña, A;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QI;""
15 Coruña, A;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
15 Coruña, A;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
15 Coruña, A;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QII;4.115
15 Coruña, A;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QI;""
15 Coruña, A;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
15 Coruña, A;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
15 Coruña, A;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QII;""
15 Coruña, A;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QI;""
15 Coruña, A;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
15 Coruña, A;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QIII;4.102
15 Coruña, A;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QII;""
15 Coruña, A;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QI;""
15 Coruña, A;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
15 Coruña, A;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QIII;3.968
15 Coruña, A;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QII;""
15 Coruña, A;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QI;""
15 Coruña, A;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
15 Coruña, A;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
15 Coruña, A;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QII;""
15 Coruña, A;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QI;""
15 Coruña, A;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
15 Coruña, A;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
15 Coruña, A;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
15 Coruña, A;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
15 Coruña, A;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
15 Coruña, A;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
15 Coruña, A;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
15 Coruña, A;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
15 Coruña, A;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
15 Coruña, A;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
15 Coruña, A;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
15 Coruña, A;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
15 Coruña, A;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;94,42
15 Coruña, A;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
15 Coruña, A;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
15 Coruña, A;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
15 Coruña, A;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;95,07
15 Coruña, A;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
15 Coruña, A;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
15 Coruña, A;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
15 Coruña, A;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;94,74
15 Coruña, A;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
15 Coruña, A;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
15 Coruña, A;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
15 Coruña, A;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
15 Coruña, A;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
15 Coruña, A;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
15 Coruña, A;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;91,59
15 Coruña, A;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
15 Coruña, A;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
15 Coruña, A;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
15 Coruña, A;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;92,26
15 Coruña, A;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
15 Coruña, A;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
15 Coruña, A;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
15 Coruña, A;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
15 Coruña, A;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
15 Coruña, A;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
15 Coruña, A;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;88,35
15 Coruña, A;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
15 Coruña, A;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
15 Coruña, A;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
15 Coruña, A;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;89,5
15 Coruña, A;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
15 Coruña, A;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
15 Coruña, A;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
15 Coruña, A;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
15 Coruña, A;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
15 Coruña, A;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
15 Coruña, A;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;85,37
15 Coruña, A;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
15 Coruña, A;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
15 Coruña, A;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
15 Coruña, A;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;86,3
15 Coruña, A;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
15 Coruña, A;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
15 Coruña, A;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
15 Coruña, A;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
15 Coruña, A;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
15 Coruña, A;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
16 Cuenca;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
16 Cuenca;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
16 Cuenca;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
16 Cuenca;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QI;12.970
16 Cuenca;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
16 Cuenca;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
16 Cuenca;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
16 Cuenca;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QI;12.825
16 Cuenca;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
16 Cuenca;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
16 Cuenca;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
16 Cuenca;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QI;13.315
16 Cuenca;All ages;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
16 Cuenca;All ages;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
16 Cuenca;All ages;Cohort January 1;Total;Survival in the first trimester;2022QII;""
16 Cuenca;All ages;Cohort January 1;Total;Survival in the first trimester;2022QI;12.612
16 Cuenca;All ages;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
16 Cuenca;All ages;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
16 Cuenca;All ages;Cohort January 1;Total;Survival in the first trimester;2021QII;""
16 Cuenca;All ages;Cohort January 1;Total;Survival in the first trimester;2021QI;12.555
16 Cuenca;All ages;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
16 Cuenca;All ages;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
16 Cuenca;All ages;Cohort January 1;Total;Survival in the first trimester;2020QII;""
16 Cuenca;All ages;Cohort January 1;Total;Survival in the first trimester;2020QI;12.402
16 Cuenca;All ages;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
16 Cuenca;All ages;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
16 Cuenca;All ages;Cohort January 1;Total;Survival in the second trimester;2022QII;12.330
16 Cuenca;All ages;Cohort January 1;Total;Survival in the second trimester;2022QI;""
16 Cuenca;All ages;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
16 Cuenca;All ages;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
16 Cuenca;All ages;Cohort January 1;Total;Survival in the second trimester;2021QII;12.255
16 Cuenca;All ages;Cohort January 1;Total;Survival in the second trimester;2021QI;""
16 Cuenca;All ages;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
16 Cuenca;All ages;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
16 Cuenca;All ages;Cohort January 1;Total;Survival in the second trimester;2020QII;12.164
16 Cuenca;All ages;Cohort January 1;Total;Survival in the second trimester;2020QI;""
16 Cuenca;All ages;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
16 Cuenca;All ages;Cohort January 1;Total;Survival in the third trimester;2022QIII;12.042
16 Cuenca;All ages;Cohort January 1;Total;Survival in the third trimester;2022QII;""
16 Cuenca;All ages;Cohort January 1;Total;Survival in the third trimester;2022QI;""
16 Cuenca;All ages;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
16 Cuenca;All ages;Cohort January 1;Total;Survival in the third trimester;2021QIII;12.004
16 Cuenca;All ages;Cohort January 1;Total;Survival in the third trimester;2021QII;""
16 Cuenca;All ages;Cohort January 1;Total;Survival in the third trimester;2021QI;""
16 Cuenca;All ages;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
16 Cuenca;All ages;Cohort January 1;Total;Survival in the third trimester;2020QIII;11.903
16 Cuenca;All ages;Cohort January 1;Total;Survival in the third trimester;2020QII;""
16 Cuenca;All ages;Cohort January 1;Total;Survival in the third trimester;2020QI;""
16 Cuenca;All ages;Cohort January 1;Total;Survival in the third trimester;2022QIV;11.702
16 Cuenca;All ages;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
16 Cuenca;All ages;Cohort January 1;Total;Survival in the third trimester;2022QII;""
16 Cuenca;All ages;Cohort January 1;Total;Survival in the third trimester;2022QI;""
16 Cuenca;All ages;Cohort January 1;Total;Survival in the third trimester;2021QIV;11.733
16 Cuenca;All ages;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
16 Cuenca;All ages;Cohort January 1;Total;Survival in the third trimester;2021QII;""
16 Cuenca;All ages;Cohort January 1;Total;Survival in the third trimester;2021QI;""
16 Cuenca;All ages;Cohort January 1;Total;Survival in the third trimester;2020QIV;11.637
16 Cuenca;All ages;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
16 Cuenca;All ages;Cohort January 1;Total;Survival in the third trimester;2020QII;""
16 Cuenca;All ages;Cohort January 1;Total;Survival in the third trimester;2020QI;""
16 Cuenca;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
16 Cuenca;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
16 Cuenca;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
16 Cuenca;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
16 Cuenca;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
16 Cuenca;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
16 Cuenca;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
16 Cuenca;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
16 Cuenca;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
16 Cuenca;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
16 Cuenca;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
16 Cuenca;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
16 Cuenca;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
16 Cuenca;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
16 Cuenca;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
16 Cuenca;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;97,24
16 Cuenca;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
16 Cuenca;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
16 Cuenca;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
16 Cuenca;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;97,89
16 Cuenca;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
16 Cuenca;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
16 Cuenca;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
16 Cuenca;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;93,14
16 Cuenca;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
16 Cuenca;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
16 Cuenca;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;95,07
16 Cuenca;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
16 Cuenca;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
16 Cuenca;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
16 Cuenca;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;95,56
16 Cuenca;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
16 Cuenca;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
16 Cuenca;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
16 Cuenca;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;91,36
16 Cuenca;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
16 Cuenca;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
16 Cuenca;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;92,85
16 Cuenca;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
16 Cuenca;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
16 Cuenca;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
16 Cuenca;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;93,6
16 Cuenca;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
16 Cuenca;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
16 Cuenca;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
16 Cuenca;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;89,4
16 Cuenca;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
16 Cuenca;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
16 Cuenca;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;90,22
16 Cuenca;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
16 Cuenca;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
16 Cuenca;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
16 Cuenca;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;91,49
16 Cuenca;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
16 Cuenca;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
16 Cuenca;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
16 Cuenca;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;87,4
16 Cuenca;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
16 Cuenca;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
16 Cuenca;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
16 Cuenca;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
16 Cuenca;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
16 Cuenca;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
16 Cuenca;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QI;8.689
16 Cuenca;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
16 Cuenca;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
16 Cuenca;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
16 Cuenca;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QI;8.640
16 Cuenca;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
16 Cuenca;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
16 Cuenca;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
16 Cuenca;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QI;9.017
16 Cuenca;All ages;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
16 Cuenca;All ages;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
16 Cuenca;All ages;Cohort January 1;Males;Survival in the first trimester;2022QII;""
16 Cuenca;All ages;Cohort January 1;Males;Survival in the first trimester;2022QI;8.474
16 Cuenca;All ages;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
16 Cuenca;All ages;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
16 Cuenca;All ages;Cohort January 1;Males;Survival in the first trimester;2021QII;""
16 Cuenca;All ages;Cohort January 1;Males;Survival in the first trimester;2021QI;8.464
16 Cuenca;All ages;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
16 Cuenca;All ages;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
16 Cuenca;All ages;Cohort January 1;Males;Survival in the first trimester;2020QII;""
16 Cuenca;All ages;Cohort January 1;Males;Survival in the first trimester;2020QI;8.413
16 Cuenca;All ages;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
16 Cuenca;All ages;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
16 Cuenca;All ages;Cohort January 1;Males;Survival in the second trimester;2022QII;8.322
16 Cuenca;All ages;Cohort January 1;Males;Survival in the second trimester;2022QI;""
16 Cuenca;All ages;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
16 Cuenca;All ages;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
16 Cuenca;All ages;Cohort January 1;Males;Survival in the second trimester;2021QII;8.279
16 Cuenca;All ages;Cohort January 1;Males;Survival in the second trimester;2021QI;""
16 Cuenca;All ages;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
16 Cuenca;All ages;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
16 Cuenca;All ages;Cohort January 1;Males;Survival in the second trimester;2020QII;8.272
16 Cuenca;All ages;Cohort January 1;Males;Survival in the second trimester;2020QI;""
16 Cuenca;All ages;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
16 Cuenca;All ages;Cohort January 1;Males;Survival in the third trimester;2022QIII;8.162
16 Cuenca;All ages;Cohort January 1;Males;Survival in the third trimester;2022QII;""
16 Cuenca;All ages;Cohort January 1;Males;Survival in the third trimester;2022QI;""
16 Cuenca;All ages;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
16 Cuenca;All ages;Cohort January 1;Males;Survival in the third trimester;2021QIII;8.138
16 Cuenca;All ages;Cohort January 1;Males;Survival in the third trimester;2021QII;""
16 Cuenca;All ages;Cohort January 1;Males;Survival in the third trimester;2021QI;""
16 Cuenca;All ages;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
16 Cuenca;All ages;Cohort January 1;Males;Survival in the third trimester;2020QIII;8.110
16 Cuenca;All ages;Cohort January 1;Males;Survival in the third trimester;2020QII;""
16 Cuenca;All ages;Cohort January 1;Males;Survival in the third trimester;2020QI;""
16 Cuenca;All ages;Cohort January 1;Males;Survival in the third trimester;2022QIV;7.935
16 Cuenca;All ages;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
16 Cuenca;All ages;Cohort January 1;Males;Survival in the third trimester;2022QII;""
16 Cuenca;All ages;Cohort January 1;Males;Survival in the third trimester;2022QI;""
16 Cuenca;All ages;Cohort January 1;Males;Survival in the third trimester;2021QIV;7.958
16 Cuenca;All ages;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
16 Cuenca;All ages;Cohort January 1;Males;Survival in the third trimester;2021QII;""
16 Cuenca;All ages;Cohort January 1;Males;Survival in the third trimester;2021QI;""
16 Cuenca;All ages;Cohort January 1;Males;Survival in the third trimester;2020QIV;7.931
16 Cuenca;All ages;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
16 Cuenca;All ages;Cohort January 1;Males;Survival in the third trimester;2020QII;""
16 Cuenca;All ages;Cohort January 1;Males;Survival in the third trimester;2020QI;""
16 Cuenca;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
16 Cuenca;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
16 Cuenca;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
16 Cuenca;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
16 Cuenca;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
16 Cuenca;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
16 Cuenca;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
16 Cuenca;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
16 Cuenca;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
16 Cuenca;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
16 Cuenca;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
16 Cuenca;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
16 Cuenca;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
16 Cuenca;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
16 Cuenca;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
16 Cuenca;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;97,53
16 Cuenca;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
16 Cuenca;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
16 Cuenca;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
16 Cuenca;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;97,96
16 Cuenca;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
16 Cuenca;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
16 Cuenca;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
16 Cuenca;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;93,3
16 Cuenca;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
16 Cuenca;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
16 Cuenca;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;95,78
16 Cuenca;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
16 Cuenca;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
16 Cuenca;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
16 Cuenca;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;95,82
16 Cuenca;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
16 Cuenca;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
16 Cuenca;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
16 Cuenca;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;91,74
16 Cuenca;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
16 Cuenca;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
16 Cuenca;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;93,93
16 Cuenca;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
16 Cuenca;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
16 Cuenca;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
16 Cuenca;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;94,19
16 Cuenca;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
16 Cuenca;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
16 Cuenca;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
16 Cuenca;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;89,94
16 Cuenca;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
16 Cuenca;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
16 Cuenca;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;91,32
16 Cuenca;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
16 Cuenca;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
16 Cuenca;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
16 Cuenca;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;92,11
16 Cuenca;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
16 Cuenca;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
16 Cuenca;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
16 Cuenca;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;87,96
16 Cuenca;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
16 Cuenca;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
16 Cuenca;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
16 Cuenca;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
16 Cuenca;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
16 Cuenca;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
16 Cuenca;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QI;4.281
16 Cuenca;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
16 Cuenca;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
16 Cuenca;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
16 Cuenca;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QI;4.185
16 Cuenca;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
16 Cuenca;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
16 Cuenca;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
16 Cuenca;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QI;4.298
16 Cuenca;All ages;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
16 Cuenca;All ages;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
16 Cuenca;All ages;Cohort January 1;Females;Survival in the first trimester;2022QII;""
16 Cuenca;All ages;Cohort January 1;Females;Survival in the first trimester;2022QI;4.138
16 Cuenca;All ages;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
16 Cuenca;All ages;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
16 Cuenca;All ages;Cohort January 1;Females;Survival in the first trimester;2021QII;""
16 Cuenca;All ages;Cohort January 1;Females;Survival in the first trimester;2021QI;4.091
16 Cuenca;All ages;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
16 Cuenca;All ages;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
16 Cuenca;All ages;Cohort January 1;Females;Survival in the first trimester;2020QII;""
16 Cuenca;All ages;Cohort January 1;Females;Survival in the first trimester;2020QI;3.989
16 Cuenca;All ages;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
16 Cuenca;All ages;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
16 Cuenca;All ages;Cohort January 1;Females;Survival in the second trimester;2022QII;4.008
16 Cuenca;All ages;Cohort January 1;Females;Survival in the second trimester;2022QI;""
16 Cuenca;All ages;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
16 Cuenca;All ages;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
16 Cuenca;All ages;Cohort January 1;Females;Survival in the second trimester;2021QII;3.976
16 Cuenca;All ages;Cohort January 1;Females;Survival in the second trimester;2021QI;""
16 Cuenca;All ages;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
16 Cuenca;All ages;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
16 Cuenca;All ages;Cohort January 1;Females;Survival in the second trimester;2020QII;3.892
16 Cuenca;All ages;Cohort January 1;Females;Survival in the second trimester;2020QI;""
16 Cuenca;All ages;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
16 Cuenca;All ages;Cohort January 1;Females;Survival in the third trimester;2022QIII;3.880
16 Cuenca;All ages;Cohort January 1;Females;Survival in the third trimester;2022QII;""
16 Cuenca;All ages;Cohort January 1;Females;Survival in the third trimester;2022QI;""
16 Cuenca;All ages;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
16 Cuenca;All ages;Cohort January 1;Females;Survival in the third trimester;2021QIII;3.866
16 Cuenca;All ages;Cohort January 1;Females;Survival in the third trimester;2021QII;""
16 Cuenca;All ages;Cohort January 1;Females;Survival in the third trimester;2021QI;""
16 Cuenca;All ages;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
16 Cuenca;All ages;Cohort January 1;Females;Survival in the third trimester;2020QIII;3.793
16 Cuenca;All ages;Cohort January 1;Females;Survival in the third trimester;2020QII;""
16 Cuenca;All ages;Cohort January 1;Females;Survival in the third trimester;2020QI;""
16 Cuenca;All ages;Cohort January 1;Females;Survival in the third trimester;2022QIV;3.767
16 Cuenca;All ages;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
16 Cuenca;All ages;Cohort January 1;Females;Survival in the third trimester;2022QII;""
16 Cuenca;All ages;Cohort January 1;Females;Survival in the third trimester;2022QI;""
16 Cuenca;All ages;Cohort January 1;Females;Survival in the third trimester;2021QIV;3.775
16 Cuenca;All ages;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
16 Cuenca;All ages;Cohort January 1;Females;Survival in the third trimester;2021QII;""
16 Cuenca;All ages;Cohort January 1;Females;Survival in the third trimester;2021QI;""
16 Cuenca;All ages;Cohort January 1;Females;Survival in the third trimester;2020QIV;3.706
16 Cuenca;All ages;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
16 Cuenca;All ages;Cohort January 1;Females;Survival in the third trimester;2020QII;""
16 Cuenca;All ages;Cohort January 1;Females;Survival in the third trimester;2020QI;""
16 Cuenca;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
16 Cuenca;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
16 Cuenca;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
16 Cuenca;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
16 Cuenca;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
16 Cuenca;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
16 Cuenca;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
16 Cuenca;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
16 Cuenca;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
16 Cuenca;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
16 Cuenca;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
16 Cuenca;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
16 Cuenca;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
16 Cuenca;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
16 Cuenca;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
16 Cuenca;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;96,66
16 Cuenca;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
16 Cuenca;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
16 Cuenca;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
16 Cuenca;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;97,75
16 Cuenca;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
16 Cuenca;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
16 Cuenca;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
16 Cuenca;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;92,81
16 Cuenca;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
16 Cuenca;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
16 Cuenca;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;93,62
16 Cuenca;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
16 Cuenca;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
16 Cuenca;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
16 Cuenca;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;95,01
16 Cuenca;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
16 Cuenca;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
16 Cuenca;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
16 Cuenca;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;90,55
16 Cuenca;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
16 Cuenca;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
16 Cuenca;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;90,63
16 Cuenca;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
16 Cuenca;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
16 Cuenca;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
16 Cuenca;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;92,38
16 Cuenca;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
16 Cuenca;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
16 Cuenca;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
16 Cuenca;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;88,25
16 Cuenca;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
16 Cuenca;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
16 Cuenca;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;87,99
16 Cuenca;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
16 Cuenca;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
16 Cuenca;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
16 Cuenca;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;90,2
16 Cuenca;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
16 Cuenca;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
16 Cuenca;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
16 Cuenca;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;86,23
16 Cuenca;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
16 Cuenca;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
16 Cuenca;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
16 Cuenca;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
16 Cuenca;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
16 Cuenca;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QII;13.006
16 Cuenca;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
16 Cuenca;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
16 Cuenca;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
16 Cuenca;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QII;12.925
16 Cuenca;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
16 Cuenca;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
16 Cuenca;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
16 Cuenca;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QII;12.812
16 Cuenca;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
16 Cuenca;All ages;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
16 Cuenca;All ages;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
16 Cuenca;All ages;Cohort April 1;Total;Survival in the first trimester;2022QII;12.692
16 Cuenca;All ages;Cohort April 1;Total;Survival in the first trimester;2022QI;""
16 Cuenca;All ages;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
16 Cuenca;All ages;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
16 Cuenca;All ages;Cohort April 1;Total;Survival in the first trimester;2021QII;12.600
16 Cuenca;All ages;Cohort April 1;Total;Survival in the first trimester;2021QI;""
16 Cuenca;All ages;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
16 Cuenca;All ages;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
16 Cuenca;All ages;Cohort April 1;Total;Survival in the first trimester;2020QII;12.554
16 Cuenca;All ages;Cohort April 1;Total;Survival in the first trimester;2020QI;""
16 Cuenca;All ages;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
16 Cuenca;All ages;Cohort April 1;Total;Survival in the second trimester;2022QIII;12.377
16 Cuenca;All ages;Cohort April 1;Total;Survival in the second trimester;2022QII;""
16 Cuenca;All ages;Cohort April 1;Total;Survival in the second trimester;2022QI;""
16 Cuenca;All ages;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
16 Cuenca;All ages;Cohort April 1;Total;Survival in the second trimester;2021QIII;12.327
16 Cuenca;All ages;Cohort April 1;Total;Survival in the second trimester;2021QII;""
16 Cuenca;All ages;Cohort April 1;Total;Survival in the second trimester;2021QI;""
16 Cuenca;All ages;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
16 Cuenca;All ages;Cohort April 1;Total;Survival in the second trimester;2020QIII;12.259
16 Cuenca;All ages;Cohort April 1;Total;Survival in the second trimester;2020QII;""
16 Cuenca;All ages;Cohort April 1;Total;Survival in the second trimester;2020QI;""
16 Cuenca;All ages;Cohort April 1;Total;Survival in the third trimester;2022QIV;12.006
16 Cuenca;All ages;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
16 Cuenca;All ages;Cohort April 1;Total;Survival in the third trimester;2022QII;""
16 Cuenca;All ages;Cohort April 1;Total;Survival in the third trimester;2022QI;""
16 Cuenca;All ages;Cohort April 1;Total;Survival in the third trimester;2021QIV;12.025
16 Cuenca;All ages;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
16 Cuenca;All ages;Cohort April 1;Total;Survival in the third trimester;2021QII;""
16 Cuenca;All ages;Cohort April 1;Total;Survival in the third trimester;2021QI;""
16 Cuenca;All ages;Cohort April 1;Total;Survival in the third trimester;2020QIV;11.974
16 Cuenca;All ages;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
16 Cuenca;All ages;Cohort April 1;Total;Survival in the third trimester;2020QII;""
16 Cuenca;All ages;Cohort April 1;Total;Survival in the third trimester;2020QI;""
16 Cuenca;All ages;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
16 Cuenca;All ages;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
16 Cuenca;All ages;Cohort April 1;Total;Survival in the third trimester;2022QII;""
16 Cuenca;All ages;Cohort April 1;Total;Survival in the third trimester;2022QI;11.749
16 Cuenca;All ages;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
16 Cuenca;All ages;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
16 Cuenca;All ages;Cohort April 1;Total;Survival in the third trimester;2021QII;""
16 Cuenca;All ages;Cohort April 1;Total;Survival in the third trimester;2021QI;11.771
16 Cuenca;All ages;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
16 Cuenca;All ages;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
16 Cuenca;All ages;Cohort April 1;Total;Survival in the third trimester;2020QII;""
16 Cuenca;All ages;Cohort April 1;Total;Survival in the third trimester;2020QI;""
16 Cuenca;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
16 Cuenca;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
16 Cuenca;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
16 Cuenca;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
16 Cuenca;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
16 Cuenca;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
16 Cuenca;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
16 Cuenca;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
16 Cuenca;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
16 Cuenca;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
16 Cuenca;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
16 Cuenca;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
16 Cuenca;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
16 Cuenca;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
16 Cuenca;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;97,59
16 Cuenca;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
16 Cuenca;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
16 Cuenca;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
16 Cuenca;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;97,49
16 Cuenca;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
16 Cuenca;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
16 Cuenca;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
16 Cuenca;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;97,99
16 Cuenca;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
16 Cuenca;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
16 Cuenca;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;95,16
16 Cuenca;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
16 Cuenca;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
16 Cuenca;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
16 Cuenca;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;95,37
16 Cuenca;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
16 Cuenca;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
16 Cuenca;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
16 Cuenca;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;95,68
16 Cuenca;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
16 Cuenca;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
16 Cuenca;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;92,31
16 Cuenca;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
16 Cuenca;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
16 Cuenca;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
16 Cuenca;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;93,04
16 Cuenca;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
16 Cuenca;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
16 Cuenca;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
16 Cuenca;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;93,46
16 Cuenca;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
16 Cuenca;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
16 Cuenca;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
16 Cuenca;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
16 Cuenca;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
16 Cuenca;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
16 Cuenca;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;90,9
16 Cuenca;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
16 Cuenca;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
16 Cuenca;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
16 Cuenca;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;91,87
16 Cuenca;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
16 Cuenca;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
16 Cuenca;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
16 Cuenca;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
16 Cuenca;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
16 Cuenca;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
16 Cuenca;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QII;8.711
16 Cuenca;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
16 Cuenca;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
16 Cuenca;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
16 Cuenca;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QII;8.697
16 Cuenca;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
16 Cuenca;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
16 Cuenca;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
16 Cuenca;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QII;8.670
16 Cuenca;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
16 Cuenca;All ages;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
16 Cuenca;All ages;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
16 Cuenca;All ages;Cohort April 1;Males;Survival in the first trimester;2022QII;8.539
16 Cuenca;All ages;Cohort April 1;Males;Survival in the first trimester;2022QI;""
16 Cuenca;All ages;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
16 Cuenca;All ages;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
16 Cuenca;All ages;Cohort April 1;Males;Survival in the first trimester;2021QII;8.499
16 Cuenca;All ages;Cohort April 1;Males;Survival in the first trimester;2021QI;""
16 Cuenca;All ages;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
16 Cuenca;All ages;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
16 Cuenca;All ages;Cohort April 1;Males;Survival in the first trimester;2020QII;8.517
16 Cuenca;All ages;Cohort April 1;Males;Survival in the first trimester;2020QI;""
16 Cuenca;All ages;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
16 Cuenca;All ages;Cohort April 1;Males;Survival in the second trimester;2022QIII;8.363
16 Cuenca;All ages;Cohort April 1;Males;Survival in the second trimester;2022QII;""
16 Cuenca;All ages;Cohort April 1;Males;Survival in the second trimester;2022QI;""
16 Cuenca;All ages;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
16 Cuenca;All ages;Cohort April 1;Males;Survival in the second trimester;2021QIII;8.342
16 Cuenca;All ages;Cohort April 1;Males;Survival in the second trimester;2021QII;""
16 Cuenca;All ages;Cohort April 1;Males;Survival in the second trimester;2021QI;""
16 Cuenca;All ages;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
16 Cuenca;All ages;Cohort April 1;Males;Survival in the second trimester;2020QIII;8.332
16 Cuenca;All ages;Cohort April 1;Males;Survival in the second trimester;2020QII;""
16 Cuenca;All ages;Cohort April 1;Males;Survival in the second trimester;2020QI;""
16 Cuenca;All ages;Cohort April 1;Males;Survival in the third trimester;2022QIV;8.117
16 Cuenca;All ages;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
16 Cuenca;All ages;Cohort April 1;Males;Survival in the third trimester;2022QII;""
16 Cuenca;All ages;Cohort April 1;Males;Survival in the third trimester;2022QI;""
16 Cuenca;All ages;Cohort April 1;Males;Survival in the third trimester;2021QIV;8.142
16 Cuenca;All ages;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
16 Cuenca;All ages;Cohort April 1;Males;Survival in the third trimester;2021QII;""
16 Cuenca;All ages;Cohort April 1;Males;Survival in the third trimester;2021QI;""
16 Cuenca;All ages;Cohort April 1;Males;Survival in the third trimester;2020QIV;8.141
16 Cuenca;All ages;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
16 Cuenca;All ages;Cohort April 1;Males;Survival in the third trimester;2020QII;""
16 Cuenca;All ages;Cohort April 1;Males;Survival in the third trimester;2020QI;""
16 Cuenca;All ages;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
16 Cuenca;All ages;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
16 Cuenca;All ages;Cohort April 1;Males;Survival in the third trimester;2022QII;""
16 Cuenca;All ages;Cohort April 1;Males;Survival in the third trimester;2022QI;7.970
16 Cuenca;All ages;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
16 Cuenca;All ages;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
16 Cuenca;All ages;Cohort April 1;Males;Survival in the third trimester;2021QII;""
16 Cuenca;All ages;Cohort April 1;Males;Survival in the third trimester;2021QI;8.011
16 Cuenca;All ages;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
16 Cuenca;All ages;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
16 Cuenca;All ages;Cohort April 1;Males;Survival in the third trimester;2020QII;""
16 Cuenca;All ages;Cohort April 1;Males;Survival in the third trimester;2020QI;""
16 Cuenca;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
16 Cuenca;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
16 Cuenca;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
16 Cuenca;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
16 Cuenca;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
16 Cuenca;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
16 Cuenca;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
16 Cuenca;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
16 Cuenca;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
16 Cuenca;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
16 Cuenca;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
16 Cuenca;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
16 Cuenca;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
16 Cuenca;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
16 Cuenca;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;98,03
16 Cuenca;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
16 Cuenca;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
16 Cuenca;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
16 Cuenca;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;97,72
16 Cuenca;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
16 Cuenca;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
16 Cuenca;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
16 Cuenca;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;98,24
16 Cuenca;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
16 Cuenca;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
16 Cuenca;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;96,01
16 Cuenca;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
16 Cuenca;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
16 Cuenca;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
16 Cuenca;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;95,92
16 Cuenca;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
16 Cuenca;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
16 Cuenca;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
16 Cuenca;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;96,1
16 Cuenca;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
16 Cuenca;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
16 Cuenca;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;93,18
16 Cuenca;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
16 Cuenca;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
16 Cuenca;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
16 Cuenca;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;93,62
16 Cuenca;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
16 Cuenca;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
16 Cuenca;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
16 Cuenca;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;93,9
16 Cuenca;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
16 Cuenca;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
16 Cuenca;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
16 Cuenca;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
16 Cuenca;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
16 Cuenca;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
16 Cuenca;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;91,64
16 Cuenca;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
16 Cuenca;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
16 Cuenca;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
16 Cuenca;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;92,4
16 Cuenca;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
16 Cuenca;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
16 Cuenca;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
16 Cuenca;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
16 Cuenca;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
16 Cuenca;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
16 Cuenca;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QII;4.295
16 Cuenca;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
16 Cuenca;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
16 Cuenca;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
16 Cuenca;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QII;4.228
16 Cuenca;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
16 Cuenca;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
16 Cuenca;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
16 Cuenca;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QII;4.142
16 Cuenca;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
16 Cuenca;All ages;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
16 Cuenca;All ages;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
16 Cuenca;All ages;Cohort April 1;Females;Survival in the first trimester;2022QII;4.153
16 Cuenca;All ages;Cohort April 1;Females;Survival in the first trimester;2022QI;""
16 Cuenca;All ages;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
16 Cuenca;All ages;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
16 Cuenca;All ages;Cohort April 1;Females;Survival in the first trimester;2021QII;4.101
16 Cuenca;All ages;Cohort April 1;Females;Survival in the first trimester;2021QI;""
16 Cuenca;All ages;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
16 Cuenca;All ages;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
16 Cuenca;All ages;Cohort April 1;Females;Survival in the first trimester;2020QII;4.037
16 Cuenca;All ages;Cohort April 1;Females;Survival in the first trimester;2020QI;""
16 Cuenca;All ages;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
16 Cuenca;All ages;Cohort April 1;Females;Survival in the second trimester;2022QIII;4.014
16 Cuenca;All ages;Cohort April 1;Females;Survival in the second trimester;2022QII;""
16 Cuenca;All ages;Cohort April 1;Females;Survival in the second trimester;2022QI;""
16 Cuenca;All ages;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
16 Cuenca;All ages;Cohort April 1;Females;Survival in the second trimester;2021QIII;3.985
16 Cuenca;All ages;Cohort April 1;Females;Survival in the second trimester;2021QII;""
16 Cuenca;All ages;Cohort April 1;Females;Survival in the second trimester;2021QI;""
16 Cuenca;All ages;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
16 Cuenca;All ages;Cohort April 1;Females;Survival in the second trimester;2020QIII;3.927
16 Cuenca;All ages;Cohort April 1;Females;Survival in the second trimester;2020QII;""
16 Cuenca;All ages;Cohort April 1;Females;Survival in the second trimester;2020QI;""
16 Cuenca;All ages;Cohort April 1;Females;Survival in the third trimester;2022QIV;3.889
16 Cuenca;All ages;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
16 Cuenca;All ages;Cohort April 1;Females;Survival in the third trimester;2022QII;""
16 Cuenca;All ages;Cohort April 1;Females;Survival in the third trimester;2022QI;""
16 Cuenca;All ages;Cohort April 1;Females;Survival in the third trimester;2021QIV;3.883
16 Cuenca;All ages;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
16 Cuenca;All ages;Cohort April 1;Females;Survival in the third trimester;2021QII;""
16 Cuenca;All ages;Cohort April 1;Females;Survival in the third trimester;2021QI;""
16 Cuenca;All ages;Cohort April 1;Females;Survival in the third trimester;2020QIV;3.833
16 Cuenca;All ages;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
16 Cuenca;All ages;Cohort April 1;Females;Survival in the third trimester;2020QII;""
16 Cuenca;All ages;Cohort April 1;Females;Survival in the third trimester;2020QI;""
16 Cuenca;All ages;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
16 Cuenca;All ages;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
16 Cuenca;All ages;Cohort April 1;Females;Survival in the third trimester;2022QII;""
16 Cuenca;All ages;Cohort April 1;Females;Survival in the third trimester;2022QI;3.779
16 Cuenca;All ages;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
16 Cuenca;All ages;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
16 Cuenca;All ages;Cohort April 1;Females;Survival in the third trimester;2021QII;""
16 Cuenca;All ages;Cohort April 1;Females;Survival in the third trimester;2021QI;3.760
16 Cuenca;All ages;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
16 Cuenca;All ages;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
16 Cuenca;All ages;Cohort April 1;Females;Survival in the third trimester;2020QII;""
16 Cuenca;All ages;Cohort April 1;Females;Survival in the third trimester;2020QI;""
16 Cuenca;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
16 Cuenca;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
16 Cuenca;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
16 Cuenca;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
16 Cuenca;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
16 Cuenca;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
16 Cuenca;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
16 Cuenca;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
16 Cuenca;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
16 Cuenca;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
16 Cuenca;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
16 Cuenca;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
16 Cuenca;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
16 Cuenca;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
16 Cuenca;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;96,69
16 Cuenca;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
16 Cuenca;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
16 Cuenca;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
16 Cuenca;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;97
16 Cuenca;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
16 Cuenca;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
16 Cuenca;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
16 Cuenca;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;97,46
16 Cuenca;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
16 Cuenca;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
16 Cuenca;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;93,46
16 Cuenca;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
16 Cuenca;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
16 Cuenca;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
16 Cuenca;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;94,25
16 Cuenca;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
16 Cuenca;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
16 Cuenca;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
16 Cuenca;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;94,81
16 Cuenca;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
16 Cuenca;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
16 Cuenca;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;90,55
16 Cuenca;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
16 Cuenca;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
16 Cuenca;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
16 Cuenca;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;91,84
16 Cuenca;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
16 Cuenca;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
16 Cuenca;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
16 Cuenca;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;92,54
16 Cuenca;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
16 Cuenca;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
16 Cuenca;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
16 Cuenca;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
16 Cuenca;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
16 Cuenca;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
16 Cuenca;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;89,38
16 Cuenca;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
16 Cuenca;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
16 Cuenca;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
16 Cuenca;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;90,78
16 Cuenca;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
16 Cuenca;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
16 Cuenca;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
16 Cuenca;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
16 Cuenca;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
16 Cuenca;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QIII;13.144
16 Cuenca;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
16 Cuenca;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
16 Cuenca;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
16 Cuenca;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QIII;13.017
16 Cuenca;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
16 Cuenca;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
16 Cuenca;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
16 Cuenca;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QIII;12.887
16 Cuenca;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
16 Cuenca;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
16 Cuenca;All ages;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
16 Cuenca;All ages;Cohort July 1;Total;Survival in the first trimester;2022QIII;12.733
16 Cuenca;All ages;Cohort July 1;Total;Survival in the first trimester;2022QII;""
16 Cuenca;All ages;Cohort July 1;Total;Survival in the first trimester;2022QI;""
16 Cuenca;All ages;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
16 Cuenca;All ages;Cohort July 1;Total;Survival in the first trimester;2021QIII;12.657
16 Cuenca;All ages;Cohort July 1;Total;Survival in the first trimester;2021QII;""
16 Cuenca;All ages;Cohort July 1;Total;Survival in the first trimester;2021QI;""
16 Cuenca;All ages;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
16 Cuenca;All ages;Cohort July 1;Total;Survival in the first trimester;2020QIII;12.530
16 Cuenca;All ages;Cohort July 1;Total;Survival in the first trimester;2020QII;""
16 Cuenca;All ages;Cohort July 1;Total;Survival in the first trimester;2020QI;""
16 Cuenca;All ages;Cohort July 1;Total;Survival in the second trimester;2022QIV;12.322
16 Cuenca;All ages;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
16 Cuenca;All ages;Cohort July 1;Total;Survival in the second trimester;2022QII;""
16 Cuenca;All ages;Cohort July 1;Total;Survival in the second trimester;2022QI;""
16 Cuenca;All ages;Cohort July 1;Total;Survival in the second trimester;2021QIV;12.319
16 Cuenca;All ages;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
16 Cuenca;All ages;Cohort July 1;Total;Survival in the second trimester;2021QII;""
16 Cuenca;All ages;Cohort July 1;Total;Survival in the second trimester;2021QI;""
16 Cuenca;All ages;Cohort July 1;Total;Survival in the second trimester;2020QIV;12.206
16 Cuenca;All ages;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
16 Cuenca;All ages;Cohort July 1;Total;Survival in the second trimester;2020QII;""
16 Cuenca;All ages;Cohort July 1;Total;Survival in the second trimester;2020QI;""
16 Cuenca;All ages;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
16 Cuenca;All ages;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
16 Cuenca;All ages;Cohort July 1;Total;Survival in the third trimester;2022QII;""
16 Cuenca;All ages;Cohort July 1;Total;Survival in the third trimester;2022QI;12.019
16 Cuenca;All ages;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
16 Cuenca;All ages;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
16 Cuenca;All ages;Cohort July 1;Total;Survival in the third trimester;2021QII;""
16 Cuenca;All ages;Cohort July 1;Total;Survival in the third trimester;2021QI;11.992
16 Cuenca;All ages;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
16 Cuenca;All ages;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
16 Cuenca;All ages;Cohort July 1;Total;Survival in the third trimester;2020QII;""
16 Cuenca;All ages;Cohort July 1;Total;Survival in the third trimester;2020QI;""
16 Cuenca;All ages;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
16 Cuenca;All ages;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
16 Cuenca;All ages;Cohort July 1;Total;Survival in the third trimester;2022QII;11.776
16 Cuenca;All ages;Cohort July 1;Total;Survival in the third trimester;2022QI;""
16 Cuenca;All ages;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
16 Cuenca;All ages;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
16 Cuenca;All ages;Cohort July 1;Total;Survival in the third trimester;2021QII;11.726
16 Cuenca;All ages;Cohort July 1;Total;Survival in the third trimester;2021QI;""
16 Cuenca;All ages;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
16 Cuenca;All ages;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
16 Cuenca;All ages;Cohort July 1;Total;Survival in the third trimester;2020QII;""
16 Cuenca;All ages;Cohort July 1;Total;Survival in the third trimester;2020QI;""
16 Cuenca;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
16 Cuenca;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
16 Cuenca;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
16 Cuenca;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
16 Cuenca;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
16 Cuenca;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
16 Cuenca;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
16 Cuenca;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
16 Cuenca;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
16 Cuenca;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
16 Cuenca;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
16 Cuenca;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
16 Cuenca;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
16 Cuenca;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;96,87
16 Cuenca;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
16 Cuenca;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
16 Cuenca;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
16 Cuenca;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;97,23
16 Cuenca;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
16 Cuenca;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
16 Cuenca;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
16 Cuenca;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;97,23
16 Cuenca;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
16 Cuenca;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
16 Cuenca;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;93,75
16 Cuenca;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
16 Cuenca;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
16 Cuenca;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
16 Cuenca;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;94,64
16 Cuenca;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
16 Cuenca;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
16 Cuenca;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
16 Cuenca;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;94,72
16 Cuenca;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
16 Cuenca;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
16 Cuenca;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
16 Cuenca;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
16 Cuenca;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
16 Cuenca;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
16 Cuenca;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;92,33
16 Cuenca;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
16 Cuenca;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
16 Cuenca;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
16 Cuenca;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;93,06
16 Cuenca;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
16 Cuenca;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
16 Cuenca;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
16 Cuenca;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
16 Cuenca;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
16 Cuenca;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
16 Cuenca;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;90,47
16 Cuenca;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
16 Cuenca;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
16 Cuenca;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
16 Cuenca;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;90,99
16 Cuenca;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
16 Cuenca;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
16 Cuenca;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
16 Cuenca;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
16 Cuenca;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
16 Cuenca;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
16 Cuenca;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QIII;8.823
16 Cuenca;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
16 Cuenca;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
16 Cuenca;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
16 Cuenca;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QIII;8.749
16 Cuenca;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
16 Cuenca;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
16 Cuenca;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
16 Cuenca;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QIII;8.746
16 Cuenca;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
16 Cuenca;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
16 Cuenca;All ages;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
16 Cuenca;All ages;Cohort July 1;Males;Survival in the first trimester;2022QIII;8.590
16 Cuenca;All ages;Cohort July 1;Males;Survival in the first trimester;2022QII;""
16 Cuenca;All ages;Cohort July 1;Males;Survival in the first trimester;2022QI;""
16 Cuenca;All ages;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
16 Cuenca;All ages;Cohort July 1;Males;Survival in the first trimester;2021QIII;8.536
16 Cuenca;All ages;Cohort July 1;Males;Survival in the first trimester;2021QII;""
16 Cuenca;All ages;Cohort July 1;Males;Survival in the first trimester;2021QI;""
16 Cuenca;All ages;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
16 Cuenca;All ages;Cohort July 1;Males;Survival in the first trimester;2020QIII;8.519
16 Cuenca;All ages;Cohort July 1;Males;Survival in the first trimester;2020QII;""
16 Cuenca;All ages;Cohort July 1;Males;Survival in the first trimester;2020QI;""
16 Cuenca;All ages;Cohort July 1;Males;Survival in the second trimester;2022QIV;8.313
16 Cuenca;All ages;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
16 Cuenca;All ages;Cohort July 1;Males;Survival in the second trimester;2022QII;""
16 Cuenca;All ages;Cohort July 1;Males;Survival in the second trimester;2022QI;""
16 Cuenca;All ages;Cohort July 1;Males;Survival in the second trimester;2021QIV;8.311
16 Cuenca;All ages;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
16 Cuenca;All ages;Cohort July 1;Males;Survival in the second trimester;2021QII;""
16 Cuenca;All ages;Cohort July 1;Males;Survival in the second trimester;2021QI;""
16 Cuenca;All ages;Cohort July 1;Males;Survival in the second trimester;2020QIV;8.292
16 Cuenca;All ages;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
16 Cuenca;All ages;Cohort July 1;Males;Survival in the second trimester;2020QII;""
16 Cuenca;All ages;Cohort July 1;Males;Survival in the second trimester;2020QI;""
16 Cuenca;All ages;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
16 Cuenca;All ages;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
16 Cuenca;All ages;Cohort July 1;Males;Survival in the third trimester;2022QII;""
16 Cuenca;All ages;Cohort July 1;Males;Survival in the third trimester;2022QI;8.126
16 Cuenca;All ages;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
16 Cuenca;All ages;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
16 Cuenca;All ages;Cohort July 1;Males;Survival in the third trimester;2021QII;""
16 Cuenca;All ages;Cohort July 1;Males;Survival in the third trimester;2021QI;8.153
16 Cuenca;All ages;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
16 Cuenca;All ages;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
16 Cuenca;All ages;Cohort July 1;Males;Survival in the third trimester;2020QII;""
16 Cuenca;All ages;Cohort July 1;Males;Survival in the third trimester;2020QI;""
16 Cuenca;All ages;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
16 Cuenca;All ages;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
16 Cuenca;All ages;Cohort July 1;Males;Survival in the third trimester;2022QII;7.994
16 Cuenca;All ages;Cohort July 1;Males;Survival in the third trimester;2022QI;""
16 Cuenca;All ages;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
16 Cuenca;All ages;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
16 Cuenca;All ages;Cohort July 1;Males;Survival in the third trimester;2021QII;7.988
16 Cuenca;All ages;Cohort July 1;Males;Survival in the third trimester;2021QI;""
16 Cuenca;All ages;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
16 Cuenca;All ages;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
16 Cuenca;All ages;Cohort July 1;Males;Survival in the third trimester;2020QII;""
16 Cuenca;All ages;Cohort July 1;Males;Survival in the third trimester;2020QI;""
16 Cuenca;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
16 Cuenca;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
16 Cuenca;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
16 Cuenca;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
16 Cuenca;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
16 Cuenca;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
16 Cuenca;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
16 Cuenca;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
16 Cuenca;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
16 Cuenca;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
16 Cuenca;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
16 Cuenca;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
16 Cuenca;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
16 Cuenca;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;97,36
16 Cuenca;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
16 Cuenca;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
16 Cuenca;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
16 Cuenca;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;97,57
16 Cuenca;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
16 Cuenca;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
16 Cuenca;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
16 Cuenca;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;97,4
16 Cuenca;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
16 Cuenca;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
16 Cuenca;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;94,22
16 Cuenca;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
16 Cuenca;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
16 Cuenca;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
16 Cuenca;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;94,99
16 Cuenca;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
16 Cuenca;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
16 Cuenca;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
16 Cuenca;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;94,81
16 Cuenca;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
16 Cuenca;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
16 Cuenca;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
16 Cuenca;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
16 Cuenca;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
16 Cuenca;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
16 Cuenca;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;92,88
16 Cuenca;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
16 Cuenca;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
16 Cuenca;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
16 Cuenca;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;93,22
16 Cuenca;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
16 Cuenca;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
16 Cuenca;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
16 Cuenca;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
16 Cuenca;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
16 Cuenca;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
16 Cuenca;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;91,37
16 Cuenca;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
16 Cuenca;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
16 Cuenca;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
16 Cuenca;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;91,33
16 Cuenca;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
16 Cuenca;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
16 Cuenca;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
16 Cuenca;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
16 Cuenca;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
16 Cuenca;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
16 Cuenca;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QIII;4.321
16 Cuenca;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
16 Cuenca;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
16 Cuenca;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
16 Cuenca;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QIII;4.268
16 Cuenca;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
16 Cuenca;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
16 Cuenca;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
16 Cuenca;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QIII;4.141
16 Cuenca;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
16 Cuenca;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
16 Cuenca;All ages;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
16 Cuenca;All ages;Cohort July 1;Females;Survival in the first trimester;2022QIII;4.143
16 Cuenca;All ages;Cohort July 1;Females;Survival in the first trimester;2022QII;""
16 Cuenca;All ages;Cohort July 1;Females;Survival in the first trimester;2022QI;""
16 Cuenca;All ages;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
16 Cuenca;All ages;Cohort July 1;Females;Survival in the first trimester;2021QIII;4.121
16 Cuenca;All ages;Cohort July 1;Females;Survival in the first trimester;2021QII;""
16 Cuenca;All ages;Cohort July 1;Females;Survival in the first trimester;2021QI;""
16 Cuenca;All ages;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
16 Cuenca;All ages;Cohort July 1;Females;Survival in the first trimester;2020QIII;4.011
16 Cuenca;All ages;Cohort July 1;Females;Survival in the first trimester;2020QII;""
16 Cuenca;All ages;Cohort July 1;Females;Survival in the first trimester;2020QI;""
16 Cuenca;All ages;Cohort July 1;Females;Survival in the second trimester;2022QIV;4.009
16 Cuenca;All ages;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
16 Cuenca;All ages;Cohort July 1;Females;Survival in the second trimester;2022QII;""
16 Cuenca;All ages;Cohort July 1;Females;Survival in the second trimester;2022QI;""
16 Cuenca;All ages;Cohort July 1;Females;Survival in the second trimester;2021QIV;4.008
16 Cuenca;All ages;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
16 Cuenca;All ages;Cohort July 1;Females;Survival in the second trimester;2021QII;""
16 Cuenca;All ages;Cohort July 1;Females;Survival in the second trimester;2021QI;""
16 Cuenca;All ages;Cohort July 1;Females;Survival in the second trimester;2020QIV;3.914
16 Cuenca;All ages;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
16 Cuenca;All ages;Cohort July 1;Females;Survival in the second trimester;2020QII;""
16 Cuenca;All ages;Cohort July 1;Females;Survival in the second trimester;2020QI;""
16 Cuenca;All ages;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
16 Cuenca;All ages;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
16 Cuenca;All ages;Cohort July 1;Females;Survival in the third trimester;2022QII;""
16 Cuenca;All ages;Cohort July 1;Females;Survival in the third trimester;2022QI;3.893
16 Cuenca;All ages;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
16 Cuenca;All ages;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
16 Cuenca;All ages;Cohort July 1;Females;Survival in the third trimester;2021QII;""
16 Cuenca;All ages;Cohort July 1;Females;Survival in the third trimester;2021QI;3.839
16 Cuenca;All ages;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
16 Cuenca;All ages;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
16 Cuenca;All ages;Cohort July 1;Females;Survival in the third trimester;2020QII;""
16 Cuenca;All ages;Cohort July 1;Females;Survival in the third trimester;2020QI;""
16 Cuenca;All ages;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
16 Cuenca;All ages;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
16 Cuenca;All ages;Cohort July 1;Females;Survival in the third trimester;2022QII;3.782
16 Cuenca;All ages;Cohort July 1;Females;Survival in the third trimester;2022QI;""
16 Cuenca;All ages;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
16 Cuenca;All ages;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
16 Cuenca;All ages;Cohort July 1;Females;Survival in the third trimester;2021QII;3.738
16 Cuenca;All ages;Cohort July 1;Females;Survival in the third trimester;2021QI;""
16 Cuenca;All ages;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
16 Cuenca;All ages;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
16 Cuenca;All ages;Cohort July 1;Females;Survival in the third trimester;2020QII;""
16 Cuenca;All ages;Cohort July 1;Females;Survival in the third trimester;2020QI;""
16 Cuenca;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
16 Cuenca;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
16 Cuenca;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
16 Cuenca;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
16 Cuenca;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
16 Cuenca;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
16 Cuenca;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
16 Cuenca;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
16 Cuenca;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
16 Cuenca;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
16 Cuenca;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
16 Cuenca;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
16 Cuenca;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
16 Cuenca;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;95,88
16 Cuenca;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
16 Cuenca;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
16 Cuenca;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
16 Cuenca;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;96,56
16 Cuenca;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
16 Cuenca;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
16 Cuenca;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
16 Cuenca;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;96,86
16 Cuenca;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
16 Cuenca;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
16 Cuenca;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;92,78
16 Cuenca;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
16 Cuenca;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
16 Cuenca;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
16 Cuenca;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;93,91
16 Cuenca;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
16 Cuenca;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
16 Cuenca;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
16 Cuenca;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;94,52
16 Cuenca;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
16 Cuenca;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
16 Cuenca;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
16 Cuenca;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
16 Cuenca;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
16 Cuenca;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
16 Cuenca;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;91,21
16 Cuenca;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
16 Cuenca;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
16 Cuenca;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
16 Cuenca;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;92,71
16 Cuenca;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
16 Cuenca;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
16 Cuenca;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
16 Cuenca;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
16 Cuenca;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
16 Cuenca;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
16 Cuenca;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;88,61
16 Cuenca;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
16 Cuenca;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
16 Cuenca;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
16 Cuenca;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;90,27
16 Cuenca;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
16 Cuenca;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
16 Cuenca;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
16 Cuenca;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
16 Cuenca;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
16 Cuenca;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QIV;13.021
16 Cuenca;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
16 Cuenca;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
16 Cuenca;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
16 Cuenca;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QIV;12.963
16 Cuenca;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
16 Cuenca;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
16 Cuenca;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
16 Cuenca;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QIV;12.880
16 Cuenca;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
16 Cuenca;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
16 Cuenca;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
16 Cuenca;All ages;Cohort October 1;Total;Survival in the first trimester;2022QIV;12.574
16 Cuenca;All ages;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
16 Cuenca;All ages;Cohort October 1;Total;Survival in the first trimester;2022QII;""
16 Cuenca;All ages;Cohort October 1;Total;Survival in the first trimester;2022QI;""
16 Cuenca;All ages;Cohort October 1;Total;Survival in the first trimester;2021QIV;12.592
16 Cuenca;All ages;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
16 Cuenca;All ages;Cohort October 1;Total;Survival in the first trimester;2021QII;""
16 Cuenca;All ages;Cohort October 1;Total;Survival in the first trimester;2021QI;""
16 Cuenca;All ages;Cohort October 1;Total;Survival in the first trimester;2020QIV;12.511
16 Cuenca;All ages;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
16 Cuenca;All ages;Cohort October 1;Total;Survival in the first trimester;2020QII;""
16 Cuenca;All ages;Cohort October 1;Total;Survival in the first trimester;2020QI;""
16 Cuenca;All ages;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
16 Cuenca;All ages;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
16 Cuenca;All ages;Cohort October 1;Total;Survival in the second trimester;2022QII;""
16 Cuenca;All ages;Cohort October 1;Total;Survival in the second trimester;2022QI;12.271
16 Cuenca;All ages;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
16 Cuenca;All ages;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
16 Cuenca;All ages;Cohort October 1;Total;Survival in the second trimester;2021QII;""
16 Cuenca;All ages;Cohort October 1;Total;Survival in the second trimester;2021QI;12.278
16 Cuenca;All ages;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
16 Cuenca;All ages;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
16 Cuenca;All ages;Cohort October 1;Total;Survival in the second trimester;2020QII;""
16 Cuenca;All ages;Cohort October 1;Total;Survival in the second trimester;2020QI;""
16 Cuenca;All ages;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
16 Cuenca;All ages;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
16 Cuenca;All ages;Cohort October 1;Total;Survival in the third trimester;2022QII;12.015
16 Cuenca;All ages;Cohort October 1;Total;Survival in the third trimester;2022QI;""
16 Cuenca;All ages;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
16 Cuenca;All ages;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
16 Cuenca;All ages;Cohort October 1;Total;Survival in the third trimester;2021QII;11.997
16 Cuenca;All ages;Cohort October 1;Total;Survival in the third trimester;2021QI;""
16 Cuenca;All ages;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
16 Cuenca;All ages;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
16 Cuenca;All ages;Cohort October 1;Total;Survival in the third trimester;2020QII;""
16 Cuenca;All ages;Cohort October 1;Total;Survival in the third trimester;2020QI;""
16 Cuenca;All ages;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
16 Cuenca;All ages;Cohort October 1;Total;Survival in the third trimester;2022QIII;11.747
16 Cuenca;All ages;Cohort October 1;Total;Survival in the third trimester;2022QII;""
16 Cuenca;All ages;Cohort October 1;Total;Survival in the third trimester;2022QI;""
16 Cuenca;All ages;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
16 Cuenca;All ages;Cohort October 1;Total;Survival in the third trimester;2021QIII;11.759
16 Cuenca;All ages;Cohort October 1;Total;Survival in the third trimester;2021QII;""
16 Cuenca;All ages;Cohort October 1;Total;Survival in the third trimester;2021QI;""
16 Cuenca;All ages;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
16 Cuenca;All ages;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
16 Cuenca;All ages;Cohort October 1;Total;Survival in the third trimester;2020QII;""
16 Cuenca;All ages;Cohort October 1;Total;Survival in the third trimester;2020QI;""
16 Cuenca;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
16 Cuenca;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
16 Cuenca;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
16 Cuenca;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
16 Cuenca;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
16 Cuenca;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
16 Cuenca;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
16 Cuenca;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
16 Cuenca;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
16 Cuenca;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
16 Cuenca;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
16 Cuenca;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
16 Cuenca;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;96,57
16 Cuenca;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
16 Cuenca;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
16 Cuenca;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
16 Cuenca;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;97,14
16 Cuenca;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
16 Cuenca;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
16 Cuenca;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
16 Cuenca;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;97,14
16 Cuenca;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
16 Cuenca;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
16 Cuenca;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
16 Cuenca;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
16 Cuenca;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
16 Cuenca;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
16 Cuenca;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;94,66
16 Cuenca;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
16 Cuenca;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
16 Cuenca;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
16 Cuenca;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;95,33
16 Cuenca;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
16 Cuenca;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
16 Cuenca;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
16 Cuenca;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
16 Cuenca;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
16 Cuenca;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
16 Cuenca;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;92,69
16 Cuenca;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
16 Cuenca;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
16 Cuenca;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
16 Cuenca;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;93,14
16 Cuenca;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
16 Cuenca;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
16 Cuenca;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
16 Cuenca;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
16 Cuenca;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
16 Cuenca;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
16 Cuenca;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;90,62
16 Cuenca;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
16 Cuenca;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
16 Cuenca;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
16 Cuenca;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;91,3
16 Cuenca;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
16 Cuenca;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
16 Cuenca;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
16 Cuenca;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
16 Cuenca;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
16 Cuenca;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
16 Cuenca;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QIV;8.766
16 Cuenca;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
16 Cuenca;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
16 Cuenca;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
16 Cuenca;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QIV;8.717
16 Cuenca;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
16 Cuenca;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
16 Cuenca;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
16 Cuenca;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QIV;8.717
16 Cuenca;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
16 Cuenca;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
16 Cuenca;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
16 Cuenca;All ages;Cohort October 1;Males;Survival in the first trimester;2022QIV;8.464
16 Cuenca;All ages;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
16 Cuenca;All ages;Cohort October 1;Males;Survival in the first trimester;2022QII;""
16 Cuenca;All ages;Cohort October 1;Males;Survival in the first trimester;2022QI;""
16 Cuenca;All ages;Cohort October 1;Males;Survival in the first trimester;2021QIV;8.470
16 Cuenca;All ages;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
16 Cuenca;All ages;Cohort October 1;Males;Survival in the first trimester;2021QII;""
16 Cuenca;All ages;Cohort October 1;Males;Survival in the first trimester;2021QI;""
16 Cuenca;All ages;Cohort October 1;Males;Survival in the first trimester;2020QIV;8.463
16 Cuenca;All ages;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
16 Cuenca;All ages;Cohort October 1;Males;Survival in the first trimester;2020QII;""
16 Cuenca;All ages;Cohort October 1;Males;Survival in the first trimester;2020QI;""
16 Cuenca;All ages;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
16 Cuenca;All ages;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
16 Cuenca;All ages;Cohort October 1;Males;Survival in the second trimester;2022QII;""
16 Cuenca;All ages;Cohort October 1;Males;Survival in the second trimester;2022QI;8.274
16 Cuenca;All ages;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
16 Cuenca;All ages;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
16 Cuenca;All ages;Cohort October 1;Males;Survival in the second trimester;2021QII;""
16 Cuenca;All ages;Cohort October 1;Males;Survival in the second trimester;2021QI;8.312
16 Cuenca;All ages;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
16 Cuenca;All ages;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
16 Cuenca;All ages;Cohort October 1;Males;Survival in the second trimester;2020QII;""
16 Cuenca;All ages;Cohort October 1;Males;Survival in the second trimester;2020QI;""
16 Cuenca;All ages;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
16 Cuenca;All ages;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
16 Cuenca;All ages;Cohort October 1;Males;Survival in the third trimester;2022QII;8.133
16 Cuenca;All ages;Cohort October 1;Males;Survival in the third trimester;2022QI;""
16 Cuenca;All ages;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
16 Cuenca;All ages;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
16 Cuenca;All ages;Cohort October 1;Males;Survival in the third trimester;2021QII;8.140
16 Cuenca;All ages;Cohort October 1;Males;Survival in the third trimester;2021QI;""
16 Cuenca;All ages;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
16 Cuenca;All ages;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
16 Cuenca;All ages;Cohort October 1;Males;Survival in the third trimester;2020QII;""
16 Cuenca;All ages;Cohort October 1;Males;Survival in the third trimester;2020QI;""
16 Cuenca;All ages;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
16 Cuenca;All ages;Cohort October 1;Males;Survival in the third trimester;2022QIII;7.984
16 Cuenca;All ages;Cohort October 1;Males;Survival in the third trimester;2022QII;""
16 Cuenca;All ages;Cohort October 1;Males;Survival in the third trimester;2022QI;""
16 Cuenca;All ages;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
16 Cuenca;All ages;Cohort October 1;Males;Survival in the third trimester;2021QIII;8.007
16 Cuenca;All ages;Cohort October 1;Males;Survival in the third trimester;2021QII;""
16 Cuenca;All ages;Cohort October 1;Males;Survival in the third trimester;2021QI;""
16 Cuenca;All ages;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
16 Cuenca;All ages;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
16 Cuenca;All ages;Cohort October 1;Males;Survival in the third trimester;2020QII;""
16 Cuenca;All ages;Cohort October 1;Males;Survival in the third trimester;2020QI;""
16 Cuenca;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
16 Cuenca;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
16 Cuenca;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
16 Cuenca;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
16 Cuenca;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
16 Cuenca;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
16 Cuenca;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
16 Cuenca;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
16 Cuenca;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
16 Cuenca;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
16 Cuenca;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
16 Cuenca;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
16 Cuenca;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;96,55
16 Cuenca;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
16 Cuenca;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
16 Cuenca;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
16 Cuenca;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;97,17
16 Cuenca;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
16 Cuenca;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
16 Cuenca;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
16 Cuenca;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;97,09
16 Cuenca;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
16 Cuenca;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
16 Cuenca;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
16 Cuenca;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
16 Cuenca;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
16 Cuenca;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
16 Cuenca;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;94,92
16 Cuenca;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
16 Cuenca;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
16 Cuenca;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
16 Cuenca;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;95,35
16 Cuenca;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
16 Cuenca;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
16 Cuenca;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
16 Cuenca;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
16 Cuenca;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
16 Cuenca;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
16 Cuenca;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;93,3
16 Cuenca;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
16 Cuenca;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
16 Cuenca;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
16 Cuenca;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;93,38
16 Cuenca;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
16 Cuenca;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
16 Cuenca;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
16 Cuenca;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
16 Cuenca;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
16 Cuenca;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
16 Cuenca;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;91,59
16 Cuenca;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
16 Cuenca;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
16 Cuenca;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
16 Cuenca;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;91,85
16 Cuenca;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
16 Cuenca;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
16 Cuenca;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
16 Cuenca;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
16 Cuenca;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
16 Cuenca;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
16 Cuenca;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QIV;4.255
16 Cuenca;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
16 Cuenca;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
16 Cuenca;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
16 Cuenca;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QIV;4.246
16 Cuenca;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
16 Cuenca;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
16 Cuenca;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
16 Cuenca;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QIV;4.163
16 Cuenca;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
16 Cuenca;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
16 Cuenca;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
16 Cuenca;All ages;Cohort October 1;Females;Survival in the first trimester;2022QIV;4.110
16 Cuenca;All ages;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
16 Cuenca;All ages;Cohort October 1;Females;Survival in the first trimester;2022QII;""
16 Cuenca;All ages;Cohort October 1;Females;Survival in the first trimester;2022QI;""
16 Cuenca;All ages;Cohort October 1;Females;Survival in the first trimester;2021QIV;4.122
16 Cuenca;All ages;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
16 Cuenca;All ages;Cohort October 1;Females;Survival in the first trimester;2021QII;""
16 Cuenca;All ages;Cohort October 1;Females;Survival in the first trimester;2021QI;""
16 Cuenca;All ages;Cohort October 1;Females;Survival in the first trimester;2020QIV;4.048
16 Cuenca;All ages;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
16 Cuenca;All ages;Cohort October 1;Females;Survival in the first trimester;2020QII;""
16 Cuenca;All ages;Cohort October 1;Females;Survival in the first trimester;2020QI;""
16 Cuenca;All ages;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
16 Cuenca;All ages;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
16 Cuenca;All ages;Cohort October 1;Females;Survival in the second trimester;2022QII;""
16 Cuenca;All ages;Cohort October 1;Females;Survival in the second trimester;2022QI;3.997
16 Cuenca;All ages;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
16 Cuenca;All ages;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
16 Cuenca;All ages;Cohort October 1;Females;Survival in the second trimester;2021QII;""
16 Cuenca;All ages;Cohort October 1;Females;Survival in the second trimester;2021QI;3.966
16 Cuenca;All ages;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
16 Cuenca;All ages;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
16 Cuenca;All ages;Cohort October 1;Females;Survival in the second trimester;2020QII;""
16 Cuenca;All ages;Cohort October 1;Females;Survival in the second trimester;2020QI;""
16 Cuenca;All ages;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
16 Cuenca;All ages;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
16 Cuenca;All ages;Cohort October 1;Females;Survival in the third trimester;2022QII;3.882
16 Cuenca;All ages;Cohort October 1;Females;Survival in the third trimester;2022QI;""
16 Cuenca;All ages;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
16 Cuenca;All ages;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
16 Cuenca;All ages;Cohort October 1;Females;Survival in the third trimester;2021QII;3.857
16 Cuenca;All ages;Cohort October 1;Females;Survival in the third trimester;2021QI;""
16 Cuenca;All ages;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
16 Cuenca;All ages;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
16 Cuenca;All ages;Cohort October 1;Females;Survival in the third trimester;2020QII;""
16 Cuenca;All ages;Cohort October 1;Females;Survival in the third trimester;2020QI;""
16 Cuenca;All ages;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
16 Cuenca;All ages;Cohort October 1;Females;Survival in the third trimester;2022QIII;3.763
16 Cuenca;All ages;Cohort October 1;Females;Survival in the third trimester;2022QII;""
16 Cuenca;All ages;Cohort October 1;Females;Survival in the third trimester;2022QI;""
16 Cuenca;All ages;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
16 Cuenca;All ages;Cohort October 1;Females;Survival in the third trimester;2021QIII;3.752
16 Cuenca;All ages;Cohort October 1;Females;Survival in the third trimester;2021QII;""
16 Cuenca;All ages;Cohort October 1;Females;Survival in the third trimester;2021QI;""
16 Cuenca;All ages;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
16 Cuenca;All ages;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
16 Cuenca;All ages;Cohort October 1;Females;Survival in the third trimester;2020QII;""
16 Cuenca;All ages;Cohort October 1;Females;Survival in the third trimester;2020QI;""
16 Cuenca;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
16 Cuenca;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
16 Cuenca;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
16 Cuenca;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
16 Cuenca;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
16 Cuenca;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
16 Cuenca;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
16 Cuenca;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
16 Cuenca;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
16 Cuenca;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
16 Cuenca;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
16 Cuenca;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
16 Cuenca;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;96,59
16 Cuenca;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
16 Cuenca;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
16 Cuenca;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
16 Cuenca;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;97,08
16 Cuenca;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
16 Cuenca;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
16 Cuenca;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
16 Cuenca;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;97,24
16 Cuenca;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
16 Cuenca;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
16 Cuenca;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
16 Cuenca;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
16 Cuenca;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
16 Cuenca;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
16 Cuenca;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;94,14
16 Cuenca;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
16 Cuenca;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
16 Cuenca;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
16 Cuenca;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;95,27
16 Cuenca;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
16 Cuenca;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
16 Cuenca;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
16 Cuenca;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
16 Cuenca;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
16 Cuenca;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
16 Cuenca;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;91,43
16 Cuenca;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
16 Cuenca;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
16 Cuenca;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
16 Cuenca;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;92,65
16 Cuenca;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
16 Cuenca;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
16 Cuenca;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
16 Cuenca;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
16 Cuenca;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
16 Cuenca;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
16 Cuenca;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;88,62
16 Cuenca;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
16 Cuenca;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
16 Cuenca;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
16 Cuenca;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;90,13
16 Cuenca;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
16 Cuenca;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
16 Cuenca;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
16 Cuenca;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
16 Cuenca;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
16 Cuenca;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
16 Cuenca;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
16 Cuenca;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
16 Cuenca;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
16 Cuenca;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QI;802
16 Cuenca;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
16 Cuenca;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
16 Cuenca;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
16 Cuenca;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QI;789
16 Cuenca;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
16 Cuenca;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
16 Cuenca;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
16 Cuenca;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QI;710
16 Cuenca;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
16 Cuenca;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
16 Cuenca;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2022QII;""
16 Cuenca;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2022QI;748
16 Cuenca;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
16 Cuenca;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
16 Cuenca;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2021QII;""
16 Cuenca;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2021QI;755
16 Cuenca;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
16 Cuenca;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
16 Cuenca;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2020QII;""
16 Cuenca;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2020QI;611
16 Cuenca;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
16 Cuenca;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
16 Cuenca;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2022QII;715
16 Cuenca;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2022QI;""
16 Cuenca;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
16 Cuenca;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
16 Cuenca;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2021QII;718
16 Cuenca;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2021QI;""
16 Cuenca;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
16 Cuenca;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
16 Cuenca;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2020QII;588
16 Cuenca;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2020QI;""
16 Cuenca;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
16 Cuenca;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QIII;675
16 Cuenca;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QII;""
16 Cuenca;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QI;""
16 Cuenca;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
16 Cuenca;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QIII;673
16 Cuenca;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QII;""
16 Cuenca;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QI;""
16 Cuenca;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
16 Cuenca;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QIII;558
16 Cuenca;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QII;""
16 Cuenca;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QI;""
16 Cuenca;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QIV;649
16 Cuenca;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
16 Cuenca;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QII;""
16 Cuenca;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QI;""
16 Cuenca;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QIV;641
16 Cuenca;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
16 Cuenca;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QII;""
16 Cuenca;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QI;""
16 Cuenca;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QIV;534
16 Cuenca;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
16 Cuenca;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QII;""
16 Cuenca;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QI;""
16 Cuenca;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
16 Cuenca;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
16 Cuenca;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
16 Cuenca;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
16 Cuenca;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
16 Cuenca;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
16 Cuenca;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
16 Cuenca;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
16 Cuenca;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
16 Cuenca;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
16 Cuenca;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
16 Cuenca;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
16 Cuenca;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
16 Cuenca;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
16 Cuenca;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
16 Cuenca;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;93,27
16 Cuenca;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
16 Cuenca;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
16 Cuenca;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
16 Cuenca;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;95,69
16 Cuenca;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
16 Cuenca;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
16 Cuenca;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
16 Cuenca;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;86,06
16 Cuenca;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
16 Cuenca;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
16 Cuenca;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;89,15
16 Cuenca;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
16 Cuenca;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
16 Cuenca;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
16 Cuenca;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;91
16 Cuenca;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
16 Cuenca;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
16 Cuenca;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
16 Cuenca;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;82,82
16 Cuenca;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
16 Cuenca;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
16 Cuenca;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;84,16
16 Cuenca;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
16 Cuenca;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
16 Cuenca;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
16 Cuenca;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;85,3
16 Cuenca;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
16 Cuenca;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
16 Cuenca;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
16 Cuenca;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;78,59
16 Cuenca;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
16 Cuenca;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
16 Cuenca;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;80,92
16 Cuenca;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
16 Cuenca;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
16 Cuenca;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
16 Cuenca;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;81,24
16 Cuenca;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
16 Cuenca;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
16 Cuenca;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
16 Cuenca;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;75,21
16 Cuenca;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
16 Cuenca;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
16 Cuenca;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
16 Cuenca;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
16 Cuenca;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
16 Cuenca;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
16 Cuenca;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QI;503
16 Cuenca;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
16 Cuenca;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
16 Cuenca;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
16 Cuenca;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QI;495
16 Cuenca;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
16 Cuenca;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
16 Cuenca;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
16 Cuenca;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QI;454
16 Cuenca;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
16 Cuenca;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
16 Cuenca;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2022QII;""
16 Cuenca;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2022QI;476
16 Cuenca;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
16 Cuenca;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
16 Cuenca;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2021QII;""
16 Cuenca;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2021QI;473
16 Cuenca;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
16 Cuenca;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
16 Cuenca;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2020QII;""
16 Cuenca;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2020QI;389
16 Cuenca;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
16 Cuenca;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
16 Cuenca;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2022QII;460
16 Cuenca;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2022QI;""
16 Cuenca;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
16 Cuenca;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
16 Cuenca;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2021QII;449
16 Cuenca;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2021QI;""
16 Cuenca;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
16 Cuenca;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
16 Cuenca;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2020QII;376
16 Cuenca;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2020QI;""
16 Cuenca;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
16 Cuenca;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QIII;441
16 Cuenca;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QII;""
16 Cuenca;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QI;""
16 Cuenca;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
16 Cuenca;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QIII;427
16 Cuenca;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QII;""
16 Cuenca;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QI;""
16 Cuenca;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
16 Cuenca;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QIII;357
16 Cuenca;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QII;""
16 Cuenca;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QI;""
16 Cuenca;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QIV;418
16 Cuenca;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
16 Cuenca;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QII;""
16 Cuenca;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QI;""
16 Cuenca;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QIV;406
16 Cuenca;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
16 Cuenca;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QII;""
16 Cuenca;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QI;""
16 Cuenca;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QIV;340
16 Cuenca;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
16 Cuenca;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QII;""
16 Cuenca;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QI;""
16 Cuenca;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
16 Cuenca;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
16 Cuenca;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
16 Cuenca;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
16 Cuenca;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
16 Cuenca;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
16 Cuenca;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
16 Cuenca;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
16 Cuenca;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
16 Cuenca;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
16 Cuenca;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
16 Cuenca;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
16 Cuenca;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
16 Cuenca;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
16 Cuenca;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
16 Cuenca;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;94,63
16 Cuenca;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
16 Cuenca;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
16 Cuenca;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
16 Cuenca;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;95,56
16 Cuenca;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
16 Cuenca;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
16 Cuenca;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
16 Cuenca;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;85,68
16 Cuenca;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
16 Cuenca;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
16 Cuenca;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;91,45
16 Cuenca;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
16 Cuenca;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
16 Cuenca;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
16 Cuenca;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;90,71
16 Cuenca;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
16 Cuenca;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
16 Cuenca;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
16 Cuenca;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;82,82
16 Cuenca;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
16 Cuenca;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
16 Cuenca;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;87,67
16 Cuenca;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
16 Cuenca;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
16 Cuenca;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
16 Cuenca;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;86,26
16 Cuenca;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
16 Cuenca;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
16 Cuenca;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
16 Cuenca;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;78,63
16 Cuenca;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
16 Cuenca;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
16 Cuenca;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;83,1
16 Cuenca;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
16 Cuenca;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
16 Cuenca;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
16 Cuenca;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;82,02
16 Cuenca;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
16 Cuenca;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
16 Cuenca;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
16 Cuenca;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;74,89
16 Cuenca;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
16 Cuenca;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
16 Cuenca;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
16 Cuenca;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
16 Cuenca;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
16 Cuenca;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
16 Cuenca;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QI;299
16 Cuenca;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
16 Cuenca;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
16 Cuenca;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
16 Cuenca;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QI;294
16 Cuenca;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
16 Cuenca;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
16 Cuenca;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
16 Cuenca;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QI;256
16 Cuenca;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
16 Cuenca;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
16 Cuenca;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2022QII;""
16 Cuenca;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2022QI;272
16 Cuenca;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
16 Cuenca;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
16 Cuenca;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2021QII;""
16 Cuenca;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2021QI;282
16 Cuenca;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
16 Cuenca;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
16 Cuenca;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2020QII;""
16 Cuenca;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2020QI;222
16 Cuenca;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
16 Cuenca;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
16 Cuenca;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2022QII;255
16 Cuenca;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2022QI;""
16 Cuenca;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
16 Cuenca;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
16 Cuenca;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2021QII;269
16 Cuenca;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2021QI;""
16 Cuenca;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
16 Cuenca;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
16 Cuenca;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2020QII;212
16 Cuenca;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2020QI;""
16 Cuenca;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
16 Cuenca;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QIII;234
16 Cuenca;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QII;""
16 Cuenca;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QI;""
16 Cuenca;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
16 Cuenca;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QIII;246
16 Cuenca;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QII;""
16 Cuenca;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QI;""
16 Cuenca;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
16 Cuenca;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QIII;201
16 Cuenca;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QII;""
16 Cuenca;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QI;""
16 Cuenca;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QIV;231
16 Cuenca;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
16 Cuenca;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QII;""
16 Cuenca;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QI;""
16 Cuenca;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QIV;235
16 Cuenca;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
16 Cuenca;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QII;""
16 Cuenca;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QI;""
16 Cuenca;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QIV;194
16 Cuenca;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
16 Cuenca;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QII;""
16 Cuenca;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QI;""
16 Cuenca;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
16 Cuenca;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
16 Cuenca;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
16 Cuenca;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
16 Cuenca;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
16 Cuenca;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
16 Cuenca;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
16 Cuenca;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
16 Cuenca;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
16 Cuenca;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
16 Cuenca;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
16 Cuenca;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
16 Cuenca;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
16 Cuenca;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
16 Cuenca;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
16 Cuenca;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;90,97
16 Cuenca;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
16 Cuenca;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
16 Cuenca;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
16 Cuenca;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;95,92
16 Cuenca;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
16 Cuenca;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
16 Cuenca;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
16 Cuenca;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;86,72
16 Cuenca;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
16 Cuenca;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
16 Cuenca;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;85,28
16 Cuenca;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
16 Cuenca;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
16 Cuenca;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
16 Cuenca;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;91,5
16 Cuenca;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
16 Cuenca;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
16 Cuenca;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
16 Cuenca;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;82,81
16 Cuenca;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
16 Cuenca;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
16 Cuenca;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;78,26
16 Cuenca;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
16 Cuenca;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
16 Cuenca;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
16 Cuenca;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;83,67
16 Cuenca;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
16 Cuenca;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
16 Cuenca;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
16 Cuenca;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;78,52
16 Cuenca;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
16 Cuenca;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
16 Cuenca;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;77,26
16 Cuenca;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
16 Cuenca;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
16 Cuenca;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
16 Cuenca;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;79,93
16 Cuenca;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
16 Cuenca;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
16 Cuenca;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
16 Cuenca;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;75,78
16 Cuenca;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
16 Cuenca;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
16 Cuenca;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
16 Cuenca;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
16 Cuenca;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
16 Cuenca;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QII;694
16 Cuenca;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
16 Cuenca;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
16 Cuenca;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
16 Cuenca;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QII;693
16 Cuenca;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
16 Cuenca;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
16 Cuenca;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
16 Cuenca;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QII;692
16 Cuenca;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
16 Cuenca;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
16 Cuenca;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
16 Cuenca;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2022QII;659
16 Cuenca;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2022QI;""
16 Cuenca;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
16 Cuenca;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
16 Cuenca;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2021QII;650
16 Cuenca;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2021QI;""
16 Cuenca;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
16 Cuenca;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
16 Cuenca;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2020QII;664
16 Cuenca;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2020QI;""
16 Cuenca;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
16 Cuenca;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2022QIII;619
16 Cuenca;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2022QII;""
16 Cuenca;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2022QI;""
16 Cuenca;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
16 Cuenca;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2021QIII;604
16 Cuenca;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2021QII;""
16 Cuenca;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2021QI;""
16 Cuenca;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
16 Cuenca;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2020QIII;623
16 Cuenca;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2020QII;""
16 Cuenca;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2020QI;""
16 Cuenca;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QIV;593
16 Cuenca;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
16 Cuenca;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QII;""
16 Cuenca;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QI;""
16 Cuenca;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QIV;569
16 Cuenca;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
16 Cuenca;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QII;""
16 Cuenca;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QI;""
16 Cuenca;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QIV;595
16 Cuenca;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
16 Cuenca;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QII;""
16 Cuenca;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QI;""
16 Cuenca;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
16 Cuenca;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
16 Cuenca;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QII;""
16 Cuenca;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QI;536
16 Cuenca;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
16 Cuenca;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
16 Cuenca;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QII;""
16 Cuenca;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QI;577
16 Cuenca;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
16 Cuenca;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
16 Cuenca;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QII;""
16 Cuenca;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QI;""
16 Cuenca;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
16 Cuenca;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
16 Cuenca;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
16 Cuenca;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
16 Cuenca;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
16 Cuenca;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
16 Cuenca;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
16 Cuenca;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
16 Cuenca;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
16 Cuenca;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
16 Cuenca;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
16 Cuenca;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
16 Cuenca;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
16 Cuenca;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
16 Cuenca;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;94,96
16 Cuenca;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
16 Cuenca;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
16 Cuenca;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
16 Cuenca;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;93,8
16 Cuenca;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
16 Cuenca;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
16 Cuenca;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
16 Cuenca;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;95,95
16 Cuenca;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
16 Cuenca;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
16 Cuenca;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;89,19
16 Cuenca;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
16 Cuenca;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
16 Cuenca;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
16 Cuenca;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;87,16
16 Cuenca;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
16 Cuenca;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
16 Cuenca;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
16 Cuenca;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;90,03
16 Cuenca;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
16 Cuenca;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
16 Cuenca;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;85,45
16 Cuenca;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
16 Cuenca;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
16 Cuenca;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
16 Cuenca;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;82,11
16 Cuenca;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
16 Cuenca;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
16 Cuenca;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
16 Cuenca;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;85,98
16 Cuenca;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
16 Cuenca;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
16 Cuenca;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
16 Cuenca;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
16 Cuenca;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
16 Cuenca;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
16 Cuenca;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;77,34
16 Cuenca;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
16 Cuenca;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
16 Cuenca;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
16 Cuenca;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;83,38
16 Cuenca;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
16 Cuenca;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
16 Cuenca;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
16 Cuenca;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
16 Cuenca;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
16 Cuenca;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
16 Cuenca;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QII;432
16 Cuenca;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
16 Cuenca;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
16 Cuenca;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
16 Cuenca;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QII;444
16 Cuenca;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
16 Cuenca;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
16 Cuenca;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
16 Cuenca;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QII;448
16 Cuenca;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
16 Cuenca;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
16 Cuenca;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
16 Cuenca;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2022QII;415
16 Cuenca;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2022QI;""
16 Cuenca;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
16 Cuenca;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
16 Cuenca;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2021QII;418
16 Cuenca;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2021QI;""
16 Cuenca;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
16 Cuenca;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
16 Cuenca;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2020QII;432
16 Cuenca;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2020QI;""
16 Cuenca;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
16 Cuenca;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2022QIII;399
16 Cuenca;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2022QII;""
16 Cuenca;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2022QI;""
16 Cuenca;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
16 Cuenca;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2021QIII;394
16 Cuenca;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2021QII;""
16 Cuenca;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2021QI;""
16 Cuenca;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
16 Cuenca;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2020QIII;406
16 Cuenca;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2020QII;""
16 Cuenca;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2020QI;""
16 Cuenca;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QIV;379
16 Cuenca;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
16 Cuenca;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QII;""
16 Cuenca;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QI;""
16 Cuenca;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QIV;369
16 Cuenca;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
16 Cuenca;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QII;""
16 Cuenca;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QI;""
16 Cuenca;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QIV;386
16 Cuenca;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
16 Cuenca;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QII;""
16 Cuenca;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QI;""
16 Cuenca;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
16 Cuenca;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
16 Cuenca;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QII;""
16 Cuenca;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QI;350
16 Cuenca;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
16 Cuenca;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
16 Cuenca;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QII;""
16 Cuenca;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QI;375
16 Cuenca;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
16 Cuenca;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
16 Cuenca;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QII;""
16 Cuenca;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QI;""
16 Cuenca;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
16 Cuenca;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
16 Cuenca;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
16 Cuenca;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
16 Cuenca;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
16 Cuenca;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
16 Cuenca;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
16 Cuenca;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
16 Cuenca;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
16 Cuenca;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
16 Cuenca;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
16 Cuenca;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
16 Cuenca;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
16 Cuenca;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
16 Cuenca;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;96,06
16 Cuenca;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
16 Cuenca;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
16 Cuenca;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
16 Cuenca;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;94,14
16 Cuenca;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
16 Cuenca;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
16 Cuenca;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
16 Cuenca;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;96,43
16 Cuenca;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
16 Cuenca;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
16 Cuenca;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;92,36
16 Cuenca;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
16 Cuenca;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
16 Cuenca;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
16 Cuenca;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;88,74
16 Cuenca;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
16 Cuenca;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
16 Cuenca;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
16 Cuenca;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;90,63
16 Cuenca;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
16 Cuenca;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
16 Cuenca;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;87,73
16 Cuenca;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
16 Cuenca;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
16 Cuenca;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
16 Cuenca;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;83,11
16 Cuenca;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
16 Cuenca;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
16 Cuenca;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
16 Cuenca;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;86,16
16 Cuenca;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
16 Cuenca;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
16 Cuenca;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
16 Cuenca;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
16 Cuenca;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
16 Cuenca;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
16 Cuenca;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;78,83
16 Cuenca;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
16 Cuenca;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
16 Cuenca;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
16 Cuenca;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;83,71
16 Cuenca;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
16 Cuenca;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
16 Cuenca;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
16 Cuenca;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
16 Cuenca;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
16 Cuenca;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
16 Cuenca;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QII;262
16 Cuenca;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
16 Cuenca;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
16 Cuenca;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
16 Cuenca;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QII;249
16 Cuenca;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
16 Cuenca;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
16 Cuenca;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
16 Cuenca;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QII;244
16 Cuenca;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
16 Cuenca;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
16 Cuenca;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
16 Cuenca;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2022QII;244
16 Cuenca;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2022QI;""
16 Cuenca;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
16 Cuenca;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
16 Cuenca;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2021QII;232
16 Cuenca;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2021QI;""
16 Cuenca;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
16 Cuenca;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
16 Cuenca;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2020QII;232
16 Cuenca;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2020QI;""
16 Cuenca;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
16 Cuenca;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2022QIII;220
16 Cuenca;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2022QII;""
16 Cuenca;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2022QI;""
16 Cuenca;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
16 Cuenca;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2021QIII;210
16 Cuenca;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2021QII;""
16 Cuenca;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2021QI;""
16 Cuenca;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
16 Cuenca;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2020QIII;217
16 Cuenca;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2020QII;""
16 Cuenca;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2020QI;""
16 Cuenca;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QIV;214
16 Cuenca;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
16 Cuenca;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QII;""
16 Cuenca;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QI;""
16 Cuenca;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QIV;200
16 Cuenca;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
16 Cuenca;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QII;""
16 Cuenca;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QI;""
16 Cuenca;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QIV;209
16 Cuenca;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
16 Cuenca;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QII;""
16 Cuenca;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QI;""
16 Cuenca;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
16 Cuenca;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
16 Cuenca;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QII;""
16 Cuenca;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QI;186
16 Cuenca;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
16 Cuenca;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
16 Cuenca;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QII;""
16 Cuenca;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QI;202
16 Cuenca;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
16 Cuenca;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
16 Cuenca;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QII;""
16 Cuenca;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QI;""
16 Cuenca;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
16 Cuenca;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
16 Cuenca;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
16 Cuenca;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
16 Cuenca;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
16 Cuenca;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
16 Cuenca;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
16 Cuenca;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
16 Cuenca;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
16 Cuenca;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
16 Cuenca;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
16 Cuenca;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
16 Cuenca;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
16 Cuenca;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
16 Cuenca;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;93,13
16 Cuenca;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
16 Cuenca;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
16 Cuenca;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
16 Cuenca;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;93,17
16 Cuenca;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
16 Cuenca;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
16 Cuenca;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
16 Cuenca;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;95,08
16 Cuenca;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
16 Cuenca;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
16 Cuenca;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;83,97
16 Cuenca;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
16 Cuenca;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
16 Cuenca;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
16 Cuenca;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;84,34
16 Cuenca;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
16 Cuenca;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
16 Cuenca;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
16 Cuenca;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;88,93
16 Cuenca;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
16 Cuenca;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
16 Cuenca;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;81,68
16 Cuenca;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
16 Cuenca;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
16 Cuenca;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
16 Cuenca;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;80,32
16 Cuenca;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
16 Cuenca;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
16 Cuenca;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
16 Cuenca;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;85,66
16 Cuenca;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
16 Cuenca;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
16 Cuenca;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
16 Cuenca;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
16 Cuenca;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
16 Cuenca;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
16 Cuenca;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;74,7
16 Cuenca;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
16 Cuenca;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
16 Cuenca;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
16 Cuenca;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;82,79
16 Cuenca;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
16 Cuenca;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
16 Cuenca;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
16 Cuenca;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
16 Cuenca;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
16 Cuenca;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QIII;783
16 Cuenca;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
16 Cuenca;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
16 Cuenca;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
16 Cuenca;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QIII;750
16 Cuenca;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
16 Cuenca;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
16 Cuenca;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
16 Cuenca;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QIII;727
16 Cuenca;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
16 Cuenca;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
16 Cuenca;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
16 Cuenca;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2022QIII;704
16 Cuenca;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2022QII;""
16 Cuenca;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2022QI;""
16 Cuenca;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
16 Cuenca;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2021QIII;672
16 Cuenca;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2021QII;""
16 Cuenca;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2021QI;""
16 Cuenca;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
16 Cuenca;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2020QIII;669
16 Cuenca;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2020QII;""
16 Cuenca;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2020QI;""
16 Cuenca;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2022QIV;669
16 Cuenca;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
16 Cuenca;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2022QII;""
16 Cuenca;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2022QI;""
16 Cuenca;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2021QIV;629
16 Cuenca;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
16 Cuenca;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2021QII;""
16 Cuenca;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2021QI;""
16 Cuenca;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2020QIV;631
16 Cuenca;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
16 Cuenca;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2020QII;""
16 Cuenca;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2020QI;""
16 Cuenca;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
16 Cuenca;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
16 Cuenca;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QII;""
16 Cuenca;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QI;593
16 Cuenca;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
16 Cuenca;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
16 Cuenca;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QII;""
16 Cuenca;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QI;612
16 Cuenca;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
16 Cuenca;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
16 Cuenca;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QII;""
16 Cuenca;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QI;""
16 Cuenca;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
16 Cuenca;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
16 Cuenca;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QII;570
16 Cuenca;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QI;""
16 Cuenca;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
16 Cuenca;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
16 Cuenca;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QII;586
16 Cuenca;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QI;""
16 Cuenca;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
16 Cuenca;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
16 Cuenca;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QII;""
16 Cuenca;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QI;""
16 Cuenca;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
16 Cuenca;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
16 Cuenca;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
16 Cuenca;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
16 Cuenca;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
16 Cuenca;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
16 Cuenca;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
16 Cuenca;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
16 Cuenca;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
16 Cuenca;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
16 Cuenca;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
16 Cuenca;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
16 Cuenca;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
16 Cuenca;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;89,91
16 Cuenca;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
16 Cuenca;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
16 Cuenca;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
16 Cuenca;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;89,6
16 Cuenca;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
16 Cuenca;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
16 Cuenca;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
16 Cuenca;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;92,02
16 Cuenca;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
16 Cuenca;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
16 Cuenca;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;85,44
16 Cuenca;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
16 Cuenca;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
16 Cuenca;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
16 Cuenca;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;83,87
16 Cuenca;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
16 Cuenca;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
16 Cuenca;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
16 Cuenca;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;86,8
16 Cuenca;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
16 Cuenca;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
16 Cuenca;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
16 Cuenca;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
16 Cuenca;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
16 Cuenca;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
16 Cuenca;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;79,07
16 Cuenca;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
16 Cuenca;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
16 Cuenca;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
16 Cuenca;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;84,18
16 Cuenca;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
16 Cuenca;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
16 Cuenca;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
16 Cuenca;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
16 Cuenca;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
16 Cuenca;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
16 Cuenca;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;76
16 Cuenca;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
16 Cuenca;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
16 Cuenca;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
16 Cuenca;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;80,61
16 Cuenca;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
16 Cuenca;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
16 Cuenca;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
16 Cuenca;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
16 Cuenca;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
16 Cuenca;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
16 Cuenca;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QIII;496
16 Cuenca;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
16 Cuenca;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
16 Cuenca;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
16 Cuenca;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QIII;474
16 Cuenca;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
16 Cuenca;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
16 Cuenca;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
16 Cuenca;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QIII;476
16 Cuenca;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
16 Cuenca;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
16 Cuenca;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
16 Cuenca;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2022QIII;457
16 Cuenca;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2022QII;""
16 Cuenca;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2022QI;""
16 Cuenca;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
16 Cuenca;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2021QIII;431
16 Cuenca;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2021QII;""
16 Cuenca;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2021QI;""
16 Cuenca;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
16 Cuenca;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2020QIII;439
16 Cuenca;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2020QII;""
16 Cuenca;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2020QI;""
16 Cuenca;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2022QIV;429
16 Cuenca;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
16 Cuenca;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2022QII;""
16 Cuenca;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2022QI;""
16 Cuenca;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2021QIV;401
16 Cuenca;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
16 Cuenca;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2021QII;""
16 Cuenca;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2021QI;""
16 Cuenca;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2020QIV;412
16 Cuenca;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
16 Cuenca;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2020QII;""
16 Cuenca;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2020QI;""
16 Cuenca;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
16 Cuenca;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
16 Cuenca;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QII;""
16 Cuenca;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QI;382
16 Cuenca;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
16 Cuenca;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
16 Cuenca;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QII;""
16 Cuenca;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QI;400
16 Cuenca;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
16 Cuenca;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
16 Cuenca;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QII;""
16 Cuenca;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QI;""
16 Cuenca;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
16 Cuenca;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
16 Cuenca;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QII;370
16 Cuenca;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QI;""
16 Cuenca;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
16 Cuenca;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
16 Cuenca;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QII;384
16 Cuenca;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QI;""
16 Cuenca;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
16 Cuenca;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
16 Cuenca;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QII;""
16 Cuenca;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QI;""
16 Cuenca;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
16 Cuenca;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
16 Cuenca;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
16 Cuenca;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
16 Cuenca;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
16 Cuenca;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
16 Cuenca;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
16 Cuenca;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
16 Cuenca;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
16 Cuenca;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
16 Cuenca;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
16 Cuenca;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
16 Cuenca;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
16 Cuenca;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;92,14
16 Cuenca;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
16 Cuenca;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
16 Cuenca;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
16 Cuenca;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;90,93
16 Cuenca;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
16 Cuenca;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
16 Cuenca;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
16 Cuenca;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;92,23
16 Cuenca;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
16 Cuenca;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
16 Cuenca;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;86,49
16 Cuenca;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
16 Cuenca;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
16 Cuenca;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
16 Cuenca;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;84,6
16 Cuenca;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
16 Cuenca;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
16 Cuenca;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
16 Cuenca;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;86,55
16 Cuenca;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
16 Cuenca;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
16 Cuenca;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
16 Cuenca;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
16 Cuenca;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
16 Cuenca;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
16 Cuenca;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;80,59
16 Cuenca;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
16 Cuenca;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
16 Cuenca;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
16 Cuenca;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;84,03
16 Cuenca;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
16 Cuenca;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
16 Cuenca;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
16 Cuenca;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
16 Cuenca;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
16 Cuenca;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
16 Cuenca;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;78,06
16 Cuenca;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
16 Cuenca;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
16 Cuenca;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
16 Cuenca;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;80,67
16 Cuenca;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
16 Cuenca;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
16 Cuenca;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
16 Cuenca;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
16 Cuenca;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
16 Cuenca;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
16 Cuenca;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QIII;287
16 Cuenca;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
16 Cuenca;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
16 Cuenca;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
16 Cuenca;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QIII;276
16 Cuenca;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
16 Cuenca;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
16 Cuenca;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
16 Cuenca;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QIII;251
16 Cuenca;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
16 Cuenca;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
16 Cuenca;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
16 Cuenca;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2022QIII;247
16 Cuenca;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2022QII;""
16 Cuenca;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2022QI;""
16 Cuenca;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
16 Cuenca;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2021QIII;241
16 Cuenca;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2021QII;""
16 Cuenca;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2021QI;""
16 Cuenca;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
16 Cuenca;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2020QIII;230
16 Cuenca;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2020QII;""
16 Cuenca;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2020QI;""
16 Cuenca;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2022QIV;240
16 Cuenca;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
16 Cuenca;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2022QII;""
16 Cuenca;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2022QI;""
16 Cuenca;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2021QIV;228
16 Cuenca;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
16 Cuenca;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2021QII;""
16 Cuenca;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2021QI;""
16 Cuenca;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2020QIV;219
16 Cuenca;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
16 Cuenca;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2020QII;""
16 Cuenca;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2020QI;""
16 Cuenca;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
16 Cuenca;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
16 Cuenca;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QII;""
16 Cuenca;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QI;211
16 Cuenca;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
16 Cuenca;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
16 Cuenca;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QII;""
16 Cuenca;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QI;212
16 Cuenca;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
16 Cuenca;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
16 Cuenca;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QII;""
16 Cuenca;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QI;""
16 Cuenca;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
16 Cuenca;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
16 Cuenca;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QII;200
16 Cuenca;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QI;""
16 Cuenca;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
16 Cuenca;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
16 Cuenca;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QII;202
16 Cuenca;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QI;""
16 Cuenca;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
16 Cuenca;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
16 Cuenca;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QII;""
16 Cuenca;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QI;""
16 Cuenca;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
16 Cuenca;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
16 Cuenca;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
16 Cuenca;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
16 Cuenca;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
16 Cuenca;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
16 Cuenca;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
16 Cuenca;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
16 Cuenca;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
16 Cuenca;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
16 Cuenca;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
16 Cuenca;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
16 Cuenca;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
16 Cuenca;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;86,06
16 Cuenca;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
16 Cuenca;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
16 Cuenca;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
16 Cuenca;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;87,32
16 Cuenca;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
16 Cuenca;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
16 Cuenca;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
16 Cuenca;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;91,63
16 Cuenca;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
16 Cuenca;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
16 Cuenca;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;83,62
16 Cuenca;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
16 Cuenca;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
16 Cuenca;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
16 Cuenca;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;82,61
16 Cuenca;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
16 Cuenca;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
16 Cuenca;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
16 Cuenca;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;87,25
16 Cuenca;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
16 Cuenca;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
16 Cuenca;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
16 Cuenca;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
16 Cuenca;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
16 Cuenca;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
16 Cuenca;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;76,45
16 Cuenca;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
16 Cuenca;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
16 Cuenca;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
16 Cuenca;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;84,46
16 Cuenca;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
16 Cuenca;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
16 Cuenca;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
16 Cuenca;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
16 Cuenca;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
16 Cuenca;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
16 Cuenca;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;72,46
16 Cuenca;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
16 Cuenca;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
16 Cuenca;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
16 Cuenca;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;80,48
16 Cuenca;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
16 Cuenca;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
16 Cuenca;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
16 Cuenca;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
16 Cuenca;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
16 Cuenca;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QIV;778
16 Cuenca;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
16 Cuenca;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
16 Cuenca;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
16 Cuenca;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QIV;753
16 Cuenca;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
16 Cuenca;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
16 Cuenca;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
16 Cuenca;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QIV;755
16 Cuenca;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
16 Cuenca;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
16 Cuenca;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
16 Cuenca;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2022QIV;737
16 Cuenca;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
16 Cuenca;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2022QII;""
16 Cuenca;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2022QI;""
16 Cuenca;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2021QIV;704
16 Cuenca;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
16 Cuenca;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2021QII;""
16 Cuenca;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2021QI;""
16 Cuenca;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2020QIV;704
16 Cuenca;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
16 Cuenca;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2020QII;""
16 Cuenca;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2020QI;""
16 Cuenca;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
16 Cuenca;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
16 Cuenca;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2022QII;""
16 Cuenca;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2022QI;661
16 Cuenca;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
16 Cuenca;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
16 Cuenca;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2021QII;""
16 Cuenca;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2021QI;679
16 Cuenca;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
16 Cuenca;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
16 Cuenca;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2020QII;""
16 Cuenca;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2020QI;""
16 Cuenca;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
16 Cuenca;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
16 Cuenca;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QII;635
16 Cuenca;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QI;""
16 Cuenca;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
16 Cuenca;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
16 Cuenca;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QII;646
16 Cuenca;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QI;""
16 Cuenca;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
16 Cuenca;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
16 Cuenca;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QII;""
16 Cuenca;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QI;""
16 Cuenca;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
16 Cuenca;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QIII;602
16 Cuenca;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QII;""
16 Cuenca;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QI;""
16 Cuenca;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
16 Cuenca;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QIII;604
16 Cuenca;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QII;""
16 Cuenca;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QI;""
16 Cuenca;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
16 Cuenca;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
16 Cuenca;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QII;""
16 Cuenca;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QI;""
16 Cuenca;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
16 Cuenca;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
16 Cuenca;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
16 Cuenca;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
16 Cuenca;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
16 Cuenca;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
16 Cuenca;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
16 Cuenca;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
16 Cuenca;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
16 Cuenca;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
16 Cuenca;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
16 Cuenca;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
16 Cuenca;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;94,73
16 Cuenca;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
16 Cuenca;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
16 Cuenca;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
16 Cuenca;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;93,49
16 Cuenca;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
16 Cuenca;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
16 Cuenca;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
16 Cuenca;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;93,25
16 Cuenca;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
16 Cuenca;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
16 Cuenca;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
16 Cuenca;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
16 Cuenca;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
16 Cuenca;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
16 Cuenca;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;87,78
16 Cuenca;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
16 Cuenca;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
16 Cuenca;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
16 Cuenca;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;89,93
16 Cuenca;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
16 Cuenca;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
16 Cuenca;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
16 Cuenca;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
16 Cuenca;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
16 Cuenca;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
16 Cuenca;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;84,33
16 Cuenca;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
16 Cuenca;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
16 Cuenca;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
16 Cuenca;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;85,56
16 Cuenca;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
16 Cuenca;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
16 Cuenca;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
16 Cuenca;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
16 Cuenca;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
16 Cuenca;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
16 Cuenca;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;79,95
16 Cuenca;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
16 Cuenca;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
16 Cuenca;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
16 Cuenca;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;80
16 Cuenca;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
16 Cuenca;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
16 Cuenca;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
16 Cuenca;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
16 Cuenca;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
16 Cuenca;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
16 Cuenca;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QIV;501
16 Cuenca;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
16 Cuenca;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
16 Cuenca;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
16 Cuenca;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QIV;485
16 Cuenca;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
16 Cuenca;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
16 Cuenca;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
16 Cuenca;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QIV;487
16 Cuenca;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
16 Cuenca;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
16 Cuenca;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
16 Cuenca;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2022QIV;471
16 Cuenca;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
16 Cuenca;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2022QII;""
16 Cuenca;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2022QI;""
16 Cuenca;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2021QIV;450
16 Cuenca;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
16 Cuenca;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2021QII;""
16 Cuenca;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2021QI;""
16 Cuenca;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2020QIV;452
16 Cuenca;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
16 Cuenca;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2020QII;""
16 Cuenca;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2020QI;""
16 Cuenca;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
16 Cuenca;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
16 Cuenca;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2022QII;""
16 Cuenca;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2022QI;428
16 Cuenca;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
16 Cuenca;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
16 Cuenca;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2021QII;""
16 Cuenca;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2021QI;437
16 Cuenca;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
16 Cuenca;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
16 Cuenca;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2020QII;""
16 Cuenca;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2020QI;""
16 Cuenca;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
16 Cuenca;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
16 Cuenca;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QII;414
16 Cuenca;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QI;""
16 Cuenca;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
16 Cuenca;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
16 Cuenca;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QII;417
16 Cuenca;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QI;""
16 Cuenca;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
16 Cuenca;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
16 Cuenca;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QII;""
16 Cuenca;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QI;""
16 Cuenca;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
16 Cuenca;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QIII;399
16 Cuenca;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QII;""
16 Cuenca;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QI;""
16 Cuenca;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
16 Cuenca;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QIII;397
16 Cuenca;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QII;""
16 Cuenca;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QI;""
16 Cuenca;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
16 Cuenca;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
16 Cuenca;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QII;""
16 Cuenca;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QI;""
16 Cuenca;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
16 Cuenca;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
16 Cuenca;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
16 Cuenca;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
16 Cuenca;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
16 Cuenca;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
16 Cuenca;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
16 Cuenca;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
16 Cuenca;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
16 Cuenca;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
16 Cuenca;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
16 Cuenca;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
16 Cuenca;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;94,01
16 Cuenca;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
16 Cuenca;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
16 Cuenca;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
16 Cuenca;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;92,78
16 Cuenca;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
16 Cuenca;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
16 Cuenca;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
16 Cuenca;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;92,81
16 Cuenca;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
16 Cuenca;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
16 Cuenca;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
16 Cuenca;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
16 Cuenca;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
16 Cuenca;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
16 Cuenca;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;88,25
16 Cuenca;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
16 Cuenca;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
16 Cuenca;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
16 Cuenca;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;89,73
16 Cuenca;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
16 Cuenca;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
16 Cuenca;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
16 Cuenca;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
16 Cuenca;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
16 Cuenca;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
16 Cuenca;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;85,36
16 Cuenca;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
16 Cuenca;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
16 Cuenca;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
16 Cuenca;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;85,63
16 Cuenca;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
16 Cuenca;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
16 Cuenca;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
16 Cuenca;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
16 Cuenca;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
16 Cuenca;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
16 Cuenca;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;82,27
16 Cuenca;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
16 Cuenca;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
16 Cuenca;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
16 Cuenca;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;81,52
16 Cuenca;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
16 Cuenca;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
16 Cuenca;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
16 Cuenca;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
16 Cuenca;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
16 Cuenca;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
16 Cuenca;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QIV;277
16 Cuenca;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
16 Cuenca;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
16 Cuenca;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
16 Cuenca;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QIV;268
16 Cuenca;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
16 Cuenca;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
16 Cuenca;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
16 Cuenca;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QIV;268
16 Cuenca;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
16 Cuenca;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
16 Cuenca;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
16 Cuenca;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2022QIV;266
16 Cuenca;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
16 Cuenca;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2022QII;""
16 Cuenca;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2022QI;""
16 Cuenca;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2021QIV;254
16 Cuenca;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
16 Cuenca;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2021QII;""
16 Cuenca;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2021QI;""
16 Cuenca;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2020QIV;252
16 Cuenca;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
16 Cuenca;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2020QII;""
16 Cuenca;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2020QI;""
16 Cuenca;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
16 Cuenca;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
16 Cuenca;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2022QII;""
16 Cuenca;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2022QI;233
16 Cuenca;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
16 Cuenca;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
16 Cuenca;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2021QII;""
16 Cuenca;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2021QI;242
16 Cuenca;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
16 Cuenca;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
16 Cuenca;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2020QII;""
16 Cuenca;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2020QI;""
16 Cuenca;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
16 Cuenca;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
16 Cuenca;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QII;221
16 Cuenca;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QI;""
16 Cuenca;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
16 Cuenca;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
16 Cuenca;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QII;229
16 Cuenca;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QI;""
16 Cuenca;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
16 Cuenca;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
16 Cuenca;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QII;""
16 Cuenca;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QI;""
16 Cuenca;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
16 Cuenca;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QIII;203
16 Cuenca;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QII;""
16 Cuenca;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QI;""
16 Cuenca;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
16 Cuenca;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QIII;207
16 Cuenca;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QII;""
16 Cuenca;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QI;""
16 Cuenca;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
16 Cuenca;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
16 Cuenca;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QII;""
16 Cuenca;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QI;""
16 Cuenca;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
16 Cuenca;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
16 Cuenca;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
16 Cuenca;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
16 Cuenca;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
16 Cuenca;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
16 Cuenca;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
16 Cuenca;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
16 Cuenca;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
16 Cuenca;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
16 Cuenca;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
16 Cuenca;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
16 Cuenca;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;96,03
16 Cuenca;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
16 Cuenca;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
16 Cuenca;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
16 Cuenca;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;94,78
16 Cuenca;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
16 Cuenca;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
16 Cuenca;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
16 Cuenca;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;94,03
16 Cuenca;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
16 Cuenca;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
16 Cuenca;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
16 Cuenca;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
16 Cuenca;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
16 Cuenca;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
16 Cuenca;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;86,94
16 Cuenca;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
16 Cuenca;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
16 Cuenca;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
16 Cuenca;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;90,3
16 Cuenca;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
16 Cuenca;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
16 Cuenca;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
16 Cuenca;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
16 Cuenca;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
16 Cuenca;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
16 Cuenca;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;82,46
16 Cuenca;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
16 Cuenca;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
16 Cuenca;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
16 Cuenca;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;85,45
16 Cuenca;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
16 Cuenca;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
16 Cuenca;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
16 Cuenca;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
16 Cuenca;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
16 Cuenca;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
16 Cuenca;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;75,75
16 Cuenca;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
16 Cuenca;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
16 Cuenca;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
16 Cuenca;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;77,24
16 Cuenca;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
16 Cuenca;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
16 Cuenca;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
16 Cuenca;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
16 Cuenca;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
16 Cuenca;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
16 Cuenca;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
16 Cuenca;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
16 Cuenca;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
16 Cuenca;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QI;2.340
16 Cuenca;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
16 Cuenca;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
16 Cuenca;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
16 Cuenca;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QI;2.350
16 Cuenca;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
16 Cuenca;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
16 Cuenca;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
16 Cuenca;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QI;2.406
16 Cuenca;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
16 Cuenca;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
16 Cuenca;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2022QII;""
16 Cuenca;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2022QI;2.256
16 Cuenca;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
16 Cuenca;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
16 Cuenca;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2021QII;""
16 Cuenca;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2021QI;2.307
16 Cuenca;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
16 Cuenca;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
16 Cuenca;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2020QII;""
16 Cuenca;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2020QI;2.167
16 Cuenca;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
16 Cuenca;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
16 Cuenca;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2022QII;2.188
16 Cuenca;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2022QI;""
16 Cuenca;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
16 Cuenca;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
16 Cuenca;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2021QII;2.240
16 Cuenca;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2021QI;""
16 Cuenca;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
16 Cuenca;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
16 Cuenca;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2020QII;2.111
16 Cuenca;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2020QI;""
16 Cuenca;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
16 Cuenca;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QIII;2.139
16 Cuenca;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QII;""
16 Cuenca;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QI;""
16 Cuenca;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
16 Cuenca;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QIII;2.191
16 Cuenca;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QII;""
16 Cuenca;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QI;""
16 Cuenca;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
16 Cuenca;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QIII;2.062
16 Cuenca;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QII;""
16 Cuenca;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QI;""
16 Cuenca;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QIV;2.064
16 Cuenca;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
16 Cuenca;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QII;""
16 Cuenca;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QI;""
16 Cuenca;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QIV;2.131
16 Cuenca;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
16 Cuenca;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QII;""
16 Cuenca;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QI;""
16 Cuenca;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QIV;2.009
16 Cuenca;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
16 Cuenca;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QII;""
16 Cuenca;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QI;""
16 Cuenca;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
16 Cuenca;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
16 Cuenca;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
16 Cuenca;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
16 Cuenca;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
16 Cuenca;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
16 Cuenca;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
16 Cuenca;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
16 Cuenca;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
16 Cuenca;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
16 Cuenca;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
16 Cuenca;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
16 Cuenca;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
16 Cuenca;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
16 Cuenca;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
16 Cuenca;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;96,41
16 Cuenca;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
16 Cuenca;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
16 Cuenca;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
16 Cuenca;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;98,17
16 Cuenca;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
16 Cuenca;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
16 Cuenca;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
16 Cuenca;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;90,07
16 Cuenca;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
16 Cuenca;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
16 Cuenca;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;93,5
16 Cuenca;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
16 Cuenca;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
16 Cuenca;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
16 Cuenca;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;95,32
16 Cuenca;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
16 Cuenca;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
16 Cuenca;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
16 Cuenca;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;87,74
16 Cuenca;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
16 Cuenca;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
16 Cuenca;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;91,41
16 Cuenca;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
16 Cuenca;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
16 Cuenca;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
16 Cuenca;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;93,23
16 Cuenca;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
16 Cuenca;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
16 Cuenca;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
16 Cuenca;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;85,7
16 Cuenca;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
16 Cuenca;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
16 Cuenca;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;88,21
16 Cuenca;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
16 Cuenca;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
16 Cuenca;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
16 Cuenca;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;90,68
16 Cuenca;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
16 Cuenca;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
16 Cuenca;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
16 Cuenca;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;83,5
16 Cuenca;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
16 Cuenca;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
16 Cuenca;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
16 Cuenca;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
16 Cuenca;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
16 Cuenca;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
16 Cuenca;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QI;1.500
16 Cuenca;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
16 Cuenca;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
16 Cuenca;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
16 Cuenca;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QI;1.529
16 Cuenca;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
16 Cuenca;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
16 Cuenca;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
16 Cuenca;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QI;1.569
16 Cuenca;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
16 Cuenca;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
16 Cuenca;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2022QII;""
16 Cuenca;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2022QI;1.450
16 Cuenca;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
16 Cuenca;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
16 Cuenca;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2021QII;""
16 Cuenca;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2021QI;1.501
16 Cuenca;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
16 Cuenca;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
16 Cuenca;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2020QII;""
16 Cuenca;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2020QI;1.419
16 Cuenca;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
16 Cuenca;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
16 Cuenca;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2022QII;1.414
16 Cuenca;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2022QI;""
16 Cuenca;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
16 Cuenca;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
16 Cuenca;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2021QII;1.466
16 Cuenca;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2021QI;""
16 Cuenca;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
16 Cuenca;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
16 Cuenca;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2020QII;1.393
16 Cuenca;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2020QI;""
16 Cuenca;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
16 Cuenca;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QIII;1.387
16 Cuenca;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QII;""
16 Cuenca;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QI;""
16 Cuenca;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
16 Cuenca;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QIII;1.439
16 Cuenca;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QII;""
16 Cuenca;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QI;""
16 Cuenca;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
16 Cuenca;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QIII;1.368
16 Cuenca;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QII;""
16 Cuenca;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QI;""
16 Cuenca;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QIV;1.339
16 Cuenca;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
16 Cuenca;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QII;""
16 Cuenca;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QI;""
16 Cuenca;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QIV;1.397
16 Cuenca;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
16 Cuenca;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QII;""
16 Cuenca;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QI;""
16 Cuenca;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QIV;1.331
16 Cuenca;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
16 Cuenca;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QII;""
16 Cuenca;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QI;""
16 Cuenca;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
16 Cuenca;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
16 Cuenca;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
16 Cuenca;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
16 Cuenca;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
16 Cuenca;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
16 Cuenca;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
16 Cuenca;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
16 Cuenca;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
16 Cuenca;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
16 Cuenca;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
16 Cuenca;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
16 Cuenca;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
16 Cuenca;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
16 Cuenca;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
16 Cuenca;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;96,67
16 Cuenca;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
16 Cuenca;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
16 Cuenca;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
16 Cuenca;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;98,17
16 Cuenca;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
16 Cuenca;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
16 Cuenca;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
16 Cuenca;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;90,44
16 Cuenca;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
16 Cuenca;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
16 Cuenca;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;94,27
16 Cuenca;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
16 Cuenca;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
16 Cuenca;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
16 Cuenca;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;95,88
16 Cuenca;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
16 Cuenca;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
16 Cuenca;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
16 Cuenca;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;88,78
16 Cuenca;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
16 Cuenca;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
16 Cuenca;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;92,47
16 Cuenca;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
16 Cuenca;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
16 Cuenca;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
16 Cuenca;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;94,11
16 Cuenca;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
16 Cuenca;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
16 Cuenca;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
16 Cuenca;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;87,19
16 Cuenca;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
16 Cuenca;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
16 Cuenca;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;89,27
16 Cuenca;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
16 Cuenca;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
16 Cuenca;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
16 Cuenca;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;91,37
16 Cuenca;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
16 Cuenca;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
16 Cuenca;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
16 Cuenca;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;84,83
16 Cuenca;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
16 Cuenca;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
16 Cuenca;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
16 Cuenca;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
16 Cuenca;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
16 Cuenca;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
16 Cuenca;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QI;840
16 Cuenca;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
16 Cuenca;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
16 Cuenca;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
16 Cuenca;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QI;821
16 Cuenca;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
16 Cuenca;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
16 Cuenca;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
16 Cuenca;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QI;837
16 Cuenca;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
16 Cuenca;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
16 Cuenca;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2022QII;""
16 Cuenca;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2022QI;806
16 Cuenca;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
16 Cuenca;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
16 Cuenca;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2021QII;""
16 Cuenca;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2021QI;806
16 Cuenca;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
16 Cuenca;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
16 Cuenca;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2020QII;""
16 Cuenca;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2020QI;748
16 Cuenca;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
16 Cuenca;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
16 Cuenca;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2022QII;774
16 Cuenca;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2022QI;""
16 Cuenca;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
16 Cuenca;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
16 Cuenca;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2021QII;774
16 Cuenca;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2021QI;""
16 Cuenca;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
16 Cuenca;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
16 Cuenca;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2020QII;718
16 Cuenca;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2020QI;""
16 Cuenca;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
16 Cuenca;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QIII;752
16 Cuenca;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QII;""
16 Cuenca;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QI;""
16 Cuenca;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
16 Cuenca;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QIII;752
16 Cuenca;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QII;""
16 Cuenca;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QI;""
16 Cuenca;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
16 Cuenca;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QIII;694
16 Cuenca;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QII;""
16 Cuenca;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QI;""
16 Cuenca;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QIV;725
16 Cuenca;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
16 Cuenca;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QII;""
16 Cuenca;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QI;""
16 Cuenca;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QIV;734
16 Cuenca;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
16 Cuenca;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QII;""
16 Cuenca;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QI;""
16 Cuenca;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QIV;678
16 Cuenca;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
16 Cuenca;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QII;""
16 Cuenca;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QI;""
16 Cuenca;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
16 Cuenca;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
16 Cuenca;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
16 Cuenca;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
16 Cuenca;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
16 Cuenca;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
16 Cuenca;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
16 Cuenca;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
16 Cuenca;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
16 Cuenca;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
16 Cuenca;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
16 Cuenca;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
16 Cuenca;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
16 Cuenca;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
16 Cuenca;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
16 Cuenca;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;95,95
16 Cuenca;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
16 Cuenca;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
16 Cuenca;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
16 Cuenca;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;98,17
16 Cuenca;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
16 Cuenca;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
16 Cuenca;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
16 Cuenca;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;89,37
16 Cuenca;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
16 Cuenca;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
16 Cuenca;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;92,14
16 Cuenca;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
16 Cuenca;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
16 Cuenca;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
16 Cuenca;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;94,28
16 Cuenca;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
16 Cuenca;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
16 Cuenca;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
16 Cuenca;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;85,78
16 Cuenca;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
16 Cuenca;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
16 Cuenca;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;89,52
16 Cuenca;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
16 Cuenca;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
16 Cuenca;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
16 Cuenca;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;91,6
16 Cuenca;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
16 Cuenca;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
16 Cuenca;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
16 Cuenca;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;82,92
16 Cuenca;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
16 Cuenca;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
16 Cuenca;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;86,31
16 Cuenca;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
16 Cuenca;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
16 Cuenca;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
16 Cuenca;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;89,4
16 Cuenca;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
16 Cuenca;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
16 Cuenca;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
16 Cuenca;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;81
16 Cuenca;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
16 Cuenca;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
16 Cuenca;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
16 Cuenca;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
16 Cuenca;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
16 Cuenca;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QII;2.240
16 Cuenca;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
16 Cuenca;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
16 Cuenca;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
16 Cuenca;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QII;2.245
16 Cuenca;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
16 Cuenca;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
16 Cuenca;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
16 Cuenca;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QII;2.286
16 Cuenca;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
16 Cuenca;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
16 Cuenca;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
16 Cuenca;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2022QII;2.169
16 Cuenca;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2022QI;""
16 Cuenca;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
16 Cuenca;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
16 Cuenca;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2021QII;2.183
16 Cuenca;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2021QI;""
16 Cuenca;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
16 Cuenca;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
16 Cuenca;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2020QII;2.226
16 Cuenca;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2020QI;""
16 Cuenca;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
16 Cuenca;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2022QIII;2.105
16 Cuenca;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2022QII;""
16 Cuenca;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2022QI;""
16 Cuenca;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
16 Cuenca;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2021QIII;2.128
16 Cuenca;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2021QII;""
16 Cuenca;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2021QI;""
16 Cuenca;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
16 Cuenca;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2020QIII;2.173
16 Cuenca;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2020QII;""
16 Cuenca;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2020QI;""
16 Cuenca;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QIV;2.028
16 Cuenca;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
16 Cuenca;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QII;""
16 Cuenca;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QI;""
16 Cuenca;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QIV;2.065
16 Cuenca;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
16 Cuenca;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QII;""
16 Cuenca;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QI;""
16 Cuenca;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QIV;2.114
16 Cuenca;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
16 Cuenca;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QII;""
16 Cuenca;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QI;""
16 Cuenca;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
16 Cuenca;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
16 Cuenca;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QII;""
16 Cuenca;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QI;2.003
16 Cuenca;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
16 Cuenca;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
16 Cuenca;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QII;""
16 Cuenca;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QI;2.082
16 Cuenca;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
16 Cuenca;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
16 Cuenca;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QII;""
16 Cuenca;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QI;""
16 Cuenca;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
16 Cuenca;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
16 Cuenca;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
16 Cuenca;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
16 Cuenca;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
16 Cuenca;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
16 Cuenca;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
16 Cuenca;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
16 Cuenca;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
16 Cuenca;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
16 Cuenca;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
16 Cuenca;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
16 Cuenca;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
16 Cuenca;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
16 Cuenca;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;96,83
16 Cuenca;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
16 Cuenca;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
16 Cuenca;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
16 Cuenca;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;97,24
16 Cuenca;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
16 Cuenca;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
16 Cuenca;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
16 Cuenca;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;97,38
16 Cuenca;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
16 Cuenca;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
16 Cuenca;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;93,97
16 Cuenca;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
16 Cuenca;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
16 Cuenca;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
16 Cuenca;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;94,79
16 Cuenca;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
16 Cuenca;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
16 Cuenca;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
16 Cuenca;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;95,06
16 Cuenca;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
16 Cuenca;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
16 Cuenca;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;90,54
16 Cuenca;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
16 Cuenca;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
16 Cuenca;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
16 Cuenca;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;91,98
16 Cuenca;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
16 Cuenca;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
16 Cuenca;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
16 Cuenca;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;92,48
16 Cuenca;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
16 Cuenca;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
16 Cuenca;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
16 Cuenca;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
16 Cuenca;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
16 Cuenca;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
16 Cuenca;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;89,22
16 Cuenca;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
16 Cuenca;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
16 Cuenca;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
16 Cuenca;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;91,08
16 Cuenca;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
16 Cuenca;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
16 Cuenca;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
16 Cuenca;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
16 Cuenca;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
16 Cuenca;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
16 Cuenca;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QII;1.428
16 Cuenca;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
16 Cuenca;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
16 Cuenca;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
16 Cuenca;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QII;1.433
16 Cuenca;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
16 Cuenca;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
16 Cuenca;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
16 Cuenca;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QII;1.487
16 Cuenca;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
16 Cuenca;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
16 Cuenca;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
16 Cuenca;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2022QII;1.390
16 Cuenca;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2022QI;""
16 Cuenca;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
16 Cuenca;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
16 Cuenca;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2021QII;1.400
16 Cuenca;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2021QI;""
16 Cuenca;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
16 Cuenca;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
16 Cuenca;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2020QII;1.460
16 Cuenca;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2020QI;""
16 Cuenca;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
16 Cuenca;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2022QIII;1.353
16 Cuenca;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2022QII;""
16 Cuenca;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2022QI;""
16 Cuenca;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
16 Cuenca;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2021QIII;1.371
16 Cuenca;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2021QII;""
16 Cuenca;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2021QI;""
16 Cuenca;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
16 Cuenca;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2020QIII;1.433
16 Cuenca;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2020QII;""
16 Cuenca;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2020QI;""
16 Cuenca;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QIV;1.300
16 Cuenca;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
16 Cuenca;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QII;""
16 Cuenca;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QI;""
16 Cuenca;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QIV;1.330
16 Cuenca;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
16 Cuenca;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QII;""
16 Cuenca;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QI;""
16 Cuenca;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QIV;1.393
16 Cuenca;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
16 Cuenca;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QII;""
16 Cuenca;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QI;""
16 Cuenca;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
16 Cuenca;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
16 Cuenca;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QII;""
16 Cuenca;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QI;1.295
16 Cuenca;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
16 Cuenca;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
16 Cuenca;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QII;""
16 Cuenca;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QI;1.372
16 Cuenca;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
16 Cuenca;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
16 Cuenca;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QII;""
16 Cuenca;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QI;""
16 Cuenca;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
16 Cuenca;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
16 Cuenca;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
16 Cuenca;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
16 Cuenca;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
16 Cuenca;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
16 Cuenca;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
16 Cuenca;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
16 Cuenca;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
16 Cuenca;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
16 Cuenca;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
16 Cuenca;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
16 Cuenca;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
16 Cuenca;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
16 Cuenca;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;97,34
16 Cuenca;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
16 Cuenca;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
16 Cuenca;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
16 Cuenca;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;97,7
16 Cuenca;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
16 Cuenca;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
16 Cuenca;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
16 Cuenca;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;98,18
16 Cuenca;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
16 Cuenca;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
16 Cuenca;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;94,75
16 Cuenca;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
16 Cuenca;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
16 Cuenca;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
16 Cuenca;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;95,67
16 Cuenca;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
16 Cuenca;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
16 Cuenca;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
16 Cuenca;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;96,37
16 Cuenca;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
16 Cuenca;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
16 Cuenca;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;91,04
16 Cuenca;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
16 Cuenca;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
16 Cuenca;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
16 Cuenca;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;92,81
16 Cuenca;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
16 Cuenca;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
16 Cuenca;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
16 Cuenca;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;93,68
16 Cuenca;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
16 Cuenca;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
16 Cuenca;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
16 Cuenca;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
16 Cuenca;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
16 Cuenca;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
16 Cuenca;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;90,37
16 Cuenca;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
16 Cuenca;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
16 Cuenca;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
16 Cuenca;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;92,27
16 Cuenca;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
16 Cuenca;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
16 Cuenca;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
16 Cuenca;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
16 Cuenca;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
16 Cuenca;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
16 Cuenca;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QII;812
16 Cuenca;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
16 Cuenca;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
16 Cuenca;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
16 Cuenca;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QII;812
16 Cuenca;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
16 Cuenca;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
16 Cuenca;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
16 Cuenca;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QII;799
16 Cuenca;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
16 Cuenca;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
16 Cuenca;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
16 Cuenca;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2022QII;779
16 Cuenca;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2022QI;""
16 Cuenca;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
16 Cuenca;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
16 Cuenca;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2021QII;783
16 Cuenca;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2021QI;""
16 Cuenca;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
16 Cuenca;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
16 Cuenca;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2020QII;766
16 Cuenca;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2020QI;""
16 Cuenca;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
16 Cuenca;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2022QIII;752
16 Cuenca;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2022QII;""
16 Cuenca;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2022QI;""
16 Cuenca;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
16 Cuenca;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2021QIII;757
16 Cuenca;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2021QII;""
16 Cuenca;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2021QI;""
16 Cuenca;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
16 Cuenca;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2020QIII;740
16 Cuenca;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2020QII;""
16 Cuenca;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2020QI;""
16 Cuenca;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QIV;728
16 Cuenca;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
16 Cuenca;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QII;""
16 Cuenca;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QI;""
16 Cuenca;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QIV;735
16 Cuenca;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
16 Cuenca;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QII;""
16 Cuenca;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QI;""
16 Cuenca;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QIV;721
16 Cuenca;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
16 Cuenca;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QII;""
16 Cuenca;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QI;""
16 Cuenca;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
16 Cuenca;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
16 Cuenca;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QII;""
16 Cuenca;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QI;708
16 Cuenca;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
16 Cuenca;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
16 Cuenca;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QII;""
16 Cuenca;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QI;710
16 Cuenca;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
16 Cuenca;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
16 Cuenca;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QII;""
16 Cuenca;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QI;""
16 Cuenca;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
16 Cuenca;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
16 Cuenca;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
16 Cuenca;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
16 Cuenca;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
16 Cuenca;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
16 Cuenca;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
16 Cuenca;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
16 Cuenca;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
16 Cuenca;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
16 Cuenca;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
16 Cuenca;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
16 Cuenca;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
16 Cuenca;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
16 Cuenca;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;95,94
16 Cuenca;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
16 Cuenca;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
16 Cuenca;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
16 Cuenca;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;96,43
16 Cuenca;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
16 Cuenca;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
16 Cuenca;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
16 Cuenca;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;95,87
16 Cuenca;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
16 Cuenca;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
16 Cuenca;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;92,61
16 Cuenca;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
16 Cuenca;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
16 Cuenca;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
16 Cuenca;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;93,23
16 Cuenca;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
16 Cuenca;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
16 Cuenca;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
16 Cuenca;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;92,62
16 Cuenca;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
16 Cuenca;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
16 Cuenca;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;89,66
16 Cuenca;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
16 Cuenca;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
16 Cuenca;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
16 Cuenca;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;90,52
16 Cuenca;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
16 Cuenca;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
16 Cuenca;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
16 Cuenca;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;90,24
16 Cuenca;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
16 Cuenca;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
16 Cuenca;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
16 Cuenca;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
16 Cuenca;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
16 Cuenca;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
16 Cuenca;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;87,19
16 Cuenca;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
16 Cuenca;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
16 Cuenca;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
16 Cuenca;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;88,86
16 Cuenca;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
16 Cuenca;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
16 Cuenca;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
16 Cuenca;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
16 Cuenca;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
16 Cuenca;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QIII;2.294
16 Cuenca;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
16 Cuenca;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
16 Cuenca;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
16 Cuenca;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QIII;2.305
16 Cuenca;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
16 Cuenca;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
16 Cuenca;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
16 Cuenca;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QIII;2.310
16 Cuenca;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
16 Cuenca;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
16 Cuenca;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
16 Cuenca;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2022QIII;2.210
16 Cuenca;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2022QII;""
16 Cuenca;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2022QI;""
16 Cuenca;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
16 Cuenca;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2021QIII;2.224
16 Cuenca;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2021QII;""
16 Cuenca;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2021QI;""
16 Cuenca;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
16 Cuenca;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2020QIII;2.246
16 Cuenca;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2020QII;""
16 Cuenca;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2020QI;""
16 Cuenca;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2022QIV;2.125
16 Cuenca;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
16 Cuenca;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2022QII;""
16 Cuenca;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2022QI;""
16 Cuenca;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2021QIV;2.150
16 Cuenca;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
16 Cuenca;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2021QII;""
16 Cuenca;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2021QI;""
16 Cuenca;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2020QIV;2.178
16 Cuenca;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
16 Cuenca;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2020QII;""
16 Cuenca;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2020QI;""
16 Cuenca;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
16 Cuenca;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
16 Cuenca;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QII;""
16 Cuenca;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QI;2.080
16 Cuenca;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
16 Cuenca;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
16 Cuenca;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QII;""
16 Cuenca;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QI;2.144
16 Cuenca;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
16 Cuenca;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
16 Cuenca;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QII;""
16 Cuenca;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QI;""
16 Cuenca;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
16 Cuenca;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
16 Cuenca;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QII;2.024
16 Cuenca;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QI;""
16 Cuenca;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
16 Cuenca;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
16 Cuenca;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QII;2.086
16 Cuenca;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QI;""
16 Cuenca;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
16 Cuenca;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
16 Cuenca;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QII;""
16 Cuenca;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QI;""
16 Cuenca;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
16 Cuenca;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
16 Cuenca;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
16 Cuenca;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
16 Cuenca;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
16 Cuenca;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
16 Cuenca;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
16 Cuenca;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
16 Cuenca;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
16 Cuenca;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
16 Cuenca;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
16 Cuenca;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
16 Cuenca;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
16 Cuenca;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;96,34
16 Cuenca;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
16 Cuenca;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
16 Cuenca;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
16 Cuenca;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;96,49
16 Cuenca;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
16 Cuenca;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
16 Cuenca;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
16 Cuenca;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;97,23
16 Cuenca;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
16 Cuenca;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
16 Cuenca;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;92,63
16 Cuenca;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
16 Cuenca;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
16 Cuenca;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
16 Cuenca;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;93,28
16 Cuenca;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
16 Cuenca;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
16 Cuenca;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
16 Cuenca;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;94,29
16 Cuenca;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
16 Cuenca;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
16 Cuenca;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
16 Cuenca;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
16 Cuenca;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
16 Cuenca;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
16 Cuenca;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;90,24
16 Cuenca;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
16 Cuenca;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
16 Cuenca;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
16 Cuenca;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;92,81
16 Cuenca;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
16 Cuenca;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
16 Cuenca;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
16 Cuenca;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
16 Cuenca;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
16 Cuenca;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
16 Cuenca;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;87,81
16 Cuenca;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
16 Cuenca;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
16 Cuenca;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
16 Cuenca;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;90,3
16 Cuenca;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
16 Cuenca;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
16 Cuenca;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
16 Cuenca;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
16 Cuenca;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
16 Cuenca;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
16 Cuenca;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QIII;1.465
16 Cuenca;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
16 Cuenca;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
16 Cuenca;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
16 Cuenca;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QIII;1.480
16 Cuenca;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
16 Cuenca;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
16 Cuenca;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
16 Cuenca;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QIII;1.519
16 Cuenca;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
16 Cuenca;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
16 Cuenca;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
16 Cuenca;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2022QIII;1.414
16 Cuenca;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2022QII;""
16 Cuenca;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2022QI;""
16 Cuenca;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
16 Cuenca;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2021QIII;1.433
16 Cuenca;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2021QII;""
16 Cuenca;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2021QI;""
16 Cuenca;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
16 Cuenca;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2020QIII;1.485
16 Cuenca;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2020QII;""
16 Cuenca;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2020QI;""
16 Cuenca;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2022QIV;1.356
16 Cuenca;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
16 Cuenca;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2022QII;""
16 Cuenca;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2022QI;""
16 Cuenca;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2021QIV;1.384
16 Cuenca;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
16 Cuenca;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2021QII;""
16 Cuenca;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2021QI;""
16 Cuenca;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2020QIV;1.436
16 Cuenca;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
16 Cuenca;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2020QII;""
16 Cuenca;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2020QI;""
16 Cuenca;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
16 Cuenca;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
16 Cuenca;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QII;""
16 Cuenca;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QI;1.343
16 Cuenca;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
16 Cuenca;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
16 Cuenca;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QII;""
16 Cuenca;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QI;1.413
16 Cuenca;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
16 Cuenca;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
16 Cuenca;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QII;""
16 Cuenca;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QI;""
16 Cuenca;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
16 Cuenca;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
16 Cuenca;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QII;1.312
16 Cuenca;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QI;""
16 Cuenca;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
16 Cuenca;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
16 Cuenca;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QII;1.381
16 Cuenca;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QI;""
16 Cuenca;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
16 Cuenca;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
16 Cuenca;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QII;""
16 Cuenca;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QI;""
16 Cuenca;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
16 Cuenca;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
16 Cuenca;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
16 Cuenca;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
16 Cuenca;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
16 Cuenca;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
16 Cuenca;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
16 Cuenca;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
16 Cuenca;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
16 Cuenca;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
16 Cuenca;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
16 Cuenca;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
16 Cuenca;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
16 Cuenca;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;96,52
16 Cuenca;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
16 Cuenca;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
16 Cuenca;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
16 Cuenca;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;96,82
16 Cuenca;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
16 Cuenca;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
16 Cuenca;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
16 Cuenca;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;97,76
16 Cuenca;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
16 Cuenca;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
16 Cuenca;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;92,56
16 Cuenca;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
16 Cuenca;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
16 Cuenca;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
16 Cuenca;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;93,51
16 Cuenca;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
16 Cuenca;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
16 Cuenca;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
16 Cuenca;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;94,54
16 Cuenca;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
16 Cuenca;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
16 Cuenca;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
16 Cuenca;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
16 Cuenca;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
16 Cuenca;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
16 Cuenca;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;90,74
16 Cuenca;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
16 Cuenca;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
16 Cuenca;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
16 Cuenca;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;93,02
16 Cuenca;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
16 Cuenca;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
16 Cuenca;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
16 Cuenca;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
16 Cuenca;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
16 Cuenca;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
16 Cuenca;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;88,65
16 Cuenca;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
16 Cuenca;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
16 Cuenca;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
16 Cuenca;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;90,92
16 Cuenca;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
16 Cuenca;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
16 Cuenca;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
16 Cuenca;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
16 Cuenca;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
16 Cuenca;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
16 Cuenca;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QIII;829
16 Cuenca;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
16 Cuenca;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
16 Cuenca;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
16 Cuenca;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QIII;825
16 Cuenca;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
16 Cuenca;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
16 Cuenca;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
16 Cuenca;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QIII;791
16 Cuenca;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
16 Cuenca;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
16 Cuenca;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
16 Cuenca;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2022QIII;796
16 Cuenca;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2022QII;""
16 Cuenca;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2022QI;""
16 Cuenca;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
16 Cuenca;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2021QIII;791
16 Cuenca;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2021QII;""
16 Cuenca;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2021QI;""
16 Cuenca;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
16 Cuenca;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2020QIII;761
16 Cuenca;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2020QII;""
16 Cuenca;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2020QI;""
16 Cuenca;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2022QIV;769
16 Cuenca;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
16 Cuenca;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2022QII;""
16 Cuenca;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2022QI;""
16 Cuenca;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2021QIV;766
16 Cuenca;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
16 Cuenca;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2021QII;""
16 Cuenca;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2021QI;""
16 Cuenca;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2020QIV;742
16 Cuenca;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
16 Cuenca;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2020QII;""
16 Cuenca;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2020QI;""
16 Cuenca;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
16 Cuenca;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
16 Cuenca;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QII;""
16 Cuenca;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QI;737
16 Cuenca;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
16 Cuenca;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
16 Cuenca;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QII;""
16 Cuenca;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QI;731
16 Cuenca;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
16 Cuenca;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
16 Cuenca;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QII;""
16 Cuenca;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QI;""
16 Cuenca;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
16 Cuenca;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
16 Cuenca;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QII;712
16 Cuenca;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QI;""
16 Cuenca;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
16 Cuenca;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
16 Cuenca;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QII;705
16 Cuenca;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QI;""
16 Cuenca;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
16 Cuenca;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
16 Cuenca;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QII;""
16 Cuenca;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QI;""
16 Cuenca;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
16 Cuenca;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
16 Cuenca;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
16 Cuenca;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
16 Cuenca;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
16 Cuenca;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
16 Cuenca;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
16 Cuenca;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
16 Cuenca;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
16 Cuenca;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
16 Cuenca;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
16 Cuenca;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
16 Cuenca;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
16 Cuenca;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;96,02
16 Cuenca;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
16 Cuenca;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
16 Cuenca;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
16 Cuenca;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;95,88
16 Cuenca;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
16 Cuenca;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
16 Cuenca;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
16 Cuenca;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;96,21
16 Cuenca;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
16 Cuenca;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
16 Cuenca;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;92,76
16 Cuenca;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
16 Cuenca;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
16 Cuenca;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
16 Cuenca;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;92,85
16 Cuenca;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
16 Cuenca;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
16 Cuenca;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
16 Cuenca;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;93,81
16 Cuenca;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
16 Cuenca;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
16 Cuenca;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
16 Cuenca;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
16 Cuenca;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
16 Cuenca;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
16 Cuenca;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;89,33
16 Cuenca;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
16 Cuenca;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
16 Cuenca;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
16 Cuenca;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;92,41
16 Cuenca;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
16 Cuenca;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
16 Cuenca;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
16 Cuenca;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
16 Cuenca;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
16 Cuenca;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
16 Cuenca;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;86,3
16 Cuenca;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
16 Cuenca;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
16 Cuenca;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
16 Cuenca;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;89,13
16 Cuenca;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
16 Cuenca;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
16 Cuenca;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
16 Cuenca;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
16 Cuenca;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
16 Cuenca;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QIV;2.281
16 Cuenca;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
16 Cuenca;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
16 Cuenca;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
16 Cuenca;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QIV;2.311
16 Cuenca;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
16 Cuenca;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
16 Cuenca;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
16 Cuenca;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QIV;2.353
16 Cuenca;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
16 Cuenca;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
16 Cuenca;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
16 Cuenca;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2022QIV;2.182
16 Cuenca;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
16 Cuenca;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2022QII;""
16 Cuenca;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2022QI;""
16 Cuenca;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2021QIV;2.226
16 Cuenca;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
16 Cuenca;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2021QII;""
16 Cuenca;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2021QI;""
16 Cuenca;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2020QIV;2.277
16 Cuenca;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
16 Cuenca;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2020QII;""
16 Cuenca;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2020QI;""
16 Cuenca;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
16 Cuenca;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
16 Cuenca;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2022QII;""
16 Cuenca;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2022QI;2.151
16 Cuenca;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
16 Cuenca;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
16 Cuenca;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2021QII;""
16 Cuenca;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2021QI;2.238
16 Cuenca;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
16 Cuenca;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
16 Cuenca;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2020QII;""
16 Cuenca;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2020QI;""
16 Cuenca;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
16 Cuenca;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
16 Cuenca;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QII;2.091
16 Cuenca;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QI;""
16 Cuenca;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
16 Cuenca;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
16 Cuenca;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QII;2.177
16 Cuenca;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QI;""
16 Cuenca;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
16 Cuenca;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
16 Cuenca;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QII;""
16 Cuenca;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QI;""
16 Cuenca;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
16 Cuenca;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QIII;2.047
16 Cuenca;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QII;""
16 Cuenca;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QI;""
16 Cuenca;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
16 Cuenca;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QIII;2.129
16 Cuenca;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QII;""
16 Cuenca;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QI;""
16 Cuenca;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
16 Cuenca;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
16 Cuenca;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QII;""
16 Cuenca;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QI;""
16 Cuenca;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
16 Cuenca;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
16 Cuenca;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
16 Cuenca;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
16 Cuenca;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
16 Cuenca;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
16 Cuenca;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
16 Cuenca;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
16 Cuenca;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
16 Cuenca;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
16 Cuenca;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
16 Cuenca;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
16 Cuenca;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;95,66
16 Cuenca;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
16 Cuenca;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
16 Cuenca;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
16 Cuenca;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;96,32
16 Cuenca;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
16 Cuenca;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
16 Cuenca;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
16 Cuenca;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;96,77
16 Cuenca;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
16 Cuenca;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
16 Cuenca;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
16 Cuenca;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
16 Cuenca;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
16 Cuenca;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
16 Cuenca;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;93,08
16 Cuenca;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
16 Cuenca;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
16 Cuenca;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
16 Cuenca;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;95,11
16 Cuenca;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
16 Cuenca;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
16 Cuenca;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
16 Cuenca;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
16 Cuenca;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
16 Cuenca;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
16 Cuenca;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;90,48
16 Cuenca;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
16 Cuenca;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
16 Cuenca;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
16 Cuenca;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;92,52
16 Cuenca;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
16 Cuenca;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
16 Cuenca;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
16 Cuenca;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
16 Cuenca;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
16 Cuenca;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
16 Cuenca;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;88,58
16 Cuenca;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
16 Cuenca;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
16 Cuenca;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
16 Cuenca;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;90,48
16 Cuenca;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
16 Cuenca;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
16 Cuenca;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
16 Cuenca;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
16 Cuenca;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
16 Cuenca;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
16 Cuenca;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QIV;1.464
16 Cuenca;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
16 Cuenca;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
16 Cuenca;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
16 Cuenca;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QIV;1.481
16 Cuenca;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
16 Cuenca;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
16 Cuenca;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
16 Cuenca;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QIV;1.539
16 Cuenca;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
16 Cuenca;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
16 Cuenca;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
16 Cuenca;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2022QIV;1.394
16 Cuenca;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
16 Cuenca;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2022QII;""
16 Cuenca;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2022QI;""
16 Cuenca;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2021QIV;1.423
16 Cuenca;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
16 Cuenca;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2021QII;""
16 Cuenca;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2021QI;""
16 Cuenca;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2020QIV;1.485
16 Cuenca;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
16 Cuenca;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2020QII;""
16 Cuenca;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2020QI;""
16 Cuenca;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
16 Cuenca;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
16 Cuenca;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2022QII;""
16 Cuenca;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2022QI;1.379
16 Cuenca;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
16 Cuenca;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
16 Cuenca;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2021QII;""
16 Cuenca;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2021QI;1.460
16 Cuenca;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
16 Cuenca;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
16 Cuenca;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2020QII;""
16 Cuenca;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2020QI;""
16 Cuenca;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
16 Cuenca;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
16 Cuenca;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QII;1.347
16 Cuenca;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QI;""
16 Cuenca;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
16 Cuenca;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
16 Cuenca;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QII;1.428
16 Cuenca;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QI;""
16 Cuenca;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
16 Cuenca;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
16 Cuenca;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QII;""
16 Cuenca;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QI;""
16 Cuenca;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
16 Cuenca;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QIII;1.323
16 Cuenca;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QII;""
16 Cuenca;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QI;""
16 Cuenca;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
16 Cuenca;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QIII;1.401
16 Cuenca;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QII;""
16 Cuenca;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QI;""
16 Cuenca;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
16 Cuenca;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
16 Cuenca;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QII;""
16 Cuenca;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QI;""
16 Cuenca;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
16 Cuenca;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
16 Cuenca;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
16 Cuenca;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
16 Cuenca;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
16 Cuenca;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
16 Cuenca;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
16 Cuenca;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
16 Cuenca;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
16 Cuenca;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
16 Cuenca;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
16 Cuenca;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
16 Cuenca;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;95,22
16 Cuenca;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
16 Cuenca;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
16 Cuenca;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
16 Cuenca;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;96,08
16 Cuenca;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
16 Cuenca;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
16 Cuenca;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
16 Cuenca;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;96,49
16 Cuenca;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
16 Cuenca;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
16 Cuenca;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
16 Cuenca;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
16 Cuenca;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
16 Cuenca;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
16 Cuenca;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;93,11
16 Cuenca;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
16 Cuenca;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
16 Cuenca;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
16 Cuenca;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;94,87
16 Cuenca;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
16 Cuenca;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
16 Cuenca;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
16 Cuenca;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
16 Cuenca;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
16 Cuenca;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
16 Cuenca;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;90,95
16 Cuenca;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
16 Cuenca;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
16 Cuenca;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
16 Cuenca;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;92,79
16 Cuenca;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
16 Cuenca;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
16 Cuenca;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
16 Cuenca;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
16 Cuenca;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
16 Cuenca;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
16 Cuenca;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;89,33
16 Cuenca;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
16 Cuenca;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
16 Cuenca;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
16 Cuenca;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;91,03
16 Cuenca;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
16 Cuenca;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
16 Cuenca;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
16 Cuenca;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
16 Cuenca;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
16 Cuenca;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
16 Cuenca;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QIV;817
16 Cuenca;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
16 Cuenca;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
16 Cuenca;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
16 Cuenca;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QIV;830
16 Cuenca;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
16 Cuenca;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
16 Cuenca;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
16 Cuenca;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QIV;814
16 Cuenca;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
16 Cuenca;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
16 Cuenca;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
16 Cuenca;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2022QIV;788
16 Cuenca;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
16 Cuenca;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2022QII;""
16 Cuenca;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2022QI;""
16 Cuenca;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2021QIV;803
16 Cuenca;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
16 Cuenca;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2021QII;""
16 Cuenca;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2021QI;""
16 Cuenca;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2020QIV;792
16 Cuenca;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
16 Cuenca;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2020QII;""
16 Cuenca;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2020QI;""
16 Cuenca;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
16 Cuenca;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
16 Cuenca;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2022QII;""
16 Cuenca;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2022QI;772
16 Cuenca;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
16 Cuenca;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
16 Cuenca;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2021QII;""
16 Cuenca;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2021QI;778
16 Cuenca;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
16 Cuenca;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
16 Cuenca;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2020QII;""
16 Cuenca;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2020QI;""
16 Cuenca;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
16 Cuenca;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
16 Cuenca;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QII;744
16 Cuenca;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QI;""
16 Cuenca;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
16 Cuenca;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
16 Cuenca;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QII;749
16 Cuenca;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QI;""
16 Cuenca;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
16 Cuenca;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
16 Cuenca;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QII;""
16 Cuenca;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QI;""
16 Cuenca;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
16 Cuenca;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QIII;724
16 Cuenca;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QII;""
16 Cuenca;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QI;""
16 Cuenca;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
16 Cuenca;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QIII;728
16 Cuenca;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QII;""
16 Cuenca;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QI;""
16 Cuenca;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
16 Cuenca;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
16 Cuenca;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QII;""
16 Cuenca;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QI;""
16 Cuenca;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
16 Cuenca;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
16 Cuenca;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
16 Cuenca;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
16 Cuenca;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
16 Cuenca;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
16 Cuenca;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
16 Cuenca;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
16 Cuenca;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
16 Cuenca;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
16 Cuenca;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
16 Cuenca;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
16 Cuenca;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;96,45
16 Cuenca;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
16 Cuenca;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
16 Cuenca;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
16 Cuenca;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;96,75
16 Cuenca;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
16 Cuenca;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
16 Cuenca;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
16 Cuenca;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;97,3
16 Cuenca;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
16 Cuenca;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
16 Cuenca;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
16 Cuenca;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
16 Cuenca;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
16 Cuenca;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
16 Cuenca;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;93,01
16 Cuenca;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
16 Cuenca;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
16 Cuenca;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
16 Cuenca;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;95,58
16 Cuenca;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
16 Cuenca;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
16 Cuenca;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
16 Cuenca;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
16 Cuenca;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
16 Cuenca;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
16 Cuenca;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;89,64
16 Cuenca;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
16 Cuenca;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
16 Cuenca;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
16 Cuenca;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;92,01
16 Cuenca;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
16 Cuenca;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
16 Cuenca;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
16 Cuenca;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
16 Cuenca;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
16 Cuenca;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
16 Cuenca;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;87,23
16 Cuenca;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
16 Cuenca;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
16 Cuenca;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
16 Cuenca;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;89,43
16 Cuenca;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
16 Cuenca;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
16 Cuenca;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
16 Cuenca;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
16 Cuenca;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
16 Cuenca;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
16 Cuenca;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
16 Cuenca;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
16 Cuenca;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
16 Cuenca;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QI;3.727
16 Cuenca;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
16 Cuenca;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
16 Cuenca;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
16 Cuenca;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QI;3.762
16 Cuenca;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
16 Cuenca;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
16 Cuenca;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
16 Cuenca;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QI;3.866
16 Cuenca;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
16 Cuenca;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
16 Cuenca;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2022QII;""
16 Cuenca;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2022QI;3.635
16 Cuenca;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
16 Cuenca;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
16 Cuenca;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2021QII;""
16 Cuenca;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2021QI;3.688
16 Cuenca;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
16 Cuenca;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
16 Cuenca;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2020QII;""
16 Cuenca;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2020QI;3.618
16 Cuenca;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
16 Cuenca;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
16 Cuenca;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2022QII;3.576
16 Cuenca;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2022QI;""
16 Cuenca;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
16 Cuenca;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
16 Cuenca;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2021QII;3.609
16 Cuenca;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2021QI;""
16 Cuenca;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
16 Cuenca;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
16 Cuenca;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2020QII;3.563
16 Cuenca;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2020QI;""
16 Cuenca;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
16 Cuenca;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QIII;3.509
16 Cuenca;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QII;""
16 Cuenca;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QI;""
16 Cuenca;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
16 Cuenca;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QIII;3.548
16 Cuenca;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QII;""
16 Cuenca;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QI;""
16 Cuenca;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
16 Cuenca;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QIII;3.505
16 Cuenca;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QII;""
16 Cuenca;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QI;""
16 Cuenca;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QIV;3.436
16 Cuenca;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
16 Cuenca;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QII;""
16 Cuenca;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QI;""
16 Cuenca;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QIV;3.495
16 Cuenca;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
16 Cuenca;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QII;""
16 Cuenca;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QI;""
16 Cuenca;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QIV;3.442
16 Cuenca;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
16 Cuenca;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QII;""
16 Cuenca;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QI;""
16 Cuenca;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
16 Cuenca;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
16 Cuenca;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
16 Cuenca;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
16 Cuenca;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
16 Cuenca;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
16 Cuenca;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
16 Cuenca;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
16 Cuenca;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
16 Cuenca;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
16 Cuenca;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
16 Cuenca;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
16 Cuenca;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
16 Cuenca;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
16 Cuenca;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
16 Cuenca;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;97,53
16 Cuenca;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
16 Cuenca;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
16 Cuenca;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
16 Cuenca;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;98,03
16 Cuenca;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
16 Cuenca;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
16 Cuenca;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
16 Cuenca;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;93,59
16 Cuenca;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
16 Cuenca;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
16 Cuenca;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;95,95
16 Cuenca;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
16 Cuenca;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
16 Cuenca;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
16 Cuenca;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;95,93
16 Cuenca;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
16 Cuenca;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
16 Cuenca;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
16 Cuenca;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;92,16
16 Cuenca;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
16 Cuenca;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
16 Cuenca;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;94,15
16 Cuenca;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
16 Cuenca;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
16 Cuenca;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
16 Cuenca;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;94,31
16 Cuenca;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
16 Cuenca;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
16 Cuenca;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
16 Cuenca;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;90,66
16 Cuenca;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
16 Cuenca;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
16 Cuenca;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;92,19
16 Cuenca;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
16 Cuenca;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
16 Cuenca;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
16 Cuenca;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;92,9
16 Cuenca;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
16 Cuenca;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
16 Cuenca;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
16 Cuenca;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;89,03
16 Cuenca;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
16 Cuenca;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
16 Cuenca;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
16 Cuenca;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
16 Cuenca;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
16 Cuenca;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
16 Cuenca;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QI;2.510
16 Cuenca;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
16 Cuenca;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
16 Cuenca;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
16 Cuenca;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QI;2.519
16 Cuenca;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
16 Cuenca;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
16 Cuenca;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
16 Cuenca;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QI;2.593
16 Cuenca;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
16 Cuenca;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
16 Cuenca;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2022QII;""
16 Cuenca;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2022QI;2.454
16 Cuenca;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
16 Cuenca;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
16 Cuenca;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2021QII;""
16 Cuenca;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2021QI;2.474
16 Cuenca;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
16 Cuenca;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
16 Cuenca;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2020QII;""
16 Cuenca;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2020QI;2.432
16 Cuenca;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
16 Cuenca;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
16 Cuenca;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2022QII;2.421
16 Cuenca;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2022QI;""
16 Cuenca;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
16 Cuenca;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
16 Cuenca;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2021QII;2.426
16 Cuenca;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2021QI;""
16 Cuenca;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
16 Cuenca;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
16 Cuenca;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2020QII;2.402
16 Cuenca;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2020QI;""
16 Cuenca;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
16 Cuenca;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QIII;2.387
16 Cuenca;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QII;""
16 Cuenca;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QI;""
16 Cuenca;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
16 Cuenca;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QIII;2.394
16 Cuenca;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QII;""
16 Cuenca;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QI;""
16 Cuenca;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
16 Cuenca;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QIII;2.372
16 Cuenca;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QII;""
16 Cuenca;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QI;""
16 Cuenca;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QIV;2.347
16 Cuenca;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
16 Cuenca;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QII;""
16 Cuenca;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QI;""
16 Cuenca;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QIV;2.362
16 Cuenca;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
16 Cuenca;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QII;""
16 Cuenca;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QI;""
16 Cuenca;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QIV;2.328
16 Cuenca;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
16 Cuenca;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QII;""
16 Cuenca;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QI;""
16 Cuenca;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
16 Cuenca;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
16 Cuenca;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
16 Cuenca;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
16 Cuenca;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
16 Cuenca;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
16 Cuenca;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
16 Cuenca;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
16 Cuenca;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
16 Cuenca;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
16 Cuenca;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
16 Cuenca;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
16 Cuenca;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
16 Cuenca;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
16 Cuenca;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
16 Cuenca;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;97,77
16 Cuenca;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
16 Cuenca;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
16 Cuenca;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
16 Cuenca;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;98,21
16 Cuenca;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
16 Cuenca;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
16 Cuenca;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
16 Cuenca;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;93,79
16 Cuenca;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
16 Cuenca;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
16 Cuenca;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;96,45
16 Cuenca;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
16 Cuenca;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
16 Cuenca;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
16 Cuenca;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;96,31
16 Cuenca;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
16 Cuenca;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
16 Cuenca;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
16 Cuenca;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;92,63
16 Cuenca;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
16 Cuenca;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
16 Cuenca;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;95,1
16 Cuenca;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
16 Cuenca;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
16 Cuenca;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
16 Cuenca;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;95,04
16 Cuenca;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
16 Cuenca;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
16 Cuenca;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
16 Cuenca;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;91,48
16 Cuenca;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
16 Cuenca;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
16 Cuenca;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;93,51
16 Cuenca;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
16 Cuenca;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
16 Cuenca;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
16 Cuenca;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;93,77
16 Cuenca;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
16 Cuenca;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
16 Cuenca;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
16 Cuenca;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;89,78
16 Cuenca;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
16 Cuenca;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
16 Cuenca;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
16 Cuenca;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
16 Cuenca;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
16 Cuenca;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
16 Cuenca;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QI;1.217
16 Cuenca;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
16 Cuenca;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
16 Cuenca;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
16 Cuenca;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QI;1.243
16 Cuenca;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
16 Cuenca;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
16 Cuenca;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
16 Cuenca;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QI;1.273
16 Cuenca;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
16 Cuenca;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
16 Cuenca;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2022QII;""
16 Cuenca;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2022QI;1.181
16 Cuenca;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
16 Cuenca;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
16 Cuenca;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2021QII;""
16 Cuenca;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2021QI;1.214
16 Cuenca;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
16 Cuenca;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
16 Cuenca;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2020QII;""
16 Cuenca;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2020QI;1.186
16 Cuenca;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
16 Cuenca;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
16 Cuenca;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2022QII;1.155
16 Cuenca;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2022QI;""
16 Cuenca;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
16 Cuenca;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
16 Cuenca;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2021QII;1.183
16 Cuenca;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2021QI;""
16 Cuenca;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
16 Cuenca;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
16 Cuenca;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2020QII;1.161
16 Cuenca;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2020QI;""
16 Cuenca;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
16 Cuenca;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QIII;1.122
16 Cuenca;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QII;""
16 Cuenca;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QI;""
16 Cuenca;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
16 Cuenca;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QIII;1.154
16 Cuenca;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QII;""
16 Cuenca;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QI;""
16 Cuenca;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
16 Cuenca;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QIII;1.133
16 Cuenca;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QII;""
16 Cuenca;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QI;""
16 Cuenca;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QIV;1.089
16 Cuenca;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
16 Cuenca;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QII;""
16 Cuenca;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QI;""
16 Cuenca;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QIV;1.133
16 Cuenca;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
16 Cuenca;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QII;""
16 Cuenca;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QI;""
16 Cuenca;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QIV;1.114
16 Cuenca;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
16 Cuenca;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QII;""
16 Cuenca;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QI;""
16 Cuenca;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
16 Cuenca;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
16 Cuenca;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
16 Cuenca;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
16 Cuenca;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
16 Cuenca;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
16 Cuenca;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
16 Cuenca;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
16 Cuenca;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
16 Cuenca;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
16 Cuenca;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
16 Cuenca;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
16 Cuenca;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
16 Cuenca;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
16 Cuenca;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
16 Cuenca;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;97,04
16 Cuenca;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
16 Cuenca;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
16 Cuenca;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
16 Cuenca;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;97,67
16 Cuenca;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
16 Cuenca;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
16 Cuenca;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
16 Cuenca;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;93,17
16 Cuenca;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
16 Cuenca;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
16 Cuenca;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;94,91
16 Cuenca;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
16 Cuenca;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
16 Cuenca;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
16 Cuenca;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;95,17
16 Cuenca;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
16 Cuenca;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
16 Cuenca;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
16 Cuenca;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;91,2
16 Cuenca;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
16 Cuenca;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
16 Cuenca;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;92,19
16 Cuenca;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
16 Cuenca;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
16 Cuenca;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
16 Cuenca;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;92,84
16 Cuenca;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
16 Cuenca;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
16 Cuenca;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
16 Cuenca;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;89
16 Cuenca;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
16 Cuenca;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
16 Cuenca;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;89,48
16 Cuenca;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
16 Cuenca;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
16 Cuenca;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
16 Cuenca;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;91,15
16 Cuenca;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
16 Cuenca;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
16 Cuenca;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
16 Cuenca;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;87,51
16 Cuenca;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
16 Cuenca;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
16 Cuenca;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
16 Cuenca;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
16 Cuenca;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
16 Cuenca;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QII;3.624
16 Cuenca;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
16 Cuenca;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
16 Cuenca;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
16 Cuenca;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QII;3.700
16 Cuenca;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
16 Cuenca;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
16 Cuenca;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
16 Cuenca;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QII;3.722
16 Cuenca;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
16 Cuenca;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
16 Cuenca;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
16 Cuenca;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2022QII;3.551
16 Cuenca;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2022QI;""
16 Cuenca;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
16 Cuenca;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
16 Cuenca;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2021QII;3.612
16 Cuenca;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2021QI;""
16 Cuenca;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
16 Cuenca;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
16 Cuenca;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2020QII;3.661
16 Cuenca;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2020QI;""
16 Cuenca;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
16 Cuenca;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2022QIII;3.485
16 Cuenca;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2022QII;""
16 Cuenca;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2022QI;""
16 Cuenca;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
16 Cuenca;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2021QIII;3.547
16 Cuenca;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2021QII;""
16 Cuenca;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2021QI;""
16 Cuenca;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
16 Cuenca;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2020QIII;3.600
16 Cuenca;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2020QII;""
16 Cuenca;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2020QI;""
16 Cuenca;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QIV;3.401
16 Cuenca;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
16 Cuenca;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QII;""
16 Cuenca;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QI;""
16 Cuenca;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QIV;3.482
16 Cuenca;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
16 Cuenca;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QII;""
16 Cuenca;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QI;""
16 Cuenca;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QIV;3.533
16 Cuenca;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
16 Cuenca;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QII;""
16 Cuenca;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QI;""
16 Cuenca;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
16 Cuenca;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
16 Cuenca;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QII;""
16 Cuenca;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QI;3.411
16 Cuenca;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
16 Cuenca;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
16 Cuenca;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QII;""
16 Cuenca;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QI;3.479
16 Cuenca;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
16 Cuenca;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
16 Cuenca;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QII;""
16 Cuenca;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QI;""
16 Cuenca;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
16 Cuenca;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
16 Cuenca;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
16 Cuenca;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
16 Cuenca;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
16 Cuenca;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
16 Cuenca;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
16 Cuenca;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
16 Cuenca;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
16 Cuenca;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
16 Cuenca;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
16 Cuenca;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
16 Cuenca;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
16 Cuenca;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
16 Cuenca;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;97,99
16 Cuenca;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
16 Cuenca;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
16 Cuenca;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
16 Cuenca;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;97,62
16 Cuenca;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
16 Cuenca;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
16 Cuenca;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
16 Cuenca;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;98,36
16 Cuenca;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
16 Cuenca;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
16 Cuenca;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;96,16
16 Cuenca;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
16 Cuenca;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
16 Cuenca;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
16 Cuenca;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;95,86
16 Cuenca;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
16 Cuenca;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
16 Cuenca;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
16 Cuenca;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;96,72
16 Cuenca;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
16 Cuenca;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
16 Cuenca;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;93,85
16 Cuenca;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
16 Cuenca;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
16 Cuenca;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
16 Cuenca;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;94,11
16 Cuenca;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
16 Cuenca;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
16 Cuenca;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
16 Cuenca;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;94,92
16 Cuenca;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
16 Cuenca;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
16 Cuenca;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
16 Cuenca;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
16 Cuenca;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
16 Cuenca;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
16 Cuenca;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;92,19
16 Cuenca;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
16 Cuenca;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
16 Cuenca;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
16 Cuenca;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;93,47
16 Cuenca;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
16 Cuenca;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
16 Cuenca;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
16 Cuenca;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
16 Cuenca;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
16 Cuenca;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
16 Cuenca;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QII;2.438
16 Cuenca;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
16 Cuenca;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
16 Cuenca;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
16 Cuenca;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QII;2.494
16 Cuenca;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
16 Cuenca;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
16 Cuenca;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
16 Cuenca;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QII;2.498
16 Cuenca;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
16 Cuenca;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
16 Cuenca;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
16 Cuenca;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2022QII;2.394
16 Cuenca;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2022QI;""
16 Cuenca;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
16 Cuenca;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
16 Cuenca;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2021QII;2.442
16 Cuenca;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2021QI;""
16 Cuenca;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
16 Cuenca;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
16 Cuenca;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2020QII;2.463
16 Cuenca;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2020QI;""
16 Cuenca;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
16 Cuenca;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2022QIII;2.363
16 Cuenca;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2022QII;""
16 Cuenca;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2022QI;""
16 Cuenca;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
16 Cuenca;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2021QIII;2.405
16 Cuenca;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2021QII;""
16 Cuenca;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2021QI;""
16 Cuenca;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
16 Cuenca;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2020QIII;2.430
16 Cuenca;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2020QII;""
16 Cuenca;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2020QI;""
16 Cuenca;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QIV;2.316
16 Cuenca;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
16 Cuenca;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QII;""
16 Cuenca;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QI;""
16 Cuenca;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QIV;2.364
16 Cuenca;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
16 Cuenca;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QII;""
16 Cuenca;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QI;""
16 Cuenca;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QIV;2.383
16 Cuenca;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
16 Cuenca;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QII;""
16 Cuenca;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QI;""
16 Cuenca;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
16 Cuenca;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
16 Cuenca;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QII;""
16 Cuenca;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QI;2.320
16 Cuenca;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
16 Cuenca;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
16 Cuenca;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QII;""
16 Cuenca;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QI;2.354
16 Cuenca;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
16 Cuenca;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
16 Cuenca;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QII;""
16 Cuenca;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QI;""
16 Cuenca;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
16 Cuenca;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
16 Cuenca;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
16 Cuenca;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
16 Cuenca;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
16 Cuenca;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
16 Cuenca;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
16 Cuenca;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
16 Cuenca;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
16 Cuenca;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
16 Cuenca;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
16 Cuenca;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
16 Cuenca;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
16 Cuenca;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
16 Cuenca;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;98,2
16 Cuenca;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
16 Cuenca;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
16 Cuenca;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
16 Cuenca;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;97,91
16 Cuenca;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
16 Cuenca;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
16 Cuenca;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
16 Cuenca;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;98,6
16 Cuenca;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
16 Cuenca;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
16 Cuenca;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;96,92
16 Cuenca;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
16 Cuenca;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
16 Cuenca;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
16 Cuenca;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;96,43
16 Cuenca;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
16 Cuenca;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
16 Cuenca;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
16 Cuenca;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;97,28
16 Cuenca;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
16 Cuenca;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
16 Cuenca;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;95
16 Cuenca;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
16 Cuenca;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
16 Cuenca;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
16 Cuenca;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;94,79
16 Cuenca;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
16 Cuenca;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
16 Cuenca;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
16 Cuenca;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;95,4
16 Cuenca;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
16 Cuenca;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
16 Cuenca;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
16 Cuenca;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
16 Cuenca;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
16 Cuenca;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
16 Cuenca;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;93,02
16 Cuenca;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
16 Cuenca;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
16 Cuenca;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
16 Cuenca;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;94,24
16 Cuenca;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
16 Cuenca;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
16 Cuenca;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
16 Cuenca;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
16 Cuenca;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
16 Cuenca;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
16 Cuenca;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QII;1.186
16 Cuenca;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
16 Cuenca;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
16 Cuenca;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
16 Cuenca;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QII;1.206
16 Cuenca;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
16 Cuenca;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
16 Cuenca;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
16 Cuenca;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QII;1.224
16 Cuenca;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
16 Cuenca;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
16 Cuenca;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
16 Cuenca;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2022QII;1.157
16 Cuenca;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2022QI;""
16 Cuenca;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
16 Cuenca;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
16 Cuenca;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2021QII;1.170
16 Cuenca;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2021QI;""
16 Cuenca;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
16 Cuenca;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
16 Cuenca;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2020QII;1.198
16 Cuenca;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2020QI;""
16 Cuenca;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
16 Cuenca;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2022QIII;1.122
16 Cuenca;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2022QII;""
16 Cuenca;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2022QI;""
16 Cuenca;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
16 Cuenca;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2021QIII;1.142
16 Cuenca;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2021QII;""
16 Cuenca;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2021QI;""
16 Cuenca;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
16 Cuenca;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2020QIII;1.170
16 Cuenca;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2020QII;""
16 Cuenca;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2020QI;""
16 Cuenca;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QIV;1.085
16 Cuenca;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
16 Cuenca;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QII;""
16 Cuenca;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QI;""
16 Cuenca;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QIV;1.118
16 Cuenca;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
16 Cuenca;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QII;""
16 Cuenca;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QI;""
16 Cuenca;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QIV;1.150
16 Cuenca;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
16 Cuenca;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QII;""
16 Cuenca;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QI;""
16 Cuenca;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
16 Cuenca;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
16 Cuenca;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QII;""
16 Cuenca;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QI;1.091
16 Cuenca;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
16 Cuenca;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
16 Cuenca;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QII;""
16 Cuenca;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QI;1.125
16 Cuenca;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
16 Cuenca;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
16 Cuenca;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QII;""
16 Cuenca;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QI;""
16 Cuenca;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
16 Cuenca;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
16 Cuenca;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
16 Cuenca;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
16 Cuenca;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
16 Cuenca;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
16 Cuenca;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
16 Cuenca;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
16 Cuenca;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
16 Cuenca;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
16 Cuenca;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
16 Cuenca;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
16 Cuenca;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
16 Cuenca;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
16 Cuenca;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;97,55
16 Cuenca;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
16 Cuenca;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
16 Cuenca;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
16 Cuenca;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;97,01
16 Cuenca;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
16 Cuenca;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
16 Cuenca;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
16 Cuenca;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;97,88
16 Cuenca;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
16 Cuenca;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
16 Cuenca;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;94,6
16 Cuenca;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
16 Cuenca;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
16 Cuenca;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
16 Cuenca;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;94,69
16 Cuenca;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
16 Cuenca;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
16 Cuenca;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
16 Cuenca;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;95,59
16 Cuenca;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
16 Cuenca;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
16 Cuenca;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;91,48
16 Cuenca;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
16 Cuenca;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
16 Cuenca;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
16 Cuenca;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;92,7
16 Cuenca;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
16 Cuenca;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
16 Cuenca;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
16 Cuenca;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;93,95
16 Cuenca;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
16 Cuenca;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
16 Cuenca;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
16 Cuenca;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
16 Cuenca;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
16 Cuenca;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
16 Cuenca;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;90,46
16 Cuenca;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
16 Cuenca;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
16 Cuenca;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
16 Cuenca;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;91,91
16 Cuenca;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
16 Cuenca;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
16 Cuenca;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
16 Cuenca;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
16 Cuenca;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
16 Cuenca;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QIII;3.659
16 Cuenca;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
16 Cuenca;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
16 Cuenca;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
16 Cuenca;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QIII;3.714
16 Cuenca;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
16 Cuenca;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
16 Cuenca;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
16 Cuenca;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QIII;3.756
16 Cuenca;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
16 Cuenca;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
16 Cuenca;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
16 Cuenca;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2022QIII;3.577
16 Cuenca;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2022QII;""
16 Cuenca;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2022QI;""
16 Cuenca;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
16 Cuenca;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2021QIII;3.631
16 Cuenca;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2021QII;""
16 Cuenca;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2021QI;""
16 Cuenca;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
16 Cuenca;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2020QIII;3.680
16 Cuenca;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2020QII;""
16 Cuenca;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2020QI;""
16 Cuenca;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2022QIV;3.483
16 Cuenca;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
16 Cuenca;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2022QII;""
16 Cuenca;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2022QI;""
16 Cuenca;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2021QIV;3.557
16 Cuenca;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
16 Cuenca;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2021QII;""
16 Cuenca;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2021QI;""
16 Cuenca;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2020QIV;3.601
16 Cuenca;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
16 Cuenca;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2020QII;""
16 Cuenca;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2020QI;""
16 Cuenca;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
16 Cuenca;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
16 Cuenca;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QII;""
16 Cuenca;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QI;3.479
16 Cuenca;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
16 Cuenca;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
16 Cuenca;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QII;""
16 Cuenca;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QI;3.542
16 Cuenca;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
16 Cuenca;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
16 Cuenca;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QII;""
16 Cuenca;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QI;""
16 Cuenca;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
16 Cuenca;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
16 Cuenca;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QII;3.429
16 Cuenca;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QI;""
16 Cuenca;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
16 Cuenca;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
16 Cuenca;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QII;3.474
16 Cuenca;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QI;""
16 Cuenca;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
16 Cuenca;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
16 Cuenca;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QII;""
16 Cuenca;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QI;""
16 Cuenca;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
16 Cuenca;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
16 Cuenca;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
16 Cuenca;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
16 Cuenca;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
16 Cuenca;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
16 Cuenca;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
16 Cuenca;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
16 Cuenca;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
16 Cuenca;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
16 Cuenca;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
16 Cuenca;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
16 Cuenca;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
16 Cuenca;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;97,76
16 Cuenca;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
16 Cuenca;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
16 Cuenca;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
16 Cuenca;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;97,77
16 Cuenca;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
16 Cuenca;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
16 Cuenca;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
16 Cuenca;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;97,98
16 Cuenca;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
16 Cuenca;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
16 Cuenca;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;95,19
16 Cuenca;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
16 Cuenca;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
16 Cuenca;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
16 Cuenca;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;95,77
16 Cuenca;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
16 Cuenca;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
16 Cuenca;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
16 Cuenca;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;95,87
16 Cuenca;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
16 Cuenca;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
16 Cuenca;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
16 Cuenca;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
16 Cuenca;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
16 Cuenca;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
16 Cuenca;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;93,67
16 Cuenca;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
16 Cuenca;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
16 Cuenca;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
16 Cuenca;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;94,3
16 Cuenca;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
16 Cuenca;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
16 Cuenca;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
16 Cuenca;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
16 Cuenca;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
16 Cuenca;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
16 Cuenca;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;92,33
16 Cuenca;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
16 Cuenca;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
16 Cuenca;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
16 Cuenca;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;92,49
16 Cuenca;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
16 Cuenca;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
16 Cuenca;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
16 Cuenca;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
16 Cuenca;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
16 Cuenca;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
16 Cuenca;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QIII;2.464
16 Cuenca;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
16 Cuenca;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
16 Cuenca;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
16 Cuenca;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QIII;2.504
16 Cuenca;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
16 Cuenca;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
16 Cuenca;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
16 Cuenca;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QIII;2.530
16 Cuenca;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
16 Cuenca;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
16 Cuenca;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
16 Cuenca;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2022QIII;2.424
16 Cuenca;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2022QII;""
16 Cuenca;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2022QI;""
16 Cuenca;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
16 Cuenca;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2021QIII;2.456
16 Cuenca;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2021QII;""
16 Cuenca;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2021QI;""
16 Cuenca;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
16 Cuenca;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2020QIII;2.486
16 Cuenca;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2020QII;""
16 Cuenca;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2020QI;""
16 Cuenca;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2022QIV;2.369
16 Cuenca;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
16 Cuenca;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2022QII;""
16 Cuenca;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2022QI;""
16 Cuenca;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2021QIV;2.409
16 Cuenca;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
16 Cuenca;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2021QII;""
16 Cuenca;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2021QI;""
16 Cuenca;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2020QIV;2.427
16 Cuenca;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
16 Cuenca;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2020QII;""
16 Cuenca;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2020QI;""
16 Cuenca;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
16 Cuenca;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
16 Cuenca;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QII;""
16 Cuenca;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QI;2.360
16 Cuenca;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
16 Cuenca;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
16 Cuenca;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QII;""
16 Cuenca;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QI;2.394
16 Cuenca;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
16 Cuenca;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
16 Cuenca;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QII;""
16 Cuenca;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QI;""
16 Cuenca;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
16 Cuenca;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
16 Cuenca;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QII;2.333
16 Cuenca;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QI;""
16 Cuenca;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
16 Cuenca;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
16 Cuenca;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QII;2.353
16 Cuenca;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QI;""
16 Cuenca;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
16 Cuenca;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
16 Cuenca;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QII;""
16 Cuenca;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QI;""
16 Cuenca;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
16 Cuenca;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
16 Cuenca;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
16 Cuenca;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
16 Cuenca;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
16 Cuenca;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
16 Cuenca;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
16 Cuenca;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
16 Cuenca;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
16 Cuenca;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
16 Cuenca;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
16 Cuenca;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
16 Cuenca;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
16 Cuenca;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;98,38
16 Cuenca;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
16 Cuenca;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
16 Cuenca;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
16 Cuenca;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;98,08
16 Cuenca;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
16 Cuenca;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
16 Cuenca;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
16 Cuenca;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;98,26
16 Cuenca;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
16 Cuenca;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
16 Cuenca;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;96,14
16 Cuenca;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
16 Cuenca;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
16 Cuenca;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
16 Cuenca;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;96,21
16 Cuenca;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
16 Cuenca;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
16 Cuenca;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
16 Cuenca;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;95,93
16 Cuenca;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
16 Cuenca;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
16 Cuenca;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
16 Cuenca;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
16 Cuenca;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
16 Cuenca;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
16 Cuenca;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;94,25
16 Cuenca;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
16 Cuenca;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
16 Cuenca;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
16 Cuenca;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;94,62
16 Cuenca;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
16 Cuenca;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
16 Cuenca;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
16 Cuenca;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
16 Cuenca;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
16 Cuenca;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
16 Cuenca;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;93,17
16 Cuenca;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
16 Cuenca;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
16 Cuenca;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
16 Cuenca;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;93
16 Cuenca;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
16 Cuenca;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
16 Cuenca;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
16 Cuenca;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
16 Cuenca;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
16 Cuenca;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
16 Cuenca;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QIII;1.195
16 Cuenca;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
16 Cuenca;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
16 Cuenca;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
16 Cuenca;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QIII;1.210
16 Cuenca;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
16 Cuenca;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
16 Cuenca;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
16 Cuenca;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QIII;1.226
16 Cuenca;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
16 Cuenca;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
16 Cuenca;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
16 Cuenca;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2022QIII;1.153
16 Cuenca;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2022QII;""
16 Cuenca;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2022QI;""
16 Cuenca;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
16 Cuenca;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2021QIII;1.175
16 Cuenca;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2021QII;""
16 Cuenca;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2021QI;""
16 Cuenca;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
16 Cuenca;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2020QIII;1.194
16 Cuenca;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2020QII;""
16 Cuenca;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2020QI;""
16 Cuenca;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2022QIV;1.114
16 Cuenca;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
16 Cuenca;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2022QII;""
16 Cuenca;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2022QI;""
16 Cuenca;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2021QIV;1.148
16 Cuenca;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
16 Cuenca;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2021QII;""
16 Cuenca;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2021QI;""
16 Cuenca;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2020QIV;1.174
16 Cuenca;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
16 Cuenca;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2020QII;""
16 Cuenca;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2020QI;""
16 Cuenca;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
16 Cuenca;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
16 Cuenca;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QII;""
16 Cuenca;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QI;1.119
16 Cuenca;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
16 Cuenca;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
16 Cuenca;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QII;""
16 Cuenca;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QI;1.148
16 Cuenca;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
16 Cuenca;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
16 Cuenca;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QII;""
16 Cuenca;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QI;""
16 Cuenca;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
16 Cuenca;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
16 Cuenca;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QII;1.096
16 Cuenca;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QI;""
16 Cuenca;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
16 Cuenca;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
16 Cuenca;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QII;1.121
16 Cuenca;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QI;""
16 Cuenca;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
16 Cuenca;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
16 Cuenca;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QII;""
16 Cuenca;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QI;""
16 Cuenca;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
16 Cuenca;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
16 Cuenca;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
16 Cuenca;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
16 Cuenca;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
16 Cuenca;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
16 Cuenca;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
16 Cuenca;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
16 Cuenca;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
16 Cuenca;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
16 Cuenca;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
16 Cuenca;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
16 Cuenca;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
16 Cuenca;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;96,49
16 Cuenca;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
16 Cuenca;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
16 Cuenca;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
16 Cuenca;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;97,11
16 Cuenca;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
16 Cuenca;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
16 Cuenca;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
16 Cuenca;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;97,39
16 Cuenca;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
16 Cuenca;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
16 Cuenca;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;93,22
16 Cuenca;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
16 Cuenca;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
16 Cuenca;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
16 Cuenca;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;94,88
16 Cuenca;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
16 Cuenca;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
16 Cuenca;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
16 Cuenca;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;95,76
16 Cuenca;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
16 Cuenca;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
16 Cuenca;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
16 Cuenca;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
16 Cuenca;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
16 Cuenca;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
16 Cuenca;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;92,48
16 Cuenca;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
16 Cuenca;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
16 Cuenca;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
16 Cuenca;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;93,64
16 Cuenca;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
16 Cuenca;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
16 Cuenca;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
16 Cuenca;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
16 Cuenca;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
16 Cuenca;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
16 Cuenca;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;90,58
16 Cuenca;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
16 Cuenca;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
16 Cuenca;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
16 Cuenca;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;91,44
16 Cuenca;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
16 Cuenca;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
16 Cuenca;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
16 Cuenca;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
16 Cuenca;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
16 Cuenca;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QIV;3.651
16 Cuenca;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
16 Cuenca;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
16 Cuenca;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
16 Cuenca;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QIV;3.714
16 Cuenca;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
16 Cuenca;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
16 Cuenca;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
16 Cuenca;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QIV;3.767
16 Cuenca;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
16 Cuenca;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
16 Cuenca;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
16 Cuenca;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2022QIV;3.551
16 Cuenca;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
16 Cuenca;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2022QII;""
16 Cuenca;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2022QI;""
16 Cuenca;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2021QIV;3.629
16 Cuenca;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
16 Cuenca;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2021QII;""
16 Cuenca;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2021QI;""
16 Cuenca;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2020QIV;3.675
16 Cuenca;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
16 Cuenca;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2020QII;""
16 Cuenca;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2020QI;""
16 Cuenca;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
16 Cuenca;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
16 Cuenca;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2022QII;""
16 Cuenca;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2022QI;3.545
16 Cuenca;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
16 Cuenca;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
16 Cuenca;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2021QII;""
16 Cuenca;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2021QI;3.611
16 Cuenca;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
16 Cuenca;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
16 Cuenca;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2020QII;""
16 Cuenca;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2020QI;""
16 Cuenca;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
16 Cuenca;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
16 Cuenca;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QII;3.492
16 Cuenca;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QI;""
16 Cuenca;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
16 Cuenca;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
16 Cuenca;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QII;3.538
16 Cuenca;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QI;""
16 Cuenca;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
16 Cuenca;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
16 Cuenca;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QII;""
16 Cuenca;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QI;""
16 Cuenca;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
16 Cuenca;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QIII;3.430
16 Cuenca;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QII;""
16 Cuenca;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QI;""
16 Cuenca;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
16 Cuenca;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QIII;3.482
16 Cuenca;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QII;""
16 Cuenca;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QI;""
16 Cuenca;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
16 Cuenca;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
16 Cuenca;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QII;""
16 Cuenca;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QI;""
16 Cuenca;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
16 Cuenca;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
16 Cuenca;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
16 Cuenca;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
16 Cuenca;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
16 Cuenca;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
16 Cuenca;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
16 Cuenca;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
16 Cuenca;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
16 Cuenca;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
16 Cuenca;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
16 Cuenca;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
16 Cuenca;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;97,26
16 Cuenca;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
16 Cuenca;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
16 Cuenca;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
16 Cuenca;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;97,71
16 Cuenca;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
16 Cuenca;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
16 Cuenca;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
16 Cuenca;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;97,56
16 Cuenca;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
16 Cuenca;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
16 Cuenca;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
16 Cuenca;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
16 Cuenca;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
16 Cuenca;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
16 Cuenca;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;95,45
16 Cuenca;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
16 Cuenca;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
16 Cuenca;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
16 Cuenca;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;95,86
16 Cuenca;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
16 Cuenca;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
16 Cuenca;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
16 Cuenca;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
16 Cuenca;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
16 Cuenca;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
16 Cuenca;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;94,02
16 Cuenca;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
16 Cuenca;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
16 Cuenca;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
16 Cuenca;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;93,92
16 Cuenca;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
16 Cuenca;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
16 Cuenca;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
16 Cuenca;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
16 Cuenca;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
16 Cuenca;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
16 Cuenca;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;92,35
16 Cuenca;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
16 Cuenca;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
16 Cuenca;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
16 Cuenca;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;92,43
16 Cuenca;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
16 Cuenca;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
16 Cuenca;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
16 Cuenca;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
16 Cuenca;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
16 Cuenca;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
16 Cuenca;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QIV;2.471
16 Cuenca;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
16 Cuenca;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
16 Cuenca;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
16 Cuenca;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QIV;2.507
16 Cuenca;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
16 Cuenca;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
16 Cuenca;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
16 Cuenca;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QIV;2.536
16 Cuenca;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
16 Cuenca;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
16 Cuenca;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
16 Cuenca;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2022QIV;2.412
16 Cuenca;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
16 Cuenca;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2022QII;""
16 Cuenca;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2022QI;""
16 Cuenca;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2021QIV;2.456
16 Cuenca;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
16 Cuenca;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2021QII;""
16 Cuenca;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2021QI;""
16 Cuenca;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2020QIV;2.469
16 Cuenca;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
16 Cuenca;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2020QII;""
16 Cuenca;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2020QI;""
16 Cuenca;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
16 Cuenca;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
16 Cuenca;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2022QII;""
16 Cuenca;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2022QI;2.404
16 Cuenca;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
16 Cuenca;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
16 Cuenca;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2021QII;""
16 Cuenca;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2021QI;2.431
16 Cuenca;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
16 Cuenca;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
16 Cuenca;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2020QII;""
16 Cuenca;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2020QI;""
16 Cuenca;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
16 Cuenca;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
16 Cuenca;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QII;2.374
16 Cuenca;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QI;""
16 Cuenca;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
16 Cuenca;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
16 Cuenca;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QII;2.387
16 Cuenca;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QI;""
16 Cuenca;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
16 Cuenca;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
16 Cuenca;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QII;""
16 Cuenca;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QI;""
16 Cuenca;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
16 Cuenca;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QIII;2.342
16 Cuenca;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QII;""
16 Cuenca;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QI;""
16 Cuenca;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
16 Cuenca;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QIII;2.359
16 Cuenca;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QII;""
16 Cuenca;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QI;""
16 Cuenca;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
16 Cuenca;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
16 Cuenca;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QII;""
16 Cuenca;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QI;""
16 Cuenca;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
16 Cuenca;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
16 Cuenca;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
16 Cuenca;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
16 Cuenca;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
16 Cuenca;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
16 Cuenca;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
16 Cuenca;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
16 Cuenca;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
16 Cuenca;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
16 Cuenca;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
16 Cuenca;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
16 Cuenca;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;97,61
16 Cuenca;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
16 Cuenca;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
16 Cuenca;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
16 Cuenca;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;97,97
16 Cuenca;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
16 Cuenca;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
16 Cuenca;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
16 Cuenca;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;97,36
16 Cuenca;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
16 Cuenca;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
16 Cuenca;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
16 Cuenca;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
16 Cuenca;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
16 Cuenca;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
16 Cuenca;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;95,89
16 Cuenca;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
16 Cuenca;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
16 Cuenca;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
16 Cuenca;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;95,86
16 Cuenca;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
16 Cuenca;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
16 Cuenca;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
16 Cuenca;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
16 Cuenca;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
16 Cuenca;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
16 Cuenca;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;94,69
16 Cuenca;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
16 Cuenca;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
16 Cuenca;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
16 Cuenca;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;94,12
16 Cuenca;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
16 Cuenca;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
16 Cuenca;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
16 Cuenca;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
16 Cuenca;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
16 Cuenca;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
16 Cuenca;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;93,42
16 Cuenca;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
16 Cuenca;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
16 Cuenca;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
16 Cuenca;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;93,02
16 Cuenca;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
16 Cuenca;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
16 Cuenca;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
16 Cuenca;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
16 Cuenca;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
16 Cuenca;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
16 Cuenca;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QIV;1.180
16 Cuenca;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
16 Cuenca;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
16 Cuenca;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
16 Cuenca;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QIV;1.207
16 Cuenca;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
16 Cuenca;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
16 Cuenca;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
16 Cuenca;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QIV;1.231
16 Cuenca;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
16 Cuenca;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
16 Cuenca;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
16 Cuenca;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2022QIV;1.139
16 Cuenca;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
16 Cuenca;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2022QII;""
16 Cuenca;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2022QI;""
16 Cuenca;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2021QIV;1.173
16 Cuenca;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
16 Cuenca;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2021QII;""
16 Cuenca;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2021QI;""
16 Cuenca;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2020QIV;1.206
16 Cuenca;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
16 Cuenca;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2020QII;""
16 Cuenca;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2020QI;""
16 Cuenca;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
16 Cuenca;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
16 Cuenca;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2022QII;""
16 Cuenca;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2022QI;1.141
16 Cuenca;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
16 Cuenca;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
16 Cuenca;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2021QII;""
16 Cuenca;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2021QI;1.180
16 Cuenca;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
16 Cuenca;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
16 Cuenca;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2020QII;""
16 Cuenca;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2020QI;""
16 Cuenca;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
16 Cuenca;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
16 Cuenca;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QII;1.118
16 Cuenca;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QI;""
16 Cuenca;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
16 Cuenca;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
16 Cuenca;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QII;1.151
16 Cuenca;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QI;""
16 Cuenca;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
16 Cuenca;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
16 Cuenca;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QII;""
16 Cuenca;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QI;""
16 Cuenca;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
16 Cuenca;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QIII;1.088
16 Cuenca;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QII;""
16 Cuenca;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QI;""
16 Cuenca;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
16 Cuenca;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QIII;1.123
16 Cuenca;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QII;""
16 Cuenca;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QI;""
16 Cuenca;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
16 Cuenca;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
16 Cuenca;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QII;""
16 Cuenca;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QI;""
16 Cuenca;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
16 Cuenca;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
16 Cuenca;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
16 Cuenca;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
16 Cuenca;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
16 Cuenca;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
16 Cuenca;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
16 Cuenca;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
16 Cuenca;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
16 Cuenca;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
16 Cuenca;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
16 Cuenca;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
16 Cuenca;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;96,53
16 Cuenca;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
16 Cuenca;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
16 Cuenca;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
16 Cuenca;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;97,18
16 Cuenca;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
16 Cuenca;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
16 Cuenca;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
16 Cuenca;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;97,97
16 Cuenca;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
16 Cuenca;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
16 Cuenca;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
16 Cuenca;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
16 Cuenca;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
16 Cuenca;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
16 Cuenca;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;94,53
16 Cuenca;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
16 Cuenca;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
16 Cuenca;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
16 Cuenca;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;95,86
16 Cuenca;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
16 Cuenca;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
16 Cuenca;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
16 Cuenca;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
16 Cuenca;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
16 Cuenca;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
16 Cuenca;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;92,63
16 Cuenca;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
16 Cuenca;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
16 Cuenca;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
16 Cuenca;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;93,5
16 Cuenca;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
16 Cuenca;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
16 Cuenca;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
16 Cuenca;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
16 Cuenca;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
16 Cuenca;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
16 Cuenca;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;90,14
16 Cuenca;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
16 Cuenca;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
16 Cuenca;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
16 Cuenca;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;91,23
16 Cuenca;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
16 Cuenca;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
16 Cuenca;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
16 Cuenca;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
16 Cuenca;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
16 Cuenca;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
16 Cuenca;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
16 Cuenca;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
16 Cuenca;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
16 Cuenca;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QI;4.203
16 Cuenca;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
16 Cuenca;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
16 Cuenca;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
16 Cuenca;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QI;4.166
16 Cuenca;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
16 Cuenca;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
16 Cuenca;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
16 Cuenca;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QI;4.298
16 Cuenca;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
16 Cuenca;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
16 Cuenca;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2022QII;""
16 Cuenca;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2022QI;4.136
16 Cuenca;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
16 Cuenca;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
16 Cuenca;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2021QII;""
16 Cuenca;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2021QI;4.112
16 Cuenca;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
16 Cuenca;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
16 Cuenca;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2020QII;""
16 Cuenca;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2020QI;4.105
16 Cuenca;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
16 Cuenca;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
16 Cuenca;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2022QII;4.082
16 Cuenca;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2022QI;""
16 Cuenca;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
16 Cuenca;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
16 Cuenca;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2021QII;4.056
16 Cuenca;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2021QI;""
16 Cuenca;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
16 Cuenca;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
16 Cuenca;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2020QII;4.055
16 Cuenca;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2020QI;""
16 Cuenca;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
16 Cuenca;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QIII;4.016
16 Cuenca;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QII;""
16 Cuenca;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QI;""
16 Cuenca;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
16 Cuenca;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QIII;4.001
16 Cuenca;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QII;""
16 Cuenca;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QI;""
16 Cuenca;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
16 Cuenca;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QIII;3.994
16 Cuenca;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QII;""
16 Cuenca;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QI;""
16 Cuenca;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QIV;3.952
16 Cuenca;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
16 Cuenca;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QII;""
16 Cuenca;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QI;""
16 Cuenca;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QIV;3.949
16 Cuenca;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
16 Cuenca;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QII;""
16 Cuenca;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QI;""
16 Cuenca;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QIV;3.954
16 Cuenca;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
16 Cuenca;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QII;""
16 Cuenca;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QI;""
16 Cuenca;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
16 Cuenca;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
16 Cuenca;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
16 Cuenca;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
16 Cuenca;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
16 Cuenca;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
16 Cuenca;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
16 Cuenca;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
16 Cuenca;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
16 Cuenca;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
16 Cuenca;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
16 Cuenca;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
16 Cuenca;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
16 Cuenca;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
16 Cuenca;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
16 Cuenca;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;98,41
16 Cuenca;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
16 Cuenca;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
16 Cuenca;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
16 Cuenca;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;98,7
16 Cuenca;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
16 Cuenca;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
16 Cuenca;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
16 Cuenca;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;95,51
16 Cuenca;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
16 Cuenca;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
16 Cuenca;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;97,12
16 Cuenca;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
16 Cuenca;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
16 Cuenca;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
16 Cuenca;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;97,36
16 Cuenca;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
16 Cuenca;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
16 Cuenca;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
16 Cuenca;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;94,35
16 Cuenca;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
16 Cuenca;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
16 Cuenca;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;95,55
16 Cuenca;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
16 Cuenca;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
16 Cuenca;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
16 Cuenca;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;96,04
16 Cuenca;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
16 Cuenca;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
16 Cuenca;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
16 Cuenca;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;92,93
16 Cuenca;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
16 Cuenca;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
16 Cuenca;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;94,03
16 Cuenca;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
16 Cuenca;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
16 Cuenca;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
16 Cuenca;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;94,79
16 Cuenca;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
16 Cuenca;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
16 Cuenca;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
16 Cuenca;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;92
16 Cuenca;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
16 Cuenca;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
16 Cuenca;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
16 Cuenca;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
16 Cuenca;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
16 Cuenca;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
16 Cuenca;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QI;2.844
16 Cuenca;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
16 Cuenca;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
16 Cuenca;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
16 Cuenca;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QI;2.864
16 Cuenca;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
16 Cuenca;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
16 Cuenca;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
16 Cuenca;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QI;2.973
16 Cuenca;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
16 Cuenca;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
16 Cuenca;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2022QII;""
16 Cuenca;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2022QI;2.803
16 Cuenca;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
16 Cuenca;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
16 Cuenca;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2021QII;""
16 Cuenca;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2021QI;2.830
16 Cuenca;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
16 Cuenca;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
16 Cuenca;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2020QII;""
16 Cuenca;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2020QI;2.838
16 Cuenca;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
16 Cuenca;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
16 Cuenca;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2022QII;2.779
16 Cuenca;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2022QI;""
16 Cuenca;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
16 Cuenca;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
16 Cuenca;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2021QII;2.794
16 Cuenca;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2021QI;""
16 Cuenca;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
16 Cuenca;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
16 Cuenca;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2020QII;2.804
16 Cuenca;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2020QI;""
16 Cuenca;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
16 Cuenca;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QIII;2.745
16 Cuenca;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QII;""
16 Cuenca;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QI;""
16 Cuenca;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
16 Cuenca;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QIII;2.763
16 Cuenca;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QII;""
16 Cuenca;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QI;""
16 Cuenca;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
16 Cuenca;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QIII;2.762
16 Cuenca;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QII;""
16 Cuenca;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QI;""
16 Cuenca;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QIV;2.697
16 Cuenca;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
16 Cuenca;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QII;""
16 Cuenca;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QI;""
16 Cuenca;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QIV;2.732
16 Cuenca;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
16 Cuenca;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QII;""
16 Cuenca;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QI;""
16 Cuenca;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QIV;2.736
16 Cuenca;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
16 Cuenca;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QII;""
16 Cuenca;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QI;""
16 Cuenca;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
16 Cuenca;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
16 Cuenca;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
16 Cuenca;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
16 Cuenca;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
16 Cuenca;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
16 Cuenca;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
16 Cuenca;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
16 Cuenca;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
16 Cuenca;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
16 Cuenca;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
16 Cuenca;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
16 Cuenca;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
16 Cuenca;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
16 Cuenca;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
16 Cuenca;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;98,56
16 Cuenca;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
16 Cuenca;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
16 Cuenca;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
16 Cuenca;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;98,81
16 Cuenca;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
16 Cuenca;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
16 Cuenca;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
16 Cuenca;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;95,46
16 Cuenca;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
16 Cuenca;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
16 Cuenca;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;97,71
16 Cuenca;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
16 Cuenca;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
16 Cuenca;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
16 Cuenca;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;97,56
16 Cuenca;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
16 Cuenca;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
16 Cuenca;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
16 Cuenca;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;94,32
16 Cuenca;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
16 Cuenca;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
16 Cuenca;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;96,52
16 Cuenca;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
16 Cuenca;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
16 Cuenca;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
16 Cuenca;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;96,47
16 Cuenca;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
16 Cuenca;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
16 Cuenca;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
16 Cuenca;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;92,9
16 Cuenca;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
16 Cuenca;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
16 Cuenca;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;94,83
16 Cuenca;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
16 Cuenca;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
16 Cuenca;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
16 Cuenca;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;95,39
16 Cuenca;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
16 Cuenca;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
16 Cuenca;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
16 Cuenca;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;92,03
16 Cuenca;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
16 Cuenca;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
16 Cuenca;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
16 Cuenca;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
16 Cuenca;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
16 Cuenca;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
16 Cuenca;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QI;1.359
16 Cuenca;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
16 Cuenca;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
16 Cuenca;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
16 Cuenca;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QI;1.302
16 Cuenca;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
16 Cuenca;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
16 Cuenca;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
16 Cuenca;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QI;1.325
16 Cuenca;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
16 Cuenca;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
16 Cuenca;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2022QII;""
16 Cuenca;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2022QI;1.333
16 Cuenca;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
16 Cuenca;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
16 Cuenca;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2021QII;""
16 Cuenca;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2021QI;1.282
16 Cuenca;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
16 Cuenca;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
16 Cuenca;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2020QII;""
16 Cuenca;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2020QI;1.267
16 Cuenca;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
16 Cuenca;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
16 Cuenca;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2022QII;1.303
16 Cuenca;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2022QI;""
16 Cuenca;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
16 Cuenca;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
16 Cuenca;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2021QII;1.262
16 Cuenca;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2021QI;""
16 Cuenca;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
16 Cuenca;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
16 Cuenca;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2020QII;1.251
16 Cuenca;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2020QI;""
16 Cuenca;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
16 Cuenca;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QIII;1.271
16 Cuenca;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QII;""
16 Cuenca;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QI;""
16 Cuenca;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
16 Cuenca;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QIII;1.238
16 Cuenca;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QII;""
16 Cuenca;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QI;""
16 Cuenca;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
16 Cuenca;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QIII;1.232
16 Cuenca;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QII;""
16 Cuenca;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QI;""
16 Cuenca;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QIV;1.255
16 Cuenca;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
16 Cuenca;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QII;""
16 Cuenca;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QI;""
16 Cuenca;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QIV;1.217
16 Cuenca;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
16 Cuenca;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QII;""
16 Cuenca;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QI;""
16 Cuenca;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QIV;1.218
16 Cuenca;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
16 Cuenca;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QII;""
16 Cuenca;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QI;""
16 Cuenca;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
16 Cuenca;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
16 Cuenca;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
16 Cuenca;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
16 Cuenca;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
16 Cuenca;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
16 Cuenca;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
16 Cuenca;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
16 Cuenca;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
16 Cuenca;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
16 Cuenca;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
16 Cuenca;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
16 Cuenca;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
16 Cuenca;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
16 Cuenca;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
16 Cuenca;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;98,09
16 Cuenca;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
16 Cuenca;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
16 Cuenca;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
16 Cuenca;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;98,46
16 Cuenca;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
16 Cuenca;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
16 Cuenca;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
16 Cuenca;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;95,62
16 Cuenca;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
16 Cuenca;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
16 Cuenca;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;95,88
16 Cuenca;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
16 Cuenca;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
16 Cuenca;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
16 Cuenca;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;96,93
16 Cuenca;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
16 Cuenca;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
16 Cuenca;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
16 Cuenca;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;94,42
16 Cuenca;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
16 Cuenca;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
16 Cuenca;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;93,52
16 Cuenca;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
16 Cuenca;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
16 Cuenca;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
16 Cuenca;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;95,08
16 Cuenca;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
16 Cuenca;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
16 Cuenca;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
16 Cuenca;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;92,98
16 Cuenca;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
16 Cuenca;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
16 Cuenca;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;92,35
16 Cuenca;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
16 Cuenca;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
16 Cuenca;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
16 Cuenca;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;93,47
16 Cuenca;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
16 Cuenca;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
16 Cuenca;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
16 Cuenca;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;91,92
16 Cuenca;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
16 Cuenca;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
16 Cuenca;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
16 Cuenca;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
16 Cuenca;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
16 Cuenca;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QII;4.170
16 Cuenca;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
16 Cuenca;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
16 Cuenca;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
16 Cuenca;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QII;4.234
16 Cuenca;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
16 Cuenca;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
16 Cuenca;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
16 Cuenca;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QII;4.183
16 Cuenca;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
16 Cuenca;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
16 Cuenca;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
16 Cuenca;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2022QII;4.109
16 Cuenca;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2022QI;""
16 Cuenca;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
16 Cuenca;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
16 Cuenca;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2021QII;4.172
16 Cuenca;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2021QI;""
16 Cuenca;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
16 Cuenca;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
16 Cuenca;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2020QII;4.130
16 Cuenca;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2020QI;""
16 Cuenca;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
16 Cuenca;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2022QIII;4.038
16 Cuenca;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2022QII;""
16 Cuenca;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2022QI;""
16 Cuenca;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
16 Cuenca;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2021QIII;4.108
16 Cuenca;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2021QII;""
16 Cuenca;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2021QI;""
16 Cuenca;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
16 Cuenca;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2020QIII;4.062
16 Cuenca;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2020QII;""
16 Cuenca;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2020QI;""
16 Cuenca;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QIV;3.966
16 Cuenca;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
16 Cuenca;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QII;""
16 Cuenca;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QI;""
16 Cuenca;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QIV;4.048
16 Cuenca;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
16 Cuenca;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QII;""
16 Cuenca;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QI;""
16 Cuenca;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QIV;4.017
16 Cuenca;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
16 Cuenca;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QII;""
16 Cuenca;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QI;""
16 Cuenca;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
16 Cuenca;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
16 Cuenca;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QII;""
16 Cuenca;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QI;3.994
16 Cuenca;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
16 Cuenca;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
16 Cuenca;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QII;""
16 Cuenca;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QI;3.977
16 Cuenca;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
16 Cuenca;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
16 Cuenca;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QII;""
16 Cuenca;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QI;""
16 Cuenca;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
16 Cuenca;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
16 Cuenca;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
16 Cuenca;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
16 Cuenca;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
16 Cuenca;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
16 Cuenca;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
16 Cuenca;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
16 Cuenca;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
16 Cuenca;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
16 Cuenca;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
16 Cuenca;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
16 Cuenca;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
16 Cuenca;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
16 Cuenca;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;98,54
16 Cuenca;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
16 Cuenca;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
16 Cuenca;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
16 Cuenca;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;98,54
16 Cuenca;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
16 Cuenca;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
16 Cuenca;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
16 Cuenca;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;98,73
16 Cuenca;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
16 Cuenca;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
16 Cuenca;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;96,83
16 Cuenca;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
16 Cuenca;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
16 Cuenca;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
16 Cuenca;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;97,02
16 Cuenca;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
16 Cuenca;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
16 Cuenca;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
16 Cuenca;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;97,11
16 Cuenca;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
16 Cuenca;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
16 Cuenca;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;95,11
16 Cuenca;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
16 Cuenca;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
16 Cuenca;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
16 Cuenca;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;95,61
16 Cuenca;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
16 Cuenca;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
16 Cuenca;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
16 Cuenca;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;96,03
16 Cuenca;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
16 Cuenca;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
16 Cuenca;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
16 Cuenca;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
16 Cuenca;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
16 Cuenca;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
16 Cuenca;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;94,33
16 Cuenca;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
16 Cuenca;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
16 Cuenca;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
16 Cuenca;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;95,08
16 Cuenca;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
16 Cuenca;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
16 Cuenca;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
16 Cuenca;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
16 Cuenca;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
16 Cuenca;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
16 Cuenca;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QII;2.830
16 Cuenca;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
16 Cuenca;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
16 Cuenca;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
16 Cuenca;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QII;2.879
16 Cuenca;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
16 Cuenca;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
16 Cuenca;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
16 Cuenca;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QII;2.884
16 Cuenca;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
16 Cuenca;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
16 Cuenca;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
16 Cuenca;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2022QII;2.803
16 Cuenca;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2022QI;""
16 Cuenca;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
16 Cuenca;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
16 Cuenca;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2021QII;2.840
16 Cuenca;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2021QI;""
16 Cuenca;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
16 Cuenca;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
16 Cuenca;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2020QII;2.848
16 Cuenca;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2020QI;""
16 Cuenca;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
16 Cuenca;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2022QIII;2.761
16 Cuenca;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2022QII;""
16 Cuenca;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2022QI;""
16 Cuenca;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
16 Cuenca;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2021QIII;2.804
16 Cuenca;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2021QII;""
16 Cuenca;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2021QI;""
16 Cuenca;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
16 Cuenca;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2020QIII;2.800
16 Cuenca;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2020QII;""
16 Cuenca;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2020QI;""
16 Cuenca;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QIV;2.707
16 Cuenca;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
16 Cuenca;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QII;""
16 Cuenca;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QI;""
16 Cuenca;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QIV;2.768
16 Cuenca;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
16 Cuenca;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QII;""
16 Cuenca;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QI;""
16 Cuenca;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QIV;2.771
16 Cuenca;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
16 Cuenca;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QII;""
16 Cuenca;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QI;""
16 Cuenca;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
16 Cuenca;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
16 Cuenca;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QII;""
16 Cuenca;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QI;2.733
16 Cuenca;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
16 Cuenca;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
16 Cuenca;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QII;""
16 Cuenca;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QI;2.745
16 Cuenca;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
16 Cuenca;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
16 Cuenca;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QII;""
16 Cuenca;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QI;""
16 Cuenca;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
16 Cuenca;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
16 Cuenca;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
16 Cuenca;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
16 Cuenca;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
16 Cuenca;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
16 Cuenca;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
16 Cuenca;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
16 Cuenca;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
16 Cuenca;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
16 Cuenca;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
16 Cuenca;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
16 Cuenca;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
16 Cuenca;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
16 Cuenca;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;99,05
16 Cuenca;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
16 Cuenca;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
16 Cuenca;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
16 Cuenca;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;98,65
16 Cuenca;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
16 Cuenca;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
16 Cuenca;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
16 Cuenca;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;98,75
16 Cuenca;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
16 Cuenca;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
16 Cuenca;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;97,56
16 Cuenca;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
16 Cuenca;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
16 Cuenca;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
16 Cuenca;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;97,39
16 Cuenca;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
16 Cuenca;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
16 Cuenca;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
16 Cuenca;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;97,09
16 Cuenca;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
16 Cuenca;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
16 Cuenca;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;95,65
16 Cuenca;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
16 Cuenca;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
16 Cuenca;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
16 Cuenca;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;96,14
16 Cuenca;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
16 Cuenca;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
16 Cuenca;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
16 Cuenca;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;96,08
16 Cuenca;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
16 Cuenca;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
16 Cuenca;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
16 Cuenca;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
16 Cuenca;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
16 Cuenca;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
16 Cuenca;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;94,93
16 Cuenca;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
16 Cuenca;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
16 Cuenca;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
16 Cuenca;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;95,18
16 Cuenca;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
16 Cuenca;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
16 Cuenca;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
16 Cuenca;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
16 Cuenca;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
16 Cuenca;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
16 Cuenca;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QII;1.340
16 Cuenca;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
16 Cuenca;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
16 Cuenca;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
16 Cuenca;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QII;1.355
16 Cuenca;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
16 Cuenca;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
16 Cuenca;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
16 Cuenca;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QII;1.299
16 Cuenca;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
16 Cuenca;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
16 Cuenca;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
16 Cuenca;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2022QII;1.306
16 Cuenca;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2022QI;""
16 Cuenca;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
16 Cuenca;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
16 Cuenca;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2021QII;1.332
16 Cuenca;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2021QI;""
16 Cuenca;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
16 Cuenca;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
16 Cuenca;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2020QII;1.282
16 Cuenca;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2020QI;""
16 Cuenca;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
16 Cuenca;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2022QIII;1.277
16 Cuenca;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2022QII;""
16 Cuenca;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2022QI;""
16 Cuenca;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
16 Cuenca;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2021QIII;1.304
16 Cuenca;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2021QII;""
16 Cuenca;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2021QI;""
16 Cuenca;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
16 Cuenca;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2020QIII;1.262
16 Cuenca;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2020QII;""
16 Cuenca;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2020QI;""
16 Cuenca;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QIV;1.259
16 Cuenca;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
16 Cuenca;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QII;""
16 Cuenca;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QI;""
16 Cuenca;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QIV;1.280
16 Cuenca;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
16 Cuenca;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QII;""
16 Cuenca;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QI;""
16 Cuenca;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QIV;1.246
16 Cuenca;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
16 Cuenca;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QII;""
16 Cuenca;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QI;""
16 Cuenca;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
16 Cuenca;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
16 Cuenca;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QII;""
16 Cuenca;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QI;1.261
16 Cuenca;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
16 Cuenca;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
16 Cuenca;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QII;""
16 Cuenca;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QI;1.232
16 Cuenca;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
16 Cuenca;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
16 Cuenca;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QII;""
16 Cuenca;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QI;""
16 Cuenca;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
16 Cuenca;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
16 Cuenca;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
16 Cuenca;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
16 Cuenca;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
16 Cuenca;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
16 Cuenca;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
16 Cuenca;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
16 Cuenca;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
16 Cuenca;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
16 Cuenca;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
16 Cuenca;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
16 Cuenca;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
16 Cuenca;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
16 Cuenca;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;97,46
16 Cuenca;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
16 Cuenca;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
16 Cuenca;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
16 Cuenca;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;98,3
16 Cuenca;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
16 Cuenca;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
16 Cuenca;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
16 Cuenca;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;98,69
16 Cuenca;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
16 Cuenca;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
16 Cuenca;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;95,3
16 Cuenca;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
16 Cuenca;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
16 Cuenca;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
16 Cuenca;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;96,24
16 Cuenca;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
16 Cuenca;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
16 Cuenca;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
16 Cuenca;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;97,15
16 Cuenca;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
16 Cuenca;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
16 Cuenca;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;93,96
16 Cuenca;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
16 Cuenca;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
16 Cuenca;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
16 Cuenca;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;94,46
16 Cuenca;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
16 Cuenca;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
16 Cuenca;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
16 Cuenca;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;95,92
16 Cuenca;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
16 Cuenca;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
16 Cuenca;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
16 Cuenca;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
16 Cuenca;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
16 Cuenca;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
16 Cuenca;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;93,06
16 Cuenca;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
16 Cuenca;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
16 Cuenca;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
16 Cuenca;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;94,84
16 Cuenca;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
16 Cuenca;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
16 Cuenca;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
16 Cuenca;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
16 Cuenca;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
16 Cuenca;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QIII;4.182
16 Cuenca;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
16 Cuenca;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
16 Cuenca;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
16 Cuenca;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QIII;4.247
16 Cuenca;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
16 Cuenca;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
16 Cuenca;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
16 Cuenca;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QIII;4.203
16 Cuenca;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
16 Cuenca;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
16 Cuenca;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
16 Cuenca;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2022QIII;4.094
16 Cuenca;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2022QII;""
16 Cuenca;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2022QI;""
16 Cuenca;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
16 Cuenca;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2021QIII;4.174
16 Cuenca;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2021QII;""
16 Cuenca;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2021QI;""
16 Cuenca;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
16 Cuenca;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2020QIII;4.121
16 Cuenca;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2020QII;""
16 Cuenca;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2020QI;""
16 Cuenca;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2022QIV;4.014
16 Cuenca;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
16 Cuenca;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2022QII;""
16 Cuenca;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2022QI;""
16 Cuenca;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2021QIV;4.108
16 Cuenca;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
16 Cuenca;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2021QII;""
16 Cuenca;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2021QI;""
16 Cuenca;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2020QIV;4.071
16 Cuenca;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
16 Cuenca;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2020QII;""
16 Cuenca;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2020QI;""
16 Cuenca;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
16 Cuenca;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
16 Cuenca;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QII;""
16 Cuenca;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QI;4.050
16 Cuenca;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
16 Cuenca;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
16 Cuenca;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QII;""
16 Cuenca;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QI;4.028
16 Cuenca;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
16 Cuenca;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
16 Cuenca;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QII;""
16 Cuenca;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QI;""
16 Cuenca;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
16 Cuenca;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
16 Cuenca;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QII;4.003
16 Cuenca;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QI;""
16 Cuenca;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
16 Cuenca;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
16 Cuenca;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QII;3.975
16 Cuenca;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QI;""
16 Cuenca;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
16 Cuenca;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
16 Cuenca;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QII;""
16 Cuenca;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QI;""
16 Cuenca;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
16 Cuenca;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
16 Cuenca;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
16 Cuenca;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
16 Cuenca;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
16 Cuenca;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
16 Cuenca;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
16 Cuenca;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
16 Cuenca;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
16 Cuenca;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
16 Cuenca;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
16 Cuenca;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
16 Cuenca;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
16 Cuenca;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;97,9
16 Cuenca;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
16 Cuenca;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
16 Cuenca;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
16 Cuenca;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;98,28
16 Cuenca;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
16 Cuenca;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
16 Cuenca;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
16 Cuenca;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;98,05
16 Cuenca;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
16 Cuenca;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
16 Cuenca;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;95,98
16 Cuenca;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
16 Cuenca;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
16 Cuenca;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
16 Cuenca;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;96,73
16 Cuenca;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
16 Cuenca;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
16 Cuenca;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
16 Cuenca;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;96,86
16 Cuenca;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
16 Cuenca;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
16 Cuenca;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
16 Cuenca;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
16 Cuenca;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
16 Cuenca;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
16 Cuenca;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;95,36
16 Cuenca;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
16 Cuenca;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
16 Cuenca;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
16 Cuenca;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;95,84
16 Cuenca;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
16 Cuenca;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
16 Cuenca;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
16 Cuenca;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
16 Cuenca;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
16 Cuenca;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
16 Cuenca;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;94,25
16 Cuenca;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
16 Cuenca;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
16 Cuenca;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
16 Cuenca;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;94,58
16 Cuenca;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
16 Cuenca;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
16 Cuenca;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
16 Cuenca;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
16 Cuenca;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
16 Cuenca;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
16 Cuenca;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QIII;2.846
16 Cuenca;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
16 Cuenca;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
16 Cuenca;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
16 Cuenca;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QIII;2.879
16 Cuenca;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
16 Cuenca;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
16 Cuenca;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
16 Cuenca;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QIII;2.893
16 Cuenca;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
16 Cuenca;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
16 Cuenca;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
16 Cuenca;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2022QIII;2.795
16 Cuenca;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2022QII;""
16 Cuenca;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2022QI;""
16 Cuenca;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
16 Cuenca;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2021QIII;2.837
16 Cuenca;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2021QII;""
16 Cuenca;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2021QI;""
16 Cuenca;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
16 Cuenca;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2020QIII;2.837
16 Cuenca;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2020QII;""
16 Cuenca;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2020QI;""
16 Cuenca;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2022QIV;2.735
16 Cuenca;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
16 Cuenca;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2022QII;""
16 Cuenca;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2022QI;""
16 Cuenca;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2021QIV;2.797
16 Cuenca;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
16 Cuenca;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2021QII;""
16 Cuenca;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2021QI;""
16 Cuenca;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2020QIV;2.803
16 Cuenca;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
16 Cuenca;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2020QII;""
16 Cuenca;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2020QI;""
16 Cuenca;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
16 Cuenca;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
16 Cuenca;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QII;""
16 Cuenca;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QI;2.760
16 Cuenca;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
16 Cuenca;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
16 Cuenca;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QII;""
16 Cuenca;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QI;2.775
16 Cuenca;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
16 Cuenca;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
16 Cuenca;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QII;""
16 Cuenca;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QI;""
16 Cuenca;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
16 Cuenca;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
16 Cuenca;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QII;2.740
16 Cuenca;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QI;""
16 Cuenca;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
16 Cuenca;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
16 Cuenca;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QII;2.741
16 Cuenca;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QI;""
16 Cuenca;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
16 Cuenca;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
16 Cuenca;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QII;""
16 Cuenca;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QI;""
16 Cuenca;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
16 Cuenca;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
16 Cuenca;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
16 Cuenca;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
16 Cuenca;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
16 Cuenca;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
16 Cuenca;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
16 Cuenca;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
16 Cuenca;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
16 Cuenca;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
16 Cuenca;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
16 Cuenca;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
16 Cuenca;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
16 Cuenca;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;98,21
16 Cuenca;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
16 Cuenca;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
16 Cuenca;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
16 Cuenca;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;98,54
16 Cuenca;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
16 Cuenca;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
16 Cuenca;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
16 Cuenca;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;98,06
16 Cuenca;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
16 Cuenca;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
16 Cuenca;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;96,1
16 Cuenca;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
16 Cuenca;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
16 Cuenca;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
16 Cuenca;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;97,15
16 Cuenca;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
16 Cuenca;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
16 Cuenca;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
16 Cuenca;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;96,89
16 Cuenca;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
16 Cuenca;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
16 Cuenca;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
16 Cuenca;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
16 Cuenca;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
16 Cuenca;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
16 Cuenca;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;95,87
16 Cuenca;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
16 Cuenca;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
16 Cuenca;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
16 Cuenca;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;95,92
16 Cuenca;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
16 Cuenca;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
16 Cuenca;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
16 Cuenca;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
16 Cuenca;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
16 Cuenca;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
16 Cuenca;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;95,17
16 Cuenca;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
16 Cuenca;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
16 Cuenca;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
16 Cuenca;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;94,75
16 Cuenca;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
16 Cuenca;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
16 Cuenca;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
16 Cuenca;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
16 Cuenca;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
16 Cuenca;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
16 Cuenca;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QIII;1.336
16 Cuenca;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
16 Cuenca;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
16 Cuenca;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
16 Cuenca;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QIII;1.368
16 Cuenca;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
16 Cuenca;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
16 Cuenca;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
16 Cuenca;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QIII;1.310
16 Cuenca;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
16 Cuenca;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
16 Cuenca;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
16 Cuenca;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2022QIII;1.299
16 Cuenca;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2022QII;""
16 Cuenca;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2022QI;""
16 Cuenca;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
16 Cuenca;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2021QIII;1.337
16 Cuenca;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2021QII;""
16 Cuenca;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2021QI;""
16 Cuenca;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
16 Cuenca;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2020QIII;1.284
16 Cuenca;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2020QII;""
16 Cuenca;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2020QI;""
16 Cuenca;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2022QIV;1.279
16 Cuenca;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
16 Cuenca;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2022QII;""
16 Cuenca;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2022QI;""
16 Cuenca;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2021QIV;1.311
16 Cuenca;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
16 Cuenca;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2021QII;""
16 Cuenca;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2021QI;""
16 Cuenca;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2020QIV;1.268
16 Cuenca;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
16 Cuenca;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2020QII;""
16 Cuenca;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2020QI;""
16 Cuenca;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
16 Cuenca;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
16 Cuenca;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QII;""
16 Cuenca;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QI;1.290
16 Cuenca;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
16 Cuenca;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
16 Cuenca;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QII;""
16 Cuenca;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QI;1.253
16 Cuenca;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
16 Cuenca;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
16 Cuenca;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QII;""
16 Cuenca;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QI;""
16 Cuenca;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
16 Cuenca;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
16 Cuenca;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QII;1.263
16 Cuenca;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QI;""
16 Cuenca;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
16 Cuenca;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
16 Cuenca;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QII;1.234
16 Cuenca;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QI;""
16 Cuenca;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
16 Cuenca;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
16 Cuenca;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QII;""
16 Cuenca;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QI;""
16 Cuenca;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
16 Cuenca;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
16 Cuenca;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
16 Cuenca;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
16 Cuenca;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
16 Cuenca;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
16 Cuenca;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
16 Cuenca;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
16 Cuenca;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
16 Cuenca;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
16 Cuenca;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
16 Cuenca;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
16 Cuenca;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
16 Cuenca;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;97,23
16 Cuenca;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
16 Cuenca;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
16 Cuenca;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
16 Cuenca;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;97,73
16 Cuenca;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
16 Cuenca;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
16 Cuenca;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
16 Cuenca;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;98,02
16 Cuenca;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
16 Cuenca;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
16 Cuenca;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;95,73
16 Cuenca;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
16 Cuenca;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
16 Cuenca;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
16 Cuenca;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;95,83
16 Cuenca;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
16 Cuenca;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
16 Cuenca;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
16 Cuenca;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;96,79
16 Cuenca;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
16 Cuenca;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
16 Cuenca;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
16 Cuenca;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
16 Cuenca;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
16 Cuenca;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
16 Cuenca;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;94,3
16 Cuenca;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
16 Cuenca;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
16 Cuenca;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
16 Cuenca;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;95,65
16 Cuenca;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
16 Cuenca;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
16 Cuenca;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
16 Cuenca;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
16 Cuenca;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
16 Cuenca;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
16 Cuenca;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;92,32
16 Cuenca;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
16 Cuenca;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
16 Cuenca;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
16 Cuenca;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;94,2
16 Cuenca;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
16 Cuenca;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
16 Cuenca;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
16 Cuenca;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
16 Cuenca;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
16 Cuenca;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QIV;4.146
16 Cuenca;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
16 Cuenca;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
16 Cuenca;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
16 Cuenca;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QIV;4.213
16 Cuenca;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
16 Cuenca;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
16 Cuenca;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
16 Cuenca;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QIV;4.169
16 Cuenca;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
16 Cuenca;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
16 Cuenca;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
16 Cuenca;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2022QIV;4.061
16 Cuenca;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
16 Cuenca;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2022QII;""
16 Cuenca;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2022QI;""
16 Cuenca;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2021QIV;4.144
16 Cuenca;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
16 Cuenca;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2021QII;""
16 Cuenca;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2021QI;""
16 Cuenca;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2020QIV;4.111
16 Cuenca;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
16 Cuenca;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2020QII;""
16 Cuenca;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2020QI;""
16 Cuenca;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
16 Cuenca;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
16 Cuenca;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2022QII;""
16 Cuenca;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2022QI;4.084
16 Cuenca;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
16 Cuenca;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
16 Cuenca;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2021QII;""
16 Cuenca;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2021QI;4.067
16 Cuenca;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
16 Cuenca;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
16 Cuenca;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2020QII;""
16 Cuenca;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2020QI;""
16 Cuenca;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
16 Cuenca;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
16 Cuenca;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QII;4.035
16 Cuenca;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QI;""
16 Cuenca;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
16 Cuenca;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
16 Cuenca;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QII;4.014
16 Cuenca;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QI;""
16 Cuenca;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
16 Cuenca;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
16 Cuenca;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QII;""
16 Cuenca;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QI;""
16 Cuenca;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
16 Cuenca;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QIII;3.972
16 Cuenca;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QII;""
16 Cuenca;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QI;""
16 Cuenca;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
16 Cuenca;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QIII;3.963
16 Cuenca;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QII;""
16 Cuenca;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QI;""
16 Cuenca;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
16 Cuenca;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
16 Cuenca;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QII;""
16 Cuenca;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QI;""
16 Cuenca;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
16 Cuenca;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
16 Cuenca;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
16 Cuenca;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
16 Cuenca;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
16 Cuenca;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
16 Cuenca;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
16 Cuenca;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
16 Cuenca;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
16 Cuenca;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
16 Cuenca;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
16 Cuenca;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
16 Cuenca;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;97,95
16 Cuenca;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
16 Cuenca;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
16 Cuenca;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
16 Cuenca;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;98,36
16 Cuenca;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
16 Cuenca;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
16 Cuenca;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
16 Cuenca;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;98,61
16 Cuenca;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
16 Cuenca;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
16 Cuenca;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
16 Cuenca;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
16 Cuenca;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
16 Cuenca;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
16 Cuenca;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;96,94
16 Cuenca;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
16 Cuenca;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
16 Cuenca;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
16 Cuenca;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;97,55
16 Cuenca;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
16 Cuenca;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
16 Cuenca;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
16 Cuenca;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
16 Cuenca;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
16 Cuenca;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
16 Cuenca;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;95,77
16 Cuenca;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
16 Cuenca;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
16 Cuenca;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
16 Cuenca;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;96,28
16 Cuenca;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
16 Cuenca;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
16 Cuenca;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
16 Cuenca;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
16 Cuenca;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
16 Cuenca;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
16 Cuenca;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;94,28
16 Cuenca;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
16 Cuenca;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
16 Cuenca;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
16 Cuenca;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;95,06
16 Cuenca;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
16 Cuenca;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
16 Cuenca;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
16 Cuenca;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
16 Cuenca;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
16 Cuenca;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
16 Cuenca;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QIV;2.820
16 Cuenca;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
16 Cuenca;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
16 Cuenca;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
16 Cuenca;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QIV;2.854
16 Cuenca;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
16 Cuenca;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
16 Cuenca;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
16 Cuenca;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QIV;2.869
16 Cuenca;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
16 Cuenca;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
16 Cuenca;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
16 Cuenca;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2022QIV;2.756
16 Cuenca;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
16 Cuenca;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2022QII;""
16 Cuenca;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2022QI;""
16 Cuenca;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2021QIV;2.812
16 Cuenca;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
16 Cuenca;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2021QII;""
16 Cuenca;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2021QI;""
16 Cuenca;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2020QIV;2.831
16 Cuenca;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
16 Cuenca;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2020QII;""
16 Cuenca;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2020QI;""
16 Cuenca;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
16 Cuenca;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
16 Cuenca;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2022QII;""
16 Cuenca;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2022QI;2.774
16 Cuenca;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
16 Cuenca;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
16 Cuenca;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2021QII;""
16 Cuenca;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2021QI;2.803
16 Cuenca;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
16 Cuenca;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
16 Cuenca;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2020QII;""
16 Cuenca;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2020QI;""
16 Cuenca;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
16 Cuenca;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
16 Cuenca;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QII;2.752
16 Cuenca;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QI;""
16 Cuenca;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
16 Cuenca;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
16 Cuenca;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QII;2.769
16 Cuenca;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QI;""
16 Cuenca;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
16 Cuenca;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
16 Cuenca;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QII;""
16 Cuenca;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QI;""
16 Cuenca;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
16 Cuenca;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QIII;2.720
16 Cuenca;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QII;""
16 Cuenca;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QI;""
16 Cuenca;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
16 Cuenca;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QIII;2.740
16 Cuenca;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QII;""
16 Cuenca;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QI;""
16 Cuenca;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
16 Cuenca;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
16 Cuenca;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QII;""
16 Cuenca;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QI;""
16 Cuenca;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
16 Cuenca;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
16 Cuenca;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
16 Cuenca;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
16 Cuenca;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
16 Cuenca;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
16 Cuenca;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
16 Cuenca;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
16 Cuenca;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
16 Cuenca;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
16 Cuenca;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
16 Cuenca;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
16 Cuenca;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;97,73
16 Cuenca;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
16 Cuenca;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
16 Cuenca;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
16 Cuenca;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;98,53
16 Cuenca;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
16 Cuenca;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
16 Cuenca;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
16 Cuenca;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;98,68
16 Cuenca;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
16 Cuenca;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
16 Cuenca;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
16 Cuenca;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
16 Cuenca;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
16 Cuenca;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
16 Cuenca;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;97,2
16 Cuenca;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
16 Cuenca;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
16 Cuenca;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
16 Cuenca;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;97,7
16 Cuenca;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
16 Cuenca;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
16 Cuenca;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
16 Cuenca;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
16 Cuenca;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
16 Cuenca;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
16 Cuenca;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;96,43
16 Cuenca;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
16 Cuenca;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
16 Cuenca;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
16 Cuenca;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;96,51
16 Cuenca;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
16 Cuenca;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
16 Cuenca;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
16 Cuenca;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
16 Cuenca;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
16 Cuenca;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
16 Cuenca;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;95,3
16 Cuenca;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
16 Cuenca;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
16 Cuenca;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
16 Cuenca;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;95,5
16 Cuenca;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
16 Cuenca;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
16 Cuenca;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
16 Cuenca;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
16 Cuenca;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
16 Cuenca;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
16 Cuenca;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QIV;1.326
16 Cuenca;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
16 Cuenca;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
16 Cuenca;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
16 Cuenca;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QIV;1.359
16 Cuenca;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
16 Cuenca;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
16 Cuenca;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
16 Cuenca;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QIV;1.300
16 Cuenca;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
16 Cuenca;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
16 Cuenca;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
16 Cuenca;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2022QIV;1.305
16 Cuenca;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
16 Cuenca;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2022QII;""
16 Cuenca;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2022QI;""
16 Cuenca;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2021QIV;1.332
16 Cuenca;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
16 Cuenca;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2021QII;""
16 Cuenca;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2021QI;""
16 Cuenca;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2020QIV;1.280
16 Cuenca;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
16 Cuenca;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2020QII;""
16 Cuenca;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2020QI;""
16 Cuenca;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
16 Cuenca;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
16 Cuenca;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2022QII;""
16 Cuenca;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2022QI;1.310
16 Cuenca;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
16 Cuenca;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
16 Cuenca;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2021QII;""
16 Cuenca;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2021QI;1.264
16 Cuenca;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
16 Cuenca;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
16 Cuenca;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2020QII;""
16 Cuenca;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2020QI;""
16 Cuenca;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
16 Cuenca;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
16 Cuenca;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QII;1.283
16 Cuenca;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QI;""
16 Cuenca;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
16 Cuenca;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
16 Cuenca;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QII;1.245
16 Cuenca;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QI;""
16 Cuenca;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
16 Cuenca;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
16 Cuenca;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QII;""
16 Cuenca;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QI;""
16 Cuenca;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
16 Cuenca;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QIII;1.252
16 Cuenca;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QII;""
16 Cuenca;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QI;""
16 Cuenca;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
16 Cuenca;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QIII;1.223
16 Cuenca;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QII;""
16 Cuenca;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QI;""
16 Cuenca;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
16 Cuenca;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
16 Cuenca;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QII;""
16 Cuenca;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QI;""
16 Cuenca;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
16 Cuenca;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
16 Cuenca;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
16 Cuenca;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
16 Cuenca;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
16 Cuenca;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
16 Cuenca;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
16 Cuenca;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
16 Cuenca;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
16 Cuenca;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
16 Cuenca;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
16 Cuenca;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
16 Cuenca;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;98,42
16 Cuenca;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
16 Cuenca;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
16 Cuenca;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
16 Cuenca;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;98,01
16 Cuenca;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
16 Cuenca;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
16 Cuenca;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
16 Cuenca;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;98,46
16 Cuenca;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
16 Cuenca;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
16 Cuenca;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
16 Cuenca;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
16 Cuenca;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
16 Cuenca;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
16 Cuenca;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;96,39
16 Cuenca;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
16 Cuenca;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
16 Cuenca;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
16 Cuenca;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;97,23
16 Cuenca;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
16 Cuenca;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
16 Cuenca;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
16 Cuenca;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
16 Cuenca;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
16 Cuenca;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
16 Cuenca;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;94,41
16 Cuenca;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
16 Cuenca;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
16 Cuenca;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
16 Cuenca;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;95,77
16 Cuenca;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
16 Cuenca;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
16 Cuenca;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
16 Cuenca;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
16 Cuenca;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
16 Cuenca;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
16 Cuenca;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;92,13
16 Cuenca;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
16 Cuenca;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
16 Cuenca;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
16 Cuenca;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;94,08
16 Cuenca;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
16 Cuenca;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
16 Cuenca;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
16 Cuenca;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
16 Cuenca;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
16 Cuenca;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
16 Cuenca;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
16 Cuenca;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
16 Cuenca;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
16 Cuenca;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QI;1.898
16 Cuenca;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
16 Cuenca;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
16 Cuenca;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
16 Cuenca;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QI;1.758
16 Cuenca;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
16 Cuenca;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
16 Cuenca;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
16 Cuenca;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QI;2.035
16 Cuenca;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
16 Cuenca;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
16 Cuenca;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2022QII;""
16 Cuenca;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2022QI;1.837
16 Cuenca;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
16 Cuenca;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
16 Cuenca;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2021QII;""
16 Cuenca;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2021QI;1.693
16 Cuenca;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
16 Cuenca;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
16 Cuenca;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2020QII;""
16 Cuenca;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2020QI;1.901
16 Cuenca;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
16 Cuenca;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
16 Cuenca;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2022QII;1.769
16 Cuenca;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2022QI;""
16 Cuenca;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
16 Cuenca;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
16 Cuenca;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2021QII;1.632
16 Cuenca;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2021QI;""
16 Cuenca;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
16 Cuenca;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
16 Cuenca;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2020QII;1.847
16 Cuenca;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2020QI;""
16 Cuenca;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
16 Cuenca;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QIII;1.703
16 Cuenca;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QII;""
16 Cuenca;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QI;""
16 Cuenca;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
16 Cuenca;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QIII;1.591
16 Cuenca;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QII;""
16 Cuenca;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QI;""
16 Cuenca;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
16 Cuenca;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QIII;1.784
16 Cuenca;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QII;""
16 Cuenca;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QI;""
16 Cuenca;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QIV;1.601
16 Cuenca;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
16 Cuenca;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QII;""
16 Cuenca;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QI;""
16 Cuenca;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QIV;1.517
16 Cuenca;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
16 Cuenca;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QII;""
16 Cuenca;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QI;""
16 Cuenca;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QIV;1.698
16 Cuenca;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
16 Cuenca;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QII;""
16 Cuenca;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QI;""
16 Cuenca;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
16 Cuenca;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
16 Cuenca;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
16 Cuenca;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
16 Cuenca;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
16 Cuenca;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
16 Cuenca;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
16 Cuenca;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
16 Cuenca;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
16 Cuenca;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
16 Cuenca;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
16 Cuenca;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
16 Cuenca;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
16 Cuenca;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
16 Cuenca;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
16 Cuenca;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;96,79
16 Cuenca;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
16 Cuenca;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
16 Cuenca;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
16 Cuenca;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;96,3
16 Cuenca;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
16 Cuenca;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
16 Cuenca;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
16 Cuenca;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;93,42
16 Cuenca;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
16 Cuenca;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
16 Cuenca;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;93,2
16 Cuenca;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
16 Cuenca;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
16 Cuenca;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
16 Cuenca;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;92,83
16 Cuenca;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
16 Cuenca;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
16 Cuenca;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
16 Cuenca;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;90,76
16 Cuenca;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
16 Cuenca;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
16 Cuenca;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;89,73
16 Cuenca;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
16 Cuenca;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
16 Cuenca;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
16 Cuenca;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;90,5
16 Cuenca;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
16 Cuenca;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
16 Cuenca;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
16 Cuenca;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;87,67
16 Cuenca;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
16 Cuenca;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
16 Cuenca;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;84,35
16 Cuenca;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
16 Cuenca;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
16 Cuenca;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
16 Cuenca;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;86,29
16 Cuenca;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
16 Cuenca;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
16 Cuenca;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
16 Cuenca;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;83,44
16 Cuenca;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
16 Cuenca;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
16 Cuenca;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
16 Cuenca;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
16 Cuenca;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
16 Cuenca;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
16 Cuenca;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QI;1.332
16 Cuenca;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
16 Cuenca;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
16 Cuenca;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
16 Cuenca;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QI;1.233
16 Cuenca;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
16 Cuenca;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
16 Cuenca;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
16 Cuenca;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QI;1.428
16 Cuenca;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
16 Cuenca;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
16 Cuenca;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2022QII;""
16 Cuenca;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2022QI;1.291
16 Cuenca;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
16 Cuenca;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
16 Cuenca;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2021QII;""
16 Cuenca;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2021QI;1.186
16 Cuenca;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
16 Cuenca;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
16 Cuenca;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2020QII;""
16 Cuenca;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2020QI;1.335
16 Cuenca;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
16 Cuenca;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
16 Cuenca;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2022QII;1.248
16 Cuenca;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2022QI;""
16 Cuenca;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
16 Cuenca;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
16 Cuenca;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2021QII;1.144
16 Cuenca;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2021QI;""
16 Cuenca;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
16 Cuenca;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
16 Cuenca;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2020QII;1.297
16 Cuenca;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2020QI;""
16 Cuenca;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
16 Cuenca;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QIII;1.202
16 Cuenca;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QII;""
16 Cuenca;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QI;""
16 Cuenca;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
16 Cuenca;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QIII;1.115
16 Cuenca;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QII;""
16 Cuenca;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QI;""
16 Cuenca;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
16 Cuenca;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QIII;1.251
16 Cuenca;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QII;""
16 Cuenca;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QI;""
16 Cuenca;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QIV;1.134
16 Cuenca;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
16 Cuenca;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QII;""
16 Cuenca;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QI;""
16 Cuenca;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QIV;1.061
16 Cuenca;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
16 Cuenca;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QII;""
16 Cuenca;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QI;""
16 Cuenca;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QIV;1.196
16 Cuenca;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
16 Cuenca;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QII;""
16 Cuenca;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QI;""
16 Cuenca;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
16 Cuenca;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
16 Cuenca;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
16 Cuenca;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
16 Cuenca;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
16 Cuenca;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
16 Cuenca;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
16 Cuenca;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
16 Cuenca;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
16 Cuenca;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
16 Cuenca;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
16 Cuenca;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
16 Cuenca;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
16 Cuenca;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
16 Cuenca;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
16 Cuenca;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;96,92
16 Cuenca;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
16 Cuenca;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
16 Cuenca;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
16 Cuenca;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;96,19
16 Cuenca;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
16 Cuenca;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
16 Cuenca;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
16 Cuenca;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;93,49
16 Cuenca;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
16 Cuenca;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
16 Cuenca;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;93,69
16 Cuenca;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
16 Cuenca;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
16 Cuenca;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
16 Cuenca;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;92,78
16 Cuenca;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
16 Cuenca;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
16 Cuenca;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
16 Cuenca;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;90,83
16 Cuenca;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
16 Cuenca;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
16 Cuenca;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;90,24
16 Cuenca;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
16 Cuenca;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
16 Cuenca;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
16 Cuenca;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;90,43
16 Cuenca;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
16 Cuenca;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
16 Cuenca;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
16 Cuenca;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;87,61
16 Cuenca;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
16 Cuenca;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
16 Cuenca;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;85,14
16 Cuenca;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
16 Cuenca;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
16 Cuenca;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
16 Cuenca;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;86,05
16 Cuenca;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
16 Cuenca;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
16 Cuenca;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
16 Cuenca;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;83,75
16 Cuenca;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
16 Cuenca;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
16 Cuenca;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
16 Cuenca;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
16 Cuenca;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
16 Cuenca;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
16 Cuenca;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QI;566
16 Cuenca;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
16 Cuenca;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
16 Cuenca;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
16 Cuenca;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QI;525
16 Cuenca;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
16 Cuenca;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
16 Cuenca;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
16 Cuenca;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QI;607
16 Cuenca;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
16 Cuenca;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
16 Cuenca;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2022QII;""
16 Cuenca;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2022QI;546
16 Cuenca;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
16 Cuenca;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
16 Cuenca;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2021QII;""
16 Cuenca;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2021QI;507
16 Cuenca;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
16 Cuenca;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
16 Cuenca;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2020QII;""
16 Cuenca;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2020QI;566
16 Cuenca;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
16 Cuenca;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
16 Cuenca;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2022QII;521
16 Cuenca;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2022QI;""
16 Cuenca;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
16 Cuenca;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
16 Cuenca;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2021QII;488
16 Cuenca;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2021QI;""
16 Cuenca;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
16 Cuenca;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
16 Cuenca;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2020QII;550
16 Cuenca;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2020QI;""
16 Cuenca;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
16 Cuenca;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QIII;501
16 Cuenca;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QII;""
16 Cuenca;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QI;""
16 Cuenca;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
16 Cuenca;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QIII;476
16 Cuenca;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QII;""
16 Cuenca;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QI;""
16 Cuenca;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
16 Cuenca;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QIII;533
16 Cuenca;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QII;""
16 Cuenca;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QI;""
16 Cuenca;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QIV;467
16 Cuenca;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
16 Cuenca;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QII;""
16 Cuenca;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QI;""
16 Cuenca;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QIV;456
16 Cuenca;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
16 Cuenca;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QII;""
16 Cuenca;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QI;""
16 Cuenca;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QIV;502
16 Cuenca;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
16 Cuenca;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QII;""
16 Cuenca;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QI;""
16 Cuenca;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
16 Cuenca;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
16 Cuenca;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
16 Cuenca;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
16 Cuenca;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
16 Cuenca;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
16 Cuenca;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
16 Cuenca;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
16 Cuenca;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
16 Cuenca;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
16 Cuenca;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
16 Cuenca;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
16 Cuenca;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
16 Cuenca;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
16 Cuenca;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
16 Cuenca;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;96,47
16 Cuenca;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
16 Cuenca;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
16 Cuenca;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
16 Cuenca;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;96,57
16 Cuenca;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
16 Cuenca;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
16 Cuenca;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
16 Cuenca;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;93,25
16 Cuenca;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
16 Cuenca;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
16 Cuenca;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;92,05
16 Cuenca;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
16 Cuenca;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
16 Cuenca;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
16 Cuenca;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;92,95
16 Cuenca;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
16 Cuenca;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
16 Cuenca;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
16 Cuenca;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;90,61
16 Cuenca;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
16 Cuenca;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
16 Cuenca;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;88,52
16 Cuenca;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
16 Cuenca;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
16 Cuenca;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
16 Cuenca;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;90,67
16 Cuenca;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
16 Cuenca;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
16 Cuenca;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
16 Cuenca;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;87,81
16 Cuenca;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
16 Cuenca;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
16 Cuenca;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;82,51
16 Cuenca;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
16 Cuenca;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
16 Cuenca;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
16 Cuenca;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;86,86
16 Cuenca;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
16 Cuenca;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
16 Cuenca;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
16 Cuenca;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;82,7
16 Cuenca;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
16 Cuenca;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
16 Cuenca;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
16 Cuenca;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
16 Cuenca;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
16 Cuenca;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QII;2.278
16 Cuenca;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
16 Cuenca;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
16 Cuenca;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
16 Cuenca;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QII;2.053
16 Cuenca;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
16 Cuenca;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
16 Cuenca;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
16 Cuenca;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QII;1.929
16 Cuenca;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
16 Cuenca;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
16 Cuenca;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
16 Cuenca;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2022QII;2.204
16 Cuenca;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2022QI;""
16 Cuenca;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
16 Cuenca;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
16 Cuenca;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2021QII;1.983
16 Cuenca;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2021QI;""
16 Cuenca;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
16 Cuenca;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
16 Cuenca;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2020QII;1.873
16 Cuenca;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2020QI;""
16 Cuenca;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
16 Cuenca;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2022QIII;2.130
16 Cuenca;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2022QII;""
16 Cuenca;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2022QI;""
16 Cuenca;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
16 Cuenca;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2021QIII;1.940
16 Cuenca;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2021QII;""
16 Cuenca;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2021QI;""
16 Cuenca;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
16 Cuenca;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2020QIII;1.801
16 Cuenca;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2020QII;""
16 Cuenca;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2020QI;""
16 Cuenca;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QIV;2.018
16 Cuenca;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
16 Cuenca;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QII;""
16 Cuenca;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QI;""
16 Cuenca;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QIV;1.861
16 Cuenca;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
16 Cuenca;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QII;""
16 Cuenca;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QI;""
16 Cuenca;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QIV;1.715
16 Cuenca;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
16 Cuenca;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QII;""
16 Cuenca;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QI;""
16 Cuenca;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
16 Cuenca;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
16 Cuenca;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QII;""
16 Cuenca;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QI;1.805
16 Cuenca;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
16 Cuenca;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
16 Cuenca;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QII;""
16 Cuenca;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QI;1.656
16 Cuenca;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
16 Cuenca;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
16 Cuenca;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QII;""
16 Cuenca;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QI;""
16 Cuenca;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
16 Cuenca;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
16 Cuenca;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
16 Cuenca;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
16 Cuenca;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
16 Cuenca;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
16 Cuenca;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
16 Cuenca;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
16 Cuenca;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
16 Cuenca;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
16 Cuenca;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
16 Cuenca;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
16 Cuenca;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
16 Cuenca;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
16 Cuenca;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;96,75
16 Cuenca;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
16 Cuenca;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
16 Cuenca;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
16 Cuenca;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;96,59
16 Cuenca;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
16 Cuenca;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
16 Cuenca;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
16 Cuenca;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;97,1
16 Cuenca;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
16 Cuenca;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
16 Cuenca;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;93,5
16 Cuenca;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
16 Cuenca;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
16 Cuenca;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
16 Cuenca;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;94,5
16 Cuenca;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
16 Cuenca;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
16 Cuenca;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
16 Cuenca;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;93,36
16 Cuenca;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
16 Cuenca;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
16 Cuenca;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;88,59
16 Cuenca;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
16 Cuenca;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
16 Cuenca;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
16 Cuenca;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;90,65
16 Cuenca;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
16 Cuenca;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
16 Cuenca;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
16 Cuenca;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;88,91
16 Cuenca;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
16 Cuenca;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
16 Cuenca;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
16 Cuenca;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
16 Cuenca;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
16 Cuenca;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
16 Cuenca;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;87,92
16 Cuenca;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
16 Cuenca;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
16 Cuenca;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
16 Cuenca;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;85,85
16 Cuenca;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
16 Cuenca;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
16 Cuenca;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
16 Cuenca;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
16 Cuenca;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
16 Cuenca;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
16 Cuenca;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QII;1.583
16 Cuenca;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
16 Cuenca;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
16 Cuenca;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
16 Cuenca;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QII;1.447
16 Cuenca;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
16 Cuenca;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
16 Cuenca;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
16 Cuenca;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QII;1.353
16 Cuenca;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
16 Cuenca;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
16 Cuenca;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
16 Cuenca;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2022QII;1.537
16 Cuenca;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2022QI;""
16 Cuenca;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
16 Cuenca;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
16 Cuenca;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2021QII;1.399
16 Cuenca;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2021QI;""
16 Cuenca;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
16 Cuenca;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
16 Cuenca;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2020QII;1.314
16 Cuenca;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2020QI;""
16 Cuenca;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
16 Cuenca;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2022QIII;1.487
16 Cuenca;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2022QII;""
16 Cuenca;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2022QI;""
16 Cuenca;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
16 Cuenca;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2021QIII;1.368
16 Cuenca;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2021QII;""
16 Cuenca;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2021QI;""
16 Cuenca;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
16 Cuenca;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2020QIII;1.263
16 Cuenca;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2020QII;""
16 Cuenca;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2020QI;""
16 Cuenca;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QIV;1.415
16 Cuenca;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
16 Cuenca;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QII;""
16 Cuenca;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QI;""
16 Cuenca;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QIV;1.311
16 Cuenca;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
16 Cuenca;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QII;""
16 Cuenca;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QI;""
16 Cuenca;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QIV;1.208
16 Cuenca;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
16 Cuenca;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QII;""
16 Cuenca;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QI;""
16 Cuenca;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
16 Cuenca;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
16 Cuenca;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QII;""
16 Cuenca;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QI;1.272
16 Cuenca;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
16 Cuenca;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
16 Cuenca;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QII;""
16 Cuenca;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QI;1.165
16 Cuenca;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
16 Cuenca;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
16 Cuenca;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QII;""
16 Cuenca;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QI;""
16 Cuenca;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
16 Cuenca;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
16 Cuenca;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
16 Cuenca;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
16 Cuenca;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
16 Cuenca;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
16 Cuenca;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
16 Cuenca;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
16 Cuenca;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
16 Cuenca;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
16 Cuenca;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
16 Cuenca;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
16 Cuenca;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
16 Cuenca;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
16 Cuenca;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;97,09
16 Cuenca;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
16 Cuenca;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
16 Cuenca;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
16 Cuenca;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;96,68
16 Cuenca;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
16 Cuenca;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
16 Cuenca;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
16 Cuenca;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;97,12
16 Cuenca;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
16 Cuenca;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
16 Cuenca;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;93,94
16 Cuenca;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
16 Cuenca;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
16 Cuenca;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
16 Cuenca;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;94,54
16 Cuenca;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
16 Cuenca;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
16 Cuenca;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
16 Cuenca;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;93,35
16 Cuenca;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
16 Cuenca;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
16 Cuenca;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;89,39
16 Cuenca;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
16 Cuenca;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
16 Cuenca;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
16 Cuenca;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;90,6
16 Cuenca;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
16 Cuenca;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
16 Cuenca;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
16 Cuenca;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;89,28
16 Cuenca;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
16 Cuenca;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
16 Cuenca;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
16 Cuenca;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
16 Cuenca;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
16 Cuenca;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
16 Cuenca;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;87,91
16 Cuenca;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
16 Cuenca;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
16 Cuenca;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
16 Cuenca;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;86,1
16 Cuenca;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
16 Cuenca;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
16 Cuenca;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
16 Cuenca;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
16 Cuenca;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
16 Cuenca;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
16 Cuenca;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QII;695
16 Cuenca;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
16 Cuenca;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
16 Cuenca;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
16 Cuenca;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QII;606
16 Cuenca;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
16 Cuenca;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
16 Cuenca;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
16 Cuenca;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QII;576
16 Cuenca;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
16 Cuenca;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
16 Cuenca;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
16 Cuenca;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2022QII;667
16 Cuenca;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2022QI;""
16 Cuenca;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
16 Cuenca;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
16 Cuenca;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2021QII;584
16 Cuenca;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2021QI;""
16 Cuenca;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
16 Cuenca;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
16 Cuenca;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2020QII;559
16 Cuenca;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2020QI;""
16 Cuenca;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
16 Cuenca;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2022QIII;643
16 Cuenca;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2022QII;""
16 Cuenca;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2022QI;""
16 Cuenca;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
16 Cuenca;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2021QIII;572
16 Cuenca;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2021QII;""
16 Cuenca;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2021QI;""
16 Cuenca;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
16 Cuenca;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2020QIII;538
16 Cuenca;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2020QII;""
16 Cuenca;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2020QI;""
16 Cuenca;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QIV;603
16 Cuenca;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
16 Cuenca;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QII;""
16 Cuenca;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QI;""
16 Cuenca;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QIV;550
16 Cuenca;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
16 Cuenca;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QII;""
16 Cuenca;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QI;""
16 Cuenca;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QIV;507
16 Cuenca;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
16 Cuenca;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QII;""
16 Cuenca;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QI;""
16 Cuenca;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
16 Cuenca;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
16 Cuenca;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QII;""
16 Cuenca;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QI;533
16 Cuenca;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
16 Cuenca;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
16 Cuenca;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QII;""
16 Cuenca;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QI;491
16 Cuenca;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
16 Cuenca;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
16 Cuenca;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QII;""
16 Cuenca;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QI;""
16 Cuenca;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
16 Cuenca;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
16 Cuenca;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
16 Cuenca;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
16 Cuenca;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
16 Cuenca;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
16 Cuenca;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
16 Cuenca;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
16 Cuenca;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
16 Cuenca;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
16 Cuenca;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
16 Cuenca;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
16 Cuenca;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
16 Cuenca;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
16 Cuenca;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;95,97
16 Cuenca;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
16 Cuenca;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
16 Cuenca;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
16 Cuenca;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;96,37
16 Cuenca;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
16 Cuenca;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
16 Cuenca;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
16 Cuenca;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;97,05
16 Cuenca;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
16 Cuenca;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
16 Cuenca;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;92,52
16 Cuenca;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
16 Cuenca;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
16 Cuenca;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
16 Cuenca;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;94,39
16 Cuenca;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
16 Cuenca;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
16 Cuenca;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
16 Cuenca;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;93,4
16 Cuenca;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
16 Cuenca;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
16 Cuenca;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;86,76
16 Cuenca;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
16 Cuenca;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
16 Cuenca;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
16 Cuenca;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;90,76
16 Cuenca;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
16 Cuenca;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
16 Cuenca;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
16 Cuenca;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;88,02
16 Cuenca;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
16 Cuenca;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
16 Cuenca;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
16 Cuenca;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
16 Cuenca;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
16 Cuenca;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
16 Cuenca;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;87,95
16 Cuenca;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
16 Cuenca;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
16 Cuenca;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
16 Cuenca;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;85,24
16 Cuenca;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
16 Cuenca;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
16 Cuenca;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
16 Cuenca;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
16 Cuenca;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
16 Cuenca;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QIII;2.226
16 Cuenca;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
16 Cuenca;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
16 Cuenca;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
16 Cuenca;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QIII;2.001
16 Cuenca;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
16 Cuenca;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
16 Cuenca;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
16 Cuenca;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QIII;1.891
16 Cuenca;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
16 Cuenca;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
16 Cuenca;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
16 Cuenca;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2022QIII;2.148
16 Cuenca;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2022QII;""
16 Cuenca;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2022QI;""
16 Cuenca;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
16 Cuenca;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2021QIII;1.956
16 Cuenca;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2021QII;""
16 Cuenca;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2021QI;""
16 Cuenca;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
16 Cuenca;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2020QIII;1.814
16 Cuenca;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2020QII;""
16 Cuenca;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2020QI;""
16 Cuenca;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2022QIV;2.031
16 Cuenca;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
16 Cuenca;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2022QII;""
16 Cuenca;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2022QI;""
16 Cuenca;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2021QIV;1.875
16 Cuenca;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
16 Cuenca;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2021QII;""
16 Cuenca;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2021QI;""
16 Cuenca;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2020QIV;1.725
16 Cuenca;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
16 Cuenca;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2020QII;""
16 Cuenca;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2020QI;""
16 Cuenca;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
16 Cuenca;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
16 Cuenca;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QII;""
16 Cuenca;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QI;1.817
16 Cuenca;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
16 Cuenca;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
16 Cuenca;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QII;""
16 Cuenca;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QI;1.666
16 Cuenca;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
16 Cuenca;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
16 Cuenca;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QII;""
16 Cuenca;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QI;""
16 Cuenca;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
16 Cuenca;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
16 Cuenca;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QII;1.750
16 Cuenca;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QI;""
16 Cuenca;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
16 Cuenca;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
16 Cuenca;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QII;1.605
16 Cuenca;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QI;""
16 Cuenca;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
16 Cuenca;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
16 Cuenca;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QII;""
16 Cuenca;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QI;""
16 Cuenca;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
16 Cuenca;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
16 Cuenca;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
16 Cuenca;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
16 Cuenca;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
16 Cuenca;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
16 Cuenca;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
16 Cuenca;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
16 Cuenca;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
16 Cuenca;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
16 Cuenca;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
16 Cuenca;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
16 Cuenca;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
16 Cuenca;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;96,5
16 Cuenca;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
16 Cuenca;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
16 Cuenca;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
16 Cuenca;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;97,75
16 Cuenca;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
16 Cuenca;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
16 Cuenca;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
16 Cuenca;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;95,93
16 Cuenca;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
16 Cuenca;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
16 Cuenca;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;91,24
16 Cuenca;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
16 Cuenca;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
16 Cuenca;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
16 Cuenca;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;93,7
16 Cuenca;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
16 Cuenca;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
16 Cuenca;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
16 Cuenca;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;91,22
16 Cuenca;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
16 Cuenca;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
16 Cuenca;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
16 Cuenca;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
16 Cuenca;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
16 Cuenca;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
16 Cuenca;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;90,8
16 Cuenca;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
16 Cuenca;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
16 Cuenca;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
16 Cuenca;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;88,1
16 Cuenca;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
16 Cuenca;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
16 Cuenca;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
16 Cuenca;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
16 Cuenca;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
16 Cuenca;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
16 Cuenca;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;87,46
16 Cuenca;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
16 Cuenca;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
16 Cuenca;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
16 Cuenca;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;84,88
16 Cuenca;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
16 Cuenca;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
16 Cuenca;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
16 Cuenca;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
16 Cuenca;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
16 Cuenca;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
16 Cuenca;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QIII;1.552
16 Cuenca;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
16 Cuenca;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
16 Cuenca;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
16 Cuenca;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QIII;1.412
16 Cuenca;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
16 Cuenca;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
16 Cuenca;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
16 Cuenca;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QIII;1.328
16 Cuenca;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
16 Cuenca;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
16 Cuenca;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
16 Cuenca;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2022QIII;1.500
16 Cuenca;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2022QII;""
16 Cuenca;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2022QI;""
16 Cuenca;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
16 Cuenca;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2021QIII;1.379
16 Cuenca;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2021QII;""
16 Cuenca;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2021QI;""
16 Cuenca;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
16 Cuenca;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2020QIII;1.272
16 Cuenca;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2020QII;""
16 Cuenca;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2020QI;""
16 Cuenca;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2022QIV;1.424
16 Cuenca;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
16 Cuenca;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2022QII;""
16 Cuenca;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2022QI;""
16 Cuenca;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2021QIV;1.320
16 Cuenca;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
16 Cuenca;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2021QII;""
16 Cuenca;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2021QI;""
16 Cuenca;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2020QIV;1.214
16 Cuenca;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
16 Cuenca;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2020QII;""
16 Cuenca;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2020QI;""
16 Cuenca;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
16 Cuenca;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
16 Cuenca;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QII;""
16 Cuenca;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QI;1.281
16 Cuenca;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
16 Cuenca;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
16 Cuenca;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QII;""
16 Cuenca;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QI;1.171
16 Cuenca;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
16 Cuenca;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
16 Cuenca;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QII;""
16 Cuenca;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QI;""
16 Cuenca;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
16 Cuenca;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
16 Cuenca;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QII;1.239
16 Cuenca;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QI;""
16 Cuenca;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
16 Cuenca;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
16 Cuenca;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QII;1.129
16 Cuenca;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QI;""
16 Cuenca;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
16 Cuenca;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
16 Cuenca;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QII;""
16 Cuenca;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QI;""
16 Cuenca;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
16 Cuenca;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
16 Cuenca;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
16 Cuenca;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
16 Cuenca;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
16 Cuenca;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
16 Cuenca;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
16 Cuenca;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
16 Cuenca;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
16 Cuenca;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
16 Cuenca;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
16 Cuenca;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
16 Cuenca;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
16 Cuenca;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;96,65
16 Cuenca;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
16 Cuenca;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
16 Cuenca;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
16 Cuenca;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;97,66
16 Cuenca;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
16 Cuenca;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
16 Cuenca;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
16 Cuenca;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;95,78
16 Cuenca;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
16 Cuenca;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
16 Cuenca;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;91,75
16 Cuenca;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
16 Cuenca;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
16 Cuenca;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
16 Cuenca;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;93,48
16 Cuenca;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
16 Cuenca;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
16 Cuenca;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
16 Cuenca;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;91,42
16 Cuenca;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
16 Cuenca;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
16 Cuenca;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
16 Cuenca;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
16 Cuenca;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
16 Cuenca;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
16 Cuenca;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;90,72
16 Cuenca;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
16 Cuenca;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
16 Cuenca;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
16 Cuenca;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;88,18
16 Cuenca;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
16 Cuenca;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
16 Cuenca;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
16 Cuenca;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
16 Cuenca;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
16 Cuenca;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
16 Cuenca;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;87,75
16 Cuenca;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
16 Cuenca;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
16 Cuenca;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
16 Cuenca;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;85,02
16 Cuenca;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
16 Cuenca;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
16 Cuenca;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
16 Cuenca;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
16 Cuenca;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
16 Cuenca;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
16 Cuenca;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QIII;674
16 Cuenca;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
16 Cuenca;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
16 Cuenca;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
16 Cuenca;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QIII;589
16 Cuenca;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
16 Cuenca;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
16 Cuenca;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
16 Cuenca;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QIII;563
16 Cuenca;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
16 Cuenca;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
16 Cuenca;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
16 Cuenca;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2022QIII;648
16 Cuenca;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2022QII;""
16 Cuenca;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2022QI;""
16 Cuenca;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
16 Cuenca;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2021QIII;577
16 Cuenca;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2021QII;""
16 Cuenca;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2021QI;""
16 Cuenca;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
16 Cuenca;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2020QIII;542
16 Cuenca;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2020QII;""
16 Cuenca;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2020QI;""
16 Cuenca;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2022QIV;607
16 Cuenca;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
16 Cuenca;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2022QII;""
16 Cuenca;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2022QI;""
16 Cuenca;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2021QIV;555
16 Cuenca;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
16 Cuenca;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2021QII;""
16 Cuenca;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2021QI;""
16 Cuenca;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2020QIV;511
16 Cuenca;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
16 Cuenca;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2020QII;""
16 Cuenca;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2020QI;""
16 Cuenca;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
16 Cuenca;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
16 Cuenca;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QII;""
16 Cuenca;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QI;536
16 Cuenca;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
16 Cuenca;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
16 Cuenca;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QII;""
16 Cuenca;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QI;495
16 Cuenca;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
16 Cuenca;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
16 Cuenca;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QII;""
16 Cuenca;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QI;""
16 Cuenca;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
16 Cuenca;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
16 Cuenca;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QII;511
16 Cuenca;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QI;""
16 Cuenca;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
16 Cuenca;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
16 Cuenca;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QII;476
16 Cuenca;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QI;""
16 Cuenca;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
16 Cuenca;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
16 Cuenca;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QII;""
16 Cuenca;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QI;""
16 Cuenca;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
16 Cuenca;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
16 Cuenca;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
16 Cuenca;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
16 Cuenca;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
16 Cuenca;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
16 Cuenca;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
16 Cuenca;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
16 Cuenca;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
16 Cuenca;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
16 Cuenca;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
16 Cuenca;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
16 Cuenca;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
16 Cuenca;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;96,14
16 Cuenca;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
16 Cuenca;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
16 Cuenca;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
16 Cuenca;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;97,96
16 Cuenca;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
16 Cuenca;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
16 Cuenca;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
16 Cuenca;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;96,27
16 Cuenca;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
16 Cuenca;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
16 Cuenca;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;90,06
16 Cuenca;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
16 Cuenca;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
16 Cuenca;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
16 Cuenca;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;94,23
16 Cuenca;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
16 Cuenca;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
16 Cuenca;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
16 Cuenca;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;90,76
16 Cuenca;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
16 Cuenca;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
16 Cuenca;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
16 Cuenca;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
16 Cuenca;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
16 Cuenca;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
16 Cuenca;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;91
16 Cuenca;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
16 Cuenca;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
16 Cuenca;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
16 Cuenca;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;87,92
16 Cuenca;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
16 Cuenca;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
16 Cuenca;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
16 Cuenca;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
16 Cuenca;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
16 Cuenca;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
16 Cuenca;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;86,76
16 Cuenca;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
16 Cuenca;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
16 Cuenca;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
16 Cuenca;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;84,55
16 Cuenca;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
16 Cuenca;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
16 Cuenca;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
16 Cuenca;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
16 Cuenca;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
16 Cuenca;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QIV;2.165
16 Cuenca;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
16 Cuenca;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
16 Cuenca;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
16 Cuenca;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QIV;1.972
16 Cuenca;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
16 Cuenca;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
16 Cuenca;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
16 Cuenca;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QIV;1.836
16 Cuenca;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
16 Cuenca;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
16 Cuenca;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
16 Cuenca;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2022QIV;2.043
16 Cuenca;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
16 Cuenca;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2022QII;""
16 Cuenca;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2022QI;""
16 Cuenca;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2021QIV;1.889
16 Cuenca;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
16 Cuenca;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2021QII;""
16 Cuenca;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2021QI;""
16 Cuenca;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2020QIV;1.744
16 Cuenca;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
16 Cuenca;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2020QII;""
16 Cuenca;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2020QI;""
16 Cuenca;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
16 Cuenca;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
16 Cuenca;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2022QII;""
16 Cuenca;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2022QI;1.830
16 Cuenca;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
16 Cuenca;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
16 Cuenca;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2021QII;""
16 Cuenca;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2021QI;1.683
16 Cuenca;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
16 Cuenca;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
16 Cuenca;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2020QII;""
16 Cuenca;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2020QI;""
16 Cuenca;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
16 Cuenca;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
16 Cuenca;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QII;1.762
16 Cuenca;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QI;""
16 Cuenca;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
16 Cuenca;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
16 Cuenca;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QII;1.622
16 Cuenca;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QI;""
16 Cuenca;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
16 Cuenca;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
16 Cuenca;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QII;""
16 Cuenca;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QI;""
16 Cuenca;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
16 Cuenca;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QIII;1.696
16 Cuenca;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QII;""
16 Cuenca;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QI;""
16 Cuenca;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
16 Cuenca;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QIII;1.581
16 Cuenca;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QII;""
16 Cuenca;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QI;""
16 Cuenca;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
16 Cuenca;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
16 Cuenca;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QII;""
16 Cuenca;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QI;""
16 Cuenca;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
16 Cuenca;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
16 Cuenca;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
16 Cuenca;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
16 Cuenca;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
16 Cuenca;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
16 Cuenca;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
16 Cuenca;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
16 Cuenca;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
16 Cuenca;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
16 Cuenca;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
16 Cuenca;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
16 Cuenca;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;94,36
16 Cuenca;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
16 Cuenca;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
16 Cuenca;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
16 Cuenca;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;95,79
16 Cuenca;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
16 Cuenca;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
16 Cuenca;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
16 Cuenca;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;94,99
16 Cuenca;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
16 Cuenca;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
16 Cuenca;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
16 Cuenca;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
16 Cuenca;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
16 Cuenca;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
16 Cuenca;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;92,8
16 Cuenca;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
16 Cuenca;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
16 Cuenca;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
16 Cuenca;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;91,67
16 Cuenca;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
16 Cuenca;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
16 Cuenca;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
16 Cuenca;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
16 Cuenca;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
16 Cuenca;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
16 Cuenca;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;89,35
16 Cuenca;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
16 Cuenca;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
16 Cuenca;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
16 Cuenca;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;88,34
16 Cuenca;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
16 Cuenca;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
16 Cuenca;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
16 Cuenca;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
16 Cuenca;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
16 Cuenca;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
16 Cuenca;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;86
16 Cuenca;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
16 Cuenca;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
16 Cuenca;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
16 Cuenca;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;86,11
16 Cuenca;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
16 Cuenca;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
16 Cuenca;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
16 Cuenca;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
16 Cuenca;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
16 Cuenca;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
16 Cuenca;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QIV;1.510
16 Cuenca;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
16 Cuenca;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
16 Cuenca;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
16 Cuenca;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QIV;1.390
16 Cuenca;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
16 Cuenca;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
16 Cuenca;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
16 Cuenca;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QIV;1.286
16 Cuenca;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
16 Cuenca;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
16 Cuenca;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
16 Cuenca;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2022QIV;1.431
16 Cuenca;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
16 Cuenca;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2022QII;""
16 Cuenca;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2022QI;""
16 Cuenca;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2021QIV;1.329
16 Cuenca;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
16 Cuenca;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2021QII;""
16 Cuenca;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2021QI;""
16 Cuenca;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2020QIV;1.226
16 Cuenca;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
16 Cuenca;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2020QII;""
16 Cuenca;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2020QI;""
16 Cuenca;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
16 Cuenca;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
16 Cuenca;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2022QII;""
16 Cuenca;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2022QI;1.289
16 Cuenca;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
16 Cuenca;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
16 Cuenca;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2021QII;""
16 Cuenca;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2021QI;1.181
16 Cuenca;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
16 Cuenca;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
16 Cuenca;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2020QII;""
16 Cuenca;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2020QI;""
16 Cuenca;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
16 Cuenca;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
16 Cuenca;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QII;1.246
16 Cuenca;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QI;""
16 Cuenca;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
16 Cuenca;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
16 Cuenca;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QII;1.139
16 Cuenca;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QI;""
16 Cuenca;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
16 Cuenca;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
16 Cuenca;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QII;""
16 Cuenca;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QI;""
16 Cuenca;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
16 Cuenca;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QIII;1.200
16 Cuenca;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QII;""
16 Cuenca;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QI;""
16 Cuenca;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
16 Cuenca;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QIII;1.110
16 Cuenca;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QII;""
16 Cuenca;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QI;""
16 Cuenca;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
16 Cuenca;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
16 Cuenca;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QII;""
16 Cuenca;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QI;""
16 Cuenca;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
16 Cuenca;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
16 Cuenca;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
16 Cuenca;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
16 Cuenca;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
16 Cuenca;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
16 Cuenca;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
16 Cuenca;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
16 Cuenca;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
16 Cuenca;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
16 Cuenca;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
16 Cuenca;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
16 Cuenca;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;94,77
16 Cuenca;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
16 Cuenca;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
16 Cuenca;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
16 Cuenca;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;95,61
16 Cuenca;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
16 Cuenca;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
16 Cuenca;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
16 Cuenca;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;95,33
16 Cuenca;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
16 Cuenca;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
16 Cuenca;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
16 Cuenca;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
16 Cuenca;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
16 Cuenca;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
16 Cuenca;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;92,73
16 Cuenca;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
16 Cuenca;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
16 Cuenca;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
16 Cuenca;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;91,84
16 Cuenca;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
16 Cuenca;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
16 Cuenca;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
16 Cuenca;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
16 Cuenca;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
16 Cuenca;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
16 Cuenca;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;89,64
16 Cuenca;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
16 Cuenca;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
16 Cuenca;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
16 Cuenca;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;88,57
16 Cuenca;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
16 Cuenca;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
16 Cuenca;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
16 Cuenca;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
16 Cuenca;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
16 Cuenca;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
16 Cuenca;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;86,33
16 Cuenca;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
16 Cuenca;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
16 Cuenca;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
16 Cuenca;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;86,31
16 Cuenca;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
16 Cuenca;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
16 Cuenca;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
16 Cuenca;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
16 Cuenca;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
16 Cuenca;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
16 Cuenca;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QIV;655
16 Cuenca;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
16 Cuenca;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
16 Cuenca;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
16 Cuenca;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QIV;582
16 Cuenca;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
16 Cuenca;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
16 Cuenca;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
16 Cuenca;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QIV;550
16 Cuenca;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
16 Cuenca;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
16 Cuenca;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
16 Cuenca;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2022QIV;612
16 Cuenca;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
16 Cuenca;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2022QII;""
16 Cuenca;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2022QI;""
16 Cuenca;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2021QIV;560
16 Cuenca;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
16 Cuenca;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2021QII;""
16 Cuenca;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2021QI;""
16 Cuenca;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2020QIV;518
16 Cuenca;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
16 Cuenca;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2020QII;""
16 Cuenca;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2020QI;""
16 Cuenca;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
16 Cuenca;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
16 Cuenca;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2022QII;""
16 Cuenca;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2022QI;541
16 Cuenca;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
16 Cuenca;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
16 Cuenca;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2021QII;""
16 Cuenca;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2021QI;502
16 Cuenca;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
16 Cuenca;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
16 Cuenca;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2020QII;""
16 Cuenca;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2020QI;""
16 Cuenca;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
16 Cuenca;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
16 Cuenca;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QII;516
16 Cuenca;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QI;""
16 Cuenca;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
16 Cuenca;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
16 Cuenca;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QII;483
16 Cuenca;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QI;""
16 Cuenca;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
16 Cuenca;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
16 Cuenca;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QII;""
16 Cuenca;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QI;""
16 Cuenca;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
16 Cuenca;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QIII;496
16 Cuenca;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QII;""
16 Cuenca;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QI;""
16 Cuenca;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
16 Cuenca;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QIII;471
16 Cuenca;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QII;""
16 Cuenca;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QI;""
16 Cuenca;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
16 Cuenca;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
16 Cuenca;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QII;""
16 Cuenca;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QI;""
16 Cuenca;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
16 Cuenca;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
16 Cuenca;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
16 Cuenca;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
16 Cuenca;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
16 Cuenca;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
16 Cuenca;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
16 Cuenca;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
16 Cuenca;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
16 Cuenca;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
16 Cuenca;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
16 Cuenca;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
16 Cuenca;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;93,44
16 Cuenca;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
16 Cuenca;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
16 Cuenca;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
16 Cuenca;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;96,22
16 Cuenca;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
16 Cuenca;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
16 Cuenca;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
16 Cuenca;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;94,18
16 Cuenca;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
16 Cuenca;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
16 Cuenca;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
16 Cuenca;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
16 Cuenca;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
16 Cuenca;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
16 Cuenca;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;92,96
16 Cuenca;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
16 Cuenca;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
16 Cuenca;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
16 Cuenca;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;91,27
16 Cuenca;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
16 Cuenca;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
16 Cuenca;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
16 Cuenca;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
16 Cuenca;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
16 Cuenca;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
16 Cuenca;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;88,66
16 Cuenca;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
16 Cuenca;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
16 Cuenca;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
16 Cuenca;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;87,82
16 Cuenca;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
16 Cuenca;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
16 Cuenca;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
16 Cuenca;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
16 Cuenca;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
16 Cuenca;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
16 Cuenca;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;85,22
16 Cuenca;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
16 Cuenca;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
16 Cuenca;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
16 Cuenca;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;85,64
16 Cuenca;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
16 Cuenca;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
16 Cuenca;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
16 Cuenca;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
16 Cuenca;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
16 Cuenca;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
20 Gipuzkoa;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
20 Gipuzkoa;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
20 Gipuzkoa;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
20 Gipuzkoa;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QI;63.359
20 Gipuzkoa;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
20 Gipuzkoa;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
20 Gipuzkoa;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
20 Gipuzkoa;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QI;63.407
20 Gipuzkoa;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
20 Gipuzkoa;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
20 Gipuzkoa;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
20 Gipuzkoa;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QI;65.017
20 Gipuzkoa;All ages;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
20 Gipuzkoa;All ages;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
20 Gipuzkoa;All ages;Cohort January 1;Total;Survival in the first trimester;2022QII;""
20 Gipuzkoa;All ages;Cohort January 1;Total;Survival in the first trimester;2022QI;61.763
20 Gipuzkoa;All ages;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
20 Gipuzkoa;All ages;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
20 Gipuzkoa;All ages;Cohort January 1;Total;Survival in the first trimester;2021QII;""
20 Gipuzkoa;All ages;Cohort January 1;Total;Survival in the first trimester;2021QI;62.010
20 Gipuzkoa;All ages;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
20 Gipuzkoa;All ages;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
20 Gipuzkoa;All ages;Cohort January 1;Total;Survival in the first trimester;2020QII;""
20 Gipuzkoa;All ages;Cohort January 1;Total;Survival in the first trimester;2020QI;62.349
20 Gipuzkoa;All ages;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
20 Gipuzkoa;All ages;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
20 Gipuzkoa;All ages;Cohort January 1;Total;Survival in the second trimester;2022QII;60.233
20 Gipuzkoa;All ages;Cohort January 1;Total;Survival in the second trimester;2022QI;""
20 Gipuzkoa;All ages;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
20 Gipuzkoa;All ages;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
20 Gipuzkoa;All ages;Cohort January 1;Total;Survival in the second trimester;2021QII;60.695
20 Gipuzkoa;All ages;Cohort January 1;Total;Survival in the second trimester;2021QI;""
20 Gipuzkoa;All ages;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
20 Gipuzkoa;All ages;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
20 Gipuzkoa;All ages;Cohort January 1;Total;Survival in the second trimester;2020QII;61.229
20 Gipuzkoa;All ages;Cohort January 1;Total;Survival in the second trimester;2020QI;""
20 Gipuzkoa;All ages;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
20 Gipuzkoa;All ages;Cohort January 1;Total;Survival in the third trimester;2022QIII;58.854
20 Gipuzkoa;All ages;Cohort January 1;Total;Survival in the third trimester;2022QII;""
20 Gipuzkoa;All ages;Cohort January 1;Total;Survival in the third trimester;2022QI;""
20 Gipuzkoa;All ages;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
20 Gipuzkoa;All ages;Cohort January 1;Total;Survival in the third trimester;2021QIII;59.536
20 Gipuzkoa;All ages;Cohort January 1;Total;Survival in the third trimester;2021QII;""
20 Gipuzkoa;All ages;Cohort January 1;Total;Survival in the third trimester;2021QI;""
20 Gipuzkoa;All ages;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
20 Gipuzkoa;All ages;Cohort January 1;Total;Survival in the third trimester;2020QIII;59.804
20 Gipuzkoa;All ages;Cohort January 1;Total;Survival in the third trimester;2020QII;""
20 Gipuzkoa;All ages;Cohort January 1;Total;Survival in the third trimester;2020QI;""
20 Gipuzkoa;All ages;Cohort January 1;Total;Survival in the third trimester;2022QIV;57.211
20 Gipuzkoa;All ages;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
20 Gipuzkoa;All ages;Cohort January 1;Total;Survival in the third trimester;2022QII;""
20 Gipuzkoa;All ages;Cohort January 1;Total;Survival in the third trimester;2022QI;""
20 Gipuzkoa;All ages;Cohort January 1;Total;Survival in the third trimester;2021QIV;58.192
20 Gipuzkoa;All ages;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
20 Gipuzkoa;All ages;Cohort January 1;Total;Survival in the third trimester;2021QII;""
20 Gipuzkoa;All ages;Cohort January 1;Total;Survival in the third trimester;2021QI;""
20 Gipuzkoa;All ages;Cohort January 1;Total;Survival in the third trimester;2020QIV;58.450
20 Gipuzkoa;All ages;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
20 Gipuzkoa;All ages;Cohort January 1;Total;Survival in the third trimester;2020QII;""
20 Gipuzkoa;All ages;Cohort January 1;Total;Survival in the third trimester;2020QI;""
20 Gipuzkoa;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
20 Gipuzkoa;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
20 Gipuzkoa;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
20 Gipuzkoa;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
20 Gipuzkoa;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
20 Gipuzkoa;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
20 Gipuzkoa;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
20 Gipuzkoa;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
20 Gipuzkoa;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
20 Gipuzkoa;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
20 Gipuzkoa;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
20 Gipuzkoa;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
20 Gipuzkoa;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
20 Gipuzkoa;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
20 Gipuzkoa;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
20 Gipuzkoa;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;97,48
20 Gipuzkoa;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
20 Gipuzkoa;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
20 Gipuzkoa;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
20 Gipuzkoa;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;97,8
20 Gipuzkoa;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
20 Gipuzkoa;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
20 Gipuzkoa;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
20 Gipuzkoa;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;95,9
20 Gipuzkoa;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
20 Gipuzkoa;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
20 Gipuzkoa;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;95,07
20 Gipuzkoa;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
20 Gipuzkoa;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
20 Gipuzkoa;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
20 Gipuzkoa;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;95,72
20 Gipuzkoa;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
20 Gipuzkoa;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
20 Gipuzkoa;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
20 Gipuzkoa;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;94,17
20 Gipuzkoa;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
20 Gipuzkoa;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
20 Gipuzkoa;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;92,89
20 Gipuzkoa;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
20 Gipuzkoa;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
20 Gipuzkoa;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
20 Gipuzkoa;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;93,89
20 Gipuzkoa;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
20 Gipuzkoa;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
20 Gipuzkoa;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
20 Gipuzkoa;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;91,98
20 Gipuzkoa;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
20 Gipuzkoa;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
20 Gipuzkoa;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;90,3
20 Gipuzkoa;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
20 Gipuzkoa;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
20 Gipuzkoa;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
20 Gipuzkoa;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;91,78
20 Gipuzkoa;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
20 Gipuzkoa;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
20 Gipuzkoa;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
20 Gipuzkoa;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;89,9
20 Gipuzkoa;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
20 Gipuzkoa;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
20 Gipuzkoa;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
20 Gipuzkoa;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
20 Gipuzkoa;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
20 Gipuzkoa;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
20 Gipuzkoa;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QI;40.915
20 Gipuzkoa;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
20 Gipuzkoa;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
20 Gipuzkoa;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
20 Gipuzkoa;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QI;41.163
20 Gipuzkoa;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
20 Gipuzkoa;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
20 Gipuzkoa;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
20 Gipuzkoa;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QI;42.361
20 Gipuzkoa;All ages;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
20 Gipuzkoa;All ages;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
20 Gipuzkoa;All ages;Cohort January 1;Males;Survival in the first trimester;2022QII;""
20 Gipuzkoa;All ages;Cohort January 1;Males;Survival in the first trimester;2022QI;39.929
20 Gipuzkoa;All ages;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
20 Gipuzkoa;All ages;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
20 Gipuzkoa;All ages;Cohort January 1;Males;Survival in the first trimester;2021QII;""
20 Gipuzkoa;All ages;Cohort January 1;Males;Survival in the first trimester;2021QI;40.302
20 Gipuzkoa;All ages;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
20 Gipuzkoa;All ages;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
20 Gipuzkoa;All ages;Cohort January 1;Males;Survival in the first trimester;2020QII;""
20 Gipuzkoa;All ages;Cohort January 1;Males;Survival in the first trimester;2020QI;40.647
20 Gipuzkoa;All ages;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
20 Gipuzkoa;All ages;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
20 Gipuzkoa;All ages;Cohort January 1;Males;Survival in the second trimester;2022QII;39.047
20 Gipuzkoa;All ages;Cohort January 1;Males;Survival in the second trimester;2022QI;""
20 Gipuzkoa;All ages;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
20 Gipuzkoa;All ages;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
20 Gipuzkoa;All ages;Cohort January 1;Males;Survival in the second trimester;2021QII;39.455
20 Gipuzkoa;All ages;Cohort January 1;Males;Survival in the second trimester;2021QI;""
20 Gipuzkoa;All ages;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
20 Gipuzkoa;All ages;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
20 Gipuzkoa;All ages;Cohort January 1;Males;Survival in the second trimester;2020QII;39.979
20 Gipuzkoa;All ages;Cohort January 1;Males;Survival in the second trimester;2020QI;""
20 Gipuzkoa;All ages;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
20 Gipuzkoa;All ages;Cohort January 1;Males;Survival in the third trimester;2022QIII;38.204
20 Gipuzkoa;All ages;Cohort January 1;Males;Survival in the third trimester;2022QII;""
20 Gipuzkoa;All ages;Cohort January 1;Males;Survival in the third trimester;2022QI;""
20 Gipuzkoa;All ages;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
20 Gipuzkoa;All ages;Cohort January 1;Males;Survival in the third trimester;2021QIII;38.712
20 Gipuzkoa;All ages;Cohort January 1;Males;Survival in the third trimester;2021QII;""
20 Gipuzkoa;All ages;Cohort January 1;Males;Survival in the third trimester;2021QI;""
20 Gipuzkoa;All ages;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
20 Gipuzkoa;All ages;Cohort January 1;Males;Survival in the third trimester;2020QIII;39.102
20 Gipuzkoa;All ages;Cohort January 1;Males;Survival in the third trimester;2020QII;""
20 Gipuzkoa;All ages;Cohort January 1;Males;Survival in the third trimester;2020QI;""
20 Gipuzkoa;All ages;Cohort January 1;Males;Survival in the third trimester;2022QIV;37.184
20 Gipuzkoa;All ages;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
20 Gipuzkoa;All ages;Cohort January 1;Males;Survival in the third trimester;2022QII;""
20 Gipuzkoa;All ages;Cohort January 1;Males;Survival in the third trimester;2022QI;""
20 Gipuzkoa;All ages;Cohort January 1;Males;Survival in the third trimester;2021QIV;37.895
20 Gipuzkoa;All ages;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
20 Gipuzkoa;All ages;Cohort January 1;Males;Survival in the third trimester;2021QII;""
20 Gipuzkoa;All ages;Cohort January 1;Males;Survival in the third trimester;2021QI;""
20 Gipuzkoa;All ages;Cohort January 1;Males;Survival in the third trimester;2020QIV;38.240
20 Gipuzkoa;All ages;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
20 Gipuzkoa;All ages;Cohort January 1;Males;Survival in the third trimester;2020QII;""
20 Gipuzkoa;All ages;Cohort January 1;Males;Survival in the third trimester;2020QI;""
20 Gipuzkoa;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
20 Gipuzkoa;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
20 Gipuzkoa;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
20 Gipuzkoa;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
20 Gipuzkoa;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
20 Gipuzkoa;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
20 Gipuzkoa;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
20 Gipuzkoa;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
20 Gipuzkoa;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
20 Gipuzkoa;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
20 Gipuzkoa;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
20 Gipuzkoa;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
20 Gipuzkoa;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
20 Gipuzkoa;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
20 Gipuzkoa;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
20 Gipuzkoa;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;97,59
20 Gipuzkoa;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
20 Gipuzkoa;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
20 Gipuzkoa;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
20 Gipuzkoa;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;97,91
20 Gipuzkoa;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
20 Gipuzkoa;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
20 Gipuzkoa;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
20 Gipuzkoa;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;95,95
20 Gipuzkoa;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
20 Gipuzkoa;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
20 Gipuzkoa;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;95,43
20 Gipuzkoa;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
20 Gipuzkoa;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
20 Gipuzkoa;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
20 Gipuzkoa;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;95,85
20 Gipuzkoa;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
20 Gipuzkoa;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
20 Gipuzkoa;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
20 Gipuzkoa;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;94,38
20 Gipuzkoa;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
20 Gipuzkoa;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
20 Gipuzkoa;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;93,37
20 Gipuzkoa;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
20 Gipuzkoa;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
20 Gipuzkoa;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
20 Gipuzkoa;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;94,05
20 Gipuzkoa;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
20 Gipuzkoa;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
20 Gipuzkoa;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
20 Gipuzkoa;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;92,31
20 Gipuzkoa;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
20 Gipuzkoa;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
20 Gipuzkoa;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;90,88
20 Gipuzkoa;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
20 Gipuzkoa;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
20 Gipuzkoa;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
20 Gipuzkoa;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;92,06
20 Gipuzkoa;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
20 Gipuzkoa;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
20 Gipuzkoa;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
20 Gipuzkoa;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;90,27
20 Gipuzkoa;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
20 Gipuzkoa;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
20 Gipuzkoa;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
20 Gipuzkoa;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
20 Gipuzkoa;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
20 Gipuzkoa;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
20 Gipuzkoa;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QI;22.444
20 Gipuzkoa;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
20 Gipuzkoa;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
20 Gipuzkoa;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
20 Gipuzkoa;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QI;22.244
20 Gipuzkoa;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
20 Gipuzkoa;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
20 Gipuzkoa;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
20 Gipuzkoa;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QI;22.656
20 Gipuzkoa;All ages;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
20 Gipuzkoa;All ages;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
20 Gipuzkoa;All ages;Cohort January 1;Females;Survival in the first trimester;2022QII;""
20 Gipuzkoa;All ages;Cohort January 1;Females;Survival in the first trimester;2022QI;21.834
20 Gipuzkoa;All ages;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
20 Gipuzkoa;All ages;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
20 Gipuzkoa;All ages;Cohort January 1;Females;Survival in the first trimester;2021QII;""
20 Gipuzkoa;All ages;Cohort January 1;Females;Survival in the first trimester;2021QI;21.708
20 Gipuzkoa;All ages;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
20 Gipuzkoa;All ages;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
20 Gipuzkoa;All ages;Cohort January 1;Females;Survival in the first trimester;2020QII;""
20 Gipuzkoa;All ages;Cohort January 1;Females;Survival in the first trimester;2020QI;21.702
20 Gipuzkoa;All ages;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
20 Gipuzkoa;All ages;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
20 Gipuzkoa;All ages;Cohort January 1;Females;Survival in the second trimester;2022QII;21.186
20 Gipuzkoa;All ages;Cohort January 1;Females;Survival in the second trimester;2022QI;""
20 Gipuzkoa;All ages;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
20 Gipuzkoa;All ages;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
20 Gipuzkoa;All ages;Cohort January 1;Females;Survival in the second trimester;2021QII;21.240
20 Gipuzkoa;All ages;Cohort January 1;Females;Survival in the second trimester;2021QI;""
20 Gipuzkoa;All ages;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
20 Gipuzkoa;All ages;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
20 Gipuzkoa;All ages;Cohort January 1;Females;Survival in the second trimester;2020QII;21.250
20 Gipuzkoa;All ages;Cohort January 1;Females;Survival in the second trimester;2020QI;""
20 Gipuzkoa;All ages;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
20 Gipuzkoa;All ages;Cohort January 1;Females;Survival in the third trimester;2022QIII;20.650
20 Gipuzkoa;All ages;Cohort January 1;Females;Survival in the third trimester;2022QII;""
20 Gipuzkoa;All ages;Cohort January 1;Females;Survival in the third trimester;2022QI;""
20 Gipuzkoa;All ages;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
20 Gipuzkoa;All ages;Cohort January 1;Females;Survival in the third trimester;2021QIII;20.824
20 Gipuzkoa;All ages;Cohort January 1;Females;Survival in the third trimester;2021QII;""
20 Gipuzkoa;All ages;Cohort January 1;Females;Survival in the third trimester;2021QI;""
20 Gipuzkoa;All ages;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
20 Gipuzkoa;All ages;Cohort January 1;Females;Survival in the third trimester;2020QIII;20.702
20 Gipuzkoa;All ages;Cohort January 1;Females;Survival in the third trimester;2020QII;""
20 Gipuzkoa;All ages;Cohort January 1;Females;Survival in the third trimester;2020QI;""
20 Gipuzkoa;All ages;Cohort January 1;Females;Survival in the third trimester;2022QIV;20.027
20 Gipuzkoa;All ages;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
20 Gipuzkoa;All ages;Cohort January 1;Females;Survival in the third trimester;2022QII;""
20 Gipuzkoa;All ages;Cohort January 1;Females;Survival in the third trimester;2022QI;""
20 Gipuzkoa;All ages;Cohort January 1;Females;Survival in the third trimester;2021QIV;20.297
20 Gipuzkoa;All ages;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
20 Gipuzkoa;All ages;Cohort January 1;Females;Survival in the third trimester;2021QII;""
20 Gipuzkoa;All ages;Cohort January 1;Females;Survival in the third trimester;2021QI;""
20 Gipuzkoa;All ages;Cohort January 1;Females;Survival in the third trimester;2020QIV;20.210
20 Gipuzkoa;All ages;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
20 Gipuzkoa;All ages;Cohort January 1;Females;Survival in the third trimester;2020QII;""
20 Gipuzkoa;All ages;Cohort January 1;Females;Survival in the third trimester;2020QI;""
20 Gipuzkoa;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
20 Gipuzkoa;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
20 Gipuzkoa;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
20 Gipuzkoa;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
20 Gipuzkoa;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
20 Gipuzkoa;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
20 Gipuzkoa;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
20 Gipuzkoa;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
20 Gipuzkoa;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
20 Gipuzkoa;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
20 Gipuzkoa;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
20 Gipuzkoa;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
20 Gipuzkoa;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
20 Gipuzkoa;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
20 Gipuzkoa;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
20 Gipuzkoa;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;97,28
20 Gipuzkoa;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
20 Gipuzkoa;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
20 Gipuzkoa;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
20 Gipuzkoa;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;97,59
20 Gipuzkoa;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
20 Gipuzkoa;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
20 Gipuzkoa;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
20 Gipuzkoa;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;95,79
20 Gipuzkoa;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
20 Gipuzkoa;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
20 Gipuzkoa;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;94,39
20 Gipuzkoa;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
20 Gipuzkoa;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
20 Gipuzkoa;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
20 Gipuzkoa;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;95,49
20 Gipuzkoa;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
20 Gipuzkoa;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
20 Gipuzkoa;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
20 Gipuzkoa;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;93,79
20 Gipuzkoa;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
20 Gipuzkoa;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
20 Gipuzkoa;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;92,01
20 Gipuzkoa;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
20 Gipuzkoa;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
20 Gipuzkoa;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
20 Gipuzkoa;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;93,62
20 Gipuzkoa;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
20 Gipuzkoa;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
20 Gipuzkoa;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
20 Gipuzkoa;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;91,38
20 Gipuzkoa;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
20 Gipuzkoa;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
20 Gipuzkoa;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;89,23
20 Gipuzkoa;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
20 Gipuzkoa;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
20 Gipuzkoa;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
20 Gipuzkoa;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;91,25
20 Gipuzkoa;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
20 Gipuzkoa;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
20 Gipuzkoa;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
20 Gipuzkoa;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;89,2
20 Gipuzkoa;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
20 Gipuzkoa;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
20 Gipuzkoa;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
20 Gipuzkoa;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
20 Gipuzkoa;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
20 Gipuzkoa;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QII;63.356
20 Gipuzkoa;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
20 Gipuzkoa;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
20 Gipuzkoa;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
20 Gipuzkoa;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QII;63.469
20 Gipuzkoa;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
20 Gipuzkoa;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
20 Gipuzkoa;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
20 Gipuzkoa;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QII;64.157
20 Gipuzkoa;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
20 Gipuzkoa;All ages;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
20 Gipuzkoa;All ages;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
20 Gipuzkoa;All ages;Cohort April 1;Total;Survival in the first trimester;2022QII;61.677
20 Gipuzkoa;All ages;Cohort April 1;Total;Survival in the first trimester;2022QI;""
20 Gipuzkoa;All ages;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
20 Gipuzkoa;All ages;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
20 Gipuzkoa;All ages;Cohort April 1;Total;Survival in the first trimester;2021QII;62.012
20 Gipuzkoa;All ages;Cohort April 1;Total;Survival in the first trimester;2021QI;""
20 Gipuzkoa;All ages;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
20 Gipuzkoa;All ages;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
20 Gipuzkoa;All ages;Cohort April 1;Total;Survival in the first trimester;2020QII;62.957
20 Gipuzkoa;All ages;Cohort April 1;Total;Survival in the first trimester;2020QI;""
20 Gipuzkoa;All ages;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
20 Gipuzkoa;All ages;Cohort April 1;Total;Survival in the second trimester;2022QIII;60.177
20 Gipuzkoa;All ages;Cohort April 1;Total;Survival in the second trimester;2022QII;""
20 Gipuzkoa;All ages;Cohort April 1;Total;Survival in the second trimester;2022QI;""
20 Gipuzkoa;All ages;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
20 Gipuzkoa;All ages;Cohort April 1;Total;Survival in the second trimester;2021QIII;60.746
20 Gipuzkoa;All ages;Cohort April 1;Total;Survival in the second trimester;2021QII;""
20 Gipuzkoa;All ages;Cohort April 1;Total;Survival in the second trimester;2021QI;""
20 Gipuzkoa;All ages;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
20 Gipuzkoa;All ages;Cohort April 1;Total;Survival in the second trimester;2020QIII;61.350
20 Gipuzkoa;All ages;Cohort April 1;Total;Survival in the second trimester;2020QII;""
20 Gipuzkoa;All ages;Cohort April 1;Total;Survival in the second trimester;2020QI;""
20 Gipuzkoa;All ages;Cohort April 1;Total;Survival in the third trimester;2022QIV;58.424
20 Gipuzkoa;All ages;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
20 Gipuzkoa;All ages;Cohort April 1;Total;Survival in the third trimester;2022QII;""
20 Gipuzkoa;All ages;Cohort April 1;Total;Survival in the third trimester;2022QI;""
20 Gipuzkoa;All ages;Cohort April 1;Total;Survival in the third trimester;2021QIV;59.308
20 Gipuzkoa;All ages;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
20 Gipuzkoa;All ages;Cohort April 1;Total;Survival in the third trimester;2021QII;""
20 Gipuzkoa;All ages;Cohort April 1;Total;Survival in the third trimester;2021QI;""
20 Gipuzkoa;All ages;Cohort April 1;Total;Survival in the third trimester;2020QIV;59.890
20 Gipuzkoa;All ages;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
20 Gipuzkoa;All ages;Cohort April 1;Total;Survival in the third trimester;2020QII;""
20 Gipuzkoa;All ages;Cohort April 1;Total;Survival in the third trimester;2020QI;""
20 Gipuzkoa;All ages;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
20 Gipuzkoa;All ages;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
20 Gipuzkoa;All ages;Cohort April 1;Total;Survival in the third trimester;2022QII;""
20 Gipuzkoa;All ages;Cohort April 1;Total;Survival in the third trimester;2022QI;58.074
20 Gipuzkoa;All ages;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
20 Gipuzkoa;All ages;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
20 Gipuzkoa;All ages;Cohort April 1;Total;Survival in the third trimester;2021QII;""
20 Gipuzkoa;All ages;Cohort April 1;Total;Survival in the third trimester;2021QI;58.751
20 Gipuzkoa;All ages;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
20 Gipuzkoa;All ages;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
20 Gipuzkoa;All ages;Cohort April 1;Total;Survival in the third trimester;2020QII;""
20 Gipuzkoa;All ages;Cohort April 1;Total;Survival in the third trimester;2020QI;""
20 Gipuzkoa;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
20 Gipuzkoa;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
20 Gipuzkoa;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
20 Gipuzkoa;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
20 Gipuzkoa;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
20 Gipuzkoa;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
20 Gipuzkoa;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
20 Gipuzkoa;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
20 Gipuzkoa;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
20 Gipuzkoa;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
20 Gipuzkoa;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
20 Gipuzkoa;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
20 Gipuzkoa;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
20 Gipuzkoa;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
20 Gipuzkoa;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;97,35
20 Gipuzkoa;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
20 Gipuzkoa;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
20 Gipuzkoa;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
20 Gipuzkoa;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;97,7
20 Gipuzkoa;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
20 Gipuzkoa;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
20 Gipuzkoa;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
20 Gipuzkoa;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;98,13
20 Gipuzkoa;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
20 Gipuzkoa;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
20 Gipuzkoa;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;94,98
20 Gipuzkoa;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
20 Gipuzkoa;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
20 Gipuzkoa;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
20 Gipuzkoa;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;95,71
20 Gipuzkoa;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
20 Gipuzkoa;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
20 Gipuzkoa;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
20 Gipuzkoa;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;95,62
20 Gipuzkoa;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
20 Gipuzkoa;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
20 Gipuzkoa;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;92,22
20 Gipuzkoa;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
20 Gipuzkoa;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
20 Gipuzkoa;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
20 Gipuzkoa;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;93,44
20 Gipuzkoa;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
20 Gipuzkoa;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
20 Gipuzkoa;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
20 Gipuzkoa;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;93,35
20 Gipuzkoa;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
20 Gipuzkoa;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
20 Gipuzkoa;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
20 Gipuzkoa;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
20 Gipuzkoa;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
20 Gipuzkoa;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
20 Gipuzkoa;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;91,5
20 Gipuzkoa;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
20 Gipuzkoa;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
20 Gipuzkoa;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
20 Gipuzkoa;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;91,57
20 Gipuzkoa;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
20 Gipuzkoa;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
20 Gipuzkoa;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
20 Gipuzkoa;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
20 Gipuzkoa;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
20 Gipuzkoa;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
20 Gipuzkoa;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QII;40.889
20 Gipuzkoa;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
20 Gipuzkoa;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
20 Gipuzkoa;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
20 Gipuzkoa;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QII;41.225
20 Gipuzkoa;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
20 Gipuzkoa;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
20 Gipuzkoa;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
20 Gipuzkoa;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QII;41.712
20 Gipuzkoa;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
20 Gipuzkoa;All ages;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
20 Gipuzkoa;All ages;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
20 Gipuzkoa;All ages;Cohort April 1;Males;Survival in the first trimester;2022QII;39.901
20 Gipuzkoa;All ages;Cohort April 1;Males;Survival in the first trimester;2022QI;""
20 Gipuzkoa;All ages;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
20 Gipuzkoa;All ages;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
20 Gipuzkoa;All ages;Cohort April 1;Males;Survival in the first trimester;2021QII;40.280
20 Gipuzkoa;All ages;Cohort April 1;Males;Survival in the first trimester;2021QI;""
20 Gipuzkoa;All ages;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
20 Gipuzkoa;All ages;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
20 Gipuzkoa;All ages;Cohort April 1;Males;Survival in the first trimester;2020QII;40.996
20 Gipuzkoa;All ages;Cohort April 1;Males;Survival in the first trimester;2020QI;""
20 Gipuzkoa;All ages;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
20 Gipuzkoa;All ages;Cohort April 1;Males;Survival in the second trimester;2022QIII;38.970
20 Gipuzkoa;All ages;Cohort April 1;Males;Survival in the second trimester;2022QII;""
20 Gipuzkoa;All ages;Cohort April 1;Males;Survival in the second trimester;2022QI;""
20 Gipuzkoa;All ages;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
20 Gipuzkoa;All ages;Cohort April 1;Males;Survival in the second trimester;2021QIII;39.456
20 Gipuzkoa;All ages;Cohort April 1;Males;Survival in the second trimester;2021QII;""
20 Gipuzkoa;All ages;Cohort April 1;Males;Survival in the second trimester;2021QI;""
20 Gipuzkoa;All ages;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
20 Gipuzkoa;All ages;Cohort April 1;Males;Survival in the second trimester;2020QIII;39.981
20 Gipuzkoa;All ages;Cohort April 1;Males;Survival in the second trimester;2020QII;""
20 Gipuzkoa;All ages;Cohort April 1;Males;Survival in the second trimester;2020QI;""
20 Gipuzkoa;All ages;Cohort April 1;Males;Survival in the third trimester;2022QIV;37.877
20 Gipuzkoa;All ages;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
20 Gipuzkoa;All ages;Cohort April 1;Males;Survival in the third trimester;2022QII;""
20 Gipuzkoa;All ages;Cohort April 1;Males;Survival in the third trimester;2022QI;""
20 Gipuzkoa;All ages;Cohort April 1;Males;Survival in the third trimester;2021QIV;38.575
20 Gipuzkoa;All ages;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
20 Gipuzkoa;All ages;Cohort April 1;Males;Survival in the third trimester;2021QII;""
20 Gipuzkoa;All ages;Cohort April 1;Males;Survival in the third trimester;2021QI;""
20 Gipuzkoa;All ages;Cohort April 1;Males;Survival in the third trimester;2020QIV;39.044
20 Gipuzkoa;All ages;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
20 Gipuzkoa;All ages;Cohort April 1;Males;Survival in the third trimester;2020QII;""
20 Gipuzkoa;All ages;Cohort April 1;Males;Survival in the third trimester;2020QI;""
20 Gipuzkoa;All ages;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
20 Gipuzkoa;All ages;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
20 Gipuzkoa;All ages;Cohort April 1;Males;Survival in the third trimester;2022QII;""
20 Gipuzkoa;All ages;Cohort April 1;Males;Survival in the third trimester;2022QI;37.829
20 Gipuzkoa;All ages;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
20 Gipuzkoa;All ages;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
20 Gipuzkoa;All ages;Cohort April 1;Males;Survival in the third trimester;2021QII;""
20 Gipuzkoa;All ages;Cohort April 1;Males;Survival in the third trimester;2021QI;38.360
20 Gipuzkoa;All ages;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
20 Gipuzkoa;All ages;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
20 Gipuzkoa;All ages;Cohort April 1;Males;Survival in the third trimester;2020QII;""
20 Gipuzkoa;All ages;Cohort April 1;Males;Survival in the third trimester;2020QI;""
20 Gipuzkoa;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
20 Gipuzkoa;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
20 Gipuzkoa;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
20 Gipuzkoa;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
20 Gipuzkoa;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
20 Gipuzkoa;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
20 Gipuzkoa;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
20 Gipuzkoa;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
20 Gipuzkoa;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
20 Gipuzkoa;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
20 Gipuzkoa;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
20 Gipuzkoa;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
20 Gipuzkoa;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
20 Gipuzkoa;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
20 Gipuzkoa;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;97,58
20 Gipuzkoa;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
20 Gipuzkoa;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
20 Gipuzkoa;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
20 Gipuzkoa;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;97,71
20 Gipuzkoa;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
20 Gipuzkoa;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
20 Gipuzkoa;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
20 Gipuzkoa;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;98,28
20 Gipuzkoa;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
20 Gipuzkoa;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
20 Gipuzkoa;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;95,31
20 Gipuzkoa;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
20 Gipuzkoa;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
20 Gipuzkoa;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
20 Gipuzkoa;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;95,71
20 Gipuzkoa;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
20 Gipuzkoa;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
20 Gipuzkoa;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
20 Gipuzkoa;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;95,85
20 Gipuzkoa;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
20 Gipuzkoa;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
20 Gipuzkoa;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;92,63
20 Gipuzkoa;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
20 Gipuzkoa;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
20 Gipuzkoa;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
20 Gipuzkoa;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;93,57
20 Gipuzkoa;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
20 Gipuzkoa;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
20 Gipuzkoa;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
20 Gipuzkoa;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;93,6
20 Gipuzkoa;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
20 Gipuzkoa;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
20 Gipuzkoa;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
20 Gipuzkoa;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
20 Gipuzkoa;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
20 Gipuzkoa;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
20 Gipuzkoa;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;91,76
20 Gipuzkoa;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
20 Gipuzkoa;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
20 Gipuzkoa;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
20 Gipuzkoa;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;91,96
20 Gipuzkoa;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
20 Gipuzkoa;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
20 Gipuzkoa;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
20 Gipuzkoa;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
20 Gipuzkoa;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
20 Gipuzkoa;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
20 Gipuzkoa;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QII;22.467
20 Gipuzkoa;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
20 Gipuzkoa;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
20 Gipuzkoa;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
20 Gipuzkoa;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QII;22.244
20 Gipuzkoa;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
20 Gipuzkoa;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
20 Gipuzkoa;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
20 Gipuzkoa;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QII;22.445
20 Gipuzkoa;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
20 Gipuzkoa;All ages;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
20 Gipuzkoa;All ages;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
20 Gipuzkoa;All ages;Cohort April 1;Females;Survival in the first trimester;2022QII;21.776
20 Gipuzkoa;All ages;Cohort April 1;Females;Survival in the first trimester;2022QI;""
20 Gipuzkoa;All ages;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
20 Gipuzkoa;All ages;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
20 Gipuzkoa;All ages;Cohort April 1;Females;Survival in the first trimester;2021QII;21.732
20 Gipuzkoa;All ages;Cohort April 1;Females;Survival in the first trimester;2021QI;""
20 Gipuzkoa;All ages;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
20 Gipuzkoa;All ages;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
20 Gipuzkoa;All ages;Cohort April 1;Females;Survival in the first trimester;2020QII;21.961
20 Gipuzkoa;All ages;Cohort April 1;Females;Survival in the first trimester;2020QI;""
20 Gipuzkoa;All ages;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
20 Gipuzkoa;All ages;Cohort April 1;Females;Survival in the second trimester;2022QIII;21.207
20 Gipuzkoa;All ages;Cohort April 1;Females;Survival in the second trimester;2022QII;""
20 Gipuzkoa;All ages;Cohort April 1;Females;Survival in the second trimester;2022QI;""
20 Gipuzkoa;All ages;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
20 Gipuzkoa;All ages;Cohort April 1;Females;Survival in the second trimester;2021QIII;21.290
20 Gipuzkoa;All ages;Cohort April 1;Females;Survival in the second trimester;2021QII;""
20 Gipuzkoa;All ages;Cohort April 1;Females;Survival in the second trimester;2021QI;""
20 Gipuzkoa;All ages;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
20 Gipuzkoa;All ages;Cohort April 1;Females;Survival in the second trimester;2020QIII;21.369
20 Gipuzkoa;All ages;Cohort April 1;Females;Survival in the second trimester;2020QII;""
20 Gipuzkoa;All ages;Cohort April 1;Females;Survival in the second trimester;2020QI;""
20 Gipuzkoa;All ages;Cohort April 1;Females;Survival in the third trimester;2022QIV;20.547
20 Gipuzkoa;All ages;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
20 Gipuzkoa;All ages;Cohort April 1;Females;Survival in the third trimester;2022QII;""
20 Gipuzkoa;All ages;Cohort April 1;Females;Survival in the third trimester;2022QI;""
20 Gipuzkoa;All ages;Cohort April 1;Females;Survival in the third trimester;2021QIV;20.733
20 Gipuzkoa;All ages;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
20 Gipuzkoa;All ages;Cohort April 1;Females;Survival in the third trimester;2021QII;""
20 Gipuzkoa;All ages;Cohort April 1;Females;Survival in the third trimester;2021QI;""
20 Gipuzkoa;All ages;Cohort April 1;Females;Survival in the third trimester;2020QIV;20.846
20 Gipuzkoa;All ages;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
20 Gipuzkoa;All ages;Cohort April 1;Females;Survival in the third trimester;2020QII;""
20 Gipuzkoa;All ages;Cohort April 1;Females;Survival in the third trimester;2020QI;""
20 Gipuzkoa;All ages;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
20 Gipuzkoa;All ages;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
20 Gipuzkoa;All ages;Cohort April 1;Females;Survival in the third trimester;2022QII;""
20 Gipuzkoa;All ages;Cohort April 1;Females;Survival in the third trimester;2022QI;20.245
20 Gipuzkoa;All ages;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
20 Gipuzkoa;All ages;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
20 Gipuzkoa;All ages;Cohort April 1;Females;Survival in the third trimester;2021QII;""
20 Gipuzkoa;All ages;Cohort April 1;Females;Survival in the third trimester;2021QI;20.391
20 Gipuzkoa;All ages;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
20 Gipuzkoa;All ages;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
20 Gipuzkoa;All ages;Cohort April 1;Females;Survival in the third trimester;2020QII;""
20 Gipuzkoa;All ages;Cohort April 1;Females;Survival in the third trimester;2020QI;""
20 Gipuzkoa;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
20 Gipuzkoa;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
20 Gipuzkoa;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
20 Gipuzkoa;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
20 Gipuzkoa;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
20 Gipuzkoa;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
20 Gipuzkoa;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
20 Gipuzkoa;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
20 Gipuzkoa;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
20 Gipuzkoa;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
20 Gipuzkoa;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
20 Gipuzkoa;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
20 Gipuzkoa;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
20 Gipuzkoa;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
20 Gipuzkoa;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;96,92
20 Gipuzkoa;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
20 Gipuzkoa;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
20 Gipuzkoa;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
20 Gipuzkoa;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;97,7
20 Gipuzkoa;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
20 Gipuzkoa;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
20 Gipuzkoa;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
20 Gipuzkoa;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;97,84
20 Gipuzkoa;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
20 Gipuzkoa;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
20 Gipuzkoa;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;94,39
20 Gipuzkoa;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
20 Gipuzkoa;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
20 Gipuzkoa;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
20 Gipuzkoa;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;95,71
20 Gipuzkoa;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
20 Gipuzkoa;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
20 Gipuzkoa;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
20 Gipuzkoa;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;95,21
20 Gipuzkoa;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
20 Gipuzkoa;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
20 Gipuzkoa;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;91,45
20 Gipuzkoa;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
20 Gipuzkoa;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
20 Gipuzkoa;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
20 Gipuzkoa;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;93,21
20 Gipuzkoa;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
20 Gipuzkoa;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
20 Gipuzkoa;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
20 Gipuzkoa;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;92,88
20 Gipuzkoa;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
20 Gipuzkoa;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
20 Gipuzkoa;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
20 Gipuzkoa;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
20 Gipuzkoa;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
20 Gipuzkoa;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
20 Gipuzkoa;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;91,01
20 Gipuzkoa;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
20 Gipuzkoa;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
20 Gipuzkoa;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
20 Gipuzkoa;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;90,85
20 Gipuzkoa;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
20 Gipuzkoa;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
20 Gipuzkoa;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
20 Gipuzkoa;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
20 Gipuzkoa;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
20 Gipuzkoa;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QIII;63.522
20 Gipuzkoa;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
20 Gipuzkoa;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
20 Gipuzkoa;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
20 Gipuzkoa;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QIII;63.578
20 Gipuzkoa;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
20 Gipuzkoa;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
20 Gipuzkoa;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
20 Gipuzkoa;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QIII;63.979
20 Gipuzkoa;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
20 Gipuzkoa;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
20 Gipuzkoa;All ages;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
20 Gipuzkoa;All ages;Cohort July 1;Total;Survival in the first trimester;2022QIII;61.774
20 Gipuzkoa;All ages;Cohort July 1;Total;Survival in the first trimester;2022QII;""
20 Gipuzkoa;All ages;Cohort July 1;Total;Survival in the first trimester;2022QI;""
20 Gipuzkoa;All ages;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
20 Gipuzkoa;All ages;Cohort July 1;Total;Survival in the first trimester;2021QIII;62.115
20 Gipuzkoa;All ages;Cohort July 1;Total;Survival in the first trimester;2021QII;""
20 Gipuzkoa;All ages;Cohort July 1;Total;Survival in the first trimester;2021QI;""
20 Gipuzkoa;All ages;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
20 Gipuzkoa;All ages;Cohort July 1;Total;Survival in the first trimester;2020QIII;62.219
20 Gipuzkoa;All ages;Cohort July 1;Total;Survival in the first trimester;2020QII;""
20 Gipuzkoa;All ages;Cohort July 1;Total;Survival in the first trimester;2020QI;""
20 Gipuzkoa;All ages;Cohort July 1;Total;Survival in the second trimester;2022QIV;59.847
20 Gipuzkoa;All ages;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
20 Gipuzkoa;All ages;Cohort July 1;Total;Survival in the second trimester;2022QII;""
20 Gipuzkoa;All ages;Cohort July 1;Total;Survival in the second trimester;2022QI;""
20 Gipuzkoa;All ages;Cohort July 1;Total;Survival in the second trimester;2021QIV;60.542
20 Gipuzkoa;All ages;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
20 Gipuzkoa;All ages;Cohort July 1;Total;Survival in the second trimester;2021QII;""
20 Gipuzkoa;All ages;Cohort July 1;Total;Survival in the second trimester;2021QI;""
20 Gipuzkoa;All ages;Cohort July 1;Total;Survival in the second trimester;2020QIV;60.675
20 Gipuzkoa;All ages;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
20 Gipuzkoa;All ages;Cohort July 1;Total;Survival in the second trimester;2020QII;""
20 Gipuzkoa;All ages;Cohort July 1;Total;Survival in the second trimester;2020QI;""
20 Gipuzkoa;All ages;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
20 Gipuzkoa;All ages;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
20 Gipuzkoa;All ages;Cohort July 1;Total;Survival in the third trimester;2022QII;""
20 Gipuzkoa;All ages;Cohort July 1;Total;Survival in the third trimester;2022QI;59.211
20 Gipuzkoa;All ages;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
20 Gipuzkoa;All ages;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
20 Gipuzkoa;All ages;Cohort July 1;Total;Survival in the third trimester;2021QII;""
20 Gipuzkoa;All ages;Cohort July 1;Total;Survival in the third trimester;2021QI;59.506
20 Gipuzkoa;All ages;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
20 Gipuzkoa;All ages;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
20 Gipuzkoa;All ages;Cohort July 1;Total;Survival in the third trimester;2020QII;""
20 Gipuzkoa;All ages;Cohort July 1;Total;Survival in the third trimester;2020QI;""
20 Gipuzkoa;All ages;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
20 Gipuzkoa;All ages;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
20 Gipuzkoa;All ages;Cohort July 1;Total;Survival in the third trimester;2022QII;57.944
20 Gipuzkoa;All ages;Cohort July 1;Total;Survival in the third trimester;2022QI;""
20 Gipuzkoa;All ages;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
20 Gipuzkoa;All ages;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
20 Gipuzkoa;All ages;Cohort July 1;Total;Survival in the third trimester;2021QII;58.386
20 Gipuzkoa;All ages;Cohort July 1;Total;Survival in the third trimester;2021QI;""
20 Gipuzkoa;All ages;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
20 Gipuzkoa;All ages;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
20 Gipuzkoa;All ages;Cohort July 1;Total;Survival in the third trimester;2020QII;""
20 Gipuzkoa;All ages;Cohort July 1;Total;Survival in the third trimester;2020QI;""
20 Gipuzkoa;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
20 Gipuzkoa;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
20 Gipuzkoa;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
20 Gipuzkoa;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
20 Gipuzkoa;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
20 Gipuzkoa;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
20 Gipuzkoa;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
20 Gipuzkoa;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
20 Gipuzkoa;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
20 Gipuzkoa;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
20 Gipuzkoa;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
20 Gipuzkoa;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
20 Gipuzkoa;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
20 Gipuzkoa;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;97,25
20 Gipuzkoa;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
20 Gipuzkoa;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
20 Gipuzkoa;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
20 Gipuzkoa;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;97,7
20 Gipuzkoa;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
20 Gipuzkoa;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
20 Gipuzkoa;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
20 Gipuzkoa;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;97,25
20 Gipuzkoa;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
20 Gipuzkoa;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
20 Gipuzkoa;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;94,21
20 Gipuzkoa;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
20 Gipuzkoa;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
20 Gipuzkoa;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
20 Gipuzkoa;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;95,22
20 Gipuzkoa;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
20 Gipuzkoa;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
20 Gipuzkoa;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
20 Gipuzkoa;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;94,84
20 Gipuzkoa;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
20 Gipuzkoa;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
20 Gipuzkoa;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
20 Gipuzkoa;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
20 Gipuzkoa;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
20 Gipuzkoa;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
20 Gipuzkoa;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;93,13
20 Gipuzkoa;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
20 Gipuzkoa;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
20 Gipuzkoa;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
20 Gipuzkoa;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;93,01
20 Gipuzkoa;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
20 Gipuzkoa;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
20 Gipuzkoa;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
20 Gipuzkoa;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
20 Gipuzkoa;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
20 Gipuzkoa;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
20 Gipuzkoa;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;91,14
20 Gipuzkoa;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
20 Gipuzkoa;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
20 Gipuzkoa;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
20 Gipuzkoa;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;91,26
20 Gipuzkoa;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
20 Gipuzkoa;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
20 Gipuzkoa;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
20 Gipuzkoa;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
20 Gipuzkoa;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
20 Gipuzkoa;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
20 Gipuzkoa;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QIII;40.958
20 Gipuzkoa;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
20 Gipuzkoa;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
20 Gipuzkoa;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
20 Gipuzkoa;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QIII;41.235
20 Gipuzkoa;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
20 Gipuzkoa;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
20 Gipuzkoa;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
20 Gipuzkoa;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QIII;41.655
20 Gipuzkoa;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
20 Gipuzkoa;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
20 Gipuzkoa;All ages;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
20 Gipuzkoa;All ages;Cohort July 1;Males;Survival in the first trimester;2022QIII;39.881
20 Gipuzkoa;All ages;Cohort July 1;Males;Survival in the first trimester;2022QII;""
20 Gipuzkoa;All ages;Cohort July 1;Males;Survival in the first trimester;2022QI;""
20 Gipuzkoa;All ages;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
20 Gipuzkoa;All ages;Cohort July 1;Males;Survival in the first trimester;2021QIII;40.276
20 Gipuzkoa;All ages;Cohort July 1;Males;Survival in the first trimester;2021QII;""
20 Gipuzkoa;All ages;Cohort July 1;Males;Survival in the first trimester;2021QI;""
20 Gipuzkoa;All ages;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
20 Gipuzkoa;All ages;Cohort July 1;Males;Survival in the first trimester;2020QIII;40.543
20 Gipuzkoa;All ages;Cohort July 1;Males;Survival in the first trimester;2020QII;""
20 Gipuzkoa;All ages;Cohort July 1;Males;Survival in the first trimester;2020QI;""
20 Gipuzkoa;All ages;Cohort July 1;Males;Survival in the second trimester;2022QIV;38.666
20 Gipuzkoa;All ages;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
20 Gipuzkoa;All ages;Cohort July 1;Males;Survival in the second trimester;2022QII;""
20 Gipuzkoa;All ages;Cohort July 1;Males;Survival in the second trimester;2022QI;""
20 Gipuzkoa;All ages;Cohort July 1;Males;Survival in the second trimester;2021QIV;39.304
20 Gipuzkoa;All ages;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
20 Gipuzkoa;All ages;Cohort July 1;Males;Survival in the second trimester;2021QII;""
20 Gipuzkoa;All ages;Cohort July 1;Males;Survival in the second trimester;2021QI;""
20 Gipuzkoa;All ages;Cohort July 1;Males;Survival in the second trimester;2020QIV;39.545
20 Gipuzkoa;All ages;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
20 Gipuzkoa;All ages;Cohort July 1;Males;Survival in the second trimester;2020QII;""
20 Gipuzkoa;All ages;Cohort July 1;Males;Survival in the second trimester;2020QI;""
20 Gipuzkoa;All ages;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
20 Gipuzkoa;All ages;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
20 Gipuzkoa;All ages;Cohort July 1;Males;Survival in the third trimester;2022QII;""
20 Gipuzkoa;All ages;Cohort July 1;Males;Survival in the third trimester;2022QI;38.500
20 Gipuzkoa;All ages;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
20 Gipuzkoa;All ages;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
20 Gipuzkoa;All ages;Cohort July 1;Males;Survival in the third trimester;2021QII;""
20 Gipuzkoa;All ages;Cohort July 1;Males;Survival in the third trimester;2021QI;38.844
20 Gipuzkoa;All ages;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
20 Gipuzkoa;All ages;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
20 Gipuzkoa;All ages;Cohort July 1;Males;Survival in the third trimester;2020QII;""
20 Gipuzkoa;All ages;Cohort July 1;Males;Survival in the third trimester;2020QI;""
20 Gipuzkoa;All ages;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
20 Gipuzkoa;All ages;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
20 Gipuzkoa;All ages;Cohort July 1;Males;Survival in the third trimester;2022QII;37.744
20 Gipuzkoa;All ages;Cohort July 1;Males;Survival in the third trimester;2022QI;""
20 Gipuzkoa;All ages;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
20 Gipuzkoa;All ages;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
20 Gipuzkoa;All ages;Cohort July 1;Males;Survival in the third trimester;2021QII;38.099
20 Gipuzkoa;All ages;Cohort July 1;Males;Survival in the third trimester;2021QI;""
20 Gipuzkoa;All ages;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
20 Gipuzkoa;All ages;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
20 Gipuzkoa;All ages;Cohort July 1;Males;Survival in the third trimester;2020QII;""
20 Gipuzkoa;All ages;Cohort July 1;Males;Survival in the third trimester;2020QI;""
20 Gipuzkoa;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
20 Gipuzkoa;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
20 Gipuzkoa;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
20 Gipuzkoa;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
20 Gipuzkoa;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
20 Gipuzkoa;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
20 Gipuzkoa;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
20 Gipuzkoa;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
20 Gipuzkoa;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
20 Gipuzkoa;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
20 Gipuzkoa;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
20 Gipuzkoa;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
20 Gipuzkoa;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
20 Gipuzkoa;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;97,37
20 Gipuzkoa;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
20 Gipuzkoa;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
20 Gipuzkoa;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
20 Gipuzkoa;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;97,67
20 Gipuzkoa;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
20 Gipuzkoa;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
20 Gipuzkoa;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
20 Gipuzkoa;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;97,33
20 Gipuzkoa;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
20 Gipuzkoa;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
20 Gipuzkoa;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;94,4
20 Gipuzkoa;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
20 Gipuzkoa;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
20 Gipuzkoa;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
20 Gipuzkoa;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;95,32
20 Gipuzkoa;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
20 Gipuzkoa;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
20 Gipuzkoa;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
20 Gipuzkoa;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;94,93
20 Gipuzkoa;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
20 Gipuzkoa;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
20 Gipuzkoa;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
20 Gipuzkoa;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
20 Gipuzkoa;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
20 Gipuzkoa;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
20 Gipuzkoa;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;93,37
20 Gipuzkoa;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
20 Gipuzkoa;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
20 Gipuzkoa;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
20 Gipuzkoa;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;93,25
20 Gipuzkoa;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
20 Gipuzkoa;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
20 Gipuzkoa;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
20 Gipuzkoa;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
20 Gipuzkoa;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
20 Gipuzkoa;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
20 Gipuzkoa;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;91,53
20 Gipuzkoa;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
20 Gipuzkoa;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
20 Gipuzkoa;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
20 Gipuzkoa;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;91,46
20 Gipuzkoa;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
20 Gipuzkoa;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
20 Gipuzkoa;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
20 Gipuzkoa;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
20 Gipuzkoa;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
20 Gipuzkoa;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
20 Gipuzkoa;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QIII;22.564
20 Gipuzkoa;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
20 Gipuzkoa;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
20 Gipuzkoa;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
20 Gipuzkoa;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QIII;22.343
20 Gipuzkoa;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
20 Gipuzkoa;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
20 Gipuzkoa;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
20 Gipuzkoa;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QIII;22.324
20 Gipuzkoa;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
20 Gipuzkoa;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
20 Gipuzkoa;All ages;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
20 Gipuzkoa;All ages;Cohort July 1;Females;Survival in the first trimester;2022QIII;21.893
20 Gipuzkoa;All ages;Cohort July 1;Females;Survival in the first trimester;2022QII;""
20 Gipuzkoa;All ages;Cohort July 1;Females;Survival in the first trimester;2022QI;""
20 Gipuzkoa;All ages;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
20 Gipuzkoa;All ages;Cohort July 1;Females;Survival in the first trimester;2021QIII;21.839
20 Gipuzkoa;All ages;Cohort July 1;Females;Survival in the first trimester;2021QII;""
20 Gipuzkoa;All ages;Cohort July 1;Females;Survival in the first trimester;2021QI;""
20 Gipuzkoa;All ages;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
20 Gipuzkoa;All ages;Cohort July 1;Females;Survival in the first trimester;2020QIII;21.676
20 Gipuzkoa;All ages;Cohort July 1;Females;Survival in the first trimester;2020QII;""
20 Gipuzkoa;All ages;Cohort July 1;Females;Survival in the first trimester;2020QI;""
20 Gipuzkoa;All ages;Cohort July 1;Females;Survival in the second trimester;2022QIV;21.181
20 Gipuzkoa;All ages;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
20 Gipuzkoa;All ages;Cohort July 1;Females;Survival in the second trimester;2022QII;""
20 Gipuzkoa;All ages;Cohort July 1;Females;Survival in the second trimester;2022QI;""
20 Gipuzkoa;All ages;Cohort July 1;Females;Survival in the second trimester;2021QIV;21.238
20 Gipuzkoa;All ages;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
20 Gipuzkoa;All ages;Cohort July 1;Females;Survival in the second trimester;2021QII;""
20 Gipuzkoa;All ages;Cohort July 1;Females;Survival in the second trimester;2021QI;""
20 Gipuzkoa;All ages;Cohort July 1;Females;Survival in the second trimester;2020QIV;21.130
20 Gipuzkoa;All ages;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
20 Gipuzkoa;All ages;Cohort July 1;Females;Survival in the second trimester;2020QII;""
20 Gipuzkoa;All ages;Cohort July 1;Females;Survival in the second trimester;2020QI;""
20 Gipuzkoa;All ages;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
20 Gipuzkoa;All ages;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
20 Gipuzkoa;All ages;Cohort July 1;Females;Survival in the third trimester;2022QII;""
20 Gipuzkoa;All ages;Cohort July 1;Females;Survival in the third trimester;2022QI;20.711
20 Gipuzkoa;All ages;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
20 Gipuzkoa;All ages;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
20 Gipuzkoa;All ages;Cohort July 1;Females;Survival in the third trimester;2021QII;""
20 Gipuzkoa;All ages;Cohort July 1;Females;Survival in the third trimester;2021QI;20.662
20 Gipuzkoa;All ages;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
20 Gipuzkoa;All ages;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
20 Gipuzkoa;All ages;Cohort July 1;Females;Survival in the third trimester;2020QII;""
20 Gipuzkoa;All ages;Cohort July 1;Females;Survival in the third trimester;2020QI;""
20 Gipuzkoa;All ages;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
20 Gipuzkoa;All ages;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
20 Gipuzkoa;All ages;Cohort July 1;Females;Survival in the third trimester;2022QII;20.200
20 Gipuzkoa;All ages;Cohort July 1;Females;Survival in the third trimester;2022QI;""
20 Gipuzkoa;All ages;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
20 Gipuzkoa;All ages;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
20 Gipuzkoa;All ages;Cohort July 1;Females;Survival in the third trimester;2021QII;20.287
20 Gipuzkoa;All ages;Cohort July 1;Females;Survival in the third trimester;2021QI;""
20 Gipuzkoa;All ages;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
20 Gipuzkoa;All ages;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
20 Gipuzkoa;All ages;Cohort July 1;Females;Survival in the third trimester;2020QII;""
20 Gipuzkoa;All ages;Cohort July 1;Females;Survival in the third trimester;2020QI;""
20 Gipuzkoa;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
20 Gipuzkoa;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
20 Gipuzkoa;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
20 Gipuzkoa;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
20 Gipuzkoa;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
20 Gipuzkoa;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
20 Gipuzkoa;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
20 Gipuzkoa;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
20 Gipuzkoa;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
20 Gipuzkoa;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
20 Gipuzkoa;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
20 Gipuzkoa;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
20 Gipuzkoa;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
20 Gipuzkoa;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;97,03
20 Gipuzkoa;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
20 Gipuzkoa;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
20 Gipuzkoa;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
20 Gipuzkoa;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;97,74
20 Gipuzkoa;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
20 Gipuzkoa;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
20 Gipuzkoa;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
20 Gipuzkoa;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;97,1
20 Gipuzkoa;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
20 Gipuzkoa;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
20 Gipuzkoa;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;93,87
20 Gipuzkoa;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
20 Gipuzkoa;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
20 Gipuzkoa;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
20 Gipuzkoa;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;95,05
20 Gipuzkoa;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
20 Gipuzkoa;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
20 Gipuzkoa;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
20 Gipuzkoa;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;94,65
20 Gipuzkoa;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
20 Gipuzkoa;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
20 Gipuzkoa;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
20 Gipuzkoa;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
20 Gipuzkoa;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
20 Gipuzkoa;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
20 Gipuzkoa;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;92,7
20 Gipuzkoa;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
20 Gipuzkoa;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
20 Gipuzkoa;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
20 Gipuzkoa;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;92,56
20 Gipuzkoa;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
20 Gipuzkoa;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
20 Gipuzkoa;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
20 Gipuzkoa;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
20 Gipuzkoa;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
20 Gipuzkoa;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
20 Gipuzkoa;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;90,41
20 Gipuzkoa;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
20 Gipuzkoa;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
20 Gipuzkoa;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
20 Gipuzkoa;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;90,88
20 Gipuzkoa;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
20 Gipuzkoa;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
20 Gipuzkoa;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
20 Gipuzkoa;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
20 Gipuzkoa;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
20 Gipuzkoa;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QIV;63.459
20 Gipuzkoa;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
20 Gipuzkoa;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
20 Gipuzkoa;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
20 Gipuzkoa;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QIV;63.533
20 Gipuzkoa;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
20 Gipuzkoa;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
20 Gipuzkoa;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
20 Gipuzkoa;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QIV;63.581
20 Gipuzkoa;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
20 Gipuzkoa;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
20 Gipuzkoa;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
20 Gipuzkoa;All ages;Cohort October 1;Total;Survival in the first trimester;2022QIV;61.377
20 Gipuzkoa;All ages;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
20 Gipuzkoa;All ages;Cohort October 1;Total;Survival in the first trimester;2022QII;""
20 Gipuzkoa;All ages;Cohort October 1;Total;Survival in the first trimester;2022QI;""
20 Gipuzkoa;All ages;Cohort October 1;Total;Survival in the first trimester;2021QIV;61.816
20 Gipuzkoa;All ages;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
20 Gipuzkoa;All ages;Cohort October 1;Total;Survival in the first trimester;2021QII;""
20 Gipuzkoa;All ages;Cohort October 1;Total;Survival in the first trimester;2021QI;""
20 Gipuzkoa;All ages;Cohort October 1;Total;Survival in the first trimester;2020QIV;61.883
20 Gipuzkoa;All ages;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
20 Gipuzkoa;All ages;Cohort October 1;Total;Survival in the first trimester;2020QII;""
20 Gipuzkoa;All ages;Cohort October 1;Total;Survival in the first trimester;2020QI;""
20 Gipuzkoa;All ages;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
20 Gipuzkoa;All ages;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
20 Gipuzkoa;All ages;Cohort October 1;Total;Survival in the second trimester;2022QII;""
20 Gipuzkoa;All ages;Cohort October 1;Total;Survival in the second trimester;2022QI;60.381
20 Gipuzkoa;All ages;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
20 Gipuzkoa;All ages;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
20 Gipuzkoa;All ages;Cohort October 1;Total;Survival in the second trimester;2021QII;""
20 Gipuzkoa;All ages;Cohort October 1;Total;Survival in the second trimester;2021QI;60.629
20 Gipuzkoa;All ages;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
20 Gipuzkoa;All ages;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
20 Gipuzkoa;All ages;Cohort October 1;Total;Survival in the second trimester;2020QII;""
20 Gipuzkoa;All ages;Cohort October 1;Total;Survival in the second trimester;2020QI;""
20 Gipuzkoa;All ages;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
20 Gipuzkoa;All ages;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
20 Gipuzkoa;All ages;Cohort October 1;Total;Survival in the third trimester;2022QII;59.003
20 Gipuzkoa;All ages;Cohort October 1;Total;Survival in the third trimester;2022QI;""
20 Gipuzkoa;All ages;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
20 Gipuzkoa;All ages;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
20 Gipuzkoa;All ages;Cohort October 1;Total;Survival in the third trimester;2021QII;59.450
20 Gipuzkoa;All ages;Cohort October 1;Total;Survival in the third trimester;2021QI;""
20 Gipuzkoa;All ages;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
20 Gipuzkoa;All ages;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
20 Gipuzkoa;All ages;Cohort October 1;Total;Survival in the third trimester;2020QII;""
20 Gipuzkoa;All ages;Cohort October 1;Total;Survival in the third trimester;2020QI;""
20 Gipuzkoa;All ages;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
20 Gipuzkoa;All ages;Cohort October 1;Total;Survival in the third trimester;2022QIII;57.704
20 Gipuzkoa;All ages;Cohort October 1;Total;Survival in the third trimester;2022QII;""
20 Gipuzkoa;All ages;Cohort October 1;Total;Survival in the third trimester;2022QI;""
20 Gipuzkoa;All ages;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
20 Gipuzkoa;All ages;Cohort October 1;Total;Survival in the third trimester;2021QIII;58.371
20 Gipuzkoa;All ages;Cohort October 1;Total;Survival in the third trimester;2021QII;""
20 Gipuzkoa;All ages;Cohort October 1;Total;Survival in the third trimester;2021QI;""
20 Gipuzkoa;All ages;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
20 Gipuzkoa;All ages;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
20 Gipuzkoa;All ages;Cohort October 1;Total;Survival in the third trimester;2020QII;""
20 Gipuzkoa;All ages;Cohort October 1;Total;Survival in the third trimester;2020QI;""
20 Gipuzkoa;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
20 Gipuzkoa;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
20 Gipuzkoa;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
20 Gipuzkoa;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
20 Gipuzkoa;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
20 Gipuzkoa;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
20 Gipuzkoa;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
20 Gipuzkoa;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
20 Gipuzkoa;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
20 Gipuzkoa;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
20 Gipuzkoa;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
20 Gipuzkoa;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
20 Gipuzkoa;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;96,72
20 Gipuzkoa;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
20 Gipuzkoa;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
20 Gipuzkoa;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
20 Gipuzkoa;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;97,3
20 Gipuzkoa;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
20 Gipuzkoa;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
20 Gipuzkoa;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
20 Gipuzkoa;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;97,33
20 Gipuzkoa;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
20 Gipuzkoa;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
20 Gipuzkoa;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
20 Gipuzkoa;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
20 Gipuzkoa;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
20 Gipuzkoa;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
20 Gipuzkoa;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;95,04
20 Gipuzkoa;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
20 Gipuzkoa;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
20 Gipuzkoa;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
20 Gipuzkoa;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;95,36
20 Gipuzkoa;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
20 Gipuzkoa;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
20 Gipuzkoa;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
20 Gipuzkoa;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
20 Gipuzkoa;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
20 Gipuzkoa;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
20 Gipuzkoa;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;92,87
20 Gipuzkoa;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
20 Gipuzkoa;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
20 Gipuzkoa;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
20 Gipuzkoa;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;93,5
20 Gipuzkoa;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
20 Gipuzkoa;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
20 Gipuzkoa;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
20 Gipuzkoa;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
20 Gipuzkoa;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
20 Gipuzkoa;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
20 Gipuzkoa;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;90,83
20 Gipuzkoa;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
20 Gipuzkoa;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
20 Gipuzkoa;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
20 Gipuzkoa;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;91,81
20 Gipuzkoa;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
20 Gipuzkoa;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
20 Gipuzkoa;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
20 Gipuzkoa;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
20 Gipuzkoa;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
20 Gipuzkoa;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
20 Gipuzkoa;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QIV;40.894
20 Gipuzkoa;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
20 Gipuzkoa;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
20 Gipuzkoa;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
20 Gipuzkoa;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QIV;41.138
20 Gipuzkoa;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
20 Gipuzkoa;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
20 Gipuzkoa;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
20 Gipuzkoa;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QIV;41.399
20 Gipuzkoa;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
20 Gipuzkoa;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
20 Gipuzkoa;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
20 Gipuzkoa;All ages;Cohort October 1;Males;Survival in the first trimester;2022QIV;39.574
20 Gipuzkoa;All ages;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
20 Gipuzkoa;All ages;Cohort October 1;Males;Survival in the first trimester;2022QII;""
20 Gipuzkoa;All ages;Cohort October 1;Males;Survival in the first trimester;2022QI;""
20 Gipuzkoa;All ages;Cohort October 1;Males;Survival in the first trimester;2021QIV;40.068
20 Gipuzkoa;All ages;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
20 Gipuzkoa;All ages;Cohort October 1;Males;Survival in the first trimester;2021QII;""
20 Gipuzkoa;All ages;Cohort October 1;Males;Survival in the first trimester;2021QI;""
20 Gipuzkoa;All ages;Cohort October 1;Males;Survival in the first trimester;2020QIV;40.299
20 Gipuzkoa;All ages;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
20 Gipuzkoa;All ages;Cohort October 1;Males;Survival in the first trimester;2020QII;""
20 Gipuzkoa;All ages;Cohort October 1;Males;Survival in the first trimester;2020QI;""
20 Gipuzkoa;All ages;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
20 Gipuzkoa;All ages;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
20 Gipuzkoa;All ages;Cohort October 1;Males;Survival in the second trimester;2022QII;""
20 Gipuzkoa;All ages;Cohort October 1;Males;Survival in the second trimester;2022QI;39.195
20 Gipuzkoa;All ages;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
20 Gipuzkoa;All ages;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
20 Gipuzkoa;All ages;Cohort October 1;Males;Survival in the second trimester;2021QII;""
20 Gipuzkoa;All ages;Cohort October 1;Males;Survival in the second trimester;2021QI;39.537
20 Gipuzkoa;All ages;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
20 Gipuzkoa;All ages;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
20 Gipuzkoa;All ages;Cohort October 1;Males;Survival in the second trimester;2020QII;""
20 Gipuzkoa;All ages;Cohort October 1;Males;Survival in the second trimester;2020QI;""
20 Gipuzkoa;All ages;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
20 Gipuzkoa;All ages;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
20 Gipuzkoa;All ages;Cohort October 1;Males;Survival in the third trimester;2022QII;38.378
20 Gipuzkoa;All ages;Cohort October 1;Males;Survival in the third trimester;2022QI;""
20 Gipuzkoa;All ages;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
20 Gipuzkoa;All ages;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
20 Gipuzkoa;All ages;Cohort October 1;Males;Survival in the third trimester;2021QII;38.764
20 Gipuzkoa;All ages;Cohort October 1;Males;Survival in the third trimester;2021QI;""
20 Gipuzkoa;All ages;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
20 Gipuzkoa;All ages;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
20 Gipuzkoa;All ages;Cohort October 1;Males;Survival in the third trimester;2020QII;""
20 Gipuzkoa;All ages;Cohort October 1;Males;Survival in the third trimester;2020QI;""
20 Gipuzkoa;All ages;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
20 Gipuzkoa;All ages;Cohort October 1;Males;Survival in the third trimester;2022QIII;37.580
20 Gipuzkoa;All ages;Cohort October 1;Males;Survival in the third trimester;2022QII;""
20 Gipuzkoa;All ages;Cohort October 1;Males;Survival in the third trimester;2022QI;""
20 Gipuzkoa;All ages;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
20 Gipuzkoa;All ages;Cohort October 1;Males;Survival in the third trimester;2021QIII;38.066
20 Gipuzkoa;All ages;Cohort October 1;Males;Survival in the third trimester;2021QII;""
20 Gipuzkoa;All ages;Cohort October 1;Males;Survival in the third trimester;2021QI;""
20 Gipuzkoa;All ages;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
20 Gipuzkoa;All ages;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
20 Gipuzkoa;All ages;Cohort October 1;Males;Survival in the third trimester;2020QII;""
20 Gipuzkoa;All ages;Cohort October 1;Males;Survival in the third trimester;2020QI;""
20 Gipuzkoa;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
20 Gipuzkoa;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
20 Gipuzkoa;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
20 Gipuzkoa;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
20 Gipuzkoa;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
20 Gipuzkoa;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
20 Gipuzkoa;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
20 Gipuzkoa;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
20 Gipuzkoa;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
20 Gipuzkoa;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
20 Gipuzkoa;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
20 Gipuzkoa;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
20 Gipuzkoa;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;96,77
20 Gipuzkoa;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
20 Gipuzkoa;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
20 Gipuzkoa;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
20 Gipuzkoa;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;97,4
20 Gipuzkoa;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
20 Gipuzkoa;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
20 Gipuzkoa;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
20 Gipuzkoa;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;97,34
20 Gipuzkoa;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
20 Gipuzkoa;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
20 Gipuzkoa;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
20 Gipuzkoa;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
20 Gipuzkoa;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
20 Gipuzkoa;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
20 Gipuzkoa;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;95,28
20 Gipuzkoa;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
20 Gipuzkoa;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
20 Gipuzkoa;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
20 Gipuzkoa;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;95,5
20 Gipuzkoa;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
20 Gipuzkoa;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
20 Gipuzkoa;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
20 Gipuzkoa;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
20 Gipuzkoa;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
20 Gipuzkoa;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
20 Gipuzkoa;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;93,29
20 Gipuzkoa;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
20 Gipuzkoa;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
20 Gipuzkoa;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
20 Gipuzkoa;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;93,64
20 Gipuzkoa;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
20 Gipuzkoa;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
20 Gipuzkoa;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
20 Gipuzkoa;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
20 Gipuzkoa;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
20 Gipuzkoa;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
20 Gipuzkoa;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;91,35
20 Gipuzkoa;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
20 Gipuzkoa;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
20 Gipuzkoa;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
20 Gipuzkoa;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;91,95
20 Gipuzkoa;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
20 Gipuzkoa;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
20 Gipuzkoa;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
20 Gipuzkoa;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
20 Gipuzkoa;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
20 Gipuzkoa;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
20 Gipuzkoa;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QIV;22.565
20 Gipuzkoa;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
20 Gipuzkoa;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
20 Gipuzkoa;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
20 Gipuzkoa;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QIV;22.395
20 Gipuzkoa;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
20 Gipuzkoa;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
20 Gipuzkoa;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
20 Gipuzkoa;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QIV;22.182
20 Gipuzkoa;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
20 Gipuzkoa;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
20 Gipuzkoa;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
20 Gipuzkoa;All ages;Cohort October 1;Females;Survival in the first trimester;2022QIV;21.803
20 Gipuzkoa;All ages;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
20 Gipuzkoa;All ages;Cohort October 1;Females;Survival in the first trimester;2022QII;""
20 Gipuzkoa;All ages;Cohort October 1;Females;Survival in the first trimester;2022QI;""
20 Gipuzkoa;All ages;Cohort October 1;Females;Survival in the first trimester;2021QIV;21.748
20 Gipuzkoa;All ages;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
20 Gipuzkoa;All ages;Cohort October 1;Females;Survival in the first trimester;2021QII;""
20 Gipuzkoa;All ages;Cohort October 1;Females;Survival in the first trimester;2021QI;""
20 Gipuzkoa;All ages;Cohort October 1;Females;Survival in the first trimester;2020QIV;21.584
20 Gipuzkoa;All ages;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
20 Gipuzkoa;All ages;Cohort October 1;Females;Survival in the first trimester;2020QII;""
20 Gipuzkoa;All ages;Cohort October 1;Females;Survival in the first trimester;2020QI;""
20 Gipuzkoa;All ages;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
20 Gipuzkoa;All ages;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
20 Gipuzkoa;All ages;Cohort October 1;Females;Survival in the second trimester;2022QII;""
20 Gipuzkoa;All ages;Cohort October 1;Females;Survival in the second trimester;2022QI;21.186
20 Gipuzkoa;All ages;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
20 Gipuzkoa;All ages;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
20 Gipuzkoa;All ages;Cohort October 1;Females;Survival in the second trimester;2021QII;""
20 Gipuzkoa;All ages;Cohort October 1;Females;Survival in the second trimester;2021QI;21.092
20 Gipuzkoa;All ages;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
20 Gipuzkoa;All ages;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
20 Gipuzkoa;All ages;Cohort October 1;Females;Survival in the second trimester;2020QII;""
20 Gipuzkoa;All ages;Cohort October 1;Females;Survival in the second trimester;2020QI;""
20 Gipuzkoa;All ages;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
20 Gipuzkoa;All ages;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
20 Gipuzkoa;All ages;Cohort October 1;Females;Survival in the third trimester;2022QII;20.625
20 Gipuzkoa;All ages;Cohort October 1;Females;Survival in the third trimester;2022QI;""
20 Gipuzkoa;All ages;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
20 Gipuzkoa;All ages;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
20 Gipuzkoa;All ages;Cohort October 1;Females;Survival in the third trimester;2021QII;20.686
20 Gipuzkoa;All ages;Cohort October 1;Females;Survival in the third trimester;2021QI;""
20 Gipuzkoa;All ages;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
20 Gipuzkoa;All ages;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
20 Gipuzkoa;All ages;Cohort October 1;Females;Survival in the third trimester;2020QII;""
20 Gipuzkoa;All ages;Cohort October 1;Females;Survival in the third trimester;2020QI;""
20 Gipuzkoa;All ages;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
20 Gipuzkoa;All ages;Cohort October 1;Females;Survival in the third trimester;2022QIII;20.124
20 Gipuzkoa;All ages;Cohort October 1;Females;Survival in the third trimester;2022QII;""
20 Gipuzkoa;All ages;Cohort October 1;Females;Survival in the third trimester;2022QI;""
20 Gipuzkoa;All ages;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
20 Gipuzkoa;All ages;Cohort October 1;Females;Survival in the third trimester;2021QIII;20.305
20 Gipuzkoa;All ages;Cohort October 1;Females;Survival in the third trimester;2021QII;""
20 Gipuzkoa;All ages;Cohort October 1;Females;Survival in the third trimester;2021QI;""
20 Gipuzkoa;All ages;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
20 Gipuzkoa;All ages;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
20 Gipuzkoa;All ages;Cohort October 1;Females;Survival in the third trimester;2020QII;""
20 Gipuzkoa;All ages;Cohort October 1;Females;Survival in the third trimester;2020QI;""
20 Gipuzkoa;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
20 Gipuzkoa;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
20 Gipuzkoa;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
20 Gipuzkoa;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
20 Gipuzkoa;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
20 Gipuzkoa;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
20 Gipuzkoa;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
20 Gipuzkoa;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
20 Gipuzkoa;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
20 Gipuzkoa;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
20 Gipuzkoa;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
20 Gipuzkoa;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
20 Gipuzkoa;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;96,62
20 Gipuzkoa;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
20 Gipuzkoa;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
20 Gipuzkoa;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
20 Gipuzkoa;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;97,11
20 Gipuzkoa;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
20 Gipuzkoa;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
20 Gipuzkoa;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
20 Gipuzkoa;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;97,3
20 Gipuzkoa;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
20 Gipuzkoa;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
20 Gipuzkoa;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
20 Gipuzkoa;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
20 Gipuzkoa;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
20 Gipuzkoa;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
20 Gipuzkoa;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;94,6
20 Gipuzkoa;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
20 Gipuzkoa;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
20 Gipuzkoa;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
20 Gipuzkoa;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;95,09
20 Gipuzkoa;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
20 Gipuzkoa;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
20 Gipuzkoa;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
20 Gipuzkoa;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
20 Gipuzkoa;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
20 Gipuzkoa;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
20 Gipuzkoa;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;92,1
20 Gipuzkoa;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
20 Gipuzkoa;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
20 Gipuzkoa;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
20 Gipuzkoa;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;93,26
20 Gipuzkoa;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
20 Gipuzkoa;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
20 Gipuzkoa;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
20 Gipuzkoa;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
20 Gipuzkoa;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
20 Gipuzkoa;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
20 Gipuzkoa;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;89,86
20 Gipuzkoa;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
20 Gipuzkoa;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
20 Gipuzkoa;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
20 Gipuzkoa;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;91,54
20 Gipuzkoa;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
20 Gipuzkoa;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
20 Gipuzkoa;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
20 Gipuzkoa;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
20 Gipuzkoa;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
20 Gipuzkoa;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QI;3.305
20 Gipuzkoa;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QI;3.131
20 Gipuzkoa;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QI;2.608
20 Gipuzkoa;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2022QII;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2022QI;3.087
20 Gipuzkoa;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2021QII;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2021QI;2.944
20 Gipuzkoa;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2020QII;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2020QI;2.313
20 Gipuzkoa;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2022QII;2.905
20 Gipuzkoa;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2022QI;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2021QII;2.803
20 Gipuzkoa;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2021QI;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2020QII;2.216
20 Gipuzkoa;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2020QI;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QIII;2.726
20 Gipuzkoa;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QII;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QI;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QIII;2.671
20 Gipuzkoa;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QII;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QI;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QIII;2.097
20 Gipuzkoa;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QII;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QI;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QIV;2.576
20 Gipuzkoa;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QII;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QI;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QIV;2.548
20 Gipuzkoa;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QII;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QI;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QIV;1.992
20 Gipuzkoa;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QII;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QI;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
20 Gipuzkoa;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
20 Gipuzkoa;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
20 Gipuzkoa;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;93,4
20 Gipuzkoa;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;94,03
20 Gipuzkoa;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;88,69
20 Gipuzkoa;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;87,9
20 Gipuzkoa;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;89,52
20 Gipuzkoa;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;84,97
20 Gipuzkoa;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;82,48
20 Gipuzkoa;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;85,31
20 Gipuzkoa;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;80,41
20 Gipuzkoa;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;77,94
20 Gipuzkoa;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;81,38
20 Gipuzkoa;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;76,38
20 Gipuzkoa;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QI;2.211
20 Gipuzkoa;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QI;2.123
20 Gipuzkoa;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QI;1.813
20 Gipuzkoa;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2022QII;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2022QI;2.070
20 Gipuzkoa;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2021QII;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2021QI;1.999
20 Gipuzkoa;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2020QII;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2020QI;1.621
20 Gipuzkoa;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2022QII;1.943
20 Gipuzkoa;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2022QI;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2021QII;1.912
20 Gipuzkoa;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2021QI;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2020QII;1.555
20 Gipuzkoa;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2020QI;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QIII;1.834
20 Gipuzkoa;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QII;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QI;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QIII;1.833
20 Gipuzkoa;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QII;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QI;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QIII;1.473
20 Gipuzkoa;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QII;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QI;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QIV;1.748
20 Gipuzkoa;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QII;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QI;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QIV;1.762
20 Gipuzkoa;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QII;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QI;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QIV;1.399
20 Gipuzkoa;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QII;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QI;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
20 Gipuzkoa;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
20 Gipuzkoa;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
20 Gipuzkoa;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;93,62
20 Gipuzkoa;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;94,16
20 Gipuzkoa;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;89,41
20 Gipuzkoa;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;87,88
20 Gipuzkoa;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;90,06
20 Gipuzkoa;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;85,77
20 Gipuzkoa;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;82,95
20 Gipuzkoa;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;86,34
20 Gipuzkoa;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;81,25
20 Gipuzkoa;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;79,06
20 Gipuzkoa;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;83
20 Gipuzkoa;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;77,16
20 Gipuzkoa;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QI;1.094
20 Gipuzkoa;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QI;1.008
20 Gipuzkoa;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QI;795
20 Gipuzkoa;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2022QII;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2022QI;1.017
20 Gipuzkoa;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2021QII;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2021QI;945
20 Gipuzkoa;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2020QII;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2020QI;692
20 Gipuzkoa;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2022QII;962
20 Gipuzkoa;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2022QI;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2021QII;891
20 Gipuzkoa;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2021QI;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2020QII;661
20 Gipuzkoa;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2020QI;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QIII;892
20 Gipuzkoa;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QII;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QI;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QIII;838
20 Gipuzkoa;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QII;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QI;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QIII;624
20 Gipuzkoa;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QII;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QI;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QIV;828
20 Gipuzkoa;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QII;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QI;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QIV;786
20 Gipuzkoa;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QII;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QI;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QIV;593
20 Gipuzkoa;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QII;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QI;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
20 Gipuzkoa;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
20 Gipuzkoa;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
20 Gipuzkoa;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;92,96
20 Gipuzkoa;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;93,75
20 Gipuzkoa;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;87,04
20 Gipuzkoa;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;87,93
20 Gipuzkoa;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;88,39
20 Gipuzkoa;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;83,14
20 Gipuzkoa;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;81,54
20 Gipuzkoa;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;83,13
20 Gipuzkoa;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;78,49
20 Gipuzkoa;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;75,69
20 Gipuzkoa;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;77,98
20 Gipuzkoa;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;74,59
20 Gipuzkoa;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QII;2.873
20 Gipuzkoa;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QII;2.738
20 Gipuzkoa;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QII;2.672
20 Gipuzkoa;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2022QII;2.680
20 Gipuzkoa;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2022QI;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2021QII;2.575
20 Gipuzkoa;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2021QI;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2020QII;2.550
20 Gipuzkoa;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2020QI;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2022QIII;2.483
20 Gipuzkoa;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2022QII;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2022QI;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2021QIII;2.426
20 Gipuzkoa;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2021QII;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2021QI;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2020QIII;2.400
20 Gipuzkoa;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2020QII;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2020QI;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QIV;2.330
20 Gipuzkoa;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QII;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QI;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QIV;2.291
20 Gipuzkoa;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QII;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QI;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QIV;2.270
20 Gipuzkoa;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QII;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QI;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QII;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QI;2.178
20 Gipuzkoa;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QII;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QI;2.160
20 Gipuzkoa;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QII;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QI;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
20 Gipuzkoa;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
20 Gipuzkoa;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
20 Gipuzkoa;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;93,28
20 Gipuzkoa;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;94,05
20 Gipuzkoa;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;95,43
20 Gipuzkoa;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;86,43
20 Gipuzkoa;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;88,6
20 Gipuzkoa;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;89,82
20 Gipuzkoa;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;81,1
20 Gipuzkoa;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;83,67
20 Gipuzkoa;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;84,96
20 Gipuzkoa;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;79,55
20 Gipuzkoa;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;80,84
20 Gipuzkoa;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QII;1.949
20 Gipuzkoa;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QII;1.860
20 Gipuzkoa;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QII;1.848
20 Gipuzkoa;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2022QII;1.809
20 Gipuzkoa;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2022QI;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2021QII;1.749
20 Gipuzkoa;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2021QI;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2020QII;1.768
20 Gipuzkoa;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2020QI;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2022QIII;1.684
20 Gipuzkoa;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2022QII;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2022QI;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2021QIII;1.654
20 Gipuzkoa;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2021QII;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2021QI;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2020QIII;1.662
20 Gipuzkoa;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2020QII;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2020QI;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QIV;1.591
20 Gipuzkoa;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QII;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QI;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QIV;1.572
20 Gipuzkoa;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QII;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QI;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QIV;1.569
20 Gipuzkoa;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QII;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QI;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QII;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QI;1.504
20 Gipuzkoa;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QII;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QI;1.504
20 Gipuzkoa;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QII;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QI;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
20 Gipuzkoa;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
20 Gipuzkoa;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
20 Gipuzkoa;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;92,82
20 Gipuzkoa;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;94,03
20 Gipuzkoa;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;95,67
20 Gipuzkoa;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;86,4
20 Gipuzkoa;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;88,92
20 Gipuzkoa;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;89,94
20 Gipuzkoa;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;81,63
20 Gipuzkoa;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;84,52
20 Gipuzkoa;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;84,9
20 Gipuzkoa;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;80,86
20 Gipuzkoa;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;81,39
20 Gipuzkoa;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QII;924
20 Gipuzkoa;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QII;878
20 Gipuzkoa;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QII;824
20 Gipuzkoa;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2022QII;871
20 Gipuzkoa;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2022QI;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2021QII;826
20 Gipuzkoa;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2021QI;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2020QII;782
20 Gipuzkoa;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2020QI;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2022QIII;799
20 Gipuzkoa;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2022QII;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2022QI;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2021QIII;772
20 Gipuzkoa;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2021QII;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2021QI;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2020QIII;738
20 Gipuzkoa;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2020QII;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2020QI;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QIV;739
20 Gipuzkoa;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QII;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QI;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QIV;719
20 Gipuzkoa;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QII;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QI;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QIV;701
20 Gipuzkoa;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QII;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QI;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QII;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QI;674
20 Gipuzkoa;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QII;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QI;656
20 Gipuzkoa;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QII;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QI;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
20 Gipuzkoa;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
20 Gipuzkoa;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
20 Gipuzkoa;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;94,26
20 Gipuzkoa;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;94,08
20 Gipuzkoa;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;94,9
20 Gipuzkoa;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;86,47
20 Gipuzkoa;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;87,93
20 Gipuzkoa;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;89,56
20 Gipuzkoa;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;79,98
20 Gipuzkoa;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;81,89
20 Gipuzkoa;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;85,07
20 Gipuzkoa;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;76,77
20 Gipuzkoa;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;79,61
20 Gipuzkoa;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QIII;3.189
20 Gipuzkoa;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QIII;2.982
20 Gipuzkoa;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QIII;2.806
20 Gipuzkoa;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2022QIII;2.910
20 Gipuzkoa;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2022QII;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2022QI;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2021QIII;2.752
20 Gipuzkoa;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2021QII;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2021QI;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2020QIII;2.605
20 Gipuzkoa;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2020QII;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2020QI;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2022QIV;2.695
20 Gipuzkoa;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2022QII;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2022QI;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2021QIV;2.574
20 Gipuzkoa;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2021QII;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2021QI;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2020QIV;2.458
20 Gipuzkoa;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2020QII;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2020QI;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QII;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QI;2.434
20 Gipuzkoa;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QII;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QI;2.338
20 Gipuzkoa;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QII;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QI;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QII;2.326
20 Gipuzkoa;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QI;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QII;2.242
20 Gipuzkoa;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QI;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QII;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QI;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
20 Gipuzkoa;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
20 Gipuzkoa;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
20 Gipuzkoa;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;91,25
20 Gipuzkoa;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;92,29
20 Gipuzkoa;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;92,84
20 Gipuzkoa;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;84,51
20 Gipuzkoa;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;86,32
20 Gipuzkoa;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;87,6
20 Gipuzkoa;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;81,62
20 Gipuzkoa;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;83,32
20 Gipuzkoa;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;78
20 Gipuzkoa;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;79,9
20 Gipuzkoa;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QIII;2.116
20 Gipuzkoa;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QIII;2.009
20 Gipuzkoa;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QIII;1.935
20 Gipuzkoa;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2022QIII;1.941
20 Gipuzkoa;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2022QII;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2022QI;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2021QIII;1.860
20 Gipuzkoa;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2021QII;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2021QI;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2020QIII;1.802
20 Gipuzkoa;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2020QII;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2020QI;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2022QIV;1.805
20 Gipuzkoa;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2022QII;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2022QI;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2021QIV;1.749
20 Gipuzkoa;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2021QII;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2021QI;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2020QIV;1.696
20 Gipuzkoa;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2020QII;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2020QI;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QII;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QI;1.663
20 Gipuzkoa;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QII;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QI;1.625
20 Gipuzkoa;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QII;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QI;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QII;1.589
20 Gipuzkoa;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QI;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QII;1.562
20 Gipuzkoa;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QI;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QII;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QI;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
20 Gipuzkoa;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
20 Gipuzkoa;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
20 Gipuzkoa;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;91,73
20 Gipuzkoa;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;92,58
20 Gipuzkoa;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;93,13
20 Gipuzkoa;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;85,3
20 Gipuzkoa;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;87,06
20 Gipuzkoa;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;87,65
20 Gipuzkoa;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;82,78
20 Gipuzkoa;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;83,98
20 Gipuzkoa;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;79,09
20 Gipuzkoa;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;80,72
20 Gipuzkoa;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QIII;1.073
20 Gipuzkoa;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QIII;973
20 Gipuzkoa;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QIII;871
20 Gipuzkoa;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2022QIII;969
20 Gipuzkoa;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2022QII;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2022QI;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2021QIII;892
20 Gipuzkoa;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2021QII;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2021QI;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2020QIII;803
20 Gipuzkoa;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2020QII;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2020QI;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2022QIV;890
20 Gipuzkoa;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2022QII;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2022QI;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2021QIV;825
20 Gipuzkoa;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2021QII;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2021QI;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2020QIV;762
20 Gipuzkoa;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2020QII;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2020QI;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QII;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QI;771
20 Gipuzkoa;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QII;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QI;713
20 Gipuzkoa;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QII;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QI;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QII;737
20 Gipuzkoa;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QI;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QII;680
20 Gipuzkoa;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QI;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QII;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QI;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
20 Gipuzkoa;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
20 Gipuzkoa;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
20 Gipuzkoa;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;90,31
20 Gipuzkoa;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;91,68
20 Gipuzkoa;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;92,19
20 Gipuzkoa;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;82,95
20 Gipuzkoa;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;84,79
20 Gipuzkoa;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;87,49
20 Gipuzkoa;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;79,24
20 Gipuzkoa;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;81,86
20 Gipuzkoa;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;75,75
20 Gipuzkoa;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;78,07
20 Gipuzkoa;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QIV;3.415
20 Gipuzkoa;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QIV;3.134
20 Gipuzkoa;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QIV;2.978
20 Gipuzkoa;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2022QIV;3.153
20 Gipuzkoa;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2022QII;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2022QI;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2021QIV;2.917
20 Gipuzkoa;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2021QII;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2021QI;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2020QIV;2.781
20 Gipuzkoa;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2020QII;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2020QI;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2022QII;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2022QI;2.737
20 Gipuzkoa;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2021QII;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2021QI;2.632
20 Gipuzkoa;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2020QII;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2020QI;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QII;2.593
20 Gipuzkoa;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QI;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QII;2.519
20 Gipuzkoa;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QI;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QII;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QI;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QIII;2.444
20 Gipuzkoa;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QII;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QI;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QIII;2.408
20 Gipuzkoa;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QII;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QI;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QII;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QI;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
20 Gipuzkoa;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
20 Gipuzkoa;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
20 Gipuzkoa;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;92,33
20 Gipuzkoa;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;93,08
20 Gipuzkoa;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;93,38
20 Gipuzkoa;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;87,33
20 Gipuzkoa;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;88,38
20 Gipuzkoa;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;82,74
20 Gipuzkoa;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;84,59
20 Gipuzkoa;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;77,98
20 Gipuzkoa;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;80,86
20 Gipuzkoa;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QIV;2.291
20 Gipuzkoa;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QIV;2.117
20 Gipuzkoa;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QIV;2.047
20 Gipuzkoa;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2022QIV;2.123
20 Gipuzkoa;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2022QII;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2022QI;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2021QIV;1.978
20 Gipuzkoa;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2021QII;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2021QI;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2020QIV;1.907
20 Gipuzkoa;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2020QII;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2020QI;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2022QII;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2022QI;1.864
20 Gipuzkoa;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2021QII;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2021QI;1.813
20 Gipuzkoa;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2020QII;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2020QI;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QII;1.762
20 Gipuzkoa;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QI;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QII;1.740
20 Gipuzkoa;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QI;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QII;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QI;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QIII;1.669
20 Gipuzkoa;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QII;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QI;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QIII;1.672
20 Gipuzkoa;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QII;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QI;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QII;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QI;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
20 Gipuzkoa;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
20 Gipuzkoa;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
20 Gipuzkoa;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;92,67
20 Gipuzkoa;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;93,43
20 Gipuzkoa;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;93,16
20 Gipuzkoa;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;88,05
20 Gipuzkoa;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;88,57
20 Gipuzkoa;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;83,23
20 Gipuzkoa;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;85
20 Gipuzkoa;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;78,84
20 Gipuzkoa;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;81,68
20 Gipuzkoa;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QIV;1.124
20 Gipuzkoa;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QIV;1.017
20 Gipuzkoa;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QIV;931
20 Gipuzkoa;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2022QIV;1.030
20 Gipuzkoa;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2022QII;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2022QI;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2021QIV;939
20 Gipuzkoa;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2021QII;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2021QI;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2020QIV;874
20 Gipuzkoa;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2020QII;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2020QI;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2022QII;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2022QI;873
20 Gipuzkoa;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2021QII;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2021QI;819
20 Gipuzkoa;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2020QII;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2020QI;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QII;831
20 Gipuzkoa;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QI;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QII;779
20 Gipuzkoa;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QI;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QII;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QI;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QIII;775
20 Gipuzkoa;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QII;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QI;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QIII;736
20 Gipuzkoa;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QII;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QI;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QII;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QI;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
20 Gipuzkoa;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
20 Gipuzkoa;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
20 Gipuzkoa;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;91,64
20 Gipuzkoa;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;92,33
20 Gipuzkoa;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;93,88
20 Gipuzkoa;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;85,84
20 Gipuzkoa;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;87,97
20 Gipuzkoa;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;81,71
20 Gipuzkoa;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;83,67
20 Gipuzkoa;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;76,2
20 Gipuzkoa;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;79,05
20 Gipuzkoa;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QI;9.866
20 Gipuzkoa;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QI;10.403
20 Gipuzkoa;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QI;10.187
20 Gipuzkoa;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2022QII;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2022QI;9.532
20 Gipuzkoa;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2021QII;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2021QI;10.127
20 Gipuzkoa;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2020QII;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2020QI;9.659
20 Gipuzkoa;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2022QII;9.219
20 Gipuzkoa;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2022QI;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2021QII;9.843
20 Gipuzkoa;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2021QI;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2020QII;9.452
20 Gipuzkoa;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2020QI;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QIII;8.986
20 Gipuzkoa;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QII;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QI;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QIII;9.624
20 Gipuzkoa;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QII;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QI;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QIII;9.198
20 Gipuzkoa;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QII;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QI;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QIV;8.736
20 Gipuzkoa;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QII;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QI;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QIV;9.379
20 Gipuzkoa;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QII;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QI;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QIV;8.968
20 Gipuzkoa;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QII;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QI;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
20 Gipuzkoa;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
20 Gipuzkoa;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
20 Gipuzkoa;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;96,61
20 Gipuzkoa;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;97,35
20 Gipuzkoa;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;94,82
20 Gipuzkoa;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;93,44
20 Gipuzkoa;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;94,62
20 Gipuzkoa;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;92,78
20 Gipuzkoa;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;91,08
20 Gipuzkoa;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;92,51
20 Gipuzkoa;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;90,29
20 Gipuzkoa;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;88,55
20 Gipuzkoa;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;90,16
20 Gipuzkoa;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;88,03
20 Gipuzkoa;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QI;6.273
20 Gipuzkoa;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QI;6.666
20 Gipuzkoa;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QI;6.557
20 Gipuzkoa;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2022QII;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2022QI;6.084
20 Gipuzkoa;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2021QII;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2021QI;6.507
20 Gipuzkoa;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2020QII;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2020QI;6.243
20 Gipuzkoa;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2022QII;5.910
20 Gipuzkoa;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2022QI;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2021QII;6.331
20 Gipuzkoa;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2021QI;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2020QII;6.126
20 Gipuzkoa;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2020QI;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QIII;5.768
20 Gipuzkoa;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QII;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QI;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QIII;6.186
20 Gipuzkoa;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QII;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QI;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QIII;5.975
20 Gipuzkoa;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QII;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QI;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QIV;5.635
20 Gipuzkoa;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QII;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QI;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QIV;6.049
20 Gipuzkoa;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QII;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QI;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QIV;5.841
20 Gipuzkoa;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QII;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QI;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
20 Gipuzkoa;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
20 Gipuzkoa;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
20 Gipuzkoa;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;96,99
20 Gipuzkoa;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;97,61
20 Gipuzkoa;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;95,21
20 Gipuzkoa;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;94,21
20 Gipuzkoa;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;94,97
20 Gipuzkoa;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;93,43
20 Gipuzkoa;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;91,95
20 Gipuzkoa;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;92,8
20 Gipuzkoa;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;91,12
20 Gipuzkoa;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;89,83
20 Gipuzkoa;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;90,74
20 Gipuzkoa;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;89,08
20 Gipuzkoa;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QI;3.593
20 Gipuzkoa;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QI;3.737
20 Gipuzkoa;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QI;3.630
20 Gipuzkoa;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2022QII;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2022QI;3.448
20 Gipuzkoa;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2021QII;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2021QI;3.620
20 Gipuzkoa;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2020QII;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2020QI;3.416
20 Gipuzkoa;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2022QII;3.309
20 Gipuzkoa;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2022QI;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2021QII;3.512
20 Gipuzkoa;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2021QI;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2020QII;3.326
20 Gipuzkoa;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2020QI;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QIII;3.218
20 Gipuzkoa;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QII;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QI;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QIII;3.438
20 Gipuzkoa;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QII;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QI;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QIII;3.223
20 Gipuzkoa;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QII;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QI;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QIV;3.101
20 Gipuzkoa;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QII;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QI;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QIV;3.330
20 Gipuzkoa;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QII;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QI;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QIV;3.127
20 Gipuzkoa;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QII;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QI;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
20 Gipuzkoa;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
20 Gipuzkoa;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
20 Gipuzkoa;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;95,96
20 Gipuzkoa;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;96,87
20 Gipuzkoa;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;94,1
20 Gipuzkoa;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;92,1
20 Gipuzkoa;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;93,98
20 Gipuzkoa;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;91,63
20 Gipuzkoa;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;89,56
20 Gipuzkoa;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;92
20 Gipuzkoa;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;88,79
20 Gipuzkoa;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;86,31
20 Gipuzkoa;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;89,11
20 Gipuzkoa;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;86,14
20 Gipuzkoa;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QII;9.142
20 Gipuzkoa;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QII;9.564
20 Gipuzkoa;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QII;10.141
20 Gipuzkoa;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2022QII;8.804
20 Gipuzkoa;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2022QI;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2021QII;9.261
20 Gipuzkoa;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2021QI;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2020QII;9.913
20 Gipuzkoa;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2020QI;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2022QIII;8.556
20 Gipuzkoa;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2022QII;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2022QI;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2021QIII;9.027
20 Gipuzkoa;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2021QII;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2021QI;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2020QIII;9.628
20 Gipuzkoa;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2020QII;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2020QI;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QIV;8.269
20 Gipuzkoa;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QII;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QI;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QIV;8.765
20 Gipuzkoa;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QII;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QI;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QIV;9.371
20 Gipuzkoa;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QII;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QI;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QII;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QI;8.518
20 Gipuzkoa;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QII;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QI;9.163
20 Gipuzkoa;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QII;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QI;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
20 Gipuzkoa;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
20 Gipuzkoa;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
20 Gipuzkoa;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;96,3
20 Gipuzkoa;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;96,83
20 Gipuzkoa;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;97,75
20 Gipuzkoa;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;93,59
20 Gipuzkoa;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;94,39
20 Gipuzkoa;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;94,94
20 Gipuzkoa;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;90,45
20 Gipuzkoa;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;91,65
20 Gipuzkoa;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;92,41
20 Gipuzkoa;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;89,06
20 Gipuzkoa;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;90,36
20 Gipuzkoa;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QII;5.798
20 Gipuzkoa;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QII;6.164
20 Gipuzkoa;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QII;6.521
20 Gipuzkoa;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2022QII;5.610
20 Gipuzkoa;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2022QI;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2021QII;5.979
20 Gipuzkoa;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2021QI;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2020QII;6.387
20 Gipuzkoa;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2020QI;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2022QIII;5.453
20 Gipuzkoa;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2022QII;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2022QI;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2021QIII;5.825
20 Gipuzkoa;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2021QII;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2021QI;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2020QIII;6.217
20 Gipuzkoa;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2020QII;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2020QI;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QIV;5.297
20 Gipuzkoa;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QII;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QI;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QIV;5.674
20 Gipuzkoa;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QII;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QI;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QIV;6.064
20 Gipuzkoa;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QII;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QI;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QII;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QI;5.540
20 Gipuzkoa;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QII;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QI;5.948
20 Gipuzkoa;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QII;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QI;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
20 Gipuzkoa;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
20 Gipuzkoa;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
20 Gipuzkoa;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;96,76
20 Gipuzkoa;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;97
20 Gipuzkoa;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;97,95
20 Gipuzkoa;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;94,05
20 Gipuzkoa;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;94,5
20 Gipuzkoa;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;95,34
20 Gipuzkoa;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;91,36
20 Gipuzkoa;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;92,05
20 Gipuzkoa;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;92,99
20 Gipuzkoa;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;89,88
20 Gipuzkoa;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;91,21
20 Gipuzkoa;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QII;3.344
20 Gipuzkoa;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QII;3.400
20 Gipuzkoa;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QII;3.620
20 Gipuzkoa;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2022QII;3.194
20 Gipuzkoa;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2022QI;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2021QII;3.282
20 Gipuzkoa;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2021QI;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2020QII;3.526
20 Gipuzkoa;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2020QI;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2022QIII;3.103
20 Gipuzkoa;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2022QII;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2022QI;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2021QIII;3.202
20 Gipuzkoa;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2021QII;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2021QI;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2020QIII;3.411
20 Gipuzkoa;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2020QII;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2020QI;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QIV;2.972
20 Gipuzkoa;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QII;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QI;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QIV;3.091
20 Gipuzkoa;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QII;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QI;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QIV;3.307
20 Gipuzkoa;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QII;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QI;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QII;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QI;2.978
20 Gipuzkoa;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QII;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QI;3.215
20 Gipuzkoa;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QII;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QI;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
20 Gipuzkoa;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
20 Gipuzkoa;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
20 Gipuzkoa;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;95,51
20 Gipuzkoa;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;96,53
20 Gipuzkoa;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;97,4
20 Gipuzkoa;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;92,79
20 Gipuzkoa;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;94,18
20 Gipuzkoa;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;94,23
20 Gipuzkoa;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;88,88
20 Gipuzkoa;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;90,91
20 Gipuzkoa;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;91,35
20 Gipuzkoa;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;87,59
20 Gipuzkoa;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;88,81
20 Gipuzkoa;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QIII;9.326
20 Gipuzkoa;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QIII;9.690
20 Gipuzkoa;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QIII;10.185
20 Gipuzkoa;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2022QIII;9.031
20 Gipuzkoa;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2022QII;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2022QI;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2021QIII;9.420
20 Gipuzkoa;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2021QII;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2021QI;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2020QIII;9.867
20 Gipuzkoa;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2020QII;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2020QI;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2022QIV;8.707
20 Gipuzkoa;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2022QII;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2022QI;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2021QIV;9.119
20 Gipuzkoa;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2021QII;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2021QI;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2020QIV;9.589
20 Gipuzkoa;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2020QII;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2020QI;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QII;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QI;8.842
20 Gipuzkoa;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QII;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QI;9.373
20 Gipuzkoa;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QII;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QI;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QII;8.593
20 Gipuzkoa;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QI;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QII;9.141
20 Gipuzkoa;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QI;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QII;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QI;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
20 Gipuzkoa;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
20 Gipuzkoa;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
20 Gipuzkoa;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;96,84
20 Gipuzkoa;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;97,21
20 Gipuzkoa;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;96,88
20 Gipuzkoa;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;93,36
20 Gipuzkoa;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;94,11
20 Gipuzkoa;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;94,15
20 Gipuzkoa;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;91,25
20 Gipuzkoa;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;92,03
20 Gipuzkoa;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;88,68
20 Gipuzkoa;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;89,75
20 Gipuzkoa;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QIII;5.903
20 Gipuzkoa;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QIII;6.235
20 Gipuzkoa;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QIII;6.552
20 Gipuzkoa;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2022QIII;5.719
20 Gipuzkoa;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2022QII;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2022QI;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2021QIII;6.058
20 Gipuzkoa;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2021QII;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2021QI;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2020QIII;6.363
20 Gipuzkoa;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2020QII;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2020QI;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2022QIV;5.543
20 Gipuzkoa;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2022QII;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2022QI;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2021QIV;5.883
20 Gipuzkoa;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2021QII;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2021QI;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2020QIV;6.195
20 Gipuzkoa;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2020QII;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2020QI;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QII;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QI;5.730
20 Gipuzkoa;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QII;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QI;6.075
20 Gipuzkoa;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QII;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QI;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QII;5.589
20 Gipuzkoa;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QI;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QII;5.925
20 Gipuzkoa;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QI;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QII;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QI;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
20 Gipuzkoa;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
20 Gipuzkoa;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
20 Gipuzkoa;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;96,88
20 Gipuzkoa;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;97,16
20 Gipuzkoa;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;97,12
20 Gipuzkoa;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;93,9
20 Gipuzkoa;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;94,35
20 Gipuzkoa;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;94,55
20 Gipuzkoa;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;91,9
20 Gipuzkoa;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;92,72
20 Gipuzkoa;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;89,64
20 Gipuzkoa;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;90,43
20 Gipuzkoa;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QIII;3.423
20 Gipuzkoa;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QIII;3.455
20 Gipuzkoa;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QIII;3.633
20 Gipuzkoa;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2022QIII;3.312
20 Gipuzkoa;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2022QII;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2022QI;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2021QIII;3.362
20 Gipuzkoa;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2021QII;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2021QI;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2020QIII;3.504
20 Gipuzkoa;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2020QII;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2020QI;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2022QIV;3.164
20 Gipuzkoa;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2022QII;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2022QI;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2021QIV;3.236
20 Gipuzkoa;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2021QII;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2021QI;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2020QIV;3.394
20 Gipuzkoa;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2020QII;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2020QI;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QII;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QI;3.112
20 Gipuzkoa;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QII;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QI;3.298
20 Gipuzkoa;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QII;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QI;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QII;3.004
20 Gipuzkoa;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QI;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QII;3.216
20 Gipuzkoa;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QI;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QII;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QI;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
20 Gipuzkoa;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
20 Gipuzkoa;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
20 Gipuzkoa;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;96,76
20 Gipuzkoa;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;97,31
20 Gipuzkoa;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;96,45
20 Gipuzkoa;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;92,43
20 Gipuzkoa;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;93,66
20 Gipuzkoa;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;93,42
20 Gipuzkoa;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;90,07
20 Gipuzkoa;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;90,78
20 Gipuzkoa;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;86,95
20 Gipuzkoa;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;88,52
20 Gipuzkoa;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QIV;9.524
20 Gipuzkoa;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QIV;9.813
20 Gipuzkoa;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QIV;10.239
20 Gipuzkoa;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2022QIV;9.170
20 Gipuzkoa;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2022QII;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2022QI;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2021QIV;9.471
20 Gipuzkoa;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2021QII;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2021QI;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2020QIV;9.925
20 Gipuzkoa;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2020QII;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2020QI;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2022QII;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2022QI;9.172
20 Gipuzkoa;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2021QII;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2021QI;9.690
20 Gipuzkoa;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2020QII;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2020QI;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QII;8.893
20 Gipuzkoa;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QI;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QII;9.440
20 Gipuzkoa;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QI;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QII;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QI;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QIII;8.677
20 Gipuzkoa;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QII;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QI;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QIII;9.245
20 Gipuzkoa;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QII;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QI;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QII;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QI;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
20 Gipuzkoa;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
20 Gipuzkoa;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
20 Gipuzkoa;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;96,28
20 Gipuzkoa;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;96,51
20 Gipuzkoa;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;96,93
20 Gipuzkoa;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;93,47
20 Gipuzkoa;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;94,64
20 Gipuzkoa;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;90,62
20 Gipuzkoa;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;92,2
20 Gipuzkoa;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;88,42
20 Gipuzkoa;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;90,29
20 Gipuzkoa;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QIV;5.996
20 Gipuzkoa;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QIV;6.274
20 Gipuzkoa;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QIV;6.593
20 Gipuzkoa;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2022QIV;5.800
20 Gipuzkoa;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2022QII;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2022QI;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2021QIV;6.073
20 Gipuzkoa;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2021QII;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2021QI;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2020QIV;6.402
20 Gipuzkoa;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2020QII;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2020QI;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2022QII;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2022QI;5.909
20 Gipuzkoa;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2021QII;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2021QI;6.267
20 Gipuzkoa;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2020QII;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2020QI;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QII;5.751
20 Gipuzkoa;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QI;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QII;6.109
20 Gipuzkoa;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QI;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QII;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QI;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QIII;5.618
20 Gipuzkoa;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QII;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QI;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QIII;5.978
20 Gipuzkoa;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QII;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QI;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QII;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QI;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
20 Gipuzkoa;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
20 Gipuzkoa;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
20 Gipuzkoa;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;96,73
20 Gipuzkoa;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;96,8
20 Gipuzkoa;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;97,1
20 Gipuzkoa;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;94,18
20 Gipuzkoa;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;95,06
20 Gipuzkoa;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;91,66
20 Gipuzkoa;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;92,66
20 Gipuzkoa;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;89,54
20 Gipuzkoa;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;90,67
20 Gipuzkoa;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QIV;3.528
20 Gipuzkoa;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QIV;3.539
20 Gipuzkoa;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QIV;3.646
20 Gipuzkoa;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2022QIV;3.370
20 Gipuzkoa;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2022QII;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2022QI;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2021QIV;3.398
20 Gipuzkoa;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2021QII;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2021QI;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2020QIV;3.523
20 Gipuzkoa;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2020QII;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2020QI;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2022QII;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2022QI;3.263
20 Gipuzkoa;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2021QII;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2021QI;3.423
20 Gipuzkoa;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2020QII;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2020QI;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QII;3.142
20 Gipuzkoa;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QI;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QII;3.331
20 Gipuzkoa;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QI;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QII;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QI;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QIII;3.059
20 Gipuzkoa;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QII;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QI;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QIII;3.267
20 Gipuzkoa;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QII;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QI;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QII;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QI;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
20 Gipuzkoa;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
20 Gipuzkoa;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
20 Gipuzkoa;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;95,52
20 Gipuzkoa;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;96,02
20 Gipuzkoa;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;96,63
20 Gipuzkoa;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;92,2
20 Gipuzkoa;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;93,88
20 Gipuzkoa;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;88,78
20 Gipuzkoa;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;91,36
20 Gipuzkoa;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;86,44
20 Gipuzkoa;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;89,61
20 Gipuzkoa;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QI;21.548
20 Gipuzkoa;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QI;22.057
20 Gipuzkoa;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QI;22.300
20 Gipuzkoa;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2022QII;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2022QI;21.179
20 Gipuzkoa;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2021QII;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2021QI;21.744
20 Gipuzkoa;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2020QII;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2020QI;21.601
20 Gipuzkoa;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2022QII;20.795
20 Gipuzkoa;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2022QI;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2021QII;21.424
20 Gipuzkoa;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2021QI;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2020QII;21.326
20 Gipuzkoa;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2020QI;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QIII;20.490
20 Gipuzkoa;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QII;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QI;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QIII;21.175
20 Gipuzkoa;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QII;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QI;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QIII;20.979
20 Gipuzkoa;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QII;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QI;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QIV;20.155
20 Gipuzkoa;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QII;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QI;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QIV;20.870
20 Gipuzkoa;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QII;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QI;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QIV;20.697
20 Gipuzkoa;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QII;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QI;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
20 Gipuzkoa;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
20 Gipuzkoa;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
20 Gipuzkoa;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;98,29
20 Gipuzkoa;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;98,58
20 Gipuzkoa;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;96,87
20 Gipuzkoa;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;96,51
20 Gipuzkoa;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;97,13
20 Gipuzkoa;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;95,63
20 Gipuzkoa;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;95,09
20 Gipuzkoa;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;96
20 Gipuzkoa;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;94,08
20 Gipuzkoa;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;93,54
20 Gipuzkoa;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;94,62
20 Gipuzkoa;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;92,81
20 Gipuzkoa;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QI;13.840
20 Gipuzkoa;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QI;14.267
20 Gipuzkoa;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QI;14.497
20 Gipuzkoa;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2022QII;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2022QI;13.616
20 Gipuzkoa;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2021QII;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2021QI;14.077
20 Gipuzkoa;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2020QII;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2020QI;14.046
20 Gipuzkoa;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2022QII;13.405
20 Gipuzkoa;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2022QI;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2021QII;13.869
20 Gipuzkoa;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2021QI;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2020QII;13.889
20 Gipuzkoa;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2020QI;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QIII;13.208
20 Gipuzkoa;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QII;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QI;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QIII;13.715
20 Gipuzkoa;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QII;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QI;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QIII;13.685
20 Gipuzkoa;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QII;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QI;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QIV;12.995
20 Gipuzkoa;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QII;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QI;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QIV;13.530
20 Gipuzkoa;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QII;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QI;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QIV;13.499
20 Gipuzkoa;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QII;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QI;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
20 Gipuzkoa;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
20 Gipuzkoa;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
20 Gipuzkoa;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;98,38
20 Gipuzkoa;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;98,67
20 Gipuzkoa;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;96,89
20 Gipuzkoa;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;96,86
20 Gipuzkoa;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;97,21
20 Gipuzkoa;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;95,81
20 Gipuzkoa;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;95,43
20 Gipuzkoa;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;96,13
20 Gipuzkoa;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;94,4
20 Gipuzkoa;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;93,89
20 Gipuzkoa;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;94,83
20 Gipuzkoa;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;93,12
20 Gipuzkoa;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QI;7.708
20 Gipuzkoa;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QI;7.790
20 Gipuzkoa;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QI;7.803
20 Gipuzkoa;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2022QII;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2022QI;7.563
20 Gipuzkoa;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2021QII;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2021QI;7.667
20 Gipuzkoa;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2020QII;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2020QI;7.555
20 Gipuzkoa;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2022QII;7.390
20 Gipuzkoa;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2022QI;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2021QII;7.555
20 Gipuzkoa;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2021QI;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2020QII;7.437
20 Gipuzkoa;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2020QI;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QIII;7.282
20 Gipuzkoa;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QII;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QI;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QIII;7.460
20 Gipuzkoa;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QII;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QI;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QIII;7.294
20 Gipuzkoa;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QII;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QI;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QIV;7.160
20 Gipuzkoa;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QII;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QI;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QIV;7.340
20 Gipuzkoa;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QII;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QI;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QIV;7.198
20 Gipuzkoa;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QII;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QI;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
20 Gipuzkoa;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
20 Gipuzkoa;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
20 Gipuzkoa;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;98,12
20 Gipuzkoa;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;98,42
20 Gipuzkoa;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;96,82
20 Gipuzkoa;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;95,87
20 Gipuzkoa;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;96,98
20 Gipuzkoa;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;95,31
20 Gipuzkoa;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;94,47
20 Gipuzkoa;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;95,76
20 Gipuzkoa;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;93,48
20 Gipuzkoa;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;92,89
20 Gipuzkoa;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;94,22
20 Gipuzkoa;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;92,25
20 Gipuzkoa;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QII;20.654
20 Gipuzkoa;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QII;21.363
20 Gipuzkoa;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QII;22.086
20 Gipuzkoa;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2022QII;20.230
20 Gipuzkoa;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2022QI;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2021QII;21.000
20 Gipuzkoa;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2021QI;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2020QII;21.790
20 Gipuzkoa;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2020QI;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2022QIII;19.892
20 Gipuzkoa;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2022QII;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2022QI;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2021QIII;20.717
20 Gipuzkoa;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2021QII;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2021QI;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2020QIII;21.400
20 Gipuzkoa;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2020QII;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2020QI;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QIV;19.543
20 Gipuzkoa;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QII;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QI;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QIV;20.382
20 Gipuzkoa;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QII;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QI;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QIV;21.087
20 Gipuzkoa;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QII;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QI;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QII;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QI;20.110
20 Gipuzkoa;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QII;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QI;20.841
20 Gipuzkoa;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QII;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QI;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
20 Gipuzkoa;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
20 Gipuzkoa;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
20 Gipuzkoa;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;97,95
20 Gipuzkoa;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;98,3
20 Gipuzkoa;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;98,66
20 Gipuzkoa;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;96,31
20 Gipuzkoa;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;96,98
20 Gipuzkoa;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;96,89
20 Gipuzkoa;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;94,62
20 Gipuzkoa;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;95,41
20 Gipuzkoa;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;95,48
20 Gipuzkoa;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;94,13
20 Gipuzkoa;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;94,36
20 Gipuzkoa;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QII;13.208
20 Gipuzkoa;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QII;13.809
20 Gipuzkoa;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QII;14.309
20 Gipuzkoa;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2022QII;12.960
20 Gipuzkoa;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2022QI;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2021QII;13.573
20 Gipuzkoa;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2021QI;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2020QII;14.143
20 Gipuzkoa;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2020QI;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2022QIII;12.742
20 Gipuzkoa;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2022QII;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2022QI;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2021QIII;13.392
20 Gipuzkoa;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2021QII;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2021QI;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2020QIII;13.904
20 Gipuzkoa;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2020QII;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2020QI;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QIV;12.521
20 Gipuzkoa;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QII;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QI;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QIV;13.186
20 Gipuzkoa;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QII;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QI;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QIV;13.695
20 Gipuzkoa;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QII;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QI;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QII;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QI;13.026
20 Gipuzkoa;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QII;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QI;13.550
20 Gipuzkoa;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QII;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QI;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
20 Gipuzkoa;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
20 Gipuzkoa;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
20 Gipuzkoa;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;98,12
20 Gipuzkoa;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;98,29
20 Gipuzkoa;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;98,84
20 Gipuzkoa;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;96,47
20 Gipuzkoa;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;96,98
20 Gipuzkoa;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;97,17
20 Gipuzkoa;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;94,8
20 Gipuzkoa;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;95,49
20 Gipuzkoa;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;95,71
20 Gipuzkoa;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;94,33
20 Gipuzkoa;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;94,7
20 Gipuzkoa;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QII;7.446
20 Gipuzkoa;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QII;7.554
20 Gipuzkoa;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QII;7.777
20 Gipuzkoa;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2022QII;7.270
20 Gipuzkoa;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2022QI;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2021QII;7.427
20 Gipuzkoa;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2021QI;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2020QII;7.647
20 Gipuzkoa;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2020QI;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2022QIII;7.150
20 Gipuzkoa;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2022QII;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2022QI;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2021QIII;7.325
20 Gipuzkoa;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2021QII;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2021QI;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2020QIII;7.496
20 Gipuzkoa;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2020QII;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2020QI;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QIV;7.022
20 Gipuzkoa;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QII;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QI;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QIV;7.196
20 Gipuzkoa;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QII;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QI;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QIV;7.392
20 Gipuzkoa;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QII;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QI;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QII;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QI;7.084
20 Gipuzkoa;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QII;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QI;7.291
20 Gipuzkoa;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QII;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QI;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
20 Gipuzkoa;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
20 Gipuzkoa;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
20 Gipuzkoa;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;97,64
20 Gipuzkoa;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;98,32
20 Gipuzkoa;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;98,33
20 Gipuzkoa;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;96,02
20 Gipuzkoa;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;96,97
20 Gipuzkoa;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;96,39
20 Gipuzkoa;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;94,31
20 Gipuzkoa;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;95,26
20 Gipuzkoa;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;95,05
20 Gipuzkoa;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;93,78
20 Gipuzkoa;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;93,75
20 Gipuzkoa;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QIII;20.694
20 Gipuzkoa;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QIII;21.432
20 Gipuzkoa;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QIII;22.074
20 Gipuzkoa;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2022QIII;20.291
20 Gipuzkoa;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2022QII;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2022QI;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2021QIII;21.106
20 Gipuzkoa;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2021QII;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2021QI;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2020QIII;21.646
20 Gipuzkoa;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2020QII;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2020QI;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2022QIV;19.902
20 Gipuzkoa;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2022QII;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2022QI;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2021QIV;20.738
20 Gipuzkoa;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2021QII;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2021QI;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2020QIV;21.304
20 Gipuzkoa;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2020QII;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2020QI;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QII;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QI;20.444
20 Gipuzkoa;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QII;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QI;21.053
20 Gipuzkoa;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QII;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QI;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QII;20.130
20 Gipuzkoa;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QI;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QII;20.800
20 Gipuzkoa;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QI;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QII;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QI;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
20 Gipuzkoa;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
20 Gipuzkoa;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
20 Gipuzkoa;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;98,05
20 Gipuzkoa;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;98,48
20 Gipuzkoa;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;98,06
20 Gipuzkoa;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;96,17
20 Gipuzkoa;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;96,76
20 Gipuzkoa;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;96,51
20 Gipuzkoa;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;95,39
20 Gipuzkoa;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;95,37
20 Gipuzkoa;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;93,92
20 Gipuzkoa;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;94,23
20 Gipuzkoa;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QIII;13.218
20 Gipuzkoa;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QIII;13.822
20 Gipuzkoa;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QIII;14.324
20 Gipuzkoa;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2022QIII;12.962
20 Gipuzkoa;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2022QII;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2022QI;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2021QIII;13.609
20 Gipuzkoa;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2021QII;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2021QI;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2020QIII;14.058
20 Gipuzkoa;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2020QII;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2020QI;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2022QIV;12.708
20 Gipuzkoa;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2022QII;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2022QI;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2021QIV;13.379
20 Gipuzkoa;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2021QII;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2021QI;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2020QIV;13.826
20 Gipuzkoa;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2020QII;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2020QI;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QII;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QI;13.208
20 Gipuzkoa;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QII;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QI;13.677
20 Gipuzkoa;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QII;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QI;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QII;13.021
20 Gipuzkoa;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QI;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QII;13.506
20 Gipuzkoa;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QI;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QII;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QI;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
20 Gipuzkoa;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
20 Gipuzkoa;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
20 Gipuzkoa;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;98,06
20 Gipuzkoa;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;98,46
20 Gipuzkoa;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;98,14
20 Gipuzkoa;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;96,14
20 Gipuzkoa;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;96,79
20 Gipuzkoa;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;96,52
20 Gipuzkoa;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;95,56
20 Gipuzkoa;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;95,48
20 Gipuzkoa;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;94,2
20 Gipuzkoa;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;94,29
20 Gipuzkoa;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QIII;7.476
20 Gipuzkoa;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QIII;7.610
20 Gipuzkoa;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QIII;7.750
20 Gipuzkoa;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2022QIII;7.329
20 Gipuzkoa;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2022QII;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2022QI;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2021QIII;7.497
20 Gipuzkoa;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2021QII;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2021QI;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2020QIII;7.588
20 Gipuzkoa;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2020QII;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2020QI;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2022QIV;7.194
20 Gipuzkoa;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2022QII;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2022QI;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2021QIV;7.359
20 Gipuzkoa;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2021QII;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2021QI;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2020QIV;7.478
20 Gipuzkoa;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2020QII;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2020QI;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QII;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QI;7.236
20 Gipuzkoa;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QII;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QI;7.376
20 Gipuzkoa;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QII;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QI;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QII;7.109
20 Gipuzkoa;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QI;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QII;7.294
20 Gipuzkoa;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QI;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QII;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QI;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
20 Gipuzkoa;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
20 Gipuzkoa;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
20 Gipuzkoa;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;98,03
20 Gipuzkoa;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;98,52
20 Gipuzkoa;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;97,91
20 Gipuzkoa;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;96,23
20 Gipuzkoa;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;96,7
20 Gipuzkoa;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;96,49
20 Gipuzkoa;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;95,09
20 Gipuzkoa;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;95,17
20 Gipuzkoa;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;93,42
20 Gipuzkoa;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;94,12
20 Gipuzkoa;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QIV;20.725
20 Gipuzkoa;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QIV;21.513
20 Gipuzkoa;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QIV;22.010
20 Gipuzkoa;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2022QIV;20.281
20 Gipuzkoa;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2022QII;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2022QI;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2021QIV;21.110
20 Gipuzkoa;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2021QII;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2021QI;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2020QIV;21.633
20 Gipuzkoa;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2020QII;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2020QI;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2022QII;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2022QI;20.783
20 Gipuzkoa;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2021QII;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2021QI;21.356
20 Gipuzkoa;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2020QII;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2020QI;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QII;20.441
20 Gipuzkoa;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QI;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QII;21.088
20 Gipuzkoa;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QI;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QII;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QI;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QIII;20.151
20 Gipuzkoa;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QII;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QI;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QIII;20.854
20 Gipuzkoa;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QII;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QI;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QII;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QI;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
20 Gipuzkoa;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
20 Gipuzkoa;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
20 Gipuzkoa;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;97,86
20 Gipuzkoa;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;98,13
20 Gipuzkoa;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;98,29
20 Gipuzkoa;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;96,61
20 Gipuzkoa;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;97,03
20 Gipuzkoa;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;95,02
20 Gipuzkoa;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;95,81
20 Gipuzkoa;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;93,67
20 Gipuzkoa;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;94,75
20 Gipuzkoa;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QIV;13.206
20 Gipuzkoa;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QIV;13.846
20 Gipuzkoa;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QIV;14.290
20 Gipuzkoa;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2022QIV;12.917
20 Gipuzkoa;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2022QII;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2022QI;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2021QIV;13.595
20 Gipuzkoa;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2021QII;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2021QI;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2020QIV;14.035
20 Gipuzkoa;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2020QII;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2020QI;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2022QII;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2022QI;13.402
20 Gipuzkoa;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2021QII;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2021QI;13.871
20 Gipuzkoa;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2020QII;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2020QI;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QII;13.204
20 Gipuzkoa;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QI;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QII;13.694
20 Gipuzkoa;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QI;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QII;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QI;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QIII;13.017
20 Gipuzkoa;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QII;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QI;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QIII;13.548
20 Gipuzkoa;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QII;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QI;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QII;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QI;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
20 Gipuzkoa;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
20 Gipuzkoa;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
20 Gipuzkoa;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;97,81
20 Gipuzkoa;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;98,19
20 Gipuzkoa;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;98,22
20 Gipuzkoa;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;96,79
20 Gipuzkoa;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;97,07
20 Gipuzkoa;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;95,36
20 Gipuzkoa;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;95,83
20 Gipuzkoa;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;94,01
20 Gipuzkoa;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;94,81
20 Gipuzkoa;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QIV;7.519
20 Gipuzkoa;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QIV;7.667
20 Gipuzkoa;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QIV;7.720
20 Gipuzkoa;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2022QIV;7.364
20 Gipuzkoa;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2022QII;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2022QI;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2021QIV;7.515
20 Gipuzkoa;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2021QII;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2021QI;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2020QIV;7.598
20 Gipuzkoa;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2020QII;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2020QI;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2022QII;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2022QI;7.381
20 Gipuzkoa;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2021QII;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2021QI;7.485
20 Gipuzkoa;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2020QII;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2020QI;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QII;7.237
20 Gipuzkoa;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QI;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QII;7.394
20 Gipuzkoa;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QI;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QII;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QI;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QIII;7.134
20 Gipuzkoa;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QII;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QI;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QIII;7.306
20 Gipuzkoa;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QII;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QI;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QII;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QI;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
20 Gipuzkoa;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
20 Gipuzkoa;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
20 Gipuzkoa;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;97,94
20 Gipuzkoa;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;98,02
20 Gipuzkoa;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;98,42
20 Gipuzkoa;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;96,27
20 Gipuzkoa;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;96,96
20 Gipuzkoa;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;94,39
20 Gipuzkoa;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;95,78
20 Gipuzkoa;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;93,05
20 Gipuzkoa;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;94,64
20 Gipuzkoa;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QI;20.310
20 Gipuzkoa;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QI;19.810
20 Gipuzkoa;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QI;20.262
20 Gipuzkoa;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2022QII;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2022QI;19.986
20 Gipuzkoa;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2021QII;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2021QI;19.550
20 Gipuzkoa;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2020QII;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2020QI;19.786
20 Gipuzkoa;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2022QII;19.671
20 Gipuzkoa;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2022QI;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2021QII;19.299
20 Gipuzkoa;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2021QI;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2020QII;19.567
20 Gipuzkoa;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2020QI;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QIII;19.370
20 Gipuzkoa;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QII;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QI;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QIII;19.078
20 Gipuzkoa;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QII;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QI;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QIII;19.280
20 Gipuzkoa;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QII;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QI;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QIV;19.047
20 Gipuzkoa;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QII;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QI;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QIV;18.810
20 Gipuzkoa;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QII;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QI;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QIV;19.016
20 Gipuzkoa;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QII;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QI;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
20 Gipuzkoa;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
20 Gipuzkoa;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
20 Gipuzkoa;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;98,4
20 Gipuzkoa;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;98,69
20 Gipuzkoa;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;97,65
20 Gipuzkoa;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;96,85
20 Gipuzkoa;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;97,42
20 Gipuzkoa;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;96,57
20 Gipuzkoa;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;95,37
20 Gipuzkoa;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;96,3
20 Gipuzkoa;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;95,15
20 Gipuzkoa;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;93,78
20 Gipuzkoa;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;94,95
20 Gipuzkoa;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;93,85
20 Gipuzkoa;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QI;13.112
20 Gipuzkoa;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QI;12.842
20 Gipuzkoa;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QI;13.151
20 Gipuzkoa;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2022QII;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2022QI;12.915
20 Gipuzkoa;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2021QII;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2021QI;12.689
20 Gipuzkoa;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2020QII;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2020QI;12.846
20 Gipuzkoa;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2022QII;12.740
20 Gipuzkoa;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2022QI;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2021QII;12.535
20 Gipuzkoa;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2021QI;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2020QII;12.727
20 Gipuzkoa;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2020QI;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QIII;12.572
20 Gipuzkoa;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QII;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QI;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QIII;12.393
20 Gipuzkoa;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QII;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QI;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QIII;12.551
20 Gipuzkoa;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QII;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QI;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QIV;12.367
20 Gipuzkoa;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QII;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QI;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QIV;12.234
20 Gipuzkoa;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QII;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QI;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QIV;12.382
20 Gipuzkoa;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QII;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QI;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
20 Gipuzkoa;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
20 Gipuzkoa;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
20 Gipuzkoa;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;98,5
20 Gipuzkoa;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;98,81
20 Gipuzkoa;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;97,68
20 Gipuzkoa;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;97,16
20 Gipuzkoa;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;97,61
20 Gipuzkoa;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;96,78
20 Gipuzkoa;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;95,88
20 Gipuzkoa;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;96,5
20 Gipuzkoa;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;95,44
20 Gipuzkoa;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;94,32
20 Gipuzkoa;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;95,27
20 Gipuzkoa;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;94,15
20 Gipuzkoa;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QI;7.198
20 Gipuzkoa;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QI;6.968
20 Gipuzkoa;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QI;7.111
20 Gipuzkoa;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2022QII;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2022QI;7.071
20 Gipuzkoa;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2021QII;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2021QI;6.861
20 Gipuzkoa;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2020QII;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2020QI;6.940
20 Gipuzkoa;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2022QII;6.931
20 Gipuzkoa;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2022QI;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2021QII;6.764
20 Gipuzkoa;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2021QI;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2020QII;6.840
20 Gipuzkoa;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2020QI;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QIII;6.798
20 Gipuzkoa;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QII;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QI;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QIII;6.685
20 Gipuzkoa;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QII;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QI;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QIII;6.729
20 Gipuzkoa;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QII;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QI;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QIV;6.680
20 Gipuzkoa;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QII;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QI;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QIV;6.576
20 Gipuzkoa;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QII;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QI;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QIV;6.634
20 Gipuzkoa;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QII;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QI;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
20 Gipuzkoa;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
20 Gipuzkoa;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
20 Gipuzkoa;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;98,24
20 Gipuzkoa;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;98,46
20 Gipuzkoa;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;97,6
20 Gipuzkoa;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;96,29
20 Gipuzkoa;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;97,07
20 Gipuzkoa;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;96,19
20 Gipuzkoa;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;94,44
20 Gipuzkoa;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;95,94
20 Gipuzkoa;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;94,63
20 Gipuzkoa;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;92,8
20 Gipuzkoa;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;94,37
20 Gipuzkoa;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;93,29
20 Gipuzkoa;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QII;20.971
20 Gipuzkoa;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QII;20.458
20 Gipuzkoa;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QII;20.130
20 Gipuzkoa;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2022QII;20.631
20 Gipuzkoa;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2022QI;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2021QII;20.192
20 Gipuzkoa;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2021QI;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2020QII;19.900
20 Gipuzkoa;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2020QI;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2022QIII;20.320
20 Gipuzkoa;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2022QII;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2022QI;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2021QIII;19.967
20 Gipuzkoa;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2021QII;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2021QI;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2020QIII;19.559
20 Gipuzkoa;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2020QII;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2020QI;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QIV;19.999
20 Gipuzkoa;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QII;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QI;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QIV;19.695
20 Gipuzkoa;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QII;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QI;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QIV;19.281
20 Gipuzkoa;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QII;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QI;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QII;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QI;19.429
20 Gipuzkoa;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QII;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QI;19.054
20 Gipuzkoa;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QII;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QI;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
20 Gipuzkoa;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
20 Gipuzkoa;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
20 Gipuzkoa;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;98,38
20 Gipuzkoa;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;98,7
20 Gipuzkoa;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;98,86
20 Gipuzkoa;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;96,9
20 Gipuzkoa;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;97,6
20 Gipuzkoa;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;97,16
20 Gipuzkoa;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;95,37
20 Gipuzkoa;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;96,27
20 Gipuzkoa;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;95,78
20 Gipuzkoa;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;94,97
20 Gipuzkoa;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;94,65
20 Gipuzkoa;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QII;13.567
20 Gipuzkoa;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QII;13.224
20 Gipuzkoa;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QII;13.052
20 Gipuzkoa;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2022QII;13.381
20 Gipuzkoa;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2022QI;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2021QII;13.061
20 Gipuzkoa;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2021QI;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2020QII;12.926
20 Gipuzkoa;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2020QI;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2022QIII;13.204
20 Gipuzkoa;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2022QII;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2022QI;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2021QIII;12.916
20 Gipuzkoa;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2021QII;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2021QI;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2020QIII;12.707
20 Gipuzkoa;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2020QII;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2020QI;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QIV;13.002
20 Gipuzkoa;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QII;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QI;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QIV;12.757
20 Gipuzkoa;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QII;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QI;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QIV;12.526
20 Gipuzkoa;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QII;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QI;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QII;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QI;12.597
20 Gipuzkoa;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QII;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QI;12.395
20 Gipuzkoa;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QII;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QI;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
20 Gipuzkoa;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
20 Gipuzkoa;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
20 Gipuzkoa;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;98,63
20 Gipuzkoa;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;98,77
20 Gipuzkoa;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;99,03
20 Gipuzkoa;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;97,32
20 Gipuzkoa;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;97,67
20 Gipuzkoa;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;97,36
20 Gipuzkoa;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;95,84
20 Gipuzkoa;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;96,47
20 Gipuzkoa;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;95,97
20 Gipuzkoa;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;95,26
20 Gipuzkoa;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;94,97
20 Gipuzkoa;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QII;7.404
20 Gipuzkoa;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QII;7.234
20 Gipuzkoa;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QII;7.078
20 Gipuzkoa;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2022QII;7.250
20 Gipuzkoa;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2022QI;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2021QII;7.131
20 Gipuzkoa;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2021QI;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2020QII;6.974
20 Gipuzkoa;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2020QI;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2022QIII;7.116
20 Gipuzkoa;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2022QII;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2022QI;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2021QIII;7.051
20 Gipuzkoa;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2021QII;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2021QI;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2020QIII;6.852
20 Gipuzkoa;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2020QII;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2020QI;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QIV;6.997
20 Gipuzkoa;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QII;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QI;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QIV;6.938
20 Gipuzkoa;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QII;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QI;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QIV;6.755
20 Gipuzkoa;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QII;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QI;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QII;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QI;6.832
20 Gipuzkoa;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QII;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QI;6.659
20 Gipuzkoa;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QII;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QI;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
20 Gipuzkoa;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
20 Gipuzkoa;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
20 Gipuzkoa;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;97,92
20 Gipuzkoa;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;98,58
20 Gipuzkoa;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;98,53
20 Gipuzkoa;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;96,11
20 Gipuzkoa;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;97,47
20 Gipuzkoa;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;96,81
20 Gipuzkoa;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;94,5
20 Gipuzkoa;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;95,91
20 Gipuzkoa;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;95,44
20 Gipuzkoa;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;94,44
20 Gipuzkoa;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;94,08
20 Gipuzkoa;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QIII;20.920
20 Gipuzkoa;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QIII;20.426
20 Gipuzkoa;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QIII;20.073
20 Gipuzkoa;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2022QIII;20.566
20 Gipuzkoa;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2022QII;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2022QI;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2021QIII;20.169
20 Gipuzkoa;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2021QII;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2021QI;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2020QIII;19.705
20 Gipuzkoa;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2020QII;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2020QI;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2022QIV;20.215
20 Gipuzkoa;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2022QII;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2022QI;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2021QIV;19.881
20 Gipuzkoa;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2021QII;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2021QI;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2020QIV;19.416
20 Gipuzkoa;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2020QII;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2020QI;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QII;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QI;19.601
20 Gipuzkoa;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QII;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QI;19.183
20 Gipuzkoa;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QII;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QI;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QII;19.331
20 Gipuzkoa;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QI;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QII;18.954
20 Gipuzkoa;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QI;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QII;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QI;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
20 Gipuzkoa;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
20 Gipuzkoa;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
20 Gipuzkoa;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;98,31
20 Gipuzkoa;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;98,74
20 Gipuzkoa;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;98,17
20 Gipuzkoa;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;96,63
20 Gipuzkoa;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;97,33
20 Gipuzkoa;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;96,73
20 Gipuzkoa;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;95,96
20 Gipuzkoa;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;95,57
20 Gipuzkoa;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;94,64
20 Gipuzkoa;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;94,43
20 Gipuzkoa;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QIII;13.544
20 Gipuzkoa;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QIII;13.209
20 Gipuzkoa;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QIII;13.051
20 Gipuzkoa;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2022QIII;13.339
20 Gipuzkoa;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2022QII;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2022QI;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2021QIII;13.041
20 Gipuzkoa;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2021QII;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2021QI;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2020QIII;12.810
20 Gipuzkoa;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2020QII;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2020QI;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2022QIV;13.115
20 Gipuzkoa;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2022QII;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2022QI;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2021QIV;12.872
20 Gipuzkoa;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2021QII;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2021QI;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2020QIV;12.622
20 Gipuzkoa;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2020QII;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2020QI;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QII;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QI;12.704
20 Gipuzkoa;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QII;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QI;12.488
20 Gipuzkoa;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QII;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QI;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QII;12.542
20 Gipuzkoa;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QI;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QII;12.344
20 Gipuzkoa;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QI;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QII;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QI;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
20 Gipuzkoa;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
20 Gipuzkoa;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
20 Gipuzkoa;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;98,49
20 Gipuzkoa;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;98,73
20 Gipuzkoa;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;98,15
20 Gipuzkoa;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;96,83
20 Gipuzkoa;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;97,45
20 Gipuzkoa;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;96,71
20 Gipuzkoa;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;96,18
20 Gipuzkoa;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;95,69
20 Gipuzkoa;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;94,95
20 Gipuzkoa;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;94,58
20 Gipuzkoa;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QIII;7.376
20 Gipuzkoa;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QIII;7.217
20 Gipuzkoa;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QIII;7.022
20 Gipuzkoa;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2022QIII;7.227
20 Gipuzkoa;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2022QII;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2022QI;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2021QIII;7.128
20 Gipuzkoa;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2021QII;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2021QI;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2020QIII;6.895
20 Gipuzkoa;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2020QII;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2020QI;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2022QIV;7.100
20 Gipuzkoa;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2022QII;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2022QI;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2021QIV;7.009
20 Gipuzkoa;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2021QII;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2021QI;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2020QIV;6.794
20 Gipuzkoa;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2020QII;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2020QI;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QII;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QI;6.897
20 Gipuzkoa;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QII;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QI;6.695
20 Gipuzkoa;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QII;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QI;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QII;6.789
20 Gipuzkoa;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QI;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QII;6.610
20 Gipuzkoa;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QI;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QII;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QI;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
20 Gipuzkoa;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
20 Gipuzkoa;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
20 Gipuzkoa;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;97,98
20 Gipuzkoa;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;98,77
20 Gipuzkoa;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;98,19
20 Gipuzkoa;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;96,26
20 Gipuzkoa;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;97,12
20 Gipuzkoa;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;96,75
20 Gipuzkoa;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;95,57
20 Gipuzkoa;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;95,34
20 Gipuzkoa;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;94,07
20 Gipuzkoa;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;94,13
20 Gipuzkoa;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QIV;20.787
20 Gipuzkoa;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QIV;20.362
20 Gipuzkoa;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QIV;19.906
20 Gipuzkoa;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2022QIV;20.414
20 Gipuzkoa;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2022QII;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2022QI;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2021QIV;20.050
20 Gipuzkoa;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2021QII;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2021QI;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2020QIV;19.591
20 Gipuzkoa;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2020QII;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2020QI;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2022QII;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2022QI;19.764
20 Gipuzkoa;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2021QII;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2021QI;19.352
20 Gipuzkoa;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2020QII;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2020QI;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QII;19.479
20 Gipuzkoa;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QI;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QII;19.116
20 Gipuzkoa;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QI;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QII;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QI;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QIII;19.194
20 Gipuzkoa;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QII;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QI;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QIII;18.912
20 Gipuzkoa;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QII;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QI;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QII;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QI;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
20 Gipuzkoa;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
20 Gipuzkoa;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
20 Gipuzkoa;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;98,21
20 Gipuzkoa;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;98,47
20 Gipuzkoa;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;98,42
20 Gipuzkoa;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;97,06
20 Gipuzkoa;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;97,22
20 Gipuzkoa;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;95,66
20 Gipuzkoa;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;96,03
20 Gipuzkoa;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;94,26
20 Gipuzkoa;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;95,01
20 Gipuzkoa;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QIV;13.460
20 Gipuzkoa;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QIV;13.162
20 Gipuzkoa;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QIV;12.924
20 Gipuzkoa;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2022QIV;13.219
20 Gipuzkoa;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2022QII;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2022QI;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2021QIV;12.975
20 Gipuzkoa;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2021QII;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2021QI;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2020QIV;12.720
20 Gipuzkoa;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2020QII;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2020QI;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2022QII;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2022QI;12.802
20 Gipuzkoa;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2021QII;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2021QI;12.582
20 Gipuzkoa;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2020QII;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2020QI;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QII;12.636
20 Gipuzkoa;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QI;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QII;12.435
20 Gipuzkoa;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QI;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QII;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QI;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QIII;12.477
20 Gipuzkoa;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QII;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QI;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QIII;12.303
20 Gipuzkoa;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QII;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QI;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QII;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QI;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
20 Gipuzkoa;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
20 Gipuzkoa;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
20 Gipuzkoa;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;98,21
20 Gipuzkoa;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;98,58
20 Gipuzkoa;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;98,42
20 Gipuzkoa;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;97,26
20 Gipuzkoa;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;97,35
20 Gipuzkoa;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;96
20 Gipuzkoa;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;96,22
20 Gipuzkoa;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;94,8
20 Gipuzkoa;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;95,19
20 Gipuzkoa;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QIV;7.327
20 Gipuzkoa;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QIV;7.200
20 Gipuzkoa;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QIV;6.982
20 Gipuzkoa;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2022QIV;7.195
20 Gipuzkoa;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2022QII;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2022QI;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2021QIV;7.075
20 Gipuzkoa;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2021QII;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2021QI;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2020QIV;6.871
20 Gipuzkoa;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2020QII;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2020QI;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2022QII;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2022QI;6.962
20 Gipuzkoa;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2021QII;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2021QI;6.770
20 Gipuzkoa;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2020QII;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2020QI;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QII;6.843
20 Gipuzkoa;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QI;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QII;6.681
20 Gipuzkoa;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QI;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QII;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QI;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QIII;6.717
20 Gipuzkoa;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QII;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QI;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QIII;6.609
20 Gipuzkoa;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QII;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QI;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QII;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QI;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
20 Gipuzkoa;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
20 Gipuzkoa;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
20 Gipuzkoa;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;98,2
20 Gipuzkoa;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;98,26
20 Gipuzkoa;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;98,41
20 Gipuzkoa;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;96,69
20 Gipuzkoa;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;96,96
20 Gipuzkoa;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;95,04
20 Gipuzkoa;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;95,69
20 Gipuzkoa;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;93,29
20 Gipuzkoa;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;94,66
20 Gipuzkoa;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QI;8.330
20 Gipuzkoa;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QI;8.006
20 Gipuzkoa;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QI;9.660
20 Gipuzkoa;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2022QII;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2022QI;7.979
20 Gipuzkoa;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2021QII;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2021QI;7.645
20 Gipuzkoa;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2020QII;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2020QI;8.990
20 Gipuzkoa;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2022QII;7.643
20 Gipuzkoa;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2022QI;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2021QII;7.326
20 Gipuzkoa;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2021QI;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2020QII;8.668
20 Gipuzkoa;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2020QI;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QIII;7.282
20 Gipuzkoa;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QII;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QI;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QIII;6.988
20 Gipuzkoa;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QII;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QI;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QIII;8.250
20 Gipuzkoa;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QII;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QI;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QIV;6.697
20 Gipuzkoa;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QII;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QI;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QIV;6.585
20 Gipuzkoa;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QII;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QI;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QIV;7.777
20 Gipuzkoa;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QII;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QI;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
20 Gipuzkoa;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
20 Gipuzkoa;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
20 Gipuzkoa;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;95,79
20 Gipuzkoa;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;95,49
20 Gipuzkoa;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;93,06
20 Gipuzkoa;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;91,75
20 Gipuzkoa;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;91,51
20 Gipuzkoa;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;89,73
20 Gipuzkoa;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;87,42
20 Gipuzkoa;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;87,28
20 Gipuzkoa;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;85,4
20 Gipuzkoa;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;80,4
20 Gipuzkoa;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;82,25
20 Gipuzkoa;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;80,51
20 Gipuzkoa;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QI;5.479
20 Gipuzkoa;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QI;5.265
20 Gipuzkoa;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QI;6.343
20 Gipuzkoa;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2022QII;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2022QI;5.244
20 Gipuzkoa;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2021QII;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2021QI;5.030
20 Gipuzkoa;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2020QII;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2020QI;5.891
20 Gipuzkoa;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2022QII;5.049
20 Gipuzkoa;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2022QI;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2021QII;4.808
20 Gipuzkoa;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2021QI;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2020QII;5.682
20 Gipuzkoa;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2020QI;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QIII;4.822
20 Gipuzkoa;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QII;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QI;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QIII;4.585
20 Gipuzkoa;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QII;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QI;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QIII;5.418
20 Gipuzkoa;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QII;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QI;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QIV;4.439
20 Gipuzkoa;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QII;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QI;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QIV;4.320
20 Gipuzkoa;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QII;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QI;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QIV;5.119
20 Gipuzkoa;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QII;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QI;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
20 Gipuzkoa;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
20 Gipuzkoa;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
20 Gipuzkoa;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;95,71
20 Gipuzkoa;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;95,54
20 Gipuzkoa;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;92,87
20 Gipuzkoa;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;92,15
20 Gipuzkoa;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;91,32
20 Gipuzkoa;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;89,58
20 Gipuzkoa;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;88,01
20 Gipuzkoa;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;87,08
20 Gipuzkoa;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;85,42
20 Gipuzkoa;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;81,02
20 Gipuzkoa;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;82,05
20 Gipuzkoa;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;80,7
20 Gipuzkoa;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QI;2.851
20 Gipuzkoa;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QI;2.741
20 Gipuzkoa;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QI;3.317
20 Gipuzkoa;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2022QII;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2022QI;2.735
20 Gipuzkoa;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2021QII;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2021QI;2.615
20 Gipuzkoa;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2020QII;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2020QI;3.099
20 Gipuzkoa;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2022QII;2.594
20 Gipuzkoa;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2022QI;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2021QII;2.518
20 Gipuzkoa;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2021QI;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2020QII;2.986
20 Gipuzkoa;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2020QI;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QIII;2.460
20 Gipuzkoa;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QII;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QI;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QIII;2.403
20 Gipuzkoa;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QII;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QI;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QIII;2.832
20 Gipuzkoa;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QII;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QI;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QIV;2.258
20 Gipuzkoa;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QII;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QI;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QIV;2.265
20 Gipuzkoa;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QII;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QI;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QIV;2.658
20 Gipuzkoa;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QII;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QI;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
20 Gipuzkoa;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
20 Gipuzkoa;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
20 Gipuzkoa;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;95,93
20 Gipuzkoa;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;95,4
20 Gipuzkoa;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;93,43
20 Gipuzkoa;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;90,99
20 Gipuzkoa;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;91,86
20 Gipuzkoa;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;90,02
20 Gipuzkoa;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;86,29
20 Gipuzkoa;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;87,67
20 Gipuzkoa;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;85,38
20 Gipuzkoa;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;79,2
20 Gipuzkoa;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;82,63
20 Gipuzkoa;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;80,13
20 Gipuzkoa;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QII;9.716
20 Gipuzkoa;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QII;9.346
20 Gipuzkoa;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QII;9.128
20 Gipuzkoa;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2022QII;9.332
20 Gipuzkoa;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2022QI;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2021QII;8.984
20 Gipuzkoa;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2021QI;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2020QII;8.804
20 Gipuzkoa;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2020QI;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2022QIII;8.926
20 Gipuzkoa;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2022QII;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2022QI;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2021QIII;8.609
20 Gipuzkoa;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2021QII;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2021QI;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2020QIII;8.363
20 Gipuzkoa;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2020QII;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2020QI;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QIV;8.283
20 Gipuzkoa;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QII;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QI;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QIV;8.175
20 Gipuzkoa;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QII;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QI;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QIV;7.881
20 Gipuzkoa;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QII;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QI;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QII;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QI;7.839
20 Gipuzkoa;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QII;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QI;7.533
20 Gipuzkoa;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QII;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QI;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
20 Gipuzkoa;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
20 Gipuzkoa;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
20 Gipuzkoa;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;96,05
20 Gipuzkoa;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;96,13
20 Gipuzkoa;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;96,45
20 Gipuzkoa;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;91,87
20 Gipuzkoa;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;92,11
20 Gipuzkoa;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;91,62
20 Gipuzkoa;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;85,25
20 Gipuzkoa;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;87,47
20 Gipuzkoa;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;86,34
20 Gipuzkoa;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;83,88
20 Gipuzkoa;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;82,53
20 Gipuzkoa;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QII;6.367
20 Gipuzkoa;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QII;6.168
20 Gipuzkoa;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QII;5.982
20 Gipuzkoa;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2022QII;6.141
20 Gipuzkoa;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2022QI;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2021QII;5.918
20 Gipuzkoa;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2021QI;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2020QII;5.772
20 Gipuzkoa;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2020QI;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2022QIII;5.887
20 Gipuzkoa;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2022QII;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2022QI;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2021QIII;5.669
20 Gipuzkoa;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2021QII;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2021QI;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2020QIII;5.491
20 Gipuzkoa;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2020QII;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2020QI;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QIV;5.466
20 Gipuzkoa;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QII;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QI;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QIV;5.386
20 Gipuzkoa;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QII;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QI;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QIV;5.190
20 Gipuzkoa;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QII;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QI;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QII;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QI;5.162
20 Gipuzkoa;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QII;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QI;4.963
20 Gipuzkoa;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QII;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QI;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
20 Gipuzkoa;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
20 Gipuzkoa;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
20 Gipuzkoa;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;96,45
20 Gipuzkoa;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;95,95
20 Gipuzkoa;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;96,49
20 Gipuzkoa;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;92,46
20 Gipuzkoa;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;91,91
20 Gipuzkoa;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;91,79
20 Gipuzkoa;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;85,85
20 Gipuzkoa;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;87,32
20 Gipuzkoa;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;86,76
20 Gipuzkoa;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;83,69
20 Gipuzkoa;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;82,97
20 Gipuzkoa;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QII;3.349
20 Gipuzkoa;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QII;3.178
20 Gipuzkoa;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QII;3.146
20 Gipuzkoa;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2022QII;3.191
20 Gipuzkoa;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2022QI;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2021QII;3.066
20 Gipuzkoa;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2021QI;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2020QII;3.032
20 Gipuzkoa;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2020QI;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2022QIII;3.039
20 Gipuzkoa;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2022QII;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2022QI;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2021QIII;2.940
20 Gipuzkoa;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2021QII;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2021QI;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2020QIII;2.872
20 Gipuzkoa;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2020QII;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2020QI;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QIV;2.817
20 Gipuzkoa;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QII;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QI;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QIV;2.789
20 Gipuzkoa;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QII;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QI;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QIV;2.691
20 Gipuzkoa;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QII;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QI;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QII;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QI;2.677
20 Gipuzkoa;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QII;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QI;2.570
20 Gipuzkoa;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QII;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QI;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
20 Gipuzkoa;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
20 Gipuzkoa;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
20 Gipuzkoa;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;95,28
20 Gipuzkoa;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;96,48
20 Gipuzkoa;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;96,38
20 Gipuzkoa;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;90,74
20 Gipuzkoa;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;92,51
20 Gipuzkoa;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;91,29
20 Gipuzkoa;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;84,11
20 Gipuzkoa;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;87,76
20 Gipuzkoa;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;85,54
20 Gipuzkoa;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;84,24
20 Gipuzkoa;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;81,69
20 Gipuzkoa;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QIII;9.393
20 Gipuzkoa;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QIII;9.048
20 Gipuzkoa;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QIII;8.841
20 Gipuzkoa;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2022QIII;8.976
20 Gipuzkoa;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2022QII;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2022QI;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2021QIII;8.668
20 Gipuzkoa;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2021QII;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2021QI;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2020QIII;8.396
20 Gipuzkoa;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2020QII;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2020QI;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2022QIV;8.328
20 Gipuzkoa;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2022QII;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2022QI;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2021QIV;8.230
20 Gipuzkoa;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2021QII;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2021QI;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2020QIV;7.908
20 Gipuzkoa;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2020QII;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2020QI;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QII;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QI;7.890
20 Gipuzkoa;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QII;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QI;7.559
20 Gipuzkoa;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QII;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QI;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QII;7.564
20 Gipuzkoa;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QI;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QII;7.249
20 Gipuzkoa;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QI;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QII;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QI;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
20 Gipuzkoa;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
20 Gipuzkoa;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
20 Gipuzkoa;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;95,56
20 Gipuzkoa;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;95,8
20 Gipuzkoa;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;94,97
20 Gipuzkoa;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;88,66
20 Gipuzkoa;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;90,96
20 Gipuzkoa;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;89,45
20 Gipuzkoa;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;87,2
20 Gipuzkoa;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;85,5
20 Gipuzkoa;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;83,6
20 Gipuzkoa;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;81,99
20 Gipuzkoa;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QIII;6.177
20 Gipuzkoa;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QIII;5.960
20 Gipuzkoa;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QIII;5.793
20 Gipuzkoa;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2022QIII;5.920
20 Gipuzkoa;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2022QII;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2022QI;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2021QIII;5.708
20 Gipuzkoa;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2021QII;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2021QI;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2020QIII;5.510
20 Gipuzkoa;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2020QII;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2020QI;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2022QIV;5.495
20 Gipuzkoa;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2022QII;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2022QI;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2021QIV;5.421
20 Gipuzkoa;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2021QII;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2021QI;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2020QIV;5.206
20 Gipuzkoa;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2020QII;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2020QI;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QII;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QI;5.195
20 Gipuzkoa;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QII;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QI;4.979
20 Gipuzkoa;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QII;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QI;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QII;5.003
20 Gipuzkoa;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QI;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QII;4.762
20 Gipuzkoa;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QI;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QII;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QI;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
20 Gipuzkoa;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
20 Gipuzkoa;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
20 Gipuzkoa;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;95,84
20 Gipuzkoa;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;95,77
20 Gipuzkoa;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;95,11
20 Gipuzkoa;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;88,96
20 Gipuzkoa;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;90,96
20 Gipuzkoa;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;89,87
20 Gipuzkoa;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;87,16
20 Gipuzkoa;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;85,95
20 Gipuzkoa;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;83,94
20 Gipuzkoa;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;82,2
20 Gipuzkoa;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QIII;3.216
20 Gipuzkoa;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QIII;3.088
20 Gipuzkoa;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QIII;3.048
20 Gipuzkoa;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2022QIII;3.056
20 Gipuzkoa;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2022QII;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2022QI;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2021QIII;2.960
20 Gipuzkoa;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2021QII;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2021QI;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2020QIII;2.886
20 Gipuzkoa;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2020QII;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2020QI;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2022QIV;2.833
20 Gipuzkoa;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2022QII;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2022QI;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2021QIV;2.809
20 Gipuzkoa;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2021QII;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2021QI;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2020QIV;2.702
20 Gipuzkoa;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2020QII;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2020QI;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QII;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QI;2.695
20 Gipuzkoa;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QII;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QI;2.580
20 Gipuzkoa;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QII;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QI;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QII;2.561
20 Gipuzkoa;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QI;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QII;2.487
20 Gipuzkoa;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QI;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QII;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QI;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
20 Gipuzkoa;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
20 Gipuzkoa;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
20 Gipuzkoa;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;95,02
20 Gipuzkoa;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;95,85
20 Gipuzkoa;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;94,69
20 Gipuzkoa;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;88,09
20 Gipuzkoa;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;90,97
20 Gipuzkoa;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;88,65
20 Gipuzkoa;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;87,27
20 Gipuzkoa;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;84,65
20 Gipuzkoa;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;82,93
20 Gipuzkoa;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;81,59
20 Gipuzkoa;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QIV;9.008
20 Gipuzkoa;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QIV;8.711
20 Gipuzkoa;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QIV;8.448
20 Gipuzkoa;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2022QIV;8.359
20 Gipuzkoa;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2022QII;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2022QI;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2021QIV;8.268
20 Gipuzkoa;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2021QII;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2021QI;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2020QIV;7.953
20 Gipuzkoa;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2020QII;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2020QI;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2022QII;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2022QI;7.925
20 Gipuzkoa;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2021QII;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2021QI;7.599
20 Gipuzkoa;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2020QII;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2020QI;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QII;7.597
20 Gipuzkoa;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QI;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QII;7.287
20 Gipuzkoa;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QI;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QII;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QI;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QIII;7.238
20 Gipuzkoa;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QII;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QI;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QIII;6.952
20 Gipuzkoa;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QII;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QI;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QII;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QI;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
20 Gipuzkoa;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
20 Gipuzkoa;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
20 Gipuzkoa;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;92,8
20 Gipuzkoa;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;94,91
20 Gipuzkoa;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;94,14
20 Gipuzkoa;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;90,98
20 Gipuzkoa;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;89,95
20 Gipuzkoa;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;87,21
20 Gipuzkoa;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;86,26
20 Gipuzkoa;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;83,09
20 Gipuzkoa;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;82,29
20 Gipuzkoa;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QIV;5.941
20 Gipuzkoa;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QIV;5.739
20 Gipuzkoa;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QIV;5.545
20 Gipuzkoa;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2022QIV;5.515
20 Gipuzkoa;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2022QII;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2022QI;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2021QIV;5.447
20 Gipuzkoa;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2021QII;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2021QI;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2020QIV;5.235
20 Gipuzkoa;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2020QII;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2020QI;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2022QII;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2022QI;5.218
20 Gipuzkoa;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2021QII;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2021QI;5.004
20 Gipuzkoa;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2020QII;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2020QI;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QII;5.025
20 Gipuzkoa;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QI;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QII;4.786
20 Gipuzkoa;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QI;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QII;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QI;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QIII;4.799
20 Gipuzkoa;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QII;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QI;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QIII;4.565
20 Gipuzkoa;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QII;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QI;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QII;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QI;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
20 Gipuzkoa;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
20 Gipuzkoa;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
20 Gipuzkoa;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;92,83
20 Gipuzkoa;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;94,91
20 Gipuzkoa;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;94,41
20 Gipuzkoa;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;90,92
20 Gipuzkoa;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;90,24
20 Gipuzkoa;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;87,56
20 Gipuzkoa;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;86,31
20 Gipuzkoa;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;83,62
20 Gipuzkoa;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;82,33
20 Gipuzkoa;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QIV;3.067
20 Gipuzkoa;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QIV;2.972
20 Gipuzkoa;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QIV;2.903
20 Gipuzkoa;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2022QIV;2.844
20 Gipuzkoa;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2022QII;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2022QI;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2021QIV;2.821
20 Gipuzkoa;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2021QII;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2021QI;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2020QIV;2.718
20 Gipuzkoa;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2020QII;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2020QI;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2022QII;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2022QI;2.707
20 Gipuzkoa;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2021QII;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2021QI;2.595
20 Gipuzkoa;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2020QII;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2020QI;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QII;2.572
20 Gipuzkoa;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QI;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QII;2.501
20 Gipuzkoa;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QI;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QII;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QI;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QIII;2.439
20 Gipuzkoa;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QII;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QI;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QIII;2.387
20 Gipuzkoa;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QII;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QI;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QII;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QI;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
20 Gipuzkoa;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
20 Gipuzkoa;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
20 Gipuzkoa;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;92,73
20 Gipuzkoa;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;94,92
20 Gipuzkoa;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;93,63
20 Gipuzkoa;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;91,08
20 Gipuzkoa;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;89,39
20 Gipuzkoa;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;86,54
20 Gipuzkoa;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;86,15
20 Gipuzkoa;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;82,07
20 Gipuzkoa;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;82,23
20 Gipuzkoa;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
17 Girona;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
17 Girona;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
17 Girona;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
17 Girona;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QI;57.231
17 Girona;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
17 Girona;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
17 Girona;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
17 Girona;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QI;56.071
17 Girona;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
17 Girona;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
17 Girona;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
17 Girona;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QI;56.918
17 Girona;All ages;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
17 Girona;All ages;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
17 Girona;All ages;Cohort January 1;Total;Survival in the first trimester;2022QII;""
17 Girona;All ages;Cohort January 1;Total;Survival in the first trimester;2022QI;55.322
17 Girona;All ages;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
17 Girona;All ages;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
17 Girona;All ages;Cohort January 1;Total;Survival in the first trimester;2021QII;""
17 Girona;All ages;Cohort January 1;Total;Survival in the first trimester;2021QI;54.721
17 Girona;All ages;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
17 Girona;All ages;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
17 Girona;All ages;Cohort January 1;Total;Survival in the first trimester;2020QII;""
17 Girona;All ages;Cohort January 1;Total;Survival in the first trimester;2020QI;53.386
17 Girona;All ages;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
17 Girona;All ages;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
17 Girona;All ages;Cohort January 1;Total;Survival in the second trimester;2022QII;53.695
17 Girona;All ages;Cohort January 1;Total;Survival in the second trimester;2022QI;""
17 Girona;All ages;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
17 Girona;All ages;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
17 Girona;All ages;Cohort January 1;Total;Survival in the second trimester;2021QII;53.333
17 Girona;All ages;Cohort January 1;Total;Survival in the second trimester;2021QI;""
17 Girona;All ages;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
17 Girona;All ages;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
17 Girona;All ages;Cohort January 1;Total;Survival in the second trimester;2020QII;52.244
17 Girona;All ages;Cohort January 1;Total;Survival in the second trimester;2020QI;""
17 Girona;All ages;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
17 Girona;All ages;Cohort January 1;Total;Survival in the third trimester;2022QIII;52.241
17 Girona;All ages;Cohort January 1;Total;Survival in the third trimester;2022QII;""
17 Girona;All ages;Cohort January 1;Total;Survival in the third trimester;2022QI;""
17 Girona;All ages;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
17 Girona;All ages;Cohort January 1;Total;Survival in the third trimester;2021QIII;52.015
17 Girona;All ages;Cohort January 1;Total;Survival in the third trimester;2021QII;""
17 Girona;All ages;Cohort January 1;Total;Survival in the third trimester;2021QI;""
17 Girona;All ages;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
17 Girona;All ages;Cohort January 1;Total;Survival in the third trimester;2020QIII;50.919
17 Girona;All ages;Cohort January 1;Total;Survival in the third trimester;2020QII;""
17 Girona;All ages;Cohort January 1;Total;Survival in the third trimester;2020QI;""
17 Girona;All ages;Cohort January 1;Total;Survival in the third trimester;2022QIV;50.350
17 Girona;All ages;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
17 Girona;All ages;Cohort January 1;Total;Survival in the third trimester;2022QII;""
17 Girona;All ages;Cohort January 1;Total;Survival in the third trimester;2022QI;""
17 Girona;All ages;Cohort January 1;Total;Survival in the third trimester;2021QIV;50.421
17 Girona;All ages;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
17 Girona;All ages;Cohort January 1;Total;Survival in the third trimester;2021QII;""
17 Girona;All ages;Cohort January 1;Total;Survival in the third trimester;2021QI;""
17 Girona;All ages;Cohort January 1;Total;Survival in the third trimester;2020QIV;49.567
17 Girona;All ages;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
17 Girona;All ages;Cohort January 1;Total;Survival in the third trimester;2020QII;""
17 Girona;All ages;Cohort January 1;Total;Survival in the third trimester;2020QI;""
17 Girona;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
17 Girona;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
17 Girona;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
17 Girona;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
17 Girona;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
17 Girona;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
17 Girona;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
17 Girona;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
17 Girona;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
17 Girona;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
17 Girona;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
17 Girona;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
17 Girona;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
17 Girona;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
17 Girona;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
17 Girona;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;96,66
17 Girona;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
17 Girona;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
17 Girona;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
17 Girona;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;97,59
17 Girona;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
17 Girona;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
17 Girona;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
17 Girona;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;93,79
17 Girona;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
17 Girona;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
17 Girona;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;93,82
17 Girona;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
17 Girona;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
17 Girona;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
17 Girona;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;95,12
17 Girona;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
17 Girona;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
17 Girona;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
17 Girona;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;91,79
17 Girona;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
17 Girona;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
17 Girona;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;91,28
17 Girona;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
17 Girona;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
17 Girona;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
17 Girona;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;92,77
17 Girona;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
17 Girona;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
17 Girona;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
17 Girona;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;89,46
17 Girona;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
17 Girona;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
17 Girona;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;87,98
17 Girona;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
17 Girona;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
17 Girona;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
17 Girona;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;89,92
17 Girona;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
17 Girona;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
17 Girona;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
17 Girona;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;87,08
17 Girona;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
17 Girona;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
17 Girona;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
17 Girona;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
17 Girona;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
17 Girona;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
17 Girona;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QI;36.461
17 Girona;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
17 Girona;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
17 Girona;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
17 Girona;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QI;35.863
17 Girona;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
17 Girona;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
17 Girona;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
17 Girona;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QI;36.315
17 Girona;All ages;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
17 Girona;All ages;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
17 Girona;All ages;Cohort January 1;Males;Survival in the first trimester;2022QII;""
17 Girona;All ages;Cohort January 1;Males;Survival in the first trimester;2022QI;35.284
17 Girona;All ages;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
17 Girona;All ages;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
17 Girona;All ages;Cohort January 1;Males;Survival in the first trimester;2021QII;""
17 Girona;All ages;Cohort January 1;Males;Survival in the first trimester;2021QI;34.993
17 Girona;All ages;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
17 Girona;All ages;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
17 Girona;All ages;Cohort January 1;Males;Survival in the first trimester;2020QII;""
17 Girona;All ages;Cohort January 1;Males;Survival in the first trimester;2020QI;34.228
17 Girona;All ages;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
17 Girona;All ages;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
17 Girona;All ages;Cohort January 1;Males;Survival in the second trimester;2022QII;34.340
17 Girona;All ages;Cohort January 1;Males;Survival in the second trimester;2022QI;""
17 Girona;All ages;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
17 Girona;All ages;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
17 Girona;All ages;Cohort January 1;Males;Survival in the second trimester;2021QII;34.137
17 Girona;All ages;Cohort January 1;Males;Survival in the second trimester;2021QI;""
17 Girona;All ages;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
17 Girona;All ages;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
17 Girona;All ages;Cohort January 1;Males;Survival in the second trimester;2020QII;33.556
17 Girona;All ages;Cohort January 1;Males;Survival in the second trimester;2020QI;""
17 Girona;All ages;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
17 Girona;All ages;Cohort January 1;Males;Survival in the third trimester;2022QIII;33.527
17 Girona;All ages;Cohort January 1;Males;Survival in the third trimester;2022QII;""
17 Girona;All ages;Cohort January 1;Males;Survival in the third trimester;2022QI;""
17 Girona;All ages;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
17 Girona;All ages;Cohort January 1;Males;Survival in the third trimester;2021QIII;33.365
17 Girona;All ages;Cohort January 1;Males;Survival in the third trimester;2021QII;""
17 Girona;All ages;Cohort January 1;Males;Survival in the third trimester;2021QI;""
17 Girona;All ages;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
17 Girona;All ages;Cohort January 1;Males;Survival in the third trimester;2020QIII;32.752
17 Girona;All ages;Cohort January 1;Males;Survival in the third trimester;2020QII;""
17 Girona;All ages;Cohort January 1;Males;Survival in the third trimester;2020QI;""
17 Girona;All ages;Cohort January 1;Males;Survival in the third trimester;2022QIV;32.369
17 Girona;All ages;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
17 Girona;All ages;Cohort January 1;Males;Survival in the third trimester;2022QII;""
17 Girona;All ages;Cohort January 1;Males;Survival in the third trimester;2022QI;""
17 Girona;All ages;Cohort January 1;Males;Survival in the third trimester;2021QIV;32.410
17 Girona;All ages;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
17 Girona;All ages;Cohort January 1;Males;Survival in the third trimester;2021QII;""
17 Girona;All ages;Cohort January 1;Males;Survival in the third trimester;2021QI;""
17 Girona;All ages;Cohort January 1;Males;Survival in the third trimester;2020QIV;31.963
17 Girona;All ages;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
17 Girona;All ages;Cohort January 1;Males;Survival in the third trimester;2020QII;""
17 Girona;All ages;Cohort January 1;Males;Survival in the third trimester;2020QI;""
17 Girona;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
17 Girona;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
17 Girona;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
17 Girona;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
17 Girona;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
17 Girona;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
17 Girona;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
17 Girona;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
17 Girona;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
17 Girona;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
17 Girona;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
17 Girona;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
17 Girona;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
17 Girona;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
17 Girona;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
17 Girona;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;96,77
17 Girona;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
17 Girona;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
17 Girona;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
17 Girona;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;97,57
17 Girona;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
17 Girona;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
17 Girona;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
17 Girona;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;94,25
17 Girona;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
17 Girona;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
17 Girona;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;94,18
17 Girona;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
17 Girona;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
17 Girona;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
17 Girona;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;95,19
17 Girona;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
17 Girona;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
17 Girona;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
17 Girona;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;92,4
17 Girona;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
17 Girona;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
17 Girona;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;91,95
17 Girona;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
17 Girona;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
17 Girona;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
17 Girona;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;93,03
17 Girona;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
17 Girona;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
17 Girona;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
17 Girona;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;90,19
17 Girona;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
17 Girona;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
17 Girona;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;88,78
17 Girona;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
17 Girona;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
17 Girona;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
17 Girona;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;90,37
17 Girona;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
17 Girona;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
17 Girona;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
17 Girona;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;88,02
17 Girona;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
17 Girona;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
17 Girona;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
17 Girona;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
17 Girona;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
17 Girona;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
17 Girona;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QI;20.770
17 Girona;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
17 Girona;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
17 Girona;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
17 Girona;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QI;20.208
17 Girona;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
17 Girona;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
17 Girona;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
17 Girona;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QI;20.603
17 Girona;All ages;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
17 Girona;All ages;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
17 Girona;All ages;Cohort January 1;Females;Survival in the first trimester;2022QII;""
17 Girona;All ages;Cohort January 1;Females;Survival in the first trimester;2022QI;20.038
17 Girona;All ages;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
17 Girona;All ages;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
17 Girona;All ages;Cohort January 1;Females;Survival in the first trimester;2021QII;""
17 Girona;All ages;Cohort January 1;Females;Survival in the first trimester;2021QI;19.728
17 Girona;All ages;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
17 Girona;All ages;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
17 Girona;All ages;Cohort January 1;Females;Survival in the first trimester;2020QII;""
17 Girona;All ages;Cohort January 1;Females;Survival in the first trimester;2020QI;19.158
17 Girona;All ages;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
17 Girona;All ages;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
17 Girona;All ages;Cohort January 1;Females;Survival in the second trimester;2022QII;19.355
17 Girona;All ages;Cohort January 1;Females;Survival in the second trimester;2022QI;""
17 Girona;All ages;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
17 Girona;All ages;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
17 Girona;All ages;Cohort January 1;Females;Survival in the second trimester;2021QII;19.196
17 Girona;All ages;Cohort January 1;Females;Survival in the second trimester;2021QI;""
17 Girona;All ages;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
17 Girona;All ages;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
17 Girona;All ages;Cohort January 1;Females;Survival in the second trimester;2020QII;18.688
17 Girona;All ages;Cohort January 1;Females;Survival in the second trimester;2020QI;""
17 Girona;All ages;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
17 Girona;All ages;Cohort January 1;Females;Survival in the third trimester;2022QIII;18.714
17 Girona;All ages;Cohort January 1;Females;Survival in the third trimester;2022QII;""
17 Girona;All ages;Cohort January 1;Females;Survival in the third trimester;2022QI;""
17 Girona;All ages;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
17 Girona;All ages;Cohort January 1;Females;Survival in the third trimester;2021QIII;18.650
17 Girona;All ages;Cohort January 1;Females;Survival in the third trimester;2021QII;""
17 Girona;All ages;Cohort January 1;Females;Survival in the third trimester;2021QI;""
17 Girona;All ages;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
17 Girona;All ages;Cohort January 1;Females;Survival in the third trimester;2020QIII;18.167
17 Girona;All ages;Cohort January 1;Females;Survival in the third trimester;2020QII;""
17 Girona;All ages;Cohort January 1;Females;Survival in the third trimester;2020QI;""
17 Girona;All ages;Cohort January 1;Females;Survival in the third trimester;2022QIV;17.981
17 Girona;All ages;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
17 Girona;All ages;Cohort January 1;Females;Survival in the third trimester;2022QII;""
17 Girona;All ages;Cohort January 1;Females;Survival in the third trimester;2022QI;""
17 Girona;All ages;Cohort January 1;Females;Survival in the third trimester;2021QIV;18.011
17 Girona;All ages;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
17 Girona;All ages;Cohort January 1;Females;Survival in the third trimester;2021QII;""
17 Girona;All ages;Cohort January 1;Females;Survival in the third trimester;2021QI;""
17 Girona;All ages;Cohort January 1;Females;Survival in the third trimester;2020QIV;17.604
17 Girona;All ages;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
17 Girona;All ages;Cohort January 1;Females;Survival in the third trimester;2020QII;""
17 Girona;All ages;Cohort January 1;Females;Survival in the third trimester;2020QI;""
17 Girona;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
17 Girona;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
17 Girona;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
17 Girona;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
17 Girona;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
17 Girona;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
17 Girona;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
17 Girona;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
17 Girona;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
17 Girona;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
17 Girona;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
17 Girona;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
17 Girona;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
17 Girona;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
17 Girona;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
17 Girona;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;96,48
17 Girona;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
17 Girona;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
17 Girona;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
17 Girona;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;97,62
17 Girona;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
17 Girona;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
17 Girona;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
17 Girona;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;92,99
17 Girona;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
17 Girona;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
17 Girona;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;93,19
17 Girona;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
17 Girona;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
17 Girona;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
17 Girona;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;94,99
17 Girona;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
17 Girona;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
17 Girona;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
17 Girona;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;90,71
17 Girona;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
17 Girona;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
17 Girona;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;90,1
17 Girona;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
17 Girona;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
17 Girona;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
17 Girona;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;92,29
17 Girona;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
17 Girona;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
17 Girona;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
17 Girona;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;88,18
17 Girona;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
17 Girona;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
17 Girona;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;86,57
17 Girona;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
17 Girona;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
17 Girona;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
17 Girona;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;89,13
17 Girona;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
17 Girona;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
17 Girona;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
17 Girona;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;85,44
17 Girona;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
17 Girona;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
17 Girona;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
17 Girona;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
17 Girona;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
17 Girona;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QII;57.539
17 Girona;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
17 Girona;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
17 Girona;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
17 Girona;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QII;56.946
17 Girona;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
17 Girona;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
17 Girona;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
17 Girona;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QII;55.574
17 Girona;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
17 Girona;All ages;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
17 Girona;All ages;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
17 Girona;All ages;Cohort April 1;Total;Survival in the first trimester;2022QII;55.720
17 Girona;All ages;Cohort April 1;Total;Survival in the first trimester;2022QI;""
17 Girona;All ages;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
17 Girona;All ages;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
17 Girona;All ages;Cohort April 1;Total;Survival in the first trimester;2021QII;55.369
17 Girona;All ages;Cohort April 1;Total;Survival in the first trimester;2021QI;""
17 Girona;All ages;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
17 Girona;All ages;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
17 Girona;All ages;Cohort April 1;Total;Survival in the first trimester;2020QII;54.328
17 Girona;All ages;Cohort April 1;Total;Survival in the first trimester;2020QI;""
17 Girona;All ages;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
17 Girona;All ages;Cohort April 1;Total;Survival in the second trimester;2022QIII;54.112
17 Girona;All ages;Cohort April 1;Total;Survival in the second trimester;2022QII;""
17 Girona;All ages;Cohort April 1;Total;Survival in the second trimester;2022QI;""
17 Girona;All ages;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
17 Girona;All ages;Cohort April 1;Total;Survival in the second trimester;2021QIII;53.846
17 Girona;All ages;Cohort April 1;Total;Survival in the second trimester;2021QII;""
17 Girona;All ages;Cohort April 1;Total;Survival in the second trimester;2021QI;""
17 Girona;All ages;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
17 Girona;All ages;Cohort April 1;Total;Survival in the second trimester;2020QIII;52.832
17 Girona;All ages;Cohort April 1;Total;Survival in the second trimester;2020QII;""
17 Girona;All ages;Cohort April 1;Total;Survival in the second trimester;2020QI;""
17 Girona;All ages;Cohort April 1;Total;Survival in the third trimester;2022QIV;51.974
17 Girona;All ages;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
17 Girona;All ages;Cohort April 1;Total;Survival in the third trimester;2022QII;""
17 Girona;All ages;Cohort April 1;Total;Survival in the third trimester;2022QI;""
17 Girona;All ages;Cohort April 1;Total;Survival in the third trimester;2021QIV;52.031
17 Girona;All ages;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
17 Girona;All ages;Cohort April 1;Total;Survival in the third trimester;2021QII;""
17 Girona;All ages;Cohort April 1;Total;Survival in the third trimester;2021QI;""
17 Girona;All ages;Cohort April 1;Total;Survival in the third trimester;2020QIV;51.309
17 Girona;All ages;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
17 Girona;All ages;Cohort April 1;Total;Survival in the third trimester;2020QII;""
17 Girona;All ages;Cohort April 1;Total;Survival in the third trimester;2020QI;""
17 Girona;All ages;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
17 Girona;All ages;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
17 Girona;All ages;Cohort April 1;Total;Survival in the third trimester;2022QII;""
17 Girona;All ages;Cohort April 1;Total;Survival in the third trimester;2022QI;50.599
17 Girona;All ages;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
17 Girona;All ages;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
17 Girona;All ages;Cohort April 1;Total;Survival in the third trimester;2021QII;""
17 Girona;All ages;Cohort April 1;Total;Survival in the third trimester;2021QI;50.293
17 Girona;All ages;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
17 Girona;All ages;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
17 Girona;All ages;Cohort April 1;Total;Survival in the third trimester;2020QII;""
17 Girona;All ages;Cohort April 1;Total;Survival in the third trimester;2020QI;""
17 Girona;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
17 Girona;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
17 Girona;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
17 Girona;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
17 Girona;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
17 Girona;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
17 Girona;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
17 Girona;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
17 Girona;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
17 Girona;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
17 Girona;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
17 Girona;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
17 Girona;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
17 Girona;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
17 Girona;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;96,84
17 Girona;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
17 Girona;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
17 Girona;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
17 Girona;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;97,23
17 Girona;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
17 Girona;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
17 Girona;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
17 Girona;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;97,76
17 Girona;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
17 Girona;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
17 Girona;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;94,04
17 Girona;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
17 Girona;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
17 Girona;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
17 Girona;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;94,56
17 Girona;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
17 Girona;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
17 Girona;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
17 Girona;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;95,07
17 Girona;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
17 Girona;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
17 Girona;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;90,33
17 Girona;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
17 Girona;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
17 Girona;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
17 Girona;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;91,37
17 Girona;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
17 Girona;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
17 Girona;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
17 Girona;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;92,33
17 Girona;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
17 Girona;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
17 Girona;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
17 Girona;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
17 Girona;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
17 Girona;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
17 Girona;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;88,85
17 Girona;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
17 Girona;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
17 Girona;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
17 Girona;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;90,5
17 Girona;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
17 Girona;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
17 Girona;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
17 Girona;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
17 Girona;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
17 Girona;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
17 Girona;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QII;36.609
17 Girona;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
17 Girona;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
17 Girona;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
17 Girona;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QII;36.296
17 Girona;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
17 Girona;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
17 Girona;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
17 Girona;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QII;35.564
17 Girona;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
17 Girona;All ages;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
17 Girona;All ages;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
17 Girona;All ages;Cohort April 1;Males;Survival in the first trimester;2022QII;35.545
17 Girona;All ages;Cohort April 1;Males;Survival in the first trimester;2022QI;""
17 Girona;All ages;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
17 Girona;All ages;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
17 Girona;All ages;Cohort April 1;Males;Survival in the first trimester;2021QII;35.333
17 Girona;All ages;Cohort April 1;Males;Survival in the first trimester;2021QI;""
17 Girona;All ages;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
17 Girona;All ages;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
17 Girona;All ages;Cohort April 1;Males;Survival in the first trimester;2020QII;34.827
17 Girona;All ages;Cohort April 1;Males;Survival in the first trimester;2020QI;""
17 Girona;All ages;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
17 Girona;All ages;Cohort April 1;Males;Survival in the second trimester;2022QIII;34.629
17 Girona;All ages;Cohort April 1;Males;Survival in the second trimester;2022QII;""
17 Girona;All ages;Cohort April 1;Males;Survival in the second trimester;2022QI;""
17 Girona;All ages;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
17 Girona;All ages;Cohort April 1;Males;Survival in the second trimester;2021QIII;34.433
17 Girona;All ages;Cohort April 1;Males;Survival in the second trimester;2021QII;""
17 Girona;All ages;Cohort April 1;Males;Survival in the second trimester;2021QI;""
17 Girona;All ages;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
17 Girona;All ages;Cohort April 1;Males;Survival in the second trimester;2020QIII;33.919
17 Girona;All ages;Cohort April 1;Males;Survival in the second trimester;2020QII;""
17 Girona;All ages;Cohort April 1;Males;Survival in the second trimester;2020QI;""
17 Girona;All ages;Cohort April 1;Males;Survival in the third trimester;2022QIV;33.345
17 Girona;All ages;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
17 Girona;All ages;Cohort April 1;Males;Survival in the third trimester;2022QII;""
17 Girona;All ages;Cohort April 1;Males;Survival in the third trimester;2022QI;""
17 Girona;All ages;Cohort April 1;Males;Survival in the third trimester;2021QIV;33.369
17 Girona;All ages;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
17 Girona;All ages;Cohort April 1;Males;Survival in the third trimester;2021QII;""
17 Girona;All ages;Cohort April 1;Males;Survival in the third trimester;2021QI;""
17 Girona;All ages;Cohort April 1;Males;Survival in the third trimester;2020QIV;33.023
17 Girona;All ages;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
17 Girona;All ages;Cohort April 1;Males;Survival in the third trimester;2020QII;""
17 Girona;All ages;Cohort April 1;Males;Survival in the third trimester;2020QI;""
17 Girona;All ages;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
17 Girona;All ages;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
17 Girona;All ages;Cohort April 1;Males;Survival in the third trimester;2022QII;""
17 Girona;All ages;Cohort April 1;Males;Survival in the third trimester;2022QI;32.491
17 Girona;All ages;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
17 Girona;All ages;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
17 Girona;All ages;Cohort April 1;Males;Survival in the third trimester;2021QII;""
17 Girona;All ages;Cohort April 1;Males;Survival in the third trimester;2021QI;32.354
17 Girona;All ages;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
17 Girona;All ages;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
17 Girona;All ages;Cohort April 1;Males;Survival in the third trimester;2020QII;""
17 Girona;All ages;Cohort April 1;Males;Survival in the third trimester;2020QI;""
17 Girona;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
17 Girona;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
17 Girona;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
17 Girona;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
17 Girona;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
17 Girona;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
17 Girona;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
17 Girona;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
17 Girona;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
17 Girona;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
17 Girona;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
17 Girona;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
17 Girona;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
17 Girona;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
17 Girona;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;97,09
17 Girona;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
17 Girona;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
17 Girona;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
17 Girona;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;97,35
17 Girona;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
17 Girona;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
17 Girona;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
17 Girona;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;97,93
17 Girona;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
17 Girona;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
17 Girona;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;94,59
17 Girona;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
17 Girona;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
17 Girona;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
17 Girona;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;94,87
17 Girona;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
17 Girona;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
17 Girona;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
17 Girona;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;95,37
17 Girona;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
17 Girona;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
17 Girona;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;91,08
17 Girona;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
17 Girona;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
17 Girona;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
17 Girona;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;91,94
17 Girona;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
17 Girona;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
17 Girona;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
17 Girona;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;92,86
17 Girona;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
17 Girona;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
17 Girona;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
17 Girona;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
17 Girona;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
17 Girona;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
17 Girona;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;89,52
17 Girona;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
17 Girona;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
17 Girona;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
17 Girona;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;90,97
17 Girona;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
17 Girona;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
17 Girona;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
17 Girona;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
17 Girona;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
17 Girona;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
17 Girona;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QII;20.930
17 Girona;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
17 Girona;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
17 Girona;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
17 Girona;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QII;20.650
17 Girona;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
17 Girona;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
17 Girona;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
17 Girona;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QII;20.010
17 Girona;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
17 Girona;All ages;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
17 Girona;All ages;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
17 Girona;All ages;Cohort April 1;Females;Survival in the first trimester;2022QII;20.175
17 Girona;All ages;Cohort April 1;Females;Survival in the first trimester;2022QI;""
17 Girona;All ages;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
17 Girona;All ages;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
17 Girona;All ages;Cohort April 1;Females;Survival in the first trimester;2021QII;20.036
17 Girona;All ages;Cohort April 1;Females;Survival in the first trimester;2021QI;""
17 Girona;All ages;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
17 Girona;All ages;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
17 Girona;All ages;Cohort April 1;Females;Survival in the first trimester;2020QII;19.501
17 Girona;All ages;Cohort April 1;Females;Survival in the first trimester;2020QI;""
17 Girona;All ages;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
17 Girona;All ages;Cohort April 1;Females;Survival in the second trimester;2022QIII;19.483
17 Girona;All ages;Cohort April 1;Females;Survival in the second trimester;2022QII;""
17 Girona;All ages;Cohort April 1;Females;Survival in the second trimester;2022QI;""
17 Girona;All ages;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
17 Girona;All ages;Cohort April 1;Females;Survival in the second trimester;2021QIII;19.413
17 Girona;All ages;Cohort April 1;Females;Survival in the second trimester;2021QII;""
17 Girona;All ages;Cohort April 1;Females;Survival in the second trimester;2021QI;""
17 Girona;All ages;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
17 Girona;All ages;Cohort April 1;Females;Survival in the second trimester;2020QIII;18.913
17 Girona;All ages;Cohort April 1;Females;Survival in the second trimester;2020QII;""
17 Girona;All ages;Cohort April 1;Females;Survival in the second trimester;2020QI;""
17 Girona;All ages;Cohort April 1;Females;Survival in the third trimester;2022QIV;18.629
17 Girona;All ages;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
17 Girona;All ages;Cohort April 1;Females;Survival in the third trimester;2022QII;""
17 Girona;All ages;Cohort April 1;Females;Survival in the third trimester;2022QI;""
17 Girona;All ages;Cohort April 1;Females;Survival in the third trimester;2021QIV;18.662
17 Girona;All ages;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
17 Girona;All ages;Cohort April 1;Females;Survival in the third trimester;2021QII;""
17 Girona;All ages;Cohort April 1;Females;Survival in the third trimester;2021QI;""
17 Girona;All ages;Cohort April 1;Females;Survival in the third trimester;2020QIV;18.286
17 Girona;All ages;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
17 Girona;All ages;Cohort April 1;Females;Survival in the third trimester;2020QII;""
17 Girona;All ages;Cohort April 1;Females;Survival in the third trimester;2020QI;""
17 Girona;All ages;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
17 Girona;All ages;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
17 Girona;All ages;Cohort April 1;Females;Survival in the third trimester;2022QII;""
17 Girona;All ages;Cohort April 1;Females;Survival in the third trimester;2022QI;18.108
17 Girona;All ages;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
17 Girona;All ages;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
17 Girona;All ages;Cohort April 1;Females;Survival in the third trimester;2021QII;""
17 Girona;All ages;Cohort April 1;Females;Survival in the third trimester;2021QI;17.939
17 Girona;All ages;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
17 Girona;All ages;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
17 Girona;All ages;Cohort April 1;Females;Survival in the third trimester;2020QII;""
17 Girona;All ages;Cohort April 1;Females;Survival in the third trimester;2020QI;""
17 Girona;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
17 Girona;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
17 Girona;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
17 Girona;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
17 Girona;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
17 Girona;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
17 Girona;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
17 Girona;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
17 Girona;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
17 Girona;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
17 Girona;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
17 Girona;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
17 Girona;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
17 Girona;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
17 Girona;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;96,39
17 Girona;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
17 Girona;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
17 Girona;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
17 Girona;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;97,03
17 Girona;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
17 Girona;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
17 Girona;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
17 Girona;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;97,46
17 Girona;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
17 Girona;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
17 Girona;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;93,09
17 Girona;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
17 Girona;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
17 Girona;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
17 Girona;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;94,01
17 Girona;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
17 Girona;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
17 Girona;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
17 Girona;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;94,52
17 Girona;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
17 Girona;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
17 Girona;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;89,01
17 Girona;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
17 Girona;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
17 Girona;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
17 Girona;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;90,37
17 Girona;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
17 Girona;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
17 Girona;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
17 Girona;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;91,38
17 Girona;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
17 Girona;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
17 Girona;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
17 Girona;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
17 Girona;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
17 Girona;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
17 Girona;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;87,69
17 Girona;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
17 Girona;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
17 Girona;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
17 Girona;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;89,65
17 Girona;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
17 Girona;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
17 Girona;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
17 Girona;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
17 Girona;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
17 Girona;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QIII;58.808
17 Girona;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
17 Girona;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
17 Girona;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
17 Girona;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QIII;58.427
17 Girona;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
17 Girona;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
17 Girona;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
17 Girona;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QIII;56.406
17 Girona;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
17 Girona;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
17 Girona;All ages;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
17 Girona;All ages;Cohort July 1;Total;Survival in the first trimester;2022QIII;56.485
17 Girona;All ages;Cohort July 1;Total;Survival in the first trimester;2022QII;""
17 Girona;All ages;Cohort July 1;Total;Survival in the first trimester;2022QI;""
17 Girona;All ages;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
17 Girona;All ages;Cohort July 1;Total;Survival in the first trimester;2021QIII;56.208
17 Girona;All ages;Cohort July 1;Total;Survival in the first trimester;2021QII;""
17 Girona;All ages;Cohort July 1;Total;Survival in the first trimester;2021QI;""
17 Girona;All ages;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
17 Girona;All ages;Cohort July 1;Total;Survival in the first trimester;2020QIII;54.375
17 Girona;All ages;Cohort July 1;Total;Survival in the first trimester;2020QII;""
17 Girona;All ages;Cohort July 1;Total;Survival in the first trimester;2020QI;""
17 Girona;All ages;Cohort July 1;Total;Survival in the second trimester;2022QIV;53.706
17 Girona;All ages;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
17 Girona;All ages;Cohort July 1;Total;Survival in the second trimester;2022QII;""
17 Girona;All ages;Cohort July 1;Total;Survival in the second trimester;2022QI;""
17 Girona;All ages;Cohort July 1;Total;Survival in the second trimester;2021QIV;53.859
17 Girona;All ages;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
17 Girona;All ages;Cohort July 1;Total;Survival in the second trimester;2021QII;""
17 Girona;All ages;Cohort July 1;Total;Survival in the second trimester;2021QI;""
17 Girona;All ages;Cohort July 1;Total;Survival in the second trimester;2020QIV;52.567
17 Girona;All ages;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
17 Girona;All ages;Cohort July 1;Total;Survival in the second trimester;2020QII;""
17 Girona;All ages;Cohort July 1;Total;Survival in the second trimester;2020QI;""
17 Girona;All ages;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
17 Girona;All ages;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
17 Girona;All ages;Cohort July 1;Total;Survival in the third trimester;2022QII;""
17 Girona;All ages;Cohort July 1;Total;Survival in the third trimester;2022QI;52.290
17 Girona;All ages;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
17 Girona;All ages;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
17 Girona;All ages;Cohort July 1;Total;Survival in the third trimester;2021QII;""
17 Girona;All ages;Cohort July 1;Total;Survival in the third trimester;2021QI;51.482
17 Girona;All ages;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
17 Girona;All ages;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
17 Girona;All ages;Cohort July 1;Total;Survival in the third trimester;2020QII;""
17 Girona;All ages;Cohort July 1;Total;Survival in the third trimester;2020QI;""
17 Girona;All ages;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
17 Girona;All ages;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
17 Girona;All ages;Cohort July 1;Total;Survival in the third trimester;2022QII;50.947
17 Girona;All ages;Cohort July 1;Total;Survival in the third trimester;2022QI;""
17 Girona;All ages;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
17 Girona;All ages;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
17 Girona;All ages;Cohort July 1;Total;Survival in the third trimester;2021QII;50.387
17 Girona;All ages;Cohort July 1;Total;Survival in the third trimester;2021QI;""
17 Girona;All ages;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
17 Girona;All ages;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
17 Girona;All ages;Cohort July 1;Total;Survival in the third trimester;2020QII;""
17 Girona;All ages;Cohort July 1;Total;Survival in the third trimester;2020QI;""
17 Girona;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
17 Girona;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
17 Girona;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
17 Girona;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
17 Girona;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
17 Girona;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
17 Girona;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
17 Girona;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
17 Girona;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
17 Girona;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
17 Girona;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
17 Girona;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
17 Girona;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
17 Girona;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;96,05
17 Girona;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
17 Girona;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
17 Girona;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
17 Girona;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;96,2
17 Girona;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
17 Girona;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
17 Girona;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
17 Girona;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;96,4
17 Girona;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
17 Girona;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
17 Girona;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;91,32
17 Girona;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
17 Girona;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
17 Girona;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
17 Girona;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;92,18
17 Girona;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
17 Girona;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
17 Girona;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
17 Girona;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;93,19
17 Girona;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
17 Girona;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
17 Girona;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
17 Girona;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
17 Girona;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
17 Girona;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
17 Girona;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;89,5
17 Girona;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
17 Girona;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
17 Girona;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
17 Girona;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;91,27
17 Girona;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
17 Girona;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
17 Girona;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
17 Girona;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
17 Girona;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
17 Girona;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
17 Girona;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;87,2
17 Girona;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
17 Girona;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
17 Girona;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
17 Girona;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;89,33
17 Girona;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
17 Girona;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
17 Girona;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
17 Girona;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
17 Girona;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
17 Girona;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
17 Girona;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QIII;37.295
17 Girona;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
17 Girona;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
17 Girona;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
17 Girona;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QIII;37.103
17 Girona;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
17 Girona;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
17 Girona;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
17 Girona;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QIII;36.064
17 Girona;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
17 Girona;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
17 Girona;All ages;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
17 Girona;All ages;Cohort July 1;Males;Survival in the first trimester;2022QIII;35.992
17 Girona;All ages;Cohort July 1;Males;Survival in the first trimester;2022QII;""
17 Girona;All ages;Cohort July 1;Males;Survival in the first trimester;2022QI;""
17 Girona;All ages;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
17 Girona;All ages;Cohort July 1;Males;Survival in the first trimester;2021QIII;35.824
17 Girona;All ages;Cohort July 1;Males;Survival in the first trimester;2021QII;""
17 Girona;All ages;Cohort July 1;Males;Survival in the first trimester;2021QI;""
17 Girona;All ages;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
17 Girona;All ages;Cohort July 1;Males;Survival in the first trimester;2020QIII;34.869
17 Girona;All ages;Cohort July 1;Males;Survival in the first trimester;2020QII;""
17 Girona;All ages;Cohort July 1;Males;Survival in the first trimester;2020QI;""
17 Girona;All ages;Cohort July 1;Males;Survival in the second trimester;2022QIV;34.359
17 Girona;All ages;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
17 Girona;All ages;Cohort July 1;Males;Survival in the second trimester;2022QII;""
17 Girona;All ages;Cohort July 1;Males;Survival in the second trimester;2022QI;""
17 Girona;All ages;Cohort July 1;Males;Survival in the second trimester;2021QIV;34.468
17 Girona;All ages;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
17 Girona;All ages;Cohort July 1;Males;Survival in the second trimester;2021QII;""
17 Girona;All ages;Cohort July 1;Males;Survival in the second trimester;2021QI;""
17 Girona;All ages;Cohort July 1;Males;Survival in the second trimester;2020QIV;33.821
17 Girona;All ages;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
17 Girona;All ages;Cohort July 1;Males;Survival in the second trimester;2020QII;""
17 Girona;All ages;Cohort July 1;Males;Survival in the second trimester;2020QI;""
17 Girona;All ages;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
17 Girona;All ages;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
17 Girona;All ages;Cohort July 1;Males;Survival in the third trimester;2022QII;""
17 Girona;All ages;Cohort July 1;Males;Survival in the third trimester;2022QI;33.497
17 Girona;All ages;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
17 Girona;All ages;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
17 Girona;All ages;Cohort July 1;Males;Survival in the third trimester;2021QII;""
17 Girona;All ages;Cohort July 1;Males;Survival in the third trimester;2021QI;33.105
17 Girona;All ages;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
17 Girona;All ages;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
17 Girona;All ages;Cohort July 1;Males;Survival in the third trimester;2020QII;""
17 Girona;All ages;Cohort July 1;Males;Survival in the third trimester;2020QI;""
17 Girona;All ages;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
17 Girona;All ages;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
17 Girona;All ages;Cohort July 1;Males;Survival in the third trimester;2022QII;32.703
17 Girona;All ages;Cohort July 1;Males;Survival in the third trimester;2022QI;""
17 Girona;All ages;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
17 Girona;All ages;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
17 Girona;All ages;Cohort July 1;Males;Survival in the third trimester;2021QII;32.416
17 Girona;All ages;Cohort July 1;Males;Survival in the third trimester;2021QI;""
17 Girona;All ages;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
17 Girona;All ages;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
17 Girona;All ages;Cohort July 1;Males;Survival in the third trimester;2020QII;""
17 Girona;All ages;Cohort July 1;Males;Survival in the third trimester;2020QI;""
17 Girona;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
17 Girona;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
17 Girona;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
17 Girona;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
17 Girona;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
17 Girona;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
17 Girona;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
17 Girona;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
17 Girona;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
17 Girona;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
17 Girona;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
17 Girona;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
17 Girona;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
17 Girona;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;96,51
17 Girona;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
17 Girona;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
17 Girona;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
17 Girona;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;96,55
17 Girona;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
17 Girona;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
17 Girona;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
17 Girona;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;96,69
17 Girona;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
17 Girona;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
17 Girona;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;92,13
17 Girona;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
17 Girona;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
17 Girona;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
17 Girona;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;92,9
17 Girona;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
17 Girona;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
17 Girona;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
17 Girona;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;93,78
17 Girona;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
17 Girona;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
17 Girona;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
17 Girona;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
17 Girona;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
17 Girona;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
17 Girona;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;90,28
17 Girona;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
17 Girona;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
17 Girona;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
17 Girona;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;91,8
17 Girona;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
17 Girona;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
17 Girona;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
17 Girona;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
17 Girona;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
17 Girona;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
17 Girona;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;88,14
17 Girona;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
17 Girona;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
17 Girona;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
17 Girona;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;89,88
17 Girona;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
17 Girona;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
17 Girona;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
17 Girona;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
17 Girona;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
17 Girona;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
17 Girona;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QIII;21.513
17 Girona;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
17 Girona;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
17 Girona;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
17 Girona;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QIII;21.324
17 Girona;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
17 Girona;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
17 Girona;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
17 Girona;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QIII;20.342
17 Girona;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
17 Girona;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
17 Girona;All ages;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
17 Girona;All ages;Cohort July 1;Females;Survival in the first trimester;2022QIII;20.493
17 Girona;All ages;Cohort July 1;Females;Survival in the first trimester;2022QII;""
17 Girona;All ages;Cohort July 1;Females;Survival in the first trimester;2022QI;""
17 Girona;All ages;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
17 Girona;All ages;Cohort July 1;Females;Survival in the first trimester;2021QIII;20.384
17 Girona;All ages;Cohort July 1;Females;Survival in the first trimester;2021QII;""
17 Girona;All ages;Cohort July 1;Females;Survival in the first trimester;2021QI;""
17 Girona;All ages;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
17 Girona;All ages;Cohort July 1;Females;Survival in the first trimester;2020QIII;19.506
17 Girona;All ages;Cohort July 1;Females;Survival in the first trimester;2020QII;""
17 Girona;All ages;Cohort July 1;Females;Survival in the first trimester;2020QI;""
17 Girona;All ages;Cohort July 1;Females;Survival in the second trimester;2022QIV;19.347
17 Girona;All ages;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
17 Girona;All ages;Cohort July 1;Females;Survival in the second trimester;2022QII;""
17 Girona;All ages;Cohort July 1;Females;Survival in the second trimester;2022QI;""
17 Girona;All ages;Cohort July 1;Females;Survival in the second trimester;2021QIV;19.391
17 Girona;All ages;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
17 Girona;All ages;Cohort July 1;Females;Survival in the second trimester;2021QII;""
17 Girona;All ages;Cohort July 1;Females;Survival in the second trimester;2021QI;""
17 Girona;All ages;Cohort July 1;Females;Survival in the second trimester;2020QIV;18.746
17 Girona;All ages;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
17 Girona;All ages;Cohort July 1;Females;Survival in the second trimester;2020QII;""
17 Girona;All ages;Cohort July 1;Females;Survival in the second trimester;2020QI;""
17 Girona;All ages;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
17 Girona;All ages;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
17 Girona;All ages;Cohort July 1;Females;Survival in the third trimester;2022QII;""
17 Girona;All ages;Cohort July 1;Females;Survival in the third trimester;2022QI;18.793
17 Girona;All ages;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
17 Girona;All ages;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
17 Girona;All ages;Cohort July 1;Females;Survival in the third trimester;2021QII;""
17 Girona;All ages;Cohort July 1;Females;Survival in the third trimester;2021QI;18.377
17 Girona;All ages;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
17 Girona;All ages;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
17 Girona;All ages;Cohort July 1;Females;Survival in the third trimester;2020QII;""
17 Girona;All ages;Cohort July 1;Females;Survival in the third trimester;2020QI;""
17 Girona;All ages;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
17 Girona;All ages;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
17 Girona;All ages;Cohort July 1;Females;Survival in the third trimester;2022QII;18.244
17 Girona;All ages;Cohort July 1;Females;Survival in the third trimester;2022QI;""
17 Girona;All ages;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
17 Girona;All ages;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
17 Girona;All ages;Cohort July 1;Females;Survival in the third trimester;2021QII;17.971
17 Girona;All ages;Cohort July 1;Females;Survival in the third trimester;2021QI;""
17 Girona;All ages;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
17 Girona;All ages;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
17 Girona;All ages;Cohort July 1;Females;Survival in the third trimester;2020QII;""
17 Girona;All ages;Cohort July 1;Females;Survival in the third trimester;2020QI;""
17 Girona;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
17 Girona;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
17 Girona;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
17 Girona;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
17 Girona;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
17 Girona;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
17 Girona;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
17 Girona;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
17 Girona;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
17 Girona;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
17 Girona;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
17 Girona;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
17 Girona;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
17 Girona;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;95,26
17 Girona;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
17 Girona;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
17 Girona;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
17 Girona;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;95,59
17 Girona;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
17 Girona;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
17 Girona;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
17 Girona;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;95,89
17 Girona;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
17 Girona;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
17 Girona;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;89,93
17 Girona;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
17 Girona;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
17 Girona;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
17 Girona;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;90,94
17 Girona;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
17 Girona;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
17 Girona;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
17 Girona;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;92,15
17 Girona;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
17 Girona;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
17 Girona;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
17 Girona;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
17 Girona;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
17 Girona;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
17 Girona;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;88,13
17 Girona;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
17 Girona;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
17 Girona;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
17 Girona;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;90,34
17 Girona;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
17 Girona;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
17 Girona;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
17 Girona;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
17 Girona;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
17 Girona;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
17 Girona;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;85,56
17 Girona;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
17 Girona;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
17 Girona;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
17 Girona;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;88,34
17 Girona;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
17 Girona;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
17 Girona;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
17 Girona;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
17 Girona;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
17 Girona;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QIV;58.139
17 Girona;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
17 Girona;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
17 Girona;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
17 Girona;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QIV;57.884
17 Girona;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
17 Girona;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
17 Girona;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
17 Girona;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QIV;56.410
17 Girona;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
17 Girona;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
17 Girona;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
17 Girona;All ages;Cohort October 1;Total;Survival in the first trimester;2022QIV;55.136
17 Girona;All ages;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
17 Girona;All ages;Cohort October 1;Total;Survival in the first trimester;2022QII;""
17 Girona;All ages;Cohort October 1;Total;Survival in the first trimester;2022QI;""
17 Girona;All ages;Cohort October 1;Total;Survival in the first trimester;2021QIV;55.319
17 Girona;All ages;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
17 Girona;All ages;Cohort October 1;Total;Survival in the first trimester;2021QII;""
17 Girona;All ages;Cohort October 1;Total;Survival in the first trimester;2021QI;""
17 Girona;All ages;Cohort October 1;Total;Survival in the first trimester;2020QIV;54.259
17 Girona;All ages;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
17 Girona;All ages;Cohort October 1;Total;Survival in the first trimester;2020QII;""
17 Girona;All ages;Cohort October 1;Total;Survival in the first trimester;2020QI;""
17 Girona;All ages;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
17 Girona;All ages;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
17 Girona;All ages;Cohort October 1;Total;Survival in the second trimester;2022QII;""
17 Girona;All ages;Cohort October 1;Total;Survival in the second trimester;2022QI;53.629
17 Girona;All ages;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
17 Girona;All ages;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
17 Girona;All ages;Cohort October 1;Total;Survival in the second trimester;2021QII;""
17 Girona;All ages;Cohort October 1;Total;Survival in the second trimester;2021QI;53.072
17 Girona;All ages;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
17 Girona;All ages;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
17 Girona;All ages;Cohort October 1;Total;Survival in the second trimester;2020QII;""
17 Girona;All ages;Cohort October 1;Total;Survival in the second trimester;2020QI;""
17 Girona;All ages;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
17 Girona;All ages;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
17 Girona;All ages;Cohort October 1;Total;Survival in the third trimester;2022QII;52.176
17 Girona;All ages;Cohort October 1;Total;Survival in the third trimester;2022QI;""
17 Girona;All ages;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
17 Girona;All ages;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
17 Girona;All ages;Cohort October 1;Total;Survival in the third trimester;2021QII;51.856
17 Girona;All ages;Cohort October 1;Total;Survival in the third trimester;2021QI;""
17 Girona;All ages;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
17 Girona;All ages;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
17 Girona;All ages;Cohort October 1;Total;Survival in the third trimester;2020QII;""
17 Girona;All ages;Cohort October 1;Total;Survival in the third trimester;2020QI;""
17 Girona;All ages;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
17 Girona;All ages;Cohort October 1;Total;Survival in the third trimester;2022QIII;50.825
17 Girona;All ages;Cohort October 1;Total;Survival in the third trimester;2022QII;""
17 Girona;All ages;Cohort October 1;Total;Survival in the third trimester;2022QI;""
17 Girona;All ages;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
17 Girona;All ages;Cohort October 1;Total;Survival in the third trimester;2021QIII;50.653
17 Girona;All ages;Cohort October 1;Total;Survival in the third trimester;2021QII;""
17 Girona;All ages;Cohort October 1;Total;Survival in the third trimester;2021QI;""
17 Girona;All ages;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
17 Girona;All ages;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
17 Girona;All ages;Cohort October 1;Total;Survival in the third trimester;2020QII;""
17 Girona;All ages;Cohort October 1;Total;Survival in the third trimester;2020QI;""
17 Girona;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
17 Girona;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
17 Girona;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
17 Girona;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
17 Girona;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
17 Girona;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
17 Girona;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
17 Girona;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
17 Girona;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
17 Girona;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
17 Girona;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
17 Girona;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
17 Girona;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;94,83
17 Girona;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
17 Girona;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
17 Girona;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
17 Girona;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;95,57
17 Girona;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
17 Girona;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
17 Girona;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
17 Girona;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;96,19
17 Girona;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
17 Girona;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
17 Girona;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
17 Girona;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
17 Girona;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
17 Girona;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
17 Girona;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;92,65
17 Girona;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
17 Girona;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
17 Girona;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
17 Girona;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;94,08
17 Girona;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
17 Girona;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
17 Girona;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
17 Girona;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
17 Girona;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
17 Girona;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
17 Girona;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;90,14
17 Girona;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
17 Girona;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
17 Girona;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
17 Girona;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;91,93
17 Girona;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
17 Girona;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
17 Girona;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
17 Girona;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
17 Girona;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
17 Girona;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
17 Girona;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;87,8
17 Girona;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
17 Girona;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
17 Girona;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
17 Girona;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;89,79
17 Girona;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
17 Girona;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
17 Girona;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
17 Girona;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
17 Girona;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
17 Girona;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
17 Girona;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QIV;36.962
17 Girona;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
17 Girona;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
17 Girona;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
17 Girona;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QIV;36.847
17 Girona;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
17 Girona;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
17 Girona;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
17 Girona;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QIV;36.031
17 Girona;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
17 Girona;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
17 Girona;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
17 Girona;All ages;Cohort October 1;Males;Survival in the first trimester;2022QIV;35.196
17 Girona;All ages;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
17 Girona;All ages;Cohort October 1;Males;Survival in the first trimester;2022QII;""
17 Girona;All ages;Cohort October 1;Males;Survival in the first trimester;2022QI;""
17 Girona;All ages;Cohort October 1;Males;Survival in the first trimester;2021QIV;35.357
17 Girona;All ages;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
17 Girona;All ages;Cohort October 1;Males;Survival in the first trimester;2021QII;""
17 Girona;All ages;Cohort October 1;Males;Survival in the first trimester;2021QI;""
17 Girona;All ages;Cohort October 1;Males;Survival in the first trimester;2020QIV;34.789
17 Girona;All ages;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
17 Girona;All ages;Cohort October 1;Males;Survival in the first trimester;2020QII;""
17 Girona;All ages;Cohort October 1;Males;Survival in the first trimester;2020QI;""
17 Girona;All ages;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
17 Girona;All ages;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
17 Girona;All ages;Cohort October 1;Males;Survival in the second trimester;2022QII;""
17 Girona;All ages;Cohort October 1;Males;Survival in the second trimester;2022QI;34.313
17 Girona;All ages;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
17 Girona;All ages;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
17 Girona;All ages;Cohort October 1;Males;Survival in the second trimester;2021QII;""
17 Girona;All ages;Cohort October 1;Males;Survival in the second trimester;2021QI;34.019
17 Girona;All ages;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
17 Girona;All ages;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
17 Girona;All ages;Cohort October 1;Males;Survival in the second trimester;2020QII;""
17 Girona;All ages;Cohort October 1;Males;Survival in the second trimester;2020QI;""
17 Girona;All ages;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
17 Girona;All ages;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
17 Girona;All ages;Cohort October 1;Males;Survival in the third trimester;2022QII;33.461
17 Girona;All ages;Cohort October 1;Males;Survival in the third trimester;2022QI;""
17 Girona;All ages;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
17 Girona;All ages;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
17 Girona;All ages;Cohort October 1;Males;Survival in the third trimester;2021QII;33.272
17 Girona;All ages;Cohort October 1;Males;Survival in the third trimester;2021QI;""
17 Girona;All ages;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
17 Girona;All ages;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
17 Girona;All ages;Cohort October 1;Males;Survival in the third trimester;2020QII;""
17 Girona;All ages;Cohort October 1;Males;Survival in the third trimester;2020QI;""
17 Girona;All ages;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
17 Girona;All ages;Cohort October 1;Males;Survival in the third trimester;2022QIII;32.704
17 Girona;All ages;Cohort October 1;Males;Survival in the third trimester;2022QII;""
17 Girona;All ages;Cohort October 1;Males;Survival in the third trimester;2022QI;""
17 Girona;All ages;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
17 Girona;All ages;Cohort October 1;Males;Survival in the third trimester;2021QIII;32.565
17 Girona;All ages;Cohort October 1;Males;Survival in the third trimester;2021QII;""
17 Girona;All ages;Cohort October 1;Males;Survival in the third trimester;2021QI;""
17 Girona;All ages;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
17 Girona;All ages;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
17 Girona;All ages;Cohort October 1;Males;Survival in the third trimester;2020QII;""
17 Girona;All ages;Cohort October 1;Males;Survival in the third trimester;2020QI;""
17 Girona;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
17 Girona;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
17 Girona;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
17 Girona;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
17 Girona;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
17 Girona;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
17 Girona;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
17 Girona;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
17 Girona;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
17 Girona;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
17 Girona;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
17 Girona;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
17 Girona;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;95,22
17 Girona;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
17 Girona;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
17 Girona;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
17 Girona;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;95,96
17 Girona;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
17 Girona;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
17 Girona;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
17 Girona;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;96,55
17 Girona;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
17 Girona;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
17 Girona;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
17 Girona;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
17 Girona;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
17 Girona;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
17 Girona;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;93,12
17 Girona;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
17 Girona;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
17 Girona;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
17 Girona;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;94,42
17 Girona;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
17 Girona;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
17 Girona;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
17 Girona;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
17 Girona;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
17 Girona;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
17 Girona;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;90,81
17 Girona;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
17 Girona;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
17 Girona;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
17 Girona;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;92,34
17 Girona;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
17 Girona;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
17 Girona;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
17 Girona;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
17 Girona;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
17 Girona;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
17 Girona;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;88,76
17 Girona;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
17 Girona;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
17 Girona;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
17 Girona;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;90,38
17 Girona;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
17 Girona;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
17 Girona;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
17 Girona;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
17 Girona;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
17 Girona;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
17 Girona;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QIV;21.177
17 Girona;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
17 Girona;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
17 Girona;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
17 Girona;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QIV;21.037
17 Girona;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
17 Girona;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
17 Girona;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
17 Girona;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QIV;20.379
17 Girona;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
17 Girona;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
17 Girona;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
17 Girona;All ages;Cohort October 1;Females;Survival in the first trimester;2022QIV;19.940
17 Girona;All ages;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
17 Girona;All ages;Cohort October 1;Females;Survival in the first trimester;2022QII;""
17 Girona;All ages;Cohort October 1;Females;Survival in the first trimester;2022QI;""
17 Girona;All ages;Cohort October 1;Females;Survival in the first trimester;2021QIV;19.962
17 Girona;All ages;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
17 Girona;All ages;Cohort October 1;Females;Survival in the first trimester;2021QII;""
17 Girona;All ages;Cohort October 1;Females;Survival in the first trimester;2021QI;""
17 Girona;All ages;Cohort October 1;Females;Survival in the first trimester;2020QIV;19.470
17 Girona;All ages;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
17 Girona;All ages;Cohort October 1;Females;Survival in the first trimester;2020QII;""
17 Girona;All ages;Cohort October 1;Females;Survival in the first trimester;2020QI;""
17 Girona;All ages;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
17 Girona;All ages;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
17 Girona;All ages;Cohort October 1;Females;Survival in the second trimester;2022QII;""
17 Girona;All ages;Cohort October 1;Females;Survival in the second trimester;2022QI;19.316
17 Girona;All ages;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
17 Girona;All ages;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
17 Girona;All ages;Cohort October 1;Females;Survival in the second trimester;2021QII;""
17 Girona;All ages;Cohort October 1;Females;Survival in the second trimester;2021QI;19.053
17 Girona;All ages;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
17 Girona;All ages;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
17 Girona;All ages;Cohort October 1;Females;Survival in the second trimester;2020QII;""
17 Girona;All ages;Cohort October 1;Females;Survival in the second trimester;2020QI;""
17 Girona;All ages;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
17 Girona;All ages;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
17 Girona;All ages;Cohort October 1;Females;Survival in the third trimester;2022QII;18.715
17 Girona;All ages;Cohort October 1;Females;Survival in the third trimester;2022QI;""
17 Girona;All ages;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
17 Girona;All ages;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
17 Girona;All ages;Cohort October 1;Females;Survival in the third trimester;2021QII;18.584
17 Girona;All ages;Cohort October 1;Females;Survival in the third trimester;2021QI;""
17 Girona;All ages;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
17 Girona;All ages;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
17 Girona;All ages;Cohort October 1;Females;Survival in the third trimester;2020QII;""
17 Girona;All ages;Cohort October 1;Females;Survival in the third trimester;2020QI;""
17 Girona;All ages;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
17 Girona;All ages;Cohort October 1;Females;Survival in the third trimester;2022QIII;18.121
17 Girona;All ages;Cohort October 1;Females;Survival in the third trimester;2022QII;""
17 Girona;All ages;Cohort October 1;Females;Survival in the third trimester;2022QI;""
17 Girona;All ages;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
17 Girona;All ages;Cohort October 1;Females;Survival in the third trimester;2021QIII;18.088
17 Girona;All ages;Cohort October 1;Females;Survival in the third trimester;2021QII;""
17 Girona;All ages;Cohort October 1;Females;Survival in the third trimester;2021QI;""
17 Girona;All ages;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
17 Girona;All ages;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
17 Girona;All ages;Cohort October 1;Females;Survival in the third trimester;2020QII;""
17 Girona;All ages;Cohort October 1;Females;Survival in the third trimester;2020QI;""
17 Girona;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
17 Girona;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
17 Girona;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
17 Girona;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
17 Girona;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
17 Girona;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
17 Girona;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
17 Girona;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
17 Girona;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
17 Girona;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
17 Girona;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
17 Girona;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
17 Girona;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;94,16
17 Girona;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
17 Girona;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
17 Girona;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
17 Girona;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;94,89
17 Girona;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
17 Girona;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
17 Girona;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
17 Girona;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;95,54
17 Girona;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
17 Girona;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
17 Girona;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
17 Girona;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
17 Girona;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
17 Girona;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
17 Girona;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;91,82
17 Girona;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
17 Girona;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
17 Girona;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
17 Girona;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;93,49
17 Girona;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
17 Girona;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
17 Girona;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
17 Girona;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
17 Girona;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
17 Girona;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
17 Girona;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;88,96
17 Girona;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
17 Girona;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
17 Girona;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
17 Girona;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;91,19
17 Girona;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
17 Girona;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
17 Girona;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
17 Girona;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
17 Girona;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
17 Girona;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
17 Girona;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;86,14
17 Girona;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
17 Girona;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
17 Girona;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
17 Girona;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;88,76
17 Girona;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
17 Girona;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
17 Girona;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
17 Girona;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
17 Girona;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
17 Girona;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
17 Girona;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
17 Girona;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
17 Girona;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
17 Girona;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QI;3.633
17 Girona;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
17 Girona;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
17 Girona;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
17 Girona;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QI;3.471
17 Girona;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
17 Girona;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
17 Girona;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
17 Girona;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QI;2.758
17 Girona;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
17 Girona;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
17 Girona;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2022QII;""
17 Girona;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2022QI;3.331
17 Girona;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
17 Girona;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
17 Girona;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2021QII;""
17 Girona;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2021QI;3.287
17 Girona;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
17 Girona;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
17 Girona;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2020QII;""
17 Girona;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2020QI;2.403
17 Girona;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
17 Girona;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
17 Girona;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2022QII;3.131
17 Girona;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2022QI;""
17 Girona;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
17 Girona;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
17 Girona;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2021QII;3.103
17 Girona;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2021QI;""
17 Girona;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
17 Girona;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
17 Girona;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2020QII;2.298
17 Girona;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2020QI;""
17 Girona;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
17 Girona;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QIII;2.949
17 Girona;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QII;""
17 Girona;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QI;""
17 Girona;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
17 Girona;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QIII;2.895
17 Girona;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QII;""
17 Girona;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QI;""
17 Girona;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
17 Girona;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QIII;2.205
17 Girona;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QII;""
17 Girona;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QI;""
17 Girona;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QIV;2.730
17 Girona;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
17 Girona;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QII;""
17 Girona;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QI;""
17 Girona;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QIV;2.730
17 Girona;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
17 Girona;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QII;""
17 Girona;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QI;""
17 Girona;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QIV;2.114
17 Girona;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
17 Girona;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QII;""
17 Girona;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QI;""
17 Girona;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
17 Girona;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
17 Girona;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
17 Girona;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
17 Girona;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
17 Girona;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
17 Girona;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
17 Girona;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
17 Girona;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
17 Girona;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
17 Girona;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
17 Girona;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
17 Girona;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
17 Girona;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
17 Girona;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
17 Girona;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;91,69
17 Girona;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
17 Girona;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
17 Girona;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
17 Girona;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;94,7
17 Girona;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
17 Girona;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
17 Girona;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
17 Girona;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;87,13
17 Girona;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
17 Girona;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
17 Girona;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;86,18
17 Girona;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
17 Girona;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
17 Girona;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
17 Girona;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;89,4
17 Girona;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
17 Girona;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
17 Girona;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
17 Girona;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;83,32
17 Girona;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
17 Girona;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
17 Girona;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;81,17
17 Girona;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
17 Girona;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
17 Girona;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
17 Girona;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;83,41
17 Girona;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
17 Girona;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
17 Girona;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
17 Girona;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;79,95
17 Girona;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
17 Girona;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
17 Girona;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;75,14
17 Girona;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
17 Girona;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
17 Girona;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
17 Girona;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;78,65
17 Girona;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
17 Girona;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
17 Girona;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
17 Girona;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;76,65
17 Girona;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
17 Girona;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
17 Girona;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
17 Girona;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
17 Girona;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
17 Girona;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
17 Girona;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QI;2.272
17 Girona;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
17 Girona;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
17 Girona;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
17 Girona;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QI;2.201
17 Girona;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
17 Girona;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
17 Girona;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
17 Girona;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QI;1.747
17 Girona;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
17 Girona;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
17 Girona;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2022QII;""
17 Girona;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2022QI;2.097
17 Girona;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
17 Girona;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
17 Girona;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2021QII;""
17 Girona;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2021QI;2.085
17 Girona;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
17 Girona;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
17 Girona;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2020QII;""
17 Girona;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2020QI;1.543
17 Girona;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
17 Girona;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
17 Girona;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2022QII;1.974
17 Girona;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2022QI;""
17 Girona;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
17 Girona;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
17 Girona;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2021QII;1.977
17 Girona;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2021QI;""
17 Girona;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
17 Girona;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
17 Girona;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2020QII;1.486
17 Girona;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2020QI;""
17 Girona;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
17 Girona;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QIII;1.881
17 Girona;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QII;""
17 Girona;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QI;""
17 Girona;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
17 Girona;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QIII;1.858
17 Girona;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QII;""
17 Girona;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QI;""
17 Girona;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
17 Girona;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QIII;1.430
17 Girona;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QII;""
17 Girona;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QI;""
17 Girona;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QIV;1.756
17 Girona;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
17 Girona;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QII;""
17 Girona;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QI;""
17 Girona;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QIV;1.752
17 Girona;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
17 Girona;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QII;""
17 Girona;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QI;""
17 Girona;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QIV;1.371
17 Girona;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
17 Girona;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QII;""
17 Girona;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QI;""
17 Girona;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
17 Girona;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
17 Girona;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
17 Girona;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
17 Girona;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
17 Girona;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
17 Girona;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
17 Girona;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
17 Girona;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
17 Girona;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
17 Girona;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
17 Girona;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
17 Girona;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
17 Girona;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
17 Girona;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
17 Girona;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;92,3
17 Girona;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
17 Girona;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
17 Girona;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
17 Girona;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;94,73
17 Girona;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
17 Girona;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
17 Girona;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
17 Girona;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;88,32
17 Girona;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
17 Girona;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
17 Girona;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;86,88
17 Girona;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
17 Girona;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
17 Girona;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
17 Girona;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;89,82
17 Girona;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
17 Girona;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
17 Girona;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
17 Girona;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;85,06
17 Girona;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
17 Girona;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
17 Girona;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;82,79
17 Girona;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
17 Girona;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
17 Girona;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
17 Girona;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;84,42
17 Girona;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
17 Girona;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
17 Girona;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
17 Girona;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;81,85
17 Girona;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
17 Girona;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
17 Girona;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;77,29
17 Girona;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
17 Girona;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
17 Girona;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
17 Girona;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;79,6
17 Girona;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
17 Girona;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
17 Girona;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
17 Girona;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;78,48
17 Girona;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
17 Girona;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
17 Girona;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
17 Girona;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
17 Girona;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
17 Girona;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
17 Girona;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QI;1.361
17 Girona;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
17 Girona;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
17 Girona;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
17 Girona;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QI;1.270
17 Girona;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
17 Girona;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
17 Girona;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
17 Girona;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QI;1.011
17 Girona;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
17 Girona;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
17 Girona;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2022QII;""
17 Girona;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2022QI;1.234
17 Girona;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
17 Girona;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
17 Girona;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2021QII;""
17 Girona;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2021QI;1.202
17 Girona;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
17 Girona;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
17 Girona;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2020QII;""
17 Girona;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2020QI;860
17 Girona;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
17 Girona;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
17 Girona;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2022QII;1.157
17 Girona;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2022QI;""
17 Girona;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
17 Girona;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
17 Girona;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2021QII;1.126
17 Girona;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2021QI;""
17 Girona;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
17 Girona;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
17 Girona;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2020QII;812
17 Girona;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2020QI;""
17 Girona;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
17 Girona;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QIII;1.068
17 Girona;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QII;""
17 Girona;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QI;""
17 Girona;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
17 Girona;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QIII;1.037
17 Girona;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QII;""
17 Girona;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QI;""
17 Girona;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
17 Girona;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QIII;775
17 Girona;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QII;""
17 Girona;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QI;""
17 Girona;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QIV;974
17 Girona;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
17 Girona;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QII;""
17 Girona;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QI;""
17 Girona;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QIV;978
17 Girona;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
17 Girona;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QII;""
17 Girona;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QI;""
17 Girona;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QIV;743
17 Girona;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
17 Girona;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QII;""
17 Girona;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QI;""
17 Girona;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
17 Girona;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
17 Girona;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
17 Girona;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
17 Girona;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
17 Girona;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
17 Girona;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
17 Girona;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
17 Girona;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
17 Girona;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
17 Girona;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
17 Girona;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
17 Girona;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
17 Girona;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
17 Girona;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
17 Girona;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;90,67
17 Girona;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
17 Girona;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
17 Girona;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
17 Girona;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;94,65
17 Girona;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
17 Girona;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
17 Girona;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
17 Girona;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;85,06
17 Girona;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
17 Girona;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
17 Girona;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;85,01
17 Girona;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
17 Girona;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
17 Girona;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
17 Girona;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;88,66
17 Girona;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
17 Girona;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
17 Girona;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
17 Girona;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;80,32
17 Girona;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
17 Girona;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
17 Girona;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;78,47
17 Girona;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
17 Girona;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
17 Girona;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
17 Girona;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;81,65
17 Girona;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
17 Girona;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
17 Girona;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
17 Girona;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;76,66
17 Girona;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
17 Girona;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
17 Girona;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;71,57
17 Girona;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
17 Girona;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
17 Girona;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
17 Girona;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;77,01
17 Girona;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
17 Girona;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
17 Girona;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
17 Girona;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;73,49
17 Girona;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
17 Girona;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
17 Girona;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
17 Girona;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
17 Girona;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
17 Girona;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QII;3.214
17 Girona;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
17 Girona;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
17 Girona;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
17 Girona;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QII;3.093
17 Girona;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
17 Girona;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
17 Girona;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
17 Girona;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QII;2.761
17 Girona;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
17 Girona;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
17 Girona;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
17 Girona;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2022QII;3.002
17 Girona;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2022QI;""
17 Girona;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
17 Girona;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
17 Girona;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2021QII;2.888
17 Girona;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2021QI;""
17 Girona;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
17 Girona;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
17 Girona;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2020QII;2.638
17 Girona;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2020QI;""
17 Girona;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
17 Girona;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2022QIII;2.811
17 Girona;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2022QII;""
17 Girona;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2022QI;""
17 Girona;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
17 Girona;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2021QIII;2.658
17 Girona;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2021QII;""
17 Girona;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2021QI;""
17 Girona;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
17 Girona;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2020QIII;2.512
17 Girona;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2020QII;""
17 Girona;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2020QI;""
17 Girona;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QIV;2.571
17 Girona;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
17 Girona;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QII;""
17 Girona;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QI;""
17 Girona;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QIV;2.490
17 Girona;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
17 Girona;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QII;""
17 Girona;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QI;""
17 Girona;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QIV;2.391
17 Girona;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
17 Girona;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QII;""
17 Girona;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QI;""
17 Girona;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
17 Girona;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
17 Girona;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QII;""
17 Girona;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QI;2.306
17 Girona;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
17 Girona;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
17 Girona;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QII;""
17 Girona;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QI;2.285
17 Girona;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
17 Girona;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
17 Girona;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QII;""
17 Girona;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QI;""
17 Girona;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
17 Girona;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
17 Girona;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
17 Girona;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
17 Girona;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
17 Girona;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
17 Girona;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
17 Girona;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
17 Girona;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
17 Girona;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
17 Girona;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
17 Girona;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
17 Girona;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
17 Girona;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
17 Girona;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;93,4
17 Girona;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
17 Girona;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
17 Girona;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
17 Girona;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;93,37
17 Girona;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
17 Girona;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
17 Girona;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
17 Girona;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;95,55
17 Girona;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
17 Girona;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
17 Girona;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;87,46
17 Girona;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
17 Girona;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
17 Girona;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
17 Girona;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;85,94
17 Girona;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
17 Girona;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
17 Girona;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
17 Girona;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;90,98
17 Girona;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
17 Girona;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
17 Girona;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;79,99
17 Girona;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
17 Girona;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
17 Girona;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
17 Girona;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;80,5
17 Girona;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
17 Girona;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
17 Girona;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
17 Girona;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;86,6
17 Girona;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
17 Girona;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
17 Girona;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
17 Girona;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
17 Girona;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
17 Girona;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
17 Girona;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;74,56
17 Girona;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
17 Girona;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
17 Girona;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
17 Girona;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;82,76
17 Girona;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
17 Girona;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
17 Girona;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
17 Girona;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
17 Girona;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
17 Girona;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
17 Girona;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QII;2.005
17 Girona;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
17 Girona;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
17 Girona;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
17 Girona;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QII;1.954
17 Girona;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
17 Girona;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
17 Girona;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
17 Girona;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QII;1.767
17 Girona;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
17 Girona;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
17 Girona;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
17 Girona;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2022QII;1.874
17 Girona;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2022QI;""
17 Girona;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
17 Girona;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
17 Girona;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2021QII;1.836
17 Girona;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2021QI;""
17 Girona;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
17 Girona;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
17 Girona;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2020QII;1.698
17 Girona;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2020QI;""
17 Girona;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
17 Girona;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2022QIII;1.772
17 Girona;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2022QII;""
17 Girona;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2022QI;""
17 Girona;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
17 Girona;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2021QIII;1.703
17 Girona;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2021QII;""
17 Girona;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2021QI;""
17 Girona;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
17 Girona;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2020QIII;1.621
17 Girona;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2020QII;""
17 Girona;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2020QI;""
17 Girona;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QIV;1.638
17 Girona;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
17 Girona;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QII;""
17 Girona;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QI;""
17 Girona;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QIV;1.600
17 Girona;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
17 Girona;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QII;""
17 Girona;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QI;""
17 Girona;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QIV;1.544
17 Girona;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
17 Girona;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QII;""
17 Girona;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QI;""
17 Girona;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
17 Girona;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
17 Girona;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QII;""
17 Girona;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QI;1.488
17 Girona;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
17 Girona;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
17 Girona;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QII;""
17 Girona;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QI;1.477
17 Girona;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
17 Girona;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
17 Girona;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QII;""
17 Girona;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QI;""
17 Girona;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
17 Girona;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
17 Girona;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
17 Girona;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
17 Girona;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
17 Girona;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
17 Girona;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
17 Girona;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
17 Girona;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
17 Girona;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
17 Girona;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
17 Girona;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
17 Girona;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
17 Girona;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
17 Girona;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;93,47
17 Girona;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
17 Girona;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
17 Girona;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
17 Girona;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;93,96
17 Girona;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
17 Girona;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
17 Girona;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
17 Girona;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;96,1
17 Girona;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
17 Girona;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
17 Girona;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;88,38
17 Girona;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
17 Girona;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
17 Girona;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
17 Girona;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;87,15
17 Girona;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
17 Girona;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
17 Girona;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
17 Girona;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;91,74
17 Girona;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
17 Girona;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
17 Girona;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;81,7
17 Girona;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
17 Girona;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
17 Girona;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
17 Girona;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;81,88
17 Girona;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
17 Girona;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
17 Girona;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
17 Girona;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;87,38
17 Girona;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
17 Girona;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
17 Girona;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
17 Girona;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
17 Girona;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
17 Girona;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
17 Girona;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;76,15
17 Girona;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
17 Girona;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
17 Girona;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
17 Girona;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;83,59
17 Girona;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
17 Girona;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
17 Girona;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
17 Girona;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
17 Girona;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
17 Girona;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
17 Girona;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QII;1.209
17 Girona;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
17 Girona;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
17 Girona;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
17 Girona;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QII;1.139
17 Girona;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
17 Girona;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
17 Girona;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
17 Girona;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QII;994
17 Girona;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
17 Girona;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
17 Girona;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
17 Girona;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2022QII;1.128
17 Girona;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2022QI;""
17 Girona;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
17 Girona;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
17 Girona;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2021QII;1.052
17 Girona;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2021QI;""
17 Girona;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
17 Girona;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
17 Girona;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2020QII;940
17 Girona;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2020QI;""
17 Girona;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
17 Girona;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2022QIII;1.039
17 Girona;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2022QII;""
17 Girona;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2022QI;""
17 Girona;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
17 Girona;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2021QIII;955
17 Girona;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2021QII;""
17 Girona;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2021QI;""
17 Girona;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
17 Girona;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2020QIII;891
17 Girona;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2020QII;""
17 Girona;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2020QI;""
17 Girona;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QIV;933
17 Girona;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
17 Girona;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QII;""
17 Girona;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QI;""
17 Girona;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QIV;890
17 Girona;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
17 Girona;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QII;""
17 Girona;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QI;""
17 Girona;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QIV;847
17 Girona;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
17 Girona;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QII;""
17 Girona;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QI;""
17 Girona;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
17 Girona;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
17 Girona;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QII;""
17 Girona;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QI;818
17 Girona;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
17 Girona;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
17 Girona;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QII;""
17 Girona;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QI;808
17 Girona;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
17 Girona;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
17 Girona;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QII;""
17 Girona;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QI;""
17 Girona;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
17 Girona;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
17 Girona;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
17 Girona;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
17 Girona;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
17 Girona;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
17 Girona;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
17 Girona;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
17 Girona;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
17 Girona;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
17 Girona;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
17 Girona;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
17 Girona;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
17 Girona;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
17 Girona;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;93,3
17 Girona;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
17 Girona;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
17 Girona;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
17 Girona;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;92,36
17 Girona;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
17 Girona;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
17 Girona;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
17 Girona;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;94,57
17 Girona;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
17 Girona;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
17 Girona;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;85,94
17 Girona;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
17 Girona;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
17 Girona;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
17 Girona;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;83,85
17 Girona;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
17 Girona;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
17 Girona;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
17 Girona;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;89,64
17 Girona;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
17 Girona;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
17 Girona;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;77,17
17 Girona;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
17 Girona;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
17 Girona;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
17 Girona;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;78,14
17 Girona;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
17 Girona;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
17 Girona;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
17 Girona;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;85,21
17 Girona;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
17 Girona;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
17 Girona;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
17 Girona;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
17 Girona;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
17 Girona;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
17 Girona;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;71,82
17 Girona;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
17 Girona;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
17 Girona;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
17 Girona;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;81,29
17 Girona;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
17 Girona;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
17 Girona;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
17 Girona;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
17 Girona;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
17 Girona;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QIII;3.503
17 Girona;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
17 Girona;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
17 Girona;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
17 Girona;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QIII;3.470
17 Girona;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
17 Girona;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
17 Girona;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
17 Girona;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QIII;3.000
17 Girona;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
17 Girona;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
17 Girona;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
17 Girona;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2022QIII;3.194
17 Girona;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2022QII;""
17 Girona;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2022QI;""
17 Girona;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
17 Girona;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2021QIII;3.105
17 Girona;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2021QII;""
17 Girona;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2021QI;""
17 Girona;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
17 Girona;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2020QIII;2.781
17 Girona;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2020QII;""
17 Girona;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2020QI;""
17 Girona;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2022QIV;2.892
17 Girona;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
17 Girona;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2022QII;""
17 Girona;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2022QI;""
17 Girona;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2021QIV;2.878
17 Girona;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
17 Girona;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2021QII;""
17 Girona;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2021QI;""
17 Girona;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2020QIV;2.634
17 Girona;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
17 Girona;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2020QII;""
17 Girona;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2020QI;""
17 Girona;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
17 Girona;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
17 Girona;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QII;""
17 Girona;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QI;2.664
17 Girona;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
17 Girona;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
17 Girona;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QII;""
17 Girona;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QI;2.514
17 Girona;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
17 Girona;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
17 Girona;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QII;""
17 Girona;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QI;""
17 Girona;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
17 Girona;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
17 Girona;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QII;2.522
17 Girona;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QI;""
17 Girona;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
17 Girona;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
17 Girona;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QII;2.402
17 Girona;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QI;""
17 Girona;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
17 Girona;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
17 Girona;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QII;""
17 Girona;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QI;""
17 Girona;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
17 Girona;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
17 Girona;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
17 Girona;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
17 Girona;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
17 Girona;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
17 Girona;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
17 Girona;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
17 Girona;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
17 Girona;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
17 Girona;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
17 Girona;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
17 Girona;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
17 Girona;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;91,18
17 Girona;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
17 Girona;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
17 Girona;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
17 Girona;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;89,48
17 Girona;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
17 Girona;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
17 Girona;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
17 Girona;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;92,7
17 Girona;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
17 Girona;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
17 Girona;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;82,56
17 Girona;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
17 Girona;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
17 Girona;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
17 Girona;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;82,94
17 Girona;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
17 Girona;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
17 Girona;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
17 Girona;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;87,8
17 Girona;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
17 Girona;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
17 Girona;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
17 Girona;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
17 Girona;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
17 Girona;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
17 Girona;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;76,77
17 Girona;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
17 Girona;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
17 Girona;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
17 Girona;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;83,8
17 Girona;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
17 Girona;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
17 Girona;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
17 Girona;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
17 Girona;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
17 Girona;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
17 Girona;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;72,68
17 Girona;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
17 Girona;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
17 Girona;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
17 Girona;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;80,07
17 Girona;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
17 Girona;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
17 Girona;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
17 Girona;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
17 Girona;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
17 Girona;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
17 Girona;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QIII;2.193
17 Girona;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
17 Girona;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
17 Girona;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
17 Girona;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QIII;2.183
17 Girona;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
17 Girona;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
17 Girona;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
17 Girona;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QIII;1.923
17 Girona;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
17 Girona;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
17 Girona;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
17 Girona;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2022QIII;2.019
17 Girona;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2022QII;""
17 Girona;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2022QI;""
17 Girona;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
17 Girona;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2021QIII;1.961
17 Girona;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2021QII;""
17 Girona;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2021QI;""
17 Girona;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
17 Girona;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2020QIII;1.787
17 Girona;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2020QII;""
17 Girona;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2020QI;""
17 Girona;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2022QIV;1.842
17 Girona;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
17 Girona;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2022QII;""
17 Girona;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2022QI;""
17 Girona;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2021QIV;1.832
17 Girona;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
17 Girona;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2021QII;""
17 Girona;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2021QI;""
17 Girona;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2020QIV;1.697
17 Girona;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
17 Girona;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2020QII;""
17 Girona;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2020QI;""
17 Girona;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
17 Girona;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
17 Girona;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QII;""
17 Girona;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QI;1.703
17 Girona;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
17 Girona;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
17 Girona;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QII;""
17 Girona;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QI;1.619
17 Girona;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
17 Girona;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
17 Girona;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QII;""
17 Girona;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QI;""
17 Girona;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
17 Girona;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
17 Girona;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QII;1.612
17 Girona;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QI;""
17 Girona;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
17 Girona;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
17 Girona;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QII;1.553
17 Girona;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QI;""
17 Girona;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
17 Girona;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
17 Girona;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QII;""
17 Girona;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QI;""
17 Girona;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
17 Girona;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
17 Girona;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
17 Girona;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
17 Girona;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
17 Girona;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
17 Girona;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
17 Girona;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
17 Girona;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
17 Girona;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
17 Girona;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
17 Girona;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
17 Girona;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
17 Girona;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;92,07
17 Girona;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
17 Girona;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
17 Girona;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
17 Girona;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;89,83
17 Girona;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
17 Girona;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
17 Girona;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
17 Girona;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;92,93
17 Girona;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
17 Girona;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
17 Girona;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;83,99
17 Girona;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
17 Girona;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
17 Girona;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
17 Girona;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;83,92
17 Girona;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
17 Girona;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
17 Girona;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
17 Girona;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;88,25
17 Girona;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
17 Girona;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
17 Girona;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
17 Girona;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
17 Girona;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
17 Girona;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
17 Girona;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;78,01
17 Girona;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
17 Girona;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
17 Girona;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
17 Girona;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;84,19
17 Girona;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
17 Girona;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
17 Girona;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
17 Girona;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
17 Girona;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
17 Girona;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
17 Girona;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;73,84
17 Girona;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
17 Girona;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
17 Girona;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
17 Girona;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;80,76
17 Girona;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
17 Girona;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
17 Girona;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
17 Girona;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
17 Girona;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
17 Girona;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
17 Girona;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QIII;1.310
17 Girona;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
17 Girona;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
17 Girona;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
17 Girona;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QIII;1.287
17 Girona;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
17 Girona;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
17 Girona;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
17 Girona;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QIII;1.077
17 Girona;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
17 Girona;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
17 Girona;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
17 Girona;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2022QIII;1.175
17 Girona;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2022QII;""
17 Girona;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2022QI;""
17 Girona;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
17 Girona;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2021QIII;1.144
17 Girona;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2021QII;""
17 Girona;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2021QI;""
17 Girona;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
17 Girona;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2020QIII;994
17 Girona;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2020QII;""
17 Girona;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2020QI;""
17 Girona;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2022QIV;1.050
17 Girona;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
17 Girona;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2022QII;""
17 Girona;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2022QI;""
17 Girona;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2021QIV;1.046
17 Girona;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
17 Girona;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2021QII;""
17 Girona;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2021QI;""
17 Girona;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2020QIV;937
17 Girona;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
17 Girona;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2020QII;""
17 Girona;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2020QI;""
17 Girona;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
17 Girona;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
17 Girona;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QII;""
17 Girona;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QI;961
17 Girona;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
17 Girona;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
17 Girona;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QII;""
17 Girona;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QI;895
17 Girona;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
17 Girona;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
17 Girona;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QII;""
17 Girona;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QI;""
17 Girona;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
17 Girona;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
17 Girona;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QII;910
17 Girona;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QI;""
17 Girona;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
17 Girona;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
17 Girona;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QII;849
17 Girona;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QI;""
17 Girona;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
17 Girona;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
17 Girona;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QII;""
17 Girona;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QI;""
17 Girona;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
17 Girona;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
17 Girona;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
17 Girona;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
17 Girona;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
17 Girona;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
17 Girona;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
17 Girona;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
17 Girona;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
17 Girona;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
17 Girona;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
17 Girona;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
17 Girona;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
17 Girona;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;89,69
17 Girona;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
17 Girona;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
17 Girona;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
17 Girona;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;88,89
17 Girona;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
17 Girona;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
17 Girona;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
17 Girona;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;92,29
17 Girona;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
17 Girona;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
17 Girona;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;80,15
17 Girona;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
17 Girona;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
17 Girona;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
17 Girona;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;81,27
17 Girona;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
17 Girona;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
17 Girona;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
17 Girona;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;87
17 Girona;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
17 Girona;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
17 Girona;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
17 Girona;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
17 Girona;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
17 Girona;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
17 Girona;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;74,67
17 Girona;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
17 Girona;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
17 Girona;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
17 Girona;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;83,1
17 Girona;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
17 Girona;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
17 Girona;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
17 Girona;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
17 Girona;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
17 Girona;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
17 Girona;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;70,71
17 Girona;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
17 Girona;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
17 Girona;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
17 Girona;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;78,83
17 Girona;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
17 Girona;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
17 Girona;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
17 Girona;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
17 Girona;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
17 Girona;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QIV;3.558
17 Girona;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
17 Girona;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
17 Girona;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
17 Girona;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QIV;3.473
17 Girona;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
17 Girona;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
17 Girona;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
17 Girona;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QIV;3.259
17 Girona;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
17 Girona;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
17 Girona;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
17 Girona;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2022QIV;3.210
17 Girona;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
17 Girona;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2022QII;""
17 Girona;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2022QI;""
17 Girona;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2021QIV;3.206
17 Girona;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
17 Girona;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2021QII;""
17 Girona;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2021QI;""
17 Girona;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2020QIV;3.046
17 Girona;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
17 Girona;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2020QII;""
17 Girona;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2020QI;""
17 Girona;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
17 Girona;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
17 Girona;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2022QII;""
17 Girona;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2022QI;2.956
17 Girona;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
17 Girona;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
17 Girona;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2021QII;""
17 Girona;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2021QI;2.903
17 Girona;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
17 Girona;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
17 Girona;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2020QII;""
17 Girona;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2020QI;""
17 Girona;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
17 Girona;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
17 Girona;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QII;2.790
17 Girona;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QI;""
17 Girona;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
17 Girona;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
17 Girona;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QII;2.758
17 Girona;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QI;""
17 Girona;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
17 Girona;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
17 Girona;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QII;""
17 Girona;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QI;""
17 Girona;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
17 Girona;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QIII;2.631
17 Girona;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QII;""
17 Girona;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QI;""
17 Girona;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
17 Girona;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QIII;2.581
17 Girona;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QII;""
17 Girona;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QI;""
17 Girona;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
17 Girona;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
17 Girona;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QII;""
17 Girona;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QI;""
17 Girona;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
17 Girona;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
17 Girona;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
17 Girona;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
17 Girona;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
17 Girona;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
17 Girona;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
17 Girona;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
17 Girona;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
17 Girona;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
17 Girona;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
17 Girona;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
17 Girona;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;90,22
17 Girona;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
17 Girona;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
17 Girona;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
17 Girona;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;92,31
17 Girona;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
17 Girona;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
17 Girona;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
17 Girona;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;93,46
17 Girona;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
17 Girona;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
17 Girona;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
17 Girona;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
17 Girona;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
17 Girona;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
17 Girona;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;85,11
17 Girona;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
17 Girona;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
17 Girona;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
17 Girona;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;89,08
17 Girona;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
17 Girona;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
17 Girona;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
17 Girona;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
17 Girona;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
17 Girona;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
17 Girona;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;80,33
17 Girona;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
17 Girona;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
17 Girona;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
17 Girona;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;84,63
17 Girona;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
17 Girona;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
17 Girona;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
17 Girona;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
17 Girona;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
17 Girona;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
17 Girona;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;75,76
17 Girona;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
17 Girona;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
17 Girona;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
17 Girona;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;79,2
17 Girona;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
17 Girona;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
17 Girona;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
17 Girona;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
17 Girona;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
17 Girona;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
17 Girona;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QIV;2.257
17 Girona;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
17 Girona;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
17 Girona;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
17 Girona;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QIV;2.184
17 Girona;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
17 Girona;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
17 Girona;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
17 Girona;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QIV;2.062
17 Girona;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
17 Girona;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
17 Girona;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
17 Girona;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2022QIV;2.047
17 Girona;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
17 Girona;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2022QII;""
17 Girona;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2022QI;""
17 Girona;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2021QIV;2.029
17 Girona;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
17 Girona;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2021QII;""
17 Girona;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2021QI;""
17 Girona;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2020QIV;1.935
17 Girona;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
17 Girona;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2020QII;""
17 Girona;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2020QI;""
17 Girona;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
17 Girona;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
17 Girona;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2022QII;""
17 Girona;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2022QI;1.881
17 Girona;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
17 Girona;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
17 Girona;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2021QII;""
17 Girona;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2021QI;1.848
17 Girona;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
17 Girona;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
17 Girona;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2020QII;""
17 Girona;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2020QI;""
17 Girona;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
17 Girona;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
17 Girona;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QII;1.775
17 Girona;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QI;""
17 Girona;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
17 Girona;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
17 Girona;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QII;1.765
17 Girona;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QI;""
17 Girona;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
17 Girona;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
17 Girona;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QII;""
17 Girona;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QI;""
17 Girona;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
17 Girona;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QIII;1.695
17 Girona;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QII;""
17 Girona;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QI;""
17 Girona;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
17 Girona;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QIII;1.666
17 Girona;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QII;""
17 Girona;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QI;""
17 Girona;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
17 Girona;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
17 Girona;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QII;""
17 Girona;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QI;""
17 Girona;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
17 Girona;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
17 Girona;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
17 Girona;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
17 Girona;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
17 Girona;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
17 Girona;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
17 Girona;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
17 Girona;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
17 Girona;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
17 Girona;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
17 Girona;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
17 Girona;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;90,7
17 Girona;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
17 Girona;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
17 Girona;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
17 Girona;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;92,9
17 Girona;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
17 Girona;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
17 Girona;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
17 Girona;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;93,84
17 Girona;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
17 Girona;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
17 Girona;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
17 Girona;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
17 Girona;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
17 Girona;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
17 Girona;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;86,13
17 Girona;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
17 Girona;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
17 Girona;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
17 Girona;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;89,62
17 Girona;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
17 Girona;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
17 Girona;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
17 Girona;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
17 Girona;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
17 Girona;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
17 Girona;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;81,27
17 Girona;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
17 Girona;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
17 Girona;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
17 Girona;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;85,6
17 Girona;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
17 Girona;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
17 Girona;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
17 Girona;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
17 Girona;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
17 Girona;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
17 Girona;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;77,61
17 Girona;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
17 Girona;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
17 Girona;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
17 Girona;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;80,8
17 Girona;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
17 Girona;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
17 Girona;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
17 Girona;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
17 Girona;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
17 Girona;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
17 Girona;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QIV;1.301
17 Girona;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
17 Girona;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
17 Girona;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
17 Girona;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QIV;1.289
17 Girona;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
17 Girona;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
17 Girona;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
17 Girona;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QIV;1.197
17 Girona;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
17 Girona;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
17 Girona;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
17 Girona;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2022QIV;1.163
17 Girona;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
17 Girona;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2022QII;""
17 Girona;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2022QI;""
17 Girona;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2021QIV;1.177
17 Girona;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
17 Girona;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2021QII;""
17 Girona;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2021QI;""
17 Girona;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2020QIV;1.111
17 Girona;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
17 Girona;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2020QII;""
17 Girona;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2020QI;""
17 Girona;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
17 Girona;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
17 Girona;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2022QII;""
17 Girona;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2022QI;1.075
17 Girona;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
17 Girona;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
17 Girona;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2021QII;""
17 Girona;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2021QI;1.055
17 Girona;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
17 Girona;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
17 Girona;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2020QII;""
17 Girona;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2020QI;""
17 Girona;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
17 Girona;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
17 Girona;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QII;1.015
17 Girona;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QI;""
17 Girona;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
17 Girona;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
17 Girona;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QII;993
17 Girona;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QI;""
17 Girona;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
17 Girona;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
17 Girona;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QII;""
17 Girona;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QI;""
17 Girona;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
17 Girona;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QIII;936
17 Girona;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QII;""
17 Girona;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QI;""
17 Girona;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
17 Girona;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QIII;915
17 Girona;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QII;""
17 Girona;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QI;""
17 Girona;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
17 Girona;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
17 Girona;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QII;""
17 Girona;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QI;""
17 Girona;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
17 Girona;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
17 Girona;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
17 Girona;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
17 Girona;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
17 Girona;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
17 Girona;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
17 Girona;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
17 Girona;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
17 Girona;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
17 Girona;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
17 Girona;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
17 Girona;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;89,39
17 Girona;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
17 Girona;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
17 Girona;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
17 Girona;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;91,31
17 Girona;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
17 Girona;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
17 Girona;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
17 Girona;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;92,82
17 Girona;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
17 Girona;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
17 Girona;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
17 Girona;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
17 Girona;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
17 Girona;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
17 Girona;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;83,4
17 Girona;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
17 Girona;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
17 Girona;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
17 Girona;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;88,14
17 Girona;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
17 Girona;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
17 Girona;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
17 Girona;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
17 Girona;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
17 Girona;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
17 Girona;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;78,74
17 Girona;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
17 Girona;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
17 Girona;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
17 Girona;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;82,96
17 Girona;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
17 Girona;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
17 Girona;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
17 Girona;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
17 Girona;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
17 Girona;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
17 Girona;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;72,61
17 Girona;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
17 Girona;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
17 Girona;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
17 Girona;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;76,44
17 Girona;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
17 Girona;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
17 Girona;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
17 Girona;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
17 Girona;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
17 Girona;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
17 Girona;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
17 Girona;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
17 Girona;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
17 Girona;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QI;9.736
17 Girona;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
17 Girona;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
17 Girona;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
17 Girona;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QI;9.684
17 Girona;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
17 Girona;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
17 Girona;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
17 Girona;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QI;9.371
17 Girona;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
17 Girona;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
17 Girona;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2022QII;""
17 Girona;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2022QI;9.295
17 Girona;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
17 Girona;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
17 Girona;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2021QII;""
17 Girona;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2021QI;9.421
17 Girona;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
17 Girona;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
17 Girona;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2020QII;""
17 Girona;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2020QI;8.698
17 Girona;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
17 Girona;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
17 Girona;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2022QII;8.926
17 Girona;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2022QI;""
17 Girona;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
17 Girona;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
17 Girona;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2021QII;9.110
17 Girona;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2021QI;""
17 Girona;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
17 Girona;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
17 Girona;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2020QII;8.489
17 Girona;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2020QI;""
17 Girona;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
17 Girona;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QIII;8.627
17 Girona;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QII;""
17 Girona;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QI;""
17 Girona;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
17 Girona;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QIII;8.871
17 Girona;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QII;""
17 Girona;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QI;""
17 Girona;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
17 Girona;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QIII;8.215
17 Girona;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QII;""
17 Girona;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QI;""
17 Girona;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QIV;8.262
17 Girona;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
17 Girona;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QII;""
17 Girona;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QI;""
17 Girona;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QIV;8.564
17 Girona;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
17 Girona;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QII;""
17 Girona;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QI;""
17 Girona;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QIV;7.984
17 Girona;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
17 Girona;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QII;""
17 Girona;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QI;""
17 Girona;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
17 Girona;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
17 Girona;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
17 Girona;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
17 Girona;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
17 Girona;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
17 Girona;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
17 Girona;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
17 Girona;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
17 Girona;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
17 Girona;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
17 Girona;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
17 Girona;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
17 Girona;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
17 Girona;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
17 Girona;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;95,47
17 Girona;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
17 Girona;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
17 Girona;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
17 Girona;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;97,28
17 Girona;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
17 Girona;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
17 Girona;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
17 Girona;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;92,82
17 Girona;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
17 Girona;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
17 Girona;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;91,68
17 Girona;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
17 Girona;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
17 Girona;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
17 Girona;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;94,07
17 Girona;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
17 Girona;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
17 Girona;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
17 Girona;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;90,59
17 Girona;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
17 Girona;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
17 Girona;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;88,61
17 Girona;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
17 Girona;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
17 Girona;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
17 Girona;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;91,6
17 Girona;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
17 Girona;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
17 Girona;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
17 Girona;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;87,66
17 Girona;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
17 Girona;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
17 Girona;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;84,86
17 Girona;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
17 Girona;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
17 Girona;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
17 Girona;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;88,43
17 Girona;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
17 Girona;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
17 Girona;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
17 Girona;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;85,2
17 Girona;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
17 Girona;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
17 Girona;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
17 Girona;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
17 Girona;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
17 Girona;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
17 Girona;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QI;6.063
17 Girona;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
17 Girona;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
17 Girona;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
17 Girona;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QI;6.061
17 Girona;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
17 Girona;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
17 Girona;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
17 Girona;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QI;5.845
17 Girona;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
17 Girona;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
17 Girona;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2022QII;""
17 Girona;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2022QI;5.807
17 Girona;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
17 Girona;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
17 Girona;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2021QII;""
17 Girona;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2021QI;5.912
17 Girona;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
17 Girona;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
17 Girona;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2020QII;""
17 Girona;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2020QI;5.455
17 Girona;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
17 Girona;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
17 Girona;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2022QII;5.603
17 Girona;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2022QI;""
17 Girona;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
17 Girona;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
17 Girona;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2021QII;5.722
17 Girona;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2021QI;""
17 Girona;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
17 Girona;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
17 Girona;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2020QII;5.343
17 Girona;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2020QI;""
17 Girona;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
17 Girona;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QIII;5.448
17 Girona;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QII;""
17 Girona;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QI;""
17 Girona;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
17 Girona;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QIII;5.581
17 Girona;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QII;""
17 Girona;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QI;""
17 Girona;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
17 Girona;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QIII;5.192
17 Girona;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QII;""
17 Girona;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QI;""
17 Girona;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QIV;5.231
17 Girona;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
17 Girona;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QII;""
17 Girona;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QI;""
17 Girona;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QIV;5.404
17 Girona;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
17 Girona;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QII;""
17 Girona;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QI;""
17 Girona;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QIV;5.065
17 Girona;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
17 Girona;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QII;""
17 Girona;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QI;""
17 Girona;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
17 Girona;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
17 Girona;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
17 Girona;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
17 Girona;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
17 Girona;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
17 Girona;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
17 Girona;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
17 Girona;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
17 Girona;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
17 Girona;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
17 Girona;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
17 Girona;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
17 Girona;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
17 Girona;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
17 Girona;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;95,78
17 Girona;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
17 Girona;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
17 Girona;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
17 Girona;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;97,54
17 Girona;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
17 Girona;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
17 Girona;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
17 Girona;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;93,33
17 Girona;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
17 Girona;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
17 Girona;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;92,41
17 Girona;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
17 Girona;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
17 Girona;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
17 Girona;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;94,41
17 Girona;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
17 Girona;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
17 Girona;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
17 Girona;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;91,41
17 Girona;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
17 Girona;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
17 Girona;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;89,86
17 Girona;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
17 Girona;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
17 Girona;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
17 Girona;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;92,08
17 Girona;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
17 Girona;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
17 Girona;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
17 Girona;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;88,83
17 Girona;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
17 Girona;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
17 Girona;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;86,28
17 Girona;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
17 Girona;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
17 Girona;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
17 Girona;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;89,16
17 Girona;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
17 Girona;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
17 Girona;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
17 Girona;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;86,66
17 Girona;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
17 Girona;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
17 Girona;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
17 Girona;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
17 Girona;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
17 Girona;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
17 Girona;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QI;3.673
17 Girona;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
17 Girona;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
17 Girona;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
17 Girona;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QI;3.623
17 Girona;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
17 Girona;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
17 Girona;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
17 Girona;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QI;3.526
17 Girona;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
17 Girona;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
17 Girona;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2022QII;""
17 Girona;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2022QI;3.488
17 Girona;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
17 Girona;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
17 Girona;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2021QII;""
17 Girona;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2021QI;3.509
17 Girona;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
17 Girona;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
17 Girona;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2020QII;""
17 Girona;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2020QI;3.243
17 Girona;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
17 Girona;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
17 Girona;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2022QII;3.323
17 Girona;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2022QI;""
17 Girona;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
17 Girona;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
17 Girona;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2021QII;3.388
17 Girona;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2021QI;""
17 Girona;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
17 Girona;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
17 Girona;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2020QII;3.146
17 Girona;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2020QI;""
17 Girona;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
17 Girona;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QIII;3.179
17 Girona;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QII;""
17 Girona;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QI;""
17 Girona;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
17 Girona;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QIII;3.290
17 Girona;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QII;""
17 Girona;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QI;""
17 Girona;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
17 Girona;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QIII;3.023
17 Girona;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QII;""
17 Girona;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QI;""
17 Girona;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QIV;3.031
17 Girona;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
17 Girona;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QII;""
17 Girona;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QI;""
17 Girona;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QIV;3.160
17 Girona;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
17 Girona;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QII;""
17 Girona;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QI;""
17 Girona;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QIV;2.919
17 Girona;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
17 Girona;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QII;""
17 Girona;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QI;""
17 Girona;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
17 Girona;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
17 Girona;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
17 Girona;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
17 Girona;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
17 Girona;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
17 Girona;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
17 Girona;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
17 Girona;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
17 Girona;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
17 Girona;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
17 Girona;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
17 Girona;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
17 Girona;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
17 Girona;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
17 Girona;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;94,96
17 Girona;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
17 Girona;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
17 Girona;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
17 Girona;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;96,85
17 Girona;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
17 Girona;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
17 Girona;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
17 Girona;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;91,97
17 Girona;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
17 Girona;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
17 Girona;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;90,47
17 Girona;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
17 Girona;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
17 Girona;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
17 Girona;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;93,51
17 Girona;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
17 Girona;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
17 Girona;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
17 Girona;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;89,22
17 Girona;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
17 Girona;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
17 Girona;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;86,55
17 Girona;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
17 Girona;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
17 Girona;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
17 Girona;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;90,81
17 Girona;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
17 Girona;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
17 Girona;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
17 Girona;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;85,73
17 Girona;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
17 Girona;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
17 Girona;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;82,52
17 Girona;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
17 Girona;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
17 Girona;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
17 Girona;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;87,22
17 Girona;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
17 Girona;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
17 Girona;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
17 Girona;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;82,79
17 Girona;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
17 Girona;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
17 Girona;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
17 Girona;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
17 Girona;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
17 Girona;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QII;9.168
17 Girona;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
17 Girona;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
17 Girona;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
17 Girona;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QII;9.247
17 Girona;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
17 Girona;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
17 Girona;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
17 Girona;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QII;9.290
17 Girona;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
17 Girona;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
17 Girona;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
17 Girona;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2022QII;8.781
17 Girona;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2022QI;""
17 Girona;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
17 Girona;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
17 Girona;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2021QII;8.906
17 Girona;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2021QI;""
17 Girona;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
17 Girona;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
17 Girona;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2020QII;9.055
17 Girona;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2020QI;""
17 Girona;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
17 Girona;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2022QIII;8.462
17 Girona;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2022QII;""
17 Girona;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2022QI;""
17 Girona;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
17 Girona;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2021QIII;8.615
17 Girona;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2021QII;""
17 Girona;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2021QI;""
17 Girona;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
17 Girona;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2020QIII;8.738
17 Girona;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2020QII;""
17 Girona;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2020QI;""
17 Girona;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QIV;8.055
17 Girona;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
17 Girona;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QII;""
17 Girona;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QI;""
17 Girona;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QIV;8.278
17 Girona;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
17 Girona;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QII;""
17 Girona;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QI;""
17 Girona;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QIV;8.466
17 Girona;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
17 Girona;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QII;""
17 Girona;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QI;""
17 Girona;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
17 Girona;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
17 Girona;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QII;""
17 Girona;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QI;7.961
17 Girona;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
17 Girona;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
17 Girona;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QII;""
17 Girona;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QI;8.281
17 Girona;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
17 Girona;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
17 Girona;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QII;""
17 Girona;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QI;""
17 Girona;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
17 Girona;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
17 Girona;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
17 Girona;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
17 Girona;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
17 Girona;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
17 Girona;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
17 Girona;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
17 Girona;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
17 Girona;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
17 Girona;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
17 Girona;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
17 Girona;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
17 Girona;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
17 Girona;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;95,78
17 Girona;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
17 Girona;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
17 Girona;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
17 Girona;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;96,31
17 Girona;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
17 Girona;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
17 Girona;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
17 Girona;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;97,47
17 Girona;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
17 Girona;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
17 Girona;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;92,3
17 Girona;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
17 Girona;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
17 Girona;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
17 Girona;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;93,17
17 Girona;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
17 Girona;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
17 Girona;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
17 Girona;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;94,06
17 Girona;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
17 Girona;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
17 Girona;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;87,86
17 Girona;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
17 Girona;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
17 Girona;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
17 Girona;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;89,52
17 Girona;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
17 Girona;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
17 Girona;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
17 Girona;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;91,13
17 Girona;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
17 Girona;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
17 Girona;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
17 Girona;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
17 Girona;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
17 Girona;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
17 Girona;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;86,09
17 Girona;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
17 Girona;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
17 Girona;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
17 Girona;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;89,14
17 Girona;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
17 Girona;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
17 Girona;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
17 Girona;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
17 Girona;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
17 Girona;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
17 Girona;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QII;5.694
17 Girona;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
17 Girona;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
17 Girona;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
17 Girona;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QII;5.736
17 Girona;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
17 Girona;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
17 Girona;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
17 Girona;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QII;5.813
17 Girona;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
17 Girona;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
17 Girona;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
17 Girona;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2022QII;5.480
17 Girona;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2022QI;""
17 Girona;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
17 Girona;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
17 Girona;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2021QII;5.535
17 Girona;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2021QI;""
17 Girona;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
17 Girona;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
17 Girona;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2020QII;5.688
17 Girona;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2020QI;""
17 Girona;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
17 Girona;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2022QIII;5.308
17 Girona;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2022QII;""
17 Girona;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2022QI;""
17 Girona;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
17 Girona;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2021QIII;5.362
17 Girona;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2021QII;""
17 Girona;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2021QI;""
17 Girona;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
17 Girona;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2020QIII;5.510
17 Girona;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2020QII;""
17 Girona;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2020QI;""
17 Girona;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QIV;5.072
17 Girona;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
17 Girona;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QII;""
17 Girona;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QI;""
17 Girona;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QIV;5.176
17 Girona;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
17 Girona;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QII;""
17 Girona;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QI;""
17 Girona;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QIV;5.351
17 Girona;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
17 Girona;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QII;""
17 Girona;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QI;""
17 Girona;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
17 Girona;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
17 Girona;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QII;""
17 Girona;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QI;5.002
17 Girona;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
17 Girona;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
17 Girona;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QII;""
17 Girona;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QI;5.241
17 Girona;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
17 Girona;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
17 Girona;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QII;""
17 Girona;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QI;""
17 Girona;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
17 Girona;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
17 Girona;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
17 Girona;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
17 Girona;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
17 Girona;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
17 Girona;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
17 Girona;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
17 Girona;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
17 Girona;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
17 Girona;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
17 Girona;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
17 Girona;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
17 Girona;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
17 Girona;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;96,24
17 Girona;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
17 Girona;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
17 Girona;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
17 Girona;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;96,5
17 Girona;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
17 Girona;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
17 Girona;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
17 Girona;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;97,85
17 Girona;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
17 Girona;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
17 Girona;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;93,22
17 Girona;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
17 Girona;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
17 Girona;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
17 Girona;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;93,48
17 Girona;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
17 Girona;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
17 Girona;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
17 Girona;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;94,79
17 Girona;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
17 Girona;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
17 Girona;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;89,08
17 Girona;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
17 Girona;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
17 Girona;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
17 Girona;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;90,24
17 Girona;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
17 Girona;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
17 Girona;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
17 Girona;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;92,05
17 Girona;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
17 Girona;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
17 Girona;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
17 Girona;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
17 Girona;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
17 Girona;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
17 Girona;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;87,2
17 Girona;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
17 Girona;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
17 Girona;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
17 Girona;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;90,16
17 Girona;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
17 Girona;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
17 Girona;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
17 Girona;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
17 Girona;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
17 Girona;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
17 Girona;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QII;3.474
17 Girona;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
17 Girona;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
17 Girona;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
17 Girona;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QII;3.511
17 Girona;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
17 Girona;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
17 Girona;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
17 Girona;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QII;3.477
17 Girona;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
17 Girona;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
17 Girona;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
17 Girona;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2022QII;3.301
17 Girona;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2022QI;""
17 Girona;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
17 Girona;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
17 Girona;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2021QII;3.371
17 Girona;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2021QI;""
17 Girona;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
17 Girona;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
17 Girona;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2020QII;3.367
17 Girona;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2020QI;""
17 Girona;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
17 Girona;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2022QIII;3.154
17 Girona;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2022QII;""
17 Girona;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2022QI;""
17 Girona;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
17 Girona;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2021QIII;3.253
17 Girona;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2021QII;""
17 Girona;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2021QI;""
17 Girona;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
17 Girona;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2020QIII;3.228
17 Girona;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2020QII;""
17 Girona;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2020QI;""
17 Girona;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QIV;2.983
17 Girona;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
17 Girona;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QII;""
17 Girona;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QI;""
17 Girona;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QIV;3.102
17 Girona;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
17 Girona;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QII;""
17 Girona;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QI;""
17 Girona;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QIV;3.115
17 Girona;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
17 Girona;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QII;""
17 Girona;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QI;""
17 Girona;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
17 Girona;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
17 Girona;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QII;""
17 Girona;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QI;2.959
17 Girona;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
17 Girona;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
17 Girona;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QII;""
17 Girona;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QI;3.040
17 Girona;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
17 Girona;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
17 Girona;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QII;""
17 Girona;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QI;""
17 Girona;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
17 Girona;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
17 Girona;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
17 Girona;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
17 Girona;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
17 Girona;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
17 Girona;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
17 Girona;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
17 Girona;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
17 Girona;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
17 Girona;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
17 Girona;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
17 Girona;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
17 Girona;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
17 Girona;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;95,02
17 Girona;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
17 Girona;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
17 Girona;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
17 Girona;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;96,01
17 Girona;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
17 Girona;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
17 Girona;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
17 Girona;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;96,84
17 Girona;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
17 Girona;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
17 Girona;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;90,79
17 Girona;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
17 Girona;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
17 Girona;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
17 Girona;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;92,65
17 Girona;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
17 Girona;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
17 Girona;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
17 Girona;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;92,84
17 Girona;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
17 Girona;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
17 Girona;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;85,87
17 Girona;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
17 Girona;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
17 Girona;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
17 Girona;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;88,35
17 Girona;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
17 Girona;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
17 Girona;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
17 Girona;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;89,59
17 Girona;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
17 Girona;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
17 Girona;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
17 Girona;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
17 Girona;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
17 Girona;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
17 Girona;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;84,28
17 Girona;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
17 Girona;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
17 Girona;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
17 Girona;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;87,43
17 Girona;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
17 Girona;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
17 Girona;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
17 Girona;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
17 Girona;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
17 Girona;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QIII;9.486
17 Girona;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
17 Girona;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
17 Girona;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
17 Girona;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QIII;9.601
17 Girona;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
17 Girona;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
17 Girona;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
17 Girona;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QIII;9.450
17 Girona;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
17 Girona;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
17 Girona;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
17 Girona;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2022QIII;9.048
17 Girona;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2022QII;""
17 Girona;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2022QI;""
17 Girona;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
17 Girona;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2021QIII;9.218
17 Girona;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2021QII;""
17 Girona;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2021QI;""
17 Girona;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
17 Girona;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2020QIII;9.057
17 Girona;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2020QII;""
17 Girona;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2020QI;""
17 Girona;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2022QIV;8.531
17 Girona;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
17 Girona;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2022QII;""
17 Girona;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2022QI;""
17 Girona;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2021QIV;8.779
17 Girona;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
17 Girona;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2021QII;""
17 Girona;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2021QI;""
17 Girona;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2020QIV;8.732
17 Girona;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
17 Girona;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2020QII;""
17 Girona;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2020QI;""
17 Girona;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
17 Girona;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
17 Girona;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QII;""
17 Girona;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QI;8.416
17 Girona;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
17 Girona;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
17 Girona;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QII;""
17 Girona;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QI;8.531
17 Girona;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
17 Girona;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
17 Girona;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QII;""
17 Girona;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QI;""
17 Girona;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
17 Girona;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
17 Girona;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QII;8.129
17 Girona;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QI;""
17 Girona;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
17 Girona;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
17 Girona;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QII;8.299
17 Girona;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QI;""
17 Girona;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
17 Girona;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
17 Girona;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QII;""
17 Girona;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QI;""
17 Girona;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
17 Girona;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
17 Girona;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
17 Girona;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
17 Girona;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
17 Girona;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
17 Girona;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
17 Girona;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
17 Girona;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
17 Girona;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
17 Girona;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
17 Girona;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
17 Girona;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
17 Girona;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;95,38
17 Girona;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
17 Girona;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
17 Girona;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
17 Girona;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;96,01
17 Girona;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
17 Girona;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
17 Girona;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
17 Girona;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;95,84
17 Girona;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
17 Girona;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
17 Girona;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;89,93
17 Girona;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
17 Girona;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
17 Girona;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
17 Girona;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;91,44
17 Girona;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
17 Girona;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
17 Girona;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
17 Girona;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;92,4
17 Girona;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
17 Girona;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
17 Girona;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
17 Girona;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
17 Girona;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
17 Girona;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
17 Girona;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;87,66
17 Girona;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
17 Girona;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
17 Girona;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
17 Girona;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;90,28
17 Girona;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
17 Girona;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
17 Girona;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
17 Girona;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
17 Girona;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
17 Girona;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
17 Girona;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;84,67
17 Girona;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
17 Girona;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
17 Girona;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
17 Girona;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;87,82
17 Girona;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
17 Girona;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
17 Girona;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
17 Girona;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
17 Girona;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
17 Girona;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
17 Girona;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QIII;5.877
17 Girona;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
17 Girona;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
17 Girona;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
17 Girona;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QIII;5.944
17 Girona;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
17 Girona;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
17 Girona;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
17 Girona;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QIII;5.921
17 Girona;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
17 Girona;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
17 Girona;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
17 Girona;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2022QIII;5.637
17 Girona;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2022QII;""
17 Girona;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2022QI;""
17 Girona;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
17 Girona;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2021QIII;5.720
17 Girona;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2021QII;""
17 Girona;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2021QI;""
17 Girona;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
17 Girona;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2020QIII;5.706
17 Girona;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2020QII;""
17 Girona;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2020QI;""
17 Girona;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2022QIV;5.331
17 Girona;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
17 Girona;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2022QII;""
17 Girona;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2022QI;""
17 Girona;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2021QIV;5.473
17 Girona;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
17 Girona;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2021QII;""
17 Girona;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2021QI;""
17 Girona;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2020QIV;5.513
17 Girona;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
17 Girona;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2020QII;""
17 Girona;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2020QI;""
17 Girona;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
17 Girona;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
17 Girona;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QII;""
17 Girona;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QI;5.268
17 Girona;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
17 Girona;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
17 Girona;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QII;""
17 Girona;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QI;5.394
17 Girona;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
17 Girona;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
17 Girona;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QII;""
17 Girona;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QI;""
17 Girona;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
17 Girona;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
17 Girona;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QII;5.109
17 Girona;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QI;""
17 Girona;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
17 Girona;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
17 Girona;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QII;5.256
17 Girona;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QI;""
17 Girona;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
17 Girona;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
17 Girona;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QII;""
17 Girona;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QI;""
17 Girona;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
17 Girona;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
17 Girona;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
17 Girona;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
17 Girona;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
17 Girona;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
17 Girona;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
17 Girona;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
17 Girona;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
17 Girona;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
17 Girona;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
17 Girona;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
17 Girona;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
17 Girona;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;95,92
17 Girona;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
17 Girona;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
17 Girona;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
17 Girona;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;96,23
17 Girona;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
17 Girona;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
17 Girona;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
17 Girona;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;96,37
17 Girona;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
17 Girona;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
17 Girona;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;90,71
17 Girona;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
17 Girona;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
17 Girona;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
17 Girona;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;92,08
17 Girona;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
17 Girona;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
17 Girona;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
17 Girona;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;93,11
17 Girona;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
17 Girona;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
17 Girona;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
17 Girona;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
17 Girona;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
17 Girona;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
17 Girona;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;88,63
17 Girona;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
17 Girona;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
17 Girona;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
17 Girona;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;91,1
17 Girona;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
17 Girona;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
17 Girona;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
17 Girona;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
17 Girona;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
17 Girona;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
17 Girona;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;85,95
17 Girona;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
17 Girona;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
17 Girona;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
17 Girona;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;88,77
17 Girona;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
17 Girona;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
17 Girona;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
17 Girona;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
17 Girona;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
17 Girona;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
17 Girona;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QIII;3.609
17 Girona;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
17 Girona;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
17 Girona;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
17 Girona;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QIII;3.657
17 Girona;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
17 Girona;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
17 Girona;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
17 Girona;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QIII;3.529
17 Girona;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
17 Girona;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
17 Girona;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
17 Girona;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2022QIII;3.411
17 Girona;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2022QII;""
17 Girona;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2022QI;""
17 Girona;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
17 Girona;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2021QIII;3.498
17 Girona;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2021QII;""
17 Girona;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2021QI;""
17 Girona;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
17 Girona;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2020QIII;3.351
17 Girona;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2020QII;""
17 Girona;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2020QI;""
17 Girona;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2022QIV;3.200
17 Girona;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
17 Girona;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2022QII;""
17 Girona;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2022QI;""
17 Girona;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2021QIV;3.306
17 Girona;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
17 Girona;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2021QII;""
17 Girona;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2021QI;""
17 Girona;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2020QIV;3.219
17 Girona;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
17 Girona;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2020QII;""
17 Girona;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2020QI;""
17 Girona;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
17 Girona;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
17 Girona;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QII;""
17 Girona;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QI;3.148
17 Girona;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
17 Girona;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
17 Girona;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QII;""
17 Girona;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QI;3.137
17 Girona;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
17 Girona;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
17 Girona;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QII;""
17 Girona;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QI;""
17 Girona;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
17 Girona;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
17 Girona;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QII;3.020
17 Girona;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QI;""
17 Girona;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
17 Girona;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
17 Girona;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QII;3.043
17 Girona;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QI;""
17 Girona;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
17 Girona;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
17 Girona;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QII;""
17 Girona;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QI;""
17 Girona;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
17 Girona;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
17 Girona;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
17 Girona;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
17 Girona;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
17 Girona;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
17 Girona;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
17 Girona;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
17 Girona;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
17 Girona;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
17 Girona;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
17 Girona;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
17 Girona;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
17 Girona;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;94,51
17 Girona;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
17 Girona;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
17 Girona;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
17 Girona;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;95,65
17 Girona;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
17 Girona;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
17 Girona;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
17 Girona;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;94,96
17 Girona;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
17 Girona;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
17 Girona;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;88,67
17 Girona;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
17 Girona;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
17 Girona;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
17 Girona;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;90,4
17 Girona;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
17 Girona;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
17 Girona;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
17 Girona;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;91,22
17 Girona;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
17 Girona;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
17 Girona;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
17 Girona;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
17 Girona;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
17 Girona;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
17 Girona;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;86,08
17 Girona;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
17 Girona;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
17 Girona;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
17 Girona;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;88,89
17 Girona;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
17 Girona;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
17 Girona;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
17 Girona;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
17 Girona;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
17 Girona;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
17 Girona;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;82,58
17 Girona;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
17 Girona;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
17 Girona;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
17 Girona;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;86,23
17 Girona;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
17 Girona;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
17 Girona;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
17 Girona;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
17 Girona;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
17 Girona;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QIV;9.497
17 Girona;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
17 Girona;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
17 Girona;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
17 Girona;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QIV;9.668
17 Girona;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
17 Girona;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
17 Girona;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
17 Girona;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QIV;9.570
17 Girona;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
17 Girona;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
17 Girona;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
17 Girona;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2022QIV;8.921
17 Girona;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
17 Girona;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2022QII;""
17 Girona;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2022QI;""
17 Girona;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2021QIV;9.191
17 Girona;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
17 Girona;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2021QII;""
17 Girona;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2021QI;""
17 Girona;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2020QIV;9.174
17 Girona;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
17 Girona;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2020QII;""
17 Girona;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2020QI;""
17 Girona;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
17 Girona;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
17 Girona;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2022QII;""
17 Girona;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2022QI;8.798
17 Girona;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
17 Girona;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
17 Girona;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2021QII;""
17 Girona;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2021QI;8.948
17 Girona;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
17 Girona;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
17 Girona;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2020QII;""
17 Girona;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2020QI;""
17 Girona;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
17 Girona;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
17 Girona;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QII;8.482
17 Girona;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QI;""
17 Girona;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
17 Girona;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
17 Girona;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QII;8.687
17 Girona;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QI;""
17 Girona;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
17 Girona;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
17 Girona;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QII;""
17 Girona;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QI;""
17 Girona;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
17 Girona;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QIII;8.206
17 Girona;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QII;""
17 Girona;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QI;""
17 Girona;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
17 Girona;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QIII;8.475
17 Girona;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QII;""
17 Girona;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QI;""
17 Girona;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
17 Girona;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
17 Girona;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QII;""
17 Girona;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QI;""
17 Girona;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
17 Girona;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
17 Girona;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
17 Girona;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
17 Girona;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
17 Girona;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
17 Girona;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
17 Girona;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
17 Girona;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
17 Girona;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
17 Girona;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
17 Girona;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
17 Girona;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;93,93
17 Girona;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
17 Girona;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
17 Girona;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
17 Girona;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;95,07
17 Girona;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
17 Girona;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
17 Girona;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
17 Girona;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;95,86
17 Girona;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
17 Girona;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
17 Girona;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
17 Girona;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
17 Girona;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
17 Girona;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
17 Girona;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;91
17 Girona;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
17 Girona;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
17 Girona;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
17 Girona;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;93,5
17 Girona;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
17 Girona;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
17 Girona;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
17 Girona;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
17 Girona;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
17 Girona;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
17 Girona;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;87,73
17 Girona;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
17 Girona;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
17 Girona;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
17 Girona;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;90,77
17 Girona;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
17 Girona;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
17 Girona;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
17 Girona;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
17 Girona;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
17 Girona;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
17 Girona;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;84,88
17 Girona;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
17 Girona;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
17 Girona;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
17 Girona;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;88,56
17 Girona;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
17 Girona;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
17 Girona;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
17 Girona;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
17 Girona;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
17 Girona;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
17 Girona;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QIV;5.887
17 Girona;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
17 Girona;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
17 Girona;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
17 Girona;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QIV;5.998
17 Girona;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
17 Girona;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
17 Girona;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
17 Girona;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QIV;6.003
17 Girona;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
17 Girona;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
17 Girona;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
17 Girona;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2022QIV;5.547
17 Girona;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
17 Girona;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2022QII;""
17 Girona;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2022QI;""
17 Girona;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2021QIV;5.730
17 Girona;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
17 Girona;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2021QII;""
17 Girona;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2021QI;""
17 Girona;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2020QIV;5.767
17 Girona;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
17 Girona;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2020QII;""
17 Girona;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2020QI;""
17 Girona;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
17 Girona;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
17 Girona;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2022QII;""
17 Girona;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2022QI;5.506
17 Girona;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
17 Girona;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
17 Girona;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2021QII;""
17 Girona;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2021QI;5.634
17 Girona;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
17 Girona;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
17 Girona;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2020QII;""
17 Girona;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2020QI;""
17 Girona;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
17 Girona;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
17 Girona;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QII;5.331
17 Girona;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QI;""
17 Girona;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
17 Girona;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
17 Girona;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QII;5.482
17 Girona;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QI;""
17 Girona;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
17 Girona;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
17 Girona;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QII;""
17 Girona;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QI;""
17 Girona;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
17 Girona;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QIII;5.192
17 Girona;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QII;""
17 Girona;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QI;""
17 Girona;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
17 Girona;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QIII;5.355
17 Girona;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QII;""
17 Girona;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QI;""
17 Girona;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
17 Girona;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
17 Girona;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QII;""
17 Girona;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QI;""
17 Girona;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
17 Girona;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
17 Girona;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
17 Girona;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
17 Girona;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
17 Girona;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
17 Girona;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
17 Girona;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
17 Girona;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
17 Girona;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
17 Girona;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
17 Girona;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
17 Girona;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;94,22
17 Girona;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
17 Girona;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
17 Girona;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
17 Girona;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;95,53
17 Girona;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
17 Girona;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
17 Girona;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
17 Girona;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;96,07
17 Girona;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
17 Girona;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
17 Girona;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
17 Girona;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
17 Girona;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
17 Girona;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
17 Girona;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;91,8
17 Girona;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
17 Girona;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
17 Girona;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
17 Girona;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;93,85
17 Girona;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
17 Girona;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
17 Girona;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
17 Girona;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
17 Girona;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
17 Girona;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
17 Girona;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;88,88
17 Girona;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
17 Girona;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
17 Girona;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
17 Girona;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;91,32
17 Girona;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
17 Girona;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
17 Girona;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
17 Girona;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
17 Girona;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
17 Girona;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
17 Girona;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;86,56
17 Girona;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
17 Girona;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
17 Girona;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
17 Girona;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;89,21
17 Girona;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
17 Girona;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
17 Girona;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
17 Girona;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
17 Girona;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
17 Girona;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
17 Girona;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QIV;3.610
17 Girona;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
17 Girona;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
17 Girona;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
17 Girona;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QIV;3.670
17 Girona;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
17 Girona;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
17 Girona;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
17 Girona;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QIV;3.567
17 Girona;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
17 Girona;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
17 Girona;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
17 Girona;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2022QIV;3.374
17 Girona;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
17 Girona;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2022QII;""
17 Girona;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2022QI;""
17 Girona;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2021QIV;3.461
17 Girona;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
17 Girona;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2021QII;""
17 Girona;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2021QI;""
17 Girona;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2020QIV;3.407
17 Girona;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
17 Girona;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2020QII;""
17 Girona;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2020QI;""
17 Girona;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
17 Girona;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
17 Girona;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2022QII;""
17 Girona;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2022QI;3.292
17 Girona;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
17 Girona;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
17 Girona;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2021QII;""
17 Girona;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2021QI;3.314
17 Girona;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
17 Girona;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
17 Girona;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2020QII;""
17 Girona;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2020QI;""
17 Girona;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
17 Girona;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
17 Girona;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QII;3.151
17 Girona;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QI;""
17 Girona;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
17 Girona;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
17 Girona;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QII;3.205
17 Girona;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QI;""
17 Girona;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
17 Girona;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
17 Girona;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QII;""
17 Girona;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QI;""
17 Girona;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
17 Girona;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QIII;3.014
17 Girona;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QII;""
17 Girona;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QI;""
17 Girona;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
17 Girona;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QIII;3.120
17 Girona;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QII;""
17 Girona;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QI;""
17 Girona;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
17 Girona;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
17 Girona;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QII;""
17 Girona;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QI;""
17 Girona;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
17 Girona;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
17 Girona;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
17 Girona;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
17 Girona;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
17 Girona;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
17 Girona;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
17 Girona;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
17 Girona;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
17 Girona;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
17 Girona;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
17 Girona;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
17 Girona;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;93,46
17 Girona;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
17 Girona;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
17 Girona;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
17 Girona;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;94,31
17 Girona;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
17 Girona;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
17 Girona;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
17 Girona;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;95,51
17 Girona;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
17 Girona;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
17 Girona;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
17 Girona;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
17 Girona;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
17 Girona;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
17 Girona;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;89,7
17 Girona;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
17 Girona;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
17 Girona;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
17 Girona;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;92,91
17 Girona;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
17 Girona;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
17 Girona;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
17 Girona;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
17 Girona;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
17 Girona;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
17 Girona;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;85,86
17 Girona;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
17 Girona;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
17 Girona;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
17 Girona;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;89,85
17 Girona;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
17 Girona;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
17 Girona;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
17 Girona;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
17 Girona;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
17 Girona;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
17 Girona;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;82,13
17 Girona;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
17 Girona;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
17 Girona;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
17 Girona;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;87,47
17 Girona;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
17 Girona;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
17 Girona;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
17 Girona;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
17 Girona;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
17 Girona;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
17 Girona;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
17 Girona;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
17 Girona;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
17 Girona;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QI;17.879
17 Girona;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
17 Girona;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
17 Girona;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
17 Girona;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QI;17.672
17 Girona;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
17 Girona;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
17 Girona;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
17 Girona;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QI;17.739
17 Girona;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
17 Girona;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
17 Girona;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2022QII;""
17 Girona;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2022QI;17.366
17 Girona;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
17 Girona;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
17 Girona;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2021QII;""
17 Girona;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2021QI;17.334
17 Girona;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
17 Girona;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
17 Girona;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2020QII;""
17 Girona;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2020QI;16.721
17 Girona;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
17 Girona;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
17 Girona;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2022QII;16.955
17 Girona;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2022QI;""
17 Girona;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
17 Girona;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
17 Girona;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2021QII;16.993
17 Girona;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2021QI;""
17 Girona;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
17 Girona;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
17 Girona;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2020QII;16.417
17 Girona;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2020QI;""
17 Girona;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
17 Girona;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QIII;16.589
17 Girona;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QII;""
17 Girona;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QI;""
17 Girona;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
17 Girona;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QIII;16.644
17 Girona;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QII;""
17 Girona;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QI;""
17 Girona;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
17 Girona;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QIII;16.066
17 Girona;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QII;""
17 Girona;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QI;""
17 Girona;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QIV;16.110
17 Girona;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
17 Girona;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QII;""
17 Girona;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QI;""
17 Girona;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QIV;16.232
17 Girona;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
17 Girona;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QII;""
17 Girona;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QI;""
17 Girona;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QIV;15.715
17 Girona;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
17 Girona;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QII;""
17 Girona;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QI;""
17 Girona;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
17 Girona;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
17 Girona;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
17 Girona;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
17 Girona;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
17 Girona;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
17 Girona;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
17 Girona;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
17 Girona;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
17 Girona;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
17 Girona;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
17 Girona;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
17 Girona;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
17 Girona;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
17 Girona;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
17 Girona;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;97,13
17 Girona;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
17 Girona;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
17 Girona;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
17 Girona;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;98,09
17 Girona;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
17 Girona;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
17 Girona;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
17 Girona;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;94,26
17 Girona;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
17 Girona;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
17 Girona;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;94,83
17 Girona;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
17 Girona;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
17 Girona;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
17 Girona;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;96,16
17 Girona;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
17 Girona;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
17 Girona;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
17 Girona;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;92,55
17 Girona;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
17 Girona;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
17 Girona;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;92,78
17 Girona;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
17 Girona;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
17 Girona;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
17 Girona;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;94,18
17 Girona;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
17 Girona;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
17 Girona;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
17 Girona;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;90,57
17 Girona;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
17 Girona;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
17 Girona;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;90,11
17 Girona;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
17 Girona;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
17 Girona;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
17 Girona;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;91,85
17 Girona;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
17 Girona;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
17 Girona;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
17 Girona;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;88,59
17 Girona;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
17 Girona;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
17 Girona;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
17 Girona;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
17 Girona;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
17 Girona;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
17 Girona;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QI;11.562
17 Girona;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
17 Girona;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
17 Girona;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
17 Girona;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QI;11.513
17 Girona;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
17 Girona;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
17 Girona;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
17 Girona;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QI;11.531
17 Girona;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
17 Girona;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
17 Girona;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2022QII;""
17 Girona;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2022QI;11.242
17 Girona;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
17 Girona;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
17 Girona;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2021QII;""
17 Girona;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2021QI;11.280
17 Girona;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
17 Girona;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
17 Girona;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2020QII;""
17 Girona;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2020QI;10.916
17 Girona;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
17 Girona;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
17 Girona;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2022QII;11.008
17 Girona;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2022QI;""
17 Girona;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
17 Girona;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
17 Girona;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2021QII;11.061
17 Girona;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2021QI;""
17 Girona;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
17 Girona;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
17 Girona;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2020QII;10.741
17 Girona;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2020QI;""
17 Girona;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
17 Girona;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QIII;10.797
17 Girona;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QII;""
17 Girona;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QI;""
17 Girona;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
17 Girona;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QIII;10.848
17 Girona;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QII;""
17 Girona;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QI;""
17 Girona;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
17 Girona;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QIII;10.515
17 Girona;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QII;""
17 Girona;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QI;""
17 Girona;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QIV;10.510
17 Girona;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
17 Girona;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QII;""
17 Girona;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QI;""
17 Girona;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QIV;10.609
17 Girona;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
17 Girona;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QII;""
17 Girona;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QI;""
17 Girona;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QIV;10.310
17 Girona;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
17 Girona;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QII;""
17 Girona;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QI;""
17 Girona;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
17 Girona;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
17 Girona;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
17 Girona;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
17 Girona;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
17 Girona;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
17 Girona;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
17 Girona;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
17 Girona;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
17 Girona;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
17 Girona;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
17 Girona;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
17 Girona;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
17 Girona;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
17 Girona;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
17 Girona;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;97,23
17 Girona;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
17 Girona;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
17 Girona;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
17 Girona;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;97,98
17 Girona;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
17 Girona;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
17 Girona;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
17 Girona;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;94,67
17 Girona;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
17 Girona;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
17 Girona;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;95,21
17 Girona;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
17 Girona;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
17 Girona;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
17 Girona;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;96,07
17 Girona;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
17 Girona;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
17 Girona;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
17 Girona;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;93,15
17 Girona;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
17 Girona;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
17 Girona;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;93,38
17 Girona;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
17 Girona;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
17 Girona;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
17 Girona;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;94,22
17 Girona;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
17 Girona;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
17 Girona;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
17 Girona;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;91,19
17 Girona;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
17 Girona;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
17 Girona;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;90,9
17 Girona;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
17 Girona;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
17 Girona;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
17 Girona;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;92,15
17 Girona;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
17 Girona;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
17 Girona;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
17 Girona;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;89,41
17 Girona;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
17 Girona;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
17 Girona;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
17 Girona;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
17 Girona;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
17 Girona;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
17 Girona;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QI;6.317
17 Girona;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
17 Girona;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
17 Girona;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
17 Girona;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QI;6.159
17 Girona;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
17 Girona;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
17 Girona;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
17 Girona;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QI;6.208
17 Girona;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
17 Girona;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
17 Girona;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2022QII;""
17 Girona;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2022QI;6.124
17 Girona;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
17 Girona;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
17 Girona;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2021QII;""
17 Girona;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2021QI;6.054
17 Girona;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
17 Girona;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
17 Girona;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2020QII;""
17 Girona;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2020QI;5.805
17 Girona;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
17 Girona;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
17 Girona;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2022QII;5.947
17 Girona;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2022QI;""
17 Girona;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
17 Girona;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
17 Girona;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2021QII;5.932
17 Girona;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2021QI;""
17 Girona;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
17 Girona;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
17 Girona;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2020QII;5.676
17 Girona;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2020QI;""
17 Girona;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
17 Girona;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QIII;5.792
17 Girona;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QII;""
17 Girona;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QI;""
17 Girona;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
17 Girona;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QIII;5.796
17 Girona;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QII;""
17 Girona;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QI;""
17 Girona;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
17 Girona;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QIII;5.551
17 Girona;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QII;""
17 Girona;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QI;""
17 Girona;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QIV;5.600
17 Girona;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
17 Girona;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QII;""
17 Girona;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QI;""
17 Girona;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QIV;5.623
17 Girona;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
17 Girona;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QII;""
17 Girona;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QI;""
17 Girona;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QIV;5.405
17 Girona;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
17 Girona;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QII;""
17 Girona;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QI;""
17 Girona;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
17 Girona;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
17 Girona;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
17 Girona;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
17 Girona;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
17 Girona;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
17 Girona;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
17 Girona;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
17 Girona;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
17 Girona;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
17 Girona;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
17 Girona;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
17 Girona;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
17 Girona;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
17 Girona;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
17 Girona;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;96,94
17 Girona;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
17 Girona;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
17 Girona;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
17 Girona;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;98,3
17 Girona;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
17 Girona;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
17 Girona;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
17 Girona;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;93,51
17 Girona;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
17 Girona;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
17 Girona;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;94,14
17 Girona;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
17 Girona;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
17 Girona;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
17 Girona;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;96,31
17 Girona;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
17 Girona;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
17 Girona;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
17 Girona;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;91,43
17 Girona;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
17 Girona;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
17 Girona;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;91,69
17 Girona;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
17 Girona;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
17 Girona;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
17 Girona;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;94,11
17 Girona;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
17 Girona;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
17 Girona;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
17 Girona;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;89,42
17 Girona;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
17 Girona;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
17 Girona;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;88,65
17 Girona;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
17 Girona;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
17 Girona;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
17 Girona;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;91,3
17 Girona;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
17 Girona;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
17 Girona;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
17 Girona;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;87,07
17 Girona;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
17 Girona;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
17 Girona;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
17 Girona;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
17 Girona;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
17 Girona;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QII;17.476
17 Girona;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
17 Girona;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
17 Girona;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
17 Girona;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QII;17.630
17 Girona;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
17 Girona;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
17 Girona;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
17 Girona;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QII;17.377
17 Girona;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
17 Girona;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
17 Girona;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
17 Girona;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2022QII;17.002
17 Girona;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2022QI;""
17 Girona;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
17 Girona;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
17 Girona;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2021QII;17.225
17 Girona;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2021QI;""
17 Girona;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
17 Girona;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
17 Girona;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2020QII;17.054
17 Girona;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2020QI;""
17 Girona;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
17 Girona;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2022QIII;16.592
17 Girona;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2022QII;""
17 Girona;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2022QI;""
17 Girona;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
17 Girona;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2021QIII;16.829
17 Girona;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2021QII;""
17 Girona;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2021QI;""
17 Girona;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
17 Girona;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2020QIII;16.656
17 Girona;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2020QII;""
17 Girona;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2020QI;""
17 Girona;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QIV;16.061
17 Girona;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
17 Girona;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QII;""
17 Girona;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QI;""
17 Girona;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QIV;16.352
17 Girona;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
17 Girona;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QII;""
17 Girona;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QI;""
17 Girona;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QIV;16.262
17 Girona;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
17 Girona;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QII;""
17 Girona;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QI;""
17 Girona;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
17 Girona;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
17 Girona;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QII;""
17 Girona;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QI;15.983
17 Girona;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
17 Girona;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
17 Girona;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QII;""
17 Girona;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QI;16.016
17 Girona;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
17 Girona;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
17 Girona;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QII;""
17 Girona;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QI;""
17 Girona;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
17 Girona;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
17 Girona;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
17 Girona;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
17 Girona;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
17 Girona;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
17 Girona;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
17 Girona;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
17 Girona;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
17 Girona;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
17 Girona;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
17 Girona;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
17 Girona;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
17 Girona;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
17 Girona;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;97,29
17 Girona;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
17 Girona;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
17 Girona;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
17 Girona;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;97,7
17 Girona;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
17 Girona;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
17 Girona;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
17 Girona;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;98,14
17 Girona;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
17 Girona;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
17 Girona;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;94,94
17 Girona;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
17 Girona;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
17 Girona;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
17 Girona;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;95,46
17 Girona;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
17 Girona;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
17 Girona;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
17 Girona;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;95,85
17 Girona;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
17 Girona;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
17 Girona;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;91,9
17 Girona;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
17 Girona;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
17 Girona;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
17 Girona;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;92,75
17 Girona;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
17 Girona;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
17 Girona;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
17 Girona;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;93,58
17 Girona;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
17 Girona;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
17 Girona;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
17 Girona;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
17 Girona;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
17 Girona;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
17 Girona;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;90,66
17 Girona;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
17 Girona;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
17 Girona;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
17 Girona;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;92,17
17 Girona;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
17 Girona;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
17 Girona;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
17 Girona;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
17 Girona;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
17 Girona;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
17 Girona;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QII;11.282
17 Girona;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
17 Girona;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
17 Girona;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
17 Girona;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QII;11.453
17 Girona;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
17 Girona;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
17 Girona;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
17 Girona;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QII;11.317
17 Girona;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
17 Girona;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
17 Girona;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
17 Girona;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2022QII;11.014
17 Girona;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2022QI;""
17 Girona;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
17 Girona;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
17 Girona;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2021QII;11.200
17 Girona;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2021QI;""
17 Girona;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
17 Girona;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
17 Girona;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2020QII;11.130
17 Girona;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2020QI;""
17 Girona;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
17 Girona;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2022QIII;10.779
17 Girona;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2022QII;""
17 Girona;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2022QI;""
17 Girona;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
17 Girona;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2021QIII;10.958
17 Girona;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2021QII;""
17 Girona;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2021QI;""
17 Girona;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
17 Girona;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2020QIII;10.874
17 Girona;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2020QII;""
17 Girona;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2020QI;""
17 Girona;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QIV;10.469
17 Girona;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
17 Girona;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QII;""
17 Girona;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QI;""
17 Girona;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QIV;10.682
17 Girona;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
17 Girona;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QII;""
17 Girona;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QI;""
17 Girona;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QIV;10.648
17 Girona;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
17 Girona;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QII;""
17 Girona;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QI;""
17 Girona;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
17 Girona;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
17 Girona;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QII;""
17 Girona;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QI;10.451
17 Girona;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
17 Girona;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
17 Girona;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QII;""
17 Girona;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QI;10.479
17 Girona;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
17 Girona;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
17 Girona;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QII;""
17 Girona;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QI;""
17 Girona;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
17 Girona;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
17 Girona;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
17 Girona;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
17 Girona;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
17 Girona;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
17 Girona;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
17 Girona;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
17 Girona;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
17 Girona;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
17 Girona;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
17 Girona;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
17 Girona;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
17 Girona;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
17 Girona;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;97,62
17 Girona;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
17 Girona;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
17 Girona;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
17 Girona;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;97,79
17 Girona;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
17 Girona;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
17 Girona;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
17 Girona;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;98,35
17 Girona;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
17 Girona;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
17 Girona;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;95,54
17 Girona;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
17 Girona;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
17 Girona;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
17 Girona;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;95,68
17 Girona;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
17 Girona;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
17 Girona;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
17 Girona;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;96,09
17 Girona;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
17 Girona;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
17 Girona;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;92,79
17 Girona;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
17 Girona;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
17 Girona;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
17 Girona;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;93,27
17 Girona;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
17 Girona;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
17 Girona;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
17 Girona;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;94,09
17 Girona;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
17 Girona;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
17 Girona;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
17 Girona;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
17 Girona;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
17 Girona;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
17 Girona;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;91,25
17 Girona;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
17 Girona;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
17 Girona;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
17 Girona;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;92,6
17 Girona;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
17 Girona;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
17 Girona;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
17 Girona;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
17 Girona;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
17 Girona;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
17 Girona;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QII;6.194
17 Girona;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
17 Girona;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
17 Girona;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
17 Girona;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QII;6.177
17 Girona;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
17 Girona;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
17 Girona;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
17 Girona;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QII;6.060
17 Girona;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
17 Girona;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
17 Girona;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
17 Girona;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2022QII;5.988
17 Girona;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2022QI;""
17 Girona;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
17 Girona;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
17 Girona;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2021QII;6.025
17 Girona;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2021QI;""
17 Girona;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
17 Girona;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
17 Girona;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2020QII;5.924
17 Girona;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2020QI;""
17 Girona;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
17 Girona;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2022QIII;5.813
17 Girona;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2022QII;""
17 Girona;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2022QI;""
17 Girona;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
17 Girona;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2021QIII;5.871
17 Girona;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2021QII;""
17 Girona;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2021QI;""
17 Girona;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
17 Girona;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2020QIII;5.782
17 Girona;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2020QII;""
17 Girona;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2020QI;""
17 Girona;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QIV;5.592
17 Girona;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
17 Girona;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QII;""
17 Girona;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QI;""
17 Girona;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QIV;5.670
17 Girona;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
17 Girona;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QII;""
17 Girona;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QI;""
17 Girona;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QIV;5.614
17 Girona;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
17 Girona;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QII;""
17 Girona;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QI;""
17 Girona;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
17 Girona;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
17 Girona;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QII;""
17 Girona;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QI;5.532
17 Girona;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
17 Girona;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
17 Girona;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QII;""
17 Girona;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QI;5.537
17 Girona;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
17 Girona;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
17 Girona;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QII;""
17 Girona;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QI;""
17 Girona;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
17 Girona;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
17 Girona;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
17 Girona;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
17 Girona;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
17 Girona;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
17 Girona;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
17 Girona;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
17 Girona;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
17 Girona;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
17 Girona;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
17 Girona;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
17 Girona;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
17 Girona;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
17 Girona;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;96,67
17 Girona;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
17 Girona;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
17 Girona;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
17 Girona;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;97,54
17 Girona;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
17 Girona;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
17 Girona;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
17 Girona;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;97,76
17 Girona;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
17 Girona;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
17 Girona;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;93,85
17 Girona;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
17 Girona;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
17 Girona;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
17 Girona;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;95,05
17 Girona;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
17 Girona;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
17 Girona;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
17 Girona;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;95,41
17 Girona;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
17 Girona;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
17 Girona;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;90,28
17 Girona;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
17 Girona;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
17 Girona;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
17 Girona;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;91,79
17 Girona;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
17 Girona;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
17 Girona;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
17 Girona;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;92,64
17 Girona;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
17 Girona;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
17 Girona;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
17 Girona;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
17 Girona;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
17 Girona;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
17 Girona;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;89,56
17 Girona;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
17 Girona;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
17 Girona;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
17 Girona;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;91,37
17 Girona;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
17 Girona;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
17 Girona;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
17 Girona;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
17 Girona;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
17 Girona;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QIII;17.858
17 Girona;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
17 Girona;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
17 Girona;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
17 Girona;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QIII;18.117
17 Girona;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
17 Girona;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
17 Girona;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
17 Girona;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QIII;17.693
17 Girona;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
17 Girona;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
17 Girona;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
17 Girona;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2022QIII;17.257
17 Girona;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2022QII;""
17 Girona;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2022QI;""
17 Girona;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
17 Girona;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2021QIII;17.542
17 Girona;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2021QII;""
17 Girona;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2021QI;""
17 Girona;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
17 Girona;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2020QIII;17.137
17 Girona;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2020QII;""
17 Girona;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2020QI;""
17 Girona;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2022QIV;16.547
17 Girona;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
17 Girona;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2022QII;""
17 Girona;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2022QI;""
17 Girona;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2021QIV;16.919
17 Girona;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
17 Girona;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2021QII;""
17 Girona;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2021QI;""
17 Girona;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2020QIV;16.673
17 Girona;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
17 Girona;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2020QII;""
17 Girona;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2020QI;""
17 Girona;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
17 Girona;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
17 Girona;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QII;""
17 Girona;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QI;16.510
17 Girona;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
17 Girona;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
17 Girona;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QII;""
17 Girona;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QI;16.411
17 Girona;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
17 Girona;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
17 Girona;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QII;""
17 Girona;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QI;""
17 Girona;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
17 Girona;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
17 Girona;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QII;16.176
17 Girona;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QI;""
17 Girona;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
17 Girona;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
17 Girona;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QII;16.148
17 Girona;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QI;""
17 Girona;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
17 Girona;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
17 Girona;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QII;""
17 Girona;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QI;""
17 Girona;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
17 Girona;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
17 Girona;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
17 Girona;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
17 Girona;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
17 Girona;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
17 Girona;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
17 Girona;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
17 Girona;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
17 Girona;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
17 Girona;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
17 Girona;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
17 Girona;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
17 Girona;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;96,63
17 Girona;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
17 Girona;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
17 Girona;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
17 Girona;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;96,83
17 Girona;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
17 Girona;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
17 Girona;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
17 Girona;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;96,86
17 Girona;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
17 Girona;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
17 Girona;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;92,66
17 Girona;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
17 Girona;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
17 Girona;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
17 Girona;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;93,39
17 Girona;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
17 Girona;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
17 Girona;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
17 Girona;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;94,24
17 Girona;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
17 Girona;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
17 Girona;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
17 Girona;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
17 Girona;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
17 Girona;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
17 Girona;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;91,13
17 Girona;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
17 Girona;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
17 Girona;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
17 Girona;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;92,75
17 Girona;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
17 Girona;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
17 Girona;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
17 Girona;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
17 Girona;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
17 Girona;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
17 Girona;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;89,29
17 Girona;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
17 Girona;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
17 Girona;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
17 Girona;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;91,27
17 Girona;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
17 Girona;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
17 Girona;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
17 Girona;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
17 Girona;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
17 Girona;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
17 Girona;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QIII;11.507
17 Girona;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
17 Girona;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
17 Girona;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
17 Girona;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QIII;11.732
17 Girona;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
17 Girona;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
17 Girona;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
17 Girona;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QIII;11.521
17 Girona;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
17 Girona;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
17 Girona;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
17 Girona;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2022QIII;11.162
17 Girona;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2022QII;""
17 Girona;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2022QI;""
17 Girona;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
17 Girona;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2021QIII;11.395
17 Girona;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2021QII;""
17 Girona;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2021QI;""
17 Girona;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
17 Girona;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2020QIII;11.176
17 Girona;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2020QII;""
17 Girona;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2020QI;""
17 Girona;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2022QIV;10.764
17 Girona;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
17 Girona;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2022QII;""
17 Girona;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2022QI;""
17 Girona;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2021QIV;11.032
17 Girona;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
17 Girona;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2021QII;""
17 Girona;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2021QI;""
17 Girona;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2020QIV;10.917
17 Girona;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
17 Girona;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2020QII;""
17 Girona;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2020QI;""
17 Girona;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
17 Girona;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
17 Girona;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QII;""
17 Girona;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QI;10.774
17 Girona;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
17 Girona;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
17 Girona;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QII;""
17 Girona;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QI;10.737
17 Girona;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
17 Girona;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
17 Girona;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QII;""
17 Girona;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QI;""
17 Girona;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
17 Girona;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
17 Girona;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QII;10.581
17 Girona;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QI;""
17 Girona;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
17 Girona;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
17 Girona;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QII;10.566
17 Girona;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QI;""
17 Girona;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
17 Girona;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
17 Girona;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QII;""
17 Girona;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QI;""
17 Girona;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
17 Girona;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
17 Girona;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
17 Girona;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
17 Girona;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
17 Girona;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
17 Girona;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
17 Girona;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
17 Girona;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
17 Girona;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
17 Girona;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
17 Girona;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
17 Girona;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
17 Girona;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;97
17 Girona;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
17 Girona;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
17 Girona;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
17 Girona;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;97,13
17 Girona;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
17 Girona;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
17 Girona;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
17 Girona;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;97,01
17 Girona;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
17 Girona;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
17 Girona;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;93,54
17 Girona;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
17 Girona;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
17 Girona;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
17 Girona;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;94,03
17 Girona;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
17 Girona;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
17 Girona;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
17 Girona;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;94,76
17 Girona;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
17 Girona;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
17 Girona;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
17 Girona;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
17 Girona;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
17 Girona;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
17 Girona;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;91,83
17 Girona;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
17 Girona;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
17 Girona;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
17 Girona;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;93,2
17 Girona;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
17 Girona;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
17 Girona;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
17 Girona;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
17 Girona;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
17 Girona;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
17 Girona;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;90,19
17 Girona;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
17 Girona;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
17 Girona;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
17 Girona;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;91,71
17 Girona;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
17 Girona;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
17 Girona;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
17 Girona;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
17 Girona;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
17 Girona;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
17 Girona;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QIII;6.351
17 Girona;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
17 Girona;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
17 Girona;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
17 Girona;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QIII;6.385
17 Girona;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
17 Girona;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
17 Girona;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
17 Girona;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QIII;6.172
17 Girona;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
17 Girona;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
17 Girona;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
17 Girona;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2022QIII;6.095
17 Girona;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2022QII;""
17 Girona;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2022QI;""
17 Girona;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
17 Girona;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2021QIII;6.147
17 Girona;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2021QII;""
17 Girona;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2021QI;""
17 Girona;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
17 Girona;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2020QIII;5.961
17 Girona;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2020QII;""
17 Girona;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2020QI;""
17 Girona;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2022QIV;5.783
17 Girona;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
17 Girona;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2022QII;""
17 Girona;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2022QI;""
17 Girona;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2021QIV;5.887
17 Girona;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
17 Girona;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2021QII;""
17 Girona;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2021QI;""
17 Girona;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2020QIV;5.756
17 Girona;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
17 Girona;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2020QII;""
17 Girona;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2020QI;""
17 Girona;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
17 Girona;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
17 Girona;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QII;""
17 Girona;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QI;5.736
17 Girona;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
17 Girona;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
17 Girona;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QII;""
17 Girona;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QI;5.674
17 Girona;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
17 Girona;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
17 Girona;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QII;""
17 Girona;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QI;""
17 Girona;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
17 Girona;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
17 Girona;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QII;5.595
17 Girona;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QI;""
17 Girona;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
17 Girona;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
17 Girona;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QII;5.582
17 Girona;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QI;""
17 Girona;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
17 Girona;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
17 Girona;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QII;""
17 Girona;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QI;""
17 Girona;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
17 Girona;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
17 Girona;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
17 Girona;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
17 Girona;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
17 Girona;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
17 Girona;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
17 Girona;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
17 Girona;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
17 Girona;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
17 Girona;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
17 Girona;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
17 Girona;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
17 Girona;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;95,97
17 Girona;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
17 Girona;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
17 Girona;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
17 Girona;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;96,27
17 Girona;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
17 Girona;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
17 Girona;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
17 Girona;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;96,58
17 Girona;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
17 Girona;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
17 Girona;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;91,06
17 Girona;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
17 Girona;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
17 Girona;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
17 Girona;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;92,2
17 Girona;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
17 Girona;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
17 Girona;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
17 Girona;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;93,26
17 Girona;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
17 Girona;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
17 Girona;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
17 Girona;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
17 Girona;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
17 Girona;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
17 Girona;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;89,84
17 Girona;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
17 Girona;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
17 Girona;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
17 Girona;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;91,93
17 Girona;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
17 Girona;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
17 Girona;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
17 Girona;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
17 Girona;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
17 Girona;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
17 Girona;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;87,63
17 Girona;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
17 Girona;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
17 Girona;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
17 Girona;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;90,44
17 Girona;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
17 Girona;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
17 Girona;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
17 Girona;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
17 Girona;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
17 Girona;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QIV;17.746
17 Girona;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
17 Girona;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
17 Girona;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
17 Girona;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QIV;18.048
17 Girona;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
17 Girona;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
17 Girona;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
17 Girona;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QIV;17.719
17 Girona;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
17 Girona;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
17 Girona;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
17 Girona;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2022QIV;16.967
17 Girona;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
17 Girona;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2022QII;""
17 Girona;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2022QI;""
17 Girona;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2021QIV;17.348
17 Girona;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
17 Girona;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2021QII;""
17 Girona;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2021QI;""
17 Girona;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2020QIV;17.159
17 Girona;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
17 Girona;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2020QII;""
17 Girona;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2020QI;""
17 Girona;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
17 Girona;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
17 Girona;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2022QII;""
17 Girona;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2022QI;16.904
17 Girona;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
17 Girona;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
17 Girona;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2021QII;""
17 Girona;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2021QI;16.863
17 Girona;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
17 Girona;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
17 Girona;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2020QII;""
17 Girona;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2020QI;""
17 Girona;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
17 Girona;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
17 Girona;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QII;16.540
17 Girona;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QI;""
17 Girona;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
17 Girona;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
17 Girona;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QII;16.566
17 Girona;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QI;""
17 Girona;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
17 Girona;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
17 Girona;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QII;""
17 Girona;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QI;""
17 Girona;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
17 Girona;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QIII;16.201
17 Girona;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QII;""
17 Girona;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QI;""
17 Girona;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
17 Girona;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QIII;16.254
17 Girona;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QII;""
17 Girona;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QI;""
17 Girona;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
17 Girona;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
17 Girona;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QII;""
17 Girona;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QI;""
17 Girona;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
17 Girona;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
17 Girona;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
17 Girona;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
17 Girona;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
17 Girona;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
17 Girona;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
17 Girona;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
17 Girona;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
17 Girona;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
17 Girona;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
17 Girona;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
17 Girona;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;95,61
17 Girona;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
17 Girona;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
17 Girona;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
17 Girona;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;96,12
17 Girona;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
17 Girona;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
17 Girona;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
17 Girona;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;96,84
17 Girona;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
17 Girona;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
17 Girona;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
17 Girona;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
17 Girona;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
17 Girona;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
17 Girona;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;93,66
17 Girona;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
17 Girona;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
17 Girona;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
17 Girona;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;95,17
17 Girona;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
17 Girona;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
17 Girona;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
17 Girona;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
17 Girona;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
17 Girona;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
17 Girona;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;91,64
17 Girona;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
17 Girona;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
17 Girona;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
17 Girona;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;93,49
17 Girona;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
17 Girona;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
17 Girona;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
17 Girona;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
17 Girona;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
17 Girona;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
17 Girona;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;89,77
17 Girona;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
17 Girona;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
17 Girona;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
17 Girona;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;91,73
17 Girona;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
17 Girona;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
17 Girona;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
17 Girona;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
17 Girona;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
17 Girona;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
17 Girona;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QIV;11.437
17 Girona;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
17 Girona;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
17 Girona;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
17 Girona;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QIV;11.694
17 Girona;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
17 Girona;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
17 Girona;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
17 Girona;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QIV;11.520
17 Girona;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
17 Girona;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
17 Girona;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
17 Girona;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2022QIV;10.999
17 Girona;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
17 Girona;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2022QII;""
17 Girona;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2022QI;""
17 Girona;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2021QIV;11.285
17 Girona;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
17 Girona;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2021QII;""
17 Girona;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2021QI;""
17 Girona;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2020QIV;11.209
17 Girona;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
17 Girona;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2020QII;""
17 Girona;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2020QI;""
17 Girona;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
17 Girona;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
17 Girona;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2022QII;""
17 Girona;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2022QI;11.005
17 Girona;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
17 Girona;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
17 Girona;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2021QII;""
17 Girona;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2021QI;11.007
17 Girona;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
17 Girona;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
17 Girona;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2020QII;""
17 Girona;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2020QI;""
17 Girona;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
17 Girona;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
17 Girona;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QII;10.796
17 Girona;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QI;""
17 Girona;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
17 Girona;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
17 Girona;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QII;10.818
17 Girona;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QI;""
17 Girona;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
17 Girona;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
17 Girona;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QII;""
17 Girona;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QI;""
17 Girona;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
17 Girona;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QIII;10.599
17 Girona;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QII;""
17 Girona;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QI;""
17 Girona;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
17 Girona;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QIII;10.625
17 Girona;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QII;""
17 Girona;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QI;""
17 Girona;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
17 Girona;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
17 Girona;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QII;""
17 Girona;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QI;""
17 Girona;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
17 Girona;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
17 Girona;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
17 Girona;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
17 Girona;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
17 Girona;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
17 Girona;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
17 Girona;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
17 Girona;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
17 Girona;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
17 Girona;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
17 Girona;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
17 Girona;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;96,17
17 Girona;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
17 Girona;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
17 Girona;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
17 Girona;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;96,5
17 Girona;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
17 Girona;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
17 Girona;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
17 Girona;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;97,3
17 Girona;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
17 Girona;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
17 Girona;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
17 Girona;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
17 Girona;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
17 Girona;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
17 Girona;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;94,11
17 Girona;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
17 Girona;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
17 Girona;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
17 Girona;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;95,55
17 Girona;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
17 Girona;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
17 Girona;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
17 Girona;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
17 Girona;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
17 Girona;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
17 Girona;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;92,32
17 Girona;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
17 Girona;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
17 Girona;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
17 Girona;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;93,91
17 Girona;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
17 Girona;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
17 Girona;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
17 Girona;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
17 Girona;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
17 Girona;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
17 Girona;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;90,64
17 Girona;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
17 Girona;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
17 Girona;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
17 Girona;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;92,23
17 Girona;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
17 Girona;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
17 Girona;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
17 Girona;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
17 Girona;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
17 Girona;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
17 Girona;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QIV;6.309
17 Girona;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
17 Girona;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
17 Girona;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
17 Girona;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QIV;6.354
17 Girona;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
17 Girona;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
17 Girona;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
17 Girona;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QIV;6.199
17 Girona;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
17 Girona;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
17 Girona;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
17 Girona;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2022QIV;5.968
17 Girona;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
17 Girona;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2022QII;""
17 Girona;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2022QI;""
17 Girona;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2021QIV;6.063
17 Girona;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
17 Girona;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2021QII;""
17 Girona;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2021QI;""
17 Girona;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2020QIV;5.950
17 Girona;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
17 Girona;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2020QII;""
17 Girona;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2020QI;""
17 Girona;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
17 Girona;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
17 Girona;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2022QII;""
17 Girona;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2022QI;5.899
17 Girona;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
17 Girona;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
17 Girona;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2021QII;""
17 Girona;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2021QI;5.856
17 Girona;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
17 Girona;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
17 Girona;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2020QII;""
17 Girona;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2020QI;""
17 Girona;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
17 Girona;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
17 Girona;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QII;5.744
17 Girona;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QI;""
17 Girona;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
17 Girona;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
17 Girona;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QII;5.748
17 Girona;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QI;""
17 Girona;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
17 Girona;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
17 Girona;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QII;""
17 Girona;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QI;""
17 Girona;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
17 Girona;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QIII;5.602
17 Girona;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QII;""
17 Girona;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QI;""
17 Girona;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
17 Girona;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QIII;5.629
17 Girona;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QII;""
17 Girona;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QI;""
17 Girona;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
17 Girona;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
17 Girona;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QII;""
17 Girona;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QI;""
17 Girona;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
17 Girona;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
17 Girona;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
17 Girona;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
17 Girona;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
17 Girona;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
17 Girona;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
17 Girona;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
17 Girona;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
17 Girona;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
17 Girona;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
17 Girona;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
17 Girona;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;94,6
17 Girona;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
17 Girona;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
17 Girona;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
17 Girona;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;95,42
17 Girona;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
17 Girona;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
17 Girona;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
17 Girona;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;95,98
17 Girona;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
17 Girona;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
17 Girona;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
17 Girona;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
17 Girona;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
17 Girona;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
17 Girona;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;92,84
17 Girona;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
17 Girona;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
17 Girona;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
17 Girona;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;94,47
17 Girona;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
17 Girona;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
17 Girona;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
17 Girona;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
17 Girona;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
17 Girona;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
17 Girona;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;90,4
17 Girona;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
17 Girona;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
17 Girona;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
17 Girona;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;92,72
17 Girona;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
17 Girona;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
17 Girona;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
17 Girona;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
17 Girona;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
17 Girona;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
17 Girona;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;88,16
17 Girona;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
17 Girona;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
17 Girona;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
17 Girona;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;90,8
17 Girona;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
17 Girona;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
17 Girona;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
17 Girona;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
17 Girona;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
17 Girona;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
17 Girona;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
17 Girona;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
17 Girona;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
17 Girona;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QI;16.523
17 Girona;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
17 Girona;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
17 Girona;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
17 Girona;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QI;16.134
17 Girona;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
17 Girona;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
17 Girona;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
17 Girona;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QI;16.581
17 Girona;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
17 Girona;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
17 Girona;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2022QII;""
17 Girona;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2022QI;16.184
17 Girona;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
17 Girona;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
17 Girona;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2021QII;""
17 Girona;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2021QI;15.891
17 Girona;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
17 Girona;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
17 Girona;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2020QII;""
17 Girona;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2020QI;15.800
17 Girona;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
17 Girona;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
17 Girona;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2022QII;15.864
17 Girona;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2022QI;""
17 Girona;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
17 Girona;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
17 Girona;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2021QII;15.632
17 Girona;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2021QI;""
17 Girona;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
17 Girona;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
17 Girona;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2020QII;15.562
17 Girona;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2020QI;""
17 Girona;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
17 Girona;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QIII;15.583
17 Girona;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QII;""
17 Girona;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QI;""
17 Girona;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
17 Girona;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QIII;15.401
17 Girona;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QII;""
17 Girona;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QI;""
17 Girona;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
17 Girona;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QIII;15.302
17 Girona;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QII;""
17 Girona;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QI;""
17 Girona;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QIV;15.227
17 Girona;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
17 Girona;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QII;""
17 Girona;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QI;""
17 Girona;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QIV;15.088
17 Girona;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
17 Girona;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QII;""
17 Girona;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QI;""
17 Girona;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QIV;15.041
17 Girona;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
17 Girona;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QII;""
17 Girona;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QI;""
17 Girona;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
17 Girona;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
17 Girona;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
17 Girona;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
17 Girona;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
17 Girona;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
17 Girona;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
17 Girona;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
17 Girona;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
17 Girona;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
17 Girona;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
17 Girona;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
17 Girona;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
17 Girona;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
17 Girona;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
17 Girona;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;97,95
17 Girona;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
17 Girona;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
17 Girona;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
17 Girona;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;98,49
17 Girona;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
17 Girona;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
17 Girona;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
17 Girona;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;95,29
17 Girona;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
17 Girona;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
17 Girona;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;96,01
17 Girona;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
17 Girona;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
17 Girona;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
17 Girona;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;96,89
17 Girona;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
17 Girona;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
17 Girona;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
17 Girona;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;93,85
17 Girona;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
17 Girona;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
17 Girona;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;94,31
17 Girona;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
17 Girona;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
17 Girona;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
17 Girona;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;95,46
17 Girona;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
17 Girona;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
17 Girona;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
17 Girona;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;92,29
17 Girona;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
17 Girona;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
17 Girona;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;92,16
17 Girona;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
17 Girona;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
17 Girona;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
17 Girona;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;93,52
17 Girona;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
17 Girona;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
17 Girona;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
17 Girona;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;90,71
17 Girona;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
17 Girona;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
17 Girona;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
17 Girona;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
17 Girona;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
17 Girona;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
17 Girona;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QI;10.512
17 Girona;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
17 Girona;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
17 Girona;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
17 Girona;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QI;10.259
17 Girona;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
17 Girona;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
17 Girona;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
17 Girona;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QI;10.526
17 Girona;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
17 Girona;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
17 Girona;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2022QII;""
17 Girona;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2022QI;10.287
17 Girona;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
17 Girona;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
17 Girona;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2021QII;""
17 Girona;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2021QI;10.097
17 Girona;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
17 Girona;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
17 Girona;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2020QII;""
17 Girona;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2020QI;10.068
17 Girona;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
17 Girona;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
17 Girona;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2022QII;10.103
17 Girona;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2022QI;""
17 Girona;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
17 Girona;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
17 Girona;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2021QII;9.944
17 Girona;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2021QI;""
17 Girona;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
17 Girona;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
17 Girona;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2020QII;9.929
17 Girona;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2020QI;""
17 Girona;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
17 Girona;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QIII;9.933
17 Girona;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QII;""
17 Girona;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QI;""
17 Girona;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
17 Girona;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QIII;9.808
17 Girona;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QII;""
17 Girona;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QI;""
17 Girona;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
17 Girona;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QIII;9.780
17 Girona;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QII;""
17 Girona;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QI;""
17 Girona;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QIV;9.709
17 Girona;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
17 Girona;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QII;""
17 Girona;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QI;""
17 Girona;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QIV;9.620
17 Girona;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
17 Girona;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QII;""
17 Girona;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QI;""
17 Girona;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QIV;9.621
17 Girona;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
17 Girona;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QII;""
17 Girona;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QI;""
17 Girona;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
17 Girona;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
17 Girona;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
17 Girona;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
17 Girona;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
17 Girona;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
17 Girona;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
17 Girona;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
17 Girona;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
17 Girona;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
17 Girona;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
17 Girona;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
17 Girona;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
17 Girona;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
17 Girona;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
17 Girona;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;97,86
17 Girona;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
17 Girona;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
17 Girona;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
17 Girona;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;98,42
17 Girona;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
17 Girona;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
17 Girona;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
17 Girona;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;95,65
17 Girona;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
17 Girona;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
17 Girona;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;96,11
17 Girona;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
17 Girona;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
17 Girona;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
17 Girona;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;96,93
17 Girona;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
17 Girona;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
17 Girona;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
17 Girona;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;94,33
17 Girona;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
17 Girona;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
17 Girona;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;94,49
17 Girona;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
17 Girona;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
17 Girona;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
17 Girona;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;95,6
17 Girona;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
17 Girona;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
17 Girona;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
17 Girona;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;92,91
17 Girona;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
17 Girona;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
17 Girona;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;92,36
17 Girona;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
17 Girona;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
17 Girona;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
17 Girona;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;93,77
17 Girona;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
17 Girona;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
17 Girona;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
17 Girona;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;91,4
17 Girona;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
17 Girona;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
17 Girona;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
17 Girona;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
17 Girona;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
17 Girona;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
17 Girona;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QI;6.011
17 Girona;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
17 Girona;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
17 Girona;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
17 Girona;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QI;5.875
17 Girona;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
17 Girona;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
17 Girona;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
17 Girona;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QI;6.055
17 Girona;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
17 Girona;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
17 Girona;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2022QII;""
17 Girona;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2022QI;5.897
17 Girona;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
17 Girona;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
17 Girona;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2021QII;""
17 Girona;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2021QI;5.794
17 Girona;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
17 Girona;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
17 Girona;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2020QII;""
17 Girona;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2020QI;5.732
17 Girona;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
17 Girona;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
17 Girona;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2022QII;5.761
17 Girona;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2022QI;""
17 Girona;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
17 Girona;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
17 Girona;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2021QII;5.688
17 Girona;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2021QI;""
17 Girona;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
17 Girona;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
17 Girona;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2020QII;5.633
17 Girona;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2020QI;""
17 Girona;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
17 Girona;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QIII;5.650
17 Girona;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QII;""
17 Girona;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QI;""
17 Girona;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
17 Girona;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QIII;5.593
17 Girona;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QII;""
17 Girona;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QI;""
17 Girona;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
17 Girona;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QIII;5.522
17 Girona;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QII;""
17 Girona;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QI;""
17 Girona;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QIV;5.518
17 Girona;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
17 Girona;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QII;""
17 Girona;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QI;""
17 Girona;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QIV;5.468
17 Girona;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
17 Girona;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QII;""
17 Girona;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QI;""
17 Girona;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QIV;5.420
17 Girona;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
17 Girona;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QII;""
17 Girona;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QI;""
17 Girona;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
17 Girona;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
17 Girona;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
17 Girona;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
17 Girona;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
17 Girona;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
17 Girona;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
17 Girona;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
17 Girona;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
17 Girona;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
17 Girona;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
17 Girona;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
17 Girona;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
17 Girona;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
17 Girona;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
17 Girona;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;98,1
17 Girona;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
17 Girona;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
17 Girona;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
17 Girona;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;98,62
17 Girona;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
17 Girona;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
17 Girona;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
17 Girona;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;94,67
17 Girona;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
17 Girona;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
17 Girona;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;95,84
17 Girona;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
17 Girona;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
17 Girona;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
17 Girona;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;96,82
17 Girona;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
17 Girona;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
17 Girona;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
17 Girona;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;93,03
17 Girona;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
17 Girona;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
17 Girona;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;93,99
17 Girona;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
17 Girona;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
17 Girona;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
17 Girona;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;95,2
17 Girona;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
17 Girona;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
17 Girona;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
17 Girona;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;91,2
17 Girona;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
17 Girona;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
17 Girona;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;91,8
17 Girona;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
17 Girona;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
17 Girona;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
17 Girona;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;93,07
17 Girona;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
17 Girona;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
17 Girona;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
17 Girona;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;89,51
17 Girona;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
17 Girona;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
17 Girona;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
17 Girona;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
17 Girona;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
17 Girona;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QII;16.879
17 Girona;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
17 Girona;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
17 Girona;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
17 Girona;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QII;16.660
17 Girona;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
17 Girona;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
17 Girona;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
17 Girona;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QII;16.215
17 Girona;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
17 Girona;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
17 Girona;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
17 Girona;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2022QII;16.497
17 Girona;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2022QI;""
17 Girona;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
17 Girona;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
17 Girona;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2021QII;16.354
17 Girona;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2021QI;""
17 Girona;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
17 Girona;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
17 Girona;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2020QII;15.953
17 Girona;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2020QI;""
17 Girona;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
17 Girona;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2022QIII;16.166
17 Girona;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2022QII;""
17 Girona;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2022QI;""
17 Girona;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
17 Girona;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2021QIII;16.075
17 Girona;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2021QII;""
17 Girona;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2021QI;""
17 Girona;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
17 Girona;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2020QIII;15.665
17 Girona;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2020QII;""
17 Girona;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2020QI;""
17 Girona;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QIV;15.731
17 Girona;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
17 Girona;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QII;""
17 Girona;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QI;""
17 Girona;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QIV;15.697
17 Girona;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
17 Girona;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QII;""
17 Girona;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QI;""
17 Girona;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QIV;15.364
17 Girona;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
17 Girona;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QII;""
17 Girona;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QI;""
17 Girona;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
17 Girona;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
17 Girona;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QII;""
17 Girona;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QI;15.421
17 Girona;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
17 Girona;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
17 Girona;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QII;""
17 Girona;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QI;15.176
17 Girona;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
17 Girona;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
17 Girona;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QII;""
17 Girona;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QI;""
17 Girona;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
17 Girona;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
17 Girona;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
17 Girona;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
17 Girona;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
17 Girona;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
17 Girona;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
17 Girona;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
17 Girona;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
17 Girona;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
17 Girona;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
17 Girona;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
17 Girona;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
17 Girona;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
17 Girona;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;97,74
17 Girona;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
17 Girona;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
17 Girona;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
17 Girona;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;98,16
17 Girona;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
17 Girona;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
17 Girona;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
17 Girona;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;98,38
17 Girona;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
17 Girona;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
17 Girona;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;95,78
17 Girona;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
17 Girona;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
17 Girona;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
17 Girona;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;96,49
17 Girona;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
17 Girona;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
17 Girona;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
17 Girona;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;96,61
17 Girona;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
17 Girona;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
17 Girona;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;93,2
17 Girona;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
17 Girona;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
17 Girona;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
17 Girona;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;94,22
17 Girona;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
17 Girona;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
17 Girona;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
17 Girona;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;94,75
17 Girona;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
17 Girona;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
17 Girona;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
17 Girona;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
17 Girona;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
17 Girona;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
17 Girona;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;92,56
17 Girona;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
17 Girona;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
17 Girona;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
17 Girona;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;93,59
17 Girona;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
17 Girona;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
17 Girona;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
17 Girona;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
17 Girona;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
17 Girona;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
17 Girona;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QII;10.730
17 Girona;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
17 Girona;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
17 Girona;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
17 Girona;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QII;10.574
17 Girona;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
17 Girona;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
17 Girona;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
17 Girona;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QII;10.318
17 Girona;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
17 Girona;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
17 Girona;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
17 Girona;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2022QII;10.506
17 Girona;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2022QI;""
17 Girona;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
17 Girona;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
17 Girona;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2021QII;10.390
17 Girona;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2021QI;""
17 Girona;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
17 Girona;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
17 Girona;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2020QII;10.165
17 Girona;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2020QI;""
17 Girona;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
17 Girona;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2022QIII;10.302
17 Girona;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2022QII;""
17 Girona;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2022QI;""
17 Girona;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
17 Girona;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2021QIII;10.222
17 Girona;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2021QII;""
17 Girona;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2021QI;""
17 Girona;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
17 Girona;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2020QIII;10.002
17 Girona;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2020QII;""
17 Girona;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2020QI;""
17 Girona;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QIV;10.032
17 Girona;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
17 Girona;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QII;""
17 Girona;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QI;""
17 Girona;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QIV;10.001
17 Girona;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
17 Girona;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QII;""
17 Girona;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QI;""
17 Girona;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QIV;9.818
17 Girona;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
17 Girona;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QII;""
17 Girona;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QI;""
17 Girona;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
17 Girona;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
17 Girona;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QII;""
17 Girona;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QI;9.823
17 Girona;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
17 Girona;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
17 Girona;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QII;""
17 Girona;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QI;9.687
17 Girona;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
17 Girona;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
17 Girona;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QII;""
17 Girona;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QI;""
17 Girona;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
17 Girona;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
17 Girona;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
17 Girona;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
17 Girona;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
17 Girona;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
17 Girona;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
17 Girona;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
17 Girona;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
17 Girona;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
17 Girona;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
17 Girona;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
17 Girona;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
17 Girona;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
17 Girona;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;97,91
17 Girona;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
17 Girona;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
17 Girona;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
17 Girona;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;98,26
17 Girona;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
17 Girona;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
17 Girona;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
17 Girona;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;98,52
17 Girona;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
17 Girona;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
17 Girona;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;96,01
17 Girona;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
17 Girona;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
17 Girona;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
17 Girona;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;96,67
17 Girona;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
17 Girona;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
17 Girona;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
17 Girona;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;96,94
17 Girona;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
17 Girona;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
17 Girona;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;93,49
17 Girona;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
17 Girona;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
17 Girona;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
17 Girona;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;94,58
17 Girona;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
17 Girona;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
17 Girona;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
17 Girona;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;95,15
17 Girona;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
17 Girona;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
17 Girona;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
17 Girona;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
17 Girona;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
17 Girona;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
17 Girona;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;92,9
17 Girona;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
17 Girona;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
17 Girona;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
17 Girona;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;93,88
17 Girona;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
17 Girona;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
17 Girona;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
17 Girona;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
17 Girona;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
17 Girona;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
17 Girona;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QII;6.149
17 Girona;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
17 Girona;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
17 Girona;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
17 Girona;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QII;6.086
17 Girona;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
17 Girona;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
17 Girona;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
17 Girona;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QII;5.897
17 Girona;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
17 Girona;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
17 Girona;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
17 Girona;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2022QII;5.991
17 Girona;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2022QI;""
17 Girona;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
17 Girona;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
17 Girona;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2021QII;5.964
17 Girona;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2021QI;""
17 Girona;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
17 Girona;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
17 Girona;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2020QII;5.788
17 Girona;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2020QI;""
17 Girona;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
17 Girona;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2022QIII;5.864
17 Girona;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2022QII;""
17 Girona;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2022QI;""
17 Girona;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
17 Girona;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2021QIII;5.853
17 Girona;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2021QII;""
17 Girona;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2021QI;""
17 Girona;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
17 Girona;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2020QIII;5.663
17 Girona;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2020QII;""
17 Girona;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2020QI;""
17 Girona;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QIV;5.699
17 Girona;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
17 Girona;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QII;""
17 Girona;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QI;""
17 Girona;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QIV;5.696
17 Girona;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
17 Girona;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QII;""
17 Girona;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QI;""
17 Girona;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QIV;5.546
17 Girona;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
17 Girona;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QII;""
17 Girona;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QI;""
17 Girona;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
17 Girona;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
17 Girona;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QII;""
17 Girona;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QI;5.598
17 Girona;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
17 Girona;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
17 Girona;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QII;""
17 Girona;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QI;5.489
17 Girona;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
17 Girona;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
17 Girona;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QII;""
17 Girona;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QI;""
17 Girona;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
17 Girona;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
17 Girona;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
17 Girona;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
17 Girona;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
17 Girona;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
17 Girona;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
17 Girona;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
17 Girona;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
17 Girona;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
17 Girona;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
17 Girona;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
17 Girona;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
17 Girona;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
17 Girona;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;97,43
17 Girona;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
17 Girona;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
17 Girona;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
17 Girona;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;98
17 Girona;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
17 Girona;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
17 Girona;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
17 Girona;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;98,15
17 Girona;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
17 Girona;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
17 Girona;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;95,37
17 Girona;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
17 Girona;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
17 Girona;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
17 Girona;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;96,17
17 Girona;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
17 Girona;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
17 Girona;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
17 Girona;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;96,03
17 Girona;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
17 Girona;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
17 Girona;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;92,68
17 Girona;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
17 Girona;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
17 Girona;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
17 Girona;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;93,59
17 Girona;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
17 Girona;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
17 Girona;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
17 Girona;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;94,05
17 Girona;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
17 Girona;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
17 Girona;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
17 Girona;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
17 Girona;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
17 Girona;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
17 Girona;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;91,98
17 Girona;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
17 Girona;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
17 Girona;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
17 Girona;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;93,08
17 Girona;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
17 Girona;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
17 Girona;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
17 Girona;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
17 Girona;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
17 Girona;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QIII;17.161
17 Girona;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
17 Girona;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
17 Girona;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
17 Girona;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QIII;16.922
17 Girona;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
17 Girona;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
17 Girona;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
17 Girona;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QIII;16.400
17 Girona;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
17 Girona;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
17 Girona;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
17 Girona;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2022QIII;16.662
17 Girona;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2022QII;""
17 Girona;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2022QI;""
17 Girona;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
17 Girona;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2021QIII;16.481
17 Girona;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2021QII;""
17 Girona;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2021QI;""
17 Girona;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
17 Girona;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2020QIII;15.986
17 Girona;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2020QII;""
17 Girona;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2020QI;""
17 Girona;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2022QIV;16.073
17 Girona;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
17 Girona;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2022QII;""
17 Girona;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2022QI;""
17 Girona;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2021QIV;15.980
17 Girona;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
17 Girona;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2021QII;""
17 Girona;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2021QI;""
17 Girona;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2020QIV;15.606
17 Girona;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
17 Girona;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2020QII;""
17 Girona;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2020QI;""
17 Girona;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
17 Girona;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
17 Girona;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QII;""
17 Girona;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QI;15.689
17 Girona;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
17 Girona;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
17 Girona;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QII;""
17 Girona;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QI;15.403
17 Girona;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
17 Girona;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
17 Girona;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QII;""
17 Girona;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QI;""
17 Girona;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
17 Girona;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
17 Girona;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QII;15.418
17 Girona;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QI;""
17 Girona;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
17 Girona;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
17 Girona;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QII;15.191
17 Girona;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QI;""
17 Girona;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
17 Girona;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
17 Girona;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QII;""
17 Girona;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QI;""
17 Girona;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
17 Girona;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
17 Girona;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
17 Girona;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
17 Girona;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
17 Girona;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
17 Girona;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
17 Girona;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
17 Girona;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
17 Girona;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
17 Girona;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
17 Girona;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
17 Girona;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
17 Girona;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;97,09
17 Girona;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
17 Girona;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
17 Girona;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
17 Girona;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;97,39
17 Girona;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
17 Girona;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
17 Girona;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
17 Girona;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;97,48
17 Girona;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
17 Girona;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
17 Girona;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;93,66
17 Girona;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
17 Girona;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
17 Girona;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
17 Girona;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;94,43
17 Girona;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
17 Girona;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
17 Girona;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
17 Girona;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;95,16
17 Girona;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
17 Girona;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
17 Girona;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
17 Girona;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
17 Girona;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
17 Girona;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
17 Girona;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;92,71
17 Girona;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
17 Girona;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
17 Girona;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
17 Girona;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;93,92
17 Girona;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
17 Girona;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
17 Girona;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
17 Girona;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
17 Girona;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
17 Girona;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
17 Girona;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;91,11
17 Girona;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
17 Girona;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
17 Girona;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
17 Girona;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;92,63
17 Girona;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
17 Girona;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
17 Girona;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
17 Girona;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
17 Girona;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
17 Girona;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
17 Girona;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QIII;10.862
17 Girona;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
17 Girona;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
17 Girona;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
17 Girona;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QIII;10.707
17 Girona;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
17 Girona;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
17 Girona;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
17 Girona;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QIII;10.421
17 Girona;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
17 Girona;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
17 Girona;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
17 Girona;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2022QIII;10.570
17 Girona;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2022QII;""
17 Girona;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2022QI;""
17 Girona;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
17 Girona;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2021QIII;10.458
17 Girona;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2021QII;""
17 Girona;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2021QI;""
17 Girona;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
17 Girona;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2020QIII;10.194
17 Girona;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2020QII;""
17 Girona;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2020QI;""
17 Girona;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2022QIV;10.223
17 Girona;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
17 Girona;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2022QII;""
17 Girona;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2022QI;""
17 Girona;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2021QIV;10.169
17 Girona;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
17 Girona;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2021QII;""
17 Girona;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2021QI;""
17 Girona;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2020QIV;9.965
17 Girona;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
17 Girona;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2020QII;""
17 Girona;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2020QI;""
17 Girona;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
17 Girona;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
17 Girona;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QII;""
17 Girona;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QI;9.977
17 Girona;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
17 Girona;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
17 Girona;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QII;""
17 Girona;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QI;9.823
17 Girona;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
17 Girona;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
17 Girona;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QII;""
17 Girona;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QI;""
17 Girona;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
17 Girona;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
17 Girona;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QII;9.814
17 Girona;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QI;""
17 Girona;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
17 Girona;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
17 Girona;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QII;9.689
17 Girona;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QI;""
17 Girona;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
17 Girona;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
17 Girona;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QII;""
17 Girona;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QI;""
17 Girona;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
17 Girona;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
17 Girona;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
17 Girona;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
17 Girona;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
17 Girona;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
17 Girona;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
17 Girona;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
17 Girona;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
17 Girona;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
17 Girona;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
17 Girona;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
17 Girona;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
17 Girona;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;97,31
17 Girona;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
17 Girona;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
17 Girona;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
17 Girona;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;97,67
17 Girona;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
17 Girona;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
17 Girona;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
17 Girona;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;97,82
17 Girona;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
17 Girona;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
17 Girona;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;94,12
17 Girona;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
17 Girona;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
17 Girona;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
17 Girona;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;94,98
17 Girona;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
17 Girona;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
17 Girona;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
17 Girona;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;95,62
17 Girona;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
17 Girona;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
17 Girona;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
17 Girona;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
17 Girona;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
17 Girona;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
17 Girona;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;93,18
17 Girona;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
17 Girona;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
17 Girona;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
17 Girona;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;94,26
17 Girona;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
17 Girona;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
17 Girona;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
17 Girona;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
17 Girona;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
17 Girona;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
17 Girona;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;91,66
17 Girona;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
17 Girona;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
17 Girona;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
17 Girona;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;92,98
17 Girona;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
17 Girona;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
17 Girona;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
17 Girona;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
17 Girona;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
17 Girona;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
17 Girona;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QIII;6.299
17 Girona;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
17 Girona;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
17 Girona;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
17 Girona;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QIII;6.215
17 Girona;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
17 Girona;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
17 Girona;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
17 Girona;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QIII;5.979
17 Girona;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
17 Girona;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
17 Girona;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
17 Girona;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2022QIII;6.092
17 Girona;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2022QII;""
17 Girona;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2022QI;""
17 Girona;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
17 Girona;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2021QIII;6.023
17 Girona;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2021QII;""
17 Girona;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2021QI;""
17 Girona;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
17 Girona;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2020QIII;5.792
17 Girona;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2020QII;""
17 Girona;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2020QI;""
17 Girona;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2022QIV;5.850
17 Girona;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
17 Girona;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2022QII;""
17 Girona;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2022QI;""
17 Girona;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2021QIV;5.811
17 Girona;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
17 Girona;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2021QII;""
17 Girona;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2021QI;""
17 Girona;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2020QIV;5.641
17 Girona;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
17 Girona;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2020QII;""
17 Girona;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2020QI;""
17 Girona;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
17 Girona;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
17 Girona;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QII;""
17 Girona;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QI;5.712
17 Girona;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
17 Girona;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
17 Girona;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QII;""
17 Girona;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QI;5.580
17 Girona;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
17 Girona;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
17 Girona;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QII;""
17 Girona;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QI;""
17 Girona;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
17 Girona;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
17 Girona;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QII;5.604
17 Girona;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QI;""
17 Girona;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
17 Girona;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
17 Girona;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QII;5.502
17 Girona;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QI;""
17 Girona;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
17 Girona;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
17 Girona;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QII;""
17 Girona;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QI;""
17 Girona;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
17 Girona;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
17 Girona;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
17 Girona;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
17 Girona;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
17 Girona;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
17 Girona;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
17 Girona;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
17 Girona;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
17 Girona;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
17 Girona;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
17 Girona;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
17 Girona;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
17 Girona;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;96,71
17 Girona;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
17 Girona;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
17 Girona;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
17 Girona;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;96,91
17 Girona;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
17 Girona;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
17 Girona;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
17 Girona;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;96,87
17 Girona;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
17 Girona;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
17 Girona;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;92,87
17 Girona;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
17 Girona;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
17 Girona;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
17 Girona;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;93,5
17 Girona;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
17 Girona;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
17 Girona;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
17 Girona;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;94,35
17 Girona;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
17 Girona;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
17 Girona;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
17 Girona;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
17 Girona;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
17 Girona;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
17 Girona;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;91,91
17 Girona;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
17 Girona;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
17 Girona;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
17 Girona;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;93,33
17 Girona;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
17 Girona;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
17 Girona;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
17 Girona;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
17 Girona;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
17 Girona;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
17 Girona;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;90,17
17 Girona;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
17 Girona;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
17 Girona;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
17 Girona;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;92,02
17 Girona;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
17 Girona;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
17 Girona;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
17 Girona;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
17 Girona;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
17 Girona;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QIV;16.938
17 Girona;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
17 Girona;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
17 Girona;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
17 Girona;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QIV;16.748
17 Girona;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
17 Girona;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
17 Girona;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
17 Girona;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QIV;16.316
17 Girona;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
17 Girona;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
17 Girona;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
17 Girona;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2022QIV;16.317
17 Girona;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
17 Girona;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2022QII;""
17 Girona;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2022QI;""
17 Girona;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2021QIV;16.210
17 Girona;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
17 Girona;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2021QII;""
17 Girona;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2021QI;""
17 Girona;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2020QIV;15.862
17 Girona;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
17 Girona;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2020QII;""
17 Girona;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2020QI;""
17 Girona;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
17 Girona;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
17 Girona;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2022QII;""
17 Girona;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2022QI;15.908
17 Girona;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
17 Girona;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
17 Girona;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2021QII;""
17 Girona;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2021QI;15.645
17 Girona;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
17 Girona;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
17 Girona;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2020QII;""
17 Girona;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2020QI;""
17 Girona;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
17 Girona;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
17 Girona;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QII;15.614
17 Girona;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QI;""
17 Girona;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
17 Girona;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
17 Girona;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QII;15.415
17 Girona;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QI;""
17 Girona;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
17 Girona;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
17 Girona;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QII;""
17 Girona;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QI;""
17 Girona;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
17 Girona;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QIII;15.357
17 Girona;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QII;""
17 Girona;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QI;""
17 Girona;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
17 Girona;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QIII;15.199
17 Girona;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QII;""
17 Girona;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QI;""
17 Girona;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
17 Girona;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
17 Girona;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QII;""
17 Girona;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QI;""
17 Girona;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
17 Girona;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
17 Girona;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
17 Girona;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
17 Girona;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
17 Girona;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
17 Girona;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
17 Girona;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
17 Girona;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
17 Girona;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
17 Girona;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
17 Girona;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
17 Girona;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;96,33
17 Girona;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
17 Girona;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
17 Girona;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
17 Girona;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;96,79
17 Girona;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
17 Girona;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
17 Girona;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
17 Girona;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;97,22
17 Girona;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
17 Girona;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
17 Girona;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
17 Girona;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
17 Girona;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
17 Girona;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
17 Girona;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;94,98
17 Girona;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
17 Girona;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
17 Girona;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
17 Girona;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;95,89
17 Girona;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
17 Girona;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
17 Girona;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
17 Girona;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
17 Girona;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
17 Girona;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
17 Girona;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;93,23
17 Girona;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
17 Girona;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
17 Girona;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
17 Girona;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;94,48
17 Girona;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
17 Girona;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
17 Girona;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
17 Girona;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
17 Girona;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
17 Girona;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
17 Girona;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;91,69
17 Girona;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
17 Girona;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
17 Girona;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
17 Girona;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;93,15
17 Girona;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
17 Girona;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
17 Girona;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
17 Girona;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
17 Girona;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
17 Girona;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
17 Girona;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QIV;10.733
17 Girona;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
17 Girona;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
17 Girona;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
17 Girona;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QIV;10.629
17 Girona;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
17 Girona;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
17 Girona;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
17 Girona;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QIV;10.371
17 Girona;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
17 Girona;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
17 Girona;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
17 Girona;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2022QIV;10.369
17 Girona;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
17 Girona;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2022QII;""
17 Girona;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2022QI;""
17 Girona;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2021QIV;10.314
17 Girona;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
17 Girona;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2021QII;""
17 Girona;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2021QI;""
17 Girona;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2020QIV;10.098
17 Girona;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
17 Girona;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2020QII;""
17 Girona;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2020QI;""
17 Girona;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
17 Girona;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
17 Girona;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2022QII;""
17 Girona;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2022QI;10.116
17 Girona;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
17 Girona;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
17 Girona;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2021QII;""
17 Girona;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2021QI;9.951
17 Girona;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
17 Girona;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
17 Girona;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2020QII;""
17 Girona;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2020QI;""
17 Girona;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
17 Girona;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
17 Girona;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QII;9.944
17 Girona;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QI;""
17 Girona;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
17 Girona;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
17 Girona;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QII;9.810
17 Girona;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QI;""
17 Girona;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
17 Girona;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
17 Girona;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QII;""
17 Girona;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QI;""
17 Girona;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
17 Girona;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QIII;9.787
17 Girona;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QII;""
17 Girona;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QI;""
17 Girona;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
17 Girona;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QIII;9.683
17 Girona;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QII;""
17 Girona;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QI;""
17 Girona;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
17 Girona;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
17 Girona;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QII;""
17 Girona;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QI;""
17 Girona;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
17 Girona;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
17 Girona;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
17 Girona;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
17 Girona;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
17 Girona;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
17 Girona;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
17 Girona;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
17 Girona;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
17 Girona;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
17 Girona;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
17 Girona;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
17 Girona;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;96,61
17 Girona;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
17 Girona;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
17 Girona;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
17 Girona;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;97,04
17 Girona;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
17 Girona;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
17 Girona;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
17 Girona;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;97,37
17 Girona;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
17 Girona;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
17 Girona;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
17 Girona;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
17 Girona;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
17 Girona;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
17 Girona;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;95,17
17 Girona;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
17 Girona;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
17 Girona;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
17 Girona;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;95,95
17 Girona;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
17 Girona;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
17 Girona;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
17 Girona;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
17 Girona;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
17 Girona;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
17 Girona;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;93,56
17 Girona;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
17 Girona;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
17 Girona;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
17 Girona;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;94,59
17 Girona;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
17 Girona;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
17 Girona;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
17 Girona;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
17 Girona;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
17 Girona;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
17 Girona;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;92,08
17 Girona;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
17 Girona;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
17 Girona;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
17 Girona;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;93,37
17 Girona;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
17 Girona;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
17 Girona;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
17 Girona;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
17 Girona;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
17 Girona;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
17 Girona;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QIV;6.205
17 Girona;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
17 Girona;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
17 Girona;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
17 Girona;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QIV;6.119
17 Girona;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
17 Girona;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
17 Girona;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
17 Girona;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QIV;5.945
17 Girona;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
17 Girona;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
17 Girona;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
17 Girona;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2022QIV;5.948
17 Girona;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
17 Girona;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2022QII;""
17 Girona;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2022QI;""
17 Girona;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2021QIV;5.896
17 Girona;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
17 Girona;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2021QII;""
17 Girona;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2021QI;""
17 Girona;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2020QIV;5.764
17 Girona;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
17 Girona;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2020QII;""
17 Girona;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2020QI;""
17 Girona;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
17 Girona;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
17 Girona;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2022QII;""
17 Girona;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2022QI;5.792
17 Girona;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
17 Girona;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
17 Girona;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2021QII;""
17 Girona;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2021QI;5.694
17 Girona;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
17 Girona;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
17 Girona;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2020QII;""
17 Girona;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2020QI;""
17 Girona;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
17 Girona;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
17 Girona;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QII;5.670
17 Girona;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QI;""
17 Girona;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
17 Girona;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
17 Girona;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QII;5.605
17 Girona;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QI;""
17 Girona;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
17 Girona;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
17 Girona;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QII;""
17 Girona;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QI;""
17 Girona;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
17 Girona;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QIII;5.570
17 Girona;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QII;""
17 Girona;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QI;""
17 Girona;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
17 Girona;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QIII;5.516
17 Girona;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QII;""
17 Girona;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QI;""
17 Girona;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
17 Girona;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
17 Girona;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QII;""
17 Girona;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QI;""
17 Girona;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
17 Girona;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
17 Girona;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
17 Girona;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
17 Girona;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
17 Girona;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
17 Girona;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
17 Girona;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
17 Girona;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
17 Girona;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
17 Girona;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
17 Girona;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
17 Girona;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;95,86
17 Girona;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
17 Girona;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
17 Girona;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
17 Girona;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;96,36
17 Girona;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
17 Girona;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
17 Girona;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
17 Girona;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;96,96
17 Girona;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
17 Girona;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
17 Girona;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
17 Girona;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
17 Girona;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
17 Girona;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
17 Girona;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;94,66
17 Girona;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
17 Girona;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
17 Girona;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
17 Girona;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;95,78
17 Girona;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
17 Girona;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
17 Girona;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
17 Girona;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
17 Girona;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
17 Girona;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
17 Girona;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;92,66
17 Girona;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
17 Girona;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
17 Girona;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
17 Girona;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;94,28
17 Girona;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
17 Girona;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
17 Girona;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
17 Girona;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
17 Girona;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
17 Girona;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
17 Girona;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;91,03
17 Girona;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
17 Girona;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
17 Girona;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
17 Girona;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;92,78
17 Girona;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
17 Girona;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
17 Girona;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
17 Girona;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
17 Girona;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
17 Girona;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
17 Girona;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
17 Girona;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
17 Girona;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
17 Girona;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QI;9.460
17 Girona;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
17 Girona;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
17 Girona;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
17 Girona;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QI;9.110
17 Girona;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
17 Girona;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
17 Girona;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
17 Girona;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QI;10.469
17 Girona;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
17 Girona;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
17 Girona;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2022QII;""
17 Girona;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2022QI;9.146
17 Girona;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
17 Girona;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
17 Girona;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2021QII;""
17 Girona;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2021QI;8.788
17 Girona;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
17 Girona;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
17 Girona;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2020QII;""
17 Girona;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2020QI;9.764
17 Girona;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
17 Girona;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
17 Girona;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2022QII;8.819
17 Girona;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2022QI;""
17 Girona;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
17 Girona;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
17 Girona;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2021QII;8.495
17 Girona;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2021QI;""
17 Girona;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
17 Girona;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
17 Girona;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2020QII;9.478
17 Girona;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2020QI;""
17 Girona;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
17 Girona;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QIII;8.493
17 Girona;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QII;""
17 Girona;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QI;""
17 Girona;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
17 Girona;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QIII;8.204
17 Girona;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QII;""
17 Girona;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QI;""
17 Girona;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
17 Girona;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QIII;9.131
17 Girona;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QII;""
17 Girona;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QI;""
17 Girona;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QIV;8.021
17 Girona;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
17 Girona;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QII;""
17 Girona;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QI;""
17 Girona;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QIV;7.807
17 Girona;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
17 Girona;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QII;""
17 Girona;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QI;""
17 Girona;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QIV;8.713
17 Girona;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
17 Girona;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QII;""
17 Girona;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QI;""
17 Girona;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
17 Girona;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
17 Girona;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
17 Girona;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
17 Girona;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
17 Girona;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
17 Girona;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
17 Girona;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
17 Girona;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
17 Girona;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
17 Girona;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
17 Girona;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
17 Girona;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
17 Girona;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
17 Girona;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
17 Girona;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;96,68
17 Girona;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
17 Girona;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
17 Girona;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
17 Girona;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;96,47
17 Girona;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
17 Girona;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
17 Girona;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
17 Girona;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;93,27
17 Girona;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
17 Girona;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
17 Girona;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;93,22
17 Girona;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
17 Girona;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
17 Girona;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
17 Girona;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;93,25
17 Girona;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
17 Girona;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
17 Girona;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
17 Girona;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;90,53
17 Girona;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
17 Girona;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
17 Girona;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;89,78
17 Girona;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
17 Girona;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
17 Girona;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
17 Girona;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;90,05
17 Girona;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
17 Girona;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
17 Girona;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
17 Girona;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;87,22
17 Girona;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
17 Girona;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
17 Girona;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;84,79
17 Girona;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
17 Girona;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
17 Girona;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
17 Girona;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;85,7
17 Girona;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
17 Girona;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
17 Girona;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
17 Girona;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;83,23
17 Girona;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
17 Girona;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
17 Girona;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
17 Girona;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
17 Girona;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
17 Girona;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
17 Girona;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QI;6.052
17 Girona;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
17 Girona;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
17 Girona;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
17 Girona;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QI;5.829
17 Girona;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
17 Girona;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
17 Girona;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
17 Girona;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QI;6.666
17 Girona;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
17 Girona;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
17 Girona;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2022QII;""
17 Girona;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2022QI;5.851
17 Girona;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
17 Girona;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
17 Girona;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2021QII;""
17 Girona;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2021QI;5.619
17 Girona;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
17 Girona;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
17 Girona;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2020QII;""
17 Girona;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2020QI;6.246
17 Girona;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
17 Girona;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
17 Girona;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2022QII;5.652
17 Girona;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2022QI;""
17 Girona;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
17 Girona;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
17 Girona;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2021QII;5.433
17 Girona;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2021QI;""
17 Girona;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
17 Girona;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
17 Girona;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2020QII;6.057
17 Girona;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2020QI;""
17 Girona;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
17 Girona;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QIII;5.468
17 Girona;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QII;""
17 Girona;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QI;""
17 Girona;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
17 Girona;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QIII;5.270
17 Girona;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QII;""
17 Girona;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QI;""
17 Girona;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
17 Girona;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QIII;5.835
17 Girona;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QII;""
17 Girona;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QI;""
17 Girona;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QIV;5.163
17 Girona;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
17 Girona;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QII;""
17 Girona;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QI;""
17 Girona;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QIV;5.025
17 Girona;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
17 Girona;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QII;""
17 Girona;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QI;""
17 Girona;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QIV;5.596
17 Girona;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
17 Girona;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QII;""
17 Girona;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QI;""
17 Girona;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
17 Girona;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
17 Girona;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
17 Girona;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
17 Girona;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
17 Girona;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
17 Girona;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
17 Girona;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
17 Girona;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
17 Girona;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
17 Girona;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
17 Girona;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
17 Girona;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
17 Girona;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
17 Girona;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
17 Girona;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;96,68
17 Girona;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
17 Girona;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
17 Girona;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
17 Girona;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;96,4
17 Girona;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
17 Girona;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
17 Girona;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
17 Girona;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;93,7
17 Girona;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
17 Girona;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
17 Girona;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;93,39
17 Girona;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
17 Girona;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
17 Girona;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
17 Girona;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;93,21
17 Girona;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
17 Girona;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
17 Girona;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
17 Girona;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;90,86
17 Girona;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
17 Girona;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
17 Girona;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;90,35
17 Girona;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
17 Girona;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
17 Girona;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
17 Girona;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;90,41
17 Girona;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
17 Girona;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
17 Girona;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
17 Girona;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;87,53
17 Girona;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
17 Girona;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
17 Girona;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;85,31
17 Girona;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
17 Girona;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
17 Girona;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
17 Girona;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;86,21
17 Girona;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
17 Girona;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
17 Girona;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
17 Girona;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;83,95
17 Girona;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
17 Girona;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
17 Girona;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
17 Girona;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
17 Girona;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
17 Girona;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
17 Girona;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QI;3.408
17 Girona;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
17 Girona;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
17 Girona;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
17 Girona;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QI;3.281
17 Girona;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
17 Girona;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
17 Girona;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
17 Girona;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QI;3.803
17 Girona;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
17 Girona;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
17 Girona;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2022QII;""
17 Girona;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2022QI;3.295
17 Girona;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
17 Girona;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
17 Girona;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2021QII;""
17 Girona;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2021QI;3.169
17 Girona;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
17 Girona;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
17 Girona;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2020QII;""
17 Girona;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2020QI;3.518
17 Girona;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
17 Girona;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
17 Girona;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2022QII;3.167
17 Girona;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2022QI;""
17 Girona;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
17 Girona;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
17 Girona;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2021QII;3.062
17 Girona;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2021QI;""
17 Girona;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
17 Girona;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
17 Girona;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2020QII;3.421
17 Girona;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2020QI;""
17 Girona;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
17 Girona;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QIII;3.025
17 Girona;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QII;""
17 Girona;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QI;""
17 Girona;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
17 Girona;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QIII;2.934
17 Girona;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QII;""
17 Girona;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QI;""
17 Girona;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
17 Girona;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QIII;3.296
17 Girona;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QII;""
17 Girona;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QI;""
17 Girona;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QIV;2.858
17 Girona;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
17 Girona;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QII;""
17 Girona;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QI;""
17 Girona;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QIV;2.782
17 Girona;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
17 Girona;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QII;""
17 Girona;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QI;""
17 Girona;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QIV;3.117
17 Girona;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
17 Girona;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QII;""
17 Girona;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QI;""
17 Girona;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
17 Girona;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
17 Girona;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
17 Girona;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
17 Girona;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
17 Girona;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
17 Girona;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
17 Girona;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
17 Girona;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
17 Girona;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
17 Girona;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
17 Girona;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
17 Girona;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
17 Girona;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
17 Girona;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
17 Girona;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;96,68
17 Girona;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
17 Girona;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
17 Girona;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
17 Girona;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;96,59
17 Girona;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
17 Girona;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
17 Girona;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
17 Girona;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;92,51
17 Girona;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
17 Girona;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
17 Girona;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;92,93
17 Girona;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
17 Girona;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
17 Girona;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
17 Girona;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;93,33
17 Girona;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
17 Girona;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
17 Girona;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
17 Girona;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;89,96
17 Girona;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
17 Girona;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
17 Girona;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;88,76
17 Girona;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
17 Girona;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
17 Girona;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
17 Girona;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;89,42
17 Girona;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
17 Girona;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
17 Girona;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
17 Girona;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;86,67
17 Girona;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
17 Girona;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
17 Girona;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;83,86
17 Girona;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
17 Girona;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
17 Girona;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
17 Girona;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;84,79
17 Girona;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
17 Girona;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
17 Girona;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
17 Girona;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;81,96
17 Girona;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
17 Girona;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
17 Girona;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
17 Girona;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
17 Girona;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
17 Girona;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QII;10.802
17 Girona;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
17 Girona;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
17 Girona;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
17 Girona;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QII;10.316
17 Girona;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
17 Girona;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
17 Girona;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
17 Girona;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QII;9.931
17 Girona;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
17 Girona;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
17 Girona;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
17 Girona;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2022QII;10.438
17 Girona;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2022QI;""
17 Girona;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
17 Girona;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
17 Girona;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2021QII;9.996
17 Girona;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2021QI;""
17 Girona;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
17 Girona;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
17 Girona;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2020QII;9.628
17 Girona;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2020QI;""
17 Girona;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
17 Girona;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2022QIII;10.081
17 Girona;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2022QII;""
17 Girona;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2022QI;""
17 Girona;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
17 Girona;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2021QIII;9.669
17 Girona;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2021QII;""
17 Girona;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2021QI;""
17 Girona;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
17 Girona;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2020QIII;9.261
17 Girona;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2020QII;""
17 Girona;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2020QI;""
17 Girona;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QIV;9.556
17 Girona;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
17 Girona;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QII;""
17 Girona;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QI;""
17 Girona;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QIV;9.214
17 Girona;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
17 Girona;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QII;""
17 Girona;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QI;""
17 Girona;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QIV;8.826
17 Girona;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
17 Girona;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QII;""
17 Girona;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QI;""
17 Girona;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
17 Girona;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
17 Girona;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QII;""
17 Girona;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QI;8.928
17 Girona;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
17 Girona;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
17 Girona;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QII;""
17 Girona;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QI;8.535
17 Girona;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
17 Girona;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
17 Girona;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QII;""
17 Girona;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QI;""
17 Girona;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
17 Girona;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
17 Girona;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
17 Girona;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
17 Girona;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
17 Girona;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
17 Girona;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
17 Girona;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
17 Girona;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
17 Girona;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
17 Girona;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
17 Girona;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
17 Girona;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
17 Girona;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
17 Girona;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;96,63
17 Girona;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
17 Girona;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
17 Girona;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
17 Girona;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;96,9
17 Girona;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
17 Girona;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
17 Girona;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
17 Girona;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;96,95
17 Girona;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
17 Girona;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
17 Girona;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;93,33
17 Girona;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
17 Girona;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
17 Girona;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
17 Girona;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;93,73
17 Girona;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
17 Girona;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
17 Girona;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
17 Girona;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;93,25
17 Girona;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
17 Girona;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
17 Girona;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;88,47
17 Girona;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
17 Girona;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
17 Girona;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
17 Girona;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;89,32
17 Girona;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
17 Girona;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
17 Girona;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
17 Girona;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;88,87
17 Girona;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
17 Girona;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
17 Girona;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
17 Girona;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
17 Girona;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
17 Girona;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
17 Girona;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;86,55
17 Girona;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
17 Girona;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
17 Girona;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
17 Girona;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;85,94
17 Girona;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
17 Girona;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
17 Girona;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
17 Girona;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
17 Girona;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
17 Girona;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
17 Girona;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QII;6.898
17 Girona;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
17 Girona;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
17 Girona;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
17 Girona;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QII;6.579
17 Girona;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
17 Girona;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
17 Girona;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
17 Girona;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QII;6.349
17 Girona;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
17 Girona;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
17 Girona;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
17 Girona;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2022QII;6.671
17 Girona;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2022QI;""
17 Girona;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
17 Girona;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
17 Girona;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2021QII;6.372
17 Girona;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2021QI;""
17 Girona;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
17 Girona;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
17 Girona;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2020QII;6.146
17 Girona;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2020QI;""
17 Girona;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
17 Girona;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2022QIII;6.468
17 Girona;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2022QII;""
17 Girona;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2022QI;""
17 Girona;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
17 Girona;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2021QIII;6.188
17 Girona;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2021QII;""
17 Girona;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2021QI;""
17 Girona;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
17 Girona;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2020QIII;5.912
17 Girona;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2020QII;""
17 Girona;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2020QI;""
17 Girona;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QIV;6.134
17 Girona;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
17 Girona;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QII;""
17 Girona;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QI;""
17 Girona;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QIV;5.910
17 Girona;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
17 Girona;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QII;""
17 Girona;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QI;""
17 Girona;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QIV;5.662
17 Girona;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
17 Girona;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QII;""
17 Girona;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QI;""
17 Girona;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
17 Girona;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
17 Girona;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QII;""
17 Girona;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QI;5.727
17 Girona;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
17 Girona;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
17 Girona;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QII;""
17 Girona;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QI;5.470
17 Girona;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
17 Girona;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
17 Girona;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QII;""
17 Girona;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QI;""
17 Girona;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
17 Girona;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
17 Girona;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
17 Girona;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
17 Girona;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
17 Girona;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
17 Girona;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
17 Girona;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
17 Girona;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
17 Girona;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
17 Girona;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
17 Girona;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
17 Girona;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
17 Girona;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
17 Girona;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;96,71
17 Girona;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
17 Girona;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
17 Girona;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
17 Girona;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;96,85
17 Girona;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
17 Girona;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
17 Girona;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
17 Girona;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;96,8
17 Girona;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
17 Girona;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
17 Girona;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;93,77
17 Girona;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
17 Girona;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
17 Girona;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
17 Girona;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;94,06
17 Girona;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
17 Girona;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
17 Girona;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
17 Girona;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;93,12
17 Girona;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
17 Girona;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
17 Girona;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;88,92
17 Girona;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
17 Girona;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
17 Girona;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
17 Girona;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;89,83
17 Girona;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
17 Girona;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
17 Girona;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
17 Girona;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;89,18
17 Girona;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
17 Girona;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
17 Girona;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
17 Girona;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
17 Girona;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
17 Girona;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
17 Girona;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;87,05
17 Girona;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
17 Girona;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
17 Girona;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
17 Girona;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;86,16
17 Girona;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
17 Girona;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
17 Girona;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
17 Girona;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
17 Girona;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
17 Girona;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
17 Girona;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QII;3.904
17 Girona;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
17 Girona;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
17 Girona;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
17 Girona;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QII;3.737
17 Girona;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
17 Girona;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
17 Girona;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
17 Girona;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QII;3.582
17 Girona;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
17 Girona;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
17 Girona;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
17 Girona;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2022QII;3.767
17 Girona;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2022QI;""
17 Girona;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
17 Girona;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
17 Girona;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2021QII;3.624
17 Girona;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2021QI;""
17 Girona;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
17 Girona;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
17 Girona;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2020QII;3.482
17 Girona;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2020QI;""
17 Girona;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
17 Girona;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2022QIII;3.613
17 Girona;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2022QII;""
17 Girona;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2022QI;""
17 Girona;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
17 Girona;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2021QIII;3.481
17 Girona;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2021QII;""
17 Girona;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2021QI;""
17 Girona;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
17 Girona;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2020QIII;3.349
17 Girona;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2020QII;""
17 Girona;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2020QI;""
17 Girona;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QIV;3.422
17 Girona;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
17 Girona;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QII;""
17 Girona;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QI;""
17 Girona;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QIV;3.304
17 Girona;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
17 Girona;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QII;""
17 Girona;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QI;""
17 Girona;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QIV;3.164
17 Girona;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
17 Girona;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QII;""
17 Girona;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QI;""
17 Girona;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
17 Girona;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
17 Girona;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QII;""
17 Girona;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QI;3.201
17 Girona;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
17 Girona;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
17 Girona;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QII;""
17 Girona;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QI;3.065
17 Girona;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
17 Girona;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
17 Girona;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QII;""
17 Girona;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QI;""
17 Girona;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
17 Girona;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
17 Girona;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
17 Girona;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
17 Girona;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
17 Girona;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
17 Girona;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
17 Girona;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
17 Girona;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
17 Girona;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
17 Girona;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
17 Girona;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
17 Girona;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
17 Girona;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
17 Girona;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;96,49
17 Girona;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
17 Girona;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
17 Girona;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
17 Girona;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;96,98
17 Girona;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
17 Girona;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
17 Girona;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
17 Girona;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;97,21
17 Girona;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
17 Girona;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
17 Girona;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;92,55
17 Girona;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
17 Girona;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
17 Girona;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
17 Girona;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;93,15
17 Girona;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
17 Girona;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
17 Girona;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
17 Girona;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;93,5
17 Girona;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
17 Girona;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
17 Girona;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;87,65
17 Girona;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
17 Girona;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
17 Girona;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
17 Girona;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;88,41
17 Girona;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
17 Girona;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
17 Girona;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
17 Girona;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;88,33
17 Girona;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
17 Girona;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
17 Girona;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
17 Girona;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
17 Girona;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
17 Girona;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
17 Girona;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;85,66
17 Girona;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
17 Girona;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
17 Girona;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
17 Girona;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;85,57
17 Girona;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
17 Girona;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
17 Girona;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
17 Girona;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
17 Girona;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
17 Girona;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QIII;10.800
17 Girona;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
17 Girona;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
17 Girona;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
17 Girona;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QIII;10.317
17 Girona;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
17 Girona;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
17 Girona;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
17 Girona;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QIII;9.863
17 Girona;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
17 Girona;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
17 Girona;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
17 Girona;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2022QIII;10.324
17 Girona;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2022QII;""
17 Girona;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2022QI;""
17 Girona;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
17 Girona;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2021QIII;9.862
17 Girona;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2021QII;""
17 Girona;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2021QI;""
17 Girona;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
17 Girona;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2020QIII;9.414
17 Girona;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2020QII;""
17 Girona;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2020QI;""
17 Girona;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2022QIV;9.663
17 Girona;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
17 Girona;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2022QII;""
17 Girona;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2022QI;""
17 Girona;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2021QIV;9.303
17 Girona;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
17 Girona;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2021QII;""
17 Girona;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2021QI;""
17 Girona;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2020QIV;8.922
17 Girona;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
17 Girona;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2020QII;""
17 Girona;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2020QI;""
17 Girona;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
17 Girona;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
17 Girona;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QII;""
17 Girona;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QI;9.011
17 Girona;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
17 Girona;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
17 Girona;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QII;""
17 Girona;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QI;8.623
17 Girona;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
17 Girona;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
17 Girona;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QII;""
17 Girona;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QI;""
17 Girona;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
17 Girona;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
17 Girona;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QII;8.702
17 Girona;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QI;""
17 Girona;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
17 Girona;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
17 Girona;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QII;8.347
17 Girona;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QI;""
17 Girona;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
17 Girona;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
17 Girona;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QII;""
17 Girona;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QI;""
17 Girona;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
17 Girona;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
17 Girona;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
17 Girona;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
17 Girona;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
17 Girona;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
17 Girona;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
17 Girona;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
17 Girona;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
17 Girona;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
17 Girona;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
17 Girona;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
17 Girona;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
17 Girona;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;95,59
17 Girona;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
17 Girona;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
17 Girona;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
17 Girona;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;95,59
17 Girona;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
17 Girona;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
17 Girona;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
17 Girona;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;95,45
17 Girona;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
17 Girona;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
17 Girona;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;89,47
17 Girona;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
17 Girona;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
17 Girona;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
17 Girona;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;90,17
17 Girona;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
17 Girona;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
17 Girona;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
17 Girona;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;90,46
17 Girona;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
17 Girona;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
17 Girona;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
17 Girona;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
17 Girona;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
17 Girona;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
17 Girona;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;87,34
17 Girona;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
17 Girona;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
17 Girona;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
17 Girona;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;87,43
17 Girona;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
17 Girona;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
17 Girona;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
17 Girona;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
17 Girona;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
17 Girona;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
17 Girona;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;84,35
17 Girona;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
17 Girona;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
17 Girona;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
17 Girona;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;84,63
17 Girona;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
17 Girona;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
17 Girona;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
17 Girona;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
17 Girona;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
17 Girona;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
17 Girona;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QIII;6.856
17 Girona;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
17 Girona;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
17 Girona;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
17 Girona;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QIII;6.537
17 Girona;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
17 Girona;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
17 Girona;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
17 Girona;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QIII;6.278
17 Girona;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
17 Girona;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
17 Girona;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
17 Girona;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2022QIII;6.604
17 Girona;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2022QII;""
17 Girona;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2022QI;""
17 Girona;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
17 Girona;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2021QIII;6.290
17 Girona;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2021QII;""
17 Girona;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2021QI;""
17 Girona;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
17 Girona;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2020QIII;6.006
17 Girona;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2020QII;""
17 Girona;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2020QI;""
17 Girona;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2022QIV;6.199
17 Girona;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
17 Girona;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2022QII;""
17 Girona;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2022QI;""
17 Girona;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2021QIV;5.962
17 Girona;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
17 Girona;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2021QII;""
17 Girona;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2021QI;""
17 Girona;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2020QIV;5.729
17 Girona;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
17 Girona;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2020QII;""
17 Girona;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2020QI;""
17 Girona;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
17 Girona;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
17 Girona;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QII;""
17 Girona;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QI;5.775
17 Girona;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
17 Girona;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
17 Girona;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QII;""
17 Girona;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QI;5.532
17 Girona;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
17 Girona;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
17 Girona;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QII;""
17 Girona;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QI;""
17 Girona;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
17 Girona;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
17 Girona;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QII;5.587
17 Girona;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QI;""
17 Girona;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
17 Girona;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
17 Girona;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QII;5.352
17 Girona;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QI;""
17 Girona;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
17 Girona;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
17 Girona;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QII;""
17 Girona;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QI;""
17 Girona;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
17 Girona;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
17 Girona;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
17 Girona;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
17 Girona;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
17 Girona;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
17 Girona;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
17 Girona;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
17 Girona;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
17 Girona;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
17 Girona;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
17 Girona;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
17 Girona;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
17 Girona;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;96,32
17 Girona;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
17 Girona;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
17 Girona;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
17 Girona;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;96,22
17 Girona;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
17 Girona;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
17 Girona;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
17 Girona;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;95,67
17 Girona;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
17 Girona;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
17 Girona;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;90,42
17 Girona;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
17 Girona;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
17 Girona;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
17 Girona;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;91,2
17 Girona;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
17 Girona;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
17 Girona;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
17 Girona;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;91,26
17 Girona;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
17 Girona;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
17 Girona;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
17 Girona;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
17 Girona;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
17 Girona;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
17 Girona;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;88,34
17 Girona;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
17 Girona;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
17 Girona;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
17 Girona;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;88,12
17 Girona;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
17 Girona;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
17 Girona;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
17 Girona;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
17 Girona;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
17 Girona;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
17 Girona;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;85,47
17 Girona;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
17 Girona;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
17 Girona;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
17 Girona;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;85,25
17 Girona;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
17 Girona;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
17 Girona;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
17 Girona;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
17 Girona;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
17 Girona;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
17 Girona;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QIII;3.944
17 Girona;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
17 Girona;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
17 Girona;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
17 Girona;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QIII;3.780
17 Girona;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
17 Girona;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
17 Girona;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
17 Girona;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QIII;3.585
17 Girona;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
17 Girona;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
17 Girona;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
17 Girona;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2022QIII;3.720
17 Girona;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2022QII;""
17 Girona;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2022QI;""
17 Girona;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
17 Girona;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2021QIII;3.572
17 Girona;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2021QII;""
17 Girona;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2021QI;""
17 Girona;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
17 Girona;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2020QIII;3.408
17 Girona;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2020QII;""
17 Girona;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2020QI;""
17 Girona;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2022QIV;3.464
17 Girona;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
17 Girona;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2022QII;""
17 Girona;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2022QI;""
17 Girona;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2021QIV;3.341
17 Girona;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
17 Girona;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2021QII;""
17 Girona;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2021QI;""
17 Girona;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2020QIV;3.193
17 Girona;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
17 Girona;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2020QII;""
17 Girona;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2020QI;""
17 Girona;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
17 Girona;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
17 Girona;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QII;""
17 Girona;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QI;3.236
17 Girona;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
17 Girona;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
17 Girona;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QII;""
17 Girona;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QI;3.091
17 Girona;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
17 Girona;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
17 Girona;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QII;""
17 Girona;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QI;""
17 Girona;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
17 Girona;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
17 Girona;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QII;3.115
17 Girona;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QI;""
17 Girona;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
17 Girona;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
17 Girona;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QII;2.995
17 Girona;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QI;""
17 Girona;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
17 Girona;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
17 Girona;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QII;""
17 Girona;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QI;""
17 Girona;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
17 Girona;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
17 Girona;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
17 Girona;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
17 Girona;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
17 Girona;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
17 Girona;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
17 Girona;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
17 Girona;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
17 Girona;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
17 Girona;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
17 Girona;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
17 Girona;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
17 Girona;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;94,32
17 Girona;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
17 Girona;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
17 Girona;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
17 Girona;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;94,5
17 Girona;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
17 Girona;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
17 Girona;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
17 Girona;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;95,06
17 Girona;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
17 Girona;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
17 Girona;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;87,83
17 Girona;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
17 Girona;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
17 Girona;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
17 Girona;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;88,39
17 Girona;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
17 Girona;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
17 Girona;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
17 Girona;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;89,07
17 Girona;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
17 Girona;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
17 Girona;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
17 Girona;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
17 Girona;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
17 Girona;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
17 Girona;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;85,61
17 Girona;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
17 Girona;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
17 Girona;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
17 Girona;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;86,22
17 Girona;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
17 Girona;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
17 Girona;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
17 Girona;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
17 Girona;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
17 Girona;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
17 Girona;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;82,41
17 Girona;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
17 Girona;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
17 Girona;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
17 Girona;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;83,54
17 Girona;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
17 Girona;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
17 Girona;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
17 Girona;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
17 Girona;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
17 Girona;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QIV;10.400
17 Girona;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
17 Girona;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
17 Girona;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
17 Girona;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QIV;9.947
17 Girona;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
17 Girona;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
17 Girona;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
17 Girona;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QIV;9.546
17 Girona;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
17 Girona;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
17 Girona;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
17 Girona;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2022QIV;9.721
17 Girona;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
17 Girona;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2022QII;""
17 Girona;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2022QI;""
17 Girona;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2021QIV;9.364
17 Girona;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
17 Girona;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2021QII;""
17 Girona;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2021QI;""
17 Girona;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2020QIV;9.018
17 Girona;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
17 Girona;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2020QII;""
17 Girona;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2020QI;""
17 Girona;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
17 Girona;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
17 Girona;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2022QII;""
17 Girona;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2022QI;9.063
17 Girona;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
17 Girona;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
17 Girona;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2021QII;""
17 Girona;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2021QI;8.713
17 Girona;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
17 Girona;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
17 Girona;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2020QII;""
17 Girona;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2020QI;""
17 Girona;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
17 Girona;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
17 Girona;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QII;8.750
17 Girona;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QI;""
17 Girona;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
17 Girona;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
17 Girona;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QII;8.430
17 Girona;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QI;""
17 Girona;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
17 Girona;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
17 Girona;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QII;""
17 Girona;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QI;""
17 Girona;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
17 Girona;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QIII;8.430
17 Girona;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QII;""
17 Girona;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QI;""
17 Girona;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
17 Girona;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QIII;8.144
17 Girona;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QII;""
17 Girona;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QI;""
17 Girona;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
17 Girona;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
17 Girona;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QII;""
17 Girona;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QI;""
17 Girona;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
17 Girona;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
17 Girona;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
17 Girona;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
17 Girona;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
17 Girona;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
17 Girona;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
17 Girona;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
17 Girona;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
17 Girona;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
17 Girona;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
17 Girona;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
17 Girona;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;93,47
17 Girona;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
17 Girona;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
17 Girona;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
17 Girona;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;94,14
17 Girona;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
17 Girona;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
17 Girona;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
17 Girona;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;94,47
17 Girona;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
17 Girona;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
17 Girona;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
17 Girona;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
17 Girona;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
17 Girona;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
17 Girona;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;91,11
17 Girona;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
17 Girona;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
17 Girona;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
17 Girona;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;91,27
17 Girona;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
17 Girona;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
17 Girona;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
17 Girona;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
17 Girona;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
17 Girona;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
17 Girona;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;87,97
17 Girona;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
17 Girona;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
17 Girona;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
17 Girona;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;88,31
17 Girona;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
17 Girona;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
17 Girona;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
17 Girona;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
17 Girona;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
17 Girona;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
17 Girona;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;84,75
17 Girona;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
17 Girona;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
17 Girona;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
17 Girona;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;85,31
17 Girona;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
17 Girona;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
17 Girona;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
17 Girona;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
17 Girona;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
17 Girona;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
17 Girona;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QIV;6.648
17 Girona;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
17 Girona;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
17 Girona;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
17 Girona;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QIV;6.342
17 Girona;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
17 Girona;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
17 Girona;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
17 Girona;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QIV;6.075
17 Girona;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
17 Girona;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
17 Girona;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
17 Girona;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2022QIV;6.234
17 Girona;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
17 Girona;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2022QII;""
17 Girona;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2022QI;""
17 Girona;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2021QIV;5.999
17 Girona;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
17 Girona;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2021QII;""
17 Girona;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2021QI;""
17 Girona;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2020QIV;5.780
17 Girona;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
17 Girona;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2020QII;""
17 Girona;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2020QI;""
17 Girona;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
17 Girona;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
17 Girona;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2022QII;""
17 Girona;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2022QI;5.805
17 Girona;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
17 Girona;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
17 Girona;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2021QII;""
17 Girona;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2021QI;5.579
17 Girona;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
17 Girona;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
17 Girona;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2020QII;""
17 Girona;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2020QI;""
17 Girona;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
17 Girona;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
17 Girona;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QII;5.615
17 Girona;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QI;""
17 Girona;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
17 Girona;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
17 Girona;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QII;5.397
17 Girona;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QI;""
17 Girona;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
17 Girona;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
17 Girona;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QII;""
17 Girona;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QI;""
17 Girona;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
17 Girona;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QIII;5.431
17 Girona;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QII;""
17 Girona;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QI;""
17 Girona;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
17 Girona;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QIII;5.236
17 Girona;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QII;""
17 Girona;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QI;""
17 Girona;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
17 Girona;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
17 Girona;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QII;""
17 Girona;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QI;""
17 Girona;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
17 Girona;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
17 Girona;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
17 Girona;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
17 Girona;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
17 Girona;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
17 Girona;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
17 Girona;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
17 Girona;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
17 Girona;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
17 Girona;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
17 Girona;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
17 Girona;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;93,77
17 Girona;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
17 Girona;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
17 Girona;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
17 Girona;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;94,59
17 Girona;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
17 Girona;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
17 Girona;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
17 Girona;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;95,14
17 Girona;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
17 Girona;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
17 Girona;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
17 Girona;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
17 Girona;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
17 Girona;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
17 Girona;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;91,53
17 Girona;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
17 Girona;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
17 Girona;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
17 Girona;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;91,84
17 Girona;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
17 Girona;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
17 Girona;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
17 Girona;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
17 Girona;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
17 Girona;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
17 Girona;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;88,54
17 Girona;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
17 Girona;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
17 Girona;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
17 Girona;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;88,84
17 Girona;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
17 Girona;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
17 Girona;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
17 Girona;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
17 Girona;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
17 Girona;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
17 Girona;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;85,64
17 Girona;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
17 Girona;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
17 Girona;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
17 Girona;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;86,19
17 Girona;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
17 Girona;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
17 Girona;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
17 Girona;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
17 Girona;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
17 Girona;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
17 Girona;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QIV;3.752
17 Girona;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
17 Girona;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
17 Girona;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
17 Girona;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QIV;3.605
17 Girona;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
17 Girona;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
17 Girona;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
17 Girona;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QIV;3.471
17 Girona;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
17 Girona;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
17 Girona;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
17 Girona;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2022QIV;3.487
17 Girona;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
17 Girona;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2022QII;""
17 Girona;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2022QI;""
17 Girona;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2021QIV;3.365
17 Girona;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
17 Girona;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2021QII;""
17 Girona;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2021QI;""
17 Girona;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2020QIV;3.238
17 Girona;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
17 Girona;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2020QII;""
17 Girona;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2020QI;""
17 Girona;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
17 Girona;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
17 Girona;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2022QII;""
17 Girona;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2022QI;3.258
17 Girona;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
17 Girona;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
17 Girona;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2021QII;""
17 Girona;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2021QI;3.134
17 Girona;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
17 Girona;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
17 Girona;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2020QII;""
17 Girona;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2020QI;""
17 Girona;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
17 Girona;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
17 Girona;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QII;3.135
17 Girona;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QI;""
17 Girona;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
17 Girona;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
17 Girona;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QII;3.033
17 Girona;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QI;""
17 Girona;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
17 Girona;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
17 Girona;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QII;""
17 Girona;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QI;""
17 Girona;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
17 Girona;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QIII;2.999
17 Girona;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QII;""
17 Girona;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QI;""
17 Girona;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
17 Girona;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QIII;2.908
17 Girona;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QII;""
17 Girona;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QI;""
17 Girona;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
17 Girona;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
17 Girona;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QII;""
17 Girona;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QI;""
17 Girona;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
17 Girona;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
17 Girona;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
17 Girona;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
17 Girona;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
17 Girona;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
17 Girona;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
17 Girona;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
17 Girona;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
17 Girona;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
17 Girona;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
17 Girona;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
17 Girona;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;92,94
17 Girona;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
17 Girona;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
17 Girona;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
17 Girona;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;93,34
17 Girona;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
17 Girona;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
17 Girona;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
17 Girona;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;93,29
17 Girona;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
17 Girona;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
17 Girona;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
17 Girona;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
17 Girona;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
17 Girona;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
17 Girona;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;90,37
17 Girona;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
17 Girona;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
17 Girona;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
17 Girona;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;90,29
17 Girona;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
17 Girona;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
17 Girona;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
17 Girona;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
17 Girona;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
17 Girona;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
17 Girona;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;86,96
17 Girona;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
17 Girona;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
17 Girona;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
17 Girona;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;87,38
17 Girona;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
17 Girona;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
17 Girona;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
17 Girona;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
17 Girona;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
17 Girona;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
17 Girona;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;83,19
17 Girona;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
17 Girona;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
17 Girona;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
17 Girona;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;83,78
17 Girona;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
17 Girona;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
17 Girona;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
17 Girona;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
17 Girona;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
17 Girona;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
18 Granada;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
18 Granada;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
18 Granada;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
18 Granada;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QI;59.195
18 Granada;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
18 Granada;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
18 Granada;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
18 Granada;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QI;57.667
18 Granada;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
18 Granada;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
18 Granada;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
18 Granada;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QI;57.652
18 Granada;All ages;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
18 Granada;All ages;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
18 Granada;All ages;Cohort January 1;Total;Survival in the first trimester;2022QII;""
18 Granada;All ages;Cohort January 1;Total;Survival in the first trimester;2022QI;57.149
18 Granada;All ages;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
18 Granada;All ages;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
18 Granada;All ages;Cohort January 1;Total;Survival in the first trimester;2021QII;""
18 Granada;All ages;Cohort January 1;Total;Survival in the first trimester;2021QI;56.093
18 Granada;All ages;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
18 Granada;All ages;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
18 Granada;All ages;Cohort January 1;Total;Survival in the first trimester;2020QII;""
18 Granada;All ages;Cohort January 1;Total;Survival in the first trimester;2020QI;53.680
18 Granada;All ages;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
18 Granada;All ages;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
18 Granada;All ages;Cohort January 1;Total;Survival in the second trimester;2022QII;54.981
18 Granada;All ages;Cohort January 1;Total;Survival in the second trimester;2022QI;""
18 Granada;All ages;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
18 Granada;All ages;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
18 Granada;All ages;Cohort January 1;Total;Survival in the second trimester;2021QII;54.413
18 Granada;All ages;Cohort January 1;Total;Survival in the second trimester;2021QI;""
18 Granada;All ages;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
18 Granada;All ages;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
18 Granada;All ages;Cohort January 1;Total;Survival in the second trimester;2020QII;52.539
18 Granada;All ages;Cohort January 1;Total;Survival in the second trimester;2020QI;""
18 Granada;All ages;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
18 Granada;All ages;Cohort January 1;Total;Survival in the third trimester;2022QIII;53.280
18 Granada;All ages;Cohort January 1;Total;Survival in the third trimester;2022QII;""
18 Granada;All ages;Cohort January 1;Total;Survival in the third trimester;2022QI;""
18 Granada;All ages;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
18 Granada;All ages;Cohort January 1;Total;Survival in the third trimester;2021QIII;52.965
18 Granada;All ages;Cohort January 1;Total;Survival in the third trimester;2021QII;""
18 Granada;All ages;Cohort January 1;Total;Survival in the third trimester;2021QI;""
18 Granada;All ages;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
18 Granada;All ages;Cohort January 1;Total;Survival in the third trimester;2020QIII;51.027
18 Granada;All ages;Cohort January 1;Total;Survival in the third trimester;2020QII;""
18 Granada;All ages;Cohort January 1;Total;Survival in the third trimester;2020QI;""
18 Granada;All ages;Cohort January 1;Total;Survival in the third trimester;2022QIV;51.394
18 Granada;All ages;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
18 Granada;All ages;Cohort January 1;Total;Survival in the third trimester;2022QII;""
18 Granada;All ages;Cohort January 1;Total;Survival in the third trimester;2022QI;""
18 Granada;All ages;Cohort January 1;Total;Survival in the third trimester;2021QIV;51.399
18 Granada;All ages;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
18 Granada;All ages;Cohort January 1;Total;Survival in the third trimester;2021QII;""
18 Granada;All ages;Cohort January 1;Total;Survival in the third trimester;2021QI;""
18 Granada;All ages;Cohort January 1;Total;Survival in the third trimester;2020QIV;49.549
18 Granada;All ages;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
18 Granada;All ages;Cohort January 1;Total;Survival in the third trimester;2020QII;""
18 Granada;All ages;Cohort January 1;Total;Survival in the third trimester;2020QI;""
18 Granada;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
18 Granada;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
18 Granada;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
18 Granada;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
18 Granada;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
18 Granada;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
18 Granada;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
18 Granada;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
18 Granada;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
18 Granada;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
18 Granada;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
18 Granada;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
18 Granada;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
18 Granada;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
18 Granada;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
18 Granada;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;96,54
18 Granada;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
18 Granada;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
18 Granada;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
18 Granada;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;97,27
18 Granada;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
18 Granada;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
18 Granada;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
18 Granada;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;93,11
18 Granada;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
18 Granada;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
18 Granada;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;92,88
18 Granada;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
18 Granada;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
18 Granada;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
18 Granada;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;94,36
18 Granada;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
18 Granada;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
18 Granada;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
18 Granada;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;91,13
18 Granada;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
18 Granada;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
18 Granada;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;90,01
18 Granada;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
18 Granada;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
18 Granada;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
18 Granada;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;91,85
18 Granada;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
18 Granada;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
18 Granada;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
18 Granada;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;88,51
18 Granada;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
18 Granada;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
18 Granada;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;86,82
18 Granada;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
18 Granada;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
18 Granada;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
18 Granada;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;89,13
18 Granada;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
18 Granada;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
18 Granada;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
18 Granada;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;85,94
18 Granada;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
18 Granada;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
18 Granada;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
18 Granada;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
18 Granada;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
18 Granada;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
18 Granada;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QI;37.584
18 Granada;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
18 Granada;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
18 Granada;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
18 Granada;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QI;36.925
18 Granada;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
18 Granada;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
18 Granada;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
18 Granada;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QI;36.760
18 Granada;All ages;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
18 Granada;All ages;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
18 Granada;All ages;Cohort January 1;Males;Survival in the first trimester;2022QII;""
18 Granada;All ages;Cohort January 1;Males;Survival in the first trimester;2022QI;36.374
18 Granada;All ages;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
18 Granada;All ages;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
18 Granada;All ages;Cohort January 1;Males;Survival in the first trimester;2021QII;""
18 Granada;All ages;Cohort January 1;Males;Survival in the first trimester;2021QI;35.919
18 Granada;All ages;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
18 Granada;All ages;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
18 Granada;All ages;Cohort January 1;Males;Survival in the first trimester;2020QII;""
18 Granada;All ages;Cohort January 1;Males;Survival in the first trimester;2020QI;34.352
18 Granada;All ages;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
18 Granada;All ages;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
18 Granada;All ages;Cohort January 1;Males;Survival in the second trimester;2022QII;35.064
18 Granada;All ages;Cohort January 1;Males;Survival in the second trimester;2022QI;""
18 Granada;All ages;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
18 Granada;All ages;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
18 Granada;All ages;Cohort January 1;Males;Survival in the second trimester;2021QII;34.891
18 Granada;All ages;Cohort January 1;Males;Survival in the second trimester;2021QI;""
18 Granada;All ages;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
18 Granada;All ages;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
18 Granada;All ages;Cohort January 1;Males;Survival in the second trimester;2020QII;33.679
18 Granada;All ages;Cohort January 1;Males;Survival in the second trimester;2020QI;""
18 Granada;All ages;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
18 Granada;All ages;Cohort January 1;Males;Survival in the third trimester;2022QIII;34.034
18 Granada;All ages;Cohort January 1;Males;Survival in the third trimester;2022QII;""
18 Granada;All ages;Cohort January 1;Males;Survival in the third trimester;2022QI;""
18 Granada;All ages;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
18 Granada;All ages;Cohort January 1;Males;Survival in the third trimester;2021QIII;34.013
18 Granada;All ages;Cohort January 1;Males;Survival in the third trimester;2021QII;""
18 Granada;All ages;Cohort January 1;Males;Survival in the third trimester;2021QI;""
18 Granada;All ages;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
18 Granada;All ages;Cohort January 1;Males;Survival in the third trimester;2020QIII;32.802
18 Granada;All ages;Cohort January 1;Males;Survival in the third trimester;2020QII;""
18 Granada;All ages;Cohort January 1;Males;Survival in the third trimester;2020QI;""
18 Granada;All ages;Cohort January 1;Males;Survival in the third trimester;2022QIV;32.854
18 Granada;All ages;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
18 Granada;All ages;Cohort January 1;Males;Survival in the third trimester;2022QII;""
18 Granada;All ages;Cohort January 1;Males;Survival in the third trimester;2022QI;""
18 Granada;All ages;Cohort January 1;Males;Survival in the third trimester;2021QIV;33.038
18 Granada;All ages;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
18 Granada;All ages;Cohort January 1;Males;Survival in the third trimester;2021QII;""
18 Granada;All ages;Cohort January 1;Males;Survival in the third trimester;2021QI;""
18 Granada;All ages;Cohort January 1;Males;Survival in the third trimester;2020QIV;31.921
18 Granada;All ages;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
18 Granada;All ages;Cohort January 1;Males;Survival in the third trimester;2020QII;""
18 Granada;All ages;Cohort January 1;Males;Survival in the third trimester;2020QI;""
18 Granada;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
18 Granada;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
18 Granada;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
18 Granada;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
18 Granada;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
18 Granada;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
18 Granada;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
18 Granada;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
18 Granada;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
18 Granada;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
18 Granada;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
18 Granada;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
18 Granada;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
18 Granada;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
18 Granada;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
18 Granada;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;96,78
18 Granada;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
18 Granada;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
18 Granada;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
18 Granada;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;97,28
18 Granada;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
18 Granada;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
18 Granada;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
18 Granada;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;93,45
18 Granada;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
18 Granada;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
18 Granada;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;93,3
18 Granada;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
18 Granada;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
18 Granada;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
18 Granada;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;94,49
18 Granada;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
18 Granada;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
18 Granada;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
18 Granada;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;91,62
18 Granada;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
18 Granada;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
18 Granada;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;90,55
18 Granada;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
18 Granada;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
18 Granada;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
18 Granada;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;92,11
18 Granada;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
18 Granada;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
18 Granada;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
18 Granada;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;89,23
18 Granada;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
18 Granada;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
18 Granada;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;87,41
18 Granada;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
18 Granada;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
18 Granada;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
18 Granada;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;89,47
18 Granada;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
18 Granada;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
18 Granada;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
18 Granada;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;86,84
18 Granada;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
18 Granada;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
18 Granada;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
18 Granada;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
18 Granada;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
18 Granada;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
18 Granada;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QI;21.611
18 Granada;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
18 Granada;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
18 Granada;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
18 Granada;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QI;20.742
18 Granada;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
18 Granada;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
18 Granada;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
18 Granada;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QI;20.892
18 Granada;All ages;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
18 Granada;All ages;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
18 Granada;All ages;Cohort January 1;Females;Survival in the first trimester;2022QII;""
18 Granada;All ages;Cohort January 1;Females;Survival in the first trimester;2022QI;20.775
18 Granada;All ages;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
18 Granada;All ages;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
18 Granada;All ages;Cohort January 1;Females;Survival in the first trimester;2021QII;""
18 Granada;All ages;Cohort January 1;Females;Survival in the first trimester;2021QI;20.174
18 Granada;All ages;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
18 Granada;All ages;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
18 Granada;All ages;Cohort January 1;Females;Survival in the first trimester;2020QII;""
18 Granada;All ages;Cohort January 1;Females;Survival in the first trimester;2020QI;19.328
18 Granada;All ages;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
18 Granada;All ages;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
18 Granada;All ages;Cohort January 1;Females;Survival in the second trimester;2022QII;19.917
18 Granada;All ages;Cohort January 1;Females;Survival in the second trimester;2022QI;""
18 Granada;All ages;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
18 Granada;All ages;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
18 Granada;All ages;Cohort January 1;Females;Survival in the second trimester;2021QII;19.522
18 Granada;All ages;Cohort January 1;Females;Survival in the second trimester;2021QI;""
18 Granada;All ages;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
18 Granada;All ages;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
18 Granada;All ages;Cohort January 1;Females;Survival in the second trimester;2020QII;18.860
18 Granada;All ages;Cohort January 1;Females;Survival in the second trimester;2020QI;""
18 Granada;All ages;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
18 Granada;All ages;Cohort January 1;Females;Survival in the third trimester;2022QIII;19.246
18 Granada;All ages;Cohort January 1;Females;Survival in the third trimester;2022QII;""
18 Granada;All ages;Cohort January 1;Females;Survival in the third trimester;2022QI;""
18 Granada;All ages;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
18 Granada;All ages;Cohort January 1;Females;Survival in the third trimester;2021QIII;18.952
18 Granada;All ages;Cohort January 1;Females;Survival in the third trimester;2021QII;""
18 Granada;All ages;Cohort January 1;Females;Survival in the third trimester;2021QI;""
18 Granada;All ages;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
18 Granada;All ages;Cohort January 1;Females;Survival in the third trimester;2020QIII;18.225
18 Granada;All ages;Cohort January 1;Females;Survival in the third trimester;2020QII;""
18 Granada;All ages;Cohort January 1;Females;Survival in the third trimester;2020QI;""
18 Granada;All ages;Cohort January 1;Females;Survival in the third trimester;2022QIV;18.540
18 Granada;All ages;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
18 Granada;All ages;Cohort January 1;Females;Survival in the third trimester;2022QII;""
18 Granada;All ages;Cohort January 1;Females;Survival in the third trimester;2022QI;""
18 Granada;All ages;Cohort January 1;Females;Survival in the third trimester;2021QIV;18.361
18 Granada;All ages;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
18 Granada;All ages;Cohort January 1;Females;Survival in the third trimester;2021QII;""
18 Granada;All ages;Cohort January 1;Females;Survival in the third trimester;2021QI;""
18 Granada;All ages;Cohort January 1;Females;Survival in the third trimester;2020QIV;17.628
18 Granada;All ages;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
18 Granada;All ages;Cohort January 1;Females;Survival in the third trimester;2020QII;""
18 Granada;All ages;Cohort January 1;Females;Survival in the third trimester;2020QI;""
18 Granada;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
18 Granada;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
18 Granada;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
18 Granada;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
18 Granada;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
18 Granada;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
18 Granada;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
18 Granada;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
18 Granada;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
18 Granada;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
18 Granada;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
18 Granada;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
18 Granada;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
18 Granada;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
18 Granada;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
18 Granada;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;96,13
18 Granada;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
18 Granada;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
18 Granada;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
18 Granada;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;97,26
18 Granada;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
18 Granada;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
18 Granada;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
18 Granada;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;92,51
18 Granada;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
18 Granada;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
18 Granada;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;92,16
18 Granada;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
18 Granada;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
18 Granada;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
18 Granada;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;94,12
18 Granada;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
18 Granada;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
18 Granada;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
18 Granada;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;90,27
18 Granada;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
18 Granada;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
18 Granada;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;89,06
18 Granada;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
18 Granada;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
18 Granada;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
18 Granada;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;91,37
18 Granada;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
18 Granada;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
18 Granada;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
18 Granada;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;87,23
18 Granada;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
18 Granada;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
18 Granada;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;85,79
18 Granada;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
18 Granada;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
18 Granada;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
18 Granada;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;88,52
18 Granada;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
18 Granada;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
18 Granada;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
18 Granada;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;84,38
18 Granada;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
18 Granada;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
18 Granada;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
18 Granada;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
18 Granada;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
18 Granada;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QII;59.352
18 Granada;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
18 Granada;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
18 Granada;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
18 Granada;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QII;58.378
18 Granada;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
18 Granada;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
18 Granada;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
18 Granada;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QII;56.457
18 Granada;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
18 Granada;All ages;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
18 Granada;All ages;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
18 Granada;All ages;Cohort April 1;Total;Survival in the first trimester;2022QII;56.953
18 Granada;All ages;Cohort April 1;Total;Survival in the first trimester;2022QI;""
18 Granada;All ages;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
18 Granada;All ages;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
18 Granada;All ages;Cohort April 1;Total;Survival in the first trimester;2021QII;56.440
18 Granada;All ages;Cohort April 1;Total;Survival in the first trimester;2021QI;""
18 Granada;All ages;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
18 Granada;All ages;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
18 Granada;All ages;Cohort April 1;Total;Survival in the first trimester;2020QII;55.184
18 Granada;All ages;Cohort April 1;Total;Survival in the first trimester;2020QI;""
18 Granada;All ages;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
18 Granada;All ages;Cohort April 1;Total;Survival in the second trimester;2022QIII;55.101
18 Granada;All ages;Cohort April 1;Total;Survival in the second trimester;2022QII;""
18 Granada;All ages;Cohort April 1;Total;Survival in the second trimester;2022QI;""
18 Granada;All ages;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
18 Granada;All ages;Cohort April 1;Total;Survival in the second trimester;2021QIII;54.855
18 Granada;All ages;Cohort April 1;Total;Survival in the second trimester;2021QII;""
18 Granada;All ages;Cohort April 1;Total;Survival in the second trimester;2021QI;""
18 Granada;All ages;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
18 Granada;All ages;Cohort April 1;Total;Survival in the second trimester;2020QIII;53.370
18 Granada;All ages;Cohort April 1;Total;Survival in the second trimester;2020QII;""
18 Granada;All ages;Cohort April 1;Total;Survival in the second trimester;2020QI;""
18 Granada;All ages;Cohort April 1;Total;Survival in the third trimester;2022QIV;53.068
18 Granada;All ages;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
18 Granada;All ages;Cohort April 1;Total;Survival in the third trimester;2022QII;""
18 Granada;All ages;Cohort April 1;Total;Survival in the third trimester;2022QI;""
18 Granada;All ages;Cohort April 1;Total;Survival in the third trimester;2021QIV;53.138
18 Granada;All ages;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
18 Granada;All ages;Cohort April 1;Total;Survival in the third trimester;2021QII;""
18 Granada;All ages;Cohort April 1;Total;Survival in the third trimester;2021QI;""
18 Granada;All ages;Cohort April 1;Total;Survival in the third trimester;2020QIV;51.703
18 Granada;All ages;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
18 Granada;All ages;Cohort April 1;Total;Survival in the third trimester;2020QII;""
18 Granada;All ages;Cohort April 1;Total;Survival in the third trimester;2020QI;""
18 Granada;All ages;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
18 Granada;All ages;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
18 Granada;All ages;Cohort April 1;Total;Survival in the third trimester;2022QII;""
18 Granada;All ages;Cohort April 1;Total;Survival in the third trimester;2022QI;51.582
18 Granada;All ages;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
18 Granada;All ages;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
18 Granada;All ages;Cohort April 1;Total;Survival in the third trimester;2021QII;""
18 Granada;All ages;Cohort April 1;Total;Survival in the third trimester;2021QI;50.620
18 Granada;All ages;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
18 Granada;All ages;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
18 Granada;All ages;Cohort April 1;Total;Survival in the third trimester;2020QII;""
18 Granada;All ages;Cohort April 1;Total;Survival in the third trimester;2020QI;""
18 Granada;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
18 Granada;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
18 Granada;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
18 Granada;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
18 Granada;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
18 Granada;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
18 Granada;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
18 Granada;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
18 Granada;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
18 Granada;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
18 Granada;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
18 Granada;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
18 Granada;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
18 Granada;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
18 Granada;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;95,96
18 Granada;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
18 Granada;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
18 Granada;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
18 Granada;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;96,68
18 Granada;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
18 Granada;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
18 Granada;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
18 Granada;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;97,75
18 Granada;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
18 Granada;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
18 Granada;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;92,84
18 Granada;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
18 Granada;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
18 Granada;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
18 Granada;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;93,97
18 Granada;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
18 Granada;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
18 Granada;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
18 Granada;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;94,53
18 Granada;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
18 Granada;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
18 Granada;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;89,41
18 Granada;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
18 Granada;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
18 Granada;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
18 Granada;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;91,02
18 Granada;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
18 Granada;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
18 Granada;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
18 Granada;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;91,58
18 Granada;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
18 Granada;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
18 Granada;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
18 Granada;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
18 Granada;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
18 Granada;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
18 Granada;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;88,36
18 Granada;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
18 Granada;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
18 Granada;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
18 Granada;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;89,66
18 Granada;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
18 Granada;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
18 Granada;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
18 Granada;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
18 Granada;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
18 Granada;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
18 Granada;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QII;37.666
18 Granada;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
18 Granada;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
18 Granada;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
18 Granada;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QII;37.284
18 Granada;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
18 Granada;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
18 Granada;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
18 Granada;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QII;36.005
18 Granada;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
18 Granada;All ages;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
18 Granada;All ages;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
18 Granada;All ages;Cohort April 1;Males;Survival in the first trimester;2022QII;36.207
18 Granada;All ages;Cohort April 1;Males;Survival in the first trimester;2022QI;""
18 Granada;All ages;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
18 Granada;All ages;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
18 Granada;All ages;Cohort April 1;Males;Survival in the first trimester;2021QII;36.088
18 Granada;All ages;Cohort April 1;Males;Survival in the first trimester;2021QI;""
18 Granada;All ages;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
18 Granada;All ages;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
18 Granada;All ages;Cohort April 1;Males;Survival in the first trimester;2020QII;35.249
18 Granada;All ages;Cohort April 1;Males;Survival in the first trimester;2020QI;""
18 Granada;All ages;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
18 Granada;All ages;Cohort April 1;Males;Survival in the second trimester;2022QIII;35.079
18 Granada;All ages;Cohort April 1;Males;Survival in the second trimester;2022QII;""
18 Granada;All ages;Cohort April 1;Males;Survival in the second trimester;2022QI;""
18 Granada;All ages;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
18 Granada;All ages;Cohort April 1;Males;Survival in the second trimester;2021QIII;35.132
18 Granada;All ages;Cohort April 1;Males;Survival in the second trimester;2021QII;""
18 Granada;All ages;Cohort April 1;Males;Survival in the second trimester;2021QI;""
18 Granada;All ages;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
18 Granada;All ages;Cohort April 1;Males;Survival in the second trimester;2020QIII;34.175
18 Granada;All ages;Cohort April 1;Males;Survival in the second trimester;2020QII;""
18 Granada;All ages;Cohort April 1;Males;Survival in the second trimester;2020QI;""
18 Granada;All ages;Cohort April 1;Males;Survival in the third trimester;2022QIV;33.808
18 Granada;All ages;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
18 Granada;All ages;Cohort April 1;Males;Survival in the third trimester;2022QII;""
18 Granada;All ages;Cohort April 1;Males;Survival in the third trimester;2022QI;""
18 Granada;All ages;Cohort April 1;Males;Survival in the third trimester;2021QIV;34.058
18 Granada;All ages;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
18 Granada;All ages;Cohort April 1;Males;Survival in the third trimester;2021QII;""
18 Granada;All ages;Cohort April 1;Males;Survival in the third trimester;2021QI;""
18 Granada;All ages;Cohort April 1;Males;Survival in the third trimester;2020QIV;33.189
18 Granada;All ages;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
18 Granada;All ages;Cohort April 1;Males;Survival in the third trimester;2020QII;""
18 Granada;All ages;Cohort April 1;Males;Survival in the third trimester;2020QI;""
18 Granada;All ages;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
18 Granada;All ages;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
18 Granada;All ages;Cohort April 1;Males;Survival in the third trimester;2022QII;""
18 Granada;All ages;Cohort April 1;Males;Survival in the third trimester;2022QI;33.124
18 Granada;All ages;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
18 Granada;All ages;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
18 Granada;All ages;Cohort April 1;Males;Survival in the third trimester;2021QII;""
18 Granada;All ages;Cohort April 1;Males;Survival in the third trimester;2021QI;32.515
18 Granada;All ages;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
18 Granada;All ages;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
18 Granada;All ages;Cohort April 1;Males;Survival in the third trimester;2020QII;""
18 Granada;All ages;Cohort April 1;Males;Survival in the third trimester;2020QI;""
18 Granada;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
18 Granada;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
18 Granada;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
18 Granada;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
18 Granada;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
18 Granada;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
18 Granada;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
18 Granada;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
18 Granada;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
18 Granada;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
18 Granada;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
18 Granada;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
18 Granada;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
18 Granada;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
18 Granada;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;96,13
18 Granada;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
18 Granada;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
18 Granada;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
18 Granada;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;96,79
18 Granada;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
18 Granada;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
18 Granada;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
18 Granada;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;97,9
18 Granada;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
18 Granada;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
18 Granada;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;93,13
18 Granada;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
18 Granada;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
18 Granada;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
18 Granada;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;94,23
18 Granada;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
18 Granada;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
18 Granada;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
18 Granada;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;94,92
18 Granada;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
18 Granada;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
18 Granada;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;89,76
18 Granada;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
18 Granada;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
18 Granada;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
18 Granada;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;91,35
18 Granada;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
18 Granada;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
18 Granada;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
18 Granada;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;92,18
18 Granada;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
18 Granada;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
18 Granada;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
18 Granada;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
18 Granada;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
18 Granada;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
18 Granada;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;88,84
18 Granada;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
18 Granada;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
18 Granada;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
18 Granada;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;90,31
18 Granada;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
18 Granada;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
18 Granada;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
18 Granada;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
18 Granada;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
18 Granada;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
18 Granada;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QII;21.686
18 Granada;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
18 Granada;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
18 Granada;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
18 Granada;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QII;21.094
18 Granada;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
18 Granada;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
18 Granada;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
18 Granada;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QII;20.452
18 Granada;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
18 Granada;All ages;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
18 Granada;All ages;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
18 Granada;All ages;Cohort April 1;Females;Survival in the first trimester;2022QII;20.746
18 Granada;All ages;Cohort April 1;Females;Survival in the first trimester;2022QI;""
18 Granada;All ages;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
18 Granada;All ages;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
18 Granada;All ages;Cohort April 1;Females;Survival in the first trimester;2021QII;20.352
18 Granada;All ages;Cohort April 1;Females;Survival in the first trimester;2021QI;""
18 Granada;All ages;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
18 Granada;All ages;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
18 Granada;All ages;Cohort April 1;Females;Survival in the first trimester;2020QII;19.935
18 Granada;All ages;Cohort April 1;Females;Survival in the first trimester;2020QI;""
18 Granada;All ages;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
18 Granada;All ages;Cohort April 1;Females;Survival in the second trimester;2022QIII;20.022
18 Granada;All ages;Cohort April 1;Females;Survival in the second trimester;2022QII;""
18 Granada;All ages;Cohort April 1;Females;Survival in the second trimester;2022QI;""
18 Granada;All ages;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
18 Granada;All ages;Cohort April 1;Females;Survival in the second trimester;2021QIII;19.723
18 Granada;All ages;Cohort April 1;Females;Survival in the second trimester;2021QII;""
18 Granada;All ages;Cohort April 1;Females;Survival in the second trimester;2021QI;""
18 Granada;All ages;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
18 Granada;All ages;Cohort April 1;Females;Survival in the second trimester;2020QIII;19.195
18 Granada;All ages;Cohort April 1;Females;Survival in the second trimester;2020QII;""
18 Granada;All ages;Cohort April 1;Females;Survival in the second trimester;2020QI;""
18 Granada;All ages;Cohort April 1;Females;Survival in the third trimester;2022QIV;19.260
18 Granada;All ages;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
18 Granada;All ages;Cohort April 1;Females;Survival in the third trimester;2022QII;""
18 Granada;All ages;Cohort April 1;Females;Survival in the third trimester;2022QI;""
18 Granada;All ages;Cohort April 1;Females;Survival in the third trimester;2021QIV;19.080
18 Granada;All ages;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
18 Granada;All ages;Cohort April 1;Females;Survival in the third trimester;2021QII;""
18 Granada;All ages;Cohort April 1;Females;Survival in the third trimester;2021QI;""
18 Granada;All ages;Cohort April 1;Females;Survival in the third trimester;2020QIV;18.514
18 Granada;All ages;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
18 Granada;All ages;Cohort April 1;Females;Survival in the third trimester;2020QII;""
18 Granada;All ages;Cohort April 1;Females;Survival in the third trimester;2020QI;""
18 Granada;All ages;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
18 Granada;All ages;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
18 Granada;All ages;Cohort April 1;Females;Survival in the third trimester;2022QII;""
18 Granada;All ages;Cohort April 1;Females;Survival in the third trimester;2022QI;18.458
18 Granada;All ages;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
18 Granada;All ages;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
18 Granada;All ages;Cohort April 1;Females;Survival in the third trimester;2021QII;""
18 Granada;All ages;Cohort April 1;Females;Survival in the third trimester;2021QI;18.105
18 Granada;All ages;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
18 Granada;All ages;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
18 Granada;All ages;Cohort April 1;Females;Survival in the third trimester;2020QII;""
18 Granada;All ages;Cohort April 1;Females;Survival in the third trimester;2020QI;""
18 Granada;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
18 Granada;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
18 Granada;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
18 Granada;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
18 Granada;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
18 Granada;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
18 Granada;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
18 Granada;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
18 Granada;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
18 Granada;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
18 Granada;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
18 Granada;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
18 Granada;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
18 Granada;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
18 Granada;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;95,67
18 Granada;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
18 Granada;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
18 Granada;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
18 Granada;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;96,48
18 Granada;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
18 Granada;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
18 Granada;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
18 Granada;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;97,47
18 Granada;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
18 Granada;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
18 Granada;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;92,33
18 Granada;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
18 Granada;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
18 Granada;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
18 Granada;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;93,5
18 Granada;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
18 Granada;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
18 Granada;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
18 Granada;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;93,85
18 Granada;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
18 Granada;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
18 Granada;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;88,81
18 Granada;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
18 Granada;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
18 Granada;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
18 Granada;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;90,45
18 Granada;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
18 Granada;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
18 Granada;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
18 Granada;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;90,52
18 Granada;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
18 Granada;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
18 Granada;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
18 Granada;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
18 Granada;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
18 Granada;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
18 Granada;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;87,5
18 Granada;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
18 Granada;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
18 Granada;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
18 Granada;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;88,52
18 Granada;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
18 Granada;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
18 Granada;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
18 Granada;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
18 Granada;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
18 Granada;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QIII;59.247
18 Granada;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
18 Granada;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
18 Granada;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
18 Granada;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QIII;58.895
18 Granada;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
18 Granada;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
18 Granada;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
18 Granada;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QIII;57.227
18 Granada;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
18 Granada;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
18 Granada;All ages;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
18 Granada;All ages;Cohort July 1;Total;Survival in the first trimester;2022QIII;57.048
18 Granada;All ages;Cohort July 1;Total;Survival in the first trimester;2022QII;""
18 Granada;All ages;Cohort July 1;Total;Survival in the first trimester;2022QI;""
18 Granada;All ages;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
18 Granada;All ages;Cohort July 1;Total;Survival in the first trimester;2021QIII;56.971
18 Granada;All ages;Cohort July 1;Total;Survival in the first trimester;2021QII;""
18 Granada;All ages;Cohort July 1;Total;Survival in the first trimester;2021QI;""
18 Granada;All ages;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
18 Granada;All ages;Cohort July 1;Total;Survival in the first trimester;2020QIII;55.118
18 Granada;All ages;Cohort July 1;Total;Survival in the first trimester;2020QII;""
18 Granada;All ages;Cohort July 1;Total;Survival in the first trimester;2020QI;""
18 Granada;All ages;Cohort July 1;Total;Survival in the second trimester;2022QIV;54.798
18 Granada;All ages;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
18 Granada;All ages;Cohort July 1;Total;Survival in the second trimester;2022QII;""
18 Granada;All ages;Cohort July 1;Total;Survival in the second trimester;2022QI;""
18 Granada;All ages;Cohort July 1;Total;Survival in the second trimester;2021QIV;55.048
18 Granada;All ages;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
18 Granada;All ages;Cohort July 1;Total;Survival in the second trimester;2021QII;""
18 Granada;All ages;Cohort July 1;Total;Survival in the second trimester;2021QI;""
18 Granada;All ages;Cohort July 1;Total;Survival in the second trimester;2020QIV;53.282
18 Granada;All ages;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
18 Granada;All ages;Cohort July 1;Total;Survival in the second trimester;2020QII;""
18 Granada;All ages;Cohort July 1;Total;Survival in the second trimester;2020QI;""
18 Granada;All ages;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
18 Granada;All ages;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
18 Granada;All ages;Cohort July 1;Total;Survival in the third trimester;2022QII;""
18 Granada;All ages;Cohort July 1;Total;Survival in the third trimester;2022QI;53.369
18 Granada;All ages;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
18 Granada;All ages;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
18 Granada;All ages;Cohort July 1;Total;Survival in the third trimester;2021QII;""
18 Granada;All ages;Cohort July 1;Total;Survival in the third trimester;2021QI;52.127
18 Granada;All ages;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
18 Granada;All ages;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
18 Granada;All ages;Cohort July 1;Total;Survival in the third trimester;2020QII;""
18 Granada;All ages;Cohort July 1;Total;Survival in the third trimester;2020QI;""
18 Granada;All ages;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
18 Granada;All ages;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
18 Granada;All ages;Cohort July 1;Total;Survival in the third trimester;2022QII;51.597
18 Granada;All ages;Cohort July 1;Total;Survival in the third trimester;2022QI;""
18 Granada;All ages;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
18 Granada;All ages;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
18 Granada;All ages;Cohort July 1;Total;Survival in the third trimester;2021QII;50.851
18 Granada;All ages;Cohort July 1;Total;Survival in the third trimester;2021QI;""
18 Granada;All ages;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
18 Granada;All ages;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
18 Granada;All ages;Cohort July 1;Total;Survival in the third trimester;2020QII;""
18 Granada;All ages;Cohort July 1;Total;Survival in the third trimester;2020QI;""
18 Granada;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
18 Granada;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
18 Granada;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
18 Granada;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
18 Granada;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
18 Granada;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
18 Granada;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
18 Granada;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
18 Granada;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
18 Granada;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
18 Granada;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
18 Granada;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
18 Granada;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
18 Granada;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;96,29
18 Granada;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
18 Granada;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
18 Granada;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
18 Granada;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;96,73
18 Granada;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
18 Granada;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
18 Granada;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
18 Granada;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;96,31
18 Granada;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
18 Granada;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
18 Granada;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;92,49
18 Granada;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
18 Granada;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
18 Granada;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
18 Granada;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;93,47
18 Granada;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
18 Granada;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
18 Granada;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
18 Granada;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;93,11
18 Granada;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
18 Granada;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
18 Granada;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
18 Granada;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
18 Granada;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
18 Granada;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
18 Granada;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;90,62
18 Granada;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
18 Granada;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
18 Granada;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
18 Granada;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;91,09
18 Granada;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
18 Granada;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
18 Granada;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
18 Granada;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
18 Granada;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
18 Granada;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
18 Granada;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;87,61
18 Granada;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
18 Granada;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
18 Granada;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
18 Granada;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;88,86
18 Granada;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
18 Granada;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
18 Granada;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
18 Granada;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
18 Granada;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
18 Granada;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
18 Granada;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QIII;37.561
18 Granada;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
18 Granada;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
18 Granada;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
18 Granada;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QIII;37.554
18 Granada;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
18 Granada;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
18 Granada;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
18 Granada;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QIII;36.607
18 Granada;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
18 Granada;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
18 Granada;All ages;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
18 Granada;All ages;Cohort July 1;Males;Survival in the first trimester;2022QIII;36.228
18 Granada;All ages;Cohort July 1;Males;Survival in the first trimester;2022QII;""
18 Granada;All ages;Cohort July 1;Males;Survival in the first trimester;2022QI;""
18 Granada;All ages;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
18 Granada;All ages;Cohort July 1;Males;Survival in the first trimester;2021QIII;36.389
18 Granada;All ages;Cohort July 1;Males;Survival in the first trimester;2021QII;""
18 Granada;All ages;Cohort July 1;Males;Survival in the first trimester;2021QI;""
18 Granada;All ages;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
18 Granada;All ages;Cohort July 1;Males;Survival in the first trimester;2020QIII;35.340
18 Granada;All ages;Cohort July 1;Males;Survival in the first trimester;2020QII;""
18 Granada;All ages;Cohort July 1;Males;Survival in the first trimester;2020QI;""
18 Granada;All ages;Cohort July 1;Males;Survival in the second trimester;2022QIV;34.822
18 Granada;All ages;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
18 Granada;All ages;Cohort July 1;Males;Survival in the second trimester;2022QII;""
18 Granada;All ages;Cohort July 1;Males;Survival in the second trimester;2022QI;""
18 Granada;All ages;Cohort July 1;Males;Survival in the second trimester;2021QIV;35.177
18 Granada;All ages;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
18 Granada;All ages;Cohort July 1;Males;Survival in the second trimester;2021QII;""
18 Granada;All ages;Cohort July 1;Males;Survival in the second trimester;2021QI;""
18 Granada;All ages;Cohort July 1;Males;Survival in the second trimester;2020QIV;34.231
18 Granada;All ages;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
18 Granada;All ages;Cohort July 1;Males;Survival in the second trimester;2020QII;""
18 Granada;All ages;Cohort July 1;Males;Survival in the second trimester;2020QI;""
18 Granada;All ages;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
18 Granada;All ages;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
18 Granada;All ages;Cohort July 1;Males;Survival in the third trimester;2022QII;""
18 Granada;All ages;Cohort July 1;Males;Survival in the third trimester;2022QI;34.169
18 Granada;All ages;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
18 Granada;All ages;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
18 Granada;All ages;Cohort July 1;Males;Survival in the third trimester;2021QII;""
18 Granada;All ages;Cohort July 1;Males;Survival in the third trimester;2021QI;33.507
18 Granada;All ages;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
18 Granada;All ages;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
18 Granada;All ages;Cohort July 1;Males;Survival in the third trimester;2020QII;""
18 Granada;All ages;Cohort July 1;Males;Survival in the third trimester;2020QI;""
18 Granada;All ages;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
18 Granada;All ages;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
18 Granada;All ages;Cohort July 1;Males;Survival in the third trimester;2022QII;33.102
18 Granada;All ages;Cohort July 1;Males;Survival in the third trimester;2022QI;""
18 Granada;All ages;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
18 Granada;All ages;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
18 Granada;All ages;Cohort July 1;Males;Survival in the third trimester;2021QII;32.716
18 Granada;All ages;Cohort July 1;Males;Survival in the third trimester;2021QI;""
18 Granada;All ages;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
18 Granada;All ages;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
18 Granada;All ages;Cohort July 1;Males;Survival in the third trimester;2020QII;""
18 Granada;All ages;Cohort July 1;Males;Survival in the third trimester;2020QI;""
18 Granada;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
18 Granada;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
18 Granada;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
18 Granada;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
18 Granada;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
18 Granada;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
18 Granada;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
18 Granada;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
18 Granada;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
18 Granada;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
18 Granada;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
18 Granada;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
18 Granada;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
18 Granada;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;96,45
18 Granada;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
18 Granada;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
18 Granada;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
18 Granada;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;96,9
18 Granada;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
18 Granada;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
18 Granada;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
18 Granada;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;96,54
18 Granada;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
18 Granada;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
18 Granada;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;92,71
18 Granada;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
18 Granada;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
18 Granada;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
18 Granada;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;93,67
18 Granada;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
18 Granada;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
18 Granada;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
18 Granada;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;93,51
18 Granada;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
18 Granada;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
18 Granada;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
18 Granada;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
18 Granada;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
18 Granada;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
18 Granada;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;90,99
18 Granada;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
18 Granada;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
18 Granada;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
18 Granada;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;91,53
18 Granada;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
18 Granada;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
18 Granada;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
18 Granada;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
18 Granada;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
18 Granada;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
18 Granada;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;88,15
18 Granada;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
18 Granada;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
18 Granada;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
18 Granada;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;89,37
18 Granada;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
18 Granada;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
18 Granada;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
18 Granada;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
18 Granada;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
18 Granada;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
18 Granada;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QIII;21.686
18 Granada;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
18 Granada;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
18 Granada;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
18 Granada;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QIII;21.341
18 Granada;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
18 Granada;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
18 Granada;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
18 Granada;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QIII;20.620
18 Granada;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
18 Granada;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
18 Granada;All ages;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
18 Granada;All ages;Cohort July 1;Females;Survival in the first trimester;2022QIII;20.820
18 Granada;All ages;Cohort July 1;Females;Survival in the first trimester;2022QII;""
18 Granada;All ages;Cohort July 1;Females;Survival in the first trimester;2022QI;""
18 Granada;All ages;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
18 Granada;All ages;Cohort July 1;Females;Survival in the first trimester;2021QIII;20.582
18 Granada;All ages;Cohort July 1;Females;Survival in the first trimester;2021QII;""
18 Granada;All ages;Cohort July 1;Females;Survival in the first trimester;2021QI;""
18 Granada;All ages;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
18 Granada;All ages;Cohort July 1;Females;Survival in the first trimester;2020QIII;19.778
18 Granada;All ages;Cohort July 1;Females;Survival in the first trimester;2020QII;""
18 Granada;All ages;Cohort July 1;Females;Survival in the first trimester;2020QI;""
18 Granada;All ages;Cohort July 1;Females;Survival in the second trimester;2022QIV;19.976
18 Granada;All ages;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
18 Granada;All ages;Cohort July 1;Females;Survival in the second trimester;2022QII;""
18 Granada;All ages;Cohort July 1;Females;Survival in the second trimester;2022QI;""
18 Granada;All ages;Cohort July 1;Females;Survival in the second trimester;2021QIV;19.871
18 Granada;All ages;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
18 Granada;All ages;Cohort July 1;Females;Survival in the second trimester;2021QII;""
18 Granada;All ages;Cohort July 1;Females;Survival in the second trimester;2021QI;""
18 Granada;All ages;Cohort July 1;Females;Survival in the second trimester;2020QIV;19.051
18 Granada;All ages;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
18 Granada;All ages;Cohort July 1;Females;Survival in the second trimester;2020QII;""
18 Granada;All ages;Cohort July 1;Females;Survival in the second trimester;2020QI;""
18 Granada;All ages;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
18 Granada;All ages;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
18 Granada;All ages;Cohort July 1;Females;Survival in the third trimester;2022QII;""
18 Granada;All ages;Cohort July 1;Females;Survival in the third trimester;2022QI;19.200
18 Granada;All ages;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
18 Granada;All ages;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
18 Granada;All ages;Cohort July 1;Females;Survival in the third trimester;2021QII;""
18 Granada;All ages;Cohort July 1;Females;Survival in the third trimester;2021QI;18.620
18 Granada;All ages;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
18 Granada;All ages;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
18 Granada;All ages;Cohort July 1;Females;Survival in the third trimester;2020QII;""
18 Granada;All ages;Cohort July 1;Females;Survival in the third trimester;2020QI;""
18 Granada;All ages;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
18 Granada;All ages;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
18 Granada;All ages;Cohort July 1;Females;Survival in the third trimester;2022QII;18.495
18 Granada;All ages;Cohort July 1;Females;Survival in the third trimester;2022QI;""
18 Granada;All ages;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
18 Granada;All ages;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
18 Granada;All ages;Cohort July 1;Females;Survival in the third trimester;2021QII;18.135
18 Granada;All ages;Cohort July 1;Females;Survival in the third trimester;2021QI;""
18 Granada;All ages;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
18 Granada;All ages;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
18 Granada;All ages;Cohort July 1;Females;Survival in the third trimester;2020QII;""
18 Granada;All ages;Cohort July 1;Females;Survival in the third trimester;2020QI;""
18 Granada;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
18 Granada;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
18 Granada;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
18 Granada;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
18 Granada;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
18 Granada;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
18 Granada;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
18 Granada;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
18 Granada;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
18 Granada;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
18 Granada;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
18 Granada;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
18 Granada;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
18 Granada;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;96,01
18 Granada;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
18 Granada;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
18 Granada;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
18 Granada;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;96,44
18 Granada;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
18 Granada;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
18 Granada;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
18 Granada;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;95,92
18 Granada;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
18 Granada;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
18 Granada;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;92,11
18 Granada;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
18 Granada;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
18 Granada;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
18 Granada;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;93,11
18 Granada;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
18 Granada;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
18 Granada;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
18 Granada;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;92,39
18 Granada;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
18 Granada;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
18 Granada;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
18 Granada;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
18 Granada;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
18 Granada;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
18 Granada;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;89,97
18 Granada;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
18 Granada;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
18 Granada;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
18 Granada;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;90,3
18 Granada;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
18 Granada;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
18 Granada;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
18 Granada;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
18 Granada;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
18 Granada;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
18 Granada;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;86,66
18 Granada;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
18 Granada;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
18 Granada;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
18 Granada;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;87,95
18 Granada;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
18 Granada;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
18 Granada;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
18 Granada;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
18 Granada;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
18 Granada;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QIV;59.111
18 Granada;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
18 Granada;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
18 Granada;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
18 Granada;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QIV;59.007
18 Granada;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
18 Granada;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
18 Granada;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
18 Granada;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QIV;57.363
18 Granada;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
18 Granada;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
18 Granada;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
18 Granada;All ages;Cohort October 1;Total;Survival in the first trimester;2022QIV;56.596
18 Granada;All ages;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
18 Granada;All ages;Cohort October 1;Total;Survival in the first trimester;2022QII;""
18 Granada;All ages;Cohort October 1;Total;Survival in the first trimester;2022QI;""
18 Granada;All ages;Cohort October 1;Total;Survival in the first trimester;2021QIV;56.847
18 Granada;All ages;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
18 Granada;All ages;Cohort October 1;Total;Survival in the first trimester;2021QII;""
18 Granada;All ages;Cohort October 1;Total;Survival in the first trimester;2021QI;""
18 Granada;All ages;Cohort October 1;Total;Survival in the first trimester;2020QIV;55.239
18 Granada;All ages;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
18 Granada;All ages;Cohort October 1;Total;Survival in the first trimester;2020QII;""
18 Granada;All ages;Cohort October 1;Total;Survival in the first trimester;2020QI;""
18 Granada;All ages;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
18 Granada;All ages;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
18 Granada;All ages;Cohort October 1;Total;Survival in the second trimester;2022QII;""
18 Granada;All ages;Cohort October 1;Total;Survival in the second trimester;2022QI;55.060
18 Granada;All ages;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
18 Granada;All ages;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
18 Granada;All ages;Cohort October 1;Total;Survival in the second trimester;2021QII;""
18 Granada;All ages;Cohort October 1;Total;Survival in the second trimester;2021QI;53.927
18 Granada;All ages;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
18 Granada;All ages;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
18 Granada;All ages;Cohort October 1;Total;Survival in the second trimester;2020QII;""
18 Granada;All ages;Cohort October 1;Total;Survival in the second trimester;2020QI;""
18 Granada;All ages;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
18 Granada;All ages;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
18 Granada;All ages;Cohort October 1;Total;Survival in the third trimester;2022QII;53.169
18 Granada;All ages;Cohort October 1;Total;Survival in the third trimester;2022QI;""
18 Granada;All ages;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
18 Granada;All ages;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
18 Granada;All ages;Cohort October 1;Total;Survival in the third trimester;2021QII;52.502
18 Granada;All ages;Cohort October 1;Total;Survival in the third trimester;2021QI;""
18 Granada;All ages;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
18 Granada;All ages;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
18 Granada;All ages;Cohort October 1;Total;Survival in the third trimester;2020QII;""
18 Granada;All ages;Cohort October 1;Total;Survival in the third trimester;2020QI;""
18 Granada;All ages;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
18 Granada;All ages;Cohort October 1;Total;Survival in the third trimester;2022QIII;51.591
18 Granada;All ages;Cohort October 1;Total;Survival in the third trimester;2022QII;""
18 Granada;All ages;Cohort October 1;Total;Survival in the third trimester;2022QI;""
18 Granada;All ages;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
18 Granada;All ages;Cohort October 1;Total;Survival in the third trimester;2021QIII;51.187
18 Granada;All ages;Cohort October 1;Total;Survival in the third trimester;2021QII;""
18 Granada;All ages;Cohort October 1;Total;Survival in the third trimester;2021QI;""
18 Granada;All ages;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
18 Granada;All ages;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
18 Granada;All ages;Cohort October 1;Total;Survival in the third trimester;2020QII;""
18 Granada;All ages;Cohort October 1;Total;Survival in the third trimester;2020QI;""
18 Granada;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
18 Granada;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
18 Granada;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
18 Granada;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
18 Granada;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
18 Granada;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
18 Granada;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
18 Granada;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
18 Granada;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
18 Granada;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
18 Granada;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
18 Granada;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
18 Granada;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;95,75
18 Granada;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
18 Granada;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
18 Granada;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
18 Granada;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;96,34
18 Granada;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
18 Granada;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
18 Granada;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
18 Granada;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;96,3
18 Granada;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
18 Granada;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
18 Granada;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
18 Granada;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
18 Granada;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
18 Granada;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
18 Granada;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;93,31
18 Granada;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
18 Granada;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
18 Granada;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
18 Granada;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;94,01
18 Granada;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
18 Granada;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
18 Granada;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
18 Granada;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
18 Granada;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
18 Granada;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
18 Granada;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;90,11
18 Granada;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
18 Granada;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
18 Granada;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
18 Granada;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;91,53
18 Granada;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
18 Granada;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
18 Granada;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
18 Granada;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
18 Granada;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
18 Granada;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
18 Granada;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;87,43
18 Granada;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
18 Granada;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
18 Granada;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
18 Granada;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;89,23
18 Granada;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
18 Granada;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
18 Granada;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
18 Granada;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
18 Granada;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
18 Granada;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
18 Granada;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QIV;37.432
18 Granada;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
18 Granada;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
18 Granada;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
18 Granada;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QIV;37.577
18 Granada;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
18 Granada;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
18 Granada;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
18 Granada;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QIV;36.723
18 Granada;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
18 Granada;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
18 Granada;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
18 Granada;All ages;Cohort October 1;Males;Survival in the first trimester;2022QIV;35.850
18 Granada;All ages;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
18 Granada;All ages;Cohort October 1;Males;Survival in the first trimester;2022QII;""
18 Granada;All ages;Cohort October 1;Males;Survival in the first trimester;2022QI;""
18 Granada;All ages;Cohort October 1;Males;Survival in the first trimester;2021QIV;36.210
18 Granada;All ages;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
18 Granada;All ages;Cohort October 1;Males;Survival in the first trimester;2021QII;""
18 Granada;All ages;Cohort October 1;Males;Survival in the first trimester;2021QI;""
18 Granada;All ages;Cohort October 1;Males;Survival in the first trimester;2020QIV;35.420
18 Granada;All ages;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
18 Granada;All ages;Cohort October 1;Males;Survival in the first trimester;2020QII;""
18 Granada;All ages;Cohort October 1;Males;Survival in the first trimester;2020QI;""
18 Granada;All ages;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
18 Granada;All ages;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
18 Granada;All ages;Cohort October 1;Males;Survival in the second trimester;2022QII;""
18 Granada;All ages;Cohort October 1;Males;Survival in the second trimester;2022QI;35.145
18 Granada;All ages;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
18 Granada;All ages;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
18 Granada;All ages;Cohort October 1;Males;Survival in the second trimester;2021QII;""
18 Granada;All ages;Cohort October 1;Males;Survival in the second trimester;2021QI;34.598
18 Granada;All ages;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
18 Granada;All ages;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
18 Granada;All ages;Cohort October 1;Males;Survival in the second trimester;2020QII;""
18 Granada;All ages;Cohort October 1;Males;Survival in the second trimester;2020QI;""
18 Granada;All ages;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
18 Granada;All ages;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
18 Granada;All ages;Cohort October 1;Males;Survival in the third trimester;2022QII;34.007
18 Granada;All ages;Cohort October 1;Males;Survival in the third trimester;2022QI;""
18 Granada;All ages;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
18 Granada;All ages;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
18 Granada;All ages;Cohort October 1;Males;Survival in the third trimester;2021QII;33.723
18 Granada;All ages;Cohort October 1;Males;Survival in the third trimester;2021QI;""
18 Granada;All ages;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
18 Granada;All ages;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
18 Granada;All ages;Cohort October 1;Males;Survival in the third trimester;2020QII;""
18 Granada;All ages;Cohort October 1;Males;Survival in the third trimester;2020QI;""
18 Granada;All ages;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
18 Granada;All ages;Cohort October 1;Males;Survival in the third trimester;2022QIII;33.050
18 Granada;All ages;Cohort October 1;Males;Survival in the third trimester;2022QII;""
18 Granada;All ages;Cohort October 1;Males;Survival in the third trimester;2022QI;""
18 Granada;All ages;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
18 Granada;All ages;Cohort October 1;Males;Survival in the third trimester;2021QIII;32.917
18 Granada;All ages;Cohort October 1;Males;Survival in the third trimester;2021QII;""
18 Granada;All ages;Cohort October 1;Males;Survival in the third trimester;2021QI;""
18 Granada;All ages;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
18 Granada;All ages;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
18 Granada;All ages;Cohort October 1;Males;Survival in the third trimester;2020QII;""
18 Granada;All ages;Cohort October 1;Males;Survival in the third trimester;2020QI;""
18 Granada;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
18 Granada;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
18 Granada;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
18 Granada;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
18 Granada;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
18 Granada;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
18 Granada;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
18 Granada;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
18 Granada;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
18 Granada;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
18 Granada;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
18 Granada;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
18 Granada;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;95,77
18 Granada;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
18 Granada;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
18 Granada;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
18 Granada;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;96,36
18 Granada;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
18 Granada;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
18 Granada;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
18 Granada;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;96,45
18 Granada;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
18 Granada;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
18 Granada;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
18 Granada;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
18 Granada;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
18 Granada;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
18 Granada;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;93,53
18 Granada;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
18 Granada;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
18 Granada;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
18 Granada;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;94,21
18 Granada;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
18 Granada;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
18 Granada;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
18 Granada;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
18 Granada;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
18 Granada;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
18 Granada;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;90,5
18 Granada;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
18 Granada;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
18 Granada;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
18 Granada;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;91,83
18 Granada;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
18 Granada;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
18 Granada;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
18 Granada;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
18 Granada;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
18 Granada;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
18 Granada;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;87,95
18 Granada;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
18 Granada;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
18 Granada;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
18 Granada;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;89,64
18 Granada;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
18 Granada;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
18 Granada;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
18 Granada;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
18 Granada;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
18 Granada;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
18 Granada;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QIV;21.679
18 Granada;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
18 Granada;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
18 Granada;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
18 Granada;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QIV;21.430
18 Granada;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
18 Granada;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
18 Granada;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
18 Granada;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QIV;20.640
18 Granada;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
18 Granada;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
18 Granada;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
18 Granada;All ages;Cohort October 1;Females;Survival in the first trimester;2022QIV;20.746
18 Granada;All ages;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
18 Granada;All ages;Cohort October 1;Females;Survival in the first trimester;2022QII;""
18 Granada;All ages;Cohort October 1;Females;Survival in the first trimester;2022QI;""
18 Granada;All ages;Cohort October 1;Females;Survival in the first trimester;2021QIV;20.637
18 Granada;All ages;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
18 Granada;All ages;Cohort October 1;Females;Survival in the first trimester;2021QII;""
18 Granada;All ages;Cohort October 1;Females;Survival in the first trimester;2021QI;""
18 Granada;All ages;Cohort October 1;Females;Survival in the first trimester;2020QIV;19.819
18 Granada;All ages;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
18 Granada;All ages;Cohort October 1;Females;Survival in the first trimester;2020QII;""
18 Granada;All ages;Cohort October 1;Females;Survival in the first trimester;2020QI;""
18 Granada;All ages;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
18 Granada;All ages;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
18 Granada;All ages;Cohort October 1;Females;Survival in the second trimester;2022QII;""
18 Granada;All ages;Cohort October 1;Females;Survival in the second trimester;2022QI;19.915
18 Granada;All ages;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
18 Granada;All ages;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
18 Granada;All ages;Cohort October 1;Females;Survival in the second trimester;2021QII;""
18 Granada;All ages;Cohort October 1;Females;Survival in the second trimester;2021QI;19.329
18 Granada;All ages;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
18 Granada;All ages;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
18 Granada;All ages;Cohort October 1;Females;Survival in the second trimester;2020QII;""
18 Granada;All ages;Cohort October 1;Females;Survival in the second trimester;2020QI;""
18 Granada;All ages;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
18 Granada;All ages;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
18 Granada;All ages;Cohort October 1;Females;Survival in the third trimester;2022QII;19.162
18 Granada;All ages;Cohort October 1;Females;Survival in the third trimester;2022QI;""
18 Granada;All ages;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
18 Granada;All ages;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
18 Granada;All ages;Cohort October 1;Females;Survival in the third trimester;2021QII;18.779
18 Granada;All ages;Cohort October 1;Females;Survival in the third trimester;2021QI;""
18 Granada;All ages;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
18 Granada;All ages;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
18 Granada;All ages;Cohort October 1;Females;Survival in the third trimester;2020QII;""
18 Granada;All ages;Cohort October 1;Females;Survival in the third trimester;2020QI;""
18 Granada;All ages;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
18 Granada;All ages;Cohort October 1;Females;Survival in the third trimester;2022QIII;18.541
18 Granada;All ages;Cohort October 1;Females;Survival in the third trimester;2022QII;""
18 Granada;All ages;Cohort October 1;Females;Survival in the third trimester;2022QI;""
18 Granada;All ages;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
18 Granada;All ages;Cohort October 1;Females;Survival in the third trimester;2021QIII;18.270
18 Granada;All ages;Cohort October 1;Females;Survival in the third trimester;2021QII;""
18 Granada;All ages;Cohort October 1;Females;Survival in the third trimester;2021QI;""
18 Granada;All ages;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
18 Granada;All ages;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
18 Granada;All ages;Cohort October 1;Females;Survival in the third trimester;2020QII;""
18 Granada;All ages;Cohort October 1;Females;Survival in the third trimester;2020QI;""
18 Granada;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
18 Granada;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
18 Granada;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
18 Granada;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
18 Granada;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
18 Granada;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
18 Granada;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
18 Granada;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
18 Granada;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
18 Granada;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
18 Granada;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
18 Granada;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
18 Granada;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;95,7
18 Granada;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
18 Granada;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
18 Granada;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
18 Granada;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;96,3
18 Granada;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
18 Granada;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
18 Granada;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
18 Granada;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;96,02
18 Granada;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
18 Granada;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
18 Granada;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
18 Granada;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
18 Granada;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
18 Granada;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
18 Granada;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;92,93
18 Granada;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
18 Granada;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
18 Granada;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
18 Granada;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;93,65
18 Granada;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
18 Granada;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
18 Granada;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
18 Granada;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
18 Granada;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
18 Granada;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
18 Granada;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;89,42
18 Granada;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
18 Granada;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
18 Granada;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
18 Granada;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;90,98
18 Granada;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
18 Granada;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
18 Granada;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
18 Granada;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
18 Granada;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
18 Granada;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
18 Granada;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;86,52
18 Granada;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
18 Granada;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
18 Granada;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
18 Granada;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;88,52
18 Granada;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
18 Granada;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
18 Granada;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
18 Granada;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
18 Granada;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
18 Granada;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
18 Granada;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
18 Granada;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
18 Granada;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
18 Granada;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QI;4.410
18 Granada;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
18 Granada;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
18 Granada;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
18 Granada;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QI;4.311
18 Granada;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
18 Granada;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
18 Granada;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
18 Granada;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QI;3.530
18 Granada;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
18 Granada;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
18 Granada;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2022QII;""
18 Granada;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2022QI;4.094
18 Granada;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
18 Granada;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
18 Granada;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2021QII;""
18 Granada;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2021QI;4.073
18 Granada;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
18 Granada;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
18 Granada;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2020QII;""
18 Granada;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2020QI;3.078
18 Granada;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
18 Granada;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
18 Granada;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2022QII;3.784
18 Granada;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2022QI;""
18 Granada;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
18 Granada;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
18 Granada;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2021QII;3.817
18 Granada;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2021QI;""
18 Granada;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
18 Granada;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
18 Granada;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2020QII;2.978
18 Granada;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2020QI;""
18 Granada;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
18 Granada;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QIII;3.540
18 Granada;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QII;""
18 Granada;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QI;""
18 Granada;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
18 Granada;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QIII;3.573
18 Granada;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QII;""
18 Granada;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QI;""
18 Granada;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
18 Granada;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QIII;2.813
18 Granada;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QII;""
18 Granada;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QI;""
18 Granada;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QIV;3.270
18 Granada;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
18 Granada;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QII;""
18 Granada;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QI;""
18 Granada;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QIV;3.354
18 Granada;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
18 Granada;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QII;""
18 Granada;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QI;""
18 Granada;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QIV;2.666
18 Granada;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
18 Granada;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QII;""
18 Granada;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QI;""
18 Granada;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
18 Granada;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
18 Granada;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
18 Granada;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
18 Granada;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
18 Granada;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
18 Granada;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
18 Granada;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
18 Granada;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
18 Granada;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
18 Granada;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
18 Granada;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
18 Granada;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
18 Granada;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
18 Granada;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
18 Granada;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;92,83
18 Granada;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
18 Granada;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
18 Granada;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
18 Granada;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;94,48
18 Granada;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
18 Granada;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
18 Granada;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
18 Granada;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;87,2
18 Granada;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
18 Granada;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
18 Granada;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;85,8
18 Granada;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
18 Granada;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
18 Granada;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
18 Granada;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;88,54
18 Granada;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
18 Granada;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
18 Granada;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
18 Granada;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;84,36
18 Granada;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
18 Granada;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
18 Granada;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;80,27
18 Granada;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
18 Granada;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
18 Granada;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
18 Granada;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;82,88
18 Granada;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
18 Granada;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
18 Granada;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
18 Granada;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;79,69
18 Granada;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
18 Granada;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
18 Granada;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;74,15
18 Granada;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
18 Granada;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
18 Granada;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
18 Granada;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;77,8
18 Granada;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
18 Granada;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
18 Granada;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
18 Granada;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;75,52
18 Granada;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
18 Granada;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
18 Granada;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
18 Granada;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
18 Granada;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
18 Granada;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
18 Granada;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QI;2.761
18 Granada;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
18 Granada;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
18 Granada;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
18 Granada;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QI;2.704
18 Granada;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
18 Granada;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
18 Granada;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
18 Granada;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QI;2.218
18 Granada;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
18 Granada;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
18 Granada;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2022QII;""
18 Granada;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2022QI;2.577
18 Granada;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
18 Granada;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
18 Granada;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2021QII;""
18 Granada;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2021QI;2.556
18 Granada;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
18 Granada;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
18 Granada;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2020QII;""
18 Granada;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2020QI;1.927
18 Granada;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
18 Granada;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
18 Granada;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2022QII;2.393
18 Granada;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2022QI;""
18 Granada;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
18 Granada;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
18 Granada;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2021QII;2.396
18 Granada;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2021QI;""
18 Granada;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
18 Granada;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
18 Granada;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2020QII;1.868
18 Granada;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2020QI;""
18 Granada;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
18 Granada;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QIII;2.232
18 Granada;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QII;""
18 Granada;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QI;""
18 Granada;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
18 Granada;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QIII;2.258
18 Granada;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QII;""
18 Granada;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QI;""
18 Granada;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
18 Granada;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QIII;1.765
18 Granada;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QII;""
18 Granada;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QI;""
18 Granada;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QIV;2.076
18 Granada;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
18 Granada;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QII;""
18 Granada;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QI;""
18 Granada;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QIV;2.125
18 Granada;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
18 Granada;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QII;""
18 Granada;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QI;""
18 Granada;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QIV;1.672
18 Granada;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
18 Granada;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QII;""
18 Granada;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QI;""
18 Granada;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
18 Granada;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
18 Granada;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
18 Granada;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
18 Granada;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
18 Granada;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
18 Granada;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
18 Granada;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
18 Granada;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
18 Granada;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
18 Granada;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
18 Granada;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
18 Granada;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
18 Granada;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
18 Granada;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
18 Granada;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;93,34
18 Granada;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
18 Granada;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
18 Granada;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
18 Granada;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;94,53
18 Granada;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
18 Granada;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
18 Granada;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
18 Granada;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;86,88
18 Granada;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
18 Granada;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
18 Granada;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;86,67
18 Granada;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
18 Granada;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
18 Granada;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
18 Granada;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;88,61
18 Granada;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
18 Granada;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
18 Granada;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
18 Granada;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;84,22
18 Granada;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
18 Granada;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
18 Granada;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;80,84
18 Granada;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
18 Granada;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
18 Granada;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
18 Granada;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;83,51
18 Granada;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
18 Granada;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
18 Granada;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
18 Granada;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;79,58
18 Granada;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
18 Granada;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
18 Granada;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;75,19
18 Granada;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
18 Granada;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
18 Granada;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
18 Granada;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;78,59
18 Granada;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
18 Granada;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
18 Granada;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
18 Granada;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;75,38
18 Granada;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
18 Granada;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
18 Granada;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
18 Granada;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
18 Granada;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
18 Granada;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
18 Granada;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QI;1.649
18 Granada;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
18 Granada;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
18 Granada;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
18 Granada;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QI;1.607
18 Granada;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
18 Granada;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
18 Granada;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
18 Granada;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QI;1.312
18 Granada;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
18 Granada;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
18 Granada;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2022QII;""
18 Granada;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2022QI;1.517
18 Granada;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
18 Granada;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
18 Granada;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2021QII;""
18 Granada;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2021QI;1.517
18 Granada;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
18 Granada;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
18 Granada;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2020QII;""
18 Granada;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2020QI;1.151
18 Granada;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
18 Granada;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
18 Granada;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2022QII;1.391
18 Granada;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2022QI;""
18 Granada;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
18 Granada;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
18 Granada;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2021QII;1.421
18 Granada;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2021QI;""
18 Granada;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
18 Granada;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
18 Granada;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2020QII;1.110
18 Granada;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2020QI;""
18 Granada;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
18 Granada;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QIII;1.308
18 Granada;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QII;""
18 Granada;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QI;""
18 Granada;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
18 Granada;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QIII;1.315
18 Granada;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QII;""
18 Granada;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QI;""
18 Granada;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
18 Granada;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QIII;1.048
18 Granada;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QII;""
18 Granada;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QI;""
18 Granada;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QIV;1.194
18 Granada;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
18 Granada;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QII;""
18 Granada;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QI;""
18 Granada;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QIV;1.229
18 Granada;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
18 Granada;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QII;""
18 Granada;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QI;""
18 Granada;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QIV;994
18 Granada;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
18 Granada;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QII;""
18 Granada;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QI;""
18 Granada;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
18 Granada;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
18 Granada;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
18 Granada;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
18 Granada;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
18 Granada;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
18 Granada;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
18 Granada;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
18 Granada;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
18 Granada;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
18 Granada;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
18 Granada;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
18 Granada;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
18 Granada;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
18 Granada;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
18 Granada;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;92
18 Granada;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
18 Granada;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
18 Granada;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
18 Granada;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;94,4
18 Granada;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
18 Granada;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
18 Granada;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
18 Granada;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;87,73
18 Granada;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
18 Granada;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
18 Granada;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;84,35
18 Granada;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
18 Granada;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
18 Granada;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
18 Granada;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;88,43
18 Granada;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
18 Granada;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
18 Granada;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
18 Granada;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;84,6
18 Granada;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
18 Granada;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
18 Granada;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;79,32
18 Granada;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
18 Granada;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
18 Granada;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
18 Granada;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;81,83
18 Granada;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
18 Granada;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
18 Granada;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
18 Granada;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;79,88
18 Granada;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
18 Granada;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
18 Granada;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;72,41
18 Granada;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
18 Granada;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
18 Granada;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
18 Granada;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;76,48
18 Granada;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
18 Granada;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
18 Granada;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
18 Granada;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;75,76
18 Granada;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
18 Granada;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
18 Granada;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
18 Granada;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
18 Granada;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
18 Granada;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QII;3.807
18 Granada;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
18 Granada;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
18 Granada;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
18 Granada;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QII;3.801
18 Granada;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
18 Granada;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
18 Granada;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
18 Granada;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QII;3.562
18 Granada;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
18 Granada;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
18 Granada;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
18 Granada;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2022QII;3.494
18 Granada;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2022QI;""
18 Granada;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
18 Granada;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
18 Granada;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2021QII;3.522
18 Granada;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2021QI;""
18 Granada;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
18 Granada;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
18 Granada;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2020QII;3.437
18 Granada;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2020QI;""
18 Granada;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
18 Granada;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2022QIII;3.249
18 Granada;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2022QII;""
18 Granada;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2022QI;""
18 Granada;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
18 Granada;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2021QIII;3.281
18 Granada;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2021QII;""
18 Granada;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2021QI;""
18 Granada;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
18 Granada;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2020QIII;3.215
18 Granada;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2020QII;""
18 Granada;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2020QI;""
18 Granada;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QIV;2.985
18 Granada;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
18 Granada;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QII;""
18 Granada;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QI;""
18 Granada;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QIV;3.062
18 Granada;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
18 Granada;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QII;""
18 Granada;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QI;""
18 Granada;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QIV;3.026
18 Granada;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
18 Granada;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QII;""
18 Granada;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QI;""
18 Granada;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
18 Granada;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
18 Granada;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QII;""
18 Granada;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QI;2.860
18 Granada;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
18 Granada;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
18 Granada;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QII;""
18 Granada;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QI;2.904
18 Granada;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
18 Granada;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
18 Granada;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QII;""
18 Granada;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QI;""
18 Granada;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
18 Granada;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
18 Granada;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
18 Granada;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
18 Granada;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
18 Granada;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
18 Granada;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
18 Granada;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
18 Granada;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
18 Granada;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
18 Granada;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
18 Granada;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
18 Granada;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
18 Granada;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
18 Granada;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;91,78
18 Granada;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
18 Granada;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
18 Granada;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
18 Granada;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;92,66
18 Granada;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
18 Granada;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
18 Granada;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
18 Granada;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;96,49
18 Granada;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
18 Granada;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
18 Granada;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;85,34
18 Granada;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
18 Granada;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
18 Granada;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
18 Granada;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;86,32
18 Granada;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
18 Granada;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
18 Granada;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
18 Granada;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;90,26
18 Granada;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
18 Granada;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
18 Granada;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;78,41
18 Granada;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
18 Granada;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
18 Granada;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
18 Granada;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;80,56
18 Granada;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
18 Granada;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
18 Granada;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
18 Granada;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;84,95
18 Granada;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
18 Granada;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
18 Granada;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
18 Granada;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
18 Granada;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
18 Granada;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
18 Granada;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;75,24
18 Granada;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
18 Granada;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
18 Granada;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
18 Granada;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;81,53
18 Granada;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
18 Granada;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
18 Granada;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
18 Granada;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
18 Granada;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
18 Granada;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
18 Granada;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QII;2.411
18 Granada;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
18 Granada;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
18 Granada;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
18 Granada;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QII;2.406
18 Granada;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
18 Granada;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
18 Granada;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
18 Granada;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QII;2.220
18 Granada;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
18 Granada;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
18 Granada;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
18 Granada;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2022QII;2.220
18 Granada;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2022QI;""
18 Granada;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
18 Granada;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
18 Granada;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2021QII;2.228
18 Granada;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2021QI;""
18 Granada;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
18 Granada;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
18 Granada;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2020QII;2.149
18 Granada;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2020QI;""
18 Granada;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
18 Granada;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2022QIII;2.062
18 Granada;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2022QII;""
18 Granada;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2022QI;""
18 Granada;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
18 Granada;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2021QIII;2.091
18 Granada;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2021QII;""
18 Granada;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2021QI;""
18 Granada;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
18 Granada;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2020QIII;2.013
18 Granada;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2020QII;""
18 Granada;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2020QI;""
18 Granada;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QIV;1.906
18 Granada;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
18 Granada;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QII;""
18 Granada;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QI;""
18 Granada;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QIV;1.959
18 Granada;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
18 Granada;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QII;""
18 Granada;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QI;""
18 Granada;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QIV;1.897
18 Granada;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
18 Granada;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QII;""
18 Granada;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QI;""
18 Granada;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
18 Granada;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
18 Granada;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QII;""
18 Granada;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QI;1.837
18 Granada;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
18 Granada;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
18 Granada;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QII;""
18 Granada;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QI;1.822
18 Granada;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
18 Granada;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
18 Granada;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QII;""
18 Granada;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QI;""
18 Granada;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
18 Granada;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
18 Granada;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
18 Granada;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
18 Granada;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
18 Granada;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
18 Granada;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
18 Granada;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
18 Granada;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
18 Granada;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
18 Granada;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
18 Granada;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
18 Granada;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
18 Granada;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
18 Granada;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;92,08
18 Granada;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
18 Granada;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
18 Granada;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
18 Granada;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;92,6
18 Granada;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
18 Granada;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
18 Granada;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
18 Granada;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;96,8
18 Granada;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
18 Granada;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
18 Granada;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;85,52
18 Granada;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
18 Granada;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
18 Granada;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
18 Granada;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;86,91
18 Granada;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
18 Granada;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
18 Granada;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
18 Granada;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;90,68
18 Granada;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
18 Granada;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
18 Granada;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;79,05
18 Granada;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
18 Granada;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
18 Granada;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
18 Granada;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;81,42
18 Granada;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
18 Granada;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
18 Granada;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
18 Granada;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;85,45
18 Granada;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
18 Granada;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
18 Granada;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
18 Granada;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
18 Granada;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
18 Granada;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
18 Granada;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;76,35
18 Granada;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
18 Granada;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
18 Granada;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
18 Granada;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;82,07
18 Granada;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
18 Granada;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
18 Granada;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
18 Granada;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
18 Granada;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
18 Granada;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
18 Granada;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QII;1.396
18 Granada;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
18 Granada;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
18 Granada;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
18 Granada;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QII;1.395
18 Granada;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
18 Granada;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
18 Granada;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
18 Granada;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QII;1.342
18 Granada;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
18 Granada;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
18 Granada;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
18 Granada;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2022QII;1.274
18 Granada;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2022QI;""
18 Granada;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
18 Granada;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
18 Granada;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2021QII;1.294
18 Granada;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2021QI;""
18 Granada;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
18 Granada;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
18 Granada;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2020QII;1.288
18 Granada;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2020QI;""
18 Granada;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
18 Granada;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2022QIII;1.187
18 Granada;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2022QII;""
18 Granada;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2022QI;""
18 Granada;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
18 Granada;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2021QIII;1.190
18 Granada;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2021QII;""
18 Granada;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2021QI;""
18 Granada;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
18 Granada;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2020QIII;1.202
18 Granada;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2020QII;""
18 Granada;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2020QI;""
18 Granada;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QIV;1.079
18 Granada;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
18 Granada;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QII;""
18 Granada;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QI;""
18 Granada;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QIV;1.103
18 Granada;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
18 Granada;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QII;""
18 Granada;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QI;""
18 Granada;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QIV;1.129
18 Granada;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
18 Granada;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QII;""
18 Granada;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QI;""
18 Granada;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
18 Granada;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
18 Granada;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QII;""
18 Granada;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QI;1.023
18 Granada;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
18 Granada;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
18 Granada;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QII;""
18 Granada;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QI;1.082
18 Granada;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
18 Granada;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
18 Granada;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QII;""
18 Granada;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QI;""
18 Granada;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
18 Granada;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
18 Granada;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
18 Granada;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
18 Granada;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
18 Granada;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
18 Granada;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
18 Granada;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
18 Granada;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
18 Granada;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
18 Granada;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
18 Granada;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
18 Granada;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
18 Granada;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
18 Granada;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;91,26
18 Granada;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
18 Granada;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
18 Granada;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
18 Granada;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;92,76
18 Granada;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
18 Granada;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
18 Granada;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
18 Granada;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;95,98
18 Granada;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
18 Granada;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
18 Granada;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;85,03
18 Granada;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
18 Granada;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
18 Granada;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
18 Granada;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;85,3
18 Granada;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
18 Granada;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
18 Granada;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
18 Granada;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;89,57
18 Granada;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
18 Granada;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
18 Granada;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;77,29
18 Granada;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
18 Granada;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
18 Granada;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
18 Granada;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;79,07
18 Granada;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
18 Granada;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
18 Granada;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
18 Granada;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;84,13
18 Granada;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
18 Granada;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
18 Granada;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
18 Granada;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
18 Granada;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
18 Granada;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
18 Granada;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;73,33
18 Granada;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
18 Granada;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
18 Granada;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
18 Granada;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;80,63
18 Granada;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
18 Granada;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
18 Granada;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
18 Granada;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
18 Granada;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
18 Granada;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QIII;3.932
18 Granada;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
18 Granada;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
18 Granada;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
18 Granada;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QIII;4.068
18 Granada;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
18 Granada;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
18 Granada;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
18 Granada;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QIII;3.794
18 Granada;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
18 Granada;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
18 Granada;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
18 Granada;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2022QIII;3.623
18 Granada;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2022QII;""
18 Granada;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2022QI;""
18 Granada;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
18 Granada;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2021QIII;3.723
18 Granada;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2021QII;""
18 Granada;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2021QI;""
18 Granada;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
18 Granada;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2020QIII;3.504
18 Granada;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2020QII;""
18 Granada;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2020QI;""
18 Granada;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2022QIV;3.329
18 Granada;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
18 Granada;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2022QII;""
18 Granada;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2022QI;""
18 Granada;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2021QIV;3.465
18 Granada;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
18 Granada;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2021QII;""
18 Granada;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2021QI;""
18 Granada;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2020QIV;3.282
18 Granada;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
18 Granada;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2020QII;""
18 Granada;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2020QI;""
18 Granada;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
18 Granada;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
18 Granada;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QII;""
18 Granada;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QI;3.233
18 Granada;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
18 Granada;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
18 Granada;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QII;""
18 Granada;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QI;3.147
18 Granada;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
18 Granada;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
18 Granada;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QII;""
18 Granada;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QI;""
18 Granada;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
18 Granada;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
18 Granada;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QII;3.000
18 Granada;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QI;""
18 Granada;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
18 Granada;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
18 Granada;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QII;2.987
18 Granada;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QI;""
18 Granada;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
18 Granada;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
18 Granada;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QII;""
18 Granada;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QI;""
18 Granada;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
18 Granada;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
18 Granada;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
18 Granada;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
18 Granada;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
18 Granada;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
18 Granada;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
18 Granada;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
18 Granada;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
18 Granada;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
18 Granada;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
18 Granada;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
18 Granada;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
18 Granada;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;92,14
18 Granada;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
18 Granada;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
18 Granada;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
18 Granada;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;91,52
18 Granada;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
18 Granada;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
18 Granada;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
18 Granada;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;92,36
18 Granada;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
18 Granada;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
18 Granada;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;84,66
18 Granada;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
18 Granada;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
18 Granada;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
18 Granada;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;85,18
18 Granada;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
18 Granada;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
18 Granada;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
18 Granada;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;86,51
18 Granada;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
18 Granada;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
18 Granada;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
18 Granada;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
18 Granada;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
18 Granada;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
18 Granada;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;79,47
18 Granada;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
18 Granada;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
18 Granada;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
18 Granada;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;82,95
18 Granada;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
18 Granada;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
18 Granada;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
18 Granada;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
18 Granada;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
18 Granada;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
18 Granada;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;73,75
18 Granada;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
18 Granada;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
18 Granada;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
18 Granada;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;78,73
18 Granada;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
18 Granada;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
18 Granada;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
18 Granada;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
18 Granada;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
18 Granada;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
18 Granada;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QIII;2.497
18 Granada;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
18 Granada;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
18 Granada;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
18 Granada;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QIII;2.580
18 Granada;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
18 Granada;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
18 Granada;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
18 Granada;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QIII;2.387
18 Granada;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
18 Granada;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
18 Granada;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
18 Granada;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2022QIII;2.295
18 Granada;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2022QII;""
18 Granada;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2022QI;""
18 Granada;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
18 Granada;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2021QIII;2.373
18 Granada;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2021QII;""
18 Granada;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2021QI;""
18 Granada;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
18 Granada;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2020QIII;2.200
18 Granada;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2020QII;""
18 Granada;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2020QI;""
18 Granada;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2022QIV;2.119
18 Granada;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
18 Granada;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2022QII;""
18 Granada;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2022QI;""
18 Granada;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2021QIV;2.220
18 Granada;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
18 Granada;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2021QII;""
18 Granada;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2021QI;""
18 Granada;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2020QIV;2.064
18 Granada;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
18 Granada;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2020QII;""
18 Granada;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2020QI;""
18 Granada;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
18 Granada;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
18 Granada;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QII;""
18 Granada;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QI;2.077
18 Granada;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
18 Granada;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
18 Granada;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QII;""
18 Granada;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QI;1.979
18 Granada;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
18 Granada;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
18 Granada;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QII;""
18 Granada;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QI;""
18 Granada;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
18 Granada;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
18 Granada;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QII;1.936
18 Granada;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QI;""
18 Granada;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
18 Granada;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
18 Granada;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QII;1.875
18 Granada;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QI;""
18 Granada;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
18 Granada;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
18 Granada;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QII;""
18 Granada;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QI;""
18 Granada;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
18 Granada;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
18 Granada;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
18 Granada;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
18 Granada;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
18 Granada;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
18 Granada;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
18 Granada;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
18 Granada;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
18 Granada;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
18 Granada;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
18 Granada;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
18 Granada;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
18 Granada;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;91,91
18 Granada;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
18 Granada;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
18 Granada;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
18 Granada;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;91,98
18 Granada;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
18 Granada;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
18 Granada;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
18 Granada;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;92,17
18 Granada;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
18 Granada;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
18 Granada;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;84,86
18 Granada;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
18 Granada;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
18 Granada;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
18 Granada;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;86,05
18 Granada;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
18 Granada;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
18 Granada;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
18 Granada;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;86,47
18 Granada;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
18 Granada;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
18 Granada;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
18 Granada;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
18 Granada;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
18 Granada;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
18 Granada;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;80,5
18 Granada;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
18 Granada;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
18 Granada;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
18 Granada;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;82,91
18 Granada;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
18 Granada;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
18 Granada;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
18 Granada;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
18 Granada;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
18 Granada;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
18 Granada;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;75,04
18 Granada;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
18 Granada;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
18 Granada;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
18 Granada;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;78,55
18 Granada;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
18 Granada;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
18 Granada;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
18 Granada;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
18 Granada;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
18 Granada;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
18 Granada;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QIII;1.435
18 Granada;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
18 Granada;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
18 Granada;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
18 Granada;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QIII;1.488
18 Granada;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
18 Granada;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
18 Granada;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
18 Granada;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QIII;1.407
18 Granada;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
18 Granada;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
18 Granada;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
18 Granada;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2022QIII;1.328
18 Granada;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2022QII;""
18 Granada;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2022QI;""
18 Granada;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
18 Granada;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2021QIII;1.350
18 Granada;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2021QII;""
18 Granada;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2021QI;""
18 Granada;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
18 Granada;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2020QIII;1.304
18 Granada;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2020QII;""
18 Granada;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2020QI;""
18 Granada;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2022QIV;1.210
18 Granada;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
18 Granada;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2022QII;""
18 Granada;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2022QI;""
18 Granada;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2021QIV;1.245
18 Granada;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
18 Granada;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2021QII;""
18 Granada;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2021QI;""
18 Granada;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2020QIV;1.218
18 Granada;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
18 Granada;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2020QII;""
18 Granada;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2020QI;""
18 Granada;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
18 Granada;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
18 Granada;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QII;""
18 Granada;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QI;1.156
18 Granada;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
18 Granada;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
18 Granada;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QII;""
18 Granada;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QI;1.168
18 Granada;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
18 Granada;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
18 Granada;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QII;""
18 Granada;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QI;""
18 Granada;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
18 Granada;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
18 Granada;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QII;1.064
18 Granada;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QI;""
18 Granada;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
18 Granada;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
18 Granada;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QII;1.112
18 Granada;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QI;""
18 Granada;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
18 Granada;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
18 Granada;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QII;""
18 Granada;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QI;""
18 Granada;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
18 Granada;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
18 Granada;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
18 Granada;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
18 Granada;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
18 Granada;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
18 Granada;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
18 Granada;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
18 Granada;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
18 Granada;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
18 Granada;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
18 Granada;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
18 Granada;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
18 Granada;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;92,54
18 Granada;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
18 Granada;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
18 Granada;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
18 Granada;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;90,73
18 Granada;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
18 Granada;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
18 Granada;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
18 Granada;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;92,68
18 Granada;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
18 Granada;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
18 Granada;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;84,32
18 Granada;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
18 Granada;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
18 Granada;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
18 Granada;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;83,67
18 Granada;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
18 Granada;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
18 Granada;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
18 Granada;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;86,57
18 Granada;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
18 Granada;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
18 Granada;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
18 Granada;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
18 Granada;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
18 Granada;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
18 Granada;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;77,69
18 Granada;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
18 Granada;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
18 Granada;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
18 Granada;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;83,01
18 Granada;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
18 Granada;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
18 Granada;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
18 Granada;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
18 Granada;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
18 Granada;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
18 Granada;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;71,51
18 Granada;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
18 Granada;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
18 Granada;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
18 Granada;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;79,03
18 Granada;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
18 Granada;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
18 Granada;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
18 Granada;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
18 Granada;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
18 Granada;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QIV;4.113
18 Granada;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
18 Granada;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
18 Granada;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
18 Granada;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QIV;4.225
18 Granada;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
18 Granada;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
18 Granada;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
18 Granada;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QIV;4.020
18 Granada;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
18 Granada;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
18 Granada;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
18 Granada;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2022QIV;3.751
18 Granada;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
18 Granada;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2022QII;""
18 Granada;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2022QI;""
18 Granada;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2021QIV;3.916
18 Granada;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
18 Granada;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2021QII;""
18 Granada;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2021QI;""
18 Granada;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2020QIV;3.739
18 Granada;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
18 Granada;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2020QII;""
18 Granada;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2020QI;""
18 Granada;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
18 Granada;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
18 Granada;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2022QII;""
18 Granada;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2022QI;3.659
18 Granada;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
18 Granada;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
18 Granada;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2021QII;""
18 Granada;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2021QI;3.563
18 Granada;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
18 Granada;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
18 Granada;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2020QII;""
18 Granada;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2020QI;""
18 Granada;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
18 Granada;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
18 Granada;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QII;3.402
18 Granada;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QI;""
18 Granada;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
18 Granada;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
18 Granada;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QII;3.365
18 Granada;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QI;""
18 Granada;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
18 Granada;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
18 Granada;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QII;""
18 Granada;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QI;""
18 Granada;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
18 Granada;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QIII;3.190
18 Granada;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QII;""
18 Granada;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QI;""
18 Granada;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
18 Granada;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QIII;3.165
18 Granada;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QII;""
18 Granada;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QI;""
18 Granada;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
18 Granada;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
18 Granada;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QII;""
18 Granada;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QI;""
18 Granada;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
18 Granada;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
18 Granada;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
18 Granada;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
18 Granada;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
18 Granada;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
18 Granada;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
18 Granada;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
18 Granada;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
18 Granada;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
18 Granada;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
18 Granada;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
18 Granada;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;91,2
18 Granada;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
18 Granada;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
18 Granada;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
18 Granada;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;92,69
18 Granada;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
18 Granada;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
18 Granada;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
18 Granada;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;93,01
18 Granada;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
18 Granada;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
18 Granada;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
18 Granada;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
18 Granada;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
18 Granada;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
18 Granada;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;86,6
18 Granada;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
18 Granada;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
18 Granada;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
18 Granada;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;88,63
18 Granada;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
18 Granada;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
18 Granada;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
18 Granada;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
18 Granada;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
18 Granada;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
18 Granada;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;80,52
18 Granada;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
18 Granada;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
18 Granada;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
18 Granada;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;83,71
18 Granada;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
18 Granada;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
18 Granada;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
18 Granada;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
18 Granada;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
18 Granada;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
18 Granada;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;75,5
18 Granada;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
18 Granada;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
18 Granada;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
18 Granada;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;78,73
18 Granada;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
18 Granada;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
18 Granada;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
18 Granada;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
18 Granada;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
18 Granada;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
18 Granada;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QIV;2.571
18 Granada;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
18 Granada;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
18 Granada;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
18 Granada;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QIV;2.670
18 Granada;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
18 Granada;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
18 Granada;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
18 Granada;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QIV;2.512
18 Granada;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
18 Granada;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
18 Granada;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
18 Granada;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2022QIV;2.355
18 Granada;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
18 Granada;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2022QII;""
18 Granada;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2022QI;""
18 Granada;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2021QIV;2.480
18 Granada;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
18 Granada;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2021QII;""
18 Granada;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2021QI;""
18 Granada;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2020QIV;2.338
18 Granada;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
18 Granada;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2020QII;""
18 Granada;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2020QI;""
18 Granada;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
18 Granada;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
18 Granada;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2022QII;""
18 Granada;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2022QI;2.322
18 Granada;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
18 Granada;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
18 Granada;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2021QII;""
18 Granada;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2021QI;2.232
18 Granada;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
18 Granada;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
18 Granada;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2020QII;""
18 Granada;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2020QI;""
18 Granada;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
18 Granada;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
18 Granada;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QII;2.168
18 Granada;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QI;""
18 Granada;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
18 Granada;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
18 Granada;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QII;2.108
18 Granada;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QI;""
18 Granada;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
18 Granada;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
18 Granada;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QII;""
18 Granada;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QI;""
18 Granada;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
18 Granada;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QIII;2.026
18 Granada;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QII;""
18 Granada;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QI;""
18 Granada;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
18 Granada;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QIII;1.995
18 Granada;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QII;""
18 Granada;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QI;""
18 Granada;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
18 Granada;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
18 Granada;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QII;""
18 Granada;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QI;""
18 Granada;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
18 Granada;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
18 Granada;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
18 Granada;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
18 Granada;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
18 Granada;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
18 Granada;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
18 Granada;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
18 Granada;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
18 Granada;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
18 Granada;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
18 Granada;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
18 Granada;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;91,6
18 Granada;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
18 Granada;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
18 Granada;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
18 Granada;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;92,88
18 Granada;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
18 Granada;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
18 Granada;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
18 Granada;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;93,07
18 Granada;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
18 Granada;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
18 Granada;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
18 Granada;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
18 Granada;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
18 Granada;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
18 Granada;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;86,97
18 Granada;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
18 Granada;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
18 Granada;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
18 Granada;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;88,85
18 Granada;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
18 Granada;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
18 Granada;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
18 Granada;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
18 Granada;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
18 Granada;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
18 Granada;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;81,2
18 Granada;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
18 Granada;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
18 Granada;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
18 Granada;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;83,92
18 Granada;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
18 Granada;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
18 Granada;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
18 Granada;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
18 Granada;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
18 Granada;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
18 Granada;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;75,88
18 Granada;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
18 Granada;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
18 Granada;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
18 Granada;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;79,42
18 Granada;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
18 Granada;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
18 Granada;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
18 Granada;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
18 Granada;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
18 Granada;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
18 Granada;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QIV;1.542
18 Granada;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
18 Granada;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
18 Granada;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
18 Granada;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QIV;1.555
18 Granada;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
18 Granada;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
18 Granada;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
18 Granada;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QIV;1.508
18 Granada;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
18 Granada;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
18 Granada;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
18 Granada;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2022QIV;1.396
18 Granada;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
18 Granada;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2022QII;""
18 Granada;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2022QI;""
18 Granada;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2021QIV;1.436
18 Granada;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
18 Granada;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2021QII;""
18 Granada;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2021QI;""
18 Granada;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2020QIV;1.401
18 Granada;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
18 Granada;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2020QII;""
18 Granada;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2020QI;""
18 Granada;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
18 Granada;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
18 Granada;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2022QII;""
18 Granada;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2022QI;1.337
18 Granada;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
18 Granada;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
18 Granada;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2021QII;""
18 Granada;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2021QI;1.331
18 Granada;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
18 Granada;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
18 Granada;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2020QII;""
18 Granada;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2020QI;""
18 Granada;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
18 Granada;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
18 Granada;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QII;1.234
18 Granada;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QI;""
18 Granada;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
18 Granada;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
18 Granada;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QII;1.257
18 Granada;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QI;""
18 Granada;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
18 Granada;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
18 Granada;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QII;""
18 Granada;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QI;""
18 Granada;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
18 Granada;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QIII;1.164
18 Granada;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QII;""
18 Granada;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QI;""
18 Granada;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
18 Granada;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QIII;1.170
18 Granada;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QII;""
18 Granada;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QI;""
18 Granada;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
18 Granada;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
18 Granada;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QII;""
18 Granada;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QI;""
18 Granada;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
18 Granada;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
18 Granada;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
18 Granada;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
18 Granada;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
18 Granada;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
18 Granada;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
18 Granada;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
18 Granada;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
18 Granada;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
18 Granada;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
18 Granada;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
18 Granada;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;90,53
18 Granada;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
18 Granada;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
18 Granada;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
18 Granada;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;92,35
18 Granada;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
18 Granada;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
18 Granada;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
18 Granada;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;92,9
18 Granada;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
18 Granada;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
18 Granada;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
18 Granada;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
18 Granada;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
18 Granada;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
18 Granada;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;85,98
18 Granada;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
18 Granada;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
18 Granada;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
18 Granada;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;88,26
18 Granada;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
18 Granada;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
18 Granada;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
18 Granada;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
18 Granada;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
18 Granada;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
18 Granada;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;79,36
18 Granada;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
18 Granada;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
18 Granada;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
18 Granada;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;83,36
18 Granada;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
18 Granada;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
18 Granada;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
18 Granada;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
18 Granada;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
18 Granada;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
18 Granada;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;74,86
18 Granada;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
18 Granada;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
18 Granada;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
18 Granada;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;77,59
18 Granada;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
18 Granada;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
18 Granada;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
18 Granada;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
18 Granada;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
18 Granada;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
18 Granada;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
18 Granada;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
18 Granada;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
18 Granada;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QI;12.320
18 Granada;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
18 Granada;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
18 Granada;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
18 Granada;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QI;12.212
18 Granada;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
18 Granada;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
18 Granada;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
18 Granada;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QI;11.858
18 Granada;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
18 Granada;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
18 Granada;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2022QII;""
18 Granada;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2022QI;11.820
18 Granada;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
18 Granada;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
18 Granada;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2021QII;""
18 Granada;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2021QI;11.843
18 Granada;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
18 Granada;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
18 Granada;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2020QII;""
18 Granada;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2020QI;10.880
18 Granada;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
18 Granada;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
18 Granada;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2022QII;11.282
18 Granada;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2022QI;""
18 Granada;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
18 Granada;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
18 Granada;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2021QII;11.440
18 Granada;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2021QI;""
18 Granada;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
18 Granada;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
18 Granada;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2020QII;10.618
18 Granada;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2020QI;""
18 Granada;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
18 Granada;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QIII;10.836
18 Granada;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QII;""
18 Granada;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QI;""
18 Granada;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
18 Granada;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QIII;11.077
18 Granada;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QII;""
18 Granada;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QI;""
18 Granada;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
18 Granada;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QIII;10.208
18 Granada;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QII;""
18 Granada;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QI;""
18 Granada;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QIV;10.430
18 Granada;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
18 Granada;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QII;""
18 Granada;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QI;""
18 Granada;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QIV;10.719
18 Granada;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
18 Granada;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QII;""
18 Granada;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QI;""
18 Granada;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QIV;9.858
18 Granada;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
18 Granada;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QII;""
18 Granada;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QI;""
18 Granada;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
18 Granada;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
18 Granada;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
18 Granada;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
18 Granada;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
18 Granada;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
18 Granada;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
18 Granada;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
18 Granada;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
18 Granada;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
18 Granada;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
18 Granada;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
18 Granada;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
18 Granada;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
18 Granada;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
18 Granada;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;95,94
18 Granada;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
18 Granada;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
18 Granada;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
18 Granada;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;96,98
18 Granada;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
18 Granada;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
18 Granada;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
18 Granada;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;91,75
18 Granada;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
18 Granada;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
18 Granada;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;91,57
18 Granada;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
18 Granada;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
18 Granada;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
18 Granada;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;93,68
18 Granada;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
18 Granada;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
18 Granada;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
18 Granada;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;89,54
18 Granada;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
18 Granada;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
18 Granada;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;87,95
18 Granada;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
18 Granada;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
18 Granada;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
18 Granada;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;90,71
18 Granada;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
18 Granada;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
18 Granada;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
18 Granada;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;86,09
18 Granada;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
18 Granada;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
18 Granada;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;84,66
18 Granada;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
18 Granada;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
18 Granada;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
18 Granada;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;87,77
18 Granada;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
18 Granada;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
18 Granada;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
18 Granada;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;83,13
18 Granada;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
18 Granada;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
18 Granada;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
18 Granada;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
18 Granada;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
18 Granada;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
18 Granada;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QI;7.532
18 Granada;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
18 Granada;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
18 Granada;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
18 Granada;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QI;7.553
18 Granada;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
18 Granada;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
18 Granada;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
18 Granada;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QI;7.271
18 Granada;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
18 Granada;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
18 Granada;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2022QII;""
18 Granada;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2022QI;7.255
18 Granada;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
18 Granada;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
18 Granada;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2021QII;""
18 Granada;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2021QI;7.326
18 Granada;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
18 Granada;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
18 Granada;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2020QII;""
18 Granada;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2020QI;6.694
18 Granada;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
18 Granada;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
18 Granada;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2022QII;6.935
18 Granada;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2022QI;""
18 Granada;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
18 Granada;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
18 Granada;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2021QII;7.077
18 Granada;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2021QI;""
18 Granada;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
18 Granada;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
18 Granada;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2020QII;6.545
18 Granada;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2020QI;""
18 Granada;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
18 Granada;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QIII;6.681
18 Granada;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QII;""
18 Granada;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QI;""
18 Granada;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
18 Granada;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QIII;6.872
18 Granada;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QII;""
18 Granada;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QI;""
18 Granada;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
18 Granada;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QIII;6.314
18 Granada;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QII;""
18 Granada;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QI;""
18 Granada;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QIV;6.430
18 Granada;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
18 Granada;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QII;""
18 Granada;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QI;""
18 Granada;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QIV;6.660
18 Granada;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
18 Granada;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QII;""
18 Granada;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QI;""
18 Granada;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QIV;6.094
18 Granada;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
18 Granada;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QII;""
18 Granada;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QI;""
18 Granada;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
18 Granada;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
18 Granada;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
18 Granada;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
18 Granada;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
18 Granada;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
18 Granada;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
18 Granada;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
18 Granada;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
18 Granada;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
18 Granada;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
18 Granada;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
18 Granada;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
18 Granada;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
18 Granada;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
18 Granada;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;96,32
18 Granada;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
18 Granada;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
18 Granada;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
18 Granada;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;96,99
18 Granada;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
18 Granada;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
18 Granada;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
18 Granada;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;92,06
18 Granada;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
18 Granada;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
18 Granada;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;92,07
18 Granada;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
18 Granada;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
18 Granada;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
18 Granada;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;93,7
18 Granada;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
18 Granada;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
18 Granada;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
18 Granada;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;90,02
18 Granada;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
18 Granada;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
18 Granada;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;88,7
18 Granada;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
18 Granada;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
18 Granada;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
18 Granada;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;90,98
18 Granada;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
18 Granada;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
18 Granada;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
18 Granada;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;86,84
18 Granada;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
18 Granada;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
18 Granada;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;85,37
18 Granada;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
18 Granada;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
18 Granada;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
18 Granada;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;88,18
18 Granada;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
18 Granada;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
18 Granada;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
18 Granada;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;83,81
18 Granada;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
18 Granada;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
18 Granada;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
18 Granada;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
18 Granada;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
18 Granada;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
18 Granada;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QI;4.788
18 Granada;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
18 Granada;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
18 Granada;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
18 Granada;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QI;4.659
18 Granada;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
18 Granada;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
18 Granada;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
18 Granada;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QI;4.587
18 Granada;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
18 Granada;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
18 Granada;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2022QII;""
18 Granada;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2022QI;4.565
18 Granada;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
18 Granada;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
18 Granada;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2021QII;""
18 Granada;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2021QI;4.517
18 Granada;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
18 Granada;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
18 Granada;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2020QII;""
18 Granada;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2020QI;4.186
18 Granada;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
18 Granada;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
18 Granada;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2022QII;4.347
18 Granada;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2022QI;""
18 Granada;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
18 Granada;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
18 Granada;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2021QII;4.363
18 Granada;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2021QI;""
18 Granada;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
18 Granada;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
18 Granada;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2020QII;4.073
18 Granada;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2020QI;""
18 Granada;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
18 Granada;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QIII;4.155
18 Granada;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QII;""
18 Granada;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QI;""
18 Granada;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
18 Granada;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QIII;4.205
18 Granada;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QII;""
18 Granada;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QI;""
18 Granada;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
18 Granada;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QIII;3.894
18 Granada;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QII;""
18 Granada;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QI;""
18 Granada;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QIV;4.000
18 Granada;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
18 Granada;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QII;""
18 Granada;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QI;""
18 Granada;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QIV;4.059
18 Granada;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
18 Granada;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QII;""
18 Granada;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QI;""
18 Granada;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QIV;3.764
18 Granada;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
18 Granada;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QII;""
18 Granada;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QI;""
18 Granada;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
18 Granada;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
18 Granada;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
18 Granada;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
18 Granada;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
18 Granada;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
18 Granada;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
18 Granada;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
18 Granada;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
18 Granada;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
18 Granada;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
18 Granada;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
18 Granada;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
18 Granada;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
18 Granada;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
18 Granada;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;95,34
18 Granada;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
18 Granada;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
18 Granada;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
18 Granada;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;96,95
18 Granada;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
18 Granada;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
18 Granada;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
18 Granada;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;91,26
18 Granada;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
18 Granada;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
18 Granada;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;90,79
18 Granada;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
18 Granada;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
18 Granada;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
18 Granada;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;93,65
18 Granada;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
18 Granada;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
18 Granada;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
18 Granada;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;88,79
18 Granada;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
18 Granada;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
18 Granada;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;86,78
18 Granada;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
18 Granada;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
18 Granada;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
18 Granada;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;90,26
18 Granada;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
18 Granada;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
18 Granada;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
18 Granada;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;84,89
18 Granada;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
18 Granada;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
18 Granada;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;83,54
18 Granada;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
18 Granada;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
18 Granada;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
18 Granada;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;87,12
18 Granada;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
18 Granada;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
18 Granada;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
18 Granada;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;82,06
18 Granada;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
18 Granada;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
18 Granada;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
18 Granada;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
18 Granada;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
18 Granada;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QII;11.714
18 Granada;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
18 Granada;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
18 Granada;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
18 Granada;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QII;11.749
18 Granada;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
18 Granada;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
18 Granada;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
18 Granada;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QII;11.636
18 Granada;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
18 Granada;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
18 Granada;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
18 Granada;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2022QII;11.135
18 Granada;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2022QI;""
18 Granada;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
18 Granada;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
18 Granada;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2021QII;11.281
18 Granada;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2021QI;""
18 Granada;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
18 Granada;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
18 Granada;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2020QII;11.341
18 Granada;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2020QI;""
18 Granada;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
18 Granada;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2022QIII;10.644
18 Granada;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2022QII;""
18 Granada;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2022QI;""
18 Granada;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
18 Granada;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2021QIII;10.878
18 Granada;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2021QII;""
18 Granada;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2021QI;""
18 Granada;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
18 Granada;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2020QIII;10.868
18 Granada;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2020QII;""
18 Granada;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2020QI;""
18 Granada;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QIV;10.226
18 Granada;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
18 Granada;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QII;""
18 Granada;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QI;""
18 Granada;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QIV;10.472
18 Granada;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
18 Granada;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QII;""
18 Granada;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QI;""
18 Granada;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QIV;10.462
18 Granada;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
18 Granada;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QII;""
18 Granada;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QI;""
18 Granada;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
18 Granada;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
18 Granada;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QII;""
18 Granada;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QI;10.101
18 Granada;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
18 Granada;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
18 Granada;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QII;""
18 Granada;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QI;10.209
18 Granada;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
18 Granada;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
18 Granada;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QII;""
18 Granada;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QI;""
18 Granada;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
18 Granada;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
18 Granada;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
18 Granada;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
18 Granada;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
18 Granada;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
18 Granada;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
18 Granada;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
18 Granada;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
18 Granada;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
18 Granada;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
18 Granada;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
18 Granada;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
18 Granada;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
18 Granada;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;95,06
18 Granada;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
18 Granada;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
18 Granada;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
18 Granada;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;96,02
18 Granada;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
18 Granada;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
18 Granada;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
18 Granada;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;97,46
18 Granada;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
18 Granada;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
18 Granada;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;90,87
18 Granada;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
18 Granada;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
18 Granada;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
18 Granada;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;92,59
18 Granada;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
18 Granada;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
18 Granada;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
18 Granada;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;93,4
18 Granada;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
18 Granada;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
18 Granada;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;87,3
18 Granada;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
18 Granada;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
18 Granada;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
18 Granada;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;89,13
18 Granada;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
18 Granada;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
18 Granada;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
18 Granada;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;89,91
18 Granada;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
18 Granada;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
18 Granada;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
18 Granada;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
18 Granada;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
18 Granada;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
18 Granada;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;85,97
18 Granada;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
18 Granada;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
18 Granada;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
18 Granada;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;87,74
18 Granada;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
18 Granada;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
18 Granada;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
18 Granada;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
18 Granada;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
18 Granada;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
18 Granada;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QII;7.141
18 Granada;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
18 Granada;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
18 Granada;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
18 Granada;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QII;7.225
18 Granada;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
18 Granada;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
18 Granada;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
18 Granada;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QII;7.126
18 Granada;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
18 Granada;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
18 Granada;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
18 Granada;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2022QII;6.806
18 Granada;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2022QI;""
18 Granada;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
18 Granada;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
18 Granada;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2021QII;6.922
18 Granada;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2021QI;""
18 Granada;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
18 Granada;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
18 Granada;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2020QII;6.957
18 Granada;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2020QI;""
18 Granada;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
18 Granada;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2022QIII;6.521
18 Granada;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2022QII;""
18 Granada;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2022QI;""
18 Granada;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
18 Granada;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2021QIII;6.701
18 Granada;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2021QII;""
18 Granada;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2021QI;""
18 Granada;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
18 Granada;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2020QIII;6.686
18 Granada;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2020QII;""
18 Granada;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2020QI;""
18 Granada;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QIV;6.262
18 Granada;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
18 Granada;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QII;""
18 Granada;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QI;""
18 Granada;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QIV;6.453
18 Granada;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
18 Granada;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QII;""
18 Granada;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QI;""
18 Granada;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QIV;6.434
18 Granada;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
18 Granada;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QII;""
18 Granada;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QI;""
18 Granada;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
18 Granada;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
18 Granada;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QII;""
18 Granada;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QI;6.247
18 Granada;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
18 Granada;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
18 Granada;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QII;""
18 Granada;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QI;6.285
18 Granada;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
18 Granada;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
18 Granada;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QII;""
18 Granada;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QI;""
18 Granada;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
18 Granada;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
18 Granada;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
18 Granada;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
18 Granada;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
18 Granada;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
18 Granada;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
18 Granada;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
18 Granada;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
18 Granada;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
18 Granada;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
18 Granada;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
18 Granada;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
18 Granada;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
18 Granada;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;95,31
18 Granada;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
18 Granada;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
18 Granada;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
18 Granada;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;95,81
18 Granada;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
18 Granada;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
18 Granada;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
18 Granada;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;97,63
18 Granada;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
18 Granada;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
18 Granada;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;91,32
18 Granada;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
18 Granada;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
18 Granada;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
18 Granada;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;92,75
18 Granada;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
18 Granada;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
18 Granada;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
18 Granada;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;93,83
18 Granada;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
18 Granada;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
18 Granada;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;87,69
18 Granada;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
18 Granada;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
18 Granada;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
18 Granada;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;89,31
18 Granada;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
18 Granada;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
18 Granada;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
18 Granada;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;90,29
18 Granada;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
18 Granada;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
18 Granada;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
18 Granada;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
18 Granada;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
18 Granada;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
18 Granada;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;86,46
18 Granada;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
18 Granada;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
18 Granada;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
18 Granada;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;88,2
18 Granada;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
18 Granada;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
18 Granada;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
18 Granada;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
18 Granada;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
18 Granada;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
18 Granada;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QII;4.573
18 Granada;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
18 Granada;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
18 Granada;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
18 Granada;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QII;4.524
18 Granada;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
18 Granada;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
18 Granada;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
18 Granada;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QII;4.510
18 Granada;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
18 Granada;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
18 Granada;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
18 Granada;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2022QII;4.329
18 Granada;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2022QI;""
18 Granada;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
18 Granada;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
18 Granada;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2021QII;4.359
18 Granada;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2021QI;""
18 Granada;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
18 Granada;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
18 Granada;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2020QII;4.384
18 Granada;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2020QI;""
18 Granada;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
18 Granada;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2022QIII;4.123
18 Granada;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2022QII;""
18 Granada;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2022QI;""
18 Granada;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
18 Granada;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2021QIII;4.177
18 Granada;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2021QII;""
18 Granada;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2021QI;""
18 Granada;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
18 Granada;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2020QIII;4.182
18 Granada;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2020QII;""
18 Granada;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2020QI;""
18 Granada;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QIV;3.964
18 Granada;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
18 Granada;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QII;""
18 Granada;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QI;""
18 Granada;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QIV;4.019
18 Granada;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
18 Granada;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QII;""
18 Granada;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QI;""
18 Granada;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QIV;4.028
18 Granada;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
18 Granada;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QII;""
18 Granada;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QI;""
18 Granada;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
18 Granada;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
18 Granada;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QII;""
18 Granada;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QI;3.854
18 Granada;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
18 Granada;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
18 Granada;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QII;""
18 Granada;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QI;3.924
18 Granada;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
18 Granada;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
18 Granada;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QII;""
18 Granada;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QI;""
18 Granada;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
18 Granada;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
18 Granada;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
18 Granada;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
18 Granada;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
18 Granada;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
18 Granada;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
18 Granada;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
18 Granada;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
18 Granada;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
18 Granada;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
18 Granada;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
18 Granada;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
18 Granada;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
18 Granada;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;94,66
18 Granada;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
18 Granada;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
18 Granada;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
18 Granada;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;96,35
18 Granada;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
18 Granada;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
18 Granada;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
18 Granada;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;97,21
18 Granada;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
18 Granada;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
18 Granada;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;90,16
18 Granada;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
18 Granada;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
18 Granada;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
18 Granada;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;92,33
18 Granada;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
18 Granada;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
18 Granada;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
18 Granada;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;92,73
18 Granada;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
18 Granada;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
18 Granada;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;86,68
18 Granada;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
18 Granada;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
18 Granada;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
18 Granada;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;88,84
18 Granada;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
18 Granada;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
18 Granada;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
18 Granada;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;89,31
18 Granada;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
18 Granada;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
18 Granada;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
18 Granada;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
18 Granada;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
18 Granada;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
18 Granada;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;85,19
18 Granada;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
18 Granada;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
18 Granada;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
18 Granada;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;87,01
18 Granada;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
18 Granada;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
18 Granada;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
18 Granada;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
18 Granada;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
18 Granada;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QIII;11.813
18 Granada;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
18 Granada;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
18 Granada;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
18 Granada;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QIII;11.991
18 Granada;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
18 Granada;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
18 Granada;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
18 Granada;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QIII;11.927
18 Granada;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
18 Granada;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
18 Granada;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
18 Granada;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2022QIII;11.232
18 Granada;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2022QII;""
18 Granada;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2022QI;""
18 Granada;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
18 Granada;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2021QIII;11.522
18 Granada;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2021QII;""
18 Granada;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2021QI;""
18 Granada;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
18 Granada;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2020QIII;11.382
18 Granada;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2020QII;""
18 Granada;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2020QI;""
18 Granada;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2022QIV;10.758
18 Granada;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
18 Granada;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2022QII;""
18 Granada;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2022QI;""
18 Granada;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2021QIV;11.060
18 Granada;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
18 Granada;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2021QII;""
18 Granada;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2021QI;""
18 Granada;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2020QIV;10.932
18 Granada;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
18 Granada;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2020QII;""
18 Granada;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2020QI;""
18 Granada;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
18 Granada;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
18 Granada;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QII;""
18 Granada;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QI;10.659
18 Granada;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
18 Granada;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
18 Granada;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QII;""
18 Granada;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QI;10.660
18 Granada;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
18 Granada;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
18 Granada;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QII;""
18 Granada;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QI;""
18 Granada;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
18 Granada;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
18 Granada;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QII;10.225
18 Granada;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QI;""
18 Granada;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
18 Granada;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
18 Granada;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QII;10.353
18 Granada;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QI;""
18 Granada;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
18 Granada;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
18 Granada;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QII;""
18 Granada;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QI;""
18 Granada;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
18 Granada;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
18 Granada;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
18 Granada;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
18 Granada;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
18 Granada;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
18 Granada;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
18 Granada;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
18 Granada;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
18 Granada;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
18 Granada;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
18 Granada;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
18 Granada;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
18 Granada;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;95,08
18 Granada;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
18 Granada;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
18 Granada;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
18 Granada;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;96,09
18 Granada;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
18 Granada;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
18 Granada;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
18 Granada;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;95,43
18 Granada;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
18 Granada;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
18 Granada;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;91,07
18 Granada;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
18 Granada;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
18 Granada;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
18 Granada;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;92,24
18 Granada;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
18 Granada;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
18 Granada;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
18 Granada;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;91,66
18 Granada;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
18 Granada;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
18 Granada;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
18 Granada;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
18 Granada;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
18 Granada;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
18 Granada;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;88,89
18 Granada;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
18 Granada;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
18 Granada;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
18 Granada;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;89,38
18 Granada;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
18 Granada;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
18 Granada;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
18 Granada;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
18 Granada;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
18 Granada;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
18 Granada;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;85,27
18 Granada;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
18 Granada;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
18 Granada;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
18 Granada;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;86,8
18 Granada;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
18 Granada;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
18 Granada;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
18 Granada;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
18 Granada;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
18 Granada;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
18 Granada;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QIII;7.194
18 Granada;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
18 Granada;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
18 Granada;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
18 Granada;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QIII;7.340
18 Granada;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
18 Granada;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
18 Granada;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
18 Granada;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QIII;7.348
18 Granada;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
18 Granada;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
18 Granada;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
18 Granada;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2022QIII;6.853
18 Granada;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2022QII;""
18 Granada;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2022QI;""
18 Granada;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
18 Granada;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2021QIII;7.078
18 Granada;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2021QII;""
18 Granada;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2021QI;""
18 Granada;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
18 Granada;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2020QIII;7.034
18 Granada;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2020QII;""
18 Granada;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2020QI;""
18 Granada;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2022QIV;6.559
18 Granada;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
18 Granada;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2022QII;""
18 Granada;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2022QI;""
18 Granada;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2021QIV;6.792
18 Granada;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
18 Granada;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2021QII;""
18 Granada;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2021QI;""
18 Granada;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2020QIV;6.749
18 Granada;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
18 Granada;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2020QII;""
18 Granada;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2020QI;""
18 Granada;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
18 Granada;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
18 Granada;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QII;""
18 Granada;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QI;6.570
18 Granada;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
18 Granada;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
18 Granada;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QII;""
18 Granada;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QI;6.588
18 Granada;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
18 Granada;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
18 Granada;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QII;""
18 Granada;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QI;""
18 Granada;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
18 Granada;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
18 Granada;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QII;6.317
18 Granada;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QI;""
18 Granada;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
18 Granada;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
18 Granada;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QII;6.400
18 Granada;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QI;""
18 Granada;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
18 Granada;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
18 Granada;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QII;""
18 Granada;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QI;""
18 Granada;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
18 Granada;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
18 Granada;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
18 Granada;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
18 Granada;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
18 Granada;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
18 Granada;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
18 Granada;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
18 Granada;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
18 Granada;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
18 Granada;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
18 Granada;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
18 Granada;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
18 Granada;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;95,26
18 Granada;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
18 Granada;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
18 Granada;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
18 Granada;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;96,43
18 Granada;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
18 Granada;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
18 Granada;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
18 Granada;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;95,73
18 Granada;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
18 Granada;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
18 Granada;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;91,17
18 Granada;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
18 Granada;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
18 Granada;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
18 Granada;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;92,53
18 Granada;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
18 Granada;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
18 Granada;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
18 Granada;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;91,85
18 Granada;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
18 Granada;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
18 Granada;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
18 Granada;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
18 Granada;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
18 Granada;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
18 Granada;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;89,51
18 Granada;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
18 Granada;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
18 Granada;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
18 Granada;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;89,66
18 Granada;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
18 Granada;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
18 Granada;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
18 Granada;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
18 Granada;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
18 Granada;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
18 Granada;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;86,06
18 Granada;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
18 Granada;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
18 Granada;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
18 Granada;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;87,1
18 Granada;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
18 Granada;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
18 Granada;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
18 Granada;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
18 Granada;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
18 Granada;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
18 Granada;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QIII;4.619
18 Granada;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
18 Granada;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
18 Granada;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
18 Granada;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QIII;4.651
18 Granada;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
18 Granada;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
18 Granada;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
18 Granada;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QIII;4.579
18 Granada;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
18 Granada;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
18 Granada;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
18 Granada;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2022QIII;4.379
18 Granada;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2022QII;""
18 Granada;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2022QI;""
18 Granada;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
18 Granada;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2021QIII;4.444
18 Granada;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2021QII;""
18 Granada;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2021QI;""
18 Granada;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
18 Granada;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2020QIII;4.348
18 Granada;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2020QII;""
18 Granada;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2020QI;""
18 Granada;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2022QIV;4.199
18 Granada;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
18 Granada;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2022QII;""
18 Granada;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2022QI;""
18 Granada;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2021QIV;4.268
18 Granada;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
18 Granada;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2021QII;""
18 Granada;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2021QI;""
18 Granada;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2020QIV;4.183
18 Granada;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
18 Granada;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2020QII;""
18 Granada;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2020QI;""
18 Granada;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
18 Granada;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
18 Granada;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QII;""
18 Granada;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QI;4.089
18 Granada;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
18 Granada;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
18 Granada;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QII;""
18 Granada;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QI;4.072
18 Granada;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
18 Granada;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
18 Granada;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QII;""
18 Granada;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QI;""
18 Granada;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
18 Granada;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
18 Granada;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QII;3.908
18 Granada;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QI;""
18 Granada;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
18 Granada;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
18 Granada;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QII;3.953
18 Granada;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QI;""
18 Granada;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
18 Granada;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
18 Granada;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QII;""
18 Granada;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QI;""
18 Granada;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
18 Granada;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
18 Granada;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
18 Granada;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
18 Granada;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
18 Granada;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
18 Granada;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
18 Granada;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
18 Granada;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
18 Granada;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
18 Granada;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
18 Granada;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
18 Granada;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
18 Granada;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;94,8
18 Granada;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
18 Granada;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
18 Granada;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
18 Granada;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;95,55
18 Granada;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
18 Granada;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
18 Granada;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
18 Granada;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;94,96
18 Granada;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
18 Granada;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
18 Granada;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;90,91
18 Granada;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
18 Granada;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
18 Granada;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
18 Granada;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;91,77
18 Granada;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
18 Granada;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
18 Granada;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
18 Granada;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;91,35
18 Granada;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
18 Granada;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
18 Granada;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
18 Granada;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
18 Granada;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
18 Granada;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
18 Granada;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;87,92
18 Granada;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
18 Granada;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
18 Granada;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
18 Granada;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;88,93
18 Granada;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
18 Granada;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
18 Granada;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
18 Granada;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
18 Granada;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
18 Granada;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
18 Granada;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;84,02
18 Granada;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
18 Granada;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
18 Granada;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
18 Granada;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;86,33
18 Granada;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
18 Granada;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
18 Granada;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
18 Granada;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
18 Granada;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
18 Granada;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QIV;11.834
18 Granada;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
18 Granada;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
18 Granada;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
18 Granada;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QIV;12.130
18 Granada;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
18 Granada;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
18 Granada;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
18 Granada;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QIV;12.035
18 Granada;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
18 Granada;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
18 Granada;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
18 Granada;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2022QIV;11.300
18 Granada;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
18 Granada;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2022QII;""
18 Granada;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2022QI;""
18 Granada;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2021QIV;11.617
18 Granada;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
18 Granada;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2021QII;""
18 Granada;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2021QI;""
18 Granada;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2020QIV;11.516
18 Granada;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
18 Granada;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2020QII;""
18 Granada;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2020QI;""
18 Granada;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
18 Granada;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
18 Granada;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2022QII;""
18 Granada;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2022QI;11.184
18 Granada;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
18 Granada;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
18 Granada;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2021QII;""
18 Granada;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2021QI;11.202
18 Granada;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
18 Granada;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
18 Granada;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2020QII;""
18 Granada;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2020QI;""
18 Granada;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
18 Granada;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
18 Granada;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QII;10.715
18 Granada;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QI;""
18 Granada;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
18 Granada;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
18 Granada;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QII;10.862
18 Granada;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QI;""
18 Granada;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
18 Granada;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
18 Granada;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QII;""
18 Granada;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QI;""
18 Granada;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
18 Granada;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QIII;10.303
18 Granada;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QII;""
18 Granada;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QI;""
18 Granada;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
18 Granada;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QIII;10.536
18 Granada;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QII;""
18 Granada;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QI;""
18 Granada;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
18 Granada;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
18 Granada;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QII;""
18 Granada;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QI;""
18 Granada;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
18 Granada;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
18 Granada;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
18 Granada;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
18 Granada;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
18 Granada;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
18 Granada;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
18 Granada;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
18 Granada;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
18 Granada;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
18 Granada;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
18 Granada;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
18 Granada;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;95,49
18 Granada;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
18 Granada;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
18 Granada;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
18 Granada;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;95,77
18 Granada;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
18 Granada;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
18 Granada;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
18 Granada;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;95,69
18 Granada;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
18 Granada;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
18 Granada;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
18 Granada;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
18 Granada;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
18 Granada;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
18 Granada;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;92,2
18 Granada;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
18 Granada;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
18 Granada;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
18 Granada;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;93,08
18 Granada;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
18 Granada;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
18 Granada;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
18 Granada;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
18 Granada;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
18 Granada;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
18 Granada;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;88,33
18 Granada;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
18 Granada;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
18 Granada;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
18 Granada;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;90,25
18 Granada;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
18 Granada;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
18 Granada;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
18 Granada;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
18 Granada;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
18 Granada;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
18 Granada;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;84,94
18 Granada;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
18 Granada;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
18 Granada;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
18 Granada;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;87,54
18 Granada;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
18 Granada;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
18 Granada;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
18 Granada;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
18 Granada;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
18 Granada;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
18 Granada;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QIV;7.213
18 Granada;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
18 Granada;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
18 Granada;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
18 Granada;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QIV;7.429
18 Granada;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
18 Granada;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
18 Granada;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
18 Granada;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QIV;7.428
18 Granada;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
18 Granada;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
18 Granada;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
18 Granada;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2022QIV;6.882
18 Granada;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
18 Granada;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2022QII;""
18 Granada;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2022QI;""
18 Granada;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2021QIV;7.112
18 Granada;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
18 Granada;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2021QII;""
18 Granada;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2021QI;""
18 Granada;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2020QIV;7.096
18 Granada;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
18 Granada;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2020QII;""
18 Granada;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2020QI;""
18 Granada;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
18 Granada;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
18 Granada;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2022QII;""
18 Granada;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2022QI;6.877
18 Granada;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
18 Granada;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
18 Granada;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2021QII;""
18 Granada;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2021QI;6.907
18 Granada;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
18 Granada;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
18 Granada;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2020QII;""
18 Granada;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2020QI;""
18 Granada;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
18 Granada;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
18 Granada;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QII;6.603
18 Granada;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QI;""
18 Granada;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
18 Granada;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
18 Granada;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QII;6.703
18 Granada;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QI;""
18 Granada;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
18 Granada;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
18 Granada;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QII;""
18 Granada;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QI;""
18 Granada;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
18 Granada;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QIII;6.368
18 Granada;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QII;""
18 Granada;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QI;""
18 Granada;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
18 Granada;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QIII;6.519
18 Granada;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QII;""
18 Granada;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QI;""
18 Granada;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
18 Granada;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
18 Granada;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QII;""
18 Granada;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QI;""
18 Granada;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
18 Granada;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
18 Granada;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
18 Granada;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
18 Granada;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
18 Granada;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
18 Granada;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
18 Granada;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
18 Granada;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
18 Granada;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
18 Granada;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
18 Granada;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
18 Granada;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;95,41
18 Granada;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
18 Granada;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
18 Granada;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
18 Granada;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;95,73
18 Granada;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
18 Granada;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
18 Granada;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
18 Granada;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;95,53
18 Granada;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
18 Granada;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
18 Granada;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
18 Granada;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
18 Granada;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
18 Granada;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
18 Granada;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;92,57
18 Granada;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
18 Granada;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
18 Granada;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
18 Granada;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;92,99
18 Granada;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
18 Granada;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
18 Granada;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
18 Granada;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
18 Granada;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
18 Granada;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
18 Granada;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;88,88
18 Granada;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
18 Granada;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
18 Granada;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
18 Granada;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;90,24
18 Granada;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
18 Granada;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
18 Granada;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
18 Granada;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
18 Granada;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
18 Granada;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
18 Granada;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;85,72
18 Granada;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
18 Granada;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
18 Granada;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
18 Granada;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;87,76
18 Granada;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
18 Granada;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
18 Granada;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
18 Granada;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
18 Granada;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
18 Granada;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
18 Granada;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QIV;4.621
18 Granada;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
18 Granada;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
18 Granada;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
18 Granada;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QIV;4.701
18 Granada;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
18 Granada;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
18 Granada;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
18 Granada;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QIV;4.607
18 Granada;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
18 Granada;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
18 Granada;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
18 Granada;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2022QIV;4.418
18 Granada;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
18 Granada;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2022QII;""
18 Granada;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2022QI;""
18 Granada;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2021QIV;4.505
18 Granada;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
18 Granada;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2021QII;""
18 Granada;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2021QI;""
18 Granada;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2020QIV;4.420
18 Granada;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
18 Granada;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2020QII;""
18 Granada;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2020QI;""
18 Granada;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
18 Granada;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
18 Granada;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2022QII;""
18 Granada;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2022QI;4.307
18 Granada;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
18 Granada;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
18 Granada;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2021QII;""
18 Granada;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2021QI;4.295
18 Granada;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
18 Granada;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
18 Granada;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2020QII;""
18 Granada;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2020QI;""
18 Granada;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
18 Granada;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
18 Granada;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QII;4.112
18 Granada;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QI;""
18 Granada;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
18 Granada;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
18 Granada;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QII;4.159
18 Granada;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QI;""
18 Granada;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
18 Granada;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
18 Granada;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QII;""
18 Granada;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QI;""
18 Granada;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
18 Granada;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QIII;3.935
18 Granada;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QII;""
18 Granada;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QI;""
18 Granada;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
18 Granada;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QIII;4.017
18 Granada;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QII;""
18 Granada;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QI;""
18 Granada;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
18 Granada;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
18 Granada;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QII;""
18 Granada;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QI;""
18 Granada;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
18 Granada;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
18 Granada;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
18 Granada;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
18 Granada;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
18 Granada;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
18 Granada;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
18 Granada;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
18 Granada;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
18 Granada;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
18 Granada;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
18 Granada;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
18 Granada;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;95,61
18 Granada;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
18 Granada;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
18 Granada;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
18 Granada;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;95,83
18 Granada;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
18 Granada;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
18 Granada;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
18 Granada;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;95,94
18 Granada;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
18 Granada;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
18 Granada;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
18 Granada;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
18 Granada;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
18 Granada;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
18 Granada;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;91,62
18 Granada;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
18 Granada;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
18 Granada;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
18 Granada;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;93,23
18 Granada;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
18 Granada;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
18 Granada;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
18 Granada;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
18 Granada;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
18 Granada;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
18 Granada;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;87,47
18 Granada;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
18 Granada;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
18 Granada;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
18 Granada;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;90,28
18 Granada;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
18 Granada;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
18 Granada;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
18 Granada;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
18 Granada;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
18 Granada;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
18 Granada;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;83,71
18 Granada;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
18 Granada;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
18 Granada;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
18 Granada;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;87,19
18 Granada;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
18 Granada;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
18 Granada;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
18 Granada;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
18 Granada;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
18 Granada;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
18 Granada;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
18 Granada;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
18 Granada;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
18 Granada;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QI;18.585
18 Granada;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
18 Granada;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
18 Granada;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
18 Granada;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QI;18.350
18 Granada;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
18 Granada;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
18 Granada;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
18 Granada;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QI;18.369
18 Granada;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
18 Granada;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
18 Granada;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2022QII;""
18 Granada;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2022QI;18.033
18 Granada;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
18 Granada;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
18 Granada;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2021QII;""
18 Granada;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2021QI;17.923
18 Granada;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
18 Granada;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
18 Granada;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2020QII;""
18 Granada;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2020QI;17.136
18 Granada;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
18 Granada;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
18 Granada;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2022QII;17.407
18 Granada;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2022QI;""
18 Granada;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
18 Granada;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
18 Granada;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2021QII;17.462
18 Granada;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2021QI;""
18 Granada;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
18 Granada;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
18 Granada;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2020QII;16.805
18 Granada;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2020QI;""
18 Granada;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
18 Granada;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QIII;16.977
18 Granada;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QII;""
18 Granada;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QI;""
18 Granada;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
18 Granada;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QIII;17.088
18 Granada;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QII;""
18 Granada;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QI;""
18 Granada;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
18 Granada;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QIII;16.423
18 Granada;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QII;""
18 Granada;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QI;""
18 Granada;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QIV;16.498
18 Granada;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
18 Granada;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QII;""
18 Granada;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QI;""
18 Granada;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QIV;16.662
18 Granada;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
18 Granada;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QII;""
18 Granada;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QI;""
18 Granada;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QIV;16.022
18 Granada;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
18 Granada;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QII;""
18 Granada;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QI;""
18 Granada;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
18 Granada;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
18 Granada;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
18 Granada;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
18 Granada;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
18 Granada;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
18 Granada;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
18 Granada;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
18 Granada;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
18 Granada;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
18 Granada;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
18 Granada;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
18 Granada;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
18 Granada;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
18 Granada;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
18 Granada;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;97,03
18 Granada;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
18 Granada;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
18 Granada;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
18 Granada;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;97,67
18 Granada;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
18 Granada;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
18 Granada;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
18 Granada;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;93,29
18 Granada;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
18 Granada;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
18 Granada;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;93,66
18 Granada;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
18 Granada;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
18 Granada;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
18 Granada;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;95,16
18 Granada;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
18 Granada;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
18 Granada;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
18 Granada;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;91,49
18 Granada;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
18 Granada;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
18 Granada;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;91,35
18 Granada;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
18 Granada;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
18 Granada;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
18 Granada;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;93,12
18 Granada;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
18 Granada;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
18 Granada;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
18 Granada;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;89,41
18 Granada;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
18 Granada;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
18 Granada;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;88,77
18 Granada;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
18 Granada;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
18 Granada;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
18 Granada;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;90,8
18 Granada;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
18 Granada;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
18 Granada;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
18 Granada;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;87,22
18 Granada;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
18 Granada;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
18 Granada;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
18 Granada;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
18 Granada;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
18 Granada;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
18 Granada;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QI;11.830
18 Granada;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
18 Granada;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
18 Granada;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
18 Granada;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QI;11.782
18 Granada;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
18 Granada;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
18 Granada;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
18 Granada;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QI;11.702
18 Granada;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
18 Granada;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
18 Granada;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2022QII;""
18 Granada;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2022QI;11.503
18 Granada;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
18 Granada;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
18 Granada;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2021QII;""
18 Granada;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2021QI;11.512
18 Granada;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
18 Granada;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
18 Granada;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2020QII;""
18 Granada;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2020QI;10.968
18 Granada;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
18 Granada;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
18 Granada;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2022QII;11.121
18 Granada;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2022QI;""
18 Granada;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
18 Granada;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
18 Granada;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2021QII;11.240
18 Granada;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2021QI;""
18 Granada;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
18 Granada;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
18 Granada;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2020QII;10.784
18 Granada;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2020QI;""
18 Granada;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
18 Granada;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QIII;10.874
18 Granada;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QII;""
18 Granada;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QI;""
18 Granada;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
18 Granada;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QIII;11.001
18 Granada;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QII;""
18 Granada;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QI;""
18 Granada;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
18 Granada;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QIII;10.569
18 Granada;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QII;""
18 Granada;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QI;""
18 Granada;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QIV;10.578
18 Granada;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
18 Granada;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QII;""
18 Granada;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QI;""
18 Granada;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QIV;10.736
18 Granada;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
18 Granada;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QII;""
18 Granada;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QI;""
18 Granada;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QIV;10.351
18 Granada;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
18 Granada;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QII;""
18 Granada;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QI;""
18 Granada;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
18 Granada;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
18 Granada;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
18 Granada;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
18 Granada;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
18 Granada;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
18 Granada;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
18 Granada;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
18 Granada;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
18 Granada;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
18 Granada;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
18 Granada;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
18 Granada;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
18 Granada;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
18 Granada;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
18 Granada;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;97,24
18 Granada;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
18 Granada;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
18 Granada;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
18 Granada;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;97,71
18 Granada;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
18 Granada;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
18 Granada;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
18 Granada;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;93,73
18 Granada;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
18 Granada;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
18 Granada;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;94,01
18 Granada;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
18 Granada;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
18 Granada;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
18 Granada;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;95,4
18 Granada;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
18 Granada;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
18 Granada;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
18 Granada;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;92,16
18 Granada;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
18 Granada;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
18 Granada;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;91,92
18 Granada;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
18 Granada;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
18 Granada;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
18 Granada;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;93,37
18 Granada;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
18 Granada;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
18 Granada;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
18 Granada;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;90,32
18 Granada;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
18 Granada;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
18 Granada;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;89,42
18 Granada;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
18 Granada;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
18 Granada;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
18 Granada;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;91,12
18 Granada;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
18 Granada;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
18 Granada;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
18 Granada;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;88,45
18 Granada;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
18 Granada;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
18 Granada;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
18 Granada;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
18 Granada;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
18 Granada;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
18 Granada;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QI;6.755
18 Granada;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
18 Granada;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
18 Granada;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
18 Granada;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QI;6.568
18 Granada;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
18 Granada;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
18 Granada;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
18 Granada;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QI;6.667
18 Granada;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
18 Granada;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
18 Granada;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2022QII;""
18 Granada;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2022QI;6.530
18 Granada;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
18 Granada;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
18 Granada;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2021QII;""
18 Granada;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2021QI;6.411
18 Granada;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
18 Granada;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
18 Granada;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2020QII;""
18 Granada;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2020QI;6.168
18 Granada;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
18 Granada;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
18 Granada;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2022QII;6.286
18 Granada;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2022QI;""
18 Granada;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
18 Granada;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
18 Granada;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2021QII;6.222
18 Granada;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2021QI;""
18 Granada;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
18 Granada;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
18 Granada;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2020QII;6.021
18 Granada;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2020QI;""
18 Granada;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
18 Granada;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QIII;6.103
18 Granada;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QII;""
18 Granada;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QI;""
18 Granada;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
18 Granada;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QIII;6.087
18 Granada;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QII;""
18 Granada;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QI;""
18 Granada;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
18 Granada;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QIII;5.854
18 Granada;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QII;""
18 Granada;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QI;""
18 Granada;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QIV;5.920
18 Granada;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
18 Granada;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QII;""
18 Granada;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QI;""
18 Granada;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QIV;5.926
18 Granada;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
18 Granada;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QII;""
18 Granada;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QI;""
18 Granada;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QIV;5.671
18 Granada;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
18 Granada;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QII;""
18 Granada;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QI;""
18 Granada;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
18 Granada;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
18 Granada;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
18 Granada;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
18 Granada;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
18 Granada;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
18 Granada;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
18 Granada;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
18 Granada;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
18 Granada;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
18 Granada;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
18 Granada;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
18 Granada;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
18 Granada;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
18 Granada;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
18 Granada;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;96,67
18 Granada;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
18 Granada;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
18 Granada;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
18 Granada;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;97,61
18 Granada;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
18 Granada;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
18 Granada;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
18 Granada;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;92,52
18 Granada;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
18 Granada;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
18 Granada;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;93,06
18 Granada;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
18 Granada;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
18 Granada;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
18 Granada;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;94,73
18 Granada;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
18 Granada;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
18 Granada;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
18 Granada;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;90,31
18 Granada;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
18 Granada;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
18 Granada;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;90,35
18 Granada;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
18 Granada;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
18 Granada;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
18 Granada;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;92,68
18 Granada;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
18 Granada;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
18 Granada;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
18 Granada;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;87,81
18 Granada;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
18 Granada;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
18 Granada;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;87,64
18 Granada;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
18 Granada;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
18 Granada;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
18 Granada;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;90,23
18 Granada;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
18 Granada;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
18 Granada;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
18 Granada;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;85,06
18 Granada;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
18 Granada;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
18 Granada;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
18 Granada;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
18 Granada;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
18 Granada;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QII;18.354
18 Granada;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
18 Granada;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
18 Granada;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
18 Granada;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QII;18.356
18 Granada;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
18 Granada;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
18 Granada;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
18 Granada;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QII;17.927
18 Granada;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
18 Granada;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
18 Granada;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
18 Granada;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2022QII;17.639
18 Granada;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2022QI;""
18 Granada;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
18 Granada;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
18 Granada;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2021QII;17.804
18 Granada;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2021QI;""
18 Granada;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
18 Granada;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
18 Granada;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2020QII;17.556
18 Granada;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2020QI;""
18 Granada;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
18 Granada;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2022QIII;17.170
18 Granada;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2022QII;""
18 Granada;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2022QI;""
18 Granada;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
18 Granada;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2021QIII;17.381
18 Granada;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2021QII;""
18 Granada;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2021QI;""
18 Granada;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
18 Granada;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2020QIII;17.104
18 Granada;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2020QII;""
18 Granada;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2020QI;""
18 Granada;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QIV;16.644
18 Granada;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
18 Granada;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QII;""
18 Granada;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QI;""
18 Granada;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QIV;16.925
18 Granada;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
18 Granada;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QII;""
18 Granada;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QI;""
18 Granada;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QIV;16.658
18 Granada;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
18 Granada;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QII;""
18 Granada;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QI;""
18 Granada;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
18 Granada;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
18 Granada;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QII;""
18 Granada;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QI;16.516
18 Granada;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
18 Granada;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
18 Granada;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QII;""
18 Granada;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QI;16.370
18 Granada;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
18 Granada;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
18 Granada;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QII;""
18 Granada;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QI;""
18 Granada;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
18 Granada;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
18 Granada;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
18 Granada;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
18 Granada;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
18 Granada;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
18 Granada;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
18 Granada;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
18 Granada;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
18 Granada;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
18 Granada;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
18 Granada;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
18 Granada;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
18 Granada;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
18 Granada;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;96,1
18 Granada;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
18 Granada;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
18 Granada;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
18 Granada;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;96,99
18 Granada;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
18 Granada;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
18 Granada;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
18 Granada;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;97,93
18 Granada;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
18 Granada;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
18 Granada;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;93,55
18 Granada;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
18 Granada;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
18 Granada;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
18 Granada;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;94,69
18 Granada;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
18 Granada;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
18 Granada;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
18 Granada;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;95,41
18 Granada;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
18 Granada;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
18 Granada;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;90,68
18 Granada;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
18 Granada;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
18 Granada;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
18 Granada;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;92,2
18 Granada;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
18 Granada;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
18 Granada;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
18 Granada;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;92,92
18 Granada;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
18 Granada;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
18 Granada;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
18 Granada;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
18 Granada;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
18 Granada;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
18 Granada;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;89,98
18 Granada;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
18 Granada;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
18 Granada;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
18 Granada;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;91,31
18 Granada;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
18 Granada;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
18 Granada;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
18 Granada;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
18 Granada;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
18 Granada;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
18 Granada;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QII;11.648
18 Granada;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
18 Granada;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
18 Granada;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
18 Granada;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QII;11.728
18 Granada;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
18 Granada;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
18 Granada;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
18 Granada;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QII;11.438
18 Granada;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
18 Granada;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
18 Granada;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
18 Granada;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2022QII;11.209
18 Granada;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2022QI;""
18 Granada;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
18 Granada;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
18 Granada;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2021QII;11.406
18 Granada;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2021QI;""
18 Granada;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
18 Granada;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
18 Granada;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2020QII;11.224
18 Granada;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2020QI;""
18 Granada;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
18 Granada;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2022QIII;10.934
18 Granada;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2022QII;""
18 Granada;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2022QI;""
18 Granada;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
18 Granada;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2021QIII;11.140
18 Granada;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2021QII;""
18 Granada;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2021QI;""
18 Granada;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
18 Granada;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2020QIII;10.967
18 Granada;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2020QII;""
18 Granada;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2020QI;""
18 Granada;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QIV;10.611
18 Granada;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
18 Granada;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QII;""
18 Granada;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QI;""
18 Granada;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QIV;10.854
18 Granada;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
18 Granada;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QII;""
18 Granada;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QI;""
18 Granada;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QIV;10.727
18 Granada;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
18 Granada;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QII;""
18 Granada;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QI;""
18 Granada;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
18 Granada;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
18 Granada;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QII;""
18 Granada;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QI;10.612
18 Granada;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
18 Granada;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
18 Granada;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QII;""
18 Granada;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QI;10.552
18 Granada;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
18 Granada;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
18 Granada;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QII;""
18 Granada;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QI;""
18 Granada;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
18 Granada;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
18 Granada;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
18 Granada;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
18 Granada;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
18 Granada;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
18 Granada;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
18 Granada;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
18 Granada;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
18 Granada;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
18 Granada;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
18 Granada;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
18 Granada;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
18 Granada;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
18 Granada;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;96,23
18 Granada;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
18 Granada;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
18 Granada;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
18 Granada;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;97,25
18 Granada;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
18 Granada;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
18 Granada;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
18 Granada;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;98,13
18 Granada;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
18 Granada;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
18 Granada;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;93,87
18 Granada;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
18 Granada;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
18 Granada;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
18 Granada;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;94,99
18 Granada;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
18 Granada;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
18 Granada;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
18 Granada;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;95,88
18 Granada;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
18 Granada;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
18 Granada;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;91,1
18 Granada;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
18 Granada;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
18 Granada;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
18 Granada;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;92,55
18 Granada;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
18 Granada;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
18 Granada;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
18 Granada;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;93,78
18 Granada;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
18 Granada;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
18 Granada;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
18 Granada;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
18 Granada;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
18 Granada;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
18 Granada;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;90,48
18 Granada;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
18 Granada;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
18 Granada;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
18 Granada;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;92,25
18 Granada;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
18 Granada;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
18 Granada;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
18 Granada;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
18 Granada;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
18 Granada;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
18 Granada;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QII;6.706
18 Granada;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
18 Granada;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
18 Granada;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
18 Granada;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QII;6.628
18 Granada;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
18 Granada;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
18 Granada;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
18 Granada;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QII;6.489
18 Granada;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
18 Granada;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
18 Granada;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
18 Granada;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2022QII;6.430
18 Granada;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2022QI;""
18 Granada;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
18 Granada;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
18 Granada;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2021QII;6.398
18 Granada;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2021QI;""
18 Granada;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
18 Granada;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
18 Granada;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2020QII;6.332
18 Granada;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2020QI;""
18 Granada;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
18 Granada;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2022QIII;6.236
18 Granada;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2022QII;""
18 Granada;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2022QI;""
18 Granada;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
18 Granada;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2021QIII;6.241
18 Granada;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2021QII;""
18 Granada;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2021QI;""
18 Granada;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
18 Granada;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2020QIII;6.137
18 Granada;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2020QII;""
18 Granada;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2020QI;""
18 Granada;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QIV;6.033
18 Granada;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
18 Granada;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QII;""
18 Granada;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QI;""
18 Granada;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QIV;6.071
18 Granada;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
18 Granada;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QII;""
18 Granada;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QI;""
18 Granada;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QIV;5.931
18 Granada;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
18 Granada;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QII;""
18 Granada;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QI;""
18 Granada;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
18 Granada;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
18 Granada;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QII;""
18 Granada;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QI;5.904
18 Granada;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
18 Granada;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
18 Granada;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QII;""
18 Granada;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QI;5.818
18 Granada;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
18 Granada;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
18 Granada;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QII;""
18 Granada;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QI;""
18 Granada;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
18 Granada;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
18 Granada;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
18 Granada;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
18 Granada;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
18 Granada;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
18 Granada;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
18 Granada;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
18 Granada;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
18 Granada;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
18 Granada;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
18 Granada;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
18 Granada;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
18 Granada;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
18 Granada;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;95,88
18 Granada;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
18 Granada;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
18 Granada;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
18 Granada;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;96,53
18 Granada;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
18 Granada;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
18 Granada;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
18 Granada;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;97,58
18 Granada;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
18 Granada;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
18 Granada;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;92,99
18 Granada;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
18 Granada;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
18 Granada;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
18 Granada;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;94,16
18 Granada;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
18 Granada;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
18 Granada;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
18 Granada;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;94,58
18 Granada;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
18 Granada;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
18 Granada;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;89,96
18 Granada;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
18 Granada;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
18 Granada;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
18 Granada;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;91,6
18 Granada;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
18 Granada;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
18 Granada;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
18 Granada;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;91,4
18 Granada;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
18 Granada;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
18 Granada;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
18 Granada;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
18 Granada;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
18 Granada;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
18 Granada;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;89,08
18 Granada;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
18 Granada;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
18 Granada;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
18 Granada;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;89,66
18 Granada;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
18 Granada;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
18 Granada;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
18 Granada;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
18 Granada;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
18 Granada;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QIII;18.310
18 Granada;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
18 Granada;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
18 Granada;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
18 Granada;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QIII;18.478
18 Granada;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
18 Granada;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
18 Granada;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
18 Granada;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QIII;18.178
18 Granada;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
18 Granada;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
18 Granada;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
18 Granada;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2022QIII;17.742
18 Granada;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2022QII;""
18 Granada;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2022QI;""
18 Granada;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
18 Granada;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2021QIII;17.969
18 Granada;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2021QII;""
18 Granada;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2021QI;""
18 Granada;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
18 Granada;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2020QIII;17.639
18 Granada;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2020QII;""
18 Granada;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2020QI;""
18 Granada;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2022QIV;17.149
18 Granada;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
18 Granada;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2022QII;""
18 Granada;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2022QI;""
18 Granada;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2021QIV;17.446
18 Granada;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
18 Granada;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2021QII;""
18 Granada;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2021QI;""
18 Granada;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2020QIV;17.145
18 Granada;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
18 Granada;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2020QII;""
18 Granada;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2020QI;""
18 Granada;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
18 Granada;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
18 Granada;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QII;""
18 Granada;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QI;16.998
18 Granada;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
18 Granada;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
18 Granada;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QII;""
18 Granada;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QI;16.833
18 Granada;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
18 Granada;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
18 Granada;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QII;""
18 Granada;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QI;""
18 Granada;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
18 Granada;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
18 Granada;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QII;16.500
18 Granada;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QI;""
18 Granada;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
18 Granada;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
18 Granada;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QII;16.482
18 Granada;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QI;""
18 Granada;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
18 Granada;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
18 Granada;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QII;""
18 Granada;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QI;""
18 Granada;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
18 Granada;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
18 Granada;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
18 Granada;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
18 Granada;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
18 Granada;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
18 Granada;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
18 Granada;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
18 Granada;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
18 Granada;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
18 Granada;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
18 Granada;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
18 Granada;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
18 Granada;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;96,9
18 Granada;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
18 Granada;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
18 Granada;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
18 Granada;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;97,25
18 Granada;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
18 Granada;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
18 Granada;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
18 Granada;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;97,03
18 Granada;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
18 Granada;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
18 Granada;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;93,66
18 Granada;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
18 Granada;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
18 Granada;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
18 Granada;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;94,41
18 Granada;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
18 Granada;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
18 Granada;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
18 Granada;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;94,32
18 Granada;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
18 Granada;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
18 Granada;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
18 Granada;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
18 Granada;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
18 Granada;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
18 Granada;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;91,99
18 Granada;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
18 Granada;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
18 Granada;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
18 Granada;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;92,6
18 Granada;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
18 Granada;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
18 Granada;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
18 Granada;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
18 Granada;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
18 Granada;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
18 Granada;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;89,3
18 Granada;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
18 Granada;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
18 Granada;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
18 Granada;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;90,67
18 Granada;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
18 Granada;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
18 Granada;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
18 Granada;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
18 Granada;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
18 Granada;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
18 Granada;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QIII;11.601
18 Granada;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
18 Granada;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
18 Granada;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
18 Granada;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QIII;11.803
18 Granada;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
18 Granada;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
18 Granada;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
18 Granada;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QIII;11.648
18 Granada;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
18 Granada;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
18 Granada;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
18 Granada;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2022QIII;11.276
18 Granada;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2022QII;""
18 Granada;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2022QI;""
18 Granada;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
18 Granada;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2021QIII;11.485
18 Granada;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2021QII;""
18 Granada;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2021QI;""
18 Granada;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
18 Granada;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2020QIII;11.329
18 Granada;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2020QII;""
18 Granada;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2020QI;""
18 Granada;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2022QIV;10.910
18 Granada;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
18 Granada;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2022QII;""
18 Granada;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2022QI;""
18 Granada;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2021QIV;11.156
18 Granada;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
18 Granada;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2021QII;""
18 Granada;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2021QI;""
18 Granada;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2020QIV;11.053
18 Granada;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
18 Granada;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2020QII;""
18 Granada;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2020QI;""
18 Granada;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
18 Granada;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
18 Granada;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QII;""
18 Granada;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QI;10.889
18 Granada;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
18 Granada;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
18 Granada;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QII;""
18 Granada;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QI;10.860
18 Granada;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
18 Granada;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
18 Granada;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QII;""
18 Granada;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QI;""
18 Granada;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
18 Granada;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
18 Granada;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QII;10.584
18 Granada;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QI;""
18 Granada;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
18 Granada;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
18 Granada;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QII;10.651
18 Granada;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QI;""
18 Granada;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
18 Granada;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
18 Granada;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QII;""
18 Granada;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QI;""
18 Granada;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
18 Granada;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
18 Granada;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
18 Granada;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
18 Granada;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
18 Granada;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
18 Granada;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
18 Granada;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
18 Granada;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
18 Granada;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
18 Granada;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
18 Granada;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
18 Granada;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
18 Granada;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;97,2
18 Granada;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
18 Granada;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
18 Granada;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
18 Granada;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;97,31
18 Granada;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
18 Granada;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
18 Granada;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
18 Granada;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;97,26
18 Granada;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
18 Granada;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
18 Granada;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;94,04
18 Granada;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
18 Granada;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
18 Granada;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
18 Granada;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;94,52
18 Granada;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
18 Granada;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
18 Granada;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
18 Granada;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;94,89
18 Granada;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
18 Granada;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
18 Granada;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
18 Granada;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
18 Granada;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
18 Granada;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
18 Granada;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;92,26
18 Granada;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
18 Granada;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
18 Granada;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
18 Granada;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;93,23
18 Granada;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
18 Granada;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
18 Granada;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
18 Granada;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
18 Granada;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
18 Granada;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
18 Granada;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;89,67
18 Granada;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
18 Granada;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
18 Granada;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
18 Granada;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;91,44
18 Granada;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
18 Granada;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
18 Granada;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
18 Granada;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
18 Granada;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
18 Granada;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
18 Granada;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QIII;6.709
18 Granada;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
18 Granada;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
18 Granada;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
18 Granada;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QIII;6.675
18 Granada;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
18 Granada;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
18 Granada;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
18 Granada;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QIII;6.530
18 Granada;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
18 Granada;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
18 Granada;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
18 Granada;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2022QIII;6.466
18 Granada;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2022QII;""
18 Granada;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2022QI;""
18 Granada;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
18 Granada;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2021QIII;6.484
18 Granada;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2021QII;""
18 Granada;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2021QI;""
18 Granada;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
18 Granada;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2020QIII;6.310
18 Granada;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2020QII;""
18 Granada;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2020QI;""
18 Granada;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2022QIV;6.239
18 Granada;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
18 Granada;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2022QII;""
18 Granada;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2022QI;""
18 Granada;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2021QIV;6.290
18 Granada;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
18 Granada;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2021QII;""
18 Granada;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2021QI;""
18 Granada;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2020QIV;6.092
18 Granada;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
18 Granada;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2020QII;""
18 Granada;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2020QI;""
18 Granada;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
18 Granada;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
18 Granada;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QII;""
18 Granada;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QI;6.109
18 Granada;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
18 Granada;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
18 Granada;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QII;""
18 Granada;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QI;5.973
18 Granada;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
18 Granada;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
18 Granada;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QII;""
18 Granada;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QI;""
18 Granada;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
18 Granada;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
18 Granada;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QII;5.916
18 Granada;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QI;""
18 Granada;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
18 Granada;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
18 Granada;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QII;5.831
18 Granada;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QI;""
18 Granada;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
18 Granada;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
18 Granada;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QII;""
18 Granada;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QI;""
18 Granada;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
18 Granada;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
18 Granada;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
18 Granada;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
18 Granada;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
18 Granada;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
18 Granada;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
18 Granada;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
18 Granada;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
18 Granada;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
18 Granada;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
18 Granada;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
18 Granada;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
18 Granada;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;96,38
18 Granada;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
18 Granada;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
18 Granada;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
18 Granada;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;97,14
18 Granada;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
18 Granada;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
18 Granada;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
18 Granada;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;96,63
18 Granada;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
18 Granada;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
18 Granada;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;92,99
18 Granada;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
18 Granada;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
18 Granada;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
18 Granada;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;94,23
18 Granada;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
18 Granada;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
18 Granada;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
18 Granada;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;93,29
18 Granada;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
18 Granada;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
18 Granada;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
18 Granada;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
18 Granada;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
18 Granada;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
18 Granada;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;91,52
18 Granada;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
18 Granada;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
18 Granada;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
18 Granada;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;91,47
18 Granada;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
18 Granada;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
18 Granada;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
18 Granada;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
18 Granada;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
18 Granada;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
18 Granada;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;88,63
18 Granada;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
18 Granada;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
18 Granada;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
18 Granada;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;89,3
18 Granada;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
18 Granada;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
18 Granada;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
18 Granada;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
18 Granada;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
18 Granada;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QIV;18.283
18 Granada;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
18 Granada;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
18 Granada;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
18 Granada;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QIV;18.521
18 Granada;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
18 Granada;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
18 Granada;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
18 Granada;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QIV;18.262
18 Granada;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
18 Granada;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
18 Granada;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
18 Granada;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2022QIV;17.622
18 Granada;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
18 Granada;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2022QII;""
18 Granada;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2022QI;""
18 Granada;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2021QIV;17.921
18 Granada;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
18 Granada;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2021QII;""
18 Granada;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2021QI;""
18 Granada;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2020QIV;17.683
18 Granada;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
18 Granada;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2020QII;""
18 Granada;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2020QI;""
18 Granada;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
18 Granada;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
18 Granada;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2022QII;""
18 Granada;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2022QI;17.447
18 Granada;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
18 Granada;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
18 Granada;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2021QII;""
18 Granada;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2021QI;17.338
18 Granada;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
18 Granada;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
18 Granada;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2020QII;""
18 Granada;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2020QI;""
18 Granada;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
18 Granada;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
18 Granada;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QII;16.910
18 Granada;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QI;""
18 Granada;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
18 Granada;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
18 Granada;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QII;16.943
18 Granada;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QI;""
18 Granada;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
18 Granada;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
18 Granada;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QII;""
18 Granada;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QI;""
18 Granada;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
18 Granada;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QIII;16.511
18 Granada;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QII;""
18 Granada;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QI;""
18 Granada;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
18 Granada;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QIII;16.600
18 Granada;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QII;""
18 Granada;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QI;""
18 Granada;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
18 Granada;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
18 Granada;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QII;""
18 Granada;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QI;""
18 Granada;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
18 Granada;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
18 Granada;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
18 Granada;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
18 Granada;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
18 Granada;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
18 Granada;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
18 Granada;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
18 Granada;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
18 Granada;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
18 Granada;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
18 Granada;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
18 Granada;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;96,38
18 Granada;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
18 Granada;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
18 Granada;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
18 Granada;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;96,76
18 Granada;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
18 Granada;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
18 Granada;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
18 Granada;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;96,83
18 Granada;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
18 Granada;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
18 Granada;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
18 Granada;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
18 Granada;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
18 Granada;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
18 Granada;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;94,2
18 Granada;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
18 Granada;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
18 Granada;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
18 Granada;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;94,94
18 Granada;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
18 Granada;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
18 Granada;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
18 Granada;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
18 Granada;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
18 Granada;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
18 Granada;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;91,3
18 Granada;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
18 Granada;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
18 Granada;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
18 Granada;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;92,78
18 Granada;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
18 Granada;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
18 Granada;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
18 Granada;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
18 Granada;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
18 Granada;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
18 Granada;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;89,15
18 Granada;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
18 Granada;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
18 Granada;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
18 Granada;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;90,9
18 Granada;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
18 Granada;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
18 Granada;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
18 Granada;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
18 Granada;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
18 Granada;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
18 Granada;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QIV;11.589
18 Granada;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
18 Granada;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
18 Granada;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
18 Granada;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QIV;11.809
18 Granada;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
18 Granada;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
18 Granada;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
18 Granada;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QIV;11.727
18 Granada;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
18 Granada;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
18 Granada;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
18 Granada;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2022QIV;11.175
18 Granada;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
18 Granada;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2022QII;""
18 Granada;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2022QI;""
18 Granada;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2021QIV;11.436
18 Granada;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
18 Granada;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2021QII;""
18 Granada;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2021QI;""
18 Granada;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2020QIV;11.394
18 Granada;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
18 Granada;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2020QII;""
18 Granada;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2020QI;""
18 Granada;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
18 Granada;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
18 Granada;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2022QII;""
18 Granada;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2022QI;11.153
18 Granada;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
18 Granada;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
18 Granada;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2021QII;""
18 Granada;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2021QI;11.181
18 Granada;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
18 Granada;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
18 Granada;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2020QII;""
18 Granada;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2020QI;""
18 Granada;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
18 Granada;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
18 Granada;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QII;10.825
18 Granada;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QI;""
18 Granada;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
18 Granada;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
18 Granada;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QII;10.944
18 Granada;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QI;""
18 Granada;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
18 Granada;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
18 Granada;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QII;""
18 Granada;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QI;""
18 Granada;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
18 Granada;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QIII;10.594
18 Granada;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QII;""
18 Granada;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QI;""
18 Granada;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
18 Granada;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QIII;10.721
18 Granada;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QII;""
18 Granada;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QI;""
18 Granada;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
18 Granada;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
18 Granada;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QII;""
18 Granada;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QI;""
18 Granada;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
18 Granada;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
18 Granada;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
18 Granada;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
18 Granada;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
18 Granada;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
18 Granada;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
18 Granada;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
18 Granada;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
18 Granada;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
18 Granada;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
18 Granada;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
18 Granada;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;96,43
18 Granada;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
18 Granada;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
18 Granada;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
18 Granada;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;96,84
18 Granada;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
18 Granada;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
18 Granada;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
18 Granada;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;97,16
18 Granada;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
18 Granada;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
18 Granada;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
18 Granada;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
18 Granada;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
18 Granada;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
18 Granada;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;94,44
18 Granada;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
18 Granada;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
18 Granada;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
18 Granada;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;95,34
18 Granada;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
18 Granada;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
18 Granada;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
18 Granada;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
18 Granada;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
18 Granada;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
18 Granada;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;91,67
18 Granada;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
18 Granada;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
18 Granada;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
18 Granada;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;93,32
18 Granada;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
18 Granada;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
18 Granada;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
18 Granada;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
18 Granada;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
18 Granada;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
18 Granada;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;89,71
18 Granada;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
18 Granada;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
18 Granada;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
18 Granada;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;91,42
18 Granada;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
18 Granada;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
18 Granada;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
18 Granada;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
18 Granada;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
18 Granada;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
18 Granada;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QIV;6.694
18 Granada;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
18 Granada;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
18 Granada;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
18 Granada;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QIV;6.712
18 Granada;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
18 Granada;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
18 Granada;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
18 Granada;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QIV;6.535
18 Granada;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
18 Granada;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
18 Granada;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
18 Granada;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2022QIV;6.447
18 Granada;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
18 Granada;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2022QII;""
18 Granada;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2022QI;""
18 Granada;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2021QIV;6.485
18 Granada;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
18 Granada;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2021QII;""
18 Granada;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2021QI;""
18 Granada;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2020QIV;6.289
18 Granada;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
18 Granada;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2020QII;""
18 Granada;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2020QI;""
18 Granada;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
18 Granada;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
18 Granada;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2022QII;""
18 Granada;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2022QI;6.294
18 Granada;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
18 Granada;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
18 Granada;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2021QII;""
18 Granada;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2021QI;6.157
18 Granada;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
18 Granada;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
18 Granada;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2020QII;""
18 Granada;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2020QI;""
18 Granada;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
18 Granada;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
18 Granada;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QII;6.085
18 Granada;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QI;""
18 Granada;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
18 Granada;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
18 Granada;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QII;5.999
18 Granada;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QI;""
18 Granada;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
18 Granada;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
18 Granada;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QII;""
18 Granada;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QI;""
18 Granada;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
18 Granada;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QIII;5.917
18 Granada;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QII;""
18 Granada;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QI;""
18 Granada;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
18 Granada;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QIII;5.879
18 Granada;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QII;""
18 Granada;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QI;""
18 Granada;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
18 Granada;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
18 Granada;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QII;""
18 Granada;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QI;""
18 Granada;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
18 Granada;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
18 Granada;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
18 Granada;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
18 Granada;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
18 Granada;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
18 Granada;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
18 Granada;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
18 Granada;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
18 Granada;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
18 Granada;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
18 Granada;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
18 Granada;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;96,31
18 Granada;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
18 Granada;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
18 Granada;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
18 Granada;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;96,62
18 Granada;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
18 Granada;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
18 Granada;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
18 Granada;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;96,24
18 Granada;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
18 Granada;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
18 Granada;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
18 Granada;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
18 Granada;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
18 Granada;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
18 Granada;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;93,77
18 Granada;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
18 Granada;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
18 Granada;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
18 Granada;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;94,22
18 Granada;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
18 Granada;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
18 Granada;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
18 Granada;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
18 Granada;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
18 Granada;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
18 Granada;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;90,66
18 Granada;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
18 Granada;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
18 Granada;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
18 Granada;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;91,8
18 Granada;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
18 Granada;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
18 Granada;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
18 Granada;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
18 Granada;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
18 Granada;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
18 Granada;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;88,16
18 Granada;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
18 Granada;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
18 Granada;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
18 Granada;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;89,96
18 Granada;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
18 Granada;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
18 Granada;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
18 Granada;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
18 Granada;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
18 Granada;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
18 Granada;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
18 Granada;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
18 Granada;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
18 Granada;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QI;16.664
18 Granada;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
18 Granada;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
18 Granada;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
18 Granada;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QI;16.146
18 Granada;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
18 Granada;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
18 Granada;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
18 Granada;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QI;16.339
18 Granada;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
18 Granada;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
18 Granada;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2022QII;""
18 Granada;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2022QI;16.278
18 Granada;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
18 Granada;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
18 Granada;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2021QII;""
18 Granada;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2021QI;15.842
18 Granada;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
18 Granada;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
18 Granada;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2020QII;""
18 Granada;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2020QI;15.519
18 Granada;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
18 Granada;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
18 Granada;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2022QII;15.852
18 Granada;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2022QI;""
18 Granada;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
18 Granada;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
18 Granada;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2021QII;15.542
18 Granada;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2021QI;""
18 Granada;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
18 Granada;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
18 Granada;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2020QII;15.291
18 Granada;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2020QI;""
18 Granada;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
18 Granada;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QIII;15.549
18 Granada;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QII;""
18 Granada;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QI;""
18 Granada;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
18 Granada;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QIII;15.310
18 Granada;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QII;""
18 Granada;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QI;""
18 Granada;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
18 Granada;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QIII;15.019
18 Granada;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QII;""
18 Granada;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QI;""
18 Granada;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QIV;15.193
18 Granada;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
18 Granada;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QII;""
18 Granada;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QI;""
18 Granada;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QIV;15.029
18 Granada;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
18 Granada;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QII;""
18 Granada;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QI;""
18 Granada;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QIV;14.770
18 Granada;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
18 Granada;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QII;""
18 Granada;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QI;""
18 Granada;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
18 Granada;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
18 Granada;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
18 Granada;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
18 Granada;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
18 Granada;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
18 Granada;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
18 Granada;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
18 Granada;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
18 Granada;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
18 Granada;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
18 Granada;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
18 Granada;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
18 Granada;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
18 Granada;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
18 Granada;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;97,68
18 Granada;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
18 Granada;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
18 Granada;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
18 Granada;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;98,12
18 Granada;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
18 Granada;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
18 Granada;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
18 Granada;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;94,98
18 Granada;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
18 Granada;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
18 Granada;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;95,13
18 Granada;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
18 Granada;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
18 Granada;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
18 Granada;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;96,26
18 Granada;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
18 Granada;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
18 Granada;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
18 Granada;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;93,59
18 Granada;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
18 Granada;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
18 Granada;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;93,31
18 Granada;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
18 Granada;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
18 Granada;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
18 Granada;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;94,82
18 Granada;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
18 Granada;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
18 Granada;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
18 Granada;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;91,92
18 Granada;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
18 Granada;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
18 Granada;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;91,17
18 Granada;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
18 Granada;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
18 Granada;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
18 Granada;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;93,08
18 Granada;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
18 Granada;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
18 Granada;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
18 Granada;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;90,4
18 Granada;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
18 Granada;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
18 Granada;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
18 Granada;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
18 Granada;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
18 Granada;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
18 Granada;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QI;10.777
18 Granada;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
18 Granada;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
18 Granada;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
18 Granada;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QI;10.508
18 Granada;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
18 Granada;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
18 Granada;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
18 Granada;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QI;10.610
18 Granada;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
18 Granada;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
18 Granada;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2022QII;""
18 Granada;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2022QI;10.544
18 Granada;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
18 Granada;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
18 Granada;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2021QII;""
18 Granada;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2021QI;10.314
18 Granada;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
18 Granada;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
18 Granada;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2020QII;""
18 Granada;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2020QI;10.124
18 Granada;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
18 Granada;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
18 Granada;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2022QII;10.283
18 Granada;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2022QI;""
18 Granada;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
18 Granada;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
18 Granada;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2021QII;10.132
18 Granada;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2021QI;""
18 Granada;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
18 Granada;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
18 Granada;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2020QII;9.978
18 Granada;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2020QI;""
18 Granada;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
18 Granada;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QIII;10.105
18 Granada;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QII;""
18 Granada;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QI;""
18 Granada;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
18 Granada;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QIII;9.985
18 Granada;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QII;""
18 Granada;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QI;""
18 Granada;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
18 Granada;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QIII;9.817
18 Granada;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QII;""
18 Granada;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QI;""
18 Granada;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QIV;9.877
18 Granada;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
18 Granada;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QII;""
18 Granada;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QI;""
18 Granada;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QIV;9.812
18 Granada;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
18 Granada;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QII;""
18 Granada;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QI;""
18 Granada;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QIV;9.675
18 Granada;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
18 Granada;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QII;""
18 Granada;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QI;""
18 Granada;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
18 Granada;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
18 Granada;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
18 Granada;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
18 Granada;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
18 Granada;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
18 Granada;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
18 Granada;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
18 Granada;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
18 Granada;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
18 Granada;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
18 Granada;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
18 Granada;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
18 Granada;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
18 Granada;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
18 Granada;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;97,84
18 Granada;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
18 Granada;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
18 Granada;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
18 Granada;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;98,15
18 Granada;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
18 Granada;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
18 Granada;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
18 Granada;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;95,42
18 Granada;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
18 Granada;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
18 Granada;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;95,42
18 Granada;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
18 Granada;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
18 Granada;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
18 Granada;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;96,42
18 Granada;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
18 Granada;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
18 Granada;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
18 Granada;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;94,04
18 Granada;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
18 Granada;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
18 Granada;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;93,76
18 Granada;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
18 Granada;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
18 Granada;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
18 Granada;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;95,02
18 Granada;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
18 Granada;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
18 Granada;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
18 Granada;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;92,53
18 Granada;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
18 Granada;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
18 Granada;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;91,65
18 Granada;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
18 Granada;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
18 Granada;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
18 Granada;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;93,38
18 Granada;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
18 Granada;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
18 Granada;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
18 Granada;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;91,19
18 Granada;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
18 Granada;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
18 Granada;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
18 Granada;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
18 Granada;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
18 Granada;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
18 Granada;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QI;5.887
18 Granada;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
18 Granada;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
18 Granada;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
18 Granada;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QI;5.638
18 Granada;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
18 Granada;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
18 Granada;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
18 Granada;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QI;5.729
18 Granada;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
18 Granada;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
18 Granada;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2022QII;""
18 Granada;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2022QI;5.734
18 Granada;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
18 Granada;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
18 Granada;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2021QII;""
18 Granada;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2021QI;5.528
18 Granada;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
18 Granada;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
18 Granada;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2020QII;""
18 Granada;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2020QI;5.395
18 Granada;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
18 Granada;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
18 Granada;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2022QII;5.569
18 Granada;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2022QI;""
18 Granada;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
18 Granada;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
18 Granada;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2021QII;5.410
18 Granada;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2021QI;""
18 Granada;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
18 Granada;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
18 Granada;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2020QII;5.313
18 Granada;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2020QI;""
18 Granada;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
18 Granada;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QIII;5.444
18 Granada;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QII;""
18 Granada;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QI;""
18 Granada;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
18 Granada;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QIII;5.325
18 Granada;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QII;""
18 Granada;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QI;""
18 Granada;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
18 Granada;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QIII;5.202
18 Granada;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QII;""
18 Granada;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QI;""
18 Granada;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QIV;5.316
18 Granada;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
18 Granada;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QII;""
18 Granada;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QI;""
18 Granada;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QIV;5.217
18 Granada;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
18 Granada;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QII;""
18 Granada;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QI;""
18 Granada;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QIV;5.095
18 Granada;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
18 Granada;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QII;""
18 Granada;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QI;""
18 Granada;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
18 Granada;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
18 Granada;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
18 Granada;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
18 Granada;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
18 Granada;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
18 Granada;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
18 Granada;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
18 Granada;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
18 Granada;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
18 Granada;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
18 Granada;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
18 Granada;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
18 Granada;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
18 Granada;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
18 Granada;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;97,4
18 Granada;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
18 Granada;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
18 Granada;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
18 Granada;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;98,05
18 Granada;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
18 Granada;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
18 Granada;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
18 Granada;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;94,17
18 Granada;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
18 Granada;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
18 Granada;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;94,6
18 Granada;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
18 Granada;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
18 Granada;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
18 Granada;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;95,96
18 Granada;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
18 Granada;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
18 Granada;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
18 Granada;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;92,74
18 Granada;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
18 Granada;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
18 Granada;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;92,47
18 Granada;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
18 Granada;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
18 Granada;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
18 Granada;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;94,45
18 Granada;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
18 Granada;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
18 Granada;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
18 Granada;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;90,8
18 Granada;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
18 Granada;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
18 Granada;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;90,3
18 Granada;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
18 Granada;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
18 Granada;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
18 Granada;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;92,53
18 Granada;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
18 Granada;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
18 Granada;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
18 Granada;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;88,93
18 Granada;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
18 Granada;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
18 Granada;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
18 Granada;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
18 Granada;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
18 Granada;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QII;17.122
18 Granada;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
18 Granada;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
18 Granada;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
18 Granada;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QII;16.692
18 Granada;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
18 Granada;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
18 Granada;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
18 Granada;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QII;16.046
18 Granada;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
18 Granada;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
18 Granada;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
18 Granada;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2022QII;16.653
18 Granada;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2022QI;""
18 Granada;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
18 Granada;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
18 Granada;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2021QII;16.334
18 Granada;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2021QI;""
18 Granada;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
18 Granada;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
18 Granada;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2020QII;15.795
18 Granada;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2020QI;""
18 Granada;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
18 Granada;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2022QIII;16.309
18 Granada;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2022QII;""
18 Granada;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2022QI;""
18 Granada;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
18 Granada;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2021QIII;16.075
18 Granada;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2021QII;""
18 Granada;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2021QI;""
18 Granada;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
18 Granada;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2020QIII;15.457
18 Granada;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2020QII;""
18 Granada;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2020QI;""
18 Granada;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QIV;15.891
18 Granada;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
18 Granada;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QII;""
18 Granada;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QI;""
18 Granada;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QIV;15.754
18 Granada;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
18 Granada;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QII;""
18 Granada;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QI;""
18 Granada;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QIV;15.172
18 Granada;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
18 Granada;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QII;""
18 Granada;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QI;""
18 Granada;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
18 Granada;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
18 Granada;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QII;""
18 Granada;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QI;15.443
18 Granada;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
18 Granada;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
18 Granada;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QII;""
18 Granada;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QI;14.959
18 Granada;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
18 Granada;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
18 Granada;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QII;""
18 Granada;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QI;""
18 Granada;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
18 Granada;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
18 Granada;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
18 Granada;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
18 Granada;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
18 Granada;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
18 Granada;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
18 Granada;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
18 Granada;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
18 Granada;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
18 Granada;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
18 Granada;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
18 Granada;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
18 Granada;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
18 Granada;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;97,26
18 Granada;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
18 Granada;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
18 Granada;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
18 Granada;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;97,86
18 Granada;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
18 Granada;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
18 Granada;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
18 Granada;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;98,44
18 Granada;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
18 Granada;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
18 Granada;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;95,25
18 Granada;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
18 Granada;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
18 Granada;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
18 Granada;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;96,3
18 Granada;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
18 Granada;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
18 Granada;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
18 Granada;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;96,33
18 Granada;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
18 Granada;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
18 Granada;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;92,81
18 Granada;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
18 Granada;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
18 Granada;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
18 Granada;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;94,38
18 Granada;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
18 Granada;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
18 Granada;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
18 Granada;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;94,55
18 Granada;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
18 Granada;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
18 Granada;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
18 Granada;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
18 Granada;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
18 Granada;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
18 Granada;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;92,52
18 Granada;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
18 Granada;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
18 Granada;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
18 Granada;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;93,23
18 Granada;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
18 Granada;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
18 Granada;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
18 Granada;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
18 Granada;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
18 Granada;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
18 Granada;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QII;11.053
18 Granada;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
18 Granada;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
18 Granada;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
18 Granada;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QII;10.840
18 Granada;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
18 Granada;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
18 Granada;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
18 Granada;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QII;10.451
18 Granada;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
18 Granada;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
18 Granada;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
18 Granada;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2022QII;10.755
18 Granada;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2022QI;""
18 Granada;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
18 Granada;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
18 Granada;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2021QII;10.627
18 Granada;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2021QI;""
18 Granada;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
18 Granada;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
18 Granada;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2020QII;10.292
18 Granada;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2020QI;""
18 Granada;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
18 Granada;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2022QIII;10.550
18 Granada;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2022QII;""
18 Granada;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2022QI;""
18 Granada;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
18 Granada;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2021QIII;10.458
18 Granada;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2021QII;""
18 Granada;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2021QI;""
18 Granada;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
18 Granada;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2020QIII;10.079
18 Granada;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2020QII;""
18 Granada;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2020QI;""
18 Granada;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QIV;10.283
18 Granada;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
18 Granada;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QII;""
18 Granada;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QI;""
18 Granada;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QIV;10.260
18 Granada;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
18 Granada;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QII;""
18 Granada;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QI;""
18 Granada;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QIV;9.916
18 Granada;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
18 Granada;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QII;""
18 Granada;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QI;""
18 Granada;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
18 Granada;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
18 Granada;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QII;""
18 Granada;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QI;10.068
18 Granada;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
18 Granada;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
18 Granada;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QII;""
18 Granada;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QI;9.787
18 Granada;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
18 Granada;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
18 Granada;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QII;""
18 Granada;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QI;""
18 Granada;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
18 Granada;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
18 Granada;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
18 Granada;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
18 Granada;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
18 Granada;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
18 Granada;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
18 Granada;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
18 Granada;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
18 Granada;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
18 Granada;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
18 Granada;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
18 Granada;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
18 Granada;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
18 Granada;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;97,3
18 Granada;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
18 Granada;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
18 Granada;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
18 Granada;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;98,04
18 Granada;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
18 Granada;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
18 Granada;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
18 Granada;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;98,48
18 Granada;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
18 Granada;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
18 Granada;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;95,45
18 Granada;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
18 Granada;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
18 Granada;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
18 Granada;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;96,48
18 Granada;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
18 Granada;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
18 Granada;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
18 Granada;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;96,44
18 Granada;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
18 Granada;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
18 Granada;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;93,03
18 Granada;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
18 Granada;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
18 Granada;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
18 Granada;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;94,65
18 Granada;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
18 Granada;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
18 Granada;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
18 Granada;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;94,88
18 Granada;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
18 Granada;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
18 Granada;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
18 Granada;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
18 Granada;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
18 Granada;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
18 Granada;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;92,88
18 Granada;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
18 Granada;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
18 Granada;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
18 Granada;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;93,65
18 Granada;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
18 Granada;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
18 Granada;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
18 Granada;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
18 Granada;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
18 Granada;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
18 Granada;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QII;6.069
18 Granada;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
18 Granada;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
18 Granada;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
18 Granada;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QII;5.852
18 Granada;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
18 Granada;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
18 Granada;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
18 Granada;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QII;5.595
18 Granada;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
18 Granada;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
18 Granada;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
18 Granada;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2022QII;5.898
18 Granada;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2022QI;""
18 Granada;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
18 Granada;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
18 Granada;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2021QII;5.707
18 Granada;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2021QI;""
18 Granada;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
18 Granada;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
18 Granada;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2020QII;5.503
18 Granada;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2020QI;""
18 Granada;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
18 Granada;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2022QIII;5.759
18 Granada;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2022QII;""
18 Granada;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2022QI;""
18 Granada;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
18 Granada;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2021QIII;5.617
18 Granada;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2021QII;""
18 Granada;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2021QI;""
18 Granada;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
18 Granada;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2020QIII;5.378
18 Granada;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2020QII;""
18 Granada;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2020QI;""
18 Granada;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QIV;5.608
18 Granada;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
18 Granada;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QII;""
18 Granada;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QI;""
18 Granada;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QIV;5.494
18 Granada;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
18 Granada;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QII;""
18 Granada;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QI;""
18 Granada;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QIV;5.256
18 Granada;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
18 Granada;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QII;""
18 Granada;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QI;""
18 Granada;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
18 Granada;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
18 Granada;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QII;""
18 Granada;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QI;5.375
18 Granada;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
18 Granada;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
18 Granada;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QII;""
18 Granada;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QI;5.172
18 Granada;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
18 Granada;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
18 Granada;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QII;""
18 Granada;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QI;""
18 Granada;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
18 Granada;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
18 Granada;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
18 Granada;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
18 Granada;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
18 Granada;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
18 Granada;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
18 Granada;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
18 Granada;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
18 Granada;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
18 Granada;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
18 Granada;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
18 Granada;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
18 Granada;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
18 Granada;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;97,18
18 Granada;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
18 Granada;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
18 Granada;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
18 Granada;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;97,52
18 Granada;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
18 Granada;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
18 Granada;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
18 Granada;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;98,36
18 Granada;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
18 Granada;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
18 Granada;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;94,89
18 Granada;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
18 Granada;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
18 Granada;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
18 Granada;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;95,98
18 Granada;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
18 Granada;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
18 Granada;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
18 Granada;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;96,12
18 Granada;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
18 Granada;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
18 Granada;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;92,4
18 Granada;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
18 Granada;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
18 Granada;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
18 Granada;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;93,88
18 Granada;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
18 Granada;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
18 Granada;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
18 Granada;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;93,94
18 Granada;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
18 Granada;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
18 Granada;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
18 Granada;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
18 Granada;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
18 Granada;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
18 Granada;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;91,85
18 Granada;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
18 Granada;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
18 Granada;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
18 Granada;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;92,44
18 Granada;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
18 Granada;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
18 Granada;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
18 Granada;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
18 Granada;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
18 Granada;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QIII;17.037
18 Granada;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
18 Granada;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
18 Granada;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
18 Granada;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QIII;16.726
18 Granada;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
18 Granada;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
18 Granada;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
18 Granada;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QIII;16.171
18 Granada;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
18 Granada;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
18 Granada;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
18 Granada;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2022QIII;16.627
18 Granada;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2022QII;""
18 Granada;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2022QI;""
18 Granada;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
18 Granada;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2021QIII;16.417
18 Granada;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2021QII;""
18 Granada;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2021QI;""
18 Granada;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
18 Granada;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2020QIII;15.792
18 Granada;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2020QII;""
18 Granada;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2020QI;""
18 Granada;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2022QIV;16.167
18 Granada;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
18 Granada;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2022QII;""
18 Granada;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2022QI;""
18 Granada;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2021QIV;16.064
18 Granada;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
18 Granada;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2021QII;""
18 Granada;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2021QI;""
18 Granada;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2020QIV;15.472
18 Granada;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
18 Granada;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2020QII;""
18 Granada;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2020QI;""
18 Granada;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
18 Granada;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
18 Granada;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QII;""
18 Granada;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QI;15.735
18 Granada;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
18 Granada;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
18 Granada;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QII;""
18 Granada;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QI;15.245
18 Granada;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
18 Granada;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
18 Granada;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QII;""
18 Granada;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QI;""
18 Granada;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
18 Granada;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
18 Granada;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QII;15.370
18 Granada;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QI;""
18 Granada;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
18 Granada;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
18 Granada;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QII;15.020
18 Granada;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QI;""
18 Granada;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
18 Granada;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
18 Granada;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QII;""
18 Granada;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QI;""
18 Granada;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
18 Granada;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
18 Granada;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
18 Granada;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
18 Granada;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
18 Granada;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
18 Granada;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
18 Granada;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
18 Granada;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
18 Granada;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
18 Granada;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
18 Granada;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
18 Granada;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
18 Granada;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;97,59
18 Granada;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
18 Granada;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
18 Granada;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
18 Granada;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;98,15
18 Granada;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
18 Granada;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
18 Granada;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
18 Granada;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;97,66
18 Granada;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
18 Granada;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
18 Granada;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;94,89
18 Granada;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
18 Granada;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
18 Granada;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
18 Granada;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;96,04
18 Granada;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
18 Granada;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
18 Granada;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
18 Granada;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;95,68
18 Granada;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
18 Granada;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
18 Granada;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
18 Granada;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
18 Granada;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
18 Granada;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
18 Granada;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;94,08
18 Granada;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
18 Granada;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
18 Granada;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
18 Granada;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;94,27
18 Granada;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
18 Granada;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
18 Granada;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
18 Granada;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
18 Granada;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
18 Granada;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
18 Granada;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;91,89
18 Granada;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
18 Granada;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
18 Granada;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
18 Granada;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;92,88
18 Granada;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
18 Granada;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
18 Granada;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
18 Granada;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
18 Granada;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
18 Granada;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
18 Granada;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QIII;10.990
18 Granada;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
18 Granada;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
18 Granada;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
18 Granada;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QIII;10.859
18 Granada;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
18 Granada;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
18 Granada;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
18 Granada;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QIII;10.533
18 Granada;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
18 Granada;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
18 Granada;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
18 Granada;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2022QIII;10.743
18 Granada;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2022QII;""
18 Granada;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2022QI;""
18 Granada;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
18 Granada;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2021QIII;10.662
18 Granada;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2021QII;""
18 Granada;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2021QI;""
18 Granada;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
18 Granada;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2020QIII;10.293
18 Granada;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2020QII;""
18 Granada;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2020QI;""
18 Granada;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2022QIV;10.450
18 Granada;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
18 Granada;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2022QII;""
18 Granada;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2022QI;""
18 Granada;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2021QIV;10.437
18 Granada;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
18 Granada;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2021QII;""
18 Granada;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2021QI;""
18 Granada;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2020QIV;10.105
18 Granada;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
18 Granada;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2020QII;""
18 Granada;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2020QI;""
18 Granada;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
18 Granada;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
18 Granada;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QII;""
18 Granada;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QI;10.236
18 Granada;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
18 Granada;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
18 Granada;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QII;""
18 Granada;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QI;9.968
18 Granada;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
18 Granada;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
18 Granada;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QII;""
18 Granada;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QI;""
18 Granada;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
18 Granada;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
18 Granada;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QII;10.017
18 Granada;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QI;""
18 Granada;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
18 Granada;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
18 Granada;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QII;9.827
18 Granada;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QI;""
18 Granada;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
18 Granada;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
18 Granada;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QII;""
18 Granada;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QI;""
18 Granada;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
18 Granada;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
18 Granada;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
18 Granada;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
18 Granada;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
18 Granada;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
18 Granada;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
18 Granada;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
18 Granada;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
18 Granada;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
18 Granada;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
18 Granada;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
18 Granada;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
18 Granada;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;97,75
18 Granada;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
18 Granada;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
18 Granada;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
18 Granada;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;98,19
18 Granada;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
18 Granada;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
18 Granada;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
18 Granada;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;97,72
18 Granada;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
18 Granada;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
18 Granada;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;95,09
18 Granada;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
18 Granada;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
18 Granada;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
18 Granada;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;96,11
18 Granada;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
18 Granada;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
18 Granada;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
18 Granada;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;95,94
18 Granada;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
18 Granada;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
18 Granada;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
18 Granada;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
18 Granada;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
18 Granada;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
18 Granada;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;94,26
18 Granada;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
18 Granada;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
18 Granada;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
18 Granada;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;94,64
18 Granada;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
18 Granada;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
18 Granada;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
18 Granada;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
18 Granada;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
18 Granada;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
18 Granada;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;92,25
18 Granada;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
18 Granada;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
18 Granada;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
18 Granada;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;93,3
18 Granada;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
18 Granada;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
18 Granada;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
18 Granada;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
18 Granada;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
18 Granada;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
18 Granada;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QIII;6.047
18 Granada;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
18 Granada;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
18 Granada;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
18 Granada;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QIII;5.867
18 Granada;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
18 Granada;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
18 Granada;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
18 Granada;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QIII;5.638
18 Granada;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
18 Granada;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
18 Granada;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
18 Granada;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2022QIII;5.884
18 Granada;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2022QII;""
18 Granada;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2022QI;""
18 Granada;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
18 Granada;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2021QIII;5.755
18 Granada;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2021QII;""
18 Granada;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2021QI;""
18 Granada;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
18 Granada;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2020QIII;5.499
18 Granada;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2020QII;""
18 Granada;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2020QI;""
18 Granada;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2022QIV;5.717
18 Granada;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
18 Granada;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2022QII;""
18 Granada;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2022QI;""
18 Granada;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2021QIV;5.627
18 Granada;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
18 Granada;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2021QII;""
18 Granada;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2021QI;""
18 Granada;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2020QIV;5.367
18 Granada;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
18 Granada;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2020QII;""
18 Granada;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2020QI;""
18 Granada;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
18 Granada;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
18 Granada;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QII;""
18 Granada;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QI;5.499
18 Granada;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
18 Granada;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
18 Granada;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QII;""
18 Granada;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QI;5.277
18 Granada;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
18 Granada;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
18 Granada;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QII;""
18 Granada;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QI;""
18 Granada;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
18 Granada;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
18 Granada;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QII;5.353
18 Granada;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QI;""
18 Granada;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
18 Granada;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
18 Granada;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QII;5.193
18 Granada;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QI;""
18 Granada;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
18 Granada;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
18 Granada;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QII;""
18 Granada;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QI;""
18 Granada;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
18 Granada;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
18 Granada;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
18 Granada;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
18 Granada;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
18 Granada;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
18 Granada;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
18 Granada;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
18 Granada;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
18 Granada;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
18 Granada;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
18 Granada;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
18 Granada;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
18 Granada;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;97,3
18 Granada;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
18 Granada;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
18 Granada;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
18 Granada;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;98,09
18 Granada;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
18 Granada;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
18 Granada;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
18 Granada;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;97,53
18 Granada;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
18 Granada;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
18 Granada;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;94,54
18 Granada;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
18 Granada;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
18 Granada;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
18 Granada;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;95,91
18 Granada;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
18 Granada;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
18 Granada;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
18 Granada;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;95,19
18 Granada;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
18 Granada;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
18 Granada;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
18 Granada;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
18 Granada;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
18 Granada;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
18 Granada;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;93,73
18 Granada;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
18 Granada;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
18 Granada;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
18 Granada;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;93,6
18 Granada;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
18 Granada;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
18 Granada;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
18 Granada;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
18 Granada;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
18 Granada;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
18 Granada;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;91,24
18 Granada;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
18 Granada;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
18 Granada;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
18 Granada;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;92,11
18 Granada;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
18 Granada;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
18 Granada;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
18 Granada;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
18 Granada;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
18 Granada;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QIV;16.964
18 Granada;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
18 Granada;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
18 Granada;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
18 Granada;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QIV;16.696
18 Granada;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
18 Granada;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
18 Granada;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
18 Granada;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QIV;16.150
18 Granada;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
18 Granada;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
18 Granada;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
18 Granada;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2022QIV;16.450
18 Granada;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
18 Granada;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2022QII;""
18 Granada;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2022QI;""
18 Granada;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2021QIV;16.302
18 Granada;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
18 Granada;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2021QII;""
18 Granada;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2021QI;""
18 Granada;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2020QIV;15.772
18 Granada;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
18 Granada;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2020QII;""
18 Granada;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2020QI;""
18 Granada;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
18 Granada;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
18 Granada;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2022QII;""
18 Granada;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2022QI;15.950
18 Granada;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
18 Granada;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
18 Granada;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2021QII;""
18 Granada;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2021QI;15.516
18 Granada;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
18 Granada;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
18 Granada;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2020QII;""
18 Granada;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2020QI;""
18 Granada;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
18 Granada;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
18 Granada;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QII;15.568
18 Granada;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QI;""
18 Granada;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
18 Granada;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
18 Granada;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QII;15.262
18 Granada;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QI;""
18 Granada;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
18 Granada;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
18 Granada;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QII;""
18 Granada;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QI;""
18 Granada;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
18 Granada;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QIII;15.280
18 Granada;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QII;""
18 Granada;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QI;""
18 Granada;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
18 Granada;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QIII;15.044
18 Granada;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QII;""
18 Granada;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QI;""
18 Granada;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
18 Granada;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
18 Granada;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QII;""
18 Granada;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QI;""
18 Granada;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
18 Granada;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
18 Granada;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
18 Granada;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
18 Granada;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
18 Granada;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
18 Granada;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
18 Granada;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
18 Granada;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
18 Granada;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
18 Granada;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
18 Granada;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
18 Granada;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;96,97
18 Granada;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
18 Granada;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
18 Granada;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
18 Granada;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;97,64
18 Granada;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
18 Granada;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
18 Granada;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
18 Granada;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;97,66
18 Granada;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
18 Granada;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
18 Granada;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
18 Granada;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
18 Granada;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
18 Granada;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
18 Granada;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;95,53
18 Granada;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
18 Granada;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
18 Granada;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
18 Granada;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;96,07
18 Granada;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
18 Granada;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
18 Granada;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
18 Granada;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
18 Granada;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
18 Granada;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
18 Granada;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;93,24
18 Granada;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
18 Granada;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
18 Granada;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
18 Granada;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;94,5
18 Granada;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
18 Granada;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
18 Granada;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
18 Granada;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
18 Granada;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
18 Granada;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
18 Granada;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;91,52
18 Granada;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
18 Granada;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
18 Granada;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
18 Granada;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;93,15
18 Granada;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
18 Granada;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
18 Granada;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
18 Granada;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
18 Granada;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
18 Granada;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
18 Granada;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QIV;10.940
18 Granada;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
18 Granada;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
18 Granada;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
18 Granada;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QIV;10.823
18 Granada;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
18 Granada;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
18 Granada;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
18 Granada;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QIV;10.514
18 Granada;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
18 Granada;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
18 Granada;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
18 Granada;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2022QIV;10.609
18 Granada;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
18 Granada;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2022QII;""
18 Granada;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2022QI;""
18 Granada;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2021QIV;10.567
18 Granada;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
18 Granada;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2021QII;""
18 Granada;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2021QI;""
18 Granada;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2020QIV;10.285
18 Granada;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
18 Granada;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2020QII;""
18 Granada;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2020QI;""
18 Granada;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
18 Granada;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
18 Granada;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2022QII;""
18 Granada;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2022QI;10.354
18 Granada;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
18 Granada;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
18 Granada;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2021QII;""
18 Granada;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2021QI;10.127
18 Granada;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
18 Granada;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
18 Granada;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2020QII;""
18 Granada;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2020QI;""
18 Granada;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
18 Granada;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
18 Granada;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QII;10.125
18 Granada;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QI;""
18 Granada;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
18 Granada;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
18 Granada;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QII;9.970
18 Granada;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QI;""
18 Granada;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
18 Granada;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
18 Granada;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QII;""
18 Granada;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QI;""
18 Granada;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
18 Granada;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QIII;9.956
18 Granada;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QII;""
18 Granada;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QI;""
18 Granada;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
18 Granada;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QIII;9.830
18 Granada;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QII;""
18 Granada;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QI;""
18 Granada;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
18 Granada;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
18 Granada;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QII;""
18 Granada;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QI;""
18 Granada;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
18 Granada;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
18 Granada;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
18 Granada;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
18 Granada;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
18 Granada;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
18 Granada;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
18 Granada;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
18 Granada;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
18 Granada;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
18 Granada;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
18 Granada;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
18 Granada;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;96,97
18 Granada;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
18 Granada;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
18 Granada;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
18 Granada;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;97,63
18 Granada;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
18 Granada;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
18 Granada;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
18 Granada;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;97,82
18 Granada;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
18 Granada;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
18 Granada;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
18 Granada;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
18 Granada;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
18 Granada;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
18 Granada;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;95,67
18 Granada;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
18 Granada;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
18 Granada;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
18 Granada;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;96,32
18 Granada;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
18 Granada;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
18 Granada;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
18 Granada;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
18 Granada;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
18 Granada;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
18 Granada;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;93,55
18 Granada;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
18 Granada;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
18 Granada;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
18 Granada;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;94,83
18 Granada;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
18 Granada;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
18 Granada;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
18 Granada;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
18 Granada;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
18 Granada;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
18 Granada;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;91,99
18 Granada;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
18 Granada;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
18 Granada;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
18 Granada;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;93,49
18 Granada;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
18 Granada;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
18 Granada;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
18 Granada;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
18 Granada;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
18 Granada;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
18 Granada;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QIV;6.024
18 Granada;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
18 Granada;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
18 Granada;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
18 Granada;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QIV;5.873
18 Granada;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
18 Granada;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
18 Granada;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
18 Granada;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QIV;5.636
18 Granada;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
18 Granada;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
18 Granada;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
18 Granada;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2022QIV;5.841
18 Granada;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
18 Granada;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2022QII;""
18 Granada;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2022QI;""
18 Granada;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2021QIV;5.735
18 Granada;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
18 Granada;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2021QII;""
18 Granada;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2021QI;""
18 Granada;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2020QIV;5.487
18 Granada;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
18 Granada;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2020QII;""
18 Granada;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2020QI;""
18 Granada;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
18 Granada;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
18 Granada;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2022QII;""
18 Granada;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2022QI;5.596
18 Granada;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
18 Granada;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
18 Granada;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2021QII;""
18 Granada;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2021QI;5.389
18 Granada;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
18 Granada;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
18 Granada;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2020QII;""
18 Granada;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2020QI;""
18 Granada;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
18 Granada;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
18 Granada;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QII;5.443
18 Granada;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QI;""
18 Granada;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
18 Granada;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
18 Granada;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QII;5.292
18 Granada;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QI;""
18 Granada;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
18 Granada;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
18 Granada;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QII;""
18 Granada;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QI;""
18 Granada;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
18 Granada;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QIII;5.324
18 Granada;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QII;""
18 Granada;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QI;""
18 Granada;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
18 Granada;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QIII;5.214
18 Granada;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QII;""
18 Granada;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QI;""
18 Granada;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
18 Granada;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
18 Granada;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QII;""
18 Granada;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QI;""
18 Granada;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
18 Granada;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
18 Granada;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
18 Granada;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
18 Granada;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
18 Granada;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
18 Granada;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
18 Granada;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
18 Granada;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
18 Granada;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
18 Granada;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
18 Granada;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
18 Granada;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;96,96
18 Granada;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
18 Granada;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
18 Granada;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
18 Granada;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;97,65
18 Granada;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
18 Granada;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
18 Granada;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
18 Granada;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;97,36
18 Granada;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
18 Granada;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
18 Granada;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
18 Granada;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
18 Granada;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
18 Granada;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
18 Granada;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;95,28
18 Granada;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
18 Granada;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
18 Granada;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
18 Granada;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;95,62
18 Granada;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
18 Granada;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
18 Granada;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
18 Granada;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
18 Granada;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
18 Granada;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
18 Granada;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;92,68
18 Granada;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
18 Granada;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
18 Granada;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
18 Granada;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;93,9
18 Granada;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
18 Granada;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
18 Granada;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
18 Granada;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
18 Granada;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
18 Granada;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
18 Granada;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;90,65
18 Granada;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
18 Granada;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
18 Granada;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
18 Granada;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;92,51
18 Granada;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
18 Granada;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
18 Granada;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
18 Granada;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
18 Granada;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
18 Granada;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
18 Granada;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
18 Granada;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
18 Granada;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
18 Granada;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QI;7.216
18 Granada;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
18 Granada;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
18 Granada;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
18 Granada;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QI;6.648
18 Granada;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
18 Granada;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
18 Granada;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
18 Granada;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QI;7.556
18 Granada;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
18 Granada;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
18 Granada;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2022QII;""
18 Granada;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2022QI;6.924
18 Granada;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
18 Granada;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
18 Granada;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2021QII;""
18 Granada;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2021QI;6.412
18 Granada;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
18 Granada;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
18 Granada;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2020QII;""
18 Granada;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2020QI;7.067
18 Granada;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
18 Granada;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
18 Granada;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2022QII;6.656
18 Granada;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2022QI;""
18 Granada;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
18 Granada;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
18 Granada;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2021QII;6.152
18 Granada;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2021QI;""
18 Granada;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
18 Granada;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
18 Granada;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2020QII;6.847
18 Granada;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2020QI;""
18 Granada;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
18 Granada;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QIII;6.378
18 Granada;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QII;""
18 Granada;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QI;""
18 Granada;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
18 Granada;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QIII;5.917
18 Granada;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QII;""
18 Granada;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QI;""
18 Granada;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
18 Granada;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QIII;6.564
18 Granada;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QII;""
18 Granada;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QI;""
18 Granada;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QIV;6.003
18 Granada;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
18 Granada;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QII;""
18 Granada;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QI;""
18 Granada;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QIV;5.635
18 Granada;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
18 Granada;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QII;""
18 Granada;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QI;""
18 Granada;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QIV;6.233
18 Granada;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
18 Granada;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QII;""
18 Granada;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QI;""
18 Granada;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
18 Granada;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
18 Granada;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
18 Granada;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
18 Granada;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
18 Granada;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
18 Granada;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
18 Granada;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
18 Granada;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
18 Granada;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
18 Granada;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
18 Granada;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
18 Granada;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
18 Granada;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
18 Granada;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
18 Granada;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;95,95
18 Granada;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
18 Granada;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
18 Granada;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
18 Granada;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;96,45
18 Granada;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
18 Granada;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
18 Granada;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
18 Granada;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;93,53
18 Granada;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
18 Granada;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
18 Granada;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;92,24
18 Granada;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
18 Granada;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
18 Granada;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
18 Granada;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;92,54
18 Granada;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
18 Granada;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
18 Granada;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
18 Granada;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;90,62
18 Granada;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
18 Granada;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
18 Granada;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;88,39
18 Granada;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
18 Granada;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
18 Granada;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
18 Granada;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;89
18 Granada;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
18 Granada;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
18 Granada;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
18 Granada;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;86,87
18 Granada;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
18 Granada;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
18 Granada;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;83,19
18 Granada;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
18 Granada;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
18 Granada;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
18 Granada;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;84,76
18 Granada;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
18 Granada;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
18 Granada;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
18 Granada;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;82,49
18 Granada;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
18 Granada;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
18 Granada;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
18 Granada;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
18 Granada;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
18 Granada;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
18 Granada;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QI;4.684
18 Granada;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
18 Granada;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
18 Granada;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
18 Granada;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QI;4.378
18 Granada;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
18 Granada;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
18 Granada;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
18 Granada;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QI;4.959
18 Granada;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
18 Granada;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
18 Granada;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2022QII;""
18 Granada;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2022QI;4.495
18 Granada;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
18 Granada;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
18 Granada;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2021QII;""
18 Granada;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2021QI;4.211
18 Granada;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
18 Granada;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
18 Granada;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2020QII;""
18 Granada;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2020QI;4.639
18 Granada;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
18 Granada;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
18 Granada;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2022QII;4.332
18 Granada;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2022QI;""
18 Granada;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
18 Granada;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
18 Granada;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2021QII;4.046
18 Granada;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2021QI;""
18 Granada;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
18 Granada;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
18 Granada;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2020QII;4.504
18 Granada;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2020QI;""
18 Granada;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
18 Granada;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QIII;4.142
18 Granada;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QII;""
18 Granada;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QI;""
18 Granada;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
18 Granada;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QIII;3.897
18 Granada;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QII;""
18 Granada;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QI;""
18 Granada;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
18 Granada;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QIII;4.337
18 Granada;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QII;""
18 Granada;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QI;""
18 Granada;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QIV;3.893
18 Granada;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
18 Granada;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QII;""
18 Granada;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QI;""
18 Granada;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QIV;3.705
18 Granada;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
18 Granada;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QII;""
18 Granada;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QI;""
18 Granada;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QIV;4.129
18 Granada;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
18 Granada;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QII;""
18 Granada;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QI;""
18 Granada;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
18 Granada;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
18 Granada;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
18 Granada;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
18 Granada;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
18 Granada;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
18 Granada;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
18 Granada;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
18 Granada;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
18 Granada;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
18 Granada;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
18 Granada;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
18 Granada;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
18 Granada;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
18 Granada;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
18 Granada;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;95,96
18 Granada;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
18 Granada;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
18 Granada;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
18 Granada;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;96,19
18 Granada;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
18 Granada;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
18 Granada;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
18 Granada;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;93,55
18 Granada;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
18 Granada;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
18 Granada;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;92,49
18 Granada;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
18 Granada;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
18 Granada;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
18 Granada;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;92,42
18 Granada;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
18 Granada;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
18 Granada;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
18 Granada;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;90,82
18 Granada;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
18 Granada;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
18 Granada;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;88,43
18 Granada;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
18 Granada;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
18 Granada;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
18 Granada;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;89,01
18 Granada;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
18 Granada;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
18 Granada;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
18 Granada;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;87,46
18 Granada;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
18 Granada;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
18 Granada;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;83,11
18 Granada;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
18 Granada;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
18 Granada;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
18 Granada;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;84,63
18 Granada;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
18 Granada;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
18 Granada;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
18 Granada;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;83,26
18 Granada;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
18 Granada;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
18 Granada;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
18 Granada;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
18 Granada;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
18 Granada;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
18 Granada;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QI;2.532
18 Granada;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
18 Granada;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
18 Granada;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
18 Granada;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QI;2.270
18 Granada;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
18 Granada;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
18 Granada;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
18 Granada;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QI;2.597
18 Granada;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
18 Granada;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
18 Granada;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2022QII;""
18 Granada;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2022QI;2.429
18 Granada;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
18 Granada;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
18 Granada;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2021QII;""
18 Granada;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2021QI;2.201
18 Granada;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
18 Granada;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
18 Granada;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2020QII;""
18 Granada;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2020QI;2.428
18 Granada;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
18 Granada;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
18 Granada;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2022QII;2.324
18 Granada;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2022QI;""
18 Granada;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
18 Granada;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
18 Granada;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2021QII;2.106
18 Granada;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2021QI;""
18 Granada;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
18 Granada;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
18 Granada;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2020QII;2.343
18 Granada;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2020QI;""
18 Granada;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
18 Granada;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QIII;2.236
18 Granada;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QII;""
18 Granada;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QI;""
18 Granada;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
18 Granada;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QIII;2.020
18 Granada;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QII;""
18 Granada;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QI;""
18 Granada;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
18 Granada;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QIII;2.227
18 Granada;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QII;""
18 Granada;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QI;""
18 Granada;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QIV;2.110
18 Granada;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
18 Granada;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QII;""
18 Granada;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QI;""
18 Granada;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QIV;1.930
18 Granada;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
18 Granada;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QII;""
18 Granada;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QI;""
18 Granada;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QIV;2.104
18 Granada;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
18 Granada;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QII;""
18 Granada;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QI;""
18 Granada;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
18 Granada;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
18 Granada;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
18 Granada;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
18 Granada;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
18 Granada;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
18 Granada;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
18 Granada;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
18 Granada;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
18 Granada;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
18 Granada;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
18 Granada;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
18 Granada;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
18 Granada;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
18 Granada;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
18 Granada;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;95,93
18 Granada;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
18 Granada;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
18 Granada;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
18 Granada;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;96,96
18 Granada;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
18 Granada;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
18 Granada;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
18 Granada;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;93,49
18 Granada;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
18 Granada;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
18 Granada;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;91,79
18 Granada;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
18 Granada;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
18 Granada;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
18 Granada;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;92,78
18 Granada;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
18 Granada;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
18 Granada;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
18 Granada;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;90,22
18 Granada;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
18 Granada;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
18 Granada;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;88,31
18 Granada;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
18 Granada;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
18 Granada;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
18 Granada;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;88,99
18 Granada;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
18 Granada;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
18 Granada;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
18 Granada;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;85,75
18 Granada;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
18 Granada;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
18 Granada;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;83,33
18 Granada;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
18 Granada;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
18 Granada;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
18 Granada;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;85,02
18 Granada;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
18 Granada;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
18 Granada;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
18 Granada;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;81,02
18 Granada;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
18 Granada;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
18 Granada;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
18 Granada;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
18 Granada;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
18 Granada;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QII;8.355
18 Granada;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
18 Granada;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
18 Granada;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
18 Granada;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QII;7.780
18 Granada;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
18 Granada;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
18 Granada;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
18 Granada;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QII;7.286
18 Granada;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
18 Granada;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
18 Granada;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
18 Granada;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2022QII;8.032
18 Granada;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2022QI;""
18 Granada;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
18 Granada;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
18 Granada;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2021QII;7.499
18 Granada;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2021QI;""
18 Granada;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
18 Granada;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
18 Granada;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2020QII;7.055
18 Granada;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2020QI;""
18 Granada;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
18 Granada;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2022QIII;7.729
18 Granada;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2022QII;""
18 Granada;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2022QI;""
18 Granada;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
18 Granada;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2021QIII;7.240
18 Granada;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2021QII;""
18 Granada;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2021QI;""
18 Granada;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
18 Granada;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2020QIII;6.726
18 Granada;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2020QII;""
18 Granada;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2020QI;""
18 Granada;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QIV;7.322
18 Granada;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
18 Granada;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QII;""
18 Granada;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QI;""
18 Granada;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QIV;6.925
18 Granada;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
18 Granada;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QII;""
18 Granada;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QI;""
18 Granada;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QIV;6.385
18 Granada;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
18 Granada;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QII;""
18 Granada;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QI;""
18 Granada;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
18 Granada;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
18 Granada;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QII;""
18 Granada;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QI;6.662
18 Granada;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
18 Granada;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
18 Granada;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QII;""
18 Granada;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QI;6.178
18 Granada;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
18 Granada;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
18 Granada;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QII;""
18 Granada;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QI;""
18 Granada;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
18 Granada;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
18 Granada;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
18 Granada;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
18 Granada;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
18 Granada;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
18 Granada;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
18 Granada;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
18 Granada;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
18 Granada;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
18 Granada;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
18 Granada;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
18 Granada;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
18 Granada;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
18 Granada;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;96,13
18 Granada;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
18 Granada;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
18 Granada;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
18 Granada;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;96,39
18 Granada;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
18 Granada;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
18 Granada;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
18 Granada;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;96,83
18 Granada;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
18 Granada;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
18 Granada;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;92,51
18 Granada;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
18 Granada;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
18 Granada;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
18 Granada;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;93,06
18 Granada;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
18 Granada;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
18 Granada;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
18 Granada;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;92,31
18 Granada;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
18 Granada;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
18 Granada;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;87,64
18 Granada;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
18 Granada;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
18 Granada;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
18 Granada;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;89,01
18 Granada;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
18 Granada;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
18 Granada;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
18 Granada;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;87,63
18 Granada;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
18 Granada;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
18 Granada;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
18 Granada;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
18 Granada;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
18 Granada;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
18 Granada;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;85,63
18 Granada;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
18 Granada;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
18 Granada;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
18 Granada;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;84,79
18 Granada;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
18 Granada;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
18 Granada;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
18 Granada;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
18 Granada;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
18 Granada;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
18 Granada;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QII;5.413
18 Granada;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
18 Granada;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
18 Granada;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
18 Granada;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QII;5.085
18 Granada;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
18 Granada;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
18 Granada;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
18 Granada;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QII;4.770
18 Granada;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
18 Granada;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
18 Granada;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
18 Granada;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2022QII;5.217
18 Granada;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2022QI;""
18 Granada;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
18 Granada;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
18 Granada;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2021QII;4.905
18 Granada;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2021QI;""
18 Granada;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
18 Granada;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
18 Granada;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2020QII;4.627
18 Granada;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2020QI;""
18 Granada;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
18 Granada;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2022QIII;5.012
18 Granada;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2022QII;""
18 Granada;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2022QI;""
18 Granada;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
18 Granada;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2021QIII;4.742
18 Granada;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2021QII;""
18 Granada;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2021QI;""
18 Granada;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
18 Granada;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2020QIII;4.430
18 Granada;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2020QII;""
18 Granada;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2020QI;""
18 Granada;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QIV;4.746
18 Granada;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
18 Granada;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QII;""
18 Granada;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QI;""
18 Granada;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QIV;4.532
18 Granada;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
18 Granada;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QII;""
18 Granada;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QI;""
18 Granada;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QIV;4.215
18 Granada;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
18 Granada;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QII;""
18 Granada;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QI;""
18 Granada;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
18 Granada;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
18 Granada;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QII;""
18 Granada;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QI;4.360
18 Granada;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
18 Granada;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
18 Granada;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QII;""
18 Granada;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QI;4.069
18 Granada;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
18 Granada;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
18 Granada;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QII;""
18 Granada;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QI;""
18 Granada;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
18 Granada;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
18 Granada;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
18 Granada;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
18 Granada;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
18 Granada;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
18 Granada;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
18 Granada;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
18 Granada;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
18 Granada;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
18 Granada;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
18 Granada;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
18 Granada;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
18 Granada;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
18 Granada;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;96,38
18 Granada;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
18 Granada;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
18 Granada;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
18 Granada;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;96,46
18 Granada;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
18 Granada;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
18 Granada;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
18 Granada;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;97
18 Granada;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
18 Granada;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
18 Granada;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;92,59
18 Granada;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
18 Granada;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
18 Granada;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
18 Granada;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;93,25
18 Granada;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
18 Granada;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
18 Granada;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
18 Granada;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;92,87
18 Granada;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
18 Granada;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
18 Granada;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;87,68
18 Granada;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
18 Granada;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
18 Granada;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
18 Granada;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;89,12
18 Granada;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
18 Granada;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
18 Granada;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
18 Granada;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;88,36
18 Granada;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
18 Granada;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
18 Granada;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
18 Granada;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
18 Granada;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
18 Granada;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
18 Granada;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;85,74
18 Granada;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
18 Granada;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
18 Granada;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
18 Granada;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;85,3
18 Granada;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
18 Granada;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
18 Granada;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
18 Granada;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
18 Granada;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
18 Granada;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
18 Granada;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QII;2.942
18 Granada;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
18 Granada;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
18 Granada;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
18 Granada;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QII;2.695
18 Granada;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
18 Granada;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
18 Granada;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
18 Granada;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QII;2.516
18 Granada;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
18 Granada;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
18 Granada;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
18 Granada;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2022QII;2.815
18 Granada;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2022QI;""
18 Granada;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
18 Granada;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
18 Granada;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2021QII;2.594
18 Granada;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2021QI;""
18 Granada;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
18 Granada;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
18 Granada;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2020QII;2.428
18 Granada;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2020QI;""
18 Granada;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
18 Granada;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2022QIII;2.717
18 Granada;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2022QII;""
18 Granada;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2022QI;""
18 Granada;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
18 Granada;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2021QIII;2.498
18 Granada;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2021QII;""
18 Granada;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2021QI;""
18 Granada;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
18 Granada;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2020QIII;2.296
18 Granada;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2020QII;""
18 Granada;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2020QI;""
18 Granada;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QIV;2.576
18 Granada;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
18 Granada;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QII;""
18 Granada;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QI;""
18 Granada;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QIV;2.393
18 Granada;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
18 Granada;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QII;""
18 Granada;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QI;""
18 Granada;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QIV;2.170
18 Granada;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
18 Granada;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QII;""
18 Granada;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QI;""
18 Granada;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
18 Granada;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
18 Granada;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QII;""
18 Granada;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QI;2.302
18 Granada;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
18 Granada;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
18 Granada;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QII;""
18 Granada;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QI;2.109
18 Granada;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
18 Granada;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
18 Granada;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QII;""
18 Granada;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QI;""
18 Granada;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
18 Granada;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
18 Granada;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
18 Granada;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
18 Granada;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
18 Granada;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
18 Granada;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
18 Granada;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
18 Granada;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
18 Granada;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
18 Granada;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
18 Granada;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
18 Granada;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
18 Granada;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
18 Granada;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;95,68
18 Granada;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
18 Granada;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
18 Granada;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
18 Granada;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;96,25
18 Granada;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
18 Granada;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
18 Granada;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
18 Granada;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;96,5
18 Granada;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
18 Granada;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
18 Granada;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;92,35
18 Granada;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
18 Granada;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
18 Granada;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
18 Granada;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;92,69
18 Granada;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
18 Granada;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
18 Granada;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
18 Granada;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;91,26
18 Granada;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
18 Granada;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
18 Granada;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;87,56
18 Granada;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
18 Granada;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
18 Granada;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
18 Granada;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;88,79
18 Granada;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
18 Granada;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
18 Granada;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
18 Granada;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;86,25
18 Granada;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
18 Granada;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
18 Granada;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
18 Granada;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
18 Granada;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
18 Granada;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
18 Granada;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;85,42
18 Granada;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
18 Granada;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
18 Granada;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
18 Granada;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;83,82
18 Granada;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
18 Granada;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
18 Granada;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
18 Granada;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
18 Granada;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
18 Granada;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QIII;8.155
18 Granada;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
18 Granada;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
18 Granada;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
18 Granada;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QIII;7.632
18 Granada;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
18 Granada;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
18 Granada;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
18 Granada;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QIII;7.157
18 Granada;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
18 Granada;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
18 Granada;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
18 Granada;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2022QIII;7.824
18 Granada;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2022QII;""
18 Granada;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2022QI;""
18 Granada;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
18 Granada;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2021QIII;7.340
18 Granada;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2021QII;""
18 Granada;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2021QI;""
18 Granada;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
18 Granada;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2020QIII;6.801
18 Granada;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2020QII;""
18 Granada;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2020QI;""
18 Granada;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2022QIV;7.395
18 Granada;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
18 Granada;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2022QII;""
18 Granada;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2022QI;""
18 Granada;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2021QIV;7.013
18 Granada;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
18 Granada;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2021QII;""
18 Granada;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2021QI;""
18 Granada;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2020QIV;6.451
18 Granada;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
18 Granada;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2020QII;""
18 Granada;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2020QI;""
18 Granada;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
18 Granada;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
18 Granada;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QII;""
18 Granada;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QI;6.744
18 Granada;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
18 Granada;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
18 Granada;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QII;""
18 Granada;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QI;6.242
18 Granada;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
18 Granada;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
18 Granada;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QII;""
18 Granada;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QI;""
18 Granada;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
18 Granada;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
18 Granada;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QII;6.502
18 Granada;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QI;""
18 Granada;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
18 Granada;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
18 Granada;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QII;6.009
18 Granada;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QI;""
18 Granada;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
18 Granada;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
18 Granada;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QII;""
18 Granada;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QI;""
18 Granada;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
18 Granada;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
18 Granada;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
18 Granada;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
18 Granada;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
18 Granada;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
18 Granada;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
18 Granada;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
18 Granada;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
18 Granada;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
18 Granada;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
18 Granada;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
18 Granada;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
18 Granada;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;95,94
18 Granada;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
18 Granada;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
18 Granada;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
18 Granada;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;96,17
18 Granada;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
18 Granada;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
18 Granada;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
18 Granada;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;95,03
18 Granada;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
18 Granada;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
18 Granada;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;90,68
18 Granada;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
18 Granada;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
18 Granada;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
18 Granada;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;91,89
18 Granada;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
18 Granada;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
18 Granada;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
18 Granada;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;90,14
18 Granada;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
18 Granada;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
18 Granada;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
18 Granada;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
18 Granada;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
18 Granada;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
18 Granada;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;88,36
18 Granada;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
18 Granada;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
18 Granada;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
18 Granada;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;87,22
18 Granada;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
18 Granada;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
18 Granada;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
18 Granada;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
18 Granada;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
18 Granada;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
18 Granada;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;85,19
18 Granada;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
18 Granada;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
18 Granada;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
18 Granada;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;83,96
18 Granada;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
18 Granada;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
18 Granada;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
18 Granada;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
18 Granada;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
18 Granada;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
18 Granada;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QIII;5.279
18 Granada;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
18 Granada;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
18 Granada;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
18 Granada;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QIII;4.972
18 Granada;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
18 Granada;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
18 Granada;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
18 Granada;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QIII;4.691
18 Granada;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
18 Granada;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
18 Granada;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
18 Granada;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2022QIII;5.061
18 Granada;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2022QII;""
18 Granada;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2022QI;""
18 Granada;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
18 Granada;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2021QIII;4.791
18 Granada;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2021QII;""
18 Granada;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2021QI;""
18 Granada;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
18 Granada;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2020QIII;4.484
18 Granada;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2020QII;""
18 Granada;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2020QI;""
18 Granada;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2022QIV;4.784
18 Granada;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
18 Granada;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2022QII;""
18 Granada;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2022QI;""
18 Granada;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2021QIV;4.572
18 Granada;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
18 Granada;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2021QII;""
18 Granada;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2021QI;""
18 Granada;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2020QIV;4.260
18 Granada;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
18 Granada;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2020QII;""
18 Granada;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2020QI;""
18 Granada;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
18 Granada;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
18 Granada;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QII;""
18 Granada;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QI;4.397
18 Granada;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
18 Granada;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
18 Granada;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QII;""
18 Granada;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QI;4.112
18 Granada;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
18 Granada;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
18 Granada;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QII;""
18 Granada;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QI;""
18 Granada;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
18 Granada;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
18 Granada;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QII;4.248
18 Granada;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QI;""
18 Granada;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
18 Granada;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
18 Granada;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QII;3.963
18 Granada;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QI;""
18 Granada;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
18 Granada;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
18 Granada;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QII;""
18 Granada;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QI;""
18 Granada;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
18 Granada;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
18 Granada;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
18 Granada;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
18 Granada;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
18 Granada;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
18 Granada;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
18 Granada;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
18 Granada;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
18 Granada;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
18 Granada;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
18 Granada;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
18 Granada;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
18 Granada;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;95,87
18 Granada;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
18 Granada;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
18 Granada;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
18 Granada;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;96,36
18 Granada;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
18 Granada;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
18 Granada;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
18 Granada;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;95,59
18 Granada;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
18 Granada;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
18 Granada;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;90,62
18 Granada;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
18 Granada;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
18 Granada;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
18 Granada;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;91,95
18 Granada;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
18 Granada;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
18 Granada;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
18 Granada;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;90,81
18 Granada;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
18 Granada;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
18 Granada;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
18 Granada;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
18 Granada;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
18 Granada;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
18 Granada;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;88,44
18 Granada;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
18 Granada;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
18 Granada;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
18 Granada;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;87,66
18 Granada;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
18 Granada;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
18 Granada;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
18 Granada;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
18 Granada;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
18 Granada;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
18 Granada;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;85,44
18 Granada;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
18 Granada;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
18 Granada;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
18 Granada;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;84,48
18 Granada;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
18 Granada;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
18 Granada;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
18 Granada;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
18 Granada;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
18 Granada;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
18 Granada;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QIII;2.876
18 Granada;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
18 Granada;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
18 Granada;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
18 Granada;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QIII;2.660
18 Granada;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
18 Granada;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
18 Granada;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
18 Granada;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QIII;2.466
18 Granada;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
18 Granada;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
18 Granada;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
18 Granada;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2022QIII;2.763
18 Granada;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2022QII;""
18 Granada;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2022QI;""
18 Granada;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
18 Granada;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2021QIII;2.549
18 Granada;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2021QII;""
18 Granada;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2021QI;""
18 Granada;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
18 Granada;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2020QIII;2.317
18 Granada;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2020QII;""
18 Granada;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2020QI;""
18 Granada;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2022QIV;2.611
18 Granada;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
18 Granada;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2022QII;""
18 Granada;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2022QI;""
18 Granada;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2021QIV;2.441
18 Granada;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
18 Granada;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2021QII;""
18 Granada;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2021QI;""
18 Granada;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2020QIV;2.191
18 Granada;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
18 Granada;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2020QII;""
18 Granada;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2020QI;""
18 Granada;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
18 Granada;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
18 Granada;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QII;""
18 Granada;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QI;2.347
18 Granada;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
18 Granada;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
18 Granada;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QII;""
18 Granada;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QI;2.130
18 Granada;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
18 Granada;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
18 Granada;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QII;""
18 Granada;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QI;""
18 Granada;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
18 Granada;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
18 Granada;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QII;2.254
18 Granada;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QI;""
18 Granada;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
18 Granada;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
18 Granada;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QII;2.046
18 Granada;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QI;""
18 Granada;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
18 Granada;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
18 Granada;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QII;""
18 Granada;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QI;""
18 Granada;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
18 Granada;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
18 Granada;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
18 Granada;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
18 Granada;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
18 Granada;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
18 Granada;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
18 Granada;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
18 Granada;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
18 Granada;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
18 Granada;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
18 Granada;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
18 Granada;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
18 Granada;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;96,07
18 Granada;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
18 Granada;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
18 Granada;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
18 Granada;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;95,83
18 Granada;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
18 Granada;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
18 Granada;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
18 Granada;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;93,96
18 Granada;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
18 Granada;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
18 Granada;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;90,79
18 Granada;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
18 Granada;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
18 Granada;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
18 Granada;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;91,77
18 Granada;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
18 Granada;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
18 Granada;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
18 Granada;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;88,85
18 Granada;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
18 Granada;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
18 Granada;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
18 Granada;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
18 Granada;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
18 Granada;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
18 Granada;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;88,23
18 Granada;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
18 Granada;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
18 Granada;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
18 Granada;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;86,37
18 Granada;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
18 Granada;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
18 Granada;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
18 Granada;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
18 Granada;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
18 Granada;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
18 Granada;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;84,74
18 Granada;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
18 Granada;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
18 Granada;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
18 Granada;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;82,97
18 Granada;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
18 Granada;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
18 Granada;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
18 Granada;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
18 Granada;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
18 Granada;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QIV;7.917
18 Granada;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
18 Granada;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
18 Granada;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
18 Granada;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QIV;7.435
18 Granada;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
18 Granada;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
18 Granada;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
18 Granada;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QIV;6.896
18 Granada;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
18 Granada;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
18 Granada;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
18 Granada;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2022QIV;7.473
18 Granada;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
18 Granada;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2022QII;""
18 Granada;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2022QI;""
18 Granada;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2021QIV;7.091
18 Granada;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
18 Granada;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2021QII;""
18 Granada;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2021QI;""
18 Granada;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2020QIV;6.529
18 Granada;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
18 Granada;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2020QII;""
18 Granada;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2020QI;""
18 Granada;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
18 Granada;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
18 Granada;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2022QII;""
18 Granada;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2022QI;6.820
18 Granada;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
18 Granada;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
18 Granada;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2021QII;""
18 Granada;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2021QI;6.308
18 Granada;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
18 Granada;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
18 Granada;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2020QII;""
18 Granada;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2020QI;""
18 Granada;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
18 Granada;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
18 Granada;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QII;6.574
18 Granada;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QI;""
18 Granada;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
18 Granada;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
18 Granada;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QII;6.070
18 Granada;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QI;""
18 Granada;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
18 Granada;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
18 Granada;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QII;""
18 Granada;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QI;""
18 Granada;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
18 Granada;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QIII;6.307
18 Granada;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QII;""
18 Granada;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QI;""
18 Granada;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
18 Granada;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QIII;5.842
18 Granada;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QII;""
18 Granada;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QI;""
18 Granada;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
18 Granada;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
18 Granada;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QII;""
18 Granada;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QI;""
18 Granada;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
18 Granada;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
18 Granada;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
18 Granada;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
18 Granada;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
18 Granada;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
18 Granada;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
18 Granada;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
18 Granada;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
18 Granada;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
18 Granada;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
18 Granada;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
18 Granada;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;94,39
18 Granada;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
18 Granada;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
18 Granada;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
18 Granada;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;95,37
18 Granada;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
18 Granada;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
18 Granada;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
18 Granada;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;94,68
18 Granada;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
18 Granada;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
18 Granada;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
18 Granada;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
18 Granada;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
18 Granada;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
18 Granada;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;91,73
18 Granada;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
18 Granada;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
18 Granada;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
18 Granada;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;91,47
18 Granada;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
18 Granada;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
18 Granada;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
18 Granada;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
18 Granada;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
18 Granada;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
18 Granada;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;88,42
18 Granada;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
18 Granada;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
18 Granada;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
18 Granada;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;88,02
18 Granada;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
18 Granada;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
18 Granada;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
18 Granada;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
18 Granada;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
18 Granada;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
18 Granada;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;84,83
18 Granada;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
18 Granada;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
18 Granada;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
18 Granada;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;84,72
18 Granada;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
18 Granada;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
18 Granada;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
18 Granada;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
18 Granada;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
18 Granada;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
18 Granada;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QIV;5.119
18 Granada;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
18 Granada;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
18 Granada;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
18 Granada;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QIV;4.846
18 Granada;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
18 Granada;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
18 Granada;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
18 Granada;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QIV;4.542
18 Granada;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
18 Granada;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
18 Granada;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
18 Granada;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2022QIV;4.829
18 Granada;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
18 Granada;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2022QII;""
18 Granada;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2022QI;""
18 Granada;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2021QIV;4.615
18 Granada;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
18 Granada;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2021QII;""
18 Granada;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2021QI;""
18 Granada;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2020QIV;4.307
18 Granada;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
18 Granada;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2020QII;""
18 Granada;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2020QI;""
18 Granada;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
18 Granada;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
18 Granada;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2022QII;""
18 Granada;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2022QI;4.439
18 Granada;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
18 Granada;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
18 Granada;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2021QII;""
18 Granada;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2021QI;4.151
18 Granada;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
18 Granada;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
18 Granada;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2020QII;""
18 Granada;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2020QI;""
18 Granada;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
18 Granada;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
18 Granada;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QII;4.286
18 Granada;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QI;""
18 Granada;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
18 Granada;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
18 Granada;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QII;3.998
18 Granada;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QI;""
18 Granada;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
18 Granada;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
18 Granada;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QII;""
18 Granada;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QI;""
18 Granada;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
18 Granada;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QIII;4.106
18 Granada;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QII;""
18 Granada;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QI;""
18 Granada;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
18 Granada;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QIII;3.852
18 Granada;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QII;""
18 Granada;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QI;""
18 Granada;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
18 Granada;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
18 Granada;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QII;""
18 Granada;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QI;""
18 Granada;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
18 Granada;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
18 Granada;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
18 Granada;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
18 Granada;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
18 Granada;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
18 Granada;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
18 Granada;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
18 Granada;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
18 Granada;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
18 Granada;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
18 Granada;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
18 Granada;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;94,33
18 Granada;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
18 Granada;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
18 Granada;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
18 Granada;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;95,23
18 Granada;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
18 Granada;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
18 Granada;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
18 Granada;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;94,83
18 Granada;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
18 Granada;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
18 Granada;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
18 Granada;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
18 Granada;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
18 Granada;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
18 Granada;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;91,6
18 Granada;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
18 Granada;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
18 Granada;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
18 Granada;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;91,39
18 Granada;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
18 Granada;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
18 Granada;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
18 Granada;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
18 Granada;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
18 Granada;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
18 Granada;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;88,44
18 Granada;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
18 Granada;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
18 Granada;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
18 Granada;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;88,02
18 Granada;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
18 Granada;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
18 Granada;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
18 Granada;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
18 Granada;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
18 Granada;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
18 Granada;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;84,73
18 Granada;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
18 Granada;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
18 Granada;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
18 Granada;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;84,81
18 Granada;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
18 Granada;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
18 Granada;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
18 Granada;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
18 Granada;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
18 Granada;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
18 Granada;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QIV;2.798
18 Granada;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
18 Granada;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
18 Granada;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
18 Granada;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QIV;2.589
18 Granada;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
18 Granada;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
18 Granada;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
18 Granada;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QIV;2.354
18 Granada;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
18 Granada;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
18 Granada;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
18 Granada;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2022QIV;2.644
18 Granada;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
18 Granada;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2022QII;""
18 Granada;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2022QI;""
18 Granada;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2021QIV;2.476
18 Granada;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
18 Granada;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2021QII;""
18 Granada;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2021QI;""
18 Granada;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2020QIV;2.222
18 Granada;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
18 Granada;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2020QII;""
18 Granada;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2020QI;""
18 Granada;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
18 Granada;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
18 Granada;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2022QII;""
18 Granada;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2022QI;2.381
18 Granada;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
18 Granada;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
18 Granada;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2021QII;""
18 Granada;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2021QI;2.157
18 Granada;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
18 Granada;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
18 Granada;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2020QII;""
18 Granada;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2020QI;""
18 Granada;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
18 Granada;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
18 Granada;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QII;2.288
18 Granada;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QI;""
18 Granada;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
18 Granada;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
18 Granada;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QII;2.072
18 Granada;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QI;""
18 Granada;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
18 Granada;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
18 Granada;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QII;""
18 Granada;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QI;""
18 Granada;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
18 Granada;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QIII;2.201
18 Granada;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QII;""
18 Granada;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QI;""
18 Granada;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
18 Granada;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QIII;1.990
18 Granada;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QII;""
18 Granada;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QI;""
18 Granada;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
18 Granada;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
18 Granada;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QII;""
18 Granada;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QI;""
18 Granada;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
18 Granada;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
18 Granada;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
18 Granada;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
18 Granada;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
18 Granada;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
18 Granada;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
18 Granada;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
18 Granada;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
18 Granada;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
18 Granada;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
18 Granada;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
18 Granada;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;94,5
18 Granada;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
18 Granada;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
18 Granada;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
18 Granada;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;95,64
18 Granada;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
18 Granada;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
18 Granada;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
18 Granada;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;94,39
18 Granada;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
18 Granada;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
18 Granada;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
18 Granada;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
18 Granada;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
18 Granada;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
18 Granada;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;91,97
18 Granada;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
18 Granada;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
18 Granada;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
18 Granada;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;91,63
18 Granada;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
18 Granada;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
18 Granada;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
18 Granada;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
18 Granada;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
18 Granada;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
18 Granada;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;88,37
18 Granada;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
18 Granada;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
18 Granada;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
18 Granada;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;88,02
18 Granada;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
18 Granada;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
18 Granada;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
18 Granada;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
18 Granada;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
18 Granada;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
18 Granada;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;85,01
18 Granada;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
18 Granada;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
18 Granada;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
18 Granada;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;84,54
18 Granada;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
18 Granada;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
18 Granada;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
18 Granada;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
18 Granada;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
18 Granada;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
19 Guadalajara;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
19 Guadalajara;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
19 Guadalajara;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
19 Guadalajara;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QI;13.417
19 Guadalajara;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
19 Guadalajara;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
19 Guadalajara;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
19 Guadalajara;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QI;13.086
19 Guadalajara;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
19 Guadalajara;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
19 Guadalajara;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
19 Guadalajara;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QI;13.130
19 Guadalajara;All ages;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
19 Guadalajara;All ages;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
19 Guadalajara;All ages;Cohort January 1;Total;Survival in the first trimester;2022QII;""
19 Guadalajara;All ages;Cohort January 1;Total;Survival in the first trimester;2022QI;12.964
19 Guadalajara;All ages;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
19 Guadalajara;All ages;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
19 Guadalajara;All ages;Cohort January 1;Total;Survival in the first trimester;2021QII;""
19 Guadalajara;All ages;Cohort January 1;Total;Survival in the first trimester;2021QI;12.729
19 Guadalajara;All ages;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
19 Guadalajara;All ages;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
19 Guadalajara;All ages;Cohort January 1;Total;Survival in the first trimester;2020QII;""
19 Guadalajara;All ages;Cohort January 1;Total;Survival in the first trimester;2020QI;12.166
19 Guadalajara;All ages;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
19 Guadalajara;All ages;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
19 Guadalajara;All ages;Cohort January 1;Total;Survival in the second trimester;2022QII;12.506
19 Guadalajara;All ages;Cohort January 1;Total;Survival in the second trimester;2022QI;""
19 Guadalajara;All ages;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
19 Guadalajara;All ages;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
19 Guadalajara;All ages;Cohort January 1;Total;Survival in the second trimester;2021QII;12.368
19 Guadalajara;All ages;Cohort January 1;Total;Survival in the second trimester;2021QI;""
19 Guadalajara;All ages;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
19 Guadalajara;All ages;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
19 Guadalajara;All ages;Cohort January 1;Total;Survival in the second trimester;2020QII;11.922
19 Guadalajara;All ages;Cohort January 1;Total;Survival in the second trimester;2020QI;""
19 Guadalajara;All ages;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
19 Guadalajara;All ages;Cohort January 1;Total;Survival in the third trimester;2022QIII;12.110
19 Guadalajara;All ages;Cohort January 1;Total;Survival in the third trimester;2022QII;""
19 Guadalajara;All ages;Cohort January 1;Total;Survival in the third trimester;2022QI;""
19 Guadalajara;All ages;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
19 Guadalajara;All ages;Cohort January 1;Total;Survival in the third trimester;2021QIII;12.038
19 Guadalajara;All ages;Cohort January 1;Total;Survival in the third trimester;2021QII;""
19 Guadalajara;All ages;Cohort January 1;Total;Survival in the third trimester;2021QI;""
19 Guadalajara;All ages;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
19 Guadalajara;All ages;Cohort January 1;Total;Survival in the third trimester;2020QIII;11.617
19 Guadalajara;All ages;Cohort January 1;Total;Survival in the third trimester;2020QII;""
19 Guadalajara;All ages;Cohort January 1;Total;Survival in the third trimester;2020QI;""
19 Guadalajara;All ages;Cohort January 1;Total;Survival in the third trimester;2022QIV;11.697
19 Guadalajara;All ages;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
19 Guadalajara;All ages;Cohort January 1;Total;Survival in the third trimester;2022QII;""
19 Guadalajara;All ages;Cohort January 1;Total;Survival in the third trimester;2022QI;""
19 Guadalajara;All ages;Cohort January 1;Total;Survival in the third trimester;2021QIV;11.697
19 Guadalajara;All ages;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
19 Guadalajara;All ages;Cohort January 1;Total;Survival in the third trimester;2021QII;""
19 Guadalajara;All ages;Cohort January 1;Total;Survival in the third trimester;2021QI;""
19 Guadalajara;All ages;Cohort January 1;Total;Survival in the third trimester;2020QIV;11.310
19 Guadalajara;All ages;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
19 Guadalajara;All ages;Cohort January 1;Total;Survival in the third trimester;2020QII;""
19 Guadalajara;All ages;Cohort January 1;Total;Survival in the third trimester;2020QI;""
19 Guadalajara;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
19 Guadalajara;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
19 Guadalajara;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
19 Guadalajara;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
19 Guadalajara;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
19 Guadalajara;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
19 Guadalajara;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
19 Guadalajara;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
19 Guadalajara;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
19 Guadalajara;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
19 Guadalajara;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
19 Guadalajara;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
19 Guadalajara;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
19 Guadalajara;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
19 Guadalajara;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
19 Guadalajara;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;96,62
19 Guadalajara;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
19 Guadalajara;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
19 Guadalajara;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
19 Guadalajara;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;97,27
19 Guadalajara;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
19 Guadalajara;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
19 Guadalajara;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
19 Guadalajara;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;92,66
19 Guadalajara;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
19 Guadalajara;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
19 Guadalajara;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;93,21
19 Guadalajara;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
19 Guadalajara;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
19 Guadalajara;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
19 Guadalajara;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;94,51
19 Guadalajara;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
19 Guadalajara;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
19 Guadalajara;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
19 Guadalajara;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;90,8
19 Guadalajara;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
19 Guadalajara;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
19 Guadalajara;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;90,26
19 Guadalajara;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
19 Guadalajara;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
19 Guadalajara;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
19 Guadalajara;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;91,99
19 Guadalajara;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
19 Guadalajara;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
19 Guadalajara;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
19 Guadalajara;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;88,48
19 Guadalajara;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
19 Guadalajara;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
19 Guadalajara;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;87,18
19 Guadalajara;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
19 Guadalajara;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
19 Guadalajara;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
19 Guadalajara;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;89,39
19 Guadalajara;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
19 Guadalajara;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
19 Guadalajara;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
19 Guadalajara;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;86,14
19 Guadalajara;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
19 Guadalajara;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
19 Guadalajara;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
19 Guadalajara;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
19 Guadalajara;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
19 Guadalajara;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
19 Guadalajara;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QI;8.836
19 Guadalajara;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
19 Guadalajara;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
19 Guadalajara;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
19 Guadalajara;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QI;8.647
19 Guadalajara;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
19 Guadalajara;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
19 Guadalajara;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
19 Guadalajara;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QI;8.706
19 Guadalajara;All ages;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
19 Guadalajara;All ages;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
19 Guadalajara;All ages;Cohort January 1;Males;Survival in the first trimester;2022QII;""
19 Guadalajara;All ages;Cohort January 1;Males;Survival in the first trimester;2022QI;8.559
19 Guadalajara;All ages;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
19 Guadalajara;All ages;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
19 Guadalajara;All ages;Cohort January 1;Males;Survival in the first trimester;2021QII;""
19 Guadalajara;All ages;Cohort January 1;Males;Survival in the first trimester;2021QI;8.430
19 Guadalajara;All ages;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
19 Guadalajara;All ages;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
19 Guadalajara;All ages;Cohort January 1;Males;Survival in the first trimester;2020QII;""
19 Guadalajara;All ages;Cohort January 1;Males;Survival in the first trimester;2020QI;8.098
19 Guadalajara;All ages;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
19 Guadalajara;All ages;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
19 Guadalajara;All ages;Cohort January 1;Males;Survival in the second trimester;2022QII;8.301
19 Guadalajara;All ages;Cohort January 1;Males;Survival in the second trimester;2022QI;""
19 Guadalajara;All ages;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
19 Guadalajara;All ages;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
19 Guadalajara;All ages;Cohort January 1;Males;Survival in the second trimester;2021QII;8.231
19 Guadalajara;All ages;Cohort January 1;Males;Survival in the second trimester;2021QI;""
19 Guadalajara;All ages;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
19 Guadalajara;All ages;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
19 Guadalajara;All ages;Cohort January 1;Males;Survival in the second trimester;2020QII;7.949
19 Guadalajara;All ages;Cohort January 1;Males;Survival in the second trimester;2020QI;""
19 Guadalajara;All ages;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
19 Guadalajara;All ages;Cohort January 1;Males;Survival in the third trimester;2022QIII;8.044
19 Guadalajara;All ages;Cohort January 1;Males;Survival in the third trimester;2022QII;""
19 Guadalajara;All ages;Cohort January 1;Males;Survival in the third trimester;2022QI;""
19 Guadalajara;All ages;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
19 Guadalajara;All ages;Cohort January 1;Males;Survival in the third trimester;2021QIII;8.034
19 Guadalajara;All ages;Cohort January 1;Males;Survival in the third trimester;2021QII;""
19 Guadalajara;All ages;Cohort January 1;Males;Survival in the third trimester;2021QI;""
19 Guadalajara;All ages;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
19 Guadalajara;All ages;Cohort January 1;Males;Survival in the third trimester;2020QIII;7.771
19 Guadalajara;All ages;Cohort January 1;Males;Survival in the third trimester;2020QII;""
19 Guadalajara;All ages;Cohort January 1;Males;Survival in the third trimester;2020QI;""
19 Guadalajara;All ages;Cohort January 1;Males;Survival in the third trimester;2022QIV;7.795
19 Guadalajara;All ages;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
19 Guadalajara;All ages;Cohort January 1;Males;Survival in the third trimester;2022QII;""
19 Guadalajara;All ages;Cohort January 1;Males;Survival in the third trimester;2022QI;""
19 Guadalajara;All ages;Cohort January 1;Males;Survival in the third trimester;2021QIV;7.826
19 Guadalajara;All ages;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
19 Guadalajara;All ages;Cohort January 1;Males;Survival in the third trimester;2021QII;""
19 Guadalajara;All ages;Cohort January 1;Males;Survival in the third trimester;2021QI;""
19 Guadalajara;All ages;Cohort January 1;Males;Survival in the third trimester;2020QIV;7.572
19 Guadalajara;All ages;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
19 Guadalajara;All ages;Cohort January 1;Males;Survival in the third trimester;2020QII;""
19 Guadalajara;All ages;Cohort January 1;Males;Survival in the third trimester;2020QI;""
19 Guadalajara;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
19 Guadalajara;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
19 Guadalajara;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
19 Guadalajara;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
19 Guadalajara;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
19 Guadalajara;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
19 Guadalajara;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
19 Guadalajara;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
19 Guadalajara;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
19 Guadalajara;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
19 Guadalajara;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
19 Guadalajara;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
19 Guadalajara;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
19 Guadalajara;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
19 Guadalajara;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
19 Guadalajara;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;96,87
19 Guadalajara;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
19 Guadalajara;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
19 Guadalajara;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
19 Guadalajara;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;97,49
19 Guadalajara;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
19 Guadalajara;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
19 Guadalajara;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
19 Guadalajara;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;93,02
19 Guadalajara;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
19 Guadalajara;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
19 Guadalajara;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;93,95
19 Guadalajara;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
19 Guadalajara;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
19 Guadalajara;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
19 Guadalajara;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;95,19
19 Guadalajara;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
19 Guadalajara;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
19 Guadalajara;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
19 Guadalajara;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;91,3
19 Guadalajara;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
19 Guadalajara;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
19 Guadalajara;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;91,04
19 Guadalajara;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
19 Guadalajara;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
19 Guadalajara;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
19 Guadalajara;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;92,91
19 Guadalajara;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
19 Guadalajara;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
19 Guadalajara;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
19 Guadalajara;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;89,26
19 Guadalajara;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
19 Guadalajara;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
19 Guadalajara;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;88,22
19 Guadalajara;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
19 Guadalajara;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
19 Guadalajara;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
19 Guadalajara;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;90,51
19 Guadalajara;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
19 Guadalajara;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
19 Guadalajara;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
19 Guadalajara;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;86,97
19 Guadalajara;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
19 Guadalajara;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
19 Guadalajara;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
19 Guadalajara;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
19 Guadalajara;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
19 Guadalajara;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
19 Guadalajara;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QI;4.581
19 Guadalajara;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
19 Guadalajara;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
19 Guadalajara;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
19 Guadalajara;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QI;4.439
19 Guadalajara;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
19 Guadalajara;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
19 Guadalajara;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
19 Guadalajara;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QI;4.424
19 Guadalajara;All ages;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
19 Guadalajara;All ages;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
19 Guadalajara;All ages;Cohort January 1;Females;Survival in the first trimester;2022QII;""
19 Guadalajara;All ages;Cohort January 1;Females;Survival in the first trimester;2022QI;4.405
19 Guadalajara;All ages;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
19 Guadalajara;All ages;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
19 Guadalajara;All ages;Cohort January 1;Females;Survival in the first trimester;2021QII;""
19 Guadalajara;All ages;Cohort January 1;Females;Survival in the first trimester;2021QI;4.299
19 Guadalajara;All ages;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
19 Guadalajara;All ages;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
19 Guadalajara;All ages;Cohort January 1;Females;Survival in the first trimester;2020QII;""
19 Guadalajara;All ages;Cohort January 1;Females;Survival in the first trimester;2020QI;4.068
19 Guadalajara;All ages;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
19 Guadalajara;All ages;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
19 Guadalajara;All ages;Cohort January 1;Females;Survival in the second trimester;2022QII;4.205
19 Guadalajara;All ages;Cohort January 1;Females;Survival in the second trimester;2022QI;""
19 Guadalajara;All ages;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
19 Guadalajara;All ages;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
19 Guadalajara;All ages;Cohort January 1;Females;Survival in the second trimester;2021QII;4.137
19 Guadalajara;All ages;Cohort January 1;Females;Survival in the second trimester;2021QI;""
19 Guadalajara;All ages;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
19 Guadalajara;All ages;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
19 Guadalajara;All ages;Cohort January 1;Females;Survival in the second trimester;2020QII;3.973
19 Guadalajara;All ages;Cohort January 1;Females;Survival in the second trimester;2020QI;""
19 Guadalajara;All ages;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
19 Guadalajara;All ages;Cohort January 1;Females;Survival in the third trimester;2022QIII;4.066
19 Guadalajara;All ages;Cohort January 1;Females;Survival in the third trimester;2022QII;""
19 Guadalajara;All ages;Cohort January 1;Females;Survival in the third trimester;2022QI;""
19 Guadalajara;All ages;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
19 Guadalajara;All ages;Cohort January 1;Females;Survival in the third trimester;2021QIII;4.004
19 Guadalajara;All ages;Cohort January 1;Females;Survival in the third trimester;2021QII;""
19 Guadalajara;All ages;Cohort January 1;Females;Survival in the third trimester;2021QI;""
19 Guadalajara;All ages;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
19 Guadalajara;All ages;Cohort January 1;Females;Survival in the third trimester;2020QIII;3.846
19 Guadalajara;All ages;Cohort January 1;Females;Survival in the third trimester;2020QII;""
19 Guadalajara;All ages;Cohort January 1;Females;Survival in the third trimester;2020QI;""
19 Guadalajara;All ages;Cohort January 1;Females;Survival in the third trimester;2022QIV;3.902
19 Guadalajara;All ages;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
19 Guadalajara;All ages;Cohort January 1;Females;Survival in the third trimester;2022QII;""
19 Guadalajara;All ages;Cohort January 1;Females;Survival in the third trimester;2022QI;""
19 Guadalajara;All ages;Cohort January 1;Females;Survival in the third trimester;2021QIV;3.871
19 Guadalajara;All ages;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
19 Guadalajara;All ages;Cohort January 1;Females;Survival in the third trimester;2021QII;""
19 Guadalajara;All ages;Cohort January 1;Females;Survival in the third trimester;2021QI;""
19 Guadalajara;All ages;Cohort January 1;Females;Survival in the third trimester;2020QIV;3.738
19 Guadalajara;All ages;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
19 Guadalajara;All ages;Cohort January 1;Females;Survival in the third trimester;2020QII;""
19 Guadalajara;All ages;Cohort January 1;Females;Survival in the third trimester;2020QI;""
19 Guadalajara;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
19 Guadalajara;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
19 Guadalajara;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
19 Guadalajara;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
19 Guadalajara;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
19 Guadalajara;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
19 Guadalajara;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
19 Guadalajara;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
19 Guadalajara;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
19 Guadalajara;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
19 Guadalajara;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
19 Guadalajara;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
19 Guadalajara;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
19 Guadalajara;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
19 Guadalajara;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
19 Guadalajara;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;96,16
19 Guadalajara;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
19 Guadalajara;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
19 Guadalajara;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
19 Guadalajara;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;96,85
19 Guadalajara;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
19 Guadalajara;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
19 Guadalajara;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
19 Guadalajara;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;91,95
19 Guadalajara;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
19 Guadalajara;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
19 Guadalajara;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;91,79
19 Guadalajara;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
19 Guadalajara;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
19 Guadalajara;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
19 Guadalajara;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;93,2
19 Guadalajara;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
19 Guadalajara;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
19 Guadalajara;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
19 Guadalajara;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;89,81
19 Guadalajara;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
19 Guadalajara;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
19 Guadalajara;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;88,76
19 Guadalajara;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
19 Guadalajara;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
19 Guadalajara;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
19 Guadalajara;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;90,2
19 Guadalajara;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
19 Guadalajara;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
19 Guadalajara;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
19 Guadalajara;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;86,93
19 Guadalajara;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
19 Guadalajara;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
19 Guadalajara;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;85,18
19 Guadalajara;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
19 Guadalajara;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
19 Guadalajara;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
19 Guadalajara;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;87,2
19 Guadalajara;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
19 Guadalajara;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
19 Guadalajara;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
19 Guadalajara;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;84,49
19 Guadalajara;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
19 Guadalajara;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
19 Guadalajara;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
19 Guadalajara;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
19 Guadalajara;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
19 Guadalajara;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QII;13.505
19 Guadalajara;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
19 Guadalajara;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
19 Guadalajara;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
19 Guadalajara;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QII;13.219
19 Guadalajara;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
19 Guadalajara;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
19 Guadalajara;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
19 Guadalajara;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QII;12.768
19 Guadalajara;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
19 Guadalajara;All ages;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
19 Guadalajara;All ages;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
19 Guadalajara;All ages;Cohort April 1;Total;Survival in the first trimester;2022QII;12.998
19 Guadalajara;All ages;Cohort April 1;Total;Survival in the first trimester;2022QI;""
19 Guadalajara;All ages;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
19 Guadalajara;All ages;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
19 Guadalajara;All ages;Cohort April 1;Total;Survival in the first trimester;2021QII;12.798
19 Guadalajara;All ages;Cohort April 1;Total;Survival in the first trimester;2021QI;""
19 Guadalajara;All ages;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
19 Guadalajara;All ages;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
19 Guadalajara;All ages;Cohort April 1;Total;Survival in the first trimester;2020QII;12.493
19 Guadalajara;All ages;Cohort April 1;Total;Survival in the first trimester;2020QI;""
19 Guadalajara;All ages;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
19 Guadalajara;All ages;Cohort April 1;Total;Survival in the second trimester;2022QIII;12.556
19 Guadalajara;All ages;Cohort April 1;Total;Survival in the second trimester;2022QII;""
19 Guadalajara;All ages;Cohort April 1;Total;Survival in the second trimester;2022QI;""
19 Guadalajara;All ages;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
19 Guadalajara;All ages;Cohort April 1;Total;Survival in the second trimester;2021QIII;12.433
19 Guadalajara;All ages;Cohort April 1;Total;Survival in the second trimester;2021QII;""
19 Guadalajara;All ages;Cohort April 1;Total;Survival in the second trimester;2021QI;""
19 Guadalajara;All ages;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
19 Guadalajara;All ages;Cohort April 1;Total;Survival in the second trimester;2020QIII;12.136
19 Guadalajara;All ages;Cohort April 1;Total;Survival in the second trimester;2020QII;""
19 Guadalajara;All ages;Cohort April 1;Total;Survival in the second trimester;2020QI;""
19 Guadalajara;All ages;Cohort April 1;Total;Survival in the third trimester;2022QIV;12.105
19 Guadalajara;All ages;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
19 Guadalajara;All ages;Cohort April 1;Total;Survival in the third trimester;2022QII;""
19 Guadalajara;All ages;Cohort April 1;Total;Survival in the third trimester;2022QI;""
19 Guadalajara;All ages;Cohort April 1;Total;Survival in the third trimester;2021QIV;12.050
19 Guadalajara;All ages;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
19 Guadalajara;All ages;Cohort April 1;Total;Survival in the third trimester;2021QII;""
19 Guadalajara;All ages;Cohort April 1;Total;Survival in the third trimester;2021QI;""
19 Guadalajara;All ages;Cohort April 1;Total;Survival in the third trimester;2020QIV;11.789
19 Guadalajara;All ages;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
19 Guadalajara;All ages;Cohort April 1;Total;Survival in the third trimester;2020QII;""
19 Guadalajara;All ages;Cohort April 1;Total;Survival in the third trimester;2020QI;""
19 Guadalajara;All ages;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
19 Guadalajara;All ages;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
19 Guadalajara;All ages;Cohort April 1;Total;Survival in the third trimester;2022QII;""
19 Guadalajara;All ages;Cohort April 1;Total;Survival in the third trimester;2022QI;11.726
19 Guadalajara;All ages;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
19 Guadalajara;All ages;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
19 Guadalajara;All ages;Cohort April 1;Total;Survival in the third trimester;2021QII;""
19 Guadalajara;All ages;Cohort April 1;Total;Survival in the third trimester;2021QI;11.531
19 Guadalajara;All ages;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
19 Guadalajara;All ages;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
19 Guadalajara;All ages;Cohort April 1;Total;Survival in the third trimester;2020QII;""
19 Guadalajara;All ages;Cohort April 1;Total;Survival in the third trimester;2020QI;""
19 Guadalajara;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
19 Guadalajara;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
19 Guadalajara;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
19 Guadalajara;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
19 Guadalajara;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
19 Guadalajara;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
19 Guadalajara;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
19 Guadalajara;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
19 Guadalajara;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
19 Guadalajara;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
19 Guadalajara;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
19 Guadalajara;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
19 Guadalajara;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
19 Guadalajara;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
19 Guadalajara;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;96,25
19 Guadalajara;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
19 Guadalajara;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
19 Guadalajara;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
19 Guadalajara;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;96,82
19 Guadalajara;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
19 Guadalajara;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
19 Guadalajara;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
19 Guadalajara;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;97,85
19 Guadalajara;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
19 Guadalajara;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
19 Guadalajara;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;92,97
19 Guadalajara;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
19 Guadalajara;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
19 Guadalajara;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
19 Guadalajara;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;94,05
19 Guadalajara;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
19 Guadalajara;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
19 Guadalajara;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
19 Guadalajara;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;95,05
19 Guadalajara;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
19 Guadalajara;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
19 Guadalajara;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;89,63
19 Guadalajara;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
19 Guadalajara;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
19 Guadalajara;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
19 Guadalajara;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;91,16
19 Guadalajara;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
19 Guadalajara;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
19 Guadalajara;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
19 Guadalajara;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;92,33
19 Guadalajara;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
19 Guadalajara;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
19 Guadalajara;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
19 Guadalajara;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
19 Guadalajara;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
19 Guadalajara;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
19 Guadalajara;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;88,71
19 Guadalajara;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
19 Guadalajara;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
19 Guadalajara;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
19 Guadalajara;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;90,31
19 Guadalajara;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
19 Guadalajara;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
19 Guadalajara;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
19 Guadalajara;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
19 Guadalajara;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
19 Guadalajara;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
19 Guadalajara;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QII;8.897
19 Guadalajara;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
19 Guadalajara;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
19 Guadalajara;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
19 Guadalajara;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QII;8.738
19 Guadalajara;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
19 Guadalajara;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
19 Guadalajara;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
19 Guadalajara;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QII;8.486
19 Guadalajara;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
19 Guadalajara;All ages;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
19 Guadalajara;All ages;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
19 Guadalajara;All ages;Cohort April 1;Males;Survival in the first trimester;2022QII;8.607
19 Guadalajara;All ages;Cohort April 1;Males;Survival in the first trimester;2022QI;""
19 Guadalajara;All ages;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
19 Guadalajara;All ages;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
19 Guadalajara;All ages;Cohort April 1;Males;Survival in the first trimester;2021QII;8.503
19 Guadalajara;All ages;Cohort April 1;Males;Survival in the first trimester;2021QI;""
19 Guadalajara;All ages;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
19 Guadalajara;All ages;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
19 Guadalajara;All ages;Cohort April 1;Males;Survival in the first trimester;2020QII;8.315
19 Guadalajara;All ages;Cohort April 1;Males;Survival in the first trimester;2020QI;""
19 Guadalajara;All ages;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
19 Guadalajara;All ages;Cohort April 1;Males;Survival in the second trimester;2022QIII;8.325
19 Guadalajara;All ages;Cohort April 1;Males;Survival in the second trimester;2022QII;""
19 Guadalajara;All ages;Cohort April 1;Males;Survival in the second trimester;2022QI;""
19 Guadalajara;All ages;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
19 Guadalajara;All ages;Cohort April 1;Males;Survival in the second trimester;2021QIII;8.284
19 Guadalajara;All ages;Cohort April 1;Males;Survival in the second trimester;2021QII;""
19 Guadalajara;All ages;Cohort April 1;Males;Survival in the second trimester;2021QI;""
19 Guadalajara;All ages;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
19 Guadalajara;All ages;Cohort April 1;Males;Survival in the second trimester;2020QIII;8.097
19 Guadalajara;All ages;Cohort April 1;Males;Survival in the second trimester;2020QII;""
19 Guadalajara;All ages;Cohort April 1;Males;Survival in the second trimester;2020QI;""
19 Guadalajara;All ages;Cohort April 1;Males;Survival in the third trimester;2022QIV;8.047
19 Guadalajara;All ages;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
19 Guadalajara;All ages;Cohort April 1;Males;Survival in the third trimester;2022QII;""
19 Guadalajara;All ages;Cohort April 1;Males;Survival in the third trimester;2022QI;""
19 Guadalajara;All ages;Cohort April 1;Males;Survival in the third trimester;2021QIV;8.047
19 Guadalajara;All ages;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
19 Guadalajara;All ages;Cohort April 1;Males;Survival in the third trimester;2021QII;""
19 Guadalajara;All ages;Cohort April 1;Males;Survival in the third trimester;2021QI;""
19 Guadalajara;All ages;Cohort April 1;Males;Survival in the third trimester;2020QIV;7.865
19 Guadalajara;All ages;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
19 Guadalajara;All ages;Cohort April 1;Males;Survival in the third trimester;2020QII;""
19 Guadalajara;All ages;Cohort April 1;Males;Survival in the third trimester;2020QI;""
19 Guadalajara;All ages;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
19 Guadalajara;All ages;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
19 Guadalajara;All ages;Cohort April 1;Males;Survival in the third trimester;2022QII;""
19 Guadalajara;All ages;Cohort April 1;Males;Survival in the third trimester;2022QI;7.846
19 Guadalajara;All ages;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
19 Guadalajara;All ages;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
19 Guadalajara;All ages;Cohort April 1;Males;Survival in the third trimester;2021QII;""
19 Guadalajara;All ages;Cohort April 1;Males;Survival in the third trimester;2021QI;7.716
19 Guadalajara;All ages;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
19 Guadalajara;All ages;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
19 Guadalajara;All ages;Cohort April 1;Males;Survival in the third trimester;2020QII;""
19 Guadalajara;All ages;Cohort April 1;Males;Survival in the third trimester;2020QI;""
19 Guadalajara;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
19 Guadalajara;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
19 Guadalajara;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
19 Guadalajara;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
19 Guadalajara;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
19 Guadalajara;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
19 Guadalajara;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
19 Guadalajara;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
19 Guadalajara;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
19 Guadalajara;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
19 Guadalajara;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
19 Guadalajara;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
19 Guadalajara;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
19 Guadalajara;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
19 Guadalajara;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;96,74
19 Guadalajara;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
19 Guadalajara;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
19 Guadalajara;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
19 Guadalajara;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;97,31
19 Guadalajara;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
19 Guadalajara;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
19 Guadalajara;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
19 Guadalajara;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;97,98
19 Guadalajara;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
19 Guadalajara;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
19 Guadalajara;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;93,57
19 Guadalajara;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
19 Guadalajara;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
19 Guadalajara;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
19 Guadalajara;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;94,8
19 Guadalajara;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
19 Guadalajara;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
19 Guadalajara;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
19 Guadalajara;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;95,42
19 Guadalajara;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
19 Guadalajara;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
19 Guadalajara;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;90,45
19 Guadalajara;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
19 Guadalajara;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
19 Guadalajara;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
19 Guadalajara;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;92,09
19 Guadalajara;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
19 Guadalajara;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
19 Guadalajara;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
19 Guadalajara;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;92,68
19 Guadalajara;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
19 Guadalajara;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
19 Guadalajara;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
19 Guadalajara;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
19 Guadalajara;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
19 Guadalajara;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
19 Guadalajara;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;89,79
19 Guadalajara;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
19 Guadalajara;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
19 Guadalajara;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
19 Guadalajara;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;90,93
19 Guadalajara;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
19 Guadalajara;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
19 Guadalajara;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
19 Guadalajara;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
19 Guadalajara;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
19 Guadalajara;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
19 Guadalajara;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QII;4.608
19 Guadalajara;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
19 Guadalajara;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
19 Guadalajara;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
19 Guadalajara;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QII;4.481
19 Guadalajara;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
19 Guadalajara;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
19 Guadalajara;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
19 Guadalajara;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QII;4.282
19 Guadalajara;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
19 Guadalajara;All ages;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
19 Guadalajara;All ages;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
19 Guadalajara;All ages;Cohort April 1;Females;Survival in the first trimester;2022QII;4.391
19 Guadalajara;All ages;Cohort April 1;Females;Survival in the first trimester;2022QI;""
19 Guadalajara;All ages;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
19 Guadalajara;All ages;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
19 Guadalajara;All ages;Cohort April 1;Females;Survival in the first trimester;2021QII;4.295
19 Guadalajara;All ages;Cohort April 1;Females;Survival in the first trimester;2021QI;""
19 Guadalajara;All ages;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
19 Guadalajara;All ages;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
19 Guadalajara;All ages;Cohort April 1;Females;Survival in the first trimester;2020QII;4.178
19 Guadalajara;All ages;Cohort April 1;Females;Survival in the first trimester;2020QI;""
19 Guadalajara;All ages;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
19 Guadalajara;All ages;Cohort April 1;Females;Survival in the second trimester;2022QIII;4.231
19 Guadalajara;All ages;Cohort April 1;Females;Survival in the second trimester;2022QII;""
19 Guadalajara;All ages;Cohort April 1;Females;Survival in the second trimester;2022QI;""
19 Guadalajara;All ages;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
19 Guadalajara;All ages;Cohort April 1;Females;Survival in the second trimester;2021QIII;4.149
19 Guadalajara;All ages;Cohort April 1;Females;Survival in the second trimester;2021QII;""
19 Guadalajara;All ages;Cohort April 1;Females;Survival in the second trimester;2021QI;""
19 Guadalajara;All ages;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
19 Guadalajara;All ages;Cohort April 1;Females;Survival in the second trimester;2020QIII;4.039
19 Guadalajara;All ages;Cohort April 1;Females;Survival in the second trimester;2020QII;""
19 Guadalajara;All ages;Cohort April 1;Females;Survival in the second trimester;2020QI;""
19 Guadalajara;All ages;Cohort April 1;Females;Survival in the third trimester;2022QIV;4.058
19 Guadalajara;All ages;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
19 Guadalajara;All ages;Cohort April 1;Females;Survival in the third trimester;2022QII;""
19 Guadalajara;All ages;Cohort April 1;Females;Survival in the third trimester;2022QI;""
19 Guadalajara;All ages;Cohort April 1;Females;Survival in the third trimester;2021QIV;4.003
19 Guadalajara;All ages;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
19 Guadalajara;All ages;Cohort April 1;Females;Survival in the third trimester;2021QII;""
19 Guadalajara;All ages;Cohort April 1;Females;Survival in the third trimester;2021QI;""
19 Guadalajara;All ages;Cohort April 1;Females;Survival in the third trimester;2020QIV;3.924
19 Guadalajara;All ages;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
19 Guadalajara;All ages;Cohort April 1;Females;Survival in the third trimester;2020QII;""
19 Guadalajara;All ages;Cohort April 1;Females;Survival in the third trimester;2020QI;""
19 Guadalajara;All ages;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
19 Guadalajara;All ages;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
19 Guadalajara;All ages;Cohort April 1;Females;Survival in the third trimester;2022QII;""
19 Guadalajara;All ages;Cohort April 1;Females;Survival in the third trimester;2022QI;3.880
19 Guadalajara;All ages;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
19 Guadalajara;All ages;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
19 Guadalajara;All ages;Cohort April 1;Females;Survival in the third trimester;2021QII;""
19 Guadalajara;All ages;Cohort April 1;Females;Survival in the third trimester;2021QI;3.815
19 Guadalajara;All ages;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
19 Guadalajara;All ages;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
19 Guadalajara;All ages;Cohort April 1;Females;Survival in the third trimester;2020QII;""
19 Guadalajara;All ages;Cohort April 1;Females;Survival in the third trimester;2020QI;""
19 Guadalajara;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
19 Guadalajara;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
19 Guadalajara;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
19 Guadalajara;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
19 Guadalajara;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
19 Guadalajara;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
19 Guadalajara;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
19 Guadalajara;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
19 Guadalajara;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
19 Guadalajara;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
19 Guadalajara;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
19 Guadalajara;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
19 Guadalajara;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
19 Guadalajara;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
19 Guadalajara;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;95,29
19 Guadalajara;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
19 Guadalajara;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
19 Guadalajara;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
19 Guadalajara;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;95,85
19 Guadalajara;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
19 Guadalajara;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
19 Guadalajara;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
19 Guadalajara;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;97,57
19 Guadalajara;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
19 Guadalajara;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
19 Guadalajara;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;91,82
19 Guadalajara;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
19 Guadalajara;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
19 Guadalajara;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
19 Guadalajara;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;92,59
19 Guadalajara;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
19 Guadalajara;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
19 Guadalajara;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
19 Guadalajara;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;94,33
19 Guadalajara;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
19 Guadalajara;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
19 Guadalajara;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;88,06
19 Guadalajara;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
19 Guadalajara;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
19 Guadalajara;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
19 Guadalajara;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;89,33
19 Guadalajara;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
19 Guadalajara;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
19 Guadalajara;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
19 Guadalajara;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;91,64
19 Guadalajara;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
19 Guadalajara;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
19 Guadalajara;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
19 Guadalajara;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
19 Guadalajara;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
19 Guadalajara;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
19 Guadalajara;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;86,59
19 Guadalajara;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
19 Guadalajara;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
19 Guadalajara;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
19 Guadalajara;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;89,09
19 Guadalajara;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
19 Guadalajara;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
19 Guadalajara;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
19 Guadalajara;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
19 Guadalajara;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
19 Guadalajara;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QIII;13.555
19 Guadalajara;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
19 Guadalajara;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
19 Guadalajara;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
19 Guadalajara;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QIII;13.344
19 Guadalajara;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
19 Guadalajara;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
19 Guadalajara;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
19 Guadalajara;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QIII;12.945
19 Guadalajara;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
19 Guadalajara;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
19 Guadalajara;All ages;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
19 Guadalajara;All ages;Cohort July 1;Total;Survival in the first trimester;2022QIII;13.022
19 Guadalajara;All ages;Cohort July 1;Total;Survival in the first trimester;2022QII;""
19 Guadalajara;All ages;Cohort July 1;Total;Survival in the first trimester;2022QI;""
19 Guadalajara;All ages;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
19 Guadalajara;All ages;Cohort July 1;Total;Survival in the first trimester;2021QIII;12.884
19 Guadalajara;All ages;Cohort July 1;Total;Survival in the first trimester;2021QII;""
19 Guadalajara;All ages;Cohort July 1;Total;Survival in the first trimester;2021QI;""
19 Guadalajara;All ages;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
19 Guadalajara;All ages;Cohort July 1;Total;Survival in the first trimester;2020QIII;12.517
19 Guadalajara;All ages;Cohort July 1;Total;Survival in the first trimester;2020QII;""
19 Guadalajara;All ages;Cohort July 1;Total;Survival in the first trimester;2020QI;""
19 Guadalajara;All ages;Cohort July 1;Total;Survival in the second trimester;2022QIV;12.519
19 Guadalajara;All ages;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
19 Guadalajara;All ages;Cohort July 1;Total;Survival in the second trimester;2022QII;""
19 Guadalajara;All ages;Cohort July 1;Total;Survival in the second trimester;2022QI;""
19 Guadalajara;All ages;Cohort July 1;Total;Survival in the second trimester;2021QIV;12.455
19 Guadalajara;All ages;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
19 Guadalajara;All ages;Cohort July 1;Total;Survival in the second trimester;2021QII;""
19 Guadalajara;All ages;Cohort July 1;Total;Survival in the second trimester;2021QI;""
19 Guadalajara;All ages;Cohort July 1;Total;Survival in the second trimester;2020QIV;12.127
19 Guadalajara;All ages;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
19 Guadalajara;All ages;Cohort July 1;Total;Survival in the second trimester;2020QII;""
19 Guadalajara;All ages;Cohort July 1;Total;Survival in the second trimester;2020QI;""
19 Guadalajara;All ages;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
19 Guadalajara;All ages;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
19 Guadalajara;All ages;Cohort July 1;Total;Survival in the third trimester;2022QII;""
19 Guadalajara;All ages;Cohort July 1;Total;Survival in the third trimester;2022QI;12.093
19 Guadalajara;All ages;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
19 Guadalajara;All ages;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
19 Guadalajara;All ages;Cohort July 1;Total;Survival in the third trimester;2021QII;""
19 Guadalajara;All ages;Cohort July 1;Total;Survival in the third trimester;2021QI;11.851
19 Guadalajara;All ages;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
19 Guadalajara;All ages;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
19 Guadalajara;All ages;Cohort July 1;Total;Survival in the third trimester;2020QII;""
19 Guadalajara;All ages;Cohort July 1;Total;Survival in the third trimester;2020QI;""
19 Guadalajara;All ages;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
19 Guadalajara;All ages;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
19 Guadalajara;All ages;Cohort July 1;Total;Survival in the third trimester;2022QII;11.735
19 Guadalajara;All ages;Cohort July 1;Total;Survival in the third trimester;2022QI;""
19 Guadalajara;All ages;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
19 Guadalajara;All ages;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
19 Guadalajara;All ages;Cohort July 1;Total;Survival in the third trimester;2021QII;11.579
19 Guadalajara;All ages;Cohort July 1;Total;Survival in the third trimester;2021QI;""
19 Guadalajara;All ages;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
19 Guadalajara;All ages;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
19 Guadalajara;All ages;Cohort July 1;Total;Survival in the third trimester;2020QII;""
19 Guadalajara;All ages;Cohort July 1;Total;Survival in the third trimester;2020QI;""
19 Guadalajara;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
19 Guadalajara;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
19 Guadalajara;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
19 Guadalajara;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
19 Guadalajara;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
19 Guadalajara;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
19 Guadalajara;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
19 Guadalajara;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
19 Guadalajara;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
19 Guadalajara;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
19 Guadalajara;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
19 Guadalajara;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
19 Guadalajara;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
19 Guadalajara;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;96,07
19 Guadalajara;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
19 Guadalajara;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
19 Guadalajara;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
19 Guadalajara;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;96,55
19 Guadalajara;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
19 Guadalajara;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
19 Guadalajara;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
19 Guadalajara;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;96,69
19 Guadalajara;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
19 Guadalajara;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
19 Guadalajara;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;92,36
19 Guadalajara;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
19 Guadalajara;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
19 Guadalajara;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
19 Guadalajara;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;93,34
19 Guadalajara;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
19 Guadalajara;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
19 Guadalajara;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
19 Guadalajara;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;93,68
19 Guadalajara;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
19 Guadalajara;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
19 Guadalajara;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
19 Guadalajara;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
19 Guadalajara;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
19 Guadalajara;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
19 Guadalajara;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;90,63
19 Guadalajara;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
19 Guadalajara;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
19 Guadalajara;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
19 Guadalajara;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;91,55
19 Guadalajara;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
19 Guadalajara;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
19 Guadalajara;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
19 Guadalajara;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
19 Guadalajara;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
19 Guadalajara;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
19 Guadalajara;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;87,94
19 Guadalajara;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
19 Guadalajara;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
19 Guadalajara;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
19 Guadalajara;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;89,45
19 Guadalajara;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
19 Guadalajara;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
19 Guadalajara;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
19 Guadalajara;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
19 Guadalajara;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
19 Guadalajara;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
19 Guadalajara;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QIII;8.927
19 Guadalajara;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
19 Guadalajara;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
19 Guadalajara;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
19 Guadalajara;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QIII;8.819
19 Guadalajara;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
19 Guadalajara;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
19 Guadalajara;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
19 Guadalajara;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QIII;8.623
19 Guadalajara;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
19 Guadalajara;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
19 Guadalajara;All ages;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
19 Guadalajara;All ages;Cohort July 1;Males;Survival in the first trimester;2022QIII;8.593
19 Guadalajara;All ages;Cohort July 1;Males;Survival in the first trimester;2022QII;""
19 Guadalajara;All ages;Cohort July 1;Males;Survival in the first trimester;2022QI;""
19 Guadalajara;All ages;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
19 Guadalajara;All ages;Cohort July 1;Males;Survival in the first trimester;2021QIII;8.548
19 Guadalajara;All ages;Cohort July 1;Males;Survival in the first trimester;2021QII;""
19 Guadalajara;All ages;Cohort July 1;Males;Survival in the first trimester;2021QI;""
19 Guadalajara;All ages;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
19 Guadalajara;All ages;Cohort July 1;Males;Survival in the first trimester;2020QIII;8.356
19 Guadalajara;All ages;Cohort July 1;Males;Survival in the first trimester;2020QII;""
19 Guadalajara;All ages;Cohort July 1;Males;Survival in the first trimester;2020QI;""
19 Guadalajara;All ages;Cohort July 1;Males;Survival in the second trimester;2022QIV;8.283
19 Guadalajara;All ages;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
19 Guadalajara;All ages;Cohort July 1;Males;Survival in the second trimester;2022QII;""
19 Guadalajara;All ages;Cohort July 1;Males;Survival in the second trimester;2022QI;""
19 Guadalajara;All ages;Cohort July 1;Males;Survival in the second trimester;2021QIV;8.280
19 Guadalajara;All ages;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
19 Guadalajara;All ages;Cohort July 1;Males;Survival in the second trimester;2021QII;""
19 Guadalajara;All ages;Cohort July 1;Males;Survival in the second trimester;2021QI;""
19 Guadalajara;All ages;Cohort July 1;Males;Survival in the second trimester;2020QIV;8.100
19 Guadalajara;All ages;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
19 Guadalajara;All ages;Cohort July 1;Males;Survival in the second trimester;2020QII;""
19 Guadalajara;All ages;Cohort July 1;Males;Survival in the second trimester;2020QI;""
19 Guadalajara;All ages;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
19 Guadalajara;All ages;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
19 Guadalajara;All ages;Cohort July 1;Males;Survival in the third trimester;2022QII;""
19 Guadalajara;All ages;Cohort July 1;Males;Survival in the third trimester;2022QI;8.056
19 Guadalajara;All ages;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
19 Guadalajara;All ages;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
19 Guadalajara;All ages;Cohort July 1;Males;Survival in the third trimester;2021QII;""
19 Guadalajara;All ages;Cohort July 1;Males;Survival in the third trimester;2021QI;7.938
19 Guadalajara;All ages;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
19 Guadalajara;All ages;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
19 Guadalajara;All ages;Cohort July 1;Males;Survival in the third trimester;2020QII;""
19 Guadalajara;All ages;Cohort July 1;Males;Survival in the third trimester;2020QI;""
19 Guadalajara;All ages;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
19 Guadalajara;All ages;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
19 Guadalajara;All ages;Cohort July 1;Males;Survival in the third trimester;2022QII;7.852
19 Guadalajara;All ages;Cohort July 1;Males;Survival in the third trimester;2022QI;""
19 Guadalajara;All ages;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
19 Guadalajara;All ages;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
19 Guadalajara;All ages;Cohort July 1;Males;Survival in the third trimester;2021QII;7.784
19 Guadalajara;All ages;Cohort July 1;Males;Survival in the third trimester;2021QI;""
19 Guadalajara;All ages;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
19 Guadalajara;All ages;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
19 Guadalajara;All ages;Cohort July 1;Males;Survival in the third trimester;2020QII;""
19 Guadalajara;All ages;Cohort July 1;Males;Survival in the third trimester;2020QI;""
19 Guadalajara;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
19 Guadalajara;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
19 Guadalajara;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
19 Guadalajara;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
19 Guadalajara;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
19 Guadalajara;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
19 Guadalajara;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
19 Guadalajara;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
19 Guadalajara;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
19 Guadalajara;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
19 Guadalajara;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
19 Guadalajara;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
19 Guadalajara;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
19 Guadalajara;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;96,26
19 Guadalajara;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
19 Guadalajara;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
19 Guadalajara;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
19 Guadalajara;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;96,93
19 Guadalajara;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
19 Guadalajara;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
19 Guadalajara;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
19 Guadalajara;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;96,9
19 Guadalajara;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
19 Guadalajara;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
19 Guadalajara;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;92,79
19 Guadalajara;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
19 Guadalajara;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
19 Guadalajara;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
19 Guadalajara;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;93,89
19 Guadalajara;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
19 Guadalajara;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
19 Guadalajara;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
19 Guadalajara;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;93,93
19 Guadalajara;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
19 Guadalajara;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
19 Guadalajara;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
19 Guadalajara;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
19 Guadalajara;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
19 Guadalajara;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
19 Guadalajara;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;91,35
19 Guadalajara;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
19 Guadalajara;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
19 Guadalajara;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
19 Guadalajara;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;92,06
19 Guadalajara;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
19 Guadalajara;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
19 Guadalajara;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
19 Guadalajara;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
19 Guadalajara;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
19 Guadalajara;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
19 Guadalajara;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;89,04
19 Guadalajara;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
19 Guadalajara;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
19 Guadalajara;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
19 Guadalajara;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;90,27
19 Guadalajara;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
19 Guadalajara;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
19 Guadalajara;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
19 Guadalajara;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
19 Guadalajara;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
19 Guadalajara;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
19 Guadalajara;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QIII;4.628
19 Guadalajara;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
19 Guadalajara;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
19 Guadalajara;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
19 Guadalajara;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QIII;4.525
19 Guadalajara;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
19 Guadalajara;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
19 Guadalajara;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
19 Guadalajara;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QIII;4.322
19 Guadalajara;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
19 Guadalajara;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
19 Guadalajara;All ages;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
19 Guadalajara;All ages;Cohort July 1;Females;Survival in the first trimester;2022QIII;4.429
19 Guadalajara;All ages;Cohort July 1;Females;Survival in the first trimester;2022QII;""
19 Guadalajara;All ages;Cohort July 1;Females;Survival in the first trimester;2022QI;""
19 Guadalajara;All ages;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
19 Guadalajara;All ages;Cohort July 1;Females;Survival in the first trimester;2021QIII;4.336
19 Guadalajara;All ages;Cohort July 1;Females;Survival in the first trimester;2021QII;""
19 Guadalajara;All ages;Cohort July 1;Females;Survival in the first trimester;2021QI;""
19 Guadalajara;All ages;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
19 Guadalajara;All ages;Cohort July 1;Females;Survival in the first trimester;2020QIII;4.161
19 Guadalajara;All ages;Cohort July 1;Females;Survival in the first trimester;2020QII;""
19 Guadalajara;All ages;Cohort July 1;Females;Survival in the first trimester;2020QI;""
19 Guadalajara;All ages;Cohort July 1;Females;Survival in the second trimester;2022QIV;4.236
19 Guadalajara;All ages;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
19 Guadalajara;All ages;Cohort July 1;Females;Survival in the second trimester;2022QII;""
19 Guadalajara;All ages;Cohort July 1;Females;Survival in the second trimester;2022QI;""
19 Guadalajara;All ages;Cohort July 1;Females;Survival in the second trimester;2021QIV;4.175
19 Guadalajara;All ages;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
19 Guadalajara;All ages;Cohort July 1;Females;Survival in the second trimester;2021QII;""
19 Guadalajara;All ages;Cohort July 1;Females;Survival in the second trimester;2021QI;""
19 Guadalajara;All ages;Cohort July 1;Females;Survival in the second trimester;2020QIV;4.027
19 Guadalajara;All ages;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
19 Guadalajara;All ages;Cohort July 1;Females;Survival in the second trimester;2020QII;""
19 Guadalajara;All ages;Cohort July 1;Females;Survival in the second trimester;2020QI;""
19 Guadalajara;All ages;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
19 Guadalajara;All ages;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
19 Guadalajara;All ages;Cohort July 1;Females;Survival in the third trimester;2022QII;""
19 Guadalajara;All ages;Cohort July 1;Females;Survival in the third trimester;2022QI;4.037
19 Guadalajara;All ages;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
19 Guadalajara;All ages;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
19 Guadalajara;All ages;Cohort July 1;Females;Survival in the third trimester;2021QII;""
19 Guadalajara;All ages;Cohort July 1;Females;Survival in the third trimester;2021QI;3.913
19 Guadalajara;All ages;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
19 Guadalajara;All ages;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
19 Guadalajara;All ages;Cohort July 1;Females;Survival in the third trimester;2020QII;""
19 Guadalajara;All ages;Cohort July 1;Females;Survival in the third trimester;2020QI;""
19 Guadalajara;All ages;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
19 Guadalajara;All ages;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
19 Guadalajara;All ages;Cohort July 1;Females;Survival in the third trimester;2022QII;3.883
19 Guadalajara;All ages;Cohort July 1;Females;Survival in the third trimester;2022QI;""
19 Guadalajara;All ages;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
19 Guadalajara;All ages;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
19 Guadalajara;All ages;Cohort July 1;Females;Survival in the third trimester;2021QII;3.795
19 Guadalajara;All ages;Cohort July 1;Females;Survival in the third trimester;2021QI;""
19 Guadalajara;All ages;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
19 Guadalajara;All ages;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
19 Guadalajara;All ages;Cohort July 1;Females;Survival in the third trimester;2020QII;""
19 Guadalajara;All ages;Cohort July 1;Females;Survival in the third trimester;2020QI;""
19 Guadalajara;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
19 Guadalajara;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
19 Guadalajara;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
19 Guadalajara;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
19 Guadalajara;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
19 Guadalajara;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
19 Guadalajara;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
19 Guadalajara;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
19 Guadalajara;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
19 Guadalajara;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
19 Guadalajara;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
19 Guadalajara;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
19 Guadalajara;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
19 Guadalajara;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;95,7
19 Guadalajara;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
19 Guadalajara;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
19 Guadalajara;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
19 Guadalajara;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;95,82
19 Guadalajara;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
19 Guadalajara;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
19 Guadalajara;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
19 Guadalajara;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;96,27
19 Guadalajara;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
19 Guadalajara;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
19 Guadalajara;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;91,53
19 Guadalajara;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
19 Guadalajara;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
19 Guadalajara;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
19 Guadalajara;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;92,27
19 Guadalajara;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
19 Guadalajara;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
19 Guadalajara;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
19 Guadalajara;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;93,17
19 Guadalajara;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
19 Guadalajara;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
19 Guadalajara;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
19 Guadalajara;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
19 Guadalajara;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
19 Guadalajara;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
19 Guadalajara;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;89,22
19 Guadalajara;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
19 Guadalajara;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
19 Guadalajara;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
19 Guadalajara;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;90,54
19 Guadalajara;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
19 Guadalajara;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
19 Guadalajara;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
19 Guadalajara;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
19 Guadalajara;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
19 Guadalajara;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
19 Guadalajara;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;85,81
19 Guadalajara;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
19 Guadalajara;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
19 Guadalajara;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
19 Guadalajara;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;87,81
19 Guadalajara;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
19 Guadalajara;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
19 Guadalajara;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
19 Guadalajara;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
19 Guadalajara;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
19 Guadalajara;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QIV;13.439
19 Guadalajara;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
19 Guadalajara;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
19 Guadalajara;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
19 Guadalajara;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QIV;13.378
19 Guadalajara;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
19 Guadalajara;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
19 Guadalajara;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
19 Guadalajara;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QIV;13.025
19 Guadalajara;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
19 Guadalajara;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
19 Guadalajara;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
19 Guadalajara;All ages;Cohort October 1;Total;Survival in the first trimester;2022QIV;12.883
19 Guadalajara;All ages;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
19 Guadalajara;All ages;Cohort October 1;Total;Survival in the first trimester;2022QII;""
19 Guadalajara;All ages;Cohort October 1;Total;Survival in the first trimester;2022QI;""
19 Guadalajara;All ages;Cohort October 1;Total;Survival in the first trimester;2021QIV;12.876
19 Guadalajara;All ages;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
19 Guadalajara;All ages;Cohort October 1;Total;Survival in the first trimester;2021QII;""
19 Guadalajara;All ages;Cohort October 1;Total;Survival in the first trimester;2021QI;""
19 Guadalajara;All ages;Cohort October 1;Total;Survival in the first trimester;2020QIV;12.568
19 Guadalajara;All ages;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
19 Guadalajara;All ages;Cohort October 1;Total;Survival in the first trimester;2020QII;""
19 Guadalajara;All ages;Cohort October 1;Total;Survival in the first trimester;2020QI;""
19 Guadalajara;All ages;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
19 Guadalajara;All ages;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
19 Guadalajara;All ages;Cohort October 1;Total;Survival in the second trimester;2022QII;""
19 Guadalajara;All ages;Cohort October 1;Total;Survival in the second trimester;2022QI;12.481
19 Guadalajara;All ages;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
19 Guadalajara;All ages;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
19 Guadalajara;All ages;Cohort October 1;Total;Survival in the second trimester;2021QII;""
19 Guadalajara;All ages;Cohort October 1;Total;Survival in the second trimester;2021QI;12.261
19 Guadalajara;All ages;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
19 Guadalajara;All ages;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
19 Guadalajara;All ages;Cohort October 1;Total;Survival in the second trimester;2020QII;""
19 Guadalajara;All ages;Cohort October 1;Total;Survival in the second trimester;2020QI;""
19 Guadalajara;All ages;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
19 Guadalajara;All ages;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
19 Guadalajara;All ages;Cohort October 1;Total;Survival in the third trimester;2022QII;12.077
19 Guadalajara;All ages;Cohort October 1;Total;Survival in the third trimester;2022QI;""
19 Guadalajara;All ages;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
19 Guadalajara;All ages;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
19 Guadalajara;All ages;Cohort October 1;Total;Survival in the third trimester;2021QII;11.952
19 Guadalajara;All ages;Cohort October 1;Total;Survival in the third trimester;2021QI;""
19 Guadalajara;All ages;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
19 Guadalajara;All ages;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
19 Guadalajara;All ages;Cohort October 1;Total;Survival in the third trimester;2020QII;""
19 Guadalajara;All ages;Cohort October 1;Total;Survival in the third trimester;2020QI;""
19 Guadalajara;All ages;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
19 Guadalajara;All ages;Cohort October 1;Total;Survival in the third trimester;2022QIII;11.719
19 Guadalajara;All ages;Cohort October 1;Total;Survival in the third trimester;2022QII;""
19 Guadalajara;All ages;Cohort October 1;Total;Survival in the third trimester;2022QI;""
19 Guadalajara;All ages;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
19 Guadalajara;All ages;Cohort October 1;Total;Survival in the third trimester;2021QIII;11.649
19 Guadalajara;All ages;Cohort October 1;Total;Survival in the third trimester;2021QII;""
19 Guadalajara;All ages;Cohort October 1;Total;Survival in the third trimester;2021QI;""
19 Guadalajara;All ages;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
19 Guadalajara;All ages;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
19 Guadalajara;All ages;Cohort October 1;Total;Survival in the third trimester;2020QII;""
19 Guadalajara;All ages;Cohort October 1;Total;Survival in the third trimester;2020QI;""
19 Guadalajara;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
19 Guadalajara;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
19 Guadalajara;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
19 Guadalajara;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
19 Guadalajara;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
19 Guadalajara;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
19 Guadalajara;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
19 Guadalajara;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
19 Guadalajara;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
19 Guadalajara;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
19 Guadalajara;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
19 Guadalajara;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
19 Guadalajara;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;95,86
19 Guadalajara;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
19 Guadalajara;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
19 Guadalajara;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
19 Guadalajara;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;96,25
19 Guadalajara;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
19 Guadalajara;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
19 Guadalajara;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
19 Guadalajara;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;96,49
19 Guadalajara;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
19 Guadalajara;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
19 Guadalajara;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
19 Guadalajara;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
19 Guadalajara;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
19 Guadalajara;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
19 Guadalajara;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;93,29
19 Guadalajara;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
19 Guadalajara;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
19 Guadalajara;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
19 Guadalajara;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;94,13
19 Guadalajara;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
19 Guadalajara;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
19 Guadalajara;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
19 Guadalajara;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
19 Guadalajara;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
19 Guadalajara;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
19 Guadalajara;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;90,28
19 Guadalajara;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
19 Guadalajara;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
19 Guadalajara;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
19 Guadalajara;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;91,76
19 Guadalajara;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
19 Guadalajara;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
19 Guadalajara;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
19 Guadalajara;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
19 Guadalajara;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
19 Guadalajara;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
19 Guadalajara;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;87,6
19 Guadalajara;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
19 Guadalajara;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
19 Guadalajara;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
19 Guadalajara;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;89,44
19 Guadalajara;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
19 Guadalajara;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
19 Guadalajara;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
19 Guadalajara;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
19 Guadalajara;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
19 Guadalajara;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
19 Guadalajara;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QIV;8.837
19 Guadalajara;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
19 Guadalajara;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
19 Guadalajara;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
19 Guadalajara;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QIV;8.820
19 Guadalajara;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
19 Guadalajara;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
19 Guadalajara;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
19 Guadalajara;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QIV;8.666
19 Guadalajara;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
19 Guadalajara;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
19 Guadalajara;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
19 Guadalajara;All ages;Cohort October 1;Males;Survival in the first trimester;2022QIV;8.495
19 Guadalajara;All ages;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
19 Guadalajara;All ages;Cohort October 1;Males;Survival in the first trimester;2022QII;""
19 Guadalajara;All ages;Cohort October 1;Males;Survival in the first trimester;2022QI;""
19 Guadalajara;All ages;Cohort October 1;Males;Survival in the first trimester;2021QIV;8.512
19 Guadalajara;All ages;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
19 Guadalajara;All ages;Cohort October 1;Males;Survival in the first trimester;2021QII;""
19 Guadalajara;All ages;Cohort October 1;Males;Survival in the first trimester;2021QI;""
19 Guadalajara;All ages;Cohort October 1;Males;Survival in the first trimester;2020QIV;8.362
19 Guadalajara;All ages;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
19 Guadalajara;All ages;Cohort October 1;Males;Survival in the first trimester;2020QII;""
19 Guadalajara;All ages;Cohort October 1;Males;Survival in the first trimester;2020QI;""
19 Guadalajara;All ages;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
19 Guadalajara;All ages;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
19 Guadalajara;All ages;Cohort October 1;Males;Survival in the second trimester;2022QII;""
19 Guadalajara;All ages;Cohort October 1;Males;Survival in the second trimester;2022QI;8.269
19 Guadalajara;All ages;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
19 Guadalajara;All ages;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
19 Guadalajara;All ages;Cohort October 1;Males;Survival in the second trimester;2021QII;""
19 Guadalajara;All ages;Cohort October 1;Males;Survival in the second trimester;2021QI;8.177
19 Guadalajara;All ages;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
19 Guadalajara;All ages;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
19 Guadalajara;All ages;Cohort October 1;Males;Survival in the second trimester;2020QII;""
19 Guadalajara;All ages;Cohort October 1;Males;Survival in the second trimester;2020QI;""
19 Guadalajara;All ages;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
19 Guadalajara;All ages;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
19 Guadalajara;All ages;Cohort October 1;Males;Survival in the third trimester;2022QII;8.040
19 Guadalajara;All ages;Cohort October 1;Males;Survival in the third trimester;2022QI;""
19 Guadalajara;All ages;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
19 Guadalajara;All ages;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
19 Guadalajara;All ages;Cohort October 1;Males;Survival in the third trimester;2021QII;8.007
19 Guadalajara;All ages;Cohort October 1;Males;Survival in the third trimester;2021QI;""
19 Guadalajara;All ages;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
19 Guadalajara;All ages;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
19 Guadalajara;All ages;Cohort October 1;Males;Survival in the third trimester;2020QII;""
19 Guadalajara;All ages;Cohort October 1;Males;Survival in the third trimester;2020QI;""
19 Guadalajara;All ages;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
19 Guadalajara;All ages;Cohort October 1;Males;Survival in the third trimester;2022QIII;7.802
19 Guadalajara;All ages;Cohort October 1;Males;Survival in the third trimester;2022QII;""
19 Guadalajara;All ages;Cohort October 1;Males;Survival in the third trimester;2022QI;""
19 Guadalajara;All ages;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
19 Guadalajara;All ages;Cohort October 1;Males;Survival in the third trimester;2021QIII;7.823
19 Guadalajara;All ages;Cohort October 1;Males;Survival in the third trimester;2021QII;""
19 Guadalajara;All ages;Cohort October 1;Males;Survival in the third trimester;2021QI;""
19 Guadalajara;All ages;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
19 Guadalajara;All ages;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
19 Guadalajara;All ages;Cohort October 1;Males;Survival in the third trimester;2020QII;""
19 Guadalajara;All ages;Cohort October 1;Males;Survival in the third trimester;2020QI;""
19 Guadalajara;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
19 Guadalajara;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
19 Guadalajara;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
19 Guadalajara;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
19 Guadalajara;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
19 Guadalajara;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
19 Guadalajara;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
19 Guadalajara;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
19 Guadalajara;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
19 Guadalajara;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
19 Guadalajara;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
19 Guadalajara;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
19 Guadalajara;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;96,13
19 Guadalajara;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
19 Guadalajara;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
19 Guadalajara;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
19 Guadalajara;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;96,51
19 Guadalajara;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
19 Guadalajara;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
19 Guadalajara;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
19 Guadalajara;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;96,49
19 Guadalajara;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
19 Guadalajara;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
19 Guadalajara;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
19 Guadalajara;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
19 Guadalajara;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
19 Guadalajara;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
19 Guadalajara;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;93,75
19 Guadalajara;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
19 Guadalajara;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
19 Guadalajara;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
19 Guadalajara;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;94,36
19 Guadalajara;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
19 Guadalajara;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
19 Guadalajara;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
19 Guadalajara;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
19 Guadalajara;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
19 Guadalajara;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
19 Guadalajara;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;91,16
19 Guadalajara;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
19 Guadalajara;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
19 Guadalajara;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
19 Guadalajara;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;92,4
19 Guadalajara;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
19 Guadalajara;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
19 Guadalajara;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
19 Guadalajara;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
19 Guadalajara;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
19 Guadalajara;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
19 Guadalajara;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;88,46
19 Guadalajara;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
19 Guadalajara;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
19 Guadalajara;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
19 Guadalajara;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;90,27
19 Guadalajara;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
19 Guadalajara;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
19 Guadalajara;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
19 Guadalajara;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
19 Guadalajara;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
19 Guadalajara;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
19 Guadalajara;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QIV;4.602
19 Guadalajara;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
19 Guadalajara;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
19 Guadalajara;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
19 Guadalajara;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QIV;4.558
19 Guadalajara;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
19 Guadalajara;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
19 Guadalajara;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
19 Guadalajara;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QIV;4.359
19 Guadalajara;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
19 Guadalajara;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
19 Guadalajara;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
19 Guadalajara;All ages;Cohort October 1;Females;Survival in the first trimester;2022QIV;4.388
19 Guadalajara;All ages;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
19 Guadalajara;All ages;Cohort October 1;Females;Survival in the first trimester;2022QII;""
19 Guadalajara;All ages;Cohort October 1;Females;Survival in the first trimester;2022QI;""
19 Guadalajara;All ages;Cohort October 1;Females;Survival in the first trimester;2021QIV;4.364
19 Guadalajara;All ages;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
19 Guadalajara;All ages;Cohort October 1;Females;Survival in the first trimester;2021QII;""
19 Guadalajara;All ages;Cohort October 1;Females;Survival in the first trimester;2021QI;""
19 Guadalajara;All ages;Cohort October 1;Females;Survival in the first trimester;2020QIV;4.206
19 Guadalajara;All ages;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
19 Guadalajara;All ages;Cohort October 1;Females;Survival in the first trimester;2020QII;""
19 Guadalajara;All ages;Cohort October 1;Females;Survival in the first trimester;2020QI;""
19 Guadalajara;All ages;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
19 Guadalajara;All ages;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
19 Guadalajara;All ages;Cohort October 1;Females;Survival in the second trimester;2022QII;""
19 Guadalajara;All ages;Cohort October 1;Females;Survival in the second trimester;2022QI;4.212
19 Guadalajara;All ages;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
19 Guadalajara;All ages;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
19 Guadalajara;All ages;Cohort October 1;Females;Survival in the second trimester;2021QII;""
19 Guadalajara;All ages;Cohort October 1;Females;Survival in the second trimester;2021QI;4.084
19 Guadalajara;All ages;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
19 Guadalajara;All ages;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
19 Guadalajara;All ages;Cohort October 1;Females;Survival in the second trimester;2020QII;""
19 Guadalajara;All ages;Cohort October 1;Females;Survival in the second trimester;2020QI;""
19 Guadalajara;All ages;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
19 Guadalajara;All ages;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
19 Guadalajara;All ages;Cohort October 1;Females;Survival in the third trimester;2022QII;4.037
19 Guadalajara;All ages;Cohort October 1;Females;Survival in the third trimester;2022QI;""
19 Guadalajara;All ages;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
19 Guadalajara;All ages;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
19 Guadalajara;All ages;Cohort October 1;Females;Survival in the third trimester;2021QII;3.945
19 Guadalajara;All ages;Cohort October 1;Females;Survival in the third trimester;2021QI;""
19 Guadalajara;All ages;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
19 Guadalajara;All ages;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
19 Guadalajara;All ages;Cohort October 1;Females;Survival in the third trimester;2020QII;""
19 Guadalajara;All ages;Cohort October 1;Females;Survival in the third trimester;2020QI;""
19 Guadalajara;All ages;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
19 Guadalajara;All ages;Cohort October 1;Females;Survival in the third trimester;2022QIII;3.917
19 Guadalajara;All ages;Cohort October 1;Females;Survival in the third trimester;2022QII;""
19 Guadalajara;All ages;Cohort October 1;Females;Survival in the third trimester;2022QI;""
19 Guadalajara;All ages;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
19 Guadalajara;All ages;Cohort October 1;Females;Survival in the third trimester;2021QIII;3.826
19 Guadalajara;All ages;Cohort October 1;Females;Survival in the third trimester;2021QII;""
19 Guadalajara;All ages;Cohort October 1;Females;Survival in the third trimester;2021QI;""
19 Guadalajara;All ages;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
19 Guadalajara;All ages;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
19 Guadalajara;All ages;Cohort October 1;Females;Survival in the third trimester;2020QII;""
19 Guadalajara;All ages;Cohort October 1;Females;Survival in the third trimester;2020QI;""
19 Guadalajara;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
19 Guadalajara;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
19 Guadalajara;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
19 Guadalajara;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
19 Guadalajara;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
19 Guadalajara;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
19 Guadalajara;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
19 Guadalajara;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
19 Guadalajara;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
19 Guadalajara;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
19 Guadalajara;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
19 Guadalajara;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
19 Guadalajara;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;95,35
19 Guadalajara;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
19 Guadalajara;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
19 Guadalajara;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
19 Guadalajara;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;95,74
19 Guadalajara;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
19 Guadalajara;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
19 Guadalajara;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
19 Guadalajara;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;96,49
19 Guadalajara;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
19 Guadalajara;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
19 Guadalajara;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
19 Guadalajara;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
19 Guadalajara;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
19 Guadalajara;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
19 Guadalajara;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;92,41
19 Guadalajara;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
19 Guadalajara;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
19 Guadalajara;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
19 Guadalajara;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;93,69
19 Guadalajara;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
19 Guadalajara;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
19 Guadalajara;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
19 Guadalajara;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
19 Guadalajara;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
19 Guadalajara;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
19 Guadalajara;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;88,57
19 Guadalajara;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
19 Guadalajara;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
19 Guadalajara;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
19 Guadalajara;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;90,5
19 Guadalajara;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
19 Guadalajara;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
19 Guadalajara;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
19 Guadalajara;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
19 Guadalajara;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
19 Guadalajara;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
19 Guadalajara;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;85,94
19 Guadalajara;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
19 Guadalajara;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
19 Guadalajara;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
19 Guadalajara;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;87,77
19 Guadalajara;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
19 Guadalajara;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
19 Guadalajara;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
19 Guadalajara;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
19 Guadalajara;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
19 Guadalajara;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
19 Guadalajara;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
19 Guadalajara;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
19 Guadalajara;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
19 Guadalajara;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QI;875
19 Guadalajara;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
19 Guadalajara;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
19 Guadalajara;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
19 Guadalajara;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QI;829
19 Guadalajara;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
19 Guadalajara;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
19 Guadalajara;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
19 Guadalajara;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QI;670
19 Guadalajara;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
19 Guadalajara;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
19 Guadalajara;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2022QII;""
19 Guadalajara;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2022QI;804
19 Guadalajara;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
19 Guadalajara;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
19 Guadalajara;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2021QII;""
19 Guadalajara;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2021QI;785
19 Guadalajara;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
19 Guadalajara;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
19 Guadalajara;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2020QII;""
19 Guadalajara;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2020QI;561
19 Guadalajara;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
19 Guadalajara;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
19 Guadalajara;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2022QII;739
19 Guadalajara;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2022QI;""
19 Guadalajara;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
19 Guadalajara;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
19 Guadalajara;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2021QII;731
19 Guadalajara;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2021QI;""
19 Guadalajara;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
19 Guadalajara;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
19 Guadalajara;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2020QII;542
19 Guadalajara;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2020QI;""
19 Guadalajara;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
19 Guadalajara;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QIII;690
19 Guadalajara;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QII;""
19 Guadalajara;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QI;""
19 Guadalajara;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
19 Guadalajara;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QIII;682
19 Guadalajara;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QII;""
19 Guadalajara;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QI;""
19 Guadalajara;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
19 Guadalajara;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QIII;516
19 Guadalajara;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QII;""
19 Guadalajara;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QI;""
19 Guadalajara;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QIV;643
19 Guadalajara;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
19 Guadalajara;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QII;""
19 Guadalajara;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QI;""
19 Guadalajara;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QIV;650
19 Guadalajara;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
19 Guadalajara;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QII;""
19 Guadalajara;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QI;""
19 Guadalajara;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QIV;494
19 Guadalajara;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
19 Guadalajara;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QII;""
19 Guadalajara;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QI;""
19 Guadalajara;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
19 Guadalajara;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
19 Guadalajara;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
19 Guadalajara;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
19 Guadalajara;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
19 Guadalajara;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
19 Guadalajara;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
19 Guadalajara;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
19 Guadalajara;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
19 Guadalajara;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
19 Guadalajara;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
19 Guadalajara;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
19 Guadalajara;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
19 Guadalajara;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
19 Guadalajara;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
19 Guadalajara;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;91,89
19 Guadalajara;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
19 Guadalajara;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
19 Guadalajara;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
19 Guadalajara;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;94,69
19 Guadalajara;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
19 Guadalajara;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
19 Guadalajara;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
19 Guadalajara;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;83,73
19 Guadalajara;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
19 Guadalajara;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
19 Guadalajara;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;84,46
19 Guadalajara;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
19 Guadalajara;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
19 Guadalajara;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
19 Guadalajara;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;88,18
19 Guadalajara;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
19 Guadalajara;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
19 Guadalajara;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
19 Guadalajara;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;80,9
19 Guadalajara;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
19 Guadalajara;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
19 Guadalajara;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;78,86
19 Guadalajara;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
19 Guadalajara;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
19 Guadalajara;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
19 Guadalajara;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;82,27
19 Guadalajara;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
19 Guadalajara;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
19 Guadalajara;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
19 Guadalajara;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;77,01
19 Guadalajara;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
19 Guadalajara;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
19 Guadalajara;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;73,49
19 Guadalajara;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
19 Guadalajara;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
19 Guadalajara;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
19 Guadalajara;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;78,41
19 Guadalajara;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
19 Guadalajara;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
19 Guadalajara;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
19 Guadalajara;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;73,73
19 Guadalajara;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
19 Guadalajara;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
19 Guadalajara;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
19 Guadalajara;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
19 Guadalajara;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
19 Guadalajara;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
19 Guadalajara;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QI;555
19 Guadalajara;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
19 Guadalajara;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
19 Guadalajara;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
19 Guadalajara;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QI;543
19 Guadalajara;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
19 Guadalajara;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
19 Guadalajara;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
19 Guadalajara;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QI;446
19 Guadalajara;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
19 Guadalajara;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
19 Guadalajara;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2022QII;""
19 Guadalajara;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2022QI;504
19 Guadalajara;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
19 Guadalajara;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
19 Guadalajara;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2021QII;""
19 Guadalajara;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2021QI;513
19 Guadalajara;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
19 Guadalajara;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
19 Guadalajara;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2020QII;""
19 Guadalajara;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2020QI;380
19 Guadalajara;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
19 Guadalajara;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
19 Guadalajara;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2022QII;468
19 Guadalajara;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2022QI;""
19 Guadalajara;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
19 Guadalajara;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
19 Guadalajara;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2021QII;486
19 Guadalajara;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2021QI;""
19 Guadalajara;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
19 Guadalajara;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
19 Guadalajara;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2020QII;367
19 Guadalajara;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2020QI;""
19 Guadalajara;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
19 Guadalajara;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QIII;442
19 Guadalajara;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QII;""
19 Guadalajara;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QI;""
19 Guadalajara;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
19 Guadalajara;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QIII;460
19 Guadalajara;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QII;""
19 Guadalajara;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QI;""
19 Guadalajara;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
19 Guadalajara;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QIII;350
19 Guadalajara;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QII;""
19 Guadalajara;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QI;""
19 Guadalajara;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QIV;415
19 Guadalajara;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
19 Guadalajara;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QII;""
19 Guadalajara;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QI;""
19 Guadalajara;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QIV;440
19 Guadalajara;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
19 Guadalajara;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QII;""
19 Guadalajara;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QI;""
19 Guadalajara;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QIV;338
19 Guadalajara;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
19 Guadalajara;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QII;""
19 Guadalajara;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QI;""
19 Guadalajara;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
19 Guadalajara;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
19 Guadalajara;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
19 Guadalajara;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
19 Guadalajara;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
19 Guadalajara;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
19 Guadalajara;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
19 Guadalajara;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
19 Guadalajara;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
19 Guadalajara;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
19 Guadalajara;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
19 Guadalajara;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
19 Guadalajara;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
19 Guadalajara;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
19 Guadalajara;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
19 Guadalajara;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;90,81
19 Guadalajara;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
19 Guadalajara;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
19 Guadalajara;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
19 Guadalajara;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;94,48
19 Guadalajara;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
19 Guadalajara;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
19 Guadalajara;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
19 Guadalajara;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;85,2
19 Guadalajara;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
19 Guadalajara;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
19 Guadalajara;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;84,32
19 Guadalajara;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
19 Guadalajara;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
19 Guadalajara;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
19 Guadalajara;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;89,5
19 Guadalajara;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
19 Guadalajara;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
19 Guadalajara;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
19 Guadalajara;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;82,29
19 Guadalajara;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
19 Guadalajara;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
19 Guadalajara;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;79,64
19 Guadalajara;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
19 Guadalajara;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
19 Guadalajara;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
19 Guadalajara;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;84,71
19 Guadalajara;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
19 Guadalajara;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
19 Guadalajara;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
19 Guadalajara;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;78,48
19 Guadalajara;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
19 Guadalajara;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
19 Guadalajara;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;74,77
19 Guadalajara;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
19 Guadalajara;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
19 Guadalajara;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
19 Guadalajara;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;81,03
19 Guadalajara;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
19 Guadalajara;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
19 Guadalajara;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
19 Guadalajara;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;75,78
19 Guadalajara;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
19 Guadalajara;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
19 Guadalajara;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
19 Guadalajara;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
19 Guadalajara;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
19 Guadalajara;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
19 Guadalajara;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QI;320
19 Guadalajara;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
19 Guadalajara;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
19 Guadalajara;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
19 Guadalajara;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QI;286
19 Guadalajara;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
19 Guadalajara;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
19 Guadalajara;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
19 Guadalajara;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QI;224
19 Guadalajara;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
19 Guadalajara;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
19 Guadalajara;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2022QII;""
19 Guadalajara;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2022QI;300
19 Guadalajara;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
19 Guadalajara;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
19 Guadalajara;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2021QII;""
19 Guadalajara;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2021QI;272
19 Guadalajara;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
19 Guadalajara;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
19 Guadalajara;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2020QII;""
19 Guadalajara;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2020QI;181
19 Guadalajara;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
19 Guadalajara;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
19 Guadalajara;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2022QII;271
19 Guadalajara;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2022QI;""
19 Guadalajara;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
19 Guadalajara;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
19 Guadalajara;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2021QII;245
19 Guadalajara;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2021QI;""
19 Guadalajara;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
19 Guadalajara;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
19 Guadalajara;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2020QII;175
19 Guadalajara;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2020QI;""
19 Guadalajara;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
19 Guadalajara;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QIII;248
19 Guadalajara;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QII;""
19 Guadalajara;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QI;""
19 Guadalajara;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
19 Guadalajara;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QIII;222
19 Guadalajara;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QII;""
19 Guadalajara;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QI;""
19 Guadalajara;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
19 Guadalajara;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QIII;166
19 Guadalajara;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QII;""
19 Guadalajara;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QI;""
19 Guadalajara;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QIV;228
19 Guadalajara;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
19 Guadalajara;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QII;""
19 Guadalajara;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QI;""
19 Guadalajara;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QIV;210
19 Guadalajara;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
19 Guadalajara;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QII;""
19 Guadalajara;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QI;""
19 Guadalajara;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QIV;156
19 Guadalajara;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
19 Guadalajara;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QII;""
19 Guadalajara;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QI;""
19 Guadalajara;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
19 Guadalajara;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
19 Guadalajara;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
19 Guadalajara;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
19 Guadalajara;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
19 Guadalajara;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
19 Guadalajara;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
19 Guadalajara;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
19 Guadalajara;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
19 Guadalajara;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
19 Guadalajara;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
19 Guadalajara;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
19 Guadalajara;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
19 Guadalajara;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
19 Guadalajara;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
19 Guadalajara;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;93,75
19 Guadalajara;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
19 Guadalajara;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
19 Guadalajara;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
19 Guadalajara;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;95,1
19 Guadalajara;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
19 Guadalajara;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
19 Guadalajara;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
19 Guadalajara;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;80,8
19 Guadalajara;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
19 Guadalajara;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
19 Guadalajara;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;84,69
19 Guadalajara;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
19 Guadalajara;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
19 Guadalajara;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
19 Guadalajara;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;85,66
19 Guadalajara;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
19 Guadalajara;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
19 Guadalajara;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
19 Guadalajara;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;78,13
19 Guadalajara;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
19 Guadalajara;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
19 Guadalajara;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;77,5
19 Guadalajara;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
19 Guadalajara;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
19 Guadalajara;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
19 Guadalajara;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;77,62
19 Guadalajara;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
19 Guadalajara;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
19 Guadalajara;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
19 Guadalajara;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;74,11
19 Guadalajara;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
19 Guadalajara;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
19 Guadalajara;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;71,25
19 Guadalajara;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
19 Guadalajara;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
19 Guadalajara;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
19 Guadalajara;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;73,43
19 Guadalajara;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
19 Guadalajara;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
19 Guadalajara;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
19 Guadalajara;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;69,64
19 Guadalajara;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
19 Guadalajara;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
19 Guadalajara;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
19 Guadalajara;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
19 Guadalajara;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
19 Guadalajara;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QII;758
19 Guadalajara;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
19 Guadalajara;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
19 Guadalajara;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
19 Guadalajara;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QII;725
19 Guadalajara;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
19 Guadalajara;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
19 Guadalajara;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
19 Guadalajara;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QII;657
19 Guadalajara;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
19 Guadalajara;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
19 Guadalajara;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
19 Guadalajara;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2022QII;688
19 Guadalajara;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2022QI;""
19 Guadalajara;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
19 Guadalajara;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
19 Guadalajara;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2021QII;665
19 Guadalajara;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2021QI;""
19 Guadalajara;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
19 Guadalajara;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
19 Guadalajara;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2020QII;635
19 Guadalajara;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2020QI;""
19 Guadalajara;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
19 Guadalajara;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2022QIII;633
19 Guadalajara;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2022QII;""
19 Guadalajara;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2022QI;""
19 Guadalajara;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
19 Guadalajara;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2021QIII;613
19 Guadalajara;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2021QII;""
19 Guadalajara;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2021QI;""
19 Guadalajara;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
19 Guadalajara;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2020QIII;600
19 Guadalajara;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2020QII;""
19 Guadalajara;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2020QI;""
19 Guadalajara;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QIV;588
19 Guadalajara;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
19 Guadalajara;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QII;""
19 Guadalajara;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QI;""
19 Guadalajara;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QIV;579
19 Guadalajara;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
19 Guadalajara;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QII;""
19 Guadalajara;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QI;""
19 Guadalajara;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QIV;563
19 Guadalajara;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
19 Guadalajara;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QII;""
19 Guadalajara;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QI;""
19 Guadalajara;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
19 Guadalajara;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
19 Guadalajara;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QII;""
19 Guadalajara;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QI;540
19 Guadalajara;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
19 Guadalajara;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
19 Guadalajara;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QII;""
19 Guadalajara;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QI;538
19 Guadalajara;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
19 Guadalajara;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
19 Guadalajara;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QII;""
19 Guadalajara;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QI;""
19 Guadalajara;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
19 Guadalajara;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
19 Guadalajara;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
19 Guadalajara;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
19 Guadalajara;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
19 Guadalajara;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
19 Guadalajara;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
19 Guadalajara;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
19 Guadalajara;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
19 Guadalajara;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
19 Guadalajara;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
19 Guadalajara;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
19 Guadalajara;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
19 Guadalajara;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
19 Guadalajara;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;90,77
19 Guadalajara;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
19 Guadalajara;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
19 Guadalajara;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
19 Guadalajara;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;91,72
19 Guadalajara;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
19 Guadalajara;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
19 Guadalajara;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
19 Guadalajara;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;96,65
19 Guadalajara;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
19 Guadalajara;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
19 Guadalajara;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;83,51
19 Guadalajara;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
19 Guadalajara;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
19 Guadalajara;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
19 Guadalajara;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;84,55
19 Guadalajara;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
19 Guadalajara;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
19 Guadalajara;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
19 Guadalajara;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;91,32
19 Guadalajara;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
19 Guadalajara;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
19 Guadalajara;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;77,57
19 Guadalajara;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
19 Guadalajara;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
19 Guadalajara;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
19 Guadalajara;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;79,86
19 Guadalajara;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
19 Guadalajara;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
19 Guadalajara;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
19 Guadalajara;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;85,69
19 Guadalajara;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
19 Guadalajara;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
19 Guadalajara;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
19 Guadalajara;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
19 Guadalajara;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
19 Guadalajara;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
19 Guadalajara;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;74,48
19 Guadalajara;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
19 Guadalajara;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
19 Guadalajara;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
19 Guadalajara;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;81,89
19 Guadalajara;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
19 Guadalajara;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
19 Guadalajara;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
19 Guadalajara;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
19 Guadalajara;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
19 Guadalajara;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
19 Guadalajara;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QII;484
19 Guadalajara;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
19 Guadalajara;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
19 Guadalajara;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
19 Guadalajara;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QII;470
19 Guadalajara;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
19 Guadalajara;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
19 Guadalajara;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
19 Guadalajara;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QII;444
19 Guadalajara;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
19 Guadalajara;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
19 Guadalajara;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
19 Guadalajara;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2022QII;444
19 Guadalajara;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2022QI;""
19 Guadalajara;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
19 Guadalajara;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
19 Guadalajara;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2021QII;436
19 Guadalajara;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2021QI;""
19 Guadalajara;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
19 Guadalajara;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
19 Guadalajara;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2020QII;430
19 Guadalajara;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2020QI;""
19 Guadalajara;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
19 Guadalajara;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2022QIII;418
19 Guadalajara;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2022QII;""
19 Guadalajara;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2022QI;""
19 Guadalajara;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
19 Guadalajara;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2021QIII;406
19 Guadalajara;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2021QII;""
19 Guadalajara;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2021QI;""
19 Guadalajara;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
19 Guadalajara;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2020QIII;407
19 Guadalajara;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2020QII;""
19 Guadalajara;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2020QI;""
19 Guadalajara;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QIV;390
19 Guadalajara;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
19 Guadalajara;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QII;""
19 Guadalajara;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QI;""
19 Guadalajara;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QIV;385
19 Guadalajara;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
19 Guadalajara;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QII;""
19 Guadalajara;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QI;""
19 Guadalajara;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QIV;384
19 Guadalajara;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
19 Guadalajara;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QII;""
19 Guadalajara;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QI;""
19 Guadalajara;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
19 Guadalajara;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
19 Guadalajara;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QII;""
19 Guadalajara;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QI;356
19 Guadalajara;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
19 Guadalajara;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
19 Guadalajara;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QII;""
19 Guadalajara;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QI;367
19 Guadalajara;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
19 Guadalajara;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
19 Guadalajara;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QII;""
19 Guadalajara;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QI;""
19 Guadalajara;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
19 Guadalajara;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
19 Guadalajara;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
19 Guadalajara;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
19 Guadalajara;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
19 Guadalajara;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
19 Guadalajara;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
19 Guadalajara;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
19 Guadalajara;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
19 Guadalajara;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
19 Guadalajara;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
19 Guadalajara;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
19 Guadalajara;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
19 Guadalajara;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
19 Guadalajara;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;91,74
19 Guadalajara;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
19 Guadalajara;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
19 Guadalajara;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
19 Guadalajara;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;92,77
19 Guadalajara;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
19 Guadalajara;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
19 Guadalajara;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
19 Guadalajara;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;96,85
19 Guadalajara;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
19 Guadalajara;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
19 Guadalajara;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;86,36
19 Guadalajara;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
19 Guadalajara;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
19 Guadalajara;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
19 Guadalajara;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;86,38
19 Guadalajara;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
19 Guadalajara;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
19 Guadalajara;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
19 Guadalajara;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;91,67
19 Guadalajara;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
19 Guadalajara;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
19 Guadalajara;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;80,58
19 Guadalajara;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
19 Guadalajara;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
19 Guadalajara;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
19 Guadalajara;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;81,91
19 Guadalajara;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
19 Guadalajara;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
19 Guadalajara;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
19 Guadalajara;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;86,49
19 Guadalajara;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
19 Guadalajara;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
19 Guadalajara;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
19 Guadalajara;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
19 Guadalajara;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
19 Guadalajara;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
19 Guadalajara;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;75,74
19 Guadalajara;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
19 Guadalajara;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
19 Guadalajara;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
19 Guadalajara;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;82,66
19 Guadalajara;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
19 Guadalajara;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
19 Guadalajara;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
19 Guadalajara;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
19 Guadalajara;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
19 Guadalajara;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
19 Guadalajara;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QII;274
19 Guadalajara;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
19 Guadalajara;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
19 Guadalajara;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
19 Guadalajara;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QII;255
19 Guadalajara;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
19 Guadalajara;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
19 Guadalajara;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
19 Guadalajara;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QII;213
19 Guadalajara;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
19 Guadalajara;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
19 Guadalajara;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
19 Guadalajara;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2022QII;244
19 Guadalajara;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2022QI;""
19 Guadalajara;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
19 Guadalajara;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
19 Guadalajara;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2021QII;229
19 Guadalajara;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2021QI;""
19 Guadalajara;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
19 Guadalajara;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
19 Guadalajara;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2020QII;205
19 Guadalajara;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2020QI;""
19 Guadalajara;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
19 Guadalajara;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2022QIII;215
19 Guadalajara;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2022QII;""
19 Guadalajara;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2022QI;""
19 Guadalajara;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
19 Guadalajara;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2021QIII;207
19 Guadalajara;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2021QII;""
19 Guadalajara;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2021QI;""
19 Guadalajara;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
19 Guadalajara;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2020QIII;193
19 Guadalajara;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2020QII;""
19 Guadalajara;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2020QI;""
19 Guadalajara;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QIV;198
19 Guadalajara;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
19 Guadalajara;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QII;""
19 Guadalajara;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QI;""
19 Guadalajara;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QIV;194
19 Guadalajara;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
19 Guadalajara;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QII;""
19 Guadalajara;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QI;""
19 Guadalajara;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QIV;179
19 Guadalajara;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
19 Guadalajara;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QII;""
19 Guadalajara;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QI;""
19 Guadalajara;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
19 Guadalajara;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
19 Guadalajara;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QII;""
19 Guadalajara;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QI;184
19 Guadalajara;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
19 Guadalajara;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
19 Guadalajara;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QII;""
19 Guadalajara;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QI;171
19 Guadalajara;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
19 Guadalajara;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
19 Guadalajara;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QII;""
19 Guadalajara;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QI;""
19 Guadalajara;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
19 Guadalajara;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
19 Guadalajara;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
19 Guadalajara;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
19 Guadalajara;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
19 Guadalajara;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
19 Guadalajara;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
19 Guadalajara;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
19 Guadalajara;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
19 Guadalajara;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
19 Guadalajara;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
19 Guadalajara;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
19 Guadalajara;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
19 Guadalajara;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
19 Guadalajara;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;89,05
19 Guadalajara;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
19 Guadalajara;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
19 Guadalajara;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
19 Guadalajara;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;89,8
19 Guadalajara;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
19 Guadalajara;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
19 Guadalajara;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
19 Guadalajara;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;96,24
19 Guadalajara;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
19 Guadalajara;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
19 Guadalajara;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;78,47
19 Guadalajara;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
19 Guadalajara;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
19 Guadalajara;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
19 Guadalajara;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;81,18
19 Guadalajara;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
19 Guadalajara;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
19 Guadalajara;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
19 Guadalajara;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;90,61
19 Guadalajara;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
19 Guadalajara;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
19 Guadalajara;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;72,26
19 Guadalajara;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
19 Guadalajara;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
19 Guadalajara;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
19 Guadalajara;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;76,08
19 Guadalajara;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
19 Guadalajara;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
19 Guadalajara;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
19 Guadalajara;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;84,04
19 Guadalajara;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
19 Guadalajara;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
19 Guadalajara;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
19 Guadalajara;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
19 Guadalajara;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
19 Guadalajara;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
19 Guadalajara;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;72,16
19 Guadalajara;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
19 Guadalajara;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
19 Guadalajara;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
19 Guadalajara;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;80,28
19 Guadalajara;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
19 Guadalajara;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
19 Guadalajara;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
19 Guadalajara;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
19 Guadalajara;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
19 Guadalajara;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QIII;816
19 Guadalajara;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
19 Guadalajara;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
19 Guadalajara;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
19 Guadalajara;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QIII;796
19 Guadalajara;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
19 Guadalajara;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
19 Guadalajara;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
19 Guadalajara;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QIII;733
19 Guadalajara;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
19 Guadalajara;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
19 Guadalajara;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
19 Guadalajara;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2022QIII;731
19 Guadalajara;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2022QII;""
19 Guadalajara;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2022QI;""
19 Guadalajara;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
19 Guadalajara;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2021QIII;707
19 Guadalajara;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2021QII;""
19 Guadalajara;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2021QI;""
19 Guadalajara;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
19 Guadalajara;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2020QIII;674
19 Guadalajara;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2020QII;""
19 Guadalajara;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2020QI;""
19 Guadalajara;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2022QIV;676
19 Guadalajara;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
19 Guadalajara;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2022QII;""
19 Guadalajara;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2022QI;""
19 Guadalajara;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2021QIV;661
19 Guadalajara;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
19 Guadalajara;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2021QII;""
19 Guadalajara;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2021QI;""
19 Guadalajara;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2020QIV;628
19 Guadalajara;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
19 Guadalajara;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2020QII;""
19 Guadalajara;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2020QI;""
19 Guadalajara;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
19 Guadalajara;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
19 Guadalajara;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QII;""
19 Guadalajara;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QI;611
19 Guadalajara;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
19 Guadalajara;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
19 Guadalajara;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QII;""
19 Guadalajara;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QI;600
19 Guadalajara;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
19 Guadalajara;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
19 Guadalajara;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QII;""
19 Guadalajara;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QI;""
19 Guadalajara;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
19 Guadalajara;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
19 Guadalajara;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QII;571
19 Guadalajara;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QI;""
19 Guadalajara;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
19 Guadalajara;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
19 Guadalajara;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QII;567
19 Guadalajara;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QI;""
19 Guadalajara;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
19 Guadalajara;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
19 Guadalajara;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QII;""
19 Guadalajara;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QI;""
19 Guadalajara;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
19 Guadalajara;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
19 Guadalajara;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
19 Guadalajara;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
19 Guadalajara;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
19 Guadalajara;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
19 Guadalajara;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
19 Guadalajara;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
19 Guadalajara;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
19 Guadalajara;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
19 Guadalajara;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
19 Guadalajara;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
19 Guadalajara;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
19 Guadalajara;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;89,58
19 Guadalajara;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
19 Guadalajara;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
19 Guadalajara;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
19 Guadalajara;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;88,82
19 Guadalajara;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
19 Guadalajara;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
19 Guadalajara;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
19 Guadalajara;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;91,95
19 Guadalajara;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
19 Guadalajara;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
19 Guadalajara;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;82,84
19 Guadalajara;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
19 Guadalajara;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
19 Guadalajara;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
19 Guadalajara;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;83,04
19 Guadalajara;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
19 Guadalajara;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
19 Guadalajara;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
19 Guadalajara;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;85,68
19 Guadalajara;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
19 Guadalajara;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
19 Guadalajara;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
19 Guadalajara;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
19 Guadalajara;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
19 Guadalajara;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
19 Guadalajara;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;76,76
19 Guadalajara;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
19 Guadalajara;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
19 Guadalajara;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
19 Guadalajara;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;81,86
19 Guadalajara;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
19 Guadalajara;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
19 Guadalajara;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
19 Guadalajara;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
19 Guadalajara;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
19 Guadalajara;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
19 Guadalajara;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;71,73
19 Guadalajara;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
19 Guadalajara;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
19 Guadalajara;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
19 Guadalajara;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;77,35
19 Guadalajara;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
19 Guadalajara;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
19 Guadalajara;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
19 Guadalajara;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
19 Guadalajara;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
19 Guadalajara;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
19 Guadalajara;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QIII;523
19 Guadalajara;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
19 Guadalajara;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
19 Guadalajara;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
19 Guadalajara;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QIII;512
19 Guadalajara;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
19 Guadalajara;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
19 Guadalajara;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
19 Guadalajara;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QIII;495
19 Guadalajara;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
19 Guadalajara;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
19 Guadalajara;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
19 Guadalajara;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2022QIII;478
19 Guadalajara;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2022QII;""
19 Guadalajara;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2022QI;""
19 Guadalajara;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
19 Guadalajara;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2021QIII;460
19 Guadalajara;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2021QII;""
19 Guadalajara;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2021QI;""
19 Guadalajara;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
19 Guadalajara;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2020QIII;455
19 Guadalajara;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2020QII;""
19 Guadalajara;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2020QI;""
19 Guadalajara;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2022QIV;443
19 Guadalajara;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
19 Guadalajara;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2022QII;""
19 Guadalajara;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2022QI;""
19 Guadalajara;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2021QIV;431
19 Guadalajara;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
19 Guadalajara;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2021QII;""
19 Guadalajara;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2021QI;""
19 Guadalajara;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2020QIV;426
19 Guadalajara;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
19 Guadalajara;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2020QII;""
19 Guadalajara;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2020QI;""
19 Guadalajara;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
19 Guadalajara;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
19 Guadalajara;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QII;""
19 Guadalajara;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QI;393
19 Guadalajara;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
19 Guadalajara;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
19 Guadalajara;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QII;""
19 Guadalajara;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QI;408
19 Guadalajara;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
19 Guadalajara;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
19 Guadalajara;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QII;""
19 Guadalajara;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QI;""
19 Guadalajara;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
19 Guadalajara;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
19 Guadalajara;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QII;373
19 Guadalajara;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QI;""
19 Guadalajara;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
19 Guadalajara;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
19 Guadalajara;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QII;387
19 Guadalajara;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QI;""
19 Guadalajara;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
19 Guadalajara;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
19 Guadalajara;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QII;""
19 Guadalajara;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QI;""
19 Guadalajara;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
19 Guadalajara;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
19 Guadalajara;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
19 Guadalajara;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
19 Guadalajara;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
19 Guadalajara;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
19 Guadalajara;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
19 Guadalajara;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
19 Guadalajara;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
19 Guadalajara;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
19 Guadalajara;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
19 Guadalajara;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
19 Guadalajara;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
19 Guadalajara;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;91,4
19 Guadalajara;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
19 Guadalajara;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
19 Guadalajara;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
19 Guadalajara;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;89,84
19 Guadalajara;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
19 Guadalajara;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
19 Guadalajara;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
19 Guadalajara;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;91,92
19 Guadalajara;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
19 Guadalajara;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
19 Guadalajara;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;84,7
19 Guadalajara;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
19 Guadalajara;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
19 Guadalajara;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
19 Guadalajara;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;84,18
19 Guadalajara;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
19 Guadalajara;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
19 Guadalajara;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
19 Guadalajara;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;86,06
19 Guadalajara;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
19 Guadalajara;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
19 Guadalajara;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
19 Guadalajara;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
19 Guadalajara;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
19 Guadalajara;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
19 Guadalajara;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;76,76
19 Guadalajara;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
19 Guadalajara;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
19 Guadalajara;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
19 Guadalajara;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;82,42
19 Guadalajara;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
19 Guadalajara;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
19 Guadalajara;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
19 Guadalajara;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
19 Guadalajara;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
19 Guadalajara;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
19 Guadalajara;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;72,85
19 Guadalajara;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
19 Guadalajara;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
19 Guadalajara;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
19 Guadalajara;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;78,18
19 Guadalajara;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
19 Guadalajara;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
19 Guadalajara;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
19 Guadalajara;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
19 Guadalajara;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
19 Guadalajara;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
19 Guadalajara;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QIII;293
19 Guadalajara;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
19 Guadalajara;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
19 Guadalajara;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
19 Guadalajara;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QIII;284
19 Guadalajara;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
19 Guadalajara;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
19 Guadalajara;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
19 Guadalajara;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QIII;238
19 Guadalajara;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
19 Guadalajara;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
19 Guadalajara;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
19 Guadalajara;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2022QIII;253
19 Guadalajara;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2022QII;""
19 Guadalajara;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2022QI;""
19 Guadalajara;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
19 Guadalajara;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2021QIII;247
19 Guadalajara;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2021QII;""
19 Guadalajara;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2021QI;""
19 Guadalajara;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
19 Guadalajara;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2020QIII;219
19 Guadalajara;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2020QII;""
19 Guadalajara;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2020QI;""
19 Guadalajara;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2022QIV;233
19 Guadalajara;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
19 Guadalajara;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2022QII;""
19 Guadalajara;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2022QI;""
19 Guadalajara;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2021QIV;230
19 Guadalajara;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
19 Guadalajara;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2021QII;""
19 Guadalajara;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2021QI;""
19 Guadalajara;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2020QIV;202
19 Guadalajara;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
19 Guadalajara;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2020QII;""
19 Guadalajara;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2020QI;""
19 Guadalajara;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
19 Guadalajara;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
19 Guadalajara;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QII;""
19 Guadalajara;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QI;218
19 Guadalajara;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
19 Guadalajara;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
19 Guadalajara;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QII;""
19 Guadalajara;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QI;192
19 Guadalajara;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
19 Guadalajara;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
19 Guadalajara;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QII;""
19 Guadalajara;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QI;""
19 Guadalajara;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
19 Guadalajara;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
19 Guadalajara;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QII;198
19 Guadalajara;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QI;""
19 Guadalajara;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
19 Guadalajara;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
19 Guadalajara;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QII;180
19 Guadalajara;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QI;""
19 Guadalajara;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
19 Guadalajara;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
19 Guadalajara;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QII;""
19 Guadalajara;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QI;""
19 Guadalajara;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
19 Guadalajara;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
19 Guadalajara;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
19 Guadalajara;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
19 Guadalajara;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
19 Guadalajara;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
19 Guadalajara;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
19 Guadalajara;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
19 Guadalajara;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
19 Guadalajara;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
19 Guadalajara;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
19 Guadalajara;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
19 Guadalajara;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
19 Guadalajara;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;86,35
19 Guadalajara;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
19 Guadalajara;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
19 Guadalajara;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
19 Guadalajara;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;86,97
19 Guadalajara;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
19 Guadalajara;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
19 Guadalajara;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
19 Guadalajara;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;92,02
19 Guadalajara;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
19 Guadalajara;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
19 Guadalajara;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;79,52
19 Guadalajara;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
19 Guadalajara;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
19 Guadalajara;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
19 Guadalajara;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;80,99
19 Guadalajara;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
19 Guadalajara;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
19 Guadalajara;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
19 Guadalajara;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;84,87
19 Guadalajara;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
19 Guadalajara;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
19 Guadalajara;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
19 Guadalajara;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
19 Guadalajara;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
19 Guadalajara;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
19 Guadalajara;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;76,76
19 Guadalajara;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
19 Guadalajara;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
19 Guadalajara;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
19 Guadalajara;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;80,67
19 Guadalajara;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
19 Guadalajara;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
19 Guadalajara;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
19 Guadalajara;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
19 Guadalajara;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
19 Guadalajara;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
19 Guadalajara;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;69,72
19 Guadalajara;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
19 Guadalajara;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
19 Guadalajara;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
19 Guadalajara;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;75,63
19 Guadalajara;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
19 Guadalajara;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
19 Guadalajara;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
19 Guadalajara;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
19 Guadalajara;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
19 Guadalajara;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QIV;826
19 Guadalajara;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
19 Guadalajara;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
19 Guadalajara;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
19 Guadalajara;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QIV;817
19 Guadalajara;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
19 Guadalajara;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
19 Guadalajara;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
19 Guadalajara;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QIV;771
19 Guadalajara;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
19 Guadalajara;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
19 Guadalajara;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
19 Guadalajara;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2022QIV;760
19 Guadalajara;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
19 Guadalajara;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2022QII;""
19 Guadalajara;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2022QI;""
19 Guadalajara;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2021QIV;754
19 Guadalajara;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
19 Guadalajara;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2021QII;""
19 Guadalajara;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2021QI;""
19 Guadalajara;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2020QIV;711
19 Guadalajara;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
19 Guadalajara;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2020QII;""
19 Guadalajara;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2020QI;""
19 Guadalajara;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
19 Guadalajara;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
19 Guadalajara;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2022QII;""
19 Guadalajara;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2022QI;698
19 Guadalajara;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
19 Guadalajara;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
19 Guadalajara;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2021QII;""
19 Guadalajara;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2021QI;676
19 Guadalajara;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
19 Guadalajara;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
19 Guadalajara;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2020QII;""
19 Guadalajara;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2020QI;""
19 Guadalajara;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
19 Guadalajara;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
19 Guadalajara;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QII;647
19 Guadalajara;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QI;""
19 Guadalajara;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
19 Guadalajara;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
19 Guadalajara;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QII;633
19 Guadalajara;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QI;""
19 Guadalajara;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
19 Guadalajara;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
19 Guadalajara;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QII;""
19 Guadalajara;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QI;""
19 Guadalajara;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
19 Guadalajara;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QIII;608
19 Guadalajara;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QII;""
19 Guadalajara;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QI;""
19 Guadalajara;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
19 Guadalajara;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QIII;591
19 Guadalajara;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QII;""
19 Guadalajara;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QI;""
19 Guadalajara;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
19 Guadalajara;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
19 Guadalajara;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QII;""
19 Guadalajara;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QI;""
19 Guadalajara;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
19 Guadalajara;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
19 Guadalajara;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
19 Guadalajara;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
19 Guadalajara;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
19 Guadalajara;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
19 Guadalajara;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
19 Guadalajara;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
19 Guadalajara;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
19 Guadalajara;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
19 Guadalajara;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
19 Guadalajara;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
19 Guadalajara;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;92,01
19 Guadalajara;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
19 Guadalajara;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
19 Guadalajara;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
19 Guadalajara;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;92,29
19 Guadalajara;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
19 Guadalajara;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
19 Guadalajara;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
19 Guadalajara;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;92,22
19 Guadalajara;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
19 Guadalajara;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
19 Guadalajara;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
19 Guadalajara;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
19 Guadalajara;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
19 Guadalajara;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
19 Guadalajara;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;85,43
19 Guadalajara;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
19 Guadalajara;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
19 Guadalajara;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
19 Guadalajara;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;87,68
19 Guadalajara;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
19 Guadalajara;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
19 Guadalajara;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
19 Guadalajara;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
19 Guadalajara;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
19 Guadalajara;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
19 Guadalajara;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;79,19
19 Guadalajara;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
19 Guadalajara;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
19 Guadalajara;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
19 Guadalajara;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;82,1
19 Guadalajara;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
19 Guadalajara;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
19 Guadalajara;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
19 Guadalajara;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
19 Guadalajara;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
19 Guadalajara;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
19 Guadalajara;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;74,42
19 Guadalajara;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
19 Guadalajara;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
19 Guadalajara;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
19 Guadalajara;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;76,65
19 Guadalajara;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
19 Guadalajara;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
19 Guadalajara;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
19 Guadalajara;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
19 Guadalajara;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
19 Guadalajara;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
19 Guadalajara;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QIV;537
19 Guadalajara;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
19 Guadalajara;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
19 Guadalajara;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
19 Guadalajara;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QIV;523
19 Guadalajara;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
19 Guadalajara;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
19 Guadalajara;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
19 Guadalajara;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QIV;513
19 Guadalajara;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
19 Guadalajara;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
19 Guadalajara;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
19 Guadalajara;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2022QIV;494
19 Guadalajara;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
19 Guadalajara;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2022QII;""
19 Guadalajara;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2022QI;""
19 Guadalajara;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2021QIV;484
19 Guadalajara;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
19 Guadalajara;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2021QII;""
19 Guadalajara;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2021QI;""
19 Guadalajara;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2020QIV;472
19 Guadalajara;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
19 Guadalajara;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2020QII;""
19 Guadalajara;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2020QI;""
19 Guadalajara;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
19 Guadalajara;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
19 Guadalajara;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2022QII;""
19 Guadalajara;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2022QI;442
19 Guadalajara;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
19 Guadalajara;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
19 Guadalajara;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2021QII;""
19 Guadalajara;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2021QI;449
19 Guadalajara;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
19 Guadalajara;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
19 Guadalajara;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2020QII;""
19 Guadalajara;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2020QI;""
19 Guadalajara;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
19 Guadalajara;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
19 Guadalajara;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QII;415
19 Guadalajara;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QI;""
19 Guadalajara;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
19 Guadalajara;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
19 Guadalajara;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QII;427
19 Guadalajara;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QI;""
19 Guadalajara;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
19 Guadalajara;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
19 Guadalajara;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QII;""
19 Guadalajara;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QI;""
19 Guadalajara;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
19 Guadalajara;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QIII;395
19 Guadalajara;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QII;""
19 Guadalajara;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QI;""
19 Guadalajara;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
19 Guadalajara;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QIII;402
19 Guadalajara;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QII;""
19 Guadalajara;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QI;""
19 Guadalajara;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
19 Guadalajara;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
19 Guadalajara;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QII;""
19 Guadalajara;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QI;""
19 Guadalajara;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
19 Guadalajara;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
19 Guadalajara;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
19 Guadalajara;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
19 Guadalajara;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
19 Guadalajara;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
19 Guadalajara;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
19 Guadalajara;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
19 Guadalajara;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
19 Guadalajara;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
19 Guadalajara;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
19 Guadalajara;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
19 Guadalajara;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;91,99
19 Guadalajara;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
19 Guadalajara;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
19 Guadalajara;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
19 Guadalajara;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;92,54
19 Guadalajara;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
19 Guadalajara;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
19 Guadalajara;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
19 Guadalajara;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;92,01
19 Guadalajara;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
19 Guadalajara;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
19 Guadalajara;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
19 Guadalajara;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
19 Guadalajara;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
19 Guadalajara;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
19 Guadalajara;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;84,51
19 Guadalajara;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
19 Guadalajara;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
19 Guadalajara;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
19 Guadalajara;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;87,52
19 Guadalajara;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
19 Guadalajara;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
19 Guadalajara;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
19 Guadalajara;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
19 Guadalajara;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
19 Guadalajara;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
19 Guadalajara;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;79,35
19 Guadalajara;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
19 Guadalajara;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
19 Guadalajara;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
19 Guadalajara;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;83,24
19 Guadalajara;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
19 Guadalajara;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
19 Guadalajara;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
19 Guadalajara;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
19 Guadalajara;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
19 Guadalajara;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
19 Guadalajara;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;75,53
19 Guadalajara;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
19 Guadalajara;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
19 Guadalajara;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
19 Guadalajara;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;78,36
19 Guadalajara;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
19 Guadalajara;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
19 Guadalajara;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
19 Guadalajara;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
19 Guadalajara;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
19 Guadalajara;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
19 Guadalajara;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QIV;289
19 Guadalajara;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
19 Guadalajara;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
19 Guadalajara;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
19 Guadalajara;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QIV;294
19 Guadalajara;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
19 Guadalajara;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
19 Guadalajara;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
19 Guadalajara;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QIV;258
19 Guadalajara;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
19 Guadalajara;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
19 Guadalajara;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
19 Guadalajara;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2022QIV;266
19 Guadalajara;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
19 Guadalajara;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2022QII;""
19 Guadalajara;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2022QI;""
19 Guadalajara;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2021QIV;270
19 Guadalajara;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
19 Guadalajara;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2021QII;""
19 Guadalajara;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2021QI;""
19 Guadalajara;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2020QIV;239
19 Guadalajara;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
19 Guadalajara;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2020QII;""
19 Guadalajara;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2020QI;""
19 Guadalajara;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
19 Guadalajara;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
19 Guadalajara;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2022QII;""
19 Guadalajara;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2022QI;256
19 Guadalajara;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
19 Guadalajara;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
19 Guadalajara;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2021QII;""
19 Guadalajara;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2021QI;227
19 Guadalajara;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
19 Guadalajara;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
19 Guadalajara;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2020QII;""
19 Guadalajara;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2020QI;""
19 Guadalajara;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
19 Guadalajara;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
19 Guadalajara;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QII;232
19 Guadalajara;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QI;""
19 Guadalajara;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
19 Guadalajara;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
19 Guadalajara;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QII;206
19 Guadalajara;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QI;""
19 Guadalajara;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
19 Guadalajara;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
19 Guadalajara;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QII;""
19 Guadalajara;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QI;""
19 Guadalajara;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
19 Guadalajara;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QIII;213
19 Guadalajara;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QII;""
19 Guadalajara;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QI;""
19 Guadalajara;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
19 Guadalajara;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QIII;189
19 Guadalajara;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QII;""
19 Guadalajara;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QI;""
19 Guadalajara;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
19 Guadalajara;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
19 Guadalajara;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QII;""
19 Guadalajara;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QI;""
19 Guadalajara;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
19 Guadalajara;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
19 Guadalajara;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
19 Guadalajara;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
19 Guadalajara;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
19 Guadalajara;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
19 Guadalajara;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
19 Guadalajara;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
19 Guadalajara;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
19 Guadalajara;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
19 Guadalajara;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
19 Guadalajara;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
19 Guadalajara;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;92,04
19 Guadalajara;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
19 Guadalajara;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
19 Guadalajara;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
19 Guadalajara;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;91,84
19 Guadalajara;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
19 Guadalajara;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
19 Guadalajara;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
19 Guadalajara;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;92,64
19 Guadalajara;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
19 Guadalajara;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
19 Guadalajara;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
19 Guadalajara;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
19 Guadalajara;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
19 Guadalajara;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
19 Guadalajara;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;87,07
19 Guadalajara;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
19 Guadalajara;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
19 Guadalajara;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
19 Guadalajara;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;87,98
19 Guadalajara;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
19 Guadalajara;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
19 Guadalajara;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
19 Guadalajara;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
19 Guadalajara;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
19 Guadalajara;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
19 Guadalajara;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;78,91
19 Guadalajara;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
19 Guadalajara;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
19 Guadalajara;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
19 Guadalajara;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;79,84
19 Guadalajara;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
19 Guadalajara;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
19 Guadalajara;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
19 Guadalajara;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
19 Guadalajara;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
19 Guadalajara;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
19 Guadalajara;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;72,45
19 Guadalajara;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
19 Guadalajara;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
19 Guadalajara;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
19 Guadalajara;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;73,26
19 Guadalajara;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
19 Guadalajara;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
19 Guadalajara;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
19 Guadalajara;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
19 Guadalajara;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
19 Guadalajara;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
19 Guadalajara;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
19 Guadalajara;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
19 Guadalajara;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
19 Guadalajara;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QI;2.396
19 Guadalajara;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
19 Guadalajara;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
19 Guadalajara;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
19 Guadalajara;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QI;2.394
19 Guadalajara;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
19 Guadalajara;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
19 Guadalajara;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
19 Guadalajara;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QI;2.264
19 Guadalajara;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
19 Guadalajara;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
19 Guadalajara;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2022QII;""
19 Guadalajara;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2022QI;2.273
19 Guadalajara;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
19 Guadalajara;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
19 Guadalajara;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2021QII;""
19 Guadalajara;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2021QI;2.313
19 Guadalajara;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
19 Guadalajara;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
19 Guadalajara;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2020QII;""
19 Guadalajara;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2020QI;2.071
19 Guadalajara;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
19 Guadalajara;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
19 Guadalajara;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2022QII;2.165
19 Guadalajara;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2022QI;""
19 Guadalajara;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
19 Guadalajara;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
19 Guadalajara;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2021QII;2.228
19 Guadalajara;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2021QI;""
19 Guadalajara;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
19 Guadalajara;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
19 Guadalajara;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2020QII;2.035
19 Guadalajara;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2020QI;""
19 Guadalajara;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
19 Guadalajara;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QIII;2.080
19 Guadalajara;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QII;""
19 Guadalajara;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QI;""
19 Guadalajara;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
19 Guadalajara;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QIII;2.146
19 Guadalajara;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QII;""
19 Guadalajara;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QI;""
19 Guadalajara;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
19 Guadalajara;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QIII;1.975
19 Guadalajara;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QII;""
19 Guadalajara;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QI;""
19 Guadalajara;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QIV;2.001
19 Guadalajara;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
19 Guadalajara;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QII;""
19 Guadalajara;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QI;""
19 Guadalajara;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QIV;2.071
19 Guadalajara;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
19 Guadalajara;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QII;""
19 Guadalajara;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QI;""
19 Guadalajara;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QIV;1.918
19 Guadalajara;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
19 Guadalajara;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QII;""
19 Guadalajara;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QI;""
19 Guadalajara;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
19 Guadalajara;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
19 Guadalajara;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
19 Guadalajara;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
19 Guadalajara;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
19 Guadalajara;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
19 Guadalajara;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
19 Guadalajara;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
19 Guadalajara;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
19 Guadalajara;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
19 Guadalajara;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
19 Guadalajara;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
19 Guadalajara;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
19 Guadalajara;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
19 Guadalajara;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
19 Guadalajara;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;94,87
19 Guadalajara;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
19 Guadalajara;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
19 Guadalajara;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
19 Guadalajara;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;96,62
19 Guadalajara;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
19 Guadalajara;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
19 Guadalajara;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
19 Guadalajara;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;91,48
19 Guadalajara;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
19 Guadalajara;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
19 Guadalajara;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;90,36
19 Guadalajara;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
19 Guadalajara;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
19 Guadalajara;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
19 Guadalajara;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;93,07
19 Guadalajara;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
19 Guadalajara;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
19 Guadalajara;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
19 Guadalajara;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;89,89
19 Guadalajara;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
19 Guadalajara;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
19 Guadalajara;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;86,81
19 Guadalajara;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
19 Guadalajara;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
19 Guadalajara;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
19 Guadalajara;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;89,64
19 Guadalajara;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
19 Guadalajara;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
19 Guadalajara;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
19 Guadalajara;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;87,23
19 Guadalajara;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
19 Guadalajara;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
19 Guadalajara;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;83,51
19 Guadalajara;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
19 Guadalajara;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
19 Guadalajara;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
19 Guadalajara;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;86,51
19 Guadalajara;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
19 Guadalajara;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
19 Guadalajara;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
19 Guadalajara;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;84,72
19 Guadalajara;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
19 Guadalajara;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
19 Guadalajara;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
19 Guadalajara;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
19 Guadalajara;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
19 Guadalajara;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
19 Guadalajara;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QI;1.464
19 Guadalajara;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
19 Guadalajara;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
19 Guadalajara;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
19 Guadalajara;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QI;1.474
19 Guadalajara;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
19 Guadalajara;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
19 Guadalajara;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
19 Guadalajara;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QI;1.379
19 Guadalajara;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
19 Guadalajara;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
19 Guadalajara;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2022QII;""
19 Guadalajara;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2022QI;1.398
19 Guadalajara;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
19 Guadalajara;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
19 Guadalajara;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2021QII;""
19 Guadalajara;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2021QI;1.428
19 Guadalajara;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
19 Guadalajara;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
19 Guadalajara;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2020QII;""
19 Guadalajara;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2020QI;1.266
19 Guadalajara;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
19 Guadalajara;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
19 Guadalajara;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2022QII;1.340
19 Guadalajara;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2022QI;""
19 Guadalajara;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
19 Guadalajara;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
19 Guadalajara;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2021QII;1.381
19 Guadalajara;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2021QI;""
19 Guadalajara;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
19 Guadalajara;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
19 Guadalajara;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2020QII;1.243
19 Guadalajara;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2020QI;""
19 Guadalajara;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
19 Guadalajara;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QIII;1.283
19 Guadalajara;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QII;""
19 Guadalajara;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QI;""
19 Guadalajara;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
19 Guadalajara;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QIII;1.337
19 Guadalajara;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QII;""
19 Guadalajara;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QI;""
19 Guadalajara;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
19 Guadalajara;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QIII;1.218
19 Guadalajara;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QII;""
19 Guadalajara;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QI;""
19 Guadalajara;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QIV;1.240
19 Guadalajara;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
19 Guadalajara;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QII;""
19 Guadalajara;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QI;""
19 Guadalajara;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QIV;1.288
19 Guadalajara;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
19 Guadalajara;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QII;""
19 Guadalajara;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QI;""
19 Guadalajara;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QIV;1.188
19 Guadalajara;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
19 Guadalajara;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QII;""
19 Guadalajara;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QI;""
19 Guadalajara;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
19 Guadalajara;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
19 Guadalajara;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
19 Guadalajara;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
19 Guadalajara;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
19 Guadalajara;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
19 Guadalajara;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
19 Guadalajara;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
19 Guadalajara;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
19 Guadalajara;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
19 Guadalajara;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
19 Guadalajara;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
19 Guadalajara;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
19 Guadalajara;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
19 Guadalajara;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
19 Guadalajara;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;95,49
19 Guadalajara;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
19 Guadalajara;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
19 Guadalajara;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
19 Guadalajara;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;96,88
19 Guadalajara;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
19 Guadalajara;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
19 Guadalajara;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
19 Guadalajara;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;91,81
19 Guadalajara;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
19 Guadalajara;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
19 Guadalajara;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;91,53
19 Guadalajara;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
19 Guadalajara;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
19 Guadalajara;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
19 Guadalajara;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;93,69
19 Guadalajara;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
19 Guadalajara;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
19 Guadalajara;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
19 Guadalajara;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;90,14
19 Guadalajara;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
19 Guadalajara;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
19 Guadalajara;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;87,64
19 Guadalajara;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
19 Guadalajara;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
19 Guadalajara;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
19 Guadalajara;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;90,71
19 Guadalajara;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
19 Guadalajara;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
19 Guadalajara;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
19 Guadalajara;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;88,32
19 Guadalajara;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
19 Guadalajara;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
19 Guadalajara;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;84,7
19 Guadalajara;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
19 Guadalajara;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
19 Guadalajara;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
19 Guadalajara;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;87,38
19 Guadalajara;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
19 Guadalajara;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
19 Guadalajara;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
19 Guadalajara;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;86,15
19 Guadalajara;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
19 Guadalajara;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
19 Guadalajara;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
19 Guadalajara;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
19 Guadalajara;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
19 Guadalajara;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
19 Guadalajara;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QI;932
19 Guadalajara;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
19 Guadalajara;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
19 Guadalajara;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
19 Guadalajara;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QI;920
19 Guadalajara;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
19 Guadalajara;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
19 Guadalajara;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
19 Guadalajara;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QI;885
19 Guadalajara;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
19 Guadalajara;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
19 Guadalajara;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2022QII;""
19 Guadalajara;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2022QI;875
19 Guadalajara;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
19 Guadalajara;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
19 Guadalajara;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2021QII;""
19 Guadalajara;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2021QI;885
19 Guadalajara;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
19 Guadalajara;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
19 Guadalajara;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2020QII;""
19 Guadalajara;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2020QI;805
19 Guadalajara;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
19 Guadalajara;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
19 Guadalajara;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2022QII;825
19 Guadalajara;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2022QI;""
19 Guadalajara;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
19 Guadalajara;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
19 Guadalajara;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2021QII;847
19 Guadalajara;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2021QI;""
19 Guadalajara;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
19 Guadalajara;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
19 Guadalajara;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2020QII;792
19 Guadalajara;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2020QI;""
19 Guadalajara;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
19 Guadalajara;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QIII;797
19 Guadalajara;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QII;""
19 Guadalajara;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QI;""
19 Guadalajara;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
19 Guadalajara;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QIII;809
19 Guadalajara;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QII;""
19 Guadalajara;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QI;""
19 Guadalajara;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
19 Guadalajara;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QIII;757
19 Guadalajara;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QII;""
19 Guadalajara;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QI;""
19 Guadalajara;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QIV;761
19 Guadalajara;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
19 Guadalajara;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QII;""
19 Guadalajara;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QI;""
19 Guadalajara;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QIV;783
19 Guadalajara;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
19 Guadalajara;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QII;""
19 Guadalajara;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QI;""
19 Guadalajara;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QIV;730
19 Guadalajara;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
19 Guadalajara;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QII;""
19 Guadalajara;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QI;""
19 Guadalajara;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
19 Guadalajara;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
19 Guadalajara;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
19 Guadalajara;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
19 Guadalajara;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
19 Guadalajara;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
19 Guadalajara;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
19 Guadalajara;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
19 Guadalajara;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
19 Guadalajara;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
19 Guadalajara;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
19 Guadalajara;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
19 Guadalajara;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
19 Guadalajara;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
19 Guadalajara;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
19 Guadalajara;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;93,88
19 Guadalajara;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
19 Guadalajara;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
19 Guadalajara;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
19 Guadalajara;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;96,2
19 Guadalajara;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
19 Guadalajara;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
19 Guadalajara;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
19 Guadalajara;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;90,96
19 Guadalajara;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
19 Guadalajara;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
19 Guadalajara;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;88,52
19 Guadalajara;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
19 Guadalajara;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
19 Guadalajara;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
19 Guadalajara;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;92,07
19 Guadalajara;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
19 Guadalajara;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
19 Guadalajara;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
19 Guadalajara;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;89,49
19 Guadalajara;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
19 Guadalajara;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
19 Guadalajara;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;85,52
19 Guadalajara;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
19 Guadalajara;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
19 Guadalajara;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
19 Guadalajara;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;87,93
19 Guadalajara;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
19 Guadalajara;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
19 Guadalajara;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
19 Guadalajara;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;85,54
19 Guadalajara;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
19 Guadalajara;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
19 Guadalajara;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;81,65
19 Guadalajara;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
19 Guadalajara;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
19 Guadalajara;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
19 Guadalajara;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;85,11
19 Guadalajara;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
19 Guadalajara;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
19 Guadalajara;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
19 Guadalajara;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;82,49
19 Guadalajara;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
19 Guadalajara;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
19 Guadalajara;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
19 Guadalajara;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
19 Guadalajara;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
19 Guadalajara;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QII;2.241
19 Guadalajara;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
19 Guadalajara;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
19 Guadalajara;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
19 Guadalajara;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QII;2.309
19 Guadalajara;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
19 Guadalajara;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
19 Guadalajara;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
19 Guadalajara;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QII;2.219
19 Guadalajara;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
19 Guadalajara;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
19 Guadalajara;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
19 Guadalajara;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2022QII;2.128
19 Guadalajara;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2022QI;""
19 Guadalajara;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
19 Guadalajara;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
19 Guadalajara;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2021QII;2.213
19 Guadalajara;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2021QI;""
19 Guadalajara;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
19 Guadalajara;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
19 Guadalajara;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2020QII;2.180
19 Guadalajara;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2020QI;""
19 Guadalajara;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
19 Guadalajara;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2022QIII;2.040
19 Guadalajara;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2022QII;""
19 Guadalajara;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2022QI;""
19 Guadalajara;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
19 Guadalajara;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2021QIII;2.119
19 Guadalajara;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2021QII;""
19 Guadalajara;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2021QI;""
19 Guadalajara;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
19 Guadalajara;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2020QIII;2.109
19 Guadalajara;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2020QII;""
19 Guadalajara;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2020QI;""
19 Guadalajara;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QIV;1.952
19 Guadalajara;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
19 Guadalajara;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QII;""
19 Guadalajara;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QI;""
19 Guadalajara;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QIV;2.038
19 Guadalajara;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
19 Guadalajara;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QII;""
19 Guadalajara;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QI;""
19 Guadalajara;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QIV;2.043
19 Guadalajara;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
19 Guadalajara;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QII;""
19 Guadalajara;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QI;""
19 Guadalajara;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
19 Guadalajara;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
19 Guadalajara;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QII;""
19 Guadalajara;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QI;1.954
19 Guadalajara;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
19 Guadalajara;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
19 Guadalajara;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QII;""
19 Guadalajara;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QI;1.991
19 Guadalajara;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
19 Guadalajara;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
19 Guadalajara;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QII;""
19 Guadalajara;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QI;""
19 Guadalajara;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
19 Guadalajara;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
19 Guadalajara;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
19 Guadalajara;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
19 Guadalajara;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
19 Guadalajara;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
19 Guadalajara;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
19 Guadalajara;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
19 Guadalajara;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
19 Guadalajara;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
19 Guadalajara;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
19 Guadalajara;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
19 Guadalajara;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
19 Guadalajara;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
19 Guadalajara;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;94,96
19 Guadalajara;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
19 Guadalajara;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
19 Guadalajara;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
19 Guadalajara;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;95,84
19 Guadalajara;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
19 Guadalajara;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
19 Guadalajara;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
19 Guadalajara;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;98,24
19 Guadalajara;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
19 Guadalajara;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
19 Guadalajara;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;91,03
19 Guadalajara;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
19 Guadalajara;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
19 Guadalajara;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
19 Guadalajara;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;91,77
19 Guadalajara;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
19 Guadalajara;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
19 Guadalajara;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
19 Guadalajara;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;95,04
19 Guadalajara;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
19 Guadalajara;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
19 Guadalajara;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;87,1
19 Guadalajara;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
19 Guadalajara;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
19 Guadalajara;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
19 Guadalajara;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;88,26
19 Guadalajara;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
19 Guadalajara;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
19 Guadalajara;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
19 Guadalajara;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;92,07
19 Guadalajara;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
19 Guadalajara;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
19 Guadalajara;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
19 Guadalajara;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
19 Guadalajara;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
19 Guadalajara;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
19 Guadalajara;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;84,63
19 Guadalajara;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
19 Guadalajara;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
19 Guadalajara;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
19 Guadalajara;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;89,73
19 Guadalajara;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
19 Guadalajara;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
19 Guadalajara;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
19 Guadalajara;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
19 Guadalajara;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
19 Guadalajara;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
19 Guadalajara;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QII;1.373
19 Guadalajara;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
19 Guadalajara;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
19 Guadalajara;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
19 Guadalajara;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QII;1.423
19 Guadalajara;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
19 Guadalajara;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
19 Guadalajara;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
19 Guadalajara;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QII;1.362
19 Guadalajara;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
19 Guadalajara;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
19 Guadalajara;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
19 Guadalajara;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2022QII;1.309
19 Guadalajara;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2022QI;""
19 Guadalajara;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
19 Guadalajara;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
19 Guadalajara;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2021QII;1.368
19 Guadalajara;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2021QI;""
19 Guadalajara;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
19 Guadalajara;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
19 Guadalajara;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2020QII;1.337
19 Guadalajara;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2020QI;""
19 Guadalajara;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
19 Guadalajara;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2022QIII;1.249
19 Guadalajara;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2022QII;""
19 Guadalajara;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2022QI;""
19 Guadalajara;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
19 Guadalajara;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2021QIII;1.318
19 Guadalajara;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2021QII;""
19 Guadalajara;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2021QI;""
19 Guadalajara;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
19 Guadalajara;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2020QIII;1.305
19 Guadalajara;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2020QII;""
19 Guadalajara;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2020QI;""
19 Guadalajara;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QIV;1.199
19 Guadalajara;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
19 Guadalajara;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QII;""
19 Guadalajara;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QI;""
19 Guadalajara;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QIV;1.262
19 Guadalajara;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
19 Guadalajara;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QII;""
19 Guadalajara;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QI;""
19 Guadalajara;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QIV;1.267
19 Guadalajara;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
19 Guadalajara;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QII;""
19 Guadalajara;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QI;""
19 Guadalajara;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
19 Guadalajara;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
19 Guadalajara;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QII;""
19 Guadalajara;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QI;1.213
19 Guadalajara;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
19 Guadalajara;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
19 Guadalajara;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QII;""
19 Guadalajara;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QI;1.240
19 Guadalajara;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
19 Guadalajara;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
19 Guadalajara;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QII;""
19 Guadalajara;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QI;""
19 Guadalajara;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
19 Guadalajara;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
19 Guadalajara;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
19 Guadalajara;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
19 Guadalajara;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
19 Guadalajara;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
19 Guadalajara;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
19 Guadalajara;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
19 Guadalajara;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
19 Guadalajara;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
19 Guadalajara;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
19 Guadalajara;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
19 Guadalajara;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
19 Guadalajara;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
19 Guadalajara;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;95,34
19 Guadalajara;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
19 Guadalajara;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
19 Guadalajara;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
19 Guadalajara;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;96,13
19 Guadalajara;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
19 Guadalajara;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
19 Guadalajara;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
19 Guadalajara;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;98,16
19 Guadalajara;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
19 Guadalajara;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
19 Guadalajara;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;90,97
19 Guadalajara;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
19 Guadalajara;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
19 Guadalajara;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
19 Guadalajara;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;92,62
19 Guadalajara;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
19 Guadalajara;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
19 Guadalajara;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
19 Guadalajara;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;95,81
19 Guadalajara;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
19 Guadalajara;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
19 Guadalajara;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;87,33
19 Guadalajara;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
19 Guadalajara;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
19 Guadalajara;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
19 Guadalajara;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;88,69
19 Guadalajara;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
19 Guadalajara;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
19 Guadalajara;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
19 Guadalajara;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;93,02
19 Guadalajara;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
19 Guadalajara;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
19 Guadalajara;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
19 Guadalajara;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
19 Guadalajara;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
19 Guadalajara;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
19 Guadalajara;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;85,24
19 Guadalajara;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
19 Guadalajara;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
19 Guadalajara;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
19 Guadalajara;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;91,04
19 Guadalajara;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
19 Guadalajara;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
19 Guadalajara;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
19 Guadalajara;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
19 Guadalajara;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
19 Guadalajara;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
19 Guadalajara;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QII;868
19 Guadalajara;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
19 Guadalajara;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
19 Guadalajara;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
19 Guadalajara;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QII;886
19 Guadalajara;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
19 Guadalajara;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
19 Guadalajara;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
19 Guadalajara;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QII;857
19 Guadalajara;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
19 Guadalajara;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
19 Guadalajara;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
19 Guadalajara;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2022QII;819
19 Guadalajara;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2022QI;""
19 Guadalajara;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
19 Guadalajara;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
19 Guadalajara;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2021QII;845
19 Guadalajara;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2021QI;""
19 Guadalajara;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
19 Guadalajara;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
19 Guadalajara;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2020QII;843
19 Guadalajara;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2020QI;""
19 Guadalajara;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
19 Guadalajara;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2022QIII;791
19 Guadalajara;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2022QII;""
19 Guadalajara;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2022QI;""
19 Guadalajara;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
19 Guadalajara;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2021QIII;801
19 Guadalajara;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2021QII;""
19 Guadalajara;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2021QI;""
19 Guadalajara;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
19 Guadalajara;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2020QIII;804
19 Guadalajara;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2020QII;""
19 Guadalajara;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2020QI;""
19 Guadalajara;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QIV;753
19 Guadalajara;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
19 Guadalajara;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QII;""
19 Guadalajara;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QI;""
19 Guadalajara;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QIV;776
19 Guadalajara;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
19 Guadalajara;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QII;""
19 Guadalajara;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QI;""
19 Guadalajara;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QIV;776
19 Guadalajara;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
19 Guadalajara;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QII;""
19 Guadalajara;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QI;""
19 Guadalajara;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
19 Guadalajara;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
19 Guadalajara;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QII;""
19 Guadalajara;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QI;741
19 Guadalajara;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
19 Guadalajara;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
19 Guadalajara;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QII;""
19 Guadalajara;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QI;751
19 Guadalajara;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
19 Guadalajara;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
19 Guadalajara;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QII;""
19 Guadalajara;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QI;""
19 Guadalajara;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
19 Guadalajara;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
19 Guadalajara;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
19 Guadalajara;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
19 Guadalajara;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
19 Guadalajara;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
19 Guadalajara;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
19 Guadalajara;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
19 Guadalajara;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
19 Guadalajara;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
19 Guadalajara;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
19 Guadalajara;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
19 Guadalajara;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
19 Guadalajara;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
19 Guadalajara;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;94,35
19 Guadalajara;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
19 Guadalajara;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
19 Guadalajara;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
19 Guadalajara;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;95,37
19 Guadalajara;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
19 Guadalajara;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
19 Guadalajara;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
19 Guadalajara;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;98,37
19 Guadalajara;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
19 Guadalajara;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
19 Guadalajara;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;91,13
19 Guadalajara;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
19 Guadalajara;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
19 Guadalajara;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
19 Guadalajara;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;90,41
19 Guadalajara;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
19 Guadalajara;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
19 Guadalajara;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
19 Guadalajara;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;93,82
19 Guadalajara;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
19 Guadalajara;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
19 Guadalajara;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;86,75
19 Guadalajara;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
19 Guadalajara;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
19 Guadalajara;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
19 Guadalajara;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;87,58
19 Guadalajara;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
19 Guadalajara;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
19 Guadalajara;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
19 Guadalajara;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;90,55
19 Guadalajara;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
19 Guadalajara;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
19 Guadalajara;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
19 Guadalajara;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
19 Guadalajara;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
19 Guadalajara;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
19 Guadalajara;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;83,63
19 Guadalajara;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
19 Guadalajara;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
19 Guadalajara;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
19 Guadalajara;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;87,63
19 Guadalajara;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
19 Guadalajara;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
19 Guadalajara;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
19 Guadalajara;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
19 Guadalajara;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
19 Guadalajara;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QIII;2.272
19 Guadalajara;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
19 Guadalajara;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
19 Guadalajara;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
19 Guadalajara;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QIII;2.348
19 Guadalajara;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
19 Guadalajara;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
19 Guadalajara;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
19 Guadalajara;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QIII;2.281
19 Guadalajara;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
19 Guadalajara;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
19 Guadalajara;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
19 Guadalajara;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2022QIII;2.171
19 Guadalajara;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2022QII;""
19 Guadalajara;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2022QI;""
19 Guadalajara;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
19 Guadalajara;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2021QIII;2.235
19 Guadalajara;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2021QII;""
19 Guadalajara;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2021QI;""
19 Guadalajara;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
19 Guadalajara;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2020QIII;2.196
19 Guadalajara;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2020QII;""
19 Guadalajara;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2020QI;""
19 Guadalajara;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2022QIV;2.070
19 Guadalajara;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
19 Guadalajara;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2022QII;""
19 Guadalajara;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2022QI;""
19 Guadalajara;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2021QIV;2.140
19 Guadalajara;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
19 Guadalajara;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2021QII;""
19 Guadalajara;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2021QI;""
19 Guadalajara;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2020QIV;2.123
19 Guadalajara;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
19 Guadalajara;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2020QII;""
19 Guadalajara;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2020QI;""
19 Guadalajara;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
19 Guadalajara;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
19 Guadalajara;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QII;""
19 Guadalajara;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QI;2.048
19 Guadalajara;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
19 Guadalajara;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
19 Guadalajara;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QII;""
19 Guadalajara;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QI;2.067
19 Guadalajara;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
19 Guadalajara;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
19 Guadalajara;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QII;""
19 Guadalajara;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QI;""
19 Guadalajara;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
19 Guadalajara;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
19 Guadalajara;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QII;1.963
19 Guadalajara;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QI;""
19 Guadalajara;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
19 Guadalajara;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
19 Guadalajara;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QII;2.006
19 Guadalajara;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QI;""
19 Guadalajara;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
19 Guadalajara;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
19 Guadalajara;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QII;""
19 Guadalajara;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QI;""
19 Guadalajara;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
19 Guadalajara;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
19 Guadalajara;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
19 Guadalajara;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
19 Guadalajara;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
19 Guadalajara;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
19 Guadalajara;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
19 Guadalajara;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
19 Guadalajara;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
19 Guadalajara;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
19 Guadalajara;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
19 Guadalajara;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
19 Guadalajara;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
19 Guadalajara;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;95,55
19 Guadalajara;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
19 Guadalajara;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
19 Guadalajara;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
19 Guadalajara;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;95,19
19 Guadalajara;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
19 Guadalajara;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
19 Guadalajara;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
19 Guadalajara;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;96,27
19 Guadalajara;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
19 Guadalajara;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
19 Guadalajara;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;91,11
19 Guadalajara;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
19 Guadalajara;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
19 Guadalajara;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
19 Guadalajara;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;91,14
19 Guadalajara;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
19 Guadalajara;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
19 Guadalajara;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
19 Guadalajara;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;93,07
19 Guadalajara;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
19 Guadalajara;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
19 Guadalajara;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
19 Guadalajara;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
19 Guadalajara;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
19 Guadalajara;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
19 Guadalajara;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;87,22
19 Guadalajara;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
19 Guadalajara;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
19 Guadalajara;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
19 Guadalajara;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;90,62
19 Guadalajara;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
19 Guadalajara;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
19 Guadalajara;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
19 Guadalajara;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
19 Guadalajara;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
19 Guadalajara;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
19 Guadalajara;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;83,6
19 Guadalajara;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
19 Guadalajara;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
19 Guadalajara;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
19 Guadalajara;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;87,94
19 Guadalajara;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
19 Guadalajara;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
19 Guadalajara;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
19 Guadalajara;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
19 Guadalajara;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
19 Guadalajara;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
19 Guadalajara;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QIII;1.382
19 Guadalajara;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
19 Guadalajara;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
19 Guadalajara;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
19 Guadalajara;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QIII;1.447
19 Guadalajara;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
19 Guadalajara;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
19 Guadalajara;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
19 Guadalajara;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QIII;1.406
19 Guadalajara;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
19 Guadalajara;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
19 Guadalajara;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
19 Guadalajara;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2022QIII;1.317
19 Guadalajara;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2022QII;""
19 Guadalajara;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2022QI;""
19 Guadalajara;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
19 Guadalajara;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2021QIII;1.387
19 Guadalajara;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2021QII;""
19 Guadalajara;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2021QI;""
19 Guadalajara;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
19 Guadalajara;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2020QIII;1.364
19 Guadalajara;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2020QII;""
19 Guadalajara;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2020QI;""
19 Guadalajara;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2022QIV;1.258
19 Guadalajara;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
19 Guadalajara;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2022QII;""
19 Guadalajara;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2022QI;""
19 Guadalajara;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2021QIV;1.322
19 Guadalajara;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
19 Guadalajara;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2021QII;""
19 Guadalajara;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2021QI;""
19 Guadalajara;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2020QIV;1.322
19 Guadalajara;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
19 Guadalajara;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2020QII;""
19 Guadalajara;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2020QI;""
19 Guadalajara;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
19 Guadalajara;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
19 Guadalajara;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QII;""
19 Guadalajara;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QI;1.269
19 Guadalajara;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
19 Guadalajara;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
19 Guadalajara;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QII;""
19 Guadalajara;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QI;1.292
19 Guadalajara;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
19 Guadalajara;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
19 Guadalajara;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QII;""
19 Guadalajara;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QI;""
19 Guadalajara;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
19 Guadalajara;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
19 Guadalajara;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QII;1.223
19 Guadalajara;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QI;""
19 Guadalajara;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
19 Guadalajara;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
19 Guadalajara;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QII;1.262
19 Guadalajara;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QI;""
19 Guadalajara;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
19 Guadalajara;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
19 Guadalajara;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QII;""
19 Guadalajara;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QI;""
19 Guadalajara;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
19 Guadalajara;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
19 Guadalajara;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
19 Guadalajara;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
19 Guadalajara;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
19 Guadalajara;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
19 Guadalajara;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
19 Guadalajara;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
19 Guadalajara;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
19 Guadalajara;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
19 Guadalajara;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
19 Guadalajara;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
19 Guadalajara;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
19 Guadalajara;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;95,3
19 Guadalajara;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
19 Guadalajara;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
19 Guadalajara;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
19 Guadalajara;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;95,85
19 Guadalajara;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
19 Guadalajara;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
19 Guadalajara;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
19 Guadalajara;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;97,01
19 Guadalajara;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
19 Guadalajara;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
19 Guadalajara;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;91,03
19 Guadalajara;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
19 Guadalajara;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
19 Guadalajara;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
19 Guadalajara;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;91,36
19 Guadalajara;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
19 Guadalajara;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
19 Guadalajara;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
19 Guadalajara;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;94,03
19 Guadalajara;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
19 Guadalajara;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
19 Guadalajara;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
19 Guadalajara;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
19 Guadalajara;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
19 Guadalajara;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
19 Guadalajara;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;87,7
19 Guadalajara;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
19 Guadalajara;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
19 Guadalajara;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
19 Guadalajara;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;91,89
19 Guadalajara;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
19 Guadalajara;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
19 Guadalajara;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
19 Guadalajara;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
19 Guadalajara;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
19 Guadalajara;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
19 Guadalajara;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;84,52
19 Guadalajara;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
19 Guadalajara;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
19 Guadalajara;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
19 Guadalajara;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;89,76
19 Guadalajara;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
19 Guadalajara;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
19 Guadalajara;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
19 Guadalajara;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
19 Guadalajara;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
19 Guadalajara;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
19 Guadalajara;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QIII;890
19 Guadalajara;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
19 Guadalajara;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
19 Guadalajara;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
19 Guadalajara;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QIII;901
19 Guadalajara;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
19 Guadalajara;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
19 Guadalajara;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
19 Guadalajara;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QIII;875
19 Guadalajara;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
19 Guadalajara;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
19 Guadalajara;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
19 Guadalajara;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2022QIII;854
19 Guadalajara;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2022QII;""
19 Guadalajara;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2022QI;""
19 Guadalajara;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
19 Guadalajara;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2021QIII;848
19 Guadalajara;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2021QII;""
19 Guadalajara;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2021QI;""
19 Guadalajara;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
19 Guadalajara;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2020QIII;832
19 Guadalajara;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2020QII;""
19 Guadalajara;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2020QI;""
19 Guadalajara;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2022QIV;812
19 Guadalajara;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
19 Guadalajara;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2022QII;""
19 Guadalajara;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2022QI;""
19 Guadalajara;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2021QIV;818
19 Guadalajara;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
19 Guadalajara;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2021QII;""
19 Guadalajara;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2021QI;""
19 Guadalajara;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2020QIV;801
19 Guadalajara;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
19 Guadalajara;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2020QII;""
19 Guadalajara;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2020QI;""
19 Guadalajara;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
19 Guadalajara;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
19 Guadalajara;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QII;""
19 Guadalajara;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QI;779
19 Guadalajara;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
19 Guadalajara;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
19 Guadalajara;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QII;""
19 Guadalajara;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QI;775
19 Guadalajara;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
19 Guadalajara;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
19 Guadalajara;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QII;""
19 Guadalajara;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QI;""
19 Guadalajara;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
19 Guadalajara;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
19 Guadalajara;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QII;740
19 Guadalajara;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QI;""
19 Guadalajara;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
19 Guadalajara;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
19 Guadalajara;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QII;744
19 Guadalajara;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QI;""
19 Guadalajara;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
19 Guadalajara;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
19 Guadalajara;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QII;""
19 Guadalajara;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QI;""
19 Guadalajara;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
19 Guadalajara;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
19 Guadalajara;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
19 Guadalajara;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
19 Guadalajara;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
19 Guadalajara;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
19 Guadalajara;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
19 Guadalajara;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
19 Guadalajara;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
19 Guadalajara;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
19 Guadalajara;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
19 Guadalajara;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
19 Guadalajara;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
19 Guadalajara;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;95,96
19 Guadalajara;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
19 Guadalajara;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
19 Guadalajara;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
19 Guadalajara;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;94,12
19 Guadalajara;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
19 Guadalajara;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
19 Guadalajara;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
19 Guadalajara;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;95,09
19 Guadalajara;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
19 Guadalajara;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
19 Guadalajara;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;91,24
19 Guadalajara;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
19 Guadalajara;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
19 Guadalajara;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
19 Guadalajara;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;90,79
19 Guadalajara;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
19 Guadalajara;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
19 Guadalajara;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
19 Guadalajara;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;91,54
19 Guadalajara;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
19 Guadalajara;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
19 Guadalajara;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
19 Guadalajara;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
19 Guadalajara;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
19 Guadalajara;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
19 Guadalajara;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;86,46
19 Guadalajara;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
19 Guadalajara;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
19 Guadalajara;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
19 Guadalajara;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;88,57
19 Guadalajara;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
19 Guadalajara;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
19 Guadalajara;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
19 Guadalajara;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
19 Guadalajara;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
19 Guadalajara;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
19 Guadalajara;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;82,13
19 Guadalajara;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
19 Guadalajara;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
19 Guadalajara;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
19 Guadalajara;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;85,03
19 Guadalajara;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
19 Guadalajara;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
19 Guadalajara;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
19 Guadalajara;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
19 Guadalajara;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
19 Guadalajara;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QIV;2.276
19 Guadalajara;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
19 Guadalajara;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
19 Guadalajara;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
19 Guadalajara;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QIV;2.353
19 Guadalajara;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
19 Guadalajara;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
19 Guadalajara;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
19 Guadalajara;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QIV;2.322
19 Guadalajara;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
19 Guadalajara;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
19 Guadalajara;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
19 Guadalajara;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2022QIV;2.166
19 Guadalajara;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
19 Guadalajara;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2022QII;""
19 Guadalajara;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2022QI;""
19 Guadalajara;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2021QIV;2.242
19 Guadalajara;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
19 Guadalajara;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2021QII;""
19 Guadalajara;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2021QI;""
19 Guadalajara;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2020QIV;2.239
19 Guadalajara;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
19 Guadalajara;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2020QII;""
19 Guadalajara;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2020QI;""
19 Guadalajara;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
19 Guadalajara;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
19 Guadalajara;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2022QII;""
19 Guadalajara;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2022QI;2.142
19 Guadalajara;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
19 Guadalajara;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
19 Guadalajara;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2021QII;""
19 Guadalajara;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2021QI;2.176
19 Guadalajara;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
19 Guadalajara;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
19 Guadalajara;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2020QII;""
19 Guadalajara;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2020QI;""
19 Guadalajara;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
19 Guadalajara;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
19 Guadalajara;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QII;2.048
19 Guadalajara;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QI;""
19 Guadalajara;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
19 Guadalajara;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
19 Guadalajara;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QII;2.107
19 Guadalajara;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QI;""
19 Guadalajara;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
19 Guadalajara;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
19 Guadalajara;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QII;""
19 Guadalajara;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QI;""
19 Guadalajara;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
19 Guadalajara;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QIII;1.974
19 Guadalajara;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QII;""
19 Guadalajara;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QI;""
19 Guadalajara;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
19 Guadalajara;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QIII;2.033
19 Guadalajara;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QII;""
19 Guadalajara;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QI;""
19 Guadalajara;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
19 Guadalajara;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
19 Guadalajara;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QII;""
19 Guadalajara;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QI;""
19 Guadalajara;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
19 Guadalajara;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
19 Guadalajara;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
19 Guadalajara;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
19 Guadalajara;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
19 Guadalajara;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
19 Guadalajara;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
19 Guadalajara;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
19 Guadalajara;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
19 Guadalajara;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
19 Guadalajara;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
19 Guadalajara;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
19 Guadalajara;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;95,17
19 Guadalajara;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
19 Guadalajara;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
19 Guadalajara;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
19 Guadalajara;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;95,28
19 Guadalajara;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
19 Guadalajara;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
19 Guadalajara;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
19 Guadalajara;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;96,43
19 Guadalajara;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
19 Guadalajara;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
19 Guadalajara;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
19 Guadalajara;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
19 Guadalajara;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
19 Guadalajara;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
19 Guadalajara;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;91,03
19 Guadalajara;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
19 Guadalajara;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
19 Guadalajara;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
19 Guadalajara;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;93,71
19 Guadalajara;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
19 Guadalajara;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
19 Guadalajara;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
19 Guadalajara;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
19 Guadalajara;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
19 Guadalajara;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
19 Guadalajara;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;87,04
19 Guadalajara;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
19 Guadalajara;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
19 Guadalajara;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
19 Guadalajara;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;90,74
19 Guadalajara;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
19 Guadalajara;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
19 Guadalajara;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
19 Guadalajara;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
19 Guadalajara;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
19 Guadalajara;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
19 Guadalajara;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;83,89
19 Guadalajara;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
19 Guadalajara;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
19 Guadalajara;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
19 Guadalajara;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;87,55
19 Guadalajara;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
19 Guadalajara;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
19 Guadalajara;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
19 Guadalajara;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
19 Guadalajara;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
19 Guadalajara;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
19 Guadalajara;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QIV;1.376
19 Guadalajara;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
19 Guadalajara;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
19 Guadalajara;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
19 Guadalajara;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QIV;1.448
19 Guadalajara;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
19 Guadalajara;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
19 Guadalajara;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
19 Guadalajara;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QIV;1.449
19 Guadalajara;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
19 Guadalajara;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
19 Guadalajara;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
19 Guadalajara;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2022QIV;1.314
19 Guadalajara;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
19 Guadalajara;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2022QII;""
19 Guadalajara;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2022QI;""
19 Guadalajara;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2021QIV;1.373
19 Guadalajara;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
19 Guadalajara;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2021QII;""
19 Guadalajara;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2021QI;""
19 Guadalajara;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2020QIV;1.398
19 Guadalajara;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
19 Guadalajara;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2020QII;""
19 Guadalajara;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2020QI;""
19 Guadalajara;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
19 Guadalajara;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
19 Guadalajara;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2022QII;""
19 Guadalajara;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2022QI;1.318
19 Guadalajara;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
19 Guadalajara;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
19 Guadalajara;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2021QII;""
19 Guadalajara;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2021QI;1.362
19 Guadalajara;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
19 Guadalajara;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
19 Guadalajara;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2020QII;""
19 Guadalajara;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2020QI;""
19 Guadalajara;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
19 Guadalajara;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
19 Guadalajara;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QII;1.267
19 Guadalajara;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QI;""
19 Guadalajara;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
19 Guadalajara;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
19 Guadalajara;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QII;1.327
19 Guadalajara;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QI;""
19 Guadalajara;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
19 Guadalajara;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
19 Guadalajara;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QII;""
19 Guadalajara;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QI;""
19 Guadalajara;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
19 Guadalajara;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QIII;1.218
19 Guadalajara;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QII;""
19 Guadalajara;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QI;""
19 Guadalajara;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
19 Guadalajara;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QIII;1.288
19 Guadalajara;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QII;""
19 Guadalajara;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QI;""
19 Guadalajara;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
19 Guadalajara;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
19 Guadalajara;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QII;""
19 Guadalajara;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QI;""
19 Guadalajara;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
19 Guadalajara;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
19 Guadalajara;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
19 Guadalajara;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
19 Guadalajara;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
19 Guadalajara;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
19 Guadalajara;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
19 Guadalajara;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
19 Guadalajara;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
19 Guadalajara;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
19 Guadalajara;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
19 Guadalajara;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
19 Guadalajara;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;95,49
19 Guadalajara;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
19 Guadalajara;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
19 Guadalajara;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
19 Guadalajara;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;94,82
19 Guadalajara;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
19 Guadalajara;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
19 Guadalajara;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
19 Guadalajara;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;96,48
19 Guadalajara;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
19 Guadalajara;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
19 Guadalajara;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
19 Guadalajara;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
19 Guadalajara;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
19 Guadalajara;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
19 Guadalajara;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;91,02
19 Guadalajara;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
19 Guadalajara;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
19 Guadalajara;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
19 Guadalajara;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;94
19 Guadalajara;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
19 Guadalajara;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
19 Guadalajara;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
19 Guadalajara;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
19 Guadalajara;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
19 Guadalajara;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
19 Guadalajara;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;87,5
19 Guadalajara;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
19 Guadalajara;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
19 Guadalajara;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
19 Guadalajara;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;91,58
19 Guadalajara;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
19 Guadalajara;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
19 Guadalajara;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
19 Guadalajara;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
19 Guadalajara;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
19 Guadalajara;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
19 Guadalajara;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;84,12
19 Guadalajara;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
19 Guadalajara;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
19 Guadalajara;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
19 Guadalajara;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;88,89
19 Guadalajara;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
19 Guadalajara;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
19 Guadalajara;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
19 Guadalajara;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
19 Guadalajara;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
19 Guadalajara;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
19 Guadalajara;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QIV;900
19 Guadalajara;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
19 Guadalajara;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
19 Guadalajara;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
19 Guadalajara;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QIV;905
19 Guadalajara;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
19 Guadalajara;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
19 Guadalajara;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
19 Guadalajara;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QIV;873
19 Guadalajara;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
19 Guadalajara;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
19 Guadalajara;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
19 Guadalajara;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2022QIV;852
19 Guadalajara;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
19 Guadalajara;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2022QII;""
19 Guadalajara;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2022QI;""
19 Guadalajara;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2021QIV;869
19 Guadalajara;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
19 Guadalajara;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2021QII;""
19 Guadalajara;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2021QI;""
19 Guadalajara;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2020QIV;841
19 Guadalajara;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
19 Guadalajara;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2020QII;""
19 Guadalajara;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2020QI;""
19 Guadalajara;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
19 Guadalajara;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
19 Guadalajara;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2022QII;""
19 Guadalajara;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2022QI;824
19 Guadalajara;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
19 Guadalajara;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
19 Guadalajara;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2021QII;""
19 Guadalajara;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2021QI;814
19 Guadalajara;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
19 Guadalajara;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
19 Guadalajara;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2020QII;""
19 Guadalajara;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2020QI;""
19 Guadalajara;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
19 Guadalajara;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
19 Guadalajara;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QII;781
19 Guadalajara;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QI;""
19 Guadalajara;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
19 Guadalajara;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
19 Guadalajara;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QII;780
19 Guadalajara;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QI;""
19 Guadalajara;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
19 Guadalajara;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
19 Guadalajara;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QII;""
19 Guadalajara;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QI;""
19 Guadalajara;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
19 Guadalajara;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QIII;756
19 Guadalajara;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QII;""
19 Guadalajara;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QI;""
19 Guadalajara;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
19 Guadalajara;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QIII;745
19 Guadalajara;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QII;""
19 Guadalajara;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QI;""
19 Guadalajara;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
19 Guadalajara;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
19 Guadalajara;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QII;""
19 Guadalajara;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QI;""
19 Guadalajara;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
19 Guadalajara;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
19 Guadalajara;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
19 Guadalajara;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
19 Guadalajara;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
19 Guadalajara;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
19 Guadalajara;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
19 Guadalajara;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
19 Guadalajara;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
19 Guadalajara;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
19 Guadalajara;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
19 Guadalajara;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
19 Guadalajara;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;94,67
19 Guadalajara;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
19 Guadalajara;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
19 Guadalajara;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
19 Guadalajara;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;96,02
19 Guadalajara;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
19 Guadalajara;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
19 Guadalajara;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
19 Guadalajara;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;96,33
19 Guadalajara;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
19 Guadalajara;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
19 Guadalajara;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
19 Guadalajara;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
19 Guadalajara;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
19 Guadalajara;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
19 Guadalajara;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;91,05
19 Guadalajara;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
19 Guadalajara;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
19 Guadalajara;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
19 Guadalajara;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;93,24
19 Guadalajara;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
19 Guadalajara;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
19 Guadalajara;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
19 Guadalajara;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
19 Guadalajara;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
19 Guadalajara;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
19 Guadalajara;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;86,3
19 Guadalajara;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
19 Guadalajara;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
19 Guadalajara;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
19 Guadalajara;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;89,35
19 Guadalajara;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
19 Guadalajara;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
19 Guadalajara;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
19 Guadalajara;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
19 Guadalajara;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
19 Guadalajara;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
19 Guadalajara;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;83,54
19 Guadalajara;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
19 Guadalajara;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
19 Guadalajara;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
19 Guadalajara;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;85,34
19 Guadalajara;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
19 Guadalajara;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
19 Guadalajara;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
19 Guadalajara;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
19 Guadalajara;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
19 Guadalajara;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
19 Guadalajara;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
19 Guadalajara;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
19 Guadalajara;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
19 Guadalajara;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QI;4.292
19 Guadalajara;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
19 Guadalajara;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
19 Guadalajara;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
19 Guadalajara;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QI;4.303
19 Guadalajara;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
19 Guadalajara;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
19 Guadalajara;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
19 Guadalajara;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QI;4.290
19 Guadalajara;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
19 Guadalajara;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
19 Guadalajara;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2022QII;""
19 Guadalajara;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2022QI;4.176
19 Guadalajara;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
19 Guadalajara;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
19 Guadalajara;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2021QII;""
19 Guadalajara;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2021QI;4.204
19 Guadalajara;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
19 Guadalajara;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
19 Guadalajara;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2020QII;""
19 Guadalajara;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2020QI;3.995
19 Guadalajara;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
19 Guadalajara;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
19 Guadalajara;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2022QII;4.053
19 Guadalajara;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2022QI;""
19 Guadalajara;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
19 Guadalajara;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
19 Guadalajara;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2021QII;4.100
19 Guadalajara;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2021QI;""
19 Guadalajara;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
19 Guadalajara;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
19 Guadalajara;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2020QII;3.923
19 Guadalajara;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2020QI;""
19 Guadalajara;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
19 Guadalajara;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QIII;3.938
19 Guadalajara;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QII;""
19 Guadalajara;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QI;""
19 Guadalajara;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
19 Guadalajara;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QIII;4.016
19 Guadalajara;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QII;""
19 Guadalajara;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QI;""
19 Guadalajara;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
19 Guadalajara;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QIII;3.846
19 Guadalajara;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QII;""
19 Guadalajara;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QI;""
19 Guadalajara;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QIV;3.834
19 Guadalajara;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
19 Guadalajara;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QII;""
19 Guadalajara;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QI;""
19 Guadalajara;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QIV;3.919
19 Guadalajara;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
19 Guadalajara;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QII;""
19 Guadalajara;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QI;""
19 Guadalajara;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QIV;3.754
19 Guadalajara;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
19 Guadalajara;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QII;""
19 Guadalajara;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QI;""
19 Guadalajara;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
19 Guadalajara;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
19 Guadalajara;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
19 Guadalajara;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
19 Guadalajara;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
19 Guadalajara;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
19 Guadalajara;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
19 Guadalajara;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
19 Guadalajara;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
19 Guadalajara;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
19 Guadalajara;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
19 Guadalajara;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
19 Guadalajara;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
19 Guadalajara;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
19 Guadalajara;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
19 Guadalajara;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;97,3
19 Guadalajara;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
19 Guadalajara;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
19 Guadalajara;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
19 Guadalajara;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;97,7
19 Guadalajara;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
19 Guadalajara;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
19 Guadalajara;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
19 Guadalajara;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;93,12
19 Guadalajara;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
19 Guadalajara;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
19 Guadalajara;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;94,43
19 Guadalajara;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
19 Guadalajara;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
19 Guadalajara;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
19 Guadalajara;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;95,28
19 Guadalajara;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
19 Guadalajara;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
19 Guadalajara;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
19 Guadalajara;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;91,45
19 Guadalajara;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
19 Guadalajara;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
19 Guadalajara;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;91,75
19 Guadalajara;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
19 Guadalajara;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
19 Guadalajara;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
19 Guadalajara;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;93,33
19 Guadalajara;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
19 Guadalajara;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
19 Guadalajara;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
19 Guadalajara;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;89,65
19 Guadalajara;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
19 Guadalajara;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
19 Guadalajara;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;89,33
19 Guadalajara;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
19 Guadalajara;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
19 Guadalajara;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
19 Guadalajara;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;91,08
19 Guadalajara;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
19 Guadalajara;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
19 Guadalajara;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
19 Guadalajara;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;87,51
19 Guadalajara;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
19 Guadalajara;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
19 Guadalajara;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
19 Guadalajara;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
19 Guadalajara;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
19 Guadalajara;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
19 Guadalajara;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QI;2.862
19 Guadalajara;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
19 Guadalajara;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
19 Guadalajara;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
19 Guadalajara;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QI;2.876
19 Guadalajara;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
19 Guadalajara;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
19 Guadalajara;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
19 Guadalajara;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QI;2.873
19 Guadalajara;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
19 Guadalajara;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
19 Guadalajara;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2022QII;""
19 Guadalajara;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2022QI;2.795
19 Guadalajara;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
19 Guadalajara;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
19 Guadalajara;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2021QII;""
19 Guadalajara;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2021QI;2.819
19 Guadalajara;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
19 Guadalajara;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
19 Guadalajara;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2020QII;""
19 Guadalajara;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2020QI;2.688
19 Guadalajara;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
19 Guadalajara;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
19 Guadalajara;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2022QII;2.727
19 Guadalajara;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2022QI;""
19 Guadalajara;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
19 Guadalajara;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
19 Guadalajara;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2021QII;2.763
19 Guadalajara;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2021QI;""
19 Guadalajara;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
19 Guadalajara;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
19 Guadalajara;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2020QII;2.650
19 Guadalajara;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2020QI;""
19 Guadalajara;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
19 Guadalajara;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QIII;2.649
19 Guadalajara;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QII;""
19 Guadalajara;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QI;""
19 Guadalajara;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
19 Guadalajara;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QIII;2.708
19 Guadalajara;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QII;""
19 Guadalajara;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QI;""
19 Guadalajara;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
19 Guadalajara;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QIII;2.606
19 Guadalajara;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QII;""
19 Guadalajara;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QI;""
19 Guadalajara;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QIV;2.587
19 Guadalajara;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
19 Guadalajara;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QII;""
19 Guadalajara;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QI;""
19 Guadalajara;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QIV;2.654
19 Guadalajara;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
19 Guadalajara;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QII;""
19 Guadalajara;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QI;""
19 Guadalajara;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QIV;2.549
19 Guadalajara;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
19 Guadalajara;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QII;""
19 Guadalajara;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QI;""
19 Guadalajara;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
19 Guadalajara;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
19 Guadalajara;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
19 Guadalajara;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
19 Guadalajara;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
19 Guadalajara;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
19 Guadalajara;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
19 Guadalajara;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
19 Guadalajara;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
19 Guadalajara;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
19 Guadalajara;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
19 Guadalajara;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
19 Guadalajara;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
19 Guadalajara;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
19 Guadalajara;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
19 Guadalajara;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;97,66
19 Guadalajara;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
19 Guadalajara;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
19 Guadalajara;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
19 Guadalajara;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;98,02
19 Guadalajara;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
19 Guadalajara;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
19 Guadalajara;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
19 Guadalajara;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;93,56
19 Guadalajara;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
19 Guadalajara;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
19 Guadalajara;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;95,28
19 Guadalajara;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
19 Guadalajara;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
19 Guadalajara;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
19 Guadalajara;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;96,07
19 Guadalajara;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
19 Guadalajara;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
19 Guadalajara;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
19 Guadalajara;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;92,24
19 Guadalajara;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
19 Guadalajara;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
19 Guadalajara;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;92,56
19 Guadalajara;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
19 Guadalajara;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
19 Guadalajara;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
19 Guadalajara;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;94,16
19 Guadalajara;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
19 Guadalajara;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
19 Guadalajara;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
19 Guadalajara;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;90,71
19 Guadalajara;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
19 Guadalajara;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
19 Guadalajara;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;90,39
19 Guadalajara;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
19 Guadalajara;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
19 Guadalajara;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
19 Guadalajara;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;92,28
19 Guadalajara;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
19 Guadalajara;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
19 Guadalajara;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
19 Guadalajara;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;88,72
19 Guadalajara;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
19 Guadalajara;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
19 Guadalajara;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
19 Guadalajara;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
19 Guadalajara;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
19 Guadalajara;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
19 Guadalajara;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QI;1.430
19 Guadalajara;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
19 Guadalajara;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
19 Guadalajara;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
19 Guadalajara;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QI;1.427
19 Guadalajara;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
19 Guadalajara;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
19 Guadalajara;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
19 Guadalajara;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QI;1.417
19 Guadalajara;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
19 Guadalajara;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
19 Guadalajara;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2022QII;""
19 Guadalajara;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2022QI;1.381
19 Guadalajara;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
19 Guadalajara;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
19 Guadalajara;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2021QII;""
19 Guadalajara;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2021QI;1.385
19 Guadalajara;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
19 Guadalajara;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
19 Guadalajara;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2020QII;""
19 Guadalajara;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2020QI;1.307
19 Guadalajara;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
19 Guadalajara;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
19 Guadalajara;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2022QII;1.326
19 Guadalajara;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2022QI;""
19 Guadalajara;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
19 Guadalajara;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
19 Guadalajara;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2021QII;1.337
19 Guadalajara;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2021QI;""
19 Guadalajara;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
19 Guadalajara;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
19 Guadalajara;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2020QII;1.273
19 Guadalajara;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2020QI;""
19 Guadalajara;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
19 Guadalajara;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QIII;1.289
19 Guadalajara;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QII;""
19 Guadalajara;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QI;""
19 Guadalajara;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
19 Guadalajara;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QIII;1.308
19 Guadalajara;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QII;""
19 Guadalajara;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QI;""
19 Guadalajara;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
19 Guadalajara;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QIII;1.240
19 Guadalajara;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QII;""
19 Guadalajara;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QI;""
19 Guadalajara;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QIV;1.247
19 Guadalajara;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
19 Guadalajara;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QII;""
19 Guadalajara;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QI;""
19 Guadalajara;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QIV;1.265
19 Guadalajara;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
19 Guadalajara;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QII;""
19 Guadalajara;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QI;""
19 Guadalajara;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QIV;1.205
19 Guadalajara;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
19 Guadalajara;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QII;""
19 Guadalajara;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QI;""
19 Guadalajara;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
19 Guadalajara;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
19 Guadalajara;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
19 Guadalajara;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
19 Guadalajara;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
19 Guadalajara;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
19 Guadalajara;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
19 Guadalajara;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
19 Guadalajara;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
19 Guadalajara;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
19 Guadalajara;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
19 Guadalajara;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
19 Guadalajara;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
19 Guadalajara;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
19 Guadalajara;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
19 Guadalajara;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;96,57
19 Guadalajara;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
19 Guadalajara;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
19 Guadalajara;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
19 Guadalajara;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;97,06
19 Guadalajara;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
19 Guadalajara;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
19 Guadalajara;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
19 Guadalajara;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;92,24
19 Guadalajara;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
19 Guadalajara;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
19 Guadalajara;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;92,73
19 Guadalajara;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
19 Guadalajara;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
19 Guadalajara;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
19 Guadalajara;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;93,69
19 Guadalajara;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
19 Guadalajara;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
19 Guadalajara;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
19 Guadalajara;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;89,84
19 Guadalajara;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
19 Guadalajara;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
19 Guadalajara;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;90,14
19 Guadalajara;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
19 Guadalajara;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
19 Guadalajara;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
19 Guadalajara;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;91,66
19 Guadalajara;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
19 Guadalajara;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
19 Guadalajara;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
19 Guadalajara;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;87,51
19 Guadalajara;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
19 Guadalajara;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
19 Guadalajara;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;87,2
19 Guadalajara;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
19 Guadalajara;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
19 Guadalajara;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
19 Guadalajara;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;88,65
19 Guadalajara;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
19 Guadalajara;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
19 Guadalajara;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
19 Guadalajara;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;85,04
19 Guadalajara;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
19 Guadalajara;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
19 Guadalajara;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
19 Guadalajara;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
19 Guadalajara;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
19 Guadalajara;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QII;4.259
19 Guadalajara;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
19 Guadalajara;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
19 Guadalajara;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
19 Guadalajara;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QII;4.205
19 Guadalajara;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
19 Guadalajara;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
19 Guadalajara;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
19 Guadalajara;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QII;4.182
19 Guadalajara;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
19 Guadalajara;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
19 Guadalajara;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
19 Guadalajara;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2022QII;4.111
19 Guadalajara;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2022QI;""
19 Guadalajara;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
19 Guadalajara;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
19 Guadalajara;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2021QII;4.075
19 Guadalajara;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2021QI;""
19 Guadalajara;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
19 Guadalajara;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
19 Guadalajara;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2020QII;4.092
19 Guadalajara;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2020QI;""
19 Guadalajara;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
19 Guadalajara;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2022QIII;3.984
19 Guadalajara;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2022QII;""
19 Guadalajara;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2022QI;""
19 Guadalajara;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
19 Guadalajara;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2021QIII;3.985
19 Guadalajara;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2021QII;""
19 Guadalajara;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2021QI;""
19 Guadalajara;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
19 Guadalajara;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2020QIII;4.005
19 Guadalajara;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2020QII;""
19 Guadalajara;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2020QI;""
19 Guadalajara;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QIV;3.867
19 Guadalajara;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
19 Guadalajara;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QII;""
19 Guadalajara;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QI;""
19 Guadalajara;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QIV;3.870
19 Guadalajara;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
19 Guadalajara;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QII;""
19 Guadalajara;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QI;""
19 Guadalajara;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QIV;3.907
19 Guadalajara;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
19 Guadalajara;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QII;""
19 Guadalajara;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QI;""
19 Guadalajara;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
19 Guadalajara;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
19 Guadalajara;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QII;""
19 Guadalajara;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QI;3.784
19 Guadalajara;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
19 Guadalajara;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
19 Guadalajara;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QII;""
19 Guadalajara;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QI;3.836
19 Guadalajara;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
19 Guadalajara;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
19 Guadalajara;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QII;""
19 Guadalajara;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QI;""
19 Guadalajara;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
19 Guadalajara;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
19 Guadalajara;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
19 Guadalajara;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
19 Guadalajara;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
19 Guadalajara;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
19 Guadalajara;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
19 Guadalajara;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
19 Guadalajara;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
19 Guadalajara;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
19 Guadalajara;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
19 Guadalajara;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
19 Guadalajara;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
19 Guadalajara;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
19 Guadalajara;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;96,53
19 Guadalajara;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
19 Guadalajara;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
19 Guadalajara;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
19 Guadalajara;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;96,91
19 Guadalajara;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
19 Guadalajara;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
19 Guadalajara;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
19 Guadalajara;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;97,85
19 Guadalajara;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
19 Guadalajara;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
19 Guadalajara;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;93,54
19 Guadalajara;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
19 Guadalajara;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
19 Guadalajara;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
19 Guadalajara;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;94,77
19 Guadalajara;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
19 Guadalajara;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
19 Guadalajara;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
19 Guadalajara;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;95,77
19 Guadalajara;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
19 Guadalajara;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
19 Guadalajara;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;90,8
19 Guadalajara;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
19 Guadalajara;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
19 Guadalajara;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
19 Guadalajara;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;92,03
19 Guadalajara;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
19 Guadalajara;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
19 Guadalajara;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
19 Guadalajara;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;93,42
19 Guadalajara;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
19 Guadalajara;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
19 Guadalajara;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
19 Guadalajara;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
19 Guadalajara;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
19 Guadalajara;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
19 Guadalajara;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;89,99
19 Guadalajara;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
19 Guadalajara;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
19 Guadalajara;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
19 Guadalajara;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;91,73
19 Guadalajara;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
19 Guadalajara;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
19 Guadalajara;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
19 Guadalajara;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
19 Guadalajara;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
19 Guadalajara;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
19 Guadalajara;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QII;2.827
19 Guadalajara;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
19 Guadalajara;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
19 Guadalajara;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
19 Guadalajara;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QII;2.803
19 Guadalajara;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
19 Guadalajara;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
19 Guadalajara;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
19 Guadalajara;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QII;2.798
19 Guadalajara;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
19 Guadalajara;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
19 Guadalajara;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
19 Guadalajara;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2022QII;2.746
19 Guadalajara;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2022QI;""
19 Guadalajara;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
19 Guadalajara;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
19 Guadalajara;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2021QII;2.735
19 Guadalajara;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2021QI;""
19 Guadalajara;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
19 Guadalajara;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
19 Guadalajara;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2020QII;2.746
19 Guadalajara;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2020QI;""
19 Guadalajara;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
19 Guadalajara;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2022QIII;2.661
19 Guadalajara;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2022QII;""
19 Guadalajara;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2022QI;""
19 Guadalajara;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
19 Guadalajara;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2021QIII;2.678
19 Guadalajara;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2021QII;""
19 Guadalajara;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2021QI;""
19 Guadalajara;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
19 Guadalajara;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2020QIII;2.693
19 Guadalajara;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2020QII;""
19 Guadalajara;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2020QI;""
19 Guadalajara;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QIV;2.591
19 Guadalajara;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
19 Guadalajara;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QII;""
19 Guadalajara;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QI;""
19 Guadalajara;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QIV;2.613
19 Guadalajara;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
19 Guadalajara;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QII;""
19 Guadalajara;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QI;""
19 Guadalajara;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QIV;2.632
19 Guadalajara;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
19 Guadalajara;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QII;""
19 Guadalajara;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QI;""
19 Guadalajara;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
19 Guadalajara;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
19 Guadalajara;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QII;""
19 Guadalajara;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QI;2.564
19 Guadalajara;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
19 Guadalajara;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
19 Guadalajara;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QII;""
19 Guadalajara;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QI;2.594
19 Guadalajara;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
19 Guadalajara;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
19 Guadalajara;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QII;""
19 Guadalajara;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QI;""
19 Guadalajara;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
19 Guadalajara;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
19 Guadalajara;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
19 Guadalajara;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
19 Guadalajara;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
19 Guadalajara;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
19 Guadalajara;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
19 Guadalajara;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
19 Guadalajara;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
19 Guadalajara;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
19 Guadalajara;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
19 Guadalajara;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
19 Guadalajara;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
19 Guadalajara;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
19 Guadalajara;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;97,13
19 Guadalajara;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
19 Guadalajara;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
19 Guadalajara;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
19 Guadalajara;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;97,57
19 Guadalajara;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
19 Guadalajara;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
19 Guadalajara;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
19 Guadalajara;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;98,14
19 Guadalajara;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
19 Guadalajara;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
19 Guadalajara;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;94,13
19 Guadalajara;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
19 Guadalajara;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
19 Guadalajara;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
19 Guadalajara;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;95,54
19 Guadalajara;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
19 Guadalajara;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
19 Guadalajara;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
19 Guadalajara;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;96,25
19 Guadalajara;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
19 Guadalajara;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
19 Guadalajara;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;91,65
19 Guadalajara;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
19 Guadalajara;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
19 Guadalajara;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
19 Guadalajara;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;93,22
19 Guadalajara;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
19 Guadalajara;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
19 Guadalajara;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
19 Guadalajara;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;94,07
19 Guadalajara;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
19 Guadalajara;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
19 Guadalajara;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
19 Guadalajara;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
19 Guadalajara;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
19 Guadalajara;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
19 Guadalajara;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;91,47
19 Guadalajara;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
19 Guadalajara;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
19 Guadalajara;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
19 Guadalajara;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;92,71
19 Guadalajara;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
19 Guadalajara;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
19 Guadalajara;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
19 Guadalajara;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
19 Guadalajara;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
19 Guadalajara;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
19 Guadalajara;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QII;1.432
19 Guadalajara;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
19 Guadalajara;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
19 Guadalajara;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
19 Guadalajara;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QII;1.402
19 Guadalajara;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
19 Guadalajara;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
19 Guadalajara;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
19 Guadalajara;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QII;1.384
19 Guadalajara;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
19 Guadalajara;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
19 Guadalajara;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
19 Guadalajara;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2022QII;1.365
19 Guadalajara;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2022QI;""
19 Guadalajara;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
19 Guadalajara;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
19 Guadalajara;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2021QII;1.340
19 Guadalajara;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2021QI;""
19 Guadalajara;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
19 Guadalajara;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
19 Guadalajara;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2020QII;1.346
19 Guadalajara;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2020QI;""
19 Guadalajara;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
19 Guadalajara;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2022QIII;1.323
19 Guadalajara;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2022QII;""
19 Guadalajara;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2022QI;""
19 Guadalajara;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
19 Guadalajara;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2021QIII;1.307
19 Guadalajara;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2021QII;""
19 Guadalajara;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2021QI;""
19 Guadalajara;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
19 Guadalajara;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2020QIII;1.312
19 Guadalajara;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2020QII;""
19 Guadalajara;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2020QI;""
19 Guadalajara;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QIV;1.276
19 Guadalajara;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
19 Guadalajara;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QII;""
19 Guadalajara;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QI;""
19 Guadalajara;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QIV;1.257
19 Guadalajara;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
19 Guadalajara;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QII;""
19 Guadalajara;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QI;""
19 Guadalajara;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QIV;1.275
19 Guadalajara;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
19 Guadalajara;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QII;""
19 Guadalajara;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QI;""
19 Guadalajara;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
19 Guadalajara;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
19 Guadalajara;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QII;""
19 Guadalajara;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QI;1.220
19 Guadalajara;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
19 Guadalajara;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
19 Guadalajara;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QII;""
19 Guadalajara;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QI;1.242
19 Guadalajara;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
19 Guadalajara;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
19 Guadalajara;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QII;""
19 Guadalajara;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QI;""
19 Guadalajara;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
19 Guadalajara;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
19 Guadalajara;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
19 Guadalajara;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
19 Guadalajara;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
19 Guadalajara;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
19 Guadalajara;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
19 Guadalajara;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
19 Guadalajara;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
19 Guadalajara;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
19 Guadalajara;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
19 Guadalajara;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
19 Guadalajara;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
19 Guadalajara;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
19 Guadalajara;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;95,32
19 Guadalajara;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
19 Guadalajara;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
19 Guadalajara;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
19 Guadalajara;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;95,58
19 Guadalajara;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
19 Guadalajara;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
19 Guadalajara;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
19 Guadalajara;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;97,25
19 Guadalajara;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
19 Guadalajara;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
19 Guadalajara;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;92,39
19 Guadalajara;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
19 Guadalajara;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
19 Guadalajara;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
19 Guadalajara;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;93,22
19 Guadalajara;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
19 Guadalajara;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
19 Guadalajara;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
19 Guadalajara;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;94,8
19 Guadalajara;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
19 Guadalajara;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
19 Guadalajara;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;89,11
19 Guadalajara;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
19 Guadalajara;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
19 Guadalajara;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
19 Guadalajara;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;89,66
19 Guadalajara;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
19 Guadalajara;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
19 Guadalajara;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
19 Guadalajara;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;92,12
19 Guadalajara;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
19 Guadalajara;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
19 Guadalajara;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
19 Guadalajara;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
19 Guadalajara;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
19 Guadalajara;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
19 Guadalajara;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;87,02
19 Guadalajara;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
19 Guadalajara;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
19 Guadalajara;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
19 Guadalajara;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;89,74
19 Guadalajara;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
19 Guadalajara;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
19 Guadalajara;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
19 Guadalajara;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
19 Guadalajara;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
19 Guadalajara;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QIII;4.278
19 Guadalajara;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
19 Guadalajara;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
19 Guadalajara;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
19 Guadalajara;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QIII;4.236
19 Guadalajara;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
19 Guadalajara;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
19 Guadalajara;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
19 Guadalajara;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QIII;4.238
19 Guadalajara;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
19 Guadalajara;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
19 Guadalajara;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
19 Guadalajara;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2022QIII;4.124
19 Guadalajara;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2022QII;""
19 Guadalajara;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2022QI;""
19 Guadalajara;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
19 Guadalajara;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2021QIII;4.128
19 Guadalajara;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2021QII;""
19 Guadalajara;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2021QI;""
19 Guadalajara;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
19 Guadalajara;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2020QIII;4.135
19 Guadalajara;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2020QII;""
19 Guadalajara;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2020QI;""
19 Guadalajara;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2022QIV;3.989
19 Guadalajara;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
19 Guadalajara;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2022QII;""
19 Guadalajara;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2022QI;""
19 Guadalajara;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2021QIV;4.002
19 Guadalajara;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
19 Guadalajara;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2021QII;""
19 Guadalajara;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2021QI;""
19 Guadalajara;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2020QIV;4.023
19 Guadalajara;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
19 Guadalajara;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2020QII;""
19 Guadalajara;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2020QI;""
19 Guadalajara;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
19 Guadalajara;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
19 Guadalajara;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QII;""
19 Guadalajara;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QI;3.905
19 Guadalajara;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
19 Guadalajara;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
19 Guadalajara;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QII;""
19 Guadalajara;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QI;3.944
19 Guadalajara;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
19 Guadalajara;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
19 Guadalajara;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QII;""
19 Guadalajara;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QI;""
19 Guadalajara;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
19 Guadalajara;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
19 Guadalajara;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QII;3.812
19 Guadalajara;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QI;""
19 Guadalajara;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
19 Guadalajara;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
19 Guadalajara;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QII;3.871
19 Guadalajara;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QI;""
19 Guadalajara;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
19 Guadalajara;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
19 Guadalajara;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QII;""
19 Guadalajara;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QI;""
19 Guadalajara;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
19 Guadalajara;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
19 Guadalajara;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
19 Guadalajara;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
19 Guadalajara;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
19 Guadalajara;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
19 Guadalajara;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
19 Guadalajara;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
19 Guadalajara;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
19 Guadalajara;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
19 Guadalajara;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
19 Guadalajara;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
19 Guadalajara;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
19 Guadalajara;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;96,4
19 Guadalajara;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
19 Guadalajara;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
19 Guadalajara;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
19 Guadalajara;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;97,45
19 Guadalajara;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
19 Guadalajara;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
19 Guadalajara;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
19 Guadalajara;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;97,57
19 Guadalajara;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
19 Guadalajara;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
19 Guadalajara;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;93,24
19 Guadalajara;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
19 Guadalajara;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
19 Guadalajara;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
19 Guadalajara;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;94,48
19 Guadalajara;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
19 Guadalajara;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
19 Guadalajara;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
19 Guadalajara;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;94,93
19 Guadalajara;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
19 Guadalajara;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
19 Guadalajara;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
19 Guadalajara;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
19 Guadalajara;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
19 Guadalajara;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
19 Guadalajara;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;92,19
19 Guadalajara;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
19 Guadalajara;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
19 Guadalajara;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
19 Guadalajara;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;93,06
19 Guadalajara;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
19 Guadalajara;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
19 Guadalajara;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
19 Guadalajara;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
19 Guadalajara;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
19 Guadalajara;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
19 Guadalajara;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;89,99
19 Guadalajara;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
19 Guadalajara;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
19 Guadalajara;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
19 Guadalajara;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;91,34
19 Guadalajara;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
19 Guadalajara;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
19 Guadalajara;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
19 Guadalajara;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
19 Guadalajara;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
19 Guadalajara;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
19 Guadalajara;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QIII;2.840
19 Guadalajara;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
19 Guadalajara;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
19 Guadalajara;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
19 Guadalajara;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QIII;2.826
19 Guadalajara;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
19 Guadalajara;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
19 Guadalajara;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
19 Guadalajara;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QIII;2.848
19 Guadalajara;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
19 Guadalajara;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
19 Guadalajara;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
19 Guadalajara;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2022QIII;2.740
19 Guadalajara;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2022QII;""
19 Guadalajara;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2022QI;""
19 Guadalajara;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
19 Guadalajara;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2021QIII;2.761
19 Guadalajara;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2021QII;""
19 Guadalajara;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2021QI;""
19 Guadalajara;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
19 Guadalajara;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2020QIII;2.786
19 Guadalajara;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2020QII;""
19 Guadalajara;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2020QI;""
19 Guadalajara;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2022QIV;2.660
19 Guadalajara;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
19 Guadalajara;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2022QII;""
19 Guadalajara;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2022QI;""
19 Guadalajara;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2021QIV;2.688
19 Guadalajara;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
19 Guadalajara;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2021QII;""
19 Guadalajara;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2021QI;""
19 Guadalajara;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2020QIV;2.717
19 Guadalajara;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
19 Guadalajara;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2020QII;""
19 Guadalajara;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2020QI;""
19 Guadalajara;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
19 Guadalajara;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
19 Guadalajara;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QII;""
19 Guadalajara;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QI;2.634
19 Guadalajara;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
19 Guadalajara;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
19 Guadalajara;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QII;""
19 Guadalajara;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QI;2.673
19 Guadalajara;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
19 Guadalajara;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
19 Guadalajara;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QII;""
19 Guadalajara;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QI;""
19 Guadalajara;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
19 Guadalajara;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
19 Guadalajara;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QII;2.582
19 Guadalajara;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QI;""
19 Guadalajara;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
19 Guadalajara;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
19 Guadalajara;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QII;2.633
19 Guadalajara;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QI;""
19 Guadalajara;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
19 Guadalajara;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
19 Guadalajara;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QII;""
19 Guadalajara;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QI;""
19 Guadalajara;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
19 Guadalajara;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
19 Guadalajara;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
19 Guadalajara;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
19 Guadalajara;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
19 Guadalajara;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
19 Guadalajara;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
19 Guadalajara;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
19 Guadalajara;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
19 Guadalajara;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
19 Guadalajara;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
19 Guadalajara;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
19 Guadalajara;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
19 Guadalajara;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;96,48
19 Guadalajara;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
19 Guadalajara;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
19 Guadalajara;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
19 Guadalajara;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;97,7
19 Guadalajara;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
19 Guadalajara;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
19 Guadalajara;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
19 Guadalajara;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;97,82
19 Guadalajara;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
19 Guadalajara;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
19 Guadalajara;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;93,66
19 Guadalajara;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
19 Guadalajara;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
19 Guadalajara;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
19 Guadalajara;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;95,12
19 Guadalajara;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
19 Guadalajara;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
19 Guadalajara;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
19 Guadalajara;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;95,4
19 Guadalajara;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
19 Guadalajara;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
19 Guadalajara;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
19 Guadalajara;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
19 Guadalajara;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
19 Guadalajara;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
19 Guadalajara;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;93,21
19 Guadalajara;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
19 Guadalajara;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
19 Guadalajara;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
19 Guadalajara;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;93,86
19 Guadalajara;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
19 Guadalajara;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
19 Guadalajara;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
19 Guadalajara;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
19 Guadalajara;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
19 Guadalajara;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
19 Guadalajara;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;91,37
19 Guadalajara;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
19 Guadalajara;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
19 Guadalajara;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
19 Guadalajara;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;92,45
19 Guadalajara;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
19 Guadalajara;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
19 Guadalajara;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
19 Guadalajara;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
19 Guadalajara;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
19 Guadalajara;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
19 Guadalajara;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QIII;1.438
19 Guadalajara;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
19 Guadalajara;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
19 Guadalajara;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
19 Guadalajara;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QIII;1.410
19 Guadalajara;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
19 Guadalajara;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
19 Guadalajara;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
19 Guadalajara;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QIII;1.390
19 Guadalajara;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
19 Guadalajara;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
19 Guadalajara;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
19 Guadalajara;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2022QIII;1.384
19 Guadalajara;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2022QII;""
19 Guadalajara;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2022QI;""
19 Guadalajara;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
19 Guadalajara;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2021QIII;1.367
19 Guadalajara;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2021QII;""
19 Guadalajara;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2021QI;""
19 Guadalajara;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
19 Guadalajara;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2020QIII;1.349
19 Guadalajara;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2020QII;""
19 Guadalajara;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2020QI;""
19 Guadalajara;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2022QIV;1.329
19 Guadalajara;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
19 Guadalajara;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2022QII;""
19 Guadalajara;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2022QI;""
19 Guadalajara;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2021QIV;1.314
19 Guadalajara;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
19 Guadalajara;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2021QII;""
19 Guadalajara;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2021QI;""
19 Guadalajara;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2020QIV;1.306
19 Guadalajara;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
19 Guadalajara;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2020QII;""
19 Guadalajara;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2020QI;""
19 Guadalajara;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
19 Guadalajara;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
19 Guadalajara;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QII;""
19 Guadalajara;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QI;1.271
19 Guadalajara;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
19 Guadalajara;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
19 Guadalajara;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QII;""
19 Guadalajara;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QI;1.271
19 Guadalajara;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
19 Guadalajara;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
19 Guadalajara;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QII;""
19 Guadalajara;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QI;""
19 Guadalajara;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
19 Guadalajara;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
19 Guadalajara;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QII;1.230
19 Guadalajara;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QI;""
19 Guadalajara;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
19 Guadalajara;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
19 Guadalajara;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QII;1.238
19 Guadalajara;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QI;""
19 Guadalajara;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
19 Guadalajara;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
19 Guadalajara;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QII;""
19 Guadalajara;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QI;""
19 Guadalajara;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
19 Guadalajara;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
19 Guadalajara;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
19 Guadalajara;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
19 Guadalajara;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
19 Guadalajara;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
19 Guadalajara;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
19 Guadalajara;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
19 Guadalajara;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
19 Guadalajara;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
19 Guadalajara;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
19 Guadalajara;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
19 Guadalajara;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
19 Guadalajara;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;96,24
19 Guadalajara;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
19 Guadalajara;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
19 Guadalajara;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
19 Guadalajara;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;96,95
19 Guadalajara;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
19 Guadalajara;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
19 Guadalajara;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
19 Guadalajara;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;97,05
19 Guadalajara;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
19 Guadalajara;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
19 Guadalajara;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;92,42
19 Guadalajara;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
19 Guadalajara;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
19 Guadalajara;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
19 Guadalajara;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;93,19
19 Guadalajara;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
19 Guadalajara;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
19 Guadalajara;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
19 Guadalajara;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;93,96
19 Guadalajara;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
19 Guadalajara;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
19 Guadalajara;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
19 Guadalajara;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
19 Guadalajara;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
19 Guadalajara;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
19 Guadalajara;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;90,14
19 Guadalajara;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
19 Guadalajara;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
19 Guadalajara;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
19 Guadalajara;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;91,44
19 Guadalajara;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
19 Guadalajara;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
19 Guadalajara;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
19 Guadalajara;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
19 Guadalajara;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
19 Guadalajara;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
19 Guadalajara;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;87,23
19 Guadalajara;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
19 Guadalajara;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
19 Guadalajara;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
19 Guadalajara;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;89,06
19 Guadalajara;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
19 Guadalajara;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
19 Guadalajara;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
19 Guadalajara;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
19 Guadalajara;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
19 Guadalajara;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QIV;4.240
19 Guadalajara;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
19 Guadalajara;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
19 Guadalajara;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
19 Guadalajara;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QIV;4.274
19 Guadalajara;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
19 Guadalajara;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
19 Guadalajara;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
19 Guadalajara;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QIV;4.293
19 Guadalajara;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
19 Guadalajara;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
19 Guadalajara;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
19 Guadalajara;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2022QIV;4.085
19 Guadalajara;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
19 Guadalajara;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2022QII;""
19 Guadalajara;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2022QI;""
19 Guadalajara;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2021QIV;4.124
19 Guadalajara;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
19 Guadalajara;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2021QII;""
19 Guadalajara;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2021QI;""
19 Guadalajara;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2020QIV;4.157
19 Guadalajara;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
19 Guadalajara;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2020QII;""
19 Guadalajara;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2020QI;""
19 Guadalajara;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
19 Guadalajara;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
19 Guadalajara;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2022QII;""
19 Guadalajara;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2022QI;4.018
19 Guadalajara;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
19 Guadalajara;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
19 Guadalajara;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2021QII;""
19 Guadalajara;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2021QI;4.073
19 Guadalajara;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
19 Guadalajara;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
19 Guadalajara;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2020QII;""
19 Guadalajara;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2020QI;""
19 Guadalajara;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
19 Guadalajara;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
19 Guadalajara;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QII;3.912
19 Guadalajara;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QI;""
19 Guadalajara;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
19 Guadalajara;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
19 Guadalajara;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QII;3.987
19 Guadalajara;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QI;""
19 Guadalajara;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
19 Guadalajara;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
19 Guadalajara;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QII;""
19 Guadalajara;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QI;""
19 Guadalajara;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
19 Guadalajara;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QIII;3.810
19 Guadalajara;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QII;""
19 Guadalajara;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QI;""
19 Guadalajara;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
19 Guadalajara;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QIII;3.911
19 Guadalajara;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QII;""
19 Guadalajara;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QI;""
19 Guadalajara;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
19 Guadalajara;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
19 Guadalajara;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QII;""
19 Guadalajara;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QI;""
19 Guadalajara;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
19 Guadalajara;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
19 Guadalajara;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
19 Guadalajara;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
19 Guadalajara;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
19 Guadalajara;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
19 Guadalajara;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
19 Guadalajara;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
19 Guadalajara;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
19 Guadalajara;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
19 Guadalajara;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
19 Guadalajara;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
19 Guadalajara;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;96,34
19 Guadalajara;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
19 Guadalajara;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
19 Guadalajara;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
19 Guadalajara;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;96,49
19 Guadalajara;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
19 Guadalajara;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
19 Guadalajara;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
19 Guadalajara;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;96,83
19 Guadalajara;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
19 Guadalajara;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
19 Guadalajara;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
19 Guadalajara;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
19 Guadalajara;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
19 Guadalajara;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
19 Guadalajara;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;94,01
19 Guadalajara;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
19 Guadalajara;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
19 Guadalajara;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
19 Guadalajara;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;94,88
19 Guadalajara;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
19 Guadalajara;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
19 Guadalajara;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
19 Guadalajara;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
19 Guadalajara;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
19 Guadalajara;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
19 Guadalajara;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;91,53
19 Guadalajara;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
19 Guadalajara;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
19 Guadalajara;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
19 Guadalajara;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;92,87
19 Guadalajara;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
19 Guadalajara;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
19 Guadalajara;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
19 Guadalajara;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
19 Guadalajara;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
19 Guadalajara;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
19 Guadalajara;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;89,14
19 Guadalajara;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
19 Guadalajara;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
19 Guadalajara;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
19 Guadalajara;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;91,1
19 Guadalajara;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
19 Guadalajara;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
19 Guadalajara;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
19 Guadalajara;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
19 Guadalajara;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
19 Guadalajara;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
19 Guadalajara;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QIV;2.808
19 Guadalajara;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
19 Guadalajara;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
19 Guadalajara;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
19 Guadalajara;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QIV;2.840
19 Guadalajara;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
19 Guadalajara;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
19 Guadalajara;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
19 Guadalajara;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QIV;2.875
19 Guadalajara;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
19 Guadalajara;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
19 Guadalajara;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
19 Guadalajara;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2022QIV;2.717
19 Guadalajara;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
19 Guadalajara;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2022QII;""
19 Guadalajara;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2022QI;""
19 Guadalajara;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2021QIV;2.756
19 Guadalajara;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
19 Guadalajara;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2021QII;""
19 Guadalajara;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2021QI;""
19 Guadalajara;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2020QIV;2.793
19 Guadalajara;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
19 Guadalajara;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2020QII;""
19 Guadalajara;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2020QI;""
19 Guadalajara;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
19 Guadalajara;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
19 Guadalajara;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2022QII;""
19 Guadalajara;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2022QI;2.696
19 Guadalajara;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
19 Guadalajara;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
19 Guadalajara;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2021QII;""
19 Guadalajara;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2021QI;2.746
19 Guadalajara;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
19 Guadalajara;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
19 Guadalajara;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2020QII;""
19 Guadalajara;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2020QI;""
19 Guadalajara;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
19 Guadalajara;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
19 Guadalajara;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QII;2.638
19 Guadalajara;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QI;""
19 Guadalajara;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
19 Guadalajara;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
19 Guadalajara;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QII;2.700
19 Guadalajara;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QI;""
19 Guadalajara;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
19 Guadalajara;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
19 Guadalajara;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QII;""
19 Guadalajara;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QI;""
19 Guadalajara;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
19 Guadalajara;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QIII;2.565
19 Guadalajara;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QII;""
19 Guadalajara;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QI;""
19 Guadalajara;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
19 Guadalajara;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QIII;2.650
19 Guadalajara;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QII;""
19 Guadalajara;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QI;""
19 Guadalajara;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
19 Guadalajara;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
19 Guadalajara;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QII;""
19 Guadalajara;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QI;""
19 Guadalajara;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
19 Guadalajara;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
19 Guadalajara;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
19 Guadalajara;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
19 Guadalajara;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
19 Guadalajara;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
19 Guadalajara;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
19 Guadalajara;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
19 Guadalajara;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
19 Guadalajara;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
19 Guadalajara;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
19 Guadalajara;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
19 Guadalajara;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;96,76
19 Guadalajara;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
19 Guadalajara;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
19 Guadalajara;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
19 Guadalajara;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;97,04
19 Guadalajara;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
19 Guadalajara;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
19 Guadalajara;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
19 Guadalajara;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;97,15
19 Guadalajara;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
19 Guadalajara;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
19 Guadalajara;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
19 Guadalajara;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
19 Guadalajara;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
19 Guadalajara;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
19 Guadalajara;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;94,93
19 Guadalajara;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
19 Guadalajara;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
19 Guadalajara;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
19 Guadalajara;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;95,51
19 Guadalajara;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
19 Guadalajara;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
19 Guadalajara;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
19 Guadalajara;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
19 Guadalajara;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
19 Guadalajara;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
19 Guadalajara;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;92,89
19 Guadalajara;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
19 Guadalajara;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
19 Guadalajara;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
19 Guadalajara;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;93,91
19 Guadalajara;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
19 Guadalajara;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
19 Guadalajara;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
19 Guadalajara;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
19 Guadalajara;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
19 Guadalajara;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
19 Guadalajara;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;90,32
19 Guadalajara;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
19 Guadalajara;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
19 Guadalajara;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
19 Guadalajara;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;92,17
19 Guadalajara;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
19 Guadalajara;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
19 Guadalajara;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
19 Guadalajara;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
19 Guadalajara;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
19 Guadalajara;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
19 Guadalajara;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QIV;1.432
19 Guadalajara;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
19 Guadalajara;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
19 Guadalajara;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
19 Guadalajara;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QIV;1.434
19 Guadalajara;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
19 Guadalajara;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
19 Guadalajara;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
19 Guadalajara;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QIV;1.418
19 Guadalajara;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
19 Guadalajara;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
19 Guadalajara;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
19 Guadalajara;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2022QIV;1.368
19 Guadalajara;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
19 Guadalajara;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2022QII;""
19 Guadalajara;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2022QI;""
19 Guadalajara;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2021QIV;1.368
19 Guadalajara;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
19 Guadalajara;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2021QII;""
19 Guadalajara;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2021QI;""
19 Guadalajara;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2020QIV;1.364
19 Guadalajara;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
19 Guadalajara;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2020QII;""
19 Guadalajara;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2020QI;""
19 Guadalajara;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
19 Guadalajara;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
19 Guadalajara;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2022QII;""
19 Guadalajara;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2022QI;1.322
19 Guadalajara;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
19 Guadalajara;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
19 Guadalajara;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2021QII;""
19 Guadalajara;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2021QI;1.327
19 Guadalajara;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
19 Guadalajara;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
19 Guadalajara;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2020QII;""
19 Guadalajara;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2020QI;""
19 Guadalajara;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
19 Guadalajara;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
19 Guadalajara;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QII;1.274
19 Guadalajara;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QI;""
19 Guadalajara;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
19 Guadalajara;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
19 Guadalajara;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QII;1.287
19 Guadalajara;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QI;""
19 Guadalajara;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
19 Guadalajara;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
19 Guadalajara;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QII;""
19 Guadalajara;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QI;""
19 Guadalajara;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
19 Guadalajara;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QIII;1.245
19 Guadalajara;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QII;""
19 Guadalajara;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QI;""
19 Guadalajara;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
19 Guadalajara;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QIII;1.261
19 Guadalajara;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QII;""
19 Guadalajara;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QI;""
19 Guadalajara;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
19 Guadalajara;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
19 Guadalajara;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QII;""
19 Guadalajara;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QI;""
19 Guadalajara;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
19 Guadalajara;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
19 Guadalajara;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
19 Guadalajara;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
19 Guadalajara;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
19 Guadalajara;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
19 Guadalajara;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
19 Guadalajara;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
19 Guadalajara;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
19 Guadalajara;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
19 Guadalajara;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
19 Guadalajara;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
19 Guadalajara;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;95,53
19 Guadalajara;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
19 Guadalajara;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
19 Guadalajara;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
19 Guadalajara;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;95,4
19 Guadalajara;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
19 Guadalajara;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
19 Guadalajara;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
19 Guadalajara;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;96,19
19 Guadalajara;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
19 Guadalajara;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
19 Guadalajara;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
19 Guadalajara;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
19 Guadalajara;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
19 Guadalajara;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
19 Guadalajara;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;92,19
19 Guadalajara;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
19 Guadalajara;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
19 Guadalajara;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
19 Guadalajara;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;93,58
19 Guadalajara;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
19 Guadalajara;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
19 Guadalajara;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
19 Guadalajara;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
19 Guadalajara;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
19 Guadalajara;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
19 Guadalajara;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;88,84
19 Guadalajara;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
19 Guadalajara;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
19 Guadalajara;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
19 Guadalajara;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;90,76
19 Guadalajara;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
19 Guadalajara;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
19 Guadalajara;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
19 Guadalajara;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
19 Guadalajara;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
19 Guadalajara;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
19 Guadalajara;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;86,82
19 Guadalajara;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
19 Guadalajara;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
19 Guadalajara;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
19 Guadalajara;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;88,93
19 Guadalajara;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
19 Guadalajara;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
19 Guadalajara;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
19 Guadalajara;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
19 Guadalajara;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
19 Guadalajara;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
19 Guadalajara;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
19 Guadalajara;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
19 Guadalajara;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
19 Guadalajara;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QI;4.086
19 Guadalajara;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
19 Guadalajara;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
19 Guadalajara;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
19 Guadalajara;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QI;3.887
19 Guadalajara;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
19 Guadalajara;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
19 Guadalajara;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
19 Guadalajara;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QI;3.981
19 Guadalajara;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
19 Guadalajara;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
19 Guadalajara;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2022QII;""
19 Guadalajara;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2022QI;4.003
19 Guadalajara;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
19 Guadalajara;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
19 Guadalajara;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2021QII;""
19 Guadalajara;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2021QI;3.812
19 Guadalajara;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
19 Guadalajara;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
19 Guadalajara;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2020QII;""
19 Guadalajara;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2020QI;3.757
19 Guadalajara;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
19 Guadalajara;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
19 Guadalajara;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2022QII;3.898
19 Guadalajara;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2022QI;""
19 Guadalajara;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
19 Guadalajara;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
19 Guadalajara;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2021QII;3.757
19 Guadalajara;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2021QI;""
19 Guadalajara;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
19 Guadalajara;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
19 Guadalajara;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2020QII;3.696
19 Guadalajara;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2020QI;""
19 Guadalajara;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
19 Guadalajara;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QIII;3.822
19 Guadalajara;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QII;""
19 Guadalajara;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QI;""
19 Guadalajara;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
19 Guadalajara;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QIII;3.693
19 Guadalajara;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QII;""
19 Guadalajara;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QI;""
19 Guadalajara;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
19 Guadalajara;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QIII;3.620
19 Guadalajara;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QII;""
19 Guadalajara;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QI;""
19 Guadalajara;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QIV;3.738
19 Guadalajara;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
19 Guadalajara;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QII;""
19 Guadalajara;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QI;""
19 Guadalajara;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QIV;3.631
19 Guadalajara;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
19 Guadalajara;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QII;""
19 Guadalajara;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QI;""
19 Guadalajara;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QIV;3.567
19 Guadalajara;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
19 Guadalajara;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QII;""
19 Guadalajara;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QI;""
19 Guadalajara;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
19 Guadalajara;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
19 Guadalajara;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
19 Guadalajara;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
19 Guadalajara;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
19 Guadalajara;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
19 Guadalajara;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
19 Guadalajara;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
19 Guadalajara;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
19 Guadalajara;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
19 Guadalajara;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
19 Guadalajara;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
19 Guadalajara;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
19 Guadalajara;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
19 Guadalajara;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
19 Guadalajara;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;97,97
19 Guadalajara;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
19 Guadalajara;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
19 Guadalajara;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
19 Guadalajara;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;98,07
19 Guadalajara;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
19 Guadalajara;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
19 Guadalajara;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
19 Guadalajara;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;94,37
19 Guadalajara;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
19 Guadalajara;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
19 Guadalajara;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;95,4
19 Guadalajara;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
19 Guadalajara;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
19 Guadalajara;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
19 Guadalajara;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;96,66
19 Guadalajara;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
19 Guadalajara;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
19 Guadalajara;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
19 Guadalajara;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;92,84
19 Guadalajara;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
19 Guadalajara;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
19 Guadalajara;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;93,54
19 Guadalajara;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
19 Guadalajara;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
19 Guadalajara;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
19 Guadalajara;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;95,01
19 Guadalajara;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
19 Guadalajara;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
19 Guadalajara;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
19 Guadalajara;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;90,93
19 Guadalajara;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
19 Guadalajara;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
19 Guadalajara;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;91,48
19 Guadalajara;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
19 Guadalajara;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
19 Guadalajara;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
19 Guadalajara;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;93,41
19 Guadalajara;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
19 Guadalajara;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
19 Guadalajara;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
19 Guadalajara;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;89,6
19 Guadalajara;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
19 Guadalajara;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
19 Guadalajara;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
19 Guadalajara;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
19 Guadalajara;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
19 Guadalajara;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
19 Guadalajara;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QI;2.726
19 Guadalajara;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
19 Guadalajara;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
19 Guadalajara;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
19 Guadalajara;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QI;2.606
19 Guadalajara;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
19 Guadalajara;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
19 Guadalajara;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
19 Guadalajara;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QI;2.682
19 Guadalajara;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
19 Guadalajara;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
19 Guadalajara;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2022QII;""
19 Guadalajara;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2022QI;2.677
19 Guadalajara;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
19 Guadalajara;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
19 Guadalajara;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2021QII;""
19 Guadalajara;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2021QI;2.562
19 Guadalajara;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
19 Guadalajara;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
19 Guadalajara;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2020QII;""
19 Guadalajara;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2020QI;2.541
19 Guadalajara;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
19 Guadalajara;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
19 Guadalajara;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2022QII;2.613
19 Guadalajara;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2022QI;""
19 Guadalajara;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
19 Guadalajara;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
19 Guadalajara;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2021QII;2.532
19 Guadalajara;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2021QI;""
19 Guadalajara;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
19 Guadalajara;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
19 Guadalajara;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2020QII;2.500
19 Guadalajara;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2020QI;""
19 Guadalajara;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
19 Guadalajara;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QIII;2.571
19 Guadalajara;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QII;""
19 Guadalajara;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QI;""
19 Guadalajara;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
19 Guadalajara;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QIII;2.493
19 Guadalajara;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QII;""
19 Guadalajara;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QI;""
19 Guadalajara;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
19 Guadalajara;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QIII;2.448
19 Guadalajara;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QII;""
19 Guadalajara;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QI;""
19 Guadalajara;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QIV;2.520
19 Guadalajara;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
19 Guadalajara;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QII;""
19 Guadalajara;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QI;""
19 Guadalajara;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QIV;2.454
19 Guadalajara;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
19 Guadalajara;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QII;""
19 Guadalajara;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QI;""
19 Guadalajara;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QIV;2.409
19 Guadalajara;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
19 Guadalajara;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QII;""
19 Guadalajara;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QI;""
19 Guadalajara;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
19 Guadalajara;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
19 Guadalajara;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
19 Guadalajara;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
19 Guadalajara;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
19 Guadalajara;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
19 Guadalajara;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
19 Guadalajara;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
19 Guadalajara;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
19 Guadalajara;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
19 Guadalajara;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
19 Guadalajara;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
19 Guadalajara;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
19 Guadalajara;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
19 Guadalajara;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
19 Guadalajara;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;98,2
19 Guadalajara;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
19 Guadalajara;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
19 Guadalajara;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
19 Guadalajara;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;98,31
19 Guadalajara;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
19 Guadalajara;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
19 Guadalajara;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
19 Guadalajara;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;94,74
19 Guadalajara;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
19 Guadalajara;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
19 Guadalajara;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;95,85
19 Guadalajara;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
19 Guadalajara;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
19 Guadalajara;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
19 Guadalajara;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;97,16
19 Guadalajara;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
19 Guadalajara;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
19 Guadalajara;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
19 Guadalajara;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;93,21
19 Guadalajara;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
19 Guadalajara;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
19 Guadalajara;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;94,31
19 Guadalajara;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
19 Guadalajara;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
19 Guadalajara;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
19 Guadalajara;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;95,66
19 Guadalajara;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
19 Guadalajara;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
19 Guadalajara;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
19 Guadalajara;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;91,28
19 Guadalajara;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
19 Guadalajara;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
19 Guadalajara;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;92,44
19 Guadalajara;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
19 Guadalajara;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
19 Guadalajara;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
19 Guadalajara;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;94,17
19 Guadalajara;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
19 Guadalajara;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
19 Guadalajara;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
19 Guadalajara;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;89,82
19 Guadalajara;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
19 Guadalajara;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
19 Guadalajara;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
19 Guadalajara;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
19 Guadalajara;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
19 Guadalajara;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
19 Guadalajara;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QI;1.360
19 Guadalajara;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
19 Guadalajara;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
19 Guadalajara;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
19 Guadalajara;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QI;1.281
19 Guadalajara;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
19 Guadalajara;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
19 Guadalajara;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
19 Guadalajara;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QI;1.299
19 Guadalajara;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
19 Guadalajara;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
19 Guadalajara;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2022QII;""
19 Guadalajara;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2022QI;1.326
19 Guadalajara;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
19 Guadalajara;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
19 Guadalajara;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2021QII;""
19 Guadalajara;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2021QI;1.250
19 Guadalajara;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
19 Guadalajara;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
19 Guadalajara;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2020QII;""
19 Guadalajara;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2020QI;1.216
19 Guadalajara;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
19 Guadalajara;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
19 Guadalajara;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2022QII;1.285
19 Guadalajara;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2022QI;""
19 Guadalajara;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
19 Guadalajara;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
19 Guadalajara;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2021QII;1.225
19 Guadalajara;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2021QI;""
19 Guadalajara;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
19 Guadalajara;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
19 Guadalajara;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2020QII;1.196
19 Guadalajara;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2020QI;""
19 Guadalajara;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
19 Guadalajara;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QIII;1.251
19 Guadalajara;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QII;""
19 Guadalajara;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QI;""
19 Guadalajara;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
19 Guadalajara;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QIII;1.200
19 Guadalajara;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QII;""
19 Guadalajara;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QI;""
19 Guadalajara;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
19 Guadalajara;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QIII;1.172
19 Guadalajara;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QII;""
19 Guadalajara;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QI;""
19 Guadalajara;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QIV;1.218
19 Guadalajara;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
19 Guadalajara;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QII;""
19 Guadalajara;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QI;""
19 Guadalajara;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QIV;1.177
19 Guadalajara;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
19 Guadalajara;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QII;""
19 Guadalajara;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QI;""
19 Guadalajara;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QIV;1.158
19 Guadalajara;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
19 Guadalajara;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QII;""
19 Guadalajara;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QI;""
19 Guadalajara;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
19 Guadalajara;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
19 Guadalajara;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
19 Guadalajara;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
19 Guadalajara;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
19 Guadalajara;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
19 Guadalajara;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
19 Guadalajara;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
19 Guadalajara;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
19 Guadalajara;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
19 Guadalajara;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
19 Guadalajara;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
19 Guadalajara;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
19 Guadalajara;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
19 Guadalajara;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
19 Guadalajara;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;97,5
19 Guadalajara;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
19 Guadalajara;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
19 Guadalajara;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
19 Guadalajara;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;97,58
19 Guadalajara;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
19 Guadalajara;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
19 Guadalajara;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
19 Guadalajara;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;93,61
19 Guadalajara;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
19 Guadalajara;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
19 Guadalajara;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;94,49
19 Guadalajara;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
19 Guadalajara;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
19 Guadalajara;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
19 Guadalajara;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;95,63
19 Guadalajara;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
19 Guadalajara;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
19 Guadalajara;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
19 Guadalajara;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;92,07
19 Guadalajara;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
19 Guadalajara;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
19 Guadalajara;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;91,99
19 Guadalajara;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
19 Guadalajara;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
19 Guadalajara;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
19 Guadalajara;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;93,68
19 Guadalajara;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
19 Guadalajara;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
19 Guadalajara;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
19 Guadalajara;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;90,22
19 Guadalajara;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
19 Guadalajara;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
19 Guadalajara;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;89,56
19 Guadalajara;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
19 Guadalajara;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
19 Guadalajara;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
19 Guadalajara;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;91,88
19 Guadalajara;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
19 Guadalajara;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
19 Guadalajara;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
19 Guadalajara;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;89,15
19 Guadalajara;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
19 Guadalajara;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
19 Guadalajara;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
19 Guadalajara;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
19 Guadalajara;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
19 Guadalajara;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QII;4.166
19 Guadalajara;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
19 Guadalajara;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
19 Guadalajara;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
19 Guadalajara;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QII;4.050
19 Guadalajara;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
19 Guadalajara;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
19 Guadalajara;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
19 Guadalajara;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QII;3.879
19 Guadalajara;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
19 Guadalajara;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
19 Guadalajara;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
19 Guadalajara;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2022QII;4.057
19 Guadalajara;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2022QI;""
19 Guadalajara;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
19 Guadalajara;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
19 Guadalajara;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2021QII;3.984
19 Guadalajara;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2021QI;""
19 Guadalajara;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
19 Guadalajara;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
19 Guadalajara;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2020QII;3.813
19 Guadalajara;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2020QI;""
19 Guadalajara;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
19 Guadalajara;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2022QIII;3.966
19 Guadalajara;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2022QII;""
19 Guadalajara;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2022QI;""
19 Guadalajara;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
19 Guadalajara;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2021QIII;3.914
19 Guadalajara;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2021QII;""
19 Guadalajara;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2021QI;""
19 Guadalajara;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
19 Guadalajara;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2020QIII;3.721
19 Guadalajara;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2020QII;""
19 Guadalajara;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2020QI;""
19 Guadalajara;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QIV;3.877
19 Guadalajara;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
19 Guadalajara;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QII;""
19 Guadalajara;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QI;""
19 Guadalajara;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QIV;3.844
19 Guadalajara;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
19 Guadalajara;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QII;""
19 Guadalajara;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QI;""
19 Guadalajara;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QIV;3.663
19 Guadalajara;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
19 Guadalajara;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QII;""
19 Guadalajara;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QI;""
19 Guadalajara;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
19 Guadalajara;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
19 Guadalajara;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QII;""
19 Guadalajara;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QI;3.782
19 Guadalajara;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
19 Guadalajara;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
19 Guadalajara;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QII;""
19 Guadalajara;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QI;3.608
19 Guadalajara;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
19 Guadalajara;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
19 Guadalajara;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QII;""
19 Guadalajara;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QI;""
19 Guadalajara;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
19 Guadalajara;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
19 Guadalajara;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
19 Guadalajara;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
19 Guadalajara;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
19 Guadalajara;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
19 Guadalajara;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
19 Guadalajara;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
19 Guadalajara;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
19 Guadalajara;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
19 Guadalajara;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
19 Guadalajara;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
19 Guadalajara;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
19 Guadalajara;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
19 Guadalajara;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;97,38
19 Guadalajara;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
19 Guadalajara;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
19 Guadalajara;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
19 Guadalajara;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;98,37
19 Guadalajara;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
19 Guadalajara;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
19 Guadalajara;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
19 Guadalajara;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;98,3
19 Guadalajara;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
19 Guadalajara;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
19 Guadalajara;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;95,2
19 Guadalajara;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
19 Guadalajara;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
19 Guadalajara;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
19 Guadalajara;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;96,64
19 Guadalajara;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
19 Guadalajara;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
19 Guadalajara;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
19 Guadalajara;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;95,93
19 Guadalajara;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
19 Guadalajara;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
19 Guadalajara;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;93,06
19 Guadalajara;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
19 Guadalajara;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
19 Guadalajara;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
19 Guadalajara;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;94,91
19 Guadalajara;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
19 Guadalajara;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
19 Guadalajara;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
19 Guadalajara;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;94,43
19 Guadalajara;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
19 Guadalajara;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
19 Guadalajara;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
19 Guadalajara;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
19 Guadalajara;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
19 Guadalajara;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
19 Guadalajara;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;93,38
19 Guadalajara;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
19 Guadalajara;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
19 Guadalajara;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
19 Guadalajara;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;93,01
19 Guadalajara;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
19 Guadalajara;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
19 Guadalajara;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
19 Guadalajara;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
19 Guadalajara;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
19 Guadalajara;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
19 Guadalajara;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QII;2.769
19 Guadalajara;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
19 Guadalajara;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
19 Guadalajara;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
19 Guadalajara;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QII;2.711
19 Guadalajara;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
19 Guadalajara;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
19 Guadalajara;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
19 Guadalajara;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QII;2.625
19 Guadalajara;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
19 Guadalajara;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
19 Guadalajara;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
19 Guadalajara;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2022QII;2.699
19 Guadalajara;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2022QI;""
19 Guadalajara;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
19 Guadalajara;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
19 Guadalajara;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2021QII;2.674
19 Guadalajara;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2021QI;""
19 Guadalajara;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
19 Guadalajara;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
19 Guadalajara;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2020QII;2.581
19 Guadalajara;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2020QI;""
19 Guadalajara;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
19 Guadalajara;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2022QIII;2.648
19 Guadalajara;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2022QII;""
19 Guadalajara;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2022QI;""
19 Guadalajara;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
19 Guadalajara;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2021QIII;2.631
19 Guadalajara;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2021QII;""
19 Guadalajara;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2021QI;""
19 Guadalajara;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
19 Guadalajara;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2020QIII;2.515
19 Guadalajara;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2020QII;""
19 Guadalajara;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2020QI;""
19 Guadalajara;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QIV;2.593
19 Guadalajara;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
19 Guadalajara;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QII;""
19 Guadalajara;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QI;""
19 Guadalajara;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QIV;2.588
19 Guadalajara;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
19 Guadalajara;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QII;""
19 Guadalajara;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QI;""
19 Guadalajara;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QIV;2.471
19 Guadalajara;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
19 Guadalajara;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QII;""
19 Guadalajara;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QI;""
19 Guadalajara;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
19 Guadalajara;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
19 Guadalajara;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QII;""
19 Guadalajara;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QI;2.551
19 Guadalajara;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
19 Guadalajara;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
19 Guadalajara;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QII;""
19 Guadalajara;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QI;2.442
19 Guadalajara;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
19 Guadalajara;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
19 Guadalajara;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QII;""
19 Guadalajara;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QI;""
19 Guadalajara;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
19 Guadalajara;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
19 Guadalajara;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
19 Guadalajara;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
19 Guadalajara;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
19 Guadalajara;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
19 Guadalajara;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
19 Guadalajara;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
19 Guadalajara;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
19 Guadalajara;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
19 Guadalajara;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
19 Guadalajara;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
19 Guadalajara;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
19 Guadalajara;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
19 Guadalajara;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;97,47
19 Guadalajara;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
19 Guadalajara;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
19 Guadalajara;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
19 Guadalajara;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;98,64
19 Guadalajara;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
19 Guadalajara;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
19 Guadalajara;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
19 Guadalajara;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;98,32
19 Guadalajara;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
19 Guadalajara;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
19 Guadalajara;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;95,63
19 Guadalajara;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
19 Guadalajara;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
19 Guadalajara;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
19 Guadalajara;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;97,05
19 Guadalajara;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
19 Guadalajara;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
19 Guadalajara;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
19 Guadalajara;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;95,81
19 Guadalajara;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
19 Guadalajara;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
19 Guadalajara;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;93,64
19 Guadalajara;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
19 Guadalajara;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
19 Guadalajara;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
19 Guadalajara;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;95,46
19 Guadalajara;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
19 Guadalajara;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
19 Guadalajara;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
19 Guadalajara;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;94,13
19 Guadalajara;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
19 Guadalajara;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
19 Guadalajara;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
19 Guadalajara;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
19 Guadalajara;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
19 Guadalajara;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
19 Guadalajara;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;94,1
19 Guadalajara;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
19 Guadalajara;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
19 Guadalajara;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
19 Guadalajara;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;93,03
19 Guadalajara;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
19 Guadalajara;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
19 Guadalajara;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
19 Guadalajara;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
19 Guadalajara;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
19 Guadalajara;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
19 Guadalajara;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QII;1.397
19 Guadalajara;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
19 Guadalajara;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
19 Guadalajara;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
19 Guadalajara;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QII;1.339
19 Guadalajara;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
19 Guadalajara;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
19 Guadalajara;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
19 Guadalajara;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QII;1.254
19 Guadalajara;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
19 Guadalajara;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
19 Guadalajara;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
19 Guadalajara;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2022QII;1.358
19 Guadalajara;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2022QI;""
19 Guadalajara;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
19 Guadalajara;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
19 Guadalajara;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2021QII;1.310
19 Guadalajara;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2021QI;""
19 Guadalajara;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
19 Guadalajara;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
19 Guadalajara;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2020QII;1.232
19 Guadalajara;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2020QI;""
19 Guadalajara;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
19 Guadalajara;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2022QIII;1.318
19 Guadalajara;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2022QII;""
19 Guadalajara;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2022QI;""
19 Guadalajara;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
19 Guadalajara;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2021QIII;1.283
19 Guadalajara;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2021QII;""
19 Guadalajara;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2021QI;""
19 Guadalajara;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
19 Guadalajara;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2020QIII;1.206
19 Guadalajara;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2020QII;""
19 Guadalajara;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2020QI;""
19 Guadalajara;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QIV;1.284
19 Guadalajara;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
19 Guadalajara;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QII;""
19 Guadalajara;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QI;""
19 Guadalajara;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QIV;1.256
19 Guadalajara;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
19 Guadalajara;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QII;""
19 Guadalajara;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QI;""
19 Guadalajara;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QIV;1.192
19 Guadalajara;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
19 Guadalajara;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QII;""
19 Guadalajara;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QI;""
19 Guadalajara;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
19 Guadalajara;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
19 Guadalajara;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QII;""
19 Guadalajara;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QI;1.231
19 Guadalajara;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
19 Guadalajara;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
19 Guadalajara;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QII;""
19 Guadalajara;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QI;1.166
19 Guadalajara;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
19 Guadalajara;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
19 Guadalajara;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QII;""
19 Guadalajara;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QI;""
19 Guadalajara;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
19 Guadalajara;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
19 Guadalajara;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
19 Guadalajara;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
19 Guadalajara;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
19 Guadalajara;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
19 Guadalajara;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
19 Guadalajara;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
19 Guadalajara;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
19 Guadalajara;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
19 Guadalajara;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
19 Guadalajara;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
19 Guadalajara;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
19 Guadalajara;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
19 Guadalajara;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;97,21
19 Guadalajara;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
19 Guadalajara;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
19 Guadalajara;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
19 Guadalajara;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;97,83
19 Guadalajara;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
19 Guadalajara;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
19 Guadalajara;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
19 Guadalajara;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;98,25
19 Guadalajara;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
19 Guadalajara;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
19 Guadalajara;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;94,35
19 Guadalajara;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
19 Guadalajara;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
19 Guadalajara;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
19 Guadalajara;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;95,82
19 Guadalajara;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
19 Guadalajara;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
19 Guadalajara;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
19 Guadalajara;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;96,17
19 Guadalajara;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
19 Guadalajara;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
19 Guadalajara;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;91,91
19 Guadalajara;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
19 Guadalajara;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
19 Guadalajara;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
19 Guadalajara;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;93,8
19 Guadalajara;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
19 Guadalajara;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
19 Guadalajara;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
19 Guadalajara;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;95,06
19 Guadalajara;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
19 Guadalajara;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
19 Guadalajara;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
19 Guadalajara;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
19 Guadalajara;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
19 Guadalajara;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
19 Guadalajara;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;91,93
19 Guadalajara;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
19 Guadalajara;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
19 Guadalajara;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
19 Guadalajara;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;92,98
19 Guadalajara;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
19 Guadalajara;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
19 Guadalajara;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
19 Guadalajara;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
19 Guadalajara;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
19 Guadalajara;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QIII;4.148
19 Guadalajara;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
19 Guadalajara;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
19 Guadalajara;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
19 Guadalajara;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QIII;4.080
19 Guadalajara;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
19 Guadalajara;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
19 Guadalajara;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
19 Guadalajara;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QIII;3.897
19 Guadalajara;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
19 Guadalajara;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
19 Guadalajara;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
19 Guadalajara;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2022QIII;4.038
19 Guadalajara;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2022QII;""
19 Guadalajara;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2022QI;""
19 Guadalajara;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
19 Guadalajara;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2021QIII;3.993
19 Guadalajara;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2021QII;""
19 Guadalajara;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2021QI;""
19 Guadalajara;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
19 Guadalajara;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2020QIII;3.791
19 Guadalajara;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2020QII;""
19 Guadalajara;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2020QI;""
19 Guadalajara;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2022QIV;3.941
19 Guadalajara;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
19 Guadalajara;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2022QII;""
19 Guadalajara;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2022QI;""
19 Guadalajara;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2021QIV;3.917
19 Guadalajara;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
19 Guadalajara;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2021QII;""
19 Guadalajara;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2021QI;""
19 Guadalajara;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2020QIV;3.723
19 Guadalajara;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
19 Guadalajara;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2020QII;""
19 Guadalajara;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2020QI;""
19 Guadalajara;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
19 Guadalajara;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
19 Guadalajara;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QII;""
19 Guadalajara;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QI;3.849
19 Guadalajara;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
19 Guadalajara;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
19 Guadalajara;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QII;""
19 Guadalajara;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QI;3.665
19 Guadalajara;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
19 Guadalajara;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
19 Guadalajara;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QII;""
19 Guadalajara;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QI;""
19 Guadalajara;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
19 Guadalajara;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
19 Guadalajara;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QII;3.763
19 Guadalajara;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QI;""
19 Guadalajara;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
19 Guadalajara;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
19 Guadalajara;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QII;3.618
19 Guadalajara;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QI;""
19 Guadalajara;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
19 Guadalajara;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
19 Guadalajara;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QII;""
19 Guadalajara;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QI;""
19 Guadalajara;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
19 Guadalajara;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
19 Guadalajara;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
19 Guadalajara;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
19 Guadalajara;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
19 Guadalajara;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
19 Guadalajara;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
19 Guadalajara;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
19 Guadalajara;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
19 Guadalajara;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
19 Guadalajara;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
19 Guadalajara;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
19 Guadalajara;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
19 Guadalajara;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;97,35
19 Guadalajara;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
19 Guadalajara;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
19 Guadalajara;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
19 Guadalajara;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;97,87
19 Guadalajara;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
19 Guadalajara;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
19 Guadalajara;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
19 Guadalajara;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;97,28
19 Guadalajara;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
19 Guadalajara;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
19 Guadalajara;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;95,01
19 Guadalajara;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
19 Guadalajara;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
19 Guadalajara;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
19 Guadalajara;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;96
19 Guadalajara;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
19 Guadalajara;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
19 Guadalajara;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
19 Guadalajara;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;95,54
19 Guadalajara;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
19 Guadalajara;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
19 Guadalajara;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
19 Guadalajara;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
19 Guadalajara;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
19 Guadalajara;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
19 Guadalajara;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;94,34
19 Guadalajara;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
19 Guadalajara;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
19 Guadalajara;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
19 Guadalajara;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;94,05
19 Guadalajara;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
19 Guadalajara;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
19 Guadalajara;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
19 Guadalajara;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
19 Guadalajara;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
19 Guadalajara;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
19 Guadalajara;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;92,23
19 Guadalajara;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
19 Guadalajara;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
19 Guadalajara;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
19 Guadalajara;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;92,84
19 Guadalajara;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
19 Guadalajara;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
19 Guadalajara;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
19 Guadalajara;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
19 Guadalajara;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
19 Guadalajara;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
19 Guadalajara;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QIII;2.756
19 Guadalajara;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
19 Guadalajara;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
19 Guadalajara;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
19 Guadalajara;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QIII;2.736
19 Guadalajara;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
19 Guadalajara;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
19 Guadalajara;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
19 Guadalajara;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QIII;2.639
19 Guadalajara;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
19 Guadalajara;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
19 Guadalajara;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
19 Guadalajara;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2022QIII;2.693
19 Guadalajara;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2022QII;""
19 Guadalajara;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2022QI;""
19 Guadalajara;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
19 Guadalajara;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2021QIII;2.681
19 Guadalajara;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2021QII;""
19 Guadalajara;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2021QI;""
19 Guadalajara;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
19 Guadalajara;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2020QIII;2.562
19 Guadalajara;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2020QII;""
19 Guadalajara;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2020QI;""
19 Guadalajara;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2022QIV;2.633
19 Guadalajara;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
19 Guadalajara;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2022QII;""
19 Guadalajara;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2022QI;""
19 Guadalajara;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2021QIV;2.633
19 Guadalajara;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
19 Guadalajara;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2021QII;""
19 Guadalajara;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2021QI;""
19 Guadalajara;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2020QIV;2.513
19 Guadalajara;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
19 Guadalajara;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2020QII;""
19 Guadalajara;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2020QI;""
19 Guadalajara;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
19 Guadalajara;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
19 Guadalajara;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QII;""
19 Guadalajara;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QI;2.593
19 Guadalajara;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
19 Guadalajara;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
19 Guadalajara;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QII;""
19 Guadalajara;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QI;2.481
19 Guadalajara;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
19 Guadalajara;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
19 Guadalajara;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QII;""
19 Guadalajara;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QI;""
19 Guadalajara;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
19 Guadalajara;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
19 Guadalajara;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QII;2.537
19 Guadalajara;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QI;""
19 Guadalajara;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
19 Guadalajara;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
19 Guadalajara;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QII;2.454
19 Guadalajara;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QI;""
19 Guadalajara;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
19 Guadalajara;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
19 Guadalajara;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QII;""
19 Guadalajara;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QI;""
19 Guadalajara;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
19 Guadalajara;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
19 Guadalajara;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
19 Guadalajara;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
19 Guadalajara;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
19 Guadalajara;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
19 Guadalajara;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
19 Guadalajara;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
19 Guadalajara;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
19 Guadalajara;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
19 Guadalajara;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
19 Guadalajara;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
19 Guadalajara;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
19 Guadalajara;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;97,71
19 Guadalajara;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
19 Guadalajara;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
19 Guadalajara;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
19 Guadalajara;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;97,99
19 Guadalajara;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
19 Guadalajara;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
19 Guadalajara;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
19 Guadalajara;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;97,08
19 Guadalajara;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
19 Guadalajara;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
19 Guadalajara;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;95,54
19 Guadalajara;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
19 Guadalajara;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
19 Guadalajara;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
19 Guadalajara;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;96,24
19 Guadalajara;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
19 Guadalajara;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
19 Guadalajara;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
19 Guadalajara;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;95,23
19 Guadalajara;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
19 Guadalajara;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
19 Guadalajara;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
19 Guadalajara;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
19 Guadalajara;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
19 Guadalajara;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
19 Guadalajara;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;94,77
19 Guadalajara;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
19 Guadalajara;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
19 Guadalajara;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
19 Guadalajara;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;94,01
19 Guadalajara;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
19 Guadalajara;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
19 Guadalajara;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
19 Guadalajara;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
19 Guadalajara;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
19 Guadalajara;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
19 Guadalajara;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;92,73
19 Guadalajara;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
19 Guadalajara;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
19 Guadalajara;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
19 Guadalajara;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;92,99
19 Guadalajara;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
19 Guadalajara;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
19 Guadalajara;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
19 Guadalajara;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
19 Guadalajara;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
19 Guadalajara;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
19 Guadalajara;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QIII;1.392
19 Guadalajara;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
19 Guadalajara;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
19 Guadalajara;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
19 Guadalajara;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QIII;1.344
19 Guadalajara;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
19 Guadalajara;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
19 Guadalajara;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
19 Guadalajara;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QIII;1.258
19 Guadalajara;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
19 Guadalajara;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
19 Guadalajara;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
19 Guadalajara;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2022QIII;1.345
19 Guadalajara;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2022QII;""
19 Guadalajara;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2022QI;""
19 Guadalajara;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
19 Guadalajara;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2021QIII;1.312
19 Guadalajara;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2021QII;""
19 Guadalajara;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2021QI;""
19 Guadalajara;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
19 Guadalajara;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2020QIII;1.229
19 Guadalajara;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2020QII;""
19 Guadalajara;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2020QI;""
19 Guadalajara;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2022QIV;1.308
19 Guadalajara;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
19 Guadalajara;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2022QII;""
19 Guadalajara;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2022QI;""
19 Guadalajara;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2021QIV;1.284
19 Guadalajara;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
19 Guadalajara;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2021QII;""
19 Guadalajara;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2021QI;""
19 Guadalajara;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2020QIV;1.210
19 Guadalajara;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
19 Guadalajara;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2020QII;""
19 Guadalajara;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2020QI;""
19 Guadalajara;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
19 Guadalajara;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
19 Guadalajara;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QII;""
19 Guadalajara;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QI;1.256
19 Guadalajara;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
19 Guadalajara;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
19 Guadalajara;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QII;""
19 Guadalajara;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QI;1.184
19 Guadalajara;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
19 Guadalajara;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
19 Guadalajara;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QII;""
19 Guadalajara;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QI;""
19 Guadalajara;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
19 Guadalajara;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
19 Guadalajara;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QII;1.226
19 Guadalajara;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QI;""
19 Guadalajara;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
19 Guadalajara;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
19 Guadalajara;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QII;1.164
19 Guadalajara;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QI;""
19 Guadalajara;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
19 Guadalajara;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
19 Guadalajara;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QII;""
19 Guadalajara;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QI;""
19 Guadalajara;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
19 Guadalajara;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
19 Guadalajara;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
19 Guadalajara;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
19 Guadalajara;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
19 Guadalajara;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
19 Guadalajara;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
19 Guadalajara;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
19 Guadalajara;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
19 Guadalajara;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
19 Guadalajara;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
19 Guadalajara;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
19 Guadalajara;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
19 Guadalajara;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;96,62
19 Guadalajara;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
19 Guadalajara;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
19 Guadalajara;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
19 Guadalajara;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;97,62
19 Guadalajara;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
19 Guadalajara;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
19 Guadalajara;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
19 Guadalajara;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;97,69
19 Guadalajara;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
19 Guadalajara;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
19 Guadalajara;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;93,97
19 Guadalajara;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
19 Guadalajara;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
19 Guadalajara;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
19 Guadalajara;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;95,54
19 Guadalajara;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
19 Guadalajara;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
19 Guadalajara;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
19 Guadalajara;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;96,18
19 Guadalajara;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
19 Guadalajara;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
19 Guadalajara;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
19 Guadalajara;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
19 Guadalajara;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
19 Guadalajara;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
19 Guadalajara;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;93,45
19 Guadalajara;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
19 Guadalajara;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
19 Guadalajara;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
19 Guadalajara;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;94,12
19 Guadalajara;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
19 Guadalajara;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
19 Guadalajara;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
19 Guadalajara;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
19 Guadalajara;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
19 Guadalajara;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
19 Guadalajara;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;91,22
19 Guadalajara;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
19 Guadalajara;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
19 Guadalajara;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
19 Guadalajara;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;92,53
19 Guadalajara;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
19 Guadalajara;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
19 Guadalajara;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
19 Guadalajara;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
19 Guadalajara;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
19 Guadalajara;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QIV;4.119
19 Guadalajara;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
19 Guadalajara;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
19 Guadalajara;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
19 Guadalajara;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QIV;4.092
19 Guadalajara;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
19 Guadalajara;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
19 Guadalajara;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
19 Guadalajara;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QIV;3.893
19 Guadalajara;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
19 Guadalajara;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
19 Guadalajara;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
19 Guadalajara;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2022QIV;4.012
19 Guadalajara;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
19 Guadalajara;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2022QII;""
19 Guadalajara;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2022QI;""
19 Guadalajara;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2021QIV;4.005
19 Guadalajara;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
19 Guadalajara;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2021QII;""
19 Guadalajara;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2021QI;""
19 Guadalajara;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2020QIV;3.809
19 Guadalajara;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
19 Guadalajara;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2020QII;""
19 Guadalajara;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2020QI;""
19 Guadalajara;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
19 Guadalajara;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
19 Guadalajara;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2022QII;""
19 Guadalajara;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2022QI;3.930
19 Guadalajara;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
19 Guadalajara;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
19 Guadalajara;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2021QII;""
19 Guadalajara;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2021QI;3.740
19 Guadalajara;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
19 Guadalajara;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
19 Guadalajara;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2020QII;""
19 Guadalajara;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2020QI;""
19 Guadalajara;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
19 Guadalajara;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
19 Guadalajara;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QII;3.832
19 Guadalajara;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QI;""
19 Guadalajara;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
19 Guadalajara;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
19 Guadalajara;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QII;3.690
19 Guadalajara;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QI;""
19 Guadalajara;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
19 Guadalajara;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
19 Guadalajara;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QII;""
19 Guadalajara;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QI;""
19 Guadalajara;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
19 Guadalajara;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QIII;3.759
19 Guadalajara;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QII;""
19 Guadalajara;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QI;""
19 Guadalajara;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
19 Guadalajara;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QIII;3.629
19 Guadalajara;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QII;""
19 Guadalajara;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QI;""
19 Guadalajara;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
19 Guadalajara;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
19 Guadalajara;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QII;""
19 Guadalajara;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QI;""
19 Guadalajara;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
19 Guadalajara;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
19 Guadalajara;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
19 Guadalajara;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
19 Guadalajara;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
19 Guadalajara;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
19 Guadalajara;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
19 Guadalajara;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
19 Guadalajara;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
19 Guadalajara;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
19 Guadalajara;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
19 Guadalajara;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
19 Guadalajara;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;97,4
19 Guadalajara;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
19 Guadalajara;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
19 Guadalajara;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
19 Guadalajara;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;97,87
19 Guadalajara;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
19 Guadalajara;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
19 Guadalajara;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
19 Guadalajara;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;97,84
19 Guadalajara;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
19 Guadalajara;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
19 Guadalajara;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
19 Guadalajara;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
19 Guadalajara;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
19 Guadalajara;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
19 Guadalajara;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;96,04
19 Guadalajara;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
19 Guadalajara;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
19 Guadalajara;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
19 Guadalajara;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;96,07
19 Guadalajara;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
19 Guadalajara;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
19 Guadalajara;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
19 Guadalajara;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
19 Guadalajara;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
19 Guadalajara;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
19 Guadalajara;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;93,65
19 Guadalajara;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
19 Guadalajara;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
19 Guadalajara;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
19 Guadalajara;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;94,79
19 Guadalajara;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
19 Guadalajara;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
19 Guadalajara;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
19 Guadalajara;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
19 Guadalajara;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
19 Guadalajara;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
19 Guadalajara;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;91,86
19 Guadalajara;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
19 Guadalajara;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
19 Guadalajara;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
19 Guadalajara;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;93,22
19 Guadalajara;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
19 Guadalajara;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
19 Guadalajara;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
19 Guadalajara;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
19 Guadalajara;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
19 Guadalajara;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
19 Guadalajara;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QIV;2.739
19 Guadalajara;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
19 Guadalajara;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
19 Guadalajara;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
19 Guadalajara;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QIV;2.736
19 Guadalajara;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
19 Guadalajara;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
19 Guadalajara;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
19 Guadalajara;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QIV;2.623
19 Guadalajara;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
19 Guadalajara;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
19 Guadalajara;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
19 Guadalajara;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2022QIV;2.671
19 Guadalajara;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
19 Guadalajara;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2022QII;""
19 Guadalajara;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2022QI;""
19 Guadalajara;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2021QIV;2.683
19 Guadalajara;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
19 Guadalajara;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2021QII;""
19 Guadalajara;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2021QI;""
19 Guadalajara;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2020QIV;2.562
19 Guadalajara;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
19 Guadalajara;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2020QII;""
19 Guadalajara;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2020QI;""
19 Guadalajara;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
19 Guadalajara;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
19 Guadalajara;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2022QII;""
19 Guadalajara;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2022QI;2.639
19 Guadalajara;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
19 Guadalajara;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
19 Guadalajara;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2021QII;""
19 Guadalajara;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2021QI;2.522
19 Guadalajara;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
19 Guadalajara;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
19 Guadalajara;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2020QII;""
19 Guadalajara;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2020QI;""
19 Guadalajara;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
19 Guadalajara;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
19 Guadalajara;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QII;2.576
19 Guadalajara;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QI;""
19 Guadalajara;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
19 Guadalajara;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
19 Guadalajara;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QII;2.493
19 Guadalajara;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QI;""
19 Guadalajara;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
19 Guadalajara;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
19 Guadalajara;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QII;""
19 Guadalajara;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QI;""
19 Guadalajara;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
19 Guadalajara;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QIII;2.534
19 Guadalajara;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QII;""
19 Guadalajara;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QI;""
19 Guadalajara;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
19 Guadalajara;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QIII;2.456
19 Guadalajara;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QII;""
19 Guadalajara;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QI;""
19 Guadalajara;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
19 Guadalajara;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
19 Guadalajara;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QII;""
19 Guadalajara;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QI;""
19 Guadalajara;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
19 Guadalajara;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
19 Guadalajara;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
19 Guadalajara;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
19 Guadalajara;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
19 Guadalajara;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
19 Guadalajara;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
19 Guadalajara;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
19 Guadalajara;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
19 Guadalajara;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
19 Guadalajara;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
19 Guadalajara;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
19 Guadalajara;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;97,52
19 Guadalajara;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
19 Guadalajara;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
19 Guadalajara;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
19 Guadalajara;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;98,06
19 Guadalajara;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
19 Guadalajara;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
19 Guadalajara;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
19 Guadalajara;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;97,67
19 Guadalajara;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
19 Guadalajara;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
19 Guadalajara;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
19 Guadalajara;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
19 Guadalajara;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
19 Guadalajara;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
19 Guadalajara;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;96,45
19 Guadalajara;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
19 Guadalajara;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
19 Guadalajara;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
19 Guadalajara;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;96,15
19 Guadalajara;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
19 Guadalajara;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
19 Guadalajara;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
19 Guadalajara;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
19 Guadalajara;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
19 Guadalajara;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
19 Guadalajara;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;94,15
19 Guadalajara;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
19 Guadalajara;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
19 Guadalajara;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
19 Guadalajara;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;95,04
19 Guadalajara;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
19 Guadalajara;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
19 Guadalajara;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
19 Guadalajara;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
19 Guadalajara;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
19 Guadalajara;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
19 Guadalajara;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;92,62
19 Guadalajara;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
19 Guadalajara;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
19 Guadalajara;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
19 Guadalajara;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;93,63
19 Guadalajara;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
19 Guadalajara;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
19 Guadalajara;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
19 Guadalajara;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
19 Guadalajara;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
19 Guadalajara;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
19 Guadalajara;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QIV;1.380
19 Guadalajara;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
19 Guadalajara;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
19 Guadalajara;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
19 Guadalajara;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QIV;1.356
19 Guadalajara;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
19 Guadalajara;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
19 Guadalajara;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
19 Guadalajara;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QIV;1.270
19 Guadalajara;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
19 Guadalajara;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
19 Guadalajara;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
19 Guadalajara;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2022QIV;1.341
19 Guadalajara;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
19 Guadalajara;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2022QII;""
19 Guadalajara;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2022QI;""
19 Guadalajara;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2021QIV;1.322
19 Guadalajara;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
19 Guadalajara;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2021QII;""
19 Guadalajara;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2021QI;""
19 Guadalajara;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2020QIV;1.247
19 Guadalajara;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
19 Guadalajara;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2020QII;""
19 Guadalajara;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2020QI;""
19 Guadalajara;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
19 Guadalajara;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
19 Guadalajara;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2022QII;""
19 Guadalajara;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2022QI;1.291
19 Guadalajara;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
19 Guadalajara;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
19 Guadalajara;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2021QII;""
19 Guadalajara;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2021QI;1.218
19 Guadalajara;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
19 Guadalajara;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
19 Guadalajara;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2020QII;""
19 Guadalajara;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2020QI;""
19 Guadalajara;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
19 Guadalajara;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
19 Guadalajara;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QII;1.256
19 Guadalajara;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QI;""
19 Guadalajara;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
19 Guadalajara;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
19 Guadalajara;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QII;1.197
19 Guadalajara;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QI;""
19 Guadalajara;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
19 Guadalajara;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
19 Guadalajara;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QII;""
19 Guadalajara;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QI;""
19 Guadalajara;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
19 Guadalajara;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QIII;1.225
19 Guadalajara;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QII;""
19 Guadalajara;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QI;""
19 Guadalajara;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
19 Guadalajara;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QIII;1.173
19 Guadalajara;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QII;""
19 Guadalajara;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QI;""
19 Guadalajara;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
19 Guadalajara;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
19 Guadalajara;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QII;""
19 Guadalajara;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QI;""
19 Guadalajara;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
19 Guadalajara;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
19 Guadalajara;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
19 Guadalajara;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
19 Guadalajara;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
19 Guadalajara;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
19 Guadalajara;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
19 Guadalajara;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
19 Guadalajara;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
19 Guadalajara;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
19 Guadalajara;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
19 Guadalajara;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
19 Guadalajara;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;97,17
19 Guadalajara;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
19 Guadalajara;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
19 Guadalajara;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
19 Guadalajara;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;97,49
19 Guadalajara;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
19 Guadalajara;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
19 Guadalajara;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
19 Guadalajara;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;98,19
19 Guadalajara;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
19 Guadalajara;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
19 Guadalajara;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
19 Guadalajara;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
19 Guadalajara;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
19 Guadalajara;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
19 Guadalajara;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;95,21
19 Guadalajara;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
19 Guadalajara;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
19 Guadalajara;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
19 Guadalajara;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;95,91
19 Guadalajara;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
19 Guadalajara;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
19 Guadalajara;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
19 Guadalajara;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
19 Guadalajara;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
19 Guadalajara;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
19 Guadalajara;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;92,63
19 Guadalajara;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
19 Guadalajara;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
19 Guadalajara;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
19 Guadalajara;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;94,25
19 Guadalajara;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
19 Guadalajara;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
19 Guadalajara;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
19 Guadalajara;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
19 Guadalajara;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
19 Guadalajara;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
19 Guadalajara;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;90,34
19 Guadalajara;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
19 Guadalajara;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
19 Guadalajara;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
19 Guadalajara;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;92,36
19 Guadalajara;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
19 Guadalajara;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
19 Guadalajara;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
19 Guadalajara;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
19 Guadalajara;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
19 Guadalajara;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
19 Guadalajara;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
19 Guadalajara;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
19 Guadalajara;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
19 Guadalajara;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QI;1.768
19 Guadalajara;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
19 Guadalajara;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
19 Guadalajara;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
19 Guadalajara;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QI;1.673
19 Guadalajara;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
19 Guadalajara;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
19 Guadalajara;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
19 Guadalajara;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QI;1.925
19 Guadalajara;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
19 Guadalajara;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
19 Guadalajara;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2022QII;""
19 Guadalajara;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2022QI;1.708
19 Guadalajara;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
19 Guadalajara;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
19 Guadalajara;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2021QII;""
19 Guadalajara;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2021QI;1.615
19 Guadalajara;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
19 Guadalajara;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
19 Guadalajara;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2020QII;""
19 Guadalajara;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2020QI;1.782
19 Guadalajara;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
19 Guadalajara;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
19 Guadalajara;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2022QII;1.651
19 Guadalajara;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2022QI;""
19 Guadalajara;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
19 Guadalajara;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
19 Guadalajara;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2021QII;1.552
19 Guadalajara;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2021QI;""
19 Guadalajara;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
19 Guadalajara;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
19 Guadalajara;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2020QII;1.726
19 Guadalajara;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2020QI;""
19 Guadalajara;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
19 Guadalajara;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QIII;1.580
19 Guadalajara;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QII;""
19 Guadalajara;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QI;""
19 Guadalajara;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
19 Guadalajara;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QIII;1.501
19 Guadalajara;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QII;""
19 Guadalajara;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QI;""
19 Guadalajara;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
19 Guadalajara;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QIII;1.660
19 Guadalajara;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QII;""
19 Guadalajara;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QI;""
19 Guadalajara;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QIV;1.481
19 Guadalajara;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
19 Guadalajara;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QII;""
19 Guadalajara;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QI;""
19 Guadalajara;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QIV;1.426
19 Guadalajara;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
19 Guadalajara;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QII;""
19 Guadalajara;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QI;""
19 Guadalajara;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QIV;1.577
19 Guadalajara;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
19 Guadalajara;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QII;""
19 Guadalajara;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QI;""
19 Guadalajara;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
19 Guadalajara;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
19 Guadalajara;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
19 Guadalajara;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
19 Guadalajara;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
19 Guadalajara;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
19 Guadalajara;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
19 Guadalajara;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
19 Guadalajara;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
19 Guadalajara;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
19 Guadalajara;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
19 Guadalajara;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
19 Guadalajara;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
19 Guadalajara;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
19 Guadalajara;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
19 Guadalajara;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;96,61
19 Guadalajara;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
19 Guadalajara;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
19 Guadalajara;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
19 Guadalajara;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;96,53
19 Guadalajara;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
19 Guadalajara;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
19 Guadalajara;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
19 Guadalajara;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;92,57
19 Guadalajara;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
19 Guadalajara;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
19 Guadalajara;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;93,38
19 Guadalajara;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
19 Guadalajara;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
19 Guadalajara;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
19 Guadalajara;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;92,77
19 Guadalajara;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
19 Guadalajara;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
19 Guadalajara;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
19 Guadalajara;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;89,66
19 Guadalajara;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
19 Guadalajara;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
19 Guadalajara;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;89,37
19 Guadalajara;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
19 Guadalajara;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
19 Guadalajara;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
19 Guadalajara;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;89,72
19 Guadalajara;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
19 Guadalajara;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
19 Guadalajara;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
19 Guadalajara;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;86,23
19 Guadalajara;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
19 Guadalajara;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
19 Guadalajara;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;83,77
19 Guadalajara;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
19 Guadalajara;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
19 Guadalajara;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
19 Guadalajara;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;85,24
19 Guadalajara;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
19 Guadalajara;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
19 Guadalajara;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
19 Guadalajara;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;81,92
19 Guadalajara;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
19 Guadalajara;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
19 Guadalajara;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
19 Guadalajara;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
19 Guadalajara;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
19 Guadalajara;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
19 Guadalajara;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QI;1.229
19 Guadalajara;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
19 Guadalajara;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
19 Guadalajara;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
19 Guadalajara;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QI;1.148
19 Guadalajara;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
19 Guadalajara;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
19 Guadalajara;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
19 Guadalajara;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QI;1.326
19 Guadalajara;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
19 Guadalajara;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
19 Guadalajara;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2022QII;""
19 Guadalajara;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2022QI;1.185
19 Guadalajara;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
19 Guadalajara;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
19 Guadalajara;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2021QII;""
19 Guadalajara;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2021QI;1.108
19 Guadalajara;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
19 Guadalajara;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
19 Guadalajara;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2020QII;""
19 Guadalajara;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2020QI;1.223
19 Guadalajara;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
19 Guadalajara;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
19 Guadalajara;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2022QII;1.153
19 Guadalajara;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2022QI;""
19 Guadalajara;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
19 Guadalajara;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
19 Guadalajara;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2021QII;1.069
19 Guadalajara;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2021QI;""
19 Guadalajara;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
19 Guadalajara;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
19 Guadalajara;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2020QII;1.189
19 Guadalajara;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2020QI;""
19 Guadalajara;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
19 Guadalajara;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QIII;1.099
19 Guadalajara;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QII;""
19 Guadalajara;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QI;""
19 Guadalajara;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
19 Guadalajara;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QIII;1.036
19 Guadalajara;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QII;""
19 Guadalajara;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QI;""
19 Guadalajara;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
19 Guadalajara;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QIII;1.149
19 Guadalajara;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QII;""
19 Guadalajara;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QI;""
19 Guadalajara;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QIV;1.033
19 Guadalajara;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
19 Guadalajara;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QII;""
19 Guadalajara;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QI;""
19 Guadalajara;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QIV;990
19 Guadalajara;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
19 Guadalajara;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QII;""
19 Guadalajara;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QI;""
19 Guadalajara;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QIV;1.088
19 Guadalajara;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
19 Guadalajara;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QII;""
19 Guadalajara;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QI;""
19 Guadalajara;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
19 Guadalajara;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
19 Guadalajara;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
19 Guadalajara;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
19 Guadalajara;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
19 Guadalajara;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
19 Guadalajara;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
19 Guadalajara;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
19 Guadalajara;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
19 Guadalajara;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
19 Guadalajara;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
19 Guadalajara;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
19 Guadalajara;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
19 Guadalajara;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
19 Guadalajara;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
19 Guadalajara;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;96,42
19 Guadalajara;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
19 Guadalajara;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
19 Guadalajara;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
19 Guadalajara;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;96,52
19 Guadalajara;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
19 Guadalajara;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
19 Guadalajara;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
19 Guadalajara;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;92,23
19 Guadalajara;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
19 Guadalajara;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
19 Guadalajara;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;93,82
19 Guadalajara;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
19 Guadalajara;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
19 Guadalajara;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
19 Guadalajara;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;93,12
19 Guadalajara;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
19 Guadalajara;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
19 Guadalajara;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
19 Guadalajara;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;89,67
19 Guadalajara;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
19 Guadalajara;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
19 Guadalajara;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;89,42
19 Guadalajara;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
19 Guadalajara;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
19 Guadalajara;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
19 Guadalajara;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;90,24
19 Guadalajara;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
19 Guadalajara;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
19 Guadalajara;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
19 Guadalajara;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;86,65
19 Guadalajara;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
19 Guadalajara;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
19 Guadalajara;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;84,05
19 Guadalajara;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
19 Guadalajara;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
19 Guadalajara;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
19 Guadalajara;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;86,24
19 Guadalajara;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
19 Guadalajara;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
19 Guadalajara;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
19 Guadalajara;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;82,05
19 Guadalajara;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
19 Guadalajara;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
19 Guadalajara;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
19 Guadalajara;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
19 Guadalajara;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
19 Guadalajara;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
19 Guadalajara;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QI;539
19 Guadalajara;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
19 Guadalajara;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
19 Guadalajara;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
19 Guadalajara;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QI;525
19 Guadalajara;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
19 Guadalajara;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
19 Guadalajara;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
19 Guadalajara;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QI;599
19 Guadalajara;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
19 Guadalajara;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
19 Guadalajara;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2022QII;""
19 Guadalajara;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2022QI;523
19 Guadalajara;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
19 Guadalajara;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
19 Guadalajara;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2021QII;""
19 Guadalajara;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2021QI;507
19 Guadalajara;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
19 Guadalajara;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
19 Guadalajara;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2020QII;""
19 Guadalajara;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2020QI;559
19 Guadalajara;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
19 Guadalajara;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
19 Guadalajara;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2022QII;498
19 Guadalajara;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2022QI;""
19 Guadalajara;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
19 Guadalajara;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
19 Guadalajara;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2021QII;483
19 Guadalajara;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2021QI;""
19 Guadalajara;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
19 Guadalajara;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
19 Guadalajara;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2020QII;537
19 Guadalajara;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2020QI;""
19 Guadalajara;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
19 Guadalajara;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QIII;481
19 Guadalajara;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QII;""
19 Guadalajara;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QI;""
19 Guadalajara;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
19 Guadalajara;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QIII;465
19 Guadalajara;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QII;""
19 Guadalajara;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QI;""
19 Guadalajara;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
19 Guadalajara;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QIII;511
19 Guadalajara;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QII;""
19 Guadalajara;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QI;""
19 Guadalajara;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QIV;448
19 Guadalajara;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
19 Guadalajara;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QII;""
19 Guadalajara;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QI;""
19 Guadalajara;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QIV;436
19 Guadalajara;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
19 Guadalajara;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QII;""
19 Guadalajara;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QI;""
19 Guadalajara;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QIV;489
19 Guadalajara;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
19 Guadalajara;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QII;""
19 Guadalajara;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QI;""
19 Guadalajara;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
19 Guadalajara;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
19 Guadalajara;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
19 Guadalajara;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
19 Guadalajara;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
19 Guadalajara;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
19 Guadalajara;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
19 Guadalajara;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
19 Guadalajara;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
19 Guadalajara;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
19 Guadalajara;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
19 Guadalajara;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
19 Guadalajara;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
19 Guadalajara;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
19 Guadalajara;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
19 Guadalajara;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;97,03
19 Guadalajara;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
19 Guadalajara;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
19 Guadalajara;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
19 Guadalajara;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;96,57
19 Guadalajara;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
19 Guadalajara;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
19 Guadalajara;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
19 Guadalajara;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;93,32
19 Guadalajara;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
19 Guadalajara;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
19 Guadalajara;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;92,39
19 Guadalajara;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
19 Guadalajara;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
19 Guadalajara;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
19 Guadalajara;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;92
19 Guadalajara;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
19 Guadalajara;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
19 Guadalajara;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
19 Guadalajara;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;89,65
19 Guadalajara;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
19 Guadalajara;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
19 Guadalajara;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;89,24
19 Guadalajara;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
19 Guadalajara;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
19 Guadalajara;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
19 Guadalajara;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;88,57
19 Guadalajara;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
19 Guadalajara;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
19 Guadalajara;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
19 Guadalajara;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;85,31
19 Guadalajara;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
19 Guadalajara;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
19 Guadalajara;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;83,12
19 Guadalajara;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
19 Guadalajara;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
19 Guadalajara;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
19 Guadalajara;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;83,05
19 Guadalajara;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
19 Guadalajara;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
19 Guadalajara;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
19 Guadalajara;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;81,64
19 Guadalajara;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
19 Guadalajara;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
19 Guadalajara;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
19 Guadalajara;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
19 Guadalajara;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
19 Guadalajara;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QII;2.081
19 Guadalajara;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
19 Guadalajara;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
19 Guadalajara;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
19 Guadalajara;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QII;1.930
19 Guadalajara;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
19 Guadalajara;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
19 Guadalajara;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
19 Guadalajara;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QII;1.831
19 Guadalajara;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
19 Guadalajara;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
19 Guadalajara;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
19 Guadalajara;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2022QII;2.014
19 Guadalajara;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2022QI;""
19 Guadalajara;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
19 Guadalajara;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
19 Guadalajara;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2021QII;1.861
19 Guadalajara;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2021QI;""
19 Guadalajara;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
19 Guadalajara;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
19 Guadalajara;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2020QII;1.773
19 Guadalajara;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2020QI;""
19 Guadalajara;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
19 Guadalajara;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2022QIII;1.933
19 Guadalajara;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2022QII;""
19 Guadalajara;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2022QI;""
19 Guadalajara;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
19 Guadalajara;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2021QIII;1.802
19 Guadalajara;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2021QII;""
19 Guadalajara;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2021QI;""
19 Guadalajara;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
19 Guadalajara;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2020QIII;1.701
19 Guadalajara;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2020QII;""
19 Guadalajara;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2020QI;""
19 Guadalajara;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QIV;1.821
19 Guadalajara;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
19 Guadalajara;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QII;""
19 Guadalajara;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QI;""
19 Guadalajara;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QIV;1.719
19 Guadalajara;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
19 Guadalajara;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QII;""
19 Guadalajara;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QI;""
19 Guadalajara;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QIV;1.613
19 Guadalajara;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
19 Guadalajara;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QII;""
19 Guadalajara;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QI;""
19 Guadalajara;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
19 Guadalajara;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
19 Guadalajara;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QII;""
19 Guadalajara;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QI;1.666
19 Guadalajara;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
19 Guadalajara;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
19 Guadalajara;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QII;""
19 Guadalajara;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QI;1.558
19 Guadalajara;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
19 Guadalajara;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
19 Guadalajara;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QII;""
19 Guadalajara;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QI;""
19 Guadalajara;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
19 Guadalajara;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
19 Guadalajara;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
19 Guadalajara;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
19 Guadalajara;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
19 Guadalajara;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
19 Guadalajara;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
19 Guadalajara;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
19 Guadalajara;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
19 Guadalajara;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
19 Guadalajara;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
19 Guadalajara;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
19 Guadalajara;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
19 Guadalajara;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
19 Guadalajara;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;96,78
19 Guadalajara;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
19 Guadalajara;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
19 Guadalajara;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
19 Guadalajara;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;96,42
19 Guadalajara;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
19 Guadalajara;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
19 Guadalajara;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
19 Guadalajara;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;96,83
19 Guadalajara;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
19 Guadalajara;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
19 Guadalajara;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;92,89
19 Guadalajara;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
19 Guadalajara;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
19 Guadalajara;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
19 Guadalajara;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;93,37
19 Guadalajara;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
19 Guadalajara;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
19 Guadalajara;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
19 Guadalajara;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;92,9
19 Guadalajara;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
19 Guadalajara;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
19 Guadalajara;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;87,51
19 Guadalajara;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
19 Guadalajara;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
19 Guadalajara;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
19 Guadalajara;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;89,07
19 Guadalajara;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
19 Guadalajara;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
19 Guadalajara;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
19 Guadalajara;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;88,09
19 Guadalajara;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
19 Guadalajara;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
19 Guadalajara;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
19 Guadalajara;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
19 Guadalajara;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
19 Guadalajara;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
19 Guadalajara;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;86,32
19 Guadalajara;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
19 Guadalajara;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
19 Guadalajara;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
19 Guadalajara;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;85,09
19 Guadalajara;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
19 Guadalajara;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
19 Guadalajara;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
19 Guadalajara;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
19 Guadalajara;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
19 Guadalajara;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
19 Guadalajara;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QII;1.444
19 Guadalajara;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
19 Guadalajara;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
19 Guadalajara;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
19 Guadalajara;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QII;1.331
19 Guadalajara;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
19 Guadalajara;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
19 Guadalajara;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
19 Guadalajara;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QII;1.257
19 Guadalajara;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
19 Guadalajara;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
19 Guadalajara;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
19 Guadalajara;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2022QII;1.409
19 Guadalajara;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2022QI;""
19 Guadalajara;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
19 Guadalajara;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
19 Guadalajara;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2021QII;1.290
19 Guadalajara;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2021QI;""
19 Guadalajara;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
19 Guadalajara;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
19 Guadalajara;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2020QII;1.221
19 Guadalajara;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2020QI;""
19 Guadalajara;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
19 Guadalajara;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2022QIII;1.349
19 Guadalajara;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2022QII;""
19 Guadalajara;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2022QI;""
19 Guadalajara;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
19 Guadalajara;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2021QIII;1.251
19 Guadalajara;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2021QII;""
19 Guadalajara;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2021QI;""
19 Guadalajara;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
19 Guadalajara;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2020QIII;1.177
19 Guadalajara;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2020QII;""
19 Guadalajara;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2020QI;""
19 Guadalajara;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QIV;1.274
19 Guadalajara;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
19 Guadalajara;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QII;""
19 Guadalajara;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QI;""
19 Guadalajara;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QIV;1.199
19 Guadalajara;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
19 Guadalajara;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QII;""
19 Guadalajara;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QI;""
19 Guadalajara;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QIV;1.111
19 Guadalajara;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
19 Guadalajara;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QII;""
19 Guadalajara;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QI;""
19 Guadalajara;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
19 Guadalajara;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
19 Guadalajara;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QII;""
19 Guadalajara;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QI;1.162
19 Guadalajara;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
19 Guadalajara;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
19 Guadalajara;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QII;""
19 Guadalajara;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QI;1.073
19 Guadalajara;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
19 Guadalajara;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
19 Guadalajara;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QII;""
19 Guadalajara;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QI;""
19 Guadalajara;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
19 Guadalajara;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
19 Guadalajara;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
19 Guadalajara;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
19 Guadalajara;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
19 Guadalajara;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
19 Guadalajara;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
19 Guadalajara;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
19 Guadalajara;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
19 Guadalajara;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
19 Guadalajara;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
19 Guadalajara;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
19 Guadalajara;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
19 Guadalajara;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
19 Guadalajara;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;97,58
19 Guadalajara;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
19 Guadalajara;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
19 Guadalajara;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
19 Guadalajara;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;96,92
19 Guadalajara;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
19 Guadalajara;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
19 Guadalajara;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
19 Guadalajara;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;97,14
19 Guadalajara;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
19 Guadalajara;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
19 Guadalajara;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;93,42
19 Guadalajara;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
19 Guadalajara;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
19 Guadalajara;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
19 Guadalajara;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;93,99
19 Guadalajara;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
19 Guadalajara;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
19 Guadalajara;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
19 Guadalajara;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;93,64
19 Guadalajara;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
19 Guadalajara;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
19 Guadalajara;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;88,23
19 Guadalajara;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
19 Guadalajara;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
19 Guadalajara;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
19 Guadalajara;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;90,08
19 Guadalajara;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
19 Guadalajara;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
19 Guadalajara;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
19 Guadalajara;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;88,39
19 Guadalajara;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
19 Guadalajara;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
19 Guadalajara;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
19 Guadalajara;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
19 Guadalajara;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
19 Guadalajara;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
19 Guadalajara;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;87,3
19 Guadalajara;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
19 Guadalajara;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
19 Guadalajara;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
19 Guadalajara;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;85,36
19 Guadalajara;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
19 Guadalajara;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
19 Guadalajara;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
19 Guadalajara;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
19 Guadalajara;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
19 Guadalajara;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
19 Guadalajara;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QII;637
19 Guadalajara;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
19 Guadalajara;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
19 Guadalajara;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
19 Guadalajara;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QII;599
19 Guadalajara;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
19 Guadalajara;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
19 Guadalajara;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
19 Guadalajara;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QII;574
19 Guadalajara;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
19 Guadalajara;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
19 Guadalajara;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
19 Guadalajara;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2022QII;605
19 Guadalajara;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2022QI;""
19 Guadalajara;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
19 Guadalajara;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
19 Guadalajara;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2021QII;571
19 Guadalajara;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2021QI;""
19 Guadalajara;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
19 Guadalajara;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
19 Guadalajara;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2020QII;552
19 Guadalajara;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2020QI;""
19 Guadalajara;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
19 Guadalajara;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2022QIII;584
19 Guadalajara;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2022QII;""
19 Guadalajara;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2022QI;""
19 Guadalajara;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
19 Guadalajara;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2021QIII;551
19 Guadalajara;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2021QII;""
19 Guadalajara;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2021QI;""
19 Guadalajara;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
19 Guadalajara;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2020QIII;524
19 Guadalajara;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2020QII;""
19 Guadalajara;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2020QI;""
19 Guadalajara;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QIV;547
19 Guadalajara;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
19 Guadalajara;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QII;""
19 Guadalajara;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QI;""
19 Guadalajara;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QIV;520
19 Guadalajara;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
19 Guadalajara;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QII;""
19 Guadalajara;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QI;""
19 Guadalajara;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QIV;502
19 Guadalajara;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
19 Guadalajara;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QII;""
19 Guadalajara;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QI;""
19 Guadalajara;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
19 Guadalajara;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
19 Guadalajara;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QII;""
19 Guadalajara;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QI;504
19 Guadalajara;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
19 Guadalajara;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
19 Guadalajara;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QII;""
19 Guadalajara;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QI;485
19 Guadalajara;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
19 Guadalajara;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
19 Guadalajara;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QII;""
19 Guadalajara;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QI;""
19 Guadalajara;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
19 Guadalajara;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
19 Guadalajara;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
19 Guadalajara;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
19 Guadalajara;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
19 Guadalajara;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
19 Guadalajara;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
19 Guadalajara;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
19 Guadalajara;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
19 Guadalajara;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
19 Guadalajara;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
19 Guadalajara;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
19 Guadalajara;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
19 Guadalajara;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
19 Guadalajara;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;94,98
19 Guadalajara;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
19 Guadalajara;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
19 Guadalajara;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
19 Guadalajara;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;95,33
19 Guadalajara;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
19 Guadalajara;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
19 Guadalajara;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
19 Guadalajara;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;96,17
19 Guadalajara;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
19 Guadalajara;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
19 Guadalajara;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;91,68
19 Guadalajara;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
19 Guadalajara;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
19 Guadalajara;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
19 Guadalajara;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;91,99
19 Guadalajara;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
19 Guadalajara;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
19 Guadalajara;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
19 Guadalajara;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;91,29
19 Guadalajara;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
19 Guadalajara;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
19 Guadalajara;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;85,87
19 Guadalajara;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
19 Guadalajara;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
19 Guadalajara;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
19 Guadalajara;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;86,81
19 Guadalajara;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
19 Guadalajara;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
19 Guadalajara;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
19 Guadalajara;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;87,46
19 Guadalajara;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
19 Guadalajara;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
19 Guadalajara;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
19 Guadalajara;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
19 Guadalajara;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
19 Guadalajara;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
19 Guadalajara;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;84,14
19 Guadalajara;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
19 Guadalajara;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
19 Guadalajara;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
19 Guadalajara;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;84,49
19 Guadalajara;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
19 Guadalajara;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
19 Guadalajara;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
19 Guadalajara;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
19 Guadalajara;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
19 Guadalajara;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QIII;2.041
19 Guadalajara;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
19 Guadalajara;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
19 Guadalajara;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
19 Guadalajara;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QIII;1.884
19 Guadalajara;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
19 Guadalajara;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
19 Guadalajara;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
19 Guadalajara;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QIII;1.796
19 Guadalajara;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
19 Guadalajara;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
19 Guadalajara;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
19 Guadalajara;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2022QIII;1.958
19 Guadalajara;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2022QII;""
19 Guadalajara;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2022QI;""
19 Guadalajara;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
19 Guadalajara;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2021QIII;1.821
19 Guadalajara;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2021QII;""
19 Guadalajara;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2021QI;""
19 Guadalajara;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
19 Guadalajara;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2020QIII;1.721
19 Guadalajara;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2020QII;""
19 Guadalajara;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2020QI;""
19 Guadalajara;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2022QIV;1.843
19 Guadalajara;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
19 Guadalajara;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2022QII;""
19 Guadalajara;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2022QI;""
19 Guadalajara;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2021QIV;1.735
19 Guadalajara;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
19 Guadalajara;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2021QII;""
19 Guadalajara;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2021QI;""
19 Guadalajara;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2020QIV;1.630
19 Guadalajara;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
19 Guadalajara;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2020QII;""
19 Guadalajara;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2020QI;""
19 Guadalajara;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
19 Guadalajara;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
19 Guadalajara;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QII;""
19 Guadalajara;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QI;1.680
19 Guadalajara;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
19 Guadalajara;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
19 Guadalajara;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QII;""
19 Guadalajara;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QI;1.575
19 Guadalajara;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
19 Guadalajara;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
19 Guadalajara;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QII;""
19 Guadalajara;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QI;""
19 Guadalajara;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
19 Guadalajara;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
19 Guadalajara;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QII;1.626
19 Guadalajara;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QI;""
19 Guadalajara;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
19 Guadalajara;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
19 Guadalajara;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QII;1.517
19 Guadalajara;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QI;""
19 Guadalajara;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
19 Guadalajara;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
19 Guadalajara;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QII;""
19 Guadalajara;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QI;""
19 Guadalajara;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
19 Guadalajara;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
19 Guadalajara;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
19 Guadalajara;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
19 Guadalajara;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
19 Guadalajara;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
19 Guadalajara;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
19 Guadalajara;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
19 Guadalajara;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
19 Guadalajara;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
19 Guadalajara;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
19 Guadalajara;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
19 Guadalajara;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
19 Guadalajara;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;95,93
19 Guadalajara;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
19 Guadalajara;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
19 Guadalajara;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
19 Guadalajara;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;96,66
19 Guadalajara;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
19 Guadalajara;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
19 Guadalajara;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
19 Guadalajara;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;95,82
19 Guadalajara;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
19 Guadalajara;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
19 Guadalajara;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;90,3
19 Guadalajara;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
19 Guadalajara;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
19 Guadalajara;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
19 Guadalajara;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;92,09
19 Guadalajara;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
19 Guadalajara;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
19 Guadalajara;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
19 Guadalajara;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;90,76
19 Guadalajara;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
19 Guadalajara;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
19 Guadalajara;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
19 Guadalajara;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
19 Guadalajara;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
19 Guadalajara;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
19 Guadalajara;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;89,17
19 Guadalajara;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
19 Guadalajara;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
19 Guadalajara;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
19 Guadalajara;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;87,69
19 Guadalajara;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
19 Guadalajara;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
19 Guadalajara;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
19 Guadalajara;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
19 Guadalajara;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
19 Guadalajara;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
19 Guadalajara;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;86,31
19 Guadalajara;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
19 Guadalajara;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
19 Guadalajara;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
19 Guadalajara;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;84,47
19 Guadalajara;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
19 Guadalajara;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
19 Guadalajara;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
19 Guadalajara;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
19 Guadalajara;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
19 Guadalajara;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
19 Guadalajara;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QIII;1.426
19 Guadalajara;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
19 Guadalajara;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
19 Guadalajara;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
19 Guadalajara;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QIII;1.298
19 Guadalajara;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
19 Guadalajara;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
19 Guadalajara;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
19 Guadalajara;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QIII;1.235
19 Guadalajara;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
19 Guadalajara;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
19 Guadalajara;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
19 Guadalajara;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2022QIII;1.365
19 Guadalajara;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2022QII;""
19 Guadalajara;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2022QI;""
19 Guadalajara;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
19 Guadalajara;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2021QIII;1.259
19 Guadalajara;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2021QII;""
19 Guadalajara;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2021QI;""
19 Guadalajara;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
19 Guadalajara;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2020QIII;1.189
19 Guadalajara;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2020QII;""
19 Guadalajara;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2020QI;""
19 Guadalajara;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2022QIV;1.289
19 Guadalajara;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
19 Guadalajara;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2022QII;""
19 Guadalajara;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2022QI;""
19 Guadalajara;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2021QIV;1.206
19 Guadalajara;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
19 Guadalajara;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2021QII;""
19 Guadalajara;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2021QI;""
19 Guadalajara;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2020QIV;1.122
19 Guadalajara;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
19 Guadalajara;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2020QII;""
19 Guadalajara;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2020QI;""
19 Guadalajara;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
19 Guadalajara;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
19 Guadalajara;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QII;""
19 Guadalajara;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QI;1.167
19 Guadalajara;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
19 Guadalajara;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
19 Guadalajara;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QII;""
19 Guadalajara;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QI;1.084
19 Guadalajara;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
19 Guadalajara;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
19 Guadalajara;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QII;""
19 Guadalajara;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QI;""
19 Guadalajara;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
19 Guadalajara;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
19 Guadalajara;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QII;1.137
19 Guadalajara;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QI;""
19 Guadalajara;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
19 Guadalajara;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
19 Guadalajara;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QII;1.048
19 Guadalajara;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QI;""
19 Guadalajara;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
19 Guadalajara;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
19 Guadalajara;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QII;""
19 Guadalajara;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QI;""
19 Guadalajara;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
19 Guadalajara;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
19 Guadalajara;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
19 Guadalajara;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
19 Guadalajara;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
19 Guadalajara;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
19 Guadalajara;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
19 Guadalajara;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
19 Guadalajara;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
19 Guadalajara;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
19 Guadalajara;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
19 Guadalajara;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
19 Guadalajara;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
19 Guadalajara;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;95,72
19 Guadalajara;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
19 Guadalajara;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
19 Guadalajara;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
19 Guadalajara;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;97
19 Guadalajara;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
19 Guadalajara;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
19 Guadalajara;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
19 Guadalajara;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;96,28
19 Guadalajara;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
19 Guadalajara;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
19 Guadalajara;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;90,39
19 Guadalajara;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
19 Guadalajara;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
19 Guadalajara;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
19 Guadalajara;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;92,91
19 Guadalajara;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
19 Guadalajara;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
19 Guadalajara;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
19 Guadalajara;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;90,85
19 Guadalajara;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
19 Guadalajara;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
19 Guadalajara;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
19 Guadalajara;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
19 Guadalajara;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
19 Guadalajara;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
19 Guadalajara;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;89,91
19 Guadalajara;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
19 Guadalajara;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
19 Guadalajara;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
19 Guadalajara;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;87,77
19 Guadalajara;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
19 Guadalajara;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
19 Guadalajara;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
19 Guadalajara;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
19 Guadalajara;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
19 Guadalajara;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
19 Guadalajara;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;87,6
19 Guadalajara;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
19 Guadalajara;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
19 Guadalajara;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
19 Guadalajara;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;84,86
19 Guadalajara;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
19 Guadalajara;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
19 Guadalajara;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
19 Guadalajara;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
19 Guadalajara;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
19 Guadalajara;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
19 Guadalajara;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QIII;615
19 Guadalajara;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
19 Guadalajara;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
19 Guadalajara;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
19 Guadalajara;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QIII;586
19 Guadalajara;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
19 Guadalajara;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
19 Guadalajara;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
19 Guadalajara;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QIII;561
19 Guadalajara;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
19 Guadalajara;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
19 Guadalajara;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
19 Guadalajara;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2022QIII;593
19 Guadalajara;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2022QII;""
19 Guadalajara;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2022QI;""
19 Guadalajara;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
19 Guadalajara;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2021QIII;562
19 Guadalajara;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2021QII;""
19 Guadalajara;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2021QI;""
19 Guadalajara;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
19 Guadalajara;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2020QIII;532
19 Guadalajara;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2020QII;""
19 Guadalajara;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2020QI;""
19 Guadalajara;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2022QIV;554
19 Guadalajara;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
19 Guadalajara;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2022QII;""
19 Guadalajara;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2022QI;""
19 Guadalajara;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2021QIV;529
19 Guadalajara;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
19 Guadalajara;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2021QII;""
19 Guadalajara;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2021QI;""
19 Guadalajara;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2020QIV;508
19 Guadalajara;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
19 Guadalajara;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2020QII;""
19 Guadalajara;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2020QI;""
19 Guadalajara;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
19 Guadalajara;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
19 Guadalajara;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QII;""
19 Guadalajara;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QI;513
19 Guadalajara;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
19 Guadalajara;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
19 Guadalajara;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QII;""
19 Guadalajara;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QI;491
19 Guadalajara;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
19 Guadalajara;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
19 Guadalajara;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QII;""
19 Guadalajara;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QI;""
19 Guadalajara;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
19 Guadalajara;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
19 Guadalajara;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QII;489
19 Guadalajara;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QI;""
19 Guadalajara;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
19 Guadalajara;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
19 Guadalajara;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QII;469
19 Guadalajara;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QI;""
19 Guadalajara;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
19 Guadalajara;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
19 Guadalajara;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QII;""
19 Guadalajara;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QI;""
19 Guadalajara;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
19 Guadalajara;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
19 Guadalajara;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
19 Guadalajara;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
19 Guadalajara;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
19 Guadalajara;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
19 Guadalajara;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
19 Guadalajara;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
19 Guadalajara;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
19 Guadalajara;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
19 Guadalajara;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
19 Guadalajara;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
19 Guadalajara;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
19 Guadalajara;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;96,42
19 Guadalajara;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
19 Guadalajara;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
19 Guadalajara;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
19 Guadalajara;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;95,9
19 Guadalajara;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
19 Guadalajara;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
19 Guadalajara;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
19 Guadalajara;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;94,83
19 Guadalajara;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
19 Guadalajara;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
19 Guadalajara;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;90,08
19 Guadalajara;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
19 Guadalajara;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
19 Guadalajara;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
19 Guadalajara;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;90,27
19 Guadalajara;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
19 Guadalajara;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
19 Guadalajara;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
19 Guadalajara;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;90,55
19 Guadalajara;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
19 Guadalajara;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
19 Guadalajara;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
19 Guadalajara;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
19 Guadalajara;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
19 Guadalajara;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
19 Guadalajara;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;87,54
19 Guadalajara;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
19 Guadalajara;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
19 Guadalajara;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
19 Guadalajara;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;87,52
19 Guadalajara;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
19 Guadalajara;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
19 Guadalajara;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
19 Guadalajara;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
19 Guadalajara;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
19 Guadalajara;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
19 Guadalajara;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;83,45
19 Guadalajara;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
19 Guadalajara;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
19 Guadalajara;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
19 Guadalajara;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;83,6
19 Guadalajara;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
19 Guadalajara;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
19 Guadalajara;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
19 Guadalajara;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
19 Guadalajara;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
19 Guadalajara;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QIV;1.978
19 Guadalajara;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
19 Guadalajara;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
19 Guadalajara;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
19 Guadalajara;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QIV;1.842
19 Guadalajara;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
19 Guadalajara;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
19 Guadalajara;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
19 Guadalajara;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QIV;1.746
19 Guadalajara;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
19 Guadalajara;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
19 Guadalajara;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
19 Guadalajara;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2022QIV;1.860
19 Guadalajara;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
19 Guadalajara;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2022QII;""
19 Guadalajara;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2022QI;""
19 Guadalajara;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2021QIV;1.751
19 Guadalajara;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
19 Guadalajara;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2021QII;""
19 Guadalajara;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2021QI;""
19 Guadalajara;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2020QIV;1.652
19 Guadalajara;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
19 Guadalajara;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2020QII;""
19 Guadalajara;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2020QI;""
19 Guadalajara;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
19 Guadalajara;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
19 Guadalajara;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2022QII;""
19 Guadalajara;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2022QI;1.693
19 Guadalajara;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
19 Guadalajara;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
19 Guadalajara;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2021QII;""
19 Guadalajara;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2021QI;1.596
19 Guadalajara;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
19 Guadalajara;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
19 Guadalajara;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2020QII;""
19 Guadalajara;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2020QI;""
19 Guadalajara;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
19 Guadalajara;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
19 Guadalajara;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QII;1.638
19 Guadalajara;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QI;""
19 Guadalajara;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
19 Guadalajara;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
19 Guadalajara;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QII;1.535
19 Guadalajara;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QI;""
19 Guadalajara;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
19 Guadalajara;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
19 Guadalajara;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QII;""
19 Guadalajara;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QI;""
19 Guadalajara;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
19 Guadalajara;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QIII;1.568
19 Guadalajara;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QII;""
19 Guadalajara;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QI;""
19 Guadalajara;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
19 Guadalajara;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QIII;1.485
19 Guadalajara;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QII;""
19 Guadalajara;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QI;""
19 Guadalajara;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
19 Guadalajara;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
19 Guadalajara;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QII;""
19 Guadalajara;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QI;""
19 Guadalajara;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
19 Guadalajara;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
19 Guadalajara;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
19 Guadalajara;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
19 Guadalajara;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
19 Guadalajara;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
19 Guadalajara;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
19 Guadalajara;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
19 Guadalajara;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
19 Guadalajara;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
19 Guadalajara;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
19 Guadalajara;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
19 Guadalajara;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;94,03
19 Guadalajara;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
19 Guadalajara;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
19 Guadalajara;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
19 Guadalajara;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;95,06
19 Guadalajara;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
19 Guadalajara;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
19 Guadalajara;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
19 Guadalajara;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;94,62
19 Guadalajara;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
19 Guadalajara;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
19 Guadalajara;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
19 Guadalajara;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
19 Guadalajara;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
19 Guadalajara;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
19 Guadalajara;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;91,91
19 Guadalajara;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
19 Guadalajara;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
19 Guadalajara;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
19 Guadalajara;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;91,41
19 Guadalajara;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
19 Guadalajara;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
19 Guadalajara;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
19 Guadalajara;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
19 Guadalajara;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
19 Guadalajara;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
19 Guadalajara;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;88,93
19 Guadalajara;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
19 Guadalajara;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
19 Guadalajara;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
19 Guadalajara;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;87,92
19 Guadalajara;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
19 Guadalajara;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
19 Guadalajara;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
19 Guadalajara;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
19 Guadalajara;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
19 Guadalajara;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
19 Guadalajara;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;85,12
19 Guadalajara;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
19 Guadalajara;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
19 Guadalajara;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
19 Guadalajara;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;85,05
19 Guadalajara;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
19 Guadalajara;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
19 Guadalajara;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
19 Guadalajara;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
19 Guadalajara;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
19 Guadalajara;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
19 Guadalajara;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QIV;1.377
19 Guadalajara;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
19 Guadalajara;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
19 Guadalajara;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
19 Guadalajara;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QIV;1.273
19 Guadalajara;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
19 Guadalajara;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
19 Guadalajara;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
19 Guadalajara;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QIV;1.206
19 Guadalajara;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
19 Guadalajara;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
19 Guadalajara;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
19 Guadalajara;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2022QIV;1.299
19 Guadalajara;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
19 Guadalajara;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2022QII;""
19 Guadalajara;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2022QI;""
19 Guadalajara;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2021QIV;1.216
19 Guadalajara;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
19 Guadalajara;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2021QII;""
19 Guadalajara;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2021QI;""
19 Guadalajara;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2020QIV;1.137
19 Guadalajara;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
19 Guadalajara;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2020QII;""
19 Guadalajara;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2020QI;""
19 Guadalajara;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
19 Guadalajara;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
19 Guadalajara;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2022QII;""
19 Guadalajara;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2022QI;1.174
19 Guadalajara;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
19 Guadalajara;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
19 Guadalajara;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2021QII;""
19 Guadalajara;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2021QI;1.098
19 Guadalajara;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
19 Guadalajara;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
19 Guadalajara;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2020QII;""
19 Guadalajara;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2020QI;""
19 Guadalajara;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
19 Guadalajara;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
19 Guadalajara;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QII;1.144
19 Guadalajara;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QI;""
19 Guadalajara;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
19 Guadalajara;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
19 Guadalajara;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QII;1.060
19 Guadalajara;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QI;""
19 Guadalajara;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
19 Guadalajara;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
19 Guadalajara;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QII;""
19 Guadalajara;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QI;""
19 Guadalajara;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
19 Guadalajara;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QIII;1.090
19 Guadalajara;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QII;""
19 Guadalajara;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QI;""
19 Guadalajara;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
19 Guadalajara;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QIII;1.027
19 Guadalajara;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QII;""
19 Guadalajara;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QI;""
19 Guadalajara;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
19 Guadalajara;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
19 Guadalajara;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QII;""
19 Guadalajara;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QI;""
19 Guadalajara;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
19 Guadalajara;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
19 Guadalajara;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
19 Guadalajara;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
19 Guadalajara;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
19 Guadalajara;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
19 Guadalajara;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
19 Guadalajara;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
19 Guadalajara;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
19 Guadalajara;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
19 Guadalajara;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
19 Guadalajara;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
19 Guadalajara;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;94,34
19 Guadalajara;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
19 Guadalajara;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
19 Guadalajara;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
19 Guadalajara;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;95,52
19 Guadalajara;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
19 Guadalajara;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
19 Guadalajara;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
19 Guadalajara;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;94,28
19 Guadalajara;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
19 Guadalajara;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
19 Guadalajara;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
19 Guadalajara;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
19 Guadalajara;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
19 Guadalajara;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
19 Guadalajara;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;92,22
19 Guadalajara;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
19 Guadalajara;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
19 Guadalajara;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
19 Guadalajara;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;91,04
19 Guadalajara;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
19 Guadalajara;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
19 Guadalajara;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
19 Guadalajara;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
19 Guadalajara;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
19 Guadalajara;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
19 Guadalajara;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;89,87
19 Guadalajara;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
19 Guadalajara;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
19 Guadalajara;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
19 Guadalajara;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;87,89
19 Guadalajara;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
19 Guadalajara;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
19 Guadalajara;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
19 Guadalajara;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
19 Guadalajara;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
19 Guadalajara;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
19 Guadalajara;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;85,62
19 Guadalajara;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
19 Guadalajara;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
19 Guadalajara;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
19 Guadalajara;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;85,16
19 Guadalajara;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
19 Guadalajara;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
19 Guadalajara;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
19 Guadalajara;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
19 Guadalajara;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
19 Guadalajara;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
19 Guadalajara;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QIV;601
19 Guadalajara;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
19 Guadalajara;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
19 Guadalajara;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
19 Guadalajara;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QIV;569
19 Guadalajara;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
19 Guadalajara;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
19 Guadalajara;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
19 Guadalajara;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QIV;540
19 Guadalajara;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
19 Guadalajara;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
19 Guadalajara;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
19 Guadalajara;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2022QIV;561
19 Guadalajara;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
19 Guadalajara;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2022QII;""
19 Guadalajara;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2022QI;""
19 Guadalajara;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2021QIV;535
19 Guadalajara;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
19 Guadalajara;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2021QII;""
19 Guadalajara;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2021QI;""
19 Guadalajara;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2020QIV;515
19 Guadalajara;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
19 Guadalajara;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2020QII;""
19 Guadalajara;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2020QI;""
19 Guadalajara;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
19 Guadalajara;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
19 Guadalajara;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2022QII;""
19 Guadalajara;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2022QI;519
19 Guadalajara;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
19 Guadalajara;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
19 Guadalajara;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2021QII;""
19 Guadalajara;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2021QI;498
19 Guadalajara;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
19 Guadalajara;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
19 Guadalajara;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2020QII;""
19 Guadalajara;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2020QI;""
19 Guadalajara;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
19 Guadalajara;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
19 Guadalajara;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QII;494
19 Guadalajara;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QI;""
19 Guadalajara;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
19 Guadalajara;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
19 Guadalajara;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QII;475
19 Guadalajara;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QI;""
19 Guadalajara;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
19 Guadalajara;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
19 Guadalajara;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QII;""
19 Guadalajara;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QI;""
19 Guadalajara;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
19 Guadalajara;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QIII;478
19 Guadalajara;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QII;""
19 Guadalajara;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QI;""
19 Guadalajara;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
19 Guadalajara;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QIII;458
19 Guadalajara;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QII;""
19 Guadalajara;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QI;""
19 Guadalajara;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
19 Guadalajara;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
19 Guadalajara;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QII;""
19 Guadalajara;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QI;""
19 Guadalajara;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
19 Guadalajara;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
19 Guadalajara;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
19 Guadalajara;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
19 Guadalajara;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
19 Guadalajara;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
19 Guadalajara;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
19 Guadalajara;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
19 Guadalajara;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
19 Guadalajara;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
19 Guadalajara;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
19 Guadalajara;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
19 Guadalajara;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;93,34
19 Guadalajara;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
19 Guadalajara;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
19 Guadalajara;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
19 Guadalajara;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;94,02
19 Guadalajara;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
19 Guadalajara;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
19 Guadalajara;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
19 Guadalajara;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;95,37
19 Guadalajara;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
19 Guadalajara;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
19 Guadalajara;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
19 Guadalajara;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
19 Guadalajara;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
19 Guadalajara;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
19 Guadalajara;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;91,21
19 Guadalajara;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
19 Guadalajara;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
19 Guadalajara;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
19 Guadalajara;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;92,22
19 Guadalajara;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
19 Guadalajara;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
19 Guadalajara;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
19 Guadalajara;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
19 Guadalajara;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
19 Guadalajara;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
19 Guadalajara;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;86,82
19 Guadalajara;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
19 Guadalajara;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
19 Guadalajara;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
19 Guadalajara;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;87,96
19 Guadalajara;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
19 Guadalajara;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
19 Guadalajara;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
19 Guadalajara;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
19 Guadalajara;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
19 Guadalajara;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
19 Guadalajara;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;84,01
19 Guadalajara;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
19 Guadalajara;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
19 Guadalajara;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
19 Guadalajara;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;84,81
19 Guadalajara;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
19 Guadalajara;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
19 Guadalajara;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
19 Guadalajara;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
19 Guadalajara;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
19 Guadalajara;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
21 Huelva;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
21 Huelva;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
21 Huelva;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
21 Huelva;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QI;25.246
21 Huelva;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
21 Huelva;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
21 Huelva;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
21 Huelva;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QI;24.542
21 Huelva;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
21 Huelva;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
21 Huelva;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
21 Huelva;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QI;24.672
21 Huelva;All ages;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
21 Huelva;All ages;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
21 Huelva;All ages;Cohort January 1;Total;Survival in the first trimester;2022QII;""
21 Huelva;All ages;Cohort January 1;Total;Survival in the first trimester;2022QI;24.451
21 Huelva;All ages;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
21 Huelva;All ages;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
21 Huelva;All ages;Cohort January 1;Total;Survival in the first trimester;2021QII;""
21 Huelva;All ages;Cohort January 1;Total;Survival in the first trimester;2021QI;23.856
21 Huelva;All ages;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
21 Huelva;All ages;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
21 Huelva;All ages;Cohort January 1;Total;Survival in the first trimester;2020QII;""
21 Huelva;All ages;Cohort January 1;Total;Survival in the first trimester;2020QI;22.747
21 Huelva;All ages;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
21 Huelva;All ages;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
21 Huelva;All ages;Cohort January 1;Total;Survival in the second trimester;2022QII;23.589
21 Huelva;All ages;Cohort January 1;Total;Survival in the second trimester;2022QI;""
21 Huelva;All ages;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
21 Huelva;All ages;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
21 Huelva;All ages;Cohort January 1;Total;Survival in the second trimester;2021QII;23.188
21 Huelva;All ages;Cohort January 1;Total;Survival in the second trimester;2021QI;""
21 Huelva;All ages;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
21 Huelva;All ages;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
21 Huelva;All ages;Cohort January 1;Total;Survival in the second trimester;2020QII;22.277
21 Huelva;All ages;Cohort January 1;Total;Survival in the second trimester;2020QI;""
21 Huelva;All ages;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
21 Huelva;All ages;Cohort January 1;Total;Survival in the third trimester;2022QIII;22.869
21 Huelva;All ages;Cohort January 1;Total;Survival in the third trimester;2022QII;""
21 Huelva;All ages;Cohort January 1;Total;Survival in the third trimester;2022QI;""
21 Huelva;All ages;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
21 Huelva;All ages;Cohort January 1;Total;Survival in the third trimester;2021QIII;22.659
21 Huelva;All ages;Cohort January 1;Total;Survival in the third trimester;2021QII;""
21 Huelva;All ages;Cohort January 1;Total;Survival in the third trimester;2021QI;""
21 Huelva;All ages;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
21 Huelva;All ages;Cohort January 1;Total;Survival in the third trimester;2020QIII;21.676
21 Huelva;All ages;Cohort January 1;Total;Survival in the third trimester;2020QII;""
21 Huelva;All ages;Cohort January 1;Total;Survival in the third trimester;2020QI;""
21 Huelva;All ages;Cohort January 1;Total;Survival in the third trimester;2022QIV;22.085
21 Huelva;All ages;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
21 Huelva;All ages;Cohort January 1;Total;Survival in the third trimester;2022QII;""
21 Huelva;All ages;Cohort January 1;Total;Survival in the third trimester;2022QI;""
21 Huelva;All ages;Cohort January 1;Total;Survival in the third trimester;2021QIV;21.970
21 Huelva;All ages;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
21 Huelva;All ages;Cohort January 1;Total;Survival in the third trimester;2021QII;""
21 Huelva;All ages;Cohort January 1;Total;Survival in the third trimester;2021QI;""
21 Huelva;All ages;Cohort January 1;Total;Survival in the third trimester;2020QIV;21.073
21 Huelva;All ages;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
21 Huelva;All ages;Cohort January 1;Total;Survival in the third trimester;2020QII;""
21 Huelva;All ages;Cohort January 1;Total;Survival in the third trimester;2020QI;""
21 Huelva;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
21 Huelva;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
21 Huelva;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
21 Huelva;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
21 Huelva;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
21 Huelva;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
21 Huelva;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
21 Huelva;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
21 Huelva;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
21 Huelva;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
21 Huelva;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
21 Huelva;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
21 Huelva;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
21 Huelva;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
21 Huelva;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
21 Huelva;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;96,85
21 Huelva;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
21 Huelva;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
21 Huelva;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
21 Huelva;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;97,2
21 Huelva;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
21 Huelva;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
21 Huelva;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
21 Huelva;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;92,2
21 Huelva;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
21 Huelva;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
21 Huelva;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;93,44
21 Huelva;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
21 Huelva;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
21 Huelva;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
21 Huelva;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;94,48
21 Huelva;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
21 Huelva;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
21 Huelva;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
21 Huelva;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;90,29
21 Huelva;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
21 Huelva;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
21 Huelva;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;90,58
21 Huelva;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
21 Huelva;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
21 Huelva;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
21 Huelva;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;92,33
21 Huelva;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
21 Huelva;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
21 Huelva;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
21 Huelva;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;87,86
21 Huelva;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
21 Huelva;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
21 Huelva;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;87,48
21 Huelva;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
21 Huelva;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
21 Huelva;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
21 Huelva;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;89,52
21 Huelva;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
21 Huelva;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
21 Huelva;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
21 Huelva;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;85,41
21 Huelva;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
21 Huelva;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
21 Huelva;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
21 Huelva;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
21 Huelva;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
21 Huelva;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
21 Huelva;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QI;16.149
21 Huelva;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
21 Huelva;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
21 Huelva;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
21 Huelva;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QI;15.771
21 Huelva;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
21 Huelva;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
21 Huelva;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
21 Huelva;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QI;15.846
21 Huelva;All ages;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
21 Huelva;All ages;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
21 Huelva;All ages;Cohort January 1;Males;Survival in the first trimester;2022QII;""
21 Huelva;All ages;Cohort January 1;Males;Survival in the first trimester;2022QI;15.695
21 Huelva;All ages;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
21 Huelva;All ages;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
21 Huelva;All ages;Cohort January 1;Males;Survival in the first trimester;2021QII;""
21 Huelva;All ages;Cohort January 1;Males;Survival in the first trimester;2021QI;15.363
21 Huelva;All ages;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
21 Huelva;All ages;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
21 Huelva;All ages;Cohort January 1;Males;Survival in the first trimester;2020QII;""
21 Huelva;All ages;Cohort January 1;Males;Survival in the first trimester;2020QI;14.690
21 Huelva;All ages;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
21 Huelva;All ages;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
21 Huelva;All ages;Cohort January 1;Males;Survival in the second trimester;2022QII;15.212
21 Huelva;All ages;Cohort January 1;Males;Survival in the second trimester;2022QI;""
21 Huelva;All ages;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
21 Huelva;All ages;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
21 Huelva;All ages;Cohort January 1;Males;Survival in the second trimester;2021QII;14.972
21 Huelva;All ages;Cohort January 1;Males;Survival in the second trimester;2021QI;""
21 Huelva;All ages;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
21 Huelva;All ages;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
21 Huelva;All ages;Cohort January 1;Males;Survival in the second trimester;2020QII;14.412
21 Huelva;All ages;Cohort January 1;Males;Survival in the second trimester;2020QI;""
21 Huelva;All ages;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
21 Huelva;All ages;Cohort January 1;Males;Survival in the third trimester;2022QIII;14.800
21 Huelva;All ages;Cohort January 1;Males;Survival in the third trimester;2022QII;""
21 Huelva;All ages;Cohort January 1;Males;Survival in the third trimester;2022QI;""
21 Huelva;All ages;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
21 Huelva;All ages;Cohort January 1;Males;Survival in the third trimester;2021QIII;14.678
21 Huelva;All ages;Cohort January 1;Males;Survival in the third trimester;2021QII;""
21 Huelva;All ages;Cohort January 1;Males;Survival in the third trimester;2021QI;""
21 Huelva;All ages;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
21 Huelva;All ages;Cohort January 1;Males;Survival in the third trimester;2020QIII;14.060
21 Huelva;All ages;Cohort January 1;Males;Survival in the third trimester;2020QII;""
21 Huelva;All ages;Cohort January 1;Males;Survival in the third trimester;2020QI;""
21 Huelva;All ages;Cohort January 1;Males;Survival in the third trimester;2022QIV;14.356
21 Huelva;All ages;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
21 Huelva;All ages;Cohort January 1;Males;Survival in the third trimester;2022QII;""
21 Huelva;All ages;Cohort January 1;Males;Survival in the third trimester;2022QI;""
21 Huelva;All ages;Cohort January 1;Males;Survival in the third trimester;2021QIV;14.286
21 Huelva;All ages;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
21 Huelva;All ages;Cohort January 1;Males;Survival in the third trimester;2021QII;""
21 Huelva;All ages;Cohort January 1;Males;Survival in the third trimester;2021QI;""
21 Huelva;All ages;Cohort January 1;Males;Survival in the third trimester;2020QIV;13.720
21 Huelva;All ages;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
21 Huelva;All ages;Cohort January 1;Males;Survival in the third trimester;2020QII;""
21 Huelva;All ages;Cohort January 1;Males;Survival in the third trimester;2020QI;""
21 Huelva;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
21 Huelva;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
21 Huelva;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
21 Huelva;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
21 Huelva;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
21 Huelva;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
21 Huelva;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
21 Huelva;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
21 Huelva;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
21 Huelva;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
21 Huelva;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
21 Huelva;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
21 Huelva;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
21 Huelva;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
21 Huelva;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
21 Huelva;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;97,19
21 Huelva;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
21 Huelva;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
21 Huelva;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
21 Huelva;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;97,41
21 Huelva;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
21 Huelva;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
21 Huelva;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
21 Huelva;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;92,7
21 Huelva;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
21 Huelva;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
21 Huelva;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;94,2
21 Huelva;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
21 Huelva;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
21 Huelva;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
21 Huelva;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;94,93
21 Huelva;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
21 Huelva;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
21 Huelva;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
21 Huelva;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;90,95
21 Huelva;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
21 Huelva;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
21 Huelva;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;91,65
21 Huelva;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
21 Huelva;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
21 Huelva;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
21 Huelva;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;93,07
21 Huelva;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
21 Huelva;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
21 Huelva;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
21 Huelva;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;88,73
21 Huelva;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
21 Huelva;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
21 Huelva;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;88,9
21 Huelva;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
21 Huelva;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
21 Huelva;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
21 Huelva;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;90,58
21 Huelva;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
21 Huelva;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
21 Huelva;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
21 Huelva;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;86,58
21 Huelva;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
21 Huelva;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
21 Huelva;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
21 Huelva;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
21 Huelva;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
21 Huelva;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
21 Huelva;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QI;9.097
21 Huelva;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
21 Huelva;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
21 Huelva;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
21 Huelva;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QI;8.771
21 Huelva;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
21 Huelva;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
21 Huelva;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
21 Huelva;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QI;8.826
21 Huelva;All ages;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
21 Huelva;All ages;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
21 Huelva;All ages;Cohort January 1;Females;Survival in the first trimester;2022QII;""
21 Huelva;All ages;Cohort January 1;Females;Survival in the first trimester;2022QI;8.756
21 Huelva;All ages;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
21 Huelva;All ages;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
21 Huelva;All ages;Cohort January 1;Females;Survival in the first trimester;2021QII;""
21 Huelva;All ages;Cohort January 1;Females;Survival in the first trimester;2021QI;8.493
21 Huelva;All ages;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
21 Huelva;All ages;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
21 Huelva;All ages;Cohort January 1;Females;Survival in the first trimester;2020QII;""
21 Huelva;All ages;Cohort January 1;Females;Survival in the first trimester;2020QI;8.057
21 Huelva;All ages;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
21 Huelva;All ages;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
21 Huelva;All ages;Cohort January 1;Females;Survival in the second trimester;2022QII;8.377
21 Huelva;All ages;Cohort January 1;Females;Survival in the second trimester;2022QI;""
21 Huelva;All ages;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
21 Huelva;All ages;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
21 Huelva;All ages;Cohort January 1;Females;Survival in the second trimester;2021QII;8.216
21 Huelva;All ages;Cohort January 1;Females;Survival in the second trimester;2021QI;""
21 Huelva;All ages;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
21 Huelva;All ages;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
21 Huelva;All ages;Cohort January 1;Females;Survival in the second trimester;2020QII;7.865
21 Huelva;All ages;Cohort January 1;Females;Survival in the second trimester;2020QI;""
21 Huelva;All ages;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
21 Huelva;All ages;Cohort January 1;Females;Survival in the third trimester;2022QIII;8.069
21 Huelva;All ages;Cohort January 1;Females;Survival in the third trimester;2022QII;""
21 Huelva;All ages;Cohort January 1;Females;Survival in the third trimester;2022QI;""
21 Huelva;All ages;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
21 Huelva;All ages;Cohort January 1;Females;Survival in the third trimester;2021QIII;7.981
21 Huelva;All ages;Cohort January 1;Females;Survival in the third trimester;2021QII;""
21 Huelva;All ages;Cohort January 1;Females;Survival in the third trimester;2021QI;""
21 Huelva;All ages;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
21 Huelva;All ages;Cohort January 1;Females;Survival in the third trimester;2020QIII;7.616
21 Huelva;All ages;Cohort January 1;Females;Survival in the third trimester;2020QII;""
21 Huelva;All ages;Cohort January 1;Females;Survival in the third trimester;2020QI;""
21 Huelva;All ages;Cohort January 1;Females;Survival in the third trimester;2022QIV;7.729
21 Huelva;All ages;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
21 Huelva;All ages;Cohort January 1;Females;Survival in the third trimester;2022QII;""
21 Huelva;All ages;Cohort January 1;Females;Survival in the third trimester;2022QI;""
21 Huelva;All ages;Cohort January 1;Females;Survival in the third trimester;2021QIV;7.684
21 Huelva;All ages;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
21 Huelva;All ages;Cohort January 1;Females;Survival in the third trimester;2021QII;""
21 Huelva;All ages;Cohort January 1;Females;Survival in the third trimester;2021QI;""
21 Huelva;All ages;Cohort January 1;Females;Survival in the third trimester;2020QIV;7.353
21 Huelva;All ages;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
21 Huelva;All ages;Cohort January 1;Females;Survival in the third trimester;2020QII;""
21 Huelva;All ages;Cohort January 1;Females;Survival in the third trimester;2020QI;""
21 Huelva;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
21 Huelva;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
21 Huelva;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
21 Huelva;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
21 Huelva;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
21 Huelva;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
21 Huelva;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
21 Huelva;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
21 Huelva;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
21 Huelva;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
21 Huelva;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
21 Huelva;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
21 Huelva;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
21 Huelva;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
21 Huelva;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
21 Huelva;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;96,25
21 Huelva;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
21 Huelva;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
21 Huelva;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
21 Huelva;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;96,83
21 Huelva;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
21 Huelva;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
21 Huelva;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
21 Huelva;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;91,29
21 Huelva;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
21 Huelva;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
21 Huelva;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;92,09
21 Huelva;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
21 Huelva;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
21 Huelva;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
21 Huelva;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;93,67
21 Huelva;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
21 Huelva;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
21 Huelva;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
21 Huelva;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;89,11
21 Huelva;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
21 Huelva;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
21 Huelva;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;88,7
21 Huelva;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
21 Huelva;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
21 Huelva;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
21 Huelva;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;90,99
21 Huelva;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
21 Huelva;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
21 Huelva;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
21 Huelva;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;86,29
21 Huelva;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
21 Huelva;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
21 Huelva;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;84,96
21 Huelva;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
21 Huelva;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
21 Huelva;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
21 Huelva;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;87,61
21 Huelva;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
21 Huelva;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
21 Huelva;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
21 Huelva;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;83,31
21 Huelva;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
21 Huelva;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
21 Huelva;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
21 Huelva;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
21 Huelva;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
21 Huelva;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QII;25.517
21 Huelva;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
21 Huelva;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
21 Huelva;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
21 Huelva;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QII;24.898
21 Huelva;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
21 Huelva;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
21 Huelva;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
21 Huelva;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QII;23.930
21 Huelva;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
21 Huelva;All ages;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
21 Huelva;All ages;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
21 Huelva;All ages;Cohort April 1;Total;Survival in the first trimester;2022QII;24.512
21 Huelva;All ages;Cohort April 1;Total;Survival in the first trimester;2022QI;""
21 Huelva;All ages;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
21 Huelva;All ages;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
21 Huelva;All ages;Cohort April 1;Total;Survival in the first trimester;2021QII;24.134
21 Huelva;All ages;Cohort April 1;Total;Survival in the first trimester;2021QI;""
21 Huelva;All ages;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
21 Huelva;All ages;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
21 Huelva;All ages;Cohort April 1;Total;Survival in the first trimester;2020QII;23.394
21 Huelva;All ages;Cohort April 1;Total;Survival in the first trimester;2020QI;""
21 Huelva;All ages;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
21 Huelva;All ages;Cohort April 1;Total;Survival in the second trimester;2022QIII;23.683
21 Huelva;All ages;Cohort April 1;Total;Survival in the second trimester;2022QII;""
21 Huelva;All ages;Cohort April 1;Total;Survival in the second trimester;2022QI;""
21 Huelva;All ages;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
21 Huelva;All ages;Cohort April 1;Total;Survival in the second trimester;2021QIII;23.489
21 Huelva;All ages;Cohort April 1;Total;Survival in the second trimester;2021QII;""
21 Huelva;All ages;Cohort April 1;Total;Survival in the second trimester;2021QI;""
21 Huelva;All ages;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
21 Huelva;All ages;Cohort April 1;Total;Survival in the second trimester;2020QIII;22.682
21 Huelva;All ages;Cohort April 1;Total;Survival in the second trimester;2020QII;""
21 Huelva;All ages;Cohort April 1;Total;Survival in the second trimester;2020QI;""
21 Huelva;All ages;Cohort April 1;Total;Survival in the third trimester;2022QIV;22.798
21 Huelva;All ages;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
21 Huelva;All ages;Cohort April 1;Total;Survival in the third trimester;2022QII;""
21 Huelva;All ages;Cohort April 1;Total;Survival in the third trimester;2022QI;""
21 Huelva;All ages;Cohort April 1;Total;Survival in the third trimester;2021QIV;22.707
21 Huelva;All ages;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
21 Huelva;All ages;Cohort April 1;Total;Survival in the third trimester;2021QII;""
21 Huelva;All ages;Cohort April 1;Total;Survival in the third trimester;2021QI;""
21 Huelva;All ages;Cohort April 1;Total;Survival in the third trimester;2020QIV;21.990
21 Huelva;All ages;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
21 Huelva;All ages;Cohort April 1;Total;Survival in the third trimester;2020QII;""
21 Huelva;All ages;Cohort April 1;Total;Survival in the third trimester;2020QI;""
21 Huelva;All ages;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
21 Huelva;All ages;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
21 Huelva;All ages;Cohort April 1;Total;Survival in the third trimester;2022QII;""
21 Huelva;All ages;Cohort April 1;Total;Survival in the third trimester;2022QI;22.101
21 Huelva;All ages;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
21 Huelva;All ages;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
21 Huelva;All ages;Cohort April 1;Total;Survival in the third trimester;2021QII;""
21 Huelva;All ages;Cohort April 1;Total;Survival in the third trimester;2021QI;21.524
21 Huelva;All ages;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
21 Huelva;All ages;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
21 Huelva;All ages;Cohort April 1;Total;Survival in the third trimester;2020QII;""
21 Huelva;All ages;Cohort April 1;Total;Survival in the third trimester;2020QI;""
21 Huelva;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
21 Huelva;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
21 Huelva;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
21 Huelva;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
21 Huelva;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
21 Huelva;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
21 Huelva;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
21 Huelva;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
21 Huelva;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
21 Huelva;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
21 Huelva;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
21 Huelva;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
21 Huelva;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
21 Huelva;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
21 Huelva;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;96,06
21 Huelva;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
21 Huelva;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
21 Huelva;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
21 Huelva;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;96,93
21 Huelva;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
21 Huelva;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
21 Huelva;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
21 Huelva;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;97,76
21 Huelva;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
21 Huelva;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
21 Huelva;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;92,81
21 Huelva;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
21 Huelva;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
21 Huelva;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
21 Huelva;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;94,34
21 Huelva;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
21 Huelva;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
21 Huelva;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
21 Huelva;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;94,78
21 Huelva;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
21 Huelva;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
21 Huelva;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;89,34
21 Huelva;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
21 Huelva;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
21 Huelva;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
21 Huelva;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;91,2
21 Huelva;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
21 Huelva;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
21 Huelva;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
21 Huelva;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;91,89
21 Huelva;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
21 Huelva;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
21 Huelva;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
21 Huelva;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
21 Huelva;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
21 Huelva;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
21 Huelva;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;88,77
21 Huelva;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
21 Huelva;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
21 Huelva;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
21 Huelva;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;89,95
21 Huelva;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
21 Huelva;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
21 Huelva;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
21 Huelva;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
21 Huelva;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
21 Huelva;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
21 Huelva;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QII;16.327
21 Huelva;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
21 Huelva;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
21 Huelva;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
21 Huelva;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QII;16.012
21 Huelva;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
21 Huelva;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
21 Huelva;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
21 Huelva;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QII;15.419
21 Huelva;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
21 Huelva;All ages;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
21 Huelva;All ages;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
21 Huelva;All ages;Cohort April 1;Males;Survival in the first trimester;2022QII;15.763
21 Huelva;All ages;Cohort April 1;Males;Survival in the first trimester;2022QI;""
21 Huelva;All ages;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
21 Huelva;All ages;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
21 Huelva;All ages;Cohort April 1;Males;Survival in the first trimester;2021QII;15.554
21 Huelva;All ages;Cohort April 1;Males;Survival in the first trimester;2021QI;""
21 Huelva;All ages;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
21 Huelva;All ages;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
21 Huelva;All ages;Cohort April 1;Males;Survival in the first trimester;2020QII;15.100
21 Huelva;All ages;Cohort April 1;Males;Survival in the first trimester;2020QI;""
21 Huelva;All ages;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
21 Huelva;All ages;Cohort April 1;Males;Survival in the second trimester;2022QIII;15.289
21 Huelva;All ages;Cohort April 1;Males;Survival in the second trimester;2022QII;""
21 Huelva;All ages;Cohort April 1;Males;Survival in the second trimester;2022QI;""
21 Huelva;All ages;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
21 Huelva;All ages;Cohort April 1;Males;Survival in the second trimester;2021QIII;15.188
21 Huelva;All ages;Cohort April 1;Males;Survival in the second trimester;2021QII;""
21 Huelva;All ages;Cohort April 1;Males;Survival in the second trimester;2021QI;""
21 Huelva;All ages;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
21 Huelva;All ages;Cohort April 1;Males;Survival in the second trimester;2020QIII;14.681
21 Huelva;All ages;Cohort April 1;Males;Survival in the second trimester;2020QII;""
21 Huelva;All ages;Cohort April 1;Males;Survival in the second trimester;2020QI;""
21 Huelva;All ages;Cohort April 1;Males;Survival in the third trimester;2022QIV;14.786
21 Huelva;All ages;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
21 Huelva;All ages;Cohort April 1;Males;Survival in the third trimester;2022QII;""
21 Huelva;All ages;Cohort April 1;Males;Survival in the third trimester;2022QI;""
21 Huelva;All ages;Cohort April 1;Males;Survival in the third trimester;2021QIV;14.737
21 Huelva;All ages;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
21 Huelva;All ages;Cohort April 1;Males;Survival in the third trimester;2021QII;""
21 Huelva;All ages;Cohort April 1;Males;Survival in the third trimester;2021QI;""
21 Huelva;All ages;Cohort April 1;Males;Survival in the third trimester;2020QIV;14.284
21 Huelva;All ages;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
21 Huelva;All ages;Cohort April 1;Males;Survival in the third trimester;2020QII;""
21 Huelva;All ages;Cohort April 1;Males;Survival in the third trimester;2020QI;""
21 Huelva;All ages;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
21 Huelva;All ages;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
21 Huelva;All ages;Cohort April 1;Males;Survival in the third trimester;2022QII;""
21 Huelva;All ages;Cohort April 1;Males;Survival in the third trimester;2022QI;14.388
21 Huelva;All ages;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
21 Huelva;All ages;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
21 Huelva;All ages;Cohort April 1;Males;Survival in the third trimester;2021QII;""
21 Huelva;All ages;Cohort April 1;Males;Survival in the third trimester;2021QI;14.014
21 Huelva;All ages;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
21 Huelva;All ages;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
21 Huelva;All ages;Cohort April 1;Males;Survival in the third trimester;2020QII;""
21 Huelva;All ages;Cohort April 1;Males;Survival in the third trimester;2020QI;""
21 Huelva;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
21 Huelva;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
21 Huelva;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
21 Huelva;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
21 Huelva;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
21 Huelva;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
21 Huelva;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
21 Huelva;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
21 Huelva;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
21 Huelva;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
21 Huelva;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
21 Huelva;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
21 Huelva;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
21 Huelva;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
21 Huelva;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;96,55
21 Huelva;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
21 Huelva;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
21 Huelva;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
21 Huelva;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;97,14
21 Huelva;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
21 Huelva;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
21 Huelva;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
21 Huelva;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;97,93
21 Huelva;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
21 Huelva;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
21 Huelva;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;93,64
21 Huelva;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
21 Huelva;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
21 Huelva;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
21 Huelva;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;94,85
21 Huelva;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
21 Huelva;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
21 Huelva;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
21 Huelva;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;95,21
21 Huelva;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
21 Huelva;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
21 Huelva;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;90,56
21 Huelva;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
21 Huelva;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
21 Huelva;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
21 Huelva;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;92,04
21 Huelva;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
21 Huelva;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
21 Huelva;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
21 Huelva;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;92,64
21 Huelva;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
21 Huelva;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
21 Huelva;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
21 Huelva;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
21 Huelva;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
21 Huelva;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
21 Huelva;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;89,86
21 Huelva;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
21 Huelva;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
21 Huelva;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
21 Huelva;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;90,89
21 Huelva;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
21 Huelva;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
21 Huelva;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
21 Huelva;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
21 Huelva;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
21 Huelva;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
21 Huelva;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QII;9.190
21 Huelva;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
21 Huelva;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
21 Huelva;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
21 Huelva;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QII;8.886
21 Huelva;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
21 Huelva;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
21 Huelva;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
21 Huelva;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QII;8.511
21 Huelva;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
21 Huelva;All ages;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
21 Huelva;All ages;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
21 Huelva;All ages;Cohort April 1;Females;Survival in the first trimester;2022QII;8.749
21 Huelva;All ages;Cohort April 1;Females;Survival in the first trimester;2022QI;""
21 Huelva;All ages;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
21 Huelva;All ages;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
21 Huelva;All ages;Cohort April 1;Females;Survival in the first trimester;2021QII;8.580
21 Huelva;All ages;Cohort April 1;Females;Survival in the first trimester;2021QI;""
21 Huelva;All ages;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
21 Huelva;All ages;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
21 Huelva;All ages;Cohort April 1;Females;Survival in the first trimester;2020QII;8.294
21 Huelva;All ages;Cohort April 1;Females;Survival in the first trimester;2020QI;""
21 Huelva;All ages;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
21 Huelva;All ages;Cohort April 1;Females;Survival in the second trimester;2022QIII;8.394
21 Huelva;All ages;Cohort April 1;Females;Survival in the second trimester;2022QII;""
21 Huelva;All ages;Cohort April 1;Females;Survival in the second trimester;2022QI;""
21 Huelva;All ages;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
21 Huelva;All ages;Cohort April 1;Females;Survival in the second trimester;2021QIII;8.301
21 Huelva;All ages;Cohort April 1;Females;Survival in the second trimester;2021QII;""
21 Huelva;All ages;Cohort April 1;Females;Survival in the second trimester;2021QI;""
21 Huelva;All ages;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
21 Huelva;All ages;Cohort April 1;Females;Survival in the second trimester;2020QIII;8.001
21 Huelva;All ages;Cohort April 1;Females;Survival in the second trimester;2020QII;""
21 Huelva;All ages;Cohort April 1;Females;Survival in the second trimester;2020QI;""
21 Huelva;All ages;Cohort April 1;Females;Survival in the third trimester;2022QIV;8.012
21 Huelva;All ages;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
21 Huelva;All ages;Cohort April 1;Females;Survival in the third trimester;2022QII;""
21 Huelva;All ages;Cohort April 1;Females;Survival in the third trimester;2022QI;""
21 Huelva;All ages;Cohort April 1;Females;Survival in the third trimester;2021QIV;7.970
21 Huelva;All ages;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
21 Huelva;All ages;Cohort April 1;Females;Survival in the third trimester;2021QII;""
21 Huelva;All ages;Cohort April 1;Females;Survival in the third trimester;2021QI;""
21 Huelva;All ages;Cohort April 1;Females;Survival in the third trimester;2020QIV;7.706
21 Huelva;All ages;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
21 Huelva;All ages;Cohort April 1;Females;Survival in the third trimester;2020QII;""
21 Huelva;All ages;Cohort April 1;Females;Survival in the third trimester;2020QI;""
21 Huelva;All ages;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
21 Huelva;All ages;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
21 Huelva;All ages;Cohort April 1;Females;Survival in the third trimester;2022QII;""
21 Huelva;All ages;Cohort April 1;Females;Survival in the third trimester;2022QI;7.713
21 Huelva;All ages;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
21 Huelva;All ages;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
21 Huelva;All ages;Cohort April 1;Females;Survival in the third trimester;2021QII;""
21 Huelva;All ages;Cohort April 1;Females;Survival in the third trimester;2021QI;7.510
21 Huelva;All ages;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
21 Huelva;All ages;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
21 Huelva;All ages;Cohort April 1;Females;Survival in the third trimester;2020QII;""
21 Huelva;All ages;Cohort April 1;Females;Survival in the third trimester;2020QI;""
21 Huelva;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
21 Huelva;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
21 Huelva;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
21 Huelva;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
21 Huelva;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
21 Huelva;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
21 Huelva;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
21 Huelva;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
21 Huelva;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
21 Huelva;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
21 Huelva;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
21 Huelva;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
21 Huelva;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
21 Huelva;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
21 Huelva;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;95,2
21 Huelva;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
21 Huelva;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
21 Huelva;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
21 Huelva;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;96,56
21 Huelva;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
21 Huelva;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
21 Huelva;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
21 Huelva;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;97,45
21 Huelva;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
21 Huelva;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
21 Huelva;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;91,34
21 Huelva;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
21 Huelva;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
21 Huelva;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
21 Huelva;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;93,42
21 Huelva;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
21 Huelva;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
21 Huelva;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
21 Huelva;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;94,01
21 Huelva;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
21 Huelva;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
21 Huelva;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;87,18
21 Huelva;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
21 Huelva;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
21 Huelva;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
21 Huelva;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;89,69
21 Huelva;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
21 Huelva;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
21 Huelva;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
21 Huelva;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;90,54
21 Huelva;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
21 Huelva;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
21 Huelva;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
21 Huelva;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
21 Huelva;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
21 Huelva;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
21 Huelva;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;86,8
21 Huelva;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
21 Huelva;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
21 Huelva;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
21 Huelva;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;88,24
21 Huelva;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
21 Huelva;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
21 Huelva;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
21 Huelva;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
21 Huelva;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
21 Huelva;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QIII;25.745
21 Huelva;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
21 Huelva;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
21 Huelva;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
21 Huelva;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QIII;25.465
21 Huelva;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
21 Huelva;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
21 Huelva;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
21 Huelva;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QIII;24.646
21 Huelva;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
21 Huelva;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
21 Huelva;All ages;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
21 Huelva;All ages;Cohort July 1;Total;Survival in the first trimester;2022QIII;24.588
21 Huelva;All ages;Cohort July 1;Total;Survival in the first trimester;2022QII;""
21 Huelva;All ages;Cohort July 1;Total;Survival in the first trimester;2022QI;""
21 Huelva;All ages;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
21 Huelva;All ages;Cohort July 1;Total;Survival in the first trimester;2021QIII;24.493
21 Huelva;All ages;Cohort July 1;Total;Survival in the first trimester;2021QII;""
21 Huelva;All ages;Cohort July 1;Total;Survival in the first trimester;2021QI;""
21 Huelva;All ages;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
21 Huelva;All ages;Cohort July 1;Total;Survival in the first trimester;2020QIII;23.635
21 Huelva;All ages;Cohort July 1;Total;Survival in the first trimester;2020QII;""
21 Huelva;All ages;Cohort July 1;Total;Survival in the first trimester;2020QI;""
21 Huelva;All ages;Cohort July 1;Total;Survival in the second trimester;2022QIV;23.558
21 Huelva;All ages;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
21 Huelva;All ages;Cohort July 1;Total;Survival in the second trimester;2022QII;""
21 Huelva;All ages;Cohort July 1;Total;Survival in the second trimester;2022QI;""
21 Huelva;All ages;Cohort July 1;Total;Survival in the second trimester;2021QIV;23.577
21 Huelva;All ages;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
21 Huelva;All ages;Cohort July 1;Total;Survival in the second trimester;2021QII;""
21 Huelva;All ages;Cohort July 1;Total;Survival in the second trimester;2021QI;""
21 Huelva;All ages;Cohort July 1;Total;Survival in the second trimester;2020QIV;22.780
21 Huelva;All ages;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
21 Huelva;All ages;Cohort July 1;Total;Survival in the second trimester;2020QII;""
21 Huelva;All ages;Cohort July 1;Total;Survival in the second trimester;2020QI;""
21 Huelva;All ages;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
21 Huelva;All ages;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
21 Huelva;All ages;Cohort July 1;Total;Survival in the third trimester;2022QII;""
21 Huelva;All ages;Cohort July 1;Total;Survival in the third trimester;2022QI;22.920
21 Huelva;All ages;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
21 Huelva;All ages;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
21 Huelva;All ages;Cohort July 1;Total;Survival in the third trimester;2021QII;""
21 Huelva;All ages;Cohort July 1;Total;Survival in the third trimester;2021QI;22.269
21 Huelva;All ages;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
21 Huelva;All ages;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
21 Huelva;All ages;Cohort July 1;Total;Survival in the third trimester;2020QII;""
21 Huelva;All ages;Cohort July 1;Total;Survival in the third trimester;2020QI;""
21 Huelva;All ages;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
21 Huelva;All ages;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
21 Huelva;All ages;Cohort July 1;Total;Survival in the third trimester;2022QII;22.233
21 Huelva;All ages;Cohort July 1;Total;Survival in the third trimester;2022QI;""
21 Huelva;All ages;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
21 Huelva;All ages;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
21 Huelva;All ages;Cohort July 1;Total;Survival in the third trimester;2021QII;21.746
21 Huelva;All ages;Cohort July 1;Total;Survival in the third trimester;2021QI;""
21 Huelva;All ages;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
21 Huelva;All ages;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
21 Huelva;All ages;Cohort July 1;Total;Survival in the third trimester;2020QII;""
21 Huelva;All ages;Cohort July 1;Total;Survival in the third trimester;2020QI;""
21 Huelva;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
21 Huelva;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
21 Huelva;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
21 Huelva;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
21 Huelva;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
21 Huelva;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
21 Huelva;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
21 Huelva;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
21 Huelva;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
21 Huelva;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
21 Huelva;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
21 Huelva;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
21 Huelva;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
21 Huelva;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;95,51
21 Huelva;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
21 Huelva;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
21 Huelva;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
21 Huelva;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;96,18
21 Huelva;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
21 Huelva;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
21 Huelva;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
21 Huelva;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;95,9
21 Huelva;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
21 Huelva;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
21 Huelva;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;91,51
21 Huelva;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
21 Huelva;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
21 Huelva;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
21 Huelva;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;92,59
21 Huelva;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
21 Huelva;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
21 Huelva;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
21 Huelva;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;92,43
21 Huelva;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
21 Huelva;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
21 Huelva;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
21 Huelva;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
21 Huelva;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
21 Huelva;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
21 Huelva;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;90,01
21 Huelva;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
21 Huelva;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
21 Huelva;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
21 Huelva;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;90,36
21 Huelva;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
21 Huelva;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
21 Huelva;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
21 Huelva;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
21 Huelva;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
21 Huelva;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
21 Huelva;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;87,31
21 Huelva;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
21 Huelva;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
21 Huelva;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
21 Huelva;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;88,23
21 Huelva;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
21 Huelva;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
21 Huelva;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
21 Huelva;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
21 Huelva;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
21 Huelva;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
21 Huelva;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QIII;16.464
21 Huelva;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
21 Huelva;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
21 Huelva;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
21 Huelva;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QIII;16.308
21 Huelva;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
21 Huelva;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
21 Huelva;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
21 Huelva;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QIII;15.866
21 Huelva;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
21 Huelva;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
21 Huelva;All ages;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
21 Huelva;All ages;Cohort July 1;Males;Survival in the first trimester;2022QIII;15.813
21 Huelva;All ages;Cohort July 1;Males;Survival in the first trimester;2022QII;""
21 Huelva;All ages;Cohort July 1;Males;Survival in the first trimester;2022QI;""
21 Huelva;All ages;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
21 Huelva;All ages;Cohort July 1;Males;Survival in the first trimester;2021QIII;15.773
21 Huelva;All ages;Cohort July 1;Males;Survival in the first trimester;2021QII;""
21 Huelva;All ages;Cohort July 1;Males;Survival in the first trimester;2021QI;""
21 Huelva;All ages;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
21 Huelva;All ages;Cohort July 1;Males;Survival in the first trimester;2020QIII;15.255
21 Huelva;All ages;Cohort July 1;Males;Survival in the first trimester;2020QII;""
21 Huelva;All ages;Cohort July 1;Males;Survival in the first trimester;2020QI;""
21 Huelva;All ages;Cohort July 1;Males;Survival in the second trimester;2022QIV;15.226
21 Huelva;All ages;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
21 Huelva;All ages;Cohort July 1;Males;Survival in the second trimester;2022QII;""
21 Huelva;All ages;Cohort July 1;Males;Survival in the second trimester;2022QI;""
21 Huelva;All ages;Cohort July 1;Males;Survival in the second trimester;2021QIV;15.247
21 Huelva;All ages;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
21 Huelva;All ages;Cohort July 1;Males;Survival in the second trimester;2021QII;""
21 Huelva;All ages;Cohort July 1;Males;Survival in the second trimester;2021QI;""
21 Huelva;All ages;Cohort July 1;Males;Survival in the second trimester;2020QIV;14.757
21 Huelva;All ages;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
21 Huelva;All ages;Cohort July 1;Males;Survival in the second trimester;2020QII;""
21 Huelva;All ages;Cohort July 1;Males;Survival in the second trimester;2020QI;""
21 Huelva;All ages;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
21 Huelva;All ages;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
21 Huelva;All ages;Cohort July 1;Males;Survival in the third trimester;2022QII;""
21 Huelva;All ages;Cohort July 1;Males;Survival in the third trimester;2022QI;14.866
21 Huelva;All ages;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
21 Huelva;All ages;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
21 Huelva;All ages;Cohort July 1;Males;Survival in the third trimester;2021QII;""
21 Huelva;All ages;Cohort July 1;Males;Survival in the third trimester;2021QI;14.457
21 Huelva;All ages;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
21 Huelva;All ages;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
21 Huelva;All ages;Cohort July 1;Males;Survival in the third trimester;2020QII;""
21 Huelva;All ages;Cohort July 1;Males;Survival in the third trimester;2020QI;""
21 Huelva;All ages;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
21 Huelva;All ages;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
21 Huelva;All ages;Cohort July 1;Males;Survival in the third trimester;2022QII;14.476
21 Huelva;All ages;Cohort July 1;Males;Survival in the third trimester;2022QI;""
21 Huelva;All ages;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
21 Huelva;All ages;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
21 Huelva;All ages;Cohort July 1;Males;Survival in the third trimester;2021QII;14.142
21 Huelva;All ages;Cohort July 1;Males;Survival in the third trimester;2021QI;""
21 Huelva;All ages;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
21 Huelva;All ages;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
21 Huelva;All ages;Cohort July 1;Males;Survival in the third trimester;2020QII;""
21 Huelva;All ages;Cohort July 1;Males;Survival in the third trimester;2020QI;""
21 Huelva;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
21 Huelva;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
21 Huelva;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
21 Huelva;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
21 Huelva;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
21 Huelva;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
21 Huelva;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
21 Huelva;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
21 Huelva;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
21 Huelva;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
21 Huelva;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
21 Huelva;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
21 Huelva;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
21 Huelva;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;96,05
21 Huelva;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
21 Huelva;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
21 Huelva;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
21 Huelva;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;96,72
21 Huelva;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
21 Huelva;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
21 Huelva;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
21 Huelva;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;96,15
21 Huelva;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
21 Huelva;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
21 Huelva;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;92,48
21 Huelva;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
21 Huelva;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
21 Huelva;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
21 Huelva;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;93,49
21 Huelva;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
21 Huelva;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
21 Huelva;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
21 Huelva;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;93,01
21 Huelva;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
21 Huelva;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
21 Huelva;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
21 Huelva;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
21 Huelva;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
21 Huelva;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
21 Huelva;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;91,16
21 Huelva;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
21 Huelva;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
21 Huelva;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
21 Huelva;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;91,12
21 Huelva;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
21 Huelva;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
21 Huelva;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
21 Huelva;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
21 Huelva;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
21 Huelva;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
21 Huelva;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;88,77
21 Huelva;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
21 Huelva;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
21 Huelva;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
21 Huelva;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;89,13
21 Huelva;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
21 Huelva;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
21 Huelva;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
21 Huelva;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
21 Huelva;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
21 Huelva;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
21 Huelva;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QIII;9.281
21 Huelva;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
21 Huelva;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
21 Huelva;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
21 Huelva;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QIII;9.157
21 Huelva;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
21 Huelva;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
21 Huelva;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
21 Huelva;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QIII;8.780
21 Huelva;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
21 Huelva;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
21 Huelva;All ages;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
21 Huelva;All ages;Cohort July 1;Females;Survival in the first trimester;2022QIII;8.775
21 Huelva;All ages;Cohort July 1;Females;Survival in the first trimester;2022QII;""
21 Huelva;All ages;Cohort July 1;Females;Survival in the first trimester;2022QI;""
21 Huelva;All ages;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
21 Huelva;All ages;Cohort July 1;Females;Survival in the first trimester;2021QIII;8.720
21 Huelva;All ages;Cohort July 1;Females;Survival in the first trimester;2021QII;""
21 Huelva;All ages;Cohort July 1;Females;Survival in the first trimester;2021QI;""
21 Huelva;All ages;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
21 Huelva;All ages;Cohort July 1;Females;Survival in the first trimester;2020QIII;8.380
21 Huelva;All ages;Cohort July 1;Females;Survival in the first trimester;2020QII;""
21 Huelva;All ages;Cohort July 1;Females;Survival in the first trimester;2020QI;""
21 Huelva;All ages;Cohort July 1;Females;Survival in the second trimester;2022QIV;8.332
21 Huelva;All ages;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
21 Huelva;All ages;Cohort July 1;Females;Survival in the second trimester;2022QII;""
21 Huelva;All ages;Cohort July 1;Females;Survival in the second trimester;2022QI;""
21 Huelva;All ages;Cohort July 1;Females;Survival in the second trimester;2021QIV;8.330
21 Huelva;All ages;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
21 Huelva;All ages;Cohort July 1;Females;Survival in the second trimester;2021QII;""
21 Huelva;All ages;Cohort July 1;Females;Survival in the second trimester;2021QI;""
21 Huelva;All ages;Cohort July 1;Females;Survival in the second trimester;2020QIV;8.023
21 Huelva;All ages;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
21 Huelva;All ages;Cohort July 1;Females;Survival in the second trimester;2020QII;""
21 Huelva;All ages;Cohort July 1;Females;Survival in the second trimester;2020QI;""
21 Huelva;All ages;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
21 Huelva;All ages;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
21 Huelva;All ages;Cohort July 1;Females;Survival in the third trimester;2022QII;""
21 Huelva;All ages;Cohort July 1;Females;Survival in the third trimester;2022QI;8.054
21 Huelva;All ages;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
21 Huelva;All ages;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
21 Huelva;All ages;Cohort July 1;Females;Survival in the third trimester;2021QII;""
21 Huelva;All ages;Cohort July 1;Females;Survival in the third trimester;2021QI;7.812
21 Huelva;All ages;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
21 Huelva;All ages;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
21 Huelva;All ages;Cohort July 1;Females;Survival in the third trimester;2020QII;""
21 Huelva;All ages;Cohort July 1;Females;Survival in the third trimester;2020QI;""
21 Huelva;All ages;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
21 Huelva;All ages;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
21 Huelva;All ages;Cohort July 1;Females;Survival in the third trimester;2022QII;7.757
21 Huelva;All ages;Cohort July 1;Females;Survival in the third trimester;2022QI;""
21 Huelva;All ages;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
21 Huelva;All ages;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
21 Huelva;All ages;Cohort July 1;Females;Survival in the third trimester;2021QII;7.604
21 Huelva;All ages;Cohort July 1;Females;Survival in the third trimester;2021QI;""
21 Huelva;All ages;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
21 Huelva;All ages;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
21 Huelva;All ages;Cohort July 1;Females;Survival in the third trimester;2020QII;""
21 Huelva;All ages;Cohort July 1;Females;Survival in the third trimester;2020QI;""
21 Huelva;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
21 Huelva;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
21 Huelva;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
21 Huelva;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
21 Huelva;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
21 Huelva;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
21 Huelva;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
21 Huelva;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
21 Huelva;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
21 Huelva;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
21 Huelva;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
21 Huelva;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
21 Huelva;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
21 Huelva;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;94,55
21 Huelva;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
21 Huelva;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
21 Huelva;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
21 Huelva;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;95,23
21 Huelva;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
21 Huelva;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
21 Huelva;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
21 Huelva;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;95,44
21 Huelva;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
21 Huelva;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
21 Huelva;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;89,77
21 Huelva;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
21 Huelva;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
21 Huelva;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
21 Huelva;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;90,97
21 Huelva;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
21 Huelva;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
21 Huelva;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
21 Huelva;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;91,38
21 Huelva;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
21 Huelva;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
21 Huelva;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
21 Huelva;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
21 Huelva;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
21 Huelva;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
21 Huelva;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;87,95
21 Huelva;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
21 Huelva;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
21 Huelva;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
21 Huelva;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;88,97
21 Huelva;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
21 Huelva;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
21 Huelva;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
21 Huelva;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
21 Huelva;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
21 Huelva;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
21 Huelva;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;84,71
21 Huelva;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
21 Huelva;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
21 Huelva;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
21 Huelva;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;86,61
21 Huelva;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
21 Huelva;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
21 Huelva;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
21 Huelva;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
21 Huelva;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
21 Huelva;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QIV;25.472
21 Huelva;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
21 Huelva;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
21 Huelva;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
21 Huelva;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QIV;25.333
21 Huelva;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
21 Huelva;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
21 Huelva;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
21 Huelva;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QIV;24.594
21 Huelva;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
21 Huelva;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
21 Huelva;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
21 Huelva;All ages;Cohort October 1;Total;Survival in the first trimester;2022QIV;24.322
21 Huelva;All ages;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
21 Huelva;All ages;Cohort October 1;Total;Survival in the first trimester;2022QII;""
21 Huelva;All ages;Cohort October 1;Total;Survival in the first trimester;2022QI;""
21 Huelva;All ages;Cohort October 1;Total;Survival in the first trimester;2021QIV;24.306
21 Huelva;All ages;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
21 Huelva;All ages;Cohort October 1;Total;Survival in the first trimester;2021QII;""
21 Huelva;All ages;Cohort October 1;Total;Survival in the first trimester;2021QI;""
21 Huelva;All ages;Cohort October 1;Total;Survival in the first trimester;2020QIV;23.600
21 Huelva;All ages;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
21 Huelva;All ages;Cohort October 1;Total;Survival in the first trimester;2020QII;""
21 Huelva;All ages;Cohort October 1;Total;Survival in the first trimester;2020QI;""
21 Huelva;All ages;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
21 Huelva;All ages;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
21 Huelva;All ages;Cohort October 1;Total;Survival in the second trimester;2022QII;""
21 Huelva;All ages;Cohort October 1;Total;Survival in the second trimester;2022QI;23.609
21 Huelva;All ages;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
21 Huelva;All ages;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
21 Huelva;All ages;Cohort October 1;Total;Survival in the second trimester;2021QII;""
21 Huelva;All ages;Cohort October 1;Total;Survival in the second trimester;2021QI;23.015
21 Huelva;All ages;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
21 Huelva;All ages;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
21 Huelva;All ages;Cohort October 1;Total;Survival in the second trimester;2020QII;""
21 Huelva;All ages;Cohort October 1;Total;Survival in the second trimester;2020QI;""
21 Huelva;All ages;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
21 Huelva;All ages;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
21 Huelva;All ages;Cohort October 1;Total;Survival in the third trimester;2022QII;22.858
21 Huelva;All ages;Cohort October 1;Total;Survival in the third trimester;2022QI;""
21 Huelva;All ages;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
21 Huelva;All ages;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
21 Huelva;All ages;Cohort October 1;Total;Survival in the third trimester;2021QII;22.438
21 Huelva;All ages;Cohort October 1;Total;Survival in the third trimester;2021QI;""
21 Huelva;All ages;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
21 Huelva;All ages;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
21 Huelva;All ages;Cohort October 1;Total;Survival in the third trimester;2020QII;""
21 Huelva;All ages;Cohort October 1;Total;Survival in the third trimester;2020QI;""
21 Huelva;All ages;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
21 Huelva;All ages;Cohort October 1;Total;Survival in the third trimester;2022QIII;22.197
21 Huelva;All ages;Cohort October 1;Total;Survival in the third trimester;2022QII;""
21 Huelva;All ages;Cohort October 1;Total;Survival in the third trimester;2022QI;""
21 Huelva;All ages;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
21 Huelva;All ages;Cohort October 1;Total;Survival in the third trimester;2021QIII;21.958
21 Huelva;All ages;Cohort October 1;Total;Survival in the third trimester;2021QII;""
21 Huelva;All ages;Cohort October 1;Total;Survival in the third trimester;2021QI;""
21 Huelva;All ages;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
21 Huelva;All ages;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
21 Huelva;All ages;Cohort October 1;Total;Survival in the third trimester;2020QII;""
21 Huelva;All ages;Cohort October 1;Total;Survival in the third trimester;2020QI;""
21 Huelva;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
21 Huelva;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
21 Huelva;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
21 Huelva;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
21 Huelva;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
21 Huelva;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
21 Huelva;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
21 Huelva;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
21 Huelva;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
21 Huelva;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
21 Huelva;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
21 Huelva;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
21 Huelva;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;95,49
21 Huelva;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
21 Huelva;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
21 Huelva;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
21 Huelva;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;95,95
21 Huelva;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
21 Huelva;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
21 Huelva;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
21 Huelva;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;95,96
21 Huelva;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
21 Huelva;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
21 Huelva;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
21 Huelva;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
21 Huelva;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
21 Huelva;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
21 Huelva;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;93,19
21 Huelva;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
21 Huelva;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
21 Huelva;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
21 Huelva;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;93,58
21 Huelva;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
21 Huelva;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
21 Huelva;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
21 Huelva;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
21 Huelva;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
21 Huelva;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
21 Huelva;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;90,23
21 Huelva;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
21 Huelva;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
21 Huelva;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
21 Huelva;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;91,23
21 Huelva;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
21 Huelva;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
21 Huelva;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
21 Huelva;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
21 Huelva;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
21 Huelva;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
21 Huelva;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;87,62
21 Huelva;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
21 Huelva;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
21 Huelva;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
21 Huelva;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;89,28
21 Huelva;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
21 Huelva;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
21 Huelva;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
21 Huelva;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
21 Huelva;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
21 Huelva;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
21 Huelva;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QIV;16.308
21 Huelva;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
21 Huelva;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
21 Huelva;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
21 Huelva;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QIV;16.241
21 Huelva;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
21 Huelva;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
21 Huelva;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
21 Huelva;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QIV;15.835
21 Huelva;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
21 Huelva;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
21 Huelva;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
21 Huelva;All ages;Cohort October 1;Males;Survival in the first trimester;2022QIV;15.645
21 Huelva;All ages;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
21 Huelva;All ages;Cohort October 1;Males;Survival in the first trimester;2022QII;""
21 Huelva;All ages;Cohort October 1;Males;Survival in the first trimester;2022QI;""
21 Huelva;All ages;Cohort October 1;Males;Survival in the first trimester;2021QIV;15.650
21 Huelva;All ages;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
21 Huelva;All ages;Cohort October 1;Males;Survival in the first trimester;2021QII;""
21 Huelva;All ages;Cohort October 1;Males;Survival in the first trimester;2021QI;""
21 Huelva;All ages;Cohort October 1;Males;Survival in the first trimester;2020QIV;15.239
21 Huelva;All ages;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
21 Huelva;All ages;Cohort October 1;Males;Survival in the first trimester;2020QII;""
21 Huelva;All ages;Cohort October 1;Males;Survival in the first trimester;2020QI;""
21 Huelva;All ages;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
21 Huelva;All ages;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
21 Huelva;All ages;Cohort October 1;Males;Survival in the second trimester;2022QII;""
21 Huelva;All ages;Cohort October 1;Males;Survival in the second trimester;2022QI;15.250
21 Huelva;All ages;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
21 Huelva;All ages;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
21 Huelva;All ages;Cohort October 1;Males;Survival in the second trimester;2021QII;""
21 Huelva;All ages;Cohort October 1;Males;Survival in the second trimester;2021QI;14.889
21 Huelva;All ages;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
21 Huelva;All ages;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
21 Huelva;All ages;Cohort October 1;Males;Survival in the second trimester;2020QII;""
21 Huelva;All ages;Cohort October 1;Males;Survival in the second trimester;2020QI;""
21 Huelva;All ages;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
21 Huelva;All ages;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
21 Huelva;All ages;Cohort October 1;Males;Survival in the third trimester;2022QII;14.834
21 Huelva;All ages;Cohort October 1;Males;Survival in the third trimester;2022QI;""
21 Huelva;All ages;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
21 Huelva;All ages;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
21 Huelva;All ages;Cohort October 1;Males;Survival in the third trimester;2021QII;14.542
21 Huelva;All ages;Cohort October 1;Males;Survival in the third trimester;2021QI;""
21 Huelva;All ages;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
21 Huelva;All ages;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
21 Huelva;All ages;Cohort October 1;Males;Survival in the third trimester;2020QII;""
21 Huelva;All ages;Cohort October 1;Males;Survival in the third trimester;2020QI;""
21 Huelva;All ages;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
21 Huelva;All ages;Cohort October 1;Males;Survival in the third trimester;2022QIII;14.456
21 Huelva;All ages;Cohort October 1;Males;Survival in the third trimester;2022QII;""
21 Huelva;All ages;Cohort October 1;Males;Survival in the third trimester;2022QI;""
21 Huelva;All ages;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
21 Huelva;All ages;Cohort October 1;Males;Survival in the third trimester;2021QIII;14.274
21 Huelva;All ages;Cohort October 1;Males;Survival in the third trimester;2021QII;""
21 Huelva;All ages;Cohort October 1;Males;Survival in the third trimester;2021QI;""
21 Huelva;All ages;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
21 Huelva;All ages;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
21 Huelva;All ages;Cohort October 1;Males;Survival in the third trimester;2020QII;""
21 Huelva;All ages;Cohort October 1;Males;Survival in the third trimester;2020QI;""
21 Huelva;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
21 Huelva;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
21 Huelva;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
21 Huelva;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
21 Huelva;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
21 Huelva;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
21 Huelva;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
21 Huelva;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
21 Huelva;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
21 Huelva;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
21 Huelva;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
21 Huelva;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
21 Huelva;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;95,93
21 Huelva;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
21 Huelva;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
21 Huelva;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
21 Huelva;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;96,36
21 Huelva;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
21 Huelva;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
21 Huelva;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
21 Huelva;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;96,24
21 Huelva;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
21 Huelva;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
21 Huelva;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
21 Huelva;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
21 Huelva;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
21 Huelva;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
21 Huelva;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;93,9
21 Huelva;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
21 Huelva;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
21 Huelva;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
21 Huelva;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;94,03
21 Huelva;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
21 Huelva;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
21 Huelva;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
21 Huelva;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
21 Huelva;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
21 Huelva;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
21 Huelva;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;91,34
21 Huelva;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
21 Huelva;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
21 Huelva;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
21 Huelva;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;91,83
21 Huelva;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
21 Huelva;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
21 Huelva;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
21 Huelva;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
21 Huelva;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
21 Huelva;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
21 Huelva;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;89,01
21 Huelva;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
21 Huelva;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
21 Huelva;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
21 Huelva;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;90,14
21 Huelva;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
21 Huelva;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
21 Huelva;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
21 Huelva;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
21 Huelva;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
21 Huelva;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
21 Huelva;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QIV;9.164
21 Huelva;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
21 Huelva;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
21 Huelva;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
21 Huelva;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QIV;9.092
21 Huelva;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
21 Huelva;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
21 Huelva;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
21 Huelva;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QIV;8.759
21 Huelva;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
21 Huelva;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
21 Huelva;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
21 Huelva;All ages;Cohort October 1;Females;Survival in the first trimester;2022QIV;8.677
21 Huelva;All ages;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
21 Huelva;All ages;Cohort October 1;Females;Survival in the first trimester;2022QII;""
21 Huelva;All ages;Cohort October 1;Females;Survival in the first trimester;2022QI;""
21 Huelva;All ages;Cohort October 1;Females;Survival in the first trimester;2021QIV;8.656
21 Huelva;All ages;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
21 Huelva;All ages;Cohort October 1;Females;Survival in the first trimester;2021QII;""
21 Huelva;All ages;Cohort October 1;Females;Survival in the first trimester;2021QI;""
21 Huelva;All ages;Cohort October 1;Females;Survival in the first trimester;2020QIV;8.361
21 Huelva;All ages;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
21 Huelva;All ages;Cohort October 1;Females;Survival in the first trimester;2020QII;""
21 Huelva;All ages;Cohort October 1;Females;Survival in the first trimester;2020QI;""
21 Huelva;All ages;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
21 Huelva;All ages;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
21 Huelva;All ages;Cohort October 1;Females;Survival in the second trimester;2022QII;""
21 Huelva;All ages;Cohort October 1;Females;Survival in the second trimester;2022QI;8.359
21 Huelva;All ages;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
21 Huelva;All ages;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
21 Huelva;All ages;Cohort October 1;Females;Survival in the second trimester;2021QII;""
21 Huelva;All ages;Cohort October 1;Females;Survival in the second trimester;2021QI;8.126
21 Huelva;All ages;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
21 Huelva;All ages;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
21 Huelva;All ages;Cohort October 1;Females;Survival in the second trimester;2020QII;""
21 Huelva;All ages;Cohort October 1;Females;Survival in the second trimester;2020QI;""
21 Huelva;All ages;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
21 Huelva;All ages;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
21 Huelva;All ages;Cohort October 1;Females;Survival in the third trimester;2022QII;8.024
21 Huelva;All ages;Cohort October 1;Females;Survival in the third trimester;2022QI;""
21 Huelva;All ages;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
21 Huelva;All ages;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
21 Huelva;All ages;Cohort October 1;Females;Survival in the third trimester;2021QII;7.896
21 Huelva;All ages;Cohort October 1;Females;Survival in the third trimester;2021QI;""
21 Huelva;All ages;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
21 Huelva;All ages;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
21 Huelva;All ages;Cohort October 1;Females;Survival in the third trimester;2020QII;""
21 Huelva;All ages;Cohort October 1;Females;Survival in the third trimester;2020QI;""
21 Huelva;All ages;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
21 Huelva;All ages;Cohort October 1;Females;Survival in the third trimester;2022QIII;7.741
21 Huelva;All ages;Cohort October 1;Females;Survival in the third trimester;2022QII;""
21 Huelva;All ages;Cohort October 1;Females;Survival in the third trimester;2022QI;""
21 Huelva;All ages;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
21 Huelva;All ages;Cohort October 1;Females;Survival in the third trimester;2021QIII;7.684
21 Huelva;All ages;Cohort October 1;Females;Survival in the third trimester;2021QII;""
21 Huelva;All ages;Cohort October 1;Females;Survival in the third trimester;2021QI;""
21 Huelva;All ages;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
21 Huelva;All ages;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
21 Huelva;All ages;Cohort October 1;Females;Survival in the third trimester;2020QII;""
21 Huelva;All ages;Cohort October 1;Females;Survival in the third trimester;2020QI;""
21 Huelva;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
21 Huelva;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
21 Huelva;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
21 Huelva;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
21 Huelva;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
21 Huelva;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
21 Huelva;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
21 Huelva;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
21 Huelva;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
21 Huelva;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
21 Huelva;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
21 Huelva;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
21 Huelva;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;94,69
21 Huelva;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
21 Huelva;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
21 Huelva;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
21 Huelva;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;95,2
21 Huelva;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
21 Huelva;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
21 Huelva;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
21 Huelva;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;95,46
21 Huelva;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
21 Huelva;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
21 Huelva;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
21 Huelva;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
21 Huelva;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
21 Huelva;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
21 Huelva;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;91,94
21 Huelva;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
21 Huelva;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
21 Huelva;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
21 Huelva;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;92,77
21 Huelva;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
21 Huelva;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
21 Huelva;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
21 Huelva;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
21 Huelva;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
21 Huelva;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
21 Huelva;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;88,25
21 Huelva;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
21 Huelva;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
21 Huelva;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
21 Huelva;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;90,15
21 Huelva;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
21 Huelva;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
21 Huelva;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
21 Huelva;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
21 Huelva;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
21 Huelva;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
21 Huelva;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;85,14
21 Huelva;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
21 Huelva;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
21 Huelva;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
21 Huelva;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;87,73
21 Huelva;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
21 Huelva;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
21 Huelva;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
21 Huelva;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
21 Huelva;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
21 Huelva;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
21 Huelva;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
21 Huelva;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
21 Huelva;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
21 Huelva;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QI;1.919
21 Huelva;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
21 Huelva;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
21 Huelva;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
21 Huelva;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QI;1.867
21 Huelva;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
21 Huelva;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
21 Huelva;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
21 Huelva;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QI;1.541
21 Huelva;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
21 Huelva;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
21 Huelva;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2022QII;""
21 Huelva;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2022QI;1.792
21 Huelva;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
21 Huelva;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
21 Huelva;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2021QII;""
21 Huelva;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2021QI;1.737
21 Huelva;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
21 Huelva;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
21 Huelva;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2020QII;""
21 Huelva;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2020QI;1.325
21 Huelva;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
21 Huelva;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
21 Huelva;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2022QII;1.669
21 Huelva;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2022QI;""
21 Huelva;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
21 Huelva;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
21 Huelva;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2021QII;1.646
21 Huelva;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2021QI;""
21 Huelva;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
21 Huelva;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
21 Huelva;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2020QII;1.286
21 Huelva;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2020QI;""
21 Huelva;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
21 Huelva;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QIII;1.560
21 Huelva;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QII;""
21 Huelva;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QI;""
21 Huelva;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
21 Huelva;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QIII;1.579
21 Huelva;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QII;""
21 Huelva;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QI;""
21 Huelva;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
21 Huelva;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QIII;1.211
21 Huelva;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QII;""
21 Huelva;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QI;""
21 Huelva;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QIV;1.462
21 Huelva;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
21 Huelva;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QII;""
21 Huelva;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QI;""
21 Huelva;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QIV;1.477
21 Huelva;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
21 Huelva;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QII;""
21 Huelva;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QI;""
21 Huelva;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QIV;1.140
21 Huelva;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
21 Huelva;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QII;""
21 Huelva;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QI;""
21 Huelva;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
21 Huelva;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
21 Huelva;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
21 Huelva;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
21 Huelva;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
21 Huelva;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
21 Huelva;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
21 Huelva;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
21 Huelva;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
21 Huelva;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
21 Huelva;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
21 Huelva;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
21 Huelva;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
21 Huelva;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
21 Huelva;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
21 Huelva;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;93,38
21 Huelva;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
21 Huelva;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
21 Huelva;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
21 Huelva;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;93,04
21 Huelva;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
21 Huelva;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
21 Huelva;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
21 Huelva;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;85,98
21 Huelva;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
21 Huelva;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
21 Huelva;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;86,97
21 Huelva;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
21 Huelva;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
21 Huelva;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
21 Huelva;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;88,16
21 Huelva;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
21 Huelva;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
21 Huelva;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
21 Huelva;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;83,45
21 Huelva;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
21 Huelva;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
21 Huelva;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;81,29
21 Huelva;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
21 Huelva;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
21 Huelva;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
21 Huelva;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;84,57
21 Huelva;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
21 Huelva;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
21 Huelva;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
21 Huelva;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;78,59
21 Huelva;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
21 Huelva;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
21 Huelva;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;76,19
21 Huelva;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
21 Huelva;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
21 Huelva;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
21 Huelva;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;79,11
21 Huelva;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
21 Huelva;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
21 Huelva;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
21 Huelva;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;73,98
21 Huelva;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
21 Huelva;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
21 Huelva;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
21 Huelva;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
21 Huelva;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
21 Huelva;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
21 Huelva;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QI;1.139
21 Huelva;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
21 Huelva;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
21 Huelva;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
21 Huelva;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QI;1.141
21 Huelva;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
21 Huelva;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
21 Huelva;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
21 Huelva;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QI;956
21 Huelva;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
21 Huelva;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
21 Huelva;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2022QII;""
21 Huelva;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2022QI;1.078
21 Huelva;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
21 Huelva;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
21 Huelva;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2021QII;""
21 Huelva;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2021QI;1.067
21 Huelva;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
21 Huelva;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
21 Huelva;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2020QII;""
21 Huelva;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2020QI;819
21 Huelva;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
21 Huelva;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
21 Huelva;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2022QII;1.012
21 Huelva;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2022QI;""
21 Huelva;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
21 Huelva;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
21 Huelva;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2021QII;1.013
21 Huelva;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2021QI;""
21 Huelva;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
21 Huelva;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
21 Huelva;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2020QII;801
21 Huelva;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2020QI;""
21 Huelva;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
21 Huelva;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QIII;959
21 Huelva;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QII;""
21 Huelva;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QI;""
21 Huelva;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
21 Huelva;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QIII;973
21 Huelva;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QII;""
21 Huelva;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QI;""
21 Huelva;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
21 Huelva;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QIII;761
21 Huelva;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QII;""
21 Huelva;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QI;""
21 Huelva;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QIV;913
21 Huelva;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
21 Huelva;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QII;""
21 Huelva;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QI;""
21 Huelva;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QIV;912
21 Huelva;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
21 Huelva;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QII;""
21 Huelva;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QI;""
21 Huelva;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QIV;719
21 Huelva;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
21 Huelva;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QII;""
21 Huelva;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QI;""
21 Huelva;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
21 Huelva;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
21 Huelva;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
21 Huelva;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
21 Huelva;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
21 Huelva;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
21 Huelva;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
21 Huelva;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
21 Huelva;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
21 Huelva;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
21 Huelva;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
21 Huelva;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
21 Huelva;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
21 Huelva;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
21 Huelva;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
21 Huelva;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;94,64
21 Huelva;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
21 Huelva;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
21 Huelva;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
21 Huelva;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;93,51
21 Huelva;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
21 Huelva;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
21 Huelva;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
21 Huelva;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;85,67
21 Huelva;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
21 Huelva;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
21 Huelva;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;88,85
21 Huelva;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
21 Huelva;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
21 Huelva;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
21 Huelva;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;88,78
21 Huelva;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
21 Huelva;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
21 Huelva;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
21 Huelva;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;83,79
21 Huelva;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
21 Huelva;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
21 Huelva;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;84,2
21 Huelva;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
21 Huelva;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
21 Huelva;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
21 Huelva;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;85,28
21 Huelva;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
21 Huelva;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
21 Huelva;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
21 Huelva;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;79,6
21 Huelva;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
21 Huelva;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
21 Huelva;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;80,16
21 Huelva;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
21 Huelva;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
21 Huelva;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
21 Huelva;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;79,93
21 Huelva;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
21 Huelva;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
21 Huelva;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
21 Huelva;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;75,21
21 Huelva;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
21 Huelva;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
21 Huelva;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
21 Huelva;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
21 Huelva;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
21 Huelva;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
21 Huelva;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QI;780
21 Huelva;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
21 Huelva;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
21 Huelva;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
21 Huelva;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QI;726
21 Huelva;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
21 Huelva;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
21 Huelva;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
21 Huelva;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QI;585
21 Huelva;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
21 Huelva;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
21 Huelva;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2022QII;""
21 Huelva;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2022QI;714
21 Huelva;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
21 Huelva;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
21 Huelva;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2021QII;""
21 Huelva;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2021QI;670
21 Huelva;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
21 Huelva;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
21 Huelva;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2020QII;""
21 Huelva;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2020QI;506
21 Huelva;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
21 Huelva;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
21 Huelva;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2022QII;657
21 Huelva;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2022QI;""
21 Huelva;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
21 Huelva;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
21 Huelva;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2021QII;633
21 Huelva;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2021QI;""
21 Huelva;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
21 Huelva;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
21 Huelva;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2020QII;485
21 Huelva;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2020QI;""
21 Huelva;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
21 Huelva;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QIII;601
21 Huelva;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QII;""
21 Huelva;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QI;""
21 Huelva;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
21 Huelva;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QIII;606
21 Huelva;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QII;""
21 Huelva;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QI;""
21 Huelva;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
21 Huelva;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QIII;450
21 Huelva;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QII;""
21 Huelva;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QI;""
21 Huelva;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QIV;549
21 Huelva;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
21 Huelva;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QII;""
21 Huelva;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QI;""
21 Huelva;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QIV;565
21 Huelva;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
21 Huelva;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QII;""
21 Huelva;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QI;""
21 Huelva;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QIV;421
21 Huelva;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
21 Huelva;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QII;""
21 Huelva;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QI;""
21 Huelva;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
21 Huelva;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
21 Huelva;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
21 Huelva;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
21 Huelva;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
21 Huelva;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
21 Huelva;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
21 Huelva;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
21 Huelva;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
21 Huelva;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
21 Huelva;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
21 Huelva;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
21 Huelva;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
21 Huelva;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
21 Huelva;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
21 Huelva;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;91,54
21 Huelva;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
21 Huelva;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
21 Huelva;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
21 Huelva;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;92,29
21 Huelva;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
21 Huelva;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
21 Huelva;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
21 Huelva;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;86,5
21 Huelva;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
21 Huelva;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
21 Huelva;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;84,23
21 Huelva;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
21 Huelva;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
21 Huelva;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
21 Huelva;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;87,19
21 Huelva;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
21 Huelva;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
21 Huelva;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
21 Huelva;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;82,91
21 Huelva;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
21 Huelva;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
21 Huelva;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;77,05
21 Huelva;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
21 Huelva;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
21 Huelva;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
21 Huelva;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;83,47
21 Huelva;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
21 Huelva;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
21 Huelva;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
21 Huelva;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;76,92
21 Huelva;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
21 Huelva;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
21 Huelva;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;70,38
21 Huelva;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
21 Huelva;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
21 Huelva;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
21 Huelva;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;77,82
21 Huelva;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
21 Huelva;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
21 Huelva;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
21 Huelva;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;71,97
21 Huelva;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
21 Huelva;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
21 Huelva;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
21 Huelva;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
21 Huelva;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
21 Huelva;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QII;1.675
21 Huelva;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
21 Huelva;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
21 Huelva;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
21 Huelva;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QII;1.652
21 Huelva;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
21 Huelva;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
21 Huelva;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
21 Huelva;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QII;1.531
21 Huelva;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
21 Huelva;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
21 Huelva;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
21 Huelva;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2022QII;1.544
21 Huelva;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2022QI;""
21 Huelva;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
21 Huelva;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
21 Huelva;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2021QII;1.560
21 Huelva;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2021QI;""
21 Huelva;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
21 Huelva;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
21 Huelva;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2020QII;1.472
21 Huelva;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2020QI;""
21 Huelva;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
21 Huelva;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2022QIII;1.418
21 Huelva;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2022QII;""
21 Huelva;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2022QI;""
21 Huelva;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
21 Huelva;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2021QIII;1.459
21 Huelva;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2021QII;""
21 Huelva;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2021QI;""
21 Huelva;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
21 Huelva;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2020QIII;1.381
21 Huelva;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2020QII;""
21 Huelva;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2020QI;""
21 Huelva;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QIV;1.316
21 Huelva;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
21 Huelva;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QII;""
21 Huelva;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QI;""
21 Huelva;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QIV;1.356
21 Huelva;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
21 Huelva;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QII;""
21 Huelva;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QI;""
21 Huelva;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QIV;1.294
21 Huelva;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
21 Huelva;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QII;""
21 Huelva;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QI;""
21 Huelva;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
21 Huelva;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
21 Huelva;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QII;""
21 Huelva;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QI;1.281
21 Huelva;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
21 Huelva;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
21 Huelva;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QII;""
21 Huelva;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QI;1.233
21 Huelva;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
21 Huelva;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
21 Huelva;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QII;""
21 Huelva;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QI;""
21 Huelva;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
21 Huelva;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
21 Huelva;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
21 Huelva;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
21 Huelva;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
21 Huelva;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
21 Huelva;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
21 Huelva;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
21 Huelva;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
21 Huelva;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
21 Huelva;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
21 Huelva;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
21 Huelva;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
21 Huelva;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
21 Huelva;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;92,18
21 Huelva;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
21 Huelva;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
21 Huelva;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
21 Huelva;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;94,43
21 Huelva;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
21 Huelva;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
21 Huelva;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
21 Huelva;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;96,15
21 Huelva;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
21 Huelva;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
21 Huelva;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;84,66
21 Huelva;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
21 Huelva;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
21 Huelva;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
21 Huelva;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;88,32
21 Huelva;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
21 Huelva;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
21 Huelva;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
21 Huelva;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;90,2
21 Huelva;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
21 Huelva;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
21 Huelva;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;78,57
21 Huelva;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
21 Huelva;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
21 Huelva;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
21 Huelva;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;82,08
21 Huelva;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
21 Huelva;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
21 Huelva;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
21 Huelva;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;84,52
21 Huelva;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
21 Huelva;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
21 Huelva;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
21 Huelva;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
21 Huelva;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
21 Huelva;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
21 Huelva;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;77,54
21 Huelva;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
21 Huelva;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
21 Huelva;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
21 Huelva;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;80,54
21 Huelva;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
21 Huelva;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
21 Huelva;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
21 Huelva;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
21 Huelva;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
21 Huelva;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
21 Huelva;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QII;1.006
21 Huelva;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
21 Huelva;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
21 Huelva;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
21 Huelva;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QII;1.012
21 Huelva;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
21 Huelva;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
21 Huelva;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
21 Huelva;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QII;950
21 Huelva;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
21 Huelva;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
21 Huelva;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
21 Huelva;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2022QII;936
21 Huelva;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2022QI;""
21 Huelva;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
21 Huelva;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
21 Huelva;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2021QII;953
21 Huelva;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2021QI;""
21 Huelva;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
21 Huelva;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
21 Huelva;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2020QII;918
21 Huelva;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2020QI;""
21 Huelva;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
21 Huelva;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2022QIII;876
21 Huelva;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2022QII;""
21 Huelva;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2022QI;""
21 Huelva;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
21 Huelva;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2021QIII;890
21 Huelva;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2021QII;""
21 Huelva;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2021QI;""
21 Huelva;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
21 Huelva;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2020QIII;867
21 Huelva;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2020QII;""
21 Huelva;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2020QI;""
21 Huelva;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QIV;823
21 Huelva;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
21 Huelva;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QII;""
21 Huelva;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QI;""
21 Huelva;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QIV;830
21 Huelva;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
21 Huelva;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QII;""
21 Huelva;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QI;""
21 Huelva;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QIV;813
21 Huelva;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
21 Huelva;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QII;""
21 Huelva;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QI;""
21 Huelva;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
21 Huelva;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
21 Huelva;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QII;""
21 Huelva;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QI;796
21 Huelva;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
21 Huelva;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
21 Huelva;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QII;""
21 Huelva;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QI;782
21 Huelva;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
21 Huelva;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
21 Huelva;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QII;""
21 Huelva;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QI;""
21 Huelva;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
21 Huelva;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
21 Huelva;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
21 Huelva;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
21 Huelva;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
21 Huelva;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
21 Huelva;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
21 Huelva;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
21 Huelva;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
21 Huelva;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
21 Huelva;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
21 Huelva;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
21 Huelva;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
21 Huelva;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
21 Huelva;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;93,04
21 Huelva;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
21 Huelva;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
21 Huelva;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
21 Huelva;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;94,17
21 Huelva;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
21 Huelva;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
21 Huelva;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
21 Huelva;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;96,63
21 Huelva;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
21 Huelva;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
21 Huelva;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;87,08
21 Huelva;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
21 Huelva;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
21 Huelva;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
21 Huelva;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;87,94
21 Huelva;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
21 Huelva;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
21 Huelva;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
21 Huelva;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;91,26
21 Huelva;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
21 Huelva;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
21 Huelva;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;81,81
21 Huelva;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
21 Huelva;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
21 Huelva;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
21 Huelva;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;82,02
21 Huelva;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
21 Huelva;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
21 Huelva;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
21 Huelva;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;85,58
21 Huelva;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
21 Huelva;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
21 Huelva;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
21 Huelva;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
21 Huelva;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
21 Huelva;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
21 Huelva;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;78,66
21 Huelva;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
21 Huelva;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
21 Huelva;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
21 Huelva;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;82,32
21 Huelva;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
21 Huelva;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
21 Huelva;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
21 Huelva;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
21 Huelva;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
21 Huelva;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
21 Huelva;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QII;669
21 Huelva;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
21 Huelva;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
21 Huelva;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
21 Huelva;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QII;640
21 Huelva;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
21 Huelva;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
21 Huelva;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
21 Huelva;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QII;581
21 Huelva;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
21 Huelva;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
21 Huelva;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
21 Huelva;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2022QII;608
21 Huelva;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2022QI;""
21 Huelva;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
21 Huelva;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
21 Huelva;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2021QII;607
21 Huelva;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2021QI;""
21 Huelva;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
21 Huelva;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
21 Huelva;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2020QII;554
21 Huelva;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2020QI;""
21 Huelva;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
21 Huelva;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2022QIII;542
21 Huelva;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2022QII;""
21 Huelva;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2022QI;""
21 Huelva;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
21 Huelva;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2021QIII;569
21 Huelva;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2021QII;""
21 Huelva;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2021QI;""
21 Huelva;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
21 Huelva;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2020QIII;514
21 Huelva;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2020QII;""
21 Huelva;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2020QI;""
21 Huelva;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QIV;493
21 Huelva;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
21 Huelva;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QII;""
21 Huelva;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QI;""
21 Huelva;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QIV;526
21 Huelva;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
21 Huelva;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QII;""
21 Huelva;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QI;""
21 Huelva;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QIV;481
21 Huelva;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
21 Huelva;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QII;""
21 Huelva;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QI;""
21 Huelva;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
21 Huelva;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
21 Huelva;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QII;""
21 Huelva;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QI;485
21 Huelva;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
21 Huelva;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
21 Huelva;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QII;""
21 Huelva;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QI;451
21 Huelva;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
21 Huelva;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
21 Huelva;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QII;""
21 Huelva;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QI;""
21 Huelva;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
21 Huelva;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
21 Huelva;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
21 Huelva;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
21 Huelva;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
21 Huelva;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
21 Huelva;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
21 Huelva;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
21 Huelva;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
21 Huelva;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
21 Huelva;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
21 Huelva;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
21 Huelva;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
21 Huelva;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
21 Huelva;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;90,88
21 Huelva;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
21 Huelva;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
21 Huelva;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
21 Huelva;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;94,84
21 Huelva;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
21 Huelva;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
21 Huelva;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
21 Huelva;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;95,35
21 Huelva;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
21 Huelva;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
21 Huelva;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;81,02
21 Huelva;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
21 Huelva;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
21 Huelva;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
21 Huelva;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;88,91
21 Huelva;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
21 Huelva;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
21 Huelva;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
21 Huelva;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;88,47
21 Huelva;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
21 Huelva;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
21 Huelva;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;73,69
21 Huelva;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
21 Huelva;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
21 Huelva;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
21 Huelva;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;82,19
21 Huelva;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
21 Huelva;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
21 Huelva;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
21 Huelva;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;82,79
21 Huelva;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
21 Huelva;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
21 Huelva;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
21 Huelva;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
21 Huelva;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
21 Huelva;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
21 Huelva;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;75,78
21 Huelva;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
21 Huelva;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
21 Huelva;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
21 Huelva;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;77,62
21 Huelva;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
21 Huelva;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
21 Huelva;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
21 Huelva;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
21 Huelva;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
21 Huelva;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QIII;1.799
21 Huelva;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
21 Huelva;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
21 Huelva;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
21 Huelva;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QIII;1.823
21 Huelva;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
21 Huelva;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
21 Huelva;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
21 Huelva;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QIII;1.685
21 Huelva;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
21 Huelva;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
21 Huelva;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
21 Huelva;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2022QIII;1.610
21 Huelva;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2022QII;""
21 Huelva;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2022QI;""
21 Huelva;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
21 Huelva;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2021QIII;1.662
21 Huelva;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2021QII;""
21 Huelva;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2021QI;""
21 Huelva;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
21 Huelva;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2020QIII;1.532
21 Huelva;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2020QII;""
21 Huelva;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2020QI;""
21 Huelva;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2022QIV;1.484
21 Huelva;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
21 Huelva;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2022QII;""
21 Huelva;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2022QI;""
21 Huelva;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2021QIV;1.533
21 Huelva;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
21 Huelva;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2021QII;""
21 Huelva;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2021QI;""
21 Huelva;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2020QIV;1.425
21 Huelva;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
21 Huelva;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2020QII;""
21 Huelva;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2020QI;""
21 Huelva;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
21 Huelva;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
21 Huelva;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QII;""
21 Huelva;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QI;1.448
21 Huelva;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
21 Huelva;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
21 Huelva;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QII;""
21 Huelva;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QI;1.350
21 Huelva;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
21 Huelva;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
21 Huelva;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QII;""
21 Huelva;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QI;""
21 Huelva;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
21 Huelva;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
21 Huelva;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QII;1.365
21 Huelva;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QI;""
21 Huelva;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
21 Huelva;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
21 Huelva;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QII;1.296
21 Huelva;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QI;""
21 Huelva;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
21 Huelva;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
21 Huelva;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QII;""
21 Huelva;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QI;""
21 Huelva;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
21 Huelva;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
21 Huelva;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
21 Huelva;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
21 Huelva;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
21 Huelva;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
21 Huelva;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
21 Huelva;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
21 Huelva;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
21 Huelva;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
21 Huelva;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
21 Huelva;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
21 Huelva;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
21 Huelva;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;89,49
21 Huelva;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
21 Huelva;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
21 Huelva;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
21 Huelva;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;91,17
21 Huelva;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
21 Huelva;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
21 Huelva;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
21 Huelva;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;90,92
21 Huelva;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
21 Huelva;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
21 Huelva;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;82,49
21 Huelva;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
21 Huelva;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
21 Huelva;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
21 Huelva;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;84,09
21 Huelva;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
21 Huelva;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
21 Huelva;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
21 Huelva;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;84,57
21 Huelva;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
21 Huelva;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
21 Huelva;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
21 Huelva;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
21 Huelva;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
21 Huelva;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
21 Huelva;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;79,43
21 Huelva;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
21 Huelva;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
21 Huelva;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
21 Huelva;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;80,12
21 Huelva;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
21 Huelva;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
21 Huelva;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
21 Huelva;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
21 Huelva;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
21 Huelva;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
21 Huelva;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;74,88
21 Huelva;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
21 Huelva;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
21 Huelva;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
21 Huelva;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;76,91
21 Huelva;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
21 Huelva;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
21 Huelva;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
21 Huelva;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
21 Huelva;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
21 Huelva;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
21 Huelva;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QIII;1.078
21 Huelva;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
21 Huelva;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
21 Huelva;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
21 Huelva;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QIII;1.102
21 Huelva;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
21 Huelva;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
21 Huelva;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
21 Huelva;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QIII;1.047
21 Huelva;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
21 Huelva;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
21 Huelva;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
21 Huelva;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2022QIII;983
21 Huelva;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2022QII;""
21 Huelva;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2022QI;""
21 Huelva;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
21 Huelva;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2021QIII;1.005
21 Huelva;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2021QII;""
21 Huelva;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2021QI;""
21 Huelva;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
21 Huelva;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2020QIII;956
21 Huelva;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2020QII;""
21 Huelva;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2020QI;""
21 Huelva;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2022QIV;916
21 Huelva;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
21 Huelva;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2022QII;""
21 Huelva;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2022QI;""
21 Huelva;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2021QIV;932
21 Huelva;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
21 Huelva;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2021QII;""
21 Huelva;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2021QI;""
21 Huelva;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2020QIV;889
21 Huelva;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
21 Huelva;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2020QII;""
21 Huelva;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2020QI;""
21 Huelva;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
21 Huelva;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
21 Huelva;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QII;""
21 Huelva;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QI;895
21 Huelva;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
21 Huelva;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
21 Huelva;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QII;""
21 Huelva;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QI;851
21 Huelva;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
21 Huelva;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
21 Huelva;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QII;""
21 Huelva;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QI;""
21 Huelva;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
21 Huelva;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
21 Huelva;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QII;854
21 Huelva;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QI;""
21 Huelva;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
21 Huelva;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
21 Huelva;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QII;814
21 Huelva;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QI;""
21 Huelva;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
21 Huelva;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
21 Huelva;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QII;""
21 Huelva;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QI;""
21 Huelva;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
21 Huelva;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
21 Huelva;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
21 Huelva;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
21 Huelva;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
21 Huelva;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
21 Huelva;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
21 Huelva;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
21 Huelva;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
21 Huelva;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
21 Huelva;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
21 Huelva;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
21 Huelva;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
21 Huelva;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;91,19
21 Huelva;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
21 Huelva;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
21 Huelva;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
21 Huelva;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;91,2
21 Huelva;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
21 Huelva;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
21 Huelva;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
21 Huelva;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;91,31
21 Huelva;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
21 Huelva;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
21 Huelva;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;84,97
21 Huelva;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
21 Huelva;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
21 Huelva;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
21 Huelva;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;84,57
21 Huelva;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
21 Huelva;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
21 Huelva;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
21 Huelva;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;84,91
21 Huelva;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
21 Huelva;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
21 Huelva;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
21 Huelva;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
21 Huelva;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
21 Huelva;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
21 Huelva;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;81,22
21 Huelva;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
21 Huelva;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
21 Huelva;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
21 Huelva;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;81,28
21 Huelva;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
21 Huelva;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
21 Huelva;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
21 Huelva;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
21 Huelva;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
21 Huelva;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
21 Huelva;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;77,5
21 Huelva;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
21 Huelva;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
21 Huelva;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
21 Huelva;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;77,75
21 Huelva;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
21 Huelva;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
21 Huelva;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
21 Huelva;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
21 Huelva;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
21 Huelva;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
21 Huelva;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QIII;721
21 Huelva;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
21 Huelva;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
21 Huelva;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
21 Huelva;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QIII;721
21 Huelva;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
21 Huelva;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
21 Huelva;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
21 Huelva;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QIII;638
21 Huelva;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
21 Huelva;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
21 Huelva;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
21 Huelva;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2022QIII;627
21 Huelva;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2022QII;""
21 Huelva;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2022QI;""
21 Huelva;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
21 Huelva;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2021QIII;657
21 Huelva;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2021QII;""
21 Huelva;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2021QI;""
21 Huelva;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
21 Huelva;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2020QIII;576
21 Huelva;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2020QII;""
21 Huelva;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2020QI;""
21 Huelva;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2022QIV;568
21 Huelva;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
21 Huelva;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2022QII;""
21 Huelva;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2022QI;""
21 Huelva;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2021QIV;601
21 Huelva;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
21 Huelva;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2021QII;""
21 Huelva;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2021QI;""
21 Huelva;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2020QIV;536
21 Huelva;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
21 Huelva;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2020QII;""
21 Huelva;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2020QI;""
21 Huelva;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
21 Huelva;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
21 Huelva;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QII;""
21 Huelva;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QI;553
21 Huelva;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
21 Huelva;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
21 Huelva;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QII;""
21 Huelva;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QI;499
21 Huelva;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
21 Huelva;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
21 Huelva;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QII;""
21 Huelva;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QI;""
21 Huelva;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
21 Huelva;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
21 Huelva;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QII;511
21 Huelva;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QI;""
21 Huelva;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
21 Huelva;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
21 Huelva;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QII;482
21 Huelva;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QI;""
21 Huelva;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
21 Huelva;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
21 Huelva;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QII;""
21 Huelva;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QI;""
21 Huelva;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
21 Huelva;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
21 Huelva;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
21 Huelva;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
21 Huelva;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
21 Huelva;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
21 Huelva;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
21 Huelva;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
21 Huelva;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
21 Huelva;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
21 Huelva;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
21 Huelva;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
21 Huelva;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
21 Huelva;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;86,96
21 Huelva;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
21 Huelva;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
21 Huelva;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
21 Huelva;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;91,12
21 Huelva;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
21 Huelva;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
21 Huelva;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
21 Huelva;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;90,28
21 Huelva;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
21 Huelva;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
21 Huelva;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;78,78
21 Huelva;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
21 Huelva;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
21 Huelva;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
21 Huelva;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;83,36
21 Huelva;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
21 Huelva;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
21 Huelva;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
21 Huelva;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;84,01
21 Huelva;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
21 Huelva;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
21 Huelva;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
21 Huelva;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
21 Huelva;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
21 Huelva;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
21 Huelva;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;76,7
21 Huelva;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
21 Huelva;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
21 Huelva;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
21 Huelva;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;78,21
21 Huelva;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
21 Huelva;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
21 Huelva;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
21 Huelva;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
21 Huelva;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
21 Huelva;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
21 Huelva;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;70,87
21 Huelva;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
21 Huelva;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
21 Huelva;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
21 Huelva;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;75,55
21 Huelva;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
21 Huelva;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
21 Huelva;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
21 Huelva;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
21 Huelva;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
21 Huelva;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QIV;1.805
21 Huelva;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
21 Huelva;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
21 Huelva;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
21 Huelva;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QIV;1.855
21 Huelva;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
21 Huelva;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
21 Huelva;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
21 Huelva;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QIV;1.763
21 Huelva;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
21 Huelva;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
21 Huelva;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
21 Huelva;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2022QIV;1.657
21 Huelva;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
21 Huelva;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2022QII;""
21 Huelva;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2022QI;""
21 Huelva;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2021QIV;1.702
21 Huelva;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
21 Huelva;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2021QII;""
21 Huelva;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2021QI;""
21 Huelva;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2020QIV;1.624
21 Huelva;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
21 Huelva;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2020QII;""
21 Huelva;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2020QI;""
21 Huelva;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
21 Huelva;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
21 Huelva;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2022QII;""
21 Huelva;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2022QI;1.604
21 Huelva;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
21 Huelva;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
21 Huelva;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2021QII;""
21 Huelva;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2021QI;1.525
21 Huelva;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
21 Huelva;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
21 Huelva;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2020QII;""
21 Huelva;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2020QI;""
21 Huelva;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
21 Huelva;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
21 Huelva;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QII;1.501
21 Huelva;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QI;""
21 Huelva;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
21 Huelva;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
21 Huelva;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QII;1.460
21 Huelva;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QI;""
21 Huelva;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
21 Huelva;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
21 Huelva;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QII;""
21 Huelva;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QI;""
21 Huelva;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
21 Huelva;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QIII;1.411
21 Huelva;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QII;""
21 Huelva;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QI;""
21 Huelva;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
21 Huelva;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QIII;1.408
21 Huelva;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QII;""
21 Huelva;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QI;""
21 Huelva;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
21 Huelva;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
21 Huelva;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QII;""
21 Huelva;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QI;""
21 Huelva;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
21 Huelva;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
21 Huelva;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
21 Huelva;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
21 Huelva;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
21 Huelva;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
21 Huelva;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
21 Huelva;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
21 Huelva;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
21 Huelva;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
21 Huelva;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
21 Huelva;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
21 Huelva;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;91,8
21 Huelva;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
21 Huelva;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
21 Huelva;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
21 Huelva;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;91,75
21 Huelva;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
21 Huelva;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
21 Huelva;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
21 Huelva;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;92,12
21 Huelva;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
21 Huelva;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
21 Huelva;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
21 Huelva;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
21 Huelva;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
21 Huelva;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
21 Huelva;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;86,47
21 Huelva;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
21 Huelva;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
21 Huelva;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
21 Huelva;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;86,5
21 Huelva;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
21 Huelva;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
21 Huelva;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
21 Huelva;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
21 Huelva;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
21 Huelva;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
21 Huelva;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;80,92
21 Huelva;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
21 Huelva;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
21 Huelva;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
21 Huelva;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;82,81
21 Huelva;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
21 Huelva;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
21 Huelva;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
21 Huelva;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
21 Huelva;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
21 Huelva;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
21 Huelva;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;76,06
21 Huelva;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
21 Huelva;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
21 Huelva;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
21 Huelva;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;79,86
21 Huelva;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
21 Huelva;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
21 Huelva;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
21 Huelva;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
21 Huelva;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
21 Huelva;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
21 Huelva;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QIV;1.089
21 Huelva;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
21 Huelva;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
21 Huelva;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
21 Huelva;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QIV;1.111
21 Huelva;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
21 Huelva;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
21 Huelva;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
21 Huelva;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QIV;1.097
21 Huelva;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
21 Huelva;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
21 Huelva;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
21 Huelva;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2022QIV;1.013
21 Huelva;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
21 Huelva;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2022QII;""
21 Huelva;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2022QI;""
21 Huelva;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2021QIV;1.024
21 Huelva;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
21 Huelva;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2021QII;""
21 Huelva;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2021QI;""
21 Huelva;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2020QIV;1.006
21 Huelva;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
21 Huelva;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2020QII;""
21 Huelva;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2020QI;""
21 Huelva;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
21 Huelva;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
21 Huelva;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2022QII;""
21 Huelva;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2022QI;982
21 Huelva;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
21 Huelva;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
21 Huelva;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2021QII;""
21 Huelva;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2021QI;950
21 Huelva;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
21 Huelva;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
21 Huelva;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2020QII;""
21 Huelva;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2020QI;""
21 Huelva;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
21 Huelva;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
21 Huelva;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QII;930
21 Huelva;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QI;""
21 Huelva;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
21 Huelva;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
21 Huelva;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QII;906
21 Huelva;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QI;""
21 Huelva;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
21 Huelva;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
21 Huelva;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QII;""
21 Huelva;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QI;""
21 Huelva;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
21 Huelva;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QIII;889
21 Huelva;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QII;""
21 Huelva;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QI;""
21 Huelva;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
21 Huelva;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QIII;875
21 Huelva;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QII;""
21 Huelva;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QI;""
21 Huelva;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
21 Huelva;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
21 Huelva;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QII;""
21 Huelva;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QI;""
21 Huelva;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
21 Huelva;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
21 Huelva;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
21 Huelva;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
21 Huelva;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
21 Huelva;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
21 Huelva;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
21 Huelva;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
21 Huelva;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
21 Huelva;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
21 Huelva;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
21 Huelva;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
21 Huelva;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;93,02
21 Huelva;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
21 Huelva;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
21 Huelva;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
21 Huelva;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;92,17
21 Huelva;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
21 Huelva;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
21 Huelva;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
21 Huelva;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;91,7
21 Huelva;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
21 Huelva;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
21 Huelva;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
21 Huelva;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
21 Huelva;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
21 Huelva;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
21 Huelva;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;88,39
21 Huelva;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
21 Huelva;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
21 Huelva;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
21 Huelva;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;86,6
21 Huelva;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
21 Huelva;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
21 Huelva;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
21 Huelva;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
21 Huelva;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
21 Huelva;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
21 Huelva;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;83,71
21 Huelva;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
21 Huelva;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
21 Huelva;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
21 Huelva;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;82,59
21 Huelva;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
21 Huelva;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
21 Huelva;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
21 Huelva;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
21 Huelva;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
21 Huelva;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
21 Huelva;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;80,02
21 Huelva;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
21 Huelva;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
21 Huelva;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
21 Huelva;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;79,76
21 Huelva;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
21 Huelva;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
21 Huelva;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
21 Huelva;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
21 Huelva;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
21 Huelva;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
21 Huelva;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QIV;716
21 Huelva;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
21 Huelva;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
21 Huelva;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
21 Huelva;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QIV;744
21 Huelva;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
21 Huelva;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
21 Huelva;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
21 Huelva;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QIV;666
21 Huelva;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
21 Huelva;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
21 Huelva;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
21 Huelva;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2022QIV;644
21 Huelva;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
21 Huelva;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2022QII;""
21 Huelva;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2022QI;""
21 Huelva;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2021QIV;678
21 Huelva;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
21 Huelva;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2021QII;""
21 Huelva;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2021QI;""
21 Huelva;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2020QIV;618
21 Huelva;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
21 Huelva;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2020QII;""
21 Huelva;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2020QI;""
21 Huelva;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
21 Huelva;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
21 Huelva;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2022QII;""
21 Huelva;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2022QI;622
21 Huelva;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
21 Huelva;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
21 Huelva;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2021QII;""
21 Huelva;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2021QI;575
21 Huelva;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
21 Huelva;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
21 Huelva;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2020QII;""
21 Huelva;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2020QI;""
21 Huelva;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
21 Huelva;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
21 Huelva;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QII;571
21 Huelva;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QI;""
21 Huelva;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
21 Huelva;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
21 Huelva;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QII;554
21 Huelva;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QI;""
21 Huelva;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
21 Huelva;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
21 Huelva;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QII;""
21 Huelva;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QI;""
21 Huelva;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
21 Huelva;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QIII;522
21 Huelva;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QII;""
21 Huelva;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QI;""
21 Huelva;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
21 Huelva;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QIII;533
21 Huelva;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QII;""
21 Huelva;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QI;""
21 Huelva;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
21 Huelva;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
21 Huelva;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QII;""
21 Huelva;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QI;""
21 Huelva;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
21 Huelva;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
21 Huelva;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
21 Huelva;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
21 Huelva;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
21 Huelva;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
21 Huelva;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
21 Huelva;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
21 Huelva;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
21 Huelva;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
21 Huelva;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
21 Huelva;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
21 Huelva;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;89,94
21 Huelva;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
21 Huelva;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
21 Huelva;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
21 Huelva;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;91,13
21 Huelva;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
21 Huelva;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
21 Huelva;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
21 Huelva;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;92,79
21 Huelva;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
21 Huelva;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
21 Huelva;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
21 Huelva;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
21 Huelva;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
21 Huelva;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
21 Huelva;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;83,6
21 Huelva;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
21 Huelva;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
21 Huelva;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
21 Huelva;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;86,34
21 Huelva;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
21 Huelva;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
21 Huelva;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
21 Huelva;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
21 Huelva;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
21 Huelva;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
21 Huelva;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;76,75
21 Huelva;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
21 Huelva;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
21 Huelva;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
21 Huelva;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;83,18
21 Huelva;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
21 Huelva;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
21 Huelva;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
21 Huelva;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
21 Huelva;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
21 Huelva;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
21 Huelva;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;70,16
21 Huelva;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
21 Huelva;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
21 Huelva;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
21 Huelva;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;80,03
21 Huelva;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
21 Huelva;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
21 Huelva;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
21 Huelva;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
21 Huelva;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
21 Huelva;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
21 Huelva;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
21 Huelva;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
21 Huelva;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
21 Huelva;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QI;5.249
21 Huelva;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
21 Huelva;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
21 Huelva;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
21 Huelva;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QI;5.198
21 Huelva;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
21 Huelva;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
21 Huelva;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
21 Huelva;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QI;5.051
21 Huelva;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
21 Huelva;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
21 Huelva;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2022QII;""
21 Huelva;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2022QI;5.049
21 Huelva;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
21 Huelva;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
21 Huelva;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2021QII;""
21 Huelva;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2021QI;5.044
21 Huelva;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
21 Huelva;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
21 Huelva;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2020QII;""
21 Huelva;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2020QI;4.599
21 Huelva;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
21 Huelva;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
21 Huelva;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2022QII;4.839
21 Huelva;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2022QI;""
21 Huelva;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
21 Huelva;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
21 Huelva;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2021QII;4.882
21 Huelva;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2021QI;""
21 Huelva;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
21 Huelva;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
21 Huelva;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2020QII;4.484
21 Huelva;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2020QI;""
21 Huelva;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
21 Huelva;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QIII;4.664
21 Huelva;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QII;""
21 Huelva;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QI;""
21 Huelva;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
21 Huelva;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QIII;4.754
21 Huelva;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QII;""
21 Huelva;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QI;""
21 Huelva;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
21 Huelva;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QIII;4.341
21 Huelva;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QII;""
21 Huelva;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QI;""
21 Huelva;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QIV;4.502
21 Huelva;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
21 Huelva;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QII;""
21 Huelva;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QI;""
21 Huelva;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QIV;4.614
21 Huelva;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
21 Huelva;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QII;""
21 Huelva;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QI;""
21 Huelva;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QIV;4.219
21 Huelva;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
21 Huelva;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QII;""
21 Huelva;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QI;""
21 Huelva;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
21 Huelva;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
21 Huelva;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
21 Huelva;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
21 Huelva;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
21 Huelva;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
21 Huelva;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
21 Huelva;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
21 Huelva;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
21 Huelva;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
21 Huelva;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
21 Huelva;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
21 Huelva;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
21 Huelva;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
21 Huelva;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
21 Huelva;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;96,19
21 Huelva;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
21 Huelva;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
21 Huelva;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
21 Huelva;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;97,04
21 Huelva;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
21 Huelva;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
21 Huelva;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
21 Huelva;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;91,05
21 Huelva;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
21 Huelva;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
21 Huelva;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;92,19
21 Huelva;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
21 Huelva;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
21 Huelva;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
21 Huelva;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;93,92
21 Huelva;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
21 Huelva;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
21 Huelva;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
21 Huelva;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;88,77
21 Huelva;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
21 Huelva;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
21 Huelva;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;88,86
21 Huelva;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
21 Huelva;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
21 Huelva;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
21 Huelva;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;91,46
21 Huelva;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
21 Huelva;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
21 Huelva;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
21 Huelva;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;85,94
21 Huelva;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
21 Huelva;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
21 Huelva;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;85,77
21 Huelva;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
21 Huelva;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
21 Huelva;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
21 Huelva;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;88,76
21 Huelva;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
21 Huelva;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
21 Huelva;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
21 Huelva;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;83,53
21 Huelva;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
21 Huelva;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
21 Huelva;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
21 Huelva;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
21 Huelva;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
21 Huelva;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
21 Huelva;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QI;3.097
21 Huelva;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
21 Huelva;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
21 Huelva;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
21 Huelva;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QI;3.116
21 Huelva;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
21 Huelva;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
21 Huelva;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
21 Huelva;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QI;2.998
21 Huelva;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
21 Huelva;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
21 Huelva;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2022QII;""
21 Huelva;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2022QI;2.992
21 Huelva;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
21 Huelva;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
21 Huelva;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2021QII;""
21 Huelva;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2021QI;3.031
21 Huelva;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
21 Huelva;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
21 Huelva;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2020QII;""
21 Huelva;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2020QI;2.746
21 Huelva;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
21 Huelva;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
21 Huelva;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2022QII;2.884
21 Huelva;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2022QI;""
21 Huelva;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
21 Huelva;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
21 Huelva;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2021QII;2.941
21 Huelva;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2021QI;""
21 Huelva;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
21 Huelva;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
21 Huelva;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2020QII;2.682
21 Huelva;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2020QI;""
21 Huelva;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
21 Huelva;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QIII;2.786
21 Huelva;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QII;""
21 Huelva;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QI;""
21 Huelva;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
21 Huelva;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QIII;2.879
21 Huelva;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QII;""
21 Huelva;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QI;""
21 Huelva;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
21 Huelva;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QIII;2.610
21 Huelva;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QII;""
21 Huelva;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QI;""
21 Huelva;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QIV;2.700
21 Huelva;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
21 Huelva;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QII;""
21 Huelva;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QI;""
21 Huelva;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QIV;2.805
21 Huelva;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
21 Huelva;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QII;""
21 Huelva;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QI;""
21 Huelva;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QIV;2.542
21 Huelva;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
21 Huelva;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QII;""
21 Huelva;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QI;""
21 Huelva;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
21 Huelva;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
21 Huelva;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
21 Huelva;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
21 Huelva;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
21 Huelva;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
21 Huelva;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
21 Huelva;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
21 Huelva;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
21 Huelva;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
21 Huelva;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
21 Huelva;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
21 Huelva;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
21 Huelva;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
21 Huelva;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
21 Huelva;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;96,61
21 Huelva;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
21 Huelva;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
21 Huelva;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
21 Huelva;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;97,27
21 Huelva;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
21 Huelva;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
21 Huelva;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
21 Huelva;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;91,59
21 Huelva;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
21 Huelva;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
21 Huelva;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;93,12
21 Huelva;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
21 Huelva;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
21 Huelva;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
21 Huelva;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;94,38
21 Huelva;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
21 Huelva;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
21 Huelva;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
21 Huelva;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;89,46
21 Huelva;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
21 Huelva;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
21 Huelva;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;89,96
21 Huelva;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
21 Huelva;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
21 Huelva;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
21 Huelva;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;92,39
21 Huelva;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
21 Huelva;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
21 Huelva;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
21 Huelva;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;87,06
21 Huelva;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
21 Huelva;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
21 Huelva;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;87,18
21 Huelva;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
21 Huelva;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
21 Huelva;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
21 Huelva;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;90,02
21 Huelva;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
21 Huelva;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
21 Huelva;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
21 Huelva;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;84,79
21 Huelva;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
21 Huelva;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
21 Huelva;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
21 Huelva;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
21 Huelva;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
21 Huelva;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
21 Huelva;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QI;2.152
21 Huelva;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
21 Huelva;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
21 Huelva;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
21 Huelva;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QI;2.082
21 Huelva;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
21 Huelva;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
21 Huelva;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
21 Huelva;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QI;2.053
21 Huelva;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
21 Huelva;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
21 Huelva;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2022QII;""
21 Huelva;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2022QI;2.057
21 Huelva;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
21 Huelva;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
21 Huelva;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2021QII;""
21 Huelva;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2021QI;2.013
21 Huelva;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
21 Huelva;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
21 Huelva;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2020QII;""
21 Huelva;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2020QI;1.853
21 Huelva;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
21 Huelva;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
21 Huelva;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2022QII;1.955
21 Huelva;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2022QI;""
21 Huelva;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
21 Huelva;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
21 Huelva;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2021QII;1.941
21 Huelva;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2021QI;""
21 Huelva;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
21 Huelva;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
21 Huelva;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2020QII;1.802
21 Huelva;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2020QI;""
21 Huelva;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
21 Huelva;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QIII;1.878
21 Huelva;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QII;""
21 Huelva;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QI;""
21 Huelva;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
21 Huelva;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QIII;1.875
21 Huelva;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QII;""
21 Huelva;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QI;""
21 Huelva;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
21 Huelva;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QIII;1.731
21 Huelva;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QII;""
21 Huelva;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QI;""
21 Huelva;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QIV;1.802
21 Huelva;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
21 Huelva;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QII;""
21 Huelva;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QI;""
21 Huelva;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QIV;1.809
21 Huelva;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
21 Huelva;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QII;""
21 Huelva;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QI;""
21 Huelva;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QIV;1.677
21 Huelva;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
21 Huelva;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QII;""
21 Huelva;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QI;""
21 Huelva;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
21 Huelva;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
21 Huelva;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
21 Huelva;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
21 Huelva;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
21 Huelva;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
21 Huelva;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
21 Huelva;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
21 Huelva;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
21 Huelva;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
21 Huelva;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
21 Huelva;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
21 Huelva;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
21 Huelva;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
21 Huelva;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
21 Huelva;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;95,59
21 Huelva;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
21 Huelva;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
21 Huelva;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
21 Huelva;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;96,69
21 Huelva;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
21 Huelva;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
21 Huelva;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
21 Huelva;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;90,26
21 Huelva;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
21 Huelva;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
21 Huelva;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;90,85
21 Huelva;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
21 Huelva;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
21 Huelva;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
21 Huelva;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;93,23
21 Huelva;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
21 Huelva;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
21 Huelva;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
21 Huelva;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;87,77
21 Huelva;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
21 Huelva;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
21 Huelva;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;87,27
21 Huelva;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
21 Huelva;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
21 Huelva;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
21 Huelva;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;90,06
21 Huelva;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
21 Huelva;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
21 Huelva;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
21 Huelva;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;84,32
21 Huelva;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
21 Huelva;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
21 Huelva;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;83,74
21 Huelva;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
21 Huelva;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
21 Huelva;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
21 Huelva;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;86,89
21 Huelva;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
21 Huelva;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
21 Huelva;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
21 Huelva;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;81,69
21 Huelva;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
21 Huelva;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
21 Huelva;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
21 Huelva;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
21 Huelva;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
21 Huelva;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QII;4.936
21 Huelva;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
21 Huelva;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
21 Huelva;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
21 Huelva;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QII;4.984
21 Huelva;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
21 Huelva;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
21 Huelva;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
21 Huelva;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QII;4.908
21 Huelva;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
21 Huelva;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
21 Huelva;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
21 Huelva;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2022QII;4.695
21 Huelva;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2022QI;""
21 Huelva;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
21 Huelva;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
21 Huelva;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2021QII;4.789
21 Huelva;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2021QI;""
21 Huelva;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
21 Huelva;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
21 Huelva;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2020QII;4.777
21 Huelva;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2020QI;""
21 Huelva;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
21 Huelva;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2022QIII;4.513
21 Huelva;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2022QII;""
21 Huelva;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2022QI;""
21 Huelva;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
21 Huelva;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2021QIII;4.643
21 Huelva;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2021QII;""
21 Huelva;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2021QI;""
21 Huelva;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
21 Huelva;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2020QIII;4.615
21 Huelva;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2020QII;""
21 Huelva;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2020QI;""
21 Huelva;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QIV;4.336
21 Huelva;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
21 Huelva;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QII;""
21 Huelva;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QI;""
21 Huelva;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QIV;4.485
21 Huelva;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
21 Huelva;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QII;""
21 Huelva;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QI;""
21 Huelva;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QIV;4.475
21 Huelva;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
21 Huelva;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QII;""
21 Huelva;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QI;""
21 Huelva;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
21 Huelva;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
21 Huelva;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QII;""
21 Huelva;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QI;4.331
21 Huelva;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
21 Huelva;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
21 Huelva;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QII;""
21 Huelva;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QI;4.372
21 Huelva;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
21 Huelva;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
21 Huelva;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QII;""
21 Huelva;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QI;""
21 Huelva;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
21 Huelva;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
21 Huelva;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
21 Huelva;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
21 Huelva;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
21 Huelva;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
21 Huelva;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
21 Huelva;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
21 Huelva;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
21 Huelva;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
21 Huelva;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
21 Huelva;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
21 Huelva;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
21 Huelva;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
21 Huelva;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;95,12
21 Huelva;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
21 Huelva;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
21 Huelva;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
21 Huelva;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;96,09
21 Huelva;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
21 Huelva;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
21 Huelva;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
21 Huelva;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;97,33
21 Huelva;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
21 Huelva;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
21 Huelva;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;91,43
21 Huelva;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
21 Huelva;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
21 Huelva;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
21 Huelva;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;93,16
21 Huelva;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
21 Huelva;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
21 Huelva;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
21 Huelva;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;94,03
21 Huelva;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
21 Huelva;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
21 Huelva;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;87,84
21 Huelva;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
21 Huelva;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
21 Huelva;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
21 Huelva;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;89,99
21 Huelva;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
21 Huelva;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
21 Huelva;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
21 Huelva;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;91,18
21 Huelva;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
21 Huelva;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
21 Huelva;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
21 Huelva;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
21 Huelva;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
21 Huelva;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
21 Huelva;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;86,9
21 Huelva;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
21 Huelva;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
21 Huelva;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
21 Huelva;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;89,08
21 Huelva;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
21 Huelva;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
21 Huelva;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
21 Huelva;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
21 Huelva;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
21 Huelva;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
21 Huelva;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QII;2.914
21 Huelva;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
21 Huelva;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
21 Huelva;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
21 Huelva;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QII;2.960
21 Huelva;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
21 Huelva;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
21 Huelva;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
21 Huelva;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QII;2.932
21 Huelva;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
21 Huelva;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
21 Huelva;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
21 Huelva;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2022QII;2.788
21 Huelva;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2022QI;""
21 Huelva;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
21 Huelva;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
21 Huelva;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2021QII;2.852
21 Huelva;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2021QI;""
21 Huelva;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
21 Huelva;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
21 Huelva;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2020QII;2.861
21 Huelva;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2020QI;""
21 Huelva;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
21 Huelva;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2022QIII;2.684
21 Huelva;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2022QII;""
21 Huelva;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2022QI;""
21 Huelva;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
21 Huelva;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2021QIII;2.780
21 Huelva;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2021QII;""
21 Huelva;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2021QI;""
21 Huelva;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
21 Huelva;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2020QIII;2.776
21 Huelva;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2020QII;""
21 Huelva;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2020QI;""
21 Huelva;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QIV;2.596
21 Huelva;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
21 Huelva;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QII;""
21 Huelva;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QI;""
21 Huelva;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QIV;2.695
21 Huelva;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
21 Huelva;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QII;""
21 Huelva;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QI;""
21 Huelva;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QIV;2.698
21 Huelva;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
21 Huelva;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QII;""
21 Huelva;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QI;""
21 Huelva;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
21 Huelva;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
21 Huelva;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QII;""
21 Huelva;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QI;2.609
21 Huelva;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
21 Huelva;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
21 Huelva;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QII;""
21 Huelva;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QI;2.644
21 Huelva;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
21 Huelva;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
21 Huelva;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QII;""
21 Huelva;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QI;""
21 Huelva;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
21 Huelva;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
21 Huelva;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
21 Huelva;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
21 Huelva;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
21 Huelva;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
21 Huelva;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
21 Huelva;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
21 Huelva;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
21 Huelva;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
21 Huelva;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
21 Huelva;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
21 Huelva;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
21 Huelva;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
21 Huelva;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;95,68
21 Huelva;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
21 Huelva;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
21 Huelva;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
21 Huelva;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;96,35
21 Huelva;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
21 Huelva;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
21 Huelva;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
21 Huelva;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;97,58
21 Huelva;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
21 Huelva;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
21 Huelva;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;92,11
21 Huelva;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
21 Huelva;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
21 Huelva;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
21 Huelva;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;93,92
21 Huelva;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
21 Huelva;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
21 Huelva;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
21 Huelva;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;94,68
21 Huelva;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
21 Huelva;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
21 Huelva;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;89,09
21 Huelva;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
21 Huelva;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
21 Huelva;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
21 Huelva;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;91,05
21 Huelva;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
21 Huelva;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
21 Huelva;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
21 Huelva;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;92,02
21 Huelva;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
21 Huelva;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
21 Huelva;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
21 Huelva;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
21 Huelva;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
21 Huelva;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
21 Huelva;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;88,14
21 Huelva;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
21 Huelva;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
21 Huelva;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
21 Huelva;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;90,18
21 Huelva;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
21 Huelva;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
21 Huelva;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
21 Huelva;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
21 Huelva;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
21 Huelva;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
21 Huelva;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QII;2.022
21 Huelva;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
21 Huelva;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
21 Huelva;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
21 Huelva;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QII;2.024
21 Huelva;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
21 Huelva;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
21 Huelva;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
21 Huelva;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QII;1.976
21 Huelva;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
21 Huelva;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
21 Huelva;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
21 Huelva;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2022QII;1.907
21 Huelva;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2022QI;""
21 Huelva;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
21 Huelva;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
21 Huelva;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2021QII;1.937
21 Huelva;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2021QI;""
21 Huelva;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
21 Huelva;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
21 Huelva;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2020QII;1.916
21 Huelva;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2020QI;""
21 Huelva;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
21 Huelva;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2022QIII;1.829
21 Huelva;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2022QII;""
21 Huelva;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2022QI;""
21 Huelva;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
21 Huelva;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2021QIII;1.863
21 Huelva;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2021QII;""
21 Huelva;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2021QI;""
21 Huelva;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
21 Huelva;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2020QIII;1.839
21 Huelva;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2020QII;""
21 Huelva;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2020QI;""
21 Huelva;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QIV;1.740
21 Huelva;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
21 Huelva;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QII;""
21 Huelva;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QI;""
21 Huelva;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QIV;1.790
21 Huelva;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
21 Huelva;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QII;""
21 Huelva;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QI;""
21 Huelva;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QIV;1.777
21 Huelva;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
21 Huelva;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QII;""
21 Huelva;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QI;""
21 Huelva;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
21 Huelva;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
21 Huelva;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QII;""
21 Huelva;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QI;1.722
21 Huelva;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
21 Huelva;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
21 Huelva;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QII;""
21 Huelva;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QI;1.728
21 Huelva;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
21 Huelva;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
21 Huelva;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QII;""
21 Huelva;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QI;""
21 Huelva;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
21 Huelva;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
21 Huelva;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
21 Huelva;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
21 Huelva;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
21 Huelva;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
21 Huelva;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
21 Huelva;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
21 Huelva;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
21 Huelva;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
21 Huelva;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
21 Huelva;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
21 Huelva;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
21 Huelva;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
21 Huelva;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;94,31
21 Huelva;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
21 Huelva;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
21 Huelva;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
21 Huelva;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;95,7
21 Huelva;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
21 Huelva;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
21 Huelva;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
21 Huelva;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;96,96
21 Huelva;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
21 Huelva;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
21 Huelva;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;90,45
21 Huelva;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
21 Huelva;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
21 Huelva;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
21 Huelva;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;92,05
21 Huelva;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
21 Huelva;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
21 Huelva;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
21 Huelva;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;93,07
21 Huelva;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
21 Huelva;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
21 Huelva;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;86,05
21 Huelva;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
21 Huelva;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
21 Huelva;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
21 Huelva;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;88,44
21 Huelva;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
21 Huelva;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
21 Huelva;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
21 Huelva;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;89,93
21 Huelva;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
21 Huelva;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
21 Huelva;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
21 Huelva;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
21 Huelva;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
21 Huelva;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
21 Huelva;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;85,08
21 Huelva;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
21 Huelva;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
21 Huelva;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
21 Huelva;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;87,45
21 Huelva;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
21 Huelva;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
21 Huelva;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
21 Huelva;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
21 Huelva;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
21 Huelva;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QIII;5.017
21 Huelva;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
21 Huelva;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
21 Huelva;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
21 Huelva;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QIII;5.135
21 Huelva;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
21 Huelva;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
21 Huelva;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
21 Huelva;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QIII;5.079
21 Huelva;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
21 Huelva;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
21 Huelva;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
21 Huelva;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2022QIII;4.773
21 Huelva;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2022QII;""
21 Huelva;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2022QI;""
21 Huelva;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
21 Huelva;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2021QIII;4.930
21 Huelva;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2021QII;""
21 Huelva;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2021QI;""
21 Huelva;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
21 Huelva;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2020QIII;4.874
21 Huelva;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2020QII;""
21 Huelva;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2020QI;""
21 Huelva;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2022QIV;4.566
21 Huelva;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
21 Huelva;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2022QII;""
21 Huelva;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2022QI;""
21 Huelva;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2021QIV;4.748
21 Huelva;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
21 Huelva;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2021QII;""
21 Huelva;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2021QI;""
21 Huelva;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2020QIV;4.696
21 Huelva;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
21 Huelva;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2020QII;""
21 Huelva;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2020QI;""
21 Huelva;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
21 Huelva;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
21 Huelva;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QII;""
21 Huelva;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QI;4.583
21 Huelva;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
21 Huelva;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
21 Huelva;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QII;""
21 Huelva;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QI;4.584
21 Huelva;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
21 Huelva;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
21 Huelva;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QII;""
21 Huelva;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QI;""
21 Huelva;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
21 Huelva;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
21 Huelva;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QII;4.413
21 Huelva;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QI;""
21 Huelva;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
21 Huelva;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
21 Huelva;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QII;4.459
21 Huelva;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QI;""
21 Huelva;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
21 Huelva;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
21 Huelva;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QII;""
21 Huelva;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QI;""
21 Huelva;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
21 Huelva;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
21 Huelva;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
21 Huelva;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
21 Huelva;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
21 Huelva;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
21 Huelva;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
21 Huelva;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
21 Huelva;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
21 Huelva;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
21 Huelva;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
21 Huelva;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
21 Huelva;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
21 Huelva;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;95,14
21 Huelva;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
21 Huelva;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
21 Huelva;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
21 Huelva;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;96,01
21 Huelva;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
21 Huelva;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
21 Huelva;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
21 Huelva;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;95,96
21 Huelva;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
21 Huelva;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
21 Huelva;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;91,01
21 Huelva;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
21 Huelva;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
21 Huelva;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
21 Huelva;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;92,46
21 Huelva;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
21 Huelva;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
21 Huelva;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
21 Huelva;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;92,46
21 Huelva;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
21 Huelva;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
21 Huelva;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
21 Huelva;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
21 Huelva;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
21 Huelva;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
21 Huelva;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;89,25
21 Huelva;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
21 Huelva;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
21 Huelva;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
21 Huelva;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;90,25
21 Huelva;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
21 Huelva;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
21 Huelva;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
21 Huelva;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
21 Huelva;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
21 Huelva;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
21 Huelva;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;85,94
21 Huelva;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
21 Huelva;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
21 Huelva;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
21 Huelva;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;87,79
21 Huelva;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
21 Huelva;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
21 Huelva;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
21 Huelva;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
21 Huelva;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
21 Huelva;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
21 Huelva;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QIII;2.972
21 Huelva;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
21 Huelva;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
21 Huelva;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
21 Huelva;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QIII;3.042
21 Huelva;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
21 Huelva;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
21 Huelva;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
21 Huelva;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QIII;3.044
21 Huelva;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
21 Huelva;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
21 Huelva;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
21 Huelva;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2022QIII;2.836
21 Huelva;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2022QII;""
21 Huelva;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2022QI;""
21 Huelva;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
21 Huelva;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2021QIII;2.939
21 Huelva;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2021QII;""
21 Huelva;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2021QI;""
21 Huelva;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
21 Huelva;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2020QIII;2.932
21 Huelva;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2020QII;""
21 Huelva;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2020QI;""
21 Huelva;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2022QIV;2.731
21 Huelva;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
21 Huelva;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2022QII;""
21 Huelva;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2022QI;""
21 Huelva;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2021QIV;2.841
21 Huelva;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
21 Huelva;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2021QII;""
21 Huelva;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2021QI;""
21 Huelva;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2020QIV;2.830
21 Huelva;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
21 Huelva;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2020QII;""
21 Huelva;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2020QI;""
21 Huelva;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
21 Huelva;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
21 Huelva;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QII;""
21 Huelva;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QI;2.748
21 Huelva;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
21 Huelva;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
21 Huelva;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QII;""
21 Huelva;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QI;2.770
21 Huelva;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
21 Huelva;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
21 Huelva;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QII;""
21 Huelva;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QI;""
21 Huelva;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
21 Huelva;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
21 Huelva;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QII;2.661
21 Huelva;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QI;""
21 Huelva;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
21 Huelva;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
21 Huelva;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QII;2.701
21 Huelva;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QI;""
21 Huelva;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
21 Huelva;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
21 Huelva;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QII;""
21 Huelva;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QI;""
21 Huelva;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
21 Huelva;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
21 Huelva;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
21 Huelva;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
21 Huelva;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
21 Huelva;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
21 Huelva;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
21 Huelva;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
21 Huelva;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
21 Huelva;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
21 Huelva;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
21 Huelva;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
21 Huelva;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
21 Huelva;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;95,42
21 Huelva;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
21 Huelva;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
21 Huelva;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
21 Huelva;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;96,61
21 Huelva;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
21 Huelva;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
21 Huelva;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
21 Huelva;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;96,32
21 Huelva;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
21 Huelva;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
21 Huelva;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;91,89
21 Huelva;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
21 Huelva;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
21 Huelva;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
21 Huelva;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;93,39
21 Huelva;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
21 Huelva;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
21 Huelva;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
21 Huelva;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;92,97
21 Huelva;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
21 Huelva;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
21 Huelva;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
21 Huelva;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
21 Huelva;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
21 Huelva;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
21 Huelva;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;90,34
21 Huelva;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
21 Huelva;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
21 Huelva;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
21 Huelva;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;91
21 Huelva;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
21 Huelva;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
21 Huelva;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
21 Huelva;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
21 Huelva;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
21 Huelva;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
21 Huelva;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;87,48
21 Huelva;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
21 Huelva;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
21 Huelva;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
21 Huelva;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;88,73
21 Huelva;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
21 Huelva;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
21 Huelva;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
21 Huelva;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
21 Huelva;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
21 Huelva;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
21 Huelva;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QIII;2.045
21 Huelva;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
21 Huelva;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
21 Huelva;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
21 Huelva;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QIII;2.093
21 Huelva;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
21 Huelva;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
21 Huelva;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
21 Huelva;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QIII;2.035
21 Huelva;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
21 Huelva;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
21 Huelva;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
21 Huelva;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2022QIII;1.937
21 Huelva;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2022QII;""
21 Huelva;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2022QI;""
21 Huelva;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
21 Huelva;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2021QIII;1.991
21 Huelva;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2021QII;""
21 Huelva;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2021QI;""
21 Huelva;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
21 Huelva;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2020QIII;1.942
21 Huelva;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2020QII;""
21 Huelva;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2020QI;""
21 Huelva;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2022QIV;1.835
21 Huelva;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
21 Huelva;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2022QII;""
21 Huelva;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2022QI;""
21 Huelva;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2021QIV;1.907
21 Huelva;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
21 Huelva;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2021QII;""
21 Huelva;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2021QI;""
21 Huelva;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2020QIV;1.866
21 Huelva;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
21 Huelva;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2020QII;""
21 Huelva;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2020QI;""
21 Huelva;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
21 Huelva;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
21 Huelva;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QII;""
21 Huelva;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QI;1.835
21 Huelva;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
21 Huelva;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
21 Huelva;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QII;""
21 Huelva;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QI;1.814
21 Huelva;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
21 Huelva;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
21 Huelva;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QII;""
21 Huelva;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QI;""
21 Huelva;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
21 Huelva;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
21 Huelva;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QII;1.752
21 Huelva;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QI;""
21 Huelva;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
21 Huelva;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
21 Huelva;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QII;1.758
21 Huelva;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QI;""
21 Huelva;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
21 Huelva;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
21 Huelva;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QII;""
21 Huelva;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QI;""
21 Huelva;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
21 Huelva;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
21 Huelva;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
21 Huelva;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
21 Huelva;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
21 Huelva;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
21 Huelva;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
21 Huelva;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
21 Huelva;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
21 Huelva;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
21 Huelva;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
21 Huelva;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
21 Huelva;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
21 Huelva;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;94,72
21 Huelva;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
21 Huelva;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
21 Huelva;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
21 Huelva;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;95,13
21 Huelva;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
21 Huelva;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
21 Huelva;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
21 Huelva;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;95,43
21 Huelva;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
21 Huelva;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
21 Huelva;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;89,73
21 Huelva;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
21 Huelva;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
21 Huelva;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
21 Huelva;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;91,11
21 Huelva;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
21 Huelva;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
21 Huelva;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
21 Huelva;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;91,7
21 Huelva;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
21 Huelva;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
21 Huelva;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
21 Huelva;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
21 Huelva;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
21 Huelva;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
21 Huelva;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;87,67
21 Huelva;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
21 Huelva;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
21 Huelva;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
21 Huelva;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;89,14
21 Huelva;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
21 Huelva;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
21 Huelva;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
21 Huelva;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
21 Huelva;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
21 Huelva;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
21 Huelva;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;83,71
21 Huelva;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
21 Huelva;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
21 Huelva;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
21 Huelva;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;86,39
21 Huelva;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
21 Huelva;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
21 Huelva;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
21 Huelva;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
21 Huelva;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
21 Huelva;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QIV;5.023
21 Huelva;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
21 Huelva;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
21 Huelva;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
21 Huelva;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QIV;5.167
21 Huelva;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
21 Huelva;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
21 Huelva;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
21 Huelva;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QIV;5.159
21 Huelva;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
21 Huelva;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
21 Huelva;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
21 Huelva;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2022QIV;4.792
21 Huelva;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
21 Huelva;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2022QII;""
21 Huelva;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2022QI;""
21 Huelva;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2021QIV;4.955
21 Huelva;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
21 Huelva;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2021QII;""
21 Huelva;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2021QI;""
21 Huelva;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2020QIV;4.942
21 Huelva;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
21 Huelva;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2020QII;""
21 Huelva;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2020QI;""
21 Huelva;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
21 Huelva;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
21 Huelva;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2022QII;""
21 Huelva;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2022QI;4.781
21 Huelva;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
21 Huelva;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
21 Huelva;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2021QII;""
21 Huelva;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2021QI;4.806
21 Huelva;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
21 Huelva;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
21 Huelva;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2020QII;""
21 Huelva;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2020QI;""
21 Huelva;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
21 Huelva;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
21 Huelva;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QII;4.600
21 Huelva;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QI;""
21 Huelva;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
21 Huelva;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
21 Huelva;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QII;4.662
21 Huelva;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QI;""
21 Huelva;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
21 Huelva;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
21 Huelva;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QII;""
21 Huelva;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QI;""
21 Huelva;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
21 Huelva;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QIII;4.439
21 Huelva;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QII;""
21 Huelva;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QI;""
21 Huelva;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
21 Huelva;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QIII;4.549
21 Huelva;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QII;""
21 Huelva;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QI;""
21 Huelva;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
21 Huelva;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
21 Huelva;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QII;""
21 Huelva;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QI;""
21 Huelva;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
21 Huelva;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
21 Huelva;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
21 Huelva;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
21 Huelva;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
21 Huelva;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
21 Huelva;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
21 Huelva;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
21 Huelva;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
21 Huelva;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
21 Huelva;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
21 Huelva;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
21 Huelva;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;95,4
21 Huelva;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
21 Huelva;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
21 Huelva;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
21 Huelva;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;95,9
21 Huelva;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
21 Huelva;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
21 Huelva;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
21 Huelva;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;95,79
21 Huelva;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
21 Huelva;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
21 Huelva;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
21 Huelva;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
21 Huelva;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
21 Huelva;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
21 Huelva;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;92,53
21 Huelva;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
21 Huelva;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
21 Huelva;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
21 Huelva;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;93,16
21 Huelva;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
21 Huelva;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
21 Huelva;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
21 Huelva;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
21 Huelva;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
21 Huelva;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
21 Huelva;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;89,03
21 Huelva;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
21 Huelva;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
21 Huelva;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
21 Huelva;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;90,37
21 Huelva;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
21 Huelva;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
21 Huelva;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
21 Huelva;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
21 Huelva;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
21 Huelva;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
21 Huelva;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;85,91
21 Huelva;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
21 Huelva;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
21 Huelva;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
21 Huelva;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;88,18
21 Huelva;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
21 Huelva;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
21 Huelva;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
21 Huelva;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
21 Huelva;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
21 Huelva;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
21 Huelva;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QIV;2.973
21 Huelva;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
21 Huelva;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
21 Huelva;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
21 Huelva;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QIV;3.060
21 Huelva;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
21 Huelva;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
21 Huelva;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
21 Huelva;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QIV;3.097
21 Huelva;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
21 Huelva;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
21 Huelva;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
21 Huelva;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2022QIV;2.856
21 Huelva;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
21 Huelva;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2022QII;""
21 Huelva;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2022QI;""
21 Huelva;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2021QIV;2.946
21 Huelva;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
21 Huelva;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2021QII;""
21 Huelva;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2021QI;""
21 Huelva;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2020QIV;2.970
21 Huelva;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
21 Huelva;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2020QII;""
21 Huelva;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2020QI;""
21 Huelva;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
21 Huelva;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
21 Huelva;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2022QII;""
21 Huelva;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2022QI;2.850
21 Huelva;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
21 Huelva;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
21 Huelva;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2021QII;""
21 Huelva;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2021QI;2.896
21 Huelva;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
21 Huelva;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
21 Huelva;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2020QII;""
21 Huelva;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2020QI;""
21 Huelva;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
21 Huelva;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
21 Huelva;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QII;2.761
21 Huelva;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QI;""
21 Huelva;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
21 Huelva;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
21 Huelva;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QII;2.814
21 Huelva;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QI;""
21 Huelva;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
21 Huelva;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
21 Huelva;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QII;""
21 Huelva;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QI;""
21 Huelva;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
21 Huelva;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QIII;2.671
21 Huelva;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QII;""
21 Huelva;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QI;""
21 Huelva;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
21 Huelva;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QIII;2.759
21 Huelva;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QII;""
21 Huelva;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QI;""
21 Huelva;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
21 Huelva;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
21 Huelva;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QII;""
21 Huelva;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QI;""
21 Huelva;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
21 Huelva;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
21 Huelva;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
21 Huelva;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
21 Huelva;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
21 Huelva;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
21 Huelva;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
21 Huelva;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
21 Huelva;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
21 Huelva;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
21 Huelva;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
21 Huelva;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
21 Huelva;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;96,06
21 Huelva;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
21 Huelva;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
21 Huelva;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
21 Huelva;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;96,27
21 Huelva;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
21 Huelva;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
21 Huelva;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
21 Huelva;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;95,9
21 Huelva;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
21 Huelva;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
21 Huelva;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
21 Huelva;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
21 Huelva;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
21 Huelva;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
21 Huelva;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;93,14
21 Huelva;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
21 Huelva;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
21 Huelva;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
21 Huelva;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;93,51
21 Huelva;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
21 Huelva;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
21 Huelva;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
21 Huelva;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
21 Huelva;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
21 Huelva;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
21 Huelva;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;90,23
21 Huelva;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
21 Huelva;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
21 Huelva;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
21 Huelva;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;90,86
21 Huelva;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
21 Huelva;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
21 Huelva;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
21 Huelva;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
21 Huelva;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
21 Huelva;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
21 Huelva;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;87,29
21 Huelva;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
21 Huelva;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
21 Huelva;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
21 Huelva;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;89,09
21 Huelva;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
21 Huelva;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
21 Huelva;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
21 Huelva;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
21 Huelva;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
21 Huelva;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
21 Huelva;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QIV;2.050
21 Huelva;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
21 Huelva;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
21 Huelva;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
21 Huelva;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QIV;2.107
21 Huelva;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
21 Huelva;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
21 Huelva;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
21 Huelva;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QIV;2.062
21 Huelva;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
21 Huelva;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
21 Huelva;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
21 Huelva;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2022QIV;1.936
21 Huelva;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
21 Huelva;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2022QII;""
21 Huelva;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2022QI;""
21 Huelva;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2021QIV;2.009
21 Huelva;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
21 Huelva;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2021QII;""
21 Huelva;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2021QI;""
21 Huelva;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2020QIV;1.972
21 Huelva;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
21 Huelva;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2020QII;""
21 Huelva;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2020QI;""
21 Huelva;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
21 Huelva;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
21 Huelva;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2022QII;""
21 Huelva;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2022QI;1.931
21 Huelva;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
21 Huelva;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
21 Huelva;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2021QII;""
21 Huelva;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2021QI;1.910
21 Huelva;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
21 Huelva;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
21 Huelva;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2020QII;""
21 Huelva;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2020QI;""
21 Huelva;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
21 Huelva;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
21 Huelva;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QII;1.839
21 Huelva;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QI;""
21 Huelva;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
21 Huelva;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
21 Huelva;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QII;1.848
21 Huelva;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QI;""
21 Huelva;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
21 Huelva;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
21 Huelva;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QII;""
21 Huelva;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QI;""
21 Huelva;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
21 Huelva;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QIII;1.768
21 Huelva;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QII;""
21 Huelva;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QI;""
21 Huelva;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
21 Huelva;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QIII;1.790
21 Huelva;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QII;""
21 Huelva;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QI;""
21 Huelva;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
21 Huelva;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
21 Huelva;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QII;""
21 Huelva;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QI;""
21 Huelva;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
21 Huelva;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
21 Huelva;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
21 Huelva;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
21 Huelva;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
21 Huelva;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
21 Huelva;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
21 Huelva;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
21 Huelva;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
21 Huelva;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
21 Huelva;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
21 Huelva;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
21 Huelva;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;94,44
21 Huelva;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
21 Huelva;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
21 Huelva;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
21 Huelva;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;95,35
21 Huelva;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
21 Huelva;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
21 Huelva;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
21 Huelva;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;95,64
21 Huelva;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
21 Huelva;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
21 Huelva;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
21 Huelva;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
21 Huelva;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
21 Huelva;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
21 Huelva;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;91,65
21 Huelva;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
21 Huelva;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
21 Huelva;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
21 Huelva;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;92,63
21 Huelva;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
21 Huelva;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
21 Huelva;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
21 Huelva;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
21 Huelva;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
21 Huelva;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
21 Huelva;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;87,28
21 Huelva;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
21 Huelva;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
21 Huelva;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
21 Huelva;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;89,62
21 Huelva;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
21 Huelva;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
21 Huelva;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
21 Huelva;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
21 Huelva;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
21 Huelva;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
21 Huelva;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;83,91
21 Huelva;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
21 Huelva;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
21 Huelva;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
21 Huelva;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;86,81
21 Huelva;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
21 Huelva;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
21 Huelva;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
21 Huelva;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
21 Huelva;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
21 Huelva;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
21 Huelva;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
21 Huelva;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
21 Huelva;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
21 Huelva;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QI;8.259
21 Huelva;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
21 Huelva;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
21 Huelva;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
21 Huelva;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QI;8.147
21 Huelva;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
21 Huelva;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
21 Huelva;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
21 Huelva;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QI;8.164
21 Huelva;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
21 Huelva;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
21 Huelva;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2022QII;""
21 Huelva;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2022QI;8.056
21 Huelva;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
21 Huelva;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
21 Huelva;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2021QII;""
21 Huelva;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2021QI;7.969
21 Huelva;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
21 Huelva;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
21 Huelva;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2020QII;""
21 Huelva;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2020QI;7.566
21 Huelva;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
21 Huelva;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
21 Huelva;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2022QII;7.809
21 Huelva;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2022QI;""
21 Huelva;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
21 Huelva;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
21 Huelva;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2021QII;7.765
21 Huelva;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2021QI;""
21 Huelva;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
21 Huelva;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
21 Huelva;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2020QII;7.437
21 Huelva;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2020QI;""
21 Huelva;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
21 Huelva;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QIII;7.618
21 Huelva;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QII;""
21 Huelva;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QI;""
21 Huelva;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
21 Huelva;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QIII;7.630
21 Huelva;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QII;""
21 Huelva;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QI;""
21 Huelva;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
21 Huelva;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QIII;7.268
21 Huelva;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QII;""
21 Huelva;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QI;""
21 Huelva;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QIV;7.417
21 Huelva;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
21 Huelva;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QII;""
21 Huelva;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QI;""
21 Huelva;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QIV;7.450
21 Huelva;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
21 Huelva;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QII;""
21 Huelva;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QI;""
21 Huelva;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QIV;7.103
21 Huelva;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
21 Huelva;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QII;""
21 Huelva;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QI;""
21 Huelva;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
21 Huelva;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
21 Huelva;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
21 Huelva;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
21 Huelva;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
21 Huelva;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
21 Huelva;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
21 Huelva;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
21 Huelva;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
21 Huelva;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
21 Huelva;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
21 Huelva;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
21 Huelva;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
21 Huelva;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
21 Huelva;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
21 Huelva;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;97,54
21 Huelva;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
21 Huelva;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
21 Huelva;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
21 Huelva;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;97,82
21 Huelva;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
21 Huelva;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
21 Huelva;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
21 Huelva;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;92,68
21 Huelva;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
21 Huelva;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
21 Huelva;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;94,55
21 Huelva;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
21 Huelva;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
21 Huelva;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
21 Huelva;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;95,31
21 Huelva;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
21 Huelva;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
21 Huelva;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
21 Huelva;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;91,1
21 Huelva;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
21 Huelva;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
21 Huelva;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;92,24
21 Huelva;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
21 Huelva;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
21 Huelva;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
21 Huelva;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;93,65
21 Huelva;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
21 Huelva;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
21 Huelva;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
21 Huelva;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;89,02
21 Huelva;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
21 Huelva;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
21 Huelva;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;89,81
21 Huelva;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
21 Huelva;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
21 Huelva;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
21 Huelva;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;91,44
21 Huelva;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
21 Huelva;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
21 Huelva;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
21 Huelva;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;87
21 Huelva;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
21 Huelva;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
21 Huelva;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
21 Huelva;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
21 Huelva;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
21 Huelva;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
21 Huelva;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QI;5.346
21 Huelva;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
21 Huelva;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
21 Huelva;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
21 Huelva;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QI;5.299
21 Huelva;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
21 Huelva;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
21 Huelva;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
21 Huelva;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QI;5.323
21 Huelva;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
21 Huelva;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
21 Huelva;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2022QII;""
21 Huelva;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2022QI;5.223
21 Huelva;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
21 Huelva;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
21 Huelva;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2021QII;""
21 Huelva;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2021QI;5.191
21 Huelva;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
21 Huelva;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
21 Huelva;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2020QII;""
21 Huelva;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2020QI;4.958
21 Huelva;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
21 Huelva;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
21 Huelva;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2022QII;5.089
21 Huelva;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2022QI;""
21 Huelva;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
21 Huelva;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
21 Huelva;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2021QII;5.069
21 Huelva;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2021QI;""
21 Huelva;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
21 Huelva;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
21 Huelva;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2020QII;4.877
21 Huelva;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2020QI;""
21 Huelva;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
21 Huelva;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QIII;4.981
21 Huelva;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QII;""
21 Huelva;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QI;""
21 Huelva;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
21 Huelva;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QIII;4.999
21 Huelva;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QII;""
21 Huelva;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QI;""
21 Huelva;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
21 Huelva;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QIII;4.781
21 Huelva;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QII;""
21 Huelva;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QI;""
21 Huelva;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QIV;4.870
21 Huelva;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
21 Huelva;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QII;""
21 Huelva;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QI;""
21 Huelva;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QIV;4.897
21 Huelva;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
21 Huelva;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QII;""
21 Huelva;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QI;""
21 Huelva;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QIV;4.687
21 Huelva;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
21 Huelva;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QII;""
21 Huelva;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QI;""
21 Huelva;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
21 Huelva;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
21 Huelva;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
21 Huelva;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
21 Huelva;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
21 Huelva;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
21 Huelva;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
21 Huelva;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
21 Huelva;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
21 Huelva;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
21 Huelva;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
21 Huelva;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
21 Huelva;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
21 Huelva;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
21 Huelva;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
21 Huelva;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;97,7
21 Huelva;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
21 Huelva;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
21 Huelva;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
21 Huelva;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;97,96
21 Huelva;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
21 Huelva;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
21 Huelva;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
21 Huelva;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;93,14
21 Huelva;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
21 Huelva;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
21 Huelva;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;95,19
21 Huelva;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
21 Huelva;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
21 Huelva;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
21 Huelva;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;95,66
21 Huelva;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
21 Huelva;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
21 Huelva;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
21 Huelva;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;91,62
21 Huelva;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
21 Huelva;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
21 Huelva;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;93,17
21 Huelva;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
21 Huelva;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
21 Huelva;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
21 Huelva;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;94,34
21 Huelva;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
21 Huelva;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
21 Huelva;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
21 Huelva;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;89,82
21 Huelva;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
21 Huelva;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
21 Huelva;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;91,1
21 Huelva;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
21 Huelva;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
21 Huelva;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
21 Huelva;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;92,41
21 Huelva;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
21 Huelva;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
21 Huelva;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
21 Huelva;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;88,05
21 Huelva;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
21 Huelva;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
21 Huelva;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
21 Huelva;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
21 Huelva;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
21 Huelva;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
21 Huelva;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QI;2.913
21 Huelva;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
21 Huelva;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
21 Huelva;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
21 Huelva;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QI;2.848
21 Huelva;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
21 Huelva;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
21 Huelva;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
21 Huelva;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QI;2.841
21 Huelva;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
21 Huelva;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
21 Huelva;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2022QII;""
21 Huelva;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2022QI;2.833
21 Huelva;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
21 Huelva;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
21 Huelva;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2021QII;""
21 Huelva;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2021QI;2.778
21 Huelva;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
21 Huelva;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
21 Huelva;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2020QII;""
21 Huelva;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2020QI;2.608
21 Huelva;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
21 Huelva;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
21 Huelva;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2022QII;2.720
21 Huelva;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2022QI;""
21 Huelva;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
21 Huelva;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
21 Huelva;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2021QII;2.696
21 Huelva;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2021QI;""
21 Huelva;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
21 Huelva;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
21 Huelva;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2020QII;2.560
21 Huelva;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2020QI;""
21 Huelva;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
21 Huelva;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QIII;2.637
21 Huelva;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QII;""
21 Huelva;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QI;""
21 Huelva;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
21 Huelva;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QIII;2.631
21 Huelva;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QII;""
21 Huelva;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QI;""
21 Huelva;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
21 Huelva;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QIII;2.487
21 Huelva;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QII;""
21 Huelva;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QI;""
21 Huelva;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QIV;2.547
21 Huelva;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
21 Huelva;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QII;""
21 Huelva;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QI;""
21 Huelva;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QIV;2.553
21 Huelva;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
21 Huelva;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QII;""
21 Huelva;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QI;""
21 Huelva;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QIV;2.416
21 Huelva;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
21 Huelva;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QII;""
21 Huelva;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QI;""
21 Huelva;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
21 Huelva;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
21 Huelva;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
21 Huelva;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
21 Huelva;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
21 Huelva;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
21 Huelva;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
21 Huelva;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
21 Huelva;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
21 Huelva;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
21 Huelva;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
21 Huelva;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
21 Huelva;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
21 Huelva;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
21 Huelva;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
21 Huelva;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;97,25
21 Huelva;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
21 Huelva;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
21 Huelva;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
21 Huelva;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;97,54
21 Huelva;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
21 Huelva;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
21 Huelva;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
21 Huelva;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;91,8
21 Huelva;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
21 Huelva;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
21 Huelva;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;93,37
21 Huelva;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
21 Huelva;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
21 Huelva;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
21 Huelva;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;94,66
21 Huelva;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
21 Huelva;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
21 Huelva;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
21 Huelva;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;90,11
21 Huelva;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
21 Huelva;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
21 Huelva;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;90,53
21 Huelva;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
21 Huelva;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
21 Huelva;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
21 Huelva;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;92,38
21 Huelva;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
21 Huelva;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
21 Huelva;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
21 Huelva;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;87,54
21 Huelva;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
21 Huelva;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
21 Huelva;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;87,44
21 Huelva;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
21 Huelva;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
21 Huelva;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
21 Huelva;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;89,64
21 Huelva;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
21 Huelva;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
21 Huelva;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
21 Huelva;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;85,04
21 Huelva;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
21 Huelva;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
21 Huelva;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
21 Huelva;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
21 Huelva;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
21 Huelva;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QII;8.263
21 Huelva;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
21 Huelva;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
21 Huelva;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
21 Huelva;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QII;8.118
21 Huelva;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
21 Huelva;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
21 Huelva;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
21 Huelva;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QII;7.941
21 Huelva;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
21 Huelva;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
21 Huelva;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
21 Huelva;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2022QII;7.970
21 Huelva;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2022QI;""
21 Huelva;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
21 Huelva;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
21 Huelva;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2021QII;7.888
21 Huelva;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2021QI;""
21 Huelva;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
21 Huelva;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
21 Huelva;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2020QII;7.797
21 Huelva;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2020QI;""
21 Huelva;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
21 Huelva;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2022QIII;7.741
21 Huelva;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2022QII;""
21 Huelva;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2022QI;""
21 Huelva;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
21 Huelva;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2021QIII;7.729
21 Huelva;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2021QII;""
21 Huelva;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2021QI;""
21 Huelva;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
21 Huelva;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2020QIII;7.601
21 Huelva;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2020QII;""
21 Huelva;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2020QI;""
21 Huelva;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QIV;7.520
21 Huelva;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
21 Huelva;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QII;""
21 Huelva;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QI;""
21 Huelva;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QIV;7.521
21 Huelva;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
21 Huelva;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QII;""
21 Huelva;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QI;""
21 Huelva;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QIV;7.406
21 Huelva;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
21 Huelva;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QII;""
21 Huelva;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QI;""
21 Huelva;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
21 Huelva;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
21 Huelva;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QII;""
21 Huelva;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QI;7.378
21 Huelva;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
21 Huelva;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
21 Huelva;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QII;""
21 Huelva;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QI;7.280
21 Huelva;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
21 Huelva;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
21 Huelva;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QII;""
21 Huelva;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QI;""
21 Huelva;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
21 Huelva;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
21 Huelva;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
21 Huelva;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
21 Huelva;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
21 Huelva;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
21 Huelva;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
21 Huelva;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
21 Huelva;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
21 Huelva;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
21 Huelva;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
21 Huelva;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
21 Huelva;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
21 Huelva;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
21 Huelva;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;96,45
21 Huelva;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
21 Huelva;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
21 Huelva;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
21 Huelva;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;97,17
21 Huelva;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
21 Huelva;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
21 Huelva;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
21 Huelva;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;98,19
21 Huelva;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
21 Huelva;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
21 Huelva;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;93,68
21 Huelva;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
21 Huelva;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
21 Huelva;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
21 Huelva;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;95,21
21 Huelva;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
21 Huelva;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
21 Huelva;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
21 Huelva;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;95,72
21 Huelva;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
21 Huelva;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
21 Huelva;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;91,01
21 Huelva;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
21 Huelva;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
21 Huelva;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
21 Huelva;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;92,65
21 Huelva;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
21 Huelva;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
21 Huelva;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
21 Huelva;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;93,26
21 Huelva;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
21 Huelva;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
21 Huelva;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
21 Huelva;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
21 Huelva;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
21 Huelva;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
21 Huelva;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;90,88
21 Huelva;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
21 Huelva;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
21 Huelva;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
21 Huelva;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;91,68
21 Huelva;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
21 Huelva;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
21 Huelva;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
21 Huelva;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
21 Huelva;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
21 Huelva;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
21 Huelva;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QII;5.261
21 Huelva;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
21 Huelva;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
21 Huelva;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
21 Huelva;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QII;5.272
21 Huelva;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
21 Huelva;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
21 Huelva;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
21 Huelva;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QII;5.189
21 Huelva;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
21 Huelva;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
21 Huelva;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
21 Huelva;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2022QII;5.102
21 Huelva;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2022QI;""
21 Huelva;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
21 Huelva;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
21 Huelva;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2021QII;5.130
21 Huelva;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2021QI;""
21 Huelva;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
21 Huelva;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
21 Huelva;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2020QII;5.099
21 Huelva;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2020QI;""
21 Huelva;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
21 Huelva;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2022QIII;4.975
21 Huelva;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2022QII;""
21 Huelva;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2022QI;""
21 Huelva;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
21 Huelva;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2021QIII;5.041
21 Huelva;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2021QII;""
21 Huelva;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2021QI;""
21 Huelva;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
21 Huelva;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2020QIII;4.988
21 Huelva;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2020QII;""
21 Huelva;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2020QI;""
21 Huelva;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QIV;4.847
21 Huelva;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
21 Huelva;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QII;""
21 Huelva;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QI;""
21 Huelva;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QIV;4.921
21 Huelva;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
21 Huelva;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QII;""
21 Huelva;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QI;""
21 Huelva;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QIV;4.874
21 Huelva;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
21 Huelva;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QII;""
21 Huelva;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QI;""
21 Huelva;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
21 Huelva;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
21 Huelva;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QII;""
21 Huelva;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QI;4.839
21 Huelva;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
21 Huelva;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
21 Huelva;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QII;""
21 Huelva;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QI;4.798
21 Huelva;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
21 Huelva;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
21 Huelva;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QII;""
21 Huelva;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QI;""
21 Huelva;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
21 Huelva;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
21 Huelva;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
21 Huelva;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
21 Huelva;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
21 Huelva;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
21 Huelva;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
21 Huelva;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
21 Huelva;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
21 Huelva;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
21 Huelva;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
21 Huelva;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
21 Huelva;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
21 Huelva;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
21 Huelva;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;96,98
21 Huelva;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
21 Huelva;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
21 Huelva;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
21 Huelva;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;97,31
21 Huelva;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
21 Huelva;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
21 Huelva;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
21 Huelva;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;98,27
21 Huelva;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
21 Huelva;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
21 Huelva;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;94,56
21 Huelva;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
21 Huelva;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
21 Huelva;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
21 Huelva;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;95,62
21 Huelva;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
21 Huelva;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
21 Huelva;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
21 Huelva;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;96,13
21 Huelva;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
21 Huelva;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
21 Huelva;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;92,13
21 Huelva;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
21 Huelva;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
21 Huelva;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
21 Huelva;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;93,34
21 Huelva;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
21 Huelva;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
21 Huelva;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
21 Huelva;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;93,93
21 Huelva;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
21 Huelva;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
21 Huelva;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
21 Huelva;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
21 Huelva;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
21 Huelva;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
21 Huelva;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;91,79
21 Huelva;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
21 Huelva;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
21 Huelva;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
21 Huelva;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;92,46
21 Huelva;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
21 Huelva;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
21 Huelva;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
21 Huelva;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
21 Huelva;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
21 Huelva;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
21 Huelva;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QII;3.002
21 Huelva;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
21 Huelva;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
21 Huelva;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
21 Huelva;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QII;2.846
21 Huelva;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
21 Huelva;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
21 Huelva;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
21 Huelva;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QII;2.752
21 Huelva;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
21 Huelva;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
21 Huelva;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
21 Huelva;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2022QII;2.868
21 Huelva;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2022QI;""
21 Huelva;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
21 Huelva;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
21 Huelva;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2021QII;2.758
21 Huelva;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2021QI;""
21 Huelva;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
21 Huelva;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
21 Huelva;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2020QII;2.698
21 Huelva;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2020QI;""
21 Huelva;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
21 Huelva;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2022QIII;2.766
21 Huelva;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2022QII;""
21 Huelva;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2022QI;""
21 Huelva;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
21 Huelva;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2021QIII;2.688
21 Huelva;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2021QII;""
21 Huelva;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2021QI;""
21 Huelva;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
21 Huelva;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2020QIII;2.613
21 Huelva;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2020QII;""
21 Huelva;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2020QI;""
21 Huelva;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QIV;2.673
21 Huelva;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
21 Huelva;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QII;""
21 Huelva;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QI;""
21 Huelva;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QIV;2.600
21 Huelva;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
21 Huelva;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QII;""
21 Huelva;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QI;""
21 Huelva;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QIV;2.532
21 Huelva;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
21 Huelva;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QII;""
21 Huelva;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QI;""
21 Huelva;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
21 Huelva;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
21 Huelva;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QII;""
21 Huelva;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QI;2.539
21 Huelva;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
21 Huelva;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
21 Huelva;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QII;""
21 Huelva;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QI;2.482
21 Huelva;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
21 Huelva;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
21 Huelva;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QII;""
21 Huelva;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QI;""
21 Huelva;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
21 Huelva;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
21 Huelva;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
21 Huelva;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
21 Huelva;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
21 Huelva;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
21 Huelva;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
21 Huelva;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
21 Huelva;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
21 Huelva;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
21 Huelva;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
21 Huelva;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
21 Huelva;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
21 Huelva;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
21 Huelva;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;95,54
21 Huelva;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
21 Huelva;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
21 Huelva;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
21 Huelva;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;96,91
21 Huelva;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
21 Huelva;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
21 Huelva;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
21 Huelva;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;98,04
21 Huelva;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
21 Huelva;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
21 Huelva;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;92,14
21 Huelva;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
21 Huelva;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
21 Huelva;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
21 Huelva;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;94,45
21 Huelva;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
21 Huelva;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
21 Huelva;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
21 Huelva;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;94,95
21 Huelva;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
21 Huelva;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
21 Huelva;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;89,04
21 Huelva;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
21 Huelva;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
21 Huelva;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
21 Huelva;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;91,36
21 Huelva;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
21 Huelva;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
21 Huelva;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
21 Huelva;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;92,01
21 Huelva;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
21 Huelva;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
21 Huelva;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
21 Huelva;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
21 Huelva;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
21 Huelva;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
21 Huelva;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;89,21
21 Huelva;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
21 Huelva;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
21 Huelva;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
21 Huelva;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;90,19
21 Huelva;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
21 Huelva;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
21 Huelva;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
21 Huelva;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
21 Huelva;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
21 Huelva;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QIII;8.311
21 Huelva;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
21 Huelva;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
21 Huelva;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
21 Huelva;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QIII;8.274
21 Huelva;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
21 Huelva;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
21 Huelva;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
21 Huelva;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QIII;8.202
21 Huelva;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
21 Huelva;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
21 Huelva;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
21 Huelva;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2022QIII;7.994
21 Huelva;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2022QII;""
21 Huelva;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2022QI;""
21 Huelva;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
21 Huelva;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2021QIII;8.029
21 Huelva;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2021QII;""
21 Huelva;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2021QI;""
21 Huelva;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
21 Huelva;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2020QIII;7.915
21 Huelva;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2020QII;""
21 Huelva;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2020QI;""
21 Huelva;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2022QIV;7.727
21 Huelva;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
21 Huelva;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2022QII;""
21 Huelva;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2022QI;""
21 Huelva;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2021QIV;7.779
21 Huelva;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
21 Huelva;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2021QII;""
21 Huelva;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2021QI;""
21 Huelva;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2020QIV;7.670
21 Huelva;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
21 Huelva;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2020QII;""
21 Huelva;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2020QI;""
21 Huelva;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
21 Huelva;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
21 Huelva;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QII;""
21 Huelva;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QI;7.614
21 Huelva;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
21 Huelva;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
21 Huelva;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QII;""
21 Huelva;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QI;7.531
21 Huelva;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
21 Huelva;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
21 Huelva;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QII;""
21 Huelva;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QI;""
21 Huelva;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
21 Huelva;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
21 Huelva;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QII;7.421
21 Huelva;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QI;""
21 Huelva;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
21 Huelva;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
21 Huelva;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QII;7.376
21 Huelva;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QI;""
21 Huelva;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
21 Huelva;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
21 Huelva;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QII;""
21 Huelva;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QI;""
21 Huelva;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
21 Huelva;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
21 Huelva;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
21 Huelva;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
21 Huelva;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
21 Huelva;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
21 Huelva;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
21 Huelva;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
21 Huelva;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
21 Huelva;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
21 Huelva;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
21 Huelva;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
21 Huelva;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
21 Huelva;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;96,19
21 Huelva;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
21 Huelva;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
21 Huelva;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
21 Huelva;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;97,04
21 Huelva;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
21 Huelva;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
21 Huelva;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
21 Huelva;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;96,5
21 Huelva;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
21 Huelva;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
21 Huelva;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;92,97
21 Huelva;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
21 Huelva;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
21 Huelva;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
21 Huelva;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;94,02
21 Huelva;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
21 Huelva;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
21 Huelva;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
21 Huelva;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;93,51
21 Huelva;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
21 Huelva;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
21 Huelva;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
21 Huelva;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
21 Huelva;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
21 Huelva;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
21 Huelva;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;92,02
21 Huelva;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
21 Huelva;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
21 Huelva;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
21 Huelva;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;91,82
21 Huelva;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
21 Huelva;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
21 Huelva;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
21 Huelva;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
21 Huelva;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
21 Huelva;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
21 Huelva;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;89,69
21 Huelva;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
21 Huelva;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
21 Huelva;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
21 Huelva;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;89,93
21 Huelva;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
21 Huelva;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
21 Huelva;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
21 Huelva;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
21 Huelva;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
21 Huelva;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
21 Huelva;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QIII;5.297
21 Huelva;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
21 Huelva;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
21 Huelva;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
21 Huelva;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QIII;5.357
21 Huelva;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
21 Huelva;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
21 Huelva;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
21 Huelva;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QIII;5.348
21 Huelva;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
21 Huelva;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
21 Huelva;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
21 Huelva;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2022QIII;5.120
21 Huelva;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2022QII;""
21 Huelva;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2022QI;""
21 Huelva;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
21 Huelva;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2021QIII;5.223
21 Huelva;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2021QII;""
21 Huelva;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2021QI;""
21 Huelva;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
21 Huelva;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2020QIII;5.177
21 Huelva;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2020QII;""
21 Huelva;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2020QI;""
21 Huelva;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2022QIV;4.965
21 Huelva;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
21 Huelva;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2022QII;""
21 Huelva;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2022QI;""
21 Huelva;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2021QIV;5.076
21 Huelva;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
21 Huelva;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2021QII;""
21 Huelva;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2021QI;""
21 Huelva;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2020QIV;5.029
21 Huelva;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
21 Huelva;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2020QII;""
21 Huelva;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2020QI;""
21 Huelva;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
21 Huelva;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
21 Huelva;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QII;""
21 Huelva;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QI;4.977
21 Huelva;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
21 Huelva;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
21 Huelva;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QII;""
21 Huelva;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QI;4.942
21 Huelva;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
21 Huelva;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
21 Huelva;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QII;""
21 Huelva;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QI;""
21 Huelva;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
21 Huelva;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
21 Huelva;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QII;4.868
21 Huelva;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QI;""
21 Huelva;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
21 Huelva;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
21 Huelva;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QII;4.844
21 Huelva;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QI;""
21 Huelva;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
21 Huelva;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
21 Huelva;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QII;""
21 Huelva;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QI;""
21 Huelva;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
21 Huelva;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
21 Huelva;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
21 Huelva;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
21 Huelva;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
21 Huelva;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
21 Huelva;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
21 Huelva;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
21 Huelva;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
21 Huelva;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
21 Huelva;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
21 Huelva;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
21 Huelva;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
21 Huelva;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;96,66
21 Huelva;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
21 Huelva;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
21 Huelva;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
21 Huelva;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;97,5
21 Huelva;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
21 Huelva;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
21 Huelva;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
21 Huelva;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;96,8
21 Huelva;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
21 Huelva;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
21 Huelva;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;93,73
21 Huelva;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
21 Huelva;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
21 Huelva;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
21 Huelva;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;94,75
21 Huelva;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
21 Huelva;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
21 Huelva;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
21 Huelva;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;94,04
21 Huelva;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
21 Huelva;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
21 Huelva;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
21 Huelva;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
21 Huelva;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
21 Huelva;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
21 Huelva;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;92,91
21 Huelva;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
21 Huelva;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
21 Huelva;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
21 Huelva;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;92,41
21 Huelva;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
21 Huelva;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
21 Huelva;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
21 Huelva;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
21 Huelva;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
21 Huelva;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
21 Huelva;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;90,87
21 Huelva;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
21 Huelva;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
21 Huelva;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
21 Huelva;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;90,58
21 Huelva;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
21 Huelva;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
21 Huelva;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
21 Huelva;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
21 Huelva;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
21 Huelva;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
21 Huelva;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QIII;3.014
21 Huelva;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
21 Huelva;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
21 Huelva;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
21 Huelva;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QIII;2.917
21 Huelva;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
21 Huelva;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
21 Huelva;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
21 Huelva;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QIII;2.854
21 Huelva;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
21 Huelva;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
21 Huelva;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
21 Huelva;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2022QIII;2.874
21 Huelva;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2022QII;""
21 Huelva;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2022QI;""
21 Huelva;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
21 Huelva;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2021QIII;2.806
21 Huelva;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2021QII;""
21 Huelva;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2021QI;""
21 Huelva;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
21 Huelva;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2020QIII;2.738
21 Huelva;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2020QII;""
21 Huelva;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2020QI;""
21 Huelva;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2022QIV;2.762
21 Huelva;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
21 Huelva;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2022QII;""
21 Huelva;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2022QI;""
21 Huelva;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2021QIV;2.703
21 Huelva;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
21 Huelva;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2021QII;""
21 Huelva;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2021QI;""
21 Huelva;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2020QIV;2.641
21 Huelva;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
21 Huelva;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2020QII;""
21 Huelva;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2020QI;""
21 Huelva;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
21 Huelva;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
21 Huelva;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QII;""
21 Huelva;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QI;2.637
21 Huelva;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
21 Huelva;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
21 Huelva;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QII;""
21 Huelva;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QI;2.589
21 Huelva;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
21 Huelva;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
21 Huelva;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QII;""
21 Huelva;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QI;""
21 Huelva;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
21 Huelva;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
21 Huelva;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QII;2.553
21 Huelva;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QI;""
21 Huelva;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
21 Huelva;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
21 Huelva;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QII;2.532
21 Huelva;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QI;""
21 Huelva;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
21 Huelva;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
21 Huelva;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QII;""
21 Huelva;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QI;""
21 Huelva;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
21 Huelva;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
21 Huelva;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
21 Huelva;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
21 Huelva;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
21 Huelva;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
21 Huelva;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
21 Huelva;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
21 Huelva;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
21 Huelva;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
21 Huelva;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
21 Huelva;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
21 Huelva;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
21 Huelva;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;95,36
21 Huelva;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
21 Huelva;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
21 Huelva;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
21 Huelva;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;96,19
21 Huelva;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
21 Huelva;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
21 Huelva;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
21 Huelva;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;95,94
21 Huelva;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
21 Huelva;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
21 Huelva;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;91,64
21 Huelva;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
21 Huelva;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
21 Huelva;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
21 Huelva;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;92,66
21 Huelva;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
21 Huelva;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
21 Huelva;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
21 Huelva;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;92,54
21 Huelva;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
21 Huelva;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
21 Huelva;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
21 Huelva;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
21 Huelva;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
21 Huelva;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
21 Huelva;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;90,4
21 Huelva;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
21 Huelva;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
21 Huelva;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
21 Huelva;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;90,71
21 Huelva;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
21 Huelva;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
21 Huelva;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
21 Huelva;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
21 Huelva;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
21 Huelva;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
21 Huelva;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;87,52
21 Huelva;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
21 Huelva;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
21 Huelva;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
21 Huelva;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;88,72
21 Huelva;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
21 Huelva;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
21 Huelva;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
21 Huelva;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
21 Huelva;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
21 Huelva;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QIV;8.248
21 Huelva;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
21 Huelva;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
21 Huelva;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
21 Huelva;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QIV;8.278
21 Huelva;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
21 Huelva;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
21 Huelva;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
21 Huelva;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QIV;8.166
21 Huelva;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
21 Huelva;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
21 Huelva;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
21 Huelva;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2022QIV;7.941
21 Huelva;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
21 Huelva;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2022QII;""
21 Huelva;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2022QI;""
21 Huelva;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2021QIV;7.994
21 Huelva;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
21 Huelva;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2021QII;""
21 Huelva;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2021QI;""
21 Huelva;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2020QIV;7.891
21 Huelva;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
21 Huelva;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2020QII;""
21 Huelva;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2020QI;""
21 Huelva;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
21 Huelva;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
21 Huelva;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2022QII;""
21 Huelva;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2022QI;7.817
21 Huelva;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
21 Huelva;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
21 Huelva;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2021QII;""
21 Huelva;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2021QI;7.738
21 Huelva;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
21 Huelva;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
21 Huelva;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2020QII;""
21 Huelva;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2020QI;""
21 Huelva;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
21 Huelva;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
21 Huelva;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QII;7.603
21 Huelva;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QI;""
21 Huelva;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
21 Huelva;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
21 Huelva;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QII;7.564
21 Huelva;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QI;""
21 Huelva;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
21 Huelva;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
21 Huelva;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QII;""
21 Huelva;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QI;""
21 Huelva;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
21 Huelva;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QIII;7.424
21 Huelva;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QII;""
21 Huelva;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QI;""
21 Huelva;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
21 Huelva;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QIII;7.438
21 Huelva;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QII;""
21 Huelva;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QI;""
21 Huelva;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
21 Huelva;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
21 Huelva;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QII;""
21 Huelva;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QI;""
21 Huelva;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
21 Huelva;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
21 Huelva;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
21 Huelva;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
21 Huelva;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
21 Huelva;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
21 Huelva;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
21 Huelva;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
21 Huelva;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
21 Huelva;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
21 Huelva;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
21 Huelva;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
21 Huelva;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;96,28
21 Huelva;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
21 Huelva;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
21 Huelva;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
21 Huelva;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;96,57
21 Huelva;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
21 Huelva;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
21 Huelva;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
21 Huelva;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;96,63
21 Huelva;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
21 Huelva;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
21 Huelva;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
21 Huelva;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
21 Huelva;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
21 Huelva;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
21 Huelva;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;94,43
21 Huelva;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
21 Huelva;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
21 Huelva;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
21 Huelva;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;94,76
21 Huelva;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
21 Huelva;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
21 Huelva;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
21 Huelva;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
21 Huelva;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
21 Huelva;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
21 Huelva;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;91,85
21 Huelva;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
21 Huelva;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
21 Huelva;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
21 Huelva;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;92,63
21 Huelva;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
21 Huelva;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
21 Huelva;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
21 Huelva;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
21 Huelva;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
21 Huelva;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
21 Huelva;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;89,68
21 Huelva;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
21 Huelva;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
21 Huelva;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
21 Huelva;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;91,08
21 Huelva;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
21 Huelva;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
21 Huelva;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
21 Huelva;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
21 Huelva;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
21 Huelva;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
21 Huelva;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QIV;5.269
21 Huelva;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
21 Huelva;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
21 Huelva;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
21 Huelva;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QIV;5.365
21 Huelva;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
21 Huelva;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
21 Huelva;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
21 Huelva;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QIV;5.328
21 Huelva;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
21 Huelva;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
21 Huelva;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
21 Huelva;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2022QIV;5.082
21 Huelva;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
21 Huelva;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2022QII;""
21 Huelva;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2022QI;""
21 Huelva;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2021QIV;5.199
21 Huelva;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
21 Huelva;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2021QII;""
21 Huelva;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2021QI;""
21 Huelva;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2020QIV;5.156
21 Huelva;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
21 Huelva;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2020QII;""
21 Huelva;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2020QI;""
21 Huelva;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
21 Huelva;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
21 Huelva;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2022QII;""
21 Huelva;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2022QI;5.092
21 Huelva;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
21 Huelva;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
21 Huelva;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2021QII;""
21 Huelva;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2021QI;5.061
21 Huelva;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
21 Huelva;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
21 Huelva;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2020QII;""
21 Huelva;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2020QI;""
21 Huelva;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
21 Huelva;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
21 Huelva;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QII;4.977
21 Huelva;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QI;""
21 Huelva;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
21 Huelva;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
21 Huelva;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QII;4.955
21 Huelva;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QI;""
21 Huelva;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
21 Huelva;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
21 Huelva;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QII;""
21 Huelva;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QI;""
21 Huelva;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
21 Huelva;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QIII;4.876
21 Huelva;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QII;""
21 Huelva;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QI;""
21 Huelva;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
21 Huelva;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QIII;4.891
21 Huelva;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QII;""
21 Huelva;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QI;""
21 Huelva;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
21 Huelva;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
21 Huelva;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QII;""
21 Huelva;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QI;""
21 Huelva;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
21 Huelva;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
21 Huelva;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
21 Huelva;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
21 Huelva;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
21 Huelva;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
21 Huelva;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
21 Huelva;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
21 Huelva;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
21 Huelva;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
21 Huelva;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
21 Huelva;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
21 Huelva;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;96,45
21 Huelva;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
21 Huelva;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
21 Huelva;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
21 Huelva;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;96,91
21 Huelva;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
21 Huelva;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
21 Huelva;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
21 Huelva;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;96,77
21 Huelva;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
21 Huelva;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
21 Huelva;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
21 Huelva;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
21 Huelva;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
21 Huelva;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
21 Huelva;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;94,91
21 Huelva;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
21 Huelva;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
21 Huelva;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
21 Huelva;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;94,99
21 Huelva;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
21 Huelva;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
21 Huelva;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
21 Huelva;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
21 Huelva;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
21 Huelva;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
21 Huelva;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;92,77
21 Huelva;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
21 Huelva;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
21 Huelva;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
21 Huelva;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;93
21 Huelva;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
21 Huelva;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
21 Huelva;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
21 Huelva;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
21 Huelva;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
21 Huelva;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
21 Huelva;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;90,89
21 Huelva;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
21 Huelva;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
21 Huelva;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
21 Huelva;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;91,8
21 Huelva;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
21 Huelva;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
21 Huelva;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
21 Huelva;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
21 Huelva;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
21 Huelva;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
21 Huelva;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QIV;2.979
21 Huelva;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
21 Huelva;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
21 Huelva;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
21 Huelva;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QIV;2.913
21 Huelva;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
21 Huelva;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
21 Huelva;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
21 Huelva;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QIV;2.838
21 Huelva;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
21 Huelva;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
21 Huelva;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
21 Huelva;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2022QIV;2.859
21 Huelva;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
21 Huelva;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2022QII;""
21 Huelva;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2022QI;""
21 Huelva;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2021QIV;2.795
21 Huelva;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
21 Huelva;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2021QII;""
21 Huelva;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2021QI;""
21 Huelva;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2020QIV;2.735
21 Huelva;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
21 Huelva;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2020QII;""
21 Huelva;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2020QI;""
21 Huelva;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
21 Huelva;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
21 Huelva;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2022QII;""
21 Huelva;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2022QI;2.725
21 Huelva;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
21 Huelva;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
21 Huelva;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2021QII;""
21 Huelva;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2021QI;2.677
21 Huelva;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
21 Huelva;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
21 Huelva;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2020QII;""
21 Huelva;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2020QI;""
21 Huelva;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
21 Huelva;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
21 Huelva;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QII;2.626
21 Huelva;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QI;""
21 Huelva;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
21 Huelva;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
21 Huelva;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QII;2.609
21 Huelva;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QI;""
21 Huelva;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
21 Huelva;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
21 Huelva;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QII;""
21 Huelva;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QI;""
21 Huelva;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
21 Huelva;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QIII;2.548
21 Huelva;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QII;""
21 Huelva;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QI;""
21 Huelva;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
21 Huelva;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QIII;2.547
21 Huelva;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QII;""
21 Huelva;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QI;""
21 Huelva;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
21 Huelva;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
21 Huelva;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QII;""
21 Huelva;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QI;""
21 Huelva;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
21 Huelva;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
21 Huelva;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
21 Huelva;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
21 Huelva;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
21 Huelva;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
21 Huelva;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
21 Huelva;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
21 Huelva;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
21 Huelva;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
21 Huelva;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
21 Huelva;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
21 Huelva;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;95,97
21 Huelva;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
21 Huelva;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
21 Huelva;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
21 Huelva;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;95,95
21 Huelva;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
21 Huelva;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
21 Huelva;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
21 Huelva;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;96,37
21 Huelva;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
21 Huelva;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
21 Huelva;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
21 Huelva;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
21 Huelva;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
21 Huelva;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
21 Huelva;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;93,55
21 Huelva;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
21 Huelva;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
21 Huelva;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
21 Huelva;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;94,33
21 Huelva;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
21 Huelva;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
21 Huelva;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
21 Huelva;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
21 Huelva;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
21 Huelva;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
21 Huelva;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;90,15
21 Huelva;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
21 Huelva;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
21 Huelva;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
21 Huelva;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;91,93
21 Huelva;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
21 Huelva;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
21 Huelva;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
21 Huelva;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
21 Huelva;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
21 Huelva;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
21 Huelva;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;87,47
21 Huelva;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
21 Huelva;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
21 Huelva;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
21 Huelva;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;89,75
21 Huelva;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
21 Huelva;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
21 Huelva;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
21 Huelva;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
21 Huelva;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
21 Huelva;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
21 Huelva;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
21 Huelva;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
21 Huelva;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
21 Huelva;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QI;6.865
21 Huelva;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
21 Huelva;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
21 Huelva;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
21 Huelva;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QI;6.531
21 Huelva;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
21 Huelva;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
21 Huelva;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
21 Huelva;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QI;6.719
21 Huelva;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
21 Huelva;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
21 Huelva;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2022QII;""
21 Huelva;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2022QI;6.712
21 Huelva;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
21 Huelva;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
21 Huelva;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2021QII;""
21 Huelva;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2021QI;6.411
21 Huelva;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
21 Huelva;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
21 Huelva;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2020QII;""
21 Huelva;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2020QI;6.271
21 Huelva;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
21 Huelva;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
21 Huelva;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2022QII;6.543
21 Huelva;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2022QI;""
21 Huelva;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
21 Huelva;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
21 Huelva;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2021QII;6.307
21 Huelva;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2021QI;""
21 Huelva;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
21 Huelva;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
21 Huelva;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2020QII;6.188
21 Huelva;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2020QI;""
21 Huelva;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
21 Huelva;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QIII;6.415
21 Huelva;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QII;""
21 Huelva;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QI;""
21 Huelva;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
21 Huelva;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QIII;6.208
21 Huelva;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QII;""
21 Huelva;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QI;""
21 Huelva;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
21 Huelva;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QIII;6.076
21 Huelva;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QII;""
21 Huelva;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QI;""
21 Huelva;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QIV;6.248
21 Huelva;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
21 Huelva;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QII;""
21 Huelva;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QI;""
21 Huelva;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QIV;6.077
21 Huelva;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
21 Huelva;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QII;""
21 Huelva;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QI;""
21 Huelva;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QIV;5.960
21 Huelva;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
21 Huelva;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QII;""
21 Huelva;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QI;""
21 Huelva;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
21 Huelva;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
21 Huelva;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
21 Huelva;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
21 Huelva;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
21 Huelva;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
21 Huelva;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
21 Huelva;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
21 Huelva;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
21 Huelva;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
21 Huelva;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
21 Huelva;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
21 Huelva;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
21 Huelva;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
21 Huelva;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
21 Huelva;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;97,77
21 Huelva;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
21 Huelva;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
21 Huelva;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
21 Huelva;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;98,16
21 Huelva;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
21 Huelva;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
21 Huelva;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
21 Huelva;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;93,33
21 Huelva;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
21 Huelva;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
21 Huelva;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;95,31
21 Huelva;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
21 Huelva;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
21 Huelva;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
21 Huelva;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;96,57
21 Huelva;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
21 Huelva;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
21 Huelva;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
21 Huelva;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;92,1
21 Huelva;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
21 Huelva;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
21 Huelva;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;93,45
21 Huelva;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
21 Huelva;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
21 Huelva;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
21 Huelva;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;95,05
21 Huelva;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
21 Huelva;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
21 Huelva;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
21 Huelva;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;90,43
21 Huelva;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
21 Huelva;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
21 Huelva;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;91,01
21 Huelva;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
21 Huelva;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
21 Huelva;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
21 Huelva;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;93,05
21 Huelva;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
21 Huelva;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
21 Huelva;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
21 Huelva;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;88,7
21 Huelva;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
21 Huelva;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
21 Huelva;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
21 Huelva;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
21 Huelva;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
21 Huelva;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
21 Huelva;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QI;4.606
21 Huelva;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
21 Huelva;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
21 Huelva;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
21 Huelva;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QI;4.377
21 Huelva;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
21 Huelva;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
21 Huelva;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
21 Huelva;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QI;4.468
21 Huelva;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
21 Huelva;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
21 Huelva;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2022QII;""
21 Huelva;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2022QI;4.511
21 Huelva;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
21 Huelva;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
21 Huelva;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2021QII;""
21 Huelva;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2021QI;4.302
21 Huelva;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
21 Huelva;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
21 Huelva;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2020QII;""
21 Huelva;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2020QI;4.195
21 Huelva;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
21 Huelva;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
21 Huelva;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2022QII;4.413
21 Huelva;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2022QI;""
21 Huelva;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
21 Huelva;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
21 Huelva;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2021QII;4.244
21 Huelva;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2021QI;""
21 Huelva;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
21 Huelva;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
21 Huelva;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2020QII;4.145
21 Huelva;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2020QI;""
21 Huelva;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
21 Huelva;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QIII;4.330
21 Huelva;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QII;""
21 Huelva;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QI;""
21 Huelva;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
21 Huelva;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QIII;4.185
21 Huelva;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QII;""
21 Huelva;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QI;""
21 Huelva;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
21 Huelva;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QIII;4.076
21 Huelva;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QII;""
21 Huelva;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QI;""
21 Huelva;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QIV;4.234
21 Huelva;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
21 Huelva;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QII;""
21 Huelva;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QI;""
21 Huelva;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QIV;4.111
21 Huelva;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
21 Huelva;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QII;""
21 Huelva;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QI;""
21 Huelva;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QIV;4.014
21 Huelva;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
21 Huelva;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QII;""
21 Huelva;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QI;""
21 Huelva;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
21 Huelva;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
21 Huelva;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
21 Huelva;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
21 Huelva;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
21 Huelva;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
21 Huelva;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
21 Huelva;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
21 Huelva;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
21 Huelva;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
21 Huelva;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
21 Huelva;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
21 Huelva;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
21 Huelva;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
21 Huelva;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
21 Huelva;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;97,94
21 Huelva;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
21 Huelva;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
21 Huelva;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
21 Huelva;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;98,29
21 Huelva;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
21 Huelva;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
21 Huelva;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
21 Huelva;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;93,89
21 Huelva;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
21 Huelva;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
21 Huelva;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;95,81
21 Huelva;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
21 Huelva;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
21 Huelva;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
21 Huelva;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;96,96
21 Huelva;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
21 Huelva;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
21 Huelva;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
21 Huelva;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;92,77
21 Huelva;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
21 Huelva;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
21 Huelva;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;94,01
21 Huelva;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
21 Huelva;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
21 Huelva;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
21 Huelva;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;95,61
21 Huelva;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
21 Huelva;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
21 Huelva;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
21 Huelva;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;91,23
21 Huelva;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
21 Huelva;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
21 Huelva;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;91,92
21 Huelva;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
21 Huelva;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
21 Huelva;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
21 Huelva;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;93,92
21 Huelva;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
21 Huelva;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
21 Huelva;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
21 Huelva;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;89,84
21 Huelva;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
21 Huelva;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
21 Huelva;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
21 Huelva;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
21 Huelva;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
21 Huelva;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
21 Huelva;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QI;2.259
21 Huelva;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
21 Huelva;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
21 Huelva;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
21 Huelva;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QI;2.154
21 Huelva;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
21 Huelva;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
21 Huelva;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
21 Huelva;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QI;2.251
21 Huelva;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
21 Huelva;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
21 Huelva;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2022QII;""
21 Huelva;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2022QI;2.201
21 Huelva;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
21 Huelva;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
21 Huelva;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2021QII;""
21 Huelva;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2021QI;2.109
21 Huelva;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
21 Huelva;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
21 Huelva;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2020QII;""
21 Huelva;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2020QI;2.076
21 Huelva;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
21 Huelva;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
21 Huelva;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2022QII;2.130
21 Huelva;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2022QI;""
21 Huelva;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
21 Huelva;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
21 Huelva;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2021QII;2.063
21 Huelva;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2021QI;""
21 Huelva;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
21 Huelva;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
21 Huelva;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2020QII;2.043
21 Huelva;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2020QI;""
21 Huelva;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
21 Huelva;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QIII;2.085
21 Huelva;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QII;""
21 Huelva;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QI;""
21 Huelva;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
21 Huelva;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QIII;2.023
21 Huelva;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QII;""
21 Huelva;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QI;""
21 Huelva;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
21 Huelva;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QIII;2.000
21 Huelva;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QII;""
21 Huelva;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QI;""
21 Huelva;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QIV;2.014
21 Huelva;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
21 Huelva;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QII;""
21 Huelva;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QI;""
21 Huelva;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QIV;1.966
21 Huelva;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
21 Huelva;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QII;""
21 Huelva;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QI;""
21 Huelva;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QIV;1.946
21 Huelva;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
21 Huelva;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QII;""
21 Huelva;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QI;""
21 Huelva;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
21 Huelva;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
21 Huelva;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
21 Huelva;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
21 Huelva;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
21 Huelva;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
21 Huelva;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
21 Huelva;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
21 Huelva;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
21 Huelva;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
21 Huelva;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
21 Huelva;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
21 Huelva;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
21 Huelva;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
21 Huelva;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
21 Huelva;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;97,43
21 Huelva;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
21 Huelva;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
21 Huelva;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
21 Huelva;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;97,91
21 Huelva;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
21 Huelva;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
21 Huelva;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
21 Huelva;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;92,23
21 Huelva;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
21 Huelva;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
21 Huelva;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;94,29
21 Huelva;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
21 Huelva;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
21 Huelva;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
21 Huelva;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;95,78
21 Huelva;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
21 Huelva;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
21 Huelva;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
21 Huelva;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;90,76
21 Huelva;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
21 Huelva;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
21 Huelva;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;92,3
21 Huelva;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
21 Huelva;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
21 Huelva;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
21 Huelva;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;93,92
21 Huelva;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
21 Huelva;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
21 Huelva;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
21 Huelva;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;88,85
21 Huelva;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
21 Huelva;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
21 Huelva;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;89,15
21 Huelva;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
21 Huelva;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
21 Huelva;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
21 Huelva;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;91,27
21 Huelva;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
21 Huelva;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
21 Huelva;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
21 Huelva;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;86,45
21 Huelva;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
21 Huelva;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
21 Huelva;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
21 Huelva;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
21 Huelva;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
21 Huelva;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QII;7.252
21 Huelva;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
21 Huelva;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
21 Huelva;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
21 Huelva;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QII;6.894
21 Huelva;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
21 Huelva;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
21 Huelva;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
21 Huelva;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QII;6.487
21 Huelva;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
21 Huelva;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
21 Huelva;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
21 Huelva;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2022QII;7.047
21 Huelva;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2022QI;""
21 Huelva;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
21 Huelva;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
21 Huelva;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2021QII;6.769
21 Huelva;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2021QI;""
21 Huelva;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
21 Huelva;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
21 Huelva;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2020QII;6.392
21 Huelva;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2020QI;""
21 Huelva;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
21 Huelva;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2022QIII;6.891
21 Huelva;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2022QII;""
21 Huelva;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2022QI;""
21 Huelva;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
21 Huelva;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2021QIII;6.649
21 Huelva;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2021QII;""
21 Huelva;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2021QI;""
21 Huelva;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
21 Huelva;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2020QIII;6.248
21 Huelva;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2020QII;""
21 Huelva;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2020QI;""
21 Huelva;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QIV;6.682
21 Huelva;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
21 Huelva;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QII;""
21 Huelva;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QI;""
21 Huelva;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QIV;6.493
21 Huelva;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
21 Huelva;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QII;""
21 Huelva;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QI;""
21 Huelva;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QIV;6.114
21 Huelva;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
21 Huelva;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QII;""
21 Huelva;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QI;""
21 Huelva;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
21 Huelva;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
21 Huelva;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QII;""
21 Huelva;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QI;6.363
21 Huelva;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
21 Huelva;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
21 Huelva;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QII;""
21 Huelva;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QI;6.032
21 Huelva;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
21 Huelva;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
21 Huelva;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QII;""
21 Huelva;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QI;""
21 Huelva;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
21 Huelva;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
21 Huelva;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
21 Huelva;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
21 Huelva;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
21 Huelva;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
21 Huelva;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
21 Huelva;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
21 Huelva;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
21 Huelva;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
21 Huelva;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
21 Huelva;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
21 Huelva;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
21 Huelva;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
21 Huelva;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;97,17
21 Huelva;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
21 Huelva;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
21 Huelva;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
21 Huelva;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;98,19
21 Huelva;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
21 Huelva;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
21 Huelva;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
21 Huelva;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;98,54
21 Huelva;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
21 Huelva;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
21 Huelva;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;95,02
21 Huelva;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
21 Huelva;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
21 Huelva;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
21 Huelva;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;96,45
21 Huelva;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
21 Huelva;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
21 Huelva;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
21 Huelva;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;96,32
21 Huelva;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
21 Huelva;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
21 Huelva;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;92,14
21 Huelva;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
21 Huelva;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
21 Huelva;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
21 Huelva;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;94,18
21 Huelva;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
21 Huelva;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
21 Huelva;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
21 Huelva;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;94,25
21 Huelva;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
21 Huelva;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
21 Huelva;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
21 Huelva;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
21 Huelva;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
21 Huelva;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
21 Huelva;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;92,3
21 Huelva;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
21 Huelva;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
21 Huelva;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
21 Huelva;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;92,99
21 Huelva;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
21 Huelva;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
21 Huelva;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
21 Huelva;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
21 Huelva;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
21 Huelva;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
21 Huelva;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QII;4.902
21 Huelva;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
21 Huelva;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
21 Huelva;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
21 Huelva;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QII;4.615
21 Huelva;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
21 Huelva;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
21 Huelva;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
21 Huelva;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QII;4.336
21 Huelva;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
21 Huelva;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
21 Huelva;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
21 Huelva;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2022QII;4.781
21 Huelva;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2022QI;""
21 Huelva;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
21 Huelva;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
21 Huelva;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2021QII;4.542
21 Huelva;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2021QI;""
21 Huelva;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
21 Huelva;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
21 Huelva;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2020QII;4.276
21 Huelva;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2020QI;""
21 Huelva;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
21 Huelva;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2022QIII;4.680
21 Huelva;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2022QII;""
21 Huelva;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2022QI;""
21 Huelva;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
21 Huelva;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2021QIII;4.476
21 Huelva;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2021QII;""
21 Huelva;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2021QI;""
21 Huelva;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
21 Huelva;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2020QIII;4.189
21 Huelva;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2020QII;""
21 Huelva;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2020QI;""
21 Huelva;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QIV;4.561
21 Huelva;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
21 Huelva;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QII;""
21 Huelva;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QI;""
21 Huelva;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QIV;4.385
21 Huelva;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
21 Huelva;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QII;""
21 Huelva;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QI;""
21 Huelva;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QIV;4.116
21 Huelva;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
21 Huelva;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QII;""
21 Huelva;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QI;""
21 Huelva;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
21 Huelva;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
21 Huelva;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QII;""
21 Huelva;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QI;4.304
21 Huelva;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
21 Huelva;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
21 Huelva;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QII;""
21 Huelva;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QI;4.068
21 Huelva;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
21 Huelva;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
21 Huelva;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QII;""
21 Huelva;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QI;""
21 Huelva;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
21 Huelva;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
21 Huelva;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
21 Huelva;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
21 Huelva;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
21 Huelva;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
21 Huelva;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
21 Huelva;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
21 Huelva;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
21 Huelva;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
21 Huelva;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
21 Huelva;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
21 Huelva;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
21 Huelva;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
21 Huelva;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;97,53
21 Huelva;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
21 Huelva;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
21 Huelva;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
21 Huelva;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;98,42
21 Huelva;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
21 Huelva;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
21 Huelva;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
21 Huelva;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;98,62
21 Huelva;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
21 Huelva;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
21 Huelva;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;95,47
21 Huelva;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
21 Huelva;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
21 Huelva;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
21 Huelva;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;96,99
21 Huelva;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
21 Huelva;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
21 Huelva;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
21 Huelva;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;96,61
21 Huelva;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
21 Huelva;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
21 Huelva;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;93,04
21 Huelva;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
21 Huelva;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
21 Huelva;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
21 Huelva;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;95,02
21 Huelva;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
21 Huelva;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
21 Huelva;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
21 Huelva;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;94,93
21 Huelva;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
21 Huelva;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
21 Huelva;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
21 Huelva;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
21 Huelva;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
21 Huelva;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
21 Huelva;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;93,26
21 Huelva;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
21 Huelva;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
21 Huelva;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
21 Huelva;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;93,82
21 Huelva;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
21 Huelva;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
21 Huelva;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
21 Huelva;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
21 Huelva;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
21 Huelva;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
21 Huelva;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QII;2.350
21 Huelva;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
21 Huelva;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
21 Huelva;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
21 Huelva;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QII;2.279
21 Huelva;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
21 Huelva;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
21 Huelva;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
21 Huelva;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QII;2.151
21 Huelva;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
21 Huelva;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
21 Huelva;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
21 Huelva;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2022QII;2.266
21 Huelva;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2022QI;""
21 Huelva;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
21 Huelva;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
21 Huelva;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2021QII;2.227
21 Huelva;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2021QI;""
21 Huelva;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
21 Huelva;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
21 Huelva;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2020QII;2.116
21 Huelva;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2020QI;""
21 Huelva;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
21 Huelva;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2022QIII;2.211
21 Huelva;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2022QII;""
21 Huelva;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2022QI;""
21 Huelva;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
21 Huelva;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2021QIII;2.173
21 Huelva;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2021QII;""
21 Huelva;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2021QI;""
21 Huelva;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
21 Huelva;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2020QIII;2.059
21 Huelva;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2020QII;""
21 Huelva;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2020QI;""
21 Huelva;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QIV;2.121
21 Huelva;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
21 Huelva;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QII;""
21 Huelva;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QI;""
21 Huelva;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QIV;2.108
21 Huelva;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
21 Huelva;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QII;""
21 Huelva;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QI;""
21 Huelva;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QIV;1.998
21 Huelva;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
21 Huelva;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QII;""
21 Huelva;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QI;""
21 Huelva;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
21 Huelva;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
21 Huelva;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QII;""
21 Huelva;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QI;2.059
21 Huelva;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
21 Huelva;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
21 Huelva;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QII;""
21 Huelva;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QI;1.964
21 Huelva;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
21 Huelva;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
21 Huelva;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QII;""
21 Huelva;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QI;""
21 Huelva;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
21 Huelva;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
21 Huelva;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
21 Huelva;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
21 Huelva;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
21 Huelva;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
21 Huelva;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
21 Huelva;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
21 Huelva;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
21 Huelva;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
21 Huelva;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
21 Huelva;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
21 Huelva;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
21 Huelva;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
21 Huelva;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;96,43
21 Huelva;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
21 Huelva;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
21 Huelva;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
21 Huelva;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;97,72
21 Huelva;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
21 Huelva;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
21 Huelva;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
21 Huelva;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;98,37
21 Huelva;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
21 Huelva;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
21 Huelva;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;94,09
21 Huelva;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
21 Huelva;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
21 Huelva;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
21 Huelva;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;95,35
21 Huelva;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
21 Huelva;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
21 Huelva;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
21 Huelva;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;95,72
21 Huelva;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
21 Huelva;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
21 Huelva;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;90,26
21 Huelva;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
21 Huelva;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
21 Huelva;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
21 Huelva;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;92,5
21 Huelva;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
21 Huelva;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
21 Huelva;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
21 Huelva;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;92,89
21 Huelva;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
21 Huelva;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
21 Huelva;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
21 Huelva;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
21 Huelva;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
21 Huelva;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
21 Huelva;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;90,35
21 Huelva;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
21 Huelva;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
21 Huelva;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
21 Huelva;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;91,31
21 Huelva;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
21 Huelva;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
21 Huelva;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
21 Huelva;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
21 Huelva;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
21 Huelva;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QIII;7.282
21 Huelva;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
21 Huelva;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
21 Huelva;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
21 Huelva;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QIII;7.014
21 Huelva;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
21 Huelva;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
21 Huelva;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
21 Huelva;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QIII;6.649
21 Huelva;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
21 Huelva;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
21 Huelva;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
21 Huelva;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2022QIII;7.044
21 Huelva;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2022QII;""
21 Huelva;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2022QI;""
21 Huelva;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
21 Huelva;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2021QIII;6.818
21 Huelva;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2021QII;""
21 Huelva;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2021QI;""
21 Huelva;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
21 Huelva;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2020QIII;6.434
21 Huelva;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2020QII;""
21 Huelva;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2020QI;""
21 Huelva;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2022QIV;6.806
21 Huelva;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
21 Huelva;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2022QII;""
21 Huelva;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2022QI;""
21 Huelva;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2021QIV;6.630
21 Huelva;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
21 Huelva;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2021QII;""
21 Huelva;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2021QI;""
21 Huelva;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2020QIV;6.257
21 Huelva;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
21 Huelva;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2020QII;""
21 Huelva;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2020QI;""
21 Huelva;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
21 Huelva;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
21 Huelva;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QII;""
21 Huelva;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QI;6.496
21 Huelva;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
21 Huelva;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
21 Huelva;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QII;""
21 Huelva;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QI;6.171
21 Huelva;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
21 Huelva;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
21 Huelva;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QII;""
21 Huelva;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QI;""
21 Huelva;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
21 Huelva;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
21 Huelva;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QII;6.360
21 Huelva;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QI;""
21 Huelva;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
21 Huelva;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
21 Huelva;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QII;6.084
21 Huelva;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QI;""
21 Huelva;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
21 Huelva;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
21 Huelva;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QII;""
21 Huelva;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QI;""
21 Huelva;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
21 Huelva;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
21 Huelva;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
21 Huelva;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
21 Huelva;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
21 Huelva;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
21 Huelva;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
21 Huelva;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
21 Huelva;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
21 Huelva;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
21 Huelva;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
21 Huelva;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
21 Huelva;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
21 Huelva;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;96,73
21 Huelva;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
21 Huelva;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
21 Huelva;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
21 Huelva;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;97,21
21 Huelva;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
21 Huelva;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
21 Huelva;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
21 Huelva;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;96,77
21 Huelva;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
21 Huelva;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
21 Huelva;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;93,46
21 Huelva;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
21 Huelva;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
21 Huelva;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
21 Huelva;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;94,53
21 Huelva;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
21 Huelva;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
21 Huelva;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
21 Huelva;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;94,1
21 Huelva;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
21 Huelva;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
21 Huelva;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
21 Huelva;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
21 Huelva;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
21 Huelva;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
21 Huelva;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;92,61
21 Huelva;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
21 Huelva;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
21 Huelva;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
21 Huelva;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;92,81
21 Huelva;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
21 Huelva;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
21 Huelva;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
21 Huelva;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
21 Huelva;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
21 Huelva;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
21 Huelva;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;90,68
21 Huelva;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
21 Huelva;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
21 Huelva;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
21 Huelva;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;91,5
21 Huelva;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
21 Huelva;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
21 Huelva;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
21 Huelva;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
21 Huelva;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
21 Huelva;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
21 Huelva;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QIII;4.919
21 Huelva;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
21 Huelva;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
21 Huelva;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
21 Huelva;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QIII;4.682
21 Huelva;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
21 Huelva;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
21 Huelva;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
21 Huelva;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QIII;4.444
21 Huelva;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
21 Huelva;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
21 Huelva;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
21 Huelva;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2022QIII;4.774
21 Huelva;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2022QII;""
21 Huelva;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2022QI;""
21 Huelva;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
21 Huelva;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2021QIII;4.582
21 Huelva;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2021QII;""
21 Huelva;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2021QI;""
21 Huelva;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
21 Huelva;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2020QIII;4.310
21 Huelva;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2020QII;""
21 Huelva;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2020QI;""
21 Huelva;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2022QIV;4.638
21 Huelva;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
21 Huelva;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2022QII;""
21 Huelva;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2022QI;""
21 Huelva;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2021QIV;4.473
21 Huelva;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
21 Huelva;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2021QII;""
21 Huelva;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2021QI;""
21 Huelva;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2020QIV;4.212
21 Huelva;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
21 Huelva;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2020QII;""
21 Huelva;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2020QI;""
21 Huelva;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
21 Huelva;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
21 Huelva;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QII;""
21 Huelva;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QI;4.389
21 Huelva;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
21 Huelva;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
21 Huelva;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QII;""
21 Huelva;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QI;4.160
21 Huelva;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
21 Huelva;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
21 Huelva;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QII;""
21 Huelva;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QI;""
21 Huelva;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
21 Huelva;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
21 Huelva;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QII;4.307
21 Huelva;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QI;""
21 Huelva;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
21 Huelva;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
21 Huelva;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QII;4.113
21 Huelva;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QI;""
21 Huelva;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
21 Huelva;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
21 Huelva;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QII;""
21 Huelva;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QI;""
21 Huelva;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
21 Huelva;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
21 Huelva;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
21 Huelva;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
21 Huelva;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
21 Huelva;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
21 Huelva;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
21 Huelva;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
21 Huelva;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
21 Huelva;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
21 Huelva;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
21 Huelva;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
21 Huelva;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
21 Huelva;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;97,05
21 Huelva;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
21 Huelva;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
21 Huelva;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
21 Huelva;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;97,86
21 Huelva;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
21 Huelva;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
21 Huelva;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
21 Huelva;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;96,98
21 Huelva;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
21 Huelva;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
21 Huelva;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;94,29
21 Huelva;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
21 Huelva;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
21 Huelva;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
21 Huelva;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;95,54
21 Huelva;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
21 Huelva;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
21 Huelva;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
21 Huelva;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;94,78
21 Huelva;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
21 Huelva;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
21 Huelva;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
21 Huelva;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
21 Huelva;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
21 Huelva;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
21 Huelva;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;93,74
21 Huelva;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
21 Huelva;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
21 Huelva;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
21 Huelva;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;93,61
21 Huelva;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
21 Huelva;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
21 Huelva;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
21 Huelva;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
21 Huelva;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
21 Huelva;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
21 Huelva;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;91,99
21 Huelva;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
21 Huelva;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
21 Huelva;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
21 Huelva;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;92,55
21 Huelva;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
21 Huelva;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
21 Huelva;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
21 Huelva;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
21 Huelva;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
21 Huelva;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
21 Huelva;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QIII;2.363
21 Huelva;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
21 Huelva;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
21 Huelva;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
21 Huelva;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QIII;2.332
21 Huelva;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
21 Huelva;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
21 Huelva;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
21 Huelva;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QIII;2.205
21 Huelva;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
21 Huelva;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
21 Huelva;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
21 Huelva;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2022QIII;2.270
21 Huelva;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2022QII;""
21 Huelva;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2022QI;""
21 Huelva;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
21 Huelva;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2021QIII;2.236
21 Huelva;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2021QII;""
21 Huelva;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2021QI;""
21 Huelva;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
21 Huelva;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2020QIII;2.124
21 Huelva;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2020QII;""
21 Huelva;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2020QI;""
21 Huelva;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2022QIV;2.168
21 Huelva;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
21 Huelva;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2022QII;""
21 Huelva;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2022QI;""
21 Huelva;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2021QIV;2.157
21 Huelva;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
21 Huelva;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2021QII;""
21 Huelva;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2021QI;""
21 Huelva;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2020QIV;2.045
21 Huelva;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
21 Huelva;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2020QII;""
21 Huelva;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2020QI;""
21 Huelva;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
21 Huelva;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
21 Huelva;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QII;""
21 Huelva;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QI;2.107
21 Huelva;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
21 Huelva;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
21 Huelva;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QII;""
21 Huelva;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QI;2.011
21 Huelva;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
21 Huelva;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
21 Huelva;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QII;""
21 Huelva;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QI;""
21 Huelva;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
21 Huelva;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
21 Huelva;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QII;2.053
21 Huelva;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QI;""
21 Huelva;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
21 Huelva;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
21 Huelva;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QII;1.971
21 Huelva;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QI;""
21 Huelva;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
21 Huelva;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
21 Huelva;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QII;""
21 Huelva;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QI;""
21 Huelva;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
21 Huelva;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
21 Huelva;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
21 Huelva;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
21 Huelva;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
21 Huelva;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
21 Huelva;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
21 Huelva;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
21 Huelva;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
21 Huelva;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
21 Huelva;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
21 Huelva;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
21 Huelva;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
21 Huelva;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;96,06
21 Huelva;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
21 Huelva;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
21 Huelva;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
21 Huelva;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;95,88
21 Huelva;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
21 Huelva;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
21 Huelva;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
21 Huelva;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;96,33
21 Huelva;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
21 Huelva;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
21 Huelva;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;91,75
21 Huelva;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
21 Huelva;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
21 Huelva;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
21 Huelva;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;92,5
21 Huelva;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
21 Huelva;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
21 Huelva;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
21 Huelva;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;92,74
21 Huelva;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
21 Huelva;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
21 Huelva;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
21 Huelva;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
21 Huelva;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
21 Huelva;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
21 Huelva;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;90,35
21 Huelva;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
21 Huelva;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
21 Huelva;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
21 Huelva;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;91,2
21 Huelva;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
21 Huelva;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
21 Huelva;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
21 Huelva;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
21 Huelva;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
21 Huelva;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
21 Huelva;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;88,04
21 Huelva;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
21 Huelva;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
21 Huelva;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
21 Huelva;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;89,39
21 Huelva;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
21 Huelva;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
21 Huelva;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
21 Huelva;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
21 Huelva;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
21 Huelva;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QIV;7.196
21 Huelva;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
21 Huelva;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
21 Huelva;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
21 Huelva;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QIV;6.938
21 Huelva;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
21 Huelva;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
21 Huelva;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
21 Huelva;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QIV;6.587
21 Huelva;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
21 Huelva;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
21 Huelva;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
21 Huelva;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2022QIV;6.931
21 Huelva;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
21 Huelva;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2022QII;""
21 Huelva;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2022QI;""
21 Huelva;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2021QIV;6.737
21 Huelva;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
21 Huelva;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2021QII;""
21 Huelva;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2021QI;""
21 Huelva;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2020QIV;6.379
21 Huelva;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
21 Huelva;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2020QII;""
21 Huelva;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2020QI;""
21 Huelva;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
21 Huelva;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
21 Huelva;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2022QII;""
21 Huelva;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2022QI;6.597
21 Huelva;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
21 Huelva;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
21 Huelva;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2021QII;""
21 Huelva;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2021QI;6.283
21 Huelva;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
21 Huelva;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
21 Huelva;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2020QII;""
21 Huelva;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2020QI;""
21 Huelva;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
21 Huelva;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
21 Huelva;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QII;6.452
21 Huelva;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QI;""
21 Huelva;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
21 Huelva;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
21 Huelva;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QII;6.193
21 Huelva;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QI;""
21 Huelva;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
21 Huelva;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
21 Huelva;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QII;""
21 Huelva;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QI;""
21 Huelva;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
21 Huelva;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QIII;6.333
21 Huelva;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QII;""
21 Huelva;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QI;""
21 Huelva;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
21 Huelva;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QIII;6.103
21 Huelva;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QII;""
21 Huelva;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QI;""
21 Huelva;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
21 Huelva;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
21 Huelva;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QII;""
21 Huelva;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QI;""
21 Huelva;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
21 Huelva;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
21 Huelva;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
21 Huelva;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
21 Huelva;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
21 Huelva;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
21 Huelva;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
21 Huelva;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
21 Huelva;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
21 Huelva;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
21 Huelva;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
21 Huelva;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
21 Huelva;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;96,32
21 Huelva;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
21 Huelva;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
21 Huelva;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
21 Huelva;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;97,1
21 Huelva;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
21 Huelva;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
21 Huelva;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
21 Huelva;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;96,84
21 Huelva;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
21 Huelva;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
21 Huelva;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
21 Huelva;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
21 Huelva;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
21 Huelva;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
21 Huelva;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;95,09
21 Huelva;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
21 Huelva;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
21 Huelva;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
21 Huelva;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;95,38
21 Huelva;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
21 Huelva;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
21 Huelva;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
21 Huelva;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
21 Huelva;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
21 Huelva;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
21 Huelva;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;93
21 Huelva;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
21 Huelva;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
21 Huelva;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
21 Huelva;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;94,02
21 Huelva;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
21 Huelva;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
21 Huelva;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
21 Huelva;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
21 Huelva;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
21 Huelva;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
21 Huelva;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;91,28
21 Huelva;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
21 Huelva;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
21 Huelva;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
21 Huelva;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;92,65
21 Huelva;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
21 Huelva;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
21 Huelva;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
21 Huelva;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
21 Huelva;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
21 Huelva;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
21 Huelva;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QIV;4.857
21 Huelva;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
21 Huelva;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
21 Huelva;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
21 Huelva;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QIV;4.654
21 Huelva;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
21 Huelva;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
21 Huelva;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
21 Huelva;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QIV;4.407
21 Huelva;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
21 Huelva;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
21 Huelva;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
21 Huelva;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2022QIV;4.703
21 Huelva;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
21 Huelva;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2022QII;""
21 Huelva;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2022QI;""
21 Huelva;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2021QIV;4.537
21 Huelva;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
21 Huelva;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2021QII;""
21 Huelva;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2021QI;""
21 Huelva;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2020QIV;4.289
21 Huelva;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
21 Huelva;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2020QII;""
21 Huelva;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2020QI;""
21 Huelva;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
21 Huelva;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
21 Huelva;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2022QII;""
21 Huelva;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2022QI;4.450
21 Huelva;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
21 Huelva;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
21 Huelva;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2021QII;""
21 Huelva;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2021QI;4.228
21 Huelva;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
21 Huelva;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
21 Huelva;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2020QII;""
21 Huelva;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2020QI;""
21 Huelva;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
21 Huelva;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
21 Huelva;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QII;4.364
21 Huelva;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QI;""
21 Huelva;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
21 Huelva;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
21 Huelva;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QII;4.179
21 Huelva;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QI;""
21 Huelva;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
21 Huelva;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
21 Huelva;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QII;""
21 Huelva;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QI;""
21 Huelva;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
21 Huelva;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QIII;4.285
21 Huelva;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QII;""
21 Huelva;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QI;""
21 Huelva;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
21 Huelva;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QIII;4.124
21 Huelva;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QII;""
21 Huelva;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QI;""
21 Huelva;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
21 Huelva;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
21 Huelva;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QII;""
21 Huelva;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QI;""
21 Huelva;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
21 Huelva;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
21 Huelva;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
21 Huelva;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
21 Huelva;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
21 Huelva;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
21 Huelva;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
21 Huelva;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
21 Huelva;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
21 Huelva;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
21 Huelva;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
21 Huelva;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
21 Huelva;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;96,83
21 Huelva;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
21 Huelva;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
21 Huelva;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
21 Huelva;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;97,49
21 Huelva;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
21 Huelva;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
21 Huelva;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
21 Huelva;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;97,32
21 Huelva;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
21 Huelva;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
21 Huelva;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
21 Huelva;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
21 Huelva;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
21 Huelva;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
21 Huelva;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;95,62
21 Huelva;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
21 Huelva;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
21 Huelva;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
21 Huelva;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;95,94
21 Huelva;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
21 Huelva;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
21 Huelva;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
21 Huelva;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
21 Huelva;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
21 Huelva;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
21 Huelva;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;93,77
21 Huelva;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
21 Huelva;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
21 Huelva;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
21 Huelva;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;94,83
21 Huelva;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
21 Huelva;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
21 Huelva;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
21 Huelva;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
21 Huelva;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
21 Huelva;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
21 Huelva;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;92,07
21 Huelva;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
21 Huelva;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
21 Huelva;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
21 Huelva;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;93,58
21 Huelva;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
21 Huelva;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
21 Huelva;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
21 Huelva;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
21 Huelva;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
21 Huelva;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
21 Huelva;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QIV;2.339
21 Huelva;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
21 Huelva;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
21 Huelva;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
21 Huelva;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QIV;2.284
21 Huelva;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
21 Huelva;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
21 Huelva;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
21 Huelva;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QIV;2.180
21 Huelva;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
21 Huelva;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
21 Huelva;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
21 Huelva;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2022QIV;2.228
21 Huelva;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
21 Huelva;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2022QII;""
21 Huelva;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2022QI;""
21 Huelva;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2021QIV;2.200
21 Huelva;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
21 Huelva;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2021QII;""
21 Huelva;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2021QI;""
21 Huelva;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2020QIV;2.090
21 Huelva;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
21 Huelva;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2020QII;""
21 Huelva;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2020QI;""
21 Huelva;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
21 Huelva;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
21 Huelva;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2022QII;""
21 Huelva;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2022QI;2.147
21 Huelva;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
21 Huelva;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
21 Huelva;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2021QII;""
21 Huelva;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2021QI;2.055
21 Huelva;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
21 Huelva;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
21 Huelva;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2020QII;""
21 Huelva;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2020QI;""
21 Huelva;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
21 Huelva;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
21 Huelva;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QII;2.088
21 Huelva;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QI;""
21 Huelva;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
21 Huelva;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
21 Huelva;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QII;2.014
21 Huelva;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QI;""
21 Huelva;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
21 Huelva;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
21 Huelva;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QII;""
21 Huelva;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QI;""
21 Huelva;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
21 Huelva;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QIII;2.048
21 Huelva;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QII;""
21 Huelva;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QI;""
21 Huelva;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
21 Huelva;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QIII;1.979
21 Huelva;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QII;""
21 Huelva;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QI;""
21 Huelva;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
21 Huelva;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
21 Huelva;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QII;""
21 Huelva;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QI;""
21 Huelva;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
21 Huelva;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
21 Huelva;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
21 Huelva;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
21 Huelva;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
21 Huelva;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
21 Huelva;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
21 Huelva;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
21 Huelva;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
21 Huelva;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
21 Huelva;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
21 Huelva;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
21 Huelva;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;95,25
21 Huelva;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
21 Huelva;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
21 Huelva;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
21 Huelva;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;96,32
21 Huelva;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
21 Huelva;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
21 Huelva;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
21 Huelva;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;95,87
21 Huelva;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
21 Huelva;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
21 Huelva;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
21 Huelva;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
21 Huelva;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
21 Huelva;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
21 Huelva;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;94
21 Huelva;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
21 Huelva;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
21 Huelva;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
21 Huelva;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;94,27
21 Huelva;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
21 Huelva;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
21 Huelva;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
21 Huelva;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
21 Huelva;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
21 Huelva;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
21 Huelva;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;91,42
21 Huelva;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
21 Huelva;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
21 Huelva;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
21 Huelva;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;92,39
21 Huelva;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
21 Huelva;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
21 Huelva;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
21 Huelva;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
21 Huelva;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
21 Huelva;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
21 Huelva;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;89,67
21 Huelva;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
21 Huelva;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
21 Huelva;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
21 Huelva;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;90,78
21 Huelva;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
21 Huelva;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
21 Huelva;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
21 Huelva;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
21 Huelva;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
21 Huelva;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
21 Huelva;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
21 Huelva;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
21 Huelva;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
21 Huelva;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QI;2.954
21 Huelva;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
21 Huelva;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
21 Huelva;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
21 Huelva;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QI;2.799
21 Huelva;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
21 Huelva;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
21 Huelva;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
21 Huelva;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QI;3.197
21 Huelva;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
21 Huelva;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
21 Huelva;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2022QII;""
21 Huelva;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2022QI;2.842
21 Huelva;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
21 Huelva;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
21 Huelva;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2021QII;""
21 Huelva;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2021QI;2.695
21 Huelva;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
21 Huelva;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
21 Huelva;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2020QII;""
21 Huelva;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2020QI;2.986
21 Huelva;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
21 Huelva;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
21 Huelva;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2022QII;2.729
21 Huelva;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2022QI;""
21 Huelva;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
21 Huelva;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
21 Huelva;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2021QII;2.588
21 Huelva;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2021QI;""
21 Huelva;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
21 Huelva;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
21 Huelva;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2020QII;2.882
21 Huelva;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2020QI;""
21 Huelva;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
21 Huelva;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QIII;2.612
21 Huelva;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QII;""
21 Huelva;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QI;""
21 Huelva;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
21 Huelva;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QIII;2.488
21 Huelva;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QII;""
21 Huelva;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QI;""
21 Huelva;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
21 Huelva;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QIII;2.780
21 Huelva;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QII;""
21 Huelva;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QI;""
21 Huelva;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QIV;2.456
21 Huelva;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
21 Huelva;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QII;""
21 Huelva;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QI;""
21 Huelva;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QIV;2.352
21 Huelva;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
21 Huelva;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QII;""
21 Huelva;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QI;""
21 Huelva;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QIV;2.651
21 Huelva;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
21 Huelva;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QII;""
21 Huelva;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QI;""
21 Huelva;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
21 Huelva;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
21 Huelva;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
21 Huelva;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
21 Huelva;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
21 Huelva;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
21 Huelva;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
21 Huelva;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
21 Huelva;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
21 Huelva;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
21 Huelva;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
21 Huelva;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
21 Huelva;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
21 Huelva;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
21 Huelva;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
21 Huelva;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;96,21
21 Huelva;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
21 Huelva;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
21 Huelva;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
21 Huelva;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;96,28
21 Huelva;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
21 Huelva;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
21 Huelva;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
21 Huelva;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;93,4
21 Huelva;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
21 Huelva;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
21 Huelva;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;92,38
21 Huelva;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
21 Huelva;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
21 Huelva;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
21 Huelva;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;92,46
21 Huelva;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
21 Huelva;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
21 Huelva;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
21 Huelva;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;90,15
21 Huelva;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
21 Huelva;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
21 Huelva;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;88,42
21 Huelva;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
21 Huelva;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
21 Huelva;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
21 Huelva;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;88,89
21 Huelva;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
21 Huelva;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
21 Huelva;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
21 Huelva;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;86,96
21 Huelva;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
21 Huelva;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
21 Huelva;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;83,14
21 Huelva;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
21 Huelva;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
21 Huelva;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
21 Huelva;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;84,03
21 Huelva;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
21 Huelva;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
21 Huelva;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
21 Huelva;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;82,92
21 Huelva;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
21 Huelva;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
21 Huelva;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
21 Huelva;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
21 Huelva;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
21 Huelva;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
21 Huelva;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QI;1.961
21 Huelva;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
21 Huelva;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
21 Huelva;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
21 Huelva;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QI;1.838
21 Huelva;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
21 Huelva;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
21 Huelva;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
21 Huelva;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QI;2.101
21 Huelva;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
21 Huelva;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
21 Huelva;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2022QII;""
21 Huelva;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2022QI;1.891
21 Huelva;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
21 Huelva;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
21 Huelva;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2021QII;""
21 Huelva;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2021QI;1.772
21 Huelva;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
21 Huelva;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
21 Huelva;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2020QII;""
21 Huelva;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2020QI;1.972
21 Huelva;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
21 Huelva;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
21 Huelva;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2022QII;1.814
21 Huelva;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2022QI;""
21 Huelva;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
21 Huelva;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
21 Huelva;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2021QII;1.705
21 Huelva;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2021QI;""
21 Huelva;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
21 Huelva;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
21 Huelva;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2020QII;1.907
21 Huelva;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2020QI;""
21 Huelva;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
21 Huelva;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QIII;1.744
21 Huelva;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QII;""
21 Huelva;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QI;""
21 Huelva;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
21 Huelva;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QIII;1.642
21 Huelva;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QII;""
21 Huelva;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QI;""
21 Huelva;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
21 Huelva;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QIII;1.832
21 Huelva;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QII;""
21 Huelva;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QI;""
21 Huelva;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QIV;1.639
21 Huelva;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
21 Huelva;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QII;""
21 Huelva;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QI;""
21 Huelva;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QIV;1.561
21 Huelva;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
21 Huelva;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QII;""
21 Huelva;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QI;""
21 Huelva;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QIV;1.758
21 Huelva;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
21 Huelva;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QII;""
21 Huelva;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QI;""
21 Huelva;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
21 Huelva;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
21 Huelva;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
21 Huelva;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
21 Huelva;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
21 Huelva;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
21 Huelva;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
21 Huelva;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
21 Huelva;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
21 Huelva;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
21 Huelva;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
21 Huelva;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
21 Huelva;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
21 Huelva;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
21 Huelva;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
21 Huelva;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;96,43
21 Huelva;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
21 Huelva;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
21 Huelva;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
21 Huelva;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;96,41
21 Huelva;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
21 Huelva;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
21 Huelva;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
21 Huelva;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;93,86
21 Huelva;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
21 Huelva;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
21 Huelva;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;92,5
21 Huelva;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
21 Huelva;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
21 Huelva;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
21 Huelva;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;92,76
21 Huelva;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
21 Huelva;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
21 Huelva;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
21 Huelva;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;90,77
21 Huelva;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
21 Huelva;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
21 Huelva;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;88,93
21 Huelva;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
21 Huelva;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
21 Huelva;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
21 Huelva;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;89,34
21 Huelva;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
21 Huelva;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
21 Huelva;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
21 Huelva;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;87,2
21 Huelva;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
21 Huelva;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
21 Huelva;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;83,58
21 Huelva;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
21 Huelva;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
21 Huelva;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
21 Huelva;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;84,93
21 Huelva;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
21 Huelva;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
21 Huelva;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
21 Huelva;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;83,67
21 Huelva;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
21 Huelva;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
21 Huelva;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
21 Huelva;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
21 Huelva;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
21 Huelva;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
21 Huelva;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QI;993
21 Huelva;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
21 Huelva;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
21 Huelva;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
21 Huelva;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QI;961
21 Huelva;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
21 Huelva;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
21 Huelva;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
21 Huelva;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QI;1.096
21 Huelva;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
21 Huelva;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
21 Huelva;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2022QII;""
21 Huelva;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2022QI;951
21 Huelva;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
21 Huelva;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
21 Huelva;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2021QII;""
21 Huelva;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2021QI;923
21 Huelva;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
21 Huelva;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
21 Huelva;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2020QII;""
21 Huelva;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2020QI;1.014
21 Huelva;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
21 Huelva;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
21 Huelva;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2022QII;915
21 Huelva;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2022QI;""
21 Huelva;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
21 Huelva;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
21 Huelva;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2021QII;883
21 Huelva;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2021QI;""
21 Huelva;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
21 Huelva;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
21 Huelva;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2020QII;975
21 Huelva;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2020QI;""
21 Huelva;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
21 Huelva;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QIII;868
21 Huelva;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QII;""
21 Huelva;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QI;""
21 Huelva;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
21 Huelva;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QIII;846
21 Huelva;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QII;""
21 Huelva;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QI;""
21 Huelva;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
21 Huelva;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QIII;948
21 Huelva;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QII;""
21 Huelva;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QI;""
21 Huelva;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QIV;817
21 Huelva;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
21 Huelva;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QII;""
21 Huelva;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QI;""
21 Huelva;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QIV;791
21 Huelva;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
21 Huelva;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QII;""
21 Huelva;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QI;""
21 Huelva;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QIV;893
21 Huelva;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
21 Huelva;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QII;""
21 Huelva;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QI;""
21 Huelva;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
21 Huelva;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
21 Huelva;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
21 Huelva;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
21 Huelva;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
21 Huelva;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
21 Huelva;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
21 Huelva;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
21 Huelva;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
21 Huelva;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
21 Huelva;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
21 Huelva;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
21 Huelva;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
21 Huelva;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
21 Huelva;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
21 Huelva;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;95,77
21 Huelva;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
21 Huelva;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
21 Huelva;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
21 Huelva;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;96,05
21 Huelva;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
21 Huelva;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
21 Huelva;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
21 Huelva;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;92,52
21 Huelva;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
21 Huelva;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
21 Huelva;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;92,15
21 Huelva;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
21 Huelva;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
21 Huelva;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
21 Huelva;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;91,88
21 Huelva;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
21 Huelva;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
21 Huelva;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
21 Huelva;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;88,96
21 Huelva;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
21 Huelva;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
21 Huelva;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;87,41
21 Huelva;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
21 Huelva;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
21 Huelva;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
21 Huelva;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;88,03
21 Huelva;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
21 Huelva;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
21 Huelva;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
21 Huelva;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;86,5
21 Huelva;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
21 Huelva;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
21 Huelva;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;82,28
21 Huelva;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
21 Huelva;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
21 Huelva;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
21 Huelva;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;82,31
21 Huelva;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
21 Huelva;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
21 Huelva;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
21 Huelva;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;81,48
21 Huelva;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
21 Huelva;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
21 Huelva;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
21 Huelva;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
21 Huelva;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
21 Huelva;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QII;3.391
21 Huelva;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
21 Huelva;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
21 Huelva;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
21 Huelva;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QII;3.250
21 Huelva;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
21 Huelva;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
21 Huelva;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
21 Huelva;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QII;3.063
21 Huelva;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
21 Huelva;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
21 Huelva;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
21 Huelva;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2022QII;3.256
21 Huelva;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2022QI;""
21 Huelva;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
21 Huelva;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
21 Huelva;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2021QII;3.128
21 Huelva;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2021QI;""
21 Huelva;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
21 Huelva;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
21 Huelva;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2020QII;2.956
21 Huelva;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2020QI;""
21 Huelva;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
21 Huelva;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2022QIII;3.120
21 Huelva;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2022QII;""
21 Huelva;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2022QI;""
21 Huelva;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
21 Huelva;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2021QIII;3.009
21 Huelva;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2021QII;""
21 Huelva;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2021QI;""
21 Huelva;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
21 Huelva;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2020QIII;2.837
21 Huelva;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2020QII;""
21 Huelva;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2020QI;""
21 Huelva;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QIV;2.944
21 Huelva;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
21 Huelva;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QII;""
21 Huelva;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QI;""
21 Huelva;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QIV;2.852
21 Huelva;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
21 Huelva;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QII;""
21 Huelva;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QI;""
21 Huelva;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QIV;2.701
21 Huelva;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
21 Huelva;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QII;""
21 Huelva;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QI;""
21 Huelva;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
21 Huelva;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
21 Huelva;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QII;""
21 Huelva;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QI;2.748
21 Huelva;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
21 Huelva;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
21 Huelva;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QII;""
21 Huelva;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QI;2.607
21 Huelva;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
21 Huelva;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
21 Huelva;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QII;""
21 Huelva;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QI;""
21 Huelva;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
21 Huelva;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
21 Huelva;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
21 Huelva;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
21 Huelva;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
21 Huelva;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
21 Huelva;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
21 Huelva;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
21 Huelva;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
21 Huelva;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
21 Huelva;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
21 Huelva;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
21 Huelva;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
21 Huelva;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
21 Huelva;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;96,02
21 Huelva;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
21 Huelva;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
21 Huelva;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
21 Huelva;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;96,25
21 Huelva;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
21 Huelva;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
21 Huelva;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
21 Huelva;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;96,51
21 Huelva;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
21 Huelva;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
21 Huelva;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;92,01
21 Huelva;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
21 Huelva;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
21 Huelva;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
21 Huelva;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;92,58
21 Huelva;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
21 Huelva;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
21 Huelva;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
21 Huelva;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;92,62
21 Huelva;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
21 Huelva;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
21 Huelva;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;86,82
21 Huelva;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
21 Huelva;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
21 Huelva;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
21 Huelva;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;87,75
21 Huelva;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
21 Huelva;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
21 Huelva;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
21 Huelva;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;88,18
21 Huelva;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
21 Huelva;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
21 Huelva;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
21 Huelva;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
21 Huelva;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
21 Huelva;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
21 Huelva;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;84,55
21 Huelva;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
21 Huelva;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
21 Huelva;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
21 Huelva;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;85,11
21 Huelva;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
21 Huelva;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
21 Huelva;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
21 Huelva;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
21 Huelva;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
21 Huelva;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
21 Huelva;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QII;2.244
21 Huelva;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
21 Huelva;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
21 Huelva;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
21 Huelva;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QII;2.153
21 Huelva;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
21 Huelva;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
21 Huelva;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
21 Huelva;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QII;2.012
21 Huelva;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
21 Huelva;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
21 Huelva;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
21 Huelva;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2022QII;2.156
21 Huelva;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2022QI;""
21 Huelva;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
21 Huelva;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
21 Huelva;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2021QII;2.077
21 Huelva;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2021QI;""
21 Huelva;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
21 Huelva;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
21 Huelva;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2020QII;1.946
21 Huelva;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2020QI;""
21 Huelva;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
21 Huelva;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2022QIII;2.074
21 Huelva;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2022QII;""
21 Huelva;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2022QI;""
21 Huelva;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
21 Huelva;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2021QIII;2.001
21 Huelva;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2021QII;""
21 Huelva;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2021QI;""
21 Huelva;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
21 Huelva;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2020QIII;1.861
21 Huelva;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2020QII;""
21 Huelva;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2020QI;""
21 Huelva;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QIV;1.959
21 Huelva;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
21 Huelva;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QII;""
21 Huelva;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QI;""
21 Huelva;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QIV;1.906
21 Huelva;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
21 Huelva;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QII;""
21 Huelva;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QI;""
21 Huelva;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QIV;1.783
21 Huelva;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
21 Huelva;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QII;""
21 Huelva;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QI;""
21 Huelva;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
21 Huelva;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
21 Huelva;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QII;""
21 Huelva;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QI;1.840
21 Huelva;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
21 Huelva;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
21 Huelva;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QII;""
21 Huelva;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QI;1.722
21 Huelva;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
21 Huelva;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
21 Huelva;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QII;""
21 Huelva;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QI;""
21 Huelva;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
21 Huelva;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
21 Huelva;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
21 Huelva;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
21 Huelva;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
21 Huelva;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
21 Huelva;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
21 Huelva;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
21 Huelva;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
21 Huelva;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
21 Huelva;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
21 Huelva;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
21 Huelva;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
21 Huelva;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
21 Huelva;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;96,08
21 Huelva;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
21 Huelva;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
21 Huelva;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
21 Huelva;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;96,47
21 Huelva;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
21 Huelva;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
21 Huelva;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
21 Huelva;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;96,72
21 Huelva;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
21 Huelva;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
21 Huelva;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;92,42
21 Huelva;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
21 Huelva;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
21 Huelva;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
21 Huelva;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;92,94
21 Huelva;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
21 Huelva;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
21 Huelva;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
21 Huelva;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;92,5
21 Huelva;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
21 Huelva;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
21 Huelva;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;87,3
21 Huelva;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
21 Huelva;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
21 Huelva;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
21 Huelva;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;88,53
21 Huelva;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
21 Huelva;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
21 Huelva;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
21 Huelva;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;88,62
21 Huelva;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
21 Huelva;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
21 Huelva;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
21 Huelva;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
21 Huelva;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
21 Huelva;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
21 Huelva;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;85,46
21 Huelva;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
21 Huelva;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
21 Huelva;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
21 Huelva;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;85,59
21 Huelva;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
21 Huelva;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
21 Huelva;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
21 Huelva;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
21 Huelva;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
21 Huelva;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
21 Huelva;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QII;1.147
21 Huelva;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
21 Huelva;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
21 Huelva;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
21 Huelva;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QII;1.097
21 Huelva;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
21 Huelva;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
21 Huelva;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
21 Huelva;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QII;1.051
21 Huelva;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
21 Huelva;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
21 Huelva;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
21 Huelva;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2022QII;1.100
21 Huelva;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2022QI;""
21 Huelva;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
21 Huelva;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
21 Huelva;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2021QII;1.051
21 Huelva;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2021QI;""
21 Huelva;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
21 Huelva;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
21 Huelva;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2020QII;1.010
21 Huelva;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2020QI;""
21 Huelva;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
21 Huelva;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2022QIII;1.046
21 Huelva;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2022QII;""
21 Huelva;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2022QI;""
21 Huelva;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
21 Huelva;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2021QIII;1.008
21 Huelva;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2021QII;""
21 Huelva;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2021QI;""
21 Huelva;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
21 Huelva;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2020QIII;976
21 Huelva;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2020QII;""
21 Huelva;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2020QI;""
21 Huelva;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QIV;985
21 Huelva;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
21 Huelva;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QII;""
21 Huelva;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QI;""
21 Huelva;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QIV;946
21 Huelva;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
21 Huelva;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QII;""
21 Huelva;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QI;""
21 Huelva;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QIV;918
21 Huelva;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
21 Huelva;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QII;""
21 Huelva;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QI;""
21 Huelva;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
21 Huelva;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
21 Huelva;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QII;""
21 Huelva;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QI;908
21 Huelva;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
21 Huelva;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
21 Huelva;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QII;""
21 Huelva;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QI;885
21 Huelva;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
21 Huelva;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
21 Huelva;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QII;""
21 Huelva;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QI;""
21 Huelva;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
21 Huelva;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
21 Huelva;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
21 Huelva;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
21 Huelva;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
21 Huelva;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
21 Huelva;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
21 Huelva;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
21 Huelva;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
21 Huelva;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
21 Huelva;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
21 Huelva;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
21 Huelva;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
21 Huelva;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
21 Huelva;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;95,9
21 Huelva;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
21 Huelva;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
21 Huelva;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
21 Huelva;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;95,81
21 Huelva;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
21 Huelva;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
21 Huelva;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
21 Huelva;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;96,1
21 Huelva;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
21 Huelva;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
21 Huelva;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;91,19
21 Huelva;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
21 Huelva;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
21 Huelva;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
21 Huelva;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;91,89
21 Huelva;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
21 Huelva;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
21 Huelva;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
21 Huelva;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;92,86
21 Huelva;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
21 Huelva;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
21 Huelva;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;85,88
21 Huelva;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
21 Huelva;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
21 Huelva;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
21 Huelva;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;86,24
21 Huelva;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
21 Huelva;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
21 Huelva;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
21 Huelva;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;87,35
21 Huelva;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
21 Huelva;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
21 Huelva;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
21 Huelva;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
21 Huelva;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
21 Huelva;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
21 Huelva;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;82,77
21 Huelva;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
21 Huelva;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
21 Huelva;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
21 Huelva;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;84,21
21 Huelva;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
21 Huelva;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
21 Huelva;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
21 Huelva;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
21 Huelva;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
21 Huelva;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QIII;3.336
21 Huelva;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
21 Huelva;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
21 Huelva;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
21 Huelva;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QIII;3.219
21 Huelva;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
21 Huelva;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
21 Huelva;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
21 Huelva;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QIII;3.031
21 Huelva;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
21 Huelva;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
21 Huelva;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
21 Huelva;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2022QIII;3.167
21 Huelva;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2022QII;""
21 Huelva;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2022QI;""
21 Huelva;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
21 Huelva;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2021QIII;3.054
21 Huelva;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2021QII;""
21 Huelva;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2021QI;""
21 Huelva;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
21 Huelva;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2020QIII;2.880
21 Huelva;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2020QII;""
21 Huelva;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2020QI;""
21 Huelva;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2022QIV;2.975
21 Huelva;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
21 Huelva;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2022QII;""
21 Huelva;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2022QI;""
21 Huelva;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2021QIV;2.887
21 Huelva;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
21 Huelva;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2021QII;""
21 Huelva;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2021QI;""
21 Huelva;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2020QIV;2.732
21 Huelva;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
21 Huelva;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2020QII;""
21 Huelva;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2020QI;""
21 Huelva;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
21 Huelva;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
21 Huelva;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QII;""
21 Huelva;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QI;2.779
21 Huelva;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
21 Huelva;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
21 Huelva;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QII;""
21 Huelva;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QI;2.633
21 Huelva;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
21 Huelva;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
21 Huelva;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QII;""
21 Huelva;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QI;""
21 Huelva;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
21 Huelva;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
21 Huelva;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QII;2.674
21 Huelva;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QI;""
21 Huelva;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
21 Huelva;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
21 Huelva;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QII;2.531
21 Huelva;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QI;""
21 Huelva;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
21 Huelva;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
21 Huelva;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QII;""
21 Huelva;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QI;""
21 Huelva;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
21 Huelva;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
21 Huelva;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
21 Huelva;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
21 Huelva;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
21 Huelva;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
21 Huelva;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
21 Huelva;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
21 Huelva;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
21 Huelva;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
21 Huelva;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
21 Huelva;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
21 Huelva;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
21 Huelva;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;94,93
21 Huelva;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
21 Huelva;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
21 Huelva;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
21 Huelva;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;94,87
21 Huelva;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
21 Huelva;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
21 Huelva;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
21 Huelva;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;95,02
21 Huelva;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
21 Huelva;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
21 Huelva;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;89,18
21 Huelva;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
21 Huelva;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
21 Huelva;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
21 Huelva;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;89,69
21 Huelva;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
21 Huelva;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
21 Huelva;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
21 Huelva;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;90,14
21 Huelva;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
21 Huelva;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
21 Huelva;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
21 Huelva;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
21 Huelva;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
21 Huelva;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
21 Huelva;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;86,33
21 Huelva;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
21 Huelva;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
21 Huelva;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
21 Huelva;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;86,87
21 Huelva;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
21 Huelva;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
21 Huelva;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
21 Huelva;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
21 Huelva;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
21 Huelva;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
21 Huelva;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;83,07
21 Huelva;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
21 Huelva;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
21 Huelva;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
21 Huelva;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;83,5
21 Huelva;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
21 Huelva;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
21 Huelva;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
21 Huelva;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
21 Huelva;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
21 Huelva;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
21 Huelva;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QIII;2.198
21 Huelva;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
21 Huelva;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
21 Huelva;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
21 Huelva;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QIII;2.125
21 Huelva;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
21 Huelva;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
21 Huelva;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
21 Huelva;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QIII;1.983
21 Huelva;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
21 Huelva;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
21 Huelva;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
21 Huelva;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2022QIII;2.100
21 Huelva;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2022QII;""
21 Huelva;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2022QI;""
21 Huelva;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
21 Huelva;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2021QIII;2.024
21 Huelva;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2021QII;""
21 Huelva;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2021QI;""
21 Huelva;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
21 Huelva;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2020QIII;1.880
21 Huelva;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2020QII;""
21 Huelva;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2020QI;""
21 Huelva;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2022QIV;1.976
21 Huelva;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
21 Huelva;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2022QII;""
21 Huelva;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2022QI;""
21 Huelva;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2021QIV;1.925
21 Huelva;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
21 Huelva;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2021QII;""
21 Huelva;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2021QI;""
21 Huelva;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2020QIV;1.797
21 Huelva;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
21 Huelva;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2020QII;""
21 Huelva;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2020QI;""
21 Huelva;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
21 Huelva;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
21 Huelva;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QII;""
21 Huelva;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QI;1.857
21 Huelva;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
21 Huelva;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
21 Huelva;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QII;""
21 Huelva;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QI;1.734
21 Huelva;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
21 Huelva;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
21 Huelva;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QII;""
21 Huelva;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QI;""
21 Huelva;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
21 Huelva;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
21 Huelva;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QII;1.786
21 Huelva;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QI;""
21 Huelva;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
21 Huelva;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
21 Huelva;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QII;1.670
21 Huelva;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QI;""
21 Huelva;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
21 Huelva;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
21 Huelva;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QII;""
21 Huelva;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QI;""
21 Huelva;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
21 Huelva;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
21 Huelva;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
21 Huelva;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
21 Huelva;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
21 Huelva;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
21 Huelva;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
21 Huelva;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
21 Huelva;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
21 Huelva;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
21 Huelva;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
21 Huelva;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
21 Huelva;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
21 Huelva;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;95,54
21 Huelva;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
21 Huelva;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
21 Huelva;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
21 Huelva;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;95,25
21 Huelva;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
21 Huelva;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
21 Huelva;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
21 Huelva;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;94,81
21 Huelva;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
21 Huelva;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
21 Huelva;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;89,9
21 Huelva;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
21 Huelva;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
21 Huelva;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
21 Huelva;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;90,59
21 Huelva;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
21 Huelva;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
21 Huelva;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
21 Huelva;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;90,62
21 Huelva;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
21 Huelva;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
21 Huelva;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
21 Huelva;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
21 Huelva;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
21 Huelva;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
21 Huelva;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;87,39
21 Huelva;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
21 Huelva;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
21 Huelva;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
21 Huelva;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;87,44
21 Huelva;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
21 Huelva;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
21 Huelva;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
21 Huelva;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
21 Huelva;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
21 Huelva;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
21 Huelva;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;84,05
21 Huelva;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
21 Huelva;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
21 Huelva;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
21 Huelva;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;84,22
21 Huelva;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
21 Huelva;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
21 Huelva;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
21 Huelva;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
21 Huelva;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
21 Huelva;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
21 Huelva;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QIII;1.138
21 Huelva;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
21 Huelva;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
21 Huelva;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
21 Huelva;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QIII;1.094
21 Huelva;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
21 Huelva;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
21 Huelva;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
21 Huelva;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QIII;1.048
21 Huelva;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
21 Huelva;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
21 Huelva;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
21 Huelva;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2022QIII;1.067
21 Huelva;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2022QII;""
21 Huelva;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2022QI;""
21 Huelva;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
21 Huelva;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2021QIII;1.030
21 Huelva;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2021QII;""
21 Huelva;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2021QI;""
21 Huelva;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
21 Huelva;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2020QIII;1.000
21 Huelva;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2020QII;""
21 Huelva;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2020QI;""
21 Huelva;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2022QIV;999
21 Huelva;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
21 Huelva;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2022QII;""
21 Huelva;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2022QI;""
21 Huelva;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2021QIV;962
21 Huelva;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
21 Huelva;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2021QII;""
21 Huelva;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2021QI;""
21 Huelva;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2020QIV;935
21 Huelva;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
21 Huelva;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2020QII;""
21 Huelva;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2020QI;""
21 Huelva;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
21 Huelva;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
21 Huelva;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QII;""
21 Huelva;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QI;922
21 Huelva;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
21 Huelva;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
21 Huelva;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QII;""
21 Huelva;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QI;899
21 Huelva;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
21 Huelva;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
21 Huelva;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QII;""
21 Huelva;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QI;""
21 Huelva;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
21 Huelva;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
21 Huelva;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QII;888
21 Huelva;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QI;""
21 Huelva;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
21 Huelva;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
21 Huelva;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QII;861
21 Huelva;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QI;""
21 Huelva;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
21 Huelva;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
21 Huelva;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QII;""
21 Huelva;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QI;""
21 Huelva;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
21 Huelva;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
21 Huelva;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
21 Huelva;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
21 Huelva;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
21 Huelva;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
21 Huelva;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
21 Huelva;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
21 Huelva;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
21 Huelva;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
21 Huelva;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
21 Huelva;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
21 Huelva;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
21 Huelva;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;93,76
21 Huelva;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
21 Huelva;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
21 Huelva;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
21 Huelva;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;94,15
21 Huelva;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
21 Huelva;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
21 Huelva;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
21 Huelva;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;95,42
21 Huelva;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
21 Huelva;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
21 Huelva;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;87,79
21 Huelva;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
21 Huelva;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
21 Huelva;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
21 Huelva;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;87,93
21 Huelva;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
21 Huelva;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
21 Huelva;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
21 Huelva;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;89,22
21 Huelva;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
21 Huelva;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
21 Huelva;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
21 Huelva;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
21 Huelva;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
21 Huelva;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
21 Huelva;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;84,28
21 Huelva;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
21 Huelva;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
21 Huelva;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
21 Huelva;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;85,78
21 Huelva;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
21 Huelva;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
21 Huelva;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
21 Huelva;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
21 Huelva;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
21 Huelva;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
21 Huelva;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;81,17
21 Huelva;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
21 Huelva;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
21 Huelva;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
21 Huelva;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;82,16
21 Huelva;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
21 Huelva;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
21 Huelva;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
21 Huelva;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
21 Huelva;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
21 Huelva;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QIV;3.200
21 Huelva;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
21 Huelva;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
21 Huelva;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
21 Huelva;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QIV;3.095
21 Huelva;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
21 Huelva;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
21 Huelva;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
21 Huelva;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QIV;2.919
21 Huelva;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
21 Huelva;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
21 Huelva;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
21 Huelva;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2022QIV;3.001
21 Huelva;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
21 Huelva;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2022QII;""
21 Huelva;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2022QI;""
21 Huelva;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2021QIV;2.918
21 Huelva;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
21 Huelva;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2021QII;""
21 Huelva;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2021QI;""
21 Huelva;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2020QIV;2.764
21 Huelva;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
21 Huelva;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2020QII;""
21 Huelva;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2020QI;""
21 Huelva;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
21 Huelva;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
21 Huelva;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2022QII;""
21 Huelva;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2022QI;2.810
21 Huelva;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
21 Huelva;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
21 Huelva;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2021QII;""
21 Huelva;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2021QI;2.663
21 Huelva;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
21 Huelva;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
21 Huelva;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2020QII;""
21 Huelva;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2020QI;""
21 Huelva;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
21 Huelva;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
21 Huelva;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QII;2.702
21 Huelva;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QI;""
21 Huelva;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
21 Huelva;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
21 Huelva;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QII;2.559
21 Huelva;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QI;""
21 Huelva;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
21 Huelva;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
21 Huelva;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QII;""
21 Huelva;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QI;""
21 Huelva;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
21 Huelva;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QIII;2.590
21 Huelva;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QII;""
21 Huelva;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QI;""
21 Huelva;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
21 Huelva;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QIII;2.460
21 Huelva;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QII;""
21 Huelva;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QI;""
21 Huelva;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
21 Huelva;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
21 Huelva;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QII;""
21 Huelva;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QI;""
21 Huelva;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
21 Huelva;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
21 Huelva;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
21 Huelva;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
21 Huelva;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
21 Huelva;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
21 Huelva;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
21 Huelva;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
21 Huelva;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
21 Huelva;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
21 Huelva;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
21 Huelva;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
21 Huelva;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;93,78
21 Huelva;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
21 Huelva;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
21 Huelva;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
21 Huelva;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;94,28
21 Huelva;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
21 Huelva;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
21 Huelva;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
21 Huelva;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;94,69
21 Huelva;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
21 Huelva;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
21 Huelva;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
21 Huelva;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
21 Huelva;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
21 Huelva;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
21 Huelva;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;90,79
21 Huelva;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
21 Huelva;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
21 Huelva;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
21 Huelva;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;91,23
21 Huelva;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
21 Huelva;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
21 Huelva;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
21 Huelva;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
21 Huelva;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
21 Huelva;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
21 Huelva;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;87,3
21 Huelva;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
21 Huelva;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
21 Huelva;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
21 Huelva;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;87,67
21 Huelva;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
21 Huelva;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
21 Huelva;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
21 Huelva;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
21 Huelva;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
21 Huelva;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
21 Huelva;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;83,68
21 Huelva;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
21 Huelva;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
21 Huelva;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
21 Huelva;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;84,28
21 Huelva;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
21 Huelva;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
21 Huelva;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
21 Huelva;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
21 Huelva;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
21 Huelva;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
21 Huelva;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QIV;2.120
21 Huelva;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
21 Huelva;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
21 Huelva;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
21 Huelva;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QIV;2.051
21 Huelva;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
21 Huelva;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
21 Huelva;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
21 Huelva;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QIV;1.906
21 Huelva;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
21 Huelva;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
21 Huelva;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
21 Huelva;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2022QIV;1.991
21 Huelva;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
21 Huelva;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2022QII;""
21 Huelva;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2022QI;""
21 Huelva;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2021QIV;1.944
21 Huelva;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
21 Huelva;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2021QII;""
21 Huelva;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2021QI;""
21 Huelva;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2020QIV;1.818
21 Huelva;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
21 Huelva;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2020QII;""
21 Huelva;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2020QI;""
21 Huelva;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
21 Huelva;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
21 Huelva;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2022QII;""
21 Huelva;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2022QI;1.876
21 Huelva;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
21 Huelva;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
21 Huelva;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2021QII;""
21 Huelva;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2021QI;1.754
21 Huelva;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
21 Huelva;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
21 Huelva;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2020QII;""
21 Huelva;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2020QI;""
21 Huelva;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
21 Huelva;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
21 Huelva;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QII;1.802
21 Huelva;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QI;""
21 Huelva;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
21 Huelva;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
21 Huelva;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QII;1.688
21 Huelva;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QI;""
21 Huelva;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
21 Huelva;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
21 Huelva;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QII;""
21 Huelva;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QI;""
21 Huelva;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
21 Huelva;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QIII;1.735
21 Huelva;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QII;""
21 Huelva;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QI;""
21 Huelva;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
21 Huelva;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QIII;1.625
21 Huelva;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QII;""
21 Huelva;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QI;""
21 Huelva;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
21 Huelva;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
21 Huelva;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QII;""
21 Huelva;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QI;""
21 Huelva;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
21 Huelva;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
21 Huelva;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
21 Huelva;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
21 Huelva;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
21 Huelva;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
21 Huelva;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
21 Huelva;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
21 Huelva;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
21 Huelva;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
21 Huelva;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
21 Huelva;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
21 Huelva;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;93,92
21 Huelva;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
21 Huelva;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
21 Huelva;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
21 Huelva;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;94,78
21 Huelva;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
21 Huelva;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
21 Huelva;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
21 Huelva;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;95,38
21 Huelva;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
21 Huelva;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
21 Huelva;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
21 Huelva;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
21 Huelva;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
21 Huelva;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
21 Huelva;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;91,47
21 Huelva;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
21 Huelva;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
21 Huelva;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
21 Huelva;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;92,03
21 Huelva;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
21 Huelva;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
21 Huelva;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
21 Huelva;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
21 Huelva;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
21 Huelva;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
21 Huelva;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;87,86
21 Huelva;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
21 Huelva;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
21 Huelva;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
21 Huelva;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;88,56
21 Huelva;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
21 Huelva;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
21 Huelva;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
21 Huelva;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
21 Huelva;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
21 Huelva;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
21 Huelva;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;84,59
21 Huelva;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
21 Huelva;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
21 Huelva;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
21 Huelva;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;85,26
21 Huelva;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
21 Huelva;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
21 Huelva;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
21 Huelva;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
21 Huelva;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
21 Huelva;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
21 Huelva;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QIV;1.080
21 Huelva;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
21 Huelva;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
21 Huelva;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
21 Huelva;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QIV;1.044
21 Huelva;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
21 Huelva;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
21 Huelva;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
21 Huelva;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QIV;1.013
21 Huelva;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
21 Huelva;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
21 Huelva;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
21 Huelva;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2022QIV;1.010
21 Huelva;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
21 Huelva;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2022QII;""
21 Huelva;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2022QI;""
21 Huelva;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2021QIV;974
21 Huelva;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
21 Huelva;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2021QII;""
21 Huelva;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2021QI;""
21 Huelva;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2020QIV;946
21 Huelva;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
21 Huelva;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2020QII;""
21 Huelva;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2020QI;""
21 Huelva;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
21 Huelva;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
21 Huelva;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2022QII;""
21 Huelva;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2022QI;934
21 Huelva;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
21 Huelva;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
21 Huelva;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2021QII;""
21 Huelva;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2021QI;909
21 Huelva;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
21 Huelva;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
21 Huelva;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2020QII;""
21 Huelva;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2020QI;""
21 Huelva;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
21 Huelva;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
21 Huelva;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QII;900
21 Huelva;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QI;""
21 Huelva;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
21 Huelva;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
21 Huelva;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QII;871
21 Huelva;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QI;""
21 Huelva;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
21 Huelva;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
21 Huelva;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QII;""
21 Huelva;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QI;""
21 Huelva;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
21 Huelva;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QIII;855
21 Huelva;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QII;""
21 Huelva;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QI;""
21 Huelva;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
21 Huelva;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QIII;835
21 Huelva;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QII;""
21 Huelva;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QI;""
21 Huelva;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
21 Huelva;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
21 Huelva;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QII;""
21 Huelva;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QI;""
21 Huelva;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
21 Huelva;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
21 Huelva;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
21 Huelva;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
21 Huelva;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
21 Huelva;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
21 Huelva;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
21 Huelva;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
21 Huelva;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
21 Huelva;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
21 Huelva;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
21 Huelva;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
21 Huelva;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;93,52
21 Huelva;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
21 Huelva;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
21 Huelva;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
21 Huelva;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;93,3
21 Huelva;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
21 Huelva;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
21 Huelva;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
21 Huelva;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;93,39
21 Huelva;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
21 Huelva;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
21 Huelva;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
21 Huelva;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
21 Huelva;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
21 Huelva;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
21 Huelva;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;89,46
21 Huelva;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
21 Huelva;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
21 Huelva;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
21 Huelva;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;89,73
21 Huelva;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
21 Huelva;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
21 Huelva;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
21 Huelva;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
21 Huelva;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
21 Huelva;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
21 Huelva;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;86,21
21 Huelva;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
21 Huelva;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
21 Huelva;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
21 Huelva;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;85,98
21 Huelva;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
21 Huelva;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
21 Huelva;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
21 Huelva;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
21 Huelva;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
21 Huelva;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
21 Huelva;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;81,9
21 Huelva;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
21 Huelva;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
21 Huelva;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
21 Huelva;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;82,43
21 Huelva;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
21 Huelva;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
21 Huelva;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
21 Huelva;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
21 Huelva;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
21 Huelva;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
22 Huesca;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
22 Huesca;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
22 Huesca;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
22 Huesca;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QI;14.753
22 Huesca;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
22 Huesca;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
22 Huesca;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
22 Huesca;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QI;14.579
22 Huesca;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
22 Huesca;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
22 Huesca;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
22 Huesca;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QI;15.090
22 Huesca;All ages;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
22 Huesca;All ages;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
22 Huesca;All ages;Cohort January 1;Total;Survival in the first trimester;2022QII;""
22 Huesca;All ages;Cohort January 1;Total;Survival in the first trimester;2022QI;14.372
22 Huesca;All ages;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
22 Huesca;All ages;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
22 Huesca;All ages;Cohort January 1;Total;Survival in the first trimester;2021QII;""
22 Huesca;All ages;Cohort January 1;Total;Survival in the first trimester;2021QI;14.237
22 Huesca;All ages;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
22 Huesca;All ages;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
22 Huesca;All ages;Cohort January 1;Total;Survival in the first trimester;2020QII;""
22 Huesca;All ages;Cohort January 1;Total;Survival in the first trimester;2020QI;14.190
22 Huesca;All ages;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
22 Huesca;All ages;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
22 Huesca;All ages;Cohort January 1;Total;Survival in the second trimester;2022QII;13.955
22 Huesca;All ages;Cohort January 1;Total;Survival in the second trimester;2022QI;""
22 Huesca;All ages;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
22 Huesca;All ages;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
22 Huesca;All ages;Cohort January 1;Total;Survival in the second trimester;2021QII;13.929
22 Huesca;All ages;Cohort January 1;Total;Survival in the second trimester;2021QI;""
22 Huesca;All ages;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
22 Huesca;All ages;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
22 Huesca;All ages;Cohort January 1;Total;Survival in the second trimester;2020QII;13.920
22 Huesca;All ages;Cohort January 1;Total;Survival in the second trimester;2020QI;""
22 Huesca;All ages;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
22 Huesca;All ages;Cohort January 1;Total;Survival in the third trimester;2022QIII;13.637
22 Huesca;All ages;Cohort January 1;Total;Survival in the third trimester;2022QII;""
22 Huesca;All ages;Cohort January 1;Total;Survival in the third trimester;2022QI;""
22 Huesca;All ages;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
22 Huesca;All ages;Cohort January 1;Total;Survival in the third trimester;2021QIII;13.668
22 Huesca;All ages;Cohort January 1;Total;Survival in the third trimester;2021QII;""
22 Huesca;All ages;Cohort January 1;Total;Survival in the third trimester;2021QI;""
22 Huesca;All ages;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
22 Huesca;All ages;Cohort January 1;Total;Survival in the third trimester;2020QIII;13.610
22 Huesca;All ages;Cohort January 1;Total;Survival in the third trimester;2020QII;""
22 Huesca;All ages;Cohort January 1;Total;Survival in the third trimester;2020QI;""
22 Huesca;All ages;Cohort January 1;Total;Survival in the third trimester;2022QIV;13.216
22 Huesca;All ages;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
22 Huesca;All ages;Cohort January 1;Total;Survival in the third trimester;2022QII;""
22 Huesca;All ages;Cohort January 1;Total;Survival in the third trimester;2022QI;""
22 Huesca;All ages;Cohort January 1;Total;Survival in the third trimester;2021QIV;13.322
22 Huesca;All ages;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
22 Huesca;All ages;Cohort January 1;Total;Survival in the third trimester;2021QII;""
22 Huesca;All ages;Cohort January 1;Total;Survival in the third trimester;2021QI;""
22 Huesca;All ages;Cohort January 1;Total;Survival in the third trimester;2020QIV;13.260
22 Huesca;All ages;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
22 Huesca;All ages;Cohort January 1;Total;Survival in the third trimester;2020QII;""
22 Huesca;All ages;Cohort January 1;Total;Survival in the third trimester;2020QI;""
22 Huesca;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
22 Huesca;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
22 Huesca;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
22 Huesca;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
22 Huesca;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
22 Huesca;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
22 Huesca;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
22 Huesca;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
22 Huesca;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
22 Huesca;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
22 Huesca;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
22 Huesca;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
22 Huesca;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
22 Huesca;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
22 Huesca;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
22 Huesca;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;97,42
22 Huesca;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
22 Huesca;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
22 Huesca;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
22 Huesca;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;97,65
22 Huesca;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
22 Huesca;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
22 Huesca;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
22 Huesca;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;94,04
22 Huesca;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
22 Huesca;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
22 Huesca;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;94,59
22 Huesca;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
22 Huesca;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
22 Huesca;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
22 Huesca;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;95,54
22 Huesca;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
22 Huesca;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
22 Huesca;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
22 Huesca;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;92,25
22 Huesca;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
22 Huesca;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
22 Huesca;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;92,44
22 Huesca;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
22 Huesca;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
22 Huesca;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
22 Huesca;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;93,75
22 Huesca;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
22 Huesca;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
22 Huesca;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
22 Huesca;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;90,19
22 Huesca;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
22 Huesca;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
22 Huesca;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;89,58
22 Huesca;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
22 Huesca;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
22 Huesca;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
22 Huesca;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;91,38
22 Huesca;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
22 Huesca;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
22 Huesca;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
22 Huesca;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;87,87
22 Huesca;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
22 Huesca;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
22 Huesca;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
22 Huesca;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
22 Huesca;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
22 Huesca;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
22 Huesca;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QI;9.072
22 Huesca;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
22 Huesca;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
22 Huesca;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
22 Huesca;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QI;8.972
22 Huesca;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
22 Huesca;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
22 Huesca;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
22 Huesca;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QI;9.285
22 Huesca;All ages;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
22 Huesca;All ages;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
22 Huesca;All ages;Cohort January 1;Males;Survival in the first trimester;2022QII;""
22 Huesca;All ages;Cohort January 1;Males;Survival in the first trimester;2022QI;8.853
22 Huesca;All ages;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
22 Huesca;All ages;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
22 Huesca;All ages;Cohort January 1;Males;Survival in the first trimester;2021QII;""
22 Huesca;All ages;Cohort January 1;Males;Survival in the first trimester;2021QI;8.776
22 Huesca;All ages;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
22 Huesca;All ages;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
22 Huesca;All ages;Cohort January 1;Males;Survival in the first trimester;2020QII;""
22 Huesca;All ages;Cohort January 1;Males;Survival in the first trimester;2020QI;8.784
22 Huesca;All ages;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
22 Huesca;All ages;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
22 Huesca;All ages;Cohort January 1;Males;Survival in the second trimester;2022QII;8.623
22 Huesca;All ages;Cohort January 1;Males;Survival in the second trimester;2022QI;""
22 Huesca;All ages;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
22 Huesca;All ages;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
22 Huesca;All ages;Cohort January 1;Males;Survival in the second trimester;2021QII;8.621
22 Huesca;All ages;Cohort January 1;Males;Survival in the second trimester;2021QI;""
22 Huesca;All ages;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
22 Huesca;All ages;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
22 Huesca;All ages;Cohort January 1;Males;Survival in the second trimester;2020QII;8.625
22 Huesca;All ages;Cohort January 1;Males;Survival in the second trimester;2020QI;""
22 Huesca;All ages;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
22 Huesca;All ages;Cohort January 1;Males;Survival in the third trimester;2022QIII;8.432
22 Huesca;All ages;Cohort January 1;Males;Survival in the third trimester;2022QII;""
22 Huesca;All ages;Cohort January 1;Males;Survival in the third trimester;2022QI;""
22 Huesca;All ages;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
22 Huesca;All ages;Cohort January 1;Males;Survival in the third trimester;2021QIII;8.481
22 Huesca;All ages;Cohort January 1;Males;Survival in the third trimester;2021QII;""
22 Huesca;All ages;Cohort January 1;Males;Survival in the third trimester;2021QI;""
22 Huesca;All ages;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
22 Huesca;All ages;Cohort January 1;Males;Survival in the third trimester;2020QIII;8.444
22 Huesca;All ages;Cohort January 1;Males;Survival in the third trimester;2020QII;""
22 Huesca;All ages;Cohort January 1;Males;Survival in the third trimester;2020QI;""
22 Huesca;All ages;Cohort January 1;Males;Survival in the third trimester;2022QIV;8.179
22 Huesca;All ages;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
22 Huesca;All ages;Cohort January 1;Males;Survival in the third trimester;2022QII;""
22 Huesca;All ages;Cohort January 1;Males;Survival in the third trimester;2022QI;""
22 Huesca;All ages;Cohort January 1;Males;Survival in the third trimester;2021QIV;8.268
22 Huesca;All ages;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
22 Huesca;All ages;Cohort January 1;Males;Survival in the third trimester;2021QII;""
22 Huesca;All ages;Cohort January 1;Males;Survival in the third trimester;2021QI;""
22 Huesca;All ages;Cohort January 1;Males;Survival in the third trimester;2020QIV;8.237
22 Huesca;All ages;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
22 Huesca;All ages;Cohort January 1;Males;Survival in the third trimester;2020QII;""
22 Huesca;All ages;Cohort January 1;Males;Survival in the third trimester;2020QI;""
22 Huesca;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
22 Huesca;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
22 Huesca;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
22 Huesca;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
22 Huesca;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
22 Huesca;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
22 Huesca;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
22 Huesca;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
22 Huesca;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
22 Huesca;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
22 Huesca;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
22 Huesca;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
22 Huesca;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
22 Huesca;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
22 Huesca;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
22 Huesca;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;97,59
22 Huesca;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
22 Huesca;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
22 Huesca;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
22 Huesca;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;97,82
22 Huesca;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
22 Huesca;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
22 Huesca;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
22 Huesca;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;94,6
22 Huesca;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
22 Huesca;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
22 Huesca;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;95,05
22 Huesca;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
22 Huesca;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
22 Huesca;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
22 Huesca;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;96,09
22 Huesca;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
22 Huesca;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
22 Huesca;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
22 Huesca;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;92,89
22 Huesca;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
22 Huesca;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
22 Huesca;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;92,95
22 Huesca;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
22 Huesca;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
22 Huesca;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
22 Huesca;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;94,53
22 Huesca;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
22 Huesca;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
22 Huesca;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
22 Huesca;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;90,94
22 Huesca;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
22 Huesca;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
22 Huesca;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;90,16
22 Huesca;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
22 Huesca;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
22 Huesca;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
22 Huesca;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;92,15
22 Huesca;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
22 Huesca;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
22 Huesca;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
22 Huesca;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;88,71
22 Huesca;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
22 Huesca;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
22 Huesca;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
22 Huesca;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
22 Huesca;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
22 Huesca;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
22 Huesca;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QI;5.681
22 Huesca;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
22 Huesca;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
22 Huesca;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
22 Huesca;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QI;5.607
22 Huesca;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
22 Huesca;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
22 Huesca;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
22 Huesca;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QI;5.805
22 Huesca;All ages;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
22 Huesca;All ages;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
22 Huesca;All ages;Cohort January 1;Females;Survival in the first trimester;2022QII;""
22 Huesca;All ages;Cohort January 1;Females;Survival in the first trimester;2022QI;5.519
22 Huesca;All ages;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
22 Huesca;All ages;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
22 Huesca;All ages;Cohort January 1;Females;Survival in the first trimester;2021QII;""
22 Huesca;All ages;Cohort January 1;Females;Survival in the first trimester;2021QI;5.461
22 Huesca;All ages;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
22 Huesca;All ages;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
22 Huesca;All ages;Cohort January 1;Females;Survival in the first trimester;2020QII;""
22 Huesca;All ages;Cohort January 1;Females;Survival in the first trimester;2020QI;5.406
22 Huesca;All ages;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
22 Huesca;All ages;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
22 Huesca;All ages;Cohort January 1;Females;Survival in the second trimester;2022QII;5.332
22 Huesca;All ages;Cohort January 1;Females;Survival in the second trimester;2022QI;""
22 Huesca;All ages;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
22 Huesca;All ages;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
22 Huesca;All ages;Cohort January 1;Females;Survival in the second trimester;2021QII;5.308
22 Huesca;All ages;Cohort January 1;Females;Survival in the second trimester;2021QI;""
22 Huesca;All ages;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
22 Huesca;All ages;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
22 Huesca;All ages;Cohort January 1;Females;Survival in the second trimester;2020QII;5.295
22 Huesca;All ages;Cohort January 1;Females;Survival in the second trimester;2020QI;""
22 Huesca;All ages;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
22 Huesca;All ages;Cohort January 1;Females;Survival in the third trimester;2022QIII;5.205
22 Huesca;All ages;Cohort January 1;Females;Survival in the third trimester;2022QII;""
22 Huesca;All ages;Cohort January 1;Females;Survival in the third trimester;2022QI;""
22 Huesca;All ages;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
22 Huesca;All ages;Cohort January 1;Females;Survival in the third trimester;2021QIII;5.187
22 Huesca;All ages;Cohort January 1;Females;Survival in the third trimester;2021QII;""
22 Huesca;All ages;Cohort January 1;Females;Survival in the third trimester;2021QI;""
22 Huesca;All ages;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
22 Huesca;All ages;Cohort January 1;Females;Survival in the third trimester;2020QIII;5.166
22 Huesca;All ages;Cohort January 1;Females;Survival in the third trimester;2020QII;""
22 Huesca;All ages;Cohort January 1;Females;Survival in the third trimester;2020QI;""
22 Huesca;All ages;Cohort January 1;Females;Survival in the third trimester;2022QIV;5.037
22 Huesca;All ages;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
22 Huesca;All ages;Cohort January 1;Females;Survival in the third trimester;2022QII;""
22 Huesca;All ages;Cohort January 1;Females;Survival in the third trimester;2022QI;""
22 Huesca;All ages;Cohort January 1;Females;Survival in the third trimester;2021QIV;5.054
22 Huesca;All ages;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
22 Huesca;All ages;Cohort January 1;Females;Survival in the third trimester;2021QII;""
22 Huesca;All ages;Cohort January 1;Females;Survival in the third trimester;2021QI;""
22 Huesca;All ages;Cohort January 1;Females;Survival in the third trimester;2020QIV;5.023
22 Huesca;All ages;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
22 Huesca;All ages;Cohort January 1;Females;Survival in the third trimester;2020QII;""
22 Huesca;All ages;Cohort January 1;Females;Survival in the third trimester;2020QI;""
22 Huesca;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
22 Huesca;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
22 Huesca;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
22 Huesca;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
22 Huesca;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
22 Huesca;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
22 Huesca;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
22 Huesca;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
22 Huesca;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
22 Huesca;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
22 Huesca;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
22 Huesca;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
22 Huesca;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
22 Huesca;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
22 Huesca;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
22 Huesca;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;97,15
22 Huesca;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
22 Huesca;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
22 Huesca;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
22 Huesca;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;97,4
22 Huesca;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
22 Huesca;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
22 Huesca;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
22 Huesca;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;93,13
22 Huesca;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
22 Huesca;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
22 Huesca;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;93,86
22 Huesca;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
22 Huesca;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
22 Huesca;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
22 Huesca;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;94,67
22 Huesca;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
22 Huesca;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
22 Huesca;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
22 Huesca;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;91,21
22 Huesca;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
22 Huesca;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
22 Huesca;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;91,62
22 Huesca;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
22 Huesca;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
22 Huesca;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
22 Huesca;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;92,51
22 Huesca;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
22 Huesca;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
22 Huesca;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
22 Huesca;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;88,99
22 Huesca;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
22 Huesca;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
22 Huesca;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;88,66
22 Huesca;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
22 Huesca;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
22 Huesca;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
22 Huesca;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;90,14
22 Huesca;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
22 Huesca;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
22 Huesca;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
22 Huesca;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;86,53
22 Huesca;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
22 Huesca;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
22 Huesca;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
22 Huesca;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
22 Huesca;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
22 Huesca;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QII;14.768
22 Huesca;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
22 Huesca;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
22 Huesca;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
22 Huesca;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QII;14.616
22 Huesca;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
22 Huesca;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
22 Huesca;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
22 Huesca;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QII;14.671
22 Huesca;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
22 Huesca;All ages;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
22 Huesca;All ages;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
22 Huesca;All ages;Cohort April 1;Total;Survival in the first trimester;2022QII;14.293
22 Huesca;All ages;Cohort April 1;Total;Survival in the first trimester;2022QI;""
22 Huesca;All ages;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
22 Huesca;All ages;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
22 Huesca;All ages;Cohort April 1;Total;Survival in the first trimester;2021QII;14.256
22 Huesca;All ages;Cohort April 1;Total;Survival in the first trimester;2021QI;""
22 Huesca;All ages;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
22 Huesca;All ages;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
22 Huesca;All ages;Cohort April 1;Total;Survival in the first trimester;2020QII;14.383
22 Huesca;All ages;Cohort April 1;Total;Survival in the first trimester;2020QI;""
22 Huesca;All ages;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
22 Huesca;All ages;Cohort April 1;Total;Survival in the second trimester;2022QIII;13.951
22 Huesca;All ages;Cohort April 1;Total;Survival in the second trimester;2022QII;""
22 Huesca;All ages;Cohort April 1;Total;Survival in the second trimester;2022QI;""
22 Huesca;All ages;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
22 Huesca;All ages;Cohort April 1;Total;Survival in the second trimester;2021QIII;13.968
22 Huesca;All ages;Cohort April 1;Total;Survival in the second trimester;2021QII;""
22 Huesca;All ages;Cohort April 1;Total;Survival in the second trimester;2021QI;""
22 Huesca;All ages;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
22 Huesca;All ages;Cohort April 1;Total;Survival in the second trimester;2020QIII;14.020
22 Huesca;All ages;Cohort April 1;Total;Survival in the second trimester;2020QII;""
22 Huesca;All ages;Cohort April 1;Total;Survival in the second trimester;2020QI;""
22 Huesca;All ages;Cohort April 1;Total;Survival in the third trimester;2022QIV;13.499
22 Huesca;All ages;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
22 Huesca;All ages;Cohort April 1;Total;Survival in the third trimester;2022QII;""
22 Huesca;All ages;Cohort April 1;Total;Survival in the third trimester;2022QI;""
22 Huesca;All ages;Cohort April 1;Total;Survival in the third trimester;2021QIV;13.594
22 Huesca;All ages;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
22 Huesca;All ages;Cohort April 1;Total;Survival in the third trimester;2021QII;""
22 Huesca;All ages;Cohort April 1;Total;Survival in the third trimester;2021QI;""
22 Huesca;All ages;Cohort April 1;Total;Survival in the third trimester;2020QIV;13.638
22 Huesca;All ages;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
22 Huesca;All ages;Cohort April 1;Total;Survival in the third trimester;2020QII;""
22 Huesca;All ages;Cohort April 1;Total;Survival in the third trimester;2020QI;""
22 Huesca;All ages;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
22 Huesca;All ages;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
22 Huesca;All ages;Cohort April 1;Total;Survival in the third trimester;2022QII;""
22 Huesca;All ages;Cohort April 1;Total;Survival in the third trimester;2022QI;13.311
22 Huesca;All ages;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
22 Huesca;All ages;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
22 Huesca;All ages;Cohort April 1;Total;Survival in the third trimester;2021QII;""
22 Huesca;All ages;Cohort April 1;Total;Survival in the third trimester;2021QI;13.374
22 Huesca;All ages;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
22 Huesca;All ages;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
22 Huesca;All ages;Cohort April 1;Total;Survival in the third trimester;2020QII;""
22 Huesca;All ages;Cohort April 1;Total;Survival in the third trimester;2020QI;""
22 Huesca;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
22 Huesca;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
22 Huesca;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
22 Huesca;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
22 Huesca;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
22 Huesca;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
22 Huesca;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
22 Huesca;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
22 Huesca;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
22 Huesca;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
22 Huesca;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
22 Huesca;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
22 Huesca;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
22 Huesca;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
22 Huesca;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;96,78
22 Huesca;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
22 Huesca;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
22 Huesca;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
22 Huesca;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;97,54
22 Huesca;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
22 Huesca;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
22 Huesca;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
22 Huesca;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;98,04
22 Huesca;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
22 Huesca;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
22 Huesca;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;94,47
22 Huesca;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
22 Huesca;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
22 Huesca;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
22 Huesca;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;95,57
22 Huesca;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
22 Huesca;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
22 Huesca;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
22 Huesca;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;95,56
22 Huesca;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
22 Huesca;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
22 Huesca;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;91,41
22 Huesca;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
22 Huesca;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
22 Huesca;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
22 Huesca;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;93,01
22 Huesca;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
22 Huesca;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
22 Huesca;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
22 Huesca;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;92,96
22 Huesca;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
22 Huesca;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
22 Huesca;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
22 Huesca;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
22 Huesca;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
22 Huesca;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
22 Huesca;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;91,07
22 Huesca;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
22 Huesca;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
22 Huesca;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
22 Huesca;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;91,16
22 Huesca;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
22 Huesca;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
22 Huesca;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
22 Huesca;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
22 Huesca;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
22 Huesca;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
22 Huesca;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QII;9.074
22 Huesca;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
22 Huesca;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
22 Huesca;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
22 Huesca;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QII;8.997
22 Huesca;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
22 Huesca;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
22 Huesca;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
22 Huesca;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QII;9.057
22 Huesca;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
22 Huesca;All ages;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
22 Huesca;All ages;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
22 Huesca;All ages;Cohort April 1;Males;Survival in the first trimester;2022QII;8.809
22 Huesca;All ages;Cohort April 1;Males;Survival in the first trimester;2022QI;""
22 Huesca;All ages;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
22 Huesca;All ages;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
22 Huesca;All ages;Cohort April 1;Males;Survival in the first trimester;2021QII;8.817
22 Huesca;All ages;Cohort April 1;Males;Survival in the first trimester;2021QI;""
22 Huesca;All ages;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
22 Huesca;All ages;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
22 Huesca;All ages;Cohort April 1;Males;Survival in the first trimester;2020QII;8.888
22 Huesca;All ages;Cohort April 1;Males;Survival in the first trimester;2020QI;""
22 Huesca;All ages;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
22 Huesca;All ages;Cohort April 1;Males;Survival in the second trimester;2022QIII;8.603
22 Huesca;All ages;Cohort April 1;Males;Survival in the second trimester;2022QII;""
22 Huesca;All ages;Cohort April 1;Males;Survival in the second trimester;2022QI;""
22 Huesca;All ages;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
22 Huesca;All ages;Cohort April 1;Males;Survival in the second trimester;2021QIII;8.659
22 Huesca;All ages;Cohort April 1;Males;Survival in the second trimester;2021QII;""
22 Huesca;All ages;Cohort April 1;Males;Survival in the second trimester;2021QI;""
22 Huesca;All ages;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
22 Huesca;All ages;Cohort April 1;Males;Survival in the second trimester;2020QIII;8.673
22 Huesca;All ages;Cohort April 1;Males;Survival in the second trimester;2020QII;""
22 Huesca;All ages;Cohort April 1;Males;Survival in the second trimester;2020QI;""
22 Huesca;All ages;Cohort April 1;Males;Survival in the third trimester;2022QIV;8.334
22 Huesca;All ages;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
22 Huesca;All ages;Cohort April 1;Males;Survival in the third trimester;2022QII;""
22 Huesca;All ages;Cohort April 1;Males;Survival in the third trimester;2022QI;""
22 Huesca;All ages;Cohort April 1;Males;Survival in the third trimester;2021QIV;8.426
22 Huesca;All ages;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
22 Huesca;All ages;Cohort April 1;Males;Survival in the third trimester;2021QII;""
22 Huesca;All ages;Cohort April 1;Males;Survival in the third trimester;2021QI;""
22 Huesca;All ages;Cohort April 1;Males;Survival in the third trimester;2020QIV;8.447
22 Huesca;All ages;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
22 Huesca;All ages;Cohort April 1;Males;Survival in the third trimester;2020QII;""
22 Huesca;All ages;Cohort April 1;Males;Survival in the third trimester;2020QI;""
22 Huesca;All ages;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
22 Huesca;All ages;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
22 Huesca;All ages;Cohort April 1;Males;Survival in the third trimester;2022QII;""
22 Huesca;All ages;Cohort April 1;Males;Survival in the third trimester;2022QI;8.261
22 Huesca;All ages;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
22 Huesca;All ages;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
22 Huesca;All ages;Cohort April 1;Males;Survival in the third trimester;2021QII;""
22 Huesca;All ages;Cohort April 1;Males;Survival in the third trimester;2021QI;8.305
22 Huesca;All ages;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
22 Huesca;All ages;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
22 Huesca;All ages;Cohort April 1;Males;Survival in the third trimester;2020QII;""
22 Huesca;All ages;Cohort April 1;Males;Survival in the third trimester;2020QI;""
22 Huesca;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
22 Huesca;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
22 Huesca;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
22 Huesca;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
22 Huesca;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
22 Huesca;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
22 Huesca;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
22 Huesca;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
22 Huesca;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
22 Huesca;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
22 Huesca;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
22 Huesca;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
22 Huesca;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
22 Huesca;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
22 Huesca;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;97,08
22 Huesca;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
22 Huesca;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
22 Huesca;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
22 Huesca;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;98
22 Huesca;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
22 Huesca;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
22 Huesca;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
22 Huesca;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;98,13
22 Huesca;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
22 Huesca;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
22 Huesca;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;94,81
22 Huesca;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
22 Huesca;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
22 Huesca;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
22 Huesca;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;96,24
22 Huesca;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
22 Huesca;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
22 Huesca;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
22 Huesca;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;95,76
22 Huesca;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
22 Huesca;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
22 Huesca;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;91,84
22 Huesca;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
22 Huesca;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
22 Huesca;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
22 Huesca;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;93,65
22 Huesca;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
22 Huesca;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
22 Huesca;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
22 Huesca;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;93,26
22 Huesca;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
22 Huesca;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
22 Huesca;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
22 Huesca;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
22 Huesca;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
22 Huesca;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
22 Huesca;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;91,82
22 Huesca;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
22 Huesca;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
22 Huesca;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
22 Huesca;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;91,7
22 Huesca;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
22 Huesca;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
22 Huesca;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
22 Huesca;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
22 Huesca;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
22 Huesca;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
22 Huesca;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QII;5.694
22 Huesca;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
22 Huesca;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
22 Huesca;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
22 Huesca;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QII;5.619
22 Huesca;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
22 Huesca;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
22 Huesca;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
22 Huesca;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QII;5.614
22 Huesca;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
22 Huesca;All ages;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
22 Huesca;All ages;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
22 Huesca;All ages;Cohort April 1;Females;Survival in the first trimester;2022QII;5.484
22 Huesca;All ages;Cohort April 1;Females;Survival in the first trimester;2022QI;""
22 Huesca;All ages;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
22 Huesca;All ages;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
22 Huesca;All ages;Cohort April 1;Females;Survival in the first trimester;2021QII;5.439
22 Huesca;All ages;Cohort April 1;Females;Survival in the first trimester;2021QI;""
22 Huesca;All ages;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
22 Huesca;All ages;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
22 Huesca;All ages;Cohort April 1;Females;Survival in the first trimester;2020QII;5.495
22 Huesca;All ages;Cohort April 1;Females;Survival in the first trimester;2020QI;""
22 Huesca;All ages;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
22 Huesca;All ages;Cohort April 1;Females;Survival in the second trimester;2022QIII;5.348
22 Huesca;All ages;Cohort April 1;Females;Survival in the second trimester;2022QII;""
22 Huesca;All ages;Cohort April 1;Females;Survival in the second trimester;2022QI;""
22 Huesca;All ages;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
22 Huesca;All ages;Cohort April 1;Females;Survival in the second trimester;2021QIII;5.309
22 Huesca;All ages;Cohort April 1;Females;Survival in the second trimester;2021QII;""
22 Huesca;All ages;Cohort April 1;Females;Survival in the second trimester;2021QI;""
22 Huesca;All ages;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
22 Huesca;All ages;Cohort April 1;Females;Survival in the second trimester;2020QIII;5.347
22 Huesca;All ages;Cohort April 1;Females;Survival in the second trimester;2020QII;""
22 Huesca;All ages;Cohort April 1;Females;Survival in the second trimester;2020QI;""
22 Huesca;All ages;Cohort April 1;Females;Survival in the third trimester;2022QIV;5.165
22 Huesca;All ages;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
22 Huesca;All ages;Cohort April 1;Females;Survival in the third trimester;2022QII;""
22 Huesca;All ages;Cohort April 1;Females;Survival in the third trimester;2022QI;""
22 Huesca;All ages;Cohort April 1;Females;Survival in the third trimester;2021QIV;5.168
22 Huesca;All ages;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
22 Huesca;All ages;Cohort April 1;Females;Survival in the third trimester;2021QII;""
22 Huesca;All ages;Cohort April 1;Females;Survival in the third trimester;2021QI;""
22 Huesca;All ages;Cohort April 1;Females;Survival in the third trimester;2020QIV;5.191
22 Huesca;All ages;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
22 Huesca;All ages;Cohort April 1;Females;Survival in the third trimester;2020QII;""
22 Huesca;All ages;Cohort April 1;Females;Survival in the third trimester;2020QI;""
22 Huesca;All ages;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
22 Huesca;All ages;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
22 Huesca;All ages;Cohort April 1;Females;Survival in the third trimester;2022QII;""
22 Huesca;All ages;Cohort April 1;Females;Survival in the third trimester;2022QI;5.050
22 Huesca;All ages;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
22 Huesca;All ages;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
22 Huesca;All ages;Cohort April 1;Females;Survival in the third trimester;2021QII;""
22 Huesca;All ages;Cohort April 1;Females;Survival in the third trimester;2021QI;5.069
22 Huesca;All ages;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
22 Huesca;All ages;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
22 Huesca;All ages;Cohort April 1;Females;Survival in the third trimester;2020QII;""
22 Huesca;All ages;Cohort April 1;Females;Survival in the third trimester;2020QI;""
22 Huesca;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
22 Huesca;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
22 Huesca;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
22 Huesca;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
22 Huesca;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
22 Huesca;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
22 Huesca;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
22 Huesca;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
22 Huesca;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
22 Huesca;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
22 Huesca;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
22 Huesca;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
22 Huesca;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
22 Huesca;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
22 Huesca;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;96,31
22 Huesca;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
22 Huesca;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
22 Huesca;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
22 Huesca;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;96,8
22 Huesca;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
22 Huesca;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
22 Huesca;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
22 Huesca;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;97,88
22 Huesca;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
22 Huesca;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
22 Huesca;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;93,92
22 Huesca;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
22 Huesca;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
22 Huesca;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
22 Huesca;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;94,48
22 Huesca;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
22 Huesca;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
22 Huesca;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
22 Huesca;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;95,24
22 Huesca;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
22 Huesca;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
22 Huesca;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;90,71
22 Huesca;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
22 Huesca;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
22 Huesca;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
22 Huesca;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;91,97
22 Huesca;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
22 Huesca;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
22 Huesca;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
22 Huesca;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;92,47
22 Huesca;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
22 Huesca;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
22 Huesca;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
22 Huesca;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
22 Huesca;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
22 Huesca;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
22 Huesca;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;89,87
22 Huesca;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
22 Huesca;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
22 Huesca;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
22 Huesca;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;90,29
22 Huesca;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
22 Huesca;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
22 Huesca;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
22 Huesca;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
22 Huesca;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
22 Huesca;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QIII;14.882
22 Huesca;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
22 Huesca;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
22 Huesca;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
22 Huesca;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QIII;14.798
22 Huesca;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
22 Huesca;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
22 Huesca;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
22 Huesca;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QIII;14.763
22 Huesca;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
22 Huesca;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
22 Huesca;All ages;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
22 Huesca;All ages;Cohort July 1;Total;Survival in the first trimester;2022QIII;14.382
22 Huesca;All ages;Cohort July 1;Total;Survival in the first trimester;2022QII;""
22 Huesca;All ages;Cohort July 1;Total;Survival in the first trimester;2022QI;""
22 Huesca;All ages;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
22 Huesca;All ages;Cohort July 1;Total;Survival in the first trimester;2021QIII;14.386
22 Huesca;All ages;Cohort July 1;Total;Survival in the first trimester;2021QII;""
22 Huesca;All ages;Cohort July 1;Total;Survival in the first trimester;2021QI;""
22 Huesca;All ages;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
22 Huesca;All ages;Cohort July 1;Total;Survival in the first trimester;2020QIII;14.304
22 Huesca;All ages;Cohort July 1;Total;Survival in the first trimester;2020QII;""
22 Huesca;All ages;Cohort July 1;Total;Survival in the first trimester;2020QI;""
22 Huesca;All ages;Cohort July 1;Total;Survival in the second trimester;2022QIV;13.861
22 Huesca;All ages;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
22 Huesca;All ages;Cohort July 1;Total;Survival in the second trimester;2022QII;""
22 Huesca;All ages;Cohort July 1;Total;Survival in the second trimester;2022QI;""
22 Huesca;All ages;Cohort July 1;Total;Survival in the second trimester;2021QIV;13.939
22 Huesca;All ages;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
22 Huesca;All ages;Cohort July 1;Total;Survival in the second trimester;2021QII;""
22 Huesca;All ages;Cohort July 1;Total;Survival in the second trimester;2021QI;""
22 Huesca;All ages;Cohort July 1;Total;Survival in the second trimester;2020QIV;13.876
22 Huesca;All ages;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
22 Huesca;All ages;Cohort July 1;Total;Survival in the second trimester;2020QII;""
22 Huesca;All ages;Cohort July 1;Total;Survival in the second trimester;2020QI;""
22 Huesca;All ages;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
22 Huesca;All ages;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
22 Huesca;All ages;Cohort July 1;Total;Survival in the third trimester;2022QII;""
22 Huesca;All ages;Cohort July 1;Total;Survival in the third trimester;2022QI;13.640
22 Huesca;All ages;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
22 Huesca;All ages;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
22 Huesca;All ages;Cohort July 1;Total;Survival in the third trimester;2021QII;""
22 Huesca;All ages;Cohort July 1;Total;Survival in the third trimester;2021QI;13.601
22 Huesca;All ages;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
22 Huesca;All ages;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
22 Huesca;All ages;Cohort July 1;Total;Survival in the third trimester;2020QII;""
22 Huesca;All ages;Cohort July 1;Total;Survival in the third trimester;2020QI;""
22 Huesca;All ages;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
22 Huesca;All ages;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
22 Huesca;All ages;Cohort July 1;Total;Survival in the third trimester;2022QII;13.341
22 Huesca;All ages;Cohort July 1;Total;Survival in the third trimester;2022QI;""
22 Huesca;All ages;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
22 Huesca;All ages;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
22 Huesca;All ages;Cohort July 1;Total;Survival in the third trimester;2021QII;13.356
22 Huesca;All ages;Cohort July 1;Total;Survival in the third trimester;2021QI;""
22 Huesca;All ages;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
22 Huesca;All ages;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
22 Huesca;All ages;Cohort July 1;Total;Survival in the third trimester;2020QII;""
22 Huesca;All ages;Cohort July 1;Total;Survival in the third trimester;2020QI;""
22 Huesca;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
22 Huesca;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
22 Huesca;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
22 Huesca;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
22 Huesca;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
22 Huesca;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
22 Huesca;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
22 Huesca;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
22 Huesca;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
22 Huesca;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
22 Huesca;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
22 Huesca;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
22 Huesca;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
22 Huesca;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;96,64
22 Huesca;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
22 Huesca;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
22 Huesca;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
22 Huesca;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;97,22
22 Huesca;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
22 Huesca;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
22 Huesca;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
22 Huesca;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;96,89
22 Huesca;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
22 Huesca;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
22 Huesca;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;93,14
22 Huesca;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
22 Huesca;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
22 Huesca;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
22 Huesca;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;94,2
22 Huesca;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
22 Huesca;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
22 Huesca;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
22 Huesca;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;93,99
22 Huesca;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
22 Huesca;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
22 Huesca;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
22 Huesca;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
22 Huesca;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
22 Huesca;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
22 Huesca;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;92,17
22 Huesca;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
22 Huesca;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
22 Huesca;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
22 Huesca;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;92,13
22 Huesca;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
22 Huesca;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
22 Huesca;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
22 Huesca;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
22 Huesca;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
22 Huesca;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
22 Huesca;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;90,15
22 Huesca;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
22 Huesca;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
22 Huesca;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
22 Huesca;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;90,47
22 Huesca;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
22 Huesca;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
22 Huesca;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
22 Huesca;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
22 Huesca;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
22 Huesca;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
22 Huesca;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QIII;9.123
22 Huesca;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
22 Huesca;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
22 Huesca;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
22 Huesca;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QIII;9.122
22 Huesca;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
22 Huesca;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
22 Huesca;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
22 Huesca;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QIII;9.110
22 Huesca;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
22 Huesca;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
22 Huesca;All ages;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
22 Huesca;All ages;Cohort July 1;Males;Survival in the first trimester;2022QIII;8.831
22 Huesca;All ages;Cohort July 1;Males;Survival in the first trimester;2022QII;""
22 Huesca;All ages;Cohort July 1;Males;Survival in the first trimester;2022QI;""
22 Huesca;All ages;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
22 Huesca;All ages;Cohort July 1;Males;Survival in the first trimester;2021QIII;8.900
22 Huesca;All ages;Cohort July 1;Males;Survival in the first trimester;2021QII;""
22 Huesca;All ages;Cohort July 1;Males;Survival in the first trimester;2021QI;""
22 Huesca;All ages;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
22 Huesca;All ages;Cohort July 1;Males;Survival in the first trimester;2020QIII;8.834
22 Huesca;All ages;Cohort July 1;Males;Survival in the first trimester;2020QII;""
22 Huesca;All ages;Cohort July 1;Males;Survival in the first trimester;2020QI;""
22 Huesca;All ages;Cohort July 1;Males;Survival in the second trimester;2022QIV;8.526
22 Huesca;All ages;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
22 Huesca;All ages;Cohort July 1;Males;Survival in the second trimester;2022QII;""
22 Huesca;All ages;Cohort July 1;Males;Survival in the second trimester;2022QI;""
22 Huesca;All ages;Cohort July 1;Males;Survival in the second trimester;2021QIV;8.626
22 Huesca;All ages;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
22 Huesca;All ages;Cohort July 1;Males;Survival in the second trimester;2021QII;""
22 Huesca;All ages;Cohort July 1;Males;Survival in the second trimester;2021QI;""
22 Huesca;All ages;Cohort July 1;Males;Survival in the second trimester;2020QIV;8.582
22 Huesca;All ages;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
22 Huesca;All ages;Cohort July 1;Males;Survival in the second trimester;2020QII;""
22 Huesca;All ages;Cohort July 1;Males;Survival in the second trimester;2020QI;""
22 Huesca;All ages;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
22 Huesca;All ages;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
22 Huesca;All ages;Cohort July 1;Males;Survival in the third trimester;2022QII;""
22 Huesca;All ages;Cohort July 1;Males;Survival in the third trimester;2022QI;8.452
22 Huesca;All ages;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
22 Huesca;All ages;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
22 Huesca;All ages;Cohort July 1;Males;Survival in the third trimester;2021QII;""
22 Huesca;All ages;Cohort July 1;Males;Survival in the third trimester;2021QI;8.431
22 Huesca;All ages;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
22 Huesca;All ages;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
22 Huesca;All ages;Cohort July 1;Males;Survival in the third trimester;2020QII;""
22 Huesca;All ages;Cohort July 1;Males;Survival in the third trimester;2020QI;""
22 Huesca;All ages;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
22 Huesca;All ages;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
22 Huesca;All ages;Cohort July 1;Males;Survival in the third trimester;2022QII;8.285
22 Huesca;All ages;Cohort July 1;Males;Survival in the third trimester;2022QI;""
22 Huesca;All ages;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
22 Huesca;All ages;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
22 Huesca;All ages;Cohort July 1;Males;Survival in the third trimester;2021QII;8.303
22 Huesca;All ages;Cohort July 1;Males;Survival in the third trimester;2021QI;""
22 Huesca;All ages;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
22 Huesca;All ages;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
22 Huesca;All ages;Cohort July 1;Males;Survival in the third trimester;2020QII;""
22 Huesca;All ages;Cohort July 1;Males;Survival in the third trimester;2020QI;""
22 Huesca;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
22 Huesca;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
22 Huesca;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
22 Huesca;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
22 Huesca;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
22 Huesca;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
22 Huesca;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
22 Huesca;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
22 Huesca;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
22 Huesca;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
22 Huesca;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
22 Huesca;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
22 Huesca;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
22 Huesca;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;96,8
22 Huesca;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
22 Huesca;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
22 Huesca;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
22 Huesca;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;97,57
22 Huesca;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
22 Huesca;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
22 Huesca;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
22 Huesca;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;96,97
22 Huesca;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
22 Huesca;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
22 Huesca;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;93,46
22 Huesca;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
22 Huesca;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
22 Huesca;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
22 Huesca;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;94,56
22 Huesca;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
22 Huesca;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
22 Huesca;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
22 Huesca;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;94,2
22 Huesca;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
22 Huesca;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
22 Huesca;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
22 Huesca;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
22 Huesca;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
22 Huesca;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
22 Huesca;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;92,66
22 Huesca;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
22 Huesca;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
22 Huesca;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
22 Huesca;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;92,55
22 Huesca;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
22 Huesca;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
22 Huesca;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
22 Huesca;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
22 Huesca;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
22 Huesca;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
22 Huesca;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;90,82
22 Huesca;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
22 Huesca;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
22 Huesca;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
22 Huesca;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;91,14
22 Huesca;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
22 Huesca;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
22 Huesca;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
22 Huesca;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
22 Huesca;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
22 Huesca;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
22 Huesca;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QIII;5.759
22 Huesca;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
22 Huesca;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
22 Huesca;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
22 Huesca;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QIII;5.676
22 Huesca;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
22 Huesca;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
22 Huesca;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
22 Huesca;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QIII;5.653
22 Huesca;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
22 Huesca;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
22 Huesca;All ages;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
22 Huesca;All ages;Cohort July 1;Females;Survival in the first trimester;2022QIII;5.551
22 Huesca;All ages;Cohort July 1;Females;Survival in the first trimester;2022QII;""
22 Huesca;All ages;Cohort July 1;Females;Survival in the first trimester;2022QI;""
22 Huesca;All ages;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
22 Huesca;All ages;Cohort July 1;Females;Survival in the first trimester;2021QIII;5.486
22 Huesca;All ages;Cohort July 1;Females;Survival in the first trimester;2021QII;""
22 Huesca;All ages;Cohort July 1;Females;Survival in the first trimester;2021QI;""
22 Huesca;All ages;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
22 Huesca;All ages;Cohort July 1;Females;Survival in the first trimester;2020QIII;5.470
22 Huesca;All ages;Cohort July 1;Females;Survival in the first trimester;2020QII;""
22 Huesca;All ages;Cohort July 1;Females;Survival in the first trimester;2020QI;""
22 Huesca;All ages;Cohort July 1;Females;Survival in the second trimester;2022QIV;5.335
22 Huesca;All ages;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
22 Huesca;All ages;Cohort July 1;Females;Survival in the second trimester;2022QII;""
22 Huesca;All ages;Cohort July 1;Females;Survival in the second trimester;2022QI;""
22 Huesca;All ages;Cohort July 1;Females;Survival in the second trimester;2021QIV;5.313
22 Huesca;All ages;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
22 Huesca;All ages;Cohort July 1;Females;Survival in the second trimester;2021QII;""
22 Huesca;All ages;Cohort July 1;Females;Survival in the second trimester;2021QI;""
22 Huesca;All ages;Cohort July 1;Females;Survival in the second trimester;2020QIV;5.294
22 Huesca;All ages;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
22 Huesca;All ages;Cohort July 1;Females;Survival in the second trimester;2020QII;""
22 Huesca;All ages;Cohort July 1;Females;Survival in the second trimester;2020QI;""
22 Huesca;All ages;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
22 Huesca;All ages;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
22 Huesca;All ages;Cohort July 1;Females;Survival in the third trimester;2022QII;""
22 Huesca;All ages;Cohort July 1;Females;Survival in the third trimester;2022QI;5.188
22 Huesca;All ages;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
22 Huesca;All ages;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
22 Huesca;All ages;Cohort July 1;Females;Survival in the third trimester;2021QII;""
22 Huesca;All ages;Cohort July 1;Females;Survival in the third trimester;2021QI;5.170
22 Huesca;All ages;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
22 Huesca;All ages;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
22 Huesca;All ages;Cohort July 1;Females;Survival in the third trimester;2020QII;""
22 Huesca;All ages;Cohort July 1;Females;Survival in the third trimester;2020QI;""
22 Huesca;All ages;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
22 Huesca;All ages;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
22 Huesca;All ages;Cohort July 1;Females;Survival in the third trimester;2022QII;5.056
22 Huesca;All ages;Cohort July 1;Females;Survival in the third trimester;2022QI;""
22 Huesca;All ages;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
22 Huesca;All ages;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
22 Huesca;All ages;Cohort July 1;Females;Survival in the third trimester;2021QII;5.053
22 Huesca;All ages;Cohort July 1;Females;Survival in the third trimester;2021QI;""
22 Huesca;All ages;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
22 Huesca;All ages;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
22 Huesca;All ages;Cohort July 1;Females;Survival in the third trimester;2020QII;""
22 Huesca;All ages;Cohort July 1;Females;Survival in the third trimester;2020QI;""
22 Huesca;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
22 Huesca;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
22 Huesca;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
22 Huesca;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
22 Huesca;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
22 Huesca;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
22 Huesca;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
22 Huesca;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
22 Huesca;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
22 Huesca;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
22 Huesca;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
22 Huesca;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
22 Huesca;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
22 Huesca;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;96,39
22 Huesca;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
22 Huesca;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
22 Huesca;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
22 Huesca;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;96,65
22 Huesca;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
22 Huesca;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
22 Huesca;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
22 Huesca;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;96,76
22 Huesca;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
22 Huesca;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
22 Huesca;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;92,64
22 Huesca;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
22 Huesca;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
22 Huesca;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
22 Huesca;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;93,6
22 Huesca;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
22 Huesca;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
22 Huesca;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
22 Huesca;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;93,65
22 Huesca;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
22 Huesca;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
22 Huesca;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
22 Huesca;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
22 Huesca;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
22 Huesca;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
22 Huesca;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;91,4
22 Huesca;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
22 Huesca;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
22 Huesca;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
22 Huesca;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;91,46
22 Huesca;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
22 Huesca;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
22 Huesca;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
22 Huesca;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
22 Huesca;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
22 Huesca;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
22 Huesca;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;89,08
22 Huesca;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
22 Huesca;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
22 Huesca;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
22 Huesca;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;89,39
22 Huesca;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
22 Huesca;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
22 Huesca;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
22 Huesca;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
22 Huesca;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
22 Huesca;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QIV;14.727
22 Huesca;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
22 Huesca;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
22 Huesca;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
22 Huesca;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QIV;14.791
22 Huesca;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
22 Huesca;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
22 Huesca;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
22 Huesca;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QIV;14.711
22 Huesca;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
22 Huesca;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
22 Huesca;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
22 Huesca;All ages;Cohort October 1;Total;Survival in the first trimester;2022QIV;14.151
22 Huesca;All ages;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
22 Huesca;All ages;Cohort October 1;Total;Survival in the first trimester;2022QII;""
22 Huesca;All ages;Cohort October 1;Total;Survival in the first trimester;2022QI;""
22 Huesca;All ages;Cohort October 1;Total;Survival in the first trimester;2021QIV;14.270
22 Huesca;All ages;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
22 Huesca;All ages;Cohort October 1;Total;Survival in the first trimester;2021QII;""
22 Huesca;All ages;Cohort October 1;Total;Survival in the first trimester;2021QI;""
22 Huesca;All ages;Cohort October 1;Total;Survival in the first trimester;2020QIV;14.204
22 Huesca;All ages;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
22 Huesca;All ages;Cohort October 1;Total;Survival in the first trimester;2020QII;""
22 Huesca;All ages;Cohort October 1;Total;Survival in the first trimester;2020QI;""
22 Huesca;All ages;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
22 Huesca;All ages;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
22 Huesca;All ages;Cohort October 1;Total;Survival in the second trimester;2022QII;""
22 Huesca;All ages;Cohort October 1;Total;Survival in the second trimester;2022QI;13.945
22 Huesca;All ages;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
22 Huesca;All ages;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
22 Huesca;All ages;Cohort October 1;Total;Survival in the second trimester;2021QII;""
22 Huesca;All ages;Cohort October 1;Total;Survival in the second trimester;2021QI;13.904
22 Huesca;All ages;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
22 Huesca;All ages;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
22 Huesca;All ages;Cohort October 1;Total;Survival in the second trimester;2020QII;""
22 Huesca;All ages;Cohort October 1;Total;Survival in the second trimester;2020QI;""
22 Huesca;All ages;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
22 Huesca;All ages;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
22 Huesca;All ages;Cohort October 1;Total;Survival in the third trimester;2022QII;13.622
22 Huesca;All ages;Cohort October 1;Total;Survival in the third trimester;2022QI;""
22 Huesca;All ages;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
22 Huesca;All ages;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
22 Huesca;All ages;Cohort October 1;Total;Survival in the third trimester;2021QII;13.638
22 Huesca;All ages;Cohort October 1;Total;Survival in the third trimester;2021QI;""
22 Huesca;All ages;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
22 Huesca;All ages;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
22 Huesca;All ages;Cohort October 1;Total;Survival in the third trimester;2020QII;""
22 Huesca;All ages;Cohort October 1;Total;Survival in the third trimester;2020QI;""
22 Huesca;All ages;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
22 Huesca;All ages;Cohort October 1;Total;Survival in the third trimester;2022QIII;13.334
22 Huesca;All ages;Cohort October 1;Total;Survival in the third trimester;2022QII;""
22 Huesca;All ages;Cohort October 1;Total;Survival in the third trimester;2022QI;""
22 Huesca;All ages;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
22 Huesca;All ages;Cohort October 1;Total;Survival in the third trimester;2021QIII;13.399
22 Huesca;All ages;Cohort October 1;Total;Survival in the third trimester;2021QII;""
22 Huesca;All ages;Cohort October 1;Total;Survival in the third trimester;2021QI;""
22 Huesca;All ages;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
22 Huesca;All ages;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
22 Huesca;All ages;Cohort October 1;Total;Survival in the third trimester;2020QII;""
22 Huesca;All ages;Cohort October 1;Total;Survival in the third trimester;2020QI;""
22 Huesca;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
22 Huesca;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
22 Huesca;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
22 Huesca;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
22 Huesca;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
22 Huesca;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
22 Huesca;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
22 Huesca;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
22 Huesca;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
22 Huesca;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
22 Huesca;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
22 Huesca;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
22 Huesca;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;96,09
22 Huesca;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
22 Huesca;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
22 Huesca;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
22 Huesca;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;96,48
22 Huesca;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
22 Huesca;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
22 Huesca;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
22 Huesca;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;96,55
22 Huesca;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
22 Huesca;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
22 Huesca;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
22 Huesca;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
22 Huesca;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
22 Huesca;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
22 Huesca;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;94,28
22 Huesca;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
22 Huesca;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
22 Huesca;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
22 Huesca;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;94,51
22 Huesca;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
22 Huesca;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
22 Huesca;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
22 Huesca;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
22 Huesca;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
22 Huesca;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
22 Huesca;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;92,1
22 Huesca;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
22 Huesca;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
22 Huesca;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
22 Huesca;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;92,71
22 Huesca;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
22 Huesca;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
22 Huesca;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
22 Huesca;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
22 Huesca;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
22 Huesca;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
22 Huesca;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;90,15
22 Huesca;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
22 Huesca;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
22 Huesca;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
22 Huesca;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;91,08
22 Huesca;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
22 Huesca;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
22 Huesca;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
22 Huesca;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
22 Huesca;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
22 Huesca;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
22 Huesca;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QIV;9.021
22 Huesca;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
22 Huesca;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
22 Huesca;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
22 Huesca;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QIV;9.133
22 Huesca;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
22 Huesca;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
22 Huesca;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
22 Huesca;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QIV;9.074
22 Huesca;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
22 Huesca;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
22 Huesca;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
22 Huesca;All ages;Cohort October 1;Males;Survival in the first trimester;2022QIV;8.685
22 Huesca;All ages;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
22 Huesca;All ages;Cohort October 1;Males;Survival in the first trimester;2022QII;""
22 Huesca;All ages;Cohort October 1;Males;Survival in the first trimester;2022QI;""
22 Huesca;All ages;Cohort October 1;Males;Survival in the first trimester;2021QIV;8.816
22 Huesca;All ages;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
22 Huesca;All ages;Cohort October 1;Males;Survival in the first trimester;2021QII;""
22 Huesca;All ages;Cohort October 1;Males;Survival in the first trimester;2021QI;""
22 Huesca;All ages;Cohort October 1;Males;Survival in the first trimester;2020QIV;8.773
22 Huesca;All ages;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
22 Huesca;All ages;Cohort October 1;Males;Survival in the first trimester;2020QII;""
22 Huesca;All ages;Cohort October 1;Males;Survival in the first trimester;2020QI;""
22 Huesca;All ages;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
22 Huesca;All ages;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
22 Huesca;All ages;Cohort October 1;Males;Survival in the second trimester;2022QII;""
22 Huesca;All ages;Cohort October 1;Males;Survival in the second trimester;2022QI;8.629
22 Huesca;All ages;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
22 Huesca;All ages;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
22 Huesca;All ages;Cohort October 1;Males;Survival in the second trimester;2021QII;""
22 Huesca;All ages;Cohort October 1;Males;Survival in the second trimester;2021QI;8.602
22 Huesca;All ages;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
22 Huesca;All ages;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
22 Huesca;All ages;Cohort October 1;Males;Survival in the second trimester;2020QII;""
22 Huesca;All ages;Cohort October 1;Males;Survival in the second trimester;2020QI;""
22 Huesca;All ages;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
22 Huesca;All ages;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
22 Huesca;All ages;Cohort October 1;Males;Survival in the third trimester;2022QII;8.449
22 Huesca;All ages;Cohort October 1;Males;Survival in the third trimester;2022QI;""
22 Huesca;All ages;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
22 Huesca;All ages;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
22 Huesca;All ages;Cohort October 1;Males;Survival in the third trimester;2021QII;8.465
22 Huesca;All ages;Cohort October 1;Males;Survival in the third trimester;2021QI;""
22 Huesca;All ages;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
22 Huesca;All ages;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
22 Huesca;All ages;Cohort October 1;Males;Survival in the third trimester;2020QII;""
22 Huesca;All ages;Cohort October 1;Males;Survival in the third trimester;2020QI;""
22 Huesca;All ages;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
22 Huesca;All ages;Cohort October 1;Males;Survival in the third trimester;2022QIII;8.274
22 Huesca;All ages;Cohort October 1;Males;Survival in the third trimester;2022QII;""
22 Huesca;All ages;Cohort October 1;Males;Survival in the third trimester;2022QI;""
22 Huesca;All ages;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
22 Huesca;All ages;Cohort October 1;Males;Survival in the third trimester;2021QIII;8.336
22 Huesca;All ages;Cohort October 1;Males;Survival in the third trimester;2021QII;""
22 Huesca;All ages;Cohort October 1;Males;Survival in the third trimester;2021QI;""
22 Huesca;All ages;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
22 Huesca;All ages;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
22 Huesca;All ages;Cohort October 1;Males;Survival in the third trimester;2020QII;""
22 Huesca;All ages;Cohort October 1;Males;Survival in the third trimester;2020QI;""
22 Huesca;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
22 Huesca;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
22 Huesca;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
22 Huesca;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
22 Huesca;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
22 Huesca;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
22 Huesca;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
22 Huesca;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
22 Huesca;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
22 Huesca;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
22 Huesca;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
22 Huesca;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
22 Huesca;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;96,28
22 Huesca;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
22 Huesca;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
22 Huesca;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
22 Huesca;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;96,53
22 Huesca;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
22 Huesca;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
22 Huesca;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
22 Huesca;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;96,68
22 Huesca;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
22 Huesca;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
22 Huesca;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
22 Huesca;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
22 Huesca;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
22 Huesca;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
22 Huesca;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;94,48
22 Huesca;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
22 Huesca;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
22 Huesca;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
22 Huesca;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;94,8
22 Huesca;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
22 Huesca;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
22 Huesca;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
22 Huesca;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
22 Huesca;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
22 Huesca;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
22 Huesca;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;92,51
22 Huesca;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
22 Huesca;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
22 Huesca;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
22 Huesca;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;93,29
22 Huesca;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
22 Huesca;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
22 Huesca;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
22 Huesca;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
22 Huesca;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
22 Huesca;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
22 Huesca;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;90,59
22 Huesca;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
22 Huesca;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
22 Huesca;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
22 Huesca;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;91,87
22 Huesca;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
22 Huesca;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
22 Huesca;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
22 Huesca;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
22 Huesca;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
22 Huesca;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
22 Huesca;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QIV;5.706
22 Huesca;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
22 Huesca;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
22 Huesca;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
22 Huesca;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QIV;5.658
22 Huesca;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
22 Huesca;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
22 Huesca;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
22 Huesca;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QIV;5.637
22 Huesca;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
22 Huesca;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
22 Huesca;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
22 Huesca;All ages;Cohort October 1;Females;Survival in the first trimester;2022QIV;5.466
22 Huesca;All ages;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
22 Huesca;All ages;Cohort October 1;Females;Survival in the first trimester;2022QII;""
22 Huesca;All ages;Cohort October 1;Females;Survival in the first trimester;2022QI;""
22 Huesca;All ages;Cohort October 1;Females;Survival in the first trimester;2021QIV;5.454
22 Huesca;All ages;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
22 Huesca;All ages;Cohort October 1;Females;Survival in the first trimester;2021QII;""
22 Huesca;All ages;Cohort October 1;Females;Survival in the first trimester;2021QI;""
22 Huesca;All ages;Cohort October 1;Females;Survival in the first trimester;2020QIV;5.431
22 Huesca;All ages;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
22 Huesca;All ages;Cohort October 1;Females;Survival in the first trimester;2020QII;""
22 Huesca;All ages;Cohort October 1;Females;Survival in the first trimester;2020QI;""
22 Huesca;All ages;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
22 Huesca;All ages;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
22 Huesca;All ages;Cohort October 1;Females;Survival in the second trimester;2022QII;""
22 Huesca;All ages;Cohort October 1;Females;Survival in the second trimester;2022QI;5.316
22 Huesca;All ages;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
22 Huesca;All ages;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
22 Huesca;All ages;Cohort October 1;Females;Survival in the second trimester;2021QII;""
22 Huesca;All ages;Cohort October 1;Females;Survival in the second trimester;2021QI;5.302
22 Huesca;All ages;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
22 Huesca;All ages;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
22 Huesca;All ages;Cohort October 1;Females;Survival in the second trimester;2020QII;""
22 Huesca;All ages;Cohort October 1;Females;Survival in the second trimester;2020QI;""
22 Huesca;All ages;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
22 Huesca;All ages;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
22 Huesca;All ages;Cohort October 1;Females;Survival in the third trimester;2022QII;5.173
22 Huesca;All ages;Cohort October 1;Females;Survival in the third trimester;2022QI;""
22 Huesca;All ages;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
22 Huesca;All ages;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
22 Huesca;All ages;Cohort October 1;Females;Survival in the third trimester;2021QII;5.173
22 Huesca;All ages;Cohort October 1;Females;Survival in the third trimester;2021QI;""
22 Huesca;All ages;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
22 Huesca;All ages;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
22 Huesca;All ages;Cohort October 1;Females;Survival in the third trimester;2020QII;""
22 Huesca;All ages;Cohort October 1;Females;Survival in the third trimester;2020QI;""
22 Huesca;All ages;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
22 Huesca;All ages;Cohort October 1;Females;Survival in the third trimester;2022QIII;5.060
22 Huesca;All ages;Cohort October 1;Females;Survival in the third trimester;2022QII;""
22 Huesca;All ages;Cohort October 1;Females;Survival in the third trimester;2022QI;""
22 Huesca;All ages;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
22 Huesca;All ages;Cohort October 1;Females;Survival in the third trimester;2021QIII;5.063
22 Huesca;All ages;Cohort October 1;Females;Survival in the third trimester;2021QII;""
22 Huesca;All ages;Cohort October 1;Females;Survival in the third trimester;2021QI;""
22 Huesca;All ages;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
22 Huesca;All ages;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
22 Huesca;All ages;Cohort October 1;Females;Survival in the third trimester;2020QII;""
22 Huesca;All ages;Cohort October 1;Females;Survival in the third trimester;2020QI;""
22 Huesca;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
22 Huesca;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
22 Huesca;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
22 Huesca;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
22 Huesca;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
22 Huesca;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
22 Huesca;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
22 Huesca;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
22 Huesca;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
22 Huesca;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
22 Huesca;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
22 Huesca;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
22 Huesca;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;95,79
22 Huesca;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
22 Huesca;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
22 Huesca;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
22 Huesca;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;96,39
22 Huesca;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
22 Huesca;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
22 Huesca;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
22 Huesca;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;96,35
22 Huesca;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
22 Huesca;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
22 Huesca;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
22 Huesca;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
22 Huesca;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
22 Huesca;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
22 Huesca;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;93,96
22 Huesca;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
22 Huesca;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
22 Huesca;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
22 Huesca;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;94,06
22 Huesca;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
22 Huesca;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
22 Huesca;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
22 Huesca;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
22 Huesca;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
22 Huesca;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
22 Huesca;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;91,43
22 Huesca;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
22 Huesca;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
22 Huesca;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
22 Huesca;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;91,77
22 Huesca;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
22 Huesca;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
22 Huesca;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
22 Huesca;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
22 Huesca;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
22 Huesca;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
22 Huesca;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;89,43
22 Huesca;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
22 Huesca;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
22 Huesca;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
22 Huesca;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;89,82
22 Huesca;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
22 Huesca;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
22 Huesca;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
22 Huesca;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
22 Huesca;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
22 Huesca;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
22 Huesca;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
22 Huesca;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
22 Huesca;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
22 Huesca;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QI;835
22 Huesca;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
22 Huesca;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
22 Huesca;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
22 Huesca;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QI;789
22 Huesca;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
22 Huesca;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
22 Huesca;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
22 Huesca;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QI;677
22 Huesca;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
22 Huesca;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
22 Huesca;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2022QII;""
22 Huesca;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2022QI;775
22 Huesca;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
22 Huesca;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
22 Huesca;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2021QII;""
22 Huesca;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2021QI;743
22 Huesca;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
22 Huesca;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
22 Huesca;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2020QII;""
22 Huesca;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2020QI;590
22 Huesca;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
22 Huesca;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
22 Huesca;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2022QII;730
22 Huesca;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2022QI;""
22 Huesca;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
22 Huesca;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
22 Huesca;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2021QII;689
22 Huesca;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2021QI;""
22 Huesca;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
22 Huesca;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
22 Huesca;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2020QII;568
22 Huesca;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2020QI;""
22 Huesca;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
22 Huesca;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QIII;687
22 Huesca;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QII;""
22 Huesca;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QI;""
22 Huesca;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
22 Huesca;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QIII;654
22 Huesca;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QII;""
22 Huesca;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QI;""
22 Huesca;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
22 Huesca;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QIII;539
22 Huesca;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QII;""
22 Huesca;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QI;""
22 Huesca;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QIV;646
22 Huesca;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
22 Huesca;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QII;""
22 Huesca;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QI;""
22 Huesca;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QIV;626
22 Huesca;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
22 Huesca;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QII;""
22 Huesca;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QI;""
22 Huesca;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QIV;511
22 Huesca;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
22 Huesca;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QII;""
22 Huesca;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QI;""
22 Huesca;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
22 Huesca;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
22 Huesca;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
22 Huesca;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
22 Huesca;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
22 Huesca;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
22 Huesca;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
22 Huesca;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
22 Huesca;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
22 Huesca;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
22 Huesca;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
22 Huesca;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
22 Huesca;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
22 Huesca;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
22 Huesca;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
22 Huesca;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;92,81
22 Huesca;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
22 Huesca;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
22 Huesca;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
22 Huesca;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;94,17
22 Huesca;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
22 Huesca;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
22 Huesca;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
22 Huesca;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;87,15
22 Huesca;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
22 Huesca;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
22 Huesca;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;87,43
22 Huesca;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
22 Huesca;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
22 Huesca;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
22 Huesca;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;87,33
22 Huesca;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
22 Huesca;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
22 Huesca;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
22 Huesca;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;83,9
22 Huesca;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
22 Huesca;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
22 Huesca;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;82,28
22 Huesca;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
22 Huesca;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
22 Huesca;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
22 Huesca;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;82,89
22 Huesca;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
22 Huesca;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
22 Huesca;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
22 Huesca;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;79,62
22 Huesca;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
22 Huesca;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
22 Huesca;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;77,37
22 Huesca;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
22 Huesca;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
22 Huesca;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
22 Huesca;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;79,34
22 Huesca;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
22 Huesca;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
22 Huesca;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
22 Huesca;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;75,48
22 Huesca;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
22 Huesca;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
22 Huesca;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
22 Huesca;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
22 Huesca;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
22 Huesca;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
22 Huesca;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QI;526
22 Huesca;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
22 Huesca;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
22 Huesca;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
22 Huesca;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QI;494
22 Huesca;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
22 Huesca;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
22 Huesca;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
22 Huesca;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QI;408
22 Huesca;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
22 Huesca;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
22 Huesca;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2022QII;""
22 Huesca;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2022QI;491
22 Huesca;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
22 Huesca;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
22 Huesca;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2021QII;""
22 Huesca;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2021QI;469
22 Huesca;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
22 Huesca;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
22 Huesca;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2020QII;""
22 Huesca;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2020QI;371
22 Huesca;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
22 Huesca;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
22 Huesca;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2022QII;465
22 Huesca;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2022QI;""
22 Huesca;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
22 Huesca;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
22 Huesca;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2021QII;446
22 Huesca;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2021QI;""
22 Huesca;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
22 Huesca;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
22 Huesca;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2020QII;355
22 Huesca;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2020QI;""
22 Huesca;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
22 Huesca;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QIII;439
22 Huesca;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QII;""
22 Huesca;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QI;""
22 Huesca;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
22 Huesca;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QIII;425
22 Huesca;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QII;""
22 Huesca;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QI;""
22 Huesca;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
22 Huesca;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QIII;340
22 Huesca;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QII;""
22 Huesca;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QI;""
22 Huesca;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QIV;413
22 Huesca;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
22 Huesca;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QII;""
22 Huesca;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QI;""
22 Huesca;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QIV;402
22 Huesca;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
22 Huesca;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QII;""
22 Huesca;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QI;""
22 Huesca;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QIV;324
22 Huesca;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
22 Huesca;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QII;""
22 Huesca;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QI;""
22 Huesca;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
22 Huesca;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
22 Huesca;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
22 Huesca;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
22 Huesca;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
22 Huesca;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
22 Huesca;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
22 Huesca;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
22 Huesca;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
22 Huesca;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
22 Huesca;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
22 Huesca;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
22 Huesca;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
22 Huesca;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
22 Huesca;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
22 Huesca;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;93,35
22 Huesca;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
22 Huesca;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
22 Huesca;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
22 Huesca;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;94,94
22 Huesca;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
22 Huesca;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
22 Huesca;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
22 Huesca;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;90,93
22 Huesca;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
22 Huesca;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
22 Huesca;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;88,4
22 Huesca;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
22 Huesca;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
22 Huesca;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
22 Huesca;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;90,28
22 Huesca;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
22 Huesca;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
22 Huesca;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
22 Huesca;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;87,01
22 Huesca;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
22 Huesca;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
22 Huesca;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;83,46
22 Huesca;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
22 Huesca;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
22 Huesca;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
22 Huesca;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;86,03
22 Huesca;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
22 Huesca;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
22 Huesca;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
22 Huesca;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;83,33
22 Huesca;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
22 Huesca;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
22 Huesca;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;78,52
22 Huesca;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
22 Huesca;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
22 Huesca;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
22 Huesca;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;81,38
22 Huesca;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
22 Huesca;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
22 Huesca;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
22 Huesca;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;79,41
22 Huesca;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
22 Huesca;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
22 Huesca;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
22 Huesca;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
22 Huesca;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
22 Huesca;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
22 Huesca;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QI;309
22 Huesca;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
22 Huesca;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
22 Huesca;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
22 Huesca;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QI;295
22 Huesca;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
22 Huesca;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
22 Huesca;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
22 Huesca;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QI;269
22 Huesca;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
22 Huesca;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
22 Huesca;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2022QII;""
22 Huesca;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2022QI;284
22 Huesca;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
22 Huesca;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
22 Huesca;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2021QII;""
22 Huesca;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2021QI;274
22 Huesca;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
22 Huesca;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
22 Huesca;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2020QII;""
22 Huesca;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2020QI;219
22 Huesca;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
22 Huesca;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
22 Huesca;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2022QII;265
22 Huesca;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2022QI;""
22 Huesca;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
22 Huesca;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
22 Huesca;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2021QII;243
22 Huesca;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2021QI;""
22 Huesca;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
22 Huesca;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
22 Huesca;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2020QII;213
22 Huesca;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2020QI;""
22 Huesca;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
22 Huesca;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QIII;248
22 Huesca;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QII;""
22 Huesca;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QI;""
22 Huesca;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
22 Huesca;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QIII;229
22 Huesca;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QII;""
22 Huesca;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QI;""
22 Huesca;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
22 Huesca;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QIII;199
22 Huesca;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QII;""
22 Huesca;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QI;""
22 Huesca;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QIV;233
22 Huesca;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
22 Huesca;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QII;""
22 Huesca;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QI;""
22 Huesca;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QIV;224
22 Huesca;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
22 Huesca;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QII;""
22 Huesca;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QI;""
22 Huesca;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QIV;187
22 Huesca;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
22 Huesca;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QII;""
22 Huesca;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QI;""
22 Huesca;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
22 Huesca;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
22 Huesca;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
22 Huesca;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
22 Huesca;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
22 Huesca;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
22 Huesca;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
22 Huesca;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
22 Huesca;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
22 Huesca;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
22 Huesca;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
22 Huesca;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
22 Huesca;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
22 Huesca;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
22 Huesca;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
22 Huesca;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;91,91
22 Huesca;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
22 Huesca;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
22 Huesca;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
22 Huesca;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;92,88
22 Huesca;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
22 Huesca;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
22 Huesca;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
22 Huesca;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;81,41
22 Huesca;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
22 Huesca;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
22 Huesca;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;85,76
22 Huesca;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
22 Huesca;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
22 Huesca;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
22 Huesca;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;82,37
22 Huesca;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
22 Huesca;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
22 Huesca;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
22 Huesca;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;79,18
22 Huesca;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
22 Huesca;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
22 Huesca;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;80,26
22 Huesca;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
22 Huesca;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
22 Huesca;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
22 Huesca;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;77,63
22 Huesca;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
22 Huesca;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
22 Huesca;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
22 Huesca;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;73,98
22 Huesca;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
22 Huesca;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
22 Huesca;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;75,4
22 Huesca;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
22 Huesca;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
22 Huesca;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
22 Huesca;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;75,93
22 Huesca;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
22 Huesca;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
22 Huesca;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
22 Huesca;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;69,52
22 Huesca;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
22 Huesca;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
22 Huesca;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
22 Huesca;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
22 Huesca;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
22 Huesca;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QII;698
22 Huesca;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
22 Huesca;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
22 Huesca;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
22 Huesca;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QII;726
22 Huesca;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
22 Huesca;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
22 Huesca;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
22 Huesca;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QII;678
22 Huesca;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
22 Huesca;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
22 Huesca;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
22 Huesca;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2022QII;650
22 Huesca;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2022QI;""
22 Huesca;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
22 Huesca;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
22 Huesca;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2021QII;661
22 Huesca;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2021QI;""
22 Huesca;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
22 Huesca;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
22 Huesca;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2020QII;651
22 Huesca;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2020QI;""
22 Huesca;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
22 Huesca;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2022QIII;606
22 Huesca;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2022QII;""
22 Huesca;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2022QI;""
22 Huesca;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
22 Huesca;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2021QIII;625
22 Huesca;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2021QII;""
22 Huesca;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2021QI;""
22 Huesca;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
22 Huesca;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2020QIII;615
22 Huesca;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2020QII;""
22 Huesca;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2020QI;""
22 Huesca;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QIV;562
22 Huesca;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
22 Huesca;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QII;""
22 Huesca;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QI;""
22 Huesca;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QIV;591
22 Huesca;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
22 Huesca;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QII;""
22 Huesca;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QI;""
22 Huesca;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QIV;580
22 Huesca;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
22 Huesca;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QII;""
22 Huesca;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QI;""
22 Huesca;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
22 Huesca;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
22 Huesca;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QII;""
22 Huesca;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QI;559
22 Huesca;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
22 Huesca;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
22 Huesca;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QII;""
22 Huesca;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QI;555
22 Huesca;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
22 Huesca;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
22 Huesca;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QII;""
22 Huesca;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QI;""
22 Huesca;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
22 Huesca;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
22 Huesca;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
22 Huesca;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
22 Huesca;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
22 Huesca;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
22 Huesca;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
22 Huesca;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
22 Huesca;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
22 Huesca;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
22 Huesca;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
22 Huesca;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
22 Huesca;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
22 Huesca;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
22 Huesca;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;93,12
22 Huesca;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
22 Huesca;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
22 Huesca;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
22 Huesca;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;91,05
22 Huesca;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
22 Huesca;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
22 Huesca;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
22 Huesca;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;96,02
22 Huesca;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
22 Huesca;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
22 Huesca;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;86,82
22 Huesca;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
22 Huesca;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
22 Huesca;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
22 Huesca;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;86,09
22 Huesca;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
22 Huesca;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
22 Huesca;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
22 Huesca;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;90,71
22 Huesca;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
22 Huesca;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
22 Huesca;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;80,52
22 Huesca;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
22 Huesca;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
22 Huesca;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
22 Huesca;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;81,4
22 Huesca;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
22 Huesca;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
22 Huesca;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
22 Huesca;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;85,55
22 Huesca;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
22 Huesca;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
22 Huesca;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
22 Huesca;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
22 Huesca;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
22 Huesca;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
22 Huesca;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;77
22 Huesca;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
22 Huesca;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
22 Huesca;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
22 Huesca;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;81,86
22 Huesca;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
22 Huesca;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
22 Huesca;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
22 Huesca;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
22 Huesca;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
22 Huesca;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
22 Huesca;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QII;443
22 Huesca;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
22 Huesca;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
22 Huesca;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
22 Huesca;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QII;453
22 Huesca;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
22 Huesca;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
22 Huesca;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
22 Huesca;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QII;428
22 Huesca;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
22 Huesca;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
22 Huesca;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
22 Huesca;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2022QII;414
22 Huesca;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2022QI;""
22 Huesca;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
22 Huesca;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
22 Huesca;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2021QII;428
22 Huesca;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2021QI;""
22 Huesca;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
22 Huesca;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
22 Huesca;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2020QII;408
22 Huesca;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2020QI;""
22 Huesca;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
22 Huesca;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2022QIII;386
22 Huesca;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2022QII;""
22 Huesca;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2022QI;""
22 Huesca;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
22 Huesca;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2021QIII;406
22 Huesca;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2021QII;""
22 Huesca;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2021QI;""
22 Huesca;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
22 Huesca;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2020QIII;391
22 Huesca;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2020QII;""
22 Huesca;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2020QI;""
22 Huesca;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QIV;359
22 Huesca;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
22 Huesca;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QII;""
22 Huesca;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QI;""
22 Huesca;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QIV;380
22 Huesca;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
22 Huesca;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QII;""
22 Huesca;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QI;""
22 Huesca;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QIV;372
22 Huesca;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
22 Huesca;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QII;""
22 Huesca;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QI;""
22 Huesca;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
22 Huesca;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
22 Huesca;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QII;""
22 Huesca;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QI;363
22 Huesca;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
22 Huesca;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
22 Huesca;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QII;""
22 Huesca;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QI;361
22 Huesca;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
22 Huesca;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
22 Huesca;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QII;""
22 Huesca;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QI;""
22 Huesca;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
22 Huesca;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
22 Huesca;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
22 Huesca;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
22 Huesca;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
22 Huesca;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
22 Huesca;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
22 Huesca;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
22 Huesca;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
22 Huesca;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
22 Huesca;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
22 Huesca;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
22 Huesca;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
22 Huesca;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
22 Huesca;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;93,45
22 Huesca;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
22 Huesca;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
22 Huesca;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
22 Huesca;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;94,48
22 Huesca;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
22 Huesca;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
22 Huesca;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
22 Huesca;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;95,33
22 Huesca;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
22 Huesca;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
22 Huesca;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;87,13
22 Huesca;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
22 Huesca;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
22 Huesca;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
22 Huesca;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;89,62
22 Huesca;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
22 Huesca;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
22 Huesca;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
22 Huesca;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;91,36
22 Huesca;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
22 Huesca;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
22 Huesca;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;81,04
22 Huesca;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
22 Huesca;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
22 Huesca;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
22 Huesca;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;83,89
22 Huesca;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
22 Huesca;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
22 Huesca;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
22 Huesca;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;86,92
22 Huesca;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
22 Huesca;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
22 Huesca;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
22 Huesca;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
22 Huesca;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
22 Huesca;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
22 Huesca;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;80,13
22 Huesca;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
22 Huesca;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
22 Huesca;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
22 Huesca;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;84,35
22 Huesca;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
22 Huesca;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
22 Huesca;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
22 Huesca;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
22 Huesca;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
22 Huesca;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
22 Huesca;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QII;255
22 Huesca;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
22 Huesca;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
22 Huesca;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
22 Huesca;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QII;273
22 Huesca;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
22 Huesca;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
22 Huesca;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
22 Huesca;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QII;250
22 Huesca;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
22 Huesca;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
22 Huesca;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
22 Huesca;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2022QII;236
22 Huesca;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2022QI;""
22 Huesca;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
22 Huesca;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
22 Huesca;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2021QII;233
22 Huesca;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2021QI;""
22 Huesca;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
22 Huesca;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
22 Huesca;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2020QII;243
22 Huesca;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2020QI;""
22 Huesca;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
22 Huesca;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2022QIII;220
22 Huesca;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2022QII;""
22 Huesca;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2022QI;""
22 Huesca;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
22 Huesca;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2021QIII;219
22 Huesca;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2021QII;""
22 Huesca;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2021QI;""
22 Huesca;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
22 Huesca;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2020QIII;224
22 Huesca;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2020QII;""
22 Huesca;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2020QI;""
22 Huesca;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QIV;203
22 Huesca;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
22 Huesca;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QII;""
22 Huesca;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QI;""
22 Huesca;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QIV;211
22 Huesca;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
22 Huesca;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QII;""
22 Huesca;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QI;""
22 Huesca;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QIV;208
22 Huesca;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
22 Huesca;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QII;""
22 Huesca;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QI;""
22 Huesca;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
22 Huesca;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
22 Huesca;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QII;""
22 Huesca;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QI;196
22 Huesca;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
22 Huesca;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
22 Huesca;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QII;""
22 Huesca;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QI;194
22 Huesca;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
22 Huesca;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
22 Huesca;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QII;""
22 Huesca;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QI;""
22 Huesca;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
22 Huesca;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
22 Huesca;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
22 Huesca;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
22 Huesca;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
22 Huesca;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
22 Huesca;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
22 Huesca;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
22 Huesca;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
22 Huesca;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
22 Huesca;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
22 Huesca;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
22 Huesca;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
22 Huesca;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
22 Huesca;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;92,55
22 Huesca;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
22 Huesca;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
22 Huesca;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
22 Huesca;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;85,35
22 Huesca;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
22 Huesca;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
22 Huesca;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
22 Huesca;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;97,2
22 Huesca;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
22 Huesca;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
22 Huesca;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;86,27
22 Huesca;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
22 Huesca;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
22 Huesca;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
22 Huesca;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;80,22
22 Huesca;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
22 Huesca;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
22 Huesca;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
22 Huesca;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;89,6
22 Huesca;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
22 Huesca;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
22 Huesca;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;79,61
22 Huesca;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
22 Huesca;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
22 Huesca;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
22 Huesca;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;77,29
22 Huesca;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
22 Huesca;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
22 Huesca;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
22 Huesca;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;83,2
22 Huesca;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
22 Huesca;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
22 Huesca;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
22 Huesca;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
22 Huesca;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
22 Huesca;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
22 Huesca;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;71,79
22 Huesca;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
22 Huesca;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
22 Huesca;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
22 Huesca;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;77,6
22 Huesca;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
22 Huesca;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
22 Huesca;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
22 Huesca;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
22 Huesca;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
22 Huesca;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QIII;796
22 Huesca;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
22 Huesca;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
22 Huesca;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
22 Huesca;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QIII;781
22 Huesca;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
22 Huesca;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
22 Huesca;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
22 Huesca;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QIII;734
22 Huesca;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
22 Huesca;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
22 Huesca;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
22 Huesca;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2022QIII;701
22 Huesca;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2022QII;""
22 Huesca;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2022QI;""
22 Huesca;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
22 Huesca;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2021QIII;695
22 Huesca;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2021QII;""
22 Huesca;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2021QI;""
22 Huesca;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
22 Huesca;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2020QIII;665
22 Huesca;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2020QII;""
22 Huesca;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2020QI;""
22 Huesca;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2022QIV;649
22 Huesca;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
22 Huesca;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2022QII;""
22 Huesca;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2022QI;""
22 Huesca;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2021QIV;654
22 Huesca;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
22 Huesca;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2021QII;""
22 Huesca;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2021QI;""
22 Huesca;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2020QIV;626
22 Huesca;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
22 Huesca;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2020QII;""
22 Huesca;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2020QI;""
22 Huesca;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
22 Huesca;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
22 Huesca;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QII;""
22 Huesca;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QI;618
22 Huesca;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
22 Huesca;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
22 Huesca;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QII;""
22 Huesca;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QI;599
22 Huesca;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
22 Huesca;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
22 Huesca;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QII;""
22 Huesca;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QI;""
22 Huesca;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
22 Huesca;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
22 Huesca;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QII;588
22 Huesca;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QI;""
22 Huesca;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
22 Huesca;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
22 Huesca;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QII;564
22 Huesca;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QI;""
22 Huesca;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
22 Huesca;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
22 Huesca;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QII;""
22 Huesca;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QI;""
22 Huesca;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
22 Huesca;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
22 Huesca;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
22 Huesca;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
22 Huesca;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
22 Huesca;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
22 Huesca;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
22 Huesca;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
22 Huesca;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
22 Huesca;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
22 Huesca;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
22 Huesca;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
22 Huesca;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
22 Huesca;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;88,07
22 Huesca;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
22 Huesca;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
22 Huesca;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
22 Huesca;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;88,99
22 Huesca;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
22 Huesca;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
22 Huesca;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
22 Huesca;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;90,6
22 Huesca;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
22 Huesca;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
22 Huesca;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;81,53
22 Huesca;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
22 Huesca;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
22 Huesca;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
22 Huesca;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;83,74
22 Huesca;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
22 Huesca;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
22 Huesca;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
22 Huesca;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;85,29
22 Huesca;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
22 Huesca;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
22 Huesca;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
22 Huesca;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
22 Huesca;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
22 Huesca;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
22 Huesca;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;79,13
22 Huesca;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
22 Huesca;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
22 Huesca;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
22 Huesca;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;81,61
22 Huesca;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
22 Huesca;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
22 Huesca;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
22 Huesca;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
22 Huesca;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
22 Huesca;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
22 Huesca;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;75,29
22 Huesca;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
22 Huesca;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
22 Huesca;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
22 Huesca;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;76,84
22 Huesca;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
22 Huesca;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
22 Huesca;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
22 Huesca;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
22 Huesca;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
22 Huesca;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
22 Huesca;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QIII;498
22 Huesca;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
22 Huesca;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
22 Huesca;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
22 Huesca;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QIII;495
22 Huesca;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
22 Huesca;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
22 Huesca;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
22 Huesca;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QIII;458
22 Huesca;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
22 Huesca;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
22 Huesca;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
22 Huesca;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2022QIII;441
22 Huesca;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2022QII;""
22 Huesca;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2022QI;""
22 Huesca;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
22 Huesca;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2021QIII;450
22 Huesca;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2021QII;""
22 Huesca;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2021QI;""
22 Huesca;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
22 Huesca;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2020QIII;419
22 Huesca;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2020QII;""
22 Huesca;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2020QI;""
22 Huesca;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2022QIV;410
22 Huesca;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
22 Huesca;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2022QII;""
22 Huesca;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2022QI;""
22 Huesca;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2021QIV;419
22 Huesca;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
22 Huesca;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2021QII;""
22 Huesca;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2021QI;""
22 Huesca;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2020QIV;398
22 Huesca;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
22 Huesca;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2020QII;""
22 Huesca;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2020QI;""
22 Huesca;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
22 Huesca;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
22 Huesca;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QII;""
22 Huesca;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QI;400
22 Huesca;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
22 Huesca;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
22 Huesca;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QII;""
22 Huesca;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QI;385
22 Huesca;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
22 Huesca;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
22 Huesca;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QII;""
22 Huesca;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QI;""
22 Huesca;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
22 Huesca;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
22 Huesca;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QII;381
22 Huesca;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QI;""
22 Huesca;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
22 Huesca;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
22 Huesca;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QII;368
22 Huesca;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QI;""
22 Huesca;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
22 Huesca;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
22 Huesca;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QII;""
22 Huesca;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QI;""
22 Huesca;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
22 Huesca;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
22 Huesca;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
22 Huesca;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
22 Huesca;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
22 Huesca;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
22 Huesca;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
22 Huesca;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
22 Huesca;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
22 Huesca;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
22 Huesca;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
22 Huesca;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
22 Huesca;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
22 Huesca;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;88,55
22 Huesca;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
22 Huesca;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
22 Huesca;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
22 Huesca;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;90,91
22 Huesca;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
22 Huesca;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
22 Huesca;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
22 Huesca;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;91,48
22 Huesca;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
22 Huesca;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
22 Huesca;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;82,33
22 Huesca;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
22 Huesca;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
22 Huesca;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
22 Huesca;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;84,65
22 Huesca;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
22 Huesca;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
22 Huesca;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
22 Huesca;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;86,9
22 Huesca;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
22 Huesca;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
22 Huesca;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
22 Huesca;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
22 Huesca;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
22 Huesca;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
22 Huesca;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;80,81
22 Huesca;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
22 Huesca;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
22 Huesca;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
22 Huesca;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;84,06
22 Huesca;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
22 Huesca;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
22 Huesca;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
22 Huesca;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
22 Huesca;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
22 Huesca;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
22 Huesca;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;76,97
22 Huesca;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
22 Huesca;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
22 Huesca;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
22 Huesca;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;80,35
22 Huesca;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
22 Huesca;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
22 Huesca;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
22 Huesca;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
22 Huesca;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
22 Huesca;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
22 Huesca;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QIII;298
22 Huesca;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
22 Huesca;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
22 Huesca;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
22 Huesca;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QIII;286
22 Huesca;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
22 Huesca;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
22 Huesca;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
22 Huesca;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QIII;276
22 Huesca;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
22 Huesca;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
22 Huesca;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
22 Huesca;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2022QIII;260
22 Huesca;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2022QII;""
22 Huesca;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2022QI;""
22 Huesca;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
22 Huesca;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2021QIII;245
22 Huesca;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2021QII;""
22 Huesca;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2021QI;""
22 Huesca;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
22 Huesca;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2020QIII;246
22 Huesca;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2020QII;""
22 Huesca;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2020QI;""
22 Huesca;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2022QIV;239
22 Huesca;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
22 Huesca;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2022QII;""
22 Huesca;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2022QI;""
22 Huesca;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2021QIV;235
22 Huesca;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
22 Huesca;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2021QII;""
22 Huesca;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2021QI;""
22 Huesca;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2020QIV;228
22 Huesca;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
22 Huesca;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2020QII;""
22 Huesca;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2020QI;""
22 Huesca;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
22 Huesca;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
22 Huesca;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QII;""
22 Huesca;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QI;218
22 Huesca;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
22 Huesca;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
22 Huesca;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QII;""
22 Huesca;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QI;214
22 Huesca;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
22 Huesca;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
22 Huesca;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QII;""
22 Huesca;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QI;""
22 Huesca;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
22 Huesca;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
22 Huesca;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QII;207
22 Huesca;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QI;""
22 Huesca;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
22 Huesca;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
22 Huesca;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QII;196
22 Huesca;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QI;""
22 Huesca;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
22 Huesca;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
22 Huesca;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QII;""
22 Huesca;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QI;""
22 Huesca;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
22 Huesca;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
22 Huesca;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
22 Huesca;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
22 Huesca;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
22 Huesca;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
22 Huesca;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
22 Huesca;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
22 Huesca;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
22 Huesca;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
22 Huesca;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
22 Huesca;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
22 Huesca;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
22 Huesca;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;87,25
22 Huesca;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
22 Huesca;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
22 Huesca;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
22 Huesca;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;85,66
22 Huesca;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
22 Huesca;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
22 Huesca;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
22 Huesca;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;89,13
22 Huesca;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
22 Huesca;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
22 Huesca;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;80,2
22 Huesca;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
22 Huesca;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
22 Huesca;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
22 Huesca;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;82,17
22 Huesca;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
22 Huesca;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
22 Huesca;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
22 Huesca;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;82,61
22 Huesca;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
22 Huesca;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
22 Huesca;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
22 Huesca;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
22 Huesca;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
22 Huesca;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
22 Huesca;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;76,22
22 Huesca;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
22 Huesca;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
22 Huesca;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
22 Huesca;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;77,54
22 Huesca;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
22 Huesca;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
22 Huesca;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
22 Huesca;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
22 Huesca;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
22 Huesca;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
22 Huesca;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;72,38
22 Huesca;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
22 Huesca;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
22 Huesca;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
22 Huesca;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;71,01
22 Huesca;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
22 Huesca;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
22 Huesca;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
22 Huesca;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
22 Huesca;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
22 Huesca;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QIV;786
22 Huesca;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
22 Huesca;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
22 Huesca;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
22 Huesca;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QIV;799
22 Huesca;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
22 Huesca;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
22 Huesca;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
22 Huesca;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QIV;746
22 Huesca;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
22 Huesca;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
22 Huesca;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
22 Huesca;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2022QIV;719
22 Huesca;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
22 Huesca;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2022QII;""
22 Huesca;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2022QI;""
22 Huesca;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2021QIV;736
22 Huesca;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
22 Huesca;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2021QII;""
22 Huesca;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2021QI;""
22 Huesca;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2020QIV;697
22 Huesca;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
22 Huesca;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2020QII;""
22 Huesca;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2020QI;""
22 Huesca;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
22 Huesca;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
22 Huesca;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2022QII;""
22 Huesca;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2022QI;691
22 Huesca;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
22 Huesca;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
22 Huesca;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2021QII;""
22 Huesca;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2021QI;664
22 Huesca;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
22 Huesca;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
22 Huesca;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2020QII;""
22 Huesca;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2020QI;""
22 Huesca;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
22 Huesca;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
22 Huesca;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QII;656
22 Huesca;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QI;""
22 Huesca;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
22 Huesca;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
22 Huesca;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QII;621
22 Huesca;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QI;""
22 Huesca;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
22 Huesca;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
22 Huesca;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QII;""
22 Huesca;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QI;""
22 Huesca;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
22 Huesca;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QIII;621
22 Huesca;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QII;""
22 Huesca;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QI;""
22 Huesca;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
22 Huesca;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QIII;591
22 Huesca;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QII;""
22 Huesca;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QI;""
22 Huesca;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
22 Huesca;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
22 Huesca;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QII;""
22 Huesca;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QI;""
22 Huesca;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
22 Huesca;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
22 Huesca;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
22 Huesca;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
22 Huesca;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
22 Huesca;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
22 Huesca;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
22 Huesca;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
22 Huesca;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
22 Huesca;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
22 Huesca;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
22 Huesca;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
22 Huesca;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;91,48
22 Huesca;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
22 Huesca;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
22 Huesca;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
22 Huesca;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;92,12
22 Huesca;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
22 Huesca;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
22 Huesca;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
22 Huesca;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;93,43
22 Huesca;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
22 Huesca;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
22 Huesca;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
22 Huesca;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
22 Huesca;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
22 Huesca;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
22 Huesca;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;86,48
22 Huesca;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
22 Huesca;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
22 Huesca;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
22 Huesca;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;89,01
22 Huesca;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
22 Huesca;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
22 Huesca;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
22 Huesca;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
22 Huesca;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
22 Huesca;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
22 Huesca;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;82,1
22 Huesca;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
22 Huesca;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
22 Huesca;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
22 Huesca;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;83,24
22 Huesca;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
22 Huesca;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
22 Huesca;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
22 Huesca;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
22 Huesca;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
22 Huesca;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
22 Huesca;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;77,72
22 Huesca;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
22 Huesca;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
22 Huesca;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
22 Huesca;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;79,22
22 Huesca;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
22 Huesca;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
22 Huesca;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
22 Huesca;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
22 Huesca;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
22 Huesca;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
22 Huesca;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QIV;491
22 Huesca;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
22 Huesca;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
22 Huesca;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
22 Huesca;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QIV;520
22 Huesca;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
22 Huesca;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
22 Huesca;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
22 Huesca;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QIV;471
22 Huesca;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
22 Huesca;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
22 Huesca;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
22 Huesca;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2022QIV;453
22 Huesca;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
22 Huesca;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2022QII;""
22 Huesca;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2022QI;""
22 Huesca;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2021QIV;474
22 Huesca;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
22 Huesca;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2021QII;""
22 Huesca;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2021QI;""
22 Huesca;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2020QIV;441
22 Huesca;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
22 Huesca;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2020QII;""
22 Huesca;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2020QI;""
22 Huesca;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
22 Huesca;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
22 Huesca;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2022QII;""
22 Huesca;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2022QI;447
22 Huesca;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
22 Huesca;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
22 Huesca;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2021QII;""
22 Huesca;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2021QI;423
22 Huesca;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
22 Huesca;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
22 Huesca;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2020QII;""
22 Huesca;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2020QI;""
22 Huesca;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
22 Huesca;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
22 Huesca;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QII;425
22 Huesca;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QI;""
22 Huesca;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
22 Huesca;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
22 Huesca;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QII;404
22 Huesca;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QI;""
22 Huesca;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
22 Huesca;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
22 Huesca;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QII;""
22 Huesca;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QI;""
22 Huesca;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
22 Huesca;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QIII;405
22 Huesca;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QII;""
22 Huesca;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QI;""
22 Huesca;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
22 Huesca;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QIII;387
22 Huesca;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QII;""
22 Huesca;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QI;""
22 Huesca;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
22 Huesca;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
22 Huesca;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QII;""
22 Huesca;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QI;""
22 Huesca;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
22 Huesca;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
22 Huesca;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
22 Huesca;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
22 Huesca;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
22 Huesca;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
22 Huesca;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
22 Huesca;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
22 Huesca;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
22 Huesca;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
22 Huesca;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
22 Huesca;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
22 Huesca;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;92,26
22 Huesca;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
22 Huesca;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
22 Huesca;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
22 Huesca;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;91,15
22 Huesca;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
22 Huesca;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
22 Huesca;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
22 Huesca;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;93,63
22 Huesca;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
22 Huesca;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
22 Huesca;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
22 Huesca;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
22 Huesca;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
22 Huesca;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
22 Huesca;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;85,96
22 Huesca;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
22 Huesca;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
22 Huesca;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
22 Huesca;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;89,81
22 Huesca;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
22 Huesca;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
22 Huesca;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
22 Huesca;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
22 Huesca;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
22 Huesca;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
22 Huesca;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;81,73
22 Huesca;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
22 Huesca;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
22 Huesca;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
22 Huesca;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;85,77
22 Huesca;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
22 Huesca;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
22 Huesca;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
22 Huesca;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
22 Huesca;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
22 Huesca;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
22 Huesca;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;77,88
22 Huesca;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
22 Huesca;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
22 Huesca;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
22 Huesca;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;82,17
22 Huesca;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
22 Huesca;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
22 Huesca;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
22 Huesca;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
22 Huesca;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
22 Huesca;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
22 Huesca;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QIV;295
22 Huesca;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
22 Huesca;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
22 Huesca;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
22 Huesca;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QIV;279
22 Huesca;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
22 Huesca;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
22 Huesca;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
22 Huesca;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QIV;275
22 Huesca;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
22 Huesca;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
22 Huesca;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
22 Huesca;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2022QIV;266
22 Huesca;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
22 Huesca;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2022QII;""
22 Huesca;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2022QI;""
22 Huesca;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2021QIV;262
22 Huesca;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
22 Huesca;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2021QII;""
22 Huesca;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2021QI;""
22 Huesca;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2020QIV;256
22 Huesca;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
22 Huesca;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2020QII;""
22 Huesca;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2020QI;""
22 Huesca;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
22 Huesca;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
22 Huesca;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2022QII;""
22 Huesca;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2022QI;244
22 Huesca;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
22 Huesca;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
22 Huesca;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2021QII;""
22 Huesca;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2021QI;241
22 Huesca;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
22 Huesca;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
22 Huesca;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2020QII;""
22 Huesca;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2020QI;""
22 Huesca;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
22 Huesca;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
22 Huesca;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QII;231
22 Huesca;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QI;""
22 Huesca;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
22 Huesca;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
22 Huesca;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QII;217
22 Huesca;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QI;""
22 Huesca;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
22 Huesca;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
22 Huesca;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QII;""
22 Huesca;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QI;""
22 Huesca;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
22 Huesca;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QIII;216
22 Huesca;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QII;""
22 Huesca;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QI;""
22 Huesca;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
22 Huesca;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QIII;204
22 Huesca;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QII;""
22 Huesca;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QI;""
22 Huesca;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
22 Huesca;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
22 Huesca;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QII;""
22 Huesca;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QI;""
22 Huesca;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
22 Huesca;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
22 Huesca;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
22 Huesca;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
22 Huesca;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
22 Huesca;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
22 Huesca;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
22 Huesca;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
22 Huesca;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
22 Huesca;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
22 Huesca;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
22 Huesca;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
22 Huesca;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;90,17
22 Huesca;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
22 Huesca;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
22 Huesca;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
22 Huesca;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;93,91
22 Huesca;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
22 Huesca;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
22 Huesca;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
22 Huesca;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;93,09
22 Huesca;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
22 Huesca;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
22 Huesca;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
22 Huesca;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
22 Huesca;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
22 Huesca;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
22 Huesca;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;87,46
22 Huesca;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
22 Huesca;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
22 Huesca;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
22 Huesca;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;87,64
22 Huesca;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
22 Huesca;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
22 Huesca;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
22 Huesca;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
22 Huesca;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
22 Huesca;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
22 Huesca;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;82,8
22 Huesca;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
22 Huesca;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
22 Huesca;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
22 Huesca;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;78,91
22 Huesca;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
22 Huesca;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
22 Huesca;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
22 Huesca;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
22 Huesca;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
22 Huesca;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
22 Huesca;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;77,42
22 Huesca;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
22 Huesca;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
22 Huesca;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
22 Huesca;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;74,18
22 Huesca;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
22 Huesca;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
22 Huesca;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
22 Huesca;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
22 Huesca;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
22 Huesca;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
22 Huesca;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
22 Huesca;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
22 Huesca;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
22 Huesca;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QI;2.309
22 Huesca;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
22 Huesca;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
22 Huesca;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
22 Huesca;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QI;2.376
22 Huesca;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
22 Huesca;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
22 Huesca;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
22 Huesca;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QI;2.339
22 Huesca;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
22 Huesca;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
22 Huesca;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2022QII;""
22 Huesca;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2022QI;2.249
22 Huesca;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
22 Huesca;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
22 Huesca;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2021QII;""
22 Huesca;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2021QI;2.312
22 Huesca;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
22 Huesca;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
22 Huesca;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2020QII;""
22 Huesca;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2020QI;2.184
22 Huesca;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
22 Huesca;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
22 Huesca;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2022QII;2.181
22 Huesca;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2022QI;""
22 Huesca;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
22 Huesca;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
22 Huesca;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2021QII;2.265
22 Huesca;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2021QI;""
22 Huesca;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
22 Huesca;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
22 Huesca;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2020QII;2.126
22 Huesca;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2020QI;""
22 Huesca;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
22 Huesca;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QIII;2.124
22 Huesca;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QII;""
22 Huesca;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QI;""
22 Huesca;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
22 Huesca;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QIII;2.220
22 Huesca;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QII;""
22 Huesca;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QI;""
22 Huesca;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
22 Huesca;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QIII;2.060
22 Huesca;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QII;""
22 Huesca;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QI;""
22 Huesca;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QIV;2.070
22 Huesca;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
22 Huesca;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QII;""
22 Huesca;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QI;""
22 Huesca;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QIV;2.153
22 Huesca;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
22 Huesca;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QII;""
22 Huesca;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QI;""
22 Huesca;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QIV;2.005
22 Huesca;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
22 Huesca;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QII;""
22 Huesca;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QI;""
22 Huesca;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
22 Huesca;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
22 Huesca;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
22 Huesca;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
22 Huesca;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
22 Huesca;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
22 Huesca;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
22 Huesca;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
22 Huesca;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
22 Huesca;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
22 Huesca;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
22 Huesca;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
22 Huesca;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
22 Huesca;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
22 Huesca;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
22 Huesca;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;97,4
22 Huesca;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
22 Huesca;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
22 Huesca;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
22 Huesca;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;97,31
22 Huesca;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
22 Huesca;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
22 Huesca;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
22 Huesca;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;93,37
22 Huesca;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
22 Huesca;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
22 Huesca;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;94,46
22 Huesca;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
22 Huesca;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
22 Huesca;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
22 Huesca;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;95,33
22 Huesca;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
22 Huesca;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
22 Huesca;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
22 Huesca;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;90,89
22 Huesca;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
22 Huesca;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
22 Huesca;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;91,99
22 Huesca;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
22 Huesca;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
22 Huesca;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
22 Huesca;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;93,43
22 Huesca;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
22 Huesca;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
22 Huesca;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
22 Huesca;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;88,07
22 Huesca;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
22 Huesca;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
22 Huesca;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;89,65
22 Huesca;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
22 Huesca;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
22 Huesca;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
22 Huesca;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;90,61
22 Huesca;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
22 Huesca;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
22 Huesca;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
22 Huesca;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;85,72
22 Huesca;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
22 Huesca;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
22 Huesca;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
22 Huesca;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
22 Huesca;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
22 Huesca;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
22 Huesca;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QI;1.339
22 Huesca;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
22 Huesca;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
22 Huesca;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
22 Huesca;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QI;1.368
22 Huesca;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
22 Huesca;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
22 Huesca;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
22 Huesca;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QI;1.358
22 Huesca;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
22 Huesca;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
22 Huesca;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2022QII;""
22 Huesca;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2022QI;1.306
22 Huesca;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
22 Huesca;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
22 Huesca;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2021QII;""
22 Huesca;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2021QI;1.335
22 Huesca;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
22 Huesca;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
22 Huesca;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2020QII;""
22 Huesca;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2020QI;1.274
22 Huesca;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
22 Huesca;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
22 Huesca;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2022QII;1.273
22 Huesca;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2022QI;""
22 Huesca;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
22 Huesca;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
22 Huesca;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2021QII;1.309
22 Huesca;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2021QI;""
22 Huesca;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
22 Huesca;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
22 Huesca;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2020QII;1.241
22 Huesca;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2020QI;""
22 Huesca;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
22 Huesca;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QIII;1.240
22 Huesca;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QII;""
22 Huesca;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QI;""
22 Huesca;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
22 Huesca;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QIII;1.286
22 Huesca;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QII;""
22 Huesca;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QI;""
22 Huesca;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
22 Huesca;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QIII;1.205
22 Huesca;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QII;""
22 Huesca;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QI;""
22 Huesca;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QIV;1.212
22 Huesca;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
22 Huesca;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QII;""
22 Huesca;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QI;""
22 Huesca;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QIV;1.249
22 Huesca;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
22 Huesca;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QII;""
22 Huesca;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QI;""
22 Huesca;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QIV;1.176
22 Huesca;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
22 Huesca;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QII;""
22 Huesca;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QI;""
22 Huesca;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
22 Huesca;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
22 Huesca;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
22 Huesca;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
22 Huesca;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
22 Huesca;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
22 Huesca;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
22 Huesca;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
22 Huesca;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
22 Huesca;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
22 Huesca;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
22 Huesca;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
22 Huesca;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
22 Huesca;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
22 Huesca;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
22 Huesca;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;97,54
22 Huesca;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
22 Huesca;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
22 Huesca;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
22 Huesca;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;97,59
22 Huesca;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
22 Huesca;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
22 Huesca;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
22 Huesca;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;93,81
22 Huesca;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
22 Huesca;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
22 Huesca;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;95,07
22 Huesca;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
22 Huesca;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
22 Huesca;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
22 Huesca;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;95,69
22 Huesca;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
22 Huesca;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
22 Huesca;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
22 Huesca;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;91,38
22 Huesca;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
22 Huesca;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
22 Huesca;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;92,61
22 Huesca;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
22 Huesca;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
22 Huesca;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
22 Huesca;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;94,01
22 Huesca;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
22 Huesca;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
22 Huesca;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
22 Huesca;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;88,73
22 Huesca;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
22 Huesca;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
22 Huesca;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;90,52
22 Huesca;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
22 Huesca;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
22 Huesca;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
22 Huesca;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;91,3
22 Huesca;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
22 Huesca;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
22 Huesca;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
22 Huesca;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;86,6
22 Huesca;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
22 Huesca;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
22 Huesca;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
22 Huesca;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
22 Huesca;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
22 Huesca;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
22 Huesca;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QI;970
22 Huesca;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
22 Huesca;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
22 Huesca;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
22 Huesca;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QI;1.008
22 Huesca;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
22 Huesca;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
22 Huesca;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
22 Huesca;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QI;981
22 Huesca;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
22 Huesca;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
22 Huesca;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2022QII;""
22 Huesca;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2022QI;943
22 Huesca;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
22 Huesca;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
22 Huesca;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2021QII;""
22 Huesca;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2021QI;977
22 Huesca;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
22 Huesca;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
22 Huesca;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2020QII;""
22 Huesca;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2020QI;910
22 Huesca;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
22 Huesca;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
22 Huesca;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2022QII;908
22 Huesca;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2022QI;""
22 Huesca;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
22 Huesca;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
22 Huesca;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2021QII;956
22 Huesca;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2021QI;""
22 Huesca;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
22 Huesca;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
22 Huesca;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2020QII;885
22 Huesca;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2020QI;""
22 Huesca;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
22 Huesca;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QIII;884
22 Huesca;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QII;""
22 Huesca;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QI;""
22 Huesca;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
22 Huesca;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QIII;934
22 Huesca;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QII;""
22 Huesca;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QI;""
22 Huesca;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
22 Huesca;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QIII;855
22 Huesca;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QII;""
22 Huesca;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QI;""
22 Huesca;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QIV;858
22 Huesca;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
22 Huesca;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QII;""
22 Huesca;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QI;""
22 Huesca;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QIV;904
22 Huesca;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
22 Huesca;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QII;""
22 Huesca;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QI;""
22 Huesca;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QIV;829
22 Huesca;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
22 Huesca;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QII;""
22 Huesca;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QI;""
22 Huesca;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
22 Huesca;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
22 Huesca;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
22 Huesca;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
22 Huesca;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
22 Huesca;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
22 Huesca;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
22 Huesca;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
22 Huesca;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
22 Huesca;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
22 Huesca;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
22 Huesca;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
22 Huesca;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
22 Huesca;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
22 Huesca;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
22 Huesca;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;97,22
22 Huesca;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
22 Huesca;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
22 Huesca;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
22 Huesca;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;96,92
22 Huesca;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
22 Huesca;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
22 Huesca;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
22 Huesca;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;92,76
22 Huesca;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
22 Huesca;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
22 Huesca;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;93,61
22 Huesca;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
22 Huesca;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
22 Huesca;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
22 Huesca;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;94,84
22 Huesca;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
22 Huesca;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
22 Huesca;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
22 Huesca;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;90,21
22 Huesca;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
22 Huesca;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
22 Huesca;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;91,13
22 Huesca;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
22 Huesca;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
22 Huesca;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
22 Huesca;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;92,66
22 Huesca;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
22 Huesca;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
22 Huesca;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
22 Huesca;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;87,16
22 Huesca;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
22 Huesca;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
22 Huesca;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;88,45
22 Huesca;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
22 Huesca;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
22 Huesca;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
22 Huesca;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;89,68
22 Huesca;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
22 Huesca;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
22 Huesca;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
22 Huesca;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;84,51
22 Huesca;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
22 Huesca;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
22 Huesca;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
22 Huesca;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
22 Huesca;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
22 Huesca;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QII;2.190
22 Huesca;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
22 Huesca;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
22 Huesca;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
22 Huesca;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QII;2.206
22 Huesca;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
22 Huesca;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
22 Huesca;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
22 Huesca;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QII;2.309
22 Huesca;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
22 Huesca;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
22 Huesca;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
22 Huesca;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2022QII;2.113
22 Huesca;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2022QI;""
22 Huesca;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
22 Huesca;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
22 Huesca;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2021QII;2.152
22 Huesca;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2021QI;""
22 Huesca;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
22 Huesca;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
22 Huesca;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2020QII;2.249
22 Huesca;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2020QI;""
22 Huesca;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
22 Huesca;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2022QIII;2.051
22 Huesca;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2022QII;""
22 Huesca;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2022QI;""
22 Huesca;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
22 Huesca;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2021QIII;2.096
22 Huesca;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2021QII;""
22 Huesca;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2021QI;""
22 Huesca;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
22 Huesca;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2020QIII;2.173
22 Huesca;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2020QII;""
22 Huesca;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2020QI;""
22 Huesca;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QIV;1.991
22 Huesca;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
22 Huesca;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QII;""
22 Huesca;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QI;""
22 Huesca;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QIV;2.033
22 Huesca;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
22 Huesca;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QII;""
22 Huesca;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QI;""
22 Huesca;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QIV;2.108
22 Huesca;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
22 Huesca;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QII;""
22 Huesca;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QI;""
22 Huesca;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
22 Huesca;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
22 Huesca;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QII;""
22 Huesca;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QI;1.988
22 Huesca;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
22 Huesca;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
22 Huesca;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QII;""
22 Huesca;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QI;2.063
22 Huesca;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
22 Huesca;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
22 Huesca;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QII;""
22 Huesca;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QI;""
22 Huesca;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
22 Huesca;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
22 Huesca;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
22 Huesca;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
22 Huesca;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
22 Huesca;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
22 Huesca;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
22 Huesca;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
22 Huesca;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
22 Huesca;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
22 Huesca;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
22 Huesca;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
22 Huesca;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
22 Huesca;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
22 Huesca;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;96,48
22 Huesca;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
22 Huesca;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
22 Huesca;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
22 Huesca;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;97,55
22 Huesca;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
22 Huesca;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
22 Huesca;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
22 Huesca;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;97,4
22 Huesca;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
22 Huesca;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
22 Huesca;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;93,65
22 Huesca;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
22 Huesca;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
22 Huesca;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
22 Huesca;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;95,01
22 Huesca;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
22 Huesca;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
22 Huesca;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
22 Huesca;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;94,11
22 Huesca;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
22 Huesca;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
22 Huesca;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;90,91
22 Huesca;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
22 Huesca;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
22 Huesca;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
22 Huesca;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;92,16
22 Huesca;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
22 Huesca;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
22 Huesca;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
22 Huesca;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;91,29
22 Huesca;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
22 Huesca;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
22 Huesca;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
22 Huesca;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
22 Huesca;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
22 Huesca;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
22 Huesca;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;90,12
22 Huesca;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
22 Huesca;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
22 Huesca;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
22 Huesca;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;89,35
22 Huesca;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
22 Huesca;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
22 Huesca;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
22 Huesca;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
22 Huesca;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
22 Huesca;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
22 Huesca;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QII;1.259
22 Huesca;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
22 Huesca;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
22 Huesca;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
22 Huesca;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QII;1.285
22 Huesca;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
22 Huesca;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
22 Huesca;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
22 Huesca;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QII;1.340
22 Huesca;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
22 Huesca;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
22 Huesca;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
22 Huesca;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2022QII;1.222
22 Huesca;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2022QI;""
22 Huesca;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
22 Huesca;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
22 Huesca;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2021QII;1.254
22 Huesca;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2021QI;""
22 Huesca;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
22 Huesca;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
22 Huesca;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2020QII;1.306
22 Huesca;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2020QI;""
22 Huesca;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
22 Huesca;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2022QIII;1.190
22 Huesca;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2022QII;""
22 Huesca;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2022QI;""
22 Huesca;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
22 Huesca;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2021QIII;1.223
22 Huesca;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2021QII;""
22 Huesca;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2021QI;""
22 Huesca;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
22 Huesca;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2020QIII;1.265
22 Huesca;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2020QII;""
22 Huesca;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2020QI;""
22 Huesca;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QIV;1.158
22 Huesca;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
22 Huesca;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QII;""
22 Huesca;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QI;""
22 Huesca;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QIV;1.188
22 Huesca;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
22 Huesca;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QII;""
22 Huesca;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QI;""
22 Huesca;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QIV;1.229
22 Huesca;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
22 Huesca;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QII;""
22 Huesca;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QI;""
22 Huesca;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
22 Huesca;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
22 Huesca;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QII;""
22 Huesca;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QI;1.163
22 Huesca;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
22 Huesca;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
22 Huesca;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QII;""
22 Huesca;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QI;1.208
22 Huesca;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
22 Huesca;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
22 Huesca;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QII;""
22 Huesca;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QI;""
22 Huesca;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
22 Huesca;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
22 Huesca;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
22 Huesca;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
22 Huesca;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
22 Huesca;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
22 Huesca;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
22 Huesca;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
22 Huesca;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
22 Huesca;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
22 Huesca;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
22 Huesca;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
22 Huesca;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
22 Huesca;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
22 Huesca;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;97,06
22 Huesca;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
22 Huesca;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
22 Huesca;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
22 Huesca;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;97,59
22 Huesca;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
22 Huesca;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
22 Huesca;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
22 Huesca;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;97,46
22 Huesca;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
22 Huesca;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
22 Huesca;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;94,52
22 Huesca;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
22 Huesca;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
22 Huesca;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
22 Huesca;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;95,18
22 Huesca;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
22 Huesca;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
22 Huesca;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
22 Huesca;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;94,4
22 Huesca;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
22 Huesca;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
22 Huesca;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;91,98
22 Huesca;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
22 Huesca;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
22 Huesca;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
22 Huesca;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;92,45
22 Huesca;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
22 Huesca;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
22 Huesca;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
22 Huesca;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;91,72
22 Huesca;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
22 Huesca;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
22 Huesca;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
22 Huesca;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
22 Huesca;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
22 Huesca;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
22 Huesca;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;90,51
22 Huesca;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
22 Huesca;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
22 Huesca;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
22 Huesca;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;90,15
22 Huesca;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
22 Huesca;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
22 Huesca;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
22 Huesca;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
22 Huesca;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
22 Huesca;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
22 Huesca;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QII;931
22 Huesca;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
22 Huesca;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
22 Huesca;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
22 Huesca;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QII;921
22 Huesca;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
22 Huesca;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
22 Huesca;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
22 Huesca;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QII;969
22 Huesca;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
22 Huesca;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
22 Huesca;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
22 Huesca;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2022QII;891
22 Huesca;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2022QI;""
22 Huesca;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
22 Huesca;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
22 Huesca;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2021QII;898
22 Huesca;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2021QI;""
22 Huesca;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
22 Huesca;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
22 Huesca;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2020QII;943
22 Huesca;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2020QI;""
22 Huesca;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
22 Huesca;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2022QIII;861
22 Huesca;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2022QII;""
22 Huesca;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2022QI;""
22 Huesca;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
22 Huesca;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2021QIII;873
22 Huesca;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2021QII;""
22 Huesca;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2021QI;""
22 Huesca;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
22 Huesca;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2020QIII;908
22 Huesca;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2020QII;""
22 Huesca;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2020QI;""
22 Huesca;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QIV;833
22 Huesca;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
22 Huesca;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QII;""
22 Huesca;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QI;""
22 Huesca;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QIV;845
22 Huesca;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
22 Huesca;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QII;""
22 Huesca;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QI;""
22 Huesca;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QIV;879
22 Huesca;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
22 Huesca;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QII;""
22 Huesca;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QI;""
22 Huesca;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
22 Huesca;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
22 Huesca;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QII;""
22 Huesca;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QI;825
22 Huesca;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
22 Huesca;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
22 Huesca;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QII;""
22 Huesca;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QI;855
22 Huesca;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
22 Huesca;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
22 Huesca;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QII;""
22 Huesca;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QI;""
22 Huesca;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
22 Huesca;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
22 Huesca;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
22 Huesca;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
22 Huesca;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
22 Huesca;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
22 Huesca;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
22 Huesca;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
22 Huesca;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
22 Huesca;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
22 Huesca;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
22 Huesca;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
22 Huesca;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
22 Huesca;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
22 Huesca;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;95,7
22 Huesca;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
22 Huesca;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
22 Huesca;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
22 Huesca;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;97,5
22 Huesca;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
22 Huesca;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
22 Huesca;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
22 Huesca;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;97,32
22 Huesca;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
22 Huesca;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
22 Huesca;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;92,48
22 Huesca;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
22 Huesca;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
22 Huesca;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
22 Huesca;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;94,79
22 Huesca;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
22 Huesca;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
22 Huesca;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
22 Huesca;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;93,7
22 Huesca;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
22 Huesca;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
22 Huesca;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;89,47
22 Huesca;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
22 Huesca;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
22 Huesca;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
22 Huesca;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;91,75
22 Huesca;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
22 Huesca;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
22 Huesca;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
22 Huesca;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;90,71
22 Huesca;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
22 Huesca;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
22 Huesca;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
22 Huesca;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
22 Huesca;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
22 Huesca;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
22 Huesca;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;89,58
22 Huesca;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
22 Huesca;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
22 Huesca;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
22 Huesca;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;88,24
22 Huesca;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
22 Huesca;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
22 Huesca;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
22 Huesca;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
22 Huesca;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
22 Huesca;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QIII;2.237
22 Huesca;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
22 Huesca;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
22 Huesca;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
22 Huesca;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QIII;2.267
22 Huesca;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
22 Huesca;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
22 Huesca;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
22 Huesca;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QIII;2.340
22 Huesca;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
22 Huesca;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
22 Huesca;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
22 Huesca;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2022QIII;2.152
22 Huesca;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2022QII;""
22 Huesca;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2022QI;""
22 Huesca;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
22 Huesca;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2021QIII;2.190
22 Huesca;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2021QII;""
22 Huesca;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2021QI;""
22 Huesca;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
22 Huesca;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2020QIII;2.243
22 Huesca;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2020QII;""
22 Huesca;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2020QI;""
22 Huesca;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2022QIV;2.081
22 Huesca;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
22 Huesca;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2022QII;""
22 Huesca;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2022QI;""
22 Huesca;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2021QIV;2.115
22 Huesca;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
22 Huesca;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2021QII;""
22 Huesca;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2021QI;""
22 Huesca;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2020QIV;2.172
22 Huesca;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
22 Huesca;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2020QII;""
22 Huesca;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2020QI;""
22 Huesca;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
22 Huesca;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
22 Huesca;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QII;""
22 Huesca;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QI;2.068
22 Huesca;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
22 Huesca;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
22 Huesca;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QII;""
22 Huesca;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QI;2.125
22 Huesca;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
22 Huesca;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
22 Huesca;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QII;""
22 Huesca;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QI;""
22 Huesca;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
22 Huesca;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
22 Huesca;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QII;2.019
22 Huesca;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QI;""
22 Huesca;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
22 Huesca;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
22 Huesca;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QII;2.088
22 Huesca;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QI;""
22 Huesca;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
22 Huesca;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
22 Huesca;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QII;""
22 Huesca;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QI;""
22 Huesca;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
22 Huesca;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
22 Huesca;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
22 Huesca;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
22 Huesca;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
22 Huesca;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
22 Huesca;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
22 Huesca;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
22 Huesca;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
22 Huesca;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
22 Huesca;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
22 Huesca;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
22 Huesca;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
22 Huesca;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;96,2
22 Huesca;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
22 Huesca;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
22 Huesca;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
22 Huesca;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;96,6
22 Huesca;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
22 Huesca;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
22 Huesca;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
22 Huesca;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;95,85
22 Huesca;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
22 Huesca;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
22 Huesca;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;93,03
22 Huesca;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
22 Huesca;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
22 Huesca;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
22 Huesca;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;93,3
22 Huesca;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
22 Huesca;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
22 Huesca;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
22 Huesca;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;92,82
22 Huesca;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
22 Huesca;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
22 Huesca;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
22 Huesca;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
22 Huesca;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
22 Huesca;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
22 Huesca;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;91,22
22 Huesca;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
22 Huesca;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
22 Huesca;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
22 Huesca;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;90,81
22 Huesca;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
22 Huesca;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
22 Huesca;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
22 Huesca;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
22 Huesca;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
22 Huesca;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
22 Huesca;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;89,06
22 Huesca;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
22 Huesca;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
22 Huesca;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
22 Huesca;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;89,23
22 Huesca;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
22 Huesca;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
22 Huesca;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
22 Huesca;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
22 Huesca;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
22 Huesca;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
22 Huesca;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QIII;1.283
22 Huesca;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
22 Huesca;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
22 Huesca;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
22 Huesca;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QIII;1.318
22 Huesca;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
22 Huesca;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
22 Huesca;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
22 Huesca;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QIII;1.351
22 Huesca;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
22 Huesca;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
22 Huesca;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
22 Huesca;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2022QIII;1.236
22 Huesca;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2022QII;""
22 Huesca;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2022QI;""
22 Huesca;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
22 Huesca;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2021QIII;1.277
22 Huesca;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2021QII;""
22 Huesca;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2021QI;""
22 Huesca;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
22 Huesca;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2020QIII;1.298
22 Huesca;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2020QII;""
22 Huesca;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2020QI;""
22 Huesca;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2022QIV;1.199
22 Huesca;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
22 Huesca;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2022QII;""
22 Huesca;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2022QI;""
22 Huesca;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2021QIV;1.237
22 Huesca;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
22 Huesca;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2021QII;""
22 Huesca;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2021QI;""
22 Huesca;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2020QIV;1.259
22 Huesca;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
22 Huesca;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2020QII;""
22 Huesca;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2020QI;""
22 Huesca;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
22 Huesca;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
22 Huesca;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QII;""
22 Huesca;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QI;1.211
22 Huesca;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
22 Huesca;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
22 Huesca;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QII;""
22 Huesca;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QI;1.237
22 Huesca;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
22 Huesca;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
22 Huesca;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QII;""
22 Huesca;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QI;""
22 Huesca;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
22 Huesca;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
22 Huesca;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QII;1.184
22 Huesca;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QI;""
22 Huesca;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
22 Huesca;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
22 Huesca;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QII;1.216
22 Huesca;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QI;""
22 Huesca;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
22 Huesca;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
22 Huesca;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QII;""
22 Huesca;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QI;""
22 Huesca;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
22 Huesca;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
22 Huesca;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
22 Huesca;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
22 Huesca;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
22 Huesca;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
22 Huesca;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
22 Huesca;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
22 Huesca;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
22 Huesca;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
22 Huesca;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
22 Huesca;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
22 Huesca;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
22 Huesca;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;96,34
22 Huesca;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
22 Huesca;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
22 Huesca;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
22 Huesca;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;96,89
22 Huesca;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
22 Huesca;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
22 Huesca;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
22 Huesca;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;96,08
22 Huesca;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
22 Huesca;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
22 Huesca;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;93,45
22 Huesca;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
22 Huesca;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
22 Huesca;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
22 Huesca;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;93,85
22 Huesca;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
22 Huesca;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
22 Huesca;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
22 Huesca;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;93,19
22 Huesca;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
22 Huesca;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
22 Huesca;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
22 Huesca;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
22 Huesca;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
22 Huesca;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
22 Huesca;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;91,88
22 Huesca;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
22 Huesca;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
22 Huesca;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
22 Huesca;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;91,56
22 Huesca;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
22 Huesca;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
22 Huesca;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
22 Huesca;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
22 Huesca;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
22 Huesca;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
22 Huesca;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;89,83
22 Huesca;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
22 Huesca;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
22 Huesca;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
22 Huesca;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;90,01
22 Huesca;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
22 Huesca;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
22 Huesca;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
22 Huesca;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
22 Huesca;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
22 Huesca;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
22 Huesca;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QIII;954
22 Huesca;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
22 Huesca;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
22 Huesca;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
22 Huesca;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QIII;949
22 Huesca;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
22 Huesca;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
22 Huesca;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
22 Huesca;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QIII;989
22 Huesca;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
22 Huesca;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
22 Huesca;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
22 Huesca;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2022QIII;916
22 Huesca;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2022QII;""
22 Huesca;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2022QI;""
22 Huesca;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
22 Huesca;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2021QIII;913
22 Huesca;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2021QII;""
22 Huesca;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2021QI;""
22 Huesca;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
22 Huesca;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2020QIII;945
22 Huesca;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2020QII;""
22 Huesca;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2020QI;""
22 Huesca;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2022QIV;882
22 Huesca;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
22 Huesca;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2022QII;""
22 Huesca;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2022QI;""
22 Huesca;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2021QIV;878
22 Huesca;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
22 Huesca;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2021QII;""
22 Huesca;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2021QI;""
22 Huesca;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2020QIV;913
22 Huesca;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
22 Huesca;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2020QII;""
22 Huesca;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2020QI;""
22 Huesca;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
22 Huesca;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
22 Huesca;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QII;""
22 Huesca;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QI;857
22 Huesca;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
22 Huesca;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
22 Huesca;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QII;""
22 Huesca;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QI;888
22 Huesca;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
22 Huesca;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
22 Huesca;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QII;""
22 Huesca;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QI;""
22 Huesca;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
22 Huesca;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
22 Huesca;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QII;835
22 Huesca;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QI;""
22 Huesca;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
22 Huesca;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
22 Huesca;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QII;872
22 Huesca;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QI;""
22 Huesca;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
22 Huesca;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
22 Huesca;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QII;""
22 Huesca;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QI;""
22 Huesca;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
22 Huesca;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
22 Huesca;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
22 Huesca;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
22 Huesca;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
22 Huesca;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
22 Huesca;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
22 Huesca;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
22 Huesca;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
22 Huesca;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
22 Huesca;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
22 Huesca;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
22 Huesca;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
22 Huesca;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;96,02
22 Huesca;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
22 Huesca;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
22 Huesca;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
22 Huesca;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;96,21
22 Huesca;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
22 Huesca;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
22 Huesca;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
22 Huesca;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;95,55
22 Huesca;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
22 Huesca;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
22 Huesca;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;92,45
22 Huesca;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
22 Huesca;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
22 Huesca;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
22 Huesca;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;92,52
22 Huesca;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
22 Huesca;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
22 Huesca;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
22 Huesca;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;92,32
22 Huesca;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
22 Huesca;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
22 Huesca;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
22 Huesca;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
22 Huesca;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
22 Huesca;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
22 Huesca;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;90,31
22 Huesca;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
22 Huesca;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
22 Huesca;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
22 Huesca;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;89,79
22 Huesca;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
22 Huesca;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
22 Huesca;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
22 Huesca;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
22 Huesca;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
22 Huesca;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
22 Huesca;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;87,99
22 Huesca;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
22 Huesca;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
22 Huesca;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
22 Huesca;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;88,17
22 Huesca;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
22 Huesca;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
22 Huesca;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
22 Huesca;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
22 Huesca;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
22 Huesca;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QIV;2.238
22 Huesca;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
22 Huesca;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
22 Huesca;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
22 Huesca;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QIV;2.288
22 Huesca;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
22 Huesca;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
22 Huesca;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
22 Huesca;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QIV;2.352
22 Huesca;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
22 Huesca;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
22 Huesca;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
22 Huesca;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2022QIV;2.157
22 Huesca;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
22 Huesca;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2022QII;""
22 Huesca;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2022QI;""
22 Huesca;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2021QIV;2.203
22 Huesca;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
22 Huesca;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2021QII;""
22 Huesca;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2021QI;""
22 Huesca;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2020QIV;2.263
22 Huesca;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
22 Huesca;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2020QII;""
22 Huesca;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2020QI;""
22 Huesca;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
22 Huesca;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
22 Huesca;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2022QII;""
22 Huesca;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2022QI;2.151
22 Huesca;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
22 Huesca;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
22 Huesca;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2021QII;""
22 Huesca;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2021QI;2.211
22 Huesca;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
22 Huesca;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
22 Huesca;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2020QII;""
22 Huesca;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2020QI;""
22 Huesca;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
22 Huesca;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
22 Huesca;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QII;2.093
22 Huesca;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QI;""
22 Huesca;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
22 Huesca;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
22 Huesca;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QII;2.173
22 Huesca;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QI;""
22 Huesca;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
22 Huesca;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
22 Huesca;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QII;""
22 Huesca;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QI;""
22 Huesca;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
22 Huesca;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QIII;2.042
22 Huesca;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QII;""
22 Huesca;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QI;""
22 Huesca;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
22 Huesca;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QIII;2.131
22 Huesca;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QII;""
22 Huesca;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QI;""
22 Huesca;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
22 Huesca;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
22 Huesca;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QII;""
22 Huesca;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QI;""
22 Huesca;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
22 Huesca;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
22 Huesca;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
22 Huesca;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
22 Huesca;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
22 Huesca;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
22 Huesca;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
22 Huesca;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
22 Huesca;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
22 Huesca;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
22 Huesca;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
22 Huesca;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
22 Huesca;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;96,38
22 Huesca;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
22 Huesca;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
22 Huesca;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
22 Huesca;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;96,28
22 Huesca;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
22 Huesca;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
22 Huesca;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
22 Huesca;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;96,22
22 Huesca;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
22 Huesca;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
22 Huesca;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
22 Huesca;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
22 Huesca;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
22 Huesca;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
22 Huesca;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;94,01
22 Huesca;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
22 Huesca;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
22 Huesca;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
22 Huesca;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;94,01
22 Huesca;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
22 Huesca;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
22 Huesca;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
22 Huesca;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
22 Huesca;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
22 Huesca;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
22 Huesca;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;91,48
22 Huesca;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
22 Huesca;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
22 Huesca;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
22 Huesca;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;92,39
22 Huesca;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
22 Huesca;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
22 Huesca;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
22 Huesca;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
22 Huesca;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
22 Huesca;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
22 Huesca;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;89,25
22 Huesca;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
22 Huesca;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
22 Huesca;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
22 Huesca;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;90,6
22 Huesca;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
22 Huesca;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
22 Huesca;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
22 Huesca;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
22 Huesca;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
22 Huesca;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
22 Huesca;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QIV;1.282
22 Huesca;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
22 Huesca;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
22 Huesca;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
22 Huesca;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QIV;1.324
22 Huesca;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
22 Huesca;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
22 Huesca;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
22 Huesca;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QIV;1.362
22 Huesca;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
22 Huesca;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
22 Huesca;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
22 Huesca;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2022QIV;1.238
22 Huesca;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
22 Huesca;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2022QII;""
22 Huesca;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2022QI;""
22 Huesca;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2021QIV;1.278
22 Huesca;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
22 Huesca;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2021QII;""
22 Huesca;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2021QI;""
22 Huesca;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2020QIV;1.313
22 Huesca;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
22 Huesca;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2020QII;""
22 Huesca;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2020QI;""
22 Huesca;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
22 Huesca;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
22 Huesca;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2022QII;""
22 Huesca;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2022QI;1.251
22 Huesca;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
22 Huesca;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
22 Huesca;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2021QII;""
22 Huesca;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2021QI;1.288
22 Huesca;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
22 Huesca;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
22 Huesca;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2020QII;""
22 Huesca;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2020QI;""
22 Huesca;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
22 Huesca;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
22 Huesca;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QII;1.222
22 Huesca;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QI;""
22 Huesca;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
22 Huesca;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
22 Huesca;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QII;1.266
22 Huesca;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QI;""
22 Huesca;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
22 Huesca;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
22 Huesca;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QII;""
22 Huesca;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QI;""
22 Huesca;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
22 Huesca;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QIII;1.190
22 Huesca;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QII;""
22 Huesca;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QI;""
22 Huesca;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
22 Huesca;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QIII;1.244
22 Huesca;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QII;""
22 Huesca;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QI;""
22 Huesca;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
22 Huesca;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
22 Huesca;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QII;""
22 Huesca;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QI;""
22 Huesca;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
22 Huesca;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
22 Huesca;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
22 Huesca;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
22 Huesca;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
22 Huesca;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
22 Huesca;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
22 Huesca;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
22 Huesca;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
22 Huesca;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
22 Huesca;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
22 Huesca;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
22 Huesca;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;96,57
22 Huesca;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
22 Huesca;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
22 Huesca;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
22 Huesca;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;96,53
22 Huesca;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
22 Huesca;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
22 Huesca;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
22 Huesca;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;96,4
22 Huesca;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
22 Huesca;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
22 Huesca;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
22 Huesca;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
22 Huesca;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
22 Huesca;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
22 Huesca;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;94,49
22 Huesca;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
22 Huesca;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
22 Huesca;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
22 Huesca;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;94,57
22 Huesca;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
22 Huesca;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
22 Huesca;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
22 Huesca;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
22 Huesca;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
22 Huesca;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
22 Huesca;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;92,3
22 Huesca;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
22 Huesca;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
22 Huesca;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
22 Huesca;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;92,95
22 Huesca;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
22 Huesca;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
22 Huesca;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
22 Huesca;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
22 Huesca;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
22 Huesca;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
22 Huesca;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;89,88
22 Huesca;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
22 Huesca;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
22 Huesca;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
22 Huesca;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;91,34
22 Huesca;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
22 Huesca;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
22 Huesca;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
22 Huesca;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
22 Huesca;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
22 Huesca;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
22 Huesca;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QIV;956
22 Huesca;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
22 Huesca;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
22 Huesca;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
22 Huesca;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QIV;964
22 Huesca;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
22 Huesca;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
22 Huesca;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
22 Huesca;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QIV;990
22 Huesca;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
22 Huesca;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
22 Huesca;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
22 Huesca;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2022QIV;919
22 Huesca;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
22 Huesca;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2022QII;""
22 Huesca;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2022QI;""
22 Huesca;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2021QIV;925
22 Huesca;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
22 Huesca;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2021QII;""
22 Huesca;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2021QI;""
22 Huesca;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2020QIV;950
22 Huesca;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
22 Huesca;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2020QII;""
22 Huesca;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2020QI;""
22 Huesca;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
22 Huesca;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
22 Huesca;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2022QII;""
22 Huesca;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2022QI;900
22 Huesca;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
22 Huesca;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
22 Huesca;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2021QII;""
22 Huesca;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2021QI;923
22 Huesca;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
22 Huesca;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
22 Huesca;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2020QII;""
22 Huesca;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2020QI;""
22 Huesca;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
22 Huesca;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
22 Huesca;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QII;871
22 Huesca;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QI;""
22 Huesca;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
22 Huesca;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
22 Huesca;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QII;907
22 Huesca;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QI;""
22 Huesca;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
22 Huesca;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
22 Huesca;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QII;""
22 Huesca;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QI;""
22 Huesca;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
22 Huesca;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QIII;852
22 Huesca;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QII;""
22 Huesca;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QI;""
22 Huesca;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
22 Huesca;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QIII;887
22 Huesca;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QII;""
22 Huesca;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QI;""
22 Huesca;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
22 Huesca;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
22 Huesca;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QII;""
22 Huesca;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QI;""
22 Huesca;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
22 Huesca;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
22 Huesca;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
22 Huesca;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
22 Huesca;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
22 Huesca;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
22 Huesca;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
22 Huesca;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
22 Huesca;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
22 Huesca;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
22 Huesca;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
22 Huesca;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
22 Huesca;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;96,13
22 Huesca;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
22 Huesca;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
22 Huesca;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
22 Huesca;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;95,95
22 Huesca;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
22 Huesca;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
22 Huesca;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
22 Huesca;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;95,96
22 Huesca;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
22 Huesca;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
22 Huesca;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
22 Huesca;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
22 Huesca;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
22 Huesca;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
22 Huesca;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;93,36
22 Huesca;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
22 Huesca;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
22 Huesca;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
22 Huesca;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;93,23
22 Huesca;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
22 Huesca;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
22 Huesca;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
22 Huesca;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
22 Huesca;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
22 Huesca;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
22 Huesca;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;90,35
22 Huesca;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
22 Huesca;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
22 Huesca;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
22 Huesca;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;91,62
22 Huesca;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
22 Huesca;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
22 Huesca;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
22 Huesca;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
22 Huesca;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
22 Huesca;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
22 Huesca;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;88,38
22 Huesca;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
22 Huesca;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
22 Huesca;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
22 Huesca;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;89,6
22 Huesca;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
22 Huesca;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
22 Huesca;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
22 Huesca;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
22 Huesca;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
22 Huesca;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
22 Huesca;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
22 Huesca;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
22 Huesca;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
22 Huesca;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QI;4.372
22 Huesca;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
22 Huesca;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
22 Huesca;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
22 Huesca;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QI;4.385
22 Huesca;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
22 Huesca;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
22 Huesca;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
22 Huesca;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QI;4.494
22 Huesca;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
22 Huesca;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
22 Huesca;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2022QII;""
22 Huesca;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2022QI;4.270
22 Huesca;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
22 Huesca;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
22 Huesca;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2021QII;""
22 Huesca;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2021QI;4.309
22 Huesca;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
22 Huesca;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
22 Huesca;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2020QII;""
22 Huesca;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2020QI;4.239
22 Huesca;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
22 Huesca;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
22 Huesca;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2022QII;4.158
22 Huesca;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2022QI;""
22 Huesca;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
22 Huesca;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
22 Huesca;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2021QII;4.233
22 Huesca;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2021QI;""
22 Huesca;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
22 Huesca;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
22 Huesca;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2020QII;4.173
22 Huesca;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2020QI;""
22 Huesca;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
22 Huesca;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QIII;4.087
22 Huesca;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QII;""
22 Huesca;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QI;""
22 Huesca;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
22 Huesca;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QIII;4.172
22 Huesca;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QII;""
22 Huesca;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QI;""
22 Huesca;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
22 Huesca;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QIII;4.111
22 Huesca;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QII;""
22 Huesca;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QI;""
22 Huesca;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QIV;3.997
22 Huesca;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
22 Huesca;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QII;""
22 Huesca;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QI;""
22 Huesca;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QIV;4.094
22 Huesca;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
22 Huesca;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QII;""
22 Huesca;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QI;""
22 Huesca;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QIV;4.029
22 Huesca;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
22 Huesca;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QII;""
22 Huesca;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QI;""
22 Huesca;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
22 Huesca;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
22 Huesca;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
22 Huesca;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
22 Huesca;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
22 Huesca;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
22 Huesca;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
22 Huesca;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
22 Huesca;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
22 Huesca;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
22 Huesca;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
22 Huesca;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
22 Huesca;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
22 Huesca;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
22 Huesca;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
22 Huesca;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;97,67
22 Huesca;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
22 Huesca;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
22 Huesca;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
22 Huesca;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;98,27
22 Huesca;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
22 Huesca;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
22 Huesca;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
22 Huesca;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;94,33
22 Huesca;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
22 Huesca;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
22 Huesca;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;95,11
22 Huesca;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
22 Huesca;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
22 Huesca;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
22 Huesca;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;96,53
22 Huesca;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
22 Huesca;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
22 Huesca;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
22 Huesca;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;92,86
22 Huesca;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
22 Huesca;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
22 Huesca;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;93,48
22 Huesca;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
22 Huesca;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
22 Huesca;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
22 Huesca;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;95,14
22 Huesca;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
22 Huesca;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
22 Huesca;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
22 Huesca;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;91,48
22 Huesca;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
22 Huesca;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
22 Huesca;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;91,42
22 Huesca;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
22 Huesca;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
22 Huesca;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
22 Huesca;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;93,36
22 Huesca;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
22 Huesca;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
22 Huesca;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
22 Huesca;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;89,65
22 Huesca;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
22 Huesca;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
22 Huesca;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
22 Huesca;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
22 Huesca;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
22 Huesca;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
22 Huesca;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QI;2.691
22 Huesca;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
22 Huesca;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
22 Huesca;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
22 Huesca;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QI;2.734
22 Huesca;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
22 Huesca;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
22 Huesca;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
22 Huesca;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QI;2.777
22 Huesca;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
22 Huesca;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
22 Huesca;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2022QII;""
22 Huesca;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2022QI;2.633
22 Huesca;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
22 Huesca;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
22 Huesca;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2021QII;""
22 Huesca;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2021QI;2.686
22 Huesca;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
22 Huesca;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
22 Huesca;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2020QII;""
22 Huesca;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2020QI;2.645
22 Huesca;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
22 Huesca;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
22 Huesca;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2022QII;2.574
22 Huesca;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2022QI;""
22 Huesca;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
22 Huesca;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
22 Huesca;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2021QII;2.644
22 Huesca;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2021QI;""
22 Huesca;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
22 Huesca;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
22 Huesca;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2020QII;2.607
22 Huesca;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2020QI;""
22 Huesca;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
22 Huesca;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QIII;2.532
22 Huesca;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QII;""
22 Huesca;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QI;""
22 Huesca;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
22 Huesca;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QIII;2.611
22 Huesca;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QII;""
22 Huesca;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QI;""
22 Huesca;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
22 Huesca;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QIII;2.575
22 Huesca;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QII;""
22 Huesca;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QI;""
22 Huesca;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QIV;2.485
22 Huesca;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
22 Huesca;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QII;""
22 Huesca;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QI;""
22 Huesca;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QIV;2.561
22 Huesca;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
22 Huesca;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QII;""
22 Huesca;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QI;""
22 Huesca;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QIV;2.526
22 Huesca;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
22 Huesca;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QII;""
22 Huesca;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QI;""
22 Huesca;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
22 Huesca;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
22 Huesca;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
22 Huesca;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
22 Huesca;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
22 Huesca;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
22 Huesca;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
22 Huesca;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
22 Huesca;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
22 Huesca;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
22 Huesca;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
22 Huesca;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
22 Huesca;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
22 Huesca;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
22 Huesca;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
22 Huesca;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;97,84
22 Huesca;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
22 Huesca;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
22 Huesca;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
22 Huesca;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;98,24
22 Huesca;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
22 Huesca;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
22 Huesca;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
22 Huesca;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;95,25
22 Huesca;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
22 Huesca;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
22 Huesca;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;95,65
22 Huesca;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
22 Huesca;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
22 Huesca;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
22 Huesca;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;96,71
22 Huesca;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
22 Huesca;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
22 Huesca;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
22 Huesca;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;93,88
22 Huesca;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
22 Huesca;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
22 Huesca;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;94,09
22 Huesca;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
22 Huesca;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
22 Huesca;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
22 Huesca;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;95,5
22 Huesca;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
22 Huesca;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
22 Huesca;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
22 Huesca;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;92,73
22 Huesca;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
22 Huesca;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
22 Huesca;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;92,34
22 Huesca;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
22 Huesca;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
22 Huesca;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
22 Huesca;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;93,67
22 Huesca;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
22 Huesca;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
22 Huesca;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
22 Huesca;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;90,96
22 Huesca;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
22 Huesca;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
22 Huesca;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
22 Huesca;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
22 Huesca;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
22 Huesca;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
22 Huesca;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QI;1.681
22 Huesca;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
22 Huesca;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
22 Huesca;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
22 Huesca;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QI;1.651
22 Huesca;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
22 Huesca;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
22 Huesca;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
22 Huesca;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QI;1.717
22 Huesca;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
22 Huesca;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
22 Huesca;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2022QII;""
22 Huesca;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2022QI;1.637
22 Huesca;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
22 Huesca;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
22 Huesca;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2021QII;""
22 Huesca;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2021QI;1.623
22 Huesca;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
22 Huesca;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
22 Huesca;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2020QII;""
22 Huesca;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2020QI;1.594
22 Huesca;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
22 Huesca;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
22 Huesca;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2022QII;1.584
22 Huesca;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2022QI;""
22 Huesca;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
22 Huesca;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
22 Huesca;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2021QII;1.589
22 Huesca;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2021QI;""
22 Huesca;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
22 Huesca;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
22 Huesca;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2020QII;1.566
22 Huesca;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2020QI;""
22 Huesca;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
22 Huesca;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QIII;1.555
22 Huesca;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QII;""
22 Huesca;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QI;""
22 Huesca;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
22 Huesca;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QIII;1.561
22 Huesca;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QII;""
22 Huesca;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QI;""
22 Huesca;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
22 Huesca;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QIII;1.536
22 Huesca;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QII;""
22 Huesca;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QI;""
22 Huesca;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QIV;1.512
22 Huesca;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
22 Huesca;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QII;""
22 Huesca;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QI;""
22 Huesca;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QIV;1.533
22 Huesca;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
22 Huesca;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QII;""
22 Huesca;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QI;""
22 Huesca;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QIV;1.503
22 Huesca;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
22 Huesca;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QII;""
22 Huesca;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QI;""
22 Huesca;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
22 Huesca;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
22 Huesca;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
22 Huesca;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
22 Huesca;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
22 Huesca;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
22 Huesca;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
22 Huesca;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
22 Huesca;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
22 Huesca;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
22 Huesca;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
22 Huesca;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
22 Huesca;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
22 Huesca;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
22 Huesca;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
22 Huesca;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;97,38
22 Huesca;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
22 Huesca;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
22 Huesca;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
22 Huesca;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;98,3
22 Huesca;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
22 Huesca;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
22 Huesca;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
22 Huesca;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;92,84
22 Huesca;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
22 Huesca;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
22 Huesca;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;94,23
22 Huesca;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
22 Huesca;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
22 Huesca;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
22 Huesca;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;96,24
22 Huesca;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
22 Huesca;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
22 Huesca;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
22 Huesca;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;91,21
22 Huesca;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
22 Huesca;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
22 Huesca;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;92,5
22 Huesca;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
22 Huesca;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
22 Huesca;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
22 Huesca;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;94,55
22 Huesca;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
22 Huesca;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
22 Huesca;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
22 Huesca;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;89,46
22 Huesca;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
22 Huesca;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
22 Huesca;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;89,95
22 Huesca;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
22 Huesca;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
22 Huesca;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
22 Huesca;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;92,85
22 Huesca;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
22 Huesca;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
22 Huesca;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
22 Huesca;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;87,54
22 Huesca;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
22 Huesca;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
22 Huesca;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
22 Huesca;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
22 Huesca;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
22 Huesca;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QII;4.251
22 Huesca;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
22 Huesca;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
22 Huesca;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
22 Huesca;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QII;4.284
22 Huesca;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
22 Huesca;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
22 Huesca;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
22 Huesca;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QII;4.382
22 Huesca;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
22 Huesca;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
22 Huesca;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
22 Huesca;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2022QII;4.123
22 Huesca;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2022QI;""
22 Huesca;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
22 Huesca;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
22 Huesca;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2021QII;4.196
22 Huesca;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2021QI;""
22 Huesca;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
22 Huesca;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
22 Huesca;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2020QII;4.308
22 Huesca;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2020QI;""
22 Huesca;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
22 Huesca;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2022QIII;4.042
22 Huesca;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2022QII;""
22 Huesca;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2022QI;""
22 Huesca;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
22 Huesca;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2021QIII;4.131
22 Huesca;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2021QII;""
22 Huesca;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2021QI;""
22 Huesca;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
22 Huesca;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2020QIII;4.228
22 Huesca;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2020QII;""
22 Huesca;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2020QI;""
22 Huesca;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QIV;3.946
22 Huesca;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
22 Huesca;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QII;""
22 Huesca;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QI;""
22 Huesca;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QIV;4.037
22 Huesca;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
22 Huesca;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QII;""
22 Huesca;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QI;""
22 Huesca;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QIV;4.140
22 Huesca;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
22 Huesca;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QII;""
22 Huesca;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QI;""
22 Huesca;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
22 Huesca;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
22 Huesca;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QII;""
22 Huesca;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QI;3.966
22 Huesca;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
22 Huesca;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
22 Huesca;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QII;""
22 Huesca;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QI;4.082
22 Huesca;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
22 Huesca;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
22 Huesca;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QII;""
22 Huesca;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QI;""
22 Huesca;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
22 Huesca;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
22 Huesca;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
22 Huesca;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
22 Huesca;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
22 Huesca;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
22 Huesca;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
22 Huesca;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
22 Huesca;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
22 Huesca;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
22 Huesca;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
22 Huesca;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
22 Huesca;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
22 Huesca;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
22 Huesca;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;96,99
22 Huesca;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
22 Huesca;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
22 Huesca;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
22 Huesca;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;97,95
22 Huesca;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
22 Huesca;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
22 Huesca;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
22 Huesca;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;98,31
22 Huesca;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
22 Huesca;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
22 Huesca;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;95,08
22 Huesca;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
22 Huesca;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
22 Huesca;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
22 Huesca;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;96,43
22 Huesca;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
22 Huesca;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
22 Huesca;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
22 Huesca;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;96,49
22 Huesca;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
22 Huesca;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
22 Huesca;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;92,83
22 Huesca;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
22 Huesca;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
22 Huesca;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
22 Huesca;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;94,23
22 Huesca;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
22 Huesca;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
22 Huesca;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
22 Huesca;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;94,48
22 Huesca;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
22 Huesca;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
22 Huesca;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
22 Huesca;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
22 Huesca;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
22 Huesca;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
22 Huesca;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;92,58
22 Huesca;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
22 Huesca;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
22 Huesca;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
22 Huesca;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;93,15
22 Huesca;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
22 Huesca;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
22 Huesca;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
22 Huesca;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
22 Huesca;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
22 Huesca;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
22 Huesca;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QII;2.617
22 Huesca;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
22 Huesca;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
22 Huesca;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
22 Huesca;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QII;2.648
22 Huesca;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
22 Huesca;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
22 Huesca;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
22 Huesca;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QII;2.729
22 Huesca;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
22 Huesca;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
22 Huesca;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
22 Huesca;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2022QII;2.547
22 Huesca;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2022QI;""
22 Huesca;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
22 Huesca;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
22 Huesca;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2021QII;2.601
22 Huesca;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2021QI;""
22 Huesca;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
22 Huesca;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
22 Huesca;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2020QII;2.686
22 Huesca;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2020QI;""
22 Huesca;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
22 Huesca;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2022QIII;2.496
22 Huesca;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2022QII;""
22 Huesca;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2022QI;""
22 Huesca;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
22 Huesca;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2021QIII;2.566
22 Huesca;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2021QII;""
22 Huesca;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2021QI;""
22 Huesca;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
22 Huesca;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2020QIII;2.639
22 Huesca;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2020QII;""
22 Huesca;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2020QI;""
22 Huesca;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QIV;2.444
22 Huesca;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
22 Huesca;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QII;""
22 Huesca;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QI;""
22 Huesca;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QIV;2.505
22 Huesca;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
22 Huesca;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QII;""
22 Huesca;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QI;""
22 Huesca;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QIV;2.586
22 Huesca;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
22 Huesca;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QII;""
22 Huesca;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QI;""
22 Huesca;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
22 Huesca;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
22 Huesca;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QII;""
22 Huesca;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QI;2.461
22 Huesca;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
22 Huesca;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
22 Huesca;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QII;""
22 Huesca;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QI;2.550
22 Huesca;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
22 Huesca;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
22 Huesca;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QII;""
22 Huesca;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QI;""
22 Huesca;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
22 Huesca;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
22 Huesca;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
22 Huesca;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
22 Huesca;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
22 Huesca;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
22 Huesca;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
22 Huesca;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
22 Huesca;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
22 Huesca;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
22 Huesca;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
22 Huesca;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
22 Huesca;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
22 Huesca;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
22 Huesca;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;97,33
22 Huesca;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
22 Huesca;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
22 Huesca;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
22 Huesca;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;98,23
22 Huesca;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
22 Huesca;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
22 Huesca;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
22 Huesca;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;98,42
22 Huesca;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
22 Huesca;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
22 Huesca;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;95,38
22 Huesca;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
22 Huesca;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
22 Huesca;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
22 Huesca;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;96,9
22 Huesca;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
22 Huesca;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
22 Huesca;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
22 Huesca;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;96,7
22 Huesca;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
22 Huesca;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
22 Huesca;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;93,39
22 Huesca;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
22 Huesca;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
22 Huesca;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
22 Huesca;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;94,6
22 Huesca;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
22 Huesca;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
22 Huesca;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
22 Huesca;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;94,76
22 Huesca;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
22 Huesca;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
22 Huesca;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
22 Huesca;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
22 Huesca;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
22 Huesca;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
22 Huesca;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;92,94
22 Huesca;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
22 Huesca;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
22 Huesca;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
22 Huesca;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;93,44
22 Huesca;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
22 Huesca;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
22 Huesca;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
22 Huesca;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
22 Huesca;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
22 Huesca;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
22 Huesca;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QII;1.634
22 Huesca;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
22 Huesca;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
22 Huesca;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
22 Huesca;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QII;1.636
22 Huesca;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
22 Huesca;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
22 Huesca;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
22 Huesca;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QII;1.653
22 Huesca;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
22 Huesca;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
22 Huesca;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
22 Huesca;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2022QII;1.576
22 Huesca;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2022QI;""
22 Huesca;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
22 Huesca;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
22 Huesca;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2021QII;1.595
22 Huesca;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2021QI;""
22 Huesca;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
22 Huesca;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
22 Huesca;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2020QII;1.622
22 Huesca;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2020QI;""
22 Huesca;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
22 Huesca;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2022QIII;1.546
22 Huesca;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2022QII;""
22 Huesca;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2022QI;""
22 Huesca;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
22 Huesca;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2021QIII;1.565
22 Huesca;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2021QII;""
22 Huesca;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2021QI;""
22 Huesca;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
22 Huesca;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2020QIII;1.589
22 Huesca;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2020QII;""
22 Huesca;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2020QI;""
22 Huesca;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QIV;1.502
22 Huesca;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
22 Huesca;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QII;""
22 Huesca;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QI;""
22 Huesca;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QIV;1.532
22 Huesca;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
22 Huesca;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QII;""
22 Huesca;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QI;""
22 Huesca;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QIV;1.554
22 Huesca;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
22 Huesca;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QII;""
22 Huesca;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QI;""
22 Huesca;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
22 Huesca;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
22 Huesca;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QII;""
22 Huesca;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QI;1.505
22 Huesca;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
22 Huesca;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
22 Huesca;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QII;""
22 Huesca;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QI;1.532
22 Huesca;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
22 Huesca;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
22 Huesca;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QII;""
22 Huesca;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QI;""
22 Huesca;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
22 Huesca;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
22 Huesca;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
22 Huesca;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
22 Huesca;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
22 Huesca;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
22 Huesca;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
22 Huesca;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
22 Huesca;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
22 Huesca;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
22 Huesca;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
22 Huesca;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
22 Huesca;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
22 Huesca;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
22 Huesca;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;96,45
22 Huesca;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
22 Huesca;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
22 Huesca;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
22 Huesca;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;97,49
22 Huesca;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
22 Huesca;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
22 Huesca;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
22 Huesca;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;98,12
22 Huesca;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
22 Huesca;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
22 Huesca;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;94,61
22 Huesca;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
22 Huesca;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
22 Huesca;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
22 Huesca;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;95,66
22 Huesca;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
22 Huesca;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
22 Huesca;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
22 Huesca;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;96,13
22 Huesca;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
22 Huesca;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
22 Huesca;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;91,92
22 Huesca;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
22 Huesca;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
22 Huesca;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
22 Huesca;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;93,64
22 Huesca;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
22 Huesca;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
22 Huesca;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
22 Huesca;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;94,01
22 Huesca;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
22 Huesca;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
22 Huesca;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
22 Huesca;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
22 Huesca;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
22 Huesca;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
22 Huesca;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;91,99
22 Huesca;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
22 Huesca;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
22 Huesca;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
22 Huesca;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;92,68
22 Huesca;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
22 Huesca;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
22 Huesca;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
22 Huesca;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
22 Huesca;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
22 Huesca;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QIII;4.293
22 Huesca;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
22 Huesca;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
22 Huesca;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
22 Huesca;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QIII;4.368
22 Huesca;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
22 Huesca;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
22 Huesca;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
22 Huesca;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QIII;4.411
22 Huesca;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
22 Huesca;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
22 Huesca;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
22 Huesca;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2022QIII;4.165
22 Huesca;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2022QII;""
22 Huesca;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2022QI;""
22 Huesca;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
22 Huesca;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2021QIII;4.274
22 Huesca;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2021QII;""
22 Huesca;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2021QI;""
22 Huesca;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
22 Huesca;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2020QIII;4.311
22 Huesca;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2020QII;""
22 Huesca;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2020QI;""
22 Huesca;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2022QIV;4.045
22 Huesca;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
22 Huesca;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2022QII;""
22 Huesca;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2022QI;""
22 Huesca;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2021QIV;4.158
22 Huesca;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
22 Huesca;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2021QII;""
22 Huesca;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2021QI;""
22 Huesca;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2020QIV;4.204
22 Huesca;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
22 Huesca;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2020QII;""
22 Huesca;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2020QI;""
22 Huesca;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
22 Huesca;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
22 Huesca;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QII;""
22 Huesca;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QI;4.080
22 Huesca;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
22 Huesca;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
22 Huesca;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QII;""
22 Huesca;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QI;4.142
22 Huesca;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
22 Huesca;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
22 Huesca;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QII;""
22 Huesca;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QI;""
22 Huesca;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
22 Huesca;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
22 Huesca;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QII;4.000
22 Huesca;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QI;""
22 Huesca;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
22 Huesca;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
22 Huesca;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QII;4.084
22 Huesca;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QI;""
22 Huesca;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
22 Huesca;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
22 Huesca;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QII;""
22 Huesca;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QI;""
22 Huesca;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
22 Huesca;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
22 Huesca;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
22 Huesca;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
22 Huesca;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
22 Huesca;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
22 Huesca;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
22 Huesca;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
22 Huesca;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
22 Huesca;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
22 Huesca;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
22 Huesca;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
22 Huesca;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
22 Huesca;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;97,02
22 Huesca;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
22 Huesca;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
22 Huesca;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
22 Huesca;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;97,85
22 Huesca;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
22 Huesca;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
22 Huesca;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
22 Huesca;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;97,73
22 Huesca;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
22 Huesca;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
22 Huesca;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;94,22
22 Huesca;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
22 Huesca;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
22 Huesca;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
22 Huesca;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;95,19
22 Huesca;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
22 Huesca;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
22 Huesca;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
22 Huesca;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;95,31
22 Huesca;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
22 Huesca;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
22 Huesca;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
22 Huesca;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
22 Huesca;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
22 Huesca;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
22 Huesca;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;93,41
22 Huesca;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
22 Huesca;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
22 Huesca;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
22 Huesca;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;93,9
22 Huesca;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
22 Huesca;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
22 Huesca;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
22 Huesca;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
22 Huesca;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
22 Huesca;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
22 Huesca;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;91,58
22 Huesca;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
22 Huesca;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
22 Huesca;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
22 Huesca;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;92,59
22 Huesca;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
22 Huesca;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
22 Huesca;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
22 Huesca;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
22 Huesca;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
22 Huesca;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
22 Huesca;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QIII;2.635
22 Huesca;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
22 Huesca;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
22 Huesca;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
22 Huesca;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QIII;2.699
22 Huesca;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
22 Huesca;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
22 Huesca;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
22 Huesca;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QIII;2.755
22 Huesca;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
22 Huesca;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
22 Huesca;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
22 Huesca;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2022QIII;2.558
22 Huesca;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2022QII;""
22 Huesca;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2022QI;""
22 Huesca;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
22 Huesca;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2021QIII;2.647
22 Huesca;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2021QII;""
22 Huesca;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2021QI;""
22 Huesca;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
22 Huesca;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2020QIII;2.694
22 Huesca;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2020QII;""
22 Huesca;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2020QI;""
22 Huesca;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2022QIV;2.495
22 Huesca;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
22 Huesca;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2022QII;""
22 Huesca;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2022QI;""
22 Huesca;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2021QIV;2.574
22 Huesca;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
22 Huesca;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2021QII;""
22 Huesca;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2021QI;""
22 Huesca;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2020QIV;2.630
22 Huesca;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
22 Huesca;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2020QII;""
22 Huesca;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2020QI;""
22 Huesca;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
22 Huesca;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
22 Huesca;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QII;""
22 Huesca;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QI;2.526
22 Huesca;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
22 Huesca;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
22 Huesca;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QII;""
22 Huesca;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QI;2.591
22 Huesca;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
22 Huesca;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
22 Huesca;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QII;""
22 Huesca;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QI;""
22 Huesca;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
22 Huesca;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
22 Huesca;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QII;2.486
22 Huesca;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QI;""
22 Huesca;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
22 Huesca;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
22 Huesca;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QII;2.559
22 Huesca;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QI;""
22 Huesca;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
22 Huesca;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
22 Huesca;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QII;""
22 Huesca;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QI;""
22 Huesca;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
22 Huesca;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
22 Huesca;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
22 Huesca;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
22 Huesca;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
22 Huesca;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
22 Huesca;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
22 Huesca;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
22 Huesca;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
22 Huesca;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
22 Huesca;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
22 Huesca;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
22 Huesca;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
22 Huesca;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;97,08
22 Huesca;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
22 Huesca;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
22 Huesca;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
22 Huesca;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;98,07
22 Huesca;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
22 Huesca;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
22 Huesca;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
22 Huesca;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;97,79
22 Huesca;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
22 Huesca;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
22 Huesca;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;94,69
22 Huesca;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
22 Huesca;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
22 Huesca;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
22 Huesca;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;95,37
22 Huesca;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
22 Huesca;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
22 Huesca;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
22 Huesca;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;95,46
22 Huesca;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
22 Huesca;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
22 Huesca;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
22 Huesca;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
22 Huesca;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
22 Huesca;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
22 Huesca;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;93,59
22 Huesca;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
22 Huesca;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
22 Huesca;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
22 Huesca;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;94,05
22 Huesca;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
22 Huesca;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
22 Huesca;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
22 Huesca;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
22 Huesca;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
22 Huesca;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
22 Huesca;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;92,11
22 Huesca;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
22 Huesca;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
22 Huesca;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
22 Huesca;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;92,89
22 Huesca;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
22 Huesca;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
22 Huesca;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
22 Huesca;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
22 Huesca;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
22 Huesca;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
22 Huesca;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QIII;1.658
22 Huesca;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
22 Huesca;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
22 Huesca;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
22 Huesca;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QIII;1.669
22 Huesca;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
22 Huesca;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
22 Huesca;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
22 Huesca;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QIII;1.656
22 Huesca;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
22 Huesca;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
22 Huesca;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
22 Huesca;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2022QIII;1.607
22 Huesca;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2022QII;""
22 Huesca;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2022QI;""
22 Huesca;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
22 Huesca;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2021QIII;1.627
22 Huesca;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2021QII;""
22 Huesca;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2021QI;""
22 Huesca;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
22 Huesca;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2020QIII;1.617
22 Huesca;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2020QII;""
22 Huesca;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2020QI;""
22 Huesca;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2022QIV;1.550
22 Huesca;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
22 Huesca;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2022QII;""
22 Huesca;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2022QI;""
22 Huesca;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2021QIV;1.584
22 Huesca;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
22 Huesca;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2021QII;""
22 Huesca;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2021QI;""
22 Huesca;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2020QIV;1.574
22 Huesca;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
22 Huesca;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2020QII;""
22 Huesca;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2020QI;""
22 Huesca;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
22 Huesca;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
22 Huesca;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QII;""
22 Huesca;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QI;1.554
22 Huesca;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
22 Huesca;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
22 Huesca;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QII;""
22 Huesca;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QI;1.551
22 Huesca;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
22 Huesca;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
22 Huesca;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QII;""
22 Huesca;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QI;""
22 Huesca;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
22 Huesca;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
22 Huesca;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QII;1.514
22 Huesca;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QI;""
22 Huesca;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
22 Huesca;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
22 Huesca;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QII;1.525
22 Huesca;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QI;""
22 Huesca;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
22 Huesca;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
22 Huesca;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QII;""
22 Huesca;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QI;""
22 Huesca;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
22 Huesca;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
22 Huesca;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
22 Huesca;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
22 Huesca;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
22 Huesca;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
22 Huesca;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
22 Huesca;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
22 Huesca;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
22 Huesca;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
22 Huesca;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
22 Huesca;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
22 Huesca;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
22 Huesca;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;96,92
22 Huesca;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
22 Huesca;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
22 Huesca;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
22 Huesca;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;97,48
22 Huesca;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
22 Huesca;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
22 Huesca;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
22 Huesca;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;97,64
22 Huesca;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
22 Huesca;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
22 Huesca;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;93,49
22 Huesca;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
22 Huesca;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
22 Huesca;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
22 Huesca;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;94,91
22 Huesca;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
22 Huesca;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
22 Huesca;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
22 Huesca;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;95,05
22 Huesca;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
22 Huesca;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
22 Huesca;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
22 Huesca;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
22 Huesca;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
22 Huesca;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
22 Huesca;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;93,11
22 Huesca;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
22 Huesca;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
22 Huesca;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
22 Huesca;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;93,66
22 Huesca;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
22 Huesca;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
22 Huesca;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
22 Huesca;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
22 Huesca;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
22 Huesca;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
22 Huesca;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;90,71
22 Huesca;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
22 Huesca;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
22 Huesca;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
22 Huesca;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;92,09
22 Huesca;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
22 Huesca;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
22 Huesca;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
22 Huesca;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
22 Huesca;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
22 Huesca;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QIV;4.258
22 Huesca;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
22 Huesca;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
22 Huesca;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
22 Huesca;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QIV;4.380
22 Huesca;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
22 Huesca;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
22 Huesca;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
22 Huesca;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QIV;4.426
22 Huesca;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
22 Huesca;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
22 Huesca;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
22 Huesca;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2022QIV;4.123
22 Huesca;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
22 Huesca;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2022QII;""
22 Huesca;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2022QI;""
22 Huesca;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2021QIV;4.245
22 Huesca;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
22 Huesca;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2021QII;""
22 Huesca;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2021QI;""
22 Huesca;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2020QIV;4.297
22 Huesca;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
22 Huesca;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2020QII;""
22 Huesca;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2020QI;""
22 Huesca;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
22 Huesca;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
22 Huesca;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2022QII;""
22 Huesca;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2022QI;4.158
22 Huesca;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
22 Huesca;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
22 Huesca;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2021QII;""
22 Huesca;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2021QI;4.230
22 Huesca;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
22 Huesca;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
22 Huesca;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2020QII;""
22 Huesca;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2020QI;""
22 Huesca;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
22 Huesca;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
22 Huesca;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QII;4.072
22 Huesca;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QI;""
22 Huesca;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
22 Huesca;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
22 Huesca;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QII;4.166
22 Huesca;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QI;""
22 Huesca;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
22 Huesca;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
22 Huesca;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QII;""
22 Huesca;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QI;""
22 Huesca;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
22 Huesca;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QIII;4.007
22 Huesca;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QII;""
22 Huesca;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QI;""
22 Huesca;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
22 Huesca;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QIII;4.111
22 Huesca;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QII;""
22 Huesca;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QI;""
22 Huesca;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
22 Huesca;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
22 Huesca;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QII;""
22 Huesca;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QI;""
22 Huesca;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
22 Huesca;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
22 Huesca;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
22 Huesca;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
22 Huesca;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
22 Huesca;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
22 Huesca;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
22 Huesca;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
22 Huesca;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
22 Huesca;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
22 Huesca;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
22 Huesca;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
22 Huesca;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;96,83
22 Huesca;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
22 Huesca;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
22 Huesca;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
22 Huesca;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;96,92
22 Huesca;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
22 Huesca;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
22 Huesca;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
22 Huesca;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;97,09
22 Huesca;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
22 Huesca;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
22 Huesca;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
22 Huesca;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
22 Huesca;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
22 Huesca;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
22 Huesca;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;94,93
22 Huesca;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
22 Huesca;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
22 Huesca;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
22 Huesca;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;95,57
22 Huesca;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
22 Huesca;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
22 Huesca;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
22 Huesca;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
22 Huesca;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
22 Huesca;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
22 Huesca;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;92,97
22 Huesca;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
22 Huesca;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
22 Huesca;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
22 Huesca;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;94,13
22 Huesca;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
22 Huesca;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
22 Huesca;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
22 Huesca;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
22 Huesca;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
22 Huesca;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
22 Huesca;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;91,48
22 Huesca;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
22 Huesca;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
22 Huesca;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
22 Huesca;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;92,88
22 Huesca;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
22 Huesca;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
22 Huesca;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
22 Huesca;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
22 Huesca;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
22 Huesca;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
22 Huesca;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QIV;2.603
22 Huesca;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
22 Huesca;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
22 Huesca;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
22 Huesca;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QIV;2.708
22 Huesca;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
22 Huesca;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
22 Huesca;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
22 Huesca;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QIV;2.763
22 Huesca;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
22 Huesca;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
22 Huesca;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
22 Huesca;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2022QIV;2.535
22 Huesca;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
22 Huesca;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2022QII;""
22 Huesca;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2022QI;""
22 Huesca;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2021QIV;2.625
22 Huesca;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
22 Huesca;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2021QII;""
22 Huesca;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2021QI;""
22 Huesca;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2020QIV;2.686
22 Huesca;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
22 Huesca;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2020QII;""
22 Huesca;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2020QI;""
22 Huesca;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
22 Huesca;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
22 Huesca;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2022QII;""
22 Huesca;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2022QI;2.575
22 Huesca;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
22 Huesca;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
22 Huesca;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2021QII;""
22 Huesca;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2021QI;2.643
22 Huesca;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
22 Huesca;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
22 Huesca;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2020QII;""
22 Huesca;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2020QI;""
22 Huesca;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
22 Huesca;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
22 Huesca;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QII;2.529
22 Huesca;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QI;""
22 Huesca;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
22 Huesca;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
22 Huesca;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QII;2.607
22 Huesca;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QI;""
22 Huesca;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
22 Huesca;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
22 Huesca;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QII;""
22 Huesca;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QI;""
22 Huesca;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
22 Huesca;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QIII;2.492
22 Huesca;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QII;""
22 Huesca;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QI;""
22 Huesca;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
22 Huesca;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QIII;2.576
22 Huesca;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QII;""
22 Huesca;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QI;""
22 Huesca;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
22 Huesca;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
22 Huesca;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QII;""
22 Huesca;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QI;""
22 Huesca;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
22 Huesca;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
22 Huesca;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
22 Huesca;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
22 Huesca;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
22 Huesca;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
22 Huesca;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
22 Huesca;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
22 Huesca;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
22 Huesca;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
22 Huesca;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
22 Huesca;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
22 Huesca;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;97,39
22 Huesca;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
22 Huesca;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
22 Huesca;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
22 Huesca;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;96,94
22 Huesca;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
22 Huesca;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
22 Huesca;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
22 Huesca;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;97,21
22 Huesca;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
22 Huesca;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
22 Huesca;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
22 Huesca;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
22 Huesca;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
22 Huesca;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
22 Huesca;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;95,09
22 Huesca;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
22 Huesca;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
22 Huesca;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
22 Huesca;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;95,66
22 Huesca;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
22 Huesca;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
22 Huesca;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
22 Huesca;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
22 Huesca;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
22 Huesca;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
22 Huesca;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;93,39
22 Huesca;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
22 Huesca;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
22 Huesca;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
22 Huesca;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;94,35
22 Huesca;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
22 Huesca;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
22 Huesca;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
22 Huesca;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
22 Huesca;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
22 Huesca;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
22 Huesca;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;92,02
22 Huesca;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
22 Huesca;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
22 Huesca;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
22 Huesca;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;93,23
22 Huesca;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
22 Huesca;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
22 Huesca;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
22 Huesca;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
22 Huesca;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
22 Huesca;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
22 Huesca;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QIV;1.655
22 Huesca;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
22 Huesca;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
22 Huesca;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
22 Huesca;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QIV;1.672
22 Huesca;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
22 Huesca;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
22 Huesca;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
22 Huesca;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QIV;1.663
22 Huesca;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
22 Huesca;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
22 Huesca;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
22 Huesca;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2022QIV;1.588
22 Huesca;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
22 Huesca;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2022QII;""
22 Huesca;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2022QI;""
22 Huesca;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2021QIV;1.620
22 Huesca;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
22 Huesca;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2021QII;""
22 Huesca;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2021QI;""
22 Huesca;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2020QIV;1.611
22 Huesca;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
22 Huesca;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2020QII;""
22 Huesca;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2020QI;""
22 Huesca;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
22 Huesca;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
22 Huesca;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2022QII;""
22 Huesca;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2022QI;1.583
22 Huesca;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
22 Huesca;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
22 Huesca;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2021QII;""
22 Huesca;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2021QI;1.587
22 Huesca;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
22 Huesca;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
22 Huesca;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2020QII;""
22 Huesca;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2020QI;""
22 Huesca;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
22 Huesca;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
22 Huesca;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QII;1.543
22 Huesca;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QI;""
22 Huesca;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
22 Huesca;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
22 Huesca;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QII;1.559
22 Huesca;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QI;""
22 Huesca;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
22 Huesca;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
22 Huesca;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QII;""
22 Huesca;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QI;""
22 Huesca;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
22 Huesca;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QIII;1.515
22 Huesca;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QII;""
22 Huesca;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QI;""
22 Huesca;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
22 Huesca;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QIII;1.535
22 Huesca;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QII;""
22 Huesca;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QI;""
22 Huesca;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
22 Huesca;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
22 Huesca;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QII;""
22 Huesca;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QI;""
22 Huesca;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
22 Huesca;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
22 Huesca;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
22 Huesca;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
22 Huesca;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
22 Huesca;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
22 Huesca;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
22 Huesca;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
22 Huesca;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
22 Huesca;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
22 Huesca;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
22 Huesca;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
22 Huesca;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;95,95
22 Huesca;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
22 Huesca;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
22 Huesca;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
22 Huesca;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;96,89
22 Huesca;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
22 Huesca;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
22 Huesca;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
22 Huesca;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;96,87
22 Huesca;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
22 Huesca;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
22 Huesca;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
22 Huesca;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
22 Huesca;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
22 Huesca;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
22 Huesca;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;94,68
22 Huesca;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
22 Huesca;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
22 Huesca;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
22 Huesca;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;95,43
22 Huesca;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
22 Huesca;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
22 Huesca;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
22 Huesca;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
22 Huesca;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
22 Huesca;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
22 Huesca;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;92,28
22 Huesca;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
22 Huesca;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
22 Huesca;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
22 Huesca;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;93,75
22 Huesca;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
22 Huesca;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
22 Huesca;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
22 Huesca;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
22 Huesca;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
22 Huesca;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
22 Huesca;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;90,61
22 Huesca;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
22 Huesca;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
22 Huesca;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
22 Huesca;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;92,3
22 Huesca;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
22 Huesca;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
22 Huesca;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
22 Huesca;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
22 Huesca;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
22 Huesca;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
22 Huesca;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
22 Huesca;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
22 Huesca;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
22 Huesca;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QI;4.622
22 Huesca;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
22 Huesca;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
22 Huesca;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
22 Huesca;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QI;4.562
22 Huesca;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
22 Huesca;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
22 Huesca;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
22 Huesca;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QI;4.666
22 Huesca;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
22 Huesca;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
22 Huesca;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2022QII;""
22 Huesca;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2022QI;4.545
22 Huesca;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
22 Huesca;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
22 Huesca;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2021QII;""
22 Huesca;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2021QI;4.500
22 Huesca;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
22 Huesca;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
22 Huesca;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2020QII;""
22 Huesca;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2020QI;4.491
22 Huesca;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
22 Huesca;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
22 Huesca;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2022QII;4.450
22 Huesca;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2022QI;""
22 Huesca;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
22 Huesca;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
22 Huesca;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2021QII;4.450
22 Huesca;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2021QI;""
22 Huesca;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
22 Huesca;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
22 Huesca;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2020QII;4.455
22 Huesca;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2020QI;""
22 Huesca;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
22 Huesca;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QIII;4.387
22 Huesca;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QII;""
22 Huesca;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QI;""
22 Huesca;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
22 Huesca;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QIII;4.403
22 Huesca;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QII;""
22 Huesca;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QI;""
22 Huesca;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
22 Huesca;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QIII;4.396
22 Huesca;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QII;""
22 Huesca;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QI;""
22 Huesca;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QIV;4.320
22 Huesca;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
22 Huesca;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QII;""
22 Huesca;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QI;""
22 Huesca;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QIV;4.344
22 Huesca;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
22 Huesca;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QII;""
22 Huesca;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QI;""
22 Huesca;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QIV;4.333
22 Huesca;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
22 Huesca;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QII;""
22 Huesca;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QI;""
22 Huesca;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
22 Huesca;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
22 Huesca;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
22 Huesca;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
22 Huesca;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
22 Huesca;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
22 Huesca;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
22 Huesca;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
22 Huesca;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
22 Huesca;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
22 Huesca;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
22 Huesca;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
22 Huesca;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
22 Huesca;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
22 Huesca;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
22 Huesca;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;98,33
22 Huesca;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
22 Huesca;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
22 Huesca;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
22 Huesca;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;98,64
22 Huesca;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
22 Huesca;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
22 Huesca;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
22 Huesca;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;96,25
22 Huesca;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
22 Huesca;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
22 Huesca;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;96,28
22 Huesca;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
22 Huesca;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
22 Huesca;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
22 Huesca;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;97,54
22 Huesca;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
22 Huesca;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
22 Huesca;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
22 Huesca;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;95,48
22 Huesca;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
22 Huesca;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
22 Huesca;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;94,92
22 Huesca;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
22 Huesca;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
22 Huesca;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
22 Huesca;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;96,51
22 Huesca;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
22 Huesca;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
22 Huesca;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
22 Huesca;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;94,21
22 Huesca;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
22 Huesca;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
22 Huesca;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;93,47
22 Huesca;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
22 Huesca;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
22 Huesca;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
22 Huesca;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;95,22
22 Huesca;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
22 Huesca;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
22 Huesca;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
22 Huesca;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;92,86
22 Huesca;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
22 Huesca;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
22 Huesca;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
22 Huesca;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
22 Huesca;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
22 Huesca;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
22 Huesca;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QI;2.822
22 Huesca;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
22 Huesca;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
22 Huesca;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
22 Huesca;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QI;2.798
22 Huesca;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
22 Huesca;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
22 Huesca;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
22 Huesca;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QI;2.871
22 Huesca;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
22 Huesca;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
22 Huesca;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2022QII;""
22 Huesca;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2022QI;2.782
22 Huesca;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
22 Huesca;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
22 Huesca;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2021QII;""
22 Huesca;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2021QI;2.761
22 Huesca;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
22 Huesca;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
22 Huesca;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2020QII;""
22 Huesca;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2020QI;2.765
22 Huesca;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
22 Huesca;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
22 Huesca;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2022QII;2.731
22 Huesca;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2022QI;""
22 Huesca;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
22 Huesca;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
22 Huesca;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2021QII;2.739
22 Huesca;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2021QI;""
22 Huesca;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
22 Huesca;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
22 Huesca;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2020QII;2.746
22 Huesca;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2020QI;""
22 Huesca;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
22 Huesca;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QIII;2.695
22 Huesca;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QII;""
22 Huesca;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QI;""
22 Huesca;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
22 Huesca;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QIII;2.717
22 Huesca;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QII;""
22 Huesca;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QI;""
22 Huesca;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
22 Huesca;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QIII;2.712
22 Huesca;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QII;""
22 Huesca;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QI;""
22 Huesca;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QIV;2.656
22 Huesca;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
22 Huesca;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QII;""
22 Huesca;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QI;""
22 Huesca;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QIV;2.686
22 Huesca;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
22 Huesca;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QII;""
22 Huesca;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QI;""
22 Huesca;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QIV;2.676
22 Huesca;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
22 Huesca;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QII;""
22 Huesca;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QI;""
22 Huesca;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
22 Huesca;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
22 Huesca;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
22 Huesca;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
22 Huesca;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
22 Huesca;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
22 Huesca;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
22 Huesca;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
22 Huesca;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
22 Huesca;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
22 Huesca;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
22 Huesca;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
22 Huesca;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
22 Huesca;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
22 Huesca;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
22 Huesca;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;98,58
22 Huesca;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
22 Huesca;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
22 Huesca;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
22 Huesca;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;98,68
22 Huesca;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
22 Huesca;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
22 Huesca;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
22 Huesca;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;96,31
22 Huesca;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
22 Huesca;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
22 Huesca;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;96,78
22 Huesca;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
22 Huesca;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
22 Huesca;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
22 Huesca;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;97,89
22 Huesca;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
22 Huesca;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
22 Huesca;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
22 Huesca;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;95,65
22 Huesca;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
22 Huesca;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
22 Huesca;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;95,5
22 Huesca;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
22 Huesca;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
22 Huesca;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
22 Huesca;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;97,11
22 Huesca;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
22 Huesca;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
22 Huesca;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
22 Huesca;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;94,46
22 Huesca;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
22 Huesca;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
22 Huesca;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;94,12
22 Huesca;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
22 Huesca;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
22 Huesca;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
22 Huesca;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;96
22 Huesca;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
22 Huesca;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
22 Huesca;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
22 Huesca;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;93,21
22 Huesca;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
22 Huesca;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
22 Huesca;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
22 Huesca;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
22 Huesca;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
22 Huesca;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
22 Huesca;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QI;1.800
22 Huesca;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
22 Huesca;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
22 Huesca;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
22 Huesca;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QI;1.764
22 Huesca;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
22 Huesca;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
22 Huesca;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
22 Huesca;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QI;1.795
22 Huesca;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
22 Huesca;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
22 Huesca;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2022QII;""
22 Huesca;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2022QI;1.763
22 Huesca;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
22 Huesca;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
22 Huesca;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2021QII;""
22 Huesca;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2021QI;1.739
22 Huesca;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
22 Huesca;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
22 Huesca;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2020QII;""
22 Huesca;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2020QI;1.726
22 Huesca;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
22 Huesca;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
22 Huesca;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2022QII;1.719
22 Huesca;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2022QI;""
22 Huesca;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
22 Huesca;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
22 Huesca;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2021QII;1.711
22 Huesca;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2021QI;""
22 Huesca;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
22 Huesca;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
22 Huesca;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2020QII;1.709
22 Huesca;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2020QI;""
22 Huesca;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
22 Huesca;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QIII;1.692
22 Huesca;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QII;""
22 Huesca;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QI;""
22 Huesca;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
22 Huesca;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QIII;1.686
22 Huesca;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QII;""
22 Huesca;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QI;""
22 Huesca;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
22 Huesca;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QIII;1.684
22 Huesca;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QII;""
22 Huesca;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QI;""
22 Huesca;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QIV;1.664
22 Huesca;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
22 Huesca;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QII;""
22 Huesca;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QI;""
22 Huesca;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QIV;1.658
22 Huesca;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
22 Huesca;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QII;""
22 Huesca;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QI;""
22 Huesca;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QIV;1.657
22 Huesca;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
22 Huesca;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QII;""
22 Huesca;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QI;""
22 Huesca;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
22 Huesca;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
22 Huesca;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
22 Huesca;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
22 Huesca;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
22 Huesca;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
22 Huesca;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
22 Huesca;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
22 Huesca;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
22 Huesca;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
22 Huesca;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
22 Huesca;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
22 Huesca;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
22 Huesca;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
22 Huesca;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
22 Huesca;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;97,94
22 Huesca;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
22 Huesca;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
22 Huesca;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
22 Huesca;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;98,58
22 Huesca;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
22 Huesca;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
22 Huesca;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
22 Huesca;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;96,16
22 Huesca;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
22 Huesca;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
22 Huesca;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;95,5
22 Huesca;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
22 Huesca;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
22 Huesca;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
22 Huesca;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;97
22 Huesca;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
22 Huesca;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
22 Huesca;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
22 Huesca;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;95,21
22 Huesca;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
22 Huesca;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
22 Huesca;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;94
22 Huesca;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
22 Huesca;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
22 Huesca;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
22 Huesca;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;95,58
22 Huesca;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
22 Huesca;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
22 Huesca;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
22 Huesca;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;93,82
22 Huesca;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
22 Huesca;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
22 Huesca;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;92,44
22 Huesca;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
22 Huesca;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
22 Huesca;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
22 Huesca;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;93,99
22 Huesca;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
22 Huesca;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
22 Huesca;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
22 Huesca;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;92,31
22 Huesca;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
22 Huesca;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
22 Huesca;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
22 Huesca;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
22 Huesca;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
22 Huesca;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QII;4.654
22 Huesca;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
22 Huesca;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
22 Huesca;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
22 Huesca;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QII;4.588
22 Huesca;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
22 Huesca;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
22 Huesca;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
22 Huesca;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QII;4.575
22 Huesca;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
22 Huesca;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
22 Huesca;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
22 Huesca;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2022QII;4.547
22 Huesca;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2022QI;""
22 Huesca;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
22 Huesca;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
22 Huesca;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2021QII;4.526
22 Huesca;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2021QI;""
22 Huesca;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
22 Huesca;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
22 Huesca;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2020QII;4.536
22 Huesca;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2020QI;""
22 Huesca;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
22 Huesca;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2022QIII;4.484
22 Huesca;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2022QII;""
22 Huesca;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2022QI;""
22 Huesca;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
22 Huesca;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2021QIII;4.472
22 Huesca;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2021QII;""
22 Huesca;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2021QI;""
22 Huesca;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
22 Huesca;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2020QIII;4.466
22 Huesca;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2020QII;""
22 Huesca;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2020QI;""
22 Huesca;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QIV;4.410
22 Huesca;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
22 Huesca;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QII;""
22 Huesca;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QI;""
22 Huesca;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QIV;4.411
22 Huesca;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
22 Huesca;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QII;""
22 Huesca;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QI;""
22 Huesca;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QIV;4.397
22 Huesca;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
22 Huesca;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QII;""
22 Huesca;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QI;""
22 Huesca;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
22 Huesca;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
22 Huesca;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QII;""
22 Huesca;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QI;4.350
22 Huesca;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
22 Huesca;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
22 Huesca;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QII;""
22 Huesca;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QI;4.348
22 Huesca;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
22 Huesca;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
22 Huesca;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QII;""
22 Huesca;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QI;""
22 Huesca;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
22 Huesca;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
22 Huesca;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
22 Huesca;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
22 Huesca;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
22 Huesca;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
22 Huesca;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
22 Huesca;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
22 Huesca;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
22 Huesca;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
22 Huesca;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
22 Huesca;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
22 Huesca;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
22 Huesca;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
22 Huesca;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;97,7
22 Huesca;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
22 Huesca;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
22 Huesca;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
22 Huesca;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;98,65
22 Huesca;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
22 Huesca;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
22 Huesca;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
22 Huesca;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;99,15
22 Huesca;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
22 Huesca;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
22 Huesca;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;96,35
22 Huesca;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
22 Huesca;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
22 Huesca;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
22 Huesca;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;97,47
22 Huesca;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
22 Huesca;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
22 Huesca;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
22 Huesca;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;97,62
22 Huesca;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
22 Huesca;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
22 Huesca;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;94,76
22 Huesca;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
22 Huesca;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
22 Huesca;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
22 Huesca;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;96,14
22 Huesca;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
22 Huesca;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
22 Huesca;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
22 Huesca;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;96,11
22 Huesca;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
22 Huesca;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
22 Huesca;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
22 Huesca;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
22 Huesca;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
22 Huesca;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
22 Huesca;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;94,81
22 Huesca;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
22 Huesca;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
22 Huesca;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
22 Huesca;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;95,04
22 Huesca;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
22 Huesca;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
22 Huesca;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
22 Huesca;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
22 Huesca;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
22 Huesca;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
22 Huesca;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QII;2.842
22 Huesca;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
22 Huesca;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
22 Huesca;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
22 Huesca;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QII;2.803
22 Huesca;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
22 Huesca;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
22 Huesca;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
22 Huesca;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QII;2.809
22 Huesca;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
22 Huesca;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
22 Huesca;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
22 Huesca;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2022QII;2.784
22 Huesca;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2022QI;""
22 Huesca;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
22 Huesca;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
22 Huesca;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2021QII;2.773
22 Huesca;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2021QI;""
22 Huesca;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
22 Huesca;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
22 Huesca;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2020QII;2.790
22 Huesca;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2020QI;""
22 Huesca;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
22 Huesca;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2022QIII;2.747
22 Huesca;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2022QII;""
22 Huesca;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2022QI;""
22 Huesca;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
22 Huesca;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2021QIII;2.745
22 Huesca;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2021QII;""
22 Huesca;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2021QI;""
22 Huesca;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
22 Huesca;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2020QIII;2.749
22 Huesca;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2020QII;""
22 Huesca;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2020QI;""
22 Huesca;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QIV;2.707
22 Huesca;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
22 Huesca;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QII;""
22 Huesca;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QI;""
22 Huesca;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QIV;2.709
22 Huesca;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
22 Huesca;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QII;""
22 Huesca;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QI;""
22 Huesca;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QIV;2.711
22 Huesca;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
22 Huesca;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QII;""
22 Huesca;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QI;""
22 Huesca;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
22 Huesca;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
22 Huesca;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QII;""
22 Huesca;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QI;2.678
22 Huesca;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
22 Huesca;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
22 Huesca;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QII;""
22 Huesca;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QI;2.686
22 Huesca;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
22 Huesca;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
22 Huesca;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QII;""
22 Huesca;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QI;""
22 Huesca;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
22 Huesca;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
22 Huesca;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
22 Huesca;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
22 Huesca;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
22 Huesca;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
22 Huesca;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
22 Huesca;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
22 Huesca;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
22 Huesca;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
22 Huesca;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
22 Huesca;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
22 Huesca;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
22 Huesca;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
22 Huesca;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;97,96
22 Huesca;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
22 Huesca;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
22 Huesca;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
22 Huesca;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;98,93
22 Huesca;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
22 Huesca;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
22 Huesca;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
22 Huesca;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;99,32
22 Huesca;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
22 Huesca;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
22 Huesca;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;96,66
22 Huesca;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
22 Huesca;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
22 Huesca;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
22 Huesca;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;97,93
22 Huesca;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
22 Huesca;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
22 Huesca;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
22 Huesca;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;97,86
22 Huesca;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
22 Huesca;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
22 Huesca;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;95,25
22 Huesca;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
22 Huesca;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
22 Huesca;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
22 Huesca;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;96,65
22 Huesca;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
22 Huesca;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
22 Huesca;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
22 Huesca;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;96,51
22 Huesca;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
22 Huesca;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
22 Huesca;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
22 Huesca;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
22 Huesca;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
22 Huesca;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
22 Huesca;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;95,54
22 Huesca;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
22 Huesca;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
22 Huesca;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
22 Huesca;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;95,62
22 Huesca;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
22 Huesca;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
22 Huesca;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
22 Huesca;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
22 Huesca;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
22 Huesca;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
22 Huesca;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QII;1.812
22 Huesca;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
22 Huesca;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
22 Huesca;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
22 Huesca;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QII;1.785
22 Huesca;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
22 Huesca;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
22 Huesca;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
22 Huesca;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QII;1.766
22 Huesca;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
22 Huesca;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
22 Huesca;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
22 Huesca;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2022QII;1.763
22 Huesca;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2022QI;""
22 Huesca;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
22 Huesca;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
22 Huesca;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2021QII;1.753
22 Huesca;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2021QI;""
22 Huesca;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
22 Huesca;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
22 Huesca;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2020QII;1.746
22 Huesca;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2020QI;""
22 Huesca;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
22 Huesca;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2022QIII;1.737
22 Huesca;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2022QII;""
22 Huesca;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2022QI;""
22 Huesca;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
22 Huesca;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2021QIII;1.727
22 Huesca;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2021QII;""
22 Huesca;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2021QI;""
22 Huesca;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
22 Huesca;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2020QIII;1.717
22 Huesca;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2020QII;""
22 Huesca;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2020QI;""
22 Huesca;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QIV;1.703
22 Huesca;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
22 Huesca;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QII;""
22 Huesca;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QI;""
22 Huesca;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QIV;1.702
22 Huesca;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
22 Huesca;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QII;""
22 Huesca;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QI;""
22 Huesca;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QIV;1.686
22 Huesca;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
22 Huesca;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QII;""
22 Huesca;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QI;""
22 Huesca;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
22 Huesca;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
22 Huesca;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QII;""
22 Huesca;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QI;1.672
22 Huesca;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
22 Huesca;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
22 Huesca;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QII;""
22 Huesca;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QI;1.662
22 Huesca;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
22 Huesca;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
22 Huesca;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QII;""
22 Huesca;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QI;""
22 Huesca;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
22 Huesca;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
22 Huesca;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
22 Huesca;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
22 Huesca;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
22 Huesca;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
22 Huesca;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
22 Huesca;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
22 Huesca;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
22 Huesca;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
22 Huesca;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
22 Huesca;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
22 Huesca;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
22 Huesca;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
22 Huesca;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;97,3
22 Huesca;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
22 Huesca;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
22 Huesca;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
22 Huesca;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;98,21
22 Huesca;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
22 Huesca;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
22 Huesca;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
22 Huesca;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;98,87
22 Huesca;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
22 Huesca;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
22 Huesca;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;95,86
22 Huesca;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
22 Huesca;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
22 Huesca;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
22 Huesca;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;96,75
22 Huesca;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
22 Huesca;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
22 Huesca;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
22 Huesca;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;97,23
22 Huesca;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
22 Huesca;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
22 Huesca;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;93,98
22 Huesca;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
22 Huesca;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
22 Huesca;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
22 Huesca;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;95,35
22 Huesca;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
22 Huesca;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
22 Huesca;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
22 Huesca;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;95,47
22 Huesca;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
22 Huesca;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
22 Huesca;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
22 Huesca;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
22 Huesca;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
22 Huesca;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
22 Huesca;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;93,67
22 Huesca;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
22 Huesca;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
22 Huesca;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
22 Huesca;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;94,11
22 Huesca;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
22 Huesca;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
22 Huesca;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
22 Huesca;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
22 Huesca;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
22 Huesca;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QIII;4.649
22 Huesca;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
22 Huesca;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
22 Huesca;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
22 Huesca;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QIII;4.616
22 Huesca;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
22 Huesca;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
22 Huesca;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
22 Huesca;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QIII;4.599
22 Huesca;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
22 Huesca;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
22 Huesca;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
22 Huesca;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2022QIII;4.563
22 Huesca;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2022QII;""
22 Huesca;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2022QI;""
22 Huesca;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
22 Huesca;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2021QIII;4.547
22 Huesca;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2021QII;""
22 Huesca;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2021QI;""
22 Huesca;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
22 Huesca;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2020QIII;4.519
22 Huesca;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2020QII;""
22 Huesca;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2020QI;""
22 Huesca;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2022QIV;4.473
22 Huesca;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
22 Huesca;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2022QII;""
22 Huesca;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2022QI;""
22 Huesca;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2021QIV;4.467
22 Huesca;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
22 Huesca;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2021QII;""
22 Huesca;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2021QI;""
22 Huesca;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2020QIV;4.444
22 Huesca;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
22 Huesca;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2020QII;""
22 Huesca;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2020QI;""
22 Huesca;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
22 Huesca;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
22 Huesca;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QII;""
22 Huesca;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QI;4.403
22 Huesca;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
22 Huesca;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
22 Huesca;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QII;""
22 Huesca;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QI;4.392
22 Huesca;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
22 Huesca;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
22 Huesca;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QII;""
22 Huesca;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QI;""
22 Huesca;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
22 Huesca;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
22 Huesca;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QII;4.339
22 Huesca;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QI;""
22 Huesca;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
22 Huesca;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
22 Huesca;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QII;4.354
22 Huesca;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QI;""
22 Huesca;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
22 Huesca;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
22 Huesca;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QII;""
22 Huesca;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QI;""
22 Huesca;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
22 Huesca;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
22 Huesca;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
22 Huesca;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
22 Huesca;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
22 Huesca;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
22 Huesca;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
22 Huesca;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
22 Huesca;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
22 Huesca;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
22 Huesca;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
22 Huesca;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
22 Huesca;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
22 Huesca;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;98,15
22 Huesca;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
22 Huesca;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
22 Huesca;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
22 Huesca;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;98,51
22 Huesca;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
22 Huesca;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
22 Huesca;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
22 Huesca;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;98,26
22 Huesca;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
22 Huesca;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
22 Huesca;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;96,21
22 Huesca;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
22 Huesca;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
22 Huesca;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
22 Huesca;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;96,77
22 Huesca;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
22 Huesca;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
22 Huesca;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
22 Huesca;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;96,63
22 Huesca;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
22 Huesca;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
22 Huesca;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
22 Huesca;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
22 Huesca;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
22 Huesca;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
22 Huesca;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;95,39
22 Huesca;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
22 Huesca;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
22 Huesca;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
22 Huesca;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;95,5
22 Huesca;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
22 Huesca;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
22 Huesca;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
22 Huesca;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
22 Huesca;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
22 Huesca;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
22 Huesca;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;94
22 Huesca;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
22 Huesca;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
22 Huesca;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
22 Huesca;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;94,67
22 Huesca;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
22 Huesca;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
22 Huesca;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
22 Huesca;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
22 Huesca;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
22 Huesca;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
22 Huesca;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QIII;2.839
22 Huesca;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
22 Huesca;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
22 Huesca;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
22 Huesca;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QIII;2.825
22 Huesca;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
22 Huesca;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
22 Huesca;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
22 Huesca;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QIII;2.825
22 Huesca;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
22 Huesca;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
22 Huesca;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
22 Huesca;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2022QIII;2.792
22 Huesca;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2022QII;""
22 Huesca;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2022QI;""
22 Huesca;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
22 Huesca;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2021QIII;2.788
22 Huesca;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2021QII;""
22 Huesca;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2021QI;""
22 Huesca;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
22 Huesca;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2020QIII;2.780
22 Huesca;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2020QII;""
22 Huesca;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2020QI;""
22 Huesca;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2022QIV;2.743
22 Huesca;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
22 Huesca;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2022QII;""
22 Huesca;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2022QI;""
22 Huesca;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2021QIV;2.740
22 Huesca;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
22 Huesca;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2021QII;""
22 Huesca;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2021QI;""
22 Huesca;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2020QIV;2.738
22 Huesca;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
22 Huesca;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2020QII;""
22 Huesca;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2020QI;""
22 Huesca;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
22 Huesca;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
22 Huesca;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QII;""
22 Huesca;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QI;2.707
22 Huesca;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
22 Huesca;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
22 Huesca;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QII;""
22 Huesca;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QI;2.710
22 Huesca;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
22 Huesca;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
22 Huesca;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QII;""
22 Huesca;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QI;""
22 Huesca;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
22 Huesca;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
22 Huesca;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QII;2.674
22 Huesca;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QI;""
22 Huesca;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
22 Huesca;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
22 Huesca;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QII;2.692
22 Huesca;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QI;""
22 Huesca;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
22 Huesca;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
22 Huesca;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QII;""
22 Huesca;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QI;""
22 Huesca;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
22 Huesca;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
22 Huesca;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
22 Huesca;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
22 Huesca;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
22 Huesca;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
22 Huesca;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
22 Huesca;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
22 Huesca;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
22 Huesca;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
22 Huesca;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
22 Huesca;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
22 Huesca;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
22 Huesca;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;98,34
22 Huesca;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
22 Huesca;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
22 Huesca;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
22 Huesca;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;98,69
22 Huesca;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
22 Huesca;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
22 Huesca;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
22 Huesca;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;98,41
22 Huesca;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
22 Huesca;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
22 Huesca;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;96,62
22 Huesca;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
22 Huesca;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
22 Huesca;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
22 Huesca;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;96,99
22 Huesca;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
22 Huesca;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
22 Huesca;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
22 Huesca;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;96,92
22 Huesca;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
22 Huesca;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
22 Huesca;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
22 Huesca;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
22 Huesca;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
22 Huesca;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
22 Huesca;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;95,82
22 Huesca;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
22 Huesca;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
22 Huesca;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
22 Huesca;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;95,93
22 Huesca;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
22 Huesca;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
22 Huesca;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
22 Huesca;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
22 Huesca;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
22 Huesca;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
22 Huesca;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;94,65
22 Huesca;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
22 Huesca;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
22 Huesca;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
22 Huesca;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;95,29
22 Huesca;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
22 Huesca;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
22 Huesca;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
22 Huesca;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
22 Huesca;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
22 Huesca;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
22 Huesca;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QIII;1.810
22 Huesca;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
22 Huesca;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
22 Huesca;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
22 Huesca;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QIII;1.791
22 Huesca;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
22 Huesca;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
22 Huesca;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
22 Huesca;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QIII;1.774
22 Huesca;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
22 Huesca;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
22 Huesca;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
22 Huesca;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2022QIII;1.771
22 Huesca;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2022QII;""
22 Huesca;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2022QI;""
22 Huesca;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
22 Huesca;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2021QIII;1.759
22 Huesca;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2021QII;""
22 Huesca;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2021QI;""
22 Huesca;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
22 Huesca;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2020QIII;1.739
22 Huesca;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2020QII;""
22 Huesca;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2020QI;""
22 Huesca;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2022QIV;1.730
22 Huesca;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
22 Huesca;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2022QII;""
22 Huesca;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2022QI;""
22 Huesca;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2021QIV;1.727
22 Huesca;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
22 Huesca;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2021QII;""
22 Huesca;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2021QI;""
22 Huesca;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2020QIV;1.706
22 Huesca;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
22 Huesca;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2020QII;""
22 Huesca;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2020QI;""
22 Huesca;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
22 Huesca;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
22 Huesca;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QII;""
22 Huesca;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QI;1.696
22 Huesca;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
22 Huesca;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
22 Huesca;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QII;""
22 Huesca;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QI;1.682
22 Huesca;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
22 Huesca;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
22 Huesca;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QII;""
22 Huesca;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QI;""
22 Huesca;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
22 Huesca;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
22 Huesca;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QII;1.665
22 Huesca;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QI;""
22 Huesca;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
22 Huesca;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
22 Huesca;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QII;1.662
22 Huesca;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QI;""
22 Huesca;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
22 Huesca;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
22 Huesca;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QII;""
22 Huesca;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QI;""
22 Huesca;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
22 Huesca;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
22 Huesca;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
22 Huesca;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
22 Huesca;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
22 Huesca;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
22 Huesca;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
22 Huesca;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
22 Huesca;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
22 Huesca;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
22 Huesca;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
22 Huesca;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
22 Huesca;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
22 Huesca;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;97,85
22 Huesca;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
22 Huesca;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
22 Huesca;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
22 Huesca;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;98,21
22 Huesca;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
22 Huesca;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
22 Huesca;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
22 Huesca;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;98,03
22 Huesca;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
22 Huesca;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
22 Huesca;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;95,58
22 Huesca;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
22 Huesca;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
22 Huesca;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
22 Huesca;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;96,43
22 Huesca;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
22 Huesca;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
22 Huesca;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
22 Huesca;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;96,17
22 Huesca;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
22 Huesca;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
22 Huesca;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
22 Huesca;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
22 Huesca;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
22 Huesca;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
22 Huesca;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;94,7
22 Huesca;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
22 Huesca;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
22 Huesca;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
22 Huesca;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;94,81
22 Huesca;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
22 Huesca;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
22 Huesca;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
22 Huesca;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
22 Huesca;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
22 Huesca;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
22 Huesca;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;92,96
22 Huesca;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
22 Huesca;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
22 Huesca;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
22 Huesca;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;93,69
22 Huesca;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
22 Huesca;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
22 Huesca;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
22 Huesca;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
22 Huesca;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
22 Huesca;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QIV;4.620
22 Huesca;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
22 Huesca;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
22 Huesca;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
22 Huesca;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QIV;4.616
22 Huesca;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
22 Huesca;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
22 Huesca;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
22 Huesca;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QIV;4.592
22 Huesca;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
22 Huesca;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
22 Huesca;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
22 Huesca;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2022QIV;4.520
22 Huesca;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
22 Huesca;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2022QII;""
22 Huesca;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2022QI;""
22 Huesca;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2021QIV;4.521
22 Huesca;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
22 Huesca;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2021QII;""
22 Huesca;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2021QI;""
22 Huesca;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2020QIV;4.499
22 Huesca;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
22 Huesca;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2020QII;""
22 Huesca;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2020QI;""
22 Huesca;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
22 Huesca;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
22 Huesca;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2022QII;""
22 Huesca;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2022QI;4.455
22 Huesca;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
22 Huesca;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
22 Huesca;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2021QII;""
22 Huesca;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2021QI;4.440
22 Huesca;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
22 Huesca;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
22 Huesca;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2020QII;""
22 Huesca;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2020QI;""
22 Huesca;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
22 Huesca;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
22 Huesca;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QII;4.388
22 Huesca;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QI;""
22 Huesca;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
22 Huesca;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
22 Huesca;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QII;4.397
22 Huesca;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QI;""
22 Huesca;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
22 Huesca;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
22 Huesca;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QII;""
22 Huesca;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QI;""
22 Huesca;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
22 Huesca;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QIII;4.329
22 Huesca;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QII;""
22 Huesca;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QI;""
22 Huesca;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
22 Huesca;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QIII;4.357
22 Huesca;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QII;""
22 Huesca;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QI;""
22 Huesca;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
22 Huesca;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
22 Huesca;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QII;""
22 Huesca;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QI;""
22 Huesca;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
22 Huesca;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
22 Huesca;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
22 Huesca;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
22 Huesca;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
22 Huesca;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
22 Huesca;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
22 Huesca;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
22 Huesca;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
22 Huesca;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
22 Huesca;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
22 Huesca;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
22 Huesca;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;97,84
22 Huesca;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
22 Huesca;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
22 Huesca;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
22 Huesca;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;97,94
22 Huesca;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
22 Huesca;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
22 Huesca;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
22 Huesca;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;97,97
22 Huesca;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
22 Huesca;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
22 Huesca;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
22 Huesca;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
22 Huesca;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
22 Huesca;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
22 Huesca;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;96,51
22 Huesca;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
22 Huesca;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
22 Huesca;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
22 Huesca;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;96,69
22 Huesca;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
22 Huesca;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
22 Huesca;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
22 Huesca;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
22 Huesca;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
22 Huesca;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
22 Huesca;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;95,06
22 Huesca;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
22 Huesca;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
22 Huesca;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
22 Huesca;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;95,75
22 Huesca;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
22 Huesca;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
22 Huesca;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
22 Huesca;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
22 Huesca;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
22 Huesca;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
22 Huesca;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;93,78
22 Huesca;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
22 Huesca;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
22 Huesca;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
22 Huesca;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;94,88
22 Huesca;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
22 Huesca;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
22 Huesca;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
22 Huesca;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
22 Huesca;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
22 Huesca;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
22 Huesca;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QIV;2.829
22 Huesca;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
22 Huesca;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
22 Huesca;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
22 Huesca;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QIV;2.826
22 Huesca;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
22 Huesca;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
22 Huesca;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
22 Huesca;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QIV;2.820
22 Huesca;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
22 Huesca;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
22 Huesca;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
22 Huesca;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2022QIV;2.771
22 Huesca;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
22 Huesca;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2022QII;""
22 Huesca;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2022QI;""
22 Huesca;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2021QIV;2.772
22 Huesca;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
22 Huesca;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2021QII;""
22 Huesca;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2021QI;""
22 Huesca;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2020QIV;2.767
22 Huesca;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
22 Huesca;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2020QII;""
22 Huesca;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2020QI;""
22 Huesca;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
22 Huesca;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
22 Huesca;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2022QII;""
22 Huesca;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2022QI;2.738
22 Huesca;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
22 Huesca;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
22 Huesca;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2021QII;""
22 Huesca;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2021QI;2.733
22 Huesca;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
22 Huesca;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
22 Huesca;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2020QII;""
22 Huesca;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2020QI;""
22 Huesca;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
22 Huesca;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
22 Huesca;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QII;2.703
22 Huesca;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QI;""
22 Huesca;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
22 Huesca;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
22 Huesca;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QII;2.713
22 Huesca;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QI;""
22 Huesca;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
22 Huesca;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
22 Huesca;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QII;""
22 Huesca;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QI;""
22 Huesca;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
22 Huesca;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QIII;2.668
22 Huesca;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QII;""
22 Huesca;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QI;""
22 Huesca;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
22 Huesca;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QIII;2.694
22 Huesca;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QII;""
22 Huesca;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QI;""
22 Huesca;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
22 Huesca;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
22 Huesca;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QII;""
22 Huesca;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QI;""
22 Huesca;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
22 Huesca;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
22 Huesca;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
22 Huesca;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
22 Huesca;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
22 Huesca;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
22 Huesca;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
22 Huesca;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
22 Huesca;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
22 Huesca;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
22 Huesca;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
22 Huesca;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
22 Huesca;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;97,95
22 Huesca;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
22 Huesca;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
22 Huesca;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
22 Huesca;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;98,09
22 Huesca;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
22 Huesca;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
22 Huesca;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
22 Huesca;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;98,12
22 Huesca;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
22 Huesca;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
22 Huesca;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
22 Huesca;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
22 Huesca;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
22 Huesca;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
22 Huesca;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;96,89
22 Huesca;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
22 Huesca;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
22 Huesca;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
22 Huesca;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;96,91
22 Huesca;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
22 Huesca;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
22 Huesca;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
22 Huesca;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
22 Huesca;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
22 Huesca;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
22 Huesca;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;95,65
22 Huesca;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
22 Huesca;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
22 Huesca;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
22 Huesca;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;96,21
22 Huesca;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
22 Huesca;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
22 Huesca;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
22 Huesca;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
22 Huesca;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
22 Huesca;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
22 Huesca;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;94,41
22 Huesca;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
22 Huesca;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
22 Huesca;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
22 Huesca;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;95,53
22 Huesca;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
22 Huesca;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
22 Huesca;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
22 Huesca;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
22 Huesca;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
22 Huesca;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
22 Huesca;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QIV;1.791
22 Huesca;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
22 Huesca;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
22 Huesca;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
22 Huesca;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QIV;1.790
22 Huesca;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
22 Huesca;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
22 Huesca;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
22 Huesca;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QIV;1.772
22 Huesca;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
22 Huesca;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
22 Huesca;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
22 Huesca;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2022QIV;1.749
22 Huesca;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
22 Huesca;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2022QII;""
22 Huesca;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2022QI;""
22 Huesca;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2021QIV;1.749
22 Huesca;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
22 Huesca;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2021QII;""
22 Huesca;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2021QI;""
22 Huesca;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2020QIV;1.732
22 Huesca;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
22 Huesca;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2020QII;""
22 Huesca;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2020QI;""
22 Huesca;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
22 Huesca;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
22 Huesca;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2022QII;""
22 Huesca;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2022QI;1.717
22 Huesca;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
22 Huesca;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
22 Huesca;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2021QII;""
22 Huesca;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2021QI;1.707
22 Huesca;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
22 Huesca;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
22 Huesca;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2020QII;""
22 Huesca;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2020QI;""
22 Huesca;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
22 Huesca;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
22 Huesca;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QII;1.685
22 Huesca;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QI;""
22 Huesca;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
22 Huesca;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
22 Huesca;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QII;1.684
22 Huesca;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QI;""
22 Huesca;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
22 Huesca;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
22 Huesca;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QII;""
22 Huesca;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QI;""
22 Huesca;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
22 Huesca;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QIII;1.661
22 Huesca;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QII;""
22 Huesca;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QI;""
22 Huesca;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
22 Huesca;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QIII;1.663
22 Huesca;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QII;""
22 Huesca;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QI;""
22 Huesca;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
22 Huesca;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
22 Huesca;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QII;""
22 Huesca;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QI;""
22 Huesca;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
22 Huesca;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
22 Huesca;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
22 Huesca;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
22 Huesca;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
22 Huesca;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
22 Huesca;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
22 Huesca;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
22 Huesca;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
22 Huesca;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
22 Huesca;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
22 Huesca;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
22 Huesca;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;97,65
22 Huesca;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
22 Huesca;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
22 Huesca;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
22 Huesca;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;97,71
22 Huesca;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
22 Huesca;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
22 Huesca;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
22 Huesca;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;97,74
22 Huesca;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
22 Huesca;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
22 Huesca;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
22 Huesca;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
22 Huesca;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
22 Huesca;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
22 Huesca;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;95,92
22 Huesca;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
22 Huesca;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
22 Huesca;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
22 Huesca;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;96,33
22 Huesca;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
22 Huesca;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
22 Huesca;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
22 Huesca;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
22 Huesca;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
22 Huesca;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
22 Huesca;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;94,13
22 Huesca;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
22 Huesca;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
22 Huesca;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
22 Huesca;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;95,03
22 Huesca;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
22 Huesca;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
22 Huesca;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
22 Huesca;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
22 Huesca;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
22 Huesca;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
22 Huesca;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;92,79
22 Huesca;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
22 Huesca;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
22 Huesca;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
22 Huesca;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;93,85
22 Huesca;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
22 Huesca;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
22 Huesca;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
22 Huesca;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
22 Huesca;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
22 Huesca;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
22 Huesca;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
22 Huesca;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
22 Huesca;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
22 Huesca;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QI;2.615
22 Huesca;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
22 Huesca;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
22 Huesca;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
22 Huesca;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QI;2.467
22 Huesca;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
22 Huesca;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
22 Huesca;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
22 Huesca;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QI;2.914
22 Huesca;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
22 Huesca;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
22 Huesca;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2022QII;""
22 Huesca;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2022QI;2.533
22 Huesca;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
22 Huesca;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
22 Huesca;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2021QII;""
22 Huesca;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2021QI;2.373
22 Huesca;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
22 Huesca;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
22 Huesca;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2020QII;""
22 Huesca;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2020QI;2.686
22 Huesca;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
22 Huesca;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
22 Huesca;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2022QII;2.436
22 Huesca;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2022QI;""
22 Huesca;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
22 Huesca;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
22 Huesca;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2021QII;2.292
22 Huesca;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2021QI;""
22 Huesca;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
22 Huesca;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
22 Huesca;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2020QII;2.598
22 Huesca;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2020QI;""
22 Huesca;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
22 Huesca;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QIII;2.352
22 Huesca;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QII;""
22 Huesca;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QI;""
22 Huesca;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
22 Huesca;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QIII;2.219
22 Huesca;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QII;""
22 Huesca;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QI;""
22 Huesca;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
22 Huesca;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QIII;2.504
22 Huesca;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QII;""
22 Huesca;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QI;""
22 Huesca;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QIV;2.183
22 Huesca;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
22 Huesca;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QII;""
22 Huesca;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QI;""
22 Huesca;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QIV;2.105
22 Huesca;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
22 Huesca;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QII;""
22 Huesca;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QI;""
22 Huesca;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QIV;2.382
22 Huesca;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
22 Huesca;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QII;""
22 Huesca;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QI;""
22 Huesca;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
22 Huesca;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
22 Huesca;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
22 Huesca;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
22 Huesca;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
22 Huesca;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
22 Huesca;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
22 Huesca;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
22 Huesca;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
22 Huesca;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
22 Huesca;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
22 Huesca;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
22 Huesca;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
22 Huesca;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
22 Huesca;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
22 Huesca;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;96,86
22 Huesca;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
22 Huesca;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
22 Huesca;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
22 Huesca;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;96,19
22 Huesca;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
22 Huesca;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
22 Huesca;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
22 Huesca;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;92,18
22 Huesca;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
22 Huesca;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
22 Huesca;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;93,15
22 Huesca;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
22 Huesca;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
22 Huesca;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
22 Huesca;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;92,91
22 Huesca;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
22 Huesca;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
22 Huesca;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
22 Huesca;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;89,16
22 Huesca;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
22 Huesca;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
22 Huesca;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;89,94
22 Huesca;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
22 Huesca;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
22 Huesca;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
22 Huesca;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;89,95
22 Huesca;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
22 Huesca;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
22 Huesca;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
22 Huesca;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;85,93
22 Huesca;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
22 Huesca;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
22 Huesca;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;83,48
22 Huesca;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
22 Huesca;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
22 Huesca;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
22 Huesca;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;85,33
22 Huesca;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
22 Huesca;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
22 Huesca;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
22 Huesca;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;81,74
22 Huesca;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
22 Huesca;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
22 Huesca;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
22 Huesca;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
22 Huesca;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
22 Huesca;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
22 Huesca;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QI;1.694
22 Huesca;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
22 Huesca;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
22 Huesca;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
22 Huesca;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QI;1.578
22 Huesca;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
22 Huesca;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
22 Huesca;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
22 Huesca;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QI;1.871
22 Huesca;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
22 Huesca;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
22 Huesca;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2022QII;""
22 Huesca;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2022QI;1.641
22 Huesca;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
22 Huesca;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
22 Huesca;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2021QII;""
22 Huesca;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2021QI;1.525
22 Huesca;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
22 Huesca;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
22 Huesca;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2020QII;""
22 Huesca;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2020QI;1.729
22 Huesca;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
22 Huesca;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
22 Huesca;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2022QII;1.580
22 Huesca;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2022QI;""
22 Huesca;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
22 Huesca;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
22 Huesca;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2021QII;1.483
22 Huesca;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2021QI;""
22 Huesca;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
22 Huesca;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
22 Huesca;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2020QII;1.676
22 Huesca;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2020QI;""
22 Huesca;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
22 Huesca;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QIII;1.526
22 Huesca;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QII;""
22 Huesca;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QI;""
22 Huesca;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
22 Huesca;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QIII;1.442
22 Huesca;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QII;""
22 Huesca;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QI;""
22 Huesca;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
22 Huesca;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QIII;1.612
22 Huesca;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QII;""
22 Huesca;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QI;""
22 Huesca;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QIV;1.413
22 Huesca;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
22 Huesca;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QII;""
22 Huesca;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QI;""
22 Huesca;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QIV;1.370
22 Huesca;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
22 Huesca;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QII;""
22 Huesca;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QI;""
22 Huesca;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QIV;1.535
22 Huesca;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
22 Huesca;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QII;""
22 Huesca;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QI;""
22 Huesca;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
22 Huesca;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
22 Huesca;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
22 Huesca;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
22 Huesca;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
22 Huesca;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
22 Huesca;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
22 Huesca;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
22 Huesca;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
22 Huesca;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
22 Huesca;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
22 Huesca;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
22 Huesca;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
22 Huesca;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
22 Huesca;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
22 Huesca;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;96,87
22 Huesca;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
22 Huesca;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
22 Huesca;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
22 Huesca;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;96,64
22 Huesca;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
22 Huesca;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
22 Huesca;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
22 Huesca;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;92,41
22 Huesca;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
22 Huesca;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
22 Huesca;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;93,27
22 Huesca;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
22 Huesca;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
22 Huesca;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
22 Huesca;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;93,98
22 Huesca;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
22 Huesca;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
22 Huesca;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
22 Huesca;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;89,58
22 Huesca;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
22 Huesca;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
22 Huesca;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;90,08
22 Huesca;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
22 Huesca;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
22 Huesca;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
22 Huesca;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;91,38
22 Huesca;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
22 Huesca;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
22 Huesca;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
22 Huesca;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;86,16
22 Huesca;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
22 Huesca;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
22 Huesca;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;83,41
22 Huesca;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
22 Huesca;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
22 Huesca;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
22 Huesca;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;86,82
22 Huesca;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
22 Huesca;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
22 Huesca;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
22 Huesca;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;82,04
22 Huesca;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
22 Huesca;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
22 Huesca;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
22 Huesca;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
22 Huesca;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
22 Huesca;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
22 Huesca;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QI;921
22 Huesca;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
22 Huesca;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
22 Huesca;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
22 Huesca;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QI;889
22 Huesca;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
22 Huesca;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
22 Huesca;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
22 Huesca;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QI;1.043
22 Huesca;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
22 Huesca;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
22 Huesca;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2022QII;""
22 Huesca;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2022QI;892
22 Huesca;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
22 Huesca;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
22 Huesca;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2021QII;""
22 Huesca;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2021QI;848
22 Huesca;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
22 Huesca;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
22 Huesca;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2020QII;""
22 Huesca;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2020QI;957
22 Huesca;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
22 Huesca;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
22 Huesca;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2022QII;856
22 Huesca;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2022QI;""
22 Huesca;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
22 Huesca;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
22 Huesca;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2021QII;809
22 Huesca;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2021QI;""
22 Huesca;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
22 Huesca;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
22 Huesca;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2020QII;922
22 Huesca;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2020QI;""
22 Huesca;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
22 Huesca;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QIII;826
22 Huesca;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QII;""
22 Huesca;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QI;""
22 Huesca;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
22 Huesca;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QIII;777
22 Huesca;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QII;""
22 Huesca;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QI;""
22 Huesca;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
22 Huesca;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QIII;892
22 Huesca;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QII;""
22 Huesca;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QI;""
22 Huesca;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QIV;770
22 Huesca;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
22 Huesca;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QII;""
22 Huesca;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QI;""
22 Huesca;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QIV;735
22 Huesca;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
22 Huesca;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QII;""
22 Huesca;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QI;""
22 Huesca;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QIV;847
22 Huesca;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
22 Huesca;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QII;""
22 Huesca;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QI;""
22 Huesca;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
22 Huesca;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
22 Huesca;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
22 Huesca;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
22 Huesca;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
22 Huesca;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
22 Huesca;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
22 Huesca;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
22 Huesca;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
22 Huesca;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
22 Huesca;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
22 Huesca;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
22 Huesca;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
22 Huesca;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
22 Huesca;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
22 Huesca;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;96,85
22 Huesca;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
22 Huesca;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
22 Huesca;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
22 Huesca;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;95,39
22 Huesca;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
22 Huesca;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
22 Huesca;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
22 Huesca;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;91,75
22 Huesca;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
22 Huesca;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
22 Huesca;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;92,94
22 Huesca;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
22 Huesca;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
22 Huesca;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
22 Huesca;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;91
22 Huesca;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
22 Huesca;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
22 Huesca;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
22 Huesca;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;88,4
22 Huesca;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
22 Huesca;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
22 Huesca;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;89,69
22 Huesca;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
22 Huesca;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
22 Huesca;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
22 Huesca;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;87,4
22 Huesca;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
22 Huesca;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
22 Huesca;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
22 Huesca;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;85,52
22 Huesca;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
22 Huesca;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
22 Huesca;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;83,6
22 Huesca;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
22 Huesca;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
22 Huesca;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
22 Huesca;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;82,68
22 Huesca;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
22 Huesca;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
22 Huesca;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
22 Huesca;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;81,21
22 Huesca;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
22 Huesca;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
22 Huesca;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
22 Huesca;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
22 Huesca;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
22 Huesca;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QII;2.975
22 Huesca;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
22 Huesca;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
22 Huesca;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
22 Huesca;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QII;2.812
22 Huesca;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
22 Huesca;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
22 Huesca;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
22 Huesca;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QII;2.727
22 Huesca;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
22 Huesca;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
22 Huesca;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
22 Huesca;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2022QII;2.860
22 Huesca;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2022QI;""
22 Huesca;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
22 Huesca;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
22 Huesca;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2021QII;2.721
22 Huesca;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2021QI;""
22 Huesca;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
22 Huesca;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
22 Huesca;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2020QII;2.639
22 Huesca;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2020QI;""
22 Huesca;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
22 Huesca;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2022QIII;2.768
22 Huesca;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2022QII;""
22 Huesca;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2022QI;""
22 Huesca;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
22 Huesca;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2021QIII;2.644
22 Huesca;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2021QII;""
22 Huesca;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2021QI;""
22 Huesca;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
22 Huesca;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2020QIII;2.538
22 Huesca;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2020QII;""
22 Huesca;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2020QI;""
22 Huesca;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QIV;2.590
22 Huesca;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
22 Huesca;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QII;""
22 Huesca;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QI;""
22 Huesca;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QIV;2.522
22 Huesca;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
22 Huesca;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QII;""
22 Huesca;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QI;""
22 Huesca;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QIV;2.413
22 Huesca;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
22 Huesca;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QII;""
22 Huesca;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QI;""
22 Huesca;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
22 Huesca;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
22 Huesca;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QII;""
22 Huesca;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QI;2.448
22 Huesca;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
22 Huesca;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
22 Huesca;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QII;""
22 Huesca;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QI;2.326
22 Huesca;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
22 Huesca;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
22 Huesca;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QII;""
22 Huesca;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QI;""
22 Huesca;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
22 Huesca;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
22 Huesca;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
22 Huesca;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
22 Huesca;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
22 Huesca;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
22 Huesca;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
22 Huesca;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
22 Huesca;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
22 Huesca;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
22 Huesca;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
22 Huesca;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
22 Huesca;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
22 Huesca;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
22 Huesca;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;96,13
22 Huesca;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
22 Huesca;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
22 Huesca;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
22 Huesca;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;96,76
22 Huesca;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
22 Huesca;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
22 Huesca;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
22 Huesca;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;96,77
22 Huesca;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
22 Huesca;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
22 Huesca;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;93,04
22 Huesca;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
22 Huesca;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
22 Huesca;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
22 Huesca;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;94,03
22 Huesca;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
22 Huesca;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
22 Huesca;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
22 Huesca;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;93,07
22 Huesca;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
22 Huesca;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
22 Huesca;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;87,06
22 Huesca;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
22 Huesca;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
22 Huesca;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
22 Huesca;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;89,69
22 Huesca;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
22 Huesca;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
22 Huesca;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
22 Huesca;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;88,49
22 Huesca;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
22 Huesca;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
22 Huesca;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
22 Huesca;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
22 Huesca;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
22 Huesca;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
22 Huesca;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;87,06
22 Huesca;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
22 Huesca;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
22 Huesca;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
22 Huesca;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;85,3
22 Huesca;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
22 Huesca;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
22 Huesca;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
22 Huesca;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
22 Huesca;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
22 Huesca;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
22 Huesca;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QII;1.913
22 Huesca;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
22 Huesca;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
22 Huesca;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
22 Huesca;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QII;1.808
22 Huesca;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
22 Huesca;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
22 Huesca;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
22 Huesca;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QII;1.751
22 Huesca;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
22 Huesca;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
22 Huesca;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
22 Huesca;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2022QII;1.842
22 Huesca;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2022QI;""
22 Huesca;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
22 Huesca;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
22 Huesca;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2021QII;1.761
22 Huesca;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2021QI;""
22 Huesca;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
22 Huesca;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
22 Huesca;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2020QII;1.698
22 Huesca;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2020QI;""
22 Huesca;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
22 Huesca;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2022QIII;1.784
22 Huesca;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2022QII;""
22 Huesca;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2022QI;""
22 Huesca;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
22 Huesca;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2021QIII;1.719
22 Huesca;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2021QII;""
22 Huesca;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2021QI;""
22 Huesca;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
22 Huesca;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2020QIII;1.629
22 Huesca;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2020QII;""
22 Huesca;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2020QI;""
22 Huesca;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QIV;1.666
22 Huesca;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
22 Huesca;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QII;""
22 Huesca;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QI;""
22 Huesca;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QIV;1.644
22 Huesca;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
22 Huesca;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QII;""
22 Huesca;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QI;""
22 Huesca;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QIV;1.549
22 Huesca;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
22 Huesca;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QII;""
22 Huesca;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QI;""
22 Huesca;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
22 Huesca;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
22 Huesca;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QII;""
22 Huesca;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QI;1.596
22 Huesca;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
22 Huesca;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
22 Huesca;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QII;""
22 Huesca;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QI;1.500
22 Huesca;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
22 Huesca;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
22 Huesca;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QII;""
22 Huesca;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QI;""
22 Huesca;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
22 Huesca;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
22 Huesca;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
22 Huesca;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
22 Huesca;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
22 Huesca;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
22 Huesca;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
22 Huesca;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
22 Huesca;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
22 Huesca;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
22 Huesca;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
22 Huesca;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
22 Huesca;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
22 Huesca;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
22 Huesca;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;96,29
22 Huesca;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
22 Huesca;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
22 Huesca;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
22 Huesca;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;97,4
22 Huesca;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
22 Huesca;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
22 Huesca;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
22 Huesca;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;96,97
22 Huesca;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
22 Huesca;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
22 Huesca;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;93,26
22 Huesca;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
22 Huesca;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
22 Huesca;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
22 Huesca;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;95,08
22 Huesca;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
22 Huesca;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
22 Huesca;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
22 Huesca;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;93,03
22 Huesca;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
22 Huesca;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
22 Huesca;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;87,09
22 Huesca;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
22 Huesca;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
22 Huesca;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
22 Huesca;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;90,93
22 Huesca;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
22 Huesca;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
22 Huesca;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
22 Huesca;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;88,46
22 Huesca;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
22 Huesca;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
22 Huesca;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
22 Huesca;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
22 Huesca;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
22 Huesca;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
22 Huesca;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;88,27
22 Huesca;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
22 Huesca;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
22 Huesca;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
22 Huesca;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;85,67
22 Huesca;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
22 Huesca;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
22 Huesca;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
22 Huesca;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
22 Huesca;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
22 Huesca;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
22 Huesca;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QII;1.062
22 Huesca;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
22 Huesca;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
22 Huesca;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
22 Huesca;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QII;1.004
22 Huesca;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
22 Huesca;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
22 Huesca;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
22 Huesca;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QII;976
22 Huesca;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
22 Huesca;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
22 Huesca;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
22 Huesca;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2022QII;1.018
22 Huesca;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2022QI;""
22 Huesca;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
22 Huesca;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
22 Huesca;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2021QII;960
22 Huesca;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2021QI;""
22 Huesca;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
22 Huesca;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
22 Huesca;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2020QII;941
22 Huesca;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2020QI;""
22 Huesca;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
22 Huesca;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2022QIII;984
22 Huesca;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2022QII;""
22 Huesca;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2022QI;""
22 Huesca;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
22 Huesca;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2021QIII;925
22 Huesca;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2021QII;""
22 Huesca;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2021QI;""
22 Huesca;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
22 Huesca;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2020QIII;909
22 Huesca;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2020QII;""
22 Huesca;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2020QI;""
22 Huesca;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QIV;924
22 Huesca;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
22 Huesca;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QII;""
22 Huesca;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QI;""
22 Huesca;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QIV;878
22 Huesca;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
22 Huesca;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QII;""
22 Huesca;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QI;""
22 Huesca;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QIV;864
22 Huesca;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
22 Huesca;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QII;""
22 Huesca;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QI;""
22 Huesca;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
22 Huesca;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
22 Huesca;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QII;""
22 Huesca;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QI;852
22 Huesca;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
22 Huesca;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
22 Huesca;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QII;""
22 Huesca;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QI;826
22 Huesca;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
22 Huesca;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
22 Huesca;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QII;""
22 Huesca;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QI;""
22 Huesca;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
22 Huesca;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
22 Huesca;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
22 Huesca;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
22 Huesca;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
22 Huesca;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
22 Huesca;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
22 Huesca;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
22 Huesca;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
22 Huesca;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
22 Huesca;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
22 Huesca;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
22 Huesca;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
22 Huesca;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
22 Huesca;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;95,86
22 Huesca;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
22 Huesca;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
22 Huesca;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
22 Huesca;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;95,62
22 Huesca;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
22 Huesca;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
22 Huesca;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
22 Huesca;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;96,41
22 Huesca;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
22 Huesca;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
22 Huesca;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;92,66
22 Huesca;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
22 Huesca;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
22 Huesca;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
22 Huesca;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;92,13
22 Huesca;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
22 Huesca;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
22 Huesca;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
22 Huesca;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;93,14
22 Huesca;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
22 Huesca;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
22 Huesca;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;87,01
22 Huesca;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
22 Huesca;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
22 Huesca;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
22 Huesca;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;87,45
22 Huesca;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
22 Huesca;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
22 Huesca;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
22 Huesca;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;88,52
22 Huesca;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
22 Huesca;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
22 Huesca;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
22 Huesca;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
22 Huesca;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
22 Huesca;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
22 Huesca;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;84,86
22 Huesca;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
22 Huesca;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
22 Huesca;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
22 Huesca;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;84,63
22 Huesca;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
22 Huesca;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
22 Huesca;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
22 Huesca;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
22 Huesca;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
22 Huesca;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QIII;2.907
22 Huesca;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
22 Huesca;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
22 Huesca;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
22 Huesca;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QIII;2.766
22 Huesca;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
22 Huesca;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
22 Huesca;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
22 Huesca;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QIII;2.679
22 Huesca;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
22 Huesca;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
22 Huesca;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
22 Huesca;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2022QIII;2.801
22 Huesca;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2022QII;""
22 Huesca;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2022QI;""
22 Huesca;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
22 Huesca;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2021QIII;2.680
22 Huesca;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2021QII;""
22 Huesca;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2021QI;""
22 Huesca;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
22 Huesca;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2020QIII;2.566
22 Huesca;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2020QII;""
22 Huesca;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2020QI;""
22 Huesca;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2022QIV;2.613
22 Huesca;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
22 Huesca;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2022QII;""
22 Huesca;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2022QI;""
22 Huesca;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2021QIV;2.545
22 Huesca;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
22 Huesca;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2021QII;""
22 Huesca;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2021QI;""
22 Huesca;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2020QIV;2.430
22 Huesca;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
22 Huesca;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2020QII;""
22 Huesca;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2020QI;""
22 Huesca;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
22 Huesca;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
22 Huesca;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QII;""
22 Huesca;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QI;2.471
22 Huesca;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
22 Huesca;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
22 Huesca;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QII;""
22 Huesca;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QI;2.343
22 Huesca;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
22 Huesca;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
22 Huesca;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QII;""
22 Huesca;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QI;""
22 Huesca;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
22 Huesca;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
22 Huesca;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QII;2.395
22 Huesca;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QI;""
22 Huesca;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
22 Huesca;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
22 Huesca;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QII;2.266
22 Huesca;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QI;""
22 Huesca;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
22 Huesca;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
22 Huesca;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QII;""
22 Huesca;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QI;""
22 Huesca;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
22 Huesca;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
22 Huesca;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
22 Huesca;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
22 Huesca;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
22 Huesca;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
22 Huesca;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
22 Huesca;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
22 Huesca;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
22 Huesca;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
22 Huesca;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
22 Huesca;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
22 Huesca;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
22 Huesca;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;96,35
22 Huesca;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
22 Huesca;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
22 Huesca;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
22 Huesca;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;96,89
22 Huesca;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
22 Huesca;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
22 Huesca;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
22 Huesca;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;95,78
22 Huesca;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
22 Huesca;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
22 Huesca;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;89,89
22 Huesca;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
22 Huesca;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
22 Huesca;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
22 Huesca;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;92,01
22 Huesca;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
22 Huesca;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
22 Huesca;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
22 Huesca;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;90,71
22 Huesca;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
22 Huesca;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
22 Huesca;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
22 Huesca;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
22 Huesca;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
22 Huesca;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
22 Huesca;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;89,33
22 Huesca;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
22 Huesca;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
22 Huesca;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
22 Huesca;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;87,46
22 Huesca;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
22 Huesca;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
22 Huesca;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
22 Huesca;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
22 Huesca;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
22 Huesca;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
22 Huesca;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;86,59
22 Huesca;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
22 Huesca;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
22 Huesca;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
22 Huesca;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;84,58
22 Huesca;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
22 Huesca;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
22 Huesca;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
22 Huesca;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
22 Huesca;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
22 Huesca;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
22 Huesca;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QIII;1.868
22 Huesca;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
22 Huesca;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
22 Huesca;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
22 Huesca;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QIII;1.785
22 Huesca;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
22 Huesca;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
22 Huesca;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
22 Huesca;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QIII;1.721
22 Huesca;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
22 Huesca;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
22 Huesca;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
22 Huesca;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2022QIII;1.804
22 Huesca;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2022QII;""
22 Huesca;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2022QI;""
22 Huesca;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
22 Huesca;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2021QIII;1.738
22 Huesca;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2021QII;""
22 Huesca;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2021QI;""
22 Huesca;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
22 Huesca;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2020QIII;1.643
22 Huesca;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2020QII;""
22 Huesca;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2020QI;""
22 Huesca;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2022QIV;1.679
22 Huesca;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
22 Huesca;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2022QII;""
22 Huesca;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2022QI;""
22 Huesca;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2021QIV;1.656
22 Huesca;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
22 Huesca;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2021QII;""
22 Huesca;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2021QI;""
22 Huesca;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2020QIV;1.557
22 Huesca;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
22 Huesca;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2020QII;""
22 Huesca;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2020QI;""
22 Huesca;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
22 Huesca;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
22 Huesca;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QII;""
22 Huesca;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QI;1.608
22 Huesca;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
22 Huesca;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
22 Huesca;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QII;""
22 Huesca;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QI;1.508
22 Huesca;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
22 Huesca;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
22 Huesca;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QII;""
22 Huesca;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QI;""
22 Huesca;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
22 Huesca;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
22 Huesca;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QII;1.560
22 Huesca;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QI;""
22 Huesca;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
22 Huesca;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
22 Huesca;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QII;1.468
22 Huesca;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QI;""
22 Huesca;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
22 Huesca;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
22 Huesca;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QII;""
22 Huesca;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QI;""
22 Huesca;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
22 Huesca;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
22 Huesca;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
22 Huesca;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
22 Huesca;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
22 Huesca;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
22 Huesca;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
22 Huesca;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
22 Huesca;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
22 Huesca;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
22 Huesca;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
22 Huesca;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
22 Huesca;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
22 Huesca;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;96,57
22 Huesca;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
22 Huesca;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
22 Huesca;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
22 Huesca;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;97,37
22 Huesca;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
22 Huesca;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
22 Huesca;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
22 Huesca;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;95,47
22 Huesca;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
22 Huesca;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
22 Huesca;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;89,88
22 Huesca;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
22 Huesca;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
22 Huesca;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
22 Huesca;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;92,77
22 Huesca;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
22 Huesca;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
22 Huesca;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
22 Huesca;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;90,47
22 Huesca;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
22 Huesca;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
22 Huesca;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
22 Huesca;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
22 Huesca;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
22 Huesca;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
22 Huesca;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;90,08
22 Huesca;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
22 Huesca;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
22 Huesca;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
22 Huesca;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;87,62
22 Huesca;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
22 Huesca;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
22 Huesca;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
22 Huesca;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
22 Huesca;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
22 Huesca;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
22 Huesca;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;87,39
22 Huesca;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
22 Huesca;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
22 Huesca;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
22 Huesca;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;85,3
22 Huesca;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
22 Huesca;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
22 Huesca;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
22 Huesca;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
22 Huesca;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
22 Huesca;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
22 Huesca;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QIII;1.039
22 Huesca;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
22 Huesca;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
22 Huesca;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
22 Huesca;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QIII;981
22 Huesca;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
22 Huesca;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
22 Huesca;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
22 Huesca;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QIII;958
22 Huesca;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
22 Huesca;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
22 Huesca;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
22 Huesca;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2022QIII;997
22 Huesca;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2022QII;""
22 Huesca;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2022QI;""
22 Huesca;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
22 Huesca;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2021QIII;942
22 Huesca;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2021QII;""
22 Huesca;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2021QI;""
22 Huesca;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
22 Huesca;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2020QIII;923
22 Huesca;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2020QII;""
22 Huesca;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2020QI;""
22 Huesca;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2022QIV;934
22 Huesca;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
22 Huesca;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2022QII;""
22 Huesca;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2022QI;""
22 Huesca;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2021QIV;889
22 Huesca;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
22 Huesca;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2021QII;""
22 Huesca;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2021QI;""
22 Huesca;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2020QIV;873
22 Huesca;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
22 Huesca;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2020QII;""
22 Huesca;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2020QI;""
22 Huesca;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
22 Huesca;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
22 Huesca;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QII;""
22 Huesca;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QI;863
22 Huesca;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
22 Huesca;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
22 Huesca;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QII;""
22 Huesca;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QI;835
22 Huesca;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
22 Huesca;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
22 Huesca;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QII;""
22 Huesca;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QI;""
22 Huesca;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
22 Huesca;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
22 Huesca;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QII;835
22 Huesca;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QI;""
22 Huesca;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
22 Huesca;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
22 Huesca;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QII;798
22 Huesca;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QI;""
22 Huesca;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
22 Huesca;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
22 Huesca;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QII;""
22 Huesca;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QI;""
22 Huesca;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
22 Huesca;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
22 Huesca;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
22 Huesca;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
22 Huesca;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
22 Huesca;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
22 Huesca;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
22 Huesca;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
22 Huesca;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
22 Huesca;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
22 Huesca;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
22 Huesca;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
22 Huesca;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
22 Huesca;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;95,96
22 Huesca;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
22 Huesca;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
22 Huesca;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
22 Huesca;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;96,02
22 Huesca;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
22 Huesca;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
22 Huesca;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
22 Huesca;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;96,35
22 Huesca;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
22 Huesca;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
22 Huesca;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;89,89
22 Huesca;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
22 Huesca;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
22 Huesca;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
22 Huesca;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;90,62
22 Huesca;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
22 Huesca;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
22 Huesca;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
22 Huesca;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;91,13
22 Huesca;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
22 Huesca;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
22 Huesca;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
22 Huesca;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
22 Huesca;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
22 Huesca;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
22 Huesca;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;87,97
22 Huesca;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
22 Huesca;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
22 Huesca;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
22 Huesca;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;87,16
22 Huesca;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
22 Huesca;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
22 Huesca;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
22 Huesca;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
22 Huesca;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
22 Huesca;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
22 Huesca;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;85,12
22 Huesca;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
22 Huesca;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
22 Huesca;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
22 Huesca;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;83,3
22 Huesca;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
22 Huesca;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
22 Huesca;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
22 Huesca;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
22 Huesca;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
22 Huesca;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QIV;2.825
22 Huesca;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
22 Huesca;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
22 Huesca;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
22 Huesca;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QIV;2.708
22 Huesca;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
22 Huesca;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
22 Huesca;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
22 Huesca;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QIV;2.595
22 Huesca;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
22 Huesca;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
22 Huesca;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
22 Huesca;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2022QIV;2.632
22 Huesca;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
22 Huesca;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2022QII;""
22 Huesca;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2022QI;""
22 Huesca;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2021QIV;2.565
22 Huesca;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
22 Huesca;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2021QII;""
22 Huesca;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2021QI;""
22 Huesca;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2020QIV;2.448
22 Huesca;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
22 Huesca;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2020QII;""
22 Huesca;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2020QI;""
22 Huesca;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
22 Huesca;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
22 Huesca;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2022QII;""
22 Huesca;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2022QI;2.490
22 Huesca;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
22 Huesca;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
22 Huesca;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2021QII;""
22 Huesca;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2021QI;2.359
22 Huesca;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
22 Huesca;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
22 Huesca;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2020QII;""
22 Huesca;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2020QI;""
22 Huesca;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
22 Huesca;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
22 Huesca;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QII;2.413
22 Huesca;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QI;""
22 Huesca;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
22 Huesca;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
22 Huesca;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QII;2.281
22 Huesca;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QI;""
22 Huesca;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
22 Huesca;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
22 Huesca;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QII;""
22 Huesca;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QI;""
22 Huesca;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
22 Huesca;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QIII;2.335
22 Huesca;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QII;""
22 Huesca;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QI;""
22 Huesca;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
22 Huesca;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QIII;2.209
22 Huesca;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QII;""
22 Huesca;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QI;""
22 Huesca;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
22 Huesca;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
22 Huesca;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QII;""
22 Huesca;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QI;""
22 Huesca;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
22 Huesca;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
22 Huesca;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
22 Huesca;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
22 Huesca;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
22 Huesca;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
22 Huesca;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
22 Huesca;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
22 Huesca;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
22 Huesca;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
22 Huesca;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
22 Huesca;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
22 Huesca;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;93,17
22 Huesca;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
22 Huesca;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
22 Huesca;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
22 Huesca;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;94,72
22 Huesca;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
22 Huesca;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
22 Huesca;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
22 Huesca;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;94,34
22 Huesca;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
22 Huesca;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
22 Huesca;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
22 Huesca;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
22 Huesca;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
22 Huesca;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
22 Huesca;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;91,95
22 Huesca;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
22 Huesca;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
22 Huesca;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
22 Huesca;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;90,91
22 Huesca;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
22 Huesca;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
22 Huesca;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
22 Huesca;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
22 Huesca;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
22 Huesca;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
22 Huesca;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;89,11
22 Huesca;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
22 Huesca;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
22 Huesca;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
22 Huesca;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;87,9
22 Huesca;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
22 Huesca;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
22 Huesca;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
22 Huesca;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
22 Huesca;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
22 Huesca;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
22 Huesca;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;86,23
22 Huesca;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
22 Huesca;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
22 Huesca;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
22 Huesca;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;85,13
22 Huesca;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
22 Huesca;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
22 Huesca;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
22 Huesca;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
22 Huesca;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
22 Huesca;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
22 Huesca;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QIV;1.816
22 Huesca;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
22 Huesca;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
22 Huesca;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
22 Huesca;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QIV;1.755
22 Huesca;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
22 Huesca;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
22 Huesca;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
22 Huesca;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QIV;1.658
22 Huesca;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
22 Huesca;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
22 Huesca;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
22 Huesca;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2022QIV;1.688
22 Huesca;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
22 Huesca;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2022QII;""
22 Huesca;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2022QI;""
22 Huesca;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2021QIV;1.667
22 Huesca;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
22 Huesca;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2021QII;""
22 Huesca;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2021QI;""
22 Huesca;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2020QIV;1.566
22 Huesca;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
22 Huesca;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2020QII;""
22 Huesca;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2020QI;""
22 Huesca;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
22 Huesca;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
22 Huesca;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2022QII;""
22 Huesca;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2022QI;1.618
22 Huesca;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
22 Huesca;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
22 Huesca;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2021QII;""
22 Huesca;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2021QI;1.515
22 Huesca;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
22 Huesca;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
22 Huesca;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2020QII;""
22 Huesca;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2020QI;""
22 Huesca;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
22 Huesca;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
22 Huesca;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QII;1.570
22 Huesca;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QI;""
22 Huesca;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
22 Huesca;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
22 Huesca;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QII;1.475
22 Huesca;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QI;""
22 Huesca;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
22 Huesca;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
22 Huesca;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QII;""
22 Huesca;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QI;""
22 Huesca;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
22 Huesca;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QIII;1.519
22 Huesca;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QII;""
22 Huesca;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QI;""
22 Huesca;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
22 Huesca;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QIII;1.435
22 Huesca;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QII;""
22 Huesca;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QI;""
22 Huesca;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
22 Huesca;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
22 Huesca;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QII;""
22 Huesca;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QI;""
22 Huesca;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
22 Huesca;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
22 Huesca;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
22 Huesca;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
22 Huesca;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
22 Huesca;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
22 Huesca;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
22 Huesca;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
22 Huesca;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
22 Huesca;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
22 Huesca;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
22 Huesca;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
22 Huesca;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;92,95
22 Huesca;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
22 Huesca;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
22 Huesca;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
22 Huesca;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;94,99
22 Huesca;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
22 Huesca;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
22 Huesca;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
22 Huesca;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;94,45
22 Huesca;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
22 Huesca;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
22 Huesca;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
22 Huesca;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
22 Huesca;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
22 Huesca;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
22 Huesca;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;92,19
22 Huesca;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
22 Huesca;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
22 Huesca;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
22 Huesca;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;91,38
22 Huesca;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
22 Huesca;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
22 Huesca;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
22 Huesca;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
22 Huesca;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
22 Huesca;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
22 Huesca;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;89,46
22 Huesca;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
22 Huesca;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
22 Huesca;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
22 Huesca;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;88,96
22 Huesca;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
22 Huesca;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
22 Huesca;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
22 Huesca;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
22 Huesca;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
22 Huesca;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
22 Huesca;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;86,55
22 Huesca;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
22 Huesca;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
22 Huesca;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
22 Huesca;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;86,55
22 Huesca;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
22 Huesca;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
22 Huesca;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
22 Huesca;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
22 Huesca;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
22 Huesca;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
22 Huesca;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QIV;1.009
22 Huesca;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
22 Huesca;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
22 Huesca;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
22 Huesca;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QIV;953
22 Huesca;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
22 Huesca;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
22 Huesca;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
22 Huesca;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QIV;937
22 Huesca;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
22 Huesca;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
22 Huesca;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
22 Huesca;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2022QIV;944
22 Huesca;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
22 Huesca;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2022QII;""
22 Huesca;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2022QI;""
22 Huesca;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2021QIV;898
22 Huesca;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
22 Huesca;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2021QII;""
22 Huesca;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2021QI;""
22 Huesca;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2020QIV;882
22 Huesca;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
22 Huesca;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2020QII;""
22 Huesca;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2020QI;""
22 Huesca;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
22 Huesca;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
22 Huesca;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2022QII;""
22 Huesca;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2022QI;872
22 Huesca;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
22 Huesca;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
22 Huesca;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2021QII;""
22 Huesca;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2021QI;844
22 Huesca;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
22 Huesca;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
22 Huesca;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2020QII;""
22 Huesca;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2020QI;""
22 Huesca;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
22 Huesca;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
22 Huesca;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QII;843
22 Huesca;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QI;""
22 Huesca;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
22 Huesca;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
22 Huesca;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QII;806
22 Huesca;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QI;""
22 Huesca;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
22 Huesca;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
22 Huesca;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QII;""
22 Huesca;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QI;""
22 Huesca;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
22 Huesca;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QIII;816
22 Huesca;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QII;""
22 Huesca;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QI;""
22 Huesca;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
22 Huesca;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QIII;774
22 Huesca;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QII;""
22 Huesca;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QI;""
22 Huesca;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
22 Huesca;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
22 Huesca;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QII;""
22 Huesca;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QI;""
22 Huesca;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
22 Huesca;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
22 Huesca;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
22 Huesca;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
22 Huesca;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
22 Huesca;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
22 Huesca;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
22 Huesca;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
22 Huesca;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
22 Huesca;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
22 Huesca;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
22 Huesca;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
22 Huesca;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;93,56
22 Huesca;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
22 Huesca;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
22 Huesca;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
22 Huesca;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;94,23
22 Huesca;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
22 Huesca;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
22 Huesca;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
22 Huesca;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;94,13
22 Huesca;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
22 Huesca;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
22 Huesca;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
22 Huesca;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
22 Huesca;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
22 Huesca;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
22 Huesca;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;91,5
22 Huesca;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
22 Huesca;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
22 Huesca;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
22 Huesca;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;90,07
22 Huesca;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
22 Huesca;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
22 Huesca;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
22 Huesca;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
22 Huesca;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
22 Huesca;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
22 Huesca;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;88,46
22 Huesca;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
22 Huesca;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
22 Huesca;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
22 Huesca;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;86,02
22 Huesca;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
22 Huesca;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
22 Huesca;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
22 Huesca;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
22 Huesca;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
22 Huesca;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
22 Huesca;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;85,62
22 Huesca;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
22 Huesca;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
22 Huesca;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
22 Huesca;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;82,6
22 Huesca;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
22 Huesca;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
22 Huesca;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
22 Huesca;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
22 Huesca;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
22 Huesca;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
23 Jaén;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
23 Jaén;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
23 Jaén;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
23 Jaén;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QI;35.767
23 Jaén;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
23 Jaén;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
23 Jaén;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
23 Jaén;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QI;35.254
23 Jaén;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
23 Jaén;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
23 Jaén;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
23 Jaén;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QI;35.596
23 Jaén;All ages;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
23 Jaén;All ages;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
23 Jaén;All ages;Cohort January 1;Total;Survival in the first trimester;2022QII;""
23 Jaén;All ages;Cohort January 1;Total;Survival in the first trimester;2022QI;34.635
23 Jaén;All ages;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
23 Jaén;All ages;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
23 Jaén;All ages;Cohort January 1;Total;Survival in the first trimester;2021QII;""
23 Jaén;All ages;Cohort January 1;Total;Survival in the first trimester;2021QI;34.418
23 Jaén;All ages;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
23 Jaén;All ages;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
23 Jaén;All ages;Cohort January 1;Total;Survival in the first trimester;2020QII;""
23 Jaén;All ages;Cohort January 1;Total;Survival in the first trimester;2020QI;33.325
23 Jaén;All ages;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
23 Jaén;All ages;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
23 Jaén;All ages;Cohort January 1;Total;Survival in the second trimester;2022QII;33.480
23 Jaén;All ages;Cohort January 1;Total;Survival in the second trimester;2022QI;""
23 Jaén;All ages;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
23 Jaén;All ages;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
23 Jaén;All ages;Cohort January 1;Total;Survival in the second trimester;2021QII;33.422
23 Jaén;All ages;Cohort January 1;Total;Survival in the second trimester;2021QI;""
23 Jaén;All ages;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
23 Jaén;All ages;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
23 Jaén;All ages;Cohort January 1;Total;Survival in the second trimester;2020QII;32.729
23 Jaén;All ages;Cohort January 1;Total;Survival in the second trimester;2020QI;""
23 Jaén;All ages;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
23 Jaén;All ages;Cohort January 1;Total;Survival in the third trimester;2022QIII;32.530
23 Jaén;All ages;Cohort January 1;Total;Survival in the third trimester;2022QII;""
23 Jaén;All ages;Cohort January 1;Total;Survival in the third trimester;2022QI;""
23 Jaén;All ages;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
23 Jaén;All ages;Cohort January 1;Total;Survival in the third trimester;2021QIII;32.642
23 Jaén;All ages;Cohort January 1;Total;Survival in the third trimester;2021QII;""
23 Jaén;All ages;Cohort January 1;Total;Survival in the third trimester;2021QI;""
23 Jaén;All ages;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
23 Jaén;All ages;Cohort January 1;Total;Survival in the third trimester;2020QIII;31.922
23 Jaén;All ages;Cohort January 1;Total;Survival in the third trimester;2020QII;""
23 Jaén;All ages;Cohort January 1;Total;Survival in the third trimester;2020QI;""
23 Jaén;All ages;Cohort January 1;Total;Survival in the third trimester;2022QIV;31.450
23 Jaén;All ages;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
23 Jaén;All ages;Cohort January 1;Total;Survival in the third trimester;2022QII;""
23 Jaén;All ages;Cohort January 1;Total;Survival in the third trimester;2022QI;""
23 Jaén;All ages;Cohort January 1;Total;Survival in the third trimester;2021QIV;31.733
23 Jaén;All ages;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
23 Jaén;All ages;Cohort January 1;Total;Survival in the third trimester;2021QII;""
23 Jaén;All ages;Cohort January 1;Total;Survival in the third trimester;2021QI;""
23 Jaén;All ages;Cohort January 1;Total;Survival in the third trimester;2020QIV;30.994
23 Jaén;All ages;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
23 Jaén;All ages;Cohort January 1;Total;Survival in the third trimester;2020QII;""
23 Jaén;All ages;Cohort January 1;Total;Survival in the third trimester;2020QI;""
23 Jaén;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
23 Jaén;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
23 Jaén;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
23 Jaén;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
23 Jaén;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
23 Jaén;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
23 Jaén;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
23 Jaén;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
23 Jaén;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
23 Jaén;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
23 Jaén;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
23 Jaén;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
23 Jaén;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
23 Jaén;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
23 Jaén;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
23 Jaén;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;96,84
23 Jaén;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
23 Jaén;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
23 Jaén;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
23 Jaén;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;97,63
23 Jaén;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
23 Jaén;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
23 Jaén;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
23 Jaén;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;93,62
23 Jaén;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
23 Jaén;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
23 Jaén;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;93,61
23 Jaén;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
23 Jaén;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
23 Jaén;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
23 Jaén;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;94,8
23 Jaén;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
23 Jaén;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
23 Jaén;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
23 Jaén;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;91,95
23 Jaén;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
23 Jaén;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
23 Jaén;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;90,95
23 Jaén;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
23 Jaén;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
23 Jaén;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
23 Jaén;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;92,59
23 Jaén;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
23 Jaén;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
23 Jaén;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
23 Jaén;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;89,68
23 Jaén;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
23 Jaén;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
23 Jaén;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;87,93
23 Jaén;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
23 Jaén;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
23 Jaén;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
23 Jaén;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;90,01
23 Jaén;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
23 Jaén;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
23 Jaén;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
23 Jaén;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;87,07
23 Jaén;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
23 Jaén;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
23 Jaén;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
23 Jaén;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
23 Jaén;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
23 Jaén;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
23 Jaén;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QI;23.048
23 Jaén;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
23 Jaén;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
23 Jaén;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
23 Jaén;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QI;22.863
23 Jaén;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
23 Jaén;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
23 Jaén;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
23 Jaén;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QI;23.194
23 Jaén;All ages;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
23 Jaén;All ages;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
23 Jaén;All ages;Cohort January 1;Males;Survival in the first trimester;2022QII;""
23 Jaén;All ages;Cohort January 1;Males;Survival in the first trimester;2022QI;22.357
23 Jaén;All ages;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
23 Jaén;All ages;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
23 Jaén;All ages;Cohort January 1;Males;Survival in the first trimester;2021QII;""
23 Jaén;All ages;Cohort January 1;Males;Survival in the first trimester;2021QI;22.361
23 Jaén;All ages;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
23 Jaén;All ages;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
23 Jaén;All ages;Cohort January 1;Males;Survival in the first trimester;2020QII;""
23 Jaén;All ages;Cohort January 1;Males;Survival in the first trimester;2020QI;21.789
23 Jaén;All ages;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
23 Jaén;All ages;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
23 Jaén;All ages;Cohort January 1;Males;Survival in the second trimester;2022QII;21.681
23 Jaén;All ages;Cohort January 1;Males;Survival in the second trimester;2022QI;""
23 Jaén;All ages;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
23 Jaén;All ages;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
23 Jaén;All ages;Cohort January 1;Males;Survival in the second trimester;2021QII;21.791
23 Jaén;All ages;Cohort January 1;Males;Survival in the second trimester;2021QI;""
23 Jaén;All ages;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
23 Jaén;All ages;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
23 Jaén;All ages;Cohort January 1;Males;Survival in the second trimester;2020QII;21.447
23 Jaén;All ages;Cohort January 1;Males;Survival in the second trimester;2020QI;""
23 Jaén;All ages;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
23 Jaén;All ages;Cohort January 1;Males;Survival in the third trimester;2022QIII;21.145
23 Jaén;All ages;Cohort January 1;Males;Survival in the third trimester;2022QII;""
23 Jaén;All ages;Cohort January 1;Males;Survival in the third trimester;2022QI;""
23 Jaén;All ages;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
23 Jaén;All ages;Cohort January 1;Males;Survival in the third trimester;2021QIII;21.318
23 Jaén;All ages;Cohort January 1;Males;Survival in the third trimester;2021QII;""
23 Jaén;All ages;Cohort January 1;Males;Survival in the third trimester;2021QI;""
23 Jaén;All ages;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
23 Jaén;All ages;Cohort January 1;Males;Survival in the third trimester;2020QIII;20.992
23 Jaén;All ages;Cohort January 1;Males;Survival in the third trimester;2020QII;""
23 Jaén;All ages;Cohort January 1;Males;Survival in the third trimester;2020QI;""
23 Jaén;All ages;Cohort January 1;Males;Survival in the third trimester;2022QIV;20.494
23 Jaén;All ages;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
23 Jaén;All ages;Cohort January 1;Males;Survival in the third trimester;2022QII;""
23 Jaén;All ages;Cohort January 1;Males;Survival in the third trimester;2022QI;""
23 Jaén;All ages;Cohort January 1;Males;Survival in the third trimester;2021QIV;20.752
23 Jaén;All ages;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
23 Jaén;All ages;Cohort January 1;Males;Survival in the third trimester;2021QII;""
23 Jaén;All ages;Cohort January 1;Males;Survival in the third trimester;2021QI;""
23 Jaén;All ages;Cohort January 1;Males;Survival in the third trimester;2020QIV;20.390
23 Jaén;All ages;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
23 Jaén;All ages;Cohort January 1;Males;Survival in the third trimester;2020QII;""
23 Jaén;All ages;Cohort January 1;Males;Survival in the third trimester;2020QI;""
23 Jaén;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
23 Jaén;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
23 Jaén;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
23 Jaén;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
23 Jaén;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
23 Jaén;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
23 Jaén;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
23 Jaén;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
23 Jaén;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
23 Jaén;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
23 Jaén;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
23 Jaén;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
23 Jaén;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
23 Jaén;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
23 Jaén;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
23 Jaén;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;97
23 Jaén;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
23 Jaén;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
23 Jaén;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
23 Jaén;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;97,8
23 Jaén;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
23 Jaén;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
23 Jaén;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
23 Jaén;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;93,94
23 Jaén;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
23 Jaén;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
23 Jaén;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;94,07
23 Jaén;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
23 Jaén;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
23 Jaén;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
23 Jaén;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;95,31
23 Jaén;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
23 Jaén;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
23 Jaén;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
23 Jaén;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;92,47
23 Jaén;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
23 Jaén;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
23 Jaén;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;91,74
23 Jaén;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
23 Jaén;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
23 Jaén;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
23 Jaén;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;93,24
23 Jaén;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
23 Jaén;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
23 Jaén;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
23 Jaén;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;90,51
23 Jaén;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
23 Jaén;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
23 Jaén;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;88,92
23 Jaén;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
23 Jaén;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
23 Jaén;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
23 Jaén;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;90,77
23 Jaén;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
23 Jaén;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
23 Jaén;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
23 Jaén;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;87,91
23 Jaén;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
23 Jaén;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
23 Jaén;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
23 Jaén;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
23 Jaén;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
23 Jaén;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
23 Jaén;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QI;12.719
23 Jaén;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
23 Jaén;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
23 Jaén;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
23 Jaén;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QI;12.391
23 Jaén;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
23 Jaén;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
23 Jaén;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
23 Jaén;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QI;12.402
23 Jaén;All ages;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
23 Jaén;All ages;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
23 Jaén;All ages;Cohort January 1;Females;Survival in the first trimester;2022QII;""
23 Jaén;All ages;Cohort January 1;Females;Survival in the first trimester;2022QI;12.278
23 Jaén;All ages;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
23 Jaén;All ages;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
23 Jaén;All ages;Cohort January 1;Females;Survival in the first trimester;2021QII;""
23 Jaén;All ages;Cohort January 1;Females;Survival in the first trimester;2021QI;12.057
23 Jaén;All ages;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
23 Jaén;All ages;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
23 Jaén;All ages;Cohort January 1;Females;Survival in the first trimester;2020QII;""
23 Jaén;All ages;Cohort January 1;Females;Survival in the first trimester;2020QI;11.536
23 Jaén;All ages;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
23 Jaén;All ages;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
23 Jaén;All ages;Cohort January 1;Females;Survival in the second trimester;2022QII;11.799
23 Jaén;All ages;Cohort January 1;Females;Survival in the second trimester;2022QI;""
23 Jaén;All ages;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
23 Jaén;All ages;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
23 Jaén;All ages;Cohort January 1;Females;Survival in the second trimester;2021QII;11.631
23 Jaén;All ages;Cohort January 1;Females;Survival in the second trimester;2021QI;""
23 Jaén;All ages;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
23 Jaén;All ages;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
23 Jaén;All ages;Cohort January 1;Females;Survival in the second trimester;2020QII;11.282
23 Jaén;All ages;Cohort January 1;Females;Survival in the second trimester;2020QI;""
23 Jaén;All ages;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
23 Jaén;All ages;Cohort January 1;Females;Survival in the third trimester;2022QIII;11.385
23 Jaén;All ages;Cohort January 1;Females;Survival in the third trimester;2022QII;""
23 Jaén;All ages;Cohort January 1;Females;Survival in the third trimester;2022QI;""
23 Jaén;All ages;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
23 Jaén;All ages;Cohort January 1;Females;Survival in the third trimester;2021QIII;11.324
23 Jaén;All ages;Cohort January 1;Females;Survival in the third trimester;2021QII;""
23 Jaén;All ages;Cohort January 1;Females;Survival in the third trimester;2021QI;""
23 Jaén;All ages;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
23 Jaén;All ages;Cohort January 1;Females;Survival in the third trimester;2020QIII;10.930
23 Jaén;All ages;Cohort January 1;Females;Survival in the third trimester;2020QII;""
23 Jaén;All ages;Cohort January 1;Females;Survival in the third trimester;2020QI;""
23 Jaén;All ages;Cohort January 1;Females;Survival in the third trimester;2022QIV;10.956
23 Jaén;All ages;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
23 Jaén;All ages;Cohort January 1;Females;Survival in the third trimester;2022QII;""
23 Jaén;All ages;Cohort January 1;Females;Survival in the third trimester;2022QI;""
23 Jaén;All ages;Cohort January 1;Females;Survival in the third trimester;2021QIV;10.981
23 Jaén;All ages;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
23 Jaén;All ages;Cohort January 1;Females;Survival in the third trimester;2021QII;""
23 Jaén;All ages;Cohort January 1;Females;Survival in the third trimester;2021QI;""
23 Jaén;All ages;Cohort January 1;Females;Survival in the third trimester;2020QIV;10.604
23 Jaén;All ages;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
23 Jaén;All ages;Cohort January 1;Females;Survival in the third trimester;2020QII;""
23 Jaén;All ages;Cohort January 1;Females;Survival in the third trimester;2020QI;""
23 Jaén;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
23 Jaén;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
23 Jaén;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
23 Jaén;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
23 Jaén;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
23 Jaén;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
23 Jaén;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
23 Jaén;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
23 Jaén;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
23 Jaén;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
23 Jaén;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
23 Jaén;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
23 Jaén;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
23 Jaén;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
23 Jaén;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
23 Jaén;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;96,53
23 Jaén;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
23 Jaén;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
23 Jaén;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
23 Jaén;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;97,3
23 Jaén;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
23 Jaén;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
23 Jaén;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
23 Jaén;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;93,02
23 Jaén;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
23 Jaén;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
23 Jaén;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;92,77
23 Jaén;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
23 Jaén;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
23 Jaén;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
23 Jaén;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;93,87
23 Jaén;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
23 Jaén;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
23 Jaén;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
23 Jaén;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;90,97
23 Jaén;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
23 Jaén;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
23 Jaén;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;89,51
23 Jaén;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
23 Jaén;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
23 Jaén;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
23 Jaén;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;91,39
23 Jaén;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
23 Jaén;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
23 Jaén;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
23 Jaén;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;88,13
23 Jaén;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
23 Jaén;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
23 Jaén;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;86,14
23 Jaén;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
23 Jaén;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
23 Jaén;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
23 Jaén;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;88,62
23 Jaén;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
23 Jaén;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
23 Jaén;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
23 Jaén;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;85,5
23 Jaén;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
23 Jaén;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
23 Jaén;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
23 Jaén;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
23 Jaén;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
23 Jaén;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QII;35.994
23 Jaén;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
23 Jaén;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
23 Jaén;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
23 Jaén;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QII;35.605
23 Jaén;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
23 Jaén;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
23 Jaén;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
23 Jaén;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QII;34.838
23 Jaén;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
23 Jaén;All ages;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
23 Jaén;All ages;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
23 Jaén;All ages;Cohort April 1;Total;Survival in the first trimester;2022QII;34.686
23 Jaén;All ages;Cohort April 1;Total;Survival in the first trimester;2022QI;""
23 Jaén;All ages;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
23 Jaén;All ages;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
23 Jaén;All ages;Cohort April 1;Total;Survival in the first trimester;2021QII;34.496
23 Jaén;All ages;Cohort April 1;Total;Survival in the first trimester;2021QI;""
23 Jaén;All ages;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
23 Jaén;All ages;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
23 Jaén;All ages;Cohort April 1;Total;Survival in the first trimester;2020QII;34.155
23 Jaén;All ages;Cohort April 1;Total;Survival in the first trimester;2020QI;""
23 Jaén;All ages;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
23 Jaén;All ages;Cohort April 1;Total;Survival in the second trimester;2022QIII;33.629
23 Jaén;All ages;Cohort April 1;Total;Survival in the second trimester;2022QII;""
23 Jaén;All ages;Cohort April 1;Total;Survival in the second trimester;2022QI;""
23 Jaén;All ages;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
23 Jaén;All ages;Cohort April 1;Total;Survival in the second trimester;2021QIII;33.639
23 Jaén;All ages;Cohort April 1;Total;Survival in the second trimester;2021QII;""
23 Jaén;All ages;Cohort April 1;Total;Survival in the second trimester;2021QI;""
23 Jaén;All ages;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
23 Jaén;All ages;Cohort April 1;Total;Survival in the second trimester;2020QIII;33.210
23 Jaén;All ages;Cohort April 1;Total;Survival in the second trimester;2020QII;""
23 Jaén;All ages;Cohort April 1;Total;Survival in the second trimester;2020QI;""
23 Jaén;All ages;Cohort April 1;Total;Survival in the third trimester;2022QIV;32.389
23 Jaén;All ages;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
23 Jaén;All ages;Cohort April 1;Total;Survival in the third trimester;2022QII;""
23 Jaén;All ages;Cohort April 1;Total;Survival in the third trimester;2022QI;""
23 Jaén;All ages;Cohort April 1;Total;Survival in the third trimester;2021QIV;32.600
23 Jaén;All ages;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
23 Jaén;All ages;Cohort April 1;Total;Survival in the third trimester;2021QII;""
23 Jaén;All ages;Cohort April 1;Total;Survival in the third trimester;2021QI;""
23 Jaén;All ages;Cohort April 1;Total;Survival in the third trimester;2020QIV;32.169
23 Jaén;All ages;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
23 Jaén;All ages;Cohort April 1;Total;Survival in the third trimester;2020QII;""
23 Jaén;All ages;Cohort April 1;Total;Survival in the third trimester;2020QI;""
23 Jaén;All ages;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
23 Jaén;All ages;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
23 Jaén;All ages;Cohort April 1;Total;Survival in the third trimester;2022QII;""
23 Jaén;All ages;Cohort April 1;Total;Survival in the third trimester;2022QI;31.726
23 Jaén;All ages;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
23 Jaén;All ages;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
23 Jaén;All ages;Cohort April 1;Total;Survival in the third trimester;2021QII;""
23 Jaén;All ages;Cohort April 1;Total;Survival in the third trimester;2021QI;31.560
23 Jaén;All ages;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
23 Jaén;All ages;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
23 Jaén;All ages;Cohort April 1;Total;Survival in the third trimester;2020QII;""
23 Jaén;All ages;Cohort April 1;Total;Survival in the third trimester;2020QI;""
23 Jaén;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
23 Jaén;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
23 Jaén;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
23 Jaén;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
23 Jaén;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
23 Jaén;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
23 Jaén;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
23 Jaén;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
23 Jaén;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
23 Jaén;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
23 Jaén;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
23 Jaén;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
23 Jaén;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
23 Jaén;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
23 Jaén;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;96,37
23 Jaén;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
23 Jaén;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
23 Jaén;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
23 Jaén;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;96,89
23 Jaén;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
23 Jaén;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
23 Jaén;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
23 Jaén;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;98,04
23 Jaén;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
23 Jaén;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
23 Jaén;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;93,43
23 Jaén;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
23 Jaén;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
23 Jaén;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
23 Jaén;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;94,48
23 Jaén;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
23 Jaén;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
23 Jaén;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
23 Jaén;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;95,33
23 Jaén;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
23 Jaén;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
23 Jaén;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;89,98
23 Jaén;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
23 Jaén;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
23 Jaén;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
23 Jaén;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;91,56
23 Jaén;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
23 Jaén;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
23 Jaén;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
23 Jaén;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;92,34
23 Jaén;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
23 Jaén;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
23 Jaén;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
23 Jaén;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
23 Jaén;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
23 Jaén;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
23 Jaén;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;89,11
23 Jaén;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
23 Jaén;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
23 Jaén;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
23 Jaén;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;90,59
23 Jaén;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
23 Jaén;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
23 Jaén;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
23 Jaén;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
23 Jaén;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
23 Jaén;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
23 Jaén;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QII;23.251
23 Jaén;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
23 Jaén;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
23 Jaén;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
23 Jaén;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QII;23.126
23 Jaén;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
23 Jaén;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
23 Jaén;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
23 Jaén;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QII;22.672
23 Jaén;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
23 Jaén;All ages;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
23 Jaén;All ages;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
23 Jaén;All ages;Cohort April 1;Males;Survival in the first trimester;2022QII;22.475
23 Jaén;All ages;Cohort April 1;Males;Survival in the first trimester;2022QI;""
23 Jaén;All ages;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
23 Jaén;All ages;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
23 Jaén;All ages;Cohort April 1;Males;Survival in the first trimester;2021QII;22.484
23 Jaén;All ages;Cohort April 1;Males;Survival in the first trimester;2021QI;""
23 Jaén;All ages;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
23 Jaén;All ages;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
23 Jaén;All ages;Cohort April 1;Males;Survival in the first trimester;2020QII;22.285
23 Jaén;All ages;Cohort April 1;Males;Survival in the first trimester;2020QI;""
23 Jaén;All ages;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
23 Jaén;All ages;Cohort April 1;Males;Survival in the second trimester;2022QIII;21.870
23 Jaén;All ages;Cohort April 1;Males;Survival in the second trimester;2022QII;""
23 Jaén;All ages;Cohort April 1;Males;Survival in the second trimester;2022QI;""
23 Jaén;All ages;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
23 Jaén;All ages;Cohort April 1;Males;Survival in the second trimester;2021QIII;21.963
23 Jaén;All ages;Cohort April 1;Males;Survival in the second trimester;2021QII;""
23 Jaén;All ages;Cohort April 1;Males;Survival in the second trimester;2021QI;""
23 Jaén;All ages;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
23 Jaén;All ages;Cohort April 1;Males;Survival in the second trimester;2020QIII;21.739
23 Jaén;All ages;Cohort April 1;Males;Survival in the second trimester;2020QII;""
23 Jaén;All ages;Cohort April 1;Males;Survival in the second trimester;2020QI;""
23 Jaén;All ages;Cohort April 1;Males;Survival in the third trimester;2022QIV;21.090
23 Jaén;All ages;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
23 Jaén;All ages;Cohort April 1;Males;Survival in the third trimester;2022QII;""
23 Jaén;All ages;Cohort April 1;Males;Survival in the third trimester;2022QI;""
23 Jaén;All ages;Cohort April 1;Males;Survival in the third trimester;2021QIV;21.298
23 Jaén;All ages;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
23 Jaén;All ages;Cohort April 1;Males;Survival in the third trimester;2021QII;""
23 Jaén;All ages;Cohort April 1;Males;Survival in the third trimester;2021QI;""
23 Jaén;All ages;Cohort April 1;Males;Survival in the third trimester;2020QIV;21.063
23 Jaén;All ages;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
23 Jaén;All ages;Cohort April 1;Males;Survival in the third trimester;2020QII;""
23 Jaén;All ages;Cohort April 1;Males;Survival in the third trimester;2020QI;""
23 Jaén;All ages;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
23 Jaén;All ages;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
23 Jaén;All ages;Cohort April 1;Males;Survival in the third trimester;2022QII;""
23 Jaén;All ages;Cohort April 1;Males;Survival in the third trimester;2022QI;20.764
23 Jaén;All ages;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
23 Jaén;All ages;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
23 Jaén;All ages;Cohort April 1;Males;Survival in the third trimester;2021QII;""
23 Jaén;All ages;Cohort April 1;Males;Survival in the third trimester;2021QI;20.704
23 Jaén;All ages;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
23 Jaén;All ages;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
23 Jaén;All ages;Cohort April 1;Males;Survival in the third trimester;2020QII;""
23 Jaén;All ages;Cohort April 1;Males;Survival in the third trimester;2020QI;""
23 Jaén;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
23 Jaén;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
23 Jaén;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
23 Jaén;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
23 Jaén;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
23 Jaén;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
23 Jaén;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
23 Jaén;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
23 Jaén;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
23 Jaén;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
23 Jaén;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
23 Jaén;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
23 Jaén;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
23 Jaén;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
23 Jaén;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;96,66
23 Jaén;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
23 Jaén;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
23 Jaén;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
23 Jaén;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;97,22
23 Jaén;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
23 Jaén;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
23 Jaén;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
23 Jaén;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;98,29
23 Jaén;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
23 Jaén;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
23 Jaén;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;94,06
23 Jaén;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
23 Jaén;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
23 Jaén;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
23 Jaén;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;94,97
23 Jaén;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
23 Jaén;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
23 Jaén;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
23 Jaén;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;95,88
23 Jaén;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
23 Jaén;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
23 Jaén;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;90,71
23 Jaén;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
23 Jaén;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
23 Jaén;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
23 Jaén;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;92,1
23 Jaén;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
23 Jaén;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
23 Jaén;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
23 Jaén;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;92,9
23 Jaén;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
23 Jaén;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
23 Jaén;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
23 Jaén;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
23 Jaén;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
23 Jaén;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
23 Jaén;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;89,79
23 Jaén;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
23 Jaén;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
23 Jaén;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
23 Jaén;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;91,32
23 Jaén;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
23 Jaén;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
23 Jaén;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
23 Jaén;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
23 Jaén;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
23 Jaén;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
23 Jaén;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QII;12.743
23 Jaén;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
23 Jaén;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
23 Jaén;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
23 Jaén;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QII;12.479
23 Jaén;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
23 Jaén;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
23 Jaén;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
23 Jaén;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QII;12.166
23 Jaén;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
23 Jaén;All ages;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
23 Jaén;All ages;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
23 Jaén;All ages;Cohort April 1;Females;Survival in the first trimester;2022QII;12.211
23 Jaén;All ages;Cohort April 1;Females;Survival in the first trimester;2022QI;""
23 Jaén;All ages;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
23 Jaén;All ages;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
23 Jaén;All ages;Cohort April 1;Females;Survival in the first trimester;2021QII;12.012
23 Jaén;All ages;Cohort April 1;Females;Survival in the first trimester;2021QI;""
23 Jaén;All ages;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
23 Jaén;All ages;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
23 Jaén;All ages;Cohort April 1;Females;Survival in the first trimester;2020QII;11.870
23 Jaén;All ages;Cohort April 1;Females;Survival in the first trimester;2020QI;""
23 Jaén;All ages;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
23 Jaén;All ages;Cohort April 1;Females;Survival in the second trimester;2022QIII;11.759
23 Jaén;All ages;Cohort April 1;Females;Survival in the second trimester;2022QII;""
23 Jaén;All ages;Cohort April 1;Females;Survival in the second trimester;2022QI;""
23 Jaén;All ages;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
23 Jaén;All ages;Cohort April 1;Females;Survival in the second trimester;2021QIII;11.676
23 Jaén;All ages;Cohort April 1;Females;Survival in the second trimester;2021QII;""
23 Jaén;All ages;Cohort April 1;Females;Survival in the second trimester;2021QI;""
23 Jaén;All ages;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
23 Jaén;All ages;Cohort April 1;Females;Survival in the second trimester;2020QIII;11.471
23 Jaén;All ages;Cohort April 1;Females;Survival in the second trimester;2020QII;""
23 Jaén;All ages;Cohort April 1;Females;Survival in the second trimester;2020QI;""
23 Jaén;All ages;Cohort April 1;Females;Survival in the third trimester;2022QIV;11.299
23 Jaén;All ages;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
23 Jaén;All ages;Cohort April 1;Females;Survival in the third trimester;2022QII;""
23 Jaén;All ages;Cohort April 1;Females;Survival in the third trimester;2022QI;""
23 Jaén;All ages;Cohort April 1;Females;Survival in the third trimester;2021QIV;11.302
23 Jaén;All ages;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
23 Jaén;All ages;Cohort April 1;Females;Survival in the third trimester;2021QII;""
23 Jaén;All ages;Cohort April 1;Females;Survival in the third trimester;2021QI;""
23 Jaén;All ages;Cohort April 1;Females;Survival in the third trimester;2020QIV;11.106
23 Jaén;All ages;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
23 Jaén;All ages;Cohort April 1;Females;Survival in the third trimester;2020QII;""
23 Jaén;All ages;Cohort April 1;Females;Survival in the third trimester;2020QI;""
23 Jaén;All ages;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
23 Jaén;All ages;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
23 Jaén;All ages;Cohort April 1;Females;Survival in the third trimester;2022QII;""
23 Jaén;All ages;Cohort April 1;Females;Survival in the third trimester;2022QI;10.962
23 Jaén;All ages;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
23 Jaén;All ages;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
23 Jaén;All ages;Cohort April 1;Females;Survival in the third trimester;2021QII;""
23 Jaén;All ages;Cohort April 1;Females;Survival in the third trimester;2021QI;10.856
23 Jaén;All ages;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
23 Jaén;All ages;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
23 Jaén;All ages;Cohort April 1;Females;Survival in the third trimester;2020QII;""
23 Jaén;All ages;Cohort April 1;Females;Survival in the third trimester;2020QI;""
23 Jaén;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
23 Jaén;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
23 Jaén;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
23 Jaén;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
23 Jaén;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
23 Jaén;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
23 Jaén;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
23 Jaén;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
23 Jaén;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
23 Jaén;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
23 Jaén;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
23 Jaén;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
23 Jaén;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
23 Jaén;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
23 Jaén;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;95,83
23 Jaén;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
23 Jaén;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
23 Jaén;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
23 Jaén;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;96,26
23 Jaén;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
23 Jaén;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
23 Jaén;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
23 Jaén;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;97,57
23 Jaén;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
23 Jaén;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
23 Jaén;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;92,28
23 Jaén;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
23 Jaén;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
23 Jaén;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
23 Jaén;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;93,57
23 Jaén;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
23 Jaén;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
23 Jaén;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
23 Jaén;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;94,29
23 Jaén;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
23 Jaén;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
23 Jaén;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;88,67
23 Jaén;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
23 Jaén;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
23 Jaén;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
23 Jaén;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;90,57
23 Jaén;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
23 Jaén;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
23 Jaén;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
23 Jaén;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;91,29
23 Jaén;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
23 Jaén;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
23 Jaén;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
23 Jaén;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
23 Jaén;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
23 Jaén;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
23 Jaén;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;87,84
23 Jaén;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
23 Jaén;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
23 Jaén;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
23 Jaén;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;89,23
23 Jaén;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
23 Jaén;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
23 Jaén;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
23 Jaén;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
23 Jaén;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
23 Jaén;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QIII;36.191
23 Jaén;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
23 Jaén;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
23 Jaén;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
23 Jaén;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QIII;36.121
23 Jaén;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
23 Jaén;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
23 Jaén;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
23 Jaén;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QIII;35.505
23 Jaén;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
23 Jaén;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
23 Jaén;All ages;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
23 Jaén;All ages;Cohort July 1;Total;Survival in the first trimester;2022QIII;34.860
23 Jaén;All ages;Cohort July 1;Total;Survival in the first trimester;2022QII;""
23 Jaén;All ages;Cohort July 1;Total;Survival in the first trimester;2022QI;""
23 Jaén;All ages;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
23 Jaén;All ages;Cohort July 1;Total;Survival in the first trimester;2021QIII;35.009
23 Jaén;All ages;Cohort July 1;Total;Survival in the first trimester;2021QII;""
23 Jaén;All ages;Cohort July 1;Total;Survival in the first trimester;2021QI;""
23 Jaén;All ages;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
23 Jaén;All ages;Cohort July 1;Total;Survival in the first trimester;2020QIII;34.328
23 Jaén;All ages;Cohort July 1;Total;Survival in the first trimester;2020QII;""
23 Jaén;All ages;Cohort July 1;Total;Survival in the first trimester;2020QI;""
23 Jaén;All ages;Cohort July 1;Total;Survival in the second trimester;2022QIV;33.389
23 Jaén;All ages;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
23 Jaén;All ages;Cohort July 1;Total;Survival in the second trimester;2022QII;""
23 Jaén;All ages;Cohort July 1;Total;Survival in the second trimester;2022QI;""
23 Jaén;All ages;Cohort July 1;Total;Survival in the second trimester;2021QIV;33.713
23 Jaén;All ages;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
23 Jaén;All ages;Cohort July 1;Total;Survival in the second trimester;2021QII;""
23 Jaén;All ages;Cohort July 1;Total;Survival in the second trimester;2021QI;""
23 Jaén;All ages;Cohort July 1;Total;Survival in the second trimester;2020QIV;33.071
23 Jaén;All ages;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
23 Jaén;All ages;Cohort July 1;Total;Survival in the second trimester;2020QII;""
23 Jaén;All ages;Cohort July 1;Total;Survival in the second trimester;2020QI;""
23 Jaén;All ages;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
23 Jaén;All ages;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
23 Jaén;All ages;Cohort July 1;Total;Survival in the third trimester;2022QII;""
23 Jaén;All ages;Cohort July 1;Total;Survival in the third trimester;2022QI;32.776
23 Jaén;All ages;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
23 Jaén;All ages;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
23 Jaén;All ages;Cohort July 1;Total;Survival in the third trimester;2021QII;""
23 Jaén;All ages;Cohort July 1;Total;Survival in the third trimester;2021QI;32.418
23 Jaén;All ages;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
23 Jaén;All ages;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
23 Jaén;All ages;Cohort July 1;Total;Survival in the third trimester;2020QII;""
23 Jaén;All ages;Cohort July 1;Total;Survival in the third trimester;2020QI;""
23 Jaén;All ages;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
23 Jaén;All ages;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
23 Jaén;All ages;Cohort July 1;Total;Survival in the third trimester;2022QII;31.810
23 Jaén;All ages;Cohort July 1;Total;Survival in the third trimester;2022QI;""
23 Jaén;All ages;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
23 Jaén;All ages;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
23 Jaén;All ages;Cohort July 1;Total;Survival in the third trimester;2021QII;31.628
23 Jaén;All ages;Cohort July 1;Total;Survival in the third trimester;2021QI;""
23 Jaén;All ages;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
23 Jaén;All ages;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
23 Jaén;All ages;Cohort July 1;Total;Survival in the third trimester;2020QII;""
23 Jaén;All ages;Cohort July 1;Total;Survival in the third trimester;2020QI;""
23 Jaén;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
23 Jaén;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
23 Jaén;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
23 Jaén;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
23 Jaén;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
23 Jaén;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
23 Jaén;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
23 Jaén;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
23 Jaén;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
23 Jaén;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
23 Jaén;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
23 Jaén;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
23 Jaén;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
23 Jaén;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;96,32
23 Jaén;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
23 Jaén;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
23 Jaén;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
23 Jaén;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;96,92
23 Jaén;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
23 Jaén;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
23 Jaén;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
23 Jaén;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;96,68
23 Jaén;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
23 Jaén;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
23 Jaén;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;92,26
23 Jaén;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
23 Jaén;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
23 Jaén;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
23 Jaén;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;93,33
23 Jaén;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
23 Jaén;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
23 Jaén;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
23 Jaén;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;93,14
23 Jaén;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
23 Jaén;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
23 Jaén;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
23 Jaén;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
23 Jaén;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
23 Jaén;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
23 Jaén;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;90,74
23 Jaén;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
23 Jaén;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
23 Jaén;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
23 Jaén;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;91,31
23 Jaén;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
23 Jaén;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
23 Jaén;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
23 Jaén;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
23 Jaén;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
23 Jaén;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
23 Jaén;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;88,07
23 Jaén;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
23 Jaén;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
23 Jaén;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
23 Jaén;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;89,08
23 Jaén;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
23 Jaén;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
23 Jaén;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
23 Jaén;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
23 Jaén;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
23 Jaén;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
23 Jaén;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QIII;23.410
23 Jaén;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
23 Jaén;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
23 Jaén;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
23 Jaén;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QIII;23.510
23 Jaén;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
23 Jaén;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
23 Jaén;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
23 Jaén;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QIII;23.165
23 Jaén;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
23 Jaén;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
23 Jaén;All ages;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
23 Jaén;All ages;Cohort July 1;Males;Survival in the first trimester;2022QIII;22.613
23 Jaén;All ages;Cohort July 1;Males;Survival in the first trimester;2022QII;""
23 Jaén;All ages;Cohort July 1;Males;Survival in the first trimester;2022QI;""
23 Jaén;All ages;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
23 Jaén;All ages;Cohort July 1;Males;Survival in the first trimester;2021QIII;22.822
23 Jaén;All ages;Cohort July 1;Males;Survival in the first trimester;2021QII;""
23 Jaén;All ages;Cohort July 1;Males;Survival in the first trimester;2021QI;""
23 Jaén;All ages;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
23 Jaén;All ages;Cohort July 1;Males;Survival in the first trimester;2020QIII;22.461
23 Jaén;All ages;Cohort July 1;Males;Survival in the first trimester;2020QII;""
23 Jaén;All ages;Cohort July 1;Males;Survival in the first trimester;2020QI;""
23 Jaén;All ages;Cohort July 1;Males;Survival in the second trimester;2022QIV;21.665
23 Jaén;All ages;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
23 Jaén;All ages;Cohort July 1;Males;Survival in the second trimester;2022QII;""
23 Jaén;All ages;Cohort July 1;Males;Survival in the second trimester;2022QI;""
23 Jaén;All ages;Cohort July 1;Males;Survival in the second trimester;2021QIV;21.941
23 Jaén;All ages;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
23 Jaén;All ages;Cohort July 1;Males;Survival in the second trimester;2021QII;""
23 Jaén;All ages;Cohort July 1;Males;Survival in the second trimester;2021QI;""
23 Jaén;All ages;Cohort July 1;Males;Survival in the second trimester;2020QIV;21.603
23 Jaén;All ages;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
23 Jaén;All ages;Cohort July 1;Males;Survival in the second trimester;2020QII;""
23 Jaén;All ages;Cohort July 1;Males;Survival in the second trimester;2020QI;""
23 Jaén;All ages;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
23 Jaén;All ages;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
23 Jaén;All ages;Cohort July 1;Males;Survival in the third trimester;2022QII;""
23 Jaén;All ages;Cohort July 1;Males;Survival in the third trimester;2022QI;21.368
23 Jaén;All ages;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
23 Jaén;All ages;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
23 Jaén;All ages;Cohort July 1;Males;Survival in the third trimester;2021QII;""
23 Jaén;All ages;Cohort July 1;Males;Survival in the third trimester;2021QI;21.216
23 Jaén;All ages;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
23 Jaén;All ages;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
23 Jaén;All ages;Cohort July 1;Males;Survival in the third trimester;2020QII;""
23 Jaén;All ages;Cohort July 1;Males;Survival in the third trimester;2020QI;""
23 Jaén;All ages;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
23 Jaén;All ages;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
23 Jaén;All ages;Cohort July 1;Males;Survival in the third trimester;2022QII;20.788
23 Jaén;All ages;Cohort July 1;Males;Survival in the third trimester;2022QI;""
23 Jaén;All ages;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
23 Jaén;All ages;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
23 Jaén;All ages;Cohort July 1;Males;Survival in the third trimester;2021QII;20.757
23 Jaén;All ages;Cohort July 1;Males;Survival in the third trimester;2021QI;""
23 Jaén;All ages;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
23 Jaén;All ages;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
23 Jaén;All ages;Cohort July 1;Males;Survival in the third trimester;2020QII;""
23 Jaén;All ages;Cohort July 1;Males;Survival in the third trimester;2020QI;""
23 Jaén;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
23 Jaén;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
23 Jaén;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
23 Jaén;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
23 Jaén;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
23 Jaén;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
23 Jaén;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
23 Jaén;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
23 Jaén;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
23 Jaén;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
23 Jaén;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
23 Jaén;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
23 Jaén;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
23 Jaén;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;96,6
23 Jaén;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
23 Jaén;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
23 Jaén;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
23 Jaén;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;97,07
23 Jaén;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
23 Jaén;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
23 Jaén;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
23 Jaén;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;96,96
23 Jaén;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
23 Jaén;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
23 Jaén;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;92,55
23 Jaén;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
23 Jaén;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
23 Jaén;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
23 Jaén;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;93,33
23 Jaén;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
23 Jaén;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
23 Jaén;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
23 Jaén;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;93,26
23 Jaén;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
23 Jaén;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
23 Jaén;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
23 Jaén;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
23 Jaén;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
23 Jaén;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
23 Jaén;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;90,89
23 Jaén;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
23 Jaén;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
23 Jaén;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
23 Jaén;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;91,59
23 Jaén;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
23 Jaén;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
23 Jaén;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
23 Jaén;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
23 Jaén;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
23 Jaén;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
23 Jaén;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;88,42
23 Jaén;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
23 Jaén;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
23 Jaén;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
23 Jaén;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;89,61
23 Jaén;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
23 Jaén;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
23 Jaén;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
23 Jaén;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
23 Jaén;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
23 Jaén;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
23 Jaén;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QIII;12.781
23 Jaén;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
23 Jaén;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
23 Jaén;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
23 Jaén;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QIII;12.611
23 Jaén;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
23 Jaén;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
23 Jaén;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
23 Jaén;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QIII;12.340
23 Jaén;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
23 Jaén;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
23 Jaén;All ages;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
23 Jaén;All ages;Cohort July 1;Females;Survival in the first trimester;2022QIII;12.247
23 Jaén;All ages;Cohort July 1;Females;Survival in the first trimester;2022QII;""
23 Jaén;All ages;Cohort July 1;Females;Survival in the first trimester;2022QI;""
23 Jaén;All ages;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
23 Jaén;All ages;Cohort July 1;Females;Survival in the first trimester;2021QIII;12.187
23 Jaén;All ages;Cohort July 1;Females;Survival in the first trimester;2021QII;""
23 Jaén;All ages;Cohort July 1;Females;Survival in the first trimester;2021QI;""
23 Jaén;All ages;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
23 Jaén;All ages;Cohort July 1;Females;Survival in the first trimester;2020QIII;11.867
23 Jaén;All ages;Cohort July 1;Females;Survival in the first trimester;2020QII;""
23 Jaén;All ages;Cohort July 1;Females;Survival in the first trimester;2020QI;""
23 Jaén;All ages;Cohort July 1;Females;Survival in the second trimester;2022QIV;11.724
23 Jaén;All ages;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
23 Jaén;All ages;Cohort July 1;Females;Survival in the second trimester;2022QII;""
23 Jaén;All ages;Cohort July 1;Females;Survival in the second trimester;2022QI;""
23 Jaén;All ages;Cohort July 1;Females;Survival in the second trimester;2021QIV;11.772
23 Jaén;All ages;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
23 Jaén;All ages;Cohort July 1;Females;Survival in the second trimester;2021QII;""
23 Jaén;All ages;Cohort July 1;Females;Survival in the second trimester;2021QI;""
23 Jaén;All ages;Cohort July 1;Females;Survival in the second trimester;2020QIV;11.468
23 Jaén;All ages;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
23 Jaén;All ages;Cohort July 1;Females;Survival in the second trimester;2020QII;""
23 Jaén;All ages;Cohort July 1;Females;Survival in the second trimester;2020QI;""
23 Jaén;All ages;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
23 Jaén;All ages;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
23 Jaén;All ages;Cohort July 1;Females;Survival in the third trimester;2022QII;""
23 Jaén;All ages;Cohort July 1;Females;Survival in the third trimester;2022QI;11.408
23 Jaén;All ages;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
23 Jaén;All ages;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
23 Jaén;All ages;Cohort July 1;Females;Survival in the third trimester;2021QII;""
23 Jaén;All ages;Cohort July 1;Females;Survival in the third trimester;2021QI;11.202
23 Jaén;All ages;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
23 Jaén;All ages;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
23 Jaén;All ages;Cohort July 1;Females;Survival in the third trimester;2020QII;""
23 Jaén;All ages;Cohort July 1;Females;Survival in the third trimester;2020QI;""
23 Jaén;All ages;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
23 Jaén;All ages;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
23 Jaén;All ages;Cohort July 1;Females;Survival in the third trimester;2022QII;11.022
23 Jaén;All ages;Cohort July 1;Females;Survival in the third trimester;2022QI;""
23 Jaén;All ages;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
23 Jaén;All ages;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
23 Jaén;All ages;Cohort July 1;Females;Survival in the third trimester;2021QII;10.871
23 Jaén;All ages;Cohort July 1;Females;Survival in the third trimester;2021QI;""
23 Jaén;All ages;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
23 Jaén;All ages;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
23 Jaén;All ages;Cohort July 1;Females;Survival in the third trimester;2020QII;""
23 Jaén;All ages;Cohort July 1;Females;Survival in the third trimester;2020QI;""
23 Jaén;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
23 Jaén;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
23 Jaén;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
23 Jaén;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
23 Jaén;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
23 Jaén;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
23 Jaén;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
23 Jaén;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
23 Jaén;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
23 Jaén;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
23 Jaén;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
23 Jaén;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
23 Jaén;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
23 Jaén;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;95,82
23 Jaén;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
23 Jaén;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
23 Jaén;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
23 Jaén;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;96,64
23 Jaén;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
23 Jaén;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
23 Jaén;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
23 Jaén;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;96,17
23 Jaén;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
23 Jaén;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
23 Jaén;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;91,73
23 Jaén;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
23 Jaén;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
23 Jaén;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
23 Jaén;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;93,35
23 Jaén;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
23 Jaén;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
23 Jaén;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
23 Jaén;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;92,93
23 Jaén;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
23 Jaén;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
23 Jaén;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
23 Jaén;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
23 Jaén;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
23 Jaén;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
23 Jaén;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;90,46
23 Jaén;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
23 Jaén;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
23 Jaén;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
23 Jaén;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;90,78
23 Jaén;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
23 Jaén;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
23 Jaén;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
23 Jaén;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
23 Jaén;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
23 Jaén;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
23 Jaén;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;87,4
23 Jaén;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
23 Jaén;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
23 Jaén;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
23 Jaén;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;88,1
23 Jaén;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
23 Jaén;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
23 Jaén;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
23 Jaén;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
23 Jaén;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
23 Jaén;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QIV;35.992
23 Jaén;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
23 Jaén;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
23 Jaén;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
23 Jaén;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QIV;36.097
23 Jaén;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
23 Jaén;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
23 Jaén;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
23 Jaén;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QIV;35.560
23 Jaén;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
23 Jaén;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
23 Jaén;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
23 Jaén;All ages;Cohort October 1;Total;Survival in the first trimester;2022QIV;34.313
23 Jaén;All ages;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
23 Jaén;All ages;Cohort October 1;Total;Survival in the first trimester;2022QII;""
23 Jaén;All ages;Cohort October 1;Total;Survival in the first trimester;2022QI;""
23 Jaén;All ages;Cohort October 1;Total;Survival in the first trimester;2021QIV;34.621
23 Jaén;All ages;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
23 Jaén;All ages;Cohort October 1;Total;Survival in the first trimester;2021QII;""
23 Jaén;All ages;Cohort October 1;Total;Survival in the first trimester;2021QI;""
23 Jaén;All ages;Cohort October 1;Total;Survival in the first trimester;2020QIV;34.087
23 Jaén;All ages;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
23 Jaén;All ages;Cohort October 1;Total;Survival in the first trimester;2020QII;""
23 Jaén;All ages;Cohort October 1;Total;Survival in the first trimester;2020QI;""
23 Jaén;All ages;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
23 Jaén;All ages;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
23 Jaén;All ages;Cohort October 1;Total;Survival in the second trimester;2022QII;""
23 Jaén;All ages;Cohort October 1;Total;Survival in the second trimester;2022QI;33.621
23 Jaén;All ages;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
23 Jaén;All ages;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
23 Jaén;All ages;Cohort October 1;Total;Survival in the second trimester;2021QII;""
23 Jaén;All ages;Cohort October 1;Total;Survival in the second trimester;2021QI;33.359
23 Jaén;All ages;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
23 Jaén;All ages;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
23 Jaén;All ages;Cohort October 1;Total;Survival in the second trimester;2020QII;""
23 Jaén;All ages;Cohort October 1;Total;Survival in the second trimester;2020QI;""
23 Jaén;All ages;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
23 Jaén;All ages;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
23 Jaén;All ages;Cohort October 1;Total;Survival in the third trimester;2022QII;32.584
23 Jaén;All ages;Cohort October 1;Total;Survival in the third trimester;2022QI;""
23 Jaén;All ages;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
23 Jaén;All ages;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
23 Jaén;All ages;Cohort October 1;Total;Survival in the third trimester;2021QII;32.501
23 Jaén;All ages;Cohort October 1;Total;Survival in the third trimester;2021QI;""
23 Jaén;All ages;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
23 Jaén;All ages;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
23 Jaén;All ages;Cohort October 1;Total;Survival in the third trimester;2020QII;""
23 Jaén;All ages;Cohort October 1;Total;Survival in the third trimester;2020QI;""
23 Jaén;All ages;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
23 Jaén;All ages;Cohort October 1;Total;Survival in the third trimester;2022QIII;31.704
23 Jaén;All ages;Cohort October 1;Total;Survival in the third trimester;2022QII;""
23 Jaén;All ages;Cohort October 1;Total;Survival in the third trimester;2022QI;""
23 Jaén;All ages;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
23 Jaén;All ages;Cohort October 1;Total;Survival in the third trimester;2021QIII;31.793
23 Jaén;All ages;Cohort October 1;Total;Survival in the third trimester;2021QII;""
23 Jaén;All ages;Cohort October 1;Total;Survival in the third trimester;2021QI;""
23 Jaén;All ages;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
23 Jaén;All ages;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
23 Jaén;All ages;Cohort October 1;Total;Survival in the third trimester;2020QII;""
23 Jaén;All ages;Cohort October 1;Total;Survival in the third trimester;2020QI;""
23 Jaén;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
23 Jaén;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
23 Jaén;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
23 Jaén;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
23 Jaén;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
23 Jaén;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
23 Jaén;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
23 Jaén;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
23 Jaén;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
23 Jaén;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
23 Jaén;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
23 Jaén;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
23 Jaén;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;95,34
23 Jaén;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
23 Jaén;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
23 Jaén;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
23 Jaén;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;95,91
23 Jaén;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
23 Jaén;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
23 Jaén;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
23 Jaén;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;95,86
23 Jaén;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
23 Jaén;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
23 Jaén;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
23 Jaén;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
23 Jaén;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
23 Jaén;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
23 Jaén;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;93,14
23 Jaén;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
23 Jaén;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
23 Jaén;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
23 Jaén;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;93,81
23 Jaén;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
23 Jaén;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
23 Jaén;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
23 Jaén;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
23 Jaén;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
23 Jaén;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
23 Jaén;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;90,27
23 Jaén;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
23 Jaén;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
23 Jaén;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
23 Jaén;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;91,4
23 Jaén;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
23 Jaén;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
23 Jaén;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
23 Jaén;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
23 Jaén;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
23 Jaén;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
23 Jaén;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;87,83
23 Jaén;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
23 Jaén;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
23 Jaén;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
23 Jaén;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;89,41
23 Jaén;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
23 Jaén;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
23 Jaén;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
23 Jaén;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
23 Jaén;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
23 Jaén;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
23 Jaén;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QIV;23.267
23 Jaén;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
23 Jaén;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
23 Jaén;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
23 Jaén;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QIV;23.429
23 Jaén;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
23 Jaén;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
23 Jaén;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
23 Jaén;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QIV;23.210
23 Jaén;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
23 Jaén;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
23 Jaén;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
23 Jaén;All ages;Cohort October 1;Males;Survival in the first trimester;2022QIV;22.172
23 Jaén;All ages;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
23 Jaén;All ages;Cohort October 1;Males;Survival in the first trimester;2022QII;""
23 Jaén;All ages;Cohort October 1;Males;Survival in the first trimester;2022QI;""
23 Jaén;All ages;Cohort October 1;Males;Survival in the first trimester;2021QIV;22.436
23 Jaén;All ages;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
23 Jaén;All ages;Cohort October 1;Males;Survival in the first trimester;2021QII;""
23 Jaén;All ages;Cohort October 1;Males;Survival in the first trimester;2021QI;""
23 Jaén;All ages;Cohort October 1;Males;Survival in the first trimester;2020QIV;22.196
23 Jaén;All ages;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
23 Jaén;All ages;Cohort October 1;Males;Survival in the first trimester;2020QII;""
23 Jaén;All ages;Cohort October 1;Males;Survival in the first trimester;2020QI;""
23 Jaén;All ages;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
23 Jaén;All ages;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
23 Jaén;All ages;Cohort October 1;Males;Survival in the second trimester;2022QII;""
23 Jaén;All ages;Cohort October 1;Males;Survival in the second trimester;2022QI;21.820
23 Jaén;All ages;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
23 Jaén;All ages;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
23 Jaén;All ages;Cohort October 1;Males;Survival in the second trimester;2021QII;""
23 Jaén;All ages;Cohort October 1;Males;Survival in the second trimester;2021QI;21.760
23 Jaén;All ages;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
23 Jaén;All ages;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
23 Jaén;All ages;Cohort October 1;Males;Survival in the second trimester;2020QII;""
23 Jaén;All ages;Cohort October 1;Males;Survival in the second trimester;2020QI;""
23 Jaén;All ages;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
23 Jaén;All ages;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
23 Jaén;All ages;Cohort October 1;Males;Survival in the third trimester;2022QII;21.202
23 Jaén;All ages;Cohort October 1;Males;Survival in the third trimester;2022QI;""
23 Jaén;All ages;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
23 Jaén;All ages;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
23 Jaén;All ages;Cohort October 1;Males;Survival in the third trimester;2021QII;21.266
23 Jaén;All ages;Cohort October 1;Males;Survival in the third trimester;2021QI;""
23 Jaén;All ages;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
23 Jaén;All ages;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
23 Jaén;All ages;Cohort October 1;Males;Survival in the third trimester;2020QII;""
23 Jaén;All ages;Cohort October 1;Males;Survival in the third trimester;2020QI;""
23 Jaén;All ages;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
23 Jaén;All ages;Cohort October 1;Males;Survival in the third trimester;2022QIII;20.704
23 Jaén;All ages;Cohort October 1;Males;Survival in the third trimester;2022QII;""
23 Jaén;All ages;Cohort October 1;Males;Survival in the third trimester;2022QI;""
23 Jaén;All ages;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
23 Jaén;All ages;Cohort October 1;Males;Survival in the third trimester;2021QIII;20.835
23 Jaén;All ages;Cohort October 1;Males;Survival in the third trimester;2021QII;""
23 Jaén;All ages;Cohort October 1;Males;Survival in the third trimester;2021QI;""
23 Jaén;All ages;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
23 Jaén;All ages;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
23 Jaén;All ages;Cohort October 1;Males;Survival in the third trimester;2020QII;""
23 Jaén;All ages;Cohort October 1;Males;Survival in the third trimester;2020QI;""
23 Jaén;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
23 Jaén;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
23 Jaén;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
23 Jaén;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
23 Jaén;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
23 Jaén;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
23 Jaén;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
23 Jaén;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
23 Jaén;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
23 Jaén;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
23 Jaén;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
23 Jaén;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
23 Jaén;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;95,29
23 Jaén;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
23 Jaén;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
23 Jaén;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
23 Jaén;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;95,76
23 Jaén;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
23 Jaén;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
23 Jaén;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
23 Jaén;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;95,63
23 Jaén;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
23 Jaén;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
23 Jaén;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
23 Jaén;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
23 Jaén;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
23 Jaén;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
23 Jaén;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;93,13
23 Jaén;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
23 Jaén;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
23 Jaén;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
23 Jaén;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;93,75
23 Jaén;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
23 Jaén;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
23 Jaén;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
23 Jaén;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
23 Jaén;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
23 Jaén;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
23 Jaén;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;90,49
23 Jaén;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
23 Jaén;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
23 Jaén;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
23 Jaén;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;91,62
23 Jaén;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
23 Jaén;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
23 Jaén;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
23 Jaén;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
23 Jaén;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
23 Jaén;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
23 Jaén;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;88,37
23 Jaén;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
23 Jaén;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
23 Jaén;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
23 Jaén;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;89,77
23 Jaén;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
23 Jaén;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
23 Jaén;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
23 Jaén;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
23 Jaén;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
23 Jaén;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
23 Jaén;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QIV;12.725
23 Jaén;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
23 Jaén;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
23 Jaén;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
23 Jaén;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QIV;12.668
23 Jaén;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
23 Jaén;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
23 Jaén;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
23 Jaén;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QIV;12.350
23 Jaén;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
23 Jaén;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
23 Jaén;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
23 Jaén;All ages;Cohort October 1;Females;Survival in the first trimester;2022QIV;12.141
23 Jaén;All ages;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
23 Jaén;All ages;Cohort October 1;Females;Survival in the first trimester;2022QII;""
23 Jaén;All ages;Cohort October 1;Females;Survival in the first trimester;2022QI;""
23 Jaén;All ages;Cohort October 1;Females;Survival in the first trimester;2021QIV;12.185
23 Jaén;All ages;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
23 Jaén;All ages;Cohort October 1;Females;Survival in the first trimester;2021QII;""
23 Jaén;All ages;Cohort October 1;Females;Survival in the first trimester;2021QI;""
23 Jaén;All ages;Cohort October 1;Females;Survival in the first trimester;2020QIV;11.891
23 Jaén;All ages;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
23 Jaén;All ages;Cohort October 1;Females;Survival in the first trimester;2020QII;""
23 Jaén;All ages;Cohort October 1;Females;Survival in the first trimester;2020QI;""
23 Jaén;All ages;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
23 Jaén;All ages;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
23 Jaén;All ages;Cohort October 1;Females;Survival in the second trimester;2022QII;""
23 Jaén;All ages;Cohort October 1;Females;Survival in the second trimester;2022QI;11.801
23 Jaén;All ages;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
23 Jaén;All ages;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
23 Jaén;All ages;Cohort October 1;Females;Survival in the second trimester;2021QII;""
23 Jaén;All ages;Cohort October 1;Females;Survival in the second trimester;2021QI;11.599
23 Jaén;All ages;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
23 Jaén;All ages;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
23 Jaén;All ages;Cohort October 1;Females;Survival in the second trimester;2020QII;""
23 Jaén;All ages;Cohort October 1;Females;Survival in the second trimester;2020QI;""
23 Jaén;All ages;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
23 Jaén;All ages;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
23 Jaén;All ages;Cohort October 1;Females;Survival in the third trimester;2022QII;11.382
23 Jaén;All ages;Cohort October 1;Females;Survival in the third trimester;2022QI;""
23 Jaén;All ages;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
23 Jaén;All ages;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
23 Jaén;All ages;Cohort October 1;Females;Survival in the third trimester;2021QII;11.235
23 Jaén;All ages;Cohort October 1;Females;Survival in the third trimester;2021QI;""
23 Jaén;All ages;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
23 Jaén;All ages;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
23 Jaén;All ages;Cohort October 1;Females;Survival in the third trimester;2020QII;""
23 Jaén;All ages;Cohort October 1;Females;Survival in the third trimester;2020QI;""
23 Jaén;All ages;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
23 Jaén;All ages;Cohort October 1;Females;Survival in the third trimester;2022QIII;11.000
23 Jaén;All ages;Cohort October 1;Females;Survival in the third trimester;2022QII;""
23 Jaén;All ages;Cohort October 1;Females;Survival in the third trimester;2022QI;""
23 Jaén;All ages;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
23 Jaén;All ages;Cohort October 1;Females;Survival in the third trimester;2021QIII;10.958
23 Jaén;All ages;Cohort October 1;Females;Survival in the third trimester;2021QII;""
23 Jaén;All ages;Cohort October 1;Females;Survival in the third trimester;2021QI;""
23 Jaén;All ages;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
23 Jaén;All ages;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
23 Jaén;All ages;Cohort October 1;Females;Survival in the third trimester;2020QII;""
23 Jaén;All ages;Cohort October 1;Females;Survival in the third trimester;2020QI;""
23 Jaén;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
23 Jaén;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
23 Jaén;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
23 Jaén;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
23 Jaén;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
23 Jaén;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
23 Jaén;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
23 Jaén;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
23 Jaén;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
23 Jaén;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
23 Jaén;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
23 Jaén;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
23 Jaén;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;95,41
23 Jaén;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
23 Jaén;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
23 Jaén;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
23 Jaén;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;96,19
23 Jaén;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
23 Jaén;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
23 Jaén;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
23 Jaén;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;96,28
23 Jaén;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
23 Jaén;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
23 Jaén;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
23 Jaén;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
23 Jaén;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
23 Jaén;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
23 Jaén;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;93,16
23 Jaén;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
23 Jaén;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
23 Jaén;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
23 Jaén;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;93,92
23 Jaén;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
23 Jaén;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
23 Jaén;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
23 Jaén;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
23 Jaén;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
23 Jaén;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
23 Jaén;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;89,85
23 Jaén;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
23 Jaén;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
23 Jaén;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
23 Jaén;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;90,97
23 Jaén;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
23 Jaén;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
23 Jaén;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
23 Jaén;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
23 Jaén;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
23 Jaén;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
23 Jaén;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;86,83
23 Jaén;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
23 Jaén;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
23 Jaén;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
23 Jaén;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;88,73
23 Jaén;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
23 Jaén;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
23 Jaén;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
23 Jaén;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
23 Jaén;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
23 Jaén;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
23 Jaén;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
23 Jaén;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
23 Jaén;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
23 Jaén;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QI;2.859
23 Jaén;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
23 Jaén;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
23 Jaén;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
23 Jaén;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QI;2.733
23 Jaén;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
23 Jaén;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
23 Jaén;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
23 Jaén;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QI;2.249
23 Jaén;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
23 Jaén;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
23 Jaén;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2022QII;""
23 Jaén;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2022QI;2.683
23 Jaén;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
23 Jaén;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
23 Jaén;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2021QII;""
23 Jaén;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2021QI;2.614
23 Jaén;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
23 Jaén;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
23 Jaén;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2020QII;""
23 Jaén;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2020QI;1.982
23 Jaén;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
23 Jaén;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
23 Jaén;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2022QII;2.502
23 Jaén;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2022QI;""
23 Jaén;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
23 Jaén;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
23 Jaén;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2021QII;2.453
23 Jaén;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2021QI;""
23 Jaén;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
23 Jaén;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
23 Jaén;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2020QII;1.933
23 Jaén;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2020QI;""
23 Jaén;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
23 Jaén;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QIII;2.343
23 Jaén;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QII;""
23 Jaén;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QI;""
23 Jaén;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
23 Jaén;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QIII;2.315
23 Jaén;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QII;""
23 Jaén;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QI;""
23 Jaén;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
23 Jaén;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QIII;1.821
23 Jaén;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QII;""
23 Jaén;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QI;""
23 Jaén;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QIV;2.216
23 Jaén;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
23 Jaén;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QII;""
23 Jaén;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QI;""
23 Jaén;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QIV;2.222
23 Jaén;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
23 Jaén;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QII;""
23 Jaén;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QI;""
23 Jaén;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QIV;1.735
23 Jaén;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
23 Jaén;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QII;""
23 Jaén;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QI;""
23 Jaén;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
23 Jaén;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
23 Jaén;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
23 Jaén;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
23 Jaén;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
23 Jaén;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
23 Jaén;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
23 Jaén;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
23 Jaén;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
23 Jaén;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
23 Jaén;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
23 Jaén;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
23 Jaén;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
23 Jaén;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
23 Jaén;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
23 Jaén;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;93,84
23 Jaén;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
23 Jaén;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
23 Jaén;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
23 Jaén;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;95,65
23 Jaén;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
23 Jaén;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
23 Jaén;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
23 Jaén;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;88,13
23 Jaén;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
23 Jaén;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
23 Jaén;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;87,51
23 Jaén;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
23 Jaén;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
23 Jaén;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
23 Jaén;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;89,75
23 Jaén;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
23 Jaén;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
23 Jaén;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
23 Jaén;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;85,95
23 Jaén;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
23 Jaén;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
23 Jaén;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;81,95
23 Jaén;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
23 Jaén;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
23 Jaén;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
23 Jaén;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;84,71
23 Jaén;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
23 Jaén;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
23 Jaén;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
23 Jaén;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;80,97
23 Jaén;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
23 Jaén;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
23 Jaén;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;77,51
23 Jaén;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
23 Jaén;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
23 Jaén;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
23 Jaén;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;81,3
23 Jaén;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
23 Jaén;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
23 Jaén;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
23 Jaén;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;77,15
23 Jaén;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
23 Jaén;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
23 Jaén;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
23 Jaén;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
23 Jaén;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
23 Jaén;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
23 Jaén;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QI;1.703
23 Jaén;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
23 Jaén;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
23 Jaén;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
23 Jaén;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QI;1.655
23 Jaén;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
23 Jaén;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
23 Jaén;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
23 Jaén;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QI;1.369
23 Jaén;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
23 Jaén;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
23 Jaén;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2022QII;""
23 Jaén;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2022QI;1.610
23 Jaén;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
23 Jaén;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
23 Jaén;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2021QII;""
23 Jaén;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2021QI;1.594
23 Jaén;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
23 Jaén;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
23 Jaén;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2020QII;""
23 Jaén;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2020QI;1.209
23 Jaén;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
23 Jaén;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
23 Jaén;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2022QII;1.500
23 Jaén;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2022QI;""
23 Jaén;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
23 Jaén;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
23 Jaén;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2021QII;1.505
23 Jaén;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2021QI;""
23 Jaén;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
23 Jaén;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
23 Jaén;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2020QII;1.183
23 Jaén;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2020QI;""
23 Jaén;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
23 Jaén;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QIII;1.411
23 Jaén;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QII;""
23 Jaén;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QI;""
23 Jaén;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
23 Jaén;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QIII;1.425
23 Jaén;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QII;""
23 Jaén;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QI;""
23 Jaén;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
23 Jaén;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QIII;1.121
23 Jaén;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QII;""
23 Jaén;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QI;""
23 Jaén;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QIV;1.343
23 Jaén;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
23 Jaén;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QII;""
23 Jaén;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QI;""
23 Jaén;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QIV;1.373
23 Jaén;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
23 Jaén;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QII;""
23 Jaén;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QI;""
23 Jaén;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QIV;1.067
23 Jaén;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
23 Jaén;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QII;""
23 Jaén;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QI;""
23 Jaén;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
23 Jaén;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
23 Jaén;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
23 Jaén;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
23 Jaén;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
23 Jaén;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
23 Jaén;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
23 Jaén;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
23 Jaén;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
23 Jaén;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
23 Jaén;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
23 Jaén;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
23 Jaén;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
23 Jaén;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
23 Jaén;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
23 Jaén;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;94,54
23 Jaén;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
23 Jaén;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
23 Jaén;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
23 Jaén;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;96,31
23 Jaén;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
23 Jaén;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
23 Jaén;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
23 Jaén;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;88,31
23 Jaén;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
23 Jaén;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
23 Jaén;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;88,08
23 Jaén;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
23 Jaén;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
23 Jaén;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
23 Jaén;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;90,94
23 Jaén;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
23 Jaén;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
23 Jaén;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
23 Jaén;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;86,41
23 Jaén;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
23 Jaén;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
23 Jaén;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;82,85
23 Jaén;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
23 Jaén;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
23 Jaén;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
23 Jaén;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;86,1
23 Jaén;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
23 Jaén;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
23 Jaén;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
23 Jaén;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;81,88
23 Jaén;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
23 Jaén;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
23 Jaén;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;78,86
23 Jaén;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
23 Jaén;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
23 Jaén;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
23 Jaén;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;82,96
23 Jaén;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
23 Jaén;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
23 Jaén;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
23 Jaén;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;77,94
23 Jaén;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
23 Jaén;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
23 Jaén;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
23 Jaén;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
23 Jaén;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
23 Jaén;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
23 Jaén;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QI;1.156
23 Jaén;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
23 Jaén;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
23 Jaén;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
23 Jaén;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QI;1.078
23 Jaén;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
23 Jaén;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
23 Jaén;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
23 Jaén;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QI;880
23 Jaén;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
23 Jaén;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
23 Jaén;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2022QII;""
23 Jaén;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2022QI;1.073
23 Jaén;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
23 Jaén;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
23 Jaén;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2021QII;""
23 Jaén;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2021QI;1.020
23 Jaén;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
23 Jaén;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
23 Jaén;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2020QII;""
23 Jaén;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2020QI;773
23 Jaén;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
23 Jaén;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
23 Jaén;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2022QII;1.002
23 Jaén;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2022QI;""
23 Jaén;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
23 Jaén;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
23 Jaén;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2021QII;948
23 Jaén;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2021QI;""
23 Jaén;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
23 Jaén;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
23 Jaén;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2020QII;750
23 Jaén;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2020QI;""
23 Jaén;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
23 Jaén;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QIII;932
23 Jaén;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QII;""
23 Jaén;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QI;""
23 Jaén;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
23 Jaén;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QIII;890
23 Jaén;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QII;""
23 Jaén;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QI;""
23 Jaén;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
23 Jaén;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QIII;700
23 Jaén;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QII;""
23 Jaén;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QI;""
23 Jaén;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QIV;873
23 Jaén;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
23 Jaén;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QII;""
23 Jaén;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QI;""
23 Jaén;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QIV;849
23 Jaén;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
23 Jaén;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QII;""
23 Jaén;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QI;""
23 Jaén;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QIV;668
23 Jaén;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
23 Jaén;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QII;""
23 Jaén;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QI;""
23 Jaén;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
23 Jaén;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
23 Jaén;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
23 Jaén;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
23 Jaén;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
23 Jaén;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
23 Jaén;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
23 Jaén;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
23 Jaén;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
23 Jaén;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
23 Jaén;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
23 Jaén;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
23 Jaén;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
23 Jaén;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
23 Jaén;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
23 Jaén;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;92,82
23 Jaén;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
23 Jaén;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
23 Jaén;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
23 Jaén;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;94,62
23 Jaén;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
23 Jaén;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
23 Jaén;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
23 Jaén;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;87,84
23 Jaén;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
23 Jaén;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
23 Jaén;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;86,68
23 Jaén;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
23 Jaén;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
23 Jaén;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
23 Jaén;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;87,94
23 Jaén;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
23 Jaén;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
23 Jaén;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
23 Jaén;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;85,23
23 Jaén;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
23 Jaén;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
23 Jaén;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;80,62
23 Jaén;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
23 Jaén;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
23 Jaén;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
23 Jaén;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;82,56
23 Jaén;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
23 Jaén;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
23 Jaén;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
23 Jaén;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;79,55
23 Jaén;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
23 Jaén;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
23 Jaén;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;75,52
23 Jaén;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
23 Jaén;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
23 Jaén;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
23 Jaén;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;78,76
23 Jaén;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
23 Jaén;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
23 Jaén;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
23 Jaén;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;75,91
23 Jaén;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
23 Jaén;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
23 Jaén;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
23 Jaén;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
23 Jaén;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
23 Jaén;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QII;2.452
23 Jaén;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
23 Jaén;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
23 Jaén;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
23 Jaén;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QII;2.395
23 Jaén;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
23 Jaén;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
23 Jaén;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
23 Jaén;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QII;2.324
23 Jaén;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
23 Jaén;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
23 Jaén;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
23 Jaén;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2022QII;2.269
23 Jaén;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2022QI;""
23 Jaén;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
23 Jaén;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
23 Jaén;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2021QII;2.229
23 Jaén;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2021QI;""
23 Jaén;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
23 Jaén;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
23 Jaén;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2020QII;2.247
23 Jaén;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2020QI;""
23 Jaén;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
23 Jaén;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2022QIII;2.120
23 Jaén;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2022QII;""
23 Jaén;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2022QI;""
23 Jaén;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
23 Jaén;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2021QIII;2.091
23 Jaén;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2021QII;""
23 Jaén;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2021QI;""
23 Jaén;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
23 Jaén;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2020QIII;2.106
23 Jaén;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2020QII;""
23 Jaén;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2020QI;""
23 Jaén;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QIV;1.989
23 Jaén;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
23 Jaén;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QII;""
23 Jaén;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QI;""
23 Jaén;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QIV;1.984
23 Jaén;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
23 Jaén;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QII;""
23 Jaén;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QI;""
23 Jaén;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QIV;1.998
23 Jaén;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
23 Jaén;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QII;""
23 Jaén;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QI;""
23 Jaén;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
23 Jaén;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
23 Jaén;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QII;""
23 Jaén;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QI;1.882
23 Jaén;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
23 Jaén;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
23 Jaén;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QII;""
23 Jaén;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QI;1.931
23 Jaén;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
23 Jaén;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
23 Jaén;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QII;""
23 Jaén;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QI;""
23 Jaén;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
23 Jaén;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
23 Jaén;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
23 Jaén;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
23 Jaén;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
23 Jaén;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
23 Jaén;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
23 Jaén;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
23 Jaén;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
23 Jaén;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
23 Jaén;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
23 Jaén;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
23 Jaén;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
23 Jaén;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
23 Jaén;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;92,54
23 Jaén;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
23 Jaén;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
23 Jaén;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
23 Jaén;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;93,07
23 Jaén;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
23 Jaén;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
23 Jaén;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
23 Jaén;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;96,69
23 Jaén;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
23 Jaén;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
23 Jaén;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;86,46
23 Jaén;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
23 Jaén;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
23 Jaén;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
23 Jaén;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;87,31
23 Jaén;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
23 Jaén;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
23 Jaén;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
23 Jaén;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;90,62
23 Jaén;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
23 Jaén;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
23 Jaén;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;81,12
23 Jaén;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
23 Jaén;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
23 Jaén;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
23 Jaén;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;82,84
23 Jaén;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
23 Jaén;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
23 Jaén;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
23 Jaén;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;85,97
23 Jaén;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
23 Jaén;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
23 Jaén;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
23 Jaén;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
23 Jaén;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
23 Jaén;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
23 Jaén;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;78,58
23 Jaén;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
23 Jaén;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
23 Jaén;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
23 Jaén;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;83,09
23 Jaén;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
23 Jaén;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
23 Jaén;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
23 Jaén;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
23 Jaén;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
23 Jaén;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
23 Jaén;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QII;1.507
23 Jaén;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
23 Jaén;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
23 Jaén;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
23 Jaén;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QII;1.463
23 Jaén;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
23 Jaén;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
23 Jaén;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
23 Jaén;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QII;1.399
23 Jaén;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
23 Jaén;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
23 Jaén;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
23 Jaén;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2022QII;1.392
23 Jaén;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2022QI;""
23 Jaén;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
23 Jaén;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
23 Jaén;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2021QII;1.372
23 Jaén;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2021QI;""
23 Jaén;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
23 Jaén;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
23 Jaén;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2020QII;1.362
23 Jaén;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2020QI;""
23 Jaén;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
23 Jaén;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2022QIII;1.311
23 Jaén;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2022QII;""
23 Jaén;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2022QI;""
23 Jaén;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
23 Jaén;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2021QIII;1.292
23 Jaén;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2021QII;""
23 Jaén;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2021QI;""
23 Jaén;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
23 Jaén;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2020QIII;1.282
23 Jaén;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2020QII;""
23 Jaén;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2020QI;""
23 Jaén;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QIV;1.240
23 Jaén;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
23 Jaén;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QII;""
23 Jaén;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QI;""
23 Jaén;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QIV;1.233
23 Jaén;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
23 Jaén;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QII;""
23 Jaén;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QI;""
23 Jaén;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QIV;1.216
23 Jaén;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
23 Jaén;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QII;""
23 Jaén;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QI;""
23 Jaén;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
23 Jaén;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
23 Jaén;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QII;""
23 Jaén;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QI;1.184
23 Jaén;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
23 Jaén;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
23 Jaén;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QII;""
23 Jaén;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QI;1.184
23 Jaén;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
23 Jaén;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
23 Jaén;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QII;""
23 Jaén;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QI;""
23 Jaén;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
23 Jaén;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
23 Jaén;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
23 Jaén;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
23 Jaén;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
23 Jaén;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
23 Jaén;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
23 Jaén;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
23 Jaén;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
23 Jaén;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
23 Jaén;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
23 Jaén;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
23 Jaén;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
23 Jaén;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
23 Jaén;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;92,37
23 Jaén;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
23 Jaén;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
23 Jaén;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
23 Jaén;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;93,78
23 Jaén;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
23 Jaén;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
23 Jaén;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
23 Jaén;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;97,36
23 Jaén;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
23 Jaén;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
23 Jaén;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;86,99
23 Jaén;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
23 Jaén;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
23 Jaén;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
23 Jaén;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;88,31
23 Jaén;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
23 Jaén;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
23 Jaén;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
23 Jaén;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;91,64
23 Jaén;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
23 Jaén;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
23 Jaén;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;82,28
23 Jaén;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
23 Jaén;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
23 Jaén;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
23 Jaén;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;84,28
23 Jaén;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
23 Jaén;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
23 Jaén;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
23 Jaén;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;86,92
23 Jaén;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
23 Jaén;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
23 Jaén;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
23 Jaén;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
23 Jaén;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
23 Jaén;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
23 Jaén;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;80,93
23 Jaén;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
23 Jaén;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
23 Jaén;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
23 Jaén;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;84,63
23 Jaén;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
23 Jaén;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
23 Jaén;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
23 Jaén;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
23 Jaén;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
23 Jaén;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
23 Jaén;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QII;945
23 Jaén;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
23 Jaén;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
23 Jaén;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
23 Jaén;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QII;932
23 Jaén;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
23 Jaén;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
23 Jaén;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
23 Jaén;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QII;925
23 Jaén;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
23 Jaén;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
23 Jaén;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
23 Jaén;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2022QII;877
23 Jaén;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2022QI;""
23 Jaén;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
23 Jaén;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
23 Jaén;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2021QII;857
23 Jaén;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2021QI;""
23 Jaén;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
23 Jaén;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
23 Jaén;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2020QII;885
23 Jaén;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2020QI;""
23 Jaén;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
23 Jaén;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2022QIII;809
23 Jaén;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2022QII;""
23 Jaén;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2022QI;""
23 Jaén;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
23 Jaén;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2021QIII;799
23 Jaén;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2021QII;""
23 Jaén;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2021QI;""
23 Jaén;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
23 Jaén;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2020QIII;824
23 Jaén;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2020QII;""
23 Jaén;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2020QI;""
23 Jaén;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QIV;749
23 Jaén;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
23 Jaén;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QII;""
23 Jaén;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QI;""
23 Jaén;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QIV;751
23 Jaén;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
23 Jaén;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QII;""
23 Jaén;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QI;""
23 Jaén;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QIV;782
23 Jaén;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
23 Jaén;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QII;""
23 Jaén;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QI;""
23 Jaén;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
23 Jaén;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
23 Jaén;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QII;""
23 Jaén;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QI;698
23 Jaén;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
23 Jaén;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
23 Jaén;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QII;""
23 Jaén;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QI;747
23 Jaén;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
23 Jaén;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
23 Jaén;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QII;""
23 Jaén;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QI;""
23 Jaén;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
23 Jaén;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
23 Jaén;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
23 Jaén;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
23 Jaén;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
23 Jaén;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
23 Jaén;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
23 Jaén;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
23 Jaén;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
23 Jaén;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
23 Jaén;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
23 Jaén;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
23 Jaén;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
23 Jaén;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
23 Jaén;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;92,8
23 Jaén;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
23 Jaén;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
23 Jaén;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
23 Jaén;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;91,95
23 Jaén;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
23 Jaén;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
23 Jaén;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
23 Jaén;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;95,68
23 Jaén;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
23 Jaén;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
23 Jaén;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;85,61
23 Jaén;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
23 Jaén;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
23 Jaén;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
23 Jaén;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;85,73
23 Jaén;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
23 Jaén;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
23 Jaén;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
23 Jaén;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;89,08
23 Jaén;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
23 Jaén;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
23 Jaén;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;79,26
23 Jaén;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
23 Jaén;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
23 Jaén;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
23 Jaén;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;80,58
23 Jaén;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
23 Jaén;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
23 Jaén;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
23 Jaén;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;84,54
23 Jaén;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
23 Jaén;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
23 Jaén;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
23 Jaén;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
23 Jaén;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
23 Jaén;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
23 Jaén;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;74,89
23 Jaén;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
23 Jaén;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
23 Jaén;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
23 Jaén;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;80,76
23 Jaén;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
23 Jaén;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
23 Jaén;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
23 Jaén;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
23 Jaén;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
23 Jaén;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QIII;2.601
23 Jaén;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
23 Jaén;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
23 Jaén;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
23 Jaén;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QIII;2.598
23 Jaén;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
23 Jaén;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
23 Jaén;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
23 Jaén;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QIII;2.525
23 Jaén;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
23 Jaén;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
23 Jaén;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
23 Jaén;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2022QIII;2.400
23 Jaén;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2022QII;""
23 Jaén;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2022QI;""
23 Jaén;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
23 Jaén;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2021QIII;2.400
23 Jaén;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2021QII;""
23 Jaén;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2021QI;""
23 Jaén;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
23 Jaén;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2020QIII;2.322
23 Jaén;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2020QII;""
23 Jaén;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2020QI;""
23 Jaén;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2022QIV;2.235
23 Jaén;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
23 Jaén;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2022QII;""
23 Jaén;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2022QI;""
23 Jaén;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2021QIV;2.267
23 Jaén;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
23 Jaén;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2021QII;""
23 Jaén;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2021QI;""
23 Jaén;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2020QIV;2.183
23 Jaén;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
23 Jaén;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2020QII;""
23 Jaén;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2020QI;""
23 Jaén;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
23 Jaén;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
23 Jaén;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QII;""
23 Jaén;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QI;2.143
23 Jaén;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
23 Jaén;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
23 Jaén;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QII;""
23 Jaén;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QI;2.105
23 Jaén;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
23 Jaén;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
23 Jaén;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QII;""
23 Jaén;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QI;""
23 Jaén;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
23 Jaén;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
23 Jaén;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QII;2.012
23 Jaén;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QI;""
23 Jaén;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
23 Jaén;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
23 Jaén;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QII;2.004
23 Jaén;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QI;""
23 Jaén;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
23 Jaén;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
23 Jaén;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QII;""
23 Jaén;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QI;""
23 Jaén;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
23 Jaén;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
23 Jaén;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
23 Jaén;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
23 Jaén;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
23 Jaén;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
23 Jaén;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
23 Jaén;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
23 Jaén;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
23 Jaén;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
23 Jaén;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
23 Jaén;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
23 Jaén;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
23 Jaén;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;92,27
23 Jaén;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
23 Jaén;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
23 Jaén;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
23 Jaén;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;92,38
23 Jaén;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
23 Jaén;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
23 Jaén;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
23 Jaén;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;91,96
23 Jaén;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
23 Jaén;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
23 Jaén;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;85,93
23 Jaén;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
23 Jaén;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
23 Jaén;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
23 Jaén;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;87,26
23 Jaén;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
23 Jaén;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
23 Jaén;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
23 Jaén;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;86,46
23 Jaén;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
23 Jaén;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
23 Jaén;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
23 Jaén;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
23 Jaén;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
23 Jaén;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
23 Jaén;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;82,49
23 Jaén;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
23 Jaén;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
23 Jaén;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
23 Jaén;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;83,37
23 Jaén;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
23 Jaén;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
23 Jaén;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
23 Jaén;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
23 Jaén;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
23 Jaén;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
23 Jaén;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;77,44
23 Jaén;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
23 Jaén;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
23 Jaén;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
23 Jaén;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;79,37
23 Jaén;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
23 Jaén;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
23 Jaén;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
23 Jaén;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
23 Jaén;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
23 Jaén;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
23 Jaén;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QIII;1.579
23 Jaén;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
23 Jaén;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
23 Jaén;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
23 Jaén;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QIII;1.576
23 Jaén;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
23 Jaén;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
23 Jaén;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
23 Jaén;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QIII;1.531
23 Jaén;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
23 Jaén;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
23 Jaén;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
23 Jaén;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2022QIII;1.467
23 Jaén;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2022QII;""
23 Jaén;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2022QI;""
23 Jaén;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
23 Jaén;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2021QIII;1.456
23 Jaén;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2021QII;""
23 Jaén;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2021QI;""
23 Jaén;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
23 Jaén;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2020QIII;1.417
23 Jaén;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2020QII;""
23 Jaén;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2020QI;""
23 Jaén;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2022QIV;1.373
23 Jaén;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
23 Jaén;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2022QII;""
23 Jaén;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2022QI;""
23 Jaén;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2021QIV;1.382
23 Jaén;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
23 Jaén;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2021QII;""
23 Jaén;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2021QI;""
23 Jaén;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2020QIV;1.328
23 Jaén;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
23 Jaén;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2020QII;""
23 Jaén;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2020QI;""
23 Jaén;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
23 Jaén;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
23 Jaén;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QII;""
23 Jaén;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QI;1.318
23 Jaén;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
23 Jaén;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
23 Jaén;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QII;""
23 Jaén;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QI;1.292
23 Jaén;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
23 Jaén;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
23 Jaén;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QII;""
23 Jaén;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QI;""
23 Jaén;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
23 Jaén;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
23 Jaén;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QII;1.237
23 Jaén;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QI;""
23 Jaén;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
23 Jaén;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
23 Jaén;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QII;1.238
23 Jaén;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QI;""
23 Jaén;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
23 Jaén;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
23 Jaén;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QII;""
23 Jaén;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QI;""
23 Jaén;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
23 Jaén;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
23 Jaén;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
23 Jaén;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
23 Jaén;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
23 Jaén;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
23 Jaén;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
23 Jaén;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
23 Jaén;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
23 Jaén;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
23 Jaén;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
23 Jaén;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
23 Jaén;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
23 Jaén;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;92,91
23 Jaén;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
23 Jaén;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
23 Jaén;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
23 Jaén;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;92,39
23 Jaén;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
23 Jaén;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
23 Jaén;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
23 Jaén;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;92,55
23 Jaén;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
23 Jaén;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
23 Jaén;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;86,95
23 Jaén;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
23 Jaén;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
23 Jaén;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
23 Jaén;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;87,69
23 Jaén;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
23 Jaén;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
23 Jaén;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
23 Jaén;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;86,74
23 Jaén;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
23 Jaén;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
23 Jaén;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
23 Jaén;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
23 Jaén;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
23 Jaén;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
23 Jaén;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;83,63
23 Jaén;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
23 Jaén;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
23 Jaén;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
23 Jaén;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;84,39
23 Jaén;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
23 Jaén;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
23 Jaén;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
23 Jaén;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
23 Jaén;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
23 Jaén;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
23 Jaén;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;78,49
23 Jaén;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
23 Jaén;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
23 Jaén;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
23 Jaén;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;80,86
23 Jaén;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
23 Jaén;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
23 Jaén;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
23 Jaén;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
23 Jaén;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
23 Jaén;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
23 Jaén;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QIII;1.022
23 Jaén;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
23 Jaén;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
23 Jaén;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
23 Jaén;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QIII;1.022
23 Jaén;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
23 Jaén;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
23 Jaén;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
23 Jaén;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QIII;994
23 Jaén;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
23 Jaén;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
23 Jaén;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
23 Jaén;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2022QIII;933
23 Jaén;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2022QII;""
23 Jaén;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2022QI;""
23 Jaén;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
23 Jaén;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2021QIII;944
23 Jaén;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2021QII;""
23 Jaén;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2021QI;""
23 Jaén;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
23 Jaén;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2020QIII;905
23 Jaén;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2020QII;""
23 Jaén;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2020QI;""
23 Jaén;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2022QIV;862
23 Jaén;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
23 Jaén;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2022QII;""
23 Jaén;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2022QI;""
23 Jaén;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2021QIV;885
23 Jaén;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
23 Jaén;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2021QII;""
23 Jaén;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2021QI;""
23 Jaén;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2020QIV;855
23 Jaén;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
23 Jaén;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2020QII;""
23 Jaén;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2020QI;""
23 Jaén;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
23 Jaén;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
23 Jaén;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QII;""
23 Jaén;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QI;825
23 Jaén;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
23 Jaén;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
23 Jaén;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QII;""
23 Jaén;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QI;813
23 Jaén;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
23 Jaén;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
23 Jaén;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QII;""
23 Jaén;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QI;""
23 Jaén;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
23 Jaén;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
23 Jaén;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QII;775
23 Jaén;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QI;""
23 Jaén;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
23 Jaén;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
23 Jaén;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QII;766
23 Jaén;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QI;""
23 Jaén;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
23 Jaén;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
23 Jaén;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QII;""
23 Jaén;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QI;""
23 Jaén;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
23 Jaén;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
23 Jaén;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
23 Jaén;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
23 Jaén;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
23 Jaén;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
23 Jaén;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
23 Jaén;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
23 Jaén;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
23 Jaén;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
23 Jaén;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
23 Jaén;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
23 Jaén;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
23 Jaén;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;91,29
23 Jaén;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
23 Jaén;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
23 Jaén;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
23 Jaén;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;92,37
23 Jaén;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
23 Jaén;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
23 Jaén;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
23 Jaén;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;91,05
23 Jaén;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
23 Jaén;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
23 Jaén;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;84,34
23 Jaén;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
23 Jaén;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
23 Jaén;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
23 Jaén;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;86,59
23 Jaén;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
23 Jaén;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
23 Jaén;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
23 Jaén;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;86,02
23 Jaén;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
23 Jaén;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
23 Jaén;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
23 Jaén;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
23 Jaén;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
23 Jaén;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
23 Jaén;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;80,72
23 Jaén;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
23 Jaén;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
23 Jaén;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
23 Jaén;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;81,79
23 Jaén;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
23 Jaén;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
23 Jaén;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
23 Jaén;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
23 Jaén;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
23 Jaén;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
23 Jaén;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;75,83
23 Jaén;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
23 Jaén;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
23 Jaén;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
23 Jaén;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;77,06
23 Jaén;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
23 Jaén;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
23 Jaén;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
23 Jaén;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
23 Jaén;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
23 Jaén;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QIV;2.703
23 Jaén;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
23 Jaén;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
23 Jaén;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
23 Jaén;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QIV;2.734
23 Jaén;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
23 Jaén;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
23 Jaén;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
23 Jaén;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QIV;2.633
23 Jaén;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
23 Jaén;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
23 Jaén;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
23 Jaén;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2022QIV;2.506
23 Jaén;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
23 Jaén;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2022QII;""
23 Jaén;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2022QI;""
23 Jaén;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2021QIV;2.565
23 Jaén;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
23 Jaén;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2021QII;""
23 Jaén;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2021QI;""
23 Jaén;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2020QIV;2.441
23 Jaén;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
23 Jaén;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2020QII;""
23 Jaén;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2020QI;""
23 Jaén;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
23 Jaén;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
23 Jaén;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2022QII;""
23 Jaén;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2022QI;2.427
23 Jaén;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
23 Jaén;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
23 Jaén;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2021QII;""
23 Jaén;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2021QI;2.346
23 Jaén;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
23 Jaén;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
23 Jaén;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2020QII;""
23 Jaén;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2020QI;""
23 Jaén;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
23 Jaén;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
23 Jaén;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QII;2.273
23 Jaén;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QI;""
23 Jaén;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
23 Jaén;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
23 Jaén;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QII;2.221
23 Jaén;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QI;""
23 Jaén;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
23 Jaén;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
23 Jaén;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QII;""
23 Jaén;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QI;""
23 Jaén;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
23 Jaén;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QIII;2.127
23 Jaén;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QII;""
23 Jaén;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QI;""
23 Jaén;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
23 Jaén;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QIII;2.114
23 Jaén;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QII;""
23 Jaén;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QI;""
23 Jaén;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
23 Jaén;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
23 Jaén;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QII;""
23 Jaén;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QI;""
23 Jaén;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
23 Jaén;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
23 Jaén;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
23 Jaén;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
23 Jaén;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
23 Jaén;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
23 Jaén;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
23 Jaén;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
23 Jaén;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
23 Jaén;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
23 Jaén;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
23 Jaén;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
23 Jaén;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;92,71
23 Jaén;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
23 Jaén;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
23 Jaén;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
23 Jaén;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;93,82
23 Jaén;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
23 Jaén;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
23 Jaén;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
23 Jaén;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;92,71
23 Jaén;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
23 Jaén;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
23 Jaén;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
23 Jaén;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
23 Jaén;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
23 Jaén;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
23 Jaén;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;88,77
23 Jaén;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
23 Jaén;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
23 Jaén;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
23 Jaén;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;89,1
23 Jaén;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
23 Jaén;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
23 Jaén;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
23 Jaén;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
23 Jaén;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
23 Jaén;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
23 Jaén;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;83,14
23 Jaén;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
23 Jaén;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
23 Jaén;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
23 Jaén;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;84,35
23 Jaén;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
23 Jaén;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
23 Jaén;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
23 Jaén;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
23 Jaén;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
23 Jaén;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
23 Jaén;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;77,8
23 Jaén;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
23 Jaén;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
23 Jaén;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
23 Jaén;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;80,29
23 Jaén;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
23 Jaén;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
23 Jaén;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
23 Jaén;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
23 Jaén;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
23 Jaén;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
23 Jaén;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QIV;1.641
23 Jaén;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
23 Jaén;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
23 Jaén;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
23 Jaén;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QIV;1.635
23 Jaén;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
23 Jaén;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
23 Jaén;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
23 Jaén;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QIV;1.600
23 Jaén;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
23 Jaén;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
23 Jaén;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
23 Jaén;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2022QIV;1.525
23 Jaén;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
23 Jaén;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2022QII;""
23 Jaén;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2022QI;""
23 Jaén;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2021QIV;1.543
23 Jaén;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
23 Jaén;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2021QII;""
23 Jaén;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2021QI;""
23 Jaén;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2020QIV;1.479
23 Jaén;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
23 Jaén;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2020QII;""
23 Jaén;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2020QI;""
23 Jaén;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
23 Jaén;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
23 Jaén;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2022QII;""
23 Jaén;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2022QI;1.471
23 Jaén;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
23 Jaén;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
23 Jaén;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2021QII;""
23 Jaén;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2021QI;1.433
23 Jaén;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
23 Jaén;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
23 Jaén;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2020QII;""
23 Jaén;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2020QI;""
23 Jaén;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
23 Jaén;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
23 Jaén;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QII;1.377
23 Jaén;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QI;""
23 Jaén;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
23 Jaén;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
23 Jaén;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QII;1.366
23 Jaén;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QI;""
23 Jaén;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
23 Jaén;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
23 Jaén;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QII;""
23 Jaén;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QI;""
23 Jaén;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
23 Jaén;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QIII;1.295
23 Jaén;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QII;""
23 Jaén;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QI;""
23 Jaén;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
23 Jaén;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QIII;1.306
23 Jaén;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QII;""
23 Jaén;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QI;""
23 Jaén;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
23 Jaén;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
23 Jaén;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QII;""
23 Jaén;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QI;""
23 Jaén;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
23 Jaén;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
23 Jaén;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
23 Jaén;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
23 Jaén;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
23 Jaén;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
23 Jaén;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
23 Jaén;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
23 Jaén;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
23 Jaén;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
23 Jaén;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
23 Jaén;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
23 Jaén;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;92,93
23 Jaén;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
23 Jaén;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
23 Jaén;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
23 Jaén;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;94,37
23 Jaén;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
23 Jaén;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
23 Jaén;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
23 Jaén;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;92,44
23 Jaén;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
23 Jaén;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
23 Jaén;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
23 Jaén;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
23 Jaén;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
23 Jaén;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
23 Jaén;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;89,97
23 Jaén;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
23 Jaén;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
23 Jaén;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
23 Jaén;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;89,56
23 Jaén;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
23 Jaén;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
23 Jaén;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
23 Jaén;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
23 Jaén;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
23 Jaén;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
23 Jaén;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;84,22
23 Jaén;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
23 Jaén;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
23 Jaén;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
23 Jaén;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;85,38
23 Jaén;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
23 Jaén;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
23 Jaén;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
23 Jaén;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
23 Jaén;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
23 Jaén;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
23 Jaén;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;79,2
23 Jaén;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
23 Jaén;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
23 Jaén;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
23 Jaén;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;81,63
23 Jaén;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
23 Jaén;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
23 Jaén;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
23 Jaén;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
23 Jaén;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
23 Jaén;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
23 Jaén;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QIV;1.062
23 Jaén;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
23 Jaén;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
23 Jaén;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
23 Jaén;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QIV;1.099
23 Jaén;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
23 Jaén;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
23 Jaén;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
23 Jaén;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QIV;1.033
23 Jaén;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
23 Jaén;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
23 Jaén;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
23 Jaén;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2022QIV;981
23 Jaén;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
23 Jaén;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2022QII;""
23 Jaén;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2022QI;""
23 Jaén;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2021QIV;1.022
23 Jaén;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
23 Jaén;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2021QII;""
23 Jaén;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2021QI;""
23 Jaén;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2020QIV;962
23 Jaén;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
23 Jaén;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2020QII;""
23 Jaén;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2020QI;""
23 Jaén;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
23 Jaén;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
23 Jaén;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2022QII;""
23 Jaén;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2022QI;956
23 Jaén;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
23 Jaén;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
23 Jaén;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2021QII;""
23 Jaén;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2021QI;913
23 Jaén;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
23 Jaén;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
23 Jaén;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2020QII;""
23 Jaén;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2020QI;""
23 Jaén;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
23 Jaén;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
23 Jaén;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QII;896
23 Jaén;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QI;""
23 Jaén;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
23 Jaén;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
23 Jaén;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QII;855
23 Jaén;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QI;""
23 Jaén;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
23 Jaén;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
23 Jaén;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QII;""
23 Jaén;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QI;""
23 Jaén;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
23 Jaén;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QIII;832
23 Jaén;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QII;""
23 Jaén;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QI;""
23 Jaén;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
23 Jaén;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QIII;808
23 Jaén;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QII;""
23 Jaén;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QI;""
23 Jaén;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
23 Jaén;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
23 Jaén;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QII;""
23 Jaén;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QI;""
23 Jaén;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
23 Jaén;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
23 Jaén;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
23 Jaén;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
23 Jaén;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
23 Jaén;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
23 Jaén;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
23 Jaén;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
23 Jaén;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
23 Jaén;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
23 Jaén;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
23 Jaén;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
23 Jaén;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;92,37
23 Jaén;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
23 Jaén;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
23 Jaén;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
23 Jaén;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;92,99
23 Jaén;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
23 Jaén;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
23 Jaén;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
23 Jaén;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;93,13
23 Jaén;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
23 Jaén;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
23 Jaén;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
23 Jaén;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
23 Jaén;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
23 Jaén;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
23 Jaén;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;86,99
23 Jaén;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
23 Jaén;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
23 Jaén;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
23 Jaén;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;88,38
23 Jaén;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
23 Jaén;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
23 Jaén;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
23 Jaén;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
23 Jaén;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
23 Jaén;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
23 Jaén;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;81,53
23 Jaén;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
23 Jaén;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
23 Jaén;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
23 Jaén;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;82,77
23 Jaén;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
23 Jaén;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
23 Jaén;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
23 Jaén;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
23 Jaén;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
23 Jaén;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
23 Jaén;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;75,71
23 Jaén;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
23 Jaén;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
23 Jaén;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
23 Jaén;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;78,22
23 Jaén;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
23 Jaén;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
23 Jaén;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
23 Jaén;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
23 Jaén;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
23 Jaén;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
23 Jaén;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
23 Jaén;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
23 Jaén;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
23 Jaén;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QI;7.294
23 Jaén;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
23 Jaén;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
23 Jaén;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
23 Jaén;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QI;7.313
23 Jaén;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
23 Jaén;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
23 Jaén;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
23 Jaén;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QI;7.162
23 Jaén;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
23 Jaén;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
23 Jaén;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2022QII;""
23 Jaén;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2022QI;7.020
23 Jaén;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
23 Jaén;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
23 Jaén;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2021QII;""
23 Jaén;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2021QI;7.122
23 Jaén;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
23 Jaén;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
23 Jaén;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2020QII;""
23 Jaén;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2020QI;6.615
23 Jaén;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
23 Jaén;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
23 Jaén;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2022QII;6.745
23 Jaén;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2022QI;""
23 Jaén;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
23 Jaén;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
23 Jaén;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2021QII;6.909
23 Jaén;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2021QI;""
23 Jaén;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
23 Jaén;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
23 Jaén;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2020QII;6.478
23 Jaén;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2020QI;""
23 Jaén;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
23 Jaén;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QIII;6.522
23 Jaén;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QII;""
23 Jaén;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QI;""
23 Jaén;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
23 Jaén;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QIII;6.727
23 Jaén;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QII;""
23 Jaén;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QI;""
23 Jaén;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
23 Jaén;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QIII;6.291
23 Jaén;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QII;""
23 Jaén;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QI;""
23 Jaén;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QIV;6.293
23 Jaén;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
23 Jaén;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QII;""
23 Jaén;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QI;""
23 Jaén;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QIV;6.507
23 Jaén;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
23 Jaén;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QII;""
23 Jaén;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QI;""
23 Jaén;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QIV;6.063
23 Jaén;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
23 Jaén;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QII;""
23 Jaén;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QI;""
23 Jaén;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
23 Jaén;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
23 Jaén;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
23 Jaén;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
23 Jaén;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
23 Jaén;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
23 Jaén;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
23 Jaén;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
23 Jaén;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
23 Jaén;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
23 Jaén;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
23 Jaén;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
23 Jaén;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
23 Jaén;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
23 Jaén;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
23 Jaén;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;96,24
23 Jaén;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
23 Jaén;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
23 Jaén;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
23 Jaén;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;97,39
23 Jaén;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
23 Jaén;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
23 Jaén;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
23 Jaén;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;92,36
23 Jaén;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
23 Jaén;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
23 Jaén;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;92,47
23 Jaén;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
23 Jaén;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
23 Jaén;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
23 Jaén;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;94,48
23 Jaén;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
23 Jaén;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
23 Jaén;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
23 Jaén;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;90,45
23 Jaén;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
23 Jaén;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
23 Jaén;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;89,42
23 Jaén;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
23 Jaén;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
23 Jaén;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
23 Jaén;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;91,99
23 Jaén;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
23 Jaén;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
23 Jaén;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
23 Jaén;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;87,84
23 Jaén;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
23 Jaén;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
23 Jaén;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;86,28
23 Jaén;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
23 Jaén;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
23 Jaén;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
23 Jaén;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;88,98
23 Jaén;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
23 Jaén;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
23 Jaén;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
23 Jaén;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;84,66
23 Jaén;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
23 Jaén;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
23 Jaén;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
23 Jaén;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
23 Jaén;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
23 Jaén;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
23 Jaén;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QI;4.385
23 Jaén;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
23 Jaén;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
23 Jaén;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
23 Jaén;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QI;4.467
23 Jaén;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
23 Jaén;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
23 Jaén;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
23 Jaén;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QI;4.411
23 Jaén;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
23 Jaén;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
23 Jaén;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2022QII;""
23 Jaén;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2022QI;4.225
23 Jaén;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
23 Jaén;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
23 Jaén;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2021QII;""
23 Jaén;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2021QI;4.362
23 Jaén;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
23 Jaén;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
23 Jaén;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2020QII;""
23 Jaén;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2020QI;4.095
23 Jaén;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
23 Jaén;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
23 Jaén;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2022QII;4.084
23 Jaén;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2022QI;""
23 Jaén;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
23 Jaén;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
23 Jaén;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2021QII;4.254
23 Jaén;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2021QI;""
23 Jaén;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
23 Jaén;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
23 Jaén;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2020QII;4.018
23 Jaén;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2020QI;""
23 Jaén;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
23 Jaén;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QIII;3.978
23 Jaén;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QII;""
23 Jaén;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QI;""
23 Jaén;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
23 Jaén;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QIII;4.147
23 Jaén;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QII;""
23 Jaén;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QI;""
23 Jaén;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
23 Jaén;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QIII;3.915
23 Jaén;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QII;""
23 Jaén;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QI;""
23 Jaén;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QIV;3.844
23 Jaén;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
23 Jaén;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QII;""
23 Jaén;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QI;""
23 Jaén;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QIV;4.021
23 Jaén;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
23 Jaén;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QII;""
23 Jaén;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QI;""
23 Jaén;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QIV;3.766
23 Jaén;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
23 Jaén;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QII;""
23 Jaén;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QI;""
23 Jaén;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
23 Jaén;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
23 Jaén;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
23 Jaén;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
23 Jaén;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
23 Jaén;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
23 Jaén;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
23 Jaén;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
23 Jaén;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
23 Jaén;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
23 Jaén;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
23 Jaén;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
23 Jaén;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
23 Jaén;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
23 Jaén;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
23 Jaén;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;96,35
23 Jaén;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
23 Jaén;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
23 Jaén;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
23 Jaén;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;97,65
23 Jaén;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
23 Jaén;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
23 Jaén;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
23 Jaén;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;92,84
23 Jaén;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
23 Jaén;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
23 Jaén;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;93,14
23 Jaén;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
23 Jaén;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
23 Jaén;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
23 Jaén;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;95,23
23 Jaén;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
23 Jaén;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
23 Jaén;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
23 Jaén;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;91,09
23 Jaén;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
23 Jaén;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
23 Jaén;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;90,72
23 Jaén;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
23 Jaén;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
23 Jaén;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
23 Jaén;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;92,84
23 Jaén;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
23 Jaén;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
23 Jaén;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
23 Jaén;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;88,76
23 Jaén;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
23 Jaén;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
23 Jaén;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;87,66
23 Jaén;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
23 Jaén;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
23 Jaén;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
23 Jaén;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;90,02
23 Jaén;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
23 Jaén;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
23 Jaén;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
23 Jaén;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;85,38
23 Jaén;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
23 Jaén;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
23 Jaén;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
23 Jaén;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
23 Jaén;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
23 Jaén;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
23 Jaén;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QI;2.909
23 Jaén;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
23 Jaén;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
23 Jaén;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
23 Jaén;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QI;2.846
23 Jaén;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
23 Jaén;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
23 Jaén;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
23 Jaén;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QI;2.751
23 Jaén;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
23 Jaén;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
23 Jaén;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2022QII;""
23 Jaén;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2022QI;2.795
23 Jaén;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
23 Jaén;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
23 Jaén;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2021QII;""
23 Jaén;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2021QI;2.760
23 Jaén;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
23 Jaén;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
23 Jaén;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2020QII;""
23 Jaén;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2020QI;2.520
23 Jaén;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
23 Jaén;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
23 Jaén;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2022QII;2.661
23 Jaén;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2022QI;""
23 Jaén;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
23 Jaén;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
23 Jaén;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2021QII;2.655
23 Jaén;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2021QI;""
23 Jaén;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
23 Jaén;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
23 Jaén;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2020QII;2.460
23 Jaén;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2020QI;""
23 Jaén;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
23 Jaén;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QIII;2.544
23 Jaén;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QII;""
23 Jaén;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QI;""
23 Jaén;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
23 Jaén;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QIII;2.580
23 Jaén;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QII;""
23 Jaén;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QI;""
23 Jaén;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
23 Jaén;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QIII;2.376
23 Jaén;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QII;""
23 Jaén;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QI;""
23 Jaén;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QIV;2.449
23 Jaén;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
23 Jaén;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QII;""
23 Jaén;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QI;""
23 Jaén;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QIV;2.486
23 Jaén;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
23 Jaén;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QII;""
23 Jaén;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QI;""
23 Jaén;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QIV;2.297
23 Jaén;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
23 Jaén;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QII;""
23 Jaén;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QI;""
23 Jaén;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
23 Jaén;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
23 Jaén;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
23 Jaén;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
23 Jaén;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
23 Jaén;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
23 Jaén;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
23 Jaén;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
23 Jaén;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
23 Jaén;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
23 Jaén;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
23 Jaén;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
23 Jaén;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
23 Jaén;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
23 Jaén;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
23 Jaén;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;96,08
23 Jaén;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
23 Jaén;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
23 Jaén;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
23 Jaén;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;96,98
23 Jaén;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
23 Jaén;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
23 Jaén;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
23 Jaén;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;91,6
23 Jaén;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
23 Jaén;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
23 Jaén;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;91,47
23 Jaén;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
23 Jaén;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
23 Jaén;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
23 Jaén;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;93,29
23 Jaén;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
23 Jaén;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
23 Jaén;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
23 Jaén;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;89,42
23 Jaén;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
23 Jaén;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
23 Jaén;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;87,45
23 Jaén;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
23 Jaén;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
23 Jaén;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
23 Jaén;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;90,65
23 Jaén;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
23 Jaén;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
23 Jaén;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
23 Jaén;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;86,37
23 Jaén;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
23 Jaén;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
23 Jaén;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;84,19
23 Jaén;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
23 Jaén;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
23 Jaén;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
23 Jaén;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;87,35
23 Jaén;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
23 Jaén;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
23 Jaén;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
23 Jaén;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;83,5
23 Jaén;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
23 Jaén;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
23 Jaén;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
23 Jaén;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
23 Jaén;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
23 Jaén;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QII;6.990
23 Jaén;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
23 Jaén;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
23 Jaén;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
23 Jaén;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QII;7.051
23 Jaén;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
23 Jaén;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
23 Jaén;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
23 Jaén;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QII;7.050
23 Jaén;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
23 Jaén;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
23 Jaén;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
23 Jaén;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2022QII;6.676
23 Jaén;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2022QI;""
23 Jaén;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
23 Jaén;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
23 Jaén;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2021QII;6.811
23 Jaén;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2021QI;""
23 Jaén;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
23 Jaén;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
23 Jaén;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2020QII;6.897
23 Jaén;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2020QI;""
23 Jaén;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
23 Jaén;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2022QIII;6.422
23 Jaén;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2022QII;""
23 Jaén;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2022QI;""
23 Jaén;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
23 Jaén;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2021QIII;6.610
23 Jaén;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2021QII;""
23 Jaén;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2021QI;""
23 Jaén;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
23 Jaén;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2020QIII;6.678
23 Jaén;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2020QII;""
23 Jaén;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2020QI;""
23 Jaén;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QIV;6.167
23 Jaén;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
23 Jaén;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QII;""
23 Jaén;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QI;""
23 Jaén;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QIV;6.377
23 Jaén;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
23 Jaén;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QII;""
23 Jaén;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QI;""
23 Jaén;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QIV;6.423
23 Jaén;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
23 Jaén;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QII;""
23 Jaén;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QI;""
23 Jaén;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
23 Jaén;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
23 Jaén;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QII;""
23 Jaén;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QI;6.173
23 Jaén;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
23 Jaén;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
23 Jaén;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QII;""
23 Jaén;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QI;6.289
23 Jaén;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
23 Jaén;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
23 Jaén;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QII;""
23 Jaén;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QI;""
23 Jaén;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
23 Jaén;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
23 Jaén;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
23 Jaén;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
23 Jaén;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
23 Jaén;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
23 Jaén;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
23 Jaén;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
23 Jaén;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
23 Jaén;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
23 Jaén;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
23 Jaén;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
23 Jaén;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
23 Jaén;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
23 Jaén;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;95,51
23 Jaén;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
23 Jaén;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
23 Jaén;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
23 Jaén;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;96,6
23 Jaén;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
23 Jaén;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
23 Jaén;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
23 Jaén;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;97,83
23 Jaén;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
23 Jaén;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
23 Jaén;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;91,87
23 Jaén;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
23 Jaén;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
23 Jaén;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
23 Jaén;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;93,75
23 Jaén;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
23 Jaén;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
23 Jaén;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
23 Jaén;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;94,72
23 Jaén;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
23 Jaén;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
23 Jaén;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;88,23
23 Jaén;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
23 Jaén;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
23 Jaén;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
23 Jaén;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;90,44
23 Jaén;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
23 Jaén;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
23 Jaén;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
23 Jaén;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;91,11
23 Jaén;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
23 Jaén;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
23 Jaén;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
23 Jaén;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
23 Jaén;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
23 Jaén;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
23 Jaén;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;87,55
23 Jaén;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
23 Jaén;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
23 Jaén;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
23 Jaén;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;89,21
23 Jaén;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
23 Jaén;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
23 Jaén;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
23 Jaén;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
23 Jaén;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
23 Jaén;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
23 Jaén;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QII;4.187
23 Jaén;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
23 Jaén;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
23 Jaén;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
23 Jaén;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QII;4.271
23 Jaén;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
23 Jaén;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
23 Jaén;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
23 Jaén;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QII;4.339
23 Jaén;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
23 Jaén;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
23 Jaén;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
23 Jaén;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2022QII;4.027
23 Jaén;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2022QI;""
23 Jaén;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
23 Jaén;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
23 Jaén;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2021QII;4.146
23 Jaén;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2021QI;""
23 Jaén;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
23 Jaén;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
23 Jaén;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2020QII;4.256
23 Jaén;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2020QI;""
23 Jaén;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
23 Jaén;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2022QIII;3.890
23 Jaén;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2022QII;""
23 Jaén;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2022QI;""
23 Jaén;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
23 Jaén;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2021QIII;4.027
23 Jaén;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2021QII;""
23 Jaén;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2021QI;""
23 Jaén;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
23 Jaén;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2020QIII;4.134
23 Jaén;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2020QII;""
23 Jaén;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2020QI;""
23 Jaén;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QIV;3.727
23 Jaén;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
23 Jaén;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QII;""
23 Jaén;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QI;""
23 Jaén;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QIV;3.892
23 Jaén;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
23 Jaén;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QII;""
23 Jaén;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QI;""
23 Jaén;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QIV;3.964
23 Jaén;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
23 Jaén;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QII;""
23 Jaén;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QI;""
23 Jaén;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
23 Jaén;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
23 Jaén;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QII;""
23 Jaén;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QI;3.772
23 Jaén;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
23 Jaén;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
23 Jaén;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QII;""
23 Jaén;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QI;3.894
23 Jaén;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
23 Jaén;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
23 Jaén;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QII;""
23 Jaén;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QI;""
23 Jaén;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
23 Jaén;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
23 Jaén;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
23 Jaén;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
23 Jaén;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
23 Jaén;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
23 Jaén;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
23 Jaén;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
23 Jaén;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
23 Jaén;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
23 Jaén;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
23 Jaén;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
23 Jaén;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
23 Jaén;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
23 Jaén;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;96,18
23 Jaén;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
23 Jaén;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
23 Jaén;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
23 Jaén;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;97,07
23 Jaén;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
23 Jaén;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
23 Jaén;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
23 Jaén;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;98,09
23 Jaén;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
23 Jaén;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
23 Jaén;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;92,91
23 Jaén;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
23 Jaén;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
23 Jaén;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
23 Jaén;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;94,29
23 Jaén;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
23 Jaén;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
23 Jaén;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
23 Jaén;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;95,28
23 Jaén;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
23 Jaén;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
23 Jaén;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;89,01
23 Jaén;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
23 Jaén;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
23 Jaén;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
23 Jaén;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;91,13
23 Jaén;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
23 Jaén;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
23 Jaén;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
23 Jaén;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;91,36
23 Jaén;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
23 Jaén;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
23 Jaén;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
23 Jaén;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
23 Jaén;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
23 Jaén;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
23 Jaén;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;88,32
23 Jaén;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
23 Jaén;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
23 Jaén;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
23 Jaén;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;89,74
23 Jaén;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
23 Jaén;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
23 Jaén;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
23 Jaén;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
23 Jaén;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
23 Jaén;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
23 Jaén;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QII;2.803
23 Jaén;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
23 Jaén;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
23 Jaén;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
23 Jaén;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QII;2.780
23 Jaén;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
23 Jaén;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
23 Jaén;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
23 Jaén;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QII;2.711
23 Jaén;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
23 Jaén;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
23 Jaén;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
23 Jaén;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2022QII;2.649
23 Jaén;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2022QI;""
23 Jaén;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
23 Jaén;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
23 Jaén;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2021QII;2.665
23 Jaén;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2021QI;""
23 Jaén;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
23 Jaén;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
23 Jaén;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2020QII;2.641
23 Jaén;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2020QI;""
23 Jaén;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
23 Jaén;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2022QIII;2.532
23 Jaén;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2022QII;""
23 Jaén;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2022QI;""
23 Jaén;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
23 Jaén;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2021QIII;2.583
23 Jaén;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2021QII;""
23 Jaén;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2021QI;""
23 Jaén;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
23 Jaén;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2020QIII;2.544
23 Jaén;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2020QII;""
23 Jaén;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2020QI;""
23 Jaén;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QIV;2.440
23 Jaén;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
23 Jaén;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QII;""
23 Jaén;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QI;""
23 Jaén;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QIV;2.485
23 Jaén;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
23 Jaén;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QII;""
23 Jaén;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QI;""
23 Jaén;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QIV;2.459
23 Jaén;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
23 Jaén;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QII;""
23 Jaén;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QI;""
23 Jaén;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
23 Jaén;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
23 Jaén;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QII;""
23 Jaén;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QI;2.401
23 Jaén;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
23 Jaén;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
23 Jaén;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QII;""
23 Jaén;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QI;2.395
23 Jaén;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
23 Jaén;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
23 Jaén;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QII;""
23 Jaén;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QI;""
23 Jaén;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
23 Jaén;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
23 Jaén;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
23 Jaén;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
23 Jaén;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
23 Jaén;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
23 Jaén;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
23 Jaén;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
23 Jaén;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
23 Jaén;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
23 Jaén;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
23 Jaén;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
23 Jaén;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
23 Jaén;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
23 Jaén;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;94,51
23 Jaén;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
23 Jaén;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
23 Jaén;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
23 Jaén;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;95,86
23 Jaén;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
23 Jaén;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
23 Jaén;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
23 Jaén;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;97,42
23 Jaén;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
23 Jaén;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
23 Jaén;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;90,33
23 Jaén;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
23 Jaén;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
23 Jaén;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
23 Jaén;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;92,91
23 Jaén;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
23 Jaén;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
23 Jaén;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
23 Jaén;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;93,84
23 Jaén;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
23 Jaén;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
23 Jaén;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;87,05
23 Jaén;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
23 Jaén;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
23 Jaén;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
23 Jaén;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;89,39
23 Jaén;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
23 Jaén;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
23 Jaén;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
23 Jaén;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;90,7
23 Jaén;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
23 Jaén;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
23 Jaén;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
23 Jaén;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
23 Jaén;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
23 Jaén;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
23 Jaén;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;86,37
23 Jaén;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
23 Jaén;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
23 Jaén;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
23 Jaén;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;88,34
23 Jaén;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
23 Jaén;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
23 Jaén;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
23 Jaén;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
23 Jaén;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
23 Jaén;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QIII;7.082
23 Jaén;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
23 Jaén;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
23 Jaén;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
23 Jaén;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QIII;7.255
23 Jaén;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
23 Jaén;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
23 Jaén;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
23 Jaén;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QIII;7.272
23 Jaén;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
23 Jaén;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
23 Jaén;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
23 Jaén;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2022QIII;6.759
23 Jaén;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2022QII;""
23 Jaén;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2022QI;""
23 Jaén;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
23 Jaén;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2021QIII;6.998
23 Jaén;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2021QII;""
23 Jaén;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2021QI;""
23 Jaén;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
23 Jaén;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2020QIII;7.002
23 Jaén;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2020QII;""
23 Jaén;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2020QI;""
23 Jaén;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2022QIV;6.456
23 Jaén;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
23 Jaén;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2022QII;""
23 Jaén;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2022QI;""
23 Jaén;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2021QIV;6.697
23 Jaén;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
23 Jaén;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2021QII;""
23 Jaén;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2021QI;""
23 Jaén;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2020QIV;6.702
23 Jaén;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
23 Jaén;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2020QII;""
23 Jaén;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2020QI;""
23 Jaén;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
23 Jaén;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
23 Jaén;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QII;""
23 Jaén;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QI;6.474
23 Jaén;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
23 Jaén;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
23 Jaén;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QII;""
23 Jaén;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QI;6.555
23 Jaén;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
23 Jaén;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
23 Jaén;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QII;""
23 Jaén;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QI;""
23 Jaén;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
23 Jaén;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
23 Jaén;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QII;6.243
23 Jaén;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QI;""
23 Jaén;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
23 Jaén;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
23 Jaén;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QII;6.386
23 Jaén;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QI;""
23 Jaén;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
23 Jaén;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
23 Jaén;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QII;""
23 Jaén;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QI;""
23 Jaén;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
23 Jaén;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
23 Jaén;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
23 Jaén;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
23 Jaén;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
23 Jaén;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
23 Jaén;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
23 Jaén;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
23 Jaén;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
23 Jaén;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
23 Jaén;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
23 Jaén;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
23 Jaén;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
23 Jaén;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;95,44
23 Jaén;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
23 Jaén;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
23 Jaén;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
23 Jaén;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;96,46
23 Jaén;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
23 Jaén;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
23 Jaén;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
23 Jaén;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;96,29
23 Jaén;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
23 Jaén;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
23 Jaén;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;91,16
23 Jaén;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
23 Jaén;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
23 Jaén;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
23 Jaén;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;92,31
23 Jaén;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
23 Jaén;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
23 Jaén;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
23 Jaén;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;92,16
23 Jaén;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
23 Jaén;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
23 Jaén;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
23 Jaén;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
23 Jaén;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
23 Jaén;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
23 Jaén;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;89,24
23 Jaén;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
23 Jaén;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
23 Jaén;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
23 Jaén;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;90,14
23 Jaén;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
23 Jaén;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
23 Jaén;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
23 Jaén;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
23 Jaén;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
23 Jaén;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
23 Jaén;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;86,05
23 Jaén;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
23 Jaén;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
23 Jaén;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
23 Jaén;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;87,82
23 Jaén;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
23 Jaén;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
23 Jaén;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
23 Jaén;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
23 Jaén;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
23 Jaén;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
23 Jaén;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QIII;4.262
23 Jaén;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
23 Jaén;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
23 Jaén;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
23 Jaén;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QIII;4.422
23 Jaén;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
23 Jaén;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
23 Jaén;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
23 Jaén;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QIII;4.483
23 Jaén;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
23 Jaén;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
23 Jaén;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
23 Jaén;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2022QIII;4.072
23 Jaén;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2022QII;""
23 Jaén;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2022QI;""
23 Jaén;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
23 Jaén;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2021QIII;4.267
23 Jaén;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2021QII;""
23 Jaén;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2021QI;""
23 Jaén;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
23 Jaén;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2020QIII;4.325
23 Jaén;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2020QII;""
23 Jaén;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2020QI;""
23 Jaén;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2022QIV;3.875
23 Jaén;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
23 Jaén;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2022QII;""
23 Jaén;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2022QI;""
23 Jaén;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2021QIV;4.077
23 Jaén;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
23 Jaén;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2021QII;""
23 Jaén;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2021QI;""
23 Jaén;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2020QIV;4.120
23 Jaén;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
23 Jaén;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2020QII;""
23 Jaén;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2020QI;""
23 Jaén;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
23 Jaén;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
23 Jaén;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QII;""
23 Jaén;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QI;3.945
23 Jaén;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
23 Jaén;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
23 Jaén;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QII;""
23 Jaén;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QI;4.040
23 Jaén;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
23 Jaén;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
23 Jaén;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QII;""
23 Jaén;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QI;""
23 Jaén;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
23 Jaén;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
23 Jaén;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QII;3.826
23 Jaén;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QI;""
23 Jaén;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
23 Jaén;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
23 Jaén;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QII;3.953
23 Jaén;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QI;""
23 Jaén;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
23 Jaén;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
23 Jaén;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QII;""
23 Jaén;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QI;""
23 Jaén;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
23 Jaén;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
23 Jaén;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
23 Jaén;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
23 Jaén;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
23 Jaén;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
23 Jaén;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
23 Jaén;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
23 Jaén;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
23 Jaén;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
23 Jaén;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
23 Jaén;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
23 Jaén;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
23 Jaén;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;95,54
23 Jaén;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
23 Jaén;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
23 Jaén;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
23 Jaén;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;96,49
23 Jaén;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
23 Jaén;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
23 Jaén;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
23 Jaén;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;96,48
23 Jaén;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
23 Jaén;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
23 Jaén;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;90,92
23 Jaén;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
23 Jaén;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
23 Jaén;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
23 Jaén;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;92,2
23 Jaén;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
23 Jaén;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
23 Jaén;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
23 Jaén;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;91,9
23 Jaén;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
23 Jaén;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
23 Jaén;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
23 Jaén;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
23 Jaén;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
23 Jaén;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
23 Jaén;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;89,21
23 Jaén;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
23 Jaén;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
23 Jaén;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
23 Jaén;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;90,12
23 Jaén;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
23 Jaén;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
23 Jaén;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
23 Jaén;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
23 Jaén;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
23 Jaén;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
23 Jaén;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;86,52
23 Jaén;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
23 Jaén;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
23 Jaén;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
23 Jaén;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;88,18
23 Jaén;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
23 Jaén;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
23 Jaén;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
23 Jaén;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
23 Jaén;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
23 Jaén;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
23 Jaén;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QIII;2.820
23 Jaén;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
23 Jaén;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
23 Jaén;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
23 Jaén;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QIII;2.833
23 Jaén;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
23 Jaén;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
23 Jaén;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
23 Jaén;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QIII;2.789
23 Jaén;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
23 Jaén;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
23 Jaén;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
23 Jaén;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2022QIII;2.687
23 Jaén;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2022QII;""
23 Jaén;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2022QI;""
23 Jaén;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
23 Jaén;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2021QIII;2.731
23 Jaén;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2021QII;""
23 Jaén;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2021QI;""
23 Jaén;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
23 Jaén;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2020QIII;2.677
23 Jaén;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2020QII;""
23 Jaén;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2020QI;""
23 Jaén;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2022QIV;2.581
23 Jaén;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
23 Jaén;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2022QII;""
23 Jaén;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2022QI;""
23 Jaén;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2021QIV;2.620
23 Jaén;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
23 Jaén;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2021QII;""
23 Jaén;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2021QI;""
23 Jaén;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2020QIV;2.582
23 Jaén;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
23 Jaén;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2020QII;""
23 Jaén;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2020QI;""
23 Jaén;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
23 Jaén;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
23 Jaén;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QII;""
23 Jaén;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QI;2.529
23 Jaén;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
23 Jaén;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
23 Jaén;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QII;""
23 Jaén;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QI;2.515
23 Jaén;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
23 Jaén;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
23 Jaén;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QII;""
23 Jaén;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QI;""
23 Jaén;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
23 Jaén;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
23 Jaén;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QII;2.417
23 Jaén;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QI;""
23 Jaén;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
23 Jaén;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
23 Jaén;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QII;2.433
23 Jaén;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QI;""
23 Jaén;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
23 Jaén;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
23 Jaén;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QII;""
23 Jaén;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QI;""
23 Jaén;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
23 Jaén;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
23 Jaén;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
23 Jaén;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
23 Jaén;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
23 Jaén;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
23 Jaén;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
23 Jaén;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
23 Jaén;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
23 Jaén;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
23 Jaén;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
23 Jaén;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
23 Jaén;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
23 Jaén;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;95,28
23 Jaén;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
23 Jaén;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
23 Jaén;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
23 Jaén;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;96,4
23 Jaén;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
23 Jaén;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
23 Jaén;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
23 Jaén;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;95,98
23 Jaén;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
23 Jaén;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
23 Jaén;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;91,52
23 Jaén;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
23 Jaén;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
23 Jaén;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
23 Jaén;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;92,48
23 Jaén;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
23 Jaén;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
23 Jaén;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
23 Jaén;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;92,58
23 Jaén;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
23 Jaén;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
23 Jaén;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
23 Jaén;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
23 Jaén;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
23 Jaén;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
23 Jaén;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;89,27
23 Jaén;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
23 Jaén;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
23 Jaén;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
23 Jaén;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;90,18
23 Jaén;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
23 Jaén;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
23 Jaén;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
23 Jaén;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
23 Jaén;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
23 Jaén;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
23 Jaén;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;85,32
23 Jaén;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
23 Jaén;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
23 Jaén;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
23 Jaén;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;87,24
23 Jaén;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
23 Jaén;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
23 Jaén;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
23 Jaén;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
23 Jaén;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
23 Jaén;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QIV;7.076
23 Jaén;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
23 Jaén;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
23 Jaén;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
23 Jaén;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QIV;7.290
23 Jaén;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
23 Jaén;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
23 Jaén;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
23 Jaén;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QIV;7.327
23 Jaén;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
23 Jaén;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
23 Jaén;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
23 Jaén;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2022QIV;6.734
23 Jaén;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
23 Jaén;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2022QII;""
23 Jaén;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2022QI;""
23 Jaén;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2021QIV;6.951
23 Jaén;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
23 Jaén;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2021QII;""
23 Jaén;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2021QI;""
23 Jaén;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2020QIV;6.988
23 Jaén;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
23 Jaén;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2020QII;""
23 Jaén;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2020QI;""
23 Jaén;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
23 Jaén;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
23 Jaén;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2022QII;""
23 Jaén;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2022QI;6.713
23 Jaén;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
23 Jaén;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
23 Jaén;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2021QII;""
23 Jaén;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2021QI;6.822
23 Jaén;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
23 Jaén;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
23 Jaén;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2020QII;""
23 Jaén;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2020QI;""
23 Jaén;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
23 Jaén;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
23 Jaén;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QII;6.464
23 Jaén;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QI;""
23 Jaén;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
23 Jaén;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
23 Jaén;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QII;6.639
23 Jaén;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QI;""
23 Jaén;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
23 Jaén;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
23 Jaén;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QII;""
23 Jaén;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QI;""
23 Jaén;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
23 Jaén;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QIII;6.260
23 Jaén;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QII;""
23 Jaén;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QI;""
23 Jaén;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
23 Jaén;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QIII;6.479
23 Jaén;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QII;""
23 Jaén;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QI;""
23 Jaén;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
23 Jaén;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
23 Jaén;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QII;""
23 Jaén;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QI;""
23 Jaén;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
23 Jaén;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
23 Jaén;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
23 Jaén;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
23 Jaén;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
23 Jaén;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
23 Jaén;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
23 Jaén;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
23 Jaén;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
23 Jaén;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
23 Jaén;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
23 Jaén;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
23 Jaén;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;95,17
23 Jaén;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
23 Jaén;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
23 Jaén;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
23 Jaén;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;95,35
23 Jaén;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
23 Jaén;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
23 Jaén;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
23 Jaén;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;95,37
23 Jaén;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
23 Jaén;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
23 Jaén;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
23 Jaén;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
23 Jaén;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
23 Jaén;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
23 Jaén;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;92,09
23 Jaén;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
23 Jaén;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
23 Jaén;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
23 Jaén;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;93,11
23 Jaén;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
23 Jaén;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
23 Jaén;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
23 Jaén;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
23 Jaén;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
23 Jaén;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
23 Jaén;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;88,67
23 Jaén;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
23 Jaén;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
23 Jaén;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
23 Jaén;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;90,61
23 Jaén;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
23 Jaén;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
23 Jaén;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
23 Jaén;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
23 Jaén;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
23 Jaén;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
23 Jaén;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;85,87
23 Jaén;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
23 Jaén;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
23 Jaén;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
23 Jaén;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;88,43
23 Jaén;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
23 Jaén;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
23 Jaén;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
23 Jaén;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
23 Jaén;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
23 Jaén;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
23 Jaén;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QIV;4.245
23 Jaén;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
23 Jaén;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
23 Jaén;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
23 Jaén;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QIV;4.425
23 Jaén;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
23 Jaén;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
23 Jaén;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
23 Jaén;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QIV;4.521
23 Jaén;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
23 Jaén;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
23 Jaén;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
23 Jaén;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2022QIV;4.025
23 Jaén;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
23 Jaén;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2022QII;""
23 Jaén;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2022QI;""
23 Jaén;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2021QIV;4.211
23 Jaén;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
23 Jaén;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2021QII;""
23 Jaén;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2021QI;""
23 Jaén;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2020QIV;4.290
23 Jaén;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
23 Jaén;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2020QII;""
23 Jaén;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2020QI;""
23 Jaén;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
23 Jaén;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
23 Jaén;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2022QII;""
23 Jaén;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2022QI;4.070
23 Jaén;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
23 Jaén;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
23 Jaén;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2021QII;""
23 Jaén;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2021QI;4.199
23 Jaén;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
23 Jaén;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
23 Jaén;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2020QII;""
23 Jaén;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2020QI;""
23 Jaén;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
23 Jaén;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
23 Jaén;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QII;3.941
23 Jaén;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QI;""
23 Jaén;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
23 Jaén;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
23 Jaén;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QII;4.108
23 Jaén;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QI;""
23 Jaén;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
23 Jaén;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
23 Jaén;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QII;""
23 Jaén;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QI;""
23 Jaén;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
23 Jaén;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QIII;3.842
23 Jaén;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QII;""
23 Jaén;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QI;""
23 Jaén;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
23 Jaén;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QIII;4.014
23 Jaén;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QII;""
23 Jaén;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QI;""
23 Jaén;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
23 Jaén;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
23 Jaén;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QII;""
23 Jaén;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QI;""
23 Jaén;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
23 Jaén;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
23 Jaén;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
23 Jaén;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
23 Jaén;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
23 Jaén;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
23 Jaén;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
23 Jaén;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
23 Jaén;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
23 Jaén;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
23 Jaén;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
23 Jaén;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
23 Jaén;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;94,82
23 Jaén;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
23 Jaén;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
23 Jaén;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
23 Jaén;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;95,16
23 Jaén;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
23 Jaén;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
23 Jaén;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
23 Jaén;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;94,89
23 Jaén;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
23 Jaén;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
23 Jaén;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
23 Jaén;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
23 Jaén;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
23 Jaén;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
23 Jaén;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;91,98
23 Jaén;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
23 Jaén;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
23 Jaén;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
23 Jaén;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;92,88
23 Jaén;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
23 Jaén;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
23 Jaén;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
23 Jaén;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
23 Jaén;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
23 Jaén;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
23 Jaén;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;89,06
23 Jaén;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
23 Jaén;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
23 Jaén;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
23 Jaén;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;90,86
23 Jaén;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
23 Jaén;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
23 Jaén;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
23 Jaén;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
23 Jaén;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
23 Jaén;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
23 Jaén;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;86,82
23 Jaén;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
23 Jaén;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
23 Jaén;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
23 Jaén;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;88,79
23 Jaén;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
23 Jaén;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
23 Jaén;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
23 Jaén;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
23 Jaén;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
23 Jaén;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
23 Jaén;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QIV;2.831
23 Jaén;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
23 Jaén;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
23 Jaén;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
23 Jaén;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QIV;2.865
23 Jaén;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
23 Jaén;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
23 Jaén;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
23 Jaén;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QIV;2.806
23 Jaén;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
23 Jaén;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
23 Jaén;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
23 Jaén;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2022QIV;2.709
23 Jaén;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
23 Jaén;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2022QII;""
23 Jaén;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2022QI;""
23 Jaén;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2021QIV;2.740
23 Jaén;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
23 Jaén;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2021QII;""
23 Jaén;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2021QI;""
23 Jaén;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2020QIV;2.698
23 Jaén;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
23 Jaén;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2020QII;""
23 Jaén;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2020QI;""
23 Jaén;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
23 Jaén;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
23 Jaén;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2022QII;""
23 Jaén;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2022QI;2.643
23 Jaén;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
23 Jaén;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
23 Jaén;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2021QII;""
23 Jaén;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2021QI;2.623
23 Jaén;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
23 Jaén;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
23 Jaén;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2020QII;""
23 Jaén;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2020QI;""
23 Jaén;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
23 Jaén;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
23 Jaén;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QII;2.523
23 Jaén;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QI;""
23 Jaén;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
23 Jaén;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
23 Jaén;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QII;2.531
23 Jaén;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QI;""
23 Jaén;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
23 Jaén;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
23 Jaén;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QII;""
23 Jaén;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QI;""
23 Jaén;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
23 Jaén;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QIII;2.418
23 Jaén;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QII;""
23 Jaén;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QI;""
23 Jaén;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
23 Jaén;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QIII;2.465
23 Jaén;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QII;""
23 Jaén;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QI;""
23 Jaén;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
23 Jaén;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
23 Jaén;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QII;""
23 Jaén;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QI;""
23 Jaén;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
23 Jaén;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
23 Jaén;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
23 Jaén;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
23 Jaén;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
23 Jaén;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
23 Jaén;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
23 Jaén;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
23 Jaén;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
23 Jaén;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
23 Jaén;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
23 Jaén;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
23 Jaén;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;95,69
23 Jaén;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
23 Jaén;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
23 Jaén;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
23 Jaén;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;95,64
23 Jaén;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
23 Jaén;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
23 Jaén;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
23 Jaén;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;96,15
23 Jaén;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
23 Jaén;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
23 Jaén;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
23 Jaén;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
23 Jaén;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
23 Jaén;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
23 Jaén;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;92,25
23 Jaén;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
23 Jaén;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
23 Jaén;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
23 Jaén;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;93,48
23 Jaén;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
23 Jaén;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
23 Jaén;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
23 Jaén;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
23 Jaén;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
23 Jaén;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
23 Jaén;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;88,06
23 Jaén;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
23 Jaén;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
23 Jaén;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
23 Jaén;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;90,2
23 Jaén;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
23 Jaén;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
23 Jaén;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
23 Jaén;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
23 Jaén;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
23 Jaén;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
23 Jaén;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;84,4
23 Jaén;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
23 Jaén;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
23 Jaén;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
23 Jaén;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;87,85
23 Jaén;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
23 Jaén;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
23 Jaén;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
23 Jaén;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
23 Jaén;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
23 Jaén;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
23 Jaén;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
23 Jaén;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
23 Jaén;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
23 Jaén;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QI;10.565
23 Jaén;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
23 Jaén;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
23 Jaén;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
23 Jaén;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QI;10.623
23 Jaén;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
23 Jaén;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
23 Jaén;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
23 Jaén;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QI;10.745
23 Jaén;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
23 Jaén;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
23 Jaén;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2022QII;""
23 Jaén;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2022QI;10.282
23 Jaén;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
23 Jaén;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
23 Jaén;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2021QII;""
23 Jaén;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2021QI;10.424
23 Jaén;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
23 Jaén;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
23 Jaén;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2020QII;""
23 Jaén;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2020QI;10.094
23 Jaén;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
23 Jaén;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
23 Jaén;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2022QII;9.982
23 Jaén;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2022QI;""
23 Jaén;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
23 Jaén;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
23 Jaén;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2021QII;10.159
23 Jaén;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2021QI;""
23 Jaén;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
23 Jaén;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
23 Jaén;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2020QII;9.954
23 Jaén;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2020QI;""
23 Jaén;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
23 Jaén;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QIII;9.763
23 Jaén;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QII;""
23 Jaén;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QI;""
23 Jaén;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
23 Jaén;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QIII;9.991
23 Jaén;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QII;""
23 Jaén;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QI;""
23 Jaén;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
23 Jaén;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QIII;9.747
23 Jaén;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QII;""
23 Jaén;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QI;""
23 Jaén;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QIV;9.529
23 Jaén;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
23 Jaén;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QII;""
23 Jaén;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QI;""
23 Jaén;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QIV;9.756
23 Jaén;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
23 Jaén;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QII;""
23 Jaén;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QI;""
23 Jaén;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QIV;9.522
23 Jaén;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
23 Jaén;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QII;""
23 Jaén;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QI;""
23 Jaén;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
23 Jaén;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
23 Jaén;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
23 Jaén;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
23 Jaén;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
23 Jaén;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
23 Jaén;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
23 Jaén;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
23 Jaén;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
23 Jaén;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
23 Jaén;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
23 Jaén;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
23 Jaén;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
23 Jaén;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
23 Jaén;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
23 Jaén;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;97,32
23 Jaén;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
23 Jaén;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
23 Jaén;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
23 Jaén;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;98,13
23 Jaén;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
23 Jaén;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
23 Jaén;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
23 Jaén;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;93,94
23 Jaén;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
23 Jaén;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
23 Jaén;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;94,48
23 Jaén;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
23 Jaén;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
23 Jaén;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
23 Jaén;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;95,63
23 Jaén;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
23 Jaén;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
23 Jaén;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
23 Jaén;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;92,64
23 Jaén;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
23 Jaén;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
23 Jaén;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;92,41
23 Jaén;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
23 Jaén;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
23 Jaén;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
23 Jaén;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;94,05
23 Jaén;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
23 Jaén;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
23 Jaén;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
23 Jaén;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;90,71
23 Jaén;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
23 Jaén;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
23 Jaén;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;90,19
23 Jaén;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
23 Jaén;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
23 Jaén;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
23 Jaén;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;91,84
23 Jaén;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
23 Jaén;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
23 Jaén;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
23 Jaén;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;88,62
23 Jaén;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
23 Jaén;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
23 Jaén;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
23 Jaén;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
23 Jaén;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
23 Jaén;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
23 Jaén;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QI;6.872
23 Jaén;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
23 Jaén;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
23 Jaén;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
23 Jaén;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QI;6.930
23 Jaén;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
23 Jaén;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
23 Jaén;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
23 Jaén;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QI;6.996
23 Jaén;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
23 Jaén;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
23 Jaén;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2022QII;""
23 Jaén;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2022QI;6.699
23 Jaén;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
23 Jaén;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
23 Jaén;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2021QII;""
23 Jaén;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2021QI;6.806
23 Jaén;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
23 Jaén;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
23 Jaén;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2020QII;""
23 Jaén;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2020QI;6.589
23 Jaén;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
23 Jaén;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
23 Jaén;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2022QII;6.527
23 Jaén;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2022QI;""
23 Jaén;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
23 Jaén;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
23 Jaén;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2021QII;6.659
23 Jaén;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2021QI;""
23 Jaén;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
23 Jaén;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
23 Jaén;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2020QII;6.516
23 Jaén;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2020QI;""
23 Jaén;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
23 Jaén;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QIII;6.410
23 Jaén;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QII;""
23 Jaén;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QI;""
23 Jaén;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
23 Jaén;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QIII;6.558
23 Jaén;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QII;""
23 Jaén;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QI;""
23 Jaén;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
23 Jaén;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QIII;6.412
23 Jaén;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QII;""
23 Jaén;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QI;""
23 Jaén;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QIV;6.269
23 Jaén;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
23 Jaén;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QII;""
23 Jaén;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QI;""
23 Jaén;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QIV;6.395
23 Jaén;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
23 Jaén;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QII;""
23 Jaén;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QI;""
23 Jaén;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QIV;6.274
23 Jaén;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
23 Jaén;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QII;""
23 Jaén;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QI;""
23 Jaén;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
23 Jaén;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
23 Jaén;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
23 Jaén;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
23 Jaén;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
23 Jaén;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
23 Jaén;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
23 Jaén;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
23 Jaén;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
23 Jaén;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
23 Jaén;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
23 Jaén;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
23 Jaén;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
23 Jaén;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
23 Jaén;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
23 Jaén;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;97,48
23 Jaén;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
23 Jaén;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
23 Jaén;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
23 Jaén;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;98,21
23 Jaén;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
23 Jaén;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
23 Jaén;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
23 Jaén;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;94,18
23 Jaén;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
23 Jaén;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
23 Jaén;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;94,98
23 Jaén;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
23 Jaén;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
23 Jaén;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
23 Jaén;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;96,09
23 Jaén;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
23 Jaén;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
23 Jaén;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
23 Jaén;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;93,14
23 Jaén;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
23 Jaén;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
23 Jaén;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;93,28
23 Jaén;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
23 Jaén;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
23 Jaén;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
23 Jaén;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;94,63
23 Jaén;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
23 Jaén;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
23 Jaén;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
23 Jaén;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;91,65
23 Jaén;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
23 Jaén;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
23 Jaén;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;91,23
23 Jaén;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
23 Jaén;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
23 Jaén;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
23 Jaén;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;92,28
23 Jaén;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
23 Jaén;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
23 Jaén;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
23 Jaén;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;89,68
23 Jaén;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
23 Jaén;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
23 Jaén;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
23 Jaén;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
23 Jaén;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
23 Jaén;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
23 Jaén;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QI;3.693
23 Jaén;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
23 Jaén;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
23 Jaén;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
23 Jaén;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QI;3.693
23 Jaén;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
23 Jaén;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
23 Jaén;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
23 Jaén;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QI;3.749
23 Jaén;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
23 Jaén;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
23 Jaén;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2022QII;""
23 Jaén;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2022QI;3.583
23 Jaén;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
23 Jaén;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
23 Jaén;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2021QII;""
23 Jaén;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2021QI;3.618
23 Jaén;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
23 Jaén;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
23 Jaén;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2020QII;""
23 Jaén;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2020QI;3.505
23 Jaén;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
23 Jaén;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
23 Jaén;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2022QII;3.455
23 Jaén;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2022QI;""
23 Jaén;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
23 Jaén;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
23 Jaén;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2021QII;3.500
23 Jaén;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2021QI;""
23 Jaén;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
23 Jaén;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
23 Jaén;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2020QII;3.438
23 Jaén;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2020QI;""
23 Jaén;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
23 Jaén;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QIII;3.353
23 Jaén;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QII;""
23 Jaén;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QI;""
23 Jaén;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
23 Jaén;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QIII;3.433
23 Jaén;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QII;""
23 Jaén;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QI;""
23 Jaén;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
23 Jaén;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QIII;3.335
23 Jaén;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QII;""
23 Jaén;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QI;""
23 Jaén;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QIV;3.260
23 Jaén;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
23 Jaén;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QII;""
23 Jaén;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QI;""
23 Jaén;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QIV;3.361
23 Jaén;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
23 Jaén;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QII;""
23 Jaén;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QI;""
23 Jaén;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QIV;3.248
23 Jaén;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
23 Jaén;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QII;""
23 Jaén;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QI;""
23 Jaén;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
23 Jaén;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
23 Jaén;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
23 Jaén;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
23 Jaén;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
23 Jaén;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
23 Jaén;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
23 Jaén;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
23 Jaén;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
23 Jaén;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
23 Jaén;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
23 Jaén;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
23 Jaén;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
23 Jaén;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
23 Jaén;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
23 Jaén;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;97,02
23 Jaén;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
23 Jaén;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
23 Jaén;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
23 Jaén;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;97,97
23 Jaén;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
23 Jaén;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
23 Jaén;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
23 Jaén;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;93,49
23 Jaén;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
23 Jaén;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
23 Jaén;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;93,56
23 Jaén;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
23 Jaén;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
23 Jaén;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
23 Jaén;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;94,77
23 Jaén;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
23 Jaén;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
23 Jaén;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
23 Jaén;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;91,7
23 Jaén;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
23 Jaén;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
23 Jaén;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;90,79
23 Jaén;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
23 Jaén;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
23 Jaén;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
23 Jaén;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;92,96
23 Jaén;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
23 Jaén;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
23 Jaén;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
23 Jaén;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;88,96
23 Jaén;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
23 Jaén;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
23 Jaén;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;88,28
23 Jaén;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
23 Jaén;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
23 Jaén;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
23 Jaén;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;91,01
23 Jaén;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
23 Jaén;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
23 Jaén;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
23 Jaén;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;86,64
23 Jaén;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
23 Jaén;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
23 Jaén;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
23 Jaén;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
23 Jaén;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
23 Jaén;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QII;10.509
23 Jaén;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
23 Jaén;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
23 Jaén;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
23 Jaén;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QII;10.541
23 Jaén;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
23 Jaén;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
23 Jaén;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
23 Jaén;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QII;10.483
23 Jaén;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
23 Jaén;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
23 Jaén;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
23 Jaén;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2022QII;10.159
23 Jaén;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2022QI;""
23 Jaén;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
23 Jaén;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
23 Jaén;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2021QII;10.251
23 Jaén;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2021QI;""
23 Jaén;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
23 Jaén;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
23 Jaén;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2020QII;10.318
23 Jaén;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2020QI;""
23 Jaén;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
23 Jaén;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2022QIII;9.894
23 Jaén;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2022QII;""
23 Jaén;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2022QI;""
23 Jaén;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
23 Jaén;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2021QIII;10.070
23 Jaén;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2021QII;""
23 Jaén;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2021QI;""
23 Jaén;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
23 Jaén;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2020QIII;10.079
23 Jaén;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2020QII;""
23 Jaén;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2020QI;""
23 Jaén;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QIV;9.606
23 Jaén;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
23 Jaén;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QII;""
23 Jaén;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QI;""
23 Jaén;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QIV;9.791
23 Jaén;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
23 Jaén;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QII;""
23 Jaén;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QI;""
23 Jaén;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QIV;9.821
23 Jaén;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
23 Jaén;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QII;""
23 Jaén;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QI;""
23 Jaén;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
23 Jaén;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
23 Jaén;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QII;""
23 Jaén;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QI;9.578
23 Jaén;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
23 Jaén;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
23 Jaén;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QII;""
23 Jaén;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QI;9.678
23 Jaén;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
23 Jaén;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
23 Jaén;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QII;""
23 Jaén;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QI;""
23 Jaén;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
23 Jaén;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
23 Jaén;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
23 Jaén;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
23 Jaén;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
23 Jaén;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
23 Jaén;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
23 Jaén;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
23 Jaén;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
23 Jaén;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
23 Jaén;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
23 Jaén;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
23 Jaén;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
23 Jaén;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
23 Jaén;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;96,67
23 Jaén;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
23 Jaén;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
23 Jaén;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
23 Jaén;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;97,25
23 Jaén;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
23 Jaén;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
23 Jaén;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
23 Jaén;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;98,43
23 Jaén;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
23 Jaén;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
23 Jaén;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;94,15
23 Jaén;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
23 Jaén;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
23 Jaén;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
23 Jaén;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;95,53
23 Jaén;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
23 Jaén;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
23 Jaén;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
23 Jaén;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;96,15
23 Jaén;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
23 Jaén;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
23 Jaén;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;91,41
23 Jaén;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
23 Jaén;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
23 Jaén;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
23 Jaén;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;92,88
23 Jaén;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
23 Jaén;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
23 Jaén;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
23 Jaén;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;93,69
23 Jaén;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
23 Jaén;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
23 Jaén;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
23 Jaén;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
23 Jaén;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
23 Jaén;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
23 Jaén;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;90,86
23 Jaén;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
23 Jaén;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
23 Jaén;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
23 Jaén;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;92,32
23 Jaén;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
23 Jaén;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
23 Jaén;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
23 Jaén;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
23 Jaén;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
23 Jaén;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
23 Jaén;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QII;6.807
23 Jaén;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
23 Jaén;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
23 Jaén;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
23 Jaén;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QII;6.883
23 Jaén;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
23 Jaén;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
23 Jaén;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
23 Jaén;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QII;6.821
23 Jaén;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
23 Jaén;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
23 Jaén;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
23 Jaén;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2022QII;6.602
23 Jaén;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2022QI;""
23 Jaén;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
23 Jaén;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
23 Jaén;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2021QII;6.721
23 Jaén;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2021QI;""
23 Jaén;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
23 Jaén;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
23 Jaén;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2020QII;6.733
23 Jaén;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2020QI;""
23 Jaén;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
23 Jaén;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2022QIII;6.468
23 Jaén;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2022QII;""
23 Jaén;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2022QI;""
23 Jaén;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
23 Jaén;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2021QIII;6.615
23 Jaén;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2021QII;""
23 Jaén;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2021QI;""
23 Jaén;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
23 Jaén;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2020QIII;6.610
23 Jaén;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2020QII;""
23 Jaén;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2020QI;""
23 Jaén;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QIV;6.287
23 Jaén;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
23 Jaén;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QII;""
23 Jaén;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QI;""
23 Jaén;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QIV;6.421
23 Jaén;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
23 Jaén;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QII;""
23 Jaén;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QI;""
23 Jaén;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QIV;6.450
23 Jaén;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
23 Jaén;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QII;""
23 Jaén;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QI;""
23 Jaén;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
23 Jaén;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
23 Jaén;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QII;""
23 Jaén;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QI;6.292
23 Jaén;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
23 Jaén;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
23 Jaén;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QII;""
23 Jaén;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QI;6.367
23 Jaén;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
23 Jaén;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
23 Jaén;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QII;""
23 Jaén;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QI;""
23 Jaén;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
23 Jaén;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
23 Jaén;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
23 Jaén;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
23 Jaén;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
23 Jaén;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
23 Jaén;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
23 Jaén;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
23 Jaén;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
23 Jaén;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
23 Jaén;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
23 Jaén;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
23 Jaén;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
23 Jaén;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
23 Jaén;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;96,99
23 Jaén;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
23 Jaén;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
23 Jaén;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
23 Jaén;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;97,65
23 Jaén;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
23 Jaén;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
23 Jaén;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
23 Jaén;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;98,71
23 Jaén;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
23 Jaén;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
23 Jaén;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;95,02
23 Jaén;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
23 Jaén;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
23 Jaén;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
23 Jaén;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;96,11
23 Jaén;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
23 Jaén;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
23 Jaén;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
23 Jaén;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;96,91
23 Jaén;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
23 Jaén;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
23 Jaén;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;92,36
23 Jaén;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
23 Jaén;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
23 Jaén;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
23 Jaén;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;93,29
23 Jaén;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
23 Jaén;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
23 Jaén;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
23 Jaén;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;94,56
23 Jaén;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
23 Jaén;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
23 Jaén;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
23 Jaén;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
23 Jaén;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
23 Jaén;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
23 Jaén;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;91,41
23 Jaén;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
23 Jaén;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
23 Jaén;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
23 Jaén;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;93,34
23 Jaén;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
23 Jaén;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
23 Jaén;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
23 Jaén;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
23 Jaén;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
23 Jaén;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
23 Jaén;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QII;3.702
23 Jaén;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
23 Jaén;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
23 Jaén;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
23 Jaén;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QII;3.658
23 Jaén;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
23 Jaén;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
23 Jaén;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
23 Jaén;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QII;3.662
23 Jaén;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
23 Jaén;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
23 Jaén;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
23 Jaén;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2022QII;3.557
23 Jaén;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2022QI;""
23 Jaén;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
23 Jaén;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
23 Jaén;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2021QII;3.530
23 Jaén;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2021QI;""
23 Jaén;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
23 Jaén;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
23 Jaén;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2020QII;3.585
23 Jaén;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2020QI;""
23 Jaén;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
23 Jaén;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2022QIII;3.426
23 Jaén;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2022QII;""
23 Jaén;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2022QI;""
23 Jaén;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
23 Jaén;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2021QIII;3.455
23 Jaén;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2021QII;""
23 Jaén;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2021QI;""
23 Jaén;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
23 Jaén;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2020QIII;3.469
23 Jaén;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2020QII;""
23 Jaén;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2020QI;""
23 Jaén;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QIV;3.319
23 Jaén;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
23 Jaén;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QII;""
23 Jaén;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QI;""
23 Jaén;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QIV;3.370
23 Jaén;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
23 Jaén;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QII;""
23 Jaén;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QI;""
23 Jaén;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QIV;3.371
23 Jaén;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
23 Jaén;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QII;""
23 Jaén;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QI;""
23 Jaén;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
23 Jaén;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
23 Jaén;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QII;""
23 Jaén;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QI;3.286
23 Jaén;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
23 Jaén;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
23 Jaén;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QII;""
23 Jaén;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QI;3.311
23 Jaén;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
23 Jaén;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
23 Jaén;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QII;""
23 Jaén;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QI;""
23 Jaén;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
23 Jaén;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
23 Jaén;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
23 Jaén;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
23 Jaén;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
23 Jaén;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
23 Jaén;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
23 Jaén;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
23 Jaén;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
23 Jaén;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
23 Jaén;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
23 Jaén;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
23 Jaén;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
23 Jaén;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
23 Jaén;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;96,08
23 Jaén;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
23 Jaén;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
23 Jaén;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
23 Jaén;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;96,5
23 Jaén;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
23 Jaén;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
23 Jaén;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
23 Jaén;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;97,9
23 Jaén;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
23 Jaén;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
23 Jaén;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;92,54
23 Jaén;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
23 Jaén;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
23 Jaén;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
23 Jaén;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;94,45
23 Jaén;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
23 Jaén;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
23 Jaén;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
23 Jaén;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;94,73
23 Jaén;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
23 Jaén;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
23 Jaén;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;89,65
23 Jaén;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
23 Jaén;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
23 Jaén;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
23 Jaén;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;92,13
23 Jaén;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
23 Jaén;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
23 Jaén;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
23 Jaén;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;92,05
23 Jaén;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
23 Jaén;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
23 Jaén;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
23 Jaén;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
23 Jaén;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
23 Jaén;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
23 Jaén;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;89,83
23 Jaén;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
23 Jaén;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
23 Jaén;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
23 Jaén;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;90,42
23 Jaén;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
23 Jaén;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
23 Jaén;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
23 Jaén;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
23 Jaén;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
23 Jaén;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QIII;10.589
23 Jaén;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
23 Jaén;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
23 Jaén;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
23 Jaén;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QIII;10.710
23 Jaén;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
23 Jaén;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
23 Jaén;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
23 Jaén;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QIII;10.697
23 Jaén;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
23 Jaén;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
23 Jaén;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
23 Jaén;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2022QIII;10.242
23 Jaén;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2022QII;""
23 Jaén;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2022QI;""
23 Jaén;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
23 Jaén;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2021QIII;10.458
23 Jaén;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2021QII;""
23 Jaén;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2021QI;""
23 Jaén;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
23 Jaén;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2020QIII;10.396
23 Jaén;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2020QII;""
23 Jaén;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2020QI;""
23 Jaén;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2022QIV;9.873
23 Jaén;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
23 Jaén;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2022QII;""
23 Jaén;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2022QI;""
23 Jaén;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2021QIV;10.084
23 Jaén;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
23 Jaén;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2021QII;""
23 Jaén;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2021QI;""
23 Jaén;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2020QIV;10.069
23 Jaén;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
23 Jaén;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2020QII;""
23 Jaén;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2020QI;""
23 Jaén;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
23 Jaén;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
23 Jaén;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QII;""
23 Jaén;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QI;9.858
23 Jaén;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
23 Jaén;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
23 Jaén;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QII;""
23 Jaén;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QI;9.915
23 Jaén;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
23 Jaén;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
23 Jaén;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QII;""
23 Jaén;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QI;""
23 Jaén;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
23 Jaén;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
23 Jaén;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QII;9.609
23 Jaén;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QI;""
23 Jaén;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
23 Jaén;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
23 Jaén;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QII;9.707
23 Jaén;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QI;""
23 Jaén;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
23 Jaén;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
23 Jaén;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QII;""
23 Jaén;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QI;""
23 Jaén;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
23 Jaén;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
23 Jaén;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
23 Jaén;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
23 Jaén;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
23 Jaén;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
23 Jaén;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
23 Jaén;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
23 Jaén;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
23 Jaén;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
23 Jaén;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
23 Jaén;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
23 Jaén;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
23 Jaén;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;96,72
23 Jaén;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
23 Jaén;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
23 Jaén;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
23 Jaén;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;97,65
23 Jaén;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
23 Jaén;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
23 Jaén;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
23 Jaén;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;97,19
23 Jaén;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
23 Jaén;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
23 Jaén;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;93,24
23 Jaén;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
23 Jaén;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
23 Jaén;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
23 Jaén;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;94,15
23 Jaén;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
23 Jaén;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
23 Jaén;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
23 Jaén;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;94,13
23 Jaén;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
23 Jaén;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
23 Jaén;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
23 Jaén;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
23 Jaén;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
23 Jaén;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
23 Jaén;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;92,04
23 Jaén;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
23 Jaén;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
23 Jaén;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
23 Jaén;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;92,69
23 Jaén;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
23 Jaén;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
23 Jaén;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
23 Jaén;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
23 Jaén;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
23 Jaén;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
23 Jaén;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;89,72
23 Jaén;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
23 Jaén;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
23 Jaén;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
23 Jaén;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;90,75
23 Jaén;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
23 Jaén;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
23 Jaén;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
23 Jaén;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
23 Jaén;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
23 Jaén;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
23 Jaén;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QIII;6.881
23 Jaén;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
23 Jaén;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
23 Jaén;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
23 Jaén;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QIII;7.030
23 Jaén;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
23 Jaén;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
23 Jaén;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
23 Jaén;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QIII;6.992
23 Jaén;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
23 Jaén;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
23 Jaén;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
23 Jaén;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2022QIII;6.690
23 Jaén;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2022QII;""
23 Jaén;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2022QI;""
23 Jaén;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
23 Jaén;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2021QIII;6.879
23 Jaén;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2021QII;""
23 Jaén;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2021QI;""
23 Jaén;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
23 Jaén;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2020QIII;6.822
23 Jaén;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2020QII;""
23 Jaén;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2020QI;""
23 Jaén;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2022QIV;6.448
23 Jaén;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
23 Jaén;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2022QII;""
23 Jaén;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2022QI;""
23 Jaén;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2021QIV;6.600
23 Jaén;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
23 Jaén;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2021QII;""
23 Jaén;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2021QI;""
23 Jaén;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2020QIV;6.598
23 Jaén;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
23 Jaén;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2020QII;""
23 Jaén;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2020QI;""
23 Jaén;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
23 Jaén;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
23 Jaén;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QII;""
23 Jaén;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QI;6.464
23 Jaén;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
23 Jaén;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
23 Jaén;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QII;""
23 Jaén;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QI;6.507
23 Jaén;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
23 Jaén;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
23 Jaén;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QII;""
23 Jaén;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QI;""
23 Jaén;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
23 Jaén;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
23 Jaén;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QII;6.315
23 Jaén;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QI;""
23 Jaén;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
23 Jaén;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
23 Jaén;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QII;6.391
23 Jaén;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QI;""
23 Jaén;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
23 Jaén;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
23 Jaén;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QII;""
23 Jaén;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QI;""
23 Jaén;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
23 Jaén;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
23 Jaén;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
23 Jaén;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
23 Jaén;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
23 Jaén;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
23 Jaén;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
23 Jaén;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
23 Jaén;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
23 Jaén;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
23 Jaén;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
23 Jaén;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
23 Jaén;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
23 Jaén;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;97,22
23 Jaén;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
23 Jaén;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
23 Jaén;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
23 Jaén;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;97,85
23 Jaén;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
23 Jaén;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
23 Jaén;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
23 Jaén;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;97,57
23 Jaén;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
23 Jaén;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
23 Jaén;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;93,71
23 Jaén;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
23 Jaén;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
23 Jaén;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
23 Jaén;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;93,88
23 Jaén;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
23 Jaén;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
23 Jaén;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
23 Jaén;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;94,36
23 Jaén;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
23 Jaén;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
23 Jaén;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
23 Jaén;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
23 Jaén;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
23 Jaén;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
23 Jaén;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;91,95
23 Jaén;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
23 Jaén;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
23 Jaén;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
23 Jaén;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;93,06
23 Jaén;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
23 Jaén;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
23 Jaén;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
23 Jaén;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
23 Jaén;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
23 Jaén;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
23 Jaén;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;89,83
23 Jaén;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
23 Jaén;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
23 Jaén;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
23 Jaén;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;91,4
23 Jaén;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
23 Jaén;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
23 Jaén;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
23 Jaén;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
23 Jaén;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
23 Jaén;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
23 Jaén;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QIII;3.708
23 Jaén;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
23 Jaén;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
23 Jaén;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
23 Jaén;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QIII;3.680
23 Jaén;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
23 Jaén;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
23 Jaén;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
23 Jaén;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QIII;3.705
23 Jaén;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
23 Jaén;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
23 Jaén;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
23 Jaén;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2022QIII;3.552
23 Jaén;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2022QII;""
23 Jaén;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2022QI;""
23 Jaén;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
23 Jaén;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2021QIII;3.579
23 Jaén;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2021QII;""
23 Jaén;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2021QI;""
23 Jaén;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
23 Jaén;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2020QIII;3.574
23 Jaén;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2020QII;""
23 Jaén;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2020QI;""
23 Jaén;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2022QIV;3.425
23 Jaén;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
23 Jaén;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2022QII;""
23 Jaén;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2022QI;""
23 Jaén;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2021QIV;3.484
23 Jaén;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
23 Jaén;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2021QII;""
23 Jaén;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2021QI;""
23 Jaén;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2020QIV;3.471
23 Jaén;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
23 Jaén;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2020QII;""
23 Jaén;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2020QI;""
23 Jaén;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
23 Jaén;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
23 Jaén;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QII;""
23 Jaén;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QI;3.394
23 Jaén;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
23 Jaén;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
23 Jaén;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QII;""
23 Jaén;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QI;3.408
23 Jaén;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
23 Jaén;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
23 Jaén;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QII;""
23 Jaén;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QI;""
23 Jaén;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
23 Jaén;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
23 Jaén;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QII;3.294
23 Jaén;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QI;""
23 Jaén;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
23 Jaén;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
23 Jaén;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QII;3.316
23 Jaén;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QI;""
23 Jaén;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
23 Jaén;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
23 Jaén;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QII;""
23 Jaén;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QI;""
23 Jaén;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
23 Jaén;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
23 Jaén;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
23 Jaén;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
23 Jaén;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
23 Jaén;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
23 Jaén;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
23 Jaén;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
23 Jaén;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
23 Jaén;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
23 Jaén;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
23 Jaén;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
23 Jaén;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
23 Jaén;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;95,79
23 Jaén;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
23 Jaén;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
23 Jaén;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
23 Jaén;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;97,26
23 Jaén;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
23 Jaén;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
23 Jaén;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
23 Jaén;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;96,46
23 Jaén;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
23 Jaén;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
23 Jaén;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;92,37
23 Jaén;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
23 Jaén;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
23 Jaén;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
23 Jaén;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;94,67
23 Jaén;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
23 Jaén;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
23 Jaén;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
23 Jaén;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;93,68
23 Jaén;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
23 Jaén;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
23 Jaén;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
23 Jaén;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
23 Jaén;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
23 Jaén;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
23 Jaén;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;92,23
23 Jaén;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
23 Jaén;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
23 Jaén;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
23 Jaén;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;91,98
23 Jaén;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
23 Jaén;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
23 Jaén;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
23 Jaén;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
23 Jaén;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
23 Jaén;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
23 Jaén;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;89,51
23 Jaén;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
23 Jaén;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
23 Jaén;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
23 Jaén;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;89,5
23 Jaén;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
23 Jaén;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
23 Jaén;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
23 Jaén;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
23 Jaén;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
23 Jaén;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QIV;10.502
23 Jaén;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
23 Jaén;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
23 Jaén;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
23 Jaén;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QIV;10.716
23 Jaén;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
23 Jaén;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
23 Jaén;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
23 Jaén;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QIV;10.716
23 Jaén;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
23 Jaén;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
23 Jaén;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
23 Jaén;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2022QIV;10.077
23 Jaén;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
23 Jaén;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2022QII;""
23 Jaén;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2022QI;""
23 Jaén;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2021QIV;10.276
23 Jaén;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
23 Jaén;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2021QII;""
23 Jaén;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2021QI;""
23 Jaén;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2020QIV;10.321
23 Jaén;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
23 Jaén;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2020QII;""
23 Jaén;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2020QI;""
23 Jaén;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
23 Jaén;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
23 Jaén;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2022QII;""
23 Jaén;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2022QI;10.027
23 Jaén;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
23 Jaén;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
23 Jaén;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2021QII;""
23 Jaén;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2021QI;10.152
23 Jaén;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
23 Jaén;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
23 Jaén;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2020QII;""
23 Jaén;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2020QI;""
23 Jaén;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
23 Jaén;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
23 Jaén;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QII;9.760
23 Jaén;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QI;""
23 Jaén;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
23 Jaén;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
23 Jaén;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QII;9.925
23 Jaén;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QI;""
23 Jaén;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
23 Jaén;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
23 Jaén;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QII;""
23 Jaén;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QI;""
23 Jaén;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
23 Jaén;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QIII;9.560
23 Jaén;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QII;""
23 Jaén;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QI;""
23 Jaén;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
23 Jaén;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QIII;9.771
23 Jaén;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QII;""
23 Jaén;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QI;""
23 Jaén;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
23 Jaén;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
23 Jaén;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QII;""
23 Jaén;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QI;""
23 Jaén;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
23 Jaén;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
23 Jaén;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
23 Jaén;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
23 Jaén;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
23 Jaén;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
23 Jaén;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
23 Jaén;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
23 Jaén;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
23 Jaén;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
23 Jaén;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
23 Jaén;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
23 Jaén;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;95,95
23 Jaén;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
23 Jaén;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
23 Jaén;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
23 Jaén;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;95,89
23 Jaén;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
23 Jaén;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
23 Jaén;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
23 Jaén;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;96,31
23 Jaén;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
23 Jaén;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
23 Jaén;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
23 Jaén;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
23 Jaén;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
23 Jaén;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
23 Jaén;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;93,57
23 Jaén;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
23 Jaén;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
23 Jaén;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
23 Jaén;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;94,74
23 Jaén;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
23 Jaén;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
23 Jaén;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
23 Jaén;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
23 Jaén;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
23 Jaén;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
23 Jaén;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;91,08
23 Jaén;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
23 Jaén;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
23 Jaén;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
23 Jaén;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;92,62
23 Jaén;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
23 Jaén;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
23 Jaén;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
23 Jaén;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
23 Jaén;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
23 Jaén;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
23 Jaén;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;89,21
23 Jaén;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
23 Jaén;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
23 Jaén;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
23 Jaén;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;91,18
23 Jaén;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
23 Jaén;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
23 Jaén;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
23 Jaén;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
23 Jaén;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
23 Jaén;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
23 Jaén;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QIV;6.839
23 Jaén;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
23 Jaén;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
23 Jaén;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
23 Jaén;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QIV;7.028
23 Jaén;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
23 Jaén;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
23 Jaén;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
23 Jaén;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QIV;7.019
23 Jaén;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
23 Jaén;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
23 Jaén;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
23 Jaén;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2022QIV;6.558
23 Jaén;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
23 Jaén;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2022QII;""
23 Jaén;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2022QI;""
23 Jaén;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2021QIV;6.705
23 Jaén;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
23 Jaén;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2021QII;""
23 Jaén;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2021QI;""
23 Jaén;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2020QIV;6.744
23 Jaén;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
23 Jaén;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2020QII;""
23 Jaén;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2020QI;""
23 Jaén;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
23 Jaén;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
23 Jaén;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2022QII;""
23 Jaén;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2022QI;6.553
23 Jaén;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
23 Jaén;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
23 Jaén;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2021QII;""
23 Jaén;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2021QI;6.641
23 Jaén;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
23 Jaén;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
23 Jaén;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2020QII;""
23 Jaén;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2020QI;""
23 Jaén;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
23 Jaén;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
23 Jaén;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QII;6.394
23 Jaén;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QI;""
23 Jaén;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
23 Jaén;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
23 Jaén;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QII;6.515
23 Jaén;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QI;""
23 Jaén;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
23 Jaén;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
23 Jaén;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QII;""
23 Jaén;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QI;""
23 Jaén;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
23 Jaén;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QIII;6.290
23 Jaén;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QII;""
23 Jaén;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QI;""
23 Jaén;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
23 Jaén;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QIII;6.422
23 Jaén;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QII;""
23 Jaén;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QI;""
23 Jaén;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
23 Jaén;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
23 Jaén;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QII;""
23 Jaén;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QI;""
23 Jaén;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
23 Jaén;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
23 Jaén;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
23 Jaén;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
23 Jaén;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
23 Jaén;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
23 Jaén;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
23 Jaén;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
23 Jaén;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
23 Jaén;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
23 Jaén;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
23 Jaén;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
23 Jaén;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;95,89
23 Jaén;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
23 Jaén;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
23 Jaén;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
23 Jaén;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;95,4
23 Jaén;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
23 Jaén;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
23 Jaén;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
23 Jaén;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;96,08
23 Jaén;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
23 Jaén;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
23 Jaén;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
23 Jaén;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
23 Jaén;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
23 Jaén;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
23 Jaén;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;93,24
23 Jaén;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
23 Jaén;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
23 Jaén;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
23 Jaén;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;94,61
23 Jaén;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
23 Jaén;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
23 Jaén;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
23 Jaén;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
23 Jaén;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
23 Jaén;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
23 Jaén;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;90,98
23 Jaén;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
23 Jaén;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
23 Jaén;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
23 Jaén;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;92,82
23 Jaén;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
23 Jaén;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
23 Jaén;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
23 Jaén;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
23 Jaén;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
23 Jaén;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
23 Jaén;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;89,5
23 Jaén;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
23 Jaén;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
23 Jaén;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
23 Jaén;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;91,49
23 Jaén;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
23 Jaén;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
23 Jaén;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
23 Jaén;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
23 Jaén;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
23 Jaén;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
23 Jaén;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QIV;3.663
23 Jaén;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
23 Jaén;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
23 Jaén;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
23 Jaén;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QIV;3.688
23 Jaén;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
23 Jaén;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
23 Jaén;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
23 Jaén;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QIV;3.697
23 Jaén;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
23 Jaén;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
23 Jaén;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
23 Jaén;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2022QIV;3.519
23 Jaén;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
23 Jaén;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2022QII;""
23 Jaén;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2022QI;""
23 Jaén;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2021QIV;3.571
23 Jaén;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
23 Jaén;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2021QII;""
23 Jaén;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2021QI;""
23 Jaén;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2020QIV;3.577
23 Jaén;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
23 Jaén;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2020QII;""
23 Jaén;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2020QI;""
23 Jaén;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
23 Jaén;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
23 Jaén;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2022QII;""
23 Jaén;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2022QI;3.474
23 Jaén;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
23 Jaén;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
23 Jaén;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2021QII;""
23 Jaén;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2021QI;3.511
23 Jaén;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
23 Jaén;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
23 Jaén;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2020QII;""
23 Jaén;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2020QI;""
23 Jaén;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
23 Jaén;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
23 Jaén;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QII;3.366
23 Jaén;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QI;""
23 Jaén;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
23 Jaén;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
23 Jaén;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QII;3.410
23 Jaén;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QI;""
23 Jaén;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
23 Jaén;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
23 Jaén;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QII;""
23 Jaén;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QI;""
23 Jaén;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
23 Jaén;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QIII;3.270
23 Jaén;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QII;""
23 Jaén;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QI;""
23 Jaén;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
23 Jaén;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QIII;3.349
23 Jaén;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QII;""
23 Jaén;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QI;""
23 Jaén;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
23 Jaén;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
23 Jaén;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QII;""
23 Jaén;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QI;""
23 Jaén;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
23 Jaén;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
23 Jaén;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
23 Jaén;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
23 Jaén;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
23 Jaén;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
23 Jaén;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
23 Jaén;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
23 Jaén;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
23 Jaén;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
23 Jaén;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
23 Jaén;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
23 Jaén;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;96,07
23 Jaén;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
23 Jaén;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
23 Jaén;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
23 Jaén;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;96,83
23 Jaén;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
23 Jaén;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
23 Jaén;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
23 Jaén;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;96,75
23 Jaén;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
23 Jaén;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
23 Jaén;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
23 Jaén;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
23 Jaén;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
23 Jaén;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
23 Jaén;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;94,2
23 Jaén;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
23 Jaén;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
23 Jaén;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
23 Jaén;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;94,97
23 Jaén;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
23 Jaén;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
23 Jaén;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
23 Jaén;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
23 Jaén;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
23 Jaén;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
23 Jaén;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;91,27
23 Jaén;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
23 Jaén;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
23 Jaén;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
23 Jaén;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;92,24
23 Jaén;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
23 Jaén;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
23 Jaén;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
23 Jaén;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
23 Jaén;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
23 Jaén;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
23 Jaén;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;88,67
23 Jaén;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
23 Jaén;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
23 Jaén;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
23 Jaén;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;90,59
23 Jaén;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
23 Jaén;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
23 Jaén;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
23 Jaén;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
23 Jaén;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
23 Jaén;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
23 Jaén;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
23 Jaén;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
23 Jaén;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
23 Jaén;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QI;10.619
23 Jaén;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
23 Jaén;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
23 Jaén;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
23 Jaén;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QI;10.457
23 Jaén;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
23 Jaén;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
23 Jaén;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
23 Jaén;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QI;10.715
23 Jaén;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
23 Jaén;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
23 Jaén;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2022QII;""
23 Jaén;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2022QI;10.405
23 Jaén;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
23 Jaén;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
23 Jaén;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2021QII;""
23 Jaén;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2021QI;10.274
23 Jaén;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
23 Jaén;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
23 Jaén;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2020QII;""
23 Jaén;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2020QI;10.222
23 Jaén;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
23 Jaén;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
23 Jaén;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2022QII;10.179
23 Jaén;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2022QI;""
23 Jaén;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
23 Jaén;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
23 Jaén;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2021QII;10.095
23 Jaén;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2021QI;""
23 Jaén;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
23 Jaén;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
23 Jaén;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2020QII;10.091
23 Jaén;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2020QI;""
23 Jaén;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
23 Jaén;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QIII;10.013
23 Jaén;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QII;""
23 Jaén;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QI;""
23 Jaén;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
23 Jaén;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QIII;9.958
23 Jaén;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QII;""
23 Jaén;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QI;""
23 Jaén;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
23 Jaén;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QIII;9.952
23 Jaén;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QII;""
23 Jaén;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QI;""
23 Jaén;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QIV;9.800
23 Jaén;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
23 Jaén;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QII;""
23 Jaén;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QI;""
23 Jaén;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QIV;9.782
23 Jaén;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
23 Jaén;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QII;""
23 Jaén;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QI;""
23 Jaén;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QIV;9.754
23 Jaén;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
23 Jaén;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QII;""
23 Jaén;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QI;""
23 Jaén;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
23 Jaén;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
23 Jaén;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
23 Jaén;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
23 Jaén;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
23 Jaén;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
23 Jaén;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
23 Jaén;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
23 Jaén;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
23 Jaén;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
23 Jaén;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
23 Jaén;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
23 Jaén;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
23 Jaén;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
23 Jaén;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
23 Jaén;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;97,98
23 Jaén;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
23 Jaén;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
23 Jaén;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
23 Jaén;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;98,25
23 Jaén;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
23 Jaén;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
23 Jaén;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
23 Jaén;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;95,4
23 Jaén;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
23 Jaén;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
23 Jaén;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;95,86
23 Jaén;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
23 Jaén;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
23 Jaén;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
23 Jaén;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;96,54
23 Jaén;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
23 Jaén;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
23 Jaén;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
23 Jaén;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;94,18
23 Jaén;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
23 Jaén;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
23 Jaén;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;94,29
23 Jaén;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
23 Jaén;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
23 Jaén;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
23 Jaén;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;95,23
23 Jaén;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
23 Jaén;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
23 Jaén;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
23 Jaén;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;92,88
23 Jaén;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
23 Jaén;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
23 Jaén;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;92,29
23 Jaén;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
23 Jaén;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
23 Jaén;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
23 Jaén;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;93,54
23 Jaén;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
23 Jaén;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
23 Jaén;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
23 Jaén;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;91,03
23 Jaén;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
23 Jaén;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
23 Jaén;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
23 Jaén;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
23 Jaén;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
23 Jaén;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
23 Jaén;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QI;7.075
23 Jaén;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
23 Jaén;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
23 Jaén;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
23 Jaén;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QI;7.001
23 Jaén;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
23 Jaén;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
23 Jaén;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
23 Jaén;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QI;7.217
23 Jaén;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
23 Jaén;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
23 Jaén;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2022QII;""
23 Jaén;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2022QI;6.936
23 Jaén;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
23 Jaén;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
23 Jaén;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2021QII;""
23 Jaén;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2021QI;6.898
23 Jaén;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
23 Jaén;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
23 Jaén;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2020QII;""
23 Jaén;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2020QI;6.899
23 Jaén;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
23 Jaén;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
23 Jaén;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2022QII;6.795
23 Jaén;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2022QI;""
23 Jaén;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
23 Jaén;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
23 Jaén;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2021QII;6.788
23 Jaén;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2021QI;""
23 Jaén;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
23 Jaén;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
23 Jaén;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2020QII;6.818
23 Jaén;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2020QI;""
23 Jaén;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
23 Jaén;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QIII;6.696
23 Jaén;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QII;""
23 Jaén;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QI;""
23 Jaén;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
23 Jaén;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QIII;6.702
23 Jaén;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QII;""
23 Jaén;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QI;""
23 Jaén;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
23 Jaén;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QIII;6.728
23 Jaén;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QII;""
23 Jaén;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QI;""
23 Jaén;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QIV;6.573
23 Jaén;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
23 Jaén;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QII;""
23 Jaén;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QI;""
23 Jaén;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QIV;6.592
23 Jaén;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
23 Jaén;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QII;""
23 Jaén;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QI;""
23 Jaén;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QIV;6.594
23 Jaén;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
23 Jaén;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QII;""
23 Jaén;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QI;""
23 Jaén;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
23 Jaén;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
23 Jaén;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
23 Jaén;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
23 Jaén;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
23 Jaén;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
23 Jaén;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
23 Jaén;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
23 Jaén;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
23 Jaén;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
23 Jaén;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
23 Jaén;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
23 Jaén;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
23 Jaén;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
23 Jaén;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
23 Jaén;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;98,04
23 Jaén;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
23 Jaén;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
23 Jaén;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
23 Jaén;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;98,53
23 Jaén;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
23 Jaén;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
23 Jaén;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
23 Jaén;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;95,59
23 Jaén;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
23 Jaén;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
23 Jaén;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;96,04
23 Jaén;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
23 Jaén;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
23 Jaén;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
23 Jaén;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;96,96
23 Jaén;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
23 Jaén;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
23 Jaén;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
23 Jaén;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;94,47
23 Jaén;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
23 Jaén;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
23 Jaén;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;94,64
23 Jaén;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
23 Jaén;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
23 Jaén;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
23 Jaén;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;95,73
23 Jaén;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
23 Jaén;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
23 Jaén;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
23 Jaén;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;93,22
23 Jaén;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
23 Jaén;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
23 Jaén;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;92,9
23 Jaén;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
23 Jaén;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
23 Jaén;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
23 Jaén;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;94,16
23 Jaén;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
23 Jaén;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
23 Jaén;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
23 Jaén;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;91,37
23 Jaén;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
23 Jaén;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
23 Jaén;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
23 Jaén;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
23 Jaén;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
23 Jaén;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
23 Jaén;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QI;3.544
23 Jaén;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
23 Jaén;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
23 Jaén;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
23 Jaén;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QI;3.456
23 Jaén;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
23 Jaén;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
23 Jaén;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
23 Jaén;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QI;3.498
23 Jaén;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
23 Jaén;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
23 Jaén;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2022QII;""
23 Jaén;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2022QI;3.469
23 Jaén;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
23 Jaén;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
23 Jaén;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2021QII;""
23 Jaén;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2021QI;3.376
23 Jaén;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
23 Jaén;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
23 Jaén;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2020QII;""
23 Jaén;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2020QI;3.323
23 Jaén;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
23 Jaén;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
23 Jaén;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2022QII;3.384
23 Jaén;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2022QI;""
23 Jaén;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
23 Jaén;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
23 Jaén;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2021QII;3.307
23 Jaén;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2021QI;""
23 Jaén;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
23 Jaén;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
23 Jaén;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2020QII;3.273
23 Jaén;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2020QI;""
23 Jaén;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
23 Jaén;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QIII;3.317
23 Jaén;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QII;""
23 Jaén;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QI;""
23 Jaén;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
23 Jaén;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QIII;3.256
23 Jaén;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QII;""
23 Jaén;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QI;""
23 Jaén;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
23 Jaén;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QIII;3.224
23 Jaén;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QII;""
23 Jaén;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QI;""
23 Jaén;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QIV;3.227
23 Jaén;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
23 Jaén;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QII;""
23 Jaén;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QI;""
23 Jaén;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QIV;3.190
23 Jaén;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
23 Jaén;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QII;""
23 Jaén;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QI;""
23 Jaén;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QIV;3.160
23 Jaén;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
23 Jaén;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QII;""
23 Jaén;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QI;""
23 Jaén;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
23 Jaén;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
23 Jaén;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
23 Jaén;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
23 Jaén;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
23 Jaén;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
23 Jaén;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
23 Jaén;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
23 Jaén;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
23 Jaén;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
23 Jaén;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
23 Jaén;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
23 Jaén;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
23 Jaén;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
23 Jaén;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
23 Jaén;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;97,88
23 Jaén;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
23 Jaén;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
23 Jaén;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
23 Jaén;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;97,69
23 Jaén;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
23 Jaén;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
23 Jaén;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
23 Jaén;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;95
23 Jaén;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
23 Jaén;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
23 Jaén;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;95,49
23 Jaén;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
23 Jaén;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
23 Jaén;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
23 Jaén;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;95,69
23 Jaén;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
23 Jaén;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
23 Jaén;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
23 Jaén;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;93,57
23 Jaén;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
23 Jaén;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
23 Jaén;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;93,59
23 Jaén;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
23 Jaén;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
23 Jaén;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
23 Jaén;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;94,21
23 Jaén;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
23 Jaén;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
23 Jaén;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
23 Jaén;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;92,17
23 Jaén;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
23 Jaén;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
23 Jaén;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;91,06
23 Jaén;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
23 Jaén;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
23 Jaén;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
23 Jaén;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;92,3
23 Jaén;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
23 Jaén;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
23 Jaén;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
23 Jaén;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;90,34
23 Jaén;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
23 Jaén;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
23 Jaén;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
23 Jaén;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
23 Jaén;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
23 Jaén;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QII;10.864
23 Jaén;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
23 Jaén;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
23 Jaén;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
23 Jaén;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QII;10.727
23 Jaén;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
23 Jaén;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
23 Jaén;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
23 Jaén;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QII;10.464
23 Jaén;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
23 Jaén;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
23 Jaén;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
23 Jaén;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2022QII;10.599
23 Jaén;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2022QI;""
23 Jaén;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
23 Jaén;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
23 Jaén;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2021QII;10.508
23 Jaén;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2021QI;""
23 Jaén;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
23 Jaén;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
23 Jaén;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2020QII;10.319
23 Jaén;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2020QI;""
23 Jaén;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
23 Jaén;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2022QIII;10.409
23 Jaén;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2022QII;""
23 Jaén;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2022QI;""
23 Jaén;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
23 Jaén;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2021QIII;10.348
23 Jaén;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2021QII;""
23 Jaén;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2021QI;""
23 Jaén;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
23 Jaén;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2020QIII;10.156
23 Jaén;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2020QII;""
23 Jaén;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2020QI;""
23 Jaén;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QIV;10.156
23 Jaén;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
23 Jaén;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QII;""
23 Jaén;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QI;""
23 Jaén;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QIV;10.135
23 Jaén;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
23 Jaén;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QII;""
23 Jaén;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QI;""
23 Jaén;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QIV;9.935
23 Jaén;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
23 Jaén;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QII;""
23 Jaén;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QI;""
23 Jaén;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
23 Jaén;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
23 Jaén;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QII;""
23 Jaén;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QI;9.951
23 Jaén;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
23 Jaén;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
23 Jaén;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QII;""
23 Jaén;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QI;9.798
23 Jaén;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
23 Jaén;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
23 Jaén;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QII;""
23 Jaén;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QI;""
23 Jaén;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
23 Jaén;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
23 Jaén;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
23 Jaén;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
23 Jaén;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
23 Jaén;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
23 Jaén;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
23 Jaén;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
23 Jaén;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
23 Jaén;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
23 Jaén;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
23 Jaén;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
23 Jaén;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
23 Jaén;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
23 Jaén;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;97,56
23 Jaén;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
23 Jaén;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
23 Jaén;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
23 Jaén;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;97,96
23 Jaén;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
23 Jaén;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
23 Jaén;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
23 Jaén;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;98,61
23 Jaén;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
23 Jaén;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
23 Jaén;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;95,81
23 Jaén;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
23 Jaén;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
23 Jaén;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
23 Jaén;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;96,47
23 Jaén;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
23 Jaén;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
23 Jaén;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
23 Jaén;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;97,06
23 Jaén;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
23 Jaén;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
23 Jaén;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;93,48
23 Jaén;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
23 Jaén;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
23 Jaén;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
23 Jaén;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;94,48
23 Jaén;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
23 Jaén;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
23 Jaén;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
23 Jaén;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;94,94
23 Jaén;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
23 Jaén;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
23 Jaén;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
23 Jaén;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
23 Jaén;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
23 Jaén;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
23 Jaén;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;92,77
23 Jaén;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
23 Jaén;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
23 Jaén;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
23 Jaén;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;93,64
23 Jaén;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
23 Jaén;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
23 Jaén;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
23 Jaén;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
23 Jaén;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
23 Jaén;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
23 Jaén;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QII;7.245
23 Jaén;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
23 Jaén;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
23 Jaén;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
23 Jaén;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QII;7.177
23 Jaén;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
23 Jaén;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
23 Jaén;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
23 Jaén;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QII;7.048
23 Jaén;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
23 Jaén;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
23 Jaén;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
23 Jaén;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2022QII;7.077
23 Jaén;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2022QI;""
23 Jaén;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
23 Jaén;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
23 Jaén;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2021QII;7.043
23 Jaén;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2021QI;""
23 Jaén;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
23 Jaén;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
23 Jaén;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2020QII;6.958
23 Jaén;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2020QI;""
23 Jaén;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
23 Jaén;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2022QIII;6.958
23 Jaén;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2022QII;""
23 Jaén;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2022QI;""
23 Jaén;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
23 Jaén;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2021QIII;6.941
23 Jaén;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2021QII;""
23 Jaén;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2021QI;""
23 Jaén;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
23 Jaén;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2020QIII;6.847
23 Jaén;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2020QII;""
23 Jaén;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2020QI;""
23 Jaén;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QIV;6.802
23 Jaén;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
23 Jaén;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QII;""
23 Jaén;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QI;""
23 Jaén;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QIV;6.795
23 Jaén;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
23 Jaén;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QII;""
23 Jaén;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QI;""
23 Jaén;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QIV;6.699
23 Jaén;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
23 Jaén;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QII;""
23 Jaén;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QI;""
23 Jaén;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
23 Jaén;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
23 Jaén;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QII;""
23 Jaén;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QI;6.677
23 Jaén;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
23 Jaén;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
23 Jaén;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QII;""
23 Jaén;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QI;6.623
23 Jaén;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
23 Jaén;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
23 Jaén;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QII;""
23 Jaén;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QI;""
23 Jaén;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
23 Jaén;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
23 Jaén;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
23 Jaén;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
23 Jaén;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
23 Jaén;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
23 Jaén;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
23 Jaén;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
23 Jaén;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
23 Jaén;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
23 Jaén;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
23 Jaén;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
23 Jaén;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
23 Jaén;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
23 Jaén;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;97,68
23 Jaén;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
23 Jaén;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
23 Jaén;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
23 Jaén;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;98,13
23 Jaén;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
23 Jaén;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
23 Jaén;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
23 Jaén;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;98,72
23 Jaén;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
23 Jaén;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
23 Jaén;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;96,04
23 Jaén;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
23 Jaén;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
23 Jaén;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
23 Jaén;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;96,71
23 Jaén;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
23 Jaén;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
23 Jaén;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
23 Jaén;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;97,15
23 Jaén;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
23 Jaén;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
23 Jaén;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;93,89
23 Jaén;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
23 Jaén;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
23 Jaén;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
23 Jaén;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;94,68
23 Jaén;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
23 Jaén;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
23 Jaén;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
23 Jaén;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;95,05
23 Jaén;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
23 Jaén;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
23 Jaén;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
23 Jaén;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
23 Jaén;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
23 Jaén;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
23 Jaén;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;93,03
23 Jaén;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
23 Jaén;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
23 Jaén;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
23 Jaén;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;93,97
23 Jaén;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
23 Jaén;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
23 Jaén;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
23 Jaén;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
23 Jaén;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
23 Jaén;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
23 Jaén;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QII;3.619
23 Jaén;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
23 Jaén;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
23 Jaén;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
23 Jaén;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QII;3.550
23 Jaén;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
23 Jaén;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
23 Jaén;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
23 Jaén;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QII;3.416
23 Jaén;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
23 Jaén;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
23 Jaén;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
23 Jaén;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2022QII;3.522
23 Jaén;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2022QI;""
23 Jaén;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
23 Jaén;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
23 Jaén;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2021QII;3.465
23 Jaén;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2021QI;""
23 Jaén;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
23 Jaén;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
23 Jaén;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2020QII;3.361
23 Jaén;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2020QI;""
23 Jaén;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
23 Jaén;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2022QIII;3.451
23 Jaén;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2022QII;""
23 Jaén;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2022QI;""
23 Jaén;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
23 Jaén;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2021QIII;3.407
23 Jaén;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2021QII;""
23 Jaén;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2021QI;""
23 Jaén;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
23 Jaén;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2020QIII;3.309
23 Jaén;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2020QII;""
23 Jaén;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2020QI;""
23 Jaén;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QIV;3.354
23 Jaén;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
23 Jaén;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QII;""
23 Jaén;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QI;""
23 Jaén;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QIV;3.340
23 Jaén;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
23 Jaén;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QII;""
23 Jaén;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QI;""
23 Jaén;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QIV;3.236
23 Jaén;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
23 Jaén;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QII;""
23 Jaén;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QI;""
23 Jaén;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
23 Jaén;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
23 Jaén;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QII;""
23 Jaén;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QI;3.274
23 Jaén;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
23 Jaén;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
23 Jaén;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QII;""
23 Jaén;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QI;3.175
23 Jaén;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
23 Jaén;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
23 Jaén;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QII;""
23 Jaén;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QI;""
23 Jaén;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
23 Jaén;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
23 Jaén;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
23 Jaén;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
23 Jaén;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
23 Jaén;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
23 Jaén;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
23 Jaén;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
23 Jaén;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
23 Jaén;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
23 Jaén;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
23 Jaén;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
23 Jaén;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
23 Jaén;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
23 Jaén;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;97,32
23 Jaén;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
23 Jaén;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
23 Jaén;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
23 Jaén;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;97,61
23 Jaén;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
23 Jaén;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
23 Jaén;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
23 Jaén;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;98,39
23 Jaén;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
23 Jaén;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
23 Jaén;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;95,36
23 Jaén;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
23 Jaén;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
23 Jaén;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
23 Jaén;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;95,97
23 Jaén;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
23 Jaén;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
23 Jaén;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
23 Jaén;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;96,87
23 Jaén;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
23 Jaén;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
23 Jaén;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;92,68
23 Jaén;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
23 Jaén;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
23 Jaén;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
23 Jaén;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;94,08
23 Jaén;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
23 Jaén;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
23 Jaén;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
23 Jaén;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;94,73
23 Jaén;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
23 Jaén;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
23 Jaén;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
23 Jaén;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
23 Jaén;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
23 Jaén;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
23 Jaén;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;92,23
23 Jaén;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
23 Jaén;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
23 Jaén;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
23 Jaén;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;92,94
23 Jaén;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
23 Jaén;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
23 Jaén;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
23 Jaén;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
23 Jaén;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
23 Jaén;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QIII;10.871
23 Jaén;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
23 Jaén;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
23 Jaén;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
23 Jaén;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QIII;10.798
23 Jaén;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
23 Jaén;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
23 Jaén;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
23 Jaén;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QIII;10.579
23 Jaén;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
23 Jaén;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
23 Jaén;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
23 Jaén;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2022QIII;10.630
23 Jaén;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2022QII;""
23 Jaén;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2022QI;""
23 Jaén;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
23 Jaén;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2021QIII;10.586
23 Jaén;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2021QII;""
23 Jaén;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2021QI;""
23 Jaén;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
23 Jaén;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2020QIII;10.369
23 Jaén;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2020QII;""
23 Jaén;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2020QI;""
23 Jaén;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2022QIV;10.325
23 Jaén;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
23 Jaén;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2022QII;""
23 Jaén;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2022QI;""
23 Jaén;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2021QIV;10.313
23 Jaén;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
23 Jaén;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2021QII;""
23 Jaén;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2021QI;""
23 Jaén;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2020QIV;10.088
23 Jaén;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
23 Jaén;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2020QII;""
23 Jaén;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2020QI;""
23 Jaén;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
23 Jaén;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
23 Jaén;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QII;""
23 Jaén;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QI;10.124
23 Jaén;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
23 Jaén;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
23 Jaén;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QII;""
23 Jaén;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QI;9.944
23 Jaén;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
23 Jaén;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
23 Jaén;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QII;""
23 Jaén;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QI;""
23 Jaén;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
23 Jaén;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
23 Jaén;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QII;9.934
23 Jaén;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QI;""
23 Jaén;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
23 Jaén;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
23 Jaén;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QII;9.796
23 Jaén;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QI;""
23 Jaén;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
23 Jaén;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
23 Jaén;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QII;""
23 Jaén;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QI;""
23 Jaén;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
23 Jaén;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
23 Jaén;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
23 Jaén;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
23 Jaén;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
23 Jaén;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
23 Jaén;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
23 Jaén;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
23 Jaén;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
23 Jaén;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
23 Jaén;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
23 Jaén;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
23 Jaén;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
23 Jaén;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;97,78
23 Jaén;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
23 Jaén;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
23 Jaén;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
23 Jaén;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;98,04
23 Jaén;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
23 Jaén;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
23 Jaén;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
23 Jaén;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;98,01
23 Jaén;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
23 Jaén;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
23 Jaén;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;94,98
23 Jaén;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
23 Jaén;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
23 Jaén;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
23 Jaén;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;95,51
23 Jaén;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
23 Jaén;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
23 Jaén;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
23 Jaén;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;95,36
23 Jaén;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
23 Jaén;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
23 Jaén;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
23 Jaén;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
23 Jaén;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
23 Jaén;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
23 Jaén;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;93,76
23 Jaén;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
23 Jaén;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
23 Jaén;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
23 Jaén;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;94
23 Jaén;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
23 Jaén;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
23 Jaén;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
23 Jaén;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
23 Jaén;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
23 Jaén;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
23 Jaén;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;92
23 Jaén;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
23 Jaén;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
23 Jaén;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
23 Jaén;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;92,6
23 Jaén;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
23 Jaén;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
23 Jaén;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
23 Jaén;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
23 Jaén;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
23 Jaén;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
23 Jaén;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QIII;7.267
23 Jaén;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
23 Jaén;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
23 Jaén;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
23 Jaén;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QIII;7.243
23 Jaén;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
23 Jaén;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
23 Jaén;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
23 Jaén;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QIII;7.144
23 Jaén;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
23 Jaén;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
23 Jaén;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
23 Jaén;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2022QIII;7.110
23 Jaén;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2022QII;""
23 Jaén;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2022QI;""
23 Jaén;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
23 Jaén;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2021QIII;7.105
23 Jaén;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2021QII;""
23 Jaén;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2021QI;""
23 Jaén;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
23 Jaén;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2020QIII;6.998
23 Jaén;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2020QII;""
23 Jaén;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2020QI;""
23 Jaén;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2022QIV;6.914
23 Jaén;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
23 Jaén;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2022QII;""
23 Jaén;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2022QI;""
23 Jaén;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2021QIV;6.906
23 Jaén;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
23 Jaén;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2021QII;""
23 Jaén;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2021QI;""
23 Jaén;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2020QIV;6.799
23 Jaén;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
23 Jaén;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2020QII;""
23 Jaén;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2020QI;""
23 Jaén;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
23 Jaén;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
23 Jaén;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QII;""
23 Jaén;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QI;6.785
23 Jaén;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
23 Jaén;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
23 Jaén;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QII;""
23 Jaén;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QI;6.719
23 Jaén;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
23 Jaén;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
23 Jaén;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QII;""
23 Jaén;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QI;""
23 Jaén;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
23 Jaén;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
23 Jaén;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QII;6.661
23 Jaén;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QI;""
23 Jaén;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
23 Jaén;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
23 Jaén;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QII;6.623
23 Jaén;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QI;""
23 Jaén;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
23 Jaén;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
23 Jaén;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QII;""
23 Jaén;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QI;""
23 Jaén;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
23 Jaén;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
23 Jaén;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
23 Jaén;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
23 Jaén;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
23 Jaén;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
23 Jaén;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
23 Jaén;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
23 Jaén;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
23 Jaén;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
23 Jaén;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
23 Jaén;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
23 Jaén;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
23 Jaén;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;97,84
23 Jaén;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
23 Jaén;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
23 Jaén;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
23 Jaén;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;98,09
23 Jaén;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
23 Jaén;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
23 Jaén;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
23 Jaén;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;97,96
23 Jaén;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
23 Jaén;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
23 Jaén;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;95,14
23 Jaén;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
23 Jaén;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
23 Jaén;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
23 Jaén;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;95,35
23 Jaén;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
23 Jaén;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
23 Jaén;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
23 Jaén;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;95,17
23 Jaén;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
23 Jaén;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
23 Jaén;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
23 Jaén;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
23 Jaén;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
23 Jaén;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
23 Jaén;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;93,68
23 Jaén;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
23 Jaén;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
23 Jaén;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
23 Jaén;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;94,05
23 Jaén;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
23 Jaén;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
23 Jaén;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
23 Jaén;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
23 Jaén;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
23 Jaén;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
23 Jaén;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;91,96
23 Jaén;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
23 Jaén;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
23 Jaén;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
23 Jaén;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;92,71
23 Jaén;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
23 Jaén;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
23 Jaén;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
23 Jaén;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
23 Jaén;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
23 Jaén;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
23 Jaén;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QIII;3.604
23 Jaén;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
23 Jaén;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
23 Jaén;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
23 Jaén;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QIII;3.555
23 Jaén;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
23 Jaén;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
23 Jaén;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
23 Jaén;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QIII;3.435
23 Jaén;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
23 Jaén;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
23 Jaén;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
23 Jaén;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2022QIII;3.520
23 Jaén;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2022QII;""
23 Jaén;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2022QI;""
23 Jaén;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
23 Jaén;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2021QIII;3.481
23 Jaén;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2021QII;""
23 Jaén;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2021QI;""
23 Jaén;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
23 Jaén;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2020QIII;3.371
23 Jaén;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2020QII;""
23 Jaén;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2020QI;""
23 Jaén;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2022QIV;3.411
23 Jaén;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
23 Jaén;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2022QII;""
23 Jaén;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2022QI;""
23 Jaén;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2021QIV;3.407
23 Jaén;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
23 Jaén;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2021QII;""
23 Jaén;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2021QI;""
23 Jaén;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2020QIV;3.289
23 Jaén;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
23 Jaén;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2020QII;""
23 Jaén;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2020QI;""
23 Jaén;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
23 Jaén;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
23 Jaén;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QII;""
23 Jaén;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QI;3.339
23 Jaén;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
23 Jaén;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
23 Jaén;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QII;""
23 Jaén;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QI;3.225
23 Jaén;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
23 Jaén;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
23 Jaén;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QII;""
23 Jaén;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QI;""
23 Jaén;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
23 Jaén;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
23 Jaén;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QII;3.273
23 Jaén;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QI;""
23 Jaén;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
23 Jaén;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
23 Jaén;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QII;3.173
23 Jaén;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QI;""
23 Jaén;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
23 Jaén;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
23 Jaén;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QII;""
23 Jaén;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QI;""
23 Jaén;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
23 Jaén;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
23 Jaén;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
23 Jaén;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
23 Jaén;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
23 Jaén;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
23 Jaén;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
23 Jaén;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
23 Jaén;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
23 Jaén;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
23 Jaén;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
23 Jaén;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
23 Jaén;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
23 Jaén;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;97,67
23 Jaén;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
23 Jaén;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
23 Jaén;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
23 Jaén;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;97,92
23 Jaén;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
23 Jaén;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
23 Jaén;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
23 Jaén;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;98,14
23 Jaén;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
23 Jaén;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
23 Jaén;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;94,64
23 Jaén;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
23 Jaén;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
23 Jaén;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
23 Jaén;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;95,84
23 Jaén;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
23 Jaén;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
23 Jaén;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
23 Jaén;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;95,75
23 Jaén;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
23 Jaén;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
23 Jaén;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
23 Jaén;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
23 Jaén;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
23 Jaén;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
23 Jaén;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;93,92
23 Jaén;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
23 Jaén;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
23 Jaén;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
23 Jaén;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;93,89
23 Jaén;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
23 Jaén;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
23 Jaén;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
23 Jaén;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
23 Jaén;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
23 Jaén;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
23 Jaén;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;92,07
23 Jaén;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
23 Jaén;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
23 Jaén;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
23 Jaén;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;92,37
23 Jaén;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
23 Jaén;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
23 Jaén;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
23 Jaén;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
23 Jaén;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
23 Jaén;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QIV;10.829
23 Jaén;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
23 Jaén;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
23 Jaén;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
23 Jaén;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QIV;10.750
23 Jaén;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
23 Jaén;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
23 Jaén;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
23 Jaén;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QIV;10.589
23 Jaén;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
23 Jaén;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
23 Jaén;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
23 Jaén;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2022QIV;10.460
23 Jaén;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
23 Jaén;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2022QII;""
23 Jaén;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2022QI;""
23 Jaén;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2021QIV;10.455
23 Jaén;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
23 Jaén;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2021QII;""
23 Jaén;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2021QI;""
23 Jaén;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2020QIV;10.261
23 Jaén;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
23 Jaén;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2020QII;""
23 Jaén;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2020QI;""
23 Jaén;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
23 Jaén;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
23 Jaén;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2022QII;""
23 Jaén;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2022QI;10.258
23 Jaén;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
23 Jaén;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
23 Jaén;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2021QII;""
23 Jaén;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2021QI;10.100
23 Jaén;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
23 Jaén;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
23 Jaén;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2020QII;""
23 Jaén;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2020QI;""
23 Jaén;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
23 Jaén;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
23 Jaén;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QII;10.056
23 Jaén;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QI;""
23 Jaén;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
23 Jaén;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
23 Jaén;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QII;9.945
23 Jaén;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QI;""
23 Jaén;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
23 Jaén;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
23 Jaén;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QII;""
23 Jaén;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QI;""
23 Jaén;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
23 Jaén;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QIII;9.904
23 Jaén;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QII;""
23 Jaén;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QI;""
23 Jaén;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
23 Jaén;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QIII;9.812
23 Jaén;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QII;""
23 Jaén;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QI;""
23 Jaén;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
23 Jaén;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
23 Jaén;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QII;""
23 Jaén;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QI;""
23 Jaén;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
23 Jaén;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
23 Jaén;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
23 Jaén;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
23 Jaén;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
23 Jaén;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
23 Jaén;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
23 Jaén;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
23 Jaén;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
23 Jaén;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
23 Jaén;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
23 Jaén;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
23 Jaén;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;96,59
23 Jaén;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
23 Jaén;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
23 Jaén;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
23 Jaén;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;97,26
23 Jaén;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
23 Jaén;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
23 Jaén;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
23 Jaén;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;96,9
23 Jaén;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
23 Jaén;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
23 Jaén;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
23 Jaén;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
23 Jaén;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
23 Jaén;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
23 Jaén;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;95,42
23 Jaén;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
23 Jaén;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
23 Jaén;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
23 Jaén;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;95,38
23 Jaén;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
23 Jaén;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
23 Jaén;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
23 Jaén;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
23 Jaén;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
23 Jaén;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
23 Jaén;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;93,54
23 Jaén;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
23 Jaén;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
23 Jaén;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
23 Jaén;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;93,92
23 Jaén;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
23 Jaén;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
23 Jaén;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
23 Jaén;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
23 Jaén;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
23 Jaén;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
23 Jaén;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;92,13
23 Jaén;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
23 Jaén;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
23 Jaén;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
23 Jaén;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;92,66
23 Jaén;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
23 Jaén;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
23 Jaén;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
23 Jaén;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
23 Jaén;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
23 Jaén;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
23 Jaén;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QIV;7.237
23 Jaén;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
23 Jaén;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
23 Jaén;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
23 Jaén;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QIV;7.201
23 Jaén;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
23 Jaén;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
23 Jaén;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
23 Jaén;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QIV;7.138
23 Jaén;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
23 Jaén;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
23 Jaén;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
23 Jaén;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2022QIV;6.990
23 Jaén;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
23 Jaén;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2022QII;""
23 Jaén;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2022QI;""
23 Jaén;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2021QIV;6.987
23 Jaén;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
23 Jaén;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2021QII;""
23 Jaén;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2021QI;""
23 Jaén;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2020QIV;6.900
23 Jaén;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
23 Jaén;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2020QII;""
23 Jaén;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2020QI;""
23 Jaén;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
23 Jaén;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
23 Jaén;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2022QII;""
23 Jaén;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2022QI;6.858
23 Jaén;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
23 Jaén;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
23 Jaén;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2021QII;""
23 Jaén;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2021QI;6.808
23 Jaén;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
23 Jaén;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
23 Jaén;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2020QII;""
23 Jaén;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2020QI;""
23 Jaén;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
23 Jaén;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
23 Jaén;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QII;6.729
23 Jaén;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QI;""
23 Jaén;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
23 Jaén;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
23 Jaén;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QII;6.707
23 Jaén;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QI;""
23 Jaén;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
23 Jaén;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
23 Jaén;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QII;""
23 Jaén;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QI;""
23 Jaén;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
23 Jaén;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QIII;6.638
23 Jaén;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QII;""
23 Jaén;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QI;""
23 Jaén;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
23 Jaén;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QIII;6.622
23 Jaén;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QII;""
23 Jaén;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QI;""
23 Jaén;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
23 Jaén;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
23 Jaén;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QII;""
23 Jaén;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QI;""
23 Jaén;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
23 Jaén;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
23 Jaén;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
23 Jaén;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
23 Jaén;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
23 Jaén;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
23 Jaén;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
23 Jaén;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
23 Jaén;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
23 Jaén;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
23 Jaén;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
23 Jaén;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
23 Jaén;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;96,59
23 Jaén;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
23 Jaén;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
23 Jaén;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
23 Jaén;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;97,03
23 Jaén;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
23 Jaén;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
23 Jaén;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
23 Jaén;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;96,67
23 Jaén;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
23 Jaén;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
23 Jaén;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
23 Jaén;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
23 Jaén;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
23 Jaén;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
23 Jaén;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;95,24
23 Jaén;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
23 Jaén;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
23 Jaén;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
23 Jaén;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;95,38
23 Jaén;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
23 Jaén;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
23 Jaén;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
23 Jaén;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
23 Jaén;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
23 Jaén;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
23 Jaén;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;93,45
23 Jaén;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
23 Jaén;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
23 Jaén;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
23 Jaén;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;93,96
23 Jaén;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
23 Jaén;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
23 Jaén;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
23 Jaén;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
23 Jaén;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
23 Jaén;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
23 Jaén;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;92,18
23 Jaén;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
23 Jaén;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
23 Jaén;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
23 Jaén;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;92,77
23 Jaén;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
23 Jaén;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
23 Jaén;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
23 Jaén;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
23 Jaén;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
23 Jaén;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
23 Jaén;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QIV;3.592
23 Jaén;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
23 Jaén;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
23 Jaén;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
23 Jaén;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QIV;3.549
23 Jaén;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
23 Jaén;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
23 Jaén;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
23 Jaén;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QIV;3.451
23 Jaén;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
23 Jaén;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
23 Jaén;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
23 Jaén;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2022QIV;3.470
23 Jaén;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
23 Jaén;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2022QII;""
23 Jaén;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2022QI;""
23 Jaén;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2021QIV;3.468
23 Jaén;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
23 Jaén;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2021QII;""
23 Jaén;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2021QI;""
23 Jaén;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2020QIV;3.361
23 Jaén;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
23 Jaén;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2020QII;""
23 Jaén;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2020QI;""
23 Jaén;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
23 Jaén;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
23 Jaén;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2022QII;""
23 Jaén;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2022QI;3.400
23 Jaén;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
23 Jaén;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
23 Jaén;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2021QII;""
23 Jaén;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2021QI;3.292
23 Jaén;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
23 Jaén;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
23 Jaén;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2020QII;""
23 Jaén;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2020QI;""
23 Jaén;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
23 Jaén;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
23 Jaén;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QII;3.327
23 Jaén;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QI;""
23 Jaén;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
23 Jaén;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
23 Jaén;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QII;3.238
23 Jaén;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QI;""
23 Jaén;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
23 Jaén;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
23 Jaén;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QII;""
23 Jaén;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QI;""
23 Jaén;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
23 Jaén;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QIII;3.266
23 Jaén;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QII;""
23 Jaén;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QI;""
23 Jaén;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
23 Jaén;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QIII;3.190
23 Jaén;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QII;""
23 Jaén;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QI;""
23 Jaén;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
23 Jaén;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
23 Jaén;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QII;""
23 Jaén;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QI;""
23 Jaén;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
23 Jaén;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
23 Jaén;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
23 Jaén;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
23 Jaén;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
23 Jaén;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
23 Jaén;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
23 Jaén;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
23 Jaén;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
23 Jaén;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
23 Jaén;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
23 Jaén;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
23 Jaén;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;96,6
23 Jaén;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
23 Jaén;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
23 Jaén;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
23 Jaén;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;97,72
23 Jaén;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
23 Jaén;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
23 Jaén;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
23 Jaén;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;97,39
23 Jaén;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
23 Jaén;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
23 Jaén;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
23 Jaén;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
23 Jaén;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
23 Jaén;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
23 Jaén;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;95,8
23 Jaén;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
23 Jaén;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
23 Jaén;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
23 Jaén;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;95,39
23 Jaén;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
23 Jaén;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
23 Jaén;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
23 Jaén;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
23 Jaén;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
23 Jaén;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
23 Jaén;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;93,74
23 Jaén;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
23 Jaén;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
23 Jaén;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
23 Jaén;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;93,83
23 Jaén;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
23 Jaén;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
23 Jaén;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
23 Jaén;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
23 Jaén;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
23 Jaén;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
23 Jaén;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;92,03
23 Jaén;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
23 Jaén;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
23 Jaén;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
23 Jaén;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;92,44
23 Jaén;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
23 Jaén;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
23 Jaén;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
23 Jaén;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
23 Jaén;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
23 Jaén;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
23 Jaén;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
23 Jaén;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
23 Jaén;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
23 Jaén;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QI;4.430
23 Jaén;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
23 Jaén;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
23 Jaén;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
23 Jaén;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QI;4.128
23 Jaén;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
23 Jaén;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
23 Jaén;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
23 Jaén;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QI;4.725
23 Jaén;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
23 Jaén;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
23 Jaén;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2022QII;""
23 Jaén;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2022QI;4.245
23 Jaén;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
23 Jaén;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
23 Jaén;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2021QII;""
23 Jaén;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2021QI;3.984
23 Jaén;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
23 Jaén;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
23 Jaén;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2020QII;""
23 Jaén;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2020QI;4.412
23 Jaén;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
23 Jaén;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
23 Jaén;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2022QII;4.072
23 Jaén;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2022QI;""
23 Jaén;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
23 Jaén;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
23 Jaén;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2021QII;3.806
23 Jaén;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2021QI;""
23 Jaén;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
23 Jaén;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
23 Jaén;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2020QII;4.273
23 Jaén;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2020QI;""
23 Jaén;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
23 Jaén;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QIII;3.889
23 Jaén;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QII;""
23 Jaén;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QI;""
23 Jaén;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
23 Jaén;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QIII;3.651
23 Jaén;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QII;""
23 Jaén;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QI;""
23 Jaén;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
23 Jaén;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QIII;4.111
23 Jaén;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QII;""
23 Jaén;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QI;""
23 Jaén;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QIV;3.612
23 Jaén;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
23 Jaén;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QII;""
23 Jaén;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QI;""
23 Jaén;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QIV;3.466
23 Jaén;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
23 Jaén;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QII;""
23 Jaén;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QI;""
23 Jaén;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QIV;3.920
23 Jaén;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
23 Jaén;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QII;""
23 Jaén;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QI;""
23 Jaén;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
23 Jaén;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
23 Jaén;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
23 Jaén;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
23 Jaén;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
23 Jaén;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
23 Jaén;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
23 Jaén;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
23 Jaén;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
23 Jaén;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
23 Jaén;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
23 Jaén;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
23 Jaén;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
23 Jaén;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
23 Jaén;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
23 Jaén;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;95,82
23 Jaén;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
23 Jaén;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
23 Jaén;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
23 Jaén;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;96,51
23 Jaén;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
23 Jaén;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
23 Jaén;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
23 Jaén;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;93,38
23 Jaén;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
23 Jaén;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
23 Jaén;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;91,92
23 Jaén;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
23 Jaén;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
23 Jaén;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
23 Jaén;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;92,2
23 Jaén;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
23 Jaén;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
23 Jaén;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
23 Jaén;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;90,43
23 Jaén;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
23 Jaén;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
23 Jaén;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;87,79
23 Jaén;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
23 Jaén;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
23 Jaén;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
23 Jaén;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;88,44
23 Jaén;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
23 Jaén;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
23 Jaén;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
23 Jaén;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;87,01
23 Jaén;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
23 Jaén;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
23 Jaén;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;81,53
23 Jaén;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
23 Jaén;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
23 Jaén;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
23 Jaén;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;83,96
23 Jaén;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
23 Jaén;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
23 Jaén;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
23 Jaén;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;82,96
23 Jaén;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
23 Jaén;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
23 Jaén;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
23 Jaén;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
23 Jaén;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
23 Jaén;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
23 Jaén;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QI;3.013
23 Jaén;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
23 Jaén;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
23 Jaén;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
23 Jaén;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QI;2.810
23 Jaén;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
23 Jaén;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
23 Jaén;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
23 Jaén;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QI;3.201
23 Jaén;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
23 Jaén;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
23 Jaén;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2022QII;""
23 Jaén;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2022QI;2.887
23 Jaén;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
23 Jaén;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
23 Jaén;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2021QII;""
23 Jaén;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2021QI;2.701
23 Jaén;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
23 Jaén;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
23 Jaén;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2020QII;""
23 Jaén;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2020QI;2.997
23 Jaén;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
23 Jaén;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
23 Jaén;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2022QII;2.775
23 Jaén;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2022QI;""
23 Jaén;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
23 Jaén;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
23 Jaén;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2021QII;2.585
23 Jaén;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2021QI;""
23 Jaén;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
23 Jaén;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
23 Jaén;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2020QII;2.912
23 Jaén;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2020QI;""
23 Jaén;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
23 Jaén;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QIII;2.650
23 Jaén;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QII;""
23 Jaén;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QI;""
23 Jaén;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
23 Jaén;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QIII;2.486
23 Jaén;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QII;""
23 Jaén;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QI;""
23 Jaén;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
23 Jaén;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QIII;2.816
23 Jaén;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QII;""
23 Jaén;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QI;""
23 Jaén;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QIV;2.465
23 Jaén;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
23 Jaén;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QII;""
23 Jaén;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QI;""
23 Jaén;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QIV;2.371
23 Jaén;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
23 Jaén;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QII;""
23 Jaén;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QI;""
23 Jaén;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QIV;2.689
23 Jaén;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
23 Jaén;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QII;""
23 Jaén;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QI;""
23 Jaén;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
23 Jaén;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
23 Jaén;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
23 Jaén;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
23 Jaén;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
23 Jaén;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
23 Jaén;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
23 Jaén;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
23 Jaén;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
23 Jaén;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
23 Jaén;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
23 Jaén;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
23 Jaén;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
23 Jaén;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
23 Jaén;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
23 Jaén;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;95,82
23 Jaén;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
23 Jaén;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
23 Jaén;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
23 Jaén;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;96,12
23 Jaén;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
23 Jaén;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
23 Jaén;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
23 Jaén;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;93,63
23 Jaén;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
23 Jaén;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
23 Jaén;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;92,1
23 Jaén;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
23 Jaén;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
23 Jaén;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
23 Jaén;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;91,99
23 Jaén;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
23 Jaén;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
23 Jaén;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
23 Jaén;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;90,97
23 Jaén;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
23 Jaén;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
23 Jaén;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;87,95
23 Jaén;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
23 Jaén;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
23 Jaén;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
23 Jaén;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;88,47
23 Jaén;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
23 Jaén;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
23 Jaén;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
23 Jaén;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;87,97
23 Jaén;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
23 Jaén;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
23 Jaén;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;81,81
23 Jaén;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
23 Jaén;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
23 Jaén;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
23 Jaén;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;84,38
23 Jaén;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
23 Jaén;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
23 Jaén;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
23 Jaén;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;84
23 Jaén;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
23 Jaén;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
23 Jaén;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
23 Jaén;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
23 Jaén;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
23 Jaén;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
23 Jaén;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QI;1.417
23 Jaén;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
23 Jaén;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
23 Jaén;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
23 Jaén;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QI;1.318
23 Jaén;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
23 Jaén;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
23 Jaén;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
23 Jaén;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QI;1.524
23 Jaén;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
23 Jaén;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
23 Jaén;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2022QII;""
23 Jaén;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2022QI;1.358
23 Jaén;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
23 Jaén;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
23 Jaén;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2021QII;""
23 Jaén;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2021QI;1.283
23 Jaén;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
23 Jaén;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
23 Jaén;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2020QII;""
23 Jaén;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2020QI;1.415
23 Jaén;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
23 Jaén;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
23 Jaén;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2022QII;1.297
23 Jaén;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2022QI;""
23 Jaén;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
23 Jaén;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
23 Jaén;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2021QII;1.221
23 Jaén;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2021QI;""
23 Jaén;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
23 Jaén;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
23 Jaén;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2020QII;1.361
23 Jaén;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2020QI;""
23 Jaén;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
23 Jaén;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QIII;1.239
23 Jaén;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QII;""
23 Jaén;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QI;""
23 Jaén;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
23 Jaén;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QIII;1.165
23 Jaén;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QII;""
23 Jaén;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QI;""
23 Jaén;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
23 Jaén;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QIII;1.295
23 Jaén;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QII;""
23 Jaén;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QI;""
23 Jaén;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QIV;1.147
23 Jaén;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
23 Jaén;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QII;""
23 Jaén;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QI;""
23 Jaén;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QIV;1.095
23 Jaén;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
23 Jaén;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QII;""
23 Jaén;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QI;""
23 Jaén;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QIV;1.231
23 Jaén;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
23 Jaén;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QII;""
23 Jaén;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QI;""
23 Jaén;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
23 Jaén;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
23 Jaén;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
23 Jaén;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
23 Jaén;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
23 Jaén;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
23 Jaén;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
23 Jaén;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
23 Jaén;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
23 Jaén;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
23 Jaén;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
23 Jaén;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
23 Jaén;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
23 Jaén;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
23 Jaén;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
23 Jaén;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;95,84
23 Jaén;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
23 Jaén;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
23 Jaén;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
23 Jaén;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;97,34
23 Jaén;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
23 Jaén;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
23 Jaén;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
23 Jaén;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;92,85
23 Jaén;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
23 Jaén;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
23 Jaén;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;91,53
23 Jaén;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
23 Jaén;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
23 Jaén;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
23 Jaén;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;92,64
23 Jaén;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
23 Jaén;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
23 Jaén;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
23 Jaén;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;89,3
23 Jaén;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
23 Jaén;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
23 Jaén;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;87,44
23 Jaén;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
23 Jaén;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
23 Jaén;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
23 Jaén;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;88,39
23 Jaén;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
23 Jaén;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
23 Jaén;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
23 Jaén;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;84,97
23 Jaén;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
23 Jaén;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
23 Jaén;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;80,95
23 Jaén;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
23 Jaén;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
23 Jaén;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
23 Jaén;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;83,08
23 Jaén;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
23 Jaén;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
23 Jaén;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
23 Jaén;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;80,77
23 Jaén;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
23 Jaén;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
23 Jaén;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
23 Jaén;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
23 Jaén;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
23 Jaén;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QII;5.179
23 Jaén;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
23 Jaén;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
23 Jaén;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
23 Jaén;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QII;4.891
23 Jaén;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
23 Jaén;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
23 Jaén;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
23 Jaén;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QII;4.517
23 Jaén;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
23 Jaén;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
23 Jaén;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
23 Jaén;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2022QII;4.983
23 Jaén;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2022QI;""
23 Jaén;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
23 Jaén;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
23 Jaén;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2021QII;4.697
23 Jaén;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2021QI;""
23 Jaén;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
23 Jaén;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
23 Jaén;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2020QII;4.374
23 Jaén;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2020QI;""
23 Jaén;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
23 Jaén;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2022QIII;4.784
23 Jaén;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2022QII;""
23 Jaén;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2022QI;""
23 Jaén;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
23 Jaén;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2021QIII;4.520
23 Jaén;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2021QII;""
23 Jaén;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2021QI;""
23 Jaén;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
23 Jaén;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2020QIII;4.191
23 Jaén;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2020QII;""
23 Jaén;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2020QI;""
23 Jaén;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QIV;4.471
23 Jaén;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
23 Jaén;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QII;""
23 Jaén;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QI;""
23 Jaén;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QIV;4.313
23 Jaén;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
23 Jaén;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QII;""
23 Jaén;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QI;""
23 Jaén;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QIV;3.992
23 Jaén;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
23 Jaén;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QII;""
23 Jaén;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QI;""
23 Jaén;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
23 Jaén;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
23 Jaén;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QII;""
23 Jaén;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QI;4.142
23 Jaén;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
23 Jaén;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
23 Jaén;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QII;""
23 Jaén;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QI;3.864
23 Jaén;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
23 Jaén;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
23 Jaén;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QII;""
23 Jaén;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QI;""
23 Jaén;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
23 Jaén;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
23 Jaén;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
23 Jaén;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
23 Jaén;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
23 Jaén;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
23 Jaén;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
23 Jaén;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
23 Jaén;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
23 Jaén;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
23 Jaén;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
23 Jaén;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
23 Jaén;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
23 Jaén;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
23 Jaén;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;96,22
23 Jaén;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
23 Jaén;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
23 Jaén;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
23 Jaén;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;96,03
23 Jaén;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
23 Jaén;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
23 Jaén;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
23 Jaén;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;96,83
23 Jaén;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
23 Jaén;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
23 Jaén;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;92,37
23 Jaén;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
23 Jaén;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
23 Jaén;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
23 Jaén;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;92,41
23 Jaén;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
23 Jaén;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
23 Jaén;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
23 Jaén;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;92,78
23 Jaén;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
23 Jaén;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
23 Jaén;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;86,33
23 Jaén;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
23 Jaén;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
23 Jaén;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
23 Jaén;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;88,18
23 Jaén;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
23 Jaén;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
23 Jaén;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
23 Jaén;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;88,38
23 Jaén;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
23 Jaén;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
23 Jaén;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
23 Jaén;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
23 Jaén;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
23 Jaén;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
23 Jaén;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;84,69
23 Jaén;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
23 Jaén;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
23 Jaén;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
23 Jaén;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;85,54
23 Jaén;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
23 Jaén;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
23 Jaén;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
23 Jaén;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
23 Jaén;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
23 Jaén;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
23 Jaén;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QII;3.505
23 Jaén;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
23 Jaén;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
23 Jaén;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
23 Jaén;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QII;3.332
23 Jaén;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
23 Jaén;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
23 Jaén;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
23 Jaén;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QII;3.065
23 Jaén;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
23 Jaén;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
23 Jaén;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
23 Jaén;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2022QII;3.377
23 Jaén;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2022QI;""
23 Jaén;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
23 Jaén;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
23 Jaén;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2021QII;3.202
23 Jaén;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2021QI;""
23 Jaén;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
23 Jaén;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
23 Jaén;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2020QII;2.976
23 Jaén;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2020QI;""
23 Jaén;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
23 Jaén;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2022QIII;3.243
23 Jaén;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2022QII;""
23 Jaén;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2022QI;""
23 Jaén;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
23 Jaén;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2021QIII;3.088
23 Jaén;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2021QII;""
23 Jaén;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2021QI;""
23 Jaén;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
23 Jaén;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2020QIII;2.866
23 Jaén;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2020QII;""
23 Jaén;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2020QI;""
23 Jaén;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QIV;3.034
23 Jaén;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
23 Jaén;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QII;""
23 Jaén;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QI;""
23 Jaén;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QIV;2.957
23 Jaén;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
23 Jaén;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QII;""
23 Jaén;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QI;""
23 Jaén;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QIV;2.734
23 Jaén;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
23 Jaén;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QII;""
23 Jaén;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QI;""
23 Jaén;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
23 Jaén;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
23 Jaén;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QII;""
23 Jaén;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QI;2.839
23 Jaén;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
23 Jaén;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
23 Jaén;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QII;""
23 Jaén;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QI;2.636
23 Jaén;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
23 Jaén;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
23 Jaén;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QII;""
23 Jaén;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QI;""
23 Jaén;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
23 Jaén;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
23 Jaén;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
23 Jaén;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
23 Jaén;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
23 Jaén;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
23 Jaén;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
23 Jaén;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
23 Jaén;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
23 Jaén;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
23 Jaén;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
23 Jaén;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
23 Jaén;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
23 Jaén;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
23 Jaén;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;96,35
23 Jaén;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
23 Jaén;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
23 Jaén;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
23 Jaén;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;96,1
23 Jaén;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
23 Jaén;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
23 Jaén;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
23 Jaén;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;97,1
23 Jaén;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
23 Jaén;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
23 Jaén;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;92,52
23 Jaén;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
23 Jaén;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
23 Jaén;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
23 Jaén;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;92,68
23 Jaén;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
23 Jaén;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
23 Jaén;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
23 Jaén;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;93,51
23 Jaén;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
23 Jaén;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
23 Jaén;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;86,56
23 Jaén;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
23 Jaén;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
23 Jaén;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
23 Jaén;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;88,75
23 Jaén;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
23 Jaén;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
23 Jaén;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
23 Jaén;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;89,2
23 Jaén;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
23 Jaén;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
23 Jaén;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
23 Jaén;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
23 Jaén;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
23 Jaén;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
23 Jaén;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;85,2
23 Jaén;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
23 Jaén;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
23 Jaén;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
23 Jaén;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;86
23 Jaén;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
23 Jaén;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
23 Jaén;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
23 Jaén;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
23 Jaén;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
23 Jaén;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
23 Jaén;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QII;1.674
23 Jaén;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
23 Jaén;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
23 Jaén;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
23 Jaén;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QII;1.559
23 Jaén;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
23 Jaén;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
23 Jaén;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
23 Jaén;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QII;1.452
23 Jaén;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
23 Jaén;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
23 Jaén;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
23 Jaén;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2022QII;1.606
23 Jaén;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2022QI;""
23 Jaén;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
23 Jaén;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
23 Jaén;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2021QII;1.495
23 Jaén;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2021QI;""
23 Jaén;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
23 Jaén;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
23 Jaén;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2020QII;1.398
23 Jaén;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2020QI;""
23 Jaén;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
23 Jaén;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2022QIII;1.541
23 Jaén;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2022QII;""
23 Jaén;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2022QI;""
23 Jaén;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
23 Jaén;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2021QIII;1.432
23 Jaén;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2021QII;""
23 Jaén;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2021QI;""
23 Jaén;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
23 Jaén;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2020QIII;1.325
23 Jaén;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2020QII;""
23 Jaén;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2020QI;""
23 Jaén;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QIV;1.437
23 Jaén;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
23 Jaén;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QII;""
23 Jaén;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QI;""
23 Jaén;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QIV;1.356
23 Jaén;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
23 Jaén;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QII;""
23 Jaén;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QI;""
23 Jaén;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QIV;1.258
23 Jaén;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
23 Jaén;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QII;""
23 Jaén;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QI;""
23 Jaén;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
23 Jaén;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
23 Jaén;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QII;""
23 Jaén;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QI;1.303
23 Jaén;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
23 Jaén;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
23 Jaén;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QII;""
23 Jaén;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QI;1.228
23 Jaén;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
23 Jaén;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
23 Jaén;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QII;""
23 Jaén;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QI;""
23 Jaén;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
23 Jaén;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
23 Jaén;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
23 Jaén;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
23 Jaén;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
23 Jaén;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
23 Jaén;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
23 Jaén;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
23 Jaén;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
23 Jaén;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
23 Jaén;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
23 Jaén;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
23 Jaén;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
23 Jaén;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
23 Jaén;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;95,94
23 Jaén;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
23 Jaén;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
23 Jaén;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
23 Jaén;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;95,89
23 Jaén;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
23 Jaén;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
23 Jaén;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
23 Jaén;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;96,28
23 Jaén;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
23 Jaén;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
23 Jaén;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;92,05
23 Jaén;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
23 Jaén;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
23 Jaén;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
23 Jaén;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;91,85
23 Jaén;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
23 Jaén;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
23 Jaén;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
23 Jaén;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;91,25
23 Jaén;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
23 Jaén;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
23 Jaén;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;85,84
23 Jaén;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
23 Jaén;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
23 Jaén;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
23 Jaén;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;86,98
23 Jaén;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
23 Jaén;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
23 Jaén;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
23 Jaén;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;86,64
23 Jaén;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
23 Jaén;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
23 Jaén;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
23 Jaén;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
23 Jaén;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
23 Jaén;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
23 Jaén;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;83,58
23 Jaén;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
23 Jaén;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
23 Jaén;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
23 Jaén;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;84,57
23 Jaén;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
23 Jaén;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
23 Jaén;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
23 Jaén;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
23 Jaén;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
23 Jaén;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QIII;5.048
23 Jaén;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
23 Jaén;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
23 Jaén;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
23 Jaén;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QIII;4.760
23 Jaén;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
23 Jaén;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
23 Jaén;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
23 Jaén;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QIII;4.432
23 Jaén;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
23 Jaén;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
23 Jaén;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
23 Jaén;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2022QIII;4.829
23 Jaén;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2022QII;""
23 Jaén;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2022QI;""
23 Jaén;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
23 Jaén;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2021QIII;4.567
23 Jaén;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2021QII;""
23 Jaén;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2021QI;""
23 Jaén;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
23 Jaén;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2020QIII;4.239
23 Jaén;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2020QII;""
23 Jaén;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2020QI;""
23 Jaén;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2022QIV;4.500
23 Jaén;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
23 Jaén;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2022QII;""
23 Jaén;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2022QI;""
23 Jaén;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2021QIV;4.352
23 Jaén;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
23 Jaén;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2021QII;""
23 Jaén;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2021QI;""
23 Jaén;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2020QIV;4.029
23 Jaén;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
23 Jaén;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2020QII;""
23 Jaén;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2020QI;""
23 Jaén;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
23 Jaén;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
23 Jaén;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QII;""
23 Jaén;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QI;4.177
23 Jaén;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
23 Jaén;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
23 Jaén;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QII;""
23 Jaén;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QI;3.899
23 Jaén;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
23 Jaén;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
23 Jaén;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QII;""
23 Jaén;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QI;""
23 Jaén;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
23 Jaén;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
23 Jaén;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QII;4.012
23 Jaén;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QI;""
23 Jaén;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
23 Jaén;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
23 Jaén;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QII;3.735
23 Jaén;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QI;""
23 Jaén;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
23 Jaén;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
23 Jaén;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QII;""
23 Jaén;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QI;""
23 Jaén;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
23 Jaén;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
23 Jaén;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
23 Jaén;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
23 Jaén;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
23 Jaén;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
23 Jaén;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
23 Jaén;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
23 Jaén;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
23 Jaén;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
23 Jaén;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
23 Jaén;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
23 Jaén;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
23 Jaén;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;95,66
23 Jaén;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
23 Jaén;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
23 Jaén;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
23 Jaén;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;95,95
23 Jaén;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
23 Jaén;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
23 Jaén;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
23 Jaén;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;95,65
23 Jaén;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
23 Jaén;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
23 Jaén;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;89,14
23 Jaén;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
23 Jaén;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
23 Jaén;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
23 Jaén;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;91,43
23 Jaén;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
23 Jaén;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
23 Jaén;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
23 Jaén;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;90,91
23 Jaén;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
23 Jaén;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
23 Jaén;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
23 Jaén;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
23 Jaén;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
23 Jaén;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
23 Jaén;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;87,75
23 Jaén;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
23 Jaén;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
23 Jaén;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
23 Jaén;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;87,97
23 Jaén;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
23 Jaén;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
23 Jaén;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
23 Jaén;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
23 Jaén;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
23 Jaén;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
23 Jaén;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;84,29
23 Jaén;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
23 Jaén;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
23 Jaén;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
23 Jaén;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;84,27
23 Jaén;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
23 Jaén;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
23 Jaén;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
23 Jaén;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
23 Jaén;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
23 Jaén;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
23 Jaén;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QIII;3.421
23 Jaén;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
23 Jaén;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
23 Jaén;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
23 Jaén;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QIII;3.239
23 Jaén;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
23 Jaén;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
23 Jaén;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
23 Jaén;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QIII;3.015
23 Jaén;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
23 Jaén;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
23 Jaén;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
23 Jaén;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2022QIII;3.274
23 Jaén;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2022QII;""
23 Jaén;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2022QI;""
23 Jaén;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
23 Jaén;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2021QIII;3.115
23 Jaén;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2021QII;""
23 Jaén;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2021QI;""
23 Jaén;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
23 Jaén;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2020QIII;2.899
23 Jaén;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2020QII;""
23 Jaén;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2020QI;""
23 Jaén;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2022QIV;3.055
23 Jaén;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
23 Jaén;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2022QII;""
23 Jaén;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2022QI;""
23 Jaén;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2021QIV;2.976
23 Jaén;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
23 Jaén;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2021QII;""
23 Jaén;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2021QI;""
23 Jaén;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2020QIV;2.758
23 Jaén;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
23 Jaén;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2020QII;""
23 Jaén;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2020QI;""
23 Jaén;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
23 Jaén;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
23 Jaén;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QII;""
23 Jaén;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QI;2.856
23 Jaén;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
23 Jaén;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
23 Jaén;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QII;""
23 Jaén;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QI;2.658
23 Jaén;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
23 Jaén;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
23 Jaén;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QII;""
23 Jaén;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QI;""
23 Jaén;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
23 Jaén;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
23 Jaén;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QII;2.749
23 Jaén;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QI;""
23 Jaén;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
23 Jaén;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
23 Jaén;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QII;2.552
23 Jaén;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QI;""
23 Jaén;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
23 Jaén;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
23 Jaén;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QII;""
23 Jaén;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QI;""
23 Jaén;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
23 Jaén;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
23 Jaén;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
23 Jaén;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
23 Jaén;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
23 Jaén;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
23 Jaén;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
23 Jaén;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
23 Jaén;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
23 Jaén;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
23 Jaén;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
23 Jaén;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
23 Jaén;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
23 Jaén;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;95,7
23 Jaén;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
23 Jaén;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
23 Jaén;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
23 Jaén;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;96,17
23 Jaén;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
23 Jaén;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
23 Jaén;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
23 Jaén;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;96,15
23 Jaén;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
23 Jaén;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
23 Jaén;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;89,3
23 Jaén;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
23 Jaén;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
23 Jaén;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
23 Jaén;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;91,88
23 Jaén;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
23 Jaén;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
23 Jaén;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
23 Jaén;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;91,48
23 Jaén;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
23 Jaén;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
23 Jaén;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
23 Jaén;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
23 Jaén;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
23 Jaén;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
23 Jaén;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;88,18
23 Jaén;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
23 Jaén;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
23 Jaén;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
23 Jaén;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;88,16
23 Jaén;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
23 Jaén;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
23 Jaén;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
23 Jaén;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
23 Jaén;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
23 Jaén;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
23 Jaén;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;84,87
23 Jaén;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
23 Jaén;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
23 Jaén;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
23 Jaén;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;84,64
23 Jaén;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
23 Jaén;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
23 Jaén;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
23 Jaén;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
23 Jaén;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
23 Jaén;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
23 Jaén;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QIII;1.627
23 Jaén;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
23 Jaén;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
23 Jaén;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
23 Jaén;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QIII;1.521
23 Jaén;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
23 Jaén;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
23 Jaén;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
23 Jaén;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QIII;1.417
23 Jaén;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
23 Jaén;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
23 Jaén;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
23 Jaén;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2022QIII;1.555
23 Jaén;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2022QII;""
23 Jaén;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2022QI;""
23 Jaén;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
23 Jaén;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2021QIII;1.452
23 Jaén;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2021QII;""
23 Jaén;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2021QI;""
23 Jaén;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
23 Jaén;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2020QIII;1.340
23 Jaén;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2020QII;""
23 Jaén;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2020QI;""
23 Jaén;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2022QIV;1.445
23 Jaén;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
23 Jaén;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2022QII;""
23 Jaén;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2022QI;""
23 Jaén;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2021QIV;1.376
23 Jaén;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
23 Jaén;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2021QII;""
23 Jaén;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2021QI;""
23 Jaén;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2020QIV;1.271
23 Jaén;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
23 Jaén;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2020QII;""
23 Jaén;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2020QI;""
23 Jaén;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
23 Jaén;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
23 Jaén;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QII;""
23 Jaén;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QI;1.321
23 Jaén;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
23 Jaén;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
23 Jaén;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QII;""
23 Jaén;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QI;1.241
23 Jaén;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
23 Jaén;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
23 Jaén;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QII;""
23 Jaén;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QI;""
23 Jaén;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
23 Jaén;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
23 Jaén;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QII;1.263
23 Jaén;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QI;""
23 Jaén;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
23 Jaén;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
23 Jaén;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QII;1.183
23 Jaén;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QI;""
23 Jaén;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
23 Jaén;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
23 Jaén;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QII;""
23 Jaén;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QI;""
23 Jaén;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
23 Jaén;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
23 Jaén;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
23 Jaén;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
23 Jaén;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
23 Jaén;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
23 Jaén;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
23 Jaén;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
23 Jaén;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
23 Jaén;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
23 Jaén;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
23 Jaén;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
23 Jaén;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
23 Jaén;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;95,57
23 Jaén;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
23 Jaén;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
23 Jaén;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
23 Jaén;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;95,46
23 Jaén;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
23 Jaén;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
23 Jaén;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
23 Jaén;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;94,57
23 Jaén;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
23 Jaén;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
23 Jaén;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;88,81
23 Jaén;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
23 Jaén;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
23 Jaén;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
23 Jaén;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;90,47
23 Jaén;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
23 Jaén;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
23 Jaén;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
23 Jaén;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;89,7
23 Jaén;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
23 Jaén;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
23 Jaén;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
23 Jaén;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
23 Jaén;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
23 Jaén;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
23 Jaén;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;86,85
23 Jaén;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
23 Jaén;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
23 Jaén;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
23 Jaén;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;87,58
23 Jaén;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
23 Jaén;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
23 Jaén;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
23 Jaén;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
23 Jaén;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
23 Jaén;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
23 Jaén;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;83,04
23 Jaén;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
23 Jaén;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
23 Jaén;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
23 Jaén;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;83,49
23 Jaén;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
23 Jaén;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
23 Jaén;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
23 Jaén;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
23 Jaén;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
23 Jaén;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QIV;4.882
23 Jaén;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
23 Jaén;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
23 Jaén;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
23 Jaén;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QIV;4.607
23 Jaén;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
23 Jaén;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
23 Jaén;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
23 Jaén;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QIV;4.295
23 Jaén;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
23 Jaén;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
23 Jaén;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
23 Jaén;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2022QIV;4.536
23 Jaén;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
23 Jaén;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2022QII;""
23 Jaén;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2022QI;""
23 Jaén;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2021QIV;4.374
23 Jaén;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
23 Jaén;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2021QII;""
23 Jaén;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2021QI;""
23 Jaén;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2020QIV;4.076
23 Jaén;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
23 Jaén;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2020QII;""
23 Jaén;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2020QI;""
23 Jaén;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
23 Jaén;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
23 Jaén;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2022QII;""
23 Jaén;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2022QI;4.196
23 Jaén;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
23 Jaén;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
23 Jaén;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2021QII;""
23 Jaén;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2021QI;3.939
23 Jaén;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
23 Jaén;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
23 Jaén;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2020QII;""
23 Jaén;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2020QI;""
23 Jaén;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
23 Jaén;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
23 Jaén;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QII;4.031
23 Jaén;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QI;""
23 Jaén;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
23 Jaén;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
23 Jaén;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QII;3.771
23 Jaén;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QI;""
23 Jaén;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
23 Jaén;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
23 Jaén;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QII;""
23 Jaén;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QI;""
23 Jaén;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
23 Jaén;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QIII;3.853
23 Jaén;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QII;""
23 Jaén;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QI;""
23 Jaén;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
23 Jaén;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QIII;3.617
23 Jaén;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QII;""
23 Jaén;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QI;""
23 Jaén;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
23 Jaén;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
23 Jaén;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QII;""
23 Jaén;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QI;""
23 Jaén;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
23 Jaén;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
23 Jaén;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
23 Jaén;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
23 Jaén;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
23 Jaén;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
23 Jaén;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
23 Jaén;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
23 Jaén;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
23 Jaén;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
23 Jaén;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
23 Jaén;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
23 Jaén;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;92,91
23 Jaén;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
23 Jaén;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
23 Jaén;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
23 Jaén;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;94,94
23 Jaén;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
23 Jaén;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
23 Jaén;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
23 Jaén;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;94,9
23 Jaén;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
23 Jaén;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
23 Jaén;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
23 Jaén;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
23 Jaén;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
23 Jaén;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
23 Jaén;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;91,08
23 Jaén;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
23 Jaén;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
23 Jaén;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
23 Jaén;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;91,71
23 Jaén;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
23 Jaén;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
23 Jaén;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
23 Jaén;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
23 Jaén;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
23 Jaén;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
23 Jaén;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;87,5
23 Jaén;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
23 Jaén;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
23 Jaén;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
23 Jaén;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;87,8
23 Jaén;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
23 Jaén;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
23 Jaén;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
23 Jaén;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
23 Jaén;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
23 Jaén;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
23 Jaén;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;83,63
23 Jaén;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
23 Jaén;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
23 Jaén;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
23 Jaén;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;84,21
23 Jaén;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
23 Jaén;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
23 Jaén;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
23 Jaén;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
23 Jaén;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
23 Jaén;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
23 Jaén;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QIV;3.305
23 Jaén;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
23 Jaén;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
23 Jaén;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
23 Jaén;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QIV;3.140
23 Jaén;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
23 Jaén;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
23 Jaén;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
23 Jaén;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QIV;2.932
23 Jaén;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
23 Jaén;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
23 Jaén;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
23 Jaén;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2022QIV;3.074
23 Jaén;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
23 Jaén;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2022QII;""
23 Jaén;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2022QI;""
23 Jaén;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2021QIV;2.990
23 Jaén;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
23 Jaén;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2021QII;""
23 Jaén;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2021QI;""
23 Jaén;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2020QIV;2.783
23 Jaén;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
23 Jaén;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2020QII;""
23 Jaén;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2020QI;""
23 Jaén;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
23 Jaén;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
23 Jaén;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2022QII;""
23 Jaén;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2022QI;2.868
23 Jaén;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
23 Jaén;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
23 Jaén;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2021QII;""
23 Jaén;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2021QI;2.679
23 Jaén;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
23 Jaén;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
23 Jaén;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2020QII;""
23 Jaén;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2020QI;""
23 Jaén;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
23 Jaén;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
23 Jaén;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QII;2.761
23 Jaén;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QI;""
23 Jaén;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
23 Jaén;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
23 Jaén;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QII;2.570
23 Jaén;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QI;""
23 Jaén;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
23 Jaén;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
23 Jaén;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QII;""
23 Jaén;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QI;""
23 Jaén;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
23 Jaén;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QIII;2.639
23 Jaén;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QII;""
23 Jaén;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QI;""
23 Jaén;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
23 Jaén;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QIII;2.471
23 Jaén;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QII;""
23 Jaén;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QI;""
23 Jaén;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
23 Jaén;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
23 Jaén;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QII;""
23 Jaén;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QI;""
23 Jaén;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
23 Jaén;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
23 Jaén;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
23 Jaén;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
23 Jaén;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
23 Jaén;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
23 Jaén;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
23 Jaén;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
23 Jaén;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
23 Jaén;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
23 Jaén;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
23 Jaén;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
23 Jaén;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;93,01
23 Jaén;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
23 Jaén;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
23 Jaén;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
23 Jaén;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;95,22
23 Jaén;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
23 Jaén;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
23 Jaén;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
23 Jaén;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;94,92
23 Jaén;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
23 Jaén;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
23 Jaén;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
23 Jaén;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
23 Jaén;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
23 Jaén;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
23 Jaén;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;91,34
23 Jaén;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
23 Jaén;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
23 Jaén;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
23 Jaén;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;91,37
23 Jaén;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
23 Jaén;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
23 Jaén;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
23 Jaén;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
23 Jaén;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
23 Jaén;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
23 Jaén;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;87,93
23 Jaén;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
23 Jaén;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
23 Jaén;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
23 Jaén;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;87,65
23 Jaén;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
23 Jaén;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
23 Jaén;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
23 Jaén;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
23 Jaén;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
23 Jaén;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
23 Jaén;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;84,04
23 Jaén;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
23 Jaén;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
23 Jaén;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
23 Jaén;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;84,28
23 Jaén;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
23 Jaén;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
23 Jaén;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
23 Jaén;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
23 Jaén;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
23 Jaén;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
23 Jaén;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QIV;1.577
23 Jaén;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
23 Jaén;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
23 Jaén;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
23 Jaén;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QIV;1.467
23 Jaén;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
23 Jaén;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
23 Jaén;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
23 Jaén;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QIV;1.363
23 Jaén;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
23 Jaén;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
23 Jaén;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
23 Jaén;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2022QIV;1.462
23 Jaén;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
23 Jaén;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2022QII;""
23 Jaén;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2022QI;""
23 Jaén;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2021QIV;1.384
23 Jaén;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
23 Jaén;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2021QII;""
23 Jaén;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2021QI;""
23 Jaén;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2020QIV;1.293
23 Jaén;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
23 Jaén;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2020QII;""
23 Jaén;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2020QI;""
23 Jaén;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
23 Jaén;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
23 Jaén;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2022QII;""
23 Jaén;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2022QI;1.328
23 Jaén;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
23 Jaén;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
23 Jaén;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2021QII;""
23 Jaén;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2021QI;1.260
23 Jaén;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
23 Jaén;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
23 Jaén;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2020QII;""
23 Jaén;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2020QI;""
23 Jaén;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
23 Jaén;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
23 Jaén;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QII;1.270
23 Jaén;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QI;""
23 Jaén;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
23 Jaén;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
23 Jaén;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QII;1.201
23 Jaén;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QI;""
23 Jaén;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
23 Jaén;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
23 Jaén;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QII;""
23 Jaén;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QI;""
23 Jaén;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
23 Jaén;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QIII;1.214
23 Jaén;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QII;""
23 Jaén;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QI;""
23 Jaén;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
23 Jaén;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QIII;1.146
23 Jaén;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QII;""
23 Jaén;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QI;""
23 Jaén;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
23 Jaén;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
23 Jaén;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QII;""
23 Jaén;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QI;""
23 Jaén;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
23 Jaén;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
23 Jaén;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
23 Jaén;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
23 Jaén;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
23 Jaén;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
23 Jaén;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
23 Jaén;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
23 Jaén;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
23 Jaén;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
23 Jaén;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
23 Jaén;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
23 Jaén;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;92,71
23 Jaén;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
23 Jaén;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
23 Jaén;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
23 Jaén;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;94,34
23 Jaén;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
23 Jaén;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
23 Jaén;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
23 Jaén;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;94,86
23 Jaén;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
23 Jaén;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
23 Jaén;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
23 Jaén;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
23 Jaén;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
23 Jaén;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
23 Jaén;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;90,52
23 Jaén;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
23 Jaén;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
23 Jaén;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
23 Jaén;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;92,44
23 Jaén;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
23 Jaén;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
23 Jaén;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
23 Jaén;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
23 Jaén;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
23 Jaén;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
23 Jaén;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;86,57
23 Jaén;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
23 Jaén;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
23 Jaén;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
23 Jaén;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;88,11
23 Jaén;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
23 Jaén;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
23 Jaén;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
23 Jaén;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
23 Jaén;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
23 Jaén;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
23 Jaén;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;82,75
23 Jaén;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
23 Jaén;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
23 Jaén;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
23 Jaén;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;84,08
23 Jaén;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
23 Jaén;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
23 Jaén;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
23 Jaén;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
23 Jaén;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
23 Jaén;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
24 León;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
24 León;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
24 León;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
24 León;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QI;29.102
24 León;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
24 León;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
24 León;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
24 León;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QI;28.933
24 León;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
24 León;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
24 León;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
24 León;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QI;29.815
24 León;All ages;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
24 León;All ages;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
24 León;All ages;Cohort January 1;Total;Survival in the first trimester;2022QII;""
24 León;All ages;Cohort January 1;Total;Survival in the first trimester;2022QI;28.275
24 León;All ages;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
24 León;All ages;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
24 León;All ages;Cohort January 1;Total;Survival in the first trimester;2021QII;""
24 León;All ages;Cohort January 1;Total;Survival in the first trimester;2021QI;28.237
24 León;All ages;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
24 León;All ages;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
24 León;All ages;Cohort January 1;Total;Survival in the first trimester;2020QII;""
24 León;All ages;Cohort January 1;Total;Survival in the first trimester;2020QI;28.241
24 León;All ages;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
24 León;All ages;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
24 León;All ages;Cohort January 1;Total;Survival in the second trimester;2022QII;27.464
24 León;All ages;Cohort January 1;Total;Survival in the second trimester;2022QI;""
24 León;All ages;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
24 León;All ages;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
24 León;All ages;Cohort January 1;Total;Survival in the second trimester;2021QII;27.587
24 León;All ages;Cohort January 1;Total;Survival in the second trimester;2021QI;""
24 León;All ages;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
24 León;All ages;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
24 León;All ages;Cohort January 1;Total;Survival in the second trimester;2020QII;27.736
24 León;All ages;Cohort January 1;Total;Survival in the second trimester;2020QI;""
24 León;All ages;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
24 León;All ages;Cohort January 1;Total;Survival in the third trimester;2022QIII;26.790
24 León;All ages;Cohort January 1;Total;Survival in the third trimester;2022QII;""
24 León;All ages;Cohort January 1;Total;Survival in the third trimester;2022QI;""
24 León;All ages;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
24 León;All ages;Cohort January 1;Total;Survival in the third trimester;2021QIII;26.983
24 León;All ages;Cohort January 1;Total;Survival in the third trimester;2021QII;""
24 León;All ages;Cohort January 1;Total;Survival in the third trimester;2021QI;""
24 León;All ages;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
24 León;All ages;Cohort January 1;Total;Survival in the third trimester;2020QIII;27.036
24 León;All ages;Cohort January 1;Total;Survival in the third trimester;2020QII;""
24 León;All ages;Cohort January 1;Total;Survival in the third trimester;2020QI;""
24 León;All ages;Cohort January 1;Total;Survival in the third trimester;2022QIV;25.894
24 León;All ages;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
24 León;All ages;Cohort January 1;Total;Survival in the third trimester;2022QII;""
24 León;All ages;Cohort January 1;Total;Survival in the third trimester;2022QI;""
24 León;All ages;Cohort January 1;Total;Survival in the third trimester;2021QIV;26.291
24 León;All ages;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
24 León;All ages;Cohort January 1;Total;Survival in the third trimester;2021QII;""
24 León;All ages;Cohort January 1;Total;Survival in the third trimester;2021QI;""
24 León;All ages;Cohort January 1;Total;Survival in the third trimester;2020QIV;26.346
24 León;All ages;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
24 León;All ages;Cohort January 1;Total;Survival in the third trimester;2020QII;""
24 León;All ages;Cohort January 1;Total;Survival in the third trimester;2020QI;""
24 León;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
24 León;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
24 León;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
24 León;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
24 León;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
24 León;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
24 León;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
24 León;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
24 León;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
24 León;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
24 León;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
24 León;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
24 León;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
24 León;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
24 León;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
24 León;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;97,16
24 León;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
24 León;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
24 León;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
24 León;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;97,59
24 León;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
24 León;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
24 León;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
24 León;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;94,72
24 León;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
24 León;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
24 León;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;94,37
24 León;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
24 León;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
24 León;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
24 León;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;95,35
24 León;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
24 León;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
24 León;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
24 León;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;93,03
24 León;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
24 León;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
24 León;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;92,06
24 León;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
24 León;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
24 León;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
24 León;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;93,26
24 León;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
24 León;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
24 León;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
24 León;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;90,68
24 León;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
24 León;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
24 León;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;88,98
24 León;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
24 León;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
24 León;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
24 León;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;90,87
24 León;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
24 León;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
24 León;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
24 León;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;88,36
24 León;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
24 León;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
24 León;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
24 León;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
24 León;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
24 León;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
24 León;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QI;17.976
24 León;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
24 León;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
24 León;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
24 León;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QI;17.884
24 León;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
24 León;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
24 León;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
24 León;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QI;18.436
24 León;All ages;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
24 León;All ages;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
24 León;All ages;Cohort January 1;Males;Survival in the first trimester;2022QII;""
24 León;All ages;Cohort January 1;Males;Survival in the first trimester;2022QI;17.467
24 León;All ages;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
24 León;All ages;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
24 León;All ages;Cohort January 1;Males;Survival in the first trimester;2021QII;""
24 León;All ages;Cohort January 1;Males;Survival in the first trimester;2021QI;17.472
24 León;All ages;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
24 León;All ages;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
24 León;All ages;Cohort January 1;Males;Survival in the first trimester;2020QII;""
24 León;All ages;Cohort January 1;Males;Survival in the first trimester;2020QI;17.471
24 León;All ages;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
24 León;All ages;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
24 León;All ages;Cohort January 1;Males;Survival in the second trimester;2022QII;17.000
24 León;All ages;Cohort January 1;Males;Survival in the second trimester;2022QI;""
24 León;All ages;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
24 León;All ages;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
24 León;All ages;Cohort January 1;Males;Survival in the second trimester;2021QII;17.095
24 León;All ages;Cohort January 1;Males;Survival in the second trimester;2021QI;""
24 León;All ages;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
24 León;All ages;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
24 León;All ages;Cohort January 1;Males;Survival in the second trimester;2020QII;17.183
24 León;All ages;Cohort January 1;Males;Survival in the second trimester;2020QI;""
24 León;All ages;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
24 León;All ages;Cohort January 1;Males;Survival in the third trimester;2022QIII;16.615
24 León;All ages;Cohort January 1;Males;Survival in the third trimester;2022QII;""
24 León;All ages;Cohort January 1;Males;Survival in the third trimester;2022QI;""
24 León;All ages;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
24 León;All ages;Cohort January 1;Males;Survival in the third trimester;2021QIII;16.722
24 León;All ages;Cohort January 1;Males;Survival in the third trimester;2021QII;""
24 León;All ages;Cohort January 1;Males;Survival in the third trimester;2021QI;""
24 León;All ages;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
24 León;All ages;Cohort January 1;Males;Survival in the third trimester;2020QIII;16.783
24 León;All ages;Cohort January 1;Males;Survival in the third trimester;2020QII;""
24 León;All ages;Cohort January 1;Males;Survival in the third trimester;2020QI;""
24 León;All ages;Cohort January 1;Males;Survival in the third trimester;2022QIV;16.073
24 León;All ages;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
24 León;All ages;Cohort January 1;Males;Survival in the third trimester;2022QII;""
24 León;All ages;Cohort January 1;Males;Survival in the third trimester;2022QI;""
24 León;All ages;Cohort January 1;Males;Survival in the third trimester;2021QIV;16.314
24 León;All ages;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
24 León;All ages;Cohort January 1;Males;Survival in the third trimester;2021QII;""
24 León;All ages;Cohort January 1;Males;Survival in the third trimester;2021QI;""
24 León;All ages;Cohort January 1;Males;Survival in the third trimester;2020QIV;16.379
24 León;All ages;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
24 León;All ages;Cohort January 1;Males;Survival in the third trimester;2020QII;""
24 León;All ages;Cohort January 1;Males;Survival in the third trimester;2020QI;""
24 León;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
24 León;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
24 León;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
24 León;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
24 León;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
24 León;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
24 León;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
24 León;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
24 León;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
24 León;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
24 León;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
24 León;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
24 León;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
24 León;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
24 León;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
24 León;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;97,17
24 León;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
24 León;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
24 León;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
24 León;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;97,7
24 León;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
24 León;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
24 León;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
24 León;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;94,77
24 León;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
24 León;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
24 León;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;94,57
24 León;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
24 León;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
24 León;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
24 León;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;95,59
24 León;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
24 León;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
24 León;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
24 León;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;93,2
24 León;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
24 León;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
24 León;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;92,43
24 León;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
24 León;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
24 León;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
24 León;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;93,5
24 León;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
24 León;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
24 León;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
24 León;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;91,03
24 León;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
24 León;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
24 León;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;89,41
24 León;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
24 León;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
24 León;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
24 León;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;91,22
24 León;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
24 León;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
24 León;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
24 León;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;88,84
24 León;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
24 León;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
24 León;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
24 León;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
24 León;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
24 León;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
24 León;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QI;11.126
24 León;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
24 León;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
24 León;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
24 León;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QI;11.049
24 León;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
24 León;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
24 León;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
24 León;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QI;11.379
24 León;All ages;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
24 León;All ages;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
24 León;All ages;Cohort January 1;Females;Survival in the first trimester;2022QII;""
24 León;All ages;Cohort January 1;Females;Survival in the first trimester;2022QI;10.808
24 León;All ages;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
24 León;All ages;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
24 León;All ages;Cohort January 1;Females;Survival in the first trimester;2021QII;""
24 León;All ages;Cohort January 1;Females;Survival in the first trimester;2021QI;10.765
24 León;All ages;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
24 León;All ages;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
24 León;All ages;Cohort January 1;Females;Survival in the first trimester;2020QII;""
24 León;All ages;Cohort January 1;Females;Survival in the first trimester;2020QI;10.770
24 León;All ages;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
24 León;All ages;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
24 León;All ages;Cohort January 1;Females;Survival in the second trimester;2022QII;10.464
24 León;All ages;Cohort January 1;Females;Survival in the second trimester;2022QI;""
24 León;All ages;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
24 León;All ages;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
24 León;All ages;Cohort January 1;Females;Survival in the second trimester;2021QII;10.492
24 León;All ages;Cohort January 1;Females;Survival in the second trimester;2021QI;""
24 León;All ages;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
24 León;All ages;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
24 León;All ages;Cohort January 1;Females;Survival in the second trimester;2020QII;10.553
24 León;All ages;Cohort January 1;Females;Survival in the second trimester;2020QI;""
24 León;All ages;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
24 León;All ages;Cohort January 1;Females;Survival in the third trimester;2022QIII;10.175
24 León;All ages;Cohort January 1;Females;Survival in the third trimester;2022QII;""
24 León;All ages;Cohort January 1;Females;Survival in the third trimester;2022QI;""
24 León;All ages;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
24 León;All ages;Cohort January 1;Females;Survival in the third trimester;2021QIII;10.261
24 León;All ages;Cohort January 1;Females;Survival in the third trimester;2021QII;""
24 León;All ages;Cohort January 1;Females;Survival in the third trimester;2021QI;""
24 León;All ages;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
24 León;All ages;Cohort January 1;Females;Survival in the third trimester;2020QIII;10.253
24 León;All ages;Cohort January 1;Females;Survival in the third trimester;2020QII;""
24 León;All ages;Cohort January 1;Females;Survival in the third trimester;2020QI;""
24 León;All ages;Cohort January 1;Females;Survival in the third trimester;2022QIV;9.821
24 León;All ages;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
24 León;All ages;Cohort January 1;Females;Survival in the third trimester;2022QII;""
24 León;All ages;Cohort January 1;Females;Survival in the third trimester;2022QI;""
24 León;All ages;Cohort January 1;Females;Survival in the third trimester;2021QIV;9.977
24 León;All ages;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
24 León;All ages;Cohort January 1;Females;Survival in the third trimester;2021QII;""
24 León;All ages;Cohort January 1;Females;Survival in the third trimester;2021QI;""
24 León;All ages;Cohort January 1;Females;Survival in the third trimester;2020QIV;9.967
24 León;All ages;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
24 León;All ages;Cohort January 1;Females;Survival in the third trimester;2020QII;""
24 León;All ages;Cohort January 1;Females;Survival in the third trimester;2020QI;""
24 León;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
24 León;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
24 León;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
24 León;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
24 León;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
24 León;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
24 León;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
24 León;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
24 León;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
24 León;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
24 León;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
24 León;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
24 León;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
24 León;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
24 León;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
24 León;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;97,14
24 León;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
24 León;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
24 León;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
24 León;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;97,43
24 León;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
24 León;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
24 León;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
24 León;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;94,65
24 León;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
24 León;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
24 León;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;94,05
24 León;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
24 León;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
24 León;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
24 León;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;94,96
24 León;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
24 León;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
24 León;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
24 León;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;92,74
24 León;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
24 León;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
24 León;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;91,45
24 León;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
24 León;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
24 León;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
24 León;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;92,87
24 León;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
24 León;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
24 León;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
24 León;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;90,1
24 León;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
24 León;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
24 León;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;88,27
24 León;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
24 León;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
24 León;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
24 León;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;90,3
24 León;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
24 León;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
24 León;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
24 León;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;87,59
24 León;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
24 León;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
24 León;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
24 León;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
24 León;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
24 León;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QII;29.036
24 León;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
24 León;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
24 León;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
24 León;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QII;29.073
24 León;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
24 León;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
24 León;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
24 León;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QII;29.179
24 León;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
24 León;All ages;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
24 León;All ages;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
24 León;All ages;Cohort April 1;Total;Survival in the first trimester;2022QII;28.154
24 León;All ages;Cohort April 1;Total;Survival in the first trimester;2022QI;""
24 León;All ages;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
24 León;All ages;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
24 León;All ages;Cohort April 1;Total;Survival in the first trimester;2021QII;28.333
24 León;All ages;Cohort April 1;Total;Survival in the first trimester;2021QI;""
24 León;All ages;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
24 León;All ages;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
24 León;All ages;Cohort April 1;Total;Survival in the first trimester;2020QII;28.632
24 León;All ages;Cohort April 1;Total;Survival in the first trimester;2020QI;""
24 León;All ages;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
24 León;All ages;Cohort April 1;Total;Survival in the second trimester;2022QIII;27.425
24 León;All ages;Cohort April 1;Total;Survival in the second trimester;2022QII;""
24 León;All ages;Cohort April 1;Total;Survival in the second trimester;2022QI;""
24 León;All ages;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
24 León;All ages;Cohort April 1;Total;Survival in the second trimester;2021QIII;27.662
24 León;All ages;Cohort April 1;Total;Survival in the second trimester;2021QII;""
24 León;All ages;Cohort April 1;Total;Survival in the second trimester;2021QI;""
24 León;All ages;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
24 León;All ages;Cohort April 1;Total;Survival in the second trimester;2020QIII;27.839
24 León;All ages;Cohort April 1;Total;Survival in the second trimester;2020QII;""
24 León;All ages;Cohort April 1;Total;Survival in the second trimester;2020QI;""
24 León;All ages;Cohort April 1;Total;Survival in the third trimester;2022QIV;26.466
24 León;All ages;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
24 León;All ages;Cohort April 1;Total;Survival in the third trimester;2022QII;""
24 León;All ages;Cohort April 1;Total;Survival in the third trimester;2022QI;""
24 León;All ages;Cohort April 1;Total;Survival in the third trimester;2021QIV;26.920
24 León;All ages;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
24 León;All ages;Cohort April 1;Total;Survival in the third trimester;2021QII;""
24 León;All ages;Cohort April 1;Total;Survival in the third trimester;2021QI;""
24 León;All ages;Cohort April 1;Total;Survival in the third trimester;2020QIV;27.077
24 León;All ages;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
24 León;All ages;Cohort April 1;Total;Survival in the third trimester;2020QII;""
24 León;All ages;Cohort April 1;Total;Survival in the third trimester;2020QI;""
24 León;All ages;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
24 León;All ages;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
24 León;All ages;Cohort April 1;Total;Survival in the third trimester;2022QII;""
24 León;All ages;Cohort April 1;Total;Survival in the third trimester;2022QI;26.290
24 León;All ages;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
24 León;All ages;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
24 León;All ages;Cohort April 1;Total;Survival in the third trimester;2021QII;""
24 León;All ages;Cohort April 1;Total;Survival in the third trimester;2021QI;26.532
24 León;All ages;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
24 León;All ages;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
24 León;All ages;Cohort April 1;Total;Survival in the third trimester;2020QII;""
24 León;All ages;Cohort April 1;Total;Survival in the third trimester;2020QI;""
24 León;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
24 León;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
24 León;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
24 León;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
24 León;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
24 León;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
24 León;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
24 León;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
24 León;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
24 León;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
24 León;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
24 León;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
24 León;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
24 León;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
24 León;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;96,96
24 León;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
24 León;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
24 León;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
24 León;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;97,45
24 León;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
24 León;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
24 León;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
24 León;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;98,13
24 León;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
24 León;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
24 León;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;94,45
24 León;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
24 León;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
24 León;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
24 León;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;95,15
24 León;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
24 León;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
24 León;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
24 León;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;95,41
24 León;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
24 León;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
24 León;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;91,15
24 León;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
24 León;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
24 León;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
24 León;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;92,59
24 León;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
24 León;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
24 León;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
24 León;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;92,8
24 León;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
24 León;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
24 León;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
24 León;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
24 León;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
24 León;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
24 León;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;90,43
24 León;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
24 León;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
24 León;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
24 León;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;90,93
24 León;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
24 León;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
24 León;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
24 León;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
24 León;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
24 León;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
24 León;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QII;17.893
24 León;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
24 León;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
24 León;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
24 León;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QII;17.999
24 León;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
24 León;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
24 León;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
24 León;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QII;18.001
24 León;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
24 León;All ages;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
24 León;All ages;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
24 León;All ages;Cohort April 1;Males;Survival in the first trimester;2022QII;17.378
24 León;All ages;Cohort April 1;Males;Survival in the first trimester;2022QI;""
24 León;All ages;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
24 León;All ages;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
24 León;All ages;Cohort April 1;Males;Survival in the first trimester;2021QII;17.556
24 León;All ages;Cohort April 1;Males;Survival in the first trimester;2021QI;""
24 León;All ages;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
24 León;All ages;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
24 León;All ages;Cohort April 1;Males;Survival in the first trimester;2020QII;17.683
24 León;All ages;Cohort April 1;Males;Survival in the first trimester;2020QI;""
24 León;All ages;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
24 León;All ages;Cohort April 1;Males;Survival in the second trimester;2022QIII;16.962
24 León;All ages;Cohort April 1;Males;Survival in the second trimester;2022QII;""
24 León;All ages;Cohort April 1;Males;Survival in the second trimester;2022QI;""
24 León;All ages;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
24 León;All ages;Cohort April 1;Males;Survival in the second trimester;2021QIII;17.146
24 León;All ages;Cohort April 1;Males;Survival in the second trimester;2021QII;""
24 León;All ages;Cohort April 1;Males;Survival in the second trimester;2021QI;""
24 León;All ages;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
24 León;All ages;Cohort April 1;Males;Survival in the second trimester;2020QIII;17.227
24 León;All ages;Cohort April 1;Males;Survival in the second trimester;2020QII;""
24 León;All ages;Cohort April 1;Males;Survival in the second trimester;2020QI;""
24 León;All ages;Cohort April 1;Males;Survival in the third trimester;2022QIV;16.380
24 León;All ages;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
24 León;All ages;Cohort April 1;Males;Survival in the third trimester;2022QII;""
24 León;All ages;Cohort April 1;Males;Survival in the third trimester;2022QI;""
24 León;All ages;Cohort April 1;Males;Survival in the third trimester;2021QIV;16.705
24 León;All ages;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
24 León;All ages;Cohort April 1;Males;Survival in the third trimester;2021QII;""
24 León;All ages;Cohort April 1;Males;Survival in the third trimester;2021QI;""
24 León;All ages;Cohort April 1;Males;Survival in the third trimester;2020QIV;16.783
24 León;All ages;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
24 León;All ages;Cohort April 1;Males;Survival in the third trimester;2020QII;""
24 León;All ages;Cohort April 1;Males;Survival in the third trimester;2020QI;""
24 León;All ages;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
24 León;All ages;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
24 León;All ages;Cohort April 1;Males;Survival in the third trimester;2022QII;""
24 León;All ages;Cohort April 1;Males;Survival in the third trimester;2022QI;16.329
24 León;All ages;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
24 León;All ages;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
24 León;All ages;Cohort April 1;Males;Survival in the third trimester;2021QII;""
24 León;All ages;Cohort April 1;Males;Survival in the third trimester;2021QI;16.475
24 León;All ages;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
24 León;All ages;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
24 León;All ages;Cohort April 1;Males;Survival in the third trimester;2020QII;""
24 León;All ages;Cohort April 1;Males;Survival in the third trimester;2020QI;""
24 León;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
24 León;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
24 León;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
24 León;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
24 León;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
24 León;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
24 León;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
24 León;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
24 León;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
24 León;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
24 León;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
24 León;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
24 León;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
24 León;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
24 León;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;97,12
24 León;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
24 León;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
24 León;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
24 León;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;97,54
24 León;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
24 León;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
24 León;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
24 León;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;98,23
24 León;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
24 León;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
24 León;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;94,8
24 León;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
24 León;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
24 León;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
24 León;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;95,26
24 León;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
24 León;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
24 León;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
24 León;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;95,7
24 León;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
24 León;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
24 León;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;91,54
24 León;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
24 León;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
24 León;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
24 León;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;92,81
24 León;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
24 León;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
24 León;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
24 León;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;93,23
24 León;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
24 León;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
24 León;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
24 León;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
24 León;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
24 León;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
24 León;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;90,72
24 León;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
24 León;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
24 León;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
24 León;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;91,52
24 León;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
24 León;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
24 León;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
24 León;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
24 León;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
24 León;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
24 León;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QII;11.143
24 León;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
24 León;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
24 León;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
24 León;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QII;11.074
24 León;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
24 León;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
24 León;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
24 León;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QII;11.178
24 León;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
24 León;All ages;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
24 León;All ages;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
24 León;All ages;Cohort April 1;Females;Survival in the first trimester;2022QII;10.776
24 León;All ages;Cohort April 1;Females;Survival in the first trimester;2022QI;""
24 León;All ages;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
24 León;All ages;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
24 León;All ages;Cohort April 1;Females;Survival in the first trimester;2021QII;10.777
24 León;All ages;Cohort April 1;Females;Survival in the first trimester;2021QI;""
24 León;All ages;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
24 León;All ages;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
24 León;All ages;Cohort April 1;Females;Survival in the first trimester;2020QII;10.949
24 León;All ages;Cohort April 1;Females;Survival in the first trimester;2020QI;""
24 León;All ages;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
24 León;All ages;Cohort April 1;Females;Survival in the second trimester;2022QIII;10.463
24 León;All ages;Cohort April 1;Females;Survival in the second trimester;2022QII;""
24 León;All ages;Cohort April 1;Females;Survival in the second trimester;2022QI;""
24 León;All ages;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
24 León;All ages;Cohort April 1;Females;Survival in the second trimester;2021QIII;10.516
24 León;All ages;Cohort April 1;Females;Survival in the second trimester;2021QII;""
24 León;All ages;Cohort April 1;Females;Survival in the second trimester;2021QI;""
24 León;All ages;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
24 León;All ages;Cohort April 1;Females;Survival in the second trimester;2020QIII;10.612
24 León;All ages;Cohort April 1;Females;Survival in the second trimester;2020QII;""
24 León;All ages;Cohort April 1;Females;Survival in the second trimester;2020QI;""
24 León;All ages;Cohort April 1;Females;Survival in the third trimester;2022QIV;10.086
24 León;All ages;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
24 León;All ages;Cohort April 1;Females;Survival in the third trimester;2022QII;""
24 León;All ages;Cohort April 1;Females;Survival in the third trimester;2022QI;""
24 León;All ages;Cohort April 1;Females;Survival in the third trimester;2021QIV;10.215
24 León;All ages;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
24 León;All ages;Cohort April 1;Females;Survival in the third trimester;2021QII;""
24 León;All ages;Cohort April 1;Females;Survival in the third trimester;2021QI;""
24 León;All ages;Cohort April 1;Females;Survival in the third trimester;2020QIV;10.294
24 León;All ages;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
24 León;All ages;Cohort April 1;Females;Survival in the third trimester;2020QII;""
24 León;All ages;Cohort April 1;Females;Survival in the third trimester;2020QI;""
24 León;All ages;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
24 León;All ages;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
24 León;All ages;Cohort April 1;Females;Survival in the third trimester;2022QII;""
24 León;All ages;Cohort April 1;Females;Survival in the third trimester;2022QI;9.961
24 León;All ages;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
24 León;All ages;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
24 León;All ages;Cohort April 1;Females;Survival in the third trimester;2021QII;""
24 León;All ages;Cohort April 1;Females;Survival in the third trimester;2021QI;10.057
24 León;All ages;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
24 León;All ages;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
24 León;All ages;Cohort April 1;Females;Survival in the third trimester;2020QII;""
24 León;All ages;Cohort April 1;Females;Survival in the third trimester;2020QI;""
24 León;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
24 León;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
24 León;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
24 León;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
24 León;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
24 León;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
24 León;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
24 León;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
24 León;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
24 León;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
24 León;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
24 León;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
24 León;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
24 León;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
24 León;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;96,71
24 León;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
24 León;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
24 León;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
24 León;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;97,32
24 León;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
24 León;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
24 León;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
24 León;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;97,95
24 León;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
24 León;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
24 León;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;93,9
24 León;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
24 León;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
24 León;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
24 León;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;94,96
24 León;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
24 León;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
24 León;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
24 León;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;94,94
24 León;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
24 León;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
24 León;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;90,51
24 León;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
24 León;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
24 León;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
24 León;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;92,24
24 León;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
24 León;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
24 León;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
24 León;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;92,09
24 León;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
24 León;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
24 León;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
24 León;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
24 León;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
24 León;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
24 León;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;89,95
24 León;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
24 León;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
24 León;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
24 León;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;89,97
24 León;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
24 León;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
24 León;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
24 León;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
24 León;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
24 León;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QIII;29.098
24 León;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
24 León;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
24 León;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
24 León;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QIII;29.230
24 León;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
24 León;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
24 León;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
24 León;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QIII;29.332
24 León;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
24 León;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
24 León;All ages;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
24 León;All ages;Cohort July 1;Total;Survival in the first trimester;2022QIII;28.171
24 León;All ages;Cohort July 1;Total;Survival in the first trimester;2022QII;""
24 León;All ages;Cohort July 1;Total;Survival in the first trimester;2022QI;""
24 León;All ages;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
24 León;All ages;Cohort July 1;Total;Survival in the first trimester;2021QIII;28.436
24 León;All ages;Cohort July 1;Total;Survival in the first trimester;2021QII;""
24 León;All ages;Cohort July 1;Total;Survival in the first trimester;2021QI;""
24 León;All ages;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
24 León;All ages;Cohort July 1;Total;Survival in the first trimester;2020QIII;28.423
24 León;All ages;Cohort July 1;Total;Survival in the first trimester;2020QII;""
24 León;All ages;Cohort July 1;Total;Survival in the first trimester;2020QI;""
24 León;All ages;Cohort July 1;Total;Survival in the second trimester;2022QIV;27.084
24 León;All ages;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
24 León;All ages;Cohort July 1;Total;Survival in the second trimester;2022QII;""
24 León;All ages;Cohort July 1;Total;Survival in the second trimester;2022QI;""
24 León;All ages;Cohort July 1;Total;Survival in the second trimester;2021QIV;27.588
24 León;All ages;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
24 León;All ages;Cohort July 1;Total;Survival in the second trimester;2021QII;""
24 León;All ages;Cohort July 1;Total;Survival in the second trimester;2021QI;""
24 León;All ages;Cohort July 1;Total;Survival in the second trimester;2020QIV;27.585
24 León;All ages;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
24 León;All ages;Cohort July 1;Total;Survival in the second trimester;2020QII;""
24 León;All ages;Cohort July 1;Total;Survival in the second trimester;2020QI;""
24 León;All ages;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
24 León;All ages;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
24 León;All ages;Cohort July 1;Total;Survival in the third trimester;2022QII;""
24 León;All ages;Cohort July 1;Total;Survival in the third trimester;2022QI;26.896
24 León;All ages;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
24 León;All ages;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
24 León;All ages;Cohort July 1;Total;Survival in the third trimester;2021QII;""
24 León;All ages;Cohort July 1;Total;Survival in the third trimester;2021QI;27.010
24 León;All ages;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
24 León;All ages;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
24 León;All ages;Cohort July 1;Total;Survival in the third trimester;2020QII;""
24 León;All ages;Cohort July 1;Total;Survival in the third trimester;2020QI;""
24 León;All ages;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
24 León;All ages;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
24 León;All ages;Cohort July 1;Total;Survival in the third trimester;2022QII;26.237
24 León;All ages;Cohort July 1;Total;Survival in the third trimester;2022QI;""
24 León;All ages;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
24 León;All ages;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
24 León;All ages;Cohort July 1;Total;Survival in the third trimester;2021QII;26.464
24 León;All ages;Cohort July 1;Total;Survival in the third trimester;2021QI;""
24 León;All ages;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
24 León;All ages;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
24 León;All ages;Cohort July 1;Total;Survival in the third trimester;2020QII;""
24 León;All ages;Cohort July 1;Total;Survival in the third trimester;2020QI;""
24 León;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
24 León;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
24 León;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
24 León;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
24 León;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
24 León;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
24 León;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
24 León;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
24 León;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
24 León;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
24 León;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
24 León;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
24 León;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
24 León;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;96,81
24 León;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
24 León;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
24 León;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
24 León;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;97,28
24 León;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
24 León;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
24 León;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
24 León;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;96,9
24 León;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
24 León;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
24 León;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;93,08
24 León;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
24 León;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
24 León;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
24 León;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;94,38
24 León;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
24 León;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
24 León;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
24 León;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;94,04
24 León;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
24 León;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
24 León;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
24 León;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
24 León;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
24 León;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
24 León;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;92,02
24 León;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
24 León;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
24 León;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
24 León;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;92,08
24 León;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
24 León;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
24 León;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
24 León;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
24 León;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
24 León;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
24 León;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;89,76
24 León;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
24 León;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
24 León;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
24 León;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;90,22
24 León;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
24 León;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
24 León;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
24 León;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
24 León;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
24 León;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
24 León;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QIII;17.923
24 León;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
24 León;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
24 León;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
24 León;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QIII;18.105
24 León;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
24 León;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
24 León;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
24 León;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QIII;18.137
24 León;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
24 León;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
24 León;All ages;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
24 León;All ages;Cohort July 1;Males;Survival in the first trimester;2022QIII;17.392
24 León;All ages;Cohort July 1;Males;Survival in the first trimester;2022QII;""
24 León;All ages;Cohort July 1;Males;Survival in the first trimester;2022QI;""
24 León;All ages;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
24 León;All ages;Cohort July 1;Males;Survival in the first trimester;2021QIII;17.618
24 León;All ages;Cohort July 1;Males;Survival in the first trimester;2021QII;""
24 León;All ages;Cohort July 1;Males;Survival in the first trimester;2021QI;""
24 León;All ages;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
24 León;All ages;Cohort July 1;Males;Survival in the first trimester;2020QIII;17.608
24 León;All ages;Cohort July 1;Males;Survival in the first trimester;2020QII;""
24 León;All ages;Cohort July 1;Males;Survival in the first trimester;2020QI;""
24 León;All ages;Cohort July 1;Males;Survival in the second trimester;2022QIV;16.739
24 León;All ages;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
24 León;All ages;Cohort July 1;Males;Survival in the second trimester;2022QII;""
24 León;All ages;Cohort July 1;Males;Survival in the second trimester;2022QI;""
24 León;All ages;Cohort July 1;Males;Survival in the second trimester;2021QIV;17.118
24 León;All ages;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
24 León;All ages;Cohort July 1;Males;Survival in the second trimester;2021QII;""
24 León;All ages;Cohort July 1;Males;Survival in the second trimester;2021QI;""
24 León;All ages;Cohort July 1;Males;Survival in the second trimester;2020QIV;17.109
24 León;All ages;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
24 León;All ages;Cohort July 1;Males;Survival in the second trimester;2020QII;""
24 León;All ages;Cohort July 1;Males;Survival in the second trimester;2020QI;""
24 León;All ages;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
24 León;All ages;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
24 León;All ages;Cohort July 1;Males;Survival in the third trimester;2022QII;""
24 León;All ages;Cohort July 1;Males;Survival in the third trimester;2022QI;16.699
24 León;All ages;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
24 León;All ages;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
24 León;All ages;Cohort July 1;Males;Survival in the third trimester;2021QII;""
24 León;All ages;Cohort July 1;Males;Survival in the third trimester;2021QI;16.780
24 León;All ages;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
24 León;All ages;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
24 León;All ages;Cohort July 1;Males;Survival in the third trimester;2020QII;""
24 León;All ages;Cohort July 1;Males;Survival in the third trimester;2020QI;""
24 León;All ages;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
24 León;All ages;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
24 León;All ages;Cohort July 1;Males;Survival in the third trimester;2022QII;16.306
24 León;All ages;Cohort July 1;Males;Survival in the third trimester;2022QI;""
24 León;All ages;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
24 León;All ages;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
24 León;All ages;Cohort July 1;Males;Survival in the third trimester;2021QII;16.464
24 León;All ages;Cohort July 1;Males;Survival in the third trimester;2021QI;""
24 León;All ages;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
24 León;All ages;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
24 León;All ages;Cohort July 1;Males;Survival in the third trimester;2020QII;""
24 León;All ages;Cohort July 1;Males;Survival in the third trimester;2020QI;""
24 León;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
24 León;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
24 León;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
24 León;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
24 León;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
24 León;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
24 León;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
24 León;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
24 León;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
24 León;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
24 León;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
24 León;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
24 León;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
24 León;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;97,04
24 León;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
24 León;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
24 León;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
24 León;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;97,31
24 León;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
24 León;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
24 León;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
24 León;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;97,08
24 León;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
24 León;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
24 León;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;93,39
24 León;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
24 León;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
24 León;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
24 León;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;94,55
24 León;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
24 León;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
24 León;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
24 León;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;94,33
24 León;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
24 León;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
24 León;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
24 León;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
24 León;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
24 León;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
24 León;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;92,23
24 León;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
24 León;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
24 León;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
24 León;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;92,52
24 León;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
24 León;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
24 León;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
24 León;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
24 León;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
24 León;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
24 León;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;90,06
24 León;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
24 León;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
24 León;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
24 León;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;90,78
24 León;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
24 León;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
24 León;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
24 León;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
24 León;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
24 León;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
24 León;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QIII;11.175
24 León;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
24 León;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
24 León;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
24 León;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QIII;11.125
24 León;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
24 León;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
24 León;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
24 León;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QIII;11.195
24 León;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
24 León;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
24 León;All ages;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
24 León;All ages;Cohort July 1;Females;Survival in the first trimester;2022QIII;10.779
24 León;All ages;Cohort July 1;Females;Survival in the first trimester;2022QII;""
24 León;All ages;Cohort July 1;Females;Survival in the first trimester;2022QI;""
24 León;All ages;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
24 León;All ages;Cohort July 1;Females;Survival in the first trimester;2021QIII;10.818
24 León;All ages;Cohort July 1;Females;Survival in the first trimester;2021QII;""
24 León;All ages;Cohort July 1;Females;Survival in the first trimester;2021QI;""
24 León;All ages;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
24 León;All ages;Cohort July 1;Females;Survival in the first trimester;2020QIII;10.815
24 León;All ages;Cohort July 1;Females;Survival in the first trimester;2020QII;""
24 León;All ages;Cohort July 1;Females;Survival in the first trimester;2020QI;""
24 León;All ages;Cohort July 1;Females;Survival in the second trimester;2022QIV;10.345
24 León;All ages;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
24 León;All ages;Cohort July 1;Females;Survival in the second trimester;2022QII;""
24 León;All ages;Cohort July 1;Females;Survival in the second trimester;2022QI;""
24 León;All ages;Cohort July 1;Females;Survival in the second trimester;2021QIV;10.470
24 León;All ages;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
24 León;All ages;Cohort July 1;Females;Survival in the second trimester;2021QII;""
24 León;All ages;Cohort July 1;Females;Survival in the second trimester;2021QI;""
24 León;All ages;Cohort July 1;Females;Survival in the second trimester;2020QIV;10.476
24 León;All ages;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
24 León;All ages;Cohort July 1;Females;Survival in the second trimester;2020QII;""
24 León;All ages;Cohort July 1;Females;Survival in the second trimester;2020QI;""
24 León;All ages;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
24 León;All ages;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
24 León;All ages;Cohort July 1;Females;Survival in the third trimester;2022QII;""
24 León;All ages;Cohort July 1;Females;Survival in the third trimester;2022QI;10.197
24 León;All ages;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
24 León;All ages;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
24 León;All ages;Cohort July 1;Females;Survival in the third trimester;2021QII;""
24 León;All ages;Cohort July 1;Females;Survival in the third trimester;2021QI;10.230
24 León;All ages;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
24 León;All ages;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
24 León;All ages;Cohort July 1;Females;Survival in the third trimester;2020QII;""
24 León;All ages;Cohort July 1;Females;Survival in the third trimester;2020QI;""
24 León;All ages;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
24 León;All ages;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
24 León;All ages;Cohort July 1;Females;Survival in the third trimester;2022QII;9.931
24 León;All ages;Cohort July 1;Females;Survival in the third trimester;2022QI;""
24 León;All ages;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
24 León;All ages;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
24 León;All ages;Cohort July 1;Females;Survival in the third trimester;2021QII;10.000
24 León;All ages;Cohort July 1;Females;Survival in the third trimester;2021QI;""
24 León;All ages;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
24 León;All ages;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
24 León;All ages;Cohort July 1;Females;Survival in the third trimester;2020QII;""
24 León;All ages;Cohort July 1;Females;Survival in the third trimester;2020QI;""
24 León;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
24 León;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
24 León;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
24 León;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
24 León;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
24 León;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
24 León;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
24 León;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
24 León;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
24 León;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
24 León;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
24 León;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
24 León;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
24 León;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;96,46
24 León;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
24 León;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
24 León;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
24 León;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;97,24
24 León;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
24 León;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
24 León;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
24 León;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;96,61
24 León;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
24 León;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
24 León;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;92,57
24 León;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
24 León;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
24 León;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
24 León;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;94,11
24 León;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
24 León;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
24 León;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
24 León;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;93,58
24 León;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
24 León;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
24 León;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
24 León;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
24 León;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
24 León;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
24 León;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;91,66
24 León;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
24 León;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
24 León;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
24 León;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;91,38
24 León;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
24 León;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
24 León;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
24 León;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
24 León;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
24 León;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
24 León;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;89,27
24 León;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
24 León;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
24 León;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
24 León;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;89,33
24 León;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
24 León;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
24 León;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
24 León;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
24 León;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
24 León;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QIV;28.874
24 León;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
24 León;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
24 León;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
24 León;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QIV;29.283
24 León;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
24 León;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
24 León;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
24 León;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QIV;29.256
24 León;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
24 León;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
24 León;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
24 León;All ages;Cohort October 1;Total;Survival in the first trimester;2022QIV;27.705
24 León;All ages;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
24 León;All ages;Cohort October 1;Total;Survival in the first trimester;2022QII;""
24 León;All ages;Cohort October 1;Total;Survival in the first trimester;2022QI;""
24 León;All ages;Cohort October 1;Total;Survival in the first trimester;2021QIV;28.322
24 León;All ages;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
24 León;All ages;Cohort October 1;Total;Survival in the first trimester;2021QII;""
24 León;All ages;Cohort October 1;Total;Survival in the first trimester;2021QI;""
24 León;All ages;Cohort October 1;Total;Survival in the first trimester;2020QIV;28.300
24 León;All ages;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
24 León;All ages;Cohort October 1;Total;Survival in the first trimester;2020QII;""
24 León;All ages;Cohort October 1;Total;Survival in the first trimester;2020QI;""
24 León;All ages;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
24 León;All ages;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
24 León;All ages;Cohort October 1;Total;Survival in the second trimester;2022QII;""
24 León;All ages;Cohort October 1;Total;Survival in the second trimester;2022QI;27.573
24 León;All ages;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
24 León;All ages;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
24 León;All ages;Cohort October 1;Total;Survival in the second trimester;2021QII;""
24 León;All ages;Cohort October 1;Total;Survival in the second trimester;2021QI;27.673
24 León;All ages;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
24 León;All ages;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
24 León;All ages;Cohort October 1;Total;Survival in the second trimester;2020QII;""
24 León;All ages;Cohort October 1;Total;Survival in the second trimester;2020QI;""
24 León;All ages;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
24 León;All ages;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
24 León;All ages;Cohort October 1;Total;Survival in the third trimester;2022QII;26.866
24 León;All ages;Cohort October 1;Total;Survival in the third trimester;2022QI;""
24 León;All ages;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
24 León;All ages;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
24 León;All ages;Cohort October 1;Total;Survival in the third trimester;2021QII;27.089
24 León;All ages;Cohort October 1;Total;Survival in the third trimester;2021QI;""
24 León;All ages;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
24 León;All ages;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
24 León;All ages;Cohort October 1;Total;Survival in the third trimester;2020QII;""
24 León;All ages;Cohort October 1;Total;Survival in the third trimester;2020QI;""
24 León;All ages;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
24 León;All ages;Cohort October 1;Total;Survival in the third trimester;2022QIII;26.243
24 León;All ages;Cohort October 1;Total;Survival in the third trimester;2022QII;""
24 León;All ages;Cohort October 1;Total;Survival in the third trimester;2022QI;""
24 León;All ages;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
24 León;All ages;Cohort October 1;Total;Survival in the third trimester;2021QIII;26.518
24 León;All ages;Cohort October 1;Total;Survival in the third trimester;2021QII;""
24 León;All ages;Cohort October 1;Total;Survival in the third trimester;2021QI;""
24 León;All ages;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
24 León;All ages;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
24 León;All ages;Cohort October 1;Total;Survival in the third trimester;2020QII;""
24 León;All ages;Cohort October 1;Total;Survival in the third trimester;2020QI;""
24 León;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
24 León;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
24 León;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
24 León;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
24 León;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
24 León;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
24 León;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
24 León;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
24 León;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
24 León;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
24 León;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
24 León;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
24 León;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;95,95
24 León;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
24 León;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
24 León;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
24 León;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;96,72
24 León;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
24 León;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
24 León;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
24 León;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;96,73
24 León;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
24 León;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
24 León;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
24 León;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
24 León;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
24 León;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
24 León;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;94,16
24 León;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
24 León;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
24 León;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
24 León;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;94,59
24 León;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
24 León;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
24 León;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
24 León;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
24 León;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
24 León;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
24 León;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;91,75
24 León;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
24 León;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
24 León;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
24 León;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;92,59
24 León;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
24 León;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
24 León;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
24 León;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
24 León;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
24 León;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
24 León;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;89,62
24 León;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
24 León;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
24 León;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
24 León;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;90,64
24 León;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
24 León;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
24 León;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
24 León;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
24 León;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
24 León;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
24 León;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QIV;17.773
24 León;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
24 León;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
24 León;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
24 León;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QIV;18.126
24 León;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
24 León;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
24 León;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
24 León;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QIV;18.111
24 León;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
24 León;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
24 León;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
24 León;All ages;Cohort October 1;Males;Survival in the first trimester;2022QIV;17.068
24 León;All ages;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
24 León;All ages;Cohort October 1;Males;Survival in the first trimester;2022QII;""
24 León;All ages;Cohort October 1;Males;Survival in the first trimester;2022QI;""
24 León;All ages;Cohort October 1;Males;Survival in the first trimester;2021QIV;17.559
24 León;All ages;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
24 León;All ages;Cohort October 1;Males;Survival in the first trimester;2021QII;""
24 León;All ages;Cohort October 1;Males;Survival in the first trimester;2021QI;""
24 León;All ages;Cohort October 1;Males;Survival in the first trimester;2020QIV;17.532
24 León;All ages;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
24 León;All ages;Cohort October 1;Males;Survival in the first trimester;2020QII;""
24 León;All ages;Cohort October 1;Males;Survival in the first trimester;2020QI;""
24 León;All ages;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
24 León;All ages;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
24 León;All ages;Cohort October 1;Males;Survival in the second trimester;2022QII;""
24 León;All ages;Cohort October 1;Males;Survival in the second trimester;2022QI;17.106
24 León;All ages;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
24 León;All ages;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
24 León;All ages;Cohort October 1;Males;Survival in the second trimester;2021QII;""
24 León;All ages;Cohort October 1;Males;Survival in the second trimester;2021QI;17.171
24 León;All ages;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
24 León;All ages;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
24 León;All ages;Cohort October 1;Males;Survival in the second trimester;2020QII;""
24 León;All ages;Cohort October 1;Males;Survival in the second trimester;2020QI;""
24 León;All ages;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
24 León;All ages;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
24 León;All ages;Cohort October 1;Males;Survival in the third trimester;2022QII;16.684
24 León;All ages;Cohort October 1;Males;Survival in the third trimester;2022QI;""
24 León;All ages;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
24 León;All ages;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
24 León;All ages;Cohort October 1;Males;Survival in the third trimester;2021QII;16.827
24 León;All ages;Cohort October 1;Males;Survival in the third trimester;2021QI;""
24 León;All ages;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
24 León;All ages;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
24 León;All ages;Cohort October 1;Males;Survival in the third trimester;2020QII;""
24 León;All ages;Cohort October 1;Males;Survival in the third trimester;2020QI;""
24 León;All ages;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
24 León;All ages;Cohort October 1;Males;Survival in the third trimester;2022QIII;16.329
24 León;All ages;Cohort October 1;Males;Survival in the third trimester;2022QII;""
24 León;All ages;Cohort October 1;Males;Survival in the third trimester;2022QI;""
24 León;All ages;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
24 León;All ages;Cohort October 1;Males;Survival in the third trimester;2021QIII;16.477
24 León;All ages;Cohort October 1;Males;Survival in the third trimester;2021QII;""
24 León;All ages;Cohort October 1;Males;Survival in the third trimester;2021QI;""
24 León;All ages;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
24 León;All ages;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
24 León;All ages;Cohort October 1;Males;Survival in the third trimester;2020QII;""
24 León;All ages;Cohort October 1;Males;Survival in the third trimester;2020QI;""
24 León;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
24 León;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
24 León;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
24 León;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
24 León;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
24 León;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
24 León;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
24 León;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
24 León;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
24 León;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
24 León;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
24 León;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
24 León;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;96,03
24 León;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
24 León;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
24 León;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
24 León;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;96,87
24 León;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
24 León;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
24 León;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
24 León;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;96,8
24 León;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
24 León;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
24 León;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
24 León;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
24 León;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
24 León;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
24 León;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;94,37
24 León;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
24 León;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
24 León;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
24 León;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;94,81
24 León;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
24 León;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
24 León;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
24 León;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
24 León;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
24 León;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
24 León;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;92,04
24 León;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
24 León;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
24 León;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
24 León;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;92,91
24 León;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
24 León;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
24 León;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
24 León;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
24 León;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
24 León;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
24 León;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;90,09
24 León;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
24 León;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
24 León;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
24 León;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;90,98
24 León;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
24 León;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
24 León;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
24 León;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
24 León;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
24 León;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
24 León;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QIV;11.101
24 León;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
24 León;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
24 León;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
24 León;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QIV;11.157
24 León;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
24 León;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
24 León;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
24 León;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QIV;11.145
24 León;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
24 León;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
24 León;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
24 León;All ages;Cohort October 1;Females;Survival in the first trimester;2022QIV;10.637
24 León;All ages;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
24 León;All ages;Cohort October 1;Females;Survival in the first trimester;2022QII;""
24 León;All ages;Cohort October 1;Females;Survival in the first trimester;2022QI;""
24 León;All ages;Cohort October 1;Females;Survival in the first trimester;2021QIV;10.763
24 León;All ages;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
24 León;All ages;Cohort October 1;Females;Survival in the first trimester;2021QII;""
24 León;All ages;Cohort October 1;Females;Survival in the first trimester;2021QI;""
24 León;All ages;Cohort October 1;Females;Survival in the first trimester;2020QIV;10.768
24 León;All ages;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
24 León;All ages;Cohort October 1;Females;Survival in the first trimester;2020QII;""
24 León;All ages;Cohort October 1;Females;Survival in the first trimester;2020QI;""
24 León;All ages;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
24 León;All ages;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
24 León;All ages;Cohort October 1;Females;Survival in the second trimester;2022QII;""
24 León;All ages;Cohort October 1;Females;Survival in the second trimester;2022QI;10.467
24 León;All ages;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
24 León;All ages;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
24 León;All ages;Cohort October 1;Females;Survival in the second trimester;2021QII;""
24 León;All ages;Cohort October 1;Females;Survival in the second trimester;2021QI;10.502
24 León;All ages;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
24 León;All ages;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
24 León;All ages;Cohort October 1;Females;Survival in the second trimester;2020QII;""
24 León;All ages;Cohort October 1;Females;Survival in the second trimester;2020QI;""
24 León;All ages;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
24 León;All ages;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
24 León;All ages;Cohort October 1;Females;Survival in the third trimester;2022QII;10.182
24 León;All ages;Cohort October 1;Females;Survival in the third trimester;2022QI;""
24 León;All ages;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
24 León;All ages;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
24 León;All ages;Cohort October 1;Females;Survival in the third trimester;2021QII;10.262
24 León;All ages;Cohort October 1;Females;Survival in the third trimester;2021QI;""
24 León;All ages;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
24 León;All ages;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
24 León;All ages;Cohort October 1;Females;Survival in the third trimester;2020QII;""
24 León;All ages;Cohort October 1;Females;Survival in the third trimester;2020QI;""
24 León;All ages;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
24 León;All ages;Cohort October 1;Females;Survival in the third trimester;2022QIII;9.914
24 León;All ages;Cohort October 1;Females;Survival in the third trimester;2022QII;""
24 León;All ages;Cohort October 1;Females;Survival in the third trimester;2022QI;""
24 León;All ages;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
24 León;All ages;Cohort October 1;Females;Survival in the third trimester;2021QIII;10.041
24 León;All ages;Cohort October 1;Females;Survival in the third trimester;2021QII;""
24 León;All ages;Cohort October 1;Females;Survival in the third trimester;2021QI;""
24 León;All ages;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
24 León;All ages;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
24 León;All ages;Cohort October 1;Females;Survival in the third trimester;2020QII;""
24 León;All ages;Cohort October 1;Females;Survival in the third trimester;2020QI;""
24 León;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
24 León;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
24 León;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
24 León;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
24 León;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
24 León;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
24 León;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
24 León;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
24 León;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
24 León;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
24 León;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
24 León;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
24 León;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;95,82
24 León;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
24 León;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
24 León;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
24 León;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;96,47
24 León;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
24 León;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
24 León;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
24 León;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;96,62
24 León;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
24 León;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
24 León;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
24 León;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
24 León;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
24 León;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
24 León;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;93,82
24 León;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
24 León;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
24 León;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
24 León;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;94,23
24 León;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
24 León;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
24 León;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
24 León;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
24 León;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
24 León;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
24 León;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;91,26
24 León;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
24 León;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
24 León;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
24 León;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;92,08
24 León;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
24 León;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
24 León;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
24 León;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
24 León;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
24 León;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
24 León;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;88,86
24 León;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
24 León;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
24 León;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
24 León;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;90,09
24 León;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
24 León;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
24 León;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
24 León;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
24 León;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
24 León;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
24 León;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
24 León;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
24 León;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
24 León;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QI;1.508
24 León;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
24 León;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
24 León;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
24 León;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QI;1.417
24 León;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
24 León;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
24 León;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
24 León;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QI;1.207
24 León;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
24 León;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
24 León;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2022QII;""
24 León;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2022QI;1.401
24 León;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
24 León;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
24 León;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2021QII;""
24 León;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2021QI;1.325
24 León;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
24 León;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
24 León;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2020QII;""
24 León;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2020QI;1.067
24 León;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
24 León;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
24 León;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2022QII;1.302
24 León;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2022QI;""
24 León;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
24 León;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
24 León;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2021QII;1.248
24 León;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2021QI;""
24 León;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
24 León;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
24 León;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2020QII;1.024
24 León;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2020QI;""
24 León;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
24 León;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QIII;1.200
24 León;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QII;""
24 León;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QI;""
24 León;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
24 León;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QIII;1.180
24 León;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QII;""
24 León;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QI;""
24 León;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
24 León;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QIII;958
24 León;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QII;""
24 León;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QI;""
24 León;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QIV;1.127
24 León;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
24 León;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QII;""
24 León;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QI;""
24 León;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QIV;1.113
24 León;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
24 León;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QII;""
24 León;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QI;""
24 León;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QIV;910
24 León;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
24 León;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QII;""
24 León;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QI;""
24 León;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
24 León;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
24 León;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
24 León;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
24 León;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
24 León;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
24 León;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
24 León;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
24 León;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
24 León;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
24 León;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
24 León;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
24 León;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
24 León;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
24 León;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
24 León;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;92,9
24 León;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
24 León;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
24 León;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
24 León;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;93,51
24 León;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
24 León;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
24 León;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
24 León;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;88,4
24 León;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
24 León;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
24 León;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;86,34
24 León;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
24 León;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
24 León;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
24 León;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;88,07
24 León;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
24 León;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
24 León;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
24 León;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;84,84
24 León;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
24 León;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
24 León;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;79,58
24 León;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
24 León;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
24 León;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
24 León;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;83,27
24 León;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
24 León;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
24 León;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
24 León;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;79,37
24 León;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
24 León;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
24 León;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;74,73
24 León;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
24 León;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
24 León;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
24 León;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;78,55
24 León;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
24 León;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
24 León;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
24 León;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;75,39
24 León;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
24 León;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
24 León;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
24 León;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
24 León;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
24 León;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
24 León;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QI;948
24 León;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
24 León;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
24 León;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
24 León;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QI;862
24 León;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
24 León;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
24 León;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
24 León;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QI;760
24 León;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
24 León;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
24 León;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2022QII;""
24 León;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2022QI;875
24 León;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
24 León;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
24 León;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2021QII;""
24 León;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2021QI;812
24 León;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
24 León;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
24 León;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2020QII;""
24 León;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2020QI;662
24 León;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
24 León;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
24 León;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2022QII;811
24 León;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2022QI;""
24 León;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
24 León;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
24 León;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2021QII;760
24 León;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2021QI;""
24 León;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
24 León;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
24 León;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2020QII;633
24 León;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2020QI;""
24 León;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
24 León;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QIII;756
24 León;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QII;""
24 León;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QI;""
24 León;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
24 León;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QIII;715
24 León;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QII;""
24 León;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QI;""
24 León;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
24 León;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QIII;587
24 León;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QII;""
24 León;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QI;""
24 León;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QIV;709
24 León;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
24 León;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QII;""
24 León;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QI;""
24 León;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QIV;676
24 León;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
24 León;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QII;""
24 León;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QI;""
24 León;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QIV;554
24 León;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
24 León;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QII;""
24 León;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QI;""
24 León;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
24 León;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
24 León;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
24 León;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
24 León;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
24 León;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
24 León;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
24 León;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
24 León;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
24 León;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
24 León;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
24 León;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
24 León;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
24 León;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
24 León;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
24 León;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;92,3
24 León;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
24 León;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
24 León;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
24 León;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;94,2
24 León;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
24 León;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
24 León;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
24 León;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;87,11
24 León;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
24 León;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
24 León;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;85,55
24 León;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
24 León;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
24 León;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
24 León;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;88,17
24 León;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
24 León;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
24 León;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
24 León;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;83,29
24 León;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
24 León;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
24 León;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;79,75
24 León;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
24 León;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
24 León;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
24 León;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;82,95
24 León;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
24 León;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
24 León;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
24 León;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;77,24
24 León;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
24 León;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
24 León;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;74,79
24 León;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
24 León;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
24 León;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
24 León;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;78,42
24 León;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
24 León;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
24 León;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
24 León;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;72,89
24 León;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
24 León;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
24 León;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
24 León;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
24 León;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
24 León;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
24 León;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QI;560
24 León;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
24 León;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
24 León;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
24 León;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QI;555
24 León;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
24 León;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
24 León;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
24 León;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QI;447
24 León;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
24 León;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
24 León;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2022QII;""
24 León;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2022QI;526
24 León;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
24 León;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
24 León;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2021QII;""
24 León;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2021QI;513
24 León;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
24 León;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
24 León;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2020QII;""
24 León;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2020QI;405
24 León;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
24 León;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
24 León;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2022QII;491
24 León;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2022QI;""
24 León;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
24 León;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
24 León;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2021QII;488
24 León;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2021QI;""
24 León;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
24 León;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
24 León;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2020QII;391
24 León;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2020QI;""
24 León;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
24 León;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QIII;444
24 León;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QII;""
24 León;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QI;""
24 León;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
24 León;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QIII;465
24 León;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QII;""
24 León;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QI;""
24 León;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
24 León;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QIII;371
24 León;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QII;""
24 León;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QI;""
24 León;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QIV;418
24 León;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
24 León;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QII;""
24 León;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QI;""
24 León;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QIV;437
24 León;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
24 León;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QII;""
24 León;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QI;""
24 León;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QIV;356
24 León;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
24 León;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QII;""
24 León;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QI;""
24 León;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
24 León;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
24 León;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
24 León;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
24 León;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
24 León;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
24 León;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
24 León;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
24 León;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
24 León;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
24 León;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
24 León;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
24 León;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
24 León;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
24 León;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
24 León;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;93,93
24 León;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
24 León;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
24 León;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
24 León;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;92,43
24 León;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
24 León;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
24 León;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
24 León;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;90,6
24 León;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
24 León;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
24 León;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;87,68
24 León;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
24 León;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
24 León;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
24 León;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;87,93
24 León;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
24 León;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
24 León;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
24 León;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;87,47
24 León;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
24 León;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
24 León;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;79,29
24 León;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
24 León;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
24 León;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
24 León;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;83,78
24 León;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
24 León;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
24 León;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
24 León;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;83
24 León;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
24 León;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
24 León;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;74,64
24 León;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
24 León;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
24 León;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
24 León;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;78,74
24 León;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
24 León;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
24 León;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
24 León;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;79,64
24 León;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
24 León;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
24 León;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
24 León;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
24 León;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
24 León;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QII;1.337
24 León;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
24 León;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
24 León;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
24 León;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QII;1.256
24 León;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
24 León;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
24 León;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
24 León;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QII;1.226
24 León;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
24 León;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
24 León;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
24 León;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2022QII;1.236
24 León;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2022QI;""
24 León;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
24 León;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
24 León;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2021QII;1.166
24 León;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2021QI;""
24 León;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
24 León;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
24 León;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2020QII;1.175
24 León;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2020QI;""
24 León;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
24 León;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2022QIII;1.127
24 León;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2022QII;""
24 León;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2022QI;""
24 León;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
24 León;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2021QIII;1.082
24 León;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2021QII;""
24 León;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2021QI;""
24 León;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
24 León;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2020QIII;1.089
24 León;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2020QII;""
24 León;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2020QI;""
24 León;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QIV;1.045
24 León;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
24 León;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QII;""
24 León;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QI;""
24 León;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QIV;1.008
24 León;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
24 León;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QII;""
24 León;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QI;""
24 León;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QIV;1.027
24 León;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
24 León;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QII;""
24 León;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QI;""
24 León;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
24 León;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
24 León;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QII;""
24 León;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QI;957
24 León;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
24 León;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
24 León;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QII;""
24 León;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QI;979
24 León;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
24 León;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
24 León;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QII;""
24 León;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QI;""
24 León;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
24 León;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
24 León;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
24 León;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
24 León;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
24 León;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
24 León;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
24 León;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
24 León;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
24 León;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
24 León;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
24 León;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
24 León;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
24 León;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
24 León;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;92,45
24 León;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
24 León;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
24 León;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
24 León;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;92,83
24 León;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
24 León;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
24 León;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
24 León;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;95,84
24 León;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
24 León;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
24 León;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;84,29
24 León;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
24 León;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
24 León;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
24 León;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;86,15
24 León;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
24 León;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
24 León;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
24 León;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;88,83
24 León;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
24 León;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
24 León;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;78,16
24 León;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
24 León;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
24 León;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
24 León;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;80,25
24 León;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
24 León;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
24 León;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
24 León;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;83,77
24 León;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
24 León;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
24 León;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
24 León;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
24 León;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
24 León;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
24 León;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;76,19
24 León;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
24 León;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
24 León;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
24 León;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;79,85
24 León;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
24 León;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
24 León;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
24 León;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
24 León;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
24 León;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
24 León;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QII;825
24 León;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
24 León;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
24 León;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
24 León;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QII;798
24 León;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
24 León;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
24 León;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
24 León;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QII;761
24 León;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
24 León;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
24 León;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
24 León;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2022QII;760
24 León;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2022QI;""
24 León;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
24 León;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
24 León;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2021QII;735
24 León;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2021QI;""
24 León;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
24 León;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
24 León;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2020QII;728
24 León;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2020QI;""
24 León;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
24 León;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2022QIII;702
24 León;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2022QII;""
24 León;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2022QI;""
24 León;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
24 León;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2021QIII;678
24 León;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2021QII;""
24 León;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2021QI;""
24 León;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
24 León;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2020QIII;673
24 León;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2020QII;""
24 León;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2020QI;""
24 León;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QIV;649
24 León;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
24 León;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QII;""
24 León;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QI;""
24 León;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QIV;631
24 León;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
24 León;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QII;""
24 León;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QI;""
24 León;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QIV;633
24 León;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
24 León;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QII;""
24 León;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QI;""
24 León;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
24 León;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
24 León;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QII;""
24 León;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QI;597
24 León;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
24 León;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
24 León;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QII;""
24 León;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QI;607
24 León;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
24 León;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
24 León;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QII;""
24 León;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QI;""
24 León;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
24 León;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
24 León;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
24 León;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
24 León;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
24 León;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
24 León;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
24 León;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
24 León;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
24 León;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
24 León;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
24 León;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
24 León;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
24 León;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
24 León;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;92,12
24 León;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
24 León;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
24 León;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
24 León;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;92,11
24 León;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
24 León;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
24 León;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
24 León;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;95,66
24 León;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
24 León;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
24 León;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;85,09
24 León;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
24 León;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
24 León;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
24 León;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;84,96
24 León;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
24 León;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
24 León;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
24 León;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;88,44
24 León;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
24 León;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
24 León;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;78,67
24 León;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
24 León;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
24 León;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
24 León;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;79,07
24 León;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
24 León;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
24 León;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
24 León;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;83,18
24 León;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
24 León;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
24 León;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
24 León;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
24 León;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
24 León;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
24 León;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;74,81
24 León;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
24 León;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
24 León;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
24 León;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;79,76
24 León;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
24 León;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
24 León;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
24 León;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
24 León;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
24 León;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
24 León;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QII;512
24 León;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
24 León;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
24 León;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
24 León;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QII;458
24 León;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
24 León;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
24 León;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
24 León;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QII;465
24 León;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
24 León;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
24 León;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
24 León;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2022QII;476
24 León;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2022QI;""
24 León;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
24 León;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
24 León;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2021QII;431
24 León;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2021QI;""
24 León;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
24 León;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
24 León;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2020QII;447
24 León;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2020QI;""
24 León;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
24 León;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2022QIII;425
24 León;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2022QII;""
24 León;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2022QI;""
24 León;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
24 León;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2021QIII;404
24 León;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2021QII;""
24 León;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2021QI;""
24 León;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
24 León;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2020QIII;416
24 León;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2020QII;""
24 León;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2020QI;""
24 León;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QIV;396
24 León;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
24 León;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QII;""
24 León;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QI;""
24 León;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QIV;377
24 León;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
24 León;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QII;""
24 León;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QI;""
24 León;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QIV;394
24 León;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
24 León;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QII;""
24 León;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QI;""
24 León;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
24 León;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
24 León;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QII;""
24 León;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QI;360
24 León;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
24 León;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
24 León;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QII;""
24 León;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QI;372
24 León;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
24 León;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
24 León;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QII;""
24 León;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QI;""
24 León;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
24 León;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
24 León;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
24 León;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
24 León;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
24 León;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
24 León;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
24 León;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
24 León;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
24 León;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
24 León;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
24 León;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
24 León;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
24 León;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
24 León;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;92,97
24 León;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
24 León;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
24 León;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
24 León;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;94,1
24 León;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
24 León;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
24 León;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
24 León;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;96,13
24 León;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
24 León;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
24 León;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;83,01
24 León;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
24 León;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
24 León;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
24 León;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;88,21
24 León;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
24 León;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
24 León;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
24 León;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;89,46
24 León;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
24 León;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
24 León;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;77,34
24 León;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
24 León;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
24 León;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
24 León;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;82,31
24 León;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
24 León;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
24 León;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
24 León;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;84,73
24 León;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
24 León;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
24 León;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
24 León;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
24 León;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
24 León;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
24 León;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;78,6
24 León;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
24 León;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
24 León;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
24 León;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;80
24 León;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
24 León;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
24 León;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
24 León;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
24 León;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
24 León;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QIII;1.439
24 León;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
24 León;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
24 León;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
24 León;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QIII;1.361
24 León;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
24 León;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
24 León;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
24 León;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QIII;1.326
24 León;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
24 León;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
24 León;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
24 León;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2022QIII;1.281
24 León;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2022QII;""
24 León;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2022QI;""
24 León;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
24 León;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2021QIII;1.245
24 León;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2021QII;""
24 León;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2021QI;""
24 León;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
24 León;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2020QIII;1.200
24 León;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2020QII;""
24 León;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2020QI;""
24 León;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2022QIV;1.180
24 León;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
24 León;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2022QII;""
24 León;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2022QI;""
24 León;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2021QIV;1.147
24 León;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
24 León;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2021QII;""
24 León;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2021QI;""
24 León;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2020QIV;1.121
24 León;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
24 León;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2020QII;""
24 León;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2020QI;""
24 León;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
24 León;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
24 León;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QII;""
24 León;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QI;1.085
24 León;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
24 León;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
24 León;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QII;""
24 León;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QI;1.062
24 León;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
24 León;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
24 León;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QII;""
24 León;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QI;""
24 León;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
24 León;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
24 León;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QII;1.023
24 León;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QI;""
24 León;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
24 León;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
24 León;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QII;1.016
24 León;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QI;""
24 León;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
24 León;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
24 León;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QII;""
24 León;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QI;""
24 León;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
24 León;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
24 León;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
24 León;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
24 León;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
24 León;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
24 León;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
24 León;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
24 León;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
24 León;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
24 León;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
24 León;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
24 León;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
24 León;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;89,02
24 León;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
24 León;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
24 León;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
24 León;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;91,48
24 León;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
24 León;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
24 León;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
24 León;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;90,5
24 León;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
24 León;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
24 León;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;82
24 León;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
24 León;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
24 León;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
24 León;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;84,28
24 León;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
24 León;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
24 León;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
24 León;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;84,54
24 León;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
24 León;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
24 León;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
24 León;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
24 León;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
24 León;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
24 León;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;79,72
24 León;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
24 León;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
24 León;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
24 León;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;80,09
24 León;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
24 León;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
24 León;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
24 León;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
24 León;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
24 León;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
24 León;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;75,17
24 León;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
24 León;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
24 León;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
24 León;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;76,62
24 León;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
24 León;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
24 León;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
24 León;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
24 León;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
24 León;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
24 León;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QIII;888
24 León;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
24 León;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
24 León;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
24 León;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QIII;871
24 León;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
24 León;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
24 León;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
24 León;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QIII;834
24 León;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
24 León;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
24 León;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
24 León;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2022QIII;802
24 León;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2022QII;""
24 León;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2022QI;""
24 León;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
24 León;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2021QIII;791
24 León;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2021QII;""
24 León;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2021QI;""
24 León;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
24 León;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2020QIII;755
24 León;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2020QII;""
24 León;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2020QI;""
24 León;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2022QIV;736
24 León;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
24 León;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2022QII;""
24 León;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2022QI;""
24 León;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2021QIV;728
24 León;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
24 León;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2021QII;""
24 León;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2021QI;""
24 León;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2020QIV;700
24 León;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
24 León;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2020QII;""
24 León;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2020QI;""
24 León;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
24 León;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
24 León;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QII;""
24 León;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QI;685
24 León;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
24 León;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
24 León;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QII;""
24 León;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QI;667
24 León;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
24 León;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
24 León;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QII;""
24 León;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QI;""
24 León;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
24 León;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
24 León;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QII;642
24 León;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QI;""
24 León;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
24 León;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
24 León;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QII;637
24 León;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QI;""
24 León;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
24 León;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
24 León;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QII;""
24 León;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QI;""
24 León;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
24 León;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
24 León;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
24 León;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
24 León;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
24 León;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
24 León;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
24 León;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
24 León;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
24 León;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
24 León;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
24 León;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
24 León;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
24 León;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;90,32
24 León;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
24 León;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
24 León;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
24 León;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;90,82
24 León;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
24 León;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
24 León;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
24 León;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;90,53
24 León;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
24 León;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
24 León;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;82,88
24 León;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
24 León;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
24 León;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
24 León;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;83,58
24 León;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
24 León;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
24 León;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
24 León;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;83,93
24 León;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
24 León;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
24 León;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
24 León;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
24 León;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
24 León;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
24 León;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;78,65
24 León;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
24 León;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
24 León;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
24 León;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;79,98
24 León;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
24 León;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
24 León;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
24 León;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
24 León;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
24 León;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
24 León;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;73,71
24 León;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
24 León;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
24 León;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
24 León;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;76,38
24 León;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
24 León;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
24 León;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
24 León;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
24 León;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
24 León;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
24 León;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QIII;551
24 León;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
24 León;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
24 León;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
24 León;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QIII;490
24 León;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
24 León;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
24 León;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
24 León;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QIII;492
24 León;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
24 León;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
24 León;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
24 León;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2022QIII;479
24 León;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2022QII;""
24 León;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2022QI;""
24 León;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
24 León;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2021QIII;454
24 León;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2021QII;""
24 León;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2021QI;""
24 León;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
24 León;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2020QIII;445
24 León;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2020QII;""
24 León;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2020QI;""
24 León;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2022QIV;444
24 León;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
24 León;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2022QII;""
24 León;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2022QI;""
24 León;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2021QIV;419
24 León;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
24 León;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2021QII;""
24 León;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2021QI;""
24 León;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2020QIV;421
24 León;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
24 León;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2020QII;""
24 León;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2020QI;""
24 León;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
24 León;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
24 León;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QII;""
24 León;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QI;400
24 León;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
24 León;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
24 León;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QII;""
24 León;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QI;395
24 León;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
24 León;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
24 León;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QII;""
24 León;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QI;""
24 León;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
24 León;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
24 León;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QII;381
24 León;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QI;""
24 León;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
24 León;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
24 León;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QII;379
24 León;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QI;""
24 León;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
24 León;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
24 León;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QII;""
24 León;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QI;""
24 León;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
24 León;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
24 León;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
24 León;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
24 León;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
24 León;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
24 León;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
24 León;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
24 León;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
24 León;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
24 León;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
24 León;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
24 León;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
24 León;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;86,93
24 León;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
24 León;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
24 León;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
24 León;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;92,65
24 León;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
24 León;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
24 León;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
24 León;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;90,45
24 León;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
24 León;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
24 León;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;80,58
24 León;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
24 León;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
24 León;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
24 León;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;85,51
24 León;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
24 León;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
24 León;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
24 León;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;85,57
24 León;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
24 León;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
24 León;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
24 León;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
24 León;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
24 León;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
24 León;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;81,63
24 León;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
24 León;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
24 León;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
24 León;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;80,28
24 León;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
24 León;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
24 León;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
24 León;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
24 León;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
24 León;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
24 León;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;77,76
24 León;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
24 León;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
24 León;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
24 León;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;77,03
24 León;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
24 León;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
24 León;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
24 León;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
24 León;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
24 León;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QIV;1.428
24 León;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
24 León;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
24 León;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
24 León;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QIV;1.459
24 León;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
24 León;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
24 León;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
24 León;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QIV;1.386
24 León;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
24 León;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
24 León;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
24 León;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2022QIV;1.311
24 León;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
24 León;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2022QII;""
24 León;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2022QI;""
24 León;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2021QIV;1.332
24 León;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
24 León;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2021QII;""
24 León;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2021QI;""
24 León;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2020QIV;1.278
24 León;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
24 León;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2020QII;""
24 León;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2020QI;""
24 León;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
24 León;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
24 León;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2022QII;""
24 León;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2022QI;1.251
24 León;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
24 León;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
24 León;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2021QII;""
24 León;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2021QI;1.206
24 León;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
24 León;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
24 León;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2020QII;""
24 León;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2020QI;""
24 León;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
24 León;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
24 León;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QII;1.172
24 León;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QI;""
24 León;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
24 León;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
24 León;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QII;1.148
24 León;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QI;""
24 León;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
24 León;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
24 León;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QII;""
24 León;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QI;""
24 León;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
24 León;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QIII;1.086
24 León;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QII;""
24 León;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QI;""
24 León;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
24 León;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QIII;1.088
24 León;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QII;""
24 León;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QI;""
24 León;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
24 León;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
24 León;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QII;""
24 León;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QI;""
24 León;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
24 León;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
24 León;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
24 León;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
24 León;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
24 León;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
24 León;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
24 León;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
24 León;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
24 León;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
24 León;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
24 León;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
24 León;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;91,81
24 León;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
24 León;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
24 León;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
24 León;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;91,3
24 León;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
24 León;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
24 León;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
24 León;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;92,21
24 León;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
24 León;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
24 León;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
24 León;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
24 León;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
24 León;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
24 León;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;85,74
24 León;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
24 León;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
24 León;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
24 León;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;87,01
24 León;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
24 León;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
24 León;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
24 León;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
24 León;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
24 León;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
24 León;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;80,33
24 León;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
24 León;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
24 León;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
24 León;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;82,83
24 León;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
24 León;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
24 León;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
24 León;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
24 León;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
24 León;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
24 León;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;74,43
24 León;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
24 León;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
24 León;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
24 León;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;78,5
24 León;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
24 León;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
24 León;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
24 León;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
24 León;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
24 León;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
24 León;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QIV;887
24 León;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
24 León;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
24 León;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
24 León;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QIV;925
24 León;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
24 León;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
24 León;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
24 León;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QIV;864
24 León;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
24 León;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
24 León;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
24 León;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2022QIV;809
24 León;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
24 León;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2022QII;""
24 León;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2022QI;""
24 León;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2021QIV;846
24 León;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
24 León;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2021QII;""
24 León;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2021QI;""
24 León;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2020QIV;787
24 León;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
24 León;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2020QII;""
24 León;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2020QI;""
24 León;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
24 León;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
24 León;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2022QII;""
24 León;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2022QI;790
24 León;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
24 León;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
24 León;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2021QII;""
24 León;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2021QI;748
24 León;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
24 León;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
24 León;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2020QII;""
24 León;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2020QI;""
24 León;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
24 León;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
24 León;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QII;734
24 León;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QI;""
24 León;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
24 León;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
24 León;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QII;709
24 León;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QI;""
24 León;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
24 León;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
24 León;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QII;""
24 León;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QI;""
24 León;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
24 León;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QIII;688
24 León;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QII;""
24 León;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QI;""
24 León;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
24 León;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QIII;671
24 León;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QII;""
24 León;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QI;""
24 León;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
24 León;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
24 León;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QII;""
24 León;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QI;""
24 León;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
24 León;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
24 León;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
24 León;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
24 León;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
24 León;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
24 León;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
24 León;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
24 León;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
24 León;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
24 León;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
24 León;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
24 León;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;91,21
24 León;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
24 León;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
24 León;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
24 León;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;91,46
24 León;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
24 León;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
24 León;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
24 León;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;91,09
24 León;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
24 León;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
24 León;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
24 León;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
24 León;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
24 León;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
24 León;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;85,41
24 León;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
24 León;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
24 León;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
24 León;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;86,57
24 León;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
24 León;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
24 León;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
24 León;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
24 León;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
24 León;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
24 León;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;79,35
24 León;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
24 León;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
24 León;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
24 León;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;82,06
24 León;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
24 León;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
24 León;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
24 León;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
24 León;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
24 León;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
24 León;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;74,38
24 León;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
24 León;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
24 León;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
24 León;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;77,66
24 León;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
24 León;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
24 León;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
24 León;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
24 León;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
24 León;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
24 León;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QIV;541
24 León;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
24 León;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
24 León;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
24 León;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QIV;534
24 León;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
24 León;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
24 León;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
24 León;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QIV;522
24 León;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
24 León;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
24 León;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
24 León;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2022QIV;502
24 León;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
24 León;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2022QII;""
24 León;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2022QI;""
24 León;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2021QIV;486
24 León;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
24 León;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2021QII;""
24 León;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2021QI;""
24 León;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2020QIV;491
24 León;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
24 León;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2020QII;""
24 León;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2020QI;""
24 León;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
24 León;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
24 León;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2022QII;""
24 León;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2022QI;461
24 León;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
24 León;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
24 León;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2021QII;""
24 León;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2021QI;458
24 León;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
24 León;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
24 León;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2020QII;""
24 León;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2020QI;""
24 León;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
24 León;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
24 León;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QII;438
24 León;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QI;""
24 León;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
24 León;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
24 León;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QII;439
24 León;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QI;""
24 León;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
24 León;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
24 León;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QII;""
24 León;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QI;""
24 León;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
24 León;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QIII;398
24 León;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QII;""
24 León;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QI;""
24 León;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
24 León;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QIII;417
24 León;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QII;""
24 León;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QI;""
24 León;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
24 León;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
24 León;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QII;""
24 León;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QI;""
24 León;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
24 León;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
24 León;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
24 León;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
24 León;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
24 León;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
24 León;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
24 León;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
24 León;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
24 León;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
24 León;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
24 León;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
24 León;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;92,79
24 León;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
24 León;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
24 León;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
24 León;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;91,01
24 León;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
24 León;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
24 León;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
24 León;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;94,06
24 León;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
24 León;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
24 León;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
24 León;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
24 León;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
24 León;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
24 León;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;86,33
24 León;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
24 León;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
24 León;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
24 León;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;87,74
24 León;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
24 León;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
24 León;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
24 León;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
24 León;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
24 León;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
24 León;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;82,02
24 León;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
24 León;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
24 León;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
24 León;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;84,1
24 León;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
24 León;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
24 León;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
24 León;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
24 León;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
24 León;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
24 León;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;74,53
24 León;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
24 León;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
24 León;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
24 León;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;79,89
24 León;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
24 León;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
24 León;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
24 León;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
24 León;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
24 León;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
24 León;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
24 León;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
24 León;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
24 León;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QI;4.710
24 León;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
24 León;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
24 León;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
24 León;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QI;4.823
24 León;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
24 León;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
24 León;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
24 León;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QI;4.806
24 León;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
24 León;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
24 León;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2022QII;""
24 León;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2022QI;4.528
24 León;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
24 León;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
24 León;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2021QII;""
24 León;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2021QI;4.699
24 León;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
24 León;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
24 León;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2020QII;""
24 León;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2020QI;4.483
24 León;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
24 León;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
24 León;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2022QII;4.365
24 León;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2022QI;""
24 León;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
24 León;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
24 León;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2021QII;4.568
24 León;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2021QI;""
24 León;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
24 León;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
24 León;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2020QII;4.401
24 León;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2020QI;""
24 León;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
24 León;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QIII;4.235
24 León;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QII;""
24 León;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QI;""
24 León;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
24 León;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QIII;4.451
24 León;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QII;""
24 León;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QI;""
24 León;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
24 León;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QIII;4.263
24 León;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QII;""
24 León;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QI;""
24 León;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QIV;4.097
24 León;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
24 León;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QII;""
24 León;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QI;""
24 León;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QIV;4.332
24 León;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
24 León;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QII;""
24 León;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QI;""
24 León;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QIV;4.128
24 León;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
24 León;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QII;""
24 León;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QI;""
24 León;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
24 León;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
24 León;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
24 León;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
24 León;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
24 León;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
24 León;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
24 León;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
24 León;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
24 León;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
24 León;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
24 León;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
24 León;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
24 León;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
24 León;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
24 León;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;96,14
24 León;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
24 León;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
24 León;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
24 León;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;97,43
24 León;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
24 León;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
24 León;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
24 León;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;93,28
24 León;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
24 León;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
24 León;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;92,68
24 León;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
24 León;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
24 León;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
24 León;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;94,71
24 León;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
24 León;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
24 León;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
24 León;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;91,57
24 León;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
24 León;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
24 León;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;89,92
24 León;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
24 León;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
24 León;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
24 León;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;92,29
24 León;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
24 León;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
24 León;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
24 León;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;88,7
24 León;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
24 León;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
24 León;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;86,99
24 León;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
24 León;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
24 León;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
24 León;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;89,82
24 León;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
24 León;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
24 León;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
24 León;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;85,89
24 León;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
24 León;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
24 León;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
24 León;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
24 León;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
24 León;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
24 León;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QI;2.737
24 León;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
24 León;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
24 León;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
24 León;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QI;2.841
24 León;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
24 León;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
24 León;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
24 León;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QI;2.805
24 León;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
24 León;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
24 León;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2022QII;""
24 León;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2022QI;2.635
24 León;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
24 León;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
24 León;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2021QII;""
24 León;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2021QI;2.759
24 León;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
24 León;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
24 León;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2020QII;""
24 León;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2020QI;2.621
24 León;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
24 León;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
24 León;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2022QII;2.552
24 León;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2022QI;""
24 León;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
24 León;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
24 León;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2021QII;2.690
24 León;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2021QI;""
24 León;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
24 León;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
24 León;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2020QII;2.580
24 León;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2020QI;""
24 León;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
24 León;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QIII;2.479
24 León;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QII;""
24 León;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QI;""
24 León;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
24 León;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QIII;2.618
24 León;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QII;""
24 León;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QI;""
24 León;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
24 León;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QIII;2.511
24 León;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QII;""
24 León;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QI;""
24 León;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QIV;2.405
24 León;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
24 León;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QII;""
24 León;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QI;""
24 León;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QIV;2.557
24 León;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
24 León;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QII;""
24 León;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QI;""
24 León;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QIV;2.439
24 León;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
24 León;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QII;""
24 León;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QI;""
24 León;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
24 León;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
24 León;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
24 León;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
24 León;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
24 León;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
24 León;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
24 León;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
24 León;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
24 León;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
24 León;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
24 León;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
24 León;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
24 León;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
24 León;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
24 León;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;96,27
24 León;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
24 León;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
24 León;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
24 León;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;97,11
24 León;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
24 León;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
24 León;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
24 León;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;93,44
24 León;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
24 León;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
24 León;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;93,24
24 León;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
24 León;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
24 León;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
24 León;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;94,68
24 León;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
24 León;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
24 León;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
24 León;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;91,98
24 León;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
24 León;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
24 León;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;90,57
24 León;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
24 León;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
24 León;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
24 León;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;92,15
24 León;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
24 León;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
24 León;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
24 León;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;89,52
24 León;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
24 León;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
24 León;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;87,87
24 León;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
24 León;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
24 León;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
24 León;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;90
24 León;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
24 León;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
24 León;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
24 León;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;86,95
24 León;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
24 León;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
24 León;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
24 León;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
24 León;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
24 León;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
24 León;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QI;1.973
24 León;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
24 León;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
24 León;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
24 León;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QI;1.982
24 León;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
24 León;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
24 León;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
24 León;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QI;2.001
24 León;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
24 León;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
24 León;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2022QII;""
24 León;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2022QI;1.893
24 León;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
24 León;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
24 León;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2021QII;""
24 León;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2021QI;1.940
24 León;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
24 León;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
24 León;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2020QII;""
24 León;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2020QI;1.862
24 León;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
24 León;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
24 León;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2022QII;1.813
24 León;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2022QI;""
24 León;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
24 León;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
24 León;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2021QII;1.878
24 León;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2021QI;""
24 León;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
24 León;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
24 León;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2020QII;1.821
24 León;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2020QI;""
24 León;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
24 León;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QIII;1.756
24 León;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QII;""
24 León;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QI;""
24 León;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
24 León;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QIII;1.833
24 León;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QII;""
24 León;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QI;""
24 León;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
24 León;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QIII;1.752
24 León;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QII;""
24 León;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QI;""
24 León;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QIV;1.692
24 León;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
24 León;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QII;""
24 León;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QI;""
24 León;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QIV;1.775
24 León;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
24 León;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QII;""
24 León;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QI;""
24 León;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QIV;1.689
24 León;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
24 León;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QII;""
24 León;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QI;""
24 León;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
24 León;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
24 León;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
24 León;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
24 León;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
24 León;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
24 León;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
24 León;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
24 León;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
24 León;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
24 León;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
24 León;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
24 León;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
24 León;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
24 León;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
24 León;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;95,95
24 León;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
24 León;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
24 León;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
24 León;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;97,88
24 León;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
24 León;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
24 León;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
24 León;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;93,05
24 León;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
24 León;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
24 León;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;91,89
24 León;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
24 León;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
24 León;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
24 León;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;94,75
24 León;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
24 León;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
24 León;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
24 León;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;91
24 León;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
24 León;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
24 León;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;89
24 León;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
24 León;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
24 León;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
24 León;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;92,48
24 León;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
24 León;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
24 León;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
24 León;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;87,56
24 León;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
24 León;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
24 León;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;85,76
24 León;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
24 León;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
24 León;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
24 León;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;89,56
24 León;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
24 León;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
24 León;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
24 León;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;84,41
24 León;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
24 León;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
24 León;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
24 León;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
24 León;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
24 León;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QII;4.299
24 León;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
24 León;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
24 León;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
24 León;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QII;4.537
24 León;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
24 León;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
24 León;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
24 León;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QII;4.719
24 León;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
24 León;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
24 León;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
24 León;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2022QII;4.121
24 León;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2022QI;""
24 León;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
24 León;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
24 León;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2021QII;4.387
24 León;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2021QI;""
24 León;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
24 León;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
24 León;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2020QII;4.623
24 León;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2020QI;""
24 León;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
24 León;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2022QIII;3.985
24 León;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2022QII;""
24 León;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2022QI;""
24 León;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
24 León;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2021QIII;4.254
24 León;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2021QII;""
24 León;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2021QI;""
24 León;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
24 León;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2020QIII;4.462
24 León;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2020QII;""
24 León;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2020QI;""
24 León;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QIV;3.848
24 León;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
24 León;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QII;""
24 León;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QI;""
24 León;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QIV;4.134
24 León;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
24 León;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QII;""
24 León;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QI;""
24 León;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QIV;4.312
24 León;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
24 León;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QII;""
24 León;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QI;""
24 León;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
24 León;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
24 León;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QII;""
24 León;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QI;4.001
24 León;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
24 León;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
24 León;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QII;""
24 León;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QI;4.218
24 León;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
24 León;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
24 León;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QII;""
24 León;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QI;""
24 León;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
24 León;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
24 León;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
24 León;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
24 León;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
24 León;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
24 León;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
24 León;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
24 León;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
24 León;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
24 León;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
24 León;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
24 León;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
24 León;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
24 León;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;95,86
24 León;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
24 León;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
24 León;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
24 León;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;96,69
24 León;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
24 León;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
24 León;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
24 León;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;97,97
24 León;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
24 León;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
24 León;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;92,7
24 León;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
24 León;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
24 León;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
24 León;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;93,76
24 León;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
24 León;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
24 León;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
24 León;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;94,55
24 León;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
24 León;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
24 León;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;89,51
24 León;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
24 León;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
24 León;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
24 León;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;91,12
24 León;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
24 León;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
24 León;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
24 León;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;91,38
24 León;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
24 León;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
24 León;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
24 León;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
24 León;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
24 León;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
24 León;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;88,19
24 León;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
24 León;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
24 León;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
24 León;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;89,38
24 León;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
24 León;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
24 León;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
24 León;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
24 León;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
24 León;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
24 León;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QII;2.521
24 León;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
24 León;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
24 León;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
24 León;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QII;2.651
24 León;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
24 León;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
24 León;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
24 León;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QII;2.755
24 León;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
24 León;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
24 León;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
24 León;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2022QII;2.431
24 León;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2022QI;""
24 León;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
24 León;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
24 León;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2021QII;2.567
24 León;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2021QI;""
24 León;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
24 León;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
24 León;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2020QII;2.701
24 León;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2020QI;""
24 León;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
24 León;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2022QIII;2.353
24 León;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2022QII;""
24 León;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2022QI;""
24 León;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
24 León;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2021QIII;2.491
24 León;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2021QII;""
24 León;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2021QI;""
24 León;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
24 León;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2020QIII;2.616
24 León;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2020QII;""
24 León;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2020QI;""
24 León;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QIV;2.278
24 León;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
24 León;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QII;""
24 León;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QI;""
24 León;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QIV;2.429
24 León;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
24 León;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QII;""
24 León;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QI;""
24 León;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QIV;2.537
24 León;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
24 León;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QII;""
24 León;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QI;""
24 León;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
24 León;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
24 León;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QII;""
24 León;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QI;2.354
24 León;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
24 León;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
24 León;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QII;""
24 León;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QI;2.480
24 León;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
24 León;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
24 León;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QII;""
24 León;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QI;""
24 León;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
24 León;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
24 León;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
24 León;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
24 León;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
24 León;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
24 León;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
24 León;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
24 León;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
24 León;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
24 León;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
24 León;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
24 León;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
24 León;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
24 León;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;96,43
24 León;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
24 León;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
24 León;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
24 León;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;96,83
24 León;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
24 León;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
24 León;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
24 León;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;98,04
24 León;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
24 León;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
24 León;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;93,34
24 León;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
24 León;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
24 León;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
24 León;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;93,96
24 León;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
24 León;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
24 León;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
24 León;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;94,95
24 León;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
24 León;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
24 León;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;90,36
24 León;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
24 León;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
24 León;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
24 León;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;91,63
24 León;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
24 León;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
24 León;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
24 León;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;92,09
24 León;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
24 León;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
24 León;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
24 León;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
24 León;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
24 León;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
24 León;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;88,8
24 León;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
24 León;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
24 León;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
24 León;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;90,02
24 León;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
24 León;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
24 León;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
24 León;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
24 León;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
24 León;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
24 León;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QII;1.778
24 León;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
24 León;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
24 León;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
24 León;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QII;1.886
24 León;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
24 León;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
24 León;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
24 León;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QII;1.964
24 León;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
24 León;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
24 León;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
24 León;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2022QII;1.690
24 León;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2022QI;""
24 León;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
24 León;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
24 León;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2021QII;1.820
24 León;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2021QI;""
24 León;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
24 León;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
24 León;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2020QII;1.922
24 León;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2020QI;""
24 León;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
24 León;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2022QIII;1.632
24 León;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2022QII;""
24 León;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2022QI;""
24 León;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
24 León;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2021QIII;1.763
24 León;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2021QII;""
24 León;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2021QI;""
24 León;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
24 León;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2020QIII;1.846
24 León;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2020QII;""
24 León;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2020QI;""
24 León;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QIV;1.570
24 León;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
24 León;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QII;""
24 León;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QI;""
24 León;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QIV;1.705
24 León;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
24 León;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QII;""
24 León;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QI;""
24 León;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QIV;1.775
24 León;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
24 León;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QII;""
24 León;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QI;""
24 León;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
24 León;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
24 León;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QII;""
24 León;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QI;1.647
24 León;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
24 León;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
24 León;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QII;""
24 León;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QI;1.738
24 León;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
24 León;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
24 León;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QII;""
24 León;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QI;""
24 León;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
24 León;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
24 León;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
24 León;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
24 León;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
24 León;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
24 León;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
24 León;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
24 León;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
24 León;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
24 León;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
24 León;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
24 León;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
24 León;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
24 León;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;95,05
24 León;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
24 León;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
24 León;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
24 León;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;96,5
24 León;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
24 León;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
24 León;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
24 León;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;97,86
24 León;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
24 León;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
24 León;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;91,79
24 León;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
24 León;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
24 León;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
24 León;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;93,48
24 León;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
24 León;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
24 León;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
24 León;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;93,99
24 León;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
24 León;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
24 León;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;88,3
24 León;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
24 León;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
24 León;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
24 León;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;90,4
24 León;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
24 León;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
24 León;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
24 León;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;90,38
24 León;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
24 León;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
24 León;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
24 León;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
24 León;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
24 León;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
24 León;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;87,33
24 León;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
24 León;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
24 León;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
24 León;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;88,49
24 León;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
24 León;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
24 León;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
24 León;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
24 León;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
24 León;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QIII;4.360
24 León;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
24 León;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
24 León;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
24 León;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QIII;4.611
24 León;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
24 León;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
24 León;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
24 León;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QIII;4.791
24 León;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
24 León;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
24 León;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
24 León;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2022QIII;4.188
24 León;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2022QII;""
24 León;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2022QI;""
24 León;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
24 León;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2021QIII;4.448
24 León;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2021QII;""
24 León;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2021QI;""
24 León;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
24 León;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2020QIII;4.603
24 León;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2020QII;""
24 León;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2020QI;""
24 León;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2022QIV;4.018
24 León;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
24 León;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2022QII;""
24 León;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2022QI;""
24 León;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2021QIV;4.300
24 León;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
24 León;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2021QII;""
24 León;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2021QI;""
24 León;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2020QIV;4.444
24 León;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
24 León;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2020QII;""
24 León;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2020QI;""
24 León;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
24 León;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
24 León;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QII;""
24 León;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QI;4.149
24 León;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
24 León;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
24 León;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QII;""
24 León;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QI;4.344
24 León;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
24 León;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
24 León;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QII;""
24 León;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QI;""
24 León;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
24 León;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
24 León;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QII;4.025
24 León;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QI;""
24 León;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
24 León;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
24 León;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QII;4.240
24 León;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QI;""
24 León;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
24 León;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
24 León;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QII;""
24 León;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QI;""
24 León;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
24 León;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
24 León;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
24 León;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
24 León;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
24 León;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
24 León;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
24 León;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
24 León;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
24 León;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
24 León;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
24 León;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
24 León;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
24 León;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;96,06
24 León;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
24 León;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
24 León;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
24 León;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;96,46
24 León;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
24 León;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
24 León;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
24 León;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;96,08
24 León;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
24 León;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
24 León;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;92,16
24 León;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
24 León;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
24 León;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
24 León;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;93,26
24 León;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
24 León;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
24 León;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
24 León;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;92,76
24 León;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
24 León;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
24 León;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
24 León;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
24 León;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
24 León;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
24 León;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;89,98
24 León;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
24 León;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
24 León;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
24 León;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;90,67
24 León;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
24 León;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
24 León;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
24 León;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
24 León;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
24 León;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
24 León;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;87,29
24 León;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
24 León;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
24 León;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
24 León;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;88,5
24 León;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
24 León;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
24 León;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
24 León;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
24 León;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
24 León;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
24 León;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QIII;2.559
24 León;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
24 León;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
24 León;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
24 León;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QIII;2.690
24 León;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
24 León;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
24 León;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
24 León;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QIII;2.810
24 León;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
24 León;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
24 León;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
24 León;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2022QIII;2.459
24 León;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2022QII;""
24 León;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2022QI;""
24 León;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
24 León;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2021QIII;2.597
24 León;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2021QII;""
24 León;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2021QI;""
24 León;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
24 León;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2020QIII;2.705
24 León;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2020QII;""
24 León;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2020QI;""
24 León;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2022QIV;2.368
24 León;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
24 León;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2022QII;""
24 León;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2022QI;""
24 León;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2021QIV;2.522
24 León;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
24 León;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2021QII;""
24 León;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2021QI;""
24 León;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2020QIV;2.622
24 León;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
24 León;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2020QII;""
24 León;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2020QI;""
24 León;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
24 León;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
24 León;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QII;""
24 León;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QI;2.437
24 León;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
24 León;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
24 León;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QII;""
24 León;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QI;2.561
24 León;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
24 León;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
24 León;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QII;""
24 León;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QI;""
24 León;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
24 León;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
24 León;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QII;2.372
24 León;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QI;""
24 León;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
24 León;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
24 León;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QII;2.508
24 León;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QI;""
24 León;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
24 León;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
24 León;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QII;""
24 León;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QI;""
24 León;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
24 León;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
24 León;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
24 León;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
24 León;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
24 León;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
24 León;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
24 León;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
24 León;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
24 León;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
24 León;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
24 León;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
24 León;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
24 León;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;96,09
24 León;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
24 León;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
24 León;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
24 León;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;96,54
24 León;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
24 León;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
24 León;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
24 León;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;96,26
24 León;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
24 León;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
24 León;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;92,54
24 León;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
24 León;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
24 León;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
24 León;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;93,75
24 León;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
24 León;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
24 León;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
24 León;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;93,31
24 León;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
24 León;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
24 León;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
24 León;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
24 León;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
24 León;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
24 León;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;90,59
24 León;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
24 León;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
24 León;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
24 León;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;91,14
24 León;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
24 León;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
24 León;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
24 León;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
24 León;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
24 León;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
24 León;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;88,18
24 León;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
24 León;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
24 León;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
24 León;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;89,25
24 León;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
24 León;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
24 León;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
24 León;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
24 León;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
24 León;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
24 León;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QIII;1.801
24 León;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
24 León;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
24 León;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
24 León;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QIII;1.921
24 León;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
24 León;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
24 León;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
24 León;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QIII;1.981
24 León;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
24 León;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
24 León;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
24 León;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2022QIII;1.729
24 León;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2022QII;""
24 León;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2022QI;""
24 León;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
24 León;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2021QIII;1.851
24 León;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2021QII;""
24 León;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2021QI;""
24 León;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
24 León;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2020QIII;1.898
24 León;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2020QII;""
24 León;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2020QI;""
24 León;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2022QIV;1.650
24 León;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
24 León;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2022QII;""
24 León;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2022QI;""
24 León;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2021QIV;1.778
24 León;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
24 León;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2021QII;""
24 León;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2021QI;""
24 León;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2020QIV;1.822
24 León;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
24 León;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2020QII;""
24 León;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2020QI;""
24 León;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
24 León;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
24 León;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QII;""
24 León;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QI;1.712
24 León;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
24 León;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
24 León;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QII;""
24 León;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QI;1.783
24 León;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
24 León;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
24 León;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QII;""
24 León;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QI;""
24 León;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
24 León;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
24 León;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QII;1.653
24 León;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QI;""
24 León;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
24 León;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
24 León;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QII;1.732
24 León;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QI;""
24 León;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
24 León;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
24 León;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QII;""
24 León;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QI;""
24 León;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
24 León;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
24 León;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
24 León;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
24 León;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
24 León;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
24 León;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
24 León;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
24 León;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
24 León;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
24 León;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
24 León;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
24 León;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
24 León;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;96
24 León;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
24 León;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
24 León;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
24 León;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;96,36
24 León;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
24 León;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
24 León;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
24 León;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;95,81
24 León;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
24 León;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
24 León;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;91,62
24 León;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
24 León;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
24 León;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
24 León;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;92,56
24 León;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
24 León;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
24 León;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
24 León;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;91,97
24 León;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
24 León;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
24 León;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
24 León;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
24 León;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
24 León;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
24 León;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;89,12
24 León;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
24 León;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
24 León;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
24 León;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;90,01
24 León;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
24 León;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
24 León;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
24 León;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
24 León;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
24 León;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
24 León;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;86,05
24 León;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
24 León;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
24 León;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
24 León;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;87,43
24 León;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
24 León;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
24 León;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
24 León;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
24 León;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
24 León;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QIV;4.391
24 León;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
24 León;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
24 León;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
24 León;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QIV;4.671
24 León;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
24 León;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
24 León;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
24 León;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QIV;4.825
24 León;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
24 León;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
24 León;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
24 León;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2022QIV;4.200
24 León;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
24 León;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2022QII;""
24 León;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2022QI;""
24 León;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2021QIV;4.493
24 León;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
24 León;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2021QII;""
24 León;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2021QI;""
24 León;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2020QIV;4.639
24 León;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
24 León;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2020QII;""
24 León;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2020QI;""
24 León;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
24 León;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
24 León;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2022QII;""
24 León;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2022QI;4.326
24 León;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
24 León;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
24 León;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2021QII;""
24 León;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2021QI;4.527
24 León;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
24 León;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
24 León;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2020QII;""
24 León;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2020QI;""
24 León;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
24 León;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
24 León;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QII;4.193
24 León;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QI;""
24 León;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
24 León;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
24 León;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QII;4.413
24 León;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QI;""
24 León;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
24 León;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
24 León;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QII;""
24 León;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QI;""
24 León;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
24 León;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QIII;4.078
24 León;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QII;""
24 León;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QI;""
24 León;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
24 León;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QIII;4.307
24 León;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QII;""
24 León;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QI;""
24 León;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
24 León;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
24 León;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QII;""
24 León;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QI;""
24 León;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
24 León;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
24 León;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
24 León;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
24 León;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
24 León;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
24 León;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
24 León;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
24 León;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
24 León;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
24 León;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
24 León;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
24 León;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;95,65
24 León;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
24 León;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
24 León;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
24 León;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;96,19
24 León;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
24 León;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
24 León;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
24 León;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;96,15
24 León;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
24 León;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
24 León;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
24 León;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
24 León;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
24 León;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
24 León;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;92,61
24 León;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
24 León;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
24 León;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
24 León;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;93,82
24 León;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
24 León;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
24 León;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
24 León;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
24 León;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
24 León;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
24 León;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;89,77
24 León;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
24 León;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
24 León;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
24 León;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;91,46
24 León;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
24 León;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
24 León;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
24 León;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
24 León;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
24 León;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
24 León;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;87,3
24 León;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
24 León;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
24 León;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
24 León;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;89,26
24 León;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
24 León;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
24 León;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
24 León;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
24 León;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
24 León;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
24 León;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QIV;2.556
24 León;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
24 León;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
24 León;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
24 León;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QIV;2.722
24 León;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
24 León;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
24 León;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
24 León;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QIV;2.839
24 León;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
24 León;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
24 León;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
24 León;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2022QIV;2.454
24 León;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
24 León;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2022QII;""
24 León;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2022QI;""
24 León;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2021QIV;2.627
24 León;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
24 León;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2021QII;""
24 León;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2021QI;""
24 León;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2020QIV;2.735
24 León;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
24 León;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2020QII;""
24 León;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2020QI;""
24 León;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
24 León;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
24 León;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2022QII;""
24 León;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2022QI;2.535
24 León;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
24 León;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
24 León;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2021QII;""
24 León;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2021QI;2.664
24 León;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
24 León;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
24 León;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2020QII;""
24 León;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2020QI;""
24 León;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
24 León;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
24 León;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QII;2.466
24 León;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QI;""
24 León;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
24 León;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
24 León;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QII;2.605
24 León;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QI;""
24 León;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
24 León;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
24 León;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QII;""
24 León;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QI;""
24 León;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
24 León;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QIII;2.402
24 León;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QII;""
24 León;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QI;""
24 León;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
24 León;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QIII;2.539
24 León;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QII;""
24 León;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QI;""
24 León;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
24 León;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
24 León;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QII;""
24 León;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QI;""
24 León;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
24 León;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
24 León;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
24 León;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
24 León;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
24 León;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
24 León;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
24 León;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
24 León;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
24 León;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
24 León;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
24 León;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
24 León;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;96,01
24 León;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
24 León;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
24 León;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
24 León;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;96,51
24 León;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
24 León;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
24 León;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
24 León;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;96,34
24 León;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
24 León;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
24 León;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
24 León;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
24 León;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
24 León;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
24 León;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;93,13
24 León;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
24 León;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
24 León;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
24 León;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;93,84
24 León;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
24 León;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
24 León;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
24 León;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
24 León;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
24 León;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
24 León;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;90,6
24 León;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
24 León;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
24 León;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
24 León;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;91,76
24 León;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
24 León;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
24 León;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
24 León;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
24 León;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
24 León;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
24 León;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;88,24
24 León;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
24 León;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
24 León;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
24 León;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;89,43
24 León;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
24 León;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
24 León;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
24 León;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
24 León;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
24 León;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
24 León;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QIV;1.835
24 León;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
24 León;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
24 León;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
24 León;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QIV;1.949
24 León;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
24 León;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
24 León;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
24 León;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QIV;1.986
24 León;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
24 León;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
24 León;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
24 León;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2022QIV;1.746
24 León;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
24 León;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2022QII;""
24 León;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2022QI;""
24 León;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2021QIV;1.866
24 León;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
24 León;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2021QII;""
24 León;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2021QI;""
24 León;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2020QIV;1.904
24 León;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
24 León;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2020QII;""
24 León;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2020QI;""
24 León;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
24 León;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
24 León;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2022QII;""
24 León;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2022QI;1.791
24 León;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
24 León;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
24 León;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2021QII;""
24 León;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2021QI;1.863
24 León;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
24 León;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
24 León;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2020QII;""
24 León;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2020QI;""
24 León;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
24 León;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
24 León;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QII;1.727
24 León;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QI;""
24 León;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
24 León;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
24 León;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QII;1.808
24 León;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QI;""
24 León;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
24 León;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
24 León;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QII;""
24 León;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QI;""
24 León;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
24 León;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QIII;1.676
24 León;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QII;""
24 León;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QI;""
24 León;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
24 León;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QIII;1.768
24 León;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QII;""
24 León;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QI;""
24 León;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
24 León;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
24 León;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QII;""
24 León;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QI;""
24 León;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
24 León;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
24 León;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
24 León;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
24 León;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
24 León;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
24 León;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
24 León;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
24 León;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
24 León;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
24 León;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
24 León;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
24 León;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;95,15
24 León;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
24 León;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
24 León;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
24 León;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;95,74
24 León;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
24 León;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
24 León;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
24 León;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;95,87
24 León;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
24 León;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
24 León;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
24 León;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
24 León;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
24 León;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
24 León;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;91,89
24 León;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
24 León;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
24 León;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
24 León;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;93,81
24 León;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
24 León;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
24 León;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
24 León;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
24 León;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
24 León;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
24 León;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;88,61
24 León;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
24 León;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
24 León;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
24 León;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;91,04
24 León;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
24 León;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
24 León;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
24 León;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
24 León;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
24 León;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
24 León;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;85,99
24 León;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
24 León;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
24 León;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
24 León;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;89,02
24 León;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
24 León;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
24 León;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
24 León;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
24 León;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
24 León;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
24 León;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
24 León;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
24 León;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
24 León;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QI;8.610
24 León;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
24 León;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
24 León;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
24 León;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QI;8.749
24 León;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
24 León;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
24 León;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
24 León;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QI;8.865
24 León;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
24 León;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
24 León;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2022QII;""
24 León;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2022QI;8.413
24 León;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
24 León;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
24 León;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2021QII;""
24 León;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2021QI;8.598
24 León;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
24 León;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
24 León;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2020QII;""
24 León;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2020QI;8.418
24 León;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
24 León;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
24 León;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2022QII;8.212
24 León;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2022QI;""
24 León;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
24 León;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
24 León;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2021QII;8.428
24 León;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2021QI;""
24 León;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
24 León;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
24 León;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2020QII;8.306
24 León;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2020QI;""
24 León;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
24 León;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QIII;8.052
24 León;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QII;""
24 León;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QI;""
24 León;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
24 León;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QIII;8.271
24 León;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QII;""
24 León;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QI;""
24 León;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
24 León;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QIII;8.133
24 León;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QII;""
24 León;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QI;""
24 León;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QIV;7.871
24 León;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
24 León;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QII;""
24 León;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QI;""
24 León;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QIV;8.108
24 León;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
24 León;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QII;""
24 León;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QI;""
24 León;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QIV;7.992
24 León;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
24 León;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QII;""
24 León;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QI;""
24 León;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
24 León;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
24 León;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
24 León;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
24 León;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
24 León;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
24 León;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
24 León;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
24 León;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
24 León;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
24 León;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
24 León;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
24 León;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
24 León;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
24 León;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
24 León;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;97,71
24 León;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
24 León;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
24 León;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
24 León;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;98,27
24 León;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
24 León;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
24 León;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
24 León;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;94,96
24 León;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
24 León;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
24 León;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;95,38
24 León;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
24 León;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
24 León;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
24 León;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;96,33
24 León;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
24 León;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
24 León;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
24 León;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;93,69
24 León;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
24 León;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
24 León;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;93,52
24 León;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
24 León;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
24 León;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
24 León;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;94,54
24 León;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
24 León;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
24 León;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
24 León;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;91,74
24 León;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
24 León;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
24 León;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;91,42
24 León;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
24 León;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
24 León;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
24 León;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;92,67
24 León;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
24 León;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
24 León;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
24 León;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;90,15
24 León;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
24 León;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
24 León;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
24 León;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
24 León;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
24 León;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
24 León;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QI;5.372
24 León;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
24 León;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
24 León;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
24 León;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QI;5.469
24 León;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
24 León;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
24 León;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
24 León;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QI;5.524
24 León;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
24 León;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
24 León;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2022QII;""
24 León;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2022QI;5.247
24 León;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
24 León;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
24 León;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2021QII;""
24 León;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2021QI;5.388
24 León;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
24 León;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
24 León;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2020QII;""
24 León;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2020QI;5.257
24 León;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
24 León;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
24 León;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2022QII;5.129
24 León;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2022QI;""
24 León;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
24 León;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
24 León;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2021QII;5.293
24 León;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2021QI;""
24 León;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
24 León;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
24 León;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2020QII;5.200
24 León;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2020QI;""
24 León;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
24 León;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QIII;5.041
24 León;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QII;""
24 León;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QI;""
24 León;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
24 León;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QIII;5.207
24 León;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QII;""
24 León;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QI;""
24 León;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
24 León;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QIII;5.106
24 León;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QII;""
24 León;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QI;""
24 León;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QIV;4.942
24 León;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
24 León;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QII;""
24 León;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QI;""
24 León;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QIV;5.105
24 León;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
24 León;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QII;""
24 León;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QI;""
24 León;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QIV;5.028
24 León;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
24 León;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QII;""
24 León;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QI;""
24 León;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
24 León;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
24 León;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
24 León;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
24 León;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
24 León;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
24 León;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
24 León;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
24 León;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
24 León;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
24 León;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
24 León;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
24 León;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
24 León;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
24 León;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
24 León;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;97,67
24 León;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
24 León;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
24 León;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
24 León;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;98,52
24 León;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
24 León;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
24 León;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
24 León;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;95,17
24 León;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
24 León;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
24 León;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;95,48
24 León;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
24 León;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
24 León;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
24 León;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;96,78
24 León;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
24 León;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
24 León;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
24 León;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;94,13
24 León;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
24 León;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
24 León;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;93,84
24 León;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
24 León;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
24 León;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
24 León;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;95,21
24 León;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
24 León;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
24 León;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
24 León;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;92,43
24 León;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
24 León;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
24 León;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;92
24 León;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
24 León;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
24 León;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
24 León;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;93,34
24 León;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
24 León;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
24 León;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
24 León;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;91,02
24 León;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
24 León;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
24 León;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
24 León;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
24 León;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
24 León;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
24 León;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QI;3.238
24 León;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
24 León;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
24 León;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
24 León;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QI;3.280
24 León;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
24 León;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
24 León;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
24 León;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QI;3.341
24 León;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
24 León;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
24 León;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2022QII;""
24 León;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2022QI;3.166
24 León;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
24 León;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
24 León;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2021QII;""
24 León;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2021QI;3.210
24 León;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
24 León;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
24 León;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2020QII;""
24 León;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2020QI;3.161
24 León;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
24 León;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
24 León;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2022QII;3.083
24 León;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2022QI;""
24 León;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
24 León;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
24 León;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2021QII;3.135
24 León;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2021QI;""
24 León;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
24 León;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
24 León;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2020QII;3.106
24 León;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2020QI;""
24 León;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
24 León;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QIII;3.011
24 León;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QII;""
24 León;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QI;""
24 León;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
24 León;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QIII;3.064
24 León;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QII;""
24 León;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QI;""
24 León;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
24 León;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QIII;3.027
24 León;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QII;""
24 León;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QI;""
24 León;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QIV;2.929
24 León;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
24 León;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QII;""
24 León;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QI;""
24 León;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QIV;3.003
24 León;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
24 León;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QII;""
24 León;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QI;""
24 León;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QIV;2.964
24 León;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
24 León;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QII;""
24 León;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QI;""
24 León;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
24 León;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
24 León;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
24 León;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
24 León;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
24 León;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
24 León;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
24 León;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
24 León;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
24 León;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
24 León;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
24 León;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
24 León;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
24 León;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
24 León;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
24 León;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;97,78
24 León;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
24 León;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
24 León;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
24 León;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;97,87
24 León;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
24 León;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
24 León;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
24 León;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;94,61
24 León;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
24 León;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
24 León;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;95,21
24 León;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
24 León;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
24 León;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
24 León;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;95,58
24 León;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
24 León;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
24 León;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
24 León;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;92,97
24 León;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
24 León;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
24 León;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;92,99
24 León;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
24 León;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
24 León;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
24 León;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;93,41
24 León;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
24 León;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
24 León;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
24 León;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;90,6
24 León;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
24 León;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
24 León;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;90,46
24 León;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
24 León;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
24 León;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
24 León;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;91,55
24 León;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
24 León;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
24 León;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
24 León;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;88,72
24 León;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
24 León;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
24 León;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
24 León;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
24 León;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
24 León;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QII;8.358
24 León;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
24 León;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
24 León;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
24 León;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QII;8.545
24 León;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
24 León;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
24 León;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
24 León;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QII;8.706
24 León;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
24 León;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
24 León;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
24 León;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2022QII;8.139
24 León;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2022QI;""
24 León;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
24 León;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
24 León;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2021QII;8.357
24 León;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2021QI;""
24 León;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
24 León;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
24 León;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2020QII;8.584
24 León;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2020QI;""
24 León;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
24 León;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2022QIII;7.963
24 León;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2022QII;""
24 León;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2022QI;""
24 León;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
24 León;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2021QIII;8.187
24 León;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2021QII;""
24 León;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2021QI;""
24 León;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
24 León;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2020QIII;8.384
24 León;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2020QII;""
24 León;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2020QI;""
24 León;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QIV;7.773
24 León;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
24 León;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QII;""
24 León;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QI;""
24 León;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QIV;8.011
24 León;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
24 León;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QII;""
24 León;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QI;""
24 León;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QIV;8.217
24 León;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
24 León;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QII;""
24 León;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QI;""
24 León;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
24 León;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
24 León;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QII;""
24 León;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QI;7.865
24 León;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
24 León;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
24 León;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QII;""
24 León;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QI;8.111
24 León;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
24 León;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
24 León;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QII;""
24 León;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QI;""
24 León;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
24 León;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
24 León;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
24 León;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
24 León;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
24 León;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
24 León;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
24 León;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
24 León;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
24 León;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
24 León;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
24 León;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
24 León;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
24 León;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
24 León;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;97,38
24 León;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
24 León;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
24 León;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
24 León;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;97,8
24 León;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
24 León;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
24 León;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
24 León;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;98,6
24 León;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
24 León;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
24 León;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;95,27
24 León;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
24 León;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
24 León;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
24 León;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;95,81
24 León;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
24 León;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
24 León;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
24 León;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;96,3
24 León;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
24 León;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
24 León;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;93
24 León;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
24 León;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
24 León;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
24 León;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;93,75
24 León;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
24 León;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
24 León;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
24 León;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;94,38
24 León;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
24 León;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
24 León;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
24 León;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
24 León;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
24 León;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
24 León;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;92,04
24 León;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
24 León;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
24 León;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
24 León;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;93,17
24 León;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
24 León;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
24 León;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
24 León;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
24 León;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
24 León;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
24 León;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QII;5.149
24 León;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
24 León;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
24 León;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
24 León;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QII;5.342
24 León;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
24 León;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
24 León;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
24 León;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QII;5.408
24 León;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
24 León;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
24 León;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
24 León;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2022QII;5.015
24 León;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2022QI;""
24 León;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
24 León;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
24 León;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2021QII;5.233
24 León;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2021QI;""
24 León;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
24 León;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
24 León;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2020QII;5.345
24 León;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2020QI;""
24 León;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
24 León;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2022QIII;4.917
24 León;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2022QII;""
24 León;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2022QI;""
24 León;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
24 León;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2021QIII;5.135
24 León;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2021QII;""
24 León;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2021QI;""
24 León;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
24 León;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2020QIII;5.235
24 León;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2020QII;""
24 León;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2020QI;""
24 León;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QIV;4.814
24 León;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
24 León;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QII;""
24 León;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QI;""
24 León;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QIV;5.025
24 León;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
24 León;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QII;""
24 León;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QI;""
24 León;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QIV;5.141
24 León;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
24 León;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QII;""
24 León;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QI;""
24 León;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
24 León;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
24 León;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QII;""
24 León;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QI;4.935
24 León;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
24 León;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
24 León;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QII;""
24 León;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QI;5.092
24 León;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
24 León;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
24 León;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QII;""
24 León;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QI;""
24 León;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
24 León;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
24 León;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
24 León;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
24 León;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
24 León;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
24 León;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
24 León;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
24 León;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
24 León;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
24 León;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
24 León;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
24 León;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
24 León;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
24 León;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;97,4
24 León;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
24 León;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
24 León;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
24 León;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;97,96
24 León;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
24 León;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
24 León;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
24 León;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;98,84
24 León;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
24 León;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
24 León;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;95,49
24 León;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
24 León;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
24 León;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
24 León;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;96,13
24 León;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
24 León;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
24 León;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
24 León;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;96,8
24 León;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
24 León;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
24 León;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;93,49
24 León;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
24 León;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
24 León;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
24 León;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;94,07
24 León;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
24 León;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
24 León;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
24 León;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;95,06
24 León;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
24 León;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
24 León;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
24 León;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
24 León;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
24 León;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
24 León;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;92,38
24 León;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
24 León;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
24 León;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
24 León;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;94,16
24 León;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
24 León;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
24 León;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
24 León;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
24 León;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
24 León;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
24 León;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QII;3.209
24 León;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
24 León;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
24 León;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
24 León;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QII;3.203
24 León;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
24 León;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
24 León;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
24 León;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QII;3.298
24 León;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
24 León;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
24 León;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
24 León;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2022QII;3.124
24 León;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2022QI;""
24 León;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
24 León;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
24 León;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2021QII;3.124
24 León;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2021QI;""
24 León;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
24 León;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
24 León;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2020QII;3.239
24 León;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2020QI;""
24 León;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
24 León;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2022QIII;3.046
24 León;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2022QII;""
24 León;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2022QI;""
24 León;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
24 León;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2021QIII;3.052
24 León;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2021QII;""
24 León;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2021QI;""
24 León;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
24 León;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2020QIII;3.149
24 León;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2020QII;""
24 León;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2020QI;""
24 León;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QIV;2.959
24 León;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
24 León;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QII;""
24 León;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QI;""
24 León;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QIV;2.986
24 León;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
24 León;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QII;""
24 León;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QI;""
24 León;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QIV;3.076
24 León;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
24 León;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QII;""
24 León;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QI;""
24 León;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
24 León;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
24 León;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QII;""
24 León;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QI;2.930
24 León;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
24 León;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
24 León;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QII;""
24 León;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QI;3.019
24 León;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
24 León;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
24 León;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QII;""
24 León;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QI;""
24 León;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
24 León;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
24 León;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
24 León;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
24 León;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
24 León;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
24 León;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
24 León;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
24 León;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
24 León;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
24 León;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
24 León;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
24 León;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
24 León;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
24 León;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;97,35
24 León;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
24 León;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
24 León;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
24 León;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;97,53
24 León;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
24 León;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
24 León;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
24 León;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;98,21
24 León;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
24 León;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
24 León;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;94,92
24 León;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
24 León;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
24 León;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
24 León;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;95,29
24 León;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
24 León;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
24 León;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
24 León;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;95,48
24 León;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
24 León;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
24 León;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;92,21
24 León;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
24 León;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
24 León;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
24 León;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;93,23
24 León;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
24 León;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
24 León;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
24 León;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;93,27
24 León;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
24 León;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
24 León;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
24 León;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
24 León;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
24 León;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
24 León;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;91,48
24 León;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
24 León;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
24 León;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
24 León;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;91,54
24 León;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
24 León;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
24 León;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
24 León;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
24 León;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
24 León;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QIII;8.406
24 León;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
24 León;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
24 León;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
24 León;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QIII;8.613
24 León;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
24 León;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
24 León;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
24 León;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QIII;8.794
24 León;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
24 León;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
24 León;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
24 León;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2022QIII;8.183
24 León;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2022QII;""
24 León;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2022QI;""
24 León;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
24 León;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2021QIII;8.413
24 León;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2021QII;""
24 León;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2021QI;""
24 León;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
24 León;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2020QIII;8.570
24 León;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2020QII;""
24 León;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2020QI;""
24 León;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2022QIV;7.963
24 León;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
24 León;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2022QII;""
24 León;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2022QI;""
24 León;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2021QIV;8.213
24 León;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
24 León;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2021QII;""
24 León;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2021QI;""
24 León;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2020QIV;8.383
24 León;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
24 León;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2020QII;""
24 León;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2020QI;""
24 León;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
24 León;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
24 León;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QII;""
24 León;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QI;8.047
24 León;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
24 León;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
24 León;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QII;""
24 León;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QI;8.269
24 León;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
24 León;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
24 León;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QII;""
24 León;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QI;""
24 León;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
24 León;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
24 León;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QII;7.876
24 León;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QI;""
24 León;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
24 León;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
24 León;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QII;8.126
24 León;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QI;""
24 León;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
24 León;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
24 León;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QII;""
24 León;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QI;""
24 León;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
24 León;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
24 León;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
24 León;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
24 León;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
24 León;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
24 León;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
24 León;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
24 León;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
24 León;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
24 León;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
24 León;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
24 León;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
24 León;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;97,35
24 León;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
24 León;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
24 León;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
24 León;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;97,68
24 León;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
24 León;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
24 León;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
24 León;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;97,45
24 León;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
24 León;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
24 León;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;94,73
24 León;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
24 León;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
24 León;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
24 León;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;95,36
24 León;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
24 León;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
24 León;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
24 León;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;95,33
24 León;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
24 León;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
24 León;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
24 León;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
24 León;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
24 León;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
24 León;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;93,43
24 León;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
24 León;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
24 León;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
24 León;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;94,03
24 León;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
24 León;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
24 León;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
24 León;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
24 León;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
24 León;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
24 León;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;91,44
24 León;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
24 León;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
24 León;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
24 León;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;92,4
24 León;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
24 León;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
24 León;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
24 León;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
24 León;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
24 León;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
24 León;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QIII;5.172
24 León;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
24 León;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
24 León;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
24 León;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QIII;5.384
24 León;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
24 León;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
24 León;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
24 León;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QIII;5.482
24 León;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
24 León;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
24 León;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
24 León;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2022QIII;5.046
24 León;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2022QII;""
24 León;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2022QI;""
24 León;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
24 León;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2021QIII;5.268
24 León;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2021QII;""
24 León;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2021QI;""
24 León;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
24 León;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2020QIII;5.357
24 León;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2020QII;""
24 León;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2020QI;""
24 León;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2022QIV;4.924
24 León;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
24 León;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2022QII;""
24 León;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2022QI;""
24 León;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2021QIV;5.143
24 León;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
24 León;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2021QII;""
24 León;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2021QI;""
24 León;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2020QIV;5.247
24 León;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
24 León;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2020QII;""
24 León;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2020QI;""
24 León;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
24 León;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
24 León;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QII;""
24 León;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QI;5.042
24 León;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
24 León;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
24 León;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QII;""
24 León;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QI;5.192
24 León;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
24 León;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
24 León;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QII;""
24 León;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QI;""
24 León;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
24 León;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
24 León;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QII;4.942
24 León;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QI;""
24 León;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
24 León;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
24 León;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QII;5.112
24 León;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QI;""
24 León;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
24 León;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
24 León;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QII;""
24 León;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QI;""
24 León;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
24 León;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
24 León;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
24 León;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
24 León;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
24 León;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
24 León;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
24 León;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
24 León;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
24 León;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
24 León;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
24 León;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
24 León;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
24 León;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;97,56
24 León;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
24 León;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
24 León;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
24 León;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;97,85
24 León;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
24 León;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
24 León;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
24 León;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;97,72
24 León;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
24 León;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
24 León;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;95,2
24 León;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
24 León;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
24 León;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
24 León;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;95,52
24 León;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
24 León;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
24 León;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
24 León;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;95,71
24 León;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
24 León;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
24 León;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
24 León;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
24 León;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
24 León;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
24 León;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;93,65
24 León;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
24 León;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
24 León;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
24 León;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;94,71
24 León;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
24 León;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
24 León;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
24 León;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
24 León;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
24 León;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
24 León;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;91,79
24 León;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
24 León;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
24 León;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
24 León;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;93,25
24 León;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
24 León;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
24 León;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
24 León;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
24 León;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
24 León;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
24 León;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QIII;3.234
24 León;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
24 León;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
24 León;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
24 León;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QIII;3.229
24 León;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
24 León;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
24 León;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
24 León;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QIII;3.312
24 León;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
24 León;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
24 León;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
24 León;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2022QIII;3.137
24 León;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2022QII;""
24 León;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2022QI;""
24 León;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
24 León;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2021QIII;3.145
24 León;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2021QII;""
24 León;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2021QI;""
24 León;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
24 León;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2020QIII;3.213
24 León;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2020QII;""
24 León;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2020QI;""
24 León;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2022QIV;3.039
24 León;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
24 León;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2022QII;""
24 León;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2022QI;""
24 León;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2021QIV;3.070
24 León;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
24 León;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2021QII;""
24 León;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2021QI;""
24 León;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2020QIV;3.136
24 León;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
24 León;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2020QII;""
24 León;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2020QI;""
24 León;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
24 León;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
24 León;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QII;""
24 León;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QI;3.005
24 León;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
24 León;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
24 León;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QII;""
24 León;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QI;3.077
24 León;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
24 León;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
24 León;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QII;""
24 León;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QI;""
24 León;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
24 León;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
24 León;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QII;2.934
24 León;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QI;""
24 León;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
24 León;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
24 León;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QII;3.014
24 León;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QI;""
24 León;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
24 León;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
24 León;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QII;""
24 León;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QI;""
24 León;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
24 León;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
24 León;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
24 León;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
24 León;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
24 León;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
24 León;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
24 León;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
24 León;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
24 León;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
24 León;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
24 León;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
24 León;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
24 León;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;97
24 León;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
24 León;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
24 León;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
24 León;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;97,4
24 León;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
24 León;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
24 León;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
24 León;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;97,01
24 León;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
24 León;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
24 León;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;93,97
24 León;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
24 León;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
24 León;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
24 León;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;95,08
24 León;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
24 León;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
24 León;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
24 León;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;94,69
24 León;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
24 León;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
24 León;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
24 León;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
24 León;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
24 León;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
24 León;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;93,06
24 León;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
24 León;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
24 León;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
24 León;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;92,9
24 León;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
24 León;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
24 León;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
24 León;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
24 León;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
24 León;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
24 León;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;90,86
24 León;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
24 León;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
24 León;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
24 León;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;91
24 León;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
24 León;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
24 León;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
24 León;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
24 León;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
24 León;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QIV;8.378
24 León;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
24 León;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
24 León;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
24 León;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QIV;8.643
24 León;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
24 León;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
24 León;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
24 León;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QIV;8.802
24 León;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
24 León;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
24 León;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
24 León;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2022QIV;8.136
24 León;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
24 León;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2022QII;""
24 León;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2022QI;""
24 León;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2021QIV;8.415
24 León;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
24 León;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2021QII;""
24 León;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2021QI;""
24 León;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2020QIV;8.588
24 León;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
24 León;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2020QII;""
24 León;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2020QI;""
24 León;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
24 León;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
24 León;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2022QII;""
24 León;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2022QI;8.238
24 León;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
24 León;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
24 León;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2021QII;""
24 León;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2021QI;8.460
24 León;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
24 León;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
24 León;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2020QII;""
24 León;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2020QI;""
24 León;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
24 León;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
24 León;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QII;8.057
24 León;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QI;""
24 León;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
24 León;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
24 León;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QII;8.306
24 León;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QI;""
24 León;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
24 León;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
24 León;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QII;""
24 León;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QI;""
24 León;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
24 León;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QIII;7.907
24 León;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QII;""
24 León;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QI;""
24 León;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
24 León;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QIII;8.158
24 León;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QII;""
24 León;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QI;""
24 León;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
24 León;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
24 León;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QII;""
24 León;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QI;""
24 León;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
24 León;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
24 León;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
24 León;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
24 León;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
24 León;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
24 León;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
24 León;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
24 León;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
24 León;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
24 León;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
24 León;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
24 León;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;97,11
24 León;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
24 León;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
24 León;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
24 León;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;97,36
24 León;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
24 León;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
24 León;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
24 León;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;97,57
24 León;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
24 León;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
24 León;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
24 León;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
24 León;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
24 León;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
24 León;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;95,31
24 León;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
24 León;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
24 León;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
24 León;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;96,11
24 León;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
24 León;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
24 León;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
24 León;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
24 León;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
24 León;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
24 León;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;93,22
24 León;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
24 León;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
24 León;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
24 León;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;94,36
24 León;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
24 León;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
24 León;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
24 León;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
24 León;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
24 León;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
24 León;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;91,48
24 León;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
24 León;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
24 León;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
24 León;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;92,68
24 León;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
24 León;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
24 León;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
24 León;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
24 León;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
24 León;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
24 León;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QIV;5.154
24 León;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
24 León;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
24 León;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
24 León;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QIV;5.406
24 León;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
24 León;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
24 León;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
24 León;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QIV;5.497
24 León;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
24 León;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
24 León;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
24 León;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2022QIV;5.020
24 León;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
24 León;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2022QII;""
24 León;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2022QI;""
24 León;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2021QIV;5.263
24 León;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
24 León;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2021QII;""
24 León;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2021QI;""
24 León;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2020QIV;5.369
24 León;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
24 León;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2020QII;""
24 León;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2020QI;""
24 León;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
24 León;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
24 León;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2022QII;""
24 León;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2022QI;5.155
24 León;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
24 León;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
24 León;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2021QII;""
24 León;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2021QI;5.306
24 León;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
24 León;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
24 León;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2020QII;""
24 León;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2020QI;""
24 León;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
24 León;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
24 León;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QII;5.049
24 León;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QI;""
24 León;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
24 León;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
24 León;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QII;5.217
24 León;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QI;""
24 León;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
24 León;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
24 León;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QII;""
24 León;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QI;""
24 León;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
24 León;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QIII;4.965
24 León;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QII;""
24 León;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QI;""
24 León;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
24 León;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QIII;5.137
24 León;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QII;""
24 León;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QI;""
24 León;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
24 León;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
24 León;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QII;""
24 León;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QI;""
24 León;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
24 León;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
24 León;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
24 León;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
24 León;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
24 León;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
24 León;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
24 León;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
24 León;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
24 León;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
24 León;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
24 León;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
24 León;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;97,4
24 León;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
24 León;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
24 León;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
24 León;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;97,35
24 León;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
24 León;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
24 León;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
24 León;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;97,67
24 León;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
24 León;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
24 León;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
24 León;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
24 León;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
24 León;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
24 León;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;95,36
24 León;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
24 León;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
24 León;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
24 León;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;96,53
24 León;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
24 León;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
24 León;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
24 León;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
24 León;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
24 León;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
24 León;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;93,4
24 León;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
24 León;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
24 León;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
24 León;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;94,91
24 León;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
24 León;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
24 León;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
24 León;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
24 León;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
24 León;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
24 León;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;91,84
24 León;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
24 León;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
24 León;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
24 León;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;93,45
24 León;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
24 León;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
24 León;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
24 León;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
24 León;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
24 León;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
24 León;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QIV;3.224
24 León;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
24 León;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
24 León;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
24 León;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QIV;3.237
24 León;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
24 León;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
24 León;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
24 León;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QIV;3.305
24 León;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
24 León;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
24 León;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
24 León;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2022QIV;3.116
24 León;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
24 León;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2022QII;""
24 León;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2022QI;""
24 León;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2021QIV;3.152
24 León;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
24 León;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2021QII;""
24 León;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2021QI;""
24 León;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2020QIV;3.219
24 León;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
24 León;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2020QII;""
24 León;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2020QI;""
24 León;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
24 León;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
24 León;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2022QII;""
24 León;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2022QI;3.083
24 León;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
24 León;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
24 León;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2021QII;""
24 León;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2021QI;3.154
24 León;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
24 León;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
24 León;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2020QII;""
24 León;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2020QI;""
24 León;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
24 León;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
24 León;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QII;3.008
24 León;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QI;""
24 León;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
24 León;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
24 León;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QII;3.089
24 León;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QI;""
24 León;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
24 León;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
24 León;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QII;""
24 León;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QI;""
24 León;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
24 León;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QIII;2.942
24 León;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QII;""
24 León;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QI;""
24 León;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
24 León;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QIII;3.021
24 León;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QII;""
24 León;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QI;""
24 León;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
24 León;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
24 León;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QII;""
24 León;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QI;""
24 León;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
24 León;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
24 León;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
24 León;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
24 León;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
24 León;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
24 León;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
24 León;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
24 León;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
24 León;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
24 León;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
24 León;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
24 León;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;96,65
24 León;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
24 León;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
24 León;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
24 León;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;97,37
24 León;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
24 León;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
24 León;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
24 León;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;97,4
24 León;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
24 León;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
24 León;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
24 León;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
24 León;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
24 León;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
24 León;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;95,24
24 León;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
24 León;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
24 León;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
24 León;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;95,43
24 León;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
24 León;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
24 León;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
24 León;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
24 León;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
24 León;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
24 León;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;92,93
24 León;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
24 León;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
24 León;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
24 León;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;93,46
24 León;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
24 León;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
24 León;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
24 León;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
24 León;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
24 León;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
24 León;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;90,89
24 León;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
24 León;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
24 León;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
24 León;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;91,41
24 León;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
24 León;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
24 León;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
24 León;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
24 León;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
24 León;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
24 León;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
24 León;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
24 León;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
24 León;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QI;9.264
24 León;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
24 León;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
24 León;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
24 León;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QI;9.145
24 León;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
24 León;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
24 León;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
24 León;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QI;9.385
24 León;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
24 León;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
24 León;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2022QII;""
24 León;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2022QI;9.103
24 León;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
24 León;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
24 León;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2021QII;""
24 León;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2021QI;9.010
24 León;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
24 León;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
24 León;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2020QII;""
24 León;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2020QI;9.045
24 León;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
24 León;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
24 León;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2022QII;8.947
24 León;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2022QI;""
24 León;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
24 León;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
24 León;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2021QII;8.894
24 León;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2021QI;""
24 León;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
24 León;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
24 León;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2020QII;8.921
24 León;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2020QI;""
24 León;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
24 León;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QIII;8.822
24 León;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QII;""
24 León;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QI;""
24 León;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
24 León;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QIII;8.793
24 León;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QII;""
24 León;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QI;""
24 León;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
24 León;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QIII;8.794
24 León;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QII;""
24 León;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QI;""
24 León;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QIV;8.657
24 León;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
24 León;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QII;""
24 León;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QI;""
24 León;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QIV;8.664
24 León;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
24 León;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QII;""
24 León;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QI;""
24 León;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QIV;8.667
24 León;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
24 León;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QII;""
24 León;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QI;""
24 León;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
24 León;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
24 León;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
24 León;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
24 León;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
24 León;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
24 León;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
24 León;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
24 León;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
24 León;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
24 León;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
24 León;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
24 León;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
24 León;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
24 León;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
24 León;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;98,26
24 León;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
24 León;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
24 León;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
24 León;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;98,52
24 León;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
24 León;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
24 León;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
24 León;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;96,38
24 León;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
24 León;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
24 León;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;96,58
24 León;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
24 León;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
24 León;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
24 León;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;97,26
24 León;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
24 León;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
24 León;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
24 León;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;95,06
24 León;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
24 León;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
24 León;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;95,23
24 León;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
24 León;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
24 León;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
24 León;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;96,15
24 León;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
24 León;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
24 León;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
24 León;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;93,7
24 León;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
24 León;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
24 León;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;93,45
24 León;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
24 León;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
24 León;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
24 León;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;94,74
24 León;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
24 León;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
24 León;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
24 León;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;92,35
24 León;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
24 León;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
24 León;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
24 León;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
24 León;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
24 León;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
24 León;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QI;5.793
24 León;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
24 León;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
24 León;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
24 León;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QI;5.694
24 León;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
24 León;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
24 León;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
24 León;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QI;5.853
24 León;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
24 León;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
24 León;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2022QII;""
24 León;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2022QI;5.696
24 León;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
24 León;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
24 León;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2021QII;""
24 León;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2021QI;5.619
24 León;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
24 León;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
24 León;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2020QII;""
24 León;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2020QI;5.637
24 León;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
24 León;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
24 León;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2022QII;5.607
24 León;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2022QI;""
24 León;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
24 León;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
24 León;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2021QII;5.560
24 León;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2021QI;""
24 León;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
24 León;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
24 León;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2020QII;5.574
24 León;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2020QI;""
24 León;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
24 León;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QIII;5.540
24 León;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QII;""
24 León;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QI;""
24 León;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
24 León;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QIII;5.501
24 León;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QII;""
24 León;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QI;""
24 León;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
24 León;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QIII;5.505
24 León;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QII;""
24 León;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QI;""
24 León;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QIV;5.442
24 León;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
24 León;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QII;""
24 León;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QI;""
24 León;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QIV;5.435
24 León;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
24 León;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QII;""
24 León;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QI;""
24 León;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QIV;5.431
24 León;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
24 León;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QII;""
24 León;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QI;""
24 León;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
24 León;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
24 León;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
24 León;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
24 León;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
24 León;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
24 León;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
24 León;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
24 León;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
24 León;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
24 León;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
24 León;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
24 León;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
24 León;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
24 León;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
24 León;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;98,33
24 León;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
24 León;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
24 León;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
24 León;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;98,68
24 León;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
24 León;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
24 León;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
24 León;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;96,31
24 León;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
24 León;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
24 León;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;96,79
24 León;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
24 León;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
24 León;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
24 León;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;97,65
24 León;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
24 León;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
24 León;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
24 León;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;95,23
24 León;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
24 León;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
24 León;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;95,63
24 León;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
24 León;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
24 León;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
24 León;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;96,61
24 León;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
24 León;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
24 León;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
24 León;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;94,05
24 León;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
24 León;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
24 León;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;93,94
24 León;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
24 León;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
24 León;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
24 León;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;95,45
24 León;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
24 León;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
24 León;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
24 León;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;92,79
24 León;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
24 León;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
24 León;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
24 León;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
24 León;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
24 León;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
24 León;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QI;3.471
24 León;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
24 León;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
24 León;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
24 León;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QI;3.451
24 León;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
24 León;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
24 León;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
24 León;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QI;3.532
24 León;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
24 León;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
24 León;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2022QII;""
24 León;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2022QI;3.407
24 León;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
24 León;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
24 León;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2021QII;""
24 León;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2021QI;3.391
24 León;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
24 León;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
24 León;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2020QII;""
24 León;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2020QI;3.408
24 León;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
24 León;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
24 León;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2022QII;3.340
24 León;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2022QI;""
24 León;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
24 León;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
24 León;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2021QII;3.334
24 León;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2021QI;""
24 León;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
24 León;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
24 León;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2020QII;3.347
24 León;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2020QI;""
24 León;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
24 León;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QIII;3.282
24 León;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QII;""
24 León;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QI;""
24 León;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
24 León;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QIII;3.292
24 León;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QII;""
24 León;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QI;""
24 León;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
24 León;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QIII;3.289
24 León;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QII;""
24 León;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QI;""
24 León;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QIV;3.215
24 León;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
24 León;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QII;""
24 León;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QI;""
24 León;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QIV;3.229
24 León;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
24 León;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QII;""
24 León;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QI;""
24 León;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QIV;3.236
24 León;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
24 León;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QII;""
24 León;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QI;""
24 León;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
24 León;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
24 León;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
24 León;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
24 León;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
24 León;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
24 León;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
24 León;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
24 León;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
24 León;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
24 León;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
24 León;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
24 León;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
24 León;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
24 León;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
24 León;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;98,16
24 León;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
24 León;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
24 León;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
24 León;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;98,26
24 León;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
24 León;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
24 León;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
24 León;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;96,49
24 León;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
24 León;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
24 León;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;96,23
24 León;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
24 León;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
24 León;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
24 León;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;96,61
24 León;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
24 León;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
24 León;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
24 León;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;94,76
24 León;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
24 León;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
24 León;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;94,55
24 León;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
24 León;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
24 León;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
24 León;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;95,39
24 León;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
24 León;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
24 León;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
24 León;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;93,12
24 León;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
24 León;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
24 León;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;92,62
24 León;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
24 León;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
24 León;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
24 León;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;93,57
24 León;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
24 León;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
24 León;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
24 León;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;91,62
24 León;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
24 León;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
24 León;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
24 León;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
24 León;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
24 León;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QII;9.285
24 León;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
24 León;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
24 León;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
24 León;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QII;9.271
24 León;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
24 León;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
24 León;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
24 León;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QII;9.241
24 León;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
24 León;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
24 León;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
24 León;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2022QII;9.110
24 León;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2022QI;""
24 León;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
24 León;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
24 León;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2021QII;9.136
24 León;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2021QI;""
24 León;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
24 León;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
24 León;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2020QII;9.111
24 León;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2020QI;""
24 León;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
24 León;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2022QIII;8.973
24 León;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2022QII;""
24 León;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2022QI;""
24 León;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
24 León;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2021QIII;9.021
24 León;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2021QII;""
24 León;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2021QI;""
24 León;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
24 León;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2020QIII;8.974
24 León;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2020QII;""
24 León;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2020QI;""
24 León;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QIV;8.786
24 León;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
24 León;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QII;""
24 León;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QI;""
24 León;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QIV;8.885
24 León;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
24 León;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QII;""
24 León;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QI;""
24 León;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QIV;8.831
24 León;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
24 León;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QII;""
24 León;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QI;""
24 León;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
24 León;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
24 León;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QII;""
24 León;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QI;8.755
24 León;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
24 León;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
24 León;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QII;""
24 León;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QI;8.717
24 León;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
24 León;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
24 León;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QII;""
24 León;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QI;""
24 León;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
24 León;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
24 León;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
24 León;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
24 León;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
24 León;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
24 León;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
24 León;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
24 León;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
24 León;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
24 León;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
24 León;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
24 León;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
24 León;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
24 León;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;98,12
24 León;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
24 León;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
24 León;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
24 León;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;98,54
24 León;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
24 León;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
24 León;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
24 León;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;98,59
24 León;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
24 León;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
24 León;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;96,64
24 León;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
24 León;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
24 León;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
24 León;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;97,3
24 León;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
24 León;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
24 León;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
24 León;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;97,11
24 León;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
24 León;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
24 León;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;94,63
24 León;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
24 León;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
24 León;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
24 León;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;95,84
24 León;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
24 León;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
24 León;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
24 León;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;95,56
24 León;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
24 León;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
24 León;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
24 León;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
24 León;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
24 León;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
24 León;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;94,43
24 León;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
24 León;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
24 León;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
24 León;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;94,33
24 León;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
24 León;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
24 León;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
24 León;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
24 León;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
24 León;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
24 León;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QII;5.771
24 León;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
24 León;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
24 León;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
24 León;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QII;5.777
24 León;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
24 León;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
24 León;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
24 León;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QII;5.746
24 León;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
24 León;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
24 León;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
24 León;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2022QII;5.673
24 León;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2022QI;""
24 León;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
24 León;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
24 León;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2021QII;5.705
24 León;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2021QI;""
24 León;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
24 León;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
24 León;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2020QII;5.680
24 León;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2020QI;""
24 León;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
24 León;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2022QIII;5.603
24 León;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2022QII;""
24 León;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2022QI;""
24 León;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
24 León;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2021QIII;5.643
24 León;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2021QII;""
24 León;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2021QI;""
24 León;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
24 León;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2020QIII;5.605
24 León;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2020QII;""
24 León;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2020QI;""
24 León;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QIV;5.492
24 León;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
24 León;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QII;""
24 León;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QI;""
24 León;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QIV;5.571
24 León;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
24 León;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QII;""
24 León;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QI;""
24 León;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QIV;5.522
24 León;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
24 León;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QII;""
24 León;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QI;""
24 León;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
24 León;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
24 León;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QII;""
24 León;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QI;5.498
24 León;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
24 León;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
24 León;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QII;""
24 León;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QI;5.461
24 León;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
24 León;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
24 León;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QII;""
24 León;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QI;""
24 León;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
24 León;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
24 León;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
24 León;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
24 León;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
24 León;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
24 León;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
24 León;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
24 León;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
24 León;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
24 León;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
24 León;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
24 León;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
24 León;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
24 León;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;98,3
24 León;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
24 León;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
24 León;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
24 León;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;98,75
24 León;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
24 León;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
24 León;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
24 León;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;98,85
24 León;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
24 León;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
24 León;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;97,09
24 León;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
24 León;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
24 León;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
24 León;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;97,68
24 León;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
24 León;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
24 León;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
24 León;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;97,55
24 León;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
24 León;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
24 León;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;95,17
24 León;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
24 León;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
24 León;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
24 León;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;96,43
24 León;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
24 León;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
24 León;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
24 León;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;96,1
24 León;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
24 León;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
24 León;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
24 León;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
24 León;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
24 León;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
24 León;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;95,17
24 León;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
24 León;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
24 León;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
24 León;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;95,04
24 León;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
24 León;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
24 León;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
24 León;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
24 León;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
24 León;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
24 León;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QII;3.514
24 León;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
24 León;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
24 León;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
24 León;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QII;3.494
24 León;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
24 León;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
24 León;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
24 León;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QII;3.495
24 León;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
24 León;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
24 León;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
24 León;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2022QII;3.437
24 León;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2022QI;""
24 León;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
24 León;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
24 León;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2021QII;3.431
24 León;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2021QI;""
24 León;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
24 León;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
24 León;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2020QII;3.431
24 León;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2020QI;""
24 León;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
24 León;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2022QIII;3.370
24 León;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2022QII;""
24 León;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2022QI;""
24 León;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
24 León;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2021QIII;3.378
24 León;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2021QII;""
24 León;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2021QI;""
24 León;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
24 León;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2020QIII;3.369
24 León;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2020QII;""
24 León;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2020QI;""
24 León;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QIV;3.294
24 León;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
24 León;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QII;""
24 León;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QI;""
24 León;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QIV;3.314
24 León;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
24 León;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QII;""
24 León;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QI;""
24 León;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QIV;3.309
24 León;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
24 León;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QII;""
24 León;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QI;""
24 León;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
24 León;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
24 León;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QII;""
24 León;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QI;3.257
24 León;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
24 León;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
24 León;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QII;""
24 León;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QI;3.256
24 León;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
24 León;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
24 León;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QII;""
24 León;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QI;""
24 León;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
24 León;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
24 León;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
24 León;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
24 León;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
24 León;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
24 León;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
24 León;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
24 León;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
24 León;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
24 León;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
24 León;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
24 León;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
24 León;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
24 León;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;97,81
24 León;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
24 León;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
24 León;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
24 León;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;98,2
24 León;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
24 León;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
24 León;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
24 León;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;98,17
24 León;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
24 León;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
24 León;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;95,9
24 León;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
24 León;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
24 León;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
24 León;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;96,68
24 León;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
24 León;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
24 León;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
24 León;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;96,39
24 León;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
24 León;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
24 León;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;93,74
24 León;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
24 León;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
24 León;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
24 León;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;94,85
24 León;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
24 León;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
24 León;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
24 León;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;94,68
24 León;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
24 León;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
24 León;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
24 León;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
24 León;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
24 León;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
24 León;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;93,22
24 León;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
24 León;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
24 León;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
24 León;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;93,16
24 León;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
24 León;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
24 León;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
24 León;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
24 León;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
24 León;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QIII;9.275
24 León;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
24 León;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
24 León;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
24 León;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QIII;9.303
24 León;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
24 León;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
24 León;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
24 León;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QIII;9.236
24 León;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
24 León;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
24 León;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
24 León;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2022QIII;9.094
24 León;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2022QII;""
24 León;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2022QI;""
24 León;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
24 León;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2021QIII;9.168
24 León;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2021QII;""
24 León;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2021QI;""
24 León;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
24 León;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2020QIII;9.085
24 León;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2020QII;""
24 León;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2020QI;""
24 León;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2022QIV;8.874
24 León;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
24 León;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2022QII;""
24 León;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2022QI;""
24 León;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2021QIV;9.014
24 León;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
24 León;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2021QII;""
24 León;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2021QI;""
24 León;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2020QIV;8.922
24 León;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
24 León;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2020QII;""
24 León;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2020QI;""
24 León;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
24 León;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
24 León;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QII;""
24 León;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QI;8.872
24 León;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
24 León;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
24 León;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QII;""
24 León;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QI;8.804
24 León;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
24 León;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
24 León;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QII;""
24 León;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QI;""
24 León;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
24 León;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
24 León;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QII;8.743
24 León;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QI;""
24 León;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
24 León;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
24 León;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QII;8.697
24 León;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QI;""
24 León;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
24 León;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
24 León;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QII;""
24 León;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QI;""
24 León;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
24 León;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
24 León;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
24 León;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
24 León;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
24 León;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
24 León;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
24 León;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
24 León;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
24 León;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
24 León;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
24 León;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
24 León;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
24 León;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;98,05
24 León;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
24 León;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
24 León;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
24 León;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;98,55
24 León;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
24 León;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
24 León;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
24 León;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;98,37
24 León;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
24 León;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
24 León;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;95,68
24 León;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
24 León;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
24 León;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
24 León;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;96,89
24 León;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
24 León;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
24 León;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
24 León;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;96,6
24 León;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
24 León;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
24 León;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
24 León;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
24 León;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
24 León;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
24 León;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;95,37
24 León;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
24 León;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
24 León;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
24 León;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;95,32
24 León;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
24 León;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
24 León;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
24 León;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
24 León;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
24 León;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
24 León;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;93,98
24 León;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
24 León;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
24 León;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
24 León;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;94,16
24 León;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
24 León;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
24 León;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
24 León;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
24 León;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
24 León;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
24 León;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QIII;5.766
24 León;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
24 León;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
24 León;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
24 León;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QIII;5.812
24 León;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
24 León;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
24 León;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
24 León;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QIII;5.752
24 León;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
24 León;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
24 León;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
24 León;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2022QIII;5.672
24 León;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2022QII;""
24 León;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2022QI;""
24 León;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
24 León;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2021QIII;5.739
24 León;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2021QII;""
24 León;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2021QI;""
24 León;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
24 León;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2020QIII;5.671
24 León;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2020QII;""
24 León;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2020QI;""
24 León;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2022QIV;5.545
24 León;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
24 León;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2022QII;""
24 León;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2022QI;""
24 León;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2021QIV;5.657
24 León;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
24 León;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2021QII;""
24 León;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2021QI;""
24 León;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2020QIV;5.575
24 León;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
24 León;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2020QII;""
24 León;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2020QI;""
24 León;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
24 León;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
24 León;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QII;""
24 León;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QI;5.572
24 León;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
24 León;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
24 León;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QII;""
24 León;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QI;5.511
24 León;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
24 León;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
24 León;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QII;""
24 León;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QI;""
24 León;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
24 León;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
24 León;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QII;5.492
24 León;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QI;""
24 León;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
24 León;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
24 León;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QII;5.454
24 León;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QI;""
24 León;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
24 León;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
24 León;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QII;""
24 León;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QI;""
24 León;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
24 León;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
24 León;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
24 León;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
24 León;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
24 León;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
24 León;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
24 León;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
24 León;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
24 León;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
24 León;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
24 León;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
24 León;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
24 León;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;98,37
24 León;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
24 León;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
24 León;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
24 León;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;98,74
24 León;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
24 León;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
24 León;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
24 León;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;98,59
24 León;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
24 León;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
24 León;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;96,17
24 León;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
24 León;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
24 León;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
24 León;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;97,33
24 León;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
24 León;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
24 León;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
24 León;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;96,92
24 León;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
24 León;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
24 León;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
24 León;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
24 León;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
24 León;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
24 León;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;95,87
24 León;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
24 León;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
24 León;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
24 León;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;95,81
24 León;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
24 León;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
24 León;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
24 León;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
24 León;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
24 León;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
24 León;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;94,49
24 León;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
24 León;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
24 León;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
24 León;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;94,82
24 León;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
24 León;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
24 León;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
24 León;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
24 León;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
24 León;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
24 León;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QIII;3.509
24 León;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
24 León;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
24 León;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
24 León;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QIII;3.491
24 León;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
24 León;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
24 León;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
24 León;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QIII;3.484
24 León;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
24 León;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
24 León;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
24 León;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2022QIII;3.422
24 León;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2022QII;""
24 León;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2022QI;""
24 León;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
24 León;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2021QIII;3.429
24 León;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2021QII;""
24 León;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2021QI;""
24 León;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
24 León;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2020QIII;3.414
24 León;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2020QII;""
24 León;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2020QI;""
24 León;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2022QIV;3.329
24 León;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
24 León;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2022QII;""
24 León;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2022QI;""
24 León;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2021QIV;3.357
24 León;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
24 León;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2021QII;""
24 León;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2021QI;""
24 León;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2020QIV;3.347
24 León;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
24 León;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2020QII;""
24 León;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2020QI;""
24 León;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
24 León;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
24 León;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QII;""
24 León;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QI;3.300
24 León;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
24 León;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
24 León;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QII;""
24 León;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QI;3.293
24 León;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
24 León;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
24 León;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QII;""
24 León;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QI;""
24 León;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
24 León;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
24 León;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QII;3.251
24 León;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QI;""
24 León;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
24 León;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
24 León;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QII;3.243
24 León;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QI;""
24 León;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
24 León;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
24 León;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QII;""
24 León;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QI;""
24 León;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
24 León;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
24 León;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
24 León;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
24 León;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
24 León;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
24 León;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
24 León;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
24 León;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
24 León;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
24 León;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
24 León;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
24 León;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
24 León;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;97,52
24 León;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
24 León;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
24 León;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
24 León;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;98,22
24 León;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
24 León;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
24 León;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
24 León;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;97,99
24 León;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
24 León;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
24 León;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;94,87
24 León;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
24 León;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
24 León;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
24 León;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;96,16
24 León;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
24 León;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
24 León;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
24 León;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;96,07
24 León;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
24 León;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
24 León;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
24 León;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
24 León;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
24 León;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
24 León;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;94,53
24 León;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
24 León;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
24 León;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
24 León;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;94,52
24 León;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
24 León;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
24 León;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
24 León;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
24 León;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
24 León;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
24 León;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;93,13
24 León;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
24 León;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
24 León;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
24 León;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;93,08
24 León;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
24 León;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
24 León;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
24 León;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
24 León;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
24 León;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QIV;9.206
24 León;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
24 León;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
24 León;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
24 León;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QIV;9.298
24 León;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
24 León;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
24 León;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
24 León;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QIV;9.229
24 León;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
24 León;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
24 León;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
24 León;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2022QIV;8.973
24 León;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
24 León;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2022QII;""
24 León;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2022QI;""
24 León;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2021QIV;9.130
24 León;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
24 León;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2021QII;""
24 León;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2021QI;""
24 León;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2020QIV;9.040
24 León;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
24 León;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2020QII;""
24 León;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2020QI;""
24 León;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
24 León;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
24 León;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2022QII;""
24 León;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2022QI;8.979
24 León;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
24 León;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
24 León;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2021QII;""
24 León;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2021QI;8.913
24 León;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
24 León;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
24 León;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2020QII;""
24 León;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2020QI;""
24 León;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
24 León;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
24 León;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QII;8.842
24 León;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QI;""
24 León;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
24 León;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
24 León;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QII;8.804
24 León;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QI;""
24 León;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
24 León;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
24 León;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QII;""
24 León;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QI;""
24 León;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
24 León;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QIII;8.725
24 León;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QII;""
24 León;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QI;""
24 León;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
24 León;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QIII;8.705
24 León;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QII;""
24 León;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QI;""
24 León;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
24 León;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
24 León;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QII;""
24 León;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QI;""
24 León;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
24 León;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
24 León;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
24 León;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
24 León;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
24 León;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
24 León;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
24 León;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
24 León;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
24 León;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
24 León;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
24 León;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
24 León;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;97,47
24 León;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
24 León;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
24 León;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
24 León;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;98,19
24 León;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
24 León;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
24 León;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
24 León;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;97,95
24 León;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
24 León;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
24 León;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
24 León;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
24 León;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
24 León;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
24 León;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;96,57
24 León;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
24 León;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
24 León;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
24 León;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;96,58
24 León;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
24 León;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
24 León;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
24 León;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
24 León;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
24 León;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
24 León;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;95,1
24 León;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
24 León;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
24 León;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
24 León;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;95,39
24 León;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
24 León;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
24 León;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
24 León;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
24 León;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
24 León;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
24 León;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;93,84
24 León;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
24 León;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
24 León;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
24 León;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;94,32
24 León;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
24 León;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
24 León;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
24 León;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
24 León;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
24 León;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
24 León;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QIV;5.738
24 León;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
24 León;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
24 León;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
24 León;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QIV;5.821
24 León;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
24 León;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
24 León;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
24 León;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QIV;5.761
24 León;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
24 León;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
24 León;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
24 León;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2022QIV;5.603
24 León;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
24 León;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2022QII;""
24 León;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2022QI;""
24 León;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2021QIV;5.733
24 León;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
24 León;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2021QII;""
24 León;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2021QI;""
24 León;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2020QIV;5.650
24 León;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
24 León;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2020QII;""
24 León;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2020QI;""
24 León;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
24 León;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
24 León;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2022QII;""
24 León;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2022QI;5.642
24 León;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
24 León;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
24 León;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2021QII;""
24 León;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2021QI;5.581
24 León;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
24 León;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
24 León;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2020QII;""
24 León;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2020QI;""
24 León;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
24 León;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
24 León;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QII;5.557
24 León;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QI;""
24 León;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
24 León;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
24 León;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QII;5.522
24 León;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QI;""
24 León;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
24 León;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
24 León;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QII;""
24 León;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QI;""
24 León;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
24 León;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QIII;5.496
24 León;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QII;""
24 León;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QI;""
24 León;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
24 León;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QIII;5.465
24 León;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QII;""
24 León;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QI;""
24 León;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
24 León;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
24 León;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QII;""
24 León;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QI;""
24 León;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
24 León;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
24 León;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
24 León;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
24 León;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
24 León;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
24 León;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
24 León;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
24 León;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
24 León;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
24 León;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
24 León;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
24 León;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;97,65
24 León;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
24 León;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
24 León;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
24 León;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;98,49
24 León;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
24 León;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
24 León;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
24 León;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;98,07
24 León;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
24 León;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
24 León;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
24 León;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
24 León;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
24 León;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
24 León;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;96,92
24 León;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
24 León;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
24 León;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
24 León;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;96,88
24 León;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
24 León;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
24 León;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
24 León;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
24 León;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
24 León;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
24 León;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;95,46
24 León;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
24 León;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
24 León;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
24 León;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;95,85
24 León;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
24 León;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
24 León;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
24 León;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
24 León;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
24 León;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
24 León;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;94,42
24 León;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
24 León;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
24 León;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
24 León;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;94,86
24 León;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
24 León;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
24 León;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
24 León;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
24 León;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
24 León;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
24 León;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QIV;3.468
24 León;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
24 León;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
24 León;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
24 León;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QIV;3.477
24 León;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
24 León;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
24 León;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
24 León;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QIV;3.468
24 León;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
24 León;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
24 León;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
24 León;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2022QIV;3.370
24 León;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
24 León;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2022QII;""
24 León;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2022QI;""
24 León;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2021QIV;3.397
24 León;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
24 León;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2021QII;""
24 León;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2021QI;""
24 León;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2020QIV;3.390
24 León;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
24 León;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2020QII;""
24 León;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2020QI;""
24 León;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
24 León;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
24 León;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2022QII;""
24 León;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2022QI;3.337
24 León;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
24 León;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
24 León;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2021QII;""
24 León;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2021QI;3.332
24 León;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
24 León;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
24 León;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2020QII;""
24 León;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2020QI;""
24 León;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
24 León;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
24 León;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QII;3.285
24 León;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QI;""
24 León;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
24 León;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
24 León;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QII;3.282
24 León;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QI;""
24 León;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
24 León;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
24 León;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QII;""
24 León;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QI;""
24 León;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
24 León;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QIII;3.229
24 León;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QII;""
24 León;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QI;""
24 León;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
24 León;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QIII;3.240
24 León;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QII;""
24 León;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QI;""
24 León;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
24 León;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
24 León;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QII;""
24 León;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QI;""
24 León;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
24 León;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
24 León;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
24 León;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
24 León;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
24 León;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
24 León;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
24 León;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
24 León;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
24 León;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
24 León;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
24 León;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
24 León;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;97,17
24 León;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
24 León;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
24 León;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
24 León;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;97,7
24 León;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
24 León;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
24 León;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
24 León;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;97,75
24 León;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
24 León;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
24 León;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
24 León;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
24 León;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
24 León;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
24 León;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;95,97
24 León;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
24 León;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
24 León;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
24 León;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;96,08
24 León;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
24 León;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
24 León;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
24 León;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
24 León;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
24 León;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
24 León;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;94,48
24 León;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
24 León;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
24 León;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
24 León;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;94,64
24 León;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
24 León;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
24 León;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
24 León;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
24 León;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
24 León;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
24 León;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;92,87
24 León;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
24 León;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
24 León;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
24 León;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;93,43
24 León;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
24 León;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
24 León;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
24 León;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
24 León;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
24 León;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
24 León;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
24 León;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
24 León;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
24 León;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QI;5.010
24 León;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
24 León;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
24 León;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
24 León;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QI;4.799
24 León;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
24 León;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
24 León;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
24 León;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QI;5.552
24 León;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
24 León;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
24 León;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2022QII;""
24 León;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2022QI;4.830
24 León;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
24 León;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
24 León;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2021QII;""
24 León;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2021QI;4.605
24 León;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
24 León;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
24 León;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2020QII;""
24 León;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2020QI;5.228
24 León;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
24 León;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
24 León;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2022QII;4.638
24 León;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2022QI;""
24 León;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
24 León;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
24 León;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2021QII;4.449
24 León;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2021QI;""
24 León;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
24 León;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
24 León;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2020QII;5.084
24 León;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2020QI;""
24 León;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
24 León;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QIII;4.481
24 León;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QII;""
24 León;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QI;""
24 León;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
24 León;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QIII;4.288
24 León;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QII;""
24 León;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QI;""
24 León;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
24 León;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QIII;4.888
24 León;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QII;""
24 León;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QI;""
24 León;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QIV;4.142
24 León;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
24 León;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QII;""
24 León;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QI;""
24 León;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QIV;4.074
24 León;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
24 León;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QII;""
24 León;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QI;""
24 León;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QIV;4.649
24 León;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
24 León;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QII;""
24 León;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QI;""
24 León;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
24 León;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
24 León;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
24 León;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
24 León;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
24 León;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
24 León;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
24 León;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
24 León;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
24 León;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
24 León;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
24 León;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
24 León;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
24 León;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
24 León;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
24 León;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;96,41
24 León;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
24 León;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
24 León;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
24 León;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;95,96
24 León;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
24 León;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
24 León;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
24 León;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;94,16
24 León;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
24 León;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
24 León;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;92,57
24 León;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
24 León;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
24 León;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
24 León;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;92,71
24 León;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
24 León;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
24 León;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
24 León;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;91,57
24 León;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
24 León;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
24 León;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;89,44
24 León;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
24 León;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
24 León;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
24 León;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;89,35
24 León;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
24 León;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
24 León;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
24 León;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;88,04
24 León;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
24 León;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
24 León;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;82,67
24 León;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
24 León;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
24 León;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
24 León;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;84,89
24 León;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
24 León;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
24 León;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
24 León;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;83,74
24 León;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
24 León;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
24 León;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
24 León;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
24 León;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
24 León;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
24 León;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QI;3.126
24 León;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
24 León;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
24 León;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
24 León;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QI;3.018
24 León;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
24 León;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
24 León;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
24 León;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QI;3.494
24 León;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
24 León;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
24 León;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2022QII;""
24 León;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2022QI;3.014
24 León;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
24 León;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
24 León;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2021QII;""
24 León;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2021QI;2.894
24 León;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
24 León;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
24 León;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2020QII;""
24 León;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2020QI;3.294
24 León;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
24 León;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
24 León;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2022QII;2.901
24 León;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2022QI;""
24 León;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
24 León;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
24 León;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2021QII;2.792
24 León;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2021QI;""
24 León;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
24 León;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
24 León;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2020QII;3.196
24 León;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2020QI;""
24 León;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
24 León;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QIII;2.799
24 León;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QII;""
24 León;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QI;""
24 León;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
24 León;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QIII;2.681
24 León;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QII;""
24 León;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QI;""
24 León;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
24 León;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QIII;3.074
24 León;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QII;""
24 León;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QI;""
24 León;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QIV;2.575
24 León;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
24 León;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QII;""
24 León;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QI;""
24 León;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QIV;2.541
24 León;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
24 León;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QII;""
24 León;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QI;""
24 León;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QIV;2.927
24 León;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
24 León;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QII;""
24 León;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QI;""
24 León;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
24 León;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
24 León;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
24 León;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
24 León;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
24 León;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
24 León;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
24 León;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
24 León;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
24 León;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
24 León;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
24 León;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
24 León;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
24 León;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
24 León;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
24 León;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;96,42
24 León;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
24 León;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
24 León;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
24 León;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;95,89
24 León;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
24 León;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
24 León;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
24 León;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;94,28
24 León;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
24 León;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
24 León;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;92,8
24 León;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
24 León;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
24 León;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
24 León;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;92,51
24 León;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
24 León;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
24 León;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
24 León;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;91,47
24 León;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
24 León;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
24 León;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;89,54
24 León;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
24 León;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
24 León;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
24 León;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;88,83
24 León;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
24 León;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
24 León;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
24 León;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;87,98
24 León;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
24 León;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
24 León;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;82,37
24 León;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
24 León;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
24 León;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
24 León;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;84,19
24 León;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
24 León;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
24 León;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
24 León;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;83,77
24 León;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
24 León;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
24 León;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
24 León;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
24 León;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
24 León;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
24 León;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QI;1.884
24 León;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
24 León;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
24 León;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
24 León;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QI;1.781
24 León;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
24 León;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
24 León;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
24 León;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QI;2.058
24 León;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
24 León;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
24 León;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2022QII;""
24 León;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2022QI;1.816
24 León;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
24 León;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
24 León;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2021QII;""
24 León;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2021QI;1.711
24 León;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
24 León;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
24 León;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2020QII;""
24 León;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2020QI;1.934
24 León;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
24 León;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
24 León;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2022QII;1.737
24 León;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2022QI;""
24 León;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
24 León;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
24 León;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2021QII;1.657
24 León;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2021QI;""
24 León;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
24 León;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
24 León;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2020QII;1.888
24 León;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2020QI;""
24 León;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
24 León;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QIII;1.682
24 León;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QII;""
24 León;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QI;""
24 León;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
24 León;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QIII;1.607
24 León;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QII;""
24 León;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QI;""
24 León;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
24 León;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QIII;1.814
24 León;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QII;""
24 León;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QI;""
24 León;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QIV;1.567
24 León;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
24 León;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QII;""
24 León;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QI;""
24 León;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QIV;1.533
24 León;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
24 León;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QII;""
24 León;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QI;""
24 León;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QIV;1.722
24 León;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
24 León;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QII;""
24 León;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QI;""
24 León;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
24 León;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
24 León;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
24 León;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
24 León;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
24 León;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
24 León;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
24 León;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
24 León;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
24 León;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
24 León;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
24 León;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
24 León;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
24 León;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
24 León;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
24 León;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;96,39
24 León;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
24 León;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
24 León;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
24 León;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;96,07
24 León;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
24 León;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
24 León;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
24 León;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;93,97
24 León;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
24 León;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
24 León;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;92,2
24 León;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
24 León;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
24 León;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
24 León;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;93,04
24 León;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
24 León;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
24 León;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
24 León;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;91,74
24 León;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
24 León;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
24 León;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;89,28
24 León;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
24 León;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
24 León;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
24 León;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;90,23
24 León;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
24 León;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
24 León;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
24 León;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;88,14
24 León;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
24 León;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
24 León;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;83,17
24 León;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
24 León;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
24 León;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
24 León;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;86,08
24 León;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
24 León;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
24 León;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
24 León;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;83,67
24 León;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
24 León;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
24 León;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
24 León;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
24 León;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
24 León;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QII;5.757
24 León;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
24 León;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
24 León;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
24 León;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QII;5.464
24 León;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
24 León;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
24 León;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
24 León;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QII;5.287
24 León;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
24 León;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
24 León;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
24 León;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2022QII;5.548
24 León;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2022QI;""
24 León;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
24 León;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
24 León;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2021QII;5.287
24 León;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2021QI;""
24 León;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
24 León;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
24 León;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2020QII;5.139
24 León;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2020QI;""
24 León;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
24 León;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2022QIII;5.377
24 León;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2022QII;""
24 León;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2022QI;""
24 León;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
24 León;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2021QIII;5.118
24 León;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2021QII;""
24 León;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2021QI;""
24 León;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
24 León;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2020QIII;4.930
24 León;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2020QII;""
24 León;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2020QI;""
24 León;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QIV;5.014
24 León;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
24 León;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QII;""
24 León;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QI;""
24 León;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QIV;4.882
24 León;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
24 León;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QII;""
24 León;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QI;""
24 León;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QIV;4.690
24 León;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
24 León;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QII;""
24 León;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QI;""
24 León;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
24 León;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
24 León;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QII;""
24 León;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QI;4.712
24 León;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
24 León;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
24 León;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QII;""
24 León;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QI;4.507
24 León;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
24 León;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
24 León;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QII;""
24 León;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QI;""
24 León;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
24 León;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
24 León;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
24 León;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
24 León;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
24 León;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
24 León;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
24 León;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
24 León;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
24 León;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
24 León;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
24 León;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
24 León;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
24 León;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
24 León;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;96,37
24 León;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
24 León;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
24 León;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
24 León;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;96,76
24 León;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
24 León;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
24 León;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
24 León;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;97,2
24 León;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
24 León;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
24 León;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;93,4
24 León;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
24 León;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
24 León;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
24 León;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;93,67
24 León;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
24 León;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
24 León;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
24 León;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;93,25
24 León;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
24 León;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
24 León;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;87,09
24 León;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
24 León;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
24 León;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
24 León;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;89,35
24 León;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
24 León;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
24 León;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
24 León;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;88,71
24 León;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
24 León;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
24 León;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
24 León;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
24 León;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
24 León;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
24 León;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;86,24
24 León;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
24 León;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
24 León;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
24 León;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;85,25
24 León;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
24 León;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
24 León;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
24 León;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
24 León;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
24 León;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
24 León;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QII;3.627
24 León;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
24 León;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
24 León;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
24 León;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QII;3.431
24 León;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
24 León;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
24 León;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
24 León;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QII;3.331
24 León;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
24 León;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
24 León;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
24 León;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2022QII;3.499
24 León;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2022QI;""
24 León;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
24 León;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
24 León;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2021QII;3.316
24 León;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2021QI;""
24 León;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
24 León;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
24 León;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2020QII;3.229
24 León;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2020QI;""
24 León;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
24 León;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2022QIII;3.387
24 León;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2022QII;""
24 León;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2022QI;""
24 León;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
24 León;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2021QIII;3.199
24 León;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2021QII;""
24 León;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2021QI;""
24 León;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
24 León;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2020QIII;3.098
24 León;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2020QII;""
24 León;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2020QI;""
24 León;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QIV;3.147
24 León;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
24 León;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QII;""
24 León;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QI;""
24 León;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QIV;3.049
24 León;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
24 León;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QII;""
24 León;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QI;""
24 León;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QIV;2.950
24 León;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
24 León;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QII;""
24 León;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QI;""
24 León;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
24 León;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
24 León;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QII;""
24 León;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QI;2.945
24 León;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
24 León;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
24 León;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QII;""
24 León;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QI;2.835
24 León;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
24 León;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
24 León;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QII;""
24 León;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QI;""
24 León;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
24 León;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
24 León;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
24 León;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
24 León;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
24 León;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
24 León;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
24 León;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
24 León;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
24 León;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
24 León;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
24 León;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
24 León;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
24 León;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
24 León;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;96,47
24 León;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
24 León;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
24 León;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
24 León;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;96,65
24 León;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
24 León;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
24 León;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
24 León;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;96,94
24 León;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
24 León;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
24 León;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;93,38
24 León;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
24 León;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
24 León;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
24 León;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;93,24
24 León;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
24 León;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
24 León;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
24 León;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;93,01
24 León;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
24 León;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
24 León;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;86,77
24 León;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
24 León;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
24 León;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
24 León;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;88,87
24 León;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
24 León;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
24 León;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
24 León;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;88,56
24 León;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
24 León;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
24 León;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
24 León;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
24 León;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
24 León;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
24 León;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;85,84
24 León;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
24 León;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
24 León;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
24 León;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;85,11
24 León;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
24 León;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
24 León;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
24 León;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
24 León;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
24 León;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
24 León;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QII;2.130
24 León;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
24 León;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
24 León;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
24 León;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QII;2.033
24 León;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
24 León;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
24 León;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
24 León;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QII;1.956
24 León;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
24 León;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
24 León;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
24 León;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2022QII;2.049
24 León;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2022QI;""
24 León;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
24 León;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
24 León;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2021QII;1.971
24 León;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2021QI;""
24 León;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
24 León;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
24 León;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2020QII;1.910
24 León;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2020QI;""
24 León;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
24 León;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2022QIII;1.990
24 León;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2022QII;""
24 León;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2022QI;""
24 León;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
24 León;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2021QIII;1.919
24 León;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2021QII;""
24 León;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2021QI;""
24 León;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
24 León;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2020QIII;1.832
24 León;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2020QII;""
24 León;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2020QI;""
24 León;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QIV;1.867
24 León;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
24 León;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QII;""
24 León;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QI;""
24 León;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QIV;1.833
24 León;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
24 León;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QII;""
24 León;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QI;""
24 León;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QIV;1.740
24 León;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
24 León;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QII;""
24 León;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QI;""
24 León;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
24 León;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
24 León;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QII;""
24 León;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QI;1.767
24 León;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
24 León;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
24 León;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QII;""
24 León;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QI;1.672
24 León;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
24 León;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
24 León;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QII;""
24 León;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QI;""
24 León;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
24 León;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
24 León;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
24 León;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
24 León;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
24 León;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
24 León;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
24 León;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
24 León;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
24 León;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
24 León;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
24 León;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
24 León;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
24 León;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
24 León;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;96,2
24 León;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
24 León;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
24 León;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
24 León;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;96,95
24 León;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
24 León;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
24 León;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
24 León;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;97,65
24 León;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
24 León;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
24 León;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;93,43
24 León;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
24 León;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
24 León;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
24 León;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;94,39
24 León;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
24 León;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
24 León;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
24 León;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;93,66
24 León;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
24 León;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
24 León;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;87,65
24 León;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
24 León;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
24 León;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
24 León;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;90,16
24 León;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
24 León;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
24 León;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
24 León;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;88,96
24 León;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
24 León;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
24 León;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
24 León;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
24 León;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
24 León;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
24 León;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;86,92
24 León;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
24 León;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
24 León;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
24 León;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;85,48
24 León;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
24 León;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
24 León;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
24 León;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
24 León;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
24 León;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QIII;5.618
24 León;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
24 León;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
24 León;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
24 León;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QIII;5.342
24 León;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
24 León;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
24 León;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
24 León;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QIII;5.185
24 León;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
24 León;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
24 León;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
24 León;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2022QIII;5.425
24 León;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2022QII;""
24 León;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2022QI;""
24 León;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
24 León;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2021QIII;5.162
24 León;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2021QII;""
24 León;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2021QI;""
24 León;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
24 León;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2020QIII;4.965
24 León;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2020QII;""
24 León;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2020QI;""
24 León;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2022QIV;5.049
24 León;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
24 León;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2022QII;""
24 León;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2022QI;""
24 León;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2021QIV;4.914
24 León;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
24 León;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2021QII;""
24 León;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2021QI;""
24 León;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2020QIV;4.715
24 León;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
24 León;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2020QII;""
24 León;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2020QI;""
24 León;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
24 León;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
24 León;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QII;""
24 León;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QI;4.743
24 León;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
24 León;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
24 León;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QII;""
24 León;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QI;4.531
24 León;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
24 León;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
24 León;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QII;""
24 León;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QI;""
24 León;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
24 León;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
24 León;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QII;4.570
24 León;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QI;""
24 León;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
24 León;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
24 León;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QII;4.385
24 León;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QI;""
24 León;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
24 León;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
24 León;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QII;""
24 León;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QI;""
24 León;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
24 León;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
24 León;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
24 León;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
24 León;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
24 León;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
24 León;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
24 León;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
24 León;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
24 León;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
24 León;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
24 León;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
24 León;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
24 León;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;96,56
24 León;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
24 León;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
24 León;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
24 León;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;96,63
24 León;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
24 León;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
24 León;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
24 León;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;95,76
24 León;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
24 León;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
24 León;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;89,87
24 León;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
24 León;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
24 León;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
24 León;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;91,99
24 León;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
24 León;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
24 León;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
24 León;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;90,94
24 León;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
24 León;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
24 León;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
24 León;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
24 León;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
24 León;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
24 León;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;88,79
24 León;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
24 León;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
24 León;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
24 León;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;87,39
24 León;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
24 León;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
24 León;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
24 León;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
24 León;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
24 León;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
24 León;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;85,55
24 León;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
24 León;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
24 León;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
24 León;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;84,57
24 León;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
24 León;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
24 León;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
24 León;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
24 León;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
24 León;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
24 León;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QIII;3.538
24 León;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
24 León;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
24 León;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
24 León;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QIII;3.348
24 León;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
24 León;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
24 León;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
24 León;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QIII;3.259
24 León;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
24 León;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
24 León;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
24 León;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2022QIII;3.413
24 León;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2022QII;""
24 León;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2022QI;""
24 León;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
24 León;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2021QIII;3.223
24 León;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2021QII;""
24 León;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2021QI;""
24 León;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
24 León;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2020QIII;3.120
24 León;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2020QII;""
24 León;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2020QI;""
24 León;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2022QIV;3.166
24 León;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
24 León;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2022QII;""
24 León;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2022QI;""
24 León;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2021QIV;3.068
24 León;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
24 León;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2021QII;""
24 León;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2021QI;""
24 León;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2020QIV;2.965
24 León;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
24 León;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2020QII;""
24 León;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2020QI;""
24 León;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
24 León;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
24 León;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QII;""
24 León;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QI;2.963
24 León;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
24 León;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
24 León;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QII;""
24 León;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QI;2.849
24 León;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
24 León;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
24 León;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QII;""
24 León;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QI;""
24 León;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
24 León;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
24 León;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QII;2.858
24 León;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QI;""
24 León;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
24 León;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
24 León;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QII;2.753
24 León;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QI;""
24 León;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
24 León;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
24 León;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QII;""
24 León;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QI;""
24 León;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
24 León;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
24 León;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
24 León;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
24 León;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
24 León;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
24 León;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
24 León;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
24 León;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
24 León;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
24 León;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
24 León;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
24 León;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
24 León;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;96,47
24 León;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
24 León;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
24 León;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
24 León;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;96,27
24 León;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
24 León;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
24 León;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
24 León;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;95,73
24 León;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
24 León;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
24 León;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;89,49
24 León;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
24 León;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
24 León;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
24 León;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;91,64
24 León;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
24 León;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
24 León;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
24 León;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;90,98
24 León;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
24 León;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
24 León;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
24 León;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
24 León;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
24 León;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
24 León;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;88,5
24 León;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
24 León;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
24 León;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
24 León;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;87,42
24 León;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
24 León;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
24 León;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
24 León;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
24 León;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
24 León;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
24 León;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;85,36
24 León;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
24 León;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
24 León;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
24 León;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;84,47
24 León;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
24 León;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
24 León;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
24 León;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
24 León;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
24 León;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
24 León;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QIII;2.080
24 León;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
24 León;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
24 León;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
24 León;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QIII;1.994
24 León;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
24 León;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
24 León;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
24 León;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QIII;1.926
24 León;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
24 León;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
24 León;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
24 León;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2022QIII;2.012
24 León;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2022QII;""
24 León;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2022QI;""
24 León;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
24 León;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2021QIII;1.939
24 León;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2021QII;""
24 León;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2021QI;""
24 León;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
24 León;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2020QIII;1.845
24 León;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2020QII;""
24 León;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2020QI;""
24 León;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2022QIV;1.883
24 León;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
24 León;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2022QII;""
24 León;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2022QI;""
24 León;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2021QIV;1.846
24 León;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
24 León;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2021QII;""
24 León;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2021QI;""
24 León;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2020QIV;1.750
24 León;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
24 León;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2020QII;""
24 León;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2020QI;""
24 León;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
24 León;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
24 León;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QII;""
24 León;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QI;1.780
24 León;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
24 León;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
24 León;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QII;""
24 León;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QI;1.682
24 León;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
24 León;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
24 León;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QII;""
24 León;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QI;""
24 León;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
24 León;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
24 León;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QII;1.712
24 León;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QI;""
24 León;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
24 León;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
24 León;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QII;1.632
24 León;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QI;""
24 León;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
24 León;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
24 León;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QII;""
24 León;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QI;""
24 León;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
24 León;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
24 León;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
24 León;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
24 León;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
24 León;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
24 León;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
24 León;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
24 León;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
24 León;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
24 León;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
24 León;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
24 León;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
24 León;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;96,73
24 León;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
24 León;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
24 León;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
24 León;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;97,24
24 León;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
24 León;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
24 León;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
24 León;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;95,79
24 León;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
24 León;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
24 León;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;90,53
24 León;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
24 León;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
24 León;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
24 León;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;92,58
24 León;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
24 León;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
24 León;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
24 León;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;90,86
24 León;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
24 León;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
24 León;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
24 León;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
24 León;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
24 León;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
24 León;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;89,27
24 León;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
24 León;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
24 León;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
24 León;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;87,33
24 León;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
24 León;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
24 León;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
24 León;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
24 León;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
24 León;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
24 León;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;85,86
24 León;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
24 León;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
24 León;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
24 León;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;84,74
24 León;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
24 León;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
24 León;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
24 León;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
24 León;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
24 León;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QIV;5.471
24 León;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
24 León;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
24 León;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
24 León;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QIV;5.212
24 León;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
24 León;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
24 León;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
24 León;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QIV;5.014
24 León;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
24 León;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
24 León;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
24 León;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2022QIV;5.085
24 León;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
24 León;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2022QII;""
24 León;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2022QI;""
24 León;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2021QIV;4.952
24 León;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
24 León;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2021QII;""
24 León;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2021QI;""
24 León;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2020QIV;4.755
24 León;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
24 León;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2020QII;""
24 León;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2020QI;""
24 León;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
24 León;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
24 León;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2022QII;""
24 León;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2022QI;4.779
24 León;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
24 León;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
24 León;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2021QII;""
24 León;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2021QI;4.567
24 León;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
24 León;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
24 León;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2020QII;""
24 León;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2020QI;""
24 León;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
24 León;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
24 León;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QII;4.602
24 León;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QI;""
24 León;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
24 León;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
24 León;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QII;4.418
24 León;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QI;""
24 León;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
24 León;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
24 León;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QII;""
24 León;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QI;""
24 León;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
24 León;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QIII;4.447
24 León;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QII;""
24 León;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QI;""
24 León;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
24 León;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QIII;4.260
24 León;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QII;""
24 León;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QI;""
24 León;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
24 León;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
24 León;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QII;""
24 León;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QI;""
24 León;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
24 León;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
24 León;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
24 León;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
24 León;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
24 León;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
24 León;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
24 León;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
24 León;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
24 León;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
24 León;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
24 León;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
24 León;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;92,94
24 León;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
24 León;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
24 León;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
24 León;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;95,01
24 León;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
24 León;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
24 León;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
24 León;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;94,83
24 León;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
24 León;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
24 León;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
24 León;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
24 León;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
24 León;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
24 León;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;91,69
24 León;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
24 León;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
24 León;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
24 León;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;91,08
24 León;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
24 León;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
24 León;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
24 León;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
24 León;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
24 León;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
24 León;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;88,3
24 León;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
24 León;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
24 León;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
24 León;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;88,11
24 León;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
24 León;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
24 León;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
24 León;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
24 León;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
24 León;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
24 León;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;85,32
24 León;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
24 León;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
24 León;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
24 León;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;84,96
24 León;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
24 León;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
24 León;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
24 León;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
24 León;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
24 León;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
24 León;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QIV;3.438
24 León;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
24 León;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
24 León;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
24 León;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QIV;3.252
24 León;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
24 León;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
24 León;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
24 León;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QIV;3.150
24 León;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
24 León;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
24 León;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
24 León;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2022QIV;3.182
24 León;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
24 León;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2022QII;""
24 León;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2022QI;""
24 León;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2021QIV;3.090
24 León;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
24 León;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2021QII;""
24 León;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2021QI;""
24 León;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2020QIV;2.991
24 León;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
24 León;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2020QII;""
24 León;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2020QI;""
24 León;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
24 León;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
24 León;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2022QII;""
24 León;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2022QI;2.984
24 León;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
24 León;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
24 León;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2021QII;""
24 León;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2021QI;2.872
24 León;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
24 León;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
24 León;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2020QII;""
24 León;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2020QI;""
24 León;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
24 León;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
24 León;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QII;2.878
24 León;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QI;""
24 León;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
24 León;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
24 León;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QII;2.774
24 León;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QI;""
24 León;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
24 León;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
24 León;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QII;""
24 León;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QI;""
24 León;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
24 León;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QIII;2.778
24 León;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QII;""
24 León;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QI;""
24 León;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
24 León;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QIII;2.665
24 León;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QII;""
24 León;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QI;""
24 León;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
24 León;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
24 León;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QII;""
24 León;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QI;""
24 León;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
24 León;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
24 León;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
24 León;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
24 León;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
24 León;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
24 León;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
24 León;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
24 León;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
24 León;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
24 León;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
24 León;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
24 León;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;92,55
24 León;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
24 León;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
24 León;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
24 León;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;95,02
24 León;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
24 León;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
24 León;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
24 León;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;94,95
24 León;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
24 León;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
24 León;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
24 León;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
24 León;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
24 León;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
24 León;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;91,76
24 León;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
24 León;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
24 León;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
24 León;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;91,17
24 León;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
24 León;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
24 León;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
24 León;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
24 León;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
24 León;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
24 León;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;88,5
24 León;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
24 León;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
24 León;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
24 León;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;88,06
24 León;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
24 León;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
24 León;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
24 León;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
24 León;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
24 León;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
24 León;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;85,42
24 León;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
24 León;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
24 León;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
24 León;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;84,6
24 León;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
24 León;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
24 León;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
24 León;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
24 León;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
24 León;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
24 León;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QIV;2.033
24 León;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
24 León;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
24 León;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
24 León;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QIV;1.960
24 León;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
24 León;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
24 León;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
24 León;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QIV;1.864
24 León;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
24 León;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
24 León;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
24 León;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2022QIV;1.903
24 León;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
24 León;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2022QII;""
24 León;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2022QI;""
24 León;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2021QIV;1.862
24 León;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
24 León;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2021QII;""
24 León;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2021QI;""
24 León;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2020QIV;1.764
24 León;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
24 León;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2020QII;""
24 León;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2020QI;""
24 León;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
24 León;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
24 León;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2022QII;""
24 León;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2022QI;1.795
24 León;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
24 León;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
24 León;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2021QII;""
24 León;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2021QI;1.695
24 León;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
24 León;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
24 León;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2020QII;""
24 León;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2020QI;""
24 León;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
24 León;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
24 León;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QII;1.724
24 León;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QI;""
24 León;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
24 León;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
24 León;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QII;1.644
24 León;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QI;""
24 León;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
24 León;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
24 León;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QII;""
24 León;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QI;""
24 León;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
24 León;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QIII;1.669
24 León;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QII;""
24 León;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QI;""
24 León;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
24 León;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QIII;1.595
24 León;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QII;""
24 León;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QI;""
24 León;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
24 León;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
24 León;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QII;""
24 León;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QI;""
24 León;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
24 León;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
24 León;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
24 León;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
24 León;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
24 León;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
24 León;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
24 León;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
24 León;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
24 León;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
24 León;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
24 León;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
24 León;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;93,61
24 León;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
24 León;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
24 León;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
24 León;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;95
24 León;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
24 León;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
24 León;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
24 León;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;94,64
24 León;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
24 León;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
24 León;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
24 León;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
24 León;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
24 León;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
24 León;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;91,58
24 León;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
24 León;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
24 León;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
24 León;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;90,93
24 León;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
24 León;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
24 León;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
24 León;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
24 León;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
24 León;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
24 León;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;87,96
24 León;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
24 León;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
24 León;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
24 León;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;88,2
24 León;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
24 León;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
24 León;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
24 León;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
24 León;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
24 León;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
24 León;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;85,15
24 León;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
24 León;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
24 León;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
24 León;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;85,57
24 León;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
24 León;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
24 León;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
24 León;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
24 León;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
24 León;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
25 Lleida;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
25 Lleida;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
25 Lleida;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
25 Lleida;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QI;28.795
25 Lleida;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
25 Lleida;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
25 Lleida;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
25 Lleida;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QI;28.588
25 Lleida;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
25 Lleida;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
25 Lleida;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
25 Lleida;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QI;29.220
25 Lleida;All ages;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
25 Lleida;All ages;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
25 Lleida;All ages;Cohort January 1;Total;Survival in the first trimester;2022QII;""
25 Lleida;All ages;Cohort January 1;Total;Survival in the first trimester;2022QI;28.019
25 Lleida;All ages;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
25 Lleida;All ages;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
25 Lleida;All ages;Cohort January 1;Total;Survival in the first trimester;2021QII;""
25 Lleida;All ages;Cohort January 1;Total;Survival in the first trimester;2021QI;27.887
25 Lleida;All ages;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
25 Lleida;All ages;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
25 Lleida;All ages;Cohort January 1;Total;Survival in the first trimester;2020QII;""
25 Lleida;All ages;Cohort January 1;Total;Survival in the first trimester;2020QI;27.722
25 Lleida;All ages;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
25 Lleida;All ages;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
25 Lleida;All ages;Cohort January 1;Total;Survival in the second trimester;2022QII;27.175
25 Lleida;All ages;Cohort January 1;Total;Survival in the second trimester;2022QI;""
25 Lleida;All ages;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
25 Lleida;All ages;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
25 Lleida;All ages;Cohort January 1;Total;Survival in the second trimester;2021QII;27.277
25 Lleida;All ages;Cohort January 1;Total;Survival in the second trimester;2021QI;""
25 Lleida;All ages;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
25 Lleida;All ages;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
25 Lleida;All ages;Cohort January 1;Total;Survival in the second trimester;2020QII;27.204
25 Lleida;All ages;Cohort January 1;Total;Survival in the second trimester;2020QI;""
25 Lleida;All ages;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
25 Lleida;All ages;Cohort January 1;Total;Survival in the third trimester;2022QIII;26.477
25 Lleida;All ages;Cohort January 1;Total;Survival in the third trimester;2022QII;""
25 Lleida;All ages;Cohort January 1;Total;Survival in the third trimester;2022QI;""
25 Lleida;All ages;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
25 Lleida;All ages;Cohort January 1;Total;Survival in the third trimester;2021QIII;26.672
25 Lleida;All ages;Cohort January 1;Total;Survival in the third trimester;2021QII;""
25 Lleida;All ages;Cohort January 1;Total;Survival in the third trimester;2021QI;""
25 Lleida;All ages;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
25 Lleida;All ages;Cohort January 1;Total;Survival in the third trimester;2020QIII;26.526
25 Lleida;All ages;Cohort January 1;Total;Survival in the third trimester;2020QII;""
25 Lleida;All ages;Cohort January 1;Total;Survival in the third trimester;2020QI;""
25 Lleida;All ages;Cohort January 1;Total;Survival in the third trimester;2022QIV;25.599
25 Lleida;All ages;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
25 Lleida;All ages;Cohort January 1;Total;Survival in the third trimester;2022QII;""
25 Lleida;All ages;Cohort January 1;Total;Survival in the third trimester;2022QI;""
25 Lleida;All ages;Cohort January 1;Total;Survival in the third trimester;2021QIV;25.921
25 Lleida;All ages;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
25 Lleida;All ages;Cohort January 1;Total;Survival in the third trimester;2021QII;""
25 Lleida;All ages;Cohort January 1;Total;Survival in the third trimester;2021QI;""
25 Lleida;All ages;Cohort January 1;Total;Survival in the third trimester;2020QIV;25.738
25 Lleida;All ages;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
25 Lleida;All ages;Cohort January 1;Total;Survival in the third trimester;2020QII;""
25 Lleida;All ages;Cohort January 1;Total;Survival in the third trimester;2020QI;""
25 Lleida;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
25 Lleida;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
25 Lleida;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
25 Lleida;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
25 Lleida;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
25 Lleida;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
25 Lleida;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
25 Lleida;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
25 Lleida;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
25 Lleida;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
25 Lleida;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
25 Lleida;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
25 Lleida;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
25 Lleida;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
25 Lleida;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
25 Lleida;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;97,31
25 Lleida;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
25 Lleida;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
25 Lleida;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
25 Lleida;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;97,55
25 Lleida;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
25 Lleida;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
25 Lleida;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
25 Lleida;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;94,87
25 Lleida;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
25 Lleida;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
25 Lleida;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;94,37
25 Lleida;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
25 Lleida;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
25 Lleida;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
25 Lleida;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;95,41
25 Lleida;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
25 Lleida;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
25 Lleida;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
25 Lleida;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;93,1
25 Lleida;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
25 Lleida;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
25 Lleida;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;91,95
25 Lleida;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
25 Lleida;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
25 Lleida;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
25 Lleida;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;93,3
25 Lleida;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
25 Lleida;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
25 Lleida;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
25 Lleida;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;90,78
25 Lleida;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
25 Lleida;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
25 Lleida;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;88,9
25 Lleida;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
25 Lleida;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
25 Lleida;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
25 Lleida;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;90,67
25 Lleida;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
25 Lleida;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
25 Lleida;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
25 Lleida;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;88,08
25 Lleida;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
25 Lleida;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
25 Lleida;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
25 Lleida;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
25 Lleida;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
25 Lleida;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
25 Lleida;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QI;18.095
25 Lleida;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
25 Lleida;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
25 Lleida;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
25 Lleida;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QI;17.958
25 Lleida;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
25 Lleida;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
25 Lleida;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
25 Lleida;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QI;18.314
25 Lleida;All ages;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
25 Lleida;All ages;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
25 Lleida;All ages;Cohort January 1;Males;Survival in the first trimester;2022QII;""
25 Lleida;All ages;Cohort January 1;Males;Survival in the first trimester;2022QI;17.642
25 Lleida;All ages;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
25 Lleida;All ages;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
25 Lleida;All ages;Cohort January 1;Males;Survival in the first trimester;2021QII;""
25 Lleida;All ages;Cohort January 1;Males;Survival in the first trimester;2021QI;17.516
25 Lleida;All ages;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
25 Lleida;All ages;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
25 Lleida;All ages;Cohort January 1;Males;Survival in the first trimester;2020QII;""
25 Lleida;All ages;Cohort January 1;Males;Survival in the first trimester;2020QI;17.406
25 Lleida;All ages;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
25 Lleida;All ages;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
25 Lleida;All ages;Cohort January 1;Males;Survival in the second trimester;2022QII;17.130
25 Lleida;All ages;Cohort January 1;Males;Survival in the second trimester;2022QI;""
25 Lleida;All ages;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
25 Lleida;All ages;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
25 Lleida;All ages;Cohort January 1;Males;Survival in the second trimester;2021QII;17.154
25 Lleida;All ages;Cohort January 1;Males;Survival in the second trimester;2021QI;""
25 Lleida;All ages;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
25 Lleida;All ages;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
25 Lleida;All ages;Cohort January 1;Males;Survival in the second trimester;2020QII;17.136
25 Lleida;All ages;Cohort January 1;Males;Survival in the second trimester;2020QI;""
25 Lleida;All ages;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
25 Lleida;All ages;Cohort January 1;Males;Survival in the third trimester;2022QIII;16.715
25 Lleida;All ages;Cohort January 1;Males;Survival in the third trimester;2022QII;""
25 Lleida;All ages;Cohort January 1;Males;Survival in the third trimester;2022QI;""
25 Lleida;All ages;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
25 Lleida;All ages;Cohort January 1;Males;Survival in the third trimester;2021QIII;16.808
25 Lleida;All ages;Cohort January 1;Males;Survival in the third trimester;2021QII;""
25 Lleida;All ages;Cohort January 1;Males;Survival in the third trimester;2021QI;""
25 Lleida;All ages;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
25 Lleida;All ages;Cohort January 1;Males;Survival in the third trimester;2020QIII;16.738
25 Lleida;All ages;Cohort January 1;Males;Survival in the third trimester;2020QII;""
25 Lleida;All ages;Cohort January 1;Males;Survival in the third trimester;2020QI;""
25 Lleida;All ages;Cohort January 1;Males;Survival in the third trimester;2022QIV;16.141
25 Lleida;All ages;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
25 Lleida;All ages;Cohort January 1;Males;Survival in the third trimester;2022QII;""
25 Lleida;All ages;Cohort January 1;Males;Survival in the third trimester;2022QI;""
25 Lleida;All ages;Cohort January 1;Males;Survival in the third trimester;2021QIV;16.370
25 Lleida;All ages;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
25 Lleida;All ages;Cohort January 1;Males;Survival in the third trimester;2021QII;""
25 Lleida;All ages;Cohort January 1;Males;Survival in the third trimester;2021QI;""
25 Lleida;All ages;Cohort January 1;Males;Survival in the third trimester;2020QIV;16.264
25 Lleida;All ages;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
25 Lleida;All ages;Cohort January 1;Males;Survival in the third trimester;2020QII;""
25 Lleida;All ages;Cohort January 1;Males;Survival in the third trimester;2020QI;""
25 Lleida;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
25 Lleida;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
25 Lleida;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
25 Lleida;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
25 Lleida;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
25 Lleida;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
25 Lleida;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
25 Lleida;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
25 Lleida;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
25 Lleida;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
25 Lleida;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
25 Lleida;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
25 Lleida;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
25 Lleida;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
25 Lleida;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
25 Lleida;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;97,5
25 Lleida;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
25 Lleida;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
25 Lleida;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
25 Lleida;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;97,54
25 Lleida;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
25 Lleida;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
25 Lleida;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
25 Lleida;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;95,04
25 Lleida;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
25 Lleida;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
25 Lleida;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;94,67
25 Lleida;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
25 Lleida;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
25 Lleida;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
25 Lleida;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;95,52
25 Lleida;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
25 Lleida;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
25 Lleida;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
25 Lleida;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;93,57
25 Lleida;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
25 Lleida;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
25 Lleida;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;92,37
25 Lleida;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
25 Lleida;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
25 Lleida;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
25 Lleida;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;93,6
25 Lleida;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
25 Lleida;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
25 Lleida;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
25 Lleida;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;91,39
25 Lleida;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
25 Lleida;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
25 Lleida;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;89,2
25 Lleida;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
25 Lleida;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
25 Lleida;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
25 Lleida;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;91,16
25 Lleida;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
25 Lleida;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
25 Lleida;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
25 Lleida;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;88,81
25 Lleida;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
25 Lleida;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
25 Lleida;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
25 Lleida;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
25 Lleida;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
25 Lleida;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
25 Lleida;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QI;10.700
25 Lleida;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
25 Lleida;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
25 Lleida;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
25 Lleida;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QI;10.630
25 Lleida;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
25 Lleida;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
25 Lleida;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
25 Lleida;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QI;10.906
25 Lleida;All ages;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
25 Lleida;All ages;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
25 Lleida;All ages;Cohort January 1;Females;Survival in the first trimester;2022QII;""
25 Lleida;All ages;Cohort January 1;Females;Survival in the first trimester;2022QI;10.377
25 Lleida;All ages;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
25 Lleida;All ages;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
25 Lleida;All ages;Cohort January 1;Females;Survival in the first trimester;2021QII;""
25 Lleida;All ages;Cohort January 1;Females;Survival in the first trimester;2021QI;10.371
25 Lleida;All ages;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
25 Lleida;All ages;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
25 Lleida;All ages;Cohort January 1;Females;Survival in the first trimester;2020QII;""
25 Lleida;All ages;Cohort January 1;Females;Survival in the first trimester;2020QI;10.316
25 Lleida;All ages;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
25 Lleida;All ages;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
25 Lleida;All ages;Cohort January 1;Females;Survival in the second trimester;2022QII;10.045
25 Lleida;All ages;Cohort January 1;Females;Survival in the second trimester;2022QI;""
25 Lleida;All ages;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
25 Lleida;All ages;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
25 Lleida;All ages;Cohort January 1;Females;Survival in the second trimester;2021QII;10.123
25 Lleida;All ages;Cohort January 1;Females;Survival in the second trimester;2021QI;""
25 Lleida;All ages;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
25 Lleida;All ages;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
25 Lleida;All ages;Cohort January 1;Females;Survival in the second trimester;2020QII;10.068
25 Lleida;All ages;Cohort January 1;Females;Survival in the second trimester;2020QI;""
25 Lleida;All ages;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
25 Lleida;All ages;Cohort January 1;Females;Survival in the third trimester;2022QIII;9.762
25 Lleida;All ages;Cohort January 1;Females;Survival in the third trimester;2022QII;""
25 Lleida;All ages;Cohort January 1;Females;Survival in the third trimester;2022QI;""
25 Lleida;All ages;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
25 Lleida;All ages;Cohort January 1;Females;Survival in the third trimester;2021QIII;9.864
25 Lleida;All ages;Cohort January 1;Females;Survival in the third trimester;2021QII;""
25 Lleida;All ages;Cohort January 1;Females;Survival in the third trimester;2021QI;""
25 Lleida;All ages;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
25 Lleida;All ages;Cohort January 1;Females;Survival in the third trimester;2020QIII;9.788
25 Lleida;All ages;Cohort January 1;Females;Survival in the third trimester;2020QII;""
25 Lleida;All ages;Cohort January 1;Females;Survival in the third trimester;2020QI;""
25 Lleida;All ages;Cohort January 1;Females;Survival in the third trimester;2022QIV;9.458
25 Lleida;All ages;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
25 Lleida;All ages;Cohort January 1;Females;Survival in the third trimester;2022QII;""
25 Lleida;All ages;Cohort January 1;Females;Survival in the third trimester;2022QI;""
25 Lleida;All ages;Cohort January 1;Females;Survival in the third trimester;2021QIV;9.551
25 Lleida;All ages;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
25 Lleida;All ages;Cohort January 1;Females;Survival in the third trimester;2021QII;""
25 Lleida;All ages;Cohort January 1;Females;Survival in the third trimester;2021QI;""
25 Lleida;All ages;Cohort January 1;Females;Survival in the third trimester;2020QIV;9.474
25 Lleida;All ages;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
25 Lleida;All ages;Cohort January 1;Females;Survival in the third trimester;2020QII;""
25 Lleida;All ages;Cohort January 1;Females;Survival in the third trimester;2020QI;""
25 Lleida;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
25 Lleida;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
25 Lleida;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
25 Lleida;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
25 Lleida;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
25 Lleida;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
25 Lleida;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
25 Lleida;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
25 Lleida;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
25 Lleida;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
25 Lleida;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
25 Lleida;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
25 Lleida;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
25 Lleida;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
25 Lleida;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
25 Lleida;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;96,98
25 Lleida;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
25 Lleida;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
25 Lleida;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
25 Lleida;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;97,56
25 Lleida;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
25 Lleida;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
25 Lleida;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
25 Lleida;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;94,59
25 Lleida;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
25 Lleida;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
25 Lleida;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;93,88
25 Lleida;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
25 Lleida;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
25 Lleida;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
25 Lleida;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;95,23
25 Lleida;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
25 Lleida;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
25 Lleida;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
25 Lleida;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;92,32
25 Lleida;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
25 Lleida;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
25 Lleida;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;91,23
25 Lleida;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
25 Lleida;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
25 Lleida;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
25 Lleida;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;92,79
25 Lleida;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
25 Lleida;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
25 Lleida;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
25 Lleida;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;89,75
25 Lleida;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
25 Lleida;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
25 Lleida;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;88,39
25 Lleida;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
25 Lleida;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
25 Lleida;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
25 Lleida;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;89,85
25 Lleida;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
25 Lleida;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
25 Lleida;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
25 Lleida;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;86,87
25 Lleida;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
25 Lleida;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
25 Lleida;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
25 Lleida;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
25 Lleida;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
25 Lleida;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QII;28.799
25 Lleida;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
25 Lleida;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
25 Lleida;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
25 Lleida;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QII;28.699
25 Lleida;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
25 Lleida;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
25 Lleida;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
25 Lleida;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QII;28.829
25 Lleida;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
25 Lleida;All ages;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
25 Lleida;All ages;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
25 Lleida;All ages;Cohort April 1;Total;Survival in the first trimester;2022QII;27.877
25 Lleida;All ages;Cohort April 1;Total;Survival in the first trimester;2022QI;""
25 Lleida;All ages;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
25 Lleida;All ages;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
25 Lleida;All ages;Cohort April 1;Total;Survival in the first trimester;2021QII;28.014
25 Lleida;All ages;Cohort April 1;Total;Survival in the first trimester;2021QI;""
25 Lleida;All ages;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
25 Lleida;All ages;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
25 Lleida;All ages;Cohort April 1;Total;Survival in the first trimester;2020QII;28.247
25 Lleida;All ages;Cohort April 1;Total;Survival in the first trimester;2020QI;""
25 Lleida;All ages;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
25 Lleida;All ages;Cohort April 1;Total;Survival in the second trimester;2022QIII;27.140
25 Lleida;All ages;Cohort April 1;Total;Survival in the second trimester;2022QII;""
25 Lleida;All ages;Cohort April 1;Total;Survival in the second trimester;2022QI;""
25 Lleida;All ages;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
25 Lleida;All ages;Cohort April 1;Total;Survival in the second trimester;2021QIII;27.344
25 Lleida;All ages;Cohort April 1;Total;Survival in the second trimester;2021QII;""
25 Lleida;All ages;Cohort April 1;Total;Survival in the second trimester;2021QI;""
25 Lleida;All ages;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
25 Lleida;All ages;Cohort April 1;Total;Survival in the second trimester;2020QIII;27.429
25 Lleida;All ages;Cohort April 1;Total;Survival in the second trimester;2020QII;""
25 Lleida;All ages;Cohort April 1;Total;Survival in the second trimester;2020QI;""
25 Lleida;All ages;Cohort April 1;Total;Survival in the third trimester;2022QIV;26.211
25 Lleida;All ages;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
25 Lleida;All ages;Cohort April 1;Total;Survival in the third trimester;2022QII;""
25 Lleida;All ages;Cohort April 1;Total;Survival in the third trimester;2022QI;""
25 Lleida;All ages;Cohort April 1;Total;Survival in the third trimester;2021QIV;26.547
25 Lleida;All ages;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
25 Lleida;All ages;Cohort April 1;Total;Survival in the third trimester;2021QII;""
25 Lleida;All ages;Cohort April 1;Total;Survival in the third trimester;2021QI;""
25 Lleida;All ages;Cohort April 1;Total;Survival in the third trimester;2020QIV;26.576
25 Lleida;All ages;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
25 Lleida;All ages;Cohort April 1;Total;Survival in the third trimester;2020QII;""
25 Lleida;All ages;Cohort April 1;Total;Survival in the third trimester;2020QI;""
25 Lleida;All ages;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
25 Lleida;All ages;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
25 Lleida;All ages;Cohort April 1;Total;Survival in the third trimester;2022QII;""
25 Lleida;All ages;Cohort April 1;Total;Survival in the third trimester;2022QI;25.956
25 Lleida;All ages;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
25 Lleida;All ages;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
25 Lleida;All ages;Cohort April 1;Total;Survival in the third trimester;2021QII;""
25 Lleida;All ages;Cohort April 1;Total;Survival in the third trimester;2021QI;26.024
25 Lleida;All ages;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
25 Lleida;All ages;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
25 Lleida;All ages;Cohort April 1;Total;Survival in the third trimester;2020QII;""
25 Lleida;All ages;Cohort April 1;Total;Survival in the third trimester;2020QI;""
25 Lleida;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
25 Lleida;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
25 Lleida;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
25 Lleida;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
25 Lleida;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
25 Lleida;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
25 Lleida;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
25 Lleida;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
25 Lleida;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
25 Lleida;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
25 Lleida;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
25 Lleida;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
25 Lleida;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
25 Lleida;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
25 Lleida;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;96,8
25 Lleida;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
25 Lleida;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
25 Lleida;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
25 Lleida;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;97,61
25 Lleida;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
25 Lleida;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
25 Lleida;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
25 Lleida;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;97,98
25 Lleida;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
25 Lleida;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
25 Lleida;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;94,24
25 Lleida;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
25 Lleida;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
25 Lleida;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
25 Lleida;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;95,28
25 Lleida;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
25 Lleida;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
25 Lleida;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
25 Lleida;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;95,14
25 Lleida;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
25 Lleida;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
25 Lleida;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;91,01
25 Lleida;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
25 Lleida;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
25 Lleida;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
25 Lleida;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;92,5
25 Lleida;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
25 Lleida;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
25 Lleida;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
25 Lleida;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;92,18
25 Lleida;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
25 Lleida;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
25 Lleida;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
25 Lleida;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
25 Lleida;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
25 Lleida;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
25 Lleida;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;90,44
25 Lleida;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
25 Lleida;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
25 Lleida;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
25 Lleida;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;90,27
25 Lleida;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
25 Lleida;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
25 Lleida;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
25 Lleida;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
25 Lleida;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
25 Lleida;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
25 Lleida;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QII;18.133
25 Lleida;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
25 Lleida;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
25 Lleida;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
25 Lleida;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QII;18.020
25 Lleida;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
25 Lleida;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
25 Lleida;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
25 Lleida;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QII;18.089
25 Lleida;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
25 Lleida;All ages;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
25 Lleida;All ages;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
25 Lleida;All ages;Cohort April 1;Males;Survival in the first trimester;2022QII;17.566
25 Lleida;All ages;Cohort April 1;Males;Survival in the first trimester;2022QI;""
25 Lleida;All ages;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
25 Lleida;All ages;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
25 Lleida;All ages;Cohort April 1;Males;Survival in the first trimester;2021QII;17.603
25 Lleida;All ages;Cohort April 1;Males;Survival in the first trimester;2021QI;""
25 Lleida;All ages;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
25 Lleida;All ages;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
25 Lleida;All ages;Cohort April 1;Males;Survival in the first trimester;2020QII;17.772
25 Lleida;All ages;Cohort April 1;Males;Survival in the first trimester;2020QI;""
25 Lleida;All ages;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
25 Lleida;All ages;Cohort April 1;Males;Survival in the second trimester;2022QIII;17.127
25 Lleida;All ages;Cohort April 1;Males;Survival in the second trimester;2022QII;""
25 Lleida;All ages;Cohort April 1;Males;Survival in the second trimester;2022QI;""
25 Lleida;All ages;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
25 Lleida;All ages;Cohort April 1;Males;Survival in the second trimester;2021QIII;17.212
25 Lleida;All ages;Cohort April 1;Males;Survival in the second trimester;2021QII;""
25 Lleida;All ages;Cohort April 1;Males;Survival in the second trimester;2021QI;""
25 Lleida;All ages;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
25 Lleida;All ages;Cohort April 1;Males;Survival in the second trimester;2020QIII;17.283
25 Lleida;All ages;Cohort April 1;Males;Survival in the second trimester;2020QII;""
25 Lleida;All ages;Cohort April 1;Males;Survival in the second trimester;2020QI;""
25 Lleida;All ages;Cohort April 1;Males;Survival in the third trimester;2022QIV;16.525
25 Lleida;All ages;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
25 Lleida;All ages;Cohort April 1;Males;Survival in the third trimester;2022QII;""
25 Lleida;All ages;Cohort April 1;Males;Survival in the third trimester;2022QI;""
25 Lleida;All ages;Cohort April 1;Males;Survival in the third trimester;2021QIV;16.745
25 Lleida;All ages;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
25 Lleida;All ages;Cohort April 1;Males;Survival in the third trimester;2021QII;""
25 Lleida;All ages;Cohort April 1;Males;Survival in the third trimester;2021QI;""
25 Lleida;All ages;Cohort April 1;Males;Survival in the third trimester;2020QIV;16.763
25 Lleida;All ages;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
25 Lleida;All ages;Cohort April 1;Males;Survival in the third trimester;2020QII;""
25 Lleida;All ages;Cohort April 1;Males;Survival in the third trimester;2020QI;""
25 Lleida;All ages;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
25 Lleida;All ages;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
25 Lleida;All ages;Cohort April 1;Males;Survival in the third trimester;2022QII;""
25 Lleida;All ages;Cohort April 1;Males;Survival in the third trimester;2022QI;16.403
25 Lleida;All ages;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
25 Lleida;All ages;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
25 Lleida;All ages;Cohort April 1;Males;Survival in the third trimester;2021QII;""
25 Lleida;All ages;Cohort April 1;Males;Survival in the third trimester;2021QI;16.412
25 Lleida;All ages;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
25 Lleida;All ages;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
25 Lleida;All ages;Cohort April 1;Males;Survival in the third trimester;2020QII;""
25 Lleida;All ages;Cohort April 1;Males;Survival in the third trimester;2020QI;""
25 Lleida;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
25 Lleida;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
25 Lleida;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
25 Lleida;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
25 Lleida;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
25 Lleida;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
25 Lleida;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
25 Lleida;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
25 Lleida;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
25 Lleida;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
25 Lleida;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
25 Lleida;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
25 Lleida;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
25 Lleida;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
25 Lleida;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;96,87
25 Lleida;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
25 Lleida;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
25 Lleida;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
25 Lleida;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;97,69
25 Lleida;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
25 Lleida;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
25 Lleida;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
25 Lleida;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;98,25
25 Lleida;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
25 Lleida;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
25 Lleida;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;94,45
25 Lleida;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
25 Lleida;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
25 Lleida;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
25 Lleida;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;95,52
25 Lleida;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
25 Lleida;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
25 Lleida;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
25 Lleida;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;95,54
25 Lleida;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
25 Lleida;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
25 Lleida;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;91,13
25 Lleida;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
25 Lleida;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
25 Lleida;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
25 Lleida;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;92,92
25 Lleida;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
25 Lleida;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
25 Lleida;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
25 Lleida;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;92,67
25 Lleida;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
25 Lleida;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
25 Lleida;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
25 Lleida;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
25 Lleida;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
25 Lleida;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
25 Lleida;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;91,03
25 Lleida;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
25 Lleida;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
25 Lleida;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
25 Lleida;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;90,73
25 Lleida;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
25 Lleida;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
25 Lleida;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
25 Lleida;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
25 Lleida;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
25 Lleida;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
25 Lleida;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QII;10.666
25 Lleida;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
25 Lleida;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
25 Lleida;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
25 Lleida;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QII;10.679
25 Lleida;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
25 Lleida;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
25 Lleida;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
25 Lleida;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QII;10.740
25 Lleida;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
25 Lleida;All ages;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
25 Lleida;All ages;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
25 Lleida;All ages;Cohort April 1;Females;Survival in the first trimester;2022QII;10.311
25 Lleida;All ages;Cohort April 1;Females;Survival in the first trimester;2022QI;""
25 Lleida;All ages;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
25 Lleida;All ages;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
25 Lleida;All ages;Cohort April 1;Females;Survival in the first trimester;2021QII;10.411
25 Lleida;All ages;Cohort April 1;Females;Survival in the first trimester;2021QI;""
25 Lleida;All ages;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
25 Lleida;All ages;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
25 Lleida;All ages;Cohort April 1;Females;Survival in the first trimester;2020QII;10.475
25 Lleida;All ages;Cohort April 1;Females;Survival in the first trimester;2020QI;""
25 Lleida;All ages;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
25 Lleida;All ages;Cohort April 1;Females;Survival in the second trimester;2022QIII;10.013
25 Lleida;All ages;Cohort April 1;Females;Survival in the second trimester;2022QII;""
25 Lleida;All ages;Cohort April 1;Females;Survival in the second trimester;2022QI;""
25 Lleida;All ages;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
25 Lleida;All ages;Cohort April 1;Females;Survival in the second trimester;2021QIII;10.132
25 Lleida;All ages;Cohort April 1;Females;Survival in the second trimester;2021QII;""
25 Lleida;All ages;Cohort April 1;Females;Survival in the second trimester;2021QI;""
25 Lleida;All ages;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
25 Lleida;All ages;Cohort April 1;Females;Survival in the second trimester;2020QIII;10.146
25 Lleida;All ages;Cohort April 1;Females;Survival in the second trimester;2020QII;""
25 Lleida;All ages;Cohort April 1;Females;Survival in the second trimester;2020QI;""
25 Lleida;All ages;Cohort April 1;Females;Survival in the third trimester;2022QIV;9.686
25 Lleida;All ages;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
25 Lleida;All ages;Cohort April 1;Females;Survival in the third trimester;2022QII;""
25 Lleida;All ages;Cohort April 1;Females;Survival in the third trimester;2022QI;""
25 Lleida;All ages;Cohort April 1;Females;Survival in the third trimester;2021QIV;9.802
25 Lleida;All ages;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
25 Lleida;All ages;Cohort April 1;Females;Survival in the third trimester;2021QII;""
25 Lleida;All ages;Cohort April 1;Females;Survival in the third trimester;2021QI;""
25 Lleida;All ages;Cohort April 1;Females;Survival in the third trimester;2020QIV;9.813
25 Lleida;All ages;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
25 Lleida;All ages;Cohort April 1;Females;Survival in the third trimester;2020QII;""
25 Lleida;All ages;Cohort April 1;Females;Survival in the third trimester;2020QI;""
25 Lleida;All ages;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
25 Lleida;All ages;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
25 Lleida;All ages;Cohort April 1;Females;Survival in the third trimester;2022QII;""
25 Lleida;All ages;Cohort April 1;Females;Survival in the third trimester;2022QI;9.553
25 Lleida;All ages;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
25 Lleida;All ages;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
25 Lleida;All ages;Cohort April 1;Females;Survival in the third trimester;2021QII;""
25 Lleida;All ages;Cohort April 1;Females;Survival in the third trimester;2021QI;9.612
25 Lleida;All ages;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
25 Lleida;All ages;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
25 Lleida;All ages;Cohort April 1;Females;Survival in the third trimester;2020QII;""
25 Lleida;All ages;Cohort April 1;Females;Survival in the third trimester;2020QI;""
25 Lleida;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
25 Lleida;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
25 Lleida;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
25 Lleida;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
25 Lleida;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
25 Lleida;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
25 Lleida;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
25 Lleida;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
25 Lleida;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
25 Lleida;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
25 Lleida;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
25 Lleida;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
25 Lleida;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
25 Lleida;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
25 Lleida;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;96,67
25 Lleida;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
25 Lleida;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
25 Lleida;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
25 Lleida;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;97,49
25 Lleida;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
25 Lleida;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
25 Lleida;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
25 Lleida;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;97,53
25 Lleida;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
25 Lleida;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
25 Lleida;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;93,88
25 Lleida;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
25 Lleida;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
25 Lleida;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
25 Lleida;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;94,88
25 Lleida;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
25 Lleida;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
25 Lleida;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
25 Lleida;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;94,47
25 Lleida;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
25 Lleida;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
25 Lleida;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;90,81
25 Lleida;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
25 Lleida;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
25 Lleida;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
25 Lleida;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;91,79
25 Lleida;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
25 Lleida;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
25 Lleida;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
25 Lleida;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;91,37
25 Lleida;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
25 Lleida;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
25 Lleida;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
25 Lleida;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
25 Lleida;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
25 Lleida;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
25 Lleida;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;89,46
25 Lleida;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
25 Lleida;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
25 Lleida;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
25 Lleida;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;89,5
25 Lleida;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
25 Lleida;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
25 Lleida;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
25 Lleida;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
25 Lleida;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
25 Lleida;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QIII;28.804
25 Lleida;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
25 Lleida;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
25 Lleida;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
25 Lleida;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QIII;28.928
25 Lleida;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
25 Lleida;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
25 Lleida;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
25 Lleida;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QIII;28.899
25 Lleida;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
25 Lleida;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
25 Lleida;All ages;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
25 Lleida;All ages;Cohort July 1;Total;Survival in the first trimester;2022QIII;27.903
25 Lleida;All ages;Cohort July 1;Total;Survival in the first trimester;2022QII;""
25 Lleida;All ages;Cohort July 1;Total;Survival in the first trimester;2022QI;""
25 Lleida;All ages;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
25 Lleida;All ages;Cohort July 1;Total;Survival in the first trimester;2021QIII;28.122
25 Lleida;All ages;Cohort July 1;Total;Survival in the first trimester;2021QII;""
25 Lleida;All ages;Cohort July 1;Total;Survival in the first trimester;2021QI;""
25 Lleida;All ages;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
25 Lleida;All ages;Cohort July 1;Total;Survival in the first trimester;2020QIII;27.984
25 Lleida;All ages;Cohort July 1;Total;Survival in the first trimester;2020QII;""
25 Lleida;All ages;Cohort July 1;Total;Survival in the first trimester;2020QI;""
25 Lleida;All ages;Cohort July 1;Total;Survival in the second trimester;2022QIV;26.877
25 Lleida;All ages;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
25 Lleida;All ages;Cohort July 1;Total;Survival in the second trimester;2022QII;""
25 Lleida;All ages;Cohort July 1;Total;Survival in the second trimester;2022QI;""
25 Lleida;All ages;Cohort July 1;Total;Survival in the second trimester;2021QIV;27.251
25 Lleida;All ages;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
25 Lleida;All ages;Cohort July 1;Total;Survival in the second trimester;2021QII;""
25 Lleida;All ages;Cohort July 1;Total;Survival in the second trimester;2021QI;""
25 Lleida;All ages;Cohort July 1;Total;Survival in the second trimester;2020QIV;27.064
25 Lleida;All ages;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
25 Lleida;All ages;Cohort July 1;Total;Survival in the second trimester;2020QII;""
25 Lleida;All ages;Cohort July 1;Total;Survival in the second trimester;2020QI;""
25 Lleida;All ages;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
25 Lleida;All ages;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
25 Lleida;All ages;Cohort July 1;Total;Survival in the third trimester;2022QII;""
25 Lleida;All ages;Cohort July 1;Total;Survival in the third trimester;2022QI;26.613
25 Lleida;All ages;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
25 Lleida;All ages;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
25 Lleida;All ages;Cohort July 1;Total;Survival in the third trimester;2021QII;""
25 Lleida;All ages;Cohort July 1;Total;Survival in the third trimester;2021QI;26.489
25 Lleida;All ages;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
25 Lleida;All ages;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
25 Lleida;All ages;Cohort July 1;Total;Survival in the third trimester;2020QII;""
25 Lleida;All ages;Cohort July 1;Total;Survival in the third trimester;2020QI;""
25 Lleida;All ages;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
25 Lleida;All ages;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
25 Lleida;All ages;Cohort July 1;Total;Survival in the third trimester;2022QII;25.935
25 Lleida;All ages;Cohort July 1;Total;Survival in the third trimester;2022QI;""
25 Lleida;All ages;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
25 Lleida;All ages;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
25 Lleida;All ages;Cohort July 1;Total;Survival in the third trimester;2021QII;25.986
25 Lleida;All ages;Cohort July 1;Total;Survival in the third trimester;2021QI;""
25 Lleida;All ages;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
25 Lleida;All ages;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
25 Lleida;All ages;Cohort July 1;Total;Survival in the third trimester;2020QII;""
25 Lleida;All ages;Cohort July 1;Total;Survival in the third trimester;2020QI;""
25 Lleida;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
25 Lleida;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
25 Lleida;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
25 Lleida;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
25 Lleida;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
25 Lleida;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
25 Lleida;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
25 Lleida;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
25 Lleida;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
25 Lleida;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
25 Lleida;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
25 Lleida;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
25 Lleida;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
25 Lleida;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;96,87
25 Lleida;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
25 Lleida;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
25 Lleida;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
25 Lleida;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;97,21
25 Lleida;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
25 Lleida;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
25 Lleida;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
25 Lleida;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;96,83
25 Lleida;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
25 Lleida;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
25 Lleida;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;93,31
25 Lleida;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
25 Lleida;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
25 Lleida;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
25 Lleida;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;94,2
25 Lleida;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
25 Lleida;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
25 Lleida;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
25 Lleida;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;93,65
25 Lleida;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
25 Lleida;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
25 Lleida;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
25 Lleida;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
25 Lleida;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
25 Lleida;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
25 Lleida;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;92
25 Lleida;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
25 Lleida;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
25 Lleida;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
25 Lleida;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;91,66
25 Lleida;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
25 Lleida;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
25 Lleida;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
25 Lleida;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
25 Lleida;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
25 Lleida;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
25 Lleida;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;89,65
25 Lleida;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
25 Lleida;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
25 Lleida;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
25 Lleida;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;89,92
25 Lleida;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
25 Lleida;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
25 Lleida;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
25 Lleida;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
25 Lleida;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
25 Lleida;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
25 Lleida;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QIII;18.111
25 Lleida;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
25 Lleida;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
25 Lleida;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
25 Lleida;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QIII;18.162
25 Lleida;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
25 Lleida;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
25 Lleida;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
25 Lleida;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QIII;18.211
25 Lleida;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
25 Lleida;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
25 Lleida;All ages;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
25 Lleida;All ages;Cohort July 1;Males;Survival in the first trimester;2022QIII;17.577
25 Lleida;All ages;Cohort July 1;Males;Survival in the first trimester;2022QII;""
25 Lleida;All ages;Cohort July 1;Males;Survival in the first trimester;2022QI;""
25 Lleida;All ages;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
25 Lleida;All ages;Cohort July 1;Males;Survival in the first trimester;2021QIII;17.700
25 Lleida;All ages;Cohort July 1;Males;Survival in the first trimester;2021QII;""
25 Lleida;All ages;Cohort July 1;Males;Survival in the first trimester;2021QI;""
25 Lleida;All ages;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
25 Lleida;All ages;Cohort July 1;Males;Survival in the first trimester;2020QIII;17.660
25 Lleida;All ages;Cohort July 1;Males;Survival in the first trimester;2020QII;""
25 Lleida;All ages;Cohort July 1;Males;Survival in the first trimester;2020QI;""
25 Lleida;All ages;Cohort July 1;Males;Survival in the second trimester;2022QIV;16.917
25 Lleida;All ages;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
25 Lleida;All ages;Cohort July 1;Males;Survival in the second trimester;2022QII;""
25 Lleida;All ages;Cohort July 1;Males;Survival in the second trimester;2022QI;""
25 Lleida;All ages;Cohort July 1;Males;Survival in the second trimester;2021QIV;17.184
25 Lleida;All ages;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
25 Lleida;All ages;Cohort July 1;Males;Survival in the second trimester;2021QII;""
25 Lleida;All ages;Cohort July 1;Males;Survival in the second trimester;2021QI;""
25 Lleida;All ages;Cohort July 1;Males;Survival in the second trimester;2020QIV;17.089
25 Lleida;All ages;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
25 Lleida;All ages;Cohort July 1;Males;Survival in the second trimester;2020QII;""
25 Lleida;All ages;Cohort July 1;Males;Survival in the second trimester;2020QI;""
25 Lleida;All ages;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
25 Lleida;All ages;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
25 Lleida;All ages;Cohort July 1;Males;Survival in the third trimester;2022QII;""
25 Lleida;All ages;Cohort July 1;Males;Survival in the third trimester;2022QI;16.814
25 Lleida;All ages;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
25 Lleida;All ages;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
25 Lleida;All ages;Cohort July 1;Males;Survival in the third trimester;2021QII;""
25 Lleida;All ages;Cohort July 1;Males;Survival in the third trimester;2021QI;16.721
25 Lleida;All ages;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
25 Lleida;All ages;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
25 Lleida;All ages;Cohort July 1;Males;Survival in the third trimester;2020QII;""
25 Lleida;All ages;Cohort July 1;Males;Survival in the third trimester;2020QI;""
25 Lleida;All ages;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
25 Lleida;All ages;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
25 Lleida;All ages;Cohort July 1;Males;Survival in the third trimester;2022QII;16.411
25 Lleida;All ages;Cohort July 1;Males;Survival in the third trimester;2022QI;""
25 Lleida;All ages;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
25 Lleida;All ages;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
25 Lleida;All ages;Cohort July 1;Males;Survival in the third trimester;2021QII;16.424
25 Lleida;All ages;Cohort July 1;Males;Survival in the third trimester;2021QI;""
25 Lleida;All ages;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
25 Lleida;All ages;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
25 Lleida;All ages;Cohort July 1;Males;Survival in the third trimester;2020QII;""
25 Lleida;All ages;Cohort July 1;Males;Survival in the third trimester;2020QI;""
25 Lleida;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
25 Lleida;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
25 Lleida;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
25 Lleida;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
25 Lleida;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
25 Lleida;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
25 Lleida;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
25 Lleida;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
25 Lleida;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
25 Lleida;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
25 Lleida;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
25 Lleida;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
25 Lleida;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
25 Lleida;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;97,05
25 Lleida;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
25 Lleida;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
25 Lleida;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
25 Lleida;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;97,46
25 Lleida;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
25 Lleida;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
25 Lleida;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
25 Lleida;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;96,97
25 Lleida;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
25 Lleida;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
25 Lleida;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;93,41
25 Lleida;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
25 Lleida;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
25 Lleida;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
25 Lleida;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;94,62
25 Lleida;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
25 Lleida;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
25 Lleida;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
25 Lleida;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;93,84
25 Lleida;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
25 Lleida;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
25 Lleida;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
25 Lleida;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
25 Lleida;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
25 Lleida;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
25 Lleida;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;92,58
25 Lleida;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
25 Lleida;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
25 Lleida;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
25 Lleida;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;91,82
25 Lleida;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
25 Lleida;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
25 Lleida;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
25 Lleida;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
25 Lleida;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
25 Lleida;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
25 Lleida;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;90,36
25 Lleida;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
25 Lleida;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
25 Lleida;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
25 Lleida;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;90,19
25 Lleida;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
25 Lleida;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
25 Lleida;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
25 Lleida;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
25 Lleida;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
25 Lleida;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
25 Lleida;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QIII;10.693
25 Lleida;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
25 Lleida;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
25 Lleida;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
25 Lleida;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QIII;10.766
25 Lleida;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
25 Lleida;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
25 Lleida;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
25 Lleida;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QIII;10.688
25 Lleida;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
25 Lleida;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
25 Lleida;All ages;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
25 Lleida;All ages;Cohort July 1;Females;Survival in the first trimester;2022QIII;10.326
25 Lleida;All ages;Cohort July 1;Females;Survival in the first trimester;2022QII;""
25 Lleida;All ages;Cohort July 1;Females;Survival in the first trimester;2022QI;""
25 Lleida;All ages;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
25 Lleida;All ages;Cohort July 1;Females;Survival in the first trimester;2021QIII;10.422
25 Lleida;All ages;Cohort July 1;Females;Survival in the first trimester;2021QII;""
25 Lleida;All ages;Cohort July 1;Females;Survival in the first trimester;2021QI;""
25 Lleida;All ages;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
25 Lleida;All ages;Cohort July 1;Females;Survival in the first trimester;2020QIII;10.324
25 Lleida;All ages;Cohort July 1;Females;Survival in the first trimester;2020QII;""
25 Lleida;All ages;Cohort July 1;Females;Survival in the first trimester;2020QI;""
25 Lleida;All ages;Cohort July 1;Females;Survival in the second trimester;2022QIV;9.960
25 Lleida;All ages;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
25 Lleida;All ages;Cohort July 1;Females;Survival in the second trimester;2022QII;""
25 Lleida;All ages;Cohort July 1;Females;Survival in the second trimester;2022QI;""
25 Lleida;All ages;Cohort July 1;Females;Survival in the second trimester;2021QIV;10.067
25 Lleida;All ages;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
25 Lleida;All ages;Cohort July 1;Females;Survival in the second trimester;2021QII;""
25 Lleida;All ages;Cohort July 1;Females;Survival in the second trimester;2021QI;""
25 Lleida;All ages;Cohort July 1;Females;Survival in the second trimester;2020QIV;9.975
25 Lleida;All ages;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
25 Lleida;All ages;Cohort July 1;Females;Survival in the second trimester;2020QII;""
25 Lleida;All ages;Cohort July 1;Females;Survival in the second trimester;2020QI;""
25 Lleida;All ages;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
25 Lleida;All ages;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
25 Lleida;All ages;Cohort July 1;Females;Survival in the third trimester;2022QII;""
25 Lleida;All ages;Cohort July 1;Females;Survival in the third trimester;2022QI;9.799
25 Lleida;All ages;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
25 Lleida;All ages;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
25 Lleida;All ages;Cohort July 1;Females;Survival in the third trimester;2021QII;""
25 Lleida;All ages;Cohort July 1;Females;Survival in the third trimester;2021QI;9.768
25 Lleida;All ages;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
25 Lleida;All ages;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
25 Lleida;All ages;Cohort July 1;Females;Survival in the third trimester;2020QII;""
25 Lleida;All ages;Cohort July 1;Females;Survival in the third trimester;2020QI;""
25 Lleida;All ages;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
25 Lleida;All ages;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
25 Lleida;All ages;Cohort July 1;Females;Survival in the third trimester;2022QII;9.524
25 Lleida;All ages;Cohort July 1;Females;Survival in the third trimester;2022QI;""
25 Lleida;All ages;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
25 Lleida;All ages;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
25 Lleida;All ages;Cohort July 1;Females;Survival in the third trimester;2021QII;9.562
25 Lleida;All ages;Cohort July 1;Females;Survival in the third trimester;2021QI;""
25 Lleida;All ages;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
25 Lleida;All ages;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
25 Lleida;All ages;Cohort July 1;Females;Survival in the third trimester;2020QII;""
25 Lleida;All ages;Cohort July 1;Females;Survival in the third trimester;2020QI;""
25 Lleida;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
25 Lleida;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
25 Lleida;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
25 Lleida;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
25 Lleida;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
25 Lleida;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
25 Lleida;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
25 Lleida;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
25 Lleida;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
25 Lleida;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
25 Lleida;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
25 Lleida;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
25 Lleida;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
25 Lleida;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;96,57
25 Lleida;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
25 Lleida;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
25 Lleida;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
25 Lleida;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;96,8
25 Lleida;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
25 Lleida;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
25 Lleida;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
25 Lleida;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;96,59
25 Lleida;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
25 Lleida;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
25 Lleida;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;93,15
25 Lleida;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
25 Lleida;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
25 Lleida;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
25 Lleida;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;93,51
25 Lleida;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
25 Lleida;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
25 Lleida;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
25 Lleida;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;93,33
25 Lleida;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
25 Lleida;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
25 Lleida;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
25 Lleida;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
25 Lleida;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
25 Lleida;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
25 Lleida;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;91,02
25 Lleida;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
25 Lleida;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
25 Lleida;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
25 Lleida;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;91,39
25 Lleida;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
25 Lleida;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
25 Lleida;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
25 Lleida;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
25 Lleida;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
25 Lleida;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
25 Lleida;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;88,46
25 Lleida;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
25 Lleida;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
25 Lleida;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
25 Lleida;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;89,46
25 Lleida;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
25 Lleida;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
25 Lleida;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
25 Lleida;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
25 Lleida;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
25 Lleida;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QIV;28.608
25 Lleida;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
25 Lleida;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
25 Lleida;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
25 Lleida;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QIV;28.816
25 Lleida;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
25 Lleida;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
25 Lleida;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
25 Lleida;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QIV;28.790
25 Lleida;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
25 Lleida;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
25 Lleida;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
25 Lleida;All ages;Cohort October 1;Total;Survival in the first trimester;2022QIV;27.503
25 Lleida;All ages;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
25 Lleida;All ages;Cohort October 1;Total;Survival in the first trimester;2022QII;""
25 Lleida;All ages;Cohort October 1;Total;Survival in the first trimester;2022QI;""
25 Lleida;All ages;Cohort October 1;Total;Survival in the first trimester;2021QIV;27.879
25 Lleida;All ages;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
25 Lleida;All ages;Cohort October 1;Total;Survival in the first trimester;2021QII;""
25 Lleida;All ages;Cohort October 1;Total;Survival in the first trimester;2021QI;""
25 Lleida;All ages;Cohort October 1;Total;Survival in the first trimester;2020QIV;27.779
25 Lleida;All ages;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
25 Lleida;All ages;Cohort October 1;Total;Survival in the first trimester;2020QII;""
25 Lleida;All ages;Cohort October 1;Total;Survival in the first trimester;2020QI;""
25 Lleida;All ages;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
25 Lleida;All ages;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
25 Lleida;All ages;Cohort October 1;Total;Survival in the second trimester;2022QII;""
25 Lleida;All ages;Cohort October 1;Total;Survival in the second trimester;2022QI;27.199
25 Lleida;All ages;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
25 Lleida;All ages;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
25 Lleida;All ages;Cohort October 1;Total;Survival in the second trimester;2021QII;""
25 Lleida;All ages;Cohort October 1;Total;Survival in the second trimester;2021QI;27.167
25 Lleida;All ages;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
25 Lleida;All ages;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
25 Lleida;All ages;Cohort October 1;Total;Survival in the second trimester;2020QII;""
25 Lleida;All ages;Cohort October 1;Total;Survival in the second trimester;2020QI;""
25 Lleida;All ages;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
25 Lleida;All ages;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
25 Lleida;All ages;Cohort October 1;Total;Survival in the third trimester;2022QII;26.476
25 Lleida;All ages;Cohort October 1;Total;Survival in the third trimester;2022QI;""
25 Lleida;All ages;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
25 Lleida;All ages;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
25 Lleida;All ages;Cohort October 1;Total;Survival in the third trimester;2021QII;26.622
25 Lleida;All ages;Cohort October 1;Total;Survival in the third trimester;2021QI;""
25 Lleida;All ages;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
25 Lleida;All ages;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
25 Lleida;All ages;Cohort October 1;Total;Survival in the third trimester;2020QII;""
25 Lleida;All ages;Cohort October 1;Total;Survival in the third trimester;2020QI;""
25 Lleida;All ages;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
25 Lleida;All ages;Cohort October 1;Total;Survival in the third trimester;2022QIII;25.835
25 Lleida;All ages;Cohort October 1;Total;Survival in the third trimester;2022QII;""
25 Lleida;All ages;Cohort October 1;Total;Survival in the third trimester;2022QI;""
25 Lleida;All ages;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
25 Lleida;All ages;Cohort October 1;Total;Survival in the third trimester;2021QIII;26.068
25 Lleida;All ages;Cohort October 1;Total;Survival in the third trimester;2021QII;""
25 Lleida;All ages;Cohort October 1;Total;Survival in the third trimester;2021QI;""
25 Lleida;All ages;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
25 Lleida;All ages;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
25 Lleida;All ages;Cohort October 1;Total;Survival in the third trimester;2020QII;""
25 Lleida;All ages;Cohort October 1;Total;Survival in the third trimester;2020QI;""
25 Lleida;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
25 Lleida;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
25 Lleida;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
25 Lleida;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
25 Lleida;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
25 Lleida;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
25 Lleida;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
25 Lleida;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
25 Lleida;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
25 Lleida;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
25 Lleida;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
25 Lleida;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
25 Lleida;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;96,14
25 Lleida;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
25 Lleida;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
25 Lleida;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
25 Lleida;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;96,75
25 Lleida;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
25 Lleida;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
25 Lleida;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
25 Lleida;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;96,49
25 Lleida;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
25 Lleida;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
25 Lleida;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
25 Lleida;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
25 Lleida;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
25 Lleida;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
25 Lleida;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;94,39
25 Lleida;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
25 Lleida;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
25 Lleida;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
25 Lleida;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;94,36
25 Lleida;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
25 Lleida;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
25 Lleida;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
25 Lleida;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
25 Lleida;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
25 Lleida;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
25 Lleida;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;91,88
25 Lleida;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
25 Lleida;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
25 Lleida;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
25 Lleida;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;92,47
25 Lleida;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
25 Lleida;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
25 Lleida;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
25 Lleida;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
25 Lleida;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
25 Lleida;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
25 Lleida;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;89,66
25 Lleida;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
25 Lleida;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
25 Lleida;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
25 Lleida;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;90,55
25 Lleida;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
25 Lleida;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
25 Lleida;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
25 Lleida;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
25 Lleida;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
25 Lleida;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
25 Lleida;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QIV;17.987
25 Lleida;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
25 Lleida;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
25 Lleida;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
25 Lleida;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QIV;18.125
25 Lleida;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
25 Lleida;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
25 Lleida;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
25 Lleida;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QIV;18.130
25 Lleida;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
25 Lleida;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
25 Lleida;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
25 Lleida;All ages;Cohort October 1;Males;Survival in the first trimester;2022QIV;17.277
25 Lleida;All ages;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
25 Lleida;All ages;Cohort October 1;Males;Survival in the first trimester;2022QII;""
25 Lleida;All ages;Cohort October 1;Males;Survival in the first trimester;2022QI;""
25 Lleida;All ages;Cohort October 1;Males;Survival in the first trimester;2021QIV;17.566
25 Lleida;All ages;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
25 Lleida;All ages;Cohort October 1;Males;Survival in the first trimester;2021QII;""
25 Lleida;All ages;Cohort October 1;Males;Survival in the first trimester;2021QI;""
25 Lleida;All ages;Cohort October 1;Males;Survival in the first trimester;2020QIV;17.496
25 Lleida;All ages;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
25 Lleida;All ages;Cohort October 1;Males;Survival in the first trimester;2020QII;""
25 Lleida;All ages;Cohort October 1;Males;Survival in the first trimester;2020QI;""
25 Lleida;All ages;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
25 Lleida;All ages;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
25 Lleida;All ages;Cohort October 1;Males;Survival in the second trimester;2022QII;""
25 Lleida;All ages;Cohort October 1;Males;Survival in the second trimester;2022QI;17.171
25 Lleida;All ages;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
25 Lleida;All ages;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
25 Lleida;All ages;Cohort October 1;Males;Survival in the second trimester;2021QII;""
25 Lleida;All ages;Cohort October 1;Males;Survival in the second trimester;2021QI;17.106
25 Lleida;All ages;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
25 Lleida;All ages;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
25 Lleida;All ages;Cohort October 1;Males;Survival in the second trimester;2020QII;""
25 Lleida;All ages;Cohort October 1;Males;Survival in the second trimester;2020QI;""
25 Lleida;All ages;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
25 Lleida;All ages;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
25 Lleida;All ages;Cohort October 1;Males;Survival in the third trimester;2022QII;16.737
25 Lleida;All ages;Cohort October 1;Males;Survival in the third trimester;2022QI;""
25 Lleida;All ages;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
25 Lleida;All ages;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
25 Lleida;All ages;Cohort October 1;Males;Survival in the third trimester;2021QII;16.787
25 Lleida;All ages;Cohort October 1;Males;Survival in the third trimester;2021QI;""
25 Lleida;All ages;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
25 Lleida;All ages;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
25 Lleida;All ages;Cohort October 1;Males;Survival in the third trimester;2020QII;""
25 Lleida;All ages;Cohort October 1;Males;Survival in the third trimester;2020QI;""
25 Lleida;All ages;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
25 Lleida;All ages;Cohort October 1;Males;Survival in the third trimester;2022QIII;16.356
25 Lleida;All ages;Cohort October 1;Males;Survival in the third trimester;2022QII;""
25 Lleida;All ages;Cohort October 1;Males;Survival in the third trimester;2022QI;""
25 Lleida;All ages;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
25 Lleida;All ages;Cohort October 1;Males;Survival in the third trimester;2021QIII;16.472
25 Lleida;All ages;Cohort October 1;Males;Survival in the third trimester;2021QII;""
25 Lleida;All ages;Cohort October 1;Males;Survival in the third trimester;2021QI;""
25 Lleida;All ages;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
25 Lleida;All ages;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
25 Lleida;All ages;Cohort October 1;Males;Survival in the third trimester;2020QII;""
25 Lleida;All ages;Cohort October 1;Males;Survival in the third trimester;2020QI;""
25 Lleida;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
25 Lleida;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
25 Lleida;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
25 Lleida;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
25 Lleida;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
25 Lleida;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
25 Lleida;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
25 Lleida;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
25 Lleida;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
25 Lleida;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
25 Lleida;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
25 Lleida;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
25 Lleida;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;96,05
25 Lleida;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
25 Lleida;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
25 Lleida;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
25 Lleida;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;96,92
25 Lleida;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
25 Lleida;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
25 Lleida;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
25 Lleida;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;96,5
25 Lleida;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
25 Lleida;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
25 Lleida;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
25 Lleida;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
25 Lleida;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
25 Lleida;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
25 Lleida;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;94,74
25 Lleida;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
25 Lleida;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
25 Lleida;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
25 Lleida;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;94,35
25 Lleida;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
25 Lleida;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
25 Lleida;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
25 Lleida;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
25 Lleida;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
25 Lleida;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
25 Lleida;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;92,34
25 Lleida;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
25 Lleida;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
25 Lleida;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
25 Lleida;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;92,59
25 Lleida;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
25 Lleida;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
25 Lleida;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
25 Lleida;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
25 Lleida;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
25 Lleida;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
25 Lleida;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;90,24
25 Lleida;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
25 Lleida;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
25 Lleida;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
25 Lleida;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;90,85
25 Lleida;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
25 Lleida;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
25 Lleida;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
25 Lleida;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
25 Lleida;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
25 Lleida;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
25 Lleida;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QIV;10.621
25 Lleida;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
25 Lleida;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
25 Lleida;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
25 Lleida;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QIV;10.691
25 Lleida;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
25 Lleida;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
25 Lleida;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
25 Lleida;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QIV;10.660
25 Lleida;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
25 Lleida;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
25 Lleida;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
25 Lleida;All ages;Cohort October 1;Females;Survival in the first trimester;2022QIV;10.226
25 Lleida;All ages;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
25 Lleida;All ages;Cohort October 1;Females;Survival in the first trimester;2022QII;""
25 Lleida;All ages;Cohort October 1;Females;Survival in the first trimester;2022QI;""
25 Lleida;All ages;Cohort October 1;Females;Survival in the first trimester;2021QIV;10.313
25 Lleida;All ages;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
25 Lleida;All ages;Cohort October 1;Females;Survival in the first trimester;2021QII;""
25 Lleida;All ages;Cohort October 1;Females;Survival in the first trimester;2021QI;""
25 Lleida;All ages;Cohort October 1;Females;Survival in the first trimester;2020QIV;10.283
25 Lleida;All ages;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
25 Lleida;All ages;Cohort October 1;Females;Survival in the first trimester;2020QII;""
25 Lleida;All ages;Cohort October 1;Females;Survival in the first trimester;2020QI;""
25 Lleida;All ages;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
25 Lleida;All ages;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
25 Lleida;All ages;Cohort October 1;Females;Survival in the second trimester;2022QII;""
25 Lleida;All ages;Cohort October 1;Females;Survival in the second trimester;2022QI;10.028
25 Lleida;All ages;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
25 Lleida;All ages;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
25 Lleida;All ages;Cohort October 1;Females;Survival in the second trimester;2021QII;""
25 Lleida;All ages;Cohort October 1;Females;Survival in the second trimester;2021QI;10.061
25 Lleida;All ages;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
25 Lleida;All ages;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
25 Lleida;All ages;Cohort October 1;Females;Survival in the second trimester;2020QII;""
25 Lleida;All ages;Cohort October 1;Females;Survival in the second trimester;2020QI;""
25 Lleida;All ages;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
25 Lleida;All ages;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
25 Lleida;All ages;Cohort October 1;Females;Survival in the third trimester;2022QII;9.739
25 Lleida;All ages;Cohort October 1;Females;Survival in the third trimester;2022QI;""
25 Lleida;All ages;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
25 Lleida;All ages;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
25 Lleida;All ages;Cohort October 1;Females;Survival in the third trimester;2021QII;9.835
25 Lleida;All ages;Cohort October 1;Females;Survival in the third trimester;2021QI;""
25 Lleida;All ages;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
25 Lleida;All ages;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
25 Lleida;All ages;Cohort October 1;Females;Survival in the third trimester;2020QII;""
25 Lleida;All ages;Cohort October 1;Females;Survival in the third trimester;2020QI;""
25 Lleida;All ages;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
25 Lleida;All ages;Cohort October 1;Females;Survival in the third trimester;2022QIII;9.479
25 Lleida;All ages;Cohort October 1;Females;Survival in the third trimester;2022QII;""
25 Lleida;All ages;Cohort October 1;Females;Survival in the third trimester;2022QI;""
25 Lleida;All ages;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
25 Lleida;All ages;Cohort October 1;Females;Survival in the third trimester;2021QIII;9.596
25 Lleida;All ages;Cohort October 1;Females;Survival in the third trimester;2021QII;""
25 Lleida;All ages;Cohort October 1;Females;Survival in the third trimester;2021QI;""
25 Lleida;All ages;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
25 Lleida;All ages;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
25 Lleida;All ages;Cohort October 1;Females;Survival in the third trimester;2020QII;""
25 Lleida;All ages;Cohort October 1;Females;Survival in the third trimester;2020QI;""
25 Lleida;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
25 Lleida;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
25 Lleida;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
25 Lleida;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
25 Lleida;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
25 Lleida;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
25 Lleida;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
25 Lleida;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
25 Lleida;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
25 Lleida;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
25 Lleida;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
25 Lleida;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
25 Lleida;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;96,28
25 Lleida;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
25 Lleida;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
25 Lleida;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
25 Lleida;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;96,46
25 Lleida;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
25 Lleida;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
25 Lleida;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
25 Lleida;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;96,46
25 Lleida;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
25 Lleida;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
25 Lleida;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
25 Lleida;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
25 Lleida;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
25 Lleida;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
25 Lleida;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;93,8
25 Lleida;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
25 Lleida;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
25 Lleida;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
25 Lleida;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;94,38
25 Lleida;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
25 Lleida;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
25 Lleida;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
25 Lleida;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
25 Lleida;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
25 Lleida;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
25 Lleida;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;91,1
25 Lleida;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
25 Lleida;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
25 Lleida;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
25 Lleida;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;92,26
25 Lleida;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
25 Lleida;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
25 Lleida;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
25 Lleida;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
25 Lleida;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
25 Lleida;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
25 Lleida;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;88,66
25 Lleida;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
25 Lleida;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
25 Lleida;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
25 Lleida;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;90,02
25 Lleida;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
25 Lleida;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
25 Lleida;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
25 Lleida;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
25 Lleida;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
25 Lleida;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
25 Lleida;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
25 Lleida;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
25 Lleida;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
25 Lleida;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QI;1.846
25 Lleida;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
25 Lleida;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
25 Lleida;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
25 Lleida;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QI;1.784
25 Lleida;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
25 Lleida;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
25 Lleida;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
25 Lleida;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QI;1.502
25 Lleida;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
25 Lleida;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
25 Lleida;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2022QII;""
25 Lleida;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2022QI;1.729
25 Lleida;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
25 Lleida;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
25 Lleida;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2021QII;""
25 Lleida;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2021QI;1.695
25 Lleida;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
25 Lleida;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
25 Lleida;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2020QII;""
25 Lleida;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2020QI;1.332
25 Lleida;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
25 Lleida;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
25 Lleida;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2022QII;1.620
25 Lleida;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2022QI;""
25 Lleida;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
25 Lleida;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
25 Lleida;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2021QII;1.602
25 Lleida;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2021QI;""
25 Lleida;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
25 Lleida;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
25 Lleida;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2020QII;1.285
25 Lleida;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2020QI;""
25 Lleida;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
25 Lleida;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QIII;1.516
25 Lleida;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QII;""
25 Lleida;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QI;""
25 Lleida;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
25 Lleida;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QIII;1.500
25 Lleida;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QII;""
25 Lleida;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QI;""
25 Lleida;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
25 Lleida;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QIII;1.205
25 Lleida;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QII;""
25 Lleida;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QI;""
25 Lleida;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QIV;1.411
25 Lleida;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
25 Lleida;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QII;""
25 Lleida;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QI;""
25 Lleida;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QIV;1.412
25 Lleida;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
25 Lleida;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QII;""
25 Lleida;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QI;""
25 Lleida;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QIV;1.122
25 Lleida;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
25 Lleida;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QII;""
25 Lleida;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QI;""
25 Lleida;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
25 Lleida;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
25 Lleida;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
25 Lleida;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
25 Lleida;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
25 Lleida;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
25 Lleida;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
25 Lleida;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
25 Lleida;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
25 Lleida;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
25 Lleida;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
25 Lleida;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
25 Lleida;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
25 Lleida;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
25 Lleida;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
25 Lleida;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;93,66
25 Lleida;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
25 Lleida;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
25 Lleida;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
25 Lleida;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;95,01
25 Lleida;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
25 Lleida;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
25 Lleida;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
25 Lleida;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;88,68
25 Lleida;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
25 Lleida;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
25 Lleida;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;87,76
25 Lleida;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
25 Lleida;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
25 Lleida;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
25 Lleida;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;89,8
25 Lleida;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
25 Lleida;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
25 Lleida;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
25 Lleida;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;85,55
25 Lleida;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
25 Lleida;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
25 Lleida;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;82,12
25 Lleida;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
25 Lleida;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
25 Lleida;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
25 Lleida;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;84,08
25 Lleida;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
25 Lleida;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
25 Lleida;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
25 Lleida;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;80,23
25 Lleida;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
25 Lleida;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
25 Lleida;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;76,44
25 Lleida;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
25 Lleida;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
25 Lleida;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
25 Lleida;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;79,15
25 Lleida;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
25 Lleida;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
25 Lleida;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
25 Lleida;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;74,7
25 Lleida;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
25 Lleida;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
25 Lleida;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
25 Lleida;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
25 Lleida;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
25 Lleida;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
25 Lleida;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QI;1.162
25 Lleida;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
25 Lleida;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
25 Lleida;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
25 Lleida;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QI;1.120
25 Lleida;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
25 Lleida;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
25 Lleida;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
25 Lleida;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QI;918
25 Lleida;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
25 Lleida;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
25 Lleida;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2022QII;""
25 Lleida;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2022QI;1.094
25 Lleida;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
25 Lleida;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
25 Lleida;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2021QII;""
25 Lleida;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2021QI;1.061
25 Lleida;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
25 Lleida;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
25 Lleida;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2020QII;""
25 Lleida;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2020QI;809
25 Lleida;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
25 Lleida;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
25 Lleida;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2022QII;1.025
25 Lleida;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2022QI;""
25 Lleida;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
25 Lleida;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
25 Lleida;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2021QII;1.005
25 Lleida;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2021QI;""
25 Lleida;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
25 Lleida;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
25 Lleida;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2020QII;783
25 Lleida;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2020QI;""
25 Lleida;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
25 Lleida;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QIII;970
25 Lleida;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QII;""
25 Lleida;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QI;""
25 Lleida;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
25 Lleida;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QIII;951
25 Lleida;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QII;""
25 Lleida;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QI;""
25 Lleida;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
25 Lleida;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QIII;745
25 Lleida;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QII;""
25 Lleida;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QI;""
25 Lleida;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QIV;888
25 Lleida;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
25 Lleida;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QII;""
25 Lleida;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QI;""
25 Lleida;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QIV;892
25 Lleida;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
25 Lleida;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QII;""
25 Lleida;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QI;""
25 Lleida;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QIV;704
25 Lleida;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
25 Lleida;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QII;""
25 Lleida;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QI;""
25 Lleida;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
25 Lleida;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
25 Lleida;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
25 Lleida;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
25 Lleida;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
25 Lleida;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
25 Lleida;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
25 Lleida;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
25 Lleida;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
25 Lleida;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
25 Lleida;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
25 Lleida;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
25 Lleida;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
25 Lleida;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
25 Lleida;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
25 Lleida;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;94,15
25 Lleida;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
25 Lleida;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
25 Lleida;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
25 Lleida;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;94,73
25 Lleida;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
25 Lleida;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
25 Lleida;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
25 Lleida;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;88,13
25 Lleida;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
25 Lleida;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
25 Lleida;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;88,21
25 Lleida;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
25 Lleida;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
25 Lleida;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
25 Lleida;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;89,73
25 Lleida;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
25 Lleida;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
25 Lleida;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
25 Lleida;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;85,29
25 Lleida;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
25 Lleida;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
25 Lleida;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;83,48
25 Lleida;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
25 Lleida;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
25 Lleida;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
25 Lleida;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;84,91
25 Lleida;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
25 Lleida;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
25 Lleida;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
25 Lleida;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;81,15
25 Lleida;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
25 Lleida;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
25 Lleida;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;76,42
25 Lleida;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
25 Lleida;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
25 Lleida;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
25 Lleida;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;79,64
25 Lleida;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
25 Lleida;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
25 Lleida;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
25 Lleida;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;76,69
25 Lleida;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
25 Lleida;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
25 Lleida;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
25 Lleida;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
25 Lleida;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
25 Lleida;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
25 Lleida;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QI;684
25 Lleida;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
25 Lleida;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
25 Lleida;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
25 Lleida;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QI;664
25 Lleida;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
25 Lleida;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
25 Lleida;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
25 Lleida;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QI;584
25 Lleida;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
25 Lleida;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
25 Lleida;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2022QII;""
25 Lleida;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2022QI;635
25 Lleida;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
25 Lleida;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
25 Lleida;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2021QII;""
25 Lleida;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2021QI;634
25 Lleida;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
25 Lleida;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
25 Lleida;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2020QII;""
25 Lleida;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2020QI;523
25 Lleida;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
25 Lleida;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
25 Lleida;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2022QII;595
25 Lleida;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2022QI;""
25 Lleida;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
25 Lleida;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
25 Lleida;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2021QII;597
25 Lleida;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2021QI;""
25 Lleida;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
25 Lleida;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
25 Lleida;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2020QII;502
25 Lleida;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2020QI;""
25 Lleida;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
25 Lleida;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QIII;546
25 Lleida;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QII;""
25 Lleida;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QI;""
25 Lleida;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
25 Lleida;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QIII;549
25 Lleida;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QII;""
25 Lleida;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QI;""
25 Lleida;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
25 Lleida;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QIII;460
25 Lleida;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QII;""
25 Lleida;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QI;""
25 Lleida;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QIV;523
25 Lleida;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
25 Lleida;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QII;""
25 Lleida;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QI;""
25 Lleida;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QIV;520
25 Lleida;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
25 Lleida;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QII;""
25 Lleida;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QI;""
25 Lleida;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QIV;418
25 Lleida;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
25 Lleida;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QII;""
25 Lleida;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QI;""
25 Lleida;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
25 Lleida;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
25 Lleida;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
25 Lleida;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
25 Lleida;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
25 Lleida;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
25 Lleida;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
25 Lleida;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
25 Lleida;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
25 Lleida;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
25 Lleida;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
25 Lleida;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
25 Lleida;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
25 Lleida;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
25 Lleida;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
25 Lleida;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;92,84
25 Lleida;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
25 Lleida;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
25 Lleida;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
25 Lleida;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;95,48
25 Lleida;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
25 Lleida;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
25 Lleida;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
25 Lleida;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;89,55
25 Lleida;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
25 Lleida;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
25 Lleida;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;86,99
25 Lleida;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
25 Lleida;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
25 Lleida;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
25 Lleida;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;89,91
25 Lleida;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
25 Lleida;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
25 Lleida;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
25 Lleida;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;85,96
25 Lleida;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
25 Lleida;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
25 Lleida;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;79,82
25 Lleida;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
25 Lleida;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
25 Lleida;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
25 Lleida;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;82,68
25 Lleida;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
25 Lleida;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
25 Lleida;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
25 Lleida;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;78,77
25 Lleida;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
25 Lleida;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
25 Lleida;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;76,46
25 Lleida;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
25 Lleida;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
25 Lleida;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
25 Lleida;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;78,31
25 Lleida;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
25 Lleida;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
25 Lleida;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
25 Lleida;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;71,58
25 Lleida;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
25 Lleida;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
25 Lleida;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
25 Lleida;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
25 Lleida;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
25 Lleida;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QII;1.610
25 Lleida;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
25 Lleida;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
25 Lleida;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
25 Lleida;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QII;1.609
25 Lleida;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
25 Lleida;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
25 Lleida;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
25 Lleida;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QII;1.550
25 Lleida;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
25 Lleida;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
25 Lleida;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
25 Lleida;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2022QII;1.499
25 Lleida;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2022QI;""
25 Lleida;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
25 Lleida;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
25 Lleida;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2021QII;1.511
25 Lleida;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2021QI;""
25 Lleida;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
25 Lleida;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
25 Lleida;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2020QII;1.485
25 Lleida;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2020QI;""
25 Lleida;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
25 Lleida;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2022QIII;1.395
25 Lleida;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2022QII;""
25 Lleida;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2022QI;""
25 Lleida;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
25 Lleida;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2021QIII;1.400
25 Lleida;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2021QII;""
25 Lleida;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2021QI;""
25 Lleida;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
25 Lleida;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2020QIII;1.383
25 Lleida;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2020QII;""
25 Lleida;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2020QI;""
25 Lleida;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QIV;1.293
25 Lleida;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
25 Lleida;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QII;""
25 Lleida;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QI;""
25 Lleida;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QIV;1.310
25 Lleida;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
25 Lleida;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QII;""
25 Lleida;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QI;""
25 Lleida;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QIV;1.286
25 Lleida;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
25 Lleida;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QII;""
25 Lleida;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QI;""
25 Lleida;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
25 Lleida;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
25 Lleida;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QII;""
25 Lleida;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QI;1.241
25 Lleida;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
25 Lleida;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
25 Lleida;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QII;""
25 Lleida;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QI;1.234
25 Lleida;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
25 Lleida;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
25 Lleida;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QII;""
25 Lleida;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QI;""
25 Lleida;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
25 Lleida;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
25 Lleida;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
25 Lleida;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
25 Lleida;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
25 Lleida;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
25 Lleida;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
25 Lleida;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
25 Lleida;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
25 Lleida;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
25 Lleida;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
25 Lleida;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
25 Lleida;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
25 Lleida;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
25 Lleida;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;93,11
25 Lleida;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
25 Lleida;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
25 Lleida;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
25 Lleida;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;93,91
25 Lleida;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
25 Lleida;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
25 Lleida;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
25 Lleida;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;95,81
25 Lleida;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
25 Lleida;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
25 Lleida;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;86,65
25 Lleida;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
25 Lleida;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
25 Lleida;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
25 Lleida;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;87,01
25 Lleida;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
25 Lleida;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
25 Lleida;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
25 Lleida;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;89,23
25 Lleida;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
25 Lleida;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
25 Lleida;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;80,31
25 Lleida;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
25 Lleida;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
25 Lleida;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
25 Lleida;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;81,42
25 Lleida;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
25 Lleida;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
25 Lleida;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
25 Lleida;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;82,97
25 Lleida;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
25 Lleida;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
25 Lleida;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
25 Lleida;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
25 Lleida;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
25 Lleida;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
25 Lleida;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;77,13
25 Lleida;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
25 Lleida;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
25 Lleida;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
25 Lleida;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;79,61
25 Lleida;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
25 Lleida;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
25 Lleida;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
25 Lleida;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
25 Lleida;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
25 Lleida;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
25 Lleida;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QII;1.021
25 Lleida;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
25 Lleida;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
25 Lleida;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
25 Lleida;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QII;1.021
25 Lleida;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
25 Lleida;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
25 Lleida;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
25 Lleida;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QII;950
25 Lleida;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
25 Lleida;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
25 Lleida;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
25 Lleida;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2022QII;951
25 Lleida;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2022QI;""
25 Lleida;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
25 Lleida;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
25 Lleida;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2021QII;958
25 Lleida;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2021QI;""
25 Lleida;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
25 Lleida;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
25 Lleida;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2020QII;911
25 Lleida;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2020QI;""
25 Lleida;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
25 Lleida;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2022QIII;899
25 Lleida;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2022QII;""
25 Lleida;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2022QI;""
25 Lleida;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
25 Lleida;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2021QIII;897
25 Lleida;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2021QII;""
25 Lleida;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2021QI;""
25 Lleida;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
25 Lleida;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2020QIII;857
25 Lleida;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2020QII;""
25 Lleida;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2020QI;""
25 Lleida;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QIV;821
25 Lleida;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
25 Lleida;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QII;""
25 Lleida;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QI;""
25 Lleida;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QIV;838
25 Lleida;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
25 Lleida;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QII;""
25 Lleida;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QI;""
25 Lleida;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QIV;807
25 Lleida;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
25 Lleida;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QII;""
25 Lleida;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QI;""
25 Lleida;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
25 Lleida;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
25 Lleida;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QII;""
25 Lleida;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QI;803
25 Lleida;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
25 Lleida;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
25 Lleida;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QII;""
25 Lleida;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QI;774
25 Lleida;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
25 Lleida;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
25 Lleida;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QII;""
25 Lleida;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QI;""
25 Lleida;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
25 Lleida;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
25 Lleida;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
25 Lleida;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
25 Lleida;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
25 Lleida;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
25 Lleida;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
25 Lleida;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
25 Lleida;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
25 Lleida;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
25 Lleida;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
25 Lleida;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
25 Lleida;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
25 Lleida;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
25 Lleida;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;93,14
25 Lleida;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
25 Lleida;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
25 Lleida;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
25 Lleida;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;93,83
25 Lleida;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
25 Lleida;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
25 Lleida;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
25 Lleida;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;95,89
25 Lleida;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
25 Lleida;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
25 Lleida;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;88,05
25 Lleida;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
25 Lleida;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
25 Lleida;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
25 Lleida;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;87,86
25 Lleida;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
25 Lleida;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
25 Lleida;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
25 Lleida;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;90,21
25 Lleida;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
25 Lleida;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
25 Lleida;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;80,41
25 Lleida;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
25 Lleida;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
25 Lleida;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
25 Lleida;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;82,08
25 Lleida;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
25 Lleida;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
25 Lleida;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
25 Lleida;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;84,95
25 Lleida;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
25 Lleida;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
25 Lleida;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
25 Lleida;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
25 Lleida;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
25 Lleida;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
25 Lleida;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;78,65
25 Lleida;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
25 Lleida;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
25 Lleida;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
25 Lleida;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;81,47
25 Lleida;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
25 Lleida;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
25 Lleida;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
25 Lleida;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
25 Lleida;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
25 Lleida;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
25 Lleida;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QII;589
25 Lleida;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
25 Lleida;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
25 Lleida;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
25 Lleida;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QII;588
25 Lleida;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
25 Lleida;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
25 Lleida;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
25 Lleida;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QII;600
25 Lleida;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
25 Lleida;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
25 Lleida;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
25 Lleida;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2022QII;548
25 Lleida;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2022QI;""
25 Lleida;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
25 Lleida;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
25 Lleida;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2021QII;553
25 Lleida;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2021QI;""
25 Lleida;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
25 Lleida;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
25 Lleida;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2020QII;574
25 Lleida;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2020QI;""
25 Lleida;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
25 Lleida;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2022QIII;496
25 Lleida;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2022QII;""
25 Lleida;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2022QI;""
25 Lleida;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
25 Lleida;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2021QIII;503
25 Lleida;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2021QII;""
25 Lleida;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2021QI;""
25 Lleida;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
25 Lleida;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2020QIII;526
25 Lleida;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2020QII;""
25 Lleida;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2020QI;""
25 Lleida;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QIV;472
25 Lleida;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
25 Lleida;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QII;""
25 Lleida;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QI;""
25 Lleida;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QIV;472
25 Lleida;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
25 Lleida;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QII;""
25 Lleida;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QI;""
25 Lleida;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QIV;479
25 Lleida;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
25 Lleida;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QII;""
25 Lleida;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QI;""
25 Lleida;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
25 Lleida;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
25 Lleida;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QII;""
25 Lleida;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QI;438
25 Lleida;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
25 Lleida;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
25 Lleida;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QII;""
25 Lleida;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QI;460
25 Lleida;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
25 Lleida;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
25 Lleida;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QII;""
25 Lleida;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QI;""
25 Lleida;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
25 Lleida;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
25 Lleida;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
25 Lleida;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
25 Lleida;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
25 Lleida;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
25 Lleida;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
25 Lleida;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
25 Lleida;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
25 Lleida;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
25 Lleida;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
25 Lleida;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
25 Lleida;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
25 Lleida;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
25 Lleida;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;93,04
25 Lleida;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
25 Lleida;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
25 Lleida;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
25 Lleida;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;94,05
25 Lleida;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
25 Lleida;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
25 Lleida;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
25 Lleida;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;95,67
25 Lleida;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
25 Lleida;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
25 Lleida;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;84,21
25 Lleida;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
25 Lleida;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
25 Lleida;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
25 Lleida;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;85,54
25 Lleida;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
25 Lleida;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
25 Lleida;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
25 Lleida;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;87,67
25 Lleida;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
25 Lleida;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
25 Lleida;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;80,14
25 Lleida;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
25 Lleida;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
25 Lleida;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
25 Lleida;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;80,27
25 Lleida;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
25 Lleida;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
25 Lleida;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
25 Lleida;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;79,83
25 Lleida;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
25 Lleida;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
25 Lleida;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
25 Lleida;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
25 Lleida;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
25 Lleida;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
25 Lleida;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;74,49
25 Lleida;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
25 Lleida;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
25 Lleida;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
25 Lleida;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;76,67
25 Lleida;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
25 Lleida;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
25 Lleida;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
25 Lleida;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
25 Lleida;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
25 Lleida;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QIII;1.748
25 Lleida;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
25 Lleida;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
25 Lleida;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
25 Lleida;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QIII;1.731
25 Lleida;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
25 Lleida;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
25 Lleida;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
25 Lleida;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QIII;1.639
25 Lleida;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
25 Lleida;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
25 Lleida;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
25 Lleida;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2022QIII;1.584
25 Lleida;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2022QII;""
25 Lleida;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2022QI;""
25 Lleida;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
25 Lleida;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2021QIII;1.574
25 Lleida;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2021QII;""
25 Lleida;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2021QI;""
25 Lleida;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
25 Lleida;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2020QIII;1.502
25 Lleida;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2020QII;""
25 Lleida;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2020QI;""
25 Lleida;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2022QIV;1.457
25 Lleida;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
25 Lleida;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2022QII;""
25 Lleida;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2022QI;""
25 Lleida;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2021QIV;1.462
25 Lleida;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
25 Lleida;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2021QII;""
25 Lleida;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2021QI;""
25 Lleida;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2020QIV;1.389
25 Lleida;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
25 Lleida;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2020QII;""
25 Lleida;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2020QI;""
25 Lleida;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
25 Lleida;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
25 Lleida;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QII;""
25 Lleida;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QI;1.381
25 Lleida;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
25 Lleida;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
25 Lleida;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QII;""
25 Lleida;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QI;1.325
25 Lleida;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
25 Lleida;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
25 Lleida;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QII;""
25 Lleida;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QI;""
25 Lleida;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
25 Lleida;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
25 Lleida;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QII;1.305
25 Lleida;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QI;""
25 Lleida;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
25 Lleida;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
25 Lleida;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QII;1.262
25 Lleida;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QI;""
25 Lleida;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
25 Lleida;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
25 Lleida;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QII;""
25 Lleida;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QI;""
25 Lleida;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
25 Lleida;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
25 Lleida;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
25 Lleida;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
25 Lleida;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
25 Lleida;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
25 Lleida;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
25 Lleida;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
25 Lleida;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
25 Lleida;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
25 Lleida;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
25 Lleida;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
25 Lleida;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
25 Lleida;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;90,62
25 Lleida;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
25 Lleida;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
25 Lleida;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
25 Lleida;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;90,93
25 Lleida;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
25 Lleida;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
25 Lleida;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
25 Lleida;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;91,64
25 Lleida;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
25 Lleida;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
25 Lleida;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;83,35
25 Lleida;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
25 Lleida;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
25 Lleida;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
25 Lleida;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;84,46
25 Lleida;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
25 Lleida;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
25 Lleida;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
25 Lleida;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;84,75
25 Lleida;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
25 Lleida;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
25 Lleida;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
25 Lleida;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
25 Lleida;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
25 Lleida;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
25 Lleida;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;79,78
25 Lleida;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
25 Lleida;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
25 Lleida;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
25 Lleida;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;80,84
25 Lleida;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
25 Lleida;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
25 Lleida;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
25 Lleida;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
25 Lleida;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
25 Lleida;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
25 Lleida;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;75,39
25 Lleida;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
25 Lleida;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
25 Lleida;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
25 Lleida;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;77
25 Lleida;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
25 Lleida;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
25 Lleida;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
25 Lleida;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
25 Lleida;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
25 Lleida;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
25 Lleida;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QIII;1.101
25 Lleida;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
25 Lleida;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
25 Lleida;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
25 Lleida;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QIII;1.096
25 Lleida;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
25 Lleida;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
25 Lleida;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
25 Lleida;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QIII;1.019
25 Lleida;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
25 Lleida;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
25 Lleida;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
25 Lleida;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2022QIII;1.012
25 Lleida;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2022QII;""
25 Lleida;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2022QI;""
25 Lleida;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
25 Lleida;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2021QIII;1.007
25 Lleida;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2021QII;""
25 Lleida;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2021QI;""
25 Lleida;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
25 Lleida;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2020QIII;939
25 Lleida;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2020QII;""
25 Lleida;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2020QI;""
25 Lleida;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2022QIV;922
25 Lleida;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
25 Lleida;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2022QII;""
25 Lleida;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2022QI;""
25 Lleida;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2021QIV;934
25 Lleida;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
25 Lleida;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2021QII;""
25 Lleida;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2021QI;""
25 Lleida;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2020QIV;874
25 Lleida;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
25 Lleida;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2020QII;""
25 Lleida;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2020QI;""
25 Lleida;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
25 Lleida;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
25 Lleida;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QII;""
25 Lleida;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QI;890
25 Lleida;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
25 Lleida;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
25 Lleida;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QII;""
25 Lleida;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QI;834
25 Lleida;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
25 Lleida;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
25 Lleida;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QII;""
25 Lleida;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QI;""
25 Lleida;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
25 Lleida;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
25 Lleida;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QII;845
25 Lleida;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QI;""
25 Lleida;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
25 Lleida;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
25 Lleida;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QII;798
25 Lleida;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QI;""
25 Lleida;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
25 Lleida;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
25 Lleida;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QII;""
25 Lleida;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QI;""
25 Lleida;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
25 Lleida;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
25 Lleida;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
25 Lleida;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
25 Lleida;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
25 Lleida;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
25 Lleida;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
25 Lleida;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
25 Lleida;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
25 Lleida;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
25 Lleida;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
25 Lleida;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
25 Lleida;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
25 Lleida;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;91,92
25 Lleida;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
25 Lleida;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
25 Lleida;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
25 Lleida;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;91,88
25 Lleida;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
25 Lleida;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
25 Lleida;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
25 Lleida;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;92,15
25 Lleida;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
25 Lleida;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
25 Lleida;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;83,74
25 Lleida;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
25 Lleida;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
25 Lleida;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
25 Lleida;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;85,22
25 Lleida;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
25 Lleida;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
25 Lleida;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
25 Lleida;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;85,77
25 Lleida;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
25 Lleida;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
25 Lleida;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
25 Lleida;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
25 Lleida;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
25 Lleida;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
25 Lleida;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;81,2
25 Lleida;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
25 Lleida;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
25 Lleida;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
25 Lleida;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;81,84
25 Lleida;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
25 Lleida;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
25 Lleida;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
25 Lleida;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
25 Lleida;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
25 Lleida;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
25 Lleida;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;77,1
25 Lleida;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
25 Lleida;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
25 Lleida;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
25 Lleida;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;78,31
25 Lleida;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
25 Lleida;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
25 Lleida;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
25 Lleida;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
25 Lleida;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
25 Lleida;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
25 Lleida;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QIII;647
25 Lleida;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
25 Lleida;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
25 Lleida;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
25 Lleida;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QIII;635
25 Lleida;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
25 Lleida;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
25 Lleida;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
25 Lleida;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QIII;620
25 Lleida;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
25 Lleida;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
25 Lleida;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
25 Lleida;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2022QIII;572
25 Lleida;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2022QII;""
25 Lleida;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2022QI;""
25 Lleida;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
25 Lleida;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2021QIII;567
25 Lleida;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2021QII;""
25 Lleida;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2021QI;""
25 Lleida;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
25 Lleida;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2020QIII;563
25 Lleida;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2020QII;""
25 Lleida;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2020QI;""
25 Lleida;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2022QIV;535
25 Lleida;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
25 Lleida;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2022QII;""
25 Lleida;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2022QI;""
25 Lleida;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2021QIV;528
25 Lleida;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
25 Lleida;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2021QII;""
25 Lleida;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2021QI;""
25 Lleida;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2020QIV;515
25 Lleida;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
25 Lleida;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2020QII;""
25 Lleida;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2020QI;""
25 Lleida;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
25 Lleida;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
25 Lleida;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QII;""
25 Lleida;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QI;491
25 Lleida;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
25 Lleida;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
25 Lleida;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QII;""
25 Lleida;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QI;491
25 Lleida;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
25 Lleida;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
25 Lleida;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QII;""
25 Lleida;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QI;""
25 Lleida;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
25 Lleida;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
25 Lleida;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QII;460
25 Lleida;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QI;""
25 Lleida;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
25 Lleida;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
25 Lleida;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QII;464
25 Lleida;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QI;""
25 Lleida;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
25 Lleida;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
25 Lleida;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QII;""
25 Lleida;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QI;""
25 Lleida;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
25 Lleida;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
25 Lleida;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
25 Lleida;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
25 Lleida;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
25 Lleida;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
25 Lleida;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
25 Lleida;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
25 Lleida;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
25 Lleida;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
25 Lleida;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
25 Lleida;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
25 Lleida;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
25 Lleida;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;88,41
25 Lleida;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
25 Lleida;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
25 Lleida;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
25 Lleida;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;89,29
25 Lleida;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
25 Lleida;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
25 Lleida;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
25 Lleida;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;90,81
25 Lleida;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
25 Lleida;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
25 Lleida;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;82,69
25 Lleida;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
25 Lleida;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
25 Lleida;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
25 Lleida;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;83,15
25 Lleida;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
25 Lleida;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
25 Lleida;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
25 Lleida;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;83,06
25 Lleida;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
25 Lleida;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
25 Lleida;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
25 Lleida;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
25 Lleida;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
25 Lleida;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
25 Lleida;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;77,32
25 Lleida;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
25 Lleida;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
25 Lleida;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
25 Lleida;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;79,19
25 Lleida;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
25 Lleida;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
25 Lleida;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
25 Lleida;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
25 Lleida;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
25 Lleida;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
25 Lleida;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;72,44
25 Lleida;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
25 Lleida;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
25 Lleida;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
25 Lleida;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;74,84
25 Lleida;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
25 Lleida;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
25 Lleida;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
25 Lleida;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
25 Lleida;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
25 Lleida;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QIV;1.771
25 Lleida;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
25 Lleida;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
25 Lleida;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
25 Lleida;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QIV;1.742
25 Lleida;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
25 Lleida;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
25 Lleida;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
25 Lleida;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QIV;1.716
25 Lleida;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
25 Lleida;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
25 Lleida;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
25 Lleida;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2022QIV;1.623
25 Lleida;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
25 Lleida;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2022QII;""
25 Lleida;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2022QI;""
25 Lleida;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2021QIV;1.622
25 Lleida;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
25 Lleida;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2021QII;""
25 Lleida;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2021QI;""
25 Lleida;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2020QIV;1.581
25 Lleida;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
25 Lleida;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2020QII;""
25 Lleida;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2020QI;""
25 Lleida;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
25 Lleida;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
25 Lleida;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2022QII;""
25 Lleida;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2022QI;1.524
25 Lleida;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
25 Lleida;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
25 Lleida;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2021QII;""
25 Lleida;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2021QI;1.509
25 Lleida;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
25 Lleida;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
25 Lleida;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2020QII;""
25 Lleida;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2020QI;""
25 Lleida;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
25 Lleida;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
25 Lleida;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QII;1.441
25 Lleida;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QI;""
25 Lleida;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
25 Lleida;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
25 Lleida;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QII;1.430
25 Lleida;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QI;""
25 Lleida;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
25 Lleida;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
25 Lleida;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QII;""
25 Lleida;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QI;""
25 Lleida;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
25 Lleida;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QIII;1.350
25 Lleida;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QII;""
25 Lleida;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QI;""
25 Lleida;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
25 Lleida;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QIII;1.345
25 Lleida;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QII;""
25 Lleida;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QI;""
25 Lleida;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
25 Lleida;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
25 Lleida;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QII;""
25 Lleida;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QI;""
25 Lleida;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
25 Lleida;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
25 Lleida;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
25 Lleida;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
25 Lleida;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
25 Lleida;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
25 Lleida;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
25 Lleida;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
25 Lleida;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
25 Lleida;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
25 Lleida;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
25 Lleida;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
25 Lleida;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;91,64
25 Lleida;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
25 Lleida;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
25 Lleida;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
25 Lleida;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;93,11
25 Lleida;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
25 Lleida;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
25 Lleida;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
25 Lleida;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;92,13
25 Lleida;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
25 Lleida;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
25 Lleida;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
25 Lleida;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
25 Lleida;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
25 Lleida;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
25 Lleida;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;87,49
25 Lleida;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
25 Lleida;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
25 Lleida;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
25 Lleida;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;87,94
25 Lleida;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
25 Lleida;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
25 Lleida;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
25 Lleida;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
25 Lleida;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
25 Lleida;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
25 Lleida;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;82,72
25 Lleida;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
25 Lleida;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
25 Lleida;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
25 Lleida;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;83,33
25 Lleida;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
25 Lleida;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
25 Lleida;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
25 Lleida;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
25 Lleida;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
25 Lleida;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
25 Lleida;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;77,5
25 Lleida;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
25 Lleida;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
25 Lleida;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
25 Lleida;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;78,38
25 Lleida;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
25 Lleida;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
25 Lleida;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
25 Lleida;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
25 Lleida;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
25 Lleida;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
25 Lleida;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QIV;1.132
25 Lleida;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
25 Lleida;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
25 Lleida;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
25 Lleida;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QIV;1.108
25 Lleida;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
25 Lleida;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
25 Lleida;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
25 Lleida;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QIV;1.080
25 Lleida;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
25 Lleida;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
25 Lleida;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
25 Lleida;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2022QIV;1.025
25 Lleida;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
25 Lleida;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2022QII;""
25 Lleida;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2022QI;""
25 Lleida;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2021QIV;1.032
25 Lleida;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
25 Lleida;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2021QII;""
25 Lleida;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2021QI;""
25 Lleida;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2020QIV;1.000
25 Lleida;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
25 Lleida;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2020QII;""
25 Lleida;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2020QI;""
25 Lleida;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
25 Lleida;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
25 Lleida;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2022QII;""
25 Lleida;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2022QI;978
25 Lleida;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
25 Lleida;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
25 Lleida;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2021QII;""
25 Lleida;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2021QI;954
25 Lleida;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
25 Lleida;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
25 Lleida;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2020QII;""
25 Lleida;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2020QI;""
25 Lleida;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
25 Lleida;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
25 Lleida;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QII;928
25 Lleida;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QI;""
25 Lleida;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
25 Lleida;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
25 Lleida;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QII;909
25 Lleida;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QI;""
25 Lleida;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
25 Lleida;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
25 Lleida;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QII;""
25 Lleida;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QI;""
25 Lleida;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
25 Lleida;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QIII;880
25 Lleida;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QII;""
25 Lleida;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QI;""
25 Lleida;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
25 Lleida;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QIII;865
25 Lleida;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QII;""
25 Lleida;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QI;""
25 Lleida;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
25 Lleida;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
25 Lleida;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QII;""
25 Lleida;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QI;""
25 Lleida;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
25 Lleida;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
25 Lleida;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
25 Lleida;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
25 Lleida;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
25 Lleida;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
25 Lleida;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
25 Lleida;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
25 Lleida;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
25 Lleida;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
25 Lleida;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
25 Lleida;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
25 Lleida;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;90,55
25 Lleida;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
25 Lleida;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
25 Lleida;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
25 Lleida;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;93,14
25 Lleida;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
25 Lleida;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
25 Lleida;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
25 Lleida;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;92,59
25 Lleida;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
25 Lleida;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
25 Lleida;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
25 Lleida;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
25 Lleida;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
25 Lleida;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
25 Lleida;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;88,27
25 Lleida;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
25 Lleida;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
25 Lleida;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
25 Lleida;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;88,33
25 Lleida;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
25 Lleida;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
25 Lleida;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
25 Lleida;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
25 Lleida;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
25 Lleida;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
25 Lleida;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;83,75
25 Lleida;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
25 Lleida;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
25 Lleida;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
25 Lleida;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;84,17
25 Lleida;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
25 Lleida;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
25 Lleida;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
25 Lleida;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
25 Lleida;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
25 Lleida;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
25 Lleida;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;79,42
25 Lleida;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
25 Lleida;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
25 Lleida;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
25 Lleida;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;80,09
25 Lleida;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
25 Lleida;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
25 Lleida;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
25 Lleida;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
25 Lleida;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
25 Lleida;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
25 Lleida;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QIV;639
25 Lleida;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
25 Lleida;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
25 Lleida;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
25 Lleida;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QIV;634
25 Lleida;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
25 Lleida;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
25 Lleida;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
25 Lleida;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QIV;636
25 Lleida;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
25 Lleida;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
25 Lleida;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
25 Lleida;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2022QIV;598
25 Lleida;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
25 Lleida;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2022QII;""
25 Lleida;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2022QI;""
25 Lleida;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2021QIV;590
25 Lleida;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
25 Lleida;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2021QII;""
25 Lleida;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2021QI;""
25 Lleida;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2020QIV;581
25 Lleida;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
25 Lleida;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2020QII;""
25 Lleida;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2020QI;""
25 Lleida;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
25 Lleida;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
25 Lleida;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2022QII;""
25 Lleida;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2022QI;546
25 Lleida;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
25 Lleida;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
25 Lleida;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2021QII;""
25 Lleida;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2021QI;555
25 Lleida;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
25 Lleida;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
25 Lleida;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2020QII;""
25 Lleida;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2020QI;""
25 Lleida;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
25 Lleida;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
25 Lleida;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QII;513
25 Lleida;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QI;""
25 Lleida;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
25 Lleida;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
25 Lleida;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QII;521
25 Lleida;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QI;""
25 Lleida;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
25 Lleida;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
25 Lleida;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QII;""
25 Lleida;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QI;""
25 Lleida;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
25 Lleida;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QIII;470
25 Lleida;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QII;""
25 Lleida;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QI;""
25 Lleida;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
25 Lleida;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QIII;480
25 Lleida;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QII;""
25 Lleida;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QI;""
25 Lleida;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
25 Lleida;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
25 Lleida;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QII;""
25 Lleida;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QI;""
25 Lleida;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
25 Lleida;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
25 Lleida;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
25 Lleida;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
25 Lleida;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
25 Lleida;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
25 Lleida;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
25 Lleida;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
25 Lleida;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
25 Lleida;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
25 Lleida;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
25 Lleida;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
25 Lleida;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;93,58
25 Lleida;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
25 Lleida;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
25 Lleida;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
25 Lleida;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;93,06
25 Lleida;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
25 Lleida;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
25 Lleida;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
25 Lleida;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;91,35
25 Lleida;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
25 Lleida;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
25 Lleida;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
25 Lleida;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
25 Lleida;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
25 Lleida;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
25 Lleida;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;86,12
25 Lleida;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
25 Lleida;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
25 Lleida;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
25 Lleida;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;87,26
25 Lleida;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
25 Lleida;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
25 Lleida;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
25 Lleida;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
25 Lleida;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
25 Lleida;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
25 Lleida;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;80,91
25 Lleida;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
25 Lleida;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
25 Lleida;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
25 Lleida;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;81,92
25 Lleida;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
25 Lleida;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
25 Lleida;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
25 Lleida;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
25 Lleida;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
25 Lleida;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
25 Lleida;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;74,13
25 Lleida;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
25 Lleida;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
25 Lleida;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
25 Lleida;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;75,47
25 Lleida;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
25 Lleida;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
25 Lleida;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
25 Lleida;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
25 Lleida;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
25 Lleida;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
25 Lleida;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
25 Lleida;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
25 Lleida;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
25 Lleida;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QI;4.592
25 Lleida;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
25 Lleida;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
25 Lleida;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
25 Lleida;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QI;4.685
25 Lleida;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
25 Lleida;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
25 Lleida;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
25 Lleida;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QI;4.733
25 Lleida;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
25 Lleida;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
25 Lleida;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2022QII;""
25 Lleida;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2022QI;4.431
25 Lleida;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
25 Lleida;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
25 Lleida;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2021QII;""
25 Lleida;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2021QI;4.549
25 Lleida;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
25 Lleida;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
25 Lleida;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2020QII;""
25 Lleida;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2020QI;4.417
25 Lleida;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
25 Lleida;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
25 Lleida;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2022QII;4.277
25 Lleida;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2022QI;""
25 Lleida;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
25 Lleida;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
25 Lleida;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2021QII;4.441
25 Lleida;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2021QI;""
25 Lleida;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
25 Lleida;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
25 Lleida;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2020QII;4.312
25 Lleida;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2020QI;""
25 Lleida;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
25 Lleida;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QIII;4.139
25 Lleida;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QII;""
25 Lleida;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QI;""
25 Lleida;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
25 Lleida;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QIII;4.322
25 Lleida;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QII;""
25 Lleida;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QI;""
25 Lleida;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
25 Lleida;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QIII;4.159
25 Lleida;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QII;""
25 Lleida;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QI;""
25 Lleida;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QIV;3.973
25 Lleida;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
25 Lleida;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QII;""
25 Lleida;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QI;""
25 Lleida;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QIV;4.210
25 Lleida;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
25 Lleida;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QII;""
25 Lleida;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QI;""
25 Lleida;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QIV;4.004
25 Lleida;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
25 Lleida;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QII;""
25 Lleida;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QI;""
25 Lleida;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
25 Lleida;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
25 Lleida;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
25 Lleida;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
25 Lleida;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
25 Lleida;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
25 Lleida;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
25 Lleida;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
25 Lleida;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
25 Lleida;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
25 Lleida;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
25 Lleida;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
25 Lleida;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
25 Lleida;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
25 Lleida;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
25 Lleida;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;96,49
25 Lleida;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
25 Lleida;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
25 Lleida;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
25 Lleida;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;97,1
25 Lleida;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
25 Lleida;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
25 Lleida;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
25 Lleida;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;93,32
25 Lleida;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
25 Lleida;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
25 Lleida;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;93,14
25 Lleida;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
25 Lleida;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
25 Lleida;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
25 Lleida;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;94,79
25 Lleida;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
25 Lleida;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
25 Lleida;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
25 Lleida;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;91,11
25 Lleida;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
25 Lleida;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
25 Lleida;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;90,14
25 Lleida;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
25 Lleida;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
25 Lleida;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
25 Lleida;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;92,25
25 Lleida;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
25 Lleida;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
25 Lleida;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
25 Lleida;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;87,87
25 Lleida;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
25 Lleida;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
25 Lleida;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;86,52
25 Lleida;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
25 Lleida;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
25 Lleida;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
25 Lleida;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;89,86
25 Lleida;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
25 Lleida;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
25 Lleida;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
25 Lleida;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;84,6
25 Lleida;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
25 Lleida;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
25 Lleida;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
25 Lleida;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
25 Lleida;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
25 Lleida;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
25 Lleida;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QI;2.821
25 Lleida;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
25 Lleida;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
25 Lleida;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
25 Lleida;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QI;2.875
25 Lleida;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
25 Lleida;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
25 Lleida;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
25 Lleida;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QI;2.904
25 Lleida;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
25 Lleida;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
25 Lleida;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2022QII;""
25 Lleida;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2022QI;2.737
25 Lleida;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
25 Lleida;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
25 Lleida;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2021QII;""
25 Lleida;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2021QI;2.795
25 Lleida;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
25 Lleida;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
25 Lleida;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2020QII;""
25 Lleida;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2020QI;2.732
25 Lleida;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
25 Lleida;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
25 Lleida;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2022QII;2.652
25 Lleida;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2022QI;""
25 Lleida;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
25 Lleida;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
25 Lleida;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2021QII;2.733
25 Lleida;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2021QI;""
25 Lleida;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
25 Lleida;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
25 Lleida;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2020QII;2.675
25 Lleida;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2020QI;""
25 Lleida;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
25 Lleida;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QIII;2.566
25 Lleida;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QII;""
25 Lleida;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QI;""
25 Lleida;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
25 Lleida;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QIII;2.674
25 Lleida;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QII;""
25 Lleida;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QI;""
25 Lleida;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
25 Lleida;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QIII;2.582
25 Lleida;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QII;""
25 Lleida;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QI;""
25 Lleida;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QIV;2.468
25 Lleida;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
25 Lleida;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QII;""
25 Lleida;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QI;""
25 Lleida;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QIV;2.607
25 Lleida;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
25 Lleida;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QII;""
25 Lleida;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QI;""
25 Lleida;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QIV;2.497
25 Lleida;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
25 Lleida;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QII;""
25 Lleida;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QI;""
25 Lleida;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
25 Lleida;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
25 Lleida;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
25 Lleida;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
25 Lleida;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
25 Lleida;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
25 Lleida;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
25 Lleida;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
25 Lleida;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
25 Lleida;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
25 Lleida;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
25 Lleida;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
25 Lleida;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
25 Lleida;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
25 Lleida;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
25 Lleida;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;97,02
25 Lleida;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
25 Lleida;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
25 Lleida;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
25 Lleida;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;97,22
25 Lleida;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
25 Lleida;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
25 Lleida;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
25 Lleida;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;94,08
25 Lleida;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
25 Lleida;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
25 Lleida;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;94,01
25 Lleida;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
25 Lleida;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
25 Lleida;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
25 Lleida;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;95,06
25 Lleida;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
25 Lleida;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
25 Lleida;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
25 Lleida;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;92,11
25 Lleida;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
25 Lleida;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
25 Lleida;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;90,96
25 Lleida;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
25 Lleida;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
25 Lleida;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
25 Lleida;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;93,01
25 Lleida;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
25 Lleida;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
25 Lleida;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
25 Lleida;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;88,91
25 Lleida;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
25 Lleida;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
25 Lleida;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;87,49
25 Lleida;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
25 Lleida;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
25 Lleida;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
25 Lleida;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;90,68
25 Lleida;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
25 Lleida;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
25 Lleida;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
25 Lleida;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;85,98
25 Lleida;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
25 Lleida;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
25 Lleida;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
25 Lleida;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
25 Lleida;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
25 Lleida;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
25 Lleida;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QI;1.771
25 Lleida;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
25 Lleida;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
25 Lleida;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
25 Lleida;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QI;1.810
25 Lleida;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
25 Lleida;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
25 Lleida;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
25 Lleida;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QI;1.829
25 Lleida;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
25 Lleida;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
25 Lleida;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2022QII;""
25 Lleida;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2022QI;1.694
25 Lleida;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
25 Lleida;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
25 Lleida;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2021QII;""
25 Lleida;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2021QI;1.754
25 Lleida;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
25 Lleida;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
25 Lleida;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2020QII;""
25 Lleida;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2020QI;1.685
25 Lleida;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
25 Lleida;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
25 Lleida;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2022QII;1.625
25 Lleida;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2022QI;""
25 Lleida;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
25 Lleida;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
25 Lleida;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2021QII;1.708
25 Lleida;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2021QI;""
25 Lleida;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
25 Lleida;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
25 Lleida;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2020QII;1.637
25 Lleida;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2020QI;""
25 Lleida;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
25 Lleida;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QIII;1.573
25 Lleida;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QII;""
25 Lleida;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QI;""
25 Lleida;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
25 Lleida;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QIII;1.648
25 Lleida;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QII;""
25 Lleida;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QI;""
25 Lleida;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
25 Lleida;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QIII;1.577
25 Lleida;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QII;""
25 Lleida;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QI;""
25 Lleida;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QIV;1.505
25 Lleida;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
25 Lleida;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QII;""
25 Lleida;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QI;""
25 Lleida;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QIV;1.603
25 Lleida;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
25 Lleida;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QII;""
25 Lleida;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QI;""
25 Lleida;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QIV;1.507
25 Lleida;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
25 Lleida;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QII;""
25 Lleida;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QI;""
25 Lleida;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
25 Lleida;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
25 Lleida;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
25 Lleida;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
25 Lleida;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
25 Lleida;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
25 Lleida;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
25 Lleida;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
25 Lleida;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
25 Lleida;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
25 Lleida;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
25 Lleida;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
25 Lleida;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
25 Lleida;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
25 Lleida;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
25 Lleida;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;95,65
25 Lleida;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
25 Lleida;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
25 Lleida;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
25 Lleida;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;96,91
25 Lleida;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
25 Lleida;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
25 Lleida;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
25 Lleida;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;92,13
25 Lleida;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
25 Lleida;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
25 Lleida;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;91,76
25 Lleida;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
25 Lleida;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
25 Lleida;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
25 Lleida;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;94,36
25 Lleida;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
25 Lleida;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
25 Lleida;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
25 Lleida;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;89,5
25 Lleida;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
25 Lleida;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
25 Lleida;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;88,82
25 Lleida;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
25 Lleida;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
25 Lleida;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
25 Lleida;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;91,05
25 Lleida;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
25 Lleida;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
25 Lleida;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
25 Lleida;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;86,22
25 Lleida;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
25 Lleida;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
25 Lleida;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;84,98
25 Lleida;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
25 Lleida;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
25 Lleida;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
25 Lleida;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;88,56
25 Lleida;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
25 Lleida;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
25 Lleida;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
25 Lleida;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;82,39
25 Lleida;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
25 Lleida;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
25 Lleida;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
25 Lleida;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
25 Lleida;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
25 Lleida;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QII;4.322
25 Lleida;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
25 Lleida;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
25 Lleida;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
25 Lleida;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QII;4.365
25 Lleida;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
25 Lleida;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
25 Lleida;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
25 Lleida;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QII;4.674
25 Lleida;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
25 Lleida;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
25 Lleida;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
25 Lleida;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2022QII;4.148
25 Lleida;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2022QI;""
25 Lleida;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
25 Lleida;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
25 Lleida;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2021QII;4.235
25 Lleida;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2021QI;""
25 Lleida;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
25 Lleida;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
25 Lleida;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2020QII;4.555
25 Lleida;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2020QI;""
25 Lleida;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
25 Lleida;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2022QIII;4.010
25 Lleida;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2022QII;""
25 Lleida;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2022QI;""
25 Lleida;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
25 Lleida;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2021QIII;4.094
25 Lleida;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2021QII;""
25 Lleida;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2021QI;""
25 Lleida;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
25 Lleida;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2020QIII;4.384
25 Lleida;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2020QII;""
25 Lleida;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2020QI;""
25 Lleida;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QIV;3.835
25 Lleida;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
25 Lleida;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QII;""
25 Lleida;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QI;""
25 Lleida;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QIV;3.976
25 Lleida;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
25 Lleida;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QII;""
25 Lleida;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QI;""
25 Lleida;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QIV;4.207
25 Lleida;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
25 Lleida;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QII;""
25 Lleida;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QI;""
25 Lleida;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
25 Lleida;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
25 Lleida;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QII;""
25 Lleida;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QI;3.861
25 Lleida;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
25 Lleida;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
25 Lleida;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QII;""
25 Lleida;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QI;4.109
25 Lleida;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
25 Lleida;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
25 Lleida;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QII;""
25 Lleida;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QI;""
25 Lleida;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
25 Lleida;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
25 Lleida;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
25 Lleida;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
25 Lleida;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
25 Lleida;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
25 Lleida;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
25 Lleida;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
25 Lleida;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
25 Lleida;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
25 Lleida;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
25 Lleida;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
25 Lleida;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
25 Lleida;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
25 Lleida;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;95,97
25 Lleida;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
25 Lleida;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
25 Lleida;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
25 Lleida;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;97,02
25 Lleida;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
25 Lleida;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
25 Lleida;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
25 Lleida;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;97,45
25 Lleida;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
25 Lleida;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
25 Lleida;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;92,78
25 Lleida;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
25 Lleida;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
25 Lleida;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
25 Lleida;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;93,79
25 Lleida;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
25 Lleida;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
25 Lleida;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
25 Lleida;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;93,8
25 Lleida;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
25 Lleida;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
25 Lleida;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;88,73
25 Lleida;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
25 Lleida;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
25 Lleida;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
25 Lleida;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;91,09
25 Lleida;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
25 Lleida;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
25 Lleida;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
25 Lleida;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;90,01
25 Lleida;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
25 Lleida;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
25 Lleida;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
25 Lleida;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
25 Lleida;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
25 Lleida;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
25 Lleida;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;88,45
25 Lleida;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
25 Lleida;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
25 Lleida;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
25 Lleida;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;87,91
25 Lleida;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
25 Lleida;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
25 Lleida;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
25 Lleida;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
25 Lleida;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
25 Lleida;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
25 Lleida;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QII;2.660
25 Lleida;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
25 Lleida;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
25 Lleida;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
25 Lleida;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QII;2.674
25 Lleida;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
25 Lleida;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
25 Lleida;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
25 Lleida;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QII;2.882
25 Lleida;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
25 Lleida;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
25 Lleida;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
25 Lleida;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2022QII;2.561
25 Lleida;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2022QI;""
25 Lleida;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
25 Lleida;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
25 Lleida;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2021QII;2.598
25 Lleida;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2021QI;""
25 Lleida;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
25 Lleida;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
25 Lleida;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2020QII;2.814
25 Lleida;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2020QI;""
25 Lleida;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
25 Lleida;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2022QIII;2.473
25 Lleida;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2022QII;""
25 Lleida;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2022QI;""
25 Lleida;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
25 Lleida;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2021QIII;2.523
25 Lleida;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2021QII;""
25 Lleida;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2021QI;""
25 Lleida;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
25 Lleida;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2020QIII;2.709
25 Lleida;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2020QII;""
25 Lleida;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2020QI;""
25 Lleida;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QIV;2.370
25 Lleida;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
25 Lleida;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QII;""
25 Lleida;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QI;""
25 Lleida;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QIV;2.450
25 Lleida;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
25 Lleida;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QII;""
25 Lleida;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QI;""
25 Lleida;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QIV;2.608
25 Lleida;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
25 Lleida;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QII;""
25 Lleida;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QI;""
25 Lleida;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
25 Lleida;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
25 Lleida;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QII;""
25 Lleida;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QI;2.391
25 Lleida;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
25 Lleida;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
25 Lleida;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QII;""
25 Lleida;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QI;2.546
25 Lleida;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
25 Lleida;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
25 Lleida;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QII;""
25 Lleida;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QI;""
25 Lleida;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
25 Lleida;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
25 Lleida;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
25 Lleida;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
25 Lleida;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
25 Lleida;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
25 Lleida;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
25 Lleida;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
25 Lleida;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
25 Lleida;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
25 Lleida;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
25 Lleida;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
25 Lleida;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
25 Lleida;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
25 Lleida;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;96,28
25 Lleida;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
25 Lleida;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
25 Lleida;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
25 Lleida;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;97,16
25 Lleida;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
25 Lleida;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
25 Lleida;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
25 Lleida;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;97,64
25 Lleida;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
25 Lleida;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
25 Lleida;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;92,97
25 Lleida;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
25 Lleida;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
25 Lleida;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
25 Lleida;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;94,35
25 Lleida;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
25 Lleida;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
25 Lleida;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
25 Lleida;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;94
25 Lleida;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
25 Lleida;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
25 Lleida;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;89,1
25 Lleida;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
25 Lleida;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
25 Lleida;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
25 Lleida;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;91,62
25 Lleida;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
25 Lleida;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
25 Lleida;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
25 Lleida;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;90,49
25 Lleida;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
25 Lleida;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
25 Lleida;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
25 Lleida;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
25 Lleida;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
25 Lleida;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
25 Lleida;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;89,42
25 Lleida;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
25 Lleida;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
25 Lleida;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
25 Lleida;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;88,34
25 Lleida;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
25 Lleida;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
25 Lleida;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
25 Lleida;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
25 Lleida;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
25 Lleida;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
25 Lleida;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QII;1.662
25 Lleida;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
25 Lleida;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
25 Lleida;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
25 Lleida;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QII;1.691
25 Lleida;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
25 Lleida;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
25 Lleida;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
25 Lleida;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QII;1.792
25 Lleida;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
25 Lleida;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
25 Lleida;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
25 Lleida;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2022QII;1.587
25 Lleida;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2022QI;""
25 Lleida;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
25 Lleida;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
25 Lleida;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2021QII;1.637
25 Lleida;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2021QI;""
25 Lleida;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
25 Lleida;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
25 Lleida;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2020QII;1.741
25 Lleida;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2020QI;""
25 Lleida;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
25 Lleida;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2022QIII;1.537
25 Lleida;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2022QII;""
25 Lleida;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2022QI;""
25 Lleida;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
25 Lleida;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2021QIII;1.571
25 Lleida;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2021QII;""
25 Lleida;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2021QI;""
25 Lleida;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
25 Lleida;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2020QIII;1.675
25 Lleida;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2020QII;""
25 Lleida;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2020QI;""
25 Lleida;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QIV;1.465
25 Lleida;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
25 Lleida;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QII;""
25 Lleida;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QI;""
25 Lleida;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QIV;1.526
25 Lleida;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
25 Lleida;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QII;""
25 Lleida;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QI;""
25 Lleida;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QIV;1.599
25 Lleida;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
25 Lleida;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QII;""
25 Lleida;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QI;""
25 Lleida;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
25 Lleida;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
25 Lleida;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QII;""
25 Lleida;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QI;1.470
25 Lleida;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
25 Lleida;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
25 Lleida;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QII;""
25 Lleida;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QI;1.563
25 Lleida;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
25 Lleida;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
25 Lleida;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QII;""
25 Lleida;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QI;""
25 Lleida;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
25 Lleida;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
25 Lleida;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
25 Lleida;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
25 Lleida;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
25 Lleida;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
25 Lleida;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
25 Lleida;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
25 Lleida;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
25 Lleida;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
25 Lleida;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
25 Lleida;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
25 Lleida;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
25 Lleida;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
25 Lleida;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;95,49
25 Lleida;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
25 Lleida;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
25 Lleida;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
25 Lleida;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;96,81
25 Lleida;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
25 Lleida;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
25 Lleida;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
25 Lleida;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;97,15
25 Lleida;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
25 Lleida;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
25 Lleida;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;92,48
25 Lleida;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
25 Lleida;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
25 Lleida;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
25 Lleida;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;92,9
25 Lleida;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
25 Lleida;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
25 Lleida;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
25 Lleida;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;93,47
25 Lleida;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
25 Lleida;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
25 Lleida;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;88,15
25 Lleida;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
25 Lleida;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
25 Lleida;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
25 Lleida;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;90,24
25 Lleida;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
25 Lleida;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
25 Lleida;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
25 Lleida;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;89,23
25 Lleida;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
25 Lleida;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
25 Lleida;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
25 Lleida;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
25 Lleida;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
25 Lleida;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
25 Lleida;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;86,93
25 Lleida;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
25 Lleida;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
25 Lleida;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
25 Lleida;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;87,22
25 Lleida;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
25 Lleida;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
25 Lleida;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
25 Lleida;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
25 Lleida;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
25 Lleida;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QIII;4.385
25 Lleida;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
25 Lleida;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
25 Lleida;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
25 Lleida;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QIII;4.466
25 Lleida;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
25 Lleida;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
25 Lleida;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
25 Lleida;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QIII;4.692
25 Lleida;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
25 Lleida;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
25 Lleida;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
25 Lleida;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2022QIII;4.215
25 Lleida;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2022QII;""
25 Lleida;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2022QI;""
25 Lleida;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
25 Lleida;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2021QIII;4.303
25 Lleida;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2021QII;""
25 Lleida;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2021QI;""
25 Lleida;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
25 Lleida;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2020QIII;4.503
25 Lleida;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2020QII;""
25 Lleida;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2020QI;""
25 Lleida;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2022QIV;4.019
25 Lleida;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
25 Lleida;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2022QII;""
25 Lleida;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2022QI;""
25 Lleida;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2021QIV;4.168
25 Lleida;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
25 Lleida;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2021QII;""
25 Lleida;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2021QI;""
25 Lleida;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2020QIV;4.309
25 Lleida;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
25 Lleida;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2020QII;""
25 Lleida;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2020QI;""
25 Lleida;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
25 Lleida;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
25 Lleida;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QII;""
25 Lleida;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QI;4.037
25 Lleida;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
25 Lleida;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
25 Lleida;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QII;""
25 Lleida;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QI;4.210
25 Lleida;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
25 Lleida;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
25 Lleida;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QII;""
25 Lleida;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QI;""
25 Lleida;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
25 Lleida;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
25 Lleida;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QII;3.918
25 Lleida;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QI;""
25 Lleida;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
25 Lleida;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
25 Lleida;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QII;4.119
25 Lleida;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QI;""
25 Lleida;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
25 Lleida;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
25 Lleida;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QII;""
25 Lleida;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QI;""
25 Lleida;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
25 Lleida;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
25 Lleida;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
25 Lleida;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
25 Lleida;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
25 Lleida;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
25 Lleida;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
25 Lleida;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
25 Lleida;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
25 Lleida;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
25 Lleida;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
25 Lleida;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
25 Lleida;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
25 Lleida;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;96,12
25 Lleida;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
25 Lleida;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
25 Lleida;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
25 Lleida;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;96,35
25 Lleida;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
25 Lleida;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
25 Lleida;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
25 Lleida;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;95,97
25 Lleida;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
25 Lleida;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
25 Lleida;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;91,65
25 Lleida;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
25 Lleida;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
25 Lleida;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
25 Lleida;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;93,33
25 Lleida;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
25 Lleida;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
25 Lleida;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
25 Lleida;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;91,84
25 Lleida;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
25 Lleida;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
25 Lleida;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
25 Lleida;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
25 Lleida;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
25 Lleida;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
25 Lleida;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;90,39
25 Lleida;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
25 Lleida;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
25 Lleida;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
25 Lleida;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;89,73
25 Lleida;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
25 Lleida;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
25 Lleida;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
25 Lleida;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
25 Lleida;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
25 Lleida;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
25 Lleida;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;87,73
25 Lleida;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
25 Lleida;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
25 Lleida;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
25 Lleida;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;87,79
25 Lleida;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
25 Lleida;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
25 Lleida;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
25 Lleida;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
25 Lleida;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
25 Lleida;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
25 Lleida;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QIII;2.704
25 Lleida;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
25 Lleida;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
25 Lleida;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
25 Lleida;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QIII;2.734
25 Lleida;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
25 Lleida;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
25 Lleida;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
25 Lleida;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QIII;2.899
25 Lleida;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
25 Lleida;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
25 Lleida;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
25 Lleida;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2022QIII;2.598
25 Lleida;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2022QII;""
25 Lleida;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2022QI;""
25 Lleida;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
25 Lleida;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2021QIII;2.647
25 Lleida;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2021QII;""
25 Lleida;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2021QI;""
25 Lleida;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
25 Lleida;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2020QIII;2.782
25 Lleida;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2020QII;""
25 Lleida;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2020QI;""
25 Lleida;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2022QIV;2.482
25 Lleida;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
25 Lleida;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2022QII;""
25 Lleida;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2022QI;""
25 Lleida;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2021QIV;2.561
25 Lleida;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
25 Lleida;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2021QII;""
25 Lleida;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2021QI;""
25 Lleida;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2020QIV;2.671
25 Lleida;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
25 Lleida;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2020QII;""
25 Lleida;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2020QI;""
25 Lleida;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
25 Lleida;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
25 Lleida;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QII;""
25 Lleida;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QI;2.495
25 Lleida;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
25 Lleida;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
25 Lleida;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QII;""
25 Lleida;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QI;2.608
25 Lleida;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
25 Lleida;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
25 Lleida;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QII;""
25 Lleida;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QI;""
25 Lleida;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
25 Lleida;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
25 Lleida;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QII;2.430
25 Lleida;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QI;""
25 Lleida;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
25 Lleida;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
25 Lleida;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QII;2.560
25 Lleida;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QI;""
25 Lleida;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
25 Lleida;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
25 Lleida;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QII;""
25 Lleida;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QI;""
25 Lleida;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
25 Lleida;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
25 Lleida;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
25 Lleida;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
25 Lleida;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
25 Lleida;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
25 Lleida;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
25 Lleida;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
25 Lleida;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
25 Lleida;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
25 Lleida;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
25 Lleida;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
25 Lleida;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
25 Lleida;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;96,08
25 Lleida;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
25 Lleida;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
25 Lleida;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
25 Lleida;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;96,82
25 Lleida;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
25 Lleida;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
25 Lleida;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
25 Lleida;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;95,96
25 Lleida;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
25 Lleida;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
25 Lleida;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;91,79
25 Lleida;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
25 Lleida;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
25 Lleida;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
25 Lleida;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;93,67
25 Lleida;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
25 Lleida;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
25 Lleida;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
25 Lleida;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;92,14
25 Lleida;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
25 Lleida;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
25 Lleida;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
25 Lleida;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
25 Lleida;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
25 Lleida;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
25 Lleida;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;91,26
25 Lleida;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
25 Lleida;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
25 Lleida;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
25 Lleida;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;89,96
25 Lleida;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
25 Lleida;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
25 Lleida;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
25 Lleida;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
25 Lleida;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
25 Lleida;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
25 Lleida;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;88,88
25 Lleida;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
25 Lleida;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
25 Lleida;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
25 Lleida;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;88,31
25 Lleida;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
25 Lleida;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
25 Lleida;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
25 Lleida;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
25 Lleida;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
25 Lleida;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
25 Lleida;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QIII;1.681
25 Lleida;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
25 Lleida;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
25 Lleida;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
25 Lleida;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QIII;1.732
25 Lleida;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
25 Lleida;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
25 Lleida;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
25 Lleida;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QIII;1.793
25 Lleida;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
25 Lleida;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
25 Lleida;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
25 Lleida;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2022QIII;1.617
25 Lleida;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2022QII;""
25 Lleida;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2022QI;""
25 Lleida;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
25 Lleida;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2021QIII;1.656
25 Lleida;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2021QII;""
25 Lleida;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2021QI;""
25 Lleida;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
25 Lleida;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2020QIII;1.721
25 Lleida;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2020QII;""
25 Lleida;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2020QI;""
25 Lleida;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2022QIV;1.537
25 Lleida;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
25 Lleida;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2022QII;""
25 Lleida;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2022QI;""
25 Lleida;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2021QIV;1.607
25 Lleida;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
25 Lleida;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2021QII;""
25 Lleida;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2021QI;""
25 Lleida;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2020QIV;1.638
25 Lleida;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
25 Lleida;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2020QII;""
25 Lleida;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2020QI;""
25 Lleida;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
25 Lleida;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
25 Lleida;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QII;""
25 Lleida;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QI;1.542
25 Lleida;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
25 Lleida;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
25 Lleida;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QII;""
25 Lleida;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QI;1.602
25 Lleida;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
25 Lleida;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
25 Lleida;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QII;""
25 Lleida;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QI;""
25 Lleida;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
25 Lleida;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
25 Lleida;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QII;1.488
25 Lleida;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QI;""
25 Lleida;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
25 Lleida;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
25 Lleida;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QII;1.559
25 Lleida;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QI;""
25 Lleida;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
25 Lleida;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
25 Lleida;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QII;""
25 Lleida;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QI;""
25 Lleida;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
25 Lleida;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
25 Lleida;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
25 Lleida;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
25 Lleida;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
25 Lleida;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
25 Lleida;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
25 Lleida;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
25 Lleida;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
25 Lleida;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
25 Lleida;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
25 Lleida;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
25 Lleida;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
25 Lleida;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;96,19
25 Lleida;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
25 Lleida;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
25 Lleida;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
25 Lleida;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;95,61
25 Lleida;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
25 Lleida;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
25 Lleida;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
25 Lleida;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;95,98
25 Lleida;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
25 Lleida;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
25 Lleida;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;91,43
25 Lleida;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
25 Lleida;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
25 Lleida;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
25 Lleida;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;92,78
25 Lleida;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
25 Lleida;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
25 Lleida;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
25 Lleida;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;91,36
25 Lleida;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
25 Lleida;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
25 Lleida;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
25 Lleida;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
25 Lleida;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
25 Lleida;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
25 Lleida;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;89,03
25 Lleida;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
25 Lleida;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
25 Lleida;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
25 Lleida;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;89,35
25 Lleida;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
25 Lleida;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
25 Lleida;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
25 Lleida;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
25 Lleida;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
25 Lleida;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
25 Lleida;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;85,91
25 Lleida;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
25 Lleida;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
25 Lleida;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
25 Lleida;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;86,95
25 Lleida;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
25 Lleida;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
25 Lleida;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
25 Lleida;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
25 Lleida;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
25 Lleida;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QIV;4.414
25 Lleida;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
25 Lleida;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
25 Lleida;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
25 Lleida;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QIV;4.497
25 Lleida;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
25 Lleida;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
25 Lleida;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
25 Lleida;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QIV;4.695
25 Lleida;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
25 Lleida;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
25 Lleida;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
25 Lleida;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2022QIV;4.193
25 Lleida;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
25 Lleida;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2022QII;""
25 Lleida;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2022QI;""
25 Lleida;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2021QIV;4.344
25 Lleida;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
25 Lleida;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2021QII;""
25 Lleida;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2021QI;""
25 Lleida;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2020QIV;4.479
25 Lleida;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
25 Lleida;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2020QII;""
25 Lleida;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2020QI;""
25 Lleida;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
25 Lleida;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
25 Lleida;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2022QII;""
25 Lleida;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2022QI;4.205
25 Lleida;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
25 Lleida;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
25 Lleida;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2021QII;""
25 Lleida;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2021QI;4.367
25 Lleida;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
25 Lleida;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
25 Lleida;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2020QII;""
25 Lleida;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2020QI;""
25 Lleida;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
25 Lleida;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
25 Lleida;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QII;4.070
25 Lleida;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QI;""
25 Lleida;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
25 Lleida;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
25 Lleida;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QII;4.268
25 Lleida;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QI;""
25 Lleida;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
25 Lleida;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
25 Lleida;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QII;""
25 Lleida;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QI;""
25 Lleida;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
25 Lleida;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QIII;3.950
25 Lleida;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QII;""
25 Lleida;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QI;""
25 Lleida;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
25 Lleida;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QIII;4.167
25 Lleida;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QII;""
25 Lleida;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QI;""
25 Lleida;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
25 Lleida;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
25 Lleida;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QII;""
25 Lleida;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QI;""
25 Lleida;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
25 Lleida;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
25 Lleida;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
25 Lleida;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
25 Lleida;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
25 Lleida;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
25 Lleida;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
25 Lleida;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
25 Lleida;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
25 Lleida;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
25 Lleida;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
25 Lleida;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
25 Lleida;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;94,99
25 Lleida;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
25 Lleida;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
25 Lleida;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
25 Lleida;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;96,6
25 Lleida;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
25 Lleida;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
25 Lleida;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
25 Lleida;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;95,4
25 Lleida;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
25 Lleida;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
25 Lleida;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
25 Lleida;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
25 Lleida;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
25 Lleida;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
25 Lleida;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;93,51
25 Lleida;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
25 Lleida;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
25 Lleida;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
25 Lleida;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;93,01
25 Lleida;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
25 Lleida;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
25 Lleida;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
25 Lleida;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
25 Lleida;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
25 Lleida;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
25 Lleida;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;90,5
25 Lleida;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
25 Lleida;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
25 Lleida;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
25 Lleida;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;90,91
25 Lleida;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
25 Lleida;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
25 Lleida;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
25 Lleida;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
25 Lleida;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
25 Lleida;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
25 Lleida;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;87,84
25 Lleida;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
25 Lleida;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
25 Lleida;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
25 Lleida;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;88,75
25 Lleida;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
25 Lleida;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
25 Lleida;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
25 Lleida;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
25 Lleida;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
25 Lleida;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
25 Lleida;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QIV;2.704
25 Lleida;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
25 Lleida;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
25 Lleida;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
25 Lleida;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QIV;2.764
25 Lleida;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
25 Lleida;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
25 Lleida;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
25 Lleida;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QIV;2.889
25 Lleida;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
25 Lleida;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
25 Lleida;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
25 Lleida;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2022QIV;2.576
25 Lleida;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
25 Lleida;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2022QII;""
25 Lleida;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2022QI;""
25 Lleida;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2021QIV;2.666
25 Lleida;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
25 Lleida;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2021QII;""
25 Lleida;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2021QI;""
25 Lleida;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2020QIV;2.764
25 Lleida;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
25 Lleida;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2020QII;""
25 Lleida;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2020QI;""
25 Lleida;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
25 Lleida;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
25 Lleida;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2022QII;""
25 Lleida;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2022QI;2.594
25 Lleida;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
25 Lleida;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
25 Lleida;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2021QII;""
25 Lleida;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2021QI;2.695
25 Lleida;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
25 Lleida;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
25 Lleida;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2020QII;""
25 Lleida;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2020QI;""
25 Lleida;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
25 Lleida;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
25 Lleida;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QII;2.519
25 Lleida;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QI;""
25 Lleida;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
25 Lleida;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
25 Lleida;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QII;2.640
25 Lleida;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QI;""
25 Lleida;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
25 Lleida;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
25 Lleida;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QII;""
25 Lleida;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QI;""
25 Lleida;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
25 Lleida;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QIII;2.446
25 Lleida;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QII;""
25 Lleida;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QI;""
25 Lleida;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
25 Lleida;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QIII;2.591
25 Lleida;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QII;""
25 Lleida;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QI;""
25 Lleida;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
25 Lleida;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
25 Lleida;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QII;""
25 Lleida;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QI;""
25 Lleida;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
25 Lleida;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
25 Lleida;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
25 Lleida;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
25 Lleida;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
25 Lleida;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
25 Lleida;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
25 Lleida;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
25 Lleida;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
25 Lleida;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
25 Lleida;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
25 Lleida;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
25 Lleida;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;95,27
25 Lleida;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
25 Lleida;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
25 Lleida;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
25 Lleida;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;96,45
25 Lleida;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
25 Lleida;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
25 Lleida;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
25 Lleida;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;95,67
25 Lleida;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
25 Lleida;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
25 Lleida;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
25 Lleida;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
25 Lleida;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
25 Lleida;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
25 Lleida;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;93,85
25 Lleida;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
25 Lleida;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
25 Lleida;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
25 Lleida;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;93,28
25 Lleida;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
25 Lleida;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
25 Lleida;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
25 Lleida;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
25 Lleida;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
25 Lleida;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
25 Lleida;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;91,14
25 Lleida;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
25 Lleida;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
25 Lleida;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
25 Lleida;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;91,38
25 Lleida;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
25 Lleida;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
25 Lleida;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
25 Lleida;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
25 Lleida;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
25 Lleida;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
25 Lleida;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;88,49
25 Lleida;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
25 Lleida;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
25 Lleida;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
25 Lleida;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;89,69
25 Lleida;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
25 Lleida;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
25 Lleida;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
25 Lleida;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
25 Lleida;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
25 Lleida;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
25 Lleida;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QIV;1.710
25 Lleida;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
25 Lleida;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
25 Lleida;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
25 Lleida;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QIV;1.733
25 Lleida;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
25 Lleida;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
25 Lleida;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
25 Lleida;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QIV;1.806
25 Lleida;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
25 Lleida;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
25 Lleida;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
25 Lleida;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2022QIV;1.617
25 Lleida;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
25 Lleida;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2022QII;""
25 Lleida;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2022QI;""
25 Lleida;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2021QIV;1.678
25 Lleida;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
25 Lleida;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2021QII;""
25 Lleida;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2021QI;""
25 Lleida;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2020QIV;1.715
25 Lleida;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
25 Lleida;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2020QII;""
25 Lleida;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2020QI;""
25 Lleida;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
25 Lleida;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
25 Lleida;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2022QII;""
25 Lleida;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2022QI;1.611
25 Lleida;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
25 Lleida;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
25 Lleida;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2021QII;""
25 Lleida;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2021QI;1.672
25 Lleida;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
25 Lleida;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
25 Lleida;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2020QII;""
25 Lleida;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2020QI;""
25 Lleida;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
25 Lleida;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
25 Lleida;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QII;1.551
25 Lleida;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QI;""
25 Lleida;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
25 Lleida;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
25 Lleida;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QII;1.628
25 Lleida;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QI;""
25 Lleida;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
25 Lleida;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
25 Lleida;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QII;""
25 Lleida;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QI;""
25 Lleida;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
25 Lleida;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QIII;1.504
25 Lleida;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QII;""
25 Lleida;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QI;""
25 Lleida;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
25 Lleida;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QIII;1.576
25 Lleida;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QII;""
25 Lleida;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QI;""
25 Lleida;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
25 Lleida;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
25 Lleida;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QII;""
25 Lleida;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QI;""
25 Lleida;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
25 Lleida;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
25 Lleida;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
25 Lleida;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
25 Lleida;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
25 Lleida;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
25 Lleida;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
25 Lleida;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
25 Lleida;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
25 Lleida;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
25 Lleida;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
25 Lleida;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
25 Lleida;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;94,56
25 Lleida;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
25 Lleida;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
25 Lleida;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
25 Lleida;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;96,83
25 Lleida;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
25 Lleida;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
25 Lleida;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
25 Lleida;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;94,96
25 Lleida;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
25 Lleida;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
25 Lleida;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
25 Lleida;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
25 Lleida;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
25 Lleida;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
25 Lleida;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;92,96
25 Lleida;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
25 Lleida;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
25 Lleida;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
25 Lleida;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;92,58
25 Lleida;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
25 Lleida;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
25 Lleida;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
25 Lleida;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
25 Lleida;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
25 Lleida;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
25 Lleida;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;89,5
25 Lleida;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
25 Lleida;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
25 Lleida;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
25 Lleida;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;90,14
25 Lleida;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
25 Lleida;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
25 Lleida;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
25 Lleida;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
25 Lleida;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
25 Lleida;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
25 Lleida;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;86,79
25 Lleida;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
25 Lleida;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
25 Lleida;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
25 Lleida;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;87,26
25 Lleida;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
25 Lleida;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
25 Lleida;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
25 Lleida;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
25 Lleida;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
25 Lleida;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
25 Lleida;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
25 Lleida;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
25 Lleida;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
25 Lleida;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QI;8.787
25 Lleida;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
25 Lleida;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
25 Lleida;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
25 Lleida;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QI;8.830
25 Lleida;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
25 Lleida;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
25 Lleida;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
25 Lleida;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QI;8.898
25 Lleida;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
25 Lleida;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
25 Lleida;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2022QII;""
25 Lleida;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2022QI;8.592
25 Lleida;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
25 Lleida;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
25 Lleida;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2021QII;""
25 Lleida;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2021QI;8.659
25 Lleida;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
25 Lleida;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
25 Lleida;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2020QII;""
25 Lleida;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2020QI;8.503
25 Lleida;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
25 Lleida;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
25 Lleida;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2022QII;8.355
25 Lleida;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2022QI;""
25 Lleida;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
25 Lleida;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
25 Lleida;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2021QII;8.490
25 Lleida;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2021QI;""
25 Lleida;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
25 Lleida;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
25 Lleida;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2020QII;8.384
25 Lleida;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2020QI;""
25 Lleida;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
25 Lleida;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QIII;8.187
25 Lleida;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QII;""
25 Lleida;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QI;""
25 Lleida;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
25 Lleida;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QIII;8.370
25 Lleida;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QII;""
25 Lleida;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QI;""
25 Lleida;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
25 Lleida;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QIII;8.202
25 Lleida;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QII;""
25 Lleida;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QI;""
25 Lleida;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QIV;8.002
25 Lleida;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
25 Lleida;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QII;""
25 Lleida;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QI;""
25 Lleida;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QIV;8.174
25 Lleida;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
25 Lleida;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QII;""
25 Lleida;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QI;""
25 Lleida;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QIV;7.994
25 Lleida;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
25 Lleida;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QII;""
25 Lleida;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QI;""
25 Lleida;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
25 Lleida;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
25 Lleida;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
25 Lleida;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
25 Lleida;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
25 Lleida;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
25 Lleida;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
25 Lleida;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
25 Lleida;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
25 Lleida;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
25 Lleida;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
25 Lleida;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
25 Lleida;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
25 Lleida;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
25 Lleida;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
25 Lleida;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;97,78
25 Lleida;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
25 Lleida;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
25 Lleida;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
25 Lleida;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;98,06
25 Lleida;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
25 Lleida;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
25 Lleida;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
25 Lleida;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;95,56
25 Lleida;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
25 Lleida;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
25 Lleida;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;95,08
25 Lleida;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
25 Lleida;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
25 Lleida;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
25 Lleida;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;96,15
25 Lleida;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
25 Lleida;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
25 Lleida;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
25 Lleida;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;94,22
25 Lleida;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
25 Lleida;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
25 Lleida;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;93,17
25 Lleida;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
25 Lleida;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
25 Lleida;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
25 Lleida;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;94,79
25 Lleida;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
25 Lleida;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
25 Lleida;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
25 Lleida;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;92,18
25 Lleida;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
25 Lleida;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
25 Lleida;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;91,07
25 Lleida;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
25 Lleida;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
25 Lleida;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
25 Lleida;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;92,57
25 Lleida;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
25 Lleida;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
25 Lleida;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
25 Lleida;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;89,84
25 Lleida;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
25 Lleida;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
25 Lleida;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
25 Lleida;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
25 Lleida;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
25 Lleida;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
25 Lleida;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QI;5.652
25 Lleida;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
25 Lleida;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
25 Lleida;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
25 Lleida;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QI;5.703
25 Lleida;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
25 Lleida;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
25 Lleida;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
25 Lleida;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QI;5.764
25 Lleida;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
25 Lleida;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
25 Lleida;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2022QII;""
25 Lleida;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2022QI;5.535
25 Lleida;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
25 Lleida;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
25 Lleida;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2021QII;""
25 Lleida;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2021QI;5.591
25 Lleida;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
25 Lleida;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
25 Lleida;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2020QII;""
25 Lleida;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2020QI;5.514
25 Lleida;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
25 Lleida;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
25 Lleida;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2022QII;5.384
25 Lleida;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2022QI;""
25 Lleida;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
25 Lleida;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
25 Lleida;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2021QII;5.488
25 Lleida;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2021QI;""
25 Lleida;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
25 Lleida;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
25 Lleida;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2020QII;5.452
25 Lleida;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2020QI;""
25 Lleida;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
25 Lleida;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QIII;5.280
25 Lleida;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QII;""
25 Lleida;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QI;""
25 Lleida;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
25 Lleida;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QIII;5.412
25 Lleida;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QII;""
25 Lleida;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QI;""
25 Lleida;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
25 Lleida;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QIII;5.347
25 Lleida;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QII;""
25 Lleida;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QI;""
25 Lleida;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QIV;5.152
25 Lleida;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
25 Lleida;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QII;""
25 Lleida;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QI;""
25 Lleida;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QIV;5.312
25 Lleida;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
25 Lleida;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QII;""
25 Lleida;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QI;""
25 Lleida;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QIV;5.213
25 Lleida;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
25 Lleida;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QII;""
25 Lleida;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QI;""
25 Lleida;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
25 Lleida;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
25 Lleida;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
25 Lleida;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
25 Lleida;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
25 Lleida;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
25 Lleida;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
25 Lleida;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
25 Lleida;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
25 Lleida;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
25 Lleida;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
25 Lleida;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
25 Lleida;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
25 Lleida;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
25 Lleida;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
25 Lleida;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;97,93
25 Lleida;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
25 Lleida;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
25 Lleida;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
25 Lleida;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;98,04
25 Lleida;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
25 Lleida;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
25 Lleida;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
25 Lleida;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;95,66
25 Lleida;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
25 Lleida;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
25 Lleida;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;95,26
25 Lleida;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
25 Lleida;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
25 Lleida;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
25 Lleida;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;96,23
25 Lleida;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
25 Lleida;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
25 Lleida;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
25 Lleida;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;94,59
25 Lleida;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
25 Lleida;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
25 Lleida;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;93,42
25 Lleida;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
25 Lleida;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
25 Lleida;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
25 Lleida;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;94,9
25 Lleida;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
25 Lleida;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
25 Lleida;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
25 Lleida;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;92,77
25 Lleida;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
25 Lleida;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
25 Lleida;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;91,15
25 Lleida;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
25 Lleida;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
25 Lleida;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
25 Lleida;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;93,14
25 Lleida;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
25 Lleida;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
25 Lleida;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
25 Lleida;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;90,44
25 Lleida;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
25 Lleida;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
25 Lleida;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
25 Lleida;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
25 Lleida;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
25 Lleida;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
25 Lleida;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QI;3.135
25 Lleida;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
25 Lleida;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
25 Lleida;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
25 Lleida;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QI;3.127
25 Lleida;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
25 Lleida;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
25 Lleida;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
25 Lleida;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QI;3.134
25 Lleida;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
25 Lleida;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
25 Lleida;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2022QII;""
25 Lleida;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2022QI;3.057
25 Lleida;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
25 Lleida;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
25 Lleida;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2021QII;""
25 Lleida;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2021QI;3.068
25 Lleida;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
25 Lleida;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
25 Lleida;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2020QII;""
25 Lleida;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2020QI;2.989
25 Lleida;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
25 Lleida;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
25 Lleida;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2022QII;2.971
25 Lleida;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2022QI;""
25 Lleida;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
25 Lleida;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
25 Lleida;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2021QII;3.002
25 Lleida;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2021QI;""
25 Lleida;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
25 Lleida;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
25 Lleida;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2020QII;2.932
25 Lleida;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2020QI;""
25 Lleida;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
25 Lleida;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QIII;2.907
25 Lleida;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QII;""
25 Lleida;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QI;""
25 Lleida;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
25 Lleida;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QIII;2.958
25 Lleida;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QII;""
25 Lleida;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QI;""
25 Lleida;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
25 Lleida;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QIII;2.855
25 Lleida;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QII;""
25 Lleida;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QI;""
25 Lleida;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QIV;2.850
25 Lleida;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
25 Lleida;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QII;""
25 Lleida;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QI;""
25 Lleida;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QIV;2.862
25 Lleida;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
25 Lleida;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QII;""
25 Lleida;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QI;""
25 Lleida;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QIV;2.781
25 Lleida;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
25 Lleida;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QII;""
25 Lleida;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QI;""
25 Lleida;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
25 Lleida;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
25 Lleida;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
25 Lleida;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
25 Lleida;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
25 Lleida;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
25 Lleida;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
25 Lleida;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
25 Lleida;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
25 Lleida;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
25 Lleida;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
25 Lleida;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
25 Lleida;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
25 Lleida;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
25 Lleida;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
25 Lleida;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;97,51
25 Lleida;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
25 Lleida;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
25 Lleida;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
25 Lleida;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;98,11
25 Lleida;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
25 Lleida;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
25 Lleida;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
25 Lleida;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;95,37
25 Lleida;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
25 Lleida;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
25 Lleida;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;94,77
25 Lleida;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
25 Lleida;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
25 Lleida;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
25 Lleida;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;96
25 Lleida;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
25 Lleida;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
25 Lleida;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
25 Lleida;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;93,55
25 Lleida;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
25 Lleida;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
25 Lleida;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;92,73
25 Lleida;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
25 Lleida;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
25 Lleida;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
25 Lleida;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;94,6
25 Lleida;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
25 Lleida;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
25 Lleida;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
25 Lleida;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;91,1
25 Lleida;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
25 Lleida;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
25 Lleida;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;90,91
25 Lleida;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
25 Lleida;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
25 Lleida;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
25 Lleida;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;91,53
25 Lleida;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
25 Lleida;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
25 Lleida;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
25 Lleida;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;88,74
25 Lleida;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
25 Lleida;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
25 Lleida;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
25 Lleida;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
25 Lleida;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
25 Lleida;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QII;8.549
25 Lleida;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
25 Lleida;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
25 Lleida;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
25 Lleida;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QII;8.701
25 Lleida;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
25 Lleida;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
25 Lleida;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
25 Lleida;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QII;8.802
25 Lleida;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
25 Lleida;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
25 Lleida;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
25 Lleida;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2022QII;8.295
25 Lleida;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2022QI;""
25 Lleida;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
25 Lleida;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
25 Lleida;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2021QII;8.512
25 Lleida;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2021QI;""
25 Lleida;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
25 Lleida;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
25 Lleida;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2020QII;8.669
25 Lleida;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2020QI;""
25 Lleida;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
25 Lleida;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2022QIII;8.112
25 Lleida;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2022QII;""
25 Lleida;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2022QI;""
25 Lleida;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
25 Lleida;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2021QIII;8.378
25 Lleida;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2021QII;""
25 Lleida;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2021QI;""
25 Lleida;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
25 Lleida;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2020QIII;8.458
25 Lleida;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2020QII;""
25 Lleida;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2020QI;""
25 Lleida;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QIV;7.911
25 Lleida;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
25 Lleida;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QII;""
25 Lleida;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QI;""
25 Lleida;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QIV;8.169
25 Lleida;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
25 Lleida;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QII;""
25 Lleida;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QI;""
25 Lleida;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QIV;8.231
25 Lleida;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
25 Lleida;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QII;""
25 Lleida;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QI;""
25 Lleida;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
25 Lleida;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
25 Lleida;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QII;""
25 Lleida;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QI;8.022
25 Lleida;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
25 Lleida;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
25 Lleida;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QII;""
25 Lleida;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QI;8.100
25 Lleida;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
25 Lleida;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
25 Lleida;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QII;""
25 Lleida;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QI;""
25 Lleida;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
25 Lleida;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
25 Lleida;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
25 Lleida;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
25 Lleida;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
25 Lleida;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
25 Lleida;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
25 Lleida;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
25 Lleida;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
25 Lleida;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
25 Lleida;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
25 Lleida;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
25 Lleida;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
25 Lleida;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
25 Lleida;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;97,03
25 Lleida;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
25 Lleida;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
25 Lleida;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
25 Lleida;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;97,83
25 Lleida;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
25 Lleida;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
25 Lleida;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
25 Lleida;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;98,49
25 Lleida;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
25 Lleida;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
25 Lleida;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;94,89
25 Lleida;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
25 Lleida;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
25 Lleida;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
25 Lleida;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;96,29
25 Lleida;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
25 Lleida;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
25 Lleida;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
25 Lleida;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;96,09
25 Lleida;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
25 Lleida;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
25 Lleida;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;92,54
25 Lleida;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
25 Lleida;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
25 Lleida;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
25 Lleida;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;93,89
25 Lleida;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
25 Lleida;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
25 Lleida;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
25 Lleida;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;93,51
25 Lleida;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
25 Lleida;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
25 Lleida;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
25 Lleida;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
25 Lleida;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
25 Lleida;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
25 Lleida;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;92,2
25 Lleida;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
25 Lleida;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
25 Lleida;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
25 Lleida;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;92,02
25 Lleida;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
25 Lleida;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
25 Lleida;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
25 Lleida;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
25 Lleida;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
25 Lleida;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
25 Lleida;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QII;5.527
25 Lleida;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
25 Lleida;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
25 Lleida;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
25 Lleida;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QII;5.590
25 Lleida;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
25 Lleida;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
25 Lleida;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
25 Lleida;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QII;5.695
25 Lleida;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
25 Lleida;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
25 Lleida;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
25 Lleida;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2022QII;5.360
25 Lleida;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2022QI;""
25 Lleida;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
25 Lleida;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
25 Lleida;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2021QII;5.468
25 Lleida;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2021QI;""
25 Lleida;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
25 Lleida;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
25 Lleida;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2020QII;5.622
25 Lleida;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2020QI;""
25 Lleida;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
25 Lleida;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2022QIII;5.248
25 Lleida;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2022QII;""
25 Lleida;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2022QI;""
25 Lleida;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
25 Lleida;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2021QIII;5.382
25 Lleida;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2021QII;""
25 Lleida;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2021QI;""
25 Lleida;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
25 Lleida;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2020QIII;5.499
25 Lleida;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2020QII;""
25 Lleida;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2020QI;""
25 Lleida;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QIV;5.109
25 Lleida;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
25 Lleida;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QII;""
25 Lleida;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QI;""
25 Lleida;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QIV;5.271
25 Lleida;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
25 Lleida;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QII;""
25 Lleida;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QI;""
25 Lleida;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QIV;5.351
25 Lleida;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
25 Lleida;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QII;""
25 Lleida;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QI;""
25 Lleida;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
25 Lleida;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
25 Lleida;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QII;""
25 Lleida;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QI;5.182
25 Lleida;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
25 Lleida;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
25 Lleida;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QII;""
25 Lleida;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QI;5.268
25 Lleida;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
25 Lleida;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
25 Lleida;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QII;""
25 Lleida;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QI;""
25 Lleida;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
25 Lleida;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
25 Lleida;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
25 Lleida;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
25 Lleida;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
25 Lleida;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
25 Lleida;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
25 Lleida;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
25 Lleida;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
25 Lleida;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
25 Lleida;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
25 Lleida;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
25 Lleida;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
25 Lleida;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
25 Lleida;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;96,98
25 Lleida;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
25 Lleida;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
25 Lleida;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
25 Lleida;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;97,82
25 Lleida;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
25 Lleida;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
25 Lleida;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
25 Lleida;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;98,72
25 Lleida;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
25 Lleida;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
25 Lleida;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;94,95
25 Lleida;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
25 Lleida;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
25 Lleida;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
25 Lleida;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;96,28
25 Lleida;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
25 Lleida;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
25 Lleida;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
25 Lleida;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;96,56
25 Lleida;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
25 Lleida;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
25 Lleida;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;92,44
25 Lleida;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
25 Lleida;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
25 Lleida;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
25 Lleida;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;94,29
25 Lleida;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
25 Lleida;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
25 Lleida;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
25 Lleida;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;93,96
25 Lleida;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
25 Lleida;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
25 Lleida;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
25 Lleida;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
25 Lleida;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
25 Lleida;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
25 Lleida;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;92,7
25 Lleida;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
25 Lleida;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
25 Lleida;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
25 Lleida;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;92,5
25 Lleida;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
25 Lleida;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
25 Lleida;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
25 Lleida;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
25 Lleida;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
25 Lleida;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
25 Lleida;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QII;3.022
25 Lleida;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
25 Lleida;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
25 Lleida;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
25 Lleida;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QII;3.111
25 Lleida;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
25 Lleida;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
25 Lleida;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
25 Lleida;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QII;3.107
25 Lleida;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
25 Lleida;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
25 Lleida;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
25 Lleida;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2022QII;2.935
25 Lleida;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2022QI;""
25 Lleida;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
25 Lleida;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
25 Lleida;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2021QII;3.044
25 Lleida;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2021QI;""
25 Lleida;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
25 Lleida;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
25 Lleida;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2020QII;3.047
25 Lleida;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2020QI;""
25 Lleida;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
25 Lleida;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2022QIII;2.864
25 Lleida;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2022QII;""
25 Lleida;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2022QI;""
25 Lleida;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
25 Lleida;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2021QIII;2.996
25 Lleida;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2021QII;""
25 Lleida;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2021QI;""
25 Lleida;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
25 Lleida;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2020QIII;2.959
25 Lleida;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2020QII;""
25 Lleida;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2020QI;""
25 Lleida;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QIV;2.802
25 Lleida;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
25 Lleida;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QII;""
25 Lleida;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QI;""
25 Lleida;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QIV;2.898
25 Lleida;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
25 Lleida;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QII;""
25 Lleida;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QI;""
25 Lleida;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QIV;2.880
25 Lleida;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
25 Lleida;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QII;""
25 Lleida;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QI;""
25 Lleida;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
25 Lleida;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
25 Lleida;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QII;""
25 Lleida;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QI;2.840
25 Lleida;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
25 Lleida;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
25 Lleida;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QII;""
25 Lleida;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QI;2.832
25 Lleida;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
25 Lleida;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
25 Lleida;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QII;""
25 Lleida;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QI;""
25 Lleida;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
25 Lleida;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
25 Lleida;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
25 Lleida;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
25 Lleida;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
25 Lleida;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
25 Lleida;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
25 Lleida;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
25 Lleida;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
25 Lleida;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
25 Lleida;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
25 Lleida;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
25 Lleida;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
25 Lleida;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
25 Lleida;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;97,12
25 Lleida;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
25 Lleida;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
25 Lleida;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
25 Lleida;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;97,85
25 Lleida;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
25 Lleida;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
25 Lleida;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
25 Lleida;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;98,07
25 Lleida;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
25 Lleida;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
25 Lleida;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;94,77
25 Lleida;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
25 Lleida;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
25 Lleida;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
25 Lleida;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;96,3
25 Lleida;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
25 Lleida;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
25 Lleida;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
25 Lleida;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;95,24
25 Lleida;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
25 Lleida;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
25 Lleida;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;92,72
25 Lleida;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
25 Lleida;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
25 Lleida;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
25 Lleida;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;93,15
25 Lleida;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
25 Lleida;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
25 Lleida;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
25 Lleida;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;92,69
25 Lleida;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
25 Lleida;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
25 Lleida;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
25 Lleida;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
25 Lleida;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
25 Lleida;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
25 Lleida;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;91,29
25 Lleida;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
25 Lleida;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
25 Lleida;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
25 Lleida;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;91,15
25 Lleida;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
25 Lleida;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
25 Lleida;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
25 Lleida;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
25 Lleida;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
25 Lleida;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QIII;8.537
25 Lleida;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
25 Lleida;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
25 Lleida;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
25 Lleida;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QIII;8.774
25 Lleida;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
25 Lleida;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
25 Lleida;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
25 Lleida;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QIII;8.867
25 Lleida;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
25 Lleida;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
25 Lleida;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
25 Lleida;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2022QIII;8.316
25 Lleida;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2022QII;""
25 Lleida;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2022QI;""
25 Lleida;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
25 Lleida;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2021QIII;8.608
25 Lleida;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2021QII;""
25 Lleida;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2021QI;""
25 Lleida;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
25 Lleida;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2020QIII;8.635
25 Lleida;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2020QII;""
25 Lleida;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2020QI;""
25 Lleida;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2022QIV;8.091
25 Lleida;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
25 Lleida;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2022QII;""
25 Lleida;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2022QI;""
25 Lleida;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2021QIV;8.379
25 Lleida;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
25 Lleida;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2021QII;""
25 Lleida;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2021QI;""
25 Lleida;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2020QIV;8.388
25 Lleida;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
25 Lleida;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2020QII;""
25 Lleida;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2020QI;""
25 Lleida;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
25 Lleida;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
25 Lleida;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QII;""
25 Lleida;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QI;8.223
25 Lleida;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
25 Lleida;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
25 Lleida;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QII;""
25 Lleida;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QI;8.251
25 Lleida;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
25 Lleida;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
25 Lleida;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QII;""
25 Lleida;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QI;""
25 Lleida;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
25 Lleida;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
25 Lleida;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QII;8.031
25 Lleida;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QI;""
25 Lleida;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
25 Lleida;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
25 Lleida;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QII;8.123
25 Lleida;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QI;""
25 Lleida;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
25 Lleida;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
25 Lleida;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QII;""
25 Lleida;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QI;""
25 Lleida;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
25 Lleida;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
25 Lleida;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
25 Lleida;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
25 Lleida;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
25 Lleida;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
25 Lleida;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
25 Lleida;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
25 Lleida;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
25 Lleida;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
25 Lleida;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
25 Lleida;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
25 Lleida;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
25 Lleida;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;97,41
25 Lleida;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
25 Lleida;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
25 Lleida;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
25 Lleida;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;98,11
25 Lleida;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
25 Lleida;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
25 Lleida;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
25 Lleida;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;97,38
25 Lleida;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
25 Lleida;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
25 Lleida;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;94,78
25 Lleida;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
25 Lleida;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
25 Lleida;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
25 Lleida;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;95,5
25 Lleida;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
25 Lleida;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
25 Lleida;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
25 Lleida;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;94,6
25 Lleida;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
25 Lleida;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
25 Lleida;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
25 Lleida;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
25 Lleida;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
25 Lleida;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
25 Lleida;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;93,72
25 Lleida;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
25 Lleida;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
25 Lleida;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
25 Lleida;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;93,05
25 Lleida;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
25 Lleida;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
25 Lleida;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
25 Lleida;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
25 Lleida;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
25 Lleida;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
25 Lleida;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;91,53
25 Lleida;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
25 Lleida;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
25 Lleida;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
25 Lleida;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;91,61
25 Lleida;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
25 Lleida;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
25 Lleida;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
25 Lleida;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
25 Lleida;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
25 Lleida;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
25 Lleida;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QIII;5.507
25 Lleida;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
25 Lleida;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
25 Lleida;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
25 Lleida;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QIII;5.632
25 Lleida;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
25 Lleida;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
25 Lleida;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
25 Lleida;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QIII;5.752
25 Lleida;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
25 Lleida;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
25 Lleida;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
25 Lleida;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2022QIII;5.374
25 Lleida;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2022QII;""
25 Lleida;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2022QI;""
25 Lleida;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
25 Lleida;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2021QIII;5.530
25 Lleida;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2021QII;""
25 Lleida;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2021QI;""
25 Lleida;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
25 Lleida;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2020QIII;5.617
25 Lleida;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2020QII;""
25 Lleida;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2020QI;""
25 Lleida;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2022QIV;5.218
25 Lleida;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
25 Lleida;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2022QII;""
25 Lleida;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2022QI;""
25 Lleida;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2021QIV;5.407
25 Lleida;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
25 Lleida;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2021QII;""
25 Lleida;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2021QI;""
25 Lleida;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2020QIV;5.453
25 Lleida;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
25 Lleida;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2020QII;""
25 Lleida;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2020QI;""
25 Lleida;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
25 Lleida;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
25 Lleida;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QII;""
25 Lleida;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QI;5.312
25 Lleida;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
25 Lleida;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
25 Lleida;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QII;""
25 Lleida;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QI;5.364
25 Lleida;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
25 Lleida;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
25 Lleida;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QII;""
25 Lleida;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QI;""
25 Lleida;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
25 Lleida;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
25 Lleida;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QII;5.194
25 Lleida;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QI;""
25 Lleida;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
25 Lleida;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
25 Lleida;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QII;5.285
25 Lleida;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QI;""
25 Lleida;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
25 Lleida;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
25 Lleida;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QII;""
25 Lleida;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QI;""
25 Lleida;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
25 Lleida;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
25 Lleida;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
25 Lleida;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
25 Lleida;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
25 Lleida;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
25 Lleida;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
25 Lleida;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
25 Lleida;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
25 Lleida;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
25 Lleida;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
25 Lleida;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
25 Lleida;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
25 Lleida;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;97,58
25 Lleida;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
25 Lleida;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
25 Lleida;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
25 Lleida;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;98,19
25 Lleida;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
25 Lleida;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
25 Lleida;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
25 Lleida;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;97,65
25 Lleida;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
25 Lleida;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
25 Lleida;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;94,75
25 Lleida;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
25 Lleida;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
25 Lleida;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
25 Lleida;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;96
25 Lleida;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
25 Lleida;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
25 Lleida;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
25 Lleida;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;94,8
25 Lleida;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
25 Lleida;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
25 Lleida;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
25 Lleida;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
25 Lleida;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
25 Lleida;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
25 Lleida;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;94,32
25 Lleida;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
25 Lleida;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
25 Lleida;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
25 Lleida;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;93,25
25 Lleida;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
25 Lleida;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
25 Lleida;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
25 Lleida;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
25 Lleida;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
25 Lleida;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
25 Lleida;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;92,22
25 Lleida;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
25 Lleida;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
25 Lleida;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
25 Lleida;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;91,88
25 Lleida;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
25 Lleida;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
25 Lleida;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
25 Lleida;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
25 Lleida;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
25 Lleida;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
25 Lleida;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QIII;3.030
25 Lleida;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
25 Lleida;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
25 Lleida;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
25 Lleida;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QIII;3.142
25 Lleida;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
25 Lleida;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
25 Lleida;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
25 Lleida;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QIII;3.115
25 Lleida;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
25 Lleida;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
25 Lleida;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
25 Lleida;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2022QIII;2.942
25 Lleida;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2022QII;""
25 Lleida;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2022QI;""
25 Lleida;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
25 Lleida;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2021QIII;3.078
25 Lleida;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2021QII;""
25 Lleida;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2021QI;""
25 Lleida;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
25 Lleida;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2020QIII;3.018
25 Lleida;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2020QII;""
25 Lleida;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2020QI;""
25 Lleida;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2022QIV;2.873
25 Lleida;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
25 Lleida;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2022QII;""
25 Lleida;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2022QI;""
25 Lleida;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2021QIV;2.972
25 Lleida;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
25 Lleida;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2021QII;""
25 Lleida;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2021QI;""
25 Lleida;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2020QIV;2.935
25 Lleida;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
25 Lleida;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2020QII;""
25 Lleida;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2020QI;""
25 Lleida;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
25 Lleida;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
25 Lleida;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QII;""
25 Lleida;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QI;2.911
25 Lleida;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
25 Lleida;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
25 Lleida;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QII;""
25 Lleida;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QI;2.887
25 Lleida;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
25 Lleida;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
25 Lleida;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QII;""
25 Lleida;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QI;""
25 Lleida;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
25 Lleida;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
25 Lleida;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QII;2.837
25 Lleida;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QI;""
25 Lleida;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
25 Lleida;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
25 Lleida;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QII;2.838
25 Lleida;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QI;""
25 Lleida;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
25 Lleida;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
25 Lleida;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QII;""
25 Lleida;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QI;""
25 Lleida;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
25 Lleida;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
25 Lleida;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
25 Lleida;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
25 Lleida;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
25 Lleida;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
25 Lleida;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
25 Lleida;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
25 Lleida;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
25 Lleida;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
25 Lleida;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
25 Lleida;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
25 Lleida;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
25 Lleida;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;97,1
25 Lleida;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
25 Lleida;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
25 Lleida;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
25 Lleida;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;97,96
25 Lleida;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
25 Lleida;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
25 Lleida;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
25 Lleida;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;96,89
25 Lleida;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
25 Lleida;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
25 Lleida;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;94,82
25 Lleida;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
25 Lleida;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
25 Lleida;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
25 Lleida;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;94,59
25 Lleida;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
25 Lleida;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
25 Lleida;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
25 Lleida;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;94,22
25 Lleida;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
25 Lleida;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
25 Lleida;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
25 Lleida;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
25 Lleida;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
25 Lleida;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
25 Lleida;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;92,65
25 Lleida;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
25 Lleida;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
25 Lleida;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
25 Lleida;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;92,68
25 Lleida;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
25 Lleida;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
25 Lleida;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
25 Lleida;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
25 Lleida;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
25 Lleida;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
25 Lleida;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;90,29
25 Lleida;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
25 Lleida;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
25 Lleida;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
25 Lleida;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;91,11
25 Lleida;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
25 Lleida;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
25 Lleida;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
25 Lleida;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
25 Lleida;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
25 Lleida;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QIV;8.493
25 Lleida;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
25 Lleida;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
25 Lleida;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
25 Lleida;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QIV;8.785
25 Lleida;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
25 Lleida;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
25 Lleida;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
25 Lleida;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QIV;8.857
25 Lleida;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
25 Lleida;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
25 Lleida;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
25 Lleida;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2022QIV;8.249
25 Lleida;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
25 Lleida;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2022QII;""
25 Lleida;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2022QI;""
25 Lleida;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2021QIV;8.536
25 Lleida;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
25 Lleida;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2021QII;""
25 Lleida;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2021QI;""
25 Lleida;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2020QIV;8.588
25 Lleida;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
25 Lleida;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2020QII;""
25 Lleida;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2020QI;""
25 Lleida;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
25 Lleida;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
25 Lleida;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2022QII;""
25 Lleida;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2022QI;8.370
25 Lleida;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
25 Lleida;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
25 Lleida;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2021QII;""
25 Lleida;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2021QI;8.441
25 Lleida;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
25 Lleida;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
25 Lleida;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2020QII;""
25 Lleida;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2020QI;""
25 Lleida;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
25 Lleida;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
25 Lleida;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QII;8.167
25 Lleida;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QI;""
25 Lleida;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
25 Lleida;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
25 Lleida;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QII;8.305
25 Lleida;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QI;""
25 Lleida;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
25 Lleida;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
25 Lleida;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QII;""
25 Lleida;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QI;""
25 Lleida;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
25 Lleida;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QIII;8.012
25 Lleida;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QII;""
25 Lleida;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QI;""
25 Lleida;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
25 Lleida;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QIII;8.192
25 Lleida;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QII;""
25 Lleida;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QI;""
25 Lleida;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
25 Lleida;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
25 Lleida;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QII;""
25 Lleida;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QI;""
25 Lleida;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
25 Lleida;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
25 Lleida;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
25 Lleida;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
25 Lleida;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
25 Lleida;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
25 Lleida;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
25 Lleida;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
25 Lleida;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
25 Lleida;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
25 Lleida;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
25 Lleida;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
25 Lleida;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;97,13
25 Lleida;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
25 Lleida;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
25 Lleida;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
25 Lleida;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;97,17
25 Lleida;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
25 Lleida;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
25 Lleida;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
25 Lleida;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;96,96
25 Lleida;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
25 Lleida;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
25 Lleida;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
25 Lleida;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
25 Lleida;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
25 Lleida;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
25 Lleida;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;95,28
25 Lleida;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
25 Lleida;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
25 Lleida;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
25 Lleida;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;95,3
25 Lleida;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
25 Lleida;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
25 Lleida;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
25 Lleida;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
25 Lleida;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
25 Lleida;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
25 Lleida;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;92,97
25 Lleida;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
25 Lleida;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
25 Lleida;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
25 Lleida;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;93,77
25 Lleida;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
25 Lleida;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
25 Lleida;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
25 Lleida;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
25 Lleida;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
25 Lleida;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
25 Lleida;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;91,2
25 Lleida;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
25 Lleida;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
25 Lleida;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
25 Lleida;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;92,49
25 Lleida;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
25 Lleida;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
25 Lleida;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
25 Lleida;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
25 Lleida;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
25 Lleida;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
25 Lleida;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QIV;5.488
25 Lleida;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
25 Lleida;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
25 Lleida;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
25 Lleida;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QIV;5.637
25 Lleida;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
25 Lleida;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
25 Lleida;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
25 Lleida;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QIV;5.745
25 Lleida;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
25 Lleida;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
25 Lleida;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
25 Lleida;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2022QIV;5.320
25 Lleida;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
25 Lleida;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2022QII;""
25 Lleida;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2022QI;""
25 Lleida;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2021QIV;5.501
25 Lleida;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
25 Lleida;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2021QII;""
25 Lleida;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2021QI;""
25 Lleida;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2020QIV;5.567
25 Lleida;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
25 Lleida;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2020QII;""
25 Lleida;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2020QI;""
25 Lleida;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
25 Lleida;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
25 Lleida;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2022QII;""
25 Lleida;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2022QI;5.402
25 Lleida;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
25 Lleida;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
25 Lleida;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2021QII;""
25 Lleida;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2021QI;5.470
25 Lleida;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
25 Lleida;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
25 Lleida;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2020QII;""
25 Lleida;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2020QI;""
25 Lleida;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
25 Lleida;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
25 Lleida;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QII;5.275
25 Lleida;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QI;""
25 Lleida;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
25 Lleida;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
25 Lleida;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QII;5.387
25 Lleida;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QI;""
25 Lleida;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
25 Lleida;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
25 Lleida;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QII;""
25 Lleida;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QI;""
25 Lleida;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
25 Lleida;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QIII;5.179
25 Lleida;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QII;""
25 Lleida;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QI;""
25 Lleida;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
25 Lleida;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QIII;5.317
25 Lleida;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QII;""
25 Lleida;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QI;""
25 Lleida;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
25 Lleida;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
25 Lleida;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QII;""
25 Lleida;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QI;""
25 Lleida;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
25 Lleida;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
25 Lleida;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
25 Lleida;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
25 Lleida;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
25 Lleida;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
25 Lleida;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
25 Lleida;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
25 Lleida;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
25 Lleida;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
25 Lleida;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
25 Lleida;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
25 Lleida;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;96,94
25 Lleida;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
25 Lleida;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
25 Lleida;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
25 Lleida;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;97,59
25 Lleida;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
25 Lleida;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
25 Lleida;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
25 Lleida;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;96,9
25 Lleida;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
25 Lleida;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
25 Lleida;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
25 Lleida;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
25 Lleida;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
25 Lleida;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
25 Lleida;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;95,83
25 Lleida;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
25 Lleida;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
25 Lleida;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
25 Lleida;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;95,21
25 Lleida;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
25 Lleida;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
25 Lleida;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
25 Lleida;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
25 Lleida;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
25 Lleida;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
25 Lleida;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;93,58
25 Lleida;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
25 Lleida;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
25 Lleida;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
25 Lleida;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;93,77
25 Lleida;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
25 Lleida;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
25 Lleida;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
25 Lleida;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
25 Lleida;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
25 Lleida;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
25 Lleida;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;91,88
25 Lleida;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
25 Lleida;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
25 Lleida;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
25 Lleida;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;92,55
25 Lleida;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
25 Lleida;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
25 Lleida;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
25 Lleida;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
25 Lleida;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
25 Lleida;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
25 Lleida;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QIV;3.005
25 Lleida;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
25 Lleida;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
25 Lleida;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
25 Lleida;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QIV;3.148
25 Lleida;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
25 Lleida;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
25 Lleida;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
25 Lleida;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QIV;3.112
25 Lleida;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
25 Lleida;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
25 Lleida;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
25 Lleida;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2022QIV;2.929
25 Lleida;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
25 Lleida;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2022QII;""
25 Lleida;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2022QI;""
25 Lleida;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2021QIV;3.035
25 Lleida;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
25 Lleida;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2021QII;""
25 Lleida;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2021QI;""
25 Lleida;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2020QIV;3.021
25 Lleida;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
25 Lleida;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2020QII;""
25 Lleida;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2020QI;""
25 Lleida;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
25 Lleida;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
25 Lleida;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2022QII;""
25 Lleida;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2022QI;2.968
25 Lleida;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
25 Lleida;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
25 Lleida;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2021QII;""
25 Lleida;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2021QI;2.971
25 Lleida;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
25 Lleida;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
25 Lleida;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2020QII;""
25 Lleida;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2020QI;""
25 Lleida;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
25 Lleida;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
25 Lleida;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QII;2.892
25 Lleida;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QI;""
25 Lleida;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
25 Lleida;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
25 Lleida;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QII;2.918
25 Lleida;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QI;""
25 Lleida;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
25 Lleida;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
25 Lleida;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QII;""
25 Lleida;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QI;""
25 Lleida;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
25 Lleida;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QIII;2.833
25 Lleida;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QII;""
25 Lleida;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QI;""
25 Lleida;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
25 Lleida;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QIII;2.875
25 Lleida;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QII;""
25 Lleida;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QI;""
25 Lleida;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
25 Lleida;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
25 Lleida;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QII;""
25 Lleida;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QI;""
25 Lleida;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
25 Lleida;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
25 Lleida;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
25 Lleida;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
25 Lleida;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
25 Lleida;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
25 Lleida;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
25 Lleida;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
25 Lleida;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
25 Lleida;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
25 Lleida;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
25 Lleida;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
25 Lleida;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;97,47
25 Lleida;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
25 Lleida;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
25 Lleida;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
25 Lleida;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;96,41
25 Lleida;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
25 Lleida;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
25 Lleida;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
25 Lleida;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;97,08
25 Lleida;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
25 Lleida;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
25 Lleida;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
25 Lleida;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
25 Lleida;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
25 Lleida;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
25 Lleida;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;94,28
25 Lleida;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
25 Lleida;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
25 Lleida;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
25 Lleida;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;95,47
25 Lleida;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
25 Lleida;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
25 Lleida;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
25 Lleida;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
25 Lleida;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
25 Lleida;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
25 Lleida;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;91,87
25 Lleida;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
25 Lleida;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
25 Lleida;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
25 Lleida;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;93,77
25 Lleida;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
25 Lleida;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
25 Lleida;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
25 Lleida;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
25 Lleida;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
25 Lleida;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
25 Lleida;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;89,99
25 Lleida;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
25 Lleida;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
25 Lleida;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
25 Lleida;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;92,38
25 Lleida;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
25 Lleida;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
25 Lleida;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
25 Lleida;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
25 Lleida;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
25 Lleida;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
25 Lleida;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
25 Lleida;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
25 Lleida;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
25 Lleida;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QI;8.664
25 Lleida;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
25 Lleida;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
25 Lleida;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
25 Lleida;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QI;8.580
25 Lleida;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
25 Lleida;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
25 Lleida;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
25 Lleida;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QI;8.711
25 Lleida;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
25 Lleida;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
25 Lleida;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2022QII;""
25 Lleida;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2022QI;8.511
25 Lleida;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
25 Lleida;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
25 Lleida;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2021QII;""
25 Lleida;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2021QI;8.444
25 Lleida;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
25 Lleida;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
25 Lleida;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2020QII;""
25 Lleida;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2020QI;8.417
25 Lleida;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
25 Lleida;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
25 Lleida;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2022QII;8.351
25 Lleida;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2022QI;""
25 Lleida;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
25 Lleida;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
25 Lleida;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2021QII;8.350
25 Lleida;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2021QI;""
25 Lleida;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
25 Lleida;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
25 Lleida;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2020QII;8.325
25 Lleida;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2020QI;""
25 Lleida;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
25 Lleida;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QIII;8.225
25 Lleida;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QII;""
25 Lleida;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QI;""
25 Lleida;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
25 Lleida;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QIII;8.247
25 Lleida;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QII;""
25 Lleida;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QI;""
25 Lleida;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
25 Lleida;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QIII;8.214
25 Lleida;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QII;""
25 Lleida;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QI;""
25 Lleida;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QIV;8.088
25 Lleida;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
25 Lleida;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QII;""
25 Lleida;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QI;""
25 Lleida;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QIV;8.106
25 Lleida;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
25 Lleida;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QII;""
25 Lleida;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QI;""
25 Lleida;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QIV;8.087
25 Lleida;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
25 Lleida;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QII;""
25 Lleida;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QI;""
25 Lleida;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
25 Lleida;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
25 Lleida;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
25 Lleida;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
25 Lleida;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
25 Lleida;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
25 Lleida;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
25 Lleida;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
25 Lleida;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
25 Lleida;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
25 Lleida;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
25 Lleida;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
25 Lleida;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
25 Lleida;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
25 Lleida;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
25 Lleida;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;98,23
25 Lleida;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
25 Lleida;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
25 Lleida;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
25 Lleida;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;98,41
25 Lleida;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
25 Lleida;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
25 Lleida;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
25 Lleida;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;96,62
25 Lleida;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
25 Lleida;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
25 Lleida;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;96,39
25 Lleida;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
25 Lleida;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
25 Lleida;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
25 Lleida;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;97,32
25 Lleida;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
25 Lleida;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
25 Lleida;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
25 Lleida;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;95,57
25 Lleida;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
25 Lleida;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
25 Lleida;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;94,93
25 Lleida;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
25 Lleida;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
25 Lleida;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
25 Lleida;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;96,12
25 Lleida;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
25 Lleida;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
25 Lleida;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
25 Lleida;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;94,29
25 Lleida;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
25 Lleida;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
25 Lleida;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;93,35
25 Lleida;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
25 Lleida;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
25 Lleida;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
25 Lleida;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;94,48
25 Lleida;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
25 Lleida;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
25 Lleida;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
25 Lleida;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;92,84
25 Lleida;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
25 Lleida;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
25 Lleida;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
25 Lleida;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
25 Lleida;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
25 Lleida;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
25 Lleida;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QI;5.364
25 Lleida;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
25 Lleida;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
25 Lleida;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
25 Lleida;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QI;5.285
25 Lleida;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
25 Lleida;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
25 Lleida;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
25 Lleida;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QI;5.341
25 Lleida;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
25 Lleida;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
25 Lleida;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2022QII;""
25 Lleida;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2022QI;5.270
25 Lleida;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
25 Lleida;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
25 Lleida;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2021QII;""
25 Lleida;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2021QI;5.202
25 Lleida;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
25 Lleida;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
25 Lleida;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2020QII;""
25 Lleida;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2020QI;5.169
25 Lleida;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
25 Lleida;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
25 Lleida;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2022QII;5.168
25 Lleida;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2022QI;""
25 Lleida;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
25 Lleida;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
25 Lleida;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2021QII;5.148
25 Lleida;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2021QI;""
25 Lleida;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
25 Lleida;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
25 Lleida;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2020QII;5.122
25 Lleida;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2020QI;""
25 Lleida;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
25 Lleida;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QIII;5.087
25 Lleida;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QII;""
25 Lleida;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QI;""
25 Lleida;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
25 Lleida;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QIII;5.091
25 Lleida;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QII;""
25 Lleida;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QI;""
25 Lleida;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
25 Lleida;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QIII;5.055
25 Lleida;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QII;""
25 Lleida;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QI;""
25 Lleida;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QIV;5.006
25 Lleida;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
25 Lleida;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QII;""
25 Lleida;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QI;""
25 Lleida;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QIV;5.005
25 Lleida;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
25 Lleida;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QII;""
25 Lleida;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QI;""
25 Lleida;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QIV;4.983
25 Lleida;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
25 Lleida;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QII;""
25 Lleida;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QI;""
25 Lleida;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
25 Lleida;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
25 Lleida;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
25 Lleida;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
25 Lleida;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
25 Lleida;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
25 Lleida;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
25 Lleida;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
25 Lleida;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
25 Lleida;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
25 Lleida;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
25 Lleida;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
25 Lleida;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
25 Lleida;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
25 Lleida;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
25 Lleida;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;98,25
25 Lleida;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
25 Lleida;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
25 Lleida;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
25 Lleida;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;98,43
25 Lleida;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
25 Lleida;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
25 Lleida;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
25 Lleida;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;96,78
25 Lleida;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
25 Lleida;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
25 Lleida;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;96,35
25 Lleida;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
25 Lleida;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
25 Lleida;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
25 Lleida;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;97,41
25 Lleida;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
25 Lleida;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
25 Lleida;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
25 Lleida;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;95,9
25 Lleida;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
25 Lleida;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
25 Lleida;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;94,84
25 Lleida;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
25 Lleida;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
25 Lleida;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
25 Lleida;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;96,33
25 Lleida;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
25 Lleida;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
25 Lleida;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
25 Lleida;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;94,65
25 Lleida;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
25 Lleida;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
25 Lleida;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;93,33
25 Lleida;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
25 Lleida;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
25 Lleida;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
25 Lleida;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;94,7
25 Lleida;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
25 Lleida;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
25 Lleida;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
25 Lleida;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;93,3
25 Lleida;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
25 Lleida;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
25 Lleida;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
25 Lleida;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
25 Lleida;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
25 Lleida;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
25 Lleida;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QI;3.300
25 Lleida;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
25 Lleida;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
25 Lleida;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
25 Lleida;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QI;3.295
25 Lleida;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
25 Lleida;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
25 Lleida;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
25 Lleida;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QI;3.370
25 Lleida;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
25 Lleida;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
25 Lleida;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2022QII;""
25 Lleida;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2022QI;3.241
25 Lleida;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
25 Lleida;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
25 Lleida;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2021QII;""
25 Lleida;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2021QI;3.242
25 Lleida;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
25 Lleida;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
25 Lleida;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2020QII;""
25 Lleida;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2020QI;3.248
25 Lleida;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
25 Lleida;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
25 Lleida;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2022QII;3.183
25 Lleida;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2022QI;""
25 Lleida;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
25 Lleida;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
25 Lleida;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2021QII;3.202
25 Lleida;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2021QI;""
25 Lleida;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
25 Lleida;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
25 Lleida;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2020QII;3.203
25 Lleida;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2020QI;""
25 Lleida;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
25 Lleida;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QIII;3.138
25 Lleida;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QII;""
25 Lleida;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QI;""
25 Lleida;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
25 Lleida;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QIII;3.156
25 Lleida;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QII;""
25 Lleida;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QI;""
25 Lleida;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
25 Lleida;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QIII;3.159
25 Lleida;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QII;""
25 Lleida;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QI;""
25 Lleida;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QIV;3.082
25 Lleida;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
25 Lleida;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QII;""
25 Lleida;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QI;""
25 Lleida;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QIV;3.101
25 Lleida;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
25 Lleida;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QII;""
25 Lleida;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QI;""
25 Lleida;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QIV;3.104
25 Lleida;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
25 Lleida;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QII;""
25 Lleida;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QI;""
25 Lleida;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
25 Lleida;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
25 Lleida;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
25 Lleida;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
25 Lleida;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
25 Lleida;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
25 Lleida;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
25 Lleida;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
25 Lleida;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
25 Lleida;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
25 Lleida;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
25 Lleida;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
25 Lleida;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
25 Lleida;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
25 Lleida;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
25 Lleida;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;98,21
25 Lleida;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
25 Lleida;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
25 Lleida;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
25 Lleida;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;98,39
25 Lleida;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
25 Lleida;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
25 Lleida;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
25 Lleida;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;96,38
25 Lleida;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
25 Lleida;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
25 Lleida;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;96,45
25 Lleida;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
25 Lleida;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
25 Lleida;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
25 Lleida;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;97,18
25 Lleida;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
25 Lleida;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
25 Lleida;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
25 Lleida;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;95,04
25 Lleida;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
25 Lleida;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
25 Lleida;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;95,09
25 Lleida;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
25 Lleida;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
25 Lleida;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
25 Lleida;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;95,78
25 Lleida;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
25 Lleida;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
25 Lleida;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
25 Lleida;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;93,74
25 Lleida;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
25 Lleida;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
25 Lleida;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;93,39
25 Lleida;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
25 Lleida;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
25 Lleida;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
25 Lleida;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;94,11
25 Lleida;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
25 Lleida;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
25 Lleida;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
25 Lleida;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;92,11
25 Lleida;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
25 Lleida;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
25 Lleida;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
25 Lleida;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
25 Lleida;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
25 Lleida;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QII;8.720
25 Lleida;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
25 Lleida;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
25 Lleida;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
25 Lleida;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QII;8.647
25 Lleida;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
25 Lleida;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
25 Lleida;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
25 Lleida;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QII;8.617
25 Lleida;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
25 Lleida;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
25 Lleida;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
25 Lleida;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2022QII;8.534
25 Lleida;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2022QI;""
25 Lleida;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
25 Lleida;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
25 Lleida;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2021QII;8.538
25 Lleida;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2021QI;""
25 Lleida;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
25 Lleida;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
25 Lleida;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2020QII;8.513
25 Lleida;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2020QI;""
25 Lleida;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
25 Lleida;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2022QIII;8.397
25 Lleida;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2022QII;""
25 Lleida;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2022QI;""
25 Lleida;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
25 Lleida;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2021QIII;8.433
25 Lleida;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2021QII;""
25 Lleida;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2021QI;""
25 Lleida;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
25 Lleida;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2020QIII;8.378
25 Lleida;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2020QII;""
25 Lleida;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2020QI;""
25 Lleida;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QIV;8.247
25 Lleida;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
25 Lleida;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QII;""
25 Lleida;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QI;""
25 Lleida;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QIV;8.292
25 Lleida;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
25 Lleida;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QII;""
25 Lleida;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QI;""
25 Lleida;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QIV;8.244
25 Lleida;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
25 Lleida;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QII;""
25 Lleida;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QI;""
25 Lleida;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
25 Lleida;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
25 Lleida;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QII;""
25 Lleida;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QI;8.171
25 Lleida;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
25 Lleida;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
25 Lleida;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QII;""
25 Lleida;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QI;8.135
25 Lleida;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
25 Lleida;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
25 Lleida;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QII;""
25 Lleida;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QI;""
25 Lleida;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
25 Lleida;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
25 Lleida;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
25 Lleida;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
25 Lleida;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
25 Lleida;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
25 Lleida;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
25 Lleida;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
25 Lleida;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
25 Lleida;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
25 Lleida;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
25 Lleida;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
25 Lleida;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
25 Lleida;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
25 Lleida;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;97,87
25 Lleida;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
25 Lleida;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
25 Lleida;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
25 Lleida;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;98,74
25 Lleida;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
25 Lleida;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
25 Lleida;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
25 Lleida;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;98,79
25 Lleida;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
25 Lleida;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
25 Lleida;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;96,3
25 Lleida;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
25 Lleida;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
25 Lleida;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
25 Lleida;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;97,53
25 Lleida;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
25 Lleida;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
25 Lleida;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
25 Lleida;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;97,23
25 Lleida;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
25 Lleida;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
25 Lleida;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;94,58
25 Lleida;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
25 Lleida;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
25 Lleida;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
25 Lleida;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;95,89
25 Lleida;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
25 Lleida;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
25 Lleida;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
25 Lleida;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;95,67
25 Lleida;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
25 Lleida;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
25 Lleida;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
25 Lleida;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
25 Lleida;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
25 Lleida;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
25 Lleida;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;94,5
25 Lleida;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
25 Lleida;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
25 Lleida;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
25 Lleida;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;94,41
25 Lleida;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
25 Lleida;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
25 Lleida;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
25 Lleida;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
25 Lleida;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
25 Lleida;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
25 Lleida;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QII;5.404
25 Lleida;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
25 Lleida;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
25 Lleida;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
25 Lleida;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QII;5.353
25 Lleida;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
25 Lleida;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
25 Lleida;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
25 Lleida;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QII;5.296
25 Lleida;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
25 Lleida;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
25 Lleida;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
25 Lleida;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2022QII;5.288
25 Lleida;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2022QI;""
25 Lleida;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
25 Lleida;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
25 Lleida;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2021QII;5.291
25 Lleida;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2021QI;""
25 Lleida;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
25 Lleida;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
25 Lleida;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2020QII;5.242
25 Lleida;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2020QI;""
25 Lleida;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
25 Lleida;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2022QIII;5.197
25 Lleida;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2022QII;""
25 Lleida;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2022QI;""
25 Lleida;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
25 Lleida;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2021QIII;5.235
25 Lleida;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2021QII;""
25 Lleida;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2021QI;""
25 Lleida;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
25 Lleida;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2020QIII;5.159
25 Lleida;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2020QII;""
25 Lleida;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2020QI;""
25 Lleida;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QIV;5.111
25 Lleida;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
25 Lleida;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QII;""
25 Lleida;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QI;""
25 Lleida;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QIV;5.152
25 Lleida;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
25 Lleida;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QII;""
25 Lleida;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QI;""
25 Lleida;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QIV;5.082
25 Lleida;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
25 Lleida;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QII;""
25 Lleida;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QI;""
25 Lleida;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
25 Lleida;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
25 Lleida;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QII;""
25 Lleida;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QI;5.078
25 Lleida;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
25 Lleida;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
25 Lleida;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QII;""
25 Lleida;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QI;5.013
25 Lleida;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
25 Lleida;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
25 Lleida;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QII;""
25 Lleida;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QI;""
25 Lleida;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
25 Lleida;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
25 Lleida;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
25 Lleida;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
25 Lleida;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
25 Lleida;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
25 Lleida;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
25 Lleida;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
25 Lleida;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
25 Lleida;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
25 Lleida;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
25 Lleida;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
25 Lleida;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
25 Lleida;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
25 Lleida;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;97,85
25 Lleida;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
25 Lleida;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
25 Lleida;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
25 Lleida;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;98,84
25 Lleida;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
25 Lleida;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
25 Lleida;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
25 Lleida;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;98,98
25 Lleida;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
25 Lleida;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
25 Lleida;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;96,17
25 Lleida;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
25 Lleida;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
25 Lleida;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
25 Lleida;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;97,8
25 Lleida;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
25 Lleida;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
25 Lleida;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
25 Lleida;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;97,41
25 Lleida;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
25 Lleida;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
25 Lleida;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;94,58
25 Lleida;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
25 Lleida;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
25 Lleida;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
25 Lleida;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;96,25
25 Lleida;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
25 Lleida;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
25 Lleida;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
25 Lleida;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;95,96
25 Lleida;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
25 Lleida;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
25 Lleida;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
25 Lleida;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
25 Lleida;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
25 Lleida;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
25 Lleida;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;94,86
25 Lleida;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
25 Lleida;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
25 Lleida;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
25 Lleida;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;94,66
25 Lleida;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
25 Lleida;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
25 Lleida;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
25 Lleida;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
25 Lleida;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
25 Lleida;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
25 Lleida;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QII;3.316
25 Lleida;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
25 Lleida;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
25 Lleida;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
25 Lleida;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QII;3.294
25 Lleida;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
25 Lleida;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
25 Lleida;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
25 Lleida;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QII;3.321
25 Lleida;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
25 Lleida;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
25 Lleida;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
25 Lleida;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2022QII;3.246
25 Lleida;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2022QI;""
25 Lleida;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
25 Lleida;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
25 Lleida;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2021QII;3.247
25 Lleida;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2021QI;""
25 Lleida;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
25 Lleida;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
25 Lleida;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2020QII;3.271
25 Lleida;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2020QI;""
25 Lleida;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
25 Lleida;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2022QIII;3.200
25 Lleida;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2022QII;""
25 Lleida;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2022QI;""
25 Lleida;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
25 Lleida;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2021QIII;3.198
25 Lleida;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2021QII;""
25 Lleida;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2021QI;""
25 Lleida;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
25 Lleida;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2020QIII;3.219
25 Lleida;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2020QII;""
25 Lleida;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2020QI;""
25 Lleida;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QIV;3.136
25 Lleida;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
25 Lleida;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QII;""
25 Lleida;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QI;""
25 Lleida;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QIV;3.140
25 Lleida;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
25 Lleida;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QII;""
25 Lleida;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QI;""
25 Lleida;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QIV;3.162
25 Lleida;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
25 Lleida;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QII;""
25 Lleida;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QI;""
25 Lleida;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
25 Lleida;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
25 Lleida;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QII;""
25 Lleida;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QI;3.093
25 Lleida;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
25 Lleida;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
25 Lleida;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QII;""
25 Lleida;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QI;3.122
25 Lleida;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
25 Lleida;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
25 Lleida;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QII;""
25 Lleida;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QI;""
25 Lleida;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
25 Lleida;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
25 Lleida;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
25 Lleida;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
25 Lleida;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
25 Lleida;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
25 Lleida;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
25 Lleida;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
25 Lleida;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
25 Lleida;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
25 Lleida;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
25 Lleida;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
25 Lleida;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
25 Lleida;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
25 Lleida;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;97,89
25 Lleida;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
25 Lleida;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
25 Lleida;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
25 Lleida;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;98,57
25 Lleida;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
25 Lleida;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
25 Lleida;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
25 Lleida;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;98,49
25 Lleida;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
25 Lleida;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
25 Lleida;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;96,5
25 Lleida;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
25 Lleida;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
25 Lleida;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
25 Lleida;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;97,09
25 Lleida;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
25 Lleida;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
25 Lleida;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
25 Lleida;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;96,93
25 Lleida;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
25 Lleida;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
25 Lleida;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;94,57
25 Lleida;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
25 Lleida;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
25 Lleida;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
25 Lleida;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;95,32
25 Lleida;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
25 Lleida;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
25 Lleida;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
25 Lleida;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;95,21
25 Lleida;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
25 Lleida;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
25 Lleida;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
25 Lleida;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
25 Lleida;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
25 Lleida;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
25 Lleida;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;93,9
25 Lleida;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
25 Lleida;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
25 Lleida;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
25 Lleida;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;94,01
25 Lleida;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
25 Lleida;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
25 Lleida;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
25 Lleida;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
25 Lleida;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
25 Lleida;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QIII;8.691
25 Lleida;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
25 Lleida;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
25 Lleida;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
25 Lleida;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QIII;8.682
25 Lleida;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
25 Lleida;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
25 Lleida;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
25 Lleida;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QIII;8.640
25 Lleida;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
25 Lleida;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
25 Lleida;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
25 Lleida;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2022QIII;8.532
25 Lleida;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2022QII;""
25 Lleida;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2022QI;""
25 Lleida;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
25 Lleida;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2021QIII;8.551
25 Lleida;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2021QII;""
25 Lleida;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2021QI;""
25 Lleida;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
25 Lleida;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2020QIII;8.486
25 Lleida;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2020QII;""
25 Lleida;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2020QI;""
25 Lleida;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2022QIV;8.363
25 Lleida;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
25 Lleida;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2022QII;""
25 Lleida;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2022QI;""
25 Lleida;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2021QIV;8.402
25 Lleida;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
25 Lleida;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2021QII;""
25 Lleida;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2021QI;""
25 Lleida;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2020QIV;8.342
25 Lleida;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
25 Lleida;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2020QII;""
25 Lleida;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2020QI;""
25 Lleida;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
25 Lleida;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
25 Lleida;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QII;""
25 Lleida;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QI;8.275
25 Lleida;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
25 Lleida;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
25 Lleida;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QII;""
25 Lleida;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QI;8.230
25 Lleida;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
25 Lleida;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
25 Lleida;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QII;""
25 Lleida;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QI;""
25 Lleida;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
25 Lleida;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
25 Lleida;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QII;8.159
25 Lleida;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QI;""
25 Lleida;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
25 Lleida;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
25 Lleida;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QII;8.150
25 Lleida;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QI;""
25 Lleida;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
25 Lleida;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
25 Lleida;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QII;""
25 Lleida;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QI;""
25 Lleida;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
25 Lleida;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
25 Lleida;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
25 Lleida;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
25 Lleida;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
25 Lleida;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
25 Lleida;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
25 Lleida;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
25 Lleida;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
25 Lleida;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
25 Lleida;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
25 Lleida;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
25 Lleida;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
25 Lleida;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;98,17
25 Lleida;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
25 Lleida;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
25 Lleida;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
25 Lleida;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;98,49
25 Lleida;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
25 Lleida;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
25 Lleida;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
25 Lleida;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;98,22
25 Lleida;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
25 Lleida;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
25 Lleida;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;96,23
25 Lleida;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
25 Lleida;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
25 Lleida;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
25 Lleida;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;96,77
25 Lleida;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
25 Lleida;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
25 Lleida;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
25 Lleida;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;96,55
25 Lleida;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
25 Lleida;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
25 Lleida;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
25 Lleida;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
25 Lleida;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
25 Lleida;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
25 Lleida;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;95,31
25 Lleida;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
25 Lleida;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
25 Lleida;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
25 Lleida;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;95,25
25 Lleida;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
25 Lleida;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
25 Lleida;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
25 Lleida;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
25 Lleida;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
25 Lleida;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
25 Lleida;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;93,98
25 Lleida;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
25 Lleida;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
25 Lleida;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
25 Lleida;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;94,33
25 Lleida;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
25 Lleida;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
25 Lleida;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
25 Lleida;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
25 Lleida;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
25 Lleida;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
25 Lleida;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QIII;5.371
25 Lleida;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
25 Lleida;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
25 Lleida;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
25 Lleida;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QIII;5.376
25 Lleida;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
25 Lleida;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
25 Lleida;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
25 Lleida;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QIII;5.331
25 Lleida;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
25 Lleida;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
25 Lleida;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
25 Lleida;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2022QIII;5.266
25 Lleida;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2022QII;""
25 Lleida;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2022QI;""
25 Lleida;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
25 Lleida;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2021QIII;5.308
25 Lleida;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2021QII;""
25 Lleida;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2021QI;""
25 Lleida;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
25 Lleida;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2020QIII;5.239
25 Lleida;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2020QII;""
25 Lleida;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2020QI;""
25 Lleida;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2022QIV;5.170
25 Lleida;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
25 Lleida;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2022QII;""
25 Lleida;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2022QI;""
25 Lleida;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2021QIV;5.220
25 Lleida;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
25 Lleida;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2021QII;""
25 Lleida;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2021QI;""
25 Lleida;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2020QIV;5.154
25 Lleida;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
25 Lleida;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2020QII;""
25 Lleida;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2020QI;""
25 Lleida;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
25 Lleida;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
25 Lleida;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QII;""
25 Lleida;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QI;5.143
25 Lleida;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
25 Lleida;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
25 Lleida;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QII;""
25 Lleida;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QI;5.083
25 Lleida;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
25 Lleida;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
25 Lleida;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QII;""
25 Lleida;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QI;""
25 Lleida;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
25 Lleida;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
25 Lleida;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QII;5.066
25 Lleida;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QI;""
25 Lleida;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
25 Lleida;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
25 Lleida;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QII;5.034
25 Lleida;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QI;""
25 Lleida;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
25 Lleida;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
25 Lleida;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QII;""
25 Lleida;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QI;""
25 Lleida;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
25 Lleida;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
25 Lleida;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
25 Lleida;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
25 Lleida;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
25 Lleida;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
25 Lleida;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
25 Lleida;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
25 Lleida;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
25 Lleida;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
25 Lleida;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
25 Lleida;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
25 Lleida;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
25 Lleida;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;98,05
25 Lleida;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
25 Lleida;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
25 Lleida;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
25 Lleida;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;98,74
25 Lleida;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
25 Lleida;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
25 Lleida;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
25 Lleida;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;98,27
25 Lleida;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
25 Lleida;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
25 Lleida;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;96,26
25 Lleida;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
25 Lleida;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
25 Lleida;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
25 Lleida;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;97,1
25 Lleida;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
25 Lleida;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
25 Lleida;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
25 Lleida;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;96,68
25 Lleida;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
25 Lleida;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
25 Lleida;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
25 Lleida;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
25 Lleida;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
25 Lleida;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
25 Lleida;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;95,67
25 Lleida;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
25 Lleida;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
25 Lleida;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
25 Lleida;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;95,35
25 Lleida;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
25 Lleida;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
25 Lleida;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
25 Lleida;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
25 Lleida;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
25 Lleida;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
25 Lleida;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;94,23
25 Lleida;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
25 Lleida;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
25 Lleida;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
25 Lleida;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;94,43
25 Lleida;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
25 Lleida;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
25 Lleida;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
25 Lleida;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
25 Lleida;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
25 Lleida;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
25 Lleida;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QIII;3.320
25 Lleida;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
25 Lleida;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
25 Lleida;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
25 Lleida;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QIII;3.306
25 Lleida;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
25 Lleida;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
25 Lleida;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
25 Lleida;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QIII;3.309
25 Lleida;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
25 Lleida;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
25 Lleida;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
25 Lleida;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2022QIII;3.266
25 Lleida;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2022QII;""
25 Lleida;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2022QI;""
25 Lleida;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
25 Lleida;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2021QIII;3.243
25 Lleida;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2021QII;""
25 Lleida;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2021QI;""
25 Lleida;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
25 Lleida;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2020QIII;3.247
25 Lleida;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2020QII;""
25 Lleida;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2020QI;""
25 Lleida;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2022QIV;3.193
25 Lleida;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
25 Lleida;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2022QII;""
25 Lleida;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2022QI;""
25 Lleida;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2021QIV;3.182
25 Lleida;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
25 Lleida;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2021QII;""
25 Lleida;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2021QI;""
25 Lleida;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2020QIV;3.188
25 Lleida;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
25 Lleida;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2020QII;""
25 Lleida;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2020QI;""
25 Lleida;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
25 Lleida;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
25 Lleida;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QII;""
25 Lleida;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QI;3.132
25 Lleida;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
25 Lleida;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
25 Lleida;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QII;""
25 Lleida;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QI;3.147
25 Lleida;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
25 Lleida;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
25 Lleida;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QII;""
25 Lleida;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QI;""
25 Lleida;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
25 Lleida;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
25 Lleida;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QII;3.093
25 Lleida;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QI;""
25 Lleida;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
25 Lleida;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
25 Lleida;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QII;3.116
25 Lleida;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QI;""
25 Lleida;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
25 Lleida;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
25 Lleida;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QII;""
25 Lleida;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QI;""
25 Lleida;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
25 Lleida;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
25 Lleida;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
25 Lleida;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
25 Lleida;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
25 Lleida;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
25 Lleida;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
25 Lleida;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
25 Lleida;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
25 Lleida;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
25 Lleida;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
25 Lleida;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
25 Lleida;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
25 Lleida;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;98,37
25 Lleida;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
25 Lleida;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
25 Lleida;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
25 Lleida;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;98,09
25 Lleida;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
25 Lleida;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
25 Lleida;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
25 Lleida;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;98,13
25 Lleida;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
25 Lleida;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
25 Lleida;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;96,17
25 Lleida;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
25 Lleida;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
25 Lleida;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
25 Lleida;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;96,25
25 Lleida;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
25 Lleida;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
25 Lleida;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
25 Lleida;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;96,34
25 Lleida;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
25 Lleida;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
25 Lleida;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
25 Lleida;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
25 Lleida;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
25 Lleida;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
25 Lleida;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;94,74
25 Lleida;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
25 Lleida;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
25 Lleida;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
25 Lleida;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;95,1
25 Lleida;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
25 Lleida;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
25 Lleida;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
25 Lleida;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
25 Lleida;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
25 Lleida;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
25 Lleida;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;93,56
25 Lleida;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
25 Lleida;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
25 Lleida;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
25 Lleida;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;94,17
25 Lleida;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
25 Lleida;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
25 Lleida;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
25 Lleida;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
25 Lleida;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
25 Lleida;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QIV;8.641
25 Lleida;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
25 Lleida;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
25 Lleida;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
25 Lleida;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QIV;8.677
25 Lleida;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
25 Lleida;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
25 Lleida;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
25 Lleida;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QIV;8.613
25 Lleida;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
25 Lleida;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
25 Lleida;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
25 Lleida;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2022QIV;8.461
25 Lleida;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
25 Lleida;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2022QII;""
25 Lleida;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2022QI;""
25 Lleida;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2021QIV;8.514
25 Lleida;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
25 Lleida;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2021QII;""
25 Lleida;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2021QI;""
25 Lleida;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2020QIV;8.455
25 Lleida;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
25 Lleida;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2020QII;""
25 Lleida;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2020QI;""
25 Lleida;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
25 Lleida;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
25 Lleida;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2022QII;""
25 Lleida;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2022QI;8.381
25 Lleida;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
25 Lleida;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
25 Lleida;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2021QII;""
25 Lleida;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2021QI;8.337
25 Lleida;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
25 Lleida;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
25 Lleida;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2020QII;""
25 Lleida;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2020QI;""
25 Lleida;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
25 Lleida;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
25 Lleida;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QII;8.255
25 Lleida;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QI;""
25 Lleida;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
25 Lleida;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
25 Lleida;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QII;8.250
25 Lleida;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QI;""
25 Lleida;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
25 Lleida;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
25 Lleida;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QII;""
25 Lleida;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QI;""
25 Lleida;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
25 Lleida;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QIII;8.136
25 Lleida;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QII;""
25 Lleida;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QI;""
25 Lleida;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
25 Lleida;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QIII;8.154
25 Lleida;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QII;""
25 Lleida;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QI;""
25 Lleida;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
25 Lleida;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
25 Lleida;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QII;""
25 Lleida;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QI;""
25 Lleida;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
25 Lleida;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
25 Lleida;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
25 Lleida;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
25 Lleida;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
25 Lleida;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
25 Lleida;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
25 Lleida;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
25 Lleida;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
25 Lleida;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
25 Lleida;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
25 Lleida;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
25 Lleida;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;97,92
25 Lleida;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
25 Lleida;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
25 Lleida;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
25 Lleida;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;98,12
25 Lleida;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
25 Lleida;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
25 Lleida;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
25 Lleida;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;98,17
25 Lleida;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
25 Lleida;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
25 Lleida;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
25 Lleida;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
25 Lleida;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
25 Lleida;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
25 Lleida;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;96,59
25 Lleida;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
25 Lleida;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
25 Lleida;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
25 Lleida;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;96,8
25 Lleida;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
25 Lleida;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
25 Lleida;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
25 Lleida;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
25 Lleida;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
25 Lleida;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
25 Lleida;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;95,14
25 Lleida;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
25 Lleida;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
25 Lleida;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
25 Lleida;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;95,79
25 Lleida;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
25 Lleida;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
25 Lleida;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
25 Lleida;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
25 Lleida;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
25 Lleida;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
25 Lleida;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;93,77
25 Lleida;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
25 Lleida;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
25 Lleida;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
25 Lleida;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;94,67
25 Lleida;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
25 Lleida;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
25 Lleida;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
25 Lleida;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
25 Lleida;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
25 Lleida;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
25 Lleida;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QIV;5.318
25 Lleida;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
25 Lleida;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
25 Lleida;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
25 Lleida;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QIV;5.393
25 Lleida;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
25 Lleida;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
25 Lleida;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
25 Lleida;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QIV;5.304
25 Lleida;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
25 Lleida;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
25 Lleida;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
25 Lleida;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2022QIV;5.216
25 Lleida;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
25 Lleida;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2022QII;""
25 Lleida;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2022QI;""
25 Lleida;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2021QIV;5.295
25 Lleida;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
25 Lleida;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2021QII;""
25 Lleida;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2021QI;""
25 Lleida;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2020QIV;5.208
25 Lleida;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
25 Lleida;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2020QII;""
25 Lleida;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2020QI;""
25 Lleida;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
25 Lleida;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
25 Lleida;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2022QII;""
25 Lleida;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2022QI;5.213
25 Lleida;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
25 Lleida;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
25 Lleida;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2021QII;""
25 Lleida;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2021QI;5.135
25 Lleida;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
25 Lleida;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
25 Lleida;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2020QII;""
25 Lleida;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2020QI;""
25 Lleida;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
25 Lleida;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
25 Lleida;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QII;5.130
25 Lleida;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QI;""
25 Lleida;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
25 Lleida;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
25 Lleida;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QII;5.085
25 Lleida;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QI;""
25 Lleida;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
25 Lleida;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
25 Lleida;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QII;""
25 Lleida;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QI;""
25 Lleida;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
25 Lleida;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QIII;5.052
25 Lleida;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QII;""
25 Lleida;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QI;""
25 Lleida;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
25 Lleida;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QIII;5.031
25 Lleida;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QII;""
25 Lleida;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QI;""
25 Lleida;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
25 Lleida;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
25 Lleida;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QII;""
25 Lleida;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QI;""
25 Lleida;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
25 Lleida;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
25 Lleida;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
25 Lleida;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
25 Lleida;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
25 Lleida;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
25 Lleida;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
25 Lleida;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
25 Lleida;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
25 Lleida;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
25 Lleida;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
25 Lleida;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
25 Lleida;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;98,08
25 Lleida;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
25 Lleida;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
25 Lleida;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
25 Lleida;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;98,18
25 Lleida;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
25 Lleida;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
25 Lleida;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
25 Lleida;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;98,19
25 Lleida;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
25 Lleida;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
25 Lleida;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
25 Lleida;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
25 Lleida;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
25 Lleida;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
25 Lleida;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;96,66
25 Lleida;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
25 Lleida;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
25 Lleida;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
25 Lleida;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;96,81
25 Lleida;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
25 Lleida;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
25 Lleida;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
25 Lleida;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
25 Lleida;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
25 Lleida;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
25 Lleida;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;95,12
25 Lleida;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
25 Lleida;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
25 Lleida;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
25 Lleida;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;95,87
25 Lleida;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
25 Lleida;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
25 Lleida;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
25 Lleida;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
25 Lleida;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
25 Lleida;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
25 Lleida;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;93,68
25 Lleida;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
25 Lleida;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
25 Lleida;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
25 Lleida;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;94,85
25 Lleida;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
25 Lleida;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
25 Lleida;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
25 Lleida;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
25 Lleida;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
25 Lleida;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
25 Lleida;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QIV;3.323
25 Lleida;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
25 Lleida;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
25 Lleida;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
25 Lleida;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QIV;3.284
25 Lleida;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
25 Lleida;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
25 Lleida;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
25 Lleida;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QIV;3.309
25 Lleida;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
25 Lleida;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
25 Lleida;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
25 Lleida;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2022QIV;3.245
25 Lleida;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
25 Lleida;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2022QII;""
25 Lleida;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2022QI;""
25 Lleida;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2021QIV;3.219
25 Lleida;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
25 Lleida;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2021QII;""
25 Lleida;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2021QI;""
25 Lleida;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2020QIV;3.247
25 Lleida;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
25 Lleida;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2020QII;""
25 Lleida;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2020QI;""
25 Lleida;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
25 Lleida;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
25 Lleida;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2022QII;""
25 Lleida;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2022QI;3.168
25 Lleida;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
25 Lleida;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
25 Lleida;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2021QII;""
25 Lleida;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2021QI;3.202
25 Lleida;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
25 Lleida;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
25 Lleida;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2020QII;""
25 Lleida;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2020QI;""
25 Lleida;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
25 Lleida;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
25 Lleida;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QII;3.125
25 Lleida;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QI;""
25 Lleida;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
25 Lleida;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
25 Lleida;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QII;3.165
25 Lleida;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QI;""
25 Lleida;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
25 Lleida;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
25 Lleida;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QII;""
25 Lleida;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QI;""
25 Lleida;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
25 Lleida;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QIII;3.084
25 Lleida;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QII;""
25 Lleida;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QI;""
25 Lleida;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
25 Lleida;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QIII;3.123
25 Lleida;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QII;""
25 Lleida;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QI;""
25 Lleida;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
25 Lleida;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
25 Lleida;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QII;""
25 Lleida;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QI;""
25 Lleida;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
25 Lleida;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
25 Lleida;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
25 Lleida;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
25 Lleida;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
25 Lleida;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
25 Lleida;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
25 Lleida;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
25 Lleida;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
25 Lleida;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
25 Lleida;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
25 Lleida;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
25 Lleida;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;97,65
25 Lleida;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
25 Lleida;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
25 Lleida;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
25 Lleida;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;98,02
25 Lleida;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
25 Lleida;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
25 Lleida;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
25 Lleida;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;98,13
25 Lleida;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
25 Lleida;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
25 Lleida;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
25 Lleida;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
25 Lleida;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
25 Lleida;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
25 Lleida;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;96,47
25 Lleida;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
25 Lleida;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
25 Lleida;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
25 Lleida;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;96,77
25 Lleida;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
25 Lleida;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
25 Lleida;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
25 Lleida;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
25 Lleida;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
25 Lleida;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
25 Lleida;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;95,16
25 Lleida;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
25 Lleida;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
25 Lleida;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
25 Lleida;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;95,65
25 Lleida;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
25 Lleida;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
25 Lleida;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
25 Lleida;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
25 Lleida;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
25 Lleida;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
25 Lleida;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;93,91
25 Lleida;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
25 Lleida;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
25 Lleida;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
25 Lleida;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;94,38
25 Lleida;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
25 Lleida;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
25 Lleida;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
25 Lleida;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
25 Lleida;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
25 Lleida;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
25 Lleida;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
25 Lleida;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
25 Lleida;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
25 Lleida;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QI;4.906
25 Lleida;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
25 Lleida;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
25 Lleida;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
25 Lleida;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QI;4.709
25 Lleida;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
25 Lleida;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
25 Lleida;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
25 Lleida;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QI;5.376
25 Lleida;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
25 Lleida;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
25 Lleida;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2022QII;""
25 Lleida;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2022QI;4.756
25 Lleida;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
25 Lleida;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
25 Lleida;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2021QII;""
25 Lleida;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2021QI;4.540
25 Lleida;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
25 Lleida;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
25 Lleida;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2020QII;""
25 Lleida;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2020QI;5.053
25 Lleida;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
25 Lleida;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
25 Lleida;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2022QII;4.572
25 Lleida;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2022QI;""
25 Lleida;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
25 Lleida;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
25 Lleida;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2021QII;4.394
25 Lleida;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2021QI;""
25 Lleida;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
25 Lleida;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
25 Lleida;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2020QII;4.898
25 Lleida;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2020QI;""
25 Lleida;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
25 Lleida;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QIII;4.410
25 Lleida;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QII;""
25 Lleida;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QI;""
25 Lleida;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
25 Lleida;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QIII;4.233
25 Lleida;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QII;""
25 Lleida;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QI;""
25 Lleida;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
25 Lleida;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QIII;4.746
25 Lleida;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QII;""
25 Lleida;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QI;""
25 Lleida;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QIV;4.125
25 Lleida;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
25 Lleida;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QII;""
25 Lleida;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QI;""
25 Lleida;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QIV;4.019
25 Lleida;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
25 Lleida;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QII;""
25 Lleida;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QI;""
25 Lleida;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QIV;4.531
25 Lleida;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
25 Lleida;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QII;""
25 Lleida;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QI;""
25 Lleida;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
25 Lleida;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
25 Lleida;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
25 Lleida;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
25 Lleida;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
25 Lleida;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
25 Lleida;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
25 Lleida;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
25 Lleida;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
25 Lleida;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
25 Lleida;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
25 Lleida;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
25 Lleida;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
25 Lleida;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
25 Lleida;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
25 Lleida;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;96,94
25 Lleida;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
25 Lleida;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
25 Lleida;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
25 Lleida;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;96,41
25 Lleida;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
25 Lleida;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
25 Lleida;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
25 Lleida;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;93,99
25 Lleida;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
25 Lleida;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
25 Lleida;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;93,19
25 Lleida;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
25 Lleida;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
25 Lleida;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
25 Lleida;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;93,31
25 Lleida;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
25 Lleida;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
25 Lleida;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
25 Lleida;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;91,11
25 Lleida;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
25 Lleida;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
25 Lleida;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;89,89
25 Lleida;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
25 Lleida;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
25 Lleida;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
25 Lleida;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;89,89
25 Lleida;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
25 Lleida;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
25 Lleida;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
25 Lleida;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;88,28
25 Lleida;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
25 Lleida;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
25 Lleida;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;84,08
25 Lleida;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
25 Lleida;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
25 Lleida;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
25 Lleida;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;85,35
25 Lleida;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
25 Lleida;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
25 Lleida;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
25 Lleida;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;84,28
25 Lleida;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
25 Lleida;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
25 Lleida;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
25 Lleida;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
25 Lleida;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
25 Lleida;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
25 Lleida;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QI;3.096
25 Lleida;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
25 Lleida;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
25 Lleida;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
25 Lleida;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QI;2.975
25 Lleida;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
25 Lleida;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
25 Lleida;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
25 Lleida;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QI;3.387
25 Lleida;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
25 Lleida;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
25 Lleida;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2022QII;""
25 Lleida;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2022QI;3.006
25 Lleida;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
25 Lleida;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
25 Lleida;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2021QII;""
25 Lleida;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2021QI;2.867
25 Lleida;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
25 Lleida;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
25 Lleida;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2020QII;""
25 Lleida;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2020QI;3.182
25 Lleida;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
25 Lleida;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
25 Lleida;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2022QII;2.901
25 Lleida;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2022QI;""
25 Lleida;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
25 Lleida;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
25 Lleida;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2021QII;2.780
25 Lleida;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2021QI;""
25 Lleida;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
25 Lleida;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
25 Lleida;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2020QII;3.104
25 Lleida;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2020QI;""
25 Lleida;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
25 Lleida;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QIII;2.812
25 Lleida;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QII;""
25 Lleida;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QI;""
25 Lleida;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
25 Lleida;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QIII;2.680
25 Lleida;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QII;""
25 Lleida;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QI;""
25 Lleida;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
25 Lleida;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QIII;3.009
25 Lleida;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QII;""
25 Lleida;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QI;""
25 Lleida;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QIV;2.627
25 Lleida;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
25 Lleida;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QII;""
25 Lleida;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QI;""
25 Lleida;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QIV;2.554
25 Lleida;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
25 Lleida;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QII;""
25 Lleida;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QI;""
25 Lleida;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QIV;2.867
25 Lleida;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
25 Lleida;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QII;""
25 Lleida;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QI;""
25 Lleida;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
25 Lleida;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
25 Lleida;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
25 Lleida;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
25 Lleida;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
25 Lleida;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
25 Lleida;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
25 Lleida;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
25 Lleida;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
25 Lleida;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
25 Lleida;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
25 Lleida;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
25 Lleida;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
25 Lleida;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
25 Lleida;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
25 Lleida;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;97,09
25 Lleida;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
25 Lleida;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
25 Lleida;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
25 Lleida;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;96,37
25 Lleida;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
25 Lleida;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
25 Lleida;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
25 Lleida;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;93,95
25 Lleida;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
25 Lleida;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
25 Lleida;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;93,7
25 Lleida;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
25 Lleida;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
25 Lleida;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
25 Lleida;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;93,45
25 Lleida;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
25 Lleida;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
25 Lleida;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
25 Lleida;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;91,64
25 Lleida;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
25 Lleida;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
25 Lleida;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;90,83
25 Lleida;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
25 Lleida;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
25 Lleida;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
25 Lleida;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;90,08
25 Lleida;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
25 Lleida;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
25 Lleida;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
25 Lleida;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;88,84
25 Lleida;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
25 Lleida;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
25 Lleida;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;84,85
25 Lleida;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
25 Lleida;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
25 Lleida;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
25 Lleida;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;85,85
25 Lleida;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
25 Lleida;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
25 Lleida;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
25 Lleida;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;84,65
25 Lleida;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
25 Lleida;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
25 Lleida;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
25 Lleida;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
25 Lleida;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
25 Lleida;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
25 Lleida;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QI;1.810
25 Lleida;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
25 Lleida;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
25 Lleida;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
25 Lleida;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QI;1.734
25 Lleida;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
25 Lleida;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
25 Lleida;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
25 Lleida;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QI;1.989
25 Lleida;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
25 Lleida;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
25 Lleida;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2022QII;""
25 Lleida;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2022QI;1.750
25 Lleida;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
25 Lleida;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
25 Lleida;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2021QII;""
25 Lleida;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2021QI;1.673
25 Lleida;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
25 Lleida;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
25 Lleida;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2020QII;""
25 Lleida;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2020QI;1.871
25 Lleida;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
25 Lleida;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
25 Lleida;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2022QII;1.671
25 Lleida;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2022QI;""
25 Lleida;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
25 Lleida;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
25 Lleida;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2021QII;1.614
25 Lleida;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2021QI;""
25 Lleida;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
25 Lleida;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
25 Lleida;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2020QII;1.794
25 Lleida;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2020QI;""
25 Lleida;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
25 Lleida;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QIII;1.598
25 Lleida;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QII;""
25 Lleida;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QI;""
25 Lleida;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
25 Lleida;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QIII;1.553
25 Lleida;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QII;""
25 Lleida;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QI;""
25 Lleida;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
25 Lleida;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QIII;1.737
25 Lleida;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QII;""
25 Lleida;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QI;""
25 Lleida;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QIV;1.498
25 Lleida;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
25 Lleida;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QII;""
25 Lleida;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QI;""
25 Lleida;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QIV;1.465
25 Lleida;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
25 Lleida;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QII;""
25 Lleida;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QI;""
25 Lleida;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QIV;1.664
25 Lleida;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
25 Lleida;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QII;""
25 Lleida;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QI;""
25 Lleida;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
25 Lleida;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
25 Lleida;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
25 Lleida;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
25 Lleida;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
25 Lleida;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
25 Lleida;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
25 Lleida;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
25 Lleida;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
25 Lleida;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
25 Lleida;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
25 Lleida;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
25 Lleida;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
25 Lleida;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
25 Lleida;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
25 Lleida;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;96,69
25 Lleida;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
25 Lleida;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
25 Lleida;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
25 Lleida;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;96,48
25 Lleida;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
25 Lleida;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
25 Lleida;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
25 Lleida;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;94,07
25 Lleida;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
25 Lleida;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
25 Lleida;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;92,32
25 Lleida;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
25 Lleida;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
25 Lleida;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
25 Lleida;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;93,08
25 Lleida;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
25 Lleida;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
25 Lleida;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
25 Lleida;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;90,2
25 Lleida;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
25 Lleida;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
25 Lleida;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;88,29
25 Lleida;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
25 Lleida;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
25 Lleida;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
25 Lleida;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;89,56
25 Lleida;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
25 Lleida;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
25 Lleida;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
25 Lleida;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;87,33
25 Lleida;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
25 Lleida;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
25 Lleida;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;82,76
25 Lleida;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
25 Lleida;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
25 Lleida;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
25 Lleida;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;84,49
25 Lleida;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
25 Lleida;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
25 Lleida;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
25 Lleida;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;83,66
25 Lleida;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
25 Lleida;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
25 Lleida;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
25 Lleida;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
25 Lleida;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
25 Lleida;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QII;5.598
25 Lleida;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
25 Lleida;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
25 Lleida;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
25 Lleida;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QII;5.377
25 Lleida;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
25 Lleida;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
25 Lleida;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
25 Lleida;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QII;5.186
25 Lleida;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
25 Lleida;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
25 Lleida;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
25 Lleida;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2022QII;5.401
25 Lleida;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2022QI;""
25 Lleida;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
25 Lleida;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
25 Lleida;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2021QII;5.218
25 Lleida;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2021QI;""
25 Lleida;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
25 Lleida;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
25 Lleida;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2020QII;5.025
25 Lleida;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2020QI;""
25 Lleida;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
25 Lleida;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2022QIII;5.226
25 Lleida;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2022QII;""
25 Lleida;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2022QI;""
25 Lleida;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
25 Lleida;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2021QIII;5.039
25 Lleida;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2021QII;""
25 Lleida;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2021QI;""
25 Lleida;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
25 Lleida;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2020QIII;4.826
25 Lleida;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2020QII;""
25 Lleida;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2020QI;""
25 Lleida;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QIV;4.925
25 Lleida;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
25 Lleida;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QII;""
25 Lleida;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QI;""
25 Lleida;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QIV;4.800
25 Lleida;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
25 Lleida;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QII;""
25 Lleida;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QI;""
25 Lleida;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QIV;4.608
25 Lleida;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
25 Lleida;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QII;""
25 Lleida;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QI;""
25 Lleida;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
25 Lleida;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
25 Lleida;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QII;""
25 Lleida;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QI;4.661
25 Lleida;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
25 Lleida;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
25 Lleida;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QII;""
25 Lleida;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QI;4.446
25 Lleida;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
25 Lleida;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
25 Lleida;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QII;""
25 Lleida;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QI;""
25 Lleida;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
25 Lleida;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
25 Lleida;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
25 Lleida;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
25 Lleida;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
25 Lleida;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
25 Lleida;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
25 Lleida;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
25 Lleida;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
25 Lleida;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
25 Lleida;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
25 Lleida;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
25 Lleida;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
25 Lleida;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
25 Lleida;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;96,48
25 Lleida;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
25 Lleida;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
25 Lleida;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
25 Lleida;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;97,04
25 Lleida;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
25 Lleida;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
25 Lleida;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
25 Lleida;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;96,9
25 Lleida;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
25 Lleida;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
25 Lleida;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;93,35
25 Lleida;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
25 Lleida;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
25 Lleida;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
25 Lleida;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;93,71
25 Lleida;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
25 Lleida;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
25 Lleida;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
25 Lleida;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;93,06
25 Lleida;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
25 Lleida;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
25 Lleida;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;87,98
25 Lleida;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
25 Lleida;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
25 Lleida;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
25 Lleida;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;89,27
25 Lleida;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
25 Lleida;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
25 Lleida;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
25 Lleida;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;88,85
25 Lleida;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
25 Lleida;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
25 Lleida;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
25 Lleida;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
25 Lleida;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
25 Lleida;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
25 Lleida;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;86,68
25 Lleida;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
25 Lleida;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
25 Lleida;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
25 Lleida;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;85,73
25 Lleida;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
25 Lleida;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
25 Lleida;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
25 Lleida;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
25 Lleida;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
25 Lleida;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
25 Lleida;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QII;3.521
25 Lleida;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
25 Lleida;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
25 Lleida;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
25 Lleida;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QII;3.382
25 Lleida;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
25 Lleida;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
25 Lleida;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
25 Lleida;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QII;3.266
25 Lleida;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
25 Lleida;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
25 Lleida;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
25 Lleida;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2022QII;3.406
25 Lleida;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2022QI;""
25 Lleida;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
25 Lleida;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
25 Lleida;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2021QII;3.288
25 Lleida;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2021QI;""
25 Lleida;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
25 Lleida;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
25 Lleida;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2020QII;3.183
25 Lleida;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2020QI;""
25 Lleida;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
25 Lleida;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2022QIII;3.310
25 Lleida;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2022QII;""
25 Lleida;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2022QI;""
25 Lleida;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
25 Lleida;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2021QIII;3.175
25 Lleida;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2021QII;""
25 Lleida;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2021QI;""
25 Lleida;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
25 Lleida;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2020QIII;3.059
25 Lleida;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2020QII;""
25 Lleida;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2020QI;""
25 Lleida;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QIV;3.114
25 Lleida;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
25 Lleida;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QII;""
25 Lleida;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QI;""
25 Lleida;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QIV;3.034
25 Lleida;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
25 Lleida;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QII;""
25 Lleida;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QI;""
25 Lleida;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QIV;2.915
25 Lleida;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
25 Lleida;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QII;""
25 Lleida;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QI;""
25 Lleida;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
25 Lleida;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
25 Lleida;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QII;""
25 Lleida;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QI;2.949
25 Lleida;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
25 Lleida;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
25 Lleida;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QII;""
25 Lleida;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QI;2.811
25 Lleida;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
25 Lleida;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
25 Lleida;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QII;""
25 Lleida;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QI;""
25 Lleida;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
25 Lleida;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
25 Lleida;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
25 Lleida;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
25 Lleida;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
25 Lleida;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
25 Lleida;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
25 Lleida;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
25 Lleida;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
25 Lleida;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
25 Lleida;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
25 Lleida;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
25 Lleida;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
25 Lleida;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
25 Lleida;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;96,73
25 Lleida;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
25 Lleida;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
25 Lleida;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
25 Lleida;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;97,22
25 Lleida;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
25 Lleida;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
25 Lleida;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
25 Lleida;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;97,46
25 Lleida;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
25 Lleida;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
25 Lleida;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;94,01
25 Lleida;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
25 Lleida;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
25 Lleida;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
25 Lleida;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;93,88
25 Lleida;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
25 Lleida;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
25 Lleida;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
25 Lleida;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;93,66
25 Lleida;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
25 Lleida;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
25 Lleida;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;88,44
25 Lleida;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
25 Lleida;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
25 Lleida;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
25 Lleida;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;89,71
25 Lleida;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
25 Lleida;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
25 Lleida;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
25 Lleida;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;89,25
25 Lleida;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
25 Lleida;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
25 Lleida;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
25 Lleida;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
25 Lleida;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
25 Lleida;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
25 Lleida;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;87,2
25 Lleida;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
25 Lleida;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
25 Lleida;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
25 Lleida;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;86,07
25 Lleida;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
25 Lleida;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
25 Lleida;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
25 Lleida;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
25 Lleida;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
25 Lleida;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
25 Lleida;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QII;2.077
25 Lleida;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
25 Lleida;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
25 Lleida;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
25 Lleida;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QII;1.995
25 Lleida;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
25 Lleida;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
25 Lleida;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
25 Lleida;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QII;1.920
25 Lleida;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
25 Lleida;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
25 Lleida;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
25 Lleida;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2022QII;1.995
25 Lleida;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2022QI;""
25 Lleida;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
25 Lleida;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
25 Lleida;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2021QII;1.930
25 Lleida;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2021QI;""
25 Lleida;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
25 Lleida;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
25 Lleida;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2020QII;1.842
25 Lleida;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2020QI;""
25 Lleida;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
25 Lleida;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2022QIII;1.916
25 Lleida;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2022QII;""
25 Lleida;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2022QI;""
25 Lleida;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
25 Lleida;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2021QIII;1.864
25 Lleida;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2021QII;""
25 Lleida;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2021QI;""
25 Lleida;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
25 Lleida;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2020QIII;1.767
25 Lleida;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2020QII;""
25 Lleida;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2020QI;""
25 Lleida;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QIV;1.811
25 Lleida;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
25 Lleida;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QII;""
25 Lleida;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QI;""
25 Lleida;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QIV;1.766
25 Lleida;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
25 Lleida;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QII;""
25 Lleida;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QI;""
25 Lleida;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QIV;1.693
25 Lleida;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
25 Lleida;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QII;""
25 Lleida;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QI;""
25 Lleida;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
25 Lleida;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
25 Lleida;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QII;""
25 Lleida;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QI;1.712
25 Lleida;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
25 Lleida;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
25 Lleida;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QII;""
25 Lleida;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QI;1.635
25 Lleida;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
25 Lleida;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
25 Lleida;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QII;""
25 Lleida;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QI;""
25 Lleida;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
25 Lleida;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
25 Lleida;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
25 Lleida;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
25 Lleida;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
25 Lleida;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
25 Lleida;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
25 Lleida;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
25 Lleida;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
25 Lleida;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
25 Lleida;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
25 Lleida;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
25 Lleida;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
25 Lleida;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
25 Lleida;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;96,05
25 Lleida;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
25 Lleida;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
25 Lleida;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
25 Lleida;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;96,74
25 Lleida;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
25 Lleida;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
25 Lleida;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
25 Lleida;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;95,94
25 Lleida;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
25 Lleida;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
25 Lleida;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;92,25
25 Lleida;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
25 Lleida;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
25 Lleida;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
25 Lleida;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;93,43
25 Lleida;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
25 Lleida;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
25 Lleida;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
25 Lleida;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;92,03
25 Lleida;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
25 Lleida;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
25 Lleida;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;87,19
25 Lleida;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
25 Lleida;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
25 Lleida;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
25 Lleida;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;88,52
25 Lleida;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
25 Lleida;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
25 Lleida;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
25 Lleida;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;88,18
25 Lleida;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
25 Lleida;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
25 Lleida;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
25 Lleida;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
25 Lleida;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
25 Lleida;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
25 Lleida;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;85,81
25 Lleida;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
25 Lleida;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
25 Lleida;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
25 Lleida;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;85,16
25 Lleida;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
25 Lleida;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
25 Lleida;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
25 Lleida;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
25 Lleida;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
25 Lleida;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QIII;5.443
25 Lleida;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
25 Lleida;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
25 Lleida;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
25 Lleida;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QIII;5.275
25 Lleida;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
25 Lleida;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
25 Lleida;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
25 Lleida;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QIII;5.061
25 Lleida;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
25 Lleida;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
25 Lleida;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
25 Lleida;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2022QIII;5.256
25 Lleida;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2022QII;""
25 Lleida;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2022QI;""
25 Lleida;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
25 Lleida;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2021QIII;5.086
25 Lleida;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2021QII;""
25 Lleida;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2021QI;""
25 Lleida;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
25 Lleida;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2020QIII;4.858
25 Lleida;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2020QII;""
25 Lleida;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2020QI;""
25 Lleida;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2022QIV;4.947
25 Lleida;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
25 Lleida;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2022QII;""
25 Lleida;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2022QI;""
25 Lleida;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2021QIV;4.840
25 Lleida;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
25 Lleida;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2021QII;""
25 Lleida;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2021QI;""
25 Lleida;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2020QIV;4.636
25 Lleida;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
25 Lleida;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2020QII;""
25 Lleida;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2020QI;""
25 Lleida;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
25 Lleida;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
25 Lleida;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QII;""
25 Lleida;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QI;4.697
25 Lleida;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
25 Lleida;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
25 Lleida;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QII;""
25 Lleida;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QI;4.473
25 Lleida;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
25 Lleida;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
25 Lleida;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QII;""
25 Lleida;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QI;""
25 Lleida;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
25 Lleida;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
25 Lleida;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QII;4.522
25 Lleida;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QI;""
25 Lleida;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
25 Lleida;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
25 Lleida;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QII;4.332
25 Lleida;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QI;""
25 Lleida;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
25 Lleida;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
25 Lleida;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QII;""
25 Lleida;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QI;""
25 Lleida;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
25 Lleida;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
25 Lleida;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
25 Lleida;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
25 Lleida;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
25 Lleida;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
25 Lleida;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
25 Lleida;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
25 Lleida;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
25 Lleida;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
25 Lleida;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
25 Lleida;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
25 Lleida;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
25 Lleida;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;96,56
25 Lleida;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
25 Lleida;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
25 Lleida;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
25 Lleida;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;96,42
25 Lleida;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
25 Lleida;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
25 Lleida;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
25 Lleida;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;95,99
25 Lleida;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
25 Lleida;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
25 Lleida;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;90,89
25 Lleida;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
25 Lleida;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
25 Lleida;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
25 Lleida;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;91,75
25 Lleida;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
25 Lleida;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
25 Lleida;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
25 Lleida;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;91,6
25 Lleida;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
25 Lleida;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
25 Lleida;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
25 Lleida;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
25 Lleida;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
25 Lleida;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
25 Lleida;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;89,04
25 Lleida;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
25 Lleida;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
25 Lleida;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
25 Lleida;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;88,38
25 Lleida;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
25 Lleida;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
25 Lleida;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
25 Lleida;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
25 Lleida;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
25 Lleida;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
25 Lleida;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;85,73
25 Lleida;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
25 Lleida;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
25 Lleida;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
25 Lleida;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;85,6
25 Lleida;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
25 Lleida;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
25 Lleida;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
25 Lleida;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
25 Lleida;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
25 Lleida;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
25 Lleida;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QIII;3.428
25 Lleida;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
25 Lleida;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
25 Lleida;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
25 Lleida;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QIII;3.324
25 Lleida;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
25 Lleida;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
25 Lleida;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
25 Lleida;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QIII;3.210
25 Lleida;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
25 Lleida;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
25 Lleida;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
25 Lleida;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2022QIII;3.327
25 Lleida;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2022QII;""
25 Lleida;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2022QI;""
25 Lleida;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
25 Lleida;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2021QIII;3.208
25 Lleida;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2021QII;""
25 Lleida;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2021QI;""
25 Lleida;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
25 Lleida;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2020QIII;3.083
25 Lleida;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2020QII;""
25 Lleida;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2020QI;""
25 Lleida;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2022QIV;3.125
25 Lleida;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
25 Lleida;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2022QII;""
25 Lleida;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2022QI;""
25 Lleida;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2021QIV;3.062
25 Lleida;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
25 Lleida;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2021QII;""
25 Lleida;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2021QI;""
25 Lleida;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2020QIV;2.937
25 Lleida;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
25 Lleida;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2020QII;""
25 Lleida;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2020QI;""
25 Lleida;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
25 Lleida;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
25 Lleida;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QII;""
25 Lleida;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QI;2.974
25 Lleida;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
25 Lleida;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
25 Lleida;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QII;""
25 Lleida;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QI;2.832
25 Lleida;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
25 Lleida;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
25 Lleida;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QII;""
25 Lleida;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QI;""
25 Lleida;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
25 Lleida;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
25 Lleida;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QII;2.876
25 Lleida;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QI;""
25 Lleida;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
25 Lleida;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
25 Lleida;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QII;2.747
25 Lleida;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QI;""
25 Lleida;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
25 Lleida;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
25 Lleida;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QII;""
25 Lleida;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QI;""
25 Lleida;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
25 Lleida;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
25 Lleida;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
25 Lleida;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
25 Lleida;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
25 Lleida;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
25 Lleida;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
25 Lleida;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
25 Lleida;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
25 Lleida;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
25 Lleida;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
25 Lleida;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
25 Lleida;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
25 Lleida;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;97,05
25 Lleida;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
25 Lleida;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
25 Lleida;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
25 Lleida;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;96,51
25 Lleida;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
25 Lleida;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
25 Lleida;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
25 Lleida;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;96,04
25 Lleida;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
25 Lleida;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
25 Lleida;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;91,16
25 Lleida;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
25 Lleida;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
25 Lleida;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
25 Lleida;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;92,12
25 Lleida;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
25 Lleida;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
25 Lleida;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
25 Lleida;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;91,5
25 Lleida;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
25 Lleida;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
25 Lleida;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
25 Lleida;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
25 Lleida;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
25 Lleida;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
25 Lleida;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;89,47
25 Lleida;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
25 Lleida;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
25 Lleida;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
25 Lleida;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;88,22
25 Lleida;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
25 Lleida;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
25 Lleida;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
25 Lleida;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
25 Lleida;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
25 Lleida;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
25 Lleida;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;86,52
25 Lleida;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
25 Lleida;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
25 Lleida;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
25 Lleida;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;85,58
25 Lleida;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
25 Lleida;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
25 Lleida;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
25 Lleida;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
25 Lleida;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
25 Lleida;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
25 Lleida;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QIII;2.015
25 Lleida;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
25 Lleida;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
25 Lleida;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
25 Lleida;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QIII;1.951
25 Lleida;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
25 Lleida;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
25 Lleida;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
25 Lleida;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QIII;1.851
25 Lleida;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
25 Lleida;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
25 Lleida;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
25 Lleida;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2022QIII;1.929
25 Lleida;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2022QII;""
25 Lleida;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2022QI;""
25 Lleida;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
25 Lleida;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2021QIII;1.878
25 Lleida;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2021QII;""
25 Lleida;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2021QI;""
25 Lleida;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
25 Lleida;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2020QIII;1.775
25 Lleida;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2020QII;""
25 Lleida;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2020QI;""
25 Lleida;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2022QIV;1.822
25 Lleida;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
25 Lleida;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2022QII;""
25 Lleida;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2022QI;""
25 Lleida;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2021QIV;1.778
25 Lleida;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
25 Lleida;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2021QII;""
25 Lleida;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2021QI;""
25 Lleida;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2020QIV;1.699
25 Lleida;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
25 Lleida;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2020QII;""
25 Lleida;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2020QI;""
25 Lleida;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
25 Lleida;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
25 Lleida;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QII;""
25 Lleida;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QI;1.723
25 Lleida;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
25 Lleida;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
25 Lleida;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QII;""
25 Lleida;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QI;1.641
25 Lleida;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
25 Lleida;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
25 Lleida;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QII;""
25 Lleida;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QI;""
25 Lleida;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
25 Lleida;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
25 Lleida;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QII;1.646
25 Lleida;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QI;""
25 Lleida;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
25 Lleida;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
25 Lleida;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QII;1.585
25 Lleida;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QI;""
25 Lleida;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
25 Lleida;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
25 Lleida;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QII;""
25 Lleida;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QI;""
25 Lleida;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
25 Lleida;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
25 Lleida;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
25 Lleida;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
25 Lleida;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
25 Lleida;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
25 Lleida;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
25 Lleida;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
25 Lleida;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
25 Lleida;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
25 Lleida;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
25 Lleida;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
25 Lleida;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
25 Lleida;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;95,73
25 Lleida;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
25 Lleida;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
25 Lleida;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
25 Lleida;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;96,26
25 Lleida;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
25 Lleida;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
25 Lleida;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
25 Lleida;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;95,89
25 Lleida;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
25 Lleida;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
25 Lleida;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;90,42
25 Lleida;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
25 Lleida;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
25 Lleida;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
25 Lleida;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;91,13
25 Lleida;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
25 Lleida;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
25 Lleida;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
25 Lleida;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;91,79
25 Lleida;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
25 Lleida;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
25 Lleida;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
25 Lleida;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
25 Lleida;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
25 Lleida;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
25 Lleida;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;88,31
25 Lleida;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
25 Lleida;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
25 Lleida;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
25 Lleida;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;88,65
25 Lleida;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
25 Lleida;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
25 Lleida;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
25 Lleida;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
25 Lleida;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
25 Lleida;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
25 Lleida;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;84,37
25 Lleida;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
25 Lleida;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
25 Lleida;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
25 Lleida;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;85,63
25 Lleida;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
25 Lleida;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
25 Lleida;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
25 Lleida;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
25 Lleida;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
25 Lleida;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QIV;5.289
25 Lleida;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
25 Lleida;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
25 Lleida;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
25 Lleida;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QIV;5.115
25 Lleida;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
25 Lleida;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
25 Lleida;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
25 Lleida;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QIV;4.909
25 Lleida;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
25 Lleida;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
25 Lleida;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
25 Lleida;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2022QIV;4.977
25 Lleida;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
25 Lleida;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2022QII;""
25 Lleida;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2022QI;""
25 Lleida;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2021QIV;4.863
25 Lleida;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
25 Lleida;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2021QII;""
25 Lleida;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2021QI;""
25 Lleida;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2020QIV;4.676
25 Lleida;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
25 Lleida;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2020QII;""
25 Lleida;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2020QI;""
25 Lleida;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
25 Lleida;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
25 Lleida;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2022QII;""
25 Lleida;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2022QI;4.719
25 Lleida;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
25 Lleida;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
25 Lleida;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2021QII;""
25 Lleida;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2021QI;4.513
25 Lleida;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
25 Lleida;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
25 Lleida;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2020QII;""
25 Lleida;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2020QI;""
25 Lleida;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
25 Lleida;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
25 Lleida;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QII;4.543
25 Lleida;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QI;""
25 Lleida;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
25 Lleida;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
25 Lleida;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QII;4.369
25 Lleida;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QI;""
25 Lleida;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
25 Lleida;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
25 Lleida;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QII;""
25 Lleida;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QI;""
25 Lleida;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
25 Lleida;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QIII;4.387
25 Lleida;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QII;""
25 Lleida;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QI;""
25 Lleida;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
25 Lleida;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QIII;4.210
25 Lleida;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QII;""
25 Lleida;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QI;""
25 Lleida;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
25 Lleida;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
25 Lleida;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QII;""
25 Lleida;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QI;""
25 Lleida;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
25 Lleida;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
25 Lleida;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
25 Lleida;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
25 Lleida;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
25 Lleida;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
25 Lleida;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
25 Lleida;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
25 Lleida;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
25 Lleida;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
25 Lleida;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
25 Lleida;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
25 Lleida;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;94,1
25 Lleida;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
25 Lleida;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
25 Lleida;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
25 Lleida;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;95,07
25 Lleida;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
25 Lleida;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
25 Lleida;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
25 Lleida;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;95,25
25 Lleida;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
25 Lleida;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
25 Lleida;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
25 Lleida;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
25 Lleida;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
25 Lleida;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
25 Lleida;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;92,26
25 Lleida;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
25 Lleida;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
25 Lleida;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
25 Lleida;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;91,93
25 Lleida;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
25 Lleida;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
25 Lleida;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
25 Lleida;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
25 Lleida;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
25 Lleida;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
25 Lleida;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;88,82
25 Lleida;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
25 Lleida;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
25 Lleida;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
25 Lleida;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;89
25 Lleida;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
25 Lleida;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
25 Lleida;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
25 Lleida;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
25 Lleida;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
25 Lleida;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
25 Lleida;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;85,77
25 Lleida;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
25 Lleida;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
25 Lleida;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
25 Lleida;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;85,76
25 Lleida;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
25 Lleida;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
25 Lleida;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
25 Lleida;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
25 Lleida;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
25 Lleida;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
25 Lleida;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QIV;3.345
25 Lleida;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
25 Lleida;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
25 Lleida;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
25 Lleida;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QIV;3.223
25 Lleida;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
25 Lleida;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
25 Lleida;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
25 Lleida;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QIV;3.112
25 Lleida;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
25 Lleida;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
25 Lleida;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
25 Lleida;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2022QIV;3.140
25 Lleida;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
25 Lleida;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2022QII;""
25 Lleida;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2022QI;""
25 Lleida;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2021QIV;3.072
25 Lleida;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
25 Lleida;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2021QII;""
25 Lleida;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2021QI;""
25 Lleida;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2020QIV;2.957
25 Lleida;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
25 Lleida;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2020QII;""
25 Lleida;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2020QI;""
25 Lleida;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
25 Lleida;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
25 Lleida;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2022QII;""
25 Lleida;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2022QI;2.984
25 Lleida;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
25 Lleida;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
25 Lleida;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2021QII;""
25 Lleida;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2021QI;2.852
25 Lleida;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
25 Lleida;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
25 Lleida;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2020QII;""
25 Lleida;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2020QI;""
25 Lleida;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
25 Lleida;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
25 Lleida;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QII;2.885
25 Lleida;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QI;""
25 Lleida;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
25 Lleida;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
25 Lleida;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QII;2.766
25 Lleida;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QI;""
25 Lleida;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
25 Lleida;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
25 Lleida;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QII;""
25 Lleida;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QI;""
25 Lleida;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
25 Lleida;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QIII;2.799
25 Lleida;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QII;""
25 Lleida;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QI;""
25 Lleida;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
25 Lleida;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QIII;2.668
25 Lleida;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QII;""
25 Lleida;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QI;""
25 Lleida;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
25 Lleida;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
25 Lleida;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QII;""
25 Lleida;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QI;""
25 Lleida;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
25 Lleida;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
25 Lleida;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
25 Lleida;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
25 Lleida;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
25 Lleida;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
25 Lleida;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
25 Lleida;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
25 Lleida;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
25 Lleida;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
25 Lleida;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
25 Lleida;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
25 Lleida;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;93,87
25 Lleida;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
25 Lleida;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
25 Lleida;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
25 Lleida;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;95,31
25 Lleida;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
25 Lleida;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
25 Lleida;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
25 Lleida;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;95,02
25 Lleida;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
25 Lleida;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
25 Lleida;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
25 Lleida;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
25 Lleida;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
25 Lleida;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
25 Lleida;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;92,58
25 Lleida;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
25 Lleida;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
25 Lleida;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
25 Lleida;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;91,65
25 Lleida;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
25 Lleida;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
25 Lleida;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
25 Lleida;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
25 Lleida;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
25 Lleida;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
25 Lleida;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;89,51
25 Lleida;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
25 Lleida;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
25 Lleida;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
25 Lleida;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;88,88
25 Lleida;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
25 Lleida;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
25 Lleida;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
25 Lleida;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
25 Lleida;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
25 Lleida;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
25 Lleida;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;86,84
25 Lleida;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
25 Lleida;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
25 Lleida;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
25 Lleida;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;85,73
25 Lleida;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
25 Lleida;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
25 Lleida;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
25 Lleida;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
25 Lleida;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
25 Lleida;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
25 Lleida;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QIV;1.944
25 Lleida;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
25 Lleida;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
25 Lleida;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
25 Lleida;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QIV;1.892
25 Lleida;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
25 Lleida;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
25 Lleida;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
25 Lleida;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QIV;1.797
25 Lleida;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
25 Lleida;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
25 Lleida;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
25 Lleida;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2022QIV;1.837
25 Lleida;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
25 Lleida;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2022QII;""
25 Lleida;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2022QI;""
25 Lleida;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2021QIV;1.791
25 Lleida;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
25 Lleida;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2021QII;""
25 Lleida;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2021QI;""
25 Lleida;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2020QIV;1.719
25 Lleida;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
25 Lleida;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2020QII;""
25 Lleida;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2020QI;""
25 Lleida;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
25 Lleida;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
25 Lleida;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2022QII;""
25 Lleida;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2022QI;1.735
25 Lleida;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
25 Lleida;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
25 Lleida;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2021QII;""
25 Lleida;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2021QI;1.661
25 Lleida;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
25 Lleida;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
25 Lleida;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2020QII;""
25 Lleida;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2020QI;""
25 Lleida;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
25 Lleida;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
25 Lleida;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QII;1.658
25 Lleida;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QI;""
25 Lleida;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
25 Lleida;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
25 Lleida;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QII;1.603
25 Lleida;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QI;""
25 Lleida;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
25 Lleida;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
25 Lleida;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QII;""
25 Lleida;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QI;""
25 Lleida;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
25 Lleida;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QIII;1.588
25 Lleida;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QII;""
25 Lleida;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QI;""
25 Lleida;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
25 Lleida;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QIII;1.542
25 Lleida;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QII;""
25 Lleida;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QI;""
25 Lleida;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
25 Lleida;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
25 Lleida;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QII;""
25 Lleida;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QI;""
25 Lleida;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
25 Lleida;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
25 Lleida;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
25 Lleida;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
25 Lleida;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
25 Lleida;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
25 Lleida;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
25 Lleida;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
25 Lleida;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
25 Lleida;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
25 Lleida;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
25 Lleida;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
25 Lleida;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;94,5
25 Lleida;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
25 Lleida;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
25 Lleida;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
25 Lleida;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;94,66
25 Lleida;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
25 Lleida;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
25 Lleida;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
25 Lleida;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;95,66
25 Lleida;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
25 Lleida;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
25 Lleida;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
25 Lleida;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
25 Lleida;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
25 Lleida;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
25 Lleida;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;91,7
25 Lleida;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
25 Lleida;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
25 Lleida;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
25 Lleida;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;92,43
25 Lleida;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
25 Lleida;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
25 Lleida;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
25 Lleida;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
25 Lleida;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
25 Lleida;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
25 Lleida;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;87,63
25 Lleida;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
25 Lleida;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
25 Lleida;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
25 Lleida;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;89,2
25 Lleida;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
25 Lleida;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
25 Lleida;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
25 Lleida;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
25 Lleida;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
25 Lleida;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
25 Lleida;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;83,93
25 Lleida;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
25 Lleida;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
25 Lleida;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
25 Lleida;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;85,81
25 Lleida;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
25 Lleida;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
25 Lleida;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
25 Lleida;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
25 Lleida;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
25 Lleida;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
27 Lugo;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
27 Lugo;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
27 Lugo;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
27 Lugo;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QI;22.178
27 Lugo;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
27 Lugo;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
27 Lugo;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
27 Lugo;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QI;22.155
27 Lugo;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
27 Lugo;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
27 Lugo;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
27 Lugo;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QI;22.556
27 Lugo;All ages;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
27 Lugo;All ages;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
27 Lugo;All ages;Cohort January 1;Total;Survival in the first trimester;2022QII;""
27 Lugo;All ages;Cohort January 1;Total;Survival in the first trimester;2022QI;21.604
27 Lugo;All ages;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
27 Lugo;All ages;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
27 Lugo;All ages;Cohort January 1;Total;Survival in the first trimester;2021QII;""
27 Lugo;All ages;Cohort January 1;Total;Survival in the first trimester;2021QI;21.722
27 Lugo;All ages;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
27 Lugo;All ages;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
27 Lugo;All ages;Cohort January 1;Total;Survival in the first trimester;2020QII;""
27 Lugo;All ages;Cohort January 1;Total;Survival in the first trimester;2020QI;21.666
27 Lugo;All ages;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
27 Lugo;All ages;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
27 Lugo;All ages;Cohort January 1;Total;Survival in the second trimester;2022QII;21.167
27 Lugo;All ages;Cohort January 1;Total;Survival in the second trimester;2022QI;""
27 Lugo;All ages;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
27 Lugo;All ages;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
27 Lugo;All ages;Cohort January 1;Total;Survival in the second trimester;2021QII;21.289
27 Lugo;All ages;Cohort January 1;Total;Survival in the second trimester;2021QI;""
27 Lugo;All ages;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
27 Lugo;All ages;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
27 Lugo;All ages;Cohort January 1;Total;Survival in the second trimester;2020QII;21.304
27 Lugo;All ages;Cohort January 1;Total;Survival in the second trimester;2020QI;""
27 Lugo;All ages;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
27 Lugo;All ages;Cohort January 1;Total;Survival in the third trimester;2022QIII;20.739
27 Lugo;All ages;Cohort January 1;Total;Survival in the third trimester;2022QII;""
27 Lugo;All ages;Cohort January 1;Total;Survival in the third trimester;2022QI;""
27 Lugo;All ages;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
27 Lugo;All ages;Cohort January 1;Total;Survival in the third trimester;2021QIII;20.870
27 Lugo;All ages;Cohort January 1;Total;Survival in the third trimester;2021QII;""
27 Lugo;All ages;Cohort January 1;Total;Survival in the third trimester;2021QI;""
27 Lugo;All ages;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
27 Lugo;All ages;Cohort January 1;Total;Survival in the third trimester;2020QIII;20.894
27 Lugo;All ages;Cohort January 1;Total;Survival in the third trimester;2020QII;""
27 Lugo;All ages;Cohort January 1;Total;Survival in the third trimester;2020QI;""
27 Lugo;All ages;Cohort January 1;Total;Survival in the third trimester;2022QIV;20.143
27 Lugo;All ages;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
27 Lugo;All ages;Cohort January 1;Total;Survival in the third trimester;2022QII;""
27 Lugo;All ages;Cohort January 1;Total;Survival in the third trimester;2022QI;""
27 Lugo;All ages;Cohort January 1;Total;Survival in the third trimester;2021QIV;20.385
27 Lugo;All ages;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
27 Lugo;All ages;Cohort January 1;Total;Survival in the third trimester;2021QII;""
27 Lugo;All ages;Cohort January 1;Total;Survival in the third trimester;2021QI;""
27 Lugo;All ages;Cohort January 1;Total;Survival in the third trimester;2020QIV;20.405
27 Lugo;All ages;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
27 Lugo;All ages;Cohort January 1;Total;Survival in the third trimester;2020QII;""
27 Lugo;All ages;Cohort January 1;Total;Survival in the third trimester;2020QI;""
27 Lugo;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
27 Lugo;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
27 Lugo;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
27 Lugo;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
27 Lugo;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
27 Lugo;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
27 Lugo;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
27 Lugo;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
27 Lugo;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
27 Lugo;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
27 Lugo;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
27 Lugo;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
27 Lugo;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
27 Lugo;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
27 Lugo;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
27 Lugo;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;97,41
27 Lugo;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
27 Lugo;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
27 Lugo;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
27 Lugo;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;98,05
27 Lugo;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
27 Lugo;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
27 Lugo;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
27 Lugo;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;96,05
27 Lugo;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
27 Lugo;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
27 Lugo;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;95,44
27 Lugo;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
27 Lugo;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
27 Lugo;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
27 Lugo;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;96,09
27 Lugo;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
27 Lugo;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
27 Lugo;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
27 Lugo;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;94,45
27 Lugo;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
27 Lugo;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
27 Lugo;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;93,51
27 Lugo;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
27 Lugo;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
27 Lugo;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
27 Lugo;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;94,2
27 Lugo;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
27 Lugo;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
27 Lugo;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
27 Lugo;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;92,63
27 Lugo;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
27 Lugo;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
27 Lugo;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;90,82
27 Lugo;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
27 Lugo;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
27 Lugo;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
27 Lugo;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;92,01
27 Lugo;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
27 Lugo;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
27 Lugo;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
27 Lugo;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;90,46
27 Lugo;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
27 Lugo;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
27 Lugo;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
27 Lugo;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
27 Lugo;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
27 Lugo;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
27 Lugo;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QI;13.712
27 Lugo;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
27 Lugo;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
27 Lugo;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
27 Lugo;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QI;13.756
27 Lugo;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
27 Lugo;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
27 Lugo;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
27 Lugo;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QI;13.928
27 Lugo;All ages;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
27 Lugo;All ages;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
27 Lugo;All ages;Cohort January 1;Males;Survival in the first trimester;2022QII;""
27 Lugo;All ages;Cohort January 1;Males;Survival in the first trimester;2022QI;13.376
27 Lugo;All ages;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
27 Lugo;All ages;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
27 Lugo;All ages;Cohort January 1;Males;Survival in the first trimester;2021QII;""
27 Lugo;All ages;Cohort January 1;Males;Survival in the first trimester;2021QI;13.517
27 Lugo;All ages;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
27 Lugo;All ages;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
27 Lugo;All ages;Cohort January 1;Males;Survival in the first trimester;2020QII;""
27 Lugo;All ages;Cohort January 1;Males;Survival in the first trimester;2020QI;13.422
27 Lugo;All ages;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
27 Lugo;All ages;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
27 Lugo;All ages;Cohort January 1;Males;Survival in the second trimester;2022QII;13.128
27 Lugo;All ages;Cohort January 1;Males;Survival in the second trimester;2022QI;""
27 Lugo;All ages;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
27 Lugo;All ages;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
27 Lugo;All ages;Cohort January 1;Males;Survival in the second trimester;2021QII;13.279
27 Lugo;All ages;Cohort January 1;Males;Survival in the second trimester;2021QI;""
27 Lugo;All ages;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
27 Lugo;All ages;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
27 Lugo;All ages;Cohort January 1;Males;Survival in the second trimester;2020QII;13.216
27 Lugo;All ages;Cohort January 1;Males;Survival in the second trimester;2020QI;""
27 Lugo;All ages;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
27 Lugo;All ages;Cohort January 1;Males;Survival in the third trimester;2022QIII;12.883
27 Lugo;All ages;Cohort January 1;Males;Survival in the third trimester;2022QII;""
27 Lugo;All ages;Cohort January 1;Males;Survival in the third trimester;2022QI;""
27 Lugo;All ages;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
27 Lugo;All ages;Cohort January 1;Males;Survival in the third trimester;2021QIII;13.021
27 Lugo;All ages;Cohort January 1;Males;Survival in the third trimester;2021QII;""
27 Lugo;All ages;Cohort January 1;Males;Survival in the third trimester;2021QI;""
27 Lugo;All ages;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
27 Lugo;All ages;Cohort January 1;Males;Survival in the third trimester;2020QIII;12.992
27 Lugo;All ages;Cohort January 1;Males;Survival in the third trimester;2020QII;""
27 Lugo;All ages;Cohort January 1;Males;Survival in the third trimester;2020QI;""
27 Lugo;All ages;Cohort January 1;Males;Survival in the third trimester;2022QIV;12.525
27 Lugo;All ages;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
27 Lugo;All ages;Cohort January 1;Males;Survival in the third trimester;2022QII;""
27 Lugo;All ages;Cohort January 1;Males;Survival in the third trimester;2022QI;""
27 Lugo;All ages;Cohort January 1;Males;Survival in the third trimester;2021QIV;12.748
27 Lugo;All ages;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
27 Lugo;All ages;Cohort January 1;Males;Survival in the third trimester;2021QII;""
27 Lugo;All ages;Cohort January 1;Males;Survival in the third trimester;2021QI;""
27 Lugo;All ages;Cohort January 1;Males;Survival in the third trimester;2020QIV;12.734
27 Lugo;All ages;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
27 Lugo;All ages;Cohort January 1;Males;Survival in the third trimester;2020QII;""
27 Lugo;All ages;Cohort January 1;Males;Survival in the third trimester;2020QI;""
27 Lugo;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
27 Lugo;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
27 Lugo;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
27 Lugo;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
27 Lugo;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
27 Lugo;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
27 Lugo;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
27 Lugo;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
27 Lugo;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
27 Lugo;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
27 Lugo;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
27 Lugo;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
27 Lugo;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
27 Lugo;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
27 Lugo;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
27 Lugo;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;97,55
27 Lugo;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
27 Lugo;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
27 Lugo;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
27 Lugo;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;98,26
27 Lugo;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
27 Lugo;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
27 Lugo;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
27 Lugo;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;96,37
27 Lugo;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
27 Lugo;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
27 Lugo;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;95,74
27 Lugo;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
27 Lugo;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
27 Lugo;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
27 Lugo;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;96,53
27 Lugo;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
27 Lugo;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
27 Lugo;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
27 Lugo;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;94,89
27 Lugo;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
27 Lugo;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
27 Lugo;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;93,95
27 Lugo;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
27 Lugo;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
27 Lugo;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
27 Lugo;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;94,66
27 Lugo;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
27 Lugo;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
27 Lugo;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
27 Lugo;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;93,28
27 Lugo;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
27 Lugo;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
27 Lugo;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;91,34
27 Lugo;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
27 Lugo;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
27 Lugo;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
27 Lugo;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;92,67
27 Lugo;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
27 Lugo;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
27 Lugo;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
27 Lugo;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;91,43
27 Lugo;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
27 Lugo;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
27 Lugo;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
27 Lugo;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
27 Lugo;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
27 Lugo;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
27 Lugo;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QI;8.466
27 Lugo;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
27 Lugo;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
27 Lugo;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
27 Lugo;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QI;8.399
27 Lugo;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
27 Lugo;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
27 Lugo;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
27 Lugo;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QI;8.628
27 Lugo;All ages;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
27 Lugo;All ages;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
27 Lugo;All ages;Cohort January 1;Females;Survival in the first trimester;2022QII;""
27 Lugo;All ages;Cohort January 1;Females;Survival in the first trimester;2022QI;8.228
27 Lugo;All ages;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
27 Lugo;All ages;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
27 Lugo;All ages;Cohort January 1;Females;Survival in the first trimester;2021QII;""
27 Lugo;All ages;Cohort January 1;Females;Survival in the first trimester;2021QI;8.205
27 Lugo;All ages;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
27 Lugo;All ages;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
27 Lugo;All ages;Cohort January 1;Females;Survival in the first trimester;2020QII;""
27 Lugo;All ages;Cohort January 1;Females;Survival in the first trimester;2020QI;8.244
27 Lugo;All ages;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
27 Lugo;All ages;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
27 Lugo;All ages;Cohort January 1;Females;Survival in the second trimester;2022QII;8.039
27 Lugo;All ages;Cohort January 1;Females;Survival in the second trimester;2022QI;""
27 Lugo;All ages;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
27 Lugo;All ages;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
27 Lugo;All ages;Cohort January 1;Females;Survival in the second trimester;2021QII;8.010
27 Lugo;All ages;Cohort January 1;Females;Survival in the second trimester;2021QI;""
27 Lugo;All ages;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
27 Lugo;All ages;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
27 Lugo;All ages;Cohort January 1;Females;Survival in the second trimester;2020QII;8.088
27 Lugo;All ages;Cohort January 1;Females;Survival in the second trimester;2020QI;""
27 Lugo;All ages;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
27 Lugo;All ages;Cohort January 1;Females;Survival in the third trimester;2022QIII;7.856
27 Lugo;All ages;Cohort January 1;Females;Survival in the third trimester;2022QII;""
27 Lugo;All ages;Cohort January 1;Females;Survival in the third trimester;2022QI;""
27 Lugo;All ages;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
27 Lugo;All ages;Cohort January 1;Females;Survival in the third trimester;2021QIII;7.849
27 Lugo;All ages;Cohort January 1;Females;Survival in the third trimester;2021QII;""
27 Lugo;All ages;Cohort January 1;Females;Survival in the third trimester;2021QI;""
27 Lugo;All ages;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
27 Lugo;All ages;Cohort January 1;Females;Survival in the third trimester;2020QIII;7.902
27 Lugo;All ages;Cohort January 1;Females;Survival in the third trimester;2020QII;""
27 Lugo;All ages;Cohort January 1;Females;Survival in the third trimester;2020QI;""
27 Lugo;All ages;Cohort January 1;Females;Survival in the third trimester;2022QIV;7.618
27 Lugo;All ages;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
27 Lugo;All ages;Cohort January 1;Females;Survival in the third trimester;2022QII;""
27 Lugo;All ages;Cohort January 1;Females;Survival in the third trimester;2022QI;""
27 Lugo;All ages;Cohort January 1;Females;Survival in the third trimester;2021QIV;7.637
27 Lugo;All ages;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
27 Lugo;All ages;Cohort January 1;Females;Survival in the third trimester;2021QII;""
27 Lugo;All ages;Cohort January 1;Females;Survival in the third trimester;2021QI;""
27 Lugo;All ages;Cohort January 1;Females;Survival in the third trimester;2020QIV;7.671
27 Lugo;All ages;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
27 Lugo;All ages;Cohort January 1;Females;Survival in the third trimester;2020QII;""
27 Lugo;All ages;Cohort January 1;Females;Survival in the third trimester;2020QI;""
27 Lugo;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
27 Lugo;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
27 Lugo;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
27 Lugo;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
27 Lugo;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
27 Lugo;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
27 Lugo;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
27 Lugo;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
27 Lugo;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
27 Lugo;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
27 Lugo;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
27 Lugo;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
27 Lugo;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
27 Lugo;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
27 Lugo;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
27 Lugo;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;97,19
27 Lugo;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
27 Lugo;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
27 Lugo;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
27 Lugo;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;97,69
27 Lugo;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
27 Lugo;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
27 Lugo;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
27 Lugo;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;95,55
27 Lugo;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
27 Lugo;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
27 Lugo;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;94,96
27 Lugo;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
27 Lugo;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
27 Lugo;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
27 Lugo;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;95,37
27 Lugo;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
27 Lugo;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
27 Lugo;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
27 Lugo;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;93,74
27 Lugo;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
27 Lugo;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
27 Lugo;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;92,79
27 Lugo;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
27 Lugo;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
27 Lugo;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
27 Lugo;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;93,45
27 Lugo;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
27 Lugo;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
27 Lugo;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
27 Lugo;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;91,59
27 Lugo;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
27 Lugo;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
27 Lugo;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;89,98
27 Lugo;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
27 Lugo;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
27 Lugo;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
27 Lugo;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;90,93
27 Lugo;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
27 Lugo;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
27 Lugo;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
27 Lugo;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;88,91
27 Lugo;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
27 Lugo;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
27 Lugo;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
27 Lugo;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
27 Lugo;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
27 Lugo;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QII;22.121
27 Lugo;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
27 Lugo;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
27 Lugo;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
27 Lugo;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QII;22.251
27 Lugo;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
27 Lugo;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
27 Lugo;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
27 Lugo;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QII;22.333
27 Lugo;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
27 Lugo;All ages;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
27 Lugo;All ages;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
27 Lugo;All ages;Cohort April 1;Total;Survival in the first trimester;2022QII;21.649
27 Lugo;All ages;Cohort April 1;Total;Survival in the first trimester;2022QI;""
27 Lugo;All ages;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
27 Lugo;All ages;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
27 Lugo;All ages;Cohort April 1;Total;Survival in the first trimester;2021QII;21.769
27 Lugo;All ages;Cohort April 1;Total;Survival in the first trimester;2021QI;""
27 Lugo;All ages;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
27 Lugo;All ages;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
27 Lugo;All ages;Cohort April 1;Total;Survival in the first trimester;2020QII;21.953
27 Lugo;All ages;Cohort April 1;Total;Survival in the first trimester;2020QI;""
27 Lugo;All ages;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
27 Lugo;All ages;Cohort April 1;Total;Survival in the second trimester;2022QIII;21.195
27 Lugo;All ages;Cohort April 1;Total;Survival in the second trimester;2022QII;""
27 Lugo;All ages;Cohort April 1;Total;Survival in the second trimester;2022QI;""
27 Lugo;All ages;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
27 Lugo;All ages;Cohort April 1;Total;Survival in the second trimester;2021QIII;21.326
27 Lugo;All ages;Cohort April 1;Total;Survival in the second trimester;2021QII;""
27 Lugo;All ages;Cohort April 1;Total;Survival in the second trimester;2021QI;""
27 Lugo;All ages;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
27 Lugo;All ages;Cohort April 1;Total;Survival in the second trimester;2020QIII;21.487
27 Lugo;All ages;Cohort April 1;Total;Survival in the second trimester;2020QII;""
27 Lugo;All ages;Cohort April 1;Total;Survival in the second trimester;2020QI;""
27 Lugo;All ages;Cohort April 1;Total;Survival in the third trimester;2022QIV;20.573
27 Lugo;All ages;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
27 Lugo;All ages;Cohort April 1;Total;Survival in the third trimester;2022QII;""
27 Lugo;All ages;Cohort April 1;Total;Survival in the third trimester;2022QI;""
27 Lugo;All ages;Cohort April 1;Total;Survival in the third trimester;2021QIV;20.804
27 Lugo;All ages;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
27 Lugo;All ages;Cohort April 1;Total;Survival in the third trimester;2021QII;""
27 Lugo;All ages;Cohort April 1;Total;Survival in the third trimester;2021QI;""
27 Lugo;All ages;Cohort April 1;Total;Survival in the third trimester;2020QIV;20.971
27 Lugo;All ages;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
27 Lugo;All ages;Cohort April 1;Total;Survival in the third trimester;2020QII;""
27 Lugo;All ages;Cohort April 1;Total;Survival in the third trimester;2020QI;""
27 Lugo;All ages;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
27 Lugo;All ages;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
27 Lugo;All ages;Cohort April 1;Total;Survival in the third trimester;2022QII;""
27 Lugo;All ages;Cohort April 1;Total;Survival in the third trimester;2022QI;20.325
27 Lugo;All ages;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
27 Lugo;All ages;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
27 Lugo;All ages;Cohort April 1;Total;Survival in the third trimester;2021QII;""
27 Lugo;All ages;Cohort April 1;Total;Survival in the third trimester;2021QI;20.614
27 Lugo;All ages;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
27 Lugo;All ages;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
27 Lugo;All ages;Cohort April 1;Total;Survival in the third trimester;2020QII;""
27 Lugo;All ages;Cohort April 1;Total;Survival in the third trimester;2020QI;""
27 Lugo;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
27 Lugo;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
27 Lugo;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
27 Lugo;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
27 Lugo;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
27 Lugo;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
27 Lugo;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
27 Lugo;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
27 Lugo;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
27 Lugo;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
27 Lugo;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
27 Lugo;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
27 Lugo;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
27 Lugo;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
27 Lugo;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;97,87
27 Lugo;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
27 Lugo;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
27 Lugo;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
27 Lugo;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;97,83
27 Lugo;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
27 Lugo;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
27 Lugo;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
27 Lugo;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;98,3
27 Lugo;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
27 Lugo;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
27 Lugo;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;95,81
27 Lugo;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
27 Lugo;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
27 Lugo;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
27 Lugo;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;95,84
27 Lugo;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
27 Lugo;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
27 Lugo;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
27 Lugo;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;96,21
27 Lugo;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
27 Lugo;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
27 Lugo;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;93
27 Lugo;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
27 Lugo;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
27 Lugo;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
27 Lugo;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;93,5
27 Lugo;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
27 Lugo;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
27 Lugo;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
27 Lugo;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;93,9
27 Lugo;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
27 Lugo;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
27 Lugo;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
27 Lugo;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
27 Lugo;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
27 Lugo;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
27 Lugo;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;91,34
27 Lugo;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
27 Lugo;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
27 Lugo;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
27 Lugo;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;92,3
27 Lugo;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
27 Lugo;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
27 Lugo;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
27 Lugo;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
27 Lugo;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
27 Lugo;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
27 Lugo;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QII;13.672
27 Lugo;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
27 Lugo;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
27 Lugo;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
27 Lugo;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QII;13.824
27 Lugo;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
27 Lugo;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
27 Lugo;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
27 Lugo;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QII;13.799
27 Lugo;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
27 Lugo;All ages;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
27 Lugo;All ages;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
27 Lugo;All ages;Cohort April 1;Males;Survival in the first trimester;2022QII;13.402
27 Lugo;All ages;Cohort April 1;Males;Survival in the first trimester;2022QI;""
27 Lugo;All ages;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
27 Lugo;All ages;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
27 Lugo;All ages;Cohort April 1;Males;Survival in the first trimester;2021QII;13.564
27 Lugo;All ages;Cohort April 1;Males;Survival in the first trimester;2021QI;""
27 Lugo;All ages;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
27 Lugo;All ages;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
27 Lugo;All ages;Cohort April 1;Males;Survival in the first trimester;2020QII;13.579
27 Lugo;All ages;Cohort April 1;Males;Survival in the first trimester;2020QI;""
27 Lugo;All ages;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
27 Lugo;All ages;Cohort April 1;Males;Survival in the second trimester;2022QIII;13.140
27 Lugo;All ages;Cohort April 1;Males;Survival in the second trimester;2022QII;""
27 Lugo;All ages;Cohort April 1;Males;Survival in the second trimester;2022QI;""
27 Lugo;All ages;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
27 Lugo;All ages;Cohort April 1;Males;Survival in the second trimester;2021QIII;13.288
27 Lugo;All ages;Cohort April 1;Males;Survival in the second trimester;2021QII;""
27 Lugo;All ages;Cohort April 1;Males;Survival in the second trimester;2021QI;""
27 Lugo;All ages;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
27 Lugo;All ages;Cohort April 1;Males;Survival in the second trimester;2020QIII;13.318
27 Lugo;All ages;Cohort April 1;Males;Survival in the second trimester;2020QII;""
27 Lugo;All ages;Cohort April 1;Males;Survival in the second trimester;2020QI;""
27 Lugo;All ages;Cohort April 1;Males;Survival in the third trimester;2022QIV;12.761
27 Lugo;All ages;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
27 Lugo;All ages;Cohort April 1;Males;Survival in the third trimester;2022QII;""
27 Lugo;All ages;Cohort April 1;Males;Survival in the third trimester;2022QI;""
27 Lugo;All ages;Cohort April 1;Males;Survival in the third trimester;2021QIV;12.990
27 Lugo;All ages;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
27 Lugo;All ages;Cohort April 1;Males;Survival in the third trimester;2021QII;""
27 Lugo;All ages;Cohort April 1;Males;Survival in the third trimester;2021QI;""
27 Lugo;All ages;Cohort April 1;Males;Survival in the third trimester;2020QIV;13.044
27 Lugo;All ages;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
27 Lugo;All ages;Cohort April 1;Males;Survival in the third trimester;2020QII;""
27 Lugo;All ages;Cohort April 1;Males;Survival in the third trimester;2020QI;""
27 Lugo;All ages;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
27 Lugo;All ages;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
27 Lugo;All ages;Cohort April 1;Males;Survival in the third trimester;2022QII;""
27 Lugo;All ages;Cohort April 1;Males;Survival in the third trimester;2022QI;12.711
27 Lugo;All ages;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
27 Lugo;All ages;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
27 Lugo;All ages;Cohort April 1;Males;Survival in the third trimester;2021QII;""
27 Lugo;All ages;Cohort April 1;Males;Survival in the third trimester;2021QI;12.850
27 Lugo;All ages;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
27 Lugo;All ages;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
27 Lugo;All ages;Cohort April 1;Males;Survival in the third trimester;2020QII;""
27 Lugo;All ages;Cohort April 1;Males;Survival in the third trimester;2020QI;""
27 Lugo;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
27 Lugo;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
27 Lugo;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
27 Lugo;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
27 Lugo;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
27 Lugo;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
27 Lugo;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
27 Lugo;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
27 Lugo;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
27 Lugo;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
27 Lugo;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
27 Lugo;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
27 Lugo;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
27 Lugo;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
27 Lugo;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;98,03
27 Lugo;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
27 Lugo;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
27 Lugo;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
27 Lugo;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;98,12
27 Lugo;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
27 Lugo;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
27 Lugo;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
27 Lugo;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;98,41
27 Lugo;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
27 Lugo;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
27 Lugo;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;96,11
27 Lugo;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
27 Lugo;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
27 Lugo;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
27 Lugo;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;96,12
27 Lugo;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
27 Lugo;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
27 Lugo;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
27 Lugo;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;96,51
27 Lugo;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
27 Lugo;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
27 Lugo;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;93,34
27 Lugo;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
27 Lugo;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
27 Lugo;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
27 Lugo;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;93,97
27 Lugo;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
27 Lugo;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
27 Lugo;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
27 Lugo;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;94,53
27 Lugo;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
27 Lugo;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
27 Lugo;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
27 Lugo;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
27 Lugo;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
27 Lugo;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
27 Lugo;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;91,95
27 Lugo;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
27 Lugo;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
27 Lugo;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
27 Lugo;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;93,12
27 Lugo;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
27 Lugo;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
27 Lugo;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
27 Lugo;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
27 Lugo;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
27 Lugo;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
27 Lugo;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QII;8.449
27 Lugo;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
27 Lugo;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
27 Lugo;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
27 Lugo;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QII;8.427
27 Lugo;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
27 Lugo;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
27 Lugo;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
27 Lugo;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QII;8.534
27 Lugo;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
27 Lugo;All ages;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
27 Lugo;All ages;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
27 Lugo;All ages;Cohort April 1;Females;Survival in the first trimester;2022QII;8.247
27 Lugo;All ages;Cohort April 1;Females;Survival in the first trimester;2022QI;""
27 Lugo;All ages;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
27 Lugo;All ages;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
27 Lugo;All ages;Cohort April 1;Females;Survival in the first trimester;2021QII;8.205
27 Lugo;All ages;Cohort April 1;Females;Survival in the first trimester;2021QI;""
27 Lugo;All ages;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
27 Lugo;All ages;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
27 Lugo;All ages;Cohort April 1;Females;Survival in the first trimester;2020QII;8.374
27 Lugo;All ages;Cohort April 1;Females;Survival in the first trimester;2020QI;""
27 Lugo;All ages;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
27 Lugo;All ages;Cohort April 1;Females;Survival in the second trimester;2022QIII;8.055
27 Lugo;All ages;Cohort April 1;Females;Survival in the second trimester;2022QII;""
27 Lugo;All ages;Cohort April 1;Females;Survival in the second trimester;2022QI;""
27 Lugo;All ages;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
27 Lugo;All ages;Cohort April 1;Females;Survival in the second trimester;2021QIII;8.038
27 Lugo;All ages;Cohort April 1;Females;Survival in the second trimester;2021QII;""
27 Lugo;All ages;Cohort April 1;Females;Survival in the second trimester;2021QI;""
27 Lugo;All ages;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
27 Lugo;All ages;Cohort April 1;Females;Survival in the second trimester;2020QIII;8.169
27 Lugo;All ages;Cohort April 1;Females;Survival in the second trimester;2020QII;""
27 Lugo;All ages;Cohort April 1;Females;Survival in the second trimester;2020QI;""
27 Lugo;All ages;Cohort April 1;Females;Survival in the third trimester;2022QIV;7.812
27 Lugo;All ages;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
27 Lugo;All ages;Cohort April 1;Females;Survival in the third trimester;2022QII;""
27 Lugo;All ages;Cohort April 1;Females;Survival in the third trimester;2022QI;""
27 Lugo;All ages;Cohort April 1;Females;Survival in the third trimester;2021QIV;7.814
27 Lugo;All ages;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
27 Lugo;All ages;Cohort April 1;Females;Survival in the third trimester;2021QII;""
27 Lugo;All ages;Cohort April 1;Females;Survival in the third trimester;2021QI;""
27 Lugo;All ages;Cohort April 1;Females;Survival in the third trimester;2020QIV;7.927
27 Lugo;All ages;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
27 Lugo;All ages;Cohort April 1;Females;Survival in the third trimester;2020QII;""
27 Lugo;All ages;Cohort April 1;Females;Survival in the third trimester;2020QI;""
27 Lugo;All ages;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
27 Lugo;All ages;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
27 Lugo;All ages;Cohort April 1;Females;Survival in the third trimester;2022QII;""
27 Lugo;All ages;Cohort April 1;Females;Survival in the third trimester;2022QI;7.614
27 Lugo;All ages;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
27 Lugo;All ages;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
27 Lugo;All ages;Cohort April 1;Females;Survival in the third trimester;2021QII;""
27 Lugo;All ages;Cohort April 1;Females;Survival in the third trimester;2021QI;7.764
27 Lugo;All ages;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
27 Lugo;All ages;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
27 Lugo;All ages;Cohort April 1;Females;Survival in the third trimester;2020QII;""
27 Lugo;All ages;Cohort April 1;Females;Survival in the third trimester;2020QI;""
27 Lugo;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
27 Lugo;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
27 Lugo;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
27 Lugo;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
27 Lugo;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
27 Lugo;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
27 Lugo;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
27 Lugo;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
27 Lugo;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
27 Lugo;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
27 Lugo;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
27 Lugo;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
27 Lugo;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
27 Lugo;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
27 Lugo;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;97,61
27 Lugo;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
27 Lugo;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
27 Lugo;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
27 Lugo;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;97,37
27 Lugo;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
27 Lugo;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
27 Lugo;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
27 Lugo;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;98,13
27 Lugo;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
27 Lugo;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
27 Lugo;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;95,34
27 Lugo;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
27 Lugo;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
27 Lugo;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
27 Lugo;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;95,38
27 Lugo;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
27 Lugo;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
27 Lugo;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
27 Lugo;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;95,72
27 Lugo;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
27 Lugo;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
27 Lugo;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;92,46
27 Lugo;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
27 Lugo;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
27 Lugo;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
27 Lugo;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;92,73
27 Lugo;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
27 Lugo;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
27 Lugo;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
27 Lugo;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;92,89
27 Lugo;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
27 Lugo;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
27 Lugo;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
27 Lugo;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
27 Lugo;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
27 Lugo;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
27 Lugo;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;90,35
27 Lugo;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
27 Lugo;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
27 Lugo;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
27 Lugo;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;90,98
27 Lugo;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
27 Lugo;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
27 Lugo;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
27 Lugo;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
27 Lugo;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
27 Lugo;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QIII;22.201
27 Lugo;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
27 Lugo;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
27 Lugo;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
27 Lugo;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QIII;22.322
27 Lugo;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
27 Lugo;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
27 Lugo;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
27 Lugo;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QIII;22.338
27 Lugo;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
27 Lugo;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
27 Lugo;All ages;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
27 Lugo;All ages;Cohort July 1;Total;Survival in the first trimester;2022QIII;21.656
27 Lugo;All ages;Cohort July 1;Total;Survival in the first trimester;2022QII;""
27 Lugo;All ages;Cohort July 1;Total;Survival in the first trimester;2022QI;""
27 Lugo;All ages;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
27 Lugo;All ages;Cohort July 1;Total;Survival in the first trimester;2021QIII;21.823
27 Lugo;All ages;Cohort July 1;Total;Survival in the first trimester;2021QII;""
27 Lugo;All ages;Cohort July 1;Total;Survival in the first trimester;2021QI;""
27 Lugo;All ages;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
27 Lugo;All ages;Cohort July 1;Total;Survival in the first trimester;2020QIII;21.822
27 Lugo;All ages;Cohort July 1;Total;Survival in the first trimester;2020QII;""
27 Lugo;All ages;Cohort July 1;Total;Survival in the first trimester;2020QI;""
27 Lugo;All ages;Cohort July 1;Total;Survival in the second trimester;2022QIV;20.961
27 Lugo;All ages;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
27 Lugo;All ages;Cohort July 1;Total;Survival in the second trimester;2022QII;""
27 Lugo;All ages;Cohort July 1;Total;Survival in the second trimester;2022QI;""
27 Lugo;All ages;Cohort July 1;Total;Survival in the second trimester;2021QIV;21.248
27 Lugo;All ages;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
27 Lugo;All ages;Cohort July 1;Total;Survival in the second trimester;2021QII;""
27 Lugo;All ages;Cohort July 1;Total;Survival in the second trimester;2021QI;""
27 Lugo;All ages;Cohort July 1;Total;Survival in the second trimester;2020QIV;21.269
27 Lugo;All ages;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
27 Lugo;All ages;Cohort July 1;Total;Survival in the second trimester;2020QII;""
27 Lugo;All ages;Cohort July 1;Total;Survival in the second trimester;2020QI;""
27 Lugo;All ages;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
27 Lugo;All ages;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
27 Lugo;All ages;Cohort July 1;Total;Survival in the third trimester;2022QII;""
27 Lugo;All ages;Cohort July 1;Total;Survival in the third trimester;2022QI;20.742
27 Lugo;All ages;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
27 Lugo;All ages;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
27 Lugo;All ages;Cohort July 1;Total;Survival in the third trimester;2021QII;""
27 Lugo;All ages;Cohort July 1;Total;Survival in the third trimester;2021QI;20.896
27 Lugo;All ages;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
27 Lugo;All ages;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
27 Lugo;All ages;Cohort July 1;Total;Survival in the third trimester;2020QII;""
27 Lugo;All ages;Cohort July 1;Total;Survival in the third trimester;2020QI;""
27 Lugo;All ages;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
27 Lugo;All ages;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
27 Lugo;All ages;Cohort July 1;Total;Survival in the third trimester;2022QII;20.375
27 Lugo;All ages;Cohort July 1;Total;Survival in the third trimester;2022QI;""
27 Lugo;All ages;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
27 Lugo;All ages;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
27 Lugo;All ages;Cohort July 1;Total;Survival in the third trimester;2021QII;20.517
27 Lugo;All ages;Cohort July 1;Total;Survival in the third trimester;2021QI;""
27 Lugo;All ages;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
27 Lugo;All ages;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
27 Lugo;All ages;Cohort July 1;Total;Survival in the third trimester;2020QII;""
27 Lugo;All ages;Cohort July 1;Total;Survival in the third trimester;2020QI;""
27 Lugo;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
27 Lugo;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
27 Lugo;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
27 Lugo;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
27 Lugo;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
27 Lugo;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
27 Lugo;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
27 Lugo;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
27 Lugo;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
27 Lugo;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
27 Lugo;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
27 Lugo;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
27 Lugo;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
27 Lugo;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;97,55
27 Lugo;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
27 Lugo;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
27 Lugo;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
27 Lugo;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;97,76
27 Lugo;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
27 Lugo;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
27 Lugo;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
27 Lugo;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;97,69
27 Lugo;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
27 Lugo;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
27 Lugo;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;94,41
27 Lugo;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
27 Lugo;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
27 Lugo;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
27 Lugo;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;95,19
27 Lugo;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
27 Lugo;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
27 Lugo;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
27 Lugo;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;95,21
27 Lugo;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
27 Lugo;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
27 Lugo;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
27 Lugo;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
27 Lugo;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
27 Lugo;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
27 Lugo;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;92,92
27 Lugo;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
27 Lugo;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
27 Lugo;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
27 Lugo;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;93,54
27 Lugo;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
27 Lugo;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
27 Lugo;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
27 Lugo;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
27 Lugo;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
27 Lugo;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
27 Lugo;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;91,28
27 Lugo;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
27 Lugo;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
27 Lugo;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
27 Lugo;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;91,85
27 Lugo;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
27 Lugo;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
27 Lugo;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
27 Lugo;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
27 Lugo;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
27 Lugo;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
27 Lugo;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QIII;13.713
27 Lugo;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
27 Lugo;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
27 Lugo;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
27 Lugo;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QIII;13.867
27 Lugo;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
27 Lugo;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
27 Lugo;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
27 Lugo;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QIII;13.844
27 Lugo;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
27 Lugo;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
27 Lugo;All ages;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
27 Lugo;All ages;Cohort July 1;Males;Survival in the first trimester;2022QIII;13.400
27 Lugo;All ages;Cohort July 1;Males;Survival in the first trimester;2022QII;""
27 Lugo;All ages;Cohort July 1;Males;Survival in the first trimester;2022QI;""
27 Lugo;All ages;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
27 Lugo;All ages;Cohort July 1;Males;Survival in the first trimester;2021QIII;13.547
27 Lugo;All ages;Cohort July 1;Males;Survival in the first trimester;2021QII;""
27 Lugo;All ages;Cohort July 1;Males;Survival in the first trimester;2021QI;""
27 Lugo;All ages;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
27 Lugo;All ages;Cohort July 1;Males;Survival in the first trimester;2020QIII;13.545
27 Lugo;All ages;Cohort July 1;Males;Survival in the first trimester;2020QII;""
27 Lugo;All ages;Cohort July 1;Males;Survival in the first trimester;2020QI;""
27 Lugo;All ages;Cohort July 1;Males;Survival in the second trimester;2022QIV;12.974
27 Lugo;All ages;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
27 Lugo;All ages;Cohort July 1;Males;Survival in the second trimester;2022QII;""
27 Lugo;All ages;Cohort July 1;Males;Survival in the second trimester;2022QI;""
27 Lugo;All ages;Cohort July 1;Males;Survival in the second trimester;2021QIV;13.227
27 Lugo;All ages;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
27 Lugo;All ages;Cohort July 1;Males;Survival in the second trimester;2021QII;""
27 Lugo;All ages;Cohort July 1;Males;Survival in the second trimester;2021QI;""
27 Lugo;All ages;Cohort July 1;Males;Survival in the second trimester;2020QIV;13.246
27 Lugo;All ages;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
27 Lugo;All ages;Cohort July 1;Males;Survival in the second trimester;2020QII;""
27 Lugo;All ages;Cohort July 1;Males;Survival in the second trimester;2020QI;""
27 Lugo;All ages;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
27 Lugo;All ages;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
27 Lugo;All ages;Cohort July 1;Males;Survival in the third trimester;2022QII;""
27 Lugo;All ages;Cohort July 1;Males;Survival in the third trimester;2022QI;12.933
27 Lugo;All ages;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
27 Lugo;All ages;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
27 Lugo;All ages;Cohort July 1;Males;Survival in the third trimester;2021QII;""
27 Lugo;All ages;Cohort July 1;Males;Survival in the third trimester;2021QI;13.040
27 Lugo;All ages;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
27 Lugo;All ages;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
27 Lugo;All ages;Cohort July 1;Males;Survival in the third trimester;2020QII;""
27 Lugo;All ages;Cohort July 1;Males;Survival in the third trimester;2020QI;""
27 Lugo;All ages;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
27 Lugo;All ages;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
27 Lugo;All ages;Cohort July 1;Males;Survival in the third trimester;2022QII;12.722
27 Lugo;All ages;Cohort July 1;Males;Survival in the third trimester;2022QI;""
27 Lugo;All ages;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
27 Lugo;All ages;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
27 Lugo;All ages;Cohort July 1;Males;Survival in the third trimester;2021QII;12.833
27 Lugo;All ages;Cohort July 1;Males;Survival in the third trimester;2021QI;""
27 Lugo;All ages;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
27 Lugo;All ages;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
27 Lugo;All ages;Cohort July 1;Males;Survival in the third trimester;2020QII;""
27 Lugo;All ages;Cohort July 1;Males;Survival in the third trimester;2020QI;""
27 Lugo;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
27 Lugo;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
27 Lugo;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
27 Lugo;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
27 Lugo;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
27 Lugo;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
27 Lugo;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
27 Lugo;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
27 Lugo;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
27 Lugo;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
27 Lugo;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
27 Lugo;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
27 Lugo;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
27 Lugo;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;97,72
27 Lugo;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
27 Lugo;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
27 Lugo;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
27 Lugo;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;97,69
27 Lugo;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
27 Lugo;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
27 Lugo;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
27 Lugo;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;97,84
27 Lugo;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
27 Lugo;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
27 Lugo;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;94,61
27 Lugo;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
27 Lugo;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
27 Lugo;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
27 Lugo;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;95,38
27 Lugo;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
27 Lugo;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
27 Lugo;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
27 Lugo;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;95,68
27 Lugo;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
27 Lugo;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
27 Lugo;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
27 Lugo;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
27 Lugo;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
27 Lugo;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
27 Lugo;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;93,26
27 Lugo;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
27 Lugo;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
27 Lugo;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
27 Lugo;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;94,19
27 Lugo;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
27 Lugo;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
27 Lugo;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
27 Lugo;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
27 Lugo;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
27 Lugo;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
27 Lugo;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;91,74
27 Lugo;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
27 Lugo;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
27 Lugo;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
27 Lugo;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;92,7
27 Lugo;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
27 Lugo;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
27 Lugo;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
27 Lugo;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
27 Lugo;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
27 Lugo;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
27 Lugo;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QIII;8.488
27 Lugo;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
27 Lugo;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
27 Lugo;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
27 Lugo;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QIII;8.455
27 Lugo;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
27 Lugo;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
27 Lugo;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
27 Lugo;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QIII;8.494
27 Lugo;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
27 Lugo;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
27 Lugo;All ages;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
27 Lugo;All ages;Cohort July 1;Females;Survival in the first trimester;2022QIII;8.256
27 Lugo;All ages;Cohort July 1;Females;Survival in the first trimester;2022QII;""
27 Lugo;All ages;Cohort July 1;Females;Survival in the first trimester;2022QI;""
27 Lugo;All ages;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
27 Lugo;All ages;Cohort July 1;Females;Survival in the first trimester;2021QIII;8.276
27 Lugo;All ages;Cohort July 1;Females;Survival in the first trimester;2021QII;""
27 Lugo;All ages;Cohort July 1;Females;Survival in the first trimester;2021QI;""
27 Lugo;All ages;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
27 Lugo;All ages;Cohort July 1;Females;Survival in the first trimester;2020QIII;8.277
27 Lugo;All ages;Cohort July 1;Females;Survival in the first trimester;2020QII;""
27 Lugo;All ages;Cohort July 1;Females;Survival in the first trimester;2020QI;""
27 Lugo;All ages;Cohort July 1;Females;Survival in the second trimester;2022QIV;7.987
27 Lugo;All ages;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
27 Lugo;All ages;Cohort July 1;Females;Survival in the second trimester;2022QII;""
27 Lugo;All ages;Cohort July 1;Females;Survival in the second trimester;2022QI;""
27 Lugo;All ages;Cohort July 1;Females;Survival in the second trimester;2021QIV;8.021
27 Lugo;All ages;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
27 Lugo;All ages;Cohort July 1;Females;Survival in the second trimester;2021QII;""
27 Lugo;All ages;Cohort July 1;Females;Survival in the second trimester;2021QI;""
27 Lugo;All ages;Cohort July 1;Females;Survival in the second trimester;2020QIV;8.023
27 Lugo;All ages;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
27 Lugo;All ages;Cohort July 1;Females;Survival in the second trimester;2020QII;""
27 Lugo;All ages;Cohort July 1;Females;Survival in the second trimester;2020QI;""
27 Lugo;All ages;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
27 Lugo;All ages;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
27 Lugo;All ages;Cohort July 1;Females;Survival in the third trimester;2022QII;""
27 Lugo;All ages;Cohort July 1;Females;Survival in the third trimester;2022QI;7.809
27 Lugo;All ages;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
27 Lugo;All ages;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
27 Lugo;All ages;Cohort July 1;Females;Survival in the third trimester;2021QII;""
27 Lugo;All ages;Cohort July 1;Females;Survival in the third trimester;2021QI;7.856
27 Lugo;All ages;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
27 Lugo;All ages;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
27 Lugo;All ages;Cohort July 1;Females;Survival in the third trimester;2020QII;""
27 Lugo;All ages;Cohort July 1;Females;Survival in the third trimester;2020QI;""
27 Lugo;All ages;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
27 Lugo;All ages;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
27 Lugo;All ages;Cohort July 1;Females;Survival in the third trimester;2022QII;7.653
27 Lugo;All ages;Cohort July 1;Females;Survival in the third trimester;2022QI;""
27 Lugo;All ages;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
27 Lugo;All ages;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
27 Lugo;All ages;Cohort July 1;Females;Survival in the third trimester;2021QII;7.684
27 Lugo;All ages;Cohort July 1;Females;Survival in the third trimester;2021QI;""
27 Lugo;All ages;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
27 Lugo;All ages;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
27 Lugo;All ages;Cohort July 1;Females;Survival in the third trimester;2020QII;""
27 Lugo;All ages;Cohort July 1;Females;Survival in the third trimester;2020QI;""
27 Lugo;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
27 Lugo;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
27 Lugo;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
27 Lugo;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
27 Lugo;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
27 Lugo;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
27 Lugo;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
27 Lugo;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
27 Lugo;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
27 Lugo;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
27 Lugo;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
27 Lugo;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
27 Lugo;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
27 Lugo;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;97,27
27 Lugo;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
27 Lugo;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
27 Lugo;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
27 Lugo;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;97,88
27 Lugo;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
27 Lugo;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
27 Lugo;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
27 Lugo;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;97,45
27 Lugo;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
27 Lugo;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
27 Lugo;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;94,1
27 Lugo;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
27 Lugo;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
27 Lugo;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
27 Lugo;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;94,87
27 Lugo;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
27 Lugo;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
27 Lugo;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
27 Lugo;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;94,45
27 Lugo;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
27 Lugo;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
27 Lugo;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
27 Lugo;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
27 Lugo;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
27 Lugo;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
27 Lugo;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;92,36
27 Lugo;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
27 Lugo;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
27 Lugo;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
27 Lugo;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;92,49
27 Lugo;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
27 Lugo;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
27 Lugo;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
27 Lugo;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
27 Lugo;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
27 Lugo;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
27 Lugo;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;90,51
27 Lugo;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
27 Lugo;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
27 Lugo;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
27 Lugo;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;90,46
27 Lugo;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
27 Lugo;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
27 Lugo;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
27 Lugo;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
27 Lugo;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
27 Lugo;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QIV;22.047
27 Lugo;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
27 Lugo;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
27 Lugo;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
27 Lugo;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QIV;22.306
27 Lugo;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
27 Lugo;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
27 Lugo;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
27 Lugo;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QIV;22.292
27 Lugo;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
27 Lugo;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
27 Lugo;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
27 Lugo;All ages;Cohort October 1;Total;Survival in the first trimester;2022QIV;21.309
27 Lugo;All ages;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
27 Lugo;All ages;Cohort October 1;Total;Survival in the first trimester;2022QII;""
27 Lugo;All ages;Cohort October 1;Total;Survival in the first trimester;2022QI;""
27 Lugo;All ages;Cohort October 1;Total;Survival in the first trimester;2021QIV;21.666
27 Lugo;All ages;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
27 Lugo;All ages;Cohort October 1;Total;Survival in the first trimester;2021QII;""
27 Lugo;All ages;Cohort October 1;Total;Survival in the first trimester;2021QI;""
27 Lugo;All ages;Cohort October 1;Total;Survival in the first trimester;2020QIV;21.674
27 Lugo;All ages;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
27 Lugo;All ages;Cohort October 1;Total;Survival in the first trimester;2020QII;""
27 Lugo;All ages;Cohort October 1;Total;Survival in the first trimester;2020QI;""
27 Lugo;All ages;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
27 Lugo;All ages;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
27 Lugo;All ages;Cohort October 1;Total;Survival in the second trimester;2022QII;""
27 Lugo;All ages;Cohort October 1;Total;Survival in the second trimester;2022QI;21.132
27 Lugo;All ages;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
27 Lugo;All ages;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
27 Lugo;All ages;Cohort October 1;Total;Survival in the second trimester;2021QII;""
27 Lugo;All ages;Cohort October 1;Total;Survival in the second trimester;2021QI;21.278
27 Lugo;All ages;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
27 Lugo;All ages;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
27 Lugo;All ages;Cohort October 1;Total;Survival in the second trimester;2020QII;""
27 Lugo;All ages;Cohort October 1;Total;Survival in the second trimester;2020QI;""
27 Lugo;All ages;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
27 Lugo;All ages;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
27 Lugo;All ages;Cohort October 1;Total;Survival in the third trimester;2022QII;20.741
27 Lugo;All ages;Cohort October 1;Total;Survival in the third trimester;2022QI;""
27 Lugo;All ages;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
27 Lugo;All ages;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
27 Lugo;All ages;Cohort October 1;Total;Survival in the third trimester;2021QII;20.880
27 Lugo;All ages;Cohort October 1;Total;Survival in the third trimester;2021QI;""
27 Lugo;All ages;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
27 Lugo;All ages;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
27 Lugo;All ages;Cohort October 1;Total;Survival in the third trimester;2020QII;""
27 Lugo;All ages;Cohort October 1;Total;Survival in the third trimester;2020QI;""
27 Lugo;All ages;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
27 Lugo;All ages;Cohort October 1;Total;Survival in the third trimester;2022QIII;20.332
27 Lugo;All ages;Cohort October 1;Total;Survival in the third trimester;2022QII;""
27 Lugo;All ages;Cohort October 1;Total;Survival in the third trimester;2022QI;""
27 Lugo;All ages;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
27 Lugo;All ages;Cohort October 1;Total;Survival in the third trimester;2021QIII;20.488
27 Lugo;All ages;Cohort October 1;Total;Survival in the third trimester;2021QII;""
27 Lugo;All ages;Cohort October 1;Total;Survival in the third trimester;2021QI;""
27 Lugo;All ages;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
27 Lugo;All ages;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
27 Lugo;All ages;Cohort October 1;Total;Survival in the third trimester;2020QII;""
27 Lugo;All ages;Cohort October 1;Total;Survival in the third trimester;2020QI;""
27 Lugo;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
27 Lugo;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
27 Lugo;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
27 Lugo;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
27 Lugo;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
27 Lugo;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
27 Lugo;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
27 Lugo;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
27 Lugo;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
27 Lugo;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
27 Lugo;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
27 Lugo;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
27 Lugo;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;96,65
27 Lugo;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
27 Lugo;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
27 Lugo;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
27 Lugo;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;97,13
27 Lugo;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
27 Lugo;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
27 Lugo;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
27 Lugo;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;97,23
27 Lugo;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
27 Lugo;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
27 Lugo;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
27 Lugo;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
27 Lugo;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
27 Lugo;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
27 Lugo;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;94,74
27 Lugo;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
27 Lugo;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
27 Lugo;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
27 Lugo;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;95,45
27 Lugo;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
27 Lugo;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
27 Lugo;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
27 Lugo;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
27 Lugo;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
27 Lugo;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
27 Lugo;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;92,98
27 Lugo;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
27 Lugo;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
27 Lugo;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
27 Lugo;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;93,67
27 Lugo;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
27 Lugo;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
27 Lugo;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
27 Lugo;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
27 Lugo;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
27 Lugo;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
27 Lugo;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;91,15
27 Lugo;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
27 Lugo;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
27 Lugo;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
27 Lugo;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;91,91
27 Lugo;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
27 Lugo;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
27 Lugo;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
27 Lugo;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
27 Lugo;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
27 Lugo;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
27 Lugo;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QIV;13.618
27 Lugo;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
27 Lugo;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
27 Lugo;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
27 Lugo;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QIV;13.821
27 Lugo;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
27 Lugo;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
27 Lugo;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
27 Lugo;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QIV;13.820
27 Lugo;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
27 Lugo;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
27 Lugo;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
27 Lugo;All ages;Cohort October 1;Males;Survival in the first trimester;2022QIV;13.167
27 Lugo;All ages;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
27 Lugo;All ages;Cohort October 1;Males;Survival in the first trimester;2022QII;""
27 Lugo;All ages;Cohort October 1;Males;Survival in the first trimester;2022QI;""
27 Lugo;All ages;Cohort October 1;Males;Survival in the first trimester;2021QIV;13.456
27 Lugo;All ages;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
27 Lugo;All ages;Cohort October 1;Males;Survival in the first trimester;2021QII;""
27 Lugo;All ages;Cohort October 1;Males;Survival in the first trimester;2021QI;""
27 Lugo;All ages;Cohort October 1;Males;Survival in the first trimester;2020QIV;13.484
27 Lugo;All ages;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
27 Lugo;All ages;Cohort October 1;Males;Survival in the first trimester;2020QII;""
27 Lugo;All ages;Cohort October 1;Males;Survival in the first trimester;2020QI;""
27 Lugo;All ages;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
27 Lugo;All ages;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
27 Lugo;All ages;Cohort October 1;Males;Survival in the second trimester;2022QII;""
27 Lugo;All ages;Cohort October 1;Males;Survival in the second trimester;2022QI;13.143
27 Lugo;All ages;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
27 Lugo;All ages;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
27 Lugo;All ages;Cohort October 1;Males;Survival in the second trimester;2021QII;""
27 Lugo;All ages;Cohort October 1;Males;Survival in the second trimester;2021QI;13.264
27 Lugo;All ages;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
27 Lugo;All ages;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
27 Lugo;All ages;Cohort October 1;Males;Survival in the second trimester;2020QII;""
27 Lugo;All ages;Cohort October 1;Males;Survival in the second trimester;2020QI;""
27 Lugo;All ages;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
27 Lugo;All ages;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
27 Lugo;All ages;Cohort October 1;Males;Survival in the third trimester;2022QII;12.918
27 Lugo;All ages;Cohort October 1;Males;Survival in the third trimester;2022QI;""
27 Lugo;All ages;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
27 Lugo;All ages;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
27 Lugo;All ages;Cohort October 1;Males;Survival in the third trimester;2021QII;13.048
27 Lugo;All ages;Cohort October 1;Males;Survival in the third trimester;2021QI;""
27 Lugo;All ages;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
27 Lugo;All ages;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
27 Lugo;All ages;Cohort October 1;Males;Survival in the third trimester;2020QII;""
27 Lugo;All ages;Cohort October 1;Males;Survival in the third trimester;2020QI;""
27 Lugo;All ages;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
27 Lugo;All ages;Cohort October 1;Males;Survival in the third trimester;2022QIII;12.679
27 Lugo;All ages;Cohort October 1;Males;Survival in the third trimester;2022QII;""
27 Lugo;All ages;Cohort October 1;Males;Survival in the third trimester;2022QI;""
27 Lugo;All ages;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
27 Lugo;All ages;Cohort October 1;Males;Survival in the third trimester;2021QIII;12.803
27 Lugo;All ages;Cohort October 1;Males;Survival in the third trimester;2021QII;""
27 Lugo;All ages;Cohort October 1;Males;Survival in the third trimester;2021QI;""
27 Lugo;All ages;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
27 Lugo;All ages;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
27 Lugo;All ages;Cohort October 1;Males;Survival in the third trimester;2020QII;""
27 Lugo;All ages;Cohort October 1;Males;Survival in the third trimester;2020QI;""
27 Lugo;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
27 Lugo;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
27 Lugo;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
27 Lugo;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
27 Lugo;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
27 Lugo;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
27 Lugo;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
27 Lugo;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
27 Lugo;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
27 Lugo;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
27 Lugo;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
27 Lugo;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
27 Lugo;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;96,69
27 Lugo;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
27 Lugo;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
27 Lugo;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
27 Lugo;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;97,36
27 Lugo;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
27 Lugo;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
27 Lugo;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
27 Lugo;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;97,57
27 Lugo;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
27 Lugo;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
27 Lugo;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
27 Lugo;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
27 Lugo;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
27 Lugo;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
27 Lugo;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;95,09
27 Lugo;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
27 Lugo;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
27 Lugo;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
27 Lugo;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;95,98
27 Lugo;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
27 Lugo;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
27 Lugo;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
27 Lugo;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
27 Lugo;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
27 Lugo;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
27 Lugo;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;93,47
27 Lugo;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
27 Lugo;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
27 Lugo;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
27 Lugo;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;94,41
27 Lugo;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
27 Lugo;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
27 Lugo;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
27 Lugo;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
27 Lugo;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
27 Lugo;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
27 Lugo;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;91,74
27 Lugo;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
27 Lugo;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
27 Lugo;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
27 Lugo;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;92,64
27 Lugo;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
27 Lugo;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
27 Lugo;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
27 Lugo;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
27 Lugo;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
27 Lugo;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
27 Lugo;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QIV;8.429
27 Lugo;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
27 Lugo;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
27 Lugo;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
27 Lugo;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QIV;8.485
27 Lugo;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
27 Lugo;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
27 Lugo;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
27 Lugo;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QIV;8.472
27 Lugo;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
27 Lugo;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
27 Lugo;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
27 Lugo;All ages;Cohort October 1;Females;Survival in the first trimester;2022QIV;8.142
27 Lugo;All ages;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
27 Lugo;All ages;Cohort October 1;Females;Survival in the first trimester;2022QII;""
27 Lugo;All ages;Cohort October 1;Females;Survival in the first trimester;2022QI;""
27 Lugo;All ages;Cohort October 1;Females;Survival in the first trimester;2021QIV;8.210
27 Lugo;All ages;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
27 Lugo;All ages;Cohort October 1;Females;Survival in the first trimester;2021QII;""
27 Lugo;All ages;Cohort October 1;Females;Survival in the first trimester;2021QI;""
27 Lugo;All ages;Cohort October 1;Females;Survival in the first trimester;2020QIV;8.190
27 Lugo;All ages;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
27 Lugo;All ages;Cohort October 1;Females;Survival in the first trimester;2020QII;""
27 Lugo;All ages;Cohort October 1;Females;Survival in the first trimester;2020QI;""
27 Lugo;All ages;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
27 Lugo;All ages;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
27 Lugo;All ages;Cohort October 1;Females;Survival in the second trimester;2022QII;""
27 Lugo;All ages;Cohort October 1;Females;Survival in the second trimester;2022QI;7.989
27 Lugo;All ages;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
27 Lugo;All ages;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
27 Lugo;All ages;Cohort October 1;Females;Survival in the second trimester;2021QII;""
27 Lugo;All ages;Cohort October 1;Females;Survival in the second trimester;2021QI;8.014
27 Lugo;All ages;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
27 Lugo;All ages;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
27 Lugo;All ages;Cohort October 1;Females;Survival in the second trimester;2020QII;""
27 Lugo;All ages;Cohort October 1;Females;Survival in the second trimester;2020QI;""
27 Lugo;All ages;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
27 Lugo;All ages;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
27 Lugo;All ages;Cohort October 1;Females;Survival in the third trimester;2022QII;7.823
27 Lugo;All ages;Cohort October 1;Females;Survival in the third trimester;2022QI;""
27 Lugo;All ages;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
27 Lugo;All ages;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
27 Lugo;All ages;Cohort October 1;Females;Survival in the third trimester;2021QII;7.832
27 Lugo;All ages;Cohort October 1;Females;Survival in the third trimester;2021QI;""
27 Lugo;All ages;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
27 Lugo;All ages;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
27 Lugo;All ages;Cohort October 1;Females;Survival in the third trimester;2020QII;""
27 Lugo;All ages;Cohort October 1;Females;Survival in the third trimester;2020QI;""
27 Lugo;All ages;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
27 Lugo;All ages;Cohort October 1;Females;Survival in the third trimester;2022QIII;7.653
27 Lugo;All ages;Cohort October 1;Females;Survival in the third trimester;2022QII;""
27 Lugo;All ages;Cohort October 1;Females;Survival in the third trimester;2022QI;""
27 Lugo;All ages;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
27 Lugo;All ages;Cohort October 1;Females;Survival in the third trimester;2021QIII;7.685
27 Lugo;All ages;Cohort October 1;Females;Survival in the third trimester;2021QII;""
27 Lugo;All ages;Cohort October 1;Females;Survival in the third trimester;2021QI;""
27 Lugo;All ages;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
27 Lugo;All ages;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
27 Lugo;All ages;Cohort October 1;Females;Survival in the third trimester;2020QII;""
27 Lugo;All ages;Cohort October 1;Females;Survival in the third trimester;2020QI;""
27 Lugo;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
27 Lugo;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
27 Lugo;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
27 Lugo;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
27 Lugo;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
27 Lugo;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
27 Lugo;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
27 Lugo;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
27 Lugo;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
27 Lugo;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
27 Lugo;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
27 Lugo;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
27 Lugo;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;96,6
27 Lugo;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
27 Lugo;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
27 Lugo;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
27 Lugo;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;96,76
27 Lugo;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
27 Lugo;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
27 Lugo;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
27 Lugo;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;96,67
27 Lugo;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
27 Lugo;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
27 Lugo;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
27 Lugo;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
27 Lugo;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
27 Lugo;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
27 Lugo;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;94,15
27 Lugo;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
27 Lugo;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
27 Lugo;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
27 Lugo;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;94,59
27 Lugo;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
27 Lugo;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
27 Lugo;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
27 Lugo;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
27 Lugo;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
27 Lugo;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
27 Lugo;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;92,2
27 Lugo;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
27 Lugo;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
27 Lugo;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
27 Lugo;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;92,45
27 Lugo;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
27 Lugo;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
27 Lugo;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
27 Lugo;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
27 Lugo;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
27 Lugo;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
27 Lugo;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;90,19
27 Lugo;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
27 Lugo;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
27 Lugo;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
27 Lugo;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;90,71
27 Lugo;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
27 Lugo;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
27 Lugo;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
27 Lugo;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
27 Lugo;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
27 Lugo;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
27 Lugo;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
27 Lugo;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
27 Lugo;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
27 Lugo;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QI;1.055
27 Lugo;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
27 Lugo;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
27 Lugo;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
27 Lugo;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QI;1.014
27 Lugo;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
27 Lugo;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
27 Lugo;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
27 Lugo;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QI;822
27 Lugo;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
27 Lugo;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
27 Lugo;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2022QII;""
27 Lugo;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2022QI;993
27 Lugo;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
27 Lugo;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
27 Lugo;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2021QII;""
27 Lugo;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2021QI;969
27 Lugo;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
27 Lugo;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
27 Lugo;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2020QII;""
27 Lugo;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2020QI;751
27 Lugo;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
27 Lugo;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
27 Lugo;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2022QII;948
27 Lugo;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2022QI;""
27 Lugo;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
27 Lugo;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
27 Lugo;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2021QII;920
27 Lugo;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2021QI;""
27 Lugo;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
27 Lugo;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
27 Lugo;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2020QII;721
27 Lugo;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2020QI;""
27 Lugo;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
27 Lugo;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QIII;912
27 Lugo;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QII;""
27 Lugo;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QI;""
27 Lugo;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
27 Lugo;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QIII;879
27 Lugo;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QII;""
27 Lugo;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QI;""
27 Lugo;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
27 Lugo;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QIII;679
27 Lugo;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QII;""
27 Lugo;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QI;""
27 Lugo;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QIV;870
27 Lugo;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
27 Lugo;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QII;""
27 Lugo;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QI;""
27 Lugo;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QIV;838
27 Lugo;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
27 Lugo;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QII;""
27 Lugo;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QI;""
27 Lugo;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QIV;657
27 Lugo;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
27 Lugo;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QII;""
27 Lugo;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QI;""
27 Lugo;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
27 Lugo;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
27 Lugo;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
27 Lugo;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
27 Lugo;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
27 Lugo;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
27 Lugo;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
27 Lugo;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
27 Lugo;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
27 Lugo;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
27 Lugo;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
27 Lugo;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
27 Lugo;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
27 Lugo;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
27 Lugo;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
27 Lugo;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;94,12
27 Lugo;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
27 Lugo;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
27 Lugo;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
27 Lugo;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;95,56
27 Lugo;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
27 Lugo;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
27 Lugo;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
27 Lugo;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;91,36
27 Lugo;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
27 Lugo;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
27 Lugo;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;89,86
27 Lugo;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
27 Lugo;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
27 Lugo;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
27 Lugo;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;90,73
27 Lugo;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
27 Lugo;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
27 Lugo;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
27 Lugo;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;87,71
27 Lugo;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
27 Lugo;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
27 Lugo;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;86,45
27 Lugo;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
27 Lugo;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
27 Lugo;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
27 Lugo;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;86,69
27 Lugo;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
27 Lugo;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
27 Lugo;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
27 Lugo;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;82,6
27 Lugo;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
27 Lugo;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
27 Lugo;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;82,46
27 Lugo;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
27 Lugo;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
27 Lugo;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
27 Lugo;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;82,64
27 Lugo;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
27 Lugo;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
27 Lugo;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
27 Lugo;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;79,93
27 Lugo;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
27 Lugo;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
27 Lugo;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
27 Lugo;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
27 Lugo;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
27 Lugo;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
27 Lugo;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QI;629
27 Lugo;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
27 Lugo;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
27 Lugo;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
27 Lugo;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QI;627
27 Lugo;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
27 Lugo;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
27 Lugo;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
27 Lugo;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QI;500
27 Lugo;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
27 Lugo;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
27 Lugo;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2022QII;""
27 Lugo;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2022QI;591
27 Lugo;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
27 Lugo;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
27 Lugo;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2021QII;""
27 Lugo;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2021QI;602
27 Lugo;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
27 Lugo;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
27 Lugo;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2020QII;""
27 Lugo;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2020QI;459
27 Lugo;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
27 Lugo;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
27 Lugo;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2022QII;568
27 Lugo;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2022QI;""
27 Lugo;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
27 Lugo;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
27 Lugo;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2021QII;569
27 Lugo;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2021QI;""
27 Lugo;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
27 Lugo;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
27 Lugo;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2020QII;445
27 Lugo;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2020QI;""
27 Lugo;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
27 Lugo;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QIII;550
27 Lugo;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QII;""
27 Lugo;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QI;""
27 Lugo;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
27 Lugo;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QIII;542
27 Lugo;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QII;""
27 Lugo;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QI;""
27 Lugo;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
27 Lugo;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QIII;420
27 Lugo;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QII;""
27 Lugo;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QI;""
27 Lugo;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QIV;523
27 Lugo;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
27 Lugo;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QII;""
27 Lugo;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QI;""
27 Lugo;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QIV;517
27 Lugo;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
27 Lugo;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QII;""
27 Lugo;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QI;""
27 Lugo;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QIV;414
27 Lugo;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
27 Lugo;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QII;""
27 Lugo;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QI;""
27 Lugo;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
27 Lugo;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
27 Lugo;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
27 Lugo;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
27 Lugo;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
27 Lugo;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
27 Lugo;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
27 Lugo;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
27 Lugo;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
27 Lugo;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
27 Lugo;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
27 Lugo;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
27 Lugo;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
27 Lugo;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
27 Lugo;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
27 Lugo;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;93,96
27 Lugo;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
27 Lugo;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
27 Lugo;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
27 Lugo;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;96,01
27 Lugo;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
27 Lugo;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
27 Lugo;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
27 Lugo;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;91,8
27 Lugo;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
27 Lugo;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
27 Lugo;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;90,3
27 Lugo;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
27 Lugo;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
27 Lugo;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
27 Lugo;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;90,75
27 Lugo;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
27 Lugo;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
27 Lugo;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
27 Lugo;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;89
27 Lugo;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
27 Lugo;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
27 Lugo;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;87,44
27 Lugo;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
27 Lugo;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
27 Lugo;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
27 Lugo;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;86,44
27 Lugo;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
27 Lugo;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
27 Lugo;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
27 Lugo;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;84
27 Lugo;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
27 Lugo;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
27 Lugo;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;83,15
27 Lugo;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
27 Lugo;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
27 Lugo;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
27 Lugo;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;82,46
27 Lugo;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
27 Lugo;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
27 Lugo;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
27 Lugo;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;82,8
27 Lugo;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
27 Lugo;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
27 Lugo;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
27 Lugo;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
27 Lugo;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
27 Lugo;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
27 Lugo;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QI;426
27 Lugo;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
27 Lugo;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
27 Lugo;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
27 Lugo;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QI;387
27 Lugo;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
27 Lugo;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
27 Lugo;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
27 Lugo;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QI;322
27 Lugo;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
27 Lugo;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
27 Lugo;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2022QII;""
27 Lugo;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2022QI;402
27 Lugo;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
27 Lugo;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
27 Lugo;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2021QII;""
27 Lugo;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2021QI;367
27 Lugo;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
27 Lugo;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
27 Lugo;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2020QII;""
27 Lugo;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2020QI;292
27 Lugo;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
27 Lugo;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
27 Lugo;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2022QII;380
27 Lugo;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2022QI;""
27 Lugo;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
27 Lugo;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
27 Lugo;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2021QII;351
27 Lugo;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2021QI;""
27 Lugo;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
27 Lugo;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
27 Lugo;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2020QII;276
27 Lugo;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2020QI;""
27 Lugo;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
27 Lugo;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QIII;362
27 Lugo;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QII;""
27 Lugo;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QI;""
27 Lugo;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
27 Lugo;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QIII;337
27 Lugo;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QII;""
27 Lugo;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QI;""
27 Lugo;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
27 Lugo;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QIII;259
27 Lugo;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QII;""
27 Lugo;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QI;""
27 Lugo;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QIV;347
27 Lugo;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
27 Lugo;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QII;""
27 Lugo;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QI;""
27 Lugo;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QIV;321
27 Lugo;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
27 Lugo;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QII;""
27 Lugo;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QI;""
27 Lugo;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QIV;243
27 Lugo;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
27 Lugo;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QII;""
27 Lugo;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QI;""
27 Lugo;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
27 Lugo;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
27 Lugo;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
27 Lugo;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
27 Lugo;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
27 Lugo;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
27 Lugo;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
27 Lugo;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
27 Lugo;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
27 Lugo;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
27 Lugo;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
27 Lugo;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
27 Lugo;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
27 Lugo;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
27 Lugo;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
27 Lugo;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;94,37
27 Lugo;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
27 Lugo;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
27 Lugo;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
27 Lugo;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;94,83
27 Lugo;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
27 Lugo;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
27 Lugo;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
27 Lugo;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;90,68
27 Lugo;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
27 Lugo;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
27 Lugo;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;89,2
27 Lugo;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
27 Lugo;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
27 Lugo;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
27 Lugo;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;90,7
27 Lugo;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
27 Lugo;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
27 Lugo;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
27 Lugo;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;85,71
27 Lugo;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
27 Lugo;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
27 Lugo;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;84,98
27 Lugo;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
27 Lugo;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
27 Lugo;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
27 Lugo;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;87,08
27 Lugo;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
27 Lugo;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
27 Lugo;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
27 Lugo;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;80,43
27 Lugo;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
27 Lugo;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
27 Lugo;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;81,46
27 Lugo;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
27 Lugo;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
27 Lugo;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
27 Lugo;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;82,95
27 Lugo;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
27 Lugo;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
27 Lugo;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
27 Lugo;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;75,47
27 Lugo;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
27 Lugo;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
27 Lugo;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
27 Lugo;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
27 Lugo;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
27 Lugo;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QII;908
27 Lugo;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
27 Lugo;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
27 Lugo;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
27 Lugo;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QII;908
27 Lugo;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
27 Lugo;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
27 Lugo;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
27 Lugo;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QII;867
27 Lugo;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
27 Lugo;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
27 Lugo;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
27 Lugo;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2022QII;863
27 Lugo;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2022QI;""
27 Lugo;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
27 Lugo;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
27 Lugo;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2021QII;851
27 Lugo;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2021QI;""
27 Lugo;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
27 Lugo;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
27 Lugo;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2020QII;831
27 Lugo;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2020QI;""
27 Lugo;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
27 Lugo;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2022QIII;822
27 Lugo;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2022QII;""
27 Lugo;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2022QI;""
27 Lugo;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
27 Lugo;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2021QIII;806
27 Lugo;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2021QII;""
27 Lugo;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2021QI;""
27 Lugo;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
27 Lugo;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2020QIII;780
27 Lugo;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2020QII;""
27 Lugo;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2020QI;""
27 Lugo;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QIV;781
27 Lugo;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
27 Lugo;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QII;""
27 Lugo;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QI;""
27 Lugo;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QIV;761
27 Lugo;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
27 Lugo;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QII;""
27 Lugo;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QI;""
27 Lugo;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QIV;754
27 Lugo;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
27 Lugo;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QII;""
27 Lugo;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QI;""
27 Lugo;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
27 Lugo;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
27 Lugo;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QII;""
27 Lugo;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QI;728
27 Lugo;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
27 Lugo;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
27 Lugo;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QII;""
27 Lugo;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QI;727
27 Lugo;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
27 Lugo;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
27 Lugo;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QII;""
27 Lugo;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QI;""
27 Lugo;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
27 Lugo;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
27 Lugo;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
27 Lugo;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
27 Lugo;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
27 Lugo;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
27 Lugo;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
27 Lugo;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
27 Lugo;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
27 Lugo;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
27 Lugo;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
27 Lugo;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
27 Lugo;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
27 Lugo;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
27 Lugo;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;95,04
27 Lugo;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
27 Lugo;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
27 Lugo;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
27 Lugo;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;93,72
27 Lugo;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
27 Lugo;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
27 Lugo;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
27 Lugo;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;95,85
27 Lugo;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
27 Lugo;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
27 Lugo;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;90,53
27 Lugo;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
27 Lugo;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
27 Lugo;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
27 Lugo;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;88,77
27 Lugo;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
27 Lugo;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
27 Lugo;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
27 Lugo;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;89,97
27 Lugo;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
27 Lugo;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
27 Lugo;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;86,01
27 Lugo;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
27 Lugo;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
27 Lugo;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
27 Lugo;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;83,81
27 Lugo;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
27 Lugo;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
27 Lugo;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
27 Lugo;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;86,97
27 Lugo;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
27 Lugo;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
27 Lugo;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
27 Lugo;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
27 Lugo;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
27 Lugo;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
27 Lugo;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;80,18
27 Lugo;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
27 Lugo;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
27 Lugo;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
27 Lugo;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;83,85
27 Lugo;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
27 Lugo;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
27 Lugo;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
27 Lugo;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
27 Lugo;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
27 Lugo;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
27 Lugo;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QII;547
27 Lugo;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
27 Lugo;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
27 Lugo;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
27 Lugo;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QII;565
27 Lugo;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
27 Lugo;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
27 Lugo;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
27 Lugo;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QII;527
27 Lugo;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
27 Lugo;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
27 Lugo;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
27 Lugo;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2022QII;523
27 Lugo;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2022QI;""
27 Lugo;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
27 Lugo;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
27 Lugo;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2021QII;526
27 Lugo;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2021QI;""
27 Lugo;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
27 Lugo;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
27 Lugo;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2020QII;508
27 Lugo;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2020QI;""
27 Lugo;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
27 Lugo;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2022QIII;501
27 Lugo;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2022QII;""
27 Lugo;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2022QI;""
27 Lugo;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
27 Lugo;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2021QIII;494
27 Lugo;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2021QII;""
27 Lugo;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2021QI;""
27 Lugo;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
27 Lugo;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2020QIII;479
27 Lugo;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2020QII;""
27 Lugo;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2020QI;""
27 Lugo;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QIV;474
27 Lugo;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
27 Lugo;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QII;""
27 Lugo;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QI;""
27 Lugo;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QIV;467
27 Lugo;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
27 Lugo;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QII;""
27 Lugo;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QI;""
27 Lugo;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QIV;470
27 Lugo;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
27 Lugo;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QII;""
27 Lugo;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QI;""
27 Lugo;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
27 Lugo;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
27 Lugo;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QII;""
27 Lugo;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QI;448
27 Lugo;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
27 Lugo;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
27 Lugo;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QII;""
27 Lugo;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QI;454
27 Lugo;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
27 Lugo;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
27 Lugo;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QII;""
27 Lugo;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QI;""
27 Lugo;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
27 Lugo;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
27 Lugo;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
27 Lugo;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
27 Lugo;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
27 Lugo;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
27 Lugo;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
27 Lugo;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
27 Lugo;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
27 Lugo;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
27 Lugo;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
27 Lugo;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
27 Lugo;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
27 Lugo;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
27 Lugo;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;95,61
27 Lugo;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
27 Lugo;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
27 Lugo;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
27 Lugo;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;93,1
27 Lugo;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
27 Lugo;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
27 Lugo;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
27 Lugo;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;96,39
27 Lugo;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
27 Lugo;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
27 Lugo;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;91,59
27 Lugo;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
27 Lugo;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
27 Lugo;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
27 Lugo;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;87,43
27 Lugo;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
27 Lugo;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
27 Lugo;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
27 Lugo;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;90,89
27 Lugo;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
27 Lugo;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
27 Lugo;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;86,65
27 Lugo;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
27 Lugo;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
27 Lugo;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
27 Lugo;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;82,65
27 Lugo;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
27 Lugo;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
27 Lugo;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
27 Lugo;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;89,18
27 Lugo;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
27 Lugo;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
27 Lugo;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
27 Lugo;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
27 Lugo;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
27 Lugo;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
27 Lugo;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;79,29
27 Lugo;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
27 Lugo;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
27 Lugo;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
27 Lugo;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;86,15
27 Lugo;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
27 Lugo;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
27 Lugo;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
27 Lugo;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
27 Lugo;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
27 Lugo;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
27 Lugo;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QII;361
27 Lugo;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
27 Lugo;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
27 Lugo;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
27 Lugo;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QII;343
27 Lugo;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
27 Lugo;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
27 Lugo;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
27 Lugo;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QII;340
27 Lugo;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
27 Lugo;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
27 Lugo;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
27 Lugo;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2022QII;340
27 Lugo;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2022QI;""
27 Lugo;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
27 Lugo;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
27 Lugo;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2021QII;325
27 Lugo;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2021QI;""
27 Lugo;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
27 Lugo;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
27 Lugo;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2020QII;323
27 Lugo;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2020QI;""
27 Lugo;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
27 Lugo;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2022QIII;321
27 Lugo;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2022QII;""
27 Lugo;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2022QI;""
27 Lugo;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
27 Lugo;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2021QIII;312
27 Lugo;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2021QII;""
27 Lugo;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2021QI;""
27 Lugo;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
27 Lugo;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2020QIII;301
27 Lugo;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2020QII;""
27 Lugo;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2020QI;""
27 Lugo;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QIV;307
27 Lugo;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
27 Lugo;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QII;""
27 Lugo;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QI;""
27 Lugo;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QIV;294
27 Lugo;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
27 Lugo;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QII;""
27 Lugo;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QI;""
27 Lugo;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QIV;284
27 Lugo;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
27 Lugo;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QII;""
27 Lugo;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QI;""
27 Lugo;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
27 Lugo;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
27 Lugo;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QII;""
27 Lugo;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QI;280
27 Lugo;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
27 Lugo;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
27 Lugo;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QII;""
27 Lugo;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QI;273
27 Lugo;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
27 Lugo;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
27 Lugo;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QII;""
27 Lugo;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QI;""
27 Lugo;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
27 Lugo;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
27 Lugo;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
27 Lugo;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
27 Lugo;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
27 Lugo;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
27 Lugo;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
27 Lugo;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
27 Lugo;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
27 Lugo;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
27 Lugo;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
27 Lugo;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
27 Lugo;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
27 Lugo;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
27 Lugo;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;94,18
27 Lugo;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
27 Lugo;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
27 Lugo;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
27 Lugo;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;94,75
27 Lugo;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
27 Lugo;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
27 Lugo;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
27 Lugo;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;95
27 Lugo;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
27 Lugo;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
27 Lugo;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;88,92
27 Lugo;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
27 Lugo;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
27 Lugo;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
27 Lugo;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;90,96
27 Lugo;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
27 Lugo;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
27 Lugo;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
27 Lugo;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;88,53
27 Lugo;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
27 Lugo;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
27 Lugo;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;85,04
27 Lugo;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
27 Lugo;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
27 Lugo;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
27 Lugo;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;85,71
27 Lugo;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
27 Lugo;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
27 Lugo;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
27 Lugo;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;83,53
27 Lugo;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
27 Lugo;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
27 Lugo;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
27 Lugo;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
27 Lugo;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
27 Lugo;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
27 Lugo;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;81,63
27 Lugo;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
27 Lugo;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
27 Lugo;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
27 Lugo;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;80,29
27 Lugo;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
27 Lugo;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
27 Lugo;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
27 Lugo;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
27 Lugo;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
27 Lugo;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QIII;964
27 Lugo;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
27 Lugo;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
27 Lugo;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
27 Lugo;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QIII;949
27 Lugo;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
27 Lugo;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
27 Lugo;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
27 Lugo;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QIII;905
27 Lugo;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
27 Lugo;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
27 Lugo;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
27 Lugo;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2022QIII;901
27 Lugo;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2022QII;""
27 Lugo;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2022QI;""
27 Lugo;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
27 Lugo;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2021QIII;895
27 Lugo;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2021QII;""
27 Lugo;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2021QI;""
27 Lugo;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
27 Lugo;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2020QIII;839
27 Lugo;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2020QII;""
27 Lugo;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2020QI;""
27 Lugo;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2022QIV;849
27 Lugo;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
27 Lugo;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2022QII;""
27 Lugo;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2022QI;""
27 Lugo;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2021QIV;838
27 Lugo;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
27 Lugo;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2021QII;""
27 Lugo;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2021QI;""
27 Lugo;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2020QIV;809
27 Lugo;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
27 Lugo;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2020QII;""
27 Lugo;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2020QI;""
27 Lugo;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
27 Lugo;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
27 Lugo;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QII;""
27 Lugo;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QI;799
27 Lugo;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
27 Lugo;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
27 Lugo;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QII;""
27 Lugo;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QI;778
27 Lugo;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
27 Lugo;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
27 Lugo;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QII;""
27 Lugo;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QI;""
27 Lugo;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
27 Lugo;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
27 Lugo;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QII;767
27 Lugo;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QI;""
27 Lugo;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
27 Lugo;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
27 Lugo;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QII;746
27 Lugo;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QI;""
27 Lugo;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
27 Lugo;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
27 Lugo;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QII;""
27 Lugo;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QI;""
27 Lugo;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
27 Lugo;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
27 Lugo;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
27 Lugo;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
27 Lugo;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
27 Lugo;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
27 Lugo;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
27 Lugo;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
27 Lugo;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
27 Lugo;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
27 Lugo;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
27 Lugo;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
27 Lugo;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
27 Lugo;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;93,46
27 Lugo;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
27 Lugo;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
27 Lugo;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
27 Lugo;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;94,31
27 Lugo;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
27 Lugo;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
27 Lugo;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
27 Lugo;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;92,71
27 Lugo;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
27 Lugo;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
27 Lugo;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;88,07
27 Lugo;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
27 Lugo;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
27 Lugo;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
27 Lugo;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;88,3
27 Lugo;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
27 Lugo;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
27 Lugo;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
27 Lugo;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;89,39
27 Lugo;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
27 Lugo;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
27 Lugo;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
27 Lugo;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
27 Lugo;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
27 Lugo;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
27 Lugo;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;84,19
27 Lugo;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
27 Lugo;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
27 Lugo;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
27 Lugo;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;85,97
27 Lugo;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
27 Lugo;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
27 Lugo;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
27 Lugo;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
27 Lugo;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
27 Lugo;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
27 Lugo;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;80,82
27 Lugo;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
27 Lugo;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
27 Lugo;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
27 Lugo;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;82,43
27 Lugo;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
27 Lugo;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
27 Lugo;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
27 Lugo;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
27 Lugo;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
27 Lugo;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
27 Lugo;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QIII;577
27 Lugo;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
27 Lugo;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
27 Lugo;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
27 Lugo;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QIII;576
27 Lugo;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
27 Lugo;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
27 Lugo;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
27 Lugo;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QIII;559
27 Lugo;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
27 Lugo;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
27 Lugo;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
27 Lugo;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2022QIII;540
27 Lugo;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2022QII;""
27 Lugo;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2022QI;""
27 Lugo;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
27 Lugo;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2021QIII;539
27 Lugo;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2021QII;""
27 Lugo;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2021QI;""
27 Lugo;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
27 Lugo;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2020QIII;520
27 Lugo;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2020QII;""
27 Lugo;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2020QI;""
27 Lugo;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2022QIV;508
27 Lugo;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
27 Lugo;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2022QII;""
27 Lugo;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2022QI;""
27 Lugo;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2021QIV;507
27 Lugo;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
27 Lugo;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2021QII;""
27 Lugo;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2021QI;""
27 Lugo;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2020QIV;509
27 Lugo;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
27 Lugo;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2020QII;""
27 Lugo;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2020QI;""
27 Lugo;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
27 Lugo;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
27 Lugo;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QII;""
27 Lugo;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QI;485
27 Lugo;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
27 Lugo;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
27 Lugo;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QII;""
27 Lugo;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QI;490
27 Lugo;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
27 Lugo;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
27 Lugo;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QII;""
27 Lugo;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QI;""
27 Lugo;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
27 Lugo;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
27 Lugo;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QII;470
27 Lugo;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QI;""
27 Lugo;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
27 Lugo;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
27 Lugo;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QII;469
27 Lugo;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QI;""
27 Lugo;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
27 Lugo;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
27 Lugo;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QII;""
27 Lugo;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QI;""
27 Lugo;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
27 Lugo;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
27 Lugo;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
27 Lugo;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
27 Lugo;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
27 Lugo;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
27 Lugo;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
27 Lugo;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
27 Lugo;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
27 Lugo;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
27 Lugo;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
27 Lugo;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
27 Lugo;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
27 Lugo;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;93,59
27 Lugo;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
27 Lugo;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
27 Lugo;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
27 Lugo;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;93,58
27 Lugo;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
27 Lugo;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
27 Lugo;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
27 Lugo;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;93,02
27 Lugo;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
27 Lugo;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
27 Lugo;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;88,04
27 Lugo;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
27 Lugo;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
27 Lugo;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
27 Lugo;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;88,02
27 Lugo;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
27 Lugo;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
27 Lugo;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
27 Lugo;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;91,06
27 Lugo;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
27 Lugo;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
27 Lugo;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
27 Lugo;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
27 Lugo;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
27 Lugo;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
27 Lugo;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;84,2
27 Lugo;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
27 Lugo;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
27 Lugo;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
27 Lugo;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;87,66
27 Lugo;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
27 Lugo;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
27 Lugo;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
27 Lugo;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
27 Lugo;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
27 Lugo;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
27 Lugo;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;81,6
27 Lugo;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
27 Lugo;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
27 Lugo;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
27 Lugo;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;83,9
27 Lugo;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
27 Lugo;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
27 Lugo;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
27 Lugo;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
27 Lugo;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
27 Lugo;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
27 Lugo;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QIII;387
27 Lugo;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
27 Lugo;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
27 Lugo;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
27 Lugo;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QIII;373
27 Lugo;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
27 Lugo;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
27 Lugo;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
27 Lugo;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QIII;346
27 Lugo;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
27 Lugo;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
27 Lugo;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
27 Lugo;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2022QIII;361
27 Lugo;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2022QII;""
27 Lugo;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2022QI;""
27 Lugo;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
27 Lugo;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2021QIII;356
27 Lugo;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2021QII;""
27 Lugo;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2021QI;""
27 Lugo;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
27 Lugo;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2020QIII;319
27 Lugo;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2020QII;""
27 Lugo;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2020QI;""
27 Lugo;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2022QIV;341
27 Lugo;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
27 Lugo;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2022QII;""
27 Lugo;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2022QI;""
27 Lugo;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2021QIV;331
27 Lugo;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
27 Lugo;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2021QII;""
27 Lugo;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2021QI;""
27 Lugo;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2020QIV;300
27 Lugo;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
27 Lugo;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2020QII;""
27 Lugo;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2020QI;""
27 Lugo;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
27 Lugo;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
27 Lugo;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QII;""
27 Lugo;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QI;314
27 Lugo;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
27 Lugo;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
27 Lugo;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QII;""
27 Lugo;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QI;288
27 Lugo;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
27 Lugo;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
27 Lugo;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QII;""
27 Lugo;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QI;""
27 Lugo;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
27 Lugo;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
27 Lugo;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QII;297
27 Lugo;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QI;""
27 Lugo;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
27 Lugo;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
27 Lugo;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QII;277
27 Lugo;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QI;""
27 Lugo;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
27 Lugo;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
27 Lugo;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QII;""
27 Lugo;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QI;""
27 Lugo;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
27 Lugo;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
27 Lugo;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
27 Lugo;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
27 Lugo;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
27 Lugo;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
27 Lugo;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
27 Lugo;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
27 Lugo;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
27 Lugo;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
27 Lugo;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
27 Lugo;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
27 Lugo;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
27 Lugo;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;93,28
27 Lugo;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
27 Lugo;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
27 Lugo;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
27 Lugo;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;95,44
27 Lugo;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
27 Lugo;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
27 Lugo;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
27 Lugo;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;92,2
27 Lugo;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
27 Lugo;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
27 Lugo;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;88,11
27 Lugo;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
27 Lugo;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
27 Lugo;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
27 Lugo;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;88,74
27 Lugo;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
27 Lugo;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
27 Lugo;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
27 Lugo;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;86,71
27 Lugo;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
27 Lugo;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
27 Lugo;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
27 Lugo;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
27 Lugo;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
27 Lugo;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
27 Lugo;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;84,18
27 Lugo;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
27 Lugo;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
27 Lugo;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
27 Lugo;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;83,24
27 Lugo;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
27 Lugo;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
27 Lugo;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
27 Lugo;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
27 Lugo;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
27 Lugo;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
27 Lugo;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;79,62
27 Lugo;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
27 Lugo;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
27 Lugo;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
27 Lugo;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;80,06
27 Lugo;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
27 Lugo;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
27 Lugo;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
27 Lugo;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
27 Lugo;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
27 Lugo;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QIV;981
27 Lugo;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
27 Lugo;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
27 Lugo;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
27 Lugo;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QIV;1.004
27 Lugo;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
27 Lugo;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
27 Lugo;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
27 Lugo;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QIV;932
27 Lugo;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
27 Lugo;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
27 Lugo;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
27 Lugo;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2022QIV;920
27 Lugo;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
27 Lugo;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2022QII;""
27 Lugo;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2022QI;""
27 Lugo;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2021QIV;935
27 Lugo;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
27 Lugo;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2021QII;""
27 Lugo;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2021QI;""
27 Lugo;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2020QIV;891
27 Lugo;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
27 Lugo;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2020QII;""
27 Lugo;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2020QI;""
27 Lugo;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
27 Lugo;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
27 Lugo;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2022QII;""
27 Lugo;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2022QI;885
27 Lugo;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
27 Lugo;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
27 Lugo;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2021QII;""
27 Lugo;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2021QI;856
27 Lugo;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
27 Lugo;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
27 Lugo;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2020QII;""
27 Lugo;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2020QI;""
27 Lugo;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
27 Lugo;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
27 Lugo;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QII;849
27 Lugo;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QI;""
27 Lugo;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
27 Lugo;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
27 Lugo;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QII;819
27 Lugo;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QI;""
27 Lugo;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
27 Lugo;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
27 Lugo;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QII;""
27 Lugo;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QI;""
27 Lugo;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
27 Lugo;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QIII;819
27 Lugo;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QII;""
27 Lugo;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QI;""
27 Lugo;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
27 Lugo;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QIII;788
27 Lugo;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QII;""
27 Lugo;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QI;""
27 Lugo;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
27 Lugo;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
27 Lugo;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QII;""
27 Lugo;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QI;""
27 Lugo;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
27 Lugo;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
27 Lugo;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
27 Lugo;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
27 Lugo;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
27 Lugo;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
27 Lugo;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
27 Lugo;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
27 Lugo;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
27 Lugo;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
27 Lugo;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
27 Lugo;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
27 Lugo;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;93,78
27 Lugo;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
27 Lugo;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
27 Lugo;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
27 Lugo;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;93,13
27 Lugo;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
27 Lugo;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
27 Lugo;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
27 Lugo;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;95,6
27 Lugo;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
27 Lugo;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
27 Lugo;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
27 Lugo;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
27 Lugo;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
27 Lugo;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
27 Lugo;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;88,15
27 Lugo;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
27 Lugo;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
27 Lugo;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
27 Lugo;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;91,85
27 Lugo;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
27 Lugo;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
27 Lugo;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
27 Lugo;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
27 Lugo;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
27 Lugo;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
27 Lugo;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;84,56
27 Lugo;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
27 Lugo;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
27 Lugo;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
27 Lugo;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;87,88
27 Lugo;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
27 Lugo;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
27 Lugo;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
27 Lugo;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
27 Lugo;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
27 Lugo;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
27 Lugo;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;81,57
27 Lugo;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
27 Lugo;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
27 Lugo;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
27 Lugo;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;84,55
27 Lugo;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
27 Lugo;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
27 Lugo;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
27 Lugo;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
27 Lugo;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
27 Lugo;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
27 Lugo;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QIV;585
27 Lugo;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
27 Lugo;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
27 Lugo;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
27 Lugo;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QIV;609
27 Lugo;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
27 Lugo;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
27 Lugo;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
27 Lugo;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QIV;573
27 Lugo;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
27 Lugo;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
27 Lugo;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
27 Lugo;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2022QIV;547
27 Lugo;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
27 Lugo;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2022QII;""
27 Lugo;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2022QI;""
27 Lugo;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2021QIV;568
27 Lugo;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
27 Lugo;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2021QII;""
27 Lugo;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2021QI;""
27 Lugo;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2020QIV;558
27 Lugo;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
27 Lugo;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2020QII;""
27 Lugo;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2020QI;""
27 Lugo;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
27 Lugo;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
27 Lugo;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2022QII;""
27 Lugo;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2022QI;538
27 Lugo;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
27 Lugo;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
27 Lugo;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2021QII;""
27 Lugo;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2021QI;537
27 Lugo;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
27 Lugo;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
27 Lugo;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2020QII;""
27 Lugo;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2020QI;""
27 Lugo;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
27 Lugo;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
27 Lugo;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QII;519
27 Lugo;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QI;""
27 Lugo;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
27 Lugo;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
27 Lugo;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QII;514
27 Lugo;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QI;""
27 Lugo;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
27 Lugo;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
27 Lugo;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QII;""
27 Lugo;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QI;""
27 Lugo;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
27 Lugo;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QIII;503
27 Lugo;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QII;""
27 Lugo;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QI;""
27 Lugo;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
27 Lugo;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QIII;492
27 Lugo;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QII;""
27 Lugo;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QI;""
27 Lugo;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
27 Lugo;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
27 Lugo;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QII;""
27 Lugo;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QI;""
27 Lugo;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
27 Lugo;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
27 Lugo;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
27 Lugo;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
27 Lugo;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
27 Lugo;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
27 Lugo;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
27 Lugo;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
27 Lugo;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
27 Lugo;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
27 Lugo;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
27 Lugo;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
27 Lugo;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;93,5
27 Lugo;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
27 Lugo;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
27 Lugo;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
27 Lugo;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;93,27
27 Lugo;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
27 Lugo;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
27 Lugo;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
27 Lugo;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;97,38
27 Lugo;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
27 Lugo;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
27 Lugo;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
27 Lugo;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
27 Lugo;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
27 Lugo;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
27 Lugo;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;88,34
27 Lugo;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
27 Lugo;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
27 Lugo;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
27 Lugo;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;93,72
27 Lugo;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
27 Lugo;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
27 Lugo;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
27 Lugo;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
27 Lugo;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
27 Lugo;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
27 Lugo;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;85,22
27 Lugo;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
27 Lugo;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
27 Lugo;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
27 Lugo;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;89,7
27 Lugo;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
27 Lugo;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
27 Lugo;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
27 Lugo;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
27 Lugo;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
27 Lugo;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
27 Lugo;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;82,59
27 Lugo;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
27 Lugo;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
27 Lugo;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
27 Lugo;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;85,86
27 Lugo;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
27 Lugo;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
27 Lugo;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
27 Lugo;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
27 Lugo;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
27 Lugo;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
27 Lugo;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QIV;396
27 Lugo;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
27 Lugo;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
27 Lugo;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
27 Lugo;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QIV;395
27 Lugo;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
27 Lugo;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
27 Lugo;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
27 Lugo;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QIV;359
27 Lugo;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
27 Lugo;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
27 Lugo;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
27 Lugo;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2022QIV;373
27 Lugo;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
27 Lugo;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2022QII;""
27 Lugo;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2022QI;""
27 Lugo;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2021QIV;367
27 Lugo;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
27 Lugo;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2021QII;""
27 Lugo;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2021QI;""
27 Lugo;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2020QIV;333
27 Lugo;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
27 Lugo;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2020QII;""
27 Lugo;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2020QI;""
27 Lugo;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
27 Lugo;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
27 Lugo;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2022QII;""
27 Lugo;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2022QI;347
27 Lugo;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
27 Lugo;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
27 Lugo;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2021QII;""
27 Lugo;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2021QI;319
27 Lugo;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
27 Lugo;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
27 Lugo;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2020QII;""
27 Lugo;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2020QI;""
27 Lugo;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
27 Lugo;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
27 Lugo;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QII;330
27 Lugo;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QI;""
27 Lugo;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
27 Lugo;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
27 Lugo;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QII;305
27 Lugo;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QI;""
27 Lugo;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
27 Lugo;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
27 Lugo;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QII;""
27 Lugo;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QI;""
27 Lugo;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
27 Lugo;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QIII;316
27 Lugo;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QII;""
27 Lugo;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QI;""
27 Lugo;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
27 Lugo;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QIII;296
27 Lugo;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QII;""
27 Lugo;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QI;""
27 Lugo;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
27 Lugo;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
27 Lugo;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QII;""
27 Lugo;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QI;""
27 Lugo;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
27 Lugo;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
27 Lugo;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
27 Lugo;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
27 Lugo;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
27 Lugo;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
27 Lugo;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
27 Lugo;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
27 Lugo;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
27 Lugo;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
27 Lugo;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
27 Lugo;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
27 Lugo;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;94,19
27 Lugo;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
27 Lugo;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
27 Lugo;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
27 Lugo;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;92,91
27 Lugo;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
27 Lugo;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
27 Lugo;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
27 Lugo;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;92,76
27 Lugo;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
27 Lugo;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
27 Lugo;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
27 Lugo;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
27 Lugo;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
27 Lugo;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
27 Lugo;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;87,85
27 Lugo;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
27 Lugo;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
27 Lugo;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
27 Lugo;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;88,86
27 Lugo;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
27 Lugo;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
27 Lugo;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
27 Lugo;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
27 Lugo;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
27 Lugo;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
27 Lugo;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;83,54
27 Lugo;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
27 Lugo;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
27 Lugo;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
27 Lugo;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;84,96
27 Lugo;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
27 Lugo;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
27 Lugo;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
27 Lugo;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
27 Lugo;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
27 Lugo;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
27 Lugo;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;80
27 Lugo;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
27 Lugo;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
27 Lugo;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
27 Lugo;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;82,45
27 Lugo;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
27 Lugo;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
27 Lugo;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
27 Lugo;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
27 Lugo;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
27 Lugo;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
27 Lugo;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
27 Lugo;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
27 Lugo;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
27 Lugo;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QI;3.798
27 Lugo;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
27 Lugo;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
27 Lugo;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
27 Lugo;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QI;3.952
27 Lugo;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
27 Lugo;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
27 Lugo;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
27 Lugo;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QI;3.862
27 Lugo;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
27 Lugo;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
27 Lugo;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2022QII;""
27 Lugo;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2022QI;3.682
27 Lugo;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
27 Lugo;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
27 Lugo;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2021QII;""
27 Lugo;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2021QI;3.866
27 Lugo;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
27 Lugo;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
27 Lugo;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2020QII;""
27 Lugo;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2020QI;3.670
27 Lugo;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
27 Lugo;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
27 Lugo;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2022QII;3.582
27 Lugo;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2022QI;""
27 Lugo;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
27 Lugo;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
27 Lugo;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2021QII;3.778
27 Lugo;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2021QI;""
27 Lugo;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
27 Lugo;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
27 Lugo;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2020QII;3.610
27 Lugo;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2020QI;""
27 Lugo;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
27 Lugo;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QIII;3.492
27 Lugo;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QII;""
27 Lugo;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QI;""
27 Lugo;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
27 Lugo;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QIII;3.710
27 Lugo;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QII;""
27 Lugo;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QI;""
27 Lugo;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
27 Lugo;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QIII;3.535
27 Lugo;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QII;""
27 Lugo;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QI;""
27 Lugo;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QIV;3.407
27 Lugo;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
27 Lugo;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QII;""
27 Lugo;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QI;""
27 Lugo;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QIV;3.620
27 Lugo;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
27 Lugo;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QII;""
27 Lugo;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QI;""
27 Lugo;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QIV;3.440
27 Lugo;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
27 Lugo;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QII;""
27 Lugo;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QI;""
27 Lugo;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
27 Lugo;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
27 Lugo;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
27 Lugo;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
27 Lugo;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
27 Lugo;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
27 Lugo;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
27 Lugo;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
27 Lugo;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
27 Lugo;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
27 Lugo;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
27 Lugo;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
27 Lugo;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
27 Lugo;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
27 Lugo;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
27 Lugo;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;96,95
27 Lugo;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
27 Lugo;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
27 Lugo;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
27 Lugo;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;97,82
27 Lugo;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
27 Lugo;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
27 Lugo;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
27 Lugo;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;95,03
27 Lugo;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
27 Lugo;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
27 Lugo;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;94,31
27 Lugo;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
27 Lugo;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
27 Lugo;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
27 Lugo;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;95,6
27 Lugo;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
27 Lugo;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
27 Lugo;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
27 Lugo;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;93,47
27 Lugo;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
27 Lugo;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
27 Lugo;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;91,94
27 Lugo;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
27 Lugo;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
27 Lugo;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
27 Lugo;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;93,88
27 Lugo;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
27 Lugo;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
27 Lugo;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
27 Lugo;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;91,53
27 Lugo;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
27 Lugo;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
27 Lugo;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;89,71
27 Lugo;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
27 Lugo;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
27 Lugo;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
27 Lugo;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;91,6
27 Lugo;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
27 Lugo;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
27 Lugo;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
27 Lugo;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;89,07
27 Lugo;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
27 Lugo;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
27 Lugo;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
27 Lugo;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
27 Lugo;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
27 Lugo;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
27 Lugo;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QI;2.254
27 Lugo;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
27 Lugo;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
27 Lugo;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
27 Lugo;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QI;2.375
27 Lugo;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
27 Lugo;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
27 Lugo;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
27 Lugo;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QI;2.285
27 Lugo;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
27 Lugo;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
27 Lugo;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2022QII;""
27 Lugo;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2022QI;2.192
27 Lugo;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
27 Lugo;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
27 Lugo;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2021QII;""
27 Lugo;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2021QI;2.326
27 Lugo;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
27 Lugo;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
27 Lugo;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2020QII;""
27 Lugo;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2020QI;2.179
27 Lugo;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
27 Lugo;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
27 Lugo;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2022QII;2.143
27 Lugo;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2022QI;""
27 Lugo;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
27 Lugo;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
27 Lugo;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2021QII;2.281
27 Lugo;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2021QI;""
27 Lugo;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
27 Lugo;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
27 Lugo;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2020QII;2.145
27 Lugo;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2020QI;""
27 Lugo;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
27 Lugo;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QIII;2.096
27 Lugo;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QII;""
27 Lugo;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QI;""
27 Lugo;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
27 Lugo;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QIII;2.240
27 Lugo;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QII;""
27 Lugo;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QI;""
27 Lugo;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
27 Lugo;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QIII;2.113
27 Lugo;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QII;""
27 Lugo;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QI;""
27 Lugo;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QIV;2.049
27 Lugo;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
27 Lugo;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QII;""
27 Lugo;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QI;""
27 Lugo;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QIV;2.191
27 Lugo;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
27 Lugo;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QII;""
27 Lugo;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QI;""
27 Lugo;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QIV;2.071
27 Lugo;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
27 Lugo;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QII;""
27 Lugo;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QI;""
27 Lugo;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
27 Lugo;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
27 Lugo;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
27 Lugo;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
27 Lugo;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
27 Lugo;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
27 Lugo;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
27 Lugo;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
27 Lugo;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
27 Lugo;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
27 Lugo;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
27 Lugo;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
27 Lugo;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
27 Lugo;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
27 Lugo;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
27 Lugo;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;97,25
27 Lugo;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
27 Lugo;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
27 Lugo;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
27 Lugo;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;97,94
27 Lugo;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
27 Lugo;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
27 Lugo;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
27 Lugo;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;95,36
27 Lugo;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
27 Lugo;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
27 Lugo;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;95,08
27 Lugo;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
27 Lugo;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
27 Lugo;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
27 Lugo;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;96,04
27 Lugo;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
27 Lugo;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
27 Lugo;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
27 Lugo;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;93,87
27 Lugo;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
27 Lugo;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
27 Lugo;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;92,99
27 Lugo;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
27 Lugo;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
27 Lugo;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
27 Lugo;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;94,32
27 Lugo;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
27 Lugo;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
27 Lugo;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
27 Lugo;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;92,47
27 Lugo;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
27 Lugo;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
27 Lugo;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;90,91
27 Lugo;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
27 Lugo;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
27 Lugo;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
27 Lugo;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;92,25
27 Lugo;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
27 Lugo;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
27 Lugo;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
27 Lugo;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;90,63
27 Lugo;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
27 Lugo;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
27 Lugo;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
27 Lugo;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
27 Lugo;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
27 Lugo;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
27 Lugo;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QI;1.544
27 Lugo;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
27 Lugo;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
27 Lugo;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
27 Lugo;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QI;1.577
27 Lugo;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
27 Lugo;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
27 Lugo;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
27 Lugo;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QI;1.577
27 Lugo;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
27 Lugo;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
27 Lugo;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2022QII;""
27 Lugo;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2022QI;1.490
27 Lugo;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
27 Lugo;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
27 Lugo;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2021QII;""
27 Lugo;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2021QI;1.540
27 Lugo;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
27 Lugo;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
27 Lugo;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2020QII;""
27 Lugo;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2020QI;1.491
27 Lugo;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
27 Lugo;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
27 Lugo;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2022QII;1.439
27 Lugo;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2022QI;""
27 Lugo;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
27 Lugo;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
27 Lugo;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2021QII;1.497
27 Lugo;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2021QI;""
27 Lugo;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
27 Lugo;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
27 Lugo;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2020QII;1.465
27 Lugo;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2020QI;""
27 Lugo;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
27 Lugo;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QIII;1.396
27 Lugo;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QII;""
27 Lugo;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QI;""
27 Lugo;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
27 Lugo;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QIII;1.470
27 Lugo;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QII;""
27 Lugo;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QI;""
27 Lugo;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
27 Lugo;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QIII;1.422
27 Lugo;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QII;""
27 Lugo;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QI;""
27 Lugo;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QIV;1.358
27 Lugo;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
27 Lugo;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QII;""
27 Lugo;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QI;""
27 Lugo;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QIV;1.429
27 Lugo;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
27 Lugo;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QII;""
27 Lugo;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QI;""
27 Lugo;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QIV;1.369
27 Lugo;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
27 Lugo;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QII;""
27 Lugo;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QI;""
27 Lugo;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
27 Lugo;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
27 Lugo;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
27 Lugo;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
27 Lugo;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
27 Lugo;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
27 Lugo;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
27 Lugo;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
27 Lugo;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
27 Lugo;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
27 Lugo;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
27 Lugo;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
27 Lugo;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
27 Lugo;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
27 Lugo;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
27 Lugo;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;96,5
27 Lugo;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
27 Lugo;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
27 Lugo;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
27 Lugo;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;97,65
27 Lugo;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
27 Lugo;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
27 Lugo;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
27 Lugo;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;94,55
27 Lugo;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
27 Lugo;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
27 Lugo;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;93,2
27 Lugo;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
27 Lugo;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
27 Lugo;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
27 Lugo;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;94,93
27 Lugo;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
27 Lugo;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
27 Lugo;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
27 Lugo;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;92,9
27 Lugo;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
27 Lugo;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
27 Lugo;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;90,41
27 Lugo;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
27 Lugo;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
27 Lugo;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
27 Lugo;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;93,21
27 Lugo;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
27 Lugo;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
27 Lugo;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
27 Lugo;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;90,17
27 Lugo;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
27 Lugo;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
27 Lugo;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;87,95
27 Lugo;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
27 Lugo;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
27 Lugo;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
27 Lugo;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;90,62
27 Lugo;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
27 Lugo;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
27 Lugo;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
27 Lugo;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;86,81
27 Lugo;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
27 Lugo;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
27 Lugo;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
27 Lugo;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
27 Lugo;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
27 Lugo;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QII;3.491
27 Lugo;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
27 Lugo;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
27 Lugo;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
27 Lugo;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QII;3.666
27 Lugo;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
27 Lugo;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
27 Lugo;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
27 Lugo;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QII;3.868
27 Lugo;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
27 Lugo;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
27 Lugo;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
27 Lugo;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2022QII;3.391
27 Lugo;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2022QI;""
27 Lugo;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
27 Lugo;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
27 Lugo;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2021QII;3.568
27 Lugo;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2021QI;""
27 Lugo;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
27 Lugo;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
27 Lugo;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2020QII;3.805
27 Lugo;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2020QI;""
27 Lugo;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
27 Lugo;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2022QIII;3.302
27 Lugo;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2022QII;""
27 Lugo;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2022QI;""
27 Lugo;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
27 Lugo;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2021QIII;3.500
27 Lugo;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2021QII;""
27 Lugo;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2021QI;""
27 Lugo;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
27 Lugo;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2020QIII;3.722
27 Lugo;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2020QII;""
27 Lugo;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2020QI;""
27 Lugo;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QIV;3.223
27 Lugo;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
27 Lugo;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QII;""
27 Lugo;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QI;""
27 Lugo;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QIV;3.407
27 Lugo;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
27 Lugo;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QII;""
27 Lugo;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QI;""
27 Lugo;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QIV;3.616
27 Lugo;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
27 Lugo;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QII;""
27 Lugo;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QI;""
27 Lugo;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
27 Lugo;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
27 Lugo;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QII;""
27 Lugo;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QI;3.309
27 Lugo;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
27 Lugo;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
27 Lugo;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QII;""
27 Lugo;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QI;3.551
27 Lugo;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
27 Lugo;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
27 Lugo;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QII;""
27 Lugo;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QI;""
27 Lugo;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
27 Lugo;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
27 Lugo;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
27 Lugo;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
27 Lugo;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
27 Lugo;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
27 Lugo;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
27 Lugo;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
27 Lugo;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
27 Lugo;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
27 Lugo;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
27 Lugo;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
27 Lugo;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
27 Lugo;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
27 Lugo;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;97,14
27 Lugo;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
27 Lugo;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
27 Lugo;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
27 Lugo;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;97,33
27 Lugo;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
27 Lugo;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
27 Lugo;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
27 Lugo;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;98,37
27 Lugo;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
27 Lugo;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
27 Lugo;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;94,59
27 Lugo;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
27 Lugo;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
27 Lugo;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
27 Lugo;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;95,47
27 Lugo;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
27 Lugo;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
27 Lugo;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
27 Lugo;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;96,23
27 Lugo;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
27 Lugo;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
27 Lugo;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;92,32
27 Lugo;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
27 Lugo;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
27 Lugo;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
27 Lugo;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;92,94
27 Lugo;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
27 Lugo;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
27 Lugo;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
27 Lugo;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;93,49
27 Lugo;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
27 Lugo;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
27 Lugo;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
27 Lugo;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
27 Lugo;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
27 Lugo;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
27 Lugo;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;90,26
27 Lugo;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
27 Lugo;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
27 Lugo;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
27 Lugo;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;91,8
27 Lugo;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
27 Lugo;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
27 Lugo;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
27 Lugo;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
27 Lugo;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
27 Lugo;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
27 Lugo;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QII;2.071
27 Lugo;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
27 Lugo;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
27 Lugo;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
27 Lugo;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QII;2.199
27 Lugo;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
27 Lugo;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
27 Lugo;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
27 Lugo;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QII;2.289
27 Lugo;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
27 Lugo;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
27 Lugo;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
27 Lugo;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2022QII;2.019
27 Lugo;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2022QI;""
27 Lugo;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
27 Lugo;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
27 Lugo;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2021QII;2.149
27 Lugo;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2021QI;""
27 Lugo;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
27 Lugo;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
27 Lugo;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2020QII;2.253
27 Lugo;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2020QI;""
27 Lugo;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
27 Lugo;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2022QIII;1.970
27 Lugo;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2022QII;""
27 Lugo;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2022QI;""
27 Lugo;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
27 Lugo;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2021QIII;2.106
27 Lugo;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2021QII;""
27 Lugo;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2021QI;""
27 Lugo;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
27 Lugo;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2020QIII;2.217
27 Lugo;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2020QII;""
27 Lugo;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2020QI;""
27 Lugo;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QIV;1.927
27 Lugo;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
27 Lugo;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QII;""
27 Lugo;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QI;""
27 Lugo;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QIV;2.056
27 Lugo;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
27 Lugo;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QII;""
27 Lugo;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QI;""
27 Lugo;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QIV;2.170
27 Lugo;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
27 Lugo;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QII;""
27 Lugo;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QI;""
27 Lugo;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
27 Lugo;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
27 Lugo;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QII;""
27 Lugo;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QI;2.002
27 Lugo;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
27 Lugo;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
27 Lugo;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QII;""
27 Lugo;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QI;2.136
27 Lugo;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
27 Lugo;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
27 Lugo;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QII;""
27 Lugo;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QI;""
27 Lugo;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
27 Lugo;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
27 Lugo;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
27 Lugo;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
27 Lugo;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
27 Lugo;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
27 Lugo;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
27 Lugo;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
27 Lugo;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
27 Lugo;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
27 Lugo;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
27 Lugo;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
27 Lugo;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
27 Lugo;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
27 Lugo;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;97,49
27 Lugo;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
27 Lugo;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
27 Lugo;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
27 Lugo;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;97,73
27 Lugo;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
27 Lugo;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
27 Lugo;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
27 Lugo;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;98,43
27 Lugo;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
27 Lugo;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
27 Lugo;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;95,12
27 Lugo;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
27 Lugo;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
27 Lugo;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
27 Lugo;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;95,77
27 Lugo;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
27 Lugo;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
27 Lugo;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
27 Lugo;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;96,85
27 Lugo;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
27 Lugo;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
27 Lugo;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;93,05
27 Lugo;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
27 Lugo;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
27 Lugo;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
27 Lugo;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;93,5
27 Lugo;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
27 Lugo;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
27 Lugo;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
27 Lugo;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;94,8
27 Lugo;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
27 Lugo;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
27 Lugo;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
27 Lugo;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
27 Lugo;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
27 Lugo;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
27 Lugo;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;91,04
27 Lugo;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
27 Lugo;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
27 Lugo;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
27 Lugo;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;93,32
27 Lugo;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
27 Lugo;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
27 Lugo;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
27 Lugo;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
27 Lugo;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
27 Lugo;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
27 Lugo;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QII;1.420
27 Lugo;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
27 Lugo;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
27 Lugo;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
27 Lugo;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QII;1.467
27 Lugo;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
27 Lugo;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
27 Lugo;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
27 Lugo;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QII;1.579
27 Lugo;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
27 Lugo;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
27 Lugo;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
27 Lugo;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2022QII;1.372
27 Lugo;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2022QI;""
27 Lugo;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
27 Lugo;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
27 Lugo;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2021QII;1.419
27 Lugo;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2021QI;""
27 Lugo;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
27 Lugo;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
27 Lugo;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2020QII;1.552
27 Lugo;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2020QI;""
27 Lugo;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
27 Lugo;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2022QIII;1.332
27 Lugo;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2022QII;""
27 Lugo;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2022QI;""
27 Lugo;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
27 Lugo;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2021QIII;1.394
27 Lugo;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2021QII;""
27 Lugo;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2021QI;""
27 Lugo;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
27 Lugo;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2020QIII;1.505
27 Lugo;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2020QII;""
27 Lugo;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2020QI;""
27 Lugo;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QIV;1.296
27 Lugo;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
27 Lugo;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QII;""
27 Lugo;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QI;""
27 Lugo;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QIV;1.351
27 Lugo;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
27 Lugo;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QII;""
27 Lugo;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QI;""
27 Lugo;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QIV;1.446
27 Lugo;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
27 Lugo;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QII;""
27 Lugo;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QI;""
27 Lugo;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
27 Lugo;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
27 Lugo;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QII;""
27 Lugo;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QI;1.307
27 Lugo;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
27 Lugo;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
27 Lugo;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QII;""
27 Lugo;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QI;1.415
27 Lugo;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
27 Lugo;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
27 Lugo;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QII;""
27 Lugo;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QI;""
27 Lugo;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
27 Lugo;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
27 Lugo;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
27 Lugo;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
27 Lugo;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
27 Lugo;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
27 Lugo;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
27 Lugo;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
27 Lugo;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
27 Lugo;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
27 Lugo;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
27 Lugo;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
27 Lugo;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
27 Lugo;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
27 Lugo;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;96,62
27 Lugo;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
27 Lugo;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
27 Lugo;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
27 Lugo;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;96,73
27 Lugo;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
27 Lugo;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
27 Lugo;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
27 Lugo;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;98,29
27 Lugo;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
27 Lugo;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
27 Lugo;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;93,8
27 Lugo;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
27 Lugo;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
27 Lugo;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
27 Lugo;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;95,02
27 Lugo;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
27 Lugo;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
27 Lugo;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
27 Lugo;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;95,31
27 Lugo;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
27 Lugo;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
27 Lugo;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;91,27
27 Lugo;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
27 Lugo;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
27 Lugo;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
27 Lugo;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;92,09
27 Lugo;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
27 Lugo;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
27 Lugo;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
27 Lugo;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;91,58
27 Lugo;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
27 Lugo;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
27 Lugo;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
27 Lugo;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
27 Lugo;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
27 Lugo;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
27 Lugo;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;89,09
27 Lugo;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
27 Lugo;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
27 Lugo;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
27 Lugo;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;89,61
27 Lugo;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
27 Lugo;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
27 Lugo;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
27 Lugo;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
27 Lugo;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
27 Lugo;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QIII;3.545
27 Lugo;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
27 Lugo;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
27 Lugo;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
27 Lugo;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QIII;3.729
27 Lugo;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
27 Lugo;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
27 Lugo;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
27 Lugo;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QIII;3.898
27 Lugo;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
27 Lugo;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
27 Lugo;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
27 Lugo;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2022QIII;3.440
27 Lugo;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2022QII;""
27 Lugo;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2022QI;""
27 Lugo;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
27 Lugo;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2021QIII;3.643
27 Lugo;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2021QII;""
27 Lugo;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2021QI;""
27 Lugo;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
27 Lugo;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2020QIII;3.811
27 Lugo;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2020QII;""
27 Lugo;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2020QI;""
27 Lugo;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2022QIV;3.340
27 Lugo;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
27 Lugo;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2022QII;""
27 Lugo;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2022QI;""
27 Lugo;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2021QIV;3.537
27 Lugo;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
27 Lugo;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2021QII;""
27 Lugo;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2021QI;""
27 Lugo;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2020QIV;3.694
27 Lugo;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
27 Lugo;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2020QII;""
27 Lugo;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2020QI;""
27 Lugo;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
27 Lugo;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
27 Lugo;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QII;""
27 Lugo;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QI;3.431
27 Lugo;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
27 Lugo;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
27 Lugo;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QII;""
27 Lugo;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QI;3.623
27 Lugo;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
27 Lugo;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
27 Lugo;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QII;""
27 Lugo;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QI;""
27 Lugo;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
27 Lugo;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
27 Lugo;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QII;3.352
27 Lugo;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QI;""
27 Lugo;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
27 Lugo;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
27 Lugo;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QII;3.554
27 Lugo;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QI;""
27 Lugo;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
27 Lugo;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
27 Lugo;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QII;""
27 Lugo;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QI;""
27 Lugo;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
27 Lugo;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
27 Lugo;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
27 Lugo;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
27 Lugo;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
27 Lugo;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
27 Lugo;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
27 Lugo;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
27 Lugo;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
27 Lugo;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
27 Lugo;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
27 Lugo;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
27 Lugo;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
27 Lugo;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;97,04
27 Lugo;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
27 Lugo;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
27 Lugo;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
27 Lugo;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;97,69
27 Lugo;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
27 Lugo;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
27 Lugo;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
27 Lugo;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;97,77
27 Lugo;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
27 Lugo;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
27 Lugo;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;94,22
27 Lugo;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
27 Lugo;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
27 Lugo;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
27 Lugo;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;94,85
27 Lugo;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
27 Lugo;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
27 Lugo;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
27 Lugo;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;94,77
27 Lugo;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
27 Lugo;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
27 Lugo;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
27 Lugo;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
27 Lugo;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
27 Lugo;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
27 Lugo;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;92,01
27 Lugo;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
27 Lugo;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
27 Lugo;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
27 Lugo;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;92,95
27 Lugo;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
27 Lugo;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
27 Lugo;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
27 Lugo;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
27 Lugo;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
27 Lugo;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
27 Lugo;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;89,89
27 Lugo;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
27 Lugo;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
27 Lugo;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
27 Lugo;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;91,17
27 Lugo;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
27 Lugo;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
27 Lugo;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
27 Lugo;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
27 Lugo;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
27 Lugo;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
27 Lugo;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QIII;2.104
27 Lugo;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
27 Lugo;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
27 Lugo;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
27 Lugo;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QIII;2.235
27 Lugo;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
27 Lugo;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
27 Lugo;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
27 Lugo;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QIII;2.316
27 Lugo;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
27 Lugo;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
27 Lugo;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
27 Lugo;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2022QIII;2.046
27 Lugo;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2022QII;""
27 Lugo;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2022QI;""
27 Lugo;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
27 Lugo;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2021QIII;2.177
27 Lugo;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2021QII;""
27 Lugo;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2021QI;""
27 Lugo;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
27 Lugo;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2020QIII;2.276
27 Lugo;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2020QII;""
27 Lugo;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2020QI;""
27 Lugo;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2022QIV;1.990
27 Lugo;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
27 Lugo;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2022QII;""
27 Lugo;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2022QI;""
27 Lugo;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2021QIV;2.122
27 Lugo;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
27 Lugo;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2021QII;""
27 Lugo;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2021QI;""
27 Lugo;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2020QIV;2.223
27 Lugo;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
27 Lugo;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2020QII;""
27 Lugo;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2020QI;""
27 Lugo;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
27 Lugo;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
27 Lugo;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QII;""
27 Lugo;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QI;2.064
27 Lugo;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
27 Lugo;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
27 Lugo;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QII;""
27 Lugo;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QI;2.184
27 Lugo;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
27 Lugo;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
27 Lugo;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QII;""
27 Lugo;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QI;""
27 Lugo;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
27 Lugo;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
27 Lugo;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QII;2.024
27 Lugo;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QI;""
27 Lugo;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
27 Lugo;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
27 Lugo;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QII;2.150
27 Lugo;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QI;""
27 Lugo;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
27 Lugo;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
27 Lugo;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QII;""
27 Lugo;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QI;""
27 Lugo;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
27 Lugo;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
27 Lugo;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
27 Lugo;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
27 Lugo;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
27 Lugo;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
27 Lugo;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
27 Lugo;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
27 Lugo;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
27 Lugo;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
27 Lugo;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
27 Lugo;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
27 Lugo;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
27 Lugo;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;97,24
27 Lugo;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
27 Lugo;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
27 Lugo;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
27 Lugo;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;97,4
27 Lugo;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
27 Lugo;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
27 Lugo;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
27 Lugo;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;98,27
27 Lugo;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
27 Lugo;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
27 Lugo;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;94,58
27 Lugo;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
27 Lugo;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
27 Lugo;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
27 Lugo;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;94,94
27 Lugo;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
27 Lugo;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
27 Lugo;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
27 Lugo;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;95,98
27 Lugo;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
27 Lugo;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
27 Lugo;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
27 Lugo;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
27 Lugo;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
27 Lugo;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
27 Lugo;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;92,35
27 Lugo;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
27 Lugo;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
27 Lugo;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
27 Lugo;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;94,3
27 Lugo;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
27 Lugo;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
27 Lugo;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
27 Lugo;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
27 Lugo;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
27 Lugo;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
27 Lugo;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;90,56
27 Lugo;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
27 Lugo;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
27 Lugo;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
27 Lugo;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;92,83
27 Lugo;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
27 Lugo;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
27 Lugo;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
27 Lugo;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
27 Lugo;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
27 Lugo;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
27 Lugo;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QIII;1.441
27 Lugo;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
27 Lugo;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
27 Lugo;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
27 Lugo;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QIII;1.494
27 Lugo;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
27 Lugo;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
27 Lugo;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
27 Lugo;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QIII;1.582
27 Lugo;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
27 Lugo;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
27 Lugo;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
27 Lugo;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2022QIII;1.394
27 Lugo;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2022QII;""
27 Lugo;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2022QI;""
27 Lugo;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
27 Lugo;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2021QIII;1.466
27 Lugo;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2021QII;""
27 Lugo;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2021QI;""
27 Lugo;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
27 Lugo;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2020QIII;1.535
27 Lugo;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2020QII;""
27 Lugo;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2020QI;""
27 Lugo;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2022QIV;1.350
27 Lugo;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
27 Lugo;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2022QII;""
27 Lugo;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2022QI;""
27 Lugo;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2021QIV;1.415
27 Lugo;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
27 Lugo;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2021QII;""
27 Lugo;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2021QI;""
27 Lugo;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2020QIV;1.471
27 Lugo;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
27 Lugo;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2020QII;""
27 Lugo;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2020QI;""
27 Lugo;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
27 Lugo;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
27 Lugo;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QII;""
27 Lugo;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QI;1.367
27 Lugo;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
27 Lugo;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
27 Lugo;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QII;""
27 Lugo;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QI;1.439
27 Lugo;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
27 Lugo;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
27 Lugo;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QII;""
27 Lugo;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QI;""
27 Lugo;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
27 Lugo;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
27 Lugo;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QII;1.328
27 Lugo;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QI;""
27 Lugo;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
27 Lugo;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
27 Lugo;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QII;1.404
27 Lugo;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QI;""
27 Lugo;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
27 Lugo;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
27 Lugo;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QII;""
27 Lugo;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QI;""
27 Lugo;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
27 Lugo;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
27 Lugo;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
27 Lugo;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
27 Lugo;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
27 Lugo;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
27 Lugo;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
27 Lugo;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
27 Lugo;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
27 Lugo;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
27 Lugo;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
27 Lugo;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
27 Lugo;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
27 Lugo;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;96,74
27 Lugo;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
27 Lugo;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
27 Lugo;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
27 Lugo;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;98,13
27 Lugo;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
27 Lugo;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
27 Lugo;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
27 Lugo;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;97,03
27 Lugo;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
27 Lugo;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
27 Lugo;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;93,68
27 Lugo;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
27 Lugo;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
27 Lugo;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
27 Lugo;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;94,71
27 Lugo;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
27 Lugo;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
27 Lugo;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
27 Lugo;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;92,98
27 Lugo;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
27 Lugo;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
27 Lugo;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
27 Lugo;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
27 Lugo;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
27 Lugo;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
27 Lugo;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;91,5
27 Lugo;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
27 Lugo;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
27 Lugo;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
27 Lugo;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;90,96
27 Lugo;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
27 Lugo;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
27 Lugo;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
27 Lugo;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
27 Lugo;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
27 Lugo;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
27 Lugo;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;88,89
27 Lugo;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
27 Lugo;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
27 Lugo;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
27 Lugo;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;88,75
27 Lugo;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
27 Lugo;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
27 Lugo;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
27 Lugo;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
27 Lugo;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
27 Lugo;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QIV;3.549
27 Lugo;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
27 Lugo;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
27 Lugo;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
27 Lugo;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QIV;3.779
27 Lugo;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
27 Lugo;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
27 Lugo;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
27 Lugo;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QIV;3.941
27 Lugo;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
27 Lugo;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
27 Lugo;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
27 Lugo;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2022QIV;3.445
27 Lugo;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
27 Lugo;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2022QII;""
27 Lugo;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2022QI;""
27 Lugo;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2021QIV;3.659
27 Lugo;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
27 Lugo;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2021QII;""
27 Lugo;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2021QI;""
27 Lugo;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2020QIV;3.809
27 Lugo;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
27 Lugo;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2020QII;""
27 Lugo;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2020QI;""
27 Lugo;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
27 Lugo;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
27 Lugo;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2022QII;""
27 Lugo;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2022QI;3.548
27 Lugo;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
27 Lugo;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
27 Lugo;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2021QII;""
27 Lugo;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2021QI;3.733
27 Lugo;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
27 Lugo;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
27 Lugo;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2020QII;""
27 Lugo;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2020QI;""
27 Lugo;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
27 Lugo;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
27 Lugo;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QII;3.459
27 Lugo;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QI;""
27 Lugo;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
27 Lugo;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
27 Lugo;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QII;3.658
27 Lugo;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QI;""
27 Lugo;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
27 Lugo;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
27 Lugo;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QII;""
27 Lugo;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QI;""
27 Lugo;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
27 Lugo;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QIII;3.374
27 Lugo;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QII;""
27 Lugo;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QI;""
27 Lugo;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
27 Lugo;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QIII;3.598
27 Lugo;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QII;""
27 Lugo;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QI;""
27 Lugo;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
27 Lugo;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
27 Lugo;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QII;""
27 Lugo;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QI;""
27 Lugo;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
27 Lugo;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
27 Lugo;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
27 Lugo;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
27 Lugo;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
27 Lugo;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
27 Lugo;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
27 Lugo;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
27 Lugo;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
27 Lugo;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
27 Lugo;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
27 Lugo;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
27 Lugo;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;97,07
27 Lugo;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
27 Lugo;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
27 Lugo;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
27 Lugo;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;96,82
27 Lugo;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
27 Lugo;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
27 Lugo;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
27 Lugo;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;96,65
27 Lugo;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
27 Lugo;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
27 Lugo;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
27 Lugo;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
27 Lugo;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
27 Lugo;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
27 Lugo;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;93,89
27 Lugo;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
27 Lugo;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
27 Lugo;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
27 Lugo;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;94,72
27 Lugo;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
27 Lugo;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
27 Lugo;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
27 Lugo;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
27 Lugo;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
27 Lugo;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
27 Lugo;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;91,53
27 Lugo;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
27 Lugo;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
27 Lugo;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
27 Lugo;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;92,82
27 Lugo;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
27 Lugo;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
27 Lugo;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
27 Lugo;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
27 Lugo;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
27 Lugo;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
27 Lugo;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;89,28
27 Lugo;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
27 Lugo;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
27 Lugo;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
27 Lugo;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;91,3
27 Lugo;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
27 Lugo;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
27 Lugo;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
27 Lugo;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
27 Lugo;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
27 Lugo;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
27 Lugo;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QIV;2.108
27 Lugo;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
27 Lugo;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
27 Lugo;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
27 Lugo;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QIV;2.249
27 Lugo;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
27 Lugo;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
27 Lugo;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
27 Lugo;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QIV;2.351
27 Lugo;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
27 Lugo;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
27 Lugo;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
27 Lugo;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2022QIV;2.049
27 Lugo;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
27 Lugo;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2022QII;""
27 Lugo;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2022QI;""
27 Lugo;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2021QIV;2.185
27 Lugo;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
27 Lugo;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2021QII;""
27 Lugo;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2021QI;""
27 Lugo;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2020QIV;2.291
27 Lugo;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
27 Lugo;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2020QII;""
27 Lugo;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2020QI;""
27 Lugo;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
27 Lugo;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
27 Lugo;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2022QII;""
27 Lugo;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2022QI;2.126
27 Lugo;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
27 Lugo;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
27 Lugo;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2021QII;""
27 Lugo;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2021QI;2.249
27 Lugo;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
27 Lugo;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
27 Lugo;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2020QII;""
27 Lugo;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2020QI;""
27 Lugo;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
27 Lugo;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
27 Lugo;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QII;2.082
27 Lugo;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QI;""
27 Lugo;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
27 Lugo;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
27 Lugo;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QII;2.212
27 Lugo;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QI;""
27 Lugo;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
27 Lugo;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
27 Lugo;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QII;""
27 Lugo;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QI;""
27 Lugo;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
27 Lugo;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QIII;2.036
27 Lugo;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QII;""
27 Lugo;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QI;""
27 Lugo;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
27 Lugo;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QIII;2.174
27 Lugo;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QII;""
27 Lugo;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QI;""
27 Lugo;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
27 Lugo;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
27 Lugo;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QII;""
27 Lugo;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QI;""
27 Lugo;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
27 Lugo;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
27 Lugo;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
27 Lugo;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
27 Lugo;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
27 Lugo;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
27 Lugo;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
27 Lugo;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
27 Lugo;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
27 Lugo;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
27 Lugo;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
27 Lugo;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
27 Lugo;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;97,2
27 Lugo;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
27 Lugo;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
27 Lugo;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
27 Lugo;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;97,15
27 Lugo;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
27 Lugo;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
27 Lugo;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
27 Lugo;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;97,45
27 Lugo;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
27 Lugo;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
27 Lugo;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
27 Lugo;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
27 Lugo;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
27 Lugo;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
27 Lugo;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;94,53
27 Lugo;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
27 Lugo;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
27 Lugo;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
27 Lugo;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;95,66
27 Lugo;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
27 Lugo;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
27 Lugo;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
27 Lugo;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
27 Lugo;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
27 Lugo;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
27 Lugo;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;92,57
27 Lugo;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
27 Lugo;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
27 Lugo;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
27 Lugo;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;94,09
27 Lugo;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
27 Lugo;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
27 Lugo;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
27 Lugo;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
27 Lugo;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
27 Lugo;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
27 Lugo;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;90,53
27 Lugo;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
27 Lugo;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
27 Lugo;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
27 Lugo;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;92,47
27 Lugo;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
27 Lugo;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
27 Lugo;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
27 Lugo;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
27 Lugo;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
27 Lugo;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
27 Lugo;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QIV;1.441
27 Lugo;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
27 Lugo;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
27 Lugo;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
27 Lugo;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QIV;1.530
27 Lugo;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
27 Lugo;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
27 Lugo;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
27 Lugo;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QIV;1.590
27 Lugo;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
27 Lugo;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
27 Lugo;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
27 Lugo;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2022QIV;1.396
27 Lugo;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
27 Lugo;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2022QII;""
27 Lugo;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2022QI;""
27 Lugo;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2021QIV;1.474
27 Lugo;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
27 Lugo;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2021QII;""
27 Lugo;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2021QI;""
27 Lugo;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2020QIV;1.518
27 Lugo;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
27 Lugo;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2020QII;""
27 Lugo;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2020QI;""
27 Lugo;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
27 Lugo;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
27 Lugo;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2022QII;""
27 Lugo;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2022QI;1.422
27 Lugo;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
27 Lugo;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
27 Lugo;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2021QII;""
27 Lugo;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2021QI;1.484
27 Lugo;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
27 Lugo;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
27 Lugo;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2020QII;""
27 Lugo;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2020QI;""
27 Lugo;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
27 Lugo;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
27 Lugo;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QII;1.377
27 Lugo;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QI;""
27 Lugo;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
27 Lugo;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
27 Lugo;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QII;1.446
27 Lugo;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QI;""
27 Lugo;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
27 Lugo;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
27 Lugo;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QII;""
27 Lugo;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QI;""
27 Lugo;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
27 Lugo;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QIII;1.338
27 Lugo;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QII;""
27 Lugo;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QI;""
27 Lugo;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
27 Lugo;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QIII;1.424
27 Lugo;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QII;""
27 Lugo;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QI;""
27 Lugo;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
27 Lugo;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
27 Lugo;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QII;""
27 Lugo;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QI;""
27 Lugo;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
27 Lugo;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
27 Lugo;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
27 Lugo;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
27 Lugo;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
27 Lugo;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
27 Lugo;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
27 Lugo;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
27 Lugo;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
27 Lugo;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
27 Lugo;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
27 Lugo;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
27 Lugo;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;96,88
27 Lugo;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
27 Lugo;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
27 Lugo;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
27 Lugo;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;96,34
27 Lugo;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
27 Lugo;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
27 Lugo;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
27 Lugo;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;95,47
27 Lugo;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
27 Lugo;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
27 Lugo;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
27 Lugo;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
27 Lugo;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
27 Lugo;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
27 Lugo;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;92,94
27 Lugo;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
27 Lugo;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
27 Lugo;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
27 Lugo;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;93,33
27 Lugo;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
27 Lugo;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
27 Lugo;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
27 Lugo;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
27 Lugo;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
27 Lugo;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
27 Lugo;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;90
27 Lugo;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
27 Lugo;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
27 Lugo;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
27 Lugo;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;90,94
27 Lugo;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
27 Lugo;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
27 Lugo;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
27 Lugo;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
27 Lugo;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
27 Lugo;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
27 Lugo;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;87,45
27 Lugo;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
27 Lugo;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
27 Lugo;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
27 Lugo;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;89,56
27 Lugo;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
27 Lugo;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
27 Lugo;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
27 Lugo;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
27 Lugo;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
27 Lugo;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
27 Lugo;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
27 Lugo;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
27 Lugo;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
27 Lugo;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QI;6.694
27 Lugo;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
27 Lugo;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
27 Lugo;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
27 Lugo;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QI;6.793
27 Lugo;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
27 Lugo;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
27 Lugo;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
27 Lugo;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QI;6.781
27 Lugo;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
27 Lugo;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
27 Lugo;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2022QII;""
27 Lugo;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2022QI;6.553
27 Lugo;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
27 Lugo;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
27 Lugo;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2021QII;""
27 Lugo;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2021QI;6.676
27 Lugo;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
27 Lugo;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
27 Lugo;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2020QII;""
27 Lugo;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2020QI;6.552
27 Lugo;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
27 Lugo;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
27 Lugo;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2022QII;6.464
27 Lugo;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2022QI;""
27 Lugo;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
27 Lugo;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
27 Lugo;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2021QII;6.580
27 Lugo;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2021QI;""
27 Lugo;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
27 Lugo;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
27 Lugo;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2020QII;6.483
27 Lugo;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2020QI;""
27 Lugo;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
27 Lugo;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QIII;6.377
27 Lugo;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QII;""
27 Lugo;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QI;""
27 Lugo;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
27 Lugo;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QIII;6.482
27 Lugo;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QII;""
27 Lugo;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QI;""
27 Lugo;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
27 Lugo;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QIII;6.393
27 Lugo;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QII;""
27 Lugo;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QI;""
27 Lugo;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QIV;6.253
27 Lugo;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
27 Lugo;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QII;""
27 Lugo;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QI;""
27 Lugo;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QIV;6.370
27 Lugo;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
27 Lugo;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QII;""
27 Lugo;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QI;""
27 Lugo;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QIV;6.298
27 Lugo;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
27 Lugo;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QII;""
27 Lugo;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QI;""
27 Lugo;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
27 Lugo;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
27 Lugo;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
27 Lugo;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
27 Lugo;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
27 Lugo;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
27 Lugo;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
27 Lugo;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
27 Lugo;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
27 Lugo;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
27 Lugo;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
27 Lugo;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
27 Lugo;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
27 Lugo;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
27 Lugo;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
27 Lugo;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;97,89
27 Lugo;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
27 Lugo;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
27 Lugo;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
27 Lugo;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;98,28
27 Lugo;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
27 Lugo;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
27 Lugo;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
27 Lugo;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;96,62
27 Lugo;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
27 Lugo;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
27 Lugo;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;96,56
27 Lugo;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
27 Lugo;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
27 Lugo;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
27 Lugo;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;96,86
27 Lugo;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
27 Lugo;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
27 Lugo;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
27 Lugo;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;95,61
27 Lugo;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
27 Lugo;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
27 Lugo;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;95,26
27 Lugo;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
27 Lugo;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
27 Lugo;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
27 Lugo;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;95,42
27 Lugo;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
27 Lugo;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
27 Lugo;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
27 Lugo;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;94,28
27 Lugo;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
27 Lugo;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
27 Lugo;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;93,41
27 Lugo;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
27 Lugo;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
27 Lugo;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
27 Lugo;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;93,77
27 Lugo;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
27 Lugo;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
27 Lugo;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
27 Lugo;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;92,88
27 Lugo;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
27 Lugo;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
27 Lugo;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
27 Lugo;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
27 Lugo;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
27 Lugo;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
27 Lugo;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QI;4.177
27 Lugo;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
27 Lugo;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
27 Lugo;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
27 Lugo;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QI;4.249
27 Lugo;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
27 Lugo;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
27 Lugo;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
27 Lugo;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QI;4.225
27 Lugo;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
27 Lugo;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
27 Lugo;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2022QII;""
27 Lugo;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2022QI;4.106
27 Lugo;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
27 Lugo;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
27 Lugo;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2021QII;""
27 Lugo;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2021QI;4.189
27 Lugo;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
27 Lugo;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
27 Lugo;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2020QII;""
27 Lugo;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2020QI;4.103
27 Lugo;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
27 Lugo;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
27 Lugo;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2022QII;4.056
27 Lugo;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2022QI;""
27 Lugo;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
27 Lugo;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
27 Lugo;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2021QII;4.131
27 Lugo;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2021QI;""
27 Lugo;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
27 Lugo;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
27 Lugo;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2020QII;4.060
27 Lugo;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2020QI;""
27 Lugo;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
27 Lugo;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QIII;4.003
27 Lugo;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QII;""
27 Lugo;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QI;""
27 Lugo;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
27 Lugo;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QIII;4.069
27 Lugo;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QII;""
27 Lugo;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QI;""
27 Lugo;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
27 Lugo;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QIII;4.015
27 Lugo;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QII;""
27 Lugo;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QI;""
27 Lugo;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QIV;3.926
27 Lugo;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
27 Lugo;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QII;""
27 Lugo;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QI;""
27 Lugo;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QIV;4.007
27 Lugo;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
27 Lugo;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QII;""
27 Lugo;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QI;""
27 Lugo;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QIV;3.964
27 Lugo;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
27 Lugo;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QII;""
27 Lugo;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QI;""
27 Lugo;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
27 Lugo;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
27 Lugo;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
27 Lugo;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
27 Lugo;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
27 Lugo;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
27 Lugo;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
27 Lugo;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
27 Lugo;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
27 Lugo;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
27 Lugo;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
27 Lugo;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
27 Lugo;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
27 Lugo;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
27 Lugo;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
27 Lugo;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;98,3
27 Lugo;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
27 Lugo;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
27 Lugo;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
27 Lugo;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;98,59
27 Lugo;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
27 Lugo;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
27 Lugo;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
27 Lugo;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;97,11
27 Lugo;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
27 Lugo;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
27 Lugo;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;97,1
27 Lugo;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
27 Lugo;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
27 Lugo;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
27 Lugo;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;97,22
27 Lugo;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
27 Lugo;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
27 Lugo;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
27 Lugo;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;96,09
27 Lugo;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
27 Lugo;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
27 Lugo;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;95,83
27 Lugo;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
27 Lugo;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
27 Lugo;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
27 Lugo;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;95,76
27 Lugo;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
27 Lugo;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
27 Lugo;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
27 Lugo;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;95,03
27 Lugo;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
27 Lugo;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
27 Lugo;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;93,99
27 Lugo;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
27 Lugo;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
27 Lugo;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
27 Lugo;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;94,3
27 Lugo;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
27 Lugo;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
27 Lugo;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
27 Lugo;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;93,82
27 Lugo;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
27 Lugo;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
27 Lugo;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
27 Lugo;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
27 Lugo;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
27 Lugo;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
27 Lugo;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QI;2.517
27 Lugo;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
27 Lugo;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
27 Lugo;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
27 Lugo;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QI;2.544
27 Lugo;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
27 Lugo;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
27 Lugo;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
27 Lugo;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QI;2.556
27 Lugo;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
27 Lugo;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
27 Lugo;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2022QII;""
27 Lugo;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2022QI;2.447
27 Lugo;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
27 Lugo;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
27 Lugo;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2021QII;""
27 Lugo;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2021QI;2.487
27 Lugo;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
27 Lugo;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
27 Lugo;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2020QII;""
27 Lugo;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2020QI;2.449
27 Lugo;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
27 Lugo;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
27 Lugo;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2022QII;2.408
27 Lugo;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2022QI;""
27 Lugo;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
27 Lugo;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
27 Lugo;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2021QII;2.449
27 Lugo;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2021QI;""
27 Lugo;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
27 Lugo;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
27 Lugo;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2020QII;2.423
27 Lugo;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2020QI;""
27 Lugo;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
27 Lugo;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QIII;2.374
27 Lugo;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QII;""
27 Lugo;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QI;""
27 Lugo;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
27 Lugo;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QIII;2.413
27 Lugo;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QII;""
27 Lugo;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QI;""
27 Lugo;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
27 Lugo;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QIII;2.378
27 Lugo;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QII;""
27 Lugo;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QI;""
27 Lugo;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QIV;2.327
27 Lugo;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
27 Lugo;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QII;""
27 Lugo;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QI;""
27 Lugo;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QIV;2.363
27 Lugo;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
27 Lugo;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QII;""
27 Lugo;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QI;""
27 Lugo;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QIV;2.334
27 Lugo;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
27 Lugo;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QII;""
27 Lugo;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QI;""
27 Lugo;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
27 Lugo;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
27 Lugo;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
27 Lugo;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
27 Lugo;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
27 Lugo;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
27 Lugo;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
27 Lugo;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
27 Lugo;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
27 Lugo;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
27 Lugo;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
27 Lugo;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
27 Lugo;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
27 Lugo;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
27 Lugo;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
27 Lugo;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;97,22
27 Lugo;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
27 Lugo;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
27 Lugo;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
27 Lugo;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;97,76
27 Lugo;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
27 Lugo;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
27 Lugo;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
27 Lugo;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;95,81
27 Lugo;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
27 Lugo;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
27 Lugo;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;95,67
27 Lugo;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
27 Lugo;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
27 Lugo;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
27 Lugo;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;96,27
27 Lugo;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
27 Lugo;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
27 Lugo;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
27 Lugo;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;94,8
27 Lugo;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
27 Lugo;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
27 Lugo;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;94,32
27 Lugo;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
27 Lugo;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
27 Lugo;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
27 Lugo;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;94,85
27 Lugo;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
27 Lugo;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
27 Lugo;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
27 Lugo;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;93,04
27 Lugo;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
27 Lugo;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
27 Lugo;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;92,45
27 Lugo;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
27 Lugo;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
27 Lugo;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
27 Lugo;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;92,89
27 Lugo;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
27 Lugo;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
27 Lugo;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
27 Lugo;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;91,31
27 Lugo;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
27 Lugo;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
27 Lugo;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
27 Lugo;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
27 Lugo;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
27 Lugo;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QII;6.522
27 Lugo;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
27 Lugo;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
27 Lugo;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
27 Lugo;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QII;6.627
27 Lugo;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
27 Lugo;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
27 Lugo;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
27 Lugo;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QII;6.740
27 Lugo;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
27 Lugo;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
27 Lugo;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
27 Lugo;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2022QII;6.414
27 Lugo;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2022QI;""
27 Lugo;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
27 Lugo;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
27 Lugo;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2021QII;6.521
27 Lugo;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2021QI;""
27 Lugo;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
27 Lugo;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
27 Lugo;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2020QII;6.666
27 Lugo;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2020QI;""
27 Lugo;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
27 Lugo;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2022QIII;6.320
27 Lugo;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2022QII;""
27 Lugo;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2022QI;""
27 Lugo;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
27 Lugo;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2021QIII;6.422
27 Lugo;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2021QII;""
27 Lugo;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2021QI;""
27 Lugo;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
27 Lugo;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2020QIII;6.562
27 Lugo;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2020QII;""
27 Lugo;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2020QI;""
27 Lugo;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QIV;6.185
27 Lugo;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
27 Lugo;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QII;""
27 Lugo;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QI;""
27 Lugo;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QIV;6.305
27 Lugo;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
27 Lugo;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QII;""
27 Lugo;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QI;""
27 Lugo;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QIV;6.462
27 Lugo;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
27 Lugo;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QII;""
27 Lugo;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QI;""
27 Lugo;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
27 Lugo;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
27 Lugo;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QII;""
27 Lugo;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QI;6.193
27 Lugo;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
27 Lugo;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
27 Lugo;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QII;""
27 Lugo;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QI;6.363
27 Lugo;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
27 Lugo;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
27 Lugo;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QII;""
27 Lugo;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QI;""
27 Lugo;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
27 Lugo;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
27 Lugo;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
27 Lugo;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
27 Lugo;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
27 Lugo;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
27 Lugo;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
27 Lugo;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
27 Lugo;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
27 Lugo;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
27 Lugo;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
27 Lugo;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
27 Lugo;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
27 Lugo;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
27 Lugo;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;98,34
27 Lugo;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
27 Lugo;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
27 Lugo;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
27 Lugo;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;98,4
27 Lugo;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
27 Lugo;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
27 Lugo;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
27 Lugo;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;98,9
27 Lugo;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
27 Lugo;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
27 Lugo;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;96,9
27 Lugo;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
27 Lugo;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
27 Lugo;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
27 Lugo;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;96,91
27 Lugo;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
27 Lugo;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
27 Lugo;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
27 Lugo;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;97,36
27 Lugo;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
27 Lugo;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
27 Lugo;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;94,83
27 Lugo;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
27 Lugo;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
27 Lugo;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
27 Lugo;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;95,14
27 Lugo;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
27 Lugo;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
27 Lugo;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
27 Lugo;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;95,88
27 Lugo;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
27 Lugo;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
27 Lugo;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
27 Lugo;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
27 Lugo;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
27 Lugo;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
27 Lugo;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;93,45
27 Lugo;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
27 Lugo;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
27 Lugo;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
27 Lugo;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;94,41
27 Lugo;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
27 Lugo;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
27 Lugo;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
27 Lugo;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
27 Lugo;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
27 Lugo;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
27 Lugo;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QII;4.063
27 Lugo;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
27 Lugo;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
27 Lugo;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
27 Lugo;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QII;4.155
27 Lugo;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
27 Lugo;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
27 Lugo;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
27 Lugo;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QII;4.202
27 Lugo;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
27 Lugo;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
27 Lugo;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
27 Lugo;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2022QII;4.006
27 Lugo;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2022QI;""
27 Lugo;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
27 Lugo;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
27 Lugo;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2021QII;4.096
27 Lugo;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2021QI;""
27 Lugo;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
27 Lugo;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
27 Lugo;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2020QII;4.155
27 Lugo;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2020QI;""
27 Lugo;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
27 Lugo;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2022QIII;3.952
27 Lugo;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2022QII;""
27 Lugo;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2022QI;""
27 Lugo;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
27 Lugo;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2021QIII;4.037
27 Lugo;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2021QII;""
27 Lugo;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2021QI;""
27 Lugo;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
27 Lugo;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2020QIII;4.102
27 Lugo;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2020QII;""
27 Lugo;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2020QI;""
27 Lugo;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QIV;3.867
27 Lugo;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
27 Lugo;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QII;""
27 Lugo;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QI;""
27 Lugo;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QIV;3.971
27 Lugo;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
27 Lugo;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QII;""
27 Lugo;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QI;""
27 Lugo;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QIV;4.047
27 Lugo;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
27 Lugo;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QII;""
27 Lugo;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QI;""
27 Lugo;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
27 Lugo;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
27 Lugo;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QII;""
27 Lugo;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QI;3.917
27 Lugo;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
27 Lugo;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
27 Lugo;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QII;""
27 Lugo;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QI;3.999
27 Lugo;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
27 Lugo;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
27 Lugo;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QII;""
27 Lugo;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QI;""
27 Lugo;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
27 Lugo;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
27 Lugo;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
27 Lugo;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
27 Lugo;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
27 Lugo;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
27 Lugo;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
27 Lugo;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
27 Lugo;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
27 Lugo;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
27 Lugo;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
27 Lugo;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
27 Lugo;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
27 Lugo;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
27 Lugo;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;98,6
27 Lugo;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
27 Lugo;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
27 Lugo;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
27 Lugo;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;98,58
27 Lugo;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
27 Lugo;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
27 Lugo;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
27 Lugo;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;98,88
27 Lugo;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
27 Lugo;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
27 Lugo;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;97,27
27 Lugo;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
27 Lugo;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
27 Lugo;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
27 Lugo;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;97,16
27 Lugo;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
27 Lugo;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
27 Lugo;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
27 Lugo;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;97,62
27 Lugo;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
27 Lugo;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
27 Lugo;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;95,18
27 Lugo;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
27 Lugo;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
27 Lugo;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
27 Lugo;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;95,57
27 Lugo;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
27 Lugo;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
27 Lugo;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
27 Lugo;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;96,31
27 Lugo;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
27 Lugo;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
27 Lugo;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
27 Lugo;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
27 Lugo;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
27 Lugo;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
27 Lugo;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;94,27
27 Lugo;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
27 Lugo;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
27 Lugo;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
27 Lugo;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;95,17
27 Lugo;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
27 Lugo;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
27 Lugo;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
27 Lugo;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
27 Lugo;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
27 Lugo;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
27 Lugo;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QII;2.459
27 Lugo;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
27 Lugo;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
27 Lugo;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
27 Lugo;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QII;2.472
27 Lugo;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
27 Lugo;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
27 Lugo;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
27 Lugo;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QII;2.538
27 Lugo;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
27 Lugo;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
27 Lugo;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
27 Lugo;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2022QII;2.408
27 Lugo;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2022QI;""
27 Lugo;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
27 Lugo;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
27 Lugo;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2021QII;2.425
27 Lugo;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2021QI;""
27 Lugo;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
27 Lugo;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
27 Lugo;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2020QII;2.511
27 Lugo;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2020QI;""
27 Lugo;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
27 Lugo;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2022QIII;2.368
27 Lugo;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2022QII;""
27 Lugo;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2022QI;""
27 Lugo;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
27 Lugo;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2021QIII;2.385
27 Lugo;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2021QII;""
27 Lugo;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2021QI;""
27 Lugo;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
27 Lugo;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2020QIII;2.460
27 Lugo;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2020QII;""
27 Lugo;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2020QI;""
27 Lugo;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QIV;2.318
27 Lugo;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
27 Lugo;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QII;""
27 Lugo;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QI;""
27 Lugo;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QIV;2.334
27 Lugo;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
27 Lugo;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QII;""
27 Lugo;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QI;""
27 Lugo;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QIV;2.415
27 Lugo;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
27 Lugo;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QII;""
27 Lugo;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QI;""
27 Lugo;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
27 Lugo;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
27 Lugo;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QII;""
27 Lugo;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QI;2.276
27 Lugo;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
27 Lugo;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
27 Lugo;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QII;""
27 Lugo;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QI;2.364
27 Lugo;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
27 Lugo;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
27 Lugo;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QII;""
27 Lugo;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QI;""
27 Lugo;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
27 Lugo;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
27 Lugo;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
27 Lugo;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
27 Lugo;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
27 Lugo;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
27 Lugo;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
27 Lugo;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
27 Lugo;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
27 Lugo;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
27 Lugo;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
27 Lugo;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
27 Lugo;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
27 Lugo;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
27 Lugo;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;97,93
27 Lugo;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
27 Lugo;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
27 Lugo;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
27 Lugo;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;98,1
27 Lugo;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
27 Lugo;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
27 Lugo;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
27 Lugo;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;98,94
27 Lugo;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
27 Lugo;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
27 Lugo;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;96,3
27 Lugo;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
27 Lugo;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
27 Lugo;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
27 Lugo;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;96,48
27 Lugo;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
27 Lugo;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
27 Lugo;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
27 Lugo;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;96,93
27 Lugo;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
27 Lugo;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
27 Lugo;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;94,27
27 Lugo;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
27 Lugo;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
27 Lugo;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
27 Lugo;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;94,42
27 Lugo;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
27 Lugo;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
27 Lugo;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
27 Lugo;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;95,15
27 Lugo;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
27 Lugo;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
27 Lugo;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
27 Lugo;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
27 Lugo;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
27 Lugo;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
27 Lugo;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;92,07
27 Lugo;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
27 Lugo;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
27 Lugo;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
27 Lugo;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;93,14
27 Lugo;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
27 Lugo;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
27 Lugo;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
27 Lugo;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
27 Lugo;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
27 Lugo;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QIII;6.594
27 Lugo;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
27 Lugo;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
27 Lugo;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
27 Lugo;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QIII;6.670
27 Lugo;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
27 Lugo;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
27 Lugo;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
27 Lugo;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QIII;6.776
27 Lugo;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
27 Lugo;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
27 Lugo;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
27 Lugo;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2022QIII;6.477
27 Lugo;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2022QII;""
27 Lugo;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2022QI;""
27 Lugo;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
27 Lugo;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2021QIII;6.561
27 Lugo;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2021QII;""
27 Lugo;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2021QI;""
27 Lugo;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
27 Lugo;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2020QIII;6.664
27 Lugo;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2020QII;""
27 Lugo;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2020QI;""
27 Lugo;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2022QIV;6.320
27 Lugo;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
27 Lugo;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2022QII;""
27 Lugo;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2022QI;""
27 Lugo;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2021QIV;6.428
27 Lugo;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
27 Lugo;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2021QII;""
27 Lugo;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2021QI;""
27 Lugo;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2020QIV;6.553
27 Lugo;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
27 Lugo;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2020QII;""
27 Lugo;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2020QI;""
27 Lugo;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
27 Lugo;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
27 Lugo;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QII;""
27 Lugo;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QI;6.308
27 Lugo;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
27 Lugo;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
27 Lugo;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QII;""
27 Lugo;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QI;6.452
27 Lugo;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
27 Lugo;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
27 Lugo;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QII;""
27 Lugo;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QI;""
27 Lugo;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
27 Lugo;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
27 Lugo;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QII;6.239
27 Lugo;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QI;""
27 Lugo;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
27 Lugo;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
27 Lugo;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QII;6.364
27 Lugo;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QI;""
27 Lugo;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
27 Lugo;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
27 Lugo;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QII;""
27 Lugo;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QI;""
27 Lugo;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
27 Lugo;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
27 Lugo;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
27 Lugo;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
27 Lugo;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
27 Lugo;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
27 Lugo;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
27 Lugo;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
27 Lugo;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
27 Lugo;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
27 Lugo;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
27 Lugo;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
27 Lugo;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
27 Lugo;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;98,23
27 Lugo;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
27 Lugo;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
27 Lugo;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
27 Lugo;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;98,37
27 Lugo;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
27 Lugo;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
27 Lugo;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
27 Lugo;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;98,35
27 Lugo;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
27 Lugo;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
27 Lugo;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;95,84
27 Lugo;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
27 Lugo;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
27 Lugo;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
27 Lugo;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;96,37
27 Lugo;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
27 Lugo;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
27 Lugo;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
27 Lugo;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;96,71
27 Lugo;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
27 Lugo;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
27 Lugo;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
27 Lugo;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
27 Lugo;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
27 Lugo;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
27 Lugo;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;94,57
27 Lugo;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
27 Lugo;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
27 Lugo;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
27 Lugo;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;95,22
27 Lugo;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
27 Lugo;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
27 Lugo;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
27 Lugo;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
27 Lugo;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
27 Lugo;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
27 Lugo;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;93,54
27 Lugo;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
27 Lugo;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
27 Lugo;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
27 Lugo;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;93,92
27 Lugo;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
27 Lugo;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
27 Lugo;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
27 Lugo;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
27 Lugo;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
27 Lugo;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
27 Lugo;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QIII;4.109
27 Lugo;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
27 Lugo;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
27 Lugo;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
27 Lugo;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QIII;4.184
27 Lugo;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
27 Lugo;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
27 Lugo;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
27 Lugo;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QIII;4.230
27 Lugo;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
27 Lugo;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
27 Lugo;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
27 Lugo;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2022QIII;4.041
27 Lugo;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2022QII;""
27 Lugo;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2022QI;""
27 Lugo;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
27 Lugo;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2021QIII;4.116
27 Lugo;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2021QII;""
27 Lugo;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2021QI;""
27 Lugo;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
27 Lugo;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2020QIII;4.170
27 Lugo;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2020QII;""
27 Lugo;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2020QI;""
27 Lugo;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2022QIV;3.941
27 Lugo;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
27 Lugo;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2022QII;""
27 Lugo;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2022QI;""
27 Lugo;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2021QIV;4.041
27 Lugo;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
27 Lugo;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2021QII;""
27 Lugo;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2021QI;""
27 Lugo;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2020QIV;4.107
27 Lugo;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
27 Lugo;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2020QII;""
27 Lugo;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2020QI;""
27 Lugo;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
27 Lugo;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
27 Lugo;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QII;""
27 Lugo;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QI;3.982
27 Lugo;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
27 Lugo;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
27 Lugo;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QII;""
27 Lugo;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QI;4.057
27 Lugo;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
27 Lugo;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
27 Lugo;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QII;""
27 Lugo;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QI;""
27 Lugo;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
27 Lugo;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
27 Lugo;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QII;3.942
27 Lugo;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QI;""
27 Lugo;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
27 Lugo;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
27 Lugo;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QII;4.004
27 Lugo;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QI;""
27 Lugo;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
27 Lugo;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
27 Lugo;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QII;""
27 Lugo;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QI;""
27 Lugo;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
27 Lugo;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
27 Lugo;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
27 Lugo;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
27 Lugo;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
27 Lugo;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
27 Lugo;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
27 Lugo;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
27 Lugo;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
27 Lugo;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
27 Lugo;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
27 Lugo;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
27 Lugo;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
27 Lugo;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;98,35
27 Lugo;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
27 Lugo;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
27 Lugo;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
27 Lugo;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;98,37
27 Lugo;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
27 Lugo;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
27 Lugo;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
27 Lugo;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;98,58
27 Lugo;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
27 Lugo;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
27 Lugo;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;95,91
27 Lugo;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
27 Lugo;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
27 Lugo;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
27 Lugo;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;96,58
27 Lugo;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
27 Lugo;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
27 Lugo;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
27 Lugo;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;97,09
27 Lugo;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
27 Lugo;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
27 Lugo;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
27 Lugo;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
27 Lugo;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
27 Lugo;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
27 Lugo;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;95,17
27 Lugo;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
27 Lugo;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
27 Lugo;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
27 Lugo;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;95,91
27 Lugo;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
27 Lugo;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
27 Lugo;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
27 Lugo;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
27 Lugo;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
27 Lugo;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
27 Lugo;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;94,22
27 Lugo;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
27 Lugo;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
27 Lugo;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
27 Lugo;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;94,66
27 Lugo;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
27 Lugo;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
27 Lugo;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
27 Lugo;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
27 Lugo;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
27 Lugo;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
27 Lugo;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QIII;2.485
27 Lugo;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
27 Lugo;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
27 Lugo;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
27 Lugo;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QIII;2.486
27 Lugo;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
27 Lugo;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
27 Lugo;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
27 Lugo;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QIII;2.546
27 Lugo;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
27 Lugo;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
27 Lugo;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
27 Lugo;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2022QIII;2.436
27 Lugo;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2022QII;""
27 Lugo;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2022QI;""
27 Lugo;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
27 Lugo;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2021QIII;2.445
27 Lugo;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2021QII;""
27 Lugo;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2021QI;""
27 Lugo;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
27 Lugo;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2020QIII;2.494
27 Lugo;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2020QII;""
27 Lugo;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2020QI;""
27 Lugo;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2022QIV;2.379
27 Lugo;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
27 Lugo;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2022QII;""
27 Lugo;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2022QI;""
27 Lugo;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2021QIV;2.387
27 Lugo;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
27 Lugo;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2021QII;""
27 Lugo;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2021QI;""
27 Lugo;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2020QIV;2.446
27 Lugo;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
27 Lugo;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2020QII;""
27 Lugo;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2020QI;""
27 Lugo;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
27 Lugo;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
27 Lugo;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QII;""
27 Lugo;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QI;2.326
27 Lugo;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
27 Lugo;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
27 Lugo;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QII;""
27 Lugo;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QI;2.395
27 Lugo;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
27 Lugo;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
27 Lugo;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QII;""
27 Lugo;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QI;""
27 Lugo;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
27 Lugo;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
27 Lugo;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QII;2.297
27 Lugo;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QI;""
27 Lugo;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
27 Lugo;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
27 Lugo;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QII;2.360
27 Lugo;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QI;""
27 Lugo;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
27 Lugo;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
27 Lugo;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QII;""
27 Lugo;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QI;""
27 Lugo;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
27 Lugo;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
27 Lugo;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
27 Lugo;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
27 Lugo;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
27 Lugo;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
27 Lugo;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
27 Lugo;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
27 Lugo;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
27 Lugo;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
27 Lugo;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
27 Lugo;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
27 Lugo;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
27 Lugo;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;98,03
27 Lugo;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
27 Lugo;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
27 Lugo;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
27 Lugo;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;98,35
27 Lugo;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
27 Lugo;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
27 Lugo;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
27 Lugo;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;97,96
27 Lugo;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
27 Lugo;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
27 Lugo;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;95,73
27 Lugo;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
27 Lugo;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
27 Lugo;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
27 Lugo;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;96,02
27 Lugo;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
27 Lugo;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
27 Lugo;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
27 Lugo;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;96,07
27 Lugo;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
27 Lugo;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
27 Lugo;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
27 Lugo;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
27 Lugo;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
27 Lugo;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
27 Lugo;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;93,56
27 Lugo;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
27 Lugo;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
27 Lugo;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
27 Lugo;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;94,07
27 Lugo;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
27 Lugo;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
27 Lugo;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
27 Lugo;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
27 Lugo;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
27 Lugo;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
27 Lugo;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;92,4
27 Lugo;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
27 Lugo;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
27 Lugo;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
27 Lugo;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;92,69
27 Lugo;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
27 Lugo;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
27 Lugo;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
27 Lugo;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
27 Lugo;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
27 Lugo;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QIV;6.588
27 Lugo;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
27 Lugo;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
27 Lugo;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
27 Lugo;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QIV;6.687
27 Lugo;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
27 Lugo;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
27 Lugo;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
27 Lugo;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QIV;6.793
27 Lugo;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
27 Lugo;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
27 Lugo;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
27 Lugo;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2022QIV;6.417
27 Lugo;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
27 Lugo;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2022QII;""
27 Lugo;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2022QI;""
27 Lugo;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2021QIV;6.536
27 Lugo;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
27 Lugo;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2021QII;""
27 Lugo;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2021QI;""
27 Lugo;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2020QIV;6.671
27 Lugo;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
27 Lugo;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2020QII;""
27 Lugo;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2020QI;""
27 Lugo;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
27 Lugo;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
27 Lugo;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2022QII;""
27 Lugo;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2022QI;6.409
27 Lugo;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
27 Lugo;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
27 Lugo;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2021QII;""
27 Lugo;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2021QI;6.561
27 Lugo;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
27 Lugo;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
27 Lugo;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2020QII;""
27 Lugo;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2020QI;""
27 Lugo;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
27 Lugo;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
27 Lugo;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QII;6.335
27 Lugo;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QI;""
27 Lugo;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
27 Lugo;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
27 Lugo;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QII;6.470
27 Lugo;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QI;""
27 Lugo;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
27 Lugo;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
27 Lugo;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QII;""
27 Lugo;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QI;""
27 Lugo;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
27 Lugo;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QIII;6.252
27 Lugo;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QII;""
27 Lugo;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QI;""
27 Lugo;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
27 Lugo;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QIII;6.378
27 Lugo;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QII;""
27 Lugo;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QI;""
27 Lugo;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
27 Lugo;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
27 Lugo;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QII;""
27 Lugo;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QI;""
27 Lugo;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
27 Lugo;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
27 Lugo;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
27 Lugo;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
27 Lugo;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
27 Lugo;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
27 Lugo;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
27 Lugo;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
27 Lugo;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
27 Lugo;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
27 Lugo;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
27 Lugo;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
27 Lugo;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;97,4
27 Lugo;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
27 Lugo;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
27 Lugo;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
27 Lugo;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;97,74
27 Lugo;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
27 Lugo;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
27 Lugo;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
27 Lugo;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;98,2
27 Lugo;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
27 Lugo;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
27 Lugo;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
27 Lugo;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
27 Lugo;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
27 Lugo;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
27 Lugo;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;95,84
27 Lugo;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
27 Lugo;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
27 Lugo;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
27 Lugo;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;96,58
27 Lugo;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
27 Lugo;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
27 Lugo;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
27 Lugo;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
27 Lugo;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
27 Lugo;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
27 Lugo;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;94,74
27 Lugo;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
27 Lugo;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
27 Lugo;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
27 Lugo;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;95,25
27 Lugo;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
27 Lugo;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
27 Lugo;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
27 Lugo;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
27 Lugo;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
27 Lugo;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
27 Lugo;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;93,49
27 Lugo;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
27 Lugo;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
27 Lugo;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
27 Lugo;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;93,89
27 Lugo;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
27 Lugo;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
27 Lugo;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
27 Lugo;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
27 Lugo;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
27 Lugo;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
27 Lugo;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QIV;4.108
27 Lugo;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
27 Lugo;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
27 Lugo;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
27 Lugo;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QIV;4.189
27 Lugo;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
27 Lugo;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
27 Lugo;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
27 Lugo;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QIV;4.249
27 Lugo;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
27 Lugo;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
27 Lugo;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
27 Lugo;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2022QIV;4.000
27 Lugo;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
27 Lugo;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2022QII;""
27 Lugo;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2022QI;""
27 Lugo;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2021QIV;4.099
27 Lugo;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
27 Lugo;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2021QII;""
27 Lugo;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2021QI;""
27 Lugo;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2020QIV;4.180
27 Lugo;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
27 Lugo;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2020QII;""
27 Lugo;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2020QI;""
27 Lugo;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
27 Lugo;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
27 Lugo;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2022QII;""
27 Lugo;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2022QI;4.035
27 Lugo;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
27 Lugo;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
27 Lugo;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2021QII;""
27 Lugo;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2021QI;4.125
27 Lugo;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
27 Lugo;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
27 Lugo;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2020QII;""
27 Lugo;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2020QI;""
27 Lugo;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
27 Lugo;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
27 Lugo;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QII;3.992
27 Lugo;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QI;""
27 Lugo;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
27 Lugo;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
27 Lugo;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QII;4.069
27 Lugo;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QI;""
27 Lugo;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
27 Lugo;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
27 Lugo;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QII;""
27 Lugo;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QI;""
27 Lugo;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
27 Lugo;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QIII;3.941
27 Lugo;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QII;""
27 Lugo;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QI;""
27 Lugo;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
27 Lugo;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QIII;4.011
27 Lugo;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QII;""
27 Lugo;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QI;""
27 Lugo;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
27 Lugo;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
27 Lugo;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QII;""
27 Lugo;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QI;""
27 Lugo;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
27 Lugo;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
27 Lugo;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
27 Lugo;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
27 Lugo;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
27 Lugo;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
27 Lugo;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
27 Lugo;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
27 Lugo;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
27 Lugo;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
27 Lugo;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
27 Lugo;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
27 Lugo;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;97,37
27 Lugo;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
27 Lugo;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
27 Lugo;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
27 Lugo;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;97,85
27 Lugo;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
27 Lugo;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
27 Lugo;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
27 Lugo;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;98,38
27 Lugo;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
27 Lugo;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
27 Lugo;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
27 Lugo;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
27 Lugo;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
27 Lugo;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
27 Lugo;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;96,32
27 Lugo;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
27 Lugo;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
27 Lugo;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
27 Lugo;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;97,08
27 Lugo;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
27 Lugo;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
27 Lugo;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
27 Lugo;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
27 Lugo;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
27 Lugo;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
27 Lugo;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;95,3
27 Lugo;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
27 Lugo;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
27 Lugo;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
27 Lugo;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;95,76
27 Lugo;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
27 Lugo;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
27 Lugo;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
27 Lugo;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
27 Lugo;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
27 Lugo;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
27 Lugo;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;94,08
27 Lugo;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
27 Lugo;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
27 Lugo;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
27 Lugo;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;94,4
27 Lugo;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
27 Lugo;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
27 Lugo;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
27 Lugo;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
27 Lugo;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
27 Lugo;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
27 Lugo;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QIV;2.480
27 Lugo;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
27 Lugo;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
27 Lugo;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
27 Lugo;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QIV;2.498
27 Lugo;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
27 Lugo;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
27 Lugo;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
27 Lugo;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QIV;2.544
27 Lugo;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
27 Lugo;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
27 Lugo;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
27 Lugo;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2022QIV;2.417
27 Lugo;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
27 Lugo;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2022QII;""
27 Lugo;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2022QI;""
27 Lugo;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2021QIV;2.437
27 Lugo;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
27 Lugo;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2021QII;""
27 Lugo;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2021QI;""
27 Lugo;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2020QIV;2.491
27 Lugo;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
27 Lugo;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2020QII;""
27 Lugo;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2020QI;""
27 Lugo;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
27 Lugo;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
27 Lugo;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2022QII;""
27 Lugo;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2022QI;2.374
27 Lugo;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
27 Lugo;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
27 Lugo;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2021QII;""
27 Lugo;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2021QI;2.436
27 Lugo;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
27 Lugo;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
27 Lugo;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2020QII;""
27 Lugo;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2020QI;""
27 Lugo;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
27 Lugo;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
27 Lugo;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QII;2.343
27 Lugo;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QI;""
27 Lugo;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
27 Lugo;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
27 Lugo;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QII;2.401
27 Lugo;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QI;""
27 Lugo;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
27 Lugo;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
27 Lugo;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QII;""
27 Lugo;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QI;""
27 Lugo;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
27 Lugo;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QIII;2.311
27 Lugo;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QII;""
27 Lugo;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QI;""
27 Lugo;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
27 Lugo;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QIII;2.367
27 Lugo;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QII;""
27 Lugo;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QI;""
27 Lugo;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
27 Lugo;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
27 Lugo;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QII;""
27 Lugo;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QI;""
27 Lugo;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
27 Lugo;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
27 Lugo;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
27 Lugo;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
27 Lugo;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
27 Lugo;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
27 Lugo;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
27 Lugo;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
27 Lugo;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
27 Lugo;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
27 Lugo;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
27 Lugo;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
27 Lugo;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;97,46
27 Lugo;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
27 Lugo;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
27 Lugo;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
27 Lugo;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;97,56
27 Lugo;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
27 Lugo;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
27 Lugo;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
27 Lugo;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;97,92
27 Lugo;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
27 Lugo;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
27 Lugo;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
27 Lugo;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
27 Lugo;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
27 Lugo;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
27 Lugo;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;95,04
27 Lugo;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
27 Lugo;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
27 Lugo;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
27 Lugo;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;95,75
27 Lugo;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
27 Lugo;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
27 Lugo;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
27 Lugo;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
27 Lugo;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
27 Lugo;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
27 Lugo;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;93,8
27 Lugo;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
27 Lugo;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
27 Lugo;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
27 Lugo;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;94,38
27 Lugo;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
27 Lugo;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
27 Lugo;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
27 Lugo;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
27 Lugo;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
27 Lugo;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
27 Lugo;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;92,51
27 Lugo;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
27 Lugo;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
27 Lugo;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
27 Lugo;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;93,04
27 Lugo;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
27 Lugo;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
27 Lugo;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
27 Lugo;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
27 Lugo;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
27 Lugo;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
27 Lugo;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
27 Lugo;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
27 Lugo;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
27 Lugo;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QI;6.963
27 Lugo;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
27 Lugo;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
27 Lugo;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
27 Lugo;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QI;6.919
27 Lugo;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
27 Lugo;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
27 Lugo;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
27 Lugo;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QI;7.032
27 Lugo;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
27 Lugo;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
27 Lugo;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2022QII;""
27 Lugo;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2022QI;6.844
27 Lugo;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
27 Lugo;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
27 Lugo;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2021QII;""
27 Lugo;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2021QI;6.844
27 Lugo;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
27 Lugo;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
27 Lugo;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2020QII;""
27 Lugo;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2020QI;6.867
27 Lugo;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
27 Lugo;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
27 Lugo;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2022QII;6.749
27 Lugo;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2022QI;""
27 Lugo;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
27 Lugo;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
27 Lugo;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2021QII;6.751
27 Lugo;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2021QI;""
27 Lugo;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
27 Lugo;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
27 Lugo;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2020QII;6.792
27 Lugo;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2020QI;""
27 Lugo;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
27 Lugo;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QIII;6.642
27 Lugo;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QII;""
27 Lugo;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QI;""
27 Lugo;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
27 Lugo;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QIII;6.661
27 Lugo;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QII;""
27 Lugo;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QI;""
27 Lugo;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
27 Lugo;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QIII;6.719
27 Lugo;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QII;""
27 Lugo;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QI;""
27 Lugo;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QIV;6.517
27 Lugo;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
27 Lugo;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QII;""
27 Lugo;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QI;""
27 Lugo;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QIV;6.567
27 Lugo;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
27 Lugo;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QII;""
27 Lugo;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QI;""
27 Lugo;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QIV;6.627
27 Lugo;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
27 Lugo;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QII;""
27 Lugo;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QI;""
27 Lugo;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
27 Lugo;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
27 Lugo;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
27 Lugo;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
27 Lugo;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
27 Lugo;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
27 Lugo;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
27 Lugo;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
27 Lugo;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
27 Lugo;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
27 Lugo;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
27 Lugo;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
27 Lugo;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
27 Lugo;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
27 Lugo;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
27 Lugo;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;98,29
27 Lugo;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
27 Lugo;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
27 Lugo;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
27 Lugo;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;98,92
27 Lugo;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
27 Lugo;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
27 Lugo;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
27 Lugo;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;97,65
27 Lugo;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
27 Lugo;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
27 Lugo;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;96,93
27 Lugo;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
27 Lugo;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
27 Lugo;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
27 Lugo;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;97,57
27 Lugo;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
27 Lugo;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
27 Lugo;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
27 Lugo;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;96,59
27 Lugo;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
27 Lugo;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
27 Lugo;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;95,39
27 Lugo;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
27 Lugo;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
27 Lugo;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
27 Lugo;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;96,27
27 Lugo;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
27 Lugo;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
27 Lugo;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
27 Lugo;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;95,55
27 Lugo;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
27 Lugo;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
27 Lugo;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;93,59
27 Lugo;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
27 Lugo;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
27 Lugo;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
27 Lugo;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;94,91
27 Lugo;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
27 Lugo;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
27 Lugo;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
27 Lugo;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;94,24
27 Lugo;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
27 Lugo;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
27 Lugo;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
27 Lugo;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
27 Lugo;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
27 Lugo;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
27 Lugo;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QI;4.290
27 Lugo;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
27 Lugo;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
27 Lugo;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
27 Lugo;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QI;4.267
27 Lugo;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
27 Lugo;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
27 Lugo;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
27 Lugo;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QI;4.340
27 Lugo;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
27 Lugo;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
27 Lugo;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2022QII;""
27 Lugo;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2022QI;4.207
27 Lugo;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
27 Lugo;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
27 Lugo;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2021QII;""
27 Lugo;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2021QI;4.227
27 Lugo;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
27 Lugo;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
27 Lugo;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2020QII;""
27 Lugo;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2020QI;4.245
27 Lugo;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
27 Lugo;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
27 Lugo;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2022QII;4.154
27 Lugo;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2022QI;""
27 Lugo;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
27 Lugo;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
27 Lugo;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2021QII;4.190
27 Lugo;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2021QI;""
27 Lugo;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
27 Lugo;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
27 Lugo;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2020QII;4.201
27 Lugo;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2020QI;""
27 Lugo;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
27 Lugo;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QIII;4.096
27 Lugo;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QII;""
27 Lugo;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QI;""
27 Lugo;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
27 Lugo;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QIII;4.139
27 Lugo;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QII;""
27 Lugo;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QI;""
27 Lugo;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
27 Lugo;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QIII;4.157
27 Lugo;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QII;""
27 Lugo;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QI;""
27 Lugo;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QIV;4.028
27 Lugo;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
27 Lugo;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QII;""
27 Lugo;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QI;""
27 Lugo;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QIV;4.087
27 Lugo;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
27 Lugo;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QII;""
27 Lugo;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QI;""
27 Lugo;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QIV;4.107
27 Lugo;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
27 Lugo;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QII;""
27 Lugo;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QI;""
27 Lugo;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
27 Lugo;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
27 Lugo;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
27 Lugo;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
27 Lugo;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
27 Lugo;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
27 Lugo;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
27 Lugo;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
27 Lugo;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
27 Lugo;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
27 Lugo;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
27 Lugo;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
27 Lugo;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
27 Lugo;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
27 Lugo;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
27 Lugo;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;98,07
27 Lugo;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
27 Lugo;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
27 Lugo;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
27 Lugo;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;99,06
27 Lugo;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
27 Lugo;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
27 Lugo;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
27 Lugo;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;97,81
27 Lugo;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
27 Lugo;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
27 Lugo;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;96,83
27 Lugo;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
27 Lugo;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
27 Lugo;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
27 Lugo;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;98,2
27 Lugo;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
27 Lugo;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
27 Lugo;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
27 Lugo;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;96,8
27 Lugo;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
27 Lugo;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
27 Lugo;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;95,48
27 Lugo;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
27 Lugo;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
27 Lugo;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
27 Lugo;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;97
27 Lugo;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
27 Lugo;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
27 Lugo;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
27 Lugo;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;95,78
27 Lugo;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
27 Lugo;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
27 Lugo;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;93,89
27 Lugo;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
27 Lugo;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
27 Lugo;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
27 Lugo;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;95,78
27 Lugo;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
27 Lugo;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
27 Lugo;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
27 Lugo;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;94,63
27 Lugo;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
27 Lugo;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
27 Lugo;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
27 Lugo;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
27 Lugo;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
27 Lugo;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
27 Lugo;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QI;2.673
27 Lugo;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
27 Lugo;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
27 Lugo;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
27 Lugo;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QI;2.652
27 Lugo;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
27 Lugo;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
27 Lugo;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
27 Lugo;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QI;2.692
27 Lugo;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
27 Lugo;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
27 Lugo;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2022QII;""
27 Lugo;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2022QI;2.637
27 Lugo;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
27 Lugo;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
27 Lugo;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2021QII;""
27 Lugo;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2021QI;2.617
27 Lugo;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
27 Lugo;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
27 Lugo;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2020QII;""
27 Lugo;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2020QI;2.622
27 Lugo;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
27 Lugo;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
27 Lugo;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2022QII;2.595
27 Lugo;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2022QI;""
27 Lugo;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
27 Lugo;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
27 Lugo;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2021QII;2.561
27 Lugo;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2021QI;""
27 Lugo;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
27 Lugo;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
27 Lugo;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2020QII;2.591
27 Lugo;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2020QI;""
27 Lugo;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
27 Lugo;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QIII;2.546
27 Lugo;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QII;""
27 Lugo;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QI;""
27 Lugo;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
27 Lugo;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QIII;2.522
27 Lugo;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QII;""
27 Lugo;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QI;""
27 Lugo;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
27 Lugo;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QIII;2.562
27 Lugo;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QII;""
27 Lugo;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QI;""
27 Lugo;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QIV;2.489
27 Lugo;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
27 Lugo;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QII;""
27 Lugo;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QI;""
27 Lugo;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QIV;2.480
27 Lugo;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
27 Lugo;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QII;""
27 Lugo;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QI;""
27 Lugo;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QIV;2.520
27 Lugo;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
27 Lugo;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QII;""
27 Lugo;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QI;""
27 Lugo;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
27 Lugo;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
27 Lugo;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
27 Lugo;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
27 Lugo;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
27 Lugo;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
27 Lugo;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
27 Lugo;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
27 Lugo;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
27 Lugo;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
27 Lugo;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
27 Lugo;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
27 Lugo;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
27 Lugo;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
27 Lugo;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
27 Lugo;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;98,65
27 Lugo;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
27 Lugo;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
27 Lugo;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
27 Lugo;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;98,68
27 Lugo;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
27 Lugo;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
27 Lugo;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
27 Lugo;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;97,4
27 Lugo;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
27 Lugo;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
27 Lugo;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;97,08
27 Lugo;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
27 Lugo;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
27 Lugo;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
27 Lugo;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;96,57
27 Lugo;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
27 Lugo;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
27 Lugo;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
27 Lugo;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;96,25
27 Lugo;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
27 Lugo;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
27 Lugo;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;95,25
27 Lugo;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
27 Lugo;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
27 Lugo;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
27 Lugo;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;95,1
27 Lugo;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
27 Lugo;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
27 Lugo;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
27 Lugo;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;95,17
27 Lugo;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
27 Lugo;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
27 Lugo;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;93,12
27 Lugo;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
27 Lugo;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
27 Lugo;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
27 Lugo;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;93,51
27 Lugo;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
27 Lugo;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
27 Lugo;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
27 Lugo;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;93,61
27 Lugo;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
27 Lugo;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
27 Lugo;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
27 Lugo;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
27 Lugo;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
27 Lugo;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QII;7.052
27 Lugo;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
27 Lugo;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
27 Lugo;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
27 Lugo;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QII;7.038
27 Lugo;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
27 Lugo;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
27 Lugo;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
27 Lugo;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QII;6.981
27 Lugo;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
27 Lugo;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
27 Lugo;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
27 Lugo;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2022QII;6.949
27 Lugo;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2022QI;""
27 Lugo;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
27 Lugo;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
27 Lugo;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2021QII;6.936
27 Lugo;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2021QI;""
27 Lugo;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
27 Lugo;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
27 Lugo;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2020QII;6.904
27 Lugo;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2020QI;""
27 Lugo;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
27 Lugo;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2022QIII;6.839
27 Lugo;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2022QII;""
27 Lugo;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2022QI;""
27 Lugo;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
27 Lugo;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2021QIII;6.838
27 Lugo;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2021QII;""
27 Lugo;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2021QI;""
27 Lugo;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
27 Lugo;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2020QIII;6.819
27 Lugo;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2020QII;""
27 Lugo;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2020QI;""
27 Lugo;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QIV;6.705
27 Lugo;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
27 Lugo;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QII;""
27 Lugo;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QI;""
27 Lugo;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QIV;6.731
27 Lugo;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
27 Lugo;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QII;""
27 Lugo;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QI;""
27 Lugo;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QIV;6.723
27 Lugo;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
27 Lugo;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QII;""
27 Lugo;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QI;""
27 Lugo;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
27 Lugo;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
27 Lugo;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QII;""
27 Lugo;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QI;6.628
27 Lugo;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
27 Lugo;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
27 Lugo;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QII;""
27 Lugo;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QI;6.662
27 Lugo;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
27 Lugo;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
27 Lugo;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QII;""
27 Lugo;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QI;""
27 Lugo;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
27 Lugo;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
27 Lugo;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
27 Lugo;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
27 Lugo;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
27 Lugo;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
27 Lugo;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
27 Lugo;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
27 Lugo;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
27 Lugo;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
27 Lugo;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
27 Lugo;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
27 Lugo;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
27 Lugo;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
27 Lugo;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;98,54
27 Lugo;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
27 Lugo;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
27 Lugo;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
27 Lugo;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;98,55
27 Lugo;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
27 Lugo;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
27 Lugo;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
27 Lugo;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;98,9
27 Lugo;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
27 Lugo;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
27 Lugo;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;96,98
27 Lugo;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
27 Lugo;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
27 Lugo;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
27 Lugo;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;97,16
27 Lugo;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
27 Lugo;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
27 Lugo;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
27 Lugo;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;97,68
27 Lugo;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
27 Lugo;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
27 Lugo;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;95,08
27 Lugo;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
27 Lugo;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
27 Lugo;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
27 Lugo;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;95,64
27 Lugo;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
27 Lugo;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
27 Lugo;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
27 Lugo;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;96,3
27 Lugo;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
27 Lugo;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
27 Lugo;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
27 Lugo;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
27 Lugo;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
27 Lugo;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
27 Lugo;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;94,17
27 Lugo;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
27 Lugo;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
27 Lugo;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
27 Lugo;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;95,43
27 Lugo;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
27 Lugo;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
27 Lugo;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
27 Lugo;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
27 Lugo;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
27 Lugo;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
27 Lugo;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QII;4.327
27 Lugo;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
27 Lugo;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
27 Lugo;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
27 Lugo;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QII;4.334
27 Lugo;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
27 Lugo;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
27 Lugo;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
27 Lugo;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QII;4.306
27 Lugo;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
27 Lugo;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
27 Lugo;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
27 Lugo;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2022QII;4.268
27 Lugo;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2022QI;""
27 Lugo;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
27 Lugo;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
27 Lugo;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2021QII;4.290
27 Lugo;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2021QI;""
27 Lugo;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
27 Lugo;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
27 Lugo;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2020QII;4.261
27 Lugo;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2020QI;""
27 Lugo;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
27 Lugo;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2022QIII;4.207
27 Lugo;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2022QII;""
27 Lugo;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2022QI;""
27 Lugo;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
27 Lugo;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2021QIII;4.233
27 Lugo;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2021QII;""
27 Lugo;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2021QI;""
27 Lugo;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
27 Lugo;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2020QIII;4.208
27 Lugo;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2020QII;""
27 Lugo;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2020QI;""
27 Lugo;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QIV;4.127
27 Lugo;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
27 Lugo;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QII;""
27 Lugo;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QI;""
27 Lugo;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QIV;4.169
27 Lugo;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
27 Lugo;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QII;""
27 Lugo;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QI;""
27 Lugo;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QIV;4.156
27 Lugo;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
27 Lugo;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QII;""
27 Lugo;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QI;""
27 Lugo;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
27 Lugo;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
27 Lugo;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QII;""
27 Lugo;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QI;4.098
27 Lugo;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
27 Lugo;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
27 Lugo;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QII;""
27 Lugo;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QI;4.124
27 Lugo;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
27 Lugo;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
27 Lugo;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QII;""
27 Lugo;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QI;""
27 Lugo;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
27 Lugo;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
27 Lugo;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
27 Lugo;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
27 Lugo;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
27 Lugo;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
27 Lugo;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
27 Lugo;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
27 Lugo;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
27 Lugo;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
27 Lugo;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
27 Lugo;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
27 Lugo;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
27 Lugo;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
27 Lugo;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;98,64
27 Lugo;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
27 Lugo;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
27 Lugo;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
27 Lugo;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;98,98
27 Lugo;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
27 Lugo;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
27 Lugo;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
27 Lugo;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;98,95
27 Lugo;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
27 Lugo;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
27 Lugo;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;97,23
27 Lugo;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
27 Lugo;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
27 Lugo;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
27 Lugo;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;97,67
27 Lugo;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
27 Lugo;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
27 Lugo;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
27 Lugo;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;97,72
27 Lugo;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
27 Lugo;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
27 Lugo;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;95,38
27 Lugo;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
27 Lugo;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
27 Lugo;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
27 Lugo;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;96,19
27 Lugo;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
27 Lugo;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
27 Lugo;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
27 Lugo;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;96,52
27 Lugo;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
27 Lugo;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
27 Lugo;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
27 Lugo;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
27 Lugo;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
27 Lugo;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
27 Lugo;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;94,55
27 Lugo;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
27 Lugo;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
27 Lugo;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
27 Lugo;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;95,77
27 Lugo;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
27 Lugo;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
27 Lugo;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
27 Lugo;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
27 Lugo;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
27 Lugo;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
27 Lugo;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QII;2.725
27 Lugo;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
27 Lugo;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
27 Lugo;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
27 Lugo;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QII;2.704
27 Lugo;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
27 Lugo;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
27 Lugo;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
27 Lugo;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QII;2.675
27 Lugo;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
27 Lugo;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
27 Lugo;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
27 Lugo;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2022QII;2.681
27 Lugo;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2022QI;""
27 Lugo;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
27 Lugo;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
27 Lugo;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2021QII;2.646
27 Lugo;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2021QI;""
27 Lugo;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
27 Lugo;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
27 Lugo;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2020QII;2.643
27 Lugo;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2020QI;""
27 Lugo;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
27 Lugo;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2022QIII;2.632
27 Lugo;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2022QII;""
27 Lugo;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2022QI;""
27 Lugo;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
27 Lugo;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2021QIII;2.605
27 Lugo;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2021QII;""
27 Lugo;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2021QI;""
27 Lugo;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
27 Lugo;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2020QIII;2.611
27 Lugo;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2020QII;""
27 Lugo;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2020QI;""
27 Lugo;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QIV;2.578
27 Lugo;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
27 Lugo;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QII;""
27 Lugo;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QI;""
27 Lugo;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QIV;2.562
27 Lugo;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
27 Lugo;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QII;""
27 Lugo;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QI;""
27 Lugo;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QIV;2.567
27 Lugo;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
27 Lugo;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QII;""
27 Lugo;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QI;""
27 Lugo;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
27 Lugo;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
27 Lugo;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QII;""
27 Lugo;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QI;2.530
27 Lugo;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
27 Lugo;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
27 Lugo;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QII;""
27 Lugo;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QI;2.538
27 Lugo;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
27 Lugo;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
27 Lugo;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QII;""
27 Lugo;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QI;""
27 Lugo;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
27 Lugo;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
27 Lugo;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
27 Lugo;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
27 Lugo;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
27 Lugo;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
27 Lugo;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
27 Lugo;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
27 Lugo;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
27 Lugo;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
27 Lugo;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
27 Lugo;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
27 Lugo;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
27 Lugo;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
27 Lugo;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;98,39
27 Lugo;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
27 Lugo;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
27 Lugo;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
27 Lugo;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;97,86
27 Lugo;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
27 Lugo;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
27 Lugo;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
27 Lugo;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;98,8
27 Lugo;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
27 Lugo;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
27 Lugo;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;96,59
27 Lugo;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
27 Lugo;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
27 Lugo;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
27 Lugo;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;96,34
27 Lugo;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
27 Lugo;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
27 Lugo;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
27 Lugo;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;97,61
27 Lugo;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
27 Lugo;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
27 Lugo;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;94,61
27 Lugo;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
27 Lugo;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
27 Lugo;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
27 Lugo;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;94,75
27 Lugo;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
27 Lugo;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
27 Lugo;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
27 Lugo;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;95,96
27 Lugo;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
27 Lugo;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
27 Lugo;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
27 Lugo;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
27 Lugo;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
27 Lugo;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
27 Lugo;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;93,57
27 Lugo;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
27 Lugo;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
27 Lugo;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
27 Lugo;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;94,88
27 Lugo;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
27 Lugo;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
27 Lugo;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
27 Lugo;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
27 Lugo;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
27 Lugo;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QIII;7.042
27 Lugo;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
27 Lugo;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
27 Lugo;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
27 Lugo;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QIII;7.041
27 Lugo;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
27 Lugo;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
27 Lugo;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
27 Lugo;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QIII;6.985
27 Lugo;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
27 Lugo;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
27 Lugo;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
27 Lugo;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2022QIII;6.911
27 Lugo;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2022QII;""
27 Lugo;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2022QI;""
27 Lugo;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
27 Lugo;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2021QIII;6.932
27 Lugo;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2021QII;""
27 Lugo;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2021QI;""
27 Lugo;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
27 Lugo;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2020QIII;6.883
27 Lugo;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2020QII;""
27 Lugo;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2020QI;""
27 Lugo;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2022QIV;6.764
27 Lugo;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
27 Lugo;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2022QII;""
27 Lugo;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2022QI;""
27 Lugo;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2021QIV;6.816
27 Lugo;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
27 Lugo;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2021QII;""
27 Lugo;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2021QI;""
27 Lugo;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2020QIV;6.780
27 Lugo;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
27 Lugo;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2020QII;""
27 Lugo;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2020QI;""
27 Lugo;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
27 Lugo;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
27 Lugo;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QII;""
27 Lugo;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QI;6.710
27 Lugo;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
27 Lugo;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
27 Lugo;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QII;""
27 Lugo;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QI;6.716
27 Lugo;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
27 Lugo;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
27 Lugo;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QII;""
27 Lugo;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QI;""
27 Lugo;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
27 Lugo;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
27 Lugo;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QII;6.628
27 Lugo;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QI;""
27 Lugo;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
27 Lugo;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
27 Lugo;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QII;6.632
27 Lugo;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QI;""
27 Lugo;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
27 Lugo;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
27 Lugo;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QII;""
27 Lugo;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QI;""
27 Lugo;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
27 Lugo;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
27 Lugo;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
27 Lugo;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
27 Lugo;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
27 Lugo;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
27 Lugo;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
27 Lugo;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
27 Lugo;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
27 Lugo;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
27 Lugo;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
27 Lugo;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
27 Lugo;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
27 Lugo;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;98,14
27 Lugo;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
27 Lugo;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
27 Lugo;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
27 Lugo;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;98,45
27 Lugo;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
27 Lugo;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
27 Lugo;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
27 Lugo;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;98,54
27 Lugo;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
27 Lugo;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
27 Lugo;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;96,05
27 Lugo;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
27 Lugo;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
27 Lugo;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
27 Lugo;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;96,8
27 Lugo;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
27 Lugo;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
27 Lugo;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
27 Lugo;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;97,07
27 Lugo;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
27 Lugo;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
27 Lugo;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
27 Lugo;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
27 Lugo;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
27 Lugo;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
27 Lugo;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;95,3
27 Lugo;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
27 Lugo;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
27 Lugo;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
27 Lugo;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;96,15
27 Lugo;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
27 Lugo;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
27 Lugo;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
27 Lugo;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
27 Lugo;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
27 Lugo;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
27 Lugo;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;94,13
27 Lugo;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
27 Lugo;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
27 Lugo;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
27 Lugo;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;94,95
27 Lugo;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
27 Lugo;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
27 Lugo;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
27 Lugo;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
27 Lugo;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
27 Lugo;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
27 Lugo;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QIII;4.322
27 Lugo;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
27 Lugo;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
27 Lugo;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
27 Lugo;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QIII;4.346
27 Lugo;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
27 Lugo;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
27 Lugo;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
27 Lugo;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QIII;4.318
27 Lugo;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
27 Lugo;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
27 Lugo;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
27 Lugo;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2022QIII;4.253
27 Lugo;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2022QII;""
27 Lugo;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2022QI;""
27 Lugo;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
27 Lugo;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2021QIII;4.280
27 Lugo;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2021QII;""
27 Lugo;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2021QI;""
27 Lugo;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
27 Lugo;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2020QIII;4.253
27 Lugo;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2020QII;""
27 Lugo;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2020QI;""
27 Lugo;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2022QIV;4.164
27 Lugo;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
27 Lugo;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2022QII;""
27 Lugo;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2022QI;""
27 Lugo;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2021QIV;4.214
27 Lugo;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
27 Lugo;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2021QII;""
27 Lugo;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2021QI;""
27 Lugo;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2020QIV;4.195
27 Lugo;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
27 Lugo;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2020QII;""
27 Lugo;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2020QI;""
27 Lugo;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
27 Lugo;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
27 Lugo;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QII;""
27 Lugo;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QI;4.141
27 Lugo;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
27 Lugo;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
27 Lugo;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QII;""
27 Lugo;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QI;4.161
27 Lugo;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
27 Lugo;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
27 Lugo;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QII;""
27 Lugo;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QI;""
27 Lugo;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
27 Lugo;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
27 Lugo;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QII;4.095
27 Lugo;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QI;""
27 Lugo;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
27 Lugo;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
27 Lugo;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QII;4.126
27 Lugo;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QI;""
27 Lugo;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
27 Lugo;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
27 Lugo;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QII;""
27 Lugo;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QI;""
27 Lugo;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
27 Lugo;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
27 Lugo;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
27 Lugo;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
27 Lugo;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
27 Lugo;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
27 Lugo;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
27 Lugo;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
27 Lugo;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
27 Lugo;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
27 Lugo;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
27 Lugo;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
27 Lugo;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
27 Lugo;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;98,4
27 Lugo;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
27 Lugo;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
27 Lugo;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
27 Lugo;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;98,48
27 Lugo;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
27 Lugo;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
27 Lugo;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
27 Lugo;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;98,49
27 Lugo;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
27 Lugo;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
27 Lugo;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;96,34
27 Lugo;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
27 Lugo;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
27 Lugo;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
27 Lugo;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;96,96
27 Lugo;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
27 Lugo;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
27 Lugo;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
27 Lugo;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;97,15
27 Lugo;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
27 Lugo;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
27 Lugo;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
27 Lugo;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
27 Lugo;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
27 Lugo;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
27 Lugo;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;95,28
27 Lugo;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
27 Lugo;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
27 Lugo;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
27 Lugo;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;96,36
27 Lugo;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
27 Lugo;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
27 Lugo;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
27 Lugo;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
27 Lugo;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
27 Lugo;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
27 Lugo;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;94,22
27 Lugo;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
27 Lugo;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
27 Lugo;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
27 Lugo;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;95,55
27 Lugo;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
27 Lugo;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
27 Lugo;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
27 Lugo;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
27 Lugo;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
27 Lugo;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
27 Lugo;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QIII;2.720
27 Lugo;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
27 Lugo;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
27 Lugo;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
27 Lugo;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QIII;2.695
27 Lugo;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
27 Lugo;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
27 Lugo;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
27 Lugo;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QIII;2.667
27 Lugo;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
27 Lugo;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
27 Lugo;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
27 Lugo;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2022QIII;2.658
27 Lugo;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2022QII;""
27 Lugo;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2022QI;""
27 Lugo;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
27 Lugo;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2021QIII;2.652
27 Lugo;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2021QII;""
27 Lugo;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2021QI;""
27 Lugo;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
27 Lugo;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2020QIII;2.630
27 Lugo;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2020QII;""
27 Lugo;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2020QI;""
27 Lugo;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2022QIV;2.600
27 Lugo;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
27 Lugo;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2022QII;""
27 Lugo;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2022QI;""
27 Lugo;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2021QIV;2.602
27 Lugo;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
27 Lugo;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2021QII;""
27 Lugo;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2021QI;""
27 Lugo;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2020QIV;2.585
27 Lugo;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
27 Lugo;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2020QII;""
27 Lugo;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2020QI;""
27 Lugo;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
27 Lugo;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
27 Lugo;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QII;""
27 Lugo;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QI;2.569
27 Lugo;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
27 Lugo;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
27 Lugo;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QII;""
27 Lugo;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QI;2.555
27 Lugo;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
27 Lugo;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
27 Lugo;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QII;""
27 Lugo;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QI;""
27 Lugo;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
27 Lugo;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
27 Lugo;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QII;2.533
27 Lugo;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QI;""
27 Lugo;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
27 Lugo;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
27 Lugo;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QII;2.506
27 Lugo;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QI;""
27 Lugo;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
27 Lugo;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
27 Lugo;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QII;""
27 Lugo;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QI;""
27 Lugo;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
27 Lugo;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
27 Lugo;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
27 Lugo;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
27 Lugo;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
27 Lugo;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
27 Lugo;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
27 Lugo;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
27 Lugo;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
27 Lugo;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
27 Lugo;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
27 Lugo;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
27 Lugo;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
27 Lugo;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;97,72
27 Lugo;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
27 Lugo;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
27 Lugo;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
27 Lugo;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;98,4
27 Lugo;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
27 Lugo;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
27 Lugo;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
27 Lugo;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;98,61
27 Lugo;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
27 Lugo;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
27 Lugo;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;95,59
27 Lugo;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
27 Lugo;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
27 Lugo;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
27 Lugo;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;96,55
27 Lugo;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
27 Lugo;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
27 Lugo;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
27 Lugo;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;96,93
27 Lugo;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
27 Lugo;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
27 Lugo;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
27 Lugo;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
27 Lugo;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
27 Lugo;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
27 Lugo;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;95,32
27 Lugo;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
27 Lugo;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
27 Lugo;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
27 Lugo;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;95,8
27 Lugo;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
27 Lugo;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
27 Lugo;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
27 Lugo;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
27 Lugo;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
27 Lugo;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
27 Lugo;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;93,99
27 Lugo;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
27 Lugo;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
27 Lugo;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
27 Lugo;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;93,96
27 Lugo;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
27 Lugo;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
27 Lugo;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
27 Lugo;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
27 Lugo;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
27 Lugo;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QIV;6.979
27 Lugo;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
27 Lugo;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
27 Lugo;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
27 Lugo;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QIV;7.011
27 Lugo;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
27 Lugo;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
27 Lugo;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
27 Lugo;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QIV;6.975
27 Lugo;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
27 Lugo;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
27 Lugo;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
27 Lugo;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2022QIV;6.821
27 Lugo;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
27 Lugo;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2022QII;""
27 Lugo;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2022QI;""
27 Lugo;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2021QIV;6.885
27 Lugo;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
27 Lugo;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2021QII;""
27 Lugo;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2021QI;""
27 Lugo;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2020QIV;6.852
27 Lugo;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
27 Lugo;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2020QII;""
27 Lugo;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2020QI;""
27 Lugo;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
27 Lugo;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
27 Lugo;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2022QII;""
27 Lugo;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2022QI;6.774
27 Lugo;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
27 Lugo;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
27 Lugo;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2021QII;""
27 Lugo;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2021QI;6.785
27 Lugo;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
27 Lugo;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
27 Lugo;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2020QII;""
27 Lugo;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2020QI;""
27 Lugo;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
27 Lugo;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
27 Lugo;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QII;6.688
27 Lugo;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QI;""
27 Lugo;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
27 Lugo;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
27 Lugo;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QII;6.696
27 Lugo;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QI;""
27 Lugo;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
27 Lugo;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
27 Lugo;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QII;""
27 Lugo;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QI;""
27 Lugo;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
27 Lugo;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QIII;6.584
27 Lugo;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QII;""
27 Lugo;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QI;""
27 Lugo;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
27 Lugo;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QIII;6.608
27 Lugo;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QII;""
27 Lugo;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QI;""
27 Lugo;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
27 Lugo;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
27 Lugo;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QII;""
27 Lugo;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QI;""
27 Lugo;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
27 Lugo;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
27 Lugo;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
27 Lugo;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
27 Lugo;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
27 Lugo;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
27 Lugo;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
27 Lugo;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
27 Lugo;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
27 Lugo;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
27 Lugo;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
27 Lugo;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
27 Lugo;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;97,74
27 Lugo;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
27 Lugo;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
27 Lugo;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
27 Lugo;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;98,2
27 Lugo;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
27 Lugo;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
27 Lugo;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
27 Lugo;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;98,24
27 Lugo;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
27 Lugo;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
27 Lugo;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
27 Lugo;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
27 Lugo;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
27 Lugo;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
27 Lugo;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;96,62
27 Lugo;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
27 Lugo;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
27 Lugo;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
27 Lugo;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;97,28
27 Lugo;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
27 Lugo;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
27 Lugo;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
27 Lugo;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
27 Lugo;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
27 Lugo;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
27 Lugo;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;95,39
27 Lugo;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
27 Lugo;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
27 Lugo;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
27 Lugo;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;96
27 Lugo;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
27 Lugo;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
27 Lugo;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
27 Lugo;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
27 Lugo;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
27 Lugo;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
27 Lugo;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;93,91
27 Lugo;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
27 Lugo;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
27 Lugo;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
27 Lugo;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;94,74
27 Lugo;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
27 Lugo;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
27 Lugo;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
27 Lugo;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
27 Lugo;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
27 Lugo;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
27 Lugo;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QIV;4.288
27 Lugo;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
27 Lugo;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
27 Lugo;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
27 Lugo;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QIV;4.324
27 Lugo;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
27 Lugo;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
27 Lugo;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
27 Lugo;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QIV;4.306
27 Lugo;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
27 Lugo;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
27 Lugo;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
27 Lugo;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2022QIV;4.191
27 Lugo;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
27 Lugo;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2022QII;""
27 Lugo;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2022QI;""
27 Lugo;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2021QIV;4.251
27 Lugo;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
27 Lugo;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2021QII;""
27 Lugo;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2021QI;""
27 Lugo;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2020QIV;4.232
27 Lugo;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
27 Lugo;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2020QII;""
27 Lugo;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2020QI;""
27 Lugo;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
27 Lugo;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
27 Lugo;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2022QII;""
27 Lugo;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2022QI;4.173
27 Lugo;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
27 Lugo;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
27 Lugo;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2021QII;""
27 Lugo;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2021QI;4.195
27 Lugo;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
27 Lugo;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
27 Lugo;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2020QII;""
27 Lugo;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2020QI;""
27 Lugo;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
27 Lugo;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
27 Lugo;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QII;4.125
27 Lugo;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QI;""
27 Lugo;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
27 Lugo;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
27 Lugo;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QII;4.159
27 Lugo;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QI;""
27 Lugo;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
27 Lugo;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
27 Lugo;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QII;""
27 Lugo;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QI;""
27 Lugo;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
27 Lugo;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QIII;4.068
27 Lugo;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QII;""
27 Lugo;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QI;""
27 Lugo;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
27 Lugo;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QIII;4.109
27 Lugo;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QII;""
27 Lugo;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QI;""
27 Lugo;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
27 Lugo;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
27 Lugo;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QII;""
27 Lugo;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QI;""
27 Lugo;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
27 Lugo;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
27 Lugo;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
27 Lugo;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
27 Lugo;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
27 Lugo;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
27 Lugo;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
27 Lugo;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
27 Lugo;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
27 Lugo;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
27 Lugo;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
27 Lugo;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
27 Lugo;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;97,74
27 Lugo;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
27 Lugo;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
27 Lugo;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
27 Lugo;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;98,31
27 Lugo;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
27 Lugo;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
27 Lugo;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
27 Lugo;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;98,28
27 Lugo;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
27 Lugo;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
27 Lugo;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
27 Lugo;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
27 Lugo;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
27 Lugo;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
27 Lugo;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;96,51
27 Lugo;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
27 Lugo;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
27 Lugo;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
27 Lugo;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;97,42
27 Lugo;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
27 Lugo;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
27 Lugo;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
27 Lugo;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
27 Lugo;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
27 Lugo;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
27 Lugo;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;95,4
27 Lugo;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
27 Lugo;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
27 Lugo;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
27 Lugo;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;96,59
27 Lugo;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
27 Lugo;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
27 Lugo;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
27 Lugo;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
27 Lugo;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
27 Lugo;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
27 Lugo;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;94,08
27 Lugo;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
27 Lugo;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
27 Lugo;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
27 Lugo;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;95,42
27 Lugo;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
27 Lugo;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
27 Lugo;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
27 Lugo;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
27 Lugo;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
27 Lugo;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
27 Lugo;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QIV;2.691
27 Lugo;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
27 Lugo;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
27 Lugo;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
27 Lugo;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QIV;2.687
27 Lugo;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
27 Lugo;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
27 Lugo;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
27 Lugo;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QIV;2.669
27 Lugo;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
27 Lugo;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
27 Lugo;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
27 Lugo;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2022QIV;2.630
27 Lugo;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
27 Lugo;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2022QII;""
27 Lugo;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2022QI;""
27 Lugo;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2021QIV;2.634
27 Lugo;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
27 Lugo;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2021QII;""
27 Lugo;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2021QI;""
27 Lugo;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2020QIV;2.620
27 Lugo;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
27 Lugo;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2020QII;""
27 Lugo;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2020QI;""
27 Lugo;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
27 Lugo;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
27 Lugo;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2022QII;""
27 Lugo;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2022QI;2.601
27 Lugo;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
27 Lugo;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
27 Lugo;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2021QII;""
27 Lugo;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2021QI;2.590
27 Lugo;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
27 Lugo;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
27 Lugo;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2020QII;""
27 Lugo;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2020QI;""
27 Lugo;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
27 Lugo;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
27 Lugo;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QII;2.563
27 Lugo;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QI;""
27 Lugo;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
27 Lugo;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
27 Lugo;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QII;2.537
27 Lugo;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QI;""
27 Lugo;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
27 Lugo;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
27 Lugo;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QII;""
27 Lugo;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QI;""
27 Lugo;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
27 Lugo;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QIII;2.516
27 Lugo;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QII;""
27 Lugo;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QI;""
27 Lugo;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
27 Lugo;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QIII;2.499
27 Lugo;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QII;""
27 Lugo;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QI;""
27 Lugo;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
27 Lugo;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
27 Lugo;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QII;""
27 Lugo;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QI;""
27 Lugo;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
27 Lugo;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
27 Lugo;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
27 Lugo;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
27 Lugo;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
27 Lugo;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
27 Lugo;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
27 Lugo;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
27 Lugo;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
27 Lugo;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
27 Lugo;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
27 Lugo;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
27 Lugo;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;97,73
27 Lugo;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
27 Lugo;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
27 Lugo;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
27 Lugo;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;98,03
27 Lugo;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
27 Lugo;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
27 Lugo;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
27 Lugo;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;98,16
27 Lugo;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
27 Lugo;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
27 Lugo;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
27 Lugo;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
27 Lugo;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
27 Lugo;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
27 Lugo;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;96,8
27 Lugo;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
27 Lugo;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
27 Lugo;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
27 Lugo;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;97,04
27 Lugo;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
27 Lugo;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
27 Lugo;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
27 Lugo;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
27 Lugo;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
27 Lugo;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
27 Lugo;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;95,39
27 Lugo;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
27 Lugo;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
27 Lugo;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
27 Lugo;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;95,05
27 Lugo;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
27 Lugo;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
27 Lugo;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
27 Lugo;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
27 Lugo;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
27 Lugo;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
27 Lugo;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;93,64
27 Lugo;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
27 Lugo;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
27 Lugo;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
27 Lugo;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;93,63
27 Lugo;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
27 Lugo;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
27 Lugo;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
27 Lugo;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
27 Lugo;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
27 Lugo;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
27 Lugo;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
27 Lugo;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
27 Lugo;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
27 Lugo;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QI;3.668
27 Lugo;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
27 Lugo;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
27 Lugo;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
27 Lugo;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QI;3.477
27 Lugo;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
27 Lugo;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
27 Lugo;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
27 Lugo;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QI;4.059
27 Lugo;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
27 Lugo;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
27 Lugo;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2022QII;""
27 Lugo;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2022QI;3.532
27 Lugo;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
27 Lugo;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
27 Lugo;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2021QII;""
27 Lugo;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2021QI;3.367
27 Lugo;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
27 Lugo;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
27 Lugo;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2020QII;""
27 Lugo;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2020QI;3.826
27 Lugo;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
27 Lugo;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
27 Lugo;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2022QII;3.424
27 Lugo;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2022QI;""
27 Lugo;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
27 Lugo;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
27 Lugo;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2021QII;3.260
27 Lugo;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2021QI;""
27 Lugo;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
27 Lugo;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
27 Lugo;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2020QII;3.698
27 Lugo;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2020QI;""
27 Lugo;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
27 Lugo;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QIII;3.316
27 Lugo;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QII;""
27 Lugo;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QI;""
27 Lugo;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
27 Lugo;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QIII;3.138
27 Lugo;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QII;""
27 Lugo;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QI;""
27 Lugo;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
27 Lugo;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QIII;3.568
27 Lugo;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QII;""
27 Lugo;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QI;""
27 Lugo;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QIV;3.096
27 Lugo;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
27 Lugo;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QII;""
27 Lugo;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QI;""
27 Lugo;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QIV;2.990
27 Lugo;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
27 Lugo;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QII;""
27 Lugo;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QI;""
27 Lugo;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QIV;3.383
27 Lugo;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
27 Lugo;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QII;""
27 Lugo;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QI;""
27 Lugo;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
27 Lugo;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
27 Lugo;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
27 Lugo;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
27 Lugo;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
27 Lugo;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
27 Lugo;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
27 Lugo;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
27 Lugo;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
27 Lugo;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
27 Lugo;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
27 Lugo;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
27 Lugo;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
27 Lugo;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
27 Lugo;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
27 Lugo;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;96,29
27 Lugo;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
27 Lugo;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
27 Lugo;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
27 Lugo;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;96,84
27 Lugo;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
27 Lugo;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
27 Lugo;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
27 Lugo;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;94,26
27 Lugo;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
27 Lugo;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
27 Lugo;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;93,35
27 Lugo;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
27 Lugo;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
27 Lugo;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
27 Lugo;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;93,76
27 Lugo;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
27 Lugo;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
27 Lugo;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
27 Lugo;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;91,11
27 Lugo;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
27 Lugo;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
27 Lugo;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;90,4
27 Lugo;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
27 Lugo;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
27 Lugo;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
27 Lugo;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;90,25
27 Lugo;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
27 Lugo;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
27 Lugo;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
27 Lugo;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;87,9
27 Lugo;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
27 Lugo;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
27 Lugo;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;84,41
27 Lugo;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
27 Lugo;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
27 Lugo;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
27 Lugo;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;85,99
27 Lugo;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
27 Lugo;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
27 Lugo;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
27 Lugo;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;83,35
27 Lugo;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
27 Lugo;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
27 Lugo;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
27 Lugo;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
27 Lugo;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
27 Lugo;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
27 Lugo;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QI;2.362
27 Lugo;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
27 Lugo;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
27 Lugo;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
27 Lugo;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QI;2.238
27 Lugo;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
27 Lugo;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
27 Lugo;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
27 Lugo;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QI;2.578
27 Lugo;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
27 Lugo;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
27 Lugo;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2022QII;""
27 Lugo;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2022QI;2.280
27 Lugo;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
27 Lugo;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
27 Lugo;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2021QII;""
27 Lugo;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2021QI;2.173
27 Lugo;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
27 Lugo;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
27 Lugo;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2020QII;""
27 Lugo;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2020QI;2.436
27 Lugo;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
27 Lugo;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
27 Lugo;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2022QII;2.207
27 Lugo;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2022QI;""
27 Lugo;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
27 Lugo;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
27 Lugo;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2021QII;2.108
27 Lugo;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2021QI;""
27 Lugo;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
27 Lugo;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
27 Lugo;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2020QII;2.365
27 Lugo;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2020QI;""
27 Lugo;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
27 Lugo;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QIII;2.138
27 Lugo;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QII;""
27 Lugo;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QI;""
27 Lugo;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
27 Lugo;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QIII;2.031
27 Lugo;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QII;""
27 Lugo;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QI;""
27 Lugo;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
27 Lugo;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QIII;2.287
27 Lugo;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QII;""
27 Lugo;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QI;""
27 Lugo;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QIV;1.999
27 Lugo;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
27 Lugo;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QII;""
27 Lugo;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QI;""
27 Lugo;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QIV;1.946
27 Lugo;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
27 Lugo;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QII;""
27 Lugo;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QI;""
27 Lugo;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QIV;2.178
27 Lugo;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
27 Lugo;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QII;""
27 Lugo;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QI;""
27 Lugo;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
27 Lugo;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
27 Lugo;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
27 Lugo;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
27 Lugo;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
27 Lugo;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
27 Lugo;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
27 Lugo;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
27 Lugo;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
27 Lugo;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
27 Lugo;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
27 Lugo;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
27 Lugo;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
27 Lugo;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
27 Lugo;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
27 Lugo;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;96,53
27 Lugo;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
27 Lugo;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
27 Lugo;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
27 Lugo;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;97,1
27 Lugo;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
27 Lugo;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
27 Lugo;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
27 Lugo;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;94,49
27 Lugo;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
27 Lugo;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
27 Lugo;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;93,44
27 Lugo;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
27 Lugo;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
27 Lugo;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
27 Lugo;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;94,19
27 Lugo;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
27 Lugo;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
27 Lugo;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
27 Lugo;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;91,74
27 Lugo;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
27 Lugo;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
27 Lugo;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;90,52
27 Lugo;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
27 Lugo;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
27 Lugo;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
27 Lugo;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;90,75
27 Lugo;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
27 Lugo;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
27 Lugo;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
27 Lugo;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;88,71
27 Lugo;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
27 Lugo;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
27 Lugo;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;84,63
27 Lugo;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
27 Lugo;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
27 Lugo;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
27 Lugo;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;86,95
27 Lugo;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
27 Lugo;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
27 Lugo;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
27 Lugo;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;84,48
27 Lugo;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
27 Lugo;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
27 Lugo;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
27 Lugo;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
27 Lugo;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
27 Lugo;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
27 Lugo;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QI;1.306
27 Lugo;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
27 Lugo;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
27 Lugo;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
27 Lugo;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QI;1.239
27 Lugo;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
27 Lugo;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
27 Lugo;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
27 Lugo;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QI;1.481
27 Lugo;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
27 Lugo;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
27 Lugo;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2022QII;""
27 Lugo;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2022QI;1.252
27 Lugo;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
27 Lugo;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
27 Lugo;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2021QII;""
27 Lugo;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2021QI;1.194
27 Lugo;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
27 Lugo;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
27 Lugo;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2020QII;""
27 Lugo;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2020QI;1.390
27 Lugo;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
27 Lugo;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
27 Lugo;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2022QII;1.217
27 Lugo;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2022QI;""
27 Lugo;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
27 Lugo;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
27 Lugo;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2021QII;1.152
27 Lugo;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2021QI;""
27 Lugo;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
27 Lugo;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
27 Lugo;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2020QII;1.333
27 Lugo;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2020QI;""
27 Lugo;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
27 Lugo;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QIII;1.178
27 Lugo;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QII;""
27 Lugo;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QI;""
27 Lugo;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
27 Lugo;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QIII;1.107
27 Lugo;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QII;""
27 Lugo;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QI;""
27 Lugo;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
27 Lugo;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QIII;1.281
27 Lugo;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QII;""
27 Lugo;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QI;""
27 Lugo;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QIV;1.097
27 Lugo;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
27 Lugo;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QII;""
27 Lugo;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QI;""
27 Lugo;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QIV;1.044
27 Lugo;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
27 Lugo;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QII;""
27 Lugo;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QI;""
27 Lugo;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QIV;1.205
27 Lugo;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
27 Lugo;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QII;""
27 Lugo;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QI;""
27 Lugo;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
27 Lugo;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
27 Lugo;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
27 Lugo;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
27 Lugo;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
27 Lugo;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
27 Lugo;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
27 Lugo;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
27 Lugo;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
27 Lugo;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
27 Lugo;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
27 Lugo;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
27 Lugo;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
27 Lugo;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
27 Lugo;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
27 Lugo;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;95,87
27 Lugo;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
27 Lugo;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
27 Lugo;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
27 Lugo;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;96,37
27 Lugo;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
27 Lugo;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
27 Lugo;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
27 Lugo;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;93,86
27 Lugo;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
27 Lugo;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
27 Lugo;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;93,19
27 Lugo;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
27 Lugo;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
27 Lugo;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
27 Lugo;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;92,98
27 Lugo;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
27 Lugo;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
27 Lugo;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
27 Lugo;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;90,01
27 Lugo;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
27 Lugo;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
27 Lugo;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;90,2
27 Lugo;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
27 Lugo;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
27 Lugo;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
27 Lugo;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;89,35
27 Lugo;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
27 Lugo;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
27 Lugo;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
27 Lugo;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;86,5
27 Lugo;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
27 Lugo;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
27 Lugo;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;84
27 Lugo;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
27 Lugo;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
27 Lugo;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
27 Lugo;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;84,26
27 Lugo;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
27 Lugo;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
27 Lugo;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
27 Lugo;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;81,36
27 Lugo;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
27 Lugo;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
27 Lugo;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
27 Lugo;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
27 Lugo;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
27 Lugo;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QII;4.148
27 Lugo;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
27 Lugo;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
27 Lugo;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
27 Lugo;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QII;4.012
27 Lugo;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
27 Lugo;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
27 Lugo;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
27 Lugo;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QII;3.877
27 Lugo;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
27 Lugo;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
27 Lugo;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
27 Lugo;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2022QII;4.032
27 Lugo;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2022QI;""
27 Lugo;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
27 Lugo;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
27 Lugo;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2021QII;3.893
27 Lugo;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2021QI;""
27 Lugo;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
27 Lugo;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
27 Lugo;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2020QII;3.747
27 Lugo;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2020QI;""
27 Lugo;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
27 Lugo;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2022QIII;3.912
27 Lugo;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2022QII;""
27 Lugo;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2022QI;""
27 Lugo;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
27 Lugo;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2021QIII;3.760
27 Lugo;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2021QII;""
27 Lugo;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2021QI;""
27 Lugo;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
27 Lugo;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2020QIII;3.604
27 Lugo;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2020QII;""
27 Lugo;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2020QI;""
27 Lugo;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QIV;3.679
27 Lugo;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
27 Lugo;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QII;""
27 Lugo;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QI;""
27 Lugo;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QIV;3.600
27 Lugo;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
27 Lugo;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QII;""
27 Lugo;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QI;""
27 Lugo;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QIV;3.416
27 Lugo;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
27 Lugo;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QII;""
27 Lugo;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QI;""
27 Lugo;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
27 Lugo;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
27 Lugo;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QII;""
27 Lugo;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QI;3.467
27 Lugo;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
27 Lugo;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
27 Lugo;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QII;""
27 Lugo;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QI;3.311
27 Lugo;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
27 Lugo;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
27 Lugo;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QII;""
27 Lugo;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QI;""
27 Lugo;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
27 Lugo;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
27 Lugo;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
27 Lugo;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
27 Lugo;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
27 Lugo;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
27 Lugo;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
27 Lugo;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
27 Lugo;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
27 Lugo;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
27 Lugo;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
27 Lugo;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
27 Lugo;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
27 Lugo;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
27 Lugo;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;97,2
27 Lugo;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
27 Lugo;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
27 Lugo;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
27 Lugo;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;97,03
27 Lugo;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
27 Lugo;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
27 Lugo;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
27 Lugo;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;96,65
27 Lugo;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
27 Lugo;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
27 Lugo;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;94,31
27 Lugo;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
27 Lugo;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
27 Lugo;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
27 Lugo;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;93,72
27 Lugo;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
27 Lugo;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
27 Lugo;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
27 Lugo;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;92,96
27 Lugo;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
27 Lugo;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
27 Lugo;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;88,69
27 Lugo;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
27 Lugo;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
27 Lugo;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
27 Lugo;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;89,73
27 Lugo;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
27 Lugo;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
27 Lugo;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
27 Lugo;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;88,11
27 Lugo;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
27 Lugo;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
27 Lugo;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
27 Lugo;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
27 Lugo;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
27 Lugo;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
27 Lugo;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;86,42
27 Lugo;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
27 Lugo;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
27 Lugo;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
27 Lugo;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;85,4
27 Lugo;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
27 Lugo;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
27 Lugo;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
27 Lugo;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
27 Lugo;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
27 Lugo;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
27 Lugo;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QII;2.664
27 Lugo;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
27 Lugo;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
27 Lugo;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
27 Lugo;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QII;2.571
27 Lugo;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
27 Lugo;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
27 Lugo;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
27 Lugo;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QII;2.475
27 Lugo;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
27 Lugo;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
27 Lugo;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
27 Lugo;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2022QII;2.586
27 Lugo;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2022QI;""
27 Lugo;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
27 Lugo;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
27 Lugo;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2021QII;2.503
27 Lugo;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2021QI;""
27 Lugo;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
27 Lugo;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
27 Lugo;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2020QII;2.402
27 Lugo;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2020QI;""
27 Lugo;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
27 Lugo;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2022QIII;2.510
27 Lugo;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2022QII;""
27 Lugo;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2022QI;""
27 Lugo;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
27 Lugo;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2021QIII;2.418
27 Lugo;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2021QII;""
27 Lugo;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2021QI;""
27 Lugo;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
27 Lugo;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2020QIII;2.312
27 Lugo;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2020QII;""
27 Lugo;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2020QI;""
27 Lugo;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QIV;2.366
27 Lugo;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
27 Lugo;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QII;""
27 Lugo;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QI;""
27 Lugo;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QIV;2.327
27 Lugo;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
27 Lugo;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QII;""
27 Lugo;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QI;""
27 Lugo;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QIV;2.201
27 Lugo;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
27 Lugo;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QII;""
27 Lugo;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QI;""
27 Lugo;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
27 Lugo;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
27 Lugo;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QII;""
27 Lugo;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QI;2.246
27 Lugo;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
27 Lugo;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
27 Lugo;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QII;""
27 Lugo;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QI;2.137
27 Lugo;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
27 Lugo;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
27 Lugo;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QII;""
27 Lugo;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QI;""
27 Lugo;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
27 Lugo;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
27 Lugo;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
27 Lugo;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
27 Lugo;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
27 Lugo;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
27 Lugo;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
27 Lugo;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
27 Lugo;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
27 Lugo;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
27 Lugo;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
27 Lugo;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
27 Lugo;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
27 Lugo;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
27 Lugo;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;97,07
27 Lugo;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
27 Lugo;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
27 Lugo;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
27 Lugo;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;97,36
27 Lugo;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
27 Lugo;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
27 Lugo;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
27 Lugo;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;97,05
27 Lugo;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
27 Lugo;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
27 Lugo;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;94,22
27 Lugo;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
27 Lugo;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
27 Lugo;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
27 Lugo;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;94,05
27 Lugo;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
27 Lugo;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
27 Lugo;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
27 Lugo;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;93,41
27 Lugo;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
27 Lugo;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
27 Lugo;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;88,81
27 Lugo;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
27 Lugo;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
27 Lugo;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
27 Lugo;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;90,51
27 Lugo;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
27 Lugo;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
27 Lugo;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
27 Lugo;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;88,93
27 Lugo;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
27 Lugo;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
27 Lugo;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
27 Lugo;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
27 Lugo;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
27 Lugo;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
27 Lugo;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;87,36
27 Lugo;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
27 Lugo;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
27 Lugo;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
27 Lugo;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;86,34
27 Lugo;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
27 Lugo;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
27 Lugo;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
27 Lugo;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
27 Lugo;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
27 Lugo;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
27 Lugo;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QII;1.484
27 Lugo;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
27 Lugo;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
27 Lugo;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
27 Lugo;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QII;1.441
27 Lugo;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
27 Lugo;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
27 Lugo;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
27 Lugo;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QII;1.402
27 Lugo;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
27 Lugo;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
27 Lugo;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
27 Lugo;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2022QII;1.446
27 Lugo;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2022QI;""
27 Lugo;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
27 Lugo;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
27 Lugo;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2021QII;1.390
27 Lugo;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2021QI;""
27 Lugo;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
27 Lugo;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
27 Lugo;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2020QII;1.345
27 Lugo;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2020QI;""
27 Lugo;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
27 Lugo;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2022QIII;1.402
27 Lugo;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2022QII;""
27 Lugo;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2022QI;""
27 Lugo;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
27 Lugo;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2021QIII;1.342
27 Lugo;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2021QII;""
27 Lugo;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2021QI;""
27 Lugo;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
27 Lugo;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2020QIII;1.292
27 Lugo;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2020QII;""
27 Lugo;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2020QI;""
27 Lugo;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QIV;1.313
27 Lugo;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
27 Lugo;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QII;""
27 Lugo;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QI;""
27 Lugo;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QIV;1.273
27 Lugo;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
27 Lugo;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QII;""
27 Lugo;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QI;""
27 Lugo;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QIV;1.215
27 Lugo;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
27 Lugo;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QII;""
27 Lugo;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QI;""
27 Lugo;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
27 Lugo;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
27 Lugo;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QII;""
27 Lugo;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QI;1.221
27 Lugo;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
27 Lugo;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
27 Lugo;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QII;""
27 Lugo;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QI;1.174
27 Lugo;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
27 Lugo;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
27 Lugo;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QII;""
27 Lugo;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QI;""
27 Lugo;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
27 Lugo;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
27 Lugo;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
27 Lugo;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
27 Lugo;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
27 Lugo;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
27 Lugo;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
27 Lugo;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
27 Lugo;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
27 Lugo;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
27 Lugo;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
27 Lugo;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
27 Lugo;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
27 Lugo;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
27 Lugo;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;97,44
27 Lugo;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
27 Lugo;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
27 Lugo;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
27 Lugo;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;96,46
27 Lugo;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
27 Lugo;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
27 Lugo;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
27 Lugo;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;95,93
27 Lugo;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
27 Lugo;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
27 Lugo;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;94,47
27 Lugo;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
27 Lugo;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
27 Lugo;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
27 Lugo;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;93,13
27 Lugo;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
27 Lugo;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
27 Lugo;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
27 Lugo;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;92,15
27 Lugo;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
27 Lugo;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
27 Lugo;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;88,48
27 Lugo;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
27 Lugo;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
27 Lugo;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
27 Lugo;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;88,34
27 Lugo;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
27 Lugo;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
27 Lugo;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
27 Lugo;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;86,66
27 Lugo;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
27 Lugo;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
27 Lugo;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
27 Lugo;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
27 Lugo;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
27 Lugo;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
27 Lugo;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;84,73
27 Lugo;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
27 Lugo;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
27 Lugo;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
27 Lugo;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;83,74
27 Lugo;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
27 Lugo;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
27 Lugo;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
27 Lugo;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
27 Lugo;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
27 Lugo;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QIII;4.056
27 Lugo;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
27 Lugo;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
27 Lugo;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
27 Lugo;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QIII;3.933
27 Lugo;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
27 Lugo;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
27 Lugo;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
27 Lugo;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QIII;3.774
27 Lugo;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
27 Lugo;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
27 Lugo;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
27 Lugo;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2022QIII;3.927
27 Lugo;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2022QII;""
27 Lugo;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2022QI;""
27 Lugo;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
27 Lugo;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2021QIII;3.792
27 Lugo;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2021QII;""
27 Lugo;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2021QI;""
27 Lugo;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
27 Lugo;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2020QIII;3.625
27 Lugo;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2020QII;""
27 Lugo;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2020QI;""
27 Lugo;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2022QIV;3.688
27 Lugo;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
27 Lugo;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2022QII;""
27 Lugo;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2022QI;""
27 Lugo;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2021QIV;3.629
27 Lugo;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
27 Lugo;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2021QII;""
27 Lugo;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2021QI;""
27 Lugo;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2020QIV;3.433
27 Lugo;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
27 Lugo;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2020QII;""
27 Lugo;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2020QI;""
27 Lugo;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
27 Lugo;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
27 Lugo;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QII;""
27 Lugo;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QI;3.494
27 Lugo;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
27 Lugo;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
27 Lugo;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QII;""
27 Lugo;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QI;3.327
27 Lugo;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
27 Lugo;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
27 Lugo;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QII;""
27 Lugo;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QI;""
27 Lugo;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
27 Lugo;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
27 Lugo;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QII;3.389
27 Lugo;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QI;""
27 Lugo;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
27 Lugo;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
27 Lugo;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QII;3.221
27 Lugo;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QI;""
27 Lugo;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
27 Lugo;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
27 Lugo;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QII;""
27 Lugo;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QI;""
27 Lugo;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
27 Lugo;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
27 Lugo;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
27 Lugo;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
27 Lugo;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
27 Lugo;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
27 Lugo;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
27 Lugo;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
27 Lugo;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
27 Lugo;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
27 Lugo;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
27 Lugo;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
27 Lugo;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
27 Lugo;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;96,82
27 Lugo;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
27 Lugo;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
27 Lugo;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
27 Lugo;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;96,41
27 Lugo;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
27 Lugo;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
27 Lugo;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
27 Lugo;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;96,05
27 Lugo;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
27 Lugo;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
27 Lugo;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;90,93
27 Lugo;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
27 Lugo;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
27 Lugo;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
27 Lugo;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;92,27
27 Lugo;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
27 Lugo;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
27 Lugo;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
27 Lugo;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;90,96
27 Lugo;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
27 Lugo;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
27 Lugo;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
27 Lugo;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
27 Lugo;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
27 Lugo;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
27 Lugo;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;88,84
27 Lugo;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
27 Lugo;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
27 Lugo;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
27 Lugo;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;88,16
27 Lugo;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
27 Lugo;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
27 Lugo;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
27 Lugo;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
27 Lugo;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
27 Lugo;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
27 Lugo;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;86,17
27 Lugo;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
27 Lugo;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
27 Lugo;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
27 Lugo;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;85,35
27 Lugo;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
27 Lugo;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
27 Lugo;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
27 Lugo;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
27 Lugo;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
27 Lugo;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
27 Lugo;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QIII;2.601
27 Lugo;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
27 Lugo;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
27 Lugo;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
27 Lugo;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QIII;2.526
27 Lugo;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
27 Lugo;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
27 Lugo;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
27 Lugo;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QIII;2.421
27 Lugo;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
27 Lugo;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
27 Lugo;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
27 Lugo;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2022QIII;2.520
27 Lugo;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2022QII;""
27 Lugo;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2022QI;""
27 Lugo;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
27 Lugo;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2021QIII;2.435
27 Lugo;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2021QII;""
27 Lugo;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2021QI;""
27 Lugo;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
27 Lugo;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2020QIII;2.326
27 Lugo;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2020QII;""
27 Lugo;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2020QI;""
27 Lugo;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2022QIV;2.371
27 Lugo;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
27 Lugo;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2022QII;""
27 Lugo;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2022QI;""
27 Lugo;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2021QIV;2.343
27 Lugo;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
27 Lugo;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2021QII;""
27 Lugo;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2021QI;""
27 Lugo;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2020QIV;2.212
27 Lugo;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
27 Lugo;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2020QII;""
27 Lugo;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2020QI;""
27 Lugo;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
27 Lugo;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
27 Lugo;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QII;""
27 Lugo;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QI;2.261
27 Lugo;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
27 Lugo;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
27 Lugo;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QII;""
27 Lugo;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QI;2.148
27 Lugo;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
27 Lugo;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
27 Lugo;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QII;""
27 Lugo;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QI;""
27 Lugo;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
27 Lugo;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
27 Lugo;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QII;2.191
27 Lugo;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QI;""
27 Lugo;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
27 Lugo;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
27 Lugo;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QII;2.084
27 Lugo;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QI;""
27 Lugo;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
27 Lugo;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
27 Lugo;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QII;""
27 Lugo;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QI;""
27 Lugo;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
27 Lugo;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
27 Lugo;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
27 Lugo;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
27 Lugo;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
27 Lugo;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
27 Lugo;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
27 Lugo;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
27 Lugo;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
27 Lugo;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
27 Lugo;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
27 Lugo;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
27 Lugo;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
27 Lugo;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;96,89
27 Lugo;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
27 Lugo;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
27 Lugo;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
27 Lugo;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;96,4
27 Lugo;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
27 Lugo;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
27 Lugo;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
27 Lugo;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;96,08
27 Lugo;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
27 Lugo;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
27 Lugo;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;91,16
27 Lugo;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
27 Lugo;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
27 Lugo;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
27 Lugo;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;92,76
27 Lugo;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
27 Lugo;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
27 Lugo;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
27 Lugo;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;91,37
27 Lugo;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
27 Lugo;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
27 Lugo;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
27 Lugo;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
27 Lugo;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
27 Lugo;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
27 Lugo;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;89,51
27 Lugo;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
27 Lugo;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
27 Lugo;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
27 Lugo;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;88,72
27 Lugo;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
27 Lugo;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
27 Lugo;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
27 Lugo;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
27 Lugo;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
27 Lugo;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
27 Lugo;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;86,74
27 Lugo;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
27 Lugo;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
27 Lugo;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
27 Lugo;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;86,08
27 Lugo;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
27 Lugo;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
27 Lugo;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
27 Lugo;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
27 Lugo;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
27 Lugo;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
27 Lugo;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QIII;1.455
27 Lugo;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
27 Lugo;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
27 Lugo;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
27 Lugo;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QIII;1.407
27 Lugo;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
27 Lugo;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
27 Lugo;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
27 Lugo;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QIII;1.353
27 Lugo;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
27 Lugo;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
27 Lugo;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
27 Lugo;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2022QIII;1.407
27 Lugo;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2022QII;""
27 Lugo;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2022QI;""
27 Lugo;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
27 Lugo;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2021QIII;1.357
27 Lugo;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2021QII;""
27 Lugo;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2021QI;""
27 Lugo;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
27 Lugo;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2020QIII;1.299
27 Lugo;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2020QII;""
27 Lugo;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2020QI;""
27 Lugo;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2022QIV;1.317
27 Lugo;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
27 Lugo;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2022QII;""
27 Lugo;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2022QI;""
27 Lugo;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2021QIV;1.286
27 Lugo;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
27 Lugo;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2021QII;""
27 Lugo;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2021QI;""
27 Lugo;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2020QIV;1.221
27 Lugo;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
27 Lugo;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2020QII;""
27 Lugo;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2020QI;""
27 Lugo;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
27 Lugo;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
27 Lugo;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QII;""
27 Lugo;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QI;1.233
27 Lugo;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
27 Lugo;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
27 Lugo;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QII;""
27 Lugo;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QI;1.179
27 Lugo;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
27 Lugo;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
27 Lugo;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QII;""
27 Lugo;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QI;""
27 Lugo;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
27 Lugo;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
27 Lugo;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QII;1.198
27 Lugo;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QI;""
27 Lugo;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
27 Lugo;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
27 Lugo;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QII;1.137
27 Lugo;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QI;""
27 Lugo;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
27 Lugo;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
27 Lugo;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QII;""
27 Lugo;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QI;""
27 Lugo;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
27 Lugo;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
27 Lugo;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
27 Lugo;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
27 Lugo;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
27 Lugo;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
27 Lugo;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
27 Lugo;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
27 Lugo;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
27 Lugo;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
27 Lugo;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
27 Lugo;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
27 Lugo;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
27 Lugo;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;96,7
27 Lugo;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
27 Lugo;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
27 Lugo;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
27 Lugo;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;96,45
27 Lugo;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
27 Lugo;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
27 Lugo;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
27 Lugo;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;96,01
27 Lugo;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
27 Lugo;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
27 Lugo;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;90,52
27 Lugo;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
27 Lugo;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
27 Lugo;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
27 Lugo;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;91,4
27 Lugo;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
27 Lugo;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
27 Lugo;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
27 Lugo;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;90,24
27 Lugo;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
27 Lugo;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
27 Lugo;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
27 Lugo;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
27 Lugo;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
27 Lugo;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
27 Lugo;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;87,63
27 Lugo;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
27 Lugo;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
27 Lugo;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
27 Lugo;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;87,14
27 Lugo;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
27 Lugo;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
27 Lugo;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
27 Lugo;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
27 Lugo;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
27 Lugo;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
27 Lugo;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;85,15
27 Lugo;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
27 Lugo;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
27 Lugo;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
27 Lugo;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;84,04
27 Lugo;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
27 Lugo;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
27 Lugo;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
27 Lugo;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
27 Lugo;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
27 Lugo;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QIV;3.950
27 Lugo;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
27 Lugo;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
27 Lugo;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
27 Lugo;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QIV;3.825
27 Lugo;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
27 Lugo;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
27 Lugo;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
27 Lugo;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QIV;3.651
27 Lugo;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
27 Lugo;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
27 Lugo;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
27 Lugo;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2022QIV;3.706
27 Lugo;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
27 Lugo;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2022QII;""
27 Lugo;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2022QI;""
27 Lugo;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2021QIV;3.651
27 Lugo;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
27 Lugo;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2021QII;""
27 Lugo;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2021QI;""
27 Lugo;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2020QIV;3.451
27 Lugo;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
27 Lugo;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2020QII;""
27 Lugo;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2020QI;""
27 Lugo;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
27 Lugo;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
27 Lugo;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2022QII;""
27 Lugo;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2022QI;3.516
27 Lugo;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
27 Lugo;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
27 Lugo;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2021QII;""
27 Lugo;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2021QI;3.343
27 Lugo;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
27 Lugo;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
27 Lugo;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2020QII;""
27 Lugo;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2020QI;""
27 Lugo;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
27 Lugo;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
27 Lugo;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QII;3.410
27 Lugo;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QI;""
27 Lugo;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
27 Lugo;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
27 Lugo;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QII;3.237
27 Lugo;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QI;""
27 Lugo;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
27 Lugo;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
27 Lugo;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QII;""
27 Lugo;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QI;""
27 Lugo;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
27 Lugo;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QIII;3.303
27 Lugo;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QII;""
27 Lugo;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QI;""
27 Lugo;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
27 Lugo;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QIII;3.116
27 Lugo;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QII;""
27 Lugo;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QI;""
27 Lugo;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
27 Lugo;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
27 Lugo;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QII;""
27 Lugo;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QI;""
27 Lugo;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
27 Lugo;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
27 Lugo;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
27 Lugo;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
27 Lugo;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
27 Lugo;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
27 Lugo;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
27 Lugo;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
27 Lugo;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
27 Lugo;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
27 Lugo;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
27 Lugo;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
27 Lugo;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;93,82
27 Lugo;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
27 Lugo;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
27 Lugo;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
27 Lugo;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;95,45
27 Lugo;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
27 Lugo;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
27 Lugo;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
27 Lugo;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;94,52
27 Lugo;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
27 Lugo;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
27 Lugo;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
27 Lugo;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
27 Lugo;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
27 Lugo;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
27 Lugo;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;91,92
27 Lugo;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
27 Lugo;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
27 Lugo;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
27 Lugo;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;91,56
27 Lugo;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
27 Lugo;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
27 Lugo;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
27 Lugo;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
27 Lugo;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
27 Lugo;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
27 Lugo;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;89,15
27 Lugo;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
27 Lugo;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
27 Lugo;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
27 Lugo;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;88,66
27 Lugo;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
27 Lugo;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
27 Lugo;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
27 Lugo;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
27 Lugo;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
27 Lugo;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
27 Lugo;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;86,35
27 Lugo;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
27 Lugo;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
27 Lugo;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
27 Lugo;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;85,35
27 Lugo;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
27 Lugo;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
27 Lugo;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
27 Lugo;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
27 Lugo;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
27 Lugo;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
27 Lugo;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QIV;2.529
27 Lugo;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
27 Lugo;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
27 Lugo;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
27 Lugo;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QIV;2.450
27 Lugo;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
27 Lugo;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
27 Lugo;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
27 Lugo;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QIV;2.341
27 Lugo;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
27 Lugo;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
27 Lugo;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
27 Lugo;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2022QIV;2.380
27 Lugo;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
27 Lugo;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2022QII;""
27 Lugo;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2022QI;""
27 Lugo;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2021QIV;2.353
27 Lugo;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
27 Lugo;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2021QII;""
27 Lugo;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2021QI;""
27 Lugo;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2020QIV;2.223
27 Lugo;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
27 Lugo;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2020QII;""
27 Lugo;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2020QI;""
27 Lugo;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
27 Lugo;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
27 Lugo;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2022QII;""
27 Lugo;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2022QI;2.271
27 Lugo;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
27 Lugo;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
27 Lugo;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2021QII;""
27 Lugo;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2021QI;2.158
27 Lugo;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
27 Lugo;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
27 Lugo;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2020QII;""
27 Lugo;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2020QI;""
27 Lugo;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
27 Lugo;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
27 Lugo;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QII;2.200
27 Lugo;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QI;""
27 Lugo;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
27 Lugo;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
27 Lugo;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QII;2.094
27 Lugo;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QI;""
27 Lugo;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
27 Lugo;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
27 Lugo;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QII;""
27 Lugo;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QI;""
27 Lugo;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
27 Lugo;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QIII;2.131
27 Lugo;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QII;""
27 Lugo;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QI;""
27 Lugo;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
27 Lugo;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QIII;2.017
27 Lugo;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QII;""
27 Lugo;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QI;""
27 Lugo;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
27 Lugo;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
27 Lugo;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QII;""
27 Lugo;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QI;""
27 Lugo;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
27 Lugo;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
27 Lugo;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
27 Lugo;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
27 Lugo;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
27 Lugo;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
27 Lugo;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
27 Lugo;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
27 Lugo;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
27 Lugo;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
27 Lugo;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
27 Lugo;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
27 Lugo;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;94,11
27 Lugo;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
27 Lugo;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
27 Lugo;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
27 Lugo;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;96,04
27 Lugo;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
27 Lugo;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
27 Lugo;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
27 Lugo;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;94,96
27 Lugo;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
27 Lugo;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
27 Lugo;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
27 Lugo;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
27 Lugo;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
27 Lugo;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
27 Lugo;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;92,69
27 Lugo;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
27 Lugo;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
27 Lugo;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
27 Lugo;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;92,18
27 Lugo;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
27 Lugo;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
27 Lugo;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
27 Lugo;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
27 Lugo;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
27 Lugo;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
27 Lugo;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;89,8
27 Lugo;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
27 Lugo;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
27 Lugo;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
27 Lugo;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;89,45
27 Lugo;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
27 Lugo;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
27 Lugo;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
27 Lugo;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
27 Lugo;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
27 Lugo;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
27 Lugo;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;86,98
27 Lugo;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
27 Lugo;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
27 Lugo;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
27 Lugo;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;86,16
27 Lugo;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
27 Lugo;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
27 Lugo;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
27 Lugo;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
27 Lugo;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
27 Lugo;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
27 Lugo;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QIV;1.421
27 Lugo;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
27 Lugo;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
27 Lugo;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
27 Lugo;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QIV;1.375
27 Lugo;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
27 Lugo;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
27 Lugo;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
27 Lugo;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QIV;1.310
27 Lugo;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
27 Lugo;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
27 Lugo;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
27 Lugo;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2022QIV;1.326
27 Lugo;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
27 Lugo;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2022QII;""
27 Lugo;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2022QI;""
27 Lugo;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2021QIV;1.298
27 Lugo;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
27 Lugo;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2021QII;""
27 Lugo;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2021QI;""
27 Lugo;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2020QIV;1.228
27 Lugo;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
27 Lugo;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2020QII;""
27 Lugo;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2020QI;""
27 Lugo;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
27 Lugo;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
27 Lugo;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2022QII;""
27 Lugo;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2022QI;1.245
27 Lugo;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
27 Lugo;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
27 Lugo;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2021QII;""
27 Lugo;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2021QI;1.185
27 Lugo;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
27 Lugo;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
27 Lugo;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2020QII;""
27 Lugo;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2020QI;""
27 Lugo;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
27 Lugo;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
27 Lugo;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QII;1.210
27 Lugo;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QI;""
27 Lugo;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
27 Lugo;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
27 Lugo;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QII;1.143
27 Lugo;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QI;""
27 Lugo;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
27 Lugo;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
27 Lugo;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QII;""
27 Lugo;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QI;""
27 Lugo;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
27 Lugo;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QIII;1.172
27 Lugo;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QII;""
27 Lugo;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QI;""
27 Lugo;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
27 Lugo;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QIII;1.099
27 Lugo;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QII;""
27 Lugo;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QI;""
27 Lugo;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
27 Lugo;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
27 Lugo;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QII;""
27 Lugo;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QI;""
27 Lugo;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
27 Lugo;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
27 Lugo;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
27 Lugo;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
27 Lugo;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
27 Lugo;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
27 Lugo;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
27 Lugo;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
27 Lugo;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
27 Lugo;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
27 Lugo;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
27 Lugo;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
27 Lugo;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;93,31
27 Lugo;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
27 Lugo;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
27 Lugo;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
27 Lugo;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;94,4
27 Lugo;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
27 Lugo;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
27 Lugo;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
27 Lugo;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;93,74
27 Lugo;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
27 Lugo;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
27 Lugo;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
27 Lugo;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
27 Lugo;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
27 Lugo;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
27 Lugo;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;90,55
27 Lugo;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
27 Lugo;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
27 Lugo;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
27 Lugo;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;90,46
27 Lugo;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
27 Lugo;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
27 Lugo;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
27 Lugo;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
27 Lugo;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
27 Lugo;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
27 Lugo;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;88
27 Lugo;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
27 Lugo;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
27 Lugo;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
27 Lugo;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;87,25
27 Lugo;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
27 Lugo;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
27 Lugo;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
27 Lugo;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
27 Lugo;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
27 Lugo;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
27 Lugo;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;85,24
27 Lugo;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
27 Lugo;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
27 Lugo;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
27 Lugo;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;83,89
27 Lugo;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
27 Lugo;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
27 Lugo;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
27 Lugo;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
27 Lugo;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
27 Lugo;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
28 Madrid;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
28 Madrid;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
28 Madrid;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
28 Madrid;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QI;410.028
28 Madrid;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
28 Madrid;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
28 Madrid;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
28 Madrid;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QI;400.372
28 Madrid;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
28 Madrid;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
28 Madrid;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
28 Madrid;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QI;403.971
28 Madrid;All ages;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
28 Madrid;All ages;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
28 Madrid;All ages;Cohort January 1;Total;Survival in the first trimester;2022QII;""
28 Madrid;All ages;Cohort January 1;Total;Survival in the first trimester;2022QI;394.336
28 Madrid;All ages;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
28 Madrid;All ages;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
28 Madrid;All ages;Cohort January 1;Total;Survival in the first trimester;2021QII;""
28 Madrid;All ages;Cohort January 1;Total;Survival in the first trimester;2021QI;387.783
28 Madrid;All ages;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
28 Madrid;All ages;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
28 Madrid;All ages;Cohort January 1;Total;Survival in the first trimester;2020QII;""
28 Madrid;All ages;Cohort January 1;Total;Survival in the first trimester;2020QI;375.413
28 Madrid;All ages;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
28 Madrid;All ages;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
28 Madrid;All ages;Cohort January 1;Total;Survival in the second trimester;2022QII;379.906
28 Madrid;All ages;Cohort January 1;Total;Survival in the second trimester;2022QI;""
28 Madrid;All ages;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
28 Madrid;All ages;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
28 Madrid;All ages;Cohort January 1;Total;Survival in the second trimester;2021QII;374.671
28 Madrid;All ages;Cohort January 1;Total;Survival in the second trimester;2021QI;""
28 Madrid;All ages;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
28 Madrid;All ages;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
28 Madrid;All ages;Cohort January 1;Total;Survival in the second trimester;2020QII;366.637
28 Madrid;All ages;Cohort January 1;Total;Survival in the second trimester;2020QI;""
28 Madrid;All ages;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
28 Madrid;All ages;Cohort January 1;Total;Survival in the third trimester;2022QIII;368.423
28 Madrid;All ages;Cohort January 1;Total;Survival in the third trimester;2022QII;""
28 Madrid;All ages;Cohort January 1;Total;Survival in the third trimester;2022QI;""
28 Madrid;All ages;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
28 Madrid;All ages;Cohort January 1;Total;Survival in the third trimester;2021QIII;364.049
28 Madrid;All ages;Cohort January 1;Total;Survival in the third trimester;2021QII;""
28 Madrid;All ages;Cohort January 1;Total;Survival in the third trimester;2021QI;""
28 Madrid;All ages;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
28 Madrid;All ages;Cohort January 1;Total;Survival in the third trimester;2020QIII;356.084
28 Madrid;All ages;Cohort January 1;Total;Survival in the third trimester;2020QII;""
28 Madrid;All ages;Cohort January 1;Total;Survival in the third trimester;2020QI;""
28 Madrid;All ages;Cohort January 1;Total;Survival in the third trimester;2022QIV;355.967
28 Madrid;All ages;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
28 Madrid;All ages;Cohort January 1;Total;Survival in the third trimester;2022QII;""
28 Madrid;All ages;Cohort January 1;Total;Survival in the third trimester;2022QI;""
28 Madrid;All ages;Cohort January 1;Total;Survival in the third trimester;2021QIV;352.799
28 Madrid;All ages;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
28 Madrid;All ages;Cohort January 1;Total;Survival in the third trimester;2021QII;""
28 Madrid;All ages;Cohort January 1;Total;Survival in the third trimester;2021QI;""
28 Madrid;All ages;Cohort January 1;Total;Survival in the third trimester;2020QIV;345.133
28 Madrid;All ages;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
28 Madrid;All ages;Cohort January 1;Total;Survival in the third trimester;2020QII;""
28 Madrid;All ages;Cohort January 1;Total;Survival in the third trimester;2020QI;""
28 Madrid;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
28 Madrid;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
28 Madrid;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
28 Madrid;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
28 Madrid;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
28 Madrid;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
28 Madrid;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
28 Madrid;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
28 Madrid;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
28 Madrid;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
28 Madrid;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
28 Madrid;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
28 Madrid;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
28 Madrid;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
28 Madrid;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
28 Madrid;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;96,17
28 Madrid;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
28 Madrid;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
28 Madrid;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
28 Madrid;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;96,86
28 Madrid;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
28 Madrid;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
28 Madrid;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
28 Madrid;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;92,93
28 Madrid;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
28 Madrid;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
28 Madrid;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;92,65
28 Madrid;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
28 Madrid;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
28 Madrid;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
28 Madrid;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;93,58
28 Madrid;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
28 Madrid;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
28 Madrid;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
28 Madrid;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;90,76
28 Madrid;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
28 Madrid;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
28 Madrid;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;89,85
28 Madrid;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
28 Madrid;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
28 Madrid;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
28 Madrid;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;90,93
28 Madrid;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
28 Madrid;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
28 Madrid;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
28 Madrid;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;88,15
28 Madrid;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
28 Madrid;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
28 Madrid;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;86,82
28 Madrid;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
28 Madrid;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
28 Madrid;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
28 Madrid;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;88,12
28 Madrid;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
28 Madrid;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
28 Madrid;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
28 Madrid;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;85,44
28 Madrid;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
28 Madrid;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
28 Madrid;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
28 Madrid;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
28 Madrid;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
28 Madrid;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
28 Madrid;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QI;262.316
28 Madrid;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
28 Madrid;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
28 Madrid;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
28 Madrid;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QI;258.656
28 Madrid;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
28 Madrid;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
28 Madrid;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
28 Madrid;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QI;260.630
28 Madrid;All ages;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
28 Madrid;All ages;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
28 Madrid;All ages;Cohort January 1;Males;Survival in the first trimester;2022QII;""
28 Madrid;All ages;Cohort January 1;Males;Survival in the first trimester;2022QI;252.943
28 Madrid;All ages;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
28 Madrid;All ages;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
28 Madrid;All ages;Cohort January 1;Males;Survival in the first trimester;2021QII;""
28 Madrid;All ages;Cohort January 1;Males;Survival in the first trimester;2021QI;250.877
28 Madrid;All ages;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
28 Madrid;All ages;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
28 Madrid;All ages;Cohort January 1;Males;Survival in the first trimester;2020QII;""
28 Madrid;All ages;Cohort January 1;Males;Survival in the first trimester;2020QI;243.508
28 Madrid;All ages;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
28 Madrid;All ages;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
28 Madrid;All ages;Cohort January 1;Males;Survival in the second trimester;2022QII;244.580
28 Madrid;All ages;Cohort January 1;Males;Survival in the second trimester;2022QI;""
28 Madrid;All ages;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
28 Madrid;All ages;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
28 Madrid;All ages;Cohort January 1;Males;Survival in the second trimester;2021QII;242.945
28 Madrid;All ages;Cohort January 1;Males;Survival in the second trimester;2021QI;""
28 Madrid;All ages;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
28 Madrid;All ages;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
28 Madrid;All ages;Cohort January 1;Males;Survival in the second trimester;2020QII;238.331
28 Madrid;All ages;Cohort January 1;Males;Survival in the second trimester;2020QI;""
28 Madrid;All ages;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
28 Madrid;All ages;Cohort January 1;Males;Survival in the third trimester;2022QIII;237.781
28 Madrid;All ages;Cohort January 1;Males;Survival in the third trimester;2022QII;""
28 Madrid;All ages;Cohort January 1;Males;Survival in the third trimester;2022QI;""
28 Madrid;All ages;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
28 Madrid;All ages;Cohort January 1;Males;Survival in the third trimester;2021QIII;236.429
28 Madrid;All ages;Cohort January 1;Males;Survival in the third trimester;2021QII;""
28 Madrid;All ages;Cohort January 1;Males;Survival in the third trimester;2021QI;""
28 Madrid;All ages;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
28 Madrid;All ages;Cohort January 1;Males;Survival in the third trimester;2020QIII;232.041
28 Madrid;All ages;Cohort January 1;Males;Survival in the third trimester;2020QII;""
28 Madrid;All ages;Cohort January 1;Males;Survival in the third trimester;2020QI;""
28 Madrid;All ages;Cohort January 1;Males;Survival in the third trimester;2022QIV;230.306
28 Madrid;All ages;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
28 Madrid;All ages;Cohort January 1;Males;Survival in the third trimester;2022QII;""
28 Madrid;All ages;Cohort January 1;Males;Survival in the third trimester;2022QI;""
28 Madrid;All ages;Cohort January 1;Males;Survival in the third trimester;2021QIV;229.430
28 Madrid;All ages;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
28 Madrid;All ages;Cohort January 1;Males;Survival in the third trimester;2021QII;""
28 Madrid;All ages;Cohort January 1;Males;Survival in the third trimester;2021QI;""
28 Madrid;All ages;Cohort January 1;Males;Survival in the third trimester;2020QIV;225.320
28 Madrid;All ages;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
28 Madrid;All ages;Cohort January 1;Males;Survival in the third trimester;2020QII;""
28 Madrid;All ages;Cohort January 1;Males;Survival in the third trimester;2020QI;""
28 Madrid;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
28 Madrid;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
28 Madrid;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
28 Madrid;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
28 Madrid;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
28 Madrid;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
28 Madrid;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
28 Madrid;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
28 Madrid;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
28 Madrid;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
28 Madrid;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
28 Madrid;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
28 Madrid;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
28 Madrid;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
28 Madrid;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
28 Madrid;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;96,43
28 Madrid;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
28 Madrid;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
28 Madrid;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
28 Madrid;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;96,99
28 Madrid;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
28 Madrid;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
28 Madrid;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
28 Madrid;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;93,43
28 Madrid;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
28 Madrid;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
28 Madrid;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;93,24
28 Madrid;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
28 Madrid;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
28 Madrid;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
28 Madrid;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;93,93
28 Madrid;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
28 Madrid;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
28 Madrid;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
28 Madrid;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;91,44
28 Madrid;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
28 Madrid;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
28 Madrid;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;90,65
28 Madrid;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
28 Madrid;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
28 Madrid;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
28 Madrid;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;91,41
28 Madrid;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
28 Madrid;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
28 Madrid;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
28 Madrid;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;89,03
28 Madrid;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
28 Madrid;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
28 Madrid;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;87,8
28 Madrid;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
28 Madrid;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
28 Madrid;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
28 Madrid;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;88,7
28 Madrid;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
28 Madrid;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
28 Madrid;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
28 Madrid;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;86,45
28 Madrid;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
28 Madrid;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
28 Madrid;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
28 Madrid;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
28 Madrid;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
28 Madrid;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
28 Madrid;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QI;147.712
28 Madrid;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
28 Madrid;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
28 Madrid;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
28 Madrid;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QI;141.716
28 Madrid;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
28 Madrid;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
28 Madrid;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
28 Madrid;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QI;143.341
28 Madrid;All ages;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
28 Madrid;All ages;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
28 Madrid;All ages;Cohort January 1;Females;Survival in the first trimester;2022QII;""
28 Madrid;All ages;Cohort January 1;Females;Survival in the first trimester;2022QI;141.393
28 Madrid;All ages;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
28 Madrid;All ages;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
28 Madrid;All ages;Cohort January 1;Females;Survival in the first trimester;2021QII;""
28 Madrid;All ages;Cohort January 1;Females;Survival in the first trimester;2021QI;136.906
28 Madrid;All ages;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
28 Madrid;All ages;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
28 Madrid;All ages;Cohort January 1;Females;Survival in the first trimester;2020QII;""
28 Madrid;All ages;Cohort January 1;Females;Survival in the first trimester;2020QI;131.905
28 Madrid;All ages;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
28 Madrid;All ages;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
28 Madrid;All ages;Cohort January 1;Females;Survival in the second trimester;2022QII;135.326
28 Madrid;All ages;Cohort January 1;Females;Survival in the second trimester;2022QI;""
28 Madrid;All ages;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
28 Madrid;All ages;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
28 Madrid;All ages;Cohort January 1;Females;Survival in the second trimester;2021QII;131.726
28 Madrid;All ages;Cohort January 1;Females;Survival in the second trimester;2021QI;""
28 Madrid;All ages;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
28 Madrid;All ages;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
28 Madrid;All ages;Cohort January 1;Females;Survival in the second trimester;2020QII;128.306
28 Madrid;All ages;Cohort January 1;Females;Survival in the second trimester;2020QI;""
28 Madrid;All ages;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
28 Madrid;All ages;Cohort January 1;Females;Survival in the third trimester;2022QIII;130.642
28 Madrid;All ages;Cohort January 1;Females;Survival in the third trimester;2022QII;""
28 Madrid;All ages;Cohort January 1;Females;Survival in the third trimester;2022QI;""
28 Madrid;All ages;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
28 Madrid;All ages;Cohort January 1;Females;Survival in the third trimester;2021QIII;127.620
28 Madrid;All ages;Cohort January 1;Females;Survival in the third trimester;2021QII;""
28 Madrid;All ages;Cohort January 1;Females;Survival in the third trimester;2021QI;""
28 Madrid;All ages;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
28 Madrid;All ages;Cohort January 1;Females;Survival in the third trimester;2020QIII;124.043
28 Madrid;All ages;Cohort January 1;Females;Survival in the third trimester;2020QII;""
28 Madrid;All ages;Cohort January 1;Females;Survival in the third trimester;2020QI;""
28 Madrid;All ages;Cohort January 1;Females;Survival in the third trimester;2022QIV;125.661
28 Madrid;All ages;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
28 Madrid;All ages;Cohort January 1;Females;Survival in the third trimester;2022QII;""
28 Madrid;All ages;Cohort January 1;Females;Survival in the third trimester;2022QI;""
28 Madrid;All ages;Cohort January 1;Females;Survival in the third trimester;2021QIV;123.369
28 Madrid;All ages;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
28 Madrid;All ages;Cohort January 1;Females;Survival in the third trimester;2021QII;""
28 Madrid;All ages;Cohort January 1;Females;Survival in the third trimester;2021QI;""
28 Madrid;All ages;Cohort January 1;Females;Survival in the third trimester;2020QIV;119.813
28 Madrid;All ages;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
28 Madrid;All ages;Cohort January 1;Females;Survival in the third trimester;2020QII;""
28 Madrid;All ages;Cohort January 1;Females;Survival in the third trimester;2020QI;""
28 Madrid;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
28 Madrid;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
28 Madrid;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
28 Madrid;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
28 Madrid;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
28 Madrid;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
28 Madrid;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
28 Madrid;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
28 Madrid;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
28 Madrid;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
28 Madrid;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
28 Madrid;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
28 Madrid;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
28 Madrid;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
28 Madrid;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
28 Madrid;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;95,72
28 Madrid;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
28 Madrid;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
28 Madrid;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
28 Madrid;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;96,61
28 Madrid;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
28 Madrid;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
28 Madrid;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
28 Madrid;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;92,02
28 Madrid;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
28 Madrid;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
28 Madrid;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;91,61
28 Madrid;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
28 Madrid;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
28 Madrid;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
28 Madrid;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;92,95
28 Madrid;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
28 Madrid;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
28 Madrid;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
28 Madrid;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;89,51
28 Madrid;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
28 Madrid;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
28 Madrid;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;88,44
28 Madrid;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
28 Madrid;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
28 Madrid;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
28 Madrid;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;90,05
28 Madrid;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
28 Madrid;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
28 Madrid;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
28 Madrid;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;86,54
28 Madrid;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
28 Madrid;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
28 Madrid;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;85,07
28 Madrid;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
28 Madrid;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
28 Madrid;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
28 Madrid;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;87,05
28 Madrid;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
28 Madrid;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
28 Madrid;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
28 Madrid;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;83,59
28 Madrid;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
28 Madrid;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
28 Madrid;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
28 Madrid;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
28 Madrid;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
28 Madrid;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QII;411.625
28 Madrid;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
28 Madrid;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
28 Madrid;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
28 Madrid;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QII;404.496
28 Madrid;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
28 Madrid;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
28 Madrid;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
28 Madrid;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QII;394.549
28 Madrid;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
28 Madrid;All ages;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
28 Madrid;All ages;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
28 Madrid;All ages;Cohort April 1;Total;Survival in the first trimester;2022QII;395.447
28 Madrid;All ages;Cohort April 1;Total;Survival in the first trimester;2022QI;""
28 Madrid;All ages;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
28 Madrid;All ages;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
28 Madrid;All ages;Cohort April 1;Total;Survival in the first trimester;2021QII;389.437
28 Madrid;All ages;Cohort April 1;Total;Survival in the first trimester;2021QI;""
28 Madrid;All ages;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
28 Madrid;All ages;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
28 Madrid;All ages;Cohort April 1;Total;Survival in the first trimester;2020QII;384.480
28 Madrid;All ages;Cohort April 1;Total;Survival in the first trimester;2020QI;""
28 Madrid;All ages;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
28 Madrid;All ages;Cohort April 1;Total;Survival in the second trimester;2022QIII;382.794
28 Madrid;All ages;Cohort April 1;Total;Survival in the second trimester;2022QII;""
28 Madrid;All ages;Cohort April 1;Total;Survival in the second trimester;2022QI;""
28 Madrid;All ages;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
28 Madrid;All ages;Cohort April 1;Total;Survival in the second trimester;2021QIII;377.559
28 Madrid;All ages;Cohort April 1;Total;Survival in the second trimester;2021QII;""
28 Madrid;All ages;Cohort April 1;Total;Survival in the second trimester;2021QI;""
28 Madrid;All ages;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
28 Madrid;All ages;Cohort April 1;Total;Survival in the second trimester;2020QIII;372.299
28 Madrid;All ages;Cohort April 1;Total;Survival in the second trimester;2020QII;""
28 Madrid;All ages;Cohort April 1;Total;Survival in the second trimester;2020QI;""
28 Madrid;All ages;Cohort April 1;Total;Survival in the third trimester;2022QIV;369.253
28 Madrid;All ages;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
28 Madrid;All ages;Cohort April 1;Total;Survival in the third trimester;2022QII;""
28 Madrid;All ages;Cohort April 1;Total;Survival in the third trimester;2022QI;""
28 Madrid;All ages;Cohort April 1;Total;Survival in the third trimester;2021QIV;365.247
28 Madrid;All ages;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
28 Madrid;All ages;Cohort April 1;Total;Survival in the third trimester;2021QII;""
28 Madrid;All ages;Cohort April 1;Total;Survival in the third trimester;2021QI;""
28 Madrid;All ages;Cohort April 1;Total;Survival in the third trimester;2020QIV;360.208
28 Madrid;All ages;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
28 Madrid;All ages;Cohort April 1;Total;Survival in the third trimester;2020QII;""
28 Madrid;All ages;Cohort April 1;Total;Survival in the third trimester;2020QI;""
28 Madrid;All ages;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
28 Madrid;All ages;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
28 Madrid;All ages;Cohort April 1;Total;Survival in the third trimester;2022QII;""
28 Madrid;All ages;Cohort April 1;Total;Survival in the third trimester;2022QI;353.587
28 Madrid;All ages;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
28 Madrid;All ages;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
28 Madrid;All ages;Cohort April 1;Total;Survival in the third trimester;2021QII;""
28 Madrid;All ages;Cohort April 1;Total;Survival in the third trimester;2021QI;351.103
28 Madrid;All ages;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
28 Madrid;All ages;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
28 Madrid;All ages;Cohort April 1;Total;Survival in the third trimester;2020QII;""
28 Madrid;All ages;Cohort April 1;Total;Survival in the third trimester;2020QI;""
28 Madrid;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
28 Madrid;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
28 Madrid;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
28 Madrid;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
28 Madrid;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
28 Madrid;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
28 Madrid;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
28 Madrid;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
28 Madrid;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
28 Madrid;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
28 Madrid;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
28 Madrid;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
28 Madrid;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
28 Madrid;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
28 Madrid;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;96,07
28 Madrid;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
28 Madrid;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
28 Madrid;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
28 Madrid;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;96,28
28 Madrid;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
28 Madrid;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
28 Madrid;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
28 Madrid;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;97,45
28 Madrid;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
28 Madrid;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
28 Madrid;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;93
28 Madrid;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
28 Madrid;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
28 Madrid;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
28 Madrid;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;93,34
28 Madrid;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
28 Madrid;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
28 Madrid;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
28 Madrid;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;94,36
28 Madrid;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
28 Madrid;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
28 Madrid;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;89,71
28 Madrid;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
28 Madrid;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
28 Madrid;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
28 Madrid;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;90,3
28 Madrid;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
28 Madrid;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
28 Madrid;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
28 Madrid;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;91,3
28 Madrid;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
28 Madrid;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
28 Madrid;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
28 Madrid;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
28 Madrid;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
28 Madrid;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
28 Madrid;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;87,41
28 Madrid;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
28 Madrid;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
28 Madrid;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
28 Madrid;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;88,99
28 Madrid;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
28 Madrid;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
28 Madrid;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
28 Madrid;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
28 Madrid;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
28 Madrid;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
28 Madrid;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QII;262.865
28 Madrid;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
28 Madrid;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
28 Madrid;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
28 Madrid;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QII;260.835
28 Madrid;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
28 Madrid;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
28 Madrid;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
28 Madrid;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QII;255.153
28 Madrid;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
28 Madrid;All ages;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
28 Madrid;All ages;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
28 Madrid;All ages;Cohort April 1;Males;Survival in the first trimester;2022QII;253.478
28 Madrid;All ages;Cohort April 1;Males;Survival in the first trimester;2022QI;""
28 Madrid;All ages;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
28 Madrid;All ages;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
28 Madrid;All ages;Cohort April 1;Males;Survival in the first trimester;2021QII;251.707
28 Madrid;All ages;Cohort April 1;Males;Survival in the first trimester;2021QI;""
28 Madrid;All ages;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
28 Madrid;All ages;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
28 Madrid;All ages;Cohort April 1;Males;Survival in the first trimester;2020QII;249.084
28 Madrid;All ages;Cohort April 1;Males;Survival in the first trimester;2020QI;""
28 Madrid;All ages;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
28 Madrid;All ages;Cohort April 1;Males;Survival in the second trimester;2022QIII;245.974
28 Madrid;All ages;Cohort April 1;Males;Survival in the second trimester;2022QII;""
28 Madrid;All ages;Cohort April 1;Males;Survival in the second trimester;2022QI;""
28 Madrid;All ages;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
28 Madrid;All ages;Cohort April 1;Males;Survival in the second trimester;2021QIII;244.419
28 Madrid;All ages;Cohort April 1;Males;Survival in the second trimester;2021QII;""
28 Madrid;All ages;Cohort April 1;Males;Survival in the second trimester;2021QI;""
28 Madrid;All ages;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
28 Madrid;All ages;Cohort April 1;Males;Survival in the second trimester;2020QIII;241.737
28 Madrid;All ages;Cohort April 1;Males;Survival in the second trimester;2020QII;""
28 Madrid;All ages;Cohort April 1;Males;Survival in the second trimester;2020QI;""
28 Madrid;All ages;Cohort April 1;Males;Survival in the third trimester;2022QIV;237.865
28 Madrid;All ages;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
28 Madrid;All ages;Cohort April 1;Males;Survival in the third trimester;2022QII;""
28 Madrid;All ages;Cohort April 1;Males;Survival in the third trimester;2022QI;""
28 Madrid;All ages;Cohort April 1;Males;Survival in the third trimester;2021QIV;236.783
28 Madrid;All ages;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
28 Madrid;All ages;Cohort April 1;Males;Survival in the third trimester;2021QII;""
28 Madrid;All ages;Cohort April 1;Males;Survival in the third trimester;2021QI;""
28 Madrid;All ages;Cohort April 1;Males;Survival in the third trimester;2020QIV;234.348
28 Madrid;All ages;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
28 Madrid;All ages;Cohort April 1;Males;Survival in the third trimester;2020QII;""
28 Madrid;All ages;Cohort April 1;Males;Survival in the third trimester;2020QI;""
28 Madrid;All ages;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
28 Madrid;All ages;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
28 Madrid;All ages;Cohort April 1;Males;Survival in the third trimester;2022QII;""
28 Madrid;All ages;Cohort April 1;Males;Survival in the third trimester;2022QI;229.766
28 Madrid;All ages;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
28 Madrid;All ages;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
28 Madrid;All ages;Cohort April 1;Males;Survival in the third trimester;2021QII;""
28 Madrid;All ages;Cohort April 1;Males;Survival in the third trimester;2021QI;228.781
28 Madrid;All ages;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
28 Madrid;All ages;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
28 Madrid;All ages;Cohort April 1;Males;Survival in the third trimester;2020QII;""
28 Madrid;All ages;Cohort April 1;Males;Survival in the third trimester;2020QI;""
28 Madrid;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
28 Madrid;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
28 Madrid;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
28 Madrid;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
28 Madrid;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
28 Madrid;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
28 Madrid;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
28 Madrid;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
28 Madrid;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
28 Madrid;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
28 Madrid;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
28 Madrid;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
28 Madrid;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
28 Madrid;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
28 Madrid;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;96,43
28 Madrid;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
28 Madrid;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
28 Madrid;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
28 Madrid;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;96,5
28 Madrid;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
28 Madrid;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
28 Madrid;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
28 Madrid;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;97,62
28 Madrid;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
28 Madrid;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
28 Madrid;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;93,57
28 Madrid;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
28 Madrid;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
28 Madrid;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
28 Madrid;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;93,71
28 Madrid;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
28 Madrid;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
28 Madrid;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
28 Madrid;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;94,74
28 Madrid;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
28 Madrid;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
28 Madrid;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;90,49
28 Madrid;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
28 Madrid;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
28 Madrid;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
28 Madrid;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;90,78
28 Madrid;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
28 Madrid;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
28 Madrid;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
28 Madrid;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;91,85
28 Madrid;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
28 Madrid;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
28 Madrid;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
28 Madrid;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
28 Madrid;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
28 Madrid;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
28 Madrid;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;88,09
28 Madrid;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
28 Madrid;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
28 Madrid;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
28 Madrid;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;89,66
28 Madrid;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
28 Madrid;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
28 Madrid;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
28 Madrid;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
28 Madrid;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
28 Madrid;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
28 Madrid;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QII;148.760
28 Madrid;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
28 Madrid;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
28 Madrid;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
28 Madrid;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QII;143.661
28 Madrid;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
28 Madrid;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
28 Madrid;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
28 Madrid;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QII;139.396
28 Madrid;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
28 Madrid;All ages;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
28 Madrid;All ages;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
28 Madrid;All ages;Cohort April 1;Females;Survival in the first trimester;2022QII;141.969
28 Madrid;All ages;Cohort April 1;Females;Survival in the first trimester;2022QI;""
28 Madrid;All ages;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
28 Madrid;All ages;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
28 Madrid;All ages;Cohort April 1;Females;Survival in the first trimester;2021QII;137.730
28 Madrid;All ages;Cohort April 1;Females;Survival in the first trimester;2021QI;""
28 Madrid;All ages;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
28 Madrid;All ages;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
28 Madrid;All ages;Cohort April 1;Females;Survival in the first trimester;2020QII;135.396
28 Madrid;All ages;Cohort April 1;Females;Survival in the first trimester;2020QI;""
28 Madrid;All ages;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
28 Madrid;All ages;Cohort April 1;Females;Survival in the second trimester;2022QIII;136.820
28 Madrid;All ages;Cohort April 1;Females;Survival in the second trimester;2022QII;""
28 Madrid;All ages;Cohort April 1;Females;Survival in the second trimester;2022QI;""
28 Madrid;All ages;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
28 Madrid;All ages;Cohort April 1;Females;Survival in the second trimester;2021QIII;133.140
28 Madrid;All ages;Cohort April 1;Females;Survival in the second trimester;2021QII;""
28 Madrid;All ages;Cohort April 1;Females;Survival in the second trimester;2021QI;""
28 Madrid;All ages;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
28 Madrid;All ages;Cohort April 1;Females;Survival in the second trimester;2020QIII;130.562
28 Madrid;All ages;Cohort April 1;Females;Survival in the second trimester;2020QII;""
28 Madrid;All ages;Cohort April 1;Females;Survival in the second trimester;2020QI;""
28 Madrid;All ages;Cohort April 1;Females;Survival in the third trimester;2022QIV;131.388
28 Madrid;All ages;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
28 Madrid;All ages;Cohort April 1;Females;Survival in the third trimester;2022QII;""
28 Madrid;All ages;Cohort April 1;Females;Survival in the third trimester;2022QI;""
28 Madrid;All ages;Cohort April 1;Females;Survival in the third trimester;2021QIV;128.464
28 Madrid;All ages;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
28 Madrid;All ages;Cohort April 1;Females;Survival in the third trimester;2021QII;""
28 Madrid;All ages;Cohort April 1;Females;Survival in the third trimester;2021QI;""
28 Madrid;All ages;Cohort April 1;Females;Survival in the third trimester;2020QIV;125.860
28 Madrid;All ages;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
28 Madrid;All ages;Cohort April 1;Females;Survival in the third trimester;2020QII;""
28 Madrid;All ages;Cohort April 1;Females;Survival in the third trimester;2020QI;""
28 Madrid;All ages;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
28 Madrid;All ages;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
28 Madrid;All ages;Cohort April 1;Females;Survival in the third trimester;2022QII;""
28 Madrid;All ages;Cohort April 1;Females;Survival in the third trimester;2022QI;123.821
28 Madrid;All ages;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
28 Madrid;All ages;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
28 Madrid;All ages;Cohort April 1;Females;Survival in the third trimester;2021QII;""
28 Madrid;All ages;Cohort April 1;Females;Survival in the third trimester;2021QI;122.322
28 Madrid;All ages;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
28 Madrid;All ages;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
28 Madrid;All ages;Cohort April 1;Females;Survival in the third trimester;2020QII;""
28 Madrid;All ages;Cohort April 1;Females;Survival in the third trimester;2020QI;""
28 Madrid;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
28 Madrid;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
28 Madrid;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
28 Madrid;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
28 Madrid;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
28 Madrid;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
28 Madrid;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
28 Madrid;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
28 Madrid;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
28 Madrid;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
28 Madrid;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
28 Madrid;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
28 Madrid;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
28 Madrid;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
28 Madrid;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;95,43
28 Madrid;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
28 Madrid;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
28 Madrid;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
28 Madrid;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;95,87
28 Madrid;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
28 Madrid;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
28 Madrid;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
28 Madrid;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;97,13
28 Madrid;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
28 Madrid;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
28 Madrid;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;91,97
28 Madrid;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
28 Madrid;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
28 Madrid;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
28 Madrid;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;92,68
28 Madrid;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
28 Madrid;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
28 Madrid;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
28 Madrid;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;93,66
28 Madrid;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
28 Madrid;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
28 Madrid;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;88,32
28 Madrid;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
28 Madrid;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
28 Madrid;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
28 Madrid;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;89,42
28 Madrid;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
28 Madrid;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
28 Madrid;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
28 Madrid;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;90,29
28 Madrid;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
28 Madrid;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
28 Madrid;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
28 Madrid;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
28 Madrid;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
28 Madrid;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
28 Madrid;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;86,19
28 Madrid;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
28 Madrid;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
28 Madrid;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
28 Madrid;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;87,75
28 Madrid;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
28 Madrid;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
28 Madrid;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
28 Madrid;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
28 Madrid;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
28 Madrid;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QIII;411.730
28 Madrid;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
28 Madrid;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
28 Madrid;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
28 Madrid;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QIII;406.863
28 Madrid;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
28 Madrid;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
28 Madrid;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
28 Madrid;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QIII;396.510
28 Madrid;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
28 Madrid;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
28 Madrid;All ages;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
28 Madrid;All ages;Cohort July 1;Total;Survival in the first trimester;2022QIII;397.277
28 Madrid;All ages;Cohort July 1;Total;Survival in the first trimester;2022QII;""
28 Madrid;All ages;Cohort July 1;Total;Survival in the first trimester;2022QI;""
28 Madrid;All ages;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
28 Madrid;All ages;Cohort July 1;Total;Survival in the first trimester;2021QIII;393.100
28 Madrid;All ages;Cohort July 1;Total;Survival in the first trimester;2021QII;""
28 Madrid;All ages;Cohort July 1;Total;Survival in the first trimester;2021QI;""
28 Madrid;All ages;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
28 Madrid;All ages;Cohort July 1;Total;Survival in the first trimester;2020QIII;382.916
28 Madrid;All ages;Cohort July 1;Total;Survival in the first trimester;2020QII;""
28 Madrid;All ages;Cohort July 1;Total;Survival in the first trimester;2020QI;""
28 Madrid;All ages;Cohort July 1;Total;Survival in the second trimester;2022QIV;382.308
28 Madrid;All ages;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
28 Madrid;All ages;Cohort July 1;Total;Survival in the second trimester;2022QII;""
28 Madrid;All ages;Cohort July 1;Total;Survival in the second trimester;2022QI;""
28 Madrid;All ages;Cohort July 1;Total;Survival in the second trimester;2021QIV;379.363
28 Madrid;All ages;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
28 Madrid;All ages;Cohort July 1;Total;Survival in the second trimester;2021QII;""
28 Madrid;All ages;Cohort July 1;Total;Survival in the second trimester;2021QI;""
28 Madrid;All ages;Cohort July 1;Total;Survival in the second trimester;2020QIV;369.878
28 Madrid;All ages;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
28 Madrid;All ages;Cohort July 1;Total;Survival in the second trimester;2020QII;""
28 Madrid;All ages;Cohort July 1;Total;Survival in the second trimester;2020QI;""
28 Madrid;All ages;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
28 Madrid;All ages;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
28 Madrid;All ages;Cohort July 1;Total;Survival in the third trimester;2022QII;""
28 Madrid;All ages;Cohort July 1;Total;Survival in the third trimester;2022QI;366.662
28 Madrid;All ages;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
28 Madrid;All ages;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
28 Madrid;All ages;Cohort July 1;Total;Survival in the third trimester;2021QII;""
28 Madrid;All ages;Cohort July 1;Total;Survival in the third trimester;2021QI;360.147
28 Madrid;All ages;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
28 Madrid;All ages;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
28 Madrid;All ages;Cohort July 1;Total;Survival in the third trimester;2020QII;""
28 Madrid;All ages;Cohort July 1;Total;Survival in the third trimester;2020QI;""
28 Madrid;All ages;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
28 Madrid;All ages;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
28 Madrid;All ages;Cohort July 1;Total;Survival in the third trimester;2022QII;355.086
28 Madrid;All ages;Cohort July 1;Total;Survival in the third trimester;2022QI;""
28 Madrid;All ages;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
28 Madrid;All ages;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
28 Madrid;All ages;Cohort July 1;Total;Survival in the third trimester;2021QII;349.896
28 Madrid;All ages;Cohort July 1;Total;Survival in the third trimester;2021QI;""
28 Madrid;All ages;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
28 Madrid;All ages;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
28 Madrid;All ages;Cohort July 1;Total;Survival in the third trimester;2020QII;""
28 Madrid;All ages;Cohort July 1;Total;Survival in the third trimester;2020QI;""
28 Madrid;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
28 Madrid;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
28 Madrid;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
28 Madrid;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
28 Madrid;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
28 Madrid;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
28 Madrid;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
28 Madrid;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
28 Madrid;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
28 Madrid;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
28 Madrid;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
28 Madrid;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
28 Madrid;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
28 Madrid;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;96,49
28 Madrid;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
28 Madrid;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
28 Madrid;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
28 Madrid;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;96,62
28 Madrid;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
28 Madrid;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
28 Madrid;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
28 Madrid;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;96,57
28 Madrid;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
28 Madrid;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
28 Madrid;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;92,85
28 Madrid;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
28 Madrid;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
28 Madrid;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
28 Madrid;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;93,24
28 Madrid;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
28 Madrid;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
28 Madrid;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
28 Madrid;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;93,28
28 Madrid;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
28 Madrid;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
28 Madrid;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
28 Madrid;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
28 Madrid;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
28 Madrid;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
28 Madrid;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;90,12
28 Madrid;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
28 Madrid;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
28 Madrid;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
28 Madrid;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;90,83
28 Madrid;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
28 Madrid;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
28 Madrid;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
28 Madrid;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
28 Madrid;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
28 Madrid;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
28 Madrid;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;87,27
28 Madrid;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
28 Madrid;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
28 Madrid;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
28 Madrid;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;88,24
28 Madrid;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
28 Madrid;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
28 Madrid;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
28 Madrid;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
28 Madrid;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
28 Madrid;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
28 Madrid;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QIII;262.951
28 Madrid;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
28 Madrid;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
28 Madrid;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
28 Madrid;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QIII;261.829
28 Madrid;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
28 Madrid;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
28 Madrid;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
28 Madrid;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QIII;256.806
28 Madrid;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
28 Madrid;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
28 Madrid;All ages;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
28 Madrid;All ages;Cohort July 1;Males;Survival in the first trimester;2022QIII;254.378
28 Madrid;All ages;Cohort July 1;Males;Survival in the first trimester;2022QII;""
28 Madrid;All ages;Cohort July 1;Males;Survival in the first trimester;2022QI;""
28 Madrid;All ages;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
28 Madrid;All ages;Cohort July 1;Males;Survival in the first trimester;2021QIII;253.385
28 Madrid;All ages;Cohort July 1;Males;Survival in the first trimester;2021QII;""
28 Madrid;All ages;Cohort July 1;Males;Survival in the first trimester;2021QI;""
28 Madrid;All ages;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
28 Madrid;All ages;Cohort July 1;Males;Survival in the first trimester;2020QIII;248.567
28 Madrid;All ages;Cohort July 1;Males;Survival in the first trimester;2020QII;""
28 Madrid;All ages;Cohort July 1;Males;Survival in the first trimester;2020QI;""
28 Madrid;All ages;Cohort July 1;Males;Survival in the second trimester;2022QIV;245.432
28 Madrid;All ages;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
28 Madrid;All ages;Cohort July 1;Males;Survival in the second trimester;2022QII;""
28 Madrid;All ages;Cohort July 1;Males;Survival in the second trimester;2022QI;""
28 Madrid;All ages;Cohort July 1;Males;Survival in the second trimester;2021QIV;244.891
28 Madrid;All ages;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
28 Madrid;All ages;Cohort July 1;Males;Survival in the second trimester;2021QII;""
28 Madrid;All ages;Cohort July 1;Males;Survival in the second trimester;2021QI;""
28 Madrid;All ages;Cohort July 1;Males;Survival in the second trimester;2020QIV;240.561
28 Madrid;All ages;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
28 Madrid;All ages;Cohort July 1;Males;Survival in the second trimester;2020QII;""
28 Madrid;All ages;Cohort July 1;Males;Survival in the second trimester;2020QI;""
28 Madrid;All ages;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
28 Madrid;All ages;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
28 Madrid;All ages;Cohort July 1;Males;Survival in the third trimester;2022QII;""
28 Madrid;All ages;Cohort July 1;Males;Survival in the third trimester;2022QI;237.252
28 Madrid;All ages;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
28 Madrid;All ages;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
28 Madrid;All ages;Cohort July 1;Males;Survival in the third trimester;2021QII;""
28 Madrid;All ages;Cohort July 1;Males;Survival in the third trimester;2021QI;234.574
28 Madrid;All ages;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
28 Madrid;All ages;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
28 Madrid;All ages;Cohort July 1;Males;Survival in the third trimester;2020QII;""
28 Madrid;All ages;Cohort July 1;Males;Survival in the third trimester;2020QI;""
28 Madrid;All ages;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
28 Madrid;All ages;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
28 Madrid;All ages;Cohort July 1;Males;Survival in the third trimester;2022QII;230.423
28 Madrid;All ages;Cohort July 1;Males;Survival in the third trimester;2022QI;""
28 Madrid;All ages;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
28 Madrid;All ages;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
28 Madrid;All ages;Cohort July 1;Males;Survival in the third trimester;2021QII;228.352
28 Madrid;All ages;Cohort July 1;Males;Survival in the third trimester;2021QI;""
28 Madrid;All ages;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
28 Madrid;All ages;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
28 Madrid;All ages;Cohort July 1;Males;Survival in the third trimester;2020QII;""
28 Madrid;All ages;Cohort July 1;Males;Survival in the third trimester;2020QI;""
28 Madrid;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
28 Madrid;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
28 Madrid;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
28 Madrid;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
28 Madrid;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
28 Madrid;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
28 Madrid;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
28 Madrid;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
28 Madrid;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
28 Madrid;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
28 Madrid;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
28 Madrid;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
28 Madrid;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
28 Madrid;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;96,74
28 Madrid;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
28 Madrid;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
28 Madrid;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
28 Madrid;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;96,77
28 Madrid;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
28 Madrid;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
28 Madrid;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
28 Madrid;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;96,79
28 Madrid;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
28 Madrid;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
28 Madrid;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;93,34
28 Madrid;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
28 Madrid;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
28 Madrid;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
28 Madrid;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;93,53
28 Madrid;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
28 Madrid;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
28 Madrid;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
28 Madrid;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;93,67
28 Madrid;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
28 Madrid;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
28 Madrid;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
28 Madrid;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
28 Madrid;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
28 Madrid;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
28 Madrid;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;90,61
28 Madrid;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
28 Madrid;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
28 Madrid;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
28 Madrid;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;91,34
28 Madrid;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
28 Madrid;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
28 Madrid;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
28 Madrid;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
28 Madrid;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
28 Madrid;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
28 Madrid;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;88,01
28 Madrid;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
28 Madrid;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
28 Madrid;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
28 Madrid;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;88,92
28 Madrid;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
28 Madrid;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
28 Madrid;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
28 Madrid;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
28 Madrid;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
28 Madrid;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
28 Madrid;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QIII;148.779
28 Madrid;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
28 Madrid;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
28 Madrid;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
28 Madrid;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QIII;145.034
28 Madrid;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
28 Madrid;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
28 Madrid;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
28 Madrid;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QIII;139.704
28 Madrid;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
28 Madrid;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
28 Madrid;All ages;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
28 Madrid;All ages;Cohort July 1;Females;Survival in the first trimester;2022QIII;142.899
28 Madrid;All ages;Cohort July 1;Females;Survival in the first trimester;2022QII;""
28 Madrid;All ages;Cohort July 1;Females;Survival in the first trimester;2022QI;""
28 Madrid;All ages;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
28 Madrid;All ages;Cohort July 1;Females;Survival in the first trimester;2021QIII;139.715
28 Madrid;All ages;Cohort July 1;Females;Survival in the first trimester;2021QII;""
28 Madrid;All ages;Cohort July 1;Females;Survival in the first trimester;2021QI;""
28 Madrid;All ages;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
28 Madrid;All ages;Cohort July 1;Females;Survival in the first trimester;2020QIII;134.349
28 Madrid;All ages;Cohort July 1;Females;Survival in the first trimester;2020QII;""
28 Madrid;All ages;Cohort July 1;Females;Survival in the first trimester;2020QI;""
28 Madrid;All ages;Cohort July 1;Females;Survival in the second trimester;2022QIV;136.876
28 Madrid;All ages;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
28 Madrid;All ages;Cohort July 1;Females;Survival in the second trimester;2022QII;""
28 Madrid;All ages;Cohort July 1;Females;Survival in the second trimester;2022QI;""
28 Madrid;All ages;Cohort July 1;Females;Survival in the second trimester;2021QIV;134.472
28 Madrid;All ages;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
28 Madrid;All ages;Cohort July 1;Females;Survival in the second trimester;2021QII;""
28 Madrid;All ages;Cohort July 1;Females;Survival in the second trimester;2021QI;""
28 Madrid;All ages;Cohort July 1;Females;Survival in the second trimester;2020QIV;129.317
28 Madrid;All ages;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
28 Madrid;All ages;Cohort July 1;Females;Survival in the second trimester;2020QII;""
28 Madrid;All ages;Cohort July 1;Females;Survival in the second trimester;2020QI;""
28 Madrid;All ages;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
28 Madrid;All ages;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
28 Madrid;All ages;Cohort July 1;Females;Survival in the third trimester;2022QII;""
28 Madrid;All ages;Cohort July 1;Females;Survival in the third trimester;2022QI;129.410
28 Madrid;All ages;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
28 Madrid;All ages;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
28 Madrid;All ages;Cohort July 1;Females;Survival in the third trimester;2021QII;""
28 Madrid;All ages;Cohort July 1;Females;Survival in the third trimester;2021QI;125.573
28 Madrid;All ages;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
28 Madrid;All ages;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
28 Madrid;All ages;Cohort July 1;Females;Survival in the third trimester;2020QII;""
28 Madrid;All ages;Cohort July 1;Females;Survival in the third trimester;2020QI;""
28 Madrid;All ages;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
28 Madrid;All ages;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
28 Madrid;All ages;Cohort July 1;Females;Survival in the third trimester;2022QII;124.663
28 Madrid;All ages;Cohort July 1;Females;Survival in the third trimester;2022QI;""
28 Madrid;All ages;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
28 Madrid;All ages;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
28 Madrid;All ages;Cohort July 1;Females;Survival in the third trimester;2021QII;121.544
28 Madrid;All ages;Cohort July 1;Females;Survival in the third trimester;2021QI;""
28 Madrid;All ages;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
28 Madrid;All ages;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
28 Madrid;All ages;Cohort July 1;Females;Survival in the third trimester;2020QII;""
28 Madrid;All ages;Cohort July 1;Females;Survival in the third trimester;2020QI;""
28 Madrid;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
28 Madrid;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
28 Madrid;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
28 Madrid;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
28 Madrid;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
28 Madrid;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
28 Madrid;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
28 Madrid;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
28 Madrid;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
28 Madrid;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
28 Madrid;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
28 Madrid;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
28 Madrid;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
28 Madrid;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;96,05
28 Madrid;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
28 Madrid;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
28 Madrid;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
28 Madrid;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;96,33
28 Madrid;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
28 Madrid;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
28 Madrid;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
28 Madrid;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;96,17
28 Madrid;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
28 Madrid;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
28 Madrid;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;92
28 Madrid;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
28 Madrid;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
28 Madrid;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
28 Madrid;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;92,72
28 Madrid;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
28 Madrid;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
28 Madrid;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
28 Madrid;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;92,56
28 Madrid;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
28 Madrid;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
28 Madrid;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
28 Madrid;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
28 Madrid;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
28 Madrid;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
28 Madrid;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;89,23
28 Madrid;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
28 Madrid;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
28 Madrid;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
28 Madrid;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;89,89
28 Madrid;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
28 Madrid;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
28 Madrid;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
28 Madrid;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
28 Madrid;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
28 Madrid;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
28 Madrid;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;85,95
28 Madrid;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
28 Madrid;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
28 Madrid;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
28 Madrid;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;87
28 Madrid;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
28 Madrid;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
28 Madrid;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
28 Madrid;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
28 Madrid;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
28 Madrid;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QIV;411.283
28 Madrid;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
28 Madrid;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
28 Madrid;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
28 Madrid;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QIV;407.566
28 Madrid;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
28 Madrid;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
28 Madrid;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
28 Madrid;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QIV;397.796
28 Madrid;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
28 Madrid;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
28 Madrid;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
28 Madrid;All ages;Cohort October 1;Total;Survival in the first trimester;2022QIV;394.726
28 Madrid;All ages;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
28 Madrid;All ages;Cohort October 1;Total;Survival in the first trimester;2022QII;""
28 Madrid;All ages;Cohort October 1;Total;Survival in the first trimester;2022QI;""
28 Madrid;All ages;Cohort October 1;Total;Survival in the first trimester;2021QIV;392.302
28 Madrid;All ages;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
28 Madrid;All ages;Cohort October 1;Total;Survival in the first trimester;2021QII;""
28 Madrid;All ages;Cohort October 1;Total;Survival in the first trimester;2021QI;""
28 Madrid;All ages;Cohort October 1;Total;Survival in the first trimester;2020QIV;382.998
28 Madrid;All ages;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
28 Madrid;All ages;Cohort October 1;Total;Survival in the first trimester;2020QII;""
28 Madrid;All ages;Cohort October 1;Total;Survival in the first trimester;2020QI;""
28 Madrid;All ages;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
28 Madrid;All ages;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
28 Madrid;All ages;Cohort October 1;Total;Survival in the second trimester;2022QII;""
28 Madrid;All ages;Cohort October 1;Total;Survival in the second trimester;2022QI;378.543
28 Madrid;All ages;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
28 Madrid;All ages;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
28 Madrid;All ages;Cohort October 1;Total;Survival in the second trimester;2021QII;""
28 Madrid;All ages;Cohort October 1;Total;Survival in the second trimester;2021QI;372.196
28 Madrid;All ages;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
28 Madrid;All ages;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
28 Madrid;All ages;Cohort October 1;Total;Survival in the second trimester;2020QII;""
28 Madrid;All ages;Cohort October 1;Total;Survival in the second trimester;2020QI;""
28 Madrid;All ages;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
28 Madrid;All ages;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
28 Madrid;All ages;Cohort October 1;Total;Survival in the third trimester;2022QII;365.833
28 Madrid;All ages;Cohort October 1;Total;Survival in the third trimester;2022QI;""
28 Madrid;All ages;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
28 Madrid;All ages;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
28 Madrid;All ages;Cohort October 1;Total;Survival in the third trimester;2021QII;360.762
28 Madrid;All ages;Cohort October 1;Total;Survival in the third trimester;2021QI;""
28 Madrid;All ages;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
28 Madrid;All ages;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
28 Madrid;All ages;Cohort October 1;Total;Survival in the third trimester;2020QII;""
28 Madrid;All ages;Cohort October 1;Total;Survival in the third trimester;2020QI;""
28 Madrid;All ages;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
28 Madrid;All ages;Cohort October 1;Total;Survival in the third trimester;2022QIII;355.410
28 Madrid;All ages;Cohort October 1;Total;Survival in the third trimester;2022QII;""
28 Madrid;All ages;Cohort October 1;Total;Survival in the third trimester;2022QI;""
28 Madrid;All ages;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
28 Madrid;All ages;Cohort October 1;Total;Survival in the third trimester;2021QIII;351.233
28 Madrid;All ages;Cohort October 1;Total;Survival in the third trimester;2021QII;""
28 Madrid;All ages;Cohort October 1;Total;Survival in the third trimester;2021QI;""
28 Madrid;All ages;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
28 Madrid;All ages;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
28 Madrid;All ages;Cohort October 1;Total;Survival in the third trimester;2020QII;""
28 Madrid;All ages;Cohort October 1;Total;Survival in the third trimester;2020QI;""
28 Madrid;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
28 Madrid;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
28 Madrid;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
28 Madrid;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
28 Madrid;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
28 Madrid;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
28 Madrid;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
28 Madrid;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
28 Madrid;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
28 Madrid;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
28 Madrid;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
28 Madrid;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
28 Madrid;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;95,97
28 Madrid;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
28 Madrid;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
28 Madrid;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
28 Madrid;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;96,25
28 Madrid;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
28 Madrid;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
28 Madrid;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
28 Madrid;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;96,28
28 Madrid;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
28 Madrid;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
28 Madrid;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
28 Madrid;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
28 Madrid;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
28 Madrid;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
28 Madrid;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;92,88
28 Madrid;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
28 Madrid;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
28 Madrid;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
28 Madrid;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;93,56
28 Madrid;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
28 Madrid;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
28 Madrid;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
28 Madrid;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
28 Madrid;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
28 Madrid;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
28 Madrid;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;89,76
28 Madrid;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
28 Madrid;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
28 Madrid;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
28 Madrid;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;90,69
28 Madrid;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
28 Madrid;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
28 Madrid;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
28 Madrid;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
28 Madrid;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
28 Madrid;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
28 Madrid;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;87,2
28 Madrid;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
28 Madrid;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
28 Madrid;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
28 Madrid;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;88,29
28 Madrid;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
28 Madrid;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
28 Madrid;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
28 Madrid;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
28 Madrid;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
28 Madrid;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
28 Madrid;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QIV;262.460
28 Madrid;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
28 Madrid;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
28 Madrid;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
28 Madrid;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QIV;261.760
28 Madrid;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
28 Madrid;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
28 Madrid;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
28 Madrid;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QIV;257.566
28 Madrid;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
28 Madrid;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
28 Madrid;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
28 Madrid;All ages;Cohort October 1;Males;Survival in the first trimester;2022QIV;252.577
28 Madrid;All ages;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
28 Madrid;All ages;Cohort October 1;Males;Survival in the first trimester;2022QII;""
28 Madrid;All ages;Cohort October 1;Males;Survival in the first trimester;2022QI;""
28 Madrid;All ages;Cohort October 1;Males;Survival in the first trimester;2021QIV;252.337
28 Madrid;All ages;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
28 Madrid;All ages;Cohort October 1;Males;Survival in the first trimester;2021QII;""
28 Madrid;All ages;Cohort October 1;Males;Survival in the first trimester;2021QI;""
28 Madrid;All ages;Cohort October 1;Males;Survival in the first trimester;2020QIV;248.484
28 Madrid;All ages;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
28 Madrid;All ages;Cohort October 1;Males;Survival in the first trimester;2020QII;""
28 Madrid;All ages;Cohort October 1;Males;Survival in the first trimester;2020QI;""
28 Madrid;All ages;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
28 Madrid;All ages;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
28 Madrid;All ages;Cohort October 1;Males;Survival in the second trimester;2022QII;""
28 Madrid;All ages;Cohort October 1;Males;Survival in the second trimester;2022QI;244.099
28 Madrid;All ages;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
28 Madrid;All ages;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
28 Madrid;All ages;Cohort October 1;Males;Survival in the second trimester;2021QII;""
28 Madrid;All ages;Cohort October 1;Males;Survival in the second trimester;2021QI;241.810
28 Madrid;All ages;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
28 Madrid;All ages;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
28 Madrid;All ages;Cohort October 1;Males;Survival in the second trimester;2020QII;""
28 Madrid;All ages;Cohort October 1;Males;Survival in the second trimester;2020QI;""
28 Madrid;All ages;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
28 Madrid;All ages;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
28 Madrid;All ages;Cohort October 1;Males;Survival in the third trimester;2022QII;236.641
28 Madrid;All ages;Cohort October 1;Males;Survival in the third trimester;2022QI;""
28 Madrid;All ages;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
28 Madrid;All ages;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
28 Madrid;All ages;Cohort October 1;Males;Survival in the third trimester;2021QII;234.883
28 Madrid;All ages;Cohort October 1;Males;Survival in the third trimester;2021QI;""
28 Madrid;All ages;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
28 Madrid;All ages;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
28 Madrid;All ages;Cohort October 1;Males;Survival in the third trimester;2020QII;""
28 Madrid;All ages;Cohort October 1;Males;Survival in the third trimester;2020QI;""
28 Madrid;All ages;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
28 Madrid;All ages;Cohort October 1;Males;Survival in the third trimester;2022QIII;230.453
28 Madrid;All ages;Cohort October 1;Males;Survival in the third trimester;2022QII;""
28 Madrid;All ages;Cohort October 1;Males;Survival in the third trimester;2022QI;""
28 Madrid;All ages;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
28 Madrid;All ages;Cohort October 1;Males;Survival in the third trimester;2021QIII;229.021
28 Madrid;All ages;Cohort October 1;Males;Survival in the third trimester;2021QII;""
28 Madrid;All ages;Cohort October 1;Males;Survival in the third trimester;2021QI;""
28 Madrid;All ages;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
28 Madrid;All ages;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
28 Madrid;All ages;Cohort October 1;Males;Survival in the third trimester;2020QII;""
28 Madrid;All ages;Cohort October 1;Males;Survival in the third trimester;2020QI;""
28 Madrid;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
28 Madrid;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
28 Madrid;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
28 Madrid;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
28 Madrid;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
28 Madrid;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
28 Madrid;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
28 Madrid;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
28 Madrid;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
28 Madrid;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
28 Madrid;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
28 Madrid;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
28 Madrid;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;96,23
28 Madrid;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
28 Madrid;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
28 Madrid;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
28 Madrid;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;96,4
28 Madrid;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
28 Madrid;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
28 Madrid;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
28 Madrid;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;96,47
28 Madrid;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
28 Madrid;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
28 Madrid;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
28 Madrid;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
28 Madrid;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
28 Madrid;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
28 Madrid;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;93,25
28 Madrid;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
28 Madrid;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
28 Madrid;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
28 Madrid;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;93,88
28 Madrid;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
28 Madrid;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
28 Madrid;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
28 Madrid;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
28 Madrid;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
28 Madrid;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
28 Madrid;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;90,4
28 Madrid;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
28 Madrid;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
28 Madrid;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
28 Madrid;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;91,19
28 Madrid;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
28 Madrid;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
28 Madrid;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
28 Madrid;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
28 Madrid;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
28 Madrid;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
28 Madrid;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;88,04
28 Madrid;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
28 Madrid;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
28 Madrid;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
28 Madrid;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;88,92
28 Madrid;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
28 Madrid;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
28 Madrid;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
28 Madrid;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
28 Madrid;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
28 Madrid;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
28 Madrid;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QIV;148.823
28 Madrid;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
28 Madrid;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
28 Madrid;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
28 Madrid;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QIV;145.806
28 Madrid;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
28 Madrid;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
28 Madrid;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
28 Madrid;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QIV;140.230
28 Madrid;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
28 Madrid;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
28 Madrid;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
28 Madrid;All ages;Cohort October 1;Females;Survival in the first trimester;2022QIV;142.149
28 Madrid;All ages;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
28 Madrid;All ages;Cohort October 1;Females;Survival in the first trimester;2022QII;""
28 Madrid;All ages;Cohort October 1;Females;Survival in the first trimester;2022QI;""
28 Madrid;All ages;Cohort October 1;Females;Survival in the first trimester;2021QIV;139.965
28 Madrid;All ages;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
28 Madrid;All ages;Cohort October 1;Females;Survival in the first trimester;2021QII;""
28 Madrid;All ages;Cohort October 1;Females;Survival in the first trimester;2021QI;""
28 Madrid;All ages;Cohort October 1;Females;Survival in the first trimester;2020QIV;134.514
28 Madrid;All ages;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
28 Madrid;All ages;Cohort October 1;Females;Survival in the first trimester;2020QII;""
28 Madrid;All ages;Cohort October 1;Females;Survival in the first trimester;2020QI;""
28 Madrid;All ages;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
28 Madrid;All ages;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
28 Madrid;All ages;Cohort October 1;Females;Survival in the second trimester;2022QII;""
28 Madrid;All ages;Cohort October 1;Females;Survival in the second trimester;2022QI;134.444
28 Madrid;All ages;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
28 Madrid;All ages;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
28 Madrid;All ages;Cohort October 1;Females;Survival in the second trimester;2021QII;""
28 Madrid;All ages;Cohort October 1;Females;Survival in the second trimester;2021QI;130.386
28 Madrid;All ages;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
28 Madrid;All ages;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
28 Madrid;All ages;Cohort October 1;Females;Survival in the second trimester;2020QII;""
28 Madrid;All ages;Cohort October 1;Females;Survival in the second trimester;2020QI;""
28 Madrid;All ages;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
28 Madrid;All ages;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
28 Madrid;All ages;Cohort October 1;Females;Survival in the third trimester;2022QII;129.192
28 Madrid;All ages;Cohort October 1;Females;Survival in the third trimester;2022QI;""
28 Madrid;All ages;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
28 Madrid;All ages;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
28 Madrid;All ages;Cohort October 1;Females;Survival in the third trimester;2021QII;125.879
28 Madrid;All ages;Cohort October 1;Females;Survival in the third trimester;2021QI;""
28 Madrid;All ages;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
28 Madrid;All ages;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
28 Madrid;All ages;Cohort October 1;Females;Survival in the third trimester;2020QII;""
28 Madrid;All ages;Cohort October 1;Females;Survival in the third trimester;2020QI;""
28 Madrid;All ages;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
28 Madrid;All ages;Cohort October 1;Females;Survival in the third trimester;2022QIII;124.957
28 Madrid;All ages;Cohort October 1;Females;Survival in the third trimester;2022QII;""
28 Madrid;All ages;Cohort October 1;Females;Survival in the third trimester;2022QI;""
28 Madrid;All ages;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
28 Madrid;All ages;Cohort October 1;Females;Survival in the third trimester;2021QIII;122.212
28 Madrid;All ages;Cohort October 1;Females;Survival in the third trimester;2021QII;""
28 Madrid;All ages;Cohort October 1;Females;Survival in the third trimester;2021QI;""
28 Madrid;All ages;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
28 Madrid;All ages;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
28 Madrid;All ages;Cohort October 1;Females;Survival in the third trimester;2020QII;""
28 Madrid;All ages;Cohort October 1;Females;Survival in the third trimester;2020QI;""
28 Madrid;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
28 Madrid;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
28 Madrid;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
28 Madrid;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
28 Madrid;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
28 Madrid;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
28 Madrid;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
28 Madrid;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
28 Madrid;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
28 Madrid;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
28 Madrid;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
28 Madrid;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
28 Madrid;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;95,52
28 Madrid;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
28 Madrid;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
28 Madrid;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
28 Madrid;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;95,99
28 Madrid;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
28 Madrid;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
28 Madrid;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
28 Madrid;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;95,92
28 Madrid;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
28 Madrid;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
28 Madrid;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
28 Madrid;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
28 Madrid;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
28 Madrid;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
28 Madrid;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;92,21
28 Madrid;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
28 Madrid;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
28 Madrid;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
28 Madrid;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;92,98
28 Madrid;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
28 Madrid;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
28 Madrid;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
28 Madrid;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
28 Madrid;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
28 Madrid;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
28 Madrid;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;88,61
28 Madrid;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
28 Madrid;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
28 Madrid;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
28 Madrid;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;89,77
28 Madrid;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
28 Madrid;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
28 Madrid;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
28 Madrid;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
28 Madrid;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
28 Madrid;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
28 Madrid;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;85,7
28 Madrid;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
28 Madrid;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
28 Madrid;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
28 Madrid;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;87,15
28 Madrid;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
28 Madrid;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
28 Madrid;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
28 Madrid;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
28 Madrid;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
28 Madrid;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
28 Madrid;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
28 Madrid;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
28 Madrid;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
28 Madrid;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QI;29.355
28 Madrid;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
28 Madrid;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
28 Madrid;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
28 Madrid;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QI;27.814
28 Madrid;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
28 Madrid;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
28 Madrid;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
28 Madrid;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QI;23.062
28 Madrid;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
28 Madrid;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
28 Madrid;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2022QII;""
28 Madrid;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2022QI;27.060
28 Madrid;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
28 Madrid;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
28 Madrid;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2021QII;""
28 Madrid;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2021QI;26.046
28 Madrid;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
28 Madrid;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
28 Madrid;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2020QII;""
28 Madrid;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2020QI;20.230
28 Madrid;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
28 Madrid;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
28 Madrid;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2022QII;25.206
28 Madrid;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2022QI;""
28 Madrid;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
28 Madrid;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
28 Madrid;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2021QII;24.152
28 Madrid;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2021QI;""
28 Madrid;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
28 Madrid;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
28 Madrid;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2020QII;19.437
28 Madrid;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2020QI;""
28 Madrid;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
28 Madrid;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QIII;23.646
28 Madrid;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QII;""
28 Madrid;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QI;""
28 Madrid;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
28 Madrid;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QIII;22.580
28 Madrid;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QII;""
28 Madrid;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QI;""
28 Madrid;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
28 Madrid;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QIII;18.393
28 Madrid;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QII;""
28 Madrid;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QI;""
28 Madrid;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QIV;22.197
28 Madrid;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
28 Madrid;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QII;""
28 Madrid;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QI;""
28 Madrid;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QIV;21.185
28 Madrid;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
28 Madrid;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QII;""
28 Madrid;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QI;""
28 Madrid;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QIV;17.391
28 Madrid;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
28 Madrid;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QII;""
28 Madrid;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QI;""
28 Madrid;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
28 Madrid;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
28 Madrid;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
28 Madrid;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
28 Madrid;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
28 Madrid;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
28 Madrid;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
28 Madrid;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
28 Madrid;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
28 Madrid;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
28 Madrid;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
28 Madrid;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
28 Madrid;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
28 Madrid;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
28 Madrid;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
28 Madrid;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;92,18
28 Madrid;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
28 Madrid;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
28 Madrid;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
28 Madrid;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;93,64
28 Madrid;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
28 Madrid;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
28 Madrid;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
28 Madrid;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;87,72
28 Madrid;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
28 Madrid;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
28 Madrid;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;85,87
28 Madrid;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
28 Madrid;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
28 Madrid;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
28 Madrid;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;86,83
28 Madrid;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
28 Madrid;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
28 Madrid;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
28 Madrid;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;84,28
28 Madrid;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
28 Madrid;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
28 Madrid;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;80,55
28 Madrid;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
28 Madrid;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
28 Madrid;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
28 Madrid;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;81,18
28 Madrid;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
28 Madrid;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
28 Madrid;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
28 Madrid;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;79,75
28 Madrid;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
28 Madrid;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
28 Madrid;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;75,62
28 Madrid;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
28 Madrid;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
28 Madrid;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
28 Madrid;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;76,17
28 Madrid;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
28 Madrid;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
28 Madrid;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
28 Madrid;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;75,41
28 Madrid;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
28 Madrid;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
28 Madrid;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
28 Madrid;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
28 Madrid;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
28 Madrid;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
28 Madrid;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QI;17.694
28 Madrid;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
28 Madrid;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
28 Madrid;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
28 Madrid;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QI;17.268
28 Madrid;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
28 Madrid;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
28 Madrid;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
28 Madrid;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QI;14.466
28 Madrid;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
28 Madrid;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
28 Madrid;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2022QII;""
28 Madrid;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2022QI;16.346
28 Madrid;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
28 Madrid;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
28 Madrid;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2021QII;""
28 Madrid;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2021QI;16.180
28 Madrid;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
28 Madrid;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
28 Madrid;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2020QII;""
28 Madrid;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2020QI;12.785
28 Madrid;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
28 Madrid;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
28 Madrid;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2022QII;15.290
28 Madrid;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2022QI;""
28 Madrid;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
28 Madrid;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
28 Madrid;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2021QII;15.010
28 Madrid;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2021QI;""
28 Madrid;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
28 Madrid;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
28 Madrid;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2020QII;12.310
28 Madrid;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2020QI;""
28 Madrid;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
28 Madrid;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QIII;14.392
28 Madrid;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QII;""
28 Madrid;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QI;""
28 Madrid;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
28 Madrid;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QIII;14.029
28 Madrid;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QII;""
28 Madrid;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QI;""
28 Madrid;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
28 Madrid;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QIII;11.705
28 Madrid;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QII;""
28 Madrid;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QI;""
28 Madrid;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QIV;13.554
28 Madrid;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
28 Madrid;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QII;""
28 Madrid;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QI;""
28 Madrid;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QIV;13.184
28 Madrid;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
28 Madrid;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QII;""
28 Madrid;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QI;""
28 Madrid;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QIV;11.071
28 Madrid;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
28 Madrid;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QII;""
28 Madrid;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QI;""
28 Madrid;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
28 Madrid;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
28 Madrid;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
28 Madrid;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
28 Madrid;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
28 Madrid;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
28 Madrid;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
28 Madrid;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
28 Madrid;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
28 Madrid;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
28 Madrid;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
28 Madrid;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
28 Madrid;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
28 Madrid;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
28 Madrid;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
28 Madrid;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;92,38
28 Madrid;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
28 Madrid;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
28 Madrid;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
28 Madrid;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;93,7
28 Madrid;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
28 Madrid;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
28 Madrid;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
28 Madrid;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;88,38
28 Madrid;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
28 Madrid;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
28 Madrid;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;86,41
28 Madrid;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
28 Madrid;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
28 Madrid;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
28 Madrid;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;86,92
28 Madrid;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
28 Madrid;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
28 Madrid;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
28 Madrid;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;85,1
28 Madrid;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
28 Madrid;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
28 Madrid;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;81,34
28 Madrid;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
28 Madrid;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
28 Madrid;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
28 Madrid;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;81,24
28 Madrid;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
28 Madrid;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
28 Madrid;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
28 Madrid;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;80,91
28 Madrid;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
28 Madrid;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
28 Madrid;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;76,6
28 Madrid;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
28 Madrid;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
28 Madrid;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
28 Madrid;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;76,35
28 Madrid;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
28 Madrid;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
28 Madrid;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
28 Madrid;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;76,53
28 Madrid;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
28 Madrid;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
28 Madrid;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
28 Madrid;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
28 Madrid;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
28 Madrid;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
28 Madrid;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QI;11.661
28 Madrid;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
28 Madrid;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
28 Madrid;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
28 Madrid;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QI;10.546
28 Madrid;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
28 Madrid;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
28 Madrid;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
28 Madrid;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QI;8.596
28 Madrid;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
28 Madrid;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
28 Madrid;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2022QII;""
28 Madrid;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2022QI;10.714
28 Madrid;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
28 Madrid;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
28 Madrid;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2021QII;""
28 Madrid;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2021QI;9.866
28 Madrid;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
28 Madrid;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
28 Madrid;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2020QII;""
28 Madrid;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2020QI;7.445
28 Madrid;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
28 Madrid;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
28 Madrid;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2022QII;9.916
28 Madrid;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2022QI;""
28 Madrid;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
28 Madrid;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
28 Madrid;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2021QII;9.142
28 Madrid;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2021QI;""
28 Madrid;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
28 Madrid;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
28 Madrid;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2020QII;7.127
28 Madrid;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2020QI;""
28 Madrid;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
28 Madrid;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QIII;9.254
28 Madrid;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QII;""
28 Madrid;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QI;""
28 Madrid;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
28 Madrid;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QIII;8.551
28 Madrid;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QII;""
28 Madrid;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QI;""
28 Madrid;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
28 Madrid;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QIII;6.688
28 Madrid;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QII;""
28 Madrid;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QI;""
28 Madrid;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QIV;8.643
28 Madrid;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
28 Madrid;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QII;""
28 Madrid;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QI;""
28 Madrid;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QIV;8.001
28 Madrid;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
28 Madrid;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QII;""
28 Madrid;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QI;""
28 Madrid;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QIV;6.320
28 Madrid;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
28 Madrid;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QII;""
28 Madrid;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QI;""
28 Madrid;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
28 Madrid;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
28 Madrid;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
28 Madrid;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
28 Madrid;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
28 Madrid;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
28 Madrid;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
28 Madrid;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
28 Madrid;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
28 Madrid;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
28 Madrid;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
28 Madrid;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
28 Madrid;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
28 Madrid;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
28 Madrid;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
28 Madrid;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;91,88
28 Madrid;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
28 Madrid;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
28 Madrid;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
28 Madrid;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;93,55
28 Madrid;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
28 Madrid;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
28 Madrid;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
28 Madrid;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;86,61
28 Madrid;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
28 Madrid;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
28 Madrid;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;85,04
28 Madrid;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
28 Madrid;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
28 Madrid;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
28 Madrid;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;86,69
28 Madrid;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
28 Madrid;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
28 Madrid;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
28 Madrid;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;82,91
28 Madrid;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
28 Madrid;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
28 Madrid;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;79,36
28 Madrid;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
28 Madrid;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
28 Madrid;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
28 Madrid;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;81,08
28 Madrid;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
28 Madrid;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
28 Madrid;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
28 Madrid;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;77,8
28 Madrid;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
28 Madrid;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
28 Madrid;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;74,12
28 Madrid;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
28 Madrid;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
28 Madrid;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
28 Madrid;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;75,87
28 Madrid;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
28 Madrid;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
28 Madrid;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
28 Madrid;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;73,52
28 Madrid;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
28 Madrid;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
28 Madrid;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
28 Madrid;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
28 Madrid;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
28 Madrid;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QII;26.195
28 Madrid;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
28 Madrid;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
28 Madrid;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
28 Madrid;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QII;25.504
28 Madrid;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
28 Madrid;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
28 Madrid;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
28 Madrid;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QII;23.364
28 Madrid;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
28 Madrid;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
28 Madrid;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
28 Madrid;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2022QII;24.246
28 Madrid;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2022QI;""
28 Madrid;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
28 Madrid;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
28 Madrid;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2021QII;23.375
28 Madrid;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2021QI;""
28 Madrid;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
28 Madrid;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
28 Madrid;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2020QII;22.358
28 Madrid;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2020QI;""
28 Madrid;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
28 Madrid;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2022QIII;22.633
28 Madrid;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2022QII;""
28 Madrid;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2022QI;""
28 Madrid;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
28 Madrid;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2021QIII;21.707
28 Madrid;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2021QII;""
28 Madrid;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2021QI;""
28 Madrid;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
28 Madrid;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2020QIII;21.026
28 Madrid;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2020QII;""
28 Madrid;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2020QI;""
28 Madrid;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QIV;21.155
28 Madrid;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
28 Madrid;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QII;""
28 Madrid;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QI;""
28 Madrid;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QIV;20.260
28 Madrid;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
28 Madrid;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QII;""
28 Madrid;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QI;""
28 Madrid;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QIV;19.809
28 Madrid;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
28 Madrid;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QII;""
28 Madrid;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QI;""
28 Madrid;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
28 Madrid;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
28 Madrid;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QII;""
28 Madrid;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QI;18.880
28 Madrid;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
28 Madrid;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
28 Madrid;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QII;""
28 Madrid;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QI;18.855
28 Madrid;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
28 Madrid;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
28 Madrid;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QII;""
28 Madrid;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QI;""
28 Madrid;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
28 Madrid;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
28 Madrid;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
28 Madrid;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
28 Madrid;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
28 Madrid;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
28 Madrid;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
28 Madrid;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
28 Madrid;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
28 Madrid;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
28 Madrid;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
28 Madrid;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
28 Madrid;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
28 Madrid;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
28 Madrid;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;92,56
28 Madrid;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
28 Madrid;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
28 Madrid;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
28 Madrid;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;91,65
28 Madrid;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
28 Madrid;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
28 Madrid;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
28 Madrid;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;95,69
28 Madrid;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
28 Madrid;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
28 Madrid;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;86,4
28 Madrid;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
28 Madrid;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
28 Madrid;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
28 Madrid;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;85,11
28 Madrid;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
28 Madrid;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
28 Madrid;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
28 Madrid;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;89,99
28 Madrid;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
28 Madrid;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
28 Madrid;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;80,76
28 Madrid;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
28 Madrid;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
28 Madrid;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
28 Madrid;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;79,44
28 Madrid;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
28 Madrid;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
28 Madrid;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
28 Madrid;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;84,78
28 Madrid;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
28 Madrid;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
28 Madrid;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
28 Madrid;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
28 Madrid;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
28 Madrid;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
28 Madrid;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;74,03
28 Madrid;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
28 Madrid;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
28 Madrid;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
28 Madrid;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;80,7
28 Madrid;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
28 Madrid;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
28 Madrid;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
28 Madrid;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
28 Madrid;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
28 Madrid;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
28 Madrid;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QII;15.808
28 Madrid;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
28 Madrid;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
28 Madrid;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
28 Madrid;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QII;15.834
28 Madrid;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
28 Madrid;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
28 Madrid;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
28 Madrid;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QII;14.651
28 Madrid;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
28 Madrid;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
28 Madrid;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
28 Madrid;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2022QII;14.692
28 Madrid;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2022QI;""
28 Madrid;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
28 Madrid;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
28 Madrid;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2021QII;14.523
28 Madrid;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2021QI;""
28 Madrid;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
28 Madrid;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
28 Madrid;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2020QII;14.031
28 Madrid;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2020QI;""
28 Madrid;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
28 Madrid;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2022QIII;13.747
28 Madrid;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2022QII;""
28 Madrid;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2022QI;""
28 Madrid;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
28 Madrid;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2021QIII;13.498
28 Madrid;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2021QII;""
28 Madrid;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2021QI;""
28 Madrid;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
28 Madrid;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2020QIII;13.254
28 Madrid;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2020QII;""
28 Madrid;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2020QI;""
28 Madrid;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QIV;12.885
28 Madrid;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
28 Madrid;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QII;""
28 Madrid;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QI;""
28 Madrid;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QIV;12.633
28 Madrid;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
28 Madrid;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QII;""
28 Madrid;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QI;""
28 Madrid;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QIV;12.488
28 Madrid;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
28 Madrid;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QII;""
28 Madrid;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QI;""
28 Madrid;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
28 Madrid;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
28 Madrid;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QII;""
28 Madrid;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QI;11.806
28 Madrid;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
28 Madrid;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
28 Madrid;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QII;""
28 Madrid;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QI;11.895
28 Madrid;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
28 Madrid;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
28 Madrid;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QII;""
28 Madrid;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QI;""
28 Madrid;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
28 Madrid;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
28 Madrid;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
28 Madrid;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
28 Madrid;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
28 Madrid;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
28 Madrid;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
28 Madrid;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
28 Madrid;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
28 Madrid;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
28 Madrid;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
28 Madrid;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
28 Madrid;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
28 Madrid;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
28 Madrid;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;92,94
28 Madrid;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
28 Madrid;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
28 Madrid;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
28 Madrid;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;91,72
28 Madrid;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
28 Madrid;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
28 Madrid;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
28 Madrid;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;95,77
28 Madrid;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
28 Madrid;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
28 Madrid;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;86,96
28 Madrid;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
28 Madrid;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
28 Madrid;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
28 Madrid;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;85,25
28 Madrid;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
28 Madrid;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
28 Madrid;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
28 Madrid;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;90,46
28 Madrid;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
28 Madrid;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
28 Madrid;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;81,51
28 Madrid;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
28 Madrid;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
28 Madrid;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
28 Madrid;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;79,78
28 Madrid;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
28 Madrid;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
28 Madrid;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
28 Madrid;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;85,24
28 Madrid;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
28 Madrid;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
28 Madrid;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
28 Madrid;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
28 Madrid;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
28 Madrid;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
28 Madrid;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;74,56
28 Madrid;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
28 Madrid;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
28 Madrid;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
28 Madrid;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;81,19
28 Madrid;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
28 Madrid;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
28 Madrid;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
28 Madrid;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
28 Madrid;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
28 Madrid;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
28 Madrid;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QII;10.387
28 Madrid;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
28 Madrid;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
28 Madrid;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
28 Madrid;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QII;9.670
28 Madrid;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
28 Madrid;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
28 Madrid;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
28 Madrid;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QII;8.713
28 Madrid;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
28 Madrid;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
28 Madrid;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
28 Madrid;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2022QII;9.554
28 Madrid;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2022QI;""
28 Madrid;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
28 Madrid;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
28 Madrid;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2021QII;8.852
28 Madrid;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2021QI;""
28 Madrid;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
28 Madrid;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
28 Madrid;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2020QII;8.327
28 Madrid;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2020QI;""
28 Madrid;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
28 Madrid;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2022QIII;8.886
28 Madrid;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2022QII;""
28 Madrid;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2022QI;""
28 Madrid;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
28 Madrid;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2021QIII;8.209
28 Madrid;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2021QII;""
28 Madrid;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2021QI;""
28 Madrid;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
28 Madrid;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2020QIII;7.772
28 Madrid;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2020QII;""
28 Madrid;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2020QI;""
28 Madrid;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QIV;8.270
28 Madrid;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
28 Madrid;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QII;""
28 Madrid;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QI;""
28 Madrid;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QIV;7.627
28 Madrid;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
28 Madrid;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QII;""
28 Madrid;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QI;""
28 Madrid;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QIV;7.321
28 Madrid;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
28 Madrid;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QII;""
28 Madrid;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QI;""
28 Madrid;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
28 Madrid;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
28 Madrid;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QII;""
28 Madrid;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QI;7.074
28 Madrid;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
28 Madrid;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
28 Madrid;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QII;""
28 Madrid;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QI;6.960
28 Madrid;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
28 Madrid;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
28 Madrid;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QII;""
28 Madrid;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QI;""
28 Madrid;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
28 Madrid;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
28 Madrid;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
28 Madrid;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
28 Madrid;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
28 Madrid;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
28 Madrid;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
28 Madrid;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
28 Madrid;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
28 Madrid;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
28 Madrid;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
28 Madrid;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
28 Madrid;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
28 Madrid;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
28 Madrid;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;91,98
28 Madrid;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
28 Madrid;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
28 Madrid;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
28 Madrid;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;91,54
28 Madrid;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
28 Madrid;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
28 Madrid;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
28 Madrid;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;95,57
28 Madrid;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
28 Madrid;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
28 Madrid;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;85,55
28 Madrid;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
28 Madrid;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
28 Madrid;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
28 Madrid;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;84,89
28 Madrid;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
28 Madrid;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
28 Madrid;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
28 Madrid;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;89,2
28 Madrid;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
28 Madrid;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
28 Madrid;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;79,62
28 Madrid;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
28 Madrid;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
28 Madrid;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
28 Madrid;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;78,87
28 Madrid;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
28 Madrid;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
28 Madrid;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
28 Madrid;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;84,02
28 Madrid;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
28 Madrid;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
28 Madrid;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
28 Madrid;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
28 Madrid;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
28 Madrid;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
28 Madrid;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;73,15
28 Madrid;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
28 Madrid;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
28 Madrid;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
28 Madrid;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;79,88
28 Madrid;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
28 Madrid;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
28 Madrid;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
28 Madrid;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
28 Madrid;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
28 Madrid;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QIII;27.510
28 Madrid;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
28 Madrid;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
28 Madrid;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
28 Madrid;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QIII;26.727
28 Madrid;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
28 Madrid;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
28 Madrid;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
28 Madrid;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QIII;24.348
28 Madrid;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
28 Madrid;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
28 Madrid;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
28 Madrid;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2022QIII;25.496
28 Madrid;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2022QII;""
28 Madrid;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2022QI;""
28 Madrid;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
28 Madrid;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2021QIII;24.615
28 Madrid;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2021QII;""
28 Madrid;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2021QI;""
28 Madrid;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
28 Madrid;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2020QIII;22.719
28 Madrid;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2020QII;""
28 Madrid;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2020QI;""
28 Madrid;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2022QIV;23.724
28 Madrid;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
28 Madrid;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2022QII;""
28 Madrid;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2022QI;""
28 Madrid;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2021QIV;22.874
28 Madrid;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
28 Madrid;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2021QII;""
28 Madrid;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2021QI;""
28 Madrid;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2020QIV;21.316
28 Madrid;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
28 Madrid;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2020QII;""
28 Madrid;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2020QI;""
28 Madrid;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
28 Madrid;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
28 Madrid;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QII;""
28 Madrid;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QI;21.260
28 Madrid;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
28 Madrid;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
28 Madrid;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QII;""
28 Madrid;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QI;20.250
28 Madrid;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
28 Madrid;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
28 Madrid;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QII;""
28 Madrid;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QI;""
28 Madrid;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
28 Madrid;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
28 Madrid;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QII;20.010
28 Madrid;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QI;""
28 Madrid;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
28 Madrid;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
28 Madrid;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QII;19.048
28 Madrid;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QI;""
28 Madrid;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
28 Madrid;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
28 Madrid;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QII;""
28 Madrid;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QI;""
28 Madrid;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
28 Madrid;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
28 Madrid;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
28 Madrid;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
28 Madrid;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
28 Madrid;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
28 Madrid;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
28 Madrid;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
28 Madrid;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
28 Madrid;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
28 Madrid;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
28 Madrid;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
28 Madrid;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
28 Madrid;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;92,68
28 Madrid;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
28 Madrid;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
28 Madrid;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
28 Madrid;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;92,1
28 Madrid;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
28 Madrid;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
28 Madrid;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
28 Madrid;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;93,31
28 Madrid;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
28 Madrid;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
28 Madrid;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;86,24
28 Madrid;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
28 Madrid;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
28 Madrid;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
28 Madrid;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;85,58
28 Madrid;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
28 Madrid;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
28 Madrid;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
28 Madrid;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;87,55
28 Madrid;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
28 Madrid;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
28 Madrid;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
28 Madrid;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
28 Madrid;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
28 Madrid;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
28 Madrid;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;79,55
28 Madrid;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
28 Madrid;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
28 Madrid;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
28 Madrid;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;83,17
28 Madrid;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
28 Madrid;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
28 Madrid;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
28 Madrid;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
28 Madrid;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
28 Madrid;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
28 Madrid;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;74,87
28 Madrid;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
28 Madrid;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
28 Madrid;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
28 Madrid;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;78,23
28 Madrid;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
28 Madrid;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
28 Madrid;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
28 Madrid;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
28 Madrid;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
28 Madrid;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
28 Madrid;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QIII;16.634
28 Madrid;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
28 Madrid;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
28 Madrid;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
28 Madrid;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QIII;16.407
28 Madrid;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
28 Madrid;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
28 Madrid;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
28 Madrid;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QIII;15.289
28 Madrid;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
28 Madrid;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
28 Madrid;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
28 Madrid;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2022QIII;15.450
28 Madrid;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2022QII;""
28 Madrid;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2022QI;""
28 Madrid;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
28 Madrid;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2021QIII;15.106
28 Madrid;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2021QII;""
28 Madrid;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2021QI;""
28 Madrid;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
28 Madrid;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2020QIII;14.318
28 Madrid;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2020QII;""
28 Madrid;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2020QI;""
28 Madrid;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2022QIV;14.434
28 Madrid;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
28 Madrid;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2022QII;""
28 Madrid;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2022QI;""
28 Madrid;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2021QIV;14.083
28 Madrid;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
28 Madrid;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2021QII;""
28 Madrid;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2021QI;""
28 Madrid;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2020QIV;13.431
28 Madrid;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
28 Madrid;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2020QII;""
28 Madrid;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2020QI;""
28 Madrid;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
28 Madrid;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
28 Madrid;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QII;""
28 Madrid;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QI;13.124
28 Madrid;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
28 Madrid;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
28 Madrid;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QII;""
28 Madrid;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QI;12.764
28 Madrid;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
28 Madrid;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
28 Madrid;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QII;""
28 Madrid;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QI;""
28 Madrid;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
28 Madrid;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
28 Madrid;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QII;12.394
28 Madrid;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QI;""
28 Madrid;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
28 Madrid;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
28 Madrid;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QII;12.029
28 Madrid;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QI;""
28 Madrid;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
28 Madrid;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
28 Madrid;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QII;""
28 Madrid;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QI;""
28 Madrid;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
28 Madrid;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
28 Madrid;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
28 Madrid;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
28 Madrid;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
28 Madrid;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
28 Madrid;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
28 Madrid;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
28 Madrid;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
28 Madrid;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
28 Madrid;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
28 Madrid;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
28 Madrid;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
28 Madrid;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;92,88
28 Madrid;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
28 Madrid;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
28 Madrid;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
28 Madrid;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;92,07
28 Madrid;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
28 Madrid;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
28 Madrid;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
28 Madrid;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;93,65
28 Madrid;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
28 Madrid;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
28 Madrid;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;86,77
28 Madrid;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
28 Madrid;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
28 Madrid;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
28 Madrid;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;85,84
28 Madrid;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
28 Madrid;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
28 Madrid;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
28 Madrid;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;87,85
28 Madrid;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
28 Madrid;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
28 Madrid;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
28 Madrid;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
28 Madrid;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
28 Madrid;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
28 Madrid;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;79,99
28 Madrid;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
28 Madrid;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
28 Madrid;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
28 Madrid;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;83,48
28 Madrid;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
28 Madrid;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
28 Madrid;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
28 Madrid;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
28 Madrid;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
28 Madrid;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
28 Madrid;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;75,54
28 Madrid;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
28 Madrid;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
28 Madrid;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
28 Madrid;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;78,68
28 Madrid;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
28 Madrid;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
28 Madrid;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
28 Madrid;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
28 Madrid;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
28 Madrid;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
28 Madrid;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QIII;10.876
28 Madrid;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
28 Madrid;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
28 Madrid;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
28 Madrid;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QIII;10.320
28 Madrid;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
28 Madrid;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
28 Madrid;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
28 Madrid;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QIII;9.059
28 Madrid;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
28 Madrid;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
28 Madrid;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
28 Madrid;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2022QIII;10.046
28 Madrid;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2022QII;""
28 Madrid;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2022QI;""
28 Madrid;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
28 Madrid;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2021QIII;9.509
28 Madrid;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2021QII;""
28 Madrid;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2021QI;""
28 Madrid;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
28 Madrid;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2020QIII;8.401
28 Madrid;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2020QII;""
28 Madrid;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2020QI;""
28 Madrid;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2022QIV;9.290
28 Madrid;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
28 Madrid;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2022QII;""
28 Madrid;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2022QI;""
28 Madrid;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2021QIV;8.791
28 Madrid;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
28 Madrid;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2021QII;""
28 Madrid;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2021QI;""
28 Madrid;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2020QIV;7.885
28 Madrid;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
28 Madrid;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2020QII;""
28 Madrid;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2020QI;""
28 Madrid;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
28 Madrid;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
28 Madrid;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QII;""
28 Madrid;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QI;8.136
28 Madrid;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
28 Madrid;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
28 Madrid;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QII;""
28 Madrid;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QI;7.486
28 Madrid;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
28 Madrid;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
28 Madrid;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QII;""
28 Madrid;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QI;""
28 Madrid;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
28 Madrid;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
28 Madrid;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QII;7.616
28 Madrid;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QI;""
28 Madrid;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
28 Madrid;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
28 Madrid;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QII;7.019
28 Madrid;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QI;""
28 Madrid;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
28 Madrid;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
28 Madrid;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QII;""
28 Madrid;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QI;""
28 Madrid;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
28 Madrid;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
28 Madrid;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
28 Madrid;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
28 Madrid;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
28 Madrid;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
28 Madrid;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
28 Madrid;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
28 Madrid;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
28 Madrid;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
28 Madrid;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
28 Madrid;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
28 Madrid;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
28 Madrid;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;92,37
28 Madrid;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
28 Madrid;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
28 Madrid;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
28 Madrid;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;92,14
28 Madrid;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
28 Madrid;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
28 Madrid;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
28 Madrid;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;92,74
28 Madrid;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
28 Madrid;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
28 Madrid;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;85,42
28 Madrid;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
28 Madrid;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
28 Madrid;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
28 Madrid;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;85,18
28 Madrid;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
28 Madrid;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
28 Madrid;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
28 Madrid;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;87,04
28 Madrid;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
28 Madrid;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
28 Madrid;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
28 Madrid;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
28 Madrid;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
28 Madrid;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
28 Madrid;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;78,84
28 Madrid;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
28 Madrid;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
28 Madrid;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
28 Madrid;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;82,64
28 Madrid;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
28 Madrid;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
28 Madrid;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
28 Madrid;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
28 Madrid;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
28 Madrid;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
28 Madrid;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;73,8
28 Madrid;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
28 Madrid;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
28 Madrid;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
28 Madrid;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;77,48
28 Madrid;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
28 Madrid;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
28 Madrid;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
28 Madrid;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
28 Madrid;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
28 Madrid;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QIV;28.422
28 Madrid;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
28 Madrid;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
28 Madrid;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
28 Madrid;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QIV;27.593
28 Madrid;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
28 Madrid;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
28 Madrid;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
28 Madrid;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QIV;25.704
28 Madrid;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
28 Madrid;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
28 Madrid;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
28 Madrid;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2022QIV;26.352
28 Madrid;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
28 Madrid;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2022QII;""
28 Madrid;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2022QI;""
28 Madrid;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2021QIV;25.541
28 Madrid;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
28 Madrid;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2021QII;""
28 Madrid;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2021QI;""
28 Madrid;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2020QIV;23.911
28 Madrid;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
28 Madrid;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2020QII;""
28 Madrid;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2020QI;""
28 Madrid;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
28 Madrid;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
28 Madrid;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2022QII;""
28 Madrid;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2022QI;23.661
28 Madrid;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
28 Madrid;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
28 Madrid;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2021QII;""
28 Madrid;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2021QI;22.597
28 Madrid;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
28 Madrid;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
28 Madrid;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2020QII;""
28 Madrid;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2020QI;""
28 Madrid;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
28 Madrid;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
28 Madrid;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QII;22.181
28 Madrid;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QI;""
28 Madrid;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
28 Madrid;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
28 Madrid;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QII;21.116
28 Madrid;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QI;""
28 Madrid;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
28 Madrid;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
28 Madrid;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QII;""
28 Madrid;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QI;""
28 Madrid;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
28 Madrid;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QIII;20.897
28 Madrid;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QII;""
28 Madrid;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QI;""
28 Madrid;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
28 Madrid;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QIII;19.848
28 Madrid;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QII;""
28 Madrid;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QI;""
28 Madrid;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
28 Madrid;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
28 Madrid;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QII;""
28 Madrid;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QI;""
28 Madrid;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
28 Madrid;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
28 Madrid;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
28 Madrid;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
28 Madrid;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
28 Madrid;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
28 Madrid;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
28 Madrid;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
28 Madrid;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
28 Madrid;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
28 Madrid;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
28 Madrid;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
28 Madrid;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;92,72
28 Madrid;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
28 Madrid;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
28 Madrid;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
28 Madrid;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;92,56
28 Madrid;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
28 Madrid;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
28 Madrid;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
28 Madrid;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;93,02
28 Madrid;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
28 Madrid;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
28 Madrid;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
28 Madrid;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
28 Madrid;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
28 Madrid;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
28 Madrid;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;85,75
28 Madrid;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
28 Madrid;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
28 Madrid;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
28 Madrid;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;87,91
28 Madrid;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
28 Madrid;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
28 Madrid;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
28 Madrid;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
28 Madrid;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
28 Madrid;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
28 Madrid;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;80,39
28 Madrid;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
28 Madrid;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
28 Madrid;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
28 Madrid;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;82,15
28 Madrid;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
28 Madrid;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
28 Madrid;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
28 Madrid;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
28 Madrid;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
28 Madrid;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
28 Madrid;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;75,73
28 Madrid;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
28 Madrid;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
28 Madrid;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
28 Madrid;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;77,22
28 Madrid;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
28 Madrid;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
28 Madrid;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
28 Madrid;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
28 Madrid;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
28 Madrid;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
28 Madrid;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QIV;17.175
28 Madrid;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
28 Madrid;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
28 Madrid;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
28 Madrid;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QIV;16.766
28 Madrid;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
28 Madrid;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
28 Madrid;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
28 Madrid;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QIV;16.137
28 Madrid;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
28 Madrid;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
28 Madrid;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
28 Madrid;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2022QIV;15.982
28 Madrid;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
28 Madrid;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2022QII;""
28 Madrid;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2022QI;""
28 Madrid;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2021QIV;15.570
28 Madrid;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
28 Madrid;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2021QII;""
28 Madrid;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2021QI;""
28 Madrid;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2020QIV;15.003
28 Madrid;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
28 Madrid;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2020QII;""
28 Madrid;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2020QI;""
28 Madrid;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
28 Madrid;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
28 Madrid;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2022QII;""
28 Madrid;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2022QI;14.464
28 Madrid;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
28 Madrid;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
28 Madrid;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2021QII;""
28 Madrid;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2021QI;14.181
28 Madrid;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
28 Madrid;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
28 Madrid;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2020QII;""
28 Madrid;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2020QI;""
28 Madrid;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
28 Madrid;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
28 Madrid;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QII;13.602
28 Madrid;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QI;""
28 Madrid;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
28 Madrid;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
28 Madrid;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QII;13.276
28 Madrid;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QI;""
28 Madrid;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
28 Madrid;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
28 Madrid;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QII;""
28 Madrid;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QI;""
28 Madrid;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
28 Madrid;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QIII;12.858
28 Madrid;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QII;""
28 Madrid;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QI;""
28 Madrid;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
28 Madrid;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QIII;12.490
28 Madrid;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QII;""
28 Madrid;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QI;""
28 Madrid;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
28 Madrid;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
28 Madrid;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QII;""
28 Madrid;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QI;""
28 Madrid;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
28 Madrid;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
28 Madrid;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
28 Madrid;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
28 Madrid;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
28 Madrid;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
28 Madrid;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
28 Madrid;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
28 Madrid;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
28 Madrid;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
28 Madrid;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
28 Madrid;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
28 Madrid;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;93,05
28 Madrid;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
28 Madrid;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
28 Madrid;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
28 Madrid;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;92,87
28 Madrid;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
28 Madrid;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
28 Madrid;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
28 Madrid;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;92,97
28 Madrid;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
28 Madrid;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
28 Madrid;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
28 Madrid;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
28 Madrid;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
28 Madrid;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
28 Madrid;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;86,27
28 Madrid;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
28 Madrid;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
28 Madrid;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
28 Madrid;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;87,88
28 Madrid;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
28 Madrid;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
28 Madrid;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
28 Madrid;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
28 Madrid;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
28 Madrid;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
28 Madrid;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;81,13
28 Madrid;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
28 Madrid;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
28 Madrid;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
28 Madrid;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;82,27
28 Madrid;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
28 Madrid;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
28 Madrid;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
28 Madrid;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
28 Madrid;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
28 Madrid;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
28 Madrid;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;76,69
28 Madrid;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
28 Madrid;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
28 Madrid;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
28 Madrid;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;77,4
28 Madrid;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
28 Madrid;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
28 Madrid;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
28 Madrid;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
28 Madrid;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
28 Madrid;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
28 Madrid;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QIV;11.247
28 Madrid;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
28 Madrid;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
28 Madrid;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
28 Madrid;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QIV;10.827
28 Madrid;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
28 Madrid;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
28 Madrid;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
28 Madrid;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QIV;9.567
28 Madrid;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
28 Madrid;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
28 Madrid;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
28 Madrid;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2022QIV;10.370
28 Madrid;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
28 Madrid;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2022QII;""
28 Madrid;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2022QI;""
28 Madrid;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2021QIV;9.971
28 Madrid;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
28 Madrid;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2021QII;""
28 Madrid;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2021QI;""
28 Madrid;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2020QIV;8.908
28 Madrid;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
28 Madrid;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2020QII;""
28 Madrid;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2020QI;""
28 Madrid;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
28 Madrid;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
28 Madrid;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2022QII;""
28 Madrid;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2022QI;9.197
28 Madrid;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
28 Madrid;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
28 Madrid;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2021QII;""
28 Madrid;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2021QI;8.416
28 Madrid;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
28 Madrid;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
28 Madrid;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2020QII;""
28 Madrid;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2020QI;""
28 Madrid;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
28 Madrid;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
28 Madrid;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QII;8.579
28 Madrid;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QI;""
28 Madrid;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
28 Madrid;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
28 Madrid;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QII;7.840
28 Madrid;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QI;""
28 Madrid;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
28 Madrid;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
28 Madrid;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QII;""
28 Madrid;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QI;""
28 Madrid;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
28 Madrid;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QIII;8.039
28 Madrid;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QII;""
28 Madrid;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QI;""
28 Madrid;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
28 Madrid;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QIII;7.358
28 Madrid;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QII;""
28 Madrid;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QI;""
28 Madrid;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
28 Madrid;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
28 Madrid;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QII;""
28 Madrid;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QI;""
28 Madrid;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
28 Madrid;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
28 Madrid;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
28 Madrid;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
28 Madrid;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
28 Madrid;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
28 Madrid;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
28 Madrid;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
28 Madrid;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
28 Madrid;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
28 Madrid;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
28 Madrid;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
28 Madrid;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;92,2
28 Madrid;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
28 Madrid;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
28 Madrid;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
28 Madrid;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;92,09
28 Madrid;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
28 Madrid;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
28 Madrid;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
28 Madrid;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;93,11
28 Madrid;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
28 Madrid;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
28 Madrid;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
28 Madrid;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
28 Madrid;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
28 Madrid;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
28 Madrid;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;84,95
28 Madrid;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
28 Madrid;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
28 Madrid;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
28 Madrid;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;87,97
28 Madrid;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
28 Madrid;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
28 Madrid;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
28 Madrid;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
28 Madrid;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
28 Madrid;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
28 Madrid;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;79,24
28 Madrid;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
28 Madrid;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
28 Madrid;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
28 Madrid;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;81,95
28 Madrid;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
28 Madrid;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
28 Madrid;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
28 Madrid;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
28 Madrid;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
28 Madrid;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
28 Madrid;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;74,25
28 Madrid;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
28 Madrid;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
28 Madrid;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
28 Madrid;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;76,91
28 Madrid;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
28 Madrid;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
28 Madrid;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
28 Madrid;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
28 Madrid;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
28 Madrid;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
28 Madrid;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
28 Madrid;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
28 Madrid;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
28 Madrid;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QI;84.410
28 Madrid;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
28 Madrid;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
28 Madrid;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
28 Madrid;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QI;84.529
28 Madrid;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
28 Madrid;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
28 Madrid;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
28 Madrid;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QI;82.900
28 Madrid;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
28 Madrid;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
28 Madrid;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2022QII;""
28 Madrid;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2022QI;80.528
28 Madrid;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
28 Madrid;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
28 Madrid;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2021QII;""
28 Madrid;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2021QI;81.250
28 Madrid;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
28 Madrid;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
28 Madrid;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2020QII;""
28 Madrid;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2020QI;75.858
28 Madrid;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
28 Madrid;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
28 Madrid;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2022QII;76.897
28 Madrid;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2022QI;""
28 Madrid;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
28 Madrid;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
28 Madrid;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2021QII;77.920
28 Madrid;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2021QI;""
28 Madrid;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
28 Madrid;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
28 Madrid;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2020QII;73.759
28 Madrid;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2020QI;""
28 Madrid;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
28 Madrid;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QIII;74.016
28 Madrid;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QII;""
28 Madrid;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QI;""
28 Madrid;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
28 Madrid;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QIII;75.173
28 Madrid;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QII;""
28 Madrid;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QI;""
28 Madrid;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
28 Madrid;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QIII;71.113
28 Madrid;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QII;""
28 Madrid;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QI;""
28 Madrid;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QIV;71.162
28 Madrid;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
28 Madrid;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QII;""
28 Madrid;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QI;""
28 Madrid;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QIV;72.348
28 Madrid;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
28 Madrid;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QII;""
28 Madrid;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QI;""
28 Madrid;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QIV;68.502
28 Madrid;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
28 Madrid;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QII;""
28 Madrid;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QI;""
28 Madrid;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
28 Madrid;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
28 Madrid;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
28 Madrid;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
28 Madrid;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
28 Madrid;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
28 Madrid;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
28 Madrid;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
28 Madrid;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
28 Madrid;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
28 Madrid;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
28 Madrid;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
28 Madrid;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
28 Madrid;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
28 Madrid;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
28 Madrid;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;95,4
28 Madrid;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
28 Madrid;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
28 Madrid;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
28 Madrid;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;96,12
28 Madrid;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
28 Madrid;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
28 Madrid;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
28 Madrid;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;91,51
28 Madrid;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
28 Madrid;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
28 Madrid;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;91,1
28 Madrid;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
28 Madrid;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
28 Madrid;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
28 Madrid;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;92,18
28 Madrid;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
28 Madrid;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
28 Madrid;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
28 Madrid;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;88,97
28 Madrid;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
28 Madrid;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
28 Madrid;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;87,69
28 Madrid;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
28 Madrid;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
28 Madrid;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
28 Madrid;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;88,93
28 Madrid;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
28 Madrid;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
28 Madrid;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
28 Madrid;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;85,78
28 Madrid;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
28 Madrid;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
28 Madrid;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;84,31
28 Madrid;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
28 Madrid;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
28 Madrid;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
28 Madrid;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;85,59
28 Madrid;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
28 Madrid;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
28 Madrid;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
28 Madrid;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;82,63
28 Madrid;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
28 Madrid;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
28 Madrid;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
28 Madrid;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
28 Madrid;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
28 Madrid;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
28 Madrid;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QI;50.877
28 Madrid;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
28 Madrid;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
28 Madrid;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
28 Madrid;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QI;51.754
28 Madrid;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
28 Madrid;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
28 Madrid;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
28 Madrid;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QI;50.413
28 Madrid;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
28 Madrid;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
28 Madrid;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2022QII;""
28 Madrid;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2022QI;48.653
28 Madrid;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
28 Madrid;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
28 Madrid;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2021QII;""
28 Madrid;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2021QI;49.755
28 Madrid;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
28 Madrid;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
28 Madrid;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2020QII;""
28 Madrid;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2020QI;46.421
28 Madrid;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
28 Madrid;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
28 Madrid;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2022QII;46.593
28 Madrid;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2022QI;""
28 Madrid;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
28 Madrid;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
28 Madrid;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2021QII;47.776
28 Madrid;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2021QI;""
28 Madrid;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
28 Madrid;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
28 Madrid;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2020QII;45.254
28 Madrid;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2020QI;""
28 Madrid;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
28 Madrid;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QIII;44.946
28 Madrid;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QII;""
28 Madrid;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QI;""
28 Madrid;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
28 Madrid;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QIII;46.094
28 Madrid;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QII;""
28 Madrid;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QI;""
28 Madrid;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
28 Madrid;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QIII;43.755
28 Madrid;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QII;""
28 Madrid;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QI;""
28 Madrid;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QIV;43.369
28 Madrid;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
28 Madrid;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QII;""
28 Madrid;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QI;""
28 Madrid;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QIV;44.378
28 Madrid;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
28 Madrid;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QII;""
28 Madrid;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QI;""
28 Madrid;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QIV;42.230
28 Madrid;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
28 Madrid;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QII;""
28 Madrid;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QI;""
28 Madrid;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
28 Madrid;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
28 Madrid;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
28 Madrid;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
28 Madrid;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
28 Madrid;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
28 Madrid;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
28 Madrid;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
28 Madrid;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
28 Madrid;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
28 Madrid;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
28 Madrid;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
28 Madrid;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
28 Madrid;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
28 Madrid;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
28 Madrid;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;95,63
28 Madrid;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
28 Madrid;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
28 Madrid;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
28 Madrid;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;96,14
28 Madrid;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
28 Madrid;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
28 Madrid;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
28 Madrid;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;92,08
28 Madrid;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
28 Madrid;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
28 Madrid;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;91,58
28 Madrid;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
28 Madrid;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
28 Madrid;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
28 Madrid;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;92,31
28 Madrid;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
28 Madrid;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
28 Madrid;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
28 Madrid;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;89,77
28 Madrid;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
28 Madrid;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
28 Madrid;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;88,34
28 Madrid;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
28 Madrid;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
28 Madrid;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
28 Madrid;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;89,06
28 Madrid;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
28 Madrid;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
28 Madrid;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
28 Madrid;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;86,79
28 Madrid;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
28 Madrid;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
28 Madrid;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;85,24
28 Madrid;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
28 Madrid;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
28 Madrid;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
28 Madrid;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;85,75
28 Madrid;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
28 Madrid;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
28 Madrid;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
28 Madrid;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;83,77
28 Madrid;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
28 Madrid;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
28 Madrid;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
28 Madrid;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
28 Madrid;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
28 Madrid;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
28 Madrid;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QI;33.533
28 Madrid;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
28 Madrid;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
28 Madrid;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
28 Madrid;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QI;32.775
28 Madrid;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
28 Madrid;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
28 Madrid;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
28 Madrid;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QI;32.487
28 Madrid;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
28 Madrid;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
28 Madrid;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2022QII;""
28 Madrid;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2022QI;31.875
28 Madrid;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
28 Madrid;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
28 Madrid;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2021QII;""
28 Madrid;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2021QI;31.495
28 Madrid;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
28 Madrid;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
28 Madrid;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2020QII;""
28 Madrid;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2020QI;29.437
28 Madrid;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
28 Madrid;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
28 Madrid;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2022QII;30.304
28 Madrid;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2022QI;""
28 Madrid;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
28 Madrid;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
28 Madrid;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2021QII;30.144
28 Madrid;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2021QI;""
28 Madrid;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
28 Madrid;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
28 Madrid;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2020QII;28.505
28 Madrid;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2020QI;""
28 Madrid;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
28 Madrid;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QIII;29.070
28 Madrid;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QII;""
28 Madrid;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QI;""
28 Madrid;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
28 Madrid;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QIII;29.079
28 Madrid;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QII;""
28 Madrid;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QI;""
28 Madrid;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
28 Madrid;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QIII;27.358
28 Madrid;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QII;""
28 Madrid;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QI;""
28 Madrid;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QIV;27.793
28 Madrid;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
28 Madrid;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QII;""
28 Madrid;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QI;""
28 Madrid;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QIV;27.970
28 Madrid;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
28 Madrid;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QII;""
28 Madrid;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QI;""
28 Madrid;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QIV;26.272
28 Madrid;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
28 Madrid;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QII;""
28 Madrid;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QI;""
28 Madrid;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
28 Madrid;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
28 Madrid;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
28 Madrid;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
28 Madrid;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
28 Madrid;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
28 Madrid;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
28 Madrid;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
28 Madrid;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
28 Madrid;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
28 Madrid;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
28 Madrid;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
28 Madrid;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
28 Madrid;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
28 Madrid;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
28 Madrid;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;95,06
28 Madrid;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
28 Madrid;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
28 Madrid;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
28 Madrid;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;96,09
28 Madrid;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
28 Madrid;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
28 Madrid;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
28 Madrid;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;90,61
28 Madrid;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
28 Madrid;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
28 Madrid;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;90,37
28 Madrid;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
28 Madrid;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
28 Madrid;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
28 Madrid;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;91,97
28 Madrid;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
28 Madrid;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
28 Madrid;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
28 Madrid;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;87,74
28 Madrid;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
28 Madrid;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
28 Madrid;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;86,69
28 Madrid;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
28 Madrid;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
28 Madrid;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
28 Madrid;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;88,72
28 Madrid;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
28 Madrid;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
28 Madrid;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
28 Madrid;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;84,21
28 Madrid;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
28 Madrid;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
28 Madrid;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;82,88
28 Madrid;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
28 Madrid;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
28 Madrid;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
28 Madrid;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;85,34
28 Madrid;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
28 Madrid;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
28 Madrid;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
28 Madrid;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;80,87
28 Madrid;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
28 Madrid;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
28 Madrid;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
28 Madrid;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
28 Madrid;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
28 Madrid;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QII;80.768
28 Madrid;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
28 Madrid;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
28 Madrid;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
28 Madrid;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QII;81.165
28 Madrid;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
28 Madrid;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
28 Madrid;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
28 Madrid;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QII;81.057
28 Madrid;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
28 Madrid;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
28 Madrid;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
28 Madrid;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2022QII;76.753
28 Madrid;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2022QI;""
28 Madrid;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
28 Madrid;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
28 Madrid;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2021QII;77.344
28 Madrid;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2021QI;""
28 Madrid;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
28 Madrid;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
28 Madrid;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2020QII;78.636
28 Madrid;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2020QI;""
28 Madrid;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
28 Madrid;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2022QIII;73.600
28 Madrid;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2022QII;""
28 Madrid;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2022QI;""
28 Madrid;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
28 Madrid;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2021QIII;74.281
28 Madrid;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2021QII;""
28 Madrid;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2021QI;""
28 Madrid;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
28 Madrid;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2020QIII;75.632
28 Madrid;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2020QII;""
28 Madrid;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2020QI;""
28 Madrid;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QIV;70.536
28 Madrid;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
28 Madrid;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QII;""
28 Madrid;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QI;""
28 Madrid;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QIV;71.253
28 Madrid;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
28 Madrid;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QII;""
28 Madrid;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QI;""
28 Madrid;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QIV;72.692
28 Madrid;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
28 Madrid;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QII;""
28 Madrid;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QI;""
28 Madrid;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
28 Madrid;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
28 Madrid;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QII;""
28 Madrid;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QI;68.478
28 Madrid;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
28 Madrid;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
28 Madrid;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QII;""
28 Madrid;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QI;70.439
28 Madrid;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
28 Madrid;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
28 Madrid;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QII;""
28 Madrid;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QI;""
28 Madrid;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
28 Madrid;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
28 Madrid;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
28 Madrid;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
28 Madrid;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
28 Madrid;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
28 Madrid;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
28 Madrid;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
28 Madrid;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
28 Madrid;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
28 Madrid;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
28 Madrid;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
28 Madrid;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
28 Madrid;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
28 Madrid;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;95,03
28 Madrid;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
28 Madrid;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
28 Madrid;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
28 Madrid;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;95,29
28 Madrid;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
28 Madrid;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
28 Madrid;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
28 Madrid;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;97,01
28 Madrid;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
28 Madrid;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
28 Madrid;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;91,13
28 Madrid;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
28 Madrid;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
28 Madrid;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
28 Madrid;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;91,52
28 Madrid;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
28 Madrid;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
28 Madrid;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
28 Madrid;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;93,31
28 Madrid;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
28 Madrid;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
28 Madrid;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;87,33
28 Madrid;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
28 Madrid;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
28 Madrid;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
28 Madrid;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;87,79
28 Madrid;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
28 Madrid;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
28 Madrid;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
28 Madrid;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;89,68
28 Madrid;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
28 Madrid;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
28 Madrid;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
28 Madrid;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
28 Madrid;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
28 Madrid;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
28 Madrid;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;84,37
28 Madrid;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
28 Madrid;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
28 Madrid;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
28 Madrid;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;86,9
28 Madrid;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
28 Madrid;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
28 Madrid;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
28 Madrid;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
28 Madrid;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
28 Madrid;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
28 Madrid;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QII;48.422
28 Madrid;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
28 Madrid;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
28 Madrid;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
28 Madrid;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QII;49.469
28 Madrid;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
28 Madrid;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
28 Madrid;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
28 Madrid;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QII;49.434
28 Madrid;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
28 Madrid;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
28 Madrid;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
28 Madrid;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2022QII;46.142
28 Madrid;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2022QI;""
28 Madrid;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
28 Madrid;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
28 Madrid;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2021QII;47.176
28 Madrid;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2021QI;""
28 Madrid;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
28 Madrid;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
28 Madrid;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2020QII;48.062
28 Madrid;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2020QI;""
28 Madrid;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
28 Madrid;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2022QIII;44.342
28 Madrid;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2022QII;""
28 Madrid;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2022QI;""
28 Madrid;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
28 Madrid;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2021QIII;45.295
28 Madrid;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2021QII;""
28 Madrid;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2021QI;""
28 Madrid;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
28 Madrid;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2020QIII;46.355
28 Madrid;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2020QII;""
28 Madrid;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2020QI;""
28 Madrid;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QIV;42.622
28 Madrid;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
28 Madrid;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QII;""
28 Madrid;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QI;""
28 Madrid;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QIV;43.452
28 Madrid;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
28 Madrid;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QII;""
28 Madrid;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QI;""
28 Madrid;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QIV;44.641
28 Madrid;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
28 Madrid;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QII;""
28 Madrid;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QI;""
28 Madrid;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
28 Madrid;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
28 Madrid;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QII;""
28 Madrid;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QI;41.875
28 Madrid;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
28 Madrid;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
28 Madrid;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QII;""
28 Madrid;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QI;43.301
28 Madrid;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
28 Madrid;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
28 Madrid;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QII;""
28 Madrid;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QI;""
28 Madrid;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
28 Madrid;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
28 Madrid;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
28 Madrid;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
28 Madrid;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
28 Madrid;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
28 Madrid;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
28 Madrid;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
28 Madrid;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
28 Madrid;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
28 Madrid;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
28 Madrid;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
28 Madrid;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
28 Madrid;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
28 Madrid;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;95,29
28 Madrid;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
28 Madrid;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
28 Madrid;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
28 Madrid;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;95,36
28 Madrid;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
28 Madrid;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
28 Madrid;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
28 Madrid;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;97,22
28 Madrid;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
28 Madrid;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
28 Madrid;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;91,57
28 Madrid;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
28 Madrid;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
28 Madrid;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
28 Madrid;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;91,56
28 Madrid;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
28 Madrid;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
28 Madrid;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
28 Madrid;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;93,77
28 Madrid;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
28 Madrid;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
28 Madrid;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;88,02
28 Madrid;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
28 Madrid;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
28 Madrid;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
28 Madrid;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;87,84
28 Madrid;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
28 Madrid;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
28 Madrid;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
28 Madrid;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;90,3
28 Madrid;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
28 Madrid;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
28 Madrid;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
28 Madrid;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
28 Madrid;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
28 Madrid;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
28 Madrid;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;84,65
28 Madrid;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
28 Madrid;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
28 Madrid;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
28 Madrid;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;87,59
28 Madrid;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
28 Madrid;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
28 Madrid;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
28 Madrid;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
28 Madrid;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
28 Madrid;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
28 Madrid;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QII;32.346
28 Madrid;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
28 Madrid;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
28 Madrid;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
28 Madrid;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QII;31.696
28 Madrid;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
28 Madrid;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
28 Madrid;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
28 Madrid;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QII;31.623
28 Madrid;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
28 Madrid;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
28 Madrid;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
28 Madrid;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2022QII;30.611
28 Madrid;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2022QI;""
28 Madrid;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
28 Madrid;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
28 Madrid;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2021QII;30.168
28 Madrid;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2021QI;""
28 Madrid;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
28 Madrid;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
28 Madrid;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2020QII;30.574
28 Madrid;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2020QI;""
28 Madrid;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
28 Madrid;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2022QIII;29.258
28 Madrid;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2022QII;""
28 Madrid;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2022QI;""
28 Madrid;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
28 Madrid;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2021QIII;28.986
28 Madrid;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2021QII;""
28 Madrid;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2021QI;""
28 Madrid;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
28 Madrid;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2020QIII;29.277
28 Madrid;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2020QII;""
28 Madrid;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2020QI;""
28 Madrid;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QIV;27.914
28 Madrid;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
28 Madrid;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QII;""
28 Madrid;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QI;""
28 Madrid;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QIV;27.801
28 Madrid;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
28 Madrid;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QII;""
28 Madrid;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QI;""
28 Madrid;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QIV;28.051
28 Madrid;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
28 Madrid;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QII;""
28 Madrid;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QI;""
28 Madrid;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
28 Madrid;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
28 Madrid;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QII;""
28 Madrid;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QI;26.603
28 Madrid;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
28 Madrid;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
28 Madrid;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QII;""
28 Madrid;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QI;27.138
28 Madrid;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
28 Madrid;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
28 Madrid;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QII;""
28 Madrid;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QI;""
28 Madrid;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
28 Madrid;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
28 Madrid;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
28 Madrid;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
28 Madrid;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
28 Madrid;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
28 Madrid;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
28 Madrid;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
28 Madrid;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
28 Madrid;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
28 Madrid;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
28 Madrid;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
28 Madrid;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
28 Madrid;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
28 Madrid;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;94,64
28 Madrid;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
28 Madrid;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
28 Madrid;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
28 Madrid;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;95,18
28 Madrid;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
28 Madrid;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
28 Madrid;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
28 Madrid;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;96,68
28 Madrid;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
28 Madrid;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
28 Madrid;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;90,45
28 Madrid;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
28 Madrid;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
28 Madrid;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
28 Madrid;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;91,45
28 Madrid;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
28 Madrid;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
28 Madrid;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
28 Madrid;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;92,58
28 Madrid;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
28 Madrid;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
28 Madrid;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;86,3
28 Madrid;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
28 Madrid;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
28 Madrid;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
28 Madrid;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;87,71
28 Madrid;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
28 Madrid;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
28 Madrid;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
28 Madrid;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;88,7
28 Madrid;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
28 Madrid;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
28 Madrid;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
28 Madrid;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
28 Madrid;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
28 Madrid;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
28 Madrid;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;83,93
28 Madrid;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
28 Madrid;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
28 Madrid;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
28 Madrid;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;85,82
28 Madrid;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
28 Madrid;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
28 Madrid;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
28 Madrid;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
28 Madrid;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
28 Madrid;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QIII;81.413
28 Madrid;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
28 Madrid;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
28 Madrid;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
28 Madrid;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QIII;82.518
28 Madrid;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
28 Madrid;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
28 Madrid;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
28 Madrid;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QIII;82.163
28 Madrid;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
28 Madrid;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
28 Madrid;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
28 Madrid;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2022QIII;77.804
28 Madrid;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2022QII;""
28 Madrid;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2022QI;""
28 Madrid;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
28 Madrid;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2021QIII;78.936
28 Madrid;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2021QII;""
28 Madrid;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2021QI;""
28 Madrid;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
28 Madrid;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2020QIII;78.799
28 Madrid;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2020QII;""
28 Madrid;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2020QI;""
28 Madrid;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2022QIV;74.368
28 Madrid;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
28 Madrid;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2022QII;""
28 Madrid;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2022QI;""
28 Madrid;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2021QIV;75.494
28 Madrid;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
28 Madrid;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2021QII;""
28 Madrid;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2021QI;""
28 Madrid;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2020QIV;75.596
28 Madrid;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
28 Madrid;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2020QII;""
28 Madrid;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2020QI;""
28 Madrid;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
28 Madrid;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
28 Madrid;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QII;""
28 Madrid;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QI;72.399
28 Madrid;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
28 Madrid;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
28 Madrid;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QII;""
28 Madrid;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QI;73.122
28 Madrid;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
28 Madrid;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
28 Madrid;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QII;""
28 Madrid;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QI;""
28 Madrid;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
28 Madrid;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
28 Madrid;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QII;69.570
28 Madrid;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QI;""
28 Madrid;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
28 Madrid;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
28 Madrid;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QII;70.588
28 Madrid;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QI;""
28 Madrid;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
28 Madrid;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
28 Madrid;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QII;""
28 Madrid;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QI;""
28 Madrid;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
28 Madrid;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
28 Madrid;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
28 Madrid;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
28 Madrid;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
28 Madrid;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
28 Madrid;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
28 Madrid;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
28 Madrid;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
28 Madrid;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
28 Madrid;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
28 Madrid;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
28 Madrid;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
28 Madrid;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;95,57
28 Madrid;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
28 Madrid;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
28 Madrid;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
28 Madrid;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;95,66
28 Madrid;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
28 Madrid;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
28 Madrid;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
28 Madrid;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;95,91
28 Madrid;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
28 Madrid;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
28 Madrid;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;91,35
28 Madrid;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
28 Madrid;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
28 Madrid;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
28 Madrid;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;91,49
28 Madrid;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
28 Madrid;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
28 Madrid;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
28 Madrid;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;92,01
28 Madrid;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
28 Madrid;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
28 Madrid;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
28 Madrid;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
28 Madrid;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
28 Madrid;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
28 Madrid;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;87,74
28 Madrid;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
28 Madrid;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
28 Madrid;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
28 Madrid;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;89
28 Madrid;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
28 Madrid;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
28 Madrid;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
28 Madrid;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
28 Madrid;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
28 Madrid;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
28 Madrid;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;84,31
28 Madrid;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
28 Madrid;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
28 Madrid;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
28 Madrid;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;85,91
28 Madrid;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
28 Madrid;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
28 Madrid;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
28 Madrid;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
28 Madrid;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
28 Madrid;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
28 Madrid;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QIII;48.826
28 Madrid;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
28 Madrid;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
28 Madrid;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
28 Madrid;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QIII;50.107
28 Madrid;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
28 Madrid;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
28 Madrid;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
28 Madrid;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QIII;50.315
28 Madrid;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
28 Madrid;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
28 Madrid;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
28 Madrid;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2022QIII;46.761
28 Madrid;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2022QII;""
28 Madrid;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2022QI;""
28 Madrid;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
28 Madrid;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2021QIII;47.919
28 Madrid;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2021QII;""
28 Madrid;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2021QI;""
28 Madrid;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
28 Madrid;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2020QIII;48.385
28 Madrid;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2020QII;""
28 Madrid;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2020QI;""
28 Madrid;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2022QIV;44.821
28 Madrid;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
28 Madrid;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2022QII;""
28 Madrid;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2022QI;""
28 Madrid;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2021QIV;45.825
28 Madrid;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
28 Madrid;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2021QII;""
28 Madrid;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2021QI;""
28 Madrid;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2020QIV;46.500
28 Madrid;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
28 Madrid;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2020QII;""
28 Madrid;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2020QI;""
28 Madrid;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
28 Madrid;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
28 Madrid;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QII;""
28 Madrid;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QI;44.052
28 Madrid;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
28 Madrid;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
28 Madrid;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QII;""
28 Madrid;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QI;45.008
28 Madrid;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
28 Madrid;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
28 Madrid;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QII;""
28 Madrid;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QI;""
28 Madrid;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
28 Madrid;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
28 Madrid;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QII;42.458
28 Madrid;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QI;""
28 Madrid;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
28 Madrid;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
28 Madrid;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QII;43.504
28 Madrid;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QI;""
28 Madrid;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
28 Madrid;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
28 Madrid;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QII;""
28 Madrid;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QI;""
28 Madrid;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
28 Madrid;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
28 Madrid;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
28 Madrid;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
28 Madrid;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
28 Madrid;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
28 Madrid;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
28 Madrid;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
28 Madrid;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
28 Madrid;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
28 Madrid;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
28 Madrid;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
28 Madrid;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
28 Madrid;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;95,77
28 Madrid;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
28 Madrid;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
28 Madrid;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
28 Madrid;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;95,63
28 Madrid;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
28 Madrid;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
28 Madrid;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
28 Madrid;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;96,16
28 Madrid;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
28 Madrid;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
28 Madrid;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;91,8
28 Madrid;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
28 Madrid;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
28 Madrid;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
28 Madrid;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;91,45
28 Madrid;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
28 Madrid;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
28 Madrid;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
28 Madrid;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;92,42
28 Madrid;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
28 Madrid;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
28 Madrid;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
28 Madrid;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
28 Madrid;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
28 Madrid;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
28 Madrid;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;87,92
28 Madrid;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
28 Madrid;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
28 Madrid;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
28 Madrid;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;89,45
28 Madrid;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
28 Madrid;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
28 Madrid;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
28 Madrid;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
28 Madrid;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
28 Madrid;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
28 Madrid;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;84,73
28 Madrid;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
28 Madrid;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
28 Madrid;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
28 Madrid;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;86,46
28 Madrid;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
28 Madrid;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
28 Madrid;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
28 Madrid;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
28 Madrid;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
28 Madrid;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
28 Madrid;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QIII;32.587
28 Madrid;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
28 Madrid;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
28 Madrid;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
28 Madrid;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QIII;32.411
28 Madrid;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
28 Madrid;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
28 Madrid;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
28 Madrid;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QIII;31.848
28 Madrid;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
28 Madrid;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
28 Madrid;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
28 Madrid;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2022QIII;31.043
28 Madrid;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2022QII;""
28 Madrid;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2022QI;""
28 Madrid;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
28 Madrid;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2021QIII;31.017
28 Madrid;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2021QII;""
28 Madrid;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2021QI;""
28 Madrid;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
28 Madrid;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2020QIII;30.414
28 Madrid;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2020QII;""
28 Madrid;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2020QI;""
28 Madrid;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2022QIV;29.547
28 Madrid;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
28 Madrid;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2022QII;""
28 Madrid;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2022QI;""
28 Madrid;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2021QIV;29.669
28 Madrid;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
28 Madrid;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2021QII;""
28 Madrid;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2021QI;""
28 Madrid;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2020QIV;29.096
28 Madrid;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
28 Madrid;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2020QII;""
28 Madrid;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2020QI;""
28 Madrid;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
28 Madrid;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
28 Madrid;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QII;""
28 Madrid;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QI;28.347
28 Madrid;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
28 Madrid;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
28 Madrid;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QII;""
28 Madrid;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QI;28.114
28 Madrid;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
28 Madrid;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
28 Madrid;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QII;""
28 Madrid;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QI;""
28 Madrid;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
28 Madrid;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
28 Madrid;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QII;27.112
28 Madrid;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QI;""
28 Madrid;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
28 Madrid;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
28 Madrid;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QII;27.084
28 Madrid;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QI;""
28 Madrid;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
28 Madrid;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
28 Madrid;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QII;""
28 Madrid;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QI;""
28 Madrid;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
28 Madrid;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
28 Madrid;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
28 Madrid;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
28 Madrid;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
28 Madrid;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
28 Madrid;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
28 Madrid;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
28 Madrid;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
28 Madrid;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
28 Madrid;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
28 Madrid;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
28 Madrid;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
28 Madrid;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;95,26
28 Madrid;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
28 Madrid;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
28 Madrid;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
28 Madrid;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;95,7
28 Madrid;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
28 Madrid;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
28 Madrid;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
28 Madrid;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;95,5
28 Madrid;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
28 Madrid;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
28 Madrid;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;90,67
28 Madrid;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
28 Madrid;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
28 Madrid;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
28 Madrid;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;91,54
28 Madrid;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
28 Madrid;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
28 Madrid;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
28 Madrid;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;91,36
28 Madrid;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
28 Madrid;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
28 Madrid;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
28 Madrid;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
28 Madrid;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
28 Madrid;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
28 Madrid;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;87,46
28 Madrid;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
28 Madrid;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
28 Madrid;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
28 Madrid;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;88,28
28 Madrid;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
28 Madrid;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
28 Madrid;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
28 Madrid;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
28 Madrid;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
28 Madrid;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
28 Madrid;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;83,65
28 Madrid;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
28 Madrid;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
28 Madrid;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
28 Madrid;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;85,04
28 Madrid;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
28 Madrid;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
28 Madrid;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
28 Madrid;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
28 Madrid;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
28 Madrid;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QIV;81.893
28 Madrid;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
28 Madrid;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
28 Madrid;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
28 Madrid;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QIV;83.209
28 Madrid;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
28 Madrid;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
28 Madrid;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
28 Madrid;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QIV;83.189
28 Madrid;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
28 Madrid;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
28 Madrid;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
28 Madrid;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2022QIV;78.040
28 Madrid;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
28 Madrid;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2022QII;""
28 Madrid;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2022QI;""
28 Madrid;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2021QIV;79.360
28 Madrid;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
28 Madrid;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2021QII;""
28 Madrid;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2021QI;""
28 Madrid;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2020QIV;79.514
28 Madrid;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
28 Madrid;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2020QII;""
28 Madrid;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2020QI;""
28 Madrid;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
28 Madrid;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
28 Madrid;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2022QII;""
28 Madrid;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2022QI;75.959
28 Madrid;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
28 Madrid;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
28 Madrid;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2021QII;""
28 Madrid;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2021QI;76.711
28 Madrid;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
28 Madrid;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
28 Madrid;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2020QII;""
28 Madrid;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2020QI;""
28 Madrid;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
28 Madrid;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
28 Madrid;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QII;72.796
28 Madrid;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QI;""
28 Madrid;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
28 Madrid;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
28 Madrid;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QII;73.833
28 Madrid;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QI;""
28 Madrid;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
28 Madrid;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
28 Madrid;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QII;""
28 Madrid;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QI;""
28 Madrid;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
28 Madrid;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QIII;70.219
28 Madrid;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QII;""
28 Madrid;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QI;""
28 Madrid;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
28 Madrid;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QIII;71.409
28 Madrid;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QII;""
28 Madrid;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QI;""
28 Madrid;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
28 Madrid;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
28 Madrid;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QII;""
28 Madrid;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QI;""
28 Madrid;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
28 Madrid;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
28 Madrid;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
28 Madrid;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
28 Madrid;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
28 Madrid;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
28 Madrid;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
28 Madrid;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
28 Madrid;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
28 Madrid;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
28 Madrid;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
28 Madrid;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
28 Madrid;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;95,3
28 Madrid;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
28 Madrid;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
28 Madrid;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
28 Madrid;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;95,37
28 Madrid;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
28 Madrid;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
28 Madrid;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
28 Madrid;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;95,58
28 Madrid;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
28 Madrid;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
28 Madrid;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
28 Madrid;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
28 Madrid;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
28 Madrid;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
28 Madrid;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;91,29
28 Madrid;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
28 Madrid;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
28 Madrid;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
28 Madrid;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;92,21
28 Madrid;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
28 Madrid;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
28 Madrid;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
28 Madrid;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
28 Madrid;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
28 Madrid;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
28 Madrid;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;87,49
28 Madrid;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
28 Madrid;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
28 Madrid;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
28 Madrid;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;88,75
28 Madrid;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
28 Madrid;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
28 Madrid;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
28 Madrid;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
28 Madrid;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
28 Madrid;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
28 Madrid;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;84,39
28 Madrid;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
28 Madrid;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
28 Madrid;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
28 Madrid;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;85,84
28 Madrid;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
28 Madrid;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
28 Madrid;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
28 Madrid;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
28 Madrid;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
28 Madrid;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
28 Madrid;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QIV;49.115
28 Madrid;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
28 Madrid;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
28 Madrid;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
28 Madrid;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QIV;50.412
28 Madrid;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
28 Madrid;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
28 Madrid;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
28 Madrid;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QIV;50.983
28 Madrid;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
28 Madrid;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
28 Madrid;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
28 Madrid;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2022QIV;46.927
28 Madrid;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
28 Madrid;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2022QII;""
28 Madrid;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2022QI;""
28 Madrid;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2021QIV;48.064
28 Madrid;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
28 Madrid;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2021QII;""
28 Madrid;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2021QI;""
28 Madrid;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2020QIV;48.830
28 Madrid;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
28 Madrid;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2020QII;""
28 Madrid;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2020QI;""
28 Madrid;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
28 Madrid;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
28 Madrid;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2022QII;""
28 Madrid;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2022QI;46.116
28 Madrid;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
28 Madrid;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
28 Madrid;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2021QII;""
28 Madrid;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2021QI;47.141
28 Madrid;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
28 Madrid;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
28 Madrid;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2020QII;""
28 Madrid;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2020QI;""
28 Madrid;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
28 Madrid;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
28 Madrid;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QII;44.312
28 Madrid;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QI;""
28 Madrid;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
28 Madrid;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
28 Madrid;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QII;45.435
28 Madrid;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QI;""
28 Madrid;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
28 Madrid;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
28 Madrid;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QII;""
28 Madrid;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QI;""
28 Madrid;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
28 Madrid;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QIII;42.839
28 Madrid;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QII;""
28 Madrid;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QI;""
28 Madrid;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
28 Madrid;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QIII;43.943
28 Madrid;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QII;""
28 Madrid;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QI;""
28 Madrid;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
28 Madrid;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
28 Madrid;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QII;""
28 Madrid;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QI;""
28 Madrid;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
28 Madrid;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
28 Madrid;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
28 Madrid;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
28 Madrid;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
28 Madrid;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
28 Madrid;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
28 Madrid;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
28 Madrid;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
28 Madrid;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
28 Madrid;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
28 Madrid;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
28 Madrid;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;95,55
28 Madrid;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
28 Madrid;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
28 Madrid;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
28 Madrid;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;95,34
28 Madrid;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
28 Madrid;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
28 Madrid;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
28 Madrid;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;95,78
28 Madrid;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
28 Madrid;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
28 Madrid;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
28 Madrid;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
28 Madrid;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
28 Madrid;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
28 Madrid;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;91,48
28 Madrid;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
28 Madrid;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
28 Madrid;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
28 Madrid;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;92,46
28 Madrid;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
28 Madrid;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
28 Madrid;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
28 Madrid;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
28 Madrid;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
28 Madrid;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
28 Madrid;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;87,9
28 Madrid;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
28 Madrid;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
28 Madrid;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
28 Madrid;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;89,12
28 Madrid;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
28 Madrid;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
28 Madrid;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
28 Madrid;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
28 Madrid;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
28 Madrid;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
28 Madrid;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;84,98
28 Madrid;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
28 Madrid;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
28 Madrid;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
28 Madrid;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;86,19
28 Madrid;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
28 Madrid;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
28 Madrid;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
28 Madrid;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
28 Madrid;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
28 Madrid;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
28 Madrid;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QIV;32.778
28 Madrid;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
28 Madrid;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
28 Madrid;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
28 Madrid;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QIV;32.797
28 Madrid;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
28 Madrid;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
28 Madrid;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
28 Madrid;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QIV;32.206
28 Madrid;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
28 Madrid;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
28 Madrid;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
28 Madrid;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2022QIV;31.113
28 Madrid;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
28 Madrid;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2022QII;""
28 Madrid;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2022QI;""
28 Madrid;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2021QIV;31.296
28 Madrid;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
28 Madrid;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2021QII;""
28 Madrid;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2021QI;""
28 Madrid;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2020QIV;30.684
28 Madrid;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
28 Madrid;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2020QII;""
28 Madrid;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2020QI;""
28 Madrid;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
28 Madrid;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
28 Madrid;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2022QII;""
28 Madrid;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2022QI;29.843
28 Madrid;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
28 Madrid;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
28 Madrid;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2021QII;""
28 Madrid;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2021QI;29.570
28 Madrid;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
28 Madrid;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
28 Madrid;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2020QII;""
28 Madrid;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2020QI;""
28 Madrid;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
28 Madrid;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
28 Madrid;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QII;28.484
28 Madrid;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QI;""
28 Madrid;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
28 Madrid;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
28 Madrid;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QII;28.398
28 Madrid;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QI;""
28 Madrid;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
28 Madrid;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
28 Madrid;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QII;""
28 Madrid;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QI;""
28 Madrid;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
28 Madrid;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QIII;27.380
28 Madrid;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QII;""
28 Madrid;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QI;""
28 Madrid;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
28 Madrid;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QIII;27.466
28 Madrid;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QII;""
28 Madrid;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QI;""
28 Madrid;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
28 Madrid;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
28 Madrid;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QII;""
28 Madrid;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QI;""
28 Madrid;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
28 Madrid;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
28 Madrid;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
28 Madrid;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
28 Madrid;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
28 Madrid;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
28 Madrid;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
28 Madrid;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
28 Madrid;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
28 Madrid;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
28 Madrid;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
28 Madrid;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
28 Madrid;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;94,92
28 Madrid;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
28 Madrid;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
28 Madrid;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
28 Madrid;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;95,42
28 Madrid;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
28 Madrid;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
28 Madrid;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
28 Madrid;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;95,27
28 Madrid;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
28 Madrid;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
28 Madrid;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
28 Madrid;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
28 Madrid;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
28 Madrid;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
28 Madrid;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;90,99
28 Madrid;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
28 Madrid;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
28 Madrid;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
28 Madrid;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;91,82
28 Madrid;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
28 Madrid;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
28 Madrid;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
28 Madrid;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
28 Madrid;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
28 Madrid;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
28 Madrid;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;86,85
28 Madrid;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
28 Madrid;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
28 Madrid;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
28 Madrid;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;88,18
28 Madrid;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
28 Madrid;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
28 Madrid;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
28 Madrid;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
28 Madrid;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
28 Madrid;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
28 Madrid;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;83,48
28 Madrid;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
28 Madrid;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
28 Madrid;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
28 Madrid;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;85,28
28 Madrid;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
28 Madrid;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
28 Madrid;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
28 Madrid;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
28 Madrid;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
28 Madrid;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
28 Madrid;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
28 Madrid;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
28 Madrid;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
28 Madrid;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QI;134.239
28 Madrid;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
28 Madrid;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
28 Madrid;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
28 Madrid;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QI;131.898
28 Madrid;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
28 Madrid;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
28 Madrid;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
28 Madrid;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QI;133.686
28 Madrid;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
28 Madrid;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
28 Madrid;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2022QII;""
28 Madrid;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2022QI;129.666
28 Madrid;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
28 Madrid;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
28 Madrid;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2021QII;""
28 Madrid;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2021QI;128.316
28 Madrid;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
28 Madrid;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
28 Madrid;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2020QII;""
28 Madrid;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2020QI;124.537
28 Madrid;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
28 Madrid;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
28 Madrid;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2022QII;125.505
28 Madrid;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2022QI;""
28 Madrid;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
28 Madrid;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
28 Madrid;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2021QII;124.614
28 Madrid;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2021QI;""
28 Madrid;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
28 Madrid;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
28 Madrid;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2020QII;121.888
28 Madrid;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2020QI;""
28 Madrid;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
28 Madrid;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QIII;122.370
28 Madrid;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QII;""
28 Madrid;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QI;""
28 Madrid;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
28 Madrid;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QIII;121.746
28 Madrid;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QII;""
28 Madrid;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QI;""
28 Madrid;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
28 Madrid;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QIII;118.920
28 Madrid;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QII;""
28 Madrid;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QI;""
28 Madrid;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QIV;118.972
28 Madrid;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
28 Madrid;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QII;""
28 Madrid;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QI;""
28 Madrid;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QIV;118.680
28 Madrid;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
28 Madrid;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QII;""
28 Madrid;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QI;""
28 Madrid;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QIV;115.737
28 Madrid;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
28 Madrid;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QII;""
28 Madrid;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QI;""
28 Madrid;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
28 Madrid;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
28 Madrid;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
28 Madrid;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
28 Madrid;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
28 Madrid;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
28 Madrid;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
28 Madrid;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
28 Madrid;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
28 Madrid;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
28 Madrid;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
28 Madrid;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
28 Madrid;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
28 Madrid;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
28 Madrid;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
28 Madrid;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;96,59
28 Madrid;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
28 Madrid;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
28 Madrid;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
28 Madrid;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;97,28
28 Madrid;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
28 Madrid;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
28 Madrid;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
28 Madrid;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;93,16
28 Madrid;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
28 Madrid;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
28 Madrid;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;93,49
28 Madrid;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
28 Madrid;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
28 Madrid;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
28 Madrid;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;94,48
28 Madrid;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
28 Madrid;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
28 Madrid;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
28 Madrid;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;91,17
28 Madrid;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
28 Madrid;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
28 Madrid;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;91,16
28 Madrid;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
28 Madrid;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
28 Madrid;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
28 Madrid;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;92,3
28 Madrid;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
28 Madrid;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
28 Madrid;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
28 Madrid;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;88,95
28 Madrid;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
28 Madrid;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
28 Madrid;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;88,63
28 Madrid;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
28 Madrid;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
28 Madrid;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
28 Madrid;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;89,98
28 Madrid;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
28 Madrid;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
28 Madrid;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
28 Madrid;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;86,57
28 Madrid;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
28 Madrid;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
28 Madrid;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
28 Madrid;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
28 Madrid;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
28 Madrid;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
28 Madrid;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QI;86.419
28 Madrid;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
28 Madrid;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
28 Madrid;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
28 Madrid;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QI;85.771
28 Madrid;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
28 Madrid;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
28 Madrid;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
28 Madrid;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QI;86.600
28 Madrid;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
28 Madrid;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
28 Madrid;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2022QII;""
28 Madrid;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2022QI;83.722
28 Madrid;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
28 Madrid;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
28 Madrid;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2021QII;""
28 Madrid;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2021QI;83.557
28 Madrid;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
28 Madrid;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
28 Madrid;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2020QII;""
28 Madrid;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2020QI;81.123
28 Madrid;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
28 Madrid;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
28 Madrid;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2022QII;81.356
28 Madrid;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2022QI;""
28 Madrid;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
28 Madrid;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
28 Madrid;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2021QII;81.340
28 Madrid;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2021QI;""
28 Madrid;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
28 Madrid;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
28 Madrid;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2020QII;79.601
28 Madrid;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2020QI;""
28 Madrid;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
28 Madrid;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QIII;79.487
28 Madrid;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QII;""
28 Madrid;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QI;""
28 Madrid;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
28 Madrid;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QIII;79.635
28 Madrid;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QII;""
28 Madrid;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QI;""
28 Madrid;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
28 Madrid;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QIII;77.837
28 Madrid;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QII;""
28 Madrid;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QI;""
28 Madrid;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QIV;77.447
28 Madrid;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
28 Madrid;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QII;""
28 Madrid;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QI;""
28 Madrid;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QIV;77.748
28 Madrid;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
28 Madrid;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QII;""
28 Madrid;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QI;""
28 Madrid;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QIV;75.905
28 Madrid;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
28 Madrid;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QII;""
28 Madrid;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QI;""
28 Madrid;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
28 Madrid;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
28 Madrid;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
28 Madrid;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
28 Madrid;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
28 Madrid;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
28 Madrid;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
28 Madrid;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
28 Madrid;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
28 Madrid;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
28 Madrid;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
28 Madrid;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
28 Madrid;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
28 Madrid;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
28 Madrid;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
28 Madrid;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;96,88
28 Madrid;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
28 Madrid;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
28 Madrid;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
28 Madrid;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;97,42
28 Madrid;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
28 Madrid;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
28 Madrid;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
28 Madrid;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;93,68
28 Madrid;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
28 Madrid;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
28 Madrid;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;94,14
28 Madrid;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
28 Madrid;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
28 Madrid;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
28 Madrid;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;94,83
28 Madrid;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
28 Madrid;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
28 Madrid;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
28 Madrid;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;91,92
28 Madrid;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
28 Madrid;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
28 Madrid;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;91,98
28 Madrid;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
28 Madrid;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
28 Madrid;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
28 Madrid;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;92,85
28 Madrid;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
28 Madrid;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
28 Madrid;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
28 Madrid;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;89,88
28 Madrid;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
28 Madrid;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
28 Madrid;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;89,62
28 Madrid;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
28 Madrid;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
28 Madrid;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
28 Madrid;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;90,65
28 Madrid;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
28 Madrid;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
28 Madrid;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
28 Madrid;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;87,65
28 Madrid;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
28 Madrid;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
28 Madrid;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
28 Madrid;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
28 Madrid;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
28 Madrid;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
28 Madrid;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QI;47.820
28 Madrid;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
28 Madrid;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
28 Madrid;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
28 Madrid;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QI;46.127
28 Madrid;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
28 Madrid;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
28 Madrid;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
28 Madrid;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QI;47.086
28 Madrid;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
28 Madrid;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
28 Madrid;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2022QII;""
28 Madrid;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2022QI;45.944
28 Madrid;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
28 Madrid;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
28 Madrid;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2021QII;""
28 Madrid;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2021QI;44.759
28 Madrid;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
28 Madrid;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
28 Madrid;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2020QII;""
28 Madrid;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2020QI;43.414
28 Madrid;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
28 Madrid;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
28 Madrid;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2022QII;44.149
28 Madrid;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2022QI;""
28 Madrid;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
28 Madrid;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
28 Madrid;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2021QII;43.274
28 Madrid;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2021QI;""
28 Madrid;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
28 Madrid;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
28 Madrid;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2020QII;42.287
28 Madrid;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2020QI;""
28 Madrid;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
28 Madrid;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QIII;42.883
28 Madrid;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QII;""
28 Madrid;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QI;""
28 Madrid;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
28 Madrid;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QIII;42.111
28 Madrid;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QII;""
28 Madrid;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QI;""
28 Madrid;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
28 Madrid;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QIII;41.083
28 Madrid;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QII;""
28 Madrid;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QI;""
28 Madrid;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QIV;41.525
28 Madrid;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
28 Madrid;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QII;""
28 Madrid;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QI;""
28 Madrid;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QIV;40.932
28 Madrid;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
28 Madrid;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QII;""
28 Madrid;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QI;""
28 Madrid;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QIV;39.832
28 Madrid;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
28 Madrid;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QII;""
28 Madrid;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QI;""
28 Madrid;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
28 Madrid;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
28 Madrid;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
28 Madrid;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
28 Madrid;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
28 Madrid;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
28 Madrid;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
28 Madrid;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
28 Madrid;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
28 Madrid;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
28 Madrid;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
28 Madrid;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
28 Madrid;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
28 Madrid;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
28 Madrid;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
28 Madrid;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;96,08
28 Madrid;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
28 Madrid;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
28 Madrid;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
28 Madrid;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;97,03
28 Madrid;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
28 Madrid;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
28 Madrid;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
28 Madrid;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;92,2
28 Madrid;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
28 Madrid;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
28 Madrid;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;92,32
28 Madrid;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
28 Madrid;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
28 Madrid;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
28 Madrid;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;93,81
28 Madrid;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
28 Madrid;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
28 Madrid;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
28 Madrid;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;89,81
28 Madrid;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
28 Madrid;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
28 Madrid;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;89,68
28 Madrid;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
28 Madrid;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
28 Madrid;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
28 Madrid;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;91,29
28 Madrid;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
28 Madrid;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
28 Madrid;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
28 Madrid;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;87,25
28 Madrid;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
28 Madrid;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
28 Madrid;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;86,84
28 Madrid;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
28 Madrid;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
28 Madrid;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
28 Madrid;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;88,74
28 Madrid;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
28 Madrid;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
28 Madrid;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
28 Madrid;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;84,59
28 Madrid;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
28 Madrid;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
28 Madrid;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
28 Madrid;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
28 Madrid;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
28 Madrid;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QII;132.997
28 Madrid;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
28 Madrid;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
28 Madrid;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
28 Madrid;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QII;132.284
28 Madrid;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
28 Madrid;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
28 Madrid;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
28 Madrid;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QII;130.054
28 Madrid;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
28 Madrid;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
28 Madrid;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
28 Madrid;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2022QII;128.321
28 Madrid;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2022QI;""
28 Madrid;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
28 Madrid;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
28 Madrid;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2021QII;128.049
28 Madrid;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2021QI;""
28 Madrid;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
28 Madrid;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
28 Madrid;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2020QII;127.019
28 Madrid;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2020QI;""
28 Madrid;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
28 Madrid;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2022QIII;124.827
28 Madrid;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2022QII;""
28 Madrid;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2022QI;""
28 Madrid;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
28 Madrid;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2021QIII;124.755
28 Madrid;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2021QII;""
28 Madrid;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2021QI;""
28 Madrid;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
28 Madrid;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2020QIII;123.698
28 Madrid;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2020QII;""
28 Madrid;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2020QI;""
28 Madrid;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QIV;121.079
28 Madrid;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
28 Madrid;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QII;""
28 Madrid;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QI;""
28 Madrid;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QIV;121.312
28 Madrid;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
28 Madrid;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QII;""
28 Madrid;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QI;""
28 Madrid;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QIV;120.183
28 Madrid;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
28 Madrid;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QII;""
28 Madrid;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QI;""
28 Madrid;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
28 Madrid;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
28 Madrid;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QII;""
28 Madrid;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QI;117.879
28 Madrid;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
28 Madrid;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
28 Madrid;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QII;""
28 Madrid;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QI;117.531
28 Madrid;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
28 Madrid;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
28 Madrid;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QII;""
28 Madrid;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QI;""
28 Madrid;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
28 Madrid;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
28 Madrid;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
28 Madrid;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
28 Madrid;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
28 Madrid;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
28 Madrid;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
28 Madrid;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
28 Madrid;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
28 Madrid;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
28 Madrid;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
28 Madrid;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
28 Madrid;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
28 Madrid;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
28 Madrid;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;96,48
28 Madrid;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
28 Madrid;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
28 Madrid;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
28 Madrid;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;96,8
28 Madrid;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
28 Madrid;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
28 Madrid;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
28 Madrid;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;97,67
28 Madrid;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
28 Madrid;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
28 Madrid;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;93,86
28 Madrid;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
28 Madrid;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
28 Madrid;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
28 Madrid;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;94,31
28 Madrid;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
28 Madrid;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
28 Madrid;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
28 Madrid;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;95,11
28 Madrid;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
28 Madrid;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
28 Madrid;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;91,04
28 Madrid;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
28 Madrid;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
28 Madrid;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
28 Madrid;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;91,71
28 Madrid;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
28 Madrid;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
28 Madrid;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
28 Madrid;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;92,41
28 Madrid;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
28 Madrid;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
28 Madrid;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
28 Madrid;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
28 Madrid;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
28 Madrid;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
28 Madrid;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;89,11
28 Madrid;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
28 Madrid;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
28 Madrid;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
28 Madrid;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;90,37
28 Madrid;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
28 Madrid;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
28 Madrid;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
28 Madrid;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
28 Madrid;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
28 Madrid;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
28 Madrid;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QII;85.108
28 Madrid;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
28 Madrid;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
28 Madrid;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
28 Madrid;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QII;85.620
28 Madrid;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
28 Madrid;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
28 Madrid;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
28 Madrid;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QII;84.494
28 Madrid;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
28 Madrid;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
28 Madrid;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
28 Madrid;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2022QII;82.442
28 Madrid;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2022QI;""
28 Madrid;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
28 Madrid;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
28 Madrid;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2021QII;83.081
28 Madrid;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2021QI;""
28 Madrid;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
28 Madrid;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
28 Madrid;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2020QII;82.701
28 Madrid;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2020QI;""
28 Madrid;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
28 Madrid;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2022QIII;80.360
28 Madrid;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2022QII;""
28 Madrid;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2022QI;""
28 Madrid;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
28 Madrid;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2021QIII;81.104
28 Madrid;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2021QII;""
28 Madrid;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2021QI;""
28 Madrid;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
28 Madrid;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2020QIII;80.721
28 Madrid;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2020QII;""
28 Madrid;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2020QI;""
28 Madrid;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QIV;78.141
28 Madrid;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
28 Madrid;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QII;""
28 Madrid;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QI;""
28 Madrid;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QIV;78.967
28 Madrid;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
28 Madrid;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QII;""
28 Madrid;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QI;""
28 Madrid;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QIV;78.605
28 Madrid;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
28 Madrid;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QII;""
28 Madrid;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QI;""
28 Madrid;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
28 Madrid;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
28 Madrid;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QII;""
28 Madrid;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QI;76.922
28 Madrid;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
28 Madrid;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
28 Madrid;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QII;""
28 Madrid;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QI;76.994
28 Madrid;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
28 Madrid;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
28 Madrid;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QII;""
28 Madrid;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QI;""
28 Madrid;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
28 Madrid;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
28 Madrid;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
28 Madrid;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
28 Madrid;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
28 Madrid;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
28 Madrid;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
28 Madrid;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
28 Madrid;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
28 Madrid;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
28 Madrid;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
28 Madrid;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
28 Madrid;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
28 Madrid;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
28 Madrid;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;96,87
28 Madrid;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
28 Madrid;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
28 Madrid;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
28 Madrid;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;97,03
28 Madrid;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
28 Madrid;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
28 Madrid;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
28 Madrid;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;97,88
28 Madrid;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
28 Madrid;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
28 Madrid;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;94,42
28 Madrid;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
28 Madrid;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
28 Madrid;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
28 Madrid;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;94,73
28 Madrid;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
28 Madrid;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
28 Madrid;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
28 Madrid;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;95,53
28 Madrid;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
28 Madrid;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
28 Madrid;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;91,81
28 Madrid;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
28 Madrid;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
28 Madrid;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
28 Madrid;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;92,23
28 Madrid;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
28 Madrid;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
28 Madrid;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
28 Madrid;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;93,03
28 Madrid;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
28 Madrid;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
28 Madrid;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
28 Madrid;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
28 Madrid;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
28 Madrid;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
28 Madrid;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;89,84
28 Madrid;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
28 Madrid;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
28 Madrid;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
28 Madrid;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;91,12
28 Madrid;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
28 Madrid;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
28 Madrid;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
28 Madrid;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
28 Madrid;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
28 Madrid;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
28 Madrid;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QII;47.889
28 Madrid;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
28 Madrid;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
28 Madrid;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
28 Madrid;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QII;46.664
28 Madrid;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
28 Madrid;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
28 Madrid;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
28 Madrid;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QII;45.560
28 Madrid;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
28 Madrid;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
28 Madrid;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
28 Madrid;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2022QII;45.879
28 Madrid;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2022QI;""
28 Madrid;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
28 Madrid;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
28 Madrid;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2021QII;44.968
28 Madrid;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2021QI;""
28 Madrid;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
28 Madrid;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
28 Madrid;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2020QII;44.318
28 Madrid;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2020QI;""
28 Madrid;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
28 Madrid;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2022QIII;44.467
28 Madrid;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2022QII;""
28 Madrid;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2022QI;""
28 Madrid;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
28 Madrid;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2021QIII;43.651
28 Madrid;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2021QII;""
28 Madrid;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2021QI;""
28 Madrid;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
28 Madrid;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2020QIII;42.977
28 Madrid;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2020QII;""
28 Madrid;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2020QI;""
28 Madrid;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QIV;42.938
28 Madrid;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
28 Madrid;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QII;""
28 Madrid;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QI;""
28 Madrid;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QIV;42.345
28 Madrid;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
28 Madrid;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QII;""
28 Madrid;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QI;""
28 Madrid;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QIV;41.578
28 Madrid;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
28 Madrid;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QII;""
28 Madrid;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QI;""
28 Madrid;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
28 Madrid;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
28 Madrid;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QII;""
28 Madrid;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QI;40.957
28 Madrid;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
28 Madrid;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
28 Madrid;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QII;""
28 Madrid;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QI;40.537
28 Madrid;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
28 Madrid;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
28 Madrid;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QII;""
28 Madrid;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QI;""
28 Madrid;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
28 Madrid;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
28 Madrid;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
28 Madrid;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
28 Madrid;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
28 Madrid;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
28 Madrid;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
28 Madrid;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
28 Madrid;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
28 Madrid;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
28 Madrid;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
28 Madrid;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
28 Madrid;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
28 Madrid;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
28 Madrid;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;95,8
28 Madrid;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
28 Madrid;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
28 Madrid;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
28 Madrid;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;96,37
28 Madrid;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
28 Madrid;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
28 Madrid;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
28 Madrid;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;97,27
28 Madrid;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
28 Madrid;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
28 Madrid;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;92,85
28 Madrid;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
28 Madrid;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
28 Madrid;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
28 Madrid;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;93,54
28 Madrid;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
28 Madrid;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
28 Madrid;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
28 Madrid;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;94,33
28 Madrid;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
28 Madrid;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
28 Madrid;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;89,66
28 Madrid;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
28 Madrid;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
28 Madrid;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
28 Madrid;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;90,74
28 Madrid;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
28 Madrid;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
28 Madrid;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
28 Madrid;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;91,26
28 Madrid;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
28 Madrid;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
28 Madrid;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
28 Madrid;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
28 Madrid;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
28 Madrid;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
28 Madrid;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;87,77
28 Madrid;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
28 Madrid;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
28 Madrid;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
28 Madrid;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;88,97
28 Madrid;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
28 Madrid;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
28 Madrid;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
28 Madrid;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
28 Madrid;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
28 Madrid;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QIII;132.968
28 Madrid;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
28 Madrid;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
28 Madrid;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
28 Madrid;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QIII;133.068
28 Madrid;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
28 Madrid;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
28 Madrid;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
28 Madrid;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QIII;130.780
28 Madrid;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
28 Madrid;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
28 Madrid;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
28 Madrid;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2022QIII;128.986
28 Madrid;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2022QII;""
28 Madrid;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2022QI;""
28 Madrid;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
28 Madrid;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2021QIII;129.281
28 Madrid;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2021QII;""
28 Madrid;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2021QI;""
28 Madrid;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
28 Madrid;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2020QIII;127.005
28 Madrid;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2020QII;""
28 Madrid;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2020QI;""
28 Madrid;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2022QIV;124.824
28 Madrid;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
28 Madrid;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2022QII;""
28 Madrid;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2022QI;""
28 Madrid;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2021QIV;125.427
28 Madrid;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
28 Madrid;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2021QII;""
28 Madrid;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2021QI;""
28 Madrid;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2020QIV;123.209
28 Madrid;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
28 Madrid;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2020QII;""
28 Madrid;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2020QI;""
28 Madrid;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
28 Madrid;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
28 Madrid;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QII;""
28 Madrid;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QI;121.713
28 Madrid;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
28 Madrid;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
28 Madrid;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QII;""
28 Madrid;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QI;120.390
28 Madrid;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
28 Madrid;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
28 Madrid;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QII;""
28 Madrid;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QI;""
28 Madrid;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
28 Madrid;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
28 Madrid;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QII;118.335
28 Madrid;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QI;""
28 Madrid;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
28 Madrid;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
28 Madrid;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QII;117.451
28 Madrid;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QI;""
28 Madrid;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
28 Madrid;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
28 Madrid;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QII;""
28 Madrid;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QI;""
28 Madrid;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
28 Madrid;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
28 Madrid;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
28 Madrid;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
28 Madrid;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
28 Madrid;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
28 Madrid;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
28 Madrid;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
28 Madrid;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
28 Madrid;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
28 Madrid;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
28 Madrid;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
28 Madrid;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
28 Madrid;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;97,01
28 Madrid;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
28 Madrid;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
28 Madrid;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
28 Madrid;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;97,15
28 Madrid;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
28 Madrid;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
28 Madrid;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
28 Madrid;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;97,11
28 Madrid;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
28 Madrid;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
28 Madrid;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;93,88
28 Madrid;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
28 Madrid;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
28 Madrid;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
28 Madrid;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;94,26
28 Madrid;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
28 Madrid;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
28 Madrid;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
28 Madrid;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;94,21
28 Madrid;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
28 Madrid;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
28 Madrid;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
28 Madrid;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
28 Madrid;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
28 Madrid;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
28 Madrid;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;91,47
28 Madrid;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
28 Madrid;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
28 Madrid;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
28 Madrid;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;92,06
28 Madrid;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
28 Madrid;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
28 Madrid;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
28 Madrid;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
28 Madrid;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
28 Madrid;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
28 Madrid;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;88,93
28 Madrid;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
28 Madrid;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
28 Madrid;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
28 Madrid;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;89,81
28 Madrid;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
28 Madrid;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
28 Madrid;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
28 Madrid;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
28 Madrid;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
28 Madrid;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
28 Madrid;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QIII;85.102
28 Madrid;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
28 Madrid;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
28 Madrid;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
28 Madrid;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QIII;86.022
28 Madrid;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
28 Madrid;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
28 Madrid;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
28 Madrid;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QIII;85.139
28 Madrid;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
28 Madrid;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
28 Madrid;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
28 Madrid;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2022QIII;82.729
28 Madrid;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2022QII;""
28 Madrid;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2022QI;""
28 Madrid;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
28 Madrid;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2021QIII;83.732
28 Madrid;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2021QII;""
28 Madrid;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2021QI;""
28 Madrid;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
28 Madrid;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2020QIII;82.870
28 Madrid;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2020QII;""
28 Madrid;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2020QI;""
28 Madrid;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2022QIV;80.273
28 Madrid;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
28 Madrid;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2022QII;""
28 Madrid;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2022QI;""
28 Madrid;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2021QIV;81.336
28 Madrid;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
28 Madrid;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2021QII;""
28 Madrid;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2021QI;""
28 Madrid;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2020QIV;80.571
28 Madrid;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
28 Madrid;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2020QII;""
28 Madrid;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2020QI;""
28 Madrid;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
28 Madrid;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
28 Madrid;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QII;""
28 Madrid;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QI;79.138
28 Madrid;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
28 Madrid;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
28 Madrid;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QII;""
28 Madrid;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QI;78.848
28 Madrid;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
28 Madrid;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
28 Madrid;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QII;""
28 Madrid;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QI;""
28 Madrid;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
28 Madrid;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
28 Madrid;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QII;77.183
28 Madrid;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QI;""
28 Madrid;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
28 Madrid;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
28 Madrid;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QII;77.075
28 Madrid;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QI;""
28 Madrid;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
28 Madrid;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
28 Madrid;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QII;""
28 Madrid;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QI;""
28 Madrid;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
28 Madrid;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
28 Madrid;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
28 Madrid;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
28 Madrid;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
28 Madrid;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
28 Madrid;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
28 Madrid;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
28 Madrid;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
28 Madrid;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
28 Madrid;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
28 Madrid;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
28 Madrid;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
28 Madrid;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;97,21
28 Madrid;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
28 Madrid;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
28 Madrid;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
28 Madrid;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;97,34
28 Madrid;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
28 Madrid;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
28 Madrid;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
28 Madrid;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;97,33
28 Madrid;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
28 Madrid;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
28 Madrid;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;94,33
28 Madrid;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
28 Madrid;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
28 Madrid;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
28 Madrid;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;94,55
28 Madrid;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
28 Madrid;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
28 Madrid;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
28 Madrid;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;94,63
28 Madrid;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
28 Madrid;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
28 Madrid;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
28 Madrid;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
28 Madrid;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
28 Madrid;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
28 Madrid;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;92
28 Madrid;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
28 Madrid;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
28 Madrid;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
28 Madrid;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;92,61
28 Madrid;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
28 Madrid;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
28 Madrid;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
28 Madrid;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
28 Madrid;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
28 Madrid;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
28 Madrid;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;89,72
28 Madrid;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
28 Madrid;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
28 Madrid;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
28 Madrid;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;90,53
28 Madrid;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
28 Madrid;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
28 Madrid;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
28 Madrid;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
28 Madrid;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
28 Madrid;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
28 Madrid;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QIII;47.866
28 Madrid;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
28 Madrid;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
28 Madrid;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
28 Madrid;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QIII;47.046
28 Madrid;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
28 Madrid;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
28 Madrid;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
28 Madrid;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QIII;45.641
28 Madrid;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
28 Madrid;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
28 Madrid;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
28 Madrid;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2022QIII;46.257
28 Madrid;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2022QII;""
28 Madrid;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2022QI;""
28 Madrid;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
28 Madrid;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2021QIII;45.549
28 Madrid;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2021QII;""
28 Madrid;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2021QI;""
28 Madrid;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
28 Madrid;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2020QIII;44.135
28 Madrid;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2020QII;""
28 Madrid;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2020QI;""
28 Madrid;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2022QIV;44.551
28 Madrid;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
28 Madrid;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2022QII;""
28 Madrid;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2022QI;""
28 Madrid;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2021QIV;44.091
28 Madrid;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
28 Madrid;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2021QII;""
28 Madrid;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2021QI;""
28 Madrid;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2020QIV;42.638
28 Madrid;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
28 Madrid;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2020QII;""
28 Madrid;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2020QI;""
28 Madrid;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
28 Madrid;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
28 Madrid;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QII;""
28 Madrid;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QI;42.575
28 Madrid;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
28 Madrid;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
28 Madrid;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QII;""
28 Madrid;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QI;41.542
28 Madrid;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
28 Madrid;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
28 Madrid;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QII;""
28 Madrid;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QI;""
28 Madrid;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
28 Madrid;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
28 Madrid;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QII;41.152
28 Madrid;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QI;""
28 Madrid;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
28 Madrid;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
28 Madrid;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QII;40.376
28 Madrid;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QI;""
28 Madrid;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
28 Madrid;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
28 Madrid;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QII;""
28 Madrid;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QI;""
28 Madrid;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
28 Madrid;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
28 Madrid;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
28 Madrid;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
28 Madrid;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
28 Madrid;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
28 Madrid;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
28 Madrid;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
28 Madrid;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
28 Madrid;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
28 Madrid;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
28 Madrid;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
28 Madrid;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
28 Madrid;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;96,64
28 Madrid;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
28 Madrid;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
28 Madrid;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
28 Madrid;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;96,82
28 Madrid;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
28 Madrid;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
28 Madrid;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
28 Madrid;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;96,7
28 Madrid;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
28 Madrid;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
28 Madrid;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;93,07
28 Madrid;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
28 Madrid;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
28 Madrid;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
28 Madrid;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;93,72
28 Madrid;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
28 Madrid;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
28 Madrid;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
28 Madrid;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;93,42
28 Madrid;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
28 Madrid;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
28 Madrid;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
28 Madrid;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
28 Madrid;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
28 Madrid;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
28 Madrid;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;90,5
28 Madrid;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
28 Madrid;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
28 Madrid;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
28 Madrid;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;91,02
28 Madrid;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
28 Madrid;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
28 Madrid;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
28 Madrid;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
28 Madrid;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
28 Madrid;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
28 Madrid;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;87,47
28 Madrid;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
28 Madrid;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
28 Madrid;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
28 Madrid;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;88,46
28 Madrid;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
28 Madrid;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
28 Madrid;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
28 Madrid;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
28 Madrid;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
28 Madrid;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QIV;132.880
28 Madrid;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
28 Madrid;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
28 Madrid;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
28 Madrid;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QIV;133.485
28 Madrid;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
28 Madrid;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
28 Madrid;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
28 Madrid;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QIV;131.289
28 Madrid;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
28 Madrid;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
28 Madrid;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
28 Madrid;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2022QIV;128.232
28 Madrid;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
28 Madrid;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2022QII;""
28 Madrid;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2022QI;""
28 Madrid;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2021QIV;129.167
28 Madrid;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
28 Madrid;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2021QII;""
28 Madrid;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2021QI;""
28 Madrid;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2020QIV;127.007
28 Madrid;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
28 Madrid;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2020QII;""
28 Madrid;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2020QI;""
28 Madrid;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
28 Madrid;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
28 Madrid;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2022QII;""
28 Madrid;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2022QI;125.171
28 Madrid;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
28 Madrid;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
28 Madrid;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2021QII;""
28 Madrid;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2021QI;123.905
28 Madrid;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
28 Madrid;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
28 Madrid;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2020QII;""
28 Madrid;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2020QI;""
28 Madrid;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
28 Madrid;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
28 Madrid;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QII;121.475
28 Madrid;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QI;""
28 Madrid;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
28 Madrid;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
28 Madrid;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QII;120.661
28 Madrid;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QI;""
28 Madrid;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
28 Madrid;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
28 Madrid;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QII;""
28 Madrid;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QI;""
28 Madrid;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
28 Madrid;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QIII;118.623
28 Madrid;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QII;""
28 Madrid;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QI;""
28 Madrid;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
28 Madrid;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QIII;118.077
28 Madrid;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QII;""
28 Madrid;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QI;""
28 Madrid;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
28 Madrid;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
28 Madrid;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QII;""
28 Madrid;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QI;""
28 Madrid;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
28 Madrid;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
28 Madrid;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
28 Madrid;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
28 Madrid;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
28 Madrid;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
28 Madrid;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
28 Madrid;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
28 Madrid;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
28 Madrid;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
28 Madrid;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
28 Madrid;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
28 Madrid;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;96,5
28 Madrid;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
28 Madrid;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
28 Madrid;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
28 Madrid;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;96,77
28 Madrid;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
28 Madrid;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
28 Madrid;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
28 Madrid;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;96,74
28 Madrid;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
28 Madrid;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
28 Madrid;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
28 Madrid;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
28 Madrid;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
28 Madrid;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
28 Madrid;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;93,77
28 Madrid;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
28 Madrid;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
28 Madrid;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
28 Madrid;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;94,38
28 Madrid;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
28 Madrid;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
28 Madrid;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
28 Madrid;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
28 Madrid;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
28 Madrid;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
28 Madrid;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;91
28 Madrid;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
28 Madrid;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
28 Madrid;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
28 Madrid;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;91,9
28 Madrid;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
28 Madrid;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
28 Madrid;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
28 Madrid;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
28 Madrid;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
28 Madrid;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
28 Madrid;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;88,87
28 Madrid;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
28 Madrid;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
28 Madrid;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
28 Madrid;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;89,94
28 Madrid;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
28 Madrid;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
28 Madrid;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
28 Madrid;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
28 Madrid;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
28 Madrid;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
28 Madrid;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QIV;84.940
28 Madrid;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
28 Madrid;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
28 Madrid;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
28 Madrid;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QIV;86.213
28 Madrid;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
28 Madrid;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
28 Madrid;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
28 Madrid;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QIV;85.510
28 Madrid;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
28 Madrid;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
28 Madrid;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
28 Madrid;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2022QIV;82.204
28 Madrid;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
28 Madrid;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2022QII;""
28 Madrid;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2022QI;""
28 Madrid;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2021QIV;83.532
28 Madrid;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
28 Madrid;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2021QII;""
28 Madrid;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2021QI;""
28 Madrid;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2020QIV;82.906
28 Madrid;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
28 Madrid;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2020QII;""
28 Madrid;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2020QI;""
28 Madrid;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
28 Madrid;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
28 Madrid;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2022QII;""
28 Madrid;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2022QI;81.167
28 Madrid;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
28 Madrid;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
28 Madrid;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2021QII;""
28 Madrid;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2021QI;80.991
28 Madrid;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
28 Madrid;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
28 Madrid;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2020QII;""
28 Madrid;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2020QI;""
28 Madrid;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
28 Madrid;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
28 Madrid;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QII;79.045
28 Madrid;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QI;""
28 Madrid;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
28 Madrid;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
28 Madrid;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QII;79.032
28 Madrid;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QI;""
28 Madrid;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
28 Madrid;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
28 Madrid;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QII;""
28 Madrid;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QI;""
28 Madrid;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
28 Madrid;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QIII;77.338
28 Madrid;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QII;""
28 Madrid;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QI;""
28 Madrid;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
28 Madrid;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QIII;77.484
28 Madrid;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QII;""
28 Madrid;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QI;""
28 Madrid;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
28 Madrid;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
28 Madrid;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QII;""
28 Madrid;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QI;""
28 Madrid;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
28 Madrid;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
28 Madrid;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
28 Madrid;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
28 Madrid;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
28 Madrid;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
28 Madrid;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
28 Madrid;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
28 Madrid;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
28 Madrid;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
28 Madrid;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
28 Madrid;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
28 Madrid;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;96,78
28 Madrid;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
28 Madrid;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
28 Madrid;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
28 Madrid;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;96,89
28 Madrid;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
28 Madrid;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
28 Madrid;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
28 Madrid;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;96,95
28 Madrid;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
28 Madrid;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
28 Madrid;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
28 Madrid;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
28 Madrid;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
28 Madrid;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
28 Madrid;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;94,15
28 Madrid;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
28 Madrid;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
28 Madrid;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
28 Madrid;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;94,72
28 Madrid;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
28 Madrid;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
28 Madrid;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
28 Madrid;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
28 Madrid;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
28 Madrid;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
28 Madrid;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;91,69
28 Madrid;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
28 Madrid;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
28 Madrid;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
28 Madrid;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;92,42
28 Madrid;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
28 Madrid;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
28 Madrid;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
28 Madrid;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
28 Madrid;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
28 Madrid;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
28 Madrid;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;89,71
28 Madrid;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
28 Madrid;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
28 Madrid;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
28 Madrid;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;90,61
28 Madrid;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
28 Madrid;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
28 Madrid;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
28 Madrid;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
28 Madrid;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
28 Madrid;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
28 Madrid;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QIV;47.940
28 Madrid;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
28 Madrid;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
28 Madrid;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
28 Madrid;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QIV;47.272
28 Madrid;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
28 Madrid;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
28 Madrid;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
28 Madrid;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QIV;45.779
28 Madrid;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
28 Madrid;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
28 Madrid;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
28 Madrid;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2022QIV;46.028
28 Madrid;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
28 Madrid;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2022QII;""
28 Madrid;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2022QI;""
28 Madrid;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2021QIV;45.635
28 Madrid;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
28 Madrid;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2021QII;""
28 Madrid;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2021QI;""
28 Madrid;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2020QIV;44.101
28 Madrid;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
28 Madrid;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2020QII;""
28 Madrid;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2020QI;""
28 Madrid;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
28 Madrid;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
28 Madrid;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2022QII;""
28 Madrid;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2022QI;44.004
28 Madrid;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
28 Madrid;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
28 Madrid;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2021QII;""
28 Madrid;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2021QI;42.914
28 Madrid;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
28 Madrid;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
28 Madrid;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2020QII;""
28 Madrid;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2020QI;""
28 Madrid;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
28 Madrid;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
28 Madrid;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QII;42.430
28 Madrid;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QI;""
28 Madrid;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
28 Madrid;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
28 Madrid;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QII;41.629
28 Madrid;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QI;""
28 Madrid;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
28 Madrid;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
28 Madrid;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QII;""
28 Madrid;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QI;""
28 Madrid;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
28 Madrid;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QIII;41.285
28 Madrid;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QII;""
28 Madrid;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QI;""
28 Madrid;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
28 Madrid;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QIII;40.593
28 Madrid;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QII;""
28 Madrid;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QI;""
28 Madrid;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
28 Madrid;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
28 Madrid;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QII;""
28 Madrid;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QI;""
28 Madrid;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
28 Madrid;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
28 Madrid;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
28 Madrid;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
28 Madrid;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
28 Madrid;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
28 Madrid;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
28 Madrid;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
28 Madrid;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
28 Madrid;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
28 Madrid;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
28 Madrid;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
28 Madrid;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;96,01
28 Madrid;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
28 Madrid;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
28 Madrid;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
28 Madrid;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;96,54
28 Madrid;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
28 Madrid;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
28 Madrid;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
28 Madrid;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;96,33
28 Madrid;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
28 Madrid;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
28 Madrid;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
28 Madrid;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
28 Madrid;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
28 Madrid;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
28 Madrid;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;93,09
28 Madrid;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
28 Madrid;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
28 Madrid;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
28 Madrid;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;93,74
28 Madrid;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
28 Madrid;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
28 Madrid;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
28 Madrid;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
28 Madrid;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
28 Madrid;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
28 Madrid;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;89,76
28 Madrid;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
28 Madrid;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
28 Madrid;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
28 Madrid;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;90,93
28 Madrid;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
28 Madrid;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
28 Madrid;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
28 Madrid;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
28 Madrid;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
28 Madrid;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
28 Madrid;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;87,33
28 Madrid;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
28 Madrid;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
28 Madrid;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
28 Madrid;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;88,67
28 Madrid;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
28 Madrid;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
28 Madrid;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
28 Madrid;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
28 Madrid;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
28 Madrid;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
28 Madrid;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
28 Madrid;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
28 Madrid;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
28 Madrid;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QI;112.335
28 Madrid;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
28 Madrid;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
28 Madrid;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
28 Madrid;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QI;108.436
28 Madrid;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
28 Madrid;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
28 Madrid;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
28 Madrid;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QI;111.031
28 Madrid;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
28 Madrid;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
28 Madrid;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2022QII;""
28 Madrid;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2022QI;109.294
28 Madrid;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
28 Madrid;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
28 Madrid;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2021QII;""
28 Madrid;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2021QI;106.104
28 Madrid;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
28 Madrid;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
28 Madrid;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2020QII;""
28 Madrid;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2020QI;104.932
28 Madrid;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
28 Madrid;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
28 Madrid;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2022QII;106.361
28 Madrid;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2022QI;""
28 Madrid;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
28 Madrid;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
28 Madrid;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2021QII;103.623
28 Madrid;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2021QI;""
28 Madrid;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
28 Madrid;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
28 Madrid;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2020QII;103.115
28 Madrid;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2020QI;""
28 Madrid;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
28 Madrid;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QIII;104.093
28 Madrid;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QII;""
28 Madrid;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QI;""
28 Madrid;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
28 Madrid;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QIII;101.714
28 Madrid;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QII;""
28 Madrid;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QI;""
28 Madrid;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
28 Madrid;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QIII;101.011
28 Madrid;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QII;""
28 Madrid;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QI;""
28 Madrid;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QIV;101.537
28 Madrid;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
28 Madrid;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QII;""
28 Madrid;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QI;""
28 Madrid;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QIV;99.590
28 Madrid;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
28 Madrid;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QII;""
28 Madrid;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QI;""
28 Madrid;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QIV;98.813
28 Madrid;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
28 Madrid;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QII;""
28 Madrid;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QI;""
28 Madrid;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
28 Madrid;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
28 Madrid;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
28 Madrid;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
28 Madrid;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
28 Madrid;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
28 Madrid;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
28 Madrid;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
28 Madrid;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
28 Madrid;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
28 Madrid;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
28 Madrid;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
28 Madrid;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
28 Madrid;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
28 Madrid;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
28 Madrid;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;97,29
28 Madrid;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
28 Madrid;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
28 Madrid;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
28 Madrid;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;97,85
28 Madrid;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
28 Madrid;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
28 Madrid;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
28 Madrid;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;94,51
28 Madrid;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
28 Madrid;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
28 Madrid;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;94,68
28 Madrid;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
28 Madrid;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
28 Madrid;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
28 Madrid;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;95,56
28 Madrid;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
28 Madrid;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
28 Madrid;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
28 Madrid;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;92,87
28 Madrid;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
28 Madrid;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
28 Madrid;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;92,66
28 Madrid;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
28 Madrid;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
28 Madrid;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
28 Madrid;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;93,8
28 Madrid;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
28 Madrid;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
28 Madrid;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
28 Madrid;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;90,98
28 Madrid;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
28 Madrid;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
28 Madrid;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;90,39
28 Madrid;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
28 Madrid;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
28 Madrid;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
28 Madrid;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;91,84
28 Madrid;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
28 Madrid;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
28 Madrid;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
28 Madrid;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;89
28 Madrid;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
28 Madrid;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
28 Madrid;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
28 Madrid;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
28 Madrid;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
28 Madrid;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
28 Madrid;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QI;73.821
28 Madrid;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
28 Madrid;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
28 Madrid;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
28 Madrid;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QI;71.562
28 Madrid;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
28 Madrid;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
28 Madrid;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
28 Madrid;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QI;73.160
28 Madrid;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
28 Madrid;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
28 Madrid;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2022QII;""
28 Madrid;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2022QI;71.931
28 Madrid;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
28 Madrid;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
28 Madrid;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2021QII;""
28 Madrid;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2021QI;70.164
28 Madrid;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
28 Madrid;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
28 Madrid;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2020QII;""
28 Madrid;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2020QI;69.432
28 Madrid;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
28 Madrid;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
28 Madrid;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2022QII;70.200
28 Madrid;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2022QI;""
28 Madrid;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
28 Madrid;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
28 Madrid;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2021QII;68.690
28 Madrid;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2021QI;""
28 Madrid;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
28 Madrid;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
28 Madrid;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2020QII;68.310
28 Madrid;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2020QI;""
28 Madrid;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
28 Madrid;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QIII;68.838
28 Madrid;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QII;""
28 Madrid;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QI;""
28 Madrid;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
28 Madrid;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QIII;67.523
28 Madrid;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QII;""
28 Madrid;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QI;""
28 Madrid;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
28 Madrid;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QIII;67.060
28 Madrid;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QII;""
28 Madrid;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QI;""
28 Madrid;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QIV;67.298
28 Madrid;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
28 Madrid;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QII;""
28 Madrid;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QI;""
28 Madrid;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QIV;66.186
28 Madrid;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
28 Madrid;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QII;""
28 Madrid;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QI;""
28 Madrid;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QIV;65.702
28 Madrid;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
28 Madrid;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QII;""
28 Madrid;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QI;""
28 Madrid;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
28 Madrid;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
28 Madrid;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
28 Madrid;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
28 Madrid;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
28 Madrid;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
28 Madrid;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
28 Madrid;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
28 Madrid;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
28 Madrid;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
28 Madrid;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
28 Madrid;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
28 Madrid;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
28 Madrid;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
28 Madrid;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
28 Madrid;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;97,44
28 Madrid;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
28 Madrid;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
28 Madrid;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
28 Madrid;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;98,05
28 Madrid;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
28 Madrid;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
28 Madrid;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
28 Madrid;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;94,9
28 Madrid;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
28 Madrid;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
28 Madrid;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;95,09
28 Madrid;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
28 Madrid;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
28 Madrid;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
28 Madrid;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;95,99
28 Madrid;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
28 Madrid;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
28 Madrid;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
28 Madrid;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;93,37
28 Madrid;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
28 Madrid;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
28 Madrid;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;93,25
28 Madrid;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
28 Madrid;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
28 Madrid;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
28 Madrid;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;94,36
28 Madrid;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
28 Madrid;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
28 Madrid;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
28 Madrid;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;91,66
28 Madrid;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
28 Madrid;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
28 Madrid;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;91,16
28 Madrid;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
28 Madrid;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
28 Madrid;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
28 Madrid;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;92,49
28 Madrid;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
28 Madrid;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
28 Madrid;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
28 Madrid;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;89,81
28 Madrid;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
28 Madrid;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
28 Madrid;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
28 Madrid;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
28 Madrid;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
28 Madrid;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
28 Madrid;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QI;38.514
28 Madrid;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
28 Madrid;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
28 Madrid;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
28 Madrid;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QI;36.874
28 Madrid;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
28 Madrid;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
28 Madrid;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
28 Madrid;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QI;37.871
28 Madrid;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
28 Madrid;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
28 Madrid;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2022QII;""
28 Madrid;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2022QI;37.363
28 Madrid;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
28 Madrid;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
28 Madrid;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2021QII;""
28 Madrid;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2021QI;35.940
28 Madrid;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
28 Madrid;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
28 Madrid;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2020QII;""
28 Madrid;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2020QI;35.500
28 Madrid;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
28 Madrid;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
28 Madrid;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2022QII;36.161
28 Madrid;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2022QI;""
28 Madrid;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
28 Madrid;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
28 Madrid;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2021QII;34.933
28 Madrid;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2021QI;""
28 Madrid;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
28 Madrid;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
28 Madrid;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2020QII;34.805
28 Madrid;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2020QI;""
28 Madrid;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
28 Madrid;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QIII;35.255
28 Madrid;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QII;""
28 Madrid;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QI;""
28 Madrid;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
28 Madrid;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QIII;34.191
28 Madrid;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QII;""
28 Madrid;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QI;""
28 Madrid;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
28 Madrid;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QIII;33.951
28 Madrid;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QII;""
28 Madrid;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QI;""
28 Madrid;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QIV;34.239
28 Madrid;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
28 Madrid;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QII;""
28 Madrid;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QI;""
28 Madrid;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QIV;33.404
28 Madrid;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
28 Madrid;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QII;""
28 Madrid;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QI;""
28 Madrid;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QIV;33.111
28 Madrid;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
28 Madrid;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QII;""
28 Madrid;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QI;""
28 Madrid;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
28 Madrid;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
28 Madrid;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
28 Madrid;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
28 Madrid;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
28 Madrid;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
28 Madrid;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
28 Madrid;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
28 Madrid;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
28 Madrid;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
28 Madrid;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
28 Madrid;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
28 Madrid;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
28 Madrid;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
28 Madrid;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
28 Madrid;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;97,01
28 Madrid;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
28 Madrid;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
28 Madrid;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
28 Madrid;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;97,47
28 Madrid;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
28 Madrid;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
28 Madrid;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
28 Madrid;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;93,74
28 Madrid;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
28 Madrid;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
28 Madrid;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;93,89
28 Madrid;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
28 Madrid;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
28 Madrid;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
28 Madrid;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;94,74
28 Madrid;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
28 Madrid;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
28 Madrid;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
28 Madrid;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;91,9
28 Madrid;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
28 Madrid;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
28 Madrid;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;91,54
28 Madrid;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
28 Madrid;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
28 Madrid;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
28 Madrid;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;92,72
28 Madrid;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
28 Madrid;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
28 Madrid;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
28 Madrid;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;89,65
28 Madrid;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
28 Madrid;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
28 Madrid;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;88,9
28 Madrid;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
28 Madrid;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
28 Madrid;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
28 Madrid;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;90,59
28 Madrid;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
28 Madrid;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
28 Madrid;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
28 Madrid;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;87,43
28 Madrid;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
28 Madrid;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
28 Madrid;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
28 Madrid;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
28 Madrid;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
28 Madrid;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QII;115.822
28 Madrid;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
28 Madrid;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
28 Madrid;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
28 Madrid;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QII;112.319
28 Madrid;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
28 Madrid;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
28 Madrid;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
28 Madrid;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QII;108.623
28 Madrid;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
28 Madrid;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
28 Madrid;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
28 Madrid;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2022QII;112.411
28 Madrid;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2022QI;""
28 Madrid;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
28 Madrid;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
28 Madrid;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2021QII;109.379
28 Madrid;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2021QI;""
28 Madrid;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
28 Madrid;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
28 Madrid;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2020QII;106.558
28 Madrid;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2020QI;""
28 Madrid;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
28 Madrid;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2022QIII;109.861
28 Madrid;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2022QII;""
28 Madrid;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2022QI;""
28 Madrid;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
28 Madrid;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2021QIII;107.202
28 Madrid;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2021QII;""
28 Madrid;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2021QI;""
28 Madrid;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
28 Madrid;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2020QIII;104.159
28 Madrid;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2020QII;""
28 Madrid;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2020QI;""
28 Madrid;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QIV;107.042
28 Madrid;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
28 Madrid;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QII;""
28 Madrid;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QI;""
28 Madrid;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QIV;104.821
28 Madrid;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
28 Madrid;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QII;""
28 Madrid;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QI;""
28 Madrid;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QIV;101.767
28 Madrid;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
28 Madrid;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QII;""
28 Madrid;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QI;""
28 Madrid;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
28 Madrid;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
28 Madrid;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QII;""
28 Madrid;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QI;102.427
28 Madrid;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
28 Madrid;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
28 Madrid;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QII;""
28 Madrid;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QI;99.979
28 Madrid;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
28 Madrid;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
28 Madrid;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QII;""
28 Madrid;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QI;""
28 Madrid;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
28 Madrid;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
28 Madrid;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
28 Madrid;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
28 Madrid;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
28 Madrid;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
28 Madrid;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
28 Madrid;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
28 Madrid;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
28 Madrid;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
28 Madrid;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
28 Madrid;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
28 Madrid;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
28 Madrid;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
28 Madrid;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;97,05
28 Madrid;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
28 Madrid;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
28 Madrid;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
28 Madrid;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;97,38
28 Madrid;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
28 Madrid;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
28 Madrid;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
28 Madrid;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;98,1
28 Madrid;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
28 Madrid;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
28 Madrid;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;94,85
28 Madrid;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
28 Madrid;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
28 Madrid;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
28 Madrid;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;95,44
28 Madrid;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
28 Madrid;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
28 Madrid;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
28 Madrid;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;95,89
28 Madrid;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
28 Madrid;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
28 Madrid;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;92,42
28 Madrid;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
28 Madrid;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
28 Madrid;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
28 Madrid;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;93,32
28 Madrid;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
28 Madrid;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
28 Madrid;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
28 Madrid;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;93,69
28 Madrid;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
28 Madrid;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
28 Madrid;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
28 Madrid;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
28 Madrid;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
28 Madrid;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
28 Madrid;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;91,19
28 Madrid;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
28 Madrid;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
28 Madrid;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
28 Madrid;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;92,04
28 Madrid;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
28 Madrid;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
28 Madrid;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
28 Madrid;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
28 Madrid;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
28 Madrid;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
28 Madrid;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QII;75.859
28 Madrid;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
28 Madrid;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
28 Madrid;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
28 Madrid;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QII;73.969
28 Madrid;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
28 Madrid;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
28 Madrid;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
28 Madrid;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QII;71.744
28 Madrid;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
28 Madrid;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
28 Madrid;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
28 Madrid;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2022QII;73.851
28 Madrid;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2022QI;""
28 Madrid;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
28 Madrid;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
28 Madrid;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2021QII;72.227
28 Madrid;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2021QI;""
28 Madrid;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
28 Madrid;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
28 Madrid;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2020QII;70.446
28 Madrid;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2020QI;""
28 Madrid;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
28 Madrid;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2022QIII;72.329
28 Madrid;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2022QII;""
28 Madrid;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2022QI;""
28 Madrid;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
28 Madrid;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2021QIII;70.900
28 Madrid;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2021QII;""
28 Madrid;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2021QI;""
28 Madrid;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
28 Madrid;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2020QIII;68.982
28 Madrid;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2020QII;""
28 Madrid;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2020QI;""
28 Madrid;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QIV;70.640
28 Madrid;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
28 Madrid;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QII;""
28 Madrid;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QI;""
28 Madrid;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QIV;69.424
28 Madrid;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
28 Madrid;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QII;""
28 Madrid;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QI;""
28 Madrid;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QIV;67.508
28 Madrid;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
28 Madrid;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QII;""
28 Madrid;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QI;""
28 Madrid;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
28 Madrid;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
28 Madrid;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QII;""
28 Madrid;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QI;67.938
28 Madrid;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
28 Madrid;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
28 Madrid;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QII;""
28 Madrid;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QI;66.452
28 Madrid;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
28 Madrid;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
28 Madrid;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QII;""
28 Madrid;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QI;""
28 Madrid;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
28 Madrid;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
28 Madrid;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
28 Madrid;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
28 Madrid;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
28 Madrid;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
28 Madrid;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
28 Madrid;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
28 Madrid;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
28 Madrid;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
28 Madrid;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
28 Madrid;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
28 Madrid;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
28 Madrid;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
28 Madrid;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;97,35
28 Madrid;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
28 Madrid;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
28 Madrid;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
28 Madrid;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;97,64
28 Madrid;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
28 Madrid;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
28 Madrid;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
28 Madrid;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;98,19
28 Madrid;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
28 Madrid;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
28 Madrid;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;95,35
28 Madrid;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
28 Madrid;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
28 Madrid;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
28 Madrid;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;95,85
28 Madrid;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
28 Madrid;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
28 Madrid;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
28 Madrid;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;96,15
28 Madrid;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
28 Madrid;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
28 Madrid;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;93,12
28 Madrid;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
28 Madrid;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
28 Madrid;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
28 Madrid;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;93,86
28 Madrid;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
28 Madrid;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
28 Madrid;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
28 Madrid;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;94,1
28 Madrid;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
28 Madrid;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
28 Madrid;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
28 Madrid;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
28 Madrid;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
28 Madrid;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
28 Madrid;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;91,85
28 Madrid;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
28 Madrid;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
28 Madrid;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
28 Madrid;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;92,62
28 Madrid;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
28 Madrid;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
28 Madrid;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
28 Madrid;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
28 Madrid;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
28 Madrid;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
28 Madrid;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QII;39.963
28 Madrid;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
28 Madrid;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
28 Madrid;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
28 Madrid;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QII;38.350
28 Madrid;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
28 Madrid;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
28 Madrid;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
28 Madrid;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QII;36.879
28 Madrid;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
28 Madrid;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
28 Madrid;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
28 Madrid;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2022QII;38.560
28 Madrid;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2022QI;""
28 Madrid;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
28 Madrid;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
28 Madrid;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2021QII;37.152
28 Madrid;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2021QI;""
28 Madrid;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
28 Madrid;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
28 Madrid;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2020QII;36.112
28 Madrid;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2020QI;""
28 Madrid;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
28 Madrid;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2022QIII;37.532
28 Madrid;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2022QII;""
28 Madrid;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2022QI;""
28 Madrid;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
28 Madrid;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2021QIII;36.302
28 Madrid;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2021QII;""
28 Madrid;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2021QI;""
28 Madrid;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
28 Madrid;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2020QIII;35.177
28 Madrid;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2020QII;""
28 Madrid;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2020QI;""
28 Madrid;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QIV;36.402
28 Madrid;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
28 Madrid;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QII;""
28 Madrid;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QI;""
28 Madrid;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QIV;35.397
28 Madrid;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
28 Madrid;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QII;""
28 Madrid;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QI;""
28 Madrid;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QIV;34.259
28 Madrid;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
28 Madrid;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QII;""
28 Madrid;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QI;""
28 Madrid;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
28 Madrid;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
28 Madrid;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QII;""
28 Madrid;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QI;34.489
28 Madrid;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
28 Madrid;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
28 Madrid;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QII;""
28 Madrid;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QI;33.527
28 Madrid;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
28 Madrid;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
28 Madrid;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QII;""
28 Madrid;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QI;""
28 Madrid;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
28 Madrid;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
28 Madrid;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
28 Madrid;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
28 Madrid;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
28 Madrid;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
28 Madrid;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
28 Madrid;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
28 Madrid;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
28 Madrid;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
28 Madrid;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
28 Madrid;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
28 Madrid;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
28 Madrid;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
28 Madrid;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;96,49
28 Madrid;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
28 Madrid;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
28 Madrid;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
28 Madrid;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;96,88
28 Madrid;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
28 Madrid;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
28 Madrid;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
28 Madrid;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;97,92
28 Madrid;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
28 Madrid;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
28 Madrid;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;93,92
28 Madrid;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
28 Madrid;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
28 Madrid;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
28 Madrid;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;94,66
28 Madrid;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
28 Madrid;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
28 Madrid;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
28 Madrid;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;95,38
28 Madrid;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
28 Madrid;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
28 Madrid;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;91,09
28 Madrid;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
28 Madrid;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
28 Madrid;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
28 Madrid;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;92,3
28 Madrid;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
28 Madrid;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
28 Madrid;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
28 Madrid;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;92,9
28 Madrid;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
28 Madrid;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
28 Madrid;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
28 Madrid;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
28 Madrid;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
28 Madrid;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
28 Madrid;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;89,93
28 Madrid;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
28 Madrid;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
28 Madrid;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
28 Madrid;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;90,91
28 Madrid;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
28 Madrid;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
28 Madrid;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
28 Madrid;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
28 Madrid;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
28 Madrid;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QIII;115.281
28 Madrid;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
28 Madrid;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
28 Madrid;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
28 Madrid;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QIII;112.431
28 Madrid;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
28 Madrid;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
28 Madrid;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
28 Madrid;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QIII;108.710
28 Madrid;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
28 Madrid;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
28 Madrid;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
28 Madrid;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2022QIII;112.396
28 Madrid;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2022QII;""
28 Madrid;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2022QI;""
28 Madrid;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
28 Madrid;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2021QIII;109.933
28 Madrid;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2021QII;""
28 Madrid;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2021QI;""
28 Madrid;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
28 Madrid;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2020QIII;106.095
28 Madrid;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2020QII;""
28 Madrid;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2020QI;""
28 Madrid;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2022QIV;109.321
28 Madrid;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
28 Madrid;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2022QII;""
28 Madrid;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2022QI;""
28 Madrid;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2021QIV;107.324
28 Madrid;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
28 Madrid;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2021QII;""
28 Madrid;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2021QI;""
28 Madrid;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2020QIV;103.531
28 Madrid;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
28 Madrid;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2020QII;""
28 Madrid;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2020QI;""
28 Madrid;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
28 Madrid;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
28 Madrid;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QII;""
28 Madrid;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QI;104.773
28 Madrid;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
28 Madrid;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
28 Madrid;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QII;""
28 Madrid;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QI;101.648
28 Madrid;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
28 Madrid;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
28 Madrid;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QII;""
28 Madrid;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QI;""
28 Madrid;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
28 Madrid;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
28 Madrid;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QII;102.358
28 Madrid;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QI;""
28 Madrid;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
28 Madrid;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
28 Madrid;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QII;99.625
28 Madrid;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QI;""
28 Madrid;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
28 Madrid;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
28 Madrid;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QII;""
28 Madrid;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QI;""
28 Madrid;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
28 Madrid;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
28 Madrid;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
28 Madrid;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
28 Madrid;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
28 Madrid;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
28 Madrid;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
28 Madrid;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
28 Madrid;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
28 Madrid;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
28 Madrid;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
28 Madrid;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
28 Madrid;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
28 Madrid;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;97,5
28 Madrid;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
28 Madrid;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
28 Madrid;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
28 Madrid;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;97,78
28 Madrid;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
28 Madrid;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
28 Madrid;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
28 Madrid;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;97,59
28 Madrid;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
28 Madrid;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
28 Madrid;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;94,83
28 Madrid;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
28 Madrid;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
28 Madrid;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
28 Madrid;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;95,46
28 Madrid;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
28 Madrid;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
28 Madrid;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
28 Madrid;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;95,24
28 Madrid;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
28 Madrid;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
28 Madrid;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
28 Madrid;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
28 Madrid;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
28 Madrid;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
28 Madrid;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;93,19
28 Madrid;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
28 Madrid;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
28 Madrid;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
28 Madrid;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;93,5
28 Madrid;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
28 Madrid;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
28 Madrid;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
28 Madrid;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
28 Madrid;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
28 Madrid;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
28 Madrid;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;91,04
28 Madrid;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
28 Madrid;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
28 Madrid;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
28 Madrid;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;91,64
28 Madrid;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
28 Madrid;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
28 Madrid;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
28 Madrid;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
28 Madrid;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
28 Madrid;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
28 Madrid;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QIII;75.567
28 Madrid;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
28 Madrid;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
28 Madrid;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
28 Madrid;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QIII;74.079
28 Madrid;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
28 Madrid;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
28 Madrid;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
28 Madrid;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QIII;71.822
28 Madrid;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
28 Madrid;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
28 Madrid;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
28 Madrid;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2022QIII;73.839
28 Madrid;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2022QII;""
28 Madrid;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2022QI;""
28 Madrid;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
28 Madrid;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2021QIII;72.560
28 Madrid;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2021QII;""
28 Madrid;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2021QI;""
28 Madrid;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
28 Madrid;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2020QIII;70.228
28 Madrid;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2020QII;""
28 Madrid;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2020QI;""
28 Madrid;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2022QIV;71.983
28 Madrid;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
28 Madrid;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2022QII;""
28 Madrid;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2022QI;""
28 Madrid;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2021QIV;70.945
28 Madrid;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
28 Madrid;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2021QII;""
28 Madrid;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2021QI;""
28 Madrid;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2020QIV;68.645
28 Madrid;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
28 Madrid;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2020QII;""
28 Madrid;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2020QI;""
28 Madrid;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
28 Madrid;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
28 Madrid;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QII;""
28 Madrid;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QI;69.348
28 Madrid;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
28 Madrid;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
28 Madrid;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QII;""
28 Madrid;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QI;67.525
28 Madrid;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
28 Madrid;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
28 Madrid;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QII;""
28 Madrid;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QI;""
28 Madrid;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
28 Madrid;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
28 Madrid;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QII;67.878
28 Madrid;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QI;""
28 Madrid;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
28 Madrid;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
28 Madrid;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QII;66.311
28 Madrid;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QI;""
28 Madrid;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
28 Madrid;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
28 Madrid;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QII;""
28 Madrid;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QI;""
28 Madrid;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
28 Madrid;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
28 Madrid;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
28 Madrid;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
28 Madrid;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
28 Madrid;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
28 Madrid;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
28 Madrid;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
28 Madrid;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
28 Madrid;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
28 Madrid;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
28 Madrid;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
28 Madrid;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
28 Madrid;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;97,71
28 Madrid;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
28 Madrid;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
28 Madrid;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
28 Madrid;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;97,95
28 Madrid;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
28 Madrid;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
28 Madrid;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
28 Madrid;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;97,78
28 Madrid;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
28 Madrid;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
28 Madrid;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;95,26
28 Madrid;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
28 Madrid;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
28 Madrid;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
28 Madrid;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;95,77
28 Madrid;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
28 Madrid;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
28 Madrid;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
28 Madrid;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;95,58
28 Madrid;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
28 Madrid;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
28 Madrid;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
28 Madrid;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
28 Madrid;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
28 Madrid;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
28 Madrid;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;93,61
28 Madrid;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
28 Madrid;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
28 Madrid;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
28 Madrid;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;94,02
28 Madrid;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
28 Madrid;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
28 Madrid;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
28 Madrid;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
28 Madrid;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
28 Madrid;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
28 Madrid;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;91,63
28 Madrid;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
28 Madrid;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
28 Madrid;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
28 Madrid;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;92,33
28 Madrid;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
28 Madrid;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
28 Madrid;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
28 Madrid;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
28 Madrid;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
28 Madrid;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
28 Madrid;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QIII;39.714
28 Madrid;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
28 Madrid;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
28 Madrid;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
28 Madrid;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QIII;38.352
28 Madrid;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
28 Madrid;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
28 Madrid;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
28 Madrid;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QIII;36.888
28 Madrid;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
28 Madrid;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
28 Madrid;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
28 Madrid;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2022QIII;38.557
28 Madrid;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2022QII;""
28 Madrid;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2022QI;""
28 Madrid;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
28 Madrid;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2021QIII;37.373
28 Madrid;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2021QII;""
28 Madrid;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2021QI;""
28 Madrid;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
28 Madrid;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2020QIII;35.867
28 Madrid;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2020QII;""
28 Madrid;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2020QI;""
28 Madrid;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2022QIV;37.338
28 Madrid;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
28 Madrid;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2022QII;""
28 Madrid;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2022QI;""
28 Madrid;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2021QIV;36.379
28 Madrid;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
28 Madrid;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2021QII;""
28 Madrid;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2021QI;""
28 Madrid;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2020QIV;34.886
28 Madrid;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
28 Madrid;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2020QII;""
28 Madrid;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2020QI;""
28 Madrid;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
28 Madrid;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
28 Madrid;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QII;""
28 Madrid;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QI;35.425
28 Madrid;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
28 Madrid;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
28 Madrid;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QII;""
28 Madrid;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QI;34.123
28 Madrid;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
28 Madrid;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
28 Madrid;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QII;""
28 Madrid;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QI;""
28 Madrid;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
28 Madrid;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
28 Madrid;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QII;34.480
28 Madrid;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QI;""
28 Madrid;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
28 Madrid;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
28 Madrid;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QII;33.314
28 Madrid;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QI;""
28 Madrid;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
28 Madrid;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
28 Madrid;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QII;""
28 Madrid;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QI;""
28 Madrid;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
28 Madrid;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
28 Madrid;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
28 Madrid;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
28 Madrid;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
28 Madrid;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
28 Madrid;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
28 Madrid;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
28 Madrid;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
28 Madrid;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
28 Madrid;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
28 Madrid;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
28 Madrid;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
28 Madrid;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;97,09
28 Madrid;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
28 Madrid;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
28 Madrid;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
28 Madrid;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;97,45
28 Madrid;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
28 Madrid;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
28 Madrid;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
28 Madrid;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;97,23
28 Madrid;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
28 Madrid;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
28 Madrid;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;94,02
28 Madrid;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
28 Madrid;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
28 Madrid;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
28 Madrid;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;94,86
28 Madrid;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
28 Madrid;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
28 Madrid;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
28 Madrid;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;94,57
28 Madrid;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
28 Madrid;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
28 Madrid;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
28 Madrid;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
28 Madrid;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
28 Madrid;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
28 Madrid;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;92,37
28 Madrid;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
28 Madrid;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
28 Madrid;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
28 Madrid;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;92,5
28 Madrid;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
28 Madrid;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
28 Madrid;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
28 Madrid;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
28 Madrid;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
28 Madrid;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
28 Madrid;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;89,9
28 Madrid;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
28 Madrid;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
28 Madrid;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
28 Madrid;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;90,31
28 Madrid;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
28 Madrid;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
28 Madrid;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
28 Madrid;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
28 Madrid;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
28 Madrid;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QIV;114.785
28 Madrid;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
28 Madrid;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
28 Madrid;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
28 Madrid;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QIV;112.259
28 Madrid;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
28 Madrid;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
28 Madrid;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
28 Madrid;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QIV;108.558
28 Madrid;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
28 Madrid;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
28 Madrid;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
28 Madrid;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2022QIV;111.423
28 Madrid;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
28 Madrid;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2022QII;""
28 Madrid;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2022QI;""
28 Madrid;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2021QIV;109.404
28 Madrid;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
28 Madrid;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2021QII;""
28 Madrid;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2021QI;""
28 Madrid;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2020QIV;105.696
28 Madrid;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
28 Madrid;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2020QII;""
28 Madrid;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2020QI;""
28 Madrid;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
28 Madrid;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
28 Madrid;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2022QII;""
28 Madrid;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2022QI;106.704
28 Madrid;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
28 Madrid;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
28 Madrid;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2021QII;""
28 Madrid;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2021QI;103.643
28 Madrid;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
28 Madrid;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
28 Madrid;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2020QII;""
28 Madrid;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2020QI;""
28 Madrid;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
28 Madrid;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
28 Madrid;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QII;104.095
28 Madrid;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QI;""
28 Madrid;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
28 Madrid;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
28 Madrid;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QII;101.422
28 Madrid;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QI;""
28 Madrid;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
28 Madrid;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
28 Madrid;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QII;""
28 Madrid;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QI;""
28 Madrid;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
28 Madrid;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QIII;101.969
28 Madrid;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QII;""
28 Madrid;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QI;""
28 Madrid;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
28 Madrid;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QIII;99.644
28 Madrid;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QII;""
28 Madrid;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QI;""
28 Madrid;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
28 Madrid;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
28 Madrid;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QII;""
28 Madrid;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QI;""
28 Madrid;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
28 Madrid;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
28 Madrid;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
28 Madrid;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
28 Madrid;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
28 Madrid;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
28 Madrid;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
28 Madrid;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
28 Madrid;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
28 Madrid;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
28 Madrid;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
28 Madrid;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
28 Madrid;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;97,07
28 Madrid;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
28 Madrid;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
28 Madrid;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
28 Madrid;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;97,46
28 Madrid;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
28 Madrid;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
28 Madrid;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
28 Madrid;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;97,36
28 Madrid;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
28 Madrid;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
28 Madrid;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
28 Madrid;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
28 Madrid;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
28 Madrid;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
28 Madrid;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;95,05
28 Madrid;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
28 Madrid;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
28 Madrid;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
28 Madrid;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;95,47
28 Madrid;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
28 Madrid;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
28 Madrid;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
28 Madrid;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
28 Madrid;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
28 Madrid;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
28 Madrid;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;92,73
28 Madrid;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
28 Madrid;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
28 Madrid;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
28 Madrid;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;93,43
28 Madrid;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
28 Madrid;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
28 Madrid;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
28 Madrid;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
28 Madrid;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
28 Madrid;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
28 Madrid;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;90,83
28 Madrid;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
28 Madrid;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
28 Madrid;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
28 Madrid;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;91,79
28 Madrid;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
28 Madrid;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
28 Madrid;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
28 Madrid;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
28 Madrid;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
28 Madrid;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
28 Madrid;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QIV;75.211
28 Madrid;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
28 Madrid;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
28 Madrid;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
28 Madrid;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QIV;73.925
28 Madrid;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
28 Madrid;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
28 Madrid;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
28 Madrid;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QIV;71.708
28 Madrid;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
28 Madrid;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
28 Madrid;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
28 Madrid;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2022QIV;73.179
28 Madrid;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
28 Madrid;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2022QII;""
28 Madrid;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2022QI;""
28 Madrid;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2021QIV;72.159
28 Madrid;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
28 Madrid;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2021QII;""
28 Madrid;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2021QI;""
28 Madrid;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2020QIV;69.934
28 Madrid;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
28 Madrid;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2020QII;""
28 Madrid;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2020QI;""
28 Madrid;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
28 Madrid;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
28 Madrid;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2022QII;""
28 Madrid;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2022QI;70.479
28 Madrid;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
28 Madrid;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
28 Madrid;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2021QII;""
28 Madrid;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2021QI;68.699
28 Madrid;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
28 Madrid;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
28 Madrid;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2020QII;""
28 Madrid;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2020QI;""
28 Madrid;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
28 Madrid;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
28 Madrid;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QII;68.919
28 Madrid;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QI;""
28 Madrid;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
28 Madrid;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
28 Madrid;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QII;67.374
28 Madrid;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QI;""
28 Madrid;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
28 Madrid;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
28 Madrid;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QII;""
28 Madrid;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QI;""
28 Madrid;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
28 Madrid;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QIII;67.649
28 Madrid;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QII;""
28 Madrid;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QI;""
28 Madrid;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
28 Madrid;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QIII;66.290
28 Madrid;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QII;""
28 Madrid;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QI;""
28 Madrid;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
28 Madrid;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
28 Madrid;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QII;""
28 Madrid;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QI;""
28 Madrid;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
28 Madrid;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
28 Madrid;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
28 Madrid;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
28 Madrid;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
28 Madrid;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
28 Madrid;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
28 Madrid;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
28 Madrid;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
28 Madrid;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
28 Madrid;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
28 Madrid;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
28 Madrid;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;97,3
28 Madrid;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
28 Madrid;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
28 Madrid;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
28 Madrid;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;97,61
28 Madrid;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
28 Madrid;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
28 Madrid;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
28 Madrid;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;97,53
28 Madrid;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
28 Madrid;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
28 Madrid;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
28 Madrid;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
28 Madrid;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
28 Madrid;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
28 Madrid;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;95,34
28 Madrid;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
28 Madrid;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
28 Madrid;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
28 Madrid;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;95,8
28 Madrid;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
28 Madrid;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
28 Madrid;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
28 Madrid;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
28 Madrid;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
28 Madrid;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
28 Madrid;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;93,23
28 Madrid;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
28 Madrid;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
28 Madrid;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
28 Madrid;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;93,96
28 Madrid;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
28 Madrid;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
28 Madrid;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
28 Madrid;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
28 Madrid;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
28 Madrid;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
28 Madrid;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;91,51
28 Madrid;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
28 Madrid;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
28 Madrid;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
28 Madrid;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;92,44
28 Madrid;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
28 Madrid;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
28 Madrid;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
28 Madrid;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
28 Madrid;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
28 Madrid;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
28 Madrid;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QIV;39.574
28 Madrid;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
28 Madrid;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
28 Madrid;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
28 Madrid;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QIV;38.334
28 Madrid;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
28 Madrid;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
28 Madrid;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
28 Madrid;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QIV;36.850
28 Madrid;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
28 Madrid;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
28 Madrid;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
28 Madrid;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2022QIV;38.244
28 Madrid;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
28 Madrid;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2022QII;""
28 Madrid;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2022QI;""
28 Madrid;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2021QIV;37.245
28 Madrid;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
28 Madrid;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2021QII;""
28 Madrid;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2021QI;""
28 Madrid;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2020QIV;35.762
28 Madrid;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
28 Madrid;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2020QII;""
28 Madrid;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2020QI;""
28 Madrid;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
28 Madrid;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
28 Madrid;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2022QII;""
28 Madrid;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2022QI;36.225
28 Madrid;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
28 Madrid;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
28 Madrid;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2021QII;""
28 Madrid;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2021QI;34.944
28 Madrid;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
28 Madrid;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
28 Madrid;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2020QII;""
28 Madrid;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2020QI;""
28 Madrid;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
28 Madrid;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
28 Madrid;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QII;35.176
28 Madrid;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QI;""
28 Madrid;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
28 Madrid;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
28 Madrid;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QII;34.048
28 Madrid;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QI;""
28 Madrid;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
28 Madrid;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
28 Madrid;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QII;""
28 Madrid;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QI;""
28 Madrid;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
28 Madrid;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QIII;34.320
28 Madrid;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QII;""
28 Madrid;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QI;""
28 Madrid;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
28 Madrid;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QIII;33.354
28 Madrid;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QII;""
28 Madrid;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QI;""
28 Madrid;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
28 Madrid;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
28 Madrid;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QII;""
28 Madrid;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QI;""
28 Madrid;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
28 Madrid;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
28 Madrid;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
28 Madrid;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
28 Madrid;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
28 Madrid;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
28 Madrid;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
28 Madrid;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
28 Madrid;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
28 Madrid;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
28 Madrid;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
28 Madrid;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
28 Madrid;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;96,64
28 Madrid;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
28 Madrid;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
28 Madrid;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
28 Madrid;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;97,16
28 Madrid;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
28 Madrid;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
28 Madrid;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
28 Madrid;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;97,05
28 Madrid;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
28 Madrid;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
28 Madrid;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
28 Madrid;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
28 Madrid;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
28 Madrid;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
28 Madrid;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;94,5
28 Madrid;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
28 Madrid;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
28 Madrid;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
28 Madrid;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;94,83
28 Madrid;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
28 Madrid;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
28 Madrid;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
28 Madrid;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
28 Madrid;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
28 Madrid;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
28 Madrid;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;91,76
28 Madrid;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
28 Madrid;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
28 Madrid;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
28 Madrid;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;92,4
28 Madrid;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
28 Madrid;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
28 Madrid;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
28 Madrid;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
28 Madrid;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
28 Madrid;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
28 Madrid;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;89,53
28 Madrid;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
28 Madrid;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
28 Madrid;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
28 Madrid;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;90,51
28 Madrid;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
28 Madrid;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
28 Madrid;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
28 Madrid;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
28 Madrid;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
28 Madrid;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
28 Madrid;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
28 Madrid;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
28 Madrid;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
28 Madrid;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QI;49.689
28 Madrid;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
28 Madrid;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
28 Madrid;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
28 Madrid;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QI;47.695
28 Madrid;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
28 Madrid;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
28 Madrid;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
28 Madrid;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QI;53.292
28 Madrid;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
28 Madrid;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
28 Madrid;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2022QII;""
28 Madrid;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2022QI;47.788
28 Madrid;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
28 Madrid;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
28 Madrid;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2021QII;""
28 Madrid;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2021QI;46.067
28 Madrid;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
28 Madrid;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
28 Madrid;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2020QII;""
28 Madrid;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2020QI;49.856
28 Madrid;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
28 Madrid;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
28 Madrid;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2022QII;45.937
28 Madrid;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2022QI;""
28 Madrid;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
28 Madrid;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
28 Madrid;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2021QII;44.362
28 Madrid;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2021QI;""
28 Madrid;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
28 Madrid;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
28 Madrid;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2020QII;48.438
28 Madrid;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2020QI;""
28 Madrid;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
28 Madrid;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QIII;44.298
28 Madrid;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QII;""
28 Madrid;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QI;""
28 Madrid;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
28 Madrid;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QIII;42.836
28 Madrid;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QII;""
28 Madrid;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QI;""
28 Madrid;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
28 Madrid;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QIII;46.647
28 Madrid;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QII;""
28 Madrid;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QI;""
28 Madrid;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QIV;42.099
28 Madrid;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
28 Madrid;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QII;""
28 Madrid;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QI;""
28 Madrid;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QIV;40.996
28 Madrid;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
28 Madrid;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QII;""
28 Madrid;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QI;""
28 Madrid;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QIV;44.690
28 Madrid;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
28 Madrid;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QII;""
28 Madrid;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QI;""
28 Madrid;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
28 Madrid;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
28 Madrid;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
28 Madrid;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
28 Madrid;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
28 Madrid;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
28 Madrid;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
28 Madrid;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
28 Madrid;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
28 Madrid;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
28 Madrid;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
28 Madrid;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
28 Madrid;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
28 Madrid;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
28 Madrid;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
28 Madrid;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;96,17
28 Madrid;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
28 Madrid;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
28 Madrid;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
28 Madrid;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;96,59
28 Madrid;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
28 Madrid;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
28 Madrid;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
28 Madrid;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;93,55
28 Madrid;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
28 Madrid;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
28 Madrid;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;92,45
28 Madrid;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
28 Madrid;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
28 Madrid;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
28 Madrid;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;93,01
28 Madrid;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
28 Madrid;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
28 Madrid;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
28 Madrid;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;90,89
28 Madrid;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
28 Madrid;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
28 Madrid;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;89,15
28 Madrid;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
28 Madrid;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
28 Madrid;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
28 Madrid;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;89,81
28 Madrid;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
28 Madrid;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
28 Madrid;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
28 Madrid;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;87,53
28 Madrid;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
28 Madrid;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
28 Madrid;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;84,72
28 Madrid;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
28 Madrid;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
28 Madrid;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
28 Madrid;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;85,95
28 Madrid;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
28 Madrid;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
28 Madrid;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
28 Madrid;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;83,86
28 Madrid;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
28 Madrid;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
28 Madrid;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
28 Madrid;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
28 Madrid;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
28 Madrid;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
28 Madrid;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QI;33.505
28 Madrid;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
28 Madrid;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
28 Madrid;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
28 Madrid;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QI;32.301
28 Madrid;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
28 Madrid;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
28 Madrid;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
28 Madrid;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QI;35.991
28 Madrid;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
28 Madrid;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
28 Madrid;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2022QII;""
28 Madrid;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2022QI;32.291
28 Madrid;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
28 Madrid;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
28 Madrid;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2021QII;""
28 Madrid;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2021QI;31.221
28 Madrid;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
28 Madrid;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
28 Madrid;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2020QII;""
28 Madrid;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2020QI;33.747
28 Madrid;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
28 Madrid;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
28 Madrid;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2022QII;31.141
28 Madrid;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2022QI;""
28 Madrid;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
28 Madrid;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
28 Madrid;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2021QII;30.129
28 Madrid;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2021QI;""
28 Madrid;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
28 Madrid;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
28 Madrid;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2020QII;32.856
28 Madrid;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2020QI;""
28 Madrid;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
28 Madrid;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QIII;30.118
28 Madrid;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QII;""
28 Madrid;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QI;""
28 Madrid;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
28 Madrid;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QIII;29.148
28 Madrid;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QII;""
28 Madrid;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QI;""
28 Madrid;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
28 Madrid;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QIII;31.684
28 Madrid;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QII;""
28 Madrid;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QI;""
28 Madrid;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QIV;28.638
28 Madrid;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
28 Madrid;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QII;""
28 Madrid;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QI;""
28 Madrid;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QIV;27.934
28 Madrid;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
28 Madrid;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QII;""
28 Madrid;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QI;""
28 Madrid;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QIV;30.412
28 Madrid;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
28 Madrid;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QII;""
28 Madrid;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QI;""
28 Madrid;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
28 Madrid;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
28 Madrid;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
28 Madrid;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
28 Madrid;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
28 Madrid;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
28 Madrid;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
28 Madrid;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
28 Madrid;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
28 Madrid;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
28 Madrid;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
28 Madrid;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
28 Madrid;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
28 Madrid;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
28 Madrid;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
28 Madrid;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;96,38
28 Madrid;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
28 Madrid;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
28 Madrid;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
28 Madrid;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;96,66
28 Madrid;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
28 Madrid;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
28 Madrid;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
28 Madrid;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;93,77
28 Madrid;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
28 Madrid;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
28 Madrid;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;92,94
28 Madrid;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
28 Madrid;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
28 Madrid;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
28 Madrid;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;93,28
28 Madrid;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
28 Madrid;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
28 Madrid;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
28 Madrid;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;91,29
28 Madrid;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
28 Madrid;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
28 Madrid;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;89,89
28 Madrid;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
28 Madrid;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
28 Madrid;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
28 Madrid;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;90,24
28 Madrid;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
28 Madrid;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
28 Madrid;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
28 Madrid;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;88,03
28 Madrid;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
28 Madrid;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
28 Madrid;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;85,47
28 Madrid;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
28 Madrid;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
28 Madrid;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
28 Madrid;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;86,48
28 Madrid;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
28 Madrid;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
28 Madrid;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
28 Madrid;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;84,5
28 Madrid;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
28 Madrid;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
28 Madrid;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
28 Madrid;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
28 Madrid;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
28 Madrid;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
28 Madrid;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QI;16.184
28 Madrid;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
28 Madrid;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
28 Madrid;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
28 Madrid;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QI;15.394
28 Madrid;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
28 Madrid;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
28 Madrid;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
28 Madrid;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QI;17.301
28 Madrid;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
28 Madrid;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
28 Madrid;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2022QII;""
28 Madrid;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2022QI;15.497
28 Madrid;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
28 Madrid;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
28 Madrid;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2021QII;""
28 Madrid;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2021QI;14.846
28 Madrid;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
28 Madrid;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
28 Madrid;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2020QII;""
28 Madrid;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2020QI;16.109
28 Madrid;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
28 Madrid;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
28 Madrid;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2022QII;14.796
28 Madrid;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2022QI;""
28 Madrid;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
28 Madrid;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
28 Madrid;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2021QII;14.233
28 Madrid;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2021QI;""
28 Madrid;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
28 Madrid;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
28 Madrid;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2020QII;15.582
28 Madrid;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2020QI;""
28 Madrid;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
28 Madrid;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QIII;14.180
28 Madrid;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QII;""
28 Madrid;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QI;""
28 Madrid;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
28 Madrid;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QIII;13.688
28 Madrid;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QII;""
28 Madrid;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QI;""
28 Madrid;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
28 Madrid;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QIII;14.963
28 Madrid;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QII;""
28 Madrid;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QI;""
28 Madrid;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QIV;13.461
28 Madrid;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
28 Madrid;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QII;""
28 Madrid;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QI;""
28 Madrid;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QIV;13.062
28 Madrid;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
28 Madrid;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QII;""
28 Madrid;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QI;""
28 Madrid;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QIV;14.278
28 Madrid;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
28 Madrid;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QII;""
28 Madrid;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QI;""
28 Madrid;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
28 Madrid;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
28 Madrid;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
28 Madrid;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
28 Madrid;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
28 Madrid;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
28 Madrid;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
28 Madrid;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
28 Madrid;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
28 Madrid;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
28 Madrid;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
28 Madrid;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
28 Madrid;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
28 Madrid;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
28 Madrid;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
28 Madrid;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;95,76
28 Madrid;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
28 Madrid;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
28 Madrid;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
28 Madrid;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;96,44
28 Madrid;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
28 Madrid;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
28 Madrid;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
28 Madrid;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;93,11
28 Madrid;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
28 Madrid;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
28 Madrid;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;91,42
28 Madrid;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
28 Madrid;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
28 Madrid;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
28 Madrid;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;92,46
28 Madrid;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
28 Madrid;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
28 Madrid;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
28 Madrid;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;90,06
28 Madrid;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
28 Madrid;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
28 Madrid;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;87,62
28 Madrid;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
28 Madrid;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
28 Madrid;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
28 Madrid;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;88,92
28 Madrid;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
28 Madrid;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
28 Madrid;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
28 Madrid;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;86,49
28 Madrid;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
28 Madrid;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
28 Madrid;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;83,17
28 Madrid;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
28 Madrid;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
28 Madrid;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
28 Madrid;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;84,85
28 Madrid;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
28 Madrid;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
28 Madrid;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
28 Madrid;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;82,53
28 Madrid;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
28 Madrid;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
28 Madrid;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
28 Madrid;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
28 Madrid;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
28 Madrid;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QII;55.843
28 Madrid;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
28 Madrid;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
28 Madrid;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
28 Madrid;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QII;53.224
28 Madrid;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
28 Madrid;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
28 Madrid;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
28 Madrid;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QII;51.451
28 Madrid;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
28 Madrid;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
28 Madrid;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
28 Madrid;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2022QII;53.716
28 Madrid;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2022QI;""
28 Madrid;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
28 Madrid;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
28 Madrid;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2021QII;51.290
28 Madrid;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2021QI;""
28 Madrid;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
28 Madrid;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
28 Madrid;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2020QII;49.909
28 Madrid;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2020QI;""
28 Madrid;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
28 Madrid;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2022QIII;51.873
28 Madrid;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2022QII;""
28 Madrid;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2022QI;""
28 Madrid;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
28 Madrid;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2021QIII;49.614
28 Madrid;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2021QII;""
28 Madrid;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2021QI;""
28 Madrid;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
28 Madrid;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2020QIII;47.784
28 Madrid;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2020QII;""
28 Madrid;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2020QI;""
28 Madrid;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QIV;49.441
28 Madrid;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
28 Madrid;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QII;""
28 Madrid;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QI;""
28 Madrid;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QIV;47.601
28 Madrid;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
28 Madrid;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QII;""
28 Madrid;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QI;""
28 Madrid;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QIV;45.757
28 Madrid;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
28 Madrid;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QII;""
28 Madrid;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QI;""
28 Madrid;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
28 Madrid;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
28 Madrid;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QII;""
28 Madrid;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QI;45.923
28 Madrid;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
28 Madrid;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
28 Madrid;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QII;""
28 Madrid;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QI;44.299
28 Madrid;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
28 Madrid;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
28 Madrid;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QII;""
28 Madrid;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QI;""
28 Madrid;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
28 Madrid;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
28 Madrid;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
28 Madrid;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
28 Madrid;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
28 Madrid;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
28 Madrid;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
28 Madrid;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
28 Madrid;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
28 Madrid;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
28 Madrid;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
28 Madrid;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
28 Madrid;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
28 Madrid;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
28 Madrid;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;96,19
28 Madrid;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
28 Madrid;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
28 Madrid;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
28 Madrid;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;96,37
28 Madrid;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
28 Madrid;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
28 Madrid;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
28 Madrid;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;97
28 Madrid;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
28 Madrid;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
28 Madrid;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;92,89
28 Madrid;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
28 Madrid;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
28 Madrid;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
28 Madrid;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;93,22
28 Madrid;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
28 Madrid;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
28 Madrid;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
28 Madrid;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;92,87
28 Madrid;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
28 Madrid;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
28 Madrid;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;88,54
28 Madrid;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
28 Madrid;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
28 Madrid;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
28 Madrid;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;89,44
28 Madrid;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
28 Madrid;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
28 Madrid;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
28 Madrid;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;88,93
28 Madrid;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
28 Madrid;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
28 Madrid;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
28 Madrid;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
28 Madrid;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
28 Madrid;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
28 Madrid;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;86,28
28 Madrid;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
28 Madrid;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
28 Madrid;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
28 Madrid;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;86,1
28 Madrid;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
28 Madrid;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
28 Madrid;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
28 Madrid;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
28 Madrid;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
28 Madrid;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
28 Madrid;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QII;37.668
28 Madrid;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
28 Madrid;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
28 Madrid;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
28 Madrid;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QII;35.943
28 Madrid;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
28 Madrid;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
28 Madrid;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
28 Madrid;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QII;34.830
28 Madrid;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
28 Madrid;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
28 Madrid;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
28 Madrid;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2022QII;36.351
28 Madrid;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2022QI;""
28 Madrid;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
28 Madrid;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
28 Madrid;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2021QII;34.700
28 Madrid;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2021QI;""
28 Madrid;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
28 Madrid;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
28 Madrid;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2020QII;33.844
28 Madrid;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2020QI;""
28 Madrid;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
28 Madrid;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2022QIII;35.196
28 Madrid;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2022QII;""
28 Madrid;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2022QI;""
28 Madrid;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
28 Madrid;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2021QIII;33.622
28 Madrid;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2021QII;""
28 Madrid;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2021QI;""
28 Madrid;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
28 Madrid;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2020QIII;32.425
28 Madrid;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2020QII;""
28 Madrid;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2020QI;""
28 Madrid;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QIV;33.577
28 Madrid;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
28 Madrid;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QII;""
28 Madrid;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QI;""
28 Madrid;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QIV;32.307
28 Madrid;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
28 Madrid;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QII;""
28 Madrid;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QI;""
28 Madrid;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QIV;31.106
28 Madrid;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
28 Madrid;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QII;""
28 Madrid;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QI;""
28 Madrid;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
28 Madrid;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
28 Madrid;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QII;""
28 Madrid;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QI;31.225
28 Madrid;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
28 Madrid;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
28 Madrid;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QII;""
28 Madrid;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QI;30.139
28 Madrid;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
28 Madrid;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
28 Madrid;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QII;""
28 Madrid;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QI;""
28 Madrid;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
28 Madrid;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
28 Madrid;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
28 Madrid;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
28 Madrid;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
28 Madrid;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
28 Madrid;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
28 Madrid;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
28 Madrid;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
28 Madrid;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
28 Madrid;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
28 Madrid;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
28 Madrid;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
28 Madrid;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
28 Madrid;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;96,5
28 Madrid;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
28 Madrid;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
28 Madrid;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
28 Madrid;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;96,54
28 Madrid;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
28 Madrid;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
28 Madrid;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
28 Madrid;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;97,17
28 Madrid;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
28 Madrid;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
28 Madrid;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;93,44
28 Madrid;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
28 Madrid;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
28 Madrid;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
28 Madrid;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;93,54
28 Madrid;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
28 Madrid;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
28 Madrid;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
28 Madrid;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;93,1
28 Madrid;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
28 Madrid;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
28 Madrid;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;89,14
28 Madrid;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
28 Madrid;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
28 Madrid;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
28 Madrid;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;89,88
28 Madrid;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
28 Madrid;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
28 Madrid;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
28 Madrid;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;89,31
28 Madrid;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
28 Madrid;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
28 Madrid;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
28 Madrid;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
28 Madrid;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
28 Madrid;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
28 Madrid;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;86,87
28 Madrid;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
28 Madrid;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
28 Madrid;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
28 Madrid;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;86,53
28 Madrid;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
28 Madrid;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
28 Madrid;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
28 Madrid;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
28 Madrid;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
28 Madrid;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
28 Madrid;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QII;18.175
28 Madrid;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
28 Madrid;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
28 Madrid;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
28 Madrid;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QII;17.281
28 Madrid;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
28 Madrid;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
28 Madrid;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
28 Madrid;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QII;16.621
28 Madrid;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
28 Madrid;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
28 Madrid;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
28 Madrid;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2022QII;17.365
28 Madrid;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2022QI;""
28 Madrid;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
28 Madrid;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
28 Madrid;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2021QII;16.590
28 Madrid;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2021QI;""
28 Madrid;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
28 Madrid;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
28 Madrid;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2020QII;16.065
28 Madrid;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2020QI;""
28 Madrid;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
28 Madrid;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2022QIII;16.677
28 Madrid;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2022QII;""
28 Madrid;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2022QI;""
28 Madrid;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
28 Madrid;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2021QIII;15.992
28 Madrid;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2021QII;""
28 Madrid;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2021QI;""
28 Madrid;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
28 Madrid;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2020QIII;15.359
28 Madrid;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2020QII;""
28 Madrid;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2020QI;""
28 Madrid;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QIV;15.864
28 Madrid;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
28 Madrid;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QII;""
28 Madrid;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QI;""
28 Madrid;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QIV;15.294
28 Madrid;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
28 Madrid;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QII;""
28 Madrid;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QI;""
28 Madrid;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QIV;14.651
28 Madrid;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
28 Madrid;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QII;""
28 Madrid;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QI;""
28 Madrid;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
28 Madrid;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
28 Madrid;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QII;""
28 Madrid;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QI;14.698
28 Madrid;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
28 Madrid;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
28 Madrid;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QII;""
28 Madrid;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QI;14.160
28 Madrid;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
28 Madrid;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
28 Madrid;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QII;""
28 Madrid;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QI;""
28 Madrid;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
28 Madrid;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
28 Madrid;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
28 Madrid;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
28 Madrid;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
28 Madrid;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
28 Madrid;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
28 Madrid;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
28 Madrid;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
28 Madrid;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
28 Madrid;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
28 Madrid;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
28 Madrid;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
28 Madrid;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
28 Madrid;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;95,54
28 Madrid;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
28 Madrid;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
28 Madrid;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
28 Madrid;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;96
28 Madrid;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
28 Madrid;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
28 Madrid;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
28 Madrid;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;96,65
28 Madrid;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
28 Madrid;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
28 Madrid;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;91,76
28 Madrid;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
28 Madrid;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
28 Madrid;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
28 Madrid;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;92,54
28 Madrid;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
28 Madrid;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
28 Madrid;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
28 Madrid;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;92,41
28 Madrid;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
28 Madrid;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
28 Madrid;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;87,28
28 Madrid;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
28 Madrid;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
28 Madrid;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
28 Madrid;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;88,5
28 Madrid;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
28 Madrid;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
28 Madrid;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
28 Madrid;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;88,15
28 Madrid;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
28 Madrid;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
28 Madrid;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
28 Madrid;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
28 Madrid;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
28 Madrid;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
28 Madrid;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;85,05
28 Madrid;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
28 Madrid;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
28 Madrid;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
28 Madrid;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;85,19
28 Madrid;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
28 Madrid;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
28 Madrid;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
28 Madrid;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
28 Madrid;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
28 Madrid;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QIII;54.558
28 Madrid;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
28 Madrid;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
28 Madrid;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
28 Madrid;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QIII;52.119
28 Madrid;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
28 Madrid;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
28 Madrid;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
28 Madrid;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QIII;50.509
28 Madrid;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
28 Madrid;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
28 Madrid;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
28 Madrid;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2022QIII;52.595
28 Madrid;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2022QII;""
28 Madrid;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2022QI;""
28 Madrid;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
28 Madrid;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2021QIII;50.335
28 Madrid;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2021QII;""
28 Madrid;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2021QI;""
28 Madrid;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
28 Madrid;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2020QIII;48.298
28 Madrid;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2020QII;""
28 Madrid;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2020QI;""
28 Madrid;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2022QIV;50.071
28 Madrid;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
28 Madrid;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2022QII;""
28 Madrid;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2022QI;""
28 Madrid;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2021QIV;48.244
28 Madrid;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
28 Madrid;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2021QII;""
28 Madrid;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2021QI;""
28 Madrid;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2020QIV;46.226
28 Madrid;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
28 Madrid;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2020QII;""
28 Madrid;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2020QI;""
28 Madrid;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
28 Madrid;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
28 Madrid;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QII;""
28 Madrid;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QI;46.517
28 Madrid;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
28 Madrid;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
28 Madrid;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QII;""
28 Madrid;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QI;44.737
28 Madrid;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
28 Madrid;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
28 Madrid;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QII;""
28 Madrid;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QI;""
28 Madrid;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
28 Madrid;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
28 Madrid;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QII;44.813
28 Madrid;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QI;""
28 Madrid;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
28 Madrid;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
28 Madrid;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QII;43.184
28 Madrid;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QI;""
28 Madrid;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
28 Madrid;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
28 Madrid;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QII;""
28 Madrid;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QI;""
28 Madrid;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
28 Madrid;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
28 Madrid;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
28 Madrid;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
28 Madrid;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
28 Madrid;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
28 Madrid;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
28 Madrid;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
28 Madrid;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
28 Madrid;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
28 Madrid;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
28 Madrid;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
28 Madrid;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
28 Madrid;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;96,4
28 Madrid;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
28 Madrid;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
28 Madrid;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
28 Madrid;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;96,58
28 Madrid;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
28 Madrid;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
28 Madrid;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
28 Madrid;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;95,62
28 Madrid;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
28 Madrid;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
28 Madrid;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;91,78
28 Madrid;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
28 Madrid;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
28 Madrid;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
28 Madrid;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;92,57
28 Madrid;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
28 Madrid;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
28 Madrid;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
28 Madrid;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;91,52
28 Madrid;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
28 Madrid;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
28 Madrid;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
28 Madrid;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
28 Madrid;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
28 Madrid;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
28 Madrid;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;89,25
28 Madrid;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
28 Madrid;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
28 Madrid;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
28 Madrid;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;88,57
28 Madrid;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
28 Madrid;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
28 Madrid;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
28 Madrid;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
28 Madrid;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
28 Madrid;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
28 Madrid;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;85,98
28 Madrid;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
28 Madrid;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
28 Madrid;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
28 Madrid;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;85,5
28 Madrid;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
28 Madrid;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
28 Madrid;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
28 Madrid;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
28 Madrid;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
28 Madrid;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
28 Madrid;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QIII;36.822
28 Madrid;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
28 Madrid;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
28 Madrid;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
28 Madrid;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QIII;35.214
28 Madrid;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
28 Madrid;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
28 Madrid;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
28 Madrid;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QIII;34.241
28 Madrid;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
28 Madrid;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
28 Madrid;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
28 Madrid;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2022QIII;35.599
28 Madrid;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2022QII;""
28 Madrid;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2022QI;""
28 Madrid;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
28 Madrid;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2021QIII;34.068
28 Madrid;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2021QII;""
28 Madrid;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2021QI;""
28 Madrid;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
28 Madrid;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2020QIII;32.766
28 Madrid;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2020QII;""
28 Madrid;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2020QI;""
28 Madrid;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2022QIV;33.921
28 Madrid;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
28 Madrid;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2022QII;""
28 Madrid;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2022QI;""
28 Madrid;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2021QIV;32.702
28 Madrid;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
28 Madrid;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2021QII;""
28 Madrid;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2021QI;""
28 Madrid;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2020QIV;31.414
28 Madrid;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
28 Madrid;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2020QII;""
28 Madrid;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2020QI;""
28 Madrid;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
28 Madrid;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
28 Madrid;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QII;""
28 Madrid;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QI;31.590
28 Madrid;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
28 Madrid;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
28 Madrid;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QII;""
28 Madrid;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QI;30.429
28 Madrid;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
28 Madrid;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
28 Madrid;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QII;""
28 Madrid;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QI;""
28 Madrid;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
28 Madrid;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
28 Madrid;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QII;30.510
28 Madrid;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QI;""
28 Madrid;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
28 Madrid;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
28 Madrid;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QII;29.433
28 Madrid;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QI;""
28 Madrid;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
28 Madrid;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
28 Madrid;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QII;""
28 Madrid;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QI;""
28 Madrid;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
28 Madrid;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
28 Madrid;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
28 Madrid;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
28 Madrid;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
28 Madrid;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
28 Madrid;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
28 Madrid;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
28 Madrid;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
28 Madrid;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
28 Madrid;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
28 Madrid;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
28 Madrid;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
28 Madrid;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;96,68
28 Madrid;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
28 Madrid;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
28 Madrid;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
28 Madrid;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;96,75
28 Madrid;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
28 Madrid;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
28 Madrid;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
28 Madrid;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;95,69
28 Madrid;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
28 Madrid;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
28 Madrid;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;92,12
28 Madrid;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
28 Madrid;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
28 Madrid;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
28 Madrid;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;92,87
28 Madrid;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
28 Madrid;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
28 Madrid;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
28 Madrid;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;91,74
28 Madrid;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
28 Madrid;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
28 Madrid;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
28 Madrid;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
28 Madrid;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
28 Madrid;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
28 Madrid;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;89,71
28 Madrid;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
28 Madrid;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
28 Madrid;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
28 Madrid;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;88,87
28 Madrid;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
28 Madrid;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
28 Madrid;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
28 Madrid;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
28 Madrid;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
28 Madrid;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
28 Madrid;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;86,64
28 Madrid;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
28 Madrid;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
28 Madrid;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
28 Madrid;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;85,96
28 Madrid;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
28 Madrid;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
28 Madrid;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
28 Madrid;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
28 Madrid;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
28 Madrid;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
28 Madrid;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QIII;17.736
28 Madrid;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
28 Madrid;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
28 Madrid;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
28 Madrid;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QIII;16.905
28 Madrid;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
28 Madrid;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
28 Madrid;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
28 Madrid;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QIII;16.268
28 Madrid;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
28 Madrid;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
28 Madrid;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
28 Madrid;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2022QIII;16.996
28 Madrid;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2022QII;""
28 Madrid;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2022QI;""
28 Madrid;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
28 Madrid;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2021QIII;16.267
28 Madrid;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2021QII;""
28 Madrid;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2021QI;""
28 Madrid;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
28 Madrid;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2020QIII;15.532
28 Madrid;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2020QII;""
28 Madrid;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2020QI;""
28 Madrid;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2022QIV;16.150
28 Madrid;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
28 Madrid;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2022QII;""
28 Madrid;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2022QI;""
28 Madrid;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2021QIV;15.542
28 Madrid;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
28 Madrid;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2021QII;""
28 Madrid;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2021QI;""
28 Madrid;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2020QIV;14.812
28 Madrid;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
28 Madrid;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2020QII;""
28 Madrid;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2020QI;""
28 Madrid;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
28 Madrid;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
28 Madrid;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QII;""
28 Madrid;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QI;14.927
28 Madrid;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
28 Madrid;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
28 Madrid;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QII;""
28 Madrid;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QI;14.308
28 Madrid;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
28 Madrid;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
28 Madrid;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QII;""
28 Madrid;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QI;""
28 Madrid;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
28 Madrid;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
28 Madrid;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QII;14.303
28 Madrid;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QI;""
28 Madrid;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
28 Madrid;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
28 Madrid;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QII;13.751
28 Madrid;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QI;""
28 Madrid;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
28 Madrid;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
28 Madrid;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QII;""
28 Madrid;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QI;""
28 Madrid;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
28 Madrid;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
28 Madrid;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
28 Madrid;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
28 Madrid;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
28 Madrid;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
28 Madrid;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
28 Madrid;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
28 Madrid;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
28 Madrid;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
28 Madrid;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
28 Madrid;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
28 Madrid;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
28 Madrid;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;95,83
28 Madrid;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
28 Madrid;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
28 Madrid;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
28 Madrid;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;96,23
28 Madrid;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
28 Madrid;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
28 Madrid;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
28 Madrid;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;95,48
28 Madrid;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
28 Madrid;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
28 Madrid;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;91,06
28 Madrid;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
28 Madrid;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
28 Madrid;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
28 Madrid;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;91,94
28 Madrid;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
28 Madrid;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
28 Madrid;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
28 Madrid;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;91,05
28 Madrid;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
28 Madrid;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
28 Madrid;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
28 Madrid;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
28 Madrid;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
28 Madrid;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
28 Madrid;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;88,3
28 Madrid;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
28 Madrid;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
28 Madrid;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
28 Madrid;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;87,95
28 Madrid;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
28 Madrid;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
28 Madrid;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
28 Madrid;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
28 Madrid;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
28 Madrid;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
28 Madrid;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;84,61
28 Madrid;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
28 Madrid;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
28 Madrid;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
28 Madrid;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;84,53
28 Madrid;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
28 Madrid;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
28 Madrid;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
28 Madrid;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
28 Madrid;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
28 Madrid;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QIV;53.303
28 Madrid;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
28 Madrid;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
28 Madrid;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
28 Madrid;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QIV;51.020
28 Madrid;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
28 Madrid;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
28 Madrid;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
28 Madrid;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QIV;49.056
28 Madrid;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
28 Madrid;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
28 Madrid;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
28 Madrid;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2022QIV;50.679
28 Madrid;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
28 Madrid;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2022QII;""
28 Madrid;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2022QI;""
28 Madrid;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2021QIV;48.830
28 Madrid;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
28 Madrid;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2021QII;""
28 Madrid;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2021QI;""
28 Madrid;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2020QIV;46.870
28 Madrid;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
28 Madrid;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2020QII;""
28 Madrid;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2020QI;""
28 Madrid;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
28 Madrid;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
28 Madrid;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2022QII;""
28 Madrid;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2022QI;47.048
28 Madrid;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
28 Madrid;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
28 Madrid;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2021QII;""
28 Madrid;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2021QI;45.340
28 Madrid;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
28 Madrid;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
28 Madrid;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2020QII;""
28 Madrid;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2020QI;""
28 Madrid;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
28 Madrid;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
28 Madrid;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QII;45.286
28 Madrid;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QI;""
28 Madrid;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
28 Madrid;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
28 Madrid;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QII;43.730
28 Madrid;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QI;""
28 Madrid;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
28 Madrid;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
28 Madrid;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QII;""
28 Madrid;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QI;""
28 Madrid;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
28 Madrid;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QIII;43.702
28 Madrid;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QII;""
28 Madrid;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QI;""
28 Madrid;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
28 Madrid;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QIII;42.255
28 Madrid;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QII;""
28 Madrid;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QI;""
28 Madrid;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
28 Madrid;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
28 Madrid;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QII;""
28 Madrid;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QI;""
28 Madrid;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
28 Madrid;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
28 Madrid;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
28 Madrid;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
28 Madrid;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
28 Madrid;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
28 Madrid;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
28 Madrid;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
28 Madrid;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
28 Madrid;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
28 Madrid;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
28 Madrid;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
28 Madrid;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;95,08
28 Madrid;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
28 Madrid;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
28 Madrid;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
28 Madrid;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;95,71
28 Madrid;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
28 Madrid;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
28 Madrid;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
28 Madrid;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;95,54
28 Madrid;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
28 Madrid;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
28 Madrid;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
28 Madrid;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
28 Madrid;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
28 Madrid;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
28 Madrid;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;92,21
28 Madrid;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
28 Madrid;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
28 Madrid;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
28 Madrid;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;92,42
28 Madrid;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
28 Madrid;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
28 Madrid;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
28 Madrid;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
28 Madrid;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
28 Madrid;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
28 Madrid;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;88,76
28 Madrid;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
28 Madrid;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
28 Madrid;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
28 Madrid;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;89,14
28 Madrid;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
28 Madrid;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
28 Madrid;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
28 Madrid;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
28 Madrid;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
28 Madrid;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
28 Madrid;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;85,66
28 Madrid;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
28 Madrid;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
28 Madrid;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
28 Madrid;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;86,14
28 Madrid;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
28 Madrid;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
28 Madrid;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
28 Madrid;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
28 Madrid;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
28 Madrid;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
28 Madrid;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QIV;36.019
28 Madrid;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
28 Madrid;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
28 Madrid;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
28 Madrid;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QIV;34.444
28 Madrid;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
28 Madrid;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
28 Madrid;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
28 Madrid;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QIV;33.228
28 Madrid;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
28 Madrid;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
28 Madrid;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
28 Madrid;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2022QIV;34.285
28 Madrid;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
28 Madrid;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2022QII;""
28 Madrid;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2022QI;""
28 Madrid;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2021QIV;33.012
28 Madrid;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
28 Madrid;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2021QII;""
28 Madrid;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2021QI;""
28 Madrid;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2020QIV;31.811
28 Madrid;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
28 Madrid;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2020QII;""
28 Madrid;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2020QI;""
28 Madrid;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
28 Madrid;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
28 Madrid;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2022QII;""
28 Madrid;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2022QI;31.873
28 Madrid;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
28 Madrid;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
28 Madrid;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2021QII;""
28 Madrid;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2021QI;30.798
28 Madrid;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
28 Madrid;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
28 Madrid;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2020QII;""
28 Madrid;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2020QI;""
28 Madrid;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
28 Madrid;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
28 Madrid;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QII;30.763
28 Madrid;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QI;""
28 Madrid;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
28 Madrid;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
28 Madrid;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QII;29.766
28 Madrid;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QI;""
28 Madrid;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
28 Madrid;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
28 Madrid;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QII;""
28 Madrid;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QI;""
28 Madrid;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
28 Madrid;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QIII;29.769
28 Madrid;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QII;""
28 Madrid;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QI;""
28 Madrid;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
28 Madrid;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QIII;28.814
28 Madrid;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QII;""
28 Madrid;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QI;""
28 Madrid;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
28 Madrid;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
28 Madrid;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QII;""
28 Madrid;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QI;""
28 Madrid;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
28 Madrid;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
28 Madrid;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
28 Madrid;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
28 Madrid;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
28 Madrid;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
28 Madrid;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
28 Madrid;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
28 Madrid;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
28 Madrid;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
28 Madrid;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
28 Madrid;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
28 Madrid;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;95,19
28 Madrid;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
28 Madrid;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
28 Madrid;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
28 Madrid;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;95,84
28 Madrid;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
28 Madrid;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
28 Madrid;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
28 Madrid;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;95,74
28 Madrid;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
28 Madrid;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
28 Madrid;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
28 Madrid;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
28 Madrid;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
28 Madrid;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
28 Madrid;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;92,54
28 Madrid;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
28 Madrid;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
28 Madrid;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
28 Madrid;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;92,69
28 Madrid;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
28 Madrid;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
28 Madrid;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
28 Madrid;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
28 Madrid;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
28 Madrid;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
28 Madrid;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;89,31
28 Madrid;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
28 Madrid;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
28 Madrid;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
28 Madrid;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;89,58
28 Madrid;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
28 Madrid;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
28 Madrid;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
28 Madrid;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
28 Madrid;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
28 Madrid;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
28 Madrid;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;86,43
28 Madrid;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
28 Madrid;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
28 Madrid;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
28 Madrid;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;86,72
28 Madrid;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
28 Madrid;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
28 Madrid;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
28 Madrid;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
28 Madrid;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
28 Madrid;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
28 Madrid;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QIV;17.284
28 Madrid;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
28 Madrid;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
28 Madrid;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
28 Madrid;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QIV;16.576
28 Madrid;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
28 Madrid;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
28 Madrid;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
28 Madrid;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QIV;15.828
28 Madrid;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
28 Madrid;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
28 Madrid;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
28 Madrid;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2022QIV;16.394
28 Madrid;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
28 Madrid;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2022QII;""
28 Madrid;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2022QI;""
28 Madrid;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2021QIV;15.818
28 Madrid;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
28 Madrid;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2021QII;""
28 Madrid;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2021QI;""
28 Madrid;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2020QIV;15.059
28 Madrid;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
28 Madrid;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2020QII;""
28 Madrid;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2020QI;""
28 Madrid;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
28 Madrid;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
28 Madrid;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2022QII;""
28 Madrid;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2022QI;15.175
28 Madrid;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
28 Madrid;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
28 Madrid;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2021QII;""
28 Madrid;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2021QI;14.542
28 Madrid;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
28 Madrid;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
28 Madrid;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2020QII;""
28 Madrid;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2020QI;""
28 Madrid;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
28 Madrid;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
28 Madrid;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QII;14.523
28 Madrid;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QI;""
28 Madrid;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
28 Madrid;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
28 Madrid;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QII;13.964
28 Madrid;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QI;""
28 Madrid;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
28 Madrid;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
28 Madrid;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QII;""
28 Madrid;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QI;""
28 Madrid;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
28 Madrid;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QIII;13.933
28 Madrid;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QII;""
28 Madrid;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QI;""
28 Madrid;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
28 Madrid;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QIII;13.441
28 Madrid;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QII;""
28 Madrid;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QI;""
28 Madrid;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
28 Madrid;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
28 Madrid;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QII;""
28 Madrid;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QI;""
28 Madrid;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
28 Madrid;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
28 Madrid;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
28 Madrid;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
28 Madrid;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
28 Madrid;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
28 Madrid;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
28 Madrid;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
28 Madrid;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
28 Madrid;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
28 Madrid;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
28 Madrid;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
28 Madrid;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;94,85
28 Madrid;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
28 Madrid;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
28 Madrid;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
28 Madrid;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;95,43
28 Madrid;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
28 Madrid;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
28 Madrid;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
28 Madrid;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;95,14
28 Madrid;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
28 Madrid;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
28 Madrid;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
28 Madrid;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
28 Madrid;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
28 Madrid;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
28 Madrid;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;91,55
28 Madrid;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
28 Madrid;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
28 Madrid;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
28 Madrid;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;91,88
28 Madrid;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
28 Madrid;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
28 Madrid;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
28 Madrid;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
28 Madrid;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
28 Madrid;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
28 Madrid;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;87,61
28 Madrid;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
28 Madrid;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
28 Madrid;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
28 Madrid;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;88,22
28 Madrid;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
28 Madrid;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
28 Madrid;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
28 Madrid;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
28 Madrid;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
28 Madrid;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
28 Madrid;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;84,06
28 Madrid;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
28 Madrid;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
28 Madrid;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
28 Madrid;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;84,92
28 Madrid;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
28 Madrid;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
28 Madrid;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
28 Madrid;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
28 Madrid;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
28 Madrid;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
29 Málaga;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
29 Málaga;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
29 Málaga;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
29 Málaga;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QI;120.577
29 Málaga;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
29 Málaga;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
29 Málaga;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
29 Málaga;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QI;116.350
29 Málaga;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
29 Málaga;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
29 Málaga;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
29 Málaga;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QI;115.920
29 Málaga;All ages;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
29 Málaga;All ages;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
29 Málaga;All ages;Cohort January 1;Total;Survival in the first trimester;2022QII;""
29 Málaga;All ages;Cohort January 1;Total;Survival in the first trimester;2022QI;115.147
29 Málaga;All ages;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
29 Málaga;All ages;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
29 Málaga;All ages;Cohort January 1;Total;Survival in the first trimester;2021QII;""
29 Málaga;All ages;Cohort January 1;Total;Survival in the first trimester;2021QI;112.757
29 Málaga;All ages;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
29 Málaga;All ages;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
29 Málaga;All ages;Cohort January 1;Total;Survival in the first trimester;2020QII;""
29 Málaga;All ages;Cohort January 1;Total;Survival in the first trimester;2020QI;106.812
29 Málaga;All ages;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
29 Málaga;All ages;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
29 Málaga;All ages;Cohort January 1;Total;Survival in the second trimester;2022QII;110.874
29 Málaga;All ages;Cohort January 1;Total;Survival in the second trimester;2022QI;""
29 Málaga;All ages;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
29 Málaga;All ages;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
29 Málaga;All ages;Cohort January 1;Total;Survival in the second trimester;2021QII;108.930
29 Málaga;All ages;Cohort January 1;Total;Survival in the second trimester;2021QI;""
29 Málaga;All ages;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
29 Málaga;All ages;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
29 Málaga;All ages;Cohort January 1;Total;Survival in the second trimester;2020QII;104.262
29 Málaga;All ages;Cohort January 1;Total;Survival in the second trimester;2020QI;""
29 Málaga;All ages;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
29 Málaga;All ages;Cohort January 1;Total;Survival in the third trimester;2022QIII;107.350
29 Málaga;All ages;Cohort January 1;Total;Survival in the third trimester;2022QII;""
29 Málaga;All ages;Cohort January 1;Total;Survival in the third trimester;2022QI;""
29 Málaga;All ages;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
29 Málaga;All ages;Cohort January 1;Total;Survival in the third trimester;2021QIII;105.650
29 Málaga;All ages;Cohort January 1;Total;Survival in the third trimester;2021QII;""
29 Málaga;All ages;Cohort January 1;Total;Survival in the third trimester;2021QI;""
29 Málaga;All ages;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
29 Málaga;All ages;Cohort January 1;Total;Survival in the third trimester;2020QIII;100.730
29 Málaga;All ages;Cohort January 1;Total;Survival in the third trimester;2020QII;""
29 Málaga;All ages;Cohort January 1;Total;Survival in the third trimester;2020QI;""
29 Málaga;All ages;Cohort January 1;Total;Survival in the third trimester;2022QIV;103.276
29 Málaga;All ages;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
29 Málaga;All ages;Cohort January 1;Total;Survival in the third trimester;2022QII;""
29 Málaga;All ages;Cohort January 1;Total;Survival in the third trimester;2022QI;""
29 Málaga;All ages;Cohort January 1;Total;Survival in the third trimester;2021QIV;101.953
29 Málaga;All ages;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
29 Málaga;All ages;Cohort January 1;Total;Survival in the third trimester;2021QII;""
29 Málaga;All ages;Cohort January 1;Total;Survival in the third trimester;2021QI;""
29 Málaga;All ages;Cohort January 1;Total;Survival in the third trimester;2020QIV;97.648
29 Málaga;All ages;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
29 Málaga;All ages;Cohort January 1;Total;Survival in the third trimester;2020QII;""
29 Málaga;All ages;Cohort January 1;Total;Survival in the third trimester;2020QI;""
29 Málaga;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
29 Málaga;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
29 Málaga;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
29 Málaga;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
29 Málaga;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
29 Málaga;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
29 Málaga;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
29 Málaga;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
29 Málaga;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
29 Málaga;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
29 Málaga;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
29 Málaga;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
29 Málaga;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
29 Málaga;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
29 Málaga;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
29 Málaga;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;95,5
29 Málaga;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
29 Málaga;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
29 Málaga;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
29 Málaga;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;96,91
29 Málaga;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
29 Málaga;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
29 Málaga;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
29 Málaga;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;92,14
29 Málaga;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
29 Málaga;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
29 Málaga;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;91,95
29 Málaga;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
29 Málaga;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
29 Málaga;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
29 Málaga;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;93,62
29 Málaga;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
29 Málaga;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
29 Málaga;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
29 Málaga;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;89,94
29 Málaga;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
29 Málaga;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
29 Málaga;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;89,03
29 Málaga;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
29 Málaga;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
29 Málaga;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
29 Málaga;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;90,8
29 Málaga;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
29 Málaga;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
29 Málaga;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
29 Málaga;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;86,9
29 Málaga;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
29 Málaga;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
29 Málaga;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;85,65
29 Málaga;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
29 Málaga;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
29 Málaga;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
29 Málaga;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;87,63
29 Málaga;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
29 Málaga;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
29 Málaga;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
29 Málaga;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;84,24
29 Málaga;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
29 Málaga;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
29 Málaga;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
29 Málaga;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
29 Málaga;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
29 Málaga;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
29 Málaga;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QI;75.481
29 Málaga;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
29 Málaga;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
29 Málaga;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
29 Málaga;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QI;73.704
29 Málaga;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
29 Málaga;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
29 Málaga;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
29 Málaga;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QI;73.221
29 Málaga;All ages;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
29 Málaga;All ages;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
29 Málaga;All ages;Cohort January 1;Males;Survival in the first trimester;2022QII;""
29 Málaga;All ages;Cohort January 1;Males;Survival in the first trimester;2022QI;72.204
29 Málaga;All ages;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
29 Málaga;All ages;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
29 Málaga;All ages;Cohort January 1;Males;Survival in the first trimester;2021QII;""
29 Málaga;All ages;Cohort January 1;Males;Survival in the first trimester;2021QI;71.523
29 Málaga;All ages;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
29 Málaga;All ages;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
29 Málaga;All ages;Cohort January 1;Males;Survival in the first trimester;2020QII;""
29 Málaga;All ages;Cohort January 1;Males;Survival in the first trimester;2020QI;67.907
29 Málaga;All ages;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
29 Málaga;All ages;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
29 Málaga;All ages;Cohort January 1;Males;Survival in the second trimester;2022QII;69.747
29 Málaga;All ages;Cohort January 1;Males;Survival in the second trimester;2022QI;""
29 Málaga;All ages;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
29 Málaga;All ages;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
29 Málaga;All ages;Cohort January 1;Males;Survival in the second trimester;2021QII;69.209
29 Málaga;All ages;Cohort January 1;Males;Survival in the second trimester;2021QI;""
29 Málaga;All ages;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
29 Málaga;All ages;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
29 Málaga;All ages;Cohort January 1;Males;Survival in the second trimester;2020QII;66.398
29 Málaga;All ages;Cohort January 1;Males;Survival in the second trimester;2020QI;""
29 Málaga;All ages;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
29 Málaga;All ages;Cohort January 1;Males;Survival in the third trimester;2022QIII;67.798
29 Málaga;All ages;Cohort January 1;Males;Survival in the third trimester;2022QII;""
29 Málaga;All ages;Cohort January 1;Males;Survival in the third trimester;2022QI;""
29 Málaga;All ages;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
29 Málaga;All ages;Cohort January 1;Males;Survival in the third trimester;2021QIII;67.206
29 Málaga;All ages;Cohort January 1;Males;Survival in the third trimester;2021QII;""
29 Málaga;All ages;Cohort January 1;Males;Survival in the third trimester;2021QI;""
29 Málaga;All ages;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
29 Málaga;All ages;Cohort January 1;Males;Survival in the third trimester;2020QIII;64.385
29 Málaga;All ages;Cohort January 1;Males;Survival in the third trimester;2020QII;""
29 Málaga;All ages;Cohort January 1;Males;Survival in the third trimester;2020QI;""
29 Málaga;All ages;Cohort January 1;Males;Survival in the third trimester;2022QIV;65.423
29 Málaga;All ages;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
29 Málaga;All ages;Cohort January 1;Males;Survival in the third trimester;2022QII;""
29 Málaga;All ages;Cohort January 1;Males;Survival in the third trimester;2022QI;""
29 Málaga;All ages;Cohort January 1;Males;Survival in the third trimester;2021QIV;65.008
29 Málaga;All ages;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
29 Málaga;All ages;Cohort January 1;Males;Survival in the third trimester;2021QII;""
29 Málaga;All ages;Cohort January 1;Males;Survival in the third trimester;2021QI;""
29 Málaga;All ages;Cohort January 1;Males;Survival in the third trimester;2020QIV;62.598
29 Málaga;All ages;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
29 Málaga;All ages;Cohort January 1;Males;Survival in the third trimester;2020QII;""
29 Málaga;All ages;Cohort January 1;Males;Survival in the third trimester;2020QI;""
29 Málaga;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
29 Málaga;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
29 Málaga;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
29 Málaga;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
29 Málaga;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
29 Málaga;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
29 Málaga;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
29 Málaga;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
29 Málaga;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
29 Málaga;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
29 Málaga;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
29 Málaga;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
29 Málaga;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
29 Málaga;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
29 Málaga;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
29 Málaga;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;95,66
29 Málaga;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
29 Málaga;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
29 Málaga;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
29 Málaga;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;97,04
29 Málaga;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
29 Málaga;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
29 Málaga;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
29 Málaga;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;92,74
29 Málaga;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
29 Málaga;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
29 Málaga;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;92,4
29 Málaga;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
29 Málaga;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
29 Málaga;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
29 Málaga;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;93,9
29 Málaga;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
29 Málaga;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
29 Málaga;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
29 Málaga;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;90,68
29 Málaga;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
29 Málaga;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
29 Málaga;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;89,82
29 Málaga;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
29 Málaga;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
29 Málaga;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
29 Málaga;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;91,18
29 Málaga;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
29 Málaga;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
29 Málaga;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
29 Málaga;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;87,93
29 Málaga;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
29 Málaga;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
29 Málaga;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;86,67
29 Málaga;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
29 Málaga;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
29 Málaga;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
29 Málaga;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;88,2
29 Málaga;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
29 Málaga;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
29 Málaga;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
29 Málaga;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;85,49
29 Málaga;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
29 Málaga;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
29 Málaga;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
29 Málaga;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
29 Málaga;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
29 Málaga;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
29 Málaga;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QI;45.096
29 Málaga;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
29 Málaga;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
29 Málaga;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
29 Málaga;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QI;42.646
29 Málaga;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
29 Málaga;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
29 Málaga;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
29 Málaga;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QI;42.699
29 Málaga;All ages;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
29 Málaga;All ages;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
29 Málaga;All ages;Cohort January 1;Females;Survival in the first trimester;2022QII;""
29 Málaga;All ages;Cohort January 1;Females;Survival in the first trimester;2022QI;42.943
29 Málaga;All ages;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
29 Málaga;All ages;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
29 Málaga;All ages;Cohort January 1;Females;Survival in the first trimester;2021QII;""
29 Málaga;All ages;Cohort January 1;Females;Survival in the first trimester;2021QI;41.234
29 Málaga;All ages;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
29 Málaga;All ages;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
29 Málaga;All ages;Cohort January 1;Females;Survival in the first trimester;2020QII;""
29 Málaga;All ages;Cohort January 1;Females;Survival in the first trimester;2020QI;38.905
29 Málaga;All ages;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
29 Málaga;All ages;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
29 Málaga;All ages;Cohort January 1;Females;Survival in the second trimester;2022QII;41.127
29 Málaga;All ages;Cohort January 1;Females;Survival in the second trimester;2022QI;""
29 Málaga;All ages;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
29 Málaga;All ages;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
29 Málaga;All ages;Cohort January 1;Females;Survival in the second trimester;2021QII;39.721
29 Málaga;All ages;Cohort January 1;Females;Survival in the second trimester;2021QI;""
29 Málaga;All ages;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
29 Málaga;All ages;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
29 Málaga;All ages;Cohort January 1;Females;Survival in the second trimester;2020QII;37.864
29 Málaga;All ages;Cohort January 1;Females;Survival in the second trimester;2020QI;""
29 Málaga;All ages;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
29 Málaga;All ages;Cohort January 1;Females;Survival in the third trimester;2022QIII;39.552
29 Málaga;All ages;Cohort January 1;Females;Survival in the third trimester;2022QII;""
29 Málaga;All ages;Cohort January 1;Females;Survival in the third trimester;2022QI;""
29 Málaga;All ages;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
29 Málaga;All ages;Cohort January 1;Females;Survival in the third trimester;2021QIII;38.444
29 Málaga;All ages;Cohort January 1;Females;Survival in the third trimester;2021QII;""
29 Málaga;All ages;Cohort January 1;Females;Survival in the third trimester;2021QI;""
29 Málaga;All ages;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
29 Málaga;All ages;Cohort January 1;Females;Survival in the third trimester;2020QIII;36.345
29 Málaga;All ages;Cohort January 1;Females;Survival in the third trimester;2020QII;""
29 Málaga;All ages;Cohort January 1;Females;Survival in the third trimester;2020QI;""
29 Málaga;All ages;Cohort January 1;Females;Survival in the third trimester;2022QIV;37.853
29 Málaga;All ages;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
29 Málaga;All ages;Cohort January 1;Females;Survival in the third trimester;2022QII;""
29 Málaga;All ages;Cohort January 1;Females;Survival in the third trimester;2022QI;""
29 Málaga;All ages;Cohort January 1;Females;Survival in the third trimester;2021QIV;36.945
29 Málaga;All ages;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
29 Málaga;All ages;Cohort January 1;Females;Survival in the third trimester;2021QII;""
29 Málaga;All ages;Cohort January 1;Females;Survival in the third trimester;2021QI;""
29 Málaga;All ages;Cohort January 1;Females;Survival in the third trimester;2020QIV;35.050
29 Málaga;All ages;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
29 Málaga;All ages;Cohort January 1;Females;Survival in the third trimester;2020QII;""
29 Málaga;All ages;Cohort January 1;Females;Survival in the third trimester;2020QI;""
29 Málaga;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
29 Málaga;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
29 Málaga;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
29 Málaga;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
29 Málaga;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
29 Málaga;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
29 Málaga;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
29 Málaga;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
29 Málaga;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
29 Málaga;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
29 Málaga;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
29 Málaga;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
29 Málaga;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
29 Málaga;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
29 Málaga;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
29 Málaga;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;95,23
29 Málaga;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
29 Málaga;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
29 Málaga;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
29 Málaga;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;96,69
29 Málaga;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
29 Málaga;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
29 Málaga;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
29 Málaga;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;91,11
29 Málaga;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
29 Málaga;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
29 Málaga;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;91,2
29 Málaga;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
29 Málaga;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
29 Málaga;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
29 Málaga;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;93,14
29 Málaga;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
29 Málaga;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
29 Málaga;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
29 Málaga;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;88,68
29 Málaga;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
29 Málaga;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
29 Málaga;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;87,71
29 Málaga;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
29 Málaga;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
29 Málaga;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
29 Málaga;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;90,15
29 Málaga;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
29 Málaga;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
29 Málaga;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
29 Málaga;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;85,12
29 Málaga;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
29 Málaga;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
29 Málaga;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;83,94
29 Málaga;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
29 Málaga;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
29 Málaga;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
29 Málaga;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;86,63
29 Málaga;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
29 Málaga;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
29 Málaga;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
29 Málaga;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;82,09
29 Málaga;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
29 Málaga;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
29 Málaga;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
29 Málaga;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
29 Málaga;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
29 Málaga;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QII;120.932
29 Málaga;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
29 Málaga;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
29 Málaga;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
29 Málaga;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QII;118.088
29 Málaga;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
29 Málaga;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
29 Málaga;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
29 Málaga;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QII;113.162
29 Málaga;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
29 Málaga;All ages;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
29 Málaga;All ages;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
29 Málaga;All ages;Cohort April 1;Total;Survival in the first trimester;2022QII;116.139
29 Málaga;All ages;Cohort April 1;Total;Survival in the first trimester;2022QI;""
29 Málaga;All ages;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
29 Málaga;All ages;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
29 Málaga;All ages;Cohort April 1;Total;Survival in the first trimester;2021QII;113.712
29 Málaga;All ages;Cohort April 1;Total;Survival in the first trimester;2021QI;""
29 Málaga;All ages;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
29 Málaga;All ages;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
29 Málaga;All ages;Cohort April 1;Total;Survival in the first trimester;2020QII;110.205
29 Málaga;All ages;Cohort April 1;Total;Survival in the first trimester;2020QI;""
29 Málaga;All ages;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
29 Málaga;All ages;Cohort April 1;Total;Survival in the second trimester;2022QIII;112.216
29 Málaga;All ages;Cohort April 1;Total;Survival in the second trimester;2022QII;""
29 Málaga;All ages;Cohort April 1;Total;Survival in the second trimester;2022QI;""
29 Málaga;All ages;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
29 Málaga;All ages;Cohort April 1;Total;Survival in the second trimester;2021QIII;110.047
29 Málaga;All ages;Cohort April 1;Total;Survival in the second trimester;2021QII;""
29 Málaga;All ages;Cohort April 1;Total;Survival in the second trimester;2021QI;""
29 Málaga;All ages;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
29 Málaga;All ages;Cohort April 1;Total;Survival in the second trimester;2020QIII;106.089
29 Málaga;All ages;Cohort April 1;Total;Survival in the second trimester;2020QII;""
29 Málaga;All ages;Cohort April 1;Total;Survival in the second trimester;2020QI;""
29 Málaga;All ages;Cohort April 1;Total;Survival in the third trimester;2022QIV;107.696
29 Málaga;All ages;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
29 Málaga;All ages;Cohort April 1;Total;Survival in the third trimester;2022QII;""
29 Málaga;All ages;Cohort April 1;Total;Survival in the third trimester;2022QI;""
29 Málaga;All ages;Cohort April 1;Total;Survival in the third trimester;2021QIV;105.995
29 Málaga;All ages;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
29 Málaga;All ages;Cohort April 1;Total;Survival in the third trimester;2021QII;""
29 Málaga;All ages;Cohort April 1;Total;Survival in the third trimester;2021QI;""
29 Málaga;All ages;Cohort April 1;Total;Survival in the third trimester;2020QIV;102.623
29 Málaga;All ages;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
29 Málaga;All ages;Cohort April 1;Total;Survival in the third trimester;2020QII;""
29 Málaga;All ages;Cohort April 1;Total;Survival in the third trimester;2020QI;""
29 Málaga;All ages;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
29 Málaga;All ages;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
29 Málaga;All ages;Cohort April 1;Total;Survival in the third trimester;2022QII;""
29 Málaga;All ages;Cohort April 1;Total;Survival in the third trimester;2022QI;101.838
29 Málaga;All ages;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
29 Málaga;All ages;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
29 Málaga;All ages;Cohort April 1;Total;Survival in the third trimester;2021QII;""
29 Málaga;All ages;Cohort April 1;Total;Survival in the third trimester;2021QI;100.174
29 Málaga;All ages;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
29 Málaga;All ages;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
29 Málaga;All ages;Cohort April 1;Total;Survival in the third trimester;2020QII;""
29 Málaga;All ages;Cohort April 1;Total;Survival in the third trimester;2020QI;""
29 Málaga;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
29 Málaga;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
29 Málaga;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
29 Málaga;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
29 Málaga;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
29 Málaga;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
29 Málaga;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
29 Málaga;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
29 Málaga;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
29 Málaga;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
29 Málaga;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
29 Málaga;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
29 Málaga;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
29 Málaga;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
29 Málaga;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;96,04
29 Málaga;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
29 Málaga;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
29 Málaga;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
29 Málaga;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;96,29
29 Málaga;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
29 Málaga;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
29 Málaga;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
29 Málaga;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;97,39
29 Málaga;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
29 Málaga;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
29 Málaga;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;92,79
29 Málaga;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
29 Málaga;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
29 Málaga;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
29 Málaga;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;93,19
29 Málaga;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
29 Málaga;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
29 Málaga;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
29 Málaga;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;93,75
29 Málaga;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
29 Málaga;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
29 Málaga;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;89,06
29 Málaga;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
29 Málaga;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
29 Málaga;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
29 Málaga;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;89,76
29 Málaga;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
29 Málaga;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
29 Málaga;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
29 Málaga;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;90,69
29 Málaga;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
29 Málaga;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
29 Málaga;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
29 Málaga;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
29 Málaga;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
29 Málaga;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
29 Málaga;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;86,24
29 Málaga;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
29 Málaga;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
29 Málaga;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
29 Málaga;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;88,52
29 Málaga;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
29 Málaga;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
29 Málaga;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
29 Málaga;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
29 Málaga;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
29 Málaga;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
29 Málaga;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QII;75.521
29 Málaga;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
29 Málaga;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
29 Málaga;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
29 Málaga;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QII;74.691
29 Málaga;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
29 Málaga;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
29 Málaga;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
29 Málaga;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QII;71.647
29 Málaga;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
29 Málaga;All ages;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
29 Málaga;All ages;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
29 Málaga;All ages;Cohort April 1;Males;Survival in the first trimester;2022QII;72.756
29 Málaga;All ages;Cohort April 1;Males;Survival in the first trimester;2022QI;""
29 Málaga;All ages;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
29 Málaga;All ages;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
29 Málaga;All ages;Cohort April 1;Males;Survival in the first trimester;2021QII;72.027
29 Málaga;All ages;Cohort April 1;Males;Survival in the first trimester;2021QI;""
29 Málaga;All ages;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
29 Málaga;All ages;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
29 Málaga;All ages;Cohort April 1;Males;Survival in the first trimester;2020QII;69.854
29 Málaga;All ages;Cohort April 1;Males;Survival in the first trimester;2020QI;""
29 Málaga;All ages;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
29 Málaga;All ages;Cohort April 1;Males;Survival in the second trimester;2022QIII;70.560
29 Málaga;All ages;Cohort April 1;Males;Survival in the second trimester;2022QII;""
29 Málaga;All ages;Cohort April 1;Males;Survival in the second trimester;2022QI;""
29 Málaga;All ages;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
29 Málaga;All ages;Cohort April 1;Males;Survival in the second trimester;2021QIII;69.792
29 Málaga;All ages;Cohort April 1;Males;Survival in the second trimester;2021QII;""
29 Málaga;All ages;Cohort April 1;Males;Survival in the second trimester;2021QI;""
29 Málaga;All ages;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
29 Málaga;All ages;Cohort April 1;Males;Survival in the second trimester;2020QIII;67.483
29 Málaga;All ages;Cohort April 1;Males;Survival in the second trimester;2020QII;""
29 Málaga;All ages;Cohort April 1;Males;Survival in the second trimester;2020QI;""
29 Málaga;All ages;Cohort April 1;Males;Survival in the third trimester;2022QIV;67.936
29 Málaga;All ages;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
29 Málaga;All ages;Cohort April 1;Males;Survival in the third trimester;2022QII;""
29 Málaga;All ages;Cohort April 1;Males;Survival in the third trimester;2022QI;""
29 Málaga;All ages;Cohort April 1;Males;Survival in the third trimester;2021QIV;67.391
29 Málaga;All ages;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
29 Málaga;All ages;Cohort April 1;Males;Survival in the third trimester;2021QII;""
29 Málaga;All ages;Cohort April 1;Males;Survival in the third trimester;2021QI;""
29 Málaga;All ages;Cohort April 1;Males;Survival in the third trimester;2020QIV;65.470
29 Málaga;All ages;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
29 Málaga;All ages;Cohort April 1;Males;Survival in the third trimester;2020QII;""
29 Málaga;All ages;Cohort April 1;Males;Survival in the third trimester;2020QI;""
29 Málaga;All ages;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
29 Málaga;All ages;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
29 Málaga;All ages;Cohort April 1;Males;Survival in the third trimester;2022QII;""
29 Málaga;All ages;Cohort April 1;Males;Survival in the third trimester;2022QI;64.872
29 Málaga;All ages;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
29 Málaga;All ages;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
29 Málaga;All ages;Cohort April 1;Males;Survival in the third trimester;2021QII;""
29 Málaga;All ages;Cohort April 1;Males;Survival in the third trimester;2021QI;63.965
29 Málaga;All ages;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
29 Málaga;All ages;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
29 Málaga;All ages;Cohort April 1;Males;Survival in the third trimester;2020QII;""
29 Málaga;All ages;Cohort April 1;Males;Survival in the third trimester;2020QI;""
29 Málaga;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
29 Málaga;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
29 Málaga;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
29 Málaga;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
29 Málaga;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
29 Málaga;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
29 Málaga;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
29 Málaga;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
29 Málaga;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
29 Málaga;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
29 Málaga;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
29 Málaga;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
29 Málaga;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
29 Málaga;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
29 Málaga;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;96,34
29 Málaga;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
29 Málaga;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
29 Málaga;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
29 Málaga;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;96,43
29 Málaga;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
29 Málaga;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
29 Málaga;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
29 Málaga;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;97,5
29 Málaga;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
29 Málaga;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
29 Málaga;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;93,43
29 Málaga;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
29 Málaga;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
29 Málaga;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
29 Málaga;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;93,44
29 Málaga;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
29 Málaga;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
29 Málaga;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
29 Málaga;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;94,19
29 Málaga;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
29 Málaga;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
29 Málaga;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;89,96
29 Málaga;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
29 Málaga;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
29 Málaga;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
29 Málaga;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;90,23
29 Málaga;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
29 Málaga;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
29 Málaga;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
29 Málaga;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;91,38
29 Málaga;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
29 Málaga;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
29 Málaga;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
29 Málaga;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
29 Málaga;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
29 Málaga;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
29 Málaga;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;86,85
29 Málaga;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
29 Málaga;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
29 Málaga;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
29 Málaga;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;89,28
29 Málaga;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
29 Málaga;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
29 Málaga;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
29 Málaga;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
29 Málaga;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
29 Málaga;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
29 Málaga;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QII;45.411
29 Málaga;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
29 Málaga;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
29 Málaga;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
29 Málaga;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QII;43.397
29 Málaga;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
29 Málaga;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
29 Málaga;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
29 Málaga;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QII;41.515
29 Málaga;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
29 Málaga;All ages;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
29 Málaga;All ages;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
29 Málaga;All ages;Cohort April 1;Females;Survival in the first trimester;2022QII;43.383
29 Málaga;All ages;Cohort April 1;Females;Survival in the first trimester;2022QI;""
29 Málaga;All ages;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
29 Málaga;All ages;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
29 Málaga;All ages;Cohort April 1;Females;Survival in the first trimester;2021QII;41.685
29 Málaga;All ages;Cohort April 1;Females;Survival in the first trimester;2021QI;""
29 Málaga;All ages;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
29 Málaga;All ages;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
29 Málaga;All ages;Cohort April 1;Females;Survival in the first trimester;2020QII;40.351
29 Málaga;All ages;Cohort April 1;Females;Survival in the first trimester;2020QI;""
29 Málaga;All ages;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
29 Málaga;All ages;Cohort April 1;Females;Survival in the second trimester;2022QIII;41.656
29 Málaga;All ages;Cohort April 1;Females;Survival in the second trimester;2022QII;""
29 Málaga;All ages;Cohort April 1;Females;Survival in the second trimester;2022QI;""
29 Málaga;All ages;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
29 Málaga;All ages;Cohort April 1;Females;Survival in the second trimester;2021QIII;40.255
29 Málaga;All ages;Cohort April 1;Females;Survival in the second trimester;2021QII;""
29 Málaga;All ages;Cohort April 1;Females;Survival in the second trimester;2021QI;""
29 Málaga;All ages;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
29 Málaga;All ages;Cohort April 1;Females;Survival in the second trimester;2020QIII;38.606
29 Málaga;All ages;Cohort April 1;Females;Survival in the second trimester;2020QII;""
29 Málaga;All ages;Cohort April 1;Females;Survival in the second trimester;2020QI;""
29 Málaga;All ages;Cohort April 1;Females;Survival in the third trimester;2022QIV;39.760
29 Málaga;All ages;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
29 Málaga;All ages;Cohort April 1;Females;Survival in the third trimester;2022QII;""
29 Málaga;All ages;Cohort April 1;Females;Survival in the third trimester;2022QI;""
29 Málaga;All ages;Cohort April 1;Females;Survival in the third trimester;2021QIV;38.604
29 Málaga;All ages;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
29 Málaga;All ages;Cohort April 1;Females;Survival in the third trimester;2021QII;""
29 Málaga;All ages;Cohort April 1;Females;Survival in the third trimester;2021QI;""
29 Málaga;All ages;Cohort April 1;Females;Survival in the third trimester;2020QIV;37.153
29 Málaga;All ages;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
29 Málaga;All ages;Cohort April 1;Females;Survival in the third trimester;2020QII;""
29 Málaga;All ages;Cohort April 1;Females;Survival in the third trimester;2020QI;""
29 Málaga;All ages;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
29 Málaga;All ages;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
29 Málaga;All ages;Cohort April 1;Females;Survival in the third trimester;2022QII;""
29 Málaga;All ages;Cohort April 1;Females;Survival in the third trimester;2022QI;36.966
29 Málaga;All ages;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
29 Málaga;All ages;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
29 Málaga;All ages;Cohort April 1;Females;Survival in the third trimester;2021QII;""
29 Málaga;All ages;Cohort April 1;Females;Survival in the third trimester;2021QI;36.209
29 Málaga;All ages;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
29 Málaga;All ages;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
29 Málaga;All ages;Cohort April 1;Females;Survival in the third trimester;2020QII;""
29 Málaga;All ages;Cohort April 1;Females;Survival in the third trimester;2020QI;""
29 Málaga;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
29 Málaga;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
29 Málaga;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
29 Málaga;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
29 Málaga;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
29 Málaga;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
29 Málaga;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
29 Málaga;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
29 Málaga;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
29 Málaga;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
29 Málaga;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
29 Málaga;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
29 Málaga;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
29 Málaga;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
29 Málaga;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;95,53
29 Málaga;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
29 Málaga;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
29 Málaga;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
29 Málaga;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;96,06
29 Málaga;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
29 Málaga;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
29 Málaga;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
29 Málaga;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;97,2
29 Málaga;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
29 Málaga;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
29 Málaga;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;91,73
29 Málaga;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
29 Málaga;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
29 Málaga;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
29 Málaga;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;92,76
29 Málaga;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
29 Málaga;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
29 Málaga;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
29 Málaga;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;92,99
29 Málaga;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
29 Málaga;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
29 Málaga;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;87,56
29 Málaga;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
29 Málaga;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
29 Málaga;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
29 Málaga;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;88,96
29 Málaga;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
29 Málaga;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
29 Málaga;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
29 Málaga;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;89,49
29 Málaga;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
29 Málaga;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
29 Málaga;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
29 Málaga;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
29 Málaga;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
29 Málaga;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
29 Málaga;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;85,18
29 Málaga;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
29 Málaga;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
29 Málaga;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
29 Málaga;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;87,22
29 Málaga;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
29 Málaga;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
29 Málaga;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
29 Málaga;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
29 Málaga;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
29 Málaga;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QIII;122.644
29 Málaga;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
29 Málaga;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
29 Málaga;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
29 Málaga;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QIII;120.159
29 Málaga;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
29 Málaga;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
29 Málaga;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
29 Málaga;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QIII;114.813
29 Málaga;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
29 Málaga;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
29 Málaga;All ages;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
29 Málaga;All ages;Cohort July 1;Total;Survival in the first trimester;2022QIII;117.881
29 Málaga;All ages;Cohort July 1;Total;Survival in the first trimester;2022QII;""
29 Málaga;All ages;Cohort July 1;Total;Survival in the first trimester;2022QI;""
29 Málaga;All ages;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
29 Málaga;All ages;Cohort July 1;Total;Survival in the first trimester;2021QIII;115.674
29 Málaga;All ages;Cohort July 1;Total;Survival in the first trimester;2021QII;""
29 Málaga;All ages;Cohort July 1;Total;Survival in the first trimester;2021QI;""
29 Málaga;All ages;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
29 Málaga;All ages;Cohort July 1;Total;Survival in the first trimester;2020QIII;110.110
29 Málaga;All ages;Cohort July 1;Total;Survival in the first trimester;2020QII;""
29 Málaga;All ages;Cohort July 1;Total;Survival in the first trimester;2020QI;""
29 Málaga;All ages;Cohort July 1;Total;Survival in the second trimester;2022QIV;112.623
29 Málaga;All ages;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
29 Málaga;All ages;Cohort July 1;Total;Survival in the second trimester;2022QII;""
29 Málaga;All ages;Cohort July 1;Total;Survival in the second trimester;2022QI;""
29 Málaga;All ages;Cohort July 1;Total;Survival in the second trimester;2021QIV;110.898
29 Málaga;All ages;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
29 Málaga;All ages;Cohort July 1;Total;Survival in the second trimester;2021QII;""
29 Málaga;All ages;Cohort July 1;Total;Survival in the second trimester;2021QI;""
29 Málaga;All ages;Cohort July 1;Total;Survival in the second trimester;2020QIV;106.191
29 Málaga;All ages;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
29 Málaga;All ages;Cohort July 1;Total;Survival in the second trimester;2020QII;""
29 Málaga;All ages;Cohort July 1;Total;Survival in the second trimester;2020QI;""
29 Málaga;All ages;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
29 Málaga;All ages;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
29 Málaga;All ages;Cohort July 1;Total;Survival in the third trimester;2022QII;""
29 Málaga;All ages;Cohort July 1;Total;Survival in the third trimester;2022QI;106.395
29 Málaga;All ages;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
29 Málaga;All ages;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
29 Málaga;All ages;Cohort July 1;Total;Survival in the third trimester;2021QII;""
29 Málaga;All ages;Cohort July 1;Total;Survival in the third trimester;2021QI;103.525
29 Málaga;All ages;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
29 Málaga;All ages;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
29 Málaga;All ages;Cohort July 1;Total;Survival in the third trimester;2020QII;""
29 Málaga;All ages;Cohort July 1;Total;Survival in the third trimester;2020QI;""
29 Málaga;All ages;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
29 Málaga;All ages;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
29 Málaga;All ages;Cohort July 1;Total;Survival in the third trimester;2022QII;102.855
29 Málaga;All ages;Cohort July 1;Total;Survival in the third trimester;2022QI;""
29 Málaga;All ages;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
29 Málaga;All ages;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
29 Málaga;All ages;Cohort July 1;Total;Survival in the third trimester;2021QII;100.520
29 Málaga;All ages;Cohort July 1;Total;Survival in the third trimester;2021QI;""
29 Málaga;All ages;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
29 Málaga;All ages;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
29 Málaga;All ages;Cohort July 1;Total;Survival in the third trimester;2020QII;""
29 Málaga;All ages;Cohort July 1;Total;Survival in the third trimester;2020QI;""
29 Málaga;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
29 Málaga;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
29 Málaga;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
29 Málaga;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
29 Málaga;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
29 Málaga;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
29 Málaga;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
29 Málaga;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
29 Málaga;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
29 Málaga;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
29 Málaga;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
29 Málaga;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
29 Málaga;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
29 Málaga;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;96,12
29 Málaga;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
29 Málaga;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
29 Málaga;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
29 Málaga;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;96,27
29 Málaga;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
29 Málaga;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
29 Málaga;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
29 Málaga;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;95,9
29 Málaga;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
29 Málaga;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
29 Málaga;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;91,83
29 Málaga;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
29 Málaga;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
29 Málaga;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
29 Málaga;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;92,29
29 Málaga;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
29 Málaga;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
29 Málaga;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
29 Málaga;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;92,49
29 Málaga;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
29 Málaga;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
29 Málaga;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
29 Málaga;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
29 Málaga;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
29 Málaga;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
29 Málaga;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;88,55
29 Málaga;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
29 Málaga;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
29 Málaga;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
29 Málaga;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;90,17
29 Málaga;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
29 Málaga;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
29 Málaga;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
29 Málaga;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
29 Málaga;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
29 Málaga;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
29 Málaga;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;85,6
29 Málaga;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
29 Málaga;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
29 Málaga;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
29 Málaga;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;87,55
29 Málaga;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
29 Málaga;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
29 Málaga;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
29 Málaga;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
29 Málaga;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
29 Málaga;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
29 Málaga;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QIII;76.411
29 Málaga;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
29 Málaga;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
29 Málaga;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
29 Málaga;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QIII;75.758
29 Málaga;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
29 Málaga;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
29 Málaga;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
29 Málaga;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QIII;72.769
29 Málaga;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
29 Málaga;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
29 Málaga;All ages;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
29 Málaga;All ages;Cohort July 1;Males;Survival in the first trimester;2022QIII;73.754
29 Málaga;All ages;Cohort July 1;Males;Survival in the first trimester;2022QII;""
29 Málaga;All ages;Cohort July 1;Males;Survival in the first trimester;2022QI;""
29 Málaga;All ages;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
29 Málaga;All ages;Cohort July 1;Males;Survival in the first trimester;2021QIII;73.045
29 Málaga;All ages;Cohort July 1;Males;Survival in the first trimester;2021QII;""
29 Málaga;All ages;Cohort July 1;Males;Survival in the first trimester;2021QI;""
29 Málaga;All ages;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
29 Málaga;All ages;Cohort July 1;Males;Survival in the first trimester;2020QIII;70.013
29 Málaga;All ages;Cohort July 1;Males;Survival in the first trimester;2020QII;""
29 Málaga;All ages;Cohort July 1;Males;Survival in the first trimester;2020QI;""
29 Málaga;All ages;Cohort July 1;Males;Survival in the second trimester;2022QIV;70.700
29 Málaga;All ages;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
29 Málaga;All ages;Cohort July 1;Males;Survival in the second trimester;2022QII;""
29 Málaga;All ages;Cohort July 1;Males;Survival in the second trimester;2022QI;""
29 Málaga;All ages;Cohort July 1;Males;Survival in the second trimester;2021QIV;70.190
29 Málaga;All ages;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
29 Málaga;All ages;Cohort July 1;Males;Survival in the second trimester;2021QII;""
29 Málaga;All ages;Cohort July 1;Males;Survival in the second trimester;2021QI;""
29 Málaga;All ages;Cohort July 1;Males;Survival in the second trimester;2020QIV;67.720
29 Málaga;All ages;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
29 Málaga;All ages;Cohort July 1;Males;Survival in the second trimester;2020QII;""
29 Málaga;All ages;Cohort July 1;Males;Survival in the second trimester;2020QI;""
29 Málaga;All ages;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
29 Málaga;All ages;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
29 Málaga;All ages;Cohort July 1;Males;Survival in the third trimester;2022QII;""
29 Málaga;All ages;Cohort July 1;Males;Survival in the third trimester;2022QI;67.475
29 Málaga;All ages;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
29 Málaga;All ages;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
29 Málaga;All ages;Cohort July 1;Males;Survival in the third trimester;2021QII;""
29 Málaga;All ages;Cohort July 1;Males;Survival in the third trimester;2021QI;66.088
29 Málaga;All ages;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
29 Málaga;All ages;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
29 Málaga;All ages;Cohort July 1;Males;Survival in the third trimester;2020QII;""
29 Málaga;All ages;Cohort July 1;Males;Survival in the third trimester;2020QI;""
29 Málaga;All ages;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
29 Málaga;All ages;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
29 Málaga;All ages;Cohort July 1;Males;Survival in the third trimester;2022QII;65.431
29 Málaga;All ages;Cohort July 1;Males;Survival in the third trimester;2022QI;""
29 Málaga;All ages;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
29 Málaga;All ages;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
29 Málaga;All ages;Cohort July 1;Males;Survival in the third trimester;2021QII;64.273
29 Málaga;All ages;Cohort July 1;Males;Survival in the third trimester;2021QI;""
29 Málaga;All ages;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
29 Málaga;All ages;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
29 Málaga;All ages;Cohort July 1;Males;Survival in the third trimester;2020QII;""
29 Málaga;All ages;Cohort July 1;Males;Survival in the third trimester;2020QI;""
29 Málaga;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
29 Málaga;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
29 Málaga;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
29 Málaga;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
29 Málaga;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
29 Málaga;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
29 Málaga;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
29 Málaga;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
29 Málaga;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
29 Málaga;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
29 Málaga;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
29 Málaga;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
29 Málaga;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
29 Málaga;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;96,52
29 Málaga;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
29 Málaga;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
29 Málaga;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
29 Málaga;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;96,42
29 Málaga;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
29 Málaga;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
29 Málaga;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
29 Málaga;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;96,21
29 Málaga;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
29 Málaga;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
29 Málaga;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;92,53
29 Málaga;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
29 Málaga;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
29 Málaga;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
29 Málaga;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;92,65
29 Málaga;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
29 Málaga;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
29 Málaga;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
29 Málaga;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;93,06
29 Málaga;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
29 Málaga;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
29 Málaga;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
29 Málaga;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
29 Málaga;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
29 Málaga;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
29 Málaga;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;89,07
29 Málaga;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
29 Málaga;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
29 Málaga;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
29 Málaga;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;90,82
29 Málaga;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
29 Málaga;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
29 Málaga;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
29 Málaga;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
29 Málaga;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
29 Málaga;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
29 Málaga;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;86,37
29 Málaga;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
29 Málaga;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
29 Málaga;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
29 Málaga;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;88,32
29 Málaga;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
29 Málaga;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
29 Málaga;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
29 Málaga;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
29 Málaga;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
29 Málaga;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
29 Málaga;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QIII;46.233
29 Málaga;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
29 Málaga;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
29 Málaga;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
29 Málaga;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QIII;44.401
29 Málaga;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
29 Málaga;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
29 Málaga;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
29 Málaga;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QIII;42.044
29 Málaga;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
29 Málaga;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
29 Málaga;All ages;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
29 Málaga;All ages;Cohort July 1;Females;Survival in the first trimester;2022QIII;44.127
29 Málaga;All ages;Cohort July 1;Females;Survival in the first trimester;2022QII;""
29 Málaga;All ages;Cohort July 1;Females;Survival in the first trimester;2022QI;""
29 Málaga;All ages;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
29 Málaga;All ages;Cohort July 1;Females;Survival in the first trimester;2021QIII;42.629
29 Málaga;All ages;Cohort July 1;Females;Survival in the first trimester;2021QII;""
29 Málaga;All ages;Cohort July 1;Females;Survival in the first trimester;2021QI;""
29 Málaga;All ages;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
29 Málaga;All ages;Cohort July 1;Females;Survival in the first trimester;2020QIII;40.097
29 Málaga;All ages;Cohort July 1;Females;Survival in the first trimester;2020QII;""
29 Málaga;All ages;Cohort July 1;Females;Survival in the first trimester;2020QI;""
29 Málaga;All ages;Cohort July 1;Females;Survival in the second trimester;2022QIV;41.923
29 Málaga;All ages;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
29 Málaga;All ages;Cohort July 1;Females;Survival in the second trimester;2022QII;""
29 Málaga;All ages;Cohort July 1;Females;Survival in the second trimester;2022QI;""
29 Málaga;All ages;Cohort July 1;Females;Survival in the second trimester;2021QIV;40.708
29 Málaga;All ages;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
29 Málaga;All ages;Cohort July 1;Females;Survival in the second trimester;2021QII;""
29 Málaga;All ages;Cohort July 1;Females;Survival in the second trimester;2021QI;""
29 Málaga;All ages;Cohort July 1;Females;Survival in the second trimester;2020QIV;38.471
29 Málaga;All ages;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
29 Málaga;All ages;Cohort July 1;Females;Survival in the second trimester;2020QII;""
29 Málaga;All ages;Cohort July 1;Females;Survival in the second trimester;2020QI;""
29 Málaga;All ages;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
29 Málaga;All ages;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
29 Málaga;All ages;Cohort July 1;Females;Survival in the third trimester;2022QII;""
29 Málaga;All ages;Cohort July 1;Females;Survival in the third trimester;2022QI;38.920
29 Málaga;All ages;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
29 Málaga;All ages;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
29 Málaga;All ages;Cohort July 1;Females;Survival in the third trimester;2021QII;""
29 Málaga;All ages;Cohort July 1;Females;Survival in the third trimester;2021QI;37.437
29 Málaga;All ages;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
29 Málaga;All ages;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
29 Málaga;All ages;Cohort July 1;Females;Survival in the third trimester;2020QII;""
29 Málaga;All ages;Cohort July 1;Females;Survival in the third trimester;2020QI;""
29 Málaga;All ages;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
29 Málaga;All ages;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
29 Málaga;All ages;Cohort July 1;Females;Survival in the third trimester;2022QII;37.424
29 Málaga;All ages;Cohort July 1;Females;Survival in the third trimester;2022QI;""
29 Málaga;All ages;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
29 Málaga;All ages;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
29 Málaga;All ages;Cohort July 1;Females;Survival in the third trimester;2021QII;36.247
29 Málaga;All ages;Cohort July 1;Females;Survival in the third trimester;2021QI;""
29 Málaga;All ages;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
29 Málaga;All ages;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
29 Málaga;All ages;Cohort July 1;Females;Survival in the third trimester;2020QII;""
29 Málaga;All ages;Cohort July 1;Females;Survival in the third trimester;2020QI;""
29 Málaga;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
29 Málaga;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
29 Málaga;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
29 Málaga;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
29 Málaga;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
29 Málaga;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
29 Málaga;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
29 Málaga;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
29 Málaga;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
29 Málaga;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
29 Málaga;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
29 Málaga;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
29 Málaga;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
29 Málaga;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;95,44
29 Málaga;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
29 Málaga;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
29 Málaga;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
29 Málaga;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;96,01
29 Málaga;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
29 Málaga;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
29 Málaga;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
29 Málaga;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;95,37
29 Málaga;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
29 Málaga;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
29 Málaga;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;90,68
29 Málaga;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
29 Málaga;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
29 Málaga;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
29 Málaga;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;91,68
29 Málaga;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
29 Málaga;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
29 Málaga;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
29 Málaga;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;91,5
29 Málaga;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
29 Málaga;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
29 Málaga;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
29 Málaga;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
29 Málaga;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
29 Málaga;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
29 Málaga;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;87,66
29 Málaga;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
29 Málaga;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
29 Málaga;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
29 Málaga;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;89,04
29 Málaga;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
29 Málaga;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
29 Málaga;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
29 Málaga;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
29 Málaga;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
29 Málaga;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
29 Málaga;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;84,29
29 Málaga;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
29 Málaga;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
29 Málaga;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
29 Málaga;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;86,21
29 Málaga;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
29 Málaga;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
29 Málaga;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
29 Málaga;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
29 Málaga;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
29 Málaga;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QIV;122.780
29 Málaga;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
29 Málaga;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
29 Málaga;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
29 Málaga;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QIV;120.689
29 Málaga;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
29 Málaga;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
29 Málaga;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
29 Málaga;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QIV;115.378
29 Málaga;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
29 Málaga;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
29 Málaga;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
29 Málaga;All ages;Cohort October 1;Total;Survival in the first trimester;2022QIV;116.964
29 Málaga;All ages;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
29 Málaga;All ages;Cohort October 1;Total;Survival in the first trimester;2022QII;""
29 Málaga;All ages;Cohort October 1;Total;Survival in the first trimester;2022QI;""
29 Málaga;All ages;Cohort October 1;Total;Survival in the first trimester;2021QIV;115.316
29 Málaga;All ages;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
29 Málaga;All ages;Cohort October 1;Total;Survival in the first trimester;2021QII;""
29 Málaga;All ages;Cohort October 1;Total;Survival in the first trimester;2021QI;""
29 Málaga;All ages;Cohort October 1;Total;Survival in the first trimester;2020QIV;110.754
29 Málaga;All ages;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
29 Málaga;All ages;Cohort October 1;Total;Survival in the first trimester;2020QII;""
29 Málaga;All ages;Cohort October 1;Total;Survival in the first trimester;2020QI;""
29 Málaga;All ages;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
29 Málaga;All ages;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
29 Málaga;All ages;Cohort October 1;Total;Survival in the second trimester;2022QII;""
29 Málaga;All ages;Cohort October 1;Total;Survival in the second trimester;2022QI;110.475
29 Málaga;All ages;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
29 Málaga;All ages;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
29 Málaga;All ages;Cohort October 1;Total;Survival in the second trimester;2021QII;""
29 Málaga;All ages;Cohort October 1;Total;Survival in the second trimester;2021QI;107.717
29 Málaga;All ages;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
29 Málaga;All ages;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
29 Málaga;All ages;Cohort October 1;Total;Survival in the second trimester;2020QII;""
29 Málaga;All ages;Cohort October 1;Total;Survival in the second trimester;2020QI;""
29 Málaga;All ages;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
29 Málaga;All ages;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
29 Málaga;All ages;Cohort October 1;Total;Survival in the third trimester;2022QII;106.635
29 Málaga;All ages;Cohort October 1;Total;Survival in the third trimester;2022QI;""
29 Málaga;All ages;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
29 Málaga;All ages;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
29 Málaga;All ages;Cohort October 1;Total;Survival in the third trimester;2021QII;104.384
29 Málaga;All ages;Cohort October 1;Total;Survival in the third trimester;2021QI;""
29 Málaga;All ages;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
29 Málaga;All ages;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
29 Málaga;All ages;Cohort October 1;Total;Survival in the third trimester;2020QII;""
29 Málaga;All ages;Cohort October 1;Total;Survival in the third trimester;2020QI;""
29 Málaga;All ages;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
29 Málaga;All ages;Cohort October 1;Total;Survival in the third trimester;2022QIII;103.409
29 Málaga;All ages;Cohort October 1;Total;Survival in the third trimester;2022QII;""
29 Málaga;All ages;Cohort October 1;Total;Survival in the third trimester;2022QI;""
29 Málaga;All ages;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
29 Málaga;All ages;Cohort October 1;Total;Survival in the third trimester;2021QIII;101.436
29 Málaga;All ages;Cohort October 1;Total;Survival in the third trimester;2021QII;""
29 Málaga;All ages;Cohort October 1;Total;Survival in the third trimester;2021QI;""
29 Málaga;All ages;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
29 Málaga;All ages;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
29 Málaga;All ages;Cohort October 1;Total;Survival in the third trimester;2020QII;""
29 Málaga;All ages;Cohort October 1;Total;Survival in the third trimester;2020QI;""
29 Málaga;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
29 Málaga;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
29 Málaga;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
29 Málaga;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
29 Málaga;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
29 Málaga;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
29 Málaga;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
29 Málaga;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
29 Málaga;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
29 Málaga;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
29 Málaga;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
29 Málaga;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
29 Málaga;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;95,26
29 Málaga;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
29 Málaga;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
29 Málaga;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
29 Málaga;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;95,55
29 Málaga;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
29 Málaga;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
29 Málaga;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
29 Málaga;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;95,99
29 Málaga;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
29 Málaga;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
29 Málaga;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
29 Málaga;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
29 Málaga;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
29 Málaga;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
29 Málaga;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;91,54
29 Málaga;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
29 Málaga;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
29 Málaga;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
29 Málaga;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;93,36
29 Málaga;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
29 Málaga;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
29 Málaga;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
29 Málaga;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
29 Málaga;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
29 Málaga;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
29 Málaga;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;88,36
29 Málaga;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
29 Málaga;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
29 Málaga;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
29 Málaga;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;90,47
29 Málaga;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
29 Málaga;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
29 Málaga;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
29 Málaga;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
29 Málaga;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
29 Málaga;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
29 Málaga;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;85,68
29 Málaga;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
29 Málaga;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
29 Málaga;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
29 Málaga;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;87,92
29 Málaga;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
29 Málaga;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
29 Málaga;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
29 Málaga;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
29 Málaga;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
29 Málaga;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
29 Málaga;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QIV;76.486
29 Málaga;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
29 Málaga;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
29 Málaga;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
29 Málaga;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QIV;75.803
29 Málaga;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
29 Málaga;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
29 Málaga;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
29 Málaga;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QIV;73.187
29 Málaga;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
29 Málaga;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
29 Málaga;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
29 Málaga;All ages;Cohort October 1;Males;Survival in the first trimester;2022QIV;73.095
29 Málaga;All ages;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
29 Málaga;All ages;Cohort October 1;Males;Survival in the first trimester;2022QII;""
29 Málaga;All ages;Cohort October 1;Males;Survival in the first trimester;2022QI;""
29 Málaga;All ages;Cohort October 1;Males;Survival in the first trimester;2021QIV;72.600
29 Málaga;All ages;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
29 Málaga;All ages;Cohort October 1;Males;Survival in the first trimester;2021QII;""
29 Málaga;All ages;Cohort October 1;Males;Survival in the first trimester;2021QI;""
29 Málaga;All ages;Cohort October 1;Males;Survival in the first trimester;2020QIV;70.461
29 Málaga;All ages;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
29 Málaga;All ages;Cohort October 1;Males;Survival in the first trimester;2020QII;""
29 Málaga;All ages;Cohort October 1;Males;Survival in the first trimester;2020QI;""
29 Málaga;All ages;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
29 Málaga;All ages;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
29 Málaga;All ages;Cohort October 1;Males;Survival in the second trimester;2022QII;""
29 Málaga;All ages;Cohort October 1;Males;Survival in the second trimester;2022QI;69.672
29 Málaga;All ages;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
29 Málaga;All ages;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
29 Málaga;All ages;Cohort October 1;Males;Survival in the second trimester;2021QII;""
29 Málaga;All ages;Cohort October 1;Males;Survival in the second trimester;2021QI;68.621
29 Málaga;All ages;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
29 Málaga;All ages;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
29 Málaga;All ages;Cohort October 1;Males;Survival in the second trimester;2020QII;""
29 Málaga;All ages;Cohort October 1;Males;Survival in the second trimester;2020QI;""
29 Málaga;All ages;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
29 Málaga;All ages;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
29 Málaga;All ages;Cohort October 1;Males;Survival in the third trimester;2022QII;67.450
29 Málaga;All ages;Cohort October 1;Males;Survival in the third trimester;2022QI;""
29 Málaga;All ages;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
29 Málaga;All ages;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
29 Málaga;All ages;Cohort October 1;Males;Survival in the third trimester;2021QII;66.611
29 Málaga;All ages;Cohort October 1;Males;Survival in the third trimester;2021QI;""
29 Málaga;All ages;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
29 Málaga;All ages;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
29 Málaga;All ages;Cohort October 1;Males;Survival in the third trimester;2020QII;""
29 Málaga;All ages;Cohort October 1;Males;Survival in the third trimester;2020QI;""
29 Málaga;All ages;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
29 Málaga;All ages;Cohort October 1;Males;Survival in the third trimester;2022QIII;65.657
29 Málaga;All ages;Cohort October 1;Males;Survival in the third trimester;2022QII;""
29 Málaga;All ages;Cohort October 1;Males;Survival in the third trimester;2022QI;""
29 Málaga;All ages;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
29 Málaga;All ages;Cohort October 1;Males;Survival in the third trimester;2021QIII;64.801
29 Málaga;All ages;Cohort October 1;Males;Survival in the third trimester;2021QII;""
29 Málaga;All ages;Cohort October 1;Males;Survival in the third trimester;2021QI;""
29 Málaga;All ages;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
29 Málaga;All ages;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
29 Málaga;All ages;Cohort October 1;Males;Survival in the third trimester;2020QII;""
29 Málaga;All ages;Cohort October 1;Males;Survival in the third trimester;2020QI;""
29 Málaga;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
29 Málaga;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
29 Málaga;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
29 Málaga;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
29 Málaga;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
29 Málaga;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
29 Málaga;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
29 Málaga;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
29 Málaga;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
29 Málaga;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
29 Málaga;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
29 Málaga;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
29 Málaga;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;95,57
29 Málaga;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
29 Málaga;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
29 Málaga;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
29 Málaga;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;95,77
29 Málaga;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
29 Málaga;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
29 Málaga;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
29 Málaga;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;96,28
29 Málaga;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
29 Málaga;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
29 Málaga;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
29 Málaga;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
29 Málaga;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
29 Málaga;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
29 Málaga;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;91,91
29 Málaga;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
29 Málaga;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
29 Málaga;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
29 Málaga;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;93,76
29 Málaga;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
29 Málaga;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
29 Málaga;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
29 Málaga;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
29 Málaga;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
29 Málaga;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
29 Málaga;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;88,98
29 Málaga;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
29 Málaga;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
29 Málaga;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
29 Málaga;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;91,01
29 Málaga;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
29 Málaga;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
29 Málaga;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
29 Málaga;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
29 Málaga;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
29 Málaga;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
29 Málaga;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;86,62
29 Málaga;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
29 Málaga;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
29 Málaga;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
29 Málaga;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;88,54
29 Málaga;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
29 Málaga;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
29 Málaga;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
29 Málaga;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
29 Málaga;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
29 Málaga;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
29 Málaga;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QIV;46.294
29 Málaga;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
29 Málaga;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
29 Málaga;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
29 Málaga;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QIV;44.886
29 Málaga;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
29 Málaga;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
29 Málaga;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
29 Málaga;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QIV;42.191
29 Málaga;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
29 Málaga;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
29 Málaga;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
29 Málaga;All ages;Cohort October 1;Females;Survival in the first trimester;2022QIV;43.869
29 Málaga;All ages;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
29 Málaga;All ages;Cohort October 1;Females;Survival in the first trimester;2022QII;""
29 Málaga;All ages;Cohort October 1;Females;Survival in the first trimester;2022QI;""
29 Málaga;All ages;Cohort October 1;Females;Survival in the first trimester;2021QIV;42.716
29 Málaga;All ages;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
29 Málaga;All ages;Cohort October 1;Females;Survival in the first trimester;2021QII;""
29 Málaga;All ages;Cohort October 1;Females;Survival in the first trimester;2021QI;""
29 Málaga;All ages;Cohort October 1;Females;Survival in the first trimester;2020QIV;40.293
29 Málaga;All ages;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
29 Málaga;All ages;Cohort October 1;Females;Survival in the first trimester;2020QII;""
29 Málaga;All ages;Cohort October 1;Females;Survival in the first trimester;2020QI;""
29 Málaga;All ages;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
29 Málaga;All ages;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
29 Málaga;All ages;Cohort October 1;Females;Survival in the second trimester;2022QII;""
29 Málaga;All ages;Cohort October 1;Females;Survival in the second trimester;2022QI;40.803
29 Málaga;All ages;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
29 Málaga;All ages;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
29 Málaga;All ages;Cohort October 1;Females;Survival in the second trimester;2021QII;""
29 Málaga;All ages;Cohort October 1;Females;Survival in the second trimester;2021QI;39.096
29 Málaga;All ages;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
29 Málaga;All ages;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
29 Málaga;All ages;Cohort October 1;Females;Survival in the second trimester;2020QII;""
29 Málaga;All ages;Cohort October 1;Females;Survival in the second trimester;2020QI;""
29 Málaga;All ages;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
29 Málaga;All ages;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
29 Málaga;All ages;Cohort October 1;Females;Survival in the third trimester;2022QII;39.185
29 Málaga;All ages;Cohort October 1;Females;Survival in the third trimester;2022QI;""
29 Málaga;All ages;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
29 Málaga;All ages;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
29 Málaga;All ages;Cohort October 1;Females;Survival in the third trimester;2021QII;37.773
29 Málaga;All ages;Cohort October 1;Females;Survival in the third trimester;2021QI;""
29 Málaga;All ages;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
29 Málaga;All ages;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
29 Málaga;All ages;Cohort October 1;Females;Survival in the third trimester;2020QII;""
29 Málaga;All ages;Cohort October 1;Females;Survival in the third trimester;2020QI;""
29 Málaga;All ages;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
29 Málaga;All ages;Cohort October 1;Females;Survival in the third trimester;2022QIII;37.752
29 Málaga;All ages;Cohort October 1;Females;Survival in the third trimester;2022QII;""
29 Málaga;All ages;Cohort October 1;Females;Survival in the third trimester;2022QI;""
29 Málaga;All ages;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
29 Málaga;All ages;Cohort October 1;Females;Survival in the third trimester;2021QIII;36.635
29 Málaga;All ages;Cohort October 1;Females;Survival in the third trimester;2021QII;""
29 Málaga;All ages;Cohort October 1;Females;Survival in the third trimester;2021QI;""
29 Málaga;All ages;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
29 Málaga;All ages;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
29 Málaga;All ages;Cohort October 1;Females;Survival in the third trimester;2020QII;""
29 Málaga;All ages;Cohort October 1;Females;Survival in the third trimester;2020QI;""
29 Málaga;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
29 Málaga;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
29 Málaga;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
29 Málaga;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
29 Málaga;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
29 Málaga;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
29 Málaga;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
29 Málaga;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
29 Málaga;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
29 Málaga;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
29 Málaga;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
29 Málaga;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
29 Málaga;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;94,76
29 Málaga;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
29 Málaga;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
29 Málaga;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
29 Málaga;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;95,17
29 Málaga;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
29 Málaga;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
29 Málaga;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
29 Málaga;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;95,5
29 Málaga;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
29 Málaga;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
29 Málaga;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
29 Málaga;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
29 Málaga;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
29 Málaga;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
29 Málaga;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;90,9
29 Málaga;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
29 Málaga;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
29 Málaga;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
29 Málaga;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;92,66
29 Málaga;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
29 Málaga;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
29 Málaga;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
29 Málaga;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
29 Málaga;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
29 Málaga;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
29 Málaga;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;87,3
29 Málaga;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
29 Málaga;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
29 Málaga;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
29 Málaga;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;89,53
29 Málaga;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
29 Málaga;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
29 Málaga;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
29 Málaga;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
29 Málaga;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
29 Málaga;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
29 Málaga;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;84,11
29 Málaga;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
29 Málaga;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
29 Málaga;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
29 Málaga;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;86,83
29 Málaga;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
29 Málaga;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
29 Málaga;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
29 Málaga;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
29 Málaga;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
29 Málaga;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
29 Málaga;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
29 Málaga;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
29 Málaga;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
29 Málaga;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QI;9.104
29 Málaga;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
29 Málaga;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
29 Málaga;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
29 Málaga;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QI;8.553
29 Málaga;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
29 Málaga;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
29 Málaga;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
29 Málaga;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QI;6.841
29 Málaga;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
29 Málaga;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
29 Málaga;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2022QII;""
29 Málaga;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2022QI;8.357
29 Málaga;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
29 Málaga;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
29 Málaga;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2021QII;""
29 Málaga;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2021QI;8.018
29 Málaga;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
29 Málaga;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
29 Málaga;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2020QII;""
29 Málaga;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2020QI;5.931
29 Málaga;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
29 Málaga;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
29 Málaga;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2022QII;7.717
29 Málaga;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2022QI;""
29 Málaga;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
29 Málaga;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
29 Málaga;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2021QII;7.463
29 Málaga;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2021QI;""
29 Málaga;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
29 Málaga;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
29 Málaga;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2020QII;5.686
29 Málaga;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2020QI;""
29 Málaga;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
29 Málaga;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QIII;7.202
29 Málaga;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QII;""
29 Málaga;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QI;""
29 Málaga;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
29 Málaga;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QIII;6.981
29 Málaga;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QII;""
29 Málaga;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QI;""
29 Málaga;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
29 Málaga;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QIII;5.323
29 Málaga;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QII;""
29 Málaga;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QI;""
29 Málaga;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QIV;6.729
29 Málaga;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
29 Málaga;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QII;""
29 Málaga;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QI;""
29 Málaga;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QIV;6.527
29 Málaga;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
29 Málaga;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QII;""
29 Málaga;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QI;""
29 Málaga;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QIV;5.055
29 Málaga;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
29 Málaga;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QII;""
29 Málaga;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QI;""
29 Málaga;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
29 Málaga;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
29 Málaga;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
29 Málaga;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
29 Málaga;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
29 Málaga;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
29 Málaga;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
29 Málaga;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
29 Málaga;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
29 Málaga;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
29 Málaga;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
29 Málaga;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
29 Málaga;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
29 Málaga;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
29 Málaga;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
29 Málaga;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;91,79
29 Málaga;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
29 Málaga;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
29 Málaga;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
29 Málaga;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;93,74
29 Málaga;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
29 Málaga;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
29 Málaga;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
29 Málaga;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;86,7
29 Málaga;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
29 Málaga;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
29 Málaga;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;84,76
29 Málaga;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
29 Málaga;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
29 Málaga;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
29 Málaga;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;87,26
29 Málaga;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
29 Málaga;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
29 Málaga;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
29 Málaga;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;83,12
29 Málaga;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
29 Málaga;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
29 Málaga;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;79,11
29 Málaga;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
29 Málaga;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
29 Málaga;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
29 Málaga;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;81,62
29 Málaga;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
29 Málaga;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
29 Málaga;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
29 Málaga;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;77,81
29 Málaga;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
29 Málaga;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
29 Málaga;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;73,91
29 Málaga;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
29 Málaga;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
29 Málaga;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
29 Málaga;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;76,31
29 Málaga;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
29 Málaga;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
29 Málaga;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
29 Málaga;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;73,89
29 Málaga;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
29 Málaga;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
29 Málaga;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
29 Málaga;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
29 Málaga;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
29 Málaga;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
29 Málaga;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QI;5.509
29 Málaga;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
29 Málaga;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
29 Málaga;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
29 Málaga;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QI;5.266
29 Málaga;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
29 Málaga;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
29 Málaga;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
29 Málaga;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QI;4.177
29 Málaga;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
29 Málaga;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
29 Málaga;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2022QII;""
29 Málaga;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2022QI;5.064
29 Málaga;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
29 Málaga;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
29 Málaga;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2021QII;""
29 Málaga;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2021QI;4.945
29 Málaga;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
29 Málaga;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
29 Málaga;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2020QII;""
29 Málaga;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2020QI;3.653
29 Málaga;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
29 Málaga;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
29 Málaga;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2022QII;4.685
29 Málaga;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2022QI;""
29 Málaga;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
29 Málaga;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
29 Málaga;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2021QII;4.590
29 Málaga;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2021QI;""
29 Málaga;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
29 Málaga;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
29 Málaga;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2020QII;3.504
29 Málaga;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2020QI;""
29 Málaga;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
29 Málaga;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QIII;4.379
29 Málaga;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QII;""
29 Málaga;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QI;""
29 Málaga;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
29 Málaga;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QIII;4.302
29 Málaga;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QII;""
29 Málaga;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QI;""
29 Málaga;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
29 Málaga;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QIII;3.320
29 Málaga;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QII;""
29 Málaga;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QI;""
29 Málaga;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QIV;4.122
29 Málaga;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
29 Málaga;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QII;""
29 Málaga;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QI;""
29 Málaga;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QIV;4.034
29 Málaga;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
29 Málaga;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QII;""
29 Málaga;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QI;""
29 Málaga;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QIV;3.160
29 Málaga;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
29 Málaga;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QII;""
29 Málaga;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QI;""
29 Málaga;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
29 Málaga;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
29 Málaga;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
29 Málaga;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
29 Málaga;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
29 Málaga;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
29 Málaga;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
29 Málaga;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
29 Málaga;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
29 Málaga;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
29 Málaga;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
29 Málaga;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
29 Málaga;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
29 Málaga;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
29 Málaga;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
29 Málaga;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;91,92
29 Málaga;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
29 Málaga;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
29 Málaga;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
29 Málaga;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;93,9
29 Málaga;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
29 Málaga;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
29 Málaga;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
29 Málaga;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;87,46
29 Málaga;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
29 Málaga;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
29 Málaga;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;85,04
29 Málaga;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
29 Málaga;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
29 Málaga;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
29 Málaga;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;87,16
29 Málaga;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
29 Málaga;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
29 Málaga;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
29 Málaga;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;83,89
29 Málaga;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
29 Málaga;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
29 Málaga;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;79,49
29 Málaga;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
29 Málaga;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
29 Málaga;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
29 Málaga;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;81,69
29 Málaga;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
29 Málaga;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
29 Málaga;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
29 Málaga;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;79,48
29 Málaga;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
29 Málaga;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
29 Málaga;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;74,82
29 Málaga;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
29 Málaga;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
29 Málaga;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
29 Málaga;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;76,6
29 Málaga;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
29 Málaga;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
29 Málaga;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
29 Málaga;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;75,65
29 Málaga;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
29 Málaga;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
29 Málaga;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
29 Málaga;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
29 Málaga;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
29 Málaga;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
29 Málaga;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QI;3.595
29 Málaga;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
29 Málaga;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
29 Málaga;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
29 Málaga;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QI;3.287
29 Málaga;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
29 Málaga;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
29 Málaga;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
29 Málaga;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QI;2.664
29 Málaga;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
29 Málaga;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
29 Málaga;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2022QII;""
29 Málaga;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2022QI;3.293
29 Málaga;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
29 Málaga;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
29 Málaga;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2021QII;""
29 Málaga;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2021QI;3.073
29 Málaga;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
29 Málaga;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
29 Málaga;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2020QII;""
29 Málaga;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2020QI;2.278
29 Málaga;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
29 Málaga;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
29 Málaga;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2022QII;3.032
29 Málaga;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2022QI;""
29 Málaga;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
29 Málaga;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
29 Málaga;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2021QII;2.873
29 Málaga;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2021QI;""
29 Málaga;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
29 Málaga;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
29 Málaga;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2020QII;2.182
29 Málaga;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2020QI;""
29 Málaga;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
29 Málaga;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QIII;2.823
29 Málaga;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QII;""
29 Málaga;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QI;""
29 Málaga;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
29 Málaga;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QIII;2.679
29 Málaga;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QII;""
29 Málaga;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QI;""
29 Málaga;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
29 Málaga;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QIII;2.003
29 Málaga;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QII;""
29 Málaga;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QI;""
29 Málaga;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QIV;2.607
29 Málaga;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
29 Málaga;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QII;""
29 Málaga;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QI;""
29 Málaga;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QIV;2.493
29 Málaga;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
29 Málaga;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QII;""
29 Málaga;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QI;""
29 Málaga;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QIV;1.895
29 Málaga;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
29 Málaga;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QII;""
29 Málaga;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QI;""
29 Málaga;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
29 Málaga;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
29 Málaga;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
29 Málaga;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
29 Málaga;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
29 Málaga;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
29 Málaga;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
29 Málaga;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
29 Málaga;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
29 Málaga;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
29 Málaga;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
29 Málaga;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
29 Málaga;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
29 Málaga;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
29 Málaga;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
29 Málaga;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;91,6
29 Málaga;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
29 Málaga;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
29 Málaga;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
29 Málaga;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;93,49
29 Málaga;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
29 Málaga;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
29 Málaga;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
29 Málaga;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;85,51
29 Málaga;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
29 Málaga;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
29 Málaga;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;84,34
29 Málaga;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
29 Málaga;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
29 Málaga;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
29 Málaga;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;87,4
29 Málaga;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
29 Málaga;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
29 Málaga;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
29 Málaga;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;81,91
29 Málaga;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
29 Málaga;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
29 Málaga;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;78,53
29 Málaga;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
29 Málaga;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
29 Málaga;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
29 Málaga;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;81,5
29 Málaga;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
29 Málaga;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
29 Málaga;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
29 Málaga;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;75,19
29 Málaga;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
29 Málaga;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
29 Málaga;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;72,52
29 Málaga;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
29 Málaga;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
29 Málaga;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
29 Málaga;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;75,84
29 Málaga;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
29 Málaga;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
29 Málaga;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
29 Málaga;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;71,13
29 Málaga;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
29 Málaga;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
29 Málaga;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
29 Málaga;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
29 Málaga;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
29 Málaga;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QII;8.086
29 Málaga;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
29 Málaga;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
29 Málaga;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
29 Málaga;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QII;7.723
29 Málaga;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
29 Málaga;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
29 Málaga;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
29 Málaga;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QII;6.925
29 Málaga;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
29 Málaga;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
29 Málaga;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
29 Málaga;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2022QII;7.403
29 Málaga;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2022QI;""
29 Málaga;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
29 Málaga;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
29 Málaga;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2021QII;7.078
29 Málaga;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2021QI;""
29 Málaga;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
29 Málaga;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
29 Málaga;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2020QII;6.614
29 Málaga;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2020QI;""
29 Málaga;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
29 Málaga;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2022QIII;6.866
29 Málaga;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2022QII;""
29 Málaga;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2022QI;""
29 Málaga;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
29 Málaga;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2021QIII;6.552
29 Málaga;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2021QII;""
29 Málaga;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2021QI;""
29 Málaga;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
29 Málaga;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2020QIII;6.164
29 Málaga;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2020QII;""
29 Málaga;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2020QI;""
29 Málaga;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QIV;6.370
29 Málaga;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
29 Málaga;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QII;""
29 Málaga;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QI;""
29 Málaga;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QIV;6.094
29 Málaga;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
29 Málaga;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QII;""
29 Málaga;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QI;""
29 Málaga;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QIV;5.821
29 Málaga;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
29 Málaga;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QII;""
29 Málaga;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QI;""
29 Málaga;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
29 Málaga;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
29 Málaga;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QII;""
29 Málaga;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QI;5.648
29 Málaga;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
29 Málaga;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
29 Málaga;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QII;""
29 Málaga;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QI;5.550
29 Málaga;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
29 Málaga;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
29 Málaga;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QII;""
29 Málaga;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QI;""
29 Málaga;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
29 Málaga;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
29 Málaga;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
29 Málaga;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
29 Málaga;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
29 Málaga;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
29 Málaga;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
29 Málaga;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
29 Málaga;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
29 Málaga;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
29 Málaga;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
29 Málaga;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
29 Málaga;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
29 Málaga;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
29 Málaga;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;91,55
29 Málaga;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
29 Málaga;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
29 Málaga;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
29 Málaga;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;91,65
29 Málaga;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
29 Málaga;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
29 Málaga;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
29 Málaga;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;95,51
29 Málaga;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
29 Málaga;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
29 Málaga;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;84,91
29 Málaga;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
29 Málaga;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
29 Málaga;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
29 Málaga;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;84,84
29 Málaga;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
29 Málaga;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
29 Málaga;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
29 Málaga;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;89,01
29 Málaga;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
29 Málaga;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
29 Málaga;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;78,78
29 Málaga;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
29 Málaga;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
29 Málaga;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
29 Málaga;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;78,91
29 Málaga;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
29 Málaga;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
29 Málaga;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
29 Málaga;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;84,06
29 Málaga;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
29 Málaga;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
29 Málaga;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
29 Málaga;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
29 Málaga;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
29 Málaga;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
29 Málaga;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;73,13
29 Málaga;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
29 Málaga;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
29 Málaga;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
29 Málaga;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;80,14
29 Málaga;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
29 Málaga;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
29 Málaga;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
29 Málaga;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
29 Málaga;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
29 Málaga;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
29 Málaga;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QII;4.911
29 Málaga;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
29 Málaga;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
29 Málaga;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
29 Málaga;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QII;4.807
29 Málaga;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
29 Málaga;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
29 Málaga;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
29 Málaga;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QII;4.244
29 Málaga;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
29 Málaga;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
29 Málaga;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
29 Málaga;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2022QII;4.508
29 Málaga;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2022QI;""
29 Málaga;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
29 Málaga;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
29 Málaga;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2021QII;4.391
29 Málaga;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2021QI;""
29 Málaga;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
29 Málaga;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
29 Málaga;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2020QII;4.055
29 Málaga;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2020QI;""
29 Málaga;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
29 Málaga;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2022QIII;4.183
29 Málaga;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2022QII;""
29 Málaga;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2022QI;""
29 Málaga;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
29 Málaga;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2021QIII;4.069
29 Málaga;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2021QII;""
29 Málaga;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2021QI;""
29 Málaga;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
29 Málaga;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2020QIII;3.816
29 Málaga;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2020QII;""
29 Málaga;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2020QI;""
29 Málaga;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QIV;3.908
29 Málaga;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
29 Málaga;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QII;""
29 Málaga;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QI;""
29 Málaga;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QIV;3.798
29 Málaga;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
29 Málaga;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QII;""
29 Málaga;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QI;""
29 Málaga;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QIV;3.612
29 Málaga;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
29 Málaga;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QII;""
29 Málaga;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QI;""
29 Málaga;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
29 Málaga;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
29 Málaga;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QII;""
29 Málaga;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QI;3.524
29 Málaga;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
29 Málaga;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
29 Málaga;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QII;""
29 Málaga;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QI;3.436
29 Málaga;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
29 Málaga;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
29 Málaga;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QII;""
29 Málaga;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QI;""
29 Málaga;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
29 Málaga;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
29 Málaga;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
29 Málaga;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
29 Málaga;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
29 Málaga;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
29 Málaga;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
29 Málaga;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
29 Málaga;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
29 Málaga;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
29 Málaga;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
29 Málaga;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
29 Málaga;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
29 Málaga;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
29 Málaga;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;91,79
29 Málaga;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
29 Málaga;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
29 Málaga;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
29 Málaga;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;91,35
29 Málaga;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
29 Málaga;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
29 Málaga;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
29 Málaga;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;95,55
29 Málaga;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
29 Málaga;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
29 Málaga;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;85,18
29 Málaga;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
29 Málaga;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
29 Málaga;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
29 Málaga;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;84,65
29 Málaga;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
29 Málaga;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
29 Málaga;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
29 Málaga;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;89,92
29 Málaga;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
29 Málaga;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
29 Málaga;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;79,58
29 Málaga;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
29 Málaga;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
29 Málaga;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
29 Málaga;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;79,01
29 Málaga;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
29 Málaga;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
29 Málaga;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
29 Málaga;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;85,11
29 Málaga;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
29 Málaga;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
29 Málaga;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
29 Málaga;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
29 Málaga;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
29 Málaga;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
29 Málaga;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;73,31
29 Málaga;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
29 Málaga;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
29 Málaga;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
29 Málaga;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;80,96
29 Málaga;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
29 Málaga;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
29 Málaga;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
29 Málaga;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
29 Málaga;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
29 Málaga;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
29 Málaga;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QII;3.175
29 Málaga;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
29 Málaga;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
29 Málaga;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
29 Málaga;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QII;2.916
29 Málaga;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
29 Málaga;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
29 Málaga;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
29 Málaga;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QII;2.681
29 Málaga;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
29 Málaga;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
29 Málaga;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
29 Málaga;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2022QII;2.895
29 Málaga;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2022QI;""
29 Málaga;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
29 Málaga;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
29 Málaga;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2021QII;2.687
29 Málaga;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2021QI;""
29 Málaga;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
29 Málaga;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
29 Málaga;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2020QII;2.559
29 Málaga;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2020QI;""
29 Málaga;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
29 Málaga;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2022QIII;2.683
29 Málaga;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2022QII;""
29 Málaga;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2022QI;""
29 Málaga;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
29 Málaga;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2021QIII;2.483
29 Málaga;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2021QII;""
29 Málaga;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2021QI;""
29 Málaga;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
29 Málaga;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2020QIII;2.348
29 Málaga;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2020QII;""
29 Málaga;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2020QI;""
29 Málaga;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QIV;2.462
29 Málaga;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
29 Málaga;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QII;""
29 Málaga;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QI;""
29 Málaga;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QIV;2.296
29 Málaga;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
29 Málaga;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QII;""
29 Málaga;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QI;""
29 Málaga;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QIV;2.209
29 Málaga;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
29 Málaga;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QII;""
29 Málaga;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QI;""
29 Málaga;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
29 Málaga;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
29 Málaga;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QII;""
29 Málaga;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QI;2.124
29 Málaga;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
29 Málaga;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
29 Málaga;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QII;""
29 Málaga;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QI;2.114
29 Málaga;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
29 Málaga;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
29 Málaga;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QII;""
29 Málaga;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QI;""
29 Málaga;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
29 Málaga;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
29 Málaga;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
29 Málaga;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
29 Málaga;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
29 Málaga;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
29 Málaga;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
29 Málaga;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
29 Málaga;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
29 Málaga;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
29 Málaga;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
29 Málaga;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
29 Málaga;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
29 Málaga;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
29 Málaga;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;91,18
29 Málaga;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
29 Málaga;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
29 Málaga;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
29 Málaga;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;92,15
29 Málaga;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
29 Málaga;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
29 Málaga;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
29 Málaga;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;95,45
29 Málaga;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
29 Málaga;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
29 Málaga;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;84,5
29 Málaga;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
29 Málaga;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
29 Málaga;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
29 Málaga;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;85,15
29 Málaga;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
29 Málaga;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
29 Málaga;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
29 Málaga;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;87,58
29 Málaga;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
29 Málaga;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
29 Málaga;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;77,54
29 Málaga;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
29 Málaga;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
29 Málaga;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
29 Málaga;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;78,74
29 Málaga;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
29 Málaga;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
29 Málaga;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
29 Málaga;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;82,39
29 Málaga;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
29 Málaga;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
29 Málaga;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
29 Málaga;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
29 Málaga;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
29 Málaga;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
29 Málaga;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;72,84
29 Málaga;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
29 Málaga;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
29 Málaga;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
29 Málaga;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;78,85
29 Málaga;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
29 Málaga;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
29 Málaga;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
29 Málaga;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
29 Málaga;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
29 Málaga;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QIII;8.539
29 Málaga;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
29 Málaga;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
29 Málaga;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
29 Málaga;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QIII;8.346
29 Málaga;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
29 Málaga;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
29 Málaga;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
29 Málaga;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QIII;7.357
29 Málaga;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
29 Málaga;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
29 Málaga;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
29 Málaga;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2022QIII;7.827
29 Málaga;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2022QII;""
29 Málaga;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2022QI;""
29 Málaga;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
29 Málaga;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2021QIII;7.629
29 Málaga;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2021QII;""
29 Málaga;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2021QI;""
29 Málaga;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
29 Málaga;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2020QIII;6.785
29 Málaga;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2020QII;""
29 Málaga;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2020QI;""
29 Málaga;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2022QIV;7.221
29 Málaga;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
29 Málaga;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2022QII;""
29 Málaga;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2022QI;""
29 Málaga;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2021QIV;7.042
29 Málaga;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
29 Málaga;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2021QII;""
29 Málaga;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2021QI;""
29 Málaga;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2020QIV;6.361
29 Málaga;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
29 Málaga;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2020QII;""
29 Málaga;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2020QI;""
29 Málaga;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
29 Málaga;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
29 Málaga;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QII;""
29 Málaga;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QI;6.521
29 Málaga;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
29 Málaga;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
29 Málaga;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QII;""
29 Málaga;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QI;6.046
29 Málaga;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
29 Málaga;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
29 Málaga;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QII;""
29 Málaga;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QI;""
29 Málaga;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
29 Málaga;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
29 Málaga;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QII;6.070
29 Málaga;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QI;""
29 Málaga;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
29 Málaga;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
29 Málaga;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QII;5.724
29 Málaga;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QI;""
29 Málaga;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
29 Málaga;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
29 Málaga;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QII;""
29 Málaga;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QI;""
29 Málaga;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
29 Málaga;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
29 Málaga;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
29 Málaga;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
29 Málaga;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
29 Málaga;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
29 Málaga;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
29 Málaga;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
29 Málaga;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
29 Málaga;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
29 Málaga;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
29 Málaga;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
29 Málaga;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
29 Málaga;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;91,66
29 Málaga;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
29 Málaga;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
29 Málaga;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
29 Málaga;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;91,41
29 Málaga;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
29 Málaga;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
29 Málaga;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
29 Málaga;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;92,23
29 Málaga;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
29 Málaga;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
29 Málaga;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;84,56
29 Málaga;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
29 Málaga;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
29 Málaga;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
29 Málaga;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;84,38
29 Málaga;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
29 Málaga;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
29 Málaga;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
29 Málaga;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;86,46
29 Málaga;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
29 Málaga;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
29 Málaga;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
29 Málaga;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
29 Málaga;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
29 Málaga;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
29 Málaga;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;78,13
29 Málaga;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
29 Málaga;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
29 Málaga;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
29 Málaga;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;82,18
29 Málaga;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
29 Málaga;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
29 Málaga;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
29 Málaga;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
29 Málaga;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
29 Málaga;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
29 Málaga;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;72,73
29 Málaga;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
29 Málaga;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
29 Málaga;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
29 Málaga;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;77,8
29 Málaga;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
29 Málaga;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
29 Málaga;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
29 Málaga;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
29 Málaga;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
29 Málaga;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
29 Málaga;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QIII;5.189
29 Málaga;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
29 Málaga;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
29 Málaga;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
29 Málaga;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QIII;5.126
29 Málaga;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
29 Málaga;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
29 Málaga;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
29 Málaga;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QIII;4.541
29 Málaga;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
29 Málaga;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
29 Málaga;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
29 Málaga;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2022QIII;4.762
29 Málaga;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2022QII;""
29 Málaga;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2022QI;""
29 Málaga;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
29 Málaga;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2021QIII;4.688
29 Málaga;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2021QII;""
29 Málaga;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2021QI;""
29 Málaga;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
29 Málaga;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2020QIII;4.209
29 Málaga;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2020QII;""
29 Málaga;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2020QI;""
29 Málaga;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2022QIV;4.422
29 Málaga;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
29 Málaga;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2022QII;""
29 Málaga;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2022QI;""
29 Málaga;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2021QIV;4.332
29 Málaga;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
29 Málaga;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2021QII;""
29 Málaga;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2021QI;""
29 Málaga;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2020QIV;3.951
29 Málaga;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
29 Málaga;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2020QII;""
29 Málaga;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2020QI;""
29 Málaga;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
29 Málaga;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
29 Málaga;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QII;""
29 Málaga;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QI;4.016
29 Málaga;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
29 Málaga;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
29 Málaga;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QII;""
29 Málaga;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QI;3.754
29 Málaga;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
29 Málaga;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
29 Málaga;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QII;""
29 Málaga;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QI;""
29 Málaga;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
29 Málaga;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
29 Málaga;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QII;3.749
29 Málaga;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QI;""
29 Málaga;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
29 Málaga;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
29 Málaga;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QII;3.563
29 Málaga;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QI;""
29 Málaga;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
29 Málaga;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
29 Málaga;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QII;""
29 Málaga;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QI;""
29 Málaga;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
29 Málaga;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
29 Málaga;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
29 Málaga;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
29 Málaga;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
29 Málaga;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
29 Málaga;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
29 Málaga;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
29 Málaga;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
29 Málaga;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
29 Málaga;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
29 Málaga;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
29 Málaga;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
29 Málaga;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;91,77
29 Málaga;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
29 Málaga;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
29 Málaga;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
29 Málaga;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;91,46
29 Málaga;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
29 Málaga;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
29 Málaga;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
29 Málaga;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;92,69
29 Málaga;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
29 Málaga;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
29 Málaga;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;85,22
29 Málaga;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
29 Málaga;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
29 Málaga;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
29 Málaga;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;84,51
29 Málaga;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
29 Málaga;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
29 Málaga;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
29 Málaga;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;87,01
29 Málaga;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
29 Málaga;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
29 Málaga;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
29 Málaga;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
29 Málaga;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
29 Málaga;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
29 Málaga;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;78,35
29 Málaga;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
29 Málaga;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
29 Málaga;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
29 Málaga;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;82,67
29 Málaga;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
29 Málaga;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
29 Málaga;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
29 Málaga;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
29 Málaga;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
29 Málaga;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
29 Málaga;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;73,14
29 Málaga;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
29 Málaga;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
29 Málaga;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
29 Málaga;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;78,46
29 Málaga;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
29 Málaga;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
29 Málaga;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
29 Málaga;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
29 Málaga;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
29 Málaga;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
29 Málaga;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QIII;3.350
29 Málaga;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
29 Málaga;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
29 Málaga;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
29 Málaga;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QIII;3.220
29 Málaga;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
29 Málaga;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
29 Málaga;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
29 Málaga;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QIII;2.816
29 Málaga;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
29 Málaga;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
29 Málaga;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
29 Málaga;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2022QIII;3.065
29 Málaga;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2022QII;""
29 Málaga;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2022QI;""
29 Málaga;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
29 Málaga;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2021QIII;2.941
29 Málaga;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2021QII;""
29 Málaga;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2021QI;""
29 Málaga;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
29 Málaga;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2020QIII;2.576
29 Málaga;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2020QII;""
29 Málaga;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2020QI;""
29 Málaga;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2022QIV;2.799
29 Málaga;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
29 Málaga;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2022QII;""
29 Málaga;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2022QI;""
29 Málaga;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2021QIV;2.710
29 Málaga;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
29 Málaga;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2021QII;""
29 Málaga;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2021QI;""
29 Málaga;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2020QIV;2.410
29 Málaga;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
29 Málaga;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2020QII;""
29 Málaga;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2020QI;""
29 Málaga;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
29 Málaga;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
29 Málaga;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QII;""
29 Málaga;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QI;2.505
29 Málaga;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
29 Málaga;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
29 Málaga;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QII;""
29 Málaga;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QI;2.292
29 Málaga;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
29 Málaga;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
29 Málaga;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QII;""
29 Málaga;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QI;""
29 Málaga;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
29 Málaga;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
29 Málaga;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QII;2.321
29 Málaga;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QI;""
29 Málaga;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
29 Málaga;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
29 Málaga;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QII;2.161
29 Málaga;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QI;""
29 Málaga;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
29 Málaga;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
29 Málaga;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QII;""
29 Málaga;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QI;""
29 Málaga;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
29 Málaga;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
29 Málaga;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
29 Málaga;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
29 Málaga;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
29 Málaga;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
29 Málaga;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
29 Málaga;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
29 Málaga;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
29 Málaga;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
29 Málaga;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
29 Málaga;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
29 Málaga;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
29 Málaga;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;91,49
29 Málaga;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
29 Málaga;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
29 Málaga;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
29 Málaga;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;91,34
29 Málaga;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
29 Málaga;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
29 Málaga;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
29 Málaga;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;91,48
29 Málaga;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
29 Málaga;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
29 Málaga;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;83,55
29 Málaga;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
29 Málaga;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
29 Málaga;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
29 Málaga;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;84,16
29 Málaga;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
29 Málaga;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
29 Málaga;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
29 Málaga;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;85,58
29 Málaga;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
29 Málaga;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
29 Málaga;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
29 Málaga;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
29 Málaga;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
29 Málaga;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
29 Málaga;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;77,8
29 Málaga;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
29 Málaga;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
29 Málaga;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
29 Málaga;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;81,39
29 Málaga;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
29 Málaga;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
29 Málaga;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
29 Málaga;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
29 Málaga;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
29 Málaga;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
29 Málaga;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;72,08
29 Málaga;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
29 Málaga;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
29 Málaga;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
29 Málaga;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;76,74
29 Málaga;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
29 Málaga;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
29 Málaga;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
29 Málaga;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
29 Málaga;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
29 Málaga;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QIV;8.808
29 Málaga;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
29 Málaga;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
29 Málaga;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
29 Málaga;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QIV;8.682
29 Málaga;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
29 Málaga;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
29 Málaga;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
29 Málaga;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QIV;7.853
29 Málaga;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
29 Málaga;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
29 Málaga;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
29 Málaga;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2022QIV;8.093
29 Málaga;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
29 Málaga;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2022QII;""
29 Málaga;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2022QI;""
29 Málaga;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2021QIV;7.986
29 Málaga;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
29 Málaga;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2021QII;""
29 Málaga;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2021QI;""
29 Málaga;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2020QIV;7.286
29 Málaga;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
29 Málaga;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2020QII;""
29 Málaga;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2020QI;""
29 Málaga;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
29 Málaga;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
29 Málaga;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2022QII;""
29 Málaga;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2022QI;7.378
29 Málaga;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
29 Málaga;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
29 Málaga;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2021QII;""
29 Málaga;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2021QI;6.880
29 Málaga;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
29 Málaga;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
29 Málaga;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2020QII;""
29 Málaga;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2020QI;""
29 Málaga;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
29 Málaga;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
29 Málaga;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QII;6.846
29 Málaga;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QI;""
29 Málaga;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
29 Málaga;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
29 Málaga;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QII;6.471
29 Málaga;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QI;""
29 Málaga;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
29 Málaga;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
29 Málaga;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QII;""
29 Málaga;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QI;""
29 Málaga;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
29 Málaga;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QIII;6.401
29 Málaga;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QII;""
29 Málaga;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QI;""
29 Málaga;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
29 Málaga;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QIII;6.085
29 Málaga;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QII;""
29 Málaga;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QI;""
29 Málaga;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
29 Málaga;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
29 Málaga;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QII;""
29 Málaga;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QI;""
29 Málaga;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
29 Málaga;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
29 Málaga;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
29 Málaga;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
29 Málaga;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
29 Málaga;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
29 Málaga;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
29 Málaga;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
29 Málaga;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
29 Málaga;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
29 Málaga;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
29 Málaga;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
29 Málaga;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;91,88
29 Málaga;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
29 Málaga;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
29 Málaga;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
29 Málaga;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;91,98
29 Málaga;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
29 Málaga;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
29 Málaga;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
29 Málaga;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;92,78
29 Málaga;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
29 Málaga;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
29 Málaga;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
29 Málaga;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
29 Málaga;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
29 Málaga;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
29 Málaga;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;84,98
29 Málaga;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
29 Málaga;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
29 Málaga;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
29 Málaga;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;87,61
29 Málaga;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
29 Málaga;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
29 Málaga;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
29 Málaga;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
29 Málaga;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
29 Málaga;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
29 Málaga;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;78,85
29 Málaga;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
29 Málaga;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
29 Málaga;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
29 Málaga;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;82,4
29 Málaga;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
29 Málaga;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
29 Málaga;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
29 Málaga;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
29 Málaga;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
29 Málaga;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
29 Málaga;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;73,73
29 Málaga;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
29 Málaga;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
29 Málaga;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
29 Málaga;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;77,49
29 Málaga;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
29 Málaga;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
29 Málaga;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
29 Málaga;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
29 Málaga;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
29 Málaga;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
29 Málaga;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QIV;5.346
29 Málaga;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
29 Málaga;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
29 Málaga;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
29 Málaga;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QIV;5.280
29 Málaga;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
29 Málaga;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
29 Málaga;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
29 Málaga;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QIV;4.872
29 Málaga;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
29 Málaga;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
29 Málaga;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
29 Málaga;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2022QIV;4.936
29 Málaga;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
29 Málaga;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2022QII;""
29 Málaga;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2022QI;""
29 Málaga;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2021QIV;4.864
29 Málaga;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
29 Málaga;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2021QII;""
29 Málaga;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2021QI;""
29 Málaga;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2020QIV;4.530
29 Málaga;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
29 Málaga;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2020QII;""
29 Málaga;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2020QI;""
29 Málaga;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
29 Málaga;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
29 Málaga;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2022QII;""
29 Málaga;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2022QI;4.495
29 Málaga;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
29 Málaga;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
29 Málaga;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2021QII;""
29 Málaga;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2021QI;4.282
29 Málaga;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
29 Málaga;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
29 Málaga;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2020QII;""
29 Málaga;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2020QI;""
29 Málaga;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
29 Málaga;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
29 Málaga;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QII;4.182
29 Málaga;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QI;""
29 Málaga;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
29 Málaga;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
29 Málaga;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QII;4.027
29 Málaga;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QI;""
29 Málaga;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
29 Málaga;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
29 Málaga;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QII;""
29 Málaga;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QI;""
29 Málaga;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
29 Málaga;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QIII;3.910
29 Málaga;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QII;""
29 Málaga;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QI;""
29 Málaga;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
29 Málaga;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QIII;3.792
29 Málaga;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QII;""
29 Málaga;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QI;""
29 Málaga;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
29 Málaga;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
29 Málaga;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QII;""
29 Málaga;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QI;""
29 Málaga;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
29 Málaga;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
29 Málaga;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
29 Málaga;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
29 Málaga;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
29 Málaga;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
29 Málaga;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
29 Málaga;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
29 Málaga;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
29 Málaga;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
29 Málaga;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
29 Málaga;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
29 Málaga;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;92,33
29 Málaga;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
29 Málaga;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
29 Málaga;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
29 Málaga;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;92,12
29 Málaga;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
29 Málaga;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
29 Málaga;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
29 Málaga;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;92,98
29 Málaga;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
29 Málaga;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
29 Málaga;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
29 Málaga;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
29 Málaga;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
29 Málaga;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
29 Málaga;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;85,13
29 Málaga;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
29 Málaga;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
29 Málaga;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
29 Málaga;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;87,89
29 Málaga;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
29 Málaga;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
29 Málaga;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
29 Málaga;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
29 Málaga;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
29 Málaga;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
29 Málaga;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;79,2
29 Málaga;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
29 Málaga;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
29 Málaga;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
29 Málaga;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;82,66
29 Málaga;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
29 Málaga;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
29 Málaga;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
29 Málaga;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
29 Málaga;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
29 Málaga;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
29 Málaga;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;74,05
29 Málaga;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
29 Málaga;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
29 Málaga;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
29 Málaga;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;77,83
29 Málaga;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
29 Málaga;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
29 Málaga;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
29 Málaga;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
29 Málaga;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
29 Málaga;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
29 Málaga;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QIV;3.462
29 Málaga;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
29 Málaga;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
29 Málaga;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
29 Málaga;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QIV;3.402
29 Málaga;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
29 Málaga;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
29 Málaga;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
29 Málaga;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QIV;2.981
29 Málaga;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
29 Málaga;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
29 Málaga;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
29 Málaga;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2022QIV;3.157
29 Málaga;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
29 Málaga;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2022QII;""
29 Málaga;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2022QI;""
29 Málaga;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2021QIV;3.122
29 Málaga;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
29 Málaga;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2021QII;""
29 Málaga;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2021QI;""
29 Málaga;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2020QIV;2.756
29 Málaga;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
29 Málaga;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2020QII;""
29 Málaga;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2020QI;""
29 Málaga;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
29 Málaga;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
29 Málaga;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2022QII;""
29 Málaga;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2022QI;2.883
29 Málaga;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
29 Málaga;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
29 Málaga;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2021QII;""
29 Málaga;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2021QI;2.598
29 Málaga;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
29 Málaga;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
29 Málaga;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2020QII;""
29 Málaga;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2020QI;""
29 Málaga;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
29 Málaga;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
29 Málaga;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QII;2.664
29 Málaga;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QI;""
29 Málaga;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
29 Málaga;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
29 Málaga;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QII;2.444
29 Málaga;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QI;""
29 Málaga;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
29 Málaga;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
29 Málaga;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QII;""
29 Málaga;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QI;""
29 Málaga;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
29 Málaga;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QIII;2.491
29 Málaga;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QII;""
29 Málaga;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QI;""
29 Málaga;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
29 Málaga;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QIII;2.293
29 Málaga;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QII;""
29 Málaga;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QI;""
29 Málaga;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
29 Málaga;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
29 Málaga;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QII;""
29 Málaga;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QI;""
29 Málaga;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
29 Málaga;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
29 Málaga;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
29 Málaga;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
29 Málaga;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
29 Málaga;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
29 Málaga;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
29 Málaga;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
29 Málaga;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
29 Málaga;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
29 Málaga;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
29 Málaga;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
29 Málaga;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;91,19
29 Málaga;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
29 Málaga;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
29 Málaga;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
29 Málaga;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;91,77
29 Málaga;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
29 Málaga;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
29 Málaga;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
29 Málaga;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;92,45
29 Málaga;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
29 Málaga;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
29 Málaga;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
29 Málaga;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
29 Málaga;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
29 Málaga;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
29 Málaga;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;84,74
29 Málaga;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
29 Málaga;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
29 Málaga;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
29 Málaga;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;87,15
29 Málaga;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
29 Málaga;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
29 Málaga;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
29 Málaga;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
29 Málaga;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
29 Málaga;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
29 Málaga;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;78,31
29 Málaga;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
29 Málaga;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
29 Málaga;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
29 Málaga;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;81,99
29 Málaga;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
29 Málaga;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
29 Málaga;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
29 Málaga;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
29 Málaga;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
29 Málaga;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
29 Málaga;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;73,22
29 Málaga;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
29 Málaga;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
29 Málaga;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
29 Málaga;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;76,92
29 Málaga;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
29 Málaga;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
29 Málaga;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
29 Málaga;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
29 Málaga;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
29 Málaga;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
29 Málaga;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
29 Málaga;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
29 Málaga;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
29 Málaga;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QI;24.876
29 Málaga;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
29 Málaga;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
29 Málaga;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
29 Málaga;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QI;24.577
29 Málaga;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
29 Málaga;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
29 Málaga;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
29 Málaga;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QI;23.525
29 Málaga;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
29 Málaga;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
29 Málaga;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2022QII;""
29 Málaga;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2022QI;23.602
29 Málaga;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
29 Málaga;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
29 Málaga;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2021QII;""
29 Málaga;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2021QI;23.768
29 Málaga;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
29 Málaga;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
29 Málaga;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2020QII;""
29 Málaga;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2020QI;21.450
29 Málaga;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
29 Málaga;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
29 Málaga;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2022QII;22.578
29 Málaga;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2022QI;""
29 Málaga;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
29 Málaga;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
29 Málaga;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2021QII;22.839
29 Málaga;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2021QI;""
29 Málaga;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
29 Málaga;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
29 Málaga;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2020QII;20.884
29 Málaga;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2020QI;""
29 Málaga;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
29 Málaga;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QIII;21.722
29 Málaga;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QII;""
29 Málaga;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QI;""
29 Málaga;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
29 Málaga;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QIII;22.034
29 Málaga;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QII;""
29 Málaga;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QI;""
29 Málaga;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
29 Málaga;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QIII;20.045
29 Málaga;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QII;""
29 Málaga;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QI;""
29 Málaga;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QIV;20.781
29 Málaga;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
29 Málaga;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QII;""
29 Málaga;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QI;""
29 Málaga;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QIV;21.110
29 Málaga;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
29 Málaga;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QII;""
29 Málaga;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QI;""
29 Málaga;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QIV;19.352
29 Málaga;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
29 Málaga;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QII;""
29 Málaga;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QI;""
29 Málaga;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
29 Málaga;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
29 Málaga;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
29 Málaga;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
29 Málaga;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
29 Málaga;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
29 Málaga;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
29 Málaga;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
29 Málaga;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
29 Málaga;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
29 Málaga;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
29 Málaga;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
29 Málaga;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
29 Málaga;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
29 Málaga;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
29 Málaga;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;94,88
29 Málaga;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
29 Málaga;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
29 Málaga;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
29 Málaga;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;96,71
29 Málaga;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
29 Málaga;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
29 Málaga;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
29 Málaga;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;91,18
29 Málaga;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
29 Málaga;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
29 Málaga;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;90,76
29 Málaga;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
29 Málaga;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
29 Málaga;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
29 Málaga;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;92,93
29 Málaga;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
29 Málaga;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
29 Málaga;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
29 Málaga;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;88,77
29 Málaga;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
29 Málaga;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
29 Málaga;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;87,32
29 Málaga;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
29 Málaga;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
29 Málaga;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
29 Málaga;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;89,65
29 Málaga;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
29 Málaga;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
29 Málaga;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
29 Málaga;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;85,21
29 Málaga;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
29 Málaga;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
29 Málaga;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;83,54
29 Málaga;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
29 Málaga;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
29 Málaga;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
29 Málaga;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;85,89
29 Málaga;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
29 Málaga;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
29 Málaga;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
29 Málaga;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;82,26
29 Málaga;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
29 Málaga;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
29 Málaga;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
29 Málaga;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
29 Málaga;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
29 Málaga;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
29 Málaga;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QI;14.674
29 Málaga;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
29 Málaga;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
29 Málaga;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
29 Málaga;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QI;14.709
29 Málaga;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
29 Málaga;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
29 Málaga;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
29 Málaga;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QI;14.040
29 Málaga;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
29 Málaga;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
29 Málaga;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2022QII;""
29 Málaga;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2022QI;13.939
29 Málaga;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
29 Málaga;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
29 Málaga;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2021QII;""
29 Málaga;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2021QI;14.250
29 Málaga;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
29 Málaga;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
29 Málaga;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2020QII;""
29 Málaga;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2020QI;12.879
29 Málaga;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
29 Málaga;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
29 Málaga;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2022QII;13.371
29 Málaga;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2022QI;""
29 Málaga;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
29 Málaga;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
29 Málaga;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2021QII;13.724
29 Málaga;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2021QI;""
29 Málaga;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
29 Málaga;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
29 Málaga;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2020QII;12.568
29 Málaga;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2020QI;""
29 Málaga;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
29 Málaga;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QIII;12.911
29 Málaga;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QII;""
29 Málaga;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QI;""
29 Málaga;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
29 Málaga;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QIII;13.245
29 Málaga;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QII;""
29 Málaga;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QI;""
29 Málaga;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
29 Málaga;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QIII;12.113
29 Málaga;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QII;""
29 Málaga;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QI;""
29 Málaga;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QIV;12.389
29 Málaga;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
29 Málaga;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QII;""
29 Málaga;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QI;""
29 Málaga;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QIV;12.743
29 Málaga;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
29 Málaga;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QII;""
29 Málaga;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QI;""
29 Málaga;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QIV;11.752
29 Málaga;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
29 Málaga;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QII;""
29 Málaga;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QI;""
29 Málaga;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
29 Málaga;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
29 Málaga;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
29 Málaga;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
29 Málaga;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
29 Málaga;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
29 Málaga;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
29 Málaga;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
29 Málaga;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
29 Málaga;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
29 Málaga;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
29 Málaga;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
29 Málaga;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
29 Málaga;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
29 Málaga;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
29 Málaga;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;94,99
29 Málaga;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
29 Málaga;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
29 Málaga;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
29 Málaga;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;96,88
29 Málaga;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
29 Málaga;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
29 Málaga;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
29 Málaga;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;91,73
29 Málaga;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
29 Málaga;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
29 Málaga;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;91,12
29 Málaga;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
29 Málaga;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
29 Málaga;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
29 Málaga;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;93,3
29 Málaga;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
29 Málaga;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
29 Málaga;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
29 Málaga;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;89,52
29 Málaga;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
29 Málaga;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
29 Málaga;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;87,99
29 Málaga;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
29 Málaga;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
29 Málaga;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
29 Málaga;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;90,05
29 Málaga;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
29 Málaga;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
29 Málaga;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
29 Málaga;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;86,27
29 Málaga;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
29 Málaga;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
29 Málaga;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;84,43
29 Málaga;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
29 Málaga;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
29 Málaga;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
29 Málaga;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;86,63
29 Málaga;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
29 Málaga;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
29 Málaga;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
29 Málaga;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;83,7
29 Málaga;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
29 Málaga;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
29 Málaga;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
29 Málaga;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
29 Málaga;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
29 Málaga;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
29 Málaga;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QI;10.202
29 Málaga;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
29 Málaga;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
29 Málaga;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
29 Málaga;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QI;9.868
29 Málaga;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
29 Málaga;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
29 Málaga;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
29 Málaga;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QI;9.485
29 Málaga;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
29 Málaga;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
29 Málaga;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2022QII;""
29 Málaga;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2022QI;9.663
29 Málaga;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
29 Málaga;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
29 Málaga;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2021QII;""
29 Málaga;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2021QI;9.518
29 Málaga;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
29 Málaga;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
29 Málaga;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2020QII;""
29 Málaga;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2020QI;8.571
29 Málaga;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
29 Málaga;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
29 Málaga;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2022QII;9.207
29 Málaga;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2022QI;""
29 Málaga;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
29 Málaga;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
29 Málaga;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2021QII;9.115
29 Málaga;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2021QI;""
29 Málaga;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
29 Málaga;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
29 Málaga;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2020QII;8.316
29 Málaga;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2020QI;""
29 Málaga;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
29 Málaga;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QIII;8.811
29 Málaga;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QII;""
29 Málaga;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QI;""
29 Málaga;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
29 Málaga;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QIII;8.789
29 Málaga;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QII;""
29 Málaga;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QI;""
29 Málaga;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
29 Málaga;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QIII;7.932
29 Málaga;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QII;""
29 Málaga;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QI;""
29 Málaga;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QIV;8.392
29 Málaga;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
29 Málaga;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QII;""
29 Málaga;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QI;""
29 Málaga;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QIV;8.367
29 Málaga;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
29 Málaga;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QII;""
29 Málaga;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QI;""
29 Málaga;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QIV;7.600
29 Málaga;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
29 Málaga;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QII;""
29 Málaga;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QI;""
29 Málaga;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
29 Málaga;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
29 Málaga;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
29 Málaga;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
29 Málaga;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
29 Málaga;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
29 Málaga;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
29 Málaga;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
29 Málaga;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
29 Málaga;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
29 Málaga;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
29 Málaga;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
29 Málaga;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
29 Málaga;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
29 Málaga;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
29 Málaga;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;94,72
29 Málaga;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
29 Málaga;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
29 Málaga;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
29 Málaga;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;96,45
29 Málaga;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
29 Málaga;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
29 Málaga;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
29 Málaga;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;90,36
29 Málaga;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
29 Málaga;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
29 Málaga;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;90,25
29 Málaga;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
29 Málaga;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
29 Málaga;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
29 Málaga;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;92,37
29 Málaga;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
29 Málaga;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
29 Málaga;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
29 Málaga;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;87,68
29 Málaga;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
29 Málaga;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
29 Málaga;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;86,37
29 Málaga;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
29 Málaga;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
29 Málaga;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
29 Málaga;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;89,07
29 Málaga;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
29 Málaga;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
29 Málaga;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
29 Málaga;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;83,63
29 Málaga;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
29 Málaga;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
29 Málaga;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;82,26
29 Málaga;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
29 Málaga;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
29 Málaga;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
29 Málaga;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;84,79
29 Málaga;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
29 Málaga;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
29 Málaga;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
29 Málaga;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;80,13
29 Málaga;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
29 Málaga;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
29 Málaga;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
29 Málaga;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
29 Málaga;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
29 Málaga;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QII;23.566
29 Málaga;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
29 Málaga;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
29 Málaga;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
29 Málaga;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QII;23.616
29 Málaga;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
29 Málaga;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
29 Málaga;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
29 Málaga;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QII;23.192
29 Málaga;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
29 Málaga;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
29 Málaga;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
29 Málaga;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2022QII;22.467
29 Málaga;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2022QI;""
29 Málaga;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
29 Málaga;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
29 Málaga;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2021QII;22.591
29 Málaga;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2021QI;""
29 Málaga;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
29 Málaga;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
29 Málaga;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2020QII;22.527
29 Málaga;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2020QI;""
29 Málaga;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
29 Málaga;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2022QIII;21.526
29 Málaga;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2022QII;""
29 Málaga;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2022QI;""
29 Málaga;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
29 Málaga;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2021QIII;21.690
29 Málaga;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2021QII;""
29 Málaga;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2021QI;""
29 Málaga;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
29 Málaga;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2020QIII;21.550
29 Málaga;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2020QII;""
29 Málaga;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2020QI;""
29 Málaga;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QIV;20.534
29 Málaga;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
29 Málaga;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QII;""
29 Málaga;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QI;""
29 Málaga;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QIV;20.718
29 Málaga;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
29 Málaga;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QII;""
29 Málaga;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QI;""
29 Málaga;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QIV;20.775
29 Málaga;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
29 Málaga;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QII;""
29 Málaga;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QI;""
29 Málaga;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
29 Málaga;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
29 Málaga;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QII;""
29 Málaga;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QI;19.793
29 Málaga;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
29 Málaga;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
29 Málaga;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QII;""
29 Málaga;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QI;20.255
29 Málaga;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
29 Málaga;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
29 Málaga;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QII;""
29 Málaga;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QI;""
29 Málaga;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
29 Málaga;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
29 Málaga;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
29 Málaga;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
29 Málaga;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
29 Málaga;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
29 Málaga;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
29 Málaga;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
29 Málaga;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
29 Málaga;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
29 Málaga;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
29 Málaga;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
29 Málaga;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
29 Málaga;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
29 Málaga;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;95,34
29 Málaga;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
29 Málaga;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
29 Málaga;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
29 Málaga;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;95,66
29 Málaga;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
29 Málaga;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
29 Málaga;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
29 Málaga;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;97,13
29 Málaga;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
29 Málaga;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
29 Málaga;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;91,34
29 Málaga;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
29 Málaga;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
29 Málaga;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
29 Málaga;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;91,84
29 Málaga;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
29 Málaga;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
29 Málaga;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
29 Málaga;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;92,92
29 Málaga;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
29 Málaga;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
29 Málaga;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;87,13
29 Málaga;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
29 Málaga;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
29 Málaga;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
29 Málaga;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;87,73
29 Málaga;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
29 Málaga;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
29 Málaga;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
29 Málaga;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;89,58
29 Málaga;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
29 Málaga;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
29 Málaga;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
29 Málaga;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
29 Málaga;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
29 Málaga;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
29 Málaga;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;83,81
29 Málaga;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
29 Málaga;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
29 Málaga;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
29 Málaga;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;87,34
29 Málaga;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
29 Málaga;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
29 Málaga;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
29 Málaga;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
29 Málaga;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
29 Málaga;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
29 Málaga;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QII;13.829
29 Málaga;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
29 Málaga;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
29 Málaga;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
29 Málaga;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QII;14.076
29 Málaga;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
29 Málaga;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
29 Málaga;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
29 Málaga;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QII;13.860
29 Málaga;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
29 Málaga;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
29 Málaga;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
29 Málaga;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2022QII;13.201
29 Málaga;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2022QI;""
29 Málaga;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
29 Málaga;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
29 Málaga;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2021QII;13.490
29 Málaga;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2021QI;""
29 Málaga;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
29 Málaga;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
29 Málaga;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2020QII;13.479
29 Málaga;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2020QI;""
29 Málaga;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
29 Málaga;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2022QIII;12.683
29 Málaga;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2022QII;""
29 Málaga;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2022QI;""
29 Málaga;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
29 Málaga;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2021QIII;12.960
29 Málaga;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2021QII;""
29 Málaga;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2021QI;""
29 Málaga;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
29 Málaga;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2020QIII;12.960
29 Málaga;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2020QII;""
29 Málaga;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2020QI;""
29 Málaga;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QIV;12.140
29 Málaga;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
29 Málaga;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QII;""
29 Málaga;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QI;""
29 Málaga;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QIV;12.421
29 Málaga;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
29 Málaga;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QII;""
29 Málaga;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QI;""
29 Málaga;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QIV;12.552
29 Málaga;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
29 Málaga;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QII;""
29 Málaga;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QI;""
29 Málaga;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
29 Málaga;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
29 Málaga;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QII;""
29 Málaga;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QI;11.893
29 Málaga;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
29 Málaga;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
29 Málaga;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QII;""
29 Málaga;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QI;12.253
29 Málaga;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
29 Málaga;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
29 Málaga;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QII;""
29 Málaga;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QI;""
29 Málaga;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
29 Málaga;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
29 Málaga;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
29 Málaga;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
29 Málaga;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
29 Málaga;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
29 Málaga;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
29 Málaga;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
29 Málaga;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
29 Málaga;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
29 Málaga;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
29 Málaga;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
29 Málaga;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
29 Málaga;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
29 Málaga;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;95,46
29 Málaga;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
29 Málaga;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
29 Málaga;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
29 Málaga;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;95,84
29 Málaga;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
29 Málaga;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
29 Málaga;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
29 Málaga;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;97,25
29 Málaga;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
29 Málaga;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
29 Málaga;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;91,71
29 Málaga;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
29 Málaga;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
29 Málaga;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
29 Málaga;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;92,07
29 Málaga;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
29 Málaga;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
29 Málaga;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
29 Málaga;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;93,51
29 Málaga;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
29 Málaga;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
29 Málaga;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;87,79
29 Málaga;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
29 Málaga;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
29 Málaga;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
29 Málaga;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;88,24
29 Málaga;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
29 Málaga;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
29 Málaga;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
29 Málaga;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;90,56
29 Málaga;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
29 Málaga;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
29 Málaga;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
29 Málaga;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
29 Málaga;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
29 Málaga;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
29 Málaga;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;84,49
29 Málaga;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
29 Málaga;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
29 Málaga;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
29 Málaga;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;88,41
29 Málaga;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
29 Málaga;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
29 Málaga;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
29 Málaga;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
29 Málaga;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
29 Málaga;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
29 Málaga;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QII;9.737
29 Málaga;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
29 Málaga;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
29 Málaga;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
29 Málaga;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QII;9.540
29 Málaga;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
29 Málaga;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
29 Málaga;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
29 Málaga;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QII;9.332
29 Málaga;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
29 Málaga;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
29 Málaga;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
29 Málaga;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2022QII;9.266
29 Málaga;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2022QI;""
29 Málaga;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
29 Málaga;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
29 Málaga;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2021QII;9.101
29 Málaga;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2021QI;""
29 Málaga;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
29 Málaga;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
29 Málaga;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2020QII;9.048
29 Málaga;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2020QI;""
29 Málaga;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
29 Málaga;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2022QIII;8.843
29 Málaga;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2022QII;""
29 Málaga;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2022QI;""
29 Málaga;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
29 Málaga;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2021QIII;8.730
29 Málaga;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2021QII;""
29 Málaga;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2021QI;""
29 Málaga;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
29 Málaga;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2020QIII;8.590
29 Málaga;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2020QII;""
29 Málaga;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2020QI;""
29 Málaga;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QIV;8.394
29 Málaga;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
29 Málaga;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QII;""
29 Málaga;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QI;""
29 Málaga;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QIV;8.297
29 Málaga;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
29 Málaga;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QII;""
29 Málaga;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QI;""
29 Málaga;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QIV;8.223
29 Málaga;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
29 Málaga;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QII;""
29 Málaga;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QI;""
29 Málaga;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
29 Málaga;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
29 Málaga;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QII;""
29 Málaga;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QI;7.900
29 Málaga;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
29 Málaga;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
29 Málaga;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QII;""
29 Málaga;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QI;8.002
29 Málaga;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
29 Málaga;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
29 Málaga;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QII;""
29 Málaga;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QI;""
29 Málaga;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
29 Málaga;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
29 Málaga;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
29 Málaga;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
29 Málaga;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
29 Málaga;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
29 Málaga;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
29 Málaga;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
29 Málaga;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
29 Málaga;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
29 Málaga;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
29 Málaga;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
29 Málaga;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
29 Málaga;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
29 Málaga;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;95,16
29 Málaga;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
29 Málaga;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
29 Málaga;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
29 Málaga;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;95,4
29 Málaga;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
29 Málaga;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
29 Málaga;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
29 Málaga;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;96,96
29 Málaga;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
29 Málaga;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
29 Málaga;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;90,82
29 Málaga;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
29 Málaga;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
29 Málaga;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
29 Málaga;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;91,51
29 Málaga;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
29 Málaga;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
29 Málaga;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
29 Málaga;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;92,05
29 Málaga;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
29 Málaga;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
29 Málaga;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;86,21
29 Málaga;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
29 Málaga;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
29 Málaga;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
29 Málaga;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;86,97
29 Málaga;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
29 Málaga;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
29 Málaga;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
29 Málaga;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;88,12
29 Málaga;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
29 Málaga;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
29 Málaga;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
29 Málaga;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
29 Málaga;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
29 Málaga;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
29 Málaga;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;82,81
29 Málaga;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
29 Málaga;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
29 Málaga;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
29 Málaga;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;85,75
29 Málaga;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
29 Málaga;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
29 Málaga;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
29 Málaga;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
29 Málaga;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
29 Málaga;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QIII;24.239
29 Málaga;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
29 Málaga;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
29 Málaga;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
29 Málaga;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QIII;24.339
29 Málaga;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
29 Málaga;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
29 Málaga;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
29 Málaga;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QIII;23.707
29 Málaga;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
29 Málaga;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
29 Málaga;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
29 Málaga;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2022QIII;23.111
29 Málaga;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2022QII;""
29 Málaga;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2022QI;""
29 Málaga;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
29 Málaga;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2021QIII;23.251
29 Málaga;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2021QII;""
29 Málaga;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2021QI;""
29 Málaga;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
29 Málaga;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2020QIII;22.623
29 Málaga;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2020QII;""
29 Málaga;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2020QI;""
29 Málaga;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2022QIV;21.960
29 Málaga;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
29 Málaga;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2022QII;""
29 Málaga;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2022QI;""
29 Málaga;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2021QIV;22.100
29 Málaga;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
29 Málaga;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2021QII;""
29 Málaga;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2021QI;""
29 Málaga;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2020QIV;21.742
29 Málaga;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
29 Málaga;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2020QII;""
29 Málaga;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2020QI;""
29 Málaga;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
29 Málaga;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
29 Málaga;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QII;""
29 Málaga;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QI;21.076
29 Málaga;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
29 Málaga;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
29 Málaga;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QII;""
29 Málaga;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QI;21.162
29 Málaga;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
29 Málaga;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
29 Málaga;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QII;""
29 Málaga;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QI;""
29 Málaga;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
29 Málaga;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
29 Málaga;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QII;20.239
29 Málaga;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QI;""
29 Málaga;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
29 Málaga;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
29 Málaga;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QII;20.445
29 Málaga;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QI;""
29 Málaga;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
29 Málaga;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
29 Málaga;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QII;""
29 Málaga;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QI;""
29 Málaga;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
29 Málaga;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
29 Málaga;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
29 Málaga;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
29 Málaga;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
29 Málaga;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
29 Málaga;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
29 Málaga;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
29 Málaga;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
29 Málaga;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
29 Málaga;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
29 Málaga;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
29 Málaga;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
29 Málaga;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;95,35
29 Málaga;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
29 Málaga;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
29 Málaga;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
29 Málaga;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;95,53
29 Málaga;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
29 Málaga;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
29 Málaga;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
29 Málaga;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;95,43
29 Málaga;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
29 Málaga;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
29 Málaga;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;90,6
29 Málaga;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
29 Málaga;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
29 Málaga;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
29 Málaga;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;90,8
29 Málaga;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
29 Málaga;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
29 Málaga;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
29 Málaga;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;91,71
29 Málaga;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
29 Málaga;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
29 Málaga;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
29 Málaga;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
29 Málaga;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
29 Málaga;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
29 Málaga;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;86,59
29 Málaga;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
29 Málaga;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
29 Málaga;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
29 Málaga;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;89,26
29 Málaga;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
29 Málaga;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
29 Málaga;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
29 Málaga;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
29 Málaga;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
29 Málaga;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
29 Málaga;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;83,15
29 Málaga;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
29 Málaga;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
29 Málaga;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
29 Málaga;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;86,24
29 Málaga;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
29 Málaga;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
29 Málaga;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
29 Málaga;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
29 Málaga;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
29 Málaga;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
29 Málaga;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QIII;14.201
29 Málaga;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
29 Málaga;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
29 Málaga;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
29 Málaga;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QIII;14.487
29 Málaga;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
29 Málaga;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
29 Málaga;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
29 Málaga;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QIII;14.183
29 Málaga;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
29 Málaga;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
29 Málaga;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
29 Málaga;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2022QIII;13.579
29 Málaga;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2022QII;""
29 Málaga;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2022QI;""
29 Málaga;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
29 Málaga;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2021QIII;13.844
29 Málaga;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2021QII;""
29 Málaga;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2021QI;""
29 Málaga;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
29 Málaga;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2020QIII;13.593
29 Málaga;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2020QII;""
29 Málaga;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2020QI;""
29 Málaga;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2022QIV;12.944
29 Málaga;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
29 Málaga;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2022QII;""
29 Málaga;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2022QI;""
29 Málaga;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2021QIV;13.202
29 Málaga;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
29 Málaga;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2021QII;""
29 Málaga;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2021QI;""
29 Málaga;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2020QIV;13.119
29 Málaga;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
29 Málaga;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2020QII;""
29 Málaga;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2020QI;""
29 Málaga;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
29 Málaga;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
29 Málaga;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QII;""
29 Málaga;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QI;12.624
29 Málaga;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
29 Málaga;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
29 Málaga;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QII;""
29 Málaga;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QI;12.783
29 Málaga;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
29 Málaga;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
29 Málaga;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QII;""
29 Málaga;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QI;""
29 Málaga;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
29 Málaga;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
29 Málaga;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QII;12.157
29 Málaga;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QI;""
29 Málaga;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
29 Málaga;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
29 Málaga;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QII;12.376
29 Málaga;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QI;""
29 Málaga;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
29 Málaga;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
29 Málaga;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QII;""
29 Málaga;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QI;""
29 Málaga;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
29 Málaga;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
29 Málaga;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
29 Málaga;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
29 Málaga;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
29 Málaga;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
29 Málaga;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
29 Málaga;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
29 Málaga;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
29 Málaga;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
29 Málaga;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
29 Málaga;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
29 Málaga;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
29 Málaga;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;95,62
29 Málaga;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
29 Málaga;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
29 Málaga;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
29 Málaga;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;95,56
29 Málaga;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
29 Málaga;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
29 Málaga;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
29 Málaga;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;95,84
29 Málaga;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
29 Málaga;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
29 Málaga;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;91,15
29 Málaga;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
29 Málaga;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
29 Málaga;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
29 Málaga;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;91,13
29 Málaga;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
29 Málaga;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
29 Málaga;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
29 Málaga;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;92,5
29 Málaga;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
29 Málaga;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
29 Málaga;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
29 Málaga;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
29 Málaga;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
29 Málaga;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
29 Málaga;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;87,14
29 Málaga;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
29 Málaga;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
29 Málaga;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
29 Málaga;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;90,13
29 Málaga;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
29 Málaga;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
29 Málaga;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
29 Málaga;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
29 Málaga;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
29 Málaga;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
29 Málaga;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;83,92
29 Málaga;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
29 Málaga;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
29 Málaga;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
29 Málaga;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;87,26
29 Málaga;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
29 Málaga;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
29 Málaga;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
29 Málaga;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
29 Málaga;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
29 Málaga;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
29 Málaga;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QIII;10.038
29 Málaga;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
29 Málaga;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
29 Málaga;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
29 Málaga;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QIII;9.852
29 Málaga;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
29 Málaga;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
29 Málaga;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
29 Málaga;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QIII;9.524
29 Málaga;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
29 Málaga;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
29 Málaga;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
29 Málaga;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2022QIII;9.532
29 Málaga;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2022QII;""
29 Málaga;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2022QI;""
29 Málaga;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
29 Málaga;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2021QIII;9.407
29 Málaga;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2021QII;""
29 Málaga;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2021QI;""
29 Málaga;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
29 Málaga;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2020QIII;9.030
29 Málaga;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2020QII;""
29 Málaga;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2020QI;""
29 Málaga;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2022QIV;9.016
29 Málaga;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
29 Málaga;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2022QII;""
29 Málaga;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2022QI;""
29 Málaga;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2021QIV;8.898
29 Málaga;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
29 Málaga;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2021QII;""
29 Málaga;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2021QI;""
29 Málaga;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2020QIV;8.623
29 Málaga;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
29 Málaga;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2020QII;""
29 Málaga;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2020QI;""
29 Málaga;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
29 Málaga;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
29 Málaga;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QII;""
29 Málaga;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QI;8.452
29 Málaga;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
29 Málaga;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
29 Málaga;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QII;""
29 Málaga;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QI;8.379
29 Málaga;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
29 Málaga;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
29 Málaga;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QII;""
29 Málaga;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QI;""
29 Málaga;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
29 Málaga;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
29 Málaga;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QII;8.082
29 Málaga;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QI;""
29 Málaga;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
29 Málaga;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
29 Málaga;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QII;8.069
29 Málaga;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QI;""
29 Málaga;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
29 Málaga;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
29 Málaga;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QII;""
29 Málaga;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QI;""
29 Málaga;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
29 Málaga;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
29 Málaga;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
29 Málaga;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
29 Málaga;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
29 Málaga;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
29 Málaga;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
29 Málaga;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
29 Málaga;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
29 Málaga;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
29 Málaga;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
29 Málaga;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
29 Málaga;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
29 Málaga;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;94,96
29 Málaga;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
29 Málaga;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
29 Málaga;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
29 Málaga;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;95,48
29 Málaga;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
29 Málaga;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
29 Málaga;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
29 Málaga;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;94,81
29 Málaga;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
29 Málaga;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
29 Málaga;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;89,82
29 Málaga;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
29 Málaga;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
29 Málaga;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
29 Málaga;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;90,32
29 Málaga;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
29 Málaga;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
29 Málaga;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
29 Málaga;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;90,54
29 Málaga;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
29 Málaga;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
29 Málaga;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
29 Málaga;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
29 Málaga;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
29 Málaga;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
29 Málaga;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;85,79
29 Málaga;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
29 Málaga;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
29 Málaga;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
29 Málaga;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;87,98
29 Málaga;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
29 Málaga;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
29 Málaga;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
29 Málaga;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
29 Málaga;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
29 Málaga;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
29 Málaga;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;82,03
29 Málaga;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
29 Málaga;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
29 Málaga;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
29 Málaga;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;84,72
29 Málaga;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
29 Málaga;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
29 Málaga;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
29 Málaga;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
29 Málaga;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
29 Málaga;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QIV;24.440
29 Málaga;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
29 Málaga;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
29 Málaga;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
29 Málaga;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QIV;24.674
29 Málaga;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
29 Málaga;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
29 Málaga;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
29 Málaga;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QIV;24.035
29 Málaga;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
29 Málaga;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
29 Málaga;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
29 Málaga;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2022QIV;23.162
29 Málaga;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
29 Málaga;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2022QII;""
29 Málaga;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2022QI;""
29 Málaga;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2021QIV;23.370
29 Málaga;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
29 Málaga;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2021QII;""
29 Málaga;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2021QI;""
29 Málaga;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2020QIV;22.985
29 Málaga;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
29 Málaga;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2020QII;""
29 Málaga;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2020QI;""
29 Málaga;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
29 Málaga;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
29 Málaga;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2022QII;""
29 Málaga;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2022QI;22.250
29 Málaga;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
29 Málaga;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
29 Málaga;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2021QII;""
29 Málaga;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2021QI;22.315
29 Málaga;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
29 Málaga;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
29 Málaga;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2020QII;""
29 Málaga;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2020QI;""
29 Málaga;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
29 Málaga;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
29 Málaga;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QII;21.335
29 Málaga;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QI;""
29 Málaga;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
29 Málaga;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
29 Málaga;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QII;21.510
29 Málaga;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QI;""
29 Málaga;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
29 Málaga;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
29 Málaga;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QII;""
29 Málaga;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QI;""
29 Málaga;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
29 Málaga;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QIII;20.574
29 Málaga;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QII;""
29 Málaga;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QI;""
29 Málaga;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
29 Málaga;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QIII;20.798
29 Málaga;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QII;""
29 Málaga;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QI;""
29 Málaga;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
29 Málaga;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
29 Málaga;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QII;""
29 Málaga;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QI;""
29 Málaga;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
29 Málaga;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
29 Málaga;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
29 Málaga;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
29 Málaga;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
29 Málaga;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
29 Málaga;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
29 Málaga;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
29 Málaga;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
29 Málaga;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
29 Málaga;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
29 Málaga;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
29 Málaga;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;94,77
29 Málaga;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
29 Málaga;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
29 Málaga;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
29 Málaga;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;94,72
29 Málaga;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
29 Málaga;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
29 Málaga;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
29 Málaga;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;95,63
29 Málaga;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
29 Málaga;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
29 Málaga;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
29 Málaga;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
29 Málaga;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
29 Málaga;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
29 Málaga;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;90,18
29 Málaga;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
29 Málaga;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
29 Málaga;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
29 Málaga;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;92,84
29 Málaga;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
29 Málaga;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
29 Málaga;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
29 Málaga;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
29 Málaga;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
29 Málaga;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
29 Málaga;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;86,47
29 Málaga;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
29 Málaga;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
29 Málaga;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
29 Málaga;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;89,49
29 Málaga;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
29 Málaga;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
29 Málaga;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
29 Málaga;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
29 Málaga;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
29 Málaga;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
29 Málaga;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;83,38
29 Málaga;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
29 Málaga;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
29 Málaga;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
29 Málaga;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;86,53
29 Málaga;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
29 Málaga;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
29 Málaga;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
29 Málaga;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
29 Málaga;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
29 Málaga;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
29 Málaga;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QIV;14.298
29 Málaga;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
29 Málaga;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
29 Málaga;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
29 Málaga;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QIV;14.590
29 Málaga;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
29 Málaga;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
29 Málaga;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
29 Málaga;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QIV;14.419
29 Málaga;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
29 Málaga;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
29 Málaga;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
29 Málaga;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2022QIV;13.586
29 Málaga;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
29 Málaga;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2022QII;""
29 Málaga;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2022QI;""
29 Málaga;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2021QIV;13.854
29 Málaga;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
29 Málaga;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2021QII;""
29 Málaga;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2021QI;""
29 Málaga;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2020QIV;13.842
29 Málaga;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
29 Málaga;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2020QII;""
29 Málaga;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2020QI;""
29 Málaga;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
29 Málaga;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
29 Málaga;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2022QII;""
29 Málaga;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2022QI;13.214
29 Málaga;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
29 Málaga;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
29 Málaga;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2021QII;""
29 Málaga;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2021QI;13.464
29 Málaga;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
29 Málaga;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
29 Málaga;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2020QII;""
29 Málaga;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2020QI;""
29 Málaga;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
29 Málaga;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
29 Málaga;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QII;12.703
29 Málaga;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QI;""
29 Málaga;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
29 Málaga;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
29 Málaga;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QII;13.013
29 Málaga;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QI;""
29 Málaga;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
29 Málaga;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
29 Málaga;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QII;""
29 Málaga;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QI;""
29 Málaga;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
29 Málaga;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QIII;12.291
29 Málaga;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QII;""
29 Málaga;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QI;""
29 Málaga;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
29 Málaga;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QIII;12.591
29 Málaga;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QII;""
29 Málaga;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QI;""
29 Málaga;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
29 Málaga;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
29 Málaga;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QII;""
29 Málaga;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QI;""
29 Málaga;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
29 Málaga;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
29 Málaga;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
29 Málaga;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
29 Málaga;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
29 Málaga;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
29 Málaga;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
29 Málaga;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
29 Málaga;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
29 Málaga;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
29 Málaga;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
29 Málaga;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
29 Málaga;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;95,02
29 Málaga;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
29 Málaga;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
29 Málaga;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
29 Málaga;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;94,96
29 Málaga;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
29 Málaga;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
29 Málaga;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
29 Málaga;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;96
29 Málaga;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
29 Málaga;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
29 Málaga;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
29 Málaga;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
29 Málaga;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
29 Málaga;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
29 Málaga;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;90,57
29 Málaga;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
29 Málaga;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
29 Málaga;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
29 Málaga;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;93,38
29 Málaga;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
29 Málaga;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
29 Málaga;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
29 Málaga;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
29 Málaga;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
29 Málaga;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
29 Málaga;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;87,07
29 Málaga;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
29 Málaga;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
29 Málaga;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
29 Málaga;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;90,25
29 Málaga;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
29 Málaga;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
29 Málaga;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
29 Málaga;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
29 Málaga;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
29 Málaga;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
29 Málaga;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;84,24
29 Málaga;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
29 Málaga;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
29 Málaga;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
29 Málaga;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;87,32
29 Málaga;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
29 Málaga;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
29 Málaga;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
29 Málaga;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
29 Málaga;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
29 Málaga;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
29 Málaga;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QIV;10.142
29 Málaga;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
29 Málaga;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
29 Málaga;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
29 Málaga;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QIV;10.084
29 Málaga;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
29 Málaga;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
29 Málaga;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
29 Málaga;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QIV;9.616
29 Málaga;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
29 Málaga;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
29 Málaga;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
29 Málaga;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2022QIV;9.576
29 Málaga;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
29 Málaga;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2022QII;""
29 Málaga;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2022QI;""
29 Málaga;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2021QIV;9.516
29 Málaga;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
29 Málaga;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2021QII;""
29 Málaga;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2021QI;""
29 Málaga;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2020QIV;9.143
29 Málaga;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
29 Málaga;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2020QII;""
29 Málaga;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2020QI;""
29 Málaga;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
29 Málaga;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
29 Málaga;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2022QII;""
29 Málaga;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2022QI;9.036
29 Málaga;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
29 Málaga;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
29 Málaga;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2021QII;""
29 Málaga;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2021QI;8.851
29 Málaga;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
29 Málaga;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
29 Málaga;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2020QII;""
29 Málaga;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2020QI;""
29 Málaga;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
29 Málaga;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
29 Málaga;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QII;8.632
29 Málaga;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QI;""
29 Málaga;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
29 Málaga;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
29 Málaga;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QII;8.497
29 Málaga;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QI;""
29 Málaga;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
29 Málaga;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
29 Málaga;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QII;""
29 Málaga;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QI;""
29 Málaga;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
29 Málaga;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QIII;8.283
29 Málaga;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QII;""
29 Málaga;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QI;""
29 Málaga;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
29 Málaga;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QIII;8.207
29 Málaga;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QII;""
29 Málaga;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QI;""
29 Málaga;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
29 Málaga;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
29 Málaga;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QII;""
29 Málaga;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QI;""
29 Málaga;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
29 Málaga;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
29 Málaga;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
29 Málaga;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
29 Málaga;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
29 Málaga;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
29 Málaga;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
29 Málaga;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
29 Málaga;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
29 Málaga;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
29 Málaga;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
29 Málaga;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
29 Málaga;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;94,42
29 Málaga;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
29 Málaga;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
29 Málaga;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
29 Málaga;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;94,37
29 Málaga;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
29 Málaga;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
29 Málaga;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
29 Málaga;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;95,08
29 Málaga;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
29 Málaga;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
29 Málaga;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
29 Málaga;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
29 Málaga;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
29 Málaga;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
29 Málaga;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;89,61
29 Málaga;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
29 Málaga;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
29 Málaga;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
29 Málaga;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;92,04
29 Málaga;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
29 Málaga;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
29 Málaga;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
29 Málaga;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
29 Málaga;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
29 Málaga;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
29 Málaga;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;85,6
29 Málaga;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
29 Málaga;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
29 Málaga;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
29 Málaga;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;88,36
29 Málaga;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
29 Málaga;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
29 Málaga;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
29 Málaga;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
29 Málaga;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
29 Málaga;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
29 Málaga;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;82,14
29 Málaga;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
29 Málaga;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
29 Málaga;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
29 Málaga;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;85,35
29 Málaga;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
29 Málaga;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
29 Málaga;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
29 Málaga;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
29 Málaga;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
29 Málaga;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
29 Málaga;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
29 Málaga;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
29 Málaga;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
29 Málaga;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QI;38.470
29 Málaga;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
29 Málaga;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
29 Málaga;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
29 Málaga;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QI;37.652
29 Málaga;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
29 Málaga;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
29 Málaga;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
29 Málaga;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QI;37.688
29 Málaga;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
29 Málaga;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
29 Málaga;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2022QII;""
29 Málaga;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2022QI;36.958
29 Málaga;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
29 Málaga;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
29 Málaga;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2021QII;""
29 Málaga;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2021QI;36.675
29 Málaga;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
29 Málaga;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
29 Málaga;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2020QII;""
29 Málaga;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2020QI;34.821
29 Málaga;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
29 Málaga;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
29 Málaga;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2022QII;35.764
29 Málaga;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2022QI;""
29 Málaga;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
29 Málaga;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
29 Málaga;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2021QII;35.647
29 Málaga;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2021QI;""
29 Málaga;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
29 Málaga;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
29 Málaga;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2020QII;34.074
29 Málaga;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2020QI;""
29 Málaga;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
29 Málaga;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QIII;34.805
29 Málaga;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QII;""
29 Málaga;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QI;""
29 Málaga;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
29 Málaga;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QIII;34.708
29 Málaga;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QII;""
29 Málaga;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QI;""
29 Málaga;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
29 Málaga;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QIII;33.083
29 Málaga;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QII;""
29 Málaga;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QI;""
29 Málaga;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QIV;33.760
29 Málaga;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
29 Málaga;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QII;""
29 Málaga;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QI;""
29 Málaga;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QIV;33.712
29 Málaga;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
29 Málaga;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QII;""
29 Málaga;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QI;""
29 Málaga;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QIV;32.237
29 Málaga;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
29 Málaga;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QII;""
29 Málaga;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QI;""
29 Málaga;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
29 Málaga;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
29 Málaga;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
29 Málaga;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
29 Málaga;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
29 Málaga;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
29 Málaga;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
29 Málaga;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
29 Málaga;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
29 Málaga;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
29 Málaga;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
29 Málaga;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
29 Málaga;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
29 Málaga;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
29 Málaga;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
29 Málaga;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;96,07
29 Málaga;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
29 Málaga;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
29 Málaga;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
29 Málaga;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;97,41
29 Málaga;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
29 Málaga;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
29 Málaga;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
29 Málaga;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;92,39
29 Málaga;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
29 Málaga;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
29 Málaga;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;92,97
29 Málaga;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
29 Málaga;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
29 Málaga;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
29 Málaga;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;94,67
29 Málaga;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
29 Málaga;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
29 Málaga;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
29 Málaga;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;90,41
29 Málaga;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
29 Málaga;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
29 Málaga;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;90,47
29 Málaga;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
29 Málaga;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
29 Málaga;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
29 Málaga;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;92,18
29 Málaga;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
29 Málaga;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
29 Málaga;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
29 Málaga;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;87,78
29 Málaga;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
29 Málaga;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
29 Málaga;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;87,76
29 Málaga;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
29 Málaga;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
29 Málaga;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
29 Málaga;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;89,54
29 Málaga;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
29 Málaga;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
29 Málaga;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
29 Málaga;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;85,54
29 Málaga;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
29 Málaga;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
29 Málaga;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
29 Málaga;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
29 Málaga;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
29 Málaga;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
29 Málaga;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QI;24.191
29 Málaga;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
29 Málaga;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
29 Málaga;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
29 Málaga;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QI;24.061
29 Málaga;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
29 Málaga;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
29 Málaga;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
29 Málaga;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QI;23.945
29 Málaga;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
29 Málaga;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
29 Málaga;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2022QII;""
29 Málaga;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2022QI;23.290
29 Málaga;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
29 Málaga;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
29 Málaga;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2021QII;""
29 Málaga;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2021QI;23.471
29 Málaga;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
29 Málaga;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
29 Málaga;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2020QII;""
29 Málaga;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2020QI;22.297
29 Málaga;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
29 Málaga;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
29 Málaga;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2022QII;22.622
29 Málaga;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2022QI;""
29 Málaga;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
29 Málaga;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
29 Málaga;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2021QII;22.880
29 Málaga;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2021QI;""
29 Málaga;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
29 Málaga;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
29 Málaga;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2020QII;21.847
29 Málaga;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2020QI;""
29 Málaga;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
29 Málaga;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QIII;22.104
29 Málaga;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QII;""
29 Málaga;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QI;""
29 Málaga;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
29 Málaga;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QIII;22.298
29 Málaga;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QII;""
29 Málaga;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QI;""
29 Málaga;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
29 Málaga;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QIII;21.282
29 Málaga;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QII;""
29 Málaga;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QI;""
29 Málaga;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QIV;21.503
29 Málaga;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
29 Málaga;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QII;""
29 Málaga;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QI;""
29 Málaga;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QIV;21.685
29 Málaga;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
29 Málaga;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QII;""
29 Málaga;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QI;""
29 Málaga;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QIV;20.813
29 Málaga;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
29 Málaga;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QII;""
29 Málaga;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QI;""
29 Málaga;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
29 Málaga;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
29 Málaga;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
29 Málaga;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
29 Málaga;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
29 Málaga;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
29 Málaga;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
29 Málaga;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
29 Málaga;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
29 Málaga;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
29 Málaga;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
29 Málaga;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
29 Málaga;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
29 Málaga;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
29 Málaga;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
29 Málaga;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;96,28
29 Málaga;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
29 Málaga;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
29 Málaga;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
29 Málaga;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;97,55
29 Málaga;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
29 Málaga;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
29 Málaga;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
29 Málaga;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;93,12
29 Málaga;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
29 Málaga;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
29 Málaga;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;93,51
29 Málaga;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
29 Málaga;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
29 Málaga;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
29 Málaga;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;95,09
29 Málaga;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
29 Málaga;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
29 Málaga;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
29 Málaga;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;91,24
29 Málaga;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
29 Málaga;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
29 Málaga;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;91,37
29 Málaga;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
29 Málaga;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
29 Málaga;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
29 Málaga;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;92,67
29 Málaga;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
29 Málaga;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
29 Málaga;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
29 Málaga;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;88,88
29 Málaga;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
29 Málaga;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
29 Málaga;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;88,89
29 Málaga;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
29 Málaga;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
29 Málaga;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
29 Málaga;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;90,13
29 Málaga;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
29 Málaga;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
29 Málaga;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
29 Málaga;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;86,92
29 Málaga;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
29 Málaga;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
29 Málaga;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
29 Málaga;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
29 Málaga;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
29 Málaga;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
29 Málaga;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QI;14.279
29 Málaga;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
29 Málaga;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
29 Málaga;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
29 Málaga;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QI;13.591
29 Málaga;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
29 Málaga;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
29 Málaga;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
29 Málaga;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QI;13.743
29 Málaga;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
29 Málaga;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
29 Málaga;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2022QII;""
29 Málaga;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2022QI;13.668
29 Málaga;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
29 Málaga;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
29 Málaga;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2021QII;""
29 Málaga;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2021QI;13.204
29 Málaga;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
29 Málaga;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
29 Málaga;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2020QII;""
29 Málaga;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2020QI;12.524
29 Málaga;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
29 Málaga;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
29 Málaga;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2022QII;13.142
29 Málaga;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2022QI;""
29 Málaga;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
29 Málaga;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
29 Málaga;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2021QII;12.767
29 Málaga;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2021QI;""
29 Málaga;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
29 Málaga;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
29 Málaga;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2020QII;12.227
29 Málaga;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2020QI;""
29 Málaga;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
29 Málaga;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QIII;12.701
29 Málaga;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QII;""
29 Málaga;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QI;""
29 Málaga;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
29 Málaga;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QIII;12.410
29 Málaga;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QII;""
29 Málaga;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QI;""
29 Málaga;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
29 Málaga;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QIII;11.801
29 Málaga;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QII;""
29 Málaga;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QI;""
29 Málaga;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QIV;12.257
29 Málaga;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
29 Málaga;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QII;""
29 Málaga;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QI;""
29 Málaga;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QIV;12.027
29 Málaga;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
29 Málaga;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QII;""
29 Málaga;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QI;""
29 Málaga;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QIV;11.424
29 Málaga;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
29 Málaga;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QII;""
29 Málaga;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QI;""
29 Málaga;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
29 Málaga;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
29 Málaga;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
29 Málaga;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
29 Málaga;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
29 Málaga;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
29 Málaga;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
29 Málaga;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
29 Málaga;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
29 Málaga;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
29 Málaga;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
29 Málaga;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
29 Málaga;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
29 Málaga;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
29 Málaga;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
29 Málaga;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;95,72
29 Málaga;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
29 Málaga;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
29 Málaga;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
29 Málaga;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;97,15
29 Málaga;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
29 Málaga;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
29 Málaga;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
29 Málaga;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;91,13
29 Málaga;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
29 Málaga;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
29 Málaga;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;92,04
29 Málaga;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
29 Málaga;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
29 Málaga;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
29 Málaga;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;93,94
29 Málaga;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
29 Málaga;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
29 Málaga;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
29 Málaga;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;88,97
29 Málaga;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
29 Málaga;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
29 Málaga;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;88,95
29 Málaga;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
29 Málaga;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
29 Málaga;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
29 Málaga;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;91,31
29 Málaga;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
29 Málaga;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
29 Málaga;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
29 Málaga;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;85,87
29 Málaga;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
29 Málaga;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
29 Málaga;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;85,84
29 Málaga;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
29 Málaga;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
29 Málaga;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
29 Málaga;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;88,49
29 Málaga;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
29 Málaga;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
29 Málaga;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
29 Málaga;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;83,13
29 Málaga;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
29 Málaga;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
29 Málaga;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
29 Málaga;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
29 Málaga;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
29 Málaga;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QII;37.926
29 Málaga;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
29 Málaga;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
29 Málaga;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
29 Málaga;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QII;37.569
29 Málaga;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
29 Málaga;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
29 Málaga;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
29 Málaga;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QII;36.641
29 Málaga;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
29 Málaga;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
29 Málaga;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
29 Málaga;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2022QII;36.572
29 Málaga;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2022QI;""
29 Málaga;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
29 Málaga;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
29 Málaga;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2021QII;36.390
29 Málaga;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2021QI;""
29 Málaga;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
29 Málaga;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
29 Málaga;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2020QII;35.779
29 Málaga;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2020QI;""
29 Málaga;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
29 Málaga;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2022QIII;35.498
29 Málaga;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2022QII;""
29 Málaga;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2022QI;""
29 Málaga;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
29 Málaga;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2021QIII;35.350
29 Málaga;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2021QII;""
29 Málaga;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2021QI;""
29 Málaga;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
29 Málaga;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2020QIII;34.640
29 Málaga;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2020QII;""
29 Málaga;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2020QI;""
29 Málaga;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QIV;34.298
29 Málaga;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
29 Málaga;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QII;""
29 Málaga;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QI;""
29 Málaga;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QIV;34.224
29 Málaga;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
29 Málaga;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QII;""
29 Málaga;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QI;""
29 Málaga;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QIV;33.672
29 Málaga;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
29 Málaga;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QII;""
29 Málaga;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QI;""
29 Málaga;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
29 Málaga;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
29 Málaga;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QII;""
29 Málaga;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QI;33.040
29 Málaga;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
29 Málaga;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
29 Málaga;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QII;""
29 Málaga;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QI;33.031
29 Málaga;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
29 Málaga;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
29 Málaga;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QII;""
29 Málaga;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QI;""
29 Málaga;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
29 Málaga;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
29 Málaga;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
29 Málaga;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
29 Málaga;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
29 Málaga;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
29 Málaga;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
29 Málaga;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
29 Málaga;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
29 Málaga;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
29 Málaga;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
29 Málaga;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
29 Málaga;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
29 Málaga;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
29 Málaga;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;96,43
29 Málaga;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
29 Málaga;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
29 Málaga;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
29 Málaga;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;96,86
29 Málaga;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
29 Málaga;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
29 Málaga;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
29 Málaga;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;97,65
29 Málaga;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
29 Málaga;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
29 Málaga;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;93,6
29 Málaga;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
29 Málaga;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
29 Málaga;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
29 Málaga;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;94,09
29 Málaga;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
29 Málaga;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
29 Málaga;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
29 Málaga;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;94,54
29 Málaga;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
29 Málaga;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
29 Málaga;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;90,43
29 Málaga;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
29 Málaga;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
29 Málaga;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
29 Málaga;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;91,1
29 Málaga;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
29 Málaga;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
29 Málaga;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
29 Málaga;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;91,9
29 Málaga;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
29 Málaga;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
29 Málaga;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
29 Málaga;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
29 Málaga;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
29 Málaga;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
29 Málaga;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;87,94
29 Málaga;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
29 Málaga;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
29 Málaga;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
29 Málaga;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;90,15
29 Málaga;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
29 Málaga;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
29 Málaga;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
29 Málaga;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
29 Málaga;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
29 Málaga;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
29 Málaga;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QII;23.699
29 Málaga;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
29 Málaga;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
29 Málaga;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
29 Málaga;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QII;23.808
29 Málaga;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
29 Málaga;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
29 Málaga;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
29 Málaga;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QII;23.376
29 Málaga;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
29 Málaga;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
29 Málaga;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
29 Málaga;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2022QII;22.943
29 Málaga;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2022QI;""
29 Málaga;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
29 Málaga;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
29 Málaga;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2021QII;23.123
29 Málaga;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2021QI;""
29 Málaga;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
29 Málaga;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
29 Málaga;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2020QII;22.844
29 Málaga;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2020QI;""
29 Málaga;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
29 Málaga;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2022QIII;22.364
29 Málaga;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2022QII;""
29 Málaga;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2022QI;""
29 Málaga;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
29 Málaga;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2021QIII;22.490
29 Málaga;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2021QII;""
29 Málaga;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2021QI;""
29 Málaga;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
29 Málaga;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2020QIII;22.185
29 Málaga;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2020QII;""
29 Málaga;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2020QI;""
29 Málaga;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QIV;21.672
29 Málaga;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
29 Málaga;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QII;""
29 Málaga;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QI;""
29 Málaga;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QIV;21.822
29 Málaga;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
29 Málaga;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QII;""
29 Málaga;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QI;""
29 Málaga;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QIV;21.644
29 Málaga;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
29 Málaga;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QII;""
29 Málaga;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QI;""
29 Málaga;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
29 Málaga;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
29 Málaga;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QII;""
29 Málaga;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QI;21.117
29 Málaga;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
29 Málaga;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
29 Málaga;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QII;""
29 Málaga;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QI;21.264
29 Málaga;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
29 Málaga;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
29 Málaga;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QII;""
29 Málaga;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QI;""
29 Málaga;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
29 Málaga;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
29 Málaga;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
29 Málaga;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
29 Málaga;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
29 Málaga;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
29 Málaga;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
29 Málaga;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
29 Málaga;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
29 Málaga;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
29 Málaga;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
29 Málaga;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
29 Málaga;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
29 Málaga;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
29 Málaga;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;96,81
29 Málaga;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
29 Málaga;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
29 Málaga;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
29 Málaga;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;97,12
29 Málaga;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
29 Málaga;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
29 Málaga;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
29 Málaga;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;97,72
29 Málaga;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
29 Málaga;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
29 Málaga;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;94,37
29 Málaga;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
29 Málaga;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
29 Málaga;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
29 Málaga;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;94,46
29 Málaga;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
29 Málaga;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
29 Málaga;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
29 Málaga;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;94,91
29 Málaga;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
29 Málaga;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
29 Málaga;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;91,45
29 Málaga;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
29 Málaga;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
29 Málaga;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
29 Málaga;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;91,66
29 Málaga;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
29 Málaga;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
29 Málaga;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
29 Málaga;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;92,59
29 Málaga;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
29 Málaga;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
29 Málaga;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
29 Málaga;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
29 Málaga;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
29 Málaga;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
29 Málaga;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;88,7
29 Málaga;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
29 Málaga;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
29 Málaga;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
29 Málaga;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;90,97
29 Málaga;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
29 Málaga;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
29 Málaga;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
29 Málaga;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
29 Málaga;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
29 Málaga;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
29 Málaga;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QII;14.227
29 Málaga;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
29 Málaga;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
29 Málaga;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
29 Málaga;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QII;13.761
29 Málaga;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
29 Málaga;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
29 Málaga;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
29 Málaga;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QII;13.265
29 Málaga;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
29 Málaga;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
29 Málaga;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
29 Málaga;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2022QII;13.629
29 Málaga;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2022QI;""
29 Málaga;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
29 Málaga;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
29 Málaga;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2021QII;13.267
29 Málaga;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2021QI;""
29 Málaga;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
29 Málaga;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
29 Málaga;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2020QII;12.935
29 Málaga;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2020QI;""
29 Málaga;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
29 Málaga;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2022QIII;13.134
29 Málaga;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2022QII;""
29 Málaga;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2022QI;""
29 Málaga;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
29 Málaga;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2021QIII;12.860
29 Málaga;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2021QII;""
29 Málaga;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2021QI;""
29 Málaga;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
29 Málaga;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2020QIII;12.455
29 Málaga;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2020QII;""
29 Málaga;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2020QI;""
29 Málaga;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QIV;12.626
29 Málaga;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
29 Málaga;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QII;""
29 Málaga;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QI;""
29 Málaga;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QIV;12.402
29 Málaga;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
29 Málaga;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QII;""
29 Málaga;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QI;""
29 Málaga;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QIV;12.028
29 Málaga;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
29 Málaga;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QII;""
29 Málaga;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QI;""
29 Málaga;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
29 Málaga;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
29 Málaga;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QII;""
29 Málaga;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QI;11.923
29 Málaga;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
29 Málaga;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
29 Málaga;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QII;""
29 Málaga;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QI;11.767
29 Málaga;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
29 Málaga;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
29 Málaga;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QII;""
29 Málaga;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QI;""
29 Málaga;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
29 Málaga;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
29 Málaga;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
29 Málaga;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
29 Málaga;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
29 Málaga;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
29 Málaga;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
29 Málaga;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
29 Málaga;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
29 Málaga;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
29 Málaga;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
29 Málaga;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
29 Málaga;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
29 Málaga;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
29 Málaga;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;95,8
29 Málaga;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
29 Málaga;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
29 Málaga;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
29 Málaga;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;96,41
29 Málaga;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
29 Málaga;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
29 Málaga;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
29 Málaga;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;97,51
29 Málaga;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
29 Málaga;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
29 Málaga;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;92,32
29 Málaga;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
29 Málaga;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
29 Málaga;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
29 Málaga;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;93,45
29 Málaga;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
29 Málaga;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
29 Málaga;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
29 Málaga;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;93,89
29 Málaga;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
29 Málaga;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
29 Málaga;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;88,75
29 Málaga;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
29 Málaga;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
29 Málaga;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
29 Málaga;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;90,12
29 Málaga;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
29 Málaga;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
29 Málaga;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
29 Málaga;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;90,67
29 Málaga;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
29 Málaga;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
29 Málaga;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
29 Málaga;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
29 Málaga;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
29 Málaga;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
29 Málaga;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;86,64
29 Málaga;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
29 Málaga;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
29 Málaga;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
29 Málaga;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;88,71
29 Málaga;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
29 Málaga;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
29 Málaga;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
29 Málaga;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
29 Málaga;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
29 Málaga;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QIII;38.501
29 Málaga;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
29 Málaga;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
29 Málaga;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
29 Málaga;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QIII;38.293
29 Málaga;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
29 Málaga;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
29 Málaga;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
29 Málaga;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QIII;37.242
29 Málaga;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
29 Málaga;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
29 Málaga;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
29 Málaga;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2022QIII;37.194
29 Málaga;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2022QII;""
29 Málaga;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2022QI;""
29 Málaga;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
29 Málaga;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2021QIII;37.046
29 Málaga;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2021QII;""
29 Málaga;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2021QI;""
29 Málaga;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
29 Málaga;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2020QIII;35.927
29 Málaga;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2020QII;""
29 Málaga;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2020QI;""
29 Málaga;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2022QIV;35.781
29 Málaga;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
29 Málaga;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2022QII;""
29 Málaga;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2022QI;""
29 Málaga;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2021QIV;35.726
29 Málaga;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
29 Málaga;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2021QII;""
29 Málaga;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2021QI;""
29 Málaga;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2020QIV;34.823
29 Málaga;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
29 Málaga;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2020QII;""
29 Málaga;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2020QI;""
29 Málaga;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
29 Málaga;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
29 Málaga;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QII;""
29 Málaga;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QI;34.440
29 Málaga;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
29 Málaga;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
29 Málaga;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QII;""
29 Málaga;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QI;34.122
29 Málaga;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
29 Málaga;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
29 Málaga;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QII;""
29 Málaga;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QI;""
29 Málaga;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
29 Málaga;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
29 Málaga;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QII;33.456
29 Málaga;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QI;""
29 Málaga;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
29 Málaga;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
29 Málaga;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QII;33.301
29 Málaga;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QI;""
29 Málaga;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
29 Málaga;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
29 Málaga;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QII;""
29 Málaga;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QI;""
29 Málaga;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
29 Málaga;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
29 Málaga;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
29 Málaga;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
29 Málaga;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
29 Málaga;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
29 Málaga;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
29 Málaga;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
29 Málaga;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
29 Málaga;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
29 Málaga;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
29 Málaga;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
29 Málaga;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
29 Málaga;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;96,61
29 Málaga;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
29 Málaga;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
29 Málaga;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
29 Málaga;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;96,74
29 Málaga;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
29 Málaga;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
29 Málaga;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
29 Málaga;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;96,47
29 Málaga;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
29 Málaga;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
29 Málaga;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;92,94
29 Málaga;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
29 Málaga;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
29 Málaga;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
29 Málaga;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;93,3
29 Málaga;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
29 Málaga;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
29 Málaga;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
29 Málaga;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;93,5
29 Málaga;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
29 Málaga;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
29 Málaga;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
29 Málaga;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
29 Málaga;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
29 Málaga;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
29 Málaga;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;89,94
29 Málaga;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
29 Málaga;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
29 Málaga;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
29 Málaga;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;91,62
29 Málaga;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
29 Málaga;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
29 Málaga;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
29 Málaga;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
29 Málaga;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
29 Málaga;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
29 Málaga;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;87,37
29 Málaga;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
29 Málaga;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
29 Málaga;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
29 Málaga;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;89,42
29 Málaga;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
29 Málaga;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
29 Málaga;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
29 Málaga;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
29 Málaga;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
29 Málaga;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
29 Málaga;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QIII;24.025
29 Málaga;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
29 Málaga;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
29 Málaga;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
29 Málaga;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QIII;24.256
29 Málaga;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
29 Málaga;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
29 Málaga;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
29 Málaga;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QIII;23.772
29 Málaga;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
29 Málaga;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
29 Málaga;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
29 Málaga;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2022QIII;23.321
29 Málaga;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2022QII;""
29 Málaga;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2022QI;""
29 Málaga;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
29 Málaga;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2021QIII;23.502
29 Málaga;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2021QII;""
29 Málaga;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2021QI;""
29 Málaga;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
29 Málaga;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2020QIII;23.001
29 Málaga;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2020QII;""
29 Málaga;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2020QI;""
29 Málaga;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2022QIV;22.501
29 Málaga;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
29 Málaga;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2022QII;""
29 Málaga;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2022QI;""
29 Málaga;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2021QIV;22.714
29 Málaga;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
29 Málaga;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2021QII;""
29 Málaga;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2021QI;""
29 Málaga;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2020QIV;22.385
29 Málaga;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
29 Málaga;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2020QII;""
29 Málaga;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2020QI;""
29 Málaga;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
29 Málaga;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
29 Málaga;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QII;""
29 Málaga;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QI;21.945
29 Málaga;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
29 Málaga;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
29 Málaga;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QII;""
29 Málaga;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QI;21.973
29 Málaga;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
29 Málaga;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
29 Málaga;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QII;""
29 Málaga;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QI;""
29 Málaga;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
29 Málaga;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
29 Málaga;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QII;21.394
29 Málaga;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QI;""
29 Málaga;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
29 Málaga;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
29 Málaga;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QII;21.501
29 Málaga;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QI;""
29 Málaga;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
29 Málaga;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
29 Málaga;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QII;""
29 Málaga;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QI;""
29 Málaga;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
29 Málaga;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
29 Málaga;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
29 Málaga;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
29 Málaga;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
29 Málaga;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
29 Málaga;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
29 Málaga;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
29 Málaga;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
29 Málaga;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
29 Málaga;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
29 Málaga;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
29 Málaga;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
29 Málaga;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;97,07
29 Málaga;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
29 Málaga;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
29 Málaga;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
29 Málaga;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;96,89
29 Málaga;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
29 Málaga;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
29 Málaga;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
29 Málaga;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;96,76
29 Málaga;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
29 Málaga;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
29 Málaga;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;93,66
29 Málaga;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
29 Málaga;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
29 Málaga;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
29 Málaga;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;93,64
29 Málaga;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
29 Málaga;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
29 Málaga;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
29 Málaga;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;94,17
29 Málaga;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
29 Málaga;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
29 Málaga;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
29 Málaga;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
29 Málaga;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
29 Málaga;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
29 Málaga;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;90,47
29 Málaga;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
29 Málaga;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
29 Málaga;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
29 Málaga;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;92,43
29 Málaga;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
29 Málaga;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
29 Málaga;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
29 Málaga;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
29 Málaga;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
29 Málaga;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
29 Málaga;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;88,2
29 Málaga;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
29 Málaga;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
29 Málaga;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
29 Málaga;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;90,45
29 Málaga;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
29 Málaga;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
29 Málaga;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
29 Málaga;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
29 Málaga;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
29 Málaga;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
29 Málaga;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QIII;14.476
29 Málaga;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
29 Málaga;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
29 Málaga;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
29 Málaga;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QIII;14.037
29 Málaga;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
29 Málaga;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
29 Málaga;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
29 Málaga;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QIII;13.470
29 Málaga;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
29 Málaga;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
29 Málaga;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
29 Málaga;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2022QIII;13.873
29 Málaga;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2022QII;""
29 Málaga;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2022QI;""
29 Málaga;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
29 Málaga;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2021QIII;13.544
29 Málaga;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2021QII;""
29 Málaga;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2021QI;""
29 Málaga;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
29 Málaga;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2020QIII;12.926
29 Málaga;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2020QII;""
29 Málaga;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2020QI;""
29 Málaga;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2022QIV;13.280
29 Málaga;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
29 Málaga;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2022QII;""
29 Málaga;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2022QI;""
29 Málaga;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2021QIV;13.012
29 Málaga;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
29 Málaga;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2021QII;""
29 Málaga;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2021QI;""
29 Málaga;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2020QIV;12.438
29 Málaga;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
29 Málaga;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2020QII;""
29 Málaga;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2020QI;""
29 Málaga;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
29 Málaga;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
29 Málaga;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QII;""
29 Málaga;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QI;12.495
29 Málaga;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
29 Málaga;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
29 Málaga;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QII;""
29 Málaga;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QI;12.149
29 Málaga;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
29 Málaga;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
29 Málaga;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QII;""
29 Málaga;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QI;""
29 Málaga;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
29 Málaga;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
29 Málaga;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QII;12.062
29 Málaga;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QI;""
29 Málaga;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
29 Málaga;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
29 Málaga;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QII;11.800
29 Málaga;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QI;""
29 Málaga;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
29 Málaga;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
29 Málaga;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QII;""
29 Málaga;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QI;""
29 Málaga;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
29 Málaga;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
29 Málaga;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
29 Málaga;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
29 Málaga;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
29 Málaga;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
29 Málaga;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
29 Málaga;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
29 Málaga;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
29 Málaga;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
29 Málaga;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
29 Málaga;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
29 Málaga;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
29 Málaga;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;95,83
29 Málaga;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
29 Málaga;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
29 Málaga;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
29 Málaga;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;96,49
29 Málaga;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
29 Málaga;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
29 Málaga;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
29 Málaga;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;95,96
29 Málaga;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
29 Málaga;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
29 Málaga;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;91,74
29 Málaga;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
29 Málaga;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
29 Málaga;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
29 Málaga;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;92,7
29 Málaga;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
29 Málaga;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
29 Málaga;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
29 Málaga;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;92,34
29 Málaga;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
29 Málaga;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
29 Málaga;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
29 Málaga;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
29 Málaga;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
29 Málaga;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
29 Málaga;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;89,01
29 Málaga;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
29 Málaga;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
29 Málaga;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
29 Málaga;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;90,19
29 Málaga;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
29 Málaga;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
29 Málaga;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
29 Málaga;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
29 Málaga;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
29 Málaga;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
29 Málaga;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;85,93
29 Málaga;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
29 Málaga;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
29 Málaga;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
29 Málaga;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;87,6
29 Málaga;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
29 Málaga;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
29 Málaga;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
29 Málaga;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
29 Málaga;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
29 Málaga;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QIV;38.676
29 Málaga;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
29 Málaga;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
29 Málaga;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
29 Málaga;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QIV;38.477
29 Málaga;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
29 Málaga;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
29 Málaga;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
29 Málaga;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QIV;37.458
29 Málaga;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
29 Málaga;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
29 Málaga;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
29 Málaga;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2022QIV;37.090
29 Málaga;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
29 Málaga;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2022QII;""
29 Málaga;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2022QI;""
29 Málaga;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2021QIV;36.985
29 Málaga;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
29 Málaga;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2021QII;""
29 Málaga;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2021QI;""
29 Málaga;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2020QIV;36.139
29 Málaga;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
29 Málaga;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2020QII;""
29 Málaga;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2020QI;""
29 Málaga;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
29 Málaga;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
29 Málaga;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2022QII;""
29 Málaga;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2022QI;35.617
29 Málaga;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
29 Málaga;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
29 Málaga;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2021QII;""
29 Málaga;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2021QI;35.329
29 Málaga;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
29 Málaga;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
29 Málaga;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2020QII;""
29 Málaga;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2020QI;""
29 Málaga;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
29 Málaga;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
29 Málaga;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QII;34.552
29 Málaga;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QI;""
29 Málaga;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
29 Málaga;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
29 Málaga;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QII;34.426
29 Málaga;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QI;""
29 Málaga;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
29 Málaga;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
29 Málaga;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QII;""
29 Málaga;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QI;""
29 Málaga;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
29 Málaga;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QIII;33.674
29 Málaga;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QII;""
29 Málaga;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QI;""
29 Málaga;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
29 Málaga;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QIII;33.567
29 Málaga;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QII;""
29 Málaga;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QI;""
29 Málaga;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
29 Málaga;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
29 Málaga;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QII;""
29 Málaga;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QI;""
29 Málaga;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
29 Málaga;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
29 Málaga;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
29 Málaga;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
29 Málaga;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
29 Málaga;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
29 Málaga;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
29 Málaga;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
29 Málaga;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
29 Málaga;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
29 Málaga;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
29 Málaga;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
29 Málaga;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;95,9
29 Málaga;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
29 Málaga;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
29 Málaga;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
29 Málaga;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;96,12
29 Málaga;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
29 Málaga;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
29 Málaga;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
29 Málaga;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;96,48
29 Málaga;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
29 Málaga;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
29 Málaga;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
29 Málaga;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
29 Málaga;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
29 Málaga;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
29 Málaga;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;92,57
29 Málaga;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
29 Málaga;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
29 Málaga;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
29 Málaga;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;94,32
29 Málaga;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
29 Málaga;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
29 Málaga;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
29 Málaga;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
29 Málaga;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
29 Málaga;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
29 Málaga;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;89,8
29 Málaga;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
29 Málaga;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
29 Málaga;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
29 Málaga;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;91,91
29 Málaga;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
29 Málaga;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
29 Málaga;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
29 Málaga;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
29 Málaga;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
29 Málaga;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
29 Málaga;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;87,52
29 Málaga;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
29 Málaga;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
29 Málaga;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
29 Málaga;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;89,61
29 Málaga;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
29 Málaga;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
29 Málaga;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
29 Málaga;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
29 Málaga;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
29 Málaga;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
29 Málaga;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QIV;24.119
29 Málaga;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
29 Málaga;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
29 Málaga;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
29 Málaga;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QIV;24.292
29 Málaga;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
29 Málaga;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
29 Málaga;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
29 Málaga;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QIV;23.916
29 Málaga;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
29 Málaga;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
29 Málaga;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
29 Málaga;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2022QIV;23.201
29 Málaga;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
29 Málaga;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2022QII;""
29 Málaga;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2022QI;""
29 Málaga;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2021QIV;23.405
29 Málaga;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
29 Málaga;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2021QII;""
29 Málaga;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2021QI;""
29 Málaga;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2020QIV;23.164
29 Málaga;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
29 Málaga;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2020QII;""
29 Málaga;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2020QI;""
29 Málaga;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
29 Málaga;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
29 Málaga;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2022QII;""
29 Málaga;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2022QI;22.582
29 Málaga;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
29 Málaga;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
29 Málaga;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2021QII;""
29 Málaga;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2021QI;22.685
29 Málaga;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
29 Málaga;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
29 Málaga;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2020QII;""
29 Málaga;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2020QI;""
29 Málaga;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
29 Málaga;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
29 Málaga;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QII;21.981
29 Málaga;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QI;""
29 Málaga;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
29 Málaga;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
29 Málaga;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QII;22.168
29 Málaga;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QI;""
29 Málaga;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
29 Málaga;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
29 Málaga;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QII;""
29 Málaga;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QI;""
29 Málaga;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
29 Málaga;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QIII;21.509
29 Málaga;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QII;""
29 Málaga;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QI;""
29 Málaga;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
29 Málaga;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QIII;21.634
29 Málaga;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QII;""
29 Málaga;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QI;""
29 Málaga;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
29 Málaga;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
29 Málaga;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QII;""
29 Málaga;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QI;""
29 Málaga;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
29 Málaga;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
29 Málaga;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
29 Málaga;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
29 Málaga;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
29 Málaga;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
29 Málaga;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
29 Málaga;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
29 Málaga;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
29 Málaga;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
29 Málaga;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
29 Málaga;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
29 Málaga;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;96,19
29 Málaga;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
29 Málaga;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
29 Málaga;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
29 Málaga;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;96,35
29 Málaga;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
29 Málaga;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
29 Málaga;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
29 Málaga;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;96,86
29 Málaga;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
29 Málaga;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
29 Málaga;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
29 Málaga;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
29 Málaga;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
29 Málaga;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
29 Málaga;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;92,96
29 Málaga;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
29 Málaga;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
29 Málaga;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
29 Málaga;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;94,85
29 Málaga;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
29 Málaga;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
29 Málaga;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
29 Málaga;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
29 Málaga;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
29 Málaga;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
29 Málaga;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;90,49
29 Málaga;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
29 Málaga;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
29 Málaga;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
29 Málaga;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;92,69
29 Málaga;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
29 Málaga;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
29 Málaga;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
29 Málaga;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
29 Málaga;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
29 Málaga;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
29 Málaga;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;88,54
29 Málaga;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
29 Málaga;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
29 Málaga;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
29 Málaga;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;90,46
29 Málaga;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
29 Málaga;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
29 Málaga;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
29 Málaga;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
29 Málaga;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
29 Málaga;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
29 Málaga;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QIV;14.557
29 Málaga;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
29 Málaga;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
29 Málaga;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
29 Málaga;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QIV;14.185
29 Málaga;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
29 Málaga;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
29 Málaga;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
29 Málaga;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QIV;13.542
29 Málaga;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
29 Málaga;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
29 Málaga;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
29 Málaga;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2022QIV;13.889
29 Málaga;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
29 Málaga;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2022QII;""
29 Málaga;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2022QI;""
29 Málaga;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2021QIV;13.580
29 Málaga;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
29 Málaga;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2021QII;""
29 Málaga;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2021QI;""
29 Málaga;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2020QIV;12.975
29 Málaga;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
29 Málaga;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2020QII;""
29 Málaga;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2020QI;""
29 Málaga;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
29 Málaga;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
29 Málaga;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2022QII;""
29 Málaga;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2022QI;13.035
29 Málaga;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
29 Málaga;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
29 Málaga;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2021QII;""
29 Málaga;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2021QI;12.644
29 Málaga;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
29 Málaga;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
29 Málaga;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2020QII;""
29 Málaga;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2020QI;""
29 Málaga;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
29 Málaga;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
29 Málaga;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QII;12.571
29 Málaga;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QI;""
29 Málaga;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
29 Málaga;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
29 Málaga;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QII;12.258
29 Málaga;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QI;""
29 Málaga;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
29 Málaga;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
29 Málaga;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QII;""
29 Málaga;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QI;""
29 Málaga;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
29 Málaga;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QIII;12.165
29 Málaga;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QII;""
29 Málaga;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QI;""
29 Málaga;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
29 Málaga;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QIII;11.933
29 Málaga;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QII;""
29 Málaga;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QI;""
29 Málaga;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
29 Málaga;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
29 Málaga;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QII;""
29 Málaga;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QI;""
29 Málaga;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
29 Málaga;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
29 Málaga;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
29 Málaga;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
29 Málaga;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
29 Málaga;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
29 Málaga;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
29 Málaga;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
29 Málaga;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
29 Málaga;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
29 Málaga;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
29 Málaga;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
29 Málaga;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;95,41
29 Málaga;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
29 Málaga;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
29 Málaga;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
29 Málaga;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;95,73
29 Málaga;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
29 Málaga;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
29 Málaga;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
29 Málaga;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;95,81
29 Málaga;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
29 Málaga;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
29 Málaga;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
29 Málaga;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
29 Málaga;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
29 Málaga;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
29 Málaga;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;91,89
29 Málaga;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
29 Málaga;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
29 Málaga;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
29 Málaga;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;93,37
29 Málaga;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
29 Málaga;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
29 Málaga;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
29 Málaga;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
29 Málaga;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
29 Málaga;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
29 Málaga;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;88,62
29 Málaga;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
29 Málaga;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
29 Málaga;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
29 Málaga;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;90,52
29 Málaga;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
29 Málaga;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
29 Málaga;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
29 Málaga;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
29 Málaga;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
29 Málaga;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
29 Málaga;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;85,76
29 Málaga;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
29 Málaga;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
29 Málaga;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
29 Málaga;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;88,12
29 Málaga;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
29 Málaga;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
29 Málaga;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
29 Málaga;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
29 Málaga;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
29 Málaga;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
29 Málaga;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
29 Málaga;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
29 Málaga;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
29 Málaga;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QI;33.456
29 Málaga;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
29 Málaga;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
29 Málaga;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
29 Málaga;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QI;31.761
29 Málaga;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
29 Málaga;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
29 Málaga;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
29 Málaga;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QI;32.298
29 Málaga;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
29 Málaga;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
29 Málaga;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2022QII;""
29 Málaga;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2022QI;32.282
29 Málaga;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
29 Málaga;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
29 Málaga;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2021QII;""
29 Málaga;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2021QI;31.092
29 Málaga;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
29 Málaga;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
29 Málaga;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2020QII;""
29 Málaga;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2020QI;30.225
29 Málaga;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
29 Málaga;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
29 Málaga;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2022QII;31.423
29 Málaga;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2022QI;""
29 Málaga;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
29 Málaga;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
29 Málaga;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2021QII;30.333
29 Málaga;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2021QI;""
29 Málaga;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
29 Málaga;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
29 Málaga;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2020QII;29.690
29 Málaga;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2020QI;""
29 Málaga;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
29 Málaga;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QIII;30.749
29 Málaga;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QII;""
29 Málaga;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QI;""
29 Málaga;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
29 Málaga;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QIII;29.711
29 Málaga;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QII;""
29 Málaga;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QI;""
29 Málaga;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
29 Málaga;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QIII;28.934
29 Málaga;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QII;""
29 Málaga;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QI;""
29 Málaga;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QIV;29.889
29 Málaga;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
29 Málaga;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QII;""
29 Málaga;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QI;""
29 Málaga;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QIV;28.978
29 Málaga;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
29 Málaga;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QII;""
29 Málaga;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QI;""
29 Málaga;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QIV;28.278
29 Málaga;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
29 Málaga;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QII;""
29 Málaga;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QI;""
29 Málaga;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
29 Málaga;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
29 Málaga;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
29 Málaga;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
29 Málaga;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
29 Málaga;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
29 Málaga;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
29 Málaga;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
29 Málaga;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
29 Málaga;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
29 Málaga;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
29 Málaga;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
29 Málaga;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
29 Málaga;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
29 Málaga;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
29 Málaga;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;96,49
29 Málaga;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
29 Málaga;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
29 Málaga;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
29 Málaga;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;97,89
29 Málaga;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
29 Málaga;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
29 Málaga;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
29 Málaga;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;93,58
29 Málaga;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
29 Málaga;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
29 Málaga;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;93,92
29 Málaga;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
29 Málaga;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
29 Málaga;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
29 Málaga;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;95,5
29 Málaga;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
29 Málaga;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
29 Málaga;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
29 Málaga;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;91,93
29 Málaga;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
29 Málaga;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
29 Málaga;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;91,91
29 Málaga;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
29 Málaga;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
29 Málaga;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
29 Málaga;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;93,55
29 Málaga;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
29 Málaga;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
29 Málaga;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
29 Málaga;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;89,58
29 Málaga;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
29 Málaga;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
29 Málaga;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;89,34
29 Málaga;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
29 Málaga;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
29 Málaga;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
29 Málaga;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;91,24
29 Málaga;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
29 Málaga;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
29 Málaga;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
29 Málaga;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;87,55
29 Málaga;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
29 Málaga;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
29 Málaga;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
29 Málaga;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
29 Málaga;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
29 Málaga;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
29 Málaga;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QI;21.539
29 Málaga;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
29 Málaga;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
29 Málaga;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
29 Málaga;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QI;20.594
29 Málaga;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
29 Málaga;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
29 Málaga;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
29 Málaga;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QI;20.867
29 Málaga;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
29 Málaga;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
29 Málaga;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2022QII;""
29 Málaga;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2022QI;20.805
29 Málaga;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
29 Málaga;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
29 Málaga;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2021QII;""
29 Málaga;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2021QI;20.186
29 Málaga;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
29 Málaga;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
29 Málaga;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2020QII;""
29 Málaga;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2020QI;19.645
29 Málaga;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
29 Málaga;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
29 Málaga;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2022QII;20.315
29 Málaga;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2022QI;""
29 Málaga;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
29 Málaga;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
29 Málaga;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2021QII;19.709
29 Málaga;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2021QI;""
29 Málaga;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
29 Málaga;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
29 Málaga;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2020QII;19.334
29 Málaga;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2020QI;""
29 Málaga;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
29 Málaga;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QIII;19.954
29 Málaga;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QII;""
29 Málaga;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QI;""
29 Málaga;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
29 Málaga;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QIII;19.332
29 Málaga;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QII;""
29 Málaga;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QI;""
29 Málaga;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
29 Málaga;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QIII;18.888
29 Málaga;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QII;""
29 Málaga;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QI;""
29 Málaga;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QIV;19.442
29 Málaga;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
29 Málaga;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QII;""
29 Málaga;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QI;""
29 Málaga;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QIV;18.889
29 Málaga;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
29 Málaga;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QII;""
29 Málaga;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QI;""
29 Málaga;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QIV;18.492
29 Málaga;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
29 Málaga;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QII;""
29 Málaga;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QI;""
29 Málaga;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
29 Málaga;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
29 Málaga;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
29 Málaga;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
29 Málaga;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
29 Málaga;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
29 Málaga;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
29 Málaga;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
29 Málaga;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
29 Málaga;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
29 Málaga;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
29 Málaga;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
29 Málaga;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
29 Málaga;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
29 Málaga;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
29 Málaga;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;96,59
29 Málaga;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
29 Málaga;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
29 Málaga;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
29 Málaga;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;98,02
29 Málaga;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
29 Málaga;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
29 Málaga;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
29 Málaga;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;94,14
29 Málaga;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
29 Málaga;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
29 Málaga;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;94,32
29 Málaga;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
29 Málaga;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
29 Málaga;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
29 Málaga;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;95,7
29 Málaga;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
29 Málaga;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
29 Málaga;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
29 Málaga;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;92,65
29 Málaga;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
29 Málaga;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
29 Málaga;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;92,64
29 Málaga;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
29 Málaga;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
29 Málaga;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
29 Málaga;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;93,87
29 Málaga;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
29 Málaga;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
29 Málaga;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
29 Málaga;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;90,52
29 Málaga;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
29 Málaga;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
29 Málaga;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;90,26
29 Málaga;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
29 Málaga;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
29 Málaga;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
29 Málaga;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;91,72
29 Málaga;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
29 Málaga;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
29 Málaga;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
29 Málaga;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;88,62
29 Málaga;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
29 Málaga;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
29 Málaga;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
29 Málaga;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
29 Málaga;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
29 Málaga;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
29 Málaga;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QI;11.917
29 Málaga;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
29 Málaga;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
29 Málaga;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
29 Málaga;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QI;11.167
29 Málaga;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
29 Málaga;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
29 Málaga;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
29 Málaga;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QI;11.431
29 Málaga;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
29 Málaga;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
29 Málaga;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2022QII;""
29 Málaga;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2022QI;11.477
29 Málaga;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
29 Málaga;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
29 Málaga;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2021QII;""
29 Málaga;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2021QI;10.906
29 Málaga;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
29 Málaga;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
29 Málaga;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2020QII;""
29 Málaga;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2020QI;10.580
29 Málaga;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
29 Málaga;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
29 Málaga;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2022QII;11.108
29 Málaga;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2022QI;""
29 Málaga;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
29 Málaga;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
29 Málaga;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2021QII;10.624
29 Málaga;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2021QI;""
29 Málaga;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
29 Málaga;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
29 Málaga;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2020QII;10.356
29 Málaga;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2020QI;""
29 Málaga;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
29 Málaga;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QIII;10.795
29 Málaga;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QII;""
29 Málaga;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QI;""
29 Málaga;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
29 Málaga;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QIII;10.379
29 Málaga;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QII;""
29 Málaga;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QI;""
29 Málaga;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
29 Málaga;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QIII;10.046
29 Málaga;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QII;""
29 Málaga;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QI;""
29 Málaga;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QIV;10.447
29 Málaga;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
29 Málaga;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QII;""
29 Málaga;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QI;""
29 Málaga;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QIV;10.089
29 Málaga;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
29 Málaga;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QII;""
29 Málaga;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QI;""
29 Málaga;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QIV;9.786
29 Málaga;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
29 Málaga;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QII;""
29 Málaga;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QI;""
29 Málaga;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
29 Málaga;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
29 Málaga;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
29 Málaga;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
29 Málaga;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
29 Málaga;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
29 Málaga;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
29 Málaga;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
29 Málaga;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
29 Málaga;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
29 Málaga;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
29 Málaga;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
29 Málaga;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
29 Málaga;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
29 Málaga;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
29 Málaga;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;96,31
29 Málaga;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
29 Málaga;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
29 Málaga;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
29 Málaga;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;97,66
29 Málaga;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
29 Málaga;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
29 Málaga;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
29 Málaga;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;92,56
29 Málaga;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
29 Málaga;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
29 Málaga;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;93,21
29 Málaga;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
29 Málaga;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
29 Málaga;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
29 Málaga;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;95,14
29 Málaga;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
29 Málaga;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
29 Málaga;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
29 Málaga;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;90,6
29 Málaga;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
29 Málaga;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
29 Málaga;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;90,58
29 Málaga;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
29 Málaga;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
29 Málaga;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
29 Málaga;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;92,94
29 Málaga;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
29 Málaga;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
29 Málaga;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
29 Málaga;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;87,88
29 Málaga;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
29 Málaga;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
29 Málaga;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;87,66
29 Málaga;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
29 Málaga;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
29 Málaga;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
29 Málaga;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;90,35
29 Málaga;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
29 Málaga;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
29 Málaga;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
29 Málaga;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;85,61
29 Málaga;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
29 Málaga;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
29 Málaga;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
29 Málaga;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
29 Málaga;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
29 Málaga;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QII;34.595
29 Málaga;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
29 Málaga;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
29 Málaga;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
29 Málaga;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QII;33.417
29 Málaga;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
29 Málaga;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
29 Málaga;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
29 Málaga;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QII;31.485
29 Málaga;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
29 Málaga;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
29 Málaga;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
29 Málaga;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2022QII;33.587
29 Málaga;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2022QI;""
29 Málaga;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
29 Málaga;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
29 Málaga;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2021QII;32.530
29 Málaga;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2021QI;""
29 Málaga;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
29 Málaga;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
29 Málaga;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2020QII;30.868
29 Málaga;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2020QI;""
29 Málaga;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
29 Málaga;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2022QIII;32.803
29 Málaga;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2022QII;""
29 Málaga;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2022QI;""
29 Málaga;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
29 Málaga;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2021QIII;31.829
29 Málaga;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2021QII;""
29 Málaga;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2021QI;""
29 Málaga;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
29 Málaga;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2020QIII;29.983
29 Málaga;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2020QII;""
29 Málaga;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2020QI;""
29 Málaga;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QIV;31.816
29 Málaga;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
29 Málaga;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QII;""
29 Málaga;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QI;""
29 Málaga;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QIV;30.988
29 Málaga;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
29 Málaga;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QII;""
29 Málaga;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QI;""
29 Málaga;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QIV;29.261
29 Málaga;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
29 Málaga;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QII;""
29 Málaga;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QI;""
29 Málaga;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
29 Málaga;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
29 Málaga;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QII;""
29 Málaga;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QI;30.034
29 Málaga;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
29 Málaga;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
29 Málaga;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QII;""
29 Málaga;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QI;28.777
29 Málaga;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
29 Málaga;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
29 Málaga;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QII;""
29 Málaga;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QI;""
29 Málaga;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
29 Málaga;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
29 Málaga;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
29 Málaga;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
29 Málaga;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
29 Málaga;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
29 Málaga;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
29 Málaga;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
29 Málaga;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
29 Málaga;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
29 Málaga;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
29 Málaga;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
29 Málaga;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
29 Málaga;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
29 Málaga;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;97,09
29 Málaga;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
29 Málaga;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
29 Málaga;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
29 Málaga;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;97,35
29 Málaga;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
29 Málaga;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
29 Málaga;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
29 Málaga;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;98,04
29 Málaga;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
29 Málaga;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
29 Málaga;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;94,82
29 Málaga;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
29 Málaga;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
29 Málaga;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
29 Málaga;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;95,25
29 Málaga;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
29 Málaga;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
29 Málaga;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
29 Málaga;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;95,23
29 Málaga;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
29 Málaga;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
29 Málaga;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;91,97
29 Málaga;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
29 Málaga;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
29 Málaga;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
29 Málaga;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;92,73
29 Málaga;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
29 Málaga;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
29 Málaga;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
29 Málaga;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;92,94
29 Málaga;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
29 Málaga;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
29 Málaga;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
29 Málaga;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
29 Málaga;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
29 Málaga;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
29 Málaga;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;89,88
29 Málaga;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
29 Málaga;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
29 Málaga;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
29 Málaga;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;91,4
29 Málaga;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
29 Málaga;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
29 Málaga;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
29 Málaga;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
29 Málaga;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
29 Málaga;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
29 Málaga;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QII;22.161
29 Málaga;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
29 Málaga;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
29 Málaga;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
29 Málaga;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QII;21.675
29 Málaga;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
29 Málaga;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
29 Málaga;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
29 Málaga;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QII;20.406
29 Málaga;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
29 Málaga;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
29 Málaga;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
29 Málaga;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2022QII;21.584
29 Málaga;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2022QI;""
29 Málaga;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
29 Málaga;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
29 Málaga;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2021QII;21.115
29 Málaga;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2021QI;""
29 Málaga;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
29 Málaga;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
29 Málaga;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2020QII;20.037
29 Málaga;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2020QI;""
29 Málaga;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
29 Málaga;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2022QIII;21.155
29 Málaga;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2022QII;""
29 Málaga;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2022QI;""
29 Málaga;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
29 Málaga;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2021QIII;20.686
29 Málaga;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2021QII;""
29 Málaga;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2021QI;""
29 Málaga;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
29 Málaga;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2020QIII;19.503
29 Málaga;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2020QII;""
29 Málaga;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2020QI;""
29 Málaga;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QIV;20.580
29 Málaga;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
29 Málaga;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QII;""
29 Málaga;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QI;""
29 Málaga;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QIV;20.180
29 Málaga;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
29 Málaga;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QII;""
29 Málaga;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QI;""
29 Málaga;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QIV;19.066
29 Málaga;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
29 Málaga;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QII;""
29 Málaga;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QI;""
29 Málaga;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
29 Málaga;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
29 Málaga;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QII;""
29 Málaga;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QI;19.583
29 Málaga;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
29 Málaga;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
29 Málaga;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QII;""
29 Málaga;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QI;18.770
29 Málaga;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
29 Málaga;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
29 Málaga;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QII;""
29 Málaga;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QI;""
29 Málaga;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
29 Málaga;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
29 Málaga;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
29 Málaga;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
29 Málaga;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
29 Málaga;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
29 Málaga;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
29 Málaga;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
29 Málaga;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
29 Málaga;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
29 Málaga;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
29 Málaga;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
29 Málaga;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
29 Málaga;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
29 Málaga;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;97,4
29 Málaga;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
29 Málaga;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
29 Málaga;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
29 Málaga;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;97,42
29 Málaga;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
29 Málaga;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
29 Málaga;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
29 Málaga;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;98,19
29 Málaga;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
29 Málaga;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
29 Málaga;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;95,46
29 Málaga;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
29 Málaga;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
29 Málaga;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
29 Málaga;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;95,44
29 Málaga;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
29 Málaga;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
29 Málaga;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
29 Málaga;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;95,57
29 Málaga;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
29 Málaga;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
29 Málaga;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;92,87
29 Málaga;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
29 Málaga;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
29 Málaga;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
29 Málaga;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;93,1
29 Málaga;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
29 Málaga;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
29 Málaga;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
29 Málaga;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;93,43
29 Málaga;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
29 Málaga;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
29 Málaga;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
29 Málaga;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
29 Málaga;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
29 Málaga;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
29 Málaga;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;90,35
29 Málaga;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
29 Málaga;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
29 Málaga;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
29 Málaga;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;91,98
29 Málaga;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
29 Málaga;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
29 Málaga;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
29 Málaga;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
29 Málaga;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
29 Málaga;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
29 Málaga;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QII;12.434
29 Málaga;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
29 Málaga;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
29 Málaga;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
29 Málaga;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QII;11.742
29 Málaga;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
29 Málaga;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
29 Málaga;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
29 Málaga;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QII;11.079
29 Málaga;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
29 Málaga;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
29 Málaga;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
29 Málaga;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2022QII;12.003
29 Málaga;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2022QI;""
29 Málaga;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
29 Málaga;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
29 Málaga;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2021QII;11.415
29 Málaga;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2021QI;""
29 Málaga;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
29 Málaga;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
29 Málaga;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2020QII;10.831
29 Málaga;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2020QI;""
29 Málaga;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
29 Málaga;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2022QIII;11.648
29 Málaga;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2022QII;""
29 Málaga;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2022QI;""
29 Málaga;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
29 Málaga;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2021QIII;11.143
29 Málaga;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2021QII;""
29 Málaga;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2021QI;""
29 Málaga;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
29 Málaga;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2020QIII;10.480
29 Málaga;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2020QII;""
29 Málaga;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2020QI;""
29 Málaga;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QIV;11.236
29 Málaga;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
29 Málaga;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QII;""
29 Málaga;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QI;""
29 Málaga;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QIV;10.808
29 Málaga;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
29 Málaga;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QII;""
29 Málaga;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QI;""
29 Málaga;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QIV;10.195
29 Málaga;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
29 Málaga;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QII;""
29 Málaga;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QI;""
29 Málaga;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
29 Málaga;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
29 Málaga;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QII;""
29 Málaga;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QI;10.451
29 Málaga;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
29 Málaga;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
29 Málaga;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QII;""
29 Málaga;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QI;10.007
29 Málaga;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
29 Málaga;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
29 Málaga;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QII;""
29 Málaga;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QI;""
29 Málaga;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
29 Málaga;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
29 Málaga;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
29 Málaga;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
29 Málaga;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
29 Málaga;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
29 Málaga;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
29 Málaga;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
29 Málaga;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
29 Málaga;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
29 Málaga;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
29 Málaga;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
29 Málaga;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
29 Málaga;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
29 Málaga;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;96,53
29 Málaga;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
29 Málaga;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
29 Málaga;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
29 Málaga;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;97,22
29 Málaga;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
29 Málaga;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
29 Málaga;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
29 Málaga;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;97,76
29 Málaga;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
29 Málaga;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
29 Málaga;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;93,68
29 Málaga;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
29 Málaga;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
29 Málaga;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
29 Málaga;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;94,9
29 Málaga;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
29 Málaga;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
29 Málaga;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
29 Málaga;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;94,59
29 Málaga;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
29 Málaga;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
29 Málaga;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;90,37
29 Málaga;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
29 Málaga;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
29 Málaga;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
29 Málaga;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;92,05
29 Málaga;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
29 Málaga;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
29 Málaga;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
29 Málaga;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;92,02
29 Málaga;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
29 Málaga;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
29 Málaga;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
29 Málaga;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
29 Málaga;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
29 Málaga;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
29 Málaga;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;89,01
29 Málaga;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
29 Málaga;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
29 Málaga;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
29 Málaga;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;90,32
29 Málaga;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
29 Málaga;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
29 Málaga;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
29 Málaga;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
29 Málaga;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
29 Málaga;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QIII;34.823
29 Málaga;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
29 Málaga;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
29 Málaga;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
29 Málaga;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QIII;33.657
29 Málaga;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
29 Málaga;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
29 Málaga;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
29 Málaga;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QIII;31.828
29 Málaga;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
29 Málaga;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
29 Málaga;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
29 Málaga;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2022QIII;33.879
29 Málaga;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2022QII;""
29 Málaga;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2022QI;""
29 Málaga;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
29 Málaga;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2021QIII;32.790
29 Málaga;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2021QII;""
29 Málaga;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2021QI;""
29 Málaga;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
29 Málaga;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2020QIII;30.808
29 Málaga;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2020QII;""
29 Málaga;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2020QI;""
29 Málaga;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2022QIV;32.727
29 Málaga;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
29 Málaga;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2022QII;""
29 Málaga;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2022QI;""
29 Málaga;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2021QIV;31.814
29 Málaga;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
29 Málaga;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2021QII;""
29 Málaga;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2021QI;""
29 Málaga;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2020QIV;29.984
29 Málaga;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
29 Málaga;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2020QII;""
29 Málaga;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2020QI;""
29 Málaga;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
29 Málaga;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
29 Málaga;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QII;""
29 Málaga;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QI;30.807
29 Málaga;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
29 Málaga;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
29 Málaga;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QII;""
29 Málaga;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QI;29.459
29 Málaga;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
29 Málaga;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
29 Málaga;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QII;""
29 Málaga;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QI;""
29 Málaga;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
29 Málaga;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
29 Málaga;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QII;30.059
29 Málaga;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QI;""
29 Málaga;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
29 Málaga;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
29 Málaga;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QII;28.834
29 Málaga;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QI;""
29 Málaga;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
29 Málaga;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
29 Málaga;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QII;""
29 Málaga;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QI;""
29 Málaga;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
29 Málaga;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
29 Málaga;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
29 Málaga;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
29 Málaga;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
29 Málaga;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
29 Málaga;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
29 Málaga;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
29 Málaga;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
29 Málaga;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
29 Málaga;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
29 Málaga;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
29 Málaga;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
29 Málaga;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;97,29
29 Málaga;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
29 Málaga;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
29 Málaga;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
29 Málaga;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;97,42
29 Málaga;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
29 Málaga;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
29 Málaga;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
29 Málaga;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;96,8
29 Málaga;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
29 Málaga;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
29 Málaga;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;93,98
29 Málaga;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
29 Málaga;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
29 Málaga;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
29 Málaga;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;94,52
29 Málaga;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
29 Málaga;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
29 Málaga;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
29 Málaga;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;94,21
29 Málaga;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
29 Málaga;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
29 Málaga;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
29 Málaga;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
29 Málaga;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
29 Málaga;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
29 Málaga;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;91,53
29 Málaga;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
29 Málaga;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
29 Málaga;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
29 Málaga;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;92,56
29 Málaga;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
29 Málaga;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
29 Málaga;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
29 Málaga;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
29 Málaga;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
29 Málaga;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
29 Málaga;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;89,31
29 Málaga;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
29 Málaga;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
29 Málaga;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
29 Málaga;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;90,59
29 Málaga;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
29 Málaga;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
29 Málaga;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
29 Málaga;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
29 Málaga;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
29 Málaga;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
29 Málaga;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QIII;22.239
29 Málaga;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
29 Málaga;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
29 Málaga;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
29 Málaga;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QIII;21.755
29 Málaga;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
29 Málaga;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
29 Málaga;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
29 Málaga;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QIII;20.652
29 Málaga;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
29 Málaga;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
29 Málaga;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
29 Málaga;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2022QIII;21.727
29 Málaga;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2022QII;""
29 Málaga;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2022QI;""
29 Málaga;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
29 Málaga;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2021QIII;21.240
29 Málaga;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2021QII;""
29 Málaga;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2021QI;""
29 Málaga;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
29 Málaga;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2020QIII;20.036
29 Málaga;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2020QII;""
29 Málaga;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2020QI;""
29 Málaga;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2022QIV;21.060
29 Málaga;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
29 Málaga;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2022QII;""
29 Málaga;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2022QI;""
29 Málaga;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2021QIV;20.641
29 Málaga;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
29 Málaga;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2021QII;""
29 Málaga;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2021QI;""
29 Málaga;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2020QIV;19.532
29 Málaga;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
29 Málaga;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2020QII;""
29 Málaga;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2020QI;""
29 Málaga;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
29 Málaga;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
29 Málaga;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QII;""
29 Málaga;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QI;20.013
29 Málaga;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
29 Málaga;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
29 Málaga;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QII;""
29 Málaga;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QI;19.210
29 Málaga;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
29 Málaga;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
29 Málaga;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QII;""
29 Málaga;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QI;""
29 Málaga;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
29 Málaga;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
29 Málaga;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QII;19.582
29 Málaga;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QI;""
29 Málaga;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
29 Málaga;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
29 Málaga;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QII;18.806
29 Málaga;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QI;""
29 Málaga;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
29 Málaga;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
29 Málaga;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QII;""
29 Málaga;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QI;""
29 Málaga;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
29 Málaga;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
29 Málaga;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
29 Málaga;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
29 Málaga;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
29 Málaga;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
29 Málaga;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
29 Málaga;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
29 Málaga;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
29 Málaga;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
29 Málaga;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
29 Málaga;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
29 Málaga;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
29 Málaga;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;97,7
29 Málaga;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
29 Málaga;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
29 Málaga;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
29 Málaga;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;97,63
29 Málaga;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
29 Málaga;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
29 Málaga;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
29 Málaga;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;97,02
29 Málaga;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
29 Málaga;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
29 Málaga;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;94,7
29 Málaga;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
29 Málaga;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
29 Málaga;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
29 Málaga;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;94,88
29 Málaga;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
29 Málaga;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
29 Málaga;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
29 Málaga;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;94,58
29 Málaga;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
29 Málaga;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
29 Málaga;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
29 Málaga;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
29 Málaga;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
29 Málaga;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
29 Málaga;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;91,99
29 Málaga;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
29 Málaga;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
29 Málaga;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
29 Málaga;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;93,02
29 Málaga;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
29 Málaga;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
29 Málaga;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
29 Málaga;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
29 Málaga;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
29 Málaga;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
29 Málaga;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;90,01
29 Málaga;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
29 Málaga;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
29 Málaga;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
29 Málaga;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;91,06
29 Málaga;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
29 Málaga;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
29 Málaga;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
29 Málaga;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
29 Málaga;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
29 Málaga;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
29 Málaga;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QIII;12.584
29 Málaga;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
29 Málaga;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
29 Málaga;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
29 Málaga;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QIII;11.902
29 Málaga;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
29 Málaga;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
29 Málaga;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
29 Málaga;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QIII;11.176
29 Málaga;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
29 Málaga;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
29 Málaga;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
29 Málaga;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2022QIII;12.152
29 Málaga;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2022QII;""
29 Málaga;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2022QI;""
29 Málaga;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
29 Málaga;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2021QIII;11.550
29 Málaga;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2021QII;""
29 Málaga;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2021QI;""
29 Málaga;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
29 Málaga;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2020QIII;10.772
29 Málaga;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2020QII;""
29 Málaga;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2020QI;""
29 Málaga;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2022QIV;11.667
29 Málaga;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
29 Málaga;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2022QII;""
29 Málaga;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2022QI;""
29 Málaga;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2021QIV;11.173
29 Málaga;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
29 Málaga;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2021QII;""
29 Málaga;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2021QI;""
29 Málaga;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2020QIV;10.452
29 Málaga;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
29 Málaga;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2020QII;""
29 Málaga;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2020QI;""
29 Málaga;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
29 Málaga;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
29 Málaga;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QII;""
29 Málaga;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QI;10.794
29 Málaga;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
29 Málaga;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
29 Málaga;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QII;""
29 Málaga;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QI;10.249
29 Málaga;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
29 Málaga;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
29 Málaga;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QII;""
29 Málaga;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QI;""
29 Málaga;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
29 Málaga;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
29 Málaga;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QII;10.477
29 Málaga;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QI;""
29 Málaga;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
29 Málaga;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
29 Málaga;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QII;10.028
29 Málaga;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QI;""
29 Málaga;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
29 Málaga;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
29 Málaga;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QII;""
29 Málaga;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QI;""
29 Málaga;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
29 Málaga;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
29 Málaga;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
29 Málaga;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
29 Málaga;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
29 Málaga;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
29 Málaga;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
29 Málaga;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
29 Málaga;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
29 Málaga;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
29 Málaga;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
29 Málaga;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
29 Málaga;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
29 Málaga;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;96,57
29 Málaga;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
29 Málaga;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
29 Málaga;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
29 Málaga;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;97,04
29 Málaga;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
29 Málaga;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
29 Málaga;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
29 Málaga;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;96,39
29 Málaga;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
29 Málaga;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
29 Málaga;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;92,71
29 Málaga;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
29 Málaga;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
29 Málaga;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
29 Málaga;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;93,87
29 Málaga;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
29 Málaga;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
29 Málaga;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
29 Málaga;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;93,52
29 Málaga;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
29 Málaga;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
29 Málaga;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
29 Málaga;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
29 Málaga;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
29 Málaga;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
29 Málaga;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;90,69
29 Málaga;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
29 Málaga;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
29 Málaga;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
29 Málaga;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;91,71
29 Málaga;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
29 Málaga;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
29 Málaga;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
29 Málaga;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
29 Málaga;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
29 Málaga;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
29 Málaga;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;88,03
29 Málaga;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
29 Málaga;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
29 Málaga;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
29 Málaga;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;89,73
29 Málaga;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
29 Málaga;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
29 Málaga;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
29 Málaga;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
29 Málaga;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
29 Málaga;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QIV;34.736
29 Málaga;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
29 Málaga;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
29 Málaga;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
29 Málaga;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QIV;33.652
29 Málaga;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
29 Málaga;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
29 Málaga;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
29 Málaga;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QIV;31.767
29 Málaga;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
29 Málaga;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
29 Málaga;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
29 Málaga;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2022QIV;33.470
29 Málaga;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
29 Málaga;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2022QII;""
29 Málaga;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2022QI;""
29 Málaga;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2021QIV;32.562
29 Málaga;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
29 Málaga;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2021QII;""
29 Málaga;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2021QI;""
29 Málaga;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2020QIV;30.818
29 Málaga;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
29 Málaga;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2020QII;""
29 Málaga;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2020QI;""
29 Málaga;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
29 Málaga;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
29 Málaga;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2022QII;""
29 Málaga;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2022QI;31.502
29 Málaga;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
29 Málaga;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
29 Málaga;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2021QII;""
29 Málaga;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2021QI;30.236
29 Málaga;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
29 Málaga;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
29 Málaga;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2020QII;""
29 Málaga;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2020QI;""
29 Málaga;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
29 Málaga;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
29 Málaga;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QII;30.706
29 Málaga;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QI;""
29 Málaga;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
29 Málaga;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
29 Málaga;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QII;29.553
29 Málaga;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QI;""
29 Málaga;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
29 Málaga;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
29 Málaga;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QII;""
29 Málaga;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QI;""
29 Málaga;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
29 Málaga;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QIII;30.066
29 Málaga;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QII;""
29 Málaga;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QI;""
29 Málaga;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
29 Málaga;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QIII;28.980
29 Málaga;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QII;""
29 Málaga;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QI;""
29 Málaga;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
29 Málaga;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
29 Málaga;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QII;""
29 Málaga;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QI;""
29 Málaga;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
29 Málaga;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
29 Málaga;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
29 Málaga;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
29 Málaga;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
29 Málaga;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
29 Málaga;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
29 Málaga;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
29 Málaga;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
29 Málaga;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
29 Málaga;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
29 Málaga;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
29 Málaga;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;96,36
29 Málaga;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
29 Málaga;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
29 Málaga;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
29 Málaga;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;96,76
29 Málaga;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
29 Málaga;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
29 Málaga;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
29 Málaga;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;97,01
29 Málaga;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
29 Málaga;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
29 Málaga;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
29 Málaga;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
29 Málaga;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
29 Málaga;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
29 Málaga;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;93,61
29 Málaga;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
29 Málaga;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
29 Málaga;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
29 Málaga;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;95,18
29 Málaga;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
29 Málaga;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
29 Málaga;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
29 Málaga;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
29 Málaga;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
29 Málaga;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
29 Málaga;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;91,25
29 Málaga;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
29 Málaga;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
29 Málaga;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
29 Málaga;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;93,03
29 Málaga;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
29 Málaga;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
29 Málaga;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
29 Málaga;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
29 Málaga;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
29 Málaga;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
29 Málaga;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;89,34
29 Málaga;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
29 Málaga;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
29 Málaga;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
29 Málaga;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;91,23
29 Málaga;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
29 Málaga;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
29 Málaga;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
29 Málaga;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
29 Málaga;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
29 Málaga;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
29 Málaga;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QIV;22.208
29 Málaga;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
29 Málaga;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
29 Málaga;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
29 Málaga;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QIV;21.734
29 Málaga;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
29 Málaga;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
29 Málaga;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
29 Málaga;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QIV;20.614
29 Málaga;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
29 Málaga;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
29 Málaga;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
29 Málaga;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2022QIV;21.470
29 Málaga;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
29 Málaga;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2022QII;""
29 Málaga;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2022QI;""
29 Málaga;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2021QIV;21.066
29 Málaga;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
29 Málaga;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2021QII;""
29 Málaga;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2021QI;""
29 Málaga;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2020QIV;20.031
29 Málaga;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
29 Málaga;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2020QII;""
29 Málaga;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2020QI;""
29 Málaga;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
29 Málaga;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
29 Málaga;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2022QII;""
29 Málaga;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2022QI;20.405
29 Málaga;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
29 Málaga;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
29 Málaga;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2021QII;""
29 Málaga;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2021QI;19.676
29 Málaga;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
29 Málaga;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
29 Málaga;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2020QII;""
29 Málaga;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2020QI;""
29 Málaga;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
29 Málaga;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
29 Málaga;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QII;19.943
29 Málaga;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QI;""
29 Málaga;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
29 Málaga;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
29 Málaga;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QII;19.239
29 Málaga;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QI;""
29 Málaga;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
29 Málaga;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
29 Málaga;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QII;""
29 Málaga;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QI;""
29 Málaga;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
29 Málaga;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QIII;19.602
29 Málaga;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QII;""
29 Málaga;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QI;""
29 Málaga;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
29 Málaga;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QIII;18.889
29 Málaga;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QII;""
29 Málaga;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QI;""
29 Málaga;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
29 Málaga;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
29 Málaga;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QII;""
29 Málaga;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QI;""
29 Málaga;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
29 Málaga;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
29 Málaga;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
29 Málaga;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
29 Málaga;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
29 Málaga;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
29 Málaga;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
29 Málaga;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
29 Málaga;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
29 Málaga;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
29 Málaga;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
29 Málaga;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
29 Málaga;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;96,68
29 Málaga;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
29 Málaga;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
29 Málaga;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
29 Málaga;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;96,93
29 Málaga;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
29 Málaga;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
29 Málaga;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
29 Málaga;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;97,17
29 Málaga;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
29 Málaga;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
29 Málaga;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
29 Málaga;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
29 Málaga;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
29 Málaga;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
29 Málaga;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;93,89
29 Málaga;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
29 Málaga;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
29 Málaga;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
29 Málaga;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;95,45
29 Málaga;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
29 Málaga;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
29 Málaga;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
29 Málaga;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
29 Málaga;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
29 Málaga;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
29 Málaga;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;91,76
29 Málaga;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
29 Málaga;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
29 Málaga;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
29 Málaga;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;93,33
29 Málaga;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
29 Málaga;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
29 Málaga;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
29 Málaga;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
29 Málaga;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
29 Málaga;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
29 Málaga;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;90,19
29 Málaga;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
29 Málaga;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
29 Málaga;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
29 Málaga;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;91,63
29 Málaga;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
29 Málaga;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
29 Málaga;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
29 Málaga;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
29 Málaga;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
29 Málaga;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
29 Málaga;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QIV;12.528
29 Málaga;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
29 Málaga;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
29 Málaga;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
29 Málaga;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QIV;11.918
29 Málaga;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
29 Málaga;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
29 Málaga;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
29 Málaga;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QIV;11.153
29 Málaga;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
29 Málaga;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
29 Málaga;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
29 Málaga;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2022QIV;12.000
29 Málaga;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
29 Málaga;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2022QII;""
29 Málaga;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2022QI;""
29 Málaga;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2021QIV;11.496
29 Málaga;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
29 Málaga;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2021QII;""
29 Málaga;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2021QI;""
29 Málaga;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2020QIV;10.787
29 Málaga;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
29 Málaga;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2020QII;""
29 Málaga;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2020QI;""
29 Málaga;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
29 Málaga;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
29 Málaga;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2022QII;""
29 Málaga;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2022QI;11.097
29 Málaga;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
29 Málaga;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
29 Málaga;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2021QII;""
29 Málaga;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2021QI;10.560
29 Málaga;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
29 Málaga;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
29 Málaga;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2020QII;""
29 Málaga;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2020QI;""
29 Málaga;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
29 Málaga;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
29 Málaga;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QII;10.763
29 Málaga;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QI;""
29 Málaga;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
29 Málaga;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
29 Málaga;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QII;10.314
29 Málaga;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QI;""
29 Málaga;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
29 Málaga;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
29 Málaga;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QII;""
29 Málaga;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QI;""
29 Málaga;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
29 Málaga;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QIII;10.464
29 Málaga;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QII;""
29 Málaga;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QI;""
29 Málaga;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
29 Málaga;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QIII;10.091
29 Málaga;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QII;""
29 Málaga;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QI;""
29 Málaga;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
29 Málaga;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
29 Málaga;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QII;""
29 Málaga;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QI;""
29 Málaga;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
29 Málaga;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
29 Málaga;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
29 Málaga;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
29 Málaga;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
29 Málaga;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
29 Málaga;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
29 Málaga;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
29 Málaga;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
29 Málaga;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
29 Málaga;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
29 Málaga;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
29 Málaga;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;95,79
29 Málaga;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
29 Málaga;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
29 Málaga;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
29 Málaga;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;96,46
29 Málaga;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
29 Málaga;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
29 Málaga;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
29 Málaga;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;96,72
29 Málaga;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
29 Málaga;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
29 Málaga;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
29 Málaga;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
29 Málaga;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
29 Málaga;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
29 Málaga;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;93,11
29 Málaga;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
29 Málaga;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
29 Málaga;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
29 Málaga;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;94,68
29 Málaga;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
29 Málaga;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
29 Málaga;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
29 Málaga;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
29 Málaga;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
29 Málaga;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
29 Málaga;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;90,31
29 Málaga;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
29 Málaga;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
29 Málaga;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
29 Málaga;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;92,48
29 Málaga;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
29 Málaga;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
29 Málaga;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
29 Málaga;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
29 Málaga;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
29 Málaga;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
29 Málaga;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;87,8
29 Málaga;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
29 Málaga;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
29 Málaga;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
29 Málaga;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;90,48
29 Málaga;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
29 Málaga;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
29 Málaga;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
29 Málaga;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
29 Málaga;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
29 Málaga;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
29 Málaga;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
29 Málaga;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
29 Málaga;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
29 Málaga;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QI;14.671
29 Málaga;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
29 Málaga;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
29 Málaga;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
29 Málaga;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QI;13.807
29 Málaga;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
29 Málaga;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
29 Málaga;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
29 Málaga;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QI;15.568
29 Málaga;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
29 Málaga;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
29 Málaga;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2022QII;""
29 Málaga;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2022QI;13.948
29 Málaga;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
29 Málaga;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
29 Málaga;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2021QII;""
29 Málaga;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2021QI;13.204
29 Málaga;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
29 Málaga;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
29 Málaga;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2020QII;""
29 Málaga;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2020QI;14.385
29 Málaga;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
29 Málaga;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
29 Málaga;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2022QII;13.392
29 Málaga;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2022QI;""
29 Málaga;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
29 Málaga;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
29 Málaga;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2021QII;12.648
29 Málaga;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2021QI;""
29 Málaga;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
29 Málaga;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
29 Málaga;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2020QII;13.928
29 Málaga;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2020QI;""
29 Málaga;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
29 Málaga;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QIII;12.872
29 Málaga;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QII;""
29 Málaga;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QI;""
29 Málaga;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
29 Málaga;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QIII;12.216
29 Málaga;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QII;""
29 Málaga;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QI;""
29 Málaga;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
29 Málaga;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QIII;13.345
29 Málaga;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QII;""
29 Málaga;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QI;""
29 Málaga;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QIV;12.117
29 Málaga;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
29 Málaga;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QII;""
29 Málaga;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QI;""
29 Málaga;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QIV;11.626
29 Málaga;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
29 Málaga;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QII;""
29 Málaga;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QI;""
29 Málaga;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QIV;12.726
29 Málaga;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
29 Málaga;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QII;""
29 Málaga;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QI;""
29 Málaga;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
29 Málaga;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
29 Málaga;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
29 Málaga;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
29 Málaga;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
29 Málaga;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
29 Málaga;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
29 Málaga;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
29 Málaga;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
29 Málaga;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
29 Málaga;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
29 Málaga;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
29 Málaga;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
29 Málaga;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
29 Málaga;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
29 Málaga;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;95,07
29 Málaga;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
29 Málaga;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
29 Málaga;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
29 Málaga;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;95,63
29 Málaga;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
29 Málaga;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
29 Málaga;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
29 Málaga;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;92,4
29 Málaga;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
29 Málaga;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
29 Málaga;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;91,28
29 Málaga;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
29 Málaga;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
29 Málaga;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
29 Málaga;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;91,61
29 Málaga;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
29 Málaga;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
29 Málaga;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
29 Málaga;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;89,47
29 Málaga;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
29 Málaga;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
29 Málaga;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;87,74
29 Málaga;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
29 Málaga;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
29 Málaga;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
29 Málaga;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;88,48
29 Málaga;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
29 Málaga;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
29 Málaga;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
29 Málaga;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;85,72
29 Málaga;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
29 Málaga;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
29 Málaga;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;82,59
29 Málaga;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
29 Málaga;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
29 Málaga;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
29 Málaga;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;84,2
29 Málaga;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
29 Málaga;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
29 Málaga;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
29 Málaga;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;81,74
29 Málaga;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
29 Málaga;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
29 Málaga;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
29 Málaga;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
29 Málaga;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
29 Málaga;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
29 Málaga;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QI;9.568
29 Málaga;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
29 Málaga;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
29 Málaga;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
29 Málaga;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QI;9.074
29 Málaga;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
29 Málaga;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
29 Málaga;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
29 Málaga;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QI;10.192
29 Málaga;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
29 Málaga;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
29 Málaga;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2022QII;""
29 Málaga;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2022QI;9.106
29 Málaga;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
29 Málaga;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
29 Málaga;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2021QII;""
29 Málaga;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2021QI;8.671
29 Málaga;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
29 Málaga;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
29 Málaga;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2020QII;""
29 Málaga;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2020QI;9.433
29 Málaga;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
29 Málaga;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
29 Málaga;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2022QII;8.754
29 Málaga;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2022QI;""
29 Málaga;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
29 Málaga;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
29 Málaga;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2021QII;8.306
29 Málaga;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2021QI;""
29 Málaga;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
29 Málaga;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
29 Málaga;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2020QII;9.145
29 Málaga;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2020QI;""
29 Málaga;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
29 Málaga;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QIII;8.450
29 Málaga;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QII;""
29 Málaga;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QI;""
29 Málaga;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
29 Málaga;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QIII;8.029
29 Málaga;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QII;""
29 Málaga;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QI;""
29 Málaga;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
29 Málaga;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QIII;8.782
29 Málaga;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QII;""
29 Málaga;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QI;""
29 Málaga;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QIV;7.967
29 Málaga;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
29 Málaga;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QII;""
29 Málaga;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QI;""
29 Málaga;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QIV;7.657
29 Málaga;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
29 Málaga;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QII;""
29 Málaga;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QI;""
29 Málaga;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QIV;8.381
29 Málaga;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
29 Málaga;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QII;""
29 Málaga;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QI;""
29 Málaga;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
29 Málaga;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
29 Málaga;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
29 Málaga;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
29 Málaga;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
29 Málaga;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
29 Málaga;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
29 Málaga;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
29 Málaga;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
29 Málaga;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
29 Málaga;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
29 Málaga;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
29 Málaga;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
29 Málaga;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
29 Málaga;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
29 Málaga;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;95,17
29 Málaga;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
29 Málaga;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
29 Málaga;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
29 Málaga;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;95,56
29 Málaga;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
29 Málaga;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
29 Málaga;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
29 Málaga;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;92,55
29 Málaga;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
29 Málaga;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
29 Málaga;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;91,49
29 Málaga;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
29 Málaga;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
29 Málaga;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
29 Málaga;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;91,54
29 Málaga;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
29 Málaga;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
29 Málaga;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
29 Málaga;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;89,73
29 Málaga;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
29 Málaga;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
29 Málaga;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;88,32
29 Málaga;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
29 Málaga;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
29 Málaga;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
29 Málaga;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;88,48
29 Málaga;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
29 Málaga;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
29 Málaga;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
29 Málaga;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;86,17
29 Málaga;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
29 Málaga;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
29 Málaga;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;83,27
29 Málaga;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
29 Málaga;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
29 Málaga;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
29 Málaga;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;84,38
29 Málaga;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
29 Málaga;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
29 Málaga;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
29 Málaga;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;82,23
29 Málaga;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
29 Málaga;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
29 Málaga;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
29 Málaga;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
29 Málaga;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
29 Málaga;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
29 Málaga;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QI;5.103
29 Málaga;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
29 Málaga;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
29 Málaga;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
29 Málaga;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QI;4.733
29 Málaga;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
29 Málaga;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
29 Málaga;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
29 Málaga;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QI;5.376
29 Málaga;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
29 Málaga;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
29 Málaga;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2022QII;""
29 Málaga;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2022QI;4.842
29 Málaga;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
29 Málaga;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
29 Málaga;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2021QII;""
29 Málaga;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2021QI;4.533
29 Málaga;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
29 Málaga;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
29 Málaga;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2020QII;""
29 Málaga;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2020QI;4.952
29 Málaga;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
29 Málaga;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
29 Málaga;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2022QII;4.638
29 Málaga;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2022QI;""
29 Málaga;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
29 Málaga;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
29 Málaga;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2021QII;4.342
29 Málaga;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2021QI;""
29 Málaga;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
29 Málaga;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
29 Málaga;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2020QII;4.783
29 Málaga;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2020QI;""
29 Málaga;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
29 Málaga;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QIII;4.422
29 Málaga;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QII;""
29 Málaga;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QI;""
29 Málaga;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
29 Málaga;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QIII;4.187
29 Málaga;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QII;""
29 Málaga;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QI;""
29 Málaga;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
29 Málaga;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QIII;4.563
29 Málaga;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QII;""
29 Málaga;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QI;""
29 Málaga;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QIV;4.150
29 Málaga;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
29 Málaga;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QII;""
29 Málaga;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QI;""
29 Málaga;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QIV;3.969
29 Málaga;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
29 Málaga;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QII;""
29 Málaga;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QI;""
29 Málaga;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QIV;4.345
29 Málaga;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
29 Málaga;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QII;""
29 Málaga;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QI;""
29 Málaga;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
29 Málaga;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
29 Málaga;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
29 Málaga;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
29 Málaga;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
29 Málaga;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
29 Málaga;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
29 Málaga;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
29 Málaga;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
29 Málaga;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
29 Málaga;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
29 Málaga;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
29 Málaga;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
29 Málaga;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
29 Málaga;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
29 Málaga;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;94,89
29 Málaga;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
29 Málaga;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
29 Málaga;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
29 Málaga;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;95,77
29 Málaga;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
29 Málaga;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
29 Málaga;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
29 Málaga;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;92,11
29 Málaga;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
29 Málaga;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
29 Málaga;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;90,89
29 Málaga;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
29 Málaga;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
29 Málaga;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
29 Málaga;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;91,74
29 Málaga;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
29 Málaga;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
29 Málaga;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
29 Málaga;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;88,97
29 Málaga;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
29 Málaga;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
29 Málaga;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;86,65
29 Málaga;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
29 Málaga;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
29 Málaga;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
29 Málaga;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;88,46
29 Málaga;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
29 Málaga;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
29 Málaga;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
29 Málaga;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;84,88
29 Málaga;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
29 Málaga;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
29 Málaga;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;81,32
29 Málaga;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
29 Málaga;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
29 Málaga;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
29 Málaga;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;83,86
29 Málaga;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
29 Málaga;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
29 Málaga;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
29 Málaga;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;80,82
29 Málaga;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
29 Málaga;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
29 Málaga;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
29 Málaga;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
29 Málaga;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
29 Málaga;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QII;16.759
29 Málaga;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
29 Málaga;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
29 Málaga;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
29 Málaga;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QII;15.763
29 Málaga;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
29 Málaga;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
29 Málaga;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
29 Málaga;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QII;14.919
29 Málaga;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
29 Málaga;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
29 Málaga;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
29 Málaga;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2022QII;16.110
29 Málaga;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2022QI;""
29 Málaga;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
29 Málaga;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
29 Málaga;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2021QII;15.123
29 Málaga;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2021QI;""
29 Málaga;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
29 Málaga;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
29 Málaga;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2020QII;14.417
29 Málaga;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2020QI;""
29 Málaga;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
29 Málaga;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2022QIII;15.523
29 Málaga;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2022QII;""
29 Málaga;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2022QI;""
29 Málaga;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
29 Málaga;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2021QIII;14.626
29 Málaga;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2021QII;""
29 Málaga;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2021QI;""
29 Málaga;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
29 Málaga;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2020QIII;13.752
29 Málaga;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2020QII;""
29 Málaga;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2020QI;""
29 Málaga;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QIV;14.678
29 Málaga;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
29 Málaga;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QII;""
29 Málaga;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QI;""
29 Málaga;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QIV;13.971
29 Málaga;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
29 Málaga;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QII;""
29 Málaga;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QI;""
29 Málaga;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QIV;13.094
29 Málaga;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
29 Málaga;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QII;""
29 Málaga;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QI;""
29 Málaga;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
29 Málaga;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
29 Málaga;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QII;""
29 Málaga;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QI;13.323
29 Málaga;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
29 Málaga;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
29 Málaga;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QII;""
29 Málaga;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QI;12.561
29 Málaga;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
29 Málaga;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
29 Málaga;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QII;""
29 Málaga;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QI;""
29 Málaga;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
29 Málaga;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
29 Málaga;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
29 Málaga;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
29 Málaga;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
29 Málaga;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
29 Málaga;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
29 Málaga;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
29 Málaga;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
29 Málaga;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
29 Málaga;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
29 Málaga;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
29 Málaga;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
29 Málaga;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
29 Málaga;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;96,13
29 Málaga;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
29 Málaga;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
29 Málaga;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
29 Málaga;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;95,94
29 Málaga;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
29 Málaga;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
29 Málaga;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
29 Málaga;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;96,64
29 Málaga;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
29 Málaga;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
29 Málaga;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;92,62
29 Málaga;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
29 Málaga;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
29 Málaga;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
29 Málaga;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;92,79
29 Málaga;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
29 Málaga;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
29 Málaga;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
29 Málaga;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;92,18
29 Málaga;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
29 Málaga;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
29 Málaga;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;87,58
29 Málaga;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
29 Málaga;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
29 Málaga;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
29 Málaga;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;88,63
29 Málaga;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
29 Málaga;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
29 Málaga;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
29 Málaga;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;87,77
29 Málaga;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
29 Málaga;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
29 Málaga;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
29 Málaga;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
29 Málaga;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
29 Málaga;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
29 Málaga;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;84,52
29 Málaga;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
29 Málaga;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
29 Málaga;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
29 Málaga;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;84,19
29 Málaga;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
29 Málaga;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
29 Málaga;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
29 Málaga;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
29 Málaga;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
29 Málaga;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
29 Málaga;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QII;10.921
29 Málaga;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
29 Málaga;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
29 Málaga;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
29 Málaga;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QII;10.325
29 Málaga;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
29 Málaga;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
29 Málaga;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
29 Málaga;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QII;9.761
29 Málaga;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
29 Málaga;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
29 Málaga;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
29 Málaga;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2022QII;10.520
29 Málaga;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2022QI;""
29 Málaga;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
29 Málaga;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
29 Málaga;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2021QII;9.908
29 Málaga;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2021QI;""
29 Málaga;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
29 Málaga;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
29 Málaga;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2020QII;9.439
29 Málaga;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2020QI;""
29 Málaga;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
29 Málaga;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2022QIII;10.175
29 Málaga;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2022QII;""
29 Málaga;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2022QI;""
29 Málaga;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
29 Málaga;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2021QIII;9.587
29 Málaga;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2021QII;""
29 Málaga;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2021QI;""
29 Málaga;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
29 Málaga;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2020QIII;9.019
29 Málaga;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2020QII;""
29 Málaga;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2020QI;""
29 Málaga;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QIV;9.636
29 Málaga;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
29 Málaga;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QII;""
29 Málaga;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QI;""
29 Málaga;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QIV;9.170
29 Málaga;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
29 Málaga;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QII;""
29 Málaga;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QI;""
29 Málaga;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QIV;8.596
29 Málaga;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
29 Málaga;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QII;""
29 Málaga;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QI;""
29 Málaga;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
29 Málaga;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
29 Málaga;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QII;""
29 Málaga;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QI;8.755
29 Málaga;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
29 Málaga;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
29 Málaga;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QII;""
29 Málaga;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QI;8.242
29 Málaga;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
29 Málaga;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
29 Málaga;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QII;""
29 Málaga;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QI;""
29 Málaga;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
29 Málaga;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
29 Málaga;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
29 Málaga;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
29 Málaga;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
29 Málaga;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
29 Málaga;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
29 Málaga;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
29 Málaga;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
29 Málaga;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
29 Málaga;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
29 Málaga;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
29 Málaga;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
29 Málaga;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
29 Málaga;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;96,33
29 Málaga;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
29 Málaga;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
29 Málaga;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
29 Málaga;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;95,96
29 Málaga;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
29 Málaga;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
29 Málaga;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
29 Málaga;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;96,7
29 Málaga;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
29 Málaga;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
29 Málaga;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;93,17
29 Málaga;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
29 Málaga;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
29 Málaga;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
29 Málaga;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;92,85
29 Málaga;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
29 Málaga;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
29 Málaga;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
29 Málaga;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;92,4
29 Málaga;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
29 Málaga;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
29 Málaga;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;88,23
29 Málaga;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
29 Málaga;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
29 Málaga;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
29 Málaga;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;88,81
29 Málaga;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
29 Málaga;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
29 Málaga;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
29 Málaga;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;88,06
29 Málaga;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
29 Málaga;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
29 Málaga;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
29 Málaga;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
29 Málaga;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
29 Málaga;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
29 Málaga;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;84,79
29 Málaga;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
29 Málaga;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
29 Málaga;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
29 Málaga;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;84,44
29 Málaga;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
29 Málaga;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
29 Málaga;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
29 Málaga;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
29 Málaga;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
29 Málaga;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
29 Málaga;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QII;5.838
29 Málaga;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
29 Málaga;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
29 Málaga;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
29 Málaga;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QII;5.438
29 Málaga;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
29 Málaga;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
29 Málaga;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
29 Málaga;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QII;5.158
29 Málaga;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
29 Málaga;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
29 Málaga;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
29 Málaga;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2022QII;5.590
29 Málaga;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2022QI;""
29 Málaga;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
29 Málaga;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
29 Málaga;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2021QII;5.215
29 Málaga;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2021QI;""
29 Málaga;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
29 Málaga;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
29 Málaga;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2020QII;4.978
29 Málaga;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2020QI;""
29 Málaga;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
29 Málaga;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2022QIII;5.348
29 Málaga;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2022QII;""
29 Málaga;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2022QI;""
29 Málaga;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
29 Málaga;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2021QIII;5.039
29 Málaga;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2021QII;""
29 Málaga;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2021QI;""
29 Málaga;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
29 Málaga;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2020QIII;4.733
29 Málaga;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2020QII;""
29 Málaga;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2020QI;""
29 Málaga;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QIV;5.042
29 Málaga;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
29 Málaga;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QII;""
29 Málaga;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QI;""
29 Málaga;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QIV;4.801
29 Málaga;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
29 Málaga;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QII;""
29 Málaga;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QI;""
29 Málaga;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QIV;4.498
29 Málaga;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
29 Málaga;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QII;""
29 Málaga;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QI;""
29 Málaga;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
29 Málaga;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
29 Málaga;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QII;""
29 Málaga;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QI;4.568
29 Málaga;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
29 Málaga;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
29 Málaga;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QII;""
29 Málaga;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QI;4.319
29 Málaga;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
29 Málaga;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
29 Málaga;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QII;""
29 Málaga;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QI;""
29 Málaga;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
29 Málaga;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
29 Málaga;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
29 Málaga;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
29 Málaga;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
29 Málaga;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
29 Málaga;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
29 Málaga;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
29 Málaga;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
29 Málaga;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
29 Málaga;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
29 Málaga;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
29 Málaga;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
29 Málaga;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
29 Málaga;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;95,75
29 Málaga;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
29 Málaga;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
29 Málaga;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
29 Málaga;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;95,9
29 Málaga;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
29 Málaga;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
29 Málaga;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
29 Málaga;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;96,51
29 Málaga;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
29 Málaga;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
29 Málaga;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;91,61
29 Málaga;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
29 Málaga;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
29 Málaga;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
29 Málaga;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;92,66
29 Málaga;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
29 Málaga;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
29 Málaga;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
29 Málaga;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;91,76
29 Málaga;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
29 Málaga;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
29 Málaga;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;86,37
29 Málaga;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
29 Málaga;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
29 Málaga;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
29 Málaga;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;88,29
29 Málaga;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
29 Málaga;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
29 Málaga;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
29 Málaga;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;87,2
29 Málaga;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
29 Málaga;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
29 Málaga;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
29 Málaga;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
29 Málaga;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
29 Málaga;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
29 Málaga;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;84
29 Málaga;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
29 Málaga;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
29 Málaga;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
29 Málaga;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;83,73
29 Málaga;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
29 Málaga;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
29 Málaga;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
29 Málaga;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
29 Málaga;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
29 Málaga;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QIII;16.542
29 Málaga;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
29 Málaga;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
29 Málaga;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
29 Málaga;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QIII;15.524
29 Málaga;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
29 Málaga;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
29 Málaga;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
29 Málaga;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QIII;14.679
29 Málaga;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
29 Málaga;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
29 Málaga;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
29 Málaga;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2022QIII;15.870
29 Málaga;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2022QII;""
29 Málaga;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2022QI;""
29 Málaga;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
29 Málaga;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2021QIII;14.958
29 Málaga;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2021QII;""
29 Málaga;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2021QI;""
29 Málaga;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
29 Málaga;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2020QIII;13.967
29 Málaga;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2020QII;""
29 Málaga;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2020QI;""
29 Málaga;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2022QIV;14.934
29 Málaga;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
29 Málaga;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2022QII;""
29 Málaga;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2022QI;""
29 Málaga;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2021QIV;14.216
29 Málaga;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
29 Málaga;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2021QII;""
29 Málaga;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2021QI;""
29 Málaga;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2020QIV;13.281
29 Málaga;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
29 Málaga;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2020QII;""
29 Málaga;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2020QI;""
29 Málaga;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
29 Málaga;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
29 Málaga;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QII;""
29 Málaga;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QI;13.551
29 Málaga;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
29 Málaga;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
29 Málaga;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QII;""
29 Málaga;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QI;12.736
29 Málaga;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
29 Málaga;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
29 Málaga;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QII;""
29 Málaga;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QI;""
29 Málaga;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
29 Málaga;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
29 Málaga;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QII;13.031
29 Málaga;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QI;""
29 Málaga;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
29 Málaga;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
29 Málaga;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QII;12.216
29 Málaga;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QI;""
29 Málaga;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
29 Málaga;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
29 Málaga;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QII;""
29 Málaga;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QI;""
29 Málaga;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
29 Málaga;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
29 Málaga;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
29 Málaga;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
29 Málaga;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
29 Málaga;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
29 Málaga;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
29 Málaga;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
29 Málaga;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
29 Málaga;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
29 Málaga;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
29 Málaga;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
29 Málaga;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
29 Málaga;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;95,94
29 Málaga;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
29 Málaga;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
29 Málaga;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
29 Málaga;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;96,35
29 Málaga;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
29 Málaga;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
29 Málaga;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
29 Málaga;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;95,15
29 Málaga;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
29 Málaga;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
29 Málaga;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;90,28
29 Málaga;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
29 Málaga;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
29 Málaga;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
29 Málaga;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;91,57
29 Málaga;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
29 Málaga;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
29 Málaga;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
29 Málaga;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;90,48
29 Málaga;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
29 Málaga;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
29 Málaga;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
29 Málaga;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
29 Málaga;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
29 Málaga;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
29 Málaga;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;87,29
29 Málaga;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
29 Málaga;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
29 Málaga;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
29 Málaga;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;86,76
29 Málaga;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
29 Málaga;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
29 Málaga;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
29 Málaga;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
29 Málaga;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
29 Málaga;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
29 Málaga;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;83,94
29 Málaga;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
29 Málaga;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
29 Málaga;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
29 Málaga;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;83,22
29 Málaga;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
29 Málaga;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
29 Málaga;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
29 Málaga;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
29 Málaga;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
29 Málaga;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
29 Málaga;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QIII;10.757
29 Málaga;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
29 Málaga;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
29 Málaga;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
29 Málaga;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QIII;10.134
29 Málaga;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
29 Málaga;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
29 Málaga;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
29 Málaga;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QIII;9.621
29 Málaga;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
29 Málaga;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
29 Málaga;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
29 Málaga;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2022QIII;10.365
29 Málaga;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2022QII;""
29 Málaga;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2022QI;""
29 Málaga;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
29 Málaga;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2021QIII;9.771
29 Málaga;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2021QII;""
29 Málaga;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2021QI;""
29 Málaga;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
29 Málaga;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2020QIII;9.174
29 Málaga;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2020QII;""
29 Málaga;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2020QI;""
29 Málaga;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2022QIV;9.773
29 Málaga;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
29 Málaga;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2022QII;""
29 Málaga;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2022QI;""
29 Málaga;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2021QIV;9.301
29 Málaga;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
29 Málaga;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2021QII;""
29 Málaga;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2021QI;""
29 Málaga;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2020QIV;8.733
29 Málaga;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
29 Málaga;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2020QII;""
29 Málaga;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2020QI;""
29 Málaga;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
29 Málaga;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
29 Málaga;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QII;""
29 Málaga;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QI;8.877
29 Málaga;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
29 Málaga;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
29 Málaga;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QII;""
29 Málaga;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QI;8.368
29 Málaga;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
29 Málaga;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
29 Málaga;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QII;""
29 Málaga;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QI;""
29 Málaga;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
29 Málaga;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
29 Málaga;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QII;8.549
29 Málaga;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QI;""
29 Málaga;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
29 Málaga;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
29 Málaga;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QII;8.027
29 Málaga;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QI;""
29 Málaga;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
29 Málaga;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
29 Málaga;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QII;""
29 Málaga;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QI;""
29 Málaga;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
29 Málaga;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
29 Málaga;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
29 Málaga;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
29 Málaga;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
29 Málaga;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
29 Málaga;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
29 Málaga;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
29 Málaga;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
29 Málaga;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
29 Málaga;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
29 Málaga;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
29 Málaga;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
29 Málaga;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;96,36
29 Málaga;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
29 Málaga;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
29 Málaga;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
29 Málaga;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;96,42
29 Málaga;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
29 Málaga;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
29 Málaga;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
29 Málaga;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;95,35
29 Málaga;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
29 Málaga;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
29 Málaga;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;90,85
29 Málaga;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
29 Málaga;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
29 Málaga;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
29 Málaga;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;91,78
29 Málaga;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
29 Málaga;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
29 Málaga;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
29 Málaga;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;90,77
29 Málaga;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
29 Málaga;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
29 Málaga;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
29 Málaga;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
29 Málaga;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
29 Málaga;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
29 Málaga;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;87,6
29 Málaga;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
29 Málaga;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
29 Málaga;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
29 Málaga;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;86,98
29 Málaga;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
29 Málaga;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
29 Málaga;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
29 Málaga;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
29 Málaga;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
29 Málaga;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
29 Málaga;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;84,36
29 Málaga;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
29 Málaga;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
29 Málaga;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
29 Málaga;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;83,43
29 Málaga;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
29 Málaga;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
29 Málaga;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
29 Málaga;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
29 Málaga;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
29 Málaga;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
29 Málaga;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QIII;5.785
29 Málaga;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
29 Málaga;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
29 Málaga;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
29 Málaga;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QIII;5.390
29 Málaga;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
29 Málaga;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
29 Málaga;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
29 Málaga;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QIII;5.058
29 Málaga;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
29 Málaga;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
29 Málaga;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
29 Málaga;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2022QIII;5.505
29 Málaga;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2022QII;""
29 Málaga;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2022QI;""
29 Málaga;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
29 Málaga;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2021QIII;5.187
29 Málaga;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2021QII;""
29 Málaga;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2021QI;""
29 Málaga;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
29 Málaga;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2020QIII;4.793
29 Málaga;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2020QII;""
29 Málaga;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2020QI;""
29 Málaga;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2022QIV;5.161
29 Málaga;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
29 Málaga;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2022QII;""
29 Málaga;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2022QI;""
29 Málaga;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2021QIV;4.915
29 Málaga;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
29 Málaga;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2021QII;""
29 Málaga;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2021QI;""
29 Málaga;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2020QIV;4.548
29 Málaga;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
29 Málaga;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2020QII;""
29 Málaga;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2020QI;""
29 Málaga;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
29 Málaga;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
29 Málaga;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QII;""
29 Málaga;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QI;4.674
29 Málaga;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
29 Málaga;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
29 Málaga;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QII;""
29 Málaga;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QI;4.368
29 Málaga;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
29 Málaga;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
29 Málaga;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QII;""
29 Málaga;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QI;""
29 Málaga;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
29 Málaga;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
29 Málaga;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QII;4.482
29 Málaga;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QI;""
29 Málaga;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
29 Málaga;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
29 Málaga;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QII;4.189
29 Málaga;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QI;""
29 Málaga;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
29 Málaga;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
29 Málaga;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QII;""
29 Málaga;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QI;""
29 Málaga;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
29 Málaga;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
29 Málaga;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
29 Málaga;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
29 Málaga;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
29 Málaga;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
29 Málaga;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
29 Málaga;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
29 Málaga;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
29 Málaga;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
29 Málaga;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
29 Málaga;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
29 Málaga;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
29 Málaga;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;95,16
29 Málaga;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
29 Málaga;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
29 Málaga;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
29 Málaga;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;96,23
29 Málaga;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
29 Málaga;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
29 Málaga;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
29 Málaga;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;94,76
29 Málaga;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
29 Málaga;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
29 Málaga;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;89,21
29 Málaga;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
29 Málaga;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
29 Málaga;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
29 Málaga;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;91,19
29 Málaga;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
29 Málaga;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
29 Málaga;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
29 Málaga;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;89,92
29 Málaga;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
29 Málaga;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
29 Málaga;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
29 Málaga;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
29 Málaga;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
29 Málaga;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
29 Málaga;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;86,72
29 Málaga;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
29 Málaga;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
29 Málaga;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
29 Málaga;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;86,36
29 Málaga;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
29 Málaga;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
29 Málaga;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
29 Málaga;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
29 Málaga;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
29 Málaga;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
29 Málaga;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;83,15
29 Málaga;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
29 Málaga;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
29 Málaga;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
29 Málaga;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;82,82
29 Málaga;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
29 Málaga;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
29 Málaga;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
29 Málaga;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
29 Málaga;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
29 Málaga;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QIV;16.120
29 Málaga;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
29 Málaga;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
29 Málaga;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
29 Málaga;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QIV;15.204
29 Málaga;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
29 Málaga;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
29 Málaga;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
29 Málaga;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QIV;14.265
29 Málaga;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
29 Málaga;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
29 Málaga;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
29 Málaga;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2022QIV;15.149
29 Málaga;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
29 Málaga;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2022QII;""
29 Málaga;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2022QI;""
29 Málaga;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2021QIV;14.413
29 Málaga;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
29 Málaga;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2021QII;""
29 Málaga;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2021QI;""
29 Málaga;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2020QIV;13.526
29 Málaga;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
29 Málaga;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2020QII;""
29 Málaga;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2020QI;""
29 Málaga;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
29 Málaga;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
29 Málaga;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2022QII;""
29 Málaga;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2022QI;13.728
29 Málaga;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
29 Málaga;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
29 Málaga;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2021QII;""
29 Málaga;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2021QI;12.957
29 Málaga;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
29 Málaga;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
29 Málaga;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2020QII;""
29 Málaga;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2020QI;""
29 Málaga;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
29 Málaga;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
29 Málaga;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QII;13.196
29 Málaga;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QI;""
29 Málaga;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
29 Málaga;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
29 Málaga;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QII;12.424
29 Málaga;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QI;""
29 Málaga;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
29 Málaga;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
29 Málaga;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QII;""
29 Málaga;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QI;""
29 Málaga;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
29 Málaga;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QIII;12.694
29 Málaga;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QII;""
29 Málaga;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QI;""
29 Málaga;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
29 Málaga;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QIII;12.006
29 Málaga;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QII;""
29 Málaga;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QI;""
29 Málaga;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
29 Málaga;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
29 Málaga;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QII;""
29 Málaga;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QI;""
29 Málaga;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
29 Málaga;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
29 Málaga;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
29 Málaga;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
29 Málaga;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
29 Málaga;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
29 Málaga;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
29 Málaga;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
29 Málaga;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
29 Málaga;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
29 Málaga;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
29 Málaga;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
29 Málaga;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;93,98
29 Málaga;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
29 Málaga;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
29 Málaga;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
29 Málaga;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;94,8
29 Málaga;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
29 Málaga;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
29 Málaga;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
29 Málaga;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;94,82
29 Málaga;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
29 Málaga;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
29 Málaga;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
29 Málaga;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
29 Málaga;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
29 Málaga;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
29 Málaga;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;90,29
29 Málaga;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
29 Málaga;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
29 Málaga;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
29 Málaga;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;90,83
29 Málaga;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
29 Málaga;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
29 Málaga;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
29 Málaga;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
29 Málaga;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
29 Málaga;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
29 Málaga;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;86,79
29 Málaga;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
29 Málaga;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
29 Málaga;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
29 Málaga;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;87,09
29 Málaga;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
29 Málaga;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
29 Málaga;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
29 Málaga;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
29 Málaga;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
29 Málaga;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
29 Málaga;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;83,49
29 Málaga;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
29 Málaga;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
29 Málaga;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
29 Málaga;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;84,16
29 Málaga;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
29 Málaga;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
29 Málaga;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
29 Málaga;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
29 Málaga;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
29 Málaga;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
29 Málaga;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QIV;10.515
29 Málaga;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
29 Málaga;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
29 Málaga;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
29 Málaga;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QIV;9.907
29 Málaga;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
29 Málaga;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
29 Málaga;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
29 Málaga;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QIV;9.366
29 Málaga;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
29 Málaga;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
29 Málaga;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
29 Málaga;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2022QIV;9.902
29 Málaga;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
29 Málaga;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2022QII;""
29 Málaga;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2022QI;""
29 Málaga;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2021QIV;9.411
29 Málaga;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
29 Málaga;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2021QII;""
29 Málaga;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2021QI;""
29 Málaga;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2020QIV;8.894
29 Málaga;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
29 Málaga;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2020QII;""
29 Málaga;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2020QI;""
29 Málaga;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
29 Málaga;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
29 Málaga;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2022QII;""
29 Málaga;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2022QI;8.976
29 Málaga;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
29 Málaga;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
29 Málaga;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2021QII;""
29 Málaga;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2021QI;8.514
29 Málaga;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
29 Málaga;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
29 Málaga;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2020QII;""
29 Málaga;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2020QI;""
29 Málaga;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
29 Málaga;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
29 Málaga;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QII;8.641
29 Málaga;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QI;""
29 Málaga;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
29 Málaga;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
29 Málaga;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QII;8.164
29 Málaga;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QI;""
29 Málaga;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
29 Málaga;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
29 Málaga;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QII;""
29 Málaga;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QI;""
29 Málaga;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
29 Málaga;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QIII;8.345
29 Málaga;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QII;""
29 Málaga;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QI;""
29 Málaga;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
29 Málaga;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QIII;7.895
29 Málaga;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QII;""
29 Málaga;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QI;""
29 Málaga;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
29 Málaga;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
29 Málaga;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QII;""
29 Málaga;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QI;""
29 Málaga;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
29 Málaga;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
29 Málaga;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
29 Málaga;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
29 Málaga;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
29 Málaga;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
29 Málaga;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
29 Málaga;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
29 Málaga;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
29 Málaga;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
29 Málaga;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
29 Málaga;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
29 Málaga;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;94,17
29 Málaga;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
29 Málaga;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
29 Málaga;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
29 Málaga;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;94,99
29 Málaga;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
29 Málaga;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
29 Málaga;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
29 Málaga;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;94,96
29 Málaga;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
29 Málaga;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
29 Málaga;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
29 Málaga;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
29 Málaga;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
29 Málaga;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
29 Málaga;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;90,6
29 Málaga;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
29 Málaga;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
29 Málaga;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
29 Málaga;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;90,9
29 Málaga;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
29 Málaga;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
29 Málaga;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
29 Málaga;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
29 Málaga;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
29 Málaga;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
29 Málaga;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;87,22
29 Málaga;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
29 Málaga;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
29 Málaga;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
29 Málaga;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;87,17
29 Málaga;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
29 Málaga;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
29 Málaga;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
29 Málaga;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
29 Málaga;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
29 Málaga;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
29 Málaga;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;84,23
29 Málaga;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
29 Málaga;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
29 Málaga;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
29 Málaga;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;84,29
29 Málaga;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
29 Málaga;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
29 Málaga;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
29 Málaga;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
29 Málaga;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
29 Málaga;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
29 Málaga;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QIV;5.605
29 Málaga;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
29 Málaga;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
29 Málaga;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
29 Málaga;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QIV;5.297
29 Málaga;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
29 Málaga;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
29 Málaga;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
29 Málaga;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QIV;4.899
29 Málaga;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
29 Málaga;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
29 Málaga;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
29 Málaga;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2022QIV;5.247
29 Málaga;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
29 Málaga;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2022QII;""
29 Málaga;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2022QI;""
29 Málaga;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2021QIV;5.002
29 Málaga;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
29 Málaga;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2021QII;""
29 Málaga;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2021QI;""
29 Málaga;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2020QIV;4.632
29 Málaga;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
29 Málaga;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2020QII;""
29 Málaga;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2020QI;""
29 Málaga;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
29 Málaga;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
29 Málaga;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2022QII;""
29 Málaga;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2022QI;4.752
29 Málaga;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
29 Málaga;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
29 Málaga;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2021QII;""
29 Málaga;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2021QI;4.443
29 Málaga;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
29 Málaga;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
29 Málaga;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2020QII;""
29 Málaga;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2020QI;""
29 Málaga;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
29 Málaga;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
29 Málaga;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QII;4.555
29 Málaga;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QI;""
29 Málaga;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
29 Málaga;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
29 Málaga;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QII;4.260
29 Málaga;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QI;""
29 Málaga;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
29 Málaga;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
29 Málaga;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QII;""
29 Málaga;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QI;""
29 Málaga;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
29 Málaga;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QIII;4.349
29 Málaga;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QII;""
29 Málaga;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QI;""
29 Málaga;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
29 Málaga;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QIII;4.111
29 Málaga;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QII;""
29 Málaga;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QI;""
29 Málaga;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
29 Málaga;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
29 Málaga;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QII;""
29 Málaga;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QI;""
29 Málaga;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
29 Málaga;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
29 Málaga;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
29 Málaga;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
29 Málaga;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
29 Málaga;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
29 Málaga;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
29 Málaga;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
29 Málaga;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
29 Málaga;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
29 Málaga;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
29 Málaga;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
29 Málaga;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;93,61
29 Málaga;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
29 Málaga;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
29 Málaga;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
29 Málaga;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;94,43
29 Málaga;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
29 Málaga;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
29 Málaga;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
29 Málaga;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;94,55
29 Málaga;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
29 Málaga;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
29 Málaga;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
29 Málaga;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
29 Málaga;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
29 Málaga;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
29 Málaga;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;89,71
29 Málaga;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
29 Málaga;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
29 Málaga;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
29 Málaga;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;90,69
29 Málaga;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
29 Málaga;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
29 Málaga;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
29 Málaga;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
29 Málaga;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
29 Málaga;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
29 Málaga;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;85,99
29 Málaga;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
29 Málaga;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
29 Málaga;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
29 Málaga;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;86,96
29 Málaga;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
29 Málaga;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
29 Málaga;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
29 Málaga;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
29 Málaga;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
29 Málaga;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
29 Málaga;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;82,1
29 Málaga;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
29 Málaga;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
29 Málaga;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
29 Málaga;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;83,92
29 Málaga;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
29 Málaga;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
29 Málaga;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
29 Málaga;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
29 Málaga;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
29 Málaga;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
30 Murcia;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
30 Murcia;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
30 Murcia;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
30 Murcia;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QI;92.618
30 Murcia;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
30 Murcia;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
30 Murcia;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
30 Murcia;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QI;90.861
30 Murcia;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
30 Murcia;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
30 Murcia;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
30 Murcia;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QI;90.780
30 Murcia;All ages;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
30 Murcia;All ages;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
30 Murcia;All ages;Cohort January 1;Total;Survival in the first trimester;2022QII;""
30 Murcia;All ages;Cohort January 1;Total;Survival in the first trimester;2022QI;89.374
30 Murcia;All ages;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
30 Murcia;All ages;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
30 Murcia;All ages;Cohort January 1;Total;Survival in the first trimester;2021QII;""
30 Murcia;All ages;Cohort January 1;Total;Survival in the first trimester;2021QI;88.513
30 Murcia;All ages;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
30 Murcia;All ages;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
30 Murcia;All ages;Cohort January 1;Total;Survival in the first trimester;2020QII;""
30 Murcia;All ages;Cohort January 1;Total;Survival in the first trimester;2020QI;85.167
30 Murcia;All ages;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
30 Murcia;All ages;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
30 Murcia;All ages;Cohort January 1;Total;Survival in the second trimester;2022QII;86.231
30 Murcia;All ages;Cohort January 1;Total;Survival in the second trimester;2022QI;""
30 Murcia;All ages;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
30 Murcia;All ages;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
30 Murcia;All ages;Cohort January 1;Total;Survival in the second trimester;2021QII;85.815
30 Murcia;All ages;Cohort January 1;Total;Survival in the second trimester;2021QI;""
30 Murcia;All ages;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
30 Murcia;All ages;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
30 Murcia;All ages;Cohort January 1;Total;Survival in the second trimester;2020QII;83.518
30 Murcia;All ages;Cohort January 1;Total;Survival in the second trimester;2020QI;""
30 Murcia;All ages;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
30 Murcia;All ages;Cohort January 1;Total;Survival in the third trimester;2022QIII;83.817
30 Murcia;All ages;Cohort January 1;Total;Survival in the third trimester;2022QII;""
30 Murcia;All ages;Cohort January 1;Total;Survival in the third trimester;2022QI;""
30 Murcia;All ages;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
30 Murcia;All ages;Cohort January 1;Total;Survival in the third trimester;2021QIII;83.659
30 Murcia;All ages;Cohort January 1;Total;Survival in the third trimester;2021QII;""
30 Murcia;All ages;Cohort January 1;Total;Survival in the third trimester;2021QI;""
30 Murcia;All ages;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
30 Murcia;All ages;Cohort January 1;Total;Survival in the third trimester;2020QIII;81.327
30 Murcia;All ages;Cohort January 1;Total;Survival in the third trimester;2020QII;""
30 Murcia;All ages;Cohort January 1;Total;Survival in the third trimester;2020QI;""
30 Murcia;All ages;Cohort January 1;Total;Survival in the third trimester;2022QIV;81.194
30 Murcia;All ages;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
30 Murcia;All ages;Cohort January 1;Total;Survival in the third trimester;2022QII;""
30 Murcia;All ages;Cohort January 1;Total;Survival in the third trimester;2022QI;""
30 Murcia;All ages;Cohort January 1;Total;Survival in the third trimester;2021QIV;81.398
30 Murcia;All ages;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
30 Murcia;All ages;Cohort January 1;Total;Survival in the third trimester;2021QII;""
30 Murcia;All ages;Cohort January 1;Total;Survival in the third trimester;2021QI;""
30 Murcia;All ages;Cohort January 1;Total;Survival in the third trimester;2020QIV;79.292
30 Murcia;All ages;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
30 Murcia;All ages;Cohort January 1;Total;Survival in the third trimester;2020QII;""
30 Murcia;All ages;Cohort January 1;Total;Survival in the third trimester;2020QI;""
30 Murcia;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
30 Murcia;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
30 Murcia;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
30 Murcia;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
30 Murcia;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
30 Murcia;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
30 Murcia;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
30 Murcia;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
30 Murcia;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
30 Murcia;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
30 Murcia;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
30 Murcia;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
30 Murcia;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
30 Murcia;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
30 Murcia;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
30 Murcia;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;96,5
30 Murcia;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
30 Murcia;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
30 Murcia;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
30 Murcia;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;97,42
30 Murcia;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
30 Murcia;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
30 Murcia;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
30 Murcia;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;93,82
30 Murcia;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
30 Murcia;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
30 Murcia;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;93,1
30 Murcia;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
30 Murcia;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
30 Murcia;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
30 Murcia;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;94,45
30 Murcia;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
30 Murcia;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
30 Murcia;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
30 Murcia;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;92
30 Murcia;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
30 Murcia;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
30 Murcia;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;90,5
30 Murcia;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
30 Murcia;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
30 Murcia;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
30 Murcia;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;92,07
30 Murcia;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
30 Murcia;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
30 Murcia;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
30 Murcia;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;89,59
30 Murcia;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
30 Murcia;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
30 Murcia;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;87,67
30 Murcia;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
30 Murcia;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
30 Murcia;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
30 Murcia;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;89,59
30 Murcia;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
30 Murcia;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
30 Murcia;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
30 Murcia;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;87,35
30 Murcia;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
30 Murcia;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
30 Murcia;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
30 Murcia;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
30 Murcia;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
30 Murcia;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
30 Murcia;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QI;58.869
30 Murcia;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
30 Murcia;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
30 Murcia;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
30 Murcia;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QI;58.183
30 Murcia;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
30 Murcia;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
30 Murcia;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
30 Murcia;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QI;58.082
30 Murcia;All ages;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
30 Murcia;All ages;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
30 Murcia;All ages;Cohort January 1;Males;Survival in the first trimester;2022QII;""
30 Murcia;All ages;Cohort January 1;Males;Survival in the first trimester;2022QI;56.965
30 Murcia;All ages;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
30 Murcia;All ages;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
30 Murcia;All ages;Cohort January 1;Males;Survival in the first trimester;2021QII;""
30 Murcia;All ages;Cohort January 1;Males;Survival in the first trimester;2021QI;56.764
30 Murcia;All ages;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
30 Murcia;All ages;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
30 Murcia;All ages;Cohort January 1;Males;Survival in the first trimester;2020QII;""
30 Murcia;All ages;Cohort January 1;Males;Survival in the first trimester;2020QI;54.737
30 Murcia;All ages;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
30 Murcia;All ages;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
30 Murcia;All ages;Cohort January 1;Males;Survival in the second trimester;2022QII;55.179
30 Murcia;All ages;Cohort January 1;Males;Survival in the second trimester;2022QI;""
30 Murcia;All ages;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
30 Murcia;All ages;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
30 Murcia;All ages;Cohort January 1;Males;Survival in the second trimester;2021QII;55.136
30 Murcia;All ages;Cohort January 1;Males;Survival in the second trimester;2021QI;""
30 Murcia;All ages;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
30 Murcia;All ages;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
30 Murcia;All ages;Cohort January 1;Males;Survival in the second trimester;2020QII;53.749
30 Murcia;All ages;Cohort January 1;Males;Survival in the second trimester;2020QI;""
30 Murcia;All ages;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
30 Murcia;All ages;Cohort January 1;Males;Survival in the third trimester;2022QIII;53.727
30 Murcia;All ages;Cohort January 1;Males;Survival in the third trimester;2022QII;""
30 Murcia;All ages;Cohort January 1;Males;Survival in the third trimester;2022QI;""
30 Murcia;All ages;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
30 Murcia;All ages;Cohort January 1;Males;Survival in the third trimester;2021QIII;53.843
30 Murcia;All ages;Cohort January 1;Males;Survival in the third trimester;2021QII;""
30 Murcia;All ages;Cohort January 1;Males;Survival in the third trimester;2021QI;""
30 Murcia;All ages;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
30 Murcia;All ages;Cohort January 1;Males;Survival in the third trimester;2020QIII;52.497
30 Murcia;All ages;Cohort January 1;Males;Survival in the third trimester;2020QII;""
30 Murcia;All ages;Cohort January 1;Males;Survival in the third trimester;2020QI;""
30 Murcia;All ages;Cohort January 1;Males;Survival in the third trimester;2022QIV;52.129
30 Murcia;All ages;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
30 Murcia;All ages;Cohort January 1;Males;Survival in the third trimester;2022QII;""
30 Murcia;All ages;Cohort January 1;Males;Survival in the third trimester;2022QI;""
30 Murcia;All ages;Cohort January 1;Males;Survival in the third trimester;2021QIV;52.443
30 Murcia;All ages;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
30 Murcia;All ages;Cohort January 1;Males;Survival in the third trimester;2021QII;""
30 Murcia;All ages;Cohort January 1;Males;Survival in the third trimester;2021QI;""
30 Murcia;All ages;Cohort January 1;Males;Survival in the third trimester;2020QIV;51.261
30 Murcia;All ages;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
30 Murcia;All ages;Cohort January 1;Males;Survival in the third trimester;2020QII;""
30 Murcia;All ages;Cohort January 1;Males;Survival in the third trimester;2020QI;""
30 Murcia;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
30 Murcia;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
30 Murcia;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
30 Murcia;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
30 Murcia;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
30 Murcia;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
30 Murcia;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
30 Murcia;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
30 Murcia;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
30 Murcia;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
30 Murcia;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
30 Murcia;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
30 Murcia;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
30 Murcia;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
30 Murcia;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
30 Murcia;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;96,77
30 Murcia;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
30 Murcia;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
30 Murcia;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
30 Murcia;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;97,56
30 Murcia;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
30 Murcia;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
30 Murcia;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
30 Murcia;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;94,24
30 Murcia;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
30 Murcia;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
30 Murcia;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;93,73
30 Murcia;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
30 Murcia;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
30 Murcia;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
30 Murcia;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;94,76
30 Murcia;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
30 Murcia;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
30 Murcia;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
30 Murcia;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;92,54
30 Murcia;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
30 Murcia;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
30 Murcia;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;91,27
30 Murcia;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
30 Murcia;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
30 Murcia;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
30 Murcia;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;92,54
30 Murcia;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
30 Murcia;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
30 Murcia;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
30 Murcia;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;90,38
30 Murcia;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
30 Murcia;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
30 Murcia;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;88,55
30 Murcia;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
30 Murcia;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
30 Murcia;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
30 Murcia;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;90,13
30 Murcia;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
30 Murcia;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
30 Murcia;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
30 Murcia;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;88,26
30 Murcia;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
30 Murcia;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
30 Murcia;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
30 Murcia;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
30 Murcia;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
30 Murcia;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
30 Murcia;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QI;33.749
30 Murcia;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
30 Murcia;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
30 Murcia;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
30 Murcia;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QI;32.678
30 Murcia;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
30 Murcia;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
30 Murcia;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
30 Murcia;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QI;32.698
30 Murcia;All ages;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
30 Murcia;All ages;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
30 Murcia;All ages;Cohort January 1;Females;Survival in the first trimester;2022QII;""
30 Murcia;All ages;Cohort January 1;Females;Survival in the first trimester;2022QI;32.409
30 Murcia;All ages;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
30 Murcia;All ages;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
30 Murcia;All ages;Cohort January 1;Females;Survival in the first trimester;2021QII;""
30 Murcia;All ages;Cohort January 1;Females;Survival in the first trimester;2021QI;31.749
30 Murcia;All ages;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
30 Murcia;All ages;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
30 Murcia;All ages;Cohort January 1;Females;Survival in the first trimester;2020QII;""
30 Murcia;All ages;Cohort January 1;Females;Survival in the first trimester;2020QI;30.430
30 Murcia;All ages;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
30 Murcia;All ages;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
30 Murcia;All ages;Cohort January 1;Females;Survival in the second trimester;2022QII;31.052
30 Murcia;All ages;Cohort January 1;Females;Survival in the second trimester;2022QI;""
30 Murcia;All ages;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
30 Murcia;All ages;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
30 Murcia;All ages;Cohort January 1;Females;Survival in the second trimester;2021QII;30.679
30 Murcia;All ages;Cohort January 1;Females;Survival in the second trimester;2021QI;""
30 Murcia;All ages;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
30 Murcia;All ages;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
30 Murcia;All ages;Cohort January 1;Females;Survival in the second trimester;2020QII;29.769
30 Murcia;All ages;Cohort January 1;Females;Survival in the second trimester;2020QI;""
30 Murcia;All ages;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
30 Murcia;All ages;Cohort January 1;Females;Survival in the third trimester;2022QIII;30.090
30 Murcia;All ages;Cohort January 1;Females;Survival in the third trimester;2022QII;""
30 Murcia;All ages;Cohort January 1;Females;Survival in the third trimester;2022QI;""
30 Murcia;All ages;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
30 Murcia;All ages;Cohort January 1;Females;Survival in the third trimester;2021QIII;29.816
30 Murcia;All ages;Cohort January 1;Females;Survival in the third trimester;2021QII;""
30 Murcia;All ages;Cohort January 1;Females;Survival in the third trimester;2021QI;""
30 Murcia;All ages;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
30 Murcia;All ages;Cohort January 1;Females;Survival in the third trimester;2020QIII;28.830
30 Murcia;All ages;Cohort January 1;Females;Survival in the third trimester;2020QII;""
30 Murcia;All ages;Cohort January 1;Females;Survival in the third trimester;2020QI;""
30 Murcia;All ages;Cohort January 1;Females;Survival in the third trimester;2022QIV;29.065
30 Murcia;All ages;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
30 Murcia;All ages;Cohort January 1;Females;Survival in the third trimester;2022QII;""
30 Murcia;All ages;Cohort January 1;Females;Survival in the third trimester;2022QI;""
30 Murcia;All ages;Cohort January 1;Females;Survival in the third trimester;2021QIV;28.955
30 Murcia;All ages;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
30 Murcia;All ages;Cohort January 1;Females;Survival in the third trimester;2021QII;""
30 Murcia;All ages;Cohort January 1;Females;Survival in the third trimester;2021QI;""
30 Murcia;All ages;Cohort January 1;Females;Survival in the third trimester;2020QIV;28.031
30 Murcia;All ages;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
30 Murcia;All ages;Cohort January 1;Females;Survival in the third trimester;2020QII;""
30 Murcia;All ages;Cohort January 1;Females;Survival in the third trimester;2020QI;""
30 Murcia;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
30 Murcia;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
30 Murcia;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
30 Murcia;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
30 Murcia;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
30 Murcia;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
30 Murcia;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
30 Murcia;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
30 Murcia;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
30 Murcia;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
30 Murcia;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
30 Murcia;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
30 Murcia;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
30 Murcia;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
30 Murcia;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
30 Murcia;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;96,03
30 Murcia;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
30 Murcia;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
30 Murcia;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
30 Murcia;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;97,16
30 Murcia;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
30 Murcia;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
30 Murcia;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
30 Murcia;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;93,06
30 Murcia;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
30 Murcia;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
30 Murcia;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;92,01
30 Murcia;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
30 Murcia;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
30 Murcia;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
30 Murcia;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;93,88
30 Murcia;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
30 Murcia;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
30 Murcia;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
30 Murcia;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;91,04
30 Murcia;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
30 Murcia;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
30 Murcia;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;89,16
30 Murcia;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
30 Murcia;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
30 Murcia;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
30 Murcia;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;91,24
30 Murcia;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
30 Murcia;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
30 Murcia;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
30 Murcia;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;88,17
30 Murcia;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
30 Murcia;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
30 Murcia;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;86,12
30 Murcia;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
30 Murcia;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
30 Murcia;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
30 Murcia;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;88,61
30 Murcia;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
30 Murcia;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
30 Murcia;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
30 Murcia;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;85,73
30 Murcia;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
30 Murcia;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
30 Murcia;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
30 Murcia;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
30 Murcia;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
30 Murcia;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QII;92.789
30 Murcia;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
30 Murcia;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
30 Murcia;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
30 Murcia;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QII;91.953
30 Murcia;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
30 Murcia;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
30 Murcia;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
30 Murcia;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QII;89.191
30 Murcia;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
30 Murcia;All ages;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
30 Murcia;All ages;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
30 Murcia;All ages;Cohort April 1;Total;Survival in the first trimester;2022QII;89.311
30 Murcia;All ages;Cohort April 1;Total;Survival in the first trimester;2022QI;""
30 Murcia;All ages;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
30 Murcia;All ages;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
30 Murcia;All ages;Cohort April 1;Total;Survival in the first trimester;2021QII;88.885
30 Murcia;All ages;Cohort April 1;Total;Survival in the first trimester;2021QI;""
30 Murcia;All ages;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
30 Murcia;All ages;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
30 Murcia;All ages;Cohort April 1;Total;Survival in the first trimester;2020QII;87.336
30 Murcia;All ages;Cohort April 1;Total;Survival in the first trimester;2020QI;""
30 Murcia;All ages;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
30 Murcia;All ages;Cohort April 1;Total;Survival in the second trimester;2022QIII;86.687
30 Murcia;All ages;Cohort April 1;Total;Survival in the second trimester;2022QII;""
30 Murcia;All ages;Cohort April 1;Total;Survival in the second trimester;2022QI;""
30 Murcia;All ages;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
30 Murcia;All ages;Cohort April 1;Total;Survival in the second trimester;2021QIII;86.481
30 Murcia;All ages;Cohort April 1;Total;Survival in the second trimester;2021QII;""
30 Murcia;All ages;Cohort April 1;Total;Survival in the second trimester;2021QI;""
30 Murcia;All ages;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
30 Murcia;All ages;Cohort April 1;Total;Survival in the second trimester;2020QIII;84.800
30 Murcia;All ages;Cohort April 1;Total;Survival in the second trimester;2020QII;""
30 Murcia;All ages;Cohort April 1;Total;Survival in the second trimester;2020QI;""
30 Murcia;All ages;Cohort April 1;Total;Survival in the third trimester;2022QIV;83.819
30 Murcia;All ages;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
30 Murcia;All ages;Cohort April 1;Total;Survival in the third trimester;2022QII;""
30 Murcia;All ages;Cohort April 1;Total;Survival in the third trimester;2022QI;""
30 Murcia;All ages;Cohort April 1;Total;Survival in the third trimester;2021QIV;83.983
30 Murcia;All ages;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
30 Murcia;All ages;Cohort April 1;Total;Survival in the third trimester;2021QII;""
30 Murcia;All ages;Cohort April 1;Total;Survival in the third trimester;2021QI;""
30 Murcia;All ages;Cohort April 1;Total;Survival in the third trimester;2020QIV;82.539
30 Murcia;All ages;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
30 Murcia;All ages;Cohort April 1;Total;Survival in the third trimester;2020QII;""
30 Murcia;All ages;Cohort April 1;Total;Survival in the third trimester;2020QI;""
30 Murcia;All ages;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
30 Murcia;All ages;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
30 Murcia;All ages;Cohort April 1;Total;Survival in the third trimester;2022QII;""
30 Murcia;All ages;Cohort April 1;Total;Survival in the third trimester;2022QI;81.465
30 Murcia;All ages;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
30 Murcia;All ages;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
30 Murcia;All ages;Cohort April 1;Total;Survival in the third trimester;2021QII;""
30 Murcia;All ages;Cohort April 1;Total;Survival in the third trimester;2021QI;80.776
30 Murcia;All ages;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
30 Murcia;All ages;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
30 Murcia;All ages;Cohort April 1;Total;Survival in the third trimester;2020QII;""
30 Murcia;All ages;Cohort April 1;Total;Survival in the third trimester;2020QI;""
30 Murcia;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
30 Murcia;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
30 Murcia;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
30 Murcia;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
30 Murcia;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
30 Murcia;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
30 Murcia;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
30 Murcia;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
30 Murcia;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
30 Murcia;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
30 Murcia;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
30 Murcia;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
30 Murcia;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
30 Murcia;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
30 Murcia;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;96,25
30 Murcia;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
30 Murcia;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
30 Murcia;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
30 Murcia;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;96,66
30 Murcia;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
30 Murcia;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
30 Murcia;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
30 Murcia;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;97,92
30 Murcia;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
30 Murcia;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
30 Murcia;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;93,42
30 Murcia;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
30 Murcia;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
30 Murcia;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
30 Murcia;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;94,05
30 Murcia;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
30 Murcia;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
30 Murcia;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
30 Murcia;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;95,08
30 Murcia;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
30 Murcia;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
30 Murcia;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;90,33
30 Murcia;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
30 Murcia;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
30 Murcia;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
30 Murcia;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;91,33
30 Murcia;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
30 Murcia;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
30 Murcia;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
30 Murcia;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;92,54
30 Murcia;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
30 Murcia;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
30 Murcia;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
30 Murcia;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
30 Murcia;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
30 Murcia;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
30 Murcia;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;88,59
30 Murcia;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
30 Murcia;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
30 Murcia;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
30 Murcia;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;90,57
30 Murcia;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
30 Murcia;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
30 Murcia;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
30 Murcia;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
30 Murcia;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
30 Murcia;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
30 Murcia;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QII;58.951
30 Murcia;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
30 Murcia;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
30 Murcia;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
30 Murcia;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QII;58.841
30 Murcia;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
30 Murcia;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
30 Murcia;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
30 Murcia;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QII;57.209
30 Murcia;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
30 Murcia;All ages;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
30 Murcia;All ages;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
30 Murcia;All ages;Cohort April 1;Males;Survival in the first trimester;2022QII;56.959
30 Murcia;All ages;Cohort April 1;Males;Survival in the first trimester;2022QI;""
30 Murcia;All ages;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
30 Murcia;All ages;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
30 Murcia;All ages;Cohort April 1;Males;Survival in the first trimester;2021QII;56.973
30 Murcia;All ages;Cohort April 1;Males;Survival in the first trimester;2021QI;""
30 Murcia;All ages;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
30 Murcia;All ages;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
30 Murcia;All ages;Cohort April 1;Males;Survival in the first trimester;2020QII;56.088
30 Murcia;All ages;Cohort April 1;Males;Survival in the first trimester;2020QI;""
30 Murcia;All ages;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
30 Murcia;All ages;Cohort April 1;Males;Survival in the second trimester;2022QIII;55.372
30 Murcia;All ages;Cohort April 1;Males;Survival in the second trimester;2022QII;""
30 Murcia;All ages;Cohort April 1;Males;Survival in the second trimester;2022QI;""
30 Murcia;All ages;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
30 Murcia;All ages;Cohort April 1;Males;Survival in the second trimester;2021QIII;55.529
30 Murcia;All ages;Cohort April 1;Males;Survival in the second trimester;2021QII;""
30 Murcia;All ages;Cohort April 1;Males;Survival in the second trimester;2021QI;""
30 Murcia;All ages;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
30 Murcia;All ages;Cohort April 1;Males;Survival in the second trimester;2020QIII;54.597
30 Murcia;All ages;Cohort April 1;Males;Survival in the second trimester;2020QII;""
30 Murcia;All ages;Cohort April 1;Males;Survival in the second trimester;2020QI;""
30 Murcia;All ages;Cohort April 1;Males;Survival in the third trimester;2022QIV;53.620
30 Murcia;All ages;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
30 Murcia;All ages;Cohort April 1;Males;Survival in the third trimester;2022QII;""
30 Murcia;All ages;Cohort April 1;Males;Survival in the third trimester;2022QI;""
30 Murcia;All ages;Cohort April 1;Males;Survival in the third trimester;2021QIV;53.978
30 Murcia;All ages;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
30 Murcia;All ages;Cohort April 1;Males;Survival in the third trimester;2021QII;""
30 Murcia;All ages;Cohort April 1;Males;Survival in the third trimester;2021QI;""
30 Murcia;All ages;Cohort April 1;Males;Survival in the third trimester;2020QIV;53.217
30 Murcia;All ages;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
30 Murcia;All ages;Cohort April 1;Males;Survival in the third trimester;2020QII;""
30 Murcia;All ages;Cohort April 1;Males;Survival in the third trimester;2020QI;""
30 Murcia;All ages;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
30 Murcia;All ages;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
30 Murcia;All ages;Cohort April 1;Males;Survival in the third trimester;2022QII;""
30 Murcia;All ages;Cohort April 1;Males;Survival in the third trimester;2022QI;52.525
30 Murcia;All ages;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
30 Murcia;All ages;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
30 Murcia;All ages;Cohort April 1;Males;Survival in the third trimester;2021QII;""
30 Murcia;All ages;Cohort April 1;Males;Survival in the third trimester;2021QI;52.164
30 Murcia;All ages;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
30 Murcia;All ages;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
30 Murcia;All ages;Cohort April 1;Males;Survival in the third trimester;2020QII;""
30 Murcia;All ages;Cohort April 1;Males;Survival in the third trimester;2020QI;""
30 Murcia;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
30 Murcia;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
30 Murcia;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
30 Murcia;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
30 Murcia;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
30 Murcia;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
30 Murcia;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
30 Murcia;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
30 Murcia;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
30 Murcia;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
30 Murcia;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
30 Murcia;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
30 Murcia;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
30 Murcia;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
30 Murcia;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;96,62
30 Murcia;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
30 Murcia;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
30 Murcia;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
30 Murcia;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;96,83
30 Murcia;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
30 Murcia;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
30 Murcia;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
30 Murcia;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;98,04
30 Murcia;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
30 Murcia;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
30 Murcia;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;93,93
30 Murcia;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
30 Murcia;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
30 Murcia;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
30 Murcia;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;94,37
30 Murcia;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
30 Murcia;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
30 Murcia;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
30 Murcia;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;95,43
30 Murcia;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
30 Murcia;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
30 Murcia;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;90,96
30 Murcia;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
30 Murcia;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
30 Murcia;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
30 Murcia;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;91,74
30 Murcia;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
30 Murcia;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
30 Murcia;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
30 Murcia;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;93,02
30 Murcia;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
30 Murcia;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
30 Murcia;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
30 Murcia;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
30 Murcia;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
30 Murcia;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
30 Murcia;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;89,27
30 Murcia;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
30 Murcia;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
30 Murcia;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
30 Murcia;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;91,18
30 Murcia;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
30 Murcia;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
30 Murcia;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
30 Murcia;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
30 Murcia;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
30 Murcia;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
30 Murcia;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QII;33.838
30 Murcia;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
30 Murcia;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
30 Murcia;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
30 Murcia;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QII;33.112
30 Murcia;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
30 Murcia;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
30 Murcia;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
30 Murcia;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QII;31.982
30 Murcia;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
30 Murcia;All ages;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
30 Murcia;All ages;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
30 Murcia;All ages;Cohort April 1;Females;Survival in the first trimester;2022QII;32.352
30 Murcia;All ages;Cohort April 1;Females;Survival in the first trimester;2022QI;""
30 Murcia;All ages;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
30 Murcia;All ages;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
30 Murcia;All ages;Cohort April 1;Females;Survival in the first trimester;2021QII;31.912
30 Murcia;All ages;Cohort April 1;Females;Survival in the first trimester;2021QI;""
30 Murcia;All ages;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
30 Murcia;All ages;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
30 Murcia;All ages;Cohort April 1;Females;Survival in the first trimester;2020QII;31.248
30 Murcia;All ages;Cohort April 1;Females;Survival in the first trimester;2020QI;""
30 Murcia;All ages;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
30 Murcia;All ages;Cohort April 1;Females;Survival in the second trimester;2022QIII;31.315
30 Murcia;All ages;Cohort April 1;Females;Survival in the second trimester;2022QII;""
30 Murcia;All ages;Cohort April 1;Females;Survival in the second trimester;2022QI;""
30 Murcia;All ages;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
30 Murcia;All ages;Cohort April 1;Females;Survival in the second trimester;2021QIII;30.952
30 Murcia;All ages;Cohort April 1;Females;Survival in the second trimester;2021QII;""
30 Murcia;All ages;Cohort April 1;Females;Survival in the second trimester;2021QI;""
30 Murcia;All ages;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
30 Murcia;All ages;Cohort April 1;Females;Survival in the second trimester;2020QIII;30.203
30 Murcia;All ages;Cohort April 1;Females;Survival in the second trimester;2020QII;""
30 Murcia;All ages;Cohort April 1;Females;Survival in the second trimester;2020QI;""
30 Murcia;All ages;Cohort April 1;Females;Survival in the third trimester;2022QIV;30.199
30 Murcia;All ages;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
30 Murcia;All ages;Cohort April 1;Females;Survival in the third trimester;2022QII;""
30 Murcia;All ages;Cohort April 1;Females;Survival in the third trimester;2022QI;""
30 Murcia;All ages;Cohort April 1;Females;Survival in the third trimester;2021QIV;30.005
30 Murcia;All ages;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
30 Murcia;All ages;Cohort April 1;Females;Survival in the third trimester;2021QII;""
30 Murcia;All ages;Cohort April 1;Females;Survival in the third trimester;2021QI;""
30 Murcia;All ages;Cohort April 1;Females;Survival in the third trimester;2020QIV;29.322
30 Murcia;All ages;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
30 Murcia;All ages;Cohort April 1;Females;Survival in the third trimester;2020QII;""
30 Murcia;All ages;Cohort April 1;Females;Survival in the third trimester;2020QI;""
30 Murcia;All ages;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
30 Murcia;All ages;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
30 Murcia;All ages;Cohort April 1;Females;Survival in the third trimester;2022QII;""
30 Murcia;All ages;Cohort April 1;Females;Survival in the third trimester;2022QI;28.940
30 Murcia;All ages;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
30 Murcia;All ages;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
30 Murcia;All ages;Cohort April 1;Females;Survival in the third trimester;2021QII;""
30 Murcia;All ages;Cohort April 1;Females;Survival in the third trimester;2021QI;28.612
30 Murcia;All ages;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
30 Murcia;All ages;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
30 Murcia;All ages;Cohort April 1;Females;Survival in the third trimester;2020QII;""
30 Murcia;All ages;Cohort April 1;Females;Survival in the third trimester;2020QI;""
30 Murcia;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
30 Murcia;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
30 Murcia;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
30 Murcia;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
30 Murcia;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
30 Murcia;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
30 Murcia;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
30 Murcia;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
30 Murcia;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
30 Murcia;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
30 Murcia;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
30 Murcia;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
30 Murcia;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
30 Murcia;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
30 Murcia;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;95,61
30 Murcia;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
30 Murcia;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
30 Murcia;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
30 Murcia;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;96,38
30 Murcia;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
30 Murcia;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
30 Murcia;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
30 Murcia;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;97,7
30 Murcia;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
30 Murcia;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
30 Murcia;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;92,54
30 Murcia;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
30 Murcia;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
30 Murcia;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
30 Murcia;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;93,48
30 Murcia;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
30 Murcia;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
30 Murcia;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
30 Murcia;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;94,44
30 Murcia;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
30 Murcia;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
30 Murcia;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;89,25
30 Murcia;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
30 Murcia;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
30 Murcia;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
30 Murcia;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;90,62
30 Murcia;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
30 Murcia;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
30 Murcia;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
30 Murcia;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;91,68
30 Murcia;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
30 Murcia;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
30 Murcia;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
30 Murcia;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
30 Murcia;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
30 Murcia;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
30 Murcia;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;87,4
30 Murcia;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
30 Murcia;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
30 Murcia;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
30 Murcia;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;89,46
30 Murcia;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
30 Murcia;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
30 Murcia;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
30 Murcia;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
30 Murcia;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
30 Murcia;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QIII;92.717
30 Murcia;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
30 Murcia;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
30 Murcia;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
30 Murcia;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QIII;92.407
30 Murcia;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
30 Murcia;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
30 Murcia;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
30 Murcia;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QIII;90.436
30 Murcia;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
30 Murcia;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
30 Murcia;All ages;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
30 Murcia;All ages;Cohort July 1;Total;Survival in the first trimester;2022QIII;89.565
30 Murcia;All ages;Cohort July 1;Total;Survival in the first trimester;2022QII;""
30 Murcia;All ages;Cohort July 1;Total;Survival in the first trimester;2022QI;""
30 Murcia;All ages;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
30 Murcia;All ages;Cohort July 1;Total;Survival in the first trimester;2021QIII;89.503
30 Murcia;All ages;Cohort July 1;Total;Survival in the first trimester;2021QII;""
30 Murcia;All ages;Cohort July 1;Total;Survival in the first trimester;2021QI;""
30 Murcia;All ages;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
30 Murcia;All ages;Cohort July 1;Total;Survival in the first trimester;2020QIII;87.420
30 Murcia;All ages;Cohort July 1;Total;Survival in the first trimester;2020QII;""
30 Murcia;All ages;Cohort July 1;Total;Survival in the first trimester;2020QI;""
30 Murcia;All ages;Cohort July 1;Total;Survival in the second trimester;2022QIV;86.317
30 Murcia;All ages;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
30 Murcia;All ages;Cohort July 1;Total;Survival in the second trimester;2022QII;""
30 Murcia;All ages;Cohort July 1;Total;Survival in the second trimester;2022QI;""
30 Murcia;All ages;Cohort July 1;Total;Survival in the second trimester;2021QIV;86.694
30 Murcia;All ages;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
30 Murcia;All ages;Cohort July 1;Total;Survival in the second trimester;2021QII;""
30 Murcia;All ages;Cohort July 1;Total;Survival in the second trimester;2021QI;""
30 Murcia;All ages;Cohort July 1;Total;Survival in the second trimester;2020QIV;84.901
30 Murcia;All ages;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
30 Murcia;All ages;Cohort July 1;Total;Survival in the second trimester;2020QII;""
30 Murcia;All ages;Cohort July 1;Total;Survival in the second trimester;2020QI;""
30 Murcia;All ages;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
30 Murcia;All ages;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
30 Murcia;All ages;Cohort July 1;Total;Survival in the third trimester;2022QII;""
30 Murcia;All ages;Cohort July 1;Total;Survival in the third trimester;2022QI;83.993
30 Murcia;All ages;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
30 Murcia;All ages;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
30 Murcia;All ages;Cohort July 1;Total;Survival in the third trimester;2021QII;""
30 Murcia;All ages;Cohort July 1;Total;Survival in the third trimester;2021QI;83.009
30 Murcia;All ages;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
30 Murcia;All ages;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
30 Murcia;All ages;Cohort July 1;Total;Survival in the third trimester;2020QII;""
30 Murcia;All ages;Cohort July 1;Total;Survival in the third trimester;2020QI;""
30 Murcia;All ages;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
30 Murcia;All ages;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
30 Murcia;All ages;Cohort July 1;Total;Survival in the third trimester;2022QII;81.403
30 Murcia;All ages;Cohort July 1;Total;Survival in the third trimester;2022QI;""
30 Murcia;All ages;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
30 Murcia;All ages;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
30 Murcia;All ages;Cohort July 1;Total;Survival in the third trimester;2021QII;80.804
30 Murcia;All ages;Cohort July 1;Total;Survival in the third trimester;2021QI;""
30 Murcia;All ages;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
30 Murcia;All ages;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
30 Murcia;All ages;Cohort July 1;Total;Survival in the third trimester;2020QII;""
30 Murcia;All ages;Cohort July 1;Total;Survival in the third trimester;2020QI;""
30 Murcia;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
30 Murcia;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
30 Murcia;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
30 Murcia;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
30 Murcia;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
30 Murcia;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
30 Murcia;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
30 Murcia;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
30 Murcia;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
30 Murcia;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
30 Murcia;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
30 Murcia;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
30 Murcia;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
30 Murcia;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;96,6
30 Murcia;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
30 Murcia;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
30 Murcia;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
30 Murcia;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;96,86
30 Murcia;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
30 Murcia;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
30 Murcia;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
30 Murcia;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;96,67
30 Murcia;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
30 Murcia;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
30 Murcia;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;93,1
30 Murcia;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
30 Murcia;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
30 Murcia;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
30 Murcia;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;93,82
30 Murcia;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
30 Murcia;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
30 Murcia;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
30 Murcia;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;93,88
30 Murcia;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
30 Murcia;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
30 Murcia;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
30 Murcia;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
30 Murcia;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
30 Murcia;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
30 Murcia;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;90,89
30 Murcia;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
30 Murcia;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
30 Murcia;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
30 Murcia;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;91,79
30 Murcia;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
30 Murcia;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
30 Murcia;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
30 Murcia;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
30 Murcia;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
30 Murcia;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
30 Murcia;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;88,09
30 Murcia;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
30 Murcia;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
30 Murcia;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
30 Murcia;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;89,35
30 Murcia;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
30 Murcia;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
30 Murcia;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
30 Murcia;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
30 Murcia;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
30 Murcia;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
30 Murcia;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QIII;58.933
30 Murcia;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
30 Murcia;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
30 Murcia;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
30 Murcia;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QIII;59.014
30 Murcia;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
30 Murcia;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
30 Murcia;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
30 Murcia;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QIII;58.061
30 Murcia;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
30 Murcia;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
30 Murcia;All ages;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
30 Murcia;All ages;Cohort July 1;Males;Survival in the first trimester;2022QIII;57.042
30 Murcia;All ages;Cohort July 1;Males;Survival in the first trimester;2022QII;""
30 Murcia;All ages;Cohort July 1;Males;Survival in the first trimester;2022QI;""
30 Murcia;All ages;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
30 Murcia;All ages;Cohort July 1;Males;Survival in the first trimester;2021QIII;57.281
30 Murcia;All ages;Cohort July 1;Males;Survival in the first trimester;2021QII;""
30 Murcia;All ages;Cohort July 1;Males;Survival in the first trimester;2021QI;""
30 Murcia;All ages;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
30 Murcia;All ages;Cohort July 1;Males;Survival in the first trimester;2020QIII;56.271
30 Murcia;All ages;Cohort July 1;Males;Survival in the first trimester;2020QII;""
30 Murcia;All ages;Cohort July 1;Males;Survival in the first trimester;2020QI;""
30 Murcia;All ages;Cohort July 1;Males;Survival in the second trimester;2022QIV;55.056
30 Murcia;All ages;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
30 Murcia;All ages;Cohort July 1;Males;Survival in the second trimester;2022QII;""
30 Murcia;All ages;Cohort July 1;Males;Survival in the second trimester;2022QI;""
30 Murcia;All ages;Cohort July 1;Males;Survival in the second trimester;2021QIV;55.558
30 Murcia;All ages;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
30 Murcia;All ages;Cohort July 1;Males;Survival in the second trimester;2021QII;""
30 Murcia;All ages;Cohort July 1;Males;Survival in the second trimester;2021QI;""
30 Murcia;All ages;Cohort July 1;Males;Survival in the second trimester;2020QIV;54.717
30 Murcia;All ages;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
30 Murcia;All ages;Cohort July 1;Males;Survival in the second trimester;2020QII;""
30 Murcia;All ages;Cohort July 1;Males;Survival in the second trimester;2020QI;""
30 Murcia;All ages;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
30 Murcia;All ages;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
30 Murcia;All ages;Cohort July 1;Males;Survival in the third trimester;2022QII;""
30 Murcia;All ages;Cohort July 1;Males;Survival in the third trimester;2022QI;53.986
30 Murcia;All ages;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
30 Murcia;All ages;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
30 Murcia;All ages;Cohort July 1;Males;Survival in the third trimester;2021QII;""
30 Murcia;All ages;Cohort July 1;Males;Survival in the third trimester;2021QI;53.579
30 Murcia;All ages;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
30 Murcia;All ages;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
30 Murcia;All ages;Cohort July 1;Males;Survival in the third trimester;2020QII;""
30 Murcia;All ages;Cohort July 1;Males;Survival in the third trimester;2020QI;""
30 Murcia;All ages;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
30 Murcia;All ages;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
30 Murcia;All ages;Cohort July 1;Males;Survival in the third trimester;2022QII;52.488
30 Murcia;All ages;Cohort July 1;Males;Survival in the third trimester;2022QI;""
30 Murcia;All ages;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
30 Murcia;All ages;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
30 Murcia;All ages;Cohort July 1;Males;Survival in the third trimester;2021QII;52.233
30 Murcia;All ages;Cohort July 1;Males;Survival in the third trimester;2021QI;""
30 Murcia;All ages;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
30 Murcia;All ages;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
30 Murcia;All ages;Cohort July 1;Males;Survival in the third trimester;2020QII;""
30 Murcia;All ages;Cohort July 1;Males;Survival in the third trimester;2020QI;""
30 Murcia;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
30 Murcia;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
30 Murcia;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
30 Murcia;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
30 Murcia;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
30 Murcia;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
30 Murcia;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
30 Murcia;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
30 Murcia;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
30 Murcia;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
30 Murcia;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
30 Murcia;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
30 Murcia;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
30 Murcia;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;96,79
30 Murcia;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
30 Murcia;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
30 Murcia;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
30 Murcia;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;97,06
30 Murcia;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
30 Murcia;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
30 Murcia;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
30 Murcia;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;96,92
30 Murcia;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
30 Murcia;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
30 Murcia;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;93,42
30 Murcia;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
30 Murcia;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
30 Murcia;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
30 Murcia;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;94,14
30 Murcia;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
30 Murcia;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
30 Murcia;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
30 Murcia;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;94,24
30 Murcia;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
30 Murcia;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
30 Murcia;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
30 Murcia;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
30 Murcia;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
30 Murcia;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
30 Murcia;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;91,48
30 Murcia;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
30 Murcia;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
30 Murcia;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
30 Murcia;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;92,28
30 Murcia;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
30 Murcia;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
30 Murcia;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
30 Murcia;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
30 Murcia;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
30 Murcia;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
30 Murcia;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;88,94
30 Murcia;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
30 Murcia;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
30 Murcia;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
30 Murcia;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;89,96
30 Murcia;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
30 Murcia;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
30 Murcia;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
30 Murcia;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
30 Murcia;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
30 Murcia;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
30 Murcia;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QIII;33.784
30 Murcia;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
30 Murcia;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
30 Murcia;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
30 Murcia;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QIII;33.393
30 Murcia;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
30 Murcia;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
30 Murcia;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
30 Murcia;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QIII;32.375
30 Murcia;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
30 Murcia;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
30 Murcia;All ages;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
30 Murcia;All ages;Cohort July 1;Females;Survival in the first trimester;2022QIII;32.523
30 Murcia;All ages;Cohort July 1;Females;Survival in the first trimester;2022QII;""
30 Murcia;All ages;Cohort July 1;Females;Survival in the first trimester;2022QI;""
30 Murcia;All ages;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
30 Murcia;All ages;Cohort July 1;Females;Survival in the first trimester;2021QIII;32.222
30 Murcia;All ages;Cohort July 1;Females;Survival in the first trimester;2021QII;""
30 Murcia;All ages;Cohort July 1;Females;Survival in the first trimester;2021QI;""
30 Murcia;All ages;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
30 Murcia;All ages;Cohort July 1;Females;Survival in the first trimester;2020QIII;31.149
30 Murcia;All ages;Cohort July 1;Females;Survival in the first trimester;2020QII;""
30 Murcia;All ages;Cohort July 1;Females;Survival in the first trimester;2020QI;""
30 Murcia;All ages;Cohort July 1;Females;Survival in the second trimester;2022QIV;31.261
30 Murcia;All ages;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
30 Murcia;All ages;Cohort July 1;Females;Survival in the second trimester;2022QII;""
30 Murcia;All ages;Cohort July 1;Females;Survival in the second trimester;2022QI;""
30 Murcia;All ages;Cohort July 1;Females;Survival in the second trimester;2021QIV;31.136
30 Murcia;All ages;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
30 Murcia;All ages;Cohort July 1;Females;Survival in the second trimester;2021QII;""
30 Murcia;All ages;Cohort July 1;Females;Survival in the second trimester;2021QI;""
30 Murcia;All ages;Cohort July 1;Females;Survival in the second trimester;2020QIV;30.184
30 Murcia;All ages;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
30 Murcia;All ages;Cohort July 1;Females;Survival in the second trimester;2020QII;""
30 Murcia;All ages;Cohort July 1;Females;Survival in the second trimester;2020QI;""
30 Murcia;All ages;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
30 Murcia;All ages;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
30 Murcia;All ages;Cohort July 1;Females;Survival in the third trimester;2022QII;""
30 Murcia;All ages;Cohort July 1;Females;Survival in the third trimester;2022QI;30.007
30 Murcia;All ages;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
30 Murcia;All ages;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
30 Murcia;All ages;Cohort July 1;Females;Survival in the third trimester;2021QII;""
30 Murcia;All ages;Cohort July 1;Females;Survival in the third trimester;2021QI;29.430
30 Murcia;All ages;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
30 Murcia;All ages;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
30 Murcia;All ages;Cohort July 1;Females;Survival in the third trimester;2020QII;""
30 Murcia;All ages;Cohort July 1;Females;Survival in the third trimester;2020QI;""
30 Murcia;All ages;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
30 Murcia;All ages;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
30 Murcia;All ages;Cohort July 1;Females;Survival in the third trimester;2022QII;28.915
30 Murcia;All ages;Cohort July 1;Females;Survival in the third trimester;2022QI;""
30 Murcia;All ages;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
30 Murcia;All ages;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
30 Murcia;All ages;Cohort July 1;Females;Survival in the third trimester;2021QII;28.571
30 Murcia;All ages;Cohort July 1;Females;Survival in the third trimester;2021QI;""
30 Murcia;All ages;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
30 Murcia;All ages;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
30 Murcia;All ages;Cohort July 1;Females;Survival in the third trimester;2020QII;""
30 Murcia;All ages;Cohort July 1;Females;Survival in the third trimester;2020QI;""
30 Murcia;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
30 Murcia;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
30 Murcia;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
30 Murcia;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
30 Murcia;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
30 Murcia;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
30 Murcia;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
30 Murcia;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
30 Murcia;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
30 Murcia;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
30 Murcia;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
30 Murcia;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
30 Murcia;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
30 Murcia;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;96,27
30 Murcia;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
30 Murcia;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
30 Murcia;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
30 Murcia;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;96,49
30 Murcia;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
30 Murcia;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
30 Murcia;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
30 Murcia;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;96,21
30 Murcia;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
30 Murcia;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
30 Murcia;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;92,53
30 Murcia;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
30 Murcia;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
30 Murcia;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
30 Murcia;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;93,24
30 Murcia;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
30 Murcia;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
30 Murcia;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
30 Murcia;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;93,23
30 Murcia;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
30 Murcia;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
30 Murcia;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
30 Murcia;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
30 Murcia;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
30 Murcia;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
30 Murcia;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;89,86
30 Murcia;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
30 Murcia;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
30 Murcia;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
30 Murcia;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;90,9
30 Murcia;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
30 Murcia;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
30 Murcia;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
30 Murcia;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
30 Murcia;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
30 Murcia;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
30 Murcia;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;86,59
30 Murcia;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
30 Murcia;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
30 Murcia;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
30 Murcia;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;88,25
30 Murcia;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
30 Murcia;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
30 Murcia;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
30 Murcia;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
30 Murcia;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
30 Murcia;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QIV;92.573
30 Murcia;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
30 Murcia;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
30 Murcia;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
30 Murcia;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QIV;92.435
30 Murcia;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
30 Murcia;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
30 Murcia;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
30 Murcia;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QIV;90.379
30 Murcia;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
30 Murcia;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
30 Murcia;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
30 Murcia;All ages;Cohort October 1;Total;Survival in the first trimester;2022QIV;88.963
30 Murcia;All ages;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
30 Murcia;All ages;Cohort October 1;Total;Survival in the first trimester;2022QII;""
30 Murcia;All ages;Cohort October 1;Total;Survival in the first trimester;2022QI;""
30 Murcia;All ages;Cohort October 1;Total;Survival in the first trimester;2021QIV;89.278
30 Murcia;All ages;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
30 Murcia;All ages;Cohort October 1;Total;Survival in the first trimester;2021QII;""
30 Murcia;All ages;Cohort October 1;Total;Survival in the first trimester;2021QI;""
30 Murcia;All ages;Cohort October 1;Total;Survival in the first trimester;2020QIV;87.539
30 Murcia;All ages;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
30 Murcia;All ages;Cohort October 1;Total;Survival in the first trimester;2020QII;""
30 Murcia;All ages;Cohort October 1;Total;Survival in the first trimester;2020QI;""
30 Murcia;All ages;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
30 Murcia;All ages;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
30 Murcia;All ages;Cohort October 1;Total;Survival in the second trimester;2022QII;""
30 Murcia;All ages;Cohort October 1;Total;Survival in the second trimester;2022QI;86.384
30 Murcia;All ages;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
30 Murcia;All ages;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
30 Murcia;All ages;Cohort October 1;Total;Survival in the second trimester;2021QII;""
30 Murcia;All ages;Cohort October 1;Total;Survival in the second trimester;2021QI;85.471
30 Murcia;All ages;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
30 Murcia;All ages;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
30 Murcia;All ages;Cohort October 1;Total;Survival in the second trimester;2020QII;""
30 Murcia;All ages;Cohort October 1;Total;Survival in the second trimester;2020QI;""
30 Murcia;All ages;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
30 Murcia;All ages;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
30 Murcia;All ages;Cohort October 1;Total;Survival in the third trimester;2022QII;83.572
30 Murcia;All ages;Cohort October 1;Total;Survival in the third trimester;2022QI;""
30 Murcia;All ages;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
30 Murcia;All ages;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
30 Murcia;All ages;Cohort October 1;Total;Survival in the third trimester;2021QII;83.062
30 Murcia;All ages;Cohort October 1;Total;Survival in the third trimester;2021QI;""
30 Murcia;All ages;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
30 Murcia;All ages;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
30 Murcia;All ages;Cohort October 1;Total;Survival in the third trimester;2020QII;""
30 Murcia;All ages;Cohort October 1;Total;Survival in the third trimester;2020QI;""
30 Murcia;All ages;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
30 Murcia;All ages;Cohort October 1;Total;Survival in the third trimester;2022QIII;81.348
30 Murcia;All ages;Cohort October 1;Total;Survival in the third trimester;2022QII;""
30 Murcia;All ages;Cohort October 1;Total;Survival in the third trimester;2022QI;""
30 Murcia;All ages;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
30 Murcia;All ages;Cohort October 1;Total;Survival in the third trimester;2021QIII;81.113
30 Murcia;All ages;Cohort October 1;Total;Survival in the third trimester;2021QII;""
30 Murcia;All ages;Cohort October 1;Total;Survival in the third trimester;2021QI;""
30 Murcia;All ages;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
30 Murcia;All ages;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
30 Murcia;All ages;Cohort October 1;Total;Survival in the third trimester;2020QII;""
30 Murcia;All ages;Cohort October 1;Total;Survival in the third trimester;2020QI;""
30 Murcia;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
30 Murcia;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
30 Murcia;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
30 Murcia;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
30 Murcia;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
30 Murcia;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
30 Murcia;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
30 Murcia;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
30 Murcia;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
30 Murcia;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
30 Murcia;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
30 Murcia;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
30 Murcia;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;96,1
30 Murcia;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
30 Murcia;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
30 Murcia;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
30 Murcia;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;96,58
30 Murcia;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
30 Murcia;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
30 Murcia;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
30 Murcia;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;96,86
30 Murcia;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
30 Murcia;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
30 Murcia;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
30 Murcia;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
30 Murcia;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
30 Murcia;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
30 Murcia;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;93,45
30 Murcia;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
30 Murcia;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
30 Murcia;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
30 Murcia;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;94,57
30 Murcia;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
30 Murcia;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
30 Murcia;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
30 Murcia;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
30 Murcia;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
30 Murcia;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
30 Murcia;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;90,41
30 Murcia;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
30 Murcia;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
30 Murcia;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
30 Murcia;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;91,9
30 Murcia;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
30 Murcia;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
30 Murcia;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
30 Murcia;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
30 Murcia;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
30 Murcia;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
30 Murcia;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;88,01
30 Murcia;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
30 Murcia;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
30 Murcia;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
30 Murcia;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;89,75
30 Murcia;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
30 Murcia;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
30 Murcia;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
30 Murcia;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
30 Murcia;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
30 Murcia;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
30 Murcia;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QIV;58.757
30 Murcia;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
30 Murcia;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
30 Murcia;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
30 Murcia;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QIV;58.952
30 Murcia;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
30 Murcia;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
30 Murcia;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
30 Murcia;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QIV;57.981
30 Murcia;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
30 Murcia;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
30 Murcia;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
30 Murcia;All ages;Cohort October 1;Males;Survival in the first trimester;2022QIV;56.550
30 Murcia;All ages;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
30 Murcia;All ages;Cohort October 1;Males;Survival in the first trimester;2022QII;""
30 Murcia;All ages;Cohort October 1;Males;Survival in the first trimester;2022QI;""
30 Murcia;All ages;Cohort October 1;Males;Survival in the first trimester;2021QIV;57.014
30 Murcia;All ages;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
30 Murcia;All ages;Cohort October 1;Males;Survival in the first trimester;2021QII;""
30 Murcia;All ages;Cohort October 1;Males;Survival in the first trimester;2021QI;""
30 Murcia;All ages;Cohort October 1;Males;Survival in the first trimester;2020QIV;56.231
30 Murcia;All ages;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
30 Murcia;All ages;Cohort October 1;Males;Survival in the first trimester;2020QII;""
30 Murcia;All ages;Cohort October 1;Males;Survival in the first trimester;2020QI;""
30 Murcia;All ages;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
30 Murcia;All ages;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
30 Murcia;All ages;Cohort October 1;Males;Survival in the second trimester;2022QII;""
30 Murcia;All ages;Cohort October 1;Males;Survival in the second trimester;2022QI;55.326
30 Murcia;All ages;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
30 Murcia;All ages;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
30 Murcia;All ages;Cohort October 1;Males;Survival in the second trimester;2021QII;""
30 Murcia;All ages;Cohort October 1;Males;Survival in the second trimester;2021QI;54.983
30 Murcia;All ages;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
30 Murcia;All ages;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
30 Murcia;All ages;Cohort October 1;Males;Survival in the second trimester;2020QII;""
30 Murcia;All ages;Cohort October 1;Males;Survival in the second trimester;2020QI;""
30 Murcia;All ages;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
30 Murcia;All ages;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
30 Murcia;All ages;Cohort October 1;Males;Survival in the third trimester;2022QII;53.711
30 Murcia;All ages;Cohort October 1;Males;Survival in the third trimester;2022QI;""
30 Murcia;All ages;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
30 Murcia;All ages;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
30 Murcia;All ages;Cohort October 1;Males;Survival in the third trimester;2021QII;53.523
30 Murcia;All ages;Cohort October 1;Males;Survival in the third trimester;2021QI;""
30 Murcia;All ages;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
30 Murcia;All ages;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
30 Murcia;All ages;Cohort October 1;Males;Survival in the third trimester;2020QII;""
30 Murcia;All ages;Cohort October 1;Males;Survival in the third trimester;2020QI;""
30 Murcia;All ages;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
30 Murcia;All ages;Cohort October 1;Males;Survival in the third trimester;2022QIII;52.376
30 Murcia;All ages;Cohort October 1;Males;Survival in the third trimester;2022QII;""
30 Murcia;All ages;Cohort October 1;Males;Survival in the third trimester;2022QI;""
30 Murcia;All ages;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
30 Murcia;All ages;Cohort October 1;Males;Survival in the third trimester;2021QIII;52.349
30 Murcia;All ages;Cohort October 1;Males;Survival in the third trimester;2021QII;""
30 Murcia;All ages;Cohort October 1;Males;Survival in the third trimester;2021QI;""
30 Murcia;All ages;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
30 Murcia;All ages;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
30 Murcia;All ages;Cohort October 1;Males;Survival in the third trimester;2020QII;""
30 Murcia;All ages;Cohort October 1;Males;Survival in the third trimester;2020QI;""
30 Murcia;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
30 Murcia;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
30 Murcia;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
30 Murcia;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
30 Murcia;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
30 Murcia;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
30 Murcia;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
30 Murcia;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
30 Murcia;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
30 Murcia;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
30 Murcia;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
30 Murcia;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
30 Murcia;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;96,24
30 Murcia;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
30 Murcia;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
30 Murcia;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
30 Murcia;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;96,71
30 Murcia;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
30 Murcia;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
30 Murcia;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
30 Murcia;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;96,98
30 Murcia;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
30 Murcia;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
30 Murcia;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
30 Murcia;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
30 Murcia;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
30 Murcia;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
30 Murcia;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;93,85
30 Murcia;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
30 Murcia;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
30 Murcia;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
30 Murcia;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;94,83
30 Murcia;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
30 Murcia;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
30 Murcia;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
30 Murcia;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
30 Murcia;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
30 Murcia;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
30 Murcia;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;91,11
30 Murcia;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
30 Murcia;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
30 Murcia;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
30 Murcia;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;92,31
30 Murcia;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
30 Murcia;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
30 Murcia;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
30 Murcia;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
30 Murcia;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
30 Murcia;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
30 Murcia;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;88,85
30 Murcia;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
30 Murcia;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
30 Murcia;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
30 Murcia;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;90,29
30 Murcia;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
30 Murcia;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
30 Murcia;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
30 Murcia;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
30 Murcia;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
30 Murcia;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
30 Murcia;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QIV;33.816
30 Murcia;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
30 Murcia;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
30 Murcia;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
30 Murcia;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QIV;33.483
30 Murcia;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
30 Murcia;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
30 Murcia;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
30 Murcia;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QIV;32.398
30 Murcia;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
30 Murcia;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
30 Murcia;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
30 Murcia;All ages;Cohort October 1;Females;Survival in the first trimester;2022QIV;32.413
30 Murcia;All ages;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
30 Murcia;All ages;Cohort October 1;Females;Survival in the first trimester;2022QII;""
30 Murcia;All ages;Cohort October 1;Females;Survival in the first trimester;2022QI;""
30 Murcia;All ages;Cohort October 1;Females;Survival in the first trimester;2021QIV;32.264
30 Murcia;All ages;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
30 Murcia;All ages;Cohort October 1;Females;Survival in the first trimester;2021QII;""
30 Murcia;All ages;Cohort October 1;Females;Survival in the first trimester;2021QI;""
30 Murcia;All ages;Cohort October 1;Females;Survival in the first trimester;2020QIV;31.308
30 Murcia;All ages;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
30 Murcia;All ages;Cohort October 1;Females;Survival in the first trimester;2020QII;""
30 Murcia;All ages;Cohort October 1;Females;Survival in the first trimester;2020QI;""
30 Murcia;All ages;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
30 Murcia;All ages;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
30 Murcia;All ages;Cohort October 1;Females;Survival in the second trimester;2022QII;""
30 Murcia;All ages;Cohort October 1;Females;Survival in the second trimester;2022QI;31.058
30 Murcia;All ages;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
30 Murcia;All ages;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
30 Murcia;All ages;Cohort October 1;Females;Survival in the second trimester;2021QII;""
30 Murcia;All ages;Cohort October 1;Females;Survival in the second trimester;2021QI;30.488
30 Murcia;All ages;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
30 Murcia;All ages;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
30 Murcia;All ages;Cohort October 1;Females;Survival in the second trimester;2020QII;""
30 Murcia;All ages;Cohort October 1;Females;Survival in the second trimester;2020QI;""
30 Murcia;All ages;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
30 Murcia;All ages;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
30 Murcia;All ages;Cohort October 1;Females;Survival in the third trimester;2022QII;29.861
30 Murcia;All ages;Cohort October 1;Females;Survival in the third trimester;2022QI;""
30 Murcia;All ages;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
30 Murcia;All ages;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
30 Murcia;All ages;Cohort October 1;Females;Survival in the third trimester;2021QII;29.539
30 Murcia;All ages;Cohort October 1;Females;Survival in the third trimester;2021QI;""
30 Murcia;All ages;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
30 Murcia;All ages;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
30 Murcia;All ages;Cohort October 1;Females;Survival in the third trimester;2020QII;""
30 Murcia;All ages;Cohort October 1;Females;Survival in the third trimester;2020QI;""
30 Murcia;All ages;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
30 Murcia;All ages;Cohort October 1;Females;Survival in the third trimester;2022QIII;28.972
30 Murcia;All ages;Cohort October 1;Females;Survival in the third trimester;2022QII;""
30 Murcia;All ages;Cohort October 1;Females;Survival in the third trimester;2022QI;""
30 Murcia;All ages;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
30 Murcia;All ages;Cohort October 1;Females;Survival in the third trimester;2021QIII;28.764
30 Murcia;All ages;Cohort October 1;Females;Survival in the third trimester;2021QII;""
30 Murcia;All ages;Cohort October 1;Females;Survival in the third trimester;2021QI;""
30 Murcia;All ages;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
30 Murcia;All ages;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
30 Murcia;All ages;Cohort October 1;Females;Survival in the third trimester;2020QII;""
30 Murcia;All ages;Cohort October 1;Females;Survival in the third trimester;2020QI;""
30 Murcia;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
30 Murcia;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
30 Murcia;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
30 Murcia;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
30 Murcia;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
30 Murcia;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
30 Murcia;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
30 Murcia;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
30 Murcia;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
30 Murcia;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
30 Murcia;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
30 Murcia;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
30 Murcia;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;95,85
30 Murcia;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
30 Murcia;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
30 Murcia;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
30 Murcia;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;96,36
30 Murcia;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
30 Murcia;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
30 Murcia;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
30 Murcia;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;96,64
30 Murcia;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
30 Murcia;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
30 Murcia;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
30 Murcia;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
30 Murcia;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
30 Murcia;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
30 Murcia;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;92,76
30 Murcia;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
30 Murcia;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
30 Murcia;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
30 Murcia;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;94,1
30 Murcia;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
30 Murcia;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
30 Murcia;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
30 Murcia;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
30 Murcia;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
30 Murcia;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
30 Murcia;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;89,18
30 Murcia;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
30 Murcia;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
30 Murcia;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
30 Murcia;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;91,18
30 Murcia;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
30 Murcia;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
30 Murcia;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
30 Murcia;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
30 Murcia;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
30 Murcia;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
30 Murcia;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;86,53
30 Murcia;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
30 Murcia;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
30 Murcia;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
30 Murcia;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;88,78
30 Murcia;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
30 Murcia;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
30 Murcia;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
30 Murcia;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
30 Murcia;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
30 Murcia;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
30 Murcia;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
30 Murcia;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
30 Murcia;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
30 Murcia;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QI;6.764
30 Murcia;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
30 Murcia;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
30 Murcia;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
30 Murcia;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QI;6.568
30 Murcia;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
30 Murcia;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
30 Murcia;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
30 Murcia;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QI;5.489
30 Murcia;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
30 Murcia;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
30 Murcia;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2022QII;""
30 Murcia;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2022QI;6.318
30 Murcia;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
30 Murcia;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
30 Murcia;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2021QII;""
30 Murcia;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2021QI;6.223
30 Murcia;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
30 Murcia;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
30 Murcia;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2020QII;""
30 Murcia;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2020QI;4.896
30 Murcia;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
30 Murcia;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
30 Murcia;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2022QII;5.879
30 Murcia;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2022QI;""
30 Murcia;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
30 Murcia;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
30 Murcia;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2021QII;5.875
30 Murcia;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2021QI;""
30 Murcia;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
30 Murcia;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
30 Murcia;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2020QII;4.733
30 Murcia;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2020QI;""
30 Murcia;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
30 Murcia;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QIII;5.517
30 Murcia;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QII;""
30 Murcia;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QI;""
30 Murcia;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
30 Murcia;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QIII;5.549
30 Murcia;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QII;""
30 Murcia;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QI;""
30 Murcia;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
30 Murcia;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QIII;4.483
30 Murcia;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QII;""
30 Murcia;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QI;""
30 Murcia;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QIV;5.211
30 Murcia;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
30 Murcia;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QII;""
30 Murcia;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QI;""
30 Murcia;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QIV;5.267
30 Murcia;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
30 Murcia;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QII;""
30 Murcia;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QI;""
30 Murcia;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QIV;4.265
30 Murcia;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
30 Murcia;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QII;""
30 Murcia;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QI;""
30 Murcia;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
30 Murcia;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
30 Murcia;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
30 Murcia;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
30 Murcia;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
30 Murcia;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
30 Murcia;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
30 Murcia;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
30 Murcia;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
30 Murcia;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
30 Murcia;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
30 Murcia;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
30 Murcia;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
30 Murcia;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
30 Murcia;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
30 Murcia;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;93,41
30 Murcia;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
30 Murcia;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
30 Murcia;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
30 Murcia;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;94,75
30 Murcia;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
30 Murcia;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
30 Murcia;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
30 Murcia;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;89,2
30 Murcia;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
30 Murcia;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
30 Murcia;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;86,92
30 Murcia;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
30 Murcia;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
30 Murcia;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
30 Murcia;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;89,45
30 Murcia;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
30 Murcia;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
30 Murcia;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
30 Murcia;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;86,23
30 Murcia;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
30 Murcia;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
30 Murcia;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;81,56
30 Murcia;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
30 Murcia;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
30 Murcia;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
30 Murcia;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;84,49
30 Murcia;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
30 Murcia;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
30 Murcia;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
30 Murcia;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;81,67
30 Murcia;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
30 Murcia;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
30 Murcia;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;77,04
30 Murcia;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
30 Murcia;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
30 Murcia;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
30 Murcia;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;80,19
30 Murcia;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
30 Murcia;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
30 Murcia;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
30 Murcia;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;77,7
30 Murcia;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
30 Murcia;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
30 Murcia;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
30 Murcia;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
30 Murcia;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
30 Murcia;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
30 Murcia;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QI;4.198
30 Murcia;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
30 Murcia;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
30 Murcia;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
30 Murcia;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QI;4.085
30 Murcia;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
30 Murcia;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
30 Murcia;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
30 Murcia;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QI;3.403
30 Murcia;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
30 Murcia;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
30 Murcia;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2022QII;""
30 Murcia;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2022QI;3.931
30 Murcia;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
30 Murcia;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
30 Murcia;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2021QII;""
30 Murcia;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2021QI;3.878
30 Murcia;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
30 Murcia;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
30 Murcia;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2020QII;""
30 Murcia;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2020QI;3.052
30 Murcia;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
30 Murcia;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
30 Murcia;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2022QII;3.688
30 Murcia;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2022QI;""
30 Murcia;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
30 Murcia;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
30 Murcia;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2021QII;3.677
30 Murcia;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2021QI;""
30 Murcia;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
30 Murcia;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
30 Murcia;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2020QII;2.961
30 Murcia;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2020QI;""
30 Murcia;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
30 Murcia;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QIII;3.470
30 Murcia;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QII;""
30 Murcia;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QI;""
30 Murcia;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
30 Murcia;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QIII;3.481
30 Murcia;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QII;""
30 Murcia;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QI;""
30 Murcia;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
30 Murcia;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QIII;2.827
30 Murcia;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QII;""
30 Murcia;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QI;""
30 Murcia;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QIV;3.282
30 Murcia;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
30 Murcia;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QII;""
30 Murcia;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QI;""
30 Murcia;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QIV;3.312
30 Murcia;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
30 Murcia;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QII;""
30 Murcia;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QI;""
30 Murcia;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QIV;2.699
30 Murcia;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
30 Murcia;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QII;""
30 Murcia;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QI;""
30 Murcia;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
30 Murcia;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
30 Murcia;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
30 Murcia;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
30 Murcia;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
30 Murcia;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
30 Murcia;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
30 Murcia;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
30 Murcia;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
30 Murcia;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
30 Murcia;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
30 Murcia;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
30 Murcia;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
30 Murcia;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
30 Murcia;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
30 Murcia;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;93,64
30 Murcia;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
30 Murcia;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
30 Murcia;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
30 Murcia;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;94,93
30 Murcia;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
30 Murcia;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
30 Murcia;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
30 Murcia;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;89,69
30 Murcia;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
30 Murcia;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
30 Murcia;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;87,85
30 Murcia;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
30 Murcia;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
30 Murcia;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
30 Murcia;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;90,01
30 Murcia;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
30 Murcia;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
30 Murcia;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
30 Murcia;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;87,01
30 Murcia;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
30 Murcia;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
30 Murcia;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;82,66
30 Murcia;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
30 Murcia;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
30 Murcia;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
30 Murcia;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;85,21
30 Murcia;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
30 Murcia;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
30 Murcia;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
30 Murcia;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;83,07
30 Murcia;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
30 Murcia;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
30 Murcia;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;78,18
30 Murcia;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
30 Murcia;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
30 Murcia;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
30 Murcia;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;81,08
30 Murcia;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
30 Murcia;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
30 Murcia;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
30 Murcia;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;79,31
30 Murcia;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
30 Murcia;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
30 Murcia;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
30 Murcia;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
30 Murcia;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
30 Murcia;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
30 Murcia;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QI;2.566
30 Murcia;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
30 Murcia;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
30 Murcia;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
30 Murcia;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QI;2.483
30 Murcia;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
30 Murcia;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
30 Murcia;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
30 Murcia;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QI;2.086
30 Murcia;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
30 Murcia;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
30 Murcia;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2022QII;""
30 Murcia;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2022QI;2.387
30 Murcia;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
30 Murcia;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
30 Murcia;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2021QII;""
30 Murcia;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2021QI;2.345
30 Murcia;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
30 Murcia;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
30 Murcia;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2020QII;""
30 Murcia;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2020QI;1.844
30 Murcia;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
30 Murcia;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
30 Murcia;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2022QII;2.191
30 Murcia;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2022QI;""
30 Murcia;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
30 Murcia;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
30 Murcia;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2021QII;2.198
30 Murcia;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2021QI;""
30 Murcia;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
30 Murcia;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
30 Murcia;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2020QII;1.772
30 Murcia;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2020QI;""
30 Murcia;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
30 Murcia;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QIII;2.047
30 Murcia;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QII;""
30 Murcia;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QI;""
30 Murcia;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
30 Murcia;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QIII;2.068
30 Murcia;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QII;""
30 Murcia;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QI;""
30 Murcia;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
30 Murcia;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QIII;1.656
30 Murcia;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QII;""
30 Murcia;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QI;""
30 Murcia;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QIV;1.929
30 Murcia;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
30 Murcia;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QII;""
30 Murcia;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QI;""
30 Murcia;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QIV;1.955
30 Murcia;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
30 Murcia;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QII;""
30 Murcia;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QI;""
30 Murcia;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QIV;1.566
30 Murcia;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
30 Murcia;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QII;""
30 Murcia;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QI;""
30 Murcia;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
30 Murcia;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
30 Murcia;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
30 Murcia;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
30 Murcia;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
30 Murcia;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
30 Murcia;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
30 Murcia;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
30 Murcia;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
30 Murcia;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
30 Murcia;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
30 Murcia;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
30 Murcia;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
30 Murcia;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
30 Murcia;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
30 Murcia;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;93,02
30 Murcia;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
30 Murcia;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
30 Murcia;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
30 Murcia;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;94,44
30 Murcia;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
30 Murcia;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
30 Murcia;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
30 Murcia;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;88,4
30 Murcia;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
30 Murcia;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
30 Murcia;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;85,39
30 Murcia;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
30 Murcia;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
30 Murcia;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
30 Murcia;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;88,52
30 Murcia;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
30 Murcia;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
30 Murcia;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
30 Murcia;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;84,95
30 Murcia;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
30 Murcia;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
30 Murcia;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;79,77
30 Murcia;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
30 Murcia;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
30 Murcia;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
30 Murcia;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;83,29
30 Murcia;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
30 Murcia;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
30 Murcia;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
30 Murcia;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;79,39
30 Murcia;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
30 Murcia;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
30 Murcia;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;75,18
30 Murcia;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
30 Murcia;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
30 Murcia;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
30 Murcia;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;78,74
30 Murcia;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
30 Murcia;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
30 Murcia;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
30 Murcia;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;75,07
30 Murcia;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
30 Murcia;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
30 Murcia;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
30 Murcia;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
30 Murcia;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
30 Murcia;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QII;5.889
30 Murcia;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
30 Murcia;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
30 Murcia;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
30 Murcia;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QII;5.823
30 Murcia;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
30 Murcia;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
30 Murcia;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
30 Murcia;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QII;5.565
30 Murcia;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
30 Murcia;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
30 Murcia;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
30 Murcia;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2022QII;5.441
30 Murcia;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2022QI;""
30 Murcia;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
30 Murcia;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
30 Murcia;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2021QII;5.429
30 Murcia;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2021QI;""
30 Murcia;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
30 Murcia;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
30 Murcia;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2020QII;5.358
30 Murcia;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2020QI;""
30 Murcia;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
30 Murcia;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2022QIII;5.075
30 Murcia;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2022QII;""
30 Murcia;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2022QI;""
30 Murcia;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
30 Murcia;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2021QIII;5.094
30 Murcia;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2021QII;""
30 Murcia;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2021QI;""
30 Murcia;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
30 Murcia;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2020QIII;5.065
30 Murcia;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2020QII;""
30 Murcia;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2020QI;""
30 Murcia;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QIV;4.767
30 Murcia;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
30 Murcia;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QII;""
30 Murcia;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QI;""
30 Murcia;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QIV;4.807
30 Murcia;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
30 Murcia;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QII;""
30 Murcia;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QI;""
30 Murcia;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QIV;4.798
30 Murcia;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
30 Murcia;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QII;""
30 Murcia;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QI;""
30 Murcia;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
30 Murcia;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
30 Murcia;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QII;""
30 Murcia;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QI;4.532
30 Murcia;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
30 Murcia;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
30 Murcia;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QII;""
30 Murcia;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QI;4.584
30 Murcia;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
30 Murcia;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
30 Murcia;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QII;""
30 Murcia;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QI;""
30 Murcia;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
30 Murcia;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
30 Murcia;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
30 Murcia;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
30 Murcia;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
30 Murcia;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
30 Murcia;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
30 Murcia;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
30 Murcia;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
30 Murcia;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
30 Murcia;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
30 Murcia;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
30 Murcia;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
30 Murcia;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
30 Murcia;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;92,39
30 Murcia;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
30 Murcia;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
30 Murcia;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
30 Murcia;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;93,23
30 Murcia;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
30 Murcia;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
30 Murcia;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
30 Murcia;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;96,28
30 Murcia;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
30 Murcia;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
30 Murcia;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;86,18
30 Murcia;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
30 Murcia;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
30 Murcia;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
30 Murcia;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;87,48
30 Murcia;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
30 Murcia;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
30 Murcia;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
30 Murcia;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;91,02
30 Murcia;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
30 Murcia;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
30 Murcia;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;80,95
30 Murcia;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
30 Murcia;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
30 Murcia;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
30 Murcia;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;82,55
30 Murcia;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
30 Murcia;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
30 Murcia;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
30 Murcia;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;86,22
30 Murcia;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
30 Murcia;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
30 Murcia;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
30 Murcia;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
30 Murcia;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
30 Murcia;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
30 Murcia;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;77,83
30 Murcia;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
30 Murcia;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
30 Murcia;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
30 Murcia;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;82,37
30 Murcia;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
30 Murcia;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
30 Murcia;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
30 Murcia;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
30 Murcia;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
30 Murcia;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
30 Murcia;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QII;3.687
30 Murcia;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
30 Murcia;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
30 Murcia;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
30 Murcia;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QII;3.660
30 Murcia;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
30 Murcia;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
30 Murcia;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
30 Murcia;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QII;3.465
30 Murcia;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
30 Murcia;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
30 Murcia;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
30 Murcia;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2022QII;3.425
30 Murcia;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2022QI;""
30 Murcia;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
30 Murcia;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
30 Murcia;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2021QII;3.424
30 Murcia;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2021QI;""
30 Murcia;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
30 Murcia;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
30 Murcia;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2020QII;3.342
30 Murcia;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2020QI;""
30 Murcia;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
30 Murcia;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2022QIII;3.203
30 Murcia;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2022QII;""
30 Murcia;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2022QI;""
30 Murcia;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
30 Murcia;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2021QIII;3.221
30 Murcia;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2021QII;""
30 Murcia;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2021QI;""
30 Murcia;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
30 Murcia;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2020QIII;3.180
30 Murcia;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2020QII;""
30 Murcia;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2020QI;""
30 Murcia;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QIV;3.018
30 Murcia;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
30 Murcia;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QII;""
30 Murcia;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QI;""
30 Murcia;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QIV;3.051
30 Murcia;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
30 Murcia;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QII;""
30 Murcia;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QI;""
30 Murcia;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QIV;3.027
30 Murcia;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
30 Murcia;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QII;""
30 Murcia;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QI;""
30 Murcia;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
30 Murcia;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
30 Murcia;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QII;""
30 Murcia;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QI;2.893
30 Murcia;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
30 Murcia;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
30 Murcia;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QII;""
30 Murcia;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QI;2.902
30 Murcia;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
30 Murcia;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
30 Murcia;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QII;""
30 Murcia;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QI;""
30 Murcia;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
30 Murcia;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
30 Murcia;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
30 Murcia;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
30 Murcia;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
30 Murcia;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
30 Murcia;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
30 Murcia;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
30 Murcia;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
30 Murcia;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
30 Murcia;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
30 Murcia;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
30 Murcia;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
30 Murcia;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
30 Murcia;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;92,89
30 Murcia;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
30 Murcia;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
30 Murcia;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
30 Murcia;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;93,55
30 Murcia;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
30 Murcia;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
30 Murcia;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
30 Murcia;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;96,45
30 Murcia;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
30 Murcia;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
30 Murcia;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;86,87
30 Murcia;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
30 Murcia;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
30 Murcia;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
30 Murcia;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;88,01
30 Murcia;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
30 Murcia;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
30 Murcia;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
30 Murcia;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;91,77
30 Murcia;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
30 Murcia;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
30 Murcia;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;81,86
30 Murcia;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
30 Murcia;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
30 Murcia;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
30 Murcia;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;83,36
30 Murcia;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
30 Murcia;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
30 Murcia;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
30 Murcia;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;87,36
30 Murcia;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
30 Murcia;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
30 Murcia;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
30 Murcia;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
30 Murcia;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
30 Murcia;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
30 Murcia;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;79,04
30 Murcia;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
30 Murcia;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
30 Murcia;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
30 Murcia;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;83,75
30 Murcia;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
30 Murcia;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
30 Murcia;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
30 Murcia;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
30 Murcia;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
30 Murcia;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
30 Murcia;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QII;2.202
30 Murcia;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
30 Murcia;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
30 Murcia;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
30 Murcia;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QII;2.163
30 Murcia;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
30 Murcia;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
30 Murcia;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
30 Murcia;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QII;2.100
30 Murcia;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
30 Murcia;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
30 Murcia;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
30 Murcia;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2022QII;2.016
30 Murcia;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2022QI;""
30 Murcia;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
30 Murcia;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
30 Murcia;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2021QII;2.005
30 Murcia;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2021QI;""
30 Murcia;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
30 Murcia;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
30 Murcia;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2020QII;2.016
30 Murcia;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2020QI;""
30 Murcia;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
30 Murcia;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2022QIII;1.872
30 Murcia;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2022QII;""
30 Murcia;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2022QI;""
30 Murcia;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
30 Murcia;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2021QIII;1.873
30 Murcia;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2021QII;""
30 Murcia;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2021QI;""
30 Murcia;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
30 Murcia;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2020QIII;1.885
30 Murcia;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2020QII;""
30 Murcia;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2020QI;""
30 Murcia;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QIV;1.749
30 Murcia;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
30 Murcia;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QII;""
30 Murcia;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QI;""
30 Murcia;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QIV;1.756
30 Murcia;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
30 Murcia;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QII;""
30 Murcia;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QI;""
30 Murcia;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QIV;1.771
30 Murcia;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
30 Murcia;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QII;""
30 Murcia;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QI;""
30 Murcia;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
30 Murcia;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
30 Murcia;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QII;""
30 Murcia;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QI;1.639
30 Murcia;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
30 Murcia;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
30 Murcia;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QII;""
30 Murcia;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QI;1.682
30 Murcia;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
30 Murcia;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
30 Murcia;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QII;""
30 Murcia;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QI;""
30 Murcia;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
30 Murcia;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
30 Murcia;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
30 Murcia;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
30 Murcia;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
30 Murcia;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
30 Murcia;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
30 Murcia;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
30 Murcia;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
30 Murcia;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
30 Murcia;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
30 Murcia;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
30 Murcia;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
30 Murcia;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
30 Murcia;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;91,55
30 Murcia;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
30 Murcia;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
30 Murcia;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
30 Murcia;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;92,7
30 Murcia;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
30 Murcia;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
30 Murcia;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
30 Murcia;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;96
30 Murcia;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
30 Murcia;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
30 Murcia;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;85,01
30 Murcia;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
30 Murcia;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
30 Murcia;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
30 Murcia;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;86,59
30 Murcia;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
30 Murcia;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
30 Murcia;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
30 Murcia;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;89,76
30 Murcia;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
30 Murcia;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
30 Murcia;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;79,43
30 Murcia;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
30 Murcia;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
30 Murcia;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
30 Murcia;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;81,18
30 Murcia;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
30 Murcia;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
30 Murcia;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
30 Murcia;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;84,33
30 Murcia;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
30 Murcia;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
30 Murcia;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
30 Murcia;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
30 Murcia;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
30 Murcia;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
30 Murcia;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;75,77
30 Murcia;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
30 Murcia;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
30 Murcia;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
30 Murcia;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;80,1
30 Murcia;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
30 Murcia;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
30 Murcia;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
30 Murcia;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
30 Murcia;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
30 Murcia;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QIII;6.139
30 Murcia;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
30 Murcia;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
30 Murcia;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
30 Murcia;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QIII;6.204
30 Murcia;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
30 Murcia;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
30 Murcia;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
30 Murcia;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QIII;5.899
30 Murcia;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
30 Murcia;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
30 Murcia;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
30 Murcia;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2022QIII;5.651
30 Murcia;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2022QII;""
30 Murcia;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2022QI;""
30 Murcia;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
30 Murcia;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2021QIII;5.765
30 Murcia;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2021QII;""
30 Murcia;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2021QI;""
30 Murcia;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
30 Murcia;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2020QIII;5.503
30 Murcia;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2020QII;""
30 Murcia;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2020QI;""
30 Murcia;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2022QIV;5.291
30 Murcia;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
30 Murcia;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2022QII;""
30 Murcia;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2022QI;""
30 Murcia;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2021QIV;5.416
30 Murcia;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
30 Murcia;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2021QII;""
30 Murcia;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2021QI;""
30 Murcia;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2020QIV;5.197
30 Murcia;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
30 Murcia;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2020QII;""
30 Murcia;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2020QI;""
30 Murcia;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
30 Murcia;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
30 Murcia;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QII;""
30 Murcia;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QI;5.098
30 Murcia;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
30 Murcia;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
30 Murcia;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QII;""
30 Murcia;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QI;4.958
30 Murcia;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
30 Murcia;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
30 Murcia;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QII;""
30 Murcia;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QI;""
30 Murcia;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
30 Murcia;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
30 Murcia;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QII;4.771
30 Murcia;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QI;""
30 Murcia;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
30 Murcia;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
30 Murcia;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QII;4.715
30 Murcia;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QI;""
30 Murcia;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
30 Murcia;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
30 Murcia;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QII;""
30 Murcia;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QI;""
30 Murcia;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
30 Murcia;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
30 Murcia;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
30 Murcia;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
30 Murcia;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
30 Murcia;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
30 Murcia;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
30 Murcia;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
30 Murcia;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
30 Murcia;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
30 Murcia;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
30 Murcia;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
30 Murcia;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
30 Murcia;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;92,05
30 Murcia;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
30 Murcia;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
30 Murcia;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
30 Murcia;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;92,92
30 Murcia;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
30 Murcia;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
30 Murcia;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
30 Murcia;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;93,29
30 Murcia;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
30 Murcia;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
30 Murcia;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;86,19
30 Murcia;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
30 Murcia;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
30 Murcia;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
30 Murcia;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;87,3
30 Murcia;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
30 Murcia;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
30 Murcia;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
30 Murcia;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;88,1
30 Murcia;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
30 Murcia;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
30 Murcia;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
30 Murcia;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
30 Murcia;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
30 Murcia;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
30 Murcia;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;82,17
30 Murcia;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
30 Murcia;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
30 Murcia;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
30 Murcia;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;84,05
30 Murcia;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
30 Murcia;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
30 Murcia;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
30 Murcia;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
30 Murcia;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
30 Murcia;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
30 Murcia;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;76,9
30 Murcia;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
30 Murcia;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
30 Murcia;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
30 Murcia;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;79,93
30 Murcia;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
30 Murcia;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
30 Murcia;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
30 Murcia;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
30 Murcia;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
30 Murcia;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
30 Murcia;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QIII;3.845
30 Murcia;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
30 Murcia;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
30 Murcia;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
30 Murcia;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QIII;3.895
30 Murcia;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
30 Murcia;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
30 Murcia;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
30 Murcia;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QIII;3.680
30 Murcia;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
30 Murcia;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
30 Murcia;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
30 Murcia;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2022QIII;3.545
30 Murcia;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2022QII;""
30 Murcia;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2022QI;""
30 Murcia;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
30 Murcia;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2021QIII;3.626
30 Murcia;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2021QII;""
30 Murcia;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2021QI;""
30 Murcia;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
30 Murcia;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2020QIII;3.451
30 Murcia;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2020QII;""
30 Murcia;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2020QI;""
30 Murcia;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2022QIV;3.322
30 Murcia;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
30 Murcia;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2022QII;""
30 Murcia;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2022QI;""
30 Murcia;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2021QIV;3.413
30 Murcia;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
30 Murcia;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2021QII;""
30 Murcia;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2021QI;""
30 Murcia;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2020QIV;3.274
30 Murcia;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
30 Murcia;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2020QII;""
30 Murcia;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2020QI;""
30 Murcia;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
30 Murcia;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
30 Murcia;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QII;""
30 Murcia;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QI;3.228
30 Murcia;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
30 Murcia;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
30 Murcia;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QII;""
30 Murcia;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QI;3.134
30 Murcia;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
30 Murcia;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
30 Murcia;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QII;""
30 Murcia;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QI;""
30 Murcia;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
30 Murcia;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
30 Murcia;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QII;3.042
30 Murcia;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QI;""
30 Murcia;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
30 Murcia;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
30 Murcia;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QII;2.996
30 Murcia;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QI;""
30 Murcia;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
30 Murcia;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
30 Murcia;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QII;""
30 Murcia;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QI;""
30 Murcia;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
30 Murcia;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
30 Murcia;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
30 Murcia;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
30 Murcia;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
30 Murcia;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
30 Murcia;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
30 Murcia;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
30 Murcia;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
30 Murcia;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
30 Murcia;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
30 Murcia;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
30 Murcia;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
30 Murcia;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;92,2
30 Murcia;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
30 Murcia;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
30 Murcia;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
30 Murcia;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;93,09
30 Murcia;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
30 Murcia;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
30 Murcia;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
30 Murcia;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;93,78
30 Murcia;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
30 Murcia;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
30 Murcia;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;86,4
30 Murcia;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
30 Murcia;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
30 Murcia;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
30 Murcia;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;87,63
30 Murcia;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
30 Murcia;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
30 Murcia;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
30 Murcia;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;88,97
30 Murcia;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
30 Murcia;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
30 Murcia;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
30 Murcia;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
30 Murcia;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
30 Murcia;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
30 Murcia;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;82,88
30 Murcia;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
30 Murcia;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
30 Murcia;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
30 Murcia;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;85,16
30 Murcia;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
30 Murcia;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
30 Murcia;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
30 Murcia;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
30 Murcia;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
30 Murcia;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
30 Murcia;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;78,1
30 Murcia;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
30 Murcia;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
30 Murcia;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
30 Murcia;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;81,41
30 Murcia;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
30 Murcia;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
30 Murcia;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
30 Murcia;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
30 Murcia;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
30 Murcia;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
30 Murcia;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QIII;2.294
30 Murcia;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
30 Murcia;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
30 Murcia;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
30 Murcia;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QIII;2.309
30 Murcia;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
30 Murcia;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
30 Murcia;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
30 Murcia;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QIII;2.219
30 Murcia;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
30 Murcia;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
30 Murcia;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
30 Murcia;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2022QIII;2.106
30 Murcia;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2022QII;""
30 Murcia;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2022QI;""
30 Murcia;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
30 Murcia;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2021QIII;2.139
30 Murcia;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2021QII;""
30 Murcia;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2021QI;""
30 Murcia;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
30 Murcia;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2020QIII;2.052
30 Murcia;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2020QII;""
30 Murcia;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2020QI;""
30 Murcia;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2022QIV;1.969
30 Murcia;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
30 Murcia;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2022QII;""
30 Murcia;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2022QI;""
30 Murcia;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2021QIV;2.003
30 Murcia;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
30 Murcia;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2021QII;""
30 Murcia;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2021QI;""
30 Murcia;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2020QIV;1.923
30 Murcia;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
30 Murcia;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2020QII;""
30 Murcia;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2020QI;""
30 Murcia;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
30 Murcia;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
30 Murcia;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QII;""
30 Murcia;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QI;1.870
30 Murcia;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
30 Murcia;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
30 Murcia;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QII;""
30 Murcia;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QI;1.824
30 Murcia;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
30 Murcia;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
30 Murcia;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QII;""
30 Murcia;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QI;""
30 Murcia;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
30 Murcia;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
30 Murcia;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QII;1.729
30 Murcia;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QI;""
30 Murcia;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
30 Murcia;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
30 Murcia;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QII;1.719
30 Murcia;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QI;""
30 Murcia;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
30 Murcia;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
30 Murcia;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QII;""
30 Murcia;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QI;""
30 Murcia;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
30 Murcia;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
30 Murcia;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
30 Murcia;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
30 Murcia;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
30 Murcia;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
30 Murcia;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
30 Murcia;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
30 Murcia;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
30 Murcia;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
30 Murcia;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
30 Murcia;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
30 Murcia;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
30 Murcia;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;91,8
30 Murcia;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
30 Murcia;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
30 Murcia;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
30 Murcia;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;92,64
30 Murcia;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
30 Murcia;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
30 Murcia;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
30 Murcia;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;92,47
30 Murcia;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
30 Murcia;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
30 Murcia;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;85,83
30 Murcia;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
30 Murcia;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
30 Murcia;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
30 Murcia;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;86,75
30 Murcia;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
30 Murcia;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
30 Murcia;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
30 Murcia;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;86,66
30 Murcia;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
30 Murcia;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
30 Murcia;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
30 Murcia;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
30 Murcia;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
30 Murcia;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
30 Murcia;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;80,99
30 Murcia;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
30 Murcia;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
30 Murcia;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
30 Murcia;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;82,2
30 Murcia;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
30 Murcia;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
30 Murcia;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
30 Murcia;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
30 Murcia;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
30 Murcia;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
30 Murcia;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;74,88
30 Murcia;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
30 Murcia;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
30 Murcia;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
30 Murcia;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;77,47
30 Murcia;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
30 Murcia;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
30 Murcia;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
30 Murcia;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
30 Murcia;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
30 Murcia;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QIV;6.395
30 Murcia;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
30 Murcia;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
30 Murcia;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
30 Murcia;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QIV;6.454
30 Murcia;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
30 Murcia;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
30 Murcia;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
30 Murcia;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QIV;6.180
30 Murcia;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
30 Murcia;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
30 Murcia;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
30 Murcia;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2022QIV;5.951
30 Murcia;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
30 Murcia;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2022QII;""
30 Murcia;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2022QI;""
30 Murcia;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2021QIV;6.036
30 Murcia;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
30 Murcia;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2021QII;""
30 Murcia;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2021QI;""
30 Murcia;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2020QIV;5.798
30 Murcia;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
30 Murcia;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2020QII;""
30 Murcia;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2020QI;""
30 Murcia;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
30 Murcia;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
30 Murcia;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2022QII;""
30 Murcia;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2022QI;5.671
30 Murcia;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
30 Murcia;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
30 Murcia;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2021QII;""
30 Murcia;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2021QI;5.523
30 Murcia;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
30 Murcia;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
30 Murcia;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2020QII;""
30 Murcia;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2020QI;""
30 Murcia;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
30 Murcia;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
30 Murcia;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QII;5.300
30 Murcia;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QI;""
30 Murcia;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
30 Murcia;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
30 Murcia;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QII;5.242
30 Murcia;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QI;""
30 Murcia;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
30 Murcia;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
30 Murcia;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QII;""
30 Murcia;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QI;""
30 Murcia;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
30 Murcia;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QIII;4.994
30 Murcia;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QII;""
30 Murcia;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QI;""
30 Murcia;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
30 Murcia;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QIII;4.978
30 Murcia;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QII;""
30 Murcia;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QI;""
30 Murcia;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
30 Murcia;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
30 Murcia;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QII;""
30 Murcia;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QI;""
30 Murcia;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
30 Murcia;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
30 Murcia;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
30 Murcia;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
30 Murcia;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
30 Murcia;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
30 Murcia;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
30 Murcia;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
30 Murcia;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
30 Murcia;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
30 Murcia;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
30 Murcia;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
30 Murcia;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;93,06
30 Murcia;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
30 Murcia;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
30 Murcia;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
30 Murcia;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;93,52
30 Murcia;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
30 Murcia;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
30 Murcia;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
30 Murcia;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;93,82
30 Murcia;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
30 Murcia;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
30 Murcia;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
30 Murcia;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
30 Murcia;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
30 Murcia;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
30 Murcia;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;87,87
30 Murcia;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
30 Murcia;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
30 Murcia;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
30 Murcia;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;89,37
30 Murcia;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
30 Murcia;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
30 Murcia;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
30 Murcia;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
30 Murcia;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
30 Murcia;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
30 Murcia;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;82,12
30 Murcia;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
30 Murcia;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
30 Murcia;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
30 Murcia;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;84,82
30 Murcia;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
30 Murcia;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
30 Murcia;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
30 Murcia;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
30 Murcia;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
30 Murcia;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
30 Murcia;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;77,38
30 Murcia;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
30 Murcia;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
30 Murcia;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
30 Murcia;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;80,55
30 Murcia;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
30 Murcia;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
30 Murcia;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
30 Murcia;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
30 Murcia;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
30 Murcia;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
30 Murcia;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QIV;3.978
30 Murcia;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
30 Murcia;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
30 Murcia;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
30 Murcia;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QIV;4.025
30 Murcia;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
30 Murcia;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
30 Murcia;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
30 Murcia;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QIV;3.847
30 Murcia;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
30 Murcia;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
30 Murcia;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
30 Murcia;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2022QIV;3.703
30 Murcia;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
30 Murcia;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2022QII;""
30 Murcia;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2022QI;""
30 Murcia;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2021QIV;3.767
30 Murcia;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
30 Murcia;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2021QII;""
30 Murcia;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2021QI;""
30 Murcia;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2020QIV;3.624
30 Murcia;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
30 Murcia;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2020QII;""
30 Murcia;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2020QI;""
30 Murcia;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
30 Murcia;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
30 Murcia;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2022QII;""
30 Murcia;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2022QI;3.554
30 Murcia;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
30 Murcia;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
30 Murcia;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2021QII;""
30 Murcia;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2021QI;3.456
30 Murcia;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
30 Murcia;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
30 Murcia;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2020QII;""
30 Murcia;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2020QI;""
30 Murcia;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
30 Murcia;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
30 Murcia;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QII;3.349
30 Murcia;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QI;""
30 Murcia;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
30 Murcia;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
30 Murcia;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QII;3.294
30 Murcia;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QI;""
30 Murcia;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
30 Murcia;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
30 Murcia;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QII;""
30 Murcia;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QI;""
30 Murcia;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
30 Murcia;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QIII;3.165
30 Murcia;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QII;""
30 Murcia;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QI;""
30 Murcia;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
30 Murcia;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QIII;3.133
30 Murcia;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QII;""
30 Murcia;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QI;""
30 Murcia;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
30 Murcia;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
30 Murcia;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QII;""
30 Murcia;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QI;""
30 Murcia;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
30 Murcia;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
30 Murcia;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
30 Murcia;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
30 Murcia;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
30 Murcia;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
30 Murcia;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
30 Murcia;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
30 Murcia;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
30 Murcia;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
30 Murcia;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
30 Murcia;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
30 Murcia;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;93,09
30 Murcia;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
30 Murcia;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
30 Murcia;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
30 Murcia;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;93,59
30 Murcia;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
30 Murcia;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
30 Murcia;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
30 Murcia;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;94,2
30 Murcia;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
30 Murcia;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
30 Murcia;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
30 Murcia;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
30 Murcia;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
30 Murcia;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
30 Murcia;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;88,3
30 Murcia;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
30 Murcia;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
30 Murcia;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
30 Murcia;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;89,84
30 Murcia;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
30 Murcia;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
30 Murcia;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
30 Murcia;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
30 Murcia;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
30 Murcia;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
30 Murcia;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;83,2
30 Murcia;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
30 Murcia;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
30 Murcia;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
30 Murcia;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;85,63
30 Murcia;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
30 Murcia;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
30 Murcia;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
30 Murcia;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
30 Murcia;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
30 Murcia;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
30 Murcia;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;78,63
30 Murcia;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
30 Murcia;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
30 Murcia;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
30 Murcia;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;81,44
30 Murcia;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
30 Murcia;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
30 Murcia;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
30 Murcia;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
30 Murcia;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
30 Murcia;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
30 Murcia;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QIV;2.417
30 Murcia;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
30 Murcia;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
30 Murcia;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
30 Murcia;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QIV;2.429
30 Murcia;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
30 Murcia;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
30 Murcia;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
30 Murcia;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QIV;2.333
30 Murcia;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
30 Murcia;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
30 Murcia;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
30 Murcia;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2022QIV;2.248
30 Murcia;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
30 Murcia;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2022QII;""
30 Murcia;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2022QI;""
30 Murcia;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2021QIV;2.269
30 Murcia;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
30 Murcia;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2021QII;""
30 Murcia;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2021QI;""
30 Murcia;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2020QIV;2.174
30 Murcia;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
30 Murcia;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2020QII;""
30 Murcia;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2020QI;""
30 Murcia;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
30 Murcia;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
30 Murcia;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2022QII;""
30 Murcia;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2022QI;2.117
30 Murcia;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
30 Murcia;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
30 Murcia;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2021QII;""
30 Murcia;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2021QI;2.067
30 Murcia;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
30 Murcia;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
30 Murcia;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2020QII;""
30 Murcia;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2020QI;""
30 Murcia;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
30 Murcia;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
30 Murcia;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QII;1.951
30 Murcia;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QI;""
30 Murcia;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
30 Murcia;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
30 Murcia;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QII;1.948
30 Murcia;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QI;""
30 Murcia;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
30 Murcia;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
30 Murcia;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QII;""
30 Murcia;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QI;""
30 Murcia;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
30 Murcia;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QIII;1.829
30 Murcia;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QII;""
30 Murcia;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QI;""
30 Murcia;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
30 Murcia;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QIII;1.845
30 Murcia;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QII;""
30 Murcia;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QI;""
30 Murcia;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
30 Murcia;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
30 Murcia;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QII;""
30 Murcia;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QI;""
30 Murcia;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
30 Murcia;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
30 Murcia;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
30 Murcia;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
30 Murcia;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
30 Murcia;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
30 Murcia;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
30 Murcia;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
30 Murcia;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
30 Murcia;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
30 Murcia;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
30 Murcia;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
30 Murcia;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;93,01
30 Murcia;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
30 Murcia;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
30 Murcia;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
30 Murcia;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;93,41
30 Murcia;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
30 Murcia;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
30 Murcia;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
30 Murcia;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;93,18
30 Murcia;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
30 Murcia;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
30 Murcia;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
30 Murcia;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
30 Murcia;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
30 Murcia;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
30 Murcia;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;87,16
30 Murcia;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
30 Murcia;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
30 Murcia;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
30 Murcia;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;88,6
30 Murcia;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
30 Murcia;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
30 Murcia;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
30 Murcia;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
30 Murcia;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
30 Murcia;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
30 Murcia;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;80,32
30 Murcia;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
30 Murcia;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
30 Murcia;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
30 Murcia;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;83,5
30 Murcia;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
30 Murcia;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
30 Murcia;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
30 Murcia;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
30 Murcia;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
30 Murcia;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
30 Murcia;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;75,3
30 Murcia;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
30 Murcia;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
30 Murcia;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
30 Murcia;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;79,08
30 Murcia;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
30 Murcia;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
30 Murcia;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
30 Murcia;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
30 Murcia;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
30 Murcia;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
30 Murcia;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
30 Murcia;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
30 Murcia;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
30 Murcia;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QI;18.085
30 Murcia;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
30 Murcia;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
30 Murcia;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
30 Murcia;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QI;18.279
30 Murcia;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
30 Murcia;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
30 Murcia;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
30 Murcia;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QI;17.625
30 Murcia;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
30 Murcia;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
30 Murcia;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2022QII;""
30 Murcia;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2022QI;17.308
30 Murcia;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
30 Murcia;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
30 Murcia;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2021QII;""
30 Murcia;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2021QI;17.722
30 Murcia;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
30 Murcia;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
30 Murcia;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2020QII;""
30 Murcia;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2020QI;16.375
30 Murcia;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
30 Murcia;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
30 Murcia;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2022QII;16.577
30 Murcia;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2022QI;""
30 Murcia;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
30 Murcia;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
30 Murcia;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2021QII;17.093
30 Murcia;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2021QI;""
30 Murcia;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
30 Murcia;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
30 Murcia;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2020QII;16.027
30 Murcia;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2020QI;""
30 Murcia;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
30 Murcia;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QIII;15.992
30 Murcia;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QII;""
30 Murcia;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QI;""
30 Murcia;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
30 Murcia;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QIII;16.601
30 Murcia;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QII;""
30 Murcia;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QI;""
30 Murcia;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
30 Murcia;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QIII;15.498
30 Murcia;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QII;""
30 Murcia;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QI;""
30 Murcia;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QIV;15.435
30 Murcia;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
30 Murcia;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QII;""
30 Murcia;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QI;""
30 Murcia;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QIV;16.121
30 Murcia;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
30 Murcia;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QII;""
30 Murcia;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QI;""
30 Murcia;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QIV;15.066
30 Murcia;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
30 Murcia;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QII;""
30 Murcia;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QI;""
30 Murcia;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
30 Murcia;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
30 Murcia;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
30 Murcia;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
30 Murcia;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
30 Murcia;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
30 Murcia;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
30 Murcia;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
30 Murcia;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
30 Murcia;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
30 Murcia;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
30 Murcia;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
30 Murcia;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
30 Murcia;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
30 Murcia;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
30 Murcia;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;95,7
30 Murcia;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
30 Murcia;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
30 Murcia;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
30 Murcia;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;96,95
30 Murcia;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
30 Murcia;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
30 Murcia;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
30 Murcia;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;92,91
30 Murcia;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
30 Murcia;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
30 Murcia;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;91,66
30 Murcia;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
30 Murcia;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
30 Murcia;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
30 Murcia;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;93,51
30 Murcia;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
30 Murcia;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
30 Murcia;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
30 Murcia;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;90,93
30 Murcia;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
30 Murcia;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
30 Murcia;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;88,43
30 Murcia;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
30 Murcia;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
30 Murcia;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
30 Murcia;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;90,82
30 Murcia;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
30 Murcia;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
30 Murcia;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
30 Murcia;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;87,93
30 Murcia;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
30 Murcia;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
30 Murcia;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;85,35
30 Murcia;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
30 Murcia;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
30 Murcia;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
30 Murcia;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;88,19
30 Murcia;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
30 Murcia;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
30 Murcia;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
30 Murcia;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;85,48
30 Murcia;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
30 Murcia;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
30 Murcia;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
30 Murcia;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
30 Murcia;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
30 Murcia;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
30 Murcia;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QI;10.683
30 Murcia;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
30 Murcia;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
30 Murcia;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
30 Murcia;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QI;11.012
30 Murcia;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
30 Murcia;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
30 Murcia;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
30 Murcia;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QI;10.613
30 Murcia;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
30 Murcia;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
30 Murcia;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2022QII;""
30 Murcia;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2022QI;10.263
30 Murcia;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
30 Murcia;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
30 Murcia;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2021QII;""
30 Murcia;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2021QI;10.692
30 Murcia;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
30 Murcia;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
30 Murcia;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2020QII;""
30 Murcia;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2020QI;9.901
30 Murcia;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
30 Murcia;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
30 Murcia;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2022QII;9.907
30 Murcia;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2022QI;""
30 Murcia;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
30 Murcia;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
30 Murcia;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2021QII;10.331
30 Murcia;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2021QI;""
30 Murcia;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
30 Murcia;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
30 Murcia;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2020QII;9.708
30 Murcia;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2020QI;""
30 Murcia;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
30 Murcia;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QIII;9.565
30 Murcia;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QII;""
30 Murcia;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QI;""
30 Murcia;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
30 Murcia;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QIII;10.073
30 Murcia;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QII;""
30 Murcia;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QI;""
30 Murcia;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
30 Murcia;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QIII;9.438
30 Murcia;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QII;""
30 Murcia;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QI;""
30 Murcia;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QIV;9.250
30 Murcia;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
30 Murcia;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QII;""
30 Murcia;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QI;""
30 Murcia;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QIV;9.790
30 Murcia;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
30 Murcia;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QII;""
30 Murcia;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QI;""
30 Murcia;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QIV;9.182
30 Murcia;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
30 Murcia;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QII;""
30 Murcia;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QI;""
30 Murcia;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
30 Murcia;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
30 Murcia;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
30 Murcia;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
30 Murcia;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
30 Murcia;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
30 Murcia;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
30 Murcia;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
30 Murcia;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
30 Murcia;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
30 Murcia;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
30 Murcia;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
30 Murcia;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
30 Murcia;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
30 Murcia;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
30 Murcia;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;96,07
30 Murcia;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
30 Murcia;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
30 Murcia;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
30 Murcia;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;97,09
30 Murcia;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
30 Murcia;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
30 Murcia;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
30 Murcia;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;93,29
30 Murcia;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
30 Murcia;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
30 Murcia;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;92,74
30 Murcia;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
30 Murcia;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
30 Murcia;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
30 Murcia;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;93,82
30 Murcia;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
30 Murcia;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
30 Murcia;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
30 Murcia;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;91,47
30 Murcia;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
30 Murcia;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
30 Murcia;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;89,53
30 Murcia;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
30 Murcia;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
30 Murcia;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
30 Murcia;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;91,47
30 Murcia;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
30 Murcia;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
30 Murcia;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
30 Murcia;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;88,93
30 Murcia;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
30 Murcia;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
30 Murcia;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;86,59
30 Murcia;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
30 Murcia;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
30 Murcia;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
30 Murcia;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;88,9
30 Murcia;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
30 Murcia;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
30 Murcia;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
30 Murcia;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;86,52
30 Murcia;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
30 Murcia;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
30 Murcia;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
30 Murcia;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
30 Murcia;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
30 Murcia;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
30 Murcia;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QI;7.402
30 Murcia;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
30 Murcia;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
30 Murcia;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
30 Murcia;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QI;7.267
30 Murcia;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
30 Murcia;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
30 Murcia;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
30 Murcia;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QI;7.012
30 Murcia;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
30 Murcia;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
30 Murcia;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2022QII;""
30 Murcia;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2022QI;7.045
30 Murcia;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
30 Murcia;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
30 Murcia;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2021QII;""
30 Murcia;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2021QI;7.030
30 Murcia;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
30 Murcia;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
30 Murcia;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2020QII;""
30 Murcia;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2020QI;6.474
30 Murcia;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
30 Murcia;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
30 Murcia;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2022QII;6.670
30 Murcia;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2022QI;""
30 Murcia;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
30 Murcia;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
30 Murcia;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2021QII;6.762
30 Murcia;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2021QI;""
30 Murcia;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
30 Murcia;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
30 Murcia;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2020QII;6.319
30 Murcia;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2020QI;""
30 Murcia;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
30 Murcia;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QIII;6.427
30 Murcia;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QII;""
30 Murcia;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QI;""
30 Murcia;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
30 Murcia;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QIII;6.528
30 Murcia;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QII;""
30 Murcia;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QI;""
30 Murcia;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
30 Murcia;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QIII;6.060
30 Murcia;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QII;""
30 Murcia;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QI;""
30 Murcia;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QIV;6.185
30 Murcia;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
30 Murcia;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QII;""
30 Murcia;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QI;""
30 Murcia;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QIV;6.331
30 Murcia;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
30 Murcia;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QII;""
30 Murcia;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QI;""
30 Murcia;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QIV;5.884
30 Murcia;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
30 Murcia;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QII;""
30 Murcia;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QI;""
30 Murcia;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
30 Murcia;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
30 Murcia;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
30 Murcia;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
30 Murcia;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
30 Murcia;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
30 Murcia;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
30 Murcia;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
30 Murcia;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
30 Murcia;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
30 Murcia;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
30 Murcia;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
30 Murcia;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
30 Murcia;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
30 Murcia;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
30 Murcia;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;95,18
30 Murcia;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
30 Murcia;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
30 Murcia;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
30 Murcia;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;96,74
30 Murcia;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
30 Murcia;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
30 Murcia;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
30 Murcia;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;92,33
30 Murcia;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
30 Murcia;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
30 Murcia;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;90,11
30 Murcia;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
30 Murcia;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
30 Murcia;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
30 Murcia;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;93,05
30 Murcia;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
30 Murcia;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
30 Murcia;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
30 Murcia;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;90,12
30 Murcia;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
30 Murcia;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
30 Murcia;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;86,83
30 Murcia;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
30 Murcia;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
30 Murcia;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
30 Murcia;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;89,83
30 Murcia;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
30 Murcia;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
30 Murcia;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
30 Murcia;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;86,42
30 Murcia;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
30 Murcia;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
30 Murcia;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;83,56
30 Murcia;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
30 Murcia;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
30 Murcia;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
30 Murcia;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;87,12
30 Murcia;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
30 Murcia;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
30 Murcia;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
30 Murcia;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;83,91
30 Murcia;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
30 Murcia;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
30 Murcia;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
30 Murcia;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
30 Murcia;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
30 Murcia;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QII;17.090
30 Murcia;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
30 Murcia;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
30 Murcia;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
30 Murcia;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QII;17.443
30 Murcia;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
30 Murcia;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
30 Murcia;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
30 Murcia;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QII;17.488
30 Murcia;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
30 Murcia;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
30 Murcia;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
30 Murcia;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2022QII;16.307
30 Murcia;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2022QI;""
30 Murcia;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
30 Murcia;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
30 Murcia;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2021QII;16.751
30 Murcia;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2021QI;""
30 Murcia;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
30 Murcia;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
30 Murcia;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2020QII;17.089
30 Murcia;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2020QI;""
30 Murcia;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
30 Murcia;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2022QIII;15.692
30 Murcia;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2022QII;""
30 Murcia;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2022QI;""
30 Murcia;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
30 Murcia;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2021QIII;16.197
30 Murcia;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2021QII;""
30 Murcia;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2021QI;""
30 Murcia;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
30 Murcia;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2020QIII;16.482
30 Murcia;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2020QII;""
30 Murcia;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2020QI;""
30 Murcia;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QIV;15.088
30 Murcia;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
30 Murcia;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QII;""
30 Murcia;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QI;""
30 Murcia;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QIV;15.659
30 Murcia;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
30 Murcia;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QII;""
30 Murcia;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QI;""
30 Murcia;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QIV;15.983
30 Murcia;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
30 Murcia;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QII;""
30 Murcia;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QI;""
30 Murcia;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
30 Murcia;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
30 Murcia;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QII;""
30 Murcia;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QI;15.088
30 Murcia;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
30 Murcia;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
30 Murcia;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QII;""
30 Murcia;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QI;15.595
30 Murcia;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
30 Murcia;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
30 Murcia;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QII;""
30 Murcia;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QI;""
30 Murcia;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
30 Murcia;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
30 Murcia;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
30 Murcia;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
30 Murcia;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
30 Murcia;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
30 Murcia;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
30 Murcia;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
30 Murcia;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
30 Murcia;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
30 Murcia;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
30 Murcia;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
30 Murcia;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
30 Murcia;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
30 Murcia;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;95,42
30 Murcia;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
30 Murcia;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
30 Murcia;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
30 Murcia;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;96,03
30 Murcia;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
30 Murcia;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
30 Murcia;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
30 Murcia;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;97,72
30 Murcia;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
30 Murcia;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
30 Murcia;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;91,82
30 Murcia;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
30 Murcia;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
30 Murcia;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
30 Murcia;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;92,86
30 Murcia;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
30 Murcia;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
30 Murcia;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
30 Murcia;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;94,25
30 Murcia;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
30 Murcia;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
30 Murcia;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;88,29
30 Murcia;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
30 Murcia;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
30 Murcia;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
30 Murcia;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;89,77
30 Murcia;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
30 Murcia;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
30 Murcia;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
30 Murcia;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;91,39
30 Murcia;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
30 Murcia;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
30 Murcia;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
30 Murcia;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
30 Murcia;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
30 Murcia;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
30 Murcia;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;86,5
30 Murcia;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
30 Murcia;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
30 Murcia;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
30 Murcia;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;89,18
30 Murcia;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
30 Murcia;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
30 Murcia;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
30 Murcia;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
30 Murcia;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
30 Murcia;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
30 Murcia;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QII;10.047
30 Murcia;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
30 Murcia;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
30 Murcia;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
30 Murcia;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QII;10.394
30 Murcia;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
30 Murcia;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
30 Murcia;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
30 Murcia;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QII;10.571
30 Murcia;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
30 Murcia;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
30 Murcia;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
30 Murcia;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2022QII;9.671
30 Murcia;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2022QI;""
30 Murcia;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
30 Murcia;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
30 Murcia;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2021QII;10.007
30 Murcia;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2021QI;""
30 Murcia;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
30 Murcia;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
30 Murcia;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2020QII;10.346
30 Murcia;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2020QI;""
30 Murcia;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
30 Murcia;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2022QIII;9.295
30 Murcia;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2022QII;""
30 Murcia;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2022QI;""
30 Murcia;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
30 Murcia;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2021QIII;9.713
30 Murcia;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2021QII;""
30 Murcia;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2021QI;""
30 Murcia;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
30 Murcia;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2020QIII;10.022
30 Murcia;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2020QII;""
30 Murcia;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2020QI;""
30 Murcia;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QIV;8.950
30 Murcia;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
30 Murcia;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QII;""
30 Murcia;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QI;""
30 Murcia;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QIV;9.393
30 Murcia;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
30 Murcia;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QII;""
30 Murcia;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QI;""
30 Murcia;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QIV;9.721
30 Murcia;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
30 Murcia;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QII;""
30 Murcia;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QI;""
30 Murcia;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
30 Murcia;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
30 Murcia;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QII;""
30 Murcia;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QI;9.093
30 Murcia;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
30 Murcia;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
30 Murcia;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QII;""
30 Murcia;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QI;9.493
30 Murcia;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
30 Murcia;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
30 Murcia;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QII;""
30 Murcia;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QI;""
30 Murcia;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
30 Murcia;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
30 Murcia;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
30 Murcia;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
30 Murcia;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
30 Murcia;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
30 Murcia;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
30 Murcia;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
30 Murcia;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
30 Murcia;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
30 Murcia;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
30 Murcia;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
30 Murcia;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
30 Murcia;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
30 Murcia;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;96,26
30 Murcia;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
30 Murcia;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
30 Murcia;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
30 Murcia;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;96,28
30 Murcia;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
30 Murcia;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
30 Murcia;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
30 Murcia;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;97,87
30 Murcia;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
30 Murcia;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
30 Murcia;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;92,52
30 Murcia;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
30 Murcia;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
30 Murcia;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
30 Murcia;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;93,45
30 Murcia;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
30 Murcia;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
30 Murcia;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
30 Murcia;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;94,81
30 Murcia;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
30 Murcia;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
30 Murcia;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;89,08
30 Murcia;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
30 Murcia;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
30 Murcia;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
30 Murcia;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;90,37
30 Murcia;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
30 Murcia;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
30 Murcia;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
30 Murcia;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;91,96
30 Murcia;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
30 Murcia;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
30 Murcia;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
30 Murcia;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
30 Murcia;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
30 Murcia;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
30 Murcia;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;87,48
30 Murcia;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
30 Murcia;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
30 Murcia;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
30 Murcia;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;89,8
30 Murcia;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
30 Murcia;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
30 Murcia;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
30 Murcia;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
30 Murcia;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
30 Murcia;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
30 Murcia;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QII;7.043
30 Murcia;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
30 Murcia;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
30 Murcia;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
30 Murcia;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QII;7.049
30 Murcia;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
30 Murcia;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
30 Murcia;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
30 Murcia;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QII;6.917
30 Murcia;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
30 Murcia;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
30 Murcia;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
30 Murcia;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2022QII;6.636
30 Murcia;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2022QI;""
30 Murcia;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
30 Murcia;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
30 Murcia;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2021QII;6.744
30 Murcia;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2021QI;""
30 Murcia;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
30 Murcia;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
30 Murcia;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2020QII;6.743
30 Murcia;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2020QI;""
30 Murcia;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
30 Murcia;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2022QIII;6.397
30 Murcia;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2022QII;""
30 Murcia;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2022QI;""
30 Murcia;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
30 Murcia;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2021QIII;6.484
30 Murcia;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2021QII;""
30 Murcia;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2021QI;""
30 Murcia;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
30 Murcia;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2020QIII;6.460
30 Murcia;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2020QII;""
30 Murcia;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2020QI;""
30 Murcia;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QIV;6.138
30 Murcia;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
30 Murcia;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QII;""
30 Murcia;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QI;""
30 Murcia;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QIV;6.266
30 Murcia;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
30 Murcia;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QII;""
30 Murcia;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QI;""
30 Murcia;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QIV;6.262
30 Murcia;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
30 Murcia;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QII;""
30 Murcia;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QI;""
30 Murcia;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
30 Murcia;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
30 Murcia;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QII;""
30 Murcia;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QI;5.995
30 Murcia;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
30 Murcia;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
30 Murcia;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QII;""
30 Murcia;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QI;6.102
30 Murcia;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
30 Murcia;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
30 Murcia;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QII;""
30 Murcia;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QI;""
30 Murcia;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
30 Murcia;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
30 Murcia;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
30 Murcia;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
30 Murcia;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
30 Murcia;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
30 Murcia;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
30 Murcia;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
30 Murcia;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
30 Murcia;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
30 Murcia;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
30 Murcia;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
30 Murcia;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
30 Murcia;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
30 Murcia;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;94,22
30 Murcia;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
30 Murcia;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
30 Murcia;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
30 Murcia;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;95,67
30 Murcia;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
30 Murcia;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
30 Murcia;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
30 Murcia;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;97,48
30 Murcia;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
30 Murcia;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
30 Murcia;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;90,83
30 Murcia;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
30 Murcia;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
30 Murcia;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
30 Murcia;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;91,98
30 Murcia;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
30 Murcia;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
30 Murcia;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
30 Murcia;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;93,39
30 Murcia;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
30 Murcia;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
30 Murcia;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;87,15
30 Murcia;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
30 Murcia;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
30 Murcia;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
30 Murcia;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;88,89
30 Murcia;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
30 Murcia;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
30 Murcia;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
30 Murcia;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;90,53
30 Murcia;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
30 Murcia;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
30 Murcia;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
30 Murcia;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
30 Murcia;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
30 Murcia;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
30 Murcia;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;85,05
30 Murcia;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
30 Murcia;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
30 Murcia;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
30 Murcia;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;88,22
30 Murcia;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
30 Murcia;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
30 Murcia;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
30 Murcia;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
30 Murcia;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
30 Murcia;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QIII;17.200
30 Murcia;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
30 Murcia;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
30 Murcia;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
30 Murcia;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QIII;17.668
30 Murcia;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
30 Murcia;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
30 Murcia;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
30 Murcia;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QIII;17.871
30 Murcia;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
30 Murcia;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
30 Murcia;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
30 Murcia;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2022QIII;16.485
30 Murcia;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2022QII;""
30 Murcia;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2022QI;""
30 Murcia;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
30 Murcia;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2021QIII;17.010
30 Murcia;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2021QII;""
30 Murcia;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2021QI;""
30 Murcia;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
30 Murcia;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2020QIII;17.133
30 Murcia;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2020QII;""
30 Murcia;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2020QI;""
30 Murcia;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2022QIV;15.771
30 Murcia;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
30 Murcia;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2022QII;""
30 Murcia;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2022QI;""
30 Murcia;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2021QIV;16.397
30 Murcia;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
30 Murcia;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2021QII;""
30 Murcia;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2021QI;""
30 Murcia;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2020QIV;16.577
30 Murcia;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
30 Murcia;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2020QII;""
30 Murcia;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2020QI;""
30 Murcia;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
30 Murcia;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
30 Murcia;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QII;""
30 Murcia;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QI;15.764
30 Murcia;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
30 Murcia;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
30 Murcia;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QII;""
30 Murcia;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QI;16.155
30 Murcia;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
30 Murcia;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
30 Murcia;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QII;""
30 Murcia;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QI;""
30 Murcia;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
30 Murcia;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
30 Murcia;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QII;15.176
30 Murcia;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QI;""
30 Murcia;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
30 Murcia;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
30 Murcia;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QII;15.647
30 Murcia;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QI;""
30 Murcia;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
30 Murcia;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
30 Murcia;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QII;""
30 Murcia;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QI;""
30 Murcia;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
30 Murcia;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
30 Murcia;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
30 Murcia;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
30 Murcia;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
30 Murcia;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
30 Murcia;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
30 Murcia;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
30 Murcia;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
30 Murcia;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
30 Murcia;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
30 Murcia;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
30 Murcia;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
30 Murcia;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;95,84
30 Murcia;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
30 Murcia;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
30 Murcia;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
30 Murcia;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;96,28
30 Murcia;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
30 Murcia;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
30 Murcia;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
30 Murcia;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;95,87
30 Murcia;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
30 Murcia;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
30 Murcia;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;91,69
30 Murcia;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
30 Murcia;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
30 Murcia;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
30 Murcia;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;92,81
30 Murcia;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
30 Murcia;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
30 Murcia;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
30 Murcia;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;92,76
30 Murcia;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
30 Murcia;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
30 Murcia;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
30 Murcia;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
30 Murcia;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
30 Murcia;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
30 Murcia;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;89,22
30 Murcia;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
30 Murcia;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
30 Murcia;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
30 Murcia;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;90,4
30 Murcia;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
30 Murcia;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
30 Murcia;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
30 Murcia;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
30 Murcia;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
30 Murcia;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
30 Murcia;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;85,9
30 Murcia;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
30 Murcia;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
30 Murcia;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
30 Murcia;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;87,56
30 Murcia;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
30 Murcia;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
30 Murcia;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
30 Murcia;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
30 Murcia;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
30 Murcia;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
30 Murcia;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QIII;10.167
30 Murcia;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
30 Murcia;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
30 Murcia;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
30 Murcia;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QIII;10.513
30 Murcia;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
30 Murcia;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
30 Murcia;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
30 Murcia;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QIII;10.825
30 Murcia;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
30 Murcia;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
30 Murcia;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
30 Murcia;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2022QIII;9.735
30 Murcia;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2022QII;""
30 Murcia;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2022QI;""
30 Murcia;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
30 Murcia;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2021QIII;10.165
30 Murcia;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2021QII;""
30 Murcia;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2021QI;""
30 Murcia;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
30 Murcia;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2020QIII;10.423
30 Murcia;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2020QII;""
30 Murcia;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2020QI;""
30 Murcia;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2022QIV;9.328
30 Murcia;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
30 Murcia;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2022QII;""
30 Murcia;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2022QI;""
30 Murcia;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2021QIV;9.806
30 Murcia;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
30 Murcia;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2021QII;""
30 Murcia;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2021QI;""
30 Murcia;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2020QIV;10.085
30 Murcia;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
30 Murcia;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2020QII;""
30 Murcia;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2020QI;""
30 Murcia;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
30 Murcia;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
30 Murcia;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QII;""
30 Murcia;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QI;9.468
30 Murcia;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
30 Murcia;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
30 Murcia;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QII;""
30 Murcia;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QI;9.837
30 Murcia;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
30 Murcia;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
30 Murcia;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QII;""
30 Murcia;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QI;""
30 Murcia;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
30 Murcia;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
30 Murcia;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QII;9.177
30 Murcia;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QI;""
30 Murcia;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
30 Murcia;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
30 Murcia;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QII;9.542
30 Murcia;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QI;""
30 Murcia;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
30 Murcia;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
30 Murcia;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QII;""
30 Murcia;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QI;""
30 Murcia;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
30 Murcia;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
30 Murcia;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
30 Murcia;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
30 Murcia;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
30 Murcia;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
30 Murcia;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
30 Murcia;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
30 Murcia;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
30 Murcia;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
30 Murcia;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
30 Murcia;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
30 Murcia;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
30 Murcia;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;95,75
30 Murcia;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
30 Murcia;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
30 Murcia;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
30 Murcia;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;96,69
30 Murcia;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
30 Murcia;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
30 Murcia;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
30 Murcia;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;96,29
30 Murcia;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
30 Murcia;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
30 Murcia;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;91,75
30 Murcia;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
30 Murcia;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
30 Murcia;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
30 Murcia;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;93,27
30 Murcia;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
30 Murcia;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
30 Murcia;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
30 Murcia;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;93,16
30 Murcia;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
30 Murcia;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
30 Murcia;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
30 Murcia;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
30 Murcia;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
30 Murcia;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
30 Murcia;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;90,06
30 Murcia;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
30 Murcia;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
30 Murcia;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
30 Murcia;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;90,87
30 Murcia;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
30 Murcia;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
30 Murcia;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
30 Murcia;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
30 Murcia;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
30 Murcia;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
30 Murcia;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;87,29
30 Murcia;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
30 Murcia;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
30 Murcia;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
30 Murcia;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;88,15
30 Murcia;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
30 Murcia;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
30 Murcia;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
30 Murcia;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
30 Murcia;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
30 Murcia;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
30 Murcia;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QIII;7.033
30 Murcia;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
30 Murcia;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
30 Murcia;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
30 Murcia;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QIII;7.155
30 Murcia;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
30 Murcia;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
30 Murcia;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
30 Murcia;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QIII;7.046
30 Murcia;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
30 Murcia;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
30 Murcia;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
30 Murcia;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2022QIII;6.750
30 Murcia;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2022QII;""
30 Murcia;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2022QI;""
30 Murcia;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
30 Murcia;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2021QIII;6.845
30 Murcia;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2021QII;""
30 Murcia;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2021QI;""
30 Murcia;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
30 Murcia;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2020QIII;6.710
30 Murcia;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2020QII;""
30 Murcia;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2020QI;""
30 Murcia;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2022QIV;6.443
30 Murcia;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
30 Murcia;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2022QII;""
30 Murcia;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2022QI;""
30 Murcia;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2021QIV;6.591
30 Murcia;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
30 Murcia;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2021QII;""
30 Murcia;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2021QI;""
30 Murcia;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2020QIV;6.492
30 Murcia;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
30 Murcia;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2020QII;""
30 Murcia;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2020QI;""
30 Murcia;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
30 Murcia;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
30 Murcia;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QII;""
30 Murcia;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QI;6.296
30 Murcia;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
30 Murcia;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
30 Murcia;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QII;""
30 Murcia;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QI;6.318
30 Murcia;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
30 Murcia;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
30 Murcia;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QII;""
30 Murcia;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QI;""
30 Murcia;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
30 Murcia;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
30 Murcia;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QII;5.999
30 Murcia;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QI;""
30 Murcia;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
30 Murcia;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
30 Murcia;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QII;6.105
30 Murcia;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QI;""
30 Murcia;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
30 Murcia;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
30 Murcia;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QII;""
30 Murcia;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QI;""
30 Murcia;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
30 Murcia;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
30 Murcia;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
30 Murcia;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
30 Murcia;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
30 Murcia;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
30 Murcia;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
30 Murcia;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
30 Murcia;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
30 Murcia;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
30 Murcia;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
30 Murcia;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
30 Murcia;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
30 Murcia;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;95,98
30 Murcia;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
30 Murcia;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
30 Murcia;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
30 Murcia;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;95,67
30 Murcia;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
30 Murcia;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
30 Murcia;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
30 Murcia;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;95,23
30 Murcia;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
30 Murcia;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
30 Murcia;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;91,61
30 Murcia;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
30 Murcia;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
30 Murcia;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
30 Murcia;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;92,12
30 Murcia;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
30 Murcia;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
30 Murcia;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
30 Murcia;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;92,14
30 Murcia;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
30 Murcia;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
30 Murcia;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
30 Murcia;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
30 Murcia;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
30 Murcia;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
30 Murcia;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;87,99
30 Murcia;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
30 Murcia;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
30 Murcia;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
30 Murcia;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;89,67
30 Murcia;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
30 Murcia;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
30 Murcia;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
30 Murcia;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
30 Murcia;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
30 Murcia;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
30 Murcia;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;83,84
30 Murcia;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
30 Murcia;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
30 Murcia;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
30 Murcia;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;86,64
30 Murcia;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
30 Murcia;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
30 Murcia;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
30 Murcia;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
30 Murcia;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
30 Murcia;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QIV;17.283
30 Murcia;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
30 Murcia;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
30 Murcia;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
30 Murcia;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QIV;17.822
30 Murcia;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
30 Murcia;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
30 Murcia;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
30 Murcia;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QIV;17.995
30 Murcia;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
30 Murcia;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
30 Murcia;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
30 Murcia;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2022QIV;16.491
30 Murcia;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
30 Murcia;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2022QII;""
30 Murcia;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2022QI;""
30 Murcia;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2021QIV;17.130
30 Murcia;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
30 Murcia;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2021QII;""
30 Murcia;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2021QI;""
30 Murcia;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2020QIV;17.361
30 Murcia;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
30 Murcia;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2020QII;""
30 Murcia;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2020QI;""
30 Murcia;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
30 Murcia;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
30 Murcia;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2022QII;""
30 Murcia;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2022QI;16.449
30 Murcia;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
30 Murcia;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
30 Murcia;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2021QII;""
30 Murcia;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2021QI;16.877
30 Murcia;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
30 Murcia;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
30 Murcia;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2020QII;""
30 Murcia;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2020QI;""
30 Murcia;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
30 Murcia;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
30 Murcia;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QII;15.803
30 Murcia;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QI;""
30 Murcia;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
30 Murcia;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
30 Murcia;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QII;16.318
30 Murcia;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QI;""
30 Murcia;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
30 Murcia;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
30 Murcia;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QII;""
30 Murcia;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QI;""
30 Murcia;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
30 Murcia;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QIII;15.273
30 Murcia;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QII;""
30 Murcia;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QI;""
30 Murcia;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
30 Murcia;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QIII;15.867
30 Murcia;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QII;""
30 Murcia;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QI;""
30 Murcia;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
30 Murcia;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
30 Murcia;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QII;""
30 Murcia;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QI;""
30 Murcia;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
30 Murcia;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
30 Murcia;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
30 Murcia;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
30 Murcia;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
30 Murcia;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
30 Murcia;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
30 Murcia;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
30 Murcia;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
30 Murcia;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
30 Murcia;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
30 Murcia;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
30 Murcia;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;95,42
30 Murcia;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
30 Murcia;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
30 Murcia;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
30 Murcia;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;96,12
30 Murcia;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
30 Murcia;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
30 Murcia;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
30 Murcia;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;96,48
30 Murcia;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
30 Murcia;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
30 Murcia;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
30 Murcia;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
30 Murcia;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
30 Murcia;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
30 Murcia;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;92,3
30 Murcia;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
30 Murcia;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
30 Murcia;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
30 Murcia;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;93,79
30 Murcia;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
30 Murcia;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
30 Murcia;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
30 Murcia;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
30 Murcia;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
30 Murcia;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
30 Murcia;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;88,67
30 Murcia;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
30 Murcia;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
30 Murcia;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
30 Murcia;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;90,68
30 Murcia;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
30 Murcia;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
30 Murcia;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
30 Murcia;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
30 Murcia;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
30 Murcia;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
30 Murcia;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;85,7
30 Murcia;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
30 Murcia;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
30 Murcia;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
30 Murcia;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;88,17
30 Murcia;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
30 Murcia;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
30 Murcia;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
30 Murcia;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
30 Murcia;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
30 Murcia;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
30 Murcia;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QIV;10.178
30 Murcia;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
30 Murcia;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
30 Murcia;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
30 Murcia;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QIV;10.611
30 Murcia;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
30 Murcia;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
30 Murcia;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
30 Murcia;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QIV;10.889
30 Murcia;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
30 Murcia;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
30 Murcia;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
30 Murcia;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2022QIV;9.725
30 Murcia;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
30 Murcia;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2022QII;""
30 Murcia;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2022QI;""
30 Murcia;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2021QIV;10.203
30 Murcia;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
30 Murcia;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2021QII;""
30 Murcia;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2021QI;""
30 Murcia;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2020QIV;10.506
30 Murcia;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
30 Murcia;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2020QII;""
30 Murcia;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2020QI;""
30 Murcia;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
30 Murcia;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
30 Murcia;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2022QII;""
30 Murcia;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2022QI;9.832
30 Murcia;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
30 Murcia;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
30 Murcia;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2021QII;""
30 Murcia;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2021QI;10.228
30 Murcia;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
30 Murcia;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
30 Murcia;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2020QII;""
30 Murcia;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2020QI;""
30 Murcia;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
30 Murcia;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
30 Murcia;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QII;9.513
30 Murcia;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QI;""
30 Murcia;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
30 Murcia;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
30 Murcia;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QII;9.908
30 Murcia;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QI;""
30 Murcia;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
30 Murcia;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
30 Murcia;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QII;""
30 Murcia;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QI;""
30 Murcia;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
30 Murcia;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QIII;9.201
30 Murcia;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QII;""
30 Murcia;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QI;""
30 Murcia;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
30 Murcia;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QIII;9.666
30 Murcia;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QII;""
30 Murcia;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QI;""
30 Murcia;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
30 Murcia;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
30 Murcia;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QII;""
30 Murcia;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QI;""
30 Murcia;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
30 Murcia;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
30 Murcia;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
30 Murcia;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
30 Murcia;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
30 Murcia;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
30 Murcia;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
30 Murcia;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
30 Murcia;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
30 Murcia;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
30 Murcia;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
30 Murcia;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
30 Murcia;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;95,55
30 Murcia;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
30 Murcia;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
30 Murcia;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
30 Murcia;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;96,15
30 Murcia;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
30 Murcia;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
30 Murcia;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
30 Murcia;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;96,48
30 Murcia;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
30 Murcia;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
30 Murcia;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
30 Murcia;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
30 Murcia;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
30 Murcia;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
30 Murcia;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;92,66
30 Murcia;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
30 Murcia;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
30 Murcia;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
30 Murcia;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;93,93
30 Murcia;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
30 Murcia;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
30 Murcia;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
30 Murcia;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
30 Murcia;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
30 Murcia;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
30 Murcia;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;89,65
30 Murcia;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
30 Murcia;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
30 Murcia;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
30 Murcia;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;90,99
30 Murcia;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
30 Murcia;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
30 Murcia;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
30 Murcia;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
30 Murcia;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
30 Murcia;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
30 Murcia;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;86,71
30 Murcia;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
30 Murcia;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
30 Murcia;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
30 Murcia;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;88,77
30 Murcia;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
30 Murcia;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
30 Murcia;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
30 Murcia;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
30 Murcia;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
30 Murcia;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
30 Murcia;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QIV;7.105
30 Murcia;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
30 Murcia;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
30 Murcia;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
30 Murcia;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QIV;7.211
30 Murcia;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
30 Murcia;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
30 Murcia;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
30 Murcia;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QIV;7.106
30 Murcia;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
30 Murcia;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
30 Murcia;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
30 Murcia;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2022QIV;6.766
30 Murcia;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
30 Murcia;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2022QII;""
30 Murcia;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2022QI;""
30 Murcia;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2021QIV;6.927
30 Murcia;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
30 Murcia;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2021QII;""
30 Murcia;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2021QI;""
30 Murcia;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2020QIV;6.855
30 Murcia;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
30 Murcia;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2020QII;""
30 Murcia;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2020QI;""
30 Murcia;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
30 Murcia;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
30 Murcia;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2022QII;""
30 Murcia;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2022QI;6.617
30 Murcia;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
30 Murcia;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
30 Murcia;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2021QII;""
30 Murcia;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2021QI;6.649
30 Murcia;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
30 Murcia;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
30 Murcia;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2020QII;""
30 Murcia;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2020QI;""
30 Murcia;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
30 Murcia;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
30 Murcia;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QII;6.290
30 Murcia;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QI;""
30 Murcia;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
30 Murcia;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
30 Murcia;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QII;6.410
30 Murcia;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QI;""
30 Murcia;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
30 Murcia;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
30 Murcia;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QII;""
30 Murcia;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QI;""
30 Murcia;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
30 Murcia;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QIII;6.072
30 Murcia;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QII;""
30 Murcia;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QI;""
30 Murcia;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
30 Murcia;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QIII;6.201
30 Murcia;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QII;""
30 Murcia;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QI;""
30 Murcia;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
30 Murcia;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
30 Murcia;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QII;""
30 Murcia;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QI;""
30 Murcia;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
30 Murcia;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
30 Murcia;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
30 Murcia;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
30 Murcia;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
30 Murcia;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
30 Murcia;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
30 Murcia;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
30 Murcia;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
30 Murcia;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
30 Murcia;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
30 Murcia;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
30 Murcia;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;95,23
30 Murcia;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
30 Murcia;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
30 Murcia;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
30 Murcia;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;96,06
30 Murcia;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
30 Murcia;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
30 Murcia;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
30 Murcia;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;96,47
30 Murcia;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
30 Murcia;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
30 Murcia;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
30 Murcia;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
30 Murcia;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
30 Murcia;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
30 Murcia;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;91,76
30 Murcia;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
30 Murcia;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
30 Murcia;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
30 Murcia;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;93,57
30 Murcia;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
30 Murcia;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
30 Murcia;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
30 Murcia;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
30 Murcia;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
30 Murcia;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
30 Murcia;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;87,23
30 Murcia;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
30 Murcia;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
30 Murcia;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
30 Murcia;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;90,21
30 Murcia;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
30 Murcia;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
30 Murcia;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
30 Murcia;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
30 Murcia;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
30 Murcia;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
30 Murcia;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;84,2
30 Murcia;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
30 Murcia;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
30 Murcia;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
30 Murcia;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;87,26
30 Murcia;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
30 Murcia;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
30 Murcia;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
30 Murcia;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
30 Murcia;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
30 Murcia;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
30 Murcia;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
30 Murcia;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
30 Murcia;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
30 Murcia;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QI;29.070
30 Murcia;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
30 Murcia;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
30 Murcia;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
30 Murcia;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QI;28.803
30 Murcia;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
30 Murcia;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
30 Murcia;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
30 Murcia;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QI;28.684
30 Murcia;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
30 Murcia;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
30 Murcia;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2022QII;""
30 Murcia;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2022QI;28.163
30 Murcia;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
30 Murcia;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
30 Murcia;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2021QII;""
30 Murcia;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2021QI;28.187
30 Murcia;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
30 Murcia;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
30 Murcia;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2020QII;""
30 Murcia;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2020QI;26.976
30 Murcia;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
30 Murcia;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
30 Murcia;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2022QII;27.233
30 Murcia;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2022QI;""
30 Murcia;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
30 Murcia;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
30 Murcia;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2021QII;27.496
30 Murcia;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2021QI;""
30 Murcia;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
30 Murcia;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
30 Murcia;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2020QII;26.511
30 Murcia;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2020QI;""
30 Murcia;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
30 Murcia;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QIII;26.638
30 Murcia;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QII;""
30 Murcia;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QI;""
30 Murcia;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
30 Murcia;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QIII;26.896
30 Murcia;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QII;""
30 Murcia;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QI;""
30 Murcia;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
30 Murcia;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QIII;25.969
30 Murcia;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QII;""
30 Murcia;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QI;""
30 Murcia;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QIV;25.981
30 Murcia;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
30 Murcia;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QII;""
30 Murcia;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QI;""
30 Murcia;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QIV;26.311
30 Murcia;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
30 Murcia;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QII;""
30 Murcia;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QI;""
30 Murcia;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QIV;25.415
30 Murcia;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
30 Murcia;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QII;""
30 Murcia;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QI;""
30 Murcia;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
30 Murcia;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
30 Murcia;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
30 Murcia;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
30 Murcia;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
30 Murcia;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
30 Murcia;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
30 Murcia;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
30 Murcia;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
30 Murcia;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
30 Murcia;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
30 Murcia;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
30 Murcia;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
30 Murcia;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
30 Murcia;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
30 Murcia;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;96,88
30 Murcia;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
30 Murcia;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
30 Murcia;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
30 Murcia;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;97,86
30 Murcia;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
30 Murcia;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
30 Murcia;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
30 Murcia;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;94,05
30 Murcia;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
30 Murcia;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
30 Murcia;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;93,68
30 Murcia;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
30 Murcia;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
30 Murcia;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
30 Murcia;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;95,46
30 Murcia;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
30 Murcia;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
30 Murcia;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
30 Murcia;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;92,42
30 Murcia;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
30 Murcia;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
30 Murcia;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;91,63
30 Murcia;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
30 Murcia;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
30 Murcia;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
30 Murcia;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;93,38
30 Murcia;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
30 Murcia;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
30 Murcia;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
30 Murcia;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;90,53
30 Murcia;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
30 Murcia;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
30 Murcia;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;89,37
30 Murcia;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
30 Murcia;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
30 Murcia;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
30 Murcia;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;91,35
30 Murcia;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
30 Murcia;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
30 Murcia;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
30 Murcia;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;88,6
30 Murcia;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
30 Murcia;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
30 Murcia;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
30 Murcia;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
30 Murcia;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
30 Murcia;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
30 Murcia;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QI;18.643
30 Murcia;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
30 Murcia;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
30 Murcia;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
30 Murcia;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QI;18.629
30 Murcia;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
30 Murcia;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
30 Murcia;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
30 Murcia;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QI;18.542
30 Murcia;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
30 Murcia;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
30 Murcia;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2022QII;""
30 Murcia;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2022QI;18.118
30 Murcia;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
30 Murcia;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
30 Murcia;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2021QII;""
30 Murcia;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2021QI;18.247
30 Murcia;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
30 Murcia;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
30 Murcia;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2020QII;""
30 Murcia;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2020QI;17.529
30 Murcia;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
30 Murcia;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
30 Murcia;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2022QII;17.573
30 Murcia;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2022QI;""
30 Murcia;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
30 Murcia;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
30 Murcia;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2021QII;17.815
30 Murcia;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2021QI;""
30 Murcia;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
30 Murcia;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
30 Murcia;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2020QII;17.240
30 Murcia;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2020QI;""
30 Murcia;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
30 Murcia;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QIII;17.230
30 Murcia;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QII;""
30 Murcia;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QI;""
30 Murcia;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
30 Murcia;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QIII;17.441
30 Murcia;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QII;""
30 Murcia;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QI;""
30 Murcia;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
30 Murcia;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QIII;16.913
30 Murcia;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QII;""
30 Murcia;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QI;""
30 Murcia;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QIV;16.838
30 Murcia;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
30 Murcia;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QII;""
30 Murcia;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QI;""
30 Murcia;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QIV;17.085
30 Murcia;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
30 Murcia;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QII;""
30 Murcia;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QI;""
30 Murcia;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QIV;16.586
30 Murcia;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
30 Murcia;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QII;""
30 Murcia;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QI;""
30 Murcia;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
30 Murcia;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
30 Murcia;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
30 Murcia;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
30 Murcia;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
30 Murcia;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
30 Murcia;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
30 Murcia;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
30 Murcia;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
30 Murcia;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
30 Murcia;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
30 Murcia;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
30 Murcia;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
30 Murcia;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
30 Murcia;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
30 Murcia;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;97,18
30 Murcia;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
30 Murcia;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
30 Murcia;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
30 Murcia;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;97,95
30 Murcia;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
30 Murcia;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
30 Murcia;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
30 Murcia;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;94,54
30 Murcia;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
30 Murcia;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
30 Murcia;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;94,26
30 Murcia;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
30 Murcia;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
30 Murcia;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
30 Murcia;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;95,63
30 Murcia;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
30 Murcia;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
30 Murcia;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
30 Murcia;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;92,98
30 Murcia;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
30 Murcia;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
30 Murcia;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;92,42
30 Murcia;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
30 Murcia;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
30 Murcia;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
30 Murcia;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;93,62
30 Murcia;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
30 Murcia;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
30 Murcia;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
30 Murcia;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;91,21
30 Murcia;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
30 Murcia;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
30 Murcia;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;90,32
30 Murcia;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
30 Murcia;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
30 Murcia;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
30 Murcia;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;91,71
30 Murcia;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
30 Murcia;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
30 Murcia;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
30 Murcia;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;89,45
30 Murcia;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
30 Murcia;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
30 Murcia;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
30 Murcia;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
30 Murcia;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
30 Murcia;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
30 Murcia;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QI;10.427
30 Murcia;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
30 Murcia;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
30 Murcia;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
30 Murcia;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QI;10.174
30 Murcia;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
30 Murcia;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
30 Murcia;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
30 Murcia;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QI;10.142
30 Murcia;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
30 Murcia;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
30 Murcia;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2022QII;""
30 Murcia;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2022QI;10.045
30 Murcia;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
30 Murcia;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
30 Murcia;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2021QII;""
30 Murcia;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2021QI;9.940
30 Murcia;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
30 Murcia;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
30 Murcia;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2020QII;""
30 Murcia;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2020QI;9.447
30 Murcia;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
30 Murcia;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
30 Murcia;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2022QII;9.660
30 Murcia;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2022QI;""
30 Murcia;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
30 Murcia;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
30 Murcia;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2021QII;9.681
30 Murcia;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2021QI;""
30 Murcia;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
30 Murcia;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
30 Murcia;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2020QII;9.271
30 Murcia;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2020QI;""
30 Murcia;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
30 Murcia;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QIII;9.408
30 Murcia;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QII;""
30 Murcia;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QI;""
30 Murcia;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
30 Murcia;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QIII;9.455
30 Murcia;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QII;""
30 Murcia;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QI;""
30 Murcia;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
30 Murcia;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QIII;9.056
30 Murcia;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QII;""
30 Murcia;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QI;""
30 Murcia;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QIV;9.143
30 Murcia;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
30 Murcia;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QII;""
30 Murcia;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QI;""
30 Murcia;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QIV;9.226
30 Murcia;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
30 Murcia;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QII;""
30 Murcia;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QI;""
30 Murcia;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QIV;8.829
30 Murcia;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
30 Murcia;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QII;""
30 Murcia;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QI;""
30 Murcia;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
30 Murcia;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
30 Murcia;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
30 Murcia;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
30 Murcia;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
30 Murcia;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
30 Murcia;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
30 Murcia;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
30 Murcia;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
30 Murcia;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
30 Murcia;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
30 Murcia;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
30 Murcia;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
30 Murcia;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
30 Murcia;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
30 Murcia;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;96,34
30 Murcia;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
30 Murcia;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
30 Murcia;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
30 Murcia;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;97,7
30 Murcia;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
30 Murcia;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
30 Murcia;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
30 Murcia;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;93,15
30 Murcia;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
30 Murcia;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
30 Murcia;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;92,64
30 Murcia;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
30 Murcia;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
30 Murcia;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
30 Murcia;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;95,15
30 Murcia;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
30 Murcia;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
30 Murcia;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
30 Murcia;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;91,41
30 Murcia;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
30 Murcia;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
30 Murcia;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;90,23
30 Murcia;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
30 Murcia;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
30 Murcia;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
30 Murcia;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;92,93
30 Murcia;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
30 Murcia;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
30 Murcia;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
30 Murcia;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;89,29
30 Murcia;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
30 Murcia;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
30 Murcia;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;87,69
30 Murcia;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
30 Murcia;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
30 Murcia;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
30 Murcia;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;90,68
30 Murcia;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
30 Murcia;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
30 Murcia;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
30 Murcia;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;87,05
30 Murcia;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
30 Murcia;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
30 Murcia;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
30 Murcia;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
30 Murcia;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
30 Murcia;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QII;28.509
30 Murcia;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
30 Murcia;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
30 Murcia;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
30 Murcia;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QII;28.755
30 Murcia;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
30 Murcia;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
30 Murcia;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
30 Murcia;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QII;28.147
30 Murcia;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
30 Murcia;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
30 Murcia;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
30 Murcia;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2022QII;27.462
30 Murcia;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2022QI;""
30 Murcia;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
30 Murcia;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
30 Murcia;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2021QII;27.928
30 Murcia;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2021QI;""
30 Murcia;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
30 Murcia;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
30 Murcia;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2020QII;27.623
30 Murcia;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2020QI;""
30 Murcia;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
30 Murcia;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2022QIII;26.814
30 Murcia;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2022QII;""
30 Murcia;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2022QI;""
30 Murcia;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
30 Murcia;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2021QIII;27.258
30 Murcia;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2021QII;""
30 Murcia;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2021QI;""
30 Murcia;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
30 Murcia;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2020QIII;27.013
30 Murcia;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2020QII;""
30 Murcia;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2020QI;""
30 Murcia;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QIV;26.095
30 Murcia;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
30 Murcia;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QII;""
30 Murcia;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QI;""
30 Murcia;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QIV;26.602
30 Murcia;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
30 Murcia;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QII;""
30 Murcia;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QI;""
30 Murcia;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QIV;26.403
30 Murcia;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
30 Murcia;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QII;""
30 Murcia;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QI;""
30 Murcia;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
30 Murcia;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
30 Murcia;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QII;""
30 Murcia;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QI;25.895
30 Murcia;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
30 Murcia;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
30 Murcia;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QII;""
30 Murcia;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QI;25.942
30 Murcia;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
30 Murcia;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
30 Murcia;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QII;""
30 Murcia;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QI;""
30 Murcia;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
30 Murcia;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
30 Murcia;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
30 Murcia;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
30 Murcia;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
30 Murcia;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
30 Murcia;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
30 Murcia;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
30 Murcia;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
30 Murcia;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
30 Murcia;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
30 Murcia;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
30 Murcia;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
30 Murcia;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
30 Murcia;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;96,33
30 Murcia;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
30 Murcia;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
30 Murcia;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
30 Murcia;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;97,12
30 Murcia;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
30 Murcia;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
30 Murcia;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
30 Murcia;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;98,14
30 Murcia;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
30 Murcia;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
30 Murcia;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;94,05
30 Murcia;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
30 Murcia;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
30 Murcia;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
30 Murcia;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;94,79
30 Murcia;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
30 Murcia;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
30 Murcia;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
30 Murcia;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;95,97
30 Murcia;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
30 Murcia;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
30 Murcia;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;91,53
30 Murcia;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
30 Murcia;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
30 Murcia;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
30 Murcia;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;92,51
30 Murcia;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
30 Murcia;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
30 Murcia;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
30 Murcia;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;93,8
30 Murcia;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
30 Murcia;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
30 Murcia;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
30 Murcia;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
30 Murcia;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
30 Murcia;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
30 Murcia;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;90,05
30 Murcia;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
30 Murcia;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
30 Murcia;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
30 Murcia;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;92,17
30 Murcia;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
30 Murcia;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
30 Murcia;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
30 Murcia;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
30 Murcia;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
30 Murcia;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
30 Murcia;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QII;18.207
30 Murcia;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
30 Murcia;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
30 Murcia;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
30 Murcia;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QII;18.539
30 Murcia;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
30 Murcia;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
30 Murcia;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
30 Murcia;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QII;18.234
30 Murcia;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
30 Murcia;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
30 Murcia;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
30 Murcia;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2022QII;17.587
30 Murcia;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2022QI;""
30 Murcia;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
30 Murcia;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
30 Murcia;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2021QII;18.015
30 Murcia;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2021QI;""
30 Murcia;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
30 Murcia;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
30 Murcia;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2020QII;17.913
30 Murcia;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2020QI;""
30 Murcia;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
30 Murcia;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2022QIII;17.225
30 Murcia;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2022QII;""
30 Murcia;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2022QI;""
30 Murcia;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
30 Murcia;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2021QIII;17.602
30 Murcia;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2021QII;""
30 Murcia;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2021QI;""
30 Murcia;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
30 Murcia;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2020QIII;17.539
30 Murcia;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2020QII;""
30 Murcia;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2020QI;""
30 Murcia;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QIV;16.798
30 Murcia;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
30 Murcia;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QII;""
30 Murcia;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QI;""
30 Murcia;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QIV;17.197
30 Murcia;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
30 Murcia;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QII;""
30 Murcia;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QI;""
30 Murcia;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QIV;17.176
30 Murcia;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
30 Murcia;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QII;""
30 Murcia;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QI;""
30 Murcia;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
30 Murcia;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
30 Murcia;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QII;""
30 Murcia;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QI;16.801
30 Murcia;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
30 Murcia;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
30 Murcia;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QII;""
30 Murcia;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QI;16.896
30 Murcia;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
30 Murcia;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
30 Murcia;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QII;""
30 Murcia;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QI;""
30 Murcia;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
30 Murcia;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
30 Murcia;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
30 Murcia;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
30 Murcia;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
30 Murcia;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
30 Murcia;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
30 Murcia;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
30 Murcia;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
30 Murcia;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
30 Murcia;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
30 Murcia;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
30 Murcia;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
30 Murcia;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
30 Murcia;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;96,59
30 Murcia;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
30 Murcia;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
30 Murcia;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
30 Murcia;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;97,17
30 Murcia;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
30 Murcia;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
30 Murcia;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
30 Murcia;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;98,24
30 Murcia;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
30 Murcia;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
30 Murcia;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;94,61
30 Murcia;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
30 Murcia;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
30 Murcia;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
30 Murcia;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;94,95
30 Murcia;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
30 Murcia;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
30 Murcia;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
30 Murcia;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;96,19
30 Murcia;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
30 Murcia;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
30 Murcia;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;92,26
30 Murcia;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
30 Murcia;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
30 Murcia;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
30 Murcia;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;92,76
30 Murcia;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
30 Murcia;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
30 Murcia;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
30 Murcia;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;94,2
30 Murcia;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
30 Murcia;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
30 Murcia;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
30 Murcia;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
30 Murcia;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
30 Murcia;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
30 Murcia;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;90,63
30 Murcia;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
30 Murcia;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
30 Murcia;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
30 Murcia;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;92,66
30 Murcia;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
30 Murcia;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
30 Murcia;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
30 Murcia;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
30 Murcia;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
30 Murcia;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
30 Murcia;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QII;10.302
30 Murcia;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
30 Murcia;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
30 Murcia;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
30 Murcia;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QII;10.216
30 Murcia;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
30 Murcia;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
30 Murcia;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
30 Murcia;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QII;9.913
30 Murcia;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
30 Murcia;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
30 Murcia;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
30 Murcia;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2022QII;9.875
30 Murcia;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2022QI;""
30 Murcia;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
30 Murcia;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
30 Murcia;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2021QII;9.913
30 Murcia;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2021QI;""
30 Murcia;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
30 Murcia;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
30 Murcia;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2020QII;9.710
30 Murcia;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2020QI;""
30 Murcia;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
30 Murcia;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2022QIII;9.589
30 Murcia;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2022QII;""
30 Murcia;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2022QI;""
30 Murcia;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
30 Murcia;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2021QIII;9.656
30 Murcia;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2021QII;""
30 Murcia;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2021QI;""
30 Murcia;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
30 Murcia;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2020QIII;9.474
30 Murcia;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2020QII;""
30 Murcia;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2020QI;""
30 Murcia;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QIV;9.297
30 Murcia;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
30 Murcia;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QII;""
30 Murcia;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QI;""
30 Murcia;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QIV;9.405
30 Murcia;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
30 Murcia;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QII;""
30 Murcia;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QI;""
30 Murcia;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QIV;9.227
30 Murcia;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
30 Murcia;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QII;""
30 Murcia;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QI;""
30 Murcia;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
30 Murcia;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
30 Murcia;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QII;""
30 Murcia;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QI;9.094
30 Murcia;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
30 Murcia;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
30 Murcia;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QII;""
30 Murcia;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QI;9.046
30 Murcia;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
30 Murcia;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
30 Murcia;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QII;""
30 Murcia;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QI;""
30 Murcia;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
30 Murcia;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
30 Murcia;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
30 Murcia;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
30 Murcia;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
30 Murcia;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
30 Murcia;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
30 Murcia;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
30 Murcia;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
30 Murcia;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
30 Murcia;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
30 Murcia;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
30 Murcia;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
30 Murcia;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
30 Murcia;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;95,86
30 Murcia;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
30 Murcia;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
30 Murcia;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
30 Murcia;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;97,03
30 Murcia;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
30 Murcia;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
30 Murcia;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
30 Murcia;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;97,95
30 Murcia;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
30 Murcia;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
30 Murcia;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;93,08
30 Murcia;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
30 Murcia;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
30 Murcia;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
30 Murcia;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;94,52
30 Murcia;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
30 Murcia;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
30 Murcia;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
30 Murcia;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;95,57
30 Murcia;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
30 Murcia;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
30 Murcia;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;90,24
30 Murcia;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
30 Murcia;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
30 Murcia;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
30 Murcia;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;92,06
30 Murcia;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
30 Murcia;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
30 Murcia;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
30 Murcia;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;93,08
30 Murcia;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
30 Murcia;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
30 Murcia;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
30 Murcia;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
30 Murcia;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
30 Murcia;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
30 Murcia;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;89,02
30 Murcia;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
30 Murcia;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
30 Murcia;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
30 Murcia;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;91,25
30 Murcia;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
30 Murcia;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
30 Murcia;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
30 Murcia;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
30 Murcia;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
30 Murcia;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QIII;28.471
30 Murcia;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
30 Murcia;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
30 Murcia;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
30 Murcia;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QIII;28.940
30 Murcia;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
30 Murcia;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
30 Murcia;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
30 Murcia;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QIII;28.607
30 Murcia;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
30 Murcia;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
30 Murcia;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
30 Murcia;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2022QIII;27.674
30 Murcia;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2022QII;""
30 Murcia;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2022QI;""
30 Murcia;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
30 Murcia;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2021QIII;28.126
30 Murcia;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2021QII;""
30 Murcia;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2021QI;""
30 Murcia;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
30 Murcia;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2020QIII;27.876
30 Murcia;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2020QII;""
30 Murcia;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2020QI;""
30 Murcia;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2022QIV;26.845
30 Murcia;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
30 Murcia;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2022QII;""
30 Murcia;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2022QI;""
30 Murcia;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2021QIV;27.379
30 Murcia;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
30 Murcia;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2021QII;""
30 Murcia;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2021QI;""
30 Murcia;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2020QIV;27.170
30 Murcia;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
30 Murcia;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2020QII;""
30 Murcia;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2020QI;""
30 Murcia;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
30 Murcia;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
30 Murcia;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QII;""
30 Murcia;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QI;26.625
30 Murcia;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
30 Murcia;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
30 Murcia;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QII;""
30 Murcia;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QI;26.677
30 Murcia;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
30 Murcia;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
30 Murcia;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QII;""
30 Murcia;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QI;""
30 Murcia;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
30 Murcia;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
30 Murcia;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QII;25.858
30 Murcia;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QI;""
30 Murcia;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
30 Murcia;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
30 Murcia;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QII;26.128
30 Murcia;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QI;""
30 Murcia;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
30 Murcia;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
30 Murcia;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QII;""
30 Murcia;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QI;""
30 Murcia;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
30 Murcia;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
30 Murcia;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
30 Murcia;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
30 Murcia;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
30 Murcia;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
30 Murcia;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
30 Murcia;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
30 Murcia;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
30 Murcia;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
30 Murcia;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
30 Murcia;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
30 Murcia;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
30 Murcia;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;97,2
30 Murcia;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
30 Murcia;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
30 Murcia;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
30 Murcia;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;97,19
30 Murcia;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
30 Murcia;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
30 Murcia;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
30 Murcia;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;97,44
30 Murcia;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
30 Murcia;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
30 Murcia;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;94,29
30 Murcia;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
30 Murcia;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
30 Murcia;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
30 Murcia;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;94,61
30 Murcia;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
30 Murcia;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
30 Murcia;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
30 Murcia;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;94,98
30 Murcia;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
30 Murcia;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
30 Murcia;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
30 Murcia;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
30 Murcia;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
30 Murcia;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
30 Murcia;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;92
30 Murcia;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
30 Murcia;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
30 Murcia;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
30 Murcia;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;93,25
30 Murcia;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
30 Murcia;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
30 Murcia;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
30 Murcia;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
30 Murcia;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
30 Murcia;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
30 Murcia;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;89,35
30 Murcia;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
30 Murcia;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
30 Murcia;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
30 Murcia;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;91,33
30 Murcia;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
30 Murcia;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
30 Murcia;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
30 Murcia;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
30 Murcia;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
30 Murcia;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
30 Murcia;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QIII;18.197
30 Murcia;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
30 Murcia;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
30 Murcia;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
30 Murcia;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QIII;18.620
30 Murcia;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
30 Murcia;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
30 Murcia;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
30 Murcia;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QIII;18.543
30 Murcia;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
30 Murcia;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
30 Murcia;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
30 Murcia;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2022QIII;17.746
30 Murcia;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2022QII;""
30 Murcia;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2022QI;""
30 Murcia;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
30 Murcia;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2021QIII;18.129
30 Murcia;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2021QII;""
30 Murcia;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2021QI;""
30 Murcia;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
30 Murcia;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2020QIII;18.090
30 Murcia;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2020QII;""
30 Murcia;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2020QI;""
30 Murcia;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2022QIV;17.243
30 Murcia;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
30 Murcia;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2022QII;""
30 Murcia;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2022QI;""
30 Murcia;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2021QIV;17.676
30 Murcia;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
30 Murcia;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2021QII;""
30 Murcia;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2021QI;""
30 Murcia;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2020QIV;17.660
30 Murcia;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
30 Murcia;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2020QII;""
30 Murcia;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2020QI;""
30 Murcia;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
30 Murcia;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
30 Murcia;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QII;""
30 Murcia;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QI;17.248
30 Murcia;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
30 Murcia;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
30 Murcia;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QII;""
30 Murcia;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QI;17.359
30 Murcia;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
30 Murcia;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
30 Murcia;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QII;""
30 Murcia;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QI;""
30 Murcia;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
30 Murcia;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
30 Murcia;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QII;16.800
30 Murcia;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QI;""
30 Murcia;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
30 Murcia;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
30 Murcia;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QII;17.016
30 Murcia;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QI;""
30 Murcia;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
30 Murcia;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
30 Murcia;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QII;""
30 Murcia;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QI;""
30 Murcia;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
30 Murcia;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
30 Murcia;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
30 Murcia;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
30 Murcia;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
30 Murcia;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
30 Murcia;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
30 Murcia;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
30 Murcia;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
30 Murcia;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
30 Murcia;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
30 Murcia;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
30 Murcia;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
30 Murcia;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;97,52
30 Murcia;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
30 Murcia;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
30 Murcia;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
30 Murcia;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;97,36
30 Murcia;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
30 Murcia;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
30 Murcia;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
30 Murcia;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;97,56
30 Murcia;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
30 Murcia;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
30 Murcia;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;94,76
30 Murcia;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
30 Murcia;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
30 Murcia;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
30 Murcia;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;94,93
30 Murcia;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
30 Murcia;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
30 Murcia;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
30 Murcia;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;95,24
30 Murcia;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
30 Murcia;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
30 Murcia;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
30 Murcia;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
30 Murcia;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
30 Murcia;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
30 Murcia;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;92,63
30 Murcia;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
30 Murcia;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
30 Murcia;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
30 Murcia;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;93,61
30 Murcia;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
30 Murcia;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
30 Murcia;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
30 Murcia;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
30 Murcia;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
30 Murcia;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
30 Murcia;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;90,23
30 Murcia;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
30 Murcia;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
30 Murcia;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
30 Murcia;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;91,77
30 Murcia;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
30 Murcia;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
30 Murcia;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
30 Murcia;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
30 Murcia;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
30 Murcia;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
30 Murcia;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QIII;10.274
30 Murcia;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
30 Murcia;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
30 Murcia;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
30 Murcia;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QIII;10.320
30 Murcia;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
30 Murcia;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
30 Murcia;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
30 Murcia;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QIII;10.064
30 Murcia;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
30 Murcia;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
30 Murcia;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
30 Murcia;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2022QIII;9.928
30 Murcia;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2022QII;""
30 Murcia;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2022QI;""
30 Murcia;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
30 Murcia;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2021QIII;9.997
30 Murcia;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2021QII;""
30 Murcia;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2021QI;""
30 Murcia;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
30 Murcia;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2020QIII;9.786
30 Murcia;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2020QII;""
30 Murcia;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2020QI;""
30 Murcia;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2022QIV;9.602
30 Murcia;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
30 Murcia;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2022QII;""
30 Murcia;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2022QI;""
30 Murcia;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2021QIV;9.703
30 Murcia;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
30 Murcia;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2021QII;""
30 Murcia;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2021QI;""
30 Murcia;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2020QIV;9.510
30 Murcia;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
30 Murcia;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2020QII;""
30 Murcia;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2020QI;""
30 Murcia;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
30 Murcia;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
30 Murcia;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QII;""
30 Murcia;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QI;9.377
30 Murcia;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
30 Murcia;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
30 Murcia;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QII;""
30 Murcia;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QI;9.318
30 Murcia;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
30 Murcia;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
30 Murcia;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QII;""
30 Murcia;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QI;""
30 Murcia;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
30 Murcia;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
30 Murcia;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QII;9.058
30 Murcia;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QI;""
30 Murcia;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
30 Murcia;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
30 Murcia;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QII;9.112
30 Murcia;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QI;""
30 Murcia;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
30 Murcia;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
30 Murcia;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QII;""
30 Murcia;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QI;""
30 Murcia;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
30 Murcia;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
30 Murcia;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
30 Murcia;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
30 Murcia;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
30 Murcia;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
30 Murcia;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
30 Murcia;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
30 Murcia;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
30 Murcia;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
30 Murcia;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
30 Murcia;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
30 Murcia;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
30 Murcia;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;96,63
30 Murcia;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
30 Murcia;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
30 Murcia;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
30 Murcia;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;96,87
30 Murcia;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
30 Murcia;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
30 Murcia;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
30 Murcia;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;97,24
30 Murcia;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
30 Murcia;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
30 Murcia;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;93,46
30 Murcia;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
30 Murcia;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
30 Murcia;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
30 Murcia;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;94,02
30 Murcia;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
30 Murcia;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
30 Murcia;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
30 Murcia;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;94,5
30 Murcia;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
30 Murcia;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
30 Murcia;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
30 Murcia;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
30 Murcia;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
30 Murcia;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
30 Murcia;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;90,86
30 Murcia;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
30 Murcia;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
30 Murcia;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
30 Murcia;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;92,59
30 Murcia;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
30 Murcia;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
30 Murcia;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
30 Murcia;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
30 Murcia;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
30 Murcia;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
30 Murcia;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;87,77
30 Murcia;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
30 Murcia;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
30 Murcia;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
30 Murcia;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;90,54
30 Murcia;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
30 Murcia;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
30 Murcia;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
30 Murcia;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
30 Murcia;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
30 Murcia;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QIV;28.495
30 Murcia;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
30 Murcia;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
30 Murcia;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
30 Murcia;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QIV;28.982
30 Murcia;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
30 Murcia;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
30 Murcia;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
30 Murcia;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QIV;28.653
30 Murcia;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
30 Murcia;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
30 Murcia;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
30 Murcia;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2022QIV;27.565
30 Murcia;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
30 Murcia;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2022QII;""
30 Murcia;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2022QI;""
30 Murcia;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2021QIV;28.118
30 Murcia;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
30 Murcia;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2021QII;""
30 Murcia;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2021QI;""
30 Murcia;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2020QIV;27.861
30 Murcia;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
30 Murcia;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2020QII;""
30 Murcia;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2020QI;""
30 Murcia;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
30 Murcia;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
30 Murcia;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2022QII;""
30 Murcia;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2022QI;27.302
30 Murcia;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
30 Murcia;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
30 Murcia;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2021QII;""
30 Murcia;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2021QI;27.326
30 Murcia;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
30 Murcia;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
30 Murcia;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2020QII;""
30 Murcia;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2020QI;""
30 Murcia;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
30 Murcia;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
30 Murcia;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QII;26.469
30 Murcia;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QI;""
30 Murcia;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
30 Murcia;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
30 Murcia;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QII;26.719
30 Murcia;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QI;""
30 Murcia;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
30 Murcia;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
30 Murcia;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QII;""
30 Murcia;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QI;""
30 Murcia;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
30 Murcia;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QIII;25.913
30 Murcia;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QII;""
30 Murcia;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QI;""
30 Murcia;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
30 Murcia;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QIII;26.180
30 Murcia;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QII;""
30 Murcia;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QI;""
30 Murcia;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
30 Murcia;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
30 Murcia;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QII;""
30 Murcia;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QI;""
30 Murcia;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
30 Murcia;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
30 Murcia;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
30 Murcia;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
30 Murcia;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
30 Murcia;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
30 Murcia;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
30 Murcia;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
30 Murcia;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
30 Murcia;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
30 Murcia;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
30 Murcia;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
30 Murcia;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;96,74
30 Murcia;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
30 Murcia;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
30 Murcia;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
30 Murcia;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;97,02
30 Murcia;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
30 Murcia;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
30 Murcia;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
30 Murcia;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;97,24
30 Murcia;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
30 Murcia;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
30 Murcia;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
30 Murcia;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
30 Murcia;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
30 Murcia;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
30 Murcia;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;94,2
30 Murcia;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
30 Murcia;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
30 Murcia;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
30 Murcia;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;95,37
30 Murcia;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
30 Murcia;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
30 Murcia;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
30 Murcia;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
30 Murcia;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
30 Murcia;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
30 Murcia;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;91,33
30 Murcia;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
30 Murcia;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
30 Murcia;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
30 Murcia;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;93,25
30 Murcia;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
30 Murcia;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
30 Murcia;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
30 Murcia;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
30 Murcia;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
30 Murcia;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
30 Murcia;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;89,41
30 Murcia;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
30 Murcia;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
30 Murcia;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
30 Murcia;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;91,37
30 Murcia;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
30 Murcia;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
30 Murcia;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
30 Murcia;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
30 Murcia;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
30 Murcia;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
30 Murcia;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QIV;18.233
30 Murcia;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
30 Murcia;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
30 Murcia;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
30 Murcia;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QIV;18.632
30 Murcia;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
30 Murcia;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
30 Murcia;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
30 Murcia;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QIV;18.534
30 Murcia;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
30 Murcia;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
30 Murcia;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
30 Murcia;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2022QIV;17.665
30 Murcia;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
30 Murcia;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2022QII;""
30 Murcia;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2022QI;""
30 Murcia;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2021QIV;18.107
30 Murcia;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
30 Murcia;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2021QII;""
30 Murcia;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2021QI;""
30 Murcia;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2020QIV;18.053
30 Murcia;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
30 Murcia;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2020QII;""
30 Murcia;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2020QI;""
30 Murcia;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
30 Murcia;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
30 Murcia;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2022QII;""
30 Murcia;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2022QI;17.643
30 Murcia;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
30 Murcia;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
30 Murcia;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2021QII;""
30 Murcia;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2021QI;17.726
30 Murcia;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
30 Murcia;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
30 Murcia;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2020QII;""
30 Murcia;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2020QI;""
30 Murcia;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
30 Murcia;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
30 Murcia;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QII;17.156
30 Murcia;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QI;""
30 Murcia;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
30 Murcia;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
30 Murcia;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QII;17.353
30 Murcia;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QI;""
30 Murcia;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
30 Murcia;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
30 Murcia;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QII;""
30 Murcia;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QI;""
30 Murcia;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
30 Murcia;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QIII;16.843
30 Murcia;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QII;""
30 Murcia;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QI;""
30 Murcia;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
30 Murcia;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QIII;17.018
30 Murcia;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QII;""
30 Murcia;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QI;""
30 Murcia;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
30 Murcia;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
30 Murcia;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QII;""
30 Murcia;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QI;""
30 Murcia;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
30 Murcia;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
30 Murcia;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
30 Murcia;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
30 Murcia;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
30 Murcia;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
30 Murcia;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
30 Murcia;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
30 Murcia;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
30 Murcia;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
30 Murcia;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
30 Murcia;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
30 Murcia;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;96,88
30 Murcia;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
30 Murcia;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
30 Murcia;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
30 Murcia;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;97,18
30 Murcia;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
30 Murcia;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
30 Murcia;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
30 Murcia;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;97,4
30 Murcia;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
30 Murcia;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
30 Murcia;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
30 Murcia;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
30 Murcia;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
30 Murcia;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
30 Murcia;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;94,69
30 Murcia;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
30 Murcia;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
30 Murcia;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
30 Murcia;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;95,64
30 Murcia;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
30 Murcia;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
30 Murcia;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
30 Murcia;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
30 Murcia;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
30 Murcia;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
30 Murcia;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;92,08
30 Murcia;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
30 Murcia;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
30 Murcia;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
30 Murcia;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;93,63
30 Murcia;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
30 Murcia;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
30 Murcia;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
30 Murcia;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
30 Murcia;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
30 Murcia;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
30 Murcia;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;90,4
30 Murcia;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
30 Murcia;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
30 Murcia;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
30 Murcia;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;91,82
30 Murcia;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
30 Murcia;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
30 Murcia;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
30 Murcia;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
30 Murcia;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
30 Murcia;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
30 Murcia;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QIV;10.262
30 Murcia;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
30 Murcia;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
30 Murcia;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
30 Murcia;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QIV;10.350
30 Murcia;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
30 Murcia;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
30 Murcia;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
30 Murcia;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QIV;10.119
30 Murcia;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
30 Murcia;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
30 Murcia;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
30 Murcia;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2022QIV;9.900
30 Murcia;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
30 Murcia;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2022QII;""
30 Murcia;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2022QI;""
30 Murcia;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2021QIV;10.011
30 Murcia;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
30 Murcia;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2021QII;""
30 Murcia;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2021QI;""
30 Murcia;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2020QIV;9.808
30 Murcia;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
30 Murcia;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2020QII;""
30 Murcia;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2020QI;""
30 Murcia;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
30 Murcia;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
30 Murcia;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2022QII;""
30 Murcia;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2022QI;9.659
30 Murcia;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
30 Murcia;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
30 Murcia;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2021QII;""
30 Murcia;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2021QI;9.600
30 Murcia;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
30 Murcia;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
30 Murcia;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2020QII;""
30 Murcia;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2020QI;""
30 Murcia;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
30 Murcia;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
30 Murcia;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QII;9.313
30 Murcia;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QI;""
30 Murcia;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
30 Murcia;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
30 Murcia;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QII;9.366
30 Murcia;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QI;""
30 Murcia;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
30 Murcia;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
30 Murcia;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QII;""
30 Murcia;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QI;""
30 Murcia;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
30 Murcia;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QIII;9.070
30 Murcia;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QII;""
30 Murcia;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QI;""
30 Murcia;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
30 Murcia;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QIII;9.162
30 Murcia;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QII;""
30 Murcia;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QI;""
30 Murcia;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
30 Murcia;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
30 Murcia;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QII;""
30 Murcia;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QI;""
30 Murcia;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
30 Murcia;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
30 Murcia;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
30 Murcia;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
30 Murcia;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
30 Murcia;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
30 Murcia;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
30 Murcia;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
30 Murcia;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
30 Murcia;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
30 Murcia;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
30 Murcia;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
30 Murcia;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;96,47
30 Murcia;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
30 Murcia;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
30 Murcia;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
30 Murcia;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;96,72
30 Murcia;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
30 Murcia;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
30 Murcia;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
30 Murcia;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;96,93
30 Murcia;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
30 Murcia;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
30 Murcia;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
30 Murcia;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
30 Murcia;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
30 Murcia;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
30 Murcia;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;93,32
30 Murcia;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
30 Murcia;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
30 Murcia;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
30 Murcia;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;94,87
30 Murcia;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
30 Murcia;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
30 Murcia;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
30 Murcia;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
30 Murcia;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
30 Murcia;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
30 Murcia;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;89,98
30 Murcia;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
30 Murcia;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
30 Murcia;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
30 Murcia;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;92,56
30 Murcia;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
30 Murcia;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
30 Murcia;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
30 Murcia;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
30 Murcia;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
30 Murcia;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
30 Murcia;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;87,63
30 Murcia;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
30 Murcia;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
30 Murcia;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
30 Murcia;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;90,54
30 Murcia;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
30 Murcia;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
30 Murcia;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
30 Murcia;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
30 Murcia;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
30 Murcia;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
30 Murcia;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
30 Murcia;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
30 Murcia;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
30 Murcia;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QI;26.793
30 Murcia;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
30 Murcia;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
30 Murcia;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
30 Murcia;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QI;26.105
30 Murcia;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
30 Murcia;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
30 Murcia;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
30 Murcia;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QI;26.468
30 Murcia;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
30 Murcia;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
30 Murcia;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2022QII;""
30 Murcia;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2022QI;26.159
30 Murcia;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
30 Murcia;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
30 Murcia;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2021QII;""
30 Murcia;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2021QI;25.647
30 Murcia;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
30 Murcia;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
30 Murcia;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2020QII;""
30 Murcia;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2020QI;25.204
30 Murcia;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
30 Murcia;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
30 Murcia;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2022QII;25.563
30 Murcia;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2022QI;""
30 Murcia;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
30 Murcia;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
30 Murcia;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2021QII;25.075
30 Murcia;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2021QI;""
30 Murcia;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
30 Murcia;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
30 Murcia;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2020QII;24.859
30 Murcia;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2020QI;""
30 Murcia;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
30 Murcia;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QIII;25.098
30 Murcia;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QII;""
30 Murcia;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QI;""
30 Murcia;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
30 Murcia;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QIII;24.671
30 Murcia;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QII;""
30 Murcia;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QI;""
30 Murcia;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
30 Murcia;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QIII;24.404
30 Murcia;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QII;""
30 Murcia;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QI;""
30 Murcia;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QIV;24.609
30 Murcia;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
30 Murcia;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QII;""
30 Murcia;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QI;""
30 Murcia;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QIV;24.222
30 Murcia;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
30 Murcia;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QII;""
30 Murcia;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QI;""
30 Murcia;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QIV;24.030
30 Murcia;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
30 Murcia;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QII;""
30 Murcia;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QI;""
30 Murcia;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
30 Murcia;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
30 Murcia;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
30 Murcia;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
30 Murcia;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
30 Murcia;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
30 Murcia;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
30 Murcia;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
30 Murcia;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
30 Murcia;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
30 Murcia;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
30 Murcia;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
30 Murcia;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
30 Murcia;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
30 Murcia;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
30 Murcia;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;97,63
30 Murcia;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
30 Murcia;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
30 Murcia;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
30 Murcia;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;98,25
30 Murcia;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
30 Murcia;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
30 Murcia;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
30 Murcia;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;95,22
30 Murcia;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
30 Murcia;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
30 Murcia;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;95,41
30 Murcia;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
30 Murcia;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
30 Murcia;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
30 Murcia;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;96,05
30 Murcia;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
30 Murcia;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
30 Murcia;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
30 Murcia;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;93,92
30 Murcia;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
30 Murcia;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
30 Murcia;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;93,67
30 Murcia;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
30 Murcia;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
30 Murcia;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
30 Murcia;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;94,51
30 Murcia;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
30 Murcia;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
30 Murcia;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
30 Murcia;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;92,2
30 Murcia;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
30 Murcia;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
30 Murcia;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;91,85
30 Murcia;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
30 Murcia;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
30 Murcia;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
30 Murcia;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;92,79
30 Murcia;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
30 Murcia;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
30 Murcia;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
30 Murcia;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;90,79
30 Murcia;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
30 Murcia;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
30 Murcia;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
30 Murcia;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
30 Murcia;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
30 Murcia;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
30 Murcia;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QI;17.441
30 Murcia;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
30 Murcia;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
30 Murcia;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
30 Murcia;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QI;17.124
30 Murcia;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
30 Murcia;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
30 Murcia;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
30 Murcia;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QI;17.310
30 Murcia;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
30 Murcia;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
30 Murcia;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2022QII;""
30 Murcia;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2022QI;17.062
30 Murcia;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
30 Murcia;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
30 Murcia;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2021QII;""
30 Murcia;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2021QI;16.852
30 Murcia;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
30 Murcia;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
30 Murcia;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2020QII;""
30 Murcia;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2020QI;16.543
30 Murcia;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
30 Murcia;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
30 Murcia;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2022QII;16.706
30 Murcia;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2022QI;""
30 Murcia;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
30 Murcia;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
30 Murcia;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2021QII;16.506
30 Murcia;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2021QI;""
30 Murcia;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
30 Murcia;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
30 Murcia;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2020QII;16.342
30 Murcia;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2020QI;""
30 Murcia;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
30 Murcia;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QIII;16.402
30 Murcia;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QII;""
30 Murcia;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QI;""
30 Murcia;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
30 Murcia;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QIII;16.245
30 Murcia;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QII;""
30 Murcia;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QI;""
30 Murcia;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
30 Murcia;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QIII;16.074
30 Murcia;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QII;""
30 Murcia;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QI;""
30 Murcia;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QIV;16.106
30 Murcia;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
30 Murcia;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QII;""
30 Murcia;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QI;""
30 Murcia;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QIV;15.955
30 Murcia;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
30 Murcia;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QII;""
30 Murcia;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QI;""
30 Murcia;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QIV;15.838
30 Murcia;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
30 Murcia;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QII;""
30 Murcia;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QI;""
30 Murcia;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
30 Murcia;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
30 Murcia;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
30 Murcia;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
30 Murcia;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
30 Murcia;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
30 Murcia;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
30 Murcia;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
30 Murcia;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
30 Murcia;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
30 Murcia;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
30 Murcia;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
30 Murcia;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
30 Murcia;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
30 Murcia;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
30 Murcia;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;97,83
30 Murcia;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
30 Murcia;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
30 Murcia;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
30 Murcia;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;98,41
30 Murcia;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
30 Murcia;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
30 Murcia;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
30 Murcia;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;95,57
30 Murcia;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
30 Murcia;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
30 Murcia;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;95,79
30 Murcia;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
30 Murcia;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
30 Murcia;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
30 Murcia;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;96,39
30 Murcia;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
30 Murcia;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
30 Murcia;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
30 Murcia;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;94,41
30 Murcia;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
30 Murcia;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
30 Murcia;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;94,04
30 Murcia;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
30 Murcia;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
30 Murcia;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
30 Murcia;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;94,87
30 Murcia;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
30 Murcia;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
30 Murcia;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
30 Murcia;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;92,86
30 Murcia;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
30 Murcia;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
30 Murcia;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;92,35
30 Murcia;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
30 Murcia;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
30 Murcia;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
30 Murcia;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;93,17
30 Murcia;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
30 Murcia;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
30 Murcia;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
30 Murcia;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;91,5
30 Murcia;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
30 Murcia;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
30 Murcia;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
30 Murcia;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
30 Murcia;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
30 Murcia;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
30 Murcia;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QI;9.352
30 Murcia;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
30 Murcia;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
30 Murcia;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
30 Murcia;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QI;8.981
30 Murcia;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
30 Murcia;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
30 Murcia;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
30 Murcia;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QI;9.158
30 Murcia;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
30 Murcia;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
30 Murcia;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2022QII;""
30 Murcia;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2022QI;9.097
30 Murcia;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
30 Murcia;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
30 Murcia;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2021QII;""
30 Murcia;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2021QI;8.795
30 Murcia;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
30 Murcia;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
30 Murcia;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2020QII;""
30 Murcia;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2020QI;8.661
30 Murcia;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
30 Murcia;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
30 Murcia;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2022QII;8.857
30 Murcia;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2022QI;""
30 Murcia;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
30 Murcia;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
30 Murcia;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2021QII;8.569
30 Murcia;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2021QI;""
30 Murcia;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
30 Murcia;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
30 Murcia;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2020QII;8.517
30 Murcia;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2020QI;""
30 Murcia;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
30 Murcia;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QIII;8.696
30 Murcia;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QII;""
30 Murcia;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QI;""
30 Murcia;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
30 Murcia;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QIII;8.426
30 Murcia;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QII;""
30 Murcia;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QI;""
30 Murcia;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
30 Murcia;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QIII;8.330
30 Murcia;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QII;""
30 Murcia;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QI;""
30 Murcia;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QIV;8.503
30 Murcia;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
30 Murcia;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QII;""
30 Murcia;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QI;""
30 Murcia;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QIV;8.267
30 Murcia;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
30 Murcia;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QII;""
30 Murcia;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QI;""
30 Murcia;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QIV;8.192
30 Murcia;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
30 Murcia;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QII;""
30 Murcia;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QI;""
30 Murcia;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
30 Murcia;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
30 Murcia;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
30 Murcia;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
30 Murcia;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
30 Murcia;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
30 Murcia;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
30 Murcia;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
30 Murcia;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
30 Murcia;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
30 Murcia;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
30 Murcia;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
30 Murcia;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
30 Murcia;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
30 Murcia;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
30 Murcia;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;97,27
30 Murcia;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
30 Murcia;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
30 Murcia;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
30 Murcia;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;97,93
30 Murcia;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
30 Murcia;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
30 Murcia;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
30 Murcia;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;94,57
30 Murcia;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
30 Murcia;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
30 Murcia;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;94,71
30 Murcia;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
30 Murcia;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
30 Murcia;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
30 Murcia;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;95,41
30 Murcia;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
30 Murcia;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
30 Murcia;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
30 Murcia;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;93
30 Murcia;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
30 Murcia;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
30 Murcia;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;92,99
30 Murcia;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
30 Murcia;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
30 Murcia;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
30 Murcia;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;93,82
30 Murcia;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
30 Murcia;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
30 Murcia;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
30 Murcia;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;90,96
30 Murcia;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
30 Murcia;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
30 Murcia;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;90,92
30 Murcia;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
30 Murcia;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
30 Murcia;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
30 Murcia;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;92,05
30 Murcia;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
30 Murcia;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
30 Murcia;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
30 Murcia;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;89,45
30 Murcia;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
30 Murcia;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
30 Murcia;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
30 Murcia;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
30 Murcia;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
30 Murcia;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QII;27.633
30 Murcia;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
30 Murcia;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
30 Murcia;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
30 Murcia;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QII;27.032
30 Murcia;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
30 Murcia;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
30 Murcia;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
30 Murcia;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QII;25.992
30 Murcia;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
30 Murcia;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
30 Murcia;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
30 Murcia;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2022QII;26.937
30 Murcia;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2022QI;""
30 Murcia;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
30 Murcia;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
30 Murcia;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2021QII;26.385
30 Murcia;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2021QI;""
30 Murcia;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
30 Murcia;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
30 Murcia;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2020QII;25.611
30 Murcia;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2020QI;""
30 Murcia;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
30 Murcia;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2022QIII;26.404
30 Murcia;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2022QII;""
30 Murcia;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2022QI;""
30 Murcia;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
30 Murcia;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2021QIII;25.922
30 Murcia;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2021QII;""
30 Murcia;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2021QI;""
30 Murcia;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
30 Murcia;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2020QIII;25.065
30 Murcia;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2020QII;""
30 Murcia;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2020QI;""
30 Murcia;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QIV;25.834
30 Murcia;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
30 Murcia;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QII;""
30 Murcia;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QI;""
30 Murcia;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QIV;25.408
30 Murcia;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
30 Murcia;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QII;""
30 Murcia;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QI;""
30 Murcia;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QIV;24.652
30 Murcia;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
30 Murcia;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QII;""
30 Murcia;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QI;""
30 Murcia;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
30 Murcia;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
30 Murcia;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QII;""
30 Murcia;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QI;24.886
30 Murcia;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
30 Murcia;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
30 Murcia;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QII;""
30 Murcia;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QI;24.294
30 Murcia;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
30 Murcia;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
30 Murcia;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QII;""
30 Murcia;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QI;""
30 Murcia;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
30 Murcia;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
30 Murcia;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
30 Murcia;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
30 Murcia;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
30 Murcia;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
30 Murcia;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
30 Murcia;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
30 Murcia;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
30 Murcia;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
30 Murcia;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
30 Murcia;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
30 Murcia;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
30 Murcia;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
30 Murcia;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;97,48
30 Murcia;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
30 Murcia;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
30 Murcia;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
30 Murcia;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;97,61
30 Murcia;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
30 Murcia;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
30 Murcia;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
30 Murcia;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;98,53
30 Murcia;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
30 Murcia;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
30 Murcia;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;95,55
30 Murcia;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
30 Murcia;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
30 Murcia;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
30 Murcia;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;95,89
30 Murcia;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
30 Murcia;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
30 Murcia;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
30 Murcia;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;96,43
30 Murcia;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
30 Murcia;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
30 Murcia;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;93,49
30 Murcia;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
30 Murcia;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
30 Murcia;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
30 Murcia;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;93,99
30 Murcia;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
30 Murcia;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
30 Murcia;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
30 Murcia;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;94,84
30 Murcia;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
30 Murcia;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
30 Murcia;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
30 Murcia;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
30 Murcia;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
30 Murcia;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
30 Murcia;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;92,06
30 Murcia;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
30 Murcia;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
30 Murcia;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
30 Murcia;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;93,47
30 Murcia;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
30 Murcia;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
30 Murcia;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
30 Murcia;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
30 Murcia;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
30 Murcia;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
30 Murcia;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QII;17.944
30 Murcia;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
30 Murcia;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
30 Murcia;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
30 Murcia;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QII;17.684
30 Murcia;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
30 Murcia;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
30 Murcia;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
30 Murcia;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QII;17.038
30 Murcia;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
30 Murcia;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
30 Murcia;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
30 Murcia;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2022QII;17.530
30 Murcia;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2022QI;""
30 Murcia;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
30 Murcia;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
30 Murcia;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2021QII;17.283
30 Murcia;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2021QI;""
30 Murcia;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
30 Murcia;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
30 Murcia;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2020QII;16.811
30 Murcia;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2020QI;""
30 Murcia;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
30 Murcia;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2022QIII;17.182
30 Murcia;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2022QII;""
30 Murcia;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2022QI;""
30 Murcia;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
30 Murcia;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2021QIII;16.980
30 Murcia;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2021QII;""
30 Murcia;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2021QI;""
30 Murcia;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
30 Murcia;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2020QIII;16.483
30 Murcia;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2020QII;""
30 Murcia;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2020QI;""
30 Murcia;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QIV;16.828
30 Murcia;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
30 Murcia;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QII;""
30 Murcia;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QI;""
30 Murcia;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QIV;16.650
30 Murcia;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
30 Murcia;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QII;""
30 Murcia;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QI;""
30 Murcia;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QIV;16.218
30 Murcia;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
30 Murcia;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QII;""
30 Murcia;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QI;""
30 Murcia;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
30 Murcia;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
30 Murcia;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QII;""
30 Murcia;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QI;16.340
30 Murcia;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
30 Murcia;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
30 Murcia;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QII;""
30 Murcia;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QI;16.018
30 Murcia;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
30 Murcia;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
30 Murcia;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QII;""
30 Murcia;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QI;""
30 Murcia;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
30 Murcia;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
30 Murcia;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
30 Murcia;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
30 Murcia;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
30 Murcia;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
30 Murcia;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
30 Murcia;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
30 Murcia;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
30 Murcia;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
30 Murcia;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
30 Murcia;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
30 Murcia;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
30 Murcia;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
30 Murcia;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;97,69
30 Murcia;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
30 Murcia;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
30 Murcia;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
30 Murcia;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;97,73
30 Murcia;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
30 Murcia;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
30 Murcia;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
30 Murcia;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;98,67
30 Murcia;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
30 Murcia;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
30 Murcia;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;95,75
30 Murcia;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
30 Murcia;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
30 Murcia;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
30 Murcia;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;96,02
30 Murcia;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
30 Murcia;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
30 Murcia;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
30 Murcia;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;96,74
30 Murcia;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
30 Murcia;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
30 Murcia;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;93,78
30 Murcia;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
30 Murcia;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
30 Murcia;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
30 Murcia;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;94,15
30 Murcia;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
30 Murcia;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
30 Murcia;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
30 Murcia;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;95,19
30 Murcia;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
30 Murcia;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
30 Murcia;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
30 Murcia;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
30 Murcia;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
30 Murcia;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
30 Murcia;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;92,4
30 Murcia;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
30 Murcia;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
30 Murcia;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
30 Murcia;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;94,01
30 Murcia;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
30 Murcia;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
30 Murcia;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
30 Murcia;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
30 Murcia;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
30 Murcia;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
30 Murcia;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QII;9.689
30 Murcia;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
30 Murcia;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
30 Murcia;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
30 Murcia;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QII;9.348
30 Murcia;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
30 Murcia;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
30 Murcia;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
30 Murcia;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QII;8.954
30 Murcia;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
30 Murcia;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
30 Murcia;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
30 Murcia;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2022QII;9.407
30 Murcia;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2022QI;""
30 Murcia;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
30 Murcia;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
30 Murcia;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2021QII;9.102
30 Murcia;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2021QI;""
30 Murcia;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
30 Murcia;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
30 Murcia;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2020QII;8.800
30 Murcia;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2020QI;""
30 Murcia;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
30 Murcia;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2022QIII;9.222
30 Murcia;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2022QII;""
30 Murcia;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2022QI;""
30 Murcia;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
30 Murcia;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2021QIII;8.942
30 Murcia;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2021QII;""
30 Murcia;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2021QI;""
30 Murcia;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
30 Murcia;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2020QIII;8.582
30 Murcia;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2020QII;""
30 Murcia;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2020QI;""
30 Murcia;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QIV;9.006
30 Murcia;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
30 Murcia;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QII;""
30 Murcia;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QI;""
30 Murcia;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QIV;8.758
30 Murcia;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
30 Murcia;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QII;""
30 Murcia;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QI;""
30 Murcia;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QIV;8.434
30 Murcia;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
30 Murcia;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QII;""
30 Murcia;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QI;""
30 Murcia;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
30 Murcia;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
30 Murcia;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QII;""
30 Murcia;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QI;8.546
30 Murcia;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
30 Murcia;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
30 Murcia;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QII;""
30 Murcia;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QI;8.276
30 Murcia;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
30 Murcia;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
30 Murcia;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QII;""
30 Murcia;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QI;""
30 Murcia;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
30 Murcia;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
30 Murcia;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
30 Murcia;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
30 Murcia;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
30 Murcia;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
30 Murcia;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
30 Murcia;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
30 Murcia;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
30 Murcia;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
30 Murcia;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
30 Murcia;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
30 Murcia;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
30 Murcia;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
30 Murcia;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;97,09
30 Murcia;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
30 Murcia;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
30 Murcia;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
30 Murcia;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;97,37
30 Murcia;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
30 Murcia;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
30 Murcia;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
30 Murcia;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;98,28
30 Murcia;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
30 Murcia;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
30 Murcia;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;95,18
30 Murcia;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
30 Murcia;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
30 Murcia;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
30 Murcia;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;95,66
30 Murcia;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
30 Murcia;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
30 Murcia;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
30 Murcia;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;95,85
30 Murcia;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
30 Murcia;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
30 Murcia;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;92,95
30 Murcia;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
30 Murcia;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
30 Murcia;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
30 Murcia;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;93,69
30 Murcia;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
30 Murcia;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
30 Murcia;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
30 Murcia;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;94,19
30 Murcia;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
30 Murcia;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
30 Murcia;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
30 Murcia;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
30 Murcia;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
30 Murcia;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
30 Murcia;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;91,42
30 Murcia;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
30 Murcia;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
30 Murcia;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
30 Murcia;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;92,43
30 Murcia;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
30 Murcia;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
30 Murcia;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
30 Murcia;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
30 Murcia;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
30 Murcia;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QIII;27.528
30 Murcia;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
30 Murcia;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
30 Murcia;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
30 Murcia;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QIII;26.999
30 Murcia;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
30 Murcia;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
30 Murcia;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
30 Murcia;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QIII;26.219
30 Murcia;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
30 Murcia;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
30 Murcia;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
30 Murcia;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2022QIII;26.889
30 Murcia;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2022QII;""
30 Murcia;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2022QI;""
30 Murcia;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
30 Murcia;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2021QIII;26.437
30 Murcia;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2021QII;""
30 Murcia;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2021QI;""
30 Murcia;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
30 Murcia;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2020QIII;25.584
30 Murcia;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2020QII;""
30 Murcia;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2020QI;""
30 Murcia;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2022QIV;26.238
30 Murcia;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
30 Murcia;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2022QII;""
30 Murcia;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2022QI;""
30 Murcia;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2021QIV;25.862
30 Murcia;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
30 Murcia;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2021QII;""
30 Murcia;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2021QI;""
30 Murcia;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2020QIV;25.118
30 Murcia;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
30 Murcia;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2020QII;""
30 Murcia;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2020QI;""
30 Murcia;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
30 Murcia;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
30 Murcia;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QII;""
30 Murcia;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QI;25.318
30 Murcia;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
30 Murcia;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
30 Murcia;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QII;""
30 Murcia;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QI;24.731
30 Murcia;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
30 Murcia;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
30 Murcia;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QII;""
30 Murcia;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QI;""
30 Murcia;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
30 Murcia;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
30 Murcia;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QII;24.827
30 Murcia;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QI;""
30 Murcia;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
30 Murcia;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
30 Murcia;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QII;24.258
30 Murcia;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QI;""
30 Murcia;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
30 Murcia;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
30 Murcia;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QII;""
30 Murcia;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QI;""
30 Murcia;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
30 Murcia;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
30 Murcia;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
30 Murcia;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
30 Murcia;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
30 Murcia;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
30 Murcia;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
30 Murcia;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
30 Murcia;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
30 Murcia;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
30 Murcia;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
30 Murcia;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
30 Murcia;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
30 Murcia;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;97,68
30 Murcia;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
30 Murcia;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
30 Murcia;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
30 Murcia;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;97,92
30 Murcia;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
30 Murcia;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
30 Murcia;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
30 Murcia;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;97,58
30 Murcia;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
30 Murcia;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
30 Murcia;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;95,31
30 Murcia;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
30 Murcia;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
30 Murcia;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
30 Murcia;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;95,79
30 Murcia;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
30 Murcia;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
30 Murcia;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
30 Murcia;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;95,8
30 Murcia;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
30 Murcia;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
30 Murcia;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
30 Murcia;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
30 Murcia;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
30 Murcia;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
30 Murcia;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;93,77
30 Murcia;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
30 Murcia;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
30 Murcia;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
30 Murcia;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;94,32
30 Murcia;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
30 Murcia;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
30 Murcia;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
30 Murcia;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
30 Murcia;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
30 Murcia;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
30 Murcia;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;91,96
30 Murcia;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
30 Murcia;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
30 Murcia;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
30 Murcia;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;92,52
30 Murcia;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
30 Murcia;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
30 Murcia;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
30 Murcia;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
30 Murcia;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
30 Murcia;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
30 Murcia;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QIII;17.855
30 Murcia;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
30 Murcia;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
30 Murcia;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
30 Murcia;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QIII;17.625
30 Murcia;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
30 Murcia;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
30 Murcia;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
30 Murcia;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QIII;17.212
30 Murcia;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
30 Murcia;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
30 Murcia;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
30 Murcia;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2022QIII;17.453
30 Murcia;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2022QII;""
30 Murcia;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2022QI;""
30 Murcia;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
30 Murcia;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2021QIII;17.261
30 Murcia;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2021QII;""
30 Murcia;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2021QI;""
30 Murcia;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
30 Murcia;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2020QIII;16.832
30 Murcia;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2020QII;""
30 Murcia;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2020QI;""
30 Murcia;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2022QIV;17.058
30 Murcia;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
30 Murcia;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2022QII;""
30 Murcia;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2022QI;""
30 Murcia;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2021QIV;16.900
30 Murcia;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
30 Murcia;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2021QII;""
30 Murcia;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2021QI;""
30 Murcia;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2020QIV;16.531
30 Murcia;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
30 Murcia;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2020QII;""
30 Murcia;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2020QI;""
30 Murcia;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
30 Murcia;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
30 Murcia;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QII;""
30 Murcia;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QI;16.577
30 Murcia;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
30 Murcia;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
30 Murcia;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QII;""
30 Murcia;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QI;16.306
30 Murcia;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
30 Murcia;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
30 Murcia;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QII;""
30 Murcia;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QI;""
30 Murcia;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
30 Murcia;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
30 Murcia;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QII;16.278
30 Murcia;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QI;""
30 Murcia;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
30 Murcia;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
30 Murcia;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QII;16.009
30 Murcia;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QI;""
30 Murcia;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
30 Murcia;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
30 Murcia;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QII;""
30 Murcia;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QI;""
30 Murcia;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
30 Murcia;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
30 Murcia;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
30 Murcia;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
30 Murcia;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
30 Murcia;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
30 Murcia;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
30 Murcia;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
30 Murcia;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
30 Murcia;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
30 Murcia;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
30 Murcia;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
30 Murcia;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
30 Murcia;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;97,75
30 Murcia;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
30 Murcia;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
30 Murcia;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
30 Murcia;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;97,93
30 Murcia;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
30 Murcia;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
30 Murcia;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
30 Murcia;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;97,79
30 Murcia;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
30 Murcia;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
30 Murcia;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;95,54
30 Murcia;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
30 Murcia;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
30 Murcia;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
30 Murcia;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;95,89
30 Murcia;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
30 Murcia;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
30 Murcia;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
30 Murcia;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;96,04
30 Murcia;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
30 Murcia;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
30 Murcia;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
30 Murcia;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
30 Murcia;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
30 Murcia;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
30 Murcia;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;94,05
30 Murcia;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
30 Murcia;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
30 Murcia;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
30 Murcia;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;94,74
30 Murcia;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
30 Murcia;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
30 Murcia;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
30 Murcia;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
30 Murcia;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
30 Murcia;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
30 Murcia;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;92,36
30 Murcia;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
30 Murcia;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
30 Murcia;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
30 Murcia;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;93,01
30 Murcia;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
30 Murcia;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
30 Murcia;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
30 Murcia;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
30 Murcia;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
30 Murcia;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
30 Murcia;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QIII;9.673
30 Murcia;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
30 Murcia;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
30 Murcia;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
30 Murcia;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QIII;9.374
30 Murcia;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
30 Murcia;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
30 Murcia;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
30 Murcia;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QIII;9.007
30 Murcia;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
30 Murcia;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
30 Murcia;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
30 Murcia;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2022QIII;9.436
30 Murcia;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2022QII;""
30 Murcia;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2022QI;""
30 Murcia;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
30 Murcia;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2021QIII;9.176
30 Murcia;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2021QII;""
30 Murcia;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2021QI;""
30 Murcia;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
30 Murcia;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2020QIII;8.752
30 Murcia;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2020QII;""
30 Murcia;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2020QI;""
30 Murcia;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2022QIV;9.180
30 Murcia;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
30 Murcia;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2022QII;""
30 Murcia;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2022QI;""
30 Murcia;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2021QIV;8.962
30 Murcia;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
30 Murcia;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2021QII;""
30 Murcia;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2021QI;""
30 Murcia;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2020QIV;8.587
30 Murcia;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
30 Murcia;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2020QII;""
30 Murcia;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2020QI;""
30 Murcia;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
30 Murcia;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
30 Murcia;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QII;""
30 Murcia;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QI;8.741
30 Murcia;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
30 Murcia;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
30 Murcia;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QII;""
30 Murcia;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QI;8.425
30 Murcia;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
30 Murcia;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
30 Murcia;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QII;""
30 Murcia;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QI;""
30 Murcia;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
30 Murcia;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
30 Murcia;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QII;8.549
30 Murcia;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QI;""
30 Murcia;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
30 Murcia;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
30 Murcia;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QII;8.249
30 Murcia;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QI;""
30 Murcia;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
30 Murcia;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
30 Murcia;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QII;""
30 Murcia;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QI;""
30 Murcia;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
30 Murcia;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
30 Murcia;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
30 Murcia;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
30 Murcia;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
30 Murcia;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
30 Murcia;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
30 Murcia;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
30 Murcia;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
30 Murcia;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
30 Murcia;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
30 Murcia;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
30 Murcia;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
30 Murcia;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;97,55
30 Murcia;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
30 Murcia;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
30 Murcia;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
30 Murcia;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;97,89
30 Murcia;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
30 Murcia;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
30 Murcia;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
30 Murcia;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;97,17
30 Murcia;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
30 Murcia;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
30 Murcia;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;94,9
30 Murcia;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
30 Murcia;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
30 Murcia;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
30 Murcia;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;95,6
30 Murcia;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
30 Murcia;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
30 Murcia;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
30 Murcia;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;95,34
30 Murcia;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
30 Murcia;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
30 Murcia;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
30 Murcia;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
30 Murcia;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
30 Murcia;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
30 Murcia;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;93,25
30 Murcia;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
30 Murcia;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
30 Murcia;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
30 Murcia;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;93,54
30 Murcia;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
30 Murcia;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
30 Murcia;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
30 Murcia;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
30 Murcia;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
30 Murcia;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
30 Murcia;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;91,2
30 Murcia;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
30 Murcia;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
30 Murcia;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
30 Murcia;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;91,58
30 Murcia;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
30 Murcia;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
30 Murcia;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
30 Murcia;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
30 Murcia;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
30 Murcia;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QIV;27.385
30 Murcia;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
30 Murcia;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
30 Murcia;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
30 Murcia;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QIV;26.879
30 Murcia;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
30 Murcia;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
30 Murcia;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
30 Murcia;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QIV;26.083
30 Murcia;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
30 Murcia;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
30 Murcia;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
30 Murcia;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2022QIV;26.658
30 Murcia;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
30 Murcia;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2022QII;""
30 Murcia;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2022QI;""
30 Murcia;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2021QIV;26.243
30 Murcia;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
30 Murcia;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2021QII;""
30 Murcia;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2021QI;""
30 Murcia;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2020QIV;25.555
30 Murcia;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
30 Murcia;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2020QII;""
30 Murcia;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2020QI;""
30 Murcia;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
30 Murcia;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
30 Murcia;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2022QII;""
30 Murcia;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2022QI;25.669
30 Murcia;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
30 Murcia;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
30 Murcia;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2021QII;""
30 Murcia;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2021QI;25.143
30 Murcia;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
30 Murcia;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
30 Murcia;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2020QII;""
30 Murcia;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2020QI;""
30 Murcia;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
30 Murcia;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
30 Murcia;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QII;25.139
30 Murcia;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QI;""
30 Murcia;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
30 Murcia;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
30 Murcia;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QII;24.629
30 Murcia;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QI;""
30 Murcia;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
30 Murcia;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
30 Murcia;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QII;""
30 Murcia;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QI;""
30 Murcia;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
30 Murcia;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QIII;24.705
30 Murcia;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QII;""
30 Murcia;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QI;""
30 Murcia;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
30 Murcia;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QIII;24.257
30 Murcia;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QII;""
30 Murcia;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QI;""
30 Murcia;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
30 Murcia;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
30 Murcia;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QII;""
30 Murcia;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QI;""
30 Murcia;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
30 Murcia;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
30 Murcia;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
30 Murcia;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
30 Murcia;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
30 Murcia;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
30 Murcia;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
30 Murcia;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
30 Murcia;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
30 Murcia;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
30 Murcia;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
30 Murcia;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
30 Murcia;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;97,35
30 Murcia;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
30 Murcia;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
30 Murcia;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
30 Murcia;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;97,63
30 Murcia;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
30 Murcia;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
30 Murcia;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
30 Murcia;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;97,98
30 Murcia;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
30 Murcia;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
30 Murcia;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
30 Murcia;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
30 Murcia;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
30 Murcia;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
30 Murcia;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;95,5
30 Murcia;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
30 Murcia;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
30 Murcia;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
30 Murcia;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;96,4
30 Murcia;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
30 Murcia;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
30 Murcia;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
30 Murcia;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
30 Murcia;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
30 Murcia;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
30 Murcia;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;93,53
30 Murcia;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
30 Murcia;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
30 Murcia;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
30 Murcia;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;94,43
30 Murcia;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
30 Murcia;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
30 Murcia;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
30 Murcia;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
30 Murcia;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
30 Murcia;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
30 Murcia;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;91,91
30 Murcia;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
30 Murcia;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
30 Murcia;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
30 Murcia;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;93
30 Murcia;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
30 Murcia;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
30 Murcia;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
30 Murcia;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
30 Murcia;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
30 Murcia;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
30 Murcia;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QIV;17.720
30 Murcia;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
30 Murcia;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
30 Murcia;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
30 Murcia;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QIV;17.516
30 Murcia;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
30 Murcia;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
30 Murcia;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
30 Murcia;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QIV;17.139
30 Murcia;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
30 Murcia;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
30 Murcia;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
30 Murcia;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2022QIV;17.284
30 Murcia;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
30 Murcia;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2022QII;""
30 Murcia;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2022QI;""
30 Murcia;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2021QIV;17.121
30 Murcia;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
30 Murcia;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2021QII;""
30 Murcia;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2021QI;""
30 Murcia;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2020QIV;16.798
30 Murcia;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
30 Murcia;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2020QII;""
30 Murcia;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2020QI;""
30 Murcia;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
30 Murcia;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
30 Murcia;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2022QII;""
30 Murcia;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2022QI;16.784
30 Murcia;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
30 Murcia;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
30 Murcia;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2021QII;""
30 Murcia;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2021QI;16.555
30 Murcia;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
30 Murcia;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
30 Murcia;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2020QII;""
30 Murcia;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2020QI;""
30 Murcia;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
30 Murcia;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
30 Murcia;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QII;16.461
30 Murcia;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QI;""
30 Murcia;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
30 Murcia;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
30 Murcia;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QII;16.231
30 Murcia;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QI;""
30 Murcia;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
30 Murcia;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
30 Murcia;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QII;""
30 Murcia;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QI;""
30 Murcia;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
30 Murcia;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QIII;16.176
30 Murcia;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QII;""
30 Murcia;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QI;""
30 Murcia;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
30 Murcia;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QIII;15.993
30 Murcia;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QII;""
30 Murcia;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QI;""
30 Murcia;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
30 Murcia;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
30 Murcia;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QII;""
30 Murcia;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QI;""
30 Murcia;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
30 Murcia;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
30 Murcia;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
30 Murcia;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
30 Murcia;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
30 Murcia;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
30 Murcia;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
30 Murcia;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
30 Murcia;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
30 Murcia;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
30 Murcia;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
30 Murcia;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
30 Murcia;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;97,54
30 Murcia;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
30 Murcia;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
30 Murcia;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
30 Murcia;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;97,74
30 Murcia;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
30 Murcia;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
30 Murcia;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
30 Murcia;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;98,01
30 Murcia;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
30 Murcia;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
30 Murcia;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
30 Murcia;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
30 Murcia;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
30 Murcia;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
30 Murcia;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;95,82
30 Murcia;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
30 Murcia;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
30 Murcia;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
30 Murcia;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;96,59
30 Murcia;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
30 Murcia;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
30 Murcia;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
30 Murcia;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
30 Murcia;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
30 Murcia;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
30 Murcia;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;93,98
30 Murcia;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
30 Murcia;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
30 Murcia;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
30 Murcia;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;94,7
30 Murcia;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
30 Murcia;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
30 Murcia;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
30 Murcia;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
30 Murcia;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
30 Murcia;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
30 Murcia;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;92,35
30 Murcia;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
30 Murcia;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
30 Murcia;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
30 Murcia;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;93,31
30 Murcia;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
30 Murcia;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
30 Murcia;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
30 Murcia;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
30 Murcia;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
30 Murcia;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
30 Murcia;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QIV;9.665
30 Murcia;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
30 Murcia;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
30 Murcia;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
30 Murcia;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QIV;9.363
30 Murcia;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
30 Murcia;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
30 Murcia;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
30 Murcia;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QIV;8.944
30 Murcia;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
30 Murcia;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
30 Murcia;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
30 Murcia;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2022QIV;9.374
30 Murcia;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
30 Murcia;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2022QII;""
30 Murcia;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2022QI;""
30 Murcia;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2021QIV;9.122
30 Murcia;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
30 Murcia;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2021QII;""
30 Murcia;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2021QI;""
30 Murcia;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2020QIV;8.757
30 Murcia;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
30 Murcia;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2020QII;""
30 Murcia;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2020QI;""
30 Murcia;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
30 Murcia;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
30 Murcia;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2022QII;""
30 Murcia;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2022QI;8.885
30 Murcia;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
30 Murcia;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
30 Murcia;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2021QII;""
30 Murcia;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2021QI;8.588
30 Murcia;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
30 Murcia;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
30 Murcia;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2020QII;""
30 Murcia;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2020QI;""
30 Murcia;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
30 Murcia;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
30 Murcia;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QII;8.678
30 Murcia;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QI;""
30 Murcia;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
30 Murcia;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
30 Murcia;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QII;8.398
30 Murcia;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QI;""
30 Murcia;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
30 Murcia;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
30 Murcia;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QII;""
30 Murcia;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QI;""
30 Murcia;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
30 Murcia;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QIII;8.529
30 Murcia;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QII;""
30 Murcia;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QI;""
30 Murcia;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
30 Murcia;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QIII;8.264
30 Murcia;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QII;""
30 Murcia;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QI;""
30 Murcia;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
30 Murcia;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
30 Murcia;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QII;""
30 Murcia;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QI;""
30 Murcia;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
30 Murcia;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
30 Murcia;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
30 Murcia;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
30 Murcia;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
30 Murcia;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
30 Murcia;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
30 Murcia;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
30 Murcia;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
30 Murcia;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
30 Murcia;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
30 Murcia;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
30 Murcia;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;96,99
30 Murcia;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
30 Murcia;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
30 Murcia;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
30 Murcia;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;97,43
30 Murcia;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
30 Murcia;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
30 Murcia;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
30 Murcia;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;97,91
30 Murcia;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
30 Murcia;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
30 Murcia;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
30 Murcia;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
30 Murcia;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
30 Murcia;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
30 Murcia;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;94,89
30 Murcia;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
30 Murcia;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
30 Murcia;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
30 Murcia;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;96,02
30 Murcia;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
30 Murcia;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
30 Murcia;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
30 Murcia;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
30 Murcia;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
30 Murcia;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
30 Murcia;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;92,68
30 Murcia;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
30 Murcia;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
30 Murcia;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
30 Murcia;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;93,9
30 Murcia;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
30 Murcia;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
30 Murcia;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
30 Murcia;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
30 Murcia;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
30 Murcia;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
30 Murcia;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;91,09
30 Murcia;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
30 Murcia;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
30 Murcia;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
30 Murcia;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;92,4
30 Murcia;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
30 Murcia;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
30 Murcia;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
30 Murcia;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
30 Murcia;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
30 Murcia;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
30 Murcia;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
30 Murcia;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
30 Murcia;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
30 Murcia;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QI;11.906
30 Murcia;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
30 Murcia;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
30 Murcia;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
30 Murcia;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QI;11.106
30 Murcia;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
30 Murcia;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
30 Murcia;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
30 Murcia;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QI;12.514
30 Murcia;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
30 Murcia;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
30 Murcia;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2022QII;""
30 Murcia;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2022QI;11.426
30 Murcia;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
30 Murcia;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
30 Murcia;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2021QII;""
30 Murcia;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2021QI;10.734
30 Murcia;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
30 Murcia;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
30 Murcia;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2020QII;""
30 Murcia;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2020QI;11.716
30 Murcia;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
30 Murcia;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
30 Murcia;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2022QII;10.979
30 Murcia;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2022QI;""
30 Murcia;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
30 Murcia;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
30 Murcia;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2021QII;10.276
30 Murcia;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2021QI;""
30 Murcia;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
30 Murcia;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
30 Murcia;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2020QII;11.388
30 Murcia;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2020QI;""
30 Murcia;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
30 Murcia;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QIII;10.572
30 Murcia;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QII;""
30 Murcia;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QI;""
30 Murcia;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
30 Murcia;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QIII;9.942
30 Murcia;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QII;""
30 Murcia;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QI;""
30 Murcia;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
30 Murcia;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QIII;10.973
30 Murcia;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QII;""
30 Murcia;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QI;""
30 Murcia;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QIV;9.958
30 Murcia;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
30 Murcia;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QII;""
30 Murcia;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QI;""
30 Murcia;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QIV;9.477
30 Murcia;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
30 Murcia;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QII;""
30 Murcia;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QI;""
30 Murcia;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QIV;10.516
30 Murcia;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
30 Murcia;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QII;""
30 Murcia;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QI;""
30 Murcia;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
30 Murcia;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
30 Murcia;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
30 Murcia;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
30 Murcia;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
30 Murcia;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
30 Murcia;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
30 Murcia;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
30 Murcia;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
30 Murcia;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
30 Murcia;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
30 Murcia;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
30 Murcia;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
30 Murcia;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
30 Murcia;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
30 Murcia;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;95,97
30 Murcia;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
30 Murcia;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
30 Murcia;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
30 Murcia;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;96,65
30 Murcia;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
30 Murcia;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
30 Murcia;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
30 Murcia;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;93,62
30 Murcia;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
30 Murcia;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
30 Murcia;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;92,21
30 Murcia;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
30 Murcia;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
30 Murcia;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
30 Murcia;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;92,53
30 Murcia;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
30 Murcia;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
30 Murcia;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
30 Murcia;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;91
30 Murcia;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
30 Murcia;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
30 Murcia;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;88,8
30 Murcia;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
30 Murcia;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
30 Murcia;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
30 Murcia;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;89,52
30 Murcia;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
30 Murcia;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
30 Murcia;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
30 Murcia;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;87,69
30 Murcia;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
30 Murcia;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
30 Murcia;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;83,64
30 Murcia;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
30 Murcia;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
30 Murcia;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
30 Murcia;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;85,33
30 Murcia;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
30 Murcia;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
30 Murcia;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
30 Murcia;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;84,03
30 Murcia;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
30 Murcia;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
30 Murcia;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
30 Murcia;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
30 Murcia;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
30 Murcia;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
30 Murcia;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QI;7.904
30 Murcia;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
30 Murcia;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
30 Murcia;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
30 Murcia;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QI;7.333
30 Murcia;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
30 Murcia;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
30 Murcia;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
30 Murcia;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QI;8.214
30 Murcia;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
30 Murcia;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
30 Murcia;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2022QII;""
30 Murcia;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2022QI;7.591
30 Murcia;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
30 Murcia;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
30 Murcia;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2021QII;""
30 Murcia;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2021QI;7.095
30 Murcia;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
30 Murcia;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
30 Murcia;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2020QII;""
30 Murcia;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2020QI;7.712
30 Murcia;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
30 Murcia;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
30 Murcia;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2022QII;7.305
30 Murcia;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2022QI;""
30 Murcia;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
30 Murcia;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
30 Murcia;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2021QII;6.807
30 Murcia;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2021QI;""
30 Murcia;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
30 Murcia;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
30 Murcia;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2020QII;7.498
30 Murcia;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2020QI;""
30 Murcia;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
30 Murcia;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QIII;7.060
30 Murcia;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QII;""
30 Murcia;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QI;""
30 Murcia;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
30 Murcia;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QIII;6.603
30 Murcia;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QII;""
30 Murcia;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QI;""
30 Murcia;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
30 Murcia;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QIII;7.245
30 Murcia;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QII;""
30 Murcia;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QI;""
30 Murcia;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QIV;6.653
30 Murcia;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
30 Murcia;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QII;""
30 Murcia;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QI;""
30 Murcia;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QIV;6.301
30 Murcia;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
30 Murcia;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QII;""
30 Murcia;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QI;""
30 Murcia;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QIV;6.956
30 Murcia;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
30 Murcia;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QII;""
30 Murcia;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QI;""
30 Murcia;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
30 Murcia;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
30 Murcia;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
30 Murcia;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
30 Murcia;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
30 Murcia;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
30 Murcia;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
30 Murcia;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
30 Murcia;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
30 Murcia;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
30 Murcia;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
30 Murcia;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
30 Murcia;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
30 Murcia;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
30 Murcia;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
30 Murcia;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;96,04
30 Murcia;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
30 Murcia;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
30 Murcia;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
30 Murcia;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;96,75
30 Murcia;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
30 Murcia;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
30 Murcia;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
30 Murcia;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;93,89
30 Murcia;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
30 Murcia;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
30 Murcia;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;92,42
30 Murcia;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
30 Murcia;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
30 Murcia;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
30 Murcia;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;92,83
30 Murcia;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
30 Murcia;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
30 Murcia;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
30 Murcia;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;91,28
30 Murcia;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
30 Murcia;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
30 Murcia;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;89,32
30 Murcia;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
30 Murcia;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
30 Murcia;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
30 Murcia;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;90,05
30 Murcia;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
30 Murcia;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
30 Murcia;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
30 Murcia;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;88,2
30 Murcia;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
30 Murcia;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
30 Murcia;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;84,17
30 Murcia;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
30 Murcia;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
30 Murcia;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
30 Murcia;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;85,93
30 Murcia;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
30 Murcia;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
30 Murcia;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
30 Murcia;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;84,68
30 Murcia;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
30 Murcia;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
30 Murcia;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
30 Murcia;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
30 Murcia;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
30 Murcia;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
30 Murcia;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QI;4.002
30 Murcia;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
30 Murcia;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
30 Murcia;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
30 Murcia;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QI;3.773
30 Murcia;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
30 Murcia;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
30 Murcia;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
30 Murcia;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QI;4.300
30 Murcia;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
30 Murcia;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
30 Murcia;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2022QII;""
30 Murcia;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2022QI;3.835
30 Murcia;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
30 Murcia;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
30 Murcia;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2021QII;""
30 Murcia;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2021QI;3.639
30 Murcia;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
30 Murcia;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
30 Murcia;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2020QII;""
30 Murcia;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2020QI;4.004
30 Murcia;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
30 Murcia;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
30 Murcia;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2022QII;3.674
30 Murcia;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2022QI;""
30 Murcia;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
30 Murcia;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
30 Murcia;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2021QII;3.469
30 Murcia;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2021QI;""
30 Murcia;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
30 Murcia;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
30 Murcia;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2020QII;3.890
30 Murcia;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2020QI;""
30 Murcia;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
30 Murcia;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QIII;3.512
30 Murcia;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QII;""
30 Murcia;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QI;""
30 Murcia;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
30 Murcia;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QIII;3.339
30 Murcia;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QII;""
30 Murcia;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QI;""
30 Murcia;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
30 Murcia;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QIII;3.728
30 Murcia;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QII;""
30 Murcia;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QI;""
30 Murcia;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QIV;3.305
30 Murcia;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
30 Murcia;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QII;""
30 Murcia;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QI;""
30 Murcia;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QIV;3.176
30 Murcia;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
30 Murcia;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QII;""
30 Murcia;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QI;""
30 Murcia;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QIV;3.560
30 Murcia;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
30 Murcia;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QII;""
30 Murcia;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QI;""
30 Murcia;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
30 Murcia;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
30 Murcia;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
30 Murcia;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
30 Murcia;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
30 Murcia;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
30 Murcia;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
30 Murcia;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
30 Murcia;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
30 Murcia;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
30 Murcia;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
30 Murcia;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
30 Murcia;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
30 Murcia;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
30 Murcia;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
30 Murcia;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;95,83
30 Murcia;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
30 Murcia;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
30 Murcia;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
30 Murcia;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;96,45
30 Murcia;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
30 Murcia;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
30 Murcia;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
30 Murcia;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;93,12
30 Murcia;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
30 Murcia;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
30 Murcia;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;91,8
30 Murcia;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
30 Murcia;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
30 Murcia;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
30 Murcia;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;91,94
30 Murcia;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
30 Murcia;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
30 Murcia;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
30 Murcia;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;90,47
30 Murcia;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
30 Murcia;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
30 Murcia;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;87,76
30 Murcia;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
30 Murcia;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
30 Murcia;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
30 Murcia;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;88,5
30 Murcia;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
30 Murcia;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
30 Murcia;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
30 Murcia;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;86,7
30 Murcia;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
30 Murcia;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
30 Murcia;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;82,58
30 Murcia;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
30 Murcia;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
30 Murcia;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
30 Murcia;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;84,18
30 Murcia;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
30 Murcia;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
30 Murcia;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
30 Murcia;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;82,79
30 Murcia;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
30 Murcia;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
30 Murcia;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
30 Murcia;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
30 Murcia;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
30 Murcia;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QII;13.668
30 Murcia;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
30 Murcia;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
30 Murcia;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
30 Murcia;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QII;12.900
30 Murcia;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
30 Murcia;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
30 Murcia;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
30 Murcia;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QII;11.999
30 Murcia;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
30 Murcia;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
30 Murcia;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
30 Murcia;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2022QII;13.164
30 Murcia;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2022QI;""
30 Murcia;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
30 Murcia;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
30 Murcia;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2021QII;12.392
30 Murcia;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2021QI;""
30 Murcia;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
30 Murcia;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
30 Murcia;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2020QII;11.655
30 Murcia;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2020QI;""
30 Murcia;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
30 Murcia;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2022QIII;12.702
30 Murcia;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2022QII;""
30 Murcia;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2022QI;""
30 Murcia;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
30 Murcia;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2021QIII;12.010
30 Murcia;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2021QII;""
30 Murcia;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2021QI;""
30 Murcia;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
30 Murcia;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2020QIII;11.175
30 Murcia;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2020QII;""
30 Murcia;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2020QI;""
30 Murcia;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QIV;12.035
30 Murcia;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
30 Murcia;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QII;""
30 Murcia;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QI;""
30 Murcia;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QIV;11.507
30 Murcia;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
30 Murcia;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QII;""
30 Murcia;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QI;""
30 Murcia;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QIV;10.703
30 Murcia;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
30 Murcia;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QII;""
30 Murcia;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QI;""
30 Murcia;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
30 Murcia;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
30 Murcia;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QII;""
30 Murcia;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QI;11.064
30 Murcia;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
30 Murcia;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
30 Murcia;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QII;""
30 Murcia;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QI;10.361
30 Murcia;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
30 Murcia;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
30 Murcia;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QII;""
30 Murcia;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QI;""
30 Murcia;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
30 Murcia;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
30 Murcia;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
30 Murcia;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
30 Murcia;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
30 Murcia;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
30 Murcia;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
30 Murcia;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
30 Murcia;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
30 Murcia;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
30 Murcia;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
30 Murcia;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
30 Murcia;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
30 Murcia;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
30 Murcia;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;96,31
30 Murcia;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
30 Murcia;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
30 Murcia;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
30 Murcia;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;96,06
30 Murcia;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
30 Murcia;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
30 Murcia;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
30 Murcia;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;97,13
30 Murcia;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
30 Murcia;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
30 Murcia;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;92,93
30 Murcia;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
30 Murcia;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
30 Murcia;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
30 Murcia;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;93,1
30 Murcia;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
30 Murcia;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
30 Murcia;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
30 Murcia;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;93,13
30 Murcia;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
30 Murcia;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
30 Murcia;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;88,05
30 Murcia;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
30 Murcia;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
30 Murcia;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
30 Murcia;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;89,2
30 Murcia;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
30 Murcia;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
30 Murcia;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
30 Murcia;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;89,2
30 Murcia;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
30 Murcia;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
30 Murcia;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
30 Murcia;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
30 Murcia;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
30 Murcia;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
30 Murcia;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;85,77
30 Murcia;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
30 Murcia;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
30 Murcia;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
30 Murcia;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;86,35
30 Murcia;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
30 Murcia;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
30 Murcia;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
30 Murcia;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
30 Murcia;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
30 Murcia;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
30 Murcia;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QII;9.066
30 Murcia;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
30 Murcia;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
30 Murcia;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
30 Murcia;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QII;8.564
30 Murcia;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
30 Murcia;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
30 Murcia;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
30 Murcia;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QII;7.901
30 Murcia;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
30 Murcia;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
30 Murcia;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
30 Murcia;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2022QII;8.746
30 Murcia;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2022QI;""
30 Murcia;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
30 Murcia;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
30 Murcia;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2021QII;8.244
30 Murcia;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2021QI;""
30 Murcia;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
30 Murcia;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
30 Murcia;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2020QII;7.676
30 Murcia;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2020QI;""
30 Murcia;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
30 Murcia;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2022QIII;8.467
30 Murcia;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2022QII;""
30 Murcia;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2022QI;""
30 Murcia;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
30 Murcia;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2021QIII;8.013
30 Murcia;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2021QII;""
30 Murcia;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2021QI;""
30 Murcia;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
30 Murcia;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2020QIII;7.373
30 Murcia;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2020QII;""
30 Murcia;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2020QI;""
30 Murcia;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QIV;8.026
30 Murcia;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
30 Murcia;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QII;""
30 Murcia;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QI;""
30 Murcia;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QIV;7.687
30 Murcia;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
30 Murcia;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QII;""
30 Murcia;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QI;""
30 Murcia;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QIV;7.075
30 Murcia;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
30 Murcia;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QII;""
30 Murcia;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QI;""
30 Murcia;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
30 Murcia;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
30 Murcia;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QII;""
30 Murcia;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QI;7.398
30 Murcia;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
30 Murcia;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
30 Murcia;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QII;""
30 Murcia;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QI;6.855
30 Murcia;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
30 Murcia;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
30 Murcia;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QII;""
30 Murcia;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QI;""
30 Murcia;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
30 Murcia;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
30 Murcia;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
30 Murcia;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
30 Murcia;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
30 Murcia;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
30 Murcia;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
30 Murcia;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
30 Murcia;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
30 Murcia;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
30 Murcia;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
30 Murcia;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
30 Murcia;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
30 Murcia;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
30 Murcia;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;96,47
30 Murcia;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
30 Murcia;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
30 Murcia;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
30 Murcia;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;96,26
30 Murcia;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
30 Murcia;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
30 Murcia;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
30 Murcia;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;97,15
30 Murcia;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
30 Murcia;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
30 Murcia;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;93,39
30 Murcia;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
30 Murcia;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
30 Murcia;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
30 Murcia;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;93,57
30 Murcia;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
30 Murcia;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
30 Murcia;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
30 Murcia;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;93,32
30 Murcia;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
30 Murcia;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
30 Murcia;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;88,53
30 Murcia;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
30 Murcia;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
30 Murcia;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
30 Murcia;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;89,76
30 Murcia;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
30 Murcia;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
30 Murcia;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
30 Murcia;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;89,55
30 Murcia;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
30 Murcia;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
30 Murcia;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
30 Murcia;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
30 Murcia;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
30 Murcia;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
30 Murcia;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;86,38
30 Murcia;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
30 Murcia;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
30 Murcia;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
30 Murcia;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;86,76
30 Murcia;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
30 Murcia;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
30 Murcia;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
30 Murcia;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
30 Murcia;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
30 Murcia;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
30 Murcia;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QII;4.602
30 Murcia;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
30 Murcia;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
30 Murcia;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
30 Murcia;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QII;4.336
30 Murcia;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
30 Murcia;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
30 Murcia;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
30 Murcia;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QII;4.098
30 Murcia;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
30 Murcia;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
30 Murcia;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
30 Murcia;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2022QII;4.418
30 Murcia;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2022QI;""
30 Murcia;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
30 Murcia;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
30 Murcia;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2021QII;4.148
30 Murcia;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2021QI;""
30 Murcia;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
30 Murcia;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
30 Murcia;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2020QII;3.979
30 Murcia;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2020QI;""
30 Murcia;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
30 Murcia;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2022QIII;4.235
30 Murcia;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2022QII;""
30 Murcia;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2022QI;""
30 Murcia;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
30 Murcia;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2021QIII;3.997
30 Murcia;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2021QII;""
30 Murcia;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2021QI;""
30 Murcia;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
30 Murcia;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2020QIII;3.802
30 Murcia;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2020QII;""
30 Murcia;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2020QI;""
30 Murcia;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QIV;4.009
30 Murcia;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
30 Murcia;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QII;""
30 Murcia;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QI;""
30 Murcia;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QIV;3.820
30 Murcia;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
30 Murcia;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QII;""
30 Murcia;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QI;""
30 Murcia;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QIV;3.628
30 Murcia;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
30 Murcia;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QII;""
30 Murcia;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QI;""
30 Murcia;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
30 Murcia;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
30 Murcia;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QII;""
30 Murcia;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QI;3.666
30 Murcia;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
30 Murcia;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
30 Murcia;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QII;""
30 Murcia;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QI;3.506
30 Murcia;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
30 Murcia;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
30 Murcia;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QII;""
30 Murcia;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QI;""
30 Murcia;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
30 Murcia;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
30 Murcia;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
30 Murcia;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
30 Murcia;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
30 Murcia;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
30 Murcia;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
30 Murcia;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
30 Murcia;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
30 Murcia;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
30 Murcia;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
30 Murcia;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
30 Murcia;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
30 Murcia;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
30 Murcia;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;96
30 Murcia;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
30 Murcia;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
30 Murcia;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
30 Murcia;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;95,66
30 Murcia;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
30 Murcia;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
30 Murcia;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
30 Murcia;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;97,1
30 Murcia;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
30 Murcia;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
30 Murcia;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;92,03
30 Murcia;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
30 Murcia;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
30 Murcia;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
30 Murcia;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;92,18
30 Murcia;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
30 Murcia;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
30 Murcia;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
30 Murcia;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;92,78
30 Murcia;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
30 Murcia;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
30 Murcia;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;87,11
30 Murcia;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
30 Murcia;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
30 Murcia;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
30 Murcia;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;88,1
30 Murcia;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
30 Murcia;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
30 Murcia;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
30 Murcia;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;88,53
30 Murcia;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
30 Murcia;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
30 Murcia;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
30 Murcia;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
30 Murcia;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
30 Murcia;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
30 Murcia;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;84,55
30 Murcia;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
30 Murcia;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
30 Murcia;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
30 Murcia;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;85,55
30 Murcia;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
30 Murcia;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
30 Murcia;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
30 Murcia;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
30 Murcia;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
30 Murcia;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QIII;13.379
30 Murcia;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
30 Murcia;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
30 Murcia;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
30 Murcia;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QIII;12.596
30 Murcia;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
30 Murcia;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
30 Murcia;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
30 Murcia;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QIII;11.840
30 Murcia;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
30 Murcia;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
30 Murcia;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
30 Murcia;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2022QIII;12.866
30 Murcia;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2022QII;""
30 Murcia;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2022QI;""
30 Murcia;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
30 Murcia;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2021QIII;12.165
30 Murcia;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2021QII;""
30 Murcia;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2021QI;""
30 Murcia;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
30 Murcia;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2020QIII;11.324
30 Murcia;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2020QII;""
30 Murcia;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2020QI;""
30 Murcia;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2022QIV;12.172
30 Murcia;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
30 Murcia;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2022QII;""
30 Murcia;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2022QI;""
30 Murcia;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2021QIV;11.640
30 Murcia;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
30 Murcia;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2021QII;""
30 Murcia;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2021QI;""
30 Murcia;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2020QIV;10.839
30 Murcia;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
30 Murcia;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2020QII;""
30 Murcia;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2020QI;""
30 Murcia;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
30 Murcia;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
30 Murcia;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QII;""
30 Murcia;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QI;11.188
30 Murcia;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
30 Murcia;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
30 Murcia;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QII;""
30 Murcia;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QI;10.488
30 Murcia;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
30 Murcia;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
30 Murcia;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QII;""
30 Murcia;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QI;""
30 Murcia;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
30 Murcia;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
30 Murcia;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QII;10.771
30 Murcia;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QI;""
30 Murcia;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
30 Murcia;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
30 Murcia;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QII;10.056
30 Murcia;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QI;""
30 Murcia;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
30 Murcia;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
30 Murcia;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QII;""
30 Murcia;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QI;""
30 Murcia;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
30 Murcia;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
30 Murcia;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
30 Murcia;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
30 Murcia;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
30 Murcia;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
30 Murcia;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
30 Murcia;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
30 Murcia;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
30 Murcia;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
30 Murcia;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
30 Murcia;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
30 Murcia;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
30 Murcia;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;96,17
30 Murcia;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
30 Murcia;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
30 Murcia;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
30 Murcia;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;96,58
30 Murcia;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
30 Murcia;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
30 Murcia;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
30 Murcia;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;95,64
30 Murcia;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
30 Murcia;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
30 Murcia;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;90,98
30 Murcia;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
30 Murcia;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
30 Murcia;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
30 Murcia;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;92,41
30 Murcia;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
30 Murcia;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
30 Murcia;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
30 Murcia;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;91,55
30 Murcia;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
30 Murcia;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
30 Murcia;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
30 Murcia;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
30 Murcia;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
30 Murcia;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
30 Murcia;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;88,82
30 Murcia;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
30 Murcia;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
30 Murcia;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
30 Murcia;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;88,58
30 Murcia;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
30 Murcia;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
30 Murcia;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
30 Murcia;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
30 Murcia;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
30 Murcia;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
30 Murcia;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;85,51
30 Murcia;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
30 Murcia;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
30 Murcia;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
30 Murcia;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;84,93
30 Murcia;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
30 Murcia;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
30 Murcia;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
30 Murcia;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
30 Murcia;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
30 Murcia;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
30 Murcia;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QIII;8.869
30 Murcia;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
30 Murcia;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
30 Murcia;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
30 Murcia;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QIII;8.361
30 Murcia;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
30 Murcia;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
30 Murcia;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
30 Murcia;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QIII;7.801
30 Murcia;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
30 Murcia;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
30 Murcia;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
30 Murcia;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2022QIII;8.563
30 Murcia;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2022QII;""
30 Murcia;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2022QI;""
30 Murcia;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
30 Murcia;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2021QIII;8.100
30 Murcia;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2021QII;""
30 Murcia;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2021QI;""
30 Murcia;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
30 Murcia;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2020QIII;7.475
30 Murcia;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2020QII;""
30 Murcia;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2020QI;""
30 Murcia;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2022QIV;8.105
30 Murcia;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
30 Murcia;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2022QII;""
30 Murcia;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2022QI;""
30 Murcia;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2021QIV;7.763
30 Murcia;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
30 Murcia;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2021QII;""
30 Murcia;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2021QI;""
30 Murcia;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2020QIV;7.167
30 Murcia;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
30 Murcia;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2020QII;""
30 Murcia;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2020QI;""
30 Murcia;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
30 Murcia;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
30 Murcia;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QII;""
30 Murcia;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QI;7.465
30 Murcia;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
30 Murcia;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
30 Murcia;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QII;""
30 Murcia;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QI;6.943
30 Murcia;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
30 Murcia;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
30 Murcia;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QII;""
30 Murcia;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QI;""
30 Murcia;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
30 Murcia;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
30 Murcia;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QII;7.191
30 Murcia;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QI;""
30 Murcia;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
30 Murcia;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
30 Murcia;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QII;6.670
30 Murcia;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QI;""
30 Murcia;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
30 Murcia;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
30 Murcia;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QII;""
30 Murcia;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QI;""
30 Murcia;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
30 Murcia;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
30 Murcia;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
30 Murcia;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
30 Murcia;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
30 Murcia;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
30 Murcia;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
30 Murcia;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
30 Murcia;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
30 Murcia;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
30 Murcia;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
30 Murcia;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
30 Murcia;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
30 Murcia;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;96,55
30 Murcia;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
30 Murcia;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
30 Murcia;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
30 Murcia;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;96,88
30 Murcia;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
30 Murcia;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
30 Murcia;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
30 Murcia;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;95,82
30 Murcia;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
30 Murcia;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
30 Murcia;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;91,39
30 Murcia;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
30 Murcia;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
30 Murcia;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
30 Murcia;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;92,85
30 Murcia;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
30 Murcia;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
30 Murcia;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
30 Murcia;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;91,87
30 Murcia;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
30 Murcia;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
30 Murcia;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
30 Murcia;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
30 Murcia;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
30 Murcia;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
30 Murcia;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;89,28
30 Murcia;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
30 Murcia;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
30 Murcia;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
30 Murcia;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;89
30 Murcia;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
30 Murcia;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
30 Murcia;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
30 Murcia;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
30 Murcia;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
30 Murcia;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
30 Murcia;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;86,01
30 Murcia;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
30 Murcia;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
30 Murcia;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
30 Murcia;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;85,5
30 Murcia;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
30 Murcia;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
30 Murcia;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
30 Murcia;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
30 Murcia;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
30 Murcia;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
30 Murcia;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QIII;4.510
30 Murcia;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
30 Murcia;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
30 Murcia;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
30 Murcia;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QIII;4.235
30 Murcia;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
30 Murcia;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
30 Murcia;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
30 Murcia;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QIII;4.039
30 Murcia;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
30 Murcia;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
30 Murcia;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
30 Murcia;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2022QIII;4.303
30 Murcia;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2022QII;""
30 Murcia;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2022QI;""
30 Murcia;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
30 Murcia;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2021QIII;4.065
30 Murcia;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2021QII;""
30 Murcia;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2021QI;""
30 Murcia;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
30 Murcia;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2020QIII;3.849
30 Murcia;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2020QII;""
30 Murcia;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2020QI;""
30 Murcia;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2022QIV;4.067
30 Murcia;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
30 Murcia;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2022QII;""
30 Murcia;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2022QI;""
30 Murcia;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2021QIV;3.877
30 Murcia;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
30 Murcia;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2021QII;""
30 Murcia;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2021QI;""
30 Murcia;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2020QIV;3.672
30 Murcia;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
30 Murcia;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2020QII;""
30 Murcia;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2020QI;""
30 Murcia;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
30 Murcia;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
30 Murcia;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QII;""
30 Murcia;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QI;3.723
30 Murcia;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
30 Murcia;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
30 Murcia;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QII;""
30 Murcia;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QI;3.545
30 Murcia;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
30 Murcia;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
30 Murcia;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QII;""
30 Murcia;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QI;""
30 Murcia;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
30 Murcia;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
30 Murcia;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QII;3.580
30 Murcia;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QI;""
30 Murcia;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
30 Murcia;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
30 Murcia;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QII;3.386
30 Murcia;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QI;""
30 Murcia;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
30 Murcia;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
30 Murcia;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QII;""
30 Murcia;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QI;""
30 Murcia;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
30 Murcia;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
30 Murcia;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
30 Murcia;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
30 Murcia;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
30 Murcia;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
30 Murcia;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
30 Murcia;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
30 Murcia;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
30 Murcia;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
30 Murcia;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
30 Murcia;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
30 Murcia;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
30 Murcia;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;95,41
30 Murcia;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
30 Murcia;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
30 Murcia;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
30 Murcia;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;95,99
30 Murcia;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
30 Murcia;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
30 Murcia;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
30 Murcia;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;95,3
30 Murcia;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
30 Murcia;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
30 Murcia;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;90,18
30 Murcia;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
30 Murcia;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
30 Murcia;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
30 Murcia;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;91,55
30 Murcia;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
30 Murcia;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
30 Murcia;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
30 Murcia;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;90,91
30 Murcia;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
30 Murcia;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
30 Murcia;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
30 Murcia;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
30 Murcia;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
30 Murcia;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
30 Murcia;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;87,91
30 Murcia;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
30 Murcia;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
30 Murcia;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
30 Murcia;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;87,77
30 Murcia;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
30 Murcia;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
30 Murcia;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
30 Murcia;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
30 Murcia;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
30 Murcia;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
30 Murcia;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;84,53
30 Murcia;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
30 Murcia;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
30 Murcia;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
30 Murcia;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;83,83
30 Murcia;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
30 Murcia;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
30 Murcia;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
30 Murcia;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
30 Murcia;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
30 Murcia;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QIV;13.015
30 Murcia;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
30 Murcia;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
30 Murcia;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
30 Murcia;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QIV;12.298
30 Murcia;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
30 Murcia;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
30 Murcia;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
30 Murcia;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QIV;11.468
30 Murcia;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
30 Murcia;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
30 Murcia;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
30 Murcia;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2022QIV;12.298
30 Murcia;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
30 Murcia;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2022QII;""
30 Murcia;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2022QI;""
30 Murcia;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2021QIV;11.751
30 Murcia;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
30 Murcia;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2021QII;""
30 Murcia;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2021QI;""
30 Murcia;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2020QIV;10.964
30 Murcia;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
30 Murcia;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2020QII;""
30 Murcia;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2020QI;""
30 Murcia;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
30 Murcia;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
30 Murcia;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2022QII;""
30 Murcia;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2022QI;11.293
30 Murcia;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
30 Murcia;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
30 Murcia;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2021QII;""
30 Murcia;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2021QI;10.602
30 Murcia;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
30 Murcia;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
30 Murcia;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2020QII;""
30 Murcia;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2020QI;""
30 Murcia;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
30 Murcia;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
30 Murcia;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QII;10.861
30 Murcia;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QI;""
30 Murcia;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
30 Murcia;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
30 Murcia;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QII;10.154
30 Murcia;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QI;""
30 Murcia;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
30 Murcia;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
30 Murcia;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QII;""
30 Murcia;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QI;""
30 Murcia;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
30 Murcia;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QIII;10.463
30 Murcia;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QII;""
30 Murcia;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QI;""
30 Murcia;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
30 Murcia;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QIII;9.831
30 Murcia;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QII;""
30 Murcia;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QI;""
30 Murcia;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
30 Murcia;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
30 Murcia;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QII;""
30 Murcia;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QI;""
30 Murcia;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
30 Murcia;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
30 Murcia;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
30 Murcia;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
30 Murcia;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
30 Murcia;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
30 Murcia;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
30 Murcia;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
30 Murcia;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
30 Murcia;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
30 Murcia;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
30 Murcia;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
30 Murcia;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;94,49
30 Murcia;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
30 Murcia;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
30 Murcia;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
30 Murcia;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;95,55
30 Murcia;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
30 Murcia;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
30 Murcia;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
30 Murcia;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;95,61
30 Murcia;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
30 Murcia;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
30 Murcia;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
30 Murcia;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
30 Murcia;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
30 Murcia;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
30 Murcia;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;91,83
30 Murcia;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
30 Murcia;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
30 Murcia;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
30 Murcia;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;92,45
30 Murcia;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
30 Murcia;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
30 Murcia;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
30 Murcia;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
30 Murcia;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
30 Murcia;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
30 Murcia;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;88,32
30 Murcia;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
30 Murcia;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
30 Murcia;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
30 Murcia;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;88,54
30 Murcia;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
30 Murcia;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
30 Murcia;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
30 Murcia;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
30 Murcia;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
30 Murcia;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
30 Murcia;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;85,08
30 Murcia;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
30 Murcia;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
30 Murcia;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
30 Murcia;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;85,73
30 Murcia;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
30 Murcia;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
30 Murcia;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
30 Murcia;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
30 Murcia;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
30 Murcia;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
30 Murcia;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QIV;8.648
30 Murcia;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
30 Murcia;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
30 Murcia;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
30 Murcia;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QIV;8.168
30 Murcia;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
30 Murcia;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
30 Murcia;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
30 Murcia;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QIV;7.572
30 Murcia;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
30 Murcia;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
30 Murcia;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
30 Murcia;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2022QIV;8.173
30 Murcia;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
30 Murcia;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2022QII;""
30 Murcia;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2022QI;""
30 Murcia;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2021QIV;7.816
30 Murcia;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
30 Murcia;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2021QII;""
30 Murcia;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2021QI;""
30 Murcia;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2020QIV;7.250
30 Murcia;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
30 Murcia;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2020QII;""
30 Murcia;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2020QI;""
30 Murcia;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
30 Murcia;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
30 Murcia;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2022QII;""
30 Murcia;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2022QI;7.513
30 Murcia;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
30 Murcia;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
30 Murcia;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2021QII;""
30 Murcia;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2021QI;7.018
30 Murcia;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
30 Murcia;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
30 Murcia;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2020QII;""
30 Murcia;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2020QI;""
30 Murcia;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
30 Murcia;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
30 Murcia;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QII;7.232
30 Murcia;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QI;""
30 Murcia;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
30 Murcia;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
30 Murcia;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QII;6.737
30 Murcia;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QI;""
30 Murcia;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
30 Murcia;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
30 Murcia;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QII;""
30 Murcia;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QI;""
30 Murcia;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
30 Murcia;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QIII;6.991
30 Murcia;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QII;""
30 Murcia;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QI;""
30 Murcia;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
30 Murcia;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QIII;6.539
30 Murcia;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QII;""
30 Murcia;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QI;""
30 Murcia;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
30 Murcia;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
30 Murcia;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QII;""
30 Murcia;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QI;""
30 Murcia;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
30 Murcia;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
30 Murcia;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
30 Murcia;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
30 Murcia;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
30 Murcia;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
30 Murcia;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
30 Murcia;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
30 Murcia;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
30 Murcia;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
30 Murcia;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
30 Murcia;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
30 Murcia;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;94,51
30 Murcia;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
30 Murcia;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
30 Murcia;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
30 Murcia;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;95,69
30 Murcia;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
30 Murcia;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
30 Murcia;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
30 Murcia;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;95,75
30 Murcia;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
30 Murcia;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
30 Murcia;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
30 Murcia;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
30 Murcia;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
30 Murcia;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
30 Murcia;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;91,98
30 Murcia;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
30 Murcia;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
30 Murcia;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
30 Murcia;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;92,68
30 Murcia;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
30 Murcia;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
30 Murcia;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
30 Murcia;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
30 Murcia;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
30 Murcia;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
30 Murcia;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;88,54
30 Murcia;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
30 Murcia;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
30 Murcia;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
30 Murcia;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;88,97
30 Murcia;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
30 Murcia;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
30 Murcia;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
30 Murcia;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
30 Murcia;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
30 Murcia;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
30 Murcia;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;85,59
30 Murcia;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
30 Murcia;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
30 Murcia;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
30 Murcia;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;86,36
30 Murcia;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
30 Murcia;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
30 Murcia;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
30 Murcia;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
30 Murcia;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
30 Murcia;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
30 Murcia;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QIV;4.367
30 Murcia;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
30 Murcia;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
30 Murcia;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
30 Murcia;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QIV;4.130
30 Murcia;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
30 Murcia;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
30 Murcia;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
30 Murcia;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QIV;3.896
30 Murcia;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
30 Murcia;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
30 Murcia;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
30 Murcia;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2022QIV;4.125
30 Murcia;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
30 Murcia;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2022QII;""
30 Murcia;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2022QI;""
30 Murcia;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2021QIV;3.935
30 Murcia;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
30 Murcia;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2021QII;""
30 Murcia;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2021QI;""
30 Murcia;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2020QIV;3.714
30 Murcia;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
30 Murcia;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2020QII;""
30 Murcia;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2020QI;""
30 Murcia;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
30 Murcia;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
30 Murcia;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2022QII;""
30 Murcia;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2022QI;3.780
30 Murcia;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
30 Murcia;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
30 Murcia;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2021QII;""
30 Murcia;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2021QI;3.584
30 Murcia;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
30 Murcia;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
30 Murcia;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2020QII;""
30 Murcia;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2020QI;""
30 Murcia;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
30 Murcia;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
30 Murcia;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QII;3.629
30 Murcia;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QI;""
30 Murcia;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
30 Murcia;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
30 Murcia;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QII;3.417
30 Murcia;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QI;""
30 Murcia;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
30 Murcia;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
30 Murcia;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QII;""
30 Murcia;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QI;""
30 Murcia;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
30 Murcia;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QIII;3.472
30 Murcia;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QII;""
30 Murcia;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QI;""
30 Murcia;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
30 Murcia;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QIII;3.292
30 Murcia;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QII;""
30 Murcia;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QI;""
30 Murcia;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
30 Murcia;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
30 Murcia;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QII;""
30 Murcia;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QI;""
30 Murcia;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
30 Murcia;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
30 Murcia;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
30 Murcia;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
30 Murcia;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
30 Murcia;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
30 Murcia;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
30 Murcia;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
30 Murcia;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
30 Murcia;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
30 Murcia;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
30 Murcia;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
30 Murcia;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;94,46
30 Murcia;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
30 Murcia;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
30 Murcia;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
30 Murcia;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;95,28
30 Murcia;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
30 Murcia;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
30 Murcia;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
30 Murcia;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;95,33
30 Murcia;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
30 Murcia;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
30 Murcia;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
30 Murcia;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
30 Murcia;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
30 Murcia;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
30 Murcia;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;91,53
30 Murcia;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
30 Murcia;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
30 Murcia;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
30 Murcia;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;91,99
30 Murcia;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
30 Murcia;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
30 Murcia;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
30 Murcia;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
30 Murcia;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
30 Murcia;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
30 Murcia;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;87,87
30 Murcia;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
30 Murcia;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
30 Murcia;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
30 Murcia;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;87,71
30 Murcia;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
30 Murcia;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
30 Murcia;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
30 Murcia;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
30 Murcia;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
30 Murcia;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
30 Murcia;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;84,07
30 Murcia;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
30 Murcia;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
30 Murcia;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
30 Murcia;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;84,5
30 Murcia;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
30 Murcia;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
30 Murcia;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
30 Murcia;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
30 Murcia;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
30 Murcia;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
31 Navarra;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
31 Navarra;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
31 Navarra;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
31 Navarra;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QI;41.696
31 Navarra;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
31 Navarra;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
31 Navarra;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
31 Navarra;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QI;41.359
31 Navarra;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
31 Navarra;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
31 Navarra;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
31 Navarra;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QI;41.662
31 Navarra;All ages;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
31 Navarra;All ages;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
31 Navarra;All ages;Cohort January 1;Total;Survival in the first trimester;2022QII;""
31 Navarra;All ages;Cohort January 1;Total;Survival in the first trimester;2022QI;40.370
31 Navarra;All ages;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
31 Navarra;All ages;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
31 Navarra;All ages;Cohort January 1;Total;Survival in the first trimester;2021QII;""
31 Navarra;All ages;Cohort January 1;Total;Survival in the first trimester;2021QI;40.334
31 Navarra;All ages;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
31 Navarra;All ages;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
31 Navarra;All ages;Cohort January 1;Total;Survival in the first trimester;2020QII;""
31 Navarra;All ages;Cohort January 1;Total;Survival in the first trimester;2020QI;39.565
31 Navarra;All ages;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
31 Navarra;All ages;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
31 Navarra;All ages;Cohort January 1;Total;Survival in the second trimester;2022QII;38.969
31 Navarra;All ages;Cohort January 1;Total;Survival in the second trimester;2022QI;""
31 Navarra;All ages;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
31 Navarra;All ages;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
31 Navarra;All ages;Cohort January 1;Total;Survival in the second trimester;2021QII;39.075
31 Navarra;All ages;Cohort January 1;Total;Survival in the second trimester;2021QI;""
31 Navarra;All ages;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
31 Navarra;All ages;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
31 Navarra;All ages;Cohort January 1;Total;Survival in the second trimester;2020QII;38.699
31 Navarra;All ages;Cohort January 1;Total;Survival in the second trimester;2020QI;""
31 Navarra;All ages;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
31 Navarra;All ages;Cohort January 1;Total;Survival in the third trimester;2022QIII;38.015
31 Navarra;All ages;Cohort January 1;Total;Survival in the third trimester;2022QII;""
31 Navarra;All ages;Cohort January 1;Total;Survival in the third trimester;2022QI;""
31 Navarra;All ages;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
31 Navarra;All ages;Cohort January 1;Total;Survival in the third trimester;2021QIII;38.043
31 Navarra;All ages;Cohort January 1;Total;Survival in the third trimester;2021QII;""
31 Navarra;All ages;Cohort January 1;Total;Survival in the third trimester;2021QI;""
31 Navarra;All ages;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
31 Navarra;All ages;Cohort January 1;Total;Survival in the third trimester;2020QIII;37.773
31 Navarra;All ages;Cohort January 1;Total;Survival in the third trimester;2020QII;""
31 Navarra;All ages;Cohort January 1;Total;Survival in the third trimester;2020QI;""
31 Navarra;All ages;Cohort January 1;Total;Survival in the third trimester;2022QIV;36.736
31 Navarra;All ages;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
31 Navarra;All ages;Cohort January 1;Total;Survival in the third trimester;2022QII;""
31 Navarra;All ages;Cohort January 1;Total;Survival in the third trimester;2022QI;""
31 Navarra;All ages;Cohort January 1;Total;Survival in the third trimester;2021QIV;36.940
31 Navarra;All ages;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
31 Navarra;All ages;Cohort January 1;Total;Survival in the third trimester;2021QII;""
31 Navarra;All ages;Cohort January 1;Total;Survival in the third trimester;2021QI;""
31 Navarra;All ages;Cohort January 1;Total;Survival in the third trimester;2020QIV;36.831
31 Navarra;All ages;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
31 Navarra;All ages;Cohort January 1;Total;Survival in the third trimester;2020QII;""
31 Navarra;All ages;Cohort January 1;Total;Survival in the third trimester;2020QI;""
31 Navarra;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
31 Navarra;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
31 Navarra;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
31 Navarra;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
31 Navarra;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
31 Navarra;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
31 Navarra;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
31 Navarra;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
31 Navarra;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
31 Navarra;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
31 Navarra;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
31 Navarra;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
31 Navarra;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
31 Navarra;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
31 Navarra;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
31 Navarra;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;96,82
31 Navarra;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
31 Navarra;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
31 Navarra;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
31 Navarra;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;97,52
31 Navarra;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
31 Navarra;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
31 Navarra;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
31 Navarra;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;94,97
31 Navarra;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
31 Navarra;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
31 Navarra;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;93,46
31 Navarra;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
31 Navarra;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
31 Navarra;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
31 Navarra;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;94,48
31 Navarra;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
31 Navarra;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
31 Navarra;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
31 Navarra;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;92,89
31 Navarra;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
31 Navarra;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
31 Navarra;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;91,17
31 Navarra;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
31 Navarra;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
31 Navarra;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
31 Navarra;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;91,98
31 Navarra;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
31 Navarra;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
31 Navarra;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
31 Navarra;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;90,67
31 Navarra;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
31 Navarra;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
31 Navarra;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;88,1
31 Navarra;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
31 Navarra;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
31 Navarra;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
31 Navarra;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;89,32
31 Navarra;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
31 Navarra;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
31 Navarra;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
31 Navarra;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;88,4
31 Navarra;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
31 Navarra;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
31 Navarra;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
31 Navarra;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
31 Navarra;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
31 Navarra;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
31 Navarra;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QI;26.404
31 Navarra;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
31 Navarra;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
31 Navarra;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
31 Navarra;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QI;26.370
31 Navarra;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
31 Navarra;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
31 Navarra;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
31 Navarra;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QI;26.589
31 Navarra;All ages;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
31 Navarra;All ages;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
31 Navarra;All ages;Cohort January 1;Males;Survival in the first trimester;2022QII;""
31 Navarra;All ages;Cohort January 1;Males;Survival in the first trimester;2022QI;25.542
31 Navarra;All ages;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
31 Navarra;All ages;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
31 Navarra;All ages;Cohort January 1;Males;Survival in the first trimester;2021QII;""
31 Navarra;All ages;Cohort January 1;Males;Survival in the first trimester;2021QI;25.693
31 Navarra;All ages;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
31 Navarra;All ages;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
31 Navarra;All ages;Cohort January 1;Males;Survival in the first trimester;2020QII;""
31 Navarra;All ages;Cohort January 1;Males;Survival in the first trimester;2020QI;25.239
31 Navarra;All ages;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
31 Navarra;All ages;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
31 Navarra;All ages;Cohort January 1;Males;Survival in the second trimester;2022QII;24.746
31 Navarra;All ages;Cohort January 1;Males;Survival in the second trimester;2022QI;""
31 Navarra;All ages;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
31 Navarra;All ages;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
31 Navarra;All ages;Cohort January 1;Males;Survival in the second trimester;2021QII;24.930
31 Navarra;All ages;Cohort January 1;Males;Survival in the second trimester;2021QI;""
31 Navarra;All ages;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
31 Navarra;All ages;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
31 Navarra;All ages;Cohort January 1;Males;Survival in the second trimester;2020QII;24.705
31 Navarra;All ages;Cohort January 1;Males;Survival in the second trimester;2020QI;""
31 Navarra;All ages;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
31 Navarra;All ages;Cohort January 1;Males;Survival in the third trimester;2022QIII;24.142
31 Navarra;All ages;Cohort January 1;Males;Survival in the third trimester;2022QII;""
31 Navarra;All ages;Cohort January 1;Males;Survival in the third trimester;2022QI;""
31 Navarra;All ages;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
31 Navarra;All ages;Cohort January 1;Males;Survival in the third trimester;2021QIII;24.276
31 Navarra;All ages;Cohort January 1;Males;Survival in the third trimester;2021QII;""
31 Navarra;All ages;Cohort January 1;Males;Survival in the third trimester;2021QI;""
31 Navarra;All ages;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
31 Navarra;All ages;Cohort January 1;Males;Survival in the third trimester;2020QIII;24.118
31 Navarra;All ages;Cohort January 1;Males;Survival in the third trimester;2020QII;""
31 Navarra;All ages;Cohort January 1;Males;Survival in the third trimester;2020QI;""
31 Navarra;All ages;Cohort January 1;Males;Survival in the third trimester;2022QIV;23.343
31 Navarra;All ages;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
31 Navarra;All ages;Cohort January 1;Males;Survival in the third trimester;2022QII;""
31 Navarra;All ages;Cohort January 1;Males;Survival in the third trimester;2022QI;""
31 Navarra;All ages;Cohort January 1;Males;Survival in the third trimester;2021QIV;23.552
31 Navarra;All ages;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
31 Navarra;All ages;Cohort January 1;Males;Survival in the third trimester;2021QII;""
31 Navarra;All ages;Cohort January 1;Males;Survival in the third trimester;2021QI;""
31 Navarra;All ages;Cohort January 1;Males;Survival in the third trimester;2020QIV;23.502
31 Navarra;All ages;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
31 Navarra;All ages;Cohort January 1;Males;Survival in the third trimester;2020QII;""
31 Navarra;All ages;Cohort January 1;Males;Survival in the third trimester;2020QI;""
31 Navarra;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
31 Navarra;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
31 Navarra;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
31 Navarra;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
31 Navarra;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
31 Navarra;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
31 Navarra;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
31 Navarra;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
31 Navarra;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
31 Navarra;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
31 Navarra;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
31 Navarra;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
31 Navarra;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
31 Navarra;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
31 Navarra;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
31 Navarra;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;96,74
31 Navarra;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
31 Navarra;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
31 Navarra;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
31 Navarra;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;97,43
31 Navarra;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
31 Navarra;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
31 Navarra;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
31 Navarra;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;94,92
31 Navarra;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
31 Navarra;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
31 Navarra;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;93,72
31 Navarra;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
31 Navarra;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
31 Navarra;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
31 Navarra;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;94,54
31 Navarra;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
31 Navarra;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
31 Navarra;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
31 Navarra;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;92,91
31 Navarra;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
31 Navarra;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
31 Navarra;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;91,43
31 Navarra;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
31 Navarra;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
31 Navarra;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
31 Navarra;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;92,06
31 Navarra;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
31 Navarra;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
31 Navarra;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
31 Navarra;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;90,71
31 Navarra;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
31 Navarra;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
31 Navarra;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;88,41
31 Navarra;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
31 Navarra;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
31 Navarra;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
31 Navarra;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;89,31
31 Navarra;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
31 Navarra;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
31 Navarra;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
31 Navarra;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;88,39
31 Navarra;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
31 Navarra;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
31 Navarra;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
31 Navarra;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
31 Navarra;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
31 Navarra;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
31 Navarra;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QI;15.292
31 Navarra;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
31 Navarra;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
31 Navarra;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
31 Navarra;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QI;14.989
31 Navarra;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
31 Navarra;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
31 Navarra;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
31 Navarra;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QI;15.073
31 Navarra;All ages;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
31 Navarra;All ages;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
31 Navarra;All ages;Cohort January 1;Females;Survival in the first trimester;2022QII;""
31 Navarra;All ages;Cohort January 1;Females;Survival in the first trimester;2022QI;14.828
31 Navarra;All ages;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
31 Navarra;All ages;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
31 Navarra;All ages;Cohort January 1;Females;Survival in the first trimester;2021QII;""
31 Navarra;All ages;Cohort January 1;Females;Survival in the first trimester;2021QI;14.641
31 Navarra;All ages;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
31 Navarra;All ages;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
31 Navarra;All ages;Cohort January 1;Females;Survival in the first trimester;2020QII;""
31 Navarra;All ages;Cohort January 1;Females;Survival in the first trimester;2020QI;14.326
31 Navarra;All ages;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
31 Navarra;All ages;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
31 Navarra;All ages;Cohort January 1;Females;Survival in the second trimester;2022QII;14.223
31 Navarra;All ages;Cohort January 1;Females;Survival in the second trimester;2022QI;""
31 Navarra;All ages;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
31 Navarra;All ages;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
31 Navarra;All ages;Cohort January 1;Females;Survival in the second trimester;2021QII;14.145
31 Navarra;All ages;Cohort January 1;Females;Survival in the second trimester;2021QI;""
31 Navarra;All ages;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
31 Navarra;All ages;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
31 Navarra;All ages;Cohort January 1;Females;Survival in the second trimester;2020QII;13.994
31 Navarra;All ages;Cohort January 1;Females;Survival in the second trimester;2020QI;""
31 Navarra;All ages;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
31 Navarra;All ages;Cohort January 1;Females;Survival in the third trimester;2022QIII;13.873
31 Navarra;All ages;Cohort January 1;Females;Survival in the third trimester;2022QII;""
31 Navarra;All ages;Cohort January 1;Females;Survival in the third trimester;2022QI;""
31 Navarra;All ages;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
31 Navarra;All ages;Cohort January 1;Females;Survival in the third trimester;2021QIII;13.767
31 Navarra;All ages;Cohort January 1;Females;Survival in the third trimester;2021QII;""
31 Navarra;All ages;Cohort January 1;Females;Survival in the third trimester;2021QI;""
31 Navarra;All ages;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
31 Navarra;All ages;Cohort January 1;Females;Survival in the third trimester;2020QIII;13.655
31 Navarra;All ages;Cohort January 1;Females;Survival in the third trimester;2020QII;""
31 Navarra;All ages;Cohort January 1;Females;Survival in the third trimester;2020QI;""
31 Navarra;All ages;Cohort January 1;Females;Survival in the third trimester;2022QIV;13.393
31 Navarra;All ages;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
31 Navarra;All ages;Cohort January 1;Females;Survival in the third trimester;2022QII;""
31 Navarra;All ages;Cohort January 1;Females;Survival in the third trimester;2022QI;""
31 Navarra;All ages;Cohort January 1;Females;Survival in the third trimester;2021QIV;13.388
31 Navarra;All ages;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
31 Navarra;All ages;Cohort January 1;Females;Survival in the third trimester;2021QII;""
31 Navarra;All ages;Cohort January 1;Females;Survival in the third trimester;2021QI;""
31 Navarra;All ages;Cohort January 1;Females;Survival in the third trimester;2020QIV;13.329
31 Navarra;All ages;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
31 Navarra;All ages;Cohort January 1;Females;Survival in the third trimester;2020QII;""
31 Navarra;All ages;Cohort January 1;Females;Survival in the third trimester;2020QI;""
31 Navarra;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
31 Navarra;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
31 Navarra;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
31 Navarra;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
31 Navarra;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
31 Navarra;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
31 Navarra;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
31 Navarra;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
31 Navarra;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
31 Navarra;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
31 Navarra;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
31 Navarra;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
31 Navarra;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
31 Navarra;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
31 Navarra;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
31 Navarra;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;96,97
31 Navarra;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
31 Navarra;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
31 Navarra;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
31 Navarra;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;97,68
31 Navarra;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
31 Navarra;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
31 Navarra;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
31 Navarra;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;95,04
31 Navarra;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
31 Navarra;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
31 Navarra;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;93,01
31 Navarra;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
31 Navarra;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
31 Navarra;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
31 Navarra;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;94,37
31 Navarra;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
31 Navarra;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
31 Navarra;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
31 Navarra;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;92,84
31 Navarra;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
31 Navarra;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
31 Navarra;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;90,72
31 Navarra;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
31 Navarra;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
31 Navarra;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
31 Navarra;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;91,85
31 Navarra;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
31 Navarra;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
31 Navarra;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
31 Navarra;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;90,59
31 Navarra;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
31 Navarra;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
31 Navarra;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;87,58
31 Navarra;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
31 Navarra;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
31 Navarra;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
31 Navarra;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;89,32
31 Navarra;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
31 Navarra;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
31 Navarra;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
31 Navarra;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;88,43
31 Navarra;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
31 Navarra;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
31 Navarra;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
31 Navarra;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
31 Navarra;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
31 Navarra;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QII;41.811
31 Navarra;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
31 Navarra;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
31 Navarra;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
31 Navarra;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QII;41.804
31 Navarra;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
31 Navarra;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
31 Navarra;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
31 Navarra;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QII;41.275
31 Navarra;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
31 Navarra;All ages;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
31 Navarra;All ages;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
31 Navarra;All ages;Cohort April 1;Total;Survival in the first trimester;2022QII;40.237
31 Navarra;All ages;Cohort April 1;Total;Survival in the first trimester;2022QI;""
31 Navarra;All ages;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
31 Navarra;All ages;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
31 Navarra;All ages;Cohort April 1;Total;Survival in the first trimester;2021QII;40.371
31 Navarra;All ages;Cohort April 1;Total;Survival in the first trimester;2021QI;""
31 Navarra;All ages;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
31 Navarra;All ages;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
31 Navarra;All ages;Cohort April 1;Total;Survival in the first trimester;2020QII;40.318
31 Navarra;All ages;Cohort April 1;Total;Survival in the first trimester;2020QI;""
31 Navarra;All ages;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
31 Navarra;All ages;Cohort April 1;Total;Survival in the second trimester;2022QIII;39.181
31 Navarra;All ages;Cohort April 1;Total;Survival in the second trimester;2022QII;""
31 Navarra;All ages;Cohort April 1;Total;Survival in the second trimester;2022QI;""
31 Navarra;All ages;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
31 Navarra;All ages;Cohort April 1;Total;Survival in the second trimester;2021QIII;39.228
31 Navarra;All ages;Cohort April 1;Total;Survival in the second trimester;2021QII;""
31 Navarra;All ages;Cohort April 1;Total;Survival in the second trimester;2021QI;""
31 Navarra;All ages;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
31 Navarra;All ages;Cohort April 1;Total;Survival in the second trimester;2020QIII;39.175
31 Navarra;All ages;Cohort April 1;Total;Survival in the second trimester;2020QII;""
31 Navarra;All ages;Cohort April 1;Total;Survival in the second trimester;2020QI;""
31 Navarra;All ages;Cohort April 1;Total;Survival in the third trimester;2022QIV;37.806
31 Navarra;All ages;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
31 Navarra;All ages;Cohort April 1;Total;Survival in the third trimester;2022QII;""
31 Navarra;All ages;Cohort April 1;Total;Survival in the third trimester;2022QI;""
31 Navarra;All ages;Cohort April 1;Total;Survival in the third trimester;2021QIV;38.025
31 Navarra;All ages;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
31 Navarra;All ages;Cohort April 1;Total;Survival in the third trimester;2021QII;""
31 Navarra;All ages;Cohort April 1;Total;Survival in the third trimester;2021QI;""
31 Navarra;All ages;Cohort April 1;Total;Survival in the third trimester;2020QIV;38.146
31 Navarra;All ages;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
31 Navarra;All ages;Cohort April 1;Total;Survival in the third trimester;2020QII;""
31 Navarra;All ages;Cohort April 1;Total;Survival in the third trimester;2020QI;""
31 Navarra;All ages;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
31 Navarra;All ages;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
31 Navarra;All ages;Cohort April 1;Total;Survival in the third trimester;2022QII;""
31 Navarra;All ages;Cohort April 1;Total;Survival in the third trimester;2022QI;37.026
31 Navarra;All ages;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
31 Navarra;All ages;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
31 Navarra;All ages;Cohort April 1;Total;Survival in the third trimester;2021QII;""
31 Navarra;All ages;Cohort April 1;Total;Survival in the third trimester;2021QI;37.369
31 Navarra;All ages;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
31 Navarra;All ages;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
31 Navarra;All ages;Cohort April 1;Total;Survival in the third trimester;2020QII;""
31 Navarra;All ages;Cohort April 1;Total;Survival in the third trimester;2020QI;""
31 Navarra;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
31 Navarra;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
31 Navarra;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
31 Navarra;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
31 Navarra;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
31 Navarra;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
31 Navarra;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
31 Navarra;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
31 Navarra;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
31 Navarra;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
31 Navarra;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
31 Navarra;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
31 Navarra;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
31 Navarra;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
31 Navarra;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;96,24
31 Navarra;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
31 Navarra;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
31 Navarra;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
31 Navarra;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;96,57
31 Navarra;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
31 Navarra;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
31 Navarra;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
31 Navarra;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;97,68
31 Navarra;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
31 Navarra;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
31 Navarra;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;93,71
31 Navarra;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
31 Navarra;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
31 Navarra;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
31 Navarra;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;93,84
31 Navarra;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
31 Navarra;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
31 Navarra;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
31 Navarra;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;94,91
31 Navarra;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
31 Navarra;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
31 Navarra;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;90,42
31 Navarra;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
31 Navarra;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
31 Navarra;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
31 Navarra;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;90,96
31 Navarra;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
31 Navarra;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
31 Navarra;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
31 Navarra;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;92,42
31 Navarra;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
31 Navarra;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
31 Navarra;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
31 Navarra;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
31 Navarra;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
31 Navarra;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
31 Navarra;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;88,57
31 Navarra;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
31 Navarra;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
31 Navarra;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
31 Navarra;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;90,54
31 Navarra;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
31 Navarra;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
31 Navarra;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
31 Navarra;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
31 Navarra;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
31 Navarra;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
31 Navarra;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QII;26.448
31 Navarra;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
31 Navarra;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
31 Navarra;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
31 Navarra;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QII;26.632
31 Navarra;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
31 Navarra;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
31 Navarra;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
31 Navarra;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QII;26.365
31 Navarra;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
31 Navarra;All ages;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
31 Navarra;All ages;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
31 Navarra;All ages;Cohort April 1;Males;Survival in the first trimester;2022QII;25.540
31 Navarra;All ages;Cohort April 1;Males;Survival in the first trimester;2022QI;""
31 Navarra;All ages;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
31 Navarra;All ages;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
31 Navarra;All ages;Cohort April 1;Males;Survival in the first trimester;2021QII;25.747
31 Navarra;All ages;Cohort April 1;Males;Survival in the first trimester;2021QI;""
31 Navarra;All ages;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
31 Navarra;All ages;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
31 Navarra;All ages;Cohort April 1;Males;Survival in the first trimester;2020QII;25.763
31 Navarra;All ages;Cohort April 1;Males;Survival in the first trimester;2020QI;""
31 Navarra;All ages;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
31 Navarra;All ages;Cohort April 1;Males;Survival in the second trimester;2022QIII;24.863
31 Navarra;All ages;Cohort April 1;Males;Survival in the second trimester;2022QII;""
31 Navarra;All ages;Cohort April 1;Males;Survival in the second trimester;2022QI;""
31 Navarra;All ages;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
31 Navarra;All ages;Cohort April 1;Males;Survival in the second trimester;2021QIII;25.005
31 Navarra;All ages;Cohort April 1;Males;Survival in the second trimester;2021QII;""
31 Navarra;All ages;Cohort April 1;Males;Survival in the second trimester;2021QI;""
31 Navarra;All ages;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
31 Navarra;All ages;Cohort April 1;Males;Survival in the second trimester;2020QIII;25.010
31 Navarra;All ages;Cohort April 1;Males;Survival in the second trimester;2020QII;""
31 Navarra;All ages;Cohort April 1;Males;Survival in the second trimester;2020QI;""
31 Navarra;All ages;Cohort April 1;Males;Survival in the third trimester;2022QIV;24.004
31 Navarra;All ages;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
31 Navarra;All ages;Cohort April 1;Males;Survival in the third trimester;2022QII;""
31 Navarra;All ages;Cohort April 1;Males;Survival in the third trimester;2022QI;""
31 Navarra;All ages;Cohort April 1;Males;Survival in the third trimester;2021QIV;24.210
31 Navarra;All ages;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
31 Navarra;All ages;Cohort April 1;Males;Survival in the third trimester;2021QII;""
31 Navarra;All ages;Cohort April 1;Males;Survival in the third trimester;2021QI;""
31 Navarra;All ages;Cohort April 1;Males;Survival in the third trimester;2020QIV;24.340
31 Navarra;All ages;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
31 Navarra;All ages;Cohort April 1;Males;Survival in the third trimester;2020QII;""
31 Navarra;All ages;Cohort April 1;Males;Survival in the third trimester;2020QI;""
31 Navarra;All ages;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
31 Navarra;All ages;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
31 Navarra;All ages;Cohort April 1;Males;Survival in the third trimester;2022QII;""
31 Navarra;All ages;Cohort April 1;Males;Survival in the third trimester;2022QI;23.578
31 Navarra;All ages;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
31 Navarra;All ages;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
31 Navarra;All ages;Cohort April 1;Males;Survival in the third trimester;2021QII;""
31 Navarra;All ages;Cohort April 1;Males;Survival in the third trimester;2021QI;23.843
31 Navarra;All ages;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
31 Navarra;All ages;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
31 Navarra;All ages;Cohort April 1;Males;Survival in the third trimester;2020QII;""
31 Navarra;All ages;Cohort April 1;Males;Survival in the third trimester;2020QI;""
31 Navarra;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
31 Navarra;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
31 Navarra;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
31 Navarra;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
31 Navarra;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
31 Navarra;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
31 Navarra;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
31 Navarra;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
31 Navarra;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
31 Navarra;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
31 Navarra;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
31 Navarra;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
31 Navarra;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
31 Navarra;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
31 Navarra;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;96,57
31 Navarra;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
31 Navarra;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
31 Navarra;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
31 Navarra;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;96,68
31 Navarra;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
31 Navarra;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
31 Navarra;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
31 Navarra;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;97,72
31 Navarra;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
31 Navarra;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
31 Navarra;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;94,01
31 Navarra;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
31 Navarra;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
31 Navarra;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
31 Navarra;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;93,89
31 Navarra;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
31 Navarra;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
31 Navarra;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
31 Navarra;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;94,86
31 Navarra;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
31 Navarra;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
31 Navarra;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;90,76
31 Navarra;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
31 Navarra;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
31 Navarra;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
31 Navarra;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;90,91
31 Navarra;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
31 Navarra;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
31 Navarra;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
31 Navarra;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;92,32
31 Navarra;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
31 Navarra;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
31 Navarra;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
31 Navarra;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
31 Navarra;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
31 Navarra;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
31 Navarra;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;88,53
31 Navarra;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
31 Navarra;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
31 Navarra;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
31 Navarra;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;90,43
31 Navarra;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
31 Navarra;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
31 Navarra;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
31 Navarra;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
31 Navarra;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
31 Navarra;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
31 Navarra;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QII;15.363
31 Navarra;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
31 Navarra;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
31 Navarra;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
31 Navarra;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QII;15.172
31 Navarra;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
31 Navarra;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
31 Navarra;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
31 Navarra;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QII;14.910
31 Navarra;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
31 Navarra;All ages;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
31 Navarra;All ages;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
31 Navarra;All ages;Cohort April 1;Females;Survival in the first trimester;2022QII;14.697
31 Navarra;All ages;Cohort April 1;Females;Survival in the first trimester;2022QI;""
31 Navarra;All ages;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
31 Navarra;All ages;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
31 Navarra;All ages;Cohort April 1;Females;Survival in the first trimester;2021QII;14.624
31 Navarra;All ages;Cohort April 1;Females;Survival in the first trimester;2021QI;""
31 Navarra;All ages;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
31 Navarra;All ages;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
31 Navarra;All ages;Cohort April 1;Females;Survival in the first trimester;2020QII;14.555
31 Navarra;All ages;Cohort April 1;Females;Survival in the first trimester;2020QI;""
31 Navarra;All ages;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
31 Navarra;All ages;Cohort April 1;Females;Survival in the second trimester;2022QIII;14.318
31 Navarra;All ages;Cohort April 1;Females;Survival in the second trimester;2022QII;""
31 Navarra;All ages;Cohort April 1;Females;Survival in the second trimester;2022QI;""
31 Navarra;All ages;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
31 Navarra;All ages;Cohort April 1;Females;Survival in the second trimester;2021QIII;14.223
31 Navarra;All ages;Cohort April 1;Females;Survival in the second trimester;2021QII;""
31 Navarra;All ages;Cohort April 1;Females;Survival in the second trimester;2021QI;""
31 Navarra;All ages;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
31 Navarra;All ages;Cohort April 1;Females;Survival in the second trimester;2020QIII;14.165
31 Navarra;All ages;Cohort April 1;Females;Survival in the second trimester;2020QII;""
31 Navarra;All ages;Cohort April 1;Females;Survival in the second trimester;2020QI;""
31 Navarra;All ages;Cohort April 1;Females;Survival in the third trimester;2022QIV;13.802
31 Navarra;All ages;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
31 Navarra;All ages;Cohort April 1;Females;Survival in the third trimester;2022QII;""
31 Navarra;All ages;Cohort April 1;Females;Survival in the third trimester;2022QI;""
31 Navarra;All ages;Cohort April 1;Females;Survival in the third trimester;2021QIV;13.815
31 Navarra;All ages;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
31 Navarra;All ages;Cohort April 1;Females;Survival in the third trimester;2021QII;""
31 Navarra;All ages;Cohort April 1;Females;Survival in the third trimester;2021QI;""
31 Navarra;All ages;Cohort April 1;Females;Survival in the third trimester;2020QIV;13.806
31 Navarra;All ages;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
31 Navarra;All ages;Cohort April 1;Females;Survival in the third trimester;2020QII;""
31 Navarra;All ages;Cohort April 1;Females;Survival in the third trimester;2020QI;""
31 Navarra;All ages;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
31 Navarra;All ages;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
31 Navarra;All ages;Cohort April 1;Females;Survival in the third trimester;2022QII;""
31 Navarra;All ages;Cohort April 1;Females;Survival in the third trimester;2022QI;13.448
31 Navarra;All ages;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
31 Navarra;All ages;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
31 Navarra;All ages;Cohort April 1;Females;Survival in the third trimester;2021QII;""
31 Navarra;All ages;Cohort April 1;Females;Survival in the third trimester;2021QI;13.526
31 Navarra;All ages;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
31 Navarra;All ages;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
31 Navarra;All ages;Cohort April 1;Females;Survival in the third trimester;2020QII;""
31 Navarra;All ages;Cohort April 1;Females;Survival in the third trimester;2020QI;""
31 Navarra;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
31 Navarra;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
31 Navarra;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
31 Navarra;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
31 Navarra;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
31 Navarra;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
31 Navarra;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
31 Navarra;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
31 Navarra;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
31 Navarra;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
31 Navarra;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
31 Navarra;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
31 Navarra;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
31 Navarra;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
31 Navarra;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;95,66
31 Navarra;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
31 Navarra;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
31 Navarra;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
31 Navarra;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;96,39
31 Navarra;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
31 Navarra;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
31 Navarra;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
31 Navarra;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;97,62
31 Navarra;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
31 Navarra;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
31 Navarra;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;93,2
31 Navarra;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
31 Navarra;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
31 Navarra;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
31 Navarra;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;93,75
31 Navarra;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
31 Navarra;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
31 Navarra;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
31 Navarra;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;95
31 Navarra;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
31 Navarra;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
31 Navarra;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;89,84
31 Navarra;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
31 Navarra;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
31 Navarra;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
31 Navarra;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;91,06
31 Navarra;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
31 Navarra;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
31 Navarra;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
31 Navarra;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;92,6
31 Navarra;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
31 Navarra;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
31 Navarra;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
31 Navarra;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
31 Navarra;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
31 Navarra;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
31 Navarra;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;88,64
31 Navarra;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
31 Navarra;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
31 Navarra;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
31 Navarra;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;90,72
31 Navarra;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
31 Navarra;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
31 Navarra;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
31 Navarra;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
31 Navarra;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
31 Navarra;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QIII;41.808
31 Navarra;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
31 Navarra;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
31 Navarra;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
31 Navarra;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QIII;41.884
31 Navarra;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
31 Navarra;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
31 Navarra;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
31 Navarra;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QIII;41.301
31 Navarra;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
31 Navarra;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
31 Navarra;All ages;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
31 Navarra;All ages;Cohort July 1;Total;Survival in the first trimester;2022QIII;40.486
31 Navarra;All ages;Cohort July 1;Total;Survival in the first trimester;2022QII;""
31 Navarra;All ages;Cohort July 1;Total;Survival in the first trimester;2022QI;""
31 Navarra;All ages;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
31 Navarra;All ages;Cohort July 1;Total;Survival in the first trimester;2021QIII;40.524
31 Navarra;All ages;Cohort July 1;Total;Survival in the first trimester;2021QII;""
31 Navarra;All ages;Cohort July 1;Total;Survival in the first trimester;2021QI;""
31 Navarra;All ages;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
31 Navarra;All ages;Cohort July 1;Total;Survival in the first trimester;2020QIII;39.977
31 Navarra;All ages;Cohort July 1;Total;Survival in the first trimester;2020QII;""
31 Navarra;All ages;Cohort July 1;Total;Survival in the first trimester;2020QI;""
31 Navarra;All ages;Cohort July 1;Total;Survival in the second trimester;2022QIV;38.970
31 Navarra;All ages;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
31 Navarra;All ages;Cohort July 1;Total;Survival in the second trimester;2022QII;""
31 Navarra;All ages;Cohort July 1;Total;Survival in the second trimester;2022QI;""
31 Navarra;All ages;Cohort July 1;Total;Survival in the second trimester;2021QIV;39.211
31 Navarra;All ages;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
31 Navarra;All ages;Cohort July 1;Total;Survival in the second trimester;2021QII;""
31 Navarra;All ages;Cohort July 1;Total;Survival in the second trimester;2021QI;""
31 Navarra;All ages;Cohort July 1;Total;Survival in the second trimester;2020QIV;38.878
31 Navarra;All ages;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
31 Navarra;All ages;Cohort July 1;Total;Survival in the second trimester;2020QII;""
31 Navarra;All ages;Cohort July 1;Total;Survival in the second trimester;2020QI;""
31 Navarra;All ages;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
31 Navarra;All ages;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
31 Navarra;All ages;Cohort July 1;Total;Survival in the third trimester;2022QII;""
31 Navarra;All ages;Cohort July 1;Total;Survival in the third trimester;2022QI;38.134
31 Navarra;All ages;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
31 Navarra;All ages;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
31 Navarra;All ages;Cohort July 1;Total;Survival in the third trimester;2021QII;""
31 Navarra;All ages;Cohort July 1;Total;Survival in the third trimester;2021QI;38.065
31 Navarra;All ages;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
31 Navarra;All ages;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
31 Navarra;All ages;Cohort July 1;Total;Survival in the third trimester;2020QII;""
31 Navarra;All ages;Cohort July 1;Total;Survival in the third trimester;2020QI;""
31 Navarra;All ages;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
31 Navarra;All ages;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
31 Navarra;All ages;Cohort July 1;Total;Survival in the third trimester;2022QII;37.021
31 Navarra;All ages;Cohort July 1;Total;Survival in the third trimester;2022QI;""
31 Navarra;All ages;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
31 Navarra;All ages;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
31 Navarra;All ages;Cohort July 1;Total;Survival in the third trimester;2021QII;37.055
31 Navarra;All ages;Cohort July 1;Total;Survival in the third trimester;2021QI;""
31 Navarra;All ages;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
31 Navarra;All ages;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
31 Navarra;All ages;Cohort July 1;Total;Survival in the third trimester;2020QII;""
31 Navarra;All ages;Cohort July 1;Total;Survival in the third trimester;2020QI;""
31 Navarra;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
31 Navarra;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
31 Navarra;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
31 Navarra;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
31 Navarra;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
31 Navarra;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
31 Navarra;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
31 Navarra;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
31 Navarra;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
31 Navarra;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
31 Navarra;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
31 Navarra;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
31 Navarra;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
31 Navarra;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;96,84
31 Navarra;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
31 Navarra;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
31 Navarra;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
31 Navarra;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;96,75
31 Navarra;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
31 Navarra;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
31 Navarra;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
31 Navarra;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;96,79
31 Navarra;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
31 Navarra;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
31 Navarra;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;93,21
31 Navarra;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
31 Navarra;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
31 Navarra;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
31 Navarra;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;93,62
31 Navarra;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
31 Navarra;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
31 Navarra;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
31 Navarra;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;94,13
31 Navarra;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
31 Navarra;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
31 Navarra;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
31 Navarra;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
31 Navarra;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
31 Navarra;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
31 Navarra;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;91,05
31 Navarra;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
31 Navarra;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
31 Navarra;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
31 Navarra;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;92,16
31 Navarra;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
31 Navarra;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
31 Navarra;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
31 Navarra;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
31 Navarra;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
31 Navarra;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
31 Navarra;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;88,39
31 Navarra;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
31 Navarra;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
31 Navarra;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
31 Navarra;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;89,72
31 Navarra;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
31 Navarra;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
31 Navarra;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
31 Navarra;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
31 Navarra;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
31 Navarra;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
31 Navarra;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QIII;26.486
31 Navarra;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
31 Navarra;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
31 Navarra;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
31 Navarra;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QIII;26.708
31 Navarra;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
31 Navarra;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
31 Navarra;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
31 Navarra;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QIII;26.451
31 Navarra;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
31 Navarra;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
31 Navarra;All ages;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
31 Navarra;All ages;Cohort July 1;Males;Survival in the first trimester;2022QIII;25.645
31 Navarra;All ages;Cohort July 1;Males;Survival in the first trimester;2022QII;""
31 Navarra;All ages;Cohort July 1;Males;Survival in the first trimester;2022QI;""
31 Navarra;All ages;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
31 Navarra;All ages;Cohort July 1;Males;Survival in the first trimester;2021QIII;25.821
31 Navarra;All ages;Cohort July 1;Males;Survival in the first trimester;2021QII;""
31 Navarra;All ages;Cohort July 1;Males;Survival in the first trimester;2021QI;""
31 Navarra;All ages;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
31 Navarra;All ages;Cohort July 1;Males;Survival in the first trimester;2020QIII;25.553
31 Navarra;All ages;Cohort July 1;Males;Survival in the first trimester;2020QII;""
31 Navarra;All ages;Cohort July 1;Males;Survival in the first trimester;2020QI;""
31 Navarra;All ages;Cohort July 1;Males;Survival in the second trimester;2022QIV;24.691
31 Navarra;All ages;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
31 Navarra;All ages;Cohort July 1;Males;Survival in the second trimester;2022QII;""
31 Navarra;All ages;Cohort July 1;Males;Survival in the second trimester;2022QI;""
31 Navarra;All ages;Cohort July 1;Males;Survival in the second trimester;2021QIV;24.941
31 Navarra;All ages;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
31 Navarra;All ages;Cohort July 1;Males;Survival in the second trimester;2021QII;""
31 Navarra;All ages;Cohort July 1;Males;Survival in the second trimester;2021QI;""
31 Navarra;All ages;Cohort July 1;Males;Survival in the second trimester;2020QIV;24.829
31 Navarra;All ages;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
31 Navarra;All ages;Cohort July 1;Males;Survival in the second trimester;2020QII;""
31 Navarra;All ages;Cohort July 1;Males;Survival in the second trimester;2020QI;""
31 Navarra;All ages;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
31 Navarra;All ages;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
31 Navarra;All ages;Cohort July 1;Males;Survival in the third trimester;2022QII;""
31 Navarra;All ages;Cohort July 1;Males;Survival in the third trimester;2022QI;24.256
31 Navarra;All ages;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
31 Navarra;All ages;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
31 Navarra;All ages;Cohort July 1;Males;Survival in the third trimester;2021QII;""
31 Navarra;All ages;Cohort July 1;Males;Survival in the third trimester;2021QI;24.306
31 Navarra;All ages;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
31 Navarra;All ages;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
31 Navarra;All ages;Cohort July 1;Males;Survival in the third trimester;2020QII;""
31 Navarra;All ages;Cohort July 1;Males;Survival in the third trimester;2020QI;""
31 Navarra;All ages;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
31 Navarra;All ages;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
31 Navarra;All ages;Cohort July 1;Males;Survival in the third trimester;2022QII;23.612
31 Navarra;All ages;Cohort July 1;Males;Survival in the third trimester;2022QI;""
31 Navarra;All ages;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
31 Navarra;All ages;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
31 Navarra;All ages;Cohort July 1;Males;Survival in the third trimester;2021QII;23.684
31 Navarra;All ages;Cohort July 1;Males;Survival in the third trimester;2021QI;""
31 Navarra;All ages;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
31 Navarra;All ages;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
31 Navarra;All ages;Cohort July 1;Males;Survival in the third trimester;2020QII;""
31 Navarra;All ages;Cohort July 1;Males;Survival in the third trimester;2020QI;""
31 Navarra;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
31 Navarra;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
31 Navarra;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
31 Navarra;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
31 Navarra;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
31 Navarra;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
31 Navarra;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
31 Navarra;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
31 Navarra;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
31 Navarra;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
31 Navarra;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
31 Navarra;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
31 Navarra;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
31 Navarra;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;96,82
31 Navarra;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
31 Navarra;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
31 Navarra;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
31 Navarra;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;96,68
31 Navarra;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
31 Navarra;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
31 Navarra;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
31 Navarra;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;96,61
31 Navarra;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
31 Navarra;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
31 Navarra;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;93,22
31 Navarra;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
31 Navarra;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
31 Navarra;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
31 Navarra;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;93,38
31 Navarra;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
31 Navarra;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
31 Navarra;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
31 Navarra;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;93,87
31 Navarra;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
31 Navarra;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
31 Navarra;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
31 Navarra;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
31 Navarra;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
31 Navarra;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
31 Navarra;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;90,82
31 Navarra;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
31 Navarra;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
31 Navarra;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
31 Navarra;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;91,89
31 Navarra;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
31 Navarra;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
31 Navarra;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
31 Navarra;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
31 Navarra;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
31 Navarra;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
31 Navarra;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;88,41
31 Navarra;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
31 Navarra;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
31 Navarra;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
31 Navarra;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;89,54
31 Navarra;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
31 Navarra;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
31 Navarra;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
31 Navarra;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
31 Navarra;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
31 Navarra;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
31 Navarra;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QIII;15.322
31 Navarra;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
31 Navarra;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
31 Navarra;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
31 Navarra;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QIII;15.176
31 Navarra;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
31 Navarra;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
31 Navarra;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
31 Navarra;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QIII;14.850
31 Navarra;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
31 Navarra;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
31 Navarra;All ages;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
31 Navarra;All ages;Cohort July 1;Females;Survival in the first trimester;2022QIII;14.841
31 Navarra;All ages;Cohort July 1;Females;Survival in the first trimester;2022QII;""
31 Navarra;All ages;Cohort July 1;Females;Survival in the first trimester;2022QI;""
31 Navarra;All ages;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
31 Navarra;All ages;Cohort July 1;Females;Survival in the first trimester;2021QIII;14.703
31 Navarra;All ages;Cohort July 1;Females;Survival in the first trimester;2021QII;""
31 Navarra;All ages;Cohort July 1;Females;Survival in the first trimester;2021QI;""
31 Navarra;All ages;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
31 Navarra;All ages;Cohort July 1;Females;Survival in the first trimester;2020QIII;14.424
31 Navarra;All ages;Cohort July 1;Females;Survival in the first trimester;2020QII;""
31 Navarra;All ages;Cohort July 1;Females;Survival in the first trimester;2020QI;""
31 Navarra;All ages;Cohort July 1;Females;Survival in the second trimester;2022QIV;14.279
31 Navarra;All ages;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
31 Navarra;All ages;Cohort July 1;Females;Survival in the second trimester;2022QII;""
31 Navarra;All ages;Cohort July 1;Females;Survival in the second trimester;2022QI;""
31 Navarra;All ages;Cohort July 1;Females;Survival in the second trimester;2021QIV;14.270
31 Navarra;All ages;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
31 Navarra;All ages;Cohort July 1;Females;Survival in the second trimester;2021QII;""
31 Navarra;All ages;Cohort July 1;Females;Survival in the second trimester;2021QI;""
31 Navarra;All ages;Cohort July 1;Females;Survival in the second trimester;2020QIV;14.049
31 Navarra;All ages;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
31 Navarra;All ages;Cohort July 1;Females;Survival in the second trimester;2020QII;""
31 Navarra;All ages;Cohort July 1;Females;Survival in the second trimester;2020QI;""
31 Navarra;All ages;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
31 Navarra;All ages;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
31 Navarra;All ages;Cohort July 1;Females;Survival in the third trimester;2022QII;""
31 Navarra;All ages;Cohort July 1;Females;Survival in the third trimester;2022QI;13.878
31 Navarra;All ages;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
31 Navarra;All ages;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
31 Navarra;All ages;Cohort July 1;Females;Survival in the third trimester;2021QII;""
31 Navarra;All ages;Cohort July 1;Females;Survival in the third trimester;2021QI;13.759
31 Navarra;All ages;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
31 Navarra;All ages;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
31 Navarra;All ages;Cohort July 1;Females;Survival in the third trimester;2020QII;""
31 Navarra;All ages;Cohort July 1;Females;Survival in the third trimester;2020QI;""
31 Navarra;All ages;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
31 Navarra;All ages;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
31 Navarra;All ages;Cohort July 1;Females;Survival in the third trimester;2022QII;13.409
31 Navarra;All ages;Cohort July 1;Females;Survival in the third trimester;2022QI;""
31 Navarra;All ages;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
31 Navarra;All ages;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
31 Navarra;All ages;Cohort July 1;Females;Survival in the third trimester;2021QII;13.371
31 Navarra;All ages;Cohort July 1;Females;Survival in the third trimester;2021QI;""
31 Navarra;All ages;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
31 Navarra;All ages;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
31 Navarra;All ages;Cohort July 1;Females;Survival in the third trimester;2020QII;""
31 Navarra;All ages;Cohort July 1;Females;Survival in the third trimester;2020QI;""
31 Navarra;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
31 Navarra;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
31 Navarra;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
31 Navarra;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
31 Navarra;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
31 Navarra;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
31 Navarra;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
31 Navarra;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
31 Navarra;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
31 Navarra;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
31 Navarra;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
31 Navarra;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
31 Navarra;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
31 Navarra;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;96,86
31 Navarra;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
31 Navarra;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
31 Navarra;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
31 Navarra;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;96,88
31 Navarra;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
31 Navarra;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
31 Navarra;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
31 Navarra;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;97,13
31 Navarra;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
31 Navarra;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
31 Navarra;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;93,19
31 Navarra;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
31 Navarra;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
31 Navarra;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
31 Navarra;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;94,03
31 Navarra;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
31 Navarra;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
31 Navarra;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
31 Navarra;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;94,61
31 Navarra;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
31 Navarra;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
31 Navarra;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
31 Navarra;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
31 Navarra;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
31 Navarra;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
31 Navarra;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;91,45
31 Navarra;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
31 Navarra;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
31 Navarra;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
31 Navarra;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;92,65
31 Navarra;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
31 Navarra;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
31 Navarra;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
31 Navarra;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
31 Navarra;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
31 Navarra;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
31 Navarra;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;88,36
31 Navarra;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
31 Navarra;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
31 Navarra;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
31 Navarra;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;90,04
31 Navarra;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
31 Navarra;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
31 Navarra;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
31 Navarra;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
31 Navarra;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
31 Navarra;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QIV;41.878
31 Navarra;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
31 Navarra;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
31 Navarra;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
31 Navarra;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QIV;41.823
31 Navarra;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
31 Navarra;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
31 Navarra;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
31 Navarra;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QIV;41.353
31 Navarra;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
31 Navarra;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
31 Navarra;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
31 Navarra;All ages;Cohort October 1;Total;Survival in the first trimester;2022QIV;40.192
31 Navarra;All ages;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
31 Navarra;All ages;Cohort October 1;Total;Survival in the first trimester;2022QII;""
31 Navarra;All ages;Cohort October 1;Total;Survival in the first trimester;2022QI;""
31 Navarra;All ages;Cohort October 1;Total;Survival in the first trimester;2021QIV;40.342
31 Navarra;All ages;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
31 Navarra;All ages;Cohort October 1;Total;Survival in the first trimester;2021QII;""
31 Navarra;All ages;Cohort October 1;Total;Survival in the first trimester;2021QI;""
31 Navarra;All ages;Cohort October 1;Total;Survival in the first trimester;2020QIV;40.085
31 Navarra;All ages;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
31 Navarra;All ages;Cohort October 1;Total;Survival in the first trimester;2020QII;""
31 Navarra;All ages;Cohort October 1;Total;Survival in the first trimester;2020QI;""
31 Navarra;All ages;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
31 Navarra;All ages;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
31 Navarra;All ages;Cohort October 1;Total;Survival in the second trimester;2022QII;""
31 Navarra;All ages;Cohort October 1;Total;Survival in the second trimester;2022QI;39.163
31 Navarra;All ages;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
31 Navarra;All ages;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
31 Navarra;All ages;Cohort October 1;Total;Survival in the second trimester;2021QII;""
31 Navarra;All ages;Cohort October 1;Total;Survival in the second trimester;2021QI;39.185
31 Navarra;All ages;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
31 Navarra;All ages;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
31 Navarra;All ages;Cohort October 1;Total;Survival in the second trimester;2020QII;""
31 Navarra;All ages;Cohort October 1;Total;Survival in the second trimester;2020QI;""
31 Navarra;All ages;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
31 Navarra;All ages;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
31 Navarra;All ages;Cohort October 1;Total;Survival in the third trimester;2022QII;37.918
31 Navarra;All ages;Cohort October 1;Total;Survival in the third trimester;2022QI;""
31 Navarra;All ages;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
31 Navarra;All ages;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
31 Navarra;All ages;Cohort October 1;Total;Survival in the third trimester;2021QII;38.074
31 Navarra;All ages;Cohort October 1;Total;Survival in the third trimester;2021QI;""
31 Navarra;All ages;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
31 Navarra;All ages;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
31 Navarra;All ages;Cohort October 1;Total;Survival in the third trimester;2020QII;""
31 Navarra;All ages;Cohort October 1;Total;Survival in the third trimester;2020QI;""
31 Navarra;All ages;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
31 Navarra;All ages;Cohort October 1;Total;Survival in the third trimester;2022QIII;37.034
31 Navarra;All ages;Cohort October 1;Total;Survival in the third trimester;2022QII;""
31 Navarra;All ages;Cohort October 1;Total;Survival in the third trimester;2022QI;""
31 Navarra;All ages;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
31 Navarra;All ages;Cohort October 1;Total;Survival in the third trimester;2021QIII;37.113
31 Navarra;All ages;Cohort October 1;Total;Survival in the third trimester;2021QII;""
31 Navarra;All ages;Cohort October 1;Total;Survival in the third trimester;2021QI;""
31 Navarra;All ages;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
31 Navarra;All ages;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
31 Navarra;All ages;Cohort October 1;Total;Survival in the third trimester;2020QII;""
31 Navarra;All ages;Cohort October 1;Total;Survival in the third trimester;2020QI;""
31 Navarra;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
31 Navarra;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
31 Navarra;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
31 Navarra;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
31 Navarra;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
31 Navarra;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
31 Navarra;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
31 Navarra;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
31 Navarra;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
31 Navarra;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
31 Navarra;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
31 Navarra;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
31 Navarra;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;95,97
31 Navarra;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
31 Navarra;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
31 Navarra;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
31 Navarra;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;96,46
31 Navarra;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
31 Navarra;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
31 Navarra;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
31 Navarra;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;96,93
31 Navarra;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
31 Navarra;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
31 Navarra;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
31 Navarra;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
31 Navarra;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
31 Navarra;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
31 Navarra;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;93,64
31 Navarra;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
31 Navarra;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
31 Navarra;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
31 Navarra;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;94,76
31 Navarra;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
31 Navarra;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
31 Navarra;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
31 Navarra;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
31 Navarra;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
31 Navarra;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
31 Navarra;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;90,66
31 Navarra;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
31 Navarra;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
31 Navarra;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
31 Navarra;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;92,07
31 Navarra;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
31 Navarra;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
31 Navarra;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
31 Navarra;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
31 Navarra;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
31 Navarra;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
31 Navarra;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;88,55
31 Navarra;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
31 Navarra;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
31 Navarra;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
31 Navarra;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;89,75
31 Navarra;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
31 Navarra;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
31 Navarra;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
31 Navarra;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
31 Navarra;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
31 Navarra;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
31 Navarra;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QIV;26.504
31 Navarra;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
31 Navarra;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
31 Navarra;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
31 Navarra;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QIV;26.579
31 Navarra;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
31 Navarra;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
31 Navarra;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
31 Navarra;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QIV;26.410
31 Navarra;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
31 Navarra;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
31 Navarra;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
31 Navarra;All ages;Cohort October 1;Males;Survival in the first trimester;2022QIV;25.431
31 Navarra;All ages;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
31 Navarra;All ages;Cohort October 1;Males;Survival in the first trimester;2022QII;""
31 Navarra;All ages;Cohort October 1;Males;Survival in the first trimester;2022QI;""
31 Navarra;All ages;Cohort October 1;Males;Survival in the first trimester;2021QIV;25.583
31 Navarra;All ages;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
31 Navarra;All ages;Cohort October 1;Males;Survival in the first trimester;2021QII;""
31 Navarra;All ages;Cohort October 1;Males;Survival in the first trimester;2021QI;""
31 Navarra;All ages;Cohort October 1;Males;Survival in the first trimester;2020QIV;25.579
31 Navarra;All ages;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
31 Navarra;All ages;Cohort October 1;Males;Survival in the first trimester;2020QII;""
31 Navarra;All ages;Cohort October 1;Males;Survival in the first trimester;2020QI;""
31 Navarra;All ages;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
31 Navarra;All ages;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
31 Navarra;All ages;Cohort October 1;Males;Survival in the second trimester;2022QII;""
31 Navarra;All ages;Cohort October 1;Males;Survival in the second trimester;2022QI;24.832
31 Navarra;All ages;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
31 Navarra;All ages;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
31 Navarra;All ages;Cohort October 1;Males;Survival in the second trimester;2021QII;""
31 Navarra;All ages;Cohort October 1;Males;Survival in the second trimester;2021QI;24.996
31 Navarra;All ages;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
31 Navarra;All ages;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
31 Navarra;All ages;Cohort October 1;Males;Survival in the second trimester;2020QII;""
31 Navarra;All ages;Cohort October 1;Males;Survival in the second trimester;2020QI;""
31 Navarra;All ages;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
31 Navarra;All ages;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
31 Navarra;All ages;Cohort October 1;Males;Survival in the third trimester;2022QII;24.122
31 Navarra;All ages;Cohort October 1;Males;Survival in the third trimester;2022QI;""
31 Navarra;All ages;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
31 Navarra;All ages;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
31 Navarra;All ages;Cohort October 1;Males;Survival in the third trimester;2021QII;24.314
31 Navarra;All ages;Cohort October 1;Males;Survival in the third trimester;2021QI;""
31 Navarra;All ages;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
31 Navarra;All ages;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
31 Navarra;All ages;Cohort October 1;Males;Survival in the third trimester;2020QII;""
31 Navarra;All ages;Cohort October 1;Males;Survival in the third trimester;2020QI;""
31 Navarra;All ages;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
31 Navarra;All ages;Cohort October 1;Males;Survival in the third trimester;2022QIII;23.565
31 Navarra;All ages;Cohort October 1;Males;Survival in the third trimester;2022QII;""
31 Navarra;All ages;Cohort October 1;Males;Survival in the third trimester;2022QI;""
31 Navarra;All ages;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
31 Navarra;All ages;Cohort October 1;Males;Survival in the third trimester;2021QIII;23.705
31 Navarra;All ages;Cohort October 1;Males;Survival in the third trimester;2021QII;""
31 Navarra;All ages;Cohort October 1;Males;Survival in the third trimester;2021QI;""
31 Navarra;All ages;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
31 Navarra;All ages;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
31 Navarra;All ages;Cohort October 1;Males;Survival in the third trimester;2020QII;""
31 Navarra;All ages;Cohort October 1;Males;Survival in the third trimester;2020QI;""
31 Navarra;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
31 Navarra;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
31 Navarra;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
31 Navarra;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
31 Navarra;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
31 Navarra;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
31 Navarra;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
31 Navarra;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
31 Navarra;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
31 Navarra;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
31 Navarra;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
31 Navarra;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
31 Navarra;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;95,95
31 Navarra;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
31 Navarra;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
31 Navarra;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
31 Navarra;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;96,25
31 Navarra;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
31 Navarra;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
31 Navarra;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
31 Navarra;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;96,85
31 Navarra;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
31 Navarra;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
31 Navarra;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
31 Navarra;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
31 Navarra;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
31 Navarra;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
31 Navarra;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;93,43
31 Navarra;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
31 Navarra;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
31 Navarra;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
31 Navarra;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;94,65
31 Navarra;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
31 Navarra;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
31 Navarra;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
31 Navarra;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
31 Navarra;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
31 Navarra;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
31 Navarra;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;90,76
31 Navarra;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
31 Navarra;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
31 Navarra;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
31 Navarra;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;92,06
31 Navarra;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
31 Navarra;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
31 Navarra;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
31 Navarra;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
31 Navarra;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
31 Navarra;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
31 Navarra;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;88,66
31 Navarra;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
31 Navarra;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
31 Navarra;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
31 Navarra;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;89,76
31 Navarra;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
31 Navarra;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
31 Navarra;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
31 Navarra;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
31 Navarra;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
31 Navarra;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
31 Navarra;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QIV;15.374
31 Navarra;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
31 Navarra;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
31 Navarra;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
31 Navarra;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QIV;15.244
31 Navarra;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
31 Navarra;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
31 Navarra;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
31 Navarra;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QIV;14.943
31 Navarra;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
31 Navarra;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
31 Navarra;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
31 Navarra;All ages;Cohort October 1;Females;Survival in the first trimester;2022QIV;14.761
31 Navarra;All ages;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
31 Navarra;All ages;Cohort October 1;Females;Survival in the first trimester;2022QII;""
31 Navarra;All ages;Cohort October 1;Females;Survival in the first trimester;2022QI;""
31 Navarra;All ages;Cohort October 1;Females;Survival in the first trimester;2021QIV;14.759
31 Navarra;All ages;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
31 Navarra;All ages;Cohort October 1;Females;Survival in the first trimester;2021QII;""
31 Navarra;All ages;Cohort October 1;Females;Survival in the first trimester;2021QI;""
31 Navarra;All ages;Cohort October 1;Females;Survival in the first trimester;2020QIV;14.506
31 Navarra;All ages;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
31 Navarra;All ages;Cohort October 1;Females;Survival in the first trimester;2020QII;""
31 Navarra;All ages;Cohort October 1;Females;Survival in the first trimester;2020QI;""
31 Navarra;All ages;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
31 Navarra;All ages;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
31 Navarra;All ages;Cohort October 1;Females;Survival in the second trimester;2022QII;""
31 Navarra;All ages;Cohort October 1;Females;Survival in the second trimester;2022QI;14.331
31 Navarra;All ages;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
31 Navarra;All ages;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
31 Navarra;All ages;Cohort October 1;Females;Survival in the second trimester;2021QII;""
31 Navarra;All ages;Cohort October 1;Females;Survival in the second trimester;2021QI;14.189
31 Navarra;All ages;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
31 Navarra;All ages;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
31 Navarra;All ages;Cohort October 1;Females;Survival in the second trimester;2020QII;""
31 Navarra;All ages;Cohort October 1;Females;Survival in the second trimester;2020QI;""
31 Navarra;All ages;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
31 Navarra;All ages;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
31 Navarra;All ages;Cohort October 1;Females;Survival in the third trimester;2022QII;13.796
31 Navarra;All ages;Cohort October 1;Females;Survival in the third trimester;2022QI;""
31 Navarra;All ages;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
31 Navarra;All ages;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
31 Navarra;All ages;Cohort October 1;Females;Survival in the third trimester;2021QII;13.760
31 Navarra;All ages;Cohort October 1;Females;Survival in the third trimester;2021QI;""
31 Navarra;All ages;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
31 Navarra;All ages;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
31 Navarra;All ages;Cohort October 1;Females;Survival in the third trimester;2020QII;""
31 Navarra;All ages;Cohort October 1;Females;Survival in the third trimester;2020QI;""
31 Navarra;All ages;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
31 Navarra;All ages;Cohort October 1;Females;Survival in the third trimester;2022QIII;13.469
31 Navarra;All ages;Cohort October 1;Females;Survival in the third trimester;2022QII;""
31 Navarra;All ages;Cohort October 1;Females;Survival in the third trimester;2022QI;""
31 Navarra;All ages;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
31 Navarra;All ages;Cohort October 1;Females;Survival in the third trimester;2021QIII;13.408
31 Navarra;All ages;Cohort October 1;Females;Survival in the third trimester;2021QII;""
31 Navarra;All ages;Cohort October 1;Females;Survival in the third trimester;2021QI;""
31 Navarra;All ages;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
31 Navarra;All ages;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
31 Navarra;All ages;Cohort October 1;Females;Survival in the third trimester;2020QII;""
31 Navarra;All ages;Cohort October 1;Females;Survival in the third trimester;2020QI;""
31 Navarra;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
31 Navarra;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
31 Navarra;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
31 Navarra;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
31 Navarra;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
31 Navarra;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
31 Navarra;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
31 Navarra;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
31 Navarra;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
31 Navarra;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
31 Navarra;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
31 Navarra;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
31 Navarra;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;96,01
31 Navarra;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
31 Navarra;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
31 Navarra;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
31 Navarra;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;96,82
31 Navarra;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
31 Navarra;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
31 Navarra;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
31 Navarra;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;97,08
31 Navarra;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
31 Navarra;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
31 Navarra;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
31 Navarra;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
31 Navarra;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
31 Navarra;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
31 Navarra;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;94,01
31 Navarra;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
31 Navarra;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
31 Navarra;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
31 Navarra;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;94,95
31 Navarra;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
31 Navarra;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
31 Navarra;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
31 Navarra;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
31 Navarra;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
31 Navarra;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
31 Navarra;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;90,5
31 Navarra;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
31 Navarra;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
31 Navarra;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
31 Navarra;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;92,08
31 Navarra;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
31 Navarra;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
31 Navarra;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
31 Navarra;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
31 Navarra;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
31 Navarra;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
31 Navarra;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;88,36
31 Navarra;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
31 Navarra;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
31 Navarra;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
31 Navarra;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;89,73
31 Navarra;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
31 Navarra;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
31 Navarra;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
31 Navarra;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
31 Navarra;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
31 Navarra;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
31 Navarra;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
31 Navarra;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
31 Navarra;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
31 Navarra;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QI;2.814
31 Navarra;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
31 Navarra;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
31 Navarra;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
31 Navarra;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QI;2.635
31 Navarra;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
31 Navarra;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
31 Navarra;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
31 Navarra;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QI;2.220
31 Navarra;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
31 Navarra;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
31 Navarra;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2022QII;""
31 Navarra;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2022QI;2.586
31 Navarra;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
31 Navarra;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
31 Navarra;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2021QII;""
31 Navarra;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2021QI;2.469
31 Navarra;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
31 Navarra;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
31 Navarra;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2020QII;""
31 Navarra;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2020QI;1.919
31 Navarra;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
31 Navarra;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
31 Navarra;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2022QII;2.370
31 Navarra;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2022QI;""
31 Navarra;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
31 Navarra;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
31 Navarra;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2021QII;2.276
31 Navarra;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2021QI;""
31 Navarra;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
31 Navarra;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
31 Navarra;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2020QII;1.830
31 Navarra;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2020QI;""
31 Navarra;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
31 Navarra;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QIII;2.237
31 Navarra;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QII;""
31 Navarra;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QI;""
31 Navarra;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
31 Navarra;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QIII;2.093
31 Navarra;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QII;""
31 Navarra;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QI;""
31 Navarra;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
31 Navarra;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QIII;1.724
31 Navarra;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QII;""
31 Navarra;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QI;""
31 Navarra;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QIV;2.094
31 Navarra;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
31 Navarra;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QII;""
31 Navarra;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QI;""
31 Navarra;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QIV;1.961
31 Navarra;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
31 Navarra;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QII;""
31 Navarra;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QI;""
31 Navarra;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QIV;1.630
31 Navarra;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
31 Navarra;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QII;""
31 Navarra;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QI;""
31 Navarra;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
31 Navarra;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
31 Navarra;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
31 Navarra;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
31 Navarra;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
31 Navarra;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
31 Navarra;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
31 Navarra;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
31 Navarra;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
31 Navarra;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
31 Navarra;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
31 Navarra;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
31 Navarra;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
31 Navarra;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
31 Navarra;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
31 Navarra;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;91,9
31 Navarra;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
31 Navarra;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
31 Navarra;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
31 Navarra;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;93,7
31 Navarra;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
31 Navarra;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
31 Navarra;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
31 Navarra;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;86,44
31 Navarra;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
31 Navarra;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
31 Navarra;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;84,22
31 Navarra;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
31 Navarra;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
31 Navarra;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
31 Navarra;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;86,38
31 Navarra;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
31 Navarra;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
31 Navarra;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
31 Navarra;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;82,43
31 Navarra;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
31 Navarra;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
31 Navarra;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;79,5
31 Navarra;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
31 Navarra;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
31 Navarra;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
31 Navarra;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;79,43
31 Navarra;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
31 Navarra;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
31 Navarra;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
31 Navarra;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;77,66
31 Navarra;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
31 Navarra;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
31 Navarra;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;74,41
31 Navarra;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
31 Navarra;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
31 Navarra;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
31 Navarra;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;74,42
31 Navarra;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
31 Navarra;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
31 Navarra;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
31 Navarra;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;73,42
31 Navarra;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
31 Navarra;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
31 Navarra;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
31 Navarra;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
31 Navarra;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
31 Navarra;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
31 Navarra;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QI;1.831
31 Navarra;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
31 Navarra;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
31 Navarra;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
31 Navarra;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QI;1.729
31 Navarra;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
31 Navarra;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
31 Navarra;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
31 Navarra;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QI;1.470
31 Navarra;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
31 Navarra;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
31 Navarra;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2022QII;""
31 Navarra;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2022QI;1.672
31 Navarra;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
31 Navarra;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
31 Navarra;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2021QII;""
31 Navarra;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2021QI;1.611
31 Navarra;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
31 Navarra;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
31 Navarra;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2020QII;""
31 Navarra;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2020QI;1.259
31 Navarra;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
31 Navarra;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
31 Navarra;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2022QII;1.534
31 Navarra;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2022QI;""
31 Navarra;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
31 Navarra;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
31 Navarra;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2021QII;1.480
31 Navarra;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2021QI;""
31 Navarra;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
31 Navarra;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
31 Navarra;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2020QII;1.193
31 Navarra;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2020QI;""
31 Navarra;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
31 Navarra;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QIII;1.455
31 Navarra;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QII;""
31 Navarra;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QI;""
31 Navarra;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
31 Navarra;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QIII;1.365
31 Navarra;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QII;""
31 Navarra;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QI;""
31 Navarra;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
31 Navarra;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QIII;1.119
31 Navarra;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QII;""
31 Navarra;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QI;""
31 Navarra;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QIV;1.368
31 Navarra;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
31 Navarra;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QII;""
31 Navarra;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QI;""
31 Navarra;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QIV;1.279
31 Navarra;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
31 Navarra;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QII;""
31 Navarra;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QI;""
31 Navarra;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QIV;1.054
31 Navarra;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
31 Navarra;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QII;""
31 Navarra;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QI;""
31 Navarra;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
31 Navarra;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
31 Navarra;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
31 Navarra;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
31 Navarra;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
31 Navarra;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
31 Navarra;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
31 Navarra;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
31 Navarra;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
31 Navarra;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
31 Navarra;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
31 Navarra;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
31 Navarra;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
31 Navarra;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
31 Navarra;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
31 Navarra;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;91,32
31 Navarra;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
31 Navarra;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
31 Navarra;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
31 Navarra;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;93,18
31 Navarra;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
31 Navarra;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
31 Navarra;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
31 Navarra;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;85,65
31 Navarra;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
31 Navarra;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
31 Navarra;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;83,78
31 Navarra;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
31 Navarra;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
31 Navarra;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
31 Navarra;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;85,6
31 Navarra;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
31 Navarra;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
31 Navarra;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
31 Navarra;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;81,16
31 Navarra;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
31 Navarra;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
31 Navarra;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;79,46
31 Navarra;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
31 Navarra;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
31 Navarra;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
31 Navarra;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;78,95
31 Navarra;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
31 Navarra;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
31 Navarra;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
31 Navarra;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;76,12
31 Navarra;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
31 Navarra;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
31 Navarra;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;74,71
31 Navarra;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
31 Navarra;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
31 Navarra;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
31 Navarra;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;73,97
31 Navarra;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
31 Navarra;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
31 Navarra;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
31 Navarra;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;71,7
31 Navarra;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
31 Navarra;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
31 Navarra;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
31 Navarra;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
31 Navarra;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
31 Navarra;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
31 Navarra;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QI;983
31 Navarra;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
31 Navarra;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
31 Navarra;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
31 Navarra;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QI;906
31 Navarra;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
31 Navarra;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
31 Navarra;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
31 Navarra;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QI;750
31 Navarra;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
31 Navarra;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
31 Navarra;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2022QII;""
31 Navarra;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2022QI;914
31 Navarra;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
31 Navarra;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
31 Navarra;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2021QII;""
31 Navarra;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2021QI;858
31 Navarra;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
31 Navarra;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
31 Navarra;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2020QII;""
31 Navarra;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2020QI;660
31 Navarra;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
31 Navarra;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
31 Navarra;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2022QII;836
31 Navarra;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2022QI;""
31 Navarra;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
31 Navarra;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
31 Navarra;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2021QII;796
31 Navarra;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2021QI;""
31 Navarra;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
31 Navarra;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
31 Navarra;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2020QII;637
31 Navarra;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2020QI;""
31 Navarra;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
31 Navarra;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QIII;782
31 Navarra;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QII;""
31 Navarra;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QI;""
31 Navarra;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
31 Navarra;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QIII;728
31 Navarra;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QII;""
31 Navarra;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QI;""
31 Navarra;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
31 Navarra;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QIII;605
31 Navarra;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QII;""
31 Navarra;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QI;""
31 Navarra;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QIV;726
31 Navarra;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
31 Navarra;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QII;""
31 Navarra;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QI;""
31 Navarra;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QIV;682
31 Navarra;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
31 Navarra;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QII;""
31 Navarra;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QI;""
31 Navarra;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QIV;576
31 Navarra;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
31 Navarra;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QII;""
31 Navarra;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QI;""
31 Navarra;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
31 Navarra;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
31 Navarra;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
31 Navarra;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
31 Navarra;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
31 Navarra;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
31 Navarra;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
31 Navarra;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
31 Navarra;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
31 Navarra;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
31 Navarra;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
31 Navarra;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
31 Navarra;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
31 Navarra;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
31 Navarra;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
31 Navarra;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;92,98
31 Navarra;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
31 Navarra;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
31 Navarra;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
31 Navarra;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;94,7
31 Navarra;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
31 Navarra;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
31 Navarra;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
31 Navarra;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;88
31 Navarra;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
31 Navarra;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
31 Navarra;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;85,05
31 Navarra;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
31 Navarra;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
31 Navarra;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
31 Navarra;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;87,86
31 Navarra;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
31 Navarra;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
31 Navarra;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
31 Navarra;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;84,93
31 Navarra;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
31 Navarra;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
31 Navarra;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;79,55
31 Navarra;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
31 Navarra;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
31 Navarra;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
31 Navarra;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;80,35
31 Navarra;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
31 Navarra;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
31 Navarra;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
31 Navarra;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;80,67
31 Navarra;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
31 Navarra;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
31 Navarra;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;73,86
31 Navarra;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
31 Navarra;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
31 Navarra;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
31 Navarra;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;75,28
31 Navarra;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
31 Navarra;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
31 Navarra;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
31 Navarra;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;76,8
31 Navarra;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
31 Navarra;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
31 Navarra;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
31 Navarra;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
31 Navarra;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
31 Navarra;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QII;2.513
31 Navarra;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
31 Navarra;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
31 Navarra;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
31 Navarra;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QII;2.462
31 Navarra;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
31 Navarra;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
31 Navarra;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
31 Navarra;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QII;2.229
31 Navarra;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
31 Navarra;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
31 Navarra;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
31 Navarra;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2022QII;2.278
31 Navarra;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2022QI;""
31 Navarra;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
31 Navarra;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
31 Navarra;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2021QII;2.233
31 Navarra;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2021QI;""
31 Navarra;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
31 Navarra;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
31 Navarra;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2020QII;2.115
31 Navarra;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2020QI;""
31 Navarra;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
31 Navarra;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2022QIII;2.141
31 Navarra;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2022QII;""
31 Navarra;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2022QI;""
31 Navarra;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
31 Navarra;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2021QIII;2.031
31 Navarra;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2021QII;""
31 Navarra;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2021QI;""
31 Navarra;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
31 Navarra;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2020QIII;1.971
31 Navarra;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2020QII;""
31 Navarra;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2020QI;""
31 Navarra;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QIV;1.990
31 Navarra;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
31 Navarra;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QII;""
31 Navarra;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QI;""
31 Navarra;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QIV;1.884
31 Navarra;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
31 Navarra;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QII;""
31 Navarra;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QI;""
31 Navarra;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QIV;1.855
31 Navarra;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
31 Navarra;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QII;""
31 Navarra;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QI;""
31 Navarra;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
31 Navarra;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
31 Navarra;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QII;""
31 Navarra;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QI;1.759
31 Navarra;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
31 Navarra;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
31 Navarra;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QII;""
31 Navarra;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QI;1.763
31 Navarra;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
31 Navarra;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
31 Navarra;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QII;""
31 Navarra;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QI;""
31 Navarra;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
31 Navarra;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
31 Navarra;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
31 Navarra;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
31 Navarra;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
31 Navarra;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
31 Navarra;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
31 Navarra;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
31 Navarra;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
31 Navarra;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
31 Navarra;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
31 Navarra;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
31 Navarra;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
31 Navarra;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
31 Navarra;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;90,65
31 Navarra;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
31 Navarra;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
31 Navarra;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
31 Navarra;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;90,7
31 Navarra;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
31 Navarra;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
31 Navarra;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
31 Navarra;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;94,89
31 Navarra;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
31 Navarra;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
31 Navarra;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;85,2
31 Navarra;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
31 Navarra;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
31 Navarra;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
31 Navarra;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;82,49
31 Navarra;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
31 Navarra;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
31 Navarra;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
31 Navarra;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;88,43
31 Navarra;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
31 Navarra;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
31 Navarra;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;79,19
31 Navarra;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
31 Navarra;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
31 Navarra;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
31 Navarra;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;76,52
31 Navarra;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
31 Navarra;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
31 Navarra;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
31 Navarra;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;83,22
31 Navarra;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
31 Navarra;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
31 Navarra;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
31 Navarra;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
31 Navarra;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
31 Navarra;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
31 Navarra;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;71,45
31 Navarra;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
31 Navarra;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
31 Navarra;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
31 Navarra;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;79,09
31 Navarra;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
31 Navarra;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
31 Navarra;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
31 Navarra;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
31 Navarra;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
31 Navarra;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
31 Navarra;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QII;1.637
31 Navarra;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
31 Navarra;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
31 Navarra;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
31 Navarra;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QII;1.633
31 Navarra;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
31 Navarra;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
31 Navarra;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
31 Navarra;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QII;1.475
31 Navarra;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
31 Navarra;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
31 Navarra;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
31 Navarra;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2022QII;1.485
31 Navarra;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2022QI;""
31 Navarra;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
31 Navarra;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
31 Navarra;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2021QII;1.472
31 Navarra;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2021QI;""
31 Navarra;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
31 Navarra;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
31 Navarra;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2020QII;1.385
31 Navarra;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2020QI;""
31 Navarra;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
31 Navarra;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2022QIII;1.398
31 Navarra;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2022QII;""
31 Navarra;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2022QI;""
31 Navarra;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
31 Navarra;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2021QIII;1.336
31 Navarra;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2021QII;""
31 Navarra;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2021QI;""
31 Navarra;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
31 Navarra;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2020QIII;1.280
31 Navarra;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2020QII;""
31 Navarra;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2020QI;""
31 Navarra;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QIV;1.307
31 Navarra;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
31 Navarra;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QII;""
31 Navarra;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QI;""
31 Navarra;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QIV;1.237
31 Navarra;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
31 Navarra;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QII;""
31 Navarra;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QI;""
31 Navarra;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QIV;1.199
31 Navarra;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
31 Navarra;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QII;""
31 Navarra;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QI;""
31 Navarra;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
31 Navarra;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
31 Navarra;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QII;""
31 Navarra;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QI;1.151
31 Navarra;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
31 Navarra;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
31 Navarra;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QII;""
31 Navarra;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QI;1.136
31 Navarra;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
31 Navarra;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
31 Navarra;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QII;""
31 Navarra;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QI;""
31 Navarra;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
31 Navarra;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
31 Navarra;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
31 Navarra;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
31 Navarra;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
31 Navarra;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
31 Navarra;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
31 Navarra;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
31 Navarra;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
31 Navarra;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
31 Navarra;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
31 Navarra;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
31 Navarra;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
31 Navarra;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
31 Navarra;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;90,71
31 Navarra;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
31 Navarra;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
31 Navarra;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
31 Navarra;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;90,14
31 Navarra;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
31 Navarra;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
31 Navarra;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
31 Navarra;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;93,9
31 Navarra;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
31 Navarra;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
31 Navarra;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;85,4
31 Navarra;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
31 Navarra;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
31 Navarra;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
31 Navarra;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;81,81
31 Navarra;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
31 Navarra;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
31 Navarra;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
31 Navarra;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;86,78
31 Navarra;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
31 Navarra;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
31 Navarra;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;79,84
31 Navarra;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
31 Navarra;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
31 Navarra;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
31 Navarra;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;75,75
31 Navarra;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
31 Navarra;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
31 Navarra;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
31 Navarra;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;81,29
31 Navarra;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
31 Navarra;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
31 Navarra;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
31 Navarra;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
31 Navarra;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
31 Navarra;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
31 Navarra;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;70,48
31 Navarra;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
31 Navarra;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
31 Navarra;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
31 Navarra;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;77,02
31 Navarra;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
31 Navarra;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
31 Navarra;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
31 Navarra;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
31 Navarra;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
31 Navarra;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
31 Navarra;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QII;876
31 Navarra;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
31 Navarra;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
31 Navarra;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
31 Navarra;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QII;829
31 Navarra;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
31 Navarra;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
31 Navarra;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
31 Navarra;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QII;754
31 Navarra;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
31 Navarra;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
31 Navarra;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
31 Navarra;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2022QII;793
31 Navarra;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2022QI;""
31 Navarra;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
31 Navarra;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
31 Navarra;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2021QII;761
31 Navarra;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2021QI;""
31 Navarra;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
31 Navarra;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
31 Navarra;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2020QII;730
31 Navarra;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2020QI;""
31 Navarra;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
31 Navarra;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2022QIII;743
31 Navarra;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2022QII;""
31 Navarra;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2022QI;""
31 Navarra;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
31 Navarra;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2021QIII;695
31 Navarra;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2021QII;""
31 Navarra;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2021QI;""
31 Navarra;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
31 Navarra;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2020QIII;691
31 Navarra;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2020QII;""
31 Navarra;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2020QI;""
31 Navarra;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QIV;683
31 Navarra;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
31 Navarra;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QII;""
31 Navarra;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QI;""
31 Navarra;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QIV;647
31 Navarra;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
31 Navarra;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QII;""
31 Navarra;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QI;""
31 Navarra;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QIV;656
31 Navarra;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
31 Navarra;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QII;""
31 Navarra;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QI;""
31 Navarra;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
31 Navarra;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
31 Navarra;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QII;""
31 Navarra;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QI;608
31 Navarra;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
31 Navarra;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
31 Navarra;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QII;""
31 Navarra;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QI;627
31 Navarra;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
31 Navarra;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
31 Navarra;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QII;""
31 Navarra;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QI;""
31 Navarra;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
31 Navarra;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
31 Navarra;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
31 Navarra;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
31 Navarra;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
31 Navarra;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
31 Navarra;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
31 Navarra;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
31 Navarra;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
31 Navarra;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
31 Navarra;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
31 Navarra;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
31 Navarra;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
31 Navarra;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
31 Navarra;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;90,53
31 Navarra;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
31 Navarra;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
31 Navarra;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
31 Navarra;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;91,8
31 Navarra;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
31 Navarra;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
31 Navarra;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
31 Navarra;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;96,82
31 Navarra;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
31 Navarra;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
31 Navarra;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;84,82
31 Navarra;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
31 Navarra;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
31 Navarra;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
31 Navarra;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;83,84
31 Navarra;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
31 Navarra;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
31 Navarra;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
31 Navarra;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;91,64
31 Navarra;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
31 Navarra;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
31 Navarra;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;77,97
31 Navarra;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
31 Navarra;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
31 Navarra;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
31 Navarra;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;78,05
31 Navarra;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
31 Navarra;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
31 Navarra;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
31 Navarra;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;87
31 Navarra;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
31 Navarra;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
31 Navarra;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
31 Navarra;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
31 Navarra;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
31 Navarra;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
31 Navarra;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;73,34
31 Navarra;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
31 Navarra;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
31 Navarra;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
31 Navarra;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;83,16
31 Navarra;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
31 Navarra;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
31 Navarra;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
31 Navarra;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
31 Navarra;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
31 Navarra;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QIII;2.725
31 Navarra;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
31 Navarra;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
31 Navarra;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
31 Navarra;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QIII;2.681
31 Navarra;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
31 Navarra;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
31 Navarra;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
31 Navarra;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QIII;2.383
31 Navarra;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
31 Navarra;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
31 Navarra;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
31 Navarra;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2022QIII;2.480
31 Navarra;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2022QII;""
31 Navarra;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2022QI;""
31 Navarra;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
31 Navarra;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2021QIII;2.381
31 Navarra;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2021QII;""
31 Navarra;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2021QI;""
31 Navarra;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
31 Navarra;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2020QIII;2.163
31 Navarra;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2020QII;""
31 Navarra;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2020QI;""
31 Navarra;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2022QIV;2.286
31 Navarra;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
31 Navarra;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2022QII;""
31 Navarra;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2022QI;""
31 Navarra;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2021QIV;2.188
31 Navarra;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
31 Navarra;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2021QII;""
31 Navarra;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2021QI;""
31 Navarra;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2020QIV;2.019
31 Navarra;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
31 Navarra;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2020QII;""
31 Navarra;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2020QI;""
31 Navarra;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
31 Navarra;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
31 Navarra;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QII;""
31 Navarra;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QI;2.038
31 Navarra;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
31 Navarra;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
31 Navarra;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QII;""
31 Navarra;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QI;1.919
31 Navarra;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
31 Navarra;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
31 Navarra;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QII;""
31 Navarra;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QI;""
31 Navarra;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
31 Navarra;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
31 Navarra;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QII;1.897
31 Navarra;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QI;""
31 Navarra;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
31 Navarra;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
31 Navarra;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QII;1.786
31 Navarra;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QI;""
31 Navarra;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
31 Navarra;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
31 Navarra;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QII;""
31 Navarra;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QI;""
31 Navarra;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
31 Navarra;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
31 Navarra;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
31 Navarra;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
31 Navarra;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
31 Navarra;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
31 Navarra;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
31 Navarra;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
31 Navarra;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
31 Navarra;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
31 Navarra;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
31 Navarra;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
31 Navarra;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
31 Navarra;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;91,01
31 Navarra;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
31 Navarra;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
31 Navarra;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
31 Navarra;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;88,81
31 Navarra;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
31 Navarra;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
31 Navarra;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
31 Navarra;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;90,77
31 Navarra;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
31 Navarra;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
31 Navarra;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;83,89
31 Navarra;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
31 Navarra;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
31 Navarra;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
31 Navarra;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;81,61
31 Navarra;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
31 Navarra;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
31 Navarra;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
31 Navarra;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;84,73
31 Navarra;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
31 Navarra;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
31 Navarra;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
31 Navarra;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
31 Navarra;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
31 Navarra;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
31 Navarra;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;76,02
31 Navarra;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
31 Navarra;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
31 Navarra;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
31 Navarra;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;80,53
31 Navarra;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
31 Navarra;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
31 Navarra;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
31 Navarra;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
31 Navarra;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
31 Navarra;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
31 Navarra;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;70,76
31 Navarra;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
31 Navarra;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
31 Navarra;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
31 Navarra;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;74,95
31 Navarra;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
31 Navarra;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
31 Navarra;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
31 Navarra;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
31 Navarra;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
31 Navarra;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
31 Navarra;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QIII;1.764
31 Navarra;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
31 Navarra;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
31 Navarra;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
31 Navarra;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QIII;1.762
31 Navarra;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
31 Navarra;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
31 Navarra;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
31 Navarra;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QIII;1.575
31 Navarra;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
31 Navarra;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
31 Navarra;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
31 Navarra;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2022QIII;1.614
31 Navarra;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2022QII;""
31 Navarra;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2022QI;""
31 Navarra;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
31 Navarra;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2021QIII;1.560
31 Navarra;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2021QII;""
31 Navarra;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2021QI;""
31 Navarra;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
31 Navarra;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2020QIII;1.411
31 Navarra;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2020QII;""
31 Navarra;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2020QI;""
31 Navarra;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2022QIV;1.496
31 Navarra;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
31 Navarra;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2022QII;""
31 Navarra;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2022QI;""
31 Navarra;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2021QIV;1.424
31 Navarra;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
31 Navarra;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2021QII;""
31 Navarra;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2021QI;""
31 Navarra;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2020QIV;1.310
31 Navarra;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
31 Navarra;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2020QII;""
31 Navarra;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2020QI;""
31 Navarra;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
31 Navarra;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
31 Navarra;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QII;""
31 Navarra;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QI;1.324
31 Navarra;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
31 Navarra;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
31 Navarra;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QII;""
31 Navarra;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QI;1.241
31 Navarra;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
31 Navarra;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
31 Navarra;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QII;""
31 Navarra;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QI;""
31 Navarra;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
31 Navarra;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
31 Navarra;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QII;1.234
31 Navarra;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QI;""
31 Navarra;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
31 Navarra;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
31 Navarra;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QII;1.153
31 Navarra;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QI;""
31 Navarra;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
31 Navarra;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
31 Navarra;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QII;""
31 Navarra;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QI;""
31 Navarra;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
31 Navarra;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
31 Navarra;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
31 Navarra;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
31 Navarra;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
31 Navarra;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
31 Navarra;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
31 Navarra;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
31 Navarra;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
31 Navarra;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
31 Navarra;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
31 Navarra;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
31 Navarra;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
31 Navarra;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;91,5
31 Navarra;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
31 Navarra;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
31 Navarra;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
31 Navarra;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;88,54
31 Navarra;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
31 Navarra;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
31 Navarra;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
31 Navarra;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;89,59
31 Navarra;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
31 Navarra;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
31 Navarra;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;84,81
31 Navarra;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
31 Navarra;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
31 Navarra;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
31 Navarra;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;80,82
31 Navarra;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
31 Navarra;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
31 Navarra;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
31 Navarra;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;83,17
31 Navarra;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
31 Navarra;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
31 Navarra;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
31 Navarra;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
31 Navarra;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
31 Navarra;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
31 Navarra;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;75,14
31 Navarra;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
31 Navarra;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
31 Navarra;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
31 Navarra;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;78,79
31 Navarra;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
31 Navarra;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
31 Navarra;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
31 Navarra;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
31 Navarra;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
31 Navarra;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
31 Navarra;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;70,03
31 Navarra;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
31 Navarra;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
31 Navarra;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
31 Navarra;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;73,21
31 Navarra;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
31 Navarra;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
31 Navarra;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
31 Navarra;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
31 Navarra;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
31 Navarra;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
31 Navarra;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QIII;961
31 Navarra;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
31 Navarra;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
31 Navarra;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
31 Navarra;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QIII;919
31 Navarra;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
31 Navarra;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
31 Navarra;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
31 Navarra;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QIII;808
31 Navarra;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
31 Navarra;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
31 Navarra;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
31 Navarra;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2022QIII;866
31 Navarra;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2022QII;""
31 Navarra;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2022QI;""
31 Navarra;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
31 Navarra;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2021QIII;821
31 Navarra;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2021QII;""
31 Navarra;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2021QI;""
31 Navarra;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
31 Navarra;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2020QIII;752
31 Navarra;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2020QII;""
31 Navarra;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2020QI;""
31 Navarra;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2022QIV;790
31 Navarra;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
31 Navarra;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2022QII;""
31 Navarra;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2022QI;""
31 Navarra;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2021QIV;764
31 Navarra;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
31 Navarra;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2021QII;""
31 Navarra;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2021QI;""
31 Navarra;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2020QIV;709
31 Navarra;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
31 Navarra;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2020QII;""
31 Navarra;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2020QI;""
31 Navarra;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
31 Navarra;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
31 Navarra;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QII;""
31 Navarra;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QI;714
31 Navarra;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
31 Navarra;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
31 Navarra;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QII;""
31 Navarra;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QI;678
31 Navarra;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
31 Navarra;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
31 Navarra;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QII;""
31 Navarra;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QI;""
31 Navarra;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
31 Navarra;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
31 Navarra;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QII;663
31 Navarra;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QI;""
31 Navarra;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
31 Navarra;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
31 Navarra;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QII;633
31 Navarra;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QI;""
31 Navarra;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
31 Navarra;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
31 Navarra;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QII;""
31 Navarra;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QI;""
31 Navarra;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
31 Navarra;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
31 Navarra;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
31 Navarra;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
31 Navarra;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
31 Navarra;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
31 Navarra;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
31 Navarra;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
31 Navarra;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
31 Navarra;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
31 Navarra;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
31 Navarra;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
31 Navarra;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
31 Navarra;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;90,11
31 Navarra;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
31 Navarra;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
31 Navarra;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
31 Navarra;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;89,34
31 Navarra;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
31 Navarra;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
31 Navarra;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
31 Navarra;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;93,07
31 Navarra;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
31 Navarra;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
31 Navarra;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;82,21
31 Navarra;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
31 Navarra;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
31 Navarra;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
31 Navarra;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;83,13
31 Navarra;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
31 Navarra;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
31 Navarra;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
31 Navarra;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;87,75
31 Navarra;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
31 Navarra;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
31 Navarra;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
31 Navarra;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
31 Navarra;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
31 Navarra;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
31 Navarra;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;77,69
31 Navarra;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
31 Navarra;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
31 Navarra;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
31 Navarra;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;83,91
31 Navarra;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
31 Navarra;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
31 Navarra;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
31 Navarra;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
31 Navarra;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
31 Navarra;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
31 Navarra;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;72,14
31 Navarra;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
31 Navarra;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
31 Navarra;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
31 Navarra;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;78,34
31 Navarra;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
31 Navarra;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
31 Navarra;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
31 Navarra;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
31 Navarra;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
31 Navarra;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QIV;2.866
31 Navarra;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
31 Navarra;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
31 Navarra;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
31 Navarra;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QIV;2.728
31 Navarra;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
31 Navarra;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
31 Navarra;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
31 Navarra;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QIV;2.502
31 Navarra;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
31 Navarra;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
31 Navarra;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
31 Navarra;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2022QIV;2.610
31 Navarra;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
31 Navarra;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2022QII;""
31 Navarra;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2022QI;""
31 Navarra;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2021QIV;2.493
31 Navarra;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
31 Navarra;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2021QII;""
31 Navarra;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2021QI;""
31 Navarra;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2020QIV;2.312
31 Navarra;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
31 Navarra;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2020QII;""
31 Navarra;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2020QI;""
31 Navarra;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
31 Navarra;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
31 Navarra;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2022QII;""
31 Navarra;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2022QI;2.305
31 Navarra;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
31 Navarra;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
31 Navarra;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2021QII;""
31 Navarra;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2021QI;2.193
31 Navarra;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
31 Navarra;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
31 Navarra;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2020QII;""
31 Navarra;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2020QI;""
31 Navarra;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
31 Navarra;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
31 Navarra;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QII;2.125
31 Navarra;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QI;""
31 Navarra;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
31 Navarra;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
31 Navarra;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QII;2.037
31 Navarra;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QI;""
31 Navarra;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
31 Navarra;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
31 Navarra;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QII;""
31 Navarra;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QI;""
31 Navarra;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
31 Navarra;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QIII;2.011
31 Navarra;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QII;""
31 Navarra;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QI;""
31 Navarra;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
31 Navarra;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QIII;1.885
31 Navarra;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QII;""
31 Navarra;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QI;""
31 Navarra;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
31 Navarra;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
31 Navarra;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QII;""
31 Navarra;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QI;""
31 Navarra;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
31 Navarra;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
31 Navarra;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
31 Navarra;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
31 Navarra;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
31 Navarra;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
31 Navarra;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
31 Navarra;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
31 Navarra;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
31 Navarra;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
31 Navarra;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
31 Navarra;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
31 Navarra;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;91,07
31 Navarra;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
31 Navarra;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
31 Navarra;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
31 Navarra;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;91,39
31 Navarra;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
31 Navarra;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
31 Navarra;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
31 Navarra;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;92,41
31 Navarra;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
31 Navarra;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
31 Navarra;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
31 Navarra;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
31 Navarra;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
31 Navarra;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
31 Navarra;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;84,49
31 Navarra;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
31 Navarra;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
31 Navarra;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
31 Navarra;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;87,65
31 Navarra;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
31 Navarra;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
31 Navarra;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
31 Navarra;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
31 Navarra;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
31 Navarra;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
31 Navarra;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;77,9
31 Navarra;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
31 Navarra;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
31 Navarra;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
31 Navarra;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;81,41
31 Navarra;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
31 Navarra;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
31 Navarra;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
31 Navarra;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
31 Navarra;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
31 Navarra;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
31 Navarra;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;73,72
31 Navarra;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
31 Navarra;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
31 Navarra;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
31 Navarra;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;75,34
31 Navarra;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
31 Navarra;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
31 Navarra;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
31 Navarra;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
31 Navarra;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
31 Navarra;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
31 Navarra;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QIV;1.854
31 Navarra;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
31 Navarra;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
31 Navarra;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
31 Navarra;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QIV;1.782
31 Navarra;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
31 Navarra;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
31 Navarra;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
31 Navarra;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QIV;1.641
31 Navarra;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
31 Navarra;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
31 Navarra;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
31 Navarra;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2022QIV;1.697
31 Navarra;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
31 Navarra;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2022QII;""
31 Navarra;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2022QI;""
31 Navarra;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2021QIV;1.612
31 Navarra;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
31 Navarra;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2021QII;""
31 Navarra;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2021QI;""
31 Navarra;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2020QIV;1.508
31 Navarra;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
31 Navarra;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2020QII;""
31 Navarra;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2020QI;""
31 Navarra;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
31 Navarra;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
31 Navarra;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2022QII;""
31 Navarra;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2022QI;1.487
31 Navarra;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
31 Navarra;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
31 Navarra;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2021QII;""
31 Navarra;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2021QI;1.425
31 Navarra;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
31 Navarra;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
31 Navarra;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2020QII;""
31 Navarra;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2020QI;""
31 Navarra;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
31 Navarra;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
31 Navarra;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QII;1.374
31 Navarra;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QI;""
31 Navarra;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
31 Navarra;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
31 Navarra;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QII;1.322
31 Navarra;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QI;""
31 Navarra;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
31 Navarra;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
31 Navarra;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QII;""
31 Navarra;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QI;""
31 Navarra;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
31 Navarra;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QIII;1.310
31 Navarra;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QII;""
31 Navarra;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QI;""
31 Navarra;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
31 Navarra;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QIII;1.230
31 Navarra;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QII;""
31 Navarra;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QI;""
31 Navarra;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
31 Navarra;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
31 Navarra;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QII;""
31 Navarra;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QI;""
31 Navarra;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
31 Navarra;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
31 Navarra;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
31 Navarra;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
31 Navarra;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
31 Navarra;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
31 Navarra;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
31 Navarra;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
31 Navarra;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
31 Navarra;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
31 Navarra;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
31 Navarra;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
31 Navarra;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;91,53
31 Navarra;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
31 Navarra;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
31 Navarra;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
31 Navarra;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;90,46
31 Navarra;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
31 Navarra;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
31 Navarra;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
31 Navarra;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;91,9
31 Navarra;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
31 Navarra;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
31 Navarra;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
31 Navarra;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
31 Navarra;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
31 Navarra;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
31 Navarra;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;83,45
31 Navarra;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
31 Navarra;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
31 Navarra;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
31 Navarra;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;86,84
31 Navarra;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
31 Navarra;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
31 Navarra;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
31 Navarra;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
31 Navarra;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
31 Navarra;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
31 Navarra;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;77,1
31 Navarra;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
31 Navarra;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
31 Navarra;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
31 Navarra;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;80,56
31 Navarra;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
31 Navarra;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
31 Navarra;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
31 Navarra;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
31 Navarra;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
31 Navarra;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
31 Navarra;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;73,51
31 Navarra;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
31 Navarra;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
31 Navarra;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
31 Navarra;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;74,95
31 Navarra;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
31 Navarra;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
31 Navarra;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
31 Navarra;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
31 Navarra;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
31 Navarra;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
31 Navarra;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QIV;1.012
31 Navarra;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
31 Navarra;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
31 Navarra;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
31 Navarra;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QIV;946
31 Navarra;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
31 Navarra;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
31 Navarra;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
31 Navarra;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QIV;861
31 Navarra;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
31 Navarra;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
31 Navarra;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
31 Navarra;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2022QIV;913
31 Navarra;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
31 Navarra;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2022QII;""
31 Navarra;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2022QI;""
31 Navarra;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2021QIV;881
31 Navarra;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
31 Navarra;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2021QII;""
31 Navarra;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2021QI;""
31 Navarra;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2020QIV;804
31 Navarra;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
31 Navarra;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2020QII;""
31 Navarra;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2020QI;""
31 Navarra;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
31 Navarra;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
31 Navarra;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2022QII;""
31 Navarra;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2022QI;818
31 Navarra;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
31 Navarra;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
31 Navarra;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2021QII;""
31 Navarra;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2021QI;768
31 Navarra;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
31 Navarra;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
31 Navarra;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2020QII;""
31 Navarra;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2020QI;""
31 Navarra;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
31 Navarra;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
31 Navarra;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QII;751
31 Navarra;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QI;""
31 Navarra;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
31 Navarra;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
31 Navarra;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QII;715
31 Navarra;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QI;""
31 Navarra;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
31 Navarra;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
31 Navarra;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QII;""
31 Navarra;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QI;""
31 Navarra;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
31 Navarra;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QIII;701
31 Navarra;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QII;""
31 Navarra;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QI;""
31 Navarra;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
31 Navarra;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QIII;655
31 Navarra;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QII;""
31 Navarra;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QI;""
31 Navarra;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
31 Navarra;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
31 Navarra;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QII;""
31 Navarra;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QI;""
31 Navarra;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
31 Navarra;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
31 Navarra;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
31 Navarra;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
31 Navarra;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
31 Navarra;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
31 Navarra;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
31 Navarra;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
31 Navarra;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
31 Navarra;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
31 Navarra;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
31 Navarra;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
31 Navarra;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;90,22
31 Navarra;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
31 Navarra;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
31 Navarra;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
31 Navarra;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;93,13
31 Navarra;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
31 Navarra;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
31 Navarra;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
31 Navarra;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;93,38
31 Navarra;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
31 Navarra;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
31 Navarra;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
31 Navarra;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
31 Navarra;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
31 Navarra;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
31 Navarra;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;86,47
31 Navarra;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
31 Navarra;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
31 Navarra;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
31 Navarra;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;89,2
31 Navarra;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
31 Navarra;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
31 Navarra;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
31 Navarra;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
31 Navarra;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
31 Navarra;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
31 Navarra;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;79,39
31 Navarra;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
31 Navarra;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
31 Navarra;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
31 Navarra;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;83,04
31 Navarra;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
31 Navarra;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
31 Navarra;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
31 Navarra;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
31 Navarra;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
31 Navarra;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
31 Navarra;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;74,1
31 Navarra;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
31 Navarra;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
31 Navarra;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
31 Navarra;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;76,07
31 Navarra;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
31 Navarra;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
31 Navarra;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
31 Navarra;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
31 Navarra;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
31 Navarra;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
31 Navarra;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
31 Navarra;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
31 Navarra;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
31 Navarra;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QI;7.135
31 Navarra;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
31 Navarra;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
31 Navarra;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
31 Navarra;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QI;7.247
31 Navarra;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
31 Navarra;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
31 Navarra;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
31 Navarra;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QI;6.917
31 Navarra;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
31 Navarra;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
31 Navarra;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2022QII;""
31 Navarra;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2022QI;6.847
31 Navarra;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
31 Navarra;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
31 Navarra;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2021QII;""
31 Navarra;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2021QI;7.015
31 Navarra;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
31 Navarra;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
31 Navarra;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2020QII;""
31 Navarra;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2020QI;6.521
31 Navarra;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
31 Navarra;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
31 Navarra;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2022QII;6.557
31 Navarra;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2022QI;""
31 Navarra;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
31 Navarra;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
31 Navarra;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2021QII;6.740
31 Navarra;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2021QI;""
31 Navarra;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
31 Navarra;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
31 Navarra;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2020QII;6.353
31 Navarra;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2020QI;""
31 Navarra;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
31 Navarra;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QIII;6.359
31 Navarra;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QII;""
31 Navarra;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QI;""
31 Navarra;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
31 Navarra;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QIII;6.534
31 Navarra;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QII;""
31 Navarra;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QI;""
31 Navarra;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
31 Navarra;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QIII;6.177
31 Navarra;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QII;""
31 Navarra;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QI;""
31 Navarra;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QIV;6.121
31 Navarra;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
31 Navarra;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QII;""
31 Navarra;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QI;""
31 Navarra;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QIV;6.340
31 Navarra;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
31 Navarra;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QII;""
31 Navarra;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QI;""
31 Navarra;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QIV;6.015
31 Navarra;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
31 Navarra;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QII;""
31 Navarra;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QI;""
31 Navarra;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
31 Navarra;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
31 Navarra;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
31 Navarra;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
31 Navarra;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
31 Navarra;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
31 Navarra;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
31 Navarra;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
31 Navarra;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
31 Navarra;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
31 Navarra;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
31 Navarra;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
31 Navarra;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
31 Navarra;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
31 Navarra;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
31 Navarra;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;95,96
31 Navarra;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
31 Navarra;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
31 Navarra;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
31 Navarra;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;96,8
31 Navarra;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
31 Navarra;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
31 Navarra;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
31 Navarra;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;94,27
31 Navarra;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
31 Navarra;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
31 Navarra;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;91,9
31 Navarra;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
31 Navarra;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
31 Navarra;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
31 Navarra;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;93
31 Navarra;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
31 Navarra;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
31 Navarra;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
31 Navarra;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;91,85
31 Navarra;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
31 Navarra;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
31 Navarra;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;89,12
31 Navarra;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
31 Navarra;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
31 Navarra;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
31 Navarra;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;90,16
31 Navarra;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
31 Navarra;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
31 Navarra;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
31 Navarra;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;89,3
31 Navarra;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
31 Navarra;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
31 Navarra;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;85,79
31 Navarra;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
31 Navarra;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
31 Navarra;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
31 Navarra;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;87,48
31 Navarra;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
31 Navarra;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
31 Navarra;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
31 Navarra;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;86,96
31 Navarra;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
31 Navarra;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
31 Navarra;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
31 Navarra;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
31 Navarra;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
31 Navarra;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
31 Navarra;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QI;4.310
31 Navarra;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
31 Navarra;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
31 Navarra;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
31 Navarra;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QI;4.414
31 Navarra;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
31 Navarra;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
31 Navarra;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
31 Navarra;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QI;4.214
31 Navarra;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
31 Navarra;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
31 Navarra;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2022QII;""
31 Navarra;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2022QI;4.134
31 Navarra;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
31 Navarra;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
31 Navarra;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2021QII;""
31 Navarra;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2021QI;4.264
31 Navarra;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
31 Navarra;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
31 Navarra;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2020QII;""
31 Navarra;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2020QI;3.968
31 Navarra;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
31 Navarra;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
31 Navarra;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2022QII;3.976
31 Navarra;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2022QI;""
31 Navarra;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
31 Navarra;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
31 Navarra;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2021QII;4.104
31 Navarra;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2021QI;""
31 Navarra;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
31 Navarra;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
31 Navarra;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2020QII;3.869
31 Navarra;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2020QI;""
31 Navarra;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
31 Navarra;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QIII;3.854
31 Navarra;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QII;""
31 Navarra;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QI;""
31 Navarra;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
31 Navarra;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QIII;3.970
31 Navarra;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QII;""
31 Navarra;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QI;""
31 Navarra;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
31 Navarra;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QIII;3.759
31 Navarra;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QII;""
31 Navarra;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QI;""
31 Navarra;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QIV;3.712
31 Navarra;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
31 Navarra;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QII;""
31 Navarra;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QI;""
31 Navarra;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QIV;3.842
31 Navarra;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
31 Navarra;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QII;""
31 Navarra;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QI;""
31 Navarra;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QIV;3.661
31 Navarra;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
31 Navarra;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QII;""
31 Navarra;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QI;""
31 Navarra;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
31 Navarra;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
31 Navarra;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
31 Navarra;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
31 Navarra;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
31 Navarra;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
31 Navarra;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
31 Navarra;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
31 Navarra;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
31 Navarra;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
31 Navarra;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
31 Navarra;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
31 Navarra;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
31 Navarra;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
31 Navarra;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
31 Navarra;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;95,92
31 Navarra;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
31 Navarra;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
31 Navarra;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
31 Navarra;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;96,6
31 Navarra;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
31 Navarra;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
31 Navarra;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
31 Navarra;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;94,16
31 Navarra;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
31 Navarra;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
31 Navarra;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;92,25
31 Navarra;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
31 Navarra;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
31 Navarra;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
31 Navarra;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;92,98
31 Navarra;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
31 Navarra;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
31 Navarra;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
31 Navarra;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;91,81
31 Navarra;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
31 Navarra;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
31 Navarra;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;89,42
31 Navarra;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
31 Navarra;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
31 Navarra;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
31 Navarra;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;89,94
31 Navarra;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
31 Navarra;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
31 Navarra;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
31 Navarra;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;89,2
31 Navarra;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
31 Navarra;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
31 Navarra;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;86,13
31 Navarra;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
31 Navarra;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
31 Navarra;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
31 Navarra;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;87,04
31 Navarra;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
31 Navarra;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
31 Navarra;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
31 Navarra;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;86,88
31 Navarra;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
31 Navarra;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
31 Navarra;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
31 Navarra;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
31 Navarra;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
31 Navarra;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
31 Navarra;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QI;2.825
31 Navarra;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
31 Navarra;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
31 Navarra;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
31 Navarra;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QI;2.833
31 Navarra;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
31 Navarra;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
31 Navarra;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
31 Navarra;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QI;2.703
31 Navarra;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
31 Navarra;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
31 Navarra;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2022QII;""
31 Navarra;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2022QI;2.713
31 Navarra;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
31 Navarra;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
31 Navarra;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2021QII;""
31 Navarra;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2021QI;2.751
31 Navarra;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
31 Navarra;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
31 Navarra;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2020QII;""
31 Navarra;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2020QI;2.553
31 Navarra;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
31 Navarra;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
31 Navarra;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2022QII;2.581
31 Navarra;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2022QI;""
31 Navarra;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
31 Navarra;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
31 Navarra;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2021QII;2.636
31 Navarra;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2021QI;""
31 Navarra;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
31 Navarra;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
31 Navarra;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2020QII;2.484
31 Navarra;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2020QI;""
31 Navarra;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
31 Navarra;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QIII;2.505
31 Navarra;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QII;""
31 Navarra;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QI;""
31 Navarra;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
31 Navarra;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QIII;2.564
31 Navarra;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QII;""
31 Navarra;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QI;""
31 Navarra;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
31 Navarra;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QIII;2.418
31 Navarra;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QII;""
31 Navarra;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QI;""
31 Navarra;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QIV;2.409
31 Navarra;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
31 Navarra;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QII;""
31 Navarra;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QI;""
31 Navarra;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QIV;2.498
31 Navarra;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
31 Navarra;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QII;""
31 Navarra;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QI;""
31 Navarra;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QIV;2.354
31 Navarra;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
31 Navarra;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QII;""
31 Navarra;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QI;""
31 Navarra;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
31 Navarra;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
31 Navarra;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
31 Navarra;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
31 Navarra;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
31 Navarra;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
31 Navarra;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
31 Navarra;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
31 Navarra;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
31 Navarra;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
31 Navarra;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
31 Navarra;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
31 Navarra;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
31 Navarra;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
31 Navarra;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
31 Navarra;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;96,04
31 Navarra;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
31 Navarra;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
31 Navarra;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
31 Navarra;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;97,11
31 Navarra;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
31 Navarra;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
31 Navarra;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
31 Navarra;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;94,45
31 Navarra;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
31 Navarra;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
31 Navarra;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;91,36
31 Navarra;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
31 Navarra;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
31 Navarra;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
31 Navarra;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;93,05
31 Navarra;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
31 Navarra;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
31 Navarra;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
31 Navarra;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;91,9
31 Navarra;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
31 Navarra;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
31 Navarra;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;88,67
31 Navarra;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
31 Navarra;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
31 Navarra;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
31 Navarra;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;90,5
31 Navarra;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
31 Navarra;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
31 Navarra;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
31 Navarra;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;89,46
31 Navarra;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
31 Navarra;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
31 Navarra;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;85,27
31 Navarra;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
31 Navarra;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
31 Navarra;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
31 Navarra;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;88,18
31 Navarra;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
31 Navarra;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
31 Navarra;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
31 Navarra;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;87,09
31 Navarra;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
31 Navarra;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
31 Navarra;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
31 Navarra;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
31 Navarra;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
31 Navarra;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QII;6.669
31 Navarra;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
31 Navarra;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
31 Navarra;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
31 Navarra;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QII;6.864
31 Navarra;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
31 Navarra;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
31 Navarra;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
31 Navarra;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QII;6.920
31 Navarra;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
31 Navarra;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
31 Navarra;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
31 Navarra;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2022QII;6.335
31 Navarra;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2022QI;""
31 Navarra;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
31 Navarra;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
31 Navarra;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2021QII;6.551
31 Navarra;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2021QI;""
31 Navarra;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
31 Navarra;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
31 Navarra;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2020QII;6.732
31 Navarra;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2020QI;""
31 Navarra;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
31 Navarra;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2022QIII;6.116
31 Navarra;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2022QII;""
31 Navarra;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2022QI;""
31 Navarra;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
31 Navarra;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2021QIII;6.322
31 Navarra;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2021QII;""
31 Navarra;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2021QI;""
31 Navarra;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
31 Navarra;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2020QIII;6.528
31 Navarra;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2020QII;""
31 Navarra;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2020QI;""
31 Navarra;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QIV;5.857
31 Navarra;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
31 Navarra;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QII;""
31 Navarra;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QI;""
31 Navarra;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QIV;6.119
31 Navarra;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
31 Navarra;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QII;""
31 Navarra;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QI;""
31 Navarra;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QIV;6.347
31 Navarra;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
31 Navarra;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QII;""
31 Navarra;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QI;""
31 Navarra;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
31 Navarra;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
31 Navarra;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QII;""
31 Navarra;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QI;5.919
31 Navarra;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
31 Navarra;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
31 Navarra;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QII;""
31 Navarra;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QI;6.175
31 Navarra;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
31 Navarra;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
31 Navarra;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QII;""
31 Navarra;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QI;""
31 Navarra;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
31 Navarra;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
31 Navarra;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
31 Navarra;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
31 Navarra;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
31 Navarra;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
31 Navarra;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
31 Navarra;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
31 Navarra;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
31 Navarra;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
31 Navarra;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
31 Navarra;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
31 Navarra;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
31 Navarra;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
31 Navarra;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;94,99
31 Navarra;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
31 Navarra;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
31 Navarra;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
31 Navarra;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;95,44
31 Navarra;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
31 Navarra;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
31 Navarra;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
31 Navarra;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;97,28
31 Navarra;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
31 Navarra;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
31 Navarra;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;91,71
31 Navarra;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
31 Navarra;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
31 Navarra;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
31 Navarra;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;92,1
31 Navarra;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
31 Navarra;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
31 Navarra;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
31 Navarra;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;94,34
31 Navarra;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
31 Navarra;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
31 Navarra;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;87,82
31 Navarra;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
31 Navarra;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
31 Navarra;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
31 Navarra;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;89,15
31 Navarra;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
31 Navarra;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
31 Navarra;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
31 Navarra;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;91,72
31 Navarra;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
31 Navarra;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
31 Navarra;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
31 Navarra;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
31 Navarra;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
31 Navarra;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
31 Navarra;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;86,23
31 Navarra;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
31 Navarra;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
31 Navarra;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
31 Navarra;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;89,23
31 Navarra;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
31 Navarra;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
31 Navarra;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
31 Navarra;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
31 Navarra;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
31 Navarra;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
31 Navarra;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QII;4.027
31 Navarra;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
31 Navarra;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
31 Navarra;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
31 Navarra;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QII;4.175
31 Navarra;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
31 Navarra;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
31 Navarra;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
31 Navarra;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QII;4.225
31 Navarra;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
31 Navarra;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
31 Navarra;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
31 Navarra;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2022QII;3.842
31 Navarra;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2022QI;""
31 Navarra;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
31 Navarra;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
31 Navarra;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2021QII;3.985
31 Navarra;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2021QI;""
31 Navarra;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
31 Navarra;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
31 Navarra;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2020QII;4.111
31 Navarra;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2020QI;""
31 Navarra;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
31 Navarra;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2022QIII;3.710
31 Navarra;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2022QII;""
31 Navarra;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2022QI;""
31 Navarra;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
31 Navarra;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2021QIII;3.840
31 Navarra;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2021QII;""
31 Navarra;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2021QI;""
31 Navarra;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
31 Navarra;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2020QIII;3.983
31 Navarra;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2020QII;""
31 Navarra;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2020QI;""
31 Navarra;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QIV;3.551
31 Navarra;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
31 Navarra;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QII;""
31 Navarra;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QI;""
31 Navarra;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QIV;3.707
31 Navarra;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
31 Navarra;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QII;""
31 Navarra;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QI;""
31 Navarra;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QIV;3.874
31 Navarra;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
31 Navarra;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QII;""
31 Navarra;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QI;""
31 Navarra;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
31 Navarra;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
31 Navarra;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QII;""
31 Navarra;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QI;3.591
31 Navarra;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
31 Navarra;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
31 Navarra;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QII;""
31 Navarra;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QI;3.763
31 Navarra;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
31 Navarra;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
31 Navarra;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QII;""
31 Navarra;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QI;""
31 Navarra;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
31 Navarra;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
31 Navarra;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
31 Navarra;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
31 Navarra;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
31 Navarra;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
31 Navarra;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
31 Navarra;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
31 Navarra;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
31 Navarra;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
31 Navarra;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
31 Navarra;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
31 Navarra;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
31 Navarra;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
31 Navarra;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;95,41
31 Navarra;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
31 Navarra;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
31 Navarra;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
31 Navarra;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;95,45
31 Navarra;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
31 Navarra;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
31 Navarra;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
31 Navarra;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;97,3
31 Navarra;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
31 Navarra;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
31 Navarra;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;92,13
31 Navarra;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
31 Navarra;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
31 Navarra;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
31 Navarra;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;91,98
31 Navarra;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
31 Navarra;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
31 Navarra;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
31 Navarra;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;94,27
31 Navarra;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
31 Navarra;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
31 Navarra;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;88,18
31 Navarra;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
31 Navarra;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
31 Navarra;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
31 Navarra;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;88,79
31 Navarra;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
31 Navarra;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
31 Navarra;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
31 Navarra;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;91,69
31 Navarra;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
31 Navarra;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
31 Navarra;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
31 Navarra;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
31 Navarra;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
31 Navarra;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
31 Navarra;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;86,01
31 Navarra;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
31 Navarra;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
31 Navarra;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
31 Navarra;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;89,07
31 Navarra;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
31 Navarra;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
31 Navarra;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
31 Navarra;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
31 Navarra;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
31 Navarra;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
31 Navarra;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QII;2.642
31 Navarra;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
31 Navarra;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
31 Navarra;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
31 Navarra;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QII;2.689
31 Navarra;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
31 Navarra;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
31 Navarra;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
31 Navarra;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QII;2.695
31 Navarra;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
31 Navarra;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
31 Navarra;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
31 Navarra;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2022QII;2.493
31 Navarra;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2022QI;""
31 Navarra;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
31 Navarra;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
31 Navarra;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2021QII;2.566
31 Navarra;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2021QI;""
31 Navarra;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
31 Navarra;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
31 Navarra;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2020QII;2.621
31 Navarra;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2020QI;""
31 Navarra;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
31 Navarra;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2022QIII;2.406
31 Navarra;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2022QII;""
31 Navarra;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2022QI;""
31 Navarra;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
31 Navarra;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2021QIII;2.482
31 Navarra;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2021QII;""
31 Navarra;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2021QI;""
31 Navarra;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
31 Navarra;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2020QIII;2.545
31 Navarra;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2020QII;""
31 Navarra;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2020QI;""
31 Navarra;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QIV;2.306
31 Navarra;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
31 Navarra;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QII;""
31 Navarra;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QI;""
31 Navarra;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QIV;2.412
31 Navarra;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
31 Navarra;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QII;""
31 Navarra;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QI;""
31 Navarra;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QIV;2.473
31 Navarra;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
31 Navarra;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QII;""
31 Navarra;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QI;""
31 Navarra;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
31 Navarra;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
31 Navarra;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QII;""
31 Navarra;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QI;2.328
31 Navarra;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
31 Navarra;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
31 Navarra;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QII;""
31 Navarra;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QI;2.412
31 Navarra;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
31 Navarra;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
31 Navarra;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QII;""
31 Navarra;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QI;""
31 Navarra;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
31 Navarra;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
31 Navarra;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
31 Navarra;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
31 Navarra;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
31 Navarra;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
31 Navarra;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
31 Navarra;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
31 Navarra;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
31 Navarra;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
31 Navarra;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
31 Navarra;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
31 Navarra;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
31 Navarra;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
31 Navarra;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;94,36
31 Navarra;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
31 Navarra;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
31 Navarra;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
31 Navarra;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;95,43
31 Navarra;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
31 Navarra;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
31 Navarra;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
31 Navarra;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;97,25
31 Navarra;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
31 Navarra;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
31 Navarra;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;91,07
31 Navarra;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
31 Navarra;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
31 Navarra;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
31 Navarra;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;92,3
31 Navarra;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
31 Navarra;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
31 Navarra;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
31 Navarra;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;94,43
31 Navarra;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
31 Navarra;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
31 Navarra;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;87,28
31 Navarra;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
31 Navarra;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
31 Navarra;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
31 Navarra;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;89,7
31 Navarra;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
31 Navarra;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
31 Navarra;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
31 Navarra;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;91,76
31 Navarra;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
31 Navarra;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
31 Navarra;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
31 Navarra;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
31 Navarra;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
31 Navarra;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
31 Navarra;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;86,57
31 Navarra;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
31 Navarra;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
31 Navarra;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
31 Navarra;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;89,5
31 Navarra;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
31 Navarra;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
31 Navarra;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
31 Navarra;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
31 Navarra;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
31 Navarra;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QIII;6.746
31 Navarra;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
31 Navarra;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
31 Navarra;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
31 Navarra;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QIII;6.950
31 Navarra;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
31 Navarra;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
31 Navarra;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
31 Navarra;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QIII;6.977
31 Navarra;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
31 Navarra;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
31 Navarra;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
31 Navarra;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2022QIII;6.471
31 Navarra;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2022QII;""
31 Navarra;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2022QI;""
31 Navarra;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
31 Navarra;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2021QIII;6.675
31 Navarra;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2021QII;""
31 Navarra;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2021QI;""
31 Navarra;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
31 Navarra;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2020QIII;6.739
31 Navarra;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2020QII;""
31 Navarra;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2020QI;""
31 Navarra;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2022QIV;6.183
31 Navarra;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
31 Navarra;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2022QII;""
31 Navarra;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2022QI;""
31 Navarra;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2021QIV;6.449
31 Navarra;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
31 Navarra;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2021QII;""
31 Navarra;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2021QI;""
31 Navarra;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2020QIV;6.542
31 Navarra;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
31 Navarra;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2020QII;""
31 Navarra;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2020QI;""
31 Navarra;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
31 Navarra;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
31 Navarra;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QII;""
31 Navarra;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QI;6.226
31 Navarra;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
31 Navarra;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
31 Navarra;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QII;""
31 Navarra;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QI;6.360
31 Navarra;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
31 Navarra;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
31 Navarra;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QII;""
31 Navarra;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QI;""
31 Navarra;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
31 Navarra;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
31 Navarra;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QII;5.996
31 Navarra;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QI;""
31 Navarra;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
31 Navarra;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
31 Navarra;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QII;6.154
31 Navarra;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QI;""
31 Navarra;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
31 Navarra;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
31 Navarra;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QII;""
31 Navarra;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QI;""
31 Navarra;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
31 Navarra;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
31 Navarra;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
31 Navarra;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
31 Navarra;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
31 Navarra;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
31 Navarra;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
31 Navarra;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
31 Navarra;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
31 Navarra;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
31 Navarra;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
31 Navarra;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
31 Navarra;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
31 Navarra;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;95,92
31 Navarra;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
31 Navarra;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
31 Navarra;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
31 Navarra;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;96,04
31 Navarra;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
31 Navarra;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
31 Navarra;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
31 Navarra;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;96,59
31 Navarra;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
31 Navarra;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
31 Navarra;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;91,65
31 Navarra;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
31 Navarra;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
31 Navarra;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
31 Navarra;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;92,79
31 Navarra;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
31 Navarra;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
31 Navarra;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
31 Navarra;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;93,77
31 Navarra;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
31 Navarra;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
31 Navarra;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
31 Navarra;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
31 Navarra;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
31 Navarra;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
31 Navarra;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;89,58
31 Navarra;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
31 Navarra;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
31 Navarra;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
31 Navarra;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;91,16
31 Navarra;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
31 Navarra;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
31 Navarra;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
31 Navarra;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
31 Navarra;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
31 Navarra;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
31 Navarra;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;86,27
31 Navarra;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
31 Navarra;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
31 Navarra;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
31 Navarra;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;88,2
31 Navarra;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
31 Navarra;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
31 Navarra;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
31 Navarra;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
31 Navarra;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
31 Navarra;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
31 Navarra;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QIII;4.088
31 Navarra;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
31 Navarra;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
31 Navarra;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
31 Navarra;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QIII;4.228
31 Navarra;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
31 Navarra;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
31 Navarra;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
31 Navarra;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QIII;4.288
31 Navarra;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
31 Navarra;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
31 Navarra;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
31 Navarra;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2022QIII;3.917
31 Navarra;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2022QII;""
31 Navarra;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2022QI;""
31 Navarra;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
31 Navarra;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2021QIII;4.054
31 Navarra;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2021QII;""
31 Navarra;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2021QI;""
31 Navarra;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
31 Navarra;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2020QIII;4.129
31 Navarra;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2020QII;""
31 Navarra;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2020QI;""
31 Navarra;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2022QIV;3.739
31 Navarra;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
31 Navarra;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2022QII;""
31 Navarra;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2022QI;""
31 Navarra;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2021QIV;3.907
31 Navarra;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
31 Navarra;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2021QII;""
31 Navarra;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2021QI;""
31 Navarra;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2020QIV;4.008
31 Navarra;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
31 Navarra;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2020QII;""
31 Navarra;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2020QI;""
31 Navarra;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
31 Navarra;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
31 Navarra;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QII;""
31 Navarra;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QI;3.774
31 Navarra;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
31 Navarra;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
31 Navarra;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QII;""
31 Navarra;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QI;3.891
31 Navarra;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
31 Navarra;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
31 Navarra;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QII;""
31 Navarra;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QI;""
31 Navarra;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
31 Navarra;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
31 Navarra;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QII;3.650
31 Navarra;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QI;""
31 Navarra;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
31 Navarra;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
31 Navarra;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QII;3.768
31 Navarra;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QI;""
31 Navarra;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
31 Navarra;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
31 Navarra;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QII;""
31 Navarra;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QI;""
31 Navarra;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
31 Navarra;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
31 Navarra;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
31 Navarra;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
31 Navarra;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
31 Navarra;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
31 Navarra;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
31 Navarra;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
31 Navarra;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
31 Navarra;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
31 Navarra;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
31 Navarra;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
31 Navarra;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
31 Navarra;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;95,82
31 Navarra;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
31 Navarra;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
31 Navarra;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
31 Navarra;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;95,88
31 Navarra;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
31 Navarra;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
31 Navarra;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
31 Navarra;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;96,29
31 Navarra;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
31 Navarra;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
31 Navarra;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;91,46
31 Navarra;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
31 Navarra;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
31 Navarra;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
31 Navarra;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;92,41
31 Navarra;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
31 Navarra;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
31 Navarra;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
31 Navarra;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;93,47
31 Navarra;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
31 Navarra;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
31 Navarra;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
31 Navarra;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
31 Navarra;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
31 Navarra;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
31 Navarra;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;89,26
31 Navarra;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
31 Navarra;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
31 Navarra;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
31 Navarra;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;90,74
31 Navarra;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
31 Navarra;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
31 Navarra;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
31 Navarra;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
31 Navarra;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
31 Navarra;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
31 Navarra;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;86,33
31 Navarra;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
31 Navarra;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
31 Navarra;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
31 Navarra;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;87,87
31 Navarra;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
31 Navarra;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
31 Navarra;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
31 Navarra;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
31 Navarra;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
31 Navarra;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
31 Navarra;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QIII;2.658
31 Navarra;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
31 Navarra;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
31 Navarra;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
31 Navarra;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QIII;2.722
31 Navarra;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
31 Navarra;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
31 Navarra;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
31 Navarra;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QIII;2.689
31 Navarra;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
31 Navarra;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
31 Navarra;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
31 Navarra;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2022QIII;2.554
31 Navarra;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2022QII;""
31 Navarra;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2022QI;""
31 Navarra;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
31 Navarra;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2021QIII;2.621
31 Navarra;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2021QII;""
31 Navarra;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2021QI;""
31 Navarra;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
31 Navarra;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2020QIII;2.610
31 Navarra;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2020QII;""
31 Navarra;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2020QI;""
31 Navarra;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2022QIV;2.444
31 Navarra;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
31 Navarra;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2022QII;""
31 Navarra;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2022QI;""
31 Navarra;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2021QIV;2.542
31 Navarra;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
31 Navarra;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2021QII;""
31 Navarra;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2021QI;""
31 Navarra;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2020QIV;2.534
31 Navarra;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
31 Navarra;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2020QII;""
31 Navarra;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2020QI;""
31 Navarra;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
31 Navarra;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
31 Navarra;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QII;""
31 Navarra;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QI;2.452
31 Navarra;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
31 Navarra;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
31 Navarra;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QII;""
31 Navarra;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QI;2.469
31 Navarra;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
31 Navarra;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
31 Navarra;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QII;""
31 Navarra;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QI;""
31 Navarra;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
31 Navarra;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
31 Navarra;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QII;2.346
31 Navarra;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QI;""
31 Navarra;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
31 Navarra;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
31 Navarra;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QII;2.386
31 Navarra;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QI;""
31 Navarra;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
31 Navarra;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
31 Navarra;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QII;""
31 Navarra;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QI;""
31 Navarra;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
31 Navarra;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
31 Navarra;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
31 Navarra;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
31 Navarra;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
31 Navarra;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
31 Navarra;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
31 Navarra;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
31 Navarra;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
31 Navarra;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
31 Navarra;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
31 Navarra;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
31 Navarra;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
31 Navarra;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;96,09
31 Navarra;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
31 Navarra;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
31 Navarra;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
31 Navarra;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;96,29
31 Navarra;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
31 Navarra;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
31 Navarra;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
31 Navarra;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;97,06
31 Navarra;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
31 Navarra;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
31 Navarra;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;91,95
31 Navarra;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
31 Navarra;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
31 Navarra;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
31 Navarra;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;93,39
31 Navarra;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
31 Navarra;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
31 Navarra;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
31 Navarra;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;94,24
31 Navarra;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
31 Navarra;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
31 Navarra;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
31 Navarra;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
31 Navarra;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
31 Navarra;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
31 Navarra;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;90,08
31 Navarra;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
31 Navarra;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
31 Navarra;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
31 Navarra;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;91,82
31 Navarra;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
31 Navarra;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
31 Navarra;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
31 Navarra;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
31 Navarra;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
31 Navarra;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
31 Navarra;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;86,19
31 Navarra;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
31 Navarra;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
31 Navarra;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
31 Navarra;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;88,73
31 Navarra;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
31 Navarra;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
31 Navarra;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
31 Navarra;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
31 Navarra;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
31 Navarra;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QIV;6.824
31 Navarra;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
31 Navarra;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
31 Navarra;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
31 Navarra;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QIV;7.014
31 Navarra;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
31 Navarra;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
31 Navarra;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
31 Navarra;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QIV;7.118
31 Navarra;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
31 Navarra;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
31 Navarra;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
31 Navarra;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2022QIV;6.498
31 Navarra;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
31 Navarra;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2022QII;""
31 Navarra;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2022QI;""
31 Navarra;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2021QIV;6.749
31 Navarra;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
31 Navarra;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2021QII;""
31 Navarra;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2021QI;""
31 Navarra;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2020QIV;6.880
31 Navarra;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
31 Navarra;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2020QII;""
31 Navarra;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2020QI;""
31 Navarra;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
31 Navarra;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
31 Navarra;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2022QII;""
31 Navarra;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2022QI;6.502
31 Navarra;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
31 Navarra;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
31 Navarra;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2021QII;""
31 Navarra;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2021QI;6.673
31 Navarra;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
31 Navarra;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
31 Navarra;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2020QII;""
31 Navarra;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2020QI;""
31 Navarra;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
31 Navarra;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
31 Navarra;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QII;6.246
31 Navarra;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QI;""
31 Navarra;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
31 Navarra;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
31 Navarra;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QII;6.449
31 Navarra;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QI;""
31 Navarra;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
31 Navarra;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
31 Navarra;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QII;""
31 Navarra;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QI;""
31 Navarra;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
31 Navarra;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QIII;6.064
31 Navarra;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QII;""
31 Navarra;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QI;""
31 Navarra;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
31 Navarra;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QIII;6.260
31 Navarra;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QII;""
31 Navarra;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QI;""
31 Navarra;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
31 Navarra;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
31 Navarra;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QII;""
31 Navarra;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QI;""
31 Navarra;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
31 Navarra;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
31 Navarra;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
31 Navarra;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
31 Navarra;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
31 Navarra;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
31 Navarra;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
31 Navarra;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
31 Navarra;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
31 Navarra;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
31 Navarra;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
31 Navarra;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
31 Navarra;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;95,22
31 Navarra;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
31 Navarra;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
31 Navarra;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
31 Navarra;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;96,22
31 Navarra;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
31 Navarra;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
31 Navarra;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
31 Navarra;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;96,66
31 Navarra;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
31 Navarra;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
31 Navarra;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
31 Navarra;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
31 Navarra;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
31 Navarra;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
31 Navarra;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;92,7
31 Navarra;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
31 Navarra;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
31 Navarra;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
31 Navarra;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;93,75
31 Navarra;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
31 Navarra;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
31 Navarra;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
31 Navarra;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
31 Navarra;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
31 Navarra;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
31 Navarra;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;89,05
31 Navarra;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
31 Navarra;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
31 Navarra;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
31 Navarra;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;90,6
31 Navarra;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
31 Navarra;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
31 Navarra;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
31 Navarra;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
31 Navarra;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
31 Navarra;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
31 Navarra;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;86,46
31 Navarra;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
31 Navarra;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
31 Navarra;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
31 Navarra;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;87,95
31 Navarra;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
31 Navarra;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
31 Navarra;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
31 Navarra;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
31 Navarra;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
31 Navarra;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
31 Navarra;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QIV;4.135
31 Navarra;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
31 Navarra;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
31 Navarra;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
31 Navarra;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QIV;4.251
31 Navarra;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
31 Navarra;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
31 Navarra;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
31 Navarra;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QIV;4.343
31 Navarra;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
31 Navarra;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
31 Navarra;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
31 Navarra;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2022QIV;3.928
31 Navarra;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
31 Navarra;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2022QII;""
31 Navarra;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2022QI;""
31 Navarra;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2021QIV;4.079
31 Navarra;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
31 Navarra;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2021QII;""
31 Navarra;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2021QI;""
31 Navarra;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2020QIV;4.196
31 Navarra;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
31 Navarra;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2020QII;""
31 Navarra;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2020QI;""
31 Navarra;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
31 Navarra;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
31 Navarra;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2022QII;""
31 Navarra;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2022QI;3.930
31 Navarra;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
31 Navarra;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
31 Navarra;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2021QII;""
31 Navarra;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2021QI;4.064
31 Navarra;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
31 Navarra;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
31 Navarra;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2020QII;""
31 Navarra;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2020QI;""
31 Navarra;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
31 Navarra;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
31 Navarra;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QII;3.794
31 Navarra;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QI;""
31 Navarra;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
31 Navarra;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
31 Navarra;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QII;3.929
31 Navarra;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QI;""
31 Navarra;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
31 Navarra;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
31 Navarra;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QII;""
31 Navarra;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QI;""
31 Navarra;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
31 Navarra;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QIII;3.684
31 Navarra;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QII;""
31 Navarra;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QI;""
31 Navarra;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
31 Navarra;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QIII;3.803
31 Navarra;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QII;""
31 Navarra;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QI;""
31 Navarra;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
31 Navarra;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
31 Navarra;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QII;""
31 Navarra;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QI;""
31 Navarra;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
31 Navarra;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
31 Navarra;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
31 Navarra;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
31 Navarra;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
31 Navarra;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
31 Navarra;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
31 Navarra;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
31 Navarra;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
31 Navarra;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
31 Navarra;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
31 Navarra;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
31 Navarra;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;94,99
31 Navarra;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
31 Navarra;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
31 Navarra;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
31 Navarra;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;95,95
31 Navarra;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
31 Navarra;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
31 Navarra;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
31 Navarra;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;96,62
31 Navarra;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
31 Navarra;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
31 Navarra;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
31 Navarra;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
31 Navarra;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
31 Navarra;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
31 Navarra;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;92,45
31 Navarra;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
31 Navarra;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
31 Navarra;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
31 Navarra;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;93,58
31 Navarra;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
31 Navarra;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
31 Navarra;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
31 Navarra;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
31 Navarra;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
31 Navarra;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
31 Navarra;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;89,25
31 Navarra;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
31 Navarra;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
31 Navarra;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
31 Navarra;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;90,47
31 Navarra;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
31 Navarra;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
31 Navarra;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
31 Navarra;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
31 Navarra;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
31 Navarra;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
31 Navarra;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;86,66
31 Navarra;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
31 Navarra;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
31 Navarra;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
31 Navarra;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;87,57
31 Navarra;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
31 Navarra;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
31 Navarra;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
31 Navarra;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
31 Navarra;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
31 Navarra;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
31 Navarra;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QIV;2.689
31 Navarra;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
31 Navarra;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
31 Navarra;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
31 Navarra;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QIV;2.763
31 Navarra;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
31 Navarra;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
31 Navarra;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
31 Navarra;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QIV;2.775
31 Navarra;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
31 Navarra;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
31 Navarra;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
31 Navarra;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2022QIV;2.570
31 Navarra;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
31 Navarra;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2022QII;""
31 Navarra;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2022QI;""
31 Navarra;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2021QIV;2.670
31 Navarra;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
31 Navarra;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2021QII;""
31 Navarra;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2021QI;""
31 Navarra;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2020QIV;2.684
31 Navarra;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
31 Navarra;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2020QII;""
31 Navarra;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2020QI;""
31 Navarra;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
31 Navarra;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
31 Navarra;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2022QII;""
31 Navarra;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2022QI;2.572
31 Navarra;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
31 Navarra;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
31 Navarra;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2021QII;""
31 Navarra;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2021QI;2.609
31 Navarra;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
31 Navarra;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
31 Navarra;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2020QII;""
31 Navarra;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2020QI;""
31 Navarra;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
31 Navarra;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
31 Navarra;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QII;2.452
31 Navarra;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QI;""
31 Navarra;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
31 Navarra;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
31 Navarra;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QII;2.520
31 Navarra;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QI;""
31 Navarra;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
31 Navarra;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
31 Navarra;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QII;""
31 Navarra;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QI;""
31 Navarra;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
31 Navarra;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QIII;2.380
31 Navarra;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QII;""
31 Navarra;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QI;""
31 Navarra;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
31 Navarra;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QIII;2.457
31 Navarra;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QII;""
31 Navarra;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QI;""
31 Navarra;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
31 Navarra;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
31 Navarra;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QII;""
31 Navarra;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QI;""
31 Navarra;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
31 Navarra;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
31 Navarra;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
31 Navarra;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
31 Navarra;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
31 Navarra;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
31 Navarra;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
31 Navarra;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
31 Navarra;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
31 Navarra;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
31 Navarra;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
31 Navarra;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
31 Navarra;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;95,57
31 Navarra;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
31 Navarra;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
31 Navarra;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
31 Navarra;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;96,63
31 Navarra;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
31 Navarra;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
31 Navarra;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
31 Navarra;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;96,72
31 Navarra;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
31 Navarra;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
31 Navarra;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
31 Navarra;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
31 Navarra;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
31 Navarra;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
31 Navarra;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;93,09
31 Navarra;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
31 Navarra;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
31 Navarra;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
31 Navarra;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;94,02
31 Navarra;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
31 Navarra;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
31 Navarra;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
31 Navarra;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
31 Navarra;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
31 Navarra;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
31 Navarra;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;88,74
31 Navarra;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
31 Navarra;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
31 Navarra;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
31 Navarra;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;90,81
31 Navarra;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
31 Navarra;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
31 Navarra;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
31 Navarra;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
31 Navarra;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
31 Navarra;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
31 Navarra;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;86,14
31 Navarra;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
31 Navarra;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
31 Navarra;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
31 Navarra;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;88,54
31 Navarra;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
31 Navarra;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
31 Navarra;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
31 Navarra;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
31 Navarra;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
31 Navarra;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
31 Navarra;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
31 Navarra;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
31 Navarra;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
31 Navarra;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QI;12.996
31 Navarra;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
31 Navarra;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
31 Navarra;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
31 Navarra;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QI;13.190
31 Navarra;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
31 Navarra;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
31 Navarra;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
31 Navarra;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QI;13.165
31 Navarra;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
31 Navarra;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
31 Navarra;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2022QII;""
31 Navarra;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2022QI;12.658
31 Navarra;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
31 Navarra;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
31 Navarra;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2021QII;""
31 Navarra;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2021QI;12.946
31 Navarra;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
31 Navarra;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
31 Navarra;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2020QII;""
31 Navarra;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2020QI;12.537
31 Navarra;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
31 Navarra;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
31 Navarra;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2022QII;12.284
31 Navarra;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2022QI;""
31 Navarra;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
31 Navarra;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
31 Navarra;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2021QII;12.593
31 Navarra;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2021QI;""
31 Navarra;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
31 Navarra;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
31 Navarra;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2020QII;12.283
31 Navarra;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2020QI;""
31 Navarra;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
31 Navarra;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QIII;12.026
31 Navarra;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QII;""
31 Navarra;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QI;""
31 Navarra;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
31 Navarra;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QIII;12.322
31 Navarra;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QII;""
31 Navarra;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QI;""
31 Navarra;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
31 Navarra;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QIII;12.049
31 Navarra;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QII;""
31 Navarra;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QI;""
31 Navarra;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QIV;11.765
31 Navarra;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
31 Navarra;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QII;""
31 Navarra;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QI;""
31 Navarra;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QIV;12.038
31 Navarra;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
31 Navarra;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QII;""
31 Navarra;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QI;""
31 Navarra;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QIV;11.833
31 Navarra;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
31 Navarra;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QII;""
31 Navarra;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QI;""
31 Navarra;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
31 Navarra;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
31 Navarra;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
31 Navarra;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
31 Navarra;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
31 Navarra;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
31 Navarra;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
31 Navarra;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
31 Navarra;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
31 Navarra;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
31 Navarra;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
31 Navarra;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
31 Navarra;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
31 Navarra;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
31 Navarra;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
31 Navarra;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;97,4
31 Navarra;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
31 Navarra;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
31 Navarra;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
31 Navarra;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;98,15
31 Navarra;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
31 Navarra;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
31 Navarra;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
31 Navarra;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;95,23
31 Navarra;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
31 Navarra;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
31 Navarra;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;94,52
31 Navarra;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
31 Navarra;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
31 Navarra;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
31 Navarra;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;95,47
31 Navarra;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
31 Navarra;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
31 Navarra;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
31 Navarra;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;93,3
31 Navarra;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
31 Navarra;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
31 Navarra;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;92,54
31 Navarra;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
31 Navarra;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
31 Navarra;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
31 Navarra;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;93,42
31 Navarra;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
31 Navarra;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
31 Navarra;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
31 Navarra;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;91,52
31 Navarra;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
31 Navarra;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
31 Navarra;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;90,53
31 Navarra;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
31 Navarra;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
31 Navarra;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
31 Navarra;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;91,27
31 Navarra;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
31 Navarra;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
31 Navarra;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
31 Navarra;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;89,88
31 Navarra;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
31 Navarra;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
31 Navarra;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
31 Navarra;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
31 Navarra;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
31 Navarra;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
31 Navarra;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QI;8.197
31 Navarra;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
31 Navarra;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
31 Navarra;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
31 Navarra;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QI;8.435
31 Navarra;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
31 Navarra;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
31 Navarra;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
31 Navarra;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QI;8.378
31 Navarra;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
31 Navarra;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
31 Navarra;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2022QII;""
31 Navarra;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2022QI;7.980
31 Navarra;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
31 Navarra;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
31 Navarra;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2021QII;""
31 Navarra;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2021QI;8.272
31 Navarra;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
31 Navarra;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
31 Navarra;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2020QII;""
31 Navarra;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2020QI;7.987
31 Navarra;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
31 Navarra;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
31 Navarra;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2022QII;7.778
31 Navarra;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2022QI;""
31 Navarra;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
31 Navarra;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
31 Navarra;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2021QII;8.071
31 Navarra;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2021QI;""
31 Navarra;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
31 Navarra;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
31 Navarra;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2020QII;7.837
31 Navarra;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2020QI;""
31 Navarra;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
31 Navarra;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QIII;7.603
31 Navarra;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QII;""
31 Navarra;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QI;""
31 Navarra;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
31 Navarra;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QIII;7.897
31 Navarra;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QII;""
31 Navarra;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QI;""
31 Navarra;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
31 Navarra;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QIII;7.695
31 Navarra;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QII;""
31 Navarra;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QI;""
31 Navarra;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QIV;7.446
31 Navarra;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
31 Navarra;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QII;""
31 Navarra;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QI;""
31 Navarra;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QIV;7.704
31 Navarra;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
31 Navarra;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QII;""
31 Navarra;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QI;""
31 Navarra;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QIV;7.560
31 Navarra;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
31 Navarra;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QII;""
31 Navarra;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QI;""
31 Navarra;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
31 Navarra;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
31 Navarra;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
31 Navarra;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
31 Navarra;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
31 Navarra;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
31 Navarra;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
31 Navarra;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
31 Navarra;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
31 Navarra;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
31 Navarra;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
31 Navarra;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
31 Navarra;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
31 Navarra;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
31 Navarra;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
31 Navarra;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;97,35
31 Navarra;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
31 Navarra;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
31 Navarra;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
31 Navarra;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;98,07
31 Navarra;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
31 Navarra;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
31 Navarra;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
31 Navarra;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;95,33
31 Navarra;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
31 Navarra;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
31 Navarra;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;94,89
31 Navarra;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
31 Navarra;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
31 Navarra;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
31 Navarra;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;95,68
31 Navarra;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
31 Navarra;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
31 Navarra;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
31 Navarra;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;93,54
31 Navarra;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
31 Navarra;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
31 Navarra;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;92,75
31 Navarra;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
31 Navarra;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
31 Navarra;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
31 Navarra;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;93,62
31 Navarra;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
31 Navarra;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
31 Navarra;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
31 Navarra;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;91,85
31 Navarra;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
31 Navarra;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
31 Navarra;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;90,84
31 Navarra;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
31 Navarra;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
31 Navarra;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
31 Navarra;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;91,33
31 Navarra;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
31 Navarra;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
31 Navarra;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
31 Navarra;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;90,24
31 Navarra;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
31 Navarra;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
31 Navarra;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
31 Navarra;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
31 Navarra;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
31 Navarra;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
31 Navarra;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QI;4.799
31 Navarra;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
31 Navarra;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
31 Navarra;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
31 Navarra;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QI;4.755
31 Navarra;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
31 Navarra;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
31 Navarra;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
31 Navarra;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QI;4.787
31 Navarra;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
31 Navarra;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
31 Navarra;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2022QII;""
31 Navarra;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2022QI;4.678
31 Navarra;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
31 Navarra;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
31 Navarra;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2021QII;""
31 Navarra;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2021QI;4.674
31 Navarra;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
31 Navarra;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
31 Navarra;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2020QII;""
31 Navarra;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2020QI;4.550
31 Navarra;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
31 Navarra;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
31 Navarra;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2022QII;4.506
31 Navarra;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2022QI;""
31 Navarra;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
31 Navarra;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
31 Navarra;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2021QII;4.522
31 Navarra;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2021QI;""
31 Navarra;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
31 Navarra;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
31 Navarra;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2020QII;4.446
31 Navarra;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2020QI;""
31 Navarra;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
31 Navarra;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QIII;4.423
31 Navarra;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QII;""
31 Navarra;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QI;""
31 Navarra;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
31 Navarra;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QIII;4.425
31 Navarra;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QII;""
31 Navarra;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QI;""
31 Navarra;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
31 Navarra;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QIII;4.354
31 Navarra;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QII;""
31 Navarra;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QI;""
31 Navarra;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QIV;4.319
31 Navarra;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
31 Navarra;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QII;""
31 Navarra;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QI;""
31 Navarra;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QIV;4.334
31 Navarra;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
31 Navarra;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QII;""
31 Navarra;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QI;""
31 Navarra;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QIV;4.273
31 Navarra;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
31 Navarra;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QII;""
31 Navarra;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QI;""
31 Navarra;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
31 Navarra;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
31 Navarra;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
31 Navarra;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
31 Navarra;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
31 Navarra;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
31 Navarra;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
31 Navarra;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
31 Navarra;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
31 Navarra;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
31 Navarra;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
31 Navarra;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
31 Navarra;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
31 Navarra;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
31 Navarra;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
31 Navarra;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;97,48
31 Navarra;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
31 Navarra;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
31 Navarra;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
31 Navarra;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;98,3
31 Navarra;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
31 Navarra;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
31 Navarra;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
31 Navarra;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;95,05
31 Navarra;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
31 Navarra;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
31 Navarra;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;93,89
31 Navarra;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
31 Navarra;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
31 Navarra;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
31 Navarra;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;95,1
31 Navarra;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
31 Navarra;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
31 Navarra;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
31 Navarra;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;92,88
31 Navarra;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
31 Navarra;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
31 Navarra;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;92,17
31 Navarra;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
31 Navarra;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
31 Navarra;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
31 Navarra;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;93,06
31 Navarra;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
31 Navarra;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
31 Navarra;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
31 Navarra;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;90,95
31 Navarra;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
31 Navarra;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
31 Navarra;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;90
31 Navarra;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
31 Navarra;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
31 Navarra;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
31 Navarra;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;91,15
31 Navarra;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
31 Navarra;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
31 Navarra;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
31 Navarra;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;89,26
31 Navarra;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
31 Navarra;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
31 Navarra;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
31 Navarra;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
31 Navarra;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
31 Navarra;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QII;12.654
31 Navarra;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
31 Navarra;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
31 Navarra;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
31 Navarra;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QII;12.955
31 Navarra;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
31 Navarra;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
31 Navarra;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
31 Navarra;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QII;13.011
31 Navarra;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
31 Navarra;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
31 Navarra;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
31 Navarra;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2022QII;12.235
31 Navarra;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2022QI;""
31 Navarra;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
31 Navarra;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
31 Navarra;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2021QII;12.554
31 Navarra;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2021QI;""
31 Navarra;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
31 Navarra;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
31 Navarra;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2020QII;12.736
31 Navarra;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2020QI;""
31 Navarra;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
31 Navarra;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2022QIII;11.949
31 Navarra;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2022QII;""
31 Navarra;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2022QI;""
31 Navarra;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
31 Navarra;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2021QIII;12.250
31 Navarra;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2021QII;""
31 Navarra;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2021QI;""
31 Navarra;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
31 Navarra;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2020QIII;12.463
31 Navarra;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2020QII;""
31 Navarra;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2020QI;""
31 Navarra;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QIV;11.664
31 Navarra;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
31 Navarra;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QII;""
31 Navarra;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QI;""
31 Navarra;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QIV;11.944
31 Navarra;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
31 Navarra;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QII;""
31 Navarra;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QI;""
31 Navarra;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QIV;12.222
31 Navarra;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
31 Navarra;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QII;""
31 Navarra;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QI;""
31 Navarra;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
31 Navarra;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
31 Navarra;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QII;""
31 Navarra;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QI;11.688
31 Navarra;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
31 Navarra;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
31 Navarra;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QII;""
31 Navarra;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QI;12.049
31 Navarra;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
31 Navarra;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
31 Navarra;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QII;""
31 Navarra;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QI;""
31 Navarra;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
31 Navarra;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
31 Navarra;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
31 Navarra;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
31 Navarra;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
31 Navarra;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
31 Navarra;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
31 Navarra;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
31 Navarra;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
31 Navarra;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
31 Navarra;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
31 Navarra;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
31 Navarra;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
31 Navarra;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
31 Navarra;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;96,69
31 Navarra;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
31 Navarra;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
31 Navarra;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
31 Navarra;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;96,9
31 Navarra;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
31 Navarra;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
31 Navarra;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
31 Navarra;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;97,89
31 Navarra;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
31 Navarra;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
31 Navarra;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;94,43
31 Navarra;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
31 Navarra;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
31 Navarra;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
31 Navarra;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;94,56
31 Navarra;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
31 Navarra;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
31 Navarra;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
31 Navarra;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;95,79
31 Navarra;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
31 Navarra;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
31 Navarra;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;92,18
31 Navarra;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
31 Navarra;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
31 Navarra;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
31 Navarra;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;92,2
31 Navarra;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
31 Navarra;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
31 Navarra;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
31 Navarra;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;93,94
31 Navarra;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
31 Navarra;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
31 Navarra;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
31 Navarra;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
31 Navarra;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
31 Navarra;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
31 Navarra;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;90,22
31 Navarra;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
31 Navarra;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
31 Navarra;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
31 Navarra;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;92,61
31 Navarra;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
31 Navarra;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
31 Navarra;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
31 Navarra;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
31 Navarra;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
31 Navarra;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
31 Navarra;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QII;7.915
31 Navarra;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
31 Navarra;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
31 Navarra;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
31 Navarra;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QII;8.232
31 Navarra;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
31 Navarra;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
31 Navarra;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
31 Navarra;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QII;8.292
31 Navarra;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
31 Navarra;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
31 Navarra;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
31 Navarra;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2022QII;7.685
31 Navarra;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2022QI;""
31 Navarra;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
31 Navarra;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
31 Navarra;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2021QII;7.997
31 Navarra;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2021QI;""
31 Navarra;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
31 Navarra;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
31 Navarra;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2020QII;8.130
31 Navarra;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2020QI;""
31 Navarra;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
31 Navarra;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2022QIII;7.485
31 Navarra;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2022QII;""
31 Navarra;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2022QI;""
31 Navarra;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
31 Navarra;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2021QIII;7.795
31 Navarra;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2021QII;""
31 Navarra;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2021QI;""
31 Navarra;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
31 Navarra;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2020QIII;7.957
31 Navarra;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2020QII;""
31 Navarra;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2020QI;""
31 Navarra;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QIV;7.319
31 Navarra;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
31 Navarra;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QII;""
31 Navarra;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QI;""
31 Navarra;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QIV;7.589
31 Navarra;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
31 Navarra;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QII;""
31 Navarra;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QI;""
31 Navarra;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QIV;7.812
31 Navarra;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
31 Navarra;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QII;""
31 Navarra;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QI;""
31 Navarra;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
31 Navarra;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
31 Navarra;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QII;""
31 Navarra;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QI;7.431
31 Navarra;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
31 Navarra;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
31 Navarra;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QII;""
31 Navarra;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QI;7.704
31 Navarra;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
31 Navarra;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
31 Navarra;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QII;""
31 Navarra;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QI;""
31 Navarra;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
31 Navarra;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
31 Navarra;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
31 Navarra;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
31 Navarra;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
31 Navarra;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
31 Navarra;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
31 Navarra;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
31 Navarra;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
31 Navarra;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
31 Navarra;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
31 Navarra;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
31 Navarra;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
31 Navarra;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
31 Navarra;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;97,09
31 Navarra;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
31 Navarra;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
31 Navarra;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
31 Navarra;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;97,15
31 Navarra;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
31 Navarra;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
31 Navarra;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
31 Navarra;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;98,05
31 Navarra;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
31 Navarra;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
31 Navarra;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;94,57
31 Navarra;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
31 Navarra;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
31 Navarra;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
31 Navarra;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;94,69
31 Navarra;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
31 Navarra;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
31 Navarra;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
31 Navarra;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;95,96
31 Navarra;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
31 Navarra;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
31 Navarra;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;92,47
31 Navarra;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
31 Navarra;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
31 Navarra;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
31 Navarra;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;92,19
31 Navarra;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
31 Navarra;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
31 Navarra;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
31 Navarra;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;94,21
31 Navarra;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
31 Navarra;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
31 Navarra;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
31 Navarra;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
31 Navarra;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
31 Navarra;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
31 Navarra;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;90,27
31 Navarra;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
31 Navarra;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
31 Navarra;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
31 Navarra;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;92,91
31 Navarra;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
31 Navarra;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
31 Navarra;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
31 Navarra;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
31 Navarra;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
31 Navarra;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
31 Navarra;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QII;4.739
31 Navarra;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
31 Navarra;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
31 Navarra;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
31 Navarra;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QII;4.723
31 Navarra;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
31 Navarra;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
31 Navarra;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
31 Navarra;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QII;4.719
31 Navarra;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
31 Navarra;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
31 Navarra;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
31 Navarra;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2022QII;4.550
31 Navarra;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2022QI;""
31 Navarra;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
31 Navarra;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
31 Navarra;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2021QII;4.557
31 Navarra;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2021QI;""
31 Navarra;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
31 Navarra;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
31 Navarra;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2020QII;4.606
31 Navarra;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2020QI;""
31 Navarra;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
31 Navarra;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2022QIII;4.464
31 Navarra;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2022QII;""
31 Navarra;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2022QI;""
31 Navarra;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
31 Navarra;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2021QIII;4.455
31 Navarra;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2021QII;""
31 Navarra;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2021QI;""
31 Navarra;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
31 Navarra;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2020QIII;4.506
31 Navarra;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2020QII;""
31 Navarra;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2020QI;""
31 Navarra;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QIV;4.345
31 Navarra;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
31 Navarra;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QII;""
31 Navarra;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QI;""
31 Navarra;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QIV;4.355
31 Navarra;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
31 Navarra;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QII;""
31 Navarra;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QI;""
31 Navarra;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QIV;4.410
31 Navarra;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
31 Navarra;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QII;""
31 Navarra;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QI;""
31 Navarra;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
31 Navarra;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
31 Navarra;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QII;""
31 Navarra;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QI;4.257
31 Navarra;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
31 Navarra;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
31 Navarra;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QII;""
31 Navarra;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QI;4.345
31 Navarra;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
31 Navarra;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
31 Navarra;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QII;""
31 Navarra;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QI;""
31 Navarra;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
31 Navarra;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
31 Navarra;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
31 Navarra;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
31 Navarra;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
31 Navarra;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
31 Navarra;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
31 Navarra;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
31 Navarra;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
31 Navarra;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
31 Navarra;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
31 Navarra;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
31 Navarra;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
31 Navarra;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
31 Navarra;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;96,01
31 Navarra;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
31 Navarra;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
31 Navarra;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
31 Navarra;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;96,49
31 Navarra;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
31 Navarra;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
31 Navarra;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
31 Navarra;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;97,61
31 Navarra;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
31 Navarra;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
31 Navarra;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;94,2
31 Navarra;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
31 Navarra;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
31 Navarra;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
31 Navarra;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;94,33
31 Navarra;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
31 Navarra;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
31 Navarra;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
31 Navarra;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;95,49
31 Navarra;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
31 Navarra;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
31 Navarra;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;91,69
31 Navarra;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
31 Navarra;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
31 Navarra;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
31 Navarra;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;92,21
31 Navarra;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
31 Navarra;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
31 Navarra;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
31 Navarra;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;93,45
31 Navarra;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
31 Navarra;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
31 Navarra;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
31 Navarra;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
31 Navarra;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
31 Navarra;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
31 Navarra;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;90,13
31 Navarra;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
31 Navarra;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
31 Navarra;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
31 Navarra;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;92,07
31 Navarra;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
31 Navarra;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
31 Navarra;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
31 Navarra;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
31 Navarra;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
31 Navarra;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QIII;12.650
31 Navarra;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
31 Navarra;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
31 Navarra;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
31 Navarra;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QIII;12.950
31 Navarra;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
31 Navarra;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
31 Navarra;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
31 Navarra;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QIII;13.000
31 Navarra;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
31 Navarra;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
31 Navarra;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
31 Navarra;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2022QIII;12.306
31 Navarra;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2022QII;""
31 Navarra;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2022QI;""
31 Navarra;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
31 Navarra;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2021QIII;12.603
31 Navarra;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2021QII;""
31 Navarra;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2021QI;""
31 Navarra;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
31 Navarra;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2020QIII;12.691
31 Navarra;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2020QII;""
31 Navarra;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2020QI;""
31 Navarra;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2022QIV;11.980
31 Navarra;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
31 Navarra;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2022QII;""
31 Navarra;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2022QI;""
31 Navarra;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2021QIV;12.273
31 Navarra;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
31 Navarra;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2021QII;""
31 Navarra;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2021QI;""
31 Navarra;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2020QIV;12.436
31 Navarra;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
31 Navarra;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2020QII;""
31 Navarra;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2020QI;""
31 Navarra;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
31 Navarra;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
31 Navarra;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QII;""
31 Navarra;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QI;11.997
31 Navarra;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
31 Navarra;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
31 Navarra;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QII;""
31 Navarra;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QI;12.251
31 Navarra;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
31 Navarra;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
31 Navarra;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QII;""
31 Navarra;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QI;""
31 Navarra;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
31 Navarra;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
31 Navarra;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QII;11.710
31 Navarra;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QI;""
31 Navarra;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
31 Navarra;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
31 Navarra;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QII;11.976
31 Navarra;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QI;""
31 Navarra;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
31 Navarra;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
31 Navarra;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QII;""
31 Navarra;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QI;""
31 Navarra;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
31 Navarra;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
31 Navarra;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
31 Navarra;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
31 Navarra;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
31 Navarra;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
31 Navarra;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
31 Navarra;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
31 Navarra;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
31 Navarra;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
31 Navarra;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
31 Navarra;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
31 Navarra;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
31 Navarra;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;97,28
31 Navarra;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
31 Navarra;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
31 Navarra;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
31 Navarra;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;97,32
31 Navarra;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
31 Navarra;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
31 Navarra;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
31 Navarra;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;97,62
31 Navarra;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
31 Navarra;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
31 Navarra;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;94,7
31 Navarra;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
31 Navarra;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
31 Navarra;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
31 Navarra;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;94,77
31 Navarra;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
31 Navarra;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
31 Navarra;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
31 Navarra;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;95,66
31 Navarra;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
31 Navarra;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
31 Navarra;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
31 Navarra;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
31 Navarra;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
31 Navarra;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
31 Navarra;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;92,64
31 Navarra;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
31 Navarra;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
31 Navarra;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
31 Navarra;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;94,24
31 Navarra;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
31 Navarra;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
31 Navarra;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
31 Navarra;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
31 Navarra;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
31 Navarra;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
31 Navarra;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;90,42
31 Navarra;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
31 Navarra;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
31 Navarra;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
31 Navarra;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;92,12
31 Navarra;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
31 Navarra;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
31 Navarra;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
31 Navarra;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
31 Navarra;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
31 Navarra;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
31 Navarra;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QIII;7.921
31 Navarra;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
31 Navarra;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
31 Navarra;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
31 Navarra;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QIII;8.255
31 Navarra;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
31 Navarra;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
31 Navarra;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
31 Navarra;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QIII;8.312
31 Navarra;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
31 Navarra;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
31 Navarra;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
31 Navarra;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2022QIII;7.686
31 Navarra;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2022QII;""
31 Navarra;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2022QI;""
31 Navarra;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
31 Navarra;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2021QIII;8.022
31 Navarra;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2021QII;""
31 Navarra;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2021QI;""
31 Navarra;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
31 Navarra;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2020QIII;8.113
31 Navarra;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2020QII;""
31 Navarra;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2020QI;""
31 Navarra;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2022QIV;7.493
31 Navarra;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
31 Navarra;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2022QII;""
31 Navarra;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2022QI;""
31 Navarra;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2021QIV;7.798
31 Navarra;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
31 Navarra;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2021QII;""
31 Navarra;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2021QI;""
31 Navarra;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2020QIV;7.957
31 Navarra;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
31 Navarra;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2020QII;""
31 Navarra;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2020QI;""
31 Navarra;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
31 Navarra;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
31 Navarra;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QII;""
31 Navarra;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QI;7.627
31 Navarra;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
31 Navarra;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
31 Navarra;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QII;""
31 Navarra;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QI;7.840
31 Navarra;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
31 Navarra;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
31 Navarra;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QII;""
31 Navarra;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QI;""
31 Navarra;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
31 Navarra;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
31 Navarra;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QII;7.463
31 Navarra;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QI;""
31 Navarra;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
31 Navarra;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
31 Navarra;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QII;7.675
31 Navarra;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QI;""
31 Navarra;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
31 Navarra;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
31 Navarra;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QII;""
31 Navarra;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QI;""
31 Navarra;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
31 Navarra;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
31 Navarra;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
31 Navarra;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
31 Navarra;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
31 Navarra;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
31 Navarra;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
31 Navarra;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
31 Navarra;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
31 Navarra;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
31 Navarra;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
31 Navarra;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
31 Navarra;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
31 Navarra;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;97,03
31 Navarra;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
31 Navarra;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
31 Navarra;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
31 Navarra;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;97,18
31 Navarra;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
31 Navarra;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
31 Navarra;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
31 Navarra;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;97,61
31 Navarra;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
31 Navarra;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
31 Navarra;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;94,6
31 Navarra;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
31 Navarra;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
31 Navarra;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
31 Navarra;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;94,46
31 Navarra;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
31 Navarra;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
31 Navarra;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
31 Navarra;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;95,73
31 Navarra;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
31 Navarra;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
31 Navarra;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
31 Navarra;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
31 Navarra;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
31 Navarra;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
31 Navarra;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;92,39
31 Navarra;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
31 Navarra;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
31 Navarra;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
31 Navarra;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;94,32
31 Navarra;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
31 Navarra;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
31 Navarra;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
31 Navarra;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
31 Navarra;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
31 Navarra;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
31 Navarra;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;90,41
31 Navarra;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
31 Navarra;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
31 Navarra;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
31 Navarra;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;92,34
31 Navarra;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
31 Navarra;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
31 Navarra;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
31 Navarra;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
31 Navarra;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
31 Navarra;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
31 Navarra;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QIII;4.729
31 Navarra;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
31 Navarra;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
31 Navarra;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
31 Navarra;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QIII;4.695
31 Navarra;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
31 Navarra;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
31 Navarra;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
31 Navarra;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QIII;4.688
31 Navarra;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
31 Navarra;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
31 Navarra;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
31 Navarra;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2022QIII;4.620
31 Navarra;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2022QII;""
31 Navarra;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2022QI;""
31 Navarra;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
31 Navarra;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2021QIII;4.581
31 Navarra;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2021QII;""
31 Navarra;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2021QI;""
31 Navarra;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
31 Navarra;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2020QIII;4.578
31 Navarra;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2020QII;""
31 Navarra;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2020QI;""
31 Navarra;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2022QIV;4.487
31 Navarra;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
31 Navarra;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2022QII;""
31 Navarra;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2022QI;""
31 Navarra;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2021QIV;4.475
31 Navarra;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
31 Navarra;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2021QII;""
31 Navarra;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2021QI;""
31 Navarra;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2020QIV;4.479
31 Navarra;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
31 Navarra;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2020QII;""
31 Navarra;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2020QI;""
31 Navarra;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
31 Navarra;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
31 Navarra;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QII;""
31 Navarra;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QI;4.370
31 Navarra;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
31 Navarra;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
31 Navarra;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QII;""
31 Navarra;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QI;4.411
31 Navarra;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
31 Navarra;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
31 Navarra;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QII;""
31 Navarra;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QI;""
31 Navarra;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
31 Navarra;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
31 Navarra;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QII;4.247
31 Navarra;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QI;""
31 Navarra;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
31 Navarra;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
31 Navarra;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QII;4.301
31 Navarra;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QI;""
31 Navarra;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
31 Navarra;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
31 Navarra;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QII;""
31 Navarra;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QI;""
31 Navarra;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
31 Navarra;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
31 Navarra;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
31 Navarra;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
31 Navarra;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
31 Navarra;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
31 Navarra;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
31 Navarra;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
31 Navarra;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
31 Navarra;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
31 Navarra;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
31 Navarra;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
31 Navarra;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
31 Navarra;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;97,7
31 Navarra;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
31 Navarra;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
31 Navarra;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
31 Navarra;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;97,57
31 Navarra;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
31 Navarra;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
31 Navarra;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
31 Navarra;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;97,65
31 Navarra;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
31 Navarra;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
31 Navarra;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;94,88
31 Navarra;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
31 Navarra;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
31 Navarra;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
31 Navarra;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;95,31
31 Navarra;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
31 Navarra;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
31 Navarra;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
31 Navarra;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;95,54
31 Navarra;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
31 Navarra;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
31 Navarra;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
31 Navarra;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
31 Navarra;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
31 Navarra;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
31 Navarra;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;93,08
31 Navarra;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
31 Navarra;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
31 Navarra;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
31 Navarra;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;94,09
31 Navarra;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
31 Navarra;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
31 Navarra;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
31 Navarra;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
31 Navarra;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
31 Navarra;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
31 Navarra;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;90,46
31 Navarra;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
31 Navarra;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
31 Navarra;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
31 Navarra;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;91,74
31 Navarra;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
31 Navarra;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
31 Navarra;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
31 Navarra;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
31 Navarra;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
31 Navarra;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QIV;12.690
31 Navarra;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
31 Navarra;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
31 Navarra;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
31 Navarra;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QIV;12.979
31 Navarra;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
31 Navarra;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
31 Navarra;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
31 Navarra;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QIV;13.105
31 Navarra;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
31 Navarra;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
31 Navarra;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
31 Navarra;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2022QIV;12.329
31 Navarra;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
31 Navarra;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2022QII;""
31 Navarra;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2022QI;""
31 Navarra;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2021QIV;12.602
31 Navarra;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
31 Navarra;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2021QII;""
31 Navarra;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2021QI;""
31 Navarra;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2020QIV;12.809
31 Navarra;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
31 Navarra;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2020QII;""
31 Navarra;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2020QI;""
31 Navarra;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
31 Navarra;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
31 Navarra;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2022QII;""
31 Navarra;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2022QI;12.302
31 Navarra;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
31 Navarra;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
31 Navarra;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2021QII;""
31 Navarra;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2021QI;12.594
31 Navarra;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
31 Navarra;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
31 Navarra;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2020QII;""
31 Navarra;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2020QI;""
31 Navarra;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
31 Navarra;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
31 Navarra;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QII;11.975
31 Navarra;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QI;""
31 Navarra;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
31 Navarra;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
31 Navarra;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QII;12.276
31 Navarra;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QI;""
31 Navarra;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
31 Navarra;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
31 Navarra;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QII;""
31 Navarra;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QI;""
31 Navarra;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
31 Navarra;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QIII;11.738
31 Navarra;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QII;""
31 Navarra;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QI;""
31 Navarra;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
31 Navarra;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QIII;12.019
31 Navarra;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QII;""
31 Navarra;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QI;""
31 Navarra;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
31 Navarra;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
31 Navarra;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QII;""
31 Navarra;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QI;""
31 Navarra;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
31 Navarra;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
31 Navarra;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
31 Navarra;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
31 Navarra;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
31 Navarra;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
31 Navarra;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
31 Navarra;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
31 Navarra;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
31 Navarra;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
31 Navarra;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
31 Navarra;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
31 Navarra;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;97,16
31 Navarra;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
31 Navarra;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
31 Navarra;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
31 Navarra;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;97,1
31 Navarra;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
31 Navarra;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
31 Navarra;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
31 Navarra;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;97,74
31 Navarra;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
31 Navarra;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
31 Navarra;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
31 Navarra;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
31 Navarra;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
31 Navarra;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
31 Navarra;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;94,78
31 Navarra;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
31 Navarra;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
31 Navarra;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
31 Navarra;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;96,1
31 Navarra;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
31 Navarra;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
31 Navarra;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
31 Navarra;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
31 Navarra;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
31 Navarra;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
31 Navarra;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;92,26
31 Navarra;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
31 Navarra;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
31 Navarra;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
31 Navarra;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;93,67
31 Navarra;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
31 Navarra;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
31 Navarra;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
31 Navarra;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
31 Navarra;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
31 Navarra;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
31 Navarra;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;90,44
31 Navarra;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
31 Navarra;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
31 Navarra;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
31 Navarra;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;91,71
31 Navarra;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
31 Navarra;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
31 Navarra;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
31 Navarra;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
31 Navarra;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
31 Navarra;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
31 Navarra;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QIV;7.920
31 Navarra;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
31 Navarra;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
31 Navarra;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
31 Navarra;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QIV;8.230
31 Navarra;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
31 Navarra;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
31 Navarra;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
31 Navarra;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QIV;8.376
31 Navarra;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
31 Navarra;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
31 Navarra;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
31 Navarra;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2022QIV;7.703
31 Navarra;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
31 Navarra;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2022QII;""
31 Navarra;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2022QI;""
31 Navarra;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2021QIV;7.976
31 Navarra;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
31 Navarra;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2021QII;""
31 Navarra;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2021QI;""
31 Navarra;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2020QIV;8.191
31 Navarra;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
31 Navarra;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2020QII;""
31 Navarra;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2020QI;""
31 Navarra;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
31 Navarra;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
31 Navarra;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2022QII;""
31 Navarra;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2022QI;7.787
31 Navarra;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
31 Navarra;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
31 Navarra;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2021QII;""
31 Navarra;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2021QI;8.052
31 Navarra;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
31 Navarra;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
31 Navarra;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2020QII;""
31 Navarra;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2020QI;""
31 Navarra;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
31 Navarra;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
31 Navarra;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QII;7.605
31 Navarra;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QI;""
31 Navarra;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
31 Navarra;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
31 Navarra;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QII;7.864
31 Navarra;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QI;""
31 Navarra;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
31 Navarra;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
31 Navarra;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QII;""
31 Navarra;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QI;""
31 Navarra;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
31 Navarra;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QIII;7.442
31 Navarra;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QII;""
31 Navarra;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QI;""
31 Navarra;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
31 Navarra;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QIII;7.700
31 Navarra;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QII;""
31 Navarra;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QI;""
31 Navarra;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
31 Navarra;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
31 Navarra;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QII;""
31 Navarra;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QI;""
31 Navarra;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
31 Navarra;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
31 Navarra;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
31 Navarra;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
31 Navarra;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
31 Navarra;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
31 Navarra;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
31 Navarra;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
31 Navarra;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
31 Navarra;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
31 Navarra;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
31 Navarra;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
31 Navarra;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;97,26
31 Navarra;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
31 Navarra;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
31 Navarra;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
31 Navarra;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;96,91
31 Navarra;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
31 Navarra;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
31 Navarra;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
31 Navarra;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;97,79
31 Navarra;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
31 Navarra;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
31 Navarra;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
31 Navarra;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
31 Navarra;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
31 Navarra;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
31 Navarra;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;94,62
31 Navarra;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
31 Navarra;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
31 Navarra;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
31 Navarra;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;96,13
31 Navarra;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
31 Navarra;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
31 Navarra;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
31 Navarra;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
31 Navarra;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
31 Navarra;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
31 Navarra;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;92,41
31 Navarra;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
31 Navarra;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
31 Navarra;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
31 Navarra;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;93,89
31 Navarra;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
31 Navarra;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
31 Navarra;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
31 Navarra;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
31 Navarra;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
31 Navarra;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
31 Navarra;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;90,43
31 Navarra;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
31 Navarra;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
31 Navarra;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
31 Navarra;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;91,93
31 Navarra;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
31 Navarra;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
31 Navarra;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
31 Navarra;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
31 Navarra;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
31 Navarra;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
31 Navarra;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QIV;4.770
31 Navarra;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
31 Navarra;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
31 Navarra;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
31 Navarra;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QIV;4.749
31 Navarra;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
31 Navarra;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
31 Navarra;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
31 Navarra;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QIV;4.729
31 Navarra;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
31 Navarra;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
31 Navarra;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
31 Navarra;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2022QIV;4.626
31 Navarra;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
31 Navarra;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2022QII;""
31 Navarra;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2022QI;""
31 Navarra;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2021QIV;4.626
31 Navarra;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
31 Navarra;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2021QII;""
31 Navarra;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2021QI;""
31 Navarra;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2020QIV;4.618
31 Navarra;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
31 Navarra;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2020QII;""
31 Navarra;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2020QI;""
31 Navarra;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
31 Navarra;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
31 Navarra;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2022QII;""
31 Navarra;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2022QI;4.515
31 Navarra;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
31 Navarra;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
31 Navarra;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2021QII;""
31 Navarra;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2021QI;4.542
31 Navarra;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
31 Navarra;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
31 Navarra;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2020QII;""
31 Navarra;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2020QI;""
31 Navarra;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
31 Navarra;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
31 Navarra;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QII;4.370
31 Navarra;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QI;""
31 Navarra;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
31 Navarra;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
31 Navarra;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QII;4.412
31 Navarra;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QI;""
31 Navarra;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
31 Navarra;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
31 Navarra;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QII;""
31 Navarra;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QI;""
31 Navarra;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
31 Navarra;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QIII;4.296
31 Navarra;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QII;""
31 Navarra;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QI;""
31 Navarra;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
31 Navarra;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QIII;4.319
31 Navarra;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QII;""
31 Navarra;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QI;""
31 Navarra;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
31 Navarra;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
31 Navarra;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QII;""
31 Navarra;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QI;""
31 Navarra;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
31 Navarra;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
31 Navarra;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
31 Navarra;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
31 Navarra;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
31 Navarra;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
31 Navarra;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
31 Navarra;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
31 Navarra;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
31 Navarra;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
31 Navarra;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
31 Navarra;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
31 Navarra;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;96,98
31 Navarra;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
31 Navarra;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
31 Navarra;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
31 Navarra;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;97,41
31 Navarra;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
31 Navarra;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
31 Navarra;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
31 Navarra;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;97,65
31 Navarra;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
31 Navarra;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
31 Navarra;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
31 Navarra;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
31 Navarra;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
31 Navarra;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
31 Navarra;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;95,07
31 Navarra;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
31 Navarra;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
31 Navarra;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
31 Navarra;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;96,05
31 Navarra;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
31 Navarra;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
31 Navarra;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
31 Navarra;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
31 Navarra;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
31 Navarra;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
31 Navarra;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;92,02
31 Navarra;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
31 Navarra;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
31 Navarra;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
31 Navarra;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;93,3
31 Navarra;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
31 Navarra;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
31 Navarra;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
31 Navarra;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
31 Navarra;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
31 Navarra;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
31 Navarra;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;90,46
31 Navarra;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
31 Navarra;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
31 Navarra;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
31 Navarra;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;91,33
31 Navarra;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
31 Navarra;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
31 Navarra;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
31 Navarra;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
31 Navarra;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
31 Navarra;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
31 Navarra;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
31 Navarra;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
31 Navarra;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
31 Navarra;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QI;12.579
31 Navarra;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
31 Navarra;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
31 Navarra;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
31 Navarra;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QI;12.475
31 Navarra;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
31 Navarra;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
31 Navarra;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
31 Navarra;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QI;12.669
31 Navarra;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
31 Navarra;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
31 Navarra;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2022QII;""
31 Navarra;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2022QI;12.323
31 Navarra;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
31 Navarra;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
31 Navarra;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2021QII;""
31 Navarra;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2021QI;12.295
31 Navarra;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
31 Navarra;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
31 Navarra;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2020QII;""
31 Navarra;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2020QI;12.261
31 Navarra;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
31 Navarra;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
31 Navarra;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2022QII;12.046
31 Navarra;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2022QI;""
31 Navarra;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
31 Navarra;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
31 Navarra;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2021QII;12.074
31 Navarra;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2021QI;""
31 Navarra;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
31 Navarra;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
31 Navarra;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2020QII;12.104
31 Navarra;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2020QI;""
31 Navarra;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
31 Navarra;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QIII;11.889
31 Navarra;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QII;""
31 Navarra;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QI;""
31 Navarra;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
31 Navarra;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QIII;11.890
31 Navarra;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QII;""
31 Navarra;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QI;""
31 Navarra;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
31 Navarra;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QIII;11.930
31 Navarra;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QII;""
31 Navarra;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QI;""
31 Navarra;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QIV;11.703
31 Navarra;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
31 Navarra;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QII;""
31 Navarra;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QI;""
31 Navarra;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QIV;11.695
31 Navarra;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
31 Navarra;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QII;""
31 Navarra;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QI;""
31 Navarra;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QIV;11.773
31 Navarra;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
31 Navarra;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QII;""
31 Navarra;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QI;""
31 Navarra;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
31 Navarra;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
31 Navarra;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
31 Navarra;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
31 Navarra;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
31 Navarra;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
31 Navarra;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
31 Navarra;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
31 Navarra;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
31 Navarra;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
31 Navarra;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
31 Navarra;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
31 Navarra;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
31 Navarra;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
31 Navarra;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
31 Navarra;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;97,96
31 Navarra;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
31 Navarra;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
31 Navarra;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
31 Navarra;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;98,56
31 Navarra;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
31 Navarra;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
31 Navarra;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
31 Navarra;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;96,78
31 Navarra;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
31 Navarra;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
31 Navarra;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;95,76
31 Navarra;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
31 Navarra;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
31 Navarra;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
31 Navarra;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;96,79
31 Navarra;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
31 Navarra;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
31 Navarra;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
31 Navarra;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;95,54
31 Navarra;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
31 Navarra;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
31 Navarra;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;94,51
31 Navarra;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
31 Navarra;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
31 Navarra;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
31 Navarra;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;95,31
31 Navarra;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
31 Navarra;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
31 Navarra;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
31 Navarra;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;94,17
31 Navarra;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
31 Navarra;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
31 Navarra;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;93,04
31 Navarra;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
31 Navarra;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
31 Navarra;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
31 Navarra;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;93,75
31 Navarra;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
31 Navarra;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
31 Navarra;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
31 Navarra;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;92,93
31 Navarra;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
31 Navarra;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
31 Navarra;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
31 Navarra;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
31 Navarra;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
31 Navarra;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
31 Navarra;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QI;7.998
31 Navarra;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
31 Navarra;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
31 Navarra;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
31 Navarra;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QI;7.957
31 Navarra;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
31 Navarra;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
31 Navarra;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
31 Navarra;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QI;8.083
31 Navarra;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
31 Navarra;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
31 Navarra;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2022QII;""
31 Navarra;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2022QI;7.840
31 Navarra;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
31 Navarra;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
31 Navarra;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2021QII;""
31 Navarra;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2021QI;7.838
31 Navarra;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
31 Navarra;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
31 Navarra;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2020QII;""
31 Navarra;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2020QI;7.830
31 Navarra;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
31 Navarra;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
31 Navarra;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2022QII;7.684
31 Navarra;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2022QI;""
31 Navarra;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
31 Navarra;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
31 Navarra;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2021QII;7.702
31 Navarra;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2021QI;""
31 Navarra;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
31 Navarra;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
31 Navarra;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2020QII;7.736
31 Navarra;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2020QI;""
31 Navarra;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
31 Navarra;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QIII;7.589
31 Navarra;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QII;""
31 Navarra;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QI;""
31 Navarra;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
31 Navarra;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QIII;7.591
31 Navarra;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QII;""
31 Navarra;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QI;""
31 Navarra;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
31 Navarra;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QIII;7.629
31 Navarra;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QII;""
31 Navarra;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QI;""
31 Navarra;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QIV;7.474
31 Navarra;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
31 Navarra;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QII;""
31 Navarra;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QI;""
31 Navarra;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QIV;7.463
31 Navarra;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
31 Navarra;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QII;""
31 Navarra;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QI;""
31 Navarra;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QIV;7.531
31 Navarra;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
31 Navarra;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QII;""
31 Navarra;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QI;""
31 Navarra;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
31 Navarra;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
31 Navarra;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
31 Navarra;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
31 Navarra;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
31 Navarra;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
31 Navarra;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
31 Navarra;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
31 Navarra;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
31 Navarra;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
31 Navarra;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
31 Navarra;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
31 Navarra;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
31 Navarra;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
31 Navarra;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
31 Navarra;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;98,02
31 Navarra;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
31 Navarra;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
31 Navarra;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
31 Navarra;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;98,5
31 Navarra;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
31 Navarra;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
31 Navarra;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
31 Navarra;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;96,87
31 Navarra;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
31 Navarra;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
31 Navarra;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;96,07
31 Navarra;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
31 Navarra;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
31 Navarra;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
31 Navarra;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;96,8
31 Navarra;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
31 Navarra;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
31 Navarra;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
31 Navarra;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;95,71
31 Navarra;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
31 Navarra;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
31 Navarra;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;94,89
31 Navarra;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
31 Navarra;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
31 Navarra;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
31 Navarra;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;95,4
31 Navarra;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
31 Navarra;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
31 Navarra;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
31 Navarra;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;94,38
31 Navarra;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
31 Navarra;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
31 Navarra;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;93,45
31 Navarra;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
31 Navarra;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
31 Navarra;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
31 Navarra;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;93,79
31 Navarra;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
31 Navarra;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
31 Navarra;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
31 Navarra;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;93,17
31 Navarra;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
31 Navarra;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
31 Navarra;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
31 Navarra;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
31 Navarra;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
31 Navarra;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
31 Navarra;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QI;4.581
31 Navarra;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
31 Navarra;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
31 Navarra;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
31 Navarra;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QI;4.518
31 Navarra;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
31 Navarra;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
31 Navarra;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
31 Navarra;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QI;4.586
31 Navarra;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
31 Navarra;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
31 Navarra;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2022QII;""
31 Navarra;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2022QI;4.483
31 Navarra;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
31 Navarra;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
31 Navarra;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2021QII;""
31 Navarra;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2021QI;4.457
31 Navarra;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
31 Navarra;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
31 Navarra;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2020QII;""
31 Navarra;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2020QI;4.431
31 Navarra;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
31 Navarra;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
31 Navarra;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2022QII;4.362
31 Navarra;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2022QI;""
31 Navarra;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
31 Navarra;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
31 Navarra;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2021QII;4.372
31 Navarra;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2021QI;""
31 Navarra;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
31 Navarra;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
31 Navarra;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2020QII;4.368
31 Navarra;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2020QI;""
31 Navarra;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
31 Navarra;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QIII;4.300
31 Navarra;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QII;""
31 Navarra;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QI;""
31 Navarra;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
31 Navarra;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QIII;4.299
31 Navarra;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QII;""
31 Navarra;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QI;""
31 Navarra;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
31 Navarra;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QIII;4.301
31 Navarra;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QII;""
31 Navarra;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QI;""
31 Navarra;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QIV;4.229
31 Navarra;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
31 Navarra;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QII;""
31 Navarra;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QI;""
31 Navarra;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QIV;4.232
31 Navarra;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
31 Navarra;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QII;""
31 Navarra;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QI;""
31 Navarra;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QIV;4.242
31 Navarra;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
31 Navarra;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QII;""
31 Navarra;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QI;""
31 Navarra;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
31 Navarra;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
31 Navarra;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
31 Navarra;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
31 Navarra;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
31 Navarra;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
31 Navarra;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
31 Navarra;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
31 Navarra;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
31 Navarra;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
31 Navarra;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
31 Navarra;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
31 Navarra;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
31 Navarra;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
31 Navarra;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
31 Navarra;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;97,86
31 Navarra;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
31 Navarra;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
31 Navarra;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
31 Navarra;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;98,65
31 Navarra;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
31 Navarra;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
31 Navarra;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
31 Navarra;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;96,62
31 Navarra;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
31 Navarra;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
31 Navarra;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;95,22
31 Navarra;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
31 Navarra;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
31 Navarra;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
31 Navarra;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;96,77
31 Navarra;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
31 Navarra;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
31 Navarra;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
31 Navarra;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;95,25
31 Navarra;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
31 Navarra;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
31 Navarra;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;93,87
31 Navarra;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
31 Navarra;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
31 Navarra;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
31 Navarra;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;95,15
31 Navarra;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
31 Navarra;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
31 Navarra;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
31 Navarra;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;93,79
31 Navarra;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
31 Navarra;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
31 Navarra;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;92,32
31 Navarra;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
31 Navarra;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
31 Navarra;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
31 Navarra;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;93,67
31 Navarra;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
31 Navarra;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
31 Navarra;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
31 Navarra;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;92,5
31 Navarra;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
31 Navarra;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
31 Navarra;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
31 Navarra;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
31 Navarra;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
31 Navarra;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QII;12.859
31 Navarra;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
31 Navarra;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
31 Navarra;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
31 Navarra;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QII;12.702
31 Navarra;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
31 Navarra;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
31 Navarra;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
31 Navarra;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QII;12.627
31 Navarra;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
31 Navarra;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
31 Navarra;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
31 Navarra;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2022QII;12.552
31 Navarra;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2022QI;""
31 Navarra;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
31 Navarra;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
31 Navarra;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2021QII;12.450
31 Navarra;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2021QI;""
31 Navarra;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
31 Navarra;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
31 Navarra;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2020QII;12.453
31 Navarra;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2020QI;""
31 Navarra;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
31 Navarra;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2022QIII;12.356
31 Navarra;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2022QII;""
31 Navarra;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2022QI;""
31 Navarra;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
31 Navarra;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2021QIII;12.256
31 Navarra;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2021QII;""
31 Navarra;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2021QI;""
31 Navarra;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
31 Navarra;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2020QIII;12.211
31 Navarra;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2020QII;""
31 Navarra;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2020QI;""
31 Navarra;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QIV;12.146
31 Navarra;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
31 Navarra;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QII;""
31 Navarra;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QI;""
31 Navarra;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QIV;12.035
31 Navarra;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
31 Navarra;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QII;""
31 Navarra;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QI;""
31 Navarra;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QIV;12.038
31 Navarra;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
31 Navarra;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QII;""
31 Navarra;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QI;""
31 Navarra;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
31 Navarra;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
31 Navarra;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QII;""
31 Navarra;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QI;11.817
31 Navarra;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
31 Navarra;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
31 Navarra;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QII;""
31 Navarra;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QI;11.891
31 Navarra;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
31 Navarra;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
31 Navarra;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QII;""
31 Navarra;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QI;""
31 Navarra;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
31 Navarra;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
31 Navarra;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
31 Navarra;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
31 Navarra;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
31 Navarra;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
31 Navarra;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
31 Navarra;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
31 Navarra;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
31 Navarra;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
31 Navarra;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
31 Navarra;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
31 Navarra;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
31 Navarra;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
31 Navarra;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;97,61
31 Navarra;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
31 Navarra;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
31 Navarra;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
31 Navarra;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;98,02
31 Navarra;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
31 Navarra;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
31 Navarra;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
31 Navarra;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;98,62
31 Navarra;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
31 Navarra;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
31 Navarra;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;96,09
31 Navarra;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
31 Navarra;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
31 Navarra;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
31 Navarra;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;96,49
31 Navarra;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
31 Navarra;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
31 Navarra;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
31 Navarra;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;96,71
31 Navarra;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
31 Navarra;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
31 Navarra;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;94,46
31 Navarra;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
31 Navarra;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
31 Navarra;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
31 Navarra;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;94,75
31 Navarra;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
31 Navarra;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
31 Navarra;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
31 Navarra;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;95,34
31 Navarra;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
31 Navarra;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
31 Navarra;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
31 Navarra;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
31 Navarra;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
31 Navarra;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
31 Navarra;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;93,03
31 Navarra;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
31 Navarra;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
31 Navarra;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
31 Navarra;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;94,17
31 Navarra;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
31 Navarra;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
31 Navarra;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
31 Navarra;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
31 Navarra;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
31 Navarra;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
31 Navarra;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QII;8.223
31 Navarra;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
31 Navarra;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
31 Navarra;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
31 Navarra;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QII;8.111
31 Navarra;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
31 Navarra;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
31 Navarra;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
31 Navarra;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QII;8.063
31 Navarra;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
31 Navarra;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
31 Navarra;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
31 Navarra;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2022QII;8.047
31 Navarra;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2022QI;""
31 Navarra;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
31 Navarra;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
31 Navarra;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2021QII;7.959
31 Navarra;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2021QI;""
31 Navarra;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
31 Navarra;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
31 Navarra;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2020QII;7.958
31 Navarra;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2020QI;""
31 Navarra;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
31 Navarra;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2022QIII;7.927
31 Navarra;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2022QII;""
31 Navarra;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2022QI;""
31 Navarra;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
31 Navarra;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2021QIII;7.839
31 Navarra;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2021QII;""
31 Navarra;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2021QI;""
31 Navarra;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
31 Navarra;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2020QIII;7.802
31 Navarra;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2020QII;""
31 Navarra;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2020QI;""
31 Navarra;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QIV;7.792
31 Navarra;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
31 Navarra;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QII;""
31 Navarra;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QI;""
31 Navarra;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QIV;7.689
31 Navarra;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
31 Navarra;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QII;""
31 Navarra;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QI;""
31 Navarra;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QIV;7.692
31 Navarra;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
31 Navarra;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QII;""
31 Navarra;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QI;""
31 Navarra;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
31 Navarra;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
31 Navarra;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QII;""
31 Navarra;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QI;7.557
31 Navarra;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
31 Navarra;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
31 Navarra;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QII;""
31 Navarra;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QI;7.598
31 Navarra;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
31 Navarra;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
31 Navarra;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QII;""
31 Navarra;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QI;""
31 Navarra;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
31 Navarra;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
31 Navarra;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
31 Navarra;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
31 Navarra;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
31 Navarra;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
31 Navarra;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
31 Navarra;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
31 Navarra;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
31 Navarra;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
31 Navarra;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
31 Navarra;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
31 Navarra;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
31 Navarra;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
31 Navarra;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;97,86
31 Navarra;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
31 Navarra;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
31 Navarra;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
31 Navarra;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;98,13
31 Navarra;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
31 Navarra;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
31 Navarra;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
31 Navarra;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;98,7
31 Navarra;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
31 Navarra;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
31 Navarra;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;96,4
31 Navarra;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
31 Navarra;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
31 Navarra;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
31 Navarra;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;96,65
31 Navarra;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
31 Navarra;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
31 Navarra;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
31 Navarra;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;96,76
31 Navarra;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
31 Navarra;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
31 Navarra;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;94,76
31 Navarra;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
31 Navarra;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
31 Navarra;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
31 Navarra;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;94,8
31 Navarra;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
31 Navarra;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
31 Navarra;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
31 Navarra;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;95,4
31 Navarra;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
31 Navarra;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
31 Navarra;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
31 Navarra;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
31 Navarra;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
31 Navarra;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
31 Navarra;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;93,17
31 Navarra;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
31 Navarra;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
31 Navarra;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
31 Navarra;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;94,23
31 Navarra;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
31 Navarra;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
31 Navarra;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
31 Navarra;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
31 Navarra;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
31 Navarra;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
31 Navarra;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QII;4.636
31 Navarra;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
31 Navarra;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
31 Navarra;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
31 Navarra;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QII;4.591
31 Navarra;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
31 Navarra;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
31 Navarra;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
31 Navarra;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QII;4.564
31 Navarra;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
31 Navarra;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
31 Navarra;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
31 Navarra;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2022QII;4.505
31 Navarra;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2022QI;""
31 Navarra;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
31 Navarra;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
31 Navarra;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2021QII;4.491
31 Navarra;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2021QI;""
31 Navarra;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
31 Navarra;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
31 Navarra;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2020QII;4.495
31 Navarra;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2020QI;""
31 Navarra;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
31 Navarra;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2022QIII;4.429
31 Navarra;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2022QII;""
31 Navarra;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2022QI;""
31 Navarra;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
31 Navarra;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2021QIII;4.417
31 Navarra;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2021QII;""
31 Navarra;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2021QI;""
31 Navarra;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
31 Navarra;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2020QIII;4.409
31 Navarra;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2020QII;""
31 Navarra;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2020QI;""
31 Navarra;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QIV;4.354
31 Navarra;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
31 Navarra;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QII;""
31 Navarra;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QI;""
31 Navarra;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QIV;4.346
31 Navarra;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
31 Navarra;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QII;""
31 Navarra;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QI;""
31 Navarra;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QIV;4.346
31 Navarra;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
31 Navarra;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QII;""
31 Navarra;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QI;""
31 Navarra;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
31 Navarra;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
31 Navarra;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QII;""
31 Navarra;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QI;4.260
31 Navarra;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
31 Navarra;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
31 Navarra;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QII;""
31 Navarra;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QI;4.293
31 Navarra;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
31 Navarra;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
31 Navarra;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QII;""
31 Navarra;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QI;""
31 Navarra;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
31 Navarra;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
31 Navarra;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
31 Navarra;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
31 Navarra;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
31 Navarra;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
31 Navarra;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
31 Navarra;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
31 Navarra;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
31 Navarra;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
31 Navarra;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
31 Navarra;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
31 Navarra;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
31 Navarra;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
31 Navarra;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;97,17
31 Navarra;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
31 Navarra;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
31 Navarra;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
31 Navarra;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;97,82
31 Navarra;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
31 Navarra;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
31 Navarra;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
31 Navarra;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;98,49
31 Navarra;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
31 Navarra;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
31 Navarra;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;95,53
31 Navarra;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
31 Navarra;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
31 Navarra;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
31 Navarra;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;96,21
31 Navarra;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
31 Navarra;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
31 Navarra;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
31 Navarra;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;96,6
31 Navarra;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
31 Navarra;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
31 Navarra;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;93,92
31 Navarra;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
31 Navarra;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
31 Navarra;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
31 Navarra;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;94,66
31 Navarra;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
31 Navarra;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
31 Navarra;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
31 Navarra;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;95,22
31 Navarra;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
31 Navarra;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
31 Navarra;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
31 Navarra;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
31 Navarra;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
31 Navarra;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
31 Navarra;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;92,79
31 Navarra;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
31 Navarra;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
31 Navarra;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
31 Navarra;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;94,06
31 Navarra;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
31 Navarra;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
31 Navarra;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
31 Navarra;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
31 Navarra;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
31 Navarra;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QIII;12.793
31 Navarra;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
31 Navarra;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
31 Navarra;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
31 Navarra;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QIII;12.663
31 Navarra;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
31 Navarra;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
31 Navarra;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
31 Navarra;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QIII;12.611
31 Navarra;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
31 Navarra;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
31 Navarra;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
31 Navarra;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2022QIII;12.564
31 Navarra;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2022QII;""
31 Navarra;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2022QI;""
31 Navarra;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
31 Navarra;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2021QIII;12.448
31 Navarra;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2021QII;""
31 Navarra;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2021QI;""
31 Navarra;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
31 Navarra;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2020QIII;12.342
31 Navarra;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2020QII;""
31 Navarra;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2020QI;""
31 Navarra;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2022QIV;12.331
31 Navarra;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
31 Navarra;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2022QII;""
31 Navarra;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2022QI;""
31 Navarra;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2021QIV;12.214
31 Navarra;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
31 Navarra;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2021QII;""
31 Navarra;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2021QI;""
31 Navarra;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2020QIV;12.158
31 Navarra;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
31 Navarra;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2020QII;""
31 Navarra;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2020QI;""
31 Navarra;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
31 Navarra;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
31 Navarra;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QII;""
31 Navarra;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QI;11.992
31 Navarra;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
31 Navarra;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
31 Navarra;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QII;""
31 Navarra;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QI;12.006
31 Navarra;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
31 Navarra;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
31 Navarra;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QII;""
31 Navarra;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QI;""
31 Navarra;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
31 Navarra;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
31 Navarra;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QII;11.765
31 Navarra;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QI;""
31 Navarra;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
31 Navarra;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
31 Navarra;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QII;11.817
31 Navarra;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QI;""
31 Navarra;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
31 Navarra;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
31 Navarra;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QII;""
31 Navarra;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QI;""
31 Navarra;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
31 Navarra;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
31 Navarra;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
31 Navarra;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
31 Navarra;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
31 Navarra;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
31 Navarra;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
31 Navarra;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
31 Navarra;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
31 Navarra;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
31 Navarra;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
31 Navarra;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
31 Navarra;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
31 Navarra;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;98,21
31 Navarra;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
31 Navarra;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
31 Navarra;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
31 Navarra;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;98,3
31 Navarra;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
31 Navarra;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
31 Navarra;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
31 Navarra;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;97,87
31 Navarra;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
31 Navarra;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
31 Navarra;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;96,39
31 Navarra;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
31 Navarra;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
31 Navarra;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
31 Navarra;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;96,45
31 Navarra;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
31 Navarra;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
31 Navarra;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
31 Navarra;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;96,41
31 Navarra;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
31 Navarra;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
31 Navarra;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
31 Navarra;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
31 Navarra;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
31 Navarra;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
31 Navarra;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;94,7
31 Navarra;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
31 Navarra;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
31 Navarra;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
31 Navarra;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;95,2
31 Navarra;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
31 Navarra;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
31 Navarra;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
31 Navarra;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
31 Navarra;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
31 Navarra;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
31 Navarra;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;92,91
31 Navarra;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
31 Navarra;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
31 Navarra;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
31 Navarra;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;93,7
31 Navarra;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
31 Navarra;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
31 Navarra;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
31 Navarra;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
31 Navarra;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
31 Navarra;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
31 Navarra;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QIII;8.193
31 Navarra;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
31 Navarra;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
31 Navarra;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
31 Navarra;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QIII;8.089
31 Navarra;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
31 Navarra;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
31 Navarra;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
31 Navarra;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QIII;8.070
31 Navarra;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
31 Navarra;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
31 Navarra;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
31 Navarra;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2022QIII;8.053
31 Navarra;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2022QII;""
31 Navarra;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2022QI;""
31 Navarra;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
31 Navarra;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2021QIII;7.957
31 Navarra;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2021QII;""
31 Navarra;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2021QI;""
31 Navarra;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
31 Navarra;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2020QIII;7.892
31 Navarra;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2020QII;""
31 Navarra;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2020QI;""
31 Navarra;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2022QIV;7.901
31 Navarra;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
31 Navarra;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2022QII;""
31 Navarra;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2022QI;""
31 Navarra;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2021QIV;7.795
31 Navarra;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
31 Navarra;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2021QII;""
31 Navarra;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2021QI;""
31 Navarra;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2020QIV;7.772
31 Navarra;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
31 Navarra;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2020QII;""
31 Navarra;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2020QI;""
31 Navarra;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
31 Navarra;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
31 Navarra;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QII;""
31 Navarra;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QI;7.660
31 Navarra;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
31 Navarra;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
31 Navarra;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QII;""
31 Navarra;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QI;7.673
31 Navarra;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
31 Navarra;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
31 Navarra;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QII;""
31 Navarra;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QI;""
31 Navarra;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
31 Navarra;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
31 Navarra;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QII;7.528
31 Navarra;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QI;""
31 Navarra;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
31 Navarra;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
31 Navarra;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QII;7.556
31 Navarra;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QI;""
31 Navarra;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
31 Navarra;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
31 Navarra;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QII;""
31 Navarra;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QI;""
31 Navarra;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
31 Navarra;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
31 Navarra;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
31 Navarra;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
31 Navarra;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
31 Navarra;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
31 Navarra;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
31 Navarra;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
31 Navarra;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
31 Navarra;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
31 Navarra;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
31 Navarra;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
31 Navarra;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
31 Navarra;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;98,29
31 Navarra;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
31 Navarra;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
31 Navarra;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
31 Navarra;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;98,37
31 Navarra;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
31 Navarra;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
31 Navarra;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
31 Navarra;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;97,79
31 Navarra;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
31 Navarra;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
31 Navarra;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;96,44
31 Navarra;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
31 Navarra;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
31 Navarra;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
31 Navarra;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;96,37
31 Navarra;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
31 Navarra;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
31 Navarra;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
31 Navarra;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;96,31
31 Navarra;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
31 Navarra;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
31 Navarra;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
31 Navarra;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
31 Navarra;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
31 Navarra;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
31 Navarra;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;94,7
31 Navarra;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
31 Navarra;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
31 Navarra;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
31 Navarra;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;95,08
31 Navarra;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
31 Navarra;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
31 Navarra;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
31 Navarra;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
31 Navarra;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
31 Navarra;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
31 Navarra;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;93,06
31 Navarra;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
31 Navarra;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
31 Navarra;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
31 Navarra;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;93,63
31 Navarra;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
31 Navarra;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
31 Navarra;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
31 Navarra;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
31 Navarra;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
31 Navarra;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
31 Navarra;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QIII;4.600
31 Navarra;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
31 Navarra;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
31 Navarra;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
31 Navarra;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QIII;4.574
31 Navarra;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
31 Navarra;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
31 Navarra;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
31 Navarra;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QIII;4.541
31 Navarra;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
31 Navarra;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
31 Navarra;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
31 Navarra;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2022QIII;4.511
31 Navarra;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2022QII;""
31 Navarra;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2022QI;""
31 Navarra;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
31 Navarra;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2021QIII;4.491
31 Navarra;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2021QII;""
31 Navarra;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2021QI;""
31 Navarra;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
31 Navarra;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2020QIII;4.450
31 Navarra;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2020QII;""
31 Navarra;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2020QI;""
31 Navarra;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2022QIV;4.430
31 Navarra;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
31 Navarra;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2022QII;""
31 Navarra;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2022QI;""
31 Navarra;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2021QIV;4.419
31 Navarra;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
31 Navarra;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2021QII;""
31 Navarra;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2021QI;""
31 Navarra;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2020QIV;4.386
31 Navarra;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
31 Navarra;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2020QII;""
31 Navarra;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2020QI;""
31 Navarra;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
31 Navarra;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
31 Navarra;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QII;""
31 Navarra;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QI;4.332
31 Navarra;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
31 Navarra;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
31 Navarra;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QII;""
31 Navarra;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QI;4.333
31 Navarra;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
31 Navarra;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
31 Navarra;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QII;""
31 Navarra;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QI;""
31 Navarra;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
31 Navarra;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
31 Navarra;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QII;4.237
31 Navarra;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QI;""
31 Navarra;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
31 Navarra;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
31 Navarra;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QII;4.261
31 Navarra;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QI;""
31 Navarra;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
31 Navarra;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
31 Navarra;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QII;""
31 Navarra;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QI;""
31 Navarra;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
31 Navarra;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
31 Navarra;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
31 Navarra;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
31 Navarra;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
31 Navarra;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
31 Navarra;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
31 Navarra;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
31 Navarra;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
31 Navarra;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
31 Navarra;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
31 Navarra;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
31 Navarra;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
31 Navarra;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;98,07
31 Navarra;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
31 Navarra;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
31 Navarra;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
31 Navarra;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;98,19
31 Navarra;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
31 Navarra;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
31 Navarra;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
31 Navarra;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;98
31 Navarra;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
31 Navarra;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
31 Navarra;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;96,3
31 Navarra;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
31 Navarra;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
31 Navarra;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
31 Navarra;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;96,61
31 Navarra;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
31 Navarra;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
31 Navarra;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
31 Navarra;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;96,59
31 Navarra;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
31 Navarra;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
31 Navarra;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
31 Navarra;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
31 Navarra;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
31 Navarra;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
31 Navarra;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;94,71
31 Navarra;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
31 Navarra;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
31 Navarra;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
31 Navarra;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;95,42
31 Navarra;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
31 Navarra;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
31 Navarra;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
31 Navarra;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
31 Navarra;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
31 Navarra;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
31 Navarra;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;92,63
31 Navarra;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
31 Navarra;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
31 Navarra;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
31 Navarra;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;93,83
31 Navarra;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
31 Navarra;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
31 Navarra;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
31 Navarra;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
31 Navarra;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
31 Navarra;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QIV;12.780
31 Navarra;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
31 Navarra;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
31 Navarra;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
31 Navarra;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QIV;12.646
31 Navarra;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
31 Navarra;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
31 Navarra;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
31 Navarra;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QIV;12.518
31 Navarra;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
31 Navarra;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
31 Navarra;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
31 Navarra;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2022QIV;12.517
31 Navarra;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
31 Navarra;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2022QII;""
31 Navarra;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2022QI;""
31 Navarra;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2021QIV;12.379
31 Navarra;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
31 Navarra;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2021QII;""
31 Navarra;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2021QI;""
31 Navarra;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2020QIV;12.306
31 Navarra;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
31 Navarra;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2020QII;""
31 Navarra;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2020QI;""
31 Navarra;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
31 Navarra;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
31 Navarra;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2022QII;""
31 Navarra;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2022QI;12.145
31 Navarra;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
31 Navarra;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
31 Navarra;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2021QII;""
31 Navarra;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2021QI;12.148
31 Navarra;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
31 Navarra;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
31 Navarra;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2020QII;""
31 Navarra;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2020QI;""
31 Navarra;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
31 Navarra;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
31 Navarra;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QII;11.896
31 Navarra;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QI;""
31 Navarra;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
31 Navarra;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
31 Navarra;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QII;11.948
31 Navarra;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QI;""
31 Navarra;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
31 Navarra;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
31 Navarra;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QII;""
31 Navarra;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QI;""
31 Navarra;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
31 Navarra;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QIII;11.750
31 Navarra;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QII;""
31 Navarra;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QI;""
31 Navarra;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
31 Navarra;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QIII;11.772
31 Navarra;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QII;""
31 Navarra;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QI;""
31 Navarra;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
31 Navarra;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
31 Navarra;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QII;""
31 Navarra;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QI;""
31 Navarra;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
31 Navarra;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
31 Navarra;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
31 Navarra;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
31 Navarra;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
31 Navarra;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
31 Navarra;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
31 Navarra;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
31 Navarra;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
31 Navarra;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
31 Navarra;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
31 Navarra;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
31 Navarra;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;97,94
31 Navarra;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
31 Navarra;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
31 Navarra;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
31 Navarra;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;97,89
31 Navarra;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
31 Navarra;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
31 Navarra;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
31 Navarra;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;98,31
31 Navarra;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
31 Navarra;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
31 Navarra;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
31 Navarra;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
31 Navarra;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
31 Navarra;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
31 Navarra;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;96,04
31 Navarra;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
31 Navarra;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
31 Navarra;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
31 Navarra;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;97,04
31 Navarra;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
31 Navarra;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
31 Navarra;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
31 Navarra;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
31 Navarra;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
31 Navarra;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
31 Navarra;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;94,07
31 Navarra;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
31 Navarra;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
31 Navarra;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
31 Navarra;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;95,45
31 Navarra;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
31 Navarra;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
31 Navarra;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
31 Navarra;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
31 Navarra;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
31 Navarra;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
31 Navarra;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;92,91
31 Navarra;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
31 Navarra;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
31 Navarra;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
31 Navarra;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;94,04
31 Navarra;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
31 Navarra;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
31 Navarra;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
31 Navarra;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
31 Navarra;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
31 Navarra;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
31 Navarra;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QIV;8.189
31 Navarra;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
31 Navarra;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
31 Navarra;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
31 Navarra;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QIV;8.068
31 Navarra;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
31 Navarra;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
31 Navarra;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
31 Navarra;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QIV;7.999
31 Navarra;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
31 Navarra;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
31 Navarra;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
31 Navarra;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2022QIV;8.014
31 Navarra;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
31 Navarra;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2022QII;""
31 Navarra;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2022QI;""
31 Navarra;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2021QIV;7.884
31 Navarra;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
31 Navarra;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2021QII;""
31 Navarra;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2021QI;""
31 Navarra;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2020QIV;7.868
31 Navarra;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
31 Navarra;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2020QII;""
31 Navarra;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2020QI;""
31 Navarra;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
31 Navarra;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
31 Navarra;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2022QII;""
31 Navarra;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2022QI;7.743
31 Navarra;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
31 Navarra;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
31 Navarra;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2021QII;""
31 Navarra;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2021QI;7.765
31 Navarra;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
31 Navarra;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
31 Navarra;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2020QII;""
31 Navarra;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2020QI;""
31 Navarra;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
31 Navarra;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
31 Navarra;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QII;7.600
31 Navarra;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QI;""
31 Navarra;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
31 Navarra;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
31 Navarra;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QII;7.643
31 Navarra;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QI;""
31 Navarra;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
31 Navarra;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
31 Navarra;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QII;""
31 Navarra;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QI;""
31 Navarra;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
31 Navarra;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QIII;7.511
31 Navarra;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QII;""
31 Navarra;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QI;""
31 Navarra;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
31 Navarra;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QIII;7.535
31 Navarra;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QII;""
31 Navarra;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QI;""
31 Navarra;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
31 Navarra;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
31 Navarra;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QII;""
31 Navarra;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QI;""
31 Navarra;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
31 Navarra;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
31 Navarra;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
31 Navarra;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
31 Navarra;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
31 Navarra;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
31 Navarra;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
31 Navarra;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
31 Navarra;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
31 Navarra;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
31 Navarra;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
31 Navarra;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
31 Navarra;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;97,86
31 Navarra;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
31 Navarra;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
31 Navarra;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
31 Navarra;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;97,72
31 Navarra;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
31 Navarra;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
31 Navarra;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
31 Navarra;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;98,36
31 Navarra;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
31 Navarra;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
31 Navarra;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
31 Navarra;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
31 Navarra;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
31 Navarra;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
31 Navarra;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;95,97
31 Navarra;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
31 Navarra;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
31 Navarra;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
31 Navarra;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;97,07
31 Navarra;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
31 Navarra;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
31 Navarra;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
31 Navarra;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
31 Navarra;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
31 Navarra;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
31 Navarra;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;94,2
31 Navarra;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
31 Navarra;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
31 Navarra;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
31 Navarra;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;95,55
31 Navarra;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
31 Navarra;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
31 Navarra;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
31 Navarra;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
31 Navarra;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
31 Navarra;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
31 Navarra;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;93,1
31 Navarra;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
31 Navarra;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
31 Navarra;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
31 Navarra;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;94,2
31 Navarra;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
31 Navarra;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
31 Navarra;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
31 Navarra;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
31 Navarra;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
31 Navarra;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
31 Navarra;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QIV;4.591
31 Navarra;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
31 Navarra;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
31 Navarra;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
31 Navarra;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QIV;4.578
31 Navarra;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
31 Navarra;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
31 Navarra;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
31 Navarra;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QIV;4.519
31 Navarra;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
31 Navarra;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
31 Navarra;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
31 Navarra;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2022QIV;4.503
31 Navarra;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
31 Navarra;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2022QII;""
31 Navarra;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2022QI;""
31 Navarra;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2021QIV;4.495
31 Navarra;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
31 Navarra;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2021QII;""
31 Navarra;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2021QI;""
31 Navarra;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2020QIV;4.438
31 Navarra;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
31 Navarra;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2020QII;""
31 Navarra;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2020QI;""
31 Navarra;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
31 Navarra;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
31 Navarra;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2022QII;""
31 Navarra;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2022QI;4.402
31 Navarra;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
31 Navarra;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
31 Navarra;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2021QII;""
31 Navarra;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2021QI;4.383
31 Navarra;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
31 Navarra;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
31 Navarra;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2020QII;""
31 Navarra;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2020QI;""
31 Navarra;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
31 Navarra;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
31 Navarra;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QII;4.296
31 Navarra;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QI;""
31 Navarra;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
31 Navarra;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
31 Navarra;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QII;4.305
31 Navarra;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QI;""
31 Navarra;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
31 Navarra;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
31 Navarra;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QII;""
31 Navarra;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QI;""
31 Navarra;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
31 Navarra;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QIII;4.239
31 Navarra;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QII;""
31 Navarra;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QI;""
31 Navarra;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
31 Navarra;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QIII;4.237
31 Navarra;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QII;""
31 Navarra;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QI;""
31 Navarra;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
31 Navarra;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
31 Navarra;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QII;""
31 Navarra;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QI;""
31 Navarra;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
31 Navarra;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
31 Navarra;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
31 Navarra;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
31 Navarra;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
31 Navarra;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
31 Navarra;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
31 Navarra;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
31 Navarra;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
31 Navarra;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
31 Navarra;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
31 Navarra;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
31 Navarra;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;98,08
31 Navarra;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
31 Navarra;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
31 Navarra;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
31 Navarra;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;98,19
31 Navarra;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
31 Navarra;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
31 Navarra;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
31 Navarra;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;98,21
31 Navarra;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
31 Navarra;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
31 Navarra;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
31 Navarra;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
31 Navarra;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
31 Navarra;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
31 Navarra;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;96,16
31 Navarra;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
31 Navarra;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
31 Navarra;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
31 Navarra;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;96,99
31 Navarra;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
31 Navarra;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
31 Navarra;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
31 Navarra;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
31 Navarra;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
31 Navarra;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
31 Navarra;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;93,84
31 Navarra;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
31 Navarra;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
31 Navarra;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
31 Navarra;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;95,26
31 Navarra;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
31 Navarra;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
31 Navarra;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
31 Navarra;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
31 Navarra;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
31 Navarra;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
31 Navarra;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;92,6
31 Navarra;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
31 Navarra;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
31 Navarra;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
31 Navarra;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;93,76
31 Navarra;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
31 Navarra;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
31 Navarra;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
31 Navarra;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
31 Navarra;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
31 Navarra;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
31 Navarra;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
31 Navarra;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
31 Navarra;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
31 Navarra;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QI;6.172
31 Navarra;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
31 Navarra;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
31 Navarra;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
31 Navarra;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QI;5.812
31 Navarra;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
31 Navarra;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
31 Navarra;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
31 Navarra;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QI;6.691
31 Navarra;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
31 Navarra;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
31 Navarra;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2022QII;""
31 Navarra;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2022QI;5.956
31 Navarra;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
31 Navarra;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
31 Navarra;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2021QII;""
31 Navarra;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2021QI;5.609
31 Navarra;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
31 Navarra;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
31 Navarra;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2020QII;""
31 Navarra;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2020QI;6.327
31 Navarra;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
31 Navarra;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
31 Navarra;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2022QII;5.712
31 Navarra;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2022QI;""
31 Navarra;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
31 Navarra;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
31 Navarra;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2021QII;5.392
31 Navarra;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2021QI;""
31 Navarra;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
31 Navarra;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
31 Navarra;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2020QII;6.129
31 Navarra;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2020QI;""
31 Navarra;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
31 Navarra;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QIII;5.504
31 Navarra;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QII;""
31 Navarra;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QI;""
31 Navarra;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
31 Navarra;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QIII;5.204
31 Navarra;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QII;""
31 Navarra;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QI;""
31 Navarra;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
31 Navarra;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QIII;5.893
31 Navarra;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QII;""
31 Navarra;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QI;""
31 Navarra;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QIV;5.053
31 Navarra;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
31 Navarra;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QII;""
31 Navarra;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QI;""
31 Navarra;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QIV;4.906
31 Navarra;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
31 Navarra;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QII;""
31 Navarra;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QI;""
31 Navarra;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QIV;5.580
31 Navarra;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
31 Navarra;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QII;""
31 Navarra;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QI;""
31 Navarra;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
31 Navarra;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
31 Navarra;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
31 Navarra;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
31 Navarra;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
31 Navarra;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
31 Navarra;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
31 Navarra;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
31 Navarra;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
31 Navarra;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
31 Navarra;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
31 Navarra;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
31 Navarra;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
31 Navarra;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
31 Navarra;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
31 Navarra;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;96,5
31 Navarra;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
31 Navarra;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
31 Navarra;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
31 Navarra;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;96,51
31 Navarra;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
31 Navarra;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
31 Navarra;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
31 Navarra;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;94,56
31 Navarra;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
31 Navarra;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
31 Navarra;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;92,55
31 Navarra;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
31 Navarra;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
31 Navarra;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
31 Navarra;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;92,77
31 Navarra;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
31 Navarra;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
31 Navarra;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
31 Navarra;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;91,6
31 Navarra;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
31 Navarra;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
31 Navarra;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;89,18
31 Navarra;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
31 Navarra;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
31 Navarra;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
31 Navarra;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;89,54
31 Navarra;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
31 Navarra;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
31 Navarra;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
31 Navarra;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;88,07
31 Navarra;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
31 Navarra;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
31 Navarra;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;81,87
31 Navarra;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
31 Navarra;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
31 Navarra;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
31 Navarra;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;84,41
31 Navarra;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
31 Navarra;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
31 Navarra;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
31 Navarra;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;83,4
31 Navarra;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
31 Navarra;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
31 Navarra;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
31 Navarra;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
31 Navarra;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
31 Navarra;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
31 Navarra;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QI;4.068
31 Navarra;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
31 Navarra;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
31 Navarra;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
31 Navarra;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QI;3.835
31 Navarra;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
31 Navarra;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
31 Navarra;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
31 Navarra;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QI;4.444
31 Navarra;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
31 Navarra;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
31 Navarra;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2022QII;""
31 Navarra;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2022QI;3.916
31 Navarra;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
31 Navarra;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
31 Navarra;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2021QII;""
31 Navarra;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2021QI;3.708
31 Navarra;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
31 Navarra;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
31 Navarra;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2020QII;""
31 Navarra;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2020QI;4.195
31 Navarra;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
31 Navarra;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
31 Navarra;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2022QII;3.774
31 Navarra;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2022QI;""
31 Navarra;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
31 Navarra;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
31 Navarra;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2021QII;3.573
31 Navarra;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2021QI;""
31 Navarra;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
31 Navarra;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
31 Navarra;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2020QII;4.070
31 Navarra;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2020QI;""
31 Navarra;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
31 Navarra;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QIII;3.641
31 Navarra;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QII;""
31 Navarra;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QI;""
31 Navarra;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
31 Navarra;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QIII;3.453
31 Navarra;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QII;""
31 Navarra;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QI;""
31 Navarra;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
31 Navarra;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QIII;3.916
31 Navarra;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QII;""
31 Navarra;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QI;""
31 Navarra;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QIV;3.343
31 Navarra;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
31 Navarra;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QII;""
31 Navarra;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QI;""
31 Navarra;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QIV;3.264
31 Navarra;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
31 Navarra;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QII;""
31 Navarra;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QI;""
31 Navarra;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QIV;3.696
31 Navarra;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
31 Navarra;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QII;""
31 Navarra;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QI;""
31 Navarra;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
31 Navarra;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
31 Navarra;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
31 Navarra;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
31 Navarra;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
31 Navarra;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
31 Navarra;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
31 Navarra;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
31 Navarra;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
31 Navarra;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
31 Navarra;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
31 Navarra;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
31 Navarra;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
31 Navarra;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
31 Navarra;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
31 Navarra;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;96,26
31 Navarra;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
31 Navarra;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
31 Navarra;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
31 Navarra;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;96,69
31 Navarra;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
31 Navarra;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
31 Navarra;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
31 Navarra;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;94,4
31 Navarra;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
31 Navarra;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
31 Navarra;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;92,77
31 Navarra;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
31 Navarra;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
31 Navarra;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
31 Navarra;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;93,17
31 Navarra;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
31 Navarra;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
31 Navarra;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
31 Navarra;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;91,58
31 Navarra;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
31 Navarra;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
31 Navarra;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;89,5
31 Navarra;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
31 Navarra;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
31 Navarra;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
31 Navarra;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;90,04
31 Navarra;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
31 Navarra;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
31 Navarra;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
31 Navarra;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;88,12
31 Navarra;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
31 Navarra;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
31 Navarra;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;82,18
31 Navarra;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
31 Navarra;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
31 Navarra;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
31 Navarra;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;85,11
31 Navarra;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
31 Navarra;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
31 Navarra;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
31 Navarra;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;83,17
31 Navarra;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
31 Navarra;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
31 Navarra;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
31 Navarra;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
31 Navarra;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
31 Navarra;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
31 Navarra;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QI;2.104
31 Navarra;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
31 Navarra;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
31 Navarra;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
31 Navarra;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QI;1.977
31 Navarra;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
31 Navarra;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
31 Navarra;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
31 Navarra;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QI;2.247
31 Navarra;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
31 Navarra;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
31 Navarra;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2022QII;""
31 Navarra;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2022QI;2.040
31 Navarra;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
31 Navarra;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
31 Navarra;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2021QII;""
31 Navarra;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2021QI;1.901
31 Navarra;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
31 Navarra;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
31 Navarra;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2020QII;""
31 Navarra;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2020QI;2.132
31 Navarra;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
31 Navarra;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
31 Navarra;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2022QII;1.938
31 Navarra;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2022QI;""
31 Navarra;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
31 Navarra;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
31 Navarra;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2021QII;1.819
31 Navarra;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2021QI;""
31 Navarra;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
31 Navarra;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
31 Navarra;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2020QII;2.059
31 Navarra;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2020QI;""
31 Navarra;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
31 Navarra;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QIII;1.863
31 Navarra;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QII;""
31 Navarra;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QI;""
31 Navarra;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
31 Navarra;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QIII;1.751
31 Navarra;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QII;""
31 Navarra;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QI;""
31 Navarra;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
31 Navarra;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QIII;1.977
31 Navarra;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QII;""
31 Navarra;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QI;""
31 Navarra;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QIV;1.710
31 Navarra;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
31 Navarra;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QII;""
31 Navarra;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QI;""
31 Navarra;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QIV;1.642
31 Navarra;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
31 Navarra;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QII;""
31 Navarra;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QI;""
31 Navarra;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QIV;1.884
31 Navarra;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
31 Navarra;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QII;""
31 Navarra;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QI;""
31 Navarra;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
31 Navarra;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
31 Navarra;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
31 Navarra;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
31 Navarra;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
31 Navarra;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
31 Navarra;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
31 Navarra;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
31 Navarra;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
31 Navarra;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
31 Navarra;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
31 Navarra;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
31 Navarra;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
31 Navarra;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
31 Navarra;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
31 Navarra;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;96,96
31 Navarra;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
31 Navarra;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
31 Navarra;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
31 Navarra;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;96,16
31 Navarra;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
31 Navarra;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
31 Navarra;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
31 Navarra;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;94,88
31 Navarra;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
31 Navarra;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
31 Navarra;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;92,11
31 Navarra;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
31 Navarra;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
31 Navarra;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
31 Navarra;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;92,01
31 Navarra;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
31 Navarra;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
31 Navarra;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
31 Navarra;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;91,63
31 Navarra;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
31 Navarra;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
31 Navarra;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;88,55
31 Navarra;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
31 Navarra;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
31 Navarra;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
31 Navarra;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;88,57
31 Navarra;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
31 Navarra;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
31 Navarra;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
31 Navarra;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;87,98
31 Navarra;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
31 Navarra;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
31 Navarra;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;81,27
31 Navarra;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
31 Navarra;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
31 Navarra;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
31 Navarra;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;83,06
31 Navarra;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
31 Navarra;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
31 Navarra;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
31 Navarra;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;83,85
31 Navarra;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
31 Navarra;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
31 Navarra;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
31 Navarra;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
31 Navarra;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
31 Navarra;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QII;7.116
31 Navarra;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
31 Navarra;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
31 Navarra;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
31 Navarra;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QII;6.821
31 Navarra;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
31 Navarra;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
31 Navarra;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
31 Navarra;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QII;6.488
31 Navarra;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
31 Navarra;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
31 Navarra;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
31 Navarra;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2022QII;6.837
31 Navarra;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2022QI;""
31 Navarra;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
31 Navarra;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
31 Navarra;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2021QII;6.583
31 Navarra;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2021QI;""
31 Navarra;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
31 Navarra;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
31 Navarra;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2020QII;6.282
31 Navarra;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2020QI;""
31 Navarra;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
31 Navarra;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2022QIII;6.619
31 Navarra;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2022QII;""
31 Navarra;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2022QI;""
31 Navarra;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
31 Navarra;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2021QIII;6.369
31 Navarra;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2021QII;""
31 Navarra;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2021QI;""
31 Navarra;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
31 Navarra;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2020QIII;6.002
31 Navarra;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2020QII;""
31 Navarra;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2020QI;""
31 Navarra;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QIV;6.149
31 Navarra;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
31 Navarra;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QII;""
31 Navarra;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QI;""
31 Navarra;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QIV;6.043
31 Navarra;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
31 Navarra;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QII;""
31 Navarra;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QI;""
31 Navarra;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QIV;5.684
31 Navarra;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
31 Navarra;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QII;""
31 Navarra;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QI;""
31 Navarra;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
31 Navarra;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
31 Navarra;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QII;""
31 Navarra;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QI;5.843
31 Navarra;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
31 Navarra;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
31 Navarra;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QII;""
31 Navarra;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QI;5.491
31 Navarra;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
31 Navarra;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
31 Navarra;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QII;""
31 Navarra;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QI;""
31 Navarra;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
31 Navarra;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
31 Navarra;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
31 Navarra;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
31 Navarra;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
31 Navarra;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
31 Navarra;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
31 Navarra;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
31 Navarra;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
31 Navarra;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
31 Navarra;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
31 Navarra;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
31 Navarra;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
31 Navarra;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
31 Navarra;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;96,08
31 Navarra;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
31 Navarra;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
31 Navarra;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
31 Navarra;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;96,51
31 Navarra;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
31 Navarra;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
31 Navarra;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
31 Navarra;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;96,82
31 Navarra;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
31 Navarra;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
31 Navarra;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;93,02
31 Navarra;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
31 Navarra;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
31 Navarra;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
31 Navarra;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;93,37
31 Navarra;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
31 Navarra;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
31 Navarra;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
31 Navarra;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;92,51
31 Navarra;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
31 Navarra;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
31 Navarra;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;86,41
31 Navarra;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
31 Navarra;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
31 Navarra;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
31 Navarra;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;88,59
31 Navarra;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
31 Navarra;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
31 Navarra;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
31 Navarra;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;87,61
31 Navarra;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
31 Navarra;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
31 Navarra;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
31 Navarra;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
31 Navarra;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
31 Navarra;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
31 Navarra;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;85,66
31 Navarra;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
31 Navarra;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
31 Navarra;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
31 Navarra;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;84,63
31 Navarra;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
31 Navarra;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
31 Navarra;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
31 Navarra;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
31 Navarra;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
31 Navarra;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
31 Navarra;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QII;4.646
31 Navarra;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
31 Navarra;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
31 Navarra;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
31 Navarra;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QII;4.481
31 Navarra;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
31 Navarra;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
31 Navarra;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
31 Navarra;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QII;4.310
31 Navarra;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
31 Navarra;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
31 Navarra;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
31 Navarra;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2022QII;4.481
31 Navarra;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2022QI;""
31 Navarra;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
31 Navarra;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
31 Navarra;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2021QII;4.334
31 Navarra;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2021QI;""
31 Navarra;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
31 Navarra;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
31 Navarra;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2020QII;4.179
31 Navarra;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2020QI;""
31 Navarra;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
31 Navarra;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2022QIII;4.343
31 Navarra;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2022QII;""
31 Navarra;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2022QI;""
31 Navarra;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
31 Navarra;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2021QIII;4.195
31 Navarra;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2021QII;""
31 Navarra;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2021QI;""
31 Navarra;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
31 Navarra;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2020QIII;3.988
31 Navarra;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2020QII;""
31 Navarra;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2020QI;""
31 Navarra;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QIV;4.035
31 Navarra;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
31 Navarra;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QII;""
31 Navarra;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QI;""
31 Navarra;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QIV;3.988
31 Navarra;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
31 Navarra;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QII;""
31 Navarra;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QI;""
31 Navarra;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QIV;3.763
31 Navarra;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
31 Navarra;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QII;""
31 Navarra;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QI;""
31 Navarra;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
31 Navarra;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
31 Navarra;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QII;""
31 Navarra;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QI;3.848
31 Navarra;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
31 Navarra;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
31 Navarra;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QII;""
31 Navarra;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QI;3.642
31 Navarra;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
31 Navarra;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
31 Navarra;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QII;""
31 Navarra;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QI;""
31 Navarra;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
31 Navarra;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
31 Navarra;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
31 Navarra;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
31 Navarra;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
31 Navarra;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
31 Navarra;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
31 Navarra;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
31 Navarra;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
31 Navarra;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
31 Navarra;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
31 Navarra;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
31 Navarra;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
31 Navarra;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
31 Navarra;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;96,45
31 Navarra;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
31 Navarra;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
31 Navarra;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
31 Navarra;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;96,72
31 Navarra;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
31 Navarra;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
31 Navarra;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
31 Navarra;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;96,96
31 Navarra;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
31 Navarra;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
31 Navarra;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;93,48
31 Navarra;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
31 Navarra;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
31 Navarra;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
31 Navarra;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;93,62
31 Navarra;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
31 Navarra;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
31 Navarra;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
31 Navarra;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;92,53
31 Navarra;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
31 Navarra;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
31 Navarra;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;86,85
31 Navarra;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
31 Navarra;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
31 Navarra;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
31 Navarra;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;89
31 Navarra;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
31 Navarra;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
31 Navarra;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
31 Navarra;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;87,31
31 Navarra;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
31 Navarra;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
31 Navarra;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
31 Navarra;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
31 Navarra;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
31 Navarra;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
31 Navarra;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;85,87
31 Navarra;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
31 Navarra;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
31 Navarra;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
31 Navarra;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;84,5
31 Navarra;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
31 Navarra;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
31 Navarra;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
31 Navarra;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
31 Navarra;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
31 Navarra;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
31 Navarra;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QII;2.470
31 Navarra;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
31 Navarra;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
31 Navarra;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
31 Navarra;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QII;2.340
31 Navarra;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
31 Navarra;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
31 Navarra;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
31 Navarra;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QII;2.178
31 Navarra;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
31 Navarra;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
31 Navarra;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
31 Navarra;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2022QII;2.356
31 Navarra;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2022QI;""
31 Navarra;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
31 Navarra;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
31 Navarra;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2021QII;2.249
31 Navarra;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2021QI;""
31 Navarra;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
31 Navarra;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
31 Navarra;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2020QII;2.103
31 Navarra;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2020QI;""
31 Navarra;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
31 Navarra;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2022QIII;2.276
31 Navarra;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2022QII;""
31 Navarra;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2022QI;""
31 Navarra;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
31 Navarra;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2021QIII;2.174
31 Navarra;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2021QII;""
31 Navarra;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2021QI;""
31 Navarra;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
31 Navarra;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2020QIII;2.014
31 Navarra;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2020QII;""
31 Navarra;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2020QI;""
31 Navarra;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QIV;2.114
31 Navarra;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
31 Navarra;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QII;""
31 Navarra;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QI;""
31 Navarra;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QIV;2.055
31 Navarra;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
31 Navarra;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QII;""
31 Navarra;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QI;""
31 Navarra;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QIV;1.921
31 Navarra;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
31 Navarra;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QII;""
31 Navarra;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QI;""
31 Navarra;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
31 Navarra;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
31 Navarra;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QII;""
31 Navarra;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QI;1.995
31 Navarra;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
31 Navarra;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
31 Navarra;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QII;""
31 Navarra;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QI;1.849
31 Navarra;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
31 Navarra;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
31 Navarra;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QII;""
31 Navarra;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QI;""
31 Navarra;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
31 Navarra;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
31 Navarra;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
31 Navarra;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
31 Navarra;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
31 Navarra;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
31 Navarra;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
31 Navarra;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
31 Navarra;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
31 Navarra;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
31 Navarra;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
31 Navarra;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
31 Navarra;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
31 Navarra;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
31 Navarra;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;95,38
31 Navarra;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
31 Navarra;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
31 Navarra;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
31 Navarra;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;96,11
31 Navarra;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
31 Navarra;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
31 Navarra;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
31 Navarra;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;96,56
31 Navarra;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
31 Navarra;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
31 Navarra;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;92,15
31 Navarra;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
31 Navarra;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
31 Navarra;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
31 Navarra;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;92,91
31 Navarra;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
31 Navarra;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
31 Navarra;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
31 Navarra;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;92,47
31 Navarra;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
31 Navarra;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
31 Navarra;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;85,59
31 Navarra;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
31 Navarra;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
31 Navarra;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
31 Navarra;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;87,82
31 Navarra;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
31 Navarra;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
31 Navarra;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
31 Navarra;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;88,2
31 Navarra;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
31 Navarra;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
31 Navarra;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
31 Navarra;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
31 Navarra;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
31 Navarra;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
31 Navarra;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;85,26
31 Navarra;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
31 Navarra;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
31 Navarra;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
31 Navarra;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;84,89
31 Navarra;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
31 Navarra;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
31 Navarra;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
31 Navarra;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
31 Navarra;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
31 Navarra;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QIII;6.894
31 Navarra;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
31 Navarra;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
31 Navarra;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
31 Navarra;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QIII;6.640
31 Navarra;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
31 Navarra;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
31 Navarra;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
31 Navarra;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QIII;6.330
31 Navarra;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
31 Navarra;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
31 Navarra;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
31 Navarra;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2022QIII;6.665
31 Navarra;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2022QII;""
31 Navarra;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2022QI;""
31 Navarra;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
31 Navarra;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2021QIII;6.417
31 Navarra;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2021QII;""
31 Navarra;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2021QI;""
31 Navarra;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
31 Navarra;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2020QIII;6.042
31 Navarra;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2020QII;""
31 Navarra;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2020QI;""
31 Navarra;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2022QIV;6.190
31 Navarra;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
31 Navarra;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2022QII;""
31 Navarra;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2022QI;""
31 Navarra;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2021QIV;6.087
31 Navarra;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
31 Navarra;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2021QII;""
31 Navarra;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2021QI;""
31 Navarra;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2020QIV;5.723
31 Navarra;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
31 Navarra;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2020QII;""
31 Navarra;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2020QI;""
31 Navarra;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
31 Navarra;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
31 Navarra;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QII;""
31 Navarra;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QI;5.881
31 Navarra;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
31 Navarra;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
31 Navarra;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QII;""
31 Navarra;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QI;5.529
31 Navarra;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
31 Navarra;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
31 Navarra;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QII;""
31 Navarra;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QI;""
31 Navarra;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
31 Navarra;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
31 Navarra;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QII;5.653
31 Navarra;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QI;""
31 Navarra;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
31 Navarra;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
31 Navarra;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QII;5.322
31 Navarra;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QI;""
31 Navarra;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
31 Navarra;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
31 Navarra;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QII;""
31 Navarra;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QI;""
31 Navarra;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
31 Navarra;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
31 Navarra;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
31 Navarra;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
31 Navarra;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
31 Navarra;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
31 Navarra;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
31 Navarra;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
31 Navarra;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
31 Navarra;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
31 Navarra;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
31 Navarra;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
31 Navarra;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
31 Navarra;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;96,68
31 Navarra;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
31 Navarra;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
31 Navarra;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
31 Navarra;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;96,64
31 Navarra;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
31 Navarra;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
31 Navarra;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
31 Navarra;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;95,45
31 Navarra;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
31 Navarra;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
31 Navarra;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;89,79
31 Navarra;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
31 Navarra;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
31 Navarra;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
31 Navarra;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;91,67
31 Navarra;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
31 Navarra;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
31 Navarra;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
31 Navarra;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;90,41
31 Navarra;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
31 Navarra;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
31 Navarra;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
31 Navarra;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
31 Navarra;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
31 Navarra;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
31 Navarra;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;88,57
31 Navarra;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
31 Navarra;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
31 Navarra;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
31 Navarra;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;87,35
31 Navarra;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
31 Navarra;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
31 Navarra;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
31 Navarra;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
31 Navarra;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
31 Navarra;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
31 Navarra;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;85,14
31 Navarra;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
31 Navarra;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
31 Navarra;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
31 Navarra;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;84,08
31 Navarra;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
31 Navarra;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
31 Navarra;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
31 Navarra;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
31 Navarra;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
31 Navarra;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
31 Navarra;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QIII;4.520
31 Navarra;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
31 Navarra;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
31 Navarra;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
31 Navarra;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QIII;4.374
31 Navarra;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
31 Navarra;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
31 Navarra;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
31 Navarra;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QIII;4.206
31 Navarra;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
31 Navarra;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
31 Navarra;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
31 Navarra;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2022QIII;4.375
31 Navarra;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2022QII;""
31 Navarra;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2022QI;""
31 Navarra;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
31 Navarra;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2021QIII;4.228
31 Navarra;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2021QII;""
31 Navarra;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2021QI;""
31 Navarra;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
31 Navarra;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2020QIII;4.008
31 Navarra;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2020QII;""
31 Navarra;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2020QI;""
31 Navarra;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2022QIV;4.062
31 Navarra;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
31 Navarra;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2022QII;""
31 Navarra;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2022QI;""
31 Navarra;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2021QIV;4.017
31 Navarra;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
31 Navarra;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2021QII;""
31 Navarra;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2021QI;""
31 Navarra;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2020QIV;3.782
31 Navarra;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
31 Navarra;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2020QII;""
31 Navarra;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2020QI;""
31 Navarra;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
31 Navarra;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
31 Navarra;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QII;""
31 Navarra;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QI;3.871
31 Navarra;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
31 Navarra;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
31 Navarra;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QII;""
31 Navarra;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QI;3.661
31 Navarra;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
31 Navarra;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
31 Navarra;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QII;""
31 Navarra;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QI;""
31 Navarra;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
31 Navarra;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
31 Navarra;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QII;3.737
31 Navarra;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QI;""
31 Navarra;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
31 Navarra;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
31 Navarra;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QII;3.532
31 Navarra;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QI;""
31 Navarra;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
31 Navarra;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
31 Navarra;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QII;""
31 Navarra;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QI;""
31 Navarra;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
31 Navarra;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
31 Navarra;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
31 Navarra;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
31 Navarra;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
31 Navarra;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
31 Navarra;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
31 Navarra;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
31 Navarra;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
31 Navarra;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
31 Navarra;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
31 Navarra;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
31 Navarra;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
31 Navarra;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;96,79
31 Navarra;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
31 Navarra;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
31 Navarra;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
31 Navarra;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;96,66
31 Navarra;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
31 Navarra;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
31 Navarra;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
31 Navarra;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;95,29
31 Navarra;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
31 Navarra;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
31 Navarra;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;89,87
31 Navarra;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
31 Navarra;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
31 Navarra;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
31 Navarra;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;91,84
31 Navarra;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
31 Navarra;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
31 Navarra;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
31 Navarra;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;89,92
31 Navarra;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
31 Navarra;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
31 Navarra;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
31 Navarra;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
31 Navarra;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
31 Navarra;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
31 Navarra;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;88,5
31 Navarra;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
31 Navarra;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
31 Navarra;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
31 Navarra;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;87,04
31 Navarra;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
31 Navarra;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
31 Navarra;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
31 Navarra;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
31 Navarra;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
31 Navarra;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
31 Navarra;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;85,44
31 Navarra;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
31 Navarra;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
31 Navarra;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
31 Navarra;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;83,98
31 Navarra;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
31 Navarra;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
31 Navarra;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
31 Navarra;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
31 Navarra;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
31 Navarra;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
31 Navarra;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QIII;2.374
31 Navarra;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
31 Navarra;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
31 Navarra;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
31 Navarra;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QIII;2.266
31 Navarra;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
31 Navarra;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
31 Navarra;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
31 Navarra;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QIII;2.124
31 Navarra;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
31 Navarra;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
31 Navarra;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
31 Navarra;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2022QIII;2.290
31 Navarra;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2022QII;""
31 Navarra;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2022QI;""
31 Navarra;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
31 Navarra;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2021QIII;2.189
31 Navarra;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2021QII;""
31 Navarra;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2021QI;""
31 Navarra;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
31 Navarra;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2020QIII;2.034
31 Navarra;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2020QII;""
31 Navarra;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2020QI;""
31 Navarra;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2022QIV;2.128
31 Navarra;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
31 Navarra;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2022QII;""
31 Navarra;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2022QI;""
31 Navarra;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2021QIV;2.070
31 Navarra;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
31 Navarra;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2021QII;""
31 Navarra;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2021QI;""
31 Navarra;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2020QIV;1.941
31 Navarra;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
31 Navarra;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2020QII;""
31 Navarra;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2020QI;""
31 Navarra;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
31 Navarra;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
31 Navarra;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QII;""
31 Navarra;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QI;2.010
31 Navarra;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
31 Navarra;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
31 Navarra;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QII;""
31 Navarra;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QI;1.868
31 Navarra;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
31 Navarra;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
31 Navarra;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QII;""
31 Navarra;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QI;""
31 Navarra;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
31 Navarra;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
31 Navarra;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QII;1.916
31 Navarra;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QI;""
31 Navarra;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
31 Navarra;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
31 Navarra;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QII;1.790
31 Navarra;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QI;""
31 Navarra;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
31 Navarra;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
31 Navarra;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QII;""
31 Navarra;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QI;""
31 Navarra;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
31 Navarra;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
31 Navarra;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
31 Navarra;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
31 Navarra;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
31 Navarra;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
31 Navarra;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
31 Navarra;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
31 Navarra;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
31 Navarra;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
31 Navarra;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
31 Navarra;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
31 Navarra;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
31 Navarra;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;96,46
31 Navarra;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
31 Navarra;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
31 Navarra;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
31 Navarra;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;96,6
31 Navarra;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
31 Navarra;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
31 Navarra;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
31 Navarra;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;95,76
31 Navarra;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
31 Navarra;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
31 Navarra;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;89,64
31 Navarra;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
31 Navarra;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
31 Navarra;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
31 Navarra;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;91,35
31 Navarra;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
31 Navarra;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
31 Navarra;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
31 Navarra;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;91,38
31 Navarra;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
31 Navarra;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
31 Navarra;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
31 Navarra;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
31 Navarra;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
31 Navarra;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
31 Navarra;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;88,7
31 Navarra;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
31 Navarra;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
31 Navarra;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
31 Navarra;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;87,95
31 Navarra;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
31 Navarra;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
31 Navarra;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
31 Navarra;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
31 Navarra;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
31 Navarra;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
31 Navarra;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;84,55
31 Navarra;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
31 Navarra;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
31 Navarra;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
31 Navarra;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;84,27
31 Navarra;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
31 Navarra;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
31 Navarra;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
31 Navarra;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
31 Navarra;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
31 Navarra;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QIV;6.718
31 Navarra;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
31 Navarra;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
31 Navarra;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
31 Navarra;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QIV;6.456
31 Navarra;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
31 Navarra;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
31 Navarra;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
31 Navarra;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QIV;6.110
31 Navarra;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
31 Navarra;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
31 Navarra;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
31 Navarra;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2022QIV;6.238
31 Navarra;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
31 Navarra;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2022QII;""
31 Navarra;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2022QI;""
31 Navarra;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2021QIV;6.119
31 Navarra;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
31 Navarra;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2021QII;""
31 Navarra;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2021QI;""
31 Navarra;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2020QIV;5.778
31 Navarra;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
31 Navarra;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2020QII;""
31 Navarra;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2020QI;""
31 Navarra;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
31 Navarra;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
31 Navarra;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2022QII;""
31 Navarra;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2022QI;5.909
31 Navarra;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
31 Navarra;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
31 Navarra;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2021QII;""
31 Navarra;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2021QI;5.577
31 Navarra;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
31 Navarra;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
31 Navarra;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2020QII;""
31 Navarra;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2020QI;""
31 Navarra;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
31 Navarra;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
31 Navarra;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QII;5.676
31 Navarra;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QI;""
31 Navarra;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
31 Navarra;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
31 Navarra;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QII;5.364
31 Navarra;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QI;""
31 Navarra;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
31 Navarra;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
31 Navarra;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QII;""
31 Navarra;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QI;""
31 Navarra;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
31 Navarra;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QIII;5.471
31 Navarra;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QII;""
31 Navarra;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QI;""
31 Navarra;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
31 Navarra;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QIII;5.177
31 Navarra;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QII;""
31 Navarra;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QI;""
31 Navarra;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
31 Navarra;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
31 Navarra;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QII;""
31 Navarra;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QI;""
31 Navarra;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
31 Navarra;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
31 Navarra;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
31 Navarra;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
31 Navarra;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
31 Navarra;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
31 Navarra;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
31 Navarra;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
31 Navarra;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
31 Navarra;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
31 Navarra;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
31 Navarra;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
31 Navarra;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;92,86
31 Navarra;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
31 Navarra;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
31 Navarra;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
31 Navarra;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;94,78
31 Navarra;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
31 Navarra;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
31 Navarra;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
31 Navarra;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;94,57
31 Navarra;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
31 Navarra;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
31 Navarra;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
31 Navarra;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
31 Navarra;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
31 Navarra;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
31 Navarra;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;91,53
31 Navarra;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
31 Navarra;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
31 Navarra;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
31 Navarra;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;91,28
31 Navarra;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
31 Navarra;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
31 Navarra;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
31 Navarra;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
31 Navarra;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
31 Navarra;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
31 Navarra;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;87,92
31 Navarra;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
31 Navarra;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
31 Navarra;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
31 Navarra;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;87,79
31 Navarra;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
31 Navarra;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
31 Navarra;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
31 Navarra;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
31 Navarra;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
31 Navarra;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
31 Navarra;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;84,74
31 Navarra;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
31 Navarra;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
31 Navarra;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
31 Navarra;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;84,73
31 Navarra;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
31 Navarra;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
31 Navarra;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
31 Navarra;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
31 Navarra;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
31 Navarra;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
31 Navarra;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QIV;4.406
31 Navarra;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
31 Navarra;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
31 Navarra;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
31 Navarra;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QIV;4.248
31 Navarra;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
31 Navarra;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
31 Navarra;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
31 Navarra;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QIV;4.051
31 Navarra;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
31 Navarra;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
31 Navarra;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
31 Navarra;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2022QIV;4.089
31 Navarra;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
31 Navarra;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2022QII;""
31 Navarra;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2022QI;""
31 Navarra;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2021QIV;4.032
31 Navarra;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
31 Navarra;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2021QII;""
31 Navarra;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2021QI;""
31 Navarra;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2020QIV;3.816
31 Navarra;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
31 Navarra;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2020QII;""
31 Navarra;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2020QI;""
31 Navarra;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
31 Navarra;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
31 Navarra;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2022QII;""
31 Navarra;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2022QI;3.885
31 Navarra;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
31 Navarra;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
31 Navarra;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2021QII;""
31 Navarra;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2021QI;3.690
31 Navarra;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
31 Navarra;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
31 Navarra;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2020QII;""
31 Navarra;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2020QI;""
31 Navarra;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
31 Navarra;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
31 Navarra;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QII;3.749
31 Navarra;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QI;""
31 Navarra;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
31 Navarra;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
31 Navarra;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QII;3.556
31 Navarra;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QI;""
31 Navarra;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
31 Navarra;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
31 Navarra;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QII;""
31 Navarra;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QI;""
31 Navarra;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
31 Navarra;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QIII;3.618
31 Navarra;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QII;""
31 Navarra;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QI;""
31 Navarra;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
31 Navarra;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QIII;3.437
31 Navarra;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QII;""
31 Navarra;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QI;""
31 Navarra;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
31 Navarra;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
31 Navarra;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QII;""
31 Navarra;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QI;""
31 Navarra;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
31 Navarra;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
31 Navarra;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
31 Navarra;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
31 Navarra;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
31 Navarra;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
31 Navarra;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
31 Navarra;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
31 Navarra;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
31 Navarra;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
31 Navarra;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
31 Navarra;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
31 Navarra;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;92,81
31 Navarra;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
31 Navarra;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
31 Navarra;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
31 Navarra;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;94,92
31 Navarra;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
31 Navarra;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
31 Navarra;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
31 Navarra;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;94,2
31 Navarra;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
31 Navarra;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
31 Navarra;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
31 Navarra;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
31 Navarra;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
31 Navarra;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
31 Navarra;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;91,45
31 Navarra;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
31 Navarra;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
31 Navarra;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
31 Navarra;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;91,09
31 Navarra;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
31 Navarra;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
31 Navarra;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
31 Navarra;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
31 Navarra;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
31 Navarra;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
31 Navarra;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;88,25
31 Navarra;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
31 Navarra;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
31 Navarra;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
31 Navarra;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;87,78
31 Navarra;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
31 Navarra;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
31 Navarra;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
31 Navarra;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
31 Navarra;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
31 Navarra;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
31 Navarra;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;85,17
31 Navarra;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
31 Navarra;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
31 Navarra;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
31 Navarra;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;84,84
31 Navarra;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
31 Navarra;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
31 Navarra;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
31 Navarra;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
31 Navarra;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
31 Navarra;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
31 Navarra;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QIV;2.312
31 Navarra;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
31 Navarra;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
31 Navarra;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
31 Navarra;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QIV;2.208
31 Navarra;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
31 Navarra;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
31 Navarra;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
31 Navarra;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QIV;2.059
31 Navarra;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
31 Navarra;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
31 Navarra;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
31 Navarra;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2022QIV;2.149
31 Navarra;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
31 Navarra;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2022QII;""
31 Navarra;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2022QI;""
31 Navarra;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2021QIV;2.087
31 Navarra;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
31 Navarra;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2021QII;""
31 Navarra;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2021QI;""
31 Navarra;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2020QIV;1.962
31 Navarra;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
31 Navarra;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2020QII;""
31 Navarra;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2020QI;""
31 Navarra;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
31 Navarra;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
31 Navarra;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2022QII;""
31 Navarra;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2022QI;2.024
31 Navarra;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
31 Navarra;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
31 Navarra;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2021QII;""
31 Navarra;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2021QI;1.887
31 Navarra;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
31 Navarra;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
31 Navarra;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2020QII;""
31 Navarra;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2020QI;""
31 Navarra;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
31 Navarra;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
31 Navarra;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QII;1.927
31 Navarra;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QI;""
31 Navarra;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
31 Navarra;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
31 Navarra;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QII;1.808
31 Navarra;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QI;""
31 Navarra;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
31 Navarra;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
31 Navarra;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QII;""
31 Navarra;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QI;""
31 Navarra;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
31 Navarra;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QIII;1.853
31 Navarra;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QII;""
31 Navarra;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QI;""
31 Navarra;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
31 Navarra;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QIII;1.740
31 Navarra;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QII;""
31 Navarra;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QI;""
31 Navarra;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
31 Navarra;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
31 Navarra;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QII;""
31 Navarra;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QI;""
31 Navarra;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
31 Navarra;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
31 Navarra;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
31 Navarra;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
31 Navarra;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
31 Navarra;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
31 Navarra;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
31 Navarra;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
31 Navarra;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
31 Navarra;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
31 Navarra;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
31 Navarra;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
31 Navarra;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;92,95
31 Navarra;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
31 Navarra;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
31 Navarra;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
31 Navarra;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;94,52
31 Navarra;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
31 Navarra;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
31 Navarra;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
31 Navarra;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;95,29
31 Navarra;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
31 Navarra;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
31 Navarra;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
31 Navarra;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
31 Navarra;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
31 Navarra;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
31 Navarra;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;91,67
31 Navarra;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
31 Navarra;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
31 Navarra;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
31 Navarra;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;91,65
31 Navarra;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
31 Navarra;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
31 Navarra;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
31 Navarra;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
31 Navarra;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
31 Navarra;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
31 Navarra;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;87,27
31 Navarra;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
31 Navarra;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
31 Navarra;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
31 Navarra;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;87,81
31 Navarra;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
31 Navarra;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
31 Navarra;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
31 Navarra;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
31 Navarra;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
31 Navarra;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
31 Navarra;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;83,92
31 Navarra;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
31 Navarra;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
31 Navarra;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
31 Navarra;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;84,51
31 Navarra;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
31 Navarra;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
31 Navarra;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
31 Navarra;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
31 Navarra;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
31 Navarra;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
32 Ourense;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
32 Ourense;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
32 Ourense;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
32 Ourense;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QI;20.256
32 Ourense;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
32 Ourense;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
32 Ourense;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
32 Ourense;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QI;20.229
32 Ourense;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
32 Ourense;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
32 Ourense;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
32 Ourense;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QI;20.641
32 Ourense;All ages;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
32 Ourense;All ages;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
32 Ourense;All ages;Cohort January 1;Total;Survival in the first trimester;2022QII;""
32 Ourense;All ages;Cohort January 1;Total;Survival in the first trimester;2022QI;19.684
32 Ourense;All ages;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
32 Ourense;All ages;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
32 Ourense;All ages;Cohort January 1;Total;Survival in the first trimester;2021QII;""
32 Ourense;All ages;Cohort January 1;Total;Survival in the first trimester;2021QI;19.756
32 Ourense;All ages;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
32 Ourense;All ages;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
32 Ourense;All ages;Cohort January 1;Total;Survival in the first trimester;2020QII;""
32 Ourense;All ages;Cohort January 1;Total;Survival in the first trimester;2020QI;19.625
32 Ourense;All ages;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
32 Ourense;All ages;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
32 Ourense;All ages;Cohort January 1;Total;Survival in the second trimester;2022QII;19.152
32 Ourense;All ages;Cohort January 1;Total;Survival in the second trimester;2022QI;""
32 Ourense;All ages;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
32 Ourense;All ages;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
32 Ourense;All ages;Cohort January 1;Total;Survival in the second trimester;2021QII;19.314
32 Ourense;All ages;Cohort January 1;Total;Survival in the second trimester;2021QI;""
32 Ourense;All ages;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
32 Ourense;All ages;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
32 Ourense;All ages;Cohort January 1;Total;Survival in the second trimester;2020QII;19.278
32 Ourense;All ages;Cohort January 1;Total;Survival in the second trimester;2020QI;""
32 Ourense;All ages;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
32 Ourense;All ages;Cohort January 1;Total;Survival in the third trimester;2022QIII;18.690
32 Ourense;All ages;Cohort January 1;Total;Survival in the third trimester;2022QII;""
32 Ourense;All ages;Cohort January 1;Total;Survival in the third trimester;2022QI;""
32 Ourense;All ages;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
32 Ourense;All ages;Cohort January 1;Total;Survival in the third trimester;2021QIII;18.870
32 Ourense;All ages;Cohort January 1;Total;Survival in the third trimester;2021QII;""
32 Ourense;All ages;Cohort January 1;Total;Survival in the third trimester;2021QI;""
32 Ourense;All ages;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
32 Ourense;All ages;Cohort January 1;Total;Survival in the third trimester;2020QIII;18.856
32 Ourense;All ages;Cohort January 1;Total;Survival in the third trimester;2020QII;""
32 Ourense;All ages;Cohort January 1;Total;Survival in the third trimester;2020QI;""
32 Ourense;All ages;Cohort January 1;Total;Survival in the third trimester;2022QIV;18.101
32 Ourense;All ages;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
32 Ourense;All ages;Cohort January 1;Total;Survival in the third trimester;2022QII;""
32 Ourense;All ages;Cohort January 1;Total;Survival in the third trimester;2022QI;""
32 Ourense;All ages;Cohort January 1;Total;Survival in the third trimester;2021QIV;18.409
32 Ourense;All ages;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
32 Ourense;All ages;Cohort January 1;Total;Survival in the third trimester;2021QII;""
32 Ourense;All ages;Cohort January 1;Total;Survival in the third trimester;2021QI;""
32 Ourense;All ages;Cohort January 1;Total;Survival in the third trimester;2020QIV;18.413
32 Ourense;All ages;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
32 Ourense;All ages;Cohort January 1;Total;Survival in the third trimester;2020QII;""
32 Ourense;All ages;Cohort January 1;Total;Survival in the third trimester;2020QI;""
32 Ourense;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
32 Ourense;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
32 Ourense;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
32 Ourense;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
32 Ourense;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
32 Ourense;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
32 Ourense;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
32 Ourense;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
32 Ourense;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
32 Ourense;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
32 Ourense;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
32 Ourense;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
32 Ourense;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
32 Ourense;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
32 Ourense;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
32 Ourense;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;97,18
32 Ourense;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
32 Ourense;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
32 Ourense;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
32 Ourense;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;97,66
32 Ourense;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
32 Ourense;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
32 Ourense;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
32 Ourense;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;95,08
32 Ourense;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
32 Ourense;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
32 Ourense;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;94,55
32 Ourense;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
32 Ourense;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
32 Ourense;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
32 Ourense;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;95,48
32 Ourense;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
32 Ourense;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
32 Ourense;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
32 Ourense;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;93,4
32 Ourense;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
32 Ourense;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
32 Ourense;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;92,27
32 Ourense;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
32 Ourense;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
32 Ourense;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
32 Ourense;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;93,28
32 Ourense;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
32 Ourense;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
32 Ourense;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
32 Ourense;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;91,35
32 Ourense;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
32 Ourense;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
32 Ourense;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;89,36
32 Ourense;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
32 Ourense;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
32 Ourense;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
32 Ourense;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;91
32 Ourense;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
32 Ourense;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
32 Ourense;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
32 Ourense;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;89,21
32 Ourense;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
32 Ourense;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
32 Ourense;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
32 Ourense;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
32 Ourense;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
32 Ourense;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
32 Ourense;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QI;12.503
32 Ourense;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
32 Ourense;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
32 Ourense;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
32 Ourense;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QI;12.469
32 Ourense;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
32 Ourense;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
32 Ourense;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
32 Ourense;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QI;12.755
32 Ourense;All ages;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
32 Ourense;All ages;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
32 Ourense;All ages;Cohort January 1;Males;Survival in the first trimester;2022QII;""
32 Ourense;All ages;Cohort January 1;Males;Survival in the first trimester;2022QI;12.180
32 Ourense;All ages;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
32 Ourense;All ages;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
32 Ourense;All ages;Cohort January 1;Males;Survival in the first trimester;2021QII;""
32 Ourense;All ages;Cohort January 1;Males;Survival in the first trimester;2021QI;12.202
32 Ourense;All ages;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
32 Ourense;All ages;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
32 Ourense;All ages;Cohort January 1;Males;Survival in the first trimester;2020QII;""
32 Ourense;All ages;Cohort January 1;Males;Survival in the first trimester;2020QI;12.139
32 Ourense;All ages;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
32 Ourense;All ages;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
32 Ourense;All ages;Cohort January 1;Males;Survival in the second trimester;2022QII;11.901
32 Ourense;All ages;Cohort January 1;Males;Survival in the second trimester;2022QI;""
32 Ourense;All ages;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
32 Ourense;All ages;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
32 Ourense;All ages;Cohort January 1;Males;Survival in the second trimester;2021QII;11.958
32 Ourense;All ages;Cohort January 1;Males;Survival in the second trimester;2021QI;""
32 Ourense;All ages;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
32 Ourense;All ages;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
32 Ourense;All ages;Cohort January 1;Males;Survival in the second trimester;2020QII;11.944
32 Ourense;All ages;Cohort January 1;Males;Survival in the second trimester;2020QI;""
32 Ourense;All ages;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
32 Ourense;All ages;Cohort January 1;Males;Survival in the third trimester;2022QIII;11.643
32 Ourense;All ages;Cohort January 1;Males;Survival in the third trimester;2022QII;""
32 Ourense;All ages;Cohort January 1;Males;Survival in the third trimester;2022QI;""
32 Ourense;All ages;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
32 Ourense;All ages;Cohort January 1;Males;Survival in the third trimester;2021QIII;11.710
32 Ourense;All ages;Cohort January 1;Males;Survival in the third trimester;2021QII;""
32 Ourense;All ages;Cohort January 1;Males;Survival in the third trimester;2021QI;""
32 Ourense;All ages;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
32 Ourense;All ages;Cohort January 1;Males;Survival in the third trimester;2020QIII;11.709
32 Ourense;All ages;Cohort January 1;Males;Survival in the third trimester;2020QII;""
32 Ourense;All ages;Cohort January 1;Males;Survival in the third trimester;2020QI;""
32 Ourense;All ages;Cohort January 1;Males;Survival in the third trimester;2022QIV;11.286
32 Ourense;All ages;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
32 Ourense;All ages;Cohort January 1;Males;Survival in the third trimester;2022QII;""
32 Ourense;All ages;Cohort January 1;Males;Survival in the third trimester;2022QI;""
32 Ourense;All ages;Cohort January 1;Males;Survival in the third trimester;2021QIV;11.457
32 Ourense;All ages;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
32 Ourense;All ages;Cohort January 1;Males;Survival in the third trimester;2021QII;""
32 Ourense;All ages;Cohort January 1;Males;Survival in the third trimester;2021QI;""
32 Ourense;All ages;Cohort January 1;Males;Survival in the third trimester;2020QIV;11.437
32 Ourense;All ages;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
32 Ourense;All ages;Cohort January 1;Males;Survival in the third trimester;2020QII;""
32 Ourense;All ages;Cohort January 1;Males;Survival in the third trimester;2020QI;""
32 Ourense;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
32 Ourense;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
32 Ourense;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
32 Ourense;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
32 Ourense;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
32 Ourense;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
32 Ourense;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
32 Ourense;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
32 Ourense;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
32 Ourense;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
32 Ourense;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
32 Ourense;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
32 Ourense;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
32 Ourense;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
32 Ourense;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
32 Ourense;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;97,42
32 Ourense;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
32 Ourense;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
32 Ourense;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
32 Ourense;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;97,86
32 Ourense;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
32 Ourense;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
32 Ourense;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
32 Ourense;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;95,17
32 Ourense;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
32 Ourense;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
32 Ourense;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;95,19
32 Ourense;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
32 Ourense;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
32 Ourense;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
32 Ourense;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;95,9
32 Ourense;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
32 Ourense;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
32 Ourense;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
32 Ourense;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;93,64
32 Ourense;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
32 Ourense;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
32 Ourense;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;93,12
32 Ourense;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
32 Ourense;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
32 Ourense;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
32 Ourense;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;93,91
32 Ourense;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
32 Ourense;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
32 Ourense;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
32 Ourense;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;91,8
32 Ourense;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
32 Ourense;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
32 Ourense;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;90,27
32 Ourense;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
32 Ourense;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
32 Ourense;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
32 Ourense;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;91,88
32 Ourense;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
32 Ourense;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
32 Ourense;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
32 Ourense;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;89,67
32 Ourense;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
32 Ourense;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
32 Ourense;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
32 Ourense;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
32 Ourense;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
32 Ourense;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
32 Ourense;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QI;7.753
32 Ourense;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
32 Ourense;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
32 Ourense;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
32 Ourense;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QI;7.760
32 Ourense;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
32 Ourense;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
32 Ourense;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
32 Ourense;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QI;7.886
32 Ourense;All ages;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
32 Ourense;All ages;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
32 Ourense;All ages;Cohort January 1;Females;Survival in the first trimester;2022QII;""
32 Ourense;All ages;Cohort January 1;Females;Survival in the first trimester;2022QI;7.504
32 Ourense;All ages;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
32 Ourense;All ages;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
32 Ourense;All ages;Cohort January 1;Females;Survival in the first trimester;2021QII;""
32 Ourense;All ages;Cohort January 1;Females;Survival in the first trimester;2021QI;7.554
32 Ourense;All ages;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
32 Ourense;All ages;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
32 Ourense;All ages;Cohort January 1;Females;Survival in the first trimester;2020QII;""
32 Ourense;All ages;Cohort January 1;Females;Survival in the first trimester;2020QI;7.486
32 Ourense;All ages;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
32 Ourense;All ages;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
32 Ourense;All ages;Cohort January 1;Females;Survival in the second trimester;2022QII;7.251
32 Ourense;All ages;Cohort January 1;Females;Survival in the second trimester;2022QI;""
32 Ourense;All ages;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
32 Ourense;All ages;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
32 Ourense;All ages;Cohort January 1;Females;Survival in the second trimester;2021QII;7.356
32 Ourense;All ages;Cohort January 1;Females;Survival in the second trimester;2021QI;""
32 Ourense;All ages;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
32 Ourense;All ages;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
32 Ourense;All ages;Cohort January 1;Females;Survival in the second trimester;2020QII;7.334
32 Ourense;All ages;Cohort January 1;Females;Survival in the second trimester;2020QI;""
32 Ourense;All ages;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
32 Ourense;All ages;Cohort January 1;Females;Survival in the third trimester;2022QIII;7.047
32 Ourense;All ages;Cohort January 1;Females;Survival in the third trimester;2022QII;""
32 Ourense;All ages;Cohort January 1;Females;Survival in the third trimester;2022QI;""
32 Ourense;All ages;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
32 Ourense;All ages;Cohort January 1;Females;Survival in the third trimester;2021QIII;7.160
32 Ourense;All ages;Cohort January 1;Females;Survival in the third trimester;2021QII;""
32 Ourense;All ages;Cohort January 1;Females;Survival in the third trimester;2021QI;""
32 Ourense;All ages;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
32 Ourense;All ages;Cohort January 1;Females;Survival in the third trimester;2020QIII;7.147
32 Ourense;All ages;Cohort January 1;Females;Survival in the third trimester;2020QII;""
32 Ourense;All ages;Cohort January 1;Females;Survival in the third trimester;2020QI;""
32 Ourense;All ages;Cohort January 1;Females;Survival in the third trimester;2022QIV;6.815
32 Ourense;All ages;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
32 Ourense;All ages;Cohort January 1;Females;Survival in the third trimester;2022QII;""
32 Ourense;All ages;Cohort January 1;Females;Survival in the third trimester;2022QI;""
32 Ourense;All ages;Cohort January 1;Females;Survival in the third trimester;2021QIV;6.952
32 Ourense;All ages;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
32 Ourense;All ages;Cohort January 1;Females;Survival in the third trimester;2021QII;""
32 Ourense;All ages;Cohort January 1;Females;Survival in the third trimester;2021QI;""
32 Ourense;All ages;Cohort January 1;Females;Survival in the third trimester;2020QIV;6.976
32 Ourense;All ages;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
32 Ourense;All ages;Cohort January 1;Females;Survival in the third trimester;2020QII;""
32 Ourense;All ages;Cohort January 1;Females;Survival in the third trimester;2020QI;""
32 Ourense;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
32 Ourense;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
32 Ourense;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
32 Ourense;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
32 Ourense;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
32 Ourense;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
32 Ourense;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
32 Ourense;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
32 Ourense;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
32 Ourense;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
32 Ourense;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
32 Ourense;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
32 Ourense;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
32 Ourense;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
32 Ourense;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
32 Ourense;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;96,79
32 Ourense;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
32 Ourense;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
32 Ourense;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
32 Ourense;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;97,35
32 Ourense;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
32 Ourense;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
32 Ourense;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
32 Ourense;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;94,93
32 Ourense;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
32 Ourense;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
32 Ourense;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;93,53
32 Ourense;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
32 Ourense;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
32 Ourense;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
32 Ourense;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;94,79
32 Ourense;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
32 Ourense;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
32 Ourense;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
32 Ourense;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;93
32 Ourense;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
32 Ourense;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
32 Ourense;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;90,89
32 Ourense;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
32 Ourense;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
32 Ourense;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
32 Ourense;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;92,27
32 Ourense;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
32 Ourense;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
32 Ourense;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
32 Ourense;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;90,63
32 Ourense;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
32 Ourense;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
32 Ourense;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;87,9
32 Ourense;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
32 Ourense;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
32 Ourense;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
32 Ourense;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;89,59
32 Ourense;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
32 Ourense;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
32 Ourense;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
32 Ourense;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;88,46
32 Ourense;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
32 Ourense;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
32 Ourense;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
32 Ourense;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
32 Ourense;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
32 Ourense;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QII;20.220
32 Ourense;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
32 Ourense;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
32 Ourense;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
32 Ourense;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QII;20.285
32 Ourense;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
32 Ourense;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
32 Ourense;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
32 Ourense;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QII;20.314
32 Ourense;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
32 Ourense;All ages;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
32 Ourense;All ages;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
32 Ourense;All ages;Cohort April 1;Total;Survival in the first trimester;2022QII;19.638
32 Ourense;All ages;Cohort April 1;Total;Survival in the first trimester;2022QI;""
32 Ourense;All ages;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
32 Ourense;All ages;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
32 Ourense;All ages;Cohort April 1;Total;Survival in the first trimester;2021QII;19.790
32 Ourense;All ages;Cohort April 1;Total;Survival in the first trimester;2021QI;""
32 Ourense;All ages;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
32 Ourense;All ages;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
32 Ourense;All ages;Cohort April 1;Total;Survival in the first trimester;2020QII;19.936
32 Ourense;All ages;Cohort April 1;Total;Survival in the first trimester;2020QI;""
32 Ourense;All ages;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
32 Ourense;All ages;Cohort April 1;Total;Survival in the second trimester;2022QIII;19.147
32 Ourense;All ages;Cohort April 1;Total;Survival in the second trimester;2022QII;""
32 Ourense;All ages;Cohort April 1;Total;Survival in the second trimester;2022QI;""
32 Ourense;All ages;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
32 Ourense;All ages;Cohort April 1;Total;Survival in the second trimester;2021QIII;19.310
32 Ourense;All ages;Cohort April 1;Total;Survival in the second trimester;2021QII;""
32 Ourense;All ages;Cohort April 1;Total;Survival in the second trimester;2021QI;""
32 Ourense;All ages;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
32 Ourense;All ages;Cohort April 1;Total;Survival in the second trimester;2020QIII;19.447
32 Ourense;All ages;Cohort April 1;Total;Survival in the second trimester;2020QII;""
32 Ourense;All ages;Cohort April 1;Total;Survival in the second trimester;2020QI;""
32 Ourense;All ages;Cohort April 1;Total;Survival in the third trimester;2022QIV;18.537
32 Ourense;All ages;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
32 Ourense;All ages;Cohort April 1;Total;Survival in the third trimester;2022QII;""
32 Ourense;All ages;Cohort April 1;Total;Survival in the third trimester;2022QI;""
32 Ourense;All ages;Cohort April 1;Total;Survival in the third trimester;2021QIV;18.818
32 Ourense;All ages;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
32 Ourense;All ages;Cohort April 1;Total;Survival in the third trimester;2021QII;""
32 Ourense;All ages;Cohort April 1;Total;Survival in the third trimester;2021QI;""
32 Ourense;All ages;Cohort April 1;Total;Survival in the third trimester;2020QIV;18.977
32 Ourense;All ages;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
32 Ourense;All ages;Cohort April 1;Total;Survival in the third trimester;2020QII;""
32 Ourense;All ages;Cohort April 1;Total;Survival in the third trimester;2020QI;""
32 Ourense;All ages;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
32 Ourense;All ages;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
32 Ourense;All ages;Cohort April 1;Total;Survival in the third trimester;2022QII;""
32 Ourense;All ages;Cohort April 1;Total;Survival in the third trimester;2022QI;18.353
32 Ourense;All ages;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
32 Ourense;All ages;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
32 Ourense;All ages;Cohort April 1;Total;Survival in the third trimester;2021QII;""
32 Ourense;All ages;Cohort April 1;Total;Survival in the third trimester;2021QI;18.599
32 Ourense;All ages;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
32 Ourense;All ages;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
32 Ourense;All ages;Cohort April 1;Total;Survival in the third trimester;2020QII;""
32 Ourense;All ages;Cohort April 1;Total;Survival in the third trimester;2020QI;""
32 Ourense;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
32 Ourense;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
32 Ourense;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
32 Ourense;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
32 Ourense;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
32 Ourense;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
32 Ourense;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
32 Ourense;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
32 Ourense;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
32 Ourense;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
32 Ourense;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
32 Ourense;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
32 Ourense;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
32 Ourense;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
32 Ourense;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;97,12
32 Ourense;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
32 Ourense;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
32 Ourense;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
32 Ourense;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;97,56
32 Ourense;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
32 Ourense;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
32 Ourense;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
32 Ourense;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;98,14
32 Ourense;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
32 Ourense;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
32 Ourense;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;94,69
32 Ourense;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
32 Ourense;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
32 Ourense;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
32 Ourense;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;95,19
32 Ourense;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
32 Ourense;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
32 Ourense;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
32 Ourense;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;95,73
32 Ourense;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
32 Ourense;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
32 Ourense;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;91,68
32 Ourense;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
32 Ourense;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
32 Ourense;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
32 Ourense;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;92,77
32 Ourense;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
32 Ourense;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
32 Ourense;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
32 Ourense;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;93,42
32 Ourense;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
32 Ourense;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
32 Ourense;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
32 Ourense;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
32 Ourense;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
32 Ourense;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
32 Ourense;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;90,48
32 Ourense;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
32 Ourense;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
32 Ourense;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
32 Ourense;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;91,56
32 Ourense;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
32 Ourense;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
32 Ourense;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
32 Ourense;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
32 Ourense;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
32 Ourense;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
32 Ourense;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QII;12.505
32 Ourense;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
32 Ourense;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
32 Ourense;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
32 Ourense;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QII;12.528
32 Ourense;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
32 Ourense;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
32 Ourense;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
32 Ourense;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QII;12.525
32 Ourense;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
32 Ourense;All ages;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
32 Ourense;All ages;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
32 Ourense;All ages;Cohort April 1;Males;Survival in the first trimester;2022QII;12.203
32 Ourense;All ages;Cohort April 1;Males;Survival in the first trimester;2022QI;""
32 Ourense;All ages;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
32 Ourense;All ages;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
32 Ourense;All ages;Cohort April 1;Males;Survival in the first trimester;2021QII;12.247
32 Ourense;All ages;Cohort April 1;Males;Survival in the first trimester;2021QI;""
32 Ourense;All ages;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
32 Ourense;All ages;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
32 Ourense;All ages;Cohort April 1;Males;Survival in the first trimester;2020QII;12.312
32 Ourense;All ages;Cohort April 1;Males;Survival in the first trimester;2020QI;""
32 Ourense;All ages;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
32 Ourense;All ages;Cohort April 1;Males;Survival in the second trimester;2022QIII;11.923
32 Ourense;All ages;Cohort April 1;Males;Survival in the second trimester;2022QII;""
32 Ourense;All ages;Cohort April 1;Males;Survival in the second trimester;2022QI;""
32 Ourense;All ages;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
32 Ourense;All ages;Cohort April 1;Males;Survival in the second trimester;2021QIII;11.975
32 Ourense;All ages;Cohort April 1;Males;Survival in the second trimester;2021QII;""
32 Ourense;All ages;Cohort April 1;Males;Survival in the second trimester;2021QI;""
32 Ourense;All ages;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
32 Ourense;All ages;Cohort April 1;Males;Survival in the second trimester;2020QIII;12.034
32 Ourense;All ages;Cohort April 1;Males;Survival in the second trimester;2020QII;""
32 Ourense;All ages;Cohort April 1;Males;Survival in the second trimester;2020QI;""
32 Ourense;All ages;Cohort April 1;Males;Survival in the third trimester;2022QIV;11.554
32 Ourense;All ages;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
32 Ourense;All ages;Cohort April 1;Males;Survival in the third trimester;2022QII;""
32 Ourense;All ages;Cohort April 1;Males;Survival in the third trimester;2022QI;""
32 Ourense;All ages;Cohort April 1;Males;Survival in the third trimester;2021QIV;11.700
32 Ourense;All ages;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
32 Ourense;All ages;Cohort April 1;Males;Survival in the third trimester;2021QII;""
32 Ourense;All ages;Cohort April 1;Males;Survival in the third trimester;2021QI;""
32 Ourense;All ages;Cohort April 1;Males;Survival in the third trimester;2020QIV;11.750
32 Ourense;All ages;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
32 Ourense;All ages;Cohort April 1;Males;Survival in the third trimester;2020QII;""
32 Ourense;All ages;Cohort April 1;Males;Survival in the third trimester;2020QI;""
32 Ourense;All ages;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
32 Ourense;All ages;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
32 Ourense;All ages;Cohort April 1;Males;Survival in the third trimester;2022QII;""
32 Ourense;All ages;Cohort April 1;Males;Survival in the third trimester;2022QI;11.432
32 Ourense;All ages;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
32 Ourense;All ages;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
32 Ourense;All ages;Cohort April 1;Males;Survival in the third trimester;2021QII;""
32 Ourense;All ages;Cohort April 1;Males;Survival in the third trimester;2021QI;11.538
32 Ourense;All ages;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
32 Ourense;All ages;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
32 Ourense;All ages;Cohort April 1;Males;Survival in the third trimester;2020QII;""
32 Ourense;All ages;Cohort April 1;Males;Survival in the third trimester;2020QI;""
32 Ourense;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
32 Ourense;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
32 Ourense;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
32 Ourense;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
32 Ourense;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
32 Ourense;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
32 Ourense;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
32 Ourense;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
32 Ourense;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
32 Ourense;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
32 Ourense;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
32 Ourense;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
32 Ourense;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
32 Ourense;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
32 Ourense;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;97,58
32 Ourense;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
32 Ourense;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
32 Ourense;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
32 Ourense;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;97,76
32 Ourense;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
32 Ourense;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
32 Ourense;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
32 Ourense;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;98,3
32 Ourense;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
32 Ourense;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
32 Ourense;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;95,35
32 Ourense;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
32 Ourense;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
32 Ourense;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
32 Ourense;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;95,59
32 Ourense;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
32 Ourense;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
32 Ourense;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
32 Ourense;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;96,08
32 Ourense;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
32 Ourense;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
32 Ourense;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;92,4
32 Ourense;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
32 Ourense;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
32 Ourense;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
32 Ourense;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;93,39
32 Ourense;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
32 Ourense;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
32 Ourense;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
32 Ourense;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;93,81
32 Ourense;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
32 Ourense;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
32 Ourense;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
32 Ourense;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
32 Ourense;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
32 Ourense;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
32 Ourense;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;91,25
32 Ourense;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
32 Ourense;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
32 Ourense;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
32 Ourense;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;92,12
32 Ourense;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
32 Ourense;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
32 Ourense;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
32 Ourense;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
32 Ourense;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
32 Ourense;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
32 Ourense;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QII;7.715
32 Ourense;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
32 Ourense;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
32 Ourense;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
32 Ourense;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QII;7.757
32 Ourense;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
32 Ourense;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
32 Ourense;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
32 Ourense;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QII;7.789
32 Ourense;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
32 Ourense;All ages;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
32 Ourense;All ages;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
32 Ourense;All ages;Cohort April 1;Females;Survival in the first trimester;2022QII;7.435
32 Ourense;All ages;Cohort April 1;Females;Survival in the first trimester;2022QI;""
32 Ourense;All ages;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
32 Ourense;All ages;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
32 Ourense;All ages;Cohort April 1;Females;Survival in the first trimester;2021QII;7.543
32 Ourense;All ages;Cohort April 1;Females;Survival in the first trimester;2021QI;""
32 Ourense;All ages;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
32 Ourense;All ages;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
32 Ourense;All ages;Cohort April 1;Females;Survival in the first trimester;2020QII;7.624
32 Ourense;All ages;Cohort April 1;Females;Survival in the first trimester;2020QI;""
32 Ourense;All ages;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
32 Ourense;All ages;Cohort April 1;Females;Survival in the second trimester;2022QIII;7.224
32 Ourense;All ages;Cohort April 1;Females;Survival in the second trimester;2022QII;""
32 Ourense;All ages;Cohort April 1;Females;Survival in the second trimester;2022QI;""
32 Ourense;All ages;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
32 Ourense;All ages;Cohort April 1;Females;Survival in the second trimester;2021QIII;7.335
32 Ourense;All ages;Cohort April 1;Females;Survival in the second trimester;2021QII;""
32 Ourense;All ages;Cohort April 1;Females;Survival in the second trimester;2021QI;""
32 Ourense;All ages;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
32 Ourense;All ages;Cohort April 1;Females;Survival in the second trimester;2020QIII;7.413
32 Ourense;All ages;Cohort April 1;Females;Survival in the second trimester;2020QII;""
32 Ourense;All ages;Cohort April 1;Females;Survival in the second trimester;2020QI;""
32 Ourense;All ages;Cohort April 1;Females;Survival in the third trimester;2022QIV;6.983
32 Ourense;All ages;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
32 Ourense;All ages;Cohort April 1;Females;Survival in the third trimester;2022QII;""
32 Ourense;All ages;Cohort April 1;Females;Survival in the third trimester;2022QI;""
32 Ourense;All ages;Cohort April 1;Females;Survival in the third trimester;2021QIV;7.118
32 Ourense;All ages;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
32 Ourense;All ages;Cohort April 1;Females;Survival in the third trimester;2021QII;""
32 Ourense;All ages;Cohort April 1;Females;Survival in the third trimester;2021QI;""
32 Ourense;All ages;Cohort April 1;Females;Survival in the third trimester;2020QIV;7.227
32 Ourense;All ages;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
32 Ourense;All ages;Cohort April 1;Females;Survival in the third trimester;2020QII;""
32 Ourense;All ages;Cohort April 1;Females;Survival in the third trimester;2020QI;""
32 Ourense;All ages;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
32 Ourense;All ages;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
32 Ourense;All ages;Cohort April 1;Females;Survival in the third trimester;2022QII;""
32 Ourense;All ages;Cohort April 1;Females;Survival in the third trimester;2022QI;6.921
32 Ourense;All ages;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
32 Ourense;All ages;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
32 Ourense;All ages;Cohort April 1;Females;Survival in the third trimester;2021QII;""
32 Ourense;All ages;Cohort April 1;Females;Survival in the third trimester;2021QI;7.061
32 Ourense;All ages;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
32 Ourense;All ages;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
32 Ourense;All ages;Cohort April 1;Females;Survival in the third trimester;2020QII;""
32 Ourense;All ages;Cohort April 1;Females;Survival in the third trimester;2020QI;""
32 Ourense;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
32 Ourense;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
32 Ourense;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
32 Ourense;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
32 Ourense;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
32 Ourense;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
32 Ourense;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
32 Ourense;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
32 Ourense;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
32 Ourense;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
32 Ourense;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
32 Ourense;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
32 Ourense;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
32 Ourense;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
32 Ourense;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;96,37
32 Ourense;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
32 Ourense;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
32 Ourense;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
32 Ourense;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;97,24
32 Ourense;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
32 Ourense;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
32 Ourense;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
32 Ourense;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;97,88
32 Ourense;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
32 Ourense;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
32 Ourense;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;93,64
32 Ourense;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
32 Ourense;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
32 Ourense;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
32 Ourense;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;94,56
32 Ourense;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
32 Ourense;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
32 Ourense;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
32 Ourense;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;95,17
32 Ourense;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
32 Ourense;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
32 Ourense;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;90,51
32 Ourense;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
32 Ourense;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
32 Ourense;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
32 Ourense;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;91,76
32 Ourense;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
32 Ourense;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
32 Ourense;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
32 Ourense;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;92,78
32 Ourense;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
32 Ourense;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
32 Ourense;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
32 Ourense;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
32 Ourense;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
32 Ourense;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
32 Ourense;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;89,22
32 Ourense;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
32 Ourense;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
32 Ourense;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
32 Ourense;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;90,65
32 Ourense;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
32 Ourense;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
32 Ourense;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
32 Ourense;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
32 Ourense;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
32 Ourense;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QIII;20.195
32 Ourense;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
32 Ourense;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
32 Ourense;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
32 Ourense;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QIII;20.323
32 Ourense;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
32 Ourense;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
32 Ourense;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
32 Ourense;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QIII;20.297
32 Ourense;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
32 Ourense;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
32 Ourense;All ages;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
32 Ourense;All ages;Cohort July 1;Total;Survival in the first trimester;2022QIII;19.637
32 Ourense;All ages;Cohort July 1;Total;Survival in the first trimester;2022QII;""
32 Ourense;All ages;Cohort July 1;Total;Survival in the first trimester;2022QI;""
32 Ourense;All ages;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
32 Ourense;All ages;Cohort July 1;Total;Survival in the first trimester;2021QIII;19.779
32 Ourense;All ages;Cohort July 1;Total;Survival in the first trimester;2021QII;""
32 Ourense;All ages;Cohort July 1;Total;Survival in the first trimester;2021QI;""
32 Ourense;All ages;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
32 Ourense;All ages;Cohort July 1;Total;Survival in the first trimester;2020QIII;19.760
32 Ourense;All ages;Cohort July 1;Total;Survival in the first trimester;2020QII;""
32 Ourense;All ages;Cohort July 1;Total;Survival in the first trimester;2020QI;""
32 Ourense;All ages;Cohort July 1;Total;Survival in the second trimester;2022QIV;18.971
32 Ourense;All ages;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
32 Ourense;All ages;Cohort July 1;Total;Survival in the second trimester;2022QII;""
32 Ourense;All ages;Cohort July 1;Total;Survival in the second trimester;2022QI;""
32 Ourense;All ages;Cohort July 1;Total;Survival in the second trimester;2021QIV;19.249
32 Ourense;All ages;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
32 Ourense;All ages;Cohort July 1;Total;Survival in the second trimester;2021QII;""
32 Ourense;All ages;Cohort July 1;Total;Survival in the second trimester;2021QI;""
32 Ourense;All ages;Cohort July 1;Total;Survival in the second trimester;2020QIV;19.264
32 Ourense;All ages;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
32 Ourense;All ages;Cohort July 1;Total;Survival in the second trimester;2020QII;""
32 Ourense;All ages;Cohort July 1;Total;Survival in the second trimester;2020QI;""
32 Ourense;All ages;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
32 Ourense;All ages;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
32 Ourense;All ages;Cohort July 1;Total;Survival in the third trimester;2022QII;""
32 Ourense;All ages;Cohort July 1;Total;Survival in the third trimester;2022QI;18.760
32 Ourense;All ages;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
32 Ourense;All ages;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
32 Ourense;All ages;Cohort July 1;Total;Survival in the third trimester;2021QII;""
32 Ourense;All ages;Cohort July 1;Total;Survival in the third trimester;2021QI;18.871
32 Ourense;All ages;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
32 Ourense;All ages;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
32 Ourense;All ages;Cohort July 1;Total;Survival in the third trimester;2020QII;""
32 Ourense;All ages;Cohort July 1;Total;Survival in the third trimester;2020QI;""
32 Ourense;All ages;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
32 Ourense;All ages;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
32 Ourense;All ages;Cohort July 1;Total;Survival in the third trimester;2022QII;18.288
32 Ourense;All ages;Cohort July 1;Total;Survival in the third trimester;2022QI;""
32 Ourense;All ages;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
32 Ourense;All ages;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
32 Ourense;All ages;Cohort July 1;Total;Survival in the third trimester;2021QII;18.486
32 Ourense;All ages;Cohort July 1;Total;Survival in the third trimester;2021QI;""
32 Ourense;All ages;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
32 Ourense;All ages;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
32 Ourense;All ages;Cohort July 1;Total;Survival in the third trimester;2020QII;""
32 Ourense;All ages;Cohort July 1;Total;Survival in the third trimester;2020QI;""
32 Ourense;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
32 Ourense;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
32 Ourense;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
32 Ourense;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
32 Ourense;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
32 Ourense;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
32 Ourense;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
32 Ourense;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
32 Ourense;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
32 Ourense;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
32 Ourense;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
32 Ourense;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
32 Ourense;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
32 Ourense;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;97,24
32 Ourense;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
32 Ourense;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
32 Ourense;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
32 Ourense;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;97,32
32 Ourense;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
32 Ourense;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
32 Ourense;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
32 Ourense;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;97,35
32 Ourense;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
32 Ourense;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
32 Ourense;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;93,94
32 Ourense;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
32 Ourense;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
32 Ourense;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
32 Ourense;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;94,72
32 Ourense;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
32 Ourense;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
32 Ourense;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
32 Ourense;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;94,91
32 Ourense;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
32 Ourense;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
32 Ourense;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
32 Ourense;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
32 Ourense;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
32 Ourense;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
32 Ourense;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;92,31
32 Ourense;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
32 Ourense;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
32 Ourense;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
32 Ourense;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;92,97
32 Ourense;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
32 Ourense;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
32 Ourense;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
32 Ourense;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
32 Ourense;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
32 Ourense;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
32 Ourense;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;89,99
32 Ourense;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
32 Ourense;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
32 Ourense;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
32 Ourense;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;91,08
32 Ourense;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
32 Ourense;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
32 Ourense;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
32 Ourense;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
32 Ourense;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
32 Ourense;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
32 Ourense;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QIII;12.527
32 Ourense;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
32 Ourense;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
32 Ourense;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
32 Ourense;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QIII;12.561
32 Ourense;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
32 Ourense;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
32 Ourense;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
32 Ourense;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QIII;12.535
32 Ourense;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
32 Ourense;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
32 Ourense;All ages;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
32 Ourense;All ages;Cohort July 1;Males;Survival in the first trimester;2022QIII;12.201
32 Ourense;All ages;Cohort July 1;Males;Survival in the first trimester;2022QII;""
32 Ourense;All ages;Cohort July 1;Males;Survival in the first trimester;2022QI;""
32 Ourense;All ages;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
32 Ourense;All ages;Cohort July 1;Males;Survival in the first trimester;2021QIII;12.249
32 Ourense;All ages;Cohort July 1;Males;Survival in the first trimester;2021QII;""
32 Ourense;All ages;Cohort July 1;Males;Survival in the first trimester;2021QI;""
32 Ourense;All ages;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
32 Ourense;All ages;Cohort July 1;Males;Survival in the first trimester;2020QIII;12.227
32 Ourense;All ages;Cohort July 1;Males;Survival in the first trimester;2020QII;""
32 Ourense;All ages;Cohort July 1;Males;Survival in the first trimester;2020QI;""
32 Ourense;All ages;Cohort July 1;Males;Survival in the second trimester;2022QIV;11.803
32 Ourense;All ages;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
32 Ourense;All ages;Cohort July 1;Males;Survival in the second trimester;2022QII;""
32 Ourense;All ages;Cohort July 1;Males;Survival in the second trimester;2022QI;""
32 Ourense;All ages;Cohort July 1;Males;Survival in the second trimester;2021QIV;11.949
32 Ourense;All ages;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
32 Ourense;All ages;Cohort July 1;Males;Survival in the second trimester;2021QII;""
32 Ourense;All ages;Cohort July 1;Males;Survival in the second trimester;2021QI;""
32 Ourense;All ages;Cohort July 1;Males;Survival in the second trimester;2020QIV;11.923
32 Ourense;All ages;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
32 Ourense;All ages;Cohort July 1;Males;Survival in the second trimester;2020QII;""
32 Ourense;All ages;Cohort July 1;Males;Survival in the second trimester;2020QI;""
32 Ourense;All ages;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
32 Ourense;All ages;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
32 Ourense;All ages;Cohort July 1;Males;Survival in the third trimester;2022QII;""
32 Ourense;All ages;Cohort July 1;Males;Survival in the third trimester;2022QI;11.671
32 Ourense;All ages;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
32 Ourense;All ages;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
32 Ourense;All ages;Cohort July 1;Males;Survival in the third trimester;2021QII;""
32 Ourense;All ages;Cohort July 1;Males;Survival in the third trimester;2021QI;11.701
32 Ourense;All ages;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
32 Ourense;All ages;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
32 Ourense;All ages;Cohort July 1;Males;Survival in the third trimester;2020QII;""
32 Ourense;All ages;Cohort July 1;Males;Survival in the third trimester;2020QI;""
32 Ourense;All ages;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
32 Ourense;All ages;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
32 Ourense;All ages;Cohort July 1;Males;Survival in the third trimester;2022QII;11.424
32 Ourense;All ages;Cohort July 1;Males;Survival in the third trimester;2022QI;""
32 Ourense;All ages;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
32 Ourense;All ages;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
32 Ourense;All ages;Cohort July 1;Males;Survival in the third trimester;2021QII;11.492
32 Ourense;All ages;Cohort July 1;Males;Survival in the third trimester;2021QI;""
32 Ourense;All ages;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
32 Ourense;All ages;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
32 Ourense;All ages;Cohort July 1;Males;Survival in the third trimester;2020QII;""
32 Ourense;All ages;Cohort July 1;Males;Survival in the third trimester;2020QI;""
32 Ourense;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
32 Ourense;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
32 Ourense;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
32 Ourense;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
32 Ourense;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
32 Ourense;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
32 Ourense;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
32 Ourense;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
32 Ourense;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
32 Ourense;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
32 Ourense;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
32 Ourense;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
32 Ourense;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
32 Ourense;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;97,4
32 Ourense;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
32 Ourense;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
32 Ourense;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
32 Ourense;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;97,52
32 Ourense;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
32 Ourense;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
32 Ourense;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
32 Ourense;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;97,54
32 Ourense;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
32 Ourense;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
32 Ourense;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;94,22
32 Ourense;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
32 Ourense;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
32 Ourense;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
32 Ourense;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;95,13
32 Ourense;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
32 Ourense;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
32 Ourense;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
32 Ourense;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;95,12
32 Ourense;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
32 Ourense;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
32 Ourense;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
32 Ourense;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
32 Ourense;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
32 Ourense;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
32 Ourense;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;92,91
32 Ourense;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
32 Ourense;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
32 Ourense;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
32 Ourense;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;93,35
32 Ourense;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
32 Ourense;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
32 Ourense;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
32 Ourense;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
32 Ourense;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
32 Ourense;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
32 Ourense;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;90,95
32 Ourense;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
32 Ourense;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
32 Ourense;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
32 Ourense;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;91,68
32 Ourense;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
32 Ourense;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
32 Ourense;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
32 Ourense;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
32 Ourense;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
32 Ourense;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
32 Ourense;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QIII;7.668
32 Ourense;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
32 Ourense;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
32 Ourense;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
32 Ourense;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QIII;7.762
32 Ourense;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
32 Ourense;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
32 Ourense;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
32 Ourense;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QIII;7.762
32 Ourense;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
32 Ourense;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
32 Ourense;All ages;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
32 Ourense;All ages;Cohort July 1;Females;Survival in the first trimester;2022QIII;7.436
32 Ourense;All ages;Cohort July 1;Females;Survival in the first trimester;2022QII;""
32 Ourense;All ages;Cohort July 1;Females;Survival in the first trimester;2022QI;""
32 Ourense;All ages;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
32 Ourense;All ages;Cohort July 1;Females;Survival in the first trimester;2021QIII;7.530
32 Ourense;All ages;Cohort July 1;Females;Survival in the first trimester;2021QII;""
32 Ourense;All ages;Cohort July 1;Females;Survival in the first trimester;2021QI;""
32 Ourense;All ages;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
32 Ourense;All ages;Cohort July 1;Females;Survival in the first trimester;2020QIII;7.533
32 Ourense;All ages;Cohort July 1;Females;Survival in the first trimester;2020QII;""
32 Ourense;All ages;Cohort July 1;Females;Survival in the first trimester;2020QI;""
32 Ourense;All ages;Cohort July 1;Females;Survival in the second trimester;2022QIV;7.168
32 Ourense;All ages;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
32 Ourense;All ages;Cohort July 1;Females;Survival in the second trimester;2022QII;""
32 Ourense;All ages;Cohort July 1;Females;Survival in the second trimester;2022QI;""
32 Ourense;All ages;Cohort July 1;Females;Survival in the second trimester;2021QIV;7.300
32 Ourense;All ages;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
32 Ourense;All ages;Cohort July 1;Females;Survival in the second trimester;2021QII;""
32 Ourense;All ages;Cohort July 1;Females;Survival in the second trimester;2021QI;""
32 Ourense;All ages;Cohort July 1;Females;Survival in the second trimester;2020QIV;7.341
32 Ourense;All ages;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
32 Ourense;All ages;Cohort July 1;Females;Survival in the second trimester;2020QII;""
32 Ourense;All ages;Cohort July 1;Females;Survival in the second trimester;2020QI;""
32 Ourense;All ages;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
32 Ourense;All ages;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
32 Ourense;All ages;Cohort July 1;Females;Survival in the third trimester;2022QII;""
32 Ourense;All ages;Cohort July 1;Females;Survival in the third trimester;2022QI;7.089
32 Ourense;All ages;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
32 Ourense;All ages;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
32 Ourense;All ages;Cohort July 1;Females;Survival in the third trimester;2021QII;""
32 Ourense;All ages;Cohort July 1;Females;Survival in the third trimester;2021QI;7.170
32 Ourense;All ages;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
32 Ourense;All ages;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
32 Ourense;All ages;Cohort July 1;Females;Survival in the third trimester;2020QII;""
32 Ourense;All ages;Cohort July 1;Females;Survival in the third trimester;2020QI;""
32 Ourense;All ages;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
32 Ourense;All ages;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
32 Ourense;All ages;Cohort July 1;Females;Survival in the third trimester;2022QII;6.864
32 Ourense;All ages;Cohort July 1;Females;Survival in the third trimester;2022QI;""
32 Ourense;All ages;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
32 Ourense;All ages;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
32 Ourense;All ages;Cohort July 1;Females;Survival in the third trimester;2021QII;6.994
32 Ourense;All ages;Cohort July 1;Females;Survival in the third trimester;2021QI;""
32 Ourense;All ages;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
32 Ourense;All ages;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
32 Ourense;All ages;Cohort July 1;Females;Survival in the third trimester;2020QII;""
32 Ourense;All ages;Cohort July 1;Females;Survival in the third trimester;2020QI;""
32 Ourense;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
32 Ourense;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
32 Ourense;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
32 Ourense;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
32 Ourense;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
32 Ourense;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
32 Ourense;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
32 Ourense;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
32 Ourense;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
32 Ourense;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
32 Ourense;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
32 Ourense;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
32 Ourense;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
32 Ourense;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;96,97
32 Ourense;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
32 Ourense;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
32 Ourense;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
32 Ourense;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;97,01
32 Ourense;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
32 Ourense;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
32 Ourense;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
32 Ourense;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;97,05
32 Ourense;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
32 Ourense;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
32 Ourense;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;93,48
32 Ourense;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
32 Ourense;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
32 Ourense;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
32 Ourense;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;94,05
32 Ourense;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
32 Ourense;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
32 Ourense;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
32 Ourense;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;94,58
32 Ourense;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
32 Ourense;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
32 Ourense;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
32 Ourense;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
32 Ourense;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
32 Ourense;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
32 Ourense;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;91,33
32 Ourense;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
32 Ourense;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
32 Ourense;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
32 Ourense;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;92,37
32 Ourense;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
32 Ourense;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
32 Ourense;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
32 Ourense;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
32 Ourense;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
32 Ourense;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
32 Ourense;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;88,43
32 Ourense;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
32 Ourense;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
32 Ourense;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
32 Ourense;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;90,11
32 Ourense;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
32 Ourense;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
32 Ourense;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
32 Ourense;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
32 Ourense;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
32 Ourense;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QIV;20.048
32 Ourense;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
32 Ourense;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
32 Ourense;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
32 Ourense;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QIV;20.266
32 Ourense;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
32 Ourense;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
32 Ourense;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
32 Ourense;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QIV;20.288
32 Ourense;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
32 Ourense;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
32 Ourense;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
32 Ourense;All ages;Cohort October 1;Total;Survival in the first trimester;2022QIV;19.333
32 Ourense;All ages;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
32 Ourense;All ages;Cohort October 1;Total;Survival in the first trimester;2022QII;""
32 Ourense;All ages;Cohort October 1;Total;Survival in the first trimester;2022QI;""
32 Ourense;All ages;Cohort October 1;Total;Survival in the first trimester;2021QIV;19.697
32 Ourense;All ages;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
32 Ourense;All ages;Cohort October 1;Total;Survival in the first trimester;2021QII;""
32 Ourense;All ages;Cohort October 1;Total;Survival in the first trimester;2021QI;""
32 Ourense;All ages;Cohort October 1;Total;Survival in the first trimester;2020QIV;19.719
32 Ourense;All ages;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
32 Ourense;All ages;Cohort October 1;Total;Survival in the first trimester;2020QII;""
32 Ourense;All ages;Cohort October 1;Total;Survival in the first trimester;2020QI;""
32 Ourense;All ages;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
32 Ourense;All ages;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
32 Ourense;All ages;Cohort October 1;Total;Survival in the second trimester;2022QII;""
32 Ourense;All ages;Cohort October 1;Total;Survival in the second trimester;2022QI;19.182
32 Ourense;All ages;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
32 Ourense;All ages;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
32 Ourense;All ages;Cohort October 1;Total;Survival in the second trimester;2021QII;""
32 Ourense;All ages;Cohort October 1;Total;Survival in the second trimester;2021QI;19.299
32 Ourense;All ages;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
32 Ourense;All ages;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
32 Ourense;All ages;Cohort October 1;Total;Survival in the second trimester;2020QII;""
32 Ourense;All ages;Cohort October 1;Total;Survival in the second trimester;2020QI;""
32 Ourense;All ages;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
32 Ourense;All ages;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
32 Ourense;All ages;Cohort October 1;Total;Survival in the third trimester;2022QII;18.695
32 Ourense;All ages;Cohort October 1;Total;Survival in the third trimester;2022QI;""
32 Ourense;All ages;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
32 Ourense;All ages;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
32 Ourense;All ages;Cohort October 1;Total;Survival in the third trimester;2021QII;18.885
32 Ourense;All ages;Cohort October 1;Total;Survival in the third trimester;2021QI;""
32 Ourense;All ages;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
32 Ourense;All ages;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
32 Ourense;All ages;Cohort October 1;Total;Survival in the third trimester;2020QII;""
32 Ourense;All ages;Cohort October 1;Total;Survival in the third trimester;2020QI;""
32 Ourense;All ages;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
32 Ourense;All ages;Cohort October 1;Total;Survival in the third trimester;2022QIII;18.259
32 Ourense;All ages;Cohort October 1;Total;Survival in the third trimester;2022QII;""
32 Ourense;All ages;Cohort October 1;Total;Survival in the third trimester;2022QI;""
32 Ourense;All ages;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
32 Ourense;All ages;Cohort October 1;Total;Survival in the third trimester;2021QIII;18.469
32 Ourense;All ages;Cohort October 1;Total;Survival in the third trimester;2021QII;""
32 Ourense;All ages;Cohort October 1;Total;Survival in the third trimester;2021QI;""
32 Ourense;All ages;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
32 Ourense;All ages;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
32 Ourense;All ages;Cohort October 1;Total;Survival in the third trimester;2020QII;""
32 Ourense;All ages;Cohort October 1;Total;Survival in the third trimester;2020QI;""
32 Ourense;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
32 Ourense;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
32 Ourense;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
32 Ourense;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
32 Ourense;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
32 Ourense;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
32 Ourense;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
32 Ourense;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
32 Ourense;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
32 Ourense;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
32 Ourense;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
32 Ourense;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
32 Ourense;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;96,43
32 Ourense;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
32 Ourense;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
32 Ourense;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
32 Ourense;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;97,19
32 Ourense;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
32 Ourense;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
32 Ourense;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
32 Ourense;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;97,2
32 Ourense;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
32 Ourense;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
32 Ourense;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
32 Ourense;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
32 Ourense;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
32 Ourense;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
32 Ourense;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;94,65
32 Ourense;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
32 Ourense;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
32 Ourense;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
32 Ourense;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;95,13
32 Ourense;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
32 Ourense;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
32 Ourense;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
32 Ourense;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
32 Ourense;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
32 Ourense;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
32 Ourense;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;92,25
32 Ourense;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
32 Ourense;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
32 Ourense;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
32 Ourense;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;93,08
32 Ourense;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
32 Ourense;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
32 Ourense;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
32 Ourense;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
32 Ourense;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
32 Ourense;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
32 Ourense;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;90,1
32 Ourense;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
32 Ourense;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
32 Ourense;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
32 Ourense;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;91,03
32 Ourense;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
32 Ourense;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
32 Ourense;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
32 Ourense;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
32 Ourense;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
32 Ourense;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
32 Ourense;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QIV;12.429
32 Ourense;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
32 Ourense;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
32 Ourense;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
32 Ourense;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QIV;12.518
32 Ourense;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
32 Ourense;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
32 Ourense;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
32 Ourense;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QIV;12.521
32 Ourense;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
32 Ourense;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
32 Ourense;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
32 Ourense;All ages;Cohort October 1;Males;Survival in the first trimester;2022QIV;11.998
32 Ourense;All ages;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
32 Ourense;All ages;Cohort October 1;Males;Survival in the first trimester;2022QII;""
32 Ourense;All ages;Cohort October 1;Males;Survival in the first trimester;2022QI;""
32 Ourense;All ages;Cohort October 1;Males;Survival in the first trimester;2021QIV;12.192
32 Ourense;All ages;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
32 Ourense;All ages;Cohort October 1;Males;Survival in the first trimester;2021QII;""
32 Ourense;All ages;Cohort October 1;Males;Survival in the first trimester;2021QI;""
32 Ourense;All ages;Cohort October 1;Males;Survival in the first trimester;2020QIV;12.172
32 Ourense;All ages;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
32 Ourense;All ages;Cohort October 1;Males;Survival in the first trimester;2020QII;""
32 Ourense;All ages;Cohort October 1;Males;Survival in the first trimester;2020QI;""
32 Ourense;All ages;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
32 Ourense;All ages;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
32 Ourense;All ages;Cohort October 1;Males;Survival in the second trimester;2022QII;""
32 Ourense;All ages;Cohort October 1;Males;Survival in the second trimester;2022QI;11.898
32 Ourense;All ages;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
32 Ourense;All ages;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
32 Ourense;All ages;Cohort October 1;Males;Survival in the second trimester;2021QII;""
32 Ourense;All ages;Cohort October 1;Males;Survival in the second trimester;2021QI;11.935
32 Ourense;All ages;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
32 Ourense;All ages;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
32 Ourense;All ages;Cohort October 1;Males;Survival in the second trimester;2020QII;""
32 Ourense;All ages;Cohort October 1;Males;Survival in the second trimester;2020QI;""
32 Ourense;All ages;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
32 Ourense;All ages;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
32 Ourense;All ages;Cohort October 1;Males;Survival in the third trimester;2022QII;11.644
32 Ourense;All ages;Cohort October 1;Males;Survival in the third trimester;2022QI;""
32 Ourense;All ages;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
32 Ourense;All ages;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
32 Ourense;All ages;Cohort October 1;Males;Survival in the third trimester;2021QII;11.708
32 Ourense;All ages;Cohort October 1;Males;Survival in the third trimester;2021QI;""
32 Ourense;All ages;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
32 Ourense;All ages;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
32 Ourense;All ages;Cohort October 1;Males;Survival in the third trimester;2020QII;""
32 Ourense;All ages;Cohort October 1;Males;Survival in the third trimester;2020QI;""
32 Ourense;All ages;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
32 Ourense;All ages;Cohort October 1;Males;Survival in the third trimester;2022QIII;11.400
32 Ourense;All ages;Cohort October 1;Males;Survival in the third trimester;2022QII;""
32 Ourense;All ages;Cohort October 1;Males;Survival in the third trimester;2022QI;""
32 Ourense;All ages;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
32 Ourense;All ages;Cohort October 1;Males;Survival in the third trimester;2021QIII;11.477
32 Ourense;All ages;Cohort October 1;Males;Survival in the third trimester;2021QII;""
32 Ourense;All ages;Cohort October 1;Males;Survival in the third trimester;2021QI;""
32 Ourense;All ages;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
32 Ourense;All ages;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
32 Ourense;All ages;Cohort October 1;Males;Survival in the third trimester;2020QII;""
32 Ourense;All ages;Cohort October 1;Males;Survival in the third trimester;2020QI;""
32 Ourense;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
32 Ourense;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
32 Ourense;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
32 Ourense;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
32 Ourense;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
32 Ourense;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
32 Ourense;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
32 Ourense;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
32 Ourense;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
32 Ourense;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
32 Ourense;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
32 Ourense;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
32 Ourense;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;96,53
32 Ourense;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
32 Ourense;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
32 Ourense;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
32 Ourense;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;97,4
32 Ourense;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
32 Ourense;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
32 Ourense;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
32 Ourense;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;97,21
32 Ourense;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
32 Ourense;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
32 Ourense;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
32 Ourense;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
32 Ourense;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
32 Ourense;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
32 Ourense;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;95,05
32 Ourense;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
32 Ourense;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
32 Ourense;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
32 Ourense;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;95,32
32 Ourense;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
32 Ourense;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
32 Ourense;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
32 Ourense;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
32 Ourense;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
32 Ourense;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
32 Ourense;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;93,02
32 Ourense;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
32 Ourense;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
32 Ourense;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
32 Ourense;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;93,51
32 Ourense;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
32 Ourense;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
32 Ourense;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
32 Ourense;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
32 Ourense;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
32 Ourense;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
32 Ourense;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;91,07
32 Ourense;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
32 Ourense;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
32 Ourense;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
32 Ourense;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;91,66
32 Ourense;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
32 Ourense;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
32 Ourense;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
32 Ourense;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
32 Ourense;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
32 Ourense;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
32 Ourense;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QIV;7.619
32 Ourense;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
32 Ourense;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
32 Ourense;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
32 Ourense;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QIV;7.748
32 Ourense;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
32 Ourense;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
32 Ourense;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
32 Ourense;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QIV;7.767
32 Ourense;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
32 Ourense;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
32 Ourense;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
32 Ourense;All ages;Cohort October 1;Females;Survival in the first trimester;2022QIV;7.335
32 Ourense;All ages;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
32 Ourense;All ages;Cohort October 1;Females;Survival in the first trimester;2022QII;""
32 Ourense;All ages;Cohort October 1;Females;Survival in the first trimester;2022QI;""
32 Ourense;All ages;Cohort October 1;Females;Survival in the first trimester;2021QIV;7.505
32 Ourense;All ages;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
32 Ourense;All ages;Cohort October 1;Females;Survival in the first trimester;2021QII;""
32 Ourense;All ages;Cohort October 1;Females;Survival in the first trimester;2021QI;""
32 Ourense;All ages;Cohort October 1;Females;Survival in the first trimester;2020QIV;7.547
32 Ourense;All ages;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
32 Ourense;All ages;Cohort October 1;Females;Survival in the first trimester;2020QII;""
32 Ourense;All ages;Cohort October 1;Females;Survival in the first trimester;2020QI;""
32 Ourense;All ages;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
32 Ourense;All ages;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
32 Ourense;All ages;Cohort October 1;Females;Survival in the second trimester;2022QII;""
32 Ourense;All ages;Cohort October 1;Females;Survival in the second trimester;2022QI;7.284
32 Ourense;All ages;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
32 Ourense;All ages;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
32 Ourense;All ages;Cohort October 1;Females;Survival in the second trimester;2021QII;""
32 Ourense;All ages;Cohort October 1;Females;Survival in the second trimester;2021QI;7.364
32 Ourense;All ages;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
32 Ourense;All ages;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
32 Ourense;All ages;Cohort October 1;Females;Survival in the second trimester;2020QII;""
32 Ourense;All ages;Cohort October 1;Females;Survival in the second trimester;2020QI;""
32 Ourense;All ages;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
32 Ourense;All ages;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
32 Ourense;All ages;Cohort October 1;Females;Survival in the third trimester;2022QII;7.051
32 Ourense;All ages;Cohort October 1;Females;Survival in the third trimester;2022QI;""
32 Ourense;All ages;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
32 Ourense;All ages;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
32 Ourense;All ages;Cohort October 1;Females;Survival in the third trimester;2021QII;7.177
32 Ourense;All ages;Cohort October 1;Females;Survival in the third trimester;2021QI;""
32 Ourense;All ages;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
32 Ourense;All ages;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
32 Ourense;All ages;Cohort October 1;Females;Survival in the third trimester;2020QII;""
32 Ourense;All ages;Cohort October 1;Females;Survival in the third trimester;2020QI;""
32 Ourense;All ages;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
32 Ourense;All ages;Cohort October 1;Females;Survival in the third trimester;2022QIII;6.859
32 Ourense;All ages;Cohort October 1;Females;Survival in the third trimester;2022QII;""
32 Ourense;All ages;Cohort October 1;Females;Survival in the third trimester;2022QI;""
32 Ourense;All ages;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
32 Ourense;All ages;Cohort October 1;Females;Survival in the third trimester;2021QIII;6.992
32 Ourense;All ages;Cohort October 1;Females;Survival in the third trimester;2021QII;""
32 Ourense;All ages;Cohort October 1;Females;Survival in the third trimester;2021QI;""
32 Ourense;All ages;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
32 Ourense;All ages;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
32 Ourense;All ages;Cohort October 1;Females;Survival in the third trimester;2020QII;""
32 Ourense;All ages;Cohort October 1;Females;Survival in the third trimester;2020QI;""
32 Ourense;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
32 Ourense;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
32 Ourense;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
32 Ourense;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
32 Ourense;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
32 Ourense;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
32 Ourense;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
32 Ourense;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
32 Ourense;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
32 Ourense;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
32 Ourense;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
32 Ourense;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
32 Ourense;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;96,27
32 Ourense;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
32 Ourense;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
32 Ourense;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
32 Ourense;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;96,86
32 Ourense;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
32 Ourense;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
32 Ourense;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
32 Ourense;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;97,17
32 Ourense;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
32 Ourense;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
32 Ourense;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
32 Ourense;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
32 Ourense;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
32 Ourense;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
32 Ourense;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;94,01
32 Ourense;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
32 Ourense;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
32 Ourense;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
32 Ourense;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;94,81
32 Ourense;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
32 Ourense;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
32 Ourense;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
32 Ourense;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
32 Ourense;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
32 Ourense;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
32 Ourense;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;91
32 Ourense;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
32 Ourense;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
32 Ourense;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
32 Ourense;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;92,4
32 Ourense;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
32 Ourense;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
32 Ourense;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
32 Ourense;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
32 Ourense;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
32 Ourense;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
32 Ourense;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;88,53
32 Ourense;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
32 Ourense;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
32 Ourense;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
32 Ourense;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;90,02
32 Ourense;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
32 Ourense;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
32 Ourense;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
32 Ourense;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
32 Ourense;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
32 Ourense;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
32 Ourense;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
32 Ourense;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
32 Ourense;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
32 Ourense;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QI;1.072
32 Ourense;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
32 Ourense;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
32 Ourense;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
32 Ourense;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QI;1.023
32 Ourense;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
32 Ourense;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
32 Ourense;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
32 Ourense;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QI;839
32 Ourense;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
32 Ourense;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
32 Ourense;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2022QII;""
32 Ourense;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2022QI;1.001
32 Ourense;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
32 Ourense;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
32 Ourense;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2021QII;""
32 Ourense;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2021QI;972
32 Ourense;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
32 Ourense;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
32 Ourense;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2020QII;""
32 Ourense;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2020QI;742
32 Ourense;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
32 Ourense;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
32 Ourense;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2022QII;945
32 Ourense;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2022QI;""
32 Ourense;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
32 Ourense;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
32 Ourense;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2021QII;925
32 Ourense;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2021QI;""
32 Ourense;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
32 Ourense;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
32 Ourense;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2020QII;722
32 Ourense;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2020QI;""
32 Ourense;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
32 Ourense;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QIII;895
32 Ourense;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QII;""
32 Ourense;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QI;""
32 Ourense;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
32 Ourense;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QIII;878
32 Ourense;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QII;""
32 Ourense;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QI;""
32 Ourense;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
32 Ourense;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QIII;677
32 Ourense;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QII;""
32 Ourense;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QI;""
32 Ourense;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QIV;847
32 Ourense;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
32 Ourense;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QII;""
32 Ourense;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QI;""
32 Ourense;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QIV;826
32 Ourense;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
32 Ourense;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QII;""
32 Ourense;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QI;""
32 Ourense;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QIV;655
32 Ourense;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
32 Ourense;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QII;""
32 Ourense;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QI;""
32 Ourense;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
32 Ourense;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
32 Ourense;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
32 Ourense;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
32 Ourense;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
32 Ourense;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
32 Ourense;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
32 Ourense;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
32 Ourense;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
32 Ourense;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
32 Ourense;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
32 Ourense;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
32 Ourense;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
32 Ourense;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
32 Ourense;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
32 Ourense;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;93,38
32 Ourense;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
32 Ourense;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
32 Ourense;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
32 Ourense;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;95,01
32 Ourense;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
32 Ourense;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
32 Ourense;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
32 Ourense;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;88,44
32 Ourense;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
32 Ourense;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
32 Ourense;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;88,15
32 Ourense;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
32 Ourense;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
32 Ourense;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
32 Ourense;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;90,42
32 Ourense;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
32 Ourense;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
32 Ourense;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
32 Ourense;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;86,05
32 Ourense;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
32 Ourense;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
32 Ourense;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;83,49
32 Ourense;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
32 Ourense;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
32 Ourense;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
32 Ourense;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;85,83
32 Ourense;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
32 Ourense;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
32 Ourense;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
32 Ourense;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;80,69
32 Ourense;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
32 Ourense;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
32 Ourense;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;79,01
32 Ourense;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
32 Ourense;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
32 Ourense;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
32 Ourense;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;80,74
32 Ourense;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
32 Ourense;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
32 Ourense;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
32 Ourense;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;78,07
32 Ourense;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
32 Ourense;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
32 Ourense;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
32 Ourense;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
32 Ourense;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
32 Ourense;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
32 Ourense;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QI;668
32 Ourense;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
32 Ourense;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
32 Ourense;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
32 Ourense;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QI;628
32 Ourense;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
32 Ourense;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
32 Ourense;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
32 Ourense;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QI;524
32 Ourense;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
32 Ourense;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
32 Ourense;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2022QII;""
32 Ourense;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2022QI;628
32 Ourense;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
32 Ourense;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
32 Ourense;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2021QII;""
32 Ourense;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2021QI;598
32 Ourense;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
32 Ourense;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
32 Ourense;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2020QII;""
32 Ourense;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2020QI;471
32 Ourense;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
32 Ourense;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
32 Ourense;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2022QII;593
32 Ourense;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2022QI;""
32 Ourense;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
32 Ourense;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
32 Ourense;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2021QII;571
32 Ourense;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2021QI;""
32 Ourense;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
32 Ourense;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
32 Ourense;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2020QII;461
32 Ourense;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2020QI;""
32 Ourense;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
32 Ourense;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QIII;563
32 Ourense;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QII;""
32 Ourense;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QI;""
32 Ourense;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
32 Ourense;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QIII;545
32 Ourense;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QII;""
32 Ourense;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QI;""
32 Ourense;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
32 Ourense;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QIII;433
32 Ourense;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QII;""
32 Ourense;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QI;""
32 Ourense;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QIV;531
32 Ourense;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
32 Ourense;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QII;""
32 Ourense;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QI;""
32 Ourense;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QIV;515
32 Ourense;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
32 Ourense;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QII;""
32 Ourense;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QI;""
32 Ourense;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QIV;416
32 Ourense;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
32 Ourense;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QII;""
32 Ourense;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QI;""
32 Ourense;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
32 Ourense;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
32 Ourense;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
32 Ourense;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
32 Ourense;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
32 Ourense;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
32 Ourense;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
32 Ourense;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
32 Ourense;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
32 Ourense;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
32 Ourense;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
32 Ourense;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
32 Ourense;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
32 Ourense;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
32 Ourense;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
32 Ourense;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;94,01
32 Ourense;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
32 Ourense;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
32 Ourense;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
32 Ourense;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;95,22
32 Ourense;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
32 Ourense;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
32 Ourense;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
32 Ourense;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;89,89
32 Ourense;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
32 Ourense;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
32 Ourense;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;88,77
32 Ourense;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
32 Ourense;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
32 Ourense;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
32 Ourense;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;90,92
32 Ourense;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
32 Ourense;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
32 Ourense;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
32 Ourense;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;87,98
32 Ourense;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
32 Ourense;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
32 Ourense;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;84,28
32 Ourense;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
32 Ourense;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
32 Ourense;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
32 Ourense;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;86,78
32 Ourense;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
32 Ourense;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
32 Ourense;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
32 Ourense;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;82,63
32 Ourense;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
32 Ourense;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
32 Ourense;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;79,49
32 Ourense;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
32 Ourense;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
32 Ourense;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
32 Ourense;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;82,01
32 Ourense;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
32 Ourense;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
32 Ourense;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
32 Ourense;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;79,39
32 Ourense;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
32 Ourense;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
32 Ourense;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
32 Ourense;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
32 Ourense;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
32 Ourense;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
32 Ourense;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QI;404
32 Ourense;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
32 Ourense;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
32 Ourense;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
32 Ourense;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QI;395
32 Ourense;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
32 Ourense;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
32 Ourense;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
32 Ourense;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QI;315
32 Ourense;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
32 Ourense;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
32 Ourense;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2022QII;""
32 Ourense;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2022QI;373
32 Ourense;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
32 Ourense;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
32 Ourense;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2021QII;""
32 Ourense;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2021QI;374
32 Ourense;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
32 Ourense;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
32 Ourense;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2020QII;""
32 Ourense;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2020QI;271
32 Ourense;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
32 Ourense;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
32 Ourense;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2022QII;352
32 Ourense;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2022QI;""
32 Ourense;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
32 Ourense;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
32 Ourense;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2021QII;354
32 Ourense;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2021QI;""
32 Ourense;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
32 Ourense;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
32 Ourense;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2020QII;261
32 Ourense;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2020QI;""
32 Ourense;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
32 Ourense;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QIII;332
32 Ourense;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QII;""
32 Ourense;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QI;""
32 Ourense;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
32 Ourense;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QIII;333
32 Ourense;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QII;""
32 Ourense;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QI;""
32 Ourense;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
32 Ourense;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QIII;244
32 Ourense;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QII;""
32 Ourense;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QI;""
32 Ourense;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QIV;316
32 Ourense;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
32 Ourense;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QII;""
32 Ourense;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QI;""
32 Ourense;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QIV;311
32 Ourense;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
32 Ourense;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QII;""
32 Ourense;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QI;""
32 Ourense;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QIV;239
32 Ourense;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
32 Ourense;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QII;""
32 Ourense;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QI;""
32 Ourense;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
32 Ourense;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
32 Ourense;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
32 Ourense;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
32 Ourense;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
32 Ourense;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
32 Ourense;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
32 Ourense;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
32 Ourense;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
32 Ourense;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
32 Ourense;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
32 Ourense;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
32 Ourense;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
32 Ourense;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
32 Ourense;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
32 Ourense;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;92,33
32 Ourense;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
32 Ourense;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
32 Ourense;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
32 Ourense;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;94,68
32 Ourense;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
32 Ourense;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
32 Ourense;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
32 Ourense;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;86,03
32 Ourense;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
32 Ourense;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
32 Ourense;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;87,13
32 Ourense;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
32 Ourense;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
32 Ourense;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
32 Ourense;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;89,62
32 Ourense;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
32 Ourense;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
32 Ourense;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
32 Ourense;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;82,86
32 Ourense;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
32 Ourense;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
32 Ourense;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;82,18
32 Ourense;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
32 Ourense;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
32 Ourense;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
32 Ourense;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;84,3
32 Ourense;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
32 Ourense;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
32 Ourense;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
32 Ourense;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;77,46
32 Ourense;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
32 Ourense;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
32 Ourense;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;78,22
32 Ourense;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
32 Ourense;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
32 Ourense;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
32 Ourense;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;78,73
32 Ourense;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
32 Ourense;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
32 Ourense;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
32 Ourense;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;75,87
32 Ourense;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
32 Ourense;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
32 Ourense;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
32 Ourense;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
32 Ourense;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
32 Ourense;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QII;892
32 Ourense;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
32 Ourense;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
32 Ourense;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
32 Ourense;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QII;931
32 Ourense;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
32 Ourense;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
32 Ourense;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
32 Ourense;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QII;868
32 Ourense;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
32 Ourense;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
32 Ourense;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
32 Ourense;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2022QII;832
32 Ourense;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2022QI;""
32 Ourense;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
32 Ourense;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
32 Ourense;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2021QII;875
32 Ourense;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2021QI;""
32 Ourense;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
32 Ourense;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
32 Ourense;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2020QII;840
32 Ourense;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2020QI;""
32 Ourense;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
32 Ourense;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2022QIII;782
32 Ourense;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2022QII;""
32 Ourense;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2022QI;""
32 Ourense;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
32 Ourense;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2021QIII;821
32 Ourense;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2021QII;""
32 Ourense;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2021QI;""
32 Ourense;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
32 Ourense;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2020QIII;784
32 Ourense;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2020QII;""
32 Ourense;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2020QI;""
32 Ourense;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QIV;736
32 Ourense;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
32 Ourense;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QII;""
32 Ourense;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QI;""
32 Ourense;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QIV;770
32 Ourense;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
32 Ourense;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QII;""
32 Ourense;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QI;""
32 Ourense;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QIV;759
32 Ourense;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
32 Ourense;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QII;""
32 Ourense;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QI;""
32 Ourense;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
32 Ourense;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
32 Ourense;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QII;""
32 Ourense;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QI;725
32 Ourense;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
32 Ourense;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
32 Ourense;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QII;""
32 Ourense;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QI;722
32 Ourense;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
32 Ourense;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
32 Ourense;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QII;""
32 Ourense;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QI;""
32 Ourense;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
32 Ourense;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
32 Ourense;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
32 Ourense;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
32 Ourense;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
32 Ourense;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
32 Ourense;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
32 Ourense;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
32 Ourense;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
32 Ourense;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
32 Ourense;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
32 Ourense;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
32 Ourense;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
32 Ourense;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
32 Ourense;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;93,27
32 Ourense;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
32 Ourense;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
32 Ourense;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
32 Ourense;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;93,98
32 Ourense;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
32 Ourense;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
32 Ourense;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
32 Ourense;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;96,77
32 Ourense;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
32 Ourense;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
32 Ourense;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;87,67
32 Ourense;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
32 Ourense;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
32 Ourense;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
32 Ourense;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;88,18
32 Ourense;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
32 Ourense;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
32 Ourense;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
32 Ourense;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;90,32
32 Ourense;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
32 Ourense;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
32 Ourense;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;82,51
32 Ourense;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
32 Ourense;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
32 Ourense;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
32 Ourense;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;82,71
32 Ourense;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
32 Ourense;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
32 Ourense;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
32 Ourense;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;87,44
32 Ourense;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
32 Ourense;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
32 Ourense;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
32 Ourense;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
32 Ourense;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
32 Ourense;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
32 Ourense;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;77,87
32 Ourense;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
32 Ourense;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
32 Ourense;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
32 Ourense;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;83,18
32 Ourense;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
32 Ourense;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
32 Ourense;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
32 Ourense;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
32 Ourense;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
32 Ourense;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
32 Ourense;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QII;571
32 Ourense;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
32 Ourense;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
32 Ourense;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
32 Ourense;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QII;580
32 Ourense;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
32 Ourense;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
32 Ourense;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
32 Ourense;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QII;535
32 Ourense;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
32 Ourense;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
32 Ourense;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
32 Ourense;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2022QII;537
32 Ourense;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2022QI;""
32 Ourense;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
32 Ourense;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
32 Ourense;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2021QII;541
32 Ourense;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2021QI;""
32 Ourense;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
32 Ourense;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
32 Ourense;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2020QII;521
32 Ourense;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2020QI;""
32 Ourense;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
32 Ourense;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2022QIII;501
32 Ourense;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2022QII;""
32 Ourense;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2022QI;""
32 Ourense;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
32 Ourense;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2021QIII;509
32 Ourense;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2021QII;""
32 Ourense;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2021QI;""
32 Ourense;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
32 Ourense;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2020QIII;490
32 Ourense;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2020QII;""
32 Ourense;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2020QI;""
32 Ourense;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QIV;469
32 Ourense;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
32 Ourense;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QII;""
32 Ourense;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QI;""
32 Ourense;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QIV;479
32 Ourense;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
32 Ourense;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QII;""
32 Ourense;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QI;""
32 Ourense;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QIV;472
32 Ourense;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
32 Ourense;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QII;""
32 Ourense;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QI;""
32 Ourense;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
32 Ourense;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
32 Ourense;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QII;""
32 Ourense;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QI;454
32 Ourense;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
32 Ourense;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
32 Ourense;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QII;""
32 Ourense;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QI;450
32 Ourense;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
32 Ourense;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
32 Ourense;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QII;""
32 Ourense;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QI;""
32 Ourense;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
32 Ourense;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
32 Ourense;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
32 Ourense;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
32 Ourense;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
32 Ourense;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
32 Ourense;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
32 Ourense;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
32 Ourense;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
32 Ourense;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
32 Ourense;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
32 Ourense;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
32 Ourense;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
32 Ourense;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
32 Ourense;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;94,05
32 Ourense;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
32 Ourense;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
32 Ourense;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
32 Ourense;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;93,28
32 Ourense;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
32 Ourense;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
32 Ourense;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
32 Ourense;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;97,38
32 Ourense;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
32 Ourense;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
32 Ourense;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;87,74
32 Ourense;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
32 Ourense;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
32 Ourense;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
32 Ourense;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;87,76
32 Ourense;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
32 Ourense;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
32 Ourense;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
32 Ourense;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;91,59
32 Ourense;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
32 Ourense;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
32 Ourense;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;82,14
32 Ourense;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
32 Ourense;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
32 Ourense;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
32 Ourense;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;82,59
32 Ourense;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
32 Ourense;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
32 Ourense;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
32 Ourense;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;88,22
32 Ourense;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
32 Ourense;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
32 Ourense;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
32 Ourense;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
32 Ourense;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
32 Ourense;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
32 Ourense;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;78,28
32 Ourense;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
32 Ourense;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
32 Ourense;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
32 Ourense;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;84,11
32 Ourense;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
32 Ourense;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
32 Ourense;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
32 Ourense;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
32 Ourense;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
32 Ourense;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
32 Ourense;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QII;321
32 Ourense;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
32 Ourense;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
32 Ourense;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
32 Ourense;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QII;351
32 Ourense;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
32 Ourense;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
32 Ourense;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
32 Ourense;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QII;333
32 Ourense;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
32 Ourense;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
32 Ourense;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
32 Ourense;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2022QII;295
32 Ourense;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2022QI;""
32 Ourense;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
32 Ourense;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
32 Ourense;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2021QII;334
32 Ourense;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2021QI;""
32 Ourense;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
32 Ourense;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
32 Ourense;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2020QII;319
32 Ourense;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2020QI;""
32 Ourense;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
32 Ourense;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2022QIII;281
32 Ourense;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2022QII;""
32 Ourense;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2022QI;""
32 Ourense;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
32 Ourense;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2021QIII;312
32 Ourense;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2021QII;""
32 Ourense;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2021QI;""
32 Ourense;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
32 Ourense;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2020QIII;294
32 Ourense;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2020QII;""
32 Ourense;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2020QI;""
32 Ourense;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QIV;267
32 Ourense;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
32 Ourense;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QII;""
32 Ourense;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QI;""
32 Ourense;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QIV;291
32 Ourense;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
32 Ourense;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QII;""
32 Ourense;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QI;""
32 Ourense;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QIV;287
32 Ourense;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
32 Ourense;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QII;""
32 Ourense;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QI;""
32 Ourense;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
32 Ourense;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
32 Ourense;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QII;""
32 Ourense;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QI;271
32 Ourense;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
32 Ourense;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
32 Ourense;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QII;""
32 Ourense;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QI;272
32 Ourense;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
32 Ourense;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
32 Ourense;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QII;""
32 Ourense;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QI;""
32 Ourense;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
32 Ourense;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
32 Ourense;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
32 Ourense;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
32 Ourense;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
32 Ourense;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
32 Ourense;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
32 Ourense;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
32 Ourense;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
32 Ourense;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
32 Ourense;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
32 Ourense;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
32 Ourense;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
32 Ourense;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
32 Ourense;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;91,9
32 Ourense;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
32 Ourense;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
32 Ourense;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
32 Ourense;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;95,16
32 Ourense;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
32 Ourense;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
32 Ourense;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
32 Ourense;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;95,8
32 Ourense;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
32 Ourense;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
32 Ourense;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;87,54
32 Ourense;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
32 Ourense;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
32 Ourense;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
32 Ourense;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;88,89
32 Ourense;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
32 Ourense;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
32 Ourense;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
32 Ourense;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;88,29
32 Ourense;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
32 Ourense;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
32 Ourense;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;83,18
32 Ourense;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
32 Ourense;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
32 Ourense;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
32 Ourense;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;82,91
32 Ourense;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
32 Ourense;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
32 Ourense;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
32 Ourense;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;86,19
32 Ourense;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
32 Ourense;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
32 Ourense;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
32 Ourense;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
32 Ourense;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
32 Ourense;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
32 Ourense;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;77,21
32 Ourense;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
32 Ourense;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
32 Ourense;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
32 Ourense;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;81,68
32 Ourense;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
32 Ourense;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
32 Ourense;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
32 Ourense;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
32 Ourense;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
32 Ourense;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QIII;940
32 Ourense;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
32 Ourense;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
32 Ourense;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
32 Ourense;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QIII;994
32 Ourense;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
32 Ourense;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
32 Ourense;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
32 Ourense;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QIII;911
32 Ourense;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
32 Ourense;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
32 Ourense;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
32 Ourense;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2022QIII;876
32 Ourense;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2022QII;""
32 Ourense;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2022QI;""
32 Ourense;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
32 Ourense;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2021QIII;923
32 Ourense;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2021QII;""
32 Ourense;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2021QI;""
32 Ourense;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
32 Ourense;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2020QIII;839
32 Ourense;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2020QII;""
32 Ourense;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2020QI;""
32 Ourense;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2022QIV;817
32 Ourense;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
32 Ourense;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2022QII;""
32 Ourense;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2022QI;""
32 Ourense;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2021QIV;868
32 Ourense;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
32 Ourense;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2021QII;""
32 Ourense;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2021QI;""
32 Ourense;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2020QIV;810
32 Ourense;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
32 Ourense;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2020QII;""
32 Ourense;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2020QI;""
32 Ourense;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
32 Ourense;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
32 Ourense;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QII;""
32 Ourense;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QI;817
32 Ourense;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
32 Ourense;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
32 Ourense;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QII;""
32 Ourense;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QI;772
32 Ourense;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
32 Ourense;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
32 Ourense;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QII;""
32 Ourense;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QI;""
32 Ourense;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
32 Ourense;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
32 Ourense;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QII;771
32 Ourense;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QI;""
32 Ourense;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
32 Ourense;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
32 Ourense;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QII;739
32 Ourense;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QI;""
32 Ourense;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
32 Ourense;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
32 Ourense;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QII;""
32 Ourense;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QI;""
32 Ourense;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
32 Ourense;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
32 Ourense;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
32 Ourense;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
32 Ourense;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
32 Ourense;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
32 Ourense;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
32 Ourense;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
32 Ourense;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
32 Ourense;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
32 Ourense;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
32 Ourense;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
32 Ourense;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
32 Ourense;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;93,19
32 Ourense;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
32 Ourense;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
32 Ourense;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
32 Ourense;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;92,86
32 Ourense;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
32 Ourense;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
32 Ourense;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
32 Ourense;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;92,1
32 Ourense;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
32 Ourense;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
32 Ourense;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;86,91
32 Ourense;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
32 Ourense;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
32 Ourense;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
32 Ourense;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;87,32
32 Ourense;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
32 Ourense;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
32 Ourense;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
32 Ourense;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;88,91
32 Ourense;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
32 Ourense;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
32 Ourense;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
32 Ourense;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
32 Ourense;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
32 Ourense;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
32 Ourense;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;82,19
32 Ourense;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
32 Ourense;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
32 Ourense;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
32 Ourense;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;84,74
32 Ourense;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
32 Ourense;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
32 Ourense;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
32 Ourense;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
32 Ourense;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
32 Ourense;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
32 Ourense;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;77,57
32 Ourense;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
32 Ourense;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
32 Ourense;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
32 Ourense;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;81,12
32 Ourense;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
32 Ourense;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
32 Ourense;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
32 Ourense;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
32 Ourense;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
32 Ourense;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
32 Ourense;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QIII;599
32 Ourense;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
32 Ourense;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
32 Ourense;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
32 Ourense;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QIII;614
32 Ourense;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
32 Ourense;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
32 Ourense;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
32 Ourense;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QIII;559
32 Ourense;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
32 Ourense;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
32 Ourense;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
32 Ourense;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2022QIII;556
32 Ourense;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2022QII;""
32 Ourense;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2022QI;""
32 Ourense;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
32 Ourense;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2021QIII;571
32 Ourense;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2021QII;""
32 Ourense;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2021QI;""
32 Ourense;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
32 Ourense;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2020QIII;518
32 Ourense;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2020QII;""
32 Ourense;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2020QI;""
32 Ourense;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2022QIV;518
32 Ourense;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
32 Ourense;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2022QII;""
32 Ourense;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2022QI;""
32 Ourense;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2021QIV;539
32 Ourense;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
32 Ourense;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2021QII;""
32 Ourense;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2021QI;""
32 Ourense;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2020QIV;498
32 Ourense;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
32 Ourense;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2020QII;""
32 Ourense;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2020QI;""
32 Ourense;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
32 Ourense;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
32 Ourense;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QII;""
32 Ourense;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QI;511
32 Ourense;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
32 Ourense;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
32 Ourense;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QII;""
32 Ourense;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QI;476
32 Ourense;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
32 Ourense;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
32 Ourense;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QII;""
32 Ourense;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QI;""
32 Ourense;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
32 Ourense;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
32 Ourense;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QII;481
32 Ourense;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QI;""
32 Ourense;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
32 Ourense;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
32 Ourense;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QII;459
32 Ourense;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QI;""
32 Ourense;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
32 Ourense;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
32 Ourense;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QII;""
32 Ourense;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QI;""
32 Ourense;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
32 Ourense;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
32 Ourense;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
32 Ourense;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
32 Ourense;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
32 Ourense;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
32 Ourense;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
32 Ourense;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
32 Ourense;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
32 Ourense;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
32 Ourense;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
32 Ourense;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
32 Ourense;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
32 Ourense;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;92,82
32 Ourense;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
32 Ourense;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
32 Ourense;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
32 Ourense;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;93
32 Ourense;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
32 Ourense;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
32 Ourense;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
32 Ourense;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;92,67
32 Ourense;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
32 Ourense;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
32 Ourense;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;86,48
32 Ourense;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
32 Ourense;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
32 Ourense;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
32 Ourense;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;87,79
32 Ourense;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
32 Ourense;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
32 Ourense;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
32 Ourense;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;89,09
32 Ourense;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
32 Ourense;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
32 Ourense;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
32 Ourense;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
32 Ourense;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
32 Ourense;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
32 Ourense;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;83,22
32 Ourense;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
32 Ourense;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
32 Ourense;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
32 Ourense;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;85,15
32 Ourense;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
32 Ourense;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
32 Ourense;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
32 Ourense;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
32 Ourense;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
32 Ourense;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
32 Ourense;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;78,34
32 Ourense;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
32 Ourense;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
32 Ourense;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
32 Ourense;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;82,11
32 Ourense;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
32 Ourense;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
32 Ourense;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
32 Ourense;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
32 Ourense;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
32 Ourense;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
32 Ourense;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QIII;341
32 Ourense;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
32 Ourense;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
32 Ourense;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
32 Ourense;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QIII;380
32 Ourense;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
32 Ourense;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
32 Ourense;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
32 Ourense;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QIII;352
32 Ourense;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
32 Ourense;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
32 Ourense;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
32 Ourense;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2022QIII;320
32 Ourense;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2022QII;""
32 Ourense;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2022QI;""
32 Ourense;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
32 Ourense;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2021QIII;352
32 Ourense;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2021QII;""
32 Ourense;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2021QI;""
32 Ourense;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
32 Ourense;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2020QIII;321
32 Ourense;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2020QII;""
32 Ourense;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2020QI;""
32 Ourense;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2022QIV;299
32 Ourense;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
32 Ourense;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2022QII;""
32 Ourense;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2022QI;""
32 Ourense;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2021QIV;329
32 Ourense;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
32 Ourense;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2021QII;""
32 Ourense;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2021QI;""
32 Ourense;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2020QIV;312
32 Ourense;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
32 Ourense;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2020QII;""
32 Ourense;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2020QI;""
32 Ourense;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
32 Ourense;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
32 Ourense;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QII;""
32 Ourense;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QI;306
32 Ourense;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
32 Ourense;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
32 Ourense;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QII;""
32 Ourense;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QI;296
32 Ourense;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
32 Ourense;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
32 Ourense;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QII;""
32 Ourense;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QI;""
32 Ourense;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
32 Ourense;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
32 Ourense;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QII;290
32 Ourense;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QI;""
32 Ourense;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
32 Ourense;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
32 Ourense;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QII;280
32 Ourense;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QI;""
32 Ourense;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
32 Ourense;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
32 Ourense;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QII;""
32 Ourense;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QI;""
32 Ourense;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
32 Ourense;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
32 Ourense;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
32 Ourense;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
32 Ourense;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
32 Ourense;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
32 Ourense;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
32 Ourense;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
32 Ourense;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
32 Ourense;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
32 Ourense;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
32 Ourense;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
32 Ourense;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
32 Ourense;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;93,84
32 Ourense;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
32 Ourense;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
32 Ourense;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
32 Ourense;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;92,63
32 Ourense;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
32 Ourense;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
32 Ourense;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
32 Ourense;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;91,19
32 Ourense;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
32 Ourense;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
32 Ourense;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;87,68
32 Ourense;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
32 Ourense;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
32 Ourense;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
32 Ourense;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;86,58
32 Ourense;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
32 Ourense;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
32 Ourense;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
32 Ourense;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;88,64
32 Ourense;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
32 Ourense;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
32 Ourense;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
32 Ourense;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
32 Ourense;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
32 Ourense;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
32 Ourense;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;80,53
32 Ourense;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
32 Ourense;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
32 Ourense;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
32 Ourense;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;84,09
32 Ourense;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
32 Ourense;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
32 Ourense;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
32 Ourense;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
32 Ourense;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
32 Ourense;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
32 Ourense;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;76,32
32 Ourense;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
32 Ourense;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
32 Ourense;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
32 Ourense;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;79,55
32 Ourense;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
32 Ourense;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
32 Ourense;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
32 Ourense;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
32 Ourense;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
32 Ourense;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QIV;966
32 Ourense;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
32 Ourense;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
32 Ourense;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
32 Ourense;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QIV;1.025
32 Ourense;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
32 Ourense;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
32 Ourense;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
32 Ourense;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QIV;959
32 Ourense;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
32 Ourense;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
32 Ourense;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
32 Ourense;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2022QIV;895
32 Ourense;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
32 Ourense;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2022QII;""
32 Ourense;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2022QI;""
32 Ourense;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2021QIV;959
32 Ourense;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
32 Ourense;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2021QII;""
32 Ourense;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2021QI;""
32 Ourense;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2020QIV;914
32 Ourense;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
32 Ourense;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2020QII;""
32 Ourense;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2020QI;""
32 Ourense;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
32 Ourense;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
32 Ourense;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2022QII;""
32 Ourense;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2022QI;901
32 Ourense;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
32 Ourense;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
32 Ourense;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2021QII;""
32 Ourense;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2021QI;873
32 Ourense;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
32 Ourense;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
32 Ourense;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2020QII;""
32 Ourense;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2020QI;""
32 Ourense;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
32 Ourense;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
32 Ourense;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QII;853
32 Ourense;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QI;""
32 Ourense;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
32 Ourense;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
32 Ourense;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QII;834
32 Ourense;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QI;""
32 Ourense;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
32 Ourense;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
32 Ourense;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QII;""
32 Ourense;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QI;""
32 Ourense;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
32 Ourense;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QIII;805
32 Ourense;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QII;""
32 Ourense;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QI;""
32 Ourense;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
32 Ourense;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QIII;794
32 Ourense;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QII;""
32 Ourense;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QI;""
32 Ourense;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
32 Ourense;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
32 Ourense;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QII;""
32 Ourense;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QI;""
32 Ourense;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
32 Ourense;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
32 Ourense;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
32 Ourense;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
32 Ourense;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
32 Ourense;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
32 Ourense;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
32 Ourense;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
32 Ourense;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
32 Ourense;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
32 Ourense;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
32 Ourense;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
32 Ourense;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;92,65
32 Ourense;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
32 Ourense;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
32 Ourense;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
32 Ourense;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;93,56
32 Ourense;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
32 Ourense;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
32 Ourense;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
32 Ourense;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;95,31
32 Ourense;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
32 Ourense;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
32 Ourense;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
32 Ourense;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
32 Ourense;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
32 Ourense;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
32 Ourense;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;87,9
32 Ourense;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
32 Ourense;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
32 Ourense;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
32 Ourense;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;91,03
32 Ourense;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
32 Ourense;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
32 Ourense;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
32 Ourense;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
32 Ourense;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
32 Ourense;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
32 Ourense;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;83,22
32 Ourense;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
32 Ourense;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
32 Ourense;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
32 Ourense;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;86,97
32 Ourense;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
32 Ourense;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
32 Ourense;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
32 Ourense;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
32 Ourense;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
32 Ourense;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
32 Ourense;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;78,54
32 Ourense;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
32 Ourense;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
32 Ourense;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
32 Ourense;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;82,79
32 Ourense;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
32 Ourense;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
32 Ourense;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
32 Ourense;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
32 Ourense;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
32 Ourense;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
32 Ourense;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QIV;615
32 Ourense;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
32 Ourense;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
32 Ourense;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
32 Ourense;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QIV;636
32 Ourense;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
32 Ourense;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
32 Ourense;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
32 Ourense;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QIV;585
32 Ourense;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
32 Ourense;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
32 Ourense;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
32 Ourense;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2022QIV;569
32 Ourense;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
32 Ourense;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2022QII;""
32 Ourense;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2022QI;""
32 Ourense;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2021QIV;596
32 Ourense;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
32 Ourense;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2021QII;""
32 Ourense;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2021QI;""
32 Ourense;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2020QIV;559
32 Ourense;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
32 Ourense;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2020QII;""
32 Ourense;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2020QI;""
32 Ourense;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
32 Ourense;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
32 Ourense;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2022QII;""
32 Ourense;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2022QI;563
32 Ourense;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
32 Ourense;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
32 Ourense;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2021QII;""
32 Ourense;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2021QI;536
32 Ourense;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
32 Ourense;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
32 Ourense;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2020QII;""
32 Ourense;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2020QI;""
32 Ourense;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
32 Ourense;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
32 Ourense;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QII;532
32 Ourense;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QI;""
32 Ourense;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
32 Ourense;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
32 Ourense;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QII;514
32 Ourense;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QI;""
32 Ourense;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
32 Ourense;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
32 Ourense;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QII;""
32 Ourense;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QI;""
32 Ourense;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
32 Ourense;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QIII;504
32 Ourense;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QII;""
32 Ourense;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QI;""
32 Ourense;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
32 Ourense;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QIII;491
32 Ourense;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QII;""
32 Ourense;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QI;""
32 Ourense;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
32 Ourense;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
32 Ourense;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QII;""
32 Ourense;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QI;""
32 Ourense;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
32 Ourense;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
32 Ourense;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
32 Ourense;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
32 Ourense;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
32 Ourense;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
32 Ourense;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
32 Ourense;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
32 Ourense;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
32 Ourense;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
32 Ourense;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
32 Ourense;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
32 Ourense;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;92,52
32 Ourense;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
32 Ourense;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
32 Ourense;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
32 Ourense;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;93,71
32 Ourense;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
32 Ourense;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
32 Ourense;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
32 Ourense;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;95,56
32 Ourense;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
32 Ourense;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
32 Ourense;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
32 Ourense;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
32 Ourense;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
32 Ourense;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
32 Ourense;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;88,52
32 Ourense;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
32 Ourense;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
32 Ourense;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
32 Ourense;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;91,62
32 Ourense;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
32 Ourense;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
32 Ourense;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
32 Ourense;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
32 Ourense;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
32 Ourense;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
32 Ourense;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;83,65
32 Ourense;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
32 Ourense;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
32 Ourense;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
32 Ourense;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;87,86
32 Ourense;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
32 Ourense;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
32 Ourense;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
32 Ourense;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
32 Ourense;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
32 Ourense;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
32 Ourense;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;79,25
32 Ourense;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
32 Ourense;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
32 Ourense;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
32 Ourense;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;83,93
32 Ourense;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
32 Ourense;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
32 Ourense;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
32 Ourense;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
32 Ourense;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
32 Ourense;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
32 Ourense;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QIV;351
32 Ourense;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
32 Ourense;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
32 Ourense;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
32 Ourense;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QIV;389
32 Ourense;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
32 Ourense;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
32 Ourense;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
32 Ourense;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QIV;374
32 Ourense;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
32 Ourense;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
32 Ourense;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
32 Ourense;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2022QIV;326
32 Ourense;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
32 Ourense;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2022QII;""
32 Ourense;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2022QI;""
32 Ourense;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2021QIV;363
32 Ourense;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
32 Ourense;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2021QII;""
32 Ourense;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2021QI;""
32 Ourense;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2020QIV;355
32 Ourense;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
32 Ourense;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2020QII;""
32 Ourense;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2020QI;""
32 Ourense;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
32 Ourense;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
32 Ourense;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2022QII;""
32 Ourense;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2022QI;338
32 Ourense;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
32 Ourense;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
32 Ourense;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2021QII;""
32 Ourense;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2021QI;337
32 Ourense;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
32 Ourense;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
32 Ourense;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2020QII;""
32 Ourense;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2020QI;""
32 Ourense;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
32 Ourense;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
32 Ourense;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QII;321
32 Ourense;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QI;""
32 Ourense;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
32 Ourense;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
32 Ourense;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QII;320
32 Ourense;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QI;""
32 Ourense;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
32 Ourense;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
32 Ourense;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QII;""
32 Ourense;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QI;""
32 Ourense;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
32 Ourense;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QIII;301
32 Ourense;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QII;""
32 Ourense;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QI;""
32 Ourense;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
32 Ourense;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QIII;303
32 Ourense;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QII;""
32 Ourense;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QI;""
32 Ourense;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
32 Ourense;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
32 Ourense;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QII;""
32 Ourense;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QI;""
32 Ourense;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
32 Ourense;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
32 Ourense;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
32 Ourense;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
32 Ourense;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
32 Ourense;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
32 Ourense;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
32 Ourense;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
32 Ourense;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
32 Ourense;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
32 Ourense;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
32 Ourense;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
32 Ourense;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;92,88
32 Ourense;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
32 Ourense;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
32 Ourense;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
32 Ourense;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;93,32
32 Ourense;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
32 Ourense;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
32 Ourense;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
32 Ourense;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;94,92
32 Ourense;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
32 Ourense;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
32 Ourense;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
32 Ourense;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
32 Ourense;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
32 Ourense;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
32 Ourense;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;86,89
32 Ourense;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
32 Ourense;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
32 Ourense;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
32 Ourense;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;90,11
32 Ourense;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
32 Ourense;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
32 Ourense;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
32 Ourense;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
32 Ourense;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
32 Ourense;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
32 Ourense;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;82,52
32 Ourense;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
32 Ourense;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
32 Ourense;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
32 Ourense;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;85,56
32 Ourense;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
32 Ourense;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
32 Ourense;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
32 Ourense;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
32 Ourense;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
32 Ourense;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
32 Ourense;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;77,38
32 Ourense;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
32 Ourense;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
32 Ourense;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
32 Ourense;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;81,02
32 Ourense;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
32 Ourense;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
32 Ourense;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
32 Ourense;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
32 Ourense;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
32 Ourense;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
32 Ourense;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
32 Ourense;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
32 Ourense;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
32 Ourense;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QI;3.520
32 Ourense;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
32 Ourense;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
32 Ourense;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
32 Ourense;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QI;3.685
32 Ourense;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
32 Ourense;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
32 Ourense;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
32 Ourense;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QI;3.607
32 Ourense;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
32 Ourense;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
32 Ourense;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2022QII;""
32 Ourense;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2022QI;3.401
32 Ourense;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
32 Ourense;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
32 Ourense;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2021QII;""
32 Ourense;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2021QI;3.580
32 Ourense;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
32 Ourense;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
32 Ourense;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2020QII;""
32 Ourense;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2020QI;3.400
32 Ourense;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
32 Ourense;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
32 Ourense;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2022QII;3.286
32 Ourense;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2022QI;""
32 Ourense;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
32 Ourense;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
32 Ourense;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2021QII;3.478
32 Ourense;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2021QI;""
32 Ourense;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
32 Ourense;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
32 Ourense;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2020QII;3.341
32 Ourense;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2020QI;""
32 Ourense;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
32 Ourense;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QIII;3.193
32 Ourense;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QII;""
32 Ourense;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QI;""
32 Ourense;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
32 Ourense;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QIII;3.375
32 Ourense;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QII;""
32 Ourense;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QI;""
32 Ourense;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
32 Ourense;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QIII;3.235
32 Ourense;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QII;""
32 Ourense;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QI;""
32 Ourense;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QIV;3.093
32 Ourense;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
32 Ourense;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QII;""
32 Ourense;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QI;""
32 Ourense;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QIV;3.293
32 Ourense;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
32 Ourense;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QII;""
32 Ourense;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QI;""
32 Ourense;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QIV;3.152
32 Ourense;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
32 Ourense;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QII;""
32 Ourense;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QI;""
32 Ourense;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
32 Ourense;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
32 Ourense;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
32 Ourense;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
32 Ourense;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
32 Ourense;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
32 Ourense;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
32 Ourense;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
32 Ourense;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
32 Ourense;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
32 Ourense;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
32 Ourense;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
32 Ourense;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
32 Ourense;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
32 Ourense;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
32 Ourense;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;96,62
32 Ourense;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
32 Ourense;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
32 Ourense;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
32 Ourense;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;97,15
32 Ourense;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
32 Ourense;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
32 Ourense;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
32 Ourense;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;94,26
32 Ourense;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
32 Ourense;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
32 Ourense;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;93,35
32 Ourense;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
32 Ourense;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
32 Ourense;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
32 Ourense;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;94,38
32 Ourense;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
32 Ourense;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
32 Ourense;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
32 Ourense;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;92,63
32 Ourense;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
32 Ourense;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
32 Ourense;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;90,71
32 Ourense;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
32 Ourense;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
32 Ourense;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
32 Ourense;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;91,59
32 Ourense;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
32 Ourense;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
32 Ourense;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
32 Ourense;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;89,69
32 Ourense;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
32 Ourense;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
32 Ourense;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;87,87
32 Ourense;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
32 Ourense;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
32 Ourense;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
32 Ourense;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;89,36
32 Ourense;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
32 Ourense;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
32 Ourense;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
32 Ourense;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;87,39
32 Ourense;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
32 Ourense;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
32 Ourense;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
32 Ourense;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
32 Ourense;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
32 Ourense;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
32 Ourense;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QI;2.051
32 Ourense;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
32 Ourense;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
32 Ourense;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
32 Ourense;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QI;2.195
32 Ourense;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
32 Ourense;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
32 Ourense;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
32 Ourense;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QI;2.140
32 Ourense;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
32 Ourense;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
32 Ourense;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2022QII;""
32 Ourense;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2022QI;1.989
32 Ourense;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
32 Ourense;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
32 Ourense;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2021QII;""
32 Ourense;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2021QI;2.138
32 Ourense;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
32 Ourense;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
32 Ourense;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2020QII;""
32 Ourense;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2020QI;2.021
32 Ourense;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
32 Ourense;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
32 Ourense;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2022QII;1.936
32 Ourense;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2022QI;""
32 Ourense;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
32 Ourense;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
32 Ourense;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2021QII;2.080
32 Ourense;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2021QI;""
32 Ourense;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
32 Ourense;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
32 Ourense;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2020QII;1.995
32 Ourense;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2020QI;""
32 Ourense;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
32 Ourense;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QIII;1.894
32 Ourense;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QII;""
32 Ourense;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QI;""
32 Ourense;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
32 Ourense;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QIII;2.015
32 Ourense;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QII;""
32 Ourense;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QI;""
32 Ourense;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
32 Ourense;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QIII;1.942
32 Ourense;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QII;""
32 Ourense;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QI;""
32 Ourense;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QIV;1.839
32 Ourense;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
32 Ourense;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QII;""
32 Ourense;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QI;""
32 Ourense;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QIV;1.970
32 Ourense;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
32 Ourense;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QII;""
32 Ourense;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QI;""
32 Ourense;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QIV;1.902
32 Ourense;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
32 Ourense;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QII;""
32 Ourense;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QI;""
32 Ourense;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
32 Ourense;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
32 Ourense;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
32 Ourense;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
32 Ourense;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
32 Ourense;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
32 Ourense;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
32 Ourense;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
32 Ourense;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
32 Ourense;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
32 Ourense;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
32 Ourense;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
32 Ourense;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
32 Ourense;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
32 Ourense;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
32 Ourense;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;96,98
32 Ourense;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
32 Ourense;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
32 Ourense;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
32 Ourense;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;97,4
32 Ourense;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
32 Ourense;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
32 Ourense;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
32 Ourense;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;94,44
32 Ourense;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
32 Ourense;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
32 Ourense;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;94,39
32 Ourense;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
32 Ourense;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
32 Ourense;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
32 Ourense;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;94,76
32 Ourense;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
32 Ourense;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
32 Ourense;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
32 Ourense;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;93,22
32 Ourense;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
32 Ourense;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
32 Ourense;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;92,35
32 Ourense;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
32 Ourense;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
32 Ourense;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
32 Ourense;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;91,8
32 Ourense;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
32 Ourense;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
32 Ourense;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
32 Ourense;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;90,75
32 Ourense;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
32 Ourense;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
32 Ourense;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;89,66
32 Ourense;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
32 Ourense;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
32 Ourense;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
32 Ourense;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;89,75
32 Ourense;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
32 Ourense;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
32 Ourense;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
32 Ourense;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;88,88
32 Ourense;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
32 Ourense;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
32 Ourense;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
32 Ourense;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
32 Ourense;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
32 Ourense;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
32 Ourense;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QI;1.469
32 Ourense;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
32 Ourense;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
32 Ourense;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
32 Ourense;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QI;1.490
32 Ourense;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
32 Ourense;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
32 Ourense;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
32 Ourense;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QI;1.467
32 Ourense;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
32 Ourense;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
32 Ourense;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2022QII;""
32 Ourense;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2022QI;1.412
32 Ourense;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
32 Ourense;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
32 Ourense;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2021QII;""
32 Ourense;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2021QI;1.442
32 Ourense;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
32 Ourense;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
32 Ourense;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2020QII;""
32 Ourense;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2020QI;1.379
32 Ourense;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
32 Ourense;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
32 Ourense;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2022QII;1.350
32 Ourense;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2022QI;""
32 Ourense;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
32 Ourense;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
32 Ourense;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2021QII;1.398
32 Ourense;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2021QI;""
32 Ourense;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
32 Ourense;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
32 Ourense;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2020QII;1.346
32 Ourense;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2020QI;""
32 Ourense;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
32 Ourense;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QIII;1.299
32 Ourense;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QII;""
32 Ourense;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QI;""
32 Ourense;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
32 Ourense;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QIII;1.360
32 Ourense;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QII;""
32 Ourense;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QI;""
32 Ourense;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
32 Ourense;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QIII;1.293
32 Ourense;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QII;""
32 Ourense;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QI;""
32 Ourense;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QIV;1.254
32 Ourense;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
32 Ourense;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QII;""
32 Ourense;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QI;""
32 Ourense;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QIV;1.323
32 Ourense;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
32 Ourense;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QII;""
32 Ourense;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QI;""
32 Ourense;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QIV;1.250
32 Ourense;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
32 Ourense;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QII;""
32 Ourense;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QI;""
32 Ourense;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
32 Ourense;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
32 Ourense;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
32 Ourense;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
32 Ourense;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
32 Ourense;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
32 Ourense;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
32 Ourense;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
32 Ourense;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
32 Ourense;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
32 Ourense;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
32 Ourense;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
32 Ourense;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
32 Ourense;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
32 Ourense;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
32 Ourense;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;96,12
32 Ourense;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
32 Ourense;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
32 Ourense;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
32 Ourense;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;96,78
32 Ourense;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
32 Ourense;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
32 Ourense;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
32 Ourense;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;94
32 Ourense;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
32 Ourense;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
32 Ourense;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;91,9
32 Ourense;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
32 Ourense;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
32 Ourense;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
32 Ourense;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;93,83
32 Ourense;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
32 Ourense;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
32 Ourense;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
32 Ourense;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;91,75
32 Ourense;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
32 Ourense;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
32 Ourense;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;88,43
32 Ourense;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
32 Ourense;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
32 Ourense;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
32 Ourense;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;91,28
32 Ourense;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
32 Ourense;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
32 Ourense;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
32 Ourense;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;88,14
32 Ourense;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
32 Ourense;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
32 Ourense;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;85,36
32 Ourense;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
32 Ourense;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
32 Ourense;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
32 Ourense;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;88,79
32 Ourense;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
32 Ourense;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
32 Ourense;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
32 Ourense;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;85,21
32 Ourense;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
32 Ourense;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
32 Ourense;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
32 Ourense;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
32 Ourense;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
32 Ourense;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QII;3.305
32 Ourense;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
32 Ourense;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
32 Ourense;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
32 Ourense;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QII;3.407
32 Ourense;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
32 Ourense;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
32 Ourense;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
32 Ourense;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QII;3.598
32 Ourense;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
32 Ourense;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
32 Ourense;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
32 Ourense;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2022QII;3.183
32 Ourense;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2022QI;""
32 Ourense;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
32 Ourense;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
32 Ourense;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2021QII;3.299
32 Ourense;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2021QI;""
32 Ourense;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
32 Ourense;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
32 Ourense;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2020QII;3.532
32 Ourense;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2020QI;""
32 Ourense;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
32 Ourense;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2022QIII;3.084
32 Ourense;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2022QII;""
32 Ourense;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2022QI;""
32 Ourense;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
32 Ourense;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2021QIII;3.186
32 Ourense;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2021QII;""
32 Ourense;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2021QI;""
32 Ourense;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
32 Ourense;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2020QIII;3.415
32 Ourense;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2020QII;""
32 Ourense;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2020QI;""
32 Ourense;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QIV;2.984
32 Ourense;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
32 Ourense;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QII;""
32 Ourense;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QI;""
32 Ourense;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QIV;3.096
32 Ourense;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
32 Ourense;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QII;""
32 Ourense;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QI;""
32 Ourense;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QIV;3.323
32 Ourense;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
32 Ourense;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QII;""
32 Ourense;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QI;""
32 Ourense;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
32 Ourense;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
32 Ourense;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QII;""
32 Ourense;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QI;3.007
32 Ourense;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
32 Ourense;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
32 Ourense;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QII;""
32 Ourense;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QI;3.245
32 Ourense;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
32 Ourense;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
32 Ourense;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QII;""
32 Ourense;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QI;""
32 Ourense;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
32 Ourense;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
32 Ourense;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
32 Ourense;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
32 Ourense;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
32 Ourense;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
32 Ourense;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
32 Ourense;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
32 Ourense;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
32 Ourense;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
32 Ourense;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
32 Ourense;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
32 Ourense;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
32 Ourense;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
32 Ourense;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;96,31
32 Ourense;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
32 Ourense;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
32 Ourense;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
32 Ourense;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;96,83
32 Ourense;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
32 Ourense;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
32 Ourense;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
32 Ourense;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;98,17
32 Ourense;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
32 Ourense;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
32 Ourense;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;93,31
32 Ourense;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
32 Ourense;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
32 Ourense;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
32 Ourense;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;93,51
32 Ourense;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
32 Ourense;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
32 Ourense;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
32 Ourense;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;94,91
32 Ourense;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
32 Ourense;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
32 Ourense;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;90,29
32 Ourense;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
32 Ourense;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
32 Ourense;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
32 Ourense;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;90,87
32 Ourense;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
32 Ourense;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
32 Ourense;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
32 Ourense;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;92,36
32 Ourense;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
32 Ourense;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
32 Ourense;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
32 Ourense;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
32 Ourense;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
32 Ourense;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
32 Ourense;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;88,26
32 Ourense;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
32 Ourense;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
32 Ourense;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
32 Ourense;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;90,19
32 Ourense;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
32 Ourense;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
32 Ourense;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
32 Ourense;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
32 Ourense;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
32 Ourense;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
32 Ourense;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QII;1.921
32 Ourense;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
32 Ourense;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
32 Ourense;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
32 Ourense;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QII;2.017
32 Ourense;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
32 Ourense;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
32 Ourense;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
32 Ourense;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QII;2.133
32 Ourense;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
32 Ourense;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
32 Ourense;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
32 Ourense;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2022QII;1.859
32 Ourense;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2022QI;""
32 Ourense;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
32 Ourense;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
32 Ourense;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2021QII;1.958
32 Ourense;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2021QI;""
32 Ourense;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
32 Ourense;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
32 Ourense;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2020QII;2.103
32 Ourense;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2020QI;""
32 Ourense;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
32 Ourense;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2022QIII;1.817
32 Ourense;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2022QII;""
32 Ourense;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2022QI;""
32 Ourense;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
32 Ourense;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2021QIII;1.884
32 Ourense;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2021QII;""
32 Ourense;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2021QI;""
32 Ourense;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
32 Ourense;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2020QIII;2.044
32 Ourense;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2020QII;""
32 Ourense;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2020QI;""
32 Ourense;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QIV;1.762
32 Ourense;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
32 Ourense;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QII;""
32 Ourense;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QI;""
32 Ourense;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QIV;1.834
32 Ourense;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
32 Ourense;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QII;""
32 Ourense;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QI;""
32 Ourense;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QIV;1.998
32 Ourense;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
32 Ourense;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QII;""
32 Ourense;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QI;""
32 Ourense;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
32 Ourense;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
32 Ourense;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QII;""
32 Ourense;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QI;1.786
32 Ourense;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
32 Ourense;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
32 Ourense;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QII;""
32 Ourense;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QI;1.956
32 Ourense;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
32 Ourense;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
32 Ourense;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QII;""
32 Ourense;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QI;""
32 Ourense;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
32 Ourense;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
32 Ourense;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
32 Ourense;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
32 Ourense;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
32 Ourense;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
32 Ourense;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
32 Ourense;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
32 Ourense;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
32 Ourense;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
32 Ourense;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
32 Ourense;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
32 Ourense;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
32 Ourense;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
32 Ourense;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;96,77
32 Ourense;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
32 Ourense;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
32 Ourense;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
32 Ourense;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;97,07
32 Ourense;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
32 Ourense;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
32 Ourense;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
32 Ourense;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;98,59
32 Ourense;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
32 Ourense;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
32 Ourense;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;94,59
32 Ourense;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
32 Ourense;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
32 Ourense;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
32 Ourense;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;93,41
32 Ourense;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
32 Ourense;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
32 Ourense;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
32 Ourense;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;95,83
32 Ourense;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
32 Ourense;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
32 Ourense;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;91,72
32 Ourense;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
32 Ourense;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
32 Ourense;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
32 Ourense;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;90,93
32 Ourense;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
32 Ourense;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
32 Ourense;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
32 Ourense;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;93,67
32 Ourense;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
32 Ourense;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
32 Ourense;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
32 Ourense;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
32 Ourense;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
32 Ourense;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
32 Ourense;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;88,55
32 Ourense;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
32 Ourense;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
32 Ourense;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
32 Ourense;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;91,7
32 Ourense;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
32 Ourense;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
32 Ourense;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
32 Ourense;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
32 Ourense;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
32 Ourense;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
32 Ourense;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QII;1.384
32 Ourense;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
32 Ourense;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
32 Ourense;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
32 Ourense;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QII;1.390
32 Ourense;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
32 Ourense;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
32 Ourense;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
32 Ourense;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QII;1.465
32 Ourense;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
32 Ourense;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
32 Ourense;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
32 Ourense;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2022QII;1.324
32 Ourense;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2022QI;""
32 Ourense;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
32 Ourense;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
32 Ourense;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2021QII;1.341
32 Ourense;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2021QI;""
32 Ourense;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
32 Ourense;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
32 Ourense;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2020QII;1.429
32 Ourense;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2020QI;""
32 Ourense;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
32 Ourense;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2022QIII;1.267
32 Ourense;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2022QII;""
32 Ourense;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2022QI;""
32 Ourense;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
32 Ourense;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2021QIII;1.302
32 Ourense;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2021QII;""
32 Ourense;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2021QI;""
32 Ourense;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
32 Ourense;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2020QIII;1.371
32 Ourense;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2020QII;""
32 Ourense;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2020QI;""
32 Ourense;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QIV;1.222
32 Ourense;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
32 Ourense;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QII;""
32 Ourense;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QI;""
32 Ourense;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QIV;1.262
32 Ourense;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
32 Ourense;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QII;""
32 Ourense;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QI;""
32 Ourense;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QIV;1.325
32 Ourense;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
32 Ourense;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QII;""
32 Ourense;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QI;""
32 Ourense;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
32 Ourense;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
32 Ourense;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QII;""
32 Ourense;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QI;1.221
32 Ourense;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
32 Ourense;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
32 Ourense;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QII;""
32 Ourense;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QI;1.289
32 Ourense;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
32 Ourense;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
32 Ourense;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QII;""
32 Ourense;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QI;""
32 Ourense;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
32 Ourense;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
32 Ourense;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
32 Ourense;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
32 Ourense;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
32 Ourense;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
32 Ourense;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
32 Ourense;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
32 Ourense;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
32 Ourense;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
32 Ourense;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
32 Ourense;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
32 Ourense;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
32 Ourense;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
32 Ourense;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;95,66
32 Ourense;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
32 Ourense;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
32 Ourense;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
32 Ourense;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;96,47
32 Ourense;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
32 Ourense;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
32 Ourense;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
32 Ourense;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;97,54
32 Ourense;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
32 Ourense;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
32 Ourense;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;91,55
32 Ourense;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
32 Ourense;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
32 Ourense;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
32 Ourense;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;93,67
32 Ourense;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
32 Ourense;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
32 Ourense;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
32 Ourense;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;93,58
32 Ourense;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
32 Ourense;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
32 Ourense;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;88,29
32 Ourense;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
32 Ourense;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
32 Ourense;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
32 Ourense;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;90,79
32 Ourense;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
32 Ourense;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
32 Ourense;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
32 Ourense;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;90,44
32 Ourense;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
32 Ourense;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
32 Ourense;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
32 Ourense;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
32 Ourense;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
32 Ourense;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
32 Ourense;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;87,84
32 Ourense;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
32 Ourense;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
32 Ourense;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
32 Ourense;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;87,99
32 Ourense;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
32 Ourense;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
32 Ourense;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
32 Ourense;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
32 Ourense;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
32 Ourense;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QIII;3.332
32 Ourense;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
32 Ourense;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
32 Ourense;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
32 Ourense;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QIII;3.442
32 Ourense;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
32 Ourense;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
32 Ourense;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
32 Ourense;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QIII;3.631
32 Ourense;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
32 Ourense;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
32 Ourense;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
32 Ourense;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2022QIII;3.219
32 Ourense;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2022QII;""
32 Ourense;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2022QI;""
32 Ourense;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
32 Ourense;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2021QIII;3.314
32 Ourense;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2021QII;""
32 Ourense;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2021QI;""
32 Ourense;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
32 Ourense;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2020QIII;3.506
32 Ourense;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2020QII;""
32 Ourense;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2020QI;""
32 Ourense;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2022QIV;3.112
32 Ourense;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
32 Ourense;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2022QII;""
32 Ourense;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2022QI;""
32 Ourense;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2021QIV;3.213
32 Ourense;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
32 Ourense;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2021QII;""
32 Ourense;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2021QI;""
32 Ourense;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2020QIV;3.408
32 Ourense;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
32 Ourense;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2020QII;""
32 Ourense;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2020QI;""
32 Ourense;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
32 Ourense;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
32 Ourense;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QII;""
32 Ourense;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QI;3.116
32 Ourense;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
32 Ourense;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
32 Ourense;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QII;""
32 Ourense;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QI;3.325
32 Ourense;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
32 Ourense;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
32 Ourense;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QII;""
32 Ourense;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QI;""
32 Ourense;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
32 Ourense;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
32 Ourense;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QII;3.026
32 Ourense;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QI;""
32 Ourense;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
32 Ourense;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
32 Ourense;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QII;3.241
32 Ourense;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QI;""
32 Ourense;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
32 Ourense;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
32 Ourense;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QII;""
32 Ourense;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QI;""
32 Ourense;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
32 Ourense;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
32 Ourense;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
32 Ourense;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
32 Ourense;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
32 Ourense;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
32 Ourense;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
32 Ourense;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
32 Ourense;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
32 Ourense;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
32 Ourense;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
32 Ourense;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
32 Ourense;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
32 Ourense;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;96,61
32 Ourense;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
32 Ourense;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
32 Ourense;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
32 Ourense;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;96,28
32 Ourense;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
32 Ourense;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
32 Ourense;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
32 Ourense;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;96,56
32 Ourense;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
32 Ourense;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
32 Ourense;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;93,4
32 Ourense;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
32 Ourense;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
32 Ourense;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
32 Ourense;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;93,35
32 Ourense;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
32 Ourense;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
32 Ourense;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
32 Ourense;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;93,86
32 Ourense;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
32 Ourense;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
32 Ourense;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
32 Ourense;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
32 Ourense;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
32 Ourense;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
32 Ourense;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;90,53
32 Ourense;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
32 Ourense;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
32 Ourense;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
32 Ourense;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;91,57
32 Ourense;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
32 Ourense;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
32 Ourense;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
32 Ourense;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
32 Ourense;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
32 Ourense;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
32 Ourense;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;87,91
32 Ourense;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
32 Ourense;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
32 Ourense;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
32 Ourense;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;89,26
32 Ourense;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
32 Ourense;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
32 Ourense;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
32 Ourense;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
32 Ourense;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
32 Ourense;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
32 Ourense;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QIII;1.955
32 Ourense;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
32 Ourense;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
32 Ourense;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
32 Ourense;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QIII;2.029
32 Ourense;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
32 Ourense;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
32 Ourense;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
32 Ourense;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QIII;2.166
32 Ourense;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
32 Ourense;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
32 Ourense;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
32 Ourense;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2022QIII;1.901
32 Ourense;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2022QII;""
32 Ourense;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2022QI;""
32 Ourense;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
32 Ourense;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2021QIII;1.945
32 Ourense;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2021QII;""
32 Ourense;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2021QI;""
32 Ourense;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
32 Ourense;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2020QIII;2.103
32 Ourense;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2020QII;""
32 Ourense;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2020QI;""
32 Ourense;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2022QIV;1.842
32 Ourense;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
32 Ourense;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2022QII;""
32 Ourense;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2022QI;""
32 Ourense;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2021QIV;1.889
32 Ourense;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
32 Ourense;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2021QII;""
32 Ourense;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2021QI;""
32 Ourense;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2020QIV;2.053
32 Ourense;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
32 Ourense;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2020QII;""
32 Ourense;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2020QI;""
32 Ourense;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
32 Ourense;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
32 Ourense;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QII;""
32 Ourense;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QI;1.839
32 Ourense;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
32 Ourense;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
32 Ourense;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QII;""
32 Ourense;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QI;2.006
32 Ourense;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
32 Ourense;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
32 Ourense;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QII;""
32 Ourense;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QI;""
32 Ourense;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
32 Ourense;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
32 Ourense;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QII;1.802
32 Ourense;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QI;""
32 Ourense;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
32 Ourense;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
32 Ourense;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QII;1.957
32 Ourense;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QI;""
32 Ourense;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
32 Ourense;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
32 Ourense;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QII;""
32 Ourense;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QI;""
32 Ourense;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
32 Ourense;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
32 Ourense;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
32 Ourense;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
32 Ourense;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
32 Ourense;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
32 Ourense;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
32 Ourense;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
32 Ourense;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
32 Ourense;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
32 Ourense;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
32 Ourense;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
32 Ourense;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
32 Ourense;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;97,24
32 Ourense;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
32 Ourense;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
32 Ourense;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
32 Ourense;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;95,86
32 Ourense;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
32 Ourense;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
32 Ourense;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
32 Ourense;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;97,09
32 Ourense;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
32 Ourense;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
32 Ourense;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;94,22
32 Ourense;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
32 Ourense;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
32 Ourense;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
32 Ourense;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;93,1
32 Ourense;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
32 Ourense;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
32 Ourense;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
32 Ourense;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;94,78
32 Ourense;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
32 Ourense;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
32 Ourense;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
32 Ourense;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
32 Ourense;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
32 Ourense;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
32 Ourense;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;90,64
32 Ourense;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
32 Ourense;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
32 Ourense;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
32 Ourense;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;92,61
32 Ourense;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
32 Ourense;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
32 Ourense;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
32 Ourense;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
32 Ourense;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
32 Ourense;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
32 Ourense;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;88,81
32 Ourense;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
32 Ourense;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
32 Ourense;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
32 Ourense;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;90,35
32 Ourense;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
32 Ourense;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
32 Ourense;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
32 Ourense;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
32 Ourense;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
32 Ourense;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
32 Ourense;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QIII;1.377
32 Ourense;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
32 Ourense;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
32 Ourense;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
32 Ourense;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QIII;1.413
32 Ourense;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
32 Ourense;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
32 Ourense;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
32 Ourense;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QIII;1.465
32 Ourense;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
32 Ourense;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
32 Ourense;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
32 Ourense;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2022QIII;1.318
32 Ourense;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2022QII;""
32 Ourense;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2022QI;""
32 Ourense;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
32 Ourense;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2021QIII;1.369
32 Ourense;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2021QII;""
32 Ourense;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2021QI;""
32 Ourense;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
32 Ourense;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2020QIII;1.403
32 Ourense;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2020QII;""
32 Ourense;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2020QI;""
32 Ourense;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2022QIV;1.270
32 Ourense;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
32 Ourense;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2022QII;""
32 Ourense;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2022QI;""
32 Ourense;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2021QIV;1.324
32 Ourense;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
32 Ourense;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2021QII;""
32 Ourense;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2021QI;""
32 Ourense;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2020QIV;1.355
32 Ourense;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
32 Ourense;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2020QII;""
32 Ourense;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2020QI;""
32 Ourense;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
32 Ourense;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
32 Ourense;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QII;""
32 Ourense;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QI;1.277
32 Ourense;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
32 Ourense;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
32 Ourense;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QII;""
32 Ourense;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QI;1.319
32 Ourense;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
32 Ourense;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
32 Ourense;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QII;""
32 Ourense;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QI;""
32 Ourense;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
32 Ourense;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
32 Ourense;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QII;1.224
32 Ourense;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QI;""
32 Ourense;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
32 Ourense;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
32 Ourense;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QII;1.284
32 Ourense;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QI;""
32 Ourense;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
32 Ourense;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
32 Ourense;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QII;""
32 Ourense;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QI;""
32 Ourense;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
32 Ourense;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
32 Ourense;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
32 Ourense;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
32 Ourense;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
32 Ourense;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
32 Ourense;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
32 Ourense;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
32 Ourense;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
32 Ourense;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
32 Ourense;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
32 Ourense;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
32 Ourense;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
32 Ourense;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;95,72
32 Ourense;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
32 Ourense;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
32 Ourense;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
32 Ourense;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;96,89
32 Ourense;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
32 Ourense;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
32 Ourense;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
32 Ourense;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;95,77
32 Ourense;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
32 Ourense;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
32 Ourense;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;92,23
32 Ourense;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
32 Ourense;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
32 Ourense;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
32 Ourense;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;93,7
32 Ourense;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
32 Ourense;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
32 Ourense;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
32 Ourense;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;92,49
32 Ourense;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
32 Ourense;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
32 Ourense;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
32 Ourense;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
32 Ourense;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
32 Ourense;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
32 Ourense;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;90,38
32 Ourense;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
32 Ourense;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
32 Ourense;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
32 Ourense;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;90,03
32 Ourense;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
32 Ourense;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
32 Ourense;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
32 Ourense;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
32 Ourense;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
32 Ourense;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
32 Ourense;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;86,62
32 Ourense;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
32 Ourense;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
32 Ourense;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
32 Ourense;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;87,65
32 Ourense;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
32 Ourense;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
32 Ourense;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
32 Ourense;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
32 Ourense;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
32 Ourense;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QIV;3.346
32 Ourense;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
32 Ourense;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
32 Ourense;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
32 Ourense;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QIV;3.451
32 Ourense;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
32 Ourense;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
32 Ourense;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
32 Ourense;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QIV;3.644
32 Ourense;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
32 Ourense;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
32 Ourense;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
32 Ourense;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2022QIV;3.226
32 Ourense;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
32 Ourense;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2022QII;""
32 Ourense;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2022QI;""
32 Ourense;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2021QIV;3.341
32 Ourense;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
32 Ourense;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2021QII;""
32 Ourense;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2021QI;""
32 Ourense;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2020QIV;3.525
32 Ourense;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
32 Ourense;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2020QII;""
32 Ourense;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2020QI;""
32 Ourense;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
32 Ourense;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
32 Ourense;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2022QII;""
32 Ourense;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2022QI;3.233
32 Ourense;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
32 Ourense;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
32 Ourense;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2021QII;""
32 Ourense;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2021QI;3.432
32 Ourense;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
32 Ourense;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
32 Ourense;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2020QII;""
32 Ourense;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2020QI;""
32 Ourense;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
32 Ourense;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
32 Ourense;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QII;3.135
32 Ourense;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QI;""
32 Ourense;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
32 Ourense;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
32 Ourense;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QII;3.338
32 Ourense;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QI;""
32 Ourense;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
32 Ourense;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
32 Ourense;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QII;""
32 Ourense;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QI;""
32 Ourense;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
32 Ourense;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QIII;3.049
32 Ourense;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QII;""
32 Ourense;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QI;""
32 Ourense;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
32 Ourense;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QIII;3.246
32 Ourense;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QII;""
32 Ourense;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QI;""
32 Ourense;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
32 Ourense;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
32 Ourense;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QII;""
32 Ourense;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QI;""
32 Ourense;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
32 Ourense;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
32 Ourense;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
32 Ourense;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
32 Ourense;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
32 Ourense;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
32 Ourense;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
32 Ourense;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
32 Ourense;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
32 Ourense;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
32 Ourense;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
32 Ourense;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
32 Ourense;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;96,41
32 Ourense;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
32 Ourense;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
32 Ourense;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
32 Ourense;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;96,81
32 Ourense;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
32 Ourense;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
32 Ourense;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
32 Ourense;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;96,73
32 Ourense;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
32 Ourense;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
32 Ourense;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
32 Ourense;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
32 Ourense;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
32 Ourense;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
32 Ourense;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;93,68
32 Ourense;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
32 Ourense;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
32 Ourense;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
32 Ourense;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;94,18
32 Ourense;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
32 Ourense;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
32 Ourense;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
32 Ourense;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
32 Ourense;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
32 Ourense;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
32 Ourense;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;90,84
32 Ourense;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
32 Ourense;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
32 Ourense;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
32 Ourense;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;91,6
32 Ourense;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
32 Ourense;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
32 Ourense;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
32 Ourense;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
32 Ourense;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
32 Ourense;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
32 Ourense;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;88,35
32 Ourense;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
32 Ourense;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
32 Ourense;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
32 Ourense;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;89,08
32 Ourense;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
32 Ourense;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
32 Ourense;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
32 Ourense;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
32 Ourense;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
32 Ourense;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
32 Ourense;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QIV;1.966
32 Ourense;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
32 Ourense;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
32 Ourense;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
32 Ourense;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QIV;2.008
32 Ourense;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
32 Ourense;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
32 Ourense;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
32 Ourense;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QIV;2.178
32 Ourense;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
32 Ourense;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
32 Ourense;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
32 Ourense;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2022QIV;1.900
32 Ourense;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
32 Ourense;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2022QII;""
32 Ourense;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2022QI;""
32 Ourense;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2021QIV;1.949
32 Ourense;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
32 Ourense;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2021QII;""
32 Ourense;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2021QI;""
32 Ourense;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2020QIV;2.111
32 Ourense;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
32 Ourense;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2020QII;""
32 Ourense;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2020QI;""
32 Ourense;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
32 Ourense;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
32 Ourense;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2022QII;""
32 Ourense;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2022QI;1.894
32 Ourense;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
32 Ourense;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
32 Ourense;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2021QII;""
32 Ourense;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2021QI;2.059
32 Ourense;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
32 Ourense;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
32 Ourense;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2020QII;""
32 Ourense;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2020QI;""
32 Ourense;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
32 Ourense;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
32 Ourense;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QII;1.853
32 Ourense;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QI;""
32 Ourense;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
32 Ourense;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
32 Ourense;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QII;2.007
32 Ourense;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QI;""
32 Ourense;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
32 Ourense;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
32 Ourense;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QII;""
32 Ourense;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QI;""
32 Ourense;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
32 Ourense;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QIII;1.813
32 Ourense;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QII;""
32 Ourense;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QI;""
32 Ourense;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
32 Ourense;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QIII;1.950
32 Ourense;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QII;""
32 Ourense;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QI;""
32 Ourense;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
32 Ourense;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
32 Ourense;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QII;""
32 Ourense;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QI;""
32 Ourense;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
32 Ourense;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
32 Ourense;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
32 Ourense;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
32 Ourense;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
32 Ourense;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
32 Ourense;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
32 Ourense;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
32 Ourense;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
32 Ourense;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
32 Ourense;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
32 Ourense;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
32 Ourense;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;96,64
32 Ourense;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
32 Ourense;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
32 Ourense;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
32 Ourense;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;97,06
32 Ourense;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
32 Ourense;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
32 Ourense;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
32 Ourense;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;96,92
32 Ourense;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
32 Ourense;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
32 Ourense;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
32 Ourense;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
32 Ourense;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
32 Ourense;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
32 Ourense;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;94,32
32 Ourense;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
32 Ourense;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
32 Ourense;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
32 Ourense;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;94,54
32 Ourense;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
32 Ourense;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
32 Ourense;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
32 Ourense;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
32 Ourense;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
32 Ourense;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
32 Ourense;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;92,28
32 Ourense;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
32 Ourense;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
32 Ourense;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
32 Ourense;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;92,15
32 Ourense;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
32 Ourense;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
32 Ourense;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
32 Ourense;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
32 Ourense;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
32 Ourense;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
32 Ourense;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;90,29
32 Ourense;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
32 Ourense;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
32 Ourense;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
32 Ourense;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;89,53
32 Ourense;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
32 Ourense;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
32 Ourense;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
32 Ourense;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
32 Ourense;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
32 Ourense;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
32 Ourense;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QIV;1.380
32 Ourense;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
32 Ourense;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
32 Ourense;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
32 Ourense;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QIV;1.443
32 Ourense;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
32 Ourense;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
32 Ourense;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
32 Ourense;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QIV;1.466
32 Ourense;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
32 Ourense;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
32 Ourense;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
32 Ourense;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2022QIV;1.326
32 Ourense;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
32 Ourense;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2022QII;""
32 Ourense;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2022QI;""
32 Ourense;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2021QIV;1.392
32 Ourense;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
32 Ourense;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2021QII;""
32 Ourense;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2021QI;""
32 Ourense;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2020QIV;1.414
32 Ourense;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
32 Ourense;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2020QII;""
32 Ourense;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2020QI;""
32 Ourense;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
32 Ourense;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
32 Ourense;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2022QII;""
32 Ourense;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2022QI;1.339
32 Ourense;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
32 Ourense;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
32 Ourense;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2021QII;""
32 Ourense;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2021QI;1.373
32 Ourense;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
32 Ourense;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
32 Ourense;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2020QII;""
32 Ourense;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2020QI;""
32 Ourense;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
32 Ourense;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
32 Ourense;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QII;1.282
32 Ourense;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QI;""
32 Ourense;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
32 Ourense;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
32 Ourense;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QII;1.331
32 Ourense;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QI;""
32 Ourense;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
32 Ourense;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
32 Ourense;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QII;""
32 Ourense;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QI;""
32 Ourense;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
32 Ourense;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QIII;1.236
32 Ourense;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QII;""
32 Ourense;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QI;""
32 Ourense;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
32 Ourense;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QIII;1.296
32 Ourense;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QII;""
32 Ourense;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QI;""
32 Ourense;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
32 Ourense;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
32 Ourense;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QII;""
32 Ourense;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QI;""
32 Ourense;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
32 Ourense;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
32 Ourense;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
32 Ourense;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
32 Ourense;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
32 Ourense;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
32 Ourense;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
32 Ourense;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
32 Ourense;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
32 Ourense;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
32 Ourense;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
32 Ourense;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
32 Ourense;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;96,09
32 Ourense;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
32 Ourense;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
32 Ourense;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
32 Ourense;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;96,47
32 Ourense;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
32 Ourense;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
32 Ourense;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
32 Ourense;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;96,45
32 Ourense;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
32 Ourense;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
32 Ourense;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
32 Ourense;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
32 Ourense;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
32 Ourense;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
32 Ourense;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;92,79
32 Ourense;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
32 Ourense;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
32 Ourense;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
32 Ourense;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;93,66
32 Ourense;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
32 Ourense;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
32 Ourense;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
32 Ourense;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
32 Ourense;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
32 Ourense;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
32 Ourense;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;88,84
32 Ourense;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
32 Ourense;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
32 Ourense;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
32 Ourense;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;90,79
32 Ourense;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
32 Ourense;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
32 Ourense;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
32 Ourense;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
32 Ourense;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
32 Ourense;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
32 Ourense;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;85,65
32 Ourense;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
32 Ourense;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
32 Ourense;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
32 Ourense;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;88,4
32 Ourense;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
32 Ourense;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
32 Ourense;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
32 Ourense;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
32 Ourense;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
32 Ourense;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
32 Ourense;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
32 Ourense;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
32 Ourense;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
32 Ourense;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QI;6.078
32 Ourense;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
32 Ourense;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
32 Ourense;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
32 Ourense;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QI;6.116
32 Ourense;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
32 Ourense;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
32 Ourense;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
32 Ourense;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QI;6.100
32 Ourense;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
32 Ourense;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
32 Ourense;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2022QII;""
32 Ourense;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2022QI;5.945
32 Ourense;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
32 Ourense;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
32 Ourense;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2021QII;""
32 Ourense;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2021QI;6.002
32 Ourense;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
32 Ourense;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
32 Ourense;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2020QII;""
32 Ourense;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2020QI;5.841
32 Ourense;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
32 Ourense;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
32 Ourense;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2022QII;5.820
32 Ourense;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2022QI;""
32 Ourense;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
32 Ourense;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
32 Ourense;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2021QII;5.913
32 Ourense;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2021QI;""
32 Ourense;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
32 Ourense;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
32 Ourense;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2020QII;5.757
32 Ourense;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2020QI;""
32 Ourense;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
32 Ourense;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QIII;5.720
32 Ourense;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QII;""
32 Ourense;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QI;""
32 Ourense;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
32 Ourense;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QIII;5.823
32 Ourense;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QII;""
32 Ourense;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QI;""
32 Ourense;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
32 Ourense;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QIII;5.683
32 Ourense;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QII;""
32 Ourense;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QI;""
32 Ourense;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QIV;5.593
32 Ourense;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
32 Ourense;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QII;""
32 Ourense;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QI;""
32 Ourense;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QIV;5.716
32 Ourense;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
32 Ourense;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QII;""
32 Ourense;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QI;""
32 Ourense;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QIV;5.589
32 Ourense;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
32 Ourense;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QII;""
32 Ourense;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QI;""
32 Ourense;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
32 Ourense;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
32 Ourense;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
32 Ourense;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
32 Ourense;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
32 Ourense;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
32 Ourense;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
32 Ourense;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
32 Ourense;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
32 Ourense;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
32 Ourense;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
32 Ourense;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
32 Ourense;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
32 Ourense;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
32 Ourense;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
32 Ourense;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;97,81
32 Ourense;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
32 Ourense;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
32 Ourense;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
32 Ourense;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;98,14
32 Ourense;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
32 Ourense;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
32 Ourense;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
32 Ourense;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;95,75
32 Ourense;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
32 Ourense;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
32 Ourense;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;95,76
32 Ourense;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
32 Ourense;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
32 Ourense;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
32 Ourense;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;96,68
32 Ourense;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
32 Ourense;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
32 Ourense;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
32 Ourense;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;94,38
32 Ourense;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
32 Ourense;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
32 Ourense;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;94,11
32 Ourense;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
32 Ourense;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
32 Ourense;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
32 Ourense;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;95,21
32 Ourense;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
32 Ourense;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
32 Ourense;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
32 Ourense;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;93,16
32 Ourense;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
32 Ourense;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
32 Ourense;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;92,02
32 Ourense;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
32 Ourense;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
32 Ourense;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
32 Ourense;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;93,46
32 Ourense;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
32 Ourense;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
32 Ourense;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
32 Ourense;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;91,62
32 Ourense;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
32 Ourense;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
32 Ourense;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
32 Ourense;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
32 Ourense;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
32 Ourense;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
32 Ourense;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QI;3.770
32 Ourense;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
32 Ourense;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
32 Ourense;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
32 Ourense;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QI;3.774
32 Ourense;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
32 Ourense;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
32 Ourense;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
32 Ourense;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QI;3.774
32 Ourense;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
32 Ourense;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
32 Ourense;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2022QII;""
32 Ourense;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2022QI;3.700
32 Ourense;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
32 Ourense;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
32 Ourense;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2021QII;""
32 Ourense;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2021QI;3.717
32 Ourense;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
32 Ourense;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
32 Ourense;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2020QII;""
32 Ourense;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2020QI;3.618
32 Ourense;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
32 Ourense;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
32 Ourense;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2022QII;3.634
32 Ourense;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2022QI;""
32 Ourense;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
32 Ourense;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
32 Ourense;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2021QII;3.675
32 Ourense;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2021QI;""
32 Ourense;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
32 Ourense;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
32 Ourense;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2020QII;3.570
32 Ourense;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2020QI;""
32 Ourense;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
32 Ourense;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QIII;3.580
32 Ourense;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QII;""
32 Ourense;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QI;""
32 Ourense;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
32 Ourense;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QIII;3.631
32 Ourense;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QII;""
32 Ourense;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QI;""
32 Ourense;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
32 Ourense;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QIII;3.529
32 Ourense;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QII;""
32 Ourense;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QI;""
32 Ourense;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QIV;3.509
32 Ourense;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
32 Ourense;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QII;""
32 Ourense;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QI;""
32 Ourense;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QIV;3.573
32 Ourense;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
32 Ourense;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QII;""
32 Ourense;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QI;""
32 Ourense;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QIV;3.471
32 Ourense;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
32 Ourense;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QII;""
32 Ourense;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QI;""
32 Ourense;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
32 Ourense;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
32 Ourense;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
32 Ourense;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
32 Ourense;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
32 Ourense;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
32 Ourense;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
32 Ourense;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
32 Ourense;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
32 Ourense;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
32 Ourense;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
32 Ourense;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
32 Ourense;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
32 Ourense;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
32 Ourense;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
32 Ourense;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;98,14
32 Ourense;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
32 Ourense;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
32 Ourense;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
32 Ourense;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;98,49
32 Ourense;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
32 Ourense;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
32 Ourense;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
32 Ourense;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;95,87
32 Ourense;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
32 Ourense;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
32 Ourense;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;96,39
32 Ourense;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
32 Ourense;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
32 Ourense;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
32 Ourense;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;97,38
32 Ourense;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
32 Ourense;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
32 Ourense;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
32 Ourense;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;94,59
32 Ourense;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
32 Ourense;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
32 Ourense;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;94,96
32 Ourense;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
32 Ourense;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
32 Ourense;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
32 Ourense;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;96,21
32 Ourense;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
32 Ourense;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
32 Ourense;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
32 Ourense;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;93,51
32 Ourense;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
32 Ourense;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
32 Ourense;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;93,08
32 Ourense;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
32 Ourense;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
32 Ourense;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
32 Ourense;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;94,67
32 Ourense;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
32 Ourense;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
32 Ourense;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
32 Ourense;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;91,97
32 Ourense;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
32 Ourense;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
32 Ourense;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
32 Ourense;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
32 Ourense;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
32 Ourense;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
32 Ourense;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QI;2.308
32 Ourense;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
32 Ourense;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
32 Ourense;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
32 Ourense;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QI;2.342
32 Ourense;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
32 Ourense;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
32 Ourense;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
32 Ourense;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QI;2.326
32 Ourense;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
32 Ourense;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
32 Ourense;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2022QII;""
32 Ourense;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2022QI;2.245
32 Ourense;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
32 Ourense;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
32 Ourense;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2021QII;""
32 Ourense;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2021QI;2.285
32 Ourense;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
32 Ourense;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
32 Ourense;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2020QII;""
32 Ourense;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2020QI;2.223
32 Ourense;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
32 Ourense;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
32 Ourense;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2022QII;2.186
32 Ourense;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2022QI;""
32 Ourense;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
32 Ourense;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
32 Ourense;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2021QII;2.238
32 Ourense;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2021QI;""
32 Ourense;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
32 Ourense;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
32 Ourense;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2020QII;2.187
32 Ourense;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2020QI;""
32 Ourense;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
32 Ourense;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QIII;2.140
32 Ourense;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QII;""
32 Ourense;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QI;""
32 Ourense;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
32 Ourense;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QIII;2.192
32 Ourense;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QII;""
32 Ourense;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QI;""
32 Ourense;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
32 Ourense;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QIII;2.154
32 Ourense;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QII;""
32 Ourense;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QI;""
32 Ourense;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QIV;2.084
32 Ourense;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
32 Ourense;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QII;""
32 Ourense;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QI;""
32 Ourense;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QIV;2.143
32 Ourense;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
32 Ourense;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QII;""
32 Ourense;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QI;""
32 Ourense;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QIV;2.118
32 Ourense;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
32 Ourense;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QII;""
32 Ourense;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QI;""
32 Ourense;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
32 Ourense;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
32 Ourense;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
32 Ourense;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
32 Ourense;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
32 Ourense;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
32 Ourense;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
32 Ourense;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
32 Ourense;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
32 Ourense;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
32 Ourense;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
32 Ourense;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
32 Ourense;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
32 Ourense;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
32 Ourense;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
32 Ourense;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;97,27
32 Ourense;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
32 Ourense;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
32 Ourense;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
32 Ourense;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;97,57
32 Ourense;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
32 Ourense;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
32 Ourense;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
32 Ourense;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;95,57
32 Ourense;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
32 Ourense;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
32 Ourense;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;94,71
32 Ourense;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
32 Ourense;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
32 Ourense;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
32 Ourense;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;95,56
32 Ourense;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
32 Ourense;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
32 Ourense;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
32 Ourense;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;94,02
32 Ourense;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
32 Ourense;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
32 Ourense;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;92,72
32 Ourense;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
32 Ourense;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
32 Ourense;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
32 Ourense;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;93,6
32 Ourense;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
32 Ourense;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
32 Ourense;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
32 Ourense;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;92,61
32 Ourense;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
32 Ourense;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
32 Ourense;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;90,29
32 Ourense;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
32 Ourense;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
32 Ourense;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
32 Ourense;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;91,5
32 Ourense;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
32 Ourense;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
32 Ourense;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
32 Ourense;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;91,06
32 Ourense;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
32 Ourense;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
32 Ourense;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
32 Ourense;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
32 Ourense;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
32 Ourense;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QII;5.941
32 Ourense;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
32 Ourense;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
32 Ourense;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
32 Ourense;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QII;5.986
32 Ourense;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
32 Ourense;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
32 Ourense;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
32 Ourense;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QII;6.037
32 Ourense;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
32 Ourense;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
32 Ourense;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
32 Ourense;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2022QII;5.798
32 Ourense;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2022QI;""
32 Ourense;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
32 Ourense;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
32 Ourense;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2021QII;5.882
32 Ourense;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2021QI;""
32 Ourense;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
32 Ourense;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
32 Ourense;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2020QII;5.945
32 Ourense;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2020QI;""
32 Ourense;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
32 Ourense;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2022QIII;5.693
32 Ourense;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2022QII;""
32 Ourense;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2022QI;""
32 Ourense;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
32 Ourense;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2021QIII;5.788
32 Ourense;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2021QII;""
32 Ourense;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2021QI;""
32 Ourense;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
32 Ourense;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2020QIII;5.856
32 Ourense;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2020QII;""
32 Ourense;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2020QI;""
32 Ourense;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QIV;5.556
32 Ourense;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
32 Ourense;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QII;""
32 Ourense;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QI;""
32 Ourense;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QIV;5.678
32 Ourense;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
32 Ourense;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QII;""
32 Ourense;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QI;""
32 Ourense;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QIV;5.752
32 Ourense;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
32 Ourense;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QII;""
32 Ourense;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QI;""
32 Ourense;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
32 Ourense;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
32 Ourense;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QII;""
32 Ourense;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QI;5.569
32 Ourense;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
32 Ourense;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
32 Ourense;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QII;""
32 Ourense;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QI;5.667
32 Ourense;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
32 Ourense;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
32 Ourense;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QII;""
32 Ourense;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QI;""
32 Ourense;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
32 Ourense;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
32 Ourense;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
32 Ourense;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
32 Ourense;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
32 Ourense;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
32 Ourense;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
32 Ourense;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
32 Ourense;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
32 Ourense;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
32 Ourense;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
32 Ourense;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
32 Ourense;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
32 Ourense;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
32 Ourense;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;97,59
32 Ourense;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
32 Ourense;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
32 Ourense;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
32 Ourense;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;98,26
32 Ourense;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
32 Ourense;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
32 Ourense;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
32 Ourense;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;98,48
32 Ourense;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
32 Ourense;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
32 Ourense;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;95,83
32 Ourense;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
32 Ourense;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
32 Ourense;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
32 Ourense;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;96,69
32 Ourense;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
32 Ourense;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
32 Ourense;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
32 Ourense;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;97
32 Ourense;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
32 Ourense;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
32 Ourense;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;93,52
32 Ourense;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
32 Ourense;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
32 Ourense;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
32 Ourense;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;94,85
32 Ourense;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
32 Ourense;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
32 Ourense;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
32 Ourense;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;95,28
32 Ourense;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
32 Ourense;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
32 Ourense;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
32 Ourense;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
32 Ourense;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
32 Ourense;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
32 Ourense;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;93,03
32 Ourense;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
32 Ourense;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
32 Ourense;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
32 Ourense;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;93,87
32 Ourense;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
32 Ourense;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
32 Ourense;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
32 Ourense;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
32 Ourense;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
32 Ourense;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
32 Ourense;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QII;3.703
32 Ourense;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
32 Ourense;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
32 Ourense;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
32 Ourense;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QII;3.703
32 Ourense;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
32 Ourense;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
32 Ourense;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
32 Ourense;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QII;3.729
32 Ourense;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
32 Ourense;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
32 Ourense;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
32 Ourense;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2022QII;3.634
32 Ourense;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2022QI;""
32 Ourense;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
32 Ourense;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
32 Ourense;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2021QII;3.649
32 Ourense;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2021QI;""
32 Ourense;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
32 Ourense;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
32 Ourense;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2020QII;3.677
32 Ourense;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2020QI;""
32 Ourense;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
32 Ourense;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2022QIII;3.578
32 Ourense;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2022QII;""
32 Ourense;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2022QI;""
32 Ourense;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
32 Ourense;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2021QIII;3.604
32 Ourense;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2021QII;""
32 Ourense;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2021QI;""
32 Ourense;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
32 Ourense;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2020QIII;3.625
32 Ourense;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2020QII;""
32 Ourense;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2020QI;""
32 Ourense;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QIV;3.499
32 Ourense;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
32 Ourense;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QII;""
32 Ourense;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QI;""
32 Ourense;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QIV;3.543
32 Ourense;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
32 Ourense;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QII;""
32 Ourense;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QI;""
32 Ourense;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QIV;3.563
32 Ourense;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
32 Ourense;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QII;""
32 Ourense;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QI;""
32 Ourense;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
32 Ourense;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
32 Ourense;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QII;""
32 Ourense;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QI;3.485
32 Ourense;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
32 Ourense;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
32 Ourense;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QII;""
32 Ourense;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QI;3.523
32 Ourense;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
32 Ourense;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
32 Ourense;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QII;""
32 Ourense;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QI;""
32 Ourense;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
32 Ourense;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
32 Ourense;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
32 Ourense;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
32 Ourense;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
32 Ourense;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
32 Ourense;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
32 Ourense;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
32 Ourense;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
32 Ourense;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
32 Ourense;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
32 Ourense;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
32 Ourense;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
32 Ourense;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
32 Ourense;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;98,14
32 Ourense;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
32 Ourense;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
32 Ourense;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
32 Ourense;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;98,54
32 Ourense;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
32 Ourense;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
32 Ourense;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
32 Ourense;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;98,61
32 Ourense;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
32 Ourense;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
32 Ourense;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;96,62
32 Ourense;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
32 Ourense;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
32 Ourense;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
32 Ourense;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;97,33
32 Ourense;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
32 Ourense;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
32 Ourense;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
32 Ourense;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;97,21
32 Ourense;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
32 Ourense;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
32 Ourense;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;94,49
32 Ourense;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
32 Ourense;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
32 Ourense;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
32 Ourense;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;95,68
32 Ourense;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
32 Ourense;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
32 Ourense;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
32 Ourense;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;95,55
32 Ourense;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
32 Ourense;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
32 Ourense;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
32 Ourense;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
32 Ourense;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
32 Ourense;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
32 Ourense;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;94,11
32 Ourense;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
32 Ourense;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
32 Ourense;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
32 Ourense;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;94,48
32 Ourense;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
32 Ourense;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
32 Ourense;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
32 Ourense;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
32 Ourense;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
32 Ourense;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
32 Ourense;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QII;2.238
32 Ourense;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
32 Ourense;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
32 Ourense;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
32 Ourense;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QII;2.283
32 Ourense;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
32 Ourense;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
32 Ourense;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
32 Ourense;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QII;2.308
32 Ourense;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
32 Ourense;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
32 Ourense;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
32 Ourense;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2022QII;2.164
32 Ourense;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2022QI;""
32 Ourense;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
32 Ourense;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
32 Ourense;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2021QII;2.233
32 Ourense;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2021QI;""
32 Ourense;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
32 Ourense;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
32 Ourense;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2020QII;2.268
32 Ourense;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2020QI;""
32 Ourense;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
32 Ourense;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2022QIII;2.115
32 Ourense;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2022QII;""
32 Ourense;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2022QI;""
32 Ourense;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
32 Ourense;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2021QIII;2.184
32 Ourense;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2021QII;""
32 Ourense;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2021QI;""
32 Ourense;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
32 Ourense;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2020QIII;2.231
32 Ourense;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2020QII;""
32 Ourense;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2020QI;""
32 Ourense;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QIV;2.057
32 Ourense;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
32 Ourense;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QII;""
32 Ourense;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QI;""
32 Ourense;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QIV;2.135
32 Ourense;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
32 Ourense;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QII;""
32 Ourense;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QI;""
32 Ourense;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QIV;2.189
32 Ourense;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
32 Ourense;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QII;""
32 Ourense;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QI;""
32 Ourense;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
32 Ourense;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
32 Ourense;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QII;""
32 Ourense;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QI;2.084
32 Ourense;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
32 Ourense;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
32 Ourense;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QII;""
32 Ourense;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QI;2.144
32 Ourense;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
32 Ourense;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
32 Ourense;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QII;""
32 Ourense;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QI;""
32 Ourense;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
32 Ourense;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
32 Ourense;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
32 Ourense;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
32 Ourense;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
32 Ourense;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
32 Ourense;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
32 Ourense;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
32 Ourense;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
32 Ourense;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
32 Ourense;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
32 Ourense;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
32 Ourense;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
32 Ourense;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
32 Ourense;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;96,69
32 Ourense;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
32 Ourense;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
32 Ourense;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
32 Ourense;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;97,81
32 Ourense;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
32 Ourense;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
32 Ourense;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
32 Ourense;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;98,27
32 Ourense;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
32 Ourense;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
32 Ourense;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;94,5
32 Ourense;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
32 Ourense;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
32 Ourense;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
32 Ourense;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;95,66
32 Ourense;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
32 Ourense;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
32 Ourense;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
32 Ourense;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;96,66
32 Ourense;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
32 Ourense;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
32 Ourense;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;91,91
32 Ourense;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
32 Ourense;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
32 Ourense;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
32 Ourense;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;93,52
32 Ourense;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
32 Ourense;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
32 Ourense;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
32 Ourense;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;94,84
32 Ourense;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
32 Ourense;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
32 Ourense;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
32 Ourense;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
32 Ourense;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
32 Ourense;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
32 Ourense;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;91,28
32 Ourense;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
32 Ourense;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
32 Ourense;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
32 Ourense;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;92,89
32 Ourense;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
32 Ourense;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
32 Ourense;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
32 Ourense;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
32 Ourense;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
32 Ourense;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QIII;5.944
32 Ourense;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
32 Ourense;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
32 Ourense;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
32 Ourense;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QIII;6.028
32 Ourense;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
32 Ourense;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
32 Ourense;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
32 Ourense;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QIII;6.047
32 Ourense;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
32 Ourense;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
32 Ourense;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
32 Ourense;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2022QIII;5.819
32 Ourense;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2022QII;""
32 Ourense;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2022QI;""
32 Ourense;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
32 Ourense;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2021QIII;5.918
32 Ourense;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2021QII;""
32 Ourense;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2021QI;""
32 Ourense;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
32 Ourense;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2020QIII;5.945
32 Ourense;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2020QII;""
32 Ourense;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2020QI;""
32 Ourense;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2022QIV;5.669
32 Ourense;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
32 Ourense;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2022QII;""
32 Ourense;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2022QI;""
32 Ourense;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2021QIV;5.801
32 Ourense;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
32 Ourense;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2021QII;""
32 Ourense;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2021QI;""
32 Ourense;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2020QIV;5.835
32 Ourense;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
32 Ourense;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2020QII;""
32 Ourense;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2020QI;""
32 Ourense;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
32 Ourense;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
32 Ourense;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QII;""
32 Ourense;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QI;5.686
32 Ourense;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
32 Ourense;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
32 Ourense;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QII;""
32 Ourense;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QI;5.747
32 Ourense;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
32 Ourense;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
32 Ourense;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QII;""
32 Ourense;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QI;""
32 Ourense;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
32 Ourense;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
32 Ourense;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QII;5.576
32 Ourense;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QI;""
32 Ourense;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
32 Ourense;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
32 Ourense;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QII;5.674
32 Ourense;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QI;""
32 Ourense;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
32 Ourense;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
32 Ourense;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QII;""
32 Ourense;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QI;""
32 Ourense;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
32 Ourense;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
32 Ourense;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
32 Ourense;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
32 Ourense;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
32 Ourense;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
32 Ourense;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
32 Ourense;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
32 Ourense;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
32 Ourense;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
32 Ourense;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
32 Ourense;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
32 Ourense;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
32 Ourense;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;97,9
32 Ourense;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
32 Ourense;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
32 Ourense;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
32 Ourense;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;98,18
32 Ourense;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
32 Ourense;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
32 Ourense;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
32 Ourense;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;98,31
32 Ourense;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
32 Ourense;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
32 Ourense;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;95,37
32 Ourense;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
32 Ourense;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
32 Ourense;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
32 Ourense;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;96,23
32 Ourense;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
32 Ourense;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
32 Ourense;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
32 Ourense;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;96,49
32 Ourense;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
32 Ourense;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
32 Ourense;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
32 Ourense;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
32 Ourense;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
32 Ourense;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
32 Ourense;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;94,33
32 Ourense;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
32 Ourense;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
32 Ourense;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
32 Ourense;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;95,04
32 Ourense;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
32 Ourense;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
32 Ourense;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
32 Ourense;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
32 Ourense;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
32 Ourense;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
32 Ourense;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;92,5
32 Ourense;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
32 Ourense;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
32 Ourense;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
32 Ourense;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;93,83
32 Ourense;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
32 Ourense;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
32 Ourense;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
32 Ourense;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
32 Ourense;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
32 Ourense;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
32 Ourense;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QIII;3.724
32 Ourense;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
32 Ourense;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
32 Ourense;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
32 Ourense;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QIII;3.745
32 Ourense;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
32 Ourense;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
32 Ourense;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
32 Ourense;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QIII;3.740
32 Ourense;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
32 Ourense;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
32 Ourense;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
32 Ourense;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2022QIII;3.654
32 Ourense;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2022QII;""
32 Ourense;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2022QI;""
32 Ourense;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
32 Ourense;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2021QIII;3.690
32 Ourense;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2021QII;""
32 Ourense;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2021QI;""
32 Ourense;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
32 Ourense;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2020QIII;3.678
32 Ourense;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2020QII;""
32 Ourense;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2020QI;""
32 Ourense;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2022QIV;3.567
32 Ourense;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
32 Ourense;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2022QII;""
32 Ourense;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2022QI;""
32 Ourense;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2021QIV;3.624
32 Ourense;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
32 Ourense;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2021QII;""
32 Ourense;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2021QI;""
32 Ourense;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2020QIV;3.611
32 Ourense;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
32 Ourense;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2020QII;""
32 Ourense;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2020QI;""
32 Ourense;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
32 Ourense;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
32 Ourense;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QII;""
32 Ourense;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QI;3.564
32 Ourense;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
32 Ourense;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
32 Ourense;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QII;""
32 Ourense;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QI;3.569
32 Ourense;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
32 Ourense;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
32 Ourense;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QII;""
32 Ourense;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QI;""
32 Ourense;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
32 Ourense;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
32 Ourense;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QII;3.504
32 Ourense;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QI;""
32 Ourense;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
32 Ourense;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
32 Ourense;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QII;3.537
32 Ourense;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QI;""
32 Ourense;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
32 Ourense;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
32 Ourense;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QII;""
32 Ourense;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QI;""
32 Ourense;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
32 Ourense;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
32 Ourense;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
32 Ourense;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
32 Ourense;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
32 Ourense;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
32 Ourense;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
32 Ourense;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
32 Ourense;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
32 Ourense;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
32 Ourense;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
32 Ourense;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
32 Ourense;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
32 Ourense;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;98,12
32 Ourense;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
32 Ourense;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
32 Ourense;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
32 Ourense;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;98,53
32 Ourense;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
32 Ourense;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
32 Ourense;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
32 Ourense;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;98,34
32 Ourense;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
32 Ourense;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
32 Ourense;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;95,78
32 Ourense;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
32 Ourense;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
32 Ourense;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
32 Ourense;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;96,77
32 Ourense;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
32 Ourense;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
32 Ourense;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
32 Ourense;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;96,55
32 Ourense;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
32 Ourense;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
32 Ourense;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
32 Ourense;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
32 Ourense;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
32 Ourense;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
32 Ourense;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;95,17
32 Ourense;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
32 Ourense;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
32 Ourense;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
32 Ourense;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;95,43
32 Ourense;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
32 Ourense;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
32 Ourense;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
32 Ourense;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
32 Ourense;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
32 Ourense;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
32 Ourense;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;93,56
32 Ourense;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
32 Ourense;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
32 Ourense;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
32 Ourense;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;94,57
32 Ourense;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
32 Ourense;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
32 Ourense;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
32 Ourense;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
32 Ourense;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
32 Ourense;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
32 Ourense;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QIII;2.220
32 Ourense;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
32 Ourense;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
32 Ourense;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
32 Ourense;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QIII;2.283
32 Ourense;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
32 Ourense;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
32 Ourense;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
32 Ourense;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QIII;2.307
32 Ourense;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
32 Ourense;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
32 Ourense;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
32 Ourense;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2022QIII;2.165
32 Ourense;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2022QII;""
32 Ourense;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2022QI;""
32 Ourense;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
32 Ourense;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2021QIII;2.228
32 Ourense;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2021QII;""
32 Ourense;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2021QI;""
32 Ourense;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
32 Ourense;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2020QIII;2.267
32 Ourense;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2020QII;""
32 Ourense;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2020QI;""
32 Ourense;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2022QIV;2.102
32 Ourense;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
32 Ourense;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2022QII;""
32 Ourense;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2022QI;""
32 Ourense;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2021QIV;2.177
32 Ourense;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
32 Ourense;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2021QII;""
32 Ourense;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2021QI;""
32 Ourense;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2020QIV;2.224
32 Ourense;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
32 Ourense;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2020QII;""
32 Ourense;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2020QI;""
32 Ourense;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
32 Ourense;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
32 Ourense;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QII;""
32 Ourense;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QI;2.122
32 Ourense;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
32 Ourense;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
32 Ourense;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QII;""
32 Ourense;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QI;2.178
32 Ourense;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
32 Ourense;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
32 Ourense;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QII;""
32 Ourense;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QI;""
32 Ourense;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
32 Ourense;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
32 Ourense;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QII;2.072
32 Ourense;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QI;""
32 Ourense;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
32 Ourense;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
32 Ourense;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QII;2.137
32 Ourense;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QI;""
32 Ourense;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
32 Ourense;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
32 Ourense;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QII;""
32 Ourense;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QI;""
32 Ourense;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
32 Ourense;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
32 Ourense;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
32 Ourense;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
32 Ourense;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
32 Ourense;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
32 Ourense;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
32 Ourense;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
32 Ourense;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
32 Ourense;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
32 Ourense;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
32 Ourense;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
32 Ourense;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
32 Ourense;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;97,52
32 Ourense;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
32 Ourense;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
32 Ourense;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
32 Ourense;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;97,59
32 Ourense;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
32 Ourense;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
32 Ourense;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
32 Ourense;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;98,27
32 Ourense;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
32 Ourense;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
32 Ourense;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;94,68
32 Ourense;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
32 Ourense;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
32 Ourense;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
32 Ourense;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;95,36
32 Ourense;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
32 Ourense;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
32 Ourense;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
32 Ourense;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;96,4
32 Ourense;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
32 Ourense;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
32 Ourense;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
32 Ourense;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
32 Ourense;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
32 Ourense;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
32 Ourense;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;92,95
32 Ourense;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
32 Ourense;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
32 Ourense;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
32 Ourense;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;94,41
32 Ourense;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
32 Ourense;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
32 Ourense;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
32 Ourense;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
32 Ourense;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
32 Ourense;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
32 Ourense;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;90,76
32 Ourense;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
32 Ourense;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
32 Ourense;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
32 Ourense;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;92,63
32 Ourense;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
32 Ourense;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
32 Ourense;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
32 Ourense;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
32 Ourense;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
32 Ourense;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QIV;5.921
32 Ourense;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
32 Ourense;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
32 Ourense;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
32 Ourense;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QIV;6.059
32 Ourense;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
32 Ourense;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
32 Ourense;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
32 Ourense;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QIV;6.095
32 Ourense;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
32 Ourense;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
32 Ourense;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
32 Ourense;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2022QIV;5.764
32 Ourense;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
32 Ourense;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2022QII;""
32 Ourense;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2022QI;""
32 Ourense;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2021QIV;5.932
32 Ourense;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
32 Ourense;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2021QII;""
32 Ourense;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2021QI;""
32 Ourense;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2020QIV;5.967
32 Ourense;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
32 Ourense;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2020QII;""
32 Ourense;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2020QI;""
32 Ourense;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
32 Ourense;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
32 Ourense;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2022QII;""
32 Ourense;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2022QI;5.814
32 Ourense;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
32 Ourense;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
32 Ourense;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2021QII;""
32 Ourense;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2021QI;5.873
32 Ourense;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
32 Ourense;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
32 Ourense;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2020QII;""
32 Ourense;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2020QI;""
32 Ourense;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
32 Ourense;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
32 Ourense;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QII;5.702
32 Ourense;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QI;""
32 Ourense;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
32 Ourense;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
32 Ourense;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QII;5.791
32 Ourense;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QI;""
32 Ourense;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
32 Ourense;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
32 Ourense;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QII;""
32 Ourense;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QI;""
32 Ourense;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
32 Ourense;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QIII;5.608
32 Ourense;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QII;""
32 Ourense;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QI;""
32 Ourense;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
32 Ourense;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QIII;5.707
32 Ourense;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QII;""
32 Ourense;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QI;""
32 Ourense;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
32 Ourense;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
32 Ourense;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QII;""
32 Ourense;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QI;""
32 Ourense;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
32 Ourense;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
32 Ourense;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
32 Ourense;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
32 Ourense;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
32 Ourense;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
32 Ourense;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
32 Ourense;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
32 Ourense;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
32 Ourense;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
32 Ourense;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
32 Ourense;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
32 Ourense;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;97,35
32 Ourense;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
32 Ourense;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
32 Ourense;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
32 Ourense;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;97,9
32 Ourense;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
32 Ourense;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
32 Ourense;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
32 Ourense;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;97,9
32 Ourense;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
32 Ourense;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
32 Ourense;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
32 Ourense;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
32 Ourense;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
32 Ourense;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
32 Ourense;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;95,96
32 Ourense;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
32 Ourense;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
32 Ourense;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
32 Ourense;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;96,36
32 Ourense;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
32 Ourense;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
32 Ourense;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
32 Ourense;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
32 Ourense;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
32 Ourense;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
32 Ourense;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;94,11
32 Ourense;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
32 Ourense;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
32 Ourense;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
32 Ourense;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;95,01
32 Ourense;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
32 Ourense;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
32 Ourense;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
32 Ourense;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
32 Ourense;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
32 Ourense;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
32 Ourense;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;92,56
32 Ourense;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
32 Ourense;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
32 Ourense;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
32 Ourense;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;93,63
32 Ourense;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
32 Ourense;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
32 Ourense;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
32 Ourense;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
32 Ourense;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
32 Ourense;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
32 Ourense;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QIV;3.710
32 Ourense;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
32 Ourense;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
32 Ourense;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
32 Ourense;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QIV;3.763
32 Ourense;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
32 Ourense;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
32 Ourense;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
32 Ourense;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QIV;3.764
32 Ourense;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
32 Ourense;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
32 Ourense;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
32 Ourense;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2022QIV;3.619
32 Ourense;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
32 Ourense;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2022QII;""
32 Ourense;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2022QI;""
32 Ourense;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2021QIV;3.690
32 Ourense;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
32 Ourense;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2021QII;""
32 Ourense;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2021QI;""
32 Ourense;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2020QIV;3.687
32 Ourense;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
32 Ourense;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2020QII;""
32 Ourense;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2020QI;""
32 Ourense;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
32 Ourense;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
32 Ourense;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2022QII;""
32 Ourense;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2022QI;3.628
32 Ourense;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
32 Ourense;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
32 Ourense;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2021QII;""
32 Ourense;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2021QI;3.641
32 Ourense;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
32 Ourense;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
32 Ourense;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2020QII;""
32 Ourense;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2020QI;""
32 Ourense;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
32 Ourense;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
32 Ourense;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QII;3.567
32 Ourense;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QI;""
32 Ourense;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
32 Ourense;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
32 Ourense;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QII;3.603
32 Ourense;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QI;""
32 Ourense;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
32 Ourense;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
32 Ourense;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QII;""
32 Ourense;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QI;""
32 Ourense;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
32 Ourense;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QIII;3.518
32 Ourense;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QII;""
32 Ourense;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QI;""
32 Ourense;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
32 Ourense;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QIII;3.562
32 Ourense;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QII;""
32 Ourense;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QI;""
32 Ourense;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
32 Ourense;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
32 Ourense;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QII;""
32 Ourense;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QI;""
32 Ourense;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
32 Ourense;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
32 Ourense;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
32 Ourense;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
32 Ourense;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
32 Ourense;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
32 Ourense;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
32 Ourense;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
32 Ourense;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
32 Ourense;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
32 Ourense;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
32 Ourense;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
32 Ourense;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;97,55
32 Ourense;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
32 Ourense;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
32 Ourense;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
32 Ourense;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;98,06
32 Ourense;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
32 Ourense;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
32 Ourense;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
32 Ourense;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;97,95
32 Ourense;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
32 Ourense;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
32 Ourense;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
32 Ourense;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
32 Ourense;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
32 Ourense;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
32 Ourense;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;96,41
32 Ourense;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
32 Ourense;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
32 Ourense;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
32 Ourense;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;96,73
32 Ourense;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
32 Ourense;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
32 Ourense;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
32 Ourense;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
32 Ourense;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
32 Ourense;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
32 Ourense;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;94,79
32 Ourense;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
32 Ourense;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
32 Ourense;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
32 Ourense;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;95,72
32 Ourense;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
32 Ourense;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
32 Ourense;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
32 Ourense;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
32 Ourense;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
32 Ourense;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
32 Ourense;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;93,49
32 Ourense;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
32 Ourense;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
32 Ourense;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
32 Ourense;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;94,63
32 Ourense;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
32 Ourense;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
32 Ourense;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
32 Ourense;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
32 Ourense;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
32 Ourense;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
32 Ourense;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QIV;2.211
32 Ourense;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
32 Ourense;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
32 Ourense;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
32 Ourense;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QIV;2.296
32 Ourense;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
32 Ourense;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
32 Ourense;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
32 Ourense;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QIV;2.331
32 Ourense;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
32 Ourense;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
32 Ourense;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
32 Ourense;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2022QIV;2.145
32 Ourense;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
32 Ourense;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2022QII;""
32 Ourense;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2022QI;""
32 Ourense;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2021QIV;2.242
32 Ourense;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
32 Ourense;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2021QII;""
32 Ourense;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2021QI;""
32 Ourense;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2020QIV;2.280
32 Ourense;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
32 Ourense;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2020QII;""
32 Ourense;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2020QI;""
32 Ourense;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
32 Ourense;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
32 Ourense;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2022QII;""
32 Ourense;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2022QI;2.186
32 Ourense;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
32 Ourense;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
32 Ourense;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2021QII;""
32 Ourense;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2021QI;2.232
32 Ourense;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
32 Ourense;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
32 Ourense;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2020QII;""
32 Ourense;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2020QI;""
32 Ourense;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
32 Ourense;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
32 Ourense;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QII;2.135
32 Ourense;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QI;""
32 Ourense;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
32 Ourense;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
32 Ourense;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QII;2.188
32 Ourense;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QI;""
32 Ourense;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
32 Ourense;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
32 Ourense;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QII;""
32 Ourense;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QI;""
32 Ourense;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
32 Ourense;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QIII;2.090
32 Ourense;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QII;""
32 Ourense;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QI;""
32 Ourense;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
32 Ourense;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QIII;2.145
32 Ourense;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QII;""
32 Ourense;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QI;""
32 Ourense;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
32 Ourense;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
32 Ourense;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QII;""
32 Ourense;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QI;""
32 Ourense;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
32 Ourense;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
32 Ourense;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
32 Ourense;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
32 Ourense;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
32 Ourense;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
32 Ourense;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
32 Ourense;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
32 Ourense;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
32 Ourense;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
32 Ourense;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
32 Ourense;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
32 Ourense;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;97,01
32 Ourense;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
32 Ourense;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
32 Ourense;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
32 Ourense;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;97,65
32 Ourense;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
32 Ourense;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
32 Ourense;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
32 Ourense;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;97,81
32 Ourense;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
32 Ourense;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
32 Ourense;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
32 Ourense;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
32 Ourense;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
32 Ourense;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
32 Ourense;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;95,21
32 Ourense;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
32 Ourense;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
32 Ourense;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
32 Ourense;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;95,75
32 Ourense;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
32 Ourense;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
32 Ourense;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
32 Ourense;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
32 Ourense;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
32 Ourense;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
32 Ourense;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;92,99
32 Ourense;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
32 Ourense;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
32 Ourense;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
32 Ourense;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;93,87
32 Ourense;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
32 Ourense;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
32 Ourense;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
32 Ourense;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
32 Ourense;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
32 Ourense;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
32 Ourense;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;91,03
32 Ourense;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
32 Ourense;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
32 Ourense;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
32 Ourense;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;92,02
32 Ourense;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
32 Ourense;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
32 Ourense;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
32 Ourense;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
32 Ourense;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
32 Ourense;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
32 Ourense;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
32 Ourense;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
32 Ourense;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
32 Ourense;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QI;6.139
32 Ourense;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
32 Ourense;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
32 Ourense;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
32 Ourense;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QI;6.107
32 Ourense;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
32 Ourense;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
32 Ourense;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
32 Ourense;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QI;6.316
32 Ourense;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
32 Ourense;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
32 Ourense;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2022QII;""
32 Ourense;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2022QI;6.016
32 Ourense;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
32 Ourense;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
32 Ourense;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2021QII;""
32 Ourense;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2021QI;6.021
32 Ourense;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
32 Ourense;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
32 Ourense;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2020QII;""
32 Ourense;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2020QI;6.087
32 Ourense;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
32 Ourense;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
32 Ourense;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2022QII;5.909
32 Ourense;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2022QI;""
32 Ourense;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
32 Ourense;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
32 Ourense;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2021QII;5.940
32 Ourense;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2021QI;""
32 Ourense;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
32 Ourense;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
32 Ourense;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2020QII;5.998
32 Ourense;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2020QI;""
32 Ourense;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
32 Ourense;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QIII;5.808
32 Ourense;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QII;""
32 Ourense;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QI;""
32 Ourense;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
32 Ourense;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QIII;5.862
32 Ourense;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QII;""
32 Ourense;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QI;""
32 Ourense;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
32 Ourense;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QIII;5.911
32 Ourense;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QII;""
32 Ourense;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QI;""
32 Ourense;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QIV;5.690
32 Ourense;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
32 Ourense;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QII;""
32 Ourense;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QI;""
32 Ourense;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QIV;5.785
32 Ourense;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
32 Ourense;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QII;""
32 Ourense;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QI;""
32 Ourense;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QIV;5.818
32 Ourense;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
32 Ourense;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QII;""
32 Ourense;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QI;""
32 Ourense;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
32 Ourense;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
32 Ourense;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
32 Ourense;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
32 Ourense;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
32 Ourense;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
32 Ourense;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
32 Ourense;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
32 Ourense;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
32 Ourense;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
32 Ourense;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
32 Ourense;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
32 Ourense;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
32 Ourense;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
32 Ourense;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
32 Ourense;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;98
32 Ourense;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
32 Ourense;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
32 Ourense;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
32 Ourense;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;98,59
32 Ourense;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
32 Ourense;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
32 Ourense;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
32 Ourense;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;96,37
32 Ourense;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
32 Ourense;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
32 Ourense;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;96,25
32 Ourense;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
32 Ourense;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
32 Ourense;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
32 Ourense;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;97,27
32 Ourense;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
32 Ourense;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
32 Ourense;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
32 Ourense;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;94,97
32 Ourense;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
32 Ourense;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
32 Ourense;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;94,61
32 Ourense;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
32 Ourense;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
32 Ourense;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
32 Ourense;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;95,99
32 Ourense;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
32 Ourense;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
32 Ourense;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
32 Ourense;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;93,59
32 Ourense;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
32 Ourense;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
32 Ourense;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;92,69
32 Ourense;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
32 Ourense;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
32 Ourense;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
32 Ourense;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;94,73
32 Ourense;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
32 Ourense;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
32 Ourense;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
32 Ourense;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;92,12
32 Ourense;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
32 Ourense;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
32 Ourense;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
32 Ourense;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
32 Ourense;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
32 Ourense;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
32 Ourense;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QI;3.862
32 Ourense;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
32 Ourense;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
32 Ourense;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
32 Ourense;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QI;3.832
32 Ourense;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
32 Ourense;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
32 Ourense;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
32 Ourense;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QI;3.951
32 Ourense;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
32 Ourense;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
32 Ourense;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2022QII;""
32 Ourense;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2022QI;3.797
32 Ourense;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
32 Ourense;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
32 Ourense;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2021QII;""
32 Ourense;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2021QI;3.783
32 Ourense;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
32 Ourense;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
32 Ourense;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2020QII;""
32 Ourense;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2020QI;3.815
32 Ourense;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
32 Ourense;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
32 Ourense;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2022QII;3.739
32 Ourense;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2022QI;""
32 Ourense;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
32 Ourense;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
32 Ourense;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2021QII;3.739
32 Ourense;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2021QI;""
32 Ourense;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
32 Ourense;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
32 Ourense;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2020QII;3.768
32 Ourense;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2020QI;""
32 Ourense;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
32 Ourense;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QIII;3.677
32 Ourense;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QII;""
32 Ourense;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QI;""
32 Ourense;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
32 Ourense;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QIII;3.695
32 Ourense;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QII;""
32 Ourense;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QI;""
32 Ourense;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
32 Ourense;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QIII;3.721
32 Ourense;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QII;""
32 Ourense;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QI;""
32 Ourense;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QIV;3.607
32 Ourense;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
32 Ourense;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QII;""
32 Ourense;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QI;""
32 Ourense;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QIV;3.654
32 Ourense;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
32 Ourense;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QII;""
32 Ourense;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QI;""
32 Ourense;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QIV;3.666
32 Ourense;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
32 Ourense;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QII;""
32 Ourense;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QI;""
32 Ourense;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
32 Ourense;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
32 Ourense;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
32 Ourense;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
32 Ourense;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
32 Ourense;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
32 Ourense;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
32 Ourense;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
32 Ourense;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
32 Ourense;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
32 Ourense;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
32 Ourense;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
32 Ourense;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
32 Ourense;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
32 Ourense;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
32 Ourense;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;98,32
32 Ourense;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
32 Ourense;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
32 Ourense;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
32 Ourense;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;98,72
32 Ourense;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
32 Ourense;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
32 Ourense;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
32 Ourense;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;96,56
32 Ourense;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
32 Ourense;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
32 Ourense;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;96,82
32 Ourense;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
32 Ourense;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
32 Ourense;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
32 Ourense;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;97,57
32 Ourense;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
32 Ourense;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
32 Ourense;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
32 Ourense;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;95,37
32 Ourense;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
32 Ourense;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
32 Ourense;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;95,21
32 Ourense;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
32 Ourense;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
32 Ourense;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
32 Ourense;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;96,42
32 Ourense;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
32 Ourense;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
32 Ourense;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
32 Ourense;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;94,18
32 Ourense;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
32 Ourense;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
32 Ourense;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;93,4
32 Ourense;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
32 Ourense;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
32 Ourense;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
32 Ourense;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;95,35
32 Ourense;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
32 Ourense;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
32 Ourense;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
32 Ourense;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;92,79
32 Ourense;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
32 Ourense;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
32 Ourense;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
32 Ourense;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
32 Ourense;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
32 Ourense;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
32 Ourense;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QI;2.277
32 Ourense;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
32 Ourense;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
32 Ourense;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
32 Ourense;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QI;2.275
32 Ourense;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
32 Ourense;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
32 Ourense;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
32 Ourense;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QI;2.365
32 Ourense;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
32 Ourense;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
32 Ourense;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2022QII;""
32 Ourense;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2022QI;2.219
32 Ourense;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
32 Ourense;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
32 Ourense;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2021QII;""
32 Ourense;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2021QI;2.238
32 Ourense;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
32 Ourense;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
32 Ourense;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2020QII;""
32 Ourense;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2020QI;2.272
32 Ourense;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
32 Ourense;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
32 Ourense;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2022QII;2.170
32 Ourense;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2022QI;""
32 Ourense;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
32 Ourense;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
32 Ourense;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2021QII;2.201
32 Ourense;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2021QI;""
32 Ourense;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
32 Ourense;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
32 Ourense;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2020QII;2.230
32 Ourense;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2020QI;""
32 Ourense;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
32 Ourense;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QIII;2.131
32 Ourense;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QII;""
32 Ourense;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QI;""
32 Ourense;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
32 Ourense;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QIII;2.167
32 Ourense;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QII;""
32 Ourense;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QI;""
32 Ourense;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
32 Ourense;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QIII;2.190
32 Ourense;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QII;""
32 Ourense;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QI;""
32 Ourense;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QIV;2.083
32 Ourense;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
32 Ourense;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QII;""
32 Ourense;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QI;""
32 Ourense;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QIV;2.131
32 Ourense;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
32 Ourense;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QII;""
32 Ourense;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QI;""
32 Ourense;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QIV;2.152
32 Ourense;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
32 Ourense;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QII;""
32 Ourense;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QI;""
32 Ourense;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
32 Ourense;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
32 Ourense;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
32 Ourense;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
32 Ourense;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
32 Ourense;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
32 Ourense;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
32 Ourense;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
32 Ourense;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
32 Ourense;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
32 Ourense;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
32 Ourense;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
32 Ourense;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
32 Ourense;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
32 Ourense;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
32 Ourense;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;97,45
32 Ourense;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
32 Ourense;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
32 Ourense;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
32 Ourense;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;98,37
32 Ourense;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
32 Ourense;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
32 Ourense;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
32 Ourense;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;96,07
32 Ourense;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
32 Ourense;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
32 Ourense;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;95,3
32 Ourense;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
32 Ourense;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
32 Ourense;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
32 Ourense;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;96,75
32 Ourense;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
32 Ourense;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
32 Ourense;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
32 Ourense;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;94,29
32 Ourense;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
32 Ourense;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
32 Ourense;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;93,59
32 Ourense;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
32 Ourense;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
32 Ourense;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
32 Ourense;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;95,25
32 Ourense;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
32 Ourense;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
32 Ourense;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
32 Ourense;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;92,6
32 Ourense;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
32 Ourense;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
32 Ourense;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;91,48
32 Ourense;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
32 Ourense;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
32 Ourense;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
32 Ourense;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;93,67
32 Ourense;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
32 Ourense;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
32 Ourense;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
32 Ourense;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;90,99
32 Ourense;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
32 Ourense;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
32 Ourense;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
32 Ourense;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
32 Ourense;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
32 Ourense;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QII;6.221
32 Ourense;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
32 Ourense;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
32 Ourense;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
32 Ourense;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QII;6.162
32 Ourense;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
32 Ourense;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
32 Ourense;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
32 Ourense;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QII;6.199
32 Ourense;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
32 Ourense;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
32 Ourense;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
32 Ourense;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2022QII;6.102
32 Ourense;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2022QI;""
32 Ourense;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
32 Ourense;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
32 Ourense;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2021QII;6.068
32 Ourense;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2021QI;""
32 Ourense;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
32 Ourense;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
32 Ourense;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2020QII;6.106
32 Ourense;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2020QI;""
32 Ourense;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
32 Ourense;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2022QIII;5.997
32 Ourense;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2022QII;""
32 Ourense;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2022QI;""
32 Ourense;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
32 Ourense;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2021QIII;5.987
32 Ourense;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2021QII;""
32 Ourense;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2021QI;""
32 Ourense;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
32 Ourense;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2020QIII;6.001
32 Ourense;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2020QII;""
32 Ourense;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2020QI;""
32 Ourense;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QIV;5.882
32 Ourense;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
32 Ourense;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QII;""
32 Ourense;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QI;""
32 Ourense;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QIV;5.898
32 Ourense;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
32 Ourense;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QII;""
32 Ourense;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QI;""
32 Ourense;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QIV;5.905
32 Ourense;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
32 Ourense;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QII;""
32 Ourense;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QI;""
32 Ourense;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
32 Ourense;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
32 Ourense;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QII;""
32 Ourense;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QI;5.795
32 Ourense;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
32 Ourense;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
32 Ourense;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QII;""
32 Ourense;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QI;5.834
32 Ourense;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
32 Ourense;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
32 Ourense;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QII;""
32 Ourense;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QI;""
32 Ourense;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
32 Ourense;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
32 Ourense;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
32 Ourense;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
32 Ourense;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
32 Ourense;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
32 Ourense;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
32 Ourense;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
32 Ourense;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
32 Ourense;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
32 Ourense;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
32 Ourense;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
32 Ourense;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
32 Ourense;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
32 Ourense;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;98,09
32 Ourense;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
32 Ourense;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
32 Ourense;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
32 Ourense;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;98,47
32 Ourense;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
32 Ourense;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
32 Ourense;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
32 Ourense;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;98,5
32 Ourense;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
32 Ourense;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
32 Ourense;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;96,4
32 Ourense;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
32 Ourense;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
32 Ourense;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
32 Ourense;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;97,16
32 Ourense;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
32 Ourense;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
32 Ourense;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
32 Ourense;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;96,81
32 Ourense;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
32 Ourense;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
32 Ourense;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;94,55
32 Ourense;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
32 Ourense;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
32 Ourense;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
32 Ourense;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;95,72
32 Ourense;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
32 Ourense;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
32 Ourense;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
32 Ourense;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;95,26
32 Ourense;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
32 Ourense;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
32 Ourense;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
32 Ourense;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
32 Ourense;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
32 Ourense;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
32 Ourense;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;94,04
32 Ourense;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
32 Ourense;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
32 Ourense;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
32 Ourense;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;94,11
32 Ourense;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
32 Ourense;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
32 Ourense;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
32 Ourense;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
32 Ourense;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
32 Ourense;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
32 Ourense;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QII;3.900
32 Ourense;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
32 Ourense;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
32 Ourense;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
32 Ourense;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QII;3.879
32 Ourense;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
32 Ourense;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
32 Ourense;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
32 Ourense;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QII;3.883
32 Ourense;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
32 Ourense;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
32 Ourense;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
32 Ourense;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2022QII;3.834
32 Ourense;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2022QI;""
32 Ourense;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
32 Ourense;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
32 Ourense;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2021QII;3.830
32 Ourense;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2021QI;""
32 Ourense;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
32 Ourense;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
32 Ourense;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2020QII;3.833
32 Ourense;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2020QI;""
32 Ourense;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
32 Ourense;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2022QIII;3.764
32 Ourense;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2022QII;""
32 Ourense;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2022QI;""
32 Ourense;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
32 Ourense;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2021QIII;3.782
32 Ourense;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2021QII;""
32 Ourense;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2021QI;""
32 Ourense;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
32 Ourense;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2020QIII;3.771
32 Ourense;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2020QII;""
32 Ourense;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2020QI;""
32 Ourense;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QIV;3.699
32 Ourense;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
32 Ourense;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QII;""
32 Ourense;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QI;""
32 Ourense;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QIV;3.732
32 Ourense;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
32 Ourense;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QII;""
32 Ourense;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QI;""
32 Ourense;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QIV;3.715
32 Ourense;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
32 Ourense;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QII;""
32 Ourense;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QI;""
32 Ourense;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
32 Ourense;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
32 Ourense;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QII;""
32 Ourense;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QI;3.677
32 Ourense;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
32 Ourense;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
32 Ourense;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QII;""
32 Ourense;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QI;3.674
32 Ourense;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
32 Ourense;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
32 Ourense;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QII;""
32 Ourense;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QI;""
32 Ourense;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
32 Ourense;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
32 Ourense;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
32 Ourense;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
32 Ourense;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
32 Ourense;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
32 Ourense;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
32 Ourense;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
32 Ourense;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
32 Ourense;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
32 Ourense;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
32 Ourense;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
32 Ourense;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
32 Ourense;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
32 Ourense;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;98,31
32 Ourense;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
32 Ourense;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
32 Ourense;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
32 Ourense;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;98,74
32 Ourense;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
32 Ourense;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
32 Ourense;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
32 Ourense;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;98,71
32 Ourense;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
32 Ourense;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
32 Ourense;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;96,51
32 Ourense;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
32 Ourense;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
32 Ourense;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
32 Ourense;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;97,5
32 Ourense;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
32 Ourense;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
32 Ourense;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
32 Ourense;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;97,12
32 Ourense;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
32 Ourense;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
32 Ourense;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;94,85
32 Ourense;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
32 Ourense;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
32 Ourense;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
32 Ourense;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;96,21
32 Ourense;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
32 Ourense;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
32 Ourense;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
32 Ourense;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;95,67
32 Ourense;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
32 Ourense;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
32 Ourense;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
32 Ourense;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
32 Ourense;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
32 Ourense;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
32 Ourense;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;94,79
32 Ourense;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
32 Ourense;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
32 Ourense;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
32 Ourense;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;94,62
32 Ourense;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
32 Ourense;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
32 Ourense;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
32 Ourense;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
32 Ourense;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
32 Ourense;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
32 Ourense;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QII;2.321
32 Ourense;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
32 Ourense;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
32 Ourense;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
32 Ourense;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QII;2.283
32 Ourense;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
32 Ourense;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
32 Ourense;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
32 Ourense;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QII;2.316
32 Ourense;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
32 Ourense;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
32 Ourense;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
32 Ourense;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2022QII;2.268
32 Ourense;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2022QI;""
32 Ourense;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
32 Ourense;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
32 Ourense;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2021QII;2.238
32 Ourense;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2021QI;""
32 Ourense;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
32 Ourense;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
32 Ourense;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2020QII;2.273
32 Ourense;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2020QI;""
32 Ourense;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
32 Ourense;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2022QIII;2.233
32 Ourense;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2022QII;""
32 Ourense;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2022QI;""
32 Ourense;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
32 Ourense;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2021QIII;2.205
32 Ourense;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2021QII;""
32 Ourense;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2021QI;""
32 Ourense;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
32 Ourense;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2020QIII;2.230
32 Ourense;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2020QII;""
32 Ourense;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2020QI;""
32 Ourense;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QIV;2.183
32 Ourense;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
32 Ourense;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QII;""
32 Ourense;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QI;""
32 Ourense;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QIV;2.166
32 Ourense;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
32 Ourense;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QII;""
32 Ourense;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QI;""
32 Ourense;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QIV;2.190
32 Ourense;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
32 Ourense;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QII;""
32 Ourense;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QI;""
32 Ourense;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
32 Ourense;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
32 Ourense;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QII;""
32 Ourense;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QI;2.118
32 Ourense;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
32 Ourense;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
32 Ourense;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QII;""
32 Ourense;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QI;2.160
32 Ourense;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
32 Ourense;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
32 Ourense;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QII;""
32 Ourense;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QI;""
32 Ourense;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
32 Ourense;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
32 Ourense;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
32 Ourense;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
32 Ourense;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
32 Ourense;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
32 Ourense;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
32 Ourense;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
32 Ourense;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
32 Ourense;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
32 Ourense;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
32 Ourense;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
32 Ourense;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
32 Ourense;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
32 Ourense;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;97,72
32 Ourense;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
32 Ourense;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
32 Ourense;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
32 Ourense;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;98,03
32 Ourense;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
32 Ourense;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
32 Ourense;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
32 Ourense;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;98,14
32 Ourense;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
32 Ourense;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
32 Ourense;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;96,21
32 Ourense;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
32 Ourense;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
32 Ourense;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
32 Ourense;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;96,58
32 Ourense;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
32 Ourense;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
32 Ourense;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
32 Ourense;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;96,29
32 Ourense;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
32 Ourense;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
32 Ourense;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;94,05
32 Ourense;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
32 Ourense;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
32 Ourense;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
32 Ourense;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;94,88
32 Ourense;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
32 Ourense;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
32 Ourense;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
32 Ourense;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;94,56
32 Ourense;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
32 Ourense;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
32 Ourense;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
32 Ourense;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
32 Ourense;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
32 Ourense;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
32 Ourense;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;92,77
32 Ourense;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
32 Ourense;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
32 Ourense;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
32 Ourense;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;93,26
32 Ourense;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
32 Ourense;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
32 Ourense;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
32 Ourense;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
32 Ourense;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
32 Ourense;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QIII;6.211
32 Ourense;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
32 Ourense;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
32 Ourense;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
32 Ourense;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QIII;6.162
32 Ourense;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
32 Ourense;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
32 Ourense;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
32 Ourense;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QIII;6.166
32 Ourense;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
32 Ourense;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
32 Ourense;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
32 Ourense;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2022QIII;6.092
32 Ourense;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2022QII;""
32 Ourense;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2022QI;""
32 Ourense;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
32 Ourense;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2021QIII;6.069
32 Ourense;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2021QII;""
32 Ourense;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2021QI;""
32 Ourense;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
32 Ourense;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2020QIII;6.056
32 Ourense;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2020QII;""
32 Ourense;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2020QI;""
32 Ourense;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2022QIV;5.962
32 Ourense;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
32 Ourense;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2022QII;""
32 Ourense;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2022QI;""
32 Ourense;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2021QIV;5.971
32 Ourense;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
32 Ourense;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2021QII;""
32 Ourense;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2021QI;""
32 Ourense;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2020QIV;5.953
32 Ourense;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
32 Ourense;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2020QII;""
32 Ourense;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2020QI;""
32 Ourense;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
32 Ourense;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
32 Ourense;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QII;""
32 Ourense;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QI;5.864
32 Ourense;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
32 Ourense;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
32 Ourense;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QII;""
32 Ourense;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QI;5.880
32 Ourense;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
32 Ourense;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
32 Ourense;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QII;""
32 Ourense;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QI;""
32 Ourense;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
32 Ourense;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
32 Ourense;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QII;5.767
32 Ourense;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QI;""
32 Ourense;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
32 Ourense;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
32 Ourense;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QII;5.804
32 Ourense;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QI;""
32 Ourense;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
32 Ourense;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
32 Ourense;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QII;""
32 Ourense;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QI;""
32 Ourense;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
32 Ourense;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
32 Ourense;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
32 Ourense;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
32 Ourense;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
32 Ourense;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
32 Ourense;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
32 Ourense;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
32 Ourense;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
32 Ourense;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
32 Ourense;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
32 Ourense;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
32 Ourense;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
32 Ourense;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;98,08
32 Ourense;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
32 Ourense;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
32 Ourense;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
32 Ourense;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;98,49
32 Ourense;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
32 Ourense;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
32 Ourense;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
32 Ourense;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;98,22
32 Ourense;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
32 Ourense;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
32 Ourense;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;95,99
32 Ourense;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
32 Ourense;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
32 Ourense;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
32 Ourense;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;96,9
32 Ourense;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
32 Ourense;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
32 Ourense;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
32 Ourense;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;96,55
32 Ourense;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
32 Ourense;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
32 Ourense;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
32 Ourense;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
32 Ourense;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
32 Ourense;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
32 Ourense;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;95,16
32 Ourense;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
32 Ourense;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
32 Ourense;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
32 Ourense;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;95,36
32 Ourense;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
32 Ourense;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
32 Ourense;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
32 Ourense;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
32 Ourense;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
32 Ourense;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
32 Ourense;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;93,59
32 Ourense;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
32 Ourense;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
32 Ourense;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
32 Ourense;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;94,13
32 Ourense;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
32 Ourense;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
32 Ourense;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
32 Ourense;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
32 Ourense;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
32 Ourense;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
32 Ourense;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QIII;3.884
32 Ourense;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
32 Ourense;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
32 Ourense;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
32 Ourense;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QIII;3.882
32 Ourense;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
32 Ourense;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
32 Ourense;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
32 Ourense;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QIII;3.873
32 Ourense;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
32 Ourense;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
32 Ourense;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
32 Ourense;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2022QIII;3.805
32 Ourense;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2022QII;""
32 Ourense;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2022QI;""
32 Ourense;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
32 Ourense;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2021QIII;3.828
32 Ourense;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2021QII;""
32 Ourense;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2021QI;""
32 Ourense;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
32 Ourense;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2020QIII;3.807
32 Ourense;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2020QII;""
32 Ourense;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2020QI;""
32 Ourense;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2022QIV;3.733
32 Ourense;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
32 Ourense;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2022QII;""
32 Ourense;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2022QI;""
32 Ourense;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2021QIV;3.772
32 Ourense;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
32 Ourense;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2021QII;""
32 Ourense;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2021QI;""
32 Ourense;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2020QIV;3.745
32 Ourense;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
32 Ourense;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2020QII;""
32 Ourense;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2020QI;""
32 Ourense;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
32 Ourense;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
32 Ourense;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QII;""
32 Ourense;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QI;3.714
32 Ourense;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
32 Ourense;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
32 Ourense;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QII;""
32 Ourense;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QI;3.703
32 Ourense;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
32 Ourense;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
32 Ourense;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QII;""
32 Ourense;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QI;""
32 Ourense;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
32 Ourense;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
32 Ourense;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QII;3.661
32 Ourense;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QI;""
32 Ourense;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
32 Ourense;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
32 Ourense;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QII;3.663
32 Ourense;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QI;""
32 Ourense;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
32 Ourense;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
32 Ourense;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QII;""
32 Ourense;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QI;""
32 Ourense;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
32 Ourense;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
32 Ourense;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
32 Ourense;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
32 Ourense;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
32 Ourense;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
32 Ourense;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
32 Ourense;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
32 Ourense;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
32 Ourense;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
32 Ourense;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
32 Ourense;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
32 Ourense;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
32 Ourense;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;97,97
32 Ourense;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
32 Ourense;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
32 Ourense;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
32 Ourense;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;98,61
32 Ourense;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
32 Ourense;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
32 Ourense;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
32 Ourense;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;98,3
32 Ourense;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
32 Ourense;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
32 Ourense;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;96,11
32 Ourense;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
32 Ourense;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
32 Ourense;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
32 Ourense;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;97,17
32 Ourense;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
32 Ourense;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
32 Ourense;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
32 Ourense;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;96,7
32 Ourense;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
32 Ourense;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
32 Ourense;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
32 Ourense;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
32 Ourense;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
32 Ourense;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
32 Ourense;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;95,67
32 Ourense;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
32 Ourense;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
32 Ourense;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
32 Ourense;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;95,61
32 Ourense;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
32 Ourense;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
32 Ourense;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
32 Ourense;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
32 Ourense;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
32 Ourense;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
32 Ourense;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;94,31
32 Ourense;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
32 Ourense;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
32 Ourense;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
32 Ourense;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;94,58
32 Ourense;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
32 Ourense;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
32 Ourense;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
32 Ourense;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
32 Ourense;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
32 Ourense;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
32 Ourense;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QIII;2.327
32 Ourense;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
32 Ourense;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
32 Ourense;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
32 Ourense;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QIII;2.280
32 Ourense;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
32 Ourense;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
32 Ourense;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
32 Ourense;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QIII;2.293
32 Ourense;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
32 Ourense;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
32 Ourense;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
32 Ourense;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2022QIII;2.287
32 Ourense;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2022QII;""
32 Ourense;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2022QI;""
32 Ourense;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
32 Ourense;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2021QIII;2.241
32 Ourense;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2021QII;""
32 Ourense;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2021QI;""
32 Ourense;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
32 Ourense;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2020QIII;2.249
32 Ourense;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2020QII;""
32 Ourense;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2020QI;""
32 Ourense;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2022QIV;2.229
32 Ourense;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
32 Ourense;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2022QII;""
32 Ourense;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2022QI;""
32 Ourense;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2021QIV;2.199
32 Ourense;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
32 Ourense;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2021QII;""
32 Ourense;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2021QI;""
32 Ourense;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2020QIV;2.208
32 Ourense;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
32 Ourense;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2020QII;""
32 Ourense;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2020QI;""
32 Ourense;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
32 Ourense;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
32 Ourense;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QII;""
32 Ourense;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QI;2.150
32 Ourense;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
32 Ourense;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
32 Ourense;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QII;""
32 Ourense;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QI;2.177
32 Ourense;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
32 Ourense;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
32 Ourense;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QII;""
32 Ourense;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QI;""
32 Ourense;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
32 Ourense;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
32 Ourense;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QII;2.106
32 Ourense;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QI;""
32 Ourense;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
32 Ourense;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
32 Ourense;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QII;2.141
32 Ourense;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QI;""
32 Ourense;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
32 Ourense;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
32 Ourense;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QII;""
32 Ourense;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QI;""
32 Ourense;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
32 Ourense;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
32 Ourense;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
32 Ourense;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
32 Ourense;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
32 Ourense;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
32 Ourense;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
32 Ourense;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
32 Ourense;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
32 Ourense;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
32 Ourense;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
32 Ourense;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
32 Ourense;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
32 Ourense;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;98,28
32 Ourense;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
32 Ourense;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
32 Ourense;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
32 Ourense;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;98,29
32 Ourense;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
32 Ourense;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
32 Ourense;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
32 Ourense;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;98,08
32 Ourense;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
32 Ourense;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
32 Ourense;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;95,79
32 Ourense;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
32 Ourense;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
32 Ourense;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
32 Ourense;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;96,45
32 Ourense;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
32 Ourense;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
32 Ourense;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
32 Ourense;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;96,29
32 Ourense;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
32 Ourense;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
32 Ourense;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
32 Ourense;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
32 Ourense;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
32 Ourense;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
32 Ourense;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;94,3
32 Ourense;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
32 Ourense;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
32 Ourense;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
32 Ourense;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;94,94
32 Ourense;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
32 Ourense;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
32 Ourense;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
32 Ourense;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
32 Ourense;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
32 Ourense;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
32 Ourense;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;92,37
32 Ourense;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
32 Ourense;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
32 Ourense;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
32 Ourense;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;93,37
32 Ourense;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
32 Ourense;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
32 Ourense;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
32 Ourense;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
32 Ourense;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
32 Ourense;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QIV;6.162
32 Ourense;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
32 Ourense;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
32 Ourense;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
32 Ourense;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QIV;6.148
32 Ourense;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
32 Ourense;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
32 Ourense;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
32 Ourense;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QIV;6.146
32 Ourense;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
32 Ourense;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
32 Ourense;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
32 Ourense;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2022QIV;6.022
32 Ourense;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
32 Ourense;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2022QII;""
32 Ourense;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2022QI;""
32 Ourense;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2021QIV;6.044
32 Ourense;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
32 Ourense;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2021QII;""
32 Ourense;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2021QI;""
32 Ourense;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2020QIV;6.032
32 Ourense;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
32 Ourense;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2020QII;""
32 Ourense;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2020QI;""
32 Ourense;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
32 Ourense;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
32 Ourense;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2022QII;""
32 Ourense;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2022QI;5.933
32 Ourense;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
32 Ourense;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
32 Ourense;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2021QII;""
32 Ourense;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2021QI;5.953
32 Ourense;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
32 Ourense;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
32 Ourense;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2020QII;""
32 Ourense;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2020QI;""
32 Ourense;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
32 Ourense;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
32 Ourense;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QII;5.833
32 Ourense;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QI;""
32 Ourense;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
32 Ourense;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
32 Ourense;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QII;5.874
32 Ourense;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QI;""
32 Ourense;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
32 Ourense;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
32 Ourense;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QII;""
32 Ourense;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QI;""
32 Ourense;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
32 Ourense;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QIII;5.741
32 Ourense;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QII;""
32 Ourense;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QI;""
32 Ourense;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
32 Ourense;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QIII;5.799
32 Ourense;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QII;""
32 Ourense;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QI;""
32 Ourense;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
32 Ourense;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
32 Ourense;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QII;""
32 Ourense;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QI;""
32 Ourense;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
32 Ourense;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
32 Ourense;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
32 Ourense;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
32 Ourense;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
32 Ourense;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
32 Ourense;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
32 Ourense;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
32 Ourense;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
32 Ourense;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
32 Ourense;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
32 Ourense;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
32 Ourense;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;97,73
32 Ourense;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
32 Ourense;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
32 Ourense;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
32 Ourense;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;98,31
32 Ourense;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
32 Ourense;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
32 Ourense;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
32 Ourense;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;98,15
32 Ourense;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
32 Ourense;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
32 Ourense;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
32 Ourense;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
32 Ourense;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
32 Ourense;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
32 Ourense;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;96,5
32 Ourense;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
32 Ourense;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
32 Ourense;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
32 Ourense;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;96,86
32 Ourense;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
32 Ourense;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
32 Ourense;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
32 Ourense;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
32 Ourense;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
32 Ourense;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
32 Ourense;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;94,88
32 Ourense;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
32 Ourense;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
32 Ourense;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
32 Ourense;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;95,57
32 Ourense;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
32 Ourense;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
32 Ourense;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
32 Ourense;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
32 Ourense;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
32 Ourense;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
32 Ourense;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;93,38
32 Ourense;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
32 Ourense;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
32 Ourense;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
32 Ourense;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;94,35
32 Ourense;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
32 Ourense;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
32 Ourense;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
32 Ourense;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
32 Ourense;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
32 Ourense;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
32 Ourense;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QIV;3.841
32 Ourense;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
32 Ourense;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
32 Ourense;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
32 Ourense;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QIV;3.880
32 Ourense;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
32 Ourense;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
32 Ourense;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
32 Ourense;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QIV;3.853
32 Ourense;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
32 Ourense;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
32 Ourense;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
32 Ourense;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2022QIV;3.760
32 Ourense;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
32 Ourense;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2022QII;""
32 Ourense;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2022QI;""
32 Ourense;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2021QIV;3.818
32 Ourense;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
32 Ourense;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2021QII;""
32 Ourense;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2021QI;""
32 Ourense;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2020QIV;3.785
32 Ourense;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
32 Ourense;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2020QII;""
32 Ourense;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2020QI;""
32 Ourense;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
32 Ourense;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
32 Ourense;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2022QII;""
32 Ourense;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2022QI;3.757
32 Ourense;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
32 Ourense;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
32 Ourense;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2021QII;""
32 Ourense;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2021QI;3.740
32 Ourense;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
32 Ourense;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
32 Ourense;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2020QII;""
32 Ourense;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2020QI;""
32 Ourense;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
32 Ourense;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
32 Ourense;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QII;3.703
32 Ourense;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QI;""
32 Ourense;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
32 Ourense;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
32 Ourense;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QII;3.697
32 Ourense;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QI;""
32 Ourense;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
32 Ourense;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
32 Ourense;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QII;""
32 Ourense;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QI;""
32 Ourense;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
32 Ourense;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QIII;3.646
32 Ourense;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QII;""
32 Ourense;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QI;""
32 Ourense;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
32 Ourense;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QIII;3.655
32 Ourense;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QII;""
32 Ourense;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QI;""
32 Ourense;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
32 Ourense;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
32 Ourense;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QII;""
32 Ourense;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QI;""
32 Ourense;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
32 Ourense;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
32 Ourense;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
32 Ourense;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
32 Ourense;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
32 Ourense;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
32 Ourense;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
32 Ourense;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
32 Ourense;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
32 Ourense;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
32 Ourense;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
32 Ourense;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
32 Ourense;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;97,89
32 Ourense;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
32 Ourense;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
32 Ourense;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
32 Ourense;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;98,4
32 Ourense;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
32 Ourense;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
32 Ourense;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
32 Ourense;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;98,24
32 Ourense;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
32 Ourense;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
32 Ourense;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
32 Ourense;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
32 Ourense;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
32 Ourense;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
32 Ourense;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;96,83
32 Ourense;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
32 Ourense;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
32 Ourense;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
32 Ourense;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;97,07
32 Ourense;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
32 Ourense;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
32 Ourense;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
32 Ourense;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
32 Ourense;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
32 Ourense;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
32 Ourense;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;95,44
32 Ourense;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
32 Ourense;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
32 Ourense;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
32 Ourense;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;95,95
32 Ourense;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
32 Ourense;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
32 Ourense;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
32 Ourense;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
32 Ourense;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
32 Ourense;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
32 Ourense;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;93,97
32 Ourense;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
32 Ourense;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
32 Ourense;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
32 Ourense;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;94,86
32 Ourense;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
32 Ourense;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
32 Ourense;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
32 Ourense;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
32 Ourense;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
32 Ourense;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
32 Ourense;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QIV;2.321
32 Ourense;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
32 Ourense;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
32 Ourense;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
32 Ourense;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QIV;2.268
32 Ourense;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
32 Ourense;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
32 Ourense;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
32 Ourense;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QIV;2.293
32 Ourense;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
32 Ourense;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
32 Ourense;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
32 Ourense;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2022QIV;2.262
32 Ourense;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
32 Ourense;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2022QII;""
32 Ourense;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2022QI;""
32 Ourense;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2021QIV;2.226
32 Ourense;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
32 Ourense;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2021QII;""
32 Ourense;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2021QI;""
32 Ourense;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2020QIV;2.247
32 Ourense;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
32 Ourense;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2020QII;""
32 Ourense;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2020QI;""
32 Ourense;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
32 Ourense;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
32 Ourense;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2022QII;""
32 Ourense;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2022QI;2.176
32 Ourense;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
32 Ourense;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
32 Ourense;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2021QII;""
32 Ourense;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2021QI;2.213
32 Ourense;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
32 Ourense;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
32 Ourense;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2020QII;""
32 Ourense;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2020QI;""
32 Ourense;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
32 Ourense;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
32 Ourense;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QII;2.130
32 Ourense;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QI;""
32 Ourense;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
32 Ourense;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
32 Ourense;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QII;2.177
32 Ourense;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QI;""
32 Ourense;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
32 Ourense;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
32 Ourense;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QII;""
32 Ourense;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QI;""
32 Ourense;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
32 Ourense;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QIII;2.095
32 Ourense;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QII;""
32 Ourense;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QI;""
32 Ourense;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
32 Ourense;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QIII;2.144
32 Ourense;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QII;""
32 Ourense;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QI;""
32 Ourense;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
32 Ourense;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
32 Ourense;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QII;""
32 Ourense;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QI;""
32 Ourense;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
32 Ourense;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
32 Ourense;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
32 Ourense;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
32 Ourense;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
32 Ourense;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
32 Ourense;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
32 Ourense;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
32 Ourense;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
32 Ourense;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
32 Ourense;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
32 Ourense;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
32 Ourense;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;97,46
32 Ourense;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
32 Ourense;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
32 Ourense;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
32 Ourense;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;98,15
32 Ourense;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
32 Ourense;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
32 Ourense;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
32 Ourense;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;97,99
32 Ourense;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
32 Ourense;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
32 Ourense;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
32 Ourense;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
32 Ourense;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
32 Ourense;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
32 Ourense;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;95,94
32 Ourense;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
32 Ourense;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
32 Ourense;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
32 Ourense;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;96,51
32 Ourense;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
32 Ourense;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
32 Ourense;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
32 Ourense;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
32 Ourense;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
32 Ourense;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
32 Ourense;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;93,92
32 Ourense;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
32 Ourense;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
32 Ourense;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
32 Ourense;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;94,94
32 Ourense;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
32 Ourense;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
32 Ourense;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
32 Ourense;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
32 Ourense;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
32 Ourense;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
32 Ourense;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;92,37
32 Ourense;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
32 Ourense;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
32 Ourense;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
32 Ourense;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;93,5
32 Ourense;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
32 Ourense;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
32 Ourense;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
32 Ourense;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
32 Ourense;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
32 Ourense;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
32 Ourense;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
32 Ourense;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
32 Ourense;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
32 Ourense;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QI;3.447
32 Ourense;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
32 Ourense;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
32 Ourense;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
32 Ourense;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QI;3.298
32 Ourense;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
32 Ourense;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
32 Ourense;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
32 Ourense;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QI;3.779
32 Ourense;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
32 Ourense;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
32 Ourense;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2022QII;""
32 Ourense;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2022QI;3.321
32 Ourense;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
32 Ourense;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
32 Ourense;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2021QII;""
32 Ourense;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2021QI;3.181
32 Ourense;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
32 Ourense;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
32 Ourense;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2020QII;""
32 Ourense;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2020QI;3.555
32 Ourense;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
32 Ourense;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
32 Ourense;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2022QII;3.192
32 Ourense;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2022QI;""
32 Ourense;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
32 Ourense;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
32 Ourense;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2021QII;3.058
32 Ourense;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2021QI;""
32 Ourense;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
32 Ourense;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
32 Ourense;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2020QII;3.460
32 Ourense;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2020QI;""
32 Ourense;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
32 Ourense;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QIII;3.074
32 Ourense;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QII;""
32 Ourense;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QI;""
32 Ourense;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
32 Ourense;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QIII;2.932
32 Ourense;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QII;""
32 Ourense;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QI;""
32 Ourense;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
32 Ourense;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QIII;3.350
32 Ourense;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QII;""
32 Ourense;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QI;""
32 Ourense;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QIV;2.878
32 Ourense;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
32 Ourense;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QII;""
32 Ourense;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QI;""
32 Ourense;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QIV;2.789
32 Ourense;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
32 Ourense;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QII;""
32 Ourense;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QI;""
32 Ourense;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QIV;3.199
32 Ourense;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
32 Ourense;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QII;""
32 Ourense;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QI;""
32 Ourense;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
32 Ourense;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
32 Ourense;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
32 Ourense;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
32 Ourense;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
32 Ourense;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
32 Ourense;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
32 Ourense;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
32 Ourense;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
32 Ourense;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
32 Ourense;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
32 Ourense;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
32 Ourense;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
32 Ourense;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
32 Ourense;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
32 Ourense;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;96,34
32 Ourense;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
32 Ourense;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
32 Ourense;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
32 Ourense;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;96,45
32 Ourense;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
32 Ourense;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
32 Ourense;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
32 Ourense;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;94,07
32 Ourense;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
32 Ourense;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
32 Ourense;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;92,6
32 Ourense;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
32 Ourense;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
32 Ourense;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
32 Ourense;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;92,72
32 Ourense;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
32 Ourense;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
32 Ourense;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
32 Ourense;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;91,56
32 Ourense;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
32 Ourense;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
32 Ourense;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;89,18
32 Ourense;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
32 Ourense;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
32 Ourense;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
32 Ourense;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;88,9
32 Ourense;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
32 Ourense;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
32 Ourense;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
32 Ourense;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;88,65
32 Ourense;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
32 Ourense;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
32 Ourense;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;83,49
32 Ourense;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
32 Ourense;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
32 Ourense;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
32 Ourense;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;84,57
32 Ourense;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
32 Ourense;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
32 Ourense;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
32 Ourense;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;84,65
32 Ourense;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
32 Ourense;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
32 Ourense;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
32 Ourense;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
32 Ourense;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
32 Ourense;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
32 Ourense;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QI;2.152
32 Ourense;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
32 Ourense;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
32 Ourense;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
32 Ourense;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QI;2.040
32 Ourense;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
32 Ourense;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
32 Ourense;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
32 Ourense;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QI;2.366
32 Ourense;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
32 Ourense;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
32 Ourense;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2022QII;""
32 Ourense;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2022QI;2.066
32 Ourense;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
32 Ourense;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
32 Ourense;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2021QII;""
32 Ourense;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2021QI;1.966
32 Ourense;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
32 Ourense;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
32 Ourense;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2020QII;""
32 Ourense;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2020QI;2.214
32 Ourense;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
32 Ourense;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
32 Ourense;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2022QII;1.999
32 Ourense;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2022QI;""
32 Ourense;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
32 Ourense;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
32 Ourense;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2021QII;1.893
32 Ourense;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2021QI;""
32 Ourense;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
32 Ourense;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
32 Ourense;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2020QII;2.150
32 Ourense;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2020QI;""
32 Ourense;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
32 Ourense;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QIII;1.929
32 Ourense;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QII;""
32 Ourense;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QI;""
32 Ourense;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
32 Ourense;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QIII;1.824
32 Ourense;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QII;""
32 Ourense;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QI;""
32 Ourense;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
32 Ourense;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QIII;2.084
32 Ourense;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QII;""
32 Ourense;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QI;""
32 Ourense;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QIV;1.800
32 Ourense;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
32 Ourense;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QII;""
32 Ourense;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QI;""
32 Ourense;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QIV;1.745
32 Ourense;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
32 Ourense;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QII;""
32 Ourense;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QI;""
32 Ourense;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QIV;1.982
32 Ourense;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
32 Ourense;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QII;""
32 Ourense;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QI;""
32 Ourense;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
32 Ourense;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
32 Ourense;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
32 Ourense;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
32 Ourense;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
32 Ourense;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
32 Ourense;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
32 Ourense;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
32 Ourense;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
32 Ourense;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
32 Ourense;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
32 Ourense;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
32 Ourense;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
32 Ourense;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
32 Ourense;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
32 Ourense;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;96
32 Ourense;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
32 Ourense;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
32 Ourense;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
32 Ourense;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;96,37
32 Ourense;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
32 Ourense;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
32 Ourense;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
32 Ourense;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;93,58
32 Ourense;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
32 Ourense;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
32 Ourense;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;92,89
32 Ourense;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
32 Ourense;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
32 Ourense;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
32 Ourense;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;92,79
32 Ourense;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
32 Ourense;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
32 Ourense;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
32 Ourense;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;90,87
32 Ourense;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
32 Ourense;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
32 Ourense;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;89,64
32 Ourense;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
32 Ourense;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
32 Ourense;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
32 Ourense;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;89,41
32 Ourense;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
32 Ourense;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
32 Ourense;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
32 Ourense;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;88,08
32 Ourense;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
32 Ourense;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
32 Ourense;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;83,64
32 Ourense;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
32 Ourense;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
32 Ourense;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
32 Ourense;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;85,54
32 Ourense;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
32 Ourense;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
32 Ourense;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
32 Ourense;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;83,77
32 Ourense;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
32 Ourense;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
32 Ourense;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
32 Ourense;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
32 Ourense;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
32 Ourense;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
32 Ourense;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QI;1.295
32 Ourense;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
32 Ourense;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
32 Ourense;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
32 Ourense;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QI;1.258
32 Ourense;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
32 Ourense;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
32 Ourense;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
32 Ourense;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QI;1.413
32 Ourense;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
32 Ourense;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
32 Ourense;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2022QII;""
32 Ourense;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2022QI;1.255
32 Ourense;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
32 Ourense;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
32 Ourense;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2021QII;""
32 Ourense;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2021QI;1.215
32 Ourense;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
32 Ourense;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
32 Ourense;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2020QII;""
32 Ourense;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2020QI;1.341
32 Ourense;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
32 Ourense;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
32 Ourense;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2022QII;1.193
32 Ourense;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2022QI;""
32 Ourense;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
32 Ourense;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
32 Ourense;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2021QII;1.165
32 Ourense;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2021QI;""
32 Ourense;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
32 Ourense;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
32 Ourense;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2020QII;1.310
32 Ourense;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2020QI;""
32 Ourense;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
32 Ourense;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QIII;1.145
32 Ourense;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QII;""
32 Ourense;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QI;""
32 Ourense;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
32 Ourense;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QIII;1.108
32 Ourense;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QII;""
32 Ourense;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QI;""
32 Ourense;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
32 Ourense;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QIII;1.266
32 Ourense;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QII;""
32 Ourense;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QI;""
32 Ourense;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QIV;1.078
32 Ourense;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
32 Ourense;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QII;""
32 Ourense;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QI;""
32 Ourense;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QIV;1.044
32 Ourense;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
32 Ourense;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QII;""
32 Ourense;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QI;""
32 Ourense;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QIV;1.217
32 Ourense;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
32 Ourense;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QII;""
32 Ourense;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QI;""
32 Ourense;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
32 Ourense;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
32 Ourense;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
32 Ourense;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
32 Ourense;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
32 Ourense;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
32 Ourense;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
32 Ourense;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
32 Ourense;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
32 Ourense;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
32 Ourense;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
32 Ourense;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
32 Ourense;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
32 Ourense;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
32 Ourense;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
32 Ourense;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;96,91
32 Ourense;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
32 Ourense;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
32 Ourense;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
32 Ourense;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;96,58
32 Ourense;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
32 Ourense;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
32 Ourense;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
32 Ourense;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;94,9
32 Ourense;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
32 Ourense;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
32 Ourense;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;92,12
32 Ourense;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
32 Ourense;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
32 Ourense;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
32 Ourense;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;92,61
32 Ourense;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
32 Ourense;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
32 Ourense;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
32 Ourense;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;92,71
32 Ourense;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
32 Ourense;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
32 Ourense;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;88,42
32 Ourense;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
32 Ourense;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
32 Ourense;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
32 Ourense;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;88,08
32 Ourense;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
32 Ourense;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
32 Ourense;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
32 Ourense;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;89,6
32 Ourense;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
32 Ourense;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
32 Ourense;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;83,24
32 Ourense;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
32 Ourense;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
32 Ourense;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
32 Ourense;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;82,99
32 Ourense;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
32 Ourense;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
32 Ourense;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
32 Ourense;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;86,13
32 Ourense;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
32 Ourense;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
32 Ourense;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
32 Ourense;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
32 Ourense;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
32 Ourense;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QII;3.861
32 Ourense;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
32 Ourense;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
32 Ourense;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
32 Ourense;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QII;3.799
32 Ourense;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
32 Ourense;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
32 Ourense;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
32 Ourense;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QII;3.612
32 Ourense;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
32 Ourense;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
32 Ourense;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
32 Ourense;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2022QII;3.723
32 Ourense;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2022QI;""
32 Ourense;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
32 Ourense;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
32 Ourense;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2021QII;3.666
32 Ourense;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2021QI;""
32 Ourense;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
32 Ourense;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
32 Ourense;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2020QII;3.513
32 Ourense;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2020QI;""
32 Ourense;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
32 Ourense;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2022QIII;3.591
32 Ourense;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2022QII;""
32 Ourense;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2022QI;""
32 Ourense;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
32 Ourense;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2021QIII;3.528
32 Ourense;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2021QII;""
32 Ourense;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2021QI;""
32 Ourense;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
32 Ourense;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2020QIII;3.391
32 Ourense;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2020QII;""
32 Ourense;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2020QI;""
32 Ourense;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QIV;3.379
32 Ourense;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
32 Ourense;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QII;""
32 Ourense;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QI;""
32 Ourense;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QIV;3.376
32 Ourense;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
32 Ourense;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QII;""
32 Ourense;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QI;""
32 Ourense;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QIV;3.238
32 Ourense;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
32 Ourense;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QII;""
32 Ourense;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QI;""
32 Ourense;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
32 Ourense;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
32 Ourense;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QII;""
32 Ourense;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QI;3.257
32 Ourense;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
32 Ourense;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
32 Ourense;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QII;""
32 Ourense;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QI;3.131
32 Ourense;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
32 Ourense;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
32 Ourense;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QII;""
32 Ourense;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QI;""
32 Ourense;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
32 Ourense;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
32 Ourense;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
32 Ourense;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
32 Ourense;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
32 Ourense;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
32 Ourense;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
32 Ourense;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
32 Ourense;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
32 Ourense;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
32 Ourense;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
32 Ourense;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
32 Ourense;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
32 Ourense;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
32 Ourense;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;96,43
32 Ourense;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
32 Ourense;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
32 Ourense;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
32 Ourense;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;96,5
32 Ourense;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
32 Ourense;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
32 Ourense;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
32 Ourense;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;97,26
32 Ourense;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
32 Ourense;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
32 Ourense;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;93,01
32 Ourense;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
32 Ourense;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
32 Ourense;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
32 Ourense;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;92,87
32 Ourense;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
32 Ourense;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
32 Ourense;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
32 Ourense;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;93,88
32 Ourense;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
32 Ourense;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
32 Ourense;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;87,52
32 Ourense;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
32 Ourense;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
32 Ourense;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
32 Ourense;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;88,87
32 Ourense;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
32 Ourense;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
32 Ourense;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
32 Ourense;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;89,65
32 Ourense;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
32 Ourense;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
32 Ourense;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
32 Ourense;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
32 Ourense;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
32 Ourense;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
32 Ourense;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;85,73
32 Ourense;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
32 Ourense;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
32 Ourense;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
32 Ourense;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;86,68
32 Ourense;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
32 Ourense;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
32 Ourense;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
32 Ourense;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
32 Ourense;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
32 Ourense;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
32 Ourense;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QII;2.410
32 Ourense;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
32 Ourense;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
32 Ourense;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
32 Ourense;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QII;2.349
32 Ourense;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
32 Ourense;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
32 Ourense;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
32 Ourense;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QII;2.245
32 Ourense;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
32 Ourense;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
32 Ourense;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
32 Ourense;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2022QII;2.339
32 Ourense;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2022QI;""
32 Ourense;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
32 Ourense;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
32 Ourense;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2021QII;2.269
32 Ourense;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2021QI;""
32 Ourense;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
32 Ourense;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
32 Ourense;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2020QII;2.178
32 Ourense;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2020QI;""
32 Ourense;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
32 Ourense;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2022QIII;2.263
32 Ourense;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2022QII;""
32 Ourense;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2022QI;""
32 Ourense;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
32 Ourense;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2021QIII;2.196
32 Ourense;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2021QII;""
32 Ourense;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2021QI;""
32 Ourense;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
32 Ourense;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2020QIII;2.104
32 Ourense;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2020QII;""
32 Ourense;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2020QI;""
32 Ourense;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QIV;2.125
32 Ourense;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
32 Ourense;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QII;""
32 Ourense;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QI;""
32 Ourense;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QIV;2.112
32 Ourense;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
32 Ourense;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QII;""
32 Ourense;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QI;""
32 Ourense;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QIV;2.002
32 Ourense;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
32 Ourense;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QII;""
32 Ourense;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QI;""
32 Ourense;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
32 Ourense;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
32 Ourense;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QII;""
32 Ourense;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QI;2.030
32 Ourense;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
32 Ourense;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
32 Ourense;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QII;""
32 Ourense;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QI;1.935
32 Ourense;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
32 Ourense;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
32 Ourense;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QII;""
32 Ourense;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QI;""
32 Ourense;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
32 Ourense;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
32 Ourense;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
32 Ourense;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
32 Ourense;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
32 Ourense;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
32 Ourense;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
32 Ourense;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
32 Ourense;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
32 Ourense;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
32 Ourense;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
32 Ourense;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
32 Ourense;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
32 Ourense;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
32 Ourense;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;97,05
32 Ourense;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
32 Ourense;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
32 Ourense;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
32 Ourense;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;96,59
32 Ourense;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
32 Ourense;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
32 Ourense;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
32 Ourense;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;97,02
32 Ourense;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
32 Ourense;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
32 Ourense;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;93,9
32 Ourense;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
32 Ourense;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
32 Ourense;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
32 Ourense;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;93,49
32 Ourense;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
32 Ourense;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
32 Ourense;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
32 Ourense;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;93,72
32 Ourense;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
32 Ourense;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
32 Ourense;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;88,17
32 Ourense;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
32 Ourense;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
32 Ourense;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
32 Ourense;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;89,91
32 Ourense;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
32 Ourense;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
32 Ourense;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
32 Ourense;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;89,18
32 Ourense;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
32 Ourense;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
32 Ourense;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
32 Ourense;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
32 Ourense;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
32 Ourense;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
32 Ourense;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;86,42
32 Ourense;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
32 Ourense;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
32 Ourense;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
32 Ourense;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;86,19
32 Ourense;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
32 Ourense;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
32 Ourense;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
32 Ourense;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
32 Ourense;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
32 Ourense;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
32 Ourense;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QII;1.451
32 Ourense;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
32 Ourense;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
32 Ourense;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
32 Ourense;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QII;1.450
32 Ourense;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
32 Ourense;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
32 Ourense;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
32 Ourense;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QII;1.367
32 Ourense;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
32 Ourense;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
32 Ourense;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
32 Ourense;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2022QII;1.384
32 Ourense;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2022QI;""
32 Ourense;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
32 Ourense;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
32 Ourense;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2021QII;1.397
32 Ourense;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2021QI;""
32 Ourense;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
32 Ourense;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
32 Ourense;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2020QII;1.335
32 Ourense;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2020QI;""
32 Ourense;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
32 Ourense;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2022QIII;1.328
32 Ourense;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2022QII;""
32 Ourense;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2022QI;""
32 Ourense;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
32 Ourense;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2021QIII;1.332
32 Ourense;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2021QII;""
32 Ourense;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2021QI;""
32 Ourense;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
32 Ourense;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2020QIII;1.287
32 Ourense;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2020QII;""
32 Ourense;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2020QI;""
32 Ourense;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QIV;1.254
32 Ourense;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
32 Ourense;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QII;""
32 Ourense;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QI;""
32 Ourense;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QIV;1.264
32 Ourense;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
32 Ourense;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QII;""
32 Ourense;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QI;""
32 Ourense;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QIV;1.236
32 Ourense;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
32 Ourense;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QII;""
32 Ourense;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QI;""
32 Ourense;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
32 Ourense;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
32 Ourense;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QII;""
32 Ourense;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QI;1.227
32 Ourense;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
32 Ourense;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
32 Ourense;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QII;""
32 Ourense;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QI;1.196
32 Ourense;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
32 Ourense;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
32 Ourense;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QII;""
32 Ourense;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QI;""
32 Ourense;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
32 Ourense;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
32 Ourense;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
32 Ourense;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
32 Ourense;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
32 Ourense;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
32 Ourense;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
32 Ourense;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
32 Ourense;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
32 Ourense;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
32 Ourense;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
32 Ourense;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
32 Ourense;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
32 Ourense;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
32 Ourense;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;95,38
32 Ourense;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
32 Ourense;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
32 Ourense;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
32 Ourense;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;96,34
32 Ourense;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
32 Ourense;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
32 Ourense;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
32 Ourense;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;97,66
32 Ourense;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
32 Ourense;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
32 Ourense;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;91,52
32 Ourense;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
32 Ourense;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
32 Ourense;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
32 Ourense;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;91,86
32 Ourense;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
32 Ourense;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
32 Ourense;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
32 Ourense;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;94,15
32 Ourense;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
32 Ourense;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
32 Ourense;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;86,42
32 Ourense;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
32 Ourense;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
32 Ourense;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
32 Ourense;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;87,17
32 Ourense;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
32 Ourense;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
32 Ourense;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
32 Ourense;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;90,42
32 Ourense;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
32 Ourense;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
32 Ourense;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
32 Ourense;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
32 Ourense;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
32 Ourense;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
32 Ourense;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;84,62
32 Ourense;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
32 Ourense;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
32 Ourense;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
32 Ourense;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;87,49
32 Ourense;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
32 Ourense;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
32 Ourense;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
32 Ourense;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
32 Ourense;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
32 Ourense;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QIII;3.768
32 Ourense;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
32 Ourense;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
32 Ourense;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
32 Ourense;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QIII;3.697
32 Ourense;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
32 Ourense;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
32 Ourense;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
32 Ourense;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QIII;3.542
32 Ourense;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
32 Ourense;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
32 Ourense;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
32 Ourense;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2022QIII;3.631
32 Ourense;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2022QII;""
32 Ourense;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2022QI;""
32 Ourense;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
32 Ourense;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2021QIII;3.555
32 Ourense;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2021QII;""
32 Ourense;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2021QI;""
32 Ourense;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
32 Ourense;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2020QIII;3.414
32 Ourense;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2020QII;""
32 Ourense;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2020QI;""
32 Ourense;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2022QIV;3.411
32 Ourense;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
32 Ourense;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2022QII;""
32 Ourense;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2022QI;""
32 Ourense;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2021QIV;3.396
32 Ourense;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
32 Ourense;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2021QII;""
32 Ourense;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2021QI;""
32 Ourense;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2020QIV;3.258
32 Ourense;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
32 Ourense;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2020QII;""
32 Ourense;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2020QI;""
32 Ourense;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
32 Ourense;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
32 Ourense;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QII;""
32 Ourense;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QI;3.277
32 Ourense;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
32 Ourense;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
32 Ourense;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QII;""
32 Ourense;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QI;3.147
32 Ourense;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
32 Ourense;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
32 Ourense;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QII;""
32 Ourense;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QI;""
32 Ourense;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
32 Ourense;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
32 Ourense;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QII;3.148
32 Ourense;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QI;""
32 Ourense;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
32 Ourense;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
32 Ourense;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QII;3.028
32 Ourense;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QI;""
32 Ourense;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
32 Ourense;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
32 Ourense;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QII;""
32 Ourense;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QI;""
32 Ourense;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
32 Ourense;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
32 Ourense;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
32 Ourense;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
32 Ourense;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
32 Ourense;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
32 Ourense;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
32 Ourense;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
32 Ourense;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
32 Ourense;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
32 Ourense;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
32 Ourense;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
32 Ourense;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
32 Ourense;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;96,36
32 Ourense;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
32 Ourense;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
32 Ourense;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
32 Ourense;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;96,16
32 Ourense;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
32 Ourense;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
32 Ourense;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
32 Ourense;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;96,39
32 Ourense;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
32 Ourense;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
32 Ourense;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;90,53
32 Ourense;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
32 Ourense;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
32 Ourense;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
32 Ourense;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;91,86
32 Ourense;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
32 Ourense;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
32 Ourense;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
32 Ourense;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;91,98
32 Ourense;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
32 Ourense;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
32 Ourense;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
32 Ourense;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
32 Ourense;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
32 Ourense;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
32 Ourense;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;88,64
32 Ourense;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
32 Ourense;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
32 Ourense;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
32 Ourense;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;88,85
32 Ourense;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
32 Ourense;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
32 Ourense;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
32 Ourense;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
32 Ourense;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
32 Ourense;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
32 Ourense;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;85,15
32 Ourense;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
32 Ourense;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
32 Ourense;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
32 Ourense;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;85,49
32 Ourense;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
32 Ourense;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
32 Ourense;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
32 Ourense;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
32 Ourense;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
32 Ourense;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
32 Ourense;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QIII;2.365
32 Ourense;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
32 Ourense;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
32 Ourense;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
32 Ourense;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QIII;2.291
32 Ourense;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
32 Ourense;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
32 Ourense;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
32 Ourense;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QIII;2.197
32 Ourense;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
32 Ourense;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
32 Ourense;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
32 Ourense;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2022QIII;2.285
32 Ourense;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2022QII;""
32 Ourense;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2022QI;""
32 Ourense;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
32 Ourense;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2021QIII;2.215
32 Ourense;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2021QII;""
32 Ourense;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2021QI;""
32 Ourense;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
32 Ourense;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2020QIII;2.121
32 Ourense;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2020QII;""
32 Ourense;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2020QI;""
32 Ourense;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2022QIV;2.143
32 Ourense;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
32 Ourense;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2022QII;""
32 Ourense;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2022QI;""
32 Ourense;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2021QIV;2.125
32 Ourense;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
32 Ourense;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2021QII;""
32 Ourense;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2021QI;""
32 Ourense;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2020QIV;2.016
32 Ourense;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
32 Ourense;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2020QII;""
32 Ourense;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2020QI;""
32 Ourense;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
32 Ourense;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
32 Ourense;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QII;""
32 Ourense;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QI;2.043
32 Ourense;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
32 Ourense;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
32 Ourense;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QII;""
32 Ourense;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QI;1.947
32 Ourense;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
32 Ourense;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
32 Ourense;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QII;""
32 Ourense;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QI;""
32 Ourense;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
32 Ourense;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
32 Ourense;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QII;1.976
32 Ourense;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QI;""
32 Ourense;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
32 Ourense;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
32 Ourense;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QII;1.876
32 Ourense;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QI;""
32 Ourense;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
32 Ourense;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
32 Ourense;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QII;""
32 Ourense;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QI;""
32 Ourense;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
32 Ourense;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
32 Ourense;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
32 Ourense;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
32 Ourense;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
32 Ourense;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
32 Ourense;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
32 Ourense;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
32 Ourense;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
32 Ourense;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
32 Ourense;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
32 Ourense;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
32 Ourense;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
32 Ourense;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;96,62
32 Ourense;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
32 Ourense;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
32 Ourense;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
32 Ourense;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;96,68
32 Ourense;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
32 Ourense;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
32 Ourense;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
32 Ourense;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;96,54
32 Ourense;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
32 Ourense;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
32 Ourense;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;90,61
32 Ourense;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
32 Ourense;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
32 Ourense;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
32 Ourense;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;92,75
32 Ourense;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
32 Ourense;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
32 Ourense;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
32 Ourense;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;91,76
32 Ourense;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
32 Ourense;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
32 Ourense;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
32 Ourense;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
32 Ourense;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
32 Ourense;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
32 Ourense;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;89,18
32 Ourense;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
32 Ourense;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
32 Ourense;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
32 Ourense;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;88,62
32 Ourense;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
32 Ourense;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
32 Ourense;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
32 Ourense;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
32 Ourense;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
32 Ourense;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
32 Ourense;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;86,25
32 Ourense;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
32 Ourense;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
32 Ourense;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
32 Ourense;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;85,39
32 Ourense;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
32 Ourense;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
32 Ourense;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
32 Ourense;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
32 Ourense;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
32 Ourense;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
32 Ourense;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QIII;1.403
32 Ourense;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
32 Ourense;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
32 Ourense;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
32 Ourense;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QIII;1.406
32 Ourense;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
32 Ourense;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
32 Ourense;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
32 Ourense;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QIII;1.345
32 Ourense;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
32 Ourense;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
32 Ourense;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
32 Ourense;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2022QIII;1.346
32 Ourense;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2022QII;""
32 Ourense;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2022QI;""
32 Ourense;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
32 Ourense;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2021QIII;1.340
32 Ourense;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2021QII;""
32 Ourense;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2021QI;""
32 Ourense;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
32 Ourense;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2020QIII;1.293
32 Ourense;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2020QII;""
32 Ourense;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2020QI;""
32 Ourense;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2022QIV;1.268
32 Ourense;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
32 Ourense;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2022QII;""
32 Ourense;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2022QI;""
32 Ourense;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2021QIV;1.271
32 Ourense;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
32 Ourense;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2021QII;""
32 Ourense;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2021QI;""
32 Ourense;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2020QIV;1.242
32 Ourense;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
32 Ourense;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2020QII;""
32 Ourense;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2020QI;""
32 Ourense;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
32 Ourense;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
32 Ourense;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QII;""
32 Ourense;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QI;1.234
32 Ourense;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
32 Ourense;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
32 Ourense;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QII;""
32 Ourense;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QI;1.200
32 Ourense;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
32 Ourense;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
32 Ourense;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QII;""
32 Ourense;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QI;""
32 Ourense;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
32 Ourense;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
32 Ourense;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QII;1.172
32 Ourense;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QI;""
32 Ourense;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
32 Ourense;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
32 Ourense;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QII;1.152
32 Ourense;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QI;""
32 Ourense;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
32 Ourense;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
32 Ourense;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QII;""
32 Ourense;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QI;""
32 Ourense;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
32 Ourense;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
32 Ourense;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
32 Ourense;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
32 Ourense;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
32 Ourense;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
32 Ourense;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
32 Ourense;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
32 Ourense;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
32 Ourense;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
32 Ourense;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
32 Ourense;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
32 Ourense;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
32 Ourense;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;95,94
32 Ourense;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
32 Ourense;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
32 Ourense;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
32 Ourense;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;95,31
32 Ourense;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
32 Ourense;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
32 Ourense;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
32 Ourense;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;96,13
32 Ourense;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
32 Ourense;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
32 Ourense;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;90,38
32 Ourense;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
32 Ourense;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
32 Ourense;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
32 Ourense;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;90,4
32 Ourense;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
32 Ourense;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
32 Ourense;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
32 Ourense;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;92,34
32 Ourense;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
32 Ourense;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
32 Ourense;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
32 Ourense;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
32 Ourense;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
32 Ourense;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
32 Ourense;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;87,77
32 Ourense;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
32 Ourense;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
32 Ourense;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
32 Ourense;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;89,22
32 Ourense;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
32 Ourense;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
32 Ourense;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
32 Ourense;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
32 Ourense;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
32 Ourense;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
32 Ourense;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;83,36
32 Ourense;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
32 Ourense;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
32 Ourense;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
32 Ourense;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;85,65
32 Ourense;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
32 Ourense;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
32 Ourense;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
32 Ourense;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
32 Ourense;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
32 Ourense;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QIV;3.653
32 Ourense;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
32 Ourense;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
32 Ourense;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
32 Ourense;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QIV;3.583
32 Ourense;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
32 Ourense;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
32 Ourense;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
32 Ourense;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QIV;3.444
32 Ourense;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
32 Ourense;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
32 Ourense;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
32 Ourense;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2022QIV;3.426
32 Ourense;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
32 Ourense;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2022QII;""
32 Ourense;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2022QI;""
32 Ourense;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2021QIV;3.421
32 Ourense;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
32 Ourense;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2021QII;""
32 Ourense;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2021QI;""
32 Ourense;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2020QIV;3.281
32 Ourense;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
32 Ourense;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2020QII;""
32 Ourense;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2020QI;""
32 Ourense;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
32 Ourense;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
32 Ourense;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2022QII;""
32 Ourense;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2022QI;3.301
32 Ourense;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
32 Ourense;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
32 Ourense;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2021QII;""
32 Ourense;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2021QI;3.168
32 Ourense;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
32 Ourense;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
32 Ourense;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2020QII;""
32 Ourense;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2020QI;""
32 Ourense;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
32 Ourense;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
32 Ourense;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QII;3.172
32 Ourense;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QI;""
32 Ourense;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
32 Ourense;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
32 Ourense;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QII;3.048
32 Ourense;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QI;""
32 Ourense;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
32 Ourense;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
32 Ourense;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QII;""
32 Ourense;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QI;""
32 Ourense;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
32 Ourense;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QIII;3.056
32 Ourense;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QII;""
32 Ourense;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QI;""
32 Ourense;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
32 Ourense;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QIII;2.923
32 Ourense;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QII;""
32 Ourense;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QI;""
32 Ourense;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
32 Ourense;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
32 Ourense;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QII;""
32 Ourense;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QI;""
32 Ourense;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
32 Ourense;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
32 Ourense;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
32 Ourense;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
32 Ourense;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
32 Ourense;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
32 Ourense;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
32 Ourense;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
32 Ourense;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
32 Ourense;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
32 Ourense;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
32 Ourense;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
32 Ourense;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;93,79
32 Ourense;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
32 Ourense;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
32 Ourense;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
32 Ourense;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;95,48
32 Ourense;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
32 Ourense;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
32 Ourense;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
32 Ourense;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;95,27
32 Ourense;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
32 Ourense;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
32 Ourense;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
32 Ourense;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
32 Ourense;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
32 Ourense;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
32 Ourense;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;92,13
32 Ourense;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
32 Ourense;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
32 Ourense;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
32 Ourense;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;91,99
32 Ourense;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
32 Ourense;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
32 Ourense;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
32 Ourense;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
32 Ourense;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
32 Ourense;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
32 Ourense;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;88,53
32 Ourense;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
32 Ourense;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
32 Ourense;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
32 Ourense;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;88,5
32 Ourense;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
32 Ourense;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
32 Ourense;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
32 Ourense;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
32 Ourense;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
32 Ourense;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
32 Ourense;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;85,29
32 Ourense;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
32 Ourense;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
32 Ourense;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
32 Ourense;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;84,87
32 Ourense;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
32 Ourense;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
32 Ourense;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
32 Ourense;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
32 Ourense;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
32 Ourense;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
32 Ourense;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QIV;2.297
32 Ourense;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
32 Ourense;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
32 Ourense;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
32 Ourense;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QIV;2.231
32 Ourense;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
32 Ourense;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
32 Ourense;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
32 Ourense;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QIV;2.141
32 Ourense;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
32 Ourense;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
32 Ourense;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
32 Ourense;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2022QIV;2.150
32 Ourense;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
32 Ourense;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2022QII;""
32 Ourense;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2022QI;""
32 Ourense;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2021QIV;2.139
32 Ourense;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
32 Ourense;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2021QII;""
32 Ourense;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2021QI;""
32 Ourense;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2020QIV;2.030
32 Ourense;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
32 Ourense;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2020QII;""
32 Ourense;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2020QI;""
32 Ourense;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
32 Ourense;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
32 Ourense;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2022QII;""
32 Ourense;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2022QI;2.056
32 Ourense;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
32 Ourense;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
32 Ourense;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2021QII;""
32 Ourense;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2021QI;1.959
32 Ourense;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
32 Ourense;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
32 Ourense;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2020QII;""
32 Ourense;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2020QI;""
32 Ourense;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
32 Ourense;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
32 Ourense;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QII;1.989
32 Ourense;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QI;""
32 Ourense;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
32 Ourense;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
32 Ourense;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QII;1.887
32 Ourense;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QI;""
32 Ourense;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
32 Ourense;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
32 Ourense;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QII;""
32 Ourense;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QI;""
32 Ourense;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
32 Ourense;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QIII;1.919
32 Ourense;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QII;""
32 Ourense;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QI;""
32 Ourense;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
32 Ourense;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QIII;1.819
32 Ourense;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QII;""
32 Ourense;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QI;""
32 Ourense;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
32 Ourense;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
32 Ourense;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QII;""
32 Ourense;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QI;""
32 Ourense;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
32 Ourense;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
32 Ourense;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
32 Ourense;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
32 Ourense;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
32 Ourense;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
32 Ourense;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
32 Ourense;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
32 Ourense;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
32 Ourense;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
32 Ourense;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
32 Ourense;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
32 Ourense;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;93,6
32 Ourense;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
32 Ourense;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
32 Ourense;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
32 Ourense;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;95,88
32 Ourense;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
32 Ourense;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
32 Ourense;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
32 Ourense;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;94,82
32 Ourense;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
32 Ourense;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
32 Ourense;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
32 Ourense;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
32 Ourense;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
32 Ourense;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
32 Ourense;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;92,16
32 Ourense;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
32 Ourense;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
32 Ourense;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
32 Ourense;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;91,5
32 Ourense;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
32 Ourense;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
32 Ourense;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
32 Ourense;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
32 Ourense;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
32 Ourense;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
32 Ourense;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;89,15
32 Ourense;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
32 Ourense;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
32 Ourense;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
32 Ourense;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;88,14
32 Ourense;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
32 Ourense;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
32 Ourense;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
32 Ourense;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
32 Ourense;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
32 Ourense;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
32 Ourense;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;86,02
32 Ourense;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
32 Ourense;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
32 Ourense;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
32 Ourense;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;84,96
32 Ourense;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
32 Ourense;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
32 Ourense;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
32 Ourense;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
32 Ourense;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
32 Ourense;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
32 Ourense;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QIV;1.356
32 Ourense;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
32 Ourense;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
32 Ourense;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
32 Ourense;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QIV;1.352
32 Ourense;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
32 Ourense;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
32 Ourense;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
32 Ourense;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QIV;1.303
32 Ourense;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
32 Ourense;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
32 Ourense;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
32 Ourense;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2022QIV;1.276
32 Ourense;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
32 Ourense;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2022QII;""
32 Ourense;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2022QI;""
32 Ourense;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2021QIV;1.282
32 Ourense;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
32 Ourense;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2021QII;""
32 Ourense;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2021QI;""
32 Ourense;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2020QIV;1.251
32 Ourense;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
32 Ourense;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2020QII;""
32 Ourense;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2020QI;""
32 Ourense;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
32 Ourense;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
32 Ourense;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2022QII;""
32 Ourense;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2022QI;1.245
32 Ourense;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
32 Ourense;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
32 Ourense;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2021QII;""
32 Ourense;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2021QI;1.209
32 Ourense;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
32 Ourense;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
32 Ourense;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2020QII;""
32 Ourense;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2020QI;""
32 Ourense;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
32 Ourense;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
32 Ourense;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QII;1.183
32 Ourense;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QI;""
32 Ourense;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
32 Ourense;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
32 Ourense;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QII;1.161
32 Ourense;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QI;""
32 Ourense;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
32 Ourense;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
32 Ourense;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QII;""
32 Ourense;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QI;""
32 Ourense;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
32 Ourense;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QIII;1.137
32 Ourense;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QII;""
32 Ourense;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QI;""
32 Ourense;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
32 Ourense;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QIII;1.104
32 Ourense;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QII;""
32 Ourense;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QI;""
32 Ourense;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
32 Ourense;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
32 Ourense;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QII;""
32 Ourense;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QI;""
32 Ourense;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
32 Ourense;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
32 Ourense;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
32 Ourense;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
32 Ourense;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
32 Ourense;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
32 Ourense;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
32 Ourense;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
32 Ourense;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
32 Ourense;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
32 Ourense;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
32 Ourense;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
32 Ourense;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;94,1
32 Ourense;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
32 Ourense;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
32 Ourense;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
32 Ourense;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;94,82
32 Ourense;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
32 Ourense;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
32 Ourense;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
32 Ourense;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;96,01
32 Ourense;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
32 Ourense;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
32 Ourense;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
32 Ourense;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
32 Ourense;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
32 Ourense;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
32 Ourense;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;92,09
32 Ourense;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
32 Ourense;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
32 Ourense;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
32 Ourense;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;92,79
32 Ourense;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
32 Ourense;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
32 Ourense;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
32 Ourense;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
32 Ourense;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
32 Ourense;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
32 Ourense;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;87,5
32 Ourense;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
32 Ourense;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
32 Ourense;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
32 Ourense;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;89,1
32 Ourense;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
32 Ourense;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
32 Ourense;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
32 Ourense;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
32 Ourense;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
32 Ourense;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
32 Ourense;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;84,1
32 Ourense;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
32 Ourense;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
32 Ourense;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
32 Ourense;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;84,73
32 Ourense;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
32 Ourense;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
32 Ourense;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
32 Ourense;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
32 Ourense;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
32 Ourense;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
34 Palencia;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
34 Palencia;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
34 Palencia;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
34 Palencia;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QI;9.373
34 Palencia;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
34 Palencia;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
34 Palencia;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
34 Palencia;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QI;9.414
34 Palencia;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
34 Palencia;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
34 Palencia;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
34 Palencia;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QI;9.617
34 Palencia;All ages;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
34 Palencia;All ages;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
34 Palencia;All ages;Cohort January 1;Total;Survival in the first trimester;2022QII;""
34 Palencia;All ages;Cohort January 1;Total;Survival in the first trimester;2022QI;9.150
34 Palencia;All ages;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
34 Palencia;All ages;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
34 Palencia;All ages;Cohort January 1;Total;Survival in the first trimester;2021QII;""
34 Palencia;All ages;Cohort January 1;Total;Survival in the first trimester;2021QI;9.214
34 Palencia;All ages;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
34 Palencia;All ages;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
34 Palencia;All ages;Cohort January 1;Total;Survival in the first trimester;2020QII;""
34 Palencia;All ages;Cohort January 1;Total;Survival in the first trimester;2020QI;9.178
34 Palencia;All ages;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
34 Palencia;All ages;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
34 Palencia;All ages;Cohort January 1;Total;Survival in the second trimester;2022QII;8.895
34 Palencia;All ages;Cohort January 1;Total;Survival in the second trimester;2022QI;""
34 Palencia;All ages;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
34 Palencia;All ages;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
34 Palencia;All ages;Cohort January 1;Total;Survival in the second trimester;2021QII;9.019
34 Palencia;All ages;Cohort January 1;Total;Survival in the second trimester;2021QI;""
34 Palencia;All ages;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
34 Palencia;All ages;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
34 Palencia;All ages;Cohort January 1;Total;Survival in the second trimester;2020QII;9.032
34 Palencia;All ages;Cohort January 1;Total;Survival in the second trimester;2020QI;""
34 Palencia;All ages;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
34 Palencia;All ages;Cohort January 1;Total;Survival in the third trimester;2022QIII;8.707
34 Palencia;All ages;Cohort January 1;Total;Survival in the third trimester;2022QII;""
34 Palencia;All ages;Cohort January 1;Total;Survival in the third trimester;2022QI;""
34 Palencia;All ages;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
34 Palencia;All ages;Cohort January 1;Total;Survival in the third trimester;2021QIII;8.827
34 Palencia;All ages;Cohort January 1;Total;Survival in the third trimester;2021QII;""
34 Palencia;All ages;Cohort January 1;Total;Survival in the third trimester;2021QI;""
34 Palencia;All ages;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
34 Palencia;All ages;Cohort January 1;Total;Survival in the third trimester;2020QIII;8.827
34 Palencia;All ages;Cohort January 1;Total;Survival in the third trimester;2020QII;""
34 Palencia;All ages;Cohort January 1;Total;Survival in the third trimester;2020QI;""
34 Palencia;All ages;Cohort January 1;Total;Survival in the third trimester;2022QIV;8.427
34 Palencia;All ages;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
34 Palencia;All ages;Cohort January 1;Total;Survival in the third trimester;2022QII;""
34 Palencia;All ages;Cohort January 1;Total;Survival in the third trimester;2022QI;""
34 Palencia;All ages;Cohort January 1;Total;Survival in the third trimester;2021QIV;8.623
34 Palencia;All ages;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
34 Palencia;All ages;Cohort January 1;Total;Survival in the third trimester;2021QII;""
34 Palencia;All ages;Cohort January 1;Total;Survival in the third trimester;2021QI;""
34 Palencia;All ages;Cohort January 1;Total;Survival in the third trimester;2020QIV;8.638
34 Palencia;All ages;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
34 Palencia;All ages;Cohort January 1;Total;Survival in the third trimester;2020QII;""
34 Palencia;All ages;Cohort January 1;Total;Survival in the third trimester;2020QI;""
34 Palencia;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
34 Palencia;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
34 Palencia;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
34 Palencia;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
34 Palencia;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
34 Palencia;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
34 Palencia;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
34 Palencia;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
34 Palencia;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
34 Palencia;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
34 Palencia;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
34 Palencia;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
34 Palencia;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
34 Palencia;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
34 Palencia;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
34 Palencia;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;97,62
34 Palencia;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
34 Palencia;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
34 Palencia;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
34 Palencia;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;97,88
34 Palencia;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
34 Palencia;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
34 Palencia;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
34 Palencia;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;95,44
34 Palencia;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
34 Palencia;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
34 Palencia;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;94,9
34 Palencia;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
34 Palencia;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
34 Palencia;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
34 Palencia;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;95,8
34 Palencia;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
34 Palencia;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
34 Palencia;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
34 Palencia;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;93,92
34 Palencia;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
34 Palencia;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
34 Palencia;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;92,89
34 Palencia;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
34 Palencia;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
34 Palencia;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
34 Palencia;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;93,76
34 Palencia;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
34 Palencia;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
34 Palencia;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
34 Palencia;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;91,79
34 Palencia;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
34 Palencia;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
34 Palencia;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;89,91
34 Palencia;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
34 Palencia;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
34 Palencia;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
34 Palencia;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;91,6
34 Palencia;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
34 Palencia;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
34 Palencia;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
34 Palencia;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;89,82
34 Palencia;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
34 Palencia;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
34 Palencia;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
34 Palencia;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
34 Palencia;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
34 Palencia;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
34 Palencia;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QI;5.972
34 Palencia;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
34 Palencia;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
34 Palencia;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
34 Palencia;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QI;6.032
34 Palencia;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
34 Palencia;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
34 Palencia;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
34 Palencia;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QI;6.185
34 Palencia;All ages;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
34 Palencia;All ages;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
34 Palencia;All ages;Cohort January 1;Males;Survival in the first trimester;2022QII;""
34 Palencia;All ages;Cohort January 1;Males;Survival in the first trimester;2022QI;5.829
34 Palencia;All ages;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
34 Palencia;All ages;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
34 Palencia;All ages;Cohort January 1;Males;Survival in the first trimester;2021QII;""
34 Palencia;All ages;Cohort January 1;Males;Survival in the first trimester;2021QI;5.902
34 Palencia;All ages;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
34 Palencia;All ages;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
34 Palencia;All ages;Cohort January 1;Males;Survival in the first trimester;2020QII;""
34 Palencia;All ages;Cohort January 1;Males;Survival in the first trimester;2020QI;5.908
34 Palencia;All ages;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
34 Palencia;All ages;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
34 Palencia;All ages;Cohort January 1;Males;Survival in the second trimester;2022QII;5.687
34 Palencia;All ages;Cohort January 1;Males;Survival in the second trimester;2022QI;""
34 Palencia;All ages;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
34 Palencia;All ages;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
34 Palencia;All ages;Cohort January 1;Males;Survival in the second trimester;2021QII;5.793
34 Palencia;All ages;Cohort January 1;Males;Survival in the second trimester;2021QI;""
34 Palencia;All ages;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
34 Palencia;All ages;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
34 Palencia;All ages;Cohort January 1;Males;Survival in the second trimester;2020QII;5.826
34 Palencia;All ages;Cohort January 1;Males;Survival in the second trimester;2020QI;""
34 Palencia;All ages;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
34 Palencia;All ages;Cohort January 1;Males;Survival in the third trimester;2022QIII;5.582
34 Palencia;All ages;Cohort January 1;Males;Survival in the third trimester;2022QII;""
34 Palencia;All ages;Cohort January 1;Males;Survival in the third trimester;2022QI;""
34 Palencia;All ages;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
34 Palencia;All ages;Cohort January 1;Males;Survival in the third trimester;2021QIII;5.677
34 Palencia;All ages;Cohort January 1;Males;Survival in the third trimester;2021QII;""
34 Palencia;All ages;Cohort January 1;Males;Survival in the third trimester;2021QI;""
34 Palencia;All ages;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
34 Palencia;All ages;Cohort January 1;Males;Survival in the third trimester;2020QIII;5.702
34 Palencia;All ages;Cohort January 1;Males;Survival in the third trimester;2020QII;""
34 Palencia;All ages;Cohort January 1;Males;Survival in the third trimester;2020QI;""
34 Palencia;All ages;Cohort January 1;Males;Survival in the third trimester;2022QIV;5.423
34 Palencia;All ages;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
34 Palencia;All ages;Cohort January 1;Males;Survival in the third trimester;2022QII;""
34 Palencia;All ages;Cohort January 1;Males;Survival in the third trimester;2022QI;""
34 Palencia;All ages;Cohort January 1;Males;Survival in the third trimester;2021QIV;5.546
34 Palencia;All ages;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
34 Palencia;All ages;Cohort January 1;Males;Survival in the third trimester;2021QII;""
34 Palencia;All ages;Cohort January 1;Males;Survival in the third trimester;2021QI;""
34 Palencia;All ages;Cohort January 1;Males;Survival in the third trimester;2020QIV;5.586
34 Palencia;All ages;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
34 Palencia;All ages;Cohort January 1;Males;Survival in the third trimester;2020QII;""
34 Palencia;All ages;Cohort January 1;Males;Survival in the third trimester;2020QI;""
34 Palencia;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
34 Palencia;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
34 Palencia;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
34 Palencia;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
34 Palencia;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
34 Palencia;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
34 Palencia;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
34 Palencia;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
34 Palencia;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
34 Palencia;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
34 Palencia;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
34 Palencia;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
34 Palencia;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
34 Palencia;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
34 Palencia;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
34 Palencia;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;97,61
34 Palencia;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
34 Palencia;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
34 Palencia;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
34 Palencia;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;97,84
34 Palencia;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
34 Palencia;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
34 Palencia;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
34 Palencia;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;95,52
34 Palencia;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
34 Palencia;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
34 Palencia;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;95,23
34 Palencia;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
34 Palencia;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
34 Palencia;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
34 Palencia;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;96,04
34 Palencia;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
34 Palencia;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
34 Palencia;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
34 Palencia;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;94,2
34 Palencia;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
34 Palencia;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
34 Palencia;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;93,47
34 Palencia;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
34 Palencia;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
34 Palencia;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
34 Palencia;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;94,11
34 Palencia;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
34 Palencia;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
34 Palencia;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
34 Palencia;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;92,19
34 Palencia;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
34 Palencia;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
34 Palencia;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;90,81
34 Palencia;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
34 Palencia;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
34 Palencia;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
34 Palencia;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;91,94
34 Palencia;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
34 Palencia;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
34 Palencia;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
34 Palencia;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;90,32
34 Palencia;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
34 Palencia;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
34 Palencia;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
34 Palencia;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
34 Palencia;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
34 Palencia;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
34 Palencia;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QI;3.401
34 Palencia;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
34 Palencia;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
34 Palencia;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
34 Palencia;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QI;3.382
34 Palencia;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
34 Palencia;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
34 Palencia;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
34 Palencia;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QI;3.432
34 Palencia;All ages;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
34 Palencia;All ages;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
34 Palencia;All ages;Cohort January 1;Females;Survival in the first trimester;2022QII;""
34 Palencia;All ages;Cohort January 1;Females;Survival in the first trimester;2022QI;3.321
34 Palencia;All ages;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
34 Palencia;All ages;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
34 Palencia;All ages;Cohort January 1;Females;Survival in the first trimester;2021QII;""
34 Palencia;All ages;Cohort January 1;Females;Survival in the first trimester;2021QI;3.312
34 Palencia;All ages;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
34 Palencia;All ages;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
34 Palencia;All ages;Cohort January 1;Females;Survival in the first trimester;2020QII;""
34 Palencia;All ages;Cohort January 1;Females;Survival in the first trimester;2020QI;3.270
34 Palencia;All ages;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
34 Palencia;All ages;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
34 Palencia;All ages;Cohort January 1;Females;Survival in the second trimester;2022QII;3.208
34 Palencia;All ages;Cohort January 1;Females;Survival in the second trimester;2022QI;""
34 Palencia;All ages;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
34 Palencia;All ages;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
34 Palencia;All ages;Cohort January 1;Females;Survival in the second trimester;2021QII;3.226
34 Palencia;All ages;Cohort January 1;Females;Survival in the second trimester;2021QI;""
34 Palencia;All ages;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
34 Palencia;All ages;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
34 Palencia;All ages;Cohort January 1;Females;Survival in the second trimester;2020QII;3.206
34 Palencia;All ages;Cohort January 1;Females;Survival in the second trimester;2020QI;""
34 Palencia;All ages;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
34 Palencia;All ages;Cohort January 1;Females;Survival in the third trimester;2022QIII;3.125
34 Palencia;All ages;Cohort January 1;Females;Survival in the third trimester;2022QII;""
34 Palencia;All ages;Cohort January 1;Females;Survival in the third trimester;2022QI;""
34 Palencia;All ages;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
34 Palencia;All ages;Cohort January 1;Females;Survival in the third trimester;2021QIII;3.150
34 Palencia;All ages;Cohort January 1;Females;Survival in the third trimester;2021QII;""
34 Palencia;All ages;Cohort January 1;Females;Survival in the third trimester;2021QI;""
34 Palencia;All ages;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
34 Palencia;All ages;Cohort January 1;Females;Survival in the third trimester;2020QIII;3.125
34 Palencia;All ages;Cohort January 1;Females;Survival in the third trimester;2020QII;""
34 Palencia;All ages;Cohort January 1;Females;Survival in the third trimester;2020QI;""
34 Palencia;All ages;Cohort January 1;Females;Survival in the third trimester;2022QIV;3.004
34 Palencia;All ages;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
34 Palencia;All ages;Cohort January 1;Females;Survival in the third trimester;2022QII;""
34 Palencia;All ages;Cohort January 1;Females;Survival in the third trimester;2022QI;""
34 Palencia;All ages;Cohort January 1;Females;Survival in the third trimester;2021QIV;3.077
34 Palencia;All ages;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
34 Palencia;All ages;Cohort January 1;Females;Survival in the third trimester;2021QII;""
34 Palencia;All ages;Cohort January 1;Females;Survival in the third trimester;2021QI;""
34 Palencia;All ages;Cohort January 1;Females;Survival in the third trimester;2020QIV;3.052
34 Palencia;All ages;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
34 Palencia;All ages;Cohort January 1;Females;Survival in the third trimester;2020QII;""
34 Palencia;All ages;Cohort January 1;Females;Survival in the third trimester;2020QI;""
34 Palencia;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
34 Palencia;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
34 Palencia;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
34 Palencia;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
34 Palencia;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
34 Palencia;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
34 Palencia;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
34 Palencia;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
34 Palencia;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
34 Palencia;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
34 Palencia;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
34 Palencia;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
34 Palencia;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
34 Palencia;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
34 Palencia;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
34 Palencia;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;97,65
34 Palencia;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
34 Palencia;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
34 Palencia;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
34 Palencia;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;97,93
34 Palencia;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
34 Palencia;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
34 Palencia;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
34 Palencia;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;95,28
34 Palencia;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
34 Palencia;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
34 Palencia;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;94,33
34 Palencia;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
34 Palencia;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
34 Palencia;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
34 Palencia;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;95,39
34 Palencia;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
34 Palencia;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
34 Palencia;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
34 Palencia;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;93,41
34 Palencia;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
34 Palencia;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
34 Palencia;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;91,88
34 Palencia;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
34 Palencia;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
34 Palencia;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
34 Palencia;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;93,14
34 Palencia;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
34 Palencia;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
34 Palencia;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
34 Palencia;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;91,05
34 Palencia;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
34 Palencia;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
34 Palencia;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;88,33
34 Palencia;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
34 Palencia;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
34 Palencia;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
34 Palencia;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;90,98
34 Palencia;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
34 Palencia;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
34 Palencia;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
34 Palencia;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;88,93
34 Palencia;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
34 Palencia;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
34 Palencia;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
34 Palencia;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
34 Palencia;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
34 Palencia;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QII;9.376
34 Palencia;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
34 Palencia;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
34 Palencia;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
34 Palencia;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QII;9.424
34 Palencia;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
34 Palencia;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
34 Palencia;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
34 Palencia;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QII;9.475
34 Palencia;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
34 Palencia;All ages;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
34 Palencia;All ages;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
34 Palencia;All ages;Cohort April 1;Total;Survival in the first trimester;2022QII;9.097
34 Palencia;All ages;Cohort April 1;Total;Survival in the first trimester;2022QI;""
34 Palencia;All ages;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
34 Palencia;All ages;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
34 Palencia;All ages;Cohort April 1;Total;Survival in the first trimester;2021QII;9.207
34 Palencia;All ages;Cohort April 1;Total;Survival in the first trimester;2021QI;""
34 Palencia;All ages;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
34 Palencia;All ages;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
34 Palencia;All ages;Cohort April 1;Total;Survival in the first trimester;2020QII;9.310
34 Palencia;All ages;Cohort April 1;Total;Survival in the first trimester;2020QI;""
34 Palencia;All ages;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
34 Palencia;All ages;Cohort April 1;Total;Survival in the second trimester;2022QIII;8.898
34 Palencia;All ages;Cohort April 1;Total;Survival in the second trimester;2022QII;""
34 Palencia;All ages;Cohort April 1;Total;Survival in the second trimester;2022QI;""
34 Palencia;All ages;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
34 Palencia;All ages;Cohort April 1;Total;Survival in the second trimester;2021QIII;8.994
34 Palencia;All ages;Cohort April 1;Total;Survival in the second trimester;2021QII;""
34 Palencia;All ages;Cohort April 1;Total;Survival in the second trimester;2021QI;""
34 Palencia;All ages;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
34 Palencia;All ages;Cohort April 1;Total;Survival in the second trimester;2020QIII;9.082
34 Palencia;All ages;Cohort April 1;Total;Survival in the second trimester;2020QII;""
34 Palencia;All ages;Cohort April 1;Total;Survival in the second trimester;2020QI;""
34 Palencia;All ages;Cohort April 1;Total;Survival in the third trimester;2022QIV;8.602
34 Palencia;All ages;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
34 Palencia;All ages;Cohort April 1;Total;Survival in the third trimester;2022QII;""
34 Palencia;All ages;Cohort April 1;Total;Survival in the third trimester;2022QI;""
34 Palencia;All ages;Cohort April 1;Total;Survival in the third trimester;2021QIV;8.774
34 Palencia;All ages;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
34 Palencia;All ages;Cohort April 1;Total;Survival in the third trimester;2021QII;""
34 Palencia;All ages;Cohort April 1;Total;Survival in the third trimester;2021QI;""
34 Palencia;All ages;Cohort April 1;Total;Survival in the third trimester;2020QIV;8.878
34 Palencia;All ages;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
34 Palencia;All ages;Cohort April 1;Total;Survival in the third trimester;2020QII;""
34 Palencia;All ages;Cohort April 1;Total;Survival in the third trimester;2020QI;""
34 Palencia;All ages;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
34 Palencia;All ages;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
34 Palencia;All ages;Cohort April 1;Total;Survival in the third trimester;2022QII;""
34 Palencia;All ages;Cohort April 1;Total;Survival in the third trimester;2022QI;8.607
34 Palencia;All ages;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
34 Palencia;All ages;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
34 Palencia;All ages;Cohort April 1;Total;Survival in the third trimester;2021QII;""
34 Palencia;All ages;Cohort April 1;Total;Survival in the third trimester;2021QI;8.713
34 Palencia;All ages;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
34 Palencia;All ages;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
34 Palencia;All ages;Cohort April 1;Total;Survival in the third trimester;2020QII;""
34 Palencia;All ages;Cohort April 1;Total;Survival in the third trimester;2020QI;""
34 Palencia;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
34 Palencia;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
34 Palencia;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
34 Palencia;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
34 Palencia;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
34 Palencia;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
34 Palencia;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
34 Palencia;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
34 Palencia;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
34 Palencia;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
34 Palencia;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
34 Palencia;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
34 Palencia;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
34 Palencia;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
34 Palencia;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;97,02
34 Palencia;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
34 Palencia;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
34 Palencia;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
34 Palencia;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;97,7
34 Palencia;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
34 Palencia;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
34 Palencia;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
34 Palencia;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;98,26
34 Palencia;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
34 Palencia;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
34 Palencia;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;94,9
34 Palencia;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
34 Palencia;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
34 Palencia;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
34 Palencia;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;95,44
34 Palencia;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
34 Palencia;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
34 Palencia;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
34 Palencia;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;95,85
34 Palencia;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
34 Palencia;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
34 Palencia;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;91,74
34 Palencia;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
34 Palencia;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
34 Palencia;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
34 Palencia;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;93,1
34 Palencia;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
34 Palencia;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
34 Palencia;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
34 Palencia;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;93,7
34 Palencia;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
34 Palencia;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
34 Palencia;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
34 Palencia;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
34 Palencia;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
34 Palencia;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
34 Palencia;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;91,33
34 Palencia;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
34 Palencia;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
34 Palencia;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
34 Palencia;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;91,96
34 Palencia;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
34 Palencia;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
34 Palencia;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
34 Palencia;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
34 Palencia;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
34 Palencia;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
34 Palencia;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QII;5.968
34 Palencia;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
34 Palencia;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
34 Palencia;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
34 Palencia;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QII;6.028
34 Palencia;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
34 Palencia;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
34 Palencia;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
34 Palencia;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QII;6.087
34 Palencia;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
34 Palencia;All ages;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
34 Palencia;All ages;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
34 Palencia;All ages;Cohort April 1;Males;Survival in the first trimester;2022QII;5.809
34 Palencia;All ages;Cohort April 1;Males;Survival in the first trimester;2022QI;""
34 Palencia;All ages;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
34 Palencia;All ages;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
34 Palencia;All ages;Cohort April 1;Males;Survival in the first trimester;2021QII;5.906
34 Palencia;All ages;Cohort April 1;Males;Survival in the first trimester;2021QI;""
34 Palencia;All ages;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
34 Palencia;All ages;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
34 Palencia;All ages;Cohort April 1;Males;Survival in the first trimester;2020QII;5.996
34 Palencia;All ages;Cohort April 1;Males;Survival in the first trimester;2020QI;""
34 Palencia;All ages;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
34 Palencia;All ages;Cohort April 1;Males;Survival in the second trimester;2022QIII;5.695
34 Palencia;All ages;Cohort April 1;Males;Survival in the second trimester;2022QII;""
34 Palencia;All ages;Cohort April 1;Males;Survival in the second trimester;2022QI;""
34 Palencia;All ages;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
34 Palencia;All ages;Cohort April 1;Males;Survival in the second trimester;2021QIII;5.776
34 Palencia;All ages;Cohort April 1;Males;Survival in the second trimester;2021QII;""
34 Palencia;All ages;Cohort April 1;Males;Survival in the second trimester;2021QI;""
34 Palencia;All ages;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
34 Palencia;All ages;Cohort April 1;Males;Survival in the second trimester;2020QIII;5.856
34 Palencia;All ages;Cohort April 1;Males;Survival in the second trimester;2020QII;""
34 Palencia;All ages;Cohort April 1;Males;Survival in the second trimester;2020QI;""
34 Palencia;All ages;Cohort April 1;Males;Survival in the third trimester;2022QIV;5.524
34 Palencia;All ages;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
34 Palencia;All ages;Cohort April 1;Males;Survival in the third trimester;2022QII;""
34 Palencia;All ages;Cohort April 1;Males;Survival in the third trimester;2022QI;""
34 Palencia;All ages;Cohort April 1;Males;Survival in the third trimester;2021QIV;5.632
34 Palencia;All ages;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
34 Palencia;All ages;Cohort April 1;Males;Survival in the third trimester;2021QII;""
34 Palencia;All ages;Cohort April 1;Males;Survival in the third trimester;2021QI;""
34 Palencia;All ages;Cohort April 1;Males;Survival in the third trimester;2020QIV;5.728
34 Palencia;All ages;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
34 Palencia;All ages;Cohort April 1;Males;Survival in the third trimester;2020QII;""
34 Palencia;All ages;Cohort April 1;Males;Survival in the third trimester;2020QI;""
34 Palencia;All ages;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
34 Palencia;All ages;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
34 Palencia;All ages;Cohort April 1;Males;Survival in the third trimester;2022QII;""
34 Palencia;All ages;Cohort April 1;Males;Survival in the third trimester;2022QI;5.526
34 Palencia;All ages;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
34 Palencia;All ages;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
34 Palencia;All ages;Cohort April 1;Males;Survival in the third trimester;2021QII;""
34 Palencia;All ages;Cohort April 1;Males;Survival in the third trimester;2021QI;5.622
34 Palencia;All ages;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
34 Palencia;All ages;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
34 Palencia;All ages;Cohort April 1;Males;Survival in the third trimester;2020QII;""
34 Palencia;All ages;Cohort April 1;Males;Survival in the third trimester;2020QI;""
34 Palencia;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
34 Palencia;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
34 Palencia;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
34 Palencia;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
34 Palencia;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
34 Palencia;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
34 Palencia;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
34 Palencia;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
34 Palencia;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
34 Palencia;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
34 Palencia;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
34 Palencia;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
34 Palencia;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
34 Palencia;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
34 Palencia;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;97,34
34 Palencia;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
34 Palencia;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
34 Palencia;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
34 Palencia;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;97,98
34 Palencia;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
34 Palencia;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
34 Palencia;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
34 Palencia;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;98,51
34 Palencia;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
34 Palencia;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
34 Palencia;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;95,43
34 Palencia;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
34 Palencia;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
34 Palencia;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
34 Palencia;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;95,82
34 Palencia;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
34 Palencia;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
34 Palencia;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
34 Palencia;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;96,21
34 Palencia;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
34 Palencia;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
34 Palencia;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;92,56
34 Palencia;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
34 Palencia;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
34 Palencia;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
34 Palencia;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;93,43
34 Palencia;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
34 Palencia;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
34 Palencia;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
34 Palencia;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;94,1
34 Palencia;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
34 Palencia;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
34 Palencia;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
34 Palencia;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
34 Palencia;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
34 Palencia;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
34 Palencia;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;91,67
34 Palencia;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
34 Palencia;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
34 Palencia;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
34 Palencia;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;92,36
34 Palencia;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
34 Palencia;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
34 Palencia;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
34 Palencia;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
34 Palencia;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
34 Palencia;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
34 Palencia;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QII;3.408
34 Palencia;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
34 Palencia;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
34 Palencia;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
34 Palencia;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QII;3.396
34 Palencia;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
34 Palencia;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
34 Palencia;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
34 Palencia;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QII;3.388
34 Palencia;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
34 Palencia;All ages;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
34 Palencia;All ages;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
34 Palencia;All ages;Cohort April 1;Females;Survival in the first trimester;2022QII;3.288
34 Palencia;All ages;Cohort April 1;Females;Survival in the first trimester;2022QI;""
34 Palencia;All ages;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
34 Palencia;All ages;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
34 Palencia;All ages;Cohort April 1;Females;Survival in the first trimester;2021QII;3.301
34 Palencia;All ages;Cohort April 1;Females;Survival in the first trimester;2021QI;""
34 Palencia;All ages;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
34 Palencia;All ages;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
34 Palencia;All ages;Cohort April 1;Females;Survival in the first trimester;2020QII;3.314
34 Palencia;All ages;Cohort April 1;Females;Survival in the first trimester;2020QI;""
34 Palencia;All ages;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
34 Palencia;All ages;Cohort April 1;Females;Survival in the second trimester;2022QIII;3.203
34 Palencia;All ages;Cohort April 1;Females;Survival in the second trimester;2022QII;""
34 Palencia;All ages;Cohort April 1;Females;Survival in the second trimester;2022QI;""
34 Palencia;All ages;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
34 Palencia;All ages;Cohort April 1;Females;Survival in the second trimester;2021QIII;3.218
34 Palencia;All ages;Cohort April 1;Females;Survival in the second trimester;2021QII;""
34 Palencia;All ages;Cohort April 1;Females;Survival in the second trimester;2021QI;""
34 Palencia;All ages;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
34 Palencia;All ages;Cohort April 1;Females;Survival in the second trimester;2020QIII;3.226
34 Palencia;All ages;Cohort April 1;Females;Survival in the second trimester;2020QII;""
34 Palencia;All ages;Cohort April 1;Females;Survival in the second trimester;2020QI;""
34 Palencia;All ages;Cohort April 1;Females;Survival in the third trimester;2022QIV;3.078
34 Palencia;All ages;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
34 Palencia;All ages;Cohort April 1;Females;Survival in the third trimester;2022QII;""
34 Palencia;All ages;Cohort April 1;Females;Survival in the third trimester;2022QI;""
34 Palencia;All ages;Cohort April 1;Females;Survival in the third trimester;2021QIV;3.142
34 Palencia;All ages;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
34 Palencia;All ages;Cohort April 1;Females;Survival in the third trimester;2021QII;""
34 Palencia;All ages;Cohort April 1;Females;Survival in the third trimester;2021QI;""
34 Palencia;All ages;Cohort April 1;Females;Survival in the third trimester;2020QIV;3.150
34 Palencia;All ages;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
34 Palencia;All ages;Cohort April 1;Females;Survival in the third trimester;2020QII;""
34 Palencia;All ages;Cohort April 1;Females;Survival in the third trimester;2020QI;""
34 Palencia;All ages;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
34 Palencia;All ages;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
34 Palencia;All ages;Cohort April 1;Females;Survival in the third trimester;2022QII;""
34 Palencia;All ages;Cohort April 1;Females;Survival in the third trimester;2022QI;3.081
34 Palencia;All ages;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
34 Palencia;All ages;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
34 Palencia;All ages;Cohort April 1;Females;Survival in the third trimester;2021QII;""
34 Palencia;All ages;Cohort April 1;Females;Survival in the third trimester;2021QI;3.091
34 Palencia;All ages;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
34 Palencia;All ages;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
34 Palencia;All ages;Cohort April 1;Females;Survival in the third trimester;2020QII;""
34 Palencia;All ages;Cohort April 1;Females;Survival in the third trimester;2020QI;""
34 Palencia;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
34 Palencia;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
34 Palencia;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
34 Palencia;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
34 Palencia;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
34 Palencia;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
34 Palencia;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
34 Palencia;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
34 Palencia;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
34 Palencia;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
34 Palencia;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
34 Palencia;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
34 Palencia;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
34 Palencia;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
34 Palencia;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;96,48
34 Palencia;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
34 Palencia;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
34 Palencia;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
34 Palencia;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;97,2
34 Palencia;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
34 Palencia;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
34 Palencia;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
34 Palencia;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;97,82
34 Palencia;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
34 Palencia;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
34 Palencia;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;93,98
34 Palencia;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
34 Palencia;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
34 Palencia;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
34 Palencia;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;94,76
34 Palencia;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
34 Palencia;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
34 Palencia;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
34 Palencia;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;95,22
34 Palencia;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
34 Palencia;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
34 Palencia;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;90,32
34 Palencia;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
34 Palencia;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
34 Palencia;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
34 Palencia;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;92,52
34 Palencia;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
34 Palencia;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
34 Palencia;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
34 Palencia;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;92,98
34 Palencia;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
34 Palencia;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
34 Palencia;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
34 Palencia;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
34 Palencia;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
34 Palencia;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
34 Palencia;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;90,72
34 Palencia;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
34 Palencia;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
34 Palencia;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
34 Palencia;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;91,23
34 Palencia;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
34 Palencia;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
34 Palencia;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
34 Palencia;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
34 Palencia;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
34 Palencia;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QIII;9.342
34 Palencia;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
34 Palencia;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
34 Palencia;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
34 Palencia;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QIII;9.463
34 Palencia;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
34 Palencia;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
34 Palencia;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
34 Palencia;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QIII;9.483
34 Palencia;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
34 Palencia;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
34 Palencia;All ages;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
34 Palencia;All ages;Cohort July 1;Total;Survival in the first trimester;2022QIII;9.085
34 Palencia;All ages;Cohort July 1;Total;Survival in the first trimester;2022QII;""
34 Palencia;All ages;Cohort July 1;Total;Survival in the first trimester;2022QI;""
34 Palencia;All ages;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
34 Palencia;All ages;Cohort July 1;Total;Survival in the first trimester;2021QIII;9.203
34 Palencia;All ages;Cohort July 1;Total;Survival in the first trimester;2021QII;""
34 Palencia;All ages;Cohort July 1;Total;Survival in the first trimester;2021QI;""
34 Palencia;All ages;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
34 Palencia;All ages;Cohort July 1;Total;Survival in the first trimester;2020QIII;9.233
34 Palencia;All ages;Cohort July 1;Total;Survival in the first trimester;2020QII;""
34 Palencia;All ages;Cohort July 1;Total;Survival in the first trimester;2020QI;""
34 Palencia;All ages;Cohort July 1;Total;Survival in the second trimester;2022QIV;8.767
34 Palencia;All ages;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
34 Palencia;All ages;Cohort July 1;Total;Survival in the second trimester;2022QII;""
34 Palencia;All ages;Cohort July 1;Total;Survival in the second trimester;2022QI;""
34 Palencia;All ages;Cohort July 1;Total;Survival in the second trimester;2021QIV;8.961
34 Palencia;All ages;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
34 Palencia;All ages;Cohort July 1;Total;Survival in the second trimester;2021QII;""
34 Palencia;All ages;Cohort July 1;Total;Survival in the second trimester;2021QI;""
34 Palencia;All ages;Cohort July 1;Total;Survival in the second trimester;2020QIV;9.012
34 Palencia;All ages;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
34 Palencia;All ages;Cohort July 1;Total;Survival in the second trimester;2020QII;""
34 Palencia;All ages;Cohort July 1;Total;Survival in the second trimester;2020QI;""
34 Palencia;All ages;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
34 Palencia;All ages;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
34 Palencia;All ages;Cohort July 1;Total;Survival in the third trimester;2022QII;""
34 Palencia;All ages;Cohort July 1;Total;Survival in the third trimester;2022QI;8.778
34 Palencia;All ages;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
34 Palencia;All ages;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
34 Palencia;All ages;Cohort July 1;Total;Survival in the third trimester;2021QII;""
34 Palencia;All ages;Cohort July 1;Total;Survival in the third trimester;2021QI;8.840
34 Palencia;All ages;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
34 Palencia;All ages;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
34 Palencia;All ages;Cohort July 1;Total;Survival in the third trimester;2020QII;""
34 Palencia;All ages;Cohort July 1;Total;Survival in the third trimester;2020QI;""
34 Palencia;All ages;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
34 Palencia;All ages;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
34 Palencia;All ages;Cohort July 1;Total;Survival in the third trimester;2022QII;8.563
34 Palencia;All ages;Cohort July 1;Total;Survival in the third trimester;2022QI;""
34 Palencia;All ages;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
34 Palencia;All ages;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
34 Palencia;All ages;Cohort July 1;Total;Survival in the third trimester;2021QII;8.674
34 Palencia;All ages;Cohort July 1;Total;Survival in the third trimester;2021QI;""
34 Palencia;All ages;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
34 Palencia;All ages;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
34 Palencia;All ages;Cohort July 1;Total;Survival in the third trimester;2020QII;""
34 Palencia;All ages;Cohort July 1;Total;Survival in the third trimester;2020QI;""
34 Palencia;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
34 Palencia;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
34 Palencia;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
34 Palencia;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
34 Palencia;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
34 Palencia;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
34 Palencia;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
34 Palencia;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
34 Palencia;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
34 Palencia;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
34 Palencia;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
34 Palencia;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
34 Palencia;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
34 Palencia;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;97,25
34 Palencia;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
34 Palencia;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
34 Palencia;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
34 Palencia;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;97,25
34 Palencia;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
34 Palencia;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
34 Palencia;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
34 Palencia;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;97,36
34 Palencia;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
34 Palencia;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
34 Palencia;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;93,85
34 Palencia;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
34 Palencia;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
34 Palencia;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
34 Palencia;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;94,7
34 Palencia;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
34 Palencia;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
34 Palencia;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
34 Palencia;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;95,03
34 Palencia;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
34 Palencia;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
34 Palencia;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
34 Palencia;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
34 Palencia;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
34 Palencia;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
34 Palencia;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;92,76
34 Palencia;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
34 Palencia;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
34 Palencia;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
34 Palencia;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;93,22
34 Palencia;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
34 Palencia;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
34 Palencia;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
34 Palencia;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
34 Palencia;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
34 Palencia;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
34 Palencia;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;90,49
34 Palencia;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
34 Palencia;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
34 Palencia;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
34 Palencia;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;91,47
34 Palencia;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
34 Palencia;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
34 Palencia;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
34 Palencia;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
34 Palencia;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
34 Palencia;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
34 Palencia;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QIII;5.939
34 Palencia;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
34 Palencia;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
34 Palencia;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
34 Palencia;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QIII;6.065
34 Palencia;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
34 Palencia;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
34 Palencia;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
34 Palencia;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QIII;6.098
34 Palencia;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
34 Palencia;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
34 Palencia;All ages;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
34 Palencia;All ages;Cohort July 1;Males;Survival in the first trimester;2022QIII;5.798
34 Palencia;All ages;Cohort July 1;Males;Survival in the first trimester;2022QII;""
34 Palencia;All ages;Cohort July 1;Males;Survival in the first trimester;2022QI;""
34 Palencia;All ages;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
34 Palencia;All ages;Cohort July 1;Males;Survival in the first trimester;2021QIII;5.910
34 Palencia;All ages;Cohort July 1;Males;Survival in the first trimester;2021QII;""
34 Palencia;All ages;Cohort July 1;Males;Survival in the first trimester;2021QI;""
34 Palencia;All ages;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
34 Palencia;All ages;Cohort July 1;Males;Survival in the first trimester;2020QIII;5.946
34 Palencia;All ages;Cohort July 1;Males;Survival in the first trimester;2020QII;""
34 Palencia;All ages;Cohort July 1;Males;Survival in the first trimester;2020QI;""
34 Palencia;All ages;Cohort July 1;Males;Survival in the second trimester;2022QIV;5.612
34 Palencia;All ages;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
34 Palencia;All ages;Cohort July 1;Males;Survival in the second trimester;2022QII;""
34 Palencia;All ages;Cohort July 1;Males;Survival in the second trimester;2022QI;""
34 Palencia;All ages;Cohort July 1;Males;Survival in the second trimester;2021QIV;5.749
34 Palencia;All ages;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
34 Palencia;All ages;Cohort July 1;Males;Survival in the second trimester;2021QII;""
34 Palencia;All ages;Cohort July 1;Males;Survival in the second trimester;2021QI;""
34 Palencia;All ages;Cohort July 1;Males;Survival in the second trimester;2020QIV;5.808
34 Palencia;All ages;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
34 Palencia;All ages;Cohort July 1;Males;Survival in the second trimester;2020QII;""
34 Palencia;All ages;Cohort July 1;Males;Survival in the second trimester;2020QI;""
34 Palencia;All ages;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
34 Palencia;All ages;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
34 Palencia;All ages;Cohort July 1;Males;Survival in the third trimester;2022QII;""
34 Palencia;All ages;Cohort July 1;Males;Survival in the third trimester;2022QI;5.633
34 Palencia;All ages;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
34 Palencia;All ages;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
34 Palencia;All ages;Cohort July 1;Males;Survival in the third trimester;2021QII;""
34 Palencia;All ages;Cohort July 1;Males;Survival in the third trimester;2021QI;5.697
34 Palencia;All ages;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
34 Palencia;All ages;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
34 Palencia;All ages;Cohort July 1;Males;Survival in the third trimester;2020QII;""
34 Palencia;All ages;Cohort July 1;Males;Survival in the third trimester;2020QI;""
34 Palencia;All ages;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
34 Palencia;All ages;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
34 Palencia;All ages;Cohort July 1;Males;Survival in the third trimester;2022QII;5.505
34 Palencia;All ages;Cohort July 1;Males;Survival in the third trimester;2022QI;""
34 Palencia;All ages;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
34 Palencia;All ages;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
34 Palencia;All ages;Cohort July 1;Males;Survival in the third trimester;2021QII;5.601
34 Palencia;All ages;Cohort July 1;Males;Survival in the third trimester;2021QI;""
34 Palencia;All ages;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
34 Palencia;All ages;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
34 Palencia;All ages;Cohort July 1;Males;Survival in the third trimester;2020QII;""
34 Palencia;All ages;Cohort July 1;Males;Survival in the third trimester;2020QI;""
34 Palencia;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
34 Palencia;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
34 Palencia;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
34 Palencia;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
34 Palencia;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
34 Palencia;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
34 Palencia;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
34 Palencia;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
34 Palencia;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
34 Palencia;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
34 Palencia;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
34 Palencia;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
34 Palencia;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
34 Palencia;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;97,63
34 Palencia;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
34 Palencia;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
34 Palencia;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
34 Palencia;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;97,44
34 Palencia;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
34 Palencia;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
34 Palencia;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
34 Palencia;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;97,51
34 Palencia;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
34 Palencia;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
34 Palencia;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;94,49
34 Palencia;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
34 Palencia;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
34 Palencia;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
34 Palencia;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;94,79
34 Palencia;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
34 Palencia;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
34 Palencia;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
34 Palencia;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;95,24
34 Palencia;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
34 Palencia;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
34 Palencia;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
34 Palencia;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
34 Palencia;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
34 Palencia;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
34 Palencia;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;92,88
34 Palencia;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
34 Palencia;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
34 Palencia;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
34 Palencia;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;93,42
34 Palencia;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
34 Palencia;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
34 Palencia;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
34 Palencia;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
34 Palencia;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
34 Palencia;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
34 Palencia;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;90,77
34 Palencia;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
34 Palencia;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
34 Palencia;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
34 Palencia;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;91,85
34 Palencia;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
34 Palencia;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
34 Palencia;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
34 Palencia;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
34 Palencia;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
34 Palencia;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
34 Palencia;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QIII;3.403
34 Palencia;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
34 Palencia;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
34 Palencia;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
34 Palencia;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QIII;3.398
34 Palencia;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
34 Palencia;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
34 Palencia;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
34 Palencia;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QIII;3.385
34 Palencia;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
34 Palencia;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
34 Palencia;All ages;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
34 Palencia;All ages;Cohort July 1;Females;Survival in the first trimester;2022QIII;3.287
34 Palencia;All ages;Cohort July 1;Females;Survival in the first trimester;2022QII;""
34 Palencia;All ages;Cohort July 1;Females;Survival in the first trimester;2022QI;""
34 Palencia;All ages;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
34 Palencia;All ages;Cohort July 1;Females;Survival in the first trimester;2021QIII;3.293
34 Palencia;All ages;Cohort July 1;Females;Survival in the first trimester;2021QII;""
34 Palencia;All ages;Cohort July 1;Females;Survival in the first trimester;2021QI;""
34 Palencia;All ages;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
34 Palencia;All ages;Cohort July 1;Females;Survival in the first trimester;2020QIII;3.287
34 Palencia;All ages;Cohort July 1;Females;Survival in the first trimester;2020QII;""
34 Palencia;All ages;Cohort July 1;Females;Survival in the first trimester;2020QI;""
34 Palencia;All ages;Cohort July 1;Females;Survival in the second trimester;2022QIV;3.155
34 Palencia;All ages;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
34 Palencia;All ages;Cohort July 1;Females;Survival in the second trimester;2022QII;""
34 Palencia;All ages;Cohort July 1;Females;Survival in the second trimester;2022QI;""
34 Palencia;All ages;Cohort July 1;Females;Survival in the second trimester;2021QIV;3.212
34 Palencia;All ages;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
34 Palencia;All ages;Cohort July 1;Females;Survival in the second trimester;2021QII;""
34 Palencia;All ages;Cohort July 1;Females;Survival in the second trimester;2021QI;""
34 Palencia;All ages;Cohort July 1;Females;Survival in the second trimester;2020QIV;3.204
34 Palencia;All ages;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
34 Palencia;All ages;Cohort July 1;Females;Survival in the second trimester;2020QII;""
34 Palencia;All ages;Cohort July 1;Females;Survival in the second trimester;2020QI;""
34 Palencia;All ages;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
34 Palencia;All ages;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
34 Palencia;All ages;Cohort July 1;Females;Survival in the third trimester;2022QII;""
34 Palencia;All ages;Cohort July 1;Females;Survival in the third trimester;2022QI;3.145
34 Palencia;All ages;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
34 Palencia;All ages;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
34 Palencia;All ages;Cohort July 1;Females;Survival in the third trimester;2021QII;""
34 Palencia;All ages;Cohort July 1;Females;Survival in the third trimester;2021QI;3.143
34 Palencia;All ages;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
34 Palencia;All ages;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
34 Palencia;All ages;Cohort July 1;Females;Survival in the third trimester;2020QII;""
34 Palencia;All ages;Cohort July 1;Females;Survival in the third trimester;2020QI;""
34 Palencia;All ages;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
34 Palencia;All ages;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
34 Palencia;All ages;Cohort July 1;Females;Survival in the third trimester;2022QII;3.058
34 Palencia;All ages;Cohort July 1;Females;Survival in the third trimester;2022QI;""
34 Palencia;All ages;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
34 Palencia;All ages;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
34 Palencia;All ages;Cohort July 1;Females;Survival in the third trimester;2021QII;3.073
34 Palencia;All ages;Cohort July 1;Females;Survival in the third trimester;2021QI;""
34 Palencia;All ages;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
34 Palencia;All ages;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
34 Palencia;All ages;Cohort July 1;Females;Survival in the third trimester;2020QII;""
34 Palencia;All ages;Cohort July 1;Females;Survival in the third trimester;2020QI;""
34 Palencia;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
34 Palencia;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
34 Palencia;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
34 Palencia;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
34 Palencia;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
34 Palencia;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
34 Palencia;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
34 Palencia;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
34 Palencia;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
34 Palencia;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
34 Palencia;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
34 Palencia;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
34 Palencia;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
34 Palencia;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;96,59
34 Palencia;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
34 Palencia;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
34 Palencia;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
34 Palencia;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;96,91
34 Palencia;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
34 Palencia;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
34 Palencia;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
34 Palencia;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;97,1
34 Palencia;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
34 Palencia;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
34 Palencia;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;92,71
34 Palencia;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
34 Palencia;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
34 Palencia;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
34 Palencia;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;94,53
34 Palencia;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
34 Palencia;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
34 Palencia;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
34 Palencia;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;94,65
34 Palencia;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
34 Palencia;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
34 Palencia;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
34 Palencia;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
34 Palencia;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
34 Palencia;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
34 Palencia;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;92,55
34 Palencia;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
34 Palencia;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
34 Palencia;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
34 Palencia;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;92,85
34 Palencia;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
34 Palencia;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
34 Palencia;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
34 Palencia;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
34 Palencia;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
34 Palencia;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
34 Palencia;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;89,99
34 Palencia;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
34 Palencia;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
34 Palencia;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
34 Palencia;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;90,78
34 Palencia;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
34 Palencia;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
34 Palencia;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
34 Palencia;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
34 Palencia;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
34 Palencia;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QIV;9.274
34 Palencia;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
34 Palencia;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
34 Palencia;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
34 Palencia;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QIV;9.411
34 Palencia;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
34 Palencia;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
34 Palencia;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
34 Palencia;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QIV;9.470
34 Palencia;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
34 Palencia;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
34 Palencia;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
34 Palencia;All ages;Cohort October 1;Total;Survival in the first trimester;2022QIV;8.935
34 Palencia;All ages;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
34 Palencia;All ages;Cohort October 1;Total;Survival in the first trimester;2022QII;""
34 Palencia;All ages;Cohort October 1;Total;Survival in the first trimester;2022QI;""
34 Palencia;All ages;Cohort October 1;Total;Survival in the first trimester;2021QIV;9.148
34 Palencia;All ages;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
34 Palencia;All ages;Cohort October 1;Total;Survival in the first trimester;2021QII;""
34 Palencia;All ages;Cohort October 1;Total;Survival in the first trimester;2021QI;""
34 Palencia;All ages;Cohort October 1;Total;Survival in the first trimester;2020QIV;9.218
34 Palencia;All ages;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
34 Palencia;All ages;Cohort October 1;Total;Survival in the first trimester;2020QII;""
34 Palencia;All ages;Cohort October 1;Total;Survival in the first trimester;2020QI;""
34 Palencia;All ages;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
34 Palencia;All ages;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
34 Palencia;All ages;Cohort October 1;Total;Survival in the second trimester;2022QII;""
34 Palencia;All ages;Cohort October 1;Total;Survival in the second trimester;2022QI;8.951
34 Palencia;All ages;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
34 Palencia;All ages;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
34 Palencia;All ages;Cohort October 1;Total;Survival in the second trimester;2021QII;""
34 Palencia;All ages;Cohort October 1;Total;Survival in the second trimester;2021QI;9.037
34 Palencia;All ages;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
34 Palencia;All ages;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
34 Palencia;All ages;Cohort October 1;Total;Survival in the second trimester;2020QII;""
34 Palencia;All ages;Cohort October 1;Total;Survival in the second trimester;2020QI;""
34 Palencia;All ages;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
34 Palencia;All ages;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
34 Palencia;All ages;Cohort October 1;Total;Survival in the third trimester;2022QII;8.726
34 Palencia;All ages;Cohort October 1;Total;Survival in the third trimester;2022QI;""
34 Palencia;All ages;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
34 Palencia;All ages;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
34 Palencia;All ages;Cohort October 1;Total;Survival in the third trimester;2021QII;8.863
34 Palencia;All ages;Cohort October 1;Total;Survival in the third trimester;2021QI;""
34 Palencia;All ages;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
34 Palencia;All ages;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
34 Palencia;All ages;Cohort October 1;Total;Survival in the third trimester;2020QII;""
34 Palencia;All ages;Cohort October 1;Total;Survival in the third trimester;2020QI;""
34 Palencia;All ages;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
34 Palencia;All ages;Cohort October 1;Total;Survival in the third trimester;2022QIII;8.545
34 Palencia;All ages;Cohort October 1;Total;Survival in the third trimester;2022QII;""
34 Palencia;All ages;Cohort October 1;Total;Survival in the third trimester;2022QI;""
34 Palencia;All ages;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
34 Palencia;All ages;Cohort October 1;Total;Survival in the third trimester;2021QIII;8.686
34 Palencia;All ages;Cohort October 1;Total;Survival in the third trimester;2021QII;""
34 Palencia;All ages;Cohort October 1;Total;Survival in the third trimester;2021QI;""
34 Palencia;All ages;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
34 Palencia;All ages;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
34 Palencia;All ages;Cohort October 1;Total;Survival in the third trimester;2020QII;""
34 Palencia;All ages;Cohort October 1;Total;Survival in the third trimester;2020QI;""
34 Palencia;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
34 Palencia;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
34 Palencia;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
34 Palencia;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
34 Palencia;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
34 Palencia;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
34 Palencia;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
34 Palencia;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
34 Palencia;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
34 Palencia;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
34 Palencia;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
34 Palencia;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
34 Palencia;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;96,34
34 Palencia;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
34 Palencia;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
34 Palencia;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
34 Palencia;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;97,21
34 Palencia;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
34 Palencia;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
34 Palencia;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
34 Palencia;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;97,34
34 Palencia;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
34 Palencia;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
34 Palencia;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
34 Palencia;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
34 Palencia;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
34 Palencia;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
34 Palencia;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;95,11
34 Palencia;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
34 Palencia;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
34 Palencia;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
34 Palencia;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;95,43
34 Palencia;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
34 Palencia;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
34 Palencia;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
34 Palencia;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
34 Palencia;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
34 Palencia;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
34 Palencia;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;92,72
34 Palencia;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
34 Palencia;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
34 Palencia;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
34 Palencia;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;93,59
34 Palencia;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
34 Palencia;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
34 Palencia;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
34 Palencia;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
34 Palencia;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
34 Palencia;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
34 Palencia;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;90,8
34 Palencia;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
34 Palencia;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
34 Palencia;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
34 Palencia;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;91,72
34 Palencia;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
34 Palencia;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
34 Palencia;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
34 Palencia;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
34 Palencia;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
34 Palencia;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
34 Palencia;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QIV;5.895
34 Palencia;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
34 Palencia;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
34 Palencia;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
34 Palencia;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QIV;6.023
34 Palencia;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
34 Palencia;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
34 Palencia;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
34 Palencia;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QIV;6.096
34 Palencia;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
34 Palencia;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
34 Palencia;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
34 Palencia;All ages;Cohort October 1;Males;Survival in the first trimester;2022QIV;5.698
34 Palencia;All ages;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
34 Palencia;All ages;Cohort October 1;Males;Survival in the first trimester;2022QII;""
34 Palencia;All ages;Cohort October 1;Males;Survival in the first trimester;2022QI;""
34 Palencia;All ages;Cohort October 1;Males;Survival in the first trimester;2021QIV;5.853
34 Palencia;All ages;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
34 Palencia;All ages;Cohort October 1;Males;Survival in the first trimester;2021QII;""
34 Palencia;All ages;Cohort October 1;Males;Survival in the first trimester;2021QI;""
34 Palencia;All ages;Cohort October 1;Males;Survival in the first trimester;2020QIV;5.933
34 Palencia;All ages;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
34 Palencia;All ages;Cohort October 1;Males;Survival in the first trimester;2020QII;""
34 Palencia;All ages;Cohort October 1;Males;Survival in the first trimester;2020QI;""
34 Palencia;All ages;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
34 Palencia;All ages;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
34 Palencia;All ages;Cohort October 1;Males;Survival in the second trimester;2022QII;""
34 Palencia;All ages;Cohort October 1;Males;Survival in the second trimester;2022QI;5.729
34 Palencia;All ages;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
34 Palencia;All ages;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
34 Palencia;All ages;Cohort October 1;Males;Survival in the second trimester;2021QII;""
34 Palencia;All ages;Cohort October 1;Males;Survival in the second trimester;2021QI;5.816
34 Palencia;All ages;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
34 Palencia;All ages;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
34 Palencia;All ages;Cohort October 1;Males;Survival in the second trimester;2020QII;""
34 Palencia;All ages;Cohort October 1;Males;Survival in the second trimester;2020QI;""
34 Palencia;All ages;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
34 Palencia;All ages;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
34 Palencia;All ages;Cohort October 1;Males;Survival in the third trimester;2022QII;5.597
34 Palencia;All ages;Cohort October 1;Males;Survival in the third trimester;2022QI;""
34 Palencia;All ages;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
34 Palencia;All ages;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
34 Palencia;All ages;Cohort October 1;Males;Survival in the third trimester;2021QII;5.717
34 Palencia;All ages;Cohort October 1;Males;Survival in the third trimester;2021QI;""
34 Palencia;All ages;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
34 Palencia;All ages;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
34 Palencia;All ages;Cohort October 1;Males;Survival in the third trimester;2020QII;""
34 Palencia;All ages;Cohort October 1;Males;Survival in the third trimester;2020QI;""
34 Palencia;All ages;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
34 Palencia;All ages;Cohort October 1;Males;Survival in the third trimester;2022QIII;5.494
34 Palencia;All ages;Cohort October 1;Males;Survival in the third trimester;2022QII;""
34 Palencia;All ages;Cohort October 1;Males;Survival in the third trimester;2022QI;""
34 Palencia;All ages;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
34 Palencia;All ages;Cohort October 1;Males;Survival in the third trimester;2021QIII;5.607
34 Palencia;All ages;Cohort October 1;Males;Survival in the third trimester;2021QII;""
34 Palencia;All ages;Cohort October 1;Males;Survival in the third trimester;2021QI;""
34 Palencia;All ages;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
34 Palencia;All ages;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
34 Palencia;All ages;Cohort October 1;Males;Survival in the third trimester;2020QII;""
34 Palencia;All ages;Cohort October 1;Males;Survival in the third trimester;2020QI;""
34 Palencia;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
34 Palencia;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
34 Palencia;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
34 Palencia;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
34 Palencia;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
34 Palencia;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
34 Palencia;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
34 Palencia;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
34 Palencia;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
34 Palencia;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
34 Palencia;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
34 Palencia;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
34 Palencia;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;96,66
34 Palencia;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
34 Palencia;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
34 Palencia;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
34 Palencia;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;97,18
34 Palencia;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
34 Palencia;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
34 Palencia;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
34 Palencia;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;97,33
34 Palencia;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
34 Palencia;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
34 Palencia;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
34 Palencia;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
34 Palencia;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
34 Palencia;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
34 Palencia;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;95,12
34 Palencia;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
34 Palencia;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
34 Palencia;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
34 Palencia;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;95,41
34 Palencia;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
34 Palencia;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
34 Palencia;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
34 Palencia;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
34 Palencia;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
34 Palencia;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
34 Palencia;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;92,93
34 Palencia;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
34 Palencia;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
34 Palencia;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
34 Palencia;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;93,78
34 Palencia;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
34 Palencia;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
34 Palencia;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
34 Palencia;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
34 Palencia;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
34 Palencia;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
34 Palencia;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;91,22
34 Palencia;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
34 Palencia;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
34 Palencia;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
34 Palencia;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;91,98
34 Palencia;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
34 Palencia;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
34 Palencia;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
34 Palencia;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
34 Palencia;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
34 Palencia;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
34 Palencia;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QIV;3.379
34 Palencia;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
34 Palencia;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
34 Palencia;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
34 Palencia;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QIV;3.388
34 Palencia;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
34 Palencia;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
34 Palencia;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
34 Palencia;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QIV;3.374
34 Palencia;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
34 Palencia;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
34 Palencia;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
34 Palencia;All ages;Cohort October 1;Females;Survival in the first trimester;2022QIV;3.237
34 Palencia;All ages;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
34 Palencia;All ages;Cohort October 1;Females;Survival in the first trimester;2022QII;""
34 Palencia;All ages;Cohort October 1;Females;Survival in the first trimester;2022QI;""
34 Palencia;All ages;Cohort October 1;Females;Survival in the first trimester;2021QIV;3.295
34 Palencia;All ages;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
34 Palencia;All ages;Cohort October 1;Females;Survival in the first trimester;2021QII;""
34 Palencia;All ages;Cohort October 1;Females;Survival in the first trimester;2021QI;""
34 Palencia;All ages;Cohort October 1;Females;Survival in the first trimester;2020QIV;3.285
34 Palencia;All ages;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
34 Palencia;All ages;Cohort October 1;Females;Survival in the first trimester;2020QII;""
34 Palencia;All ages;Cohort October 1;Females;Survival in the first trimester;2020QI;""
34 Palencia;All ages;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
34 Palencia;All ages;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
34 Palencia;All ages;Cohort October 1;Females;Survival in the second trimester;2022QII;""
34 Palencia;All ages;Cohort October 1;Females;Survival in the second trimester;2022QI;3.222
34 Palencia;All ages;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
34 Palencia;All ages;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
34 Palencia;All ages;Cohort October 1;Females;Survival in the second trimester;2021QII;""
34 Palencia;All ages;Cohort October 1;Females;Survival in the second trimester;2021QI;3.221
34 Palencia;All ages;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
34 Palencia;All ages;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
34 Palencia;All ages;Cohort October 1;Females;Survival in the second trimester;2020QII;""
34 Palencia;All ages;Cohort October 1;Females;Survival in the second trimester;2020QI;""
34 Palencia;All ages;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
34 Palencia;All ages;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
34 Palencia;All ages;Cohort October 1;Females;Survival in the third trimester;2022QII;3.129
34 Palencia;All ages;Cohort October 1;Females;Survival in the third trimester;2022QI;""
34 Palencia;All ages;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
34 Palencia;All ages;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
34 Palencia;All ages;Cohort October 1;Females;Survival in the third trimester;2021QII;3.146
34 Palencia;All ages;Cohort October 1;Females;Survival in the third trimester;2021QI;""
34 Palencia;All ages;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
34 Palencia;All ages;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
34 Palencia;All ages;Cohort October 1;Females;Survival in the third trimester;2020QII;""
34 Palencia;All ages;Cohort October 1;Females;Survival in the third trimester;2020QI;""
34 Palencia;All ages;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
34 Palencia;All ages;Cohort October 1;Females;Survival in the third trimester;2022QIII;3.051
34 Palencia;All ages;Cohort October 1;Females;Survival in the third trimester;2022QII;""
34 Palencia;All ages;Cohort October 1;Females;Survival in the third trimester;2022QI;""
34 Palencia;All ages;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
34 Palencia;All ages;Cohort October 1;Females;Survival in the third trimester;2021QIII;3.079
34 Palencia;All ages;Cohort October 1;Females;Survival in the third trimester;2021QII;""
34 Palencia;All ages;Cohort October 1;Females;Survival in the third trimester;2021QI;""
34 Palencia;All ages;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
34 Palencia;All ages;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
34 Palencia;All ages;Cohort October 1;Females;Survival in the third trimester;2020QII;""
34 Palencia;All ages;Cohort October 1;Females;Survival in the third trimester;2020QI;""
34 Palencia;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
34 Palencia;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
34 Palencia;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
34 Palencia;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
34 Palencia;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
34 Palencia;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
34 Palencia;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
34 Palencia;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
34 Palencia;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
34 Palencia;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
34 Palencia;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
34 Palencia;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
34 Palencia;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;95,8
34 Palencia;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
34 Palencia;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
34 Palencia;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
34 Palencia;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;97,26
34 Palencia;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
34 Palencia;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
34 Palencia;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
34 Palencia;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;97,36
34 Palencia;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
34 Palencia;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
34 Palencia;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
34 Palencia;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
34 Palencia;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
34 Palencia;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
34 Palencia;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;95,1
34 Palencia;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
34 Palencia;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
34 Palencia;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
34 Palencia;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;95,47
34 Palencia;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
34 Palencia;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
34 Palencia;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
34 Palencia;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
34 Palencia;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
34 Palencia;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
34 Palencia;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;92,36
34 Palencia;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
34 Palencia;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
34 Palencia;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
34 Palencia;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;93,24
34 Palencia;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
34 Palencia;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
34 Palencia;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
34 Palencia;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
34 Palencia;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
34 Palencia;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
34 Palencia;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;90,05
34 Palencia;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
34 Palencia;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
34 Palencia;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
34 Palencia;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;91,26
34 Palencia;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
34 Palencia;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
34 Palencia;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
34 Palencia;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
34 Palencia;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
34 Palencia;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
34 Palencia;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
34 Palencia;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
34 Palencia;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
34 Palencia;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QI;454
34 Palencia;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
34 Palencia;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
34 Palencia;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
34 Palencia;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QI;431
34 Palencia;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
34 Palencia;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
34 Palencia;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
34 Palencia;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QI;349
34 Palencia;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
34 Palencia;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
34 Palencia;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2022QII;""
34 Palencia;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2022QI;433
34 Palencia;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
34 Palencia;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
34 Palencia;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2021QII;""
34 Palencia;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2021QI;411
34 Palencia;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
34 Palencia;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
34 Palencia;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2020QII;""
34 Palencia;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2020QI;302
34 Palencia;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
34 Palencia;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
34 Palencia;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2022QII;400
34 Palencia;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2022QI;""
34 Palencia;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
34 Palencia;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
34 Palencia;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2021QII;393
34 Palencia;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2021QI;""
34 Palencia;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
34 Palencia;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
34 Palencia;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2020QII;296
34 Palencia;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2020QI;""
34 Palencia;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
34 Palencia;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QIII;376
34 Palencia;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QII;""
34 Palencia;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QI;""
34 Palencia;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
34 Palencia;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QIII;370
34 Palencia;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QII;""
34 Palencia;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QI;""
34 Palencia;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
34 Palencia;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QIII;290
34 Palencia;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QII;""
34 Palencia;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QI;""
34 Palencia;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QIV;356
34 Palencia;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
34 Palencia;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QII;""
34 Palencia;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QI;""
34 Palencia;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QIV;349
34 Palencia;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
34 Palencia;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QII;""
34 Palencia;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QI;""
34 Palencia;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QIV;279
34 Palencia;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
34 Palencia;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QII;""
34 Palencia;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QI;""
34 Palencia;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
34 Palencia;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
34 Palencia;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
34 Palencia;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
34 Palencia;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
34 Palencia;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
34 Palencia;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
34 Palencia;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
34 Palencia;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
34 Palencia;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
34 Palencia;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
34 Palencia;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
34 Palencia;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
34 Palencia;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
34 Palencia;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
34 Palencia;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;95,37
34 Palencia;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
34 Palencia;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
34 Palencia;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
34 Palencia;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;95,36
34 Palencia;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
34 Palencia;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
34 Palencia;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
34 Palencia;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;86,53
34 Palencia;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
34 Palencia;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
34 Palencia;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;88,11
34 Palencia;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
34 Palencia;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
34 Palencia;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
34 Palencia;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;91,18
34 Palencia;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
34 Palencia;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
34 Palencia;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
34 Palencia;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;84,81
34 Palencia;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
34 Palencia;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
34 Palencia;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;82,82
34 Palencia;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
34 Palencia;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
34 Palencia;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
34 Palencia;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;85,85
34 Palencia;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
34 Palencia;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
34 Palencia;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
34 Palencia;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;83,09
34 Palencia;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
34 Palencia;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
34 Palencia;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;78,41
34 Palencia;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
34 Palencia;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
34 Palencia;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
34 Palencia;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;80,97
34 Palencia;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
34 Palencia;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
34 Palencia;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
34 Palencia;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;79,94
34 Palencia;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
34 Palencia;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
34 Palencia;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
34 Palencia;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
34 Palencia;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
34 Palencia;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
34 Palencia;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QI;295
34 Palencia;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
34 Palencia;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
34 Palencia;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
34 Palencia;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QI;273
34 Palencia;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
34 Palencia;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
34 Palencia;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
34 Palencia;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QI;215
34 Palencia;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
34 Palencia;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
34 Palencia;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2022QII;""
34 Palencia;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2022QI;283
34 Palencia;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
34 Palencia;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
34 Palencia;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2021QII;""
34 Palencia;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2021QI;265
34 Palencia;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
34 Palencia;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
34 Palencia;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2020QII;""
34 Palencia;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2020QI;189
34 Palencia;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
34 Palencia;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
34 Palencia;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2022QII;266
34 Palencia;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2022QI;""
34 Palencia;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
34 Palencia;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
34 Palencia;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2021QII;256
34 Palencia;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2021QI;""
34 Palencia;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
34 Palencia;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
34 Palencia;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2020QII;186
34 Palencia;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2020QI;""
34 Palencia;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
34 Palencia;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QIII;253
34 Palencia;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QII;""
34 Palencia;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QI;""
34 Palencia;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
34 Palencia;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QIII;243
34 Palencia;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QII;""
34 Palencia;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QI;""
34 Palencia;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
34 Palencia;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QIII;184
34 Palencia;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QII;""
34 Palencia;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QI;""
34 Palencia;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QIV;241
34 Palencia;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
34 Palencia;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QII;""
34 Palencia;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QI;""
34 Palencia;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QIV;231
34 Palencia;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
34 Palencia;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QII;""
34 Palencia;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QI;""
34 Palencia;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QIV;178
34 Palencia;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
34 Palencia;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QII;""
34 Palencia;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QI;""
34 Palencia;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
34 Palencia;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
34 Palencia;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
34 Palencia;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
34 Palencia;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
34 Palencia;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
34 Palencia;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
34 Palencia;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
34 Palencia;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
34 Palencia;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
34 Palencia;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
34 Palencia;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
34 Palencia;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
34 Palencia;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
34 Palencia;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
34 Palencia;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;95,93
34 Palencia;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
34 Palencia;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
34 Palencia;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
34 Palencia;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;97,07
34 Palencia;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
34 Palencia;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
34 Palencia;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
34 Palencia;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;87,91
34 Palencia;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
34 Palencia;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
34 Palencia;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;90,17
34 Palencia;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
34 Palencia;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
34 Palencia;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
34 Palencia;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;93,77
34 Palencia;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
34 Palencia;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
34 Palencia;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
34 Palencia;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;86,51
34 Palencia;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
34 Palencia;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
34 Palencia;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;85,76
34 Palencia;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
34 Palencia;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
34 Palencia;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
34 Palencia;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;89,01
34 Palencia;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
34 Palencia;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
34 Palencia;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
34 Palencia;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;85,58
34 Palencia;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
34 Palencia;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
34 Palencia;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;81,69
34 Palencia;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
34 Palencia;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
34 Palencia;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
34 Palencia;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;84,62
34 Palencia;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
34 Palencia;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
34 Palencia;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
34 Palencia;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;82,79
34 Palencia;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
34 Palencia;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
34 Palencia;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
34 Palencia;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
34 Palencia;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
34 Palencia;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
34 Palencia;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QI;159
34 Palencia;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
34 Palencia;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
34 Palencia;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
34 Palencia;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QI;158
34 Palencia;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
34 Palencia;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
34 Palencia;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
34 Palencia;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QI;134
34 Palencia;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
34 Palencia;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
34 Palencia;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2022QII;""
34 Palencia;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2022QI;150
34 Palencia;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
34 Palencia;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
34 Palencia;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2021QII;""
34 Palencia;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2021QI;146
34 Palencia;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
34 Palencia;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
34 Palencia;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2020QII;""
34 Palencia;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2020QI;113
34 Palencia;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
34 Palencia;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
34 Palencia;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2022QII;134
34 Palencia;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2022QI;""
34 Palencia;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
34 Palencia;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
34 Palencia;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2021QII;137
34 Palencia;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2021QI;""
34 Palencia;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
34 Palencia;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
34 Palencia;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2020QII;110
34 Palencia;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2020QI;""
34 Palencia;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
34 Palencia;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QIII;123
34 Palencia;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QII;""
34 Palencia;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QI;""
34 Palencia;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
34 Palencia;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QIII;127
34 Palencia;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QII;""
34 Palencia;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QI;""
34 Palencia;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
34 Palencia;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QIII;106
34 Palencia;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QII;""
34 Palencia;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QI;""
34 Palencia;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QIV;115
34 Palencia;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
34 Palencia;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QII;""
34 Palencia;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QI;""
34 Palencia;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QIV;118
34 Palencia;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
34 Palencia;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QII;""
34 Palencia;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QI;""
34 Palencia;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QIV;101
34 Palencia;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
34 Palencia;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QII;""
34 Palencia;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QI;""
34 Palencia;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
34 Palencia;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
34 Palencia;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
34 Palencia;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
34 Palencia;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
34 Palencia;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
34 Palencia;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
34 Palencia;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
34 Palencia;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
34 Palencia;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
34 Palencia;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
34 Palencia;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
34 Palencia;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
34 Palencia;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
34 Palencia;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
34 Palencia;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;94,34
34 Palencia;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
34 Palencia;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
34 Palencia;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
34 Palencia;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;92,41
34 Palencia;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
34 Palencia;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
34 Palencia;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
34 Palencia;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;84,33
34 Palencia;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
34 Palencia;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
34 Palencia;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;84,28
34 Palencia;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
34 Palencia;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
34 Palencia;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
34 Palencia;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;86,71
34 Palencia;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
34 Palencia;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
34 Palencia;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
34 Palencia;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;82,09
34 Palencia;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
34 Palencia;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
34 Palencia;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;77,36
34 Palencia;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
34 Palencia;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
34 Palencia;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
34 Palencia;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;80,38
34 Palencia;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
34 Palencia;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
34 Palencia;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
34 Palencia;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;79,1
34 Palencia;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
34 Palencia;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
34 Palencia;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;72,33
34 Palencia;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
34 Palencia;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
34 Palencia;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
34 Palencia;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;74,68
34 Palencia;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
34 Palencia;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
34 Palencia;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
34 Palencia;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;75,37
34 Palencia;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
34 Palencia;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
34 Palencia;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
34 Palencia;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
34 Palencia;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
34 Palencia;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QII;399
34 Palencia;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
34 Palencia;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
34 Palencia;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
34 Palencia;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QII;386
34 Palencia;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
34 Palencia;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
34 Palencia;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
34 Palencia;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QII;349
34 Palencia;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
34 Palencia;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
34 Palencia;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
34 Palencia;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2022QII;360
34 Palencia;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2022QI;""
34 Palencia;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
34 Palencia;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
34 Palencia;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2021QII;359
34 Palencia;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2021QI;""
34 Palencia;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
34 Palencia;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
34 Palencia;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2020QII;342
34 Palencia;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2020QI;""
34 Palencia;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
34 Palencia;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2022QIII;335
34 Palencia;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2022QII;""
34 Palencia;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2022QI;""
34 Palencia;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
34 Palencia;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2021QIII;334
34 Palencia;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2021QII;""
34 Palencia;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2021QI;""
34 Palencia;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
34 Palencia;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2020QIII;330
34 Palencia;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2020QII;""
34 Palencia;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2020QI;""
34 Palencia;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QIV;317
34 Palencia;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
34 Palencia;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QII;""
34 Palencia;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QI;""
34 Palencia;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QIV;314
34 Palencia;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
34 Palencia;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QII;""
34 Palencia;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QI;""
34 Palencia;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QIV;318
34 Palencia;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
34 Palencia;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QII;""
34 Palencia;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QI;""
34 Palencia;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
34 Palencia;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
34 Palencia;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QII;""
34 Palencia;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QI;305
34 Palencia;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
34 Palencia;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
34 Palencia;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QII;""
34 Palencia;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QI;309
34 Palencia;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
34 Palencia;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
34 Palencia;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QII;""
34 Palencia;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QI;""
34 Palencia;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
34 Palencia;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
34 Palencia;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
34 Palencia;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
34 Palencia;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
34 Palencia;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
34 Palencia;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
34 Palencia;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
34 Palencia;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
34 Palencia;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
34 Palencia;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
34 Palencia;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
34 Palencia;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
34 Palencia;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
34 Palencia;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;90,23
34 Palencia;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
34 Palencia;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
34 Palencia;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
34 Palencia;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;93,01
34 Palencia;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
34 Palencia;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
34 Palencia;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
34 Palencia;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;97,99
34 Palencia;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
34 Palencia;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
34 Palencia;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;83,96
34 Palencia;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
34 Palencia;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
34 Palencia;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
34 Palencia;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;86,53
34 Palencia;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
34 Palencia;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
34 Palencia;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
34 Palencia;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;94,56
34 Palencia;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
34 Palencia;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
34 Palencia;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;79,45
34 Palencia;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
34 Palencia;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
34 Palencia;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
34 Palencia;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;81,35
34 Palencia;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
34 Palencia;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
34 Palencia;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
34 Palencia;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;91,12
34 Palencia;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
34 Palencia;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
34 Palencia;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
34 Palencia;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
34 Palencia;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
34 Palencia;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
34 Palencia;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;79,02
34 Palencia;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
34 Palencia;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
34 Palencia;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
34 Palencia;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;88,54
34 Palencia;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
34 Palencia;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
34 Palencia;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
34 Palencia;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
34 Palencia;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
34 Palencia;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
34 Palencia;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QII;261
34 Palencia;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
34 Palencia;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
34 Palencia;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
34 Palencia;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QII;244
34 Palencia;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
34 Palencia;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
34 Palencia;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
34 Palencia;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QII;219
34 Palencia;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
34 Palencia;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
34 Palencia;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
34 Palencia;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2022QII;236
34 Palencia;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2022QI;""
34 Palencia;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
34 Palencia;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
34 Palencia;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2021QII;231
34 Palencia;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2021QI;""
34 Palencia;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
34 Palencia;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
34 Palencia;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2020QII;215
34 Palencia;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2020QI;""
34 Palencia;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
34 Palencia;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2022QIII;221
34 Palencia;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2022QII;""
34 Palencia;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2022QI;""
34 Palencia;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
34 Palencia;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2021QIII;218
34 Palencia;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2021QII;""
34 Palencia;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2021QI;""
34 Palencia;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
34 Palencia;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2020QIII;210
34 Palencia;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2020QII;""
34 Palencia;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2020QI;""
34 Palencia;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QIV;211
34 Palencia;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
34 Palencia;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QII;""
34 Palencia;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QI;""
34 Palencia;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QIV;207
34 Palencia;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
34 Palencia;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QII;""
34 Palencia;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QI;""
34 Palencia;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QIV;203
34 Palencia;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
34 Palencia;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QII;""
34 Palencia;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QI;""
34 Palencia;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
34 Palencia;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
34 Palencia;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QII;""
34 Palencia;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QI;202
34 Palencia;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
34 Palencia;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
34 Palencia;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QII;""
34 Palencia;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QI;201
34 Palencia;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
34 Palencia;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
34 Palencia;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QII;""
34 Palencia;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QI;""
34 Palencia;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
34 Palencia;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
34 Palencia;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
34 Palencia;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
34 Palencia;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
34 Palencia;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
34 Palencia;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
34 Palencia;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
34 Palencia;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
34 Palencia;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
34 Palencia;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
34 Palencia;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
34 Palencia;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
34 Palencia;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
34 Palencia;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;90,42
34 Palencia;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
34 Palencia;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
34 Palencia;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
34 Palencia;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;94,67
34 Palencia;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
34 Palencia;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
34 Palencia;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
34 Palencia;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;98,17
34 Palencia;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
34 Palencia;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
34 Palencia;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;84,67
34 Palencia;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
34 Palencia;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
34 Palencia;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
34 Palencia;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;89,34
34 Palencia;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
34 Palencia;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
34 Palencia;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
34 Palencia;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;95,89
34 Palencia;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
34 Palencia;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
34 Palencia;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;80,84
34 Palencia;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
34 Palencia;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
34 Palencia;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
34 Palencia;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;84,84
34 Palencia;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
34 Palencia;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
34 Palencia;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
34 Palencia;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;92,69
34 Palencia;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
34 Palencia;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
34 Palencia;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
34 Palencia;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
34 Palencia;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
34 Palencia;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
34 Palencia;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;82,79
34 Palencia;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
34 Palencia;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
34 Palencia;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
34 Palencia;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;91,78
34 Palencia;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
34 Palencia;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
34 Palencia;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
34 Palencia;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
34 Palencia;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
34 Palencia;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
34 Palencia;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QII;138
34 Palencia;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
34 Palencia;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
34 Palencia;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
34 Palencia;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QII;142
34 Palencia;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
34 Palencia;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
34 Palencia;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
34 Palencia;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QII;130
34 Palencia;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
34 Palencia;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
34 Palencia;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
34 Palencia;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2022QII;124
34 Palencia;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2022QI;""
34 Palencia;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
34 Palencia;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
34 Palencia;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2021QII;128
34 Palencia;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2021QI;""
34 Palencia;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
34 Palencia;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
34 Palencia;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2020QII;127
34 Palencia;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2020QI;""
34 Palencia;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
34 Palencia;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2022QIII;114
34 Palencia;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2022QII;""
34 Palencia;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2022QI;""
34 Palencia;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
34 Palencia;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2021QIII;116
34 Palencia;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2021QII;""
34 Palencia;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2021QI;""
34 Palencia;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
34 Palencia;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2020QIII;120
34 Palencia;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2020QII;""
34 Palencia;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2020QI;""
34 Palencia;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QIV;106
34 Palencia;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
34 Palencia;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QII;""
34 Palencia;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QI;""
34 Palencia;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QIV;107
34 Palencia;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
34 Palencia;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QII;""
34 Palencia;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QI;""
34 Palencia;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QIV;115
34 Palencia;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
34 Palencia;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QII;""
34 Palencia;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QI;""
34 Palencia;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
34 Palencia;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
34 Palencia;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QII;""
34 Palencia;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QI;103
34 Palencia;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
34 Palencia;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
34 Palencia;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QII;""
34 Palencia;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QI;108
34 Palencia;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
34 Palencia;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
34 Palencia;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QII;""
34 Palencia;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QI;""
34 Palencia;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
34 Palencia;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
34 Palencia;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
34 Palencia;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
34 Palencia;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
34 Palencia;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
34 Palencia;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
34 Palencia;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
34 Palencia;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
34 Palencia;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
34 Palencia;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
34 Palencia;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
34 Palencia;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
34 Palencia;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
34 Palencia;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;89,86
34 Palencia;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
34 Palencia;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
34 Palencia;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
34 Palencia;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;90,14
34 Palencia;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
34 Palencia;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
34 Palencia;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
34 Palencia;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;97,69
34 Palencia;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
34 Palencia;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
34 Palencia;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;82,61
34 Palencia;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
34 Palencia;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
34 Palencia;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
34 Palencia;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;81,69
34 Palencia;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
34 Palencia;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
34 Palencia;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
34 Palencia;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;92,31
34 Palencia;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
34 Palencia;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
34 Palencia;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;76,81
34 Palencia;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
34 Palencia;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
34 Palencia;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
34 Palencia;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;75,35
34 Palencia;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
34 Palencia;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
34 Palencia;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
34 Palencia;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;88,46
34 Palencia;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
34 Palencia;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
34 Palencia;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
34 Palencia;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
34 Palencia;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
34 Palencia;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
34 Palencia;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;72,54
34 Palencia;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
34 Palencia;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
34 Palencia;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
34 Palencia;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;83,08
34 Palencia;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
34 Palencia;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
34 Palencia;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
34 Palencia;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
34 Palencia;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
34 Palencia;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QIII;419
34 Palencia;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
34 Palencia;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
34 Palencia;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
34 Palencia;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QIII;410
34 Palencia;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
34 Palencia;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
34 Palencia;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
34 Palencia;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QIII;371
34 Palencia;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
34 Palencia;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
34 Palencia;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
34 Palencia;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2022QIII;377
34 Palencia;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2022QII;""
34 Palencia;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2022QI;""
34 Palencia;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
34 Palencia;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2021QIII;374
34 Palencia;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2021QII;""
34 Palencia;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2021QI;""
34 Palencia;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
34 Palencia;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2020QIII;351
34 Palencia;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2020QII;""
34 Palencia;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2020QI;""
34 Palencia;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2022QIV;357
34 Palencia;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
34 Palencia;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2022QII;""
34 Palencia;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2022QI;""
34 Palencia;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2021QIV;351
34 Palencia;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
34 Palencia;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2021QII;""
34 Palencia;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2021QI;""
34 Palencia;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2020QIV;336
34 Palencia;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
34 Palencia;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2020QII;""
34 Palencia;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2020QI;""
34 Palencia;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
34 Palencia;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
34 Palencia;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QII;""
34 Palencia;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QI;340
34 Palencia;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
34 Palencia;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
34 Palencia;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QII;""
34 Palencia;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QI;326
34 Palencia;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
34 Palencia;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
34 Palencia;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QII;""
34 Palencia;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QI;""
34 Palencia;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
34 Palencia;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
34 Palencia;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QII;322
34 Palencia;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QI;""
34 Palencia;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
34 Palencia;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
34 Palencia;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QII;316
34 Palencia;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QI;""
34 Palencia;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
34 Palencia;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
34 Palencia;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QII;""
34 Palencia;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QI;""
34 Palencia;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
34 Palencia;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
34 Palencia;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
34 Palencia;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
34 Palencia;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
34 Palencia;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
34 Palencia;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
34 Palencia;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
34 Palencia;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
34 Palencia;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
34 Palencia;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
34 Palencia;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
34 Palencia;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
34 Palencia;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;89,98
34 Palencia;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
34 Palencia;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
34 Palencia;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
34 Palencia;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;91,22
34 Palencia;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
34 Palencia;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
34 Palencia;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
34 Palencia;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;94,61
34 Palencia;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
34 Palencia;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
34 Palencia;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;85,2
34 Palencia;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
34 Palencia;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
34 Palencia;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
34 Palencia;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;85,61
34 Palencia;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
34 Palencia;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
34 Palencia;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
34 Palencia;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;90,57
34 Palencia;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
34 Palencia;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
34 Palencia;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
34 Palencia;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
34 Palencia;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
34 Palencia;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
34 Palencia;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;82,93
34 Palencia;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
34 Palencia;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
34 Palencia;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
34 Palencia;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;87,87
34 Palencia;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
34 Palencia;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
34 Palencia;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
34 Palencia;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
34 Palencia;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
34 Palencia;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
34 Palencia;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;78,54
34 Palencia;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
34 Palencia;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
34 Palencia;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
34 Palencia;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;85,18
34 Palencia;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
34 Palencia;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
34 Palencia;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
34 Palencia;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
34 Palencia;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
34 Palencia;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
34 Palencia;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QIII;270
34 Palencia;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
34 Palencia;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
34 Palencia;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
34 Palencia;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QIII;262
34 Palencia;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
34 Palencia;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
34 Palencia;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
34 Palencia;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QIII;231
34 Palencia;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
34 Palencia;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
34 Palencia;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
34 Palencia;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2022QIII;245
34 Palencia;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2022QII;""
34 Palencia;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2022QI;""
34 Palencia;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
34 Palencia;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2021QIII;244
34 Palencia;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2021QII;""
34 Palencia;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2021QI;""
34 Palencia;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
34 Palencia;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2020QIII;220
34 Palencia;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2020QII;""
34 Palencia;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2020QI;""
34 Palencia;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2022QIV;233
34 Palencia;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
34 Palencia;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2022QII;""
34 Palencia;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2022QI;""
34 Palencia;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2021QIV;230
34 Palencia;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
34 Palencia;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2021QII;""
34 Palencia;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2021QI;""
34 Palencia;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2020QIV;213
34 Palencia;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
34 Palencia;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2020QII;""
34 Palencia;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2020QI;""
34 Palencia;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
34 Palencia;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
34 Palencia;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QII;""
34 Palencia;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QI;224
34 Palencia;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
34 Palencia;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
34 Palencia;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QII;""
34 Palencia;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QI;211
34 Palencia;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
34 Palencia;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
34 Palencia;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QII;""
34 Palencia;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QI;""
34 Palencia;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
34 Palencia;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
34 Palencia;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QII;213
34 Palencia;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QI;""
34 Palencia;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
34 Palencia;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
34 Palencia;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QII;206
34 Palencia;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QI;""
34 Palencia;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
34 Palencia;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
34 Palencia;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QII;""
34 Palencia;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QI;""
34 Palencia;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
34 Palencia;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
34 Palencia;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
34 Palencia;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
34 Palencia;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
34 Palencia;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
34 Palencia;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
34 Palencia;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
34 Palencia;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
34 Palencia;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
34 Palencia;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
34 Palencia;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
34 Palencia;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
34 Palencia;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;90,74
34 Palencia;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
34 Palencia;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
34 Palencia;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
34 Palencia;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;93,13
34 Palencia;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
34 Palencia;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
34 Palencia;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
34 Palencia;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;95,24
34 Palencia;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
34 Palencia;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
34 Palencia;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;86,3
34 Palencia;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
34 Palencia;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
34 Palencia;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
34 Palencia;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;87,79
34 Palencia;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
34 Palencia;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
34 Palencia;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
34 Palencia;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;92,21
34 Palencia;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
34 Palencia;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
34 Palencia;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
34 Palencia;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
34 Palencia;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
34 Palencia;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
34 Palencia;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;85,5
34 Palencia;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
34 Palencia;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
34 Palencia;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
34 Palencia;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;91,34
34 Palencia;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
34 Palencia;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
34 Palencia;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
34 Palencia;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
34 Palencia;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
34 Palencia;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
34 Palencia;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;81,3
34 Palencia;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
34 Palencia;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
34 Palencia;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
34 Palencia;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;89,18
34 Palencia;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
34 Palencia;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
34 Palencia;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
34 Palencia;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
34 Palencia;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
34 Palencia;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
34 Palencia;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QIII;149
34 Palencia;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
34 Palencia;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
34 Palencia;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
34 Palencia;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QIII;148
34 Palencia;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
34 Palencia;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
34 Palencia;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
34 Palencia;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QIII;140
34 Palencia;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
34 Palencia;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
34 Palencia;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
34 Palencia;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2022QIII;132
34 Palencia;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2022QII;""
34 Palencia;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2022QI;""
34 Palencia;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
34 Palencia;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2021QIII;130
34 Palencia;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2021QII;""
34 Palencia;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2021QI;""
34 Palencia;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
34 Palencia;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2020QIII;131
34 Palencia;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2020QII;""
34 Palencia;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2020QI;""
34 Palencia;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2022QIV;124
34 Palencia;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
34 Palencia;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2022QII;""
34 Palencia;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2022QI;""
34 Palencia;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2021QIV;121
34 Palencia;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
34 Palencia;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2021QII;""
34 Palencia;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2021QI;""
34 Palencia;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2020QIV;123
34 Palencia;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
34 Palencia;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2020QII;""
34 Palencia;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2020QI;""
34 Palencia;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
34 Palencia;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
34 Palencia;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QII;""
34 Palencia;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QI;116
34 Palencia;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
34 Palencia;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
34 Palencia;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QII;""
34 Palencia;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QI;115
34 Palencia;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
34 Palencia;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
34 Palencia;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QII;""
34 Palencia;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QI;""
34 Palencia;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
34 Palencia;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
34 Palencia;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QII;109
34 Palencia;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QI;""
34 Palencia;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
34 Palencia;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
34 Palencia;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QII;110
34 Palencia;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QI;""
34 Palencia;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
34 Palencia;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
34 Palencia;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QII;""
34 Palencia;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QI;""
34 Palencia;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
34 Palencia;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
34 Palencia;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
34 Palencia;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
34 Palencia;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
34 Palencia;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
34 Palencia;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
34 Palencia;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
34 Palencia;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
34 Palencia;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
34 Palencia;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
34 Palencia;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
34 Palencia;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
34 Palencia;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;88,59
34 Palencia;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
34 Palencia;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
34 Palencia;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
34 Palencia;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;87,84
34 Palencia;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
34 Palencia;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
34 Palencia;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
34 Palencia;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;93,57
34 Palencia;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
34 Palencia;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
34 Palencia;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;83,22
34 Palencia;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
34 Palencia;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
34 Palencia;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
34 Palencia;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;81,76
34 Palencia;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
34 Palencia;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
34 Palencia;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
34 Palencia;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;87,86
34 Palencia;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
34 Palencia;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
34 Palencia;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
34 Palencia;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
34 Palencia;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
34 Palencia;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
34 Palencia;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;78,38
34 Palencia;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
34 Palencia;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
34 Palencia;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
34 Palencia;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;82,14
34 Palencia;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
34 Palencia;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
34 Palencia;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
34 Palencia;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
34 Palencia;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
34 Palencia;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
34 Palencia;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;73,65
34 Palencia;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
34 Palencia;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
34 Palencia;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
34 Palencia;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;78,57
34 Palencia;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
34 Palencia;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
34 Palencia;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
34 Palencia;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
34 Palencia;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
34 Palencia;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QIV;416
34 Palencia;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
34 Palencia;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
34 Palencia;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
34 Palencia;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QIV;425
34 Palencia;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
34 Palencia;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
34 Palencia;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
34 Palencia;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QIV;407
34 Palencia;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
34 Palencia;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
34 Palencia;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
34 Palencia;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2022QIV;389
34 Palencia;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
34 Palencia;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2022QII;""
34 Palencia;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2022QI;""
34 Palencia;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2021QIV;398
34 Palencia;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
34 Palencia;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2021QII;""
34 Palencia;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2021QI;""
34 Palencia;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2020QIV;387
34 Palencia;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
34 Palencia;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2020QII;""
34 Palencia;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2020QI;""
34 Palencia;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
34 Palencia;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
34 Palencia;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2022QII;""
34 Palencia;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2022QI;383
34 Palencia;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
34 Palencia;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
34 Palencia;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2021QII;""
34 Palencia;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2021QI;376
34 Palencia;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
34 Palencia;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
34 Palencia;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2020QII;""
34 Palencia;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2020QI;""
34 Palencia;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
34 Palencia;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
34 Palencia;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QII;361
34 Palencia;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QI;""
34 Palencia;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
34 Palencia;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
34 Palencia;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QII;364
34 Palencia;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QI;""
34 Palencia;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
34 Palencia;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
34 Palencia;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QII;""
34 Palencia;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QI;""
34 Palencia;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
34 Palencia;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QIII;340
34 Palencia;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QII;""
34 Palencia;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QI;""
34 Palencia;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
34 Palencia;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QIII;345
34 Palencia;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QII;""
34 Palencia;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QI;""
34 Palencia;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
34 Palencia;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
34 Palencia;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QII;""
34 Palencia;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QI;""
34 Palencia;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
34 Palencia;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
34 Palencia;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
34 Palencia;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
34 Palencia;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
34 Palencia;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
34 Palencia;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
34 Palencia;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
34 Palencia;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
34 Palencia;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
34 Palencia;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
34 Palencia;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
34 Palencia;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;93,51
34 Palencia;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
34 Palencia;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
34 Palencia;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
34 Palencia;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;93,65
34 Palencia;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
34 Palencia;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
34 Palencia;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
34 Palencia;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;95,09
34 Palencia;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
34 Palencia;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
34 Palencia;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
34 Palencia;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
34 Palencia;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
34 Palencia;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
34 Palencia;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;90,12
34 Palencia;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
34 Palencia;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
34 Palencia;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
34 Palencia;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;92,38
34 Palencia;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
34 Palencia;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
34 Palencia;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
34 Palencia;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
34 Palencia;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
34 Palencia;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
34 Palencia;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;84,94
34 Palencia;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
34 Palencia;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
34 Palencia;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
34 Palencia;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;89,43
34 Palencia;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
34 Palencia;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
34 Palencia;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
34 Palencia;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
34 Palencia;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
34 Palencia;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
34 Palencia;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;80
34 Palencia;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
34 Palencia;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
34 Palencia;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
34 Palencia;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;84,77
34 Palencia;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
34 Palencia;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
34 Palencia;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
34 Palencia;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
34 Palencia;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
34 Palencia;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
34 Palencia;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QIV;271
34 Palencia;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
34 Palencia;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
34 Palencia;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
34 Palencia;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QIV;273
34 Palencia;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
34 Palencia;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
34 Palencia;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
34 Palencia;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QIV;258
34 Palencia;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
34 Palencia;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
34 Palencia;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
34 Palencia;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2022QIV;254
34 Palencia;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
34 Palencia;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2022QII;""
34 Palencia;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2022QI;""
34 Palencia;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2021QIV;258
34 Palencia;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
34 Palencia;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2021QII;""
34 Palencia;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2021QI;""
34 Palencia;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2020QIV;247
34 Palencia;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
34 Palencia;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2020QII;""
34 Palencia;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2020QI;""
34 Palencia;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
34 Palencia;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
34 Palencia;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2022QII;""
34 Palencia;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2022QI;251
34 Palencia;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
34 Palencia;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
34 Palencia;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2021QII;""
34 Palencia;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2021QI;244
34 Palencia;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
34 Palencia;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
34 Palencia;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2020QII;""
34 Palencia;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2020QI;""
34 Palencia;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
34 Palencia;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
34 Palencia;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QII;239
34 Palencia;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QI;""
34 Palencia;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
34 Palencia;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
34 Palencia;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QII;239
34 Palencia;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QI;""
34 Palencia;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
34 Palencia;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
34 Palencia;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QII;""
34 Palencia;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QI;""
34 Palencia;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
34 Palencia;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QIII;227
34 Palencia;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QII;""
34 Palencia;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QI;""
34 Palencia;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
34 Palencia;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QIII;228
34 Palencia;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QII;""
34 Palencia;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QI;""
34 Palencia;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
34 Palencia;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
34 Palencia;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QII;""
34 Palencia;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QI;""
34 Palencia;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
34 Palencia;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
34 Palencia;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
34 Palencia;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
34 Palencia;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
34 Palencia;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
34 Palencia;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
34 Palencia;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
34 Palencia;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
34 Palencia;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
34 Palencia;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
34 Palencia;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
34 Palencia;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;93,73
34 Palencia;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
34 Palencia;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
34 Palencia;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
34 Palencia;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;94,51
34 Palencia;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
34 Palencia;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
34 Palencia;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
34 Palencia;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;95,74
34 Palencia;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
34 Palencia;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
34 Palencia;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
34 Palencia;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
34 Palencia;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
34 Palencia;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
34 Palencia;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;91,94
34 Palencia;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
34 Palencia;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
34 Palencia;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
34 Palencia;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;94,57
34 Palencia;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
34 Palencia;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
34 Palencia;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
34 Palencia;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
34 Palencia;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
34 Palencia;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
34 Palencia;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;87,55
34 Palencia;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
34 Palencia;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
34 Palencia;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
34 Palencia;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;92,64
34 Palencia;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
34 Palencia;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
34 Palencia;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
34 Palencia;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
34 Palencia;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
34 Palencia;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
34 Palencia;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;83,15
34 Palencia;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
34 Palencia;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
34 Palencia;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
34 Palencia;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;88,37
34 Palencia;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
34 Palencia;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
34 Palencia;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
34 Palencia;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
34 Palencia;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
34 Palencia;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
34 Palencia;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QIV;145
34 Palencia;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
34 Palencia;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
34 Palencia;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
34 Palencia;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QIV;152
34 Palencia;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
34 Palencia;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
34 Palencia;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
34 Palencia;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QIV;149
34 Palencia;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
34 Palencia;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
34 Palencia;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
34 Palencia;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2022QIV;135
34 Palencia;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
34 Palencia;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2022QII;""
34 Palencia;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2022QI;""
34 Palencia;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2021QIV;140
34 Palencia;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
34 Palencia;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2021QII;""
34 Palencia;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2021QI;""
34 Palencia;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2020QIV;140
34 Palencia;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
34 Palencia;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2020QII;""
34 Palencia;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2020QI;""
34 Palencia;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
34 Palencia;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
34 Palencia;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2022QII;""
34 Palencia;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2022QI;132
34 Palencia;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
34 Palencia;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
34 Palencia;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2021QII;""
34 Palencia;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2021QI;132
34 Palencia;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
34 Palencia;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
34 Palencia;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2020QII;""
34 Palencia;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2020QI;""
34 Palencia;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
34 Palencia;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
34 Palencia;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QII;122
34 Palencia;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QI;""
34 Palencia;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
34 Palencia;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
34 Palencia;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QII;125
34 Palencia;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QI;""
34 Palencia;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
34 Palencia;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
34 Palencia;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QII;""
34 Palencia;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QI;""
34 Palencia;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
34 Palencia;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QIII;113
34 Palencia;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QII;""
34 Palencia;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QI;""
34 Palencia;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
34 Palencia;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QIII;117
34 Palencia;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QII;""
34 Palencia;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QI;""
34 Palencia;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
34 Palencia;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
34 Palencia;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QII;""
34 Palencia;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QI;""
34 Palencia;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
34 Palencia;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
34 Palencia;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
34 Palencia;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
34 Palencia;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
34 Palencia;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
34 Palencia;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
34 Palencia;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
34 Palencia;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
34 Palencia;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
34 Palencia;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
34 Palencia;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
34 Palencia;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;93,1
34 Palencia;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
34 Palencia;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
34 Palencia;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
34 Palencia;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;92,11
34 Palencia;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
34 Palencia;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
34 Palencia;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
34 Palencia;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;93,96
34 Palencia;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
34 Palencia;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
34 Palencia;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
34 Palencia;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
34 Palencia;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
34 Palencia;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
34 Palencia;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;86,84
34 Palencia;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
34 Palencia;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
34 Palencia;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
34 Palencia;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;88,59
34 Palencia;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
34 Palencia;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
34 Palencia;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
34 Palencia;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
34 Palencia;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
34 Palencia;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
34 Palencia;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;80,26
34 Palencia;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
34 Palencia;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
34 Palencia;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
34 Palencia;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;83,89
34 Palencia;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
34 Palencia;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
34 Palencia;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
34 Palencia;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
34 Palencia;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
34 Palencia;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
34 Palencia;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;74,34
34 Palencia;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
34 Palencia;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
34 Palencia;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
34 Palencia;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;78,52
34 Palencia;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
34 Palencia;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
34 Palencia;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
34 Palencia;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
34 Palencia;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
34 Palencia;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
34 Palencia;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
34 Palencia;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
34 Palencia;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
34 Palencia;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QI;1.509
34 Palencia;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
34 Palencia;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
34 Palencia;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
34 Palencia;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QI;1.529
34 Palencia;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
34 Palencia;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
34 Palencia;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
34 Palencia;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QI;1.491
34 Palencia;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
34 Palencia;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
34 Palencia;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2022QII;""
34 Palencia;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2022QI;1.465
34 Palencia;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
34 Palencia;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
34 Palencia;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2021QII;""
34 Palencia;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2021QI;1.490
34 Palencia;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
34 Palencia;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
34 Palencia;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2020QII;""
34 Palencia;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2020QI;1.428
34 Palencia;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
34 Palencia;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
34 Palencia;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2022QII;1.414
34 Palencia;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2022QI;""
34 Palencia;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
34 Palencia;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
34 Palencia;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2021QII;1.455
34 Palencia;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2021QI;""
34 Palencia;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
34 Palencia;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
34 Palencia;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2020QII;1.397
34 Palencia;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2020QI;""
34 Palencia;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
34 Palencia;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QIII;1.376
34 Palencia;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QII;""
34 Palencia;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QI;""
34 Palencia;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
34 Palencia;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QIII;1.420
34 Palencia;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QII;""
34 Palencia;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QI;""
34 Palencia;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
34 Palencia;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QIII;1.364
34 Palencia;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QII;""
34 Palencia;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QI;""
34 Palencia;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QIV;1.337
34 Palencia;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
34 Palencia;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QII;""
34 Palencia;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QI;""
34 Palencia;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QIV;1.391
34 Palencia;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
34 Palencia;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QII;""
34 Palencia;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QI;""
34 Palencia;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QIV;1.327
34 Palencia;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
34 Palencia;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QII;""
34 Palencia;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QI;""
34 Palencia;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
34 Palencia;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
34 Palencia;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
34 Palencia;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
34 Palencia;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
34 Palencia;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
34 Palencia;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
34 Palencia;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
34 Palencia;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
34 Palencia;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
34 Palencia;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
34 Palencia;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
34 Palencia;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
34 Palencia;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
34 Palencia;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
34 Palencia;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;97,08
34 Palencia;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
34 Palencia;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
34 Palencia;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
34 Palencia;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;97,45
34 Palencia;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
34 Palencia;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
34 Palencia;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
34 Palencia;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;95,77
34 Palencia;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
34 Palencia;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
34 Palencia;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;93,7
34 Palencia;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
34 Palencia;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
34 Palencia;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
34 Palencia;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;95,16
34 Palencia;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
34 Palencia;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
34 Palencia;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
34 Palencia;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;93,7
34 Palencia;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
34 Palencia;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
34 Palencia;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;91,19
34 Palencia;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
34 Palencia;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
34 Palencia;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
34 Palencia;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;92,87
34 Palencia;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
34 Palencia;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
34 Palencia;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
34 Palencia;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;91,48
34 Palencia;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
34 Palencia;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
34 Palencia;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;88,6
34 Palencia;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
34 Palencia;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
34 Palencia;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
34 Palencia;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;90,97
34 Palencia;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
34 Palencia;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
34 Palencia;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
34 Palencia;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;89
34 Palencia;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
34 Palencia;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
34 Palencia;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
34 Palencia;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
34 Palencia;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
34 Palencia;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
34 Palencia;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QI;902
34 Palencia;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
34 Palencia;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
34 Palencia;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
34 Palencia;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QI;925
34 Palencia;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
34 Palencia;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
34 Palencia;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
34 Palencia;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QI;894
34 Palencia;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
34 Palencia;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
34 Palencia;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2022QII;""
34 Palencia;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2022QI;878
34 Palencia;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
34 Palencia;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
34 Palencia;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2021QII;""
34 Palencia;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2021QI;904
34 Palencia;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
34 Palencia;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
34 Palencia;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2020QII;""
34 Palencia;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2020QI;855
34 Palencia;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
34 Palencia;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
34 Palencia;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2022QII;847
34 Palencia;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2022QI;""
34 Palencia;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
34 Palencia;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
34 Palencia;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2021QII;889
34 Palencia;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2021QI;""
34 Palencia;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
34 Palencia;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
34 Palencia;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2020QII;837
34 Palencia;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2020QI;""
34 Palencia;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
34 Palencia;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QIII;828
34 Palencia;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QII;""
34 Palencia;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QI;""
34 Palencia;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
34 Palencia;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QIII;870
34 Palencia;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QII;""
34 Palencia;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QI;""
34 Palencia;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
34 Palencia;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QIII;818
34 Palencia;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QII;""
34 Palencia;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QI;""
34 Palencia;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QIV;812
34 Palencia;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
34 Palencia;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QII;""
34 Palencia;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QI;""
34 Palencia;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QIV;854
34 Palencia;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
34 Palencia;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QII;""
34 Palencia;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QI;""
34 Palencia;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QIV;801
34 Palencia;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
34 Palencia;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QII;""
34 Palencia;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QI;""
34 Palencia;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
34 Palencia;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
34 Palencia;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
34 Palencia;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
34 Palencia;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
34 Palencia;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
34 Palencia;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
34 Palencia;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
34 Palencia;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
34 Palencia;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
34 Palencia;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
34 Palencia;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
34 Palencia;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
34 Palencia;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
34 Palencia;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
34 Palencia;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;97,34
34 Palencia;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
34 Palencia;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
34 Palencia;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
34 Palencia;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;97,73
34 Palencia;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
34 Palencia;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
34 Palencia;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
34 Palencia;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;95,64
34 Palencia;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
34 Palencia;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
34 Palencia;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;93,9
34 Palencia;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
34 Palencia;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
34 Palencia;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
34 Palencia;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;96,11
34 Palencia;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
34 Palencia;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
34 Palencia;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
34 Palencia;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;93,62
34 Palencia;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
34 Palencia;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
34 Palencia;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;91,8
34 Palencia;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
34 Palencia;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
34 Palencia;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
34 Palencia;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;94,05
34 Palencia;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
34 Palencia;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
34 Palencia;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
34 Palencia;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;91,5
34 Palencia;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
34 Palencia;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
34 Palencia;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;90,02
34 Palencia;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
34 Palencia;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
34 Palencia;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
34 Palencia;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;92,32
34 Palencia;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
34 Palencia;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
34 Palencia;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
34 Palencia;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;89,6
34 Palencia;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
34 Palencia;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
34 Palencia;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
34 Palencia;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
34 Palencia;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
34 Palencia;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
34 Palencia;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QI;607
34 Palencia;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
34 Palencia;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
34 Palencia;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
34 Palencia;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QI;604
34 Palencia;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
34 Palencia;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
34 Palencia;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
34 Palencia;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QI;597
34 Palencia;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
34 Palencia;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
34 Palencia;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2022QII;""
34 Palencia;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2022QI;587
34 Palencia;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
34 Palencia;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
34 Palencia;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2021QII;""
34 Palencia;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2021QI;586
34 Palencia;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
34 Palencia;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
34 Palencia;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2020QII;""
34 Palencia;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2020QI;573
34 Palencia;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
34 Palencia;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
34 Palencia;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2022QII;567
34 Palencia;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2022QI;""
34 Palencia;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
34 Palencia;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
34 Palencia;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2021QII;566
34 Palencia;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2021QI;""
34 Palencia;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
34 Palencia;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
34 Palencia;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2020QII;560
34 Palencia;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2020QI;""
34 Palencia;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
34 Palencia;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QIII;548
34 Palencia;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QII;""
34 Palencia;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QI;""
34 Palencia;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
34 Palencia;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QIII;550
34 Palencia;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QII;""
34 Palencia;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QI;""
34 Palencia;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
34 Palencia;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QIII;546
34 Palencia;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QII;""
34 Palencia;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QI;""
34 Palencia;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QIV;525
34 Palencia;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
34 Palencia;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QII;""
34 Palencia;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QI;""
34 Palencia;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QIV;537
34 Palencia;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
34 Palencia;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QII;""
34 Palencia;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QI;""
34 Palencia;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QIV;526
34 Palencia;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
34 Palencia;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QII;""
34 Palencia;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QI;""
34 Palencia;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
34 Palencia;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
34 Palencia;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
34 Palencia;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
34 Palencia;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
34 Palencia;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
34 Palencia;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
34 Palencia;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
34 Palencia;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
34 Palencia;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
34 Palencia;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
34 Palencia;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
34 Palencia;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
34 Palencia;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
34 Palencia;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
34 Palencia;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;96,71
34 Palencia;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
34 Palencia;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
34 Palencia;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
34 Palencia;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;97,02
34 Palencia;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
34 Palencia;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
34 Palencia;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
34 Palencia;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;95,98
34 Palencia;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
34 Palencia;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
34 Palencia;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;93,41
34 Palencia;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
34 Palencia;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
34 Palencia;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
34 Palencia;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;93,71
34 Palencia;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
34 Palencia;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
34 Palencia;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
34 Palencia;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;93,8
34 Palencia;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
34 Palencia;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
34 Palencia;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;90,28
34 Palencia;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
34 Palencia;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
34 Palencia;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
34 Palencia;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;91,06
34 Palencia;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
34 Palencia;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
34 Palencia;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
34 Palencia;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;91,46
34 Palencia;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
34 Palencia;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
34 Palencia;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;86,49
34 Palencia;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
34 Palencia;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
34 Palencia;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
34 Palencia;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;88,91
34 Palencia;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
34 Palencia;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
34 Palencia;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
34 Palencia;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;88,11
34 Palencia;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
34 Palencia;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
34 Palencia;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
34 Palencia;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
34 Palencia;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
34 Palencia;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QII;1.417
34 Palencia;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
34 Palencia;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
34 Palencia;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
34 Palencia;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QII;1.442
34 Palencia;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
34 Palencia;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
34 Palencia;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
34 Palencia;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QII;1.505
34 Palencia;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
34 Palencia;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
34 Palencia;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
34 Palencia;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2022QII;1.364
34 Palencia;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2022QI;""
34 Palencia;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
34 Palencia;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
34 Palencia;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2021QII;1.406
34 Palencia;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2021QI;""
34 Palencia;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
34 Palencia;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
34 Palencia;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2020QII;1.469
34 Palencia;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2020QI;""
34 Palencia;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
34 Palencia;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2022QIII;1.325
34 Palencia;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2022QII;""
34 Palencia;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2022QI;""
34 Palencia;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
34 Palencia;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2021QIII;1.366
34 Palencia;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2021QII;""
34 Palencia;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2021QI;""
34 Palencia;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
34 Palencia;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2020QIII;1.434
34 Palencia;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2020QII;""
34 Palencia;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2020QI;""
34 Palencia;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QIV;1.280
34 Palencia;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
34 Palencia;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QII;""
34 Palencia;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QI;""
34 Palencia;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QIV;1.332
34 Palencia;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
34 Palencia;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QII;""
34 Palencia;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QI;""
34 Palencia;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QIV;1.391
34 Palencia;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
34 Palencia;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QII;""
34 Palencia;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QI;""
34 Palencia;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
34 Palencia;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
34 Palencia;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QII;""
34 Palencia;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QI;1.298
34 Palencia;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
34 Palencia;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
34 Palencia;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QII;""
34 Palencia;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QI;1.360
34 Palencia;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
34 Palencia;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
34 Palencia;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QII;""
34 Palencia;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QI;""
34 Palencia;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
34 Palencia;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
34 Palencia;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
34 Palencia;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
34 Palencia;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
34 Palencia;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
34 Palencia;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
34 Palencia;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
34 Palencia;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
34 Palencia;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
34 Palencia;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
34 Palencia;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
34 Palencia;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
34 Palencia;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
34 Palencia;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;96,26
34 Palencia;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
34 Palencia;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
34 Palencia;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
34 Palencia;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;97,5
34 Palencia;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
34 Palencia;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
34 Palencia;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
34 Palencia;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;97,61
34 Palencia;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
34 Palencia;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
34 Palencia;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;93,51
34 Palencia;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
34 Palencia;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
34 Palencia;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
34 Palencia;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;94,73
34 Palencia;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
34 Palencia;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
34 Palencia;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
34 Palencia;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;95,28
34 Palencia;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
34 Palencia;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
34 Palencia;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;90,33
34 Palencia;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
34 Palencia;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
34 Palencia;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
34 Palencia;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;92,37
34 Palencia;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
34 Palencia;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
34 Palencia;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
34 Palencia;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;92,43
34 Palencia;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
34 Palencia;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
34 Palencia;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
34 Palencia;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
34 Palencia;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
34 Palencia;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
34 Palencia;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;90,01
34 Palencia;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
34 Palencia;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
34 Palencia;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
34 Palencia;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;90,37
34 Palencia;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
34 Palencia;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
34 Palencia;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
34 Palencia;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
34 Palencia;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
34 Palencia;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
34 Palencia;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QII;858
34 Palencia;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
34 Palencia;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
34 Palencia;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
34 Palencia;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QII;878
34 Palencia;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
34 Palencia;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
34 Palencia;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
34 Palencia;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QII;904
34 Palencia;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
34 Palencia;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
34 Palencia;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
34 Palencia;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2022QII;827
34 Palencia;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2022QI;""
34 Palencia;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
34 Palencia;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
34 Palencia;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2021QII;862
34 Palencia;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2021QI;""
34 Palencia;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
34 Palencia;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
34 Palencia;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2020QII;883
34 Palencia;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2020QI;""
34 Palencia;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
34 Palencia;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2022QIII;807
34 Palencia;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2022QII;""
34 Palencia;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2022QI;""
34 Palencia;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
34 Palencia;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2021QIII;840
34 Palencia;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2021QII;""
34 Palencia;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2021QI;""
34 Palencia;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
34 Palencia;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2020QIII;863
34 Palencia;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2020QII;""
34 Palencia;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2020QI;""
34 Palencia;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QIV;785
34 Palencia;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
34 Palencia;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QII;""
34 Palencia;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QI;""
34 Palencia;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QIV;820
34 Palencia;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
34 Palencia;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QII;""
34 Palencia;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QI;""
34 Palencia;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QIV;841
34 Palencia;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
34 Palencia;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QII;""
34 Palencia;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QI;""
34 Palencia;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
34 Palencia;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
34 Palencia;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QII;""
34 Palencia;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QI;799
34 Palencia;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
34 Palencia;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
34 Palencia;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QII;""
34 Palencia;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QI;825
34 Palencia;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
34 Palencia;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
34 Palencia;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QII;""
34 Palencia;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QI;""
34 Palencia;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
34 Palencia;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
34 Palencia;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
34 Palencia;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
34 Palencia;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
34 Palencia;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
34 Palencia;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
34 Palencia;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
34 Palencia;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
34 Palencia;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
34 Palencia;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
34 Palencia;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
34 Palencia;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
34 Palencia;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
34 Palencia;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;96,39
34 Palencia;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
34 Palencia;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
34 Palencia;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
34 Palencia;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;98,18
34 Palencia;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
34 Palencia;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
34 Palencia;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
34 Palencia;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;97,68
34 Palencia;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
34 Palencia;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
34 Palencia;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;94,06
34 Palencia;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
34 Palencia;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
34 Palencia;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
34 Palencia;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;95,67
34 Palencia;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
34 Palencia;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
34 Palencia;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
34 Palencia;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;95,46
34 Palencia;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
34 Palencia;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
34 Palencia;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;91,49
34 Palencia;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
34 Palencia;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
34 Palencia;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
34 Palencia;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;93,39
34 Palencia;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
34 Palencia;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
34 Palencia;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
34 Palencia;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;93,03
34 Palencia;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
34 Palencia;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
34 Palencia;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
34 Palencia;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
34 Palencia;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
34 Palencia;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
34 Palencia;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;91
34 Palencia;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
34 Palencia;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
34 Palencia;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
34 Palencia;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;91,26
34 Palencia;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
34 Palencia;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
34 Palencia;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
34 Palencia;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
34 Palencia;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
34 Palencia;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
34 Palencia;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QII;559
34 Palencia;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
34 Palencia;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
34 Palencia;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
34 Palencia;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QII;564
34 Palencia;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
34 Palencia;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
34 Palencia;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
34 Palencia;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QII;601
34 Palencia;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
34 Palencia;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
34 Palencia;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
34 Palencia;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2022QII;537
34 Palencia;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2022QI;""
34 Palencia;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
34 Palencia;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
34 Palencia;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2021QII;544
34 Palencia;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2021QI;""
34 Palencia;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
34 Palencia;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
34 Palencia;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2020QII;586
34 Palencia;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2020QI;""
34 Palencia;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
34 Palencia;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2022QIII;518
34 Palencia;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2022QII;""
34 Palencia;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2022QI;""
34 Palencia;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
34 Palencia;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2021QIII;526
34 Palencia;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2021QII;""
34 Palencia;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2021QI;""
34 Palencia;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
34 Palencia;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2020QIII;571
34 Palencia;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2020QII;""
34 Palencia;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2020QI;""
34 Palencia;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QIV;495
34 Palencia;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
34 Palencia;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QII;""
34 Palencia;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QI;""
34 Palencia;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QIV;512
34 Palencia;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
34 Palencia;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QII;""
34 Palencia;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QI;""
34 Palencia;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QIV;550
34 Palencia;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
34 Palencia;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QII;""
34 Palencia;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QI;""
34 Palencia;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
34 Palencia;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
34 Palencia;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QII;""
34 Palencia;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QI;499
34 Palencia;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
34 Palencia;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
34 Palencia;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QII;""
34 Palencia;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QI;535
34 Palencia;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
34 Palencia;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
34 Palencia;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QII;""
34 Palencia;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QI;""
34 Palencia;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
34 Palencia;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
34 Palencia;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
34 Palencia;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
34 Palencia;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
34 Palencia;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
34 Palencia;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
34 Palencia;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
34 Palencia;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
34 Palencia;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
34 Palencia;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
34 Palencia;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
34 Palencia;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
34 Palencia;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
34 Palencia;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;96,06
34 Palencia;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
34 Palencia;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
34 Palencia;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
34 Palencia;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;96,45
34 Palencia;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
34 Palencia;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
34 Palencia;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
34 Palencia;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;97,5
34 Palencia;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
34 Palencia;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
34 Palencia;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;92,67
34 Palencia;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
34 Palencia;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
34 Palencia;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
34 Palencia;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;93,26
34 Palencia;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
34 Palencia;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
34 Palencia;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
34 Palencia;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;95,01
34 Palencia;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
34 Palencia;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
34 Palencia;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;88,55
34 Palencia;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
34 Palencia;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
34 Palencia;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
34 Palencia;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;90,78
34 Palencia;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
34 Palencia;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
34 Palencia;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
34 Palencia;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;91,51
34 Palencia;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
34 Palencia;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
34 Palencia;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
34 Palencia;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
34 Palencia;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
34 Palencia;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
34 Palencia;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;88,48
34 Palencia;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
34 Palencia;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
34 Palencia;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
34 Palencia;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;89,02
34 Palencia;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
34 Palencia;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
34 Palencia;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
34 Palencia;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
34 Palencia;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
34 Palencia;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QIII;1.418
34 Palencia;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
34 Palencia;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
34 Palencia;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
34 Palencia;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QIII;1.482
34 Palencia;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
34 Palencia;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
34 Palencia;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
34 Palencia;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QIII;1.516
34 Palencia;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
34 Palencia;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
34 Palencia;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
34 Palencia;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2022QIII;1.367
34 Palencia;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2022QII;""
34 Palencia;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2022QI;""
34 Palencia;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
34 Palencia;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2021QIII;1.434
34 Palencia;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2021QII;""
34 Palencia;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2021QI;""
34 Palencia;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
34 Palencia;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2020QIII;1.476
34 Palencia;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2020QII;""
34 Palencia;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2020QI;""
34 Palencia;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2022QIV;1.316
34 Palencia;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
34 Palencia;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2022QII;""
34 Palencia;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2022QI;""
34 Palencia;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2021QIV;1.393
34 Palencia;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
34 Palencia;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2021QII;""
34 Palencia;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2021QI;""
34 Palencia;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2020QIV;1.429
34 Palencia;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
34 Palencia;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2020QII;""
34 Palencia;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2020QI;""
34 Palencia;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
34 Palencia;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
34 Palencia;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QII;""
34 Palencia;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QI;1.353
34 Palencia;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
34 Palencia;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
34 Palencia;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QII;""
34 Palencia;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QI;1.397
34 Palencia;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
34 Palencia;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
34 Palencia;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QII;""
34 Palencia;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QI;""
34 Palencia;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
34 Palencia;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
34 Palencia;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QII;1.311
34 Palencia;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QI;""
34 Palencia;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
34 Palencia;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
34 Palencia;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QII;1.370
34 Palencia;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QI;""
34 Palencia;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
34 Palencia;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
34 Palencia;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QII;""
34 Palencia;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QI;""
34 Palencia;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
34 Palencia;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
34 Palencia;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
34 Palencia;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
34 Palencia;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
34 Palencia;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
34 Palencia;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
34 Palencia;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
34 Palencia;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
34 Palencia;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
34 Palencia;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
34 Palencia;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
34 Palencia;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
34 Palencia;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;96,4
34 Palencia;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
34 Palencia;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
34 Palencia;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
34 Palencia;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;96,76
34 Palencia;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
34 Palencia;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
34 Palencia;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
34 Palencia;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;97,36
34 Palencia;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
34 Palencia;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
34 Palencia;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;92,81
34 Palencia;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
34 Palencia;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
34 Palencia;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
34 Palencia;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;93,99
34 Palencia;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
34 Palencia;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
34 Palencia;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
34 Palencia;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;94,26
34 Palencia;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
34 Palencia;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
34 Palencia;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
34 Palencia;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
34 Palencia;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
34 Palencia;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
34 Palencia;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;91,3
34 Palencia;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
34 Palencia;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
34 Palencia;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
34 Palencia;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;92,15
34 Palencia;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
34 Palencia;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
34 Palencia;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
34 Palencia;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
34 Palencia;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
34 Palencia;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
34 Palencia;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;88,46
34 Palencia;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
34 Palencia;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
34 Palencia;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
34 Palencia;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;90,37
34 Palencia;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
34 Palencia;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
34 Palencia;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
34 Palencia;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
34 Palencia;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
34 Palencia;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
34 Palencia;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QIII;857
34 Palencia;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
34 Palencia;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
34 Palencia;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
34 Palencia;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QIII;901
34 Palencia;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
34 Palencia;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
34 Palencia;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
34 Palencia;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QIII;914
34 Palencia;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
34 Palencia;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
34 Palencia;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
34 Palencia;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2022QIII;831
34 Palencia;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2022QII;""
34 Palencia;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2022QI;""
34 Palencia;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
34 Palencia;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2021QIII;874
34 Palencia;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2021QII;""
34 Palencia;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2021QI;""
34 Palencia;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
34 Palencia;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2020QIII;891
34 Palencia;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2020QII;""
34 Palencia;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2020QI;""
34 Palencia;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2022QIV;805
34 Palencia;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
34 Palencia;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2022QII;""
34 Palencia;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2022QI;""
34 Palencia;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2021QIV;850
34 Palencia;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
34 Palencia;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2021QII;""
34 Palencia;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2021QI;""
34 Palencia;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2020QIV;867
34 Palencia;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
34 Palencia;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2020QII;""
34 Palencia;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2020QI;""
34 Palencia;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
34 Palencia;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
34 Palencia;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QII;""
34 Palencia;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QI;828
34 Palencia;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
34 Palencia;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
34 Palencia;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QII;""
34 Palencia;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QI;850
34 Palencia;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
34 Palencia;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
34 Palencia;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QII;""
34 Palencia;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QI;""
34 Palencia;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
34 Palencia;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
34 Palencia;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QII;800
34 Palencia;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QI;""
34 Palencia;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
34 Palencia;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
34 Palencia;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QII;839
34 Palencia;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QI;""
34 Palencia;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
34 Palencia;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
34 Palencia;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QII;""
34 Palencia;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QI;""
34 Palencia;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
34 Palencia;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
34 Palencia;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
34 Palencia;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
34 Palencia;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
34 Palencia;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
34 Palencia;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
34 Palencia;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
34 Palencia;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
34 Palencia;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
34 Palencia;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
34 Palencia;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
34 Palencia;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
34 Palencia;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;96,97
34 Palencia;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
34 Palencia;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
34 Palencia;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
34 Palencia;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;97
34 Palencia;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
34 Palencia;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
34 Palencia;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
34 Palencia;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;97,48
34 Palencia;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
34 Palencia;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
34 Palencia;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;93,93
34 Palencia;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
34 Palencia;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
34 Palencia;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
34 Palencia;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;94,34
34 Palencia;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
34 Palencia;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
34 Palencia;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
34 Palencia;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;94,86
34 Palencia;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
34 Palencia;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
34 Palencia;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
34 Palencia;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
34 Palencia;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
34 Palencia;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
34 Palencia;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;91,9
34 Palencia;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
34 Palencia;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
34 Palencia;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
34 Palencia;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;93
34 Palencia;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
34 Palencia;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
34 Palencia;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
34 Palencia;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
34 Palencia;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
34 Palencia;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
34 Palencia;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;88,79
34 Palencia;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
34 Palencia;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
34 Palencia;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
34 Palencia;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;91,79
34 Palencia;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
34 Palencia;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
34 Palencia;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
34 Palencia;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
34 Palencia;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
34 Palencia;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
34 Palencia;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QIII;561
34 Palencia;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
34 Palencia;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
34 Palencia;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
34 Palencia;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QIII;581
34 Palencia;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
34 Palencia;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
34 Palencia;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
34 Palencia;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QIII;602
34 Palencia;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
34 Palencia;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
34 Palencia;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
34 Palencia;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2022QIII;536
34 Palencia;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2022QII;""
34 Palencia;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2022QI;""
34 Palencia;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
34 Palencia;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2021QIII;560
34 Palencia;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2021QII;""
34 Palencia;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2021QI;""
34 Palencia;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
34 Palencia;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2020QIII;585
34 Palencia;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2020QII;""
34 Palencia;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2020QI;""
34 Palencia;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2022QIV;511
34 Palencia;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
34 Palencia;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2022QII;""
34 Palencia;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2022QI;""
34 Palencia;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2021QIV;543
34 Palencia;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
34 Palencia;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2021QII;""
34 Palencia;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2021QI;""
34 Palencia;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2020QIV;562
34 Palencia;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
34 Palencia;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2020QII;""
34 Palencia;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2020QI;""
34 Palencia;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
34 Palencia;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
34 Palencia;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QII;""
34 Palencia;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QI;525
34 Palencia;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
34 Palencia;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
34 Palencia;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QII;""
34 Palencia;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QI;547
34 Palencia;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
34 Palencia;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
34 Palencia;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QII;""
34 Palencia;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QI;""
34 Palencia;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
34 Palencia;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
34 Palencia;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QII;511
34 Palencia;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QI;""
34 Palencia;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
34 Palencia;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
34 Palencia;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QII;531
34 Palencia;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QI;""
34 Palencia;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
34 Palencia;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
34 Palencia;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QII;""
34 Palencia;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QI;""
34 Palencia;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
34 Palencia;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
34 Palencia;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
34 Palencia;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
34 Palencia;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
34 Palencia;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
34 Palencia;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
34 Palencia;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
34 Palencia;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
34 Palencia;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
34 Palencia;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
34 Palencia;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
34 Palencia;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
34 Palencia;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;95,54
34 Palencia;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
34 Palencia;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
34 Palencia;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
34 Palencia;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;96,39
34 Palencia;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
34 Palencia;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
34 Palencia;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
34 Palencia;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;97,18
34 Palencia;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
34 Palencia;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
34 Palencia;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;91,09
34 Palencia;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
34 Palencia;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
34 Palencia;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
34 Palencia;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;93,46
34 Palencia;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
34 Palencia;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
34 Palencia;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
34 Palencia;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;93,36
34 Palencia;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
34 Palencia;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
34 Palencia;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
34 Palencia;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
34 Palencia;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
34 Palencia;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
34 Palencia;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;90,36
34 Palencia;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
34 Palencia;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
34 Palencia;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
34 Palencia;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;90,86
34 Palencia;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
34 Palencia;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
34 Palencia;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
34 Palencia;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
34 Palencia;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
34 Palencia;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
34 Palencia;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;87,95
34 Palencia;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
34 Palencia;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
34 Palencia;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
34 Palencia;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;88,21
34 Palencia;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
34 Palencia;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
34 Palencia;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
34 Palencia;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
34 Palencia;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
34 Palencia;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QIV;1.424
34 Palencia;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
34 Palencia;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
34 Palencia;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
34 Palencia;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QIV;1.494
34 Palencia;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
34 Palencia;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
34 Palencia;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
34 Palencia;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QIV;1.530
34 Palencia;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
34 Palencia;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
34 Palencia;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
34 Palencia;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2022QIV;1.370
34 Palencia;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
34 Palencia;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2022QII;""
34 Palencia;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2022QI;""
34 Palencia;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2021QIV;1.448
34 Palencia;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
34 Palencia;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2021QII;""
34 Palencia;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2021QI;""
34 Palencia;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2020QIV;1.477
34 Palencia;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
34 Palencia;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2020QII;""
34 Palencia;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2020QI;""
34 Palencia;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
34 Palencia;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
34 Palencia;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2022QII;""
34 Palencia;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2022QI;1.407
34 Palencia;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
34 Palencia;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
34 Palencia;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2021QII;""
34 Palencia;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2021QI;1.443
34 Palencia;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
34 Palencia;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
34 Palencia;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2020QII;""
34 Palencia;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2020QI;""
34 Palencia;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
34 Palencia;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
34 Palencia;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QII;1.363
34 Palencia;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QI;""
34 Palencia;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
34 Palencia;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
34 Palencia;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QII;1.412
34 Palencia;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QI;""
34 Palencia;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
34 Palencia;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
34 Palencia;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QII;""
34 Palencia;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QI;""
34 Palencia;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
34 Palencia;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QIII;1.326
34 Palencia;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QII;""
34 Palencia;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QI;""
34 Palencia;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
34 Palencia;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QIII;1.380
34 Palencia;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QII;""
34 Palencia;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QI;""
34 Palencia;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
34 Palencia;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
34 Palencia;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QII;""
34 Palencia;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QI;""
34 Palencia;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
34 Palencia;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
34 Palencia;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
34 Palencia;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
34 Palencia;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
34 Palencia;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
34 Palencia;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
34 Palencia;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
34 Palencia;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
34 Palencia;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
34 Palencia;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
34 Palencia;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
34 Palencia;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;96,21
34 Palencia;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
34 Palencia;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
34 Palencia;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
34 Palencia;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;96,92
34 Palencia;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
34 Palencia;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
34 Palencia;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
34 Palencia;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;96,54
34 Palencia;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
34 Palencia;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
34 Palencia;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
34 Palencia;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
34 Palencia;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
34 Palencia;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
34 Palencia;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;94,18
34 Palencia;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
34 Palencia;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
34 Palencia;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
34 Palencia;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;94,31
34 Palencia;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
34 Palencia;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
34 Palencia;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
34 Palencia;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
34 Palencia;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
34 Palencia;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
34 Palencia;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;91,23
34 Palencia;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
34 Palencia;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
34 Palencia;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
34 Palencia;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;92,29
34 Palencia;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
34 Palencia;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
34 Palencia;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
34 Palencia;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
34 Palencia;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
34 Palencia;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
34 Palencia;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;88,76
34 Palencia;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
34 Palencia;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
34 Palencia;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
34 Palencia;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;90,2
34 Palencia;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
34 Palencia;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
34 Palencia;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
34 Palencia;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
34 Palencia;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
34 Palencia;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
34 Palencia;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QIV;856
34 Palencia;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
34 Palencia;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
34 Palencia;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
34 Palencia;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QIV;904
34 Palencia;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
34 Palencia;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
34 Palencia;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
34 Palencia;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QIV;925
34 Palencia;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
34 Palencia;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
34 Palencia;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
34 Palencia;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2022QIV;830
34 Palencia;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
34 Palencia;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2022QII;""
34 Palencia;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2022QI;""
34 Palencia;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2021QIV;877
34 Palencia;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
34 Palencia;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2021QII;""
34 Palencia;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2021QI;""
34 Palencia;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2020QIV;898
34 Palencia;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
34 Palencia;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2020QII;""
34 Palencia;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2020QI;""
34 Palencia;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
34 Palencia;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
34 Palencia;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2022QII;""
34 Palencia;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2022QI;855
34 Palencia;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
34 Palencia;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
34 Palencia;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2021QII;""
34 Palencia;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2021QI;881
34 Palencia;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
34 Palencia;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
34 Palencia;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2020QII;""
34 Palencia;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2020QI;""
34 Palencia;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
34 Palencia;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
34 Palencia;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QII;825
34 Palencia;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QI;""
34 Palencia;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
34 Palencia;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
34 Palencia;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QII;867
34 Palencia;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QI;""
34 Palencia;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
34 Palencia;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
34 Palencia;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QII;""
34 Palencia;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QI;""
34 Palencia;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
34 Palencia;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QIII;807
34 Palencia;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QII;""
34 Palencia;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QI;""
34 Palencia;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
34 Palencia;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QIII;850
34 Palencia;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QII;""
34 Palencia;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QI;""
34 Palencia;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
34 Palencia;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
34 Palencia;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QII;""
34 Palencia;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QI;""
34 Palencia;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
34 Palencia;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
34 Palencia;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
34 Palencia;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
34 Palencia;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
34 Palencia;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
34 Palencia;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
34 Palencia;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
34 Palencia;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
34 Palencia;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
34 Palencia;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
34 Palencia;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
34 Palencia;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;96,96
34 Palencia;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
34 Palencia;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
34 Palencia;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
34 Palencia;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;97,01
34 Palencia;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
34 Palencia;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
34 Palencia;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
34 Palencia;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;97,08
34 Palencia;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
34 Palencia;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
34 Palencia;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
34 Palencia;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
34 Palencia;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
34 Palencia;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
34 Palencia;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;94,58
34 Palencia;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
34 Palencia;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
34 Palencia;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
34 Palencia;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;95,24
34 Palencia;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
34 Palencia;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
34 Palencia;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
34 Palencia;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
34 Palencia;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
34 Palencia;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
34 Palencia;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;91,26
34 Palencia;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
34 Palencia;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
34 Palencia;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
34 Palencia;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;93,73
34 Palencia;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
34 Palencia;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
34 Palencia;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
34 Palencia;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
34 Palencia;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
34 Palencia;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
34 Palencia;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;89,27
34 Palencia;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
34 Palencia;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
34 Palencia;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
34 Palencia;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;91,89
34 Palencia;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
34 Palencia;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
34 Palencia;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
34 Palencia;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
34 Palencia;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
34 Palencia;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
34 Palencia;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QIV;568
34 Palencia;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
34 Palencia;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
34 Palencia;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
34 Palencia;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QIV;590
34 Palencia;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
34 Palencia;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
34 Palencia;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
34 Palencia;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QIV;605
34 Palencia;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
34 Palencia;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
34 Palencia;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
34 Palencia;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2022QIV;540
34 Palencia;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
34 Palencia;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2022QII;""
34 Palencia;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2022QI;""
34 Palencia;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2021QIV;571
34 Palencia;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
34 Palencia;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2021QII;""
34 Palencia;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2021QI;""
34 Palencia;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2020QIV;579
34 Palencia;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
34 Palencia;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2020QII;""
34 Palencia;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2020QI;""
34 Palencia;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
34 Palencia;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
34 Palencia;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2022QII;""
34 Palencia;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2022QI;552
34 Palencia;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
34 Palencia;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
34 Palencia;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2021QII;""
34 Palencia;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2021QI;562
34 Palencia;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
34 Palencia;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
34 Palencia;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2020QII;""
34 Palencia;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2020QI;""
34 Palencia;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
34 Palencia;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
34 Palencia;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QII;538
34 Palencia;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QI;""
34 Palencia;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
34 Palencia;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
34 Palencia;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QII;545
34 Palencia;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QI;""
34 Palencia;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
34 Palencia;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
34 Palencia;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QII;""
34 Palencia;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QI;""
34 Palencia;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
34 Palencia;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QIII;519
34 Palencia;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QII;""
34 Palencia;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QI;""
34 Palencia;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
34 Palencia;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QIII;530
34 Palencia;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QII;""
34 Palencia;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QI;""
34 Palencia;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
34 Palencia;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
34 Palencia;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QII;""
34 Palencia;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QI;""
34 Palencia;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
34 Palencia;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
34 Palencia;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
34 Palencia;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
34 Palencia;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
34 Palencia;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
34 Palencia;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
34 Palencia;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
34 Palencia;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
34 Palencia;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
34 Palencia;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
34 Palencia;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
34 Palencia;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;95,07
34 Palencia;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
34 Palencia;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
34 Palencia;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
34 Palencia;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;96,78
34 Palencia;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
34 Palencia;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
34 Palencia;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
34 Palencia;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;95,7
34 Palencia;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
34 Palencia;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
34 Palencia;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
34 Palencia;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
34 Palencia;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
34 Palencia;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
34 Palencia;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;93,56
34 Palencia;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
34 Palencia;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
34 Palencia;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
34 Palencia;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;92,89
34 Palencia;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
34 Palencia;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
34 Palencia;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
34 Palencia;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
34 Palencia;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
34 Palencia;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
34 Palencia;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;91,19
34 Palencia;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
34 Palencia;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
34 Palencia;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
34 Palencia;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;90,08
34 Palencia;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
34 Palencia;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
34 Palencia;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
34 Palencia;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
34 Palencia;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
34 Palencia;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
34 Palencia;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;87,97
34 Palencia;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
34 Palencia;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
34 Palencia;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
34 Palencia;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;87,6
34 Palencia;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
34 Palencia;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
34 Palencia;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
34 Palencia;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
34 Palencia;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
34 Palencia;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
34 Palencia;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
34 Palencia;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
34 Palencia;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
34 Palencia;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QI;2.527
34 Palencia;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
34 Palencia;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
34 Palencia;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
34 Palencia;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QI;2.595
34 Palencia;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
34 Palencia;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
34 Palencia;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
34 Palencia;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QI;2.573
34 Palencia;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
34 Palencia;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
34 Palencia;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2022QII;""
34 Palencia;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2022QI;2.483
34 Palencia;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
34 Palencia;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
34 Palencia;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2021QII;""
34 Palencia;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2021QI;2.553
34 Palencia;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
34 Palencia;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
34 Palencia;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2020QII;""
34 Palencia;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2020QI;2.471
34 Palencia;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
34 Palencia;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
34 Palencia;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2022QII;2.434
34 Palencia;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2022QI;""
34 Palencia;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
34 Palencia;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
34 Palencia;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2021QII;2.514
34 Palencia;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2021QI;""
34 Palencia;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
34 Palencia;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
34 Palencia;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2020QII;2.447
34 Palencia;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2020QI;""
34 Palencia;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
34 Palencia;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QIII;2.405
34 Palencia;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QII;""
34 Palencia;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QI;""
34 Palencia;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
34 Palencia;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QIII;2.479
34 Palencia;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QII;""
34 Palencia;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QI;""
34 Palencia;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
34 Palencia;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QIII;2.415
34 Palencia;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QII;""
34 Palencia;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QI;""
34 Palencia;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QIV;2.361
34 Palencia;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
34 Palencia;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QII;""
34 Palencia;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QI;""
34 Palencia;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QIV;2.441
34 Palencia;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
34 Palencia;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QII;""
34 Palencia;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QI;""
34 Palencia;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QIV;2.378
34 Palencia;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
34 Palencia;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QII;""
34 Palencia;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QI;""
34 Palencia;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
34 Palencia;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
34 Palencia;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
34 Palencia;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
34 Palencia;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
34 Palencia;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
34 Palencia;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
34 Palencia;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
34 Palencia;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
34 Palencia;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
34 Palencia;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
34 Palencia;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
34 Palencia;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
34 Palencia;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
34 Palencia;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
34 Palencia;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;98,26
34 Palencia;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
34 Palencia;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
34 Palencia;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
34 Palencia;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;98,38
34 Palencia;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
34 Palencia;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
34 Palencia;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
34 Palencia;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;96,04
34 Palencia;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
34 Palencia;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
34 Palencia;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;96,32
34 Palencia;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
34 Palencia;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
34 Palencia;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
34 Palencia;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;96,88
34 Palencia;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
34 Palencia;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
34 Palencia;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
34 Palencia;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;95,1
34 Palencia;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
34 Palencia;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
34 Palencia;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;95,17
34 Palencia;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
34 Palencia;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
34 Palencia;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
34 Palencia;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;95,53
34 Palencia;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
34 Palencia;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
34 Palencia;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
34 Palencia;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;93,86
34 Palencia;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
34 Palencia;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
34 Palencia;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;93,43
34 Palencia;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
34 Palencia;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
34 Palencia;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
34 Palencia;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;94,07
34 Palencia;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
34 Palencia;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
34 Palencia;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
34 Palencia;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;92,42
34 Palencia;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
34 Palencia;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
34 Palencia;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
34 Palencia;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
34 Palencia;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
34 Palencia;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
34 Palencia;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QI;1.547
34 Palencia;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
34 Palencia;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
34 Palencia;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
34 Palencia;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QI;1.604
34 Palencia;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
34 Palencia;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
34 Palencia;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
34 Palencia;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QI;1.597
34 Palencia;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
34 Palencia;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
34 Palencia;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2022QII;""
34 Palencia;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2022QI;1.516
34 Palencia;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
34 Palencia;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
34 Palencia;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2021QII;""
34 Palencia;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2021QI;1.577
34 Palencia;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
34 Palencia;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
34 Palencia;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2020QII;""
34 Palencia;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2020QI;1.540
34 Palencia;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
34 Palencia;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
34 Palencia;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2022QII;1.489
34 Palencia;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2022QI;""
34 Palencia;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
34 Palencia;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
34 Palencia;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2021QII;1.555
34 Palencia;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2021QI;""
34 Palencia;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
34 Palencia;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
34 Palencia;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2020QII;1.531
34 Palencia;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2020QI;""
34 Palencia;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
34 Palencia;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QIII;1.473
34 Palencia;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QII;""
34 Palencia;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QI;""
34 Palencia;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
34 Palencia;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QIII;1.534
34 Palencia;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QII;""
34 Palencia;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QI;""
34 Palencia;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
34 Palencia;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QIII;1.514
34 Palencia;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QII;""
34 Palencia;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QI;""
34 Palencia;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QIV;1.454
34 Palencia;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
34 Palencia;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QII;""
34 Palencia;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QI;""
34 Palencia;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QIV;1.508
34 Palencia;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
34 Palencia;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QII;""
34 Palencia;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QI;""
34 Palencia;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QIV;1.492
34 Palencia;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
34 Palencia;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QII;""
34 Palencia;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QI;""
34 Palencia;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
34 Palencia;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
34 Palencia;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
34 Palencia;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
34 Palencia;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
34 Palencia;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
34 Palencia;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
34 Palencia;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
34 Palencia;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
34 Palencia;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
34 Palencia;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
34 Palencia;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
34 Palencia;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
34 Palencia;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
34 Palencia;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
34 Palencia;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;98
34 Palencia;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
34 Palencia;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
34 Palencia;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
34 Palencia;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;98,32
34 Palencia;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
34 Palencia;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
34 Palencia;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
34 Palencia;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;96,43
34 Palencia;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
34 Palencia;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
34 Palencia;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;96,25
34 Palencia;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
34 Palencia;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
34 Palencia;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
34 Palencia;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;96,95
34 Palencia;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
34 Palencia;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
34 Palencia;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
34 Palencia;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;95,87
34 Palencia;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
34 Palencia;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
34 Palencia;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;95,22
34 Palencia;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
34 Palencia;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
34 Palencia;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
34 Palencia;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;95,64
34 Palencia;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
34 Palencia;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
34 Palencia;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
34 Palencia;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;94,8
34 Palencia;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
34 Palencia;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
34 Palencia;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;93,99
34 Palencia;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
34 Palencia;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
34 Palencia;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
34 Palencia;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;94,01
34 Palencia;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
34 Palencia;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
34 Palencia;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
34 Palencia;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;93,43
34 Palencia;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
34 Palencia;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
34 Palencia;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
34 Palencia;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
34 Palencia;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
34 Palencia;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
34 Palencia;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QI;980
34 Palencia;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
34 Palencia;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
34 Palencia;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
34 Palencia;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QI;991
34 Palencia;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
34 Palencia;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
34 Palencia;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
34 Palencia;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QI;976
34 Palencia;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
34 Palencia;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
34 Palencia;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2022QII;""
34 Palencia;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2022QI;967
34 Palencia;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
34 Palencia;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
34 Palencia;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2021QII;""
34 Palencia;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2021QI;976
34 Palencia;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
34 Palencia;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
34 Palencia;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2020QII;""
34 Palencia;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2020QI;931
34 Palencia;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
34 Palencia;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
34 Palencia;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2022QII;945
34 Palencia;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2022QI;""
34 Palencia;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
34 Palencia;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
34 Palencia;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2021QII;959
34 Palencia;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2021QI;""
34 Palencia;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
34 Palencia;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
34 Palencia;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2020QII;916
34 Palencia;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2020QI;""
34 Palencia;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
34 Palencia;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QIII;932
34 Palencia;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QII;""
34 Palencia;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QI;""
34 Palencia;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
34 Palencia;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QIII;945
34 Palencia;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QII;""
34 Palencia;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QI;""
34 Palencia;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
34 Palencia;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QIII;901
34 Palencia;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QII;""
34 Palencia;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QI;""
34 Palencia;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QIV;907
34 Palencia;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
34 Palencia;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QII;""
34 Palencia;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QI;""
34 Palencia;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QIV;933
34 Palencia;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
34 Palencia;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QII;""
34 Palencia;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QI;""
34 Palencia;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QIV;886
34 Palencia;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
34 Palencia;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QII;""
34 Palencia;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QI;""
34 Palencia;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
34 Palencia;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
34 Palencia;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
34 Palencia;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
34 Palencia;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
34 Palencia;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
34 Palencia;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
34 Palencia;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
34 Palencia;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
34 Palencia;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
34 Palencia;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
34 Palencia;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
34 Palencia;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
34 Palencia;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
34 Palencia;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
34 Palencia;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;98,67
34 Palencia;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
34 Palencia;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
34 Palencia;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
34 Palencia;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;98,49
34 Palencia;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
34 Palencia;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
34 Palencia;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
34 Palencia;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;95,39
34 Palencia;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
34 Palencia;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
34 Palencia;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;96,43
34 Palencia;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
34 Palencia;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
34 Palencia;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
34 Palencia;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;96,77
34 Palencia;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
34 Palencia;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
34 Palencia;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
34 Palencia;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;93,85
34 Palencia;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
34 Palencia;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
34 Palencia;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;95,1
34 Palencia;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
34 Palencia;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
34 Palencia;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
34 Palencia;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;95,36
34 Palencia;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
34 Palencia;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
34 Palencia;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
34 Palencia;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;92,32
34 Palencia;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
34 Palencia;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
34 Palencia;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;92,55
34 Palencia;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
34 Palencia;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
34 Palencia;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
34 Palencia;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;94,15
34 Palencia;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
34 Palencia;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
34 Palencia;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
34 Palencia;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;90,78
34 Palencia;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
34 Palencia;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
34 Palencia;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
34 Palencia;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
34 Palencia;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
34 Palencia;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QII;2.449
34 Palencia;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
34 Palencia;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
34 Palencia;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
34 Palencia;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QII;2.502
34 Palencia;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
34 Palencia;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
34 Palencia;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
34 Palencia;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QII;2.546
34 Palencia;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
34 Palencia;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
34 Palencia;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
34 Palencia;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2022QII;2.395
34 Palencia;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2022QI;""
34 Palencia;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
34 Palencia;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
34 Palencia;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2021QII;2.460
34 Palencia;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2021QI;""
34 Palencia;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
34 Palencia;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
34 Palencia;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2020QII;2.517
34 Palencia;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2020QI;""
34 Palencia;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
34 Palencia;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2022QIII;2.364
34 Palencia;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2022QII;""
34 Palencia;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2022QI;""
34 Palencia;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
34 Palencia;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2021QIII;2.421
34 Palencia;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2021QII;""
34 Palencia;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2021QI;""
34 Palencia;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
34 Palencia;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2020QIII;2.480
34 Palencia;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2020QII;""
34 Palencia;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2020QI;""
34 Palencia;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QIV;2.318
34 Palencia;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
34 Palencia;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QII;""
34 Palencia;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QI;""
34 Palencia;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QIV;2.378
34 Palencia;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
34 Palencia;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QII;""
34 Palencia;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QI;""
34 Palencia;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QIV;2.439
34 Palencia;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
34 Palencia;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QII;""
34 Palencia;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QI;""
34 Palencia;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
34 Palencia;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
34 Palencia;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QII;""
34 Palencia;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QI;2.350
34 Palencia;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
34 Palencia;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
34 Palencia;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QII;""
34 Palencia;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QI;2.406
34 Palencia;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
34 Palencia;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
34 Palencia;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QII;""
34 Palencia;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QI;""
34 Palencia;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
34 Palencia;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
34 Palencia;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
34 Palencia;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
34 Palencia;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
34 Palencia;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
34 Palencia;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
34 Palencia;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
34 Palencia;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
34 Palencia;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
34 Palencia;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
34 Palencia;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
34 Palencia;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
34 Palencia;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
34 Palencia;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;97,8
34 Palencia;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
34 Palencia;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
34 Palencia;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
34 Palencia;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;98,32
34 Palencia;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
34 Palencia;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
34 Palencia;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
34 Palencia;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;98,86
34 Palencia;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
34 Palencia;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
34 Palencia;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;96,53
34 Palencia;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
34 Palencia;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
34 Palencia;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
34 Palencia;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;96,76
34 Palencia;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
34 Palencia;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
34 Palencia;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
34 Palencia;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;97,41
34 Palencia;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
34 Palencia;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
34 Palencia;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;94,65
34 Palencia;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
34 Palencia;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
34 Palencia;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
34 Palencia;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;95,04
34 Palencia;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
34 Palencia;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
34 Palencia;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
34 Palencia;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;95,8
34 Palencia;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
34 Palencia;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
34 Palencia;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
34 Palencia;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
34 Palencia;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
34 Palencia;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
34 Palencia;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;93,92
34 Palencia;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
34 Palencia;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
34 Palencia;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
34 Palencia;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;94,5
34 Palencia;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
34 Palencia;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
34 Palencia;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
34 Palencia;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
34 Palencia;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
34 Palencia;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
34 Palencia;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QII;1.488
34 Palencia;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
34 Palencia;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
34 Palencia;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
34 Palencia;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QII;1.535
34 Palencia;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
34 Palencia;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
34 Palencia;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
34 Palencia;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QII;1.586
34 Palencia;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
34 Palencia;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
34 Palencia;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
34 Palencia;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2022QII;1.457
34 Palencia;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2022QI;""
34 Palencia;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
34 Palencia;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
34 Palencia;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2021QII;1.512
34 Palencia;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2021QI;""
34 Palencia;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
34 Palencia;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
34 Palencia;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2020QII;1.576
34 Palencia;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2020QI;""
34 Palencia;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
34 Palencia;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2022QIII;1.439
34 Palencia;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2022QII;""
34 Palencia;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2022QI;""
34 Palencia;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
34 Palencia;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2021QIII;1.486
34 Palencia;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2021QII;""
34 Palencia;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2021QI;""
34 Palencia;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
34 Palencia;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2020QIII;1.555
34 Palencia;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2020QII;""
34 Palencia;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2020QI;""
34 Palencia;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QIV;1.418
34 Palencia;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
34 Palencia;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QII;""
34 Palencia;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QI;""
34 Palencia;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QIV;1.456
34 Palencia;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
34 Palencia;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QII;""
34 Palencia;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QI;""
34 Palencia;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QIV;1.530
34 Palencia;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
34 Palencia;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QII;""
34 Palencia;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QI;""
34 Palencia;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
34 Palencia;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
34 Palencia;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QII;""
34 Palencia;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QI;1.438
34 Palencia;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
34 Palencia;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
34 Palencia;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QII;""
34 Palencia;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QI;1.511
34 Palencia;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
34 Palencia;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
34 Palencia;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QII;""
34 Palencia;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QI;""
34 Palencia;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
34 Palencia;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
34 Palencia;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
34 Palencia;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
34 Palencia;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
34 Palencia;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
34 Palencia;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
34 Palencia;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
34 Palencia;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
34 Palencia;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
34 Palencia;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
34 Palencia;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
34 Palencia;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
34 Palencia;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
34 Palencia;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;97,92
34 Palencia;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
34 Palencia;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
34 Palencia;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
34 Palencia;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;98,5
34 Palencia;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
34 Palencia;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
34 Palencia;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
34 Palencia;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;99,37
34 Palencia;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
34 Palencia;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
34 Palencia;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;96,71
34 Palencia;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
34 Palencia;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
34 Palencia;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
34 Palencia;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;96,81
34 Palencia;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
34 Palencia;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
34 Palencia;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
34 Palencia;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;98,05
34 Palencia;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
34 Palencia;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
34 Palencia;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;95,3
34 Palencia;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
34 Palencia;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
34 Palencia;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
34 Palencia;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;94,85
34 Palencia;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
34 Palencia;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
34 Palencia;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
34 Palencia;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;96,47
34 Palencia;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
34 Palencia;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
34 Palencia;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
34 Palencia;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
34 Palencia;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
34 Palencia;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
34 Palencia;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;93,68
34 Palencia;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
34 Palencia;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
34 Palencia;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
34 Palencia;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;95,27
34 Palencia;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
34 Palencia;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
34 Palencia;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
34 Palencia;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
34 Palencia;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
34 Palencia;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
34 Palencia;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QII;961
34 Palencia;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
34 Palencia;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
34 Palencia;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
34 Palencia;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QII;967
34 Palencia;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
34 Palencia;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
34 Palencia;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
34 Palencia;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QII;960
34 Palencia;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
34 Palencia;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
34 Palencia;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
34 Palencia;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2022QII;938
34 Palencia;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2022QI;""
34 Palencia;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
34 Palencia;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
34 Palencia;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2021QII;948
34 Palencia;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2021QI;""
34 Palencia;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
34 Palencia;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
34 Palencia;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2020QII;941
34 Palencia;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2020QI;""
34 Palencia;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
34 Palencia;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2022QIII;925
34 Palencia;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2022QII;""
34 Palencia;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2022QI;""
34 Palencia;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
34 Palencia;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2021QIII;935
34 Palencia;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2021QII;""
34 Palencia;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2021QI;""
34 Palencia;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
34 Palencia;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2020QIII;925
34 Palencia;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2020QII;""
34 Palencia;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2020QI;""
34 Palencia;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QIV;900
34 Palencia;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
34 Palencia;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QII;""
34 Palencia;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QI;""
34 Palencia;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QIV;922
34 Palencia;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
34 Palencia;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QII;""
34 Palencia;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QI;""
34 Palencia;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QIV;909
34 Palencia;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
34 Palencia;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QII;""
34 Palencia;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QI;""
34 Palencia;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
34 Palencia;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
34 Palencia;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QII;""
34 Palencia;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QI;912
34 Palencia;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
34 Palencia;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
34 Palencia;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QII;""
34 Palencia;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QI;895
34 Palencia;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
34 Palencia;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
34 Palencia;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QII;""
34 Palencia;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QI;""
34 Palencia;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
34 Palencia;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
34 Palencia;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
34 Palencia;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
34 Palencia;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
34 Palencia;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
34 Palencia;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
34 Palencia;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
34 Palencia;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
34 Palencia;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
34 Palencia;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
34 Palencia;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
34 Palencia;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
34 Palencia;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
34 Palencia;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;97,61
34 Palencia;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
34 Palencia;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
34 Palencia;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
34 Palencia;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;98,04
34 Palencia;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
34 Palencia;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
34 Palencia;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
34 Palencia;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;98,02
34 Palencia;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
34 Palencia;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
34 Palencia;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;96,25
34 Palencia;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
34 Palencia;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
34 Palencia;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
34 Palencia;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;96,69
34 Palencia;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
34 Palencia;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
34 Palencia;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
34 Palencia;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;96,35
34 Palencia;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
34 Palencia;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
34 Palencia;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;93,65
34 Palencia;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
34 Palencia;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
34 Palencia;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
34 Palencia;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;95,35
34 Palencia;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
34 Palencia;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
34 Palencia;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
34 Palencia;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;94,69
34 Palencia;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
34 Palencia;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
34 Palencia;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
34 Palencia;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
34 Palencia;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
34 Palencia;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
34 Palencia;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;94,31
34 Palencia;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
34 Palencia;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
34 Palencia;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
34 Palencia;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;93,23
34 Palencia;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
34 Palencia;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
34 Palencia;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
34 Palencia;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
34 Palencia;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
34 Palencia;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QIII;2.469
34 Palencia;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
34 Palencia;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
34 Palencia;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
34 Palencia;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QIII;2.527
34 Palencia;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
34 Palencia;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
34 Palencia;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
34 Palencia;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QIII;2.560
34 Palencia;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
34 Palencia;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
34 Palencia;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
34 Palencia;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2022QIII;2.426
34 Palencia;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2022QII;""
34 Palencia;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2022QI;""
34 Palencia;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
34 Palencia;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2021QIII;2.470
34 Palencia;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2021QII;""
34 Palencia;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2021QI;""
34 Palencia;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
34 Palencia;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2020QIII;2.519
34 Palencia;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2020QII;""
34 Palencia;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2020QI;""
34 Palencia;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2022QIV;2.372
34 Palencia;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
34 Palencia;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2022QII;""
34 Palencia;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2022QI;""
34 Palencia;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2021QIV;2.423
34 Palencia;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
34 Palencia;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2021QII;""
34 Palencia;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2021QI;""
34 Palencia;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2020QIV;2.473
34 Palencia;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
34 Palencia;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2020QII;""
34 Palencia;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2020QI;""
34 Palencia;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
34 Palencia;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
34 Palencia;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QII;""
34 Palencia;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QI;2.391
34 Palencia;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
34 Palencia;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
34 Palencia;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QII;""
34 Palencia;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QI;2.437
34 Palencia;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
34 Palencia;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
34 Palencia;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QII;""
34 Palencia;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QI;""
34 Palencia;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
34 Palencia;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
34 Palencia;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QII;2.349
34 Palencia;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QI;""
34 Palencia;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
34 Palencia;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
34 Palencia;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QII;2.403
34 Palencia;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QI;""
34 Palencia;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
34 Palencia;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
34 Palencia;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QII;""
34 Palencia;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QI;""
34 Palencia;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
34 Palencia;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
34 Palencia;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
34 Palencia;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
34 Palencia;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
34 Palencia;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
34 Palencia;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
34 Palencia;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
34 Palencia;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
34 Palencia;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
34 Palencia;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
34 Palencia;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
34 Palencia;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
34 Palencia;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;98,26
34 Palencia;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
34 Palencia;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
34 Palencia;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
34 Palencia;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;97,74
34 Palencia;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
34 Palencia;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
34 Palencia;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
34 Palencia;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;98,4
34 Palencia;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
34 Palencia;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
34 Palencia;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;96,07
34 Palencia;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
34 Palencia;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
34 Palencia;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
34 Palencia;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;95,88
34 Palencia;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
34 Palencia;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
34 Palencia;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
34 Palencia;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;96,6
34 Palencia;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
34 Palencia;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
34 Palencia;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
34 Palencia;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
34 Palencia;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
34 Palencia;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
34 Palencia;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;94,62
34 Palencia;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
34 Palencia;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
34 Palencia;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
34 Palencia;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;95,2
34 Palencia;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
34 Palencia;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
34 Palencia;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
34 Palencia;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
34 Palencia;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
34 Palencia;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
34 Palencia;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;92,96
34 Palencia;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
34 Palencia;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
34 Palencia;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
34 Palencia;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;93,87
34 Palencia;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
34 Palencia;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
34 Palencia;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
34 Palencia;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
34 Palencia;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
34 Palencia;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
34 Palencia;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QIII;1.493
34 Palencia;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
34 Palencia;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
34 Palencia;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
34 Palencia;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QIII;1.560
34 Palencia;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
34 Palencia;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
34 Palencia;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
34 Palencia;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QIII;1.600
34 Palencia;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
34 Palencia;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
34 Palencia;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
34 Palencia;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2022QIII;1.471
34 Palencia;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2022QII;""
34 Palencia;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2022QI;""
34 Palencia;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
34 Palencia;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2021QIII;1.525
34 Palencia;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2021QII;""
34 Palencia;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2021QI;""
34 Palencia;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
34 Palencia;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2020QIII;1.577
34 Palencia;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2020QII;""
34 Palencia;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2020QI;""
34 Palencia;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2022QIV;1.445
34 Palencia;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
34 Palencia;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2022QII;""
34 Palencia;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2022QI;""
34 Palencia;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2021QIV;1.492
34 Palencia;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
34 Palencia;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2021QII;""
34 Palencia;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2021QI;""
34 Palencia;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2020QIV;1.549
34 Palencia;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
34 Palencia;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2020QII;""
34 Palencia;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2020QI;""
34 Palencia;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
34 Palencia;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
34 Palencia;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QII;""
34 Palencia;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QI;1.470
34 Palencia;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
34 Palencia;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
34 Palencia;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QII;""
34 Palencia;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QI;1.528
34 Palencia;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
34 Palencia;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
34 Palencia;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QII;""
34 Palencia;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QI;""
34 Palencia;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
34 Palencia;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
34 Palencia;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QII;1.447
34 Palencia;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QI;""
34 Palencia;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
34 Palencia;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
34 Palencia;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QII;1.508
34 Palencia;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QI;""
34 Palencia;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
34 Palencia;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
34 Palencia;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QII;""
34 Palencia;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QI;""
34 Palencia;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
34 Palencia;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
34 Palencia;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
34 Palencia;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
34 Palencia;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
34 Palencia;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
34 Palencia;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
34 Palencia;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
34 Palencia;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
34 Palencia;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
34 Palencia;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
34 Palencia;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
34 Palencia;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
34 Palencia;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;98,53
34 Palencia;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
34 Palencia;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
34 Palencia;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
34 Palencia;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;97,76
34 Palencia;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
34 Palencia;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
34 Palencia;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
34 Palencia;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;98,56
34 Palencia;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
34 Palencia;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
34 Palencia;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;96,78
34 Palencia;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
34 Palencia;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
34 Palencia;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
34 Palencia;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;95,64
34 Palencia;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
34 Palencia;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
34 Palencia;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
34 Palencia;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;96,81
34 Palencia;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
34 Palencia;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
34 Palencia;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
34 Palencia;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
34 Palencia;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
34 Palencia;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
34 Palencia;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;94,23
34 Palencia;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
34 Palencia;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
34 Palencia;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
34 Palencia;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;95,5
34 Palencia;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
34 Palencia;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
34 Palencia;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
34 Palencia;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
34 Palencia;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
34 Palencia;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
34 Palencia;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;92,76
34 Palencia;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
34 Palencia;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
34 Palencia;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
34 Palencia;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;94,25
34 Palencia;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
34 Palencia;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
34 Palencia;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
34 Palencia;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
34 Palencia;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
34 Palencia;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
34 Palencia;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QIII;976
34 Palencia;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
34 Palencia;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
34 Palencia;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
34 Palencia;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QIII;967
34 Palencia;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
34 Palencia;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
34 Palencia;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
34 Palencia;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QIII;960
34 Palencia;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
34 Palencia;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
34 Palencia;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
34 Palencia;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2022QIII;955
34 Palencia;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2022QII;""
34 Palencia;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2022QI;""
34 Palencia;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
34 Palencia;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2021QIII;945
34 Palencia;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2021QII;""
34 Palencia;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2021QI;""
34 Palencia;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
34 Palencia;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2020QIII;942
34 Palencia;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2020QII;""
34 Palencia;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2020QI;""
34 Palencia;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2022QIV;927
34 Palencia;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
34 Palencia;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2022QII;""
34 Palencia;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2022QI;""
34 Palencia;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2021QIV;931
34 Palencia;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
34 Palencia;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2021QII;""
34 Palencia;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2021QI;""
34 Palencia;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2020QIV;924
34 Palencia;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
34 Palencia;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2020QII;""
34 Palencia;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2020QI;""
34 Palencia;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
34 Palencia;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
34 Palencia;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QII;""
34 Palencia;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QI;921
34 Palencia;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
34 Palencia;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
34 Palencia;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QII;""
34 Palencia;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QI;909
34 Palencia;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
34 Palencia;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
34 Palencia;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QII;""
34 Palencia;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QI;""
34 Palencia;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
34 Palencia;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
34 Palencia;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QII;902
34 Palencia;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QI;""
34 Palencia;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
34 Palencia;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
34 Palencia;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QII;895
34 Palencia;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QI;""
34 Palencia;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
34 Palencia;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
34 Palencia;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QII;""
34 Palencia;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QI;""
34 Palencia;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
34 Palencia;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
34 Palencia;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
34 Palencia;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
34 Palencia;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
34 Palencia;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
34 Palencia;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
34 Palencia;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
34 Palencia;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
34 Palencia;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
34 Palencia;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
34 Palencia;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
34 Palencia;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
34 Palencia;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;97,85
34 Palencia;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
34 Palencia;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
34 Palencia;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
34 Palencia;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;97,72
34 Palencia;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
34 Palencia;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
34 Palencia;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
34 Palencia;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;98,13
34 Palencia;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
34 Palencia;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
34 Palencia;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;94,98
34 Palencia;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
34 Palencia;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
34 Palencia;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
34 Palencia;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;96,28
34 Palencia;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
34 Palencia;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
34 Palencia;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
34 Palencia;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;96,25
34 Palencia;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
34 Palencia;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
34 Palencia;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
34 Palencia;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
34 Palencia;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
34 Palencia;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
34 Palencia;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;95,24
34 Palencia;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
34 Palencia;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
34 Palencia;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
34 Palencia;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;94,69
34 Palencia;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
34 Palencia;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
34 Palencia;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
34 Palencia;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
34 Palencia;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
34 Palencia;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
34 Palencia;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;93,28
34 Palencia;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
34 Palencia;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
34 Palencia;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
34 Palencia;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;93,23
34 Palencia;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
34 Palencia;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
34 Palencia;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
34 Palencia;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
34 Palencia;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
34 Palencia;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QIV;2.477
34 Palencia;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
34 Palencia;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
34 Palencia;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
34 Palencia;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QIV;2.521
34 Palencia;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
34 Palencia;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
34 Palencia;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
34 Palencia;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QIV;2.590
34 Palencia;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
34 Palencia;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
34 Palencia;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
34 Palencia;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2022QIV;2.414
34 Palencia;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
34 Palencia;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2022QII;""
34 Palencia;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2022QI;""
34 Palencia;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2021QIV;2.466
34 Palencia;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
34 Palencia;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2021QII;""
34 Palencia;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2021QI;""
34 Palencia;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2020QIV;2.536
34 Palencia;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
34 Palencia;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2020QII;""
34 Palencia;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2020QI;""
34 Palencia;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
34 Palencia;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
34 Palencia;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2022QII;""
34 Palencia;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2022QI;2.430
34 Palencia;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
34 Palencia;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
34 Palencia;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2021QII;""
34 Palencia;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2021QI;2.497
34 Palencia;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
34 Palencia;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
34 Palencia;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2020QII;""
34 Palencia;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2020QI;""
34 Palencia;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
34 Palencia;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
34 Palencia;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QII;2.386
34 Palencia;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QI;""
34 Palencia;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
34 Palencia;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
34 Palencia;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QII;2.463
34 Palencia;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QI;""
34 Palencia;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
34 Palencia;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
34 Palencia;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QII;""
34 Palencia;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QI;""
34 Palencia;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
34 Palencia;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QIII;2.359
34 Palencia;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QII;""
34 Palencia;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QI;""
34 Palencia;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
34 Palencia;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QIII;2.431
34 Palencia;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QII;""
34 Palencia;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QI;""
34 Palencia;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
34 Palencia;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
34 Palencia;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QII;""
34 Palencia;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QI;""
34 Palencia;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
34 Palencia;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
34 Palencia;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
34 Palencia;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
34 Palencia;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
34 Palencia;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
34 Palencia;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
34 Palencia;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
34 Palencia;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
34 Palencia;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
34 Palencia;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
34 Palencia;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
34 Palencia;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;97,46
34 Palencia;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
34 Palencia;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
34 Palencia;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
34 Palencia;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;97,82
34 Palencia;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
34 Palencia;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
34 Palencia;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
34 Palencia;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;97,92
34 Palencia;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
34 Palencia;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
34 Palencia;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
34 Palencia;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
34 Palencia;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
34 Palencia;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
34 Palencia;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;96,39
34 Palencia;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
34 Palencia;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
34 Palencia;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
34 Palencia;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;96,41
34 Palencia;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
34 Palencia;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
34 Palencia;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
34 Palencia;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
34 Palencia;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
34 Palencia;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
34 Palencia;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;94,64
34 Palencia;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
34 Palencia;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
34 Palencia;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
34 Palencia;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;95,1
34 Palencia;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
34 Palencia;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
34 Palencia;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
34 Palencia;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
34 Palencia;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
34 Palencia;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
34 Palencia;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;93,57
34 Palencia;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
34 Palencia;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
34 Palencia;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
34 Palencia;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;93,86
34 Palencia;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
34 Palencia;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
34 Palencia;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
34 Palencia;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
34 Palencia;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
34 Palencia;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
34 Palencia;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QIV;1.493
34 Palencia;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
34 Palencia;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
34 Palencia;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
34 Palencia;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QIV;1.549
34 Palencia;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
34 Palencia;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
34 Palencia;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
34 Palencia;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QIV;1.616
34 Palencia;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
34 Palencia;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
34 Palencia;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
34 Palencia;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2022QIV;1.462
34 Palencia;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
34 Palencia;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2022QII;""
34 Palencia;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2022QI;""
34 Palencia;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2021QIV;1.514
34 Palencia;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
34 Palencia;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2021QII;""
34 Palencia;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2021QI;""
34 Palencia;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2020QIV;1.581
34 Palencia;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
34 Palencia;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2020QII;""
34 Palencia;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2020QI;""
34 Palencia;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
34 Palencia;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
34 Palencia;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2022QII;""
34 Palencia;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2022QI;1.489
34 Palencia;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
34 Palencia;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
34 Palencia;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2021QII;""
34 Palencia;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2021QI;1.557
34 Palencia;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
34 Palencia;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
34 Palencia;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2020QII;""
34 Palencia;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2020QI;""
34 Palencia;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
34 Palencia;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
34 Palencia;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QII;1.465
34 Palencia;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QI;""
34 Palencia;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
34 Palencia;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
34 Palencia;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QII;1.537
34 Palencia;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QI;""
34 Palencia;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
34 Palencia;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
34 Palencia;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QII;""
34 Palencia;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QI;""
34 Palencia;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
34 Palencia;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QIII;1.449
34 Palencia;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QII;""
34 Palencia;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QI;""
34 Palencia;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
34 Palencia;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QIII;1.517
34 Palencia;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QII;""
34 Palencia;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QI;""
34 Palencia;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
34 Palencia;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
34 Palencia;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QII;""
34 Palencia;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QI;""
34 Palencia;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
34 Palencia;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
34 Palencia;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
34 Palencia;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
34 Palencia;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
34 Palencia;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
34 Palencia;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
34 Palencia;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
34 Palencia;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
34 Palencia;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
34 Palencia;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
34 Palencia;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
34 Palencia;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;97,92
34 Palencia;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
34 Palencia;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
34 Palencia;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
34 Palencia;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;97,74
34 Palencia;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
34 Palencia;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
34 Palencia;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
34 Palencia;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;97,83
34 Palencia;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
34 Palencia;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
34 Palencia;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
34 Palencia;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
34 Palencia;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
34 Palencia;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
34 Palencia;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;96,13
34 Palencia;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
34 Palencia;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
34 Palencia;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
34 Palencia;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;96,35
34 Palencia;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
34 Palencia;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
34 Palencia;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
34 Palencia;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
34 Palencia;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
34 Palencia;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
34 Palencia;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;94,58
34 Palencia;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
34 Palencia;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
34 Palencia;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
34 Palencia;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;95,11
34 Palencia;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
34 Palencia;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
34 Palencia;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
34 Palencia;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
34 Palencia;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
34 Palencia;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
34 Palencia;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;93,54
34 Palencia;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
34 Palencia;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
34 Palencia;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
34 Palencia;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;93,87
34 Palencia;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
34 Palencia;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
34 Palencia;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
34 Palencia;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
34 Palencia;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
34 Palencia;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
34 Palencia;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QIV;984
34 Palencia;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
34 Palencia;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
34 Palencia;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
34 Palencia;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QIV;972
34 Palencia;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
34 Palencia;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
34 Palencia;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
34 Palencia;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QIV;974
34 Palencia;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
34 Palencia;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
34 Palencia;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
34 Palencia;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2022QIV;952
34 Palencia;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
34 Palencia;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2022QII;""
34 Palencia;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2022QI;""
34 Palencia;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2021QIV;952
34 Palencia;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
34 Palencia;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2021QII;""
34 Palencia;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2021QI;""
34 Palencia;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2020QIV;955
34 Palencia;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
34 Palencia;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2020QII;""
34 Palencia;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2020QI;""
34 Palencia;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
34 Palencia;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
34 Palencia;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2022QII;""
34 Palencia;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2022QI;941
34 Palencia;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
34 Palencia;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
34 Palencia;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2021QII;""
34 Palencia;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2021QI;940
34 Palencia;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
34 Palencia;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
34 Palencia;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2020QII;""
34 Palencia;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2020QI;""
34 Palencia;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
34 Palencia;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
34 Palencia;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QII;921
34 Palencia;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QI;""
34 Palencia;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
34 Palencia;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
34 Palencia;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QII;926
34 Palencia;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QI;""
34 Palencia;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
34 Palencia;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
34 Palencia;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QII;""
34 Palencia;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QI;""
34 Palencia;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
34 Palencia;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QIII;910
34 Palencia;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QII;""
34 Palencia;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QI;""
34 Palencia;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
34 Palencia;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QIII;914
34 Palencia;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QII;""
34 Palencia;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QI;""
34 Palencia;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
34 Palencia;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
34 Palencia;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QII;""
34 Palencia;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QI;""
34 Palencia;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
34 Palencia;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
34 Palencia;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
34 Palencia;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
34 Palencia;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
34 Palencia;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
34 Palencia;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
34 Palencia;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
34 Palencia;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
34 Palencia;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
34 Palencia;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
34 Palencia;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
34 Palencia;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;96,75
34 Palencia;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
34 Palencia;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
34 Palencia;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
34 Palencia;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;97,94
34 Palencia;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
34 Palencia;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
34 Palencia;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
34 Palencia;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;98,05
34 Palencia;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
34 Palencia;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
34 Palencia;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
34 Palencia;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
34 Palencia;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
34 Palencia;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
34 Palencia;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;96,81
34 Palencia;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
34 Palencia;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
34 Palencia;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
34 Palencia;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;96,51
34 Palencia;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
34 Palencia;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
34 Palencia;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
34 Palencia;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
34 Palencia;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
34 Palencia;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
34 Palencia;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;94,75
34 Palencia;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
34 Palencia;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
34 Palencia;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
34 Palencia;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;95,07
34 Palencia;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
34 Palencia;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
34 Palencia;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
34 Palencia;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
34 Palencia;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
34 Palencia;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
34 Palencia;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;93,62
34 Palencia;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
34 Palencia;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
34 Palencia;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
34 Palencia;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;93,84
34 Palencia;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
34 Palencia;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
34 Palencia;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
34 Palencia;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
34 Palencia;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
34 Palencia;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
34 Palencia;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
34 Palencia;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
34 Palencia;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
34 Palencia;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QI;3.080
34 Palencia;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
34 Palencia;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
34 Palencia;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
34 Palencia;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QI;3.111
34 Palencia;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
34 Palencia;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
34 Palencia;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
34 Palencia;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QI;3.166
34 Palencia;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
34 Palencia;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
34 Palencia;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2022QII;""
34 Palencia;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2022QI;3.031
34 Palencia;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
34 Palencia;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
34 Palencia;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2021QII;""
34 Palencia;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2021QI;3.073
34 Palencia;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
34 Palencia;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
34 Palencia;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2020QII;""
34 Palencia;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2020QI;3.065
34 Palencia;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
34 Palencia;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
34 Palencia;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2022QII;2.965
34 Palencia;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2022QI;""
34 Palencia;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
34 Palencia;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
34 Palencia;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2021QII;3.032
34 Palencia;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2021QI;""
34 Palencia;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
34 Palencia;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
34 Palencia;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2020QII;3.027
34 Palencia;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2020QI;""
34 Palencia;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
34 Palencia;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QIII;2.939
34 Palencia;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QII;""
34 Palencia;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QI;""
34 Palencia;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
34 Palencia;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QIII;2.993
34 Palencia;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QII;""
34 Palencia;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QI;""
34 Palencia;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
34 Palencia;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QIII;2.985
34 Palencia;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QII;""
34 Palencia;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QI;""
34 Palencia;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QIV;2.898
34 Palencia;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
34 Palencia;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QII;""
34 Palencia;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QI;""
34 Palencia;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QIV;2.953
34 Palencia;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
34 Palencia;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QII;""
34 Palencia;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QI;""
34 Palencia;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QIV;2.956
34 Palencia;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
34 Palencia;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QII;""
34 Palencia;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QI;""
34 Palencia;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
34 Palencia;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
34 Palencia;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
34 Palencia;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
34 Palencia;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
34 Palencia;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
34 Palencia;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
34 Palencia;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
34 Palencia;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
34 Palencia;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
34 Palencia;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
34 Palencia;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
34 Palencia;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
34 Palencia;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
34 Palencia;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
34 Palencia;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;98,41
34 Palencia;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
34 Palencia;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
34 Palencia;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
34 Palencia;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;98,78
34 Palencia;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
34 Palencia;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
34 Palencia;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
34 Palencia;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;96,81
34 Palencia;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
34 Palencia;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
34 Palencia;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;96,27
34 Palencia;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
34 Palencia;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
34 Palencia;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
34 Palencia;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;97,46
34 Palencia;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
34 Palencia;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
34 Palencia;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
34 Palencia;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;95,61
34 Palencia;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
34 Palencia;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
34 Palencia;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;95,42
34 Palencia;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
34 Palencia;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
34 Palencia;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
34 Palencia;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;96,21
34 Palencia;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
34 Palencia;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
34 Palencia;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
34 Palencia;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;94,28
34 Palencia;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
34 Palencia;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
34 Palencia;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;94,09
34 Palencia;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
34 Palencia;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
34 Palencia;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
34 Palencia;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;94,92
34 Palencia;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
34 Palencia;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
34 Palencia;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
34 Palencia;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;93,37
34 Palencia;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
34 Palencia;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
34 Palencia;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
34 Palencia;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
34 Palencia;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
34 Palencia;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
34 Palencia;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QI;2.032
34 Palencia;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
34 Palencia;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
34 Palencia;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
34 Palencia;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QI;2.068
34 Palencia;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
34 Palencia;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
34 Palencia;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
34 Palencia;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QI;2.117
34 Palencia;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
34 Palencia;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
34 Palencia;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2022QII;""
34 Palencia;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2022QI;2.004
34 Palencia;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
34 Palencia;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
34 Palencia;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2021QII;""
34 Palencia;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2021QI;2.039
34 Palencia;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
34 Palencia;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
34 Palencia;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2020QII;""
34 Palencia;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2020QI;2.050
34 Palencia;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
34 Palencia;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
34 Palencia;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2022QII;1.968
34 Palencia;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2022QI;""
34 Palencia;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
34 Palencia;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
34 Palencia;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2021QII;2.012
34 Palencia;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2021QI;""
34 Palencia;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
34 Palencia;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
34 Palencia;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2020QII;2.029
34 Palencia;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2020QI;""
34 Palencia;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
34 Palencia;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QIII;1.954
34 Palencia;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QII;""
34 Palencia;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QI;""
34 Palencia;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
34 Palencia;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QIII;1.989
34 Palencia;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QII;""
34 Palencia;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QI;""
34 Palencia;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
34 Palencia;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QIII;2.003
34 Palencia;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QII;""
34 Palencia;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QI;""
34 Palencia;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QIV;1.932
34 Palencia;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
34 Palencia;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QII;""
34 Palencia;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QI;""
34 Palencia;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QIV;1.964
34 Palencia;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
34 Palencia;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QII;""
34 Palencia;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QI;""
34 Palencia;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QIV;1.983
34 Palencia;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
34 Palencia;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QII;""
34 Palencia;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QI;""
34 Palencia;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
34 Palencia;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
34 Palencia;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
34 Palencia;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
34 Palencia;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
34 Palencia;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
34 Palencia;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
34 Palencia;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
34 Palencia;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
34 Palencia;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
34 Palencia;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
34 Palencia;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
34 Palencia;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
34 Palencia;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
34 Palencia;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
34 Palencia;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;98,62
34 Palencia;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
34 Palencia;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
34 Palencia;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
34 Palencia;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;98,6
34 Palencia;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
34 Palencia;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
34 Palencia;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
34 Palencia;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;96,84
34 Palencia;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
34 Palencia;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
34 Palencia;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;96,85
34 Palencia;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
34 Palencia;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
34 Palencia;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
34 Palencia;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;97,29
34 Palencia;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
34 Palencia;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
34 Palencia;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
34 Palencia;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;95,84
34 Palencia;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
34 Palencia;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
34 Palencia;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;96,16
34 Palencia;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
34 Palencia;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
34 Palencia;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
34 Palencia;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;96,18
34 Palencia;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
34 Palencia;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
34 Palencia;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
34 Palencia;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;94,62
34 Palencia;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
34 Palencia;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
34 Palencia;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;95,08
34 Palencia;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
34 Palencia;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
34 Palencia;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
34 Palencia;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;94,97
34 Palencia;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
34 Palencia;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
34 Palencia;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
34 Palencia;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;93,67
34 Palencia;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
34 Palencia;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
34 Palencia;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
34 Palencia;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
34 Palencia;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
34 Palencia;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
34 Palencia;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QI;1.048
34 Palencia;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
34 Palencia;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
34 Palencia;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
34 Palencia;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QI;1.043
34 Palencia;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
34 Palencia;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
34 Palencia;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
34 Palencia;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QI;1.049
34 Palencia;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
34 Palencia;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
34 Palencia;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2022QII;""
34 Palencia;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2022QI;1.027
34 Palencia;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
34 Palencia;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
34 Palencia;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2021QII;""
34 Palencia;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2021QI;1.034
34 Palencia;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
34 Palencia;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
34 Palencia;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2020QII;""
34 Palencia;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2020QI;1.015
34 Palencia;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
34 Palencia;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
34 Palencia;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2022QII;997
34 Palencia;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2022QI;""
34 Palencia;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
34 Palencia;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
34 Palencia;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2021QII;1.020
34 Palencia;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2021QI;""
34 Palencia;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
34 Palencia;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
34 Palencia;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2020QII;998
34 Palencia;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2020QI;""
34 Palencia;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
34 Palencia;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QIII;985
34 Palencia;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QII;""
34 Palencia;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QI;""
34 Palencia;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
34 Palencia;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QIII;1.004
34 Palencia;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QII;""
34 Palencia;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QI;""
34 Palencia;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
34 Palencia;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QIII;982
34 Palencia;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QII;""
34 Palencia;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QI;""
34 Palencia;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QIV;966
34 Palencia;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
34 Palencia;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QII;""
34 Palencia;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QI;""
34 Palencia;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QIV;989
34 Palencia;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
34 Palencia;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QII;""
34 Palencia;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QI;""
34 Palencia;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QIV;973
34 Palencia;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
34 Palencia;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QII;""
34 Palencia;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QI;""
34 Palencia;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
34 Palencia;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
34 Palencia;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
34 Palencia;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
34 Palencia;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
34 Palencia;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
34 Palencia;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
34 Palencia;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
34 Palencia;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
34 Palencia;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
34 Palencia;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
34 Palencia;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
34 Palencia;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
34 Palencia;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
34 Palencia;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
34 Palencia;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;98
34 Palencia;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
34 Palencia;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
34 Palencia;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
34 Palencia;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;99,14
34 Palencia;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
34 Palencia;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
34 Palencia;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
34 Palencia;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;96,76
34 Palencia;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
34 Palencia;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
34 Palencia;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;95,13
34 Palencia;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
34 Palencia;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
34 Palencia;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
34 Palencia;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;97,79
34 Palencia;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
34 Palencia;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
34 Palencia;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
34 Palencia;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;95,14
34 Palencia;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
34 Palencia;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
34 Palencia;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;93,99
34 Palencia;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
34 Palencia;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
34 Palencia;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
34 Palencia;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;96,26
34 Palencia;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
34 Palencia;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
34 Palencia;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
34 Palencia;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;93,61
34 Palencia;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
34 Palencia;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
34 Palencia;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;92,18
34 Palencia;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
34 Palencia;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
34 Palencia;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
34 Palencia;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;94,82
34 Palencia;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
34 Palencia;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
34 Palencia;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
34 Palencia;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;92,76
34 Palencia;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
34 Palencia;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
34 Palencia;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
34 Palencia;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
34 Palencia;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
34 Palencia;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QII;3.085
34 Palencia;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
34 Palencia;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
34 Palencia;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
34 Palencia;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QII;3.109
34 Palencia;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
34 Palencia;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
34 Palencia;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
34 Palencia;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QII;3.138
34 Palencia;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
34 Palencia;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
34 Palencia;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
34 Palencia;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2022QII;3.016
34 Palencia;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2022QI;""
34 Palencia;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
34 Palencia;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
34 Palencia;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2021QII;3.063
34 Palencia;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2021QI;""
34 Palencia;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
34 Palencia;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
34 Palencia;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2020QII;3.094
34 Palencia;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2020QI;""
34 Palencia;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
34 Palencia;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2022QIII;2.986
34 Palencia;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2022QII;""
34 Palencia;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2022QI;""
34 Palencia;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
34 Palencia;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2021QIII;3.018
34 Palencia;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2021QII;""
34 Palencia;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2021QI;""
34 Palencia;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
34 Palencia;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2020QIII;3.047
34 Palencia;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2020QII;""
34 Palencia;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2020QI;""
34 Palencia;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QIV;2.938
34 Palencia;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
34 Palencia;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QII;""
34 Palencia;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QI;""
34 Palencia;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QIV;2.975
34 Palencia;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
34 Palencia;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QII;""
34 Palencia;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QI;""
34 Palencia;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QIV;3.015
34 Palencia;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
34 Palencia;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QII;""
34 Palencia;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QI;""
34 Palencia;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
34 Palencia;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
34 Palencia;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QII;""
34 Palencia;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QI;2.935
34 Palencia;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
34 Palencia;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
34 Palencia;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QII;""
34 Palencia;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QI;2.982
34 Palencia;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
34 Palencia;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
34 Palencia;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QII;""
34 Palencia;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QI;""
34 Palencia;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
34 Palencia;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
34 Palencia;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
34 Palencia;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
34 Palencia;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
34 Palencia;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
34 Palencia;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
34 Palencia;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
34 Palencia;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
34 Palencia;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
34 Palencia;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
34 Palencia;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
34 Palencia;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
34 Palencia;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
34 Palencia;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;97,76
34 Palencia;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
34 Palencia;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
34 Palencia;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
34 Palencia;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;98,52
34 Palencia;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
34 Palencia;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
34 Palencia;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
34 Palencia;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;98,6
34 Palencia;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
34 Palencia;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
34 Palencia;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;96,79
34 Palencia;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
34 Palencia;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
34 Palencia;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
34 Palencia;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;97,07
34 Palencia;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
34 Palencia;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
34 Palencia;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
34 Palencia;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;97,1
34 Palencia;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
34 Palencia;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
34 Palencia;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;95,24
34 Palencia;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
34 Palencia;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
34 Palencia;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
34 Palencia;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;95,69
34 Palencia;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
34 Palencia;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
34 Palencia;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
34 Palencia;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;96,08
34 Palencia;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
34 Palencia;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
34 Palencia;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
34 Palencia;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
34 Palencia;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
34 Palencia;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
34 Palencia;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;94,4
34 Palencia;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
34 Palencia;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
34 Palencia;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
34 Palencia;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;95,03
34 Palencia;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
34 Palencia;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
34 Palencia;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
34 Palencia;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
34 Palencia;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
34 Palencia;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
34 Palencia;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QII;2.015
34 Palencia;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
34 Palencia;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
34 Palencia;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
34 Palencia;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QII;2.057
34 Palencia;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
34 Palencia;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
34 Palencia;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
34 Palencia;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QII;2.088
34 Palencia;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
34 Palencia;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
34 Palencia;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
34 Palencia;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2022QII;1.977
34 Palencia;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2022QI;""
34 Palencia;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
34 Palencia;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
34 Palencia;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2021QII;2.026
34 Palencia;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2021QI;""
34 Palencia;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
34 Palencia;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
34 Palencia;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2020QII;2.065
34 Palencia;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2020QI;""
34 Palencia;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
34 Palencia;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2022QIII;1.959
34 Palencia;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2022QII;""
34 Palencia;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2022QI;""
34 Palencia;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
34 Palencia;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2021QIII;1.999
34 Palencia;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2021QII;""
34 Palencia;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2021QI;""
34 Palencia;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
34 Palencia;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2020QIII;2.036
34 Palencia;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2020QII;""
34 Palencia;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2020QI;""
34 Palencia;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QIV;1.932
34 Palencia;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
34 Palencia;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QII;""
34 Palencia;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QI;""
34 Palencia;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QIV;1.971
34 Palencia;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
34 Palencia;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QII;""
34 Palencia;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QI;""
34 Palencia;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QIV;2.013
34 Palencia;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
34 Palencia;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QII;""
34 Palencia;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QI;""
34 Palencia;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
34 Palencia;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
34 Palencia;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QII;""
34 Palencia;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QI;1.950
34 Palencia;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
34 Palencia;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
34 Palencia;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QII;""
34 Palencia;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QI;1.987
34 Palencia;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
34 Palencia;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
34 Palencia;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QII;""
34 Palencia;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QI;""
34 Palencia;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
34 Palencia;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
34 Palencia;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
34 Palencia;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
34 Palencia;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
34 Palencia;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
34 Palencia;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
34 Palencia;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
34 Palencia;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
34 Palencia;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
34 Palencia;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
34 Palencia;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
34 Palencia;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
34 Palencia;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
34 Palencia;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;98,11
34 Palencia;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
34 Palencia;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
34 Palencia;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
34 Palencia;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;98,49
34 Palencia;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
34 Palencia;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
34 Palencia;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
34 Palencia;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;98,9
34 Palencia;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
34 Palencia;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
34 Palencia;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;97,22
34 Palencia;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
34 Palencia;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
34 Palencia;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
34 Palencia;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;97,18
34 Palencia;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
34 Palencia;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
34 Palencia;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
34 Palencia;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;97,51
34 Palencia;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
34 Palencia;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
34 Palencia;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;95,88
34 Palencia;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
34 Palencia;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
34 Palencia;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
34 Palencia;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;95,82
34 Palencia;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
34 Palencia;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
34 Palencia;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
34 Palencia;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;96,41
34 Palencia;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
34 Palencia;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
34 Palencia;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
34 Palencia;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
34 Palencia;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
34 Palencia;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
34 Palencia;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;94,8
34 Palencia;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
34 Palencia;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
34 Palencia;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
34 Palencia;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;95,16
34 Palencia;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
34 Palencia;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
34 Palencia;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
34 Palencia;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
34 Palencia;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
34 Palencia;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
34 Palencia;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QII;1.070
34 Palencia;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
34 Palencia;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
34 Palencia;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
34 Palencia;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QII;1.052
34 Palencia;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
34 Palencia;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
34 Palencia;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
34 Palencia;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QII;1.050
34 Palencia;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
34 Palencia;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
34 Palencia;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
34 Palencia;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2022QII;1.039
34 Palencia;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2022QI;""
34 Palencia;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
34 Palencia;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
34 Palencia;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2021QII;1.037
34 Palencia;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2021QI;""
34 Palencia;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
34 Palencia;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
34 Palencia;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2020QII;1.029
34 Palencia;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2020QI;""
34 Palencia;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
34 Palencia;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2022QIII;1.027
34 Palencia;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2022QII;""
34 Palencia;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2022QI;""
34 Palencia;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
34 Palencia;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2021QIII;1.019
34 Palencia;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2021QII;""
34 Palencia;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2021QI;""
34 Palencia;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
34 Palencia;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2020QIII;1.011
34 Palencia;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2020QII;""
34 Palencia;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2020QI;""
34 Palencia;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QIV;1.006
34 Palencia;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
34 Palencia;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QII;""
34 Palencia;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QI;""
34 Palencia;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QIV;1.004
34 Palencia;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
34 Palencia;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QII;""
34 Palencia;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QI;""
34 Palencia;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QIV;1.002
34 Palencia;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
34 Palencia;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QII;""
34 Palencia;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QI;""
34 Palencia;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
34 Palencia;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
34 Palencia;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QII;""
34 Palencia;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QI;985
34 Palencia;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
34 Palencia;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
34 Palencia;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QII;""
34 Palencia;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QI;995
34 Palencia;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
34 Palencia;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
34 Palencia;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QII;""
34 Palencia;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QI;""
34 Palencia;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
34 Palencia;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
34 Palencia;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
34 Palencia;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
34 Palencia;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
34 Palencia;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
34 Palencia;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
34 Palencia;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
34 Palencia;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
34 Palencia;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
34 Palencia;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
34 Palencia;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
34 Palencia;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
34 Palencia;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
34 Palencia;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;97,1
34 Palencia;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
34 Palencia;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
34 Palencia;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
34 Palencia;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;98,57
34 Palencia;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
34 Palencia;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
34 Palencia;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
34 Palencia;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;98
34 Palencia;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
34 Palencia;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
34 Palencia;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;95,98
34 Palencia;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
34 Palencia;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
34 Palencia;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
34 Palencia;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;96,86
34 Palencia;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
34 Palencia;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
34 Palencia;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
34 Palencia;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;96,29
34 Palencia;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
34 Palencia;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
34 Palencia;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;94,02
34 Palencia;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
34 Palencia;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
34 Palencia;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
34 Palencia;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;95,44
34 Palencia;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
34 Palencia;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
34 Palencia;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
34 Palencia;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;95,43
34 Palencia;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
34 Palencia;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
34 Palencia;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
34 Palencia;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
34 Palencia;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
34 Palencia;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
34 Palencia;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;93,63
34 Palencia;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
34 Palencia;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
34 Palencia;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
34 Palencia;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;94,76
34 Palencia;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
34 Palencia;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
34 Palencia;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
34 Palencia;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
34 Palencia;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
34 Palencia;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QIII;3.055
34 Palencia;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
34 Palencia;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
34 Palencia;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
34 Palencia;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QIII;3.105
34 Palencia;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
34 Palencia;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
34 Palencia;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
34 Palencia;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QIII;3.133
34 Palencia;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
34 Palencia;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
34 Palencia;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
34 Palencia;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2022QIII;3.016
34 Palencia;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2022QII;""
34 Palencia;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2022QI;""
34 Palencia;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
34 Palencia;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2021QIII;3.057
34 Palencia;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2021QII;""
34 Palencia;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2021QI;""
34 Palencia;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
34 Palencia;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2020QIII;3.082
34 Palencia;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2020QII;""
34 Palencia;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2020QI;""
34 Palencia;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2022QIV;2.967
34 Palencia;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
34 Palencia;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2022QII;""
34 Palencia;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2022QI;""
34 Palencia;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2021QIV;3.011
34 Palencia;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
34 Palencia;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2021QII;""
34 Palencia;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2021QI;""
34 Palencia;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2020QIV;3.046
34 Palencia;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
34 Palencia;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2020QII;""
34 Palencia;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2020QI;""
34 Palencia;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
34 Palencia;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
34 Palencia;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QII;""
34 Palencia;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QI;2.967
34 Palencia;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
34 Palencia;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
34 Palencia;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QII;""
34 Palencia;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QI;3.012
34 Palencia;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
34 Palencia;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
34 Palencia;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QII;""
34 Palencia;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QI;""
34 Palencia;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
34 Palencia;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
34 Palencia;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QII;2.909
34 Palencia;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QI;""
34 Palencia;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
34 Palencia;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
34 Palencia;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QII;2.977
34 Palencia;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QI;""
34 Palencia;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
34 Palencia;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
34 Palencia;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QII;""
34 Palencia;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QI;""
34 Palencia;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
34 Palencia;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
34 Palencia;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
34 Palencia;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
34 Palencia;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
34 Palencia;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
34 Palencia;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
34 Palencia;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
34 Palencia;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
34 Palencia;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
34 Palencia;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
34 Palencia;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
34 Palencia;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
34 Palencia;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;98,72
34 Palencia;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
34 Palencia;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
34 Palencia;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
34 Palencia;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;98,45
34 Palencia;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
34 Palencia;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
34 Palencia;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
34 Palencia;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;98,37
34 Palencia;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
34 Palencia;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
34 Palencia;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;97,12
34 Palencia;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
34 Palencia;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
34 Palencia;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
34 Palencia;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;96,97
34 Palencia;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
34 Palencia;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
34 Palencia;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
34 Palencia;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;97,22
34 Palencia;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
34 Palencia;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
34 Palencia;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
34 Palencia;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
34 Palencia;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
34 Palencia;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
34 Palencia;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;95,56
34 Palencia;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
34 Palencia;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
34 Palencia;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
34 Palencia;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;96,14
34 Palencia;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
34 Palencia;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
34 Palencia;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
34 Palencia;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
34 Palencia;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
34 Palencia;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
34 Palencia;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;93,69
34 Palencia;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
34 Palencia;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
34 Palencia;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
34 Palencia;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;95,02
34 Palencia;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
34 Palencia;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
34 Palencia;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
34 Palencia;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
34 Palencia;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
34 Palencia;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
34 Palencia;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QIII;1.996
34 Palencia;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
34 Palencia;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
34 Palencia;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
34 Palencia;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QIII;2.053
34 Palencia;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
34 Palencia;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
34 Palencia;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
34 Palencia;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QIII;2.085
34 Palencia;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
34 Palencia;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
34 Palencia;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
34 Palencia;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2022QIII;1.975
34 Palencia;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2022QII;""
34 Palencia;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2022QI;""
34 Palencia;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
34 Palencia;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2021QIII;2.025
34 Palencia;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2021QII;""
34 Palencia;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2021QI;""
34 Palencia;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
34 Palencia;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2020QIII;2.056
34 Palencia;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2020QII;""
34 Palencia;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2020QI;""
34 Palencia;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2022QIV;1.948
34 Palencia;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
34 Palencia;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2022QII;""
34 Palencia;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2022QI;""
34 Palencia;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2021QIV;1.994
34 Palencia;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
34 Palencia;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2021QII;""
34 Palencia;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2021QI;""
34 Palencia;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2020QIV;2.029
34 Palencia;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
34 Palencia;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2020QII;""
34 Palencia;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2020QI;""
34 Palencia;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
34 Palencia;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
34 Palencia;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QII;""
34 Palencia;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QI;1.969
34 Palencia;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
34 Palencia;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
34 Palencia;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QII;""
34 Palencia;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QI;2.002
34 Palencia;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
34 Palencia;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
34 Palencia;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QII;""
34 Palencia;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QI;""
34 Palencia;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
34 Palencia;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
34 Palencia;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QII;1.934
34 Palencia;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QI;""
34 Palencia;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
34 Palencia;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
34 Palencia;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QII;1.977
34 Palencia;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QI;""
34 Palencia;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
34 Palencia;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
34 Palencia;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QII;""
34 Palencia;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QI;""
34 Palencia;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
34 Palencia;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
34 Palencia;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
34 Palencia;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
34 Palencia;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
34 Palencia;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
34 Palencia;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
34 Palencia;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
34 Palencia;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
34 Palencia;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
34 Palencia;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
34 Palencia;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
34 Palencia;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
34 Palencia;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;98,95
34 Palencia;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
34 Palencia;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
34 Palencia;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
34 Palencia;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;98,64
34 Palencia;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
34 Palencia;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
34 Palencia;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
34 Palencia;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;98,61
34 Palencia;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
34 Palencia;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
34 Palencia;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;97,6
34 Palencia;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
34 Palencia;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
34 Palencia;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
34 Palencia;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;97,13
34 Palencia;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
34 Palencia;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
34 Palencia;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
34 Palencia;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;97,31
34 Palencia;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
34 Palencia;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
34 Palencia;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
34 Palencia;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
34 Palencia;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
34 Palencia;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
34 Palencia;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;95,91
34 Palencia;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
34 Palencia;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
34 Palencia;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
34 Palencia;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;96,02
34 Palencia;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
34 Palencia;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
34 Palencia;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
34 Palencia;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
34 Palencia;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
34 Palencia;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
34 Palencia;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;94,2
34 Palencia;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
34 Palencia;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
34 Palencia;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
34 Palencia;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;94,82
34 Palencia;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
34 Palencia;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
34 Palencia;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
34 Palencia;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
34 Palencia;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
34 Palencia;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
34 Palencia;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QIII;1.059
34 Palencia;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
34 Palencia;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
34 Palencia;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
34 Palencia;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QIII;1.052
34 Palencia;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
34 Palencia;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
34 Palencia;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
34 Palencia;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QIII;1.048
34 Palencia;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
34 Palencia;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
34 Palencia;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
34 Palencia;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2022QIII;1.041
34 Palencia;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2022QII;""
34 Palencia;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2022QI;""
34 Palencia;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
34 Palencia;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2021QIII;1.032
34 Palencia;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2021QII;""
34 Palencia;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2021QI;""
34 Palencia;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
34 Palencia;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2020QIII;1.026
34 Palencia;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2020QII;""
34 Palencia;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2020QI;""
34 Palencia;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2022QIV;1.019
34 Palencia;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
34 Palencia;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2022QII;""
34 Palencia;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2022QI;""
34 Palencia;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2021QIV;1.017
34 Palencia;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
34 Palencia;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2021QII;""
34 Palencia;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2021QI;""
34 Palencia;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2020QIV;1.017
34 Palencia;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
34 Palencia;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2020QII;""
34 Palencia;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2020QI;""
34 Palencia;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
34 Palencia;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
34 Palencia;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QII;""
34 Palencia;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QI;998
34 Palencia;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
34 Palencia;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
34 Palencia;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QII;""
34 Palencia;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QI;1.010
34 Palencia;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
34 Palencia;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
34 Palencia;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QII;""
34 Palencia;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QI;""
34 Palencia;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
34 Palencia;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
34 Palencia;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QII;975
34 Palencia;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QI;""
34 Palencia;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
34 Palencia;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
34 Palencia;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QII;1.000
34 Palencia;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QI;""
34 Palencia;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
34 Palencia;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
34 Palencia;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QII;""
34 Palencia;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QI;""
34 Palencia;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
34 Palencia;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
34 Palencia;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
34 Palencia;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
34 Palencia;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
34 Palencia;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
34 Palencia;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
34 Palencia;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
34 Palencia;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
34 Palencia;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
34 Palencia;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
34 Palencia;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
34 Palencia;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
34 Palencia;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;98,3
34 Palencia;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
34 Palencia;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
34 Palencia;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
34 Palencia;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;98,1
34 Palencia;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
34 Palencia;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
34 Palencia;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
34 Palencia;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;97,9
34 Palencia;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
34 Palencia;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
34 Palencia;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;96,22
34 Palencia;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
34 Palencia;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
34 Palencia;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
34 Palencia;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;96,67
34 Palencia;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
34 Palencia;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
34 Palencia;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
34 Palencia;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;97,04
34 Palencia;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
34 Palencia;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
34 Palencia;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
34 Palencia;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
34 Palencia;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
34 Palencia;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
34 Palencia;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;94,87
34 Palencia;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
34 Palencia;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
34 Palencia;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
34 Palencia;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;96,37
34 Palencia;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
34 Palencia;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
34 Palencia;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
34 Palencia;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
34 Palencia;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
34 Palencia;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
34 Palencia;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;92,68
34 Palencia;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
34 Palencia;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
34 Palencia;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
34 Palencia;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;95,42
34 Palencia;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
34 Palencia;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
34 Palencia;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
34 Palencia;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
34 Palencia;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
34 Palencia;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QIV;3.046
34 Palencia;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
34 Palencia;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
34 Palencia;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
34 Palencia;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QIV;3.093
34 Palencia;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
34 Palencia;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
34 Palencia;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
34 Palencia;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QIV;3.122
34 Palencia;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
34 Palencia;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
34 Palencia;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
34 Palencia;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2022QIV;2.996
34 Palencia;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
34 Palencia;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2022QII;""
34 Palencia;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2022QI;""
34 Palencia;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2021QIV;3.044
34 Palencia;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
34 Palencia;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2021QII;""
34 Palencia;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2021QI;""
34 Palencia;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2020QIV;3.082
34 Palencia;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
34 Palencia;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2020QII;""
34 Palencia;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2020QI;""
34 Palencia;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
34 Palencia;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
34 Palencia;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2022QII;""
34 Palencia;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2022QI;2.998
34 Palencia;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
34 Palencia;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
34 Palencia;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2021QII;""
34 Palencia;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2021QI;3.046
34 Palencia;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
34 Palencia;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
34 Palencia;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2020QII;""
34 Palencia;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2020QI;""
34 Palencia;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
34 Palencia;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
34 Palencia;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QII;2.938
34 Palencia;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QI;""
34 Palencia;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
34 Palencia;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
34 Palencia;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QII;3.009
34 Palencia;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QI;""
34 Palencia;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
34 Palencia;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
34 Palencia;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QII;""
34 Palencia;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QI;""
34 Palencia;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
34 Palencia;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QIII;2.912
34 Palencia;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QII;""
34 Palencia;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QI;""
34 Palencia;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
34 Palencia;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QIII;2.972
34 Palencia;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QII;""
34 Palencia;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QI;""
34 Palencia;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
34 Palencia;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
34 Palencia;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QII;""
34 Palencia;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QI;""
34 Palencia;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
34 Palencia;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
34 Palencia;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
34 Palencia;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
34 Palencia;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
34 Palencia;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
34 Palencia;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
34 Palencia;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
34 Palencia;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
34 Palencia;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
34 Palencia;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
34 Palencia;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
34 Palencia;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;98,36
34 Palencia;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
34 Palencia;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
34 Palencia;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
34 Palencia;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;98,42
34 Palencia;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
34 Palencia;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
34 Palencia;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
34 Palencia;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;98,72
34 Palencia;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
34 Palencia;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
34 Palencia;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
34 Palencia;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
34 Palencia;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
34 Palencia;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
34 Palencia;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;96,93
34 Palencia;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
34 Palencia;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
34 Palencia;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
34 Palencia;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;97,57
34 Palencia;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
34 Palencia;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
34 Palencia;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
34 Palencia;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
34 Palencia;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
34 Palencia;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
34 Palencia;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;94,99
34 Palencia;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
34 Palencia;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
34 Palencia;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
34 Palencia;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;96,38
34 Palencia;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
34 Palencia;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
34 Palencia;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
34 Palencia;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
34 Palencia;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
34 Palencia;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
34 Palencia;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;94,15
34 Palencia;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
34 Palencia;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
34 Palencia;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
34 Palencia;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;95,2
34 Palencia;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
34 Palencia;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
34 Palencia;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
34 Palencia;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
34 Palencia;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
34 Palencia;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
34 Palencia;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QIV;1.991
34 Palencia;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
34 Palencia;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
34 Palencia;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
34 Palencia;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QIV;2.046
34 Palencia;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
34 Palencia;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
34 Palencia;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
34 Palencia;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QIV;2.083
34 Palencia;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
34 Palencia;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
34 Palencia;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
34 Palencia;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2022QIV;1.964
34 Palencia;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
34 Palencia;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2022QII;""
34 Palencia;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2022QI;""
34 Palencia;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2021QIV;2.013
34 Palencia;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
34 Palencia;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2021QII;""
34 Palencia;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2021QI;""
34 Palencia;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2020QIV;2.053
34 Palencia;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
34 Palencia;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2020QII;""
34 Palencia;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2020QI;""
34 Palencia;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
34 Palencia;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
34 Palencia;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2022QII;""
34 Palencia;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2022QI;1.987
34 Palencia;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
34 Palencia;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
34 Palencia;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2021QII;""
34 Palencia;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2021QI;2.025
34 Palencia;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
34 Palencia;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
34 Palencia;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2020QII;""
34 Palencia;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2020QI;""
34 Palencia;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
34 Palencia;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
34 Palencia;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QII;1.952
34 Palencia;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QI;""
34 Palencia;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
34 Palencia;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
34 Palencia;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QII;2.000
34 Palencia;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QI;""
34 Palencia;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
34 Palencia;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
34 Palencia;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QII;""
34 Palencia;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QI;""
34 Palencia;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
34 Palencia;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QIII;1.938
34 Palencia;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QII;""
34 Palencia;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QI;""
34 Palencia;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
34 Palencia;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QIII;1.977
34 Palencia;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QII;""
34 Palencia;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QI;""
34 Palencia;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
34 Palencia;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
34 Palencia;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QII;""
34 Palencia;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QI;""
34 Palencia;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
34 Palencia;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
34 Palencia;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
34 Palencia;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
34 Palencia;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
34 Palencia;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
34 Palencia;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
34 Palencia;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
34 Palencia;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
34 Palencia;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
34 Palencia;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
34 Palencia;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
34 Palencia;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;98,64
34 Palencia;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
34 Palencia;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
34 Palencia;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
34 Palencia;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;98,39
34 Palencia;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
34 Palencia;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
34 Palencia;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
34 Palencia;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;98,56
34 Palencia;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
34 Palencia;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
34 Palencia;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
34 Palencia;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
34 Palencia;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
34 Palencia;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
34 Palencia;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;97,12
34 Palencia;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
34 Palencia;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
34 Palencia;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
34 Palencia;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;97,22
34 Palencia;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
34 Palencia;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
34 Palencia;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
34 Palencia;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
34 Palencia;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
34 Palencia;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
34 Palencia;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;95,41
34 Palencia;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
34 Palencia;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
34 Palencia;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
34 Palencia;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;96,02
34 Palencia;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
34 Palencia;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
34 Palencia;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
34 Palencia;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
34 Palencia;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
34 Palencia;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
34 Palencia;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;94,72
34 Palencia;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
34 Palencia;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
34 Palencia;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
34 Palencia;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;94,91
34 Palencia;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
34 Palencia;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
34 Palencia;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
34 Palencia;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
34 Palencia;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
34 Palencia;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
34 Palencia;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QIV;1.055
34 Palencia;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
34 Palencia;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
34 Palencia;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
34 Palencia;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QIV;1.047
34 Palencia;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
34 Palencia;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
34 Palencia;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
34 Palencia;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QIV;1.039
34 Palencia;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
34 Palencia;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
34 Palencia;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
34 Palencia;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2022QIV;1.032
34 Palencia;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
34 Palencia;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2022QII;""
34 Palencia;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2022QI;""
34 Palencia;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2021QIV;1.031
34 Palencia;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
34 Palencia;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2021QII;""
34 Palencia;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2021QI;""
34 Palencia;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2020QIV;1.029
34 Palencia;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
34 Palencia;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2020QII;""
34 Palencia;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2020QI;""
34 Palencia;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
34 Palencia;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
34 Palencia;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2022QII;""
34 Palencia;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2022QI;1.011
34 Palencia;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
34 Palencia;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
34 Palencia;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2021QII;""
34 Palencia;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2021QI;1.021
34 Palencia;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
34 Palencia;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
34 Palencia;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2020QII;""
34 Palencia;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2020QI;""
34 Palencia;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
34 Palencia;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
34 Palencia;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QII;986
34 Palencia;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QI;""
34 Palencia;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
34 Palencia;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
34 Palencia;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QII;1.009
34 Palencia;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QI;""
34 Palencia;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
34 Palencia;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
34 Palencia;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QII;""
34 Palencia;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QI;""
34 Palencia;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
34 Palencia;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QIII;974
34 Palencia;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QII;""
34 Palencia;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QI;""
34 Palencia;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
34 Palencia;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QIII;995
34 Palencia;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QII;""
34 Palencia;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QI;""
34 Palencia;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
34 Palencia;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
34 Palencia;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QII;""
34 Palencia;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QI;""
34 Palencia;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
34 Palencia;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
34 Palencia;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
34 Palencia;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
34 Palencia;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
34 Palencia;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
34 Palencia;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
34 Palencia;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
34 Palencia;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
34 Palencia;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
34 Palencia;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
34 Palencia;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
34 Palencia;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;97,82
34 Palencia;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
34 Palencia;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
34 Palencia;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
34 Palencia;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;98,47
34 Palencia;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
34 Palencia;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
34 Palencia;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
34 Palencia;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;99,04
34 Palencia;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
34 Palencia;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
34 Palencia;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
34 Palencia;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
34 Palencia;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
34 Palencia;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
34 Palencia;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;96,56
34 Palencia;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
34 Palencia;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
34 Palencia;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
34 Palencia;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;98,27
34 Palencia;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
34 Palencia;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
34 Palencia;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
34 Palencia;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
34 Palencia;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
34 Palencia;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
34 Palencia;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;94,17
34 Palencia;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
34 Palencia;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
34 Palencia;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
34 Palencia;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;97,11
34 Palencia;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
34 Palencia;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
34 Palencia;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
34 Palencia;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
34 Palencia;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
34 Palencia;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
34 Palencia;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;93,03
34 Palencia;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
34 Palencia;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
34 Palencia;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
34 Palencia;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;95,77
34 Palencia;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
34 Palencia;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
34 Palencia;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
34 Palencia;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
34 Palencia;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
34 Palencia;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
34 Palencia;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
34 Palencia;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
34 Palencia;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
34 Palencia;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QI;1.803
34 Palencia;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
34 Palencia;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
34 Palencia;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
34 Palencia;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QI;1.748
34 Palencia;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
34 Palencia;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
34 Palencia;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
34 Palencia;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QI;2.038
34 Palencia;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
34 Palencia;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
34 Palencia;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2022QII;""
34 Palencia;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2022QI;1.738
34 Palencia;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
34 Palencia;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
34 Palencia;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2021QII;""
34 Palencia;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2021QI;1.687
34 Palencia;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
34 Palencia;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
34 Palencia;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2020QII;""
34 Palencia;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2020QI;1.912
34 Palencia;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
34 Palencia;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
34 Palencia;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2022QII;1.682
34 Palencia;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2022QI;""
34 Palencia;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
34 Palencia;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
34 Palencia;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2021QII;1.625
34 Palencia;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2021QI;""
34 Palencia;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
34 Palencia;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
34 Palencia;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2020QII;1.865
34 Palencia;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2020QI;""
34 Palencia;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
34 Palencia;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QIII;1.611
34 Palencia;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QII;""
34 Palencia;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QI;""
34 Palencia;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
34 Palencia;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QIII;1.565
34 Palencia;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QII;""
34 Palencia;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QI;""
34 Palencia;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
34 Palencia;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QIII;1.773
34 Palencia;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QII;""
34 Palencia;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QI;""
34 Palencia;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QIV;1.475
34 Palencia;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
34 Palencia;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QII;""
34 Palencia;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QI;""
34 Palencia;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QIV;1.489
34 Palencia;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
34 Palencia;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QII;""
34 Palencia;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QI;""
34 Palencia;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QIV;1.698
34 Palencia;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
34 Palencia;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QII;""
34 Palencia;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QI;""
34 Palencia;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
34 Palencia;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
34 Palencia;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
34 Palencia;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
34 Palencia;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
34 Palencia;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
34 Palencia;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
34 Palencia;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
34 Palencia;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
34 Palencia;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
34 Palencia;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
34 Palencia;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
34 Palencia;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
34 Palencia;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
34 Palencia;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
34 Palencia;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;96,39
34 Palencia;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
34 Palencia;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
34 Palencia;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
34 Palencia;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;96,51
34 Palencia;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
34 Palencia;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
34 Palencia;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
34 Palencia;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;93,82
34 Palencia;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
34 Palencia;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
34 Palencia;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;93,29
34 Palencia;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
34 Palencia;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
34 Palencia;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
34 Palencia;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;92,96
34 Palencia;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
34 Palencia;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
34 Palencia;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
34 Palencia;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;91,51
34 Palencia;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
34 Palencia;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
34 Palencia;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;89,35
34 Palencia;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
34 Palencia;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
34 Palencia;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
34 Palencia;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;89,53
34 Palencia;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
34 Palencia;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
34 Palencia;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
34 Palencia;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;87
34 Palencia;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
34 Palencia;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
34 Palencia;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;81,81
34 Palencia;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
34 Palencia;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
34 Palencia;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
34 Palencia;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;85,18
34 Palencia;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
34 Palencia;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
34 Palencia;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
34 Palencia;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;83,32
34 Palencia;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
34 Palencia;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
34 Palencia;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
34 Palencia;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
34 Palencia;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
34 Palencia;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
34 Palencia;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QI;1.196
34 Palencia;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
34 Palencia;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
34 Palencia;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
34 Palencia;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QI;1.162
34 Palencia;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
34 Palencia;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
34 Palencia;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
34 Palencia;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QI;1.362
34 Palencia;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
34 Palencia;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
34 Palencia;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2022QII;""
34 Palencia;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2022QI;1.148
34 Palencia;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
34 Palencia;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
34 Palencia;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2021QII;""
34 Palencia;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2021QI;1.117
34 Palencia;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
34 Palencia;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
34 Palencia;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2020QII;""
34 Palencia;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2020QI;1.274
34 Palencia;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
34 Palencia;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
34 Palencia;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2022QII;1.117
34 Palencia;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2022QI;""
34 Palencia;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
34 Palencia;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
34 Palencia;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2021QII;1.081
34 Palencia;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2021QI;""
34 Palencia;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
34 Palencia;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
34 Palencia;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2020QII;1.243
34 Palencia;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2020QI;""
34 Palencia;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
34 Palencia;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QIII;1.074
34 Palencia;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QII;""
34 Palencia;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QI;""
34 Palencia;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
34 Palencia;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QIII;1.041
34 Palencia;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QII;""
34 Palencia;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QI;""
34 Palencia;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
34 Palencia;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QIII;1.183
34 Palencia;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QII;""
34 Palencia;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QI;""
34 Palencia;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QIV;984
34 Palencia;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
34 Palencia;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QII;""
34 Palencia;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QI;""
34 Palencia;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QIV;989
34 Palencia;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
34 Palencia;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QII;""
34 Palencia;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QI;""
34 Palencia;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QIV;1.132
34 Palencia;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
34 Palencia;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QII;""
34 Palencia;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QI;""
34 Palencia;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
34 Palencia;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
34 Palencia;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
34 Palencia;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
34 Palencia;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
34 Palencia;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
34 Palencia;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
34 Palencia;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
34 Palencia;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
34 Palencia;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
34 Palencia;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
34 Palencia;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
34 Palencia;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
34 Palencia;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
34 Palencia;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
34 Palencia;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;95,99
34 Palencia;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
34 Palencia;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
34 Palencia;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
34 Palencia;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;96,13
34 Palencia;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
34 Palencia;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
34 Palencia;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
34 Palencia;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;93,54
34 Palencia;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
34 Palencia;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
34 Palencia;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;93,39
34 Palencia;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
34 Palencia;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
34 Palencia;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
34 Palencia;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;93,03
34 Palencia;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
34 Palencia;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
34 Palencia;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
34 Palencia;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;91,26
34 Palencia;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
34 Palencia;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
34 Palencia;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;89,8
34 Palencia;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
34 Palencia;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
34 Palencia;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
34 Palencia;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;89,59
34 Palencia;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
34 Palencia;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
34 Palencia;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
34 Palencia;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;86,86
34 Palencia;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
34 Palencia;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
34 Palencia;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;82,27
34 Palencia;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
34 Palencia;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
34 Palencia;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
34 Palencia;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;85,11
34 Palencia;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
34 Palencia;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
34 Palencia;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
34 Palencia;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;83,11
34 Palencia;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
34 Palencia;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
34 Palencia;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
34 Palencia;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
34 Palencia;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
34 Palencia;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
34 Palencia;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QI;607
34 Palencia;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
34 Palencia;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
34 Palencia;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
34 Palencia;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QI;586
34 Palencia;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
34 Palencia;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
34 Palencia;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
34 Palencia;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QI;676
34 Palencia;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
34 Palencia;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
34 Palencia;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2022QII;""
34 Palencia;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2022QI;590
34 Palencia;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
34 Palencia;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
34 Palencia;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2021QII;""
34 Palencia;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2021QI;570
34 Palencia;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
34 Palencia;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
34 Palencia;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2020QII;""
34 Palencia;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2020QI;638
34 Palencia;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
34 Palencia;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
34 Palencia;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2022QII;565
34 Palencia;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2022QI;""
34 Palencia;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
34 Palencia;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
34 Palencia;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2021QII;544
34 Palencia;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2021QI;""
34 Palencia;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
34 Palencia;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
34 Palencia;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2020QII;622
34 Palencia;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2020QI;""
34 Palencia;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
34 Palencia;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QIII;537
34 Palencia;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QII;""
34 Palencia;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QI;""
34 Palencia;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
34 Palencia;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QIII;524
34 Palencia;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QII;""
34 Palencia;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QI;""
34 Palencia;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
34 Palencia;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QIII;590
34 Palencia;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QII;""
34 Palencia;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QI;""
34 Palencia;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QIV;491
34 Palencia;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
34 Palencia;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QII;""
34 Palencia;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QI;""
34 Palencia;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QIV;500
34 Palencia;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
34 Palencia;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QII;""
34 Palencia;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QI;""
34 Palencia;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QIV;566
34 Palencia;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
34 Palencia;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QII;""
34 Palencia;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QI;""
34 Palencia;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
34 Palencia;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
34 Palencia;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
34 Palencia;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
34 Palencia;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
34 Palencia;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
34 Palencia;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
34 Palencia;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
34 Palencia;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
34 Palencia;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
34 Palencia;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
34 Palencia;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
34 Palencia;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
34 Palencia;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
34 Palencia;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
34 Palencia;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;97,2
34 Palencia;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
34 Palencia;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
34 Palencia;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
34 Palencia;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;97,27
34 Palencia;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
34 Palencia;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
34 Palencia;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
34 Palencia;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;94,38
34 Palencia;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
34 Palencia;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
34 Palencia;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;93,08
34 Palencia;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
34 Palencia;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
34 Palencia;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
34 Palencia;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;92,83
34 Palencia;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
34 Palencia;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
34 Palencia;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
34 Palencia;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;92,01
34 Palencia;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
34 Palencia;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
34 Palencia;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;88,47
34 Palencia;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
34 Palencia;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
34 Palencia;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
34 Palencia;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;89,42
34 Palencia;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
34 Palencia;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
34 Palencia;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
34 Palencia;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;87,28
34 Palencia;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
34 Palencia;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
34 Palencia;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;80,89
34 Palencia;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
34 Palencia;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
34 Palencia;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
34 Palencia;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;85,32
34 Palencia;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
34 Palencia;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
34 Palencia;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
34 Palencia;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;83,73
34 Palencia;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
34 Palencia;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
34 Palencia;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
34 Palencia;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
34 Palencia;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
34 Palencia;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QII;2.026
34 Palencia;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
34 Palencia;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
34 Palencia;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
34 Palencia;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QII;1.985
34 Palencia;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
34 Palencia;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
34 Palencia;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
34 Palencia;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QII;1.937
34 Palencia;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
34 Palencia;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
34 Palencia;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
34 Palencia;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2022QII;1.962
34 Palencia;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2022QI;""
34 Palencia;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
34 Palencia;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
34 Palencia;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2021QII;1.919
34 Palencia;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2021QI;""
34 Palencia;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
34 Palencia;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
34 Palencia;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2020QII;1.888
34 Palencia;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2020QI;""
34 Palencia;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
34 Palencia;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2022QIII;1.888
34 Palencia;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2022QII;""
34 Palencia;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2022QI;""
34 Palencia;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
34 Palencia;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2021QIII;1.855
34 Palencia;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2021QII;""
34 Palencia;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2021QI;""
34 Palencia;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
34 Palencia;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2020QIII;1.791
34 Palencia;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2020QII;""
34 Palencia;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2020QI;""
34 Palencia;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QIV;1.749
34 Palencia;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
34 Palencia;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QII;""
34 Palencia;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QI;""
34 Palencia;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QIV;1.775
34 Palencia;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
34 Palencia;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QII;""
34 Palencia;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QI;""
34 Palencia;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QIV;1.715
34 Palencia;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
34 Palencia;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QII;""
34 Palencia;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QI;""
34 Palencia;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
34 Palencia;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
34 Palencia;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QII;""
34 Palencia;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QI;1.719
34 Palencia;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
34 Palencia;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
34 Palencia;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QII;""
34 Palencia;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QI;1.656
34 Palencia;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
34 Palencia;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
34 Palencia;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QII;""
34 Palencia;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QI;""
34 Palencia;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
34 Palencia;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
34 Palencia;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
34 Palencia;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
34 Palencia;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
34 Palencia;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
34 Palencia;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
34 Palencia;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
34 Palencia;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
34 Palencia;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
34 Palencia;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
34 Palencia;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
34 Palencia;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
34 Palencia;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
34 Palencia;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;96,84
34 Palencia;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
34 Palencia;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
34 Palencia;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
34 Palencia;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;96,68
34 Palencia;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
34 Palencia;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
34 Palencia;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
34 Palencia;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;97,47
34 Palencia;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
34 Palencia;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
34 Palencia;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;93,19
34 Palencia;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
34 Palencia;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
34 Palencia;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
34 Palencia;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;93,45
34 Palencia;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
34 Palencia;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
34 Palencia;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
34 Palencia;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;92,46
34 Palencia;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
34 Palencia;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
34 Palencia;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;86,33
34 Palencia;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
34 Palencia;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
34 Palencia;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
34 Palencia;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;89,42
34 Palencia;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
34 Palencia;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
34 Palencia;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
34 Palencia;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;88,54
34 Palencia;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
34 Palencia;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
34 Palencia;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
34 Palencia;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
34 Palencia;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
34 Palencia;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
34 Palencia;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;86,6
34 Palencia;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
34 Palencia;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
34 Palencia;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
34 Palencia;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;85,49
34 Palencia;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
34 Palencia;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
34 Palencia;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
34 Palencia;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
34 Palencia;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
34 Palencia;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
34 Palencia;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QII;1.346
34 Palencia;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
34 Palencia;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
34 Palencia;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
34 Palencia;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QII;1.314
34 Palencia;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
34 Palencia;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
34 Palencia;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
34 Palencia;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QII;1.290
34 Palencia;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
34 Palencia;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
34 Palencia;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
34 Palencia;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2022QII;1.312
34 Palencia;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2022QI;""
34 Palencia;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
34 Palencia;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
34 Palencia;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2021QII;1.275
34 Palencia;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2021QI;""
34 Palencia;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
34 Palencia;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
34 Palencia;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2020QII;1.257
34 Palencia;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2020QI;""
34 Palencia;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
34 Palencia;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2022QIII;1.269
34 Palencia;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2022QII;""
34 Palencia;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2022QI;""
34 Palencia;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
34 Palencia;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2021QIII;1.233
34 Palencia;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2021QII;""
34 Palencia;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2021QI;""
34 Palencia;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
34 Palencia;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2020QIII;1.192
34 Palencia;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2020QII;""
34 Palencia;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2020QI;""
34 Palencia;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QIV;1.178
34 Palencia;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
34 Palencia;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QII;""
34 Palencia;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QI;""
34 Palencia;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QIV;1.178
34 Palencia;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
34 Palencia;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QII;""
34 Palencia;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QI;""
34 Palencia;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QIV;1.141
34 Palencia;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
34 Palencia;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QII;""
34 Palencia;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QI;""
34 Palencia;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
34 Palencia;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
34 Palencia;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QII;""
34 Palencia;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QI;1.137
34 Palencia;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
34 Palencia;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
34 Palencia;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QII;""
34 Palencia;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QI;1.098
34 Palencia;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
34 Palencia;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
34 Palencia;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QII;""
34 Palencia;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QI;""
34 Palencia;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
34 Palencia;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
34 Palencia;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
34 Palencia;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
34 Palencia;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
34 Palencia;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
34 Palencia;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
34 Palencia;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
34 Palencia;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
34 Palencia;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
34 Palencia;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
34 Palencia;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
34 Palencia;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
34 Palencia;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
34 Palencia;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;97,47
34 Palencia;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
34 Palencia;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
34 Palencia;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
34 Palencia;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;97,03
34 Palencia;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
34 Palencia;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
34 Palencia;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
34 Palencia;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;97,44
34 Palencia;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
34 Palencia;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
34 Palencia;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;94,28
34 Palencia;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
34 Palencia;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
34 Palencia;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
34 Palencia;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;93,84
34 Palencia;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
34 Palencia;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
34 Palencia;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
34 Palencia;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;92,4
34 Palencia;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
34 Palencia;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
34 Palencia;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;87,52
34 Palencia;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
34 Palencia;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
34 Palencia;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
34 Palencia;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;89,65
34 Palencia;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
34 Palencia;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
34 Palencia;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
34 Palencia;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;88,45
34 Palencia;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
34 Palencia;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
34 Palencia;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
34 Palencia;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
34 Palencia;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
34 Palencia;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
34 Palencia;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;86,53
34 Palencia;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
34 Palencia;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
34 Palencia;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
34 Palencia;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;85,12
34 Palencia;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
34 Palencia;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
34 Palencia;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
34 Palencia;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
34 Palencia;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
34 Palencia;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
34 Palencia;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QII;680
34 Palencia;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
34 Palencia;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
34 Palencia;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
34 Palencia;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QII;671
34 Palencia;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
34 Palencia;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
34 Palencia;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
34 Palencia;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QII;647
34 Palencia;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
34 Palencia;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
34 Palencia;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
34 Palencia;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2022QII;650
34 Palencia;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2022QI;""
34 Palencia;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
34 Palencia;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
34 Palencia;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2021QII;644
34 Palencia;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2021QI;""
34 Palencia;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
34 Palencia;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
34 Palencia;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2020QII;631
34 Palencia;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2020QI;""
34 Palencia;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
34 Palencia;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2022QIII;619
34 Palencia;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2022QII;""
34 Palencia;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2022QI;""
34 Palencia;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
34 Palencia;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2021QIII;622
34 Palencia;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2021QII;""
34 Palencia;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2021QI;""
34 Palencia;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
34 Palencia;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2020QIII;599
34 Palencia;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2020QII;""
34 Palencia;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2020QI;""
34 Palencia;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QIV;571
34 Palencia;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
34 Palencia;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QII;""
34 Palencia;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QI;""
34 Palencia;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QIV;597
34 Palencia;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
34 Palencia;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QII;""
34 Palencia;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QI;""
34 Palencia;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QIV;574
34 Palencia;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
34 Palencia;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QII;""
34 Palencia;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QI;""
34 Palencia;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
34 Palencia;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
34 Palencia;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QII;""
34 Palencia;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QI;582
34 Palencia;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
34 Palencia;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
34 Palencia;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QII;""
34 Palencia;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QI;558
34 Palencia;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
34 Palencia;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
34 Palencia;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QII;""
34 Palencia;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QI;""
34 Palencia;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
34 Palencia;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
34 Palencia;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
34 Palencia;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
34 Palencia;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
34 Palencia;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
34 Palencia;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
34 Palencia;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
34 Palencia;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
34 Palencia;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
34 Palencia;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
34 Palencia;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
34 Palencia;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
34 Palencia;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
34 Palencia;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;95,59
34 Palencia;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
34 Palencia;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
34 Palencia;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
34 Palencia;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;95,98
34 Palencia;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
34 Palencia;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
34 Palencia;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
34 Palencia;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;97,53
34 Palencia;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
34 Palencia;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
34 Palencia;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;91,03
34 Palencia;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
34 Palencia;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
34 Palencia;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
34 Palencia;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;92,7
34 Palencia;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
34 Palencia;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
34 Palencia;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
34 Palencia;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;92,58
34 Palencia;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
34 Palencia;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
34 Palencia;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;83,97
34 Palencia;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
34 Palencia;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
34 Palencia;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
34 Palencia;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;88,97
34 Palencia;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
34 Palencia;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
34 Palencia;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
34 Palencia;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;88,72
34 Palencia;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
34 Palencia;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
34 Palencia;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
34 Palencia;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
34 Palencia;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
34 Palencia;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
34 Palencia;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;86,74
34 Palencia;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
34 Palencia;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
34 Palencia;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
34 Palencia;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;86,24
34 Palencia;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
34 Palencia;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
34 Palencia;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
34 Palencia;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
34 Palencia;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
34 Palencia;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QIII;1.981
34 Palencia;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
34 Palencia;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
34 Palencia;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
34 Palencia;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QIII;1.939
34 Palencia;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
34 Palencia;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
34 Palencia;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
34 Palencia;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QIII;1.903
34 Palencia;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
34 Palencia;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
34 Palencia;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
34 Palencia;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2022QIII;1.899
34 Palencia;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2022QII;""
34 Palencia;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2022QI;""
34 Palencia;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
34 Palencia;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2021QIII;1.868
34 Palencia;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2021QII;""
34 Palencia;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2021QI;""
34 Palencia;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
34 Palencia;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2020QIII;1.805
34 Palencia;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2020QII;""
34 Palencia;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2020QI;""
34 Palencia;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2022QIV;1.755
34 Palencia;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
34 Palencia;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2022QII;""
34 Palencia;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2022QI;""
34 Palencia;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2021QIV;1.783
34 Palencia;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
34 Palencia;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2021QII;""
34 Palencia;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2021QI;""
34 Palencia;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2020QIV;1.728
34 Palencia;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
34 Palencia;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2020QII;""
34 Palencia;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2020QI;""
34 Palencia;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
34 Palencia;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
34 Palencia;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QII;""
34 Palencia;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QI;1.727
34 Palencia;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
34 Palencia;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
34 Palencia;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QII;""
34 Palencia;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QI;1.668
34 Palencia;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
34 Palencia;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
34 Palencia;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QII;""
34 Palencia;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QI;""
34 Palencia;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
34 Palencia;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
34 Palencia;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QII;1.672
34 Palencia;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QI;""
34 Palencia;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
34 Palencia;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
34 Palencia;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QII;1.608
34 Palencia;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QI;""
34 Palencia;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
34 Palencia;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
34 Palencia;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QII;""
34 Palencia;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QI;""
34 Palencia;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
34 Palencia;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
34 Palencia;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
34 Palencia;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
34 Palencia;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
34 Palencia;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
34 Palencia;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
34 Palencia;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
34 Palencia;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
34 Palencia;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
34 Palencia;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
34 Palencia;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
34 Palencia;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
34 Palencia;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;95,86
34 Palencia;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
34 Palencia;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
34 Palencia;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
34 Palencia;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;96,34
34 Palencia;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
34 Palencia;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
34 Palencia;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
34 Palencia;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;94,85
34 Palencia;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
34 Palencia;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
34 Palencia;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;88,59
34 Palencia;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
34 Palencia;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
34 Palencia;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
34 Palencia;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;91,95
34 Palencia;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
34 Palencia;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
34 Palencia;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
34 Palencia;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;90,8
34 Palencia;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
34 Palencia;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
34 Palencia;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
34 Palencia;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
34 Palencia;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
34 Palencia;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
34 Palencia;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;89,07
34 Palencia;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
34 Palencia;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
34 Palencia;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
34 Palencia;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;87,65
34 Palencia;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
34 Palencia;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
34 Palencia;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
34 Palencia;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
34 Palencia;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
34 Palencia;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
34 Palencia;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;86,23
34 Palencia;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
34 Palencia;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
34 Palencia;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
34 Palencia;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;84,5
34 Palencia;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
34 Palencia;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
34 Palencia;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
34 Palencia;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
34 Palencia;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
34 Palencia;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
34 Palencia;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QIII;1.323
34 Palencia;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
34 Palencia;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
34 Palencia;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
34 Palencia;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QIII;1.289
34 Palencia;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
34 Palencia;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
34 Palencia;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
34 Palencia;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QIII;1.268
34 Palencia;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
34 Palencia;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
34 Palencia;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
34 Palencia;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2022QIII;1.276
34 Palencia;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2022QII;""
34 Palencia;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2022QI;""
34 Palencia;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
34 Palencia;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2021QIII;1.242
34 Palencia;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2021QII;""
34 Palencia;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2021QI;""
34 Palencia;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
34 Palencia;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2020QIII;1.202
34 Palencia;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2020QII;""
34 Palencia;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2020QI;""
34 Palencia;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2022QIV;1.181
34 Palencia;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
34 Palencia;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2022QII;""
34 Palencia;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2022QI;""
34 Palencia;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2021QIV;1.183
34 Palencia;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
34 Palencia;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2021QII;""
34 Palencia;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2021QI;""
34 Palencia;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2020QIV;1.150
34 Palencia;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
34 Palencia;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2020QII;""
34 Palencia;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2020QI;""
34 Palencia;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
34 Palencia;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
34 Palencia;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QII;""
34 Palencia;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QI;1.142
34 Palencia;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
34 Palencia;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
34 Palencia;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QII;""
34 Palencia;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QI;1.106
34 Palencia;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
34 Palencia;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
34 Palencia;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QII;""
34 Palencia;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QI;""
34 Palencia;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
34 Palencia;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
34 Palencia;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QII;1.111
34 Palencia;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QI;""
34 Palencia;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
34 Palencia;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
34 Palencia;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QII;1.071
34 Palencia;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QI;""
34 Palencia;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
34 Palencia;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
34 Palencia;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QII;""
34 Palencia;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QI;""
34 Palencia;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
34 Palencia;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
34 Palencia;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
34 Palencia;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
34 Palencia;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
34 Palencia;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
34 Palencia;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
34 Palencia;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
34 Palencia;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
34 Palencia;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
34 Palencia;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
34 Palencia;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
34 Palencia;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
34 Palencia;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;96,45
34 Palencia;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
34 Palencia;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
34 Palencia;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
34 Palencia;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;96,35
34 Palencia;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
34 Palencia;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
34 Palencia;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
34 Palencia;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;94,79
34 Palencia;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
34 Palencia;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
34 Palencia;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;89,27
34 Palencia;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
34 Palencia;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
34 Palencia;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
34 Palencia;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;91,78
34 Palencia;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
34 Palencia;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
34 Palencia;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
34 Palencia;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;90,69
34 Palencia;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
34 Palencia;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
34 Palencia;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
34 Palencia;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
34 Palencia;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
34 Palencia;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
34 Palencia;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;88,6
34 Palencia;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
34 Palencia;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
34 Palencia;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
34 Palencia;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;87,22
34 Palencia;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
34 Palencia;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
34 Palencia;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
34 Palencia;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
34 Palencia;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
34 Palencia;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
34 Palencia;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;86,19
34 Palencia;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
34 Palencia;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
34 Palencia;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
34 Palencia;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;84,46
34 Palencia;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
34 Palencia;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
34 Palencia;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
34 Palencia;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
34 Palencia;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
34 Palencia;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
34 Palencia;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QIII;658
34 Palencia;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
34 Palencia;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
34 Palencia;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
34 Palencia;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QIII;650
34 Palencia;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
34 Palencia;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
34 Palencia;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
34 Palencia;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QIII;635
34 Palencia;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
34 Palencia;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
34 Palencia;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
34 Palencia;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2022QIII;623
34 Palencia;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2022QII;""
34 Palencia;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2022QI;""
34 Palencia;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
34 Palencia;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2021QIII;626
34 Palencia;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2021QII;""
34 Palencia;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2021QI;""
34 Palencia;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
34 Palencia;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2020QIII;603
34 Palencia;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2020QII;""
34 Palencia;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2020QI;""
34 Palencia;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2022QIV;574
34 Palencia;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
34 Palencia;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2022QII;""
34 Palencia;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2022QI;""
34 Palencia;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2021QIV;600
34 Palencia;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
34 Palencia;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2021QII;""
34 Palencia;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2021QI;""
34 Palencia;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2020QIV;578
34 Palencia;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
34 Palencia;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2020QII;""
34 Palencia;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2020QI;""
34 Palencia;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
34 Palencia;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
34 Palencia;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QII;""
34 Palencia;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QI;585
34 Palencia;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
34 Palencia;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
34 Palencia;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QII;""
34 Palencia;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QI;562
34 Palencia;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
34 Palencia;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
34 Palencia;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QII;""
34 Palencia;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QI;""
34 Palencia;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
34 Palencia;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
34 Palencia;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QII;561
34 Palencia;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QI;""
34 Palencia;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
34 Palencia;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
34 Palencia;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QII;537
34 Palencia;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QI;""
34 Palencia;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
34 Palencia;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
34 Palencia;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QII;""
34 Palencia;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QI;""
34 Palencia;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
34 Palencia;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
34 Palencia;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
34 Palencia;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
34 Palencia;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
34 Palencia;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
34 Palencia;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
34 Palencia;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
34 Palencia;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
34 Palencia;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
34 Palencia;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
34 Palencia;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
34 Palencia;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
34 Palencia;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;94,68
34 Palencia;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
34 Palencia;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
34 Palencia;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
34 Palencia;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;96,31
34 Palencia;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
34 Palencia;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
34 Palencia;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
34 Palencia;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;94,96
34 Palencia;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
34 Palencia;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
34 Palencia;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;87,23
34 Palencia;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
34 Palencia;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
34 Palencia;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
34 Palencia;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;92,31
34 Palencia;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
34 Palencia;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
34 Palencia;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
34 Palencia;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;91,02
34 Palencia;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
34 Palencia;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
34 Palencia;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
34 Palencia;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
34 Palencia;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
34 Palencia;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
34 Palencia;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;90
34 Palencia;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
34 Palencia;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
34 Palencia;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
34 Palencia;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;88,5
34 Palencia;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
34 Palencia;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
34 Palencia;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
34 Palencia;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
34 Palencia;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
34 Palencia;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
34 Palencia;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;86,31
34 Palencia;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
34 Palencia;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
34 Palencia;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
34 Palencia;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;84,57
34 Palencia;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
34 Palencia;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
34 Palencia;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
34 Palencia;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
34 Palencia;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
34 Palencia;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QIV;1.911
34 Palencia;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
34 Palencia;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
34 Palencia;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
34 Palencia;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QIV;1.878
34 Palencia;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
34 Palencia;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
34 Palencia;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
34 Palencia;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QIV;1.821
34 Palencia;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
34 Palencia;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
34 Palencia;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
34 Palencia;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2022QIV;1.766
34 Palencia;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
34 Palencia;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2022QII;""
34 Palencia;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2022QI;""
34 Palencia;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2021QIV;1.792
34 Palencia;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
34 Palencia;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2021QII;""
34 Palencia;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2021QI;""
34 Palencia;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2020QIV;1.736
34 Palencia;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
34 Palencia;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2020QII;""
34 Palencia;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2020QI;""
34 Palencia;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
34 Palencia;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
34 Palencia;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2022QII;""
34 Palencia;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2022QI;1.733
34 Palencia;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
34 Palencia;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
34 Palencia;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2021QII;""
34 Palencia;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2021QI;1.675
34 Palencia;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
34 Palencia;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
34 Palencia;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2020QII;""
34 Palencia;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2020QI;""
34 Palencia;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
34 Palencia;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
34 Palencia;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QII;1.678
34 Palencia;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QI;""
34 Palencia;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
34 Palencia;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
34 Palencia;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QII;1.615
34 Palencia;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QI;""
34 Palencia;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
34 Palencia;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
34 Palencia;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QII;""
34 Palencia;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QI;""
34 Palencia;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
34 Palencia;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QIII;1.608
34 Palencia;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QII;""
34 Palencia;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QI;""
34 Palencia;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
34 Palencia;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QIII;1.558
34 Palencia;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QII;""
34 Palencia;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QI;""
34 Palencia;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
34 Palencia;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
34 Palencia;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QII;""
34 Palencia;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QI;""
34 Palencia;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
34 Palencia;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
34 Palencia;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
34 Palencia;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
34 Palencia;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
34 Palencia;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
34 Palencia;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
34 Palencia;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
34 Palencia;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
34 Palencia;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
34 Palencia;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
34 Palencia;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
34 Palencia;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;92,41
34 Palencia;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
34 Palencia;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
34 Palencia;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
34 Palencia;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;95,42
34 Palencia;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
34 Palencia;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
34 Palencia;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
34 Palencia;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;95,33
34 Palencia;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
34 Palencia;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
34 Palencia;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
34 Palencia;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
34 Palencia;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
34 Palencia;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
34 Palencia;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;92,28
34 Palencia;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
34 Palencia;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
34 Palencia;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
34 Palencia;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;91,98
34 Palencia;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
34 Palencia;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
34 Palencia;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
34 Palencia;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
34 Palencia;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
34 Palencia;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
34 Palencia;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;89,35
34 Palencia;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
34 Palencia;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
34 Palencia;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
34 Palencia;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;88,69
34 Palencia;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
34 Palencia;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
34 Palencia;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
34 Palencia;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
34 Palencia;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
34 Palencia;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
34 Palencia;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;85,62
34 Palencia;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
34 Palencia;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
34 Palencia;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
34 Palencia;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;85,56
34 Palencia;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
34 Palencia;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
34 Palencia;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
34 Palencia;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
34 Palencia;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
34 Palencia;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
34 Palencia;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QIV;1.284
34 Palencia;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
34 Palencia;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
34 Palencia;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
34 Palencia;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QIV;1.251
34 Palencia;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
34 Palencia;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
34 Palencia;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
34 Palencia;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QIV;1.214
34 Palencia;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
34 Palencia;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
34 Palencia;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
34 Palencia;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2022QIV;1.188
34 Palencia;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
34 Palencia;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2022QII;""
34 Palencia;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2022QI;""
34 Palencia;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2021QIV;1.191
34 Palencia;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
34 Palencia;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2021QII;""
34 Palencia;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2021QI;""
34 Palencia;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2020QIV;1.154
34 Palencia;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
34 Palencia;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2020QII;""
34 Palencia;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2020QI;""
34 Palencia;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
34 Palencia;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
34 Palencia;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2022QII;""
34 Palencia;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2022QI;1.147
34 Palencia;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
34 Palencia;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
34 Palencia;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2021QII;""
34 Palencia;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2021QI;1.109
34 Palencia;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
34 Palencia;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
34 Palencia;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2020QII;""
34 Palencia;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2020QI;""
34 Palencia;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
34 Palencia;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
34 Palencia;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QII;1.116
34 Palencia;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QI;""
34 Palencia;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
34 Palencia;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
34 Palencia;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QII;1.074
34 Palencia;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QI;""
34 Palencia;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
34 Palencia;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
34 Palencia;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QII;""
34 Palencia;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QI;""
34 Palencia;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
34 Palencia;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QIII;1.073
34 Palencia;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QII;""
34 Palencia;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QI;""
34 Palencia;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
34 Palencia;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QIII;1.035
34 Palencia;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QII;""
34 Palencia;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QI;""
34 Palencia;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
34 Palencia;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
34 Palencia;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QII;""
34 Palencia;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QI;""
34 Palencia;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
34 Palencia;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
34 Palencia;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
34 Palencia;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
34 Palencia;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
34 Palencia;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
34 Palencia;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
34 Palencia;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
34 Palencia;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
34 Palencia;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
34 Palencia;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
34 Palencia;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
34 Palencia;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;92,52
34 Palencia;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
34 Palencia;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
34 Palencia;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
34 Palencia;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;95,2
34 Palencia;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
34 Palencia;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
34 Palencia;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
34 Palencia;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;95,06
34 Palencia;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
34 Palencia;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
34 Palencia;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
34 Palencia;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
34 Palencia;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
34 Palencia;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
34 Palencia;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;91,69
34 Palencia;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
34 Palencia;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
34 Palencia;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
34 Palencia;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;91,35
34 Palencia;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
34 Palencia;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
34 Palencia;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
34 Palencia;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
34 Palencia;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
34 Palencia;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
34 Palencia;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;89,21
34 Palencia;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
34 Palencia;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
34 Palencia;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
34 Palencia;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;88,47
34 Palencia;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
34 Palencia;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
34 Palencia;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
34 Palencia;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
34 Palencia;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
34 Palencia;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
34 Palencia;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;85,77
34 Palencia;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
34 Palencia;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
34 Palencia;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
34 Palencia;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;85,26
34 Palencia;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
34 Palencia;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
34 Palencia;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
34 Palencia;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
34 Palencia;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
34 Palencia;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
34 Palencia;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QIV;627
34 Palencia;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
34 Palencia;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
34 Palencia;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
34 Palencia;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QIV;627
34 Palencia;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
34 Palencia;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
34 Palencia;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
34 Palencia;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QIV;607
34 Palencia;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
34 Palencia;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
34 Palencia;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
34 Palencia;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2022QIV;578
34 Palencia;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
34 Palencia;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2022QII;""
34 Palencia;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2022QI;""
34 Palencia;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2021QIV;601
34 Palencia;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
34 Palencia;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2021QII;""
34 Palencia;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2021QI;""
34 Palencia;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2020QIV;582
34 Palencia;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
34 Palencia;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2020QII;""
34 Palencia;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2020QI;""
34 Palencia;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
34 Palencia;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
34 Palencia;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2022QII;""
34 Palencia;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2022QI;586
34 Palencia;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
34 Palencia;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
34 Palencia;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2021QII;""
34 Palencia;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2021QI;566
34 Palencia;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
34 Palencia;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
34 Palencia;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2020QII;""
34 Palencia;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2020QI;""
34 Palencia;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
34 Palencia;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
34 Palencia;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QII;562
34 Palencia;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QI;""
34 Palencia;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
34 Palencia;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
34 Palencia;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QII;541
34 Palencia;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QI;""
34 Palencia;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
34 Palencia;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
34 Palencia;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QII;""
34 Palencia;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QI;""
34 Palencia;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
34 Palencia;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QIII;535
34 Palencia;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QII;""
34 Palencia;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QI;""
34 Palencia;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
34 Palencia;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QIII;523
34 Palencia;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QII;""
34 Palencia;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QI;""
34 Palencia;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
34 Palencia;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
34 Palencia;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QII;""
34 Palencia;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QI;""
34 Palencia;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
34 Palencia;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
34 Palencia;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
34 Palencia;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
34 Palencia;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
34 Palencia;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
34 Palencia;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
34 Palencia;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
34 Palencia;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
34 Palencia;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
34 Palencia;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
34 Palencia;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
34 Palencia;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;92,19
34 Palencia;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
34 Palencia;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
34 Palencia;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
34 Palencia;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;95,85
34 Palencia;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
34 Palencia;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
34 Palencia;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
34 Palencia;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;95,88
34 Palencia;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
34 Palencia;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
34 Palencia;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
34 Palencia;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
34 Palencia;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
34 Palencia;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
34 Palencia;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;93,46
34 Palencia;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
34 Palencia;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
34 Palencia;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
34 Palencia;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;93,25
34 Palencia;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
34 Palencia;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
34 Palencia;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
34 Palencia;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
34 Palencia;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
34 Palencia;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
34 Palencia;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;89,63
34 Palencia;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
34 Palencia;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
34 Palencia;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
34 Palencia;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;89,13
34 Palencia;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
34 Palencia;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
34 Palencia;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
34 Palencia;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
34 Palencia;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
34 Palencia;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
34 Palencia;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;85,33
34 Palencia;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
34 Palencia;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
34 Palencia;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
34 Palencia;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;86,16
34 Palencia;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
34 Palencia;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
34 Palencia;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
34 Palencia;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
34 Palencia;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
34 Palencia;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
35 Palmas, Las;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
35 Palmas, Las;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
35 Palmas, Las;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
35 Palmas, Las;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QI;65.236
35 Palmas, Las;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
35 Palmas, Las;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
35 Palmas, Las;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
35 Palmas, Las;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QI;62.720
35 Palmas, Las;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
35 Palmas, Las;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
35 Palmas, Las;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
35 Palmas, Las;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QI;63.610
35 Palmas, Las;All ages;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
35 Palmas, Las;All ages;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
35 Palmas, Las;All ages;Cohort January 1;Total;Survival in the first trimester;2022QII;""
35 Palmas, Las;All ages;Cohort January 1;Total;Survival in the first trimester;2022QI;62.905
35 Palmas, Las;All ages;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
35 Palmas, Las;All ages;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
35 Palmas, Las;All ages;Cohort January 1;Total;Survival in the first trimester;2021QII;""
35 Palmas, Las;All ages;Cohort January 1;Total;Survival in the first trimester;2021QI;60.765
35 Palmas, Las;All ages;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
35 Palmas, Las;All ages;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
35 Palmas, Las;All ages;Cohort January 1;Total;Survival in the first trimester;2020QII;""
35 Palmas, Las;All ages;Cohort January 1;Total;Survival in the first trimester;2020QI;59.141
35 Palmas, Las;All ages;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
35 Palmas, Las;All ages;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
35 Palmas, Las;All ages;Cohort January 1;Total;Survival in the second trimester;2022QII;60.563
35 Palmas, Las;All ages;Cohort January 1;Total;Survival in the second trimester;2022QI;""
35 Palmas, Las;All ages;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
35 Palmas, Las;All ages;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
35 Palmas, Las;All ages;Cohort January 1;Total;Survival in the second trimester;2021QII;58.923
35 Palmas, Las;All ages;Cohort January 1;Total;Survival in the second trimester;2021QI;""
35 Palmas, Las;All ages;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
35 Palmas, Las;All ages;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
35 Palmas, Las;All ages;Cohort January 1;Total;Survival in the second trimester;2020QII;57.687
35 Palmas, Las;All ages;Cohort January 1;Total;Survival in the second trimester;2020QI;""
35 Palmas, Las;All ages;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
35 Palmas, Las;All ages;Cohort January 1;Total;Survival in the third trimester;2022QIII;58.686
35 Palmas, Las;All ages;Cohort January 1;Total;Survival in the third trimester;2022QII;""
35 Palmas, Las;All ages;Cohort January 1;Total;Survival in the third trimester;2022QI;""
35 Palmas, Las;All ages;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
35 Palmas, Las;All ages;Cohort January 1;Total;Survival in the third trimester;2021QIII;57.439
35 Palmas, Las;All ages;Cohort January 1;Total;Survival in the third trimester;2021QII;""
35 Palmas, Las;All ages;Cohort January 1;Total;Survival in the third trimester;2021QI;""
35 Palmas, Las;All ages;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
35 Palmas, Las;All ages;Cohort January 1;Total;Survival in the third trimester;2020QIII;55.840
35 Palmas, Las;All ages;Cohort January 1;Total;Survival in the third trimester;2020QII;""
35 Palmas, Las;All ages;Cohort January 1;Total;Survival in the third trimester;2020QI;""
35 Palmas, Las;All ages;Cohort January 1;Total;Survival in the third trimester;2022QIV;56.732
35 Palmas, Las;All ages;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
35 Palmas, Las;All ages;Cohort January 1;Total;Survival in the third trimester;2022QII;""
35 Palmas, Las;All ages;Cohort January 1;Total;Survival in the third trimester;2022QI;""
35 Palmas, Las;All ages;Cohort January 1;Total;Survival in the third trimester;2021QIV;55.672
35 Palmas, Las;All ages;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
35 Palmas, Las;All ages;Cohort January 1;Total;Survival in the third trimester;2021QII;""
35 Palmas, Las;All ages;Cohort January 1;Total;Survival in the third trimester;2021QI;""
35 Palmas, Las;All ages;Cohort January 1;Total;Survival in the third trimester;2020QIV;54.156
35 Palmas, Las;All ages;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
35 Palmas, Las;All ages;Cohort January 1;Total;Survival in the third trimester;2020QII;""
35 Palmas, Las;All ages;Cohort January 1;Total;Survival in the third trimester;2020QI;""
35 Palmas, Las;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
35 Palmas, Las;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
35 Palmas, Las;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
35 Palmas, Las;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
35 Palmas, Las;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
35 Palmas, Las;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
35 Palmas, Las;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
35 Palmas, Las;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
35 Palmas, Las;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
35 Palmas, Las;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
35 Palmas, Las;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
35 Palmas, Las;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
35 Palmas, Las;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
35 Palmas, Las;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
35 Palmas, Las;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
35 Palmas, Las;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;96,43
35 Palmas, Las;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
35 Palmas, Las;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
35 Palmas, Las;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
35 Palmas, Las;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;96,88
35 Palmas, Las;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
35 Palmas, Las;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
35 Palmas, Las;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
35 Palmas, Las;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;92,97
35 Palmas, Las;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
35 Palmas, Las;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
35 Palmas, Las;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;92,84
35 Palmas, Las;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
35 Palmas, Las;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
35 Palmas, Las;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
35 Palmas, Las;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;93,95
35 Palmas, Las;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
35 Palmas, Las;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
35 Palmas, Las;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
35 Palmas, Las;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;90,69
35 Palmas, Las;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
35 Palmas, Las;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
35 Palmas, Las;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;89,96
35 Palmas, Las;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
35 Palmas, Las;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
35 Palmas, Las;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
35 Palmas, Las;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;91,58
35 Palmas, Las;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
35 Palmas, Las;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
35 Palmas, Las;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
35 Palmas, Las;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;87,78
35 Palmas, Las;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
35 Palmas, Las;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
35 Palmas, Las;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;86,96
35 Palmas, Las;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
35 Palmas, Las;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
35 Palmas, Las;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
35 Palmas, Las;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;88,76
35 Palmas, Las;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
35 Palmas, Las;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
35 Palmas, Las;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
35 Palmas, Las;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;85,14
35 Palmas, Las;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
35 Palmas, Las;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
35 Palmas, Las;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
35 Palmas, Las;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
35 Palmas, Las;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
35 Palmas, Las;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
35 Palmas, Las;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QI;41.768
35 Palmas, Las;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
35 Palmas, Las;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
35 Palmas, Las;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
35 Palmas, Las;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QI;40.562
35 Palmas, Las;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
35 Palmas, Las;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
35 Palmas, Las;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
35 Palmas, Las;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QI;41.187
35 Palmas, Las;All ages;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
35 Palmas, Las;All ages;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
35 Palmas, Las;All ages;Cohort January 1;Males;Survival in the first trimester;2022QII;""
35 Palmas, Las;All ages;Cohort January 1;Males;Survival in the first trimester;2022QI;40.403
35 Palmas, Las;All ages;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
35 Palmas, Las;All ages;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
35 Palmas, Las;All ages;Cohort January 1;Males;Survival in the first trimester;2021QII;""
35 Palmas, Las;All ages;Cohort January 1;Males;Survival in the first trimester;2021QI;39.382
35 Palmas, Las;All ages;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
35 Palmas, Las;All ages;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
35 Palmas, Las;All ages;Cohort January 1;Males;Survival in the first trimester;2020QII;""
35 Palmas, Las;All ages;Cohort January 1;Males;Survival in the first trimester;2020QI;38.534
35 Palmas, Las;All ages;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
35 Palmas, Las;All ages;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
35 Palmas, Las;All ages;Cohort January 1;Males;Survival in the second trimester;2022QII;39.027
35 Palmas, Las;All ages;Cohort January 1;Males;Survival in the second trimester;2022QI;""
35 Palmas, Las;All ages;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
35 Palmas, Las;All ages;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
35 Palmas, Las;All ages;Cohort January 1;Males;Survival in the second trimester;2021QII;38.306
35 Palmas, Las;All ages;Cohort January 1;Males;Survival in the second trimester;2021QI;""
35 Palmas, Las;All ages;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
35 Palmas, Las;All ages;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
35 Palmas, Las;All ages;Cohort January 1;Males;Survival in the second trimester;2020QII;37.646
35 Palmas, Las;All ages;Cohort January 1;Males;Survival in the second trimester;2020QI;""
35 Palmas, Las;All ages;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
35 Palmas, Las;All ages;Cohort January 1;Males;Survival in the third trimester;2022QIII;37.960
35 Palmas, Las;All ages;Cohort January 1;Males;Survival in the third trimester;2022QII;""
35 Palmas, Las;All ages;Cohort January 1;Males;Survival in the third trimester;2022QI;""
35 Palmas, Las;All ages;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
35 Palmas, Las;All ages;Cohort January 1;Males;Survival in the third trimester;2021QIII;37.419
35 Palmas, Las;All ages;Cohort January 1;Males;Survival in the third trimester;2021QII;""
35 Palmas, Las;All ages;Cohort January 1;Males;Survival in the third trimester;2021QI;""
35 Palmas, Las;All ages;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
35 Palmas, Las;All ages;Cohort January 1;Males;Survival in the third trimester;2020QIII;36.544
35 Palmas, Las;All ages;Cohort January 1;Males;Survival in the third trimester;2020QII;""
35 Palmas, Las;All ages;Cohort January 1;Males;Survival in the third trimester;2020QI;""
35 Palmas, Las;All ages;Cohort January 1;Males;Survival in the third trimester;2022QIV;36.777
35 Palmas, Las;All ages;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
35 Palmas, Las;All ages;Cohort January 1;Males;Survival in the third trimester;2022QII;""
35 Palmas, Las;All ages;Cohort January 1;Males;Survival in the third trimester;2022QI;""
35 Palmas, Las;All ages;Cohort January 1;Males;Survival in the third trimester;2021QIV;36.326
35 Palmas, Las;All ages;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
35 Palmas, Las;All ages;Cohort January 1;Males;Survival in the third trimester;2021QII;""
35 Palmas, Las;All ages;Cohort January 1;Males;Survival in the third trimester;2021QI;""
35 Palmas, Las;All ages;Cohort January 1;Males;Survival in the third trimester;2020QIV;35.494
35 Palmas, Las;All ages;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
35 Palmas, Las;All ages;Cohort January 1;Males;Survival in the third trimester;2020QII;""
35 Palmas, Las;All ages;Cohort January 1;Males;Survival in the third trimester;2020QI;""
35 Palmas, Las;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
35 Palmas, Las;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
35 Palmas, Las;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
35 Palmas, Las;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
35 Palmas, Las;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
35 Palmas, Las;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
35 Palmas, Las;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
35 Palmas, Las;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
35 Palmas, Las;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
35 Palmas, Las;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
35 Palmas, Las;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
35 Palmas, Las;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
35 Palmas, Las;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
35 Palmas, Las;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
35 Palmas, Las;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
35 Palmas, Las;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;96,73
35 Palmas, Las;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
35 Palmas, Las;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
35 Palmas, Las;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
35 Palmas, Las;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;97,09
35 Palmas, Las;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
35 Palmas, Las;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
35 Palmas, Las;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
35 Palmas, Las;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;93,56
35 Palmas, Las;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
35 Palmas, Las;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
35 Palmas, Las;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;93,44
35 Palmas, Las;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
35 Palmas, Las;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
35 Palmas, Las;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
35 Palmas, Las;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;94,44
35 Palmas, Las;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
35 Palmas, Las;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
35 Palmas, Las;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
35 Palmas, Las;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;91,4
35 Palmas, Las;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
35 Palmas, Las;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
35 Palmas, Las;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;90,88
35 Palmas, Las;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
35 Palmas, Las;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
35 Palmas, Las;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
35 Palmas, Las;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;92,25
35 Palmas, Las;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
35 Palmas, Las;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
35 Palmas, Las;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
35 Palmas, Las;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;88,73
35 Palmas, Las;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
35 Palmas, Las;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
35 Palmas, Las;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;88,05
35 Palmas, Las;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
35 Palmas, Las;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
35 Palmas, Las;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
35 Palmas, Las;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;89,56
35 Palmas, Las;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
35 Palmas, Las;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
35 Palmas, Las;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
35 Palmas, Las;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;86,18
35 Palmas, Las;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
35 Palmas, Las;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
35 Palmas, Las;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
35 Palmas, Las;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
35 Palmas, Las;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
35 Palmas, Las;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
35 Palmas, Las;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QI;23.468
35 Palmas, Las;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
35 Palmas, Las;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
35 Palmas, Las;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
35 Palmas, Las;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QI;22.158
35 Palmas, Las;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
35 Palmas, Las;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
35 Palmas, Las;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
35 Palmas, Las;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QI;22.423
35 Palmas, Las;All ages;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
35 Palmas, Las;All ages;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
35 Palmas, Las;All ages;Cohort January 1;Females;Survival in the first trimester;2022QII;""
35 Palmas, Las;All ages;Cohort January 1;Females;Survival in the first trimester;2022QI;22.502
35 Palmas, Las;All ages;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
35 Palmas, Las;All ages;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
35 Palmas, Las;All ages;Cohort January 1;Females;Survival in the first trimester;2021QII;""
35 Palmas, Las;All ages;Cohort January 1;Females;Survival in the first trimester;2021QI;21.383
35 Palmas, Las;All ages;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
35 Palmas, Las;All ages;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
35 Palmas, Las;All ages;Cohort January 1;Females;Survival in the first trimester;2020QII;""
35 Palmas, Las;All ages;Cohort January 1;Females;Survival in the first trimester;2020QI;20.607
35 Palmas, Las;All ages;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
35 Palmas, Las;All ages;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
35 Palmas, Las;All ages;Cohort January 1;Females;Survival in the second trimester;2022QII;21.536
35 Palmas, Las;All ages;Cohort January 1;Females;Survival in the second trimester;2022QI;""
35 Palmas, Las;All ages;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
35 Palmas, Las;All ages;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
35 Palmas, Las;All ages;Cohort January 1;Females;Survival in the second trimester;2021QII;20.617
35 Palmas, Las;All ages;Cohort January 1;Females;Survival in the second trimester;2021QI;""
35 Palmas, Las;All ages;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
35 Palmas, Las;All ages;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
35 Palmas, Las;All ages;Cohort January 1;Females;Survival in the second trimester;2020QII;20.041
35 Palmas, Las;All ages;Cohort January 1;Females;Survival in the second trimester;2020QI;""
35 Palmas, Las;All ages;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
35 Palmas, Las;All ages;Cohort January 1;Females;Survival in the third trimester;2022QIII;20.726
35 Palmas, Las;All ages;Cohort January 1;Females;Survival in the third trimester;2022QII;""
35 Palmas, Las;All ages;Cohort January 1;Females;Survival in the third trimester;2022QI;""
35 Palmas, Las;All ages;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
35 Palmas, Las;All ages;Cohort January 1;Females;Survival in the third trimester;2021QIII;20.020
35 Palmas, Las;All ages;Cohort January 1;Females;Survival in the third trimester;2021QII;""
35 Palmas, Las;All ages;Cohort January 1;Females;Survival in the third trimester;2021QI;""
35 Palmas, Las;All ages;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
35 Palmas, Las;All ages;Cohort January 1;Females;Survival in the third trimester;2020QIII;19.296
35 Palmas, Las;All ages;Cohort January 1;Females;Survival in the third trimester;2020QII;""
35 Palmas, Las;All ages;Cohort January 1;Females;Survival in the third trimester;2020QI;""
35 Palmas, Las;All ages;Cohort January 1;Females;Survival in the third trimester;2022QIV;19.955
35 Palmas, Las;All ages;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
35 Palmas, Las;All ages;Cohort January 1;Females;Survival in the third trimester;2022QII;""
35 Palmas, Las;All ages;Cohort January 1;Females;Survival in the third trimester;2022QI;""
35 Palmas, Las;All ages;Cohort January 1;Females;Survival in the third trimester;2021QIV;19.346
35 Palmas, Las;All ages;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
35 Palmas, Las;All ages;Cohort January 1;Females;Survival in the third trimester;2021QII;""
35 Palmas, Las;All ages;Cohort January 1;Females;Survival in the third trimester;2021QI;""
35 Palmas, Las;All ages;Cohort January 1;Females;Survival in the third trimester;2020QIV;18.662
35 Palmas, Las;All ages;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
35 Palmas, Las;All ages;Cohort January 1;Females;Survival in the third trimester;2020QII;""
35 Palmas, Las;All ages;Cohort January 1;Females;Survival in the third trimester;2020QI;""
35 Palmas, Las;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
35 Palmas, Las;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
35 Palmas, Las;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
35 Palmas, Las;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
35 Palmas, Las;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
35 Palmas, Las;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
35 Palmas, Las;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
35 Palmas, Las;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
35 Palmas, Las;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
35 Palmas, Las;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
35 Palmas, Las;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
35 Palmas, Las;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
35 Palmas, Las;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
35 Palmas, Las;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
35 Palmas, Las;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
35 Palmas, Las;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;95,88
35 Palmas, Las;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
35 Palmas, Las;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
35 Palmas, Las;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
35 Palmas, Las;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;96,5
35 Palmas, Las;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
35 Palmas, Las;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
35 Palmas, Las;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
35 Palmas, Las;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;91,9
35 Palmas, Las;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
35 Palmas, Las;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
35 Palmas, Las;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;91,77
35 Palmas, Las;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
35 Palmas, Las;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
35 Palmas, Las;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
35 Palmas, Las;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;93,05
35 Palmas, Las;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
35 Palmas, Las;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
35 Palmas, Las;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
35 Palmas, Las;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;89,38
35 Palmas, Las;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
35 Palmas, Las;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
35 Palmas, Las;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;88,32
35 Palmas, Las;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
35 Palmas, Las;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
35 Palmas, Las;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
35 Palmas, Las;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;90,35
35 Palmas, Las;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
35 Palmas, Las;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
35 Palmas, Las;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
35 Palmas, Las;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;86,05
35 Palmas, Las;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
35 Palmas, Las;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
35 Palmas, Las;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;85,03
35 Palmas, Las;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
35 Palmas, Las;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
35 Palmas, Las;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
35 Palmas, Las;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;87,31
35 Palmas, Las;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
35 Palmas, Las;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
35 Palmas, Las;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
35 Palmas, Las;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;83,23
35 Palmas, Las;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
35 Palmas, Las;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
35 Palmas, Las;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
35 Palmas, Las;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
35 Palmas, Las;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
35 Palmas, Las;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QII;65.844
35 Palmas, Las;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
35 Palmas, Las;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
35 Palmas, Las;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
35 Palmas, Las;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QII;63.258
35 Palmas, Las;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
35 Palmas, Las;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
35 Palmas, Las;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
35 Palmas, Las;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QII;62.364
35 Palmas, Las;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
35 Palmas, Las;All ages;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
35 Palmas, Las;All ages;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
35 Palmas, Las;All ages;Cohort April 1;Total;Survival in the first trimester;2022QII;63.279
35 Palmas, Las;All ages;Cohort April 1;Total;Survival in the first trimester;2022QI;""
35 Palmas, Las;All ages;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
35 Palmas, Las;All ages;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
35 Palmas, Las;All ages;Cohort April 1;Total;Survival in the first trimester;2021QII;61.202
35 Palmas, Las;All ages;Cohort April 1;Total;Survival in the first trimester;2021QI;""
35 Palmas, Las;All ages;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
35 Palmas, Las;All ages;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
35 Palmas, Las;All ages;Cohort April 1;Total;Survival in the first trimester;2020QII;60.739
35 Palmas, Las;All ages;Cohort April 1;Total;Survival in the first trimester;2020QI;""
35 Palmas, Las;All ages;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
35 Palmas, Las;All ages;Cohort April 1;Total;Survival in the second trimester;2022QIII;61.215
35 Palmas, Las;All ages;Cohort April 1;Total;Survival in the second trimester;2022QII;""
35 Palmas, Las;All ages;Cohort April 1;Total;Survival in the second trimester;2022QI;""
35 Palmas, Las;All ages;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
35 Palmas, Las;All ages;Cohort April 1;Total;Survival in the second trimester;2021QIII;59.562
35 Palmas, Las;All ages;Cohort April 1;Total;Survival in the second trimester;2021QII;""
35 Palmas, Las;All ages;Cohort April 1;Total;Survival in the second trimester;2021QI;""
35 Palmas, Las;All ages;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
35 Palmas, Las;All ages;Cohort April 1;Total;Survival in the second trimester;2020QIII;58.568
35 Palmas, Las;All ages;Cohort April 1;Total;Survival in the second trimester;2020QII;""
35 Palmas, Las;All ages;Cohort April 1;Total;Survival in the second trimester;2020QI;""
35 Palmas, Las;All ages;Cohort April 1;Total;Survival in the third trimester;2022QIV;59.094
35 Palmas, Las;All ages;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
35 Palmas, Las;All ages;Cohort April 1;Total;Survival in the third trimester;2022QII;""
35 Palmas, Las;All ages;Cohort April 1;Total;Survival in the third trimester;2022QI;""
35 Palmas, Las;All ages;Cohort April 1;Total;Survival in the third trimester;2021QIV;57.646
35 Palmas, Las;All ages;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
35 Palmas, Las;All ages;Cohort April 1;Total;Survival in the third trimester;2021QII;""
35 Palmas, Las;All ages;Cohort April 1;Total;Survival in the third trimester;2021QI;""
35 Palmas, Las;All ages;Cohort April 1;Total;Survival in the third trimester;2020QIV;56.707
35 Palmas, Las;All ages;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
35 Palmas, Las;All ages;Cohort April 1;Total;Survival in the third trimester;2020QII;""
35 Palmas, Las;All ages;Cohort April 1;Total;Survival in the third trimester;2020QI;""
35 Palmas, Las;All ages;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
35 Palmas, Las;All ages;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
35 Palmas, Las;All ages;Cohort April 1;Total;Survival in the third trimester;2022QII;""
35 Palmas, Las;All ages;Cohort April 1;Total;Survival in the third trimester;2022QI;55.925
35 Palmas, Las;All ages;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
35 Palmas, Las;All ages;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
35 Palmas, Las;All ages;Cohort April 1;Total;Survival in the third trimester;2021QII;""
35 Palmas, Las;All ages;Cohort April 1;Total;Survival in the third trimester;2021QI;55.258
35 Palmas, Las;All ages;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
35 Palmas, Las;All ages;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
35 Palmas, Las;All ages;Cohort April 1;Total;Survival in the third trimester;2020QII;""
35 Palmas, Las;All ages;Cohort April 1;Total;Survival in the third trimester;2020QI;""
35 Palmas, Las;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
35 Palmas, Las;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
35 Palmas, Las;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
35 Palmas, Las;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
35 Palmas, Las;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
35 Palmas, Las;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
35 Palmas, Las;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
35 Palmas, Las;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
35 Palmas, Las;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
35 Palmas, Las;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
35 Palmas, Las;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
35 Palmas, Las;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
35 Palmas, Las;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
35 Palmas, Las;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
35 Palmas, Las;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;96,1
35 Palmas, Las;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
35 Palmas, Las;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
35 Palmas, Las;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
35 Palmas, Las;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;96,75
35 Palmas, Las;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
35 Palmas, Las;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
35 Palmas, Las;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
35 Palmas, Las;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;97,39
35 Palmas, Las;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
35 Palmas, Las;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
35 Palmas, Las;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;92,97
35 Palmas, Las;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
35 Palmas, Las;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
35 Palmas, Las;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
35 Palmas, Las;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;94,16
35 Palmas, Las;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
35 Palmas, Las;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
35 Palmas, Las;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
35 Palmas, Las;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;93,91
35 Palmas, Las;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
35 Palmas, Las;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
35 Palmas, Las;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;89,75
35 Palmas, Las;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
35 Palmas, Las;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
35 Palmas, Las;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
35 Palmas, Las;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;91,13
35 Palmas, Las;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
35 Palmas, Las;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
35 Palmas, Las;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
35 Palmas, Las;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;90,93
35 Palmas, Las;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
35 Palmas, Las;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
35 Palmas, Las;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
35 Palmas, Las;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
35 Palmas, Las;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
35 Palmas, Las;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
35 Palmas, Las;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;88,41
35 Palmas, Las;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
35 Palmas, Las;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
35 Palmas, Las;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
35 Palmas, Las;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;88,61
35 Palmas, Las;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
35 Palmas, Las;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
35 Palmas, Las;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
35 Palmas, Las;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
35 Palmas, Las;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
35 Palmas, Las;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
35 Palmas, Las;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QII;42.062
35 Palmas, Las;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
35 Palmas, Las;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
35 Palmas, Las;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
35 Palmas, Las;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QII;40.827
35 Palmas, Las;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
35 Palmas, Las;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
35 Palmas, Las;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
35 Palmas, Las;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QII;40.458
35 Palmas, Las;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
35 Palmas, Las;All ages;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
35 Palmas, Las;All ages;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
35 Palmas, Las;All ages;Cohort April 1;Males;Survival in the first trimester;2022QII;40.549
35 Palmas, Las;All ages;Cohort April 1;Males;Survival in the first trimester;2022QI;""
35 Palmas, Las;All ages;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
35 Palmas, Las;All ages;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
35 Palmas, Las;All ages;Cohort April 1;Males;Survival in the first trimester;2021QII;39.614
35 Palmas, Las;All ages;Cohort April 1;Males;Survival in the first trimester;2021QI;""
35 Palmas, Las;All ages;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
35 Palmas, Las;All ages;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
35 Palmas, Las;All ages;Cohort April 1;Males;Survival in the first trimester;2020QII;39.470
35 Palmas, Las;All ages;Cohort April 1;Males;Survival in the first trimester;2020QI;""
35 Palmas, Las;All ages;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
35 Palmas, Las;All ages;Cohort April 1;Males;Survival in the second trimester;2022QIII;39.373
35 Palmas, Las;All ages;Cohort April 1;Males;Survival in the second trimester;2022QII;""
35 Palmas, Las;All ages;Cohort April 1;Males;Survival in the second trimester;2022QI;""
35 Palmas, Las;All ages;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
35 Palmas, Las;All ages;Cohort April 1;Males;Survival in the second trimester;2021QIII;38.630
35 Palmas, Las;All ages;Cohort April 1;Males;Survival in the second trimester;2021QII;""
35 Palmas, Las;All ages;Cohort April 1;Males;Survival in the second trimester;2021QI;""
35 Palmas, Las;All ages;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
35 Palmas, Las;All ages;Cohort April 1;Males;Survival in the second trimester;2020QIII;38.157
35 Palmas, Las;All ages;Cohort April 1;Males;Survival in the second trimester;2020QII;""
35 Palmas, Las;All ages;Cohort April 1;Males;Survival in the second trimester;2020QI;""
35 Palmas, Las;All ages;Cohort April 1;Males;Survival in the third trimester;2022QIV;38.099
35 Palmas, Las;All ages;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
35 Palmas, Las;All ages;Cohort April 1;Males;Survival in the third trimester;2022QII;""
35 Palmas, Las;All ages;Cohort April 1;Males;Survival in the third trimester;2022QI;""
35 Palmas, Las;All ages;Cohort April 1;Males;Survival in the third trimester;2021QIV;37.445
35 Palmas, Las;All ages;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
35 Palmas, Las;All ages;Cohort April 1;Males;Survival in the third trimester;2021QII;""
35 Palmas, Las;All ages;Cohort April 1;Males;Survival in the third trimester;2021QI;""
35 Palmas, Las;All ages;Cohort April 1;Males;Survival in the third trimester;2020QIV;37.003
35 Palmas, Las;All ages;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
35 Palmas, Las;All ages;Cohort April 1;Males;Survival in the third trimester;2020QII;""
35 Palmas, Las;All ages;Cohort April 1;Males;Survival in the third trimester;2020QI;""
35 Palmas, Las;All ages;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
35 Palmas, Las;All ages;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
35 Palmas, Las;All ages;Cohort April 1;Males;Survival in the third trimester;2022QII;""
35 Palmas, Las;All ages;Cohort April 1;Males;Survival in the third trimester;2022QI;36.431
35 Palmas, Las;All ages;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
35 Palmas, Las;All ages;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
35 Palmas, Las;All ages;Cohort April 1;Males;Survival in the third trimester;2021QII;""
35 Palmas, Las;All ages;Cohort April 1;Males;Survival in the third trimester;2021QI;36.123
35 Palmas, Las;All ages;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
35 Palmas, Las;All ages;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
35 Palmas, Las;All ages;Cohort April 1;Males;Survival in the third trimester;2020QII;""
35 Palmas, Las;All ages;Cohort April 1;Males;Survival in the third trimester;2020QI;""
35 Palmas, Las;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
35 Palmas, Las;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
35 Palmas, Las;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
35 Palmas, Las;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
35 Palmas, Las;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
35 Palmas, Las;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
35 Palmas, Las;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
35 Palmas, Las;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
35 Palmas, Las;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
35 Palmas, Las;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
35 Palmas, Las;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
35 Palmas, Las;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
35 Palmas, Las;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
35 Palmas, Las;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
35 Palmas, Las;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;96,4
35 Palmas, Las;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
35 Palmas, Las;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
35 Palmas, Las;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
35 Palmas, Las;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;97,03
35 Palmas, Las;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
35 Palmas, Las;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
35 Palmas, Las;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
35 Palmas, Las;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;97,56
35 Palmas, Las;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
35 Palmas, Las;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
35 Palmas, Las;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;93,61
35 Palmas, Las;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
35 Palmas, Las;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
35 Palmas, Las;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
35 Palmas, Las;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;94,62
35 Palmas, Las;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
35 Palmas, Las;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
35 Palmas, Las;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
35 Palmas, Las;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;94,31
35 Palmas, Las;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
35 Palmas, Las;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
35 Palmas, Las;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;90,58
35 Palmas, Las;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
35 Palmas, Las;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
35 Palmas, Las;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
35 Palmas, Las;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;91,72
35 Palmas, Las;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
35 Palmas, Las;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
35 Palmas, Las;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
35 Palmas, Las;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;91,46
35 Palmas, Las;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
35 Palmas, Las;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
35 Palmas, Las;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
35 Palmas, Las;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
35 Palmas, Las;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
35 Palmas, Las;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
35 Palmas, Las;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;89,23
35 Palmas, Las;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
35 Palmas, Las;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
35 Palmas, Las;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
35 Palmas, Las;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;89,29
35 Palmas, Las;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
35 Palmas, Las;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
35 Palmas, Las;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
35 Palmas, Las;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
35 Palmas, Las;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
35 Palmas, Las;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
35 Palmas, Las;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QII;23.782
35 Palmas, Las;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
35 Palmas, Las;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
35 Palmas, Las;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
35 Palmas, Las;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QII;22.431
35 Palmas, Las;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
35 Palmas, Las;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
35 Palmas, Las;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
35 Palmas, Las;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QII;21.906
35 Palmas, Las;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
35 Palmas, Las;All ages;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
35 Palmas, Las;All ages;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
35 Palmas, Las;All ages;Cohort April 1;Females;Survival in the first trimester;2022QII;22.730
35 Palmas, Las;All ages;Cohort April 1;Females;Survival in the first trimester;2022QI;""
35 Palmas, Las;All ages;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
35 Palmas, Las;All ages;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
35 Palmas, Las;All ages;Cohort April 1;Females;Survival in the first trimester;2021QII;21.588
35 Palmas, Las;All ages;Cohort April 1;Females;Survival in the first trimester;2021QI;""
35 Palmas, Las;All ages;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
35 Palmas, Las;All ages;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
35 Palmas, Las;All ages;Cohort April 1;Females;Survival in the first trimester;2020QII;21.269
35 Palmas, Las;All ages;Cohort April 1;Females;Survival in the first trimester;2020QI;""
35 Palmas, Las;All ages;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
35 Palmas, Las;All ages;Cohort April 1;Females;Survival in the second trimester;2022QIII;21.842
35 Palmas, Las;All ages;Cohort April 1;Females;Survival in the second trimester;2022QII;""
35 Palmas, Las;All ages;Cohort April 1;Females;Survival in the second trimester;2022QI;""
35 Palmas, Las;All ages;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
35 Palmas, Las;All ages;Cohort April 1;Females;Survival in the second trimester;2021QIII;20.932
35 Palmas, Las;All ages;Cohort April 1;Females;Survival in the second trimester;2021QII;""
35 Palmas, Las;All ages;Cohort April 1;Females;Survival in the second trimester;2021QI;""
35 Palmas, Las;All ages;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
35 Palmas, Las;All ages;Cohort April 1;Females;Survival in the second trimester;2020QIII;20.411
35 Palmas, Las;All ages;Cohort April 1;Females;Survival in the second trimester;2020QII;""
35 Palmas, Las;All ages;Cohort April 1;Females;Survival in the second trimester;2020QI;""
35 Palmas, Las;All ages;Cohort April 1;Females;Survival in the third trimester;2022QIV;20.995
35 Palmas, Las;All ages;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
35 Palmas, Las;All ages;Cohort April 1;Females;Survival in the third trimester;2022QII;""
35 Palmas, Las;All ages;Cohort April 1;Females;Survival in the third trimester;2022QI;""
35 Palmas, Las;All ages;Cohort April 1;Females;Survival in the third trimester;2021QIV;20.201
35 Palmas, Las;All ages;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
35 Palmas, Las;All ages;Cohort April 1;Females;Survival in the third trimester;2021QII;""
35 Palmas, Las;All ages;Cohort April 1;Females;Survival in the third trimester;2021QI;""
35 Palmas, Las;All ages;Cohort April 1;Females;Survival in the third trimester;2020QIV;19.704
35 Palmas, Las;All ages;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
35 Palmas, Las;All ages;Cohort April 1;Females;Survival in the third trimester;2020QII;""
35 Palmas, Las;All ages;Cohort April 1;Females;Survival in the third trimester;2020QI;""
35 Palmas, Las;All ages;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
35 Palmas, Las;All ages;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
35 Palmas, Las;All ages;Cohort April 1;Females;Survival in the third trimester;2022QII;""
35 Palmas, Las;All ages;Cohort April 1;Females;Survival in the third trimester;2022QI;19.494
35 Palmas, Las;All ages;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
35 Palmas, Las;All ages;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
35 Palmas, Las;All ages;Cohort April 1;Females;Survival in the third trimester;2021QII;""
35 Palmas, Las;All ages;Cohort April 1;Females;Survival in the third trimester;2021QI;19.135
35 Palmas, Las;All ages;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
35 Palmas, Las;All ages;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
35 Palmas, Las;All ages;Cohort April 1;Females;Survival in the third trimester;2020QII;""
35 Palmas, Las;All ages;Cohort April 1;Females;Survival in the third trimester;2020QI;""
35 Palmas, Las;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
35 Palmas, Las;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
35 Palmas, Las;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
35 Palmas, Las;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
35 Palmas, Las;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
35 Palmas, Las;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
35 Palmas, Las;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
35 Palmas, Las;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
35 Palmas, Las;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
35 Palmas, Las;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
35 Palmas, Las;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
35 Palmas, Las;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
35 Palmas, Las;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
35 Palmas, Las;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
35 Palmas, Las;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;95,58
35 Palmas, Las;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
35 Palmas, Las;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
35 Palmas, Las;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
35 Palmas, Las;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;96,24
35 Palmas, Las;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
35 Palmas, Las;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
35 Palmas, Las;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
35 Palmas, Las;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;97,09
35 Palmas, Las;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
35 Palmas, Las;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
35 Palmas, Las;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;91,84
35 Palmas, Las;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
35 Palmas, Las;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
35 Palmas, Las;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
35 Palmas, Las;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;93,32
35 Palmas, Las;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
35 Palmas, Las;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
35 Palmas, Las;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
35 Palmas, Las;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;93,18
35 Palmas, Las;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
35 Palmas, Las;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
35 Palmas, Las;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;88,28
35 Palmas, Las;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
35 Palmas, Las;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
35 Palmas, Las;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
35 Palmas, Las;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;90,06
35 Palmas, Las;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
35 Palmas, Las;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
35 Palmas, Las;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
35 Palmas, Las;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;89,95
35 Palmas, Las;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
35 Palmas, Las;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
35 Palmas, Las;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
35 Palmas, Las;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
35 Palmas, Las;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
35 Palmas, Las;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
35 Palmas, Las;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;86,91
35 Palmas, Las;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
35 Palmas, Las;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
35 Palmas, Las;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
35 Palmas, Las;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;87,35
35 Palmas, Las;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
35 Palmas, Las;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
35 Palmas, Las;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
35 Palmas, Las;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
35 Palmas, Las;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
35 Palmas, Las;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QIII;66.162
35 Palmas, Las;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
35 Palmas, Las;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
35 Palmas, Las;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
35 Palmas, Las;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QIII;63.807
35 Palmas, Las;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
35 Palmas, Las;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
35 Palmas, Las;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
35 Palmas, Las;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QIII;62.367
35 Palmas, Las;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
35 Palmas, Las;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
35 Palmas, Las;All ages;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
35 Palmas, Las;All ages;Cohort July 1;Total;Survival in the first trimester;2022QIII;63.817
35 Palmas, Las;All ages;Cohort July 1;Total;Survival in the first trimester;2022QII;""
35 Palmas, Las;All ages;Cohort July 1;Total;Survival in the first trimester;2022QI;""
35 Palmas, Las;All ages;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
35 Palmas, Las;All ages;Cohort July 1;Total;Survival in the first trimester;2021QIII;61.919
35 Palmas, Las;All ages;Cohort July 1;Total;Survival in the first trimester;2021QII;""
35 Palmas, Las;All ages;Cohort July 1;Total;Survival in the first trimester;2021QI;""
35 Palmas, Las;All ages;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
35 Palmas, Las;All ages;Cohort July 1;Total;Survival in the first trimester;2020QIII;60.002
35 Palmas, Las;All ages;Cohort July 1;Total;Survival in the first trimester;2020QII;""
35 Palmas, Las;All ages;Cohort July 1;Total;Survival in the first trimester;2020QI;""
35 Palmas, Las;All ages;Cohort July 1;Total;Survival in the second trimester;2022QIV;61.497
35 Palmas, Las;All ages;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
35 Palmas, Las;All ages;Cohort July 1;Total;Survival in the second trimester;2022QII;""
35 Palmas, Las;All ages;Cohort July 1;Total;Survival in the second trimester;2022QI;""
35 Palmas, Las;All ages;Cohort July 1;Total;Survival in the second trimester;2021QIV;59.805
35 Palmas, Las;All ages;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
35 Palmas, Las;All ages;Cohort July 1;Total;Survival in the second trimester;2021QII;""
35 Palmas, Las;All ages;Cohort July 1;Total;Survival in the second trimester;2021QI;""
35 Palmas, Las;All ages;Cohort July 1;Total;Survival in the second trimester;2020QIV;57.994
35 Palmas, Las;All ages;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
35 Palmas, Las;All ages;Cohort July 1;Total;Survival in the second trimester;2020QII;""
35 Palmas, Las;All ages;Cohort July 1;Total;Survival in the second trimester;2020QI;""
35 Palmas, Las;All ages;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
35 Palmas, Las;All ages;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
35 Palmas, Las;All ages;Cohort July 1;Total;Survival in the third trimester;2022QII;""
35 Palmas, Las;All ages;Cohort July 1;Total;Survival in the third trimester;2022QI;57.939
35 Palmas, Las;All ages;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
35 Palmas, Las;All ages;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
35 Palmas, Las;All ages;Cohort July 1;Total;Survival in the third trimester;2021QII;""
35 Palmas, Las;All ages;Cohort July 1;Total;Survival in the third trimester;2021QI;56.466
35 Palmas, Las;All ages;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
35 Palmas, Las;All ages;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
35 Palmas, Las;All ages;Cohort July 1;Total;Survival in the third trimester;2020QII;""
35 Palmas, Las;All ages;Cohort July 1;Total;Survival in the third trimester;2020QI;""
35 Palmas, Las;All ages;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
35 Palmas, Las;All ages;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
35 Palmas, Las;All ages;Cohort July 1;Total;Survival in the third trimester;2022QII;56.027
35 Palmas, Las;All ages;Cohort July 1;Total;Survival in the third trimester;2022QI;""
35 Palmas, Las;All ages;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
35 Palmas, Las;All ages;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
35 Palmas, Las;All ages;Cohort July 1;Total;Survival in the third trimester;2021QII;54.998
35 Palmas, Las;All ages;Cohort July 1;Total;Survival in the third trimester;2021QI;""
35 Palmas, Las;All ages;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
35 Palmas, Las;All ages;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
35 Palmas, Las;All ages;Cohort July 1;Total;Survival in the third trimester;2020QII;""
35 Palmas, Las;All ages;Cohort July 1;Total;Survival in the third trimester;2020QI;""
35 Palmas, Las;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
35 Palmas, Las;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
35 Palmas, Las;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
35 Palmas, Las;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
35 Palmas, Las;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
35 Palmas, Las;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
35 Palmas, Las;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
35 Palmas, Las;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
35 Palmas, Las;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
35 Palmas, Las;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
35 Palmas, Las;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
35 Palmas, Las;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
35 Palmas, Las;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
35 Palmas, Las;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;96,46
35 Palmas, Las;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
35 Palmas, Las;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
35 Palmas, Las;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
35 Palmas, Las;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;97,04
35 Palmas, Las;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
35 Palmas, Las;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
35 Palmas, Las;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
35 Palmas, Las;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;96,21
35 Palmas, Las;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
35 Palmas, Las;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
35 Palmas, Las;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;92,95
35 Palmas, Las;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
35 Palmas, Las;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
35 Palmas, Las;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
35 Palmas, Las;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;93,73
35 Palmas, Las;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
35 Palmas, Las;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
35 Palmas, Las;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
35 Palmas, Las;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;92,99
35 Palmas, Las;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
35 Palmas, Las;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
35 Palmas, Las;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
35 Palmas, Las;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
35 Palmas, Las;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
35 Palmas, Las;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
35 Palmas, Las;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;90,8
35 Palmas, Las;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
35 Palmas, Las;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
35 Palmas, Las;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
35 Palmas, Las;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;90,54
35 Palmas, Las;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
35 Palmas, Las;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
35 Palmas, Las;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
35 Palmas, Las;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
35 Palmas, Las;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
35 Palmas, Las;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
35 Palmas, Las;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;87,81
35 Palmas, Las;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
35 Palmas, Las;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
35 Palmas, Las;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
35 Palmas, Las;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;88,18
35 Palmas, Las;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
35 Palmas, Las;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
35 Palmas, Las;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
35 Palmas, Las;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
35 Palmas, Las;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
35 Palmas, Las;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
35 Palmas, Las;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QIII;42.238
35 Palmas, Las;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
35 Palmas, Las;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
35 Palmas, Las;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
35 Palmas, Las;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QIII;41.115
35 Palmas, Las;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
35 Palmas, Las;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
35 Palmas, Las;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
35 Palmas, Las;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QIII;40.506
35 Palmas, Las;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
35 Palmas, Las;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
35 Palmas, Las;All ages;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
35 Palmas, Las;All ages;Cohort July 1;Males;Survival in the first trimester;2022QIII;40.902
35 Palmas, Las;All ages;Cohort July 1;Males;Survival in the first trimester;2022QII;""
35 Palmas, Las;All ages;Cohort July 1;Males;Survival in the first trimester;2022QI;""
35 Palmas, Las;All ages;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
35 Palmas, Las;All ages;Cohort July 1;Males;Survival in the first trimester;2021QIII;39.980
35 Palmas, Las;All ages;Cohort July 1;Males;Survival in the first trimester;2021QII;""
35 Palmas, Las;All ages;Cohort July 1;Males;Survival in the first trimester;2021QI;""
35 Palmas, Las;All ages;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
35 Palmas, Las;All ages;Cohort July 1;Males;Survival in the first trimester;2020QIII;39.074
35 Palmas, Las;All ages;Cohort July 1;Males;Survival in the first trimester;2020QII;""
35 Palmas, Las;All ages;Cohort July 1;Males;Survival in the first trimester;2020QI;""
35 Palmas, Las;All ages;Cohort July 1;Males;Survival in the second trimester;2022QIV;39.512
35 Palmas, Las;All ages;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
35 Palmas, Las;All ages;Cohort July 1;Males;Survival in the second trimester;2022QII;""
35 Palmas, Las;All ages;Cohort July 1;Males;Survival in the second trimester;2022QI;""
35 Palmas, Las;All ages;Cohort July 1;Males;Survival in the second trimester;2021QIV;38.677
35 Palmas, Las;All ages;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
35 Palmas, Las;All ages;Cohort July 1;Males;Survival in the second trimester;2021QII;""
35 Palmas, Las;All ages;Cohort July 1;Males;Survival in the second trimester;2021QI;""
35 Palmas, Las;All ages;Cohort July 1;Males;Survival in the second trimester;2020QIV;37.821
35 Palmas, Las;All ages;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
35 Palmas, Las;All ages;Cohort July 1;Males;Survival in the second trimester;2020QII;""
35 Palmas, Las;All ages;Cohort July 1;Males;Survival in the second trimester;2020QI;""
35 Palmas, Las;All ages;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
35 Palmas, Las;All ages;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
35 Palmas, Las;All ages;Cohort July 1;Males;Survival in the third trimester;2022QII;""
35 Palmas, Las;All ages;Cohort July 1;Males;Survival in the third trimester;2022QI;37.576
35 Palmas, Las;All ages;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
35 Palmas, Las;All ages;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
35 Palmas, Las;All ages;Cohort July 1;Males;Survival in the third trimester;2021QII;""
35 Palmas, Las;All ages;Cohort July 1;Males;Survival in the third trimester;2021QI;36.890
35 Palmas, Las;All ages;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
35 Palmas, Las;All ages;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
35 Palmas, Las;All ages;Cohort July 1;Males;Survival in the third trimester;2020QII;""
35 Palmas, Las;All ages;Cohort July 1;Males;Survival in the third trimester;2020QI;""
35 Palmas, Las;All ages;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
35 Palmas, Las;All ages;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
35 Palmas, Las;All ages;Cohort July 1;Males;Survival in the third trimester;2022QII;36.430
35 Palmas, Las;All ages;Cohort July 1;Males;Survival in the third trimester;2022QI;""
35 Palmas, Las;All ages;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
35 Palmas, Las;All ages;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
35 Palmas, Las;All ages;Cohort July 1;Males;Survival in the third trimester;2021QII;36.030
35 Palmas, Las;All ages;Cohort July 1;Males;Survival in the third trimester;2021QI;""
35 Palmas, Las;All ages;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
35 Palmas, Las;All ages;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
35 Palmas, Las;All ages;Cohort July 1;Males;Survival in the third trimester;2020QII;""
35 Palmas, Las;All ages;Cohort July 1;Males;Survival in the third trimester;2020QI;""
35 Palmas, Las;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
35 Palmas, Las;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
35 Palmas, Las;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
35 Palmas, Las;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
35 Palmas, Las;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
35 Palmas, Las;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
35 Palmas, Las;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
35 Palmas, Las;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
35 Palmas, Las;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
35 Palmas, Las;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
35 Palmas, Las;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
35 Palmas, Las;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
35 Palmas, Las;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
35 Palmas, Las;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;96,84
35 Palmas, Las;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
35 Palmas, Las;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
35 Palmas, Las;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
35 Palmas, Las;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;97,24
35 Palmas, Las;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
35 Palmas, Las;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
35 Palmas, Las;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
35 Palmas, Las;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;96,46
35 Palmas, Las;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
35 Palmas, Las;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
35 Palmas, Las;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;93,55
35 Palmas, Las;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
35 Palmas, Las;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
35 Palmas, Las;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
35 Palmas, Las;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;94,07
35 Palmas, Las;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
35 Palmas, Las;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
35 Palmas, Las;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
35 Palmas, Las;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;93,37
35 Palmas, Las;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
35 Palmas, Las;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
35 Palmas, Las;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
35 Palmas, Las;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
35 Palmas, Las;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
35 Palmas, Las;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
35 Palmas, Las;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;91,39
35 Palmas, Las;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
35 Palmas, Las;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
35 Palmas, Las;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
35 Palmas, Las;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;91,07
35 Palmas, Las;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
35 Palmas, Las;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
35 Palmas, Las;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
35 Palmas, Las;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
35 Palmas, Las;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
35 Palmas, Las;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
35 Palmas, Las;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;88,61
35 Palmas, Las;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
35 Palmas, Las;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
35 Palmas, Las;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
35 Palmas, Las;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;88,95
35 Palmas, Las;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
35 Palmas, Las;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
35 Palmas, Las;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
35 Palmas, Las;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
35 Palmas, Las;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
35 Palmas, Las;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
35 Palmas, Las;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QIII;23.924
35 Palmas, Las;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
35 Palmas, Las;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
35 Palmas, Las;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
35 Palmas, Las;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QIII;22.692
35 Palmas, Las;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
35 Palmas, Las;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
35 Palmas, Las;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
35 Palmas, Las;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QIII;21.861
35 Palmas, Las;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
35 Palmas, Las;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
35 Palmas, Las;All ages;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
35 Palmas, Las;All ages;Cohort July 1;Females;Survival in the first trimester;2022QIII;22.915
35 Palmas, Las;All ages;Cohort July 1;Females;Survival in the first trimester;2022QII;""
35 Palmas, Las;All ages;Cohort July 1;Females;Survival in the first trimester;2022QI;""
35 Palmas, Las;All ages;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
35 Palmas, Las;All ages;Cohort July 1;Females;Survival in the first trimester;2021QIII;21.939
35 Palmas, Las;All ages;Cohort July 1;Females;Survival in the first trimester;2021QII;""
35 Palmas, Las;All ages;Cohort July 1;Females;Survival in the first trimester;2021QI;""
35 Palmas, Las;All ages;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
35 Palmas, Las;All ages;Cohort July 1;Females;Survival in the first trimester;2020QIII;20.928
35 Palmas, Las;All ages;Cohort July 1;Females;Survival in the first trimester;2020QII;""
35 Palmas, Las;All ages;Cohort July 1;Females;Survival in the first trimester;2020QI;""
35 Palmas, Las;All ages;Cohort July 1;Females;Survival in the second trimester;2022QIV;21.985
35 Palmas, Las;All ages;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
35 Palmas, Las;All ages;Cohort July 1;Females;Survival in the second trimester;2022QII;""
35 Palmas, Las;All ages;Cohort July 1;Females;Survival in the second trimester;2022QI;""
35 Palmas, Las;All ages;Cohort July 1;Females;Survival in the second trimester;2021QIV;21.128
35 Palmas, Las;All ages;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
35 Palmas, Las;All ages;Cohort July 1;Females;Survival in the second trimester;2021QII;""
35 Palmas, Las;All ages;Cohort July 1;Females;Survival in the second trimester;2021QI;""
35 Palmas, Las;All ages;Cohort July 1;Females;Survival in the second trimester;2020QIV;20.173
35 Palmas, Las;All ages;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
35 Palmas, Las;All ages;Cohort July 1;Females;Survival in the second trimester;2020QII;""
35 Palmas, Las;All ages;Cohort July 1;Females;Survival in the second trimester;2020QI;""
35 Palmas, Las;All ages;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
35 Palmas, Las;All ages;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
35 Palmas, Las;All ages;Cohort July 1;Females;Survival in the third trimester;2022QII;""
35 Palmas, Las;All ages;Cohort July 1;Females;Survival in the third trimester;2022QI;20.363
35 Palmas, Las;All ages;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
35 Palmas, Las;All ages;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
35 Palmas, Las;All ages;Cohort July 1;Females;Survival in the third trimester;2021QII;""
35 Palmas, Las;All ages;Cohort July 1;Females;Survival in the third trimester;2021QI;19.576
35 Palmas, Las;All ages;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
35 Palmas, Las;All ages;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
35 Palmas, Las;All ages;Cohort July 1;Females;Survival in the third trimester;2020QII;""
35 Palmas, Las;All ages;Cohort July 1;Females;Survival in the third trimester;2020QI;""
35 Palmas, Las;All ages;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
35 Palmas, Las;All ages;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
35 Palmas, Las;All ages;Cohort July 1;Females;Survival in the third trimester;2022QII;19.597
35 Palmas, Las;All ages;Cohort July 1;Females;Survival in the third trimester;2022QI;""
35 Palmas, Las;All ages;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
35 Palmas, Las;All ages;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
35 Palmas, Las;All ages;Cohort July 1;Females;Survival in the third trimester;2021QII;18.968
35 Palmas, Las;All ages;Cohort July 1;Females;Survival in the third trimester;2021QI;""
35 Palmas, Las;All ages;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
35 Palmas, Las;All ages;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
35 Palmas, Las;All ages;Cohort July 1;Females;Survival in the third trimester;2020QII;""
35 Palmas, Las;All ages;Cohort July 1;Females;Survival in the third trimester;2020QI;""
35 Palmas, Las;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
35 Palmas, Las;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
35 Palmas, Las;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
35 Palmas, Las;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
35 Palmas, Las;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
35 Palmas, Las;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
35 Palmas, Las;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
35 Palmas, Las;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
35 Palmas, Las;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
35 Palmas, Las;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
35 Palmas, Las;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
35 Palmas, Las;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
35 Palmas, Las;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
35 Palmas, Las;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;95,78
35 Palmas, Las;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
35 Palmas, Las;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
35 Palmas, Las;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
35 Palmas, Las;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;96,68
35 Palmas, Las;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
35 Palmas, Las;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
35 Palmas, Las;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
35 Palmas, Las;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;95,73
35 Palmas, Las;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
35 Palmas, Las;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
35 Palmas, Las;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;91,9
35 Palmas, Las;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
35 Palmas, Las;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
35 Palmas, Las;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
35 Palmas, Las;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;93,11
35 Palmas, Las;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
35 Palmas, Las;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
35 Palmas, Las;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
35 Palmas, Las;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;92,28
35 Palmas, Las;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
35 Palmas, Las;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
35 Palmas, Las;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
35 Palmas, Las;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
35 Palmas, Las;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
35 Palmas, Las;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
35 Palmas, Las;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;89,74
35 Palmas, Las;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
35 Palmas, Las;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
35 Palmas, Las;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
35 Palmas, Las;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;89,55
35 Palmas, Las;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
35 Palmas, Las;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
35 Palmas, Las;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
35 Palmas, Las;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
35 Palmas, Las;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
35 Palmas, Las;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
35 Palmas, Las;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;86,36
35 Palmas, Las;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
35 Palmas, Las;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
35 Palmas, Las;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
35 Palmas, Las;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;86,77
35 Palmas, Las;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
35 Palmas, Las;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
35 Palmas, Las;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
35 Palmas, Las;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
35 Palmas, Las;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
35 Palmas, Las;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QIV;66.297
35 Palmas, Las;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
35 Palmas, Las;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
35 Palmas, Las;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
35 Palmas, Las;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QIV;64.615
35 Palmas, Las;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
35 Palmas, Las;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
35 Palmas, Las;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
35 Palmas, Las;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QIV;62.561
35 Palmas, Las;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
35 Palmas, Las;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
35 Palmas, Las;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
35 Palmas, Las;All ages;Cohort October 1;Total;Survival in the first trimester;2022QIV;63.743
35 Palmas, Las;All ages;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
35 Palmas, Las;All ages;Cohort October 1;Total;Survival in the first trimester;2022QII;""
35 Palmas, Las;All ages;Cohort October 1;Total;Survival in the first trimester;2022QI;""
35 Palmas, Las;All ages;Cohort October 1;Total;Survival in the first trimester;2021QIV;62.246
35 Palmas, Las;All ages;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
35 Palmas, Las;All ages;Cohort October 1;Total;Survival in the first trimester;2021QII;""
35 Palmas, Las;All ages;Cohort October 1;Total;Survival in the first trimester;2021QI;""
35 Palmas, Las;All ages;Cohort October 1;Total;Survival in the first trimester;2020QIV;60.264
35 Palmas, Las;All ages;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
35 Palmas, Las;All ages;Cohort October 1;Total;Survival in the first trimester;2020QII;""
35 Palmas, Las;All ages;Cohort October 1;Total;Survival in the first trimester;2020QI;""
35 Palmas, Las;All ages;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
35 Palmas, Las;All ages;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
35 Palmas, Las;All ages;Cohort October 1;Total;Survival in the second trimester;2022QII;""
35 Palmas, Las;All ages;Cohort October 1;Total;Survival in the second trimester;2022QI;60.195
35 Palmas, Las;All ages;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
35 Palmas, Las;All ages;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
35 Palmas, Las;All ages;Cohort October 1;Total;Survival in the second trimester;2021QII;""
35 Palmas, Las;All ages;Cohort October 1;Total;Survival in the second trimester;2021QI;58.580
35 Palmas, Las;All ages;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
35 Palmas, Las;All ages;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
35 Palmas, Las;All ages;Cohort October 1;Total;Survival in the second trimester;2020QII;""
35 Palmas, Las;All ages;Cohort October 1;Total;Survival in the second trimester;2020QI;""
35 Palmas, Las;All ages;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
35 Palmas, Las;All ages;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
35 Palmas, Las;All ages;Cohort October 1;Total;Survival in the third trimester;2022QII;58.123
35 Palmas, Las;All ages;Cohort October 1;Total;Survival in the third trimester;2022QI;""
35 Palmas, Las;All ages;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
35 Palmas, Las;All ages;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
35 Palmas, Las;All ages;Cohort October 1;Total;Survival in the third trimester;2021QII;56.966
35 Palmas, Las;All ages;Cohort October 1;Total;Survival in the third trimester;2021QI;""
35 Palmas, Las;All ages;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
35 Palmas, Las;All ages;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
35 Palmas, Las;All ages;Cohort October 1;Total;Survival in the third trimester;2020QII;""
35 Palmas, Las;All ages;Cohort October 1;Total;Survival in the third trimester;2020QI;""
35 Palmas, Las;All ages;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
35 Palmas, Las;All ages;Cohort October 1;Total;Survival in the third trimester;2022QIII;56.398
35 Palmas, Las;All ages;Cohort October 1;Total;Survival in the third trimester;2022QII;""
35 Palmas, Las;All ages;Cohort October 1;Total;Survival in the third trimester;2022QI;""
35 Palmas, Las;All ages;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
35 Palmas, Las;All ages;Cohort October 1;Total;Survival in the third trimester;2021QIII;55.612
35 Palmas, Las;All ages;Cohort October 1;Total;Survival in the third trimester;2021QII;""
35 Palmas, Las;All ages;Cohort October 1;Total;Survival in the third trimester;2021QI;""
35 Palmas, Las;All ages;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
35 Palmas, Las;All ages;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
35 Palmas, Las;All ages;Cohort October 1;Total;Survival in the third trimester;2020QII;""
35 Palmas, Las;All ages;Cohort October 1;Total;Survival in the third trimester;2020QI;""
35 Palmas, Las;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
35 Palmas, Las;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
35 Palmas, Las;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
35 Palmas, Las;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
35 Palmas, Las;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
35 Palmas, Las;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
35 Palmas, Las;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
35 Palmas, Las;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
35 Palmas, Las;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
35 Palmas, Las;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
35 Palmas, Las;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
35 Palmas, Las;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
35 Palmas, Las;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;96,15
35 Palmas, Las;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
35 Palmas, Las;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
35 Palmas, Las;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
35 Palmas, Las;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;96,33
35 Palmas, Las;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
35 Palmas, Las;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
35 Palmas, Las;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
35 Palmas, Las;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;96,33
35 Palmas, Las;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
35 Palmas, Las;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
35 Palmas, Las;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
35 Palmas, Las;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
35 Palmas, Las;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
35 Palmas, Las;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
35 Palmas, Las;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;93,16
35 Palmas, Las;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
35 Palmas, Las;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
35 Palmas, Las;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
35 Palmas, Las;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;93,64
35 Palmas, Las;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
35 Palmas, Las;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
35 Palmas, Las;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
35 Palmas, Las;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
35 Palmas, Las;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
35 Palmas, Las;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
35 Palmas, Las;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;89,95
35 Palmas, Las;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
35 Palmas, Las;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
35 Palmas, Las;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
35 Palmas, Las;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;91,06
35 Palmas, Las;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
35 Palmas, Las;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
35 Palmas, Las;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
35 Palmas, Las;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
35 Palmas, Las;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
35 Palmas, Las;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
35 Palmas, Las;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;87,28
35 Palmas, Las;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
35 Palmas, Las;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
35 Palmas, Las;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
35 Palmas, Las;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;88,89
35 Palmas, Las;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
35 Palmas, Las;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
35 Palmas, Las;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
35 Palmas, Las;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
35 Palmas, Las;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
35 Palmas, Las;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
35 Palmas, Las;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QIV;42.330
35 Palmas, Las;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
35 Palmas, Las;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
35 Palmas, Las;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
35 Palmas, Las;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QIV;41.542
35 Palmas, Las;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
35 Palmas, Las;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
35 Palmas, Las;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
35 Palmas, Las;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QIV;40.597
35 Palmas, Las;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
35 Palmas, Las;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
35 Palmas, Las;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
35 Palmas, Las;All ages;Cohort October 1;Males;Survival in the first trimester;2022QIV;40.798
35 Palmas, Las;All ages;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
35 Palmas, Las;All ages;Cohort October 1;Males;Survival in the first trimester;2022QII;""
35 Palmas, Las;All ages;Cohort October 1;Males;Survival in the first trimester;2022QI;""
35 Palmas, Las;All ages;Cohort October 1;Males;Survival in the first trimester;2021QIV;40.087
35 Palmas, Las;All ages;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
35 Palmas, Las;All ages;Cohort October 1;Males;Survival in the first trimester;2021QII;""
35 Palmas, Las;All ages;Cohort October 1;Males;Survival in the first trimester;2021QI;""
35 Palmas, Las;All ages;Cohort October 1;Males;Survival in the first trimester;2020QIV;39.172
35 Palmas, Las;All ages;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
35 Palmas, Las;All ages;Cohort October 1;Males;Survival in the first trimester;2020QII;""
35 Palmas, Las;All ages;Cohort October 1;Males;Survival in the first trimester;2020QI;""
35 Palmas, Las;All ages;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
35 Palmas, Las;All ages;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
35 Palmas, Las;All ages;Cohort October 1;Males;Survival in the second trimester;2022QII;""
35 Palmas, Las;All ages;Cohort October 1;Males;Survival in the second trimester;2022QI;38.880
35 Palmas, Las;All ages;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
35 Palmas, Las;All ages;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
35 Palmas, Las;All ages;Cohort October 1;Males;Survival in the second trimester;2021QII;""
35 Palmas, Las;All ages;Cohort October 1;Males;Survival in the second trimester;2021QI;38.159
35 Palmas, Las;All ages;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
35 Palmas, Las;All ages;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
35 Palmas, Las;All ages;Cohort October 1;Males;Survival in the second trimester;2020QII;""
35 Palmas, Las;All ages;Cohort October 1;Males;Survival in the second trimester;2020QI;""
35 Palmas, Las;All ages;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
35 Palmas, Las;All ages;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
35 Palmas, Las;All ages;Cohort October 1;Males;Survival in the third trimester;2022QII;37.647
35 Palmas, Las;All ages;Cohort October 1;Males;Survival in the third trimester;2022QI;""
35 Palmas, Las;All ages;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
35 Palmas, Las;All ages;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
35 Palmas, Las;All ages;Cohort October 1;Males;Survival in the third trimester;2021QII;37.218
35 Palmas, Las;All ages;Cohort October 1;Males;Survival in the third trimester;2021QI;""
35 Palmas, Las;All ages;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
35 Palmas, Las;All ages;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
35 Palmas, Las;All ages;Cohort October 1;Males;Survival in the third trimester;2020QII;""
35 Palmas, Las;All ages;Cohort October 1;Males;Survival in the third trimester;2020QI;""
35 Palmas, Las;All ages;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
35 Palmas, Las;All ages;Cohort October 1;Males;Survival in the third trimester;2022QIII;36.676
35 Palmas, Las;All ages;Cohort October 1;Males;Survival in the third trimester;2022QII;""
35 Palmas, Las;All ages;Cohort October 1;Males;Survival in the third trimester;2022QI;""
35 Palmas, Las;All ages;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
35 Palmas, Las;All ages;Cohort October 1;Males;Survival in the third trimester;2021QIII;36.402
35 Palmas, Las;All ages;Cohort October 1;Males;Survival in the third trimester;2021QII;""
35 Palmas, Las;All ages;Cohort October 1;Males;Survival in the third trimester;2021QI;""
35 Palmas, Las;All ages;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
35 Palmas, Las;All ages;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
35 Palmas, Las;All ages;Cohort October 1;Males;Survival in the third trimester;2020QII;""
35 Palmas, Las;All ages;Cohort October 1;Males;Survival in the third trimester;2020QI;""
35 Palmas, Las;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
35 Palmas, Las;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
35 Palmas, Las;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
35 Palmas, Las;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
35 Palmas, Las;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
35 Palmas, Las;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
35 Palmas, Las;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
35 Palmas, Las;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
35 Palmas, Las;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
35 Palmas, Las;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
35 Palmas, Las;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
35 Palmas, Las;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
35 Palmas, Las;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;96,38
35 Palmas, Las;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
35 Palmas, Las;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
35 Palmas, Las;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
35 Palmas, Las;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;96,5
35 Palmas, Las;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
35 Palmas, Las;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
35 Palmas, Las;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
35 Palmas, Las;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;96,49
35 Palmas, Las;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
35 Palmas, Las;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
35 Palmas, Las;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
35 Palmas, Las;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
35 Palmas, Las;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
35 Palmas, Las;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
35 Palmas, Las;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;93,59
35 Palmas, Las;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
35 Palmas, Las;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
35 Palmas, Las;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
35 Palmas, Las;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;93,99
35 Palmas, Las;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
35 Palmas, Las;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
35 Palmas, Las;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
35 Palmas, Las;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
35 Palmas, Las;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
35 Palmas, Las;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
35 Palmas, Las;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;90,62
35 Palmas, Las;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
35 Palmas, Las;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
35 Palmas, Las;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
35 Palmas, Las;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;91,68
35 Palmas, Las;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
35 Palmas, Las;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
35 Palmas, Las;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
35 Palmas, Las;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
35 Palmas, Las;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
35 Palmas, Las;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
35 Palmas, Las;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;88,29
35 Palmas, Las;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
35 Palmas, Las;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
35 Palmas, Las;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
35 Palmas, Las;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;89,67
35 Palmas, Las;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
35 Palmas, Las;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
35 Palmas, Las;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
35 Palmas, Las;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
35 Palmas, Las;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
35 Palmas, Las;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
35 Palmas, Las;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QIV;23.967
35 Palmas, Las;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
35 Palmas, Las;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
35 Palmas, Las;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
35 Palmas, Las;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QIV;23.073
35 Palmas, Las;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
35 Palmas, Las;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
35 Palmas, Las;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
35 Palmas, Las;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QIV;21.964
35 Palmas, Las;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
35 Palmas, Las;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
35 Palmas, Las;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
35 Palmas, Las;All ages;Cohort October 1;Females;Survival in the first trimester;2022QIV;22.945
35 Palmas, Las;All ages;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
35 Palmas, Las;All ages;Cohort October 1;Females;Survival in the first trimester;2022QII;""
35 Palmas, Las;All ages;Cohort October 1;Females;Survival in the first trimester;2022QI;""
35 Palmas, Las;All ages;Cohort October 1;Females;Survival in the first trimester;2021QIV;22.159
35 Palmas, Las;All ages;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
35 Palmas, Las;All ages;Cohort October 1;Females;Survival in the first trimester;2021QII;""
35 Palmas, Las;All ages;Cohort October 1;Females;Survival in the first trimester;2021QI;""
35 Palmas, Las;All ages;Cohort October 1;Females;Survival in the first trimester;2020QIV;21.092
35 Palmas, Las;All ages;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
35 Palmas, Las;All ages;Cohort October 1;Females;Survival in the first trimester;2020QII;""
35 Palmas, Las;All ages;Cohort October 1;Females;Survival in the first trimester;2020QI;""
35 Palmas, Las;All ages;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
35 Palmas, Las;All ages;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
35 Palmas, Las;All ages;Cohort October 1;Females;Survival in the second trimester;2022QII;""
35 Palmas, Las;All ages;Cohort October 1;Females;Survival in the second trimester;2022QI;21.315
35 Palmas, Las;All ages;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
35 Palmas, Las;All ages;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
35 Palmas, Las;All ages;Cohort October 1;Females;Survival in the second trimester;2021QII;""
35 Palmas, Las;All ages;Cohort October 1;Females;Survival in the second trimester;2021QI;20.421
35 Palmas, Las;All ages;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
35 Palmas, Las;All ages;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
35 Palmas, Las;All ages;Cohort October 1;Females;Survival in the second trimester;2020QII;""
35 Palmas, Las;All ages;Cohort October 1;Females;Survival in the second trimester;2020QI;""
35 Palmas, Las;All ages;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
35 Palmas, Las;All ages;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
35 Palmas, Las;All ages;Cohort October 1;Females;Survival in the third trimester;2022QII;20.476
35 Palmas, Las;All ages;Cohort October 1;Females;Survival in the third trimester;2022QI;""
35 Palmas, Las;All ages;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
35 Palmas, Las;All ages;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
35 Palmas, Las;All ages;Cohort October 1;Females;Survival in the third trimester;2021QII;19.748
35 Palmas, Las;All ages;Cohort October 1;Females;Survival in the third trimester;2021QI;""
35 Palmas, Las;All ages;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
35 Palmas, Las;All ages;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
35 Palmas, Las;All ages;Cohort October 1;Females;Survival in the third trimester;2020QII;""
35 Palmas, Las;All ages;Cohort October 1;Females;Survival in the third trimester;2020QI;""
35 Palmas, Las;All ages;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
35 Palmas, Las;All ages;Cohort October 1;Females;Survival in the third trimester;2022QIII;19.722
35 Palmas, Las;All ages;Cohort October 1;Females;Survival in the third trimester;2022QII;""
35 Palmas, Las;All ages;Cohort October 1;Females;Survival in the third trimester;2022QI;""
35 Palmas, Las;All ages;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
35 Palmas, Las;All ages;Cohort October 1;Females;Survival in the third trimester;2021QIII;19.210
35 Palmas, Las;All ages;Cohort October 1;Females;Survival in the third trimester;2021QII;""
35 Palmas, Las;All ages;Cohort October 1;Females;Survival in the third trimester;2021QI;""
35 Palmas, Las;All ages;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
35 Palmas, Las;All ages;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
35 Palmas, Las;All ages;Cohort October 1;Females;Survival in the third trimester;2020QII;""
35 Palmas, Las;All ages;Cohort October 1;Females;Survival in the third trimester;2020QI;""
35 Palmas, Las;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
35 Palmas, Las;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
35 Palmas, Las;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
35 Palmas, Las;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
35 Palmas, Las;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
35 Palmas, Las;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
35 Palmas, Las;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
35 Palmas, Las;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
35 Palmas, Las;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
35 Palmas, Las;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
35 Palmas, Las;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
35 Palmas, Las;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
35 Palmas, Las;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;95,74
35 Palmas, Las;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
35 Palmas, Las;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
35 Palmas, Las;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
35 Palmas, Las;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;96,04
35 Palmas, Las;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
35 Palmas, Las;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
35 Palmas, Las;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
35 Palmas, Las;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;96,03
35 Palmas, Las;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
35 Palmas, Las;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
35 Palmas, Las;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
35 Palmas, Las;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
35 Palmas, Las;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
35 Palmas, Las;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
35 Palmas, Las;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;92,38
35 Palmas, Las;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
35 Palmas, Las;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
35 Palmas, Las;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
35 Palmas, Las;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;92,97
35 Palmas, Las;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
35 Palmas, Las;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
35 Palmas, Las;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
35 Palmas, Las;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
35 Palmas, Las;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
35 Palmas, Las;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
35 Palmas, Las;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;88,74
35 Palmas, Las;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
35 Palmas, Las;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
35 Palmas, Las;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
35 Palmas, Las;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;89,91
35 Palmas, Las;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
35 Palmas, Las;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
35 Palmas, Las;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
35 Palmas, Las;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
35 Palmas, Las;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
35 Palmas, Las;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
35 Palmas, Las;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;85,48
35 Palmas, Las;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
35 Palmas, Las;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
35 Palmas, Las;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
35 Palmas, Las;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;87,46
35 Palmas, Las;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
35 Palmas, Las;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
35 Palmas, Las;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
35 Palmas, Las;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
35 Palmas, Las;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
35 Palmas, Las;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QI;4.176
35 Palmas, Las;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QI;3.849
35 Palmas, Las;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QI;3.086
35 Palmas, Las;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2022QII;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2022QI;3.840
35 Palmas, Las;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2021QII;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2021QI;3.566
35 Palmas, Las;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2020QII;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2020QI;2.706
35 Palmas, Las;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2022QII;3.572
35 Palmas, Las;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2022QI;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2021QII;3.349
35 Palmas, Las;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2021QI;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2020QII;2.571
35 Palmas, Las;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2020QI;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QIII;3.351
35 Palmas, Las;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QII;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QI;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QIII;3.144
35 Palmas, Las;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QII;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QI;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QIII;2.396
35 Palmas, Las;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QII;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QI;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QIV;3.120
35 Palmas, Las;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QII;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QI;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QIV;2.932
35 Palmas, Las;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QII;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QI;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QIV;2.262
35 Palmas, Las;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QII;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QI;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
35 Palmas, Las;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
35 Palmas, Las;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
35 Palmas, Las;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;91,95
35 Palmas, Las;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;92,65
35 Palmas, Las;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;87,69
35 Palmas, Las;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;85,54
35 Palmas, Las;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;87,01
35 Palmas, Las;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;83,31
35 Palmas, Las;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;80,24
35 Palmas, Las;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;81,68
35 Palmas, Las;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;77,64
35 Palmas, Las;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;74,71
35 Palmas, Las;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;76,18
35 Palmas, Las;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;73,3
35 Palmas, Las;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QI;2.509
35 Palmas, Las;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QI;2.350
35 Palmas, Las;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QI;1.919
35 Palmas, Las;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2022QII;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2022QI;2.309
35 Palmas, Las;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2021QII;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2021QI;2.189
35 Palmas, Las;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2020QII;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2020QI;1.706
35 Palmas, Las;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2022QII;2.146
35 Palmas, Las;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2022QI;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2021QII;2.071
35 Palmas, Las;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2021QI;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2020QII;1.618
35 Palmas, Las;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2020QI;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QIII;2.020
35 Palmas, Las;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QII;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QI;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QIII;1.963
35 Palmas, Las;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QII;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QI;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QIII;1.507
35 Palmas, Las;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QII;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QI;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QIV;1.895
35 Palmas, Las;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QII;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QI;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QIV;1.830
35 Palmas, Las;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QII;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QI;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QIV;1.430
35 Palmas, Las;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QII;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QI;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
35 Palmas, Las;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
35 Palmas, Las;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
35 Palmas, Las;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;92,03
35 Palmas, Las;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;93,15
35 Palmas, Las;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;88,9
35 Palmas, Las;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;85,53
35 Palmas, Las;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;88,13
35 Palmas, Las;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;84,31
35 Palmas, Las;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;80,51
35 Palmas, Las;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;83,53
35 Palmas, Las;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;78,53
35 Palmas, Las;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;75,53
35 Palmas, Las;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;77,87
35 Palmas, Las;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;74,52
35 Palmas, Las;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QI;1.667
35 Palmas, Las;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QI;1.499
35 Palmas, Las;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QI;1.167
35 Palmas, Las;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2022QII;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2022QI;1.531
35 Palmas, Las;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2021QII;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2021QI;1.377
35 Palmas, Las;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2020QII;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2020QI;1.000
35 Palmas, Las;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2022QII;1.426
35 Palmas, Las;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2022QI;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2021QII;1.278
35 Palmas, Las;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2021QI;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2020QII;953
35 Palmas, Las;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2020QI;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QIII;1.331
35 Palmas, Las;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QII;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QI;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QIII;1.181
35 Palmas, Las;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QII;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QI;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QIII;889
35 Palmas, Las;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QII;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QI;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QIV;1.225
35 Palmas, Las;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QII;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QI;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QIV;1.102
35 Palmas, Las;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QII;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QI;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QIV;832
35 Palmas, Las;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QII;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QI;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
35 Palmas, Las;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
35 Palmas, Las;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
35 Palmas, Las;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;91,84
35 Palmas, Las;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;91,86
35 Palmas, Las;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;85,69
35 Palmas, Las;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;85,54
35 Palmas, Las;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;85,26
35 Palmas, Las;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;81,66
35 Palmas, Las;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;79,84
35 Palmas, Las;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;78,79
35 Palmas, Las;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;76,18
35 Palmas, Las;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;73,49
35 Palmas, Las;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;73,52
35 Palmas, Las;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;71,29
35 Palmas, Las;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QII;3.733
35 Palmas, Las;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QII;3.356
35 Palmas, Las;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QII;3.154
35 Palmas, Las;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2022QII;3.437
35 Palmas, Las;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2022QI;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2021QII;3.126
35 Palmas, Las;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2021QI;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2020QII;2.993
35 Palmas, Las;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2020QI;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2022QIII;3.209
35 Palmas, Las;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2022QII;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2022QI;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2021QIII;2.899
35 Palmas, Las;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2021QII;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2021QI;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2020QIII;2.780
35 Palmas, Las;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2020QII;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2020QI;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QIV;2.987
35 Palmas, Las;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QII;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QI;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QIV;2.680
35 Palmas, Las;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QII;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QI;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QIV;2.614
35 Palmas, Las;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QII;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QI;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QII;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QI;2.500
35 Palmas, Las;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QII;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QI;2.470
35 Palmas, Las;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QII;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QI;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
35 Palmas, Las;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
35 Palmas, Las;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
35 Palmas, Las;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;92,07
35 Palmas, Las;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;93,15
35 Palmas, Las;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;94,9
35 Palmas, Las;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;85,96
35 Palmas, Las;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;86,38
35 Palmas, Las;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;88,14
35 Palmas, Las;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;80,02
35 Palmas, Las;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;79,86
35 Palmas, Las;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;82,88
35 Palmas, Las;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;74,49
35 Palmas, Las;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;78,31
35 Palmas, Las;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QII;2.245
35 Palmas, Las;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QII;2.051
35 Palmas, Las;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QII;1.984
35 Palmas, Las;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2022QII;2.065
35 Palmas, Las;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2022QI;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2021QII;1.923
35 Palmas, Las;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2021QI;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2020QII;1.880
35 Palmas, Las;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2020QI;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2022QIII;1.929
35 Palmas, Las;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2022QII;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2022QI;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2021QIII;1.794
35 Palmas, Las;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2021QII;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2021QI;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2020QIII;1.746
35 Palmas, Las;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2020QII;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2020QI;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QIV;1.807
35 Palmas, Las;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QII;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QI;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QIV;1.658
35 Palmas, Las;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QII;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QI;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QIV;1.648
35 Palmas, Las;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QII;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QI;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QII;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QI;1.542
35 Palmas, Las;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QII;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QI;1.568
35 Palmas, Las;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QII;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QI;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
35 Palmas, Las;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
35 Palmas, Las;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
35 Palmas, Las;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;91,98
35 Palmas, Las;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;93,76
35 Palmas, Las;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;94,76
35 Palmas, Las;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;85,92
35 Palmas, Las;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;87,47
35 Palmas, Las;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;88
35 Palmas, Las;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;80,49
35 Palmas, Las;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;80,84
35 Palmas, Las;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;83,06
35 Palmas, Las;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;75,18
35 Palmas, Las;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;79,03
35 Palmas, Las;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QII;1.488
35 Palmas, Las;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QII;1.305
35 Palmas, Las;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QII;1.170
35 Palmas, Las;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2022QII;1.372
35 Palmas, Las;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2022QI;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2021QII;1.203
35 Palmas, Las;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2021QI;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2020QII;1.113
35 Palmas, Las;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2020QI;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2022QIII;1.280
35 Palmas, Las;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2022QII;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2022QI;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2021QIII;1.105
35 Palmas, Las;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2021QII;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2021QI;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2020QIII;1.034
35 Palmas, Las;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2020QII;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2020QI;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QIV;1.180
35 Palmas, Las;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QII;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QI;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QIV;1.022
35 Palmas, Las;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QII;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QI;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QIV;966
35 Palmas, Las;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QII;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QI;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QII;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QI;958
35 Palmas, Las;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QII;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QI;902
35 Palmas, Las;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QII;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QI;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
35 Palmas, Las;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
35 Palmas, Las;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
35 Palmas, Las;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;92,2
35 Palmas, Las;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;92,18
35 Palmas, Las;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;95,13
35 Palmas, Las;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;86,02
35 Palmas, Las;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;84,67
35 Palmas, Las;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;88,38
35 Palmas, Las;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;79,3
35 Palmas, Las;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;78,31
35 Palmas, Las;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;82,56
35 Palmas, Las;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;73,41
35 Palmas, Las;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;77,09
35 Palmas, Las;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QIII;3.950
35 Palmas, Las;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QIII;3.632
35 Palmas, Las;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QIII;3.276
35 Palmas, Las;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2022QIII;3.652
35 Palmas, Las;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2022QII;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2022QI;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2021QIII;3.340
35 Palmas, Las;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2021QII;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2021QI;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2020QIII;3.012
35 Palmas, Las;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2020QII;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2020QI;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2022QIV;3.398
35 Palmas, Las;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2022QII;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2022QI;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2021QIV;3.072
35 Palmas, Las;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2021QII;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2021QI;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2020QIV;2.825
35 Palmas, Las;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2020QII;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2020QI;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QII;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QI;2.861
35 Palmas, Las;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QII;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QI;2.659
35 Palmas, Las;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QII;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QI;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QII;2.684
35 Palmas, Las;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QI;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QII;2.525
35 Palmas, Las;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QI;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QII;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QI;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
35 Palmas, Las;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
35 Palmas, Las;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
35 Palmas, Las;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;92,46
35 Palmas, Las;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;91,96
35 Palmas, Las;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;91,94
35 Palmas, Las;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;86,03
35 Palmas, Las;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;84,58
35 Palmas, Las;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;86,23
35 Palmas, Las;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;78,77
35 Palmas, Las;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;81,17
35 Palmas, Las;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;73,9
35 Palmas, Las;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;77,08
35 Palmas, Las;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QIII;2.381
35 Palmas, Las;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QIII;2.218
35 Palmas, Las;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QIII;2.050
35 Palmas, Las;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2022QIII;2.201
35 Palmas, Las;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2022QII;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2022QI;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2021QIII;2.049
35 Palmas, Las;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2021QII;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2021QI;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2020QIII;1.885
35 Palmas, Las;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2020QII;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2020QI;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2022QIV;2.058
35 Palmas, Las;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2022QII;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2022QI;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2021QIV;1.884
35 Palmas, Las;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2021QII;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2021QI;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2020QIV;1.772
35 Palmas, Las;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2020QII;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2020QI;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QII;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QI;1.749
35 Palmas, Las;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QII;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QI;1.676
35 Palmas, Las;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QII;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QI;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QII;1.639
35 Palmas, Las;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QI;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QII;1.605
35 Palmas, Las;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QI;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QII;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QI;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
35 Palmas, Las;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
35 Palmas, Las;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
35 Palmas, Las;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;92,44
35 Palmas, Las;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;92,38
35 Palmas, Las;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;91,95
35 Palmas, Las;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;86,43
35 Palmas, Las;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;84,94
35 Palmas, Las;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;86,44
35 Palmas, Las;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;78,85
35 Palmas, Las;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;81,76
35 Palmas, Las;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;73,9
35 Palmas, Las;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;78,29
35 Palmas, Las;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QIII;1.569
35 Palmas, Las;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QIII;1.414
35 Palmas, Las;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QIII;1.226
35 Palmas, Las;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2022QIII;1.451
35 Palmas, Las;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2022QII;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2022QI;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2021QIII;1.291
35 Palmas, Las;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2021QII;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2021QI;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2020QIII;1.127
35 Palmas, Las;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2020QII;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2020QI;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2022QIV;1.340
35 Palmas, Las;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2022QII;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2022QI;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2021QIV;1.188
35 Palmas, Las;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2021QII;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2021QI;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2020QIV;1.053
35 Palmas, Las;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2020QII;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2020QI;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QII;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QI;1.112
35 Palmas, Las;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QII;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QI;983
35 Palmas, Las;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QII;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QI;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QII;1.045
35 Palmas, Las;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QI;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QII;920
35 Palmas, Las;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QI;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QII;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QI;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
35 Palmas, Las;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
35 Palmas, Las;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
35 Palmas, Las;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;92,48
35 Palmas, Las;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;91,3
35 Palmas, Las;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;91,92
35 Palmas, Las;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;85,4
35 Palmas, Las;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;84,02
35 Palmas, Las;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;85,89
35 Palmas, Las;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;78,64
35 Palmas, Las;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;80,18
35 Palmas, Las;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;73,9
35 Palmas, Las;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;75,04
35 Palmas, Las;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QIV;4.148
35 Palmas, Las;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QIV;3.883
35 Palmas, Las;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QIV;3.512
35 Palmas, Las;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2022QIV;3.826
35 Palmas, Las;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2022QII;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2022QI;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2021QIV;3.562
35 Palmas, Las;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2021QII;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2021QI;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2020QIV;3.261
35 Palmas, Las;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2020QII;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2020QI;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2022QII;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2022QI;3.299
35 Palmas, Las;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2021QII;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2021QI;3.066
35 Palmas, Las;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2020QII;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2020QI;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QII;3.086
35 Palmas, Las;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QI;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QII;2.906
35 Palmas, Las;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QI;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QII;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QI;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QIII;2.903
35 Palmas, Las;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QII;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QI;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QIII;2.751
35 Palmas, Las;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QII;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QI;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QII;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QI;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
35 Palmas, Las;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
35 Palmas, Las;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
35 Palmas, Las;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;92,24
35 Palmas, Las;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;91,73
35 Palmas, Las;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;92,85
35 Palmas, Las;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;84,96
35 Palmas, Las;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;87,3
35 Palmas, Las;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;79,47
35 Palmas, Las;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;82,74
35 Palmas, Las;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;74,76
35 Palmas, Las;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;78,33
35 Palmas, Las;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QIV;2.514
35 Palmas, Las;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QIV;2.347
35 Palmas, Las;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QIV;2.160
35 Palmas, Las;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2022QIV;2.331
35 Palmas, Las;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2022QII;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2022QI;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2021QIV;2.153
35 Palmas, Las;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2021QII;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2021QI;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2020QIV;2.015
35 Palmas, Las;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2020QII;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2020QI;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2022QII;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2022QI;1.991
35 Palmas, Las;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2021QII;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2021QI;1.908
35 Palmas, Las;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2020QII;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2020QI;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QII;1.858
35 Palmas, Las;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QI;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QII;1.821
35 Palmas, Las;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QI;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QII;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QI;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QIII;1.763
35 Palmas, Las;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QII;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QI;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QIII;1.734
35 Palmas, Las;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QII;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QI;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QII;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QI;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
35 Palmas, Las;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
35 Palmas, Las;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
35 Palmas, Las;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;92,72
35 Palmas, Las;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;91,73
35 Palmas, Las;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;93,29
35 Palmas, Las;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;84,83
35 Palmas, Las;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;88,33
35 Palmas, Las;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;79,16
35 Palmas, Las;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;84,31
35 Palmas, Las;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;75,12
35 Palmas, Las;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;80,28
35 Palmas, Las;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QIV;1.634
35 Palmas, Las;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QIV;1.536
35 Palmas, Las;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QIV;1.352
35 Palmas, Las;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2022QIV;1.495
35 Palmas, Las;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2022QII;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2022QI;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2021QIV;1.409
35 Palmas, Las;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2021QII;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2021QI;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2020QIV;1.246
35 Palmas, Las;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2020QII;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2020QI;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2022QII;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2022QI;1.308
35 Palmas, Las;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2021QII;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2021QI;1.158
35 Palmas, Las;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2020QII;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2020QI;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QII;1.228
35 Palmas, Las;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QI;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QII;1.085
35 Palmas, Las;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QI;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QII;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QI;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QIII;1.140
35 Palmas, Las;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QII;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QI;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QIII;1.017
35 Palmas, Las;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QII;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QI;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QII;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QI;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
35 Palmas, Las;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
35 Palmas, Las;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
35 Palmas, Las;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;91,49
35 Palmas, Las;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;91,73
35 Palmas, Las;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;92,16
35 Palmas, Las;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;85,16
35 Palmas, Las;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;85,65
35 Palmas, Las;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;79,95
35 Palmas, Las;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;80,25
35 Palmas, Las;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;74,22
35 Palmas, Las;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;75,22
35 Palmas, Las;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QI;12.371
35 Palmas, Las;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QI;12.019
35 Palmas, Las;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QI;11.662
35 Palmas, Las;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2022QII;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2022QI;11.838
35 Palmas, Las;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2021QII;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2021QI;11.604
35 Palmas, Las;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2020QII;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2020QI;10.613
35 Palmas, Las;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2022QII;11.301
35 Palmas, Las;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2022QI;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2021QII;11.180
35 Palmas, Las;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2021QI;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2020QII;10.328
35 Palmas, Las;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2020QI;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QIII;10.883
35 Palmas, Las;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QII;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QI;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QIII;10.801
35 Palmas, Las;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QII;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QI;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QIII;9.936
35 Palmas, Las;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QII;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QI;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QIV;10.468
35 Palmas, Las;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QII;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QI;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QIV;10.396
35 Palmas, Las;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QII;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QI;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QIV;9.585
35 Palmas, Las;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QII;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QI;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
35 Palmas, Las;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
35 Palmas, Las;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
35 Palmas, Las;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;95,69
35 Palmas, Las;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;96,55
35 Palmas, Las;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;91
35 Palmas, Las;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;91,35
35 Palmas, Las;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;93,02
35 Palmas, Las;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;88,56
35 Palmas, Las;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;87,97
35 Palmas, Las;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;89,87
35 Palmas, Las;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;85,2
35 Palmas, Las;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;84,62
35 Palmas, Las;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;86,5
35 Palmas, Las;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;82,19
35 Palmas, Las;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QI;7.149
35 Palmas, Las;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QI;7.002
35 Palmas, Las;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QI;6.750
35 Palmas, Las;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2022QII;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2022QI;6.868
35 Palmas, Las;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2021QII;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2021QI;6.771
35 Palmas, Las;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2020QII;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2020QI;6.193
35 Palmas, Las;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2022QII;6.577
35 Palmas, Las;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2022QI;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2021QII;6.549
35 Palmas, Las;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2021QI;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2020QII;6.035
35 Palmas, Las;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2020QI;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QIII;6.366
35 Palmas, Las;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QII;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QI;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QIII;6.315
35 Palmas, Las;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QII;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QI;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QIII;5.820
35 Palmas, Las;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QII;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QI;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QIV;6.116
35 Palmas, Las;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QII;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QI;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QIV;6.094
35 Palmas, Las;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QII;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QI;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QIV;5.617
35 Palmas, Las;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QII;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QI;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
35 Palmas, Las;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
35 Palmas, Las;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
35 Palmas, Las;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;96,07
35 Palmas, Las;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;96,7
35 Palmas, Las;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;91,75
35 Palmas, Las;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;92
35 Palmas, Las;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;93,53
35 Palmas, Las;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;89,41
35 Palmas, Las;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;89,05
35 Palmas, Las;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;90,19
35 Palmas, Las;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;86,22
35 Palmas, Las;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;85,55
35 Palmas, Las;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;87,03
35 Palmas, Las;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;83,21
35 Palmas, Las;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QI;5.222
35 Palmas, Las;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QI;5.017
35 Palmas, Las;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QI;4.912
35 Palmas, Las;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2022QII;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2022QI;4.970
35 Palmas, Las;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2021QII;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2021QI;4.833
35 Palmas, Las;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2020QII;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2020QI;4.420
35 Palmas, Las;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2022QII;4.724
35 Palmas, Las;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2022QI;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2021QII;4.631
35 Palmas, Las;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2021QI;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2020QII;4.293
35 Palmas, Las;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2020QI;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QIII;4.517
35 Palmas, Las;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QII;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QI;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QIII;4.486
35 Palmas, Las;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QII;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QI;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QIII;4.116
35 Palmas, Las;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QII;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QI;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QIV;4.352
35 Palmas, Las;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QII;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QI;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QIV;4.302
35 Palmas, Las;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QII;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QI;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QIV;3.968
35 Palmas, Las;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QII;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QI;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
35 Palmas, Las;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
35 Palmas, Las;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
35 Palmas, Las;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;95,17
35 Palmas, Las;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;96,33
35 Palmas, Las;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;89,98
35 Palmas, Las;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;90,46
35 Palmas, Las;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;92,31
35 Palmas, Las;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;87,4
35 Palmas, Las;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;86,5
35 Palmas, Las;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;89,42
35 Palmas, Las;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;83,79
35 Palmas, Las;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;83,34
35 Palmas, Las;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;85,75
35 Palmas, Las;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;80,78
35 Palmas, Las;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QII;11.817
35 Palmas, Las;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QII;11.435
35 Palmas, Las;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QII;11.548
35 Palmas, Las;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2022QII;11.252
35 Palmas, Las;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2022QI;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2021QII;10.968
35 Palmas, Las;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2021QI;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2020QII;11.211
35 Palmas, Las;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2020QI;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2022QIII;10.787
35 Palmas, Las;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2022QII;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2022QI;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2021QIII;10.565
35 Palmas, Las;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2021QII;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2021QI;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2020QIII;10.746
35 Palmas, Las;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2020QII;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2020QI;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QIV;10.317
35 Palmas, Las;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QII;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QI;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QIV;10.132
35 Palmas, Las;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QII;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QI;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QIV;10.347
35 Palmas, Las;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QII;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QI;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QII;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QI;9.748
35 Palmas, Las;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QII;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QI;10.039
35 Palmas, Las;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QII;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QI;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
35 Palmas, Las;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
35 Palmas, Las;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
35 Palmas, Las;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;95,22
35 Palmas, Las;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;95,92
35 Palmas, Las;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;97,08
35 Palmas, Las;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;91,28
35 Palmas, Las;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;92,39
35 Palmas, Las;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;93,06
35 Palmas, Las;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;87,31
35 Palmas, Las;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;88,61
35 Palmas, Las;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;89,6
35 Palmas, Las;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;85,25
35 Palmas, Las;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;86,93
35 Palmas, Las;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QII;6.787
35 Palmas, Las;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QII;6.651
35 Palmas, Las;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QII;6.716
35 Palmas, Las;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2022QII;6.482
35 Palmas, Las;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2022QI;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2021QII;6.407
35 Palmas, Las;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2021QI;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2020QII;6.528
35 Palmas, Las;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2020QI;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2022QIII;6.251
35 Palmas, Las;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2022QII;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2022QI;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2021QIII;6.168
35 Palmas, Las;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2021QII;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2021QI;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2020QIII;6.275
35 Palmas, Las;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2020QII;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2020QI;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QIV;5.972
35 Palmas, Las;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QII;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QI;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QIV;5.918
35 Palmas, Las;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QII;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QI;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QIV;6.042
35 Palmas, Las;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QII;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QI;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QII;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QI;5.720
35 Palmas, Las;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QII;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QI;5.876
35 Palmas, Las;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QII;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QI;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
35 Palmas, Las;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
35 Palmas, Las;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
35 Palmas, Las;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;95,51
35 Palmas, Las;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;96,33
35 Palmas, Las;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;97,2
35 Palmas, Las;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;92,1
35 Palmas, Las;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;92,74
35 Palmas, Las;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;93,43
35 Palmas, Las;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;87,99
35 Palmas, Las;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;88,98
35 Palmas, Las;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;89,96
35 Palmas, Las;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;86
35 Palmas, Las;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;87,49
35 Palmas, Las;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QII;5.030
35 Palmas, Las;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QII;4.784
35 Palmas, Las;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QII;4.832
35 Palmas, Las;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2022QII;4.770
35 Palmas, Las;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2022QI;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2021QII;4.561
35 Palmas, Las;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2021QI;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2020QII;4.683
35 Palmas, Las;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2020QI;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2022QIII;4.536
35 Palmas, Las;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2022QII;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2022QI;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2021QIII;4.397
35 Palmas, Las;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2021QII;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2021QI;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2020QIII;4.471
35 Palmas, Las;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2020QII;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2020QI;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QIV;4.345
35 Palmas, Las;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QII;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QI;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QIV;4.214
35 Palmas, Las;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QII;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QI;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QIV;4.305
35 Palmas, Las;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QII;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QI;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QII;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QI;4.028
35 Palmas, Las;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QII;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QI;4.163
35 Palmas, Las;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QII;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QI;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
35 Palmas, Las;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
35 Palmas, Las;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
35 Palmas, Las;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;94,83
35 Palmas, Las;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;95,34
35 Palmas, Las;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;96,92
35 Palmas, Las;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;90,18
35 Palmas, Las;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;91,91
35 Palmas, Las;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;92,53
35 Palmas, Las;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;86,38
35 Palmas, Las;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;88,09
35 Palmas, Las;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;89,09
35 Palmas, Las;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;84,2
35 Palmas, Las;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;86,15
35 Palmas, Las;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QIII;12.117
35 Palmas, Las;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QIII;11.736
35 Palmas, Las;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QIII;11.607
35 Palmas, Las;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2022QIII;11.585
35 Palmas, Las;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2022QII;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2022QI;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2021QIII;11.266
35 Palmas, Las;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2021QII;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2021QI;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2020QIII;11.095
35 Palmas, Las;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2020QII;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2020QI;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2022QIV;11.054
35 Palmas, Las;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2022QII;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2022QI;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2021QIV;10.781
35 Palmas, Las;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2021QII;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2021QI;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2020QIV;10.655
35 Palmas, Las;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2020QII;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2020QI;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QII;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QI;10.354
35 Palmas, Las;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QII;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QI;10.334
35 Palmas, Las;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QII;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QI;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QII;9.925
35 Palmas, Las;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QI;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QII;10.001
35 Palmas, Las;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QI;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QII;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QI;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
35 Palmas, Las;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
35 Palmas, Las;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
35 Palmas, Las;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;95,61
35 Palmas, Las;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;96
35 Palmas, Las;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;95,59
35 Palmas, Las;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;91,23
35 Palmas, Las;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;91,86
35 Palmas, Las;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;91,8
35 Palmas, Las;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;88,22
35 Palmas, Las;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;89,03
35 Palmas, Las;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;84,57
35 Palmas, Las;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;86,16
35 Palmas, Las;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QIII;6.963
35 Palmas, Las;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QIII;6.828
35 Palmas, Las;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QIII;6.775
35 Palmas, Las;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2022QIII;6.691
35 Palmas, Las;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2022QII;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2022QI;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2021QIII;6.553
35 Palmas, Las;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2021QII;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2021QI;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2020QIII;6.497
35 Palmas, Las;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2020QII;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2020QI;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2022QIV;6.382
35 Palmas, Las;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2022QII;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2022QI;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2021QIV;6.272
35 Palmas, Las;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2021QII;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2021QI;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2020QIV;6.239
35 Palmas, Las;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2020QII;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2020QI;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QII;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QI;6.050
35 Palmas, Las;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QII;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QI;6.063
35 Palmas, Las;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QII;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QI;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QII;5.814
35 Palmas, Las;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QI;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QII;5.886
35 Palmas, Las;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QI;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QII;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QI;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
35 Palmas, Las;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
35 Palmas, Las;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
35 Palmas, Las;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;96,09
35 Palmas, Las;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;95,97
35 Palmas, Las;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;95,9
35 Palmas, Las;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;91,66
35 Palmas, Las;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;91,86
35 Palmas, Las;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;92,09
35 Palmas, Las;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;88,61
35 Palmas, Las;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;89,49
35 Palmas, Las;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;85,15
35 Palmas, Las;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;86,88
35 Palmas, Las;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QIII;5.154
35 Palmas, Las;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QIII;4.908
35 Palmas, Las;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QIII;4.832
35 Palmas, Las;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2022QIII;4.894
35 Palmas, Las;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2022QII;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2022QI;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2021QIII;4.713
35 Palmas, Las;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2021QII;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2021QI;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2020QIII;4.598
35 Palmas, Las;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2020QII;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2020QI;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2022QIV;4.672
35 Palmas, Las;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2022QII;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2022QI;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2021QIV;4.509
35 Palmas, Las;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2021QII;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2021QI;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2020QIV;4.416
35 Palmas, Las;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2020QII;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2020QI;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QII;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QI;4.304
35 Palmas, Las;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QII;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QI;4.271
35 Palmas, Las;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QII;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QI;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QII;4.111
35 Palmas, Las;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QI;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QII;4.115
35 Palmas, Las;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QI;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QII;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QI;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
35 Palmas, Las;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
35 Palmas, Las;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
35 Palmas, Las;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;94,96
35 Palmas, Las;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;96,03
35 Palmas, Las;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;95,16
35 Palmas, Las;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;90,65
35 Palmas, Las;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;91,87
35 Palmas, Las;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;91,39
35 Palmas, Las;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;87,69
35 Palmas, Las;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;88,39
35 Palmas, Las;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;83,76
35 Palmas, Las;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;85,16
35 Palmas, Las;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QIV;12.294
35 Palmas, Las;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QIV;12.070
35 Palmas, Las;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QIV;11.841
35 Palmas, Las;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2022QIV;11.708
35 Palmas, Las;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2022QII;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2022QI;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2021QIV;11.511
35 Palmas, Las;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2021QII;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2021QI;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2020QIV;11.319
35 Palmas, Las;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2020QII;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2020QI;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2022QII;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2022QI;11.030
35 Palmas, Las;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2021QII;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2021QI;10.956
35 Palmas, Las;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2020QII;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2020QI;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QII;10.557
35 Palmas, Las;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QI;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QII;10.589
35 Palmas, Las;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QI;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QII;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QI;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QIII;10.176
35 Palmas, Las;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QII;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QI;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QIII;10.244
35 Palmas, Las;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QII;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QI;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QII;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QI;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
35 Palmas, Las;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
35 Palmas, Las;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
35 Palmas, Las;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;95,23
35 Palmas, Las;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;95,37
35 Palmas, Las;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;95,59
35 Palmas, Las;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;91,38
35 Palmas, Las;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;92,53
35 Palmas, Las;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;87,46
35 Palmas, Las;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;89,43
35 Palmas, Las;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;84,31
35 Palmas, Las;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;86,51
35 Palmas, Las;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QIV;7.090
35 Palmas, Las;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QIV;7.016
35 Palmas, Las;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QIV;6.920
35 Palmas, Las;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2022QIV;6.753
35 Palmas, Las;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2022QII;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2022QI;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2021QIV;6.684
35 Palmas, Las;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2021QII;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2021QI;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2020QIV;6.618
35 Palmas, Las;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2020QII;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2020QI;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2022QII;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2022QI;6.433
35 Palmas, Las;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2021QII;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2021QI;6.418
35 Palmas, Las;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2020QII;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2020QI;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QII;6.175
35 Palmas, Las;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QI;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QII;6.226
35 Palmas, Las;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QI;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QII;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QI;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QIII;5.982
35 Palmas, Las;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QII;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QI;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QIII;6.016
35 Palmas, Las;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QII;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QI;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QII;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QI;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
35 Palmas, Las;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
35 Palmas, Las;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
35 Palmas, Las;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;95,25
35 Palmas, Las;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;95,27
35 Palmas, Las;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;95,64
35 Palmas, Las;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;91,69
35 Palmas, Las;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;92,75
35 Palmas, Las;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;88,01
35 Palmas, Las;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;89,97
35 Palmas, Las;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;85,26
35 Palmas, Las;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;86,94
35 Palmas, Las;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QIV;5.204
35 Palmas, Las;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QIV;5.054
35 Palmas, Las;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QIV;4.921
35 Palmas, Las;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2022QIV;4.955
35 Palmas, Las;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2022QII;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2022QI;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2021QIV;4.827
35 Palmas, Las;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2021QII;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2021QI;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2020QIV;4.701
35 Palmas, Las;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2020QII;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2020QI;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2022QII;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2022QI;4.597
35 Palmas, Las;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2021QII;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2021QI;4.538
35 Palmas, Las;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2020QII;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2020QI;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QII;4.382
35 Palmas, Las;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QI;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QII;4.363
35 Palmas, Las;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QI;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QII;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QI;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QIII;4.194
35 Palmas, Las;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QII;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QI;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QIII;4.228
35 Palmas, Las;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QII;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QI;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QII;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QI;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
35 Palmas, Las;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
35 Palmas, Las;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
35 Palmas, Las;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;95,22
35 Palmas, Las;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;95,51
35 Palmas, Las;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;95,53
35 Palmas, Las;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;90,96
35 Palmas, Las;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;92,22
35 Palmas, Las;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;86,7
35 Palmas, Las;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;88,66
35 Palmas, Las;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;82,98
35 Palmas, Las;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;85,92
35 Palmas, Las;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QI;20.538
35 Palmas, Las;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QI;20.213
35 Palmas, Las;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QI;20.572
35 Palmas, Las;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2022QII;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2022QI;19.901
35 Palmas, Las;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2021QII;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2021QI;19.697
35 Palmas, Las;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2020QII;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2020QI;19.144
35 Palmas, Las;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2022QII;19.251
35 Palmas, Las;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2022QI;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2021QII;19.182
35 Palmas, Las;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2021QI;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2020QII;18.724
35 Palmas, Las;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2020QI;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QIII;18.708
35 Palmas, Las;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QII;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QI;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QIII;18.784
35 Palmas, Las;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QII;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QI;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QIII;18.204
35 Palmas, Las;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QII;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QI;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QIV;18.177
35 Palmas, Las;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QII;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QI;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QIV;18.288
35 Palmas, Las;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QII;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QI;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QIV;17.727
35 Palmas, Las;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QII;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QI;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
35 Palmas, Las;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
35 Palmas, Las;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
35 Palmas, Las;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;96,9
35 Palmas, Las;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;97,45
35 Palmas, Las;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;93,06
35 Palmas, Las;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;93,73
35 Palmas, Las;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;94,9
35 Palmas, Las;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;91,02
35 Palmas, Las;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;91,09
35 Palmas, Las;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;92,93
35 Palmas, Las;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;88,49
35 Palmas, Las;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;88,5
35 Palmas, Las;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;90,48
35 Palmas, Las;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;86,17
35 Palmas, Las;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QI;13.035
35 Palmas, Las;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QI;13.061
35 Palmas, Las;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QI;13.278
35 Palmas, Las;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2022QII;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2022QI;12.675
35 Palmas, Las;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2021QII;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2021QI;12.751
35 Palmas, Las;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2020QII;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2020QI;12.438
35 Palmas, Las;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2022QII;12.312
35 Palmas, Las;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2022QI;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2021QII;12.445
35 Palmas, Las;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2021QI;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2020QII;12.193
35 Palmas, Las;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2020QI;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QIII;12.008
35 Palmas, Las;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QII;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QI;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QIII;12.218
35 Palmas, Las;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QII;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QI;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QIII;11.901
35 Palmas, Las;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QII;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QI;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QIV;11.698
35 Palmas, Las;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QII;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QI;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QIV;11.909
35 Palmas, Las;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QII;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QI;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QIV;11.604
35 Palmas, Las;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QII;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QI;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
35 Palmas, Las;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
35 Palmas, Las;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
35 Palmas, Las;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;97,24
35 Palmas, Las;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;97,63
35 Palmas, Las;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;93,67
35 Palmas, Las;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;94,45
35 Palmas, Las;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;95,28
35 Palmas, Las;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;91,83
35 Palmas, Las;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;92,12
35 Palmas, Las;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;93,55
35 Palmas, Las;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;89,63
35 Palmas, Las;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;89,74
35 Palmas, Las;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;91,18
35 Palmas, Las;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;87,39
35 Palmas, Las;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QI;7.503
35 Palmas, Las;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QI;7.152
35 Palmas, Las;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QI;7.294
35 Palmas, Las;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2022QII;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2022QI;7.226
35 Palmas, Las;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2021QII;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2021QI;6.946
35 Palmas, Las;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2020QII;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2020QI;6.706
35 Palmas, Las;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2022QII;6.939
35 Palmas, Las;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2022QI;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2021QII;6.737
35 Palmas, Las;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2021QI;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2020QII;6.531
35 Palmas, Las;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2020QI;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QIII;6.700
35 Palmas, Las;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QII;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QI;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QIII;6.566
35 Palmas, Las;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QII;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QI;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QIII;6.303
35 Palmas, Las;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QII;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QI;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QIV;6.479
35 Palmas, Las;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QII;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QI;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QIV;6.379
35 Palmas, Las;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QII;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QI;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QIV;6.123
35 Palmas, Las;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QII;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QI;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
35 Palmas, Las;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
35 Palmas, Las;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
35 Palmas, Las;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;96,31
35 Palmas, Las;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;97,12
35 Palmas, Las;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;91,94
35 Palmas, Las;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;92,48
35 Palmas, Las;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;94,2
35 Palmas, Las;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;89,54
35 Palmas, Las;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;89,3
35 Palmas, Las;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;91,81
35 Palmas, Las;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;86,41
35 Palmas, Las;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;86,35
35 Palmas, Las;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;89,19
35 Palmas, Las;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;83,95
35 Palmas, Las;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QII;20.075
35 Palmas, Las;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QII;19.876
35 Palmas, Las;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QII;20.085
35 Palmas, Las;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2022QII;19.364
35 Palmas, Las;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2022QI;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2021QII;19.311
35 Palmas, Las;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2021QI;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2020QII;19.611
35 Palmas, Las;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2020QI;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2022QIII;18.774
35 Palmas, Las;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2022QII;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2022QI;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2021QIII;18.873
35 Palmas, Las;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2021QII;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2021QI;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2020QIII;19.007
35 Palmas, Las;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2020QII;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2020QI;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QIV;18.210
35 Palmas, Las;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QII;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QI;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QIV;18.344
35 Palmas, Las;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QII;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QI;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QIV;18.476
35 Palmas, Las;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QII;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QI;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QII;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QI;17.864
35 Palmas, Las;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QII;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QI;18.096
35 Palmas, Las;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QII;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QI;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
35 Palmas, Las;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
35 Palmas, Las;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
35 Palmas, Las;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;96,46
35 Palmas, Las;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;97,16
35 Palmas, Las;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;97,64
35 Palmas, Las;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;93,52
35 Palmas, Las;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;94,95
35 Palmas, Las;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;94,63
35 Palmas, Las;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;90,71
35 Palmas, Las;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;92,29
35 Palmas, Las;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;91,99
35 Palmas, Las;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;89,88
35 Palmas, Las;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;90,1
35 Palmas, Las;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QII;12.639
35 Palmas, Las;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QII;12.695
35 Palmas, Las;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QII;12.979
35 Palmas, Las;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2022QII;12.235
35 Palmas, Las;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2022QI;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2021QII;12.354
35 Palmas, Las;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2021QI;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2020QII;12.702
35 Palmas, Las;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2020QI;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2022QIII;11.899
35 Palmas, Las;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2022QII;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2022QI;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2021QIII;12.105
35 Palmas, Las;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2021QII;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2021QI;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2020QIII;12.355
35 Palmas, Las;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2020QII;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2020QI;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QIV;11.570
35 Palmas, Las;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QII;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QI;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QIV;11.783
35 Palmas, Las;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QII;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QI;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QIV;12.032
35 Palmas, Las;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QII;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QI;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QII;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QI;11.510
35 Palmas, Las;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QII;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QI;11.798
35 Palmas, Las;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QII;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QI;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
35 Palmas, Las;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
35 Palmas, Las;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
35 Palmas, Las;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;96,8
35 Palmas, Las;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;97,31
35 Palmas, Las;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;97,87
35 Palmas, Las;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;94,15
35 Palmas, Las;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;95,35
35 Palmas, Las;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;95,19
35 Palmas, Las;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;91,54
35 Palmas, Las;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;92,82
35 Palmas, Las;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;92,7
35 Palmas, Las;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;90,67
35 Palmas, Las;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;90,9
35 Palmas, Las;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QII;7.436
35 Palmas, Las;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QII;7.181
35 Palmas, Las;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QII;7.106
35 Palmas, Las;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2022QII;7.129
35 Palmas, Las;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2022QI;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2021QII;6.957
35 Palmas, Las;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2021QI;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2020QII;6.909
35 Palmas, Las;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2020QI;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2022QIII;6.875
35 Palmas, Las;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2022QII;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2022QI;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2021QIII;6.768
35 Palmas, Las;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2021QII;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2021QI;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2020QIII;6.652
35 Palmas, Las;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2020QII;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2020QI;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QIV;6.640
35 Palmas, Las;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QII;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QI;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QIV;6.561
35 Palmas, Las;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QII;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QI;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QIV;6.444
35 Palmas, Las;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QII;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QI;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QII;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QI;6.354
35 Palmas, Las;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QII;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QI;6.298
35 Palmas, Las;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QII;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QI;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
35 Palmas, Las;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
35 Palmas, Las;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
35 Palmas, Las;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;95,87
35 Palmas, Las;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;96,88
35 Palmas, Las;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;97,23
35 Palmas, Las;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;92,46
35 Palmas, Las;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;94,25
35 Palmas, Las;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;93,61
35 Palmas, Las;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;89,3
35 Palmas, Las;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;91,37
35 Palmas, Las;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;90,68
35 Palmas, Las;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;88,48
35 Palmas, Las;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;88,63
35 Palmas, Las;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QIII;20.177
35 Palmas, Las;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QIII;20.088
35 Palmas, Las;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QIII;20.150
35 Palmas, Las;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2022QIII;19.516
35 Palmas, Las;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2022QII;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2022QI;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2021QIII;19.583
35 Palmas, Las;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2021QII;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2021QI;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2020QIII;19.483
35 Palmas, Las;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2020QII;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2020QI;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2022QIV;18.894
35 Palmas, Las;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2022QII;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2022QI;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2021QIV;18.997
35 Palmas, Las;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2021QII;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2021QI;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2020QIV;18.913
35 Palmas, Las;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2020QII;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2020QI;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QII;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QI;18.479
35 Palmas, Las;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QII;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QI;18.508
35 Palmas, Las;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QII;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QI;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QII;17.954
35 Palmas, Las;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QI;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QII;18.097
35 Palmas, Las;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QI;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QII;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QI;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
35 Palmas, Las;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
35 Palmas, Las;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
35 Palmas, Las;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;96,72
35 Palmas, Las;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;97,49
35 Palmas, Las;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;96,69
35 Palmas, Las;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;93,64
35 Palmas, Las;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;94,57
35 Palmas, Las;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;93,86
35 Palmas, Las;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;91,99
35 Palmas, Las;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;91,85
35 Palmas, Las;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;89,38
35 Palmas, Las;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;89,81
35 Palmas, Las;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QIII;12.692
35 Palmas, Las;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QIII;12.802
35 Palmas, Las;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QIII;13.043
35 Palmas, Las;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2022QIII;12.321
35 Palmas, Las;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2022QII;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2022QI;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2021QIII;12.507
35 Palmas, Las;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2021QII;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2021QI;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2020QIII;12.657
35 Palmas, Las;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2020QII;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2020QI;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2022QIV;11.960
35 Palmas, Las;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2022QII;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2022QI;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2021QIV;12.153
35 Palmas, Las;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2021QII;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2021QI;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2020QIV;12.308
35 Palmas, Las;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2020QII;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2020QI;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QII;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QI;11.856
35 Palmas, Las;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QII;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QI;12.062
35 Palmas, Las;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QII;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QI;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QII;11.556
35 Palmas, Las;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QI;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QII;11.823
35 Palmas, Las;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QI;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QII;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QI;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
35 Palmas, Las;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
35 Palmas, Las;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
35 Palmas, Las;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;97,08
35 Palmas, Las;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;97,7
35 Palmas, Las;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;97,04
35 Palmas, Las;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;94,23
35 Palmas, Las;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;94,93
35 Palmas, Las;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;94,36
35 Palmas, Las;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;92,61
35 Palmas, Las;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;92,48
35 Palmas, Las;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;90,27
35 Palmas, Las;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;90,65
35 Palmas, Las;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QIII;7.485
35 Palmas, Las;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QIII;7.286
35 Palmas, Las;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QIII;7.107
35 Palmas, Las;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2022QIII;7.195
35 Palmas, Las;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2022QII;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2022QI;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2021QIII;7.076
35 Palmas, Las;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2021QII;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2021QI;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2020QIII;6.826
35 Palmas, Las;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2020QII;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2020QI;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2022QIV;6.934
35 Palmas, Las;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2022QII;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2022QI;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2021QIV;6.844
35 Palmas, Las;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2021QII;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2021QI;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2020QIV;6.605
35 Palmas, Las;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2020QII;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2020QI;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QII;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QI;6.623
35 Palmas, Las;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QII;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QI;6.446
35 Palmas, Las;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QII;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QI;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QII;6.398
35 Palmas, Las;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QI;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QII;6.274
35 Palmas, Las;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QI;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QII;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QI;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
35 Palmas, Las;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
35 Palmas, Las;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
35 Palmas, Las;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;96,13
35 Palmas, Las;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;97,12
35 Palmas, Las;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;96,05
35 Palmas, Las;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;92,64
35 Palmas, Las;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;93,93
35 Palmas, Las;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;92,94
35 Palmas, Las;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;90,9
35 Palmas, Las;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;90,7
35 Palmas, Las;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;87,81
35 Palmas, Las;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;88,28
35 Palmas, Las;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QIV;20.240
35 Palmas, Las;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QIV;20.358
35 Palmas, Las;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QIV;20.198
35 Palmas, Las;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2022QIV;19.564
35 Palmas, Las;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2022QII;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2022QI;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2021QIV;19.707
35 Palmas, Las;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2021QII;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2021QI;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2020QIV;19.556
35 Palmas, Las;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2020QII;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2020QI;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2022QII;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2022QI;19.144
35 Palmas, Las;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2021QII;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2021QI;19.111
35 Palmas, Las;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2020QII;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2020QI;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QII;18.571
35 Palmas, Las;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QI;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QII;18.653
35 Palmas, Las;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QI;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QII;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QI;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QIII;18.081
35 Palmas, Las;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QII;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QI;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QIII;18.280
35 Palmas, Las;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QII;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QI;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QII;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QI;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
35 Palmas, Las;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
35 Palmas, Las;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
35 Palmas, Las;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;96,66
35 Palmas, Las;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;96,8
35 Palmas, Las;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;96,82
35 Palmas, Las;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;94,04
35 Palmas, Las;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;94,62
35 Palmas, Las;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;91,22
35 Palmas, Las;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;92,35
35 Palmas, Las;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;88,82
35 Palmas, Las;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;90,5
35 Palmas, Las;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QIV;12.737
35 Palmas, Las;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QIV;12.971
35 Palmas, Las;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QIV;13.095
35 Palmas, Las;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2022QIV;12.341
35 Palmas, Las;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2022QII;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2022QI;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2021QIV;12.576
35 Palmas, Las;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2021QII;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2021QI;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2020QIV;12.699
35 Palmas, Las;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2020QII;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2020QI;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2022QII;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2022QI;12.255
35 Palmas, Las;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2021QII;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2021QI;12.431
35 Palmas, Las;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2020QII;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2020QI;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QII;11.929
35 Palmas, Las;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QI;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QII;12.163
35 Palmas, Las;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QI;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QII;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QI;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QIII;11.660
35 Palmas, Las;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QII;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QI;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QIII;11.950
35 Palmas, Las;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QII;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QI;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QII;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QI;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
35 Palmas, Las;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
35 Palmas, Las;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
35 Palmas, Las;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;96,89
35 Palmas, Las;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;96,95
35 Palmas, Las;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;96,98
35 Palmas, Las;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;94,48
35 Palmas, Las;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;94,93
35 Palmas, Las;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;91,97
35 Palmas, Las;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;92,88
35 Palmas, Las;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;89,89
35 Palmas, Las;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;91,26
35 Palmas, Las;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QIV;7.503
35 Palmas, Las;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QIV;7.387
35 Palmas, Las;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QIV;7.103
35 Palmas, Las;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2022QIV;7.223
35 Palmas, Las;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2022QII;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2022QI;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2021QIV;7.131
35 Palmas, Las;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2021QII;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2021QI;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2020QIV;6.857
35 Palmas, Las;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2020QII;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2020QI;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2022QII;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2022QI;6.889
35 Palmas, Las;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2021QII;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2021QI;6.680
35 Palmas, Las;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2020QII;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2020QI;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QII;6.642
35 Palmas, Las;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QI;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QII;6.490
35 Palmas, Las;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QI;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QII;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QI;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QIII;6.421
35 Palmas, Las;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QII;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QI;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QIII;6.330
35 Palmas, Las;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QII;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QI;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QII;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QI;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
35 Palmas, Las;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
35 Palmas, Las;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
35 Palmas, Las;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;96,27
35 Palmas, Las;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;96,53
35 Palmas, Las;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;96,54
35 Palmas, Las;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;93,26
35 Palmas, Las;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;94,04
35 Palmas, Las;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;89,91
35 Palmas, Las;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;91,37
35 Palmas, Las;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;86,92
35 Palmas, Las;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;89,12
35 Palmas, Las;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QI;18.803
35 Palmas, Las;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QI;17.820
35 Palmas, Las;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QI;18.355
35 Palmas, Las;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2022QII;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2022QI;18.310
35 Palmas, Las;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2021QII;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2021QI;17.390
35 Palmas, Las;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2020QII;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2020QI;17.336
35 Palmas, Las;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2022QII;17.759
35 Palmas, Las;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2022QI;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2021QII;17.010
35 Palmas, Las;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2021QI;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2020QII;16.999
35 Palmas, Las;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2020QI;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QIII;17.373
35 Palmas, Las;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QII;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QI;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QIII;16.747
35 Palmas, Las;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QII;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QI;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QIII;16.590
35 Palmas, Las;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QII;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QI;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QIV;16.963
35 Palmas, Las;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QII;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QI;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QIV;16.404
35 Palmas, Las;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QII;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QI;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QIV;16.254
35 Palmas, Las;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QII;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QI;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
35 Palmas, Las;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
35 Palmas, Las;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
35 Palmas, Las;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;97,38
35 Palmas, Las;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;97,59
35 Palmas, Las;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;94,45
35 Palmas, Las;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;94,45
35 Palmas, Las;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;95,45
35 Palmas, Las;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;92,61
35 Palmas, Las;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;92,39
35 Palmas, Las;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;93,98
35 Palmas, Las;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;90,38
35 Palmas, Las;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;90,21
35 Palmas, Las;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;92,05
35 Palmas, Las;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;88,55
35 Palmas, Las;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QI;12.604
35 Palmas, Las;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QI;11.995
35 Palmas, Las;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QI;12.336
35 Palmas, Las;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2022QII;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2022QI;12.304
35 Palmas, Las;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2021QII;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2021QI;11.731
35 Palmas, Las;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2020QII;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2020QI;11.692
35 Palmas, Las;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2022QII;11.970
35 Palmas, Las;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2022QI;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2021QII;11.506
35 Palmas, Las;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2021QI;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2020QII;11.483
35 Palmas, Las;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2020QI;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QIII;11.739
35 Palmas, Las;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QII;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QI;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QIII;11.346
35 Palmas, Las;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QII;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QI;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QIII;11.218
35 Palmas, Las;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QII;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QI;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QIV;11.496
35 Palmas, Las;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QII;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QI;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QIV;11.130
35 Palmas, Las;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QII;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QI;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QIV;11.002
35 Palmas, Las;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QII;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QI;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
35 Palmas, Las;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
35 Palmas, Las;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
35 Palmas, Las;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;97,62
35 Palmas, Las;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;97,8
35 Palmas, Las;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;94,78
35 Palmas, Las;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;94,97
35 Palmas, Las;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;95,92
35 Palmas, Las;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;93,09
35 Palmas, Las;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;93,14
35 Palmas, Las;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;94,59
35 Palmas, Las;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;90,94
35 Palmas, Las;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;91,21
35 Palmas, Las;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;92,79
35 Palmas, Las;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;89,19
35 Palmas, Las;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QI;6.199
35 Palmas, Las;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QI;5.825
35 Palmas, Las;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QI;6.019
35 Palmas, Las;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2022QII;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2022QI;6.006
35 Palmas, Las;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2021QII;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2021QI;5.659
35 Palmas, Las;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2020QII;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2020QI;5.644
35 Palmas, Las;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2022QII;5.789
35 Palmas, Las;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2022QI;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2021QII;5.504
35 Palmas, Las;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2021QI;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2020QII;5.516
35 Palmas, Las;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2020QI;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QIII;5.634
35 Palmas, Las;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QII;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QI;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QIII;5.401
35 Palmas, Las;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QII;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QI;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QIII;5.372
35 Palmas, Las;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QII;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QI;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QIV;5.467
35 Palmas, Las;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QII;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QI;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QIV;5.274
35 Palmas, Las;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QII;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QI;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QIV;5.252
35 Palmas, Las;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QII;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QI;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
35 Palmas, Las;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
35 Palmas, Las;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
35 Palmas, Las;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;96,89
35 Palmas, Las;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;97,15
35 Palmas, Las;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;93,77
35 Palmas, Las;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;93,39
35 Palmas, Las;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;94,49
35 Palmas, Las;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;91,64
35 Palmas, Las;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;90,89
35 Palmas, Las;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;92,72
35 Palmas, Las;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;89,25
35 Palmas, Las;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;88,19
35 Palmas, Las;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;90,54
35 Palmas, Las;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;87,26
35 Palmas, Las;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QII;19.617
35 Palmas, Las;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QII;18.653
35 Palmas, Las;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QII;17.967
35 Palmas, Las;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2022QII;19.005
35 Palmas, Las;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2022QI;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2021QII;18.200
35 Palmas, Las;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2021QI;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2020QII;17.600
35 Palmas, Las;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2020QI;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2022QIII;18.575
35 Palmas, Las;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2022QII;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2022QI;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2021QIII;17.895
35 Palmas, Las;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2021QII;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2021QI;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2020QIII;17.125
35 Palmas, Las;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2020QII;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2020QI;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QIV;18.123
35 Palmas, Las;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QII;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QI;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QIV;17.509
35 Palmas, Las;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QII;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QI;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QIV;16.754
35 Palmas, Las;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QII;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QI;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QII;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QI;17.114
35 Palmas, Las;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QII;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QI;16.424
35 Palmas, Las;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QII;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QI;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
35 Palmas, Las;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
35 Palmas, Las;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
35 Palmas, Las;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;96,88
35 Palmas, Las;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;97,57
35 Palmas, Las;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;97,96
35 Palmas, Las;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;94,69
35 Palmas, Las;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;95,94
35 Palmas, Las;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;95,31
35 Palmas, Las;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;92,38
35 Palmas, Las;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;93,87
35 Palmas, Las;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;93,25
35 Palmas, Las;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;91,75
35 Palmas, Las;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;91,41
35 Palmas, Las;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QII;13.053
35 Palmas, Las;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QII;12.545
35 Palmas, Las;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QII;12.108
35 Palmas, Las;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2022QII;12.685
35 Palmas, Las;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2022QI;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2021QII;12.276
35 Palmas, Las;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2021QI;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2020QII;11.880
35 Palmas, Las;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2020QI;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2022QIII;12.434
35 Palmas, Las;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2022QII;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2022QI;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2021QIII;12.086
35 Palmas, Las;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2021QII;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2021QI;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2020QIII;11.563
35 Palmas, Las;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2020QII;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2020QI;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QIV;12.172
35 Palmas, Las;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QII;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QI;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QIV;11.843
35 Palmas, Las;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QII;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QI;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QIV;11.323
35 Palmas, Las;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QII;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QI;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QII;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QI;11.610
35 Palmas, Las;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QII;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QI;11.120
35 Palmas, Las;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QII;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QI;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
35 Palmas, Las;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
35 Palmas, Las;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
35 Palmas, Las;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;97,18
35 Palmas, Las;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;97,86
35 Palmas, Las;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;98,12
35 Palmas, Las;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;95,26
35 Palmas, Las;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;96,34
35 Palmas, Las;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;95,5
35 Palmas, Las;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;93,25
35 Palmas, Las;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;94,4
35 Palmas, Las;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;93,52
35 Palmas, Las;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;92,55
35 Palmas, Las;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;91,84
35 Palmas, Las;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QII;6.564
35 Palmas, Las;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QII;6.108
35 Palmas, Las;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QII;5.859
35 Palmas, Las;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2022QII;6.320
35 Palmas, Las;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2022QI;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2021QII;5.924
35 Palmas, Las;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2021QI;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2020QII;5.720
35 Palmas, Las;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2020QI;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2022QIII;6.141
35 Palmas, Las;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2022QII;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2022QI;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2021QIII;5.809
35 Palmas, Las;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2021QII;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2021QI;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2020QIII;5.562
35 Palmas, Las;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2020QII;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2020QI;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QIV;5.951
35 Palmas, Las;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QII;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QI;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QIV;5.666
35 Palmas, Las;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QII;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QI;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QIV;5.431
35 Palmas, Las;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QII;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QI;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QII;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QI;5.504
35 Palmas, Las;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QII;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QI;5.304
35 Palmas, Las;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QII;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QI;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
35 Palmas, Las;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
35 Palmas, Las;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
35 Palmas, Las;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;96,28
35 Palmas, Las;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;96,99
35 Palmas, Las;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;97,63
35 Palmas, Las;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;93,56
35 Palmas, Las;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;95,1
35 Palmas, Las;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;94,93
35 Palmas, Las;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;90,66
35 Palmas, Las;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;92,76
35 Palmas, Las;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;92,69
35 Palmas, Las;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;90,11
35 Palmas, Las;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;90,53
35 Palmas, Las;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QIII;19.533
35 Palmas, Las;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QIII;18.632
35 Palmas, Las;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QIII;17.922
35 Palmas, Las;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2022QIII;19.044
35 Palmas, Las;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2022QII;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2022QI;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2021QIII;18.292
35 Palmas, Las;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2021QII;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2021QI;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2020QIII;17.423
35 Palmas, Las;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2020QII;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2020QI;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2022QIV;18.558
35 Palmas, Las;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2022QII;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2022QI;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2021QIV;17.879
35 Palmas, Las;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2021QII;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2021QI;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2020QIV;17.020
35 Palmas, Las;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2020QII;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2020QI;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QII;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QI;17.459
35 Palmas, Las;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QII;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QI;16.672
35 Palmas, Las;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QII;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QI;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QII;16.988
35 Palmas, Las;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QI;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QII;16.366
35 Palmas, Las;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QI;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QII;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QI;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
35 Palmas, Las;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
35 Palmas, Las;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
35 Palmas, Las;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;97,5
35 Palmas, Las;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;98,18
35 Palmas, Las;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;97,22
35 Palmas, Las;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;95,01
35 Palmas, Las;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;95,96
35 Palmas, Las;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;94,97
35 Palmas, Las;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;93,7
35 Palmas, Las;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;93,03
35 Palmas, Las;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;91,18
35 Palmas, Las;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;91,32
35 Palmas, Las;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QIII;13.015
35 Palmas, Las;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QIII;12.534
35 Palmas, Las;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QIII;12.096
35 Palmas, Las;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2022QIII;12.731
35 Palmas, Las;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2022QII;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2022QI;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2021QIII;12.323
35 Palmas, Las;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2021QII;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2021QI;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2020QIII;11.762
35 Palmas, Las;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2020QII;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2020QI;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2022QIV;12.447
35 Palmas, Las;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2022QII;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2022QI;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2021QIV;12.064
35 Palmas, Las;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2021QII;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2021QI;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2020QIV;11.500
35 Palmas, Las;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2020QII;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2020QI;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QII;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QI;11.815
35 Palmas, Las;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QII;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QI;11.285
35 Palmas, Las;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QII;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QI;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QII;11.523
35 Palmas, Las;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QI;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QII;11.100
35 Palmas, Las;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QI;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QII;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QI;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
35 Palmas, Las;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
35 Palmas, Las;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
35 Palmas, Las;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;97,82
35 Palmas, Las;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;98,32
35 Palmas, Las;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;97,24
35 Palmas, Las;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;95,64
35 Palmas, Las;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;96,25
35 Palmas, Las;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;95,07
35 Palmas, Las;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;94,26
35 Palmas, Las;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;93,3
35 Palmas, Las;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;91,93
35 Palmas, Las;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;91,77
35 Palmas, Las;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QIII;6.518
35 Palmas, Las;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QIII;6.098
35 Palmas, Las;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QIII;5.826
35 Palmas, Las;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2022QIII;6.313
35 Palmas, Las;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2022QII;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2022QI;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2021QIII;5.969
35 Palmas, Las;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2021QII;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2021QI;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2020QIII;5.661
35 Palmas, Las;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2020QII;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2020QI;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2022QIV;6.111
35 Palmas, Las;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2022QII;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2022QI;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2021QIV;5.815
35 Palmas, Las;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2021QII;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2021QI;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2020QIV;5.520
35 Palmas, Las;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2020QII;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2020QI;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QII;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QI;5.644
35 Palmas, Las;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QII;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QI;5.387
35 Palmas, Las;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QII;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QI;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QII;5.465
35 Palmas, Las;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QI;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QII;5.266
35 Palmas, Las;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QI;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QII;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QI;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
35 Palmas, Las;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
35 Palmas, Las;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
35 Palmas, Las;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;96,85
35 Palmas, Las;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;97,88
35 Palmas, Las;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;97,17
35 Palmas, Las;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;93,76
35 Palmas, Las;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;95,36
35 Palmas, Las;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;94,75
35 Palmas, Las;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;92,55
35 Palmas, Las;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;92,46
35 Palmas, Las;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;89,62
35 Palmas, Las;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;90,39
35 Palmas, Las;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QIV;19.475
35 Palmas, Las;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QIV;18.751
35 Palmas, Las;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QIV;17.889
35 Palmas, Las;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2022QIV;18.949
35 Palmas, Las;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2022QII;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2022QI;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2021QIV;18.284
35 Palmas, Las;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2021QII;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2021QI;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2020QIV;17.432
35 Palmas, Las;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2020QII;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2020QI;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2022QII;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2022QI;17.837
35 Palmas, Las;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2021QII;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2021QI;17.047
35 Palmas, Las;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2020QII;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2020QI;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QII;17.339
35 Palmas, Las;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QI;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QII;16.709
35 Palmas, Las;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QI;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QII;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QI;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QIII;16.971
35 Palmas, Las;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QII;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QI;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QIII;16.463
35 Palmas, Las;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QII;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QI;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QII;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QI;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
35 Palmas, Las;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
35 Palmas, Las;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
35 Palmas, Las;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;97,3
35 Palmas, Las;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;97,51
35 Palmas, Las;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;97,45
35 Palmas, Las;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;95,13
35 Palmas, Las;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;95,29
35 Palmas, Las;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;92,47
35 Palmas, Las;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;93,4
35 Palmas, Las;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;90,51
35 Palmas, Las;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;92,03
35 Palmas, Las;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QIV;12.961
35 Palmas, Las;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QIV;12.589
35 Palmas, Las;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QIV;12.060
35 Palmas, Las;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2022QIV;12.647
35 Palmas, Las;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2022QII;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2022QI;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2021QIV;12.304
35 Palmas, Las;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2021QII;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2021QI;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2020QIV;11.761
35 Palmas, Las;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2020QII;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2020QI;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2022QII;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2022QI;12.035
35 Palmas, Las;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2021QII;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2021QI;11.526
35 Palmas, Las;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2020QII;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2020QI;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QII;11.729
35 Palmas, Las;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QI;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QII;11.325
35 Palmas, Las;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QI;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QII;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QI;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QIII;11.506
35 Palmas, Las;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QII;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QI;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QIII;11.175
35 Palmas, Las;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QII;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QI;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QII;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QI;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
35 Palmas, Las;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
35 Palmas, Las;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
35 Palmas, Las;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;97,58
35 Palmas, Las;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;97,74
35 Palmas, Las;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;97,52
35 Palmas, Las;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;95,6
35 Palmas, Las;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;95,57
35 Palmas, Las;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;93,17
35 Palmas, Las;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;93,91
35 Palmas, Las;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;91,4
35 Palmas, Las;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;92,66
35 Palmas, Las;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QIV;6.514
35 Palmas, Las;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QIV;6.162
35 Palmas, Las;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QIV;5.829
35 Palmas, Las;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2022QIV;6.302
35 Palmas, Las;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2022QII;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2022QI;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2021QIV;5.980
35 Palmas, Las;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2021QII;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2021QI;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2020QIV;5.671
35 Palmas, Las;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2020QII;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2020QI;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2022QII;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2022QI;5.802
35 Palmas, Las;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2021QII;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2021QI;5.521
35 Palmas, Las;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2020QII;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2020QI;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QII;5.610
35 Palmas, Las;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QI;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QII;5.384
35 Palmas, Las;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QI;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QII;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QI;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QIII;5.465
35 Palmas, Las;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QII;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QI;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QIII;5.288
35 Palmas, Las;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QII;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QI;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QII;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QI;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
35 Palmas, Las;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
35 Palmas, Las;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
35 Palmas, Las;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;96,75
35 Palmas, Las;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;97,05
35 Palmas, Las;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;97,29
35 Palmas, Las;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;94,16
35 Palmas, Las;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;94,72
35 Palmas, Las;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;91,04
35 Palmas, Las;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;92,37
35 Palmas, Las;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;88,69
35 Palmas, Las;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;90,72
35 Palmas, Las;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
35 Palmas, Las;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
35 Palmas, Las;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
35 Palmas, Las;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
35 Palmas, Las;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QI;9.348
35 Palmas, Las;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
35 Palmas, Las;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
35 Palmas, Las;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
35 Palmas, Las;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QI;8.819
35 Palmas, Las;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
35 Palmas, Las;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
35 Palmas, Las;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
35 Palmas, Las;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QI;9.935
35 Palmas, Las;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
35 Palmas, Las;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
35 Palmas, Las;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2022QII;""
35 Palmas, Las;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2022QI;9.016
35 Palmas, Las;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
35 Palmas, Las;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
35 Palmas, Las;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2021QII;""
35 Palmas, Las;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2021QI;8.508
35 Palmas, Las;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
35 Palmas, Las;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
35 Palmas, Las;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2020QII;""
35 Palmas, Las;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2020QI;9.342
35 Palmas, Las;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
35 Palmas, Las;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
35 Palmas, Las;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2022QII;8.680
35 Palmas, Las;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2022QI;""
35 Palmas, Las;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
35 Palmas, Las;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
35 Palmas, Las;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2021QII;8.202
35 Palmas, Las;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2021QI;""
35 Palmas, Las;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
35 Palmas, Las;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
35 Palmas, Las;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2020QII;9.065
35 Palmas, Las;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2020QI;""
35 Palmas, Las;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
35 Palmas, Las;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QIII;8.371
35 Palmas, Las;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QII;""
35 Palmas, Las;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QI;""
35 Palmas, Las;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
35 Palmas, Las;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QIII;7.963
35 Palmas, Las;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QII;""
35 Palmas, Las;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QI;""
35 Palmas, Las;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
35 Palmas, Las;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QIII;8.714
35 Palmas, Las;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QII;""
35 Palmas, Las;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QI;""
35 Palmas, Las;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QIV;8.004
35 Palmas, Las;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
35 Palmas, Las;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QII;""
35 Palmas, Las;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QI;""
35 Palmas, Las;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QIV;7.652
35 Palmas, Las;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
35 Palmas, Las;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QII;""
35 Palmas, Las;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QI;""
35 Palmas, Las;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QIV;8.328
35 Palmas, Las;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
35 Palmas, Las;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QII;""
35 Palmas, Las;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QI;""
35 Palmas, Las;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
35 Palmas, Las;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
35 Palmas, Las;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
35 Palmas, Las;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
35 Palmas, Las;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
35 Palmas, Las;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
35 Palmas, Las;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
35 Palmas, Las;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
35 Palmas, Las;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
35 Palmas, Las;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
35 Palmas, Las;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
35 Palmas, Las;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
35 Palmas, Las;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
35 Palmas, Las;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
35 Palmas, Las;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
35 Palmas, Las;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;96,45
35 Palmas, Las;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
35 Palmas, Las;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
35 Palmas, Las;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
35 Palmas, Las;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;96,47
35 Palmas, Las;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
35 Palmas, Las;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
35 Palmas, Las;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
35 Palmas, Las;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;94,03
35 Palmas, Las;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
35 Palmas, Las;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
35 Palmas, Las;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;92,85
35 Palmas, Las;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
35 Palmas, Las;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
35 Palmas, Las;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
35 Palmas, Las;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;93
35 Palmas, Las;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
35 Palmas, Las;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
35 Palmas, Las;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
35 Palmas, Las;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;91,24
35 Palmas, Las;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
35 Palmas, Las;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
35 Palmas, Las;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;89,55
35 Palmas, Las;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
35 Palmas, Las;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
35 Palmas, Las;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
35 Palmas, Las;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;90,29
35 Palmas, Las;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
35 Palmas, Las;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
35 Palmas, Las;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
35 Palmas, Las;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;87,71
35 Palmas, Las;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
35 Palmas, Las;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
35 Palmas, Las;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;85,62
35 Palmas, Las;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
35 Palmas, Las;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
35 Palmas, Las;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
35 Palmas, Las;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;86,77
35 Palmas, Las;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
35 Palmas, Las;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
35 Palmas, Las;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
35 Palmas, Las;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;83,82
35 Palmas, Las;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
35 Palmas, Las;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
35 Palmas, Las;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
35 Palmas, Las;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
35 Palmas, Las;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
35 Palmas, Las;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
35 Palmas, Las;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QI;6.471
35 Palmas, Las;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
35 Palmas, Las;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
35 Palmas, Las;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
35 Palmas, Las;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QI;6.154
35 Palmas, Las;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
35 Palmas, Las;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
35 Palmas, Las;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
35 Palmas, Las;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QI;6.904
35 Palmas, Las;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
35 Palmas, Las;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
35 Palmas, Las;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2022QII;""
35 Palmas, Las;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2022QI;6.247
35 Palmas, Las;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
35 Palmas, Las;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
35 Palmas, Las;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2021QII;""
35 Palmas, Las;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2021QI;5.940
35 Palmas, Las;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
35 Palmas, Las;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
35 Palmas, Las;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2020QII;""
35 Palmas, Las;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2020QI;6.505
35 Palmas, Las;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
35 Palmas, Las;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
35 Palmas, Las;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2022QII;6.022
35 Palmas, Las;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2022QI;""
35 Palmas, Las;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
35 Palmas, Las;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
35 Palmas, Las;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2021QII;5.735
35 Palmas, Las;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2021QI;""
35 Palmas, Las;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
35 Palmas, Las;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
35 Palmas, Las;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2020QII;6.317
35 Palmas, Las;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2020QI;""
35 Palmas, Las;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
35 Palmas, Las;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QIII;5.827
35 Palmas, Las;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QII;""
35 Palmas, Las;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QI;""
35 Palmas, Las;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
35 Palmas, Las;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QIII;5.577
35 Palmas, Las;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QII;""
35 Palmas, Las;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QI;""
35 Palmas, Las;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
35 Palmas, Las;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QIII;6.098
35 Palmas, Las;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QII;""
35 Palmas, Las;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QI;""
35 Palmas, Las;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QIV;5.572
35 Palmas, Las;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
35 Palmas, Las;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QII;""
35 Palmas, Las;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QI;""
35 Palmas, Las;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QIV;5.363
35 Palmas, Las;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
35 Palmas, Las;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QII;""
35 Palmas, Las;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QI;""
35 Palmas, Las;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QIV;5.841
35 Palmas, Las;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
35 Palmas, Las;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QII;""
35 Palmas, Las;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QI;""
35 Palmas, Las;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
35 Palmas, Las;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
35 Palmas, Las;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
35 Palmas, Las;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
35 Palmas, Las;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
35 Palmas, Las;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
35 Palmas, Las;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
35 Palmas, Las;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
35 Palmas, Las;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
35 Palmas, Las;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
35 Palmas, Las;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
35 Palmas, Las;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
35 Palmas, Las;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
35 Palmas, Las;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
35 Palmas, Las;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
35 Palmas, Las;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;96,54
35 Palmas, Las;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
35 Palmas, Las;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
35 Palmas, Las;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
35 Palmas, Las;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;96,52
35 Palmas, Las;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
35 Palmas, Las;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
35 Palmas, Las;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
35 Palmas, Las;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;94,22
35 Palmas, Las;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
35 Palmas, Las;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
35 Palmas, Las;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;93,06
35 Palmas, Las;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
35 Palmas, Las;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
35 Palmas, Las;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
35 Palmas, Las;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;93,19
35 Palmas, Las;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
35 Palmas, Las;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
35 Palmas, Las;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
35 Palmas, Las;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;91,5
35 Palmas, Las;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
35 Palmas, Las;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
35 Palmas, Las;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;90,05
35 Palmas, Las;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
35 Palmas, Las;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
35 Palmas, Las;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
35 Palmas, Las;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;90,62
35 Palmas, Las;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
35 Palmas, Las;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
35 Palmas, Las;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
35 Palmas, Las;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;88,33
35 Palmas, Las;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
35 Palmas, Las;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
35 Palmas, Las;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;86,11
35 Palmas, Las;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
35 Palmas, Las;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
35 Palmas, Las;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
35 Palmas, Las;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;87,15
35 Palmas, Las;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
35 Palmas, Las;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
35 Palmas, Las;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
35 Palmas, Las;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;84,6
35 Palmas, Las;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
35 Palmas, Las;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
35 Palmas, Las;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
35 Palmas, Las;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
35 Palmas, Las;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
35 Palmas, Las;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
35 Palmas, Las;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QI;2.877
35 Palmas, Las;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
35 Palmas, Las;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
35 Palmas, Las;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
35 Palmas, Las;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QI;2.665
35 Palmas, Las;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
35 Palmas, Las;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
35 Palmas, Las;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
35 Palmas, Las;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QI;3.031
35 Palmas, Las;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
35 Palmas, Las;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
35 Palmas, Las;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2022QII;""
35 Palmas, Las;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2022QI;2.769
35 Palmas, Las;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
35 Palmas, Las;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
35 Palmas, Las;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2021QII;""
35 Palmas, Las;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2021QI;2.568
35 Palmas, Las;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
35 Palmas, Las;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
35 Palmas, Las;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2020QII;""
35 Palmas, Las;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2020QI;2.837
35 Palmas, Las;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
35 Palmas, Las;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
35 Palmas, Las;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2022QII;2.658
35 Palmas, Las;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2022QI;""
35 Palmas, Las;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
35 Palmas, Las;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
35 Palmas, Las;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2021QII;2.467
35 Palmas, Las;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2021QI;""
35 Palmas, Las;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
35 Palmas, Las;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
35 Palmas, Las;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2020QII;2.748
35 Palmas, Las;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2020QI;""
35 Palmas, Las;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
35 Palmas, Las;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QIII;2.544
35 Palmas, Las;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QII;""
35 Palmas, Las;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QI;""
35 Palmas, Las;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
35 Palmas, Las;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QIII;2.386
35 Palmas, Las;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QII;""
35 Palmas, Las;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QI;""
35 Palmas, Las;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
35 Palmas, Las;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QIII;2.616
35 Palmas, Las;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QII;""
35 Palmas, Las;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QI;""
35 Palmas, Las;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QIV;2.432
35 Palmas, Las;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
35 Palmas, Las;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QII;""
35 Palmas, Las;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QI;""
35 Palmas, Las;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QIV;2.289
35 Palmas, Las;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
35 Palmas, Las;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QII;""
35 Palmas, Las;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QI;""
35 Palmas, Las;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QIV;2.487
35 Palmas, Las;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
35 Palmas, Las;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QII;""
35 Palmas, Las;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QI;""
35 Palmas, Las;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
35 Palmas, Las;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
35 Palmas, Las;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
35 Palmas, Las;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
35 Palmas, Las;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
35 Palmas, Las;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
35 Palmas, Las;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
35 Palmas, Las;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
35 Palmas, Las;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
35 Palmas, Las;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
35 Palmas, Las;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
35 Palmas, Las;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
35 Palmas, Las;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
35 Palmas, Las;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
35 Palmas, Las;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
35 Palmas, Las;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;96,25
35 Palmas, Las;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
35 Palmas, Las;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
35 Palmas, Las;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
35 Palmas, Las;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;96,36
35 Palmas, Las;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
35 Palmas, Las;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
35 Palmas, Las;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
35 Palmas, Las;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;93,6
35 Palmas, Las;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
35 Palmas, Las;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
35 Palmas, Las;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;92,39
35 Palmas, Las;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
35 Palmas, Las;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
35 Palmas, Las;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
35 Palmas, Las;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;92,57
35 Palmas, Las;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
35 Palmas, Las;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
35 Palmas, Las;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
35 Palmas, Las;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;90,66
35 Palmas, Las;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
35 Palmas, Las;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
35 Palmas, Las;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;88,43
35 Palmas, Las;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
35 Palmas, Las;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
35 Palmas, Las;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
35 Palmas, Las;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;89,53
35 Palmas, Las;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
35 Palmas, Las;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
35 Palmas, Las;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
35 Palmas, Las;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;86,31
35 Palmas, Las;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
35 Palmas, Las;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
35 Palmas, Las;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;84,53
35 Palmas, Las;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
35 Palmas, Las;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
35 Palmas, Las;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
35 Palmas, Las;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;85,89
35 Palmas, Las;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
35 Palmas, Las;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
35 Palmas, Las;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
35 Palmas, Las;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;82,05
35 Palmas, Las;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
35 Palmas, Las;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
35 Palmas, Las;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
35 Palmas, Las;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
35 Palmas, Las;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
35 Palmas, Las;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QII;10.602
35 Palmas, Las;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
35 Palmas, Las;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
35 Palmas, Las;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
35 Palmas, Las;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QII;9.938
35 Palmas, Las;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
35 Palmas, Las;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
35 Palmas, Las;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
35 Palmas, Las;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QII;9.610
35 Palmas, Las;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
35 Palmas, Las;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
35 Palmas, Las;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
35 Palmas, Las;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2022QII;10.221
35 Palmas, Las;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2022QI;""
35 Palmas, Las;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
35 Palmas, Las;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
35 Palmas, Las;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2021QII;9.597
35 Palmas, Las;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2021QI;""
35 Palmas, Las;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
35 Palmas, Las;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
35 Palmas, Las;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2020QII;9.324
35 Palmas, Las;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2020QI;""
35 Palmas, Las;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
35 Palmas, Las;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2022QIII;9.870
35 Palmas, Las;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2022QII;""
35 Palmas, Las;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2022QI;""
35 Palmas, Las;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
35 Palmas, Las;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2021QIII;9.330
35 Palmas, Las;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2021QII;""
35 Palmas, Las;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2021QI;""
35 Palmas, Las;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
35 Palmas, Las;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2020QIII;8.910
35 Palmas, Las;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2020QII;""
35 Palmas, Las;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2020QI;""
35 Palmas, Las;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QIV;9.457
35 Palmas, Las;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
35 Palmas, Las;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QII;""
35 Palmas, Las;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QI;""
35 Palmas, Las;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QIV;8.981
35 Palmas, Las;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
35 Palmas, Las;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QII;""
35 Palmas, Las;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QI;""
35 Palmas, Las;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QIV;8.516
35 Palmas, Las;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
35 Palmas, Las;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QII;""
35 Palmas, Las;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QI;""
35 Palmas, Las;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
35 Palmas, Las;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
35 Palmas, Las;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QII;""
35 Palmas, Las;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QI;8.699
35 Palmas, Las;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
35 Palmas, Las;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
35 Palmas, Las;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QII;""
35 Palmas, Las;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QI;8.229
35 Palmas, Las;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
35 Palmas, Las;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
35 Palmas, Las;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QII;""
35 Palmas, Las;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QI;""
35 Palmas, Las;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
35 Palmas, Las;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
35 Palmas, Las;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
35 Palmas, Las;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
35 Palmas, Las;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
35 Palmas, Las;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
35 Palmas, Las;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
35 Palmas, Las;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
35 Palmas, Las;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
35 Palmas, Las;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
35 Palmas, Las;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
35 Palmas, Las;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
35 Palmas, Las;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
35 Palmas, Las;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
35 Palmas, Las;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;96,41
35 Palmas, Las;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
35 Palmas, Las;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
35 Palmas, Las;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
35 Palmas, Las;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;96,57
35 Palmas, Las;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
35 Palmas, Las;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
35 Palmas, Las;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
35 Palmas, Las;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;97,02
35 Palmas, Las;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
35 Palmas, Las;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
35 Palmas, Las;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;93,1
35 Palmas, Las;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
35 Palmas, Las;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
35 Palmas, Las;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
35 Palmas, Las;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;93,88
35 Palmas, Las;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
35 Palmas, Las;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
35 Palmas, Las;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
35 Palmas, Las;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;92,72
35 Palmas, Las;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
35 Palmas, Las;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
35 Palmas, Las;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;89,2
35 Palmas, Las;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
35 Palmas, Las;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
35 Palmas, Las;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
35 Palmas, Las;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;90,37
35 Palmas, Las;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
35 Palmas, Las;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
35 Palmas, Las;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
35 Palmas, Las;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;88,62
35 Palmas, Las;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
35 Palmas, Las;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
35 Palmas, Las;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
35 Palmas, Las;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
35 Palmas, Las;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
35 Palmas, Las;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
35 Palmas, Las;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;87,53
35 Palmas, Las;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
35 Palmas, Las;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
35 Palmas, Las;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
35 Palmas, Las;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;85,63
35 Palmas, Las;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
35 Palmas, Las;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
35 Palmas, Las;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
35 Palmas, Las;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
35 Palmas, Las;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
35 Palmas, Las;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
35 Palmas, Las;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QII;7.338
35 Palmas, Las;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
35 Palmas, Las;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
35 Palmas, Las;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
35 Palmas, Las;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QII;6.885
35 Palmas, Las;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
35 Palmas, Las;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
35 Palmas, Las;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
35 Palmas, Las;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QII;6.671
35 Palmas, Las;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
35 Palmas, Las;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
35 Palmas, Las;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
35 Palmas, Las;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2022QII;7.082
35 Palmas, Las;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2022QI;""
35 Palmas, Las;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
35 Palmas, Las;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
35 Palmas, Las;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2021QII;6.654
35 Palmas, Las;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2021QI;""
35 Palmas, Las;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
35 Palmas, Las;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
35 Palmas, Las;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2020QII;6.480
35 Palmas, Las;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2020QI;""
35 Palmas, Las;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
35 Palmas, Las;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2022QIII;6.860
35 Palmas, Las;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2022QII;""
35 Palmas, Las;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2022QI;""
35 Palmas, Las;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
35 Palmas, Las;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2021QIII;6.477
35 Palmas, Las;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2021QII;""
35 Palmas, Las;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2021QI;""
35 Palmas, Las;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
35 Palmas, Las;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2020QIII;6.218
35 Palmas, Las;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2020QII;""
35 Palmas, Las;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2020QI;""
35 Palmas, Las;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QIV;6.578
35 Palmas, Las;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
35 Palmas, Las;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QII;""
35 Palmas, Las;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QI;""
35 Palmas, Las;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QIV;6.243
35 Palmas, Las;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
35 Palmas, Las;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QII;""
35 Palmas, Las;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QI;""
35 Palmas, Las;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QIV;5.958
35 Palmas, Las;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
35 Palmas, Las;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QII;""
35 Palmas, Las;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QI;""
35 Palmas, Las;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
35 Palmas, Las;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
35 Palmas, Las;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QII;""
35 Palmas, Las;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QI;6.049
35 Palmas, Las;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
35 Palmas, Las;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
35 Palmas, Las;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QII;""
35 Palmas, Las;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QI;5.761
35 Palmas, Las;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
35 Palmas, Las;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
35 Palmas, Las;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QII;""
35 Palmas, Las;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QI;""
35 Palmas, Las;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
35 Palmas, Las;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
35 Palmas, Las;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
35 Palmas, Las;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
35 Palmas, Las;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
35 Palmas, Las;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
35 Palmas, Las;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
35 Palmas, Las;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
35 Palmas, Las;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
35 Palmas, Las;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
35 Palmas, Las;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
35 Palmas, Las;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
35 Palmas, Las;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
35 Palmas, Las;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
35 Palmas, Las;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;96,51
35 Palmas, Las;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
35 Palmas, Las;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
35 Palmas, Las;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
35 Palmas, Las;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;96,64
35 Palmas, Las;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
35 Palmas, Las;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
35 Palmas, Las;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
35 Palmas, Las;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;97,14
35 Palmas, Las;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
35 Palmas, Las;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
35 Palmas, Las;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;93,49
35 Palmas, Las;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
35 Palmas, Las;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
35 Palmas, Las;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
35 Palmas, Las;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;94,07
35 Palmas, Las;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
35 Palmas, Las;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
35 Palmas, Las;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
35 Palmas, Las;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;93,21
35 Palmas, Las;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
35 Palmas, Las;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
35 Palmas, Las;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;89,64
35 Palmas, Las;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
35 Palmas, Las;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
35 Palmas, Las;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
35 Palmas, Las;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;90,68
35 Palmas, Las;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
35 Palmas, Las;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
35 Palmas, Las;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
35 Palmas, Las;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;89,31
35 Palmas, Las;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
35 Palmas, Las;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
35 Palmas, Las;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
35 Palmas, Las;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
35 Palmas, Las;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
35 Palmas, Las;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
35 Palmas, Las;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;87,86
35 Palmas, Las;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
35 Palmas, Las;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
35 Palmas, Las;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
35 Palmas, Las;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;86,36
35 Palmas, Las;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
35 Palmas, Las;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
35 Palmas, Las;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
35 Palmas, Las;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
35 Palmas, Las;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
35 Palmas, Las;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
35 Palmas, Las;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QII;3.264
35 Palmas, Las;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
35 Palmas, Las;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
35 Palmas, Las;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
35 Palmas, Las;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QII;3.053
35 Palmas, Las;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
35 Palmas, Las;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
35 Palmas, Las;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
35 Palmas, Las;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QII;2.939
35 Palmas, Las;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
35 Palmas, Las;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
35 Palmas, Las;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
35 Palmas, Las;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2022QII;3.139
35 Palmas, Las;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2022QI;""
35 Palmas, Las;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
35 Palmas, Las;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
35 Palmas, Las;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2021QII;2.943
35 Palmas, Las;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2021QI;""
35 Palmas, Las;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
35 Palmas, Las;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
35 Palmas, Las;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2020QII;2.844
35 Palmas, Las;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2020QI;""
35 Palmas, Las;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
35 Palmas, Las;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2022QIII;3.010
35 Palmas, Las;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2022QII;""
35 Palmas, Las;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2022QI;""
35 Palmas, Las;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
35 Palmas, Las;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2021QIII;2.853
35 Palmas, Las;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2021QII;""
35 Palmas, Las;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2021QI;""
35 Palmas, Las;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
35 Palmas, Las;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2020QIII;2.692
35 Palmas, Las;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2020QII;""
35 Palmas, Las;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2020QI;""
35 Palmas, Las;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QIV;2.879
35 Palmas, Las;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
35 Palmas, Las;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QII;""
35 Palmas, Las;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QI;""
35 Palmas, Las;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QIV;2.738
35 Palmas, Las;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
35 Palmas, Las;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QII;""
35 Palmas, Las;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QI;""
35 Palmas, Las;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QIV;2.558
35 Palmas, Las;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
35 Palmas, Las;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QII;""
35 Palmas, Las;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QI;""
35 Palmas, Las;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
35 Palmas, Las;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
35 Palmas, Las;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QII;""
35 Palmas, Las;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QI;2.650
35 Palmas, Las;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
35 Palmas, Las;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
35 Palmas, Las;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QII;""
35 Palmas, Las;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QI;2.468
35 Palmas, Las;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
35 Palmas, Las;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
35 Palmas, Las;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QII;""
35 Palmas, Las;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QI;""
35 Palmas, Las;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
35 Palmas, Las;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
35 Palmas, Las;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
35 Palmas, Las;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
35 Palmas, Las;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
35 Palmas, Las;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
35 Palmas, Las;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
35 Palmas, Las;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
35 Palmas, Las;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
35 Palmas, Las;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
35 Palmas, Las;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
35 Palmas, Las;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
35 Palmas, Las;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
35 Palmas, Las;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
35 Palmas, Las;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;96,17
35 Palmas, Las;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
35 Palmas, Las;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
35 Palmas, Las;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
35 Palmas, Las;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;96,4
35 Palmas, Las;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
35 Palmas, Las;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
35 Palmas, Las;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
35 Palmas, Las;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;96,77
35 Palmas, Las;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
35 Palmas, Las;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
35 Palmas, Las;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;92,22
35 Palmas, Las;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
35 Palmas, Las;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
35 Palmas, Las;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
35 Palmas, Las;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;93,45
35 Palmas, Las;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
35 Palmas, Las;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
35 Palmas, Las;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
35 Palmas, Las;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;91,6
35 Palmas, Las;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
35 Palmas, Las;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
35 Palmas, Las;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;88,2
35 Palmas, Las;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
35 Palmas, Las;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
35 Palmas, Las;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
35 Palmas, Las;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;89,68
35 Palmas, Las;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
35 Palmas, Las;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
35 Palmas, Las;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
35 Palmas, Las;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;87,04
35 Palmas, Las;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
35 Palmas, Las;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
35 Palmas, Las;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
35 Palmas, Las;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
35 Palmas, Las;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
35 Palmas, Las;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
35 Palmas, Las;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;86,8
35 Palmas, Las;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
35 Palmas, Las;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
35 Palmas, Las;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
35 Palmas, Las;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;83,97
35 Palmas, Las;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
35 Palmas, Las;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
35 Palmas, Las;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
35 Palmas, Las;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
35 Palmas, Las;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
35 Palmas, Las;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QIII;10.385
35 Palmas, Las;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
35 Palmas, Las;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
35 Palmas, Las;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
35 Palmas, Las;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QIII;9.719
35 Palmas, Las;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
35 Palmas, Las;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
35 Palmas, Las;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
35 Palmas, Las;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QIII;9.412
35 Palmas, Las;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
35 Palmas, Las;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
35 Palmas, Las;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
35 Palmas, Las;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2022QIII;10.020
35 Palmas, Las;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2022QII;""
35 Palmas, Las;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2022QI;""
35 Palmas, Las;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
35 Palmas, Las;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2021QIII;9.438
35 Palmas, Las;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2021QII;""
35 Palmas, Las;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2021QI;""
35 Palmas, Las;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
35 Palmas, Las;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2020QIII;8.989
35 Palmas, Las;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2020QII;""
35 Palmas, Las;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2020QI;""
35 Palmas, Las;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2022QIV;9.593
35 Palmas, Las;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
35 Palmas, Las;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2022QII;""
35 Palmas, Las;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2022QI;""
35 Palmas, Las;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2021QIV;9.076
35 Palmas, Las;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
35 Palmas, Las;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2021QII;""
35 Palmas, Las;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2021QI;""
35 Palmas, Las;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2020QIV;8.581
35 Palmas, Las;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
35 Palmas, Las;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2020QII;""
35 Palmas, Las;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2020QI;""
35 Palmas, Las;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
35 Palmas, Las;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
35 Palmas, Las;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QII;""
35 Palmas, Las;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QI;8.786
35 Palmas, Las;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
35 Palmas, Las;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
35 Palmas, Las;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QII;""
35 Palmas, Las;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QI;8.293
35 Palmas, Las;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
35 Palmas, Las;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
35 Palmas, Las;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QII;""
35 Palmas, Las;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QI;""
35 Palmas, Las;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
35 Palmas, Las;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
35 Palmas, Las;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QII;8.476
35 Palmas, Las;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QI;""
35 Palmas, Las;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
35 Palmas, Las;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
35 Palmas, Las;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QII;8.009
35 Palmas, Las;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QI;""
35 Palmas, Las;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
35 Palmas, Las;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
35 Palmas, Las;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QII;""
35 Palmas, Las;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QI;""
35 Palmas, Las;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
35 Palmas, Las;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
35 Palmas, Las;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
35 Palmas, Las;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
35 Palmas, Las;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
35 Palmas, Las;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
35 Palmas, Las;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
35 Palmas, Las;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
35 Palmas, Las;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
35 Palmas, Las;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
35 Palmas, Las;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
35 Palmas, Las;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
35 Palmas, Las;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
35 Palmas, Las;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;96,49
35 Palmas, Las;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
35 Palmas, Las;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
35 Palmas, Las;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
35 Palmas, Las;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;97,11
35 Palmas, Las;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
35 Palmas, Las;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
35 Palmas, Las;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
35 Palmas, Las;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;95,51
35 Palmas, Las;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
35 Palmas, Las;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
35 Palmas, Las;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;92,37
35 Palmas, Las;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
35 Palmas, Las;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
35 Palmas, Las;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
35 Palmas, Las;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;93,38
35 Palmas, Las;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
35 Palmas, Las;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
35 Palmas, Las;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
35 Palmas, Las;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;91,17
35 Palmas, Las;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
35 Palmas, Las;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
35 Palmas, Las;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
35 Palmas, Las;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
35 Palmas, Las;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
35 Palmas, Las;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
35 Palmas, Las;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;90,4
35 Palmas, Las;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
35 Palmas, Las;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
35 Palmas, Las;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
35 Palmas, Las;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;88,11
35 Palmas, Las;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
35 Palmas, Las;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
35 Palmas, Las;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
35 Palmas, Las;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
35 Palmas, Las;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
35 Palmas, Las;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
35 Palmas, Las;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;87,21
35 Palmas, Las;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
35 Palmas, Las;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
35 Palmas, Las;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
35 Palmas, Las;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;85,09
35 Palmas, Las;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
35 Palmas, Las;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
35 Palmas, Las;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
35 Palmas, Las;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
35 Palmas, Las;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
35 Palmas, Las;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
35 Palmas, Las;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QIII;7.187
35 Palmas, Las;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
35 Palmas, Las;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
35 Palmas, Las;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
35 Palmas, Las;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QIII;6.733
35 Palmas, Las;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
35 Palmas, Las;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
35 Palmas, Las;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
35 Palmas, Las;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QIII;6.542
35 Palmas, Las;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
35 Palmas, Las;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
35 Palmas, Las;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
35 Palmas, Las;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2022QIII;6.958
35 Palmas, Las;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2022QII;""
35 Palmas, Las;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2022QI;""
35 Palmas, Las;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
35 Palmas, Las;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2021QIII;6.548
35 Palmas, Las;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2021QII;""
35 Palmas, Las;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2021QI;""
35 Palmas, Las;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
35 Palmas, Las;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2020QIII;6.273
35 Palmas, Las;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2020QII;""
35 Palmas, Las;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2020QI;""
35 Palmas, Las;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2022QIV;6.665
35 Palmas, Las;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
35 Palmas, Las;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2022QII;""
35 Palmas, Las;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2022QI;""
35 Palmas, Las;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2021QIV;6.304
35 Palmas, Las;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
35 Palmas, Las;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2021QII;""
35 Palmas, Las;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2021QI;""
35 Palmas, Las;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2020QIV;6.002
35 Palmas, Las;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
35 Palmas, Las;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2020QII;""
35 Palmas, Las;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2020QI;""
35 Palmas, Las;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
35 Palmas, Las;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
35 Palmas, Las;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QII;""
35 Palmas, Las;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QI;6.106
35 Palmas, Las;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
35 Palmas, Las;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
35 Palmas, Las;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QII;""
35 Palmas, Las;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QI;5.804
35 Palmas, Las;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
35 Palmas, Las;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
35 Palmas, Las;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QII;""
35 Palmas, Las;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QI;""
35 Palmas, Las;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
35 Palmas, Las;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
35 Palmas, Las;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QII;5.898
35 Palmas, Las;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QI;""
35 Palmas, Las;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
35 Palmas, Las;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
35 Palmas, Las;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QII;5.616
35 Palmas, Las;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QI;""
35 Palmas, Las;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
35 Palmas, Las;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
35 Palmas, Las;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QII;""
35 Palmas, Las;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QI;""
35 Palmas, Las;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
35 Palmas, Las;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
35 Palmas, Las;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
35 Palmas, Las;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
35 Palmas, Las;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
35 Palmas, Las;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
35 Palmas, Las;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
35 Palmas, Las;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
35 Palmas, Las;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
35 Palmas, Las;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
35 Palmas, Las;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
35 Palmas, Las;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
35 Palmas, Las;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
35 Palmas, Las;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;96,81
35 Palmas, Las;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
35 Palmas, Las;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
35 Palmas, Las;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
35 Palmas, Las;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;97,25
35 Palmas, Las;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
35 Palmas, Las;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
35 Palmas, Las;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
35 Palmas, Las;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;95,89
35 Palmas, Las;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
35 Palmas, Las;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
35 Palmas, Las;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;92,74
35 Palmas, Las;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
35 Palmas, Las;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
35 Palmas, Las;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
35 Palmas, Las;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;93,63
35 Palmas, Las;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
35 Palmas, Las;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
35 Palmas, Las;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
35 Palmas, Las;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;91,75
35 Palmas, Las;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
35 Palmas, Las;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
35 Palmas, Las;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
35 Palmas, Las;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
35 Palmas, Las;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
35 Palmas, Las;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
35 Palmas, Las;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;90,69
35 Palmas, Las;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
35 Palmas, Las;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
35 Palmas, Las;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
35 Palmas, Las;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;88,72
35 Palmas, Las;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
35 Palmas, Las;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
35 Palmas, Las;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
35 Palmas, Las;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
35 Palmas, Las;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
35 Palmas, Las;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
35 Palmas, Las;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;87,6
35 Palmas, Las;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
35 Palmas, Las;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
35 Palmas, Las;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
35 Palmas, Las;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;85,85
35 Palmas, Las;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
35 Palmas, Las;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
35 Palmas, Las;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
35 Palmas, Las;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
35 Palmas, Las;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
35 Palmas, Las;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
35 Palmas, Las;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QIII;3.198
35 Palmas, Las;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
35 Palmas, Las;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
35 Palmas, Las;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
35 Palmas, Las;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QIII;2.986
35 Palmas, Las;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
35 Palmas, Las;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
35 Palmas, Las;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
35 Palmas, Las;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QIII;2.870
35 Palmas, Las;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
35 Palmas, Las;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
35 Palmas, Las;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
35 Palmas, Las;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2022QIII;3.062
35 Palmas, Las;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2022QII;""
35 Palmas, Las;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2022QI;""
35 Palmas, Las;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
35 Palmas, Las;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2021QIII;2.890
35 Palmas, Las;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2021QII;""
35 Palmas, Las;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2021QI;""
35 Palmas, Las;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
35 Palmas, Las;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2020QIII;2.716
35 Palmas, Las;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2020QII;""
35 Palmas, Las;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2020QI;""
35 Palmas, Las;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2022QIV;2.928
35 Palmas, Las;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
35 Palmas, Las;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2022QII;""
35 Palmas, Las;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2022QI;""
35 Palmas, Las;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2021QIV;2.772
35 Palmas, Las;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
35 Palmas, Las;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2021QII;""
35 Palmas, Las;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2021QI;""
35 Palmas, Las;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2020QIV;2.579
35 Palmas, Las;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
35 Palmas, Las;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2020QII;""
35 Palmas, Las;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2020QI;""
35 Palmas, Las;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
35 Palmas, Las;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
35 Palmas, Las;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QII;""
35 Palmas, Las;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QI;2.680
35 Palmas, Las;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
35 Palmas, Las;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
35 Palmas, Las;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QII;""
35 Palmas, Las;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QI;2.489
35 Palmas, Las;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
35 Palmas, Las;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
35 Palmas, Las;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QII;""
35 Palmas, Las;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QI;""
35 Palmas, Las;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
35 Palmas, Las;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
35 Palmas, Las;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QII;2.578
35 Palmas, Las;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QI;""
35 Palmas, Las;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
35 Palmas, Las;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
35 Palmas, Las;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QII;2.393
35 Palmas, Las;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QI;""
35 Palmas, Las;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
35 Palmas, Las;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
35 Palmas, Las;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QII;""
35 Palmas, Las;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QI;""
35 Palmas, Las;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
35 Palmas, Las;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
35 Palmas, Las;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
35 Palmas, Las;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
35 Palmas, Las;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
35 Palmas, Las;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
35 Palmas, Las;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
35 Palmas, Las;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
35 Palmas, Las;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
35 Palmas, Las;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
35 Palmas, Las;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
35 Palmas, Las;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
35 Palmas, Las;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
35 Palmas, Las;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;95,75
35 Palmas, Las;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
35 Palmas, Las;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
35 Palmas, Las;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
35 Palmas, Las;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;96,78
35 Palmas, Las;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
35 Palmas, Las;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
35 Palmas, Las;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
35 Palmas, Las;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;94,63
35 Palmas, Las;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
35 Palmas, Las;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
35 Palmas, Las;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;91,56
35 Palmas, Las;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
35 Palmas, Las;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
35 Palmas, Las;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
35 Palmas, Las;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;92,83
35 Palmas, Las;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
35 Palmas, Las;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
35 Palmas, Las;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
35 Palmas, Las;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;89,86
35 Palmas, Las;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
35 Palmas, Las;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
35 Palmas, Las;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
35 Palmas, Las;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
35 Palmas, Las;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
35 Palmas, Las;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
35 Palmas, Las;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;89,75
35 Palmas, Las;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
35 Palmas, Las;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
35 Palmas, Las;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
35 Palmas, Las;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;86,72
35 Palmas, Las;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
35 Palmas, Las;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
35 Palmas, Las;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
35 Palmas, Las;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
35 Palmas, Las;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
35 Palmas, Las;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
35 Palmas, Las;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;86,34
35 Palmas, Las;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
35 Palmas, Las;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
35 Palmas, Las;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
35 Palmas, Las;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;83,38
35 Palmas, Las;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
35 Palmas, Las;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
35 Palmas, Las;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
35 Palmas, Las;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
35 Palmas, Las;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
35 Palmas, Las;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QIV;10.140
35 Palmas, Las;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
35 Palmas, Las;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
35 Palmas, Las;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
35 Palmas, Las;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QIV;9.553
35 Palmas, Las;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
35 Palmas, Las;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
35 Palmas, Las;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
35 Palmas, Las;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QIV;9.121
35 Palmas, Las;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
35 Palmas, Las;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
35 Palmas, Las;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
35 Palmas, Las;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2022QIV;9.696
35 Palmas, Las;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
35 Palmas, Las;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2022QII;""
35 Palmas, Las;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2022QI;""
35 Palmas, Las;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2021QIV;9.182
35 Palmas, Las;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
35 Palmas, Las;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2021QII;""
35 Palmas, Las;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2021QI;""
35 Palmas, Las;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2020QIV;8.696
35 Palmas, Las;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
35 Palmas, Las;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2020QII;""
35 Palmas, Las;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2020QI;""
35 Palmas, Las;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
35 Palmas, Las;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
35 Palmas, Las;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2022QII;""
35 Palmas, Las;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2022QI;8.885
35 Palmas, Las;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
35 Palmas, Las;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
35 Palmas, Las;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2021QII;""
35 Palmas, Las;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2021QI;8.400
35 Palmas, Las;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
35 Palmas, Las;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
35 Palmas, Las;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2020QII;""
35 Palmas, Las;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2020QI;""
35 Palmas, Las;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
35 Palmas, Las;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
35 Palmas, Las;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QII;8.570
35 Palmas, Las;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QI;""
35 Palmas, Las;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
35 Palmas, Las;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
35 Palmas, Las;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QII;8.109
35 Palmas, Las;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QI;""
35 Palmas, Las;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
35 Palmas, Las;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
35 Palmas, Las;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QII;""
35 Palmas, Las;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QI;""
35 Palmas, Las;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
35 Palmas, Las;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QIII;8.267
35 Palmas, Las;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QII;""
35 Palmas, Las;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QI;""
35 Palmas, Las;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
35 Palmas, Las;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QIII;7.874
35 Palmas, Las;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QII;""
35 Palmas, Las;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QI;""
35 Palmas, Las;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
35 Palmas, Las;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
35 Palmas, Las;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QII;""
35 Palmas, Las;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QI;""
35 Palmas, Las;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
35 Palmas, Las;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
35 Palmas, Las;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
35 Palmas, Las;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
35 Palmas, Las;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
35 Palmas, Las;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
35 Palmas, Las;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
35 Palmas, Las;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
35 Palmas, Las;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
35 Palmas, Las;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
35 Palmas, Las;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
35 Palmas, Las;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
35 Palmas, Las;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;95,62
35 Palmas, Las;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
35 Palmas, Las;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
35 Palmas, Las;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
35 Palmas, Las;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;96,12
35 Palmas, Las;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
35 Palmas, Las;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
35 Palmas, Las;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
35 Palmas, Las;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;95,34
35 Palmas, Las;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
35 Palmas, Las;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
35 Palmas, Las;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
35 Palmas, Las;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
35 Palmas, Las;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
35 Palmas, Las;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
35 Palmas, Las;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;93,01
35 Palmas, Las;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
35 Palmas, Las;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
35 Palmas, Las;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
35 Palmas, Las;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;92,1
35 Palmas, Las;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
35 Palmas, Las;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
35 Palmas, Las;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
35 Palmas, Las;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
35 Palmas, Las;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
35 Palmas, Las;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
35 Palmas, Las;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;89,71
35 Palmas, Las;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
35 Palmas, Las;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
35 Palmas, Las;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
35 Palmas, Las;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;88,9
35 Palmas, Las;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
35 Palmas, Las;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
35 Palmas, Las;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
35 Palmas, Las;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
35 Palmas, Las;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
35 Palmas, Las;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
35 Palmas, Las;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;86,54
35 Palmas, Las;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
35 Palmas, Las;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
35 Palmas, Las;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
35 Palmas, Las;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;86,33
35 Palmas, Las;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
35 Palmas, Las;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
35 Palmas, Las;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
35 Palmas, Las;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
35 Palmas, Las;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
35 Palmas, Las;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
35 Palmas, Las;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QIV;7.028
35 Palmas, Las;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
35 Palmas, Las;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
35 Palmas, Las;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
35 Palmas, Las;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QIV;6.619
35 Palmas, Las;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
35 Palmas, Las;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
35 Palmas, Las;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
35 Palmas, Las;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QIV;6.362
35 Palmas, Las;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
35 Palmas, Las;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
35 Palmas, Las;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
35 Palmas, Las;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2022QIV;6.726
35 Palmas, Las;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
35 Palmas, Las;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2022QII;""
35 Palmas, Las;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2022QI;""
35 Palmas, Las;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2021QIV;6.370
35 Palmas, Las;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
35 Palmas, Las;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2021QII;""
35 Palmas, Las;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2021QI;""
35 Palmas, Las;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2020QIV;6.079
35 Palmas, Las;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
35 Palmas, Las;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2020QII;""
35 Palmas, Las;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2020QI;""
35 Palmas, Las;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
35 Palmas, Las;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
35 Palmas, Las;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2022QII;""
35 Palmas, Las;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2022QI;6.166
35 Palmas, Las;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
35 Palmas, Las;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
35 Palmas, Las;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2021QII;""
35 Palmas, Las;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2021QI;5.876
35 Palmas, Las;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
35 Palmas, Las;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
35 Palmas, Las;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2020QII;""
35 Palmas, Las;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2020QI;""
35 Palmas, Las;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
35 Palmas, Las;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
35 Palmas, Las;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QII;5.956
35 Palmas, Las;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QI;""
35 Palmas, Las;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
35 Palmas, Las;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
35 Palmas, Las;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QII;5.683
35 Palmas, Las;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QI;""
35 Palmas, Las;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
35 Palmas, Las;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
35 Palmas, Las;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QII;""
35 Palmas, Las;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QI;""
35 Palmas, Las;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
35 Palmas, Las;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QIII;5.765
35 Palmas, Las;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QII;""
35 Palmas, Las;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QI;""
35 Palmas, Las;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
35 Palmas, Las;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QIII;5.527
35 Palmas, Las;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QII;""
35 Palmas, Las;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QI;""
35 Palmas, Las;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
35 Palmas, Las;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
35 Palmas, Las;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QII;""
35 Palmas, Las;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QI;""
35 Palmas, Las;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
35 Palmas, Las;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
35 Palmas, Las;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
35 Palmas, Las;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
35 Palmas, Las;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
35 Palmas, Las;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
35 Palmas, Las;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
35 Palmas, Las;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
35 Palmas, Las;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
35 Palmas, Las;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
35 Palmas, Las;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
35 Palmas, Las;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
35 Palmas, Las;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;95,7
35 Palmas, Las;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
35 Palmas, Las;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
35 Palmas, Las;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
35 Palmas, Las;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;96,24
35 Palmas, Las;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
35 Palmas, Las;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
35 Palmas, Las;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
35 Palmas, Las;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;95,55
35 Palmas, Las;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
35 Palmas, Las;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
35 Palmas, Las;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
35 Palmas, Las;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
35 Palmas, Las;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
35 Palmas, Las;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
35 Palmas, Las;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;93,16
35 Palmas, Las;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
35 Palmas, Las;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
35 Palmas, Las;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
35 Palmas, Las;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;92,36
35 Palmas, Las;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
35 Palmas, Las;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
35 Palmas, Las;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
35 Palmas, Las;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
35 Palmas, Las;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
35 Palmas, Las;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
35 Palmas, Las;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;89,98
35 Palmas, Las;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
35 Palmas, Las;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
35 Palmas, Las;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
35 Palmas, Las;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;89,33
35 Palmas, Las;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
35 Palmas, Las;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
35 Palmas, Las;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
35 Palmas, Las;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
35 Palmas, Las;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
35 Palmas, Las;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
35 Palmas, Las;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;87,1
35 Palmas, Las;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
35 Palmas, Las;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
35 Palmas, Las;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
35 Palmas, Las;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;86,88
35 Palmas, Las;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
35 Palmas, Las;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
35 Palmas, Las;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
35 Palmas, Las;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
35 Palmas, Las;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
35 Palmas, Las;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
35 Palmas, Las;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QIV;3.112
35 Palmas, Las;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
35 Palmas, Las;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
35 Palmas, Las;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
35 Palmas, Las;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QIV;2.934
35 Palmas, Las;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
35 Palmas, Las;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
35 Palmas, Las;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
35 Palmas, Las;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QIV;2.759
35 Palmas, Las;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
35 Palmas, Las;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
35 Palmas, Las;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
35 Palmas, Las;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2022QIV;2.970
35 Palmas, Las;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
35 Palmas, Las;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2022QII;""
35 Palmas, Las;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2022QI;""
35 Palmas, Las;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2021QIV;2.812
35 Palmas, Las;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
35 Palmas, Las;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2021QII;""
35 Palmas, Las;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2021QI;""
35 Palmas, Las;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2020QIV;2.617
35 Palmas, Las;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
35 Palmas, Las;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2020QII;""
35 Palmas, Las;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2020QI;""
35 Palmas, Las;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
35 Palmas, Las;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
35 Palmas, Las;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2022QII;""
35 Palmas, Las;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2022QI;2.719
35 Palmas, Las;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
35 Palmas, Las;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
35 Palmas, Las;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2021QII;""
35 Palmas, Las;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2021QI;2.524
35 Palmas, Las;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
35 Palmas, Las;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
35 Palmas, Las;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2020QII;""
35 Palmas, Las;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2020QI;""
35 Palmas, Las;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
35 Palmas, Las;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
35 Palmas, Las;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QII;2.614
35 Palmas, Las;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QI;""
35 Palmas, Las;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
35 Palmas, Las;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
35 Palmas, Las;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QII;2.426
35 Palmas, Las;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QI;""
35 Palmas, Las;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
35 Palmas, Las;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
35 Palmas, Las;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QII;""
35 Palmas, Las;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QI;""
35 Palmas, Las;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
35 Palmas, Las;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QIII;2.502
35 Palmas, Las;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QII;""
35 Palmas, Las;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QI;""
35 Palmas, Las;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
35 Palmas, Las;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QIII;2.347
35 Palmas, Las;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QII;""
35 Palmas, Las;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QI;""
35 Palmas, Las;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
35 Palmas, Las;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
35 Palmas, Las;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QII;""
35 Palmas, Las;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QI;""
35 Palmas, Las;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
35 Palmas, Las;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
35 Palmas, Las;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
35 Palmas, Las;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
35 Palmas, Las;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
35 Palmas, Las;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
35 Palmas, Las;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
35 Palmas, Las;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
35 Palmas, Las;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
35 Palmas, Las;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
35 Palmas, Las;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
35 Palmas, Las;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
35 Palmas, Las;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;95,44
35 Palmas, Las;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
35 Palmas, Las;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
35 Palmas, Las;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
35 Palmas, Las;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;95,84
35 Palmas, Las;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
35 Palmas, Las;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
35 Palmas, Las;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
35 Palmas, Las;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;94,85
35 Palmas, Las;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
35 Palmas, Las;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
35 Palmas, Las;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
35 Palmas, Las;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
35 Palmas, Las;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
35 Palmas, Las;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
35 Palmas, Las;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;92,67
35 Palmas, Las;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
35 Palmas, Las;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
35 Palmas, Las;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
35 Palmas, Las;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;91,48
35 Palmas, Las;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
35 Palmas, Las;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
35 Palmas, Las;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
35 Palmas, Las;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
35 Palmas, Las;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
35 Palmas, Las;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
35 Palmas, Las;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;89,09
35 Palmas, Las;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
35 Palmas, Las;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
35 Palmas, Las;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
35 Palmas, Las;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;87,93
35 Palmas, Las;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
35 Palmas, Las;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
35 Palmas, Las;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
35 Palmas, Las;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
35 Palmas, Las;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
35 Palmas, Las;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
35 Palmas, Las;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;85,28
35 Palmas, Las;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
35 Palmas, Las;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
35 Palmas, Las;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
35 Palmas, Las;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;85,07
35 Palmas, Las;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
35 Palmas, Las;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
35 Palmas, Las;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
35 Palmas, Las;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
35 Palmas, Las;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
35 Palmas, Las;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
36 Pontevedra;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
36 Pontevedra;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
36 Pontevedra;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
36 Pontevedra;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QI;62.328
36 Pontevedra;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
36 Pontevedra;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
36 Pontevedra;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
36 Pontevedra;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QI;61.242
36 Pontevedra;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
36 Pontevedra;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
36 Pontevedra;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
36 Pontevedra;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QI;62.048
36 Pontevedra;All ages;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
36 Pontevedra;All ages;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
36 Pontevedra;All ages;Cohort January 1;Total;Survival in the first trimester;2022QII;""
36 Pontevedra;All ages;Cohort January 1;Total;Survival in the first trimester;2022QI;60.450
36 Pontevedra;All ages;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
36 Pontevedra;All ages;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
36 Pontevedra;All ages;Cohort January 1;Total;Survival in the first trimester;2021QII;""
36 Pontevedra;All ages;Cohort January 1;Total;Survival in the first trimester;2021QI;59.872
36 Pontevedra;All ages;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
36 Pontevedra;All ages;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
36 Pontevedra;All ages;Cohort January 1;Total;Survival in the first trimester;2020QII;""
36 Pontevedra;All ages;Cohort January 1;Total;Survival in the first trimester;2020QI;58.749
36 Pontevedra;All ages;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
36 Pontevedra;All ages;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
36 Pontevedra;All ages;Cohort January 1;Total;Survival in the second trimester;2022QII;58.787
36 Pontevedra;All ages;Cohort January 1;Total;Survival in the second trimester;2022QI;""
36 Pontevedra;All ages;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
36 Pontevedra;All ages;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
36 Pontevedra;All ages;Cohort January 1;Total;Survival in the second trimester;2021QII;58.530
36 Pontevedra;All ages;Cohort January 1;Total;Survival in the second trimester;2021QI;""
36 Pontevedra;All ages;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
36 Pontevedra;All ages;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
36 Pontevedra;All ages;Cohort January 1;Total;Survival in the second trimester;2020QII;57.606
36 Pontevedra;All ages;Cohort January 1;Total;Survival in the second trimester;2020QI;""
36 Pontevedra;All ages;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
36 Pontevedra;All ages;Cohort January 1;Total;Survival in the third trimester;2022QIII;57.353
36 Pontevedra;All ages;Cohort January 1;Total;Survival in the third trimester;2022QII;""
36 Pontevedra;All ages;Cohort January 1;Total;Survival in the third trimester;2022QI;""
36 Pontevedra;All ages;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
36 Pontevedra;All ages;Cohort January 1;Total;Survival in the third trimester;2021QIII;57.298
36 Pontevedra;All ages;Cohort January 1;Total;Survival in the third trimester;2021QII;""
36 Pontevedra;All ages;Cohort January 1;Total;Survival in the third trimester;2021QI;""
36 Pontevedra;All ages;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
36 Pontevedra;All ages;Cohort January 1;Total;Survival in the third trimester;2020QIII;56.207
36 Pontevedra;All ages;Cohort January 1;Total;Survival in the third trimester;2020QII;""
36 Pontevedra;All ages;Cohort January 1;Total;Survival in the third trimester;2020QI;""
36 Pontevedra;All ages;Cohort January 1;Total;Survival in the third trimester;2022QIV;55.667
36 Pontevedra;All ages;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
36 Pontevedra;All ages;Cohort January 1;Total;Survival in the third trimester;2022QII;""
36 Pontevedra;All ages;Cohort January 1;Total;Survival in the third trimester;2022QI;""
36 Pontevedra;All ages;Cohort January 1;Total;Survival in the third trimester;2021QIV;55.849
36 Pontevedra;All ages;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
36 Pontevedra;All ages;Cohort January 1;Total;Survival in the third trimester;2021QII;""
36 Pontevedra;All ages;Cohort January 1;Total;Survival in the third trimester;2021QI;""
36 Pontevedra;All ages;Cohort January 1;Total;Survival in the third trimester;2020QIV;54.804
36 Pontevedra;All ages;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
36 Pontevedra;All ages;Cohort January 1;Total;Survival in the third trimester;2020QII;""
36 Pontevedra;All ages;Cohort January 1;Total;Survival in the third trimester;2020QI;""
36 Pontevedra;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
36 Pontevedra;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
36 Pontevedra;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
36 Pontevedra;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
36 Pontevedra;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
36 Pontevedra;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
36 Pontevedra;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
36 Pontevedra;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
36 Pontevedra;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
36 Pontevedra;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
36 Pontevedra;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
36 Pontevedra;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
36 Pontevedra;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
36 Pontevedra;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
36 Pontevedra;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
36 Pontevedra;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;96,99
36 Pontevedra;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
36 Pontevedra;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
36 Pontevedra;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
36 Pontevedra;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;97,76
36 Pontevedra;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
36 Pontevedra;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
36 Pontevedra;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
36 Pontevedra;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;94,68
36 Pontevedra;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
36 Pontevedra;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
36 Pontevedra;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;94,32
36 Pontevedra;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
36 Pontevedra;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
36 Pontevedra;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
36 Pontevedra;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;95,57
36 Pontevedra;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
36 Pontevedra;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
36 Pontevedra;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
36 Pontevedra;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;92,84
36 Pontevedra;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
36 Pontevedra;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
36 Pontevedra;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;92,02
36 Pontevedra;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
36 Pontevedra;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
36 Pontevedra;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
36 Pontevedra;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;93,56
36 Pontevedra;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
36 Pontevedra;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
36 Pontevedra;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
36 Pontevedra;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;90,59
36 Pontevedra;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
36 Pontevedra;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
36 Pontevedra;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;89,31
36 Pontevedra;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
36 Pontevedra;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
36 Pontevedra;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
36 Pontevedra;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;91,19
36 Pontevedra;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
36 Pontevedra;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
36 Pontevedra;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
36 Pontevedra;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;88,33
36 Pontevedra;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
36 Pontevedra;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
36 Pontevedra;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
36 Pontevedra;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
36 Pontevedra;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
36 Pontevedra;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
36 Pontevedra;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QI;37.377
36 Pontevedra;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
36 Pontevedra;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
36 Pontevedra;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
36 Pontevedra;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QI;36.823
36 Pontevedra;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
36 Pontevedra;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
36 Pontevedra;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
36 Pontevedra;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QI;37.158
36 Pontevedra;All ages;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
36 Pontevedra;All ages;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
36 Pontevedra;All ages;Cohort January 1;Males;Survival in the first trimester;2022QII;""
36 Pontevedra;All ages;Cohort January 1;Males;Survival in the first trimester;2022QI;36.240
36 Pontevedra;All ages;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
36 Pontevedra;All ages;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
36 Pontevedra;All ages;Cohort January 1;Males;Survival in the first trimester;2021QII;""
36 Pontevedra;All ages;Cohort January 1;Males;Survival in the first trimester;2021QI;35.987
36 Pontevedra;All ages;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
36 Pontevedra;All ages;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
36 Pontevedra;All ages;Cohort January 1;Males;Survival in the first trimester;2020QII;""
36 Pontevedra;All ages;Cohort January 1;Males;Survival in the first trimester;2020QI;35.271
36 Pontevedra;All ages;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
36 Pontevedra;All ages;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
36 Pontevedra;All ages;Cohort January 1;Males;Survival in the second trimester;2022QII;35.344
36 Pontevedra;All ages;Cohort January 1;Males;Survival in the second trimester;2022QI;""
36 Pontevedra;All ages;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
36 Pontevedra;All ages;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
36 Pontevedra;All ages;Cohort January 1;Males;Survival in the second trimester;2021QII;35.225
36 Pontevedra;All ages;Cohort January 1;Males;Survival in the second trimester;2021QI;""
36 Pontevedra;All ages;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
36 Pontevedra;All ages;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
36 Pontevedra;All ages;Cohort January 1;Males;Survival in the second trimester;2020QII;34.700
36 Pontevedra;All ages;Cohort January 1;Males;Survival in the second trimester;2020QI;""
36 Pontevedra;All ages;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
36 Pontevedra;All ages;Cohort January 1;Males;Survival in the third trimester;2022QIII;34.575
36 Pontevedra;All ages;Cohort January 1;Males;Survival in the third trimester;2022QII;""
36 Pontevedra;All ages;Cohort January 1;Males;Survival in the third trimester;2022QI;""
36 Pontevedra;All ages;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
36 Pontevedra;All ages;Cohort January 1;Males;Survival in the third trimester;2021QIII;34.509
36 Pontevedra;All ages;Cohort January 1;Males;Survival in the third trimester;2021QII;""
36 Pontevedra;All ages;Cohort January 1;Males;Survival in the third trimester;2021QI;""
36 Pontevedra;All ages;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
36 Pontevedra;All ages;Cohort January 1;Males;Survival in the third trimester;2020QIII;33.925
36 Pontevedra;All ages;Cohort January 1;Males;Survival in the third trimester;2020QII;""
36 Pontevedra;All ages;Cohort January 1;Males;Survival in the third trimester;2020QI;""
36 Pontevedra;All ages;Cohort January 1;Males;Survival in the third trimester;2022QIV;33.620
36 Pontevedra;All ages;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
36 Pontevedra;All ages;Cohort January 1;Males;Survival in the third trimester;2022QII;""
36 Pontevedra;All ages;Cohort January 1;Males;Survival in the third trimester;2022QI;""
36 Pontevedra;All ages;Cohort January 1;Males;Survival in the third trimester;2021QIV;33.717
36 Pontevedra;All ages;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
36 Pontevedra;All ages;Cohort January 1;Males;Survival in the third trimester;2021QII;""
36 Pontevedra;All ages;Cohort January 1;Males;Survival in the third trimester;2021QI;""
36 Pontevedra;All ages;Cohort January 1;Males;Survival in the third trimester;2020QIV;33.145
36 Pontevedra;All ages;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
36 Pontevedra;All ages;Cohort January 1;Males;Survival in the third trimester;2020QII;""
36 Pontevedra;All ages;Cohort January 1;Males;Survival in the third trimester;2020QI;""
36 Pontevedra;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
36 Pontevedra;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
36 Pontevedra;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
36 Pontevedra;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
36 Pontevedra;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
36 Pontevedra;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
36 Pontevedra;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
36 Pontevedra;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
36 Pontevedra;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
36 Pontevedra;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
36 Pontevedra;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
36 Pontevedra;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
36 Pontevedra;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
36 Pontevedra;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
36 Pontevedra;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
36 Pontevedra;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;96,96
36 Pontevedra;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
36 Pontevedra;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
36 Pontevedra;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
36 Pontevedra;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;97,73
36 Pontevedra;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
36 Pontevedra;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
36 Pontevedra;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
36 Pontevedra;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;94,92
36 Pontevedra;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
36 Pontevedra;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
36 Pontevedra;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;94,56
36 Pontevedra;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
36 Pontevedra;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
36 Pontevedra;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
36 Pontevedra;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;95,66
36 Pontevedra;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
36 Pontevedra;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
36 Pontevedra;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
36 Pontevedra;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;93,39
36 Pontevedra;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
36 Pontevedra;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
36 Pontevedra;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;92,5
36 Pontevedra;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
36 Pontevedra;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
36 Pontevedra;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
36 Pontevedra;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;93,72
36 Pontevedra;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
36 Pontevedra;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
36 Pontevedra;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
36 Pontevedra;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;91,3
36 Pontevedra;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
36 Pontevedra;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
36 Pontevedra;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;89,95
36 Pontevedra;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
36 Pontevedra;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
36 Pontevedra;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
36 Pontevedra;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;91,57
36 Pontevedra;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
36 Pontevedra;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
36 Pontevedra;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
36 Pontevedra;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;89,2
36 Pontevedra;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
36 Pontevedra;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
36 Pontevedra;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
36 Pontevedra;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
36 Pontevedra;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
36 Pontevedra;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
36 Pontevedra;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QI;24.951
36 Pontevedra;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
36 Pontevedra;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
36 Pontevedra;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
36 Pontevedra;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QI;24.419
36 Pontevedra;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
36 Pontevedra;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
36 Pontevedra;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
36 Pontevedra;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QI;24.890
36 Pontevedra;All ages;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
36 Pontevedra;All ages;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
36 Pontevedra;All ages;Cohort January 1;Females;Survival in the first trimester;2022QII;""
36 Pontevedra;All ages;Cohort January 1;Females;Survival in the first trimester;2022QI;24.210
36 Pontevedra;All ages;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
36 Pontevedra;All ages;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
36 Pontevedra;All ages;Cohort January 1;Females;Survival in the first trimester;2021QII;""
36 Pontevedra;All ages;Cohort January 1;Females;Survival in the first trimester;2021QI;23.885
36 Pontevedra;All ages;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
36 Pontevedra;All ages;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
36 Pontevedra;All ages;Cohort January 1;Females;Survival in the first trimester;2020QII;""
36 Pontevedra;All ages;Cohort January 1;Females;Survival in the first trimester;2020QI;23.478
36 Pontevedra;All ages;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
36 Pontevedra;All ages;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
36 Pontevedra;All ages;Cohort January 1;Females;Survival in the second trimester;2022QII;23.443
36 Pontevedra;All ages;Cohort January 1;Females;Survival in the second trimester;2022QI;""
36 Pontevedra;All ages;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
36 Pontevedra;All ages;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
36 Pontevedra;All ages;Cohort January 1;Females;Survival in the second trimester;2021QII;23.305
36 Pontevedra;All ages;Cohort January 1;Females;Survival in the second trimester;2021QI;""
36 Pontevedra;All ages;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
36 Pontevedra;All ages;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
36 Pontevedra;All ages;Cohort January 1;Females;Survival in the second trimester;2020QII;22.906
36 Pontevedra;All ages;Cohort January 1;Females;Survival in the second trimester;2020QI;""
36 Pontevedra;All ages;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
36 Pontevedra;All ages;Cohort January 1;Females;Survival in the third trimester;2022QIII;22.778
36 Pontevedra;All ages;Cohort January 1;Females;Survival in the third trimester;2022QII;""
36 Pontevedra;All ages;Cohort January 1;Females;Survival in the third trimester;2022QI;""
36 Pontevedra;All ages;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
36 Pontevedra;All ages;Cohort January 1;Females;Survival in the third trimester;2021QIII;22.789
36 Pontevedra;All ages;Cohort January 1;Females;Survival in the third trimester;2021QII;""
36 Pontevedra;All ages;Cohort January 1;Females;Survival in the third trimester;2021QI;""
36 Pontevedra;All ages;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
36 Pontevedra;All ages;Cohort January 1;Females;Survival in the third trimester;2020QIII;22.282
36 Pontevedra;All ages;Cohort January 1;Females;Survival in the third trimester;2020QII;""
36 Pontevedra;All ages;Cohort January 1;Females;Survival in the third trimester;2020QI;""
36 Pontevedra;All ages;Cohort January 1;Females;Survival in the third trimester;2022QIV;22.047
36 Pontevedra;All ages;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
36 Pontevedra;All ages;Cohort January 1;Females;Survival in the third trimester;2022QII;""
36 Pontevedra;All ages;Cohort January 1;Females;Survival in the third trimester;2022QI;""
36 Pontevedra;All ages;Cohort January 1;Females;Survival in the third trimester;2021QIV;22.132
36 Pontevedra;All ages;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
36 Pontevedra;All ages;Cohort January 1;Females;Survival in the third trimester;2021QII;""
36 Pontevedra;All ages;Cohort January 1;Females;Survival in the third trimester;2021QI;""
36 Pontevedra;All ages;Cohort January 1;Females;Survival in the third trimester;2020QIV;21.659
36 Pontevedra;All ages;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
36 Pontevedra;All ages;Cohort January 1;Females;Survival in the third trimester;2020QII;""
36 Pontevedra;All ages;Cohort January 1;Females;Survival in the third trimester;2020QI;""
36 Pontevedra;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
36 Pontevedra;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
36 Pontevedra;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
36 Pontevedra;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
36 Pontevedra;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
36 Pontevedra;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
36 Pontevedra;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
36 Pontevedra;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
36 Pontevedra;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
36 Pontevedra;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
36 Pontevedra;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
36 Pontevedra;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
36 Pontevedra;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
36 Pontevedra;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
36 Pontevedra;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
36 Pontevedra;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;97,03
36 Pontevedra;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
36 Pontevedra;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
36 Pontevedra;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
36 Pontevedra;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;97,81
36 Pontevedra;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
36 Pontevedra;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
36 Pontevedra;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
36 Pontevedra;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;94,33
36 Pontevedra;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
36 Pontevedra;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
36 Pontevedra;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;93,96
36 Pontevedra;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
36 Pontevedra;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
36 Pontevedra;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
36 Pontevedra;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;95,44
36 Pontevedra;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
36 Pontevedra;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
36 Pontevedra;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
36 Pontevedra;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;92,03
36 Pontevedra;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
36 Pontevedra;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
36 Pontevedra;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;91,29
36 Pontevedra;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
36 Pontevedra;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
36 Pontevedra;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
36 Pontevedra;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;93,32
36 Pontevedra;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
36 Pontevedra;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
36 Pontevedra;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
36 Pontevedra;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;89,52
36 Pontevedra;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
36 Pontevedra;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
36 Pontevedra;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;88,36
36 Pontevedra;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
36 Pontevedra;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
36 Pontevedra;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
36 Pontevedra;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;90,63
36 Pontevedra;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
36 Pontevedra;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
36 Pontevedra;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
36 Pontevedra;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;87,02
36 Pontevedra;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
36 Pontevedra;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
36 Pontevedra;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
36 Pontevedra;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
36 Pontevedra;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
36 Pontevedra;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QII;62.362
36 Pontevedra;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
36 Pontevedra;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
36 Pontevedra;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
36 Pontevedra;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QII;61.789
36 Pontevedra;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
36 Pontevedra;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
36 Pontevedra;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
36 Pontevedra;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QII;61.347
36 Pontevedra;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
36 Pontevedra;All ages;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
36 Pontevedra;All ages;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
36 Pontevedra;All ages;Cohort April 1;Total;Survival in the first trimester;2022QII;60.570
36 Pontevedra;All ages;Cohort April 1;Total;Survival in the first trimester;2022QI;""
36 Pontevedra;All ages;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
36 Pontevedra;All ages;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
36 Pontevedra;All ages;Cohort April 1;Total;Survival in the first trimester;2021QII;60.274
36 Pontevedra;All ages;Cohort April 1;Total;Survival in the first trimester;2021QI;""
36 Pontevedra;All ages;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
36 Pontevedra;All ages;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
36 Pontevedra;All ages;Cohort April 1;Total;Survival in the first trimester;2020QII;60.105
36 Pontevedra;All ages;Cohort April 1;Total;Survival in the first trimester;2020QI;""
36 Pontevedra;All ages;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
36 Pontevedra;All ages;Cohort April 1;Total;Survival in the second trimester;2022QIII;59.023
36 Pontevedra;All ages;Cohort April 1;Total;Survival in the second trimester;2022QII;""
36 Pontevedra;All ages;Cohort April 1;Total;Survival in the second trimester;2022QI;""
36 Pontevedra;All ages;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
36 Pontevedra;All ages;Cohort April 1;Total;Survival in the second trimester;2021QIII;58.916
36 Pontevedra;All ages;Cohort April 1;Total;Survival in the second trimester;2021QII;""
36 Pontevedra;All ages;Cohort April 1;Total;Survival in the second trimester;2021QI;""
36 Pontevedra;All ages;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
36 Pontevedra;All ages;Cohort April 1;Total;Survival in the second trimester;2020QIII;58.210
36 Pontevedra;All ages;Cohort April 1;Total;Survival in the second trimester;2020QII;""
36 Pontevedra;All ages;Cohort April 1;Total;Survival in the second trimester;2020QI;""
36 Pontevedra;All ages;Cohort April 1;Total;Survival in the third trimester;2022QIV;57.239
36 Pontevedra;All ages;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
36 Pontevedra;All ages;Cohort April 1;Total;Survival in the third trimester;2022QII;""
36 Pontevedra;All ages;Cohort April 1;Total;Survival in the third trimester;2022QI;""
36 Pontevedra;All ages;Cohort April 1;Total;Survival in the third trimester;2021QIV;57.357
36 Pontevedra;All ages;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
36 Pontevedra;All ages;Cohort April 1;Total;Survival in the third trimester;2021QII;""
36 Pontevedra;All ages;Cohort April 1;Total;Survival in the third trimester;2021QI;""
36 Pontevedra;All ages;Cohort April 1;Total;Survival in the third trimester;2020QIV;56.695
36 Pontevedra;All ages;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
36 Pontevedra;All ages;Cohort April 1;Total;Survival in the third trimester;2020QII;""
36 Pontevedra;All ages;Cohort April 1;Total;Survival in the third trimester;2020QI;""
36 Pontevedra;All ages;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
36 Pontevedra;All ages;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
36 Pontevedra;All ages;Cohort April 1;Total;Survival in the third trimester;2022QII;""
36 Pontevedra;All ages;Cohort April 1;Total;Survival in the third trimester;2022QI;55.864
36 Pontevedra;All ages;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
36 Pontevedra;All ages;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
36 Pontevedra;All ages;Cohort April 1;Total;Survival in the third trimester;2021QII;""
36 Pontevedra;All ages;Cohort April 1;Total;Survival in the third trimester;2021QI;55.652
36 Pontevedra;All ages;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
36 Pontevedra;All ages;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
36 Pontevedra;All ages;Cohort April 1;Total;Survival in the third trimester;2020QII;""
36 Pontevedra;All ages;Cohort April 1;Total;Survival in the third trimester;2020QI;""
36 Pontevedra;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
36 Pontevedra;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
36 Pontevedra;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
36 Pontevedra;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
36 Pontevedra;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
36 Pontevedra;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
36 Pontevedra;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
36 Pontevedra;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
36 Pontevedra;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
36 Pontevedra;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
36 Pontevedra;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
36 Pontevedra;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
36 Pontevedra;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
36 Pontevedra;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
36 Pontevedra;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;97,13
36 Pontevedra;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
36 Pontevedra;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
36 Pontevedra;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
36 Pontevedra;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;97,55
36 Pontevedra;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
36 Pontevedra;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
36 Pontevedra;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
36 Pontevedra;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;97,98
36 Pontevedra;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
36 Pontevedra;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
36 Pontevedra;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;94,65
36 Pontevedra;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
36 Pontevedra;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
36 Pontevedra;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
36 Pontevedra;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;95,35
36 Pontevedra;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
36 Pontevedra;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
36 Pontevedra;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
36 Pontevedra;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;94,89
36 Pontevedra;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
36 Pontevedra;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
36 Pontevedra;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;91,79
36 Pontevedra;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
36 Pontevedra;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
36 Pontevedra;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
36 Pontevedra;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;92,83
36 Pontevedra;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
36 Pontevedra;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
36 Pontevedra;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
36 Pontevedra;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;92,42
36 Pontevedra;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
36 Pontevedra;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
36 Pontevedra;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
36 Pontevedra;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
36 Pontevedra;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
36 Pontevedra;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
36 Pontevedra;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;90,41
36 Pontevedra;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
36 Pontevedra;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
36 Pontevedra;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
36 Pontevedra;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;90,72
36 Pontevedra;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
36 Pontevedra;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
36 Pontevedra;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
36 Pontevedra;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
36 Pontevedra;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
36 Pontevedra;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
36 Pontevedra;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QII;37.315
36 Pontevedra;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
36 Pontevedra;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
36 Pontevedra;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
36 Pontevedra;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QII;37.106
36 Pontevedra;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
36 Pontevedra;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
36 Pontevedra;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
36 Pontevedra;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QII;36.736
36 Pontevedra;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
36 Pontevedra;All ages;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
36 Pontevedra;All ages;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
36 Pontevedra;All ages;Cohort April 1;Males;Survival in the first trimester;2022QII;36.336
36 Pontevedra;All ages;Cohort April 1;Males;Survival in the first trimester;2022QI;""
36 Pontevedra;All ages;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
36 Pontevedra;All ages;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
36 Pontevedra;All ages;Cohort April 1;Males;Survival in the first trimester;2021QII;36.235
36 Pontevedra;All ages;Cohort April 1;Males;Survival in the first trimester;2021QI;""
36 Pontevedra;All ages;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
36 Pontevedra;All ages;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
36 Pontevedra;All ages;Cohort April 1;Males;Survival in the first trimester;2020QII;36.105
36 Pontevedra;All ages;Cohort April 1;Males;Survival in the first trimester;2020QI;""
36 Pontevedra;All ages;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
36 Pontevedra;All ages;Cohort April 1;Males;Survival in the second trimester;2022QIII;35.497
36 Pontevedra;All ages;Cohort April 1;Males;Survival in the second trimester;2022QII;""
36 Pontevedra;All ages;Cohort April 1;Males;Survival in the second trimester;2022QI;""
36 Pontevedra;All ages;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
36 Pontevedra;All ages;Cohort April 1;Males;Survival in the second trimester;2021QIII;35.441
36 Pontevedra;All ages;Cohort April 1;Males;Survival in the second trimester;2021QII;""
36 Pontevedra;All ages;Cohort April 1;Males;Survival in the second trimester;2021QI;""
36 Pontevedra;All ages;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
36 Pontevedra;All ages;Cohort April 1;Males;Survival in the second trimester;2020QIII;35.029
36 Pontevedra;All ages;Cohort April 1;Males;Survival in the second trimester;2020QII;""
36 Pontevedra;All ages;Cohort April 1;Males;Survival in the second trimester;2020QI;""
36 Pontevedra;All ages;Cohort April 1;Males;Survival in the third trimester;2022QIV;34.487
36 Pontevedra;All ages;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
36 Pontevedra;All ages;Cohort April 1;Males;Survival in the third trimester;2022QII;""
36 Pontevedra;All ages;Cohort April 1;Males;Survival in the third trimester;2022QI;""
36 Pontevedra;All ages;Cohort April 1;Males;Survival in the third trimester;2021QIV;34.589
36 Pontevedra;All ages;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
36 Pontevedra;All ages;Cohort April 1;Males;Survival in the third trimester;2021QII;""
36 Pontevedra;All ages;Cohort April 1;Males;Survival in the third trimester;2021QI;""
36 Pontevedra;All ages;Cohort April 1;Males;Survival in the third trimester;2020QIV;34.177
36 Pontevedra;All ages;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
36 Pontevedra;All ages;Cohort April 1;Males;Survival in the third trimester;2020QII;""
36 Pontevedra;All ages;Cohort April 1;Males;Survival in the third trimester;2020QI;""
36 Pontevedra;All ages;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
36 Pontevedra;All ages;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
36 Pontevedra;All ages;Cohort April 1;Males;Survival in the third trimester;2022QII;""
36 Pontevedra;All ages;Cohort April 1;Males;Survival in the third trimester;2022QI;33.706
36 Pontevedra;All ages;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
36 Pontevedra;All ages;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
36 Pontevedra;All ages;Cohort April 1;Males;Survival in the third trimester;2021QII;""
36 Pontevedra;All ages;Cohort April 1;Males;Survival in the third trimester;2021QI;33.547
36 Pontevedra;All ages;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
36 Pontevedra;All ages;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
36 Pontevedra;All ages;Cohort April 1;Males;Survival in the third trimester;2020QII;""
36 Pontevedra;All ages;Cohort April 1;Males;Survival in the third trimester;2020QI;""
36 Pontevedra;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
36 Pontevedra;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
36 Pontevedra;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
36 Pontevedra;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
36 Pontevedra;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
36 Pontevedra;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
36 Pontevedra;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
36 Pontevedra;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
36 Pontevedra;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
36 Pontevedra;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
36 Pontevedra;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
36 Pontevedra;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
36 Pontevedra;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
36 Pontevedra;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
36 Pontevedra;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;97,38
36 Pontevedra;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
36 Pontevedra;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
36 Pontevedra;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
36 Pontevedra;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;97,65
36 Pontevedra;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
36 Pontevedra;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
36 Pontevedra;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
36 Pontevedra;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;98,28
36 Pontevedra;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
36 Pontevedra;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
36 Pontevedra;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;95,13
36 Pontevedra;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
36 Pontevedra;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
36 Pontevedra;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
36 Pontevedra;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;95,51
36 Pontevedra;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
36 Pontevedra;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
36 Pontevedra;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
36 Pontevedra;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;95,35
36 Pontevedra;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
36 Pontevedra;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
36 Pontevedra;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;92,42
36 Pontevedra;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
36 Pontevedra;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
36 Pontevedra;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
36 Pontevedra;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;93,22
36 Pontevedra;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
36 Pontevedra;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
36 Pontevedra;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
36 Pontevedra;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;93,03
36 Pontevedra;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
36 Pontevedra;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
36 Pontevedra;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
36 Pontevedra;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
36 Pontevedra;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
36 Pontevedra;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
36 Pontevedra;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;90,84
36 Pontevedra;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
36 Pontevedra;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
36 Pontevedra;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
36 Pontevedra;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;91,32
36 Pontevedra;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
36 Pontevedra;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
36 Pontevedra;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
36 Pontevedra;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
36 Pontevedra;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
36 Pontevedra;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
36 Pontevedra;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QII;25.047
36 Pontevedra;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
36 Pontevedra;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
36 Pontevedra;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
36 Pontevedra;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QII;24.683
36 Pontevedra;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
36 Pontevedra;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
36 Pontevedra;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
36 Pontevedra;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QII;24.611
36 Pontevedra;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
36 Pontevedra;All ages;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
36 Pontevedra;All ages;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
36 Pontevedra;All ages;Cohort April 1;Females;Survival in the first trimester;2022QII;24.234
36 Pontevedra;All ages;Cohort April 1;Females;Survival in the first trimester;2022QI;""
36 Pontevedra;All ages;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
36 Pontevedra;All ages;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
36 Pontevedra;All ages;Cohort April 1;Females;Survival in the first trimester;2021QII;24.039
36 Pontevedra;All ages;Cohort April 1;Females;Survival in the first trimester;2021QI;""
36 Pontevedra;All ages;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
36 Pontevedra;All ages;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
36 Pontevedra;All ages;Cohort April 1;Females;Survival in the first trimester;2020QII;24.000
36 Pontevedra;All ages;Cohort April 1;Females;Survival in the first trimester;2020QI;""
36 Pontevedra;All ages;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
36 Pontevedra;All ages;Cohort April 1;Females;Survival in the second trimester;2022QIII;23.526
36 Pontevedra;All ages;Cohort April 1;Females;Survival in the second trimester;2022QII;""
36 Pontevedra;All ages;Cohort April 1;Females;Survival in the second trimester;2022QI;""
36 Pontevedra;All ages;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
36 Pontevedra;All ages;Cohort April 1;Females;Survival in the second trimester;2021QIII;23.475
36 Pontevedra;All ages;Cohort April 1;Females;Survival in the second trimester;2021QII;""
36 Pontevedra;All ages;Cohort April 1;Females;Survival in the second trimester;2021QI;""
36 Pontevedra;All ages;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
36 Pontevedra;All ages;Cohort April 1;Females;Survival in the second trimester;2020QIII;23.181
36 Pontevedra;All ages;Cohort April 1;Females;Survival in the second trimester;2020QII;""
36 Pontevedra;All ages;Cohort April 1;Females;Survival in the second trimester;2020QI;""
36 Pontevedra;All ages;Cohort April 1;Females;Survival in the third trimester;2022QIV;22.752
36 Pontevedra;All ages;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
36 Pontevedra;All ages;Cohort April 1;Females;Survival in the third trimester;2022QII;""
36 Pontevedra;All ages;Cohort April 1;Females;Survival in the third trimester;2022QI;""
36 Pontevedra;All ages;Cohort April 1;Females;Survival in the third trimester;2021QIV;22.768
36 Pontevedra;All ages;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
36 Pontevedra;All ages;Cohort April 1;Females;Survival in the third trimester;2021QII;""
36 Pontevedra;All ages;Cohort April 1;Females;Survival in the third trimester;2021QI;""
36 Pontevedra;All ages;Cohort April 1;Females;Survival in the third trimester;2020QIV;22.518
36 Pontevedra;All ages;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
36 Pontevedra;All ages;Cohort April 1;Females;Survival in the third trimester;2020QII;""
36 Pontevedra;All ages;Cohort April 1;Females;Survival in the third trimester;2020QI;""
36 Pontevedra;All ages;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
36 Pontevedra;All ages;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
36 Pontevedra;All ages;Cohort April 1;Females;Survival in the third trimester;2022QII;""
36 Pontevedra;All ages;Cohort April 1;Females;Survival in the third trimester;2022QI;22.158
36 Pontevedra;All ages;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
36 Pontevedra;All ages;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
36 Pontevedra;All ages;Cohort April 1;Females;Survival in the third trimester;2021QII;""
36 Pontevedra;All ages;Cohort April 1;Females;Survival in the third trimester;2021QI;22.105
36 Pontevedra;All ages;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
36 Pontevedra;All ages;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
36 Pontevedra;All ages;Cohort April 1;Females;Survival in the third trimester;2020QII;""
36 Pontevedra;All ages;Cohort April 1;Females;Survival in the third trimester;2020QI;""
36 Pontevedra;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
36 Pontevedra;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
36 Pontevedra;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
36 Pontevedra;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
36 Pontevedra;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
36 Pontevedra;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
36 Pontevedra;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
36 Pontevedra;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
36 Pontevedra;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
36 Pontevedra;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
36 Pontevedra;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
36 Pontevedra;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
36 Pontevedra;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
36 Pontevedra;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
36 Pontevedra;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;96,75
36 Pontevedra;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
36 Pontevedra;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
36 Pontevedra;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
36 Pontevedra;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;97,39
36 Pontevedra;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
36 Pontevedra;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
36 Pontevedra;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
36 Pontevedra;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;97,52
36 Pontevedra;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
36 Pontevedra;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
36 Pontevedra;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;93,93
36 Pontevedra;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
36 Pontevedra;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
36 Pontevedra;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
36 Pontevedra;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;95,11
36 Pontevedra;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
36 Pontevedra;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
36 Pontevedra;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
36 Pontevedra;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;94,19
36 Pontevedra;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
36 Pontevedra;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
36 Pontevedra;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;90,84
36 Pontevedra;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
36 Pontevedra;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
36 Pontevedra;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
36 Pontevedra;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;92,24
36 Pontevedra;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
36 Pontevedra;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
36 Pontevedra;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
36 Pontevedra;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;91,5
36 Pontevedra;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
36 Pontevedra;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
36 Pontevedra;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
36 Pontevedra;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
36 Pontevedra;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
36 Pontevedra;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
36 Pontevedra;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;89,77
36 Pontevedra;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
36 Pontevedra;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
36 Pontevedra;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
36 Pontevedra;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;89,82
36 Pontevedra;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
36 Pontevedra;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
36 Pontevedra;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
36 Pontevedra;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
36 Pontevedra;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
36 Pontevedra;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QIII;62.685
36 Pontevedra;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
36 Pontevedra;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
36 Pontevedra;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
36 Pontevedra;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QIII;62.533
36 Pontevedra;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
36 Pontevedra;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
36 Pontevedra;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
36 Pontevedra;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QIII;61.700
36 Pontevedra;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
36 Pontevedra;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
36 Pontevedra;All ages;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
36 Pontevedra;All ages;Cohort July 1;Total;Survival in the first trimester;2022QIII;60.753
36 Pontevedra;All ages;Cohort July 1;Total;Survival in the first trimester;2022QII;""
36 Pontevedra;All ages;Cohort July 1;Total;Survival in the first trimester;2022QI;""
36 Pontevedra;All ages;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
36 Pontevedra;All ages;Cohort July 1;Total;Survival in the first trimester;2021QIII;60.805
36 Pontevedra;All ages;Cohort July 1;Total;Survival in the first trimester;2021QII;""
36 Pontevedra;All ages;Cohort July 1;Total;Survival in the first trimester;2021QI;""
36 Pontevedra;All ages;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
36 Pontevedra;All ages;Cohort July 1;Total;Survival in the first trimester;2020QIII;59.474
36 Pontevedra;All ages;Cohort July 1;Total;Survival in the first trimester;2020QII;""
36 Pontevedra;All ages;Cohort July 1;Total;Survival in the first trimester;2020QI;""
36 Pontevedra;All ages;Cohort July 1;Total;Survival in the second trimester;2022QIV;58.723
36 Pontevedra;All ages;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
36 Pontevedra;All ages;Cohort July 1;Total;Survival in the second trimester;2022QII;""
36 Pontevedra;All ages;Cohort July 1;Total;Survival in the second trimester;2022QI;""
36 Pontevedra;All ages;Cohort July 1;Total;Survival in the second trimester;2021QIV;59.047
36 Pontevedra;All ages;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
36 Pontevedra;All ages;Cohort July 1;Total;Survival in the second trimester;2021QII;""
36 Pontevedra;All ages;Cohort July 1;Total;Survival in the second trimester;2021QI;""
36 Pontevedra;All ages;Cohort July 1;Total;Survival in the second trimester;2020QIV;57.822
36 Pontevedra;All ages;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
36 Pontevedra;All ages;Cohort July 1;Total;Survival in the second trimester;2020QII;""
36 Pontevedra;All ages;Cohort July 1;Total;Survival in the second trimester;2020QI;""
36 Pontevedra;All ages;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
36 Pontevedra;All ages;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
36 Pontevedra;All ages;Cohort July 1;Total;Survival in the third trimester;2022QII;""
36 Pontevedra;All ages;Cohort July 1;Total;Survival in the third trimester;2022QI;57.452
36 Pontevedra;All ages;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
36 Pontevedra;All ages;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
36 Pontevedra;All ages;Cohort July 1;Total;Survival in the third trimester;2021QII;""
36 Pontevedra;All ages;Cohort July 1;Total;Survival in the third trimester;2021QI;56.725
36 Pontevedra;All ages;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
36 Pontevedra;All ages;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
36 Pontevedra;All ages;Cohort July 1;Total;Survival in the third trimester;2020QII;""
36 Pontevedra;All ages;Cohort July 1;Total;Survival in the third trimester;2020QI;""
36 Pontevedra;All ages;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
36 Pontevedra;All ages;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
36 Pontevedra;All ages;Cohort July 1;Total;Survival in the third trimester;2022QII;56.041
36 Pontevedra;All ages;Cohort July 1;Total;Survival in the third trimester;2022QI;""
36 Pontevedra;All ages;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
36 Pontevedra;All ages;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
36 Pontevedra;All ages;Cohort July 1;Total;Survival in the third trimester;2021QII;55.614
36 Pontevedra;All ages;Cohort July 1;Total;Survival in the third trimester;2021QI;""
36 Pontevedra;All ages;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
36 Pontevedra;All ages;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
36 Pontevedra;All ages;Cohort July 1;Total;Survival in the third trimester;2020QII;""
36 Pontevedra;All ages;Cohort July 1;Total;Survival in the third trimester;2020QI;""
36 Pontevedra;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
36 Pontevedra;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
36 Pontevedra;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
36 Pontevedra;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
36 Pontevedra;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
36 Pontevedra;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
36 Pontevedra;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
36 Pontevedra;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
36 Pontevedra;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
36 Pontevedra;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
36 Pontevedra;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
36 Pontevedra;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
36 Pontevedra;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
36 Pontevedra;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;96,92
36 Pontevedra;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
36 Pontevedra;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
36 Pontevedra;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
36 Pontevedra;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;97,24
36 Pontevedra;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
36 Pontevedra;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
36 Pontevedra;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
36 Pontevedra;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;96,39
36 Pontevedra;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
36 Pontevedra;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
36 Pontevedra;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;93,68
36 Pontevedra;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
36 Pontevedra;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
36 Pontevedra;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
36 Pontevedra;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;94,43
36 Pontevedra;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
36 Pontevedra;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
36 Pontevedra;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
36 Pontevedra;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;93,71
36 Pontevedra;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
36 Pontevedra;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
36 Pontevedra;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
36 Pontevedra;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
36 Pontevedra;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
36 Pontevedra;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
36 Pontevedra;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;91,87
36 Pontevedra;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
36 Pontevedra;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
36 Pontevedra;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
36 Pontevedra;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;91,94
36 Pontevedra;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
36 Pontevedra;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
36 Pontevedra;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
36 Pontevedra;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
36 Pontevedra;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
36 Pontevedra;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
36 Pontevedra;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;89,62
36 Pontevedra;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
36 Pontevedra;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
36 Pontevedra;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
36 Pontevedra;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;90,14
36 Pontevedra;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
36 Pontevedra;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
36 Pontevedra;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
36 Pontevedra;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
36 Pontevedra;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
36 Pontevedra;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
36 Pontevedra;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QIII;37.453
36 Pontevedra;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
36 Pontevedra;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
36 Pontevedra;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
36 Pontevedra;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QIII;37.486
36 Pontevedra;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
36 Pontevedra;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
36 Pontevedra;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
36 Pontevedra;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QIII;37.101
36 Pontevedra;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
36 Pontevedra;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
36 Pontevedra;All ages;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
36 Pontevedra;All ages;Cohort July 1;Males;Survival in the first trimester;2022QIII;36.414
36 Pontevedra;All ages;Cohort July 1;Males;Survival in the first trimester;2022QII;""
36 Pontevedra;All ages;Cohort July 1;Males;Survival in the first trimester;2022QI;""
36 Pontevedra;All ages;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
36 Pontevedra;All ages;Cohort July 1;Males;Survival in the first trimester;2021QIII;36.490
36 Pontevedra;All ages;Cohort July 1;Males;Survival in the first trimester;2021QII;""
36 Pontevedra;All ages;Cohort July 1;Males;Survival in the first trimester;2021QI;""
36 Pontevedra;All ages;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
36 Pontevedra;All ages;Cohort July 1;Males;Survival in the first trimester;2020QIII;35.836
36 Pontevedra;All ages;Cohort July 1;Males;Survival in the first trimester;2020QII;""
36 Pontevedra;All ages;Cohort July 1;Males;Survival in the first trimester;2020QI;""
36 Pontevedra;All ages;Cohort July 1;Males;Survival in the second trimester;2022QIV;35.283
36 Pontevedra;All ages;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
36 Pontevedra;All ages;Cohort July 1;Males;Survival in the second trimester;2022QII;""
36 Pontevedra;All ages;Cohort July 1;Males;Survival in the second trimester;2022QI;""
36 Pontevedra;All ages;Cohort July 1;Males;Survival in the second trimester;2021QIV;35.530
36 Pontevedra;All ages;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
36 Pontevedra;All ages;Cohort July 1;Males;Survival in the second trimester;2021QII;""
36 Pontevedra;All ages;Cohort July 1;Males;Survival in the second trimester;2021QI;""
36 Pontevedra;All ages;Cohort July 1;Males;Survival in the second trimester;2020QIV;34.903
36 Pontevedra;All ages;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
36 Pontevedra;All ages;Cohort July 1;Males;Survival in the second trimester;2020QII;""
36 Pontevedra;All ages;Cohort July 1;Males;Survival in the second trimester;2020QI;""
36 Pontevedra;All ages;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
36 Pontevedra;All ages;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
36 Pontevedra;All ages;Cohort July 1;Males;Survival in the third trimester;2022QII;""
36 Pontevedra;All ages;Cohort July 1;Males;Survival in the third trimester;2022QI;34.584
36 Pontevedra;All ages;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
36 Pontevedra;All ages;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
36 Pontevedra;All ages;Cohort July 1;Males;Survival in the third trimester;2021QII;""
36 Pontevedra;All ages;Cohort July 1;Males;Survival in the third trimester;2021QI;34.236
36 Pontevedra;All ages;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
36 Pontevedra;All ages;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
36 Pontevedra;All ages;Cohort July 1;Males;Survival in the third trimester;2020QII;""
36 Pontevedra;All ages;Cohort July 1;Males;Survival in the third trimester;2020QI;""
36 Pontevedra;All ages;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
36 Pontevedra;All ages;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
36 Pontevedra;All ages;Cohort July 1;Males;Survival in the third trimester;2022QII;33.819
36 Pontevedra;All ages;Cohort July 1;Males;Survival in the third trimester;2022QI;""
36 Pontevedra;All ages;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
36 Pontevedra;All ages;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
36 Pontevedra;All ages;Cohort July 1;Males;Survival in the third trimester;2021QII;33.611
36 Pontevedra;All ages;Cohort July 1;Males;Survival in the third trimester;2021QI;""
36 Pontevedra;All ages;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
36 Pontevedra;All ages;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
36 Pontevedra;All ages;Cohort July 1;Males;Survival in the third trimester;2020QII;""
36 Pontevedra;All ages;Cohort July 1;Males;Survival in the third trimester;2020QI;""
36 Pontevedra;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
36 Pontevedra;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
36 Pontevedra;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
36 Pontevedra;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
36 Pontevedra;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
36 Pontevedra;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
36 Pontevedra;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
36 Pontevedra;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
36 Pontevedra;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
36 Pontevedra;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
36 Pontevedra;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
36 Pontevedra;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
36 Pontevedra;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
36 Pontevedra;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;97,23
36 Pontevedra;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
36 Pontevedra;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
36 Pontevedra;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
36 Pontevedra;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;97,34
36 Pontevedra;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
36 Pontevedra;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
36 Pontevedra;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
36 Pontevedra;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;96,59
36 Pontevedra;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
36 Pontevedra;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
36 Pontevedra;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;94,21
36 Pontevedra;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
36 Pontevedra;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
36 Pontevedra;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
36 Pontevedra;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;94,78
36 Pontevedra;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
36 Pontevedra;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
36 Pontevedra;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
36 Pontevedra;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;94,08
36 Pontevedra;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
36 Pontevedra;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
36 Pontevedra;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
36 Pontevedra;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
36 Pontevedra;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
36 Pontevedra;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
36 Pontevedra;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;92,26
36 Pontevedra;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
36 Pontevedra;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
36 Pontevedra;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
36 Pontevedra;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;92,28
36 Pontevedra;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
36 Pontevedra;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
36 Pontevedra;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
36 Pontevedra;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
36 Pontevedra;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
36 Pontevedra;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
36 Pontevedra;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;90,22
36 Pontevedra;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
36 Pontevedra;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
36 Pontevedra;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
36 Pontevedra;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;90,59
36 Pontevedra;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
36 Pontevedra;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
36 Pontevedra;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
36 Pontevedra;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
36 Pontevedra;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
36 Pontevedra;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
36 Pontevedra;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QIII;25.232
36 Pontevedra;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
36 Pontevedra;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
36 Pontevedra;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
36 Pontevedra;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QIII;25.047
36 Pontevedra;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
36 Pontevedra;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
36 Pontevedra;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
36 Pontevedra;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QIII;24.599
36 Pontevedra;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
36 Pontevedra;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
36 Pontevedra;All ages;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
36 Pontevedra;All ages;Cohort July 1;Females;Survival in the first trimester;2022QIII;24.339
36 Pontevedra;All ages;Cohort July 1;Females;Survival in the first trimester;2022QII;""
36 Pontevedra;All ages;Cohort July 1;Females;Survival in the first trimester;2022QI;""
36 Pontevedra;All ages;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
36 Pontevedra;All ages;Cohort July 1;Females;Survival in the first trimester;2021QIII;24.315
36 Pontevedra;All ages;Cohort July 1;Females;Survival in the first trimester;2021QII;""
36 Pontevedra;All ages;Cohort July 1;Females;Survival in the first trimester;2021QI;""
36 Pontevedra;All ages;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
36 Pontevedra;All ages;Cohort July 1;Females;Survival in the first trimester;2020QIII;23.638
36 Pontevedra;All ages;Cohort July 1;Females;Survival in the first trimester;2020QII;""
36 Pontevedra;All ages;Cohort July 1;Females;Survival in the first trimester;2020QI;""
36 Pontevedra;All ages;Cohort July 1;Females;Survival in the second trimester;2022QIV;23.440
36 Pontevedra;All ages;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
36 Pontevedra;All ages;Cohort July 1;Females;Survival in the second trimester;2022QII;""
36 Pontevedra;All ages;Cohort July 1;Females;Survival in the second trimester;2022QI;""
36 Pontevedra;All ages;Cohort July 1;Females;Survival in the second trimester;2021QIV;23.517
36 Pontevedra;All ages;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
36 Pontevedra;All ages;Cohort July 1;Females;Survival in the second trimester;2021QII;""
36 Pontevedra;All ages;Cohort July 1;Females;Survival in the second trimester;2021QI;""
36 Pontevedra;All ages;Cohort July 1;Females;Survival in the second trimester;2020QIV;22.919
36 Pontevedra;All ages;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
36 Pontevedra;All ages;Cohort July 1;Females;Survival in the second trimester;2020QII;""
36 Pontevedra;All ages;Cohort July 1;Females;Survival in the second trimester;2020QI;""
36 Pontevedra;All ages;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
36 Pontevedra;All ages;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
36 Pontevedra;All ages;Cohort July 1;Females;Survival in the third trimester;2022QII;""
36 Pontevedra;All ages;Cohort July 1;Females;Survival in the third trimester;2022QI;22.868
36 Pontevedra;All ages;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
36 Pontevedra;All ages;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
36 Pontevedra;All ages;Cohort July 1;Females;Survival in the third trimester;2021QII;""
36 Pontevedra;All ages;Cohort July 1;Females;Survival in the third trimester;2021QI;22.489
36 Pontevedra;All ages;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
36 Pontevedra;All ages;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
36 Pontevedra;All ages;Cohort July 1;Females;Survival in the third trimester;2020QII;""
36 Pontevedra;All ages;Cohort July 1;Females;Survival in the third trimester;2020QI;""
36 Pontevedra;All ages;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
36 Pontevedra;All ages;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
36 Pontevedra;All ages;Cohort July 1;Females;Survival in the third trimester;2022QII;22.222
36 Pontevedra;All ages;Cohort July 1;Females;Survival in the third trimester;2022QI;""
36 Pontevedra;All ages;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
36 Pontevedra;All ages;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
36 Pontevedra;All ages;Cohort July 1;Females;Survival in the third trimester;2021QII;22.003
36 Pontevedra;All ages;Cohort July 1;Females;Survival in the third trimester;2021QI;""
36 Pontevedra;All ages;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
36 Pontevedra;All ages;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
36 Pontevedra;All ages;Cohort July 1;Females;Survival in the third trimester;2020QII;""
36 Pontevedra;All ages;Cohort July 1;Females;Survival in the third trimester;2020QI;""
36 Pontevedra;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
36 Pontevedra;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
36 Pontevedra;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
36 Pontevedra;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
36 Pontevedra;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
36 Pontevedra;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
36 Pontevedra;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
36 Pontevedra;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
36 Pontevedra;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
36 Pontevedra;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
36 Pontevedra;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
36 Pontevedra;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
36 Pontevedra;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
36 Pontevedra;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;96,46
36 Pontevedra;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
36 Pontevedra;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
36 Pontevedra;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
36 Pontevedra;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;97,08
36 Pontevedra;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
36 Pontevedra;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
36 Pontevedra;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
36 Pontevedra;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;96,09
36 Pontevedra;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
36 Pontevedra;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
36 Pontevedra;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;92,9
36 Pontevedra;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
36 Pontevedra;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
36 Pontevedra;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
36 Pontevedra;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;93,89
36 Pontevedra;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
36 Pontevedra;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
36 Pontevedra;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
36 Pontevedra;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;93,17
36 Pontevedra;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
36 Pontevedra;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
36 Pontevedra;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
36 Pontevedra;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
36 Pontevedra;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
36 Pontevedra;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
36 Pontevedra;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;91,3
36 Pontevedra;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
36 Pontevedra;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
36 Pontevedra;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
36 Pontevedra;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;91,42
36 Pontevedra;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
36 Pontevedra;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
36 Pontevedra;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
36 Pontevedra;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
36 Pontevedra;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
36 Pontevedra;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
36 Pontevedra;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;88,72
36 Pontevedra;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
36 Pontevedra;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
36 Pontevedra;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
36 Pontevedra;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;89,45
36 Pontevedra;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
36 Pontevedra;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
36 Pontevedra;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
36 Pontevedra;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
36 Pontevedra;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
36 Pontevedra;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QIV;62.274
36 Pontevedra;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
36 Pontevedra;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
36 Pontevedra;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
36 Pontevedra;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QIV;62.519
36 Pontevedra;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
36 Pontevedra;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
36 Pontevedra;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
36 Pontevedra;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QIV;61.280
36 Pontevedra;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
36 Pontevedra;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
36 Pontevedra;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
36 Pontevedra;All ages;Cohort October 1;Total;Survival in the first trimester;2022QIV;60.063
36 Pontevedra;All ages;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
36 Pontevedra;All ages;Cohort October 1;Total;Survival in the first trimester;2022QII;""
36 Pontevedra;All ages;Cohort October 1;Total;Survival in the first trimester;2022QI;""
36 Pontevedra;All ages;Cohort October 1;Total;Survival in the first trimester;2021QIV;60.557
36 Pontevedra;All ages;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
36 Pontevedra;All ages;Cohort October 1;Total;Survival in the first trimester;2021QII;""
36 Pontevedra;All ages;Cohort October 1;Total;Survival in the first trimester;2021QI;""
36 Pontevedra;All ages;Cohort October 1;Total;Survival in the first trimester;2020QIV;59.373
36 Pontevedra;All ages;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
36 Pontevedra;All ages;Cohort October 1;Total;Survival in the first trimester;2020QII;""
36 Pontevedra;All ages;Cohort October 1;Total;Survival in the first trimester;2020QI;""
36 Pontevedra;All ages;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
36 Pontevedra;All ages;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
36 Pontevedra;All ages;Cohort October 1;Total;Survival in the second trimester;2022QII;""
36 Pontevedra;All ages;Cohort October 1;Total;Survival in the second trimester;2022QI;58.852
36 Pontevedra;All ages;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
36 Pontevedra;All ages;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
36 Pontevedra;All ages;Cohort October 1;Total;Survival in the second trimester;2021QII;""
36 Pontevedra;All ages;Cohort October 1;Total;Survival in the second trimester;2021QI;58.170
36 Pontevedra;All ages;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
36 Pontevedra;All ages;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
36 Pontevedra;All ages;Cohort October 1;Total;Survival in the second trimester;2020QII;""
36 Pontevedra;All ages;Cohort October 1;Total;Survival in the second trimester;2020QI;""
36 Pontevedra;All ages;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
36 Pontevedra;All ages;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
36 Pontevedra;All ages;Cohort October 1;Total;Survival in the third trimester;2022QII;57.334
36 Pontevedra;All ages;Cohort October 1;Total;Survival in the third trimester;2022QI;""
36 Pontevedra;All ages;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
36 Pontevedra;All ages;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
36 Pontevedra;All ages;Cohort October 1;Total;Survival in the third trimester;2021QII;56.952
36 Pontevedra;All ages;Cohort October 1;Total;Survival in the third trimester;2021QI;""
36 Pontevedra;All ages;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
36 Pontevedra;All ages;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
36 Pontevedra;All ages;Cohort October 1;Total;Survival in the third trimester;2020QII;""
36 Pontevedra;All ages;Cohort October 1;Total;Survival in the third trimester;2020QI;""
36 Pontevedra;All ages;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
36 Pontevedra;All ages;Cohort October 1;Total;Survival in the third trimester;2022QIII;55.986
36 Pontevedra;All ages;Cohort October 1;Total;Survival in the third trimester;2022QII;""
36 Pontevedra;All ages;Cohort October 1;Total;Survival in the third trimester;2022QI;""
36 Pontevedra;All ages;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
36 Pontevedra;All ages;Cohort October 1;Total;Survival in the third trimester;2021QIII;55.838
36 Pontevedra;All ages;Cohort October 1;Total;Survival in the third trimester;2021QII;""
36 Pontevedra;All ages;Cohort October 1;Total;Survival in the third trimester;2021QI;""
36 Pontevedra;All ages;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
36 Pontevedra;All ages;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
36 Pontevedra;All ages;Cohort October 1;Total;Survival in the third trimester;2020QII;""
36 Pontevedra;All ages;Cohort October 1;Total;Survival in the third trimester;2020QI;""
36 Pontevedra;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
36 Pontevedra;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
36 Pontevedra;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
36 Pontevedra;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
36 Pontevedra;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
36 Pontevedra;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
36 Pontevedra;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
36 Pontevedra;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
36 Pontevedra;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
36 Pontevedra;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
36 Pontevedra;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
36 Pontevedra;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
36 Pontevedra;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;96,45
36 Pontevedra;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
36 Pontevedra;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
36 Pontevedra;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
36 Pontevedra;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;96,86
36 Pontevedra;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
36 Pontevedra;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
36 Pontevedra;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
36 Pontevedra;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;96,89
36 Pontevedra;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
36 Pontevedra;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
36 Pontevedra;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
36 Pontevedra;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
36 Pontevedra;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
36 Pontevedra;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
36 Pontevedra;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;94,13
36 Pontevedra;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
36 Pontevedra;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
36 Pontevedra;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
36 Pontevedra;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;94,92
36 Pontevedra;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
36 Pontevedra;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
36 Pontevedra;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
36 Pontevedra;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
36 Pontevedra;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
36 Pontevedra;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
36 Pontevedra;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;91,71
36 Pontevedra;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
36 Pontevedra;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
36 Pontevedra;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
36 Pontevedra;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;92,94
36 Pontevedra;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
36 Pontevedra;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
36 Pontevedra;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
36 Pontevedra;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
36 Pontevedra;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
36 Pontevedra;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
36 Pontevedra;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;89,55
36 Pontevedra;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
36 Pontevedra;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
36 Pontevedra;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
36 Pontevedra;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;91,12
36 Pontevedra;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
36 Pontevedra;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
36 Pontevedra;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
36 Pontevedra;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
36 Pontevedra;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
36 Pontevedra;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
36 Pontevedra;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QIV;37.273
36 Pontevedra;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
36 Pontevedra;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
36 Pontevedra;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
36 Pontevedra;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QIV;37.470
36 Pontevedra;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
36 Pontevedra;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
36 Pontevedra;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
36 Pontevedra;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QIV;36.868
36 Pontevedra;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
36 Pontevedra;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
36 Pontevedra;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
36 Pontevedra;All ages;Cohort October 1;Males;Survival in the first trimester;2022QIV;36.033
36 Pontevedra;All ages;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
36 Pontevedra;All ages;Cohort October 1;Males;Survival in the first trimester;2022QII;""
36 Pontevedra;All ages;Cohort October 1;Males;Survival in the first trimester;2022QI;""
36 Pontevedra;All ages;Cohort October 1;Males;Survival in the first trimester;2021QIV;36.392
36 Pontevedra;All ages;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
36 Pontevedra;All ages;Cohort October 1;Males;Survival in the first trimester;2021QII;""
36 Pontevedra;All ages;Cohort October 1;Males;Survival in the first trimester;2021QI;""
36 Pontevedra;All ages;Cohort October 1;Males;Survival in the first trimester;2020QIV;35.787
36 Pontevedra;All ages;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
36 Pontevedra;All ages;Cohort October 1;Males;Survival in the first trimester;2020QII;""
36 Pontevedra;All ages;Cohort October 1;Males;Survival in the first trimester;2020QI;""
36 Pontevedra;All ages;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
36 Pontevedra;All ages;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
36 Pontevedra;All ages;Cohort October 1;Males;Survival in the second trimester;2022QII;""
36 Pontevedra;All ages;Cohort October 1;Males;Survival in the second trimester;2022QI;35.372
36 Pontevedra;All ages;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
36 Pontevedra;All ages;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
36 Pontevedra;All ages;Cohort October 1;Males;Survival in the second trimester;2021QII;""
36 Pontevedra;All ages;Cohort October 1;Males;Survival in the second trimester;2021QI;35.051
36 Pontevedra;All ages;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
36 Pontevedra;All ages;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
36 Pontevedra;All ages;Cohort October 1;Males;Survival in the second trimester;2020QII;""
36 Pontevedra;All ages;Cohort October 1;Males;Survival in the second trimester;2020QI;""
36 Pontevedra;All ages;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
36 Pontevedra;All ages;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
36 Pontevedra;All ages;Cohort October 1;Males;Survival in the third trimester;2022QII;34.554
36 Pontevedra;All ages;Cohort October 1;Males;Survival in the third trimester;2022QI;""
36 Pontevedra;All ages;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
36 Pontevedra;All ages;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
36 Pontevedra;All ages;Cohort October 1;Males;Survival in the third trimester;2021QII;34.363
36 Pontevedra;All ages;Cohort October 1;Males;Survival in the third trimester;2021QI;""
36 Pontevedra;All ages;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
36 Pontevedra;All ages;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
36 Pontevedra;All ages;Cohort October 1;Males;Survival in the third trimester;2020QII;""
36 Pontevedra;All ages;Cohort October 1;Males;Survival in the third trimester;2020QI;""
36 Pontevedra;All ages;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
36 Pontevedra;All ages;Cohort October 1;Males;Survival in the third trimester;2022QIII;33.845
36 Pontevedra;All ages;Cohort October 1;Males;Survival in the third trimester;2022QII;""
36 Pontevedra;All ages;Cohort October 1;Males;Survival in the third trimester;2022QI;""
36 Pontevedra;All ages;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
36 Pontevedra;All ages;Cohort October 1;Males;Survival in the third trimester;2021QIII;33.721
36 Pontevedra;All ages;Cohort October 1;Males;Survival in the third trimester;2021QII;""
36 Pontevedra;All ages;Cohort October 1;Males;Survival in the third trimester;2021QI;""
36 Pontevedra;All ages;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
36 Pontevedra;All ages;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
36 Pontevedra;All ages;Cohort October 1;Males;Survival in the third trimester;2020QII;""
36 Pontevedra;All ages;Cohort October 1;Males;Survival in the third trimester;2020QI;""
36 Pontevedra;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
36 Pontevedra;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
36 Pontevedra;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
36 Pontevedra;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
36 Pontevedra;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
36 Pontevedra;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
36 Pontevedra;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
36 Pontevedra;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
36 Pontevedra;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
36 Pontevedra;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
36 Pontevedra;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
36 Pontevedra;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
36 Pontevedra;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;96,67
36 Pontevedra;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
36 Pontevedra;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
36 Pontevedra;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
36 Pontevedra;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;97,12
36 Pontevedra;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
36 Pontevedra;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
36 Pontevedra;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
36 Pontevedra;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;97,07
36 Pontevedra;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
36 Pontevedra;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
36 Pontevedra;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
36 Pontevedra;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
36 Pontevedra;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
36 Pontevedra;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
36 Pontevedra;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;94,4
36 Pontevedra;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
36 Pontevedra;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
36 Pontevedra;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
36 Pontevedra;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;95,07
36 Pontevedra;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
36 Pontevedra;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
36 Pontevedra;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
36 Pontevedra;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
36 Pontevedra;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
36 Pontevedra;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
36 Pontevedra;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;92,22
36 Pontevedra;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
36 Pontevedra;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
36 Pontevedra;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
36 Pontevedra;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;93,21
36 Pontevedra;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
36 Pontevedra;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
36 Pontevedra;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
36 Pontevedra;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
36 Pontevedra;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
36 Pontevedra;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
36 Pontevedra;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;90,33
36 Pontevedra;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
36 Pontevedra;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
36 Pontevedra;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
36 Pontevedra;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;91,46
36 Pontevedra;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
36 Pontevedra;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
36 Pontevedra;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
36 Pontevedra;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
36 Pontevedra;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
36 Pontevedra;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
36 Pontevedra;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QIV;25.001
36 Pontevedra;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
36 Pontevedra;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
36 Pontevedra;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
36 Pontevedra;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QIV;25.049
36 Pontevedra;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
36 Pontevedra;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
36 Pontevedra;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
36 Pontevedra;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QIV;24.412
36 Pontevedra;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
36 Pontevedra;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
36 Pontevedra;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
36 Pontevedra;All ages;Cohort October 1;Females;Survival in the first trimester;2022QIV;24.030
36 Pontevedra;All ages;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
36 Pontevedra;All ages;Cohort October 1;Females;Survival in the first trimester;2022QII;""
36 Pontevedra;All ages;Cohort October 1;Females;Survival in the first trimester;2022QI;""
36 Pontevedra;All ages;Cohort October 1;Females;Survival in the first trimester;2021QIV;24.165
36 Pontevedra;All ages;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
36 Pontevedra;All ages;Cohort October 1;Females;Survival in the first trimester;2021QII;""
36 Pontevedra;All ages;Cohort October 1;Females;Survival in the first trimester;2021QI;""
36 Pontevedra;All ages;Cohort October 1;Females;Survival in the first trimester;2020QIV;23.586
36 Pontevedra;All ages;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
36 Pontevedra;All ages;Cohort October 1;Females;Survival in the first trimester;2020QII;""
36 Pontevedra;All ages;Cohort October 1;Females;Survival in the first trimester;2020QI;""
36 Pontevedra;All ages;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
36 Pontevedra;All ages;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
36 Pontevedra;All ages;Cohort October 1;Females;Survival in the second trimester;2022QII;""
36 Pontevedra;All ages;Cohort October 1;Females;Survival in the second trimester;2022QI;23.480
36 Pontevedra;All ages;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
36 Pontevedra;All ages;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
36 Pontevedra;All ages;Cohort October 1;Females;Survival in the second trimester;2021QII;""
36 Pontevedra;All ages;Cohort October 1;Females;Survival in the second trimester;2021QI;23.119
36 Pontevedra;All ages;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
36 Pontevedra;All ages;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
36 Pontevedra;All ages;Cohort October 1;Females;Survival in the second trimester;2020QII;""
36 Pontevedra;All ages;Cohort October 1;Females;Survival in the second trimester;2020QI;""
36 Pontevedra;All ages;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
36 Pontevedra;All ages;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
36 Pontevedra;All ages;Cohort October 1;Females;Survival in the third trimester;2022QII;22.780
36 Pontevedra;All ages;Cohort October 1;Females;Survival in the third trimester;2022QI;""
36 Pontevedra;All ages;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
36 Pontevedra;All ages;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
36 Pontevedra;All ages;Cohort October 1;Females;Survival in the third trimester;2021QII;22.589
36 Pontevedra;All ages;Cohort October 1;Females;Survival in the third trimester;2021QI;""
36 Pontevedra;All ages;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
36 Pontevedra;All ages;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
36 Pontevedra;All ages;Cohort October 1;Females;Survival in the third trimester;2020QII;""
36 Pontevedra;All ages;Cohort October 1;Females;Survival in the third trimester;2020QI;""
36 Pontevedra;All ages;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
36 Pontevedra;All ages;Cohort October 1;Females;Survival in the third trimester;2022QIII;22.141
36 Pontevedra;All ages;Cohort October 1;Females;Survival in the third trimester;2022QII;""
36 Pontevedra;All ages;Cohort October 1;Females;Survival in the third trimester;2022QI;""
36 Pontevedra;All ages;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
36 Pontevedra;All ages;Cohort October 1;Females;Survival in the third trimester;2021QIII;22.117
36 Pontevedra;All ages;Cohort October 1;Females;Survival in the third trimester;2021QII;""
36 Pontevedra;All ages;Cohort October 1;Females;Survival in the third trimester;2021QI;""
36 Pontevedra;All ages;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
36 Pontevedra;All ages;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
36 Pontevedra;All ages;Cohort October 1;Females;Survival in the third trimester;2020QII;""
36 Pontevedra;All ages;Cohort October 1;Females;Survival in the third trimester;2020QI;""
36 Pontevedra;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
36 Pontevedra;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
36 Pontevedra;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
36 Pontevedra;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
36 Pontevedra;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
36 Pontevedra;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
36 Pontevedra;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
36 Pontevedra;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
36 Pontevedra;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
36 Pontevedra;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
36 Pontevedra;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
36 Pontevedra;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
36 Pontevedra;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;96,12
36 Pontevedra;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
36 Pontevedra;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
36 Pontevedra;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
36 Pontevedra;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;96,47
36 Pontevedra;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
36 Pontevedra;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
36 Pontevedra;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
36 Pontevedra;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;96,62
36 Pontevedra;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
36 Pontevedra;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
36 Pontevedra;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
36 Pontevedra;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
36 Pontevedra;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
36 Pontevedra;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
36 Pontevedra;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;93,74
36 Pontevedra;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
36 Pontevedra;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
36 Pontevedra;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
36 Pontevedra;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;94,7
36 Pontevedra;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
36 Pontevedra;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
36 Pontevedra;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
36 Pontevedra;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
36 Pontevedra;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
36 Pontevedra;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
36 Pontevedra;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;90,94
36 Pontevedra;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
36 Pontevedra;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
36 Pontevedra;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
36 Pontevedra;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;92,53
36 Pontevedra;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
36 Pontevedra;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
36 Pontevedra;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
36 Pontevedra;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
36 Pontevedra;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
36 Pontevedra;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
36 Pontevedra;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;88,39
36 Pontevedra;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
36 Pontevedra;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
36 Pontevedra;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
36 Pontevedra;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;90,6
36 Pontevedra;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
36 Pontevedra;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
36 Pontevedra;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
36 Pontevedra;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
36 Pontevedra;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
36 Pontevedra;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
36 Pontevedra;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
36 Pontevedra;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
36 Pontevedra;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
36 Pontevedra;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QI;3.197
36 Pontevedra;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
36 Pontevedra;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
36 Pontevedra;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
36 Pontevedra;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QI;3.121
36 Pontevedra;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
36 Pontevedra;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
36 Pontevedra;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
36 Pontevedra;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QI;2.579
36 Pontevedra;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
36 Pontevedra;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
36 Pontevedra;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2022QII;""
36 Pontevedra;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2022QI;2.986
36 Pontevedra;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
36 Pontevedra;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
36 Pontevedra;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2021QII;""
36 Pontevedra;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2021QI;2.953
36 Pontevedra;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
36 Pontevedra;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
36 Pontevedra;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2020QII;""
36 Pontevedra;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2020QI;2.300
36 Pontevedra;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
36 Pontevedra;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
36 Pontevedra;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2022QII;2.804
36 Pontevedra;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2022QI;""
36 Pontevedra;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
36 Pontevedra;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
36 Pontevedra;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2021QII;2.798
36 Pontevedra;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2021QI;""
36 Pontevedra;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
36 Pontevedra;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
36 Pontevedra;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2020QII;2.222
36 Pontevedra;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2020QI;""
36 Pontevedra;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
36 Pontevedra;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QIII;2.609
36 Pontevedra;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QII;""
36 Pontevedra;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QI;""
36 Pontevedra;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
36 Pontevedra;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QIII;2.642
36 Pontevedra;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QII;""
36 Pontevedra;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QI;""
36 Pontevedra;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
36 Pontevedra;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QIII;2.083
36 Pontevedra;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QII;""
36 Pontevedra;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QI;""
36 Pontevedra;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QIV;2.444
36 Pontevedra;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
36 Pontevedra;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QII;""
36 Pontevedra;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QI;""
36 Pontevedra;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QIV;2.497
36 Pontevedra;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
36 Pontevedra;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QII;""
36 Pontevedra;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QI;""
36 Pontevedra;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QIV;1.971
36 Pontevedra;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
36 Pontevedra;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QII;""
36 Pontevedra;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QI;""
36 Pontevedra;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
36 Pontevedra;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
36 Pontevedra;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
36 Pontevedra;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
36 Pontevedra;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
36 Pontevedra;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
36 Pontevedra;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
36 Pontevedra;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
36 Pontevedra;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
36 Pontevedra;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
36 Pontevedra;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
36 Pontevedra;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
36 Pontevedra;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
36 Pontevedra;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
36 Pontevedra;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
36 Pontevedra;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;93,4
36 Pontevedra;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
36 Pontevedra;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
36 Pontevedra;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
36 Pontevedra;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;94,62
36 Pontevedra;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
36 Pontevedra;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
36 Pontevedra;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
36 Pontevedra;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;89,18
36 Pontevedra;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
36 Pontevedra;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
36 Pontevedra;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;87,71
36 Pontevedra;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
36 Pontevedra;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
36 Pontevedra;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
36 Pontevedra;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;89,65
36 Pontevedra;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
36 Pontevedra;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
36 Pontevedra;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
36 Pontevedra;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;86,16
36 Pontevedra;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
36 Pontevedra;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
36 Pontevedra;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;81,61
36 Pontevedra;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
36 Pontevedra;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
36 Pontevedra;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
36 Pontevedra;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;84,65
36 Pontevedra;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
36 Pontevedra;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
36 Pontevedra;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
36 Pontevedra;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;80,77
36 Pontevedra;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
36 Pontevedra;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
36 Pontevedra;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;76,45
36 Pontevedra;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
36 Pontevedra;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
36 Pontevedra;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
36 Pontevedra;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;80,01
36 Pontevedra;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
36 Pontevedra;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
36 Pontevedra;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
36 Pontevedra;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;76,42
36 Pontevedra;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
36 Pontevedra;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
36 Pontevedra;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
36 Pontevedra;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
36 Pontevedra;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
36 Pontevedra;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
36 Pontevedra;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QI;1.931
36 Pontevedra;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
36 Pontevedra;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
36 Pontevedra;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
36 Pontevedra;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QI;1.914
36 Pontevedra;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
36 Pontevedra;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
36 Pontevedra;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
36 Pontevedra;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QI;1.577
36 Pontevedra;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
36 Pontevedra;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
36 Pontevedra;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2022QII;""
36 Pontevedra;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2022QI;1.799
36 Pontevedra;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
36 Pontevedra;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
36 Pontevedra;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2021QII;""
36 Pontevedra;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2021QI;1.819
36 Pontevedra;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
36 Pontevedra;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
36 Pontevedra;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2020QII;""
36 Pontevedra;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2020QI;1.413
36 Pontevedra;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
36 Pontevedra;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
36 Pontevedra;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2022QII;1.695
36 Pontevedra;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2022QI;""
36 Pontevedra;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
36 Pontevedra;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
36 Pontevedra;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2021QII;1.722
36 Pontevedra;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2021QI;""
36 Pontevedra;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
36 Pontevedra;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
36 Pontevedra;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2020QII;1.373
36 Pontevedra;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2020QI;""
36 Pontevedra;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
36 Pontevedra;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QIII;1.578
36 Pontevedra;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QII;""
36 Pontevedra;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QI;""
36 Pontevedra;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
36 Pontevedra;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QIII;1.621
36 Pontevedra;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QII;""
36 Pontevedra;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QI;""
36 Pontevedra;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
36 Pontevedra;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QIII;1.289
36 Pontevedra;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QII;""
36 Pontevedra;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QI;""
36 Pontevedra;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QIV;1.480
36 Pontevedra;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
36 Pontevedra;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QII;""
36 Pontevedra;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QI;""
36 Pontevedra;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QIV;1.535
36 Pontevedra;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
36 Pontevedra;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QII;""
36 Pontevedra;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QI;""
36 Pontevedra;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QIV;1.231
36 Pontevedra;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
36 Pontevedra;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QII;""
36 Pontevedra;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QI;""
36 Pontevedra;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
36 Pontevedra;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
36 Pontevedra;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
36 Pontevedra;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
36 Pontevedra;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
36 Pontevedra;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
36 Pontevedra;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
36 Pontevedra;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
36 Pontevedra;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
36 Pontevedra;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
36 Pontevedra;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
36 Pontevedra;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
36 Pontevedra;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
36 Pontevedra;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
36 Pontevedra;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
36 Pontevedra;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;93,16
36 Pontevedra;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
36 Pontevedra;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
36 Pontevedra;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
36 Pontevedra;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;95,04
36 Pontevedra;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
36 Pontevedra;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
36 Pontevedra;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
36 Pontevedra;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;89,6
36 Pontevedra;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
36 Pontevedra;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
36 Pontevedra;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;87,78
36 Pontevedra;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
36 Pontevedra;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
36 Pontevedra;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
36 Pontevedra;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;89,97
36 Pontevedra;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
36 Pontevedra;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
36 Pontevedra;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
36 Pontevedra;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;87,06
36 Pontevedra;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
36 Pontevedra;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
36 Pontevedra;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;81,72
36 Pontevedra;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
36 Pontevedra;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
36 Pontevedra;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
36 Pontevedra;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;84,69
36 Pontevedra;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
36 Pontevedra;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
36 Pontevedra;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
36 Pontevedra;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;81,74
36 Pontevedra;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
36 Pontevedra;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
36 Pontevedra;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;76,64
36 Pontevedra;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
36 Pontevedra;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
36 Pontevedra;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
36 Pontevedra;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;80,2
36 Pontevedra;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
36 Pontevedra;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
36 Pontevedra;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
36 Pontevedra;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;78,06
36 Pontevedra;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
36 Pontevedra;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
36 Pontevedra;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
36 Pontevedra;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
36 Pontevedra;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
36 Pontevedra;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
36 Pontevedra;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QI;1.266
36 Pontevedra;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
36 Pontevedra;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
36 Pontevedra;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
36 Pontevedra;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QI;1.207
36 Pontevedra;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
36 Pontevedra;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
36 Pontevedra;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
36 Pontevedra;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QI;1.002
36 Pontevedra;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
36 Pontevedra;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
36 Pontevedra;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2022QII;""
36 Pontevedra;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2022QI;1.187
36 Pontevedra;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
36 Pontevedra;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
36 Pontevedra;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2021QII;""
36 Pontevedra;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2021QI;1.134
36 Pontevedra;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
36 Pontevedra;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
36 Pontevedra;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2020QII;""
36 Pontevedra;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2020QI;887
36 Pontevedra;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
36 Pontevedra;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
36 Pontevedra;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2022QII;1.109
36 Pontevedra;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2022QI;""
36 Pontevedra;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
36 Pontevedra;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
36 Pontevedra;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2021QII;1.076
36 Pontevedra;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2021QI;""
36 Pontevedra;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
36 Pontevedra;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
36 Pontevedra;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2020QII;849
36 Pontevedra;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2020QI;""
36 Pontevedra;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
36 Pontevedra;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QIII;1.031
36 Pontevedra;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QII;""
36 Pontevedra;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QI;""
36 Pontevedra;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
36 Pontevedra;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QIII;1.021
36 Pontevedra;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QII;""
36 Pontevedra;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QI;""
36 Pontevedra;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
36 Pontevedra;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QIII;794
36 Pontevedra;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QII;""
36 Pontevedra;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QI;""
36 Pontevedra;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QIV;964
36 Pontevedra;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
36 Pontevedra;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QII;""
36 Pontevedra;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QI;""
36 Pontevedra;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QIV;962
36 Pontevedra;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
36 Pontevedra;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QII;""
36 Pontevedra;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QI;""
36 Pontevedra;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QIV;740
36 Pontevedra;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
36 Pontevedra;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QII;""
36 Pontevedra;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QI;""
36 Pontevedra;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
36 Pontevedra;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
36 Pontevedra;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
36 Pontevedra;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
36 Pontevedra;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
36 Pontevedra;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
36 Pontevedra;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
36 Pontevedra;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
36 Pontevedra;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
36 Pontevedra;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
36 Pontevedra;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
36 Pontevedra;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
36 Pontevedra;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
36 Pontevedra;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
36 Pontevedra;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
36 Pontevedra;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;93,76
36 Pontevedra;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
36 Pontevedra;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
36 Pontevedra;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
36 Pontevedra;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;93,95
36 Pontevedra;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
36 Pontevedra;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
36 Pontevedra;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
36 Pontevedra;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;88,52
36 Pontevedra;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
36 Pontevedra;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
36 Pontevedra;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;87,6
36 Pontevedra;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
36 Pontevedra;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
36 Pontevedra;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
36 Pontevedra;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;89,15
36 Pontevedra;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
36 Pontevedra;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
36 Pontevedra;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
36 Pontevedra;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;84,73
36 Pontevedra;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
36 Pontevedra;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
36 Pontevedra;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;81,44
36 Pontevedra;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
36 Pontevedra;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
36 Pontevedra;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
36 Pontevedra;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;84,59
36 Pontevedra;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
36 Pontevedra;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
36 Pontevedra;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
36 Pontevedra;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;79,24
36 Pontevedra;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
36 Pontevedra;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
36 Pontevedra;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;76,15
36 Pontevedra;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
36 Pontevedra;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
36 Pontevedra;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
36 Pontevedra;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;79,7
36 Pontevedra;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
36 Pontevedra;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
36 Pontevedra;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
36 Pontevedra;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;73,85
36 Pontevedra;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
36 Pontevedra;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
36 Pontevedra;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
36 Pontevedra;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
36 Pontevedra;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
36 Pontevedra;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QII;2.817
36 Pontevedra;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
36 Pontevedra;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
36 Pontevedra;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
36 Pontevedra;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QII;2.772
36 Pontevedra;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
36 Pontevedra;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
36 Pontevedra;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
36 Pontevedra;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QII;2.650
36 Pontevedra;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
36 Pontevedra;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
36 Pontevedra;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
36 Pontevedra;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2022QII;2.631
36 Pontevedra;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2022QI;""
36 Pontevedra;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
36 Pontevedra;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
36 Pontevedra;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2021QII;2.587
36 Pontevedra;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2021QI;""
36 Pontevedra;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
36 Pontevedra;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
36 Pontevedra;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2020QII;2.553
36 Pontevedra;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2020QI;""
36 Pontevedra;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
36 Pontevedra;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2022QIII;2.444
36 Pontevedra;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2022QII;""
36 Pontevedra;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2022QI;""
36 Pontevedra;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
36 Pontevedra;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2021QIII;2.413
36 Pontevedra;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2021QII;""
36 Pontevedra;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2021QI;""
36 Pontevedra;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
36 Pontevedra;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2020QIII;2.377
36 Pontevedra;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2020QII;""
36 Pontevedra;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2020QI;""
36 Pontevedra;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QIV;2.285
36 Pontevedra;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
36 Pontevedra;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QII;""
36 Pontevedra;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QI;""
36 Pontevedra;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QIV;2.262
36 Pontevedra;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
36 Pontevedra;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QII;""
36 Pontevedra;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QI;""
36 Pontevedra;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QIV;2.241
36 Pontevedra;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
36 Pontevedra;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QII;""
36 Pontevedra;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QI;""
36 Pontevedra;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
36 Pontevedra;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
36 Pontevedra;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QII;""
36 Pontevedra;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QI;2.127
36 Pontevedra;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
36 Pontevedra;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
36 Pontevedra;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QII;""
36 Pontevedra;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QI;2.158
36 Pontevedra;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
36 Pontevedra;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
36 Pontevedra;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QII;""
36 Pontevedra;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QI;""
36 Pontevedra;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
36 Pontevedra;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
36 Pontevedra;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
36 Pontevedra;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
36 Pontevedra;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
36 Pontevedra;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
36 Pontevedra;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
36 Pontevedra;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
36 Pontevedra;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
36 Pontevedra;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
36 Pontevedra;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
36 Pontevedra;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
36 Pontevedra;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
36 Pontevedra;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
36 Pontevedra;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;93,4
36 Pontevedra;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
36 Pontevedra;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
36 Pontevedra;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
36 Pontevedra;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;93,33
36 Pontevedra;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
36 Pontevedra;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
36 Pontevedra;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
36 Pontevedra;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;96,34
36 Pontevedra;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
36 Pontevedra;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
36 Pontevedra;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;86,76
36 Pontevedra;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
36 Pontevedra;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
36 Pontevedra;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
36 Pontevedra;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;87,05
36 Pontevedra;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
36 Pontevedra;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
36 Pontevedra;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
36 Pontevedra;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;89,7
36 Pontevedra;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
36 Pontevedra;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
36 Pontevedra;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;81,11
36 Pontevedra;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
36 Pontevedra;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
36 Pontevedra;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
36 Pontevedra;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;81,6
36 Pontevedra;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
36 Pontevedra;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
36 Pontevedra;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
36 Pontevedra;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;84,57
36 Pontevedra;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
36 Pontevedra;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
36 Pontevedra;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
36 Pontevedra;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
36 Pontevedra;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
36 Pontevedra;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
36 Pontevedra;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;76,73
36 Pontevedra;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
36 Pontevedra;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
36 Pontevedra;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
36 Pontevedra;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;81,43
36 Pontevedra;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
36 Pontevedra;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
36 Pontevedra;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
36 Pontevedra;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
36 Pontevedra;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
36 Pontevedra;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
36 Pontevedra;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QII;1.710
36 Pontevedra;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
36 Pontevedra;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
36 Pontevedra;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
36 Pontevedra;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QII;1.702
36 Pontevedra;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
36 Pontevedra;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
36 Pontevedra;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
36 Pontevedra;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QII;1.622
36 Pontevedra;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
36 Pontevedra;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
36 Pontevedra;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
36 Pontevedra;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2022QII;1.599
36 Pontevedra;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2022QI;""
36 Pontevedra;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
36 Pontevedra;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
36 Pontevedra;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2021QII;1.589
36 Pontevedra;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2021QI;""
36 Pontevedra;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
36 Pontevedra;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
36 Pontevedra;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2020QII;1.571
36 Pontevedra;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2020QI;""
36 Pontevedra;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
36 Pontevedra;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2022QIII;1.486
36 Pontevedra;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2022QII;""
36 Pontevedra;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2022QI;""
36 Pontevedra;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
36 Pontevedra;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2021QIII;1.477
36 Pontevedra;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2021QII;""
36 Pontevedra;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2021QI;""
36 Pontevedra;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
36 Pontevedra;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2020QIII;1.464
36 Pontevedra;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2020QII;""
36 Pontevedra;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2020QI;""
36 Pontevedra;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QIV;1.395
36 Pontevedra;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
36 Pontevedra;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QII;""
36 Pontevedra;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QI;""
36 Pontevedra;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QIV;1.391
36 Pontevedra;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
36 Pontevedra;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QII;""
36 Pontevedra;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QI;""
36 Pontevedra;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QIV;1.390
36 Pontevedra;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
36 Pontevedra;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QII;""
36 Pontevedra;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QI;""
36 Pontevedra;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
36 Pontevedra;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
36 Pontevedra;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QII;""
36 Pontevedra;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QI;1.311
36 Pontevedra;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
36 Pontevedra;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
36 Pontevedra;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QII;""
36 Pontevedra;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QI;1.350
36 Pontevedra;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
36 Pontevedra;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
36 Pontevedra;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QII;""
36 Pontevedra;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QI;""
36 Pontevedra;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
36 Pontevedra;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
36 Pontevedra;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
36 Pontevedra;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
36 Pontevedra;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
36 Pontevedra;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
36 Pontevedra;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
36 Pontevedra;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
36 Pontevedra;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
36 Pontevedra;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
36 Pontevedra;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
36 Pontevedra;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
36 Pontevedra;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
36 Pontevedra;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
36 Pontevedra;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;93,51
36 Pontevedra;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
36 Pontevedra;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
36 Pontevedra;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
36 Pontevedra;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;93,36
36 Pontevedra;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
36 Pontevedra;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
36 Pontevedra;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
36 Pontevedra;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;96,86
36 Pontevedra;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
36 Pontevedra;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
36 Pontevedra;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;86,9
36 Pontevedra;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
36 Pontevedra;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
36 Pontevedra;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
36 Pontevedra;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;86,78
36 Pontevedra;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
36 Pontevedra;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
36 Pontevedra;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
36 Pontevedra;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;90,26
36 Pontevedra;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
36 Pontevedra;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
36 Pontevedra;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;81,58
36 Pontevedra;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
36 Pontevedra;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
36 Pontevedra;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
36 Pontevedra;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;81,73
36 Pontevedra;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
36 Pontevedra;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
36 Pontevedra;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
36 Pontevedra;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;85,7
36 Pontevedra;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
36 Pontevedra;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
36 Pontevedra;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
36 Pontevedra;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
36 Pontevedra;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
36 Pontevedra;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
36 Pontevedra;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;77,03
36 Pontevedra;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
36 Pontevedra;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
36 Pontevedra;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
36 Pontevedra;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;83,23
36 Pontevedra;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
36 Pontevedra;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
36 Pontevedra;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
36 Pontevedra;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
36 Pontevedra;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
36 Pontevedra;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
36 Pontevedra;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QII;1.107
36 Pontevedra;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
36 Pontevedra;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
36 Pontevedra;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
36 Pontevedra;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QII;1.070
36 Pontevedra;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
36 Pontevedra;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
36 Pontevedra;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
36 Pontevedra;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QII;1.028
36 Pontevedra;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
36 Pontevedra;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
36 Pontevedra;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
36 Pontevedra;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2022QII;1.032
36 Pontevedra;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2022QI;""
36 Pontevedra;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
36 Pontevedra;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
36 Pontevedra;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2021QII;998
36 Pontevedra;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2021QI;""
36 Pontevedra;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
36 Pontevedra;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
36 Pontevedra;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2020QII;982
36 Pontevedra;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2020QI;""
36 Pontevedra;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
36 Pontevedra;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2022QIII;958
36 Pontevedra;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2022QII;""
36 Pontevedra;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2022QI;""
36 Pontevedra;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
36 Pontevedra;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2021QIII;936
36 Pontevedra;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2021QII;""
36 Pontevedra;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2021QI;""
36 Pontevedra;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
36 Pontevedra;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2020QIII;913
36 Pontevedra;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2020QII;""
36 Pontevedra;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2020QI;""
36 Pontevedra;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QIV;890
36 Pontevedra;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
36 Pontevedra;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QII;""
36 Pontevedra;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QI;""
36 Pontevedra;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QIV;871
36 Pontevedra;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
36 Pontevedra;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QII;""
36 Pontevedra;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QI;""
36 Pontevedra;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QIV;851
36 Pontevedra;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
36 Pontevedra;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QII;""
36 Pontevedra;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QI;""
36 Pontevedra;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
36 Pontevedra;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
36 Pontevedra;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QII;""
36 Pontevedra;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QI;816
36 Pontevedra;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
36 Pontevedra;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
36 Pontevedra;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QII;""
36 Pontevedra;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QI;808
36 Pontevedra;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
36 Pontevedra;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
36 Pontevedra;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QII;""
36 Pontevedra;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QI;""
36 Pontevedra;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
36 Pontevedra;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
36 Pontevedra;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
36 Pontevedra;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
36 Pontevedra;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
36 Pontevedra;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
36 Pontevedra;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
36 Pontevedra;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
36 Pontevedra;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
36 Pontevedra;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
36 Pontevedra;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
36 Pontevedra;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
36 Pontevedra;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
36 Pontevedra;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
36 Pontevedra;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;93,22
36 Pontevedra;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
36 Pontevedra;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
36 Pontevedra;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
36 Pontevedra;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;93,27
36 Pontevedra;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
36 Pontevedra;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
36 Pontevedra;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
36 Pontevedra;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;95,53
36 Pontevedra;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
36 Pontevedra;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
36 Pontevedra;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;86,54
36 Pontevedra;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
36 Pontevedra;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
36 Pontevedra;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
36 Pontevedra;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;87,48
36 Pontevedra;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
36 Pontevedra;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
36 Pontevedra;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
36 Pontevedra;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;88,81
36 Pontevedra;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
36 Pontevedra;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
36 Pontevedra;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;80,4
36 Pontevedra;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
36 Pontevedra;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
36 Pontevedra;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
36 Pontevedra;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;81,4
36 Pontevedra;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
36 Pontevedra;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
36 Pontevedra;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
36 Pontevedra;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;82,78
36 Pontevedra;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
36 Pontevedra;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
36 Pontevedra;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
36 Pontevedra;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
36 Pontevedra;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
36 Pontevedra;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
36 Pontevedra;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;76,26
36 Pontevedra;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
36 Pontevedra;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
36 Pontevedra;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
36 Pontevedra;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;78,6
36 Pontevedra;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
36 Pontevedra;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
36 Pontevedra;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
36 Pontevedra;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
36 Pontevedra;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
36 Pontevedra;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QIII;3.039
36 Pontevedra;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
36 Pontevedra;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
36 Pontevedra;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
36 Pontevedra;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QIII;3.013
36 Pontevedra;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
36 Pontevedra;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
36 Pontevedra;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
36 Pontevedra;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QIII;2.822
36 Pontevedra;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
36 Pontevedra;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
36 Pontevedra;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
36 Pontevedra;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2022QIII;2.777
36 Pontevedra;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2022QII;""
36 Pontevedra;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2022QI;""
36 Pontevedra;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
36 Pontevedra;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2021QIII;2.757
36 Pontevedra;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2021QII;""
36 Pontevedra;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2021QI;""
36 Pontevedra;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
36 Pontevedra;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2020QIII;2.567
36 Pontevedra;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2020QII;""
36 Pontevedra;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2020QI;""
36 Pontevedra;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2022QIV;2.576
36 Pontevedra;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
36 Pontevedra;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2022QII;""
36 Pontevedra;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2022QI;""
36 Pontevedra;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2021QIV;2.581
36 Pontevedra;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
36 Pontevedra;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2021QII;""
36 Pontevedra;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2021QI;""
36 Pontevedra;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2020QIV;2.420
36 Pontevedra;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
36 Pontevedra;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2020QII;""
36 Pontevedra;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2020QI;""
36 Pontevedra;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
36 Pontevedra;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
36 Pontevedra;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QII;""
36 Pontevedra;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QI;2.420
36 Pontevedra;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
36 Pontevedra;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
36 Pontevedra;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QII;""
36 Pontevedra;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QI;2.324
36 Pontevedra;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
36 Pontevedra;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
36 Pontevedra;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QII;""
36 Pontevedra;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QI;""
36 Pontevedra;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
36 Pontevedra;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
36 Pontevedra;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QII;2.276
36 Pontevedra;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QI;""
36 Pontevedra;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
36 Pontevedra;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
36 Pontevedra;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QII;2.237
36 Pontevedra;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QI;""
36 Pontevedra;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
36 Pontevedra;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
36 Pontevedra;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QII;""
36 Pontevedra;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QI;""
36 Pontevedra;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
36 Pontevedra;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
36 Pontevedra;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
36 Pontevedra;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
36 Pontevedra;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
36 Pontevedra;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
36 Pontevedra;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
36 Pontevedra;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
36 Pontevedra;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
36 Pontevedra;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
36 Pontevedra;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
36 Pontevedra;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
36 Pontevedra;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
36 Pontevedra;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;91,38
36 Pontevedra;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
36 Pontevedra;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
36 Pontevedra;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
36 Pontevedra;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;91,5
36 Pontevedra;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
36 Pontevedra;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
36 Pontevedra;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
36 Pontevedra;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;90,96
36 Pontevedra;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
36 Pontevedra;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
36 Pontevedra;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;84,76
36 Pontevedra;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
36 Pontevedra;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
36 Pontevedra;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
36 Pontevedra;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;85,66
36 Pontevedra;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
36 Pontevedra;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
36 Pontevedra;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
36 Pontevedra;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;85,75
36 Pontevedra;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
36 Pontevedra;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
36 Pontevedra;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
36 Pontevedra;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
36 Pontevedra;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
36 Pontevedra;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
36 Pontevedra;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;80,32
36 Pontevedra;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
36 Pontevedra;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
36 Pontevedra;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
36 Pontevedra;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;82,35
36 Pontevedra;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
36 Pontevedra;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
36 Pontevedra;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
36 Pontevedra;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
36 Pontevedra;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
36 Pontevedra;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
36 Pontevedra;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;75,54
36 Pontevedra;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
36 Pontevedra;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
36 Pontevedra;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
36 Pontevedra;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;79,27
36 Pontevedra;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
36 Pontevedra;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
36 Pontevedra;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
36 Pontevedra;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
36 Pontevedra;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
36 Pontevedra;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
36 Pontevedra;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QIII;1.821
36 Pontevedra;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
36 Pontevedra;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
36 Pontevedra;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
36 Pontevedra;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QIII;1.844
36 Pontevedra;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
36 Pontevedra;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
36 Pontevedra;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
36 Pontevedra;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QIII;1.737
36 Pontevedra;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
36 Pontevedra;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
36 Pontevedra;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
36 Pontevedra;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2022QIII;1.663
36 Pontevedra;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2022QII;""
36 Pontevedra;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2022QI;""
36 Pontevedra;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
36 Pontevedra;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2021QIII;1.672
36 Pontevedra;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2021QII;""
36 Pontevedra;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2021QI;""
36 Pontevedra;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
36 Pontevedra;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2020QIII;1.587
36 Pontevedra;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2020QII;""
36 Pontevedra;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2020QI;""
36 Pontevedra;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2022QIV;1.553
36 Pontevedra;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
36 Pontevedra;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2022QII;""
36 Pontevedra;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2022QI;""
36 Pontevedra;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2021QIV;1.570
36 Pontevedra;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
36 Pontevedra;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2021QII;""
36 Pontevedra;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2021QI;""
36 Pontevedra;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2020QIV;1.508
36 Pontevedra;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
36 Pontevedra;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2020QII;""
36 Pontevedra;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2020QI;""
36 Pontevedra;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
36 Pontevedra;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
36 Pontevedra;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QII;""
36 Pontevedra;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QI;1.471
36 Pontevedra;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
36 Pontevedra;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
36 Pontevedra;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QII;""
36 Pontevedra;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QI;1.459
36 Pontevedra;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
36 Pontevedra;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
36 Pontevedra;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QII;""
36 Pontevedra;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QI;""
36 Pontevedra;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
36 Pontevedra;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
36 Pontevedra;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QII;1.389
36 Pontevedra;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QI;""
36 Pontevedra;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
36 Pontevedra;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
36 Pontevedra;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QII;1.403
36 Pontevedra;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QI;""
36 Pontevedra;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
36 Pontevedra;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
36 Pontevedra;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QII;""
36 Pontevedra;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QI;""
36 Pontevedra;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
36 Pontevedra;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
36 Pontevedra;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
36 Pontevedra;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
36 Pontevedra;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
36 Pontevedra;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
36 Pontevedra;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
36 Pontevedra;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
36 Pontevedra;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
36 Pontevedra;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
36 Pontevedra;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
36 Pontevedra;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
36 Pontevedra;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
36 Pontevedra;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;91,32
36 Pontevedra;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
36 Pontevedra;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
36 Pontevedra;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
36 Pontevedra;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;90,67
36 Pontevedra;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
36 Pontevedra;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
36 Pontevedra;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
36 Pontevedra;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;91,36
36 Pontevedra;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
36 Pontevedra;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
36 Pontevedra;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;85,28
36 Pontevedra;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
36 Pontevedra;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
36 Pontevedra;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
36 Pontevedra;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;85,14
36 Pontevedra;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
36 Pontevedra;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
36 Pontevedra;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
36 Pontevedra;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;86,82
36 Pontevedra;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
36 Pontevedra;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
36 Pontevedra;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
36 Pontevedra;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
36 Pontevedra;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
36 Pontevedra;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
36 Pontevedra;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;79,77
36 Pontevedra;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
36 Pontevedra;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
36 Pontevedra;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
36 Pontevedra;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;84
36 Pontevedra;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
36 Pontevedra;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
36 Pontevedra;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
36 Pontevedra;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
36 Pontevedra;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
36 Pontevedra;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
36 Pontevedra;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;75,33
36 Pontevedra;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
36 Pontevedra;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
36 Pontevedra;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
36 Pontevedra;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;80,77
36 Pontevedra;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
36 Pontevedra;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
36 Pontevedra;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
36 Pontevedra;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
36 Pontevedra;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
36 Pontevedra;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
36 Pontevedra;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QIII;1.218
36 Pontevedra;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
36 Pontevedra;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
36 Pontevedra;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
36 Pontevedra;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QIII;1.169
36 Pontevedra;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
36 Pontevedra;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
36 Pontevedra;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
36 Pontevedra;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QIII;1.085
36 Pontevedra;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
36 Pontevedra;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
36 Pontevedra;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
36 Pontevedra;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2022QIII;1.114
36 Pontevedra;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2022QII;""
36 Pontevedra;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2022QI;""
36 Pontevedra;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
36 Pontevedra;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2021QIII;1.085
36 Pontevedra;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2021QII;""
36 Pontevedra;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2021QI;""
36 Pontevedra;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
36 Pontevedra;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2020QIII;980
36 Pontevedra;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2020QII;""
36 Pontevedra;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2020QI;""
36 Pontevedra;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2022QIV;1.023
36 Pontevedra;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
36 Pontevedra;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2022QII;""
36 Pontevedra;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2022QI;""
36 Pontevedra;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2021QIV;1.011
36 Pontevedra;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
36 Pontevedra;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2021QII;""
36 Pontevedra;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2021QI;""
36 Pontevedra;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2020QIV;912
36 Pontevedra;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
36 Pontevedra;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2020QII;""
36 Pontevedra;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2020QI;""
36 Pontevedra;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
36 Pontevedra;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
36 Pontevedra;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QII;""
36 Pontevedra;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QI;949
36 Pontevedra;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
36 Pontevedra;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
36 Pontevedra;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QII;""
36 Pontevedra;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QI;865
36 Pontevedra;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
36 Pontevedra;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
36 Pontevedra;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QII;""
36 Pontevedra;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QI;""
36 Pontevedra;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
36 Pontevedra;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
36 Pontevedra;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QII;887
36 Pontevedra;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QI;""
36 Pontevedra;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
36 Pontevedra;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
36 Pontevedra;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QII;834
36 Pontevedra;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QI;""
36 Pontevedra;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
36 Pontevedra;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
36 Pontevedra;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QII;""
36 Pontevedra;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QI;""
36 Pontevedra;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
36 Pontevedra;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
36 Pontevedra;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
36 Pontevedra;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
36 Pontevedra;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
36 Pontevedra;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
36 Pontevedra;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
36 Pontevedra;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
36 Pontevedra;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
36 Pontevedra;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
36 Pontevedra;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
36 Pontevedra;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
36 Pontevedra;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
36 Pontevedra;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;91,46
36 Pontevedra;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
36 Pontevedra;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
36 Pontevedra;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
36 Pontevedra;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;92,81
36 Pontevedra;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
36 Pontevedra;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
36 Pontevedra;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
36 Pontevedra;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;90,32
36 Pontevedra;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
36 Pontevedra;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
36 Pontevedra;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;83,99
36 Pontevedra;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
36 Pontevedra;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
36 Pontevedra;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
36 Pontevedra;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;86,48
36 Pontevedra;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
36 Pontevedra;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
36 Pontevedra;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
36 Pontevedra;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;84,06
36 Pontevedra;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
36 Pontevedra;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
36 Pontevedra;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
36 Pontevedra;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
36 Pontevedra;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
36 Pontevedra;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
36 Pontevedra;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;81,18
36 Pontevedra;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
36 Pontevedra;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
36 Pontevedra;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
36 Pontevedra;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;79,72
36 Pontevedra;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
36 Pontevedra;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
36 Pontevedra;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
36 Pontevedra;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
36 Pontevedra;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
36 Pontevedra;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
36 Pontevedra;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;75,88
36 Pontevedra;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
36 Pontevedra;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
36 Pontevedra;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
36 Pontevedra;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;76,87
36 Pontevedra;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
36 Pontevedra;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
36 Pontevedra;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
36 Pontevedra;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
36 Pontevedra;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
36 Pontevedra;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QIV;3.085
36 Pontevedra;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
36 Pontevedra;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
36 Pontevedra;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
36 Pontevedra;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QIV;3.092
36 Pontevedra;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
36 Pontevedra;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
36 Pontevedra;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
36 Pontevedra;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QIV;2.895
36 Pontevedra;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
36 Pontevedra;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
36 Pontevedra;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
36 Pontevedra;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2022QIV;2.849
36 Pontevedra;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
36 Pontevedra;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2022QII;""
36 Pontevedra;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2022QI;""
36 Pontevedra;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2021QIV;2.876
36 Pontevedra;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
36 Pontevedra;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2021QII;""
36 Pontevedra;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2021QI;""
36 Pontevedra;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2020QIV;2.697
36 Pontevedra;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
36 Pontevedra;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2020QII;""
36 Pontevedra;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2020QI;""
36 Pontevedra;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
36 Pontevedra;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
36 Pontevedra;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2022QII;""
36 Pontevedra;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2022QI;2.694
36 Pontevedra;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
36 Pontevedra;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
36 Pontevedra;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2021QII;""
36 Pontevedra;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2021QI;2.575
36 Pontevedra;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
36 Pontevedra;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
36 Pontevedra;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2020QII;""
36 Pontevedra;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2020QI;""
36 Pontevedra;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
36 Pontevedra;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
36 Pontevedra;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QII;2.534
36 Pontevedra;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QI;""
36 Pontevedra;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
36 Pontevedra;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
36 Pontevedra;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QII;2.457
36 Pontevedra;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QI;""
36 Pontevedra;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
36 Pontevedra;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
36 Pontevedra;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QII;""
36 Pontevedra;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QI;""
36 Pontevedra;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
36 Pontevedra;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QIII;2.369
36 Pontevedra;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QII;""
36 Pontevedra;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QI;""
36 Pontevedra;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
36 Pontevedra;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QIII;2.336
36 Pontevedra;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QII;""
36 Pontevedra;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QI;""
36 Pontevedra;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
36 Pontevedra;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
36 Pontevedra;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QII;""
36 Pontevedra;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QI;""
36 Pontevedra;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
36 Pontevedra;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
36 Pontevedra;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
36 Pontevedra;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
36 Pontevedra;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
36 Pontevedra;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
36 Pontevedra;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
36 Pontevedra;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
36 Pontevedra;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
36 Pontevedra;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
36 Pontevedra;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
36 Pontevedra;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
36 Pontevedra;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;92,35
36 Pontevedra;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
36 Pontevedra;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
36 Pontevedra;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
36 Pontevedra;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;93,01
36 Pontevedra;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
36 Pontevedra;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
36 Pontevedra;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
36 Pontevedra;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;93,16
36 Pontevedra;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
36 Pontevedra;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
36 Pontevedra;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
36 Pontevedra;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
36 Pontevedra;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
36 Pontevedra;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
36 Pontevedra;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;87,13
36 Pontevedra;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
36 Pontevedra;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
36 Pontevedra;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
36 Pontevedra;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;88,95
36 Pontevedra;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
36 Pontevedra;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
36 Pontevedra;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
36 Pontevedra;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
36 Pontevedra;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
36 Pontevedra;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
36 Pontevedra;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;81,95
36 Pontevedra;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
36 Pontevedra;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
36 Pontevedra;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
36 Pontevedra;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;84,87
36 Pontevedra;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
36 Pontevedra;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
36 Pontevedra;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
36 Pontevedra;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
36 Pontevedra;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
36 Pontevedra;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
36 Pontevedra;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;76,62
36 Pontevedra;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
36 Pontevedra;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
36 Pontevedra;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
36 Pontevedra;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;80,69
36 Pontevedra;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
36 Pontevedra;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
36 Pontevedra;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
36 Pontevedra;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
36 Pontevedra;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
36 Pontevedra;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
36 Pontevedra;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QIV;1.841
36 Pontevedra;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
36 Pontevedra;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
36 Pontevedra;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
36 Pontevedra;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QIV;1.863
36 Pontevedra;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
36 Pontevedra;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
36 Pontevedra;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
36 Pontevedra;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QIV;1.783
36 Pontevedra;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
36 Pontevedra;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
36 Pontevedra;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
36 Pontevedra;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2022QIV;1.710
36 Pontevedra;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
36 Pontevedra;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2022QII;""
36 Pontevedra;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2022QI;""
36 Pontevedra;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2021QIV;1.739
36 Pontevedra;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
36 Pontevedra;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2021QII;""
36 Pontevedra;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2021QI;""
36 Pontevedra;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2020QIV;1.674
36 Pontevedra;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
36 Pontevedra;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2020QII;""
36 Pontevedra;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2020QI;""
36 Pontevedra;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
36 Pontevedra;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
36 Pontevedra;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2022QII;""
36 Pontevedra;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2022QI;1.627
36 Pontevedra;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
36 Pontevedra;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
36 Pontevedra;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2021QII;""
36 Pontevedra;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2021QI;1.608
36 Pontevedra;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
36 Pontevedra;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
36 Pontevedra;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2020QII;""
36 Pontevedra;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2020QI;""
36 Pontevedra;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
36 Pontevedra;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
36 Pontevedra;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QII;1.536
36 Pontevedra;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QI;""
36 Pontevedra;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
36 Pontevedra;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
36 Pontevedra;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QII;1.535
36 Pontevedra;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QI;""
36 Pontevedra;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
36 Pontevedra;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
36 Pontevedra;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QII;""
36 Pontevedra;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QI;""
36 Pontevedra;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
36 Pontevedra;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QIII;1.440
36 Pontevedra;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QII;""
36 Pontevedra;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QI;""
36 Pontevedra;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
36 Pontevedra;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QIII;1.454
36 Pontevedra;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QII;""
36 Pontevedra;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QI;""
36 Pontevedra;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
36 Pontevedra;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
36 Pontevedra;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QII;""
36 Pontevedra;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QI;""
36 Pontevedra;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
36 Pontevedra;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
36 Pontevedra;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
36 Pontevedra;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
36 Pontevedra;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
36 Pontevedra;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
36 Pontevedra;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
36 Pontevedra;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
36 Pontevedra;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
36 Pontevedra;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
36 Pontevedra;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
36 Pontevedra;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
36 Pontevedra;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;92,88
36 Pontevedra;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
36 Pontevedra;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
36 Pontevedra;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
36 Pontevedra;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;93,34
36 Pontevedra;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
36 Pontevedra;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
36 Pontevedra;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
36 Pontevedra;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;93,89
36 Pontevedra;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
36 Pontevedra;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
36 Pontevedra;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
36 Pontevedra;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
36 Pontevedra;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
36 Pontevedra;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
36 Pontevedra;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;87,33
36 Pontevedra;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
36 Pontevedra;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
36 Pontevedra;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
36 Pontevedra;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;90,19
36 Pontevedra;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
36 Pontevedra;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
36 Pontevedra;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
36 Pontevedra;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
36 Pontevedra;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
36 Pontevedra;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
36 Pontevedra;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;82,45
36 Pontevedra;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
36 Pontevedra;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
36 Pontevedra;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
36 Pontevedra;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;86,09
36 Pontevedra;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
36 Pontevedra;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
36 Pontevedra;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
36 Pontevedra;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
36 Pontevedra;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
36 Pontevedra;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
36 Pontevedra;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;77,29
36 Pontevedra;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
36 Pontevedra;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
36 Pontevedra;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
36 Pontevedra;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;81,55
36 Pontevedra;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
36 Pontevedra;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
36 Pontevedra;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
36 Pontevedra;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
36 Pontevedra;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
36 Pontevedra;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
36 Pontevedra;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QIV;1.244
36 Pontevedra;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
36 Pontevedra;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
36 Pontevedra;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
36 Pontevedra;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QIV;1.229
36 Pontevedra;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
36 Pontevedra;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
36 Pontevedra;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
36 Pontevedra;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QIV;1.112
36 Pontevedra;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
36 Pontevedra;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
36 Pontevedra;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
36 Pontevedra;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2022QIV;1.139
36 Pontevedra;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
36 Pontevedra;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2022QII;""
36 Pontevedra;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2022QI;""
36 Pontevedra;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2021QIV;1.137
36 Pontevedra;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
36 Pontevedra;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2021QII;""
36 Pontevedra;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2021QI;""
36 Pontevedra;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2020QIV;1.023
36 Pontevedra;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
36 Pontevedra;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2020QII;""
36 Pontevedra;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2020QI;""
36 Pontevedra;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
36 Pontevedra;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
36 Pontevedra;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2022QII;""
36 Pontevedra;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2022QI;1.067
36 Pontevedra;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
36 Pontevedra;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
36 Pontevedra;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2021QII;""
36 Pontevedra;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2021QI;967
36 Pontevedra;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
36 Pontevedra;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
36 Pontevedra;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2020QII;""
36 Pontevedra;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2020QI;""
36 Pontevedra;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
36 Pontevedra;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
36 Pontevedra;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QII;998
36 Pontevedra;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QI;""
36 Pontevedra;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
36 Pontevedra;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
36 Pontevedra;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QII;922
36 Pontevedra;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QI;""
36 Pontevedra;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
36 Pontevedra;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
36 Pontevedra;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QII;""
36 Pontevedra;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QI;""
36 Pontevedra;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
36 Pontevedra;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QIII;929
36 Pontevedra;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QII;""
36 Pontevedra;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QI;""
36 Pontevedra;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
36 Pontevedra;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QIII;882
36 Pontevedra;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QII;""
36 Pontevedra;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QI;""
36 Pontevedra;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
36 Pontevedra;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
36 Pontevedra;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QII;""
36 Pontevedra;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QI;""
36 Pontevedra;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
36 Pontevedra;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
36 Pontevedra;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
36 Pontevedra;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
36 Pontevedra;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
36 Pontevedra;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
36 Pontevedra;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
36 Pontevedra;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
36 Pontevedra;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
36 Pontevedra;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
36 Pontevedra;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
36 Pontevedra;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
36 Pontevedra;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;91,56
36 Pontevedra;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
36 Pontevedra;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
36 Pontevedra;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
36 Pontevedra;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;92,51
36 Pontevedra;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
36 Pontevedra;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
36 Pontevedra;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
36 Pontevedra;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;92
36 Pontevedra;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
36 Pontevedra;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
36 Pontevedra;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
36 Pontevedra;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
36 Pontevedra;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
36 Pontevedra;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
36 Pontevedra;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;86,82
36 Pontevedra;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
36 Pontevedra;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
36 Pontevedra;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
36 Pontevedra;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;86,96
36 Pontevedra;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
36 Pontevedra;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
36 Pontevedra;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
36 Pontevedra;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
36 Pontevedra;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
36 Pontevedra;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
36 Pontevedra;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;81,2
36 Pontevedra;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
36 Pontevedra;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
36 Pontevedra;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
36 Pontevedra;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;82,91
36 Pontevedra;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
36 Pontevedra;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
36 Pontevedra;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
36 Pontevedra;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
36 Pontevedra;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
36 Pontevedra;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
36 Pontevedra;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;75,59
36 Pontevedra;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
36 Pontevedra;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
36 Pontevedra;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
36 Pontevedra;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;79,32
36 Pontevedra;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
36 Pontevedra;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
36 Pontevedra;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
36 Pontevedra;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
36 Pontevedra;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
36 Pontevedra;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
36 Pontevedra;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
36 Pontevedra;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
36 Pontevedra;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
36 Pontevedra;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QI;10.412
36 Pontevedra;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
36 Pontevedra;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
36 Pontevedra;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
36 Pontevedra;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QI;10.620
36 Pontevedra;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
36 Pontevedra;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
36 Pontevedra;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
36 Pontevedra;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QI;10.365
36 Pontevedra;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
36 Pontevedra;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
36 Pontevedra;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2022QII;""
36 Pontevedra;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2022QI;10.021
36 Pontevedra;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
36 Pontevedra;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
36 Pontevedra;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2021QII;""
36 Pontevedra;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2021QI;10.312
36 Pontevedra;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
36 Pontevedra;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
36 Pontevedra;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2020QII;""
36 Pontevedra;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2020QI;9.687
36 Pontevedra;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
36 Pontevedra;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
36 Pontevedra;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2022QII;9.676
36 Pontevedra;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2022QI;""
36 Pontevedra;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
36 Pontevedra;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
36 Pontevedra;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2021QII;10.042
36 Pontevedra;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2021QI;""
36 Pontevedra;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
36 Pontevedra;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
36 Pontevedra;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2020QII;9.482
36 Pontevedra;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2020QI;""
36 Pontevedra;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
36 Pontevedra;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QIII;9.392
36 Pontevedra;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QII;""
36 Pontevedra;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QI;""
36 Pontevedra;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
36 Pontevedra;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QIII;9.775
36 Pontevedra;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QII;""
36 Pontevedra;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QI;""
36 Pontevedra;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
36 Pontevedra;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QIII;9.192
36 Pontevedra;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QII;""
36 Pontevedra;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QI;""
36 Pontevedra;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QIV;9.102
36 Pontevedra;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
36 Pontevedra;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QII;""
36 Pontevedra;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QI;""
36 Pontevedra;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QIV;9.509
36 Pontevedra;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
36 Pontevedra;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QII;""
36 Pontevedra;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QI;""
36 Pontevedra;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QIV;8.919
36 Pontevedra;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
36 Pontevedra;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QII;""
36 Pontevedra;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QI;""
36 Pontevedra;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
36 Pontevedra;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
36 Pontevedra;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
36 Pontevedra;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
36 Pontevedra;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
36 Pontevedra;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
36 Pontevedra;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
36 Pontevedra;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
36 Pontevedra;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
36 Pontevedra;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
36 Pontevedra;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
36 Pontevedra;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
36 Pontevedra;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
36 Pontevedra;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
36 Pontevedra;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
36 Pontevedra;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;96,24
36 Pontevedra;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
36 Pontevedra;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
36 Pontevedra;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
36 Pontevedra;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;97,1
36 Pontevedra;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
36 Pontevedra;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
36 Pontevedra;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
36 Pontevedra;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;93,46
36 Pontevedra;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
36 Pontevedra;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
36 Pontevedra;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;92,93
36 Pontevedra;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
36 Pontevedra;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
36 Pontevedra;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
36 Pontevedra;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;94,56
36 Pontevedra;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
36 Pontevedra;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
36 Pontevedra;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
36 Pontevedra;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;91,48
36 Pontevedra;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
36 Pontevedra;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
36 Pontevedra;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;90,2
36 Pontevedra;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
36 Pontevedra;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
36 Pontevedra;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
36 Pontevedra;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;92,04
36 Pontevedra;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
36 Pontevedra;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
36 Pontevedra;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
36 Pontevedra;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;88,68
36 Pontevedra;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
36 Pontevedra;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
36 Pontevedra;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;87,42
36 Pontevedra;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
36 Pontevedra;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
36 Pontevedra;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
36 Pontevedra;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;89,54
36 Pontevedra;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
36 Pontevedra;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
36 Pontevedra;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
36 Pontevedra;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;86,05
36 Pontevedra;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
36 Pontevedra;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
36 Pontevedra;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
36 Pontevedra;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
36 Pontevedra;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
36 Pontevedra;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
36 Pontevedra;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QI;6.010
36 Pontevedra;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
36 Pontevedra;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
36 Pontevedra;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
36 Pontevedra;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QI;6.128
36 Pontevedra;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
36 Pontevedra;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
36 Pontevedra;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
36 Pontevedra;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QI;5.955
36 Pontevedra;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
36 Pontevedra;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
36 Pontevedra;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2022QII;""
36 Pontevedra;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2022QI;5.772
36 Pontevedra;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
36 Pontevedra;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
36 Pontevedra;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2021QII;""
36 Pontevedra;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2021QI;5.946
36 Pontevedra;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
36 Pontevedra;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
36 Pontevedra;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2020QII;""
36 Pontevedra;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2020QI;5.590
36 Pontevedra;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
36 Pontevedra;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
36 Pontevedra;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2022QII;5.594
36 Pontevedra;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2022QI;""
36 Pontevedra;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
36 Pontevedra;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
36 Pontevedra;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2021QII;5.797
36 Pontevedra;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2021QI;""
36 Pontevedra;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
36 Pontevedra;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
36 Pontevedra;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2020QII;5.489
36 Pontevedra;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2020QI;""
36 Pontevedra;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
36 Pontevedra;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QIII;5.451
36 Pontevedra;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QII;""
36 Pontevedra;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QI;""
36 Pontevedra;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
36 Pontevedra;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QIII;5.652
36 Pontevedra;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QII;""
36 Pontevedra;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QI;""
36 Pontevedra;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
36 Pontevedra;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QIII;5.327
36 Pontevedra;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QII;""
36 Pontevedra;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QI;""
36 Pontevedra;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QIV;5.286
36 Pontevedra;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
36 Pontevedra;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QII;""
36 Pontevedra;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QI;""
36 Pontevedra;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QIV;5.521
36 Pontevedra;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
36 Pontevedra;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QII;""
36 Pontevedra;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QI;""
36 Pontevedra;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QIV;5.176
36 Pontevedra;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
36 Pontevedra;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QII;""
36 Pontevedra;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QI;""
36 Pontevedra;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
36 Pontevedra;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
36 Pontevedra;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
36 Pontevedra;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
36 Pontevedra;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
36 Pontevedra;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
36 Pontevedra;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
36 Pontevedra;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
36 Pontevedra;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
36 Pontevedra;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
36 Pontevedra;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
36 Pontevedra;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
36 Pontevedra;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
36 Pontevedra;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
36 Pontevedra;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
36 Pontevedra;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;96,04
36 Pontevedra;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
36 Pontevedra;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
36 Pontevedra;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
36 Pontevedra;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;97,03
36 Pontevedra;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
36 Pontevedra;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
36 Pontevedra;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
36 Pontevedra;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;93,87
36 Pontevedra;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
36 Pontevedra;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
36 Pontevedra;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;93,08
36 Pontevedra;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
36 Pontevedra;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
36 Pontevedra;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
36 Pontevedra;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;94,6
36 Pontevedra;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
36 Pontevedra;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
36 Pontevedra;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
36 Pontevedra;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;92,17
36 Pontevedra;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
36 Pontevedra;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
36 Pontevedra;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;90,7
36 Pontevedra;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
36 Pontevedra;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
36 Pontevedra;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
36 Pontevedra;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;92,23
36 Pontevedra;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
36 Pontevedra;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
36 Pontevedra;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
36 Pontevedra;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;89,45
36 Pontevedra;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
36 Pontevedra;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
36 Pontevedra;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;87,95
36 Pontevedra;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
36 Pontevedra;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
36 Pontevedra;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
36 Pontevedra;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;90,09
36 Pontevedra;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
36 Pontevedra;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
36 Pontevedra;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
36 Pontevedra;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;86,92
36 Pontevedra;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
36 Pontevedra;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
36 Pontevedra;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
36 Pontevedra;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
36 Pontevedra;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
36 Pontevedra;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
36 Pontevedra;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QI;4.402
36 Pontevedra;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
36 Pontevedra;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
36 Pontevedra;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
36 Pontevedra;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QI;4.492
36 Pontevedra;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
36 Pontevedra;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
36 Pontevedra;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
36 Pontevedra;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QI;4.410
36 Pontevedra;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
36 Pontevedra;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
36 Pontevedra;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2022QII;""
36 Pontevedra;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2022QI;4.249
36 Pontevedra;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
36 Pontevedra;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
36 Pontevedra;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2021QII;""
36 Pontevedra;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2021QI;4.366
36 Pontevedra;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
36 Pontevedra;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
36 Pontevedra;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2020QII;""
36 Pontevedra;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2020QI;4.097
36 Pontevedra;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
36 Pontevedra;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
36 Pontevedra;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2022QII;4.082
36 Pontevedra;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2022QI;""
36 Pontevedra;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
36 Pontevedra;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
36 Pontevedra;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2021QII;4.245
36 Pontevedra;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2021QI;""
36 Pontevedra;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
36 Pontevedra;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
36 Pontevedra;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2020QII;3.993
36 Pontevedra;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2020QI;""
36 Pontevedra;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
36 Pontevedra;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QIII;3.941
36 Pontevedra;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QII;""
36 Pontevedra;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QI;""
36 Pontevedra;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
36 Pontevedra;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QIII;4.123
36 Pontevedra;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QII;""
36 Pontevedra;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QI;""
36 Pontevedra;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
36 Pontevedra;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QIII;3.865
36 Pontevedra;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QII;""
36 Pontevedra;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QI;""
36 Pontevedra;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QIV;3.816
36 Pontevedra;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
36 Pontevedra;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QII;""
36 Pontevedra;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QI;""
36 Pontevedra;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QIV;3.988
36 Pontevedra;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
36 Pontevedra;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QII;""
36 Pontevedra;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QI;""
36 Pontevedra;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QIV;3.743
36 Pontevedra;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
36 Pontevedra;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QII;""
36 Pontevedra;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QI;""
36 Pontevedra;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
36 Pontevedra;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
36 Pontevedra;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
36 Pontevedra;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
36 Pontevedra;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
36 Pontevedra;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
36 Pontevedra;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
36 Pontevedra;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
36 Pontevedra;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
36 Pontevedra;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
36 Pontevedra;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
36 Pontevedra;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
36 Pontevedra;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
36 Pontevedra;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
36 Pontevedra;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
36 Pontevedra;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;96,52
36 Pontevedra;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
36 Pontevedra;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
36 Pontevedra;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
36 Pontevedra;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;97,2
36 Pontevedra;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
36 Pontevedra;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
36 Pontevedra;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
36 Pontevedra;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;92,9
36 Pontevedra;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
36 Pontevedra;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
36 Pontevedra;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;92,73
36 Pontevedra;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
36 Pontevedra;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
36 Pontevedra;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
36 Pontevedra;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;94,5
36 Pontevedra;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
36 Pontevedra;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
36 Pontevedra;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
36 Pontevedra;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;90,54
36 Pontevedra;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
36 Pontevedra;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
36 Pontevedra;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;89,53
36 Pontevedra;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
36 Pontevedra;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
36 Pontevedra;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
36 Pontevedra;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;91,79
36 Pontevedra;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
36 Pontevedra;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
36 Pontevedra;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
36 Pontevedra;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;87,64
36 Pontevedra;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
36 Pontevedra;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
36 Pontevedra;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;86,69
36 Pontevedra;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
36 Pontevedra;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
36 Pontevedra;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
36 Pontevedra;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;88,78
36 Pontevedra;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
36 Pontevedra;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
36 Pontevedra;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
36 Pontevedra;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;84,88
36 Pontevedra;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
36 Pontevedra;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
36 Pontevedra;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
36 Pontevedra;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
36 Pontevedra;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
36 Pontevedra;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QII;9.635
36 Pontevedra;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
36 Pontevedra;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
36 Pontevedra;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
36 Pontevedra;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QII;9.806
36 Pontevedra;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
36 Pontevedra;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
36 Pontevedra;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
36 Pontevedra;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QII;10.312
36 Pontevedra;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
36 Pontevedra;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
36 Pontevedra;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
36 Pontevedra;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2022QII;9.264
36 Pontevedra;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2022QI;""
36 Pontevedra;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
36 Pontevedra;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
36 Pontevedra;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2021QII;9.529
36 Pontevedra;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2021QI;""
36 Pontevedra;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
36 Pontevedra;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
36 Pontevedra;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2020QII;10.089
36 Pontevedra;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2020QI;""
36 Pontevedra;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
36 Pontevedra;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2022QIII;8.947
36 Pontevedra;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2022QII;""
36 Pontevedra;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2022QI;""
36 Pontevedra;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
36 Pontevedra;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2021QIII;9.256
36 Pontevedra;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2021QII;""
36 Pontevedra;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2021QI;""
36 Pontevedra;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
36 Pontevedra;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2020QIII;9.705
36 Pontevedra;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2020QII;""
36 Pontevedra;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2020QI;""
36 Pontevedra;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QIV;8.642
36 Pontevedra;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
36 Pontevedra;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QII;""
36 Pontevedra;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QI;""
36 Pontevedra;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QIV;8.994
36 Pontevedra;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
36 Pontevedra;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QII;""
36 Pontevedra;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QI;""
36 Pontevedra;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QIV;9.405
36 Pontevedra;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
36 Pontevedra;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QII;""
36 Pontevedra;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QI;""
36 Pontevedra;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
36 Pontevedra;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
36 Pontevedra;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QII;""
36 Pontevedra;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QI;8.706
36 Pontevedra;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
36 Pontevedra;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
36 Pontevedra;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QII;""
36 Pontevedra;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QI;9.190
36 Pontevedra;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
36 Pontevedra;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
36 Pontevedra;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QII;""
36 Pontevedra;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QI;""
36 Pontevedra;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
36 Pontevedra;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
36 Pontevedra;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
36 Pontevedra;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
36 Pontevedra;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
36 Pontevedra;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
36 Pontevedra;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
36 Pontevedra;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
36 Pontevedra;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
36 Pontevedra;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
36 Pontevedra;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
36 Pontevedra;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
36 Pontevedra;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
36 Pontevedra;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
36 Pontevedra;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;96,15
36 Pontevedra;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
36 Pontevedra;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
36 Pontevedra;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
36 Pontevedra;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;97,18
36 Pontevedra;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
36 Pontevedra;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
36 Pontevedra;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
36 Pontevedra;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;97,84
36 Pontevedra;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
36 Pontevedra;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
36 Pontevedra;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;92,86
36 Pontevedra;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
36 Pontevedra;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
36 Pontevedra;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
36 Pontevedra;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;94,39
36 Pontevedra;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
36 Pontevedra;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
36 Pontevedra;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
36 Pontevedra;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;94,11
36 Pontevedra;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
36 Pontevedra;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
36 Pontevedra;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;89,69
36 Pontevedra;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
36 Pontevedra;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
36 Pontevedra;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
36 Pontevedra;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;91,72
36 Pontevedra;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
36 Pontevedra;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
36 Pontevedra;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
36 Pontevedra;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;91,2
36 Pontevedra;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
36 Pontevedra;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
36 Pontevedra;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
36 Pontevedra;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
36 Pontevedra;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
36 Pontevedra;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
36 Pontevedra;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;88,78
36 Pontevedra;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
36 Pontevedra;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
36 Pontevedra;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
36 Pontevedra;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;89,12
36 Pontevedra;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
36 Pontevedra;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
36 Pontevedra;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
36 Pontevedra;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
36 Pontevedra;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
36 Pontevedra;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
36 Pontevedra;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QII;5.508
36 Pontevedra;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
36 Pontevedra;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
36 Pontevedra;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
36 Pontevedra;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QII;5.638
36 Pontevedra;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
36 Pontevedra;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
36 Pontevedra;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
36 Pontevedra;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QII;5.929
36 Pontevedra;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
36 Pontevedra;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
36 Pontevedra;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
36 Pontevedra;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2022QII;5.316
36 Pontevedra;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2022QI;""
36 Pontevedra;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
36 Pontevedra;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
36 Pontevedra;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2021QII;5.484
36 Pontevedra;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2021QI;""
36 Pontevedra;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
36 Pontevedra;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
36 Pontevedra;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2020QII;5.816
36 Pontevedra;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2020QI;""
36 Pontevedra;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
36 Pontevedra;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2022QIII;5.144
36 Pontevedra;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2022QII;""
36 Pontevedra;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2022QI;""
36 Pontevedra;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
36 Pontevedra;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2021QIII;5.332
36 Pontevedra;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2021QII;""
36 Pontevedra;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2021QI;""
36 Pontevedra;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
36 Pontevedra;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2020QIII;5.599
36 Pontevedra;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2020QII;""
36 Pontevedra;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2020QI;""
36 Pontevedra;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QIV;4.967
36 Pontevedra;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
36 Pontevedra;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QII;""
36 Pontevedra;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QI;""
36 Pontevedra;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QIV;5.203
36 Pontevedra;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
36 Pontevedra;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QII;""
36 Pontevedra;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QI;""
36 Pontevedra;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QIV;5.431
36 Pontevedra;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
36 Pontevedra;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QII;""
36 Pontevedra;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QI;""
36 Pontevedra;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
36 Pontevedra;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
36 Pontevedra;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QII;""
36 Pontevedra;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QI;5.035
36 Pontevedra;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
36 Pontevedra;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
36 Pontevedra;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QII;""
36 Pontevedra;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QI;5.306
36 Pontevedra;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
36 Pontevedra;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
36 Pontevedra;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QII;""
36 Pontevedra;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QI;""
36 Pontevedra;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
36 Pontevedra;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
36 Pontevedra;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
36 Pontevedra;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
36 Pontevedra;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
36 Pontevedra;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
36 Pontevedra;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
36 Pontevedra;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
36 Pontevedra;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
36 Pontevedra;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
36 Pontevedra;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
36 Pontevedra;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
36 Pontevedra;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
36 Pontevedra;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
36 Pontevedra;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;96,51
36 Pontevedra;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
36 Pontevedra;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
36 Pontevedra;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
36 Pontevedra;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;97,27
36 Pontevedra;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
36 Pontevedra;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
36 Pontevedra;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
36 Pontevedra;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;98,09
36 Pontevedra;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
36 Pontevedra;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
36 Pontevedra;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;93,39
36 Pontevedra;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
36 Pontevedra;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
36 Pontevedra;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
36 Pontevedra;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;94,57
36 Pontevedra;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
36 Pontevedra;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
36 Pontevedra;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
36 Pontevedra;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;94,43
36 Pontevedra;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
36 Pontevedra;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
36 Pontevedra;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;90,18
36 Pontevedra;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
36 Pontevedra;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
36 Pontevedra;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
36 Pontevedra;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;92,28
36 Pontevedra;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
36 Pontevedra;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
36 Pontevedra;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
36 Pontevedra;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;91,6
36 Pontevedra;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
36 Pontevedra;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
36 Pontevedra;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
36 Pontevedra;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
36 Pontevedra;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
36 Pontevedra;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
36 Pontevedra;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;89,3
36 Pontevedra;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
36 Pontevedra;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
36 Pontevedra;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
36 Pontevedra;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;89,49
36 Pontevedra;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
36 Pontevedra;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
36 Pontevedra;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
36 Pontevedra;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
36 Pontevedra;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
36 Pontevedra;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
36 Pontevedra;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QII;4.127
36 Pontevedra;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
36 Pontevedra;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
36 Pontevedra;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
36 Pontevedra;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QII;4.168
36 Pontevedra;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
36 Pontevedra;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
36 Pontevedra;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
36 Pontevedra;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QII;4.383
36 Pontevedra;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
36 Pontevedra;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
36 Pontevedra;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
36 Pontevedra;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2022QII;3.948
36 Pontevedra;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2022QI;""
36 Pontevedra;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
36 Pontevedra;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
36 Pontevedra;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2021QII;4.045
36 Pontevedra;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2021QI;""
36 Pontevedra;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
36 Pontevedra;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
36 Pontevedra;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2020QII;4.273
36 Pontevedra;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2020QI;""
36 Pontevedra;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
36 Pontevedra;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2022QIII;3.803
36 Pontevedra;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2022QII;""
36 Pontevedra;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2022QI;""
36 Pontevedra;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
36 Pontevedra;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2021QIII;3.924
36 Pontevedra;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2021QII;""
36 Pontevedra;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2021QI;""
36 Pontevedra;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
36 Pontevedra;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2020QIII;4.106
36 Pontevedra;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2020QII;""
36 Pontevedra;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2020QI;""
36 Pontevedra;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QIV;3.675
36 Pontevedra;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
36 Pontevedra;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QII;""
36 Pontevedra;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QI;""
36 Pontevedra;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QIV;3.791
36 Pontevedra;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
36 Pontevedra;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QII;""
36 Pontevedra;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QI;""
36 Pontevedra;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QIV;3.974
36 Pontevedra;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
36 Pontevedra;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QII;""
36 Pontevedra;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QI;""
36 Pontevedra;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
36 Pontevedra;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
36 Pontevedra;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QII;""
36 Pontevedra;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QI;3.671
36 Pontevedra;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
36 Pontevedra;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
36 Pontevedra;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QII;""
36 Pontevedra;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QI;3.884
36 Pontevedra;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
36 Pontevedra;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
36 Pontevedra;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QII;""
36 Pontevedra;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QI;""
36 Pontevedra;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
36 Pontevedra;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
36 Pontevedra;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
36 Pontevedra;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
36 Pontevedra;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
36 Pontevedra;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
36 Pontevedra;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
36 Pontevedra;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
36 Pontevedra;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
36 Pontevedra;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
36 Pontevedra;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
36 Pontevedra;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
36 Pontevedra;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
36 Pontevedra;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
36 Pontevedra;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;95,66
36 Pontevedra;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
36 Pontevedra;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
36 Pontevedra;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
36 Pontevedra;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;97,05
36 Pontevedra;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
36 Pontevedra;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
36 Pontevedra;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
36 Pontevedra;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;97,49
36 Pontevedra;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
36 Pontevedra;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
36 Pontevedra;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;92,15
36 Pontevedra;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
36 Pontevedra;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
36 Pontevedra;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
36 Pontevedra;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;94,15
36 Pontevedra;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
36 Pontevedra;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
36 Pontevedra;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
36 Pontevedra;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;93,68
36 Pontevedra;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
36 Pontevedra;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
36 Pontevedra;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;89,05
36 Pontevedra;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
36 Pontevedra;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
36 Pontevedra;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
36 Pontevedra;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;90,95
36 Pontevedra;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
36 Pontevedra;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
36 Pontevedra;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
36 Pontevedra;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;90,67
36 Pontevedra;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
36 Pontevedra;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
36 Pontevedra;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
36 Pontevedra;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
36 Pontevedra;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
36 Pontevedra;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
36 Pontevedra;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;88,08
36 Pontevedra;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
36 Pontevedra;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
36 Pontevedra;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
36 Pontevedra;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;88,62
36 Pontevedra;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
36 Pontevedra;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
36 Pontevedra;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
36 Pontevedra;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
36 Pontevedra;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
36 Pontevedra;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QIII;9.811
36 Pontevedra;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
36 Pontevedra;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
36 Pontevedra;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
36 Pontevedra;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QIII;10.139
36 Pontevedra;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
36 Pontevedra;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
36 Pontevedra;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
36 Pontevedra;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QIII;10.467
36 Pontevedra;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
36 Pontevedra;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
36 Pontevedra;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
36 Pontevedra;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2022QIII;9.422
36 Pontevedra;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2022QII;""
36 Pontevedra;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2022QI;""
36 Pontevedra;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
36 Pontevedra;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2021QIII;9.785
36 Pontevedra;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2021QII;""
36 Pontevedra;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2021QI;""
36 Pontevedra;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
36 Pontevedra;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2020QIII;10.026
36 Pontevedra;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2020QII;""
36 Pontevedra;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2020QI;""
36 Pontevedra;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2022QIV;9.067
36 Pontevedra;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
36 Pontevedra;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2022QII;""
36 Pontevedra;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2022QI;""
36 Pontevedra;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2021QIV;9.474
36 Pontevedra;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
36 Pontevedra;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2021QII;""
36 Pontevedra;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2021QI;""
36 Pontevedra;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2020QIV;9.699
36 Pontevedra;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
36 Pontevedra;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2020QII;""
36 Pontevedra;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2020QI;""
36 Pontevedra;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
36 Pontevedra;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
36 Pontevedra;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QII;""
36 Pontevedra;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QI;9.160
36 Pontevedra;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
36 Pontevedra;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
36 Pontevedra;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QII;""
36 Pontevedra;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QI;9.467
36 Pontevedra;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
36 Pontevedra;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
36 Pontevedra;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QII;""
36 Pontevedra;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QI;""
36 Pontevedra;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
36 Pontevedra;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
36 Pontevedra;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QII;8.887
36 Pontevedra;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QI;""
36 Pontevedra;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
36 Pontevedra;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
36 Pontevedra;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QII;9.253
36 Pontevedra;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QI;""
36 Pontevedra;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
36 Pontevedra;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
36 Pontevedra;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QII;""
36 Pontevedra;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QI;""
36 Pontevedra;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
36 Pontevedra;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
36 Pontevedra;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
36 Pontevedra;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
36 Pontevedra;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
36 Pontevedra;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
36 Pontevedra;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
36 Pontevedra;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
36 Pontevedra;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
36 Pontevedra;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
36 Pontevedra;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
36 Pontevedra;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
36 Pontevedra;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
36 Pontevedra;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;96,04
36 Pontevedra;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
36 Pontevedra;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
36 Pontevedra;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
36 Pontevedra;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;96,51
36 Pontevedra;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
36 Pontevedra;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
36 Pontevedra;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
36 Pontevedra;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;95,79
36 Pontevedra;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
36 Pontevedra;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
36 Pontevedra;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;92,42
36 Pontevedra;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
36 Pontevedra;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
36 Pontevedra;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
36 Pontevedra;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;93,44
36 Pontevedra;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
36 Pontevedra;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
36 Pontevedra;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
36 Pontevedra;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;92,66
36 Pontevedra;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
36 Pontevedra;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
36 Pontevedra;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
36 Pontevedra;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
36 Pontevedra;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
36 Pontevedra;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
36 Pontevedra;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;90,34
36 Pontevedra;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
36 Pontevedra;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
36 Pontevedra;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
36 Pontevedra;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;90,45
36 Pontevedra;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
36 Pontevedra;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
36 Pontevedra;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
36 Pontevedra;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
36 Pontevedra;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
36 Pontevedra;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
36 Pontevedra;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;87,65
36 Pontevedra;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
36 Pontevedra;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
36 Pontevedra;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
36 Pontevedra;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;88,4
36 Pontevedra;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
36 Pontevedra;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
36 Pontevedra;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
36 Pontevedra;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
36 Pontevedra;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
36 Pontevedra;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
36 Pontevedra;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QIII;5.614
36 Pontevedra;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
36 Pontevedra;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
36 Pontevedra;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
36 Pontevedra;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QIII;5.829
36 Pontevedra;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
36 Pontevedra;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
36 Pontevedra;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
36 Pontevedra;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QIII;6.049
36 Pontevedra;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
36 Pontevedra;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
36 Pontevedra;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
36 Pontevedra;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2022QIII;5.401
36 Pontevedra;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2022QII;""
36 Pontevedra;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2022QI;""
36 Pontevedra;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
36 Pontevedra;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2021QIII;5.629
36 Pontevedra;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2021QII;""
36 Pontevedra;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2021QI;""
36 Pontevedra;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
36 Pontevedra;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2020QIII;5.790
36 Pontevedra;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2020QII;""
36 Pontevedra;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2020QI;""
36 Pontevedra;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2022QIV;5.195
36 Pontevedra;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
36 Pontevedra;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2022QII;""
36 Pontevedra;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2022QI;""
36 Pontevedra;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2021QIV;5.473
36 Pontevedra;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
36 Pontevedra;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2021QII;""
36 Pontevedra;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2021QI;""
36 Pontevedra;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2020QIV;5.607
36 Pontevedra;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
36 Pontevedra;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2020QII;""
36 Pontevedra;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2020QI;""
36 Pontevedra;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
36 Pontevedra;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
36 Pontevedra;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QII;""
36 Pontevedra;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QI;5.290
36 Pontevedra;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
36 Pontevedra;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
36 Pontevedra;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QII;""
36 Pontevedra;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QI;5.470
36 Pontevedra;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
36 Pontevedra;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
36 Pontevedra;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QII;""
36 Pontevedra;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QI;""
36 Pontevedra;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
36 Pontevedra;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
36 Pontevedra;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QII;5.147
36 Pontevedra;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QI;""
36 Pontevedra;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
36 Pontevedra;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
36 Pontevedra;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QII;5.356
36 Pontevedra;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QI;""
36 Pontevedra;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
36 Pontevedra;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
36 Pontevedra;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QII;""
36 Pontevedra;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QI;""
36 Pontevedra;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
36 Pontevedra;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
36 Pontevedra;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
36 Pontevedra;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
36 Pontevedra;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
36 Pontevedra;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
36 Pontevedra;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
36 Pontevedra;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
36 Pontevedra;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
36 Pontevedra;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
36 Pontevedra;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
36 Pontevedra;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
36 Pontevedra;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
36 Pontevedra;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;96,21
36 Pontevedra;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
36 Pontevedra;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
36 Pontevedra;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
36 Pontevedra;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;96,57
36 Pontevedra;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
36 Pontevedra;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
36 Pontevedra;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
36 Pontevedra;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;95,72
36 Pontevedra;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
36 Pontevedra;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
36 Pontevedra;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;92,54
36 Pontevedra;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
36 Pontevedra;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
36 Pontevedra;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
36 Pontevedra;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;93,89
36 Pontevedra;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
36 Pontevedra;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
36 Pontevedra;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
36 Pontevedra;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;92,69
36 Pontevedra;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
36 Pontevedra;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
36 Pontevedra;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
36 Pontevedra;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
36 Pontevedra;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
36 Pontevedra;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
36 Pontevedra;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;90,75
36 Pontevedra;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
36 Pontevedra;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
36 Pontevedra;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
36 Pontevedra;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;90,43
36 Pontevedra;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
36 Pontevedra;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
36 Pontevedra;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
36 Pontevedra;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
36 Pontevedra;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
36 Pontevedra;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
36 Pontevedra;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;88,3
36 Pontevedra;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
36 Pontevedra;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
36 Pontevedra;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
36 Pontevedra;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;88,54
36 Pontevedra;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
36 Pontevedra;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
36 Pontevedra;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
36 Pontevedra;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
36 Pontevedra;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
36 Pontevedra;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
36 Pontevedra;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QIII;4.197
36 Pontevedra;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
36 Pontevedra;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
36 Pontevedra;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
36 Pontevedra;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QIII;4.310
36 Pontevedra;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
36 Pontevedra;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
36 Pontevedra;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
36 Pontevedra;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QIII;4.418
36 Pontevedra;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
36 Pontevedra;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
36 Pontevedra;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
36 Pontevedra;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2022QIII;4.021
36 Pontevedra;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2022QII;""
36 Pontevedra;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2022QI;""
36 Pontevedra;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
36 Pontevedra;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2021QIII;4.156
36 Pontevedra;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2021QII;""
36 Pontevedra;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2021QI;""
36 Pontevedra;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
36 Pontevedra;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2020QIII;4.236
36 Pontevedra;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2020QII;""
36 Pontevedra;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2020QI;""
36 Pontevedra;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2022QIV;3.872
36 Pontevedra;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
36 Pontevedra;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2022QII;""
36 Pontevedra;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2022QI;""
36 Pontevedra;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2021QIV;4.001
36 Pontevedra;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
36 Pontevedra;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2021QII;""
36 Pontevedra;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2021QI;""
36 Pontevedra;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2020QIV;4.092
36 Pontevedra;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
36 Pontevedra;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2020QII;""
36 Pontevedra;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2020QI;""
36 Pontevedra;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
36 Pontevedra;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
36 Pontevedra;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QII;""
36 Pontevedra;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QI;3.870
36 Pontevedra;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
36 Pontevedra;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
36 Pontevedra;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QII;""
36 Pontevedra;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QI;3.997
36 Pontevedra;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
36 Pontevedra;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
36 Pontevedra;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QII;""
36 Pontevedra;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QI;""
36 Pontevedra;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
36 Pontevedra;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
36 Pontevedra;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QII;3.740
36 Pontevedra;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QI;""
36 Pontevedra;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
36 Pontevedra;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
36 Pontevedra;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QII;3.897
36 Pontevedra;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QI;""
36 Pontevedra;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
36 Pontevedra;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
36 Pontevedra;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QII;""
36 Pontevedra;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QI;""
36 Pontevedra;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
36 Pontevedra;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
36 Pontevedra;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
36 Pontevedra;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
36 Pontevedra;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
36 Pontevedra;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
36 Pontevedra;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
36 Pontevedra;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
36 Pontevedra;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
36 Pontevedra;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
36 Pontevedra;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
36 Pontevedra;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
36 Pontevedra;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
36 Pontevedra;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;95,81
36 Pontevedra;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
36 Pontevedra;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
36 Pontevedra;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
36 Pontevedra;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;96,43
36 Pontevedra;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
36 Pontevedra;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
36 Pontevedra;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
36 Pontevedra;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;95,88
36 Pontevedra;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
36 Pontevedra;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
36 Pontevedra;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;92,26
36 Pontevedra;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
36 Pontevedra;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
36 Pontevedra;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
36 Pontevedra;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;92,83
36 Pontevedra;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
36 Pontevedra;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
36 Pontevedra;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
36 Pontevedra;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;92,62
36 Pontevedra;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
36 Pontevedra;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
36 Pontevedra;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
36 Pontevedra;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
36 Pontevedra;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
36 Pontevedra;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
36 Pontevedra;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;89,79
36 Pontevedra;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
36 Pontevedra;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
36 Pontevedra;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
36 Pontevedra;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;90,47
36 Pontevedra;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
36 Pontevedra;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
36 Pontevedra;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
36 Pontevedra;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
36 Pontevedra;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
36 Pontevedra;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
36 Pontevedra;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;86,77
36 Pontevedra;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
36 Pontevedra;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
36 Pontevedra;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
36 Pontevedra;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;88,21
36 Pontevedra;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
36 Pontevedra;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
36 Pontevedra;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
36 Pontevedra;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
36 Pontevedra;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
36 Pontevedra;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QIV;9.811
36 Pontevedra;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
36 Pontevedra;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
36 Pontevedra;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
36 Pontevedra;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QIV;10.253
36 Pontevedra;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
36 Pontevedra;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
36 Pontevedra;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
36 Pontevedra;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QIV;10.497
36 Pontevedra;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
36 Pontevedra;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
36 Pontevedra;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
36 Pontevedra;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2022QIV;9.415
36 Pontevedra;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
36 Pontevedra;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2022QII;""
36 Pontevedra;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2022QI;""
36 Pontevedra;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2021QIV;9.903
36 Pontevedra;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
36 Pontevedra;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2021QII;""
36 Pontevedra;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2021QI;""
36 Pontevedra;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2020QIV;10.128
36 Pontevedra;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
36 Pontevedra;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2020QII;""
36 Pontevedra;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2020QI;""
36 Pontevedra;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
36 Pontevedra;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
36 Pontevedra;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2022QII;""
36 Pontevedra;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2022QI;9.557
36 Pontevedra;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
36 Pontevedra;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
36 Pontevedra;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2021QII;""
36 Pontevedra;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2021QI;9.863
36 Pontevedra;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
36 Pontevedra;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
36 Pontevedra;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2020QII;""
36 Pontevedra;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2020QI;""
36 Pontevedra;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
36 Pontevedra;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
36 Pontevedra;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QII;9.251
36 Pontevedra;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QI;""
36 Pontevedra;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
36 Pontevedra;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
36 Pontevedra;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QII;9.624
36 Pontevedra;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QI;""
36 Pontevedra;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
36 Pontevedra;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
36 Pontevedra;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QII;""
36 Pontevedra;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QI;""
36 Pontevedra;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
36 Pontevedra;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QIII;8.988
36 Pontevedra;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QII;""
36 Pontevedra;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QI;""
36 Pontevedra;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
36 Pontevedra;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QIII;9.394
36 Pontevedra;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QII;""
36 Pontevedra;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QI;""
36 Pontevedra;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
36 Pontevedra;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
36 Pontevedra;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QII;""
36 Pontevedra;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QI;""
36 Pontevedra;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
36 Pontevedra;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
36 Pontevedra;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
36 Pontevedra;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
36 Pontevedra;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
36 Pontevedra;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
36 Pontevedra;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
36 Pontevedra;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
36 Pontevedra;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
36 Pontevedra;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
36 Pontevedra;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
36 Pontevedra;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
36 Pontevedra;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;95,96
36 Pontevedra;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
36 Pontevedra;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
36 Pontevedra;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
36 Pontevedra;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;96,59
36 Pontevedra;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
36 Pontevedra;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
36 Pontevedra;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
36 Pontevedra;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;96,48
36 Pontevedra;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
36 Pontevedra;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
36 Pontevedra;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
36 Pontevedra;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
36 Pontevedra;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
36 Pontevedra;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
36 Pontevedra;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;93,21
36 Pontevedra;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
36 Pontevedra;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
36 Pontevedra;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
36 Pontevedra;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;93,96
36 Pontevedra;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
36 Pontevedra;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
36 Pontevedra;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
36 Pontevedra;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
36 Pontevedra;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
36 Pontevedra;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
36 Pontevedra;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;90,23
36 Pontevedra;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
36 Pontevedra;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
36 Pontevedra;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
36 Pontevedra;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;91,68
36 Pontevedra;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
36 Pontevedra;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
36 Pontevedra;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
36 Pontevedra;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
36 Pontevedra;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
36 Pontevedra;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
36 Pontevedra;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;87,66
36 Pontevedra;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
36 Pontevedra;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
36 Pontevedra;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
36 Pontevedra;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;89,49
36 Pontevedra;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
36 Pontevedra;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
36 Pontevedra;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
36 Pontevedra;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
36 Pontevedra;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
36 Pontevedra;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
36 Pontevedra;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QIV;5.624
36 Pontevedra;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
36 Pontevedra;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
36 Pontevedra;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
36 Pontevedra;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QIV;5.902
36 Pontevedra;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
36 Pontevedra;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
36 Pontevedra;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
36 Pontevedra;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QIV;6.048
36 Pontevedra;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
36 Pontevedra;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
36 Pontevedra;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
36 Pontevedra;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2022QIV;5.389
36 Pontevedra;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
36 Pontevedra;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2022QII;""
36 Pontevedra;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2022QI;""
36 Pontevedra;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2021QIV;5.723
36 Pontevedra;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
36 Pontevedra;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2021QII;""
36 Pontevedra;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2021QI;""
36 Pontevedra;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2020QIV;5.838
36 Pontevedra;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
36 Pontevedra;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2020QII;""
36 Pontevedra;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2020QI;""
36 Pontevedra;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
36 Pontevedra;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
36 Pontevedra;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2022QII;""
36 Pontevedra;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2022QI;5.517
36 Pontevedra;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
36 Pontevedra;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
36 Pontevedra;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2021QII;""
36 Pontevedra;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2021QI;5.681
36 Pontevedra;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
36 Pontevedra;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
36 Pontevedra;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2020QII;""
36 Pontevedra;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2020QI;""
36 Pontevedra;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
36 Pontevedra;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
36 Pontevedra;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QII;5.358
36 Pontevedra;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QI;""
36 Pontevedra;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
36 Pontevedra;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
36 Pontevedra;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QII;5.552
36 Pontevedra;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QI;""
36 Pontevedra;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
36 Pontevedra;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
36 Pontevedra;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QII;""
36 Pontevedra;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QI;""
36 Pontevedra;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
36 Pontevedra;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QIII;5.230
36 Pontevedra;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QII;""
36 Pontevedra;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QI;""
36 Pontevedra;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
36 Pontevedra;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QIII;5.432
36 Pontevedra;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QII;""
36 Pontevedra;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QI;""
36 Pontevedra;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
36 Pontevedra;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
36 Pontevedra;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QII;""
36 Pontevedra;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QI;""
36 Pontevedra;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
36 Pontevedra;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
36 Pontevedra;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
36 Pontevedra;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
36 Pontevedra;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
36 Pontevedra;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
36 Pontevedra;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
36 Pontevedra;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
36 Pontevedra;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
36 Pontevedra;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
36 Pontevedra;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
36 Pontevedra;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
36 Pontevedra;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;95,82
36 Pontevedra;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
36 Pontevedra;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
36 Pontevedra;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
36 Pontevedra;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;96,97
36 Pontevedra;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
36 Pontevedra;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
36 Pontevedra;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
36 Pontevedra;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;96,53
36 Pontevedra;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
36 Pontevedra;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
36 Pontevedra;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
36 Pontevedra;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
36 Pontevedra;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
36 Pontevedra;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
36 Pontevedra;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;93,48
36 Pontevedra;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
36 Pontevedra;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
36 Pontevedra;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
36 Pontevedra;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;93,93
36 Pontevedra;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
36 Pontevedra;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
36 Pontevedra;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
36 Pontevedra;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
36 Pontevedra;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
36 Pontevedra;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
36 Pontevedra;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;90,78
36 Pontevedra;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
36 Pontevedra;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
36 Pontevedra;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
36 Pontevedra;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;91,8
36 Pontevedra;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
36 Pontevedra;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
36 Pontevedra;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
36 Pontevedra;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
36 Pontevedra;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
36 Pontevedra;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
36 Pontevedra;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;88,61
36 Pontevedra;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
36 Pontevedra;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
36 Pontevedra;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
36 Pontevedra;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;89,81
36 Pontevedra;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
36 Pontevedra;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
36 Pontevedra;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
36 Pontevedra;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
36 Pontevedra;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
36 Pontevedra;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
36 Pontevedra;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QIV;4.187
36 Pontevedra;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
36 Pontevedra;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
36 Pontevedra;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
36 Pontevedra;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QIV;4.351
36 Pontevedra;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
36 Pontevedra;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
36 Pontevedra;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
36 Pontevedra;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QIV;4.449
36 Pontevedra;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
36 Pontevedra;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
36 Pontevedra;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
36 Pontevedra;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2022QIV;4.026
36 Pontevedra;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
36 Pontevedra;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2022QII;""
36 Pontevedra;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2022QI;""
36 Pontevedra;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2021QIV;4.180
36 Pontevedra;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
36 Pontevedra;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2021QII;""
36 Pontevedra;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2021QI;""
36 Pontevedra;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2020QIV;4.290
36 Pontevedra;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
36 Pontevedra;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2020QII;""
36 Pontevedra;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2020QI;""
36 Pontevedra;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
36 Pontevedra;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
36 Pontevedra;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2022QII;""
36 Pontevedra;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2022QI;4.040
36 Pontevedra;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
36 Pontevedra;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
36 Pontevedra;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2021QII;""
36 Pontevedra;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2021QI;4.182
36 Pontevedra;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
36 Pontevedra;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
36 Pontevedra;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2020QII;""
36 Pontevedra;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2020QI;""
36 Pontevedra;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
36 Pontevedra;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
36 Pontevedra;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QII;3.893
36 Pontevedra;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QI;""
36 Pontevedra;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
36 Pontevedra;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
36 Pontevedra;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QII;4.072
36 Pontevedra;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QI;""
36 Pontevedra;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
36 Pontevedra;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
36 Pontevedra;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QII;""
36 Pontevedra;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QI;""
36 Pontevedra;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
36 Pontevedra;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QIII;3.758
36 Pontevedra;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QII;""
36 Pontevedra;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QI;""
36 Pontevedra;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
36 Pontevedra;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QIII;3.962
36 Pontevedra;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QII;""
36 Pontevedra;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QI;""
36 Pontevedra;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
36 Pontevedra;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
36 Pontevedra;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QII;""
36 Pontevedra;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QI;""
36 Pontevedra;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
36 Pontevedra;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
36 Pontevedra;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
36 Pontevedra;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
36 Pontevedra;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
36 Pontevedra;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
36 Pontevedra;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
36 Pontevedra;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
36 Pontevedra;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
36 Pontevedra;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
36 Pontevedra;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
36 Pontevedra;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
36 Pontevedra;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;96,15
36 Pontevedra;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
36 Pontevedra;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
36 Pontevedra;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
36 Pontevedra;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;96,07
36 Pontevedra;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
36 Pontevedra;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
36 Pontevedra;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
36 Pontevedra;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;96,43
36 Pontevedra;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
36 Pontevedra;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
36 Pontevedra;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
36 Pontevedra;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
36 Pontevedra;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
36 Pontevedra;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
36 Pontevedra;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;92,85
36 Pontevedra;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
36 Pontevedra;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
36 Pontevedra;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
36 Pontevedra;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;94
36 Pontevedra;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
36 Pontevedra;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
36 Pontevedra;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
36 Pontevedra;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
36 Pontevedra;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
36 Pontevedra;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
36 Pontevedra;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;89,47
36 Pontevedra;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
36 Pontevedra;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
36 Pontevedra;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
36 Pontevedra;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;91,53
36 Pontevedra;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
36 Pontevedra;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
36 Pontevedra;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
36 Pontevedra;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
36 Pontevedra;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
36 Pontevedra;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
36 Pontevedra;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;86,37
36 Pontevedra;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
36 Pontevedra;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
36 Pontevedra;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
36 Pontevedra;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;89,05
36 Pontevedra;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
36 Pontevedra;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
36 Pontevedra;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
36 Pontevedra;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
36 Pontevedra;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
36 Pontevedra;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
36 Pontevedra;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
36 Pontevedra;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
36 Pontevedra;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
36 Pontevedra;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QI;20.285
36 Pontevedra;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
36 Pontevedra;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
36 Pontevedra;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
36 Pontevedra;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QI;20.236
36 Pontevedra;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
36 Pontevedra;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
36 Pontevedra;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
36 Pontevedra;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QI;20.178
36 Pontevedra;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
36 Pontevedra;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
36 Pontevedra;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2022QII;""
36 Pontevedra;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2022QI;19.769
36 Pontevedra;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
36 Pontevedra;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
36 Pontevedra;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2021QII;""
36 Pontevedra;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2021QI;19.898
36 Pontevedra;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
36 Pontevedra;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
36 Pontevedra;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2020QII;""
36 Pontevedra;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2020QI;19.189
36 Pontevedra;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
36 Pontevedra;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
36 Pontevedra;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2022QII;19.302
36 Pontevedra;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2022QI;""
36 Pontevedra;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
36 Pontevedra;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
36 Pontevedra;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2021QII;19.520
36 Pontevedra;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2021QI;""
36 Pontevedra;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
36 Pontevedra;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
36 Pontevedra;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2020QII;18.906
36 Pontevedra;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2020QI;""
36 Pontevedra;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
36 Pontevedra;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QIII;18.940
36 Pontevedra;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QII;""
36 Pontevedra;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QI;""
36 Pontevedra;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
36 Pontevedra;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QIII;19.223
36 Pontevedra;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QII;""
36 Pontevedra;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QI;""
36 Pontevedra;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
36 Pontevedra;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QIII;18.544
36 Pontevedra;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QII;""
36 Pontevedra;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QI;""
36 Pontevedra;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QIV;18.544
36 Pontevedra;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
36 Pontevedra;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QII;""
36 Pontevedra;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QI;""
36 Pontevedra;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QIV;18.858
36 Pontevedra;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
36 Pontevedra;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QII;""
36 Pontevedra;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QI;""
36 Pontevedra;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QIV;18.199
36 Pontevedra;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
36 Pontevedra;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QII;""
36 Pontevedra;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QI;""
36 Pontevedra;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
36 Pontevedra;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
36 Pontevedra;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
36 Pontevedra;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
36 Pontevedra;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
36 Pontevedra;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
36 Pontevedra;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
36 Pontevedra;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
36 Pontevedra;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
36 Pontevedra;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
36 Pontevedra;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
36 Pontevedra;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
36 Pontevedra;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
36 Pontevedra;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
36 Pontevedra;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
36 Pontevedra;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;97,46
36 Pontevedra;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
36 Pontevedra;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
36 Pontevedra;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
36 Pontevedra;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;98,33
36 Pontevedra;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
36 Pontevedra;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
36 Pontevedra;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
36 Pontevedra;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;95,1
36 Pontevedra;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
36 Pontevedra;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
36 Pontevedra;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;95,15
36 Pontevedra;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
36 Pontevedra;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
36 Pontevedra;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
36 Pontevedra;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;96,46
36 Pontevedra;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
36 Pontevedra;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
36 Pontevedra;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
36 Pontevedra;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;93,7
36 Pontevedra;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
36 Pontevedra;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
36 Pontevedra;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;93,37
36 Pontevedra;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
36 Pontevedra;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
36 Pontevedra;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
36 Pontevedra;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;94,99
36 Pontevedra;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
36 Pontevedra;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
36 Pontevedra;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
36 Pontevedra;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;91,9
36 Pontevedra;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
36 Pontevedra;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
36 Pontevedra;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;91,42
36 Pontevedra;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
36 Pontevedra;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
36 Pontevedra;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
36 Pontevedra;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;93,19
36 Pontevedra;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
36 Pontevedra;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
36 Pontevedra;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
36 Pontevedra;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;90,19
36 Pontevedra;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
36 Pontevedra;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
36 Pontevedra;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
36 Pontevedra;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
36 Pontevedra;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
36 Pontevedra;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
36 Pontevedra;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QI;12.132
36 Pontevedra;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
36 Pontevedra;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
36 Pontevedra;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
36 Pontevedra;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QI;12.138
36 Pontevedra;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
36 Pontevedra;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
36 Pontevedra;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
36 Pontevedra;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QI;12.112
36 Pontevedra;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
36 Pontevedra;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
36 Pontevedra;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2022QII;""
36 Pontevedra;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2022QI;11.846
36 Pontevedra;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
36 Pontevedra;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
36 Pontevedra;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2021QII;""
36 Pontevedra;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2021QI;11.921
36 Pontevedra;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
36 Pontevedra;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
36 Pontevedra;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2020QII;""
36 Pontevedra;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2020QI;11.546
36 Pontevedra;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
36 Pontevedra;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
36 Pontevedra;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2022QII;11.610
36 Pontevedra;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2022QI;""
36 Pontevedra;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
36 Pontevedra;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
36 Pontevedra;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2021QII;11.731
36 Pontevedra;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2021QI;""
36 Pontevedra;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
36 Pontevedra;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
36 Pontevedra;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2020QII;11.399
36 Pontevedra;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2020QI;""
36 Pontevedra;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
36 Pontevedra;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QIII;11.404
36 Pontevedra;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QII;""
36 Pontevedra;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QI;""
36 Pontevedra;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
36 Pontevedra;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QIII;11.560
36 Pontevedra;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QII;""
36 Pontevedra;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QI;""
36 Pontevedra;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
36 Pontevedra;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QIII;11.199
36 Pontevedra;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QII;""
36 Pontevedra;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QI;""
36 Pontevedra;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QIV;11.199
36 Pontevedra;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
36 Pontevedra;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QII;""
36 Pontevedra;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QI;""
36 Pontevedra;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QIV;11.360
36 Pontevedra;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
36 Pontevedra;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QII;""
36 Pontevedra;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QI;""
36 Pontevedra;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QIV;11.011
36 Pontevedra;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
36 Pontevedra;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QII;""
36 Pontevedra;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QI;""
36 Pontevedra;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
36 Pontevedra;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
36 Pontevedra;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
36 Pontevedra;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
36 Pontevedra;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
36 Pontevedra;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
36 Pontevedra;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
36 Pontevedra;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
36 Pontevedra;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
36 Pontevedra;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
36 Pontevedra;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
36 Pontevedra;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
36 Pontevedra;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
36 Pontevedra;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
36 Pontevedra;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
36 Pontevedra;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;97,64
36 Pontevedra;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
36 Pontevedra;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
36 Pontevedra;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
36 Pontevedra;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;98,21
36 Pontevedra;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
36 Pontevedra;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
36 Pontevedra;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
36 Pontevedra;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;95,33
36 Pontevedra;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
36 Pontevedra;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
36 Pontevedra;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;95,7
36 Pontevedra;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
36 Pontevedra;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
36 Pontevedra;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
36 Pontevedra;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;96,65
36 Pontevedra;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
36 Pontevedra;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
36 Pontevedra;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
36 Pontevedra;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;94,11
36 Pontevedra;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
36 Pontevedra;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
36 Pontevedra;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;94
36 Pontevedra;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
36 Pontevedra;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
36 Pontevedra;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
36 Pontevedra;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;95,24
36 Pontevedra;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
36 Pontevedra;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
36 Pontevedra;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
36 Pontevedra;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;92,46
36 Pontevedra;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
36 Pontevedra;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
36 Pontevedra;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;92,31
36 Pontevedra;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
36 Pontevedra;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
36 Pontevedra;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
36 Pontevedra;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;93,59
36 Pontevedra;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
36 Pontevedra;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
36 Pontevedra;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
36 Pontevedra;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;90,91
36 Pontevedra;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
36 Pontevedra;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
36 Pontevedra;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
36 Pontevedra;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
36 Pontevedra;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
36 Pontevedra;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
36 Pontevedra;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QI;8.153
36 Pontevedra;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
36 Pontevedra;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
36 Pontevedra;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
36 Pontevedra;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QI;8.098
36 Pontevedra;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
36 Pontevedra;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
36 Pontevedra;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
36 Pontevedra;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QI;8.066
36 Pontevedra;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
36 Pontevedra;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
36 Pontevedra;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2022QII;""
36 Pontevedra;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2022QI;7.923
36 Pontevedra;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
36 Pontevedra;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
36 Pontevedra;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2021QII;""
36 Pontevedra;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2021QI;7.977
36 Pontevedra;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
36 Pontevedra;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
36 Pontevedra;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2020QII;""
36 Pontevedra;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2020QI;7.643
36 Pontevedra;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
36 Pontevedra;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
36 Pontevedra;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2022QII;7.692
36 Pontevedra;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2022QI;""
36 Pontevedra;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
36 Pontevedra;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
36 Pontevedra;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2021QII;7.789
36 Pontevedra;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2021QI;""
36 Pontevedra;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
36 Pontevedra;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
36 Pontevedra;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2020QII;7.507
36 Pontevedra;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2020QI;""
36 Pontevedra;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
36 Pontevedra;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QIII;7.536
36 Pontevedra;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QII;""
36 Pontevedra;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QI;""
36 Pontevedra;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
36 Pontevedra;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QIII;7.663
36 Pontevedra;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QII;""
36 Pontevedra;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QI;""
36 Pontevedra;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
36 Pontevedra;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QIII;7.345
36 Pontevedra;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QII;""
36 Pontevedra;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QI;""
36 Pontevedra;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QIV;7.345
36 Pontevedra;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
36 Pontevedra;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QII;""
36 Pontevedra;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QI;""
36 Pontevedra;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QIV;7.498
36 Pontevedra;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
36 Pontevedra;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QII;""
36 Pontevedra;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QI;""
36 Pontevedra;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QIV;7.188
36 Pontevedra;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
36 Pontevedra;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QII;""
36 Pontevedra;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QI;""
36 Pontevedra;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
36 Pontevedra;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
36 Pontevedra;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
36 Pontevedra;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
36 Pontevedra;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
36 Pontevedra;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
36 Pontevedra;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
36 Pontevedra;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
36 Pontevedra;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
36 Pontevedra;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
36 Pontevedra;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
36 Pontevedra;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
36 Pontevedra;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
36 Pontevedra;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
36 Pontevedra;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
36 Pontevedra;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;97,18
36 Pontevedra;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
36 Pontevedra;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
36 Pontevedra;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
36 Pontevedra;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;98,51
36 Pontevedra;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
36 Pontevedra;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
36 Pontevedra;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
36 Pontevedra;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;94,76
36 Pontevedra;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
36 Pontevedra;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
36 Pontevedra;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;94,35
36 Pontevedra;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
36 Pontevedra;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
36 Pontevedra;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
36 Pontevedra;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;96,18
36 Pontevedra;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
36 Pontevedra;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
36 Pontevedra;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
36 Pontevedra;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;93,07
36 Pontevedra;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
36 Pontevedra;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
36 Pontevedra;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;92,43
36 Pontevedra;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
36 Pontevedra;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
36 Pontevedra;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
36 Pontevedra;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;94,63
36 Pontevedra;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
36 Pontevedra;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
36 Pontevedra;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
36 Pontevedra;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;91,06
36 Pontevedra;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
36 Pontevedra;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
36 Pontevedra;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;90,09
36 Pontevedra;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
36 Pontevedra;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
36 Pontevedra;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
36 Pontevedra;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;92,59
36 Pontevedra;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
36 Pontevedra;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
36 Pontevedra;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
36 Pontevedra;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;89,11
36 Pontevedra;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
36 Pontevedra;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
36 Pontevedra;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
36 Pontevedra;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
36 Pontevedra;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
36 Pontevedra;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QII;19.713
36 Pontevedra;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
36 Pontevedra;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
36 Pontevedra;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
36 Pontevedra;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QII;19.973
36 Pontevedra;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
36 Pontevedra;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
36 Pontevedra;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
36 Pontevedra;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QII;20.001
36 Pontevedra;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
36 Pontevedra;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
36 Pontevedra;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
36 Pontevedra;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2022QII;19.223
36 Pontevedra;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2022QI;""
36 Pontevedra;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
36 Pontevedra;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
36 Pontevedra;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2021QII;19.545
36 Pontevedra;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2021QI;""
36 Pontevedra;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
36 Pontevedra;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
36 Pontevedra;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2020QII;19.689
36 Pontevedra;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2020QI;""
36 Pontevedra;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
36 Pontevedra;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2022QIII;18.833
36 Pontevedra;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2022QII;""
36 Pontevedra;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2022QI;""
36 Pontevedra;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
36 Pontevedra;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2021QIII;19.199
36 Pontevedra;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2021QII;""
36 Pontevedra;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2021QI;""
36 Pontevedra;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
36 Pontevedra;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2020QIII;19.174
36 Pontevedra;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2020QII;""
36 Pontevedra;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2020QI;""
36 Pontevedra;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QIV;18.402
36 Pontevedra;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
36 Pontevedra;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QII;""
36 Pontevedra;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QI;""
36 Pontevedra;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QIV;18.783
36 Pontevedra;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
36 Pontevedra;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QII;""
36 Pontevedra;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QI;""
36 Pontevedra;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QIV;18.799
36 Pontevedra;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
36 Pontevedra;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QII;""
36 Pontevedra;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QI;""
36 Pontevedra;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
36 Pontevedra;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
36 Pontevedra;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QII;""
36 Pontevedra;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QI;18.381
36 Pontevedra;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
36 Pontevedra;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
36 Pontevedra;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QII;""
36 Pontevedra;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QI;18.546
36 Pontevedra;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
36 Pontevedra;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
36 Pontevedra;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QII;""
36 Pontevedra;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QI;""
36 Pontevedra;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
36 Pontevedra;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
36 Pontevedra;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
36 Pontevedra;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
36 Pontevedra;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
36 Pontevedra;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
36 Pontevedra;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
36 Pontevedra;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
36 Pontevedra;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
36 Pontevedra;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
36 Pontevedra;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
36 Pontevedra;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
36 Pontevedra;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
36 Pontevedra;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
36 Pontevedra;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;97,51
36 Pontevedra;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
36 Pontevedra;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
36 Pontevedra;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
36 Pontevedra;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;97,86
36 Pontevedra;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
36 Pontevedra;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
36 Pontevedra;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
36 Pontevedra;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;98,44
36 Pontevedra;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
36 Pontevedra;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
36 Pontevedra;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;95,54
36 Pontevedra;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
36 Pontevedra;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
36 Pontevedra;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
36 Pontevedra;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;96,12
36 Pontevedra;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
36 Pontevedra;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
36 Pontevedra;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
36 Pontevedra;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;95,87
36 Pontevedra;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
36 Pontevedra;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
36 Pontevedra;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;93,35
36 Pontevedra;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
36 Pontevedra;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
36 Pontevedra;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
36 Pontevedra;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;94,04
36 Pontevedra;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
36 Pontevedra;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
36 Pontevedra;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
36 Pontevedra;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;93,99
36 Pontevedra;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
36 Pontevedra;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
36 Pontevedra;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
36 Pontevedra;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
36 Pontevedra;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
36 Pontevedra;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
36 Pontevedra;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;92,03
36 Pontevedra;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
36 Pontevedra;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
36 Pontevedra;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
36 Pontevedra;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;92,73
36 Pontevedra;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
36 Pontevedra;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
36 Pontevedra;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
36 Pontevedra;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
36 Pontevedra;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
36 Pontevedra;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
36 Pontevedra;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QII;11.764
36 Pontevedra;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
36 Pontevedra;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
36 Pontevedra;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
36 Pontevedra;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QII;11.938
36 Pontevedra;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
36 Pontevedra;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
36 Pontevedra;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
36 Pontevedra;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QII;11.998
36 Pontevedra;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
36 Pontevedra;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
36 Pontevedra;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
36 Pontevedra;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2022QII;11.510
36 Pontevedra;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2022QI;""
36 Pontevedra;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
36 Pontevedra;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
36 Pontevedra;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2021QII;11.710
36 Pontevedra;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2021QI;""
36 Pontevedra;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
36 Pontevedra;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
36 Pontevedra;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2020QII;11.836
36 Pontevedra;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2020QI;""
36 Pontevedra;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
36 Pontevedra;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2022QIII;11.301
36 Pontevedra;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2022QII;""
36 Pontevedra;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2022QI;""
36 Pontevedra;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
36 Pontevedra;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2021QIII;11.512
36 Pontevedra;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2021QII;""
36 Pontevedra;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2021QI;""
36 Pontevedra;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
36 Pontevedra;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2020QIII;11.542
36 Pontevedra;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2020QII;""
36 Pontevedra;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2020QI;""
36 Pontevedra;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QIV;11.073
36 Pontevedra;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
36 Pontevedra;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QII;""
36 Pontevedra;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QI;""
36 Pontevedra;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QIV;11.286
36 Pontevedra;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
36 Pontevedra;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QII;""
36 Pontevedra;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QI;""
36 Pontevedra;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QIV;11.334
36 Pontevedra;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
36 Pontevedra;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QII;""
36 Pontevedra;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QI;""
36 Pontevedra;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
36 Pontevedra;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
36 Pontevedra;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QII;""
36 Pontevedra;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QI;11.069
36 Pontevedra;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
36 Pontevedra;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
36 Pontevedra;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QII;""
36 Pontevedra;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QI;11.174
36 Pontevedra;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
36 Pontevedra;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
36 Pontevedra;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QII;""
36 Pontevedra;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QI;""
36 Pontevedra;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
36 Pontevedra;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
36 Pontevedra;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
36 Pontevedra;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
36 Pontevedra;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
36 Pontevedra;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
36 Pontevedra;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
36 Pontevedra;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
36 Pontevedra;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
36 Pontevedra;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
36 Pontevedra;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
36 Pontevedra;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
36 Pontevedra;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
36 Pontevedra;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
36 Pontevedra;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;97,84
36 Pontevedra;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
36 Pontevedra;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
36 Pontevedra;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
36 Pontevedra;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;98,09
36 Pontevedra;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
36 Pontevedra;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
36 Pontevedra;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
36 Pontevedra;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;98,65
36 Pontevedra;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
36 Pontevedra;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
36 Pontevedra;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;96,06
36 Pontevedra;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
36 Pontevedra;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
36 Pontevedra;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
36 Pontevedra;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;96,43
36 Pontevedra;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
36 Pontevedra;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
36 Pontevedra;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
36 Pontevedra;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;96,2
36 Pontevedra;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
36 Pontevedra;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
36 Pontevedra;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;94,13
36 Pontevedra;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
36 Pontevedra;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
36 Pontevedra;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
36 Pontevedra;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;94,54
36 Pontevedra;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
36 Pontevedra;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
36 Pontevedra;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
36 Pontevedra;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;94,47
36 Pontevedra;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
36 Pontevedra;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
36 Pontevedra;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
36 Pontevedra;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
36 Pontevedra;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
36 Pontevedra;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
36 Pontevedra;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;92,72
36 Pontevedra;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
36 Pontevedra;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
36 Pontevedra;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
36 Pontevedra;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;93,13
36 Pontevedra;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
36 Pontevedra;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
36 Pontevedra;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
36 Pontevedra;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
36 Pontevedra;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
36 Pontevedra;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
36 Pontevedra;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QII;7.949
36 Pontevedra;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
36 Pontevedra;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
36 Pontevedra;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
36 Pontevedra;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QII;8.035
36 Pontevedra;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
36 Pontevedra;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
36 Pontevedra;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
36 Pontevedra;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QII;8.003
36 Pontevedra;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
36 Pontevedra;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
36 Pontevedra;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
36 Pontevedra;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2022QII;7.713
36 Pontevedra;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2022QI;""
36 Pontevedra;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
36 Pontevedra;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
36 Pontevedra;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2021QII;7.835
36 Pontevedra;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2021QI;""
36 Pontevedra;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
36 Pontevedra;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
36 Pontevedra;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2020QII;7.853
36 Pontevedra;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2020QI;""
36 Pontevedra;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
36 Pontevedra;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2022QIII;7.532
36 Pontevedra;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2022QII;""
36 Pontevedra;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2022QI;""
36 Pontevedra;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
36 Pontevedra;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2021QIII;7.687
36 Pontevedra;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2021QII;""
36 Pontevedra;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2021QI;""
36 Pontevedra;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
36 Pontevedra;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2020QIII;7.632
36 Pontevedra;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2020QII;""
36 Pontevedra;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2020QI;""
36 Pontevedra;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QIV;7.329
36 Pontevedra;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
36 Pontevedra;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QII;""
36 Pontevedra;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QI;""
36 Pontevedra;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QIV;7.497
36 Pontevedra;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
36 Pontevedra;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QII;""
36 Pontevedra;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QI;""
36 Pontevedra;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QIV;7.465
36 Pontevedra;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
36 Pontevedra;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QII;""
36 Pontevedra;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QI;""
36 Pontevedra;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
36 Pontevedra;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
36 Pontevedra;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QII;""
36 Pontevedra;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QI;7.312
36 Pontevedra;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
36 Pontevedra;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
36 Pontevedra;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QII;""
36 Pontevedra;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QI;7.372
36 Pontevedra;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
36 Pontevedra;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
36 Pontevedra;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QII;""
36 Pontevedra;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QI;""
36 Pontevedra;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
36 Pontevedra;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
36 Pontevedra;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
36 Pontevedra;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
36 Pontevedra;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
36 Pontevedra;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
36 Pontevedra;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
36 Pontevedra;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
36 Pontevedra;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
36 Pontevedra;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
36 Pontevedra;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
36 Pontevedra;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
36 Pontevedra;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
36 Pontevedra;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
36 Pontevedra;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;97,03
36 Pontevedra;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
36 Pontevedra;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
36 Pontevedra;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
36 Pontevedra;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;97,51
36 Pontevedra;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
36 Pontevedra;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
36 Pontevedra;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
36 Pontevedra;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;98,13
36 Pontevedra;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
36 Pontevedra;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
36 Pontevedra;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;94,75
36 Pontevedra;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
36 Pontevedra;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
36 Pontevedra;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
36 Pontevedra;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;95,67
36 Pontevedra;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
36 Pontevedra;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
36 Pontevedra;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
36 Pontevedra;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;95,36
36 Pontevedra;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
36 Pontevedra;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
36 Pontevedra;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;92,2
36 Pontevedra;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
36 Pontevedra;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
36 Pontevedra;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
36 Pontevedra;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;93,3
36 Pontevedra;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
36 Pontevedra;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
36 Pontevedra;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
36 Pontevedra;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;93,28
36 Pontevedra;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
36 Pontevedra;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
36 Pontevedra;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
36 Pontevedra;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
36 Pontevedra;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
36 Pontevedra;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
36 Pontevedra;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;91
36 Pontevedra;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
36 Pontevedra;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
36 Pontevedra;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
36 Pontevedra;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;92,12
36 Pontevedra;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
36 Pontevedra;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
36 Pontevedra;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
36 Pontevedra;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
36 Pontevedra;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
36 Pontevedra;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QIII;19.846
36 Pontevedra;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
36 Pontevedra;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
36 Pontevedra;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
36 Pontevedra;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QIII;20.209
36 Pontevedra;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
36 Pontevedra;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
36 Pontevedra;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
36 Pontevedra;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QIII;20.196
36 Pontevedra;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
36 Pontevedra;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
36 Pontevedra;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
36 Pontevedra;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2022QIII;19.337
36 Pontevedra;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2022QII;""
36 Pontevedra;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2022QI;""
36 Pontevedra;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
36 Pontevedra;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2021QIII;19.774
36 Pontevedra;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2021QII;""
36 Pontevedra;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2021QI;""
36 Pontevedra;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
36 Pontevedra;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2020QIII;19.587
36 Pontevedra;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2020QII;""
36 Pontevedra;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2020QI;""
36 Pontevedra;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2022QIV;18.828
36 Pontevedra;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
36 Pontevedra;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2022QII;""
36 Pontevedra;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2022QI;""
36 Pontevedra;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2021QIV;19.293
36 Pontevedra;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
36 Pontevedra;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2021QII;""
36 Pontevedra;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2021QI;""
36 Pontevedra;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2020QIV;19.164
36 Pontevedra;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
36 Pontevedra;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2020QII;""
36 Pontevedra;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2020QI;""
36 Pontevedra;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
36 Pontevedra;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
36 Pontevedra;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QII;""
36 Pontevedra;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QI;18.862
36 Pontevedra;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
36 Pontevedra;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
36 Pontevedra;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QII;""
36 Pontevedra;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QI;18.895
36 Pontevedra;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
36 Pontevedra;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
36 Pontevedra;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QII;""
36 Pontevedra;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QI;""
36 Pontevedra;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
36 Pontevedra;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
36 Pontevedra;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QII;18.479
36 Pontevedra;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QI;""
36 Pontevedra;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
36 Pontevedra;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
36 Pontevedra;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QII;18.585
36 Pontevedra;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QI;""
36 Pontevedra;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
36 Pontevedra;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
36 Pontevedra;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QII;""
36 Pontevedra;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QI;""
36 Pontevedra;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
36 Pontevedra;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
36 Pontevedra;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
36 Pontevedra;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
36 Pontevedra;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
36 Pontevedra;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
36 Pontevedra;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
36 Pontevedra;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
36 Pontevedra;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
36 Pontevedra;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
36 Pontevedra;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
36 Pontevedra;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
36 Pontevedra;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
36 Pontevedra;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;97,44
36 Pontevedra;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
36 Pontevedra;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
36 Pontevedra;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
36 Pontevedra;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;97,85
36 Pontevedra;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
36 Pontevedra;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
36 Pontevedra;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
36 Pontevedra;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;96,98
36 Pontevedra;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
36 Pontevedra;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
36 Pontevedra;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;94,87
36 Pontevedra;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
36 Pontevedra;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
36 Pontevedra;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
36 Pontevedra;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;95,47
36 Pontevedra;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
36 Pontevedra;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
36 Pontevedra;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
36 Pontevedra;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;94,89
36 Pontevedra;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
36 Pontevedra;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
36 Pontevedra;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
36 Pontevedra;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
36 Pontevedra;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
36 Pontevedra;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
36 Pontevedra;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;93,33
36 Pontevedra;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
36 Pontevedra;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
36 Pontevedra;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
36 Pontevedra;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;93,56
36 Pontevedra;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
36 Pontevedra;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
36 Pontevedra;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
36 Pontevedra;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
36 Pontevedra;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
36 Pontevedra;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
36 Pontevedra;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;91,44
36 Pontevedra;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
36 Pontevedra;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
36 Pontevedra;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
36 Pontevedra;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;92,02
36 Pontevedra;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
36 Pontevedra;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
36 Pontevedra;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
36 Pontevedra;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
36 Pontevedra;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
36 Pontevedra;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
36 Pontevedra;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QIII;11.846
36 Pontevedra;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
36 Pontevedra;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
36 Pontevedra;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
36 Pontevedra;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QIII;12.076
36 Pontevedra;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
36 Pontevedra;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
36 Pontevedra;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
36 Pontevedra;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QIII;12.154
36 Pontevedra;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
36 Pontevedra;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
36 Pontevedra;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
36 Pontevedra;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2022QIII;11.568
36 Pontevedra;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2022QII;""
36 Pontevedra;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2022QI;""
36 Pontevedra;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
36 Pontevedra;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2021QIII;11.839
36 Pontevedra;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2021QII;""
36 Pontevedra;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2021QI;""
36 Pontevedra;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
36 Pontevedra;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2020QIII;11.808
36 Pontevedra;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2020QII;""
36 Pontevedra;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2020QI;""
36 Pontevedra;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2022QIV;11.301
36 Pontevedra;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
36 Pontevedra;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2022QII;""
36 Pontevedra;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2022QI;""
36 Pontevedra;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2021QIV;11.574
36 Pontevedra;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
36 Pontevedra;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2021QII;""
36 Pontevedra;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2021QI;""
36 Pontevedra;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2020QIV;11.570
36 Pontevedra;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
36 Pontevedra;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2020QII;""
36 Pontevedra;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2020QI;""
36 Pontevedra;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
36 Pontevedra;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
36 Pontevedra;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QII;""
36 Pontevedra;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QI;11.341
36 Pontevedra;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
36 Pontevedra;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
36 Pontevedra;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QII;""
36 Pontevedra;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QI;11.399
36 Pontevedra;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
36 Pontevedra;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
36 Pontevedra;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QII;""
36 Pontevedra;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QI;""
36 Pontevedra;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
36 Pontevedra;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
36 Pontevedra;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QII;11.152
36 Pontevedra;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QI;""
36 Pontevedra;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
36 Pontevedra;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
36 Pontevedra;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QII;11.248
36 Pontevedra;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QI;""
36 Pontevedra;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
36 Pontevedra;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
36 Pontevedra;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QII;""
36 Pontevedra;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QI;""
36 Pontevedra;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
36 Pontevedra;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
36 Pontevedra;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
36 Pontevedra;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
36 Pontevedra;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
36 Pontevedra;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
36 Pontevedra;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
36 Pontevedra;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
36 Pontevedra;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
36 Pontevedra;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
36 Pontevedra;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
36 Pontevedra;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
36 Pontevedra;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
36 Pontevedra;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;97,65
36 Pontevedra;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
36 Pontevedra;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
36 Pontevedra;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
36 Pontevedra;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;98,04
36 Pontevedra;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
36 Pontevedra;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
36 Pontevedra;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
36 Pontevedra;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;97,15
36 Pontevedra;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
36 Pontevedra;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
36 Pontevedra;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;95,4
36 Pontevedra;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
36 Pontevedra;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
36 Pontevedra;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
36 Pontevedra;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;95,84
36 Pontevedra;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
36 Pontevedra;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
36 Pontevedra;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
36 Pontevedra;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;95,19
36 Pontevedra;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
36 Pontevedra;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
36 Pontevedra;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
36 Pontevedra;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
36 Pontevedra;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
36 Pontevedra;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
36 Pontevedra;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;93,91
36 Pontevedra;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
36 Pontevedra;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
36 Pontevedra;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
36 Pontevedra;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;93,79
36 Pontevedra;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
36 Pontevedra;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
36 Pontevedra;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
36 Pontevedra;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
36 Pontevedra;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
36 Pontevedra;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
36 Pontevedra;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;92,35
36 Pontevedra;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
36 Pontevedra;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
36 Pontevedra;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
36 Pontevedra;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;92,55
36 Pontevedra;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
36 Pontevedra;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
36 Pontevedra;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
36 Pontevedra;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
36 Pontevedra;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
36 Pontevedra;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
36 Pontevedra;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QIII;8.000
36 Pontevedra;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
36 Pontevedra;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
36 Pontevedra;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
36 Pontevedra;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QIII;8.133
36 Pontevedra;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
36 Pontevedra;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
36 Pontevedra;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
36 Pontevedra;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QIII;8.042
36 Pontevedra;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
36 Pontevedra;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
36 Pontevedra;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
36 Pontevedra;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2022QIII;7.769
36 Pontevedra;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2022QII;""
36 Pontevedra;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2022QI;""
36 Pontevedra;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
36 Pontevedra;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2021QIII;7.935
36 Pontevedra;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2021QII;""
36 Pontevedra;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2021QI;""
36 Pontevedra;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
36 Pontevedra;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2020QIII;7.779
36 Pontevedra;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2020QII;""
36 Pontevedra;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2020QI;""
36 Pontevedra;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2022QIV;7.527
36 Pontevedra;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
36 Pontevedra;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2022QII;""
36 Pontevedra;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2022QI;""
36 Pontevedra;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2021QIV;7.719
36 Pontevedra;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
36 Pontevedra;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2021QII;""
36 Pontevedra;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2021QI;""
36 Pontevedra;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2020QIV;7.594
36 Pontevedra;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
36 Pontevedra;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2020QII;""
36 Pontevedra;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2020QI;""
36 Pontevedra;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
36 Pontevedra;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
36 Pontevedra;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QII;""
36 Pontevedra;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QI;7.521
36 Pontevedra;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
36 Pontevedra;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
36 Pontevedra;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QII;""
36 Pontevedra;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QI;7.496
36 Pontevedra;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
36 Pontevedra;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
36 Pontevedra;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QII;""
36 Pontevedra;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QI;""
36 Pontevedra;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
36 Pontevedra;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
36 Pontevedra;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QII;7.327
36 Pontevedra;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QI;""
36 Pontevedra;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
36 Pontevedra;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
36 Pontevedra;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QII;7.337
36 Pontevedra;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QI;""
36 Pontevedra;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
36 Pontevedra;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
36 Pontevedra;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QII;""
36 Pontevedra;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QI;""
36 Pontevedra;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
36 Pontevedra;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
36 Pontevedra;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
36 Pontevedra;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
36 Pontevedra;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
36 Pontevedra;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
36 Pontevedra;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
36 Pontevedra;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
36 Pontevedra;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
36 Pontevedra;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
36 Pontevedra;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
36 Pontevedra;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
36 Pontevedra;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
36 Pontevedra;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;97,11
36 Pontevedra;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
36 Pontevedra;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
36 Pontevedra;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
36 Pontevedra;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;97,57
36 Pontevedra;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
36 Pontevedra;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
36 Pontevedra;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
36 Pontevedra;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;96,73
36 Pontevedra;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
36 Pontevedra;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
36 Pontevedra;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;94,09
36 Pontevedra;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
36 Pontevedra;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
36 Pontevedra;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
36 Pontevedra;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;94,91
36 Pontevedra;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
36 Pontevedra;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
36 Pontevedra;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
36 Pontevedra;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;94,43
36 Pontevedra;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
36 Pontevedra;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
36 Pontevedra;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
36 Pontevedra;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
36 Pontevedra;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
36 Pontevedra;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
36 Pontevedra;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;92,48
36 Pontevedra;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
36 Pontevedra;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
36 Pontevedra;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
36 Pontevedra;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;93,21
36 Pontevedra;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
36 Pontevedra;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
36 Pontevedra;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
36 Pontevedra;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
36 Pontevedra;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
36 Pontevedra;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
36 Pontevedra;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;90,09
36 Pontevedra;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
36 Pontevedra;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
36 Pontevedra;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
36 Pontevedra;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;91,23
36 Pontevedra;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
36 Pontevedra;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
36 Pontevedra;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
36 Pontevedra;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
36 Pontevedra;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
36 Pontevedra;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QIV;19.786
36 Pontevedra;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
36 Pontevedra;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
36 Pontevedra;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
36 Pontevedra;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QIV;20.287
36 Pontevedra;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
36 Pontevedra;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
36 Pontevedra;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
36 Pontevedra;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QIV;20.181
36 Pontevedra;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
36 Pontevedra;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
36 Pontevedra;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
36 Pontevedra;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2022QIV;19.237
36 Pontevedra;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
36 Pontevedra;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2022QII;""
36 Pontevedra;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2022QI;""
36 Pontevedra;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2021QIV;19.747
36 Pontevedra;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
36 Pontevedra;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2021QII;""
36 Pontevedra;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2021QI;""
36 Pontevedra;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2020QIV;19.668
36 Pontevedra;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
36 Pontevedra;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2020QII;""
36 Pontevedra;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2020QI;""
36 Pontevedra;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
36 Pontevedra;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
36 Pontevedra;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2022QII;""
36 Pontevedra;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2022QI;19.284
36 Pontevedra;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
36 Pontevedra;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
36 Pontevedra;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2021QII;""
36 Pontevedra;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2021QI;19.373
36 Pontevedra;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
36 Pontevedra;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
36 Pontevedra;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2020QII;""
36 Pontevedra;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2020QI;""
36 Pontevedra;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
36 Pontevedra;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
36 Pontevedra;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QII;18.867
36 Pontevedra;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QI;""
36 Pontevedra;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
36 Pontevedra;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
36 Pontevedra;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QII;19.031
36 Pontevedra;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QI;""
36 Pontevedra;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
36 Pontevedra;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
36 Pontevedra;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QII;""
36 Pontevedra;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QI;""
36 Pontevedra;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
36 Pontevedra;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QIII;18.524
36 Pontevedra;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QII;""
36 Pontevedra;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QI;""
36 Pontevedra;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
36 Pontevedra;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QIII;18.758
36 Pontevedra;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QII;""
36 Pontevedra;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QI;""
36 Pontevedra;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
36 Pontevedra;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
36 Pontevedra;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QII;""
36 Pontevedra;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QI;""
36 Pontevedra;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
36 Pontevedra;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
36 Pontevedra;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
36 Pontevedra;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
36 Pontevedra;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
36 Pontevedra;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
36 Pontevedra;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
36 Pontevedra;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
36 Pontevedra;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
36 Pontevedra;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
36 Pontevedra;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
36 Pontevedra;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
36 Pontevedra;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;97,23
36 Pontevedra;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
36 Pontevedra;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
36 Pontevedra;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
36 Pontevedra;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;97,34
36 Pontevedra;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
36 Pontevedra;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
36 Pontevedra;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
36 Pontevedra;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;97,46
36 Pontevedra;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
36 Pontevedra;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
36 Pontevedra;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
36 Pontevedra;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
36 Pontevedra;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
36 Pontevedra;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
36 Pontevedra;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;95,06
36 Pontevedra;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
36 Pontevedra;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
36 Pontevedra;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
36 Pontevedra;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;96
36 Pontevedra;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
36 Pontevedra;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
36 Pontevedra;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
36 Pontevedra;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
36 Pontevedra;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
36 Pontevedra;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
36 Pontevedra;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;93
36 Pontevedra;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
36 Pontevedra;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
36 Pontevedra;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
36 Pontevedra;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;94,3
36 Pontevedra;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
36 Pontevedra;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
36 Pontevedra;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
36 Pontevedra;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
36 Pontevedra;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
36 Pontevedra;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
36 Pontevedra;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;91,31
36 Pontevedra;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
36 Pontevedra;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
36 Pontevedra;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
36 Pontevedra;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;92,95
36 Pontevedra;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
36 Pontevedra;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
36 Pontevedra;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
36 Pontevedra;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
36 Pontevedra;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
36 Pontevedra;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
36 Pontevedra;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QIV;11.815
36 Pontevedra;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
36 Pontevedra;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
36 Pontevedra;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
36 Pontevedra;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QIV;12.143
36 Pontevedra;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
36 Pontevedra;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
36 Pontevedra;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
36 Pontevedra;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QIV;12.138
36 Pontevedra;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
36 Pontevedra;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
36 Pontevedra;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
36 Pontevedra;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2022QIV;11.526
36 Pontevedra;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
36 Pontevedra;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2022QII;""
36 Pontevedra;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2022QI;""
36 Pontevedra;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2021QIV;11.844
36 Pontevedra;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
36 Pontevedra;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2021QII;""
36 Pontevedra;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2021QI;""
36 Pontevedra;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2020QIV;11.851
36 Pontevedra;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
36 Pontevedra;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2020QII;""
36 Pontevedra;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2020QI;""
36 Pontevedra;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
36 Pontevedra;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
36 Pontevedra;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2022QII;""
36 Pontevedra;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2022QI;11.591
36 Pontevedra;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
36 Pontevedra;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
36 Pontevedra;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2021QII;""
36 Pontevedra;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2021QI;11.662
36 Pontevedra;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
36 Pontevedra;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
36 Pontevedra;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2020QII;""
36 Pontevedra;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2020QI;""
36 Pontevedra;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
36 Pontevedra;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
36 Pontevedra;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QII;11.384
36 Pontevedra;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QI;""
36 Pontevedra;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
36 Pontevedra;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
36 Pontevedra;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QII;11.492
36 Pontevedra;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QI;""
36 Pontevedra;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
36 Pontevedra;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
36 Pontevedra;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QII;""
36 Pontevedra;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QI;""
36 Pontevedra;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
36 Pontevedra;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QIII;11.190
36 Pontevedra;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QII;""
36 Pontevedra;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QI;""
36 Pontevedra;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
36 Pontevedra;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QIII;11.333
36 Pontevedra;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QII;""
36 Pontevedra;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QI;""
36 Pontevedra;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
36 Pontevedra;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
36 Pontevedra;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QII;""
36 Pontevedra;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QI;""
36 Pontevedra;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
36 Pontevedra;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
36 Pontevedra;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
36 Pontevedra;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
36 Pontevedra;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
36 Pontevedra;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
36 Pontevedra;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
36 Pontevedra;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
36 Pontevedra;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
36 Pontevedra;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
36 Pontevedra;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
36 Pontevedra;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
36 Pontevedra;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;97,55
36 Pontevedra;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
36 Pontevedra;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
36 Pontevedra;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
36 Pontevedra;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;97,54
36 Pontevedra;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
36 Pontevedra;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
36 Pontevedra;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
36 Pontevedra;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;97,64
36 Pontevedra;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
36 Pontevedra;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
36 Pontevedra;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
36 Pontevedra;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
36 Pontevedra;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
36 Pontevedra;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
36 Pontevedra;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;95,45
36 Pontevedra;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
36 Pontevedra;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
36 Pontevedra;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
36 Pontevedra;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;96,08
36 Pontevedra;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
36 Pontevedra;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
36 Pontevedra;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
36 Pontevedra;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
36 Pontevedra;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
36 Pontevedra;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
36 Pontevedra;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;93,75
36 Pontevedra;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
36 Pontevedra;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
36 Pontevedra;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
36 Pontevedra;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;94,68
36 Pontevedra;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
36 Pontevedra;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
36 Pontevedra;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
36 Pontevedra;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
36 Pontevedra;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
36 Pontevedra;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
36 Pontevedra;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;92,15
36 Pontevedra;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
36 Pontevedra;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
36 Pontevedra;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
36 Pontevedra;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;93,37
36 Pontevedra;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
36 Pontevedra;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
36 Pontevedra;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
36 Pontevedra;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
36 Pontevedra;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
36 Pontevedra;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
36 Pontevedra;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QIV;7.971
36 Pontevedra;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
36 Pontevedra;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
36 Pontevedra;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
36 Pontevedra;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QIV;8.144
36 Pontevedra;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
36 Pontevedra;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
36 Pontevedra;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
36 Pontevedra;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QIV;8.043
36 Pontevedra;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
36 Pontevedra;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
36 Pontevedra;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
36 Pontevedra;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2022QIV;7.711
36 Pontevedra;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
36 Pontevedra;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2022QII;""
36 Pontevedra;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2022QI;""
36 Pontevedra;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2021QIV;7.903
36 Pontevedra;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
36 Pontevedra;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2021QII;""
36 Pontevedra;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2021QI;""
36 Pontevedra;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2020QIV;7.817
36 Pontevedra;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
36 Pontevedra;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2020QII;""
36 Pontevedra;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2020QI;""
36 Pontevedra;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
36 Pontevedra;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
36 Pontevedra;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2022QII;""
36 Pontevedra;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2022QI;7.693
36 Pontevedra;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
36 Pontevedra;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
36 Pontevedra;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2021QII;""
36 Pontevedra;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2021QI;7.711
36 Pontevedra;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
36 Pontevedra;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
36 Pontevedra;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2020QII;""
36 Pontevedra;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2020QI;""
36 Pontevedra;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
36 Pontevedra;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
36 Pontevedra;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QII;7.483
36 Pontevedra;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QI;""
36 Pontevedra;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
36 Pontevedra;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
36 Pontevedra;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QII;7.539
36 Pontevedra;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QI;""
36 Pontevedra;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
36 Pontevedra;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
36 Pontevedra;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QII;""
36 Pontevedra;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QI;""
36 Pontevedra;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
36 Pontevedra;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QIII;7.334
36 Pontevedra;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QII;""
36 Pontevedra;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QI;""
36 Pontevedra;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
36 Pontevedra;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QIII;7.425
36 Pontevedra;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QII;""
36 Pontevedra;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QI;""
36 Pontevedra;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
36 Pontevedra;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
36 Pontevedra;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QII;""
36 Pontevedra;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QI;""
36 Pontevedra;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
36 Pontevedra;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
36 Pontevedra;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
36 Pontevedra;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
36 Pontevedra;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
36 Pontevedra;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
36 Pontevedra;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
36 Pontevedra;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
36 Pontevedra;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
36 Pontevedra;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
36 Pontevedra;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
36 Pontevedra;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
36 Pontevedra;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;96,74
36 Pontevedra;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
36 Pontevedra;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
36 Pontevedra;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
36 Pontevedra;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;97,04
36 Pontevedra;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
36 Pontevedra;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
36 Pontevedra;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
36 Pontevedra;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;97,19
36 Pontevedra;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
36 Pontevedra;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
36 Pontevedra;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
36 Pontevedra;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
36 Pontevedra;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
36 Pontevedra;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
36 Pontevedra;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;94,46
36 Pontevedra;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
36 Pontevedra;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
36 Pontevedra;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
36 Pontevedra;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;95,87
36 Pontevedra;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
36 Pontevedra;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
36 Pontevedra;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
36 Pontevedra;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
36 Pontevedra;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
36 Pontevedra;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
36 Pontevedra;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;91,88
36 Pontevedra;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
36 Pontevedra;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
36 Pontevedra;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
36 Pontevedra;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;93,73
36 Pontevedra;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
36 Pontevedra;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
36 Pontevedra;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
36 Pontevedra;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
36 Pontevedra;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
36 Pontevedra;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
36 Pontevedra;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;90,05
36 Pontevedra;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
36 Pontevedra;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
36 Pontevedra;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
36 Pontevedra;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;92,32
36 Pontevedra;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
36 Pontevedra;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
36 Pontevedra;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
36 Pontevedra;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
36 Pontevedra;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
36 Pontevedra;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
36 Pontevedra;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
36 Pontevedra;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
36 Pontevedra;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
36 Pontevedra;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QI;18.723
36 Pontevedra;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
36 Pontevedra;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
36 Pontevedra;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
36 Pontevedra;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QI;18.093
36 Pontevedra;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
36 Pontevedra;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
36 Pontevedra;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
36 Pontevedra;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QI;18.456
36 Pontevedra;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
36 Pontevedra;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
36 Pontevedra;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2022QII;""
36 Pontevedra;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2022QI;18.297
36 Pontevedra;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
36 Pontevedra;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
36 Pontevedra;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2021QII;""
36 Pontevedra;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2021QI;17.826
36 Pontevedra;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
36 Pontevedra;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
36 Pontevedra;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2020QII;""
36 Pontevedra;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2020QI;17.745
36 Pontevedra;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
36 Pontevedra;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
36 Pontevedra;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2022QII;17.951
36 Pontevedra;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2022QI;""
36 Pontevedra;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
36 Pontevedra;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
36 Pontevedra;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2021QII;17.563
36 Pontevedra;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2021QI;""
36 Pontevedra;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
36 Pontevedra;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
36 Pontevedra;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2020QII;17.482
36 Pontevedra;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2020QI;""
36 Pontevedra;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
36 Pontevedra;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QIII;17.699
36 Pontevedra;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QII;""
36 Pontevedra;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QI;""
36 Pontevedra;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
36 Pontevedra;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QIII;17.334
36 Pontevedra;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QII;""
36 Pontevedra;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QI;""
36 Pontevedra;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
36 Pontevedra;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QIII;17.207
36 Pontevedra;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QII;""
36 Pontevedra;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QI;""
36 Pontevedra;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QIV;17.369
36 Pontevedra;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
36 Pontevedra;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QII;""
36 Pontevedra;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QI;""
36 Pontevedra;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QIV;17.059
36 Pontevedra;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
36 Pontevedra;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QII;""
36 Pontevedra;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QI;""
36 Pontevedra;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QIV;16.933
36 Pontevedra;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
36 Pontevedra;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QII;""
36 Pontevedra;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QI;""
36 Pontevedra;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
36 Pontevedra;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
36 Pontevedra;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
36 Pontevedra;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
36 Pontevedra;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
36 Pontevedra;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
36 Pontevedra;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
36 Pontevedra;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
36 Pontevedra;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
36 Pontevedra;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
36 Pontevedra;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
36 Pontevedra;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
36 Pontevedra;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
36 Pontevedra;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
36 Pontevedra;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
36 Pontevedra;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;97,72
36 Pontevedra;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
36 Pontevedra;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
36 Pontevedra;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
36 Pontevedra;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;98,52
36 Pontevedra;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
36 Pontevedra;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
36 Pontevedra;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
36 Pontevedra;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;96,15
36 Pontevedra;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
36 Pontevedra;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
36 Pontevedra;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;95,88
36 Pontevedra;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
36 Pontevedra;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
36 Pontevedra;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
36 Pontevedra;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;97,07
36 Pontevedra;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
36 Pontevedra;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
36 Pontevedra;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
36 Pontevedra;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;94,72
36 Pontevedra;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
36 Pontevedra;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
36 Pontevedra;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;94,53
36 Pontevedra;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
36 Pontevedra;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
36 Pontevedra;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
36 Pontevedra;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;95,81
36 Pontevedra;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
36 Pontevedra;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
36 Pontevedra;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
36 Pontevedra;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;93,23
36 Pontevedra;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
36 Pontevedra;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
36 Pontevedra;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;92,77
36 Pontevedra;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
36 Pontevedra;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
36 Pontevedra;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
36 Pontevedra;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;94,29
36 Pontevedra;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
36 Pontevedra;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
36 Pontevedra;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
36 Pontevedra;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;91,75
36 Pontevedra;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
36 Pontevedra;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
36 Pontevedra;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
36 Pontevedra;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
36 Pontevedra;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
36 Pontevedra;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
36 Pontevedra;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QI;11.334
36 Pontevedra;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
36 Pontevedra;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
36 Pontevedra;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
36 Pontevedra;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QI;11.020
36 Pontevedra;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
36 Pontevedra;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
36 Pontevedra;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
36 Pontevedra;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QI;11.158
36 Pontevedra;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
36 Pontevedra;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
36 Pontevedra;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2022QII;""
36 Pontevedra;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2022QI;11.064
36 Pontevedra;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
36 Pontevedra;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
36 Pontevedra;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2021QII;""
36 Pontevedra;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2021QI;10.863
36 Pontevedra;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
36 Pontevedra;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
36 Pontevedra;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2020QII;""
36 Pontevedra;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2020QI;10.750
36 Pontevedra;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
36 Pontevedra;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
36 Pontevedra;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2022QII;10.876
36 Pontevedra;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2022QI;""
36 Pontevedra;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
36 Pontevedra;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
36 Pontevedra;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2021QII;10.690
36 Pontevedra;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2021QI;""
36 Pontevedra;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
36 Pontevedra;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
36 Pontevedra;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2020QII;10.621
36 Pontevedra;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2020QI;""
36 Pontevedra;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
36 Pontevedra;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QIII;10.741
36 Pontevedra;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QII;""
36 Pontevedra;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QI;""
36 Pontevedra;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
36 Pontevedra;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QIII;10.558
36 Pontevedra;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QII;""
36 Pontevedra;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QI;""
36 Pontevedra;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
36 Pontevedra;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QIII;10.475
36 Pontevedra;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QII;""
36 Pontevedra;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QI;""
36 Pontevedra;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QIV;10.566
36 Pontevedra;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
36 Pontevedra;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QII;""
36 Pontevedra;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QI;""
36 Pontevedra;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QIV;10.413
36 Pontevedra;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
36 Pontevedra;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QII;""
36 Pontevedra;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QI;""
36 Pontevedra;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QIV;10.321
36 Pontevedra;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
36 Pontevedra;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QII;""
36 Pontevedra;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QI;""
36 Pontevedra;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
36 Pontevedra;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
36 Pontevedra;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
36 Pontevedra;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
36 Pontevedra;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
36 Pontevedra;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
36 Pontevedra;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
36 Pontevedra;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
36 Pontevedra;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
36 Pontevedra;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
36 Pontevedra;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
36 Pontevedra;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
36 Pontevedra;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
36 Pontevedra;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
36 Pontevedra;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
36 Pontevedra;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;97,62
36 Pontevedra;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
36 Pontevedra;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
36 Pontevedra;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
36 Pontevedra;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;98,58
36 Pontevedra;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
36 Pontevedra;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
36 Pontevedra;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
36 Pontevedra;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;96,34
36 Pontevedra;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
36 Pontevedra;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
36 Pontevedra;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;95,96
36 Pontevedra;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
36 Pontevedra;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
36 Pontevedra;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
36 Pontevedra;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;97,01
36 Pontevedra;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
36 Pontevedra;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
36 Pontevedra;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
36 Pontevedra;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;95,19
36 Pontevedra;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
36 Pontevedra;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
36 Pontevedra;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;94,77
36 Pontevedra;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
36 Pontevedra;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
36 Pontevedra;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
36 Pontevedra;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;95,81
36 Pontevedra;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
36 Pontevedra;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
36 Pontevedra;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
36 Pontevedra;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;93,88
36 Pontevedra;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
36 Pontevedra;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
36 Pontevedra;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;93,22
36 Pontevedra;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
36 Pontevedra;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
36 Pontevedra;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
36 Pontevedra;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;94,49
36 Pontevedra;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
36 Pontevedra;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
36 Pontevedra;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
36 Pontevedra;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;92,5
36 Pontevedra;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
36 Pontevedra;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
36 Pontevedra;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
36 Pontevedra;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
36 Pontevedra;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
36 Pontevedra;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
36 Pontevedra;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QI;7.389
36 Pontevedra;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
36 Pontevedra;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
36 Pontevedra;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
36 Pontevedra;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QI;7.073
36 Pontevedra;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
36 Pontevedra;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
36 Pontevedra;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
36 Pontevedra;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QI;7.298
36 Pontevedra;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
36 Pontevedra;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
36 Pontevedra;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2022QII;""
36 Pontevedra;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2022QI;7.233
36 Pontevedra;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
36 Pontevedra;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
36 Pontevedra;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2021QII;""
36 Pontevedra;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2021QI;6.963
36 Pontevedra;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
36 Pontevedra;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
36 Pontevedra;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2020QII;""
36 Pontevedra;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2020QI;6.995
36 Pontevedra;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
36 Pontevedra;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
36 Pontevedra;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2022QII;7.075
36 Pontevedra;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2022QI;""
36 Pontevedra;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
36 Pontevedra;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
36 Pontevedra;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2021QII;6.873
36 Pontevedra;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2021QI;""
36 Pontevedra;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
36 Pontevedra;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
36 Pontevedra;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2020QII;6.861
36 Pontevedra;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2020QI;""
36 Pontevedra;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
36 Pontevedra;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QIII;6.958
36 Pontevedra;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QII;""
36 Pontevedra;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QI;""
36 Pontevedra;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
36 Pontevedra;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QIII;6.776
36 Pontevedra;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QII;""
36 Pontevedra;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QI;""
36 Pontevedra;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
36 Pontevedra;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QIII;6.732
36 Pontevedra;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QII;""
36 Pontevedra;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QI;""
36 Pontevedra;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QIV;6.803
36 Pontevedra;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
36 Pontevedra;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QII;""
36 Pontevedra;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QI;""
36 Pontevedra;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QIV;6.646
36 Pontevedra;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
36 Pontevedra;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QII;""
36 Pontevedra;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QI;""
36 Pontevedra;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QIV;6.612
36 Pontevedra;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
36 Pontevedra;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QII;""
36 Pontevedra;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QI;""
36 Pontevedra;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
36 Pontevedra;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
36 Pontevedra;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
36 Pontevedra;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
36 Pontevedra;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
36 Pontevedra;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
36 Pontevedra;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
36 Pontevedra;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
36 Pontevedra;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
36 Pontevedra;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
36 Pontevedra;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
36 Pontevedra;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
36 Pontevedra;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
36 Pontevedra;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
36 Pontevedra;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
36 Pontevedra;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;97,89
36 Pontevedra;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
36 Pontevedra;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
36 Pontevedra;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
36 Pontevedra;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;98,44
36 Pontevedra;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
36 Pontevedra;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
36 Pontevedra;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
36 Pontevedra;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;95,85
36 Pontevedra;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
36 Pontevedra;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
36 Pontevedra;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;95,75
36 Pontevedra;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
36 Pontevedra;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
36 Pontevedra;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
36 Pontevedra;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;97,17
36 Pontevedra;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
36 Pontevedra;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
36 Pontevedra;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
36 Pontevedra;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;94,01
36 Pontevedra;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
36 Pontevedra;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
36 Pontevedra;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;94,17
36 Pontevedra;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
36 Pontevedra;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
36 Pontevedra;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
36 Pontevedra;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;95,8
36 Pontevedra;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
36 Pontevedra;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
36 Pontevedra;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
36 Pontevedra;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;92,24
36 Pontevedra;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
36 Pontevedra;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
36 Pontevedra;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;92,07
36 Pontevedra;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
36 Pontevedra;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
36 Pontevedra;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
36 Pontevedra;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;93,96
36 Pontevedra;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
36 Pontevedra;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
36 Pontevedra;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
36 Pontevedra;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;90,6
36 Pontevedra;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
36 Pontevedra;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
36 Pontevedra;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
36 Pontevedra;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
36 Pontevedra;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
36 Pontevedra;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QII;19.180
36 Pontevedra;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
36 Pontevedra;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
36 Pontevedra;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
36 Pontevedra;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QII;18.729
36 Pontevedra;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
36 Pontevedra;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
36 Pontevedra;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
36 Pontevedra;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QII;18.296
36 Pontevedra;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
36 Pontevedra;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
36 Pontevedra;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
36 Pontevedra;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2022QII;18.792
36 Pontevedra;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2022QI;""
36 Pontevedra;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
36 Pontevedra;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
36 Pontevedra;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2021QII;18.413
36 Pontevedra;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2021QI;""
36 Pontevedra;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
36 Pontevedra;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
36 Pontevedra;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2020QII;18.017
36 Pontevedra;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2020QI;""
36 Pontevedra;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
36 Pontevedra;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2022QIII;18.509
36 Pontevedra;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2022QII;""
36 Pontevedra;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2022QI;""
36 Pontevedra;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
36 Pontevedra;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2021QIII;18.154
36 Pontevedra;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2021QII;""
36 Pontevedra;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2021QI;""
36 Pontevedra;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
36 Pontevedra;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2020QIII;17.617
36 Pontevedra;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2020QII;""
36 Pontevedra;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2020QI;""
36 Pontevedra;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QIV;18.162
36 Pontevedra;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
36 Pontevedra;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QII;""
36 Pontevedra;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QI;""
36 Pontevedra;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QIV;17.853
36 Pontevedra;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
36 Pontevedra;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QII;""
36 Pontevedra;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QI;""
36 Pontevedra;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QIV;17.321
36 Pontevedra;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
36 Pontevedra;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QII;""
36 Pontevedra;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QI;""
36 Pontevedra;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
36 Pontevedra;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
36 Pontevedra;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QII;""
36 Pontevedra;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QI;17.499
36 Pontevedra;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
36 Pontevedra;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
36 Pontevedra;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QII;""
36 Pontevedra;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QI;17.102
36 Pontevedra;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
36 Pontevedra;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
36 Pontevedra;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QII;""
36 Pontevedra;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QI;""
36 Pontevedra;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
36 Pontevedra;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
36 Pontevedra;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
36 Pontevedra;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
36 Pontevedra;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
36 Pontevedra;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
36 Pontevedra;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
36 Pontevedra;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
36 Pontevedra;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
36 Pontevedra;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
36 Pontevedra;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
36 Pontevedra;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
36 Pontevedra;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
36 Pontevedra;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
36 Pontevedra;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;97,98
36 Pontevedra;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
36 Pontevedra;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
36 Pontevedra;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
36 Pontevedra;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;98,31
36 Pontevedra;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
36 Pontevedra;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
36 Pontevedra;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
36 Pontevedra;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;98,48
36 Pontevedra;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
36 Pontevedra;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
36 Pontevedra;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;96,5
36 Pontevedra;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
36 Pontevedra;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
36 Pontevedra;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
36 Pontevedra;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;96,93
36 Pontevedra;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
36 Pontevedra;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
36 Pontevedra;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
36 Pontevedra;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;96,29
36 Pontevedra;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
36 Pontevedra;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
36 Pontevedra;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;94,69
36 Pontevedra;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
36 Pontevedra;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
36 Pontevedra;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
36 Pontevedra;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;95,32
36 Pontevedra;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
36 Pontevedra;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
36 Pontevedra;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
36 Pontevedra;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;94,67
36 Pontevedra;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
36 Pontevedra;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
36 Pontevedra;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
36 Pontevedra;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
36 Pontevedra;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
36 Pontevedra;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
36 Pontevedra;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;93,43
36 Pontevedra;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
36 Pontevedra;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
36 Pontevedra;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
36 Pontevedra;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;93,47
36 Pontevedra;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
36 Pontevedra;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
36 Pontevedra;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
36 Pontevedra;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
36 Pontevedra;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
36 Pontevedra;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
36 Pontevedra;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QII;11.569
36 Pontevedra;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
36 Pontevedra;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
36 Pontevedra;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
36 Pontevedra;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QII;11.379
36 Pontevedra;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
36 Pontevedra;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
36 Pontevedra;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
36 Pontevedra;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QII;11.067
36 Pontevedra;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
36 Pontevedra;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
36 Pontevedra;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
36 Pontevedra;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2022QII;11.358
36 Pontevedra;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2022QI;""
36 Pontevedra;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
36 Pontevedra;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
36 Pontevedra;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2021QII;11.180
36 Pontevedra;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2021QI;""
36 Pontevedra;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
36 Pontevedra;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
36 Pontevedra;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2020QII;10.928
36 Pontevedra;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2020QI;""
36 Pontevedra;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
36 Pontevedra;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2022QIII;11.199
36 Pontevedra;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2022QII;""
36 Pontevedra;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2022QI;""
36 Pontevedra;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
36 Pontevedra;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2021QIII;11.034
36 Pontevedra;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2021QII;""
36 Pontevedra;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2021QI;""
36 Pontevedra;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
36 Pontevedra;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2020QIII;10.704
36 Pontevedra;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2020QII;""
36 Pontevedra;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2020QI;""
36 Pontevedra;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QIV;11.011
36 Pontevedra;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
36 Pontevedra;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QII;""
36 Pontevedra;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QI;""
36 Pontevedra;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QIV;10.871
36 Pontevedra;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
36 Pontevedra;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QII;""
36 Pontevedra;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QI;""
36 Pontevedra;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QIV;10.536
36 Pontevedra;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
36 Pontevedra;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QII;""
36 Pontevedra;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QI;""
36 Pontevedra;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
36 Pontevedra;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
36 Pontevedra;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QII;""
36 Pontevedra;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QI;10.651
36 Pontevedra;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
36 Pontevedra;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
36 Pontevedra;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QII;""
36 Pontevedra;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QI;10.409
36 Pontevedra;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
36 Pontevedra;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
36 Pontevedra;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QII;""
36 Pontevedra;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QI;""
36 Pontevedra;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
36 Pontevedra;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
36 Pontevedra;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
36 Pontevedra;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
36 Pontevedra;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
36 Pontevedra;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
36 Pontevedra;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
36 Pontevedra;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
36 Pontevedra;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
36 Pontevedra;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
36 Pontevedra;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
36 Pontevedra;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
36 Pontevedra;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
36 Pontevedra;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
36 Pontevedra;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;98,18
36 Pontevedra;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
36 Pontevedra;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
36 Pontevedra;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
36 Pontevedra;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;98,25
36 Pontevedra;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
36 Pontevedra;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
36 Pontevedra;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
36 Pontevedra;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;98,74
36 Pontevedra;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
36 Pontevedra;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
36 Pontevedra;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;96,8
36 Pontevedra;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
36 Pontevedra;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
36 Pontevedra;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
36 Pontevedra;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;96,97
36 Pontevedra;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
36 Pontevedra;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
36 Pontevedra;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
36 Pontevedra;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;96,72
36 Pontevedra;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
36 Pontevedra;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
36 Pontevedra;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;95,18
36 Pontevedra;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
36 Pontevedra;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
36 Pontevedra;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
36 Pontevedra;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;95,54
36 Pontevedra;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
36 Pontevedra;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
36 Pontevedra;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
36 Pontevedra;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;95,2
36 Pontevedra;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
36 Pontevedra;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
36 Pontevedra;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
36 Pontevedra;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
36 Pontevedra;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
36 Pontevedra;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
36 Pontevedra;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;93,6
36 Pontevedra;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
36 Pontevedra;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
36 Pontevedra;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
36 Pontevedra;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;94,05
36 Pontevedra;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
36 Pontevedra;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
36 Pontevedra;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
36 Pontevedra;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
36 Pontevedra;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
36 Pontevedra;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
36 Pontevedra;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QII;7.611
36 Pontevedra;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
36 Pontevedra;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
36 Pontevedra;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
36 Pontevedra;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QII;7.350
36 Pontevedra;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
36 Pontevedra;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
36 Pontevedra;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
36 Pontevedra;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QII;7.229
36 Pontevedra;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
36 Pontevedra;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
36 Pontevedra;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
36 Pontevedra;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2022QII;7.434
36 Pontevedra;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2022QI;""
36 Pontevedra;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
36 Pontevedra;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
36 Pontevedra;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2021QII;7.233
36 Pontevedra;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2021QI;""
36 Pontevedra;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
36 Pontevedra;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
36 Pontevedra;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2020QII;7.089
36 Pontevedra;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2020QI;""
36 Pontevedra;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
36 Pontevedra;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2022QIII;7.310
36 Pontevedra;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2022QII;""
36 Pontevedra;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2022QI;""
36 Pontevedra;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
36 Pontevedra;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2021QIII;7.120
36 Pontevedra;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2021QII;""
36 Pontevedra;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2021QI;""
36 Pontevedra;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
36 Pontevedra;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2020QIII;6.913
36 Pontevedra;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2020QII;""
36 Pontevedra;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2020QI;""
36 Pontevedra;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QIV;7.151
36 Pontevedra;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
36 Pontevedra;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QII;""
36 Pontevedra;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QI;""
36 Pontevedra;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QIV;6.982
36 Pontevedra;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
36 Pontevedra;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QII;""
36 Pontevedra;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QI;""
36 Pontevedra;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QIV;6.785
36 Pontevedra;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
36 Pontevedra;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QII;""
36 Pontevedra;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QI;""
36 Pontevedra;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
36 Pontevedra;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
36 Pontevedra;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QII;""
36 Pontevedra;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QI;6.848
36 Pontevedra;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
36 Pontevedra;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
36 Pontevedra;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QII;""
36 Pontevedra;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QI;6.693
36 Pontevedra;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
36 Pontevedra;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
36 Pontevedra;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QII;""
36 Pontevedra;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QI;""
36 Pontevedra;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
36 Pontevedra;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
36 Pontevedra;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
36 Pontevedra;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
36 Pontevedra;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
36 Pontevedra;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
36 Pontevedra;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
36 Pontevedra;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
36 Pontevedra;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
36 Pontevedra;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
36 Pontevedra;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
36 Pontevedra;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
36 Pontevedra;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
36 Pontevedra;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
36 Pontevedra;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;97,67
36 Pontevedra;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
36 Pontevedra;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
36 Pontevedra;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
36 Pontevedra;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;98,41
36 Pontevedra;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
36 Pontevedra;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
36 Pontevedra;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
36 Pontevedra;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;98,06
36 Pontevedra;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
36 Pontevedra;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
36 Pontevedra;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;96,05
36 Pontevedra;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
36 Pontevedra;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
36 Pontevedra;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
36 Pontevedra;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;96,87
36 Pontevedra;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
36 Pontevedra;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
36 Pontevedra;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
36 Pontevedra;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;95,63
36 Pontevedra;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
36 Pontevedra;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
36 Pontevedra;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;93,96
36 Pontevedra;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
36 Pontevedra;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
36 Pontevedra;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
36 Pontevedra;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;94,99
36 Pontevedra;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
36 Pontevedra;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
36 Pontevedra;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
36 Pontevedra;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;93,86
36 Pontevedra;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
36 Pontevedra;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
36 Pontevedra;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
36 Pontevedra;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
36 Pontevedra;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
36 Pontevedra;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
36 Pontevedra;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;93,17
36 Pontevedra;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
36 Pontevedra;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
36 Pontevedra;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
36 Pontevedra;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;92,59
36 Pontevedra;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
36 Pontevedra;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
36 Pontevedra;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
36 Pontevedra;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
36 Pontevedra;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
36 Pontevedra;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QIII;19.187
36 Pontevedra;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
36 Pontevedra;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
36 Pontevedra;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
36 Pontevedra;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QIII;18.820
36 Pontevedra;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
36 Pontevedra;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
36 Pontevedra;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
36 Pontevedra;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QIII;18.340
36 Pontevedra;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
36 Pontevedra;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
36 Pontevedra;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
36 Pontevedra;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2022QIII;18.826
36 Pontevedra;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2022QII;""
36 Pontevedra;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2022QI;""
36 Pontevedra;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
36 Pontevedra;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2021QIII;18.485
36 Pontevedra;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2021QII;""
36 Pontevedra;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2021QI;""
36 Pontevedra;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
36 Pontevedra;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2020QIII;17.866
36 Pontevedra;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2020QII;""
36 Pontevedra;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2020QI;""
36 Pontevedra;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2022QIV;18.425
36 Pontevedra;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
36 Pontevedra;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2022QII;""
36 Pontevedra;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2022QI;""
36 Pontevedra;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2021QIV;18.144
36 Pontevedra;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
36 Pontevedra;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2021QII;""
36 Pontevedra;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2021QI;""
36 Pontevedra;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2020QIV;17.532
36 Pontevedra;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
36 Pontevedra;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2020QII;""
36 Pontevedra;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2020QI;""
36 Pontevedra;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
36 Pontevedra;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
36 Pontevedra;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QII;""
36 Pontevedra;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QI;17.772
36 Pontevedra;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
36 Pontevedra;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
36 Pontevedra;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QII;""
36 Pontevedra;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QI;17.306
36 Pontevedra;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
36 Pontevedra;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
36 Pontevedra;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QII;""
36 Pontevedra;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QI;""
36 Pontevedra;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
36 Pontevedra;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
36 Pontevedra;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QII;17.472
36 Pontevedra;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QI;""
36 Pontevedra;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
36 Pontevedra;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
36 Pontevedra;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QII;17.070
36 Pontevedra;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QI;""
36 Pontevedra;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
36 Pontevedra;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
36 Pontevedra;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QII;""
36 Pontevedra;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QI;""
36 Pontevedra;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
36 Pontevedra;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
36 Pontevedra;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
36 Pontevedra;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
36 Pontevedra;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
36 Pontevedra;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
36 Pontevedra;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
36 Pontevedra;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
36 Pontevedra;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
36 Pontevedra;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
36 Pontevedra;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
36 Pontevedra;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
36 Pontevedra;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
36 Pontevedra;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;98,12
36 Pontevedra;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
36 Pontevedra;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
36 Pontevedra;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
36 Pontevedra;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;98,22
36 Pontevedra;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
36 Pontevedra;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
36 Pontevedra;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
36 Pontevedra;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;97,42
36 Pontevedra;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
36 Pontevedra;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
36 Pontevedra;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;96,03
36 Pontevedra;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
36 Pontevedra;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
36 Pontevedra;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
36 Pontevedra;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;96,41
36 Pontevedra;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
36 Pontevedra;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
36 Pontevedra;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
36 Pontevedra;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;95,59
36 Pontevedra;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
36 Pontevedra;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
36 Pontevedra;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
36 Pontevedra;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
36 Pontevedra;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
36 Pontevedra;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
36 Pontevedra;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;94,43
36 Pontevedra;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
36 Pontevedra;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
36 Pontevedra;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
36 Pontevedra;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;94,36
36 Pontevedra;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
36 Pontevedra;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
36 Pontevedra;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
36 Pontevedra;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
36 Pontevedra;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
36 Pontevedra;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
36 Pontevedra;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;92,84
36 Pontevedra;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
36 Pontevedra;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
36 Pontevedra;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
36 Pontevedra;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;93,08
36 Pontevedra;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
36 Pontevedra;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
36 Pontevedra;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
36 Pontevedra;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
36 Pontevedra;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
36 Pontevedra;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
36 Pontevedra;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QIII;11.558
36 Pontevedra;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
36 Pontevedra;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
36 Pontevedra;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
36 Pontevedra;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QIII;11.384
36 Pontevedra;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
36 Pontevedra;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
36 Pontevedra;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
36 Pontevedra;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QIII;11.138
36 Pontevedra;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
36 Pontevedra;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
36 Pontevedra;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
36 Pontevedra;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2022QIII;11.366
36 Pontevedra;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2022QII;""
36 Pontevedra;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2022QI;""
36 Pontevedra;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
36 Pontevedra;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2021QIII;11.202
36 Pontevedra;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2021QII;""
36 Pontevedra;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2021QI;""
36 Pontevedra;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
36 Pontevedra;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2020QIII;10.874
36 Pontevedra;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2020QII;""
36 Pontevedra;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2020QI;""
36 Pontevedra;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2022QIV;11.152
36 Pontevedra;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
36 Pontevedra;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2022QII;""
36 Pontevedra;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2022QI;""
36 Pontevedra;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2021QIV;11.023
36 Pontevedra;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
36 Pontevedra;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2021QII;""
36 Pontevedra;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2021QI;""
36 Pontevedra;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2020QIV;10.683
36 Pontevedra;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
36 Pontevedra;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2020QII;""
36 Pontevedra;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2020QI;""
36 Pontevedra;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
36 Pontevedra;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
36 Pontevedra;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QII;""
36 Pontevedra;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QI;10.791
36 Pontevedra;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
36 Pontevedra;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
36 Pontevedra;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QII;""
36 Pontevedra;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QI;10.551
36 Pontevedra;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
36 Pontevedra;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
36 Pontevedra;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QII;""
36 Pontevedra;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QI;""
36 Pontevedra;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
36 Pontevedra;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
36 Pontevedra;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QII;10.624
36 Pontevedra;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QI;""
36 Pontevedra;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
36 Pontevedra;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
36 Pontevedra;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QII;10.392
36 Pontevedra;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QI;""
36 Pontevedra;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
36 Pontevedra;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
36 Pontevedra;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QII;""
36 Pontevedra;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QI;""
36 Pontevedra;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
36 Pontevedra;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
36 Pontevedra;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
36 Pontevedra;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
36 Pontevedra;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
36 Pontevedra;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
36 Pontevedra;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
36 Pontevedra;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
36 Pontevedra;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
36 Pontevedra;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
36 Pontevedra;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
36 Pontevedra;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
36 Pontevedra;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
36 Pontevedra;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;98,34
36 Pontevedra;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
36 Pontevedra;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
36 Pontevedra;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
36 Pontevedra;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;98,4
36 Pontevedra;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
36 Pontevedra;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
36 Pontevedra;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
36 Pontevedra;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;97,63
36 Pontevedra;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
36 Pontevedra;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
36 Pontevedra;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;96,49
36 Pontevedra;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
36 Pontevedra;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
36 Pontevedra;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
36 Pontevedra;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;96,83
36 Pontevedra;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
36 Pontevedra;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
36 Pontevedra;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
36 Pontevedra;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;95,91
36 Pontevedra;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
36 Pontevedra;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
36 Pontevedra;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
36 Pontevedra;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
36 Pontevedra;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
36 Pontevedra;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
36 Pontevedra;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;94,79
36 Pontevedra;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
36 Pontevedra;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
36 Pontevedra;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
36 Pontevedra;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;94,73
36 Pontevedra;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
36 Pontevedra;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
36 Pontevedra;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
36 Pontevedra;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
36 Pontevedra;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
36 Pontevedra;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
36 Pontevedra;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;93,32
36 Pontevedra;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
36 Pontevedra;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
36 Pontevedra;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
36 Pontevedra;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;93,3
36 Pontevedra;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
36 Pontevedra;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
36 Pontevedra;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
36 Pontevedra;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
36 Pontevedra;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
36 Pontevedra;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
36 Pontevedra;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QIII;7.629
36 Pontevedra;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
36 Pontevedra;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
36 Pontevedra;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
36 Pontevedra;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QIII;7.436
36 Pontevedra;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
36 Pontevedra;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
36 Pontevedra;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
36 Pontevedra;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QIII;7.202
36 Pontevedra;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
36 Pontevedra;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
36 Pontevedra;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
36 Pontevedra;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2022QIII;7.460
36 Pontevedra;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2022QII;""
36 Pontevedra;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2022QI;""
36 Pontevedra;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
36 Pontevedra;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2021QIII;7.283
36 Pontevedra;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2021QII;""
36 Pontevedra;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2021QI;""
36 Pontevedra;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
36 Pontevedra;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2020QIII;6.992
36 Pontevedra;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2020QII;""
36 Pontevedra;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2020QI;""
36 Pontevedra;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2022QIV;7.273
36 Pontevedra;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
36 Pontevedra;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2022QII;""
36 Pontevedra;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2022QI;""
36 Pontevedra;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2021QIV;7.121
36 Pontevedra;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
36 Pontevedra;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2021QII;""
36 Pontevedra;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2021QI;""
36 Pontevedra;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2020QIV;6.849
36 Pontevedra;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
36 Pontevedra;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2020QII;""
36 Pontevedra;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2020QI;""
36 Pontevedra;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
36 Pontevedra;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
36 Pontevedra;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QII;""
36 Pontevedra;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QI;6.981
36 Pontevedra;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
36 Pontevedra;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
36 Pontevedra;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QII;""
36 Pontevedra;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QI;6.755
36 Pontevedra;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
36 Pontevedra;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
36 Pontevedra;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QII;""
36 Pontevedra;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QI;""
36 Pontevedra;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
36 Pontevedra;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
36 Pontevedra;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QII;6.848
36 Pontevedra;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QI;""
36 Pontevedra;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
36 Pontevedra;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
36 Pontevedra;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QII;6.678
36 Pontevedra;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QI;""
36 Pontevedra;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
36 Pontevedra;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
36 Pontevedra;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QII;""
36 Pontevedra;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QI;""
36 Pontevedra;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
36 Pontevedra;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
36 Pontevedra;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
36 Pontevedra;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
36 Pontevedra;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
36 Pontevedra;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
36 Pontevedra;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
36 Pontevedra;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
36 Pontevedra;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
36 Pontevedra;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
36 Pontevedra;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
36 Pontevedra;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
36 Pontevedra;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
36 Pontevedra;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;97,78
36 Pontevedra;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
36 Pontevedra;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
36 Pontevedra;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
36 Pontevedra;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;97,94
36 Pontevedra;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
36 Pontevedra;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
36 Pontevedra;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
36 Pontevedra;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;97,08
36 Pontevedra;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
36 Pontevedra;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
36 Pontevedra;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;95,33
36 Pontevedra;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
36 Pontevedra;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
36 Pontevedra;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
36 Pontevedra;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;95,76
36 Pontevedra;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
36 Pontevedra;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
36 Pontevedra;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
36 Pontevedra;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;95,1
36 Pontevedra;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
36 Pontevedra;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
36 Pontevedra;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
36 Pontevedra;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
36 Pontevedra;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
36 Pontevedra;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
36 Pontevedra;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;93,88
36 Pontevedra;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
36 Pontevedra;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
36 Pontevedra;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
36 Pontevedra;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;93,79
36 Pontevedra;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
36 Pontevedra;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
36 Pontevedra;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
36 Pontevedra;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
36 Pontevedra;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
36 Pontevedra;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
36 Pontevedra;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;92,09
36 Pontevedra;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
36 Pontevedra;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
36 Pontevedra;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
36 Pontevedra;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;92,72
36 Pontevedra;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
36 Pontevedra;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
36 Pontevedra;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
36 Pontevedra;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
36 Pontevedra;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
36 Pontevedra;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QIV;19.099
36 Pontevedra;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
36 Pontevedra;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
36 Pontevedra;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
36 Pontevedra;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QIV;18.781
36 Pontevedra;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
36 Pontevedra;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
36 Pontevedra;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
36 Pontevedra;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QIV;18.168
36 Pontevedra;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
36 Pontevedra;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
36 Pontevedra;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
36 Pontevedra;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2022QIV;18.662
36 Pontevedra;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
36 Pontevedra;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2022QII;""
36 Pontevedra;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2022QI;""
36 Pontevedra;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2021QIV;18.408
36 Pontevedra;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
36 Pontevedra;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2021QII;""
36 Pontevedra;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2021QI;""
36 Pontevedra;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2020QIV;17.793
36 Pontevedra;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
36 Pontevedra;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2020QII;""
36 Pontevedra;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2020QI;""
36 Pontevedra;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
36 Pontevedra;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
36 Pontevedra;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2022QII;""
36 Pontevedra;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2022QI;18.016
36 Pontevedra;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
36 Pontevedra;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
36 Pontevedra;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2021QII;""
36 Pontevedra;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2021QI;17.551
36 Pontevedra;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
36 Pontevedra;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
36 Pontevedra;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2020QII;""
36 Pontevedra;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2020QI;""
36 Pontevedra;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
36 Pontevedra;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
36 Pontevedra;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QII;17.698
36 Pontevedra;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QI;""
36 Pontevedra;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
36 Pontevedra;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
36 Pontevedra;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QII;17.302
36 Pontevedra;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QI;""
36 Pontevedra;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
36 Pontevedra;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
36 Pontevedra;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QII;""
36 Pontevedra;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QI;""
36 Pontevedra;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
36 Pontevedra;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QIII;17.456
36 Pontevedra;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QII;""
36 Pontevedra;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QI;""
36 Pontevedra;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
36 Pontevedra;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QIII;17.090
36 Pontevedra;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QII;""
36 Pontevedra;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QI;""
36 Pontevedra;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
36 Pontevedra;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
36 Pontevedra;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QII;""
36 Pontevedra;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QI;""
36 Pontevedra;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
36 Pontevedra;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
36 Pontevedra;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
36 Pontevedra;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
36 Pontevedra;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
36 Pontevedra;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
36 Pontevedra;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
36 Pontevedra;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
36 Pontevedra;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
36 Pontevedra;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
36 Pontevedra;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
36 Pontevedra;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
36 Pontevedra;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;97,71
36 Pontevedra;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
36 Pontevedra;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
36 Pontevedra;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
36 Pontevedra;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;98,01
36 Pontevedra;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
36 Pontevedra;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
36 Pontevedra;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
36 Pontevedra;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;97,94
36 Pontevedra;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
36 Pontevedra;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
36 Pontevedra;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
36 Pontevedra;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
36 Pontevedra;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
36 Pontevedra;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
36 Pontevedra;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;95,93
36 Pontevedra;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
36 Pontevedra;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
36 Pontevedra;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
36 Pontevedra;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;96,6
36 Pontevedra;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
36 Pontevedra;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
36 Pontevedra;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
36 Pontevedra;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
36 Pontevedra;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
36 Pontevedra;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
36 Pontevedra;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;94,23
36 Pontevedra;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
36 Pontevedra;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
36 Pontevedra;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
36 Pontevedra;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;95,23
36 Pontevedra;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
36 Pontevedra;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
36 Pontevedra;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
36 Pontevedra;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
36 Pontevedra;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
36 Pontevedra;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
36 Pontevedra;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;92,94
36 Pontevedra;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
36 Pontevedra;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
36 Pontevedra;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
36 Pontevedra;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;94,07
36 Pontevedra;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
36 Pontevedra;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
36 Pontevedra;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
36 Pontevedra;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
36 Pontevedra;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
36 Pontevedra;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
36 Pontevedra;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QIV;11.521
36 Pontevedra;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
36 Pontevedra;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
36 Pontevedra;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
36 Pontevedra;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QIV;11.361
36 Pontevedra;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
36 Pontevedra;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
36 Pontevedra;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
36 Pontevedra;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QIV;11.051
36 Pontevedra;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
36 Pontevedra;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
36 Pontevedra;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
36 Pontevedra;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2022QIV;11.285
36 Pontevedra;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
36 Pontevedra;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2022QII;""
36 Pontevedra;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2022QI;""
36 Pontevedra;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2021QIV;11.164
36 Pontevedra;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
36 Pontevedra;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2021QII;""
36 Pontevedra;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2021QI;""
36 Pontevedra;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2020QIV;10.838
36 Pontevedra;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
36 Pontevedra;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2020QII;""
36 Pontevedra;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2020QI;""
36 Pontevedra;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
36 Pontevedra;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
36 Pontevedra;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2022QII;""
36 Pontevedra;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2022QI;10.917
36 Pontevedra;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
36 Pontevedra;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
36 Pontevedra;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2021QII;""
36 Pontevedra;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2021QI;10.696
36 Pontevedra;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
36 Pontevedra;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
36 Pontevedra;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2020QII;""
36 Pontevedra;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2020QI;""
36 Pontevedra;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
36 Pontevedra;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
36 Pontevedra;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QII;10.742
36 Pontevedra;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QI;""
36 Pontevedra;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
36 Pontevedra;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
36 Pontevedra;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QII;10.530
36 Pontevedra;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QI;""
36 Pontevedra;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
36 Pontevedra;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
36 Pontevedra;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QII;""
36 Pontevedra;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QI;""
36 Pontevedra;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
36 Pontevedra;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QIII;10.614
36 Pontevedra;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QII;""
36 Pontevedra;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QI;""
36 Pontevedra;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
36 Pontevedra;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QIII;10.412
36 Pontevedra;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QII;""
36 Pontevedra;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QI;""
36 Pontevedra;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
36 Pontevedra;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
36 Pontevedra;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QII;""
36 Pontevedra;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QI;""
36 Pontevedra;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
36 Pontevedra;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
36 Pontevedra;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
36 Pontevedra;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
36 Pontevedra;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
36 Pontevedra;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
36 Pontevedra;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
36 Pontevedra;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
36 Pontevedra;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
36 Pontevedra;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
36 Pontevedra;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
36 Pontevedra;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
36 Pontevedra;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;97,95
36 Pontevedra;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
36 Pontevedra;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
36 Pontevedra;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
36 Pontevedra;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;98,27
36 Pontevedra;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
36 Pontevedra;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
36 Pontevedra;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
36 Pontevedra;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;98,07
36 Pontevedra;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
36 Pontevedra;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
36 Pontevedra;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
36 Pontevedra;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
36 Pontevedra;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
36 Pontevedra;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
36 Pontevedra;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;96,09
36 Pontevedra;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
36 Pontevedra;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
36 Pontevedra;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
36 Pontevedra;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;96,79
36 Pontevedra;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
36 Pontevedra;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
36 Pontevedra;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
36 Pontevedra;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
36 Pontevedra;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
36 Pontevedra;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
36 Pontevedra;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;94,55
36 Pontevedra;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
36 Pontevedra;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
36 Pontevedra;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
36 Pontevedra;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;95,29
36 Pontevedra;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
36 Pontevedra;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
36 Pontevedra;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
36 Pontevedra;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
36 Pontevedra;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
36 Pontevedra;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
36 Pontevedra;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;93,42
36 Pontevedra;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
36 Pontevedra;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
36 Pontevedra;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
36 Pontevedra;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;94,22
36 Pontevedra;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
36 Pontevedra;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
36 Pontevedra;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
36 Pontevedra;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
36 Pontevedra;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
36 Pontevedra;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
36 Pontevedra;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QIV;7.578
36 Pontevedra;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
36 Pontevedra;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
36 Pontevedra;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
36 Pontevedra;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QIV;7.420
36 Pontevedra;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
36 Pontevedra;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
36 Pontevedra;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
36 Pontevedra;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QIV;7.117
36 Pontevedra;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
36 Pontevedra;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
36 Pontevedra;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
36 Pontevedra;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2022QIV;7.377
36 Pontevedra;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
36 Pontevedra;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2022QII;""
36 Pontevedra;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2022QI;""
36 Pontevedra;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2021QIV;7.244
36 Pontevedra;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
36 Pontevedra;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2021QII;""
36 Pontevedra;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2021QI;""
36 Pontevedra;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2020QIV;6.955
36 Pontevedra;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
36 Pontevedra;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2020QII;""
36 Pontevedra;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2020QI;""
36 Pontevedra;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
36 Pontevedra;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
36 Pontevedra;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2022QII;""
36 Pontevedra;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2022QI;7.099
36 Pontevedra;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
36 Pontevedra;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
36 Pontevedra;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2021QII;""
36 Pontevedra;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2021QI;6.855
36 Pontevedra;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
36 Pontevedra;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
36 Pontevedra;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2020QII;""
36 Pontevedra;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2020QI;""
36 Pontevedra;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
36 Pontevedra;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
36 Pontevedra;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QII;6.956
36 Pontevedra;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QI;""
36 Pontevedra;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
36 Pontevedra;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
36 Pontevedra;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QII;6.772
36 Pontevedra;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QI;""
36 Pontevedra;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
36 Pontevedra;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
36 Pontevedra;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QII;""
36 Pontevedra;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QI;""
36 Pontevedra;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
36 Pontevedra;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QIII;6.842
36 Pontevedra;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QII;""
36 Pontevedra;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QI;""
36 Pontevedra;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
36 Pontevedra;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QIII;6.678
36 Pontevedra;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QII;""
36 Pontevedra;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QI;""
36 Pontevedra;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
36 Pontevedra;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
36 Pontevedra;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QII;""
36 Pontevedra;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QI;""
36 Pontevedra;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
36 Pontevedra;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
36 Pontevedra;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
36 Pontevedra;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
36 Pontevedra;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
36 Pontevedra;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
36 Pontevedra;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
36 Pontevedra;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
36 Pontevedra;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
36 Pontevedra;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
36 Pontevedra;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
36 Pontevedra;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
36 Pontevedra;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;97,35
36 Pontevedra;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
36 Pontevedra;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
36 Pontevedra;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
36 Pontevedra;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;97,63
36 Pontevedra;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
36 Pontevedra;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
36 Pontevedra;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
36 Pontevedra;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;97,72
36 Pontevedra;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
36 Pontevedra;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
36 Pontevedra;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
36 Pontevedra;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
36 Pontevedra;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
36 Pontevedra;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
36 Pontevedra;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;95,67
36 Pontevedra;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
36 Pontevedra;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
36 Pontevedra;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
36 Pontevedra;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;96,32
36 Pontevedra;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
36 Pontevedra;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
36 Pontevedra;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
36 Pontevedra;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
36 Pontevedra;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
36 Pontevedra;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
36 Pontevedra;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;93,75
36 Pontevedra;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
36 Pontevedra;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
36 Pontevedra;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
36 Pontevedra;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;95,15
36 Pontevedra;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
36 Pontevedra;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
36 Pontevedra;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
36 Pontevedra;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
36 Pontevedra;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
36 Pontevedra;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
36 Pontevedra;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;92,21
36 Pontevedra;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
36 Pontevedra;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
36 Pontevedra;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
36 Pontevedra;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;93,83
36 Pontevedra;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
36 Pontevedra;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
36 Pontevedra;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
36 Pontevedra;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
36 Pontevedra;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
36 Pontevedra;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
36 Pontevedra;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
36 Pontevedra;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
36 Pontevedra;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
36 Pontevedra;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QI;9.711
36 Pontevedra;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
36 Pontevedra;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
36 Pontevedra;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
36 Pontevedra;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QI;9.172
36 Pontevedra;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
36 Pontevedra;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
36 Pontevedra;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
36 Pontevedra;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QI;10.470
36 Pontevedra;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
36 Pontevedra;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
36 Pontevedra;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2022QII;""
36 Pontevedra;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2022QI;9.377
36 Pontevedra;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
36 Pontevedra;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
36 Pontevedra;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2021QII;""
36 Pontevedra;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2021QI;8.883
36 Pontevedra;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
36 Pontevedra;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
36 Pontevedra;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2020QII;""
36 Pontevedra;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2020QI;9.828
36 Pontevedra;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
36 Pontevedra;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
36 Pontevedra;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2022QII;9.054
36 Pontevedra;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2022QI;""
36 Pontevedra;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
36 Pontevedra;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
36 Pontevedra;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2021QII;8.607
36 Pontevedra;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2021QI;""
36 Pontevedra;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
36 Pontevedra;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
36 Pontevedra;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2020QII;9.514
36 Pontevedra;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2020QI;""
36 Pontevedra;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
36 Pontevedra;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QIII;8.713
36 Pontevedra;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QII;""
36 Pontevedra;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QI;""
36 Pontevedra;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
36 Pontevedra;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QIII;8.324
36 Pontevedra;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QII;""
36 Pontevedra;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QI;""
36 Pontevedra;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
36 Pontevedra;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QIII;9.181
36 Pontevedra;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QII;""
36 Pontevedra;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QI;""
36 Pontevedra;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QIV;8.208
36 Pontevedra;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
36 Pontevedra;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QII;""
36 Pontevedra;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QI;""
36 Pontevedra;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QIV;7.926
36 Pontevedra;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
36 Pontevedra;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QII;""
36 Pontevedra;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QI;""
36 Pontevedra;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QIV;8.782
36 Pontevedra;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
36 Pontevedra;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QII;""
36 Pontevedra;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QI;""
36 Pontevedra;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
36 Pontevedra;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
36 Pontevedra;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
36 Pontevedra;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
36 Pontevedra;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
36 Pontevedra;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
36 Pontevedra;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
36 Pontevedra;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
36 Pontevedra;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
36 Pontevedra;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
36 Pontevedra;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
36 Pontevedra;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
36 Pontevedra;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
36 Pontevedra;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
36 Pontevedra;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
36 Pontevedra;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;96,56
36 Pontevedra;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
36 Pontevedra;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
36 Pontevedra;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
36 Pontevedra;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;96,85
36 Pontevedra;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
36 Pontevedra;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
36 Pontevedra;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
36 Pontevedra;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;93,87
36 Pontevedra;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
36 Pontevedra;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
36 Pontevedra;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;93,23
36 Pontevedra;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
36 Pontevedra;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
36 Pontevedra;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
36 Pontevedra;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;93,84
36 Pontevedra;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
36 Pontevedra;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
36 Pontevedra;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
36 Pontevedra;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;90,87
36 Pontevedra;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
36 Pontevedra;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
36 Pontevedra;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;89,72
36 Pontevedra;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
36 Pontevedra;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
36 Pontevedra;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
36 Pontevedra;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;90,75
36 Pontevedra;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
36 Pontevedra;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
36 Pontevedra;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
36 Pontevedra;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;87,69
36 Pontevedra;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
36 Pontevedra;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
36 Pontevedra;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;84,52
36 Pontevedra;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
36 Pontevedra;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
36 Pontevedra;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
36 Pontevedra;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;86,42
36 Pontevedra;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
36 Pontevedra;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
36 Pontevedra;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
36 Pontevedra;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;83,88
36 Pontevedra;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
36 Pontevedra;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
36 Pontevedra;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
36 Pontevedra;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
36 Pontevedra;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
36 Pontevedra;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
36 Pontevedra;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QI;5.970
36 Pontevedra;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
36 Pontevedra;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
36 Pontevedra;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
36 Pontevedra;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QI;5.623
36 Pontevedra;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
36 Pontevedra;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
36 Pontevedra;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
36 Pontevedra;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QI;6.356
36 Pontevedra;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
36 Pontevedra;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
36 Pontevedra;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2022QII;""
36 Pontevedra;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2022QI;5.759
36 Pontevedra;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
36 Pontevedra;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
36 Pontevedra;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2021QII;""
36 Pontevedra;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2021QI;5.438
36 Pontevedra;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
36 Pontevedra;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
36 Pontevedra;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2020QII;""
36 Pontevedra;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2020QI;5.972
36 Pontevedra;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
36 Pontevedra;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
36 Pontevedra;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2022QII;5.569
36 Pontevedra;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2022QI;""
36 Pontevedra;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
36 Pontevedra;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
36 Pontevedra;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2021QII;5.285
36 Pontevedra;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2021QI;""
36 Pontevedra;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
36 Pontevedra;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
36 Pontevedra;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2020QII;5.818
36 Pontevedra;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2020QI;""
36 Pontevedra;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
36 Pontevedra;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QIII;5.401
36 Pontevedra;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QII;""
36 Pontevedra;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QI;""
36 Pontevedra;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
36 Pontevedra;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QIII;5.118
36 Pontevedra;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QII;""
36 Pontevedra;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QI;""
36 Pontevedra;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
36 Pontevedra;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QIII;5.635
36 Pontevedra;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QII;""
36 Pontevedra;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QI;""
36 Pontevedra;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QIV;5.089
36 Pontevedra;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
36 Pontevedra;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QII;""
36 Pontevedra;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QI;""
36 Pontevedra;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QIV;4.888
36 Pontevedra;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
36 Pontevedra;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QII;""
36 Pontevedra;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QI;""
36 Pontevedra;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QIV;5.406
36 Pontevedra;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
36 Pontevedra;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QII;""
36 Pontevedra;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QI;""
36 Pontevedra;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
36 Pontevedra;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
36 Pontevedra;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
36 Pontevedra;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
36 Pontevedra;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
36 Pontevedra;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
36 Pontevedra;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
36 Pontevedra;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
36 Pontevedra;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
36 Pontevedra;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
36 Pontevedra;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
36 Pontevedra;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
36 Pontevedra;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
36 Pontevedra;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
36 Pontevedra;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
36 Pontevedra;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;96,47
36 Pontevedra;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
36 Pontevedra;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
36 Pontevedra;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
36 Pontevedra;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;96,71
36 Pontevedra;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
36 Pontevedra;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
36 Pontevedra;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
36 Pontevedra;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;93,96
36 Pontevedra;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
36 Pontevedra;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
36 Pontevedra;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;93,28
36 Pontevedra;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
36 Pontevedra;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
36 Pontevedra;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
36 Pontevedra;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;93,99
36 Pontevedra;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
36 Pontevedra;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
36 Pontevedra;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
36 Pontevedra;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;91,54
36 Pontevedra;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
36 Pontevedra;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
36 Pontevedra;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;90,47
36 Pontevedra;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
36 Pontevedra;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
36 Pontevedra;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
36 Pontevedra;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;91,02
36 Pontevedra;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
36 Pontevedra;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
36 Pontevedra;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
36 Pontevedra;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;88,66
36 Pontevedra;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
36 Pontevedra;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
36 Pontevedra;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;85,24
36 Pontevedra;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
36 Pontevedra;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
36 Pontevedra;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
36 Pontevedra;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;86,93
36 Pontevedra;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
36 Pontevedra;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
36 Pontevedra;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
36 Pontevedra;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;85,05
36 Pontevedra;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
36 Pontevedra;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
36 Pontevedra;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
36 Pontevedra;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
36 Pontevedra;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
36 Pontevedra;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
36 Pontevedra;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QI;3.741
36 Pontevedra;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
36 Pontevedra;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
36 Pontevedra;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
36 Pontevedra;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QI;3.549
36 Pontevedra;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
36 Pontevedra;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
36 Pontevedra;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
36 Pontevedra;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QI;4.114
36 Pontevedra;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
36 Pontevedra;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
36 Pontevedra;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2022QII;""
36 Pontevedra;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2022QI;3.618
36 Pontevedra;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
36 Pontevedra;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
36 Pontevedra;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2021QII;""
36 Pontevedra;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2021QI;3.445
36 Pontevedra;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
36 Pontevedra;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
36 Pontevedra;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2020QII;""
36 Pontevedra;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2020QI;3.856
36 Pontevedra;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
36 Pontevedra;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
36 Pontevedra;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2022QII;3.485
36 Pontevedra;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2022QI;""
36 Pontevedra;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
36 Pontevedra;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
36 Pontevedra;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2021QII;3.322
36 Pontevedra;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2021QI;""
36 Pontevedra;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
36 Pontevedra;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
36 Pontevedra;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2020QII;3.696
36 Pontevedra;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2020QI;""
36 Pontevedra;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
36 Pontevedra;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QIII;3.312
36 Pontevedra;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QII;""
36 Pontevedra;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QI;""
36 Pontevedra;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
36 Pontevedra;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QIII;3.206
36 Pontevedra;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QII;""
36 Pontevedra;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QI;""
36 Pontevedra;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
36 Pontevedra;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QIII;3.546
36 Pontevedra;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QII;""
36 Pontevedra;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QI;""
36 Pontevedra;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QIV;3.119
36 Pontevedra;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
36 Pontevedra;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QII;""
36 Pontevedra;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QI;""
36 Pontevedra;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QIV;3.038
36 Pontevedra;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
36 Pontevedra;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QII;""
36 Pontevedra;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QI;""
36 Pontevedra;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QIV;3.376
36 Pontevedra;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
36 Pontevedra;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QII;""
36 Pontevedra;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QI;""
36 Pontevedra;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
36 Pontevedra;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
36 Pontevedra;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
36 Pontevedra;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
36 Pontevedra;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
36 Pontevedra;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
36 Pontevedra;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
36 Pontevedra;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
36 Pontevedra;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
36 Pontevedra;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
36 Pontevedra;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
36 Pontevedra;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
36 Pontevedra;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
36 Pontevedra;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
36 Pontevedra;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
36 Pontevedra;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;96,71
36 Pontevedra;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
36 Pontevedra;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
36 Pontevedra;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
36 Pontevedra;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;97,07
36 Pontevedra;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
36 Pontevedra;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
36 Pontevedra;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
36 Pontevedra;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;93,73
36 Pontevedra;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
36 Pontevedra;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
36 Pontevedra;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;93,16
36 Pontevedra;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
36 Pontevedra;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
36 Pontevedra;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
36 Pontevedra;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;93,6
36 Pontevedra;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
36 Pontevedra;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
36 Pontevedra;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
36 Pontevedra;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;89,84
36 Pontevedra;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
36 Pontevedra;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
36 Pontevedra;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;88,53
36 Pontevedra;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
36 Pontevedra;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
36 Pontevedra;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
36 Pontevedra;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;90,34
36 Pontevedra;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
36 Pontevedra;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
36 Pontevedra;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
36 Pontevedra;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;86,19
36 Pontevedra;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
36 Pontevedra;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
36 Pontevedra;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;83,37
36 Pontevedra;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
36 Pontevedra;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
36 Pontevedra;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
36 Pontevedra;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;85,6
36 Pontevedra;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
36 Pontevedra;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
36 Pontevedra;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
36 Pontevedra;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;82,06
36 Pontevedra;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
36 Pontevedra;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
36 Pontevedra;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
36 Pontevedra;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
36 Pontevedra;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
36 Pontevedra;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QII;11.017
36 Pontevedra;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
36 Pontevedra;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
36 Pontevedra;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
36 Pontevedra;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QII;10.509
36 Pontevedra;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
36 Pontevedra;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
36 Pontevedra;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
36 Pontevedra;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QII;10.088
36 Pontevedra;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
36 Pontevedra;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
36 Pontevedra;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
36 Pontevedra;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2022QII;10.660
36 Pontevedra;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2022QI;""
36 Pontevedra;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
36 Pontevedra;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
36 Pontevedra;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2021QII;10.200
36 Pontevedra;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2021QI;""
36 Pontevedra;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
36 Pontevedra;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
36 Pontevedra;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2020QII;9.757
36 Pontevedra;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2020QI;""
36 Pontevedra;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
36 Pontevedra;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2022QIII;10.290
36 Pontevedra;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2022QII;""
36 Pontevedra;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2022QI;""
36 Pontevedra;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
36 Pontevedra;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2021QIII;9.894
36 Pontevedra;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2021QII;""
36 Pontevedra;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2021QI;""
36 Pontevedra;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
36 Pontevedra;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2020QIII;9.337
36 Pontevedra;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2020QII;""
36 Pontevedra;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2020QI;""
36 Pontevedra;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QIV;9.748
36 Pontevedra;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
36 Pontevedra;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QII;""
36 Pontevedra;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QI;""
36 Pontevedra;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QIV;9.465
36 Pontevedra;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
36 Pontevedra;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QII;""
36 Pontevedra;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QI;""
36 Pontevedra;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QIV;8.929
36 Pontevedra;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
36 Pontevedra;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QII;""
36 Pontevedra;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QI;""
36 Pontevedra;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
36 Pontevedra;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
36 Pontevedra;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QII;""
36 Pontevedra;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QI;9.151
36 Pontevedra;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
36 Pontevedra;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
36 Pontevedra;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QII;""
36 Pontevedra;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QI;8.656
36 Pontevedra;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
36 Pontevedra;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
36 Pontevedra;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QII;""
36 Pontevedra;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QI;""
36 Pontevedra;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
36 Pontevedra;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
36 Pontevedra;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
36 Pontevedra;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
36 Pontevedra;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
36 Pontevedra;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
36 Pontevedra;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
36 Pontevedra;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
36 Pontevedra;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
36 Pontevedra;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
36 Pontevedra;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
36 Pontevedra;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
36 Pontevedra;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
36 Pontevedra;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
36 Pontevedra;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;96,76
36 Pontevedra;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
36 Pontevedra;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
36 Pontevedra;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
36 Pontevedra;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;97,06
36 Pontevedra;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
36 Pontevedra;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
36 Pontevedra;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
36 Pontevedra;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;96,72
36 Pontevedra;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
36 Pontevedra;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
36 Pontevedra;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;93,4
36 Pontevedra;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
36 Pontevedra;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
36 Pontevedra;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
36 Pontevedra;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;94,15
36 Pontevedra;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
36 Pontevedra;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
36 Pontevedra;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
36 Pontevedra;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;92,56
36 Pontevedra;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
36 Pontevedra;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
36 Pontevedra;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;88,48
36 Pontevedra;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
36 Pontevedra;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
36 Pontevedra;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
36 Pontevedra;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;90,07
36 Pontevedra;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
36 Pontevedra;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
36 Pontevedra;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
36 Pontevedra;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;88,51
36 Pontevedra;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
36 Pontevedra;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
36 Pontevedra;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
36 Pontevedra;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
36 Pontevedra;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
36 Pontevedra;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
36 Pontevedra;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;87,08
36 Pontevedra;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
36 Pontevedra;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
36 Pontevedra;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
36 Pontevedra;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;85,8
36 Pontevedra;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
36 Pontevedra;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
36 Pontevedra;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
36 Pontevedra;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
36 Pontevedra;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
36 Pontevedra;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
36 Pontevedra;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QII;6.764
36 Pontevedra;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
36 Pontevedra;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
36 Pontevedra;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
36 Pontevedra;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QII;6.449
36 Pontevedra;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
36 Pontevedra;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
36 Pontevedra;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
36 Pontevedra;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QII;6.120
36 Pontevedra;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
36 Pontevedra;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
36 Pontevedra;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
36 Pontevedra;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2022QII;6.553
36 Pontevedra;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2022QI;""
36 Pontevedra;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
36 Pontevedra;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
36 Pontevedra;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2021QII;6.272
36 Pontevedra;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2021QI;""
36 Pontevedra;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
36 Pontevedra;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
36 Pontevedra;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2020QII;5.954
36 Pontevedra;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2020QI;""
36 Pontevedra;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
36 Pontevedra;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2022QIII;6.367
36 Pontevedra;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2022QII;""
36 Pontevedra;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2022QI;""
36 Pontevedra;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
36 Pontevedra;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2021QIII;6.086
36 Pontevedra;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2021QII;""
36 Pontevedra;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2021QI;""
36 Pontevedra;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
36 Pontevedra;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2020QIII;5.720
36 Pontevedra;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2020QII;""
36 Pontevedra;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2020QI;""
36 Pontevedra;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QIV;6.041
36 Pontevedra;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
36 Pontevedra;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QII;""
36 Pontevedra;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QI;""
36 Pontevedra;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QIV;5.838
36 Pontevedra;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
36 Pontevedra;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QII;""
36 Pontevedra;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QI;""
36 Pontevedra;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QIV;5.486
36 Pontevedra;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
36 Pontevedra;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QII;""
36 Pontevedra;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QI;""
36 Pontevedra;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
36 Pontevedra;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
36 Pontevedra;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QII;""
36 Pontevedra;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QI;5.640
36 Pontevedra;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
36 Pontevedra;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
36 Pontevedra;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QII;""
36 Pontevedra;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QI;5.308
36 Pontevedra;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
36 Pontevedra;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
36 Pontevedra;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QII;""
36 Pontevedra;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QI;""
36 Pontevedra;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
36 Pontevedra;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
36 Pontevedra;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
36 Pontevedra;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
36 Pontevedra;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
36 Pontevedra;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
36 Pontevedra;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
36 Pontevedra;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
36 Pontevedra;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
36 Pontevedra;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
36 Pontevedra;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
36 Pontevedra;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
36 Pontevedra;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
36 Pontevedra;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
36 Pontevedra;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;96,88
36 Pontevedra;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
36 Pontevedra;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
36 Pontevedra;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
36 Pontevedra;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;97,26
36 Pontevedra;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
36 Pontevedra;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
36 Pontevedra;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
36 Pontevedra;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;97,29
36 Pontevedra;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
36 Pontevedra;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
36 Pontevedra;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;94,13
36 Pontevedra;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
36 Pontevedra;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
36 Pontevedra;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
36 Pontevedra;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;94,37
36 Pontevedra;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
36 Pontevedra;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
36 Pontevedra;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
36 Pontevedra;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;93,46
36 Pontevedra;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
36 Pontevedra;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
36 Pontevedra;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;89,31
36 Pontevedra;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
36 Pontevedra;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
36 Pontevedra;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
36 Pontevedra;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;90,53
36 Pontevedra;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
36 Pontevedra;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
36 Pontevedra;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
36 Pontevedra;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;89,64
36 Pontevedra;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
36 Pontevedra;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
36 Pontevedra;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
36 Pontevedra;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
36 Pontevedra;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
36 Pontevedra;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
36 Pontevedra;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;87,46
36 Pontevedra;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
36 Pontevedra;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
36 Pontevedra;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
36 Pontevedra;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;86,73
36 Pontevedra;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
36 Pontevedra;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
36 Pontevedra;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
36 Pontevedra;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
36 Pontevedra;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
36 Pontevedra;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
36 Pontevedra;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QII;4.253
36 Pontevedra;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
36 Pontevedra;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
36 Pontevedra;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
36 Pontevedra;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QII;4.060
36 Pontevedra;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
36 Pontevedra;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
36 Pontevedra;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
36 Pontevedra;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QII;3.968
36 Pontevedra;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
36 Pontevedra;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
36 Pontevedra;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
36 Pontevedra;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2022QII;4.107
36 Pontevedra;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2022QI;""
36 Pontevedra;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
36 Pontevedra;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
36 Pontevedra;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2021QII;3.928
36 Pontevedra;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2021QI;""
36 Pontevedra;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
36 Pontevedra;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
36 Pontevedra;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2020QII;3.803
36 Pontevedra;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2020QI;""
36 Pontevedra;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
36 Pontevedra;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2022QIII;3.923
36 Pontevedra;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2022QII;""
36 Pontevedra;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2022QI;""
36 Pontevedra;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
36 Pontevedra;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2021QIII;3.808
36 Pontevedra;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2021QII;""
36 Pontevedra;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2021QI;""
36 Pontevedra;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
36 Pontevedra;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2020QIII;3.617
36 Pontevedra;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2020QII;""
36 Pontevedra;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2020QI;""
36 Pontevedra;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QIV;3.707
36 Pontevedra;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
36 Pontevedra;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QII;""
36 Pontevedra;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QI;""
36 Pontevedra;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QIV;3.627
36 Pontevedra;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
36 Pontevedra;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QII;""
36 Pontevedra;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QI;""
36 Pontevedra;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QIV;3.443
36 Pontevedra;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
36 Pontevedra;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QII;""
36 Pontevedra;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QI;""
36 Pontevedra;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
36 Pontevedra;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
36 Pontevedra;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QII;""
36 Pontevedra;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QI;3.511
36 Pontevedra;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
36 Pontevedra;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
36 Pontevedra;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QII;""
36 Pontevedra;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QI;3.348
36 Pontevedra;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
36 Pontevedra;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
36 Pontevedra;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QII;""
36 Pontevedra;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QI;""
36 Pontevedra;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
36 Pontevedra;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
36 Pontevedra;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
36 Pontevedra;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
36 Pontevedra;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
36 Pontevedra;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
36 Pontevedra;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
36 Pontevedra;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
36 Pontevedra;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
36 Pontevedra;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
36 Pontevedra;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
36 Pontevedra;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
36 Pontevedra;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
36 Pontevedra;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
36 Pontevedra;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;96,57
36 Pontevedra;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
36 Pontevedra;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
36 Pontevedra;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
36 Pontevedra;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;96,75
36 Pontevedra;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
36 Pontevedra;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
36 Pontevedra;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
36 Pontevedra;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;95,84
36 Pontevedra;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
36 Pontevedra;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
36 Pontevedra;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;92,24
36 Pontevedra;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
36 Pontevedra;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
36 Pontevedra;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
36 Pontevedra;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;93,79
36 Pontevedra;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
36 Pontevedra;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
36 Pontevedra;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
36 Pontevedra;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;91,15
36 Pontevedra;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
36 Pontevedra;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
36 Pontevedra;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;87,16
36 Pontevedra;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
36 Pontevedra;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
36 Pontevedra;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
36 Pontevedra;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;89,33
36 Pontevedra;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
36 Pontevedra;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
36 Pontevedra;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
36 Pontevedra;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;86,77
36 Pontevedra;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
36 Pontevedra;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
36 Pontevedra;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
36 Pontevedra;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
36 Pontevedra;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
36 Pontevedra;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
36 Pontevedra;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;86,48
36 Pontevedra;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
36 Pontevedra;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
36 Pontevedra;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
36 Pontevedra;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;84,38
36 Pontevedra;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
36 Pontevedra;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
36 Pontevedra;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
36 Pontevedra;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
36 Pontevedra;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
36 Pontevedra;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QIII;10.802
36 Pontevedra;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
36 Pontevedra;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
36 Pontevedra;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
36 Pontevedra;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QIII;10.352
36 Pontevedra;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
36 Pontevedra;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
36 Pontevedra;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
36 Pontevedra;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QIII;9.875
36 Pontevedra;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
36 Pontevedra;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
36 Pontevedra;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
36 Pontevedra;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2022QIII;10.391
36 Pontevedra;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2022QII;""
36 Pontevedra;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2022QI;""
36 Pontevedra;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
36 Pontevedra;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2021QIII;10.004
36 Pontevedra;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2021QII;""
36 Pontevedra;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2021QI;""
36 Pontevedra;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
36 Pontevedra;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2020QIII;9.428
36 Pontevedra;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2020QII;""
36 Pontevedra;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2020QI;""
36 Pontevedra;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2022QIV;9.827
36 Pontevedra;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
36 Pontevedra;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2022QII;""
36 Pontevedra;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2022QI;""
36 Pontevedra;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2021QIV;9.555
36 Pontevedra;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
36 Pontevedra;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2021QII;""
36 Pontevedra;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2021QI;""
36 Pontevedra;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2020QIV;9.007
36 Pontevedra;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
36 Pontevedra;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2020QII;""
36 Pontevedra;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2020QI;""
36 Pontevedra;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
36 Pontevedra;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
36 Pontevedra;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QII;""
36 Pontevedra;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QI;9.238
36 Pontevedra;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
36 Pontevedra;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
36 Pontevedra;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QII;""
36 Pontevedra;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QI;8.733
36 Pontevedra;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
36 Pontevedra;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
36 Pontevedra;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QII;""
36 Pontevedra;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QI;""
36 Pontevedra;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
36 Pontevedra;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
36 Pontevedra;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QII;8.927
36 Pontevedra;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QI;""
36 Pontevedra;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
36 Pontevedra;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
36 Pontevedra;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QII;8.469
36 Pontevedra;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QI;""
36 Pontevedra;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
36 Pontevedra;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
36 Pontevedra;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QII;""
36 Pontevedra;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QI;""
36 Pontevedra;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
36 Pontevedra;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
36 Pontevedra;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
36 Pontevedra;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
36 Pontevedra;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
36 Pontevedra;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
36 Pontevedra;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
36 Pontevedra;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
36 Pontevedra;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
36 Pontevedra;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
36 Pontevedra;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
36 Pontevedra;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
36 Pontevedra;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
36 Pontevedra;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;96,2
36 Pontevedra;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
36 Pontevedra;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
36 Pontevedra;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
36 Pontevedra;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;96,64
36 Pontevedra;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
36 Pontevedra;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
36 Pontevedra;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
36 Pontevedra;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;95,47
36 Pontevedra;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
36 Pontevedra;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
36 Pontevedra;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;90,97
36 Pontevedra;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
36 Pontevedra;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
36 Pontevedra;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
36 Pontevedra;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;92,3
36 Pontevedra;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
36 Pontevedra;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
36 Pontevedra;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
36 Pontevedra;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;91,21
36 Pontevedra;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
36 Pontevedra;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
36 Pontevedra;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
36 Pontevedra;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
36 Pontevedra;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
36 Pontevedra;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
36 Pontevedra;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;89,24
36 Pontevedra;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
36 Pontevedra;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
36 Pontevedra;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
36 Pontevedra;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;88,44
36 Pontevedra;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
36 Pontevedra;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
36 Pontevedra;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
36 Pontevedra;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
36 Pontevedra;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
36 Pontevedra;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
36 Pontevedra;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;86,23
36 Pontevedra;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
36 Pontevedra;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
36 Pontevedra;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
36 Pontevedra;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;85,76
36 Pontevedra;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
36 Pontevedra;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
36 Pontevedra;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
36 Pontevedra;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
36 Pontevedra;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
36 Pontevedra;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
36 Pontevedra;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QIII;6.614
36 Pontevedra;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
36 Pontevedra;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
36 Pontevedra;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
36 Pontevedra;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QIII;6.353
36 Pontevedra;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
36 Pontevedra;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
36 Pontevedra;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
36 Pontevedra;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QIII;6.023
36 Pontevedra;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
36 Pontevedra;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
36 Pontevedra;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
36 Pontevedra;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2022QIII;6.416
36 Pontevedra;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2022QII;""
36 Pontevedra;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2022QI;""
36 Pontevedra;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
36 Pontevedra;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2021QIII;6.148
36 Pontevedra;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2021QII;""
36 Pontevedra;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2021QI;""
36 Pontevedra;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
36 Pontevedra;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2020QIII;5.777
36 Pontevedra;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2020QII;""
36 Pontevedra;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2020QI;""
36 Pontevedra;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2022QIV;6.082
36 Pontevedra;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
36 Pontevedra;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2022QII;""
36 Pontevedra;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2022QI;""
36 Pontevedra;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2021QIV;5.890
36 Pontevedra;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
36 Pontevedra;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2021QII;""
36 Pontevedra;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2021QI;""
36 Pontevedra;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2020QIV;5.535
36 Pontevedra;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
36 Pontevedra;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2020QII;""
36 Pontevedra;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2020QI;""
36 Pontevedra;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
36 Pontevedra;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
36 Pontevedra;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QII;""
36 Pontevedra;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QI;5.691
36 Pontevedra;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
36 Pontevedra;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
36 Pontevedra;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QII;""
36 Pontevedra;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QI;5.357
36 Pontevedra;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
36 Pontevedra;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
36 Pontevedra;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QII;""
36 Pontevedra;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QI;""
36 Pontevedra;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
36 Pontevedra;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
36 Pontevedra;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QII;5.507
36 Pontevedra;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QI;""
36 Pontevedra;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
36 Pontevedra;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
36 Pontevedra;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QII;5.212
36 Pontevedra;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QI;""
36 Pontevedra;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
36 Pontevedra;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
36 Pontevedra;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QII;""
36 Pontevedra;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QI;""
36 Pontevedra;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
36 Pontevedra;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
36 Pontevedra;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
36 Pontevedra;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
36 Pontevedra;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
36 Pontevedra;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
36 Pontevedra;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
36 Pontevedra;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
36 Pontevedra;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
36 Pontevedra;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
36 Pontevedra;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
36 Pontevedra;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
36 Pontevedra;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
36 Pontevedra;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;97,01
36 Pontevedra;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
36 Pontevedra;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
36 Pontevedra;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
36 Pontevedra;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;96,77
36 Pontevedra;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
36 Pontevedra;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
36 Pontevedra;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
36 Pontevedra;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;95,92
36 Pontevedra;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
36 Pontevedra;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
36 Pontevedra;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;91,96
36 Pontevedra;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
36 Pontevedra;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
36 Pontevedra;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
36 Pontevedra;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;92,71
36 Pontevedra;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
36 Pontevedra;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
36 Pontevedra;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
36 Pontevedra;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;91,9
36 Pontevedra;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
36 Pontevedra;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
36 Pontevedra;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
36 Pontevedra;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
36 Pontevedra;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
36 Pontevedra;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
36 Pontevedra;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;89,58
36 Pontevedra;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
36 Pontevedra;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
36 Pontevedra;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
36 Pontevedra;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;88,94
36 Pontevedra;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
36 Pontevedra;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
36 Pontevedra;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
36 Pontevedra;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
36 Pontevedra;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
36 Pontevedra;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
36 Pontevedra;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;86,68
36 Pontevedra;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
36 Pontevedra;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
36 Pontevedra;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
36 Pontevedra;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;86,53
36 Pontevedra;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
36 Pontevedra;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
36 Pontevedra;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
36 Pontevedra;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
36 Pontevedra;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
36 Pontevedra;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
36 Pontevedra;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QIII;4.188
36 Pontevedra;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
36 Pontevedra;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
36 Pontevedra;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
36 Pontevedra;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QIII;3.999
36 Pontevedra;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
36 Pontevedra;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
36 Pontevedra;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
36 Pontevedra;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QIII;3.852
36 Pontevedra;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
36 Pontevedra;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
36 Pontevedra;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
36 Pontevedra;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2022QIII;3.975
36 Pontevedra;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2022QII;""
36 Pontevedra;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2022QI;""
36 Pontevedra;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
36 Pontevedra;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2021QIII;3.856
36 Pontevedra;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2021QII;""
36 Pontevedra;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2021QI;""
36 Pontevedra;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
36 Pontevedra;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2020QIII;3.651
36 Pontevedra;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2020QII;""
36 Pontevedra;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2020QI;""
36 Pontevedra;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2022QIV;3.745
36 Pontevedra;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
36 Pontevedra;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2022QII;""
36 Pontevedra;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2022QI;""
36 Pontevedra;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2021QIV;3.665
36 Pontevedra;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
36 Pontevedra;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2021QII;""
36 Pontevedra;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2021QI;""
36 Pontevedra;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2020QIV;3.472
36 Pontevedra;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
36 Pontevedra;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2020QII;""
36 Pontevedra;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2020QI;""
36 Pontevedra;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
36 Pontevedra;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
36 Pontevedra;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QII;""
36 Pontevedra;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QI;3.547
36 Pontevedra;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
36 Pontevedra;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
36 Pontevedra;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QII;""
36 Pontevedra;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QI;3.376
36 Pontevedra;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
36 Pontevedra;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
36 Pontevedra;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QII;""
36 Pontevedra;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QI;""
36 Pontevedra;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
36 Pontevedra;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
36 Pontevedra;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QII;3.420
36 Pontevedra;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QI;""
36 Pontevedra;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
36 Pontevedra;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
36 Pontevedra;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QII;3.257
36 Pontevedra;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QI;""
36 Pontevedra;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
36 Pontevedra;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
36 Pontevedra;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QII;""
36 Pontevedra;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QI;""
36 Pontevedra;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
36 Pontevedra;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
36 Pontevedra;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
36 Pontevedra;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
36 Pontevedra;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
36 Pontevedra;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
36 Pontevedra;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
36 Pontevedra;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
36 Pontevedra;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
36 Pontevedra;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
36 Pontevedra;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
36 Pontevedra;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
36 Pontevedra;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
36 Pontevedra;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;94,91
36 Pontevedra;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
36 Pontevedra;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
36 Pontevedra;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
36 Pontevedra;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;96,42
36 Pontevedra;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
36 Pontevedra;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
36 Pontevedra;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
36 Pontevedra;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;94,78
36 Pontevedra;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
36 Pontevedra;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
36 Pontevedra;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;89,42
36 Pontevedra;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
36 Pontevedra;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
36 Pontevedra;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
36 Pontevedra;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;91,65
36 Pontevedra;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
36 Pontevedra;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
36 Pontevedra;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
36 Pontevedra;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;90,13
36 Pontevedra;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
36 Pontevedra;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
36 Pontevedra;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
36 Pontevedra;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
36 Pontevedra;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
36 Pontevedra;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
36 Pontevedra;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;88,7
36 Pontevedra;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
36 Pontevedra;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
36 Pontevedra;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
36 Pontevedra;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;87,64
36 Pontevedra;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
36 Pontevedra;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
36 Pontevedra;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
36 Pontevedra;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
36 Pontevedra;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
36 Pontevedra;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
36 Pontevedra;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;85,52
36 Pontevedra;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
36 Pontevedra;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
36 Pontevedra;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
36 Pontevedra;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;84,55
36 Pontevedra;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
36 Pontevedra;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
36 Pontevedra;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
36 Pontevedra;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
36 Pontevedra;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
36 Pontevedra;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QIV;10.493
36 Pontevedra;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
36 Pontevedra;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
36 Pontevedra;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
36 Pontevedra;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QIV;10.106
36 Pontevedra;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
36 Pontevedra;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
36 Pontevedra;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
36 Pontevedra;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QIV;9.539
36 Pontevedra;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
36 Pontevedra;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
36 Pontevedra;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
36 Pontevedra;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2022QIV;9.900
36 Pontevedra;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
36 Pontevedra;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2022QII;""
36 Pontevedra;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2022QI;""
36 Pontevedra;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2021QIV;9.623
36 Pontevedra;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
36 Pontevedra;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2021QII;""
36 Pontevedra;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2021QI;""
36 Pontevedra;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2020QIV;9.087
36 Pontevedra;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
36 Pontevedra;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2020QII;""
36 Pontevedra;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2020QI;""
36 Pontevedra;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
36 Pontevedra;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
36 Pontevedra;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2022QII;""
36 Pontevedra;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2022QI;9.301
36 Pontevedra;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
36 Pontevedra;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
36 Pontevedra;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2021QII;""
36 Pontevedra;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2021QI;8.808
36 Pontevedra;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
36 Pontevedra;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
36 Pontevedra;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2020QII;""
36 Pontevedra;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2020QI;""
36 Pontevedra;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
36 Pontevedra;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
36 Pontevedra;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QII;8.984
36 Pontevedra;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QI;""
36 Pontevedra;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
36 Pontevedra;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
36 Pontevedra;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QII;8.538
36 Pontevedra;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QI;""
36 Pontevedra;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
36 Pontevedra;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
36 Pontevedra;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QII;""
36 Pontevedra;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QI;""
36 Pontevedra;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
36 Pontevedra;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QIII;8.649
36 Pontevedra;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QII;""
36 Pontevedra;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QI;""
36 Pontevedra;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
36 Pontevedra;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QIII;8.260
36 Pontevedra;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QII;""
36 Pontevedra;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QI;""
36 Pontevedra;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
36 Pontevedra;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
36 Pontevedra;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QII;""
36 Pontevedra;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QI;""
36 Pontevedra;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
36 Pontevedra;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
36 Pontevedra;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
36 Pontevedra;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
36 Pontevedra;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
36 Pontevedra;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
36 Pontevedra;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
36 Pontevedra;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
36 Pontevedra;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
36 Pontevedra;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
36 Pontevedra;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
36 Pontevedra;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
36 Pontevedra;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;94,35
36 Pontevedra;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
36 Pontevedra;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
36 Pontevedra;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
36 Pontevedra;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;95,22
36 Pontevedra;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
36 Pontevedra;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
36 Pontevedra;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
36 Pontevedra;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;95,26
36 Pontevedra;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
36 Pontevedra;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
36 Pontevedra;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
36 Pontevedra;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
36 Pontevedra;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
36 Pontevedra;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
36 Pontevedra;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;92,03
36 Pontevedra;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
36 Pontevedra;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
36 Pontevedra;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
36 Pontevedra;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;92,34
36 Pontevedra;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
36 Pontevedra;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
36 Pontevedra;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
36 Pontevedra;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
36 Pontevedra;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
36 Pontevedra;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
36 Pontevedra;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;88,9
36 Pontevedra;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
36 Pontevedra;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
36 Pontevedra;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
36 Pontevedra;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;89,51
36 Pontevedra;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
36 Pontevedra;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
36 Pontevedra;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
36 Pontevedra;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
36 Pontevedra;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
36 Pontevedra;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
36 Pontevedra;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;85,58
36 Pontevedra;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
36 Pontevedra;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
36 Pontevedra;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
36 Pontevedra;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;86,59
36 Pontevedra;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
36 Pontevedra;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
36 Pontevedra;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
36 Pontevedra;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
36 Pontevedra;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
36 Pontevedra;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
36 Pontevedra;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QIV;6.472
36 Pontevedra;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
36 Pontevedra;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
36 Pontevedra;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
36 Pontevedra;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QIV;6.201
36 Pontevedra;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
36 Pontevedra;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
36 Pontevedra;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
36 Pontevedra;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QIV;5.848
36 Pontevedra;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
36 Pontevedra;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
36 Pontevedra;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
36 Pontevedra;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2022QIV;6.123
36 Pontevedra;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
36 Pontevedra;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2022QII;""
36 Pontevedra;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2022QI;""
36 Pontevedra;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2021QIV;5.922
36 Pontevedra;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
36 Pontevedra;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2021QII;""
36 Pontevedra;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2021QI;""
36 Pontevedra;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2020QIV;5.586
36 Pontevedra;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
36 Pontevedra;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2020QII;""
36 Pontevedra;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2020QI;""
36 Pontevedra;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
36 Pontevedra;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
36 Pontevedra;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2022QII;""
36 Pontevedra;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2022QI;5.720
36 Pontevedra;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
36 Pontevedra;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
36 Pontevedra;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2021QII;""
36 Pontevedra;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2021QI;5.404
36 Pontevedra;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
36 Pontevedra;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
36 Pontevedra;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2020QII;""
36 Pontevedra;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2020QI;""
36 Pontevedra;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
36 Pontevedra;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
36 Pontevedra;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QII;5.534
36 Pontevedra;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QI;""
36 Pontevedra;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
36 Pontevedra;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
36 Pontevedra;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QII;5.254
36 Pontevedra;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QI;""
36 Pontevedra;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
36 Pontevedra;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
36 Pontevedra;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QII;""
36 Pontevedra;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QI;""
36 Pontevedra;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
36 Pontevedra;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QIII;5.371
36 Pontevedra;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QII;""
36 Pontevedra;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QI;""
36 Pontevedra;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
36 Pontevedra;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QIII;5.090
36 Pontevedra;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QII;""
36 Pontevedra;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QI;""
36 Pontevedra;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
36 Pontevedra;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
36 Pontevedra;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QII;""
36 Pontevedra;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QI;""
36 Pontevedra;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
36 Pontevedra;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
36 Pontevedra;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
36 Pontevedra;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
36 Pontevedra;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
36 Pontevedra;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
36 Pontevedra;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
36 Pontevedra;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
36 Pontevedra;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
36 Pontevedra;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
36 Pontevedra;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
36 Pontevedra;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
36 Pontevedra;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;94,61
36 Pontevedra;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
36 Pontevedra;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
36 Pontevedra;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
36 Pontevedra;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;95,5
36 Pontevedra;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
36 Pontevedra;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
36 Pontevedra;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
36 Pontevedra;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;95,52
36 Pontevedra;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
36 Pontevedra;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
36 Pontevedra;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
36 Pontevedra;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
36 Pontevedra;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
36 Pontevedra;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
36 Pontevedra;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;92,24
36 Pontevedra;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
36 Pontevedra;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
36 Pontevedra;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
36 Pontevedra;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;92,41
36 Pontevedra;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
36 Pontevedra;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
36 Pontevedra;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
36 Pontevedra;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
36 Pontevedra;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
36 Pontevedra;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
36 Pontevedra;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;89,24
36 Pontevedra;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
36 Pontevedra;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
36 Pontevedra;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
36 Pontevedra;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;89,84
36 Pontevedra;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
36 Pontevedra;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
36 Pontevedra;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
36 Pontevedra;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
36 Pontevedra;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
36 Pontevedra;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
36 Pontevedra;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;86,62
36 Pontevedra;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
36 Pontevedra;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
36 Pontevedra;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
36 Pontevedra;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;87,04
36 Pontevedra;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
36 Pontevedra;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
36 Pontevedra;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
36 Pontevedra;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
36 Pontevedra;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
36 Pontevedra;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
36 Pontevedra;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QIV;4.021
36 Pontevedra;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
36 Pontevedra;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
36 Pontevedra;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
36 Pontevedra;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QIV;3.905
36 Pontevedra;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
36 Pontevedra;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
36 Pontevedra;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
36 Pontevedra;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QIV;3.691
36 Pontevedra;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
36 Pontevedra;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
36 Pontevedra;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
36 Pontevedra;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2022QIV;3.777
36 Pontevedra;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
36 Pontevedra;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2022QII;""
36 Pontevedra;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2022QI;""
36 Pontevedra;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2021QIV;3.701
36 Pontevedra;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
36 Pontevedra;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2021QII;""
36 Pontevedra;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2021QI;""
36 Pontevedra;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2020QIV;3.501
36 Pontevedra;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
36 Pontevedra;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2020QII;""
36 Pontevedra;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2020QI;""
36 Pontevedra;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
36 Pontevedra;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
36 Pontevedra;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2022QII;""
36 Pontevedra;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2022QI;3.581
36 Pontevedra;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
36 Pontevedra;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
36 Pontevedra;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2021QII;""
36 Pontevedra;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2021QI;3.404
36 Pontevedra;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
36 Pontevedra;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
36 Pontevedra;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2020QII;""
36 Pontevedra;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2020QI;""
36 Pontevedra;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
36 Pontevedra;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
36 Pontevedra;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QII;3.450
36 Pontevedra;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QI;""
36 Pontevedra;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
36 Pontevedra;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
36 Pontevedra;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QII;3.284
36 Pontevedra;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QI;""
36 Pontevedra;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
36 Pontevedra;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
36 Pontevedra;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QII;""
36 Pontevedra;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QI;""
36 Pontevedra;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
36 Pontevedra;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QIII;3.278
36 Pontevedra;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QII;""
36 Pontevedra;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QI;""
36 Pontevedra;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
36 Pontevedra;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QIII;3.170
36 Pontevedra;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QII;""
36 Pontevedra;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QI;""
36 Pontevedra;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
36 Pontevedra;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
36 Pontevedra;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QII;""
36 Pontevedra;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QI;""
36 Pontevedra;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
36 Pontevedra;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
36 Pontevedra;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
36 Pontevedra;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
36 Pontevedra;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
36 Pontevedra;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
36 Pontevedra;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
36 Pontevedra;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
36 Pontevedra;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
36 Pontevedra;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
36 Pontevedra;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
36 Pontevedra;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
36 Pontevedra;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;93,93
36 Pontevedra;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
36 Pontevedra;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
36 Pontevedra;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
36 Pontevedra;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;94,78
36 Pontevedra;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
36 Pontevedra;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
36 Pontevedra;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
36 Pontevedra;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;94,85
36 Pontevedra;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
36 Pontevedra;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
36 Pontevedra;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
36 Pontevedra;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
36 Pontevedra;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
36 Pontevedra;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
36 Pontevedra;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;91,7
36 Pontevedra;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
36 Pontevedra;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
36 Pontevedra;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
36 Pontevedra;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;92,22
36 Pontevedra;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
36 Pontevedra;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
36 Pontevedra;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
36 Pontevedra;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
36 Pontevedra;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
36 Pontevedra;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
36 Pontevedra;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;88,35
36 Pontevedra;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
36 Pontevedra;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
36 Pontevedra;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
36 Pontevedra;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;88,97
36 Pontevedra;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
36 Pontevedra;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
36 Pontevedra;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
36 Pontevedra;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
36 Pontevedra;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
36 Pontevedra;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
36 Pontevedra;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;83,94
36 Pontevedra;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
36 Pontevedra;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
36 Pontevedra;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
36 Pontevedra;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;85,88
36 Pontevedra;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
36 Pontevedra;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
36 Pontevedra;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
36 Pontevedra;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
36 Pontevedra;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
36 Pontevedra;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
26 Rioja, La;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
26 Rioja, La;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
26 Rioja, La;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
26 Rioja, La;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QI;20.794
26 Rioja, La;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
26 Rioja, La;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
26 Rioja, La;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
26 Rioja, La;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QI;20.839
26 Rioja, La;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
26 Rioja, La;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
26 Rioja, La;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
26 Rioja, La;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QI;21.422
26 Rioja, La;All ages;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
26 Rioja, La;All ages;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
26 Rioja, La;All ages;Cohort January 1;Total;Survival in the first trimester;2022QII;""
26 Rioja, La;All ages;Cohort January 1;Total;Survival in the first trimester;2022QI;20.264
26 Rioja, La;All ages;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
26 Rioja, La;All ages;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
26 Rioja, La;All ages;Cohort January 1;Total;Survival in the first trimester;2021QII;""
26 Rioja, La;All ages;Cohort January 1;Total;Survival in the first trimester;2021QI;20.371
26 Rioja, La;All ages;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
26 Rioja, La;All ages;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
26 Rioja, La;All ages;Cohort January 1;Total;Survival in the first trimester;2020QII;""
26 Rioja, La;All ages;Cohort January 1;Total;Survival in the first trimester;2020QI;20.202
26 Rioja, La;All ages;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
26 Rioja, La;All ages;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
26 Rioja, La;All ages;Cohort January 1;Total;Survival in the second trimester;2022QII;19.692
26 Rioja, La;All ages;Cohort January 1;Total;Survival in the second trimester;2022QI;""
26 Rioja, La;All ages;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
26 Rioja, La;All ages;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
26 Rioja, La;All ages;Cohort January 1;Total;Survival in the second trimester;2021QII;19.841
26 Rioja, La;All ages;Cohort January 1;Total;Survival in the second trimester;2021QI;""
26 Rioja, La;All ages;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
26 Rioja, La;All ages;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
26 Rioja, La;All ages;Cohort January 1;Total;Survival in the second trimester;2020QII;19.798
26 Rioja, La;All ages;Cohort January 1;Total;Survival in the second trimester;2020QI;""
26 Rioja, La;All ages;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
26 Rioja, La;All ages;Cohort January 1;Total;Survival in the third trimester;2022QIII;19.211
26 Rioja, La;All ages;Cohort January 1;Total;Survival in the third trimester;2022QII;""
26 Rioja, La;All ages;Cohort January 1;Total;Survival in the third trimester;2022QI;""
26 Rioja, La;All ages;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
26 Rioja, La;All ages;Cohort January 1;Total;Survival in the third trimester;2021QIII;19.371
26 Rioja, La;All ages;Cohort January 1;Total;Survival in the third trimester;2021QII;""
26 Rioja, La;All ages;Cohort January 1;Total;Survival in the third trimester;2021QI;""
26 Rioja, La;All ages;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
26 Rioja, La;All ages;Cohort January 1;Total;Survival in the third trimester;2020QIII;19.308
26 Rioja, La;All ages;Cohort January 1;Total;Survival in the third trimester;2020QII;""
26 Rioja, La;All ages;Cohort January 1;Total;Survival in the third trimester;2020QI;""
26 Rioja, La;All ages;Cohort January 1;Total;Survival in the third trimester;2022QIV;18.571
26 Rioja, La;All ages;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
26 Rioja, La;All ages;Cohort January 1;Total;Survival in the third trimester;2022QII;""
26 Rioja, La;All ages;Cohort January 1;Total;Survival in the third trimester;2022QI;""
26 Rioja, La;All ages;Cohort January 1;Total;Survival in the third trimester;2021QIV;18.838
26 Rioja, La;All ages;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
26 Rioja, La;All ages;Cohort January 1;Total;Survival in the third trimester;2021QII;""
26 Rioja, La;All ages;Cohort January 1;Total;Survival in the third trimester;2021QI;""
26 Rioja, La;All ages;Cohort January 1;Total;Survival in the third trimester;2020QIV;18.805
26 Rioja, La;All ages;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
26 Rioja, La;All ages;Cohort January 1;Total;Survival in the third trimester;2020QII;""
26 Rioja, La;All ages;Cohort January 1;Total;Survival in the third trimester;2020QI;""
26 Rioja, La;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
26 Rioja, La;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
26 Rioja, La;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
26 Rioja, La;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
26 Rioja, La;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
26 Rioja, La;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
26 Rioja, La;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
26 Rioja, La;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
26 Rioja, La;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
26 Rioja, La;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
26 Rioja, La;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
26 Rioja, La;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
26 Rioja, La;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
26 Rioja, La;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
26 Rioja, La;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
26 Rioja, La;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;97,45
26 Rioja, La;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
26 Rioja, La;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
26 Rioja, La;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
26 Rioja, La;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;97,75
26 Rioja, La;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
26 Rioja, La;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
26 Rioja, La;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
26 Rioja, La;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;94,3
26 Rioja, La;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
26 Rioja, La;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
26 Rioja, La;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;94,7
26 Rioja, La;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
26 Rioja, La;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
26 Rioja, La;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
26 Rioja, La;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;95,21
26 Rioja, La;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
26 Rioja, La;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
26 Rioja, La;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
26 Rioja, La;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;92,42
26 Rioja, La;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
26 Rioja, La;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
26 Rioja, La;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;92,39
26 Rioja, La;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
26 Rioja, La;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
26 Rioja, La;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
26 Rioja, La;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;92,96
26 Rioja, La;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
26 Rioja, La;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
26 Rioja, La;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
26 Rioja, La;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;90,13
26 Rioja, La;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
26 Rioja, La;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
26 Rioja, La;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;89,31
26 Rioja, La;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
26 Rioja, La;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
26 Rioja, La;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
26 Rioja, La;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;90,4
26 Rioja, La;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
26 Rioja, La;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
26 Rioja, La;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
26 Rioja, La;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;87,78
26 Rioja, La;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
26 Rioja, La;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
26 Rioja, La;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
26 Rioja, La;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
26 Rioja, La;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
26 Rioja, La;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
26 Rioja, La;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QI;12.879
26 Rioja, La;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
26 Rioja, La;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
26 Rioja, La;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
26 Rioja, La;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QI;12.975
26 Rioja, La;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
26 Rioja, La;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
26 Rioja, La;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
26 Rioja, La;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QI;13.307
26 Rioja, La;All ages;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
26 Rioja, La;All ages;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
26 Rioja, La;All ages;Cohort January 1;Males;Survival in the first trimester;2022QII;""
26 Rioja, La;All ages;Cohort January 1;Males;Survival in the first trimester;2022QI;12.541
26 Rioja, La;All ages;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
26 Rioja, La;All ages;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
26 Rioja, La;All ages;Cohort January 1;Males;Survival in the first trimester;2021QII;""
26 Rioja, La;All ages;Cohort January 1;Males;Survival in the first trimester;2021QI;12.681
26 Rioja, La;All ages;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
26 Rioja, La;All ages;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
26 Rioja, La;All ages;Cohort January 1;Males;Survival in the first trimester;2020QII;""
26 Rioja, La;All ages;Cohort January 1;Males;Survival in the first trimester;2020QI;12.581
26 Rioja, La;All ages;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
26 Rioja, La;All ages;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
26 Rioja, La;All ages;Cohort January 1;Males;Survival in the second trimester;2022QII;12.193
26 Rioja, La;All ages;Cohort January 1;Males;Survival in the second trimester;2022QI;""
26 Rioja, La;All ages;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
26 Rioja, La;All ages;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
26 Rioja, La;All ages;Cohort January 1;Males;Survival in the second trimester;2021QII;12.380
26 Rioja, La;All ages;Cohort January 1;Males;Survival in the second trimester;2021QI;""
26 Rioja, La;All ages;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
26 Rioja, La;All ages;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
26 Rioja, La;All ages;Cohort January 1;Males;Survival in the second trimester;2020QII;12.351
26 Rioja, La;All ages;Cohort January 1;Males;Survival in the second trimester;2020QI;""
26 Rioja, La;All ages;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
26 Rioja, La;All ages;Cohort January 1;Males;Survival in the third trimester;2022QIII;11.935
26 Rioja, La;All ages;Cohort January 1;Males;Survival in the third trimester;2022QII;""
26 Rioja, La;All ages;Cohort January 1;Males;Survival in the third trimester;2022QI;""
26 Rioja, La;All ages;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
26 Rioja, La;All ages;Cohort January 1;Males;Survival in the third trimester;2021QIII;12.088
26 Rioja, La;All ages;Cohort January 1;Males;Survival in the third trimester;2021QII;""
26 Rioja, La;All ages;Cohort January 1;Males;Survival in the third trimester;2021QI;""
26 Rioja, La;All ages;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
26 Rioja, La;All ages;Cohort January 1;Males;Survival in the third trimester;2020QIII;12.068
26 Rioja, La;All ages;Cohort January 1;Males;Survival in the third trimester;2020QII;""
26 Rioja, La;All ages;Cohort January 1;Males;Survival in the third trimester;2020QI;""
26 Rioja, La;All ages;Cohort January 1;Males;Survival in the third trimester;2022QIV;11.553
26 Rioja, La;All ages;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
26 Rioja, La;All ages;Cohort January 1;Males;Survival in the third trimester;2022QII;""
26 Rioja, La;All ages;Cohort January 1;Males;Survival in the third trimester;2022QI;""
26 Rioja, La;All ages;Cohort January 1;Males;Survival in the third trimester;2021QIV;11.763
26 Rioja, La;All ages;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
26 Rioja, La;All ages;Cohort January 1;Males;Survival in the third trimester;2021QII;""
26 Rioja, La;All ages;Cohort January 1;Males;Survival in the third trimester;2021QI;""
26 Rioja, La;All ages;Cohort January 1;Males;Survival in the third trimester;2020QIV;11.766
26 Rioja, La;All ages;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
26 Rioja, La;All ages;Cohort January 1;Males;Survival in the third trimester;2020QII;""
26 Rioja, La;All ages;Cohort January 1;Males;Survival in the third trimester;2020QI;""
26 Rioja, La;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
26 Rioja, La;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
26 Rioja, La;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
26 Rioja, La;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
26 Rioja, La;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
26 Rioja, La;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
26 Rioja, La;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
26 Rioja, La;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
26 Rioja, La;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
26 Rioja, La;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
26 Rioja, La;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
26 Rioja, La;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
26 Rioja, La;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
26 Rioja, La;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
26 Rioja, La;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
26 Rioja, La;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;97,38
26 Rioja, La;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
26 Rioja, La;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
26 Rioja, La;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
26 Rioja, La;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;97,73
26 Rioja, La;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
26 Rioja, La;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
26 Rioja, La;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
26 Rioja, La;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;94,54
26 Rioja, La;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
26 Rioja, La;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
26 Rioja, La;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;94,67
26 Rioja, La;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
26 Rioja, La;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
26 Rioja, La;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
26 Rioja, La;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;95,41
26 Rioja, La;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
26 Rioja, La;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
26 Rioja, La;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
26 Rioja, La;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;92,82
26 Rioja, La;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
26 Rioja, La;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
26 Rioja, La;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;92,67
26 Rioja, La;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
26 Rioja, La;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
26 Rioja, La;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
26 Rioja, La;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;93,16
26 Rioja, La;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
26 Rioja, La;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
26 Rioja, La;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
26 Rioja, La;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;90,69
26 Rioja, La;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
26 Rioja, La;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
26 Rioja, La;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;89,7
26 Rioja, La;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
26 Rioja, La;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
26 Rioja, La;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
26 Rioja, La;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;90,66
26 Rioja, La;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
26 Rioja, La;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
26 Rioja, La;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
26 Rioja, La;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;88,42
26 Rioja, La;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
26 Rioja, La;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
26 Rioja, La;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
26 Rioja, La;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
26 Rioja, La;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
26 Rioja, La;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
26 Rioja, La;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QI;7.915
26 Rioja, La;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
26 Rioja, La;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
26 Rioja, La;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
26 Rioja, La;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QI;7.864
26 Rioja, La;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
26 Rioja, La;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
26 Rioja, La;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
26 Rioja, La;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QI;8.115
26 Rioja, La;All ages;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
26 Rioja, La;All ages;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
26 Rioja, La;All ages;Cohort January 1;Females;Survival in the first trimester;2022QII;""
26 Rioja, La;All ages;Cohort January 1;Females;Survival in the first trimester;2022QI;7.723
26 Rioja, La;All ages;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
26 Rioja, La;All ages;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
26 Rioja, La;All ages;Cohort January 1;Females;Survival in the first trimester;2021QII;""
26 Rioja, La;All ages;Cohort January 1;Females;Survival in the first trimester;2021QI;7.690
26 Rioja, La;All ages;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
26 Rioja, La;All ages;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
26 Rioja, La;All ages;Cohort January 1;Females;Survival in the first trimester;2020QII;""
26 Rioja, La;All ages;Cohort January 1;Females;Survival in the first trimester;2020QI;7.621
26 Rioja, La;All ages;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
26 Rioja, La;All ages;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
26 Rioja, La;All ages;Cohort January 1;Females;Survival in the second trimester;2022QII;7.499
26 Rioja, La;All ages;Cohort January 1;Females;Survival in the second trimester;2022QI;""
26 Rioja, La;All ages;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
26 Rioja, La;All ages;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
26 Rioja, La;All ages;Cohort January 1;Females;Survival in the second trimester;2021QII;7.461
26 Rioja, La;All ages;Cohort January 1;Females;Survival in the second trimester;2021QI;""
26 Rioja, La;All ages;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
26 Rioja, La;All ages;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
26 Rioja, La;All ages;Cohort January 1;Females;Survival in the second trimester;2020QII;7.447
26 Rioja, La;All ages;Cohort January 1;Females;Survival in the second trimester;2020QI;""
26 Rioja, La;All ages;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
26 Rioja, La;All ages;Cohort January 1;Females;Survival in the third trimester;2022QIII;7.276
26 Rioja, La;All ages;Cohort January 1;Females;Survival in the third trimester;2022QII;""
26 Rioja, La;All ages;Cohort January 1;Females;Survival in the third trimester;2022QI;""
26 Rioja, La;All ages;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
26 Rioja, La;All ages;Cohort January 1;Females;Survival in the third trimester;2021QIII;7.283
26 Rioja, La;All ages;Cohort January 1;Females;Survival in the third trimester;2021QII;""
26 Rioja, La;All ages;Cohort January 1;Females;Survival in the third trimester;2021QI;""
26 Rioja, La;All ages;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
26 Rioja, La;All ages;Cohort January 1;Females;Survival in the third trimester;2020QIII;7.240
26 Rioja, La;All ages;Cohort January 1;Females;Survival in the third trimester;2020QII;""
26 Rioja, La;All ages;Cohort January 1;Females;Survival in the third trimester;2020QI;""
26 Rioja, La;All ages;Cohort January 1;Females;Survival in the third trimester;2022QIV;7.018
26 Rioja, La;All ages;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
26 Rioja, La;All ages;Cohort January 1;Females;Survival in the third trimester;2022QII;""
26 Rioja, La;All ages;Cohort January 1;Females;Survival in the third trimester;2022QI;""
26 Rioja, La;All ages;Cohort January 1;Females;Survival in the third trimester;2021QIV;7.075
26 Rioja, La;All ages;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
26 Rioja, La;All ages;Cohort January 1;Females;Survival in the third trimester;2021QII;""
26 Rioja, La;All ages;Cohort January 1;Females;Survival in the third trimester;2021QI;""
26 Rioja, La;All ages;Cohort January 1;Females;Survival in the third trimester;2020QIV;7.039
26 Rioja, La;All ages;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
26 Rioja, La;All ages;Cohort January 1;Females;Survival in the third trimester;2020QII;""
26 Rioja, La;All ages;Cohort January 1;Females;Survival in the third trimester;2020QI;""
26 Rioja, La;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
26 Rioja, La;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
26 Rioja, La;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
26 Rioja, La;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
26 Rioja, La;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
26 Rioja, La;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
26 Rioja, La;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
26 Rioja, La;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
26 Rioja, La;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
26 Rioja, La;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
26 Rioja, La;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
26 Rioja, La;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
26 Rioja, La;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
26 Rioja, La;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
26 Rioja, La;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
26 Rioja, La;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;97,57
26 Rioja, La;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
26 Rioja, La;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
26 Rioja, La;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
26 Rioja, La;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;97,79
26 Rioja, La;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
26 Rioja, La;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
26 Rioja, La;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
26 Rioja, La;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;93,91
26 Rioja, La;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
26 Rioja, La;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
26 Rioja, La;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;94,74
26 Rioja, La;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
26 Rioja, La;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
26 Rioja, La;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
26 Rioja, La;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;94,88
26 Rioja, La;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
26 Rioja, La;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
26 Rioja, La;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
26 Rioja, La;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;91,77
26 Rioja, La;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
26 Rioja, La;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
26 Rioja, La;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;91,93
26 Rioja, La;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
26 Rioja, La;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
26 Rioja, La;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
26 Rioja, La;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;92,61
26 Rioja, La;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
26 Rioja, La;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
26 Rioja, La;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
26 Rioja, La;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;89,22
26 Rioja, La;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
26 Rioja, La;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
26 Rioja, La;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;88,67
26 Rioja, La;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
26 Rioja, La;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
26 Rioja, La;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
26 Rioja, La;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;89,97
26 Rioja, La;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
26 Rioja, La;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
26 Rioja, La;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
26 Rioja, La;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;86,74
26 Rioja, La;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
26 Rioja, La;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
26 Rioja, La;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
26 Rioja, La;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
26 Rioja, La;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
26 Rioja, La;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QII;20.851
26 Rioja, La;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
26 Rioja, La;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
26 Rioja, La;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
26 Rioja, La;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QII;20.996
26 Rioja, La;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
26 Rioja, La;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
26 Rioja, La;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
26 Rioja, La;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QII;20.964
26 Rioja, La;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
26 Rioja, La;All ages;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
26 Rioja, La;All ages;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
26 Rioja, La;All ages;Cohort April 1;Total;Survival in the first trimester;2022QII;20.203
26 Rioja, La;All ages;Cohort April 1;Total;Survival in the first trimester;2022QI;""
26 Rioja, La;All ages;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
26 Rioja, La;All ages;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
26 Rioja, La;All ages;Cohort April 1;Total;Survival in the first trimester;2021QII;20.381
26 Rioja, La;All ages;Cohort April 1;Total;Survival in the first trimester;2021QI;""
26 Rioja, La;All ages;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
26 Rioja, La;All ages;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
26 Rioja, La;All ages;Cohort April 1;Total;Survival in the first trimester;2020QII;20.513
26 Rioja, La;All ages;Cohort April 1;Total;Survival in the first trimester;2020QI;""
26 Rioja, La;All ages;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
26 Rioja, La;All ages;Cohort April 1;Total;Survival in the second trimester;2022QIII;19.685
26 Rioja, La;All ages;Cohort April 1;Total;Survival in the second trimester;2022QII;""
26 Rioja, La;All ages;Cohort April 1;Total;Survival in the second trimester;2022QI;""
26 Rioja, La;All ages;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
26 Rioja, La;All ages;Cohort April 1;Total;Survival in the second trimester;2021QIII;19.850
26 Rioja, La;All ages;Cohort April 1;Total;Survival in the second trimester;2021QII;""
26 Rioja, La;All ages;Cohort April 1;Total;Survival in the second trimester;2021QI;""
26 Rioja, La;All ages;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
26 Rioja, La;All ages;Cohort April 1;Total;Survival in the second trimester;2020QIII;19.955
26 Rioja, La;All ages;Cohort April 1;Total;Survival in the second trimester;2020QII;""
26 Rioja, La;All ages;Cohort April 1;Total;Survival in the second trimester;2020QI;""
26 Rioja, La;All ages;Cohort April 1;Total;Survival in the third trimester;2022QIV;19.001
26 Rioja, La;All ages;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
26 Rioja, La;All ages;Cohort April 1;Total;Survival in the third trimester;2022QII;""
26 Rioja, La;All ages;Cohort April 1;Total;Survival in the third trimester;2022QI;""
26 Rioja, La;All ages;Cohort April 1;Total;Survival in the third trimester;2021QIV;19.267
26 Rioja, La;All ages;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
26 Rioja, La;All ages;Cohort April 1;Total;Survival in the third trimester;2021QII;""
26 Rioja, La;All ages;Cohort April 1;Total;Survival in the third trimester;2021QI;""
26 Rioja, La;All ages;Cohort April 1;Total;Survival in the third trimester;2020QIV;19.401
26 Rioja, La;All ages;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
26 Rioja, La;All ages;Cohort April 1;Total;Survival in the third trimester;2020QII;""
26 Rioja, La;All ages;Cohort April 1;Total;Survival in the third trimester;2020QI;""
26 Rioja, La;All ages;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
26 Rioja, La;All ages;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
26 Rioja, La;All ages;Cohort April 1;Total;Survival in the third trimester;2022QII;""
26 Rioja, La;All ages;Cohort April 1;Total;Survival in the third trimester;2022QI;18.850
26 Rioja, La;All ages;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
26 Rioja, La;All ages;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
26 Rioja, La;All ages;Cohort April 1;Total;Survival in the third trimester;2021QII;""
26 Rioja, La;All ages;Cohort April 1;Total;Survival in the third trimester;2021QI;19.051
26 Rioja, La;All ages;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
26 Rioja, La;All ages;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
26 Rioja, La;All ages;Cohort April 1;Total;Survival in the third trimester;2020QII;""
26 Rioja, La;All ages;Cohort April 1;Total;Survival in the third trimester;2020QI;""
26 Rioja, La;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
26 Rioja, La;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
26 Rioja, La;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
26 Rioja, La;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
26 Rioja, La;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
26 Rioja, La;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
26 Rioja, La;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
26 Rioja, La;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
26 Rioja, La;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
26 Rioja, La;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
26 Rioja, La;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
26 Rioja, La;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
26 Rioja, La;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
26 Rioja, La;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
26 Rioja, La;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;96,89
26 Rioja, La;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
26 Rioja, La;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
26 Rioja, La;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
26 Rioja, La;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;97,07
26 Rioja, La;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
26 Rioja, La;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
26 Rioja, La;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
26 Rioja, La;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;97,85
26 Rioja, La;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
26 Rioja, La;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
26 Rioja, La;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;94,41
26 Rioja, La;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
26 Rioja, La;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
26 Rioja, La;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
26 Rioja, La;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;94,54
26 Rioja, La;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
26 Rioja, La;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
26 Rioja, La;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
26 Rioja, La;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;95,19
26 Rioja, La;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
26 Rioja, La;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
26 Rioja, La;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;91,13
26 Rioja, La;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
26 Rioja, La;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
26 Rioja, La;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
26 Rioja, La;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;91,77
26 Rioja, La;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
26 Rioja, La;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
26 Rioja, La;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
26 Rioja, La;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;92,54
26 Rioja, La;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
26 Rioja, La;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
26 Rioja, La;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
26 Rioja, La;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
26 Rioja, La;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
26 Rioja, La;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
26 Rioja, La;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;89,78
26 Rioja, La;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
26 Rioja, La;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
26 Rioja, La;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
26 Rioja, La;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;90,87
26 Rioja, La;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
26 Rioja, La;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
26 Rioja, La;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
26 Rioja, La;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
26 Rioja, La;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
26 Rioja, La;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
26 Rioja, La;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QII;12.904
26 Rioja, La;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
26 Rioja, La;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
26 Rioja, La;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
26 Rioja, La;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QII;13.074
26 Rioja, La;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
26 Rioja, La;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
26 Rioja, La;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
26 Rioja, La;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QII;13.064
26 Rioja, La;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
26 Rioja, La;All ages;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
26 Rioja, La;All ages;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
26 Rioja, La;All ages;Cohort April 1;Males;Survival in the first trimester;2022QII;12.506
26 Rioja, La;All ages;Cohort April 1;Males;Survival in the first trimester;2022QI;""
26 Rioja, La;All ages;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
26 Rioja, La;All ages;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
26 Rioja, La;All ages;Cohort April 1;Males;Survival in the first trimester;2021QII;12.715
26 Rioja, La;All ages;Cohort April 1;Males;Survival in the first trimester;2021QI;""
26 Rioja, La;All ages;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
26 Rioja, La;All ages;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
26 Rioja, La;All ages;Cohort April 1;Males;Survival in the first trimester;2020QII;12.803
26 Rioja, La;All ages;Cohort April 1;Males;Survival in the first trimester;2020QI;""
26 Rioja, La;All ages;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
26 Rioja, La;All ages;Cohort April 1;Males;Survival in the second trimester;2022QIII;12.228
26 Rioja, La;All ages;Cohort April 1;Males;Survival in the second trimester;2022QII;""
26 Rioja, La;All ages;Cohort April 1;Males;Survival in the second trimester;2022QI;""
26 Rioja, La;All ages;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
26 Rioja, La;All ages;Cohort April 1;Males;Survival in the second trimester;2021QIII;12.382
26 Rioja, La;All ages;Cohort April 1;Males;Survival in the second trimester;2021QII;""
26 Rioja, La;All ages;Cohort April 1;Males;Survival in the second trimester;2021QI;""
26 Rioja, La;All ages;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
26 Rioja, La;All ages;Cohort April 1;Males;Survival in the second trimester;2020QIII;12.471
26 Rioja, La;All ages;Cohort April 1;Males;Survival in the second trimester;2020QII;""
26 Rioja, La;All ages;Cohort April 1;Males;Survival in the second trimester;2020QI;""
26 Rioja, La;All ages;Cohort April 1;Males;Survival in the third trimester;2022QIV;11.818
26 Rioja, La;All ages;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
26 Rioja, La;All ages;Cohort April 1;Males;Survival in the third trimester;2022QII;""
26 Rioja, La;All ages;Cohort April 1;Males;Survival in the third trimester;2022QI;""
26 Rioja, La;All ages;Cohort April 1;Males;Survival in the third trimester;2021QIV;12.022
26 Rioja, La;All ages;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
26 Rioja, La;All ages;Cohort April 1;Males;Survival in the third trimester;2021QII;""
26 Rioja, La;All ages;Cohort April 1;Males;Survival in the third trimester;2021QI;""
26 Rioja, La;All ages;Cohort April 1;Males;Survival in the third trimester;2020QIV;12.129
26 Rioja, La;All ages;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
26 Rioja, La;All ages;Cohort April 1;Males;Survival in the third trimester;2020QII;""
26 Rioja, La;All ages;Cohort April 1;Males;Survival in the third trimester;2020QI;""
26 Rioja, La;All ages;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
26 Rioja, La;All ages;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
26 Rioja, La;All ages;Cohort April 1;Males;Survival in the third trimester;2022QII;""
26 Rioja, La;All ages;Cohort April 1;Males;Survival in the third trimester;2022QI;11.763
26 Rioja, La;All ages;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
26 Rioja, La;All ages;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
26 Rioja, La;All ages;Cohort April 1;Males;Survival in the third trimester;2021QII;""
26 Rioja, La;All ages;Cohort April 1;Males;Survival in the third trimester;2021QI;11.912
26 Rioja, La;All ages;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
26 Rioja, La;All ages;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
26 Rioja, La;All ages;Cohort April 1;Males;Survival in the third trimester;2020QII;""
26 Rioja, La;All ages;Cohort April 1;Males;Survival in the third trimester;2020QI;""
26 Rioja, La;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
26 Rioja, La;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
26 Rioja, La;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
26 Rioja, La;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
26 Rioja, La;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
26 Rioja, La;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
26 Rioja, La;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
26 Rioja, La;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
26 Rioja, La;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
26 Rioja, La;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
26 Rioja, La;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
26 Rioja, La;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
26 Rioja, La;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
26 Rioja, La;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
26 Rioja, La;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;96,92
26 Rioja, La;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
26 Rioja, La;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
26 Rioja, La;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
26 Rioja, La;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;97,25
26 Rioja, La;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
26 Rioja, La;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
26 Rioja, La;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
26 Rioja, La;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;98
26 Rioja, La;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
26 Rioja, La;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
26 Rioja, La;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;94,76
26 Rioja, La;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
26 Rioja, La;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
26 Rioja, La;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
26 Rioja, La;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;94,71
26 Rioja, La;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
26 Rioja, La;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
26 Rioja, La;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
26 Rioja, La;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;95,46
26 Rioja, La;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
26 Rioja, La;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
26 Rioja, La;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;91,58
26 Rioja, La;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
26 Rioja, La;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
26 Rioja, La;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
26 Rioja, La;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;91,95
26 Rioja, La;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
26 Rioja, La;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
26 Rioja, La;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
26 Rioja, La;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;92,84
26 Rioja, La;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
26 Rioja, La;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
26 Rioja, La;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
26 Rioja, La;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
26 Rioja, La;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
26 Rioja, La;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
26 Rioja, La;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;89,97
26 Rioja, La;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
26 Rioja, La;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
26 Rioja, La;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
26 Rioja, La;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;91,18
26 Rioja, La;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
26 Rioja, La;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
26 Rioja, La;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
26 Rioja, La;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
26 Rioja, La;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
26 Rioja, La;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
26 Rioja, La;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QII;7.947
26 Rioja, La;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
26 Rioja, La;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
26 Rioja, La;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
26 Rioja, La;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QII;7.922
26 Rioja, La;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
26 Rioja, La;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
26 Rioja, La;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
26 Rioja, La;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QII;7.900
26 Rioja, La;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
26 Rioja, La;All ages;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
26 Rioja, La;All ages;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
26 Rioja, La;All ages;Cohort April 1;Females;Survival in the first trimester;2022QII;7.697
26 Rioja, La;All ages;Cohort April 1;Females;Survival in the first trimester;2022QI;""
26 Rioja, La;All ages;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
26 Rioja, La;All ages;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
26 Rioja, La;All ages;Cohort April 1;Females;Survival in the first trimester;2021QII;7.666
26 Rioja, La;All ages;Cohort April 1;Females;Survival in the first trimester;2021QI;""
26 Rioja, La;All ages;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
26 Rioja, La;All ages;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
26 Rioja, La;All ages;Cohort April 1;Females;Survival in the first trimester;2020QII;7.710
26 Rioja, La;All ages;Cohort April 1;Females;Survival in the first trimester;2020QI;""
26 Rioja, La;All ages;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
26 Rioja, La;All ages;Cohort April 1;Females;Survival in the second trimester;2022QIII;7.457
26 Rioja, La;All ages;Cohort April 1;Females;Survival in the second trimester;2022QII;""
26 Rioja, La;All ages;Cohort April 1;Females;Survival in the second trimester;2022QI;""
26 Rioja, La;All ages;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
26 Rioja, La;All ages;Cohort April 1;Females;Survival in the second trimester;2021QIII;7.468
26 Rioja, La;All ages;Cohort April 1;Females;Survival in the second trimester;2021QII;""
26 Rioja, La;All ages;Cohort April 1;Females;Survival in the second trimester;2021QI;""
26 Rioja, La;All ages;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
26 Rioja, La;All ages;Cohort April 1;Females;Survival in the second trimester;2020QIII;7.484
26 Rioja, La;All ages;Cohort April 1;Females;Survival in the second trimester;2020QII;""
26 Rioja, La;All ages;Cohort April 1;Females;Survival in the second trimester;2020QI;""
26 Rioja, La;All ages;Cohort April 1;Females;Survival in the third trimester;2022QIV;7.183
26 Rioja, La;All ages;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
26 Rioja, La;All ages;Cohort April 1;Females;Survival in the third trimester;2022QII;""
26 Rioja, La;All ages;Cohort April 1;Females;Survival in the third trimester;2022QI;""
26 Rioja, La;All ages;Cohort April 1;Females;Survival in the third trimester;2021QIV;7.245
26 Rioja, La;All ages;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
26 Rioja, La;All ages;Cohort April 1;Females;Survival in the third trimester;2021QII;""
26 Rioja, La;All ages;Cohort April 1;Females;Survival in the third trimester;2021QI;""
26 Rioja, La;All ages;Cohort April 1;Females;Survival in the third trimester;2020QIV;7.272
26 Rioja, La;All ages;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
26 Rioja, La;All ages;Cohort April 1;Females;Survival in the third trimester;2020QII;""
26 Rioja, La;All ages;Cohort April 1;Females;Survival in the third trimester;2020QI;""
26 Rioja, La;All ages;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
26 Rioja, La;All ages;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
26 Rioja, La;All ages;Cohort April 1;Females;Survival in the third trimester;2022QII;""
26 Rioja, La;All ages;Cohort April 1;Females;Survival in the third trimester;2022QI;7.087
26 Rioja, La;All ages;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
26 Rioja, La;All ages;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
26 Rioja, La;All ages;Cohort April 1;Females;Survival in the third trimester;2021QII;""
26 Rioja, La;All ages;Cohort April 1;Females;Survival in the third trimester;2021QI;7.139
26 Rioja, La;All ages;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
26 Rioja, La;All ages;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
26 Rioja, La;All ages;Cohort April 1;Females;Survival in the third trimester;2020QII;""
26 Rioja, La;All ages;Cohort April 1;Females;Survival in the third trimester;2020QI;""
26 Rioja, La;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
26 Rioja, La;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
26 Rioja, La;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
26 Rioja, La;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
26 Rioja, La;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
26 Rioja, La;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
26 Rioja, La;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
26 Rioja, La;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
26 Rioja, La;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
26 Rioja, La;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
26 Rioja, La;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
26 Rioja, La;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
26 Rioja, La;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
26 Rioja, La;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
26 Rioja, La;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;96,85
26 Rioja, La;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
26 Rioja, La;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
26 Rioja, La;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
26 Rioja, La;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;96,77
26 Rioja, La;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
26 Rioja, La;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
26 Rioja, La;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
26 Rioja, La;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;97,59
26 Rioja, La;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
26 Rioja, La;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
26 Rioja, La;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;93,83
26 Rioja, La;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
26 Rioja, La;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
26 Rioja, La;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
26 Rioja, La;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;94,27
26 Rioja, La;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
26 Rioja, La;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
26 Rioja, La;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
26 Rioja, La;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;94,73
26 Rioja, La;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
26 Rioja, La;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
26 Rioja, La;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;90,39
26 Rioja, La;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
26 Rioja, La;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
26 Rioja, La;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
26 Rioja, La;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;91,45
26 Rioja, La;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
26 Rioja, La;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
26 Rioja, La;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
26 Rioja, La;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;92,05
26 Rioja, La;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
26 Rioja, La;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
26 Rioja, La;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
26 Rioja, La;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
26 Rioja, La;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
26 Rioja, La;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
26 Rioja, La;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;89,46
26 Rioja, La;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
26 Rioja, La;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
26 Rioja, La;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
26 Rioja, La;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;90,37
26 Rioja, La;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
26 Rioja, La;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
26 Rioja, La;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
26 Rioja, La;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
26 Rioja, La;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
26 Rioja, La;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QIII;20.834
26 Rioja, La;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
26 Rioja, La;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
26 Rioja, La;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
26 Rioja, La;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QIII;20.991
26 Rioja, La;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
26 Rioja, La;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
26 Rioja, La;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
26 Rioja, La;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QIII;20.973
26 Rioja, La;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
26 Rioja, La;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
26 Rioja, La;All ages;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
26 Rioja, La;All ages;Cohort July 1;Total;Survival in the first trimester;2022QIII;20.207
26 Rioja, La;All ages;Cohort July 1;Total;Survival in the first trimester;2022QII;""
26 Rioja, La;All ages;Cohort July 1;Total;Survival in the first trimester;2022QI;""
26 Rioja, La;All ages;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
26 Rioja, La;All ages;Cohort July 1;Total;Survival in the first trimester;2021QIII;20.367
26 Rioja, La;All ages;Cohort July 1;Total;Survival in the first trimester;2021QII;""
26 Rioja, La;All ages;Cohort July 1;Total;Survival in the first trimester;2021QI;""
26 Rioja, La;All ages;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
26 Rioja, La;All ages;Cohort July 1;Total;Survival in the first trimester;2020QIII;20.339
26 Rioja, La;All ages;Cohort July 1;Total;Survival in the first trimester;2020QII;""
26 Rioja, La;All ages;Cohort July 1;Total;Survival in the first trimester;2020QI;""
26 Rioja, La;All ages;Cohort July 1;Total;Survival in the second trimester;2022QIV;19.443
26 Rioja, La;All ages;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
26 Rioja, La;All ages;Cohort July 1;Total;Survival in the second trimester;2022QII;""
26 Rioja, La;All ages;Cohort July 1;Total;Survival in the second trimester;2022QI;""
26 Rioja, La;All ages;Cohort July 1;Total;Survival in the second trimester;2021QIV;19.716
26 Rioja, La;All ages;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
26 Rioja, La;All ages;Cohort July 1;Total;Survival in the second trimester;2021QII;""
26 Rioja, La;All ages;Cohort July 1;Total;Survival in the second trimester;2021QI;""
26 Rioja, La;All ages;Cohort July 1;Total;Survival in the second trimester;2020QIV;19.749
26 Rioja, La;All ages;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
26 Rioja, La;All ages;Cohort July 1;Total;Survival in the second trimester;2020QII;""
26 Rioja, La;All ages;Cohort July 1;Total;Survival in the second trimester;2020QI;""
26 Rioja, La;All ages;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
26 Rioja, La;All ages;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
26 Rioja, La;All ages;Cohort July 1;Total;Survival in the third trimester;2022QII;""
26 Rioja, La;All ages;Cohort July 1;Total;Survival in the third trimester;2022QI;19.273
26 Rioja, La;All ages;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
26 Rioja, La;All ages;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
26 Rioja, La;All ages;Cohort July 1;Total;Survival in the third trimester;2021QII;""
26 Rioja, La;All ages;Cohort July 1;Total;Survival in the third trimester;2021QI;19.374
26 Rioja, La;All ages;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
26 Rioja, La;All ages;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
26 Rioja, La;All ages;Cohort July 1;Total;Survival in the third trimester;2020QII;""
26 Rioja, La;All ages;Cohort July 1;Total;Survival in the third trimester;2020QI;""
26 Rioja, La;All ages;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
26 Rioja, La;All ages;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
26 Rioja, La;All ages;Cohort July 1;Total;Survival in the third trimester;2022QII;18.824
26 Rioja, La;All ages;Cohort July 1;Total;Survival in the third trimester;2022QI;""
26 Rioja, La;All ages;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
26 Rioja, La;All ages;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
26 Rioja, La;All ages;Cohort July 1;Total;Survival in the third trimester;2021QII;18.964
26 Rioja, La;All ages;Cohort July 1;Total;Survival in the third trimester;2021QI;""
26 Rioja, La;All ages;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
26 Rioja, La;All ages;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
26 Rioja, La;All ages;Cohort July 1;Total;Survival in the third trimester;2020QII;""
26 Rioja, La;All ages;Cohort July 1;Total;Survival in the third trimester;2020QI;""
26 Rioja, La;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
26 Rioja, La;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
26 Rioja, La;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
26 Rioja, La;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
26 Rioja, La;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
26 Rioja, La;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
26 Rioja, La;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
26 Rioja, La;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
26 Rioja, La;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
26 Rioja, La;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
26 Rioja, La;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
26 Rioja, La;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
26 Rioja, La;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
26 Rioja, La;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;96,99
26 Rioja, La;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
26 Rioja, La;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
26 Rioja, La;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
26 Rioja, La;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;97,03
26 Rioja, La;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
26 Rioja, La;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
26 Rioja, La;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
26 Rioja, La;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;96,98
26 Rioja, La;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
26 Rioja, La;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
26 Rioja, La;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;93,32
26 Rioja, La;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
26 Rioja, La;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
26 Rioja, La;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
26 Rioja, La;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;93,93
26 Rioja, La;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
26 Rioja, La;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
26 Rioja, La;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
26 Rioja, La;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;94,16
26 Rioja, La;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
26 Rioja, La;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
26 Rioja, La;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
26 Rioja, La;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
26 Rioja, La;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
26 Rioja, La;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
26 Rioja, La;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;91,82
26 Rioja, La;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
26 Rioja, La;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
26 Rioja, La;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
26 Rioja, La;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;92,38
26 Rioja, La;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
26 Rioja, La;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
26 Rioja, La;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
26 Rioja, La;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
26 Rioja, La;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
26 Rioja, La;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
26 Rioja, La;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;89,68
26 Rioja, La;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
26 Rioja, La;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
26 Rioja, La;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
26 Rioja, La;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;90,42
26 Rioja, La;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
26 Rioja, La;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
26 Rioja, La;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
26 Rioja, La;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
26 Rioja, La;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
26 Rioja, La;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
26 Rioja, La;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QIII;12.869
26 Rioja, La;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
26 Rioja, La;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
26 Rioja, La;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
26 Rioja, La;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QIII;13.069
26 Rioja, La;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
26 Rioja, La;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
26 Rioja, La;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
26 Rioja, La;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QIII;13.097
26 Rioja, La;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
26 Rioja, La;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
26 Rioja, La;All ages;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
26 Rioja, La;All ages;Cohort July 1;Males;Survival in the first trimester;2022QIII;12.523
26 Rioja, La;All ages;Cohort July 1;Males;Survival in the first trimester;2022QII;""
26 Rioja, La;All ages;Cohort July 1;Males;Survival in the first trimester;2022QI;""
26 Rioja, La;All ages;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
26 Rioja, La;All ages;Cohort July 1;Males;Survival in the first trimester;2021QIII;12.681
26 Rioja, La;All ages;Cohort July 1;Males;Survival in the first trimester;2021QII;""
26 Rioja, La;All ages;Cohort July 1;Males;Survival in the first trimester;2021QI;""
26 Rioja, La;All ages;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
26 Rioja, La;All ages;Cohort July 1;Males;Survival in the first trimester;2020QIII;12.719
26 Rioja, La;All ages;Cohort July 1;Males;Survival in the first trimester;2020QII;""
26 Rioja, La;All ages;Cohort July 1;Males;Survival in the first trimester;2020QI;""
26 Rioja, La;All ages;Cohort July 1;Males;Survival in the second trimester;2022QIV;12.072
26 Rioja, La;All ages;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
26 Rioja, La;All ages;Cohort July 1;Males;Survival in the second trimester;2022QII;""
26 Rioja, La;All ages;Cohort July 1;Males;Survival in the second trimester;2022QI;""
26 Rioja, La;All ages;Cohort July 1;Males;Survival in the second trimester;2021QIV;12.281
26 Rioja, La;All ages;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
26 Rioja, La;All ages;Cohort July 1;Males;Survival in the second trimester;2021QII;""
26 Rioja, La;All ages;Cohort July 1;Males;Survival in the second trimester;2021QI;""
26 Rioja, La;All ages;Cohort July 1;Males;Survival in the second trimester;2020QIV;12.351
26 Rioja, La;All ages;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
26 Rioja, La;All ages;Cohort July 1;Males;Survival in the second trimester;2020QII;""
26 Rioja, La;All ages;Cohort July 1;Males;Survival in the second trimester;2020QI;""
26 Rioja, La;All ages;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
26 Rioja, La;All ages;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
26 Rioja, La;All ages;Cohort July 1;Males;Survival in the third trimester;2022QII;""
26 Rioja, La;All ages;Cohort July 1;Males;Survival in the third trimester;2022QI;12.005
26 Rioja, La;All ages;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
26 Rioja, La;All ages;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
26 Rioja, La;All ages;Cohort July 1;Males;Survival in the third trimester;2021QII;""
26 Rioja, La;All ages;Cohort July 1;Males;Survival in the third trimester;2021QI;12.116
26 Rioja, La;All ages;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
26 Rioja, La;All ages;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
26 Rioja, La;All ages;Cohort July 1;Males;Survival in the third trimester;2020QII;""
26 Rioja, La;All ages;Cohort July 1;Males;Survival in the third trimester;2020QI;""
26 Rioja, La;All ages;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
26 Rioja, La;All ages;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
26 Rioja, La;All ages;Cohort July 1;Males;Survival in the third trimester;2022QII;11.732
26 Rioja, La;All ages;Cohort July 1;Males;Survival in the third trimester;2022QI;""
26 Rioja, La;All ages;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
26 Rioja, La;All ages;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
26 Rioja, La;All ages;Cohort July 1;Males;Survival in the third trimester;2021QII;11.873
26 Rioja, La;All ages;Cohort July 1;Males;Survival in the third trimester;2021QI;""
26 Rioja, La;All ages;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
26 Rioja, La;All ages;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
26 Rioja, La;All ages;Cohort July 1;Males;Survival in the third trimester;2020QII;""
26 Rioja, La;All ages;Cohort July 1;Males;Survival in the third trimester;2020QI;""
26 Rioja, La;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
26 Rioja, La;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
26 Rioja, La;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
26 Rioja, La;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
26 Rioja, La;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
26 Rioja, La;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
26 Rioja, La;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
26 Rioja, La;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
26 Rioja, La;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
26 Rioja, La;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
26 Rioja, La;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
26 Rioja, La;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
26 Rioja, La;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
26 Rioja, La;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;97,31
26 Rioja, La;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
26 Rioja, La;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
26 Rioja, La;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
26 Rioja, La;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;97,03
26 Rioja, La;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
26 Rioja, La;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
26 Rioja, La;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
26 Rioja, La;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;97,11
26 Rioja, La;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
26 Rioja, La;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
26 Rioja, La;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;93,81
26 Rioja, La;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
26 Rioja, La;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
26 Rioja, La;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
26 Rioja, La;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;93,97
26 Rioja, La;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
26 Rioja, La;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
26 Rioja, La;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
26 Rioja, La;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;94,3
26 Rioja, La;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
26 Rioja, La;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
26 Rioja, La;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
26 Rioja, La;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
26 Rioja, La;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
26 Rioja, La;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
26 Rioja, La;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;91,86
26 Rioja, La;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
26 Rioja, La;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
26 Rioja, La;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
26 Rioja, La;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;92,51
26 Rioja, La;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
26 Rioja, La;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
26 Rioja, La;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
26 Rioja, La;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
26 Rioja, La;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
26 Rioja, La;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
26 Rioja, La;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;89,77
26 Rioja, La;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
26 Rioja, La;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
26 Rioja, La;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
26 Rioja, La;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;90,65
26 Rioja, La;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
26 Rioja, La;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
26 Rioja, La;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
26 Rioja, La;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
26 Rioja, La;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
26 Rioja, La;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
26 Rioja, La;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QIII;7.965
26 Rioja, La;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
26 Rioja, La;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
26 Rioja, La;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
26 Rioja, La;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QIII;7.922
26 Rioja, La;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
26 Rioja, La;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
26 Rioja, La;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
26 Rioja, La;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QIII;7.876
26 Rioja, La;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
26 Rioja, La;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
26 Rioja, La;All ages;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
26 Rioja, La;All ages;Cohort July 1;Females;Survival in the first trimester;2022QIII;7.684
26 Rioja, La;All ages;Cohort July 1;Females;Survival in the first trimester;2022QII;""
26 Rioja, La;All ages;Cohort July 1;Females;Survival in the first trimester;2022QI;""
26 Rioja, La;All ages;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
26 Rioja, La;All ages;Cohort July 1;Females;Survival in the first trimester;2021QIII;7.686
26 Rioja, La;All ages;Cohort July 1;Females;Survival in the first trimester;2021QII;""
26 Rioja, La;All ages;Cohort July 1;Females;Survival in the first trimester;2021QI;""
26 Rioja, La;All ages;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
26 Rioja, La;All ages;Cohort July 1;Females;Survival in the first trimester;2020QIII;7.620
26 Rioja, La;All ages;Cohort July 1;Females;Survival in the first trimester;2020QII;""
26 Rioja, La;All ages;Cohort July 1;Females;Survival in the first trimester;2020QI;""
26 Rioja, La;All ages;Cohort July 1;Females;Survival in the second trimester;2022QIV;7.371
26 Rioja, La;All ages;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
26 Rioja, La;All ages;Cohort July 1;Females;Survival in the second trimester;2022QII;""
26 Rioja, La;All ages;Cohort July 1;Females;Survival in the second trimester;2022QI;""
26 Rioja, La;All ages;Cohort July 1;Females;Survival in the second trimester;2021QIV;7.435
26 Rioja, La;All ages;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
26 Rioja, La;All ages;Cohort July 1;Females;Survival in the second trimester;2021QII;""
26 Rioja, La;All ages;Cohort July 1;Females;Survival in the second trimester;2021QI;""
26 Rioja, La;All ages;Cohort July 1;Females;Survival in the second trimester;2020QIV;7.398
26 Rioja, La;All ages;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
26 Rioja, La;All ages;Cohort July 1;Females;Survival in the second trimester;2020QII;""
26 Rioja, La;All ages;Cohort July 1;Females;Survival in the second trimester;2020QI;""
26 Rioja, La;All ages;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
26 Rioja, La;All ages;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
26 Rioja, La;All ages;Cohort July 1;Females;Survival in the third trimester;2022QII;""
26 Rioja, La;All ages;Cohort July 1;Females;Survival in the third trimester;2022QI;7.268
26 Rioja, La;All ages;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
26 Rioja, La;All ages;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
26 Rioja, La;All ages;Cohort July 1;Females;Survival in the third trimester;2021QII;""
26 Rioja, La;All ages;Cohort July 1;Females;Survival in the third trimester;2021QI;7.258
26 Rioja, La;All ages;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
26 Rioja, La;All ages;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
26 Rioja, La;All ages;Cohort July 1;Females;Survival in the third trimester;2020QII;""
26 Rioja, La;All ages;Cohort July 1;Females;Survival in the third trimester;2020QI;""
26 Rioja, La;All ages;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
26 Rioja, La;All ages;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
26 Rioja, La;All ages;Cohort July 1;Females;Survival in the third trimester;2022QII;7.092
26 Rioja, La;All ages;Cohort July 1;Females;Survival in the third trimester;2022QI;""
26 Rioja, La;All ages;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
26 Rioja, La;All ages;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
26 Rioja, La;All ages;Cohort July 1;Females;Survival in the third trimester;2021QII;7.091
26 Rioja, La;All ages;Cohort July 1;Females;Survival in the third trimester;2021QI;""
26 Rioja, La;All ages;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
26 Rioja, La;All ages;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
26 Rioja, La;All ages;Cohort July 1;Females;Survival in the third trimester;2020QII;""
26 Rioja, La;All ages;Cohort July 1;Females;Survival in the third trimester;2020QI;""
26 Rioja, La;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
26 Rioja, La;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
26 Rioja, La;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
26 Rioja, La;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
26 Rioja, La;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
26 Rioja, La;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
26 Rioja, La;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
26 Rioja, La;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
26 Rioja, La;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
26 Rioja, La;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
26 Rioja, La;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
26 Rioja, La;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
26 Rioja, La;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
26 Rioja, La;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;96,47
26 Rioja, La;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
26 Rioja, La;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
26 Rioja, La;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
26 Rioja, La;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;97,02
26 Rioja, La;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
26 Rioja, La;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
26 Rioja, La;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
26 Rioja, La;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;96,75
26 Rioja, La;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
26 Rioja, La;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
26 Rioja, La;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;92,54
26 Rioja, La;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
26 Rioja, La;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
26 Rioja, La;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
26 Rioja, La;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;93,85
26 Rioja, La;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
26 Rioja, La;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
26 Rioja, La;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
26 Rioja, La;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;93,93
26 Rioja, La;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
26 Rioja, La;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
26 Rioja, La;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
26 Rioja, La;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
26 Rioja, La;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
26 Rioja, La;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
26 Rioja, La;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;91,74
26 Rioja, La;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
26 Rioja, La;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
26 Rioja, La;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
26 Rioja, La;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;92,15
26 Rioja, La;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
26 Rioja, La;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
26 Rioja, La;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
26 Rioja, La;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
26 Rioja, La;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
26 Rioja, La;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
26 Rioja, La;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;89,52
26 Rioja, La;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
26 Rioja, La;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
26 Rioja, La;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
26 Rioja, La;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;90,03
26 Rioja, La;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
26 Rioja, La;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
26 Rioja, La;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
26 Rioja, La;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
26 Rioja, La;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
26 Rioja, La;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QIV;20.679
26 Rioja, La;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
26 Rioja, La;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
26 Rioja, La;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
26 Rioja, La;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QIV;20.903
26 Rioja, La;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
26 Rioja, La;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
26 Rioja, La;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
26 Rioja, La;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QIV;20.948
26 Rioja, La;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
26 Rioja, La;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
26 Rioja, La;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
26 Rioja, La;All ages;Cohort October 1;Total;Survival in the first trimester;2022QIV;19.848
26 Rioja, La;All ages;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
26 Rioja, La;All ages;Cohort October 1;Total;Survival in the first trimester;2022QII;""
26 Rioja, La;All ages;Cohort October 1;Total;Survival in the first trimester;2022QI;""
26 Rioja, La;All ages;Cohort October 1;Total;Survival in the first trimester;2021QIV;20.183
26 Rioja, La;All ages;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
26 Rioja, La;All ages;Cohort October 1;Total;Survival in the first trimester;2021QII;""
26 Rioja, La;All ages;Cohort October 1;Total;Survival in the first trimester;2021QI;""
26 Rioja, La;All ages;Cohort October 1;Total;Survival in the first trimester;2020QIV;20.261
26 Rioja, La;All ages;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
26 Rioja, La;All ages;Cohort October 1;Total;Survival in the first trimester;2020QII;""
26 Rioja, La;All ages;Cohort October 1;Total;Survival in the first trimester;2020QI;""
26 Rioja, La;All ages;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
26 Rioja, La;All ages;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
26 Rioja, La;All ages;Cohort October 1;Total;Survival in the second trimester;2022QII;""
26 Rioja, La;All ages;Cohort October 1;Total;Survival in the second trimester;2022QI;19.705
26 Rioja, La;All ages;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
26 Rioja, La;All ages;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
26 Rioja, La;All ages;Cohort October 1;Total;Survival in the second trimester;2021QII;""
26 Rioja, La;All ages;Cohort October 1;Total;Survival in the second trimester;2021QI;19.851
26 Rioja, La;All ages;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
26 Rioja, La;All ages;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
26 Rioja, La;All ages;Cohort October 1;Total;Survival in the second trimester;2020QII;""
26 Rioja, La;All ages;Cohort October 1;Total;Survival in the second trimester;2020QI;""
26 Rioja, La;All ages;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
26 Rioja, La;All ages;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
26 Rioja, La;All ages;Cohort October 1;Total;Survival in the third trimester;2022QII;19.201
26 Rioja, La;All ages;Cohort October 1;Total;Survival in the third trimester;2022QI;""
26 Rioja, La;All ages;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
26 Rioja, La;All ages;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
26 Rioja, La;All ages;Cohort October 1;Total;Survival in the third trimester;2021QII;19.398
26 Rioja, La;All ages;Cohort October 1;Total;Survival in the third trimester;2021QI;""
26 Rioja, La;All ages;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
26 Rioja, La;All ages;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
26 Rioja, La;All ages;Cohort October 1;Total;Survival in the third trimester;2020QII;""
26 Rioja, La;All ages;Cohort October 1;Total;Survival in the third trimester;2020QI;""
26 Rioja, La;All ages;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
26 Rioja, La;All ages;Cohort October 1;Total;Survival in the third trimester;2022QIII;18.753
26 Rioja, La;All ages;Cohort October 1;Total;Survival in the third trimester;2022QII;""
26 Rioja, La;All ages;Cohort October 1;Total;Survival in the third trimester;2022QI;""
26 Rioja, La;All ages;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
26 Rioja, La;All ages;Cohort October 1;Total;Survival in the third trimester;2021QIII;18.964
26 Rioja, La;All ages;Cohort October 1;Total;Survival in the third trimester;2021QII;""
26 Rioja, La;All ages;Cohort October 1;Total;Survival in the third trimester;2021QI;""
26 Rioja, La;All ages;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
26 Rioja, La;All ages;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
26 Rioja, La;All ages;Cohort October 1;Total;Survival in the third trimester;2020QII;""
26 Rioja, La;All ages;Cohort October 1;Total;Survival in the third trimester;2020QI;""
26 Rioja, La;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
26 Rioja, La;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
26 Rioja, La;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
26 Rioja, La;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
26 Rioja, La;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
26 Rioja, La;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
26 Rioja, La;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
26 Rioja, La;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
26 Rioja, La;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
26 Rioja, La;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
26 Rioja, La;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
26 Rioja, La;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
26 Rioja, La;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;95,98
26 Rioja, La;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
26 Rioja, La;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
26 Rioja, La;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
26 Rioja, La;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;96,56
26 Rioja, La;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
26 Rioja, La;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
26 Rioja, La;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
26 Rioja, La;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;96,72
26 Rioja, La;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
26 Rioja, La;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
26 Rioja, La;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
26 Rioja, La;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
26 Rioja, La;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
26 Rioja, La;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
26 Rioja, La;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;94,27
26 Rioja, La;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
26 Rioja, La;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
26 Rioja, La;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
26 Rioja, La;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;94,76
26 Rioja, La;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
26 Rioja, La;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
26 Rioja, La;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
26 Rioja, La;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
26 Rioja, La;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
26 Rioja, La;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
26 Rioja, La;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;91,86
26 Rioja, La;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
26 Rioja, La;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
26 Rioja, La;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
26 Rioja, La;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;92,6
26 Rioja, La;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
26 Rioja, La;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
26 Rioja, La;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
26 Rioja, La;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
26 Rioja, La;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
26 Rioja, La;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
26 Rioja, La;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;89,71
26 Rioja, La;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
26 Rioja, La;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
26 Rioja, La;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
26 Rioja, La;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;90,53
26 Rioja, La;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
26 Rioja, La;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
26 Rioja, La;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
26 Rioja, La;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
26 Rioja, La;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
26 Rioja, La;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
26 Rioja, La;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QIV;12.799
26 Rioja, La;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
26 Rioja, La;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
26 Rioja, La;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
26 Rioja, La;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QIV;12.999
26 Rioja, La;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
26 Rioja, La;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
26 Rioja, La;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
26 Rioja, La;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QIV;13.081
26 Rioja, La;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
26 Rioja, La;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
26 Rioja, La;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
26 Rioja, La;All ages;Cohort October 1;Males;Survival in the first trimester;2022QIV;12.295
26 Rioja, La;All ages;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
26 Rioja, La;All ages;Cohort October 1;Males;Survival in the first trimester;2022QII;""
26 Rioja, La;All ages;Cohort October 1;Males;Survival in the first trimester;2022QI;""
26 Rioja, La;All ages;Cohort October 1;Males;Survival in the first trimester;2021QIV;12.547
26 Rioja, La;All ages;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
26 Rioja, La;All ages;Cohort October 1;Males;Survival in the first trimester;2021QII;""
26 Rioja, La;All ages;Cohort October 1;Males;Survival in the first trimester;2021QI;""
26 Rioja, La;All ages;Cohort October 1;Males;Survival in the first trimester;2020QIV;12.650
26 Rioja, La;All ages;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
26 Rioja, La;All ages;Cohort October 1;Males;Survival in the first trimester;2020QII;""
26 Rioja, La;All ages;Cohort October 1;Males;Survival in the first trimester;2020QI;""
26 Rioja, La;All ages;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
26 Rioja, La;All ages;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
26 Rioja, La;All ages;Cohort October 1;Males;Survival in the second trimester;2022QII;""
26 Rioja, La;All ages;Cohort October 1;Males;Survival in the second trimester;2022QI;12.248
26 Rioja, La;All ages;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
26 Rioja, La;All ages;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
26 Rioja, La;All ages;Cohort October 1;Males;Survival in the second trimester;2021QII;""
26 Rioja, La;All ages;Cohort October 1;Males;Survival in the second trimester;2021QI;12.400
26 Rioja, La;All ages;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
26 Rioja, La;All ages;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
26 Rioja, La;All ages;Cohort October 1;Males;Survival in the second trimester;2020QII;""
26 Rioja, La;All ages;Cohort October 1;Males;Survival in the second trimester;2020QI;""
26 Rioja, La;All ages;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
26 Rioja, La;All ages;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
26 Rioja, La;All ages;Cohort October 1;Males;Survival in the third trimester;2022QII;11.939
26 Rioja, La;All ages;Cohort October 1;Males;Survival in the third trimester;2022QI;""
26 Rioja, La;All ages;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
26 Rioja, La;All ages;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
26 Rioja, La;All ages;Cohort October 1;Males;Survival in the third trimester;2021QII;12.138
26 Rioja, La;All ages;Cohort October 1;Males;Survival in the third trimester;2021QI;""
26 Rioja, La;All ages;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
26 Rioja, La;All ages;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
26 Rioja, La;All ages;Cohort October 1;Males;Survival in the third trimester;2020QII;""
26 Rioja, La;All ages;Cohort October 1;Males;Survival in the third trimester;2020QI;""
26 Rioja, La;All ages;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
26 Rioja, La;All ages;Cohort October 1;Males;Survival in the third trimester;2022QIII;11.702
26 Rioja, La;All ages;Cohort October 1;Males;Survival in the third trimester;2022QII;""
26 Rioja, La;All ages;Cohort October 1;Males;Survival in the third trimester;2022QI;""
26 Rioja, La;All ages;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
26 Rioja, La;All ages;Cohort October 1;Males;Survival in the third trimester;2021QIII;11.874
26 Rioja, La;All ages;Cohort October 1;Males;Survival in the third trimester;2021QII;""
26 Rioja, La;All ages;Cohort October 1;Males;Survival in the third trimester;2021QI;""
26 Rioja, La;All ages;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
26 Rioja, La;All ages;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
26 Rioja, La;All ages;Cohort October 1;Males;Survival in the third trimester;2020QII;""
26 Rioja, La;All ages;Cohort October 1;Males;Survival in the third trimester;2020QI;""
26 Rioja, La;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
26 Rioja, La;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
26 Rioja, La;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
26 Rioja, La;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
26 Rioja, La;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
26 Rioja, La;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
26 Rioja, La;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
26 Rioja, La;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
26 Rioja, La;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
26 Rioja, La;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
26 Rioja, La;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
26 Rioja, La;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
26 Rioja, La;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;96,06
26 Rioja, La;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
26 Rioja, La;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
26 Rioja, La;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
26 Rioja, La;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;96,52
26 Rioja, La;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
26 Rioja, La;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
26 Rioja, La;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
26 Rioja, La;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;96,71
26 Rioja, La;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
26 Rioja, La;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
26 Rioja, La;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
26 Rioja, La;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
26 Rioja, La;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
26 Rioja, La;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
26 Rioja, La;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;94,22
26 Rioja, La;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
26 Rioja, La;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
26 Rioja, La;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
26 Rioja, La;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;94,79
26 Rioja, La;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
26 Rioja, La;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
26 Rioja, La;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
26 Rioja, La;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
26 Rioja, La;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
26 Rioja, La;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
26 Rioja, La;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;91,85
26 Rioja, La;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
26 Rioja, La;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
26 Rioja, La;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
26 Rioja, La;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;92,79
26 Rioja, La;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
26 Rioja, La;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
26 Rioja, La;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
26 Rioja, La;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
26 Rioja, La;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
26 Rioja, La;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
26 Rioja, La;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;90,02
26 Rioja, La;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
26 Rioja, La;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
26 Rioja, La;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
26 Rioja, La;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;90,77
26 Rioja, La;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
26 Rioja, La;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
26 Rioja, La;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
26 Rioja, La;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
26 Rioja, La;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
26 Rioja, La;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
26 Rioja, La;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QIV;7.880
26 Rioja, La;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
26 Rioja, La;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
26 Rioja, La;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
26 Rioja, La;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QIV;7.904
26 Rioja, La;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
26 Rioja, La;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
26 Rioja, La;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
26 Rioja, La;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QIV;7.867
26 Rioja, La;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
26 Rioja, La;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
26 Rioja, La;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
26 Rioja, La;All ages;Cohort October 1;Females;Survival in the first trimester;2022QIV;7.553
26 Rioja, La;All ages;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
26 Rioja, La;All ages;Cohort October 1;Females;Survival in the first trimester;2022QII;""
26 Rioja, La;All ages;Cohort October 1;Females;Survival in the first trimester;2022QI;""
26 Rioja, La;All ages;Cohort October 1;Females;Survival in the first trimester;2021QIV;7.636
26 Rioja, La;All ages;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
26 Rioja, La;All ages;Cohort October 1;Females;Survival in the first trimester;2021QII;""
26 Rioja, La;All ages;Cohort October 1;Females;Survival in the first trimester;2021QI;""
26 Rioja, La;All ages;Cohort October 1;Females;Survival in the first trimester;2020QIV;7.611
26 Rioja, La;All ages;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
26 Rioja, La;All ages;Cohort October 1;Females;Survival in the first trimester;2020QII;""
26 Rioja, La;All ages;Cohort October 1;Females;Survival in the first trimester;2020QI;""
26 Rioja, La;All ages;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
26 Rioja, La;All ages;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
26 Rioja, La;All ages;Cohort October 1;Females;Survival in the second trimester;2022QII;""
26 Rioja, La;All ages;Cohort October 1;Females;Survival in the second trimester;2022QI;7.457
26 Rioja, La;All ages;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
26 Rioja, La;All ages;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
26 Rioja, La;All ages;Cohort October 1;Females;Survival in the second trimester;2021QII;""
26 Rioja, La;All ages;Cohort October 1;Females;Survival in the second trimester;2021QI;7.451
26 Rioja, La;All ages;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
26 Rioja, La;All ages;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
26 Rioja, La;All ages;Cohort October 1;Females;Survival in the second trimester;2020QII;""
26 Rioja, La;All ages;Cohort October 1;Females;Survival in the second trimester;2020QI;""
26 Rioja, La;All ages;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
26 Rioja, La;All ages;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
26 Rioja, La;All ages;Cohort October 1;Females;Survival in the third trimester;2022QII;7.262
26 Rioja, La;All ages;Cohort October 1;Females;Survival in the third trimester;2022QI;""
26 Rioja, La;All ages;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
26 Rioja, La;All ages;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
26 Rioja, La;All ages;Cohort October 1;Females;Survival in the third trimester;2021QII;7.260
26 Rioja, La;All ages;Cohort October 1;Females;Survival in the third trimester;2021QI;""
26 Rioja, La;All ages;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
26 Rioja, La;All ages;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
26 Rioja, La;All ages;Cohort October 1;Females;Survival in the third trimester;2020QII;""
26 Rioja, La;All ages;Cohort October 1;Females;Survival in the third trimester;2020QI;""
26 Rioja, La;All ages;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
26 Rioja, La;All ages;Cohort October 1;Females;Survival in the third trimester;2022QIII;7.051
26 Rioja, La;All ages;Cohort October 1;Females;Survival in the third trimester;2022QII;""
26 Rioja, La;All ages;Cohort October 1;Females;Survival in the third trimester;2022QI;""
26 Rioja, La;All ages;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
26 Rioja, La;All ages;Cohort October 1;Females;Survival in the third trimester;2021QIII;7.090
26 Rioja, La;All ages;Cohort October 1;Females;Survival in the third trimester;2021QII;""
26 Rioja, La;All ages;Cohort October 1;Females;Survival in the third trimester;2021QI;""
26 Rioja, La;All ages;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
26 Rioja, La;All ages;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
26 Rioja, La;All ages;Cohort October 1;Females;Survival in the third trimester;2020QII;""
26 Rioja, La;All ages;Cohort October 1;Females;Survival in the third trimester;2020QI;""
26 Rioja, La;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
26 Rioja, La;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
26 Rioja, La;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
26 Rioja, La;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
26 Rioja, La;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
26 Rioja, La;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
26 Rioja, La;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
26 Rioja, La;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
26 Rioja, La;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
26 Rioja, La;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
26 Rioja, La;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
26 Rioja, La;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
26 Rioja, La;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;95,85
26 Rioja, La;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
26 Rioja, La;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
26 Rioja, La;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
26 Rioja, La;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;96,61
26 Rioja, La;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
26 Rioja, La;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
26 Rioja, La;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
26 Rioja, La;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;96,75
26 Rioja, La;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
26 Rioja, La;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
26 Rioja, La;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
26 Rioja, La;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
26 Rioja, La;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
26 Rioja, La;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
26 Rioja, La;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;94,34
26 Rioja, La;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
26 Rioja, La;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
26 Rioja, La;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
26 Rioja, La;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;94,71
26 Rioja, La;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
26 Rioja, La;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
26 Rioja, La;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
26 Rioja, La;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
26 Rioja, La;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
26 Rioja, La;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
26 Rioja, La;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;91,88
26 Rioja, La;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
26 Rioja, La;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
26 Rioja, La;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
26 Rioja, La;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;92,28
26 Rioja, La;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
26 Rioja, La;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
26 Rioja, La;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
26 Rioja, La;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
26 Rioja, La;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
26 Rioja, La;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
26 Rioja, La;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;89,21
26 Rioja, La;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
26 Rioja, La;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
26 Rioja, La;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
26 Rioja, La;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;90,12
26 Rioja, La;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
26 Rioja, La;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
26 Rioja, La;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
26 Rioja, La;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
26 Rioja, La;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
26 Rioja, La;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
26 Rioja, La;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
26 Rioja, La;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
26 Rioja, La;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
26 Rioja, La;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QI;1.176
26 Rioja, La;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
26 Rioja, La;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
26 Rioja, La;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
26 Rioja, La;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QI;1.153
26 Rioja, La;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
26 Rioja, La;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
26 Rioja, La;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
26 Rioja, La;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QI;942
26 Rioja, La;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
26 Rioja, La;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
26 Rioja, La;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2022QII;""
26 Rioja, La;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2022QI;1.106
26 Rioja, La;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
26 Rioja, La;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
26 Rioja, La;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2021QII;""
26 Rioja, La;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2021QI;1.086
26 Rioja, La;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
26 Rioja, La;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
26 Rioja, La;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2020QII;""
26 Rioja, La;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2020QI;836
26 Rioja, La;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
26 Rioja, La;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
26 Rioja, La;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2022QII;1.025
26 Rioja, La;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2022QI;""
26 Rioja, La;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
26 Rioja, La;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
26 Rioja, La;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2021QII;1.017
26 Rioja, La;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2021QI;""
26 Rioja, La;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
26 Rioja, La;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
26 Rioja, La;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2020QII;807
26 Rioja, La;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2020QI;""
26 Rioja, La;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
26 Rioja, La;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QIII;958
26 Rioja, La;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QII;""
26 Rioja, La;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QI;""
26 Rioja, La;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
26 Rioja, La;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QIII;941
26 Rioja, La;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QII;""
26 Rioja, La;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QI;""
26 Rioja, La;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
26 Rioja, La;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QIII;758
26 Rioja, La;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QII;""
26 Rioja, La;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QI;""
26 Rioja, La;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QIV;897
26 Rioja, La;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
26 Rioja, La;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QII;""
26 Rioja, La;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QI;""
26 Rioja, La;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QIV;890
26 Rioja, La;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
26 Rioja, La;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QII;""
26 Rioja, La;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QI;""
26 Rioja, La;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QIV;715
26 Rioja, La;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
26 Rioja, La;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QII;""
26 Rioja, La;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QI;""
26 Rioja, La;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
26 Rioja, La;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
26 Rioja, La;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
26 Rioja, La;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
26 Rioja, La;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
26 Rioja, La;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
26 Rioja, La;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
26 Rioja, La;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
26 Rioja, La;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
26 Rioja, La;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
26 Rioja, La;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
26 Rioja, La;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
26 Rioja, La;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
26 Rioja, La;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
26 Rioja, La;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
26 Rioja, La;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;94,05
26 Rioja, La;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
26 Rioja, La;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
26 Rioja, La;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
26 Rioja, La;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;94,19
26 Rioja, La;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
26 Rioja, La;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
26 Rioja, La;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
26 Rioja, La;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;88,75
26 Rioja, La;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
26 Rioja, La;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
26 Rioja, La;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;87,16
26 Rioja, La;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
26 Rioja, La;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
26 Rioja, La;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
26 Rioja, La;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;88,2
26 Rioja, La;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
26 Rioja, La;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
26 Rioja, La;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
26 Rioja, La;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;85,67
26 Rioja, La;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
26 Rioja, La;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
26 Rioja, La;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;81,46
26 Rioja, La;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
26 Rioja, La;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
26 Rioja, La;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
26 Rioja, La;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;81,61
26 Rioja, La;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
26 Rioja, La;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
26 Rioja, La;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
26 Rioja, La;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;80,47
26 Rioja, La;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
26 Rioja, La;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
26 Rioja, La;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;76,28
26 Rioja, La;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
26 Rioja, La;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
26 Rioja, La;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
26 Rioja, La;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;77,19
26 Rioja, La;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
26 Rioja, La;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
26 Rioja, La;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
26 Rioja, La;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;75,9
26 Rioja, La;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
26 Rioja, La;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
26 Rioja, La;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
26 Rioja, La;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
26 Rioja, La;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
26 Rioja, La;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
26 Rioja, La;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QI;730
26 Rioja, La;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
26 Rioja, La;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
26 Rioja, La;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
26 Rioja, La;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QI;731
26 Rioja, La;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
26 Rioja, La;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
26 Rioja, La;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
26 Rioja, La;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QI;596
26 Rioja, La;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
26 Rioja, La;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
26 Rioja, La;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2022QII;""
26 Rioja, La;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2022QI;689
26 Rioja, La;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
26 Rioja, La;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
26 Rioja, La;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2021QII;""
26 Rioja, La;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2021QI;684
26 Rioja, La;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
26 Rioja, La;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
26 Rioja, La;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2020QII;""
26 Rioja, La;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2020QI;531
26 Rioja, La;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
26 Rioja, La;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
26 Rioja, La;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2022QII;641
26 Rioja, La;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2022QI;""
26 Rioja, La;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
26 Rioja, La;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
26 Rioja, La;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2021QII;642
26 Rioja, La;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2021QI;""
26 Rioja, La;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
26 Rioja, La;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
26 Rioja, La;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2020QII;520
26 Rioja, La;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2020QI;""
26 Rioja, La;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
26 Rioja, La;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QIII;601
26 Rioja, La;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QII;""
26 Rioja, La;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QI;""
26 Rioja, La;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
26 Rioja, La;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QIII;591
26 Rioja, La;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QII;""
26 Rioja, La;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QI;""
26 Rioja, La;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
26 Rioja, La;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QIII;488
26 Rioja, La;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QII;""
26 Rioja, La;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QI;""
26 Rioja, La;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QIV;567
26 Rioja, La;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
26 Rioja, La;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QII;""
26 Rioja, La;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QI;""
26 Rioja, La;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QIV;558
26 Rioja, La;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
26 Rioja, La;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QII;""
26 Rioja, La;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QI;""
26 Rioja, La;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QIV;460
26 Rioja, La;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
26 Rioja, La;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QII;""
26 Rioja, La;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QI;""
26 Rioja, La;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
26 Rioja, La;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
26 Rioja, La;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
26 Rioja, La;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
26 Rioja, La;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
26 Rioja, La;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
26 Rioja, La;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
26 Rioja, La;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
26 Rioja, La;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
26 Rioja, La;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
26 Rioja, La;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
26 Rioja, La;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
26 Rioja, La;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
26 Rioja, La;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
26 Rioja, La;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
26 Rioja, La;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;94,38
26 Rioja, La;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
26 Rioja, La;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
26 Rioja, La;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
26 Rioja, La;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;93,57
26 Rioja, La;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
26 Rioja, La;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
26 Rioja, La;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
26 Rioja, La;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;89,09
26 Rioja, La;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
26 Rioja, La;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
26 Rioja, La;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;87,81
26 Rioja, La;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
26 Rioja, La;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
26 Rioja, La;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
26 Rioja, La;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;87,82
26 Rioja, La;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
26 Rioja, La;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
26 Rioja, La;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
26 Rioja, La;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;87,25
26 Rioja, La;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
26 Rioja, La;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
26 Rioja, La;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;82,33
26 Rioja, La;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
26 Rioja, La;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
26 Rioja, La;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
26 Rioja, La;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;80,85
26 Rioja, La;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
26 Rioja, La;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
26 Rioja, La;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
26 Rioja, La;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;81,88
26 Rioja, La;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
26 Rioja, La;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
26 Rioja, La;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;77,67
26 Rioja, La;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
26 Rioja, La;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
26 Rioja, La;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
26 Rioja, La;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;76,33
26 Rioja, La;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
26 Rioja, La;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
26 Rioja, La;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
26 Rioja, La;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;77,18
26 Rioja, La;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
26 Rioja, La;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
26 Rioja, La;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
26 Rioja, La;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
26 Rioja, La;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
26 Rioja, La;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
26 Rioja, La;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QI;446
26 Rioja, La;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
26 Rioja, La;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
26 Rioja, La;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
26 Rioja, La;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QI;422
26 Rioja, La;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
26 Rioja, La;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
26 Rioja, La;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
26 Rioja, La;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QI;346
26 Rioja, La;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
26 Rioja, La;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
26 Rioja, La;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2022QII;""
26 Rioja, La;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2022QI;417
26 Rioja, La;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
26 Rioja, La;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
26 Rioja, La;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2021QII;""
26 Rioja, La;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2021QI;402
26 Rioja, La;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
26 Rioja, La;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
26 Rioja, La;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2020QII;""
26 Rioja, La;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2020QI;305
26 Rioja, La;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
26 Rioja, La;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
26 Rioja, La;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2022QII;384
26 Rioja, La;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2022QI;""
26 Rioja, La;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
26 Rioja, La;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
26 Rioja, La;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2021QII;375
26 Rioja, La;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2021QI;""
26 Rioja, La;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
26 Rioja, La;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
26 Rioja, La;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2020QII;287
26 Rioja, La;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2020QI;""
26 Rioja, La;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
26 Rioja, La;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QIII;357
26 Rioja, La;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QII;""
26 Rioja, La;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QI;""
26 Rioja, La;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
26 Rioja, La;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QIII;350
26 Rioja, La;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QII;""
26 Rioja, La;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QI;""
26 Rioja, La;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
26 Rioja, La;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QIII;270
26 Rioja, La;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QII;""
26 Rioja, La;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QI;""
26 Rioja, La;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QIV;330
26 Rioja, La;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
26 Rioja, La;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QII;""
26 Rioja, La;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QI;""
26 Rioja, La;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QIV;332
26 Rioja, La;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
26 Rioja, La;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QII;""
26 Rioja, La;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QI;""
26 Rioja, La;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QIV;255
26 Rioja, La;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
26 Rioja, La;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QII;""
26 Rioja, La;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QI;""
26 Rioja, La;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
26 Rioja, La;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
26 Rioja, La;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
26 Rioja, La;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
26 Rioja, La;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
26 Rioja, La;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
26 Rioja, La;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
26 Rioja, La;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
26 Rioja, La;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
26 Rioja, La;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
26 Rioja, La;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
26 Rioja, La;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
26 Rioja, La;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
26 Rioja, La;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
26 Rioja, La;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
26 Rioja, La;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;93,5
26 Rioja, La;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
26 Rioja, La;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
26 Rioja, La;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
26 Rioja, La;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;95,26
26 Rioja, La;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
26 Rioja, La;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
26 Rioja, La;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
26 Rioja, La;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;88,15
26 Rioja, La;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
26 Rioja, La;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
26 Rioja, La;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;86,1
26 Rioja, La;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
26 Rioja, La;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
26 Rioja, La;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
26 Rioja, La;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;88,86
26 Rioja, La;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
26 Rioja, La;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
26 Rioja, La;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
26 Rioja, La;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;82,95
26 Rioja, La;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
26 Rioja, La;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
26 Rioja, La;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;80,04
26 Rioja, La;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
26 Rioja, La;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
26 Rioja, La;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
26 Rioja, La;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;82,94
26 Rioja, La;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
26 Rioja, La;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
26 Rioja, La;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
26 Rioja, La;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;78,03
26 Rioja, La;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
26 Rioja, La;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
26 Rioja, La;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;73,99
26 Rioja, La;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
26 Rioja, La;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
26 Rioja, La;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
26 Rioja, La;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;78,67
26 Rioja, La;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
26 Rioja, La;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
26 Rioja, La;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
26 Rioja, La;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;73,7
26 Rioja, La;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
26 Rioja, La;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
26 Rioja, La;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
26 Rioja, La;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
26 Rioja, La;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
26 Rioja, La;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QII;1.031
26 Rioja, La;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
26 Rioja, La;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
26 Rioja, La;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
26 Rioja, La;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QII;1.038
26 Rioja, La;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
26 Rioja, La;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
26 Rioja, La;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
26 Rioja, La;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QII;986
26 Rioja, La;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
26 Rioja, La;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
26 Rioja, La;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
26 Rioja, La;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2022QII;946
26 Rioja, La;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2022QI;""
26 Rioja, La;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
26 Rioja, La;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
26 Rioja, La;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2021QII;950
26 Rioja, La;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2021QI;""
26 Rioja, La;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
26 Rioja, La;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
26 Rioja, La;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2020QII;941
26 Rioja, La;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2020QI;""
26 Rioja, La;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
26 Rioja, La;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2022QIII;879
26 Rioja, La;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2022QII;""
26 Rioja, La;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2022QI;""
26 Rioja, La;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
26 Rioja, La;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2021QIII;861
26 Rioja, La;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2021QII;""
26 Rioja, La;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2021QI;""
26 Rioja, La;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
26 Rioja, La;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2020QIII;879
26 Rioja, La;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2020QII;""
26 Rioja, La;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2020QI;""
26 Rioja, La;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QIV;817
26 Rioja, La;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
26 Rioja, La;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QII;""
26 Rioja, La;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QI;""
26 Rioja, La;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QIV;801
26 Rioja, La;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
26 Rioja, La;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QII;""
26 Rioja, La;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QI;""
26 Rioja, La;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QIV;827
26 Rioja, La;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
26 Rioja, La;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QII;""
26 Rioja, La;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QI;""
26 Rioja, La;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
26 Rioja, La;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
26 Rioja, La;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QII;""
26 Rioja, La;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QI;763
26 Rioja, La;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
26 Rioja, La;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
26 Rioja, La;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QII;""
26 Rioja, La;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QI;795
26 Rioja, La;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
26 Rioja, La;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
26 Rioja, La;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QII;""
26 Rioja, La;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QI;""
26 Rioja, La;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
26 Rioja, La;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
26 Rioja, La;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
26 Rioja, La;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
26 Rioja, La;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
26 Rioja, La;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
26 Rioja, La;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
26 Rioja, La;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
26 Rioja, La;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
26 Rioja, La;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
26 Rioja, La;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
26 Rioja, La;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
26 Rioja, La;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
26 Rioja, La;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
26 Rioja, La;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;91,76
26 Rioja, La;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
26 Rioja, La;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
26 Rioja, La;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
26 Rioja, La;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;91,52
26 Rioja, La;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
26 Rioja, La;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
26 Rioja, La;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
26 Rioja, La;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;95,44
26 Rioja, La;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
26 Rioja, La;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
26 Rioja, La;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;85,26
26 Rioja, La;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
26 Rioja, La;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
26 Rioja, La;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
26 Rioja, La;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;82,95
26 Rioja, La;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
26 Rioja, La;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
26 Rioja, La;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
26 Rioja, La;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;89,15
26 Rioja, La;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
26 Rioja, La;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
26 Rioja, La;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;79,24
26 Rioja, La;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
26 Rioja, La;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
26 Rioja, La;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
26 Rioja, La;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;77,17
26 Rioja, La;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
26 Rioja, La;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
26 Rioja, La;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
26 Rioja, La;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;83,87
26 Rioja, La;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
26 Rioja, La;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
26 Rioja, La;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
26 Rioja, La;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
26 Rioja, La;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
26 Rioja, La;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
26 Rioja, La;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;73,51
26 Rioja, La;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
26 Rioja, La;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
26 Rioja, La;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
26 Rioja, La;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;80,63
26 Rioja, La;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
26 Rioja, La;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
26 Rioja, La;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
26 Rioja, La;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
26 Rioja, La;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
26 Rioja, La;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
26 Rioja, La;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QII;644
26 Rioja, La;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
26 Rioja, La;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
26 Rioja, La;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
26 Rioja, La;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QII;659
26 Rioja, La;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
26 Rioja, La;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
26 Rioja, La;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
26 Rioja, La;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QII;634
26 Rioja, La;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
26 Rioja, La;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
26 Rioja, La;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
26 Rioja, La;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2022QII;592
26 Rioja, La;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2022QI;""
26 Rioja, La;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
26 Rioja, La;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
26 Rioja, La;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2021QII;605
26 Rioja, La;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2021QI;""
26 Rioja, La;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
26 Rioja, La;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
26 Rioja, La;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2020QII;610
26 Rioja, La;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2020QI;""
26 Rioja, La;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
26 Rioja, La;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2022QIII;551
26 Rioja, La;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2022QII;""
26 Rioja, La;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2022QI;""
26 Rioja, La;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
26 Rioja, La;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2021QIII;551
26 Rioja, La;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2021QII;""
26 Rioja, La;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2021QI;""
26 Rioja, La;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
26 Rioja, La;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2020QIII;569
26 Rioja, La;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2020QII;""
26 Rioja, La;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2020QI;""
26 Rioja, La;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QIV;516
26 Rioja, La;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
26 Rioja, La;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QII;""
26 Rioja, La;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QI;""
26 Rioja, La;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QIV;510
26 Rioja, La;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
26 Rioja, La;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QII;""
26 Rioja, La;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QI;""
26 Rioja, La;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QIV;534
26 Rioja, La;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
26 Rioja, La;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QII;""
26 Rioja, La;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QI;""
26 Rioja, La;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
26 Rioja, La;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
26 Rioja, La;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QII;""
26 Rioja, La;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QI;488
26 Rioja, La;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
26 Rioja, La;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
26 Rioja, La;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QII;""
26 Rioja, La;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QI;511
26 Rioja, La;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
26 Rioja, La;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
26 Rioja, La;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QII;""
26 Rioja, La;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QI;""
26 Rioja, La;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
26 Rioja, La;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
26 Rioja, La;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
26 Rioja, La;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
26 Rioja, La;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
26 Rioja, La;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
26 Rioja, La;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
26 Rioja, La;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
26 Rioja, La;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
26 Rioja, La;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
26 Rioja, La;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
26 Rioja, La;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
26 Rioja, La;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
26 Rioja, La;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
26 Rioja, La;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;91,93
26 Rioja, La;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
26 Rioja, La;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
26 Rioja, La;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
26 Rioja, La;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;91,81
26 Rioja, La;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
26 Rioja, La;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
26 Rioja, La;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
26 Rioja, La;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;96,21
26 Rioja, La;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
26 Rioja, La;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
26 Rioja, La;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;85,56
26 Rioja, La;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
26 Rioja, La;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
26 Rioja, La;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
26 Rioja, La;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;83,61
26 Rioja, La;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
26 Rioja, La;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
26 Rioja, La;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
26 Rioja, La;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;89,75
26 Rioja, La;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
26 Rioja, La;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
26 Rioja, La;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;80,12
26 Rioja, La;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
26 Rioja, La;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
26 Rioja, La;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
26 Rioja, La;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;77,39
26 Rioja, La;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
26 Rioja, La;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
26 Rioja, La;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
26 Rioja, La;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;84,23
26 Rioja, La;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
26 Rioja, La;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
26 Rioja, La;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
26 Rioja, La;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
26 Rioja, La;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
26 Rioja, La;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
26 Rioja, La;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;74,05
26 Rioja, La;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
26 Rioja, La;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
26 Rioja, La;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
26 Rioja, La;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;80,6
26 Rioja, La;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
26 Rioja, La;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
26 Rioja, La;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
26 Rioja, La;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
26 Rioja, La;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
26 Rioja, La;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
26 Rioja, La;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QII;387
26 Rioja, La;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
26 Rioja, La;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
26 Rioja, La;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
26 Rioja, La;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QII;379
26 Rioja, La;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
26 Rioja, La;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
26 Rioja, La;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
26 Rioja, La;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QII;352
26 Rioja, La;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
26 Rioja, La;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
26 Rioja, La;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
26 Rioja, La;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2022QII;354
26 Rioja, La;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2022QI;""
26 Rioja, La;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
26 Rioja, La;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
26 Rioja, La;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2021QII;345
26 Rioja, La;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2021QI;""
26 Rioja, La;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
26 Rioja, La;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
26 Rioja, La;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2020QII;331
26 Rioja, La;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2020QI;""
26 Rioja, La;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
26 Rioja, La;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2022QIII;328
26 Rioja, La;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2022QII;""
26 Rioja, La;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2022QI;""
26 Rioja, La;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
26 Rioja, La;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2021QIII;310
26 Rioja, La;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2021QII;""
26 Rioja, La;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2021QI;""
26 Rioja, La;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
26 Rioja, La;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2020QIII;310
26 Rioja, La;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2020QII;""
26 Rioja, La;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2020QI;""
26 Rioja, La;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QIV;301
26 Rioja, La;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
26 Rioja, La;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QII;""
26 Rioja, La;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QI;""
26 Rioja, La;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QIV;291
26 Rioja, La;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
26 Rioja, La;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QII;""
26 Rioja, La;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QI;""
26 Rioja, La;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QIV;293
26 Rioja, La;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
26 Rioja, La;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QII;""
26 Rioja, La;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QI;""
26 Rioja, La;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
26 Rioja, La;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
26 Rioja, La;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QII;""
26 Rioja, La;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QI;275
26 Rioja, La;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
26 Rioja, La;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
26 Rioja, La;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QII;""
26 Rioja, La;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QI;284
26 Rioja, La;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
26 Rioja, La;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
26 Rioja, La;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QII;""
26 Rioja, La;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QI;""
26 Rioja, La;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
26 Rioja, La;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
26 Rioja, La;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
26 Rioja, La;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
26 Rioja, La;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
26 Rioja, La;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
26 Rioja, La;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
26 Rioja, La;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
26 Rioja, La;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
26 Rioja, La;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
26 Rioja, La;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
26 Rioja, La;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
26 Rioja, La;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
26 Rioja, La;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
26 Rioja, La;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;91,47
26 Rioja, La;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
26 Rioja, La;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
26 Rioja, La;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
26 Rioja, La;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;91,03
26 Rioja, La;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
26 Rioja, La;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
26 Rioja, La;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
26 Rioja, La;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;94,03
26 Rioja, La;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
26 Rioja, La;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
26 Rioja, La;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;84,75
26 Rioja, La;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
26 Rioja, La;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
26 Rioja, La;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
26 Rioja, La;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;81,79
26 Rioja, La;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
26 Rioja, La;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
26 Rioja, La;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
26 Rioja, La;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;88,07
26 Rioja, La;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
26 Rioja, La;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
26 Rioja, La;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;77,78
26 Rioja, La;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
26 Rioja, La;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
26 Rioja, La;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
26 Rioja, La;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;76,78
26 Rioja, La;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
26 Rioja, La;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
26 Rioja, La;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
26 Rioja, La;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;83,24
26 Rioja, La;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
26 Rioja, La;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
26 Rioja, La;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
26 Rioja, La;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
26 Rioja, La;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
26 Rioja, La;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
26 Rioja, La;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;72,56
26 Rioja, La;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
26 Rioja, La;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
26 Rioja, La;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
26 Rioja, La;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;80,68
26 Rioja, La;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
26 Rioja, La;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
26 Rioja, La;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
26 Rioja, La;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
26 Rioja, La;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
26 Rioja, La;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QIII;1.090
26 Rioja, La;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
26 Rioja, La;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
26 Rioja, La;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
26 Rioja, La;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QIII;1.114
26 Rioja, La;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
26 Rioja, La;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
26 Rioja, La;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
26 Rioja, La;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QIII;1.035
26 Rioja, La;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
26 Rioja, La;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
26 Rioja, La;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
26 Rioja, La;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2022QIII;992
26 Rioja, La;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2022QII;""
26 Rioja, La;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2022QI;""
26 Rioja, La;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
26 Rioja, La;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2021QIII;986
26 Rioja, La;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2021QII;""
26 Rioja, La;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2021QI;""
26 Rioja, La;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
26 Rioja, La;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2020QIII;948
26 Rioja, La;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2020QII;""
26 Rioja, La;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2020QI;""
26 Rioja, La;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2022QIV;912
26 Rioja, La;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
26 Rioja, La;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2022QII;""
26 Rioja, La;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2022QI;""
26 Rioja, La;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2021QIV;905
26 Rioja, La;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
26 Rioja, La;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2021QII;""
26 Rioja, La;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2021QI;""
26 Rioja, La;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2020QIV;890
26 Rioja, La;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
26 Rioja, La;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2020QII;""
26 Rioja, La;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2020QI;""
26 Rioja, La;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
26 Rioja, La;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
26 Rioja, La;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QII;""
26 Rioja, La;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QI;862
26 Rioja, La;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
26 Rioja, La;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
26 Rioja, La;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QII;""
26 Rioja, La;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QI;851
26 Rioja, La;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
26 Rioja, La;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
26 Rioja, La;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QII;""
26 Rioja, La;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QI;""
26 Rioja, La;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
26 Rioja, La;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
26 Rioja, La;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QII;814
26 Rioja, La;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QI;""
26 Rioja, La;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
26 Rioja, La;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
26 Rioja, La;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QII;814
26 Rioja, La;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QI;""
26 Rioja, La;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
26 Rioja, La;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
26 Rioja, La;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QII;""
26 Rioja, La;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QI;""
26 Rioja, La;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
26 Rioja, La;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
26 Rioja, La;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
26 Rioja, La;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
26 Rioja, La;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
26 Rioja, La;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
26 Rioja, La;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
26 Rioja, La;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
26 Rioja, La;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
26 Rioja, La;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
26 Rioja, La;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
26 Rioja, La;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
26 Rioja, La;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
26 Rioja, La;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;91,01
26 Rioja, La;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
26 Rioja, La;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
26 Rioja, La;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
26 Rioja, La;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;88,51
26 Rioja, La;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
26 Rioja, La;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
26 Rioja, La;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
26 Rioja, La;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;91,59
26 Rioja, La;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
26 Rioja, La;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
26 Rioja, La;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;83,67
26 Rioja, La;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
26 Rioja, La;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
26 Rioja, La;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
26 Rioja, La;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;81,24
26 Rioja, La;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
26 Rioja, La;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
26 Rioja, La;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
26 Rioja, La;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;85,99
26 Rioja, La;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
26 Rioja, La;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
26 Rioja, La;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
26 Rioja, La;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
26 Rioja, La;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
26 Rioja, La;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
26 Rioja, La;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;77,38
26 Rioja, La;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
26 Rioja, La;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
26 Rioja, La;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
26 Rioja, La;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;82,22
26 Rioja, La;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
26 Rioja, La;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
26 Rioja, La;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
26 Rioja, La;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
26 Rioja, La;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
26 Rioja, La;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
26 Rioja, La;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;73,07
26 Rioja, La;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
26 Rioja, La;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
26 Rioja, La;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
26 Rioja, La;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;78,65
26 Rioja, La;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
26 Rioja, La;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
26 Rioja, La;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
26 Rioja, La;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
26 Rioja, La;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
26 Rioja, La;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
26 Rioja, La;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QIII;686
26 Rioja, La;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
26 Rioja, La;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
26 Rioja, La;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
26 Rioja, La;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QIII;705
26 Rioja, La;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
26 Rioja, La;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
26 Rioja, La;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
26 Rioja, La;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QIII;675
26 Rioja, La;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
26 Rioja, La;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
26 Rioja, La;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
26 Rioja, La;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2022QIII;627
26 Rioja, La;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2022QII;""
26 Rioja, La;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2022QI;""
26 Rioja, La;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
26 Rioja, La;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2021QIII;630
26 Rioja, La;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2021QII;""
26 Rioja, La;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2021QI;""
26 Rioja, La;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
26 Rioja, La;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2020QIII;617
26 Rioja, La;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2020QII;""
26 Rioja, La;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2020QI;""
26 Rioja, La;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2022QIV;581
26 Rioja, La;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
26 Rioja, La;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2022QII;""
26 Rioja, La;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2022QI;""
26 Rioja, La;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2021QIV;575
26 Rioja, La;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
26 Rioja, La;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2021QII;""
26 Rioja, La;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2021QI;""
26 Rioja, La;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2020QIV;577
26 Rioja, La;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
26 Rioja, La;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2020QII;""
26 Rioja, La;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2020QI;""
26 Rioja, La;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
26 Rioja, La;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
26 Rioja, La;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QII;""
26 Rioja, La;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QI;550
26 Rioja, La;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
26 Rioja, La;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
26 Rioja, La;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QII;""
26 Rioja, La;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QI;550
26 Rioja, La;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
26 Rioja, La;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
26 Rioja, La;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QII;""
26 Rioja, La;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QI;""
26 Rioja, La;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
26 Rioja, La;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
26 Rioja, La;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QII;521
26 Rioja, La;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QI;""
26 Rioja, La;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
26 Rioja, La;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
26 Rioja, La;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QII;527
26 Rioja, La;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QI;""
26 Rioja, La;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
26 Rioja, La;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
26 Rioja, La;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QII;""
26 Rioja, La;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QI;""
26 Rioja, La;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
26 Rioja, La;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
26 Rioja, La;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
26 Rioja, La;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
26 Rioja, La;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
26 Rioja, La;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
26 Rioja, La;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
26 Rioja, La;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
26 Rioja, La;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
26 Rioja, La;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
26 Rioja, La;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
26 Rioja, La;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
26 Rioja, La;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
26 Rioja, La;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;91,4
26 Rioja, La;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
26 Rioja, La;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
26 Rioja, La;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
26 Rioja, La;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;89,36
26 Rioja, La;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
26 Rioja, La;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
26 Rioja, La;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
26 Rioja, La;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;91,41
26 Rioja, La;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
26 Rioja, La;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
26 Rioja, La;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;84,69
26 Rioja, La;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
26 Rioja, La;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
26 Rioja, La;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
26 Rioja, La;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;81,56
26 Rioja, La;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
26 Rioja, La;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
26 Rioja, La;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
26 Rioja, La;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;85,48
26 Rioja, La;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
26 Rioja, La;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
26 Rioja, La;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
26 Rioja, La;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
26 Rioja, La;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
26 Rioja, La;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
26 Rioja, La;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;78,01
26 Rioja, La;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
26 Rioja, La;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
26 Rioja, La;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
26 Rioja, La;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;81,48
26 Rioja, La;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
26 Rioja, La;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
26 Rioja, La;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
26 Rioja, La;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
26 Rioja, La;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
26 Rioja, La;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
26 Rioja, La;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;73,9
26 Rioja, La;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
26 Rioja, La;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
26 Rioja, La;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
26 Rioja, La;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;78,07
26 Rioja, La;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
26 Rioja, La;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
26 Rioja, La;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
26 Rioja, La;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
26 Rioja, La;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
26 Rioja, La;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
26 Rioja, La;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QIII;404
26 Rioja, La;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
26 Rioja, La;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
26 Rioja, La;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
26 Rioja, La;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QIII;409
26 Rioja, La;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
26 Rioja, La;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
26 Rioja, La;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
26 Rioja, La;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QIII;360
26 Rioja, La;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
26 Rioja, La;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
26 Rioja, La;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
26 Rioja, La;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2022QIII;365
26 Rioja, La;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2022QII;""
26 Rioja, La;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2022QI;""
26 Rioja, La;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
26 Rioja, La;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2021QIII;356
26 Rioja, La;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2021QII;""
26 Rioja, La;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2021QI;""
26 Rioja, La;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
26 Rioja, La;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2020QIII;331
26 Rioja, La;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2020QII;""
26 Rioja, La;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2020QI;""
26 Rioja, La;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2022QIV;331
26 Rioja, La;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
26 Rioja, La;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2022QII;""
26 Rioja, La;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2022QI;""
26 Rioja, La;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2021QIV;330
26 Rioja, La;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
26 Rioja, La;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2021QII;""
26 Rioja, La;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2021QI;""
26 Rioja, La;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2020QIV;313
26 Rioja, La;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
26 Rioja, La;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2020QII;""
26 Rioja, La;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2020QI;""
26 Rioja, La;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
26 Rioja, La;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
26 Rioja, La;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QII;""
26 Rioja, La;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QI;312
26 Rioja, La;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
26 Rioja, La;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
26 Rioja, La;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QII;""
26 Rioja, La;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QI;301
26 Rioja, La;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
26 Rioja, La;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
26 Rioja, La;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QII;""
26 Rioja, La;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QI;""
26 Rioja, La;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
26 Rioja, La;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
26 Rioja, La;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QII;293
26 Rioja, La;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QI;""
26 Rioja, La;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
26 Rioja, La;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
26 Rioja, La;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QII;287
26 Rioja, La;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QI;""
26 Rioja, La;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
26 Rioja, La;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
26 Rioja, La;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QII;""
26 Rioja, La;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QI;""
26 Rioja, La;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
26 Rioja, La;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
26 Rioja, La;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
26 Rioja, La;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
26 Rioja, La;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
26 Rioja, La;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
26 Rioja, La;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
26 Rioja, La;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
26 Rioja, La;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
26 Rioja, La;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
26 Rioja, La;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
26 Rioja, La;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
26 Rioja, La;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
26 Rioja, La;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;90,35
26 Rioja, La;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
26 Rioja, La;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
26 Rioja, La;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
26 Rioja, La;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;87,04
26 Rioja, La;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
26 Rioja, La;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
26 Rioja, La;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
26 Rioja, La;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;91,94
26 Rioja, La;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
26 Rioja, La;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
26 Rioja, La;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;81,93
26 Rioja, La;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
26 Rioja, La;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
26 Rioja, La;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
26 Rioja, La;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;80,68
26 Rioja, La;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
26 Rioja, La;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
26 Rioja, La;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
26 Rioja, La;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;86,94
26 Rioja, La;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
26 Rioja, La;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
26 Rioja, La;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
26 Rioja, La;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
26 Rioja, La;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
26 Rioja, La;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
26 Rioja, La;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;76,28
26 Rioja, La;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
26 Rioja, La;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
26 Rioja, La;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
26 Rioja, La;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;83,61
26 Rioja, La;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
26 Rioja, La;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
26 Rioja, La;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
26 Rioja, La;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
26 Rioja, La;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
26 Rioja, La;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
26 Rioja, La;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;71,64
26 Rioja, La;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
26 Rioja, La;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
26 Rioja, La;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
26 Rioja, La;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;79,72
26 Rioja, La;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
26 Rioja, La;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
26 Rioja, La;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
26 Rioja, La;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
26 Rioja, La;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
26 Rioja, La;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QIV;1.098
26 Rioja, La;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
26 Rioja, La;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
26 Rioja, La;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
26 Rioja, La;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QIV;1.124
26 Rioja, La;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
26 Rioja, La;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
26 Rioja, La;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
26 Rioja, La;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QIV;1.095
26 Rioja, La;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
26 Rioja, La;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
26 Rioja, La;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
26 Rioja, La;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2022QIV;1.007
26 Rioja, La;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
26 Rioja, La;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2022QII;""
26 Rioja, La;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2022QI;""
26 Rioja, La;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2021QIV;1.025
26 Rioja, La;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
26 Rioja, La;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2021QII;""
26 Rioja, La;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2021QI;""
26 Rioja, La;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2020QIV;1.009
26 Rioja, La;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
26 Rioja, La;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2020QII;""
26 Rioja, La;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2020QI;""
26 Rioja, La;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
26 Rioja, La;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
26 Rioja, La;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2022QII;""
26 Rioja, La;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2022QI;972
26 Rioja, La;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
26 Rioja, La;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
26 Rioja, La;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2021QII;""
26 Rioja, La;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2021QI;962
26 Rioja, La;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
26 Rioja, La;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
26 Rioja, La;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2020QII;""
26 Rioja, La;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2020QI;""
26 Rioja, La;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
26 Rioja, La;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
26 Rioja, La;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QII;904
26 Rioja, La;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QI;""
26 Rioja, La;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
26 Rioja, La;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
26 Rioja, La;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QII;916
26 Rioja, La;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QI;""
26 Rioja, La;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
26 Rioja, La;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
26 Rioja, La;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QII;""
26 Rioja, La;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QI;""
26 Rioja, La;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
26 Rioja, La;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QIII;849
26 Rioja, La;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QII;""
26 Rioja, La;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QI;""
26 Rioja, La;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
26 Rioja, La;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QIII;850
26 Rioja, La;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QII;""
26 Rioja, La;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QI;""
26 Rioja, La;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
26 Rioja, La;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
26 Rioja, La;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QII;""
26 Rioja, La;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QI;""
26 Rioja, La;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
26 Rioja, La;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
26 Rioja, La;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
26 Rioja, La;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
26 Rioja, La;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
26 Rioja, La;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
26 Rioja, La;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
26 Rioja, La;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
26 Rioja, La;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
26 Rioja, La;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
26 Rioja, La;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
26 Rioja, La;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
26 Rioja, La;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;91,71
26 Rioja, La;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
26 Rioja, La;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
26 Rioja, La;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
26 Rioja, La;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;91,19
26 Rioja, La;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
26 Rioja, La;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
26 Rioja, La;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
26 Rioja, La;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;92,15
26 Rioja, La;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
26 Rioja, La;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
26 Rioja, La;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
26 Rioja, La;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
26 Rioja, La;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
26 Rioja, La;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
26 Rioja, La;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;86,48
26 Rioja, La;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
26 Rioja, La;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
26 Rioja, La;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
26 Rioja, La;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;87,85
26 Rioja, La;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
26 Rioja, La;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
26 Rioja, La;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
26 Rioja, La;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
26 Rioja, La;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
26 Rioja, La;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
26 Rioja, La;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;80,43
26 Rioja, La;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
26 Rioja, La;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
26 Rioja, La;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
26 Rioja, La;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;83,65
26 Rioja, La;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
26 Rioja, La;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
26 Rioja, La;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
26 Rioja, La;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
26 Rioja, La;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
26 Rioja, La;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
26 Rioja, La;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;75,53
26 Rioja, La;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
26 Rioja, La;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
26 Rioja, La;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
26 Rioja, La;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;77,63
26 Rioja, La;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
26 Rioja, La;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
26 Rioja, La;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
26 Rioja, La;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
26 Rioja, La;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
26 Rioja, La;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
26 Rioja, La;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QIV;699
26 Rioja, La;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
26 Rioja, La;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
26 Rioja, La;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
26 Rioja, La;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QIV;714
26 Rioja, La;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
26 Rioja, La;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
26 Rioja, La;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
26 Rioja, La;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QIV;710
26 Rioja, La;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
26 Rioja, La;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
26 Rioja, La;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
26 Rioja, La;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2022QIV;643
26 Rioja, La;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
26 Rioja, La;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2022QII;""
26 Rioja, La;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2022QI;""
26 Rioja, La;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2021QIV;645
26 Rioja, La;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
26 Rioja, La;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2021QII;""
26 Rioja, La;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2021QI;""
26 Rioja, La;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2020QIV;654
26 Rioja, La;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
26 Rioja, La;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2020QII;""
26 Rioja, La;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2020QI;""
26 Rioja, La;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
26 Rioja, La;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
26 Rioja, La;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2022QII;""
26 Rioja, La;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2022QI;614
26 Rioja, La;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
26 Rioja, La;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
26 Rioja, La;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2021QII;""
26 Rioja, La;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2021QI;621
26 Rioja, La;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
26 Rioja, La;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
26 Rioja, La;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2020QII;""
26 Rioja, La;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2020QI;""
26 Rioja, La;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
26 Rioja, La;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
26 Rioja, La;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QII;573
26 Rioja, La;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QI;""
26 Rioja, La;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
26 Rioja, La;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
26 Rioja, La;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QII;592
26 Rioja, La;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QI;""
26 Rioja, La;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
26 Rioja, La;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
26 Rioja, La;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QII;""
26 Rioja, La;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QI;""
26 Rioja, La;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
26 Rioja, La;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QIII;540
26 Rioja, La;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QII;""
26 Rioja, La;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QI;""
26 Rioja, La;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
26 Rioja, La;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QIII;548
26 Rioja, La;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QII;""
26 Rioja, La;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QI;""
26 Rioja, La;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
26 Rioja, La;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
26 Rioja, La;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QII;""
26 Rioja, La;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QI;""
26 Rioja, La;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
26 Rioja, La;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
26 Rioja, La;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
26 Rioja, La;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
26 Rioja, La;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
26 Rioja, La;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
26 Rioja, La;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
26 Rioja, La;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
26 Rioja, La;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
26 Rioja, La;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
26 Rioja, La;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
26 Rioja, La;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
26 Rioja, La;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;91,99
26 Rioja, La;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
26 Rioja, La;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
26 Rioja, La;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
26 Rioja, La;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;90,34
26 Rioja, La;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
26 Rioja, La;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
26 Rioja, La;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
26 Rioja, La;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;92,11
26 Rioja, La;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
26 Rioja, La;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
26 Rioja, La;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
26 Rioja, La;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
26 Rioja, La;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
26 Rioja, La;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
26 Rioja, La;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;85,99
26 Rioja, La;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
26 Rioja, La;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
26 Rioja, La;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
26 Rioja, La;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;87,46
26 Rioja, La;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
26 Rioja, La;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
26 Rioja, La;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
26 Rioja, La;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
26 Rioja, La;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
26 Rioja, La;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
26 Rioja, La;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;80,25
26 Rioja, La;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
26 Rioja, La;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
26 Rioja, La;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
26 Rioja, La;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;83,38
26 Rioja, La;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
26 Rioja, La;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
26 Rioja, La;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
26 Rioja, La;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
26 Rioja, La;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
26 Rioja, La;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
26 Rioja, La;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;75,63
26 Rioja, La;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
26 Rioja, La;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
26 Rioja, La;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
26 Rioja, La;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;77,18
26 Rioja, La;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
26 Rioja, La;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
26 Rioja, La;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
26 Rioja, La;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
26 Rioja, La;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
26 Rioja, La;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
26 Rioja, La;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QIV;399
26 Rioja, La;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
26 Rioja, La;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
26 Rioja, La;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
26 Rioja, La;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QIV;410
26 Rioja, La;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
26 Rioja, La;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
26 Rioja, La;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
26 Rioja, La;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QIV;385
26 Rioja, La;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
26 Rioja, La;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
26 Rioja, La;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
26 Rioja, La;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2022QIV;364
26 Rioja, La;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
26 Rioja, La;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2022QII;""
26 Rioja, La;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2022QI;""
26 Rioja, La;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2021QIV;380
26 Rioja, La;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
26 Rioja, La;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2021QII;""
26 Rioja, La;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2021QI;""
26 Rioja, La;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2020QIV;355
26 Rioja, La;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
26 Rioja, La;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2020QII;""
26 Rioja, La;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2020QI;""
26 Rioja, La;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
26 Rioja, La;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
26 Rioja, La;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2022QII;""
26 Rioja, La;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2022QI;358
26 Rioja, La;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
26 Rioja, La;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
26 Rioja, La;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2021QII;""
26 Rioja, La;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2021QI;341
26 Rioja, La;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
26 Rioja, La;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
26 Rioja, La;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2020QII;""
26 Rioja, La;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2020QI;""
26 Rioja, La;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
26 Rioja, La;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
26 Rioja, La;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QII;331
26 Rioja, La;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QI;""
26 Rioja, La;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
26 Rioja, La;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
26 Rioja, La;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QII;324
26 Rioja, La;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QI;""
26 Rioja, La;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
26 Rioja, La;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
26 Rioja, La;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QII;""
26 Rioja, La;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QI;""
26 Rioja, La;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
26 Rioja, La;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QIII;309
26 Rioja, La;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QII;""
26 Rioja, La;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QI;""
26 Rioja, La;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
26 Rioja, La;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QIII;302
26 Rioja, La;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QII;""
26 Rioja, La;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QI;""
26 Rioja, La;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
26 Rioja, La;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
26 Rioja, La;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QII;""
26 Rioja, La;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QI;""
26 Rioja, La;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
26 Rioja, La;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
26 Rioja, La;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
26 Rioja, La;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
26 Rioja, La;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
26 Rioja, La;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
26 Rioja, La;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
26 Rioja, La;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
26 Rioja, La;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
26 Rioja, La;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
26 Rioja, La;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
26 Rioja, La;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
26 Rioja, La;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;91,23
26 Rioja, La;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
26 Rioja, La;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
26 Rioja, La;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
26 Rioja, La;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;92,68
26 Rioja, La;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
26 Rioja, La;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
26 Rioja, La;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
26 Rioja, La;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;92,21
26 Rioja, La;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
26 Rioja, La;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
26 Rioja, La;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
26 Rioja, La;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
26 Rioja, La;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
26 Rioja, La;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
26 Rioja, La;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;87,32
26 Rioja, La;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
26 Rioja, La;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
26 Rioja, La;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
26 Rioja, La;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;88,57
26 Rioja, La;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
26 Rioja, La;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
26 Rioja, La;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
26 Rioja, La;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
26 Rioja, La;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
26 Rioja, La;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
26 Rioja, La;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;80,73
26 Rioja, La;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
26 Rioja, La;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
26 Rioja, La;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
26 Rioja, La;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;84,16
26 Rioja, La;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
26 Rioja, La;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
26 Rioja, La;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
26 Rioja, La;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
26 Rioja, La;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
26 Rioja, La;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
26 Rioja, La;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;75,37
26 Rioja, La;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
26 Rioja, La;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
26 Rioja, La;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
26 Rioja, La;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;78,44
26 Rioja, La;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
26 Rioja, La;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
26 Rioja, La;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
26 Rioja, La;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
26 Rioja, La;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
26 Rioja, La;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
26 Rioja, La;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
26 Rioja, La;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
26 Rioja, La;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
26 Rioja, La;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QI;3.261
26 Rioja, La;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
26 Rioja, La;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
26 Rioja, La;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
26 Rioja, La;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QI;3.331
26 Rioja, La;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
26 Rioja, La;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
26 Rioja, La;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
26 Rioja, La;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QI;3.321
26 Rioja, La;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
26 Rioja, La;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
26 Rioja, La;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2022QII;""
26 Rioja, La;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2022QI;3.162
26 Rioja, La;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
26 Rioja, La;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
26 Rioja, La;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2021QII;""
26 Rioja, La;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2021QI;3.238
26 Rioja, La;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
26 Rioja, La;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
26 Rioja, La;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2020QII;""
26 Rioja, La;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2020QI;3.077
26 Rioja, La;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
26 Rioja, La;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
26 Rioja, La;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2022QII;3.025
26 Rioja, La;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2022QI;""
26 Rioja, La;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
26 Rioja, La;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
26 Rioja, La;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2021QII;3.122
26 Rioja, La;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2021QI;""
26 Rioja, La;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
26 Rioja, La;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
26 Rioja, La;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2020QII;3.002
26 Rioja, La;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2020QI;""
26 Rioja, La;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
26 Rioja, La;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QIII;2.941
26 Rioja, La;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QII;""
26 Rioja, La;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QI;""
26 Rioja, La;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
26 Rioja, La;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QIII;3.055
26 Rioja, La;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QII;""
26 Rioja, La;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QI;""
26 Rioja, La;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
26 Rioja, La;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QIII;2.921
26 Rioja, La;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QII;""
26 Rioja, La;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QI;""
26 Rioja, La;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QIV;2.852
26 Rioja, La;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
26 Rioja, La;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QII;""
26 Rioja, La;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QI;""
26 Rioja, La;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QIV;2.969
26 Rioja, La;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
26 Rioja, La;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QII;""
26 Rioja, La;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QI;""
26 Rioja, La;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QIV;2.832
26 Rioja, La;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
26 Rioja, La;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QII;""
26 Rioja, La;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QI;""
26 Rioja, La;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
26 Rioja, La;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
26 Rioja, La;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
26 Rioja, La;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
26 Rioja, La;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
26 Rioja, La;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
26 Rioja, La;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
26 Rioja, La;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
26 Rioja, La;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
26 Rioja, La;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
26 Rioja, La;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
26 Rioja, La;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
26 Rioja, La;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
26 Rioja, La;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
26 Rioja, La;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
26 Rioja, La;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;96,96
26 Rioja, La;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
26 Rioja, La;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
26 Rioja, La;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
26 Rioja, La;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;97,21
26 Rioja, La;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
26 Rioja, La;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
26 Rioja, La;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
26 Rioja, La;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;92,65
26 Rioja, La;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
26 Rioja, La;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
26 Rioja, La;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;92,76
26 Rioja, La;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
26 Rioja, La;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
26 Rioja, La;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
26 Rioja, La;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;93,73
26 Rioja, La;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
26 Rioja, La;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
26 Rioja, La;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
26 Rioja, La;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;90,39
26 Rioja, La;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
26 Rioja, La;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
26 Rioja, La;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;90,19
26 Rioja, La;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
26 Rioja, La;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
26 Rioja, La;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
26 Rioja, La;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;91,71
26 Rioja, La;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
26 Rioja, La;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
26 Rioja, La;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
26 Rioja, La;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;87,96
26 Rioja, La;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
26 Rioja, La;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
26 Rioja, La;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;87,46
26 Rioja, La;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
26 Rioja, La;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
26 Rioja, La;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
26 Rioja, La;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;89,13
26 Rioja, La;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
26 Rioja, La;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
26 Rioja, La;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
26 Rioja, La;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;85,28
26 Rioja, La;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
26 Rioja, La;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
26 Rioja, La;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
26 Rioja, La;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
26 Rioja, La;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
26 Rioja, La;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
26 Rioja, La;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QI;1.869
26 Rioja, La;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
26 Rioja, La;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
26 Rioja, La;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
26 Rioja, La;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QI;1.964
26 Rioja, La;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
26 Rioja, La;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
26 Rioja, La;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
26 Rioja, La;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QI;1.961
26 Rioja, La;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
26 Rioja, La;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
26 Rioja, La;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2022QII;""
26 Rioja, La;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2022QI;1.818
26 Rioja, La;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
26 Rioja, La;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
26 Rioja, La;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2021QII;""
26 Rioja, La;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2021QI;1.907
26 Rioja, La;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
26 Rioja, La;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
26 Rioja, La;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2020QII;""
26 Rioja, La;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2020QI;1.829
26 Rioja, La;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
26 Rioja, La;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
26 Rioja, La;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2022QII;1.733
26 Rioja, La;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2022QI;""
26 Rioja, La;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
26 Rioja, La;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
26 Rioja, La;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2021QII;1.838
26 Rioja, La;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2021QI;""
26 Rioja, La;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
26 Rioja, La;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
26 Rioja, La;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2020QII;1.787
26 Rioja, La;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2020QI;""
26 Rioja, La;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
26 Rioja, La;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QIII;1.690
26 Rioja, La;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QII;""
26 Rioja, La;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QI;""
26 Rioja, La;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
26 Rioja, La;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QIII;1.793
26 Rioja, La;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QII;""
26 Rioja, La;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QI;""
26 Rioja, La;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
26 Rioja, La;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QIII;1.740
26 Rioja, La;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QII;""
26 Rioja, La;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QI;""
26 Rioja, La;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QIV;1.637
26 Rioja, La;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
26 Rioja, La;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QII;""
26 Rioja, La;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QI;""
26 Rioja, La;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QIV;1.744
26 Rioja, La;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
26 Rioja, La;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QII;""
26 Rioja, La;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QI;""
26 Rioja, La;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QIV;1.687
26 Rioja, La;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
26 Rioja, La;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QII;""
26 Rioja, La;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QI;""
26 Rioja, La;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
26 Rioja, La;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
26 Rioja, La;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
26 Rioja, La;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
26 Rioja, La;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
26 Rioja, La;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
26 Rioja, La;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
26 Rioja, La;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
26 Rioja, La;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
26 Rioja, La;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
26 Rioja, La;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
26 Rioja, La;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
26 Rioja, La;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
26 Rioja, La;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
26 Rioja, La;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
26 Rioja, La;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;97,27
26 Rioja, La;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
26 Rioja, La;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
26 Rioja, La;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
26 Rioja, La;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;97,1
26 Rioja, La;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
26 Rioja, La;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
26 Rioja, La;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
26 Rioja, La;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;93,27
26 Rioja, La;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
26 Rioja, La;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
26 Rioja, La;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;92,72
26 Rioja, La;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
26 Rioja, La;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
26 Rioja, La;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
26 Rioja, La;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;93,58
26 Rioja, La;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
26 Rioja, La;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
26 Rioja, La;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
26 Rioja, La;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;91,13
26 Rioja, La;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
26 Rioja, La;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
26 Rioja, La;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;90,42
26 Rioja, La;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
26 Rioja, La;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
26 Rioja, La;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
26 Rioja, La;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;91,29
26 Rioja, La;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
26 Rioja, La;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
26 Rioja, La;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
26 Rioja, La;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;88,73
26 Rioja, La;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
26 Rioja, La;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
26 Rioja, La;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;87,59
26 Rioja, La;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
26 Rioja, La;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
26 Rioja, La;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
26 Rioja, La;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;88,8
26 Rioja, La;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
26 Rioja, La;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
26 Rioja, La;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
26 Rioja, La;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;86,03
26 Rioja, La;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
26 Rioja, La;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
26 Rioja, La;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
26 Rioja, La;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
26 Rioja, La;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
26 Rioja, La;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
26 Rioja, La;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QI;1.392
26 Rioja, La;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
26 Rioja, La;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
26 Rioja, La;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
26 Rioja, La;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QI;1.367
26 Rioja, La;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
26 Rioja, La;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
26 Rioja, La;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
26 Rioja, La;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QI;1.360
26 Rioja, La;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
26 Rioja, La;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
26 Rioja, La;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2022QII;""
26 Rioja, La;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2022QI;1.344
26 Rioja, La;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
26 Rioja, La;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
26 Rioja, La;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2021QII;""
26 Rioja, La;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2021QI;1.331
26 Rioja, La;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
26 Rioja, La;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
26 Rioja, La;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2020QII;""
26 Rioja, La;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2020QI;1.248
26 Rioja, La;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
26 Rioja, La;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
26 Rioja, La;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2022QII;1.292
26 Rioja, La;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2022QI;""
26 Rioja, La;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
26 Rioja, La;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
26 Rioja, La;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2021QII;1.284
26 Rioja, La;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2021QI;""
26 Rioja, La;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
26 Rioja, La;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
26 Rioja, La;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2020QII;1.215
26 Rioja, La;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2020QI;""
26 Rioja, La;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
26 Rioja, La;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QIII;1.251
26 Rioja, La;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QII;""
26 Rioja, La;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QI;""
26 Rioja, La;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
26 Rioja, La;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QIII;1.262
26 Rioja, La;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QII;""
26 Rioja, La;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QI;""
26 Rioja, La;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
26 Rioja, La;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QIII;1.181
26 Rioja, La;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QII;""
26 Rioja, La;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QI;""
26 Rioja, La;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QIV;1.215
26 Rioja, La;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
26 Rioja, La;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QII;""
26 Rioja, La;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QI;""
26 Rioja, La;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QIV;1.225
26 Rioja, La;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
26 Rioja, La;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QII;""
26 Rioja, La;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QI;""
26 Rioja, La;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QIV;1.145
26 Rioja, La;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
26 Rioja, La;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QII;""
26 Rioja, La;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QI;""
26 Rioja, La;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
26 Rioja, La;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
26 Rioja, La;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
26 Rioja, La;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
26 Rioja, La;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
26 Rioja, La;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
26 Rioja, La;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
26 Rioja, La;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
26 Rioja, La;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
26 Rioja, La;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
26 Rioja, La;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
26 Rioja, La;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
26 Rioja, La;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
26 Rioja, La;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
26 Rioja, La;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
26 Rioja, La;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;96,55
26 Rioja, La;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
26 Rioja, La;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
26 Rioja, La;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
26 Rioja, La;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;97,37
26 Rioja, La;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
26 Rioja, La;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
26 Rioja, La;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
26 Rioja, La;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;91,76
26 Rioja, La;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
26 Rioja, La;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
26 Rioja, La;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;92,82
26 Rioja, La;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
26 Rioja, La;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
26 Rioja, La;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
26 Rioja, La;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;93,93
26 Rioja, La;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
26 Rioja, La;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
26 Rioja, La;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
26 Rioja, La;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;89,34
26 Rioja, La;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
26 Rioja, La;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
26 Rioja, La;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;89,87
26 Rioja, La;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
26 Rioja, La;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
26 Rioja, La;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
26 Rioja, La;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;92,32
26 Rioja, La;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
26 Rioja, La;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
26 Rioja, La;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
26 Rioja, La;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;86,84
26 Rioja, La;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
26 Rioja, La;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
26 Rioja, La;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;87,28
26 Rioja, La;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
26 Rioja, La;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
26 Rioja, La;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
26 Rioja, La;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;89,61
26 Rioja, La;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
26 Rioja, La;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
26 Rioja, La;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
26 Rioja, La;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;84,19
26 Rioja, La;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
26 Rioja, La;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
26 Rioja, La;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
26 Rioja, La;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
26 Rioja, La;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
26 Rioja, La;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QII;3.020
26 Rioja, La;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
26 Rioja, La;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
26 Rioja, La;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
26 Rioja, La;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QII;3.145
26 Rioja, La;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
26 Rioja, La;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
26 Rioja, La;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
26 Rioja, La;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QII;3.249
26 Rioja, La;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
26 Rioja, La;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
26 Rioja, La;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
26 Rioja, La;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2022QII;2.863
26 Rioja, La;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2022QI;""
26 Rioja, La;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
26 Rioja, La;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
26 Rioja, La;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2021QII;3.015
26 Rioja, La;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2021QI;""
26 Rioja, La;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
26 Rioja, La;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
26 Rioja, La;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2020QII;3.168
26 Rioja, La;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2020QI;""
26 Rioja, La;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
26 Rioja, La;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2022QIII;2.777
26 Rioja, La;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2022QII;""
26 Rioja, La;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2022QI;""
26 Rioja, La;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
26 Rioja, La;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2021QIII;2.927
26 Rioja, La;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2021QII;""
26 Rioja, La;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2021QI;""
26 Rioja, La;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
26 Rioja, La;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2020QIII;3.077
26 Rioja, La;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2020QII;""
26 Rioja, La;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2020QI;""
26 Rioja, La;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QIV;2.690
26 Rioja, La;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
26 Rioja, La;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QII;""
26 Rioja, La;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QI;""
26 Rioja, La;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QIV;2.832
26 Rioja, La;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
26 Rioja, La;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QII;""
26 Rioja, La;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QI;""
26 Rioja, La;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QIV;2.969
26 Rioja, La;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
26 Rioja, La;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QII;""
26 Rioja, La;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QI;""
26 Rioja, La;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
26 Rioja, La;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
26 Rioja, La;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QII;""
26 Rioja, La;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QI;2.760
26 Rioja, La;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
26 Rioja, La;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
26 Rioja, La;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QII;""
26 Rioja, La;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QI;2.906
26 Rioja, La;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
26 Rioja, La;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
26 Rioja, La;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QII;""
26 Rioja, La;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QI;""
26 Rioja, La;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
26 Rioja, La;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
26 Rioja, La;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
26 Rioja, La;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
26 Rioja, La;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
26 Rioja, La;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
26 Rioja, La;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
26 Rioja, La;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
26 Rioja, La;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
26 Rioja, La;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
26 Rioja, La;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
26 Rioja, La;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
26 Rioja, La;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
26 Rioja, La;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
26 Rioja, La;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;94,8
26 Rioja, La;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
26 Rioja, La;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
26 Rioja, La;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
26 Rioja, La;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;95,87
26 Rioja, La;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
26 Rioja, La;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
26 Rioja, La;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
26 Rioja, La;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;97,51
26 Rioja, La;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
26 Rioja, La;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
26 Rioja, La;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;91,95
26 Rioja, La;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
26 Rioja, La;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
26 Rioja, La;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
26 Rioja, La;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;93,07
26 Rioja, La;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
26 Rioja, La;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
26 Rioja, La;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
26 Rioja, La;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;94,71
26 Rioja, La;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
26 Rioja, La;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
26 Rioja, La;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;89,07
26 Rioja, La;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
26 Rioja, La;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
26 Rioja, La;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
26 Rioja, La;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;90,05
26 Rioja, La;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
26 Rioja, La;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
26 Rioja, La;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
26 Rioja, La;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;91,38
26 Rioja, La;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
26 Rioja, La;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
26 Rioja, La;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
26 Rioja, La;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
26 Rioja, La;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
26 Rioja, La;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
26 Rioja, La;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;87,76
26 Rioja, La;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
26 Rioja, La;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
26 Rioja, La;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
26 Rioja, La;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;89,44
26 Rioja, La;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
26 Rioja, La;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
26 Rioja, La;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
26 Rioja, La;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
26 Rioja, La;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
26 Rioja, La;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
26 Rioja, La;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QII;1.735
26 Rioja, La;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
26 Rioja, La;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
26 Rioja, La;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
26 Rioja, La;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QII;1.844
26 Rioja, La;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
26 Rioja, La;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
26 Rioja, La;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
26 Rioja, La;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QII;1.922
26 Rioja, La;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
26 Rioja, La;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
26 Rioja, La;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
26 Rioja, La;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2022QII;1.638
26 Rioja, La;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2022QI;""
26 Rioja, La;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
26 Rioja, La;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
26 Rioja, La;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2021QII;1.765
26 Rioja, La;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2021QI;""
26 Rioja, La;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
26 Rioja, La;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
26 Rioja, La;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2020QII;1.878
26 Rioja, La;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2020QI;""
26 Rioja, La;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
26 Rioja, La;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2022QIII;1.596
26 Rioja, La;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2022QII;""
26 Rioja, La;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2022QI;""
26 Rioja, La;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
26 Rioja, La;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2021QIII;1.704
26 Rioja, La;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2021QII;""
26 Rioja, La;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2021QI;""
26 Rioja, La;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
26 Rioja, La;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2020QIII;1.823
26 Rioja, La;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2020QII;""
26 Rioja, La;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2020QI;""
26 Rioja, La;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QIV;1.542
26 Rioja, La;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
26 Rioja, La;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QII;""
26 Rioja, La;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QI;""
26 Rioja, La;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QIV;1.648
26 Rioja, La;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
26 Rioja, La;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QII;""
26 Rioja, La;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QI;""
26 Rioja, La;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QIV;1.756
26 Rioja, La;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
26 Rioja, La;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QII;""
26 Rioja, La;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QI;""
26 Rioja, La;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
26 Rioja, La;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
26 Rioja, La;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QII;""
26 Rioja, La;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QI;1.611
26 Rioja, La;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
26 Rioja, La;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
26 Rioja, La;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QII;""
26 Rioja, La;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QI;1.717
26 Rioja, La;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
26 Rioja, La;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
26 Rioja, La;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QII;""
26 Rioja, La;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QI;""
26 Rioja, La;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
26 Rioja, La;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
26 Rioja, La;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
26 Rioja, La;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
26 Rioja, La;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
26 Rioja, La;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
26 Rioja, La;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
26 Rioja, La;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
26 Rioja, La;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
26 Rioja, La;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
26 Rioja, La;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
26 Rioja, La;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
26 Rioja, La;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
26 Rioja, La;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
26 Rioja, La;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;94,41
26 Rioja, La;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
26 Rioja, La;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
26 Rioja, La;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
26 Rioja, La;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;95,72
26 Rioja, La;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
26 Rioja, La;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
26 Rioja, La;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
26 Rioja, La;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;97,71
26 Rioja, La;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
26 Rioja, La;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
26 Rioja, La;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;91,99
26 Rioja, La;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
26 Rioja, La;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
26 Rioja, La;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
26 Rioja, La;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;92,41
26 Rioja, La;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
26 Rioja, La;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
26 Rioja, La;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
26 Rioja, La;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;94,85
26 Rioja, La;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
26 Rioja, La;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
26 Rioja, La;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;88,88
26 Rioja, La;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
26 Rioja, La;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
26 Rioja, La;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
26 Rioja, La;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;89,37
26 Rioja, La;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
26 Rioja, La;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
26 Rioja, La;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
26 Rioja, La;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;91,36
26 Rioja, La;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
26 Rioja, La;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
26 Rioja, La;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
26 Rioja, La;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
26 Rioja, La;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
26 Rioja, La;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
26 Rioja, La;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;87,36
26 Rioja, La;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
26 Rioja, La;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
26 Rioja, La;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
26 Rioja, La;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;89,33
26 Rioja, La;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
26 Rioja, La;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
26 Rioja, La;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
26 Rioja, La;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
26 Rioja, La;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
26 Rioja, La;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
26 Rioja, La;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QII;1.285
26 Rioja, La;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
26 Rioja, La;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
26 Rioja, La;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
26 Rioja, La;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QII;1.301
26 Rioja, La;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
26 Rioja, La;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
26 Rioja, La;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
26 Rioja, La;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QII;1.327
26 Rioja, La;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
26 Rioja, La;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
26 Rioja, La;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
26 Rioja, La;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2022QII;1.225
26 Rioja, La;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2022QI;""
26 Rioja, La;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
26 Rioja, La;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
26 Rioja, La;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2021QII;1.250
26 Rioja, La;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2021QI;""
26 Rioja, La;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
26 Rioja, La;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
26 Rioja, La;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2020QII;1.290
26 Rioja, La;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2020QI;""
26 Rioja, La;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
26 Rioja, La;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2022QIII;1.181
26 Rioja, La;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2022QII;""
26 Rioja, La;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2022QI;""
26 Rioja, La;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
26 Rioja, La;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2021QIII;1.223
26 Rioja, La;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2021QII;""
26 Rioja, La;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2021QI;""
26 Rioja, La;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
26 Rioja, La;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2020QIII;1.254
26 Rioja, La;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2020QII;""
26 Rioja, La;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2020QI;""
26 Rioja, La;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QIV;1.148
26 Rioja, La;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
26 Rioja, La;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QII;""
26 Rioja, La;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QI;""
26 Rioja, La;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QIV;1.184
26 Rioja, La;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
26 Rioja, La;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QII;""
26 Rioja, La;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QI;""
26 Rioja, La;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QIV;1.213
26 Rioja, La;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
26 Rioja, La;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QII;""
26 Rioja, La;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QI;""
26 Rioja, La;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
26 Rioja, La;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
26 Rioja, La;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QII;""
26 Rioja, La;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QI;1.149
26 Rioja, La;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
26 Rioja, La;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
26 Rioja, La;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QII;""
26 Rioja, La;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QI;1.189
26 Rioja, La;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
26 Rioja, La;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
26 Rioja, La;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QII;""
26 Rioja, La;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QI;""
26 Rioja, La;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
26 Rioja, La;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
26 Rioja, La;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
26 Rioja, La;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
26 Rioja, La;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
26 Rioja, La;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
26 Rioja, La;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
26 Rioja, La;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
26 Rioja, La;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
26 Rioja, La;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
26 Rioja, La;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
26 Rioja, La;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
26 Rioja, La;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
26 Rioja, La;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
26 Rioja, La;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;95,33
26 Rioja, La;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
26 Rioja, La;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
26 Rioja, La;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
26 Rioja, La;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;96,08
26 Rioja, La;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
26 Rioja, La;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
26 Rioja, La;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
26 Rioja, La;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;97,21
26 Rioja, La;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
26 Rioja, La;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
26 Rioja, La;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;91,91
26 Rioja, La;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
26 Rioja, La;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
26 Rioja, La;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
26 Rioja, La;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;94
26 Rioja, La;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
26 Rioja, La;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
26 Rioja, La;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
26 Rioja, La;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;94,5
26 Rioja, La;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
26 Rioja, La;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
26 Rioja, La;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;89,34
26 Rioja, La;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
26 Rioja, La;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
26 Rioja, La;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
26 Rioja, La;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;91,01
26 Rioja, La;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
26 Rioja, La;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
26 Rioja, La;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
26 Rioja, La;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;91,41
26 Rioja, La;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
26 Rioja, La;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
26 Rioja, La;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
26 Rioja, La;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
26 Rioja, La;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
26 Rioja, La;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
26 Rioja, La;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;88,32
26 Rioja, La;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
26 Rioja, La;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
26 Rioja, La;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
26 Rioja, La;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;89,6
26 Rioja, La;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
26 Rioja, La;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
26 Rioja, La;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
26 Rioja, La;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
26 Rioja, La;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
26 Rioja, La;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QIII;3.024
26 Rioja, La;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
26 Rioja, La;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
26 Rioja, La;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
26 Rioja, La;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QIII;3.165
26 Rioja, La;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
26 Rioja, La;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
26 Rioja, La;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
26 Rioja, La;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QIII;3.277
26 Rioja, La;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
26 Rioja, La;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
26 Rioja, La;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
26 Rioja, La;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2022QIII;2.916
26 Rioja, La;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2022QII;""
26 Rioja, La;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2022QI;""
26 Rioja, La;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
26 Rioja, La;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2021QIII;3.063
26 Rioja, La;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2021QII;""
26 Rioja, La;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2021QI;""
26 Rioja, La;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
26 Rioja, La;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2020QIII;3.170
26 Rioja, La;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2020QII;""
26 Rioja, La;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2020QI;""
26 Rioja, La;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2022QIV;2.812
26 Rioja, La;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
26 Rioja, La;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2022QII;""
26 Rioja, La;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2022QI;""
26 Rioja, La;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2021QIV;2.953
26 Rioja, La;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
26 Rioja, La;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2021QII;""
26 Rioja, La;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2021QI;""
26 Rioja, La;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2020QIV;3.055
26 Rioja, La;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
26 Rioja, La;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2020QII;""
26 Rioja, La;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2020QI;""
26 Rioja, La;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
26 Rioja, La;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
26 Rioja, La;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QII;""
26 Rioja, La;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QI;2.871
26 Rioja, La;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
26 Rioja, La;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
26 Rioja, La;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QII;""
26 Rioja, La;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QI;2.989
26 Rioja, La;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
26 Rioja, La;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
26 Rioja, La;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QII;""
26 Rioja, La;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QI;""
26 Rioja, La;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
26 Rioja, La;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
26 Rioja, La;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QII;2.773
26 Rioja, La;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QI;""
26 Rioja, La;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
26 Rioja, La;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
26 Rioja, La;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QII;2.905
26 Rioja, La;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QI;""
26 Rioja, La;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
26 Rioja, La;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
26 Rioja, La;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QII;""
26 Rioja, La;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QI;""
26 Rioja, La;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
26 Rioja, La;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
26 Rioja, La;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
26 Rioja, La;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
26 Rioja, La;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
26 Rioja, La;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
26 Rioja, La;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
26 Rioja, La;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
26 Rioja, La;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
26 Rioja, La;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
26 Rioja, La;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
26 Rioja, La;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
26 Rioja, La;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
26 Rioja, La;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;96,43
26 Rioja, La;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
26 Rioja, La;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
26 Rioja, La;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
26 Rioja, La;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;96,78
26 Rioja, La;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
26 Rioja, La;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
26 Rioja, La;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
26 Rioja, La;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;96,73
26 Rioja, La;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
26 Rioja, La;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
26 Rioja, La;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;92,99
26 Rioja, La;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
26 Rioja, La;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
26 Rioja, La;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
26 Rioja, La;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;93,3
26 Rioja, La;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
26 Rioja, La;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
26 Rioja, La;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
26 Rioja, La;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;93,23
26 Rioja, La;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
26 Rioja, La;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
26 Rioja, La;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
26 Rioja, La;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
26 Rioja, La;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
26 Rioja, La;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
26 Rioja, La;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;90,71
26 Rioja, La;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
26 Rioja, La;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
26 Rioja, La;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
26 Rioja, La;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;91,21
26 Rioja, La;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
26 Rioja, La;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
26 Rioja, La;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
26 Rioja, La;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
26 Rioja, La;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
26 Rioja, La;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
26 Rioja, La;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;87,61
26 Rioja, La;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
26 Rioja, La;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
26 Rioja, La;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
26 Rioja, La;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;88,65
26 Rioja, La;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
26 Rioja, La;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
26 Rioja, La;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
26 Rioja, La;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
26 Rioja, La;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
26 Rioja, La;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
26 Rioja, La;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QIII;1.725
26 Rioja, La;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
26 Rioja, La;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
26 Rioja, La;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
26 Rioja, La;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QIII;1.849
26 Rioja, La;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
26 Rioja, La;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
26 Rioja, La;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
26 Rioja, La;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QIII;1.943
26 Rioja, La;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
26 Rioja, La;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
26 Rioja, La;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
26 Rioja, La;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2022QIII;1.670
26 Rioja, La;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2022QII;""
26 Rioja, La;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2022QI;""
26 Rioja, La;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
26 Rioja, La;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2021QIII;1.780
26 Rioja, La;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2021QII;""
26 Rioja, La;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2021QI;""
26 Rioja, La;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
26 Rioja, La;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2020QIII;1.877
26 Rioja, La;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2020QII;""
26 Rioja, La;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2020QI;""
26 Rioja, La;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2022QIV;1.610
26 Rioja, La;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
26 Rioja, La;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2022QII;""
26 Rioja, La;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2022QI;""
26 Rioja, La;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2021QIV;1.715
26 Rioja, La;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
26 Rioja, La;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2021QII;""
26 Rioja, La;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2021QI;""
26 Rioja, La;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2020QIV;1.805
26 Rioja, La;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
26 Rioja, La;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2020QII;""
26 Rioja, La;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2020QI;""
26 Rioja, La;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
26 Rioja, La;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
26 Rioja, La;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QII;""
26 Rioja, La;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QI;1.673
26 Rioja, La;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
26 Rioja, La;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
26 Rioja, La;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QII;""
26 Rioja, La;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QI;1.764
26 Rioja, La;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
26 Rioja, La;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
26 Rioja, La;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QII;""
26 Rioja, La;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QI;""
26 Rioja, La;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
26 Rioja, La;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
26 Rioja, La;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QII;1.614
26 Rioja, La;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QI;""
26 Rioja, La;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
26 Rioja, La;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
26 Rioja, La;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QII;1.712
26 Rioja, La;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QI;""
26 Rioja, La;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
26 Rioja, La;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
26 Rioja, La;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QII;""
26 Rioja, La;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QI;""
26 Rioja, La;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
26 Rioja, La;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
26 Rioja, La;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
26 Rioja, La;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
26 Rioja, La;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
26 Rioja, La;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
26 Rioja, La;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
26 Rioja, La;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
26 Rioja, La;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
26 Rioja, La;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
26 Rioja, La;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
26 Rioja, La;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
26 Rioja, La;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
26 Rioja, La;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;96,81
26 Rioja, La;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
26 Rioja, La;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
26 Rioja, La;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
26 Rioja, La;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;96,27
26 Rioja, La;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
26 Rioja, La;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
26 Rioja, La;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
26 Rioja, La;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;96,6
26 Rioja, La;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
26 Rioja, La;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
26 Rioja, La;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;93,33
26 Rioja, La;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
26 Rioja, La;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
26 Rioja, La;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
26 Rioja, La;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;92,75
26 Rioja, La;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
26 Rioja, La;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
26 Rioja, La;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
26 Rioja, La;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;92,9
26 Rioja, La;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
26 Rioja, La;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
26 Rioja, La;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
26 Rioja, La;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
26 Rioja, La;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
26 Rioja, La;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
26 Rioja, La;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;90,48
26 Rioja, La;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
26 Rioja, La;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
26 Rioja, La;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
26 Rioja, La;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;90,79
26 Rioja, La;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
26 Rioja, La;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
26 Rioja, La;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
26 Rioja, La;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
26 Rioja, La;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
26 Rioja, La;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
26 Rioja, La;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;87,29
26 Rioja, La;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
26 Rioja, La;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
26 Rioja, La;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
26 Rioja, La;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;88,11
26 Rioja, La;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
26 Rioja, La;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
26 Rioja, La;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
26 Rioja, La;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
26 Rioja, La;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
26 Rioja, La;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
26 Rioja, La;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QIII;1.299
26 Rioja, La;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
26 Rioja, La;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
26 Rioja, La;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
26 Rioja, La;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QIII;1.316
26 Rioja, La;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
26 Rioja, La;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
26 Rioja, La;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
26 Rioja, La;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QIII;1.334
26 Rioja, La;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
26 Rioja, La;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
26 Rioja, La;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
26 Rioja, La;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2022QIII;1.246
26 Rioja, La;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2022QII;""
26 Rioja, La;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2022QI;""
26 Rioja, La;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
26 Rioja, La;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2021QIII;1.283
26 Rioja, La;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2021QII;""
26 Rioja, La;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2021QI;""
26 Rioja, La;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
26 Rioja, La;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2020QIII;1.293
26 Rioja, La;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2020QII;""
26 Rioja, La;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2020QI;""
26 Rioja, La;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2022QIV;1.202
26 Rioja, La;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
26 Rioja, La;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2022QII;""
26 Rioja, La;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2022QI;""
26 Rioja, La;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2021QIV;1.238
26 Rioja, La;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
26 Rioja, La;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2021QII;""
26 Rioja, La;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2021QI;""
26 Rioja, La;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2020QIV;1.250
26 Rioja, La;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
26 Rioja, La;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2020QII;""
26 Rioja, La;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2020QI;""
26 Rioja, La;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
26 Rioja, La;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
26 Rioja, La;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QII;""
26 Rioja, La;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QI;1.198
26 Rioja, La;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
26 Rioja, La;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
26 Rioja, La;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QII;""
26 Rioja, La;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QI;1.225
26 Rioja, La;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
26 Rioja, La;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
26 Rioja, La;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QII;""
26 Rioja, La;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QI;""
26 Rioja, La;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
26 Rioja, La;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
26 Rioja, La;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QII;1.159
26 Rioja, La;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QI;""
26 Rioja, La;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
26 Rioja, La;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
26 Rioja, La;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QII;1.193
26 Rioja, La;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QI;""
26 Rioja, La;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
26 Rioja, La;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
26 Rioja, La;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QII;""
26 Rioja, La;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QI;""
26 Rioja, La;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
26 Rioja, La;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
26 Rioja, La;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
26 Rioja, La;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
26 Rioja, La;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
26 Rioja, La;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
26 Rioja, La;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
26 Rioja, La;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
26 Rioja, La;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
26 Rioja, La;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
26 Rioja, La;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
26 Rioja, La;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
26 Rioja, La;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
26 Rioja, La;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;95,92
26 Rioja, La;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
26 Rioja, La;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
26 Rioja, La;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
26 Rioja, La;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;97,49
26 Rioja, La;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
26 Rioja, La;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
26 Rioja, La;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
26 Rioja, La;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;96,93
26 Rioja, La;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
26 Rioja, La;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
26 Rioja, La;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;92,53
26 Rioja, La;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
26 Rioja, La;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
26 Rioja, La;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
26 Rioja, La;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;94,07
26 Rioja, La;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
26 Rioja, La;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
26 Rioja, La;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
26 Rioja, La;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;93,7
26 Rioja, La;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
26 Rioja, La;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
26 Rioja, La;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
26 Rioja, La;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
26 Rioja, La;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
26 Rioja, La;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
26 Rioja, La;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;91,03
26 Rioja, La;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
26 Rioja, La;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
26 Rioja, La;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
26 Rioja, La;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;91,83
26 Rioja, La;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
26 Rioja, La;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
26 Rioja, La;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
26 Rioja, La;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
26 Rioja, La;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
26 Rioja, La;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
26 Rioja, La;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;88,07
26 Rioja, La;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
26 Rioja, La;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
26 Rioja, La;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
26 Rioja, La;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;89,43
26 Rioja, La;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
26 Rioja, La;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
26 Rioja, La;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
26 Rioja, La;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
26 Rioja, La;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
26 Rioja, La;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QIV;3.037
26 Rioja, La;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
26 Rioja, La;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
26 Rioja, La;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
26 Rioja, La;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QIV;3.211
26 Rioja, La;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
26 Rioja, La;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
26 Rioja, La;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
26 Rioja, La;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QIV;3.314
26 Rioja, La;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
26 Rioja, La;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
26 Rioja, La;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
26 Rioja, La;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2022QIV;2.912
26 Rioja, La;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
26 Rioja, La;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2022QII;""
26 Rioja, La;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2022QI;""
26 Rioja, La;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2021QIV;3.086
26 Rioja, La;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
26 Rioja, La;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2021QII;""
26 Rioja, La;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2021QI;""
26 Rioja, La;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2020QIV;3.180
26 Rioja, La;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
26 Rioja, La;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2020QII;""
26 Rioja, La;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2020QI;""
26 Rioja, La;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
26 Rioja, La;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
26 Rioja, La;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2022QII;""
26 Rioja, La;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2022QI;2.992
26 Rioja, La;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
26 Rioja, La;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
26 Rioja, La;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2021QII;""
26 Rioja, La;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2021QI;3.104
26 Rioja, La;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
26 Rioja, La;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
26 Rioja, La;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2020QII;""
26 Rioja, La;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2020QI;""
26 Rioja, La;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
26 Rioja, La;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
26 Rioja, La;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QII;2.878
26 Rioja, La;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QI;""
26 Rioja, La;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
26 Rioja, La;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
26 Rioja, La;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QII;3.008
26 Rioja, La;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QI;""
26 Rioja, La;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
26 Rioja, La;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
26 Rioja, La;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QII;""
26 Rioja, La;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QI;""
26 Rioja, La;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
26 Rioja, La;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QIII;2.800
26 Rioja, La;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QII;""
26 Rioja, La;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QI;""
26 Rioja, La;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
26 Rioja, La;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QIII;2.951
26 Rioja, La;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QII;""
26 Rioja, La;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QI;""
26 Rioja, La;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
26 Rioja, La;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
26 Rioja, La;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QII;""
26 Rioja, La;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QI;""
26 Rioja, La;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
26 Rioja, La;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
26 Rioja, La;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
26 Rioja, La;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
26 Rioja, La;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
26 Rioja, La;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
26 Rioja, La;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
26 Rioja, La;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
26 Rioja, La;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
26 Rioja, La;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
26 Rioja, La;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
26 Rioja, La;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
26 Rioja, La;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;95,88
26 Rioja, La;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
26 Rioja, La;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
26 Rioja, La;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
26 Rioja, La;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;96,11
26 Rioja, La;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
26 Rioja, La;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
26 Rioja, La;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
26 Rioja, La;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;95,96
26 Rioja, La;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
26 Rioja, La;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
26 Rioja, La;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
26 Rioja, La;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
26 Rioja, La;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
26 Rioja, La;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
26 Rioja, La;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;93,18
26 Rioja, La;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
26 Rioja, La;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
26 Rioja, La;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
26 Rioja, La;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;93,66
26 Rioja, La;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
26 Rioja, La;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
26 Rioja, La;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
26 Rioja, La;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
26 Rioja, La;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
26 Rioja, La;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
26 Rioja, La;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;89,63
26 Rioja, La;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
26 Rioja, La;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
26 Rioja, La;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
26 Rioja, La;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;90,77
26 Rioja, La;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
26 Rioja, La;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
26 Rioja, La;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
26 Rioja, La;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
26 Rioja, La;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
26 Rioja, La;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
26 Rioja, La;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;87,2
26 Rioja, La;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
26 Rioja, La;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
26 Rioja, La;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
26 Rioja, La;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;89,05
26 Rioja, La;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
26 Rioja, La;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
26 Rioja, La;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
26 Rioja, La;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
26 Rioja, La;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
26 Rioja, La;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
26 Rioja, La;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QIV;1.736
26 Rioja, La;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
26 Rioja, La;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
26 Rioja, La;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
26 Rioja, La;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QIV;1.854
26 Rioja, La;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
26 Rioja, La;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
26 Rioja, La;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
26 Rioja, La;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QIV;1.963
26 Rioja, La;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
26 Rioja, La;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
26 Rioja, La;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
26 Rioja, La;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2022QIV;1.660
26 Rioja, La;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
26 Rioja, La;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2022QII;""
26 Rioja, La;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2022QI;""
26 Rioja, La;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2021QIV;1.780
26 Rioja, La;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
26 Rioja, La;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2021QII;""
26 Rioja, La;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2021QI;""
26 Rioja, La;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2020QIV;1.878
26 Rioja, La;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
26 Rioja, La;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2020QII;""
26 Rioja, La;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2020QI;""
26 Rioja, La;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
26 Rioja, La;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
26 Rioja, La;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2022QII;""
26 Rioja, La;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2022QI;1.732
26 Rioja, La;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
26 Rioja, La;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
26 Rioja, La;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2021QII;""
26 Rioja, La;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2021QI;1.834
26 Rioja, La;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
26 Rioja, La;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
26 Rioja, La;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2020QII;""
26 Rioja, La;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2020QI;""
26 Rioja, La;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
26 Rioja, La;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
26 Rioja, La;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QII;1.661
26 Rioja, La;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QI;""
26 Rioja, La;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
26 Rioja, La;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
26 Rioja, La;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QII;1.776
26 Rioja, La;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QI;""
26 Rioja, La;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
26 Rioja, La;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
26 Rioja, La;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QII;""
26 Rioja, La;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QI;""
26 Rioja, La;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
26 Rioja, La;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QIII;1.621
26 Rioja, La;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QII;""
26 Rioja, La;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QI;""
26 Rioja, La;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
26 Rioja, La;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QIII;1.739
26 Rioja, La;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QII;""
26 Rioja, La;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QI;""
26 Rioja, La;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
26 Rioja, La;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
26 Rioja, La;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QII;""
26 Rioja, La;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QI;""
26 Rioja, La;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
26 Rioja, La;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
26 Rioja, La;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
26 Rioja, La;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
26 Rioja, La;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
26 Rioja, La;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
26 Rioja, La;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
26 Rioja, La;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
26 Rioja, La;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
26 Rioja, La;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
26 Rioja, La;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
26 Rioja, La;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
26 Rioja, La;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;95,62
26 Rioja, La;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
26 Rioja, La;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
26 Rioja, La;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
26 Rioja, La;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;96,01
26 Rioja, La;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
26 Rioja, La;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
26 Rioja, La;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
26 Rioja, La;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;95,67
26 Rioja, La;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
26 Rioja, La;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
26 Rioja, La;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
26 Rioja, La;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
26 Rioja, La;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
26 Rioja, La;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
26 Rioja, La;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;93,42
26 Rioja, La;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
26 Rioja, La;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
26 Rioja, La;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
26 Rioja, La;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;93,43
26 Rioja, La;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
26 Rioja, La;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
26 Rioja, La;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
26 Rioja, La;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
26 Rioja, La;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
26 Rioja, La;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
26 Rioja, La;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;89,59
26 Rioja, La;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
26 Rioja, La;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
26 Rioja, La;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
26 Rioja, La;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;90,47
26 Rioja, La;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
26 Rioja, La;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
26 Rioja, La;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
26 Rioja, La;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
26 Rioja, La;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
26 Rioja, La;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
26 Rioja, La;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;87,43
26 Rioja, La;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
26 Rioja, La;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
26 Rioja, La;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
26 Rioja, La;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;88,59
26 Rioja, La;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
26 Rioja, La;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
26 Rioja, La;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
26 Rioja, La;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
26 Rioja, La;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
26 Rioja, La;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
26 Rioja, La;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QIV;1.301
26 Rioja, La;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
26 Rioja, La;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
26 Rioja, La;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
26 Rioja, La;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QIV;1.357
26 Rioja, La;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
26 Rioja, La;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
26 Rioja, La;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
26 Rioja, La;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QIV;1.351
26 Rioja, La;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
26 Rioja, La;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
26 Rioja, La;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
26 Rioja, La;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2022QIV;1.252
26 Rioja, La;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
26 Rioja, La;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2022QII;""
26 Rioja, La;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2022QI;""
26 Rioja, La;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2021QIV;1.306
26 Rioja, La;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
26 Rioja, La;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2021QII;""
26 Rioja, La;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2021QI;""
26 Rioja, La;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2020QIV;1.302
26 Rioja, La;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
26 Rioja, La;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2020QII;""
26 Rioja, La;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2020QI;""
26 Rioja, La;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
26 Rioja, La;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
26 Rioja, La;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2022QII;""
26 Rioja, La;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2022QI;1.260
26 Rioja, La;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
26 Rioja, La;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
26 Rioja, La;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2021QII;""
26 Rioja, La;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2021QI;1.270
26 Rioja, La;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
26 Rioja, La;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
26 Rioja, La;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2020QII;""
26 Rioja, La;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2020QI;""
26 Rioja, La;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
26 Rioja, La;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
26 Rioja, La;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QII;1.217
26 Rioja, La;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QI;""
26 Rioja, La;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
26 Rioja, La;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
26 Rioja, La;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QII;1.232
26 Rioja, La;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QI;""
26 Rioja, La;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
26 Rioja, La;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
26 Rioja, La;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QII;""
26 Rioja, La;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QI;""
26 Rioja, La;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
26 Rioja, La;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QIII;1.179
26 Rioja, La;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QII;""
26 Rioja, La;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QI;""
26 Rioja, La;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
26 Rioja, La;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QIII;1.212
26 Rioja, La;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QII;""
26 Rioja, La;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QI;""
26 Rioja, La;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
26 Rioja, La;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
26 Rioja, La;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QII;""
26 Rioja, La;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QI;""
26 Rioja, La;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
26 Rioja, La;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
26 Rioja, La;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
26 Rioja, La;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
26 Rioja, La;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
26 Rioja, La;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
26 Rioja, La;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
26 Rioja, La;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
26 Rioja, La;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
26 Rioja, La;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
26 Rioja, La;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
26 Rioja, La;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
26 Rioja, La;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;96,23
26 Rioja, La;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
26 Rioja, La;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
26 Rioja, La;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
26 Rioja, La;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;96,24
26 Rioja, La;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
26 Rioja, La;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
26 Rioja, La;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
26 Rioja, La;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;96,37
26 Rioja, La;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
26 Rioja, La;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
26 Rioja, La;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
26 Rioja, La;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
26 Rioja, La;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
26 Rioja, La;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
26 Rioja, La;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;92,85
26 Rioja, La;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
26 Rioja, La;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
26 Rioja, La;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
26 Rioja, La;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;94
26 Rioja, La;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
26 Rioja, La;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
26 Rioja, La;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
26 Rioja, La;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
26 Rioja, La;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
26 Rioja, La;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
26 Rioja, La;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;89,68
26 Rioja, La;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
26 Rioja, La;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
26 Rioja, La;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
26 Rioja, La;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;91,19
26 Rioja, La;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
26 Rioja, La;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
26 Rioja, La;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
26 Rioja, La;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
26 Rioja, La;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
26 Rioja, La;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
26 Rioja, La;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;86,88
26 Rioja, La;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
26 Rioja, La;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
26 Rioja, La;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
26 Rioja, La;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;89,71
26 Rioja, La;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
26 Rioja, La;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
26 Rioja, La;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
26 Rioja, La;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
26 Rioja, La;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
26 Rioja, La;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
26 Rioja, La;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
26 Rioja, La;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
26 Rioja, La;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
26 Rioja, La;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QI;6.448
26 Rioja, La;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
26 Rioja, La;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
26 Rioja, La;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
26 Rioja, La;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QI;6.597
26 Rioja, La;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
26 Rioja, La;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
26 Rioja, La;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
26 Rioja, La;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QI;6.625
26 Rioja, La;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
26 Rioja, La;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
26 Rioja, La;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2022QII;""
26 Rioja, La;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2022QI;6.307
26 Rioja, La;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
26 Rioja, La;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
26 Rioja, La;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2021QII;""
26 Rioja, La;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2021QI;6.470
26 Rioja, La;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
26 Rioja, La;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
26 Rioja, La;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2020QII;""
26 Rioja, La;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2020QI;6.303
26 Rioja, La;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
26 Rioja, La;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
26 Rioja, La;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2022QII;6.167
26 Rioja, La;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2022QI;""
26 Rioja, La;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
26 Rioja, La;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
26 Rioja, La;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2021QII;6.340
26 Rioja, La;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2021QI;""
26 Rioja, La;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
26 Rioja, La;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
26 Rioja, La;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2020QII;6.219
26 Rioja, La;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2020QI;""
26 Rioja, La;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
26 Rioja, La;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QIII;6.046
26 Rioja, La;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QII;""
26 Rioja, La;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QI;""
26 Rioja, La;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
26 Rioja, La;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QIII;6.221
26 Rioja, La;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QII;""
26 Rioja, La;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QI;""
26 Rioja, La;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
26 Rioja, La;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QIII;6.108
26 Rioja, La;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QII;""
26 Rioja, La;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QI;""
26 Rioja, La;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QIV;5.915
26 Rioja, La;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
26 Rioja, La;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QII;""
26 Rioja, La;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QI;""
26 Rioja, La;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QIV;6.096
26 Rioja, La;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
26 Rioja, La;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QII;""
26 Rioja, La;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QI;""
26 Rioja, La;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QIV;6.004
26 Rioja, La;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
26 Rioja, La;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QII;""
26 Rioja, La;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QI;""
26 Rioja, La;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
26 Rioja, La;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
26 Rioja, La;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
26 Rioja, La;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
26 Rioja, La;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
26 Rioja, La;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
26 Rioja, La;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
26 Rioja, La;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
26 Rioja, La;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
26 Rioja, La;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
26 Rioja, La;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
26 Rioja, La;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
26 Rioja, La;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
26 Rioja, La;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
26 Rioja, La;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
26 Rioja, La;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;97,81
26 Rioja, La;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
26 Rioja, La;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
26 Rioja, La;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
26 Rioja, La;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;98,07
26 Rioja, La;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
26 Rioja, La;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
26 Rioja, La;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
26 Rioja, La;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;95,14
26 Rioja, La;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
26 Rioja, La;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
26 Rioja, La;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;95,64
26 Rioja, La;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
26 Rioja, La;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
26 Rioja, La;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
26 Rioja, La;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;96,1
26 Rioja, La;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
26 Rioja, La;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
26 Rioja, La;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
26 Rioja, La;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;93,87
26 Rioja, La;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
26 Rioja, La;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
26 Rioja, La;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;93,77
26 Rioja, La;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
26 Rioja, La;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
26 Rioja, La;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
26 Rioja, La;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;94,3
26 Rioja, La;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
26 Rioja, La;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
26 Rioja, La;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
26 Rioja, La;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;92,2
26 Rioja, La;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
26 Rioja, La;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
26 Rioja, La;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;91,73
26 Rioja, La;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
26 Rioja, La;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
26 Rioja, La;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
26 Rioja, La;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;92,41
26 Rioja, La;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
26 Rioja, La;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
26 Rioja, La;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
26 Rioja, La;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;90,63
26 Rioja, La;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
26 Rioja, La;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
26 Rioja, La;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
26 Rioja, La;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
26 Rioja, La;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
26 Rioja, La;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
26 Rioja, La;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QI;4.087
26 Rioja, La;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
26 Rioja, La;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
26 Rioja, La;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
26 Rioja, La;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QI;4.192
26 Rioja, La;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
26 Rioja, La;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
26 Rioja, La;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
26 Rioja, La;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QI;4.213
26 Rioja, La;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
26 Rioja, La;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
26 Rioja, La;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2022QII;""
26 Rioja, La;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2022QI;3.988
26 Rioja, La;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
26 Rioja, La;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
26 Rioja, La;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2021QII;""
26 Rioja, La;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2021QI;4.108
26 Rioja, La;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
26 Rioja, La;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
26 Rioja, La;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2020QII;""
26 Rioja, La;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2020QI;3.993
26 Rioja, La;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
26 Rioja, La;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
26 Rioja, La;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2022QII;3.899
26 Rioja, La;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2022QI;""
26 Rioja, La;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
26 Rioja, La;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
26 Rioja, La;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2021QII;4.041
26 Rioja, La;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2021QI;""
26 Rioja, La;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
26 Rioja, La;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
26 Rioja, La;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2020QII;3.944
26 Rioja, La;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2020QI;""
26 Rioja, La;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
26 Rioja, La;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QIII;3.841
26 Rioja, La;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QII;""
26 Rioja, La;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QI;""
26 Rioja, La;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
26 Rioja, La;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QIII;3.967
26 Rioja, La;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QII;""
26 Rioja, La;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QI;""
26 Rioja, La;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
26 Rioja, La;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QIII;3.884
26 Rioja, La;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QII;""
26 Rioja, La;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QI;""
26 Rioja, La;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QIV;3.756
26 Rioja, La;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
26 Rioja, La;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QII;""
26 Rioja, La;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QI;""
26 Rioja, La;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QIV;3.888
26 Rioja, La;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
26 Rioja, La;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QII;""
26 Rioja, La;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QI;""
26 Rioja, La;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QIV;3.826
26 Rioja, La;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
26 Rioja, La;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QII;""
26 Rioja, La;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QI;""
26 Rioja, La;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
26 Rioja, La;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
26 Rioja, La;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
26 Rioja, La;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
26 Rioja, La;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
26 Rioja, La;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
26 Rioja, La;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
26 Rioja, La;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
26 Rioja, La;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
26 Rioja, La;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
26 Rioja, La;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
26 Rioja, La;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
26 Rioja, La;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
26 Rioja, La;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
26 Rioja, La;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
26 Rioja, La;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;97,58
26 Rioja, La;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
26 Rioja, La;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
26 Rioja, La;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
26 Rioja, La;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;98
26 Rioja, La;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
26 Rioja, La;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
26 Rioja, La;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
26 Rioja, La;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;94,78
26 Rioja, La;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
26 Rioja, La;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
26 Rioja, La;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;95,4
26 Rioja, La;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
26 Rioja, La;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
26 Rioja, La;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
26 Rioja, La;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;96,4
26 Rioja, La;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
26 Rioja, La;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
26 Rioja, La;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
26 Rioja, La;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;93,62
26 Rioja, La;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
26 Rioja, La;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
26 Rioja, La;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;93,98
26 Rioja, La;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
26 Rioja, La;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
26 Rioja, La;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
26 Rioja, La;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;94,63
26 Rioja, La;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
26 Rioja, La;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
26 Rioja, La;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
26 Rioja, La;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;92,19
26 Rioja, La;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
26 Rioja, La;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
26 Rioja, La;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;91,9
26 Rioja, La;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
26 Rioja, La;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
26 Rioja, La;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
26 Rioja, La;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;92,75
26 Rioja, La;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
26 Rioja, La;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
26 Rioja, La;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
26 Rioja, La;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;90,81
26 Rioja, La;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
26 Rioja, La;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
26 Rioja, La;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
26 Rioja, La;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
26 Rioja, La;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
26 Rioja, La;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
26 Rioja, La;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QI;2.361
26 Rioja, La;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
26 Rioja, La;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
26 Rioja, La;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
26 Rioja, La;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QI;2.405
26 Rioja, La;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
26 Rioja, La;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
26 Rioja, La;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
26 Rioja, La;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QI;2.412
26 Rioja, La;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
26 Rioja, La;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
26 Rioja, La;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2022QII;""
26 Rioja, La;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2022QI;2.319
26 Rioja, La;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
26 Rioja, La;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
26 Rioja, La;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2021QII;""
26 Rioja, La;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2021QI;2.362
26 Rioja, La;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
26 Rioja, La;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
26 Rioja, La;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2020QII;""
26 Rioja, La;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2020QI;2.310
26 Rioja, La;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
26 Rioja, La;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
26 Rioja, La;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2022QII;2.268
26 Rioja, La;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2022QI;""
26 Rioja, La;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
26 Rioja, La;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
26 Rioja, La;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2021QII;2.299
26 Rioja, La;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2021QI;""
26 Rioja, La;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
26 Rioja, La;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
26 Rioja, La;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2020QII;2.275
26 Rioja, La;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2020QI;""
26 Rioja, La;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
26 Rioja, La;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QIII;2.205
26 Rioja, La;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QII;""
26 Rioja, La;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QI;""
26 Rioja, La;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
26 Rioja, La;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QIII;2.254
26 Rioja, La;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QII;""
26 Rioja, La;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QI;""
26 Rioja, La;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
26 Rioja, La;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QIII;2.224
26 Rioja, La;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QII;""
26 Rioja, La;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QI;""
26 Rioja, La;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QIV;2.159
26 Rioja, La;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
26 Rioja, La;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QII;""
26 Rioja, La;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QI;""
26 Rioja, La;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QIV;2.208
26 Rioja, La;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
26 Rioja, La;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QII;""
26 Rioja, La;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QI;""
26 Rioja, La;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QIV;2.178
26 Rioja, La;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
26 Rioja, La;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QII;""
26 Rioja, La;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QI;""
26 Rioja, La;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
26 Rioja, La;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
26 Rioja, La;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
26 Rioja, La;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
26 Rioja, La;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
26 Rioja, La;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
26 Rioja, La;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
26 Rioja, La;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
26 Rioja, La;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
26 Rioja, La;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
26 Rioja, La;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
26 Rioja, La;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
26 Rioja, La;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
26 Rioja, La;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
26 Rioja, La;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
26 Rioja, La;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;98,22
26 Rioja, La;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
26 Rioja, La;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
26 Rioja, La;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
26 Rioja, La;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;98,21
26 Rioja, La;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
26 Rioja, La;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
26 Rioja, La;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
26 Rioja, La;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;95,77
26 Rioja, La;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
26 Rioja, La;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
26 Rioja, La;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;96,06
26 Rioja, La;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
26 Rioja, La;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
26 Rioja, La;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
26 Rioja, La;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;95,59
26 Rioja, La;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
26 Rioja, La;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
26 Rioja, La;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
26 Rioja, La;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;94,32
26 Rioja, La;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
26 Rioja, La;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
26 Rioja, La;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;93,39
26 Rioja, La;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
26 Rioja, La;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
26 Rioja, La;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
26 Rioja, La;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;93,72
26 Rioja, La;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
26 Rioja, La;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
26 Rioja, La;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
26 Rioja, La;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;92,21
26 Rioja, La;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
26 Rioja, La;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
26 Rioja, La;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;91,44
26 Rioja, La;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
26 Rioja, La;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
26 Rioja, La;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
26 Rioja, La;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;91,81
26 Rioja, La;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
26 Rioja, La;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
26 Rioja, La;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
26 Rioja, La;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;90,3
26 Rioja, La;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
26 Rioja, La;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
26 Rioja, La;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
26 Rioja, La;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
26 Rioja, La;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
26 Rioja, La;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QII;6.287
26 Rioja, La;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
26 Rioja, La;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
26 Rioja, La;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
26 Rioja, La;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QII;6.431
26 Rioja, La;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
26 Rioja, La;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
26 Rioja, La;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
26 Rioja, La;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QII;6.525
26 Rioja, La;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
26 Rioja, La;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
26 Rioja, La;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
26 Rioja, La;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2022QII;6.124
26 Rioja, La;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2022QI;""
26 Rioja, La;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
26 Rioja, La;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
26 Rioja, La;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2021QII;6.267
26 Rioja, La;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2021QI;""
26 Rioja, La;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
26 Rioja, La;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
26 Rioja, La;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2020QII;6.428
26 Rioja, La;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2020QI;""
26 Rioja, La;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
26 Rioja, La;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2022QIII;5.983
26 Rioja, La;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2022QII;""
26 Rioja, La;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2022QI;""
26 Rioja, La;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
26 Rioja, La;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2021QIII;6.135
26 Rioja, La;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2021QII;""
26 Rioja, La;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2021QI;""
26 Rioja, La;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
26 Rioja, La;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2020QIII;6.300
26 Rioja, La;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2020QII;""
26 Rioja, La;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2020QI;""
26 Rioja, La;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QIV;5.827
26 Rioja, La;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
26 Rioja, La;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QII;""
26 Rioja, La;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QI;""
26 Rioja, La;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QIV;6.005
26 Rioja, La;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
26 Rioja, La;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QII;""
26 Rioja, La;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QI;""
26 Rioja, La;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QIV;6.183
26 Rioja, La;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
26 Rioja, La;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QII;""
26 Rioja, La;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QI;""
26 Rioja, La;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
26 Rioja, La;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
26 Rioja, La;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QII;""
26 Rioja, La;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QI;5.890
26 Rioja, La;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
26 Rioja, La;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
26 Rioja, La;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QII;""
26 Rioja, La;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QI;6.082
26 Rioja, La;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
26 Rioja, La;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
26 Rioja, La;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QII;""
26 Rioja, La;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QI;""
26 Rioja, La;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
26 Rioja, La;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
26 Rioja, La;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
26 Rioja, La;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
26 Rioja, La;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
26 Rioja, La;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
26 Rioja, La;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
26 Rioja, La;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
26 Rioja, La;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
26 Rioja, La;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
26 Rioja, La;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
26 Rioja, La;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
26 Rioja, La;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
26 Rioja, La;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
26 Rioja, La;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;97,41
26 Rioja, La;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
26 Rioja, La;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
26 Rioja, La;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
26 Rioja, La;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;97,45
26 Rioja, La;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
26 Rioja, La;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
26 Rioja, La;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
26 Rioja, La;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;98,51
26 Rioja, La;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
26 Rioja, La;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
26 Rioja, La;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;95,16
26 Rioja, La;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
26 Rioja, La;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
26 Rioja, La;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
26 Rioja, La;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;95,4
26 Rioja, La;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
26 Rioja, La;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
26 Rioja, La;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
26 Rioja, La;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;96,55
26 Rioja, La;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
26 Rioja, La;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
26 Rioja, La;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;92,68
26 Rioja, La;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
26 Rioja, La;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
26 Rioja, La;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
26 Rioja, La;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;93,38
26 Rioja, La;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
26 Rioja, La;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
26 Rioja, La;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
26 Rioja, La;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;94,76
26 Rioja, La;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
26 Rioja, La;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
26 Rioja, La;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
26 Rioja, La;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
26 Rioja, La;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
26 Rioja, La;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
26 Rioja, La;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;91,59
26 Rioja, La;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
26 Rioja, La;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
26 Rioja, La;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
26 Rioja, La;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;93,21
26 Rioja, La;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
26 Rioja, La;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
26 Rioja, La;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
26 Rioja, La;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
26 Rioja, La;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
26 Rioja, La;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
26 Rioja, La;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QII;3.967
26 Rioja, La;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
26 Rioja, La;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
26 Rioja, La;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
26 Rioja, La;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QII;4.088
26 Rioja, La;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
26 Rioja, La;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
26 Rioja, La;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
26 Rioja, La;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QII;4.141
26 Rioja, La;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
26 Rioja, La;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
26 Rioja, La;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
26 Rioja, La;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2022QII;3.863
26 Rioja, La;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2022QI;""
26 Rioja, La;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
26 Rioja, La;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
26 Rioja, La;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2021QII;3.994
26 Rioja, La;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2021QI;""
26 Rioja, La;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
26 Rioja, La;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
26 Rioja, La;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2020QII;4.084
26 Rioja, La;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2020QI;""
26 Rioja, La;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
26 Rioja, La;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2022QIII;3.789
26 Rioja, La;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2022QII;""
26 Rioja, La;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2022QI;""
26 Rioja, La;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
26 Rioja, La;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2021QIII;3.907
26 Rioja, La;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2021QII;""
26 Rioja, La;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2021QI;""
26 Rioja, La;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
26 Rioja, La;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2020QIII;4.010
26 Rioja, La;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2020QII;""
26 Rioja, La;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2020QI;""
26 Rioja, La;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QIV;3.691
26 Rioja, La;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
26 Rioja, La;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QII;""
26 Rioja, La;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QI;""
26 Rioja, La;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QIV;3.822
26 Rioja, La;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
26 Rioja, La;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QII;""
26 Rioja, La;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QI;""
26 Rioja, La;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QIV;3.941
26 Rioja, La;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
26 Rioja, La;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QII;""
26 Rioja, La;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QI;""
26 Rioja, La;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
26 Rioja, La;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
26 Rioja, La;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QII;""
26 Rioja, La;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QI;3.745
26 Rioja, La;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
26 Rioja, La;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
26 Rioja, La;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QII;""
26 Rioja, La;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QI;3.875
26 Rioja, La;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
26 Rioja, La;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
26 Rioja, La;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QII;""
26 Rioja, La;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QI;""
26 Rioja, La;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
26 Rioja, La;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
26 Rioja, La;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
26 Rioja, La;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
26 Rioja, La;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
26 Rioja, La;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
26 Rioja, La;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
26 Rioja, La;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
26 Rioja, La;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
26 Rioja, La;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
26 Rioja, La;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
26 Rioja, La;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
26 Rioja, La;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
26 Rioja, La;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
26 Rioja, La;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;97,38
26 Rioja, La;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
26 Rioja, La;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
26 Rioja, La;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
26 Rioja, La;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;97,7
26 Rioja, La;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
26 Rioja, La;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
26 Rioja, La;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
26 Rioja, La;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;98,62
26 Rioja, La;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
26 Rioja, La;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
26 Rioja, La;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;95,51
26 Rioja, La;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
26 Rioja, La;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
26 Rioja, La;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
26 Rioja, La;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;95,57
26 Rioja, La;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
26 Rioja, La;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
26 Rioja, La;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
26 Rioja, La;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;96,84
26 Rioja, La;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
26 Rioja, La;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
26 Rioja, La;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;93,04
26 Rioja, La;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
26 Rioja, La;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
26 Rioja, La;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
26 Rioja, La;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;93,49
26 Rioja, La;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
26 Rioja, La;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
26 Rioja, La;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
26 Rioja, La;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;95,17
26 Rioja, La;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
26 Rioja, La;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
26 Rioja, La;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
26 Rioja, La;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
26 Rioja, La;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
26 Rioja, La;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
26 Rioja, La;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;91,61
26 Rioja, La;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
26 Rioja, La;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
26 Rioja, La;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
26 Rioja, La;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;93,58
26 Rioja, La;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
26 Rioja, La;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
26 Rioja, La;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
26 Rioja, La;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
26 Rioja, La;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
26 Rioja, La;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
26 Rioja, La;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QII;2.320
26 Rioja, La;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
26 Rioja, La;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
26 Rioja, La;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
26 Rioja, La;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QII;2.343
26 Rioja, La;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
26 Rioja, La;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
26 Rioja, La;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
26 Rioja, La;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QII;2.384
26 Rioja, La;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
26 Rioja, La;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
26 Rioja, La;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
26 Rioja, La;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2022QII;2.261
26 Rioja, La;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2022QI;""
26 Rioja, La;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
26 Rioja, La;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
26 Rioja, La;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2021QII;2.273
26 Rioja, La;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2021QI;""
26 Rioja, La;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
26 Rioja, La;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
26 Rioja, La;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2020QII;2.344
26 Rioja, La;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2020QI;""
26 Rioja, La;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
26 Rioja, La;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2022QIII;2.194
26 Rioja, La;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2022QII;""
26 Rioja, La;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2022QI;""
26 Rioja, La;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
26 Rioja, La;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2021QIII;2.228
26 Rioja, La;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2021QII;""
26 Rioja, La;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2021QI;""
26 Rioja, La;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
26 Rioja, La;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2020QIII;2.290
26 Rioja, La;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2020QII;""
26 Rioja, La;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2020QI;""
26 Rioja, La;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QIV;2.136
26 Rioja, La;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
26 Rioja, La;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QII;""
26 Rioja, La;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QI;""
26 Rioja, La;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QIV;2.183
26 Rioja, La;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
26 Rioja, La;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QII;""
26 Rioja, La;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QI;""
26 Rioja, La;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QIV;2.242
26 Rioja, La;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
26 Rioja, La;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QII;""
26 Rioja, La;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QI;""
26 Rioja, La;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
26 Rioja, La;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
26 Rioja, La;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QII;""
26 Rioja, La;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QI;2.145
26 Rioja, La;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
26 Rioja, La;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
26 Rioja, La;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QII;""
26 Rioja, La;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QI;2.207
26 Rioja, La;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
26 Rioja, La;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
26 Rioja, La;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QII;""
26 Rioja, La;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QI;""
26 Rioja, La;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
26 Rioja, La;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
26 Rioja, La;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
26 Rioja, La;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
26 Rioja, La;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
26 Rioja, La;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
26 Rioja, La;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
26 Rioja, La;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
26 Rioja, La;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
26 Rioja, La;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
26 Rioja, La;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
26 Rioja, La;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
26 Rioja, La;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
26 Rioja, La;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
26 Rioja, La;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;97,46
26 Rioja, La;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
26 Rioja, La;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
26 Rioja, La;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
26 Rioja, La;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;97,01
26 Rioja, La;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
26 Rioja, La;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
26 Rioja, La;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
26 Rioja, La;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;98,32
26 Rioja, La;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
26 Rioja, La;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
26 Rioja, La;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;94,57
26 Rioja, La;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
26 Rioja, La;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
26 Rioja, La;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
26 Rioja, La;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;95,09
26 Rioja, La;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
26 Rioja, La;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
26 Rioja, La;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
26 Rioja, La;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;96,06
26 Rioja, La;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
26 Rioja, La;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
26 Rioja, La;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;92,07
26 Rioja, La;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
26 Rioja, La;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
26 Rioja, La;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
26 Rioja, La;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;93,17
26 Rioja, La;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
26 Rioja, La;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
26 Rioja, La;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
26 Rioja, La;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;94,04
26 Rioja, La;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
26 Rioja, La;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
26 Rioja, La;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
26 Rioja, La;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
26 Rioja, La;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
26 Rioja, La;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
26 Rioja, La;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;91,55
26 Rioja, La;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
26 Rioja, La;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
26 Rioja, La;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
26 Rioja, La;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;92,58
26 Rioja, La;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
26 Rioja, La;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
26 Rioja, La;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
26 Rioja, La;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
26 Rioja, La;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
26 Rioja, La;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QIII;6.302
26 Rioja, La;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
26 Rioja, La;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
26 Rioja, La;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
26 Rioja, La;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QIII;6.446
26 Rioja, La;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
26 Rioja, La;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
26 Rioja, La;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
26 Rioja, La;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QIII;6.570
26 Rioja, La;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
26 Rioja, La;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
26 Rioja, La;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
26 Rioja, La;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2022QIII;6.128
26 Rioja, La;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2022QII;""
26 Rioja, La;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2022QI;""
26 Rioja, La;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
26 Rioja, La;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2021QIII;6.287
26 Rioja, La;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2021QII;""
26 Rioja, La;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2021QI;""
26 Rioja, La;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
26 Rioja, La;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2020QIII;6.420
26 Rioja, La;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2020QII;""
26 Rioja, La;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2020QI;""
26 Rioja, La;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2022QIV;5.950
26 Rioja, La;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
26 Rioja, La;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2022QII;""
26 Rioja, La;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2022QI;""
26 Rioja, La;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2021QIV;6.138
26 Rioja, La;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
26 Rioja, La;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2021QII;""
26 Rioja, La;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2021QI;""
26 Rioja, La;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2020QIV;6.288
26 Rioja, La;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
26 Rioja, La;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2020QII;""
26 Rioja, La;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2020QI;""
26 Rioja, La;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
26 Rioja, La;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
26 Rioja, La;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QII;""
26 Rioja, La;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QI;6.017
26 Rioja, La;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
26 Rioja, La;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
26 Rioja, La;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QII;""
26 Rioja, La;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QI;6.179
26 Rioja, La;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
26 Rioja, La;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
26 Rioja, La;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QII;""
26 Rioja, La;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QI;""
26 Rioja, La;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
26 Rioja, La;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
26 Rioja, La;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QII;5.905
26 Rioja, La;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QI;""
26 Rioja, La;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
26 Rioja, La;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
26 Rioja, La;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QII;6.075
26 Rioja, La;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QI;""
26 Rioja, La;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
26 Rioja, La;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
26 Rioja, La;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QII;""
26 Rioja, La;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QI;""
26 Rioja, La;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
26 Rioja, La;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
26 Rioja, La;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
26 Rioja, La;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
26 Rioja, La;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
26 Rioja, La;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
26 Rioja, La;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
26 Rioja, La;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
26 Rioja, La;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
26 Rioja, La;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
26 Rioja, La;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
26 Rioja, La;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
26 Rioja, La;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
26 Rioja, La;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;97,24
26 Rioja, La;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
26 Rioja, La;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
26 Rioja, La;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
26 Rioja, La;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;97,53
26 Rioja, La;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
26 Rioja, La;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
26 Rioja, La;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
26 Rioja, La;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;97,72
26 Rioja, La;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
26 Rioja, La;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
26 Rioja, La;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;94,41
26 Rioja, La;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
26 Rioja, La;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
26 Rioja, La;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
26 Rioja, La;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;95,22
26 Rioja, La;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
26 Rioja, La;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
26 Rioja, La;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
26 Rioja, La;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;95,71
26 Rioja, La;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
26 Rioja, La;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
26 Rioja, La;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
26 Rioja, La;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
26 Rioja, La;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
26 Rioja, La;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
26 Rioja, La;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;93,34
26 Rioja, La;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
26 Rioja, La;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
26 Rioja, La;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
26 Rioja, La;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;94,05
26 Rioja, La;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
26 Rioja, La;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
26 Rioja, La;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
26 Rioja, La;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
26 Rioja, La;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
26 Rioja, La;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
26 Rioja, La;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;91,61
26 Rioja, La;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
26 Rioja, La;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
26 Rioja, La;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
26 Rioja, La;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;92,47
26 Rioja, La;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
26 Rioja, La;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
26 Rioja, La;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
26 Rioja, La;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
26 Rioja, La;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
26 Rioja, La;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
26 Rioja, La;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QIII;3.961
26 Rioja, La;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
26 Rioja, La;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
26 Rioja, La;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
26 Rioja, La;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QIII;4.103
26 Rioja, La;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
26 Rioja, La;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
26 Rioja, La;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
26 Rioja, La;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QIII;4.183
26 Rioja, La;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
26 Rioja, La;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
26 Rioja, La;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
26 Rioja, La;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2022QIII;3.866
26 Rioja, La;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2022QII;""
26 Rioja, La;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2022QI;""
26 Rioja, La;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
26 Rioja, La;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2021QIII;3.998
26 Rioja, La;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2021QII;""
26 Rioja, La;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2021QI;""
26 Rioja, La;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
26 Rioja, La;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2020QIII;4.097
26 Rioja, La;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2020QII;""
26 Rioja, La;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2020QI;""
26 Rioja, La;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2022QIV;3.755
26 Rioja, La;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
26 Rioja, La;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2022QII;""
26 Rioja, La;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2022QI;""
26 Rioja, La;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2021QIV;3.901
26 Rioja, La;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
26 Rioja, La;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2021QII;""
26 Rioja, La;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2021QI;""
26 Rioja, La;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2020QIV;4.018
26 Rioja, La;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
26 Rioja, La;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2020QII;""
26 Rioja, La;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2020QI;""
26 Rioja, La;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
26 Rioja, La;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
26 Rioja, La;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QII;""
26 Rioja, La;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QI;3.818
26 Rioja, La;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
26 Rioja, La;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
26 Rioja, La;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QII;""
26 Rioja, La;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QI;3.945
26 Rioja, La;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
26 Rioja, La;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
26 Rioja, La;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QII;""
26 Rioja, La;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QI;""
26 Rioja, La;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
26 Rioja, La;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
26 Rioja, La;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QII;3.748
26 Rioja, La;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QI;""
26 Rioja, La;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
26 Rioja, La;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
26 Rioja, La;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QII;3.888
26 Rioja, La;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QI;""
26 Rioja, La;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
26 Rioja, La;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
26 Rioja, La;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QII;""
26 Rioja, La;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QI;""
26 Rioja, La;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
26 Rioja, La;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
26 Rioja, La;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
26 Rioja, La;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
26 Rioja, La;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
26 Rioja, La;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
26 Rioja, La;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
26 Rioja, La;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
26 Rioja, La;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
26 Rioja, La;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
26 Rioja, La;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
26 Rioja, La;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
26 Rioja, La;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
26 Rioja, La;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;97,6
26 Rioja, La;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
26 Rioja, La;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
26 Rioja, La;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
26 Rioja, La;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;97,44
26 Rioja, La;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
26 Rioja, La;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
26 Rioja, La;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
26 Rioja, La;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;97,94
26 Rioja, La;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
26 Rioja, La;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
26 Rioja, La;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;94,8
26 Rioja, La;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
26 Rioja, La;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
26 Rioja, La;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
26 Rioja, La;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;95,08
26 Rioja, La;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
26 Rioja, La;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
26 Rioja, La;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
26 Rioja, La;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;96,06
26 Rioja, La;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
26 Rioja, La;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
26 Rioja, La;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
26 Rioja, La;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
26 Rioja, La;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
26 Rioja, La;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
26 Rioja, La;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;93,05
26 Rioja, La;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
26 Rioja, La;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
26 Rioja, La;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
26 Rioja, La;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;94,31
26 Rioja, La;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
26 Rioja, La;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
26 Rioja, La;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
26 Rioja, La;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
26 Rioja, La;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
26 Rioja, La;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
26 Rioja, La;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;91,35
26 Rioja, La;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
26 Rioja, La;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
26 Rioja, La;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
26 Rioja, La;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;92,95
26 Rioja, La;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
26 Rioja, La;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
26 Rioja, La;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
26 Rioja, La;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
26 Rioja, La;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
26 Rioja, La;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
26 Rioja, La;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QIII;2.341
26 Rioja, La;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
26 Rioja, La;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
26 Rioja, La;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
26 Rioja, La;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QIII;2.343
26 Rioja, La;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
26 Rioja, La;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
26 Rioja, La;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
26 Rioja, La;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QIII;2.387
26 Rioja, La;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
26 Rioja, La;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
26 Rioja, La;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
26 Rioja, La;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2022QIII;2.262
26 Rioja, La;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2022QII;""
26 Rioja, La;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2022QI;""
26 Rioja, La;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
26 Rioja, La;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2021QIII;2.289
26 Rioja, La;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2021QII;""
26 Rioja, La;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2021QI;""
26 Rioja, La;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
26 Rioja, La;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2020QIII;2.323
26 Rioja, La;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2020QII;""
26 Rioja, La;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2020QI;""
26 Rioja, La;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2022QIV;2.195
26 Rioja, La;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
26 Rioja, La;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2022QII;""
26 Rioja, La;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2022QI;""
26 Rioja, La;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2021QIV;2.237
26 Rioja, La;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
26 Rioja, La;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2021QII;""
26 Rioja, La;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2021QI;""
26 Rioja, La;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2020QIV;2.270
26 Rioja, La;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
26 Rioja, La;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2020QII;""
26 Rioja, La;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2020QI;""
26 Rioja, La;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
26 Rioja, La;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
26 Rioja, La;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QII;""
26 Rioja, La;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QI;2.199
26 Rioja, La;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
26 Rioja, La;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
26 Rioja, La;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QII;""
26 Rioja, La;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QI;2.234
26 Rioja, La;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
26 Rioja, La;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
26 Rioja, La;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QII;""
26 Rioja, La;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QI;""
26 Rioja, La;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
26 Rioja, La;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
26 Rioja, La;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QII;2.157
26 Rioja, La;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QI;""
26 Rioja, La;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
26 Rioja, La;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
26 Rioja, La;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QII;2.187
26 Rioja, La;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QI;""
26 Rioja, La;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
26 Rioja, La;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
26 Rioja, La;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QII;""
26 Rioja, La;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QI;""
26 Rioja, La;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
26 Rioja, La;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
26 Rioja, La;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
26 Rioja, La;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
26 Rioja, La;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
26 Rioja, La;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
26 Rioja, La;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
26 Rioja, La;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
26 Rioja, La;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
26 Rioja, La;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
26 Rioja, La;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
26 Rioja, La;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
26 Rioja, La;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
26 Rioja, La;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;96,63
26 Rioja, La;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
26 Rioja, La;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
26 Rioja, La;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
26 Rioja, La;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;97,7
26 Rioja, La;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
26 Rioja, La;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
26 Rioja, La;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
26 Rioja, La;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;97,32
26 Rioja, La;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
26 Rioja, La;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
26 Rioja, La;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;93,76
26 Rioja, La;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
26 Rioja, La;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
26 Rioja, La;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
26 Rioja, La;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;95,48
26 Rioja, La;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
26 Rioja, La;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
26 Rioja, La;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
26 Rioja, La;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;95,1
26 Rioja, La;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
26 Rioja, La;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
26 Rioja, La;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
26 Rioja, La;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
26 Rioja, La;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
26 Rioja, La;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
26 Rioja, La;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;93,85
26 Rioja, La;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
26 Rioja, La;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
26 Rioja, La;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
26 Rioja, La;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;93,59
26 Rioja, La;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
26 Rioja, La;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
26 Rioja, La;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
26 Rioja, La;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
26 Rioja, La;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
26 Rioja, La;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
26 Rioja, La;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;92,06
26 Rioja, La;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
26 Rioja, La;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
26 Rioja, La;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
26 Rioja, La;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;91,62
26 Rioja, La;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
26 Rioja, La;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
26 Rioja, La;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
26 Rioja, La;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
26 Rioja, La;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
26 Rioja, La;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QIV;6.256
26 Rioja, La;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
26 Rioja, La;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
26 Rioja, La;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
26 Rioja, La;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QIV;6.442
26 Rioja, La;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
26 Rioja, La;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
26 Rioja, La;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
26 Rioja, La;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QIV;6.595
26 Rioja, La;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
26 Rioja, La;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
26 Rioja, La;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
26 Rioja, La;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2022QIV;6.064
26 Rioja, La;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
26 Rioja, La;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2022QII;""
26 Rioja, La;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2022QI;""
26 Rioja, La;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2021QIV;6.275
26 Rioja, La;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
26 Rioja, La;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2021QII;""
26 Rioja, La;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2021QI;""
26 Rioja, La;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2020QIV;6.437
26 Rioja, La;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
26 Rioja, La;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2020QII;""
26 Rioja, La;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2020QI;""
26 Rioja, La;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
26 Rioja, La;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
26 Rioja, La;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2022QII;""
26 Rioja, La;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2022QI;6.147
26 Rioja, La;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
26 Rioja, La;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
26 Rioja, La;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2021QII;""
26 Rioja, La;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2021QI;6.319
26 Rioja, La;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
26 Rioja, La;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
26 Rioja, La;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2020QII;""
26 Rioja, La;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2020QI;""
26 Rioja, La;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
26 Rioja, La;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
26 Rioja, La;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QII;6.021
26 Rioja, La;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QI;""
26 Rioja, La;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
26 Rioja, La;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
26 Rioja, La;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QII;6.206
26 Rioja, La;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QI;""
26 Rioja, La;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
26 Rioja, La;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
26 Rioja, La;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QII;""
26 Rioja, La;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QI;""
26 Rioja, La;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
26 Rioja, La;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QIII;5.912
26 Rioja, La;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QII;""
26 Rioja, La;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QI;""
26 Rioja, La;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
26 Rioja, La;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QIII;6.096
26 Rioja, La;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QII;""
26 Rioja, La;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QI;""
26 Rioja, La;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
26 Rioja, La;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
26 Rioja, La;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QII;""
26 Rioja, La;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QI;""
26 Rioja, La;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
26 Rioja, La;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
26 Rioja, La;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
26 Rioja, La;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
26 Rioja, La;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
26 Rioja, La;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
26 Rioja, La;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
26 Rioja, La;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
26 Rioja, La;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
26 Rioja, La;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
26 Rioja, La;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
26 Rioja, La;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
26 Rioja, La;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;96,93
26 Rioja, La;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
26 Rioja, La;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
26 Rioja, La;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
26 Rioja, La;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;97,41
26 Rioja, La;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
26 Rioja, La;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
26 Rioja, La;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
26 Rioja, La;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;97,6
26 Rioja, La;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
26 Rioja, La;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
26 Rioja, La;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
26 Rioja, La;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
26 Rioja, La;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
26 Rioja, La;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
26 Rioja, La;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;95,42
26 Rioja, La;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
26 Rioja, La;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
26 Rioja, La;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
26 Rioja, La;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;95,82
26 Rioja, La;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
26 Rioja, La;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
26 Rioja, La;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
26 Rioja, La;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
26 Rioja, La;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
26 Rioja, La;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
26 Rioja, La;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;93,46
26 Rioja, La;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
26 Rioja, La;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
26 Rioja, La;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
26 Rioja, La;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;94,1
26 Rioja, La;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
26 Rioja, La;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
26 Rioja, La;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
26 Rioja, La;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
26 Rioja, La;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
26 Rioja, La;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
26 Rioja, La;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;91,77
26 Rioja, La;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
26 Rioja, La;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
26 Rioja, La;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
26 Rioja, La;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;92,43
26 Rioja, La;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
26 Rioja, La;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
26 Rioja, La;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
26 Rioja, La;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
26 Rioja, La;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
26 Rioja, La;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
26 Rioja, La;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QIV;3.937
26 Rioja, La;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
26 Rioja, La;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
26 Rioja, La;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
26 Rioja, La;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QIV;4.100
26 Rioja, La;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
26 Rioja, La;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
26 Rioja, La;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
26 Rioja, La;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QIV;4.204
26 Rioja, La;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
26 Rioja, La;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
26 Rioja, La;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
26 Rioja, La;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2022QIV;3.815
26 Rioja, La;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
26 Rioja, La;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2022QII;""
26 Rioja, La;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2022QI;""
26 Rioja, La;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2021QIV;3.987
26 Rioja, La;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
26 Rioja, La;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2021QII;""
26 Rioja, La;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2021QI;""
26 Rioja, La;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2020QIV;4.103
26 Rioja, La;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
26 Rioja, La;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2020QII;""
26 Rioja, La;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2020QI;""
26 Rioja, La;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
26 Rioja, La;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
26 Rioja, La;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2022QII;""
26 Rioja, La;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2022QI;3.898
26 Rioja, La;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
26 Rioja, La;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
26 Rioja, La;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2021QII;""
26 Rioja, La;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2021QI;4.027
26 Rioja, La;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
26 Rioja, La;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
26 Rioja, La;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2020QII;""
26 Rioja, La;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2020QI;""
26 Rioja, La;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
26 Rioja, La;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
26 Rioja, La;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QII;3.819
26 Rioja, La;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QI;""
26 Rioja, La;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
26 Rioja, La;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
26 Rioja, La;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QII;3.968
26 Rioja, La;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QI;""
26 Rioja, La;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
26 Rioja, La;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
26 Rioja, La;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QII;""
26 Rioja, La;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QI;""
26 Rioja, La;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
26 Rioja, La;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QIII;3.769
26 Rioja, La;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QII;""
26 Rioja, La;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QI;""
26 Rioja, La;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
26 Rioja, La;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QIII;3.901
26 Rioja, La;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QII;""
26 Rioja, La;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QI;""
26 Rioja, La;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
26 Rioja, La;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
26 Rioja, La;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QII;""
26 Rioja, La;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QI;""
26 Rioja, La;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
26 Rioja, La;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
26 Rioja, La;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
26 Rioja, La;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
26 Rioja, La;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
26 Rioja, La;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
26 Rioja, La;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
26 Rioja, La;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
26 Rioja, La;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
26 Rioja, La;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
26 Rioja, La;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
26 Rioja, La;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
26 Rioja, La;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;96,9
26 Rioja, La;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
26 Rioja, La;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
26 Rioja, La;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
26 Rioja, La;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;97,24
26 Rioja, La;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
26 Rioja, La;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
26 Rioja, La;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
26 Rioja, La;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;97,6
26 Rioja, La;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
26 Rioja, La;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
26 Rioja, La;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
26 Rioja, La;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
26 Rioja, La;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
26 Rioja, La;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
26 Rioja, La;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;95,07
26 Rioja, La;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
26 Rioja, La;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
26 Rioja, La;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
26 Rioja, La;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;95,79
26 Rioja, La;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
26 Rioja, La;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
26 Rioja, La;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
26 Rioja, La;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
26 Rioja, La;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
26 Rioja, La;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
26 Rioja, La;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;93,15
26 Rioja, La;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
26 Rioja, La;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
26 Rioja, La;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
26 Rioja, La;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;94,39
26 Rioja, La;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
26 Rioja, La;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
26 Rioja, La;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
26 Rioja, La;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
26 Rioja, La;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
26 Rioja, La;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
26 Rioja, La;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;91,93
26 Rioja, La;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
26 Rioja, La;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
26 Rioja, La;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
26 Rioja, La;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;92,79
26 Rioja, La;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
26 Rioja, La;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
26 Rioja, La;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
26 Rioja, La;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
26 Rioja, La;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
26 Rioja, La;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
26 Rioja, La;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QIV;2.319
26 Rioja, La;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
26 Rioja, La;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
26 Rioja, La;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
26 Rioja, La;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QIV;2.342
26 Rioja, La;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
26 Rioja, La;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
26 Rioja, La;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
26 Rioja, La;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QIV;2.391
26 Rioja, La;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
26 Rioja, La;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
26 Rioja, La;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
26 Rioja, La;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2022QIV;2.249
26 Rioja, La;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
26 Rioja, La;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2022QII;""
26 Rioja, La;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2022QI;""
26 Rioja, La;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2021QIV;2.288
26 Rioja, La;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
26 Rioja, La;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2021QII;""
26 Rioja, La;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2021QI;""
26 Rioja, La;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2020QIV;2.334
26 Rioja, La;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
26 Rioja, La;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2020QII;""
26 Rioja, La;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2020QI;""
26 Rioja, La;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
26 Rioja, La;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
26 Rioja, La;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2022QII;""
26 Rioja, La;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2022QI;2.249
26 Rioja, La;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
26 Rioja, La;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
26 Rioja, La;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2021QII;""
26 Rioja, La;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2021QI;2.292
26 Rioja, La;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
26 Rioja, La;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
26 Rioja, La;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2020QII;""
26 Rioja, La;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2020QI;""
26 Rioja, La;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
26 Rioja, La;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
26 Rioja, La;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QII;2.202
26 Rioja, La;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QI;""
26 Rioja, La;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
26 Rioja, La;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
26 Rioja, La;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QII;2.238
26 Rioja, La;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QI;""
26 Rioja, La;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
26 Rioja, La;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
26 Rioja, La;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QII;""
26 Rioja, La;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QI;""
26 Rioja, La;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
26 Rioja, La;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QIII;2.143
26 Rioja, La;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QII;""
26 Rioja, La;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QI;""
26 Rioja, La;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
26 Rioja, La;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QIII;2.195
26 Rioja, La;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QII;""
26 Rioja, La;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QI;""
26 Rioja, La;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
26 Rioja, La;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
26 Rioja, La;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QII;""
26 Rioja, La;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QI;""
26 Rioja, La;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
26 Rioja, La;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
26 Rioja, La;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
26 Rioja, La;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
26 Rioja, La;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
26 Rioja, La;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
26 Rioja, La;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
26 Rioja, La;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
26 Rioja, La;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
26 Rioja, La;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
26 Rioja, La;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
26 Rioja, La;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
26 Rioja, La;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;96,98
26 Rioja, La;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
26 Rioja, La;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
26 Rioja, La;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
26 Rioja, La;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;97,69
26 Rioja, La;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
26 Rioja, La;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
26 Rioja, La;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
26 Rioja, La;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;97,62
26 Rioja, La;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
26 Rioja, La;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
26 Rioja, La;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
26 Rioja, La;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
26 Rioja, La;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
26 Rioja, La;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
26 Rioja, La;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;96,03
26 Rioja, La;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
26 Rioja, La;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
26 Rioja, La;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
26 Rioja, La;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;95,86
26 Rioja, La;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
26 Rioja, La;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
26 Rioja, La;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
26 Rioja, La;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
26 Rioja, La;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
26 Rioja, La;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
26 Rioja, La;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;94,02
26 Rioja, La;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
26 Rioja, La;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
26 Rioja, La;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
26 Rioja, La;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;93,6
26 Rioja, La;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
26 Rioja, La;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
26 Rioja, La;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
26 Rioja, La;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
26 Rioja, La;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
26 Rioja, La;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
26 Rioja, La;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;91,5
26 Rioja, La;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
26 Rioja, La;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
26 Rioja, La;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
26 Rioja, La;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;91,8
26 Rioja, La;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
26 Rioja, La;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
26 Rioja, La;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
26 Rioja, La;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
26 Rioja, La;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
26 Rioja, La;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
26 Rioja, La;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
26 Rioja, La;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
26 Rioja, La;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
26 Rioja, La;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QI;6.385
26 Rioja, La;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
26 Rioja, La;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
26 Rioja, La;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
26 Rioja, La;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QI;6.420
26 Rioja, La;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
26 Rioja, La;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
26 Rioja, La;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
26 Rioja, La;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QI;6.583
26 Rioja, La;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
26 Rioja, La;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
26 Rioja, La;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2022QII;""
26 Rioja, La;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2022QI;6.277
26 Rioja, La;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
26 Rioja, La;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
26 Rioja, La;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2021QII;""
26 Rioja, La;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2021QI;6.337
26 Rioja, La;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
26 Rioja, La;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
26 Rioja, La;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2020QII;""
26 Rioja, La;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2020QI;6.301
26 Rioja, La;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
26 Rioja, La;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
26 Rioja, La;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2022QII;6.157
26 Rioja, La;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2022QI;""
26 Rioja, La;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
26 Rioja, La;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
26 Rioja, La;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2021QII;6.236
26 Rioja, La;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2021QI;""
26 Rioja, La;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
26 Rioja, La;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
26 Rioja, La;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2020QII;6.220
26 Rioja, La;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2020QI;""
26 Rioja, La;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
26 Rioja, La;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QIII;6.053
26 Rioja, La;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QII;""
26 Rioja, La;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QI;""
26 Rioja, La;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
26 Rioja, La;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QIII;6.155
26 Rioja, La;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QII;""
26 Rioja, La;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QI;""
26 Rioja, La;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
26 Rioja, La;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QIII;6.112
26 Rioja, La;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QII;""
26 Rioja, La;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QI;""
26 Rioja, La;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QIV;5.916
26 Rioja, La;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
26 Rioja, La;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QII;""
26 Rioja, La;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QI;""
26 Rioja, La;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QIV;6.055
26 Rioja, La;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
26 Rioja, La;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QII;""
26 Rioja, La;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QI;""
26 Rioja, La;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QIV;6.028
26 Rioja, La;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
26 Rioja, La;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QII;""
26 Rioja, La;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QI;""
26 Rioja, La;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
26 Rioja, La;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
26 Rioja, La;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
26 Rioja, La;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
26 Rioja, La;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
26 Rioja, La;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
26 Rioja, La;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
26 Rioja, La;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
26 Rioja, La;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
26 Rioja, La;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
26 Rioja, La;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
26 Rioja, La;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
26 Rioja, La;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
26 Rioja, La;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
26 Rioja, La;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
26 Rioja, La;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;98,31
26 Rioja, La;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
26 Rioja, La;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
26 Rioja, La;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
26 Rioja, La;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;98,71
26 Rioja, La;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
26 Rioja, La;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
26 Rioja, La;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
26 Rioja, La;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;95,72
26 Rioja, La;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
26 Rioja, La;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
26 Rioja, La;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;96,43
26 Rioja, La;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
26 Rioja, La;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
26 Rioja, La;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
26 Rioja, La;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;97,13
26 Rioja, La;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
26 Rioja, La;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
26 Rioja, La;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
26 Rioja, La;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;94,49
26 Rioja, La;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
26 Rioja, La;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
26 Rioja, La;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;94,8
26 Rioja, La;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
26 Rioja, La;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
26 Rioja, La;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
26 Rioja, La;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;95,87
26 Rioja, La;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
26 Rioja, La;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
26 Rioja, La;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
26 Rioja, La;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;92,85
26 Rioja, La;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
26 Rioja, La;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
26 Rioja, La;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;92,65
26 Rioja, La;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
26 Rioja, La;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
26 Rioja, La;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
26 Rioja, La;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;94,31
26 Rioja, La;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
26 Rioja, La;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
26 Rioja, La;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
26 Rioja, La;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;91,57
26 Rioja, La;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
26 Rioja, La;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
26 Rioja, La;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
26 Rioja, La;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
26 Rioja, La;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
26 Rioja, La;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
26 Rioja, La;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QI;3.901
26 Rioja, La;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
26 Rioja, La;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
26 Rioja, La;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
26 Rioja, La;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QI;3.901
26 Rioja, La;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
26 Rioja, La;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
26 Rioja, La;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
26 Rioja, La;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QI;3.971
26 Rioja, La;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
26 Rioja, La;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
26 Rioja, La;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2022QII;""
26 Rioja, La;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2022QI;3.830
26 Rioja, La;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
26 Rioja, La;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
26 Rioja, La;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2021QII;""
26 Rioja, La;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2021QI;3.857
26 Rioja, La;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
26 Rioja, La;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
26 Rioja, La;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2020QII;""
26 Rioja, La;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2020QI;3.807
26 Rioja, La;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
26 Rioja, La;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
26 Rioja, La;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2022QII;3.765
26 Rioja, La;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2022QI;""
26 Rioja, La;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
26 Rioja, La;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
26 Rioja, La;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2021QII;3.804
26 Rioja, La;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2021QI;""
26 Rioja, La;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
26 Rioja, La;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
26 Rioja, La;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2020QII;3.771
26 Rioja, La;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2020QI;""
26 Rioja, La;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
26 Rioja, La;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QIII;3.704
26 Rioja, La;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QII;""
26 Rioja, La;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QI;""
26 Rioja, La;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
26 Rioja, La;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QIII;3.758
26 Rioja, La;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QII;""
26 Rioja, La;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QI;""
26 Rioja, La;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
26 Rioja, La;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QIII;3.709
26 Rioja, La;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QII;""
26 Rioja, La;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QI;""
26 Rioja, La;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QIV;3.627
26 Rioja, La;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
26 Rioja, La;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QII;""
26 Rioja, La;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QI;""
26 Rioja, La;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QIV;3.710
26 Rioja, La;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
26 Rioja, La;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QII;""
26 Rioja, La;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QI;""
26 Rioja, La;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QIV;3.666
26 Rioja, La;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
26 Rioja, La;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QII;""
26 Rioja, La;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QI;""
26 Rioja, La;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
26 Rioja, La;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
26 Rioja, La;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
26 Rioja, La;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
26 Rioja, La;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
26 Rioja, La;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
26 Rioja, La;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
26 Rioja, La;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
26 Rioja, La;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
26 Rioja, La;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
26 Rioja, La;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
26 Rioja, La;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
26 Rioja, La;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
26 Rioja, La;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
26 Rioja, La;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
26 Rioja, La;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;98,18
26 Rioja, La;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
26 Rioja, La;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
26 Rioja, La;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
26 Rioja, La;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;98,87
26 Rioja, La;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
26 Rioja, La;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
26 Rioja, La;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
26 Rioja, La;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;95,87
26 Rioja, La;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
26 Rioja, La;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
26 Rioja, La;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;96,51
26 Rioja, La;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
26 Rioja, La;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
26 Rioja, La;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
26 Rioja, La;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;97,51
26 Rioja, La;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
26 Rioja, La;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
26 Rioja, La;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
26 Rioja, La;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;94,96
26 Rioja, La;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
26 Rioja, La;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
26 Rioja, La;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;94,95
26 Rioja, La;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
26 Rioja, La;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
26 Rioja, La;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
26 Rioja, La;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;96,33
26 Rioja, La;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
26 Rioja, La;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
26 Rioja, La;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
26 Rioja, La;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;93,4
26 Rioja, La;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
26 Rioja, La;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
26 Rioja, La;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;92,98
26 Rioja, La;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
26 Rioja, La;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
26 Rioja, La;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
26 Rioja, La;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;95,1
26 Rioja, La;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
26 Rioja, La;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
26 Rioja, La;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
26 Rioja, La;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;92,32
26 Rioja, La;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
26 Rioja, La;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
26 Rioja, La;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
26 Rioja, La;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
26 Rioja, La;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
26 Rioja, La;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
26 Rioja, La;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QI;2.484
26 Rioja, La;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
26 Rioja, La;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
26 Rioja, La;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
26 Rioja, La;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QI;2.519
26 Rioja, La;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
26 Rioja, La;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
26 Rioja, La;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
26 Rioja, La;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QI;2.612
26 Rioja, La;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
26 Rioja, La;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
26 Rioja, La;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2022QII;""
26 Rioja, La;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2022QI;2.447
26 Rioja, La;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
26 Rioja, La;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
26 Rioja, La;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2021QII;""
26 Rioja, La;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2021QI;2.480
26 Rioja, La;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
26 Rioja, La;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
26 Rioja, La;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2020QII;""
26 Rioja, La;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2020QI;2.494
26 Rioja, La;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
26 Rioja, La;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
26 Rioja, La;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2022QII;2.392
26 Rioja, La;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2022QI;""
26 Rioja, La;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
26 Rioja, La;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
26 Rioja, La;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2021QII;2.432
26 Rioja, La;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2021QI;""
26 Rioja, La;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
26 Rioja, La;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
26 Rioja, La;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2020QII;2.449
26 Rioja, La;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2020QI;""
26 Rioja, La;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
26 Rioja, La;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QIII;2.349
26 Rioja, La;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QII;""
26 Rioja, La;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QI;""
26 Rioja, La;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
26 Rioja, La;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QIII;2.397
26 Rioja, La;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QII;""
26 Rioja, La;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QI;""
26 Rioja, La;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
26 Rioja, La;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QIII;2.403
26 Rioja, La;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QII;""
26 Rioja, La;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QI;""
26 Rioja, La;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QIV;2.289
26 Rioja, La;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
26 Rioja, La;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QII;""
26 Rioja, La;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QI;""
26 Rioja, La;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QIV;2.345
26 Rioja, La;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
26 Rioja, La;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QII;""
26 Rioja, La;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QI;""
26 Rioja, La;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QIV;2.362
26 Rioja, La;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
26 Rioja, La;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QII;""
26 Rioja, La;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QI;""
26 Rioja, La;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
26 Rioja, La;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
26 Rioja, La;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
26 Rioja, La;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
26 Rioja, La;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
26 Rioja, La;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
26 Rioja, La;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
26 Rioja, La;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
26 Rioja, La;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
26 Rioja, La;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
26 Rioja, La;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
26 Rioja, La;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
26 Rioja, La;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
26 Rioja, La;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
26 Rioja, La;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
26 Rioja, La;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;98,51
26 Rioja, La;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
26 Rioja, La;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
26 Rioja, La;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
26 Rioja, La;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;98,45
26 Rioja, La;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
26 Rioja, La;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
26 Rioja, La;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
26 Rioja, La;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;95,48
26 Rioja, La;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
26 Rioja, La;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
26 Rioja, La;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;96,3
26 Rioja, La;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
26 Rioja, La;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
26 Rioja, La;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
26 Rioja, La;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;96,55
26 Rioja, La;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
26 Rioja, La;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
26 Rioja, La;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
26 Rioja, La;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;93,76
26 Rioja, La;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
26 Rioja, La;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
26 Rioja, La;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;94,57
26 Rioja, La;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
26 Rioja, La;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
26 Rioja, La;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
26 Rioja, La;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;95,16
26 Rioja, La;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
26 Rioja, La;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
26 Rioja, La;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
26 Rioja, La;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;92
26 Rioja, La;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
26 Rioja, La;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
26 Rioja, La;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;92,15
26 Rioja, La;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
26 Rioja, La;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
26 Rioja, La;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
26 Rioja, La;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;93,09
26 Rioja, La;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
26 Rioja, La;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
26 Rioja, La;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
26 Rioja, La;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;90,43
26 Rioja, La;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
26 Rioja, La;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
26 Rioja, La;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
26 Rioja, La;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
26 Rioja, La;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
26 Rioja, La;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QII;6.517
26 Rioja, La;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
26 Rioja, La;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
26 Rioja, La;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
26 Rioja, La;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QII;6.477
26 Rioja, La;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
26 Rioja, La;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
26 Rioja, La;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
26 Rioja, La;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QII;6.455
26 Rioja, La;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
26 Rioja, La;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
26 Rioja, La;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
26 Rioja, La;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2022QII;6.382
26 Rioja, La;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2022QI;""
26 Rioja, La;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
26 Rioja, La;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
26 Rioja, La;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2021QII;6.373
26 Rioja, La;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2021QI;""
26 Rioja, La;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
26 Rioja, La;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
26 Rioja, La;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2020QII;6.364
26 Rioja, La;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2020QI;""
26 Rioja, La;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
26 Rioja, La;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2022QIII;6.269
26 Rioja, La;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2022QII;""
26 Rioja, La;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2022QI;""
26 Rioja, La;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
26 Rioja, La;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2021QIII;6.287
26 Rioja, La;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2021QII;""
26 Rioja, La;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2021QI;""
26 Rioja, La;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
26 Rioja, La;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2020QIII;6.245
26 Rioja, La;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2020QII;""
26 Rioja, La;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2020QI;""
26 Rioja, La;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QIV;6.130
26 Rioja, La;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
26 Rioja, La;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QII;""
26 Rioja, La;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QI;""
26 Rioja, La;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QIV;6.171
26 Rioja, La;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
26 Rioja, La;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QII;""
26 Rioja, La;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QI;""
26 Rioja, La;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QIV;6.154
26 Rioja, La;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
26 Rioja, La;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QII;""
26 Rioja, La;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QI;""
26 Rioja, La;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
26 Rioja, La;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
26 Rioja, La;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QII;""
26 Rioja, La;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QI;6.084
26 Rioja, La;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
26 Rioja, La;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
26 Rioja, La;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QII;""
26 Rioja, La;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QI;6.090
26 Rioja, La;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
26 Rioja, La;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
26 Rioja, La;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QII;""
26 Rioja, La;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QI;""
26 Rioja, La;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
26 Rioja, La;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
26 Rioja, La;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
26 Rioja, La;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
26 Rioja, La;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
26 Rioja, La;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
26 Rioja, La;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
26 Rioja, La;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
26 Rioja, La;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
26 Rioja, La;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
26 Rioja, La;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
26 Rioja, La;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
26 Rioja, La;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
26 Rioja, La;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
26 Rioja, La;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;97,93
26 Rioja, La;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
26 Rioja, La;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
26 Rioja, La;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
26 Rioja, La;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;98,39
26 Rioja, La;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
26 Rioja, La;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
26 Rioja, La;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
26 Rioja, La;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;98,59
26 Rioja, La;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
26 Rioja, La;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
26 Rioja, La;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;96,19
26 Rioja, La;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
26 Rioja, La;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
26 Rioja, La;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
26 Rioja, La;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;97,07
26 Rioja, La;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
26 Rioja, La;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
26 Rioja, La;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
26 Rioja, La;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;96,75
26 Rioja, La;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
26 Rioja, La;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
26 Rioja, La;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;94,06
26 Rioja, La;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
26 Rioja, La;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
26 Rioja, La;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
26 Rioja, La;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;95,28
26 Rioja, La;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
26 Rioja, La;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
26 Rioja, La;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
26 Rioja, La;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;95,34
26 Rioja, La;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
26 Rioja, La;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
26 Rioja, La;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
26 Rioja, La;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
26 Rioja, La;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
26 Rioja, La;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
26 Rioja, La;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;93,93
26 Rioja, La;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
26 Rioja, La;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
26 Rioja, La;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
26 Rioja, La;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;94,35
26 Rioja, La;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
26 Rioja, La;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
26 Rioja, La;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
26 Rioja, La;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
26 Rioja, La;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
26 Rioja, La;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
26 Rioja, La;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QII;3.987
26 Rioja, La;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
26 Rioja, La;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
26 Rioja, La;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
26 Rioja, La;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QII;3.945
26 Rioja, La;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
26 Rioja, La;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
26 Rioja, La;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
26 Rioja, La;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QII;3.903
26 Rioja, La;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
26 Rioja, La;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
26 Rioja, La;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
26 Rioja, La;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2022QII;3.911
26 Rioja, La;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2022QI;""
26 Rioja, La;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
26 Rioja, La;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
26 Rioja, La;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2021QII;3.893
26 Rioja, La;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2021QI;""
26 Rioja, La;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
26 Rioja, La;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
26 Rioja, La;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2020QII;3.861
26 Rioja, La;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2020QI;""
26 Rioja, La;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
26 Rioja, La;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2022QIII;3.850
26 Rioja, La;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2022QII;""
26 Rioja, La;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2022QI;""
26 Rioja, La;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
26 Rioja, La;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2021QIII;3.842
26 Rioja, La;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2021QII;""
26 Rioja, La;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2021QI;""
26 Rioja, La;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
26 Rioja, La;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2020QIII;3.792
26 Rioja, La;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2020QII;""
26 Rioja, La;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2020QI;""
26 Rioja, La;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QIV;3.768
26 Rioja, La;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
26 Rioja, La;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QII;""
26 Rioja, La;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QI;""
26 Rioja, La;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QIV;3.785
26 Rioja, La;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
26 Rioja, La;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QII;""
26 Rioja, La;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QI;""
26 Rioja, La;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QIV;3.743
26 Rioja, La;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
26 Rioja, La;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QII;""
26 Rioja, La;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QI;""
26 Rioja, La;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
26 Rioja, La;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
26 Rioja, La;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QII;""
26 Rioja, La;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QI;3.733
26 Rioja, La;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
26 Rioja, La;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
26 Rioja, La;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QII;""
26 Rioja, La;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QI;3.712
26 Rioja, La;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
26 Rioja, La;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
26 Rioja, La;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QII;""
26 Rioja, La;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QI;""
26 Rioja, La;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
26 Rioja, La;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
26 Rioja, La;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
26 Rioja, La;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
26 Rioja, La;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
26 Rioja, La;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
26 Rioja, La;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
26 Rioja, La;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
26 Rioja, La;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
26 Rioja, La;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
26 Rioja, La;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
26 Rioja, La;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
26 Rioja, La;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
26 Rioja, La;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
26 Rioja, La;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;98,09
26 Rioja, La;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
26 Rioja, La;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
26 Rioja, La;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
26 Rioja, La;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;98,68
26 Rioja, La;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
26 Rioja, La;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
26 Rioja, La;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
26 Rioja, La;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;98,92
26 Rioja, La;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
26 Rioja, La;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
26 Rioja, La;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;96,56
26 Rioja, La;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
26 Rioja, La;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
26 Rioja, La;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
26 Rioja, La;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;97,39
26 Rioja, La;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
26 Rioja, La;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
26 Rioja, La;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
26 Rioja, La;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;97,16
26 Rioja, La;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
26 Rioja, La;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
26 Rioja, La;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;94,51
26 Rioja, La;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
26 Rioja, La;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
26 Rioja, La;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
26 Rioja, La;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;95,94
26 Rioja, La;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
26 Rioja, La;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
26 Rioja, La;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
26 Rioja, La;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;95,9
26 Rioja, La;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
26 Rioja, La;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
26 Rioja, La;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
26 Rioja, La;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
26 Rioja, La;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
26 Rioja, La;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
26 Rioja, La;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;94,63
26 Rioja, La;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
26 Rioja, La;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
26 Rioja, La;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
26 Rioja, La;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;95,11
26 Rioja, La;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
26 Rioja, La;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
26 Rioja, La;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
26 Rioja, La;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
26 Rioja, La;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
26 Rioja, La;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
26 Rioja, La;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QII;2.530
26 Rioja, La;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
26 Rioja, La;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
26 Rioja, La;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
26 Rioja, La;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QII;2.532
26 Rioja, La;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
26 Rioja, La;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
26 Rioja, La;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
26 Rioja, La;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QII;2.552
26 Rioja, La;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
26 Rioja, La;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
26 Rioja, La;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
26 Rioja, La;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2022QII;2.471
26 Rioja, La;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2022QI;""
26 Rioja, La;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
26 Rioja, La;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
26 Rioja, La;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2021QII;2.480
26 Rioja, La;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2021QI;""
26 Rioja, La;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
26 Rioja, La;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
26 Rioja, La;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2020QII;2.503
26 Rioja, La;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2020QI;""
26 Rioja, La;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
26 Rioja, La;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2022QIII;2.419
26 Rioja, La;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2022QII;""
26 Rioja, La;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2022QI;""
26 Rioja, La;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
26 Rioja, La;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2021QIII;2.445
26 Rioja, La;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2021QII;""
26 Rioja, La;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2021QI;""
26 Rioja, La;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
26 Rioja, La;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2020QIII;2.453
26 Rioja, La;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2020QII;""
26 Rioja, La;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2020QI;""
26 Rioja, La;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QIV;2.362
26 Rioja, La;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
26 Rioja, La;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QII;""
26 Rioja, La;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QI;""
26 Rioja, La;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QIV;2.386
26 Rioja, La;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
26 Rioja, La;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QII;""
26 Rioja, La;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QI;""
26 Rioja, La;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QIV;2.411
26 Rioja, La;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
26 Rioja, La;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QII;""
26 Rioja, La;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QI;""
26 Rioja, La;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
26 Rioja, La;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
26 Rioja, La;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QII;""
26 Rioja, La;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QI;2.351
26 Rioja, La;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
26 Rioja, La;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
26 Rioja, La;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QII;""
26 Rioja, La;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QI;2.378
26 Rioja, La;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
26 Rioja, La;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
26 Rioja, La;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QII;""
26 Rioja, La;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QI;""
26 Rioja, La;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
26 Rioja, La;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
26 Rioja, La;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
26 Rioja, La;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
26 Rioja, La;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
26 Rioja, La;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
26 Rioja, La;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
26 Rioja, La;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
26 Rioja, La;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
26 Rioja, La;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
26 Rioja, La;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
26 Rioja, La;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
26 Rioja, La;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
26 Rioja, La;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
26 Rioja, La;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;97,67
26 Rioja, La;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
26 Rioja, La;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
26 Rioja, La;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
26 Rioja, La;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;97,95
26 Rioja, La;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
26 Rioja, La;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
26 Rioja, La;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
26 Rioja, La;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;98,08
26 Rioja, La;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
26 Rioja, La;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
26 Rioja, La;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;95,61
26 Rioja, La;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
26 Rioja, La;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
26 Rioja, La;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
26 Rioja, La;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;96,56
26 Rioja, La;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
26 Rioja, La;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
26 Rioja, La;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
26 Rioja, La;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;96,12
26 Rioja, La;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
26 Rioja, La;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
26 Rioja, La;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;93,36
26 Rioja, La;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
26 Rioja, La;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
26 Rioja, La;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
26 Rioja, La;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;94,23
26 Rioja, La;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
26 Rioja, La;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
26 Rioja, La;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
26 Rioja, La;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;94,47
26 Rioja, La;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
26 Rioja, La;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
26 Rioja, La;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
26 Rioja, La;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
26 Rioja, La;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
26 Rioja, La;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
26 Rioja, La;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;92,85
26 Rioja, La;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
26 Rioja, La;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
26 Rioja, La;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
26 Rioja, La;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;93,18
26 Rioja, La;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
26 Rioja, La;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
26 Rioja, La;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
26 Rioja, La;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
26 Rioja, La;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
26 Rioja, La;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QIII;6.492
26 Rioja, La;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
26 Rioja, La;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
26 Rioja, La;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
26 Rioja, La;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QIII;6.456
26 Rioja, La;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
26 Rioja, La;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
26 Rioja, La;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
26 Rioja, La;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QIII;6.461
26 Rioja, La;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
26 Rioja, La;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
26 Rioja, La;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
26 Rioja, La;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2022QIII;6.364
26 Rioja, La;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2022QII;""
26 Rioja, La;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2022QI;""
26 Rioja, La;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
26 Rioja, La;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2021QIII;6.363
26 Rioja, La;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2021QII;""
26 Rioja, La;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2021QI;""
26 Rioja, La;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
26 Rioja, La;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2020QIII;6.332
26 Rioja, La;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2020QII;""
26 Rioja, La;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2020QI;""
26 Rioja, La;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2022QIV;6.209
26 Rioja, La;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
26 Rioja, La;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2022QII;""
26 Rioja, La;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2022QI;""
26 Rioja, La;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2021QIV;6.237
26 Rioja, La;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
26 Rioja, La;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2021QII;""
26 Rioja, La;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2021QI;""
26 Rioja, La;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2020QIV;6.234
26 Rioja, La;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
26 Rioja, La;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2020QII;""
26 Rioja, La;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2020QI;""
26 Rioja, La;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
26 Rioja, La;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
26 Rioja, La;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QII;""
26 Rioja, La;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QI;6.147
26 Rioja, La;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
26 Rioja, La;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
26 Rioja, La;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QII;""
26 Rioja, La;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QI;6.165
26 Rioja, La;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
26 Rioja, La;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
26 Rioja, La;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QII;""
26 Rioja, La;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QI;""
26 Rioja, La;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
26 Rioja, La;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
26 Rioja, La;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QII;6.046
26 Rioja, La;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QI;""
26 Rioja, La;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
26 Rioja, La;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
26 Rioja, La;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QII;6.086
26 Rioja, La;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QI;""
26 Rioja, La;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
26 Rioja, La;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
26 Rioja, La;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QII;""
26 Rioja, La;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QI;""
26 Rioja, La;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
26 Rioja, La;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
26 Rioja, La;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
26 Rioja, La;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
26 Rioja, La;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
26 Rioja, La;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
26 Rioja, La;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
26 Rioja, La;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
26 Rioja, La;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
26 Rioja, La;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
26 Rioja, La;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
26 Rioja, La;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
26 Rioja, La;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
26 Rioja, La;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;98,03
26 Rioja, La;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
26 Rioja, La;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
26 Rioja, La;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
26 Rioja, La;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;98,56
26 Rioja, La;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
26 Rioja, La;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
26 Rioja, La;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
26 Rioja, La;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;98
26 Rioja, La;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
26 Rioja, La;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
26 Rioja, La;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;95,64
26 Rioja, La;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
26 Rioja, La;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
26 Rioja, La;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
26 Rioja, La;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;96,61
26 Rioja, La;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
26 Rioja, La;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
26 Rioja, La;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
26 Rioja, La;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;96,49
26 Rioja, La;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
26 Rioja, La;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
26 Rioja, La;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
26 Rioja, La;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
26 Rioja, La;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
26 Rioja, La;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
26 Rioja, La;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;95,21
26 Rioja, La;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
26 Rioja, La;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
26 Rioja, La;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
26 Rioja, La;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;95,42
26 Rioja, La;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
26 Rioja, La;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
26 Rioja, La;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
26 Rioja, La;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
26 Rioja, La;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
26 Rioja, La;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
26 Rioja, La;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;93,65
26 Rioja, La;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
26 Rioja, La;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
26 Rioja, La;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
26 Rioja, La;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;94,2
26 Rioja, La;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
26 Rioja, La;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
26 Rioja, La;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
26 Rioja, La;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
26 Rioja, La;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
26 Rioja, La;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
26 Rioja, La;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QIII;3.974
26 Rioja, La;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
26 Rioja, La;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
26 Rioja, La;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
26 Rioja, La;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QIII;3.936
26 Rioja, La;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
26 Rioja, La;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
26 Rioja, La;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
26 Rioja, La;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QIII;3.918
26 Rioja, La;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
26 Rioja, La;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
26 Rioja, La;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
26 Rioja, La;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2022QIII;3.904
26 Rioja, La;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2022QII;""
26 Rioja, La;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2022QI;""
26 Rioja, La;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
26 Rioja, La;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2021QIII;3.880
26 Rioja, La;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2021QII;""
26 Rioja, La;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2021QI;""
26 Rioja, La;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
26 Rioja, La;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2020QIII;3.845
26 Rioja, La;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2020QII;""
26 Rioja, La;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2020QI;""
26 Rioja, La;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2022QIV;3.815
26 Rioja, La;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
26 Rioja, La;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2022QII;""
26 Rioja, La;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2022QI;""
26 Rioja, La;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2021QIV;3.819
26 Rioja, La;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
26 Rioja, La;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2021QII;""
26 Rioja, La;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2021QI;""
26 Rioja, La;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2020QIV;3.790
26 Rioja, La;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
26 Rioja, La;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2020QII;""
26 Rioja, La;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2020QI;""
26 Rioja, La;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
26 Rioja, La;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
26 Rioja, La;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QII;""
26 Rioja, La;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QI;3.764
26 Rioja, La;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
26 Rioja, La;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
26 Rioja, La;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QII;""
26 Rioja, La;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QI;3.756
26 Rioja, La;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
26 Rioja, La;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
26 Rioja, La;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QII;""
26 Rioja, La;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QI;""
26 Rioja, La;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
26 Rioja, La;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
26 Rioja, La;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QII;3.708
26 Rioja, La;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QI;""
26 Rioja, La;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
26 Rioja, La;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
26 Rioja, La;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QII;3.712
26 Rioja, La;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QI;""
26 Rioja, La;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
26 Rioja, La;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
26 Rioja, La;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QII;""
26 Rioja, La;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QI;""
26 Rioja, La;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
26 Rioja, La;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
26 Rioja, La;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
26 Rioja, La;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
26 Rioja, La;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
26 Rioja, La;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
26 Rioja, La;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
26 Rioja, La;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
26 Rioja, La;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
26 Rioja, La;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
26 Rioja, La;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
26 Rioja, La;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
26 Rioja, La;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
26 Rioja, La;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;98,24
26 Rioja, La;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
26 Rioja, La;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
26 Rioja, La;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
26 Rioja, La;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;98,58
26 Rioja, La;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
26 Rioja, La;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
26 Rioja, La;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
26 Rioja, La;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;98,14
26 Rioja, La;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
26 Rioja, La;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
26 Rioja, La;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;96
26 Rioja, La;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
26 Rioja, La;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
26 Rioja, La;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
26 Rioja, La;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;97,03
26 Rioja, La;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
26 Rioja, La;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
26 Rioja, La;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
26 Rioja, La;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;96,73
26 Rioja, La;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
26 Rioja, La;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
26 Rioja, La;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
26 Rioja, La;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
26 Rioja, La;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
26 Rioja, La;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
26 Rioja, La;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;95,63
26 Rioja, La;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
26 Rioja, La;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
26 Rioja, La;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
26 Rioja, La;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;95,87
26 Rioja, La;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
26 Rioja, La;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
26 Rioja, La;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
26 Rioja, La;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
26 Rioja, La;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
26 Rioja, La;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
26 Rioja, La;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;94,21
26 Rioja, La;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
26 Rioja, La;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
26 Rioja, La;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
26 Rioja, La;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;94,74
26 Rioja, La;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
26 Rioja, La;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
26 Rioja, La;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
26 Rioja, La;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
26 Rioja, La;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
26 Rioja, La;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
26 Rioja, La;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QIII;2.518
26 Rioja, La;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
26 Rioja, La;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
26 Rioja, La;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
26 Rioja, La;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QIII;2.520
26 Rioja, La;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
26 Rioja, La;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
26 Rioja, La;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
26 Rioja, La;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QIII;2.543
26 Rioja, La;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
26 Rioja, La;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
26 Rioja, La;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
26 Rioja, La;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2022QIII;2.460
26 Rioja, La;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2022QII;""
26 Rioja, La;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2022QI;""
26 Rioja, La;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
26 Rioja, La;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2021QIII;2.483
26 Rioja, La;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2021QII;""
26 Rioja, La;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2021QI;""
26 Rioja, La;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
26 Rioja, La;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2020QIII;2.487
26 Rioja, La;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2020QII;""
26 Rioja, La;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2020QI;""
26 Rioja, La;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2022QIV;2.394
26 Rioja, La;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
26 Rioja, La;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2022QII;""
26 Rioja, La;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2022QI;""
26 Rioja, La;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2021QIV;2.418
26 Rioja, La;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
26 Rioja, La;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2021QII;""
26 Rioja, La;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2021QI;""
26 Rioja, La;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2020QIV;2.444
26 Rioja, La;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
26 Rioja, La;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2020QII;""
26 Rioja, La;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2020QI;""
26 Rioja, La;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
26 Rioja, La;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
26 Rioja, La;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QII;""
26 Rioja, La;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QI;2.383
26 Rioja, La;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
26 Rioja, La;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
26 Rioja, La;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QII;""
26 Rioja, La;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QI;2.409
26 Rioja, La;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
26 Rioja, La;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
26 Rioja, La;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QII;""
26 Rioja, La;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QI;""
26 Rioja, La;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
26 Rioja, La;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
26 Rioja, La;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QII;2.338
26 Rioja, La;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QI;""
26 Rioja, La;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
26 Rioja, La;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
26 Rioja, La;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QII;2.374
26 Rioja, La;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QI;""
26 Rioja, La;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
26 Rioja, La;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
26 Rioja, La;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QII;""
26 Rioja, La;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QI;""
26 Rioja, La;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
26 Rioja, La;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
26 Rioja, La;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
26 Rioja, La;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
26 Rioja, La;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
26 Rioja, La;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
26 Rioja, La;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
26 Rioja, La;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
26 Rioja, La;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
26 Rioja, La;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
26 Rioja, La;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
26 Rioja, La;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
26 Rioja, La;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
26 Rioja, La;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;97,7
26 Rioja, La;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
26 Rioja, La;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
26 Rioja, La;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
26 Rioja, La;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;98,53
26 Rioja, La;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
26 Rioja, La;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
26 Rioja, La;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
26 Rioja, La;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;97,8
26 Rioja, La;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
26 Rioja, La;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
26 Rioja, La;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;95,08
26 Rioja, La;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
26 Rioja, La;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
26 Rioja, La;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
26 Rioja, La;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;95,95
26 Rioja, La;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
26 Rioja, La;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
26 Rioja, La;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
26 Rioja, La;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;96,11
26 Rioja, La;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
26 Rioja, La;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
26 Rioja, La;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
26 Rioja, La;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
26 Rioja, La;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
26 Rioja, La;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
26 Rioja, La;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;94,56
26 Rioja, La;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
26 Rioja, La;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
26 Rioja, La;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
26 Rioja, La;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;94,73
26 Rioja, La;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
26 Rioja, La;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
26 Rioja, La;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
26 Rioja, La;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
26 Rioja, La;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
26 Rioja, La;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
26 Rioja, La;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;92,78
26 Rioja, La;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
26 Rioja, La;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
26 Rioja, La;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
26 Rioja, La;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;93,35
26 Rioja, La;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
26 Rioja, La;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
26 Rioja, La;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
26 Rioja, La;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
26 Rioja, La;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
26 Rioja, La;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QIV;6.453
26 Rioja, La;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
26 Rioja, La;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
26 Rioja, La;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
26 Rioja, La;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QIV;6.434
26 Rioja, La;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
26 Rioja, La;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
26 Rioja, La;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
26 Rioja, La;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QIV;6.440
26 Rioja, La;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
26 Rioja, La;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
26 Rioja, La;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
26 Rioja, La;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2022QIV;6.283
26 Rioja, La;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
26 Rioja, La;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2022QII;""
26 Rioja, La;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2022QI;""
26 Rioja, La;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2021QIV;6.297
26 Rioja, La;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
26 Rioja, La;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2021QII;""
26 Rioja, La;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2021QI;""
26 Rioja, La;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2020QIV;6.324
26 Rioja, La;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
26 Rioja, La;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2020QII;""
26 Rioja, La;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2020QI;""
26 Rioja, La;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
26 Rioja, La;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
26 Rioja, La;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2022QII;""
26 Rioja, La;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2022QI;6.203
26 Rioja, La;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
26 Rioja, La;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
26 Rioja, La;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2021QII;""
26 Rioja, La;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2021QI;6.250
26 Rioja, La;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
26 Rioja, La;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
26 Rioja, La;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2020QII;""
26 Rioja, La;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2020QI;""
26 Rioja, La;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
26 Rioja, La;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
26 Rioja, La;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QII;6.097
26 Rioja, La;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QI;""
26 Rioja, La;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
26 Rioja, La;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
26 Rioja, La;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QII;6.163
26 Rioja, La;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QI;""
26 Rioja, La;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
26 Rioja, La;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
26 Rioja, La;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QII;""
26 Rioja, La;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QI;""
26 Rioja, La;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
26 Rioja, La;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QIII;5.995
26 Rioja, La;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QII;""
26 Rioja, La;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QI;""
26 Rioja, La;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
26 Rioja, La;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QIII;6.086
26 Rioja, La;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QII;""
26 Rioja, La;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QI;""
26 Rioja, La;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
26 Rioja, La;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
26 Rioja, La;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QII;""
26 Rioja, La;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QI;""
26 Rioja, La;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
26 Rioja, La;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
26 Rioja, La;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
26 Rioja, La;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
26 Rioja, La;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
26 Rioja, La;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
26 Rioja, La;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
26 Rioja, La;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
26 Rioja, La;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
26 Rioja, La;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
26 Rioja, La;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
26 Rioja, La;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
26 Rioja, La;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;97,37
26 Rioja, La;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
26 Rioja, La;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
26 Rioja, La;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
26 Rioja, La;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;97,87
26 Rioja, La;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
26 Rioja, La;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
26 Rioja, La;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
26 Rioja, La;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;98,2
26 Rioja, La;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
26 Rioja, La;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
26 Rioja, La;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
26 Rioja, La;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
26 Rioja, La;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
26 Rioja, La;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
26 Rioja, La;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;96,41
26 Rioja, La;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
26 Rioja, La;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
26 Rioja, La;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
26 Rioja, La;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;97,05
26 Rioja, La;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
26 Rioja, La;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
26 Rioja, La;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
26 Rioja, La;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
26 Rioja, La;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
26 Rioja, La;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
26 Rioja, La;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;94,76
26 Rioja, La;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
26 Rioja, La;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
26 Rioja, La;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
26 Rioja, La;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;95,7
26 Rioja, La;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
26 Rioja, La;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
26 Rioja, La;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
26 Rioja, La;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
26 Rioja, La;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
26 Rioja, La;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
26 Rioja, La;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;93,18
26 Rioja, La;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
26 Rioja, La;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
26 Rioja, La;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
26 Rioja, La;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;94,5
26 Rioja, La;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
26 Rioja, La;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
26 Rioja, La;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
26 Rioja, La;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
26 Rioja, La;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
26 Rioja, La;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
26 Rioja, La;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QIV;3.952
26 Rioja, La;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
26 Rioja, La;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
26 Rioja, La;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
26 Rioja, La;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QIV;3.923
26 Rioja, La;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
26 Rioja, La;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
26 Rioja, La;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
26 Rioja, La;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QIV;3.905
26 Rioja, La;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
26 Rioja, La;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
26 Rioja, La;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
26 Rioja, La;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2022QIV;3.853
26 Rioja, La;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
26 Rioja, La;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2022QII;""
26 Rioja, La;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2022QI;""
26 Rioja, La;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2021QIV;3.854
26 Rioja, La;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
26 Rioja, La;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2021QII;""
26 Rioja, La;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2021QI;""
26 Rioja, La;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2020QIV;3.841
26 Rioja, La;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
26 Rioja, La;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2020QII;""
26 Rioja, La;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2020QI;""
26 Rioja, La;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
26 Rioja, La;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
26 Rioja, La;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2022QII;""
26 Rioja, La;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2022QI;3.796
26 Rioja, La;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
26 Rioja, La;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
26 Rioja, La;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2021QII;""
26 Rioja, La;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2021QI;3.804
26 Rioja, La;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
26 Rioja, La;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
26 Rioja, La;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2020QII;""
26 Rioja, La;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2020QI;""
26 Rioja, La;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
26 Rioja, La;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
26 Rioja, La;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QII;3.737
26 Rioja, La;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QI;""
26 Rioja, La;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
26 Rioja, La;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
26 Rioja, La;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QII;3.756
26 Rioja, La;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QI;""
26 Rioja, La;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
26 Rioja, La;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
26 Rioja, La;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QII;""
26 Rioja, La;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QI;""
26 Rioja, La;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
26 Rioja, La;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QIII;3.678
26 Rioja, La;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QII;""
26 Rioja, La;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QI;""
26 Rioja, La;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
26 Rioja, La;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QIII;3.714
26 Rioja, La;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QII;""
26 Rioja, La;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QI;""
26 Rioja, La;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
26 Rioja, La;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
26 Rioja, La;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QII;""
26 Rioja, La;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QI;""
26 Rioja, La;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
26 Rioja, La;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
26 Rioja, La;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
26 Rioja, La;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
26 Rioja, La;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
26 Rioja, La;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
26 Rioja, La;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
26 Rioja, La;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
26 Rioja, La;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
26 Rioja, La;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
26 Rioja, La;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
26 Rioja, La;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
26 Rioja, La;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;97,49
26 Rioja, La;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
26 Rioja, La;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
26 Rioja, La;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
26 Rioja, La;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;98,24
26 Rioja, La;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
26 Rioja, La;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
26 Rioja, La;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
26 Rioja, La;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;98,36
26 Rioja, La;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
26 Rioja, La;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
26 Rioja, La;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
26 Rioja, La;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
26 Rioja, La;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
26 Rioja, La;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
26 Rioja, La;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;96,76
26 Rioja, La;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
26 Rioja, La;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
26 Rioja, La;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
26 Rioja, La;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;97,41
26 Rioja, La;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
26 Rioja, La;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
26 Rioja, La;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
26 Rioja, La;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
26 Rioja, La;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
26 Rioja, La;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
26 Rioja, La;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;95,26
26 Rioja, La;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
26 Rioja, La;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
26 Rioja, La;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
26 Rioja, La;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;96,18
26 Rioja, La;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
26 Rioja, La;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
26 Rioja, La;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
26 Rioja, La;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
26 Rioja, La;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
26 Rioja, La;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
26 Rioja, La;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;93,75
26 Rioja, La;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
26 Rioja, La;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
26 Rioja, La;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
26 Rioja, La;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;95,11
26 Rioja, La;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
26 Rioja, La;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
26 Rioja, La;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
26 Rioja, La;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
26 Rioja, La;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
26 Rioja, La;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
26 Rioja, La;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QIV;2.501
26 Rioja, La;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
26 Rioja, La;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
26 Rioja, La;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
26 Rioja, La;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QIV;2.511
26 Rioja, La;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
26 Rioja, La;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
26 Rioja, La;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
26 Rioja, La;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QIV;2.535
26 Rioja, La;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
26 Rioja, La;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
26 Rioja, La;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
26 Rioja, La;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2022QIV;2.430
26 Rioja, La;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
26 Rioja, La;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2022QII;""
26 Rioja, La;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2022QI;""
26 Rioja, La;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2021QIV;2.443
26 Rioja, La;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
26 Rioja, La;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2021QII;""
26 Rioja, La;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2021QI;""
26 Rioja, La;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2020QIV;2.483
26 Rioja, La;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
26 Rioja, La;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2020QII;""
26 Rioja, La;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2020QI;""
26 Rioja, La;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
26 Rioja, La;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
26 Rioja, La;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2022QII;""
26 Rioja, La;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2022QI;2.407
26 Rioja, La;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
26 Rioja, La;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
26 Rioja, La;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2021QII;""
26 Rioja, La;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2021QI;2.446
26 Rioja, La;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
26 Rioja, La;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
26 Rioja, La;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2020QII;""
26 Rioja, La;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2020QI;""
26 Rioja, La;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
26 Rioja, La;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
26 Rioja, La;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QII;2.360
26 Rioja, La;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QI;""
26 Rioja, La;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
26 Rioja, La;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
26 Rioja, La;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QII;2.407
26 Rioja, La;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QI;""
26 Rioja, La;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
26 Rioja, La;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
26 Rioja, La;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QII;""
26 Rioja, La;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QI;""
26 Rioja, La;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
26 Rioja, La;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QIII;2.317
26 Rioja, La;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QII;""
26 Rioja, La;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QI;""
26 Rioja, La;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
26 Rioja, La;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QIII;2.372
26 Rioja, La;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QII;""
26 Rioja, La;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QI;""
26 Rioja, La;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
26 Rioja, La;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
26 Rioja, La;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QII;""
26 Rioja, La;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QI;""
26 Rioja, La;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
26 Rioja, La;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
26 Rioja, La;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
26 Rioja, La;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
26 Rioja, La;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
26 Rioja, La;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
26 Rioja, La;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
26 Rioja, La;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
26 Rioja, La;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
26 Rioja, La;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
26 Rioja, La;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
26 Rioja, La;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
26 Rioja, La;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;97,16
26 Rioja, La;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
26 Rioja, La;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
26 Rioja, La;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
26 Rioja, La;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;97,29
26 Rioja, La;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
26 Rioja, La;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
26 Rioja, La;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
26 Rioja, La;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;97,95
26 Rioja, La;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
26 Rioja, La;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
26 Rioja, La;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
26 Rioja, La;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
26 Rioja, La;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
26 Rioja, La;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
26 Rioja, La;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;95,86
26 Rioja, La;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
26 Rioja, La;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
26 Rioja, La;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
26 Rioja, La;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;96,49
26 Rioja, La;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
26 Rioja, La;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
26 Rioja, La;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
26 Rioja, La;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
26 Rioja, La;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
26 Rioja, La;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
26 Rioja, La;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;93,99
26 Rioja, La;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
26 Rioja, La;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
26 Rioja, La;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
26 Rioja, La;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;94,95
26 Rioja, La;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
26 Rioja, La;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
26 Rioja, La;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
26 Rioja, La;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
26 Rioja, La;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
26 Rioja, La;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
26 Rioja, La;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;92,27
26 Rioja, La;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
26 Rioja, La;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
26 Rioja, La;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
26 Rioja, La;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;93,57
26 Rioja, La;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
26 Rioja, La;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
26 Rioja, La;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
26 Rioja, La;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
26 Rioja, La;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
26 Rioja, La;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
26 Rioja, La;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
26 Rioja, La;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
26 Rioja, La;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
26 Rioja, La;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QI;3.524
26 Rioja, La;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
26 Rioja, La;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
26 Rioja, La;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
26 Rioja, La;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QI;3.338
26 Rioja, La;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
26 Rioja, La;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
26 Rioja, La;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
26 Rioja, La;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QI;3.951
26 Rioja, La;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
26 Rioja, La;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
26 Rioja, La;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2022QII;""
26 Rioja, La;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2022QI;3.412
26 Rioja, La;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
26 Rioja, La;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
26 Rioja, La;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2021QII;""
26 Rioja, La;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2021QI;3.240
26 Rioja, La;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
26 Rioja, La;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
26 Rioja, La;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2020QII;""
26 Rioja, La;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2020QI;3.685
26 Rioja, La;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
26 Rioja, La;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
26 Rioja, La;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2022QII;3.318
26 Rioja, La;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2022QI;""
26 Rioja, La;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
26 Rioja, La;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
26 Rioja, La;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2021QII;3.126
26 Rioja, La;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2021QI;""
26 Rioja, La;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
26 Rioja, La;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
26 Rioja, La;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2020QII;3.550
26 Rioja, La;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2020QI;""
26 Rioja, La;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
26 Rioja, La;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QIII;3.213
26 Rioja, La;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QII;""
26 Rioja, La;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QI;""
26 Rioja, La;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
26 Rioja, La;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QIII;2.999
26 Rioja, La;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QII;""
26 Rioja, La;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QI;""
26 Rioja, La;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
26 Rioja, La;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QIII;3.409
26 Rioja, La;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QII;""
26 Rioja, La;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QI;""
26 Rioja, La;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QIV;2.991
26 Rioja, La;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
26 Rioja, La;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QII;""
26 Rioja, La;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QI;""
26 Rioja, La;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QIV;2.828
26 Rioja, La;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
26 Rioja, La;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QII;""
26 Rioja, La;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QI;""
26 Rioja, La;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QIV;3.226
26 Rioja, La;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
26 Rioja, La;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QII;""
26 Rioja, La;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QI;""
26 Rioja, La;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
26 Rioja, La;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
26 Rioja, La;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
26 Rioja, La;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
26 Rioja, La;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
26 Rioja, La;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
26 Rioja, La;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
26 Rioja, La;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
26 Rioja, La;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
26 Rioja, La;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
26 Rioja, La;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
26 Rioja, La;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
26 Rioja, La;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
26 Rioja, La;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
26 Rioja, La;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
26 Rioja, La;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;96,82
26 Rioja, La;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
26 Rioja, La;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
26 Rioja, La;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
26 Rioja, La;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;97,06
26 Rioja, La;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
26 Rioja, La;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
26 Rioja, La;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
26 Rioja, La;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;93,27
26 Rioja, La;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
26 Rioja, La;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
26 Rioja, La;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;94,15
26 Rioja, La;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
26 Rioja, La;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
26 Rioja, La;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
26 Rioja, La;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;93,65
26 Rioja, La;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
26 Rioja, La;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
26 Rioja, La;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
26 Rioja, La;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;89,85
26 Rioja, La;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
26 Rioja, La;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
26 Rioja, La;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;91,17
26 Rioja, La;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
26 Rioja, La;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
26 Rioja, La;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
26 Rioja, La;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;89,84
26 Rioja, La;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
26 Rioja, La;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
26 Rioja, La;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
26 Rioja, La;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;86,28
26 Rioja, La;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
26 Rioja, La;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
26 Rioja, La;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;84,88
26 Rioja, La;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
26 Rioja, La;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
26 Rioja, La;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
26 Rioja, La;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;84,72
26 Rioja, La;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
26 Rioja, La;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
26 Rioja, La;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
26 Rioja, La;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;81,65
26 Rioja, La;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
26 Rioja, La;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
26 Rioja, La;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
26 Rioja, La;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
26 Rioja, La;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
26 Rioja, La;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
26 Rioja, La;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QI;2.292
26 Rioja, La;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
26 Rioja, La;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
26 Rioja, La;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
26 Rioja, La;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QI;2.187
26 Rioja, La;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
26 Rioja, La;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
26 Rioja, La;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
26 Rioja, La;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QI;2.566
26 Rioja, La;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
26 Rioja, La;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
26 Rioja, La;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2022QII;""
26 Rioja, La;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2022QI;2.216
26 Rioja, La;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
26 Rioja, La;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
26 Rioja, La;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2021QII;""
26 Rioja, La;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2021QI;2.125
26 Rioja, La;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
26 Rioja, La;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
26 Rioja, La;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2020QII;""
26 Rioja, La;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2020QI;2.421
26 Rioja, La;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
26 Rioja, La;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
26 Rioja, La;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2022QII;2.155
26 Rioja, La;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2022QI;""
26 Rioja, La;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
26 Rioja, La;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
26 Rioja, La;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2021QII;2.055
26 Rioja, La;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2021QI;""
26 Rioja, La;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
26 Rioja, La;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
26 Rioja, La;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2020QII;2.329
26 Rioja, La;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2020QI;""
26 Rioja, La;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
26 Rioja, La;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QIII;2.099
26 Rioja, La;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QII;""
26 Rioja, La;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QI;""
26 Rioja, La;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
26 Rioja, La;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QIII;1.979
26 Rioja, La;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QII;""
26 Rioja, La;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QI;""
26 Rioja, La;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
26 Rioja, La;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QIII;2.247
26 Rioja, La;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QII;""
26 Rioja, La;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QI;""
26 Rioja, La;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QIV;1.966
26 Rioja, La;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
26 Rioja, La;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QII;""
26 Rioja, La;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QI;""
26 Rioja, La;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QIV;1.863
26 Rioja, La;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
26 Rioja, La;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QII;""
26 Rioja, La;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QI;""
26 Rioja, La;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QIV;2.127
26 Rioja, La;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
26 Rioja, La;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QII;""
26 Rioja, La;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QI;""
26 Rioja, La;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
26 Rioja, La;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
26 Rioja, La;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
26 Rioja, La;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
26 Rioja, La;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
26 Rioja, La;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
26 Rioja, La;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
26 Rioja, La;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
26 Rioja, La;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
26 Rioja, La;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
26 Rioja, La;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
26 Rioja, La;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
26 Rioja, La;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
26 Rioja, La;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
26 Rioja, La;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
26 Rioja, La;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;96,68
26 Rioja, La;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
26 Rioja, La;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
26 Rioja, La;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
26 Rioja, La;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;97,17
26 Rioja, La;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
26 Rioja, La;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
26 Rioja, La;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
26 Rioja, La;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;94,35
26 Rioja, La;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
26 Rioja, La;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
26 Rioja, La;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;94,02
26 Rioja, La;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
26 Rioja, La;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
26 Rioja, La;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
26 Rioja, La;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;93,96
26 Rioja, La;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
26 Rioja, La;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
26 Rioja, La;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
26 Rioja, La;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;90,76
26 Rioja, La;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
26 Rioja, La;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
26 Rioja, La;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;91,58
26 Rioja, La;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
26 Rioja, La;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
26 Rioja, La;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
26 Rioja, La;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;90,49
26 Rioja, La;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
26 Rioja, La;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
26 Rioja, La;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
26 Rioja, La;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;87,57
26 Rioja, La;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
26 Rioja, La;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
26 Rioja, La;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;85,78
26 Rioja, La;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
26 Rioja, La;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
26 Rioja, La;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
26 Rioja, La;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;85,19
26 Rioja, La;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
26 Rioja, La;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
26 Rioja, La;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
26 Rioja, La;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;82,89
26 Rioja, La;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
26 Rioja, La;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
26 Rioja, La;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
26 Rioja, La;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
26 Rioja, La;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
26 Rioja, La;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
26 Rioja, La;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QI;1.232
26 Rioja, La;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
26 Rioja, La;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
26 Rioja, La;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
26 Rioja, La;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QI;1.151
26 Rioja, La;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
26 Rioja, La;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
26 Rioja, La;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
26 Rioja, La;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QI;1.385
26 Rioja, La;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
26 Rioja, La;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
26 Rioja, La;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2022QII;""
26 Rioja, La;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2022QI;1.196
26 Rioja, La;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
26 Rioja, La;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
26 Rioja, La;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2021QII;""
26 Rioja, La;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2021QI;1.115
26 Rioja, La;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
26 Rioja, La;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
26 Rioja, La;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2020QII;""
26 Rioja, La;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2020QI;1.264
26 Rioja, La;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
26 Rioja, La;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
26 Rioja, La;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2022QII;1.163
26 Rioja, La;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2022QI;""
26 Rioja, La;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
26 Rioja, La;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
26 Rioja, La;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2021QII;1.071
26 Rioja, La;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2021QI;""
26 Rioja, La;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
26 Rioja, La;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
26 Rioja, La;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2020QII;1.221
26 Rioja, La;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2020QI;""
26 Rioja, La;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
26 Rioja, La;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QIII;1.114
26 Rioja, La;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QII;""
26 Rioja, La;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QI;""
26 Rioja, La;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
26 Rioja, La;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QIII;1.020
26 Rioja, La;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QII;""
26 Rioja, La;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QI;""
26 Rioja, La;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
26 Rioja, La;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QIII;1.162
26 Rioja, La;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QII;""
26 Rioja, La;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QI;""
26 Rioja, La;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QIV;1.025
26 Rioja, La;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
26 Rioja, La;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QII;""
26 Rioja, La;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QI;""
26 Rioja, La;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QIV;965
26 Rioja, La;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
26 Rioja, La;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QII;""
26 Rioja, La;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QI;""
26 Rioja, La;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QIV;1.099
26 Rioja, La;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
26 Rioja, La;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QII;""
26 Rioja, La;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QI;""
26 Rioja, La;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
26 Rioja, La;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
26 Rioja, La;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
26 Rioja, La;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
26 Rioja, La;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
26 Rioja, La;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
26 Rioja, La;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
26 Rioja, La;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
26 Rioja, La;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
26 Rioja, La;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
26 Rioja, La;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
26 Rioja, La;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
26 Rioja, La;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
26 Rioja, La;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
26 Rioja, La;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
26 Rioja, La;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;97,08
26 Rioja, La;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
26 Rioja, La;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
26 Rioja, La;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
26 Rioja, La;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;96,87
26 Rioja, La;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
26 Rioja, La;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
26 Rioja, La;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
26 Rioja, La;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;91,26
26 Rioja, La;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
26 Rioja, La;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
26 Rioja, La;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;94,4
26 Rioja, La;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
26 Rioja, La;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
26 Rioja, La;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
26 Rioja, La;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;93,05
26 Rioja, La;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
26 Rioja, La;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
26 Rioja, La;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
26 Rioja, La;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;88,16
26 Rioja, La;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
26 Rioja, La;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
26 Rioja, La;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;90,42
26 Rioja, La;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
26 Rioja, La;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
26 Rioja, La;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
26 Rioja, La;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;88,62
26 Rioja, La;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
26 Rioja, La;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
26 Rioja, La;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
26 Rioja, La;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;83,9
26 Rioja, La;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
26 Rioja, La;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
26 Rioja, La;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;83,2
26 Rioja, La;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
26 Rioja, La;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
26 Rioja, La;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
26 Rioja, La;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;83,84
26 Rioja, La;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
26 Rioja, La;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
26 Rioja, La;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
26 Rioja, La;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;79,35
26 Rioja, La;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
26 Rioja, La;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
26 Rioja, La;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
26 Rioja, La;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
26 Rioja, La;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
26 Rioja, La;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QII;3.996
26 Rioja, La;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
26 Rioja, La;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
26 Rioja, La;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
26 Rioja, La;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QII;3.905
26 Rioja, La;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
26 Rioja, La;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
26 Rioja, La;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
26 Rioja, La;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QII;3.749
26 Rioja, La;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
26 Rioja, La;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
26 Rioja, La;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
26 Rioja, La;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2022QII;3.888
26 Rioja, La;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2022QI;""
26 Rioja, La;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
26 Rioja, La;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
26 Rioja, La;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2021QII;3.776
26 Rioja, La;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2021QI;""
26 Rioja, La;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
26 Rioja, La;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
26 Rioja, La;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2020QII;3.612
26 Rioja, La;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2020QI;""
26 Rioja, La;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
26 Rioja, La;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2022QIII;3.777
26 Rioja, La;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2022QII;""
26 Rioja, La;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2022QI;""
26 Rioja, La;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
26 Rioja, La;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2021QIII;3.640
26 Rioja, La;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2021QII;""
26 Rioja, La;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2021QI;""
26 Rioja, La;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
26 Rioja, La;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2020QIII;3.454
26 Rioja, La;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2020QII;""
26 Rioja, La;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2020QI;""
26 Rioja, La;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QIV;3.537
26 Rioja, La;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
26 Rioja, La;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QII;""
26 Rioja, La;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QI;""
26 Rioja, La;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QIV;3.458
26 Rioja, La;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
26 Rioja, La;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QII;""
26 Rioja, La;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QI;""
26 Rioja, La;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QIV;3.268
26 Rioja, La;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
26 Rioja, La;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QII;""
26 Rioja, La;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QI;""
26 Rioja, La;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
26 Rioja, La;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
26 Rioja, La;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QII;""
26 Rioja, La;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QI;3.353
26 Rioja, La;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
26 Rioja, La;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
26 Rioja, La;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QII;""
26 Rioja, La;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QI;3.178
26 Rioja, La;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
26 Rioja, La;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
26 Rioja, La;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QII;""
26 Rioja, La;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QI;""
26 Rioja, La;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
26 Rioja, La;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
26 Rioja, La;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
26 Rioja, La;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
26 Rioja, La;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
26 Rioja, La;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
26 Rioja, La;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
26 Rioja, La;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
26 Rioja, La;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
26 Rioja, La;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
26 Rioja, La;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
26 Rioja, La;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
26 Rioja, La;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
26 Rioja, La;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
26 Rioja, La;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;97,3
26 Rioja, La;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
26 Rioja, La;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
26 Rioja, La;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
26 Rioja, La;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;96,7
26 Rioja, La;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
26 Rioja, La;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
26 Rioja, La;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
26 Rioja, La;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;96,35
26 Rioja, La;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
26 Rioja, La;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
26 Rioja, La;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;94,52
26 Rioja, La;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
26 Rioja, La;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
26 Rioja, La;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
26 Rioja, La;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;93,21
26 Rioja, La;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
26 Rioja, La;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
26 Rioja, La;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
26 Rioja, La;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;92,13
26 Rioja, La;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
26 Rioja, La;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
26 Rioja, La;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;88,51
26 Rioja, La;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
26 Rioja, La;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
26 Rioja, La;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
26 Rioja, La;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;88,55
26 Rioja, La;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
26 Rioja, La;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
26 Rioja, La;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
26 Rioja, La;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;87,17
26 Rioja, La;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
26 Rioja, La;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
26 Rioja, La;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
26 Rioja, La;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
26 Rioja, La;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
26 Rioja, La;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
26 Rioja, La;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;85,86
26 Rioja, La;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
26 Rioja, La;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
26 Rioja, La;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
26 Rioja, La;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;84,77
26 Rioja, La;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
26 Rioja, La;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
26 Rioja, La;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
26 Rioja, La;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
26 Rioja, La;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
26 Rioja, La;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
26 Rioja, La;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QII;2.571
26 Rioja, La;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
26 Rioja, La;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
26 Rioja, La;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
26 Rioja, La;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QII;2.538
26 Rioja, La;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
26 Rioja, La;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
26 Rioja, La;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
26 Rioja, La;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QII;2.464
26 Rioja, La;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
26 Rioja, La;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
26 Rioja, La;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
26 Rioja, La;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2022QII;2.502
26 Rioja, La;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2022QI;""
26 Rioja, La;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
26 Rioja, La;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
26 Rioja, La;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2021QII;2.458
26 Rioja, La;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2021QI;""
26 Rioja, La;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
26 Rioja, La;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
26 Rioja, La;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2020QII;2.370
26 Rioja, La;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2020QI;""
26 Rioja, La;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
26 Rioja, La;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2022QIII;2.442
26 Rioja, La;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2022QII;""
26 Rioja, La;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2022QI;""
26 Rioja, La;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
26 Rioja, La;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2021QIII;2.378
26 Rioja, La;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2021QII;""
26 Rioja, La;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2021QI;""
26 Rioja, La;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
26 Rioja, La;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2020QIII;2.277
26 Rioja, La;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2020QII;""
26 Rioja, La;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2020QI;""
26 Rioja, La;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QIV;2.301
26 Rioja, La;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
26 Rioja, La;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QII;""
26 Rioja, La;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QI;""
26 Rioja, La;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QIV;2.257
26 Rioja, La;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
26 Rioja, La;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QII;""
26 Rioja, La;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QI;""
26 Rioja, La;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QIV;2.155
26 Rioja, La;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
26 Rioja, La;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QII;""
26 Rioja, La;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QI;""
26 Rioja, La;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
26 Rioja, La;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
26 Rioja, La;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QII;""
26 Rioja, La;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QI;2.186
26 Rioja, La;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
26 Rioja, La;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
26 Rioja, La;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QII;""
26 Rioja, La;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QI;2.097
26 Rioja, La;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
26 Rioja, La;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
26 Rioja, La;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QII;""
26 Rioja, La;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QI;""
26 Rioja, La;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
26 Rioja, La;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
26 Rioja, La;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
26 Rioja, La;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
26 Rioja, La;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
26 Rioja, La;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
26 Rioja, La;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
26 Rioja, La;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
26 Rioja, La;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
26 Rioja, La;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
26 Rioja, La;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
26 Rioja, La;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
26 Rioja, La;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
26 Rioja, La;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
26 Rioja, La;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;97,32
26 Rioja, La;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
26 Rioja, La;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
26 Rioja, La;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
26 Rioja, La;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;96,85
26 Rioja, La;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
26 Rioja, La;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
26 Rioja, La;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
26 Rioja, La;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;96,19
26 Rioja, La;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
26 Rioja, La;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
26 Rioja, La;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;94,98
26 Rioja, La;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
26 Rioja, La;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
26 Rioja, La;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
26 Rioja, La;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;93,7
26 Rioja, La;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
26 Rioja, La;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
26 Rioja, La;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
26 Rioja, La;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;92,41
26 Rioja, La;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
26 Rioja, La;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
26 Rioja, La;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;89,5
26 Rioja, La;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
26 Rioja, La;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
26 Rioja, La;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
26 Rioja, La;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;88,93
26 Rioja, La;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
26 Rioja, La;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
26 Rioja, La;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
26 Rioja, La;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;87,46
26 Rioja, La;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
26 Rioja, La;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
26 Rioja, La;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
26 Rioja, La;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
26 Rioja, La;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
26 Rioja, La;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
26 Rioja, La;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;86,13
26 Rioja, La;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
26 Rioja, La;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
26 Rioja, La;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
26 Rioja, La;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;85,11
26 Rioja, La;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
26 Rioja, La;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
26 Rioja, La;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
26 Rioja, La;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
26 Rioja, La;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
26 Rioja, La;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
26 Rioja, La;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QII;1.425
26 Rioja, La;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
26 Rioja, La;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
26 Rioja, La;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
26 Rioja, La;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QII;1.367
26 Rioja, La;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
26 Rioja, La;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
26 Rioja, La;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
26 Rioja, La;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QII;1.285
26 Rioja, La;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
26 Rioja, La;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
26 Rioja, La;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
26 Rioja, La;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2022QII;1.386
26 Rioja, La;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2022QI;""
26 Rioja, La;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
26 Rioja, La;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
26 Rioja, La;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2021QII;1.318
26 Rioja, La;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2021QI;""
26 Rioja, La;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
26 Rioja, La;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
26 Rioja, La;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2020QII;1.242
26 Rioja, La;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2020QI;""
26 Rioja, La;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
26 Rioja, La;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2022QIII;1.335
26 Rioja, La;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2022QII;""
26 Rioja, La;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2022QI;""
26 Rioja, La;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
26 Rioja, La;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2021QIII;1.262
26 Rioja, La;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2021QII;""
26 Rioja, La;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2021QI;""
26 Rioja, La;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
26 Rioja, La;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2020QIII;1.177
26 Rioja, La;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2020QII;""
26 Rioja, La;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2020QI;""
26 Rioja, La;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QIV;1.236
26 Rioja, La;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
26 Rioja, La;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QII;""
26 Rioja, La;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QI;""
26 Rioja, La;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QIV;1.201
26 Rioja, La;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
26 Rioja, La;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QII;""
26 Rioja, La;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QI;""
26 Rioja, La;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QIV;1.113
26 Rioja, La;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
26 Rioja, La;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QII;""
26 Rioja, La;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QI;""
26 Rioja, La;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
26 Rioja, La;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
26 Rioja, La;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QII;""
26 Rioja, La;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QI;1.167
26 Rioja, La;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
26 Rioja, La;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
26 Rioja, La;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QII;""
26 Rioja, La;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QI;1.081
26 Rioja, La;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
26 Rioja, La;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
26 Rioja, La;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QII;""
26 Rioja, La;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QI;""
26 Rioja, La;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
26 Rioja, La;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
26 Rioja, La;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
26 Rioja, La;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
26 Rioja, La;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
26 Rioja, La;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
26 Rioja, La;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
26 Rioja, La;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
26 Rioja, La;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
26 Rioja, La;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
26 Rioja, La;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
26 Rioja, La;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
26 Rioja, La;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
26 Rioja, La;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
26 Rioja, La;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;97,26
26 Rioja, La;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
26 Rioja, La;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
26 Rioja, La;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
26 Rioja, La;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;96,42
26 Rioja, La;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
26 Rioja, La;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
26 Rioja, La;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
26 Rioja, La;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;96,65
26 Rioja, La;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
26 Rioja, La;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
26 Rioja, La;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;93,68
26 Rioja, La;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
26 Rioja, La;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
26 Rioja, La;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
26 Rioja, La;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;92,32
26 Rioja, La;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
26 Rioja, La;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
26 Rioja, La;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
26 Rioja, La;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;91,6
26 Rioja, La;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
26 Rioja, La;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
26 Rioja, La;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;86,74
26 Rioja, La;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
26 Rioja, La;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
26 Rioja, La;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
26 Rioja, La;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;87,86
26 Rioja, La;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
26 Rioja, La;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
26 Rioja, La;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
26 Rioja, La;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;86,61
26 Rioja, La;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
26 Rioja, La;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
26 Rioja, La;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
26 Rioja, La;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
26 Rioja, La;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
26 Rioja, La;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
26 Rioja, La;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;85,37
26 Rioja, La;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
26 Rioja, La;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
26 Rioja, La;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
26 Rioja, La;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;84,12
26 Rioja, La;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
26 Rioja, La;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
26 Rioja, La;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
26 Rioja, La;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
26 Rioja, La;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
26 Rioja, La;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QIII;3.926
26 Rioja, La;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
26 Rioja, La;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
26 Rioja, La;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
26 Rioja, La;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QIII;3.810
26 Rioja, La;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
26 Rioja, La;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
26 Rioja, La;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
26 Rioja, La;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QIII;3.630
26 Rioja, La;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
26 Rioja, La;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
26 Rioja, La;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
26 Rioja, La;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2022QIII;3.807
26 Rioja, La;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2022QII;""
26 Rioja, La;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2022QI;""
26 Rioja, La;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
26 Rioja, La;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2021QIII;3.668
26 Rioja, La;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2021QII;""
26 Rioja, La;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2021QI;""
26 Rioja, La;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
26 Rioja, La;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2020QIII;3.469
26 Rioja, La;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2020QII;""
26 Rioja, La;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2020QI;""
26 Rioja, La;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2022QIV;3.560
26 Rioja, La;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
26 Rioja, La;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2022QII;""
26 Rioja, La;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2022QI;""
26 Rioja, La;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2021QIV;3.483
26 Rioja, La;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
26 Rioja, La;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2021QII;""
26 Rioja, La;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2021QI;""
26 Rioja, La;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2020QIV;3.282
26 Rioja, La;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
26 Rioja, La;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2020QII;""
26 Rioja, La;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2020QI;""
26 Rioja, La;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
26 Rioja, La;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
26 Rioja, La;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QII;""
26 Rioja, La;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QI;3.376
26 Rioja, La;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
26 Rioja, La;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
26 Rioja, La;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QII;""
26 Rioja, La;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QI;3.190
26 Rioja, La;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
26 Rioja, La;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
26 Rioja, La;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QII;""
26 Rioja, La;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QI;""
26 Rioja, La;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
26 Rioja, La;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
26 Rioja, La;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QII;3.286
26 Rioja, La;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QI;""
26 Rioja, La;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
26 Rioja, La;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
26 Rioja, La;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QII;3.084
26 Rioja, La;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QI;""
26 Rioja, La;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
26 Rioja, La;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
26 Rioja, La;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QII;""
26 Rioja, La;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QI;""
26 Rioja, La;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
26 Rioja, La;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
26 Rioja, La;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
26 Rioja, La;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
26 Rioja, La;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
26 Rioja, La;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
26 Rioja, La;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
26 Rioja, La;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
26 Rioja, La;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
26 Rioja, La;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
26 Rioja, La;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
26 Rioja, La;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
26 Rioja, La;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
26 Rioja, La;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;96,97
26 Rioja, La;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
26 Rioja, La;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
26 Rioja, La;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
26 Rioja, La;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;96,27
26 Rioja, La;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
26 Rioja, La;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
26 Rioja, La;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
26 Rioja, La;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;95,56
26 Rioja, La;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
26 Rioja, La;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
26 Rioja, La;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;90,68
26 Rioja, La;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
26 Rioja, La;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
26 Rioja, La;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
26 Rioja, La;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;91,42
26 Rioja, La;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
26 Rioja, La;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
26 Rioja, La;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
26 Rioja, La;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;90,41
26 Rioja, La;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
26 Rioja, La;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
26 Rioja, La;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
26 Rioja, La;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
26 Rioja, La;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
26 Rioja, La;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
26 Rioja, La;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;88,61
26 Rioja, La;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
26 Rioja, La;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
26 Rioja, La;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
26 Rioja, La;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;87,88
26 Rioja, La;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
26 Rioja, La;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
26 Rioja, La;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
26 Rioja, La;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
26 Rioja, La;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
26 Rioja, La;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
26 Rioja, La;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;86,25
26 Rioja, La;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
26 Rioja, La;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
26 Rioja, La;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
26 Rioja, La;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;84,96
26 Rioja, La;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
26 Rioja, La;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
26 Rioja, La;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
26 Rioja, La;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
26 Rioja, La;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
26 Rioja, La;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
26 Rioja, La;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QIII;2.523
26 Rioja, La;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
26 Rioja, La;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
26 Rioja, La;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
26 Rioja, La;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QIII;2.476
26 Rioja, La;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
26 Rioja, La;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
26 Rioja, La;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
26 Rioja, La;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QIII;2.378
26 Rioja, La;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
26 Rioja, La;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
26 Rioja, La;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
26 Rioja, La;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2022QIII;2.456
26 Rioja, La;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2022QII;""
26 Rioja, La;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2022QI;""
26 Rioja, La;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
26 Rioja, La;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2021QIII;2.393
26 Rioja, La;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2021QII;""
26 Rioja, La;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2021QI;""
26 Rioja, La;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
26 Rioja, La;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2020QIII;2.283
26 Rioja, La;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2020QII;""
26 Rioja, La;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2020QI;""
26 Rioja, La;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2022QIV;2.311
26 Rioja, La;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
26 Rioja, La;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2022QII;""
26 Rioja, La;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2022QI;""
26 Rioja, La;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2021QIV;2.271
26 Rioja, La;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
26 Rioja, La;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2021QII;""
26 Rioja, La;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2021QI;""
26 Rioja, La;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2020QIV;2.161
26 Rioja, La;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
26 Rioja, La;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2020QII;""
26 Rioja, La;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2020QI;""
26 Rioja, La;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
26 Rioja, La;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
26 Rioja, La;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QII;""
26 Rioja, La;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QI;2.200
26 Rioja, La;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
26 Rioja, La;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
26 Rioja, La;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QII;""
26 Rioja, La;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QI;2.101
26 Rioja, La;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
26 Rioja, La;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
26 Rioja, La;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QII;""
26 Rioja, La;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QI;""
26 Rioja, La;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
26 Rioja, La;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
26 Rioja, La;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QII;2.141
26 Rioja, La;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QI;""
26 Rioja, La;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
26 Rioja, La;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
26 Rioja, La;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QII;2.034
26 Rioja, La;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QI;""
26 Rioja, La;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
26 Rioja, La;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
26 Rioja, La;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QII;""
26 Rioja, La;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QI;""
26 Rioja, La;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
26 Rioja, La;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
26 Rioja, La;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
26 Rioja, La;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
26 Rioja, La;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
26 Rioja, La;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
26 Rioja, La;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
26 Rioja, La;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
26 Rioja, La;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
26 Rioja, La;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
26 Rioja, La;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
26 Rioja, La;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
26 Rioja, La;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
26 Rioja, La;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;97,34
26 Rioja, La;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
26 Rioja, La;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
26 Rioja, La;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
26 Rioja, La;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;96,65
26 Rioja, La;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
26 Rioja, La;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
26 Rioja, La;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
26 Rioja, La;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;96,01
26 Rioja, La;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
26 Rioja, La;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
26 Rioja, La;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;91,6
26 Rioja, La;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
26 Rioja, La;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
26 Rioja, La;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
26 Rioja, La;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;91,72
26 Rioja, La;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
26 Rioja, La;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
26 Rioja, La;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
26 Rioja, La;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;90,87
26 Rioja, La;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
26 Rioja, La;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
26 Rioja, La;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
26 Rioja, La;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
26 Rioja, La;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
26 Rioja, La;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
26 Rioja, La;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;88,85
26 Rioja, La;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
26 Rioja, La;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
26 Rioja, La;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
26 Rioja, La;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;88,35
26 Rioja, La;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
26 Rioja, La;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
26 Rioja, La;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
26 Rioja, La;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
26 Rioja, La;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
26 Rioja, La;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
26 Rioja, La;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;86,47
26 Rioja, La;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
26 Rioja, La;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
26 Rioja, La;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
26 Rioja, La;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;85,53
26 Rioja, La;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
26 Rioja, La;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
26 Rioja, La;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
26 Rioja, La;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
26 Rioja, La;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
26 Rioja, La;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
26 Rioja, La;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QIII;1.403
26 Rioja, La;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
26 Rioja, La;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
26 Rioja, La;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
26 Rioja, La;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QIII;1.334
26 Rioja, La;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
26 Rioja, La;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
26 Rioja, La;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
26 Rioja, La;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QIII;1.252
26 Rioja, La;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
26 Rioja, La;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
26 Rioja, La;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
26 Rioja, La;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2022QIII;1.351
26 Rioja, La;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2022QII;""
26 Rioja, La;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2022QI;""
26 Rioja, La;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
26 Rioja, La;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2021QIII;1.275
26 Rioja, La;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2021QII;""
26 Rioja, La;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2021QI;""
26 Rioja, La;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
26 Rioja, La;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2020QIII;1.186
26 Rioja, La;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2020QII;""
26 Rioja, La;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2020QI;""
26 Rioja, La;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2022QIV;1.249
26 Rioja, La;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
26 Rioja, La;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2022QII;""
26 Rioja, La;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2022QI;""
26 Rioja, La;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2021QIV;1.212
26 Rioja, La;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
26 Rioja, La;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2021QII;""
26 Rioja, La;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2021QI;""
26 Rioja, La;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2020QIV;1.121
26 Rioja, La;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
26 Rioja, La;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2020QII;""
26 Rioja, La;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2020QI;""
26 Rioja, La;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
26 Rioja, La;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
26 Rioja, La;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QII;""
26 Rioja, La;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QI;1.176
26 Rioja, La;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
26 Rioja, La;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
26 Rioja, La;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QII;""
26 Rioja, La;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QI;1.089
26 Rioja, La;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
26 Rioja, La;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
26 Rioja, La;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QII;""
26 Rioja, La;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QI;""
26 Rioja, La;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
26 Rioja, La;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
26 Rioja, La;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QII;1.145
26 Rioja, La;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QI;""
26 Rioja, La;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
26 Rioja, La;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
26 Rioja, La;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QII;1.050
26 Rioja, La;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QI;""
26 Rioja, La;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
26 Rioja, La;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
26 Rioja, La;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QII;""
26 Rioja, La;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QI;""
26 Rioja, La;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
26 Rioja, La;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
26 Rioja, La;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
26 Rioja, La;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
26 Rioja, La;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
26 Rioja, La;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
26 Rioja, La;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
26 Rioja, La;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
26 Rioja, La;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
26 Rioja, La;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
26 Rioja, La;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
26 Rioja, La;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
26 Rioja, La;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
26 Rioja, La;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;96,29
26 Rioja, La;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
26 Rioja, La;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
26 Rioja, La;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
26 Rioja, La;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;95,58
26 Rioja, La;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
26 Rioja, La;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
26 Rioja, La;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
26 Rioja, La;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;94,73
26 Rioja, La;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
26 Rioja, La;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
26 Rioja, La;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;89,02
26 Rioja, La;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
26 Rioja, La;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
26 Rioja, La;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
26 Rioja, La;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;90,85
26 Rioja, La;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
26 Rioja, La;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
26 Rioja, La;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
26 Rioja, La;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;89,54
26 Rioja, La;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
26 Rioja, La;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
26 Rioja, La;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
26 Rioja, La;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
26 Rioja, La;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
26 Rioja, La;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
26 Rioja, La;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;88,16
26 Rioja, La;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
26 Rioja, La;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
26 Rioja, La;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
26 Rioja, La;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;86,98
26 Rioja, La;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
26 Rioja, La;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
26 Rioja, La;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
26 Rioja, La;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
26 Rioja, La;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
26 Rioja, La;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
26 Rioja, La;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;85,83
26 Rioja, La;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
26 Rioja, La;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
26 Rioja, La;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
26 Rioja, La;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;83,87
26 Rioja, La;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
26 Rioja, La;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
26 Rioja, La;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
26 Rioja, La;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
26 Rioja, La;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
26 Rioja, La;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QIV;3.835
26 Rioja, La;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
26 Rioja, La;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
26 Rioja, La;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
26 Rioja, La;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QIV;3.692
26 Rioja, La;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
26 Rioja, La;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
26 Rioja, La;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
26 Rioja, La;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QIV;3.504
26 Rioja, La;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
26 Rioja, La;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
26 Rioja, La;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
26 Rioja, La;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2022QIV;3.582
26 Rioja, La;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
26 Rioja, La;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2022QII;""
26 Rioja, La;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2022QI;""
26 Rioja, La;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2021QIV;3.500
26 Rioja, La;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
26 Rioja, La;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2021QII;""
26 Rioja, La;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2021QI;""
26 Rioja, La;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2020QIV;3.311
26 Rioja, La;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
26 Rioja, La;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2020QII;""
26 Rioja, La;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2020QI;""
26 Rioja, La;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
26 Rioja, La;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
26 Rioja, La;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2022QII;""
26 Rioja, La;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2022QI;3.391
26 Rioja, La;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
26 Rioja, La;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
26 Rioja, La;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2021QII;""
26 Rioja, La;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2021QI;3.216
26 Rioja, La;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
26 Rioja, La;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
26 Rioja, La;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2020QII;""
26 Rioja, La;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2020QI;""
26 Rioja, La;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
26 Rioja, La;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
26 Rioja, La;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QII;3.301
26 Rioja, La;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QI;""
26 Rioja, La;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
26 Rioja, La;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
26 Rioja, La;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QII;3.105
26 Rioja, La;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QI;""
26 Rioja, La;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
26 Rioja, La;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
26 Rioja, La;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QII;""
26 Rioja, La;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QI;""
26 Rioja, La;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
26 Rioja, La;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QIII;3.197
26 Rioja, La;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QII;""
26 Rioja, La;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QI;""
26 Rioja, La;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
26 Rioja, La;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QIII;2.981
26 Rioja, La;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QII;""
26 Rioja, La;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QI;""
26 Rioja, La;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
26 Rioja, La;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
26 Rioja, La;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QII;""
26 Rioja, La;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QI;""
26 Rioja, La;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
26 Rioja, La;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
26 Rioja, La;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
26 Rioja, La;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
26 Rioja, La;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
26 Rioja, La;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
26 Rioja, La;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
26 Rioja, La;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
26 Rioja, La;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
26 Rioja, La;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
26 Rioja, La;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
26 Rioja, La;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
26 Rioja, La;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;93,4
26 Rioja, La;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
26 Rioja, La;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
26 Rioja, La;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
26 Rioja, La;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;94,8
26 Rioja, La;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
26 Rioja, La;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
26 Rioja, La;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
26 Rioja, La;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;94,49
26 Rioja, La;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
26 Rioja, La;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
26 Rioja, La;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
26 Rioja, La;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
26 Rioja, La;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
26 Rioja, La;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
26 Rioja, La;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;91,85
26 Rioja, La;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
26 Rioja, La;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
26 Rioja, La;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
26 Rioja, La;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;91,78
26 Rioja, La;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
26 Rioja, La;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
26 Rioja, La;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
26 Rioja, La;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
26 Rioja, La;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
26 Rioja, La;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
26 Rioja, La;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;89,41
26 Rioja, La;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
26 Rioja, La;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
26 Rioja, La;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
26 Rioja, La;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;88,61
26 Rioja, La;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
26 Rioja, La;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
26 Rioja, La;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
26 Rioja, La;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
26 Rioja, La;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
26 Rioja, La;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
26 Rioja, La;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;86,59
26 Rioja, La;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
26 Rioja, La;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
26 Rioja, La;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
26 Rioja, La;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;85,07
26 Rioja, La;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
26 Rioja, La;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
26 Rioja, La;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
26 Rioja, La;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
26 Rioja, La;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
26 Rioja, La;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
26 Rioja, La;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QIV;2.475
26 Rioja, La;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
26 Rioja, La;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
26 Rioja, La;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
26 Rioja, La;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QIV;2.408
26 Rioja, La;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
26 Rioja, La;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
26 Rioja, La;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
26 Rioja, La;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QIV;2.299
26 Rioja, La;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
26 Rioja, La;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
26 Rioja, La;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
26 Rioja, La;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2022QIV;2.324
26 Rioja, La;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
26 Rioja, La;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2022QII;""
26 Rioja, La;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2022QI;""
26 Rioja, La;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2021QIV;2.281
26 Rioja, La;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
26 Rioja, La;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2021QII;""
26 Rioja, La;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2021QI;""
26 Rioja, La;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2020QIV;2.174
26 Rioja, La;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
26 Rioja, La;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2020QII;""
26 Rioja, La;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2020QI;""
26 Rioja, La;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
26 Rioja, La;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
26 Rioja, La;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2022QII;""
26 Rioja, La;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2022QI;2.208
26 Rioja, La;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
26 Rioja, La;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
26 Rioja, La;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2021QII;""
26 Rioja, La;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2021QI;2.114
26 Rioja, La;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
26 Rioja, La;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
26 Rioja, La;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2020QII;""
26 Rioja, La;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2020QI;""
26 Rioja, La;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
26 Rioja, La;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
26 Rioja, La;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QII;2.149
26 Rioja, La;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QI;""
26 Rioja, La;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
26 Rioja, La;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
26 Rioja, La;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QII;2.046
26 Rioja, La;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QI;""
26 Rioja, La;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
26 Rioja, La;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
26 Rioja, La;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QII;""
26 Rioja, La;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QI;""
26 Rioja, La;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
26 Rioja, La;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QIII;2.094
26 Rioja, La;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QII;""
26 Rioja, La;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QI;""
26 Rioja, La;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
26 Rioja, La;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QIII;1.972
26 Rioja, La;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QII;""
26 Rioja, La;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QI;""
26 Rioja, La;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
26 Rioja, La;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
26 Rioja, La;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QII;""
26 Rioja, La;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QI;""
26 Rioja, La;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
26 Rioja, La;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
26 Rioja, La;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
26 Rioja, La;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
26 Rioja, La;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
26 Rioja, La;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
26 Rioja, La;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
26 Rioja, La;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
26 Rioja, La;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
26 Rioja, La;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
26 Rioja, La;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
26 Rioja, La;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
26 Rioja, La;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;93,9
26 Rioja, La;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
26 Rioja, La;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
26 Rioja, La;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
26 Rioja, La;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;94,73
26 Rioja, La;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
26 Rioja, La;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
26 Rioja, La;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
26 Rioja, La;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;94,56
26 Rioja, La;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
26 Rioja, La;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
26 Rioja, La;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
26 Rioja, La;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
26 Rioja, La;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
26 Rioja, La;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
26 Rioja, La;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;91,69
26 Rioja, La;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
26 Rioja, La;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
26 Rioja, La;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
26 Rioja, La;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;91,95
26 Rioja, La;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
26 Rioja, La;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
26 Rioja, La;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
26 Rioja, La;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
26 Rioja, La;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
26 Rioja, La;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
26 Rioja, La;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;89,24
26 Rioja, La;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
26 Rioja, La;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
26 Rioja, La;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
26 Rioja, La;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;89
26 Rioja, La;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
26 Rioja, La;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
26 Rioja, La;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
26 Rioja, La;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
26 Rioja, La;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
26 Rioja, La;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
26 Rioja, La;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;86,96
26 Rioja, La;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
26 Rioja, La;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
26 Rioja, La;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
26 Rioja, La;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;85,78
26 Rioja, La;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
26 Rioja, La;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
26 Rioja, La;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
26 Rioja, La;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
26 Rioja, La;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
26 Rioja, La;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
26 Rioja, La;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QIV;1.360
26 Rioja, La;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
26 Rioja, La;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
26 Rioja, La;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
26 Rioja, La;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QIV;1.284
26 Rioja, La;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
26 Rioja, La;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
26 Rioja, La;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
26 Rioja, La;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QIV;1.205
26 Rioja, La;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
26 Rioja, La;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
26 Rioja, La;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
26 Rioja, La;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2022QIV;1.258
26 Rioja, La;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
26 Rioja, La;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2022QII;""
26 Rioja, La;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2022QI;""
26 Rioja, La;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2021QIV;1.219
26 Rioja, La;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
26 Rioja, La;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2021QII;""
26 Rioja, La;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2021QI;""
26 Rioja, La;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2020QIV;1.137
26 Rioja, La;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
26 Rioja, La;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2020QII;""
26 Rioja, La;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2020QI;""
26 Rioja, La;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
26 Rioja, La;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
26 Rioja, La;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2022QII;""
26 Rioja, La;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2022QI;1.183
26 Rioja, La;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
26 Rioja, La;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
26 Rioja, La;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2021QII;""
26 Rioja, La;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2021QI;1.102
26 Rioja, La;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
26 Rioja, La;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
26 Rioja, La;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2020QII;""
26 Rioja, La;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2020QI;""
26 Rioja, La;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
26 Rioja, La;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
26 Rioja, La;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QII;1.152
26 Rioja, La;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QI;""
26 Rioja, La;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
26 Rioja, La;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
26 Rioja, La;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QII;1.059
26 Rioja, La;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QI;""
26 Rioja, La;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
26 Rioja, La;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
26 Rioja, La;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QII;""
26 Rioja, La;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QI;""
26 Rioja, La;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
26 Rioja, La;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QIII;1.103
26 Rioja, La;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QII;""
26 Rioja, La;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QI;""
26 Rioja, La;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
26 Rioja, La;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QIII;1.009
26 Rioja, La;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QII;""
26 Rioja, La;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QI;""
26 Rioja, La;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
26 Rioja, La;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
26 Rioja, La;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QII;""
26 Rioja, La;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QI;""
26 Rioja, La;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
26 Rioja, La;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
26 Rioja, La;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
26 Rioja, La;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
26 Rioja, La;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
26 Rioja, La;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
26 Rioja, La;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
26 Rioja, La;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
26 Rioja, La;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
26 Rioja, La;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
26 Rioja, La;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
26 Rioja, La;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
26 Rioja, La;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;92,5
26 Rioja, La;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
26 Rioja, La;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
26 Rioja, La;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
26 Rioja, La;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;94,94
26 Rioja, La;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
26 Rioja, La;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
26 Rioja, La;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
26 Rioja, La;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;94,36
26 Rioja, La;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
26 Rioja, La;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
26 Rioja, La;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
26 Rioja, La;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
26 Rioja, La;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
26 Rioja, La;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
26 Rioja, La;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;92,13
26 Rioja, La;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
26 Rioja, La;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
26 Rioja, La;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
26 Rioja, La;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;91,45
26 Rioja, La;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
26 Rioja, La;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
26 Rioja, La;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
26 Rioja, La;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
26 Rioja, La;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
26 Rioja, La;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
26 Rioja, La;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;89,72
26 Rioja, La;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
26 Rioja, La;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
26 Rioja, La;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
26 Rioja, La;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;87,88
26 Rioja, La;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
26 Rioja, La;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
26 Rioja, La;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
26 Rioja, La;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
26 Rioja, La;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
26 Rioja, La;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
26 Rioja, La;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;85,9
26 Rioja, La;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
26 Rioja, La;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
26 Rioja, La;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
26 Rioja, La;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;83,73
26 Rioja, La;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
26 Rioja, La;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
26 Rioja, La;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
26 Rioja, La;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
26 Rioja, La;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
26 Rioja, La;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
37 Salamanca;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
37 Salamanca;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
37 Salamanca;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
37 Salamanca;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QI;20.552
37 Salamanca;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
37 Salamanca;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
37 Salamanca;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
37 Salamanca;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QI;20.616
37 Salamanca;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
37 Salamanca;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
37 Salamanca;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
37 Salamanca;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QI;21.207
37 Salamanca;All ages;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
37 Salamanca;All ages;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
37 Salamanca;All ages;Cohort January 1;Total;Survival in the first trimester;2022QII;""
37 Salamanca;All ages;Cohort January 1;Total;Survival in the first trimester;2022QI;20.046
37 Salamanca;All ages;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
37 Salamanca;All ages;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
37 Salamanca;All ages;Cohort January 1;Total;Survival in the first trimester;2021QII;""
37 Salamanca;All ages;Cohort January 1;Total;Survival in the first trimester;2021QI;20.175
37 Salamanca;All ages;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
37 Salamanca;All ages;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
37 Salamanca;All ages;Cohort January 1;Total;Survival in the first trimester;2020QII;""
37 Salamanca;All ages;Cohort January 1;Total;Survival in the first trimester;2020QI;20.103
37 Salamanca;All ages;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
37 Salamanca;All ages;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
37 Salamanca;All ages;Cohort January 1;Total;Survival in the second trimester;2022QII;19.532
37 Salamanca;All ages;Cohort January 1;Total;Survival in the second trimester;2022QI;""
37 Salamanca;All ages;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
37 Salamanca;All ages;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
37 Salamanca;All ages;Cohort January 1;Total;Survival in the second trimester;2021QII;19.689
37 Salamanca;All ages;Cohort January 1;Total;Survival in the second trimester;2021QI;""
37 Salamanca;All ages;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
37 Salamanca;All ages;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
37 Salamanca;All ages;Cohort January 1;Total;Survival in the second trimester;2020QII;19.701
37 Salamanca;All ages;Cohort January 1;Total;Survival in the second trimester;2020QI;""
37 Salamanca;All ages;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
37 Salamanca;All ages;Cohort January 1;Total;Survival in the third trimester;2022QIII;19.103
37 Salamanca;All ages;Cohort January 1;Total;Survival in the third trimester;2022QII;""
37 Salamanca;All ages;Cohort January 1;Total;Survival in the third trimester;2022QI;""
37 Salamanca;All ages;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
37 Salamanca;All ages;Cohort January 1;Total;Survival in the third trimester;2021QIII;19.287
37 Salamanca;All ages;Cohort January 1;Total;Survival in the third trimester;2021QII;""
37 Salamanca;All ages;Cohort January 1;Total;Survival in the third trimester;2021QI;""
37 Salamanca;All ages;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
37 Salamanca;All ages;Cohort January 1;Total;Survival in the third trimester;2020QIII;19.213
37 Salamanca;All ages;Cohort January 1;Total;Survival in the third trimester;2020QII;""
37 Salamanca;All ages;Cohort January 1;Total;Survival in the third trimester;2020QI;""
37 Salamanca;All ages;Cohort January 1;Total;Survival in the third trimester;2022QIV;18.568
37 Salamanca;All ages;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
37 Salamanca;All ages;Cohort January 1;Total;Survival in the third trimester;2022QII;""
37 Salamanca;All ages;Cohort January 1;Total;Survival in the third trimester;2022QI;""
37 Salamanca;All ages;Cohort January 1;Total;Survival in the third trimester;2021QIV;18.824
37 Salamanca;All ages;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
37 Salamanca;All ages;Cohort January 1;Total;Survival in the third trimester;2021QII;""
37 Salamanca;All ages;Cohort January 1;Total;Survival in the third trimester;2021QI;""
37 Salamanca;All ages;Cohort January 1;Total;Survival in the third trimester;2020QIV;18.773
37 Salamanca;All ages;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
37 Salamanca;All ages;Cohort January 1;Total;Survival in the third trimester;2020QII;""
37 Salamanca;All ages;Cohort January 1;Total;Survival in the third trimester;2020QI;""
37 Salamanca;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
37 Salamanca;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
37 Salamanca;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
37 Salamanca;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
37 Salamanca;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
37 Salamanca;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
37 Salamanca;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
37 Salamanca;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
37 Salamanca;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
37 Salamanca;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
37 Salamanca;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
37 Salamanca;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
37 Salamanca;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
37 Salamanca;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
37 Salamanca;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
37 Salamanca;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;97,54
37 Salamanca;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
37 Salamanca;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
37 Salamanca;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
37 Salamanca;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;97,86
37 Salamanca;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
37 Salamanca;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
37 Salamanca;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
37 Salamanca;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;94,79
37 Salamanca;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
37 Salamanca;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
37 Salamanca;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;95,04
37 Salamanca;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
37 Salamanca;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
37 Salamanca;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
37 Salamanca;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;95,5
37 Salamanca;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
37 Salamanca;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
37 Salamanca;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
37 Salamanca;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;92,9
37 Salamanca;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
37 Salamanca;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
37 Salamanca;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;92,95
37 Salamanca;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
37 Salamanca;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
37 Salamanca;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
37 Salamanca;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;93,55
37 Salamanca;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
37 Salamanca;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
37 Salamanca;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
37 Salamanca;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;90,6
37 Salamanca;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
37 Salamanca;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
37 Salamanca;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;90,35
37 Salamanca;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
37 Salamanca;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
37 Salamanca;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
37 Salamanca;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;91,31
37 Salamanca;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
37 Salamanca;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
37 Salamanca;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
37 Salamanca;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;88,52
37 Salamanca;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
37 Salamanca;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
37 Salamanca;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
37 Salamanca;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
37 Salamanca;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
37 Salamanca;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
37 Salamanca;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QI;13.428
37 Salamanca;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
37 Salamanca;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
37 Salamanca;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
37 Salamanca;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QI;13.519
37 Salamanca;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
37 Salamanca;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
37 Salamanca;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
37 Salamanca;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QI;13.884
37 Salamanca;All ages;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
37 Salamanca;All ages;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
37 Salamanca;All ages;Cohort January 1;Males;Survival in the first trimester;2022QII;""
37 Salamanca;All ages;Cohort January 1;Males;Survival in the first trimester;2022QI;13.120
37 Salamanca;All ages;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
37 Salamanca;All ages;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
37 Salamanca;All ages;Cohort January 1;Males;Survival in the first trimester;2021QII;""
37 Salamanca;All ages;Cohort January 1;Males;Survival in the first trimester;2021QI;13.233
37 Salamanca;All ages;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
37 Salamanca;All ages;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
37 Salamanca;All ages;Cohort January 1;Males;Survival in the first trimester;2020QII;""
37 Salamanca;All ages;Cohort January 1;Males;Survival in the first trimester;2020QI;13.226
37 Salamanca;All ages;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
37 Salamanca;All ages;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
37 Salamanca;All ages;Cohort January 1;Males;Survival in the second trimester;2022QII;12.835
37 Salamanca;All ages;Cohort January 1;Males;Survival in the second trimester;2022QI;""
37 Salamanca;All ages;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
37 Salamanca;All ages;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
37 Salamanca;All ages;Cohort January 1;Males;Survival in the second trimester;2021QII;12.941
37 Salamanca;All ages;Cohort January 1;Males;Survival in the second trimester;2021QI;""
37 Salamanca;All ages;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
37 Salamanca;All ages;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
37 Salamanca;All ages;Cohort January 1;Males;Survival in the second trimester;2020QII;12.991
37 Salamanca;All ages;Cohort January 1;Males;Survival in the second trimester;2020QI;""
37 Salamanca;All ages;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
37 Salamanca;All ages;Cohort January 1;Males;Survival in the third trimester;2022QIII;12.560
37 Salamanca;All ages;Cohort January 1;Males;Survival in the third trimester;2022QII;""
37 Salamanca;All ages;Cohort January 1;Males;Survival in the third trimester;2022QI;""
37 Salamanca;All ages;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
37 Salamanca;All ages;Cohort January 1;Males;Survival in the third trimester;2021QIII;12.705
37 Salamanca;All ages;Cohort January 1;Males;Survival in the third trimester;2021QII;""
37 Salamanca;All ages;Cohort January 1;Males;Survival in the third trimester;2021QI;""
37 Salamanca;All ages;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
37 Salamanca;All ages;Cohort January 1;Males;Survival in the third trimester;2020QIII;12.719
37 Salamanca;All ages;Cohort January 1;Males;Survival in the third trimester;2020QII;""
37 Salamanca;All ages;Cohort January 1;Males;Survival in the third trimester;2020QI;""
37 Salamanca;All ages;Cohort January 1;Males;Survival in the third trimester;2022QIV;12.222
37 Salamanca;All ages;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
37 Salamanca;All ages;Cohort January 1;Males;Survival in the third trimester;2022QII;""
37 Salamanca;All ages;Cohort January 1;Males;Survival in the third trimester;2022QI;""
37 Salamanca;All ages;Cohort January 1;Males;Survival in the third trimester;2021QIV;12.416
37 Salamanca;All ages;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
37 Salamanca;All ages;Cohort January 1;Males;Survival in the third trimester;2021QII;""
37 Salamanca;All ages;Cohort January 1;Males;Survival in the third trimester;2021QI;""
37 Salamanca;All ages;Cohort January 1;Males;Survival in the third trimester;2020QIV;12.442
37 Salamanca;All ages;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
37 Salamanca;All ages;Cohort January 1;Males;Survival in the third trimester;2020QII;""
37 Salamanca;All ages;Cohort January 1;Males;Survival in the third trimester;2020QI;""
37 Salamanca;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
37 Salamanca;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
37 Salamanca;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
37 Salamanca;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
37 Salamanca;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
37 Salamanca;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
37 Salamanca;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
37 Salamanca;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
37 Salamanca;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
37 Salamanca;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
37 Salamanca;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
37 Salamanca;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
37 Salamanca;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
37 Salamanca;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
37 Salamanca;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
37 Salamanca;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;97,71
37 Salamanca;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
37 Salamanca;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
37 Salamanca;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
37 Salamanca;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;97,88
37 Salamanca;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
37 Salamanca;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
37 Salamanca;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
37 Salamanca;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;95,26
37 Salamanca;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
37 Salamanca;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
37 Salamanca;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;95,58
37 Salamanca;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
37 Salamanca;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
37 Salamanca;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
37 Salamanca;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;95,72
37 Salamanca;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
37 Salamanca;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
37 Salamanca;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
37 Salamanca;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;93,57
37 Salamanca;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
37 Salamanca;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
37 Salamanca;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;93,54
37 Salamanca;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
37 Salamanca;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
37 Salamanca;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
37 Salamanca;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;93,98
37 Salamanca;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
37 Salamanca;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
37 Salamanca;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
37 Salamanca;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;91,61
37 Salamanca;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
37 Salamanca;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
37 Salamanca;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;91,02
37 Salamanca;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
37 Salamanca;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
37 Salamanca;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
37 Salamanca;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;91,84
37 Salamanca;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
37 Salamanca;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
37 Salamanca;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
37 Salamanca;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;89,61
37 Salamanca;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
37 Salamanca;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
37 Salamanca;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
37 Salamanca;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
37 Salamanca;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
37 Salamanca;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
37 Salamanca;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QI;7.124
37 Salamanca;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
37 Salamanca;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
37 Salamanca;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
37 Salamanca;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QI;7.097
37 Salamanca;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
37 Salamanca;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
37 Salamanca;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
37 Salamanca;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QI;7.323
37 Salamanca;All ages;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
37 Salamanca;All ages;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
37 Salamanca;All ages;Cohort January 1;Females;Survival in the first trimester;2022QII;""
37 Salamanca;All ages;Cohort January 1;Females;Survival in the first trimester;2022QI;6.926
37 Salamanca;All ages;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
37 Salamanca;All ages;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
37 Salamanca;All ages;Cohort January 1;Females;Survival in the first trimester;2021QII;""
37 Salamanca;All ages;Cohort January 1;Females;Survival in the first trimester;2021QI;6.942
37 Salamanca;All ages;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
37 Salamanca;All ages;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
37 Salamanca;All ages;Cohort January 1;Females;Survival in the first trimester;2020QII;""
37 Salamanca;All ages;Cohort January 1;Females;Survival in the first trimester;2020QI;6.877
37 Salamanca;All ages;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
37 Salamanca;All ages;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
37 Salamanca;All ages;Cohort January 1;Females;Survival in the second trimester;2022QII;6.697
37 Salamanca;All ages;Cohort January 1;Females;Survival in the second trimester;2022QI;""
37 Salamanca;All ages;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
37 Salamanca;All ages;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
37 Salamanca;All ages;Cohort January 1;Females;Survival in the second trimester;2021QII;6.748
37 Salamanca;All ages;Cohort January 1;Females;Survival in the second trimester;2021QI;""
37 Salamanca;All ages;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
37 Salamanca;All ages;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
37 Salamanca;All ages;Cohort January 1;Females;Survival in the second trimester;2020QII;6.710
37 Salamanca;All ages;Cohort January 1;Females;Survival in the second trimester;2020QI;""
37 Salamanca;All ages;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
37 Salamanca;All ages;Cohort January 1;Females;Survival in the third trimester;2022QIII;6.543
37 Salamanca;All ages;Cohort January 1;Females;Survival in the third trimester;2022QII;""
37 Salamanca;All ages;Cohort January 1;Females;Survival in the third trimester;2022QI;""
37 Salamanca;All ages;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
37 Salamanca;All ages;Cohort January 1;Females;Survival in the third trimester;2021QIII;6.582
37 Salamanca;All ages;Cohort January 1;Females;Survival in the third trimester;2021QII;""
37 Salamanca;All ages;Cohort January 1;Females;Survival in the third trimester;2021QI;""
37 Salamanca;All ages;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
37 Salamanca;All ages;Cohort January 1;Females;Survival in the third trimester;2020QIII;6.494
37 Salamanca;All ages;Cohort January 1;Females;Survival in the third trimester;2020QII;""
37 Salamanca;All ages;Cohort January 1;Females;Survival in the third trimester;2020QI;""
37 Salamanca;All ages;Cohort January 1;Females;Survival in the third trimester;2022QIV;6.346
37 Salamanca;All ages;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
37 Salamanca;All ages;Cohort January 1;Females;Survival in the third trimester;2022QII;""
37 Salamanca;All ages;Cohort January 1;Females;Survival in the third trimester;2022QI;""
37 Salamanca;All ages;Cohort January 1;Females;Survival in the third trimester;2021QIV;6.408
37 Salamanca;All ages;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
37 Salamanca;All ages;Cohort January 1;Females;Survival in the third trimester;2021QII;""
37 Salamanca;All ages;Cohort January 1;Females;Survival in the third trimester;2021QI;""
37 Salamanca;All ages;Cohort January 1;Females;Survival in the third trimester;2020QIV;6.331
37 Salamanca;All ages;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
37 Salamanca;All ages;Cohort January 1;Females;Survival in the third trimester;2020QII;""
37 Salamanca;All ages;Cohort January 1;Females;Survival in the third trimester;2020QI;""
37 Salamanca;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
37 Salamanca;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
37 Salamanca;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
37 Salamanca;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
37 Salamanca;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
37 Salamanca;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
37 Salamanca;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
37 Salamanca;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
37 Salamanca;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
37 Salamanca;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
37 Salamanca;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
37 Salamanca;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
37 Salamanca;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
37 Salamanca;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
37 Salamanca;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
37 Salamanca;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;97,22
37 Salamanca;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
37 Salamanca;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
37 Salamanca;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
37 Salamanca;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;97,82
37 Salamanca;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
37 Salamanca;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
37 Salamanca;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
37 Salamanca;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;93,91
37 Salamanca;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
37 Salamanca;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
37 Salamanca;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;94,01
37 Salamanca;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
37 Salamanca;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
37 Salamanca;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
37 Salamanca;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;95,08
37 Salamanca;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
37 Salamanca;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
37 Salamanca;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
37 Salamanca;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;91,63
37 Salamanca;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
37 Salamanca;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
37 Salamanca;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;91,84
37 Salamanca;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
37 Salamanca;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
37 Salamanca;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
37 Salamanca;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;92,74
37 Salamanca;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
37 Salamanca;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
37 Salamanca;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
37 Salamanca;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;88,68
37 Salamanca;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
37 Salamanca;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
37 Salamanca;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;89,08
37 Salamanca;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
37 Salamanca;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
37 Salamanca;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
37 Salamanca;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;90,29
37 Salamanca;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
37 Salamanca;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
37 Salamanca;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
37 Salamanca;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;86,45
37 Salamanca;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
37 Salamanca;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
37 Salamanca;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
37 Salamanca;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
37 Salamanca;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
37 Salamanca;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QII;20.594
37 Salamanca;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
37 Salamanca;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
37 Salamanca;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
37 Salamanca;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QII;20.682
37 Salamanca;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
37 Salamanca;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
37 Salamanca;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
37 Salamanca;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QII;20.773
37 Salamanca;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
37 Salamanca;All ages;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
37 Salamanca;All ages;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
37 Salamanca;All ages;Cohort April 1;Total;Survival in the first trimester;2022QII;20.026
37 Salamanca;All ages;Cohort April 1;Total;Survival in the first trimester;2022QI;""
37 Salamanca;All ages;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
37 Salamanca;All ages;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
37 Salamanca;All ages;Cohort April 1;Total;Survival in the first trimester;2021QII;20.136
37 Salamanca;All ages;Cohort April 1;Total;Survival in the first trimester;2021QI;""
37 Salamanca;All ages;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
37 Salamanca;All ages;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
37 Salamanca;All ages;Cohort April 1;Total;Survival in the first trimester;2020QII;20.333
37 Salamanca;All ages;Cohort April 1;Total;Survival in the first trimester;2020QI;""
37 Salamanca;All ages;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
37 Salamanca;All ages;Cohort April 1;Total;Survival in the second trimester;2022QIII;19.555
37 Salamanca;All ages;Cohort April 1;Total;Survival in the second trimester;2022QII;""
37 Salamanca;All ages;Cohort April 1;Total;Survival in the second trimester;2022QI;""
37 Salamanca;All ages;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
37 Salamanca;All ages;Cohort April 1;Total;Survival in the second trimester;2021QIII;19.696
37 Salamanca;All ages;Cohort April 1;Total;Survival in the second trimester;2021QII;""
37 Salamanca;All ages;Cohort April 1;Total;Survival in the second trimester;2021QI;""
37 Salamanca;All ages;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
37 Salamanca;All ages;Cohort April 1;Total;Survival in the second trimester;2020QIII;19.776
37 Salamanca;All ages;Cohort April 1;Total;Survival in the second trimester;2020QII;""
37 Salamanca;All ages;Cohort April 1;Total;Survival in the second trimester;2020QI;""
37 Salamanca;All ages;Cohort April 1;Total;Survival in the third trimester;2022QIV;18.975
37 Salamanca;All ages;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
37 Salamanca;All ages;Cohort April 1;Total;Survival in the third trimester;2022QII;""
37 Salamanca;All ages;Cohort April 1;Total;Survival in the third trimester;2022QI;""
37 Salamanca;All ages;Cohort April 1;Total;Survival in the third trimester;2021QIV;19.198
37 Salamanca;All ages;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
37 Salamanca;All ages;Cohort April 1;Total;Survival in the third trimester;2021QII;""
37 Salamanca;All ages;Cohort April 1;Total;Survival in the third trimester;2021QI;""
37 Salamanca;All ages;Cohort April 1;Total;Survival in the third trimester;2020QIV;19.311
37 Salamanca;All ages;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
37 Salamanca;All ages;Cohort April 1;Total;Survival in the third trimester;2020QII;""
37 Salamanca;All ages;Cohort April 1;Total;Survival in the third trimester;2020QI;""
37 Salamanca;All ages;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
37 Salamanca;All ages;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
37 Salamanca;All ages;Cohort April 1;Total;Survival in the third trimester;2022QII;""
37 Salamanca;All ages;Cohort April 1;Total;Survival in the third trimester;2022QI;18.796
37 Salamanca;All ages;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
37 Salamanca;All ages;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
37 Salamanca;All ages;Cohort April 1;Total;Survival in the third trimester;2021QII;""
37 Salamanca;All ages;Cohort April 1;Total;Survival in the third trimester;2021QI;18.979
37 Salamanca;All ages;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
37 Salamanca;All ages;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
37 Salamanca;All ages;Cohort April 1;Total;Survival in the third trimester;2020QII;""
37 Salamanca;All ages;Cohort April 1;Total;Survival in the third trimester;2020QI;""
37 Salamanca;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
37 Salamanca;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
37 Salamanca;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
37 Salamanca;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
37 Salamanca;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
37 Salamanca;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
37 Salamanca;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
37 Salamanca;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
37 Salamanca;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
37 Salamanca;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
37 Salamanca;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
37 Salamanca;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
37 Salamanca;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
37 Salamanca;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
37 Salamanca;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;97,24
37 Salamanca;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
37 Salamanca;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
37 Salamanca;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
37 Salamanca;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;97,36
37 Salamanca;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
37 Salamanca;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
37 Salamanca;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
37 Salamanca;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;97,88
37 Salamanca;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
37 Salamanca;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
37 Salamanca;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;94,95
37 Salamanca;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
37 Salamanca;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
37 Salamanca;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
37 Salamanca;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;95,23
37 Salamanca;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
37 Salamanca;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
37 Salamanca;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
37 Salamanca;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;95,2
37 Salamanca;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
37 Salamanca;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
37 Salamanca;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;92,14
37 Salamanca;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
37 Salamanca;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
37 Salamanca;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
37 Salamanca;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;92,82
37 Salamanca;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
37 Salamanca;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
37 Salamanca;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
37 Salamanca;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;92,96
37 Salamanca;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
37 Salamanca;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
37 Salamanca;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
37 Salamanca;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
37 Salamanca;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
37 Salamanca;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
37 Salamanca;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;90,88
37 Salamanca;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
37 Salamanca;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
37 Salamanca;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
37 Salamanca;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;91,36
37 Salamanca;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
37 Salamanca;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
37 Salamanca;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
37 Salamanca;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
37 Salamanca;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
37 Salamanca;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
37 Salamanca;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QII;13.427
37 Salamanca;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
37 Salamanca;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
37 Salamanca;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
37 Salamanca;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QII;13.565
37 Salamanca;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
37 Salamanca;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
37 Salamanca;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
37 Salamanca;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QII;13.607
37 Salamanca;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
37 Salamanca;All ages;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
37 Salamanca;All ages;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
37 Salamanca;All ages;Cohort April 1;Males;Survival in the first trimester;2022QII;13.104
37 Salamanca;All ages;Cohort April 1;Males;Survival in the first trimester;2022QI;""
37 Salamanca;All ages;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
37 Salamanca;All ages;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
37 Salamanca;All ages;Cohort April 1;Males;Survival in the first trimester;2021QII;13.230
37 Salamanca;All ages;Cohort April 1;Males;Survival in the first trimester;2021QI;""
37 Salamanca;All ages;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
37 Salamanca;All ages;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
37 Salamanca;All ages;Cohort April 1;Males;Survival in the first trimester;2020QII;13.347
37 Salamanca;All ages;Cohort April 1;Males;Survival in the first trimester;2020QI;""
37 Salamanca;All ages;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
37 Salamanca;All ages;Cohort April 1;Males;Survival in the second trimester;2022QIII;12.804
37 Salamanca;All ages;Cohort April 1;Males;Survival in the second trimester;2022QII;""
37 Salamanca;All ages;Cohort April 1;Males;Survival in the second trimester;2022QI;""
37 Salamanca;All ages;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
37 Salamanca;All ages;Cohort April 1;Males;Survival in the second trimester;2021QIII;12.970
37 Salamanca;All ages;Cohort April 1;Males;Survival in the second trimester;2021QII;""
37 Salamanca;All ages;Cohort April 1;Males;Survival in the second trimester;2021QI;""
37 Salamanca;All ages;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
37 Salamanca;All ages;Cohort April 1;Males;Survival in the second trimester;2020QIII;13.030
37 Salamanca;All ages;Cohort April 1;Males;Survival in the second trimester;2020QII;""
37 Salamanca;All ages;Cohort April 1;Males;Survival in the second trimester;2020QI;""
37 Salamanca;All ages;Cohort April 1;Males;Survival in the third trimester;2022QIV;12.436
37 Salamanca;All ages;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
37 Salamanca;All ages;Cohort April 1;Males;Survival in the third trimester;2022QII;""
37 Salamanca;All ages;Cohort April 1;Males;Survival in the third trimester;2022QI;""
37 Salamanca;All ages;Cohort April 1;Males;Survival in the third trimester;2021QIV;12.654
37 Salamanca;All ages;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
37 Salamanca;All ages;Cohort April 1;Males;Survival in the third trimester;2021QII;""
37 Salamanca;All ages;Cohort April 1;Males;Survival in the third trimester;2021QI;""
37 Salamanca;All ages;Cohort April 1;Males;Survival in the third trimester;2020QIV;12.740
37 Salamanca;All ages;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
37 Salamanca;All ages;Cohort April 1;Males;Survival in the third trimester;2020QII;""
37 Salamanca;All ages;Cohort April 1;Males;Survival in the third trimester;2020QI;""
37 Salamanca;All ages;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
37 Salamanca;All ages;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
37 Salamanca;All ages;Cohort April 1;Males;Survival in the third trimester;2022QII;""
37 Salamanca;All ages;Cohort April 1;Males;Survival in the third trimester;2022QI;12.410
37 Salamanca;All ages;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
37 Salamanca;All ages;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
37 Salamanca;All ages;Cohort April 1;Males;Survival in the third trimester;2021QII;""
37 Salamanca;All ages;Cohort April 1;Males;Survival in the third trimester;2021QI;12.517
37 Salamanca;All ages;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
37 Salamanca;All ages;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
37 Salamanca;All ages;Cohort April 1;Males;Survival in the third trimester;2020QII;""
37 Salamanca;All ages;Cohort April 1;Males;Survival in the third trimester;2020QI;""
37 Salamanca;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
37 Salamanca;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
37 Salamanca;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
37 Salamanca;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
37 Salamanca;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
37 Salamanca;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
37 Salamanca;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
37 Salamanca;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
37 Salamanca;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
37 Salamanca;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
37 Salamanca;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
37 Salamanca;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
37 Salamanca;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
37 Salamanca;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
37 Salamanca;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;97,59
37 Salamanca;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
37 Salamanca;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
37 Salamanca;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
37 Salamanca;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;97,53
37 Salamanca;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
37 Salamanca;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
37 Salamanca;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
37 Salamanca;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;98,09
37 Salamanca;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
37 Salamanca;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
37 Salamanca;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;95,36
37 Salamanca;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
37 Salamanca;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
37 Salamanca;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
37 Salamanca;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;95,61
37 Salamanca;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
37 Salamanca;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
37 Salamanca;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
37 Salamanca;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;95,76
37 Salamanca;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
37 Salamanca;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
37 Salamanca;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;92,62
37 Salamanca;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
37 Salamanca;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
37 Salamanca;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
37 Salamanca;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;93,28
37 Salamanca;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
37 Salamanca;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
37 Salamanca;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
37 Salamanca;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;93,63
37 Salamanca;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
37 Salamanca;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
37 Salamanca;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
37 Salamanca;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
37 Salamanca;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
37 Salamanca;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
37 Salamanca;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;91,49
37 Salamanca;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
37 Salamanca;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
37 Salamanca;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
37 Salamanca;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;91,99
37 Salamanca;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
37 Salamanca;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
37 Salamanca;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
37 Salamanca;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
37 Salamanca;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
37 Salamanca;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
37 Salamanca;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QII;7.167
37 Salamanca;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
37 Salamanca;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
37 Salamanca;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
37 Salamanca;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QII;7.117
37 Salamanca;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
37 Salamanca;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
37 Salamanca;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
37 Salamanca;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QII;7.166
37 Salamanca;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
37 Salamanca;All ages;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
37 Salamanca;All ages;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
37 Salamanca;All ages;Cohort April 1;Females;Survival in the first trimester;2022QII;6.922
37 Salamanca;All ages;Cohort April 1;Females;Survival in the first trimester;2022QI;""
37 Salamanca;All ages;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
37 Salamanca;All ages;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
37 Salamanca;All ages;Cohort April 1;Females;Survival in the first trimester;2021QII;6.906
37 Salamanca;All ages;Cohort April 1;Females;Survival in the first trimester;2021QI;""
37 Salamanca;All ages;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
37 Salamanca;All ages;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
37 Salamanca;All ages;Cohort April 1;Females;Survival in the first trimester;2020QII;6.986
37 Salamanca;All ages;Cohort April 1;Females;Survival in the first trimester;2020QI;""
37 Salamanca;All ages;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
37 Salamanca;All ages;Cohort April 1;Females;Survival in the second trimester;2022QIII;6.751
37 Salamanca;All ages;Cohort April 1;Females;Survival in the second trimester;2022QII;""
37 Salamanca;All ages;Cohort April 1;Females;Survival in the second trimester;2022QI;""
37 Salamanca;All ages;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
37 Salamanca;All ages;Cohort April 1;Females;Survival in the second trimester;2021QIII;6.726
37 Salamanca;All ages;Cohort April 1;Females;Survival in the second trimester;2021QII;""
37 Salamanca;All ages;Cohort April 1;Females;Survival in the second trimester;2021QI;""
37 Salamanca;All ages;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
37 Salamanca;All ages;Cohort April 1;Females;Survival in the second trimester;2020QIII;6.746
37 Salamanca;All ages;Cohort April 1;Females;Survival in the second trimester;2020QII;""
37 Salamanca;All ages;Cohort April 1;Females;Survival in the second trimester;2020QI;""
37 Salamanca;All ages;Cohort April 1;Females;Survival in the third trimester;2022QIV;6.539
37 Salamanca;All ages;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
37 Salamanca;All ages;Cohort April 1;Females;Survival in the third trimester;2022QII;""
37 Salamanca;All ages;Cohort April 1;Females;Survival in the third trimester;2022QI;""
37 Salamanca;All ages;Cohort April 1;Females;Survival in the third trimester;2021QIV;6.544
37 Salamanca;All ages;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
37 Salamanca;All ages;Cohort April 1;Females;Survival in the third trimester;2021QII;""
37 Salamanca;All ages;Cohort April 1;Females;Survival in the third trimester;2021QI;""
37 Salamanca;All ages;Cohort April 1;Females;Survival in the third trimester;2020QIV;6.571
37 Salamanca;All ages;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
37 Salamanca;All ages;Cohort April 1;Females;Survival in the third trimester;2020QII;""
37 Salamanca;All ages;Cohort April 1;Females;Survival in the third trimester;2020QI;""
37 Salamanca;All ages;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
37 Salamanca;All ages;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
37 Salamanca;All ages;Cohort April 1;Females;Survival in the third trimester;2022QII;""
37 Salamanca;All ages;Cohort April 1;Females;Survival in the third trimester;2022QI;6.386
37 Salamanca;All ages;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
37 Salamanca;All ages;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
37 Salamanca;All ages;Cohort April 1;Females;Survival in the third trimester;2021QII;""
37 Salamanca;All ages;Cohort April 1;Females;Survival in the third trimester;2021QI;6.462
37 Salamanca;All ages;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
37 Salamanca;All ages;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
37 Salamanca;All ages;Cohort April 1;Females;Survival in the third trimester;2020QII;""
37 Salamanca;All ages;Cohort April 1;Females;Survival in the third trimester;2020QI;""
37 Salamanca;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
37 Salamanca;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
37 Salamanca;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
37 Salamanca;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
37 Salamanca;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
37 Salamanca;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
37 Salamanca;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
37 Salamanca;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
37 Salamanca;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
37 Salamanca;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
37 Salamanca;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
37 Salamanca;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
37 Salamanca;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
37 Salamanca;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
37 Salamanca;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;96,58
37 Salamanca;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
37 Salamanca;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
37 Salamanca;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
37 Salamanca;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;97,04
37 Salamanca;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
37 Salamanca;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
37 Salamanca;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
37 Salamanca;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;97,49
37 Salamanca;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
37 Salamanca;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
37 Salamanca;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;94,2
37 Salamanca;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
37 Salamanca;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
37 Salamanca;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
37 Salamanca;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;94,51
37 Salamanca;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
37 Salamanca;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
37 Salamanca;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
37 Salamanca;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;94,14
37 Salamanca;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
37 Salamanca;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
37 Salamanca;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;91,24
37 Salamanca;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
37 Salamanca;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
37 Salamanca;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
37 Salamanca;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;91,95
37 Salamanca;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
37 Salamanca;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
37 Salamanca;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
37 Salamanca;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;91,7
37 Salamanca;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
37 Salamanca;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
37 Salamanca;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
37 Salamanca;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
37 Salamanca;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
37 Salamanca;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
37 Salamanca;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;89,73
37 Salamanca;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
37 Salamanca;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
37 Salamanca;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
37 Salamanca;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;90,18
37 Salamanca;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
37 Salamanca;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
37 Salamanca;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
37 Salamanca;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
37 Salamanca;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
37 Salamanca;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QIII;20.633
37 Salamanca;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
37 Salamanca;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
37 Salamanca;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
37 Salamanca;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QIII;20.733
37 Salamanca;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
37 Salamanca;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
37 Salamanca;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
37 Salamanca;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QIII;20.760
37 Salamanca;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
37 Salamanca;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
37 Salamanca;All ages;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
37 Salamanca;All ages;Cohort July 1;Total;Survival in the first trimester;2022QIII;20.037
37 Salamanca;All ages;Cohort July 1;Total;Survival in the first trimester;2022QII;""
37 Salamanca;All ages;Cohort July 1;Total;Survival in the first trimester;2022QI;""
37 Salamanca;All ages;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
37 Salamanca;All ages;Cohort July 1;Total;Survival in the first trimester;2021QIII;20.169
37 Salamanca;All ages;Cohort July 1;Total;Survival in the first trimester;2021QII;""
37 Salamanca;All ages;Cohort July 1;Total;Survival in the first trimester;2021QI;""
37 Salamanca;All ages;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
37 Salamanca;All ages;Cohort July 1;Total;Survival in the first trimester;2020QIII;20.125
37 Salamanca;All ages;Cohort July 1;Total;Survival in the first trimester;2020QII;""
37 Salamanca;All ages;Cohort July 1;Total;Survival in the first trimester;2020QI;""
37 Salamanca;All ages;Cohort July 1;Total;Survival in the second trimester;2022QIV;19.380
37 Salamanca;All ages;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
37 Salamanca;All ages;Cohort July 1;Total;Survival in the second trimester;2022QII;""
37 Salamanca;All ages;Cohort July 1;Total;Survival in the second trimester;2022QI;""
37 Salamanca;All ages;Cohort July 1;Total;Survival in the second trimester;2021QIV;19.619
37 Salamanca;All ages;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
37 Salamanca;All ages;Cohort July 1;Total;Survival in the second trimester;2021QII;""
37 Salamanca;All ages;Cohort July 1;Total;Survival in the second trimester;2021QI;""
37 Salamanca;All ages;Cohort July 1;Total;Survival in the second trimester;2020QIV;19.616
37 Salamanca;All ages;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
37 Salamanca;All ages;Cohort July 1;Total;Survival in the second trimester;2020QII;""
37 Salamanca;All ages;Cohort July 1;Total;Survival in the second trimester;2020QI;""
37 Salamanca;All ages;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
37 Salamanca;All ages;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
37 Salamanca;All ages;Cohort July 1;Total;Survival in the third trimester;2022QII;""
37 Salamanca;All ages;Cohort July 1;Total;Survival in the third trimester;2022QI;19.192
37 Salamanca;All ages;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
37 Salamanca;All ages;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
37 Salamanca;All ages;Cohort July 1;Total;Survival in the third trimester;2021QII;""
37 Salamanca;All ages;Cohort July 1;Total;Survival in the third trimester;2021QI;19.271
37 Salamanca;All ages;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
37 Salamanca;All ages;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
37 Salamanca;All ages;Cohort July 1;Total;Survival in the third trimester;2020QII;""
37 Salamanca;All ages;Cohort July 1;Total;Survival in the third trimester;2020QI;""
37 Salamanca;All ages;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
37 Salamanca;All ages;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
37 Salamanca;All ages;Cohort July 1;Total;Survival in the third trimester;2022QII;18.772
37 Salamanca;All ages;Cohort July 1;Total;Survival in the third trimester;2022QI;""
37 Salamanca;All ages;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
37 Salamanca;All ages;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
37 Salamanca;All ages;Cohort July 1;Total;Survival in the third trimester;2021QII;18.873
37 Salamanca;All ages;Cohort July 1;Total;Survival in the third trimester;2021QI;""
37 Salamanca;All ages;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
37 Salamanca;All ages;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
37 Salamanca;All ages;Cohort July 1;Total;Survival in the third trimester;2020QII;""
37 Salamanca;All ages;Cohort July 1;Total;Survival in the third trimester;2020QI;""
37 Salamanca;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
37 Salamanca;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
37 Salamanca;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
37 Salamanca;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
37 Salamanca;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
37 Salamanca;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
37 Salamanca;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
37 Salamanca;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
37 Salamanca;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
37 Salamanca;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
37 Salamanca;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
37 Salamanca;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
37 Salamanca;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
37 Salamanca;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;97,11
37 Salamanca;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
37 Salamanca;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
37 Salamanca;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
37 Salamanca;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;97,28
37 Salamanca;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
37 Salamanca;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
37 Salamanca;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
37 Salamanca;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;96,94
37 Salamanca;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
37 Salamanca;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
37 Salamanca;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;93,93
37 Salamanca;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
37 Salamanca;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
37 Salamanca;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
37 Salamanca;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;94,63
37 Salamanca;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
37 Salamanca;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
37 Salamanca;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
37 Salamanca;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;94,49
37 Salamanca;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
37 Salamanca;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
37 Salamanca;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
37 Salamanca;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
37 Salamanca;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
37 Salamanca;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
37 Salamanca;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;92,57
37 Salamanca;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
37 Salamanca;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
37 Salamanca;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
37 Salamanca;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;92,83
37 Salamanca;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
37 Salamanca;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
37 Salamanca;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
37 Salamanca;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
37 Salamanca;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
37 Salamanca;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
37 Salamanca;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;90,54
37 Salamanca;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
37 Salamanca;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
37 Salamanca;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
37 Salamanca;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;90,91
37 Salamanca;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
37 Salamanca;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
37 Salamanca;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
37 Salamanca;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
37 Salamanca;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
37 Salamanca;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
37 Salamanca;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QIII;13.447
37 Salamanca;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
37 Salamanca;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
37 Salamanca;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
37 Salamanca;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QIII;13.591
37 Salamanca;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
37 Salamanca;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
37 Salamanca;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
37 Salamanca;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QIII;13.620
37 Salamanca;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
37 Salamanca;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
37 Salamanca;All ages;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
37 Salamanca;All ages;Cohort July 1;Males;Survival in the first trimester;2022QIII;13.074
37 Salamanca;All ages;Cohort July 1;Males;Survival in the first trimester;2022QII;""
37 Salamanca;All ages;Cohort July 1;Males;Survival in the first trimester;2022QI;""
37 Salamanca;All ages;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
37 Salamanca;All ages;Cohort July 1;Males;Survival in the first trimester;2021QIII;13.256
37 Salamanca;All ages;Cohort July 1;Males;Survival in the first trimester;2021QII;""
37 Salamanca;All ages;Cohort July 1;Males;Survival in the first trimester;2021QI;""
37 Salamanca;All ages;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
37 Salamanca;All ages;Cohort July 1;Males;Survival in the first trimester;2020QIII;13.259
37 Salamanca;All ages;Cohort July 1;Males;Survival in the first trimester;2020QII;""
37 Salamanca;All ages;Cohort July 1;Males;Survival in the first trimester;2020QI;""
37 Salamanca;All ages;Cohort July 1;Males;Survival in the second trimester;2022QIV;12.665
37 Salamanca;All ages;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
37 Salamanca;All ages;Cohort July 1;Males;Survival in the second trimester;2022QII;""
37 Salamanca;All ages;Cohort July 1;Males;Survival in the second trimester;2022QI;""
37 Salamanca;All ages;Cohort July 1;Males;Survival in the second trimester;2021QIV;12.916
37 Salamanca;All ages;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
37 Salamanca;All ages;Cohort July 1;Males;Survival in the second trimester;2021QII;""
37 Salamanca;All ages;Cohort July 1;Males;Survival in the second trimester;2021QI;""
37 Salamanca;All ages;Cohort July 1;Males;Survival in the second trimester;2020QIV;12.933
37 Salamanca;All ages;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
37 Salamanca;All ages;Cohort July 1;Males;Survival in the second trimester;2020QII;""
37 Salamanca;All ages;Cohort July 1;Males;Survival in the second trimester;2020QI;""
37 Salamanca;All ages;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
37 Salamanca;All ages;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
37 Salamanca;All ages;Cohort July 1;Males;Survival in the third trimester;2022QII;""
37 Salamanca;All ages;Cohort July 1;Males;Survival in the third trimester;2022QI;12.654
37 Salamanca;All ages;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
37 Salamanca;All ages;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
37 Salamanca;All ages;Cohort July 1;Males;Survival in the third trimester;2021QII;""
37 Salamanca;All ages;Cohort July 1;Males;Survival in the third trimester;2021QI;12.705
37 Salamanca;All ages;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
37 Salamanca;All ages;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
37 Salamanca;All ages;Cohort July 1;Males;Survival in the third trimester;2020QII;""
37 Salamanca;All ages;Cohort July 1;Males;Survival in the third trimester;2020QI;""
37 Salamanca;All ages;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
37 Salamanca;All ages;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
37 Salamanca;All ages;Cohort July 1;Males;Survival in the third trimester;2022QII;12.414
37 Salamanca;All ages;Cohort July 1;Males;Survival in the third trimester;2022QI;""
37 Salamanca;All ages;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
37 Salamanca;All ages;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
37 Salamanca;All ages;Cohort July 1;Males;Survival in the third trimester;2021QII;12.464
37 Salamanca;All ages;Cohort July 1;Males;Survival in the third trimester;2021QI;""
37 Salamanca;All ages;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
37 Salamanca;All ages;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
37 Salamanca;All ages;Cohort July 1;Males;Survival in the third trimester;2020QII;""
37 Salamanca;All ages;Cohort July 1;Males;Survival in the third trimester;2020QI;""
37 Salamanca;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
37 Salamanca;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
37 Salamanca;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
37 Salamanca;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
37 Salamanca;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
37 Salamanca;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
37 Salamanca;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
37 Salamanca;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
37 Salamanca;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
37 Salamanca;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
37 Salamanca;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
37 Salamanca;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
37 Salamanca;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
37 Salamanca;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;97,23
37 Salamanca;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
37 Salamanca;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
37 Salamanca;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
37 Salamanca;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;97,54
37 Salamanca;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
37 Salamanca;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
37 Salamanca;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
37 Salamanca;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;97,35
37 Salamanca;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
37 Salamanca;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
37 Salamanca;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;94,18
37 Salamanca;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
37 Salamanca;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
37 Salamanca;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
37 Salamanca;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;95,03
37 Salamanca;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
37 Salamanca;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
37 Salamanca;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
37 Salamanca;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;94,96
37 Salamanca;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
37 Salamanca;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
37 Salamanca;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
37 Salamanca;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
37 Salamanca;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
37 Salamanca;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
37 Salamanca;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;93,11
37 Salamanca;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
37 Salamanca;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
37 Salamanca;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
37 Salamanca;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;93,28
37 Salamanca;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
37 Salamanca;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
37 Salamanca;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
37 Salamanca;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
37 Salamanca;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
37 Salamanca;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
37 Salamanca;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;91,34
37 Salamanca;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
37 Salamanca;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
37 Salamanca;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
37 Salamanca;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;91,51
37 Salamanca;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
37 Salamanca;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
37 Salamanca;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
37 Salamanca;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
37 Salamanca;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
37 Salamanca;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
37 Salamanca;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QIII;7.186
37 Salamanca;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
37 Salamanca;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
37 Salamanca;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
37 Salamanca;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QIII;7.142
37 Salamanca;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
37 Salamanca;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
37 Salamanca;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
37 Salamanca;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QIII;7.140
37 Salamanca;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
37 Salamanca;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
37 Salamanca;All ages;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
37 Salamanca;All ages;Cohort July 1;Females;Survival in the first trimester;2022QIII;6.963
37 Salamanca;All ages;Cohort July 1;Females;Survival in the first trimester;2022QII;""
37 Salamanca;All ages;Cohort July 1;Females;Survival in the first trimester;2022QI;""
37 Salamanca;All ages;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
37 Salamanca;All ages;Cohort July 1;Females;Survival in the first trimester;2021QIII;6.913
37 Salamanca;All ages;Cohort July 1;Females;Survival in the first trimester;2021QII;""
37 Salamanca;All ages;Cohort July 1;Females;Survival in the first trimester;2021QI;""
37 Salamanca;All ages;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
37 Salamanca;All ages;Cohort July 1;Females;Survival in the first trimester;2020QIII;6.866
37 Salamanca;All ages;Cohort July 1;Females;Survival in the first trimester;2020QII;""
37 Salamanca;All ages;Cohort July 1;Females;Survival in the first trimester;2020QI;""
37 Salamanca;All ages;Cohort July 1;Females;Survival in the second trimester;2022QIV;6.715
37 Salamanca;All ages;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
37 Salamanca;All ages;Cohort July 1;Females;Survival in the second trimester;2022QII;""
37 Salamanca;All ages;Cohort July 1;Females;Survival in the second trimester;2022QI;""
37 Salamanca;All ages;Cohort July 1;Females;Survival in the second trimester;2021QIV;6.703
37 Salamanca;All ages;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
37 Salamanca;All ages;Cohort July 1;Females;Survival in the second trimester;2021QII;""
37 Salamanca;All ages;Cohort July 1;Females;Survival in the second trimester;2021QI;""
37 Salamanca;All ages;Cohort July 1;Females;Survival in the second trimester;2020QIV;6.683
37 Salamanca;All ages;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
37 Salamanca;All ages;Cohort July 1;Females;Survival in the second trimester;2020QII;""
37 Salamanca;All ages;Cohort July 1;Females;Survival in the second trimester;2020QI;""
37 Salamanca;All ages;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
37 Salamanca;All ages;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
37 Salamanca;All ages;Cohort July 1;Females;Survival in the third trimester;2022QII;""
37 Salamanca;All ages;Cohort July 1;Females;Survival in the third trimester;2022QI;6.538
37 Salamanca;All ages;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
37 Salamanca;All ages;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
37 Salamanca;All ages;Cohort July 1;Females;Survival in the third trimester;2021QII;""
37 Salamanca;All ages;Cohort July 1;Females;Survival in the third trimester;2021QI;6.566
37 Salamanca;All ages;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
37 Salamanca;All ages;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
37 Salamanca;All ages;Cohort July 1;Females;Survival in the third trimester;2020QII;""
37 Salamanca;All ages;Cohort July 1;Females;Survival in the third trimester;2020QI;""
37 Salamanca;All ages;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
37 Salamanca;All ages;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
37 Salamanca;All ages;Cohort July 1;Females;Survival in the third trimester;2022QII;6.358
37 Salamanca;All ages;Cohort July 1;Females;Survival in the third trimester;2022QI;""
37 Salamanca;All ages;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
37 Salamanca;All ages;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
37 Salamanca;All ages;Cohort July 1;Females;Survival in the third trimester;2021QII;6.409
37 Salamanca;All ages;Cohort July 1;Females;Survival in the third trimester;2021QI;""
37 Salamanca;All ages;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
37 Salamanca;All ages;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
37 Salamanca;All ages;Cohort July 1;Females;Survival in the third trimester;2020QII;""
37 Salamanca;All ages;Cohort July 1;Females;Survival in the third trimester;2020QI;""
37 Salamanca;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
37 Salamanca;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
37 Salamanca;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
37 Salamanca;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
37 Salamanca;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
37 Salamanca;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
37 Salamanca;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
37 Salamanca;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
37 Salamanca;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
37 Salamanca;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
37 Salamanca;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
37 Salamanca;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
37 Salamanca;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
37 Salamanca;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;96,9
37 Salamanca;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
37 Salamanca;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
37 Salamanca;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
37 Salamanca;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;96,79
37 Salamanca;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
37 Salamanca;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
37 Salamanca;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
37 Salamanca;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;96,16
37 Salamanca;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
37 Salamanca;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
37 Salamanca;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;93,45
37 Salamanca;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
37 Salamanca;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
37 Salamanca;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
37 Salamanca;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;93,85
37 Salamanca;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
37 Salamanca;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
37 Salamanca;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
37 Salamanca;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;93,6
37 Salamanca;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
37 Salamanca;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
37 Salamanca;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
37 Salamanca;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
37 Salamanca;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
37 Salamanca;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
37 Salamanca;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;91,54
37 Salamanca;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
37 Salamanca;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
37 Salamanca;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
37 Salamanca;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;91,96
37 Salamanca;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
37 Salamanca;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
37 Salamanca;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
37 Salamanca;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
37 Salamanca;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
37 Salamanca;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
37 Salamanca;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;89,02
37 Salamanca;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
37 Salamanca;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
37 Salamanca;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
37 Salamanca;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;89,76
37 Salamanca;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
37 Salamanca;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
37 Salamanca;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
37 Salamanca;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
37 Salamanca;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
37 Salamanca;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QIV;20.475
37 Salamanca;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
37 Salamanca;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
37 Salamanca;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
37 Salamanca;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QIV;20.653
37 Salamanca;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
37 Salamanca;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
37 Salamanca;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
37 Salamanca;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QIV;20.673
37 Salamanca;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
37 Salamanca;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
37 Salamanca;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
37 Salamanca;All ages;Cohort October 1;Total;Survival in the first trimester;2022QIV;19.768
37 Salamanca;All ages;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
37 Salamanca;All ages;Cohort October 1;Total;Survival in the first trimester;2022QII;""
37 Salamanca;All ages;Cohort October 1;Total;Survival in the first trimester;2022QI;""
37 Salamanca;All ages;Cohort October 1;Total;Survival in the first trimester;2021QIV;20.051
37 Salamanca;All ages;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
37 Salamanca;All ages;Cohort October 1;Total;Survival in the first trimester;2021QII;""
37 Salamanca;All ages;Cohort October 1;Total;Survival in the first trimester;2021QI;""
37 Salamanca;All ages;Cohort October 1;Total;Survival in the first trimester;2020QIV;20.098
37 Salamanca;All ages;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
37 Salamanca;All ages;Cohort October 1;Total;Survival in the first trimester;2020QII;""
37 Salamanca;All ages;Cohort October 1;Total;Survival in the first trimester;2020QI;""
37 Salamanca;All ages;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
37 Salamanca;All ages;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
37 Salamanca;All ages;Cohort October 1;Total;Survival in the second trimester;2022QII;""
37 Salamanca;All ages;Cohort October 1;Total;Survival in the second trimester;2022QI;19.591
37 Salamanca;All ages;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
37 Salamanca;All ages;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
37 Salamanca;All ages;Cohort October 1;Total;Survival in the second trimester;2021QII;""
37 Salamanca;All ages;Cohort October 1;Total;Survival in the second trimester;2021QI;19.723
37 Salamanca;All ages;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
37 Salamanca;All ages;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
37 Salamanca;All ages;Cohort October 1;Total;Survival in the second trimester;2020QII;""
37 Salamanca;All ages;Cohort October 1;Total;Survival in the second trimester;2020QI;""
37 Salamanca;All ages;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
37 Salamanca;All ages;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
37 Salamanca;All ages;Cohort October 1;Total;Survival in the third trimester;2022QII;19.140
37 Salamanca;All ages;Cohort October 1;Total;Survival in the third trimester;2022QI;""
37 Salamanca;All ages;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
37 Salamanca;All ages;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
37 Salamanca;All ages;Cohort October 1;Total;Survival in the third trimester;2021QII;19.295
37 Salamanca;All ages;Cohort October 1;Total;Survival in the third trimester;2021QI;""
37 Salamanca;All ages;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
37 Salamanca;All ages;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
37 Salamanca;All ages;Cohort October 1;Total;Survival in the third trimester;2020QII;""
37 Salamanca;All ages;Cohort October 1;Total;Survival in the third trimester;2020QI;""
37 Salamanca;All ages;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
37 Salamanca;All ages;Cohort October 1;Total;Survival in the third trimester;2022QIII;18.736
37 Salamanca;All ages;Cohort October 1;Total;Survival in the third trimester;2022QII;""
37 Salamanca;All ages;Cohort October 1;Total;Survival in the third trimester;2022QI;""
37 Salamanca;All ages;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
37 Salamanca;All ages;Cohort October 1;Total;Survival in the third trimester;2021QIII;18.925
37 Salamanca;All ages;Cohort October 1;Total;Survival in the third trimester;2021QII;""
37 Salamanca;All ages;Cohort October 1;Total;Survival in the third trimester;2021QI;""
37 Salamanca;All ages;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
37 Salamanca;All ages;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
37 Salamanca;All ages;Cohort October 1;Total;Survival in the third trimester;2020QII;""
37 Salamanca;All ages;Cohort October 1;Total;Survival in the third trimester;2020QI;""
37 Salamanca;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
37 Salamanca;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
37 Salamanca;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
37 Salamanca;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
37 Salamanca;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
37 Salamanca;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
37 Salamanca;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
37 Salamanca;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
37 Salamanca;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
37 Salamanca;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
37 Salamanca;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
37 Salamanca;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
37 Salamanca;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;96,55
37 Salamanca;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
37 Salamanca;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
37 Salamanca;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
37 Salamanca;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;97,09
37 Salamanca;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
37 Salamanca;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
37 Salamanca;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
37 Salamanca;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;97,22
37 Salamanca;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
37 Salamanca;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
37 Salamanca;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
37 Salamanca;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
37 Salamanca;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
37 Salamanca;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
37 Salamanca;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;94,86
37 Salamanca;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
37 Salamanca;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
37 Salamanca;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
37 Salamanca;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;95,4
37 Salamanca;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
37 Salamanca;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
37 Salamanca;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
37 Salamanca;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
37 Salamanca;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
37 Salamanca;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
37 Salamanca;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;92,67
37 Salamanca;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
37 Salamanca;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
37 Salamanca;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
37 Salamanca;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;93,33
37 Salamanca;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
37 Salamanca;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
37 Salamanca;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
37 Salamanca;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
37 Salamanca;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
37 Salamanca;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
37 Salamanca;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;90,72
37 Salamanca;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
37 Salamanca;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
37 Salamanca;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
37 Salamanca;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;91,54
37 Salamanca;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
37 Salamanca;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
37 Salamanca;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
37 Salamanca;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
37 Salamanca;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
37 Salamanca;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
37 Salamanca;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QIV;13.301
37 Salamanca;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
37 Salamanca;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
37 Salamanca;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
37 Salamanca;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QIV;13.531
37 Salamanca;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
37 Salamanca;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
37 Salamanca;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
37 Salamanca;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QIV;13.583
37 Salamanca;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
37 Salamanca;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
37 Salamanca;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
37 Salamanca;All ages;Cohort October 1;Males;Survival in the first trimester;2022QIV;12.865
37 Salamanca;All ages;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
37 Salamanca;All ages;Cohort October 1;Males;Survival in the first trimester;2022QII;""
37 Salamanca;All ages;Cohort October 1;Males;Survival in the first trimester;2022QI;""
37 Salamanca;All ages;Cohort October 1;Males;Survival in the first trimester;2021QIV;13.158
37 Salamanca;All ages;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
37 Salamanca;All ages;Cohort October 1;Males;Survival in the first trimester;2021QII;""
37 Salamanca;All ages;Cohort October 1;Males;Survival in the first trimester;2021QI;""
37 Salamanca;All ages;Cohort October 1;Males;Survival in the first trimester;2020QIV;13.210
37 Salamanca;All ages;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
37 Salamanca;All ages;Cohort October 1;Males;Survival in the first trimester;2020QII;""
37 Salamanca;All ages;Cohort October 1;Males;Survival in the first trimester;2020QI;""
37 Salamanca;All ages;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
37 Salamanca;All ages;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
37 Salamanca;All ages;Cohort October 1;Males;Survival in the second trimester;2022QII;""
37 Salamanca;All ages;Cohort October 1;Males;Survival in the second trimester;2022QI;12.878
37 Salamanca;All ages;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
37 Salamanca;All ages;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
37 Salamanca;All ages;Cohort October 1;Males;Survival in the second trimester;2021QII;""
37 Salamanca;All ages;Cohort October 1;Males;Survival in the second trimester;2021QI;12.965
37 Salamanca;All ages;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
37 Salamanca;All ages;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
37 Salamanca;All ages;Cohort October 1;Males;Survival in the second trimester;2020QII;""
37 Salamanca;All ages;Cohort October 1;Males;Survival in the second trimester;2020QI;""
37 Salamanca;All ages;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
37 Salamanca;All ages;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
37 Salamanca;All ages;Cohort October 1;Males;Survival in the third trimester;2022QII;12.622
37 Salamanca;All ages;Cohort October 1;Males;Survival in the third trimester;2022QI;""
37 Salamanca;All ages;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
37 Salamanca;All ages;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
37 Salamanca;All ages;Cohort October 1;Males;Survival in the third trimester;2021QII;12.707
37 Salamanca;All ages;Cohort October 1;Males;Survival in the third trimester;2021QI;""
37 Salamanca;All ages;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
37 Salamanca;All ages;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
37 Salamanca;All ages;Cohort October 1;Males;Survival in the third trimester;2020QII;""
37 Salamanca;All ages;Cohort October 1;Males;Survival in the third trimester;2020QI;""
37 Salamanca;All ages;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
37 Salamanca;All ages;Cohort October 1;Males;Survival in the third trimester;2022QIII;12.366
37 Salamanca;All ages;Cohort October 1;Males;Survival in the third trimester;2022QII;""
37 Salamanca;All ages;Cohort October 1;Males;Survival in the third trimester;2022QI;""
37 Salamanca;All ages;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
37 Salamanca;All ages;Cohort October 1;Males;Survival in the third trimester;2021QIII;12.492
37 Salamanca;All ages;Cohort October 1;Males;Survival in the third trimester;2021QII;""
37 Salamanca;All ages;Cohort October 1;Males;Survival in the third trimester;2021QI;""
37 Salamanca;All ages;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
37 Salamanca;All ages;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
37 Salamanca;All ages;Cohort October 1;Males;Survival in the third trimester;2020QII;""
37 Salamanca;All ages;Cohort October 1;Males;Survival in the third trimester;2020QI;""
37 Salamanca;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
37 Salamanca;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
37 Salamanca;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
37 Salamanca;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
37 Salamanca;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
37 Salamanca;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
37 Salamanca;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
37 Salamanca;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
37 Salamanca;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
37 Salamanca;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
37 Salamanca;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
37 Salamanca;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
37 Salamanca;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;96,72
37 Salamanca;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
37 Salamanca;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
37 Salamanca;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
37 Salamanca;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;97,24
37 Salamanca;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
37 Salamanca;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
37 Salamanca;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
37 Salamanca;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;97,25
37 Salamanca;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
37 Salamanca;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
37 Salamanca;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
37 Salamanca;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
37 Salamanca;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
37 Salamanca;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
37 Salamanca;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;95,17
37 Salamanca;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
37 Salamanca;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
37 Salamanca;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
37 Salamanca;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;95,45
37 Salamanca;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
37 Salamanca;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
37 Salamanca;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
37 Salamanca;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
37 Salamanca;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
37 Salamanca;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
37 Salamanca;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;93,28
37 Salamanca;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
37 Salamanca;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
37 Salamanca;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
37 Salamanca;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;93,55
37 Salamanca;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
37 Salamanca;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
37 Salamanca;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
37 Salamanca;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
37 Salamanca;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
37 Salamanca;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
37 Salamanca;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;91,39
37 Salamanca;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
37 Salamanca;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
37 Salamanca;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
37 Salamanca;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;91,97
37 Salamanca;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
37 Salamanca;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
37 Salamanca;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
37 Salamanca;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
37 Salamanca;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
37 Salamanca;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
37 Salamanca;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QIV;7.174
37 Salamanca;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
37 Salamanca;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
37 Salamanca;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
37 Salamanca;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QIV;7.122
37 Salamanca;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
37 Salamanca;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
37 Salamanca;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
37 Salamanca;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QIV;7.090
37 Salamanca;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
37 Salamanca;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
37 Salamanca;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
37 Salamanca;All ages;Cohort October 1;Females;Survival in the first trimester;2022QIV;6.903
37 Salamanca;All ages;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
37 Salamanca;All ages;Cohort October 1;Females;Survival in the first trimester;2022QII;""
37 Salamanca;All ages;Cohort October 1;Females;Survival in the first trimester;2022QI;""
37 Salamanca;All ages;Cohort October 1;Females;Survival in the first trimester;2021QIV;6.893
37 Salamanca;All ages;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
37 Salamanca;All ages;Cohort October 1;Females;Survival in the first trimester;2021QII;""
37 Salamanca;All ages;Cohort October 1;Females;Survival in the first trimester;2021QI;""
37 Salamanca;All ages;Cohort October 1;Females;Survival in the first trimester;2020QIV;6.888
37 Salamanca;All ages;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
37 Salamanca;All ages;Cohort October 1;Females;Survival in the first trimester;2020QII;""
37 Salamanca;All ages;Cohort October 1;Females;Survival in the first trimester;2020QI;""
37 Salamanca;All ages;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
37 Salamanca;All ages;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
37 Salamanca;All ages;Cohort October 1;Females;Survival in the second trimester;2022QII;""
37 Salamanca;All ages;Cohort October 1;Females;Survival in the second trimester;2022QI;6.713
37 Salamanca;All ages;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
37 Salamanca;All ages;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
37 Salamanca;All ages;Cohort October 1;Females;Survival in the second trimester;2021QII;""
37 Salamanca;All ages;Cohort October 1;Females;Survival in the second trimester;2021QI;6.758
37 Salamanca;All ages;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
37 Salamanca;All ages;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
37 Salamanca;All ages;Cohort October 1;Females;Survival in the second trimester;2020QII;""
37 Salamanca;All ages;Cohort October 1;Females;Survival in the second trimester;2020QI;""
37 Salamanca;All ages;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
37 Salamanca;All ages;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
37 Salamanca;All ages;Cohort October 1;Females;Survival in the third trimester;2022QII;6.518
37 Salamanca;All ages;Cohort October 1;Females;Survival in the third trimester;2022QI;""
37 Salamanca;All ages;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
37 Salamanca;All ages;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
37 Salamanca;All ages;Cohort October 1;Females;Survival in the third trimester;2021QII;6.588
37 Salamanca;All ages;Cohort October 1;Females;Survival in the third trimester;2021QI;""
37 Salamanca;All ages;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
37 Salamanca;All ages;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
37 Salamanca;All ages;Cohort October 1;Females;Survival in the third trimester;2020QII;""
37 Salamanca;All ages;Cohort October 1;Females;Survival in the third trimester;2020QI;""
37 Salamanca;All ages;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
37 Salamanca;All ages;Cohort October 1;Females;Survival in the third trimester;2022QIII;6.370
37 Salamanca;All ages;Cohort October 1;Females;Survival in the third trimester;2022QII;""
37 Salamanca;All ages;Cohort October 1;Females;Survival in the third trimester;2022QI;""
37 Salamanca;All ages;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
37 Salamanca;All ages;Cohort October 1;Females;Survival in the third trimester;2021QIII;6.433
37 Salamanca;All ages;Cohort October 1;Females;Survival in the third trimester;2021QII;""
37 Salamanca;All ages;Cohort October 1;Females;Survival in the third trimester;2021QI;""
37 Salamanca;All ages;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
37 Salamanca;All ages;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
37 Salamanca;All ages;Cohort October 1;Females;Survival in the third trimester;2020QII;""
37 Salamanca;All ages;Cohort October 1;Females;Survival in the third trimester;2020QI;""
37 Salamanca;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
37 Salamanca;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
37 Salamanca;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
37 Salamanca;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
37 Salamanca;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
37 Salamanca;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
37 Salamanca;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
37 Salamanca;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
37 Salamanca;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
37 Salamanca;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
37 Salamanca;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
37 Salamanca;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
37 Salamanca;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;96,22
37 Salamanca;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
37 Salamanca;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
37 Salamanca;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
37 Salamanca;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;96,78
37 Salamanca;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
37 Salamanca;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
37 Salamanca;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
37 Salamanca;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;97,15
37 Salamanca;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
37 Salamanca;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
37 Salamanca;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
37 Salamanca;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
37 Salamanca;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
37 Salamanca;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
37 Salamanca;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;94,26
37 Salamanca;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
37 Salamanca;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
37 Salamanca;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
37 Salamanca;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;95,32
37 Salamanca;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
37 Salamanca;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
37 Salamanca;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
37 Salamanca;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
37 Salamanca;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
37 Salamanca;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
37 Salamanca;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;91,52
37 Salamanca;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
37 Salamanca;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
37 Salamanca;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
37 Salamanca;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;92,92
37 Salamanca;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
37 Salamanca;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
37 Salamanca;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
37 Salamanca;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
37 Salamanca;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
37 Salamanca;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
37 Salamanca;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;89,44
37 Salamanca;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
37 Salamanca;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
37 Salamanca;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
37 Salamanca;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;90,73
37 Salamanca;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
37 Salamanca;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
37 Salamanca;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
37 Salamanca;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
37 Salamanca;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
37 Salamanca;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
37 Salamanca;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
37 Salamanca;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
37 Salamanca;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
37 Salamanca;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QI;1.054
37 Salamanca;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
37 Salamanca;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
37 Salamanca;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
37 Salamanca;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QI;1.066
37 Salamanca;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
37 Salamanca;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
37 Salamanca;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
37 Salamanca;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QI;966
37 Salamanca;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
37 Salamanca;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
37 Salamanca;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2022QII;""
37 Salamanca;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2022QI;987
37 Salamanca;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
37 Salamanca;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
37 Salamanca;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2021QII;""
37 Salamanca;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2021QI;1.014
37 Salamanca;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
37 Salamanca;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
37 Salamanca;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2020QII;""
37 Salamanca;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2020QI;841
37 Salamanca;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
37 Salamanca;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
37 Salamanca;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2022QII;930
37 Salamanca;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2022QI;""
37 Salamanca;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
37 Salamanca;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
37 Salamanca;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2021QII;948
37 Salamanca;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2021QI;""
37 Salamanca;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
37 Salamanca;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
37 Salamanca;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2020QII;805
37 Salamanca;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2020QI;""
37 Salamanca;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
37 Salamanca;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QIII;866
37 Salamanca;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QII;""
37 Salamanca;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QI;""
37 Salamanca;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
37 Salamanca;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QIII;897
37 Salamanca;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QII;""
37 Salamanca;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QI;""
37 Salamanca;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
37 Salamanca;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QIII;752
37 Salamanca;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QII;""
37 Salamanca;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QI;""
37 Salamanca;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QIV;816
37 Salamanca;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
37 Salamanca;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QII;""
37 Salamanca;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QI;""
37 Salamanca;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QIV;844
37 Salamanca;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
37 Salamanca;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QII;""
37 Salamanca;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QI;""
37 Salamanca;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QIV;708
37 Salamanca;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
37 Salamanca;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QII;""
37 Salamanca;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QI;""
37 Salamanca;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
37 Salamanca;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
37 Salamanca;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
37 Salamanca;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
37 Salamanca;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
37 Salamanca;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
37 Salamanca;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
37 Salamanca;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
37 Salamanca;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
37 Salamanca;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
37 Salamanca;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
37 Salamanca;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
37 Salamanca;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
37 Salamanca;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
37 Salamanca;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
37 Salamanca;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;93,64
37 Salamanca;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
37 Salamanca;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
37 Salamanca;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
37 Salamanca;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;95,12
37 Salamanca;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
37 Salamanca;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
37 Salamanca;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
37 Salamanca;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;87,06
37 Salamanca;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
37 Salamanca;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
37 Salamanca;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;88,24
37 Salamanca;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
37 Salamanca;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
37 Salamanca;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
37 Salamanca;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;88,93
37 Salamanca;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
37 Salamanca;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
37 Salamanca;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
37 Salamanca;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;83,33
37 Salamanca;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
37 Salamanca;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
37 Salamanca;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;82,16
37 Salamanca;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
37 Salamanca;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
37 Salamanca;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
37 Salamanca;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;84,15
37 Salamanca;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
37 Salamanca;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
37 Salamanca;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
37 Salamanca;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;77,85
37 Salamanca;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
37 Salamanca;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
37 Salamanca;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;77,42
37 Salamanca;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
37 Salamanca;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
37 Salamanca;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
37 Salamanca;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;79,17
37 Salamanca;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
37 Salamanca;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
37 Salamanca;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
37 Salamanca;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;73,29
37 Salamanca;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
37 Salamanca;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
37 Salamanca;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
37 Salamanca;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
37 Salamanca;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
37 Salamanca;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
37 Salamanca;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QI;650
37 Salamanca;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
37 Salamanca;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
37 Salamanca;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
37 Salamanca;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QI;680
37 Salamanca;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
37 Salamanca;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
37 Salamanca;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
37 Salamanca;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QI;611
37 Salamanca;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
37 Salamanca;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
37 Salamanca;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2022QII;""
37 Salamanca;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2022QI;616
37 Salamanca;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
37 Salamanca;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
37 Salamanca;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2021QII;""
37 Salamanca;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2021QI;640
37 Salamanca;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
37 Salamanca;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
37 Salamanca;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2020QII;""
37 Salamanca;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2020QI;544
37 Salamanca;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
37 Salamanca;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
37 Salamanca;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2022QII;588
37 Salamanca;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2022QI;""
37 Salamanca;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
37 Salamanca;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
37 Salamanca;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2021QII;596
37 Salamanca;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2021QI;""
37 Salamanca;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
37 Salamanca;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
37 Salamanca;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2020QII;526
37 Salamanca;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2020QI;""
37 Salamanca;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
37 Salamanca;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QIII;552
37 Salamanca;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QII;""
37 Salamanca;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QI;""
37 Salamanca;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
37 Salamanca;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QIII;560
37 Salamanca;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QII;""
37 Salamanca;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QI;""
37 Salamanca;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
37 Salamanca;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QIII;492
37 Salamanca;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QII;""
37 Salamanca;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QI;""
37 Salamanca;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QIV;516
37 Salamanca;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
37 Salamanca;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QII;""
37 Salamanca;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QI;""
37 Salamanca;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QIV;530
37 Salamanca;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
37 Salamanca;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QII;""
37 Salamanca;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QI;""
37 Salamanca;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QIV;464
37 Salamanca;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
37 Salamanca;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QII;""
37 Salamanca;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QI;""
37 Salamanca;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
37 Salamanca;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
37 Salamanca;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
37 Salamanca;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
37 Salamanca;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
37 Salamanca;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
37 Salamanca;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
37 Salamanca;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
37 Salamanca;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
37 Salamanca;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
37 Salamanca;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
37 Salamanca;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
37 Salamanca;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
37 Salamanca;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
37 Salamanca;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
37 Salamanca;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;94,77
37 Salamanca;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
37 Salamanca;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
37 Salamanca;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
37 Salamanca;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;94,12
37 Salamanca;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
37 Salamanca;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
37 Salamanca;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
37 Salamanca;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;89,03
37 Salamanca;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
37 Salamanca;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
37 Salamanca;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;90,46
37 Salamanca;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
37 Salamanca;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
37 Salamanca;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
37 Salamanca;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;87,65
37 Salamanca;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
37 Salamanca;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
37 Salamanca;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
37 Salamanca;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;86,09
37 Salamanca;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
37 Salamanca;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
37 Salamanca;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;84,92
37 Salamanca;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
37 Salamanca;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
37 Salamanca;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
37 Salamanca;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;82,35
37 Salamanca;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
37 Salamanca;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
37 Salamanca;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
37 Salamanca;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;80,52
37 Salamanca;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
37 Salamanca;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
37 Salamanca;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;79,38
37 Salamanca;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
37 Salamanca;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
37 Salamanca;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
37 Salamanca;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;77,94
37 Salamanca;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
37 Salamanca;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
37 Salamanca;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
37 Salamanca;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;75,94
37 Salamanca;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
37 Salamanca;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
37 Salamanca;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
37 Salamanca;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
37 Salamanca;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
37 Salamanca;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
37 Salamanca;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QI;404
37 Salamanca;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
37 Salamanca;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
37 Salamanca;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
37 Salamanca;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QI;386
37 Salamanca;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
37 Salamanca;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
37 Salamanca;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
37 Salamanca;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QI;355
37 Salamanca;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
37 Salamanca;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
37 Salamanca;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2022QII;""
37 Salamanca;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2022QI;371
37 Salamanca;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
37 Salamanca;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
37 Salamanca;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2021QII;""
37 Salamanca;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2021QI;374
37 Salamanca;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
37 Salamanca;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
37 Salamanca;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2020QII;""
37 Salamanca;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2020QI;297
37 Salamanca;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
37 Salamanca;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
37 Salamanca;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2022QII;342
37 Salamanca;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2022QI;""
37 Salamanca;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
37 Salamanca;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
37 Salamanca;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2021QII;352
37 Salamanca;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2021QI;""
37 Salamanca;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
37 Salamanca;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
37 Salamanca;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2020QII;279
37 Salamanca;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2020QI;""
37 Salamanca;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
37 Salamanca;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QIII;314
37 Salamanca;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QII;""
37 Salamanca;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QI;""
37 Salamanca;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
37 Salamanca;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QIII;337
37 Salamanca;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QII;""
37 Salamanca;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QI;""
37 Salamanca;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
37 Salamanca;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QIII;260
37 Salamanca;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QII;""
37 Salamanca;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QI;""
37 Salamanca;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QIV;300
37 Salamanca;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
37 Salamanca;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QII;""
37 Salamanca;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QI;""
37 Salamanca;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QIV;314
37 Salamanca;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
37 Salamanca;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QII;""
37 Salamanca;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QI;""
37 Salamanca;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QIV;244
37 Salamanca;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
37 Salamanca;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QII;""
37 Salamanca;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QI;""
37 Salamanca;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
37 Salamanca;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
37 Salamanca;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
37 Salamanca;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
37 Salamanca;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
37 Salamanca;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
37 Salamanca;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
37 Salamanca;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
37 Salamanca;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
37 Salamanca;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
37 Salamanca;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
37 Salamanca;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
37 Salamanca;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
37 Salamanca;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
37 Salamanca;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
37 Salamanca;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;91,83
37 Salamanca;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
37 Salamanca;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
37 Salamanca;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
37 Salamanca;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;96,89
37 Salamanca;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
37 Salamanca;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
37 Salamanca;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
37 Salamanca;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;83,66
37 Salamanca;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
37 Salamanca;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
37 Salamanca;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;84,65
37 Salamanca;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
37 Salamanca;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
37 Salamanca;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
37 Salamanca;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;91,19
37 Salamanca;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
37 Salamanca;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
37 Salamanca;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
37 Salamanca;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;78,59
37 Salamanca;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
37 Salamanca;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
37 Salamanca;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;77,72
37 Salamanca;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
37 Salamanca;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
37 Salamanca;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
37 Salamanca;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;87,31
37 Salamanca;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
37 Salamanca;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
37 Salamanca;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
37 Salamanca;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;73,24
37 Salamanca;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
37 Salamanca;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
37 Salamanca;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;74,26
37 Salamanca;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
37 Salamanca;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
37 Salamanca;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
37 Salamanca;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;81,35
37 Salamanca;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
37 Salamanca;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
37 Salamanca;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
37 Salamanca;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;68,73
37 Salamanca;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
37 Salamanca;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
37 Salamanca;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
37 Salamanca;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
37 Salamanca;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
37 Salamanca;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QII;891
37 Salamanca;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
37 Salamanca;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
37 Salamanca;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
37 Salamanca;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QII;927
37 Salamanca;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
37 Salamanca;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
37 Salamanca;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
37 Salamanca;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QII;961
37 Salamanca;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
37 Salamanca;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
37 Salamanca;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
37 Salamanca;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2022QII;834
37 Salamanca;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2022QI;""
37 Salamanca;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
37 Salamanca;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
37 Salamanca;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2021QII;860
37 Salamanca;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2021QI;""
37 Salamanca;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
37 Salamanca;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
37 Salamanca;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2020QII;917
37 Salamanca;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2020QI;""
37 Salamanca;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
37 Salamanca;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2022QIII;780
37 Salamanca;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2022QII;""
37 Salamanca;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2022QI;""
37 Salamanca;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
37 Salamanca;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2021QIII;808
37 Salamanca;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2021QII;""
37 Salamanca;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2021QI;""
37 Salamanca;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
37 Salamanca;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2020QIII;847
37 Salamanca;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2020QII;""
37 Salamanca;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2020QI;""
37 Salamanca;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QIV;727
37 Salamanca;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
37 Salamanca;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QII;""
37 Salamanca;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QI;""
37 Salamanca;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QIV;752
37 Salamanca;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
37 Salamanca;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QII;""
37 Salamanca;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QI;""
37 Salamanca;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QIV;798
37 Salamanca;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
37 Salamanca;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QII;""
37 Salamanca;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QI;""
37 Salamanca;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
37 Salamanca;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
37 Salamanca;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QII;""
37 Salamanca;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QI;712
37 Salamanca;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
37 Salamanca;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
37 Salamanca;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QII;""
37 Salamanca;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QI;767
37 Salamanca;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
37 Salamanca;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
37 Salamanca;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QII;""
37 Salamanca;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QI;""
37 Salamanca;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
37 Salamanca;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
37 Salamanca;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
37 Salamanca;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
37 Salamanca;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
37 Salamanca;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
37 Salamanca;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
37 Salamanca;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
37 Salamanca;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
37 Salamanca;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
37 Salamanca;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
37 Salamanca;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
37 Salamanca;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
37 Salamanca;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
37 Salamanca;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;93,6
37 Salamanca;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
37 Salamanca;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
37 Salamanca;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
37 Salamanca;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;92,77
37 Salamanca;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
37 Salamanca;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
37 Salamanca;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
37 Salamanca;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;95,42
37 Salamanca;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
37 Salamanca;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
37 Salamanca;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;87,54
37 Salamanca;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
37 Salamanca;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
37 Salamanca;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
37 Salamanca;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;87,16
37 Salamanca;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
37 Salamanca;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
37 Salamanca;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
37 Salamanca;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;88,14
37 Salamanca;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
37 Salamanca;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
37 Salamanca;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;81,59
37 Salamanca;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
37 Salamanca;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
37 Salamanca;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
37 Salamanca;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;81,12
37 Salamanca;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
37 Salamanca;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
37 Salamanca;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
37 Salamanca;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;83,04
37 Salamanca;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
37 Salamanca;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
37 Salamanca;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
37 Salamanca;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
37 Salamanca;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
37 Salamanca;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
37 Salamanca;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;76,81
37 Salamanca;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
37 Salamanca;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
37 Salamanca;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
37 Salamanca;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;79,81
37 Salamanca;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
37 Salamanca;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
37 Salamanca;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
37 Salamanca;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
37 Salamanca;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
37 Salamanca;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
37 Salamanca;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QII;561
37 Salamanca;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
37 Salamanca;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
37 Salamanca;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
37 Salamanca;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QII;590
37 Salamanca;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
37 Salamanca;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
37 Salamanca;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
37 Salamanca;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QII;618
37 Salamanca;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
37 Salamanca;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
37 Salamanca;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
37 Salamanca;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2022QII;529
37 Salamanca;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2022QI;""
37 Salamanca;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
37 Salamanca;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
37 Salamanca;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2021QII;546
37 Salamanca;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2021QI;""
37 Salamanca;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
37 Salamanca;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
37 Salamanca;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2020QII;594
37 Salamanca;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2020QI;""
37 Salamanca;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
37 Salamanca;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2022QIII;498
37 Salamanca;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2022QII;""
37 Salamanca;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2022QI;""
37 Salamanca;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
37 Salamanca;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2021QIII;510
37 Salamanca;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2021QII;""
37 Salamanca;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2021QI;""
37 Salamanca;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
37 Salamanca;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2020QIII;549
37 Salamanca;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2020QII;""
37 Salamanca;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2020QI;""
37 Salamanca;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QIV;465
37 Salamanca;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
37 Salamanca;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QII;""
37 Salamanca;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QI;""
37 Salamanca;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QIV;476
37 Salamanca;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
37 Salamanca;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QII;""
37 Salamanca;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QI;""
37 Salamanca;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QIV;516
37 Salamanca;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
37 Salamanca;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QII;""
37 Salamanca;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QI;""
37 Salamanca;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
37 Salamanca;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
37 Salamanca;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QII;""
37 Salamanca;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QI;458
37 Salamanca;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
37 Salamanca;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
37 Salamanca;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QII;""
37 Salamanca;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QI;492
37 Salamanca;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
37 Salamanca;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
37 Salamanca;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QII;""
37 Salamanca;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QI;""
37 Salamanca;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
37 Salamanca;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
37 Salamanca;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
37 Salamanca;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
37 Salamanca;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
37 Salamanca;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
37 Salamanca;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
37 Salamanca;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
37 Salamanca;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
37 Salamanca;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
37 Salamanca;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
37 Salamanca;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
37 Salamanca;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
37 Salamanca;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
37 Salamanca;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;94,3
37 Salamanca;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
37 Salamanca;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
37 Salamanca;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
37 Salamanca;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;92,54
37 Salamanca;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
37 Salamanca;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
37 Salamanca;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
37 Salamanca;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;96,12
37 Salamanca;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
37 Salamanca;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
37 Salamanca;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;88,77
37 Salamanca;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
37 Salamanca;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
37 Salamanca;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
37 Salamanca;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;86,44
37 Salamanca;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
37 Salamanca;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
37 Salamanca;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
37 Salamanca;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;88,83
37 Salamanca;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
37 Salamanca;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
37 Salamanca;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;82,89
37 Salamanca;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
37 Salamanca;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
37 Salamanca;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
37 Salamanca;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;80,68
37 Salamanca;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
37 Salamanca;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
37 Salamanca;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
37 Salamanca;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;83,5
37 Salamanca;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
37 Salamanca;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
37 Salamanca;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
37 Salamanca;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
37 Salamanca;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
37 Salamanca;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
37 Salamanca;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;77,63
37 Salamanca;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
37 Salamanca;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
37 Salamanca;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
37 Salamanca;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;79,61
37 Salamanca;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
37 Salamanca;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
37 Salamanca;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
37 Salamanca;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
37 Salamanca;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
37 Salamanca;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
37 Salamanca;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QII;330
37 Salamanca;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
37 Salamanca;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
37 Salamanca;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
37 Salamanca;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QII;337
37 Salamanca;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
37 Salamanca;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
37 Salamanca;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
37 Salamanca;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QII;343
37 Salamanca;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
37 Salamanca;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
37 Salamanca;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
37 Salamanca;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2022QII;305
37 Salamanca;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2022QI;""
37 Salamanca;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
37 Salamanca;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
37 Salamanca;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2021QII;314
37 Salamanca;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2021QI;""
37 Salamanca;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
37 Salamanca;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
37 Salamanca;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2020QII;323
37 Salamanca;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2020QI;""
37 Salamanca;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
37 Salamanca;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2022QIII;282
37 Salamanca;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2022QII;""
37 Salamanca;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2022QI;""
37 Salamanca;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
37 Salamanca;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2021QIII;298
37 Salamanca;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2021QII;""
37 Salamanca;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2021QI;""
37 Salamanca;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
37 Salamanca;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2020QIII;298
37 Salamanca;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2020QII;""
37 Salamanca;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2020QI;""
37 Salamanca;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QIV;262
37 Salamanca;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
37 Salamanca;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QII;""
37 Salamanca;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QI;""
37 Salamanca;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QIV;276
37 Salamanca;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
37 Salamanca;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QII;""
37 Salamanca;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QI;""
37 Salamanca;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QIV;282
37 Salamanca;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
37 Salamanca;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QII;""
37 Salamanca;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QI;""
37 Salamanca;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
37 Salamanca;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
37 Salamanca;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QII;""
37 Salamanca;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QI;254
37 Salamanca;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
37 Salamanca;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
37 Salamanca;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QII;""
37 Salamanca;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QI;275
37 Salamanca;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
37 Salamanca;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
37 Salamanca;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QII;""
37 Salamanca;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QI;""
37 Salamanca;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
37 Salamanca;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
37 Salamanca;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
37 Salamanca;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
37 Salamanca;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
37 Salamanca;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
37 Salamanca;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
37 Salamanca;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
37 Salamanca;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
37 Salamanca;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
37 Salamanca;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
37 Salamanca;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
37 Salamanca;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
37 Salamanca;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
37 Salamanca;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;92,42
37 Salamanca;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
37 Salamanca;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
37 Salamanca;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
37 Salamanca;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;93,18
37 Salamanca;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
37 Salamanca;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
37 Salamanca;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
37 Salamanca;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;94,17
37 Salamanca;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
37 Salamanca;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
37 Salamanca;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;85,45
37 Salamanca;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
37 Salamanca;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
37 Salamanca;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
37 Salamanca;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;88,43
37 Salamanca;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
37 Salamanca;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
37 Salamanca;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
37 Salamanca;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;86,88
37 Salamanca;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
37 Salamanca;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
37 Salamanca;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;79,39
37 Salamanca;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
37 Salamanca;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
37 Salamanca;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
37 Salamanca;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;81,9
37 Salamanca;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
37 Salamanca;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
37 Salamanca;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
37 Salamanca;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;82,22
37 Salamanca;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
37 Salamanca;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
37 Salamanca;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
37 Salamanca;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
37 Salamanca;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
37 Salamanca;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
37 Salamanca;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;75,37
37 Salamanca;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
37 Salamanca;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
37 Salamanca;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
37 Salamanca;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;80,17
37 Salamanca;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
37 Salamanca;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
37 Salamanca;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
37 Salamanca;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
37 Salamanca;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
37 Salamanca;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QIII;988
37 Salamanca;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
37 Salamanca;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
37 Salamanca;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
37 Salamanca;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QIII;1.003
37 Salamanca;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
37 Salamanca;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
37 Salamanca;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
37 Salamanca;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QIII;1.009
37 Salamanca;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
37 Salamanca;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
37 Salamanca;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
37 Salamanca;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2022QIII;894
37 Salamanca;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2022QII;""
37 Salamanca;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2022QI;""
37 Salamanca;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
37 Salamanca;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2021QIII;904
37 Salamanca;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2021QII;""
37 Salamanca;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2021QI;""
37 Salamanca;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
37 Salamanca;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2020QIII;915
37 Salamanca;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2020QII;""
37 Salamanca;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2020QI;""
37 Salamanca;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2022QIV;825
37 Salamanca;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
37 Salamanca;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2022QII;""
37 Salamanca;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2022QI;""
37 Salamanca;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2021QIV;838
37 Salamanca;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
37 Salamanca;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2021QII;""
37 Salamanca;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2021QI;""
37 Salamanca;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2020QIV;856
37 Salamanca;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
37 Salamanca;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2020QII;""
37 Salamanca;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2020QI;""
37 Salamanca;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
37 Salamanca;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
37 Salamanca;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QII;""
37 Salamanca;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QI;791
37 Salamanca;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
37 Salamanca;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
37 Salamanca;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QII;""
37 Salamanca;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QI;820
37 Salamanca;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
37 Salamanca;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
37 Salamanca;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QII;""
37 Salamanca;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QI;""
37 Salamanca;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
37 Salamanca;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
37 Salamanca;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QII;753
37 Salamanca;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QI;""
37 Salamanca;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
37 Salamanca;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
37 Salamanca;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QII;777
37 Salamanca;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QI;""
37 Salamanca;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
37 Salamanca;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
37 Salamanca;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QII;""
37 Salamanca;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QI;""
37 Salamanca;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
37 Salamanca;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
37 Salamanca;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
37 Salamanca;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
37 Salamanca;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
37 Salamanca;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
37 Salamanca;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
37 Salamanca;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
37 Salamanca;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
37 Salamanca;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
37 Salamanca;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
37 Salamanca;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
37 Salamanca;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
37 Salamanca;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;90,49
37 Salamanca;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
37 Salamanca;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
37 Salamanca;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
37 Salamanca;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;90,13
37 Salamanca;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
37 Salamanca;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
37 Salamanca;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
37 Salamanca;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;90,68
37 Salamanca;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
37 Salamanca;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
37 Salamanca;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;83,5
37 Salamanca;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
37 Salamanca;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
37 Salamanca;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
37 Salamanca;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;83,55
37 Salamanca;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
37 Salamanca;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
37 Salamanca;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
37 Salamanca;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;84,84
37 Salamanca;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
37 Salamanca;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
37 Salamanca;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
37 Salamanca;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
37 Salamanca;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
37 Salamanca;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
37 Salamanca;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;78,86
37 Salamanca;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
37 Salamanca;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
37 Salamanca;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
37 Salamanca;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;81,27
37 Salamanca;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
37 Salamanca;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
37 Salamanca;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
37 Salamanca;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
37 Salamanca;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
37 Salamanca;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
37 Salamanca;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;75,07
37 Salamanca;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
37 Salamanca;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
37 Salamanca;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
37 Salamanca;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;77,01
37 Salamanca;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
37 Salamanca;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
37 Salamanca;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
37 Salamanca;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
37 Salamanca;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
37 Salamanca;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
37 Salamanca;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QIII;624
37 Salamanca;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
37 Salamanca;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
37 Salamanca;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
37 Salamanca;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QIII;641
37 Salamanca;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
37 Salamanca;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
37 Salamanca;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
37 Salamanca;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QIII;656
37 Salamanca;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
37 Salamanca;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
37 Salamanca;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
37 Salamanca;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2022QIII;569
37 Salamanca;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2022QII;""
37 Salamanca;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2022QI;""
37 Salamanca;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
37 Salamanca;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2021QIII;571
37 Salamanca;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2021QII;""
37 Salamanca;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2021QI;""
37 Salamanca;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
37 Salamanca;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2020QIII;594
37 Salamanca;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2020QII;""
37 Salamanca;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2020QI;""
37 Salamanca;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2022QIV;529
37 Salamanca;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
37 Salamanca;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2022QII;""
37 Salamanca;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2022QI;""
37 Salamanca;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2021QIV;532
37 Salamanca;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
37 Salamanca;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2021QII;""
37 Salamanca;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2021QI;""
37 Salamanca;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2020QIV;553
37 Salamanca;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
37 Salamanca;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2020QII;""
37 Salamanca;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2020QI;""
37 Salamanca;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
37 Salamanca;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
37 Salamanca;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QII;""
37 Salamanca;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QI;509
37 Salamanca;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
37 Salamanca;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
37 Salamanca;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QII;""
37 Salamanca;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QI;525
37 Salamanca;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
37 Salamanca;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
37 Salamanca;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QII;""
37 Salamanca;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QI;""
37 Salamanca;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
37 Salamanca;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
37 Salamanca;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QII;493
37 Salamanca;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QI;""
37 Salamanca;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
37 Salamanca;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
37 Salamanca;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QII;497
37 Salamanca;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QI;""
37 Salamanca;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
37 Salamanca;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
37 Salamanca;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QII;""
37 Salamanca;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QI;""
37 Salamanca;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
37 Salamanca;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
37 Salamanca;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
37 Salamanca;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
37 Salamanca;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
37 Salamanca;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
37 Salamanca;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
37 Salamanca;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
37 Salamanca;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
37 Salamanca;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
37 Salamanca;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
37 Salamanca;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
37 Salamanca;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
37 Salamanca;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;91,19
37 Salamanca;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
37 Salamanca;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
37 Salamanca;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
37 Salamanca;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;89,08
37 Salamanca;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
37 Salamanca;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
37 Salamanca;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
37 Salamanca;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;90,55
37 Salamanca;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
37 Salamanca;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
37 Salamanca;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;84,78
37 Salamanca;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
37 Salamanca;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
37 Salamanca;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
37 Salamanca;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;83
37 Salamanca;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
37 Salamanca;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
37 Salamanca;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
37 Salamanca;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;84,3
37 Salamanca;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
37 Salamanca;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
37 Salamanca;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
37 Salamanca;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
37 Salamanca;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
37 Salamanca;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
37 Salamanca;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;79,41
37 Salamanca;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
37 Salamanca;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
37 Salamanca;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
37 Salamanca;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;80,03
37 Salamanca;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
37 Salamanca;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
37 Salamanca;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
37 Salamanca;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
37 Salamanca;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
37 Salamanca;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
37 Salamanca;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;76,91
37 Salamanca;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
37 Salamanca;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
37 Salamanca;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
37 Salamanca;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;75,76
37 Salamanca;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
37 Salamanca;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
37 Salamanca;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
37 Salamanca;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
37 Salamanca;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
37 Salamanca;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
37 Salamanca;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QIII;364
37 Salamanca;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
37 Salamanca;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
37 Salamanca;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
37 Salamanca;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QIII;362
37 Salamanca;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
37 Salamanca;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
37 Salamanca;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
37 Salamanca;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QIII;353
37 Salamanca;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
37 Salamanca;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
37 Salamanca;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
37 Salamanca;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2022QIII;325
37 Salamanca;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2022QII;""
37 Salamanca;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2022QI;""
37 Salamanca;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
37 Salamanca;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2021QIII;333
37 Salamanca;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2021QII;""
37 Salamanca;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2021QI;""
37 Salamanca;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
37 Salamanca;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2020QIII;321
37 Salamanca;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2020QII;""
37 Salamanca;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2020QI;""
37 Salamanca;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2022QIV;296
37 Salamanca;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
37 Salamanca;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2022QII;""
37 Salamanca;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2022QI;""
37 Salamanca;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2021QIV;306
37 Salamanca;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
37 Salamanca;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2021QII;""
37 Salamanca;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2021QI;""
37 Salamanca;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2020QIV;303
37 Salamanca;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
37 Salamanca;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2020QII;""
37 Salamanca;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2020QI;""
37 Salamanca;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
37 Salamanca;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
37 Salamanca;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QII;""
37 Salamanca;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QI;282
37 Salamanca;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
37 Salamanca;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
37 Salamanca;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QII;""
37 Salamanca;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QI;295
37 Salamanca;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
37 Salamanca;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
37 Salamanca;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QII;""
37 Salamanca;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QI;""
37 Salamanca;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
37 Salamanca;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
37 Salamanca;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QII;260
37 Salamanca;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QI;""
37 Salamanca;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
37 Salamanca;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
37 Salamanca;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QII;280
37 Salamanca;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QI;""
37 Salamanca;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
37 Salamanca;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
37 Salamanca;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QII;""
37 Salamanca;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QI;""
37 Salamanca;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
37 Salamanca;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
37 Salamanca;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
37 Salamanca;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
37 Salamanca;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
37 Salamanca;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
37 Salamanca;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
37 Salamanca;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
37 Salamanca;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
37 Salamanca;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
37 Salamanca;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
37 Salamanca;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
37 Salamanca;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
37 Salamanca;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;89,29
37 Salamanca;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
37 Salamanca;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
37 Salamanca;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
37 Salamanca;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;91,99
37 Salamanca;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
37 Salamanca;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
37 Salamanca;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
37 Salamanca;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;90,93
37 Salamanca;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
37 Salamanca;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
37 Salamanca;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;81,32
37 Salamanca;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
37 Salamanca;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
37 Salamanca;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
37 Salamanca;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;84,53
37 Salamanca;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
37 Salamanca;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
37 Salamanca;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
37 Salamanca;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;85,84
37 Salamanca;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
37 Salamanca;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
37 Salamanca;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
37 Salamanca;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
37 Salamanca;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
37 Salamanca;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
37 Salamanca;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;77,9
37 Salamanca;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
37 Salamanca;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
37 Salamanca;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
37 Salamanca;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;83,57
37 Salamanca;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
37 Salamanca;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
37 Salamanca;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
37 Salamanca;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
37 Salamanca;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
37 Salamanca;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
37 Salamanca;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;71,82
37 Salamanca;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
37 Salamanca;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
37 Salamanca;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
37 Salamanca;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;79,32
37 Salamanca;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
37 Salamanca;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
37 Salamanca;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
37 Salamanca;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
37 Salamanca;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
37 Salamanca;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QIV;993
37 Salamanca;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
37 Salamanca;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
37 Salamanca;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
37 Salamanca;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QIV;1.012
37 Salamanca;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
37 Salamanca;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
37 Salamanca;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
37 Salamanca;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QIV;1.025
37 Salamanca;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
37 Salamanca;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
37 Salamanca;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
37 Salamanca;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2022QIV;915
37 Salamanca;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
37 Salamanca;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2022QII;""
37 Salamanca;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2022QI;""
37 Salamanca;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2021QIV;937
37 Salamanca;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
37 Salamanca;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2021QII;""
37 Salamanca;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2021QI;""
37 Salamanca;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2020QIV;955
37 Salamanca;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
37 Salamanca;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2020QII;""
37 Salamanca;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2020QI;""
37 Salamanca;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
37 Salamanca;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
37 Salamanca;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2022QII;""
37 Salamanca;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2022QI;878
37 Salamanca;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
37 Salamanca;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
37 Salamanca;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2021QII;""
37 Salamanca;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2021QI;915
37 Salamanca;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
37 Salamanca;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
37 Salamanca;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2020QII;""
37 Salamanca;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2020QI;""
37 Salamanca;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
37 Salamanca;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
37 Salamanca;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QII;836
37 Salamanca;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QI;""
37 Salamanca;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
37 Salamanca;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
37 Salamanca;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QII;867
37 Salamanca;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QI;""
37 Salamanca;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
37 Salamanca;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
37 Salamanca;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QII;""
37 Salamanca;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QI;""
37 Salamanca;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
37 Salamanca;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QIII;778
37 Salamanca;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QII;""
37 Salamanca;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QI;""
37 Salamanca;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
37 Salamanca;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QIII;828
37 Salamanca;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QII;""
37 Salamanca;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QI;""
37 Salamanca;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
37 Salamanca;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
37 Salamanca;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QII;""
37 Salamanca;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QI;""
37 Salamanca;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
37 Salamanca;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
37 Salamanca;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
37 Salamanca;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
37 Salamanca;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
37 Salamanca;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
37 Salamanca;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
37 Salamanca;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
37 Salamanca;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
37 Salamanca;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
37 Salamanca;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
37 Salamanca;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
37 Salamanca;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;92,15
37 Salamanca;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
37 Salamanca;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
37 Salamanca;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
37 Salamanca;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;92,59
37 Salamanca;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
37 Salamanca;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
37 Salamanca;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
37 Salamanca;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;93,17
37 Salamanca;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
37 Salamanca;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
37 Salamanca;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
37 Salamanca;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
37 Salamanca;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
37 Salamanca;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
37 Salamanca;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;86,76
37 Salamanca;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
37 Salamanca;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
37 Salamanca;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
37 Salamanca;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;89,27
37 Salamanca;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
37 Salamanca;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
37 Salamanca;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
37 Salamanca;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
37 Salamanca;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
37 Salamanca;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
37 Salamanca;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;82,61
37 Salamanca;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
37 Salamanca;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
37 Salamanca;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
37 Salamanca;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;84,59
37 Salamanca;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
37 Salamanca;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
37 Salamanca;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
37 Salamanca;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
37 Salamanca;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
37 Salamanca;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
37 Salamanca;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;76,88
37 Salamanca;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
37 Salamanca;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
37 Salamanca;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
37 Salamanca;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;80,78
37 Salamanca;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
37 Salamanca;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
37 Salamanca;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
37 Salamanca;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
37 Salamanca;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
37 Salamanca;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
37 Salamanca;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QIV;624
37 Salamanca;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
37 Salamanca;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
37 Salamanca;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
37 Salamanca;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QIV;629
37 Salamanca;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
37 Salamanca;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
37 Salamanca;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
37 Salamanca;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QIV;657
37 Salamanca;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
37 Salamanca;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
37 Salamanca;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
37 Salamanca;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2022QIV;579
37 Salamanca;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
37 Salamanca;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2022QII;""
37 Salamanca;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2022QI;""
37 Salamanca;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2021QIV;586
37 Salamanca;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
37 Salamanca;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2021QII;""
37 Salamanca;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2021QI;""
37 Salamanca;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2020QIV;608
37 Salamanca;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
37 Salamanca;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2020QII;""
37 Salamanca;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2020QI;""
37 Salamanca;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
37 Salamanca;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
37 Salamanca;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2022QII;""
37 Salamanca;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2022QI;557
37 Salamanca;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
37 Salamanca;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
37 Salamanca;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2021QII;""
37 Salamanca;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2021QI;578
37 Salamanca;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
37 Salamanca;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
37 Salamanca;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2020QII;""
37 Salamanca;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2020QI;""
37 Salamanca;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
37 Salamanca;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
37 Salamanca;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QII;537
37 Salamanca;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QI;""
37 Salamanca;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
37 Salamanca;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
37 Salamanca;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QII;547
37 Salamanca;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QI;""
37 Salamanca;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
37 Salamanca;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
37 Salamanca;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QII;""
37 Salamanca;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QI;""
37 Salamanca;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
37 Salamanca;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QIII;505
37 Salamanca;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QII;""
37 Salamanca;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QI;""
37 Salamanca;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
37 Salamanca;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QIII;518
37 Salamanca;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QII;""
37 Salamanca;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QI;""
37 Salamanca;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
37 Salamanca;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
37 Salamanca;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QII;""
37 Salamanca;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QI;""
37 Salamanca;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
37 Salamanca;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
37 Salamanca;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
37 Salamanca;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
37 Salamanca;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
37 Salamanca;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
37 Salamanca;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
37 Salamanca;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
37 Salamanca;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
37 Salamanca;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
37 Salamanca;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
37 Salamanca;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
37 Salamanca;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;92,79
37 Salamanca;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
37 Salamanca;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
37 Salamanca;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
37 Salamanca;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;93,16
37 Salamanca;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
37 Salamanca;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
37 Salamanca;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
37 Salamanca;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;92,54
37 Salamanca;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
37 Salamanca;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
37 Salamanca;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
37 Salamanca;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
37 Salamanca;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
37 Salamanca;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
37 Salamanca;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;88,55
37 Salamanca;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
37 Salamanca;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
37 Salamanca;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
37 Salamanca;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;87,98
37 Salamanca;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
37 Salamanca;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
37 Salamanca;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
37 Salamanca;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
37 Salamanca;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
37 Salamanca;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
37 Salamanca;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;85,37
37 Salamanca;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
37 Salamanca;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
37 Salamanca;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
37 Salamanca;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;83,26
37 Salamanca;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
37 Salamanca;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
37 Salamanca;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
37 Salamanca;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
37 Salamanca;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
37 Salamanca;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
37 Salamanca;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;80,29
37 Salamanca;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
37 Salamanca;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
37 Salamanca;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
37 Salamanca;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;78,84
37 Salamanca;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
37 Salamanca;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
37 Salamanca;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
37 Salamanca;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
37 Salamanca;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
37 Salamanca;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
37 Salamanca;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QIV;369
37 Salamanca;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
37 Salamanca;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
37 Salamanca;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
37 Salamanca;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QIV;383
37 Salamanca;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
37 Salamanca;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
37 Salamanca;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
37 Salamanca;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QIV;368
37 Salamanca;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
37 Salamanca;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
37 Salamanca;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
37 Salamanca;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2022QIV;336
37 Salamanca;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
37 Salamanca;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2022QII;""
37 Salamanca;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2022QI;""
37 Salamanca;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2021QIV;351
37 Salamanca;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
37 Salamanca;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2021QII;""
37 Salamanca;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2021QI;""
37 Salamanca;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2020QIV;347
37 Salamanca;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
37 Salamanca;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2020QII;""
37 Salamanca;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2020QI;""
37 Salamanca;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
37 Salamanca;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
37 Salamanca;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2022QII;""
37 Salamanca;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2022QI;321
37 Salamanca;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
37 Salamanca;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
37 Salamanca;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2021QII;""
37 Salamanca;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2021QI;337
37 Salamanca;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
37 Salamanca;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
37 Salamanca;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2020QII;""
37 Salamanca;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2020QI;""
37 Salamanca;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
37 Salamanca;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
37 Salamanca;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QII;299
37 Salamanca;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QI;""
37 Salamanca;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
37 Salamanca;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
37 Salamanca;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QII;320
37 Salamanca;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QI;""
37 Salamanca;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
37 Salamanca;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
37 Salamanca;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QII;""
37 Salamanca;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QI;""
37 Salamanca;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
37 Salamanca;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QIII;273
37 Salamanca;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QII;""
37 Salamanca;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QI;""
37 Salamanca;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
37 Salamanca;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QIII;310
37 Salamanca;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QII;""
37 Salamanca;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QI;""
37 Salamanca;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
37 Salamanca;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
37 Salamanca;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QII;""
37 Salamanca;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QI;""
37 Salamanca;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
37 Salamanca;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
37 Salamanca;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
37 Salamanca;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
37 Salamanca;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
37 Salamanca;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
37 Salamanca;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
37 Salamanca;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
37 Salamanca;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
37 Salamanca;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
37 Salamanca;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
37 Salamanca;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
37 Salamanca;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;91,06
37 Salamanca;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
37 Salamanca;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
37 Salamanca;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
37 Salamanca;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;91,64
37 Salamanca;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
37 Salamanca;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
37 Salamanca;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
37 Salamanca;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;94,29
37 Salamanca;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
37 Salamanca;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
37 Salamanca;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
37 Salamanca;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
37 Salamanca;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
37 Salamanca;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
37 Salamanca;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;83,81
37 Salamanca;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
37 Salamanca;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
37 Salamanca;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
37 Salamanca;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;91,58
37 Salamanca;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
37 Salamanca;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
37 Salamanca;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
37 Salamanca;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
37 Salamanca;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
37 Salamanca;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
37 Salamanca;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;78,07
37 Salamanca;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
37 Salamanca;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
37 Salamanca;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
37 Salamanca;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;86,96
37 Salamanca;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
37 Salamanca;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
37 Salamanca;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
37 Salamanca;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
37 Salamanca;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
37 Salamanca;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
37 Salamanca;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;71,28
37 Salamanca;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
37 Salamanca;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
37 Salamanca;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
37 Salamanca;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;84,24
37 Salamanca;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
37 Salamanca;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
37 Salamanca;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
37 Salamanca;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
37 Salamanca;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
37 Salamanca;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
37 Salamanca;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
37 Salamanca;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
37 Salamanca;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
37 Salamanca;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QI;3.342
37 Salamanca;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
37 Salamanca;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
37 Salamanca;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
37 Salamanca;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QI;3.466
37 Salamanca;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
37 Salamanca;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
37 Salamanca;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
37 Salamanca;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QI;3.433
37 Salamanca;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
37 Salamanca;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
37 Salamanca;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2022QII;""
37 Salamanca;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2022QI;3.244
37 Salamanca;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
37 Salamanca;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
37 Salamanca;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2021QII;""
37 Salamanca;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2021QI;3.372
37 Salamanca;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
37 Salamanca;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
37 Salamanca;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2020QII;""
37 Salamanca;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2020QI;3.193
37 Salamanca;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
37 Salamanca;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
37 Salamanca;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2022QII;3.140
37 Salamanca;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2022QI;""
37 Salamanca;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
37 Salamanca;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
37 Salamanca;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2021QII;3.278
37 Salamanca;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2021QI;""
37 Salamanca;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
37 Salamanca;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
37 Salamanca;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2020QII;3.118
37 Salamanca;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2020QI;""
37 Salamanca;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
37 Salamanca;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QIII;3.060
37 Salamanca;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QII;""
37 Salamanca;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QI;""
37 Salamanca;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
37 Salamanca;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QIII;3.189
37 Salamanca;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QII;""
37 Salamanca;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QI;""
37 Salamanca;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
37 Salamanca;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QIII;3.012
37 Salamanca;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QII;""
37 Salamanca;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QI;""
37 Salamanca;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QIV;2.970
37 Salamanca;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
37 Salamanca;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QII;""
37 Salamanca;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QI;""
37 Salamanca;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QIV;3.100
37 Salamanca;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
37 Salamanca;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QII;""
37 Salamanca;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QI;""
37 Salamanca;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QIV;2.941
37 Salamanca;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
37 Salamanca;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QII;""
37 Salamanca;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QI;""
37 Salamanca;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
37 Salamanca;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
37 Salamanca;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
37 Salamanca;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
37 Salamanca;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
37 Salamanca;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
37 Salamanca;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
37 Salamanca;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
37 Salamanca;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
37 Salamanca;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
37 Salamanca;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
37 Salamanca;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
37 Salamanca;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
37 Salamanca;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
37 Salamanca;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
37 Salamanca;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;97,07
37 Salamanca;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
37 Salamanca;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
37 Salamanca;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
37 Salamanca;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;97,29
37 Salamanca;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
37 Salamanca;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
37 Salamanca;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
37 Salamanca;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;93,01
37 Salamanca;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
37 Salamanca;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
37 Salamanca;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;93,96
37 Salamanca;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
37 Salamanca;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
37 Salamanca;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
37 Salamanca;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;94,58
37 Salamanca;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
37 Salamanca;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
37 Salamanca;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
37 Salamanca;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;90,82
37 Salamanca;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
37 Salamanca;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
37 Salamanca;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;91,56
37 Salamanca;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
37 Salamanca;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
37 Salamanca;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
37 Salamanca;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;92,01
37 Salamanca;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
37 Salamanca;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
37 Salamanca;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
37 Salamanca;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;87,74
37 Salamanca;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
37 Salamanca;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
37 Salamanca;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;88,87
37 Salamanca;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
37 Salamanca;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
37 Salamanca;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
37 Salamanca;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;89,44
37 Salamanca;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
37 Salamanca;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
37 Salamanca;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
37 Salamanca;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;85,67
37 Salamanca;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
37 Salamanca;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
37 Salamanca;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
37 Salamanca;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
37 Salamanca;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
37 Salamanca;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
37 Salamanca;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QI;2.111
37 Salamanca;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
37 Salamanca;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
37 Salamanca;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
37 Salamanca;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QI;2.213
37 Salamanca;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
37 Salamanca;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
37 Salamanca;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
37 Salamanca;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QI;2.161
37 Salamanca;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
37 Salamanca;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
37 Salamanca;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2022QII;""
37 Salamanca;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2022QI;2.051
37 Salamanca;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
37 Salamanca;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
37 Salamanca;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2021QII;""
37 Salamanca;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2021QI;2.162
37 Salamanca;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
37 Salamanca;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
37 Salamanca;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2020QII;""
37 Salamanca;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2020QI;2.027
37 Salamanca;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
37 Salamanca;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
37 Salamanca;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2022QII;1.992
37 Salamanca;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2022QI;""
37 Salamanca;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
37 Salamanca;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
37 Salamanca;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2021QII;2.104
37 Salamanca;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2021QI;""
37 Salamanca;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
37 Salamanca;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
37 Salamanca;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2020QII;1.986
37 Salamanca;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2020QI;""
37 Salamanca;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
37 Salamanca;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QIII;1.941
37 Salamanca;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QII;""
37 Salamanca;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QI;""
37 Salamanca;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
37 Salamanca;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QIII;2.053
37 Salamanca;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QII;""
37 Salamanca;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QI;""
37 Salamanca;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
37 Salamanca;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QIII;1.932
37 Salamanca;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QII;""
37 Salamanca;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QI;""
37 Salamanca;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QIV;1.893
37 Salamanca;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
37 Salamanca;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QII;""
37 Salamanca;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QI;""
37 Salamanca;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QIV;1.997
37 Salamanca;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
37 Salamanca;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QII;""
37 Salamanca;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QI;""
37 Salamanca;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QIV;1.893
37 Salamanca;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
37 Salamanca;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QII;""
37 Salamanca;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QI;""
37 Salamanca;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
37 Salamanca;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
37 Salamanca;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
37 Salamanca;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
37 Salamanca;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
37 Salamanca;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
37 Salamanca;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
37 Salamanca;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
37 Salamanca;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
37 Salamanca;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
37 Salamanca;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
37 Salamanca;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
37 Salamanca;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
37 Salamanca;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
37 Salamanca;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
37 Salamanca;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;97,16
37 Salamanca;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
37 Salamanca;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
37 Salamanca;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
37 Salamanca;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;97,7
37 Salamanca;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
37 Salamanca;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
37 Salamanca;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
37 Salamanca;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;93,8
37 Salamanca;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
37 Salamanca;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
37 Salamanca;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;94,36
37 Salamanca;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
37 Salamanca;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
37 Salamanca;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
37 Salamanca;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;95,07
37 Salamanca;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
37 Salamanca;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
37 Salamanca;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
37 Salamanca;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;91,9
37 Salamanca;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
37 Salamanca;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
37 Salamanca;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;91,95
37 Salamanca;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
37 Salamanca;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
37 Salamanca;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
37 Salamanca;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;92,77
37 Salamanca;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
37 Salamanca;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
37 Salamanca;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
37 Salamanca;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;89,4
37 Salamanca;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
37 Salamanca;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
37 Salamanca;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;89,67
37 Salamanca;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
37 Salamanca;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
37 Salamanca;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
37 Salamanca;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;90,24
37 Salamanca;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
37 Salamanca;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
37 Salamanca;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
37 Salamanca;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;87,6
37 Salamanca;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
37 Salamanca;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
37 Salamanca;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
37 Salamanca;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
37 Salamanca;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
37 Salamanca;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
37 Salamanca;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QI;1.231
37 Salamanca;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
37 Salamanca;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
37 Salamanca;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
37 Salamanca;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QI;1.253
37 Salamanca;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
37 Salamanca;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
37 Salamanca;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
37 Salamanca;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QI;1.272
37 Salamanca;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
37 Salamanca;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
37 Salamanca;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2022QII;""
37 Salamanca;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2022QI;1.193
37 Salamanca;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
37 Salamanca;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
37 Salamanca;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2021QII;""
37 Salamanca;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2021QI;1.210
37 Salamanca;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
37 Salamanca;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
37 Salamanca;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2020QII;""
37 Salamanca;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2020QI;1.166
37 Salamanca;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
37 Salamanca;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
37 Salamanca;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2022QII;1.148
37 Salamanca;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2022QI;""
37 Salamanca;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
37 Salamanca;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
37 Salamanca;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2021QII;1.174
37 Salamanca;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2021QI;""
37 Salamanca;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
37 Salamanca;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
37 Salamanca;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2020QII;1.132
37 Salamanca;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2020QI;""
37 Salamanca;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
37 Salamanca;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QIII;1.119
37 Salamanca;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QII;""
37 Salamanca;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QI;""
37 Salamanca;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
37 Salamanca;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QIII;1.136
37 Salamanca;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QII;""
37 Salamanca;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QI;""
37 Salamanca;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
37 Salamanca;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QIII;1.080
37 Salamanca;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QII;""
37 Salamanca;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QI;""
37 Salamanca;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QIV;1.077
37 Salamanca;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
37 Salamanca;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QII;""
37 Salamanca;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QI;""
37 Salamanca;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QIV;1.103
37 Salamanca;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
37 Salamanca;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QII;""
37 Salamanca;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QI;""
37 Salamanca;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QIV;1.048
37 Salamanca;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
37 Salamanca;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QII;""
37 Salamanca;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QI;""
37 Salamanca;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
37 Salamanca;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
37 Salamanca;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
37 Salamanca;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
37 Salamanca;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
37 Salamanca;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
37 Salamanca;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
37 Salamanca;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
37 Salamanca;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
37 Salamanca;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
37 Salamanca;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
37 Salamanca;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
37 Salamanca;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
37 Salamanca;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
37 Salamanca;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
37 Salamanca;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;96,91
37 Salamanca;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
37 Salamanca;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
37 Salamanca;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
37 Salamanca;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;96,57
37 Salamanca;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
37 Salamanca;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
37 Salamanca;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
37 Salamanca;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;91,67
37 Salamanca;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
37 Salamanca;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
37 Salamanca;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;93,26
37 Salamanca;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
37 Salamanca;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
37 Salamanca;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
37 Salamanca;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;93,7
37 Salamanca;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
37 Salamanca;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
37 Salamanca;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
37 Salamanca;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;88,99
37 Salamanca;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
37 Salamanca;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
37 Salamanca;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;90,9
37 Salamanca;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
37 Salamanca;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
37 Salamanca;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
37 Salamanca;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;90,66
37 Salamanca;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
37 Salamanca;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
37 Salamanca;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
37 Salamanca;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;84,91
37 Salamanca;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
37 Salamanca;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
37 Salamanca;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;87,49
37 Salamanca;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
37 Salamanca;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
37 Salamanca;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
37 Salamanca;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;88,03
37 Salamanca;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
37 Salamanca;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
37 Salamanca;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
37 Salamanca;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;82,39
37 Salamanca;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
37 Salamanca;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
37 Salamanca;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
37 Salamanca;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
37 Salamanca;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
37 Salamanca;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QII;3.152
37 Salamanca;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
37 Salamanca;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
37 Salamanca;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
37 Salamanca;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QII;3.269
37 Salamanca;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
37 Salamanca;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
37 Salamanca;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
37 Salamanca;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QII;3.366
37 Salamanca;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
37 Salamanca;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
37 Salamanca;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
37 Salamanca;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2022QII;3.039
37 Salamanca;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2022QI;""
37 Salamanca;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
37 Salamanca;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
37 Salamanca;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2021QII;3.155
37 Salamanca;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2021QI;""
37 Salamanca;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
37 Salamanca;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
37 Salamanca;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2020QII;3.283
37 Salamanca;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2020QI;""
37 Salamanca;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
37 Salamanca;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2022QIII;2.934
37 Salamanca;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2022QII;""
37 Salamanca;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2022QI;""
37 Salamanca;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
37 Salamanca;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2021QIII;3.058
37 Salamanca;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2021QII;""
37 Salamanca;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2021QI;""
37 Salamanca;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
37 Salamanca;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2020QIII;3.168
37 Salamanca;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2020QII;""
37 Salamanca;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2020QI;""
37 Salamanca;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QIV;2.835
37 Salamanca;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
37 Salamanca;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QII;""
37 Salamanca;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QI;""
37 Salamanca;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QIV;2.961
37 Salamanca;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
37 Salamanca;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QII;""
37 Salamanca;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QI;""
37 Salamanca;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QIV;3.091
37 Salamanca;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
37 Salamanca;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QII;""
37 Salamanca;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QI;""
37 Salamanca;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
37 Salamanca;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
37 Salamanca;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QII;""
37 Salamanca;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QI;2.884
37 Salamanca;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
37 Salamanca;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
37 Salamanca;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QII;""
37 Salamanca;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QI;3.029
37 Salamanca;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
37 Salamanca;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
37 Salamanca;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QII;""
37 Salamanca;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QI;""
37 Salamanca;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
37 Salamanca;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
37 Salamanca;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
37 Salamanca;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
37 Salamanca;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
37 Salamanca;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
37 Salamanca;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
37 Salamanca;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
37 Salamanca;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
37 Salamanca;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
37 Salamanca;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
37 Salamanca;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
37 Salamanca;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
37 Salamanca;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
37 Salamanca;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;96,41
37 Salamanca;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
37 Salamanca;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
37 Salamanca;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
37 Salamanca;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;96,51
37 Salamanca;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
37 Salamanca;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
37 Salamanca;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
37 Salamanca;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;97,53
37 Salamanca;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
37 Salamanca;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
37 Salamanca;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;93,08
37 Salamanca;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
37 Salamanca;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
37 Salamanca;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
37 Salamanca;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;93,55
37 Salamanca;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
37 Salamanca;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
37 Salamanca;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
37 Salamanca;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;94,12
37 Salamanca;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
37 Salamanca;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
37 Salamanca;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;89,94
37 Salamanca;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
37 Salamanca;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
37 Salamanca;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
37 Salamanca;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;90,58
37 Salamanca;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
37 Salamanca;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
37 Salamanca;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
37 Salamanca;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;91,83
37 Salamanca;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
37 Salamanca;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
37 Salamanca;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
37 Salamanca;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
37 Salamanca;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
37 Salamanca;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
37 Salamanca;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;88,22
37 Salamanca;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
37 Salamanca;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
37 Salamanca;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
37 Salamanca;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;89,99
37 Salamanca;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
37 Salamanca;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
37 Salamanca;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
37 Salamanca;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
37 Salamanca;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
37 Salamanca;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
37 Salamanca;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QII;1.967
37 Salamanca;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
37 Salamanca;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
37 Salamanca;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
37 Salamanca;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QII;2.082
37 Salamanca;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
37 Salamanca;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
37 Salamanca;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
37 Salamanca;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QII;2.131
37 Salamanca;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
37 Salamanca;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
37 Salamanca;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
37 Salamanca;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2022QII;1.902
37 Salamanca;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2022QI;""
37 Salamanca;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
37 Salamanca;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
37 Salamanca;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2021QII;2.007
37 Salamanca;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2021QI;""
37 Salamanca;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
37 Salamanca;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
37 Salamanca;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2020QII;2.083
37 Salamanca;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2020QI;""
37 Salamanca;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
37 Salamanca;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2022QIII;1.838
37 Salamanca;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2022QII;""
37 Salamanca;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2022QI;""
37 Salamanca;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
37 Salamanca;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2021QIII;1.950
37 Salamanca;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2021QII;""
37 Salamanca;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2021QI;""
37 Salamanca;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
37 Salamanca;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2020QIII;2.024
37 Salamanca;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2020QII;""
37 Salamanca;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2020QI;""
37 Salamanca;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QIV;1.778
37 Salamanca;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
37 Salamanca;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QII;""
37 Salamanca;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QI;""
37 Salamanca;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QIV;1.886
37 Salamanca;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
37 Salamanca;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QII;""
37 Salamanca;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QI;""
37 Salamanca;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QIV;1.984
37 Salamanca;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
37 Salamanca;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QII;""
37 Salamanca;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QI;""
37 Salamanca;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
37 Salamanca;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
37 Salamanca;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QII;""
37 Salamanca;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QI;1.839
37 Salamanca;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
37 Salamanca;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
37 Salamanca;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QII;""
37 Salamanca;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QI;1.949
37 Salamanca;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
37 Salamanca;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
37 Salamanca;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QII;""
37 Salamanca;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QI;""
37 Salamanca;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
37 Salamanca;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
37 Salamanca;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
37 Salamanca;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
37 Salamanca;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
37 Salamanca;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
37 Salamanca;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
37 Salamanca;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
37 Salamanca;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
37 Salamanca;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
37 Salamanca;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
37 Salamanca;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
37 Salamanca;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
37 Salamanca;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
37 Salamanca;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;96,7
37 Salamanca;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
37 Salamanca;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
37 Salamanca;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
37 Salamanca;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;96,4
37 Salamanca;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
37 Salamanca;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
37 Salamanca;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
37 Salamanca;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;97,75
37 Salamanca;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
37 Salamanca;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
37 Salamanca;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;93,44
37 Salamanca;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
37 Salamanca;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
37 Salamanca;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
37 Salamanca;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;93,66
37 Salamanca;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
37 Salamanca;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
37 Salamanca;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
37 Salamanca;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;94,98
37 Salamanca;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
37 Salamanca;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
37 Salamanca;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;90,39
37 Salamanca;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
37 Salamanca;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
37 Salamanca;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
37 Salamanca;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;90,59
37 Salamanca;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
37 Salamanca;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
37 Salamanca;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
37 Salamanca;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;93,1
37 Salamanca;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
37 Salamanca;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
37 Salamanca;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
37 Salamanca;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
37 Salamanca;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
37 Salamanca;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
37 Salamanca;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;88,33
37 Salamanca;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
37 Salamanca;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
37 Salamanca;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
37 Salamanca;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;91,46
37 Salamanca;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
37 Salamanca;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
37 Salamanca;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
37 Salamanca;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
37 Salamanca;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
37 Salamanca;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
37 Salamanca;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QII;1.185
37 Salamanca;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
37 Salamanca;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
37 Salamanca;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
37 Salamanca;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QII;1.187
37 Salamanca;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
37 Salamanca;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
37 Salamanca;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
37 Salamanca;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QII;1.235
37 Salamanca;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
37 Salamanca;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
37 Salamanca;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
37 Salamanca;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2022QII;1.137
37 Salamanca;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2022QI;""
37 Salamanca;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
37 Salamanca;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
37 Salamanca;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2021QII;1.148
37 Salamanca;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2021QI;""
37 Salamanca;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
37 Salamanca;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
37 Salamanca;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2020QII;1.200
37 Salamanca;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2020QI;""
37 Salamanca;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
37 Salamanca;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2022QIII;1.096
37 Salamanca;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2022QII;""
37 Salamanca;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2022QI;""
37 Salamanca;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
37 Salamanca;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2021QIII;1.108
37 Salamanca;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2021QII;""
37 Salamanca;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2021QI;""
37 Salamanca;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
37 Salamanca;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2020QIII;1.144
37 Salamanca;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2020QII;""
37 Salamanca;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2020QI;""
37 Salamanca;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QIV;1.057
37 Salamanca;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
37 Salamanca;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QII;""
37 Salamanca;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QI;""
37 Salamanca;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QIV;1.075
37 Salamanca;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
37 Salamanca;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QII;""
37 Salamanca;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QI;""
37 Salamanca;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QIV;1.107
37 Salamanca;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
37 Salamanca;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QII;""
37 Salamanca;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QI;""
37 Salamanca;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
37 Salamanca;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
37 Salamanca;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QII;""
37 Salamanca;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QI;1.045
37 Salamanca;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
37 Salamanca;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
37 Salamanca;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QII;""
37 Salamanca;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QI;1.080
37 Salamanca;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
37 Salamanca;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
37 Salamanca;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QII;""
37 Salamanca;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QI;""
37 Salamanca;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
37 Salamanca;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
37 Salamanca;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
37 Salamanca;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
37 Salamanca;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
37 Salamanca;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
37 Salamanca;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
37 Salamanca;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
37 Salamanca;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
37 Salamanca;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
37 Salamanca;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
37 Salamanca;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
37 Salamanca;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
37 Salamanca;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
37 Salamanca;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;95,95
37 Salamanca;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
37 Salamanca;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
37 Salamanca;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
37 Salamanca;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;96,71
37 Salamanca;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
37 Salamanca;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
37 Salamanca;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
37 Salamanca;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;97,17
37 Salamanca;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
37 Salamanca;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
37 Salamanca;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;92,49
37 Salamanca;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
37 Salamanca;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
37 Salamanca;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
37 Salamanca;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;93,34
37 Salamanca;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
37 Salamanca;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
37 Salamanca;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
37 Salamanca;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;92,63
37 Salamanca;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
37 Salamanca;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
37 Salamanca;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;89,2
37 Salamanca;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
37 Salamanca;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
37 Salamanca;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
37 Salamanca;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;90,56
37 Salamanca;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
37 Salamanca;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
37 Salamanca;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
37 Salamanca;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;89,64
37 Salamanca;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
37 Salamanca;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
37 Salamanca;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
37 Salamanca;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
37 Salamanca;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
37 Salamanca;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
37 Salamanca;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;88,04
37 Salamanca;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
37 Salamanca;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
37 Salamanca;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
37 Salamanca;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;87,45
37 Salamanca;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
37 Salamanca;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
37 Salamanca;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
37 Salamanca;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
37 Salamanca;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
37 Salamanca;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QIII;3.186
37 Salamanca;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
37 Salamanca;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
37 Salamanca;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
37 Salamanca;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QIII;3.301
37 Salamanca;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
37 Salamanca;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
37 Salamanca;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
37 Salamanca;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QIII;3.388
37 Salamanca;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
37 Salamanca;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
37 Salamanca;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
37 Salamanca;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2022QIII;3.064
37 Salamanca;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2022QII;""
37 Salamanca;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2022QI;""
37 Salamanca;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
37 Salamanca;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2021QIII;3.191
37 Salamanca;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2021QII;""
37 Salamanca;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2021QI;""
37 Salamanca;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
37 Salamanca;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2020QIII;3.257
37 Salamanca;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2020QII;""
37 Salamanca;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2020QI;""
37 Salamanca;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2022QIV;2.950
37 Salamanca;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
37 Salamanca;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2022QII;""
37 Salamanca;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2022QI;""
37 Salamanca;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2021QIV;3.082
37 Salamanca;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
37 Salamanca;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2021QII;""
37 Salamanca;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2021QI;""
37 Salamanca;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2020QIV;3.171
37 Salamanca;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
37 Salamanca;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2020QII;""
37 Salamanca;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2020QI;""
37 Salamanca;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
37 Salamanca;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
37 Salamanca;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QII;""
37 Salamanca;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QI;3.001
37 Salamanca;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
37 Salamanca;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
37 Salamanca;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QII;""
37 Salamanca;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QI;3.107
37 Salamanca;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
37 Salamanca;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
37 Salamanca;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QII;""
37 Salamanca;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QI;""
37 Salamanca;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
37 Salamanca;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
37 Salamanca;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QII;2.917
37 Salamanca;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QI;""
37 Salamanca;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
37 Salamanca;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
37 Salamanca;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QII;3.036
37 Salamanca;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QI;""
37 Salamanca;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
37 Salamanca;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
37 Salamanca;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QII;""
37 Salamanca;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QI;""
37 Salamanca;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
37 Salamanca;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
37 Salamanca;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
37 Salamanca;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
37 Salamanca;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
37 Salamanca;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
37 Salamanca;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
37 Salamanca;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
37 Salamanca;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
37 Salamanca;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
37 Salamanca;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
37 Salamanca;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
37 Salamanca;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
37 Salamanca;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;96,17
37 Salamanca;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
37 Salamanca;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
37 Salamanca;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
37 Salamanca;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;96,67
37 Salamanca;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
37 Salamanca;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
37 Salamanca;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
37 Salamanca;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;96,13
37 Salamanca;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
37 Salamanca;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
37 Salamanca;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;92,59
37 Salamanca;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
37 Salamanca;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
37 Salamanca;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
37 Salamanca;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;93,37
37 Salamanca;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
37 Salamanca;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
37 Salamanca;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
37 Salamanca;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;93,6
37 Salamanca;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
37 Salamanca;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
37 Salamanca;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
37 Salamanca;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
37 Salamanca;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
37 Salamanca;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
37 Salamanca;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;90,91
37 Salamanca;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
37 Salamanca;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
37 Salamanca;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
37 Salamanca;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;91,71
37 Salamanca;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
37 Salamanca;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
37 Salamanca;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
37 Salamanca;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
37 Salamanca;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
37 Salamanca;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
37 Salamanca;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;88,37
37 Salamanca;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
37 Salamanca;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
37 Salamanca;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
37 Salamanca;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;89,61
37 Salamanca;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
37 Salamanca;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
37 Salamanca;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
37 Salamanca;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
37 Salamanca;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
37 Salamanca;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
37 Salamanca;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QIII;1.985
37 Salamanca;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
37 Salamanca;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
37 Salamanca;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
37 Salamanca;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QIII;2.092
37 Salamanca;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
37 Salamanca;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
37 Salamanca;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
37 Salamanca;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QIII;2.151
37 Salamanca;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
37 Salamanca;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
37 Salamanca;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
37 Salamanca;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2022QIII;1.908
37 Salamanca;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2022QII;""
37 Salamanca;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2022QI;""
37 Salamanca;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
37 Salamanca;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2021QIII;2.028
37 Salamanca;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2021QII;""
37 Salamanca;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2021QI;""
37 Salamanca;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
37 Salamanca;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2020QIII;2.081
37 Salamanca;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2020QII;""
37 Salamanca;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2020QI;""
37 Salamanca;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2022QIV;1.839
37 Salamanca;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
37 Salamanca;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2022QII;""
37 Salamanca;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2022QI;""
37 Salamanca;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2021QIV;1.958
37 Salamanca;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
37 Salamanca;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2021QII;""
37 Salamanca;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2021QI;""
37 Salamanca;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2020QIV;2.033
37 Salamanca;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
37 Salamanca;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2020QII;""
37 Salamanca;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2020QI;""
37 Salamanca;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
37 Salamanca;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
37 Salamanca;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QII;""
37 Salamanca;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QI;1.908
37 Salamanca;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
37 Salamanca;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
37 Salamanca;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QII;""
37 Salamanca;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QI;1.998
37 Salamanca;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
37 Salamanca;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
37 Salamanca;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QII;""
37 Salamanca;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QI;""
37 Salamanca;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
37 Salamanca;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
37 Salamanca;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QII;1.860
37 Salamanca;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QI;""
37 Salamanca;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
37 Salamanca;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
37 Salamanca;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QII;1.953
37 Salamanca;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QI;""
37 Salamanca;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
37 Salamanca;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
37 Salamanca;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QII;""
37 Salamanca;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QI;""
37 Salamanca;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
37 Salamanca;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
37 Salamanca;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
37 Salamanca;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
37 Salamanca;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
37 Salamanca;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
37 Salamanca;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
37 Salamanca;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
37 Salamanca;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
37 Salamanca;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
37 Salamanca;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
37 Salamanca;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
37 Salamanca;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
37 Salamanca;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;96,12
37 Salamanca;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
37 Salamanca;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
37 Salamanca;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
37 Salamanca;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;96,94
37 Salamanca;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
37 Salamanca;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
37 Salamanca;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
37 Salamanca;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;96,75
37 Salamanca;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
37 Salamanca;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
37 Salamanca;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;92,64
37 Salamanca;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
37 Salamanca;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
37 Salamanca;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
37 Salamanca;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;93,59
37 Salamanca;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
37 Salamanca;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
37 Salamanca;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
37 Salamanca;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;94,51
37 Salamanca;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
37 Salamanca;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
37 Salamanca;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
37 Salamanca;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
37 Salamanca;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
37 Salamanca;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
37 Salamanca;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;91,2
37 Salamanca;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
37 Salamanca;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
37 Salamanca;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
37 Salamanca;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;92,89
37 Salamanca;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
37 Salamanca;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
37 Salamanca;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
37 Salamanca;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
37 Salamanca;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
37 Salamanca;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
37 Salamanca;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;88,91
37 Salamanca;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
37 Salamanca;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
37 Salamanca;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
37 Salamanca;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;90,79
37 Salamanca;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
37 Salamanca;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
37 Salamanca;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
37 Salamanca;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
37 Salamanca;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
37 Salamanca;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
37 Salamanca;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QIII;1.201
37 Salamanca;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
37 Salamanca;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
37 Salamanca;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
37 Salamanca;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QIII;1.209
37 Salamanca;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
37 Salamanca;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
37 Salamanca;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
37 Salamanca;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QIII;1.237
37 Salamanca;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
37 Salamanca;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
37 Salamanca;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
37 Salamanca;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2022QIII;1.156
37 Salamanca;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2022QII;""
37 Salamanca;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2022QI;""
37 Salamanca;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
37 Salamanca;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2021QIII;1.163
37 Salamanca;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2021QII;""
37 Salamanca;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2021QI;""
37 Salamanca;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
37 Salamanca;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2020QIII;1.176
37 Salamanca;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2020QII;""
37 Salamanca;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2020QI;""
37 Salamanca;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2022QIV;1.111
37 Salamanca;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
37 Salamanca;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2022QII;""
37 Salamanca;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2022QI;""
37 Salamanca;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2021QIV;1.124
37 Salamanca;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
37 Salamanca;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2021QII;""
37 Salamanca;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2021QI;""
37 Salamanca;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2020QIV;1.138
37 Salamanca;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
37 Salamanca;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2020QII;""
37 Salamanca;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2020QI;""
37 Salamanca;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
37 Salamanca;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
37 Salamanca;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QII;""
37 Salamanca;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QI;1.093
37 Salamanca;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
37 Salamanca;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
37 Salamanca;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QII;""
37 Salamanca;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QI;1.109
37 Salamanca;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
37 Salamanca;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
37 Salamanca;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QII;""
37 Salamanca;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QI;""
37 Salamanca;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
37 Salamanca;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
37 Salamanca;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QII;1.057
37 Salamanca;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QI;""
37 Salamanca;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
37 Salamanca;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
37 Salamanca;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QII;1.083
37 Salamanca;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QI;""
37 Salamanca;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
37 Salamanca;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
37 Salamanca;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QII;""
37 Salamanca;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QI;""
37 Salamanca;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
37 Salamanca;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
37 Salamanca;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
37 Salamanca;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
37 Salamanca;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
37 Salamanca;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
37 Salamanca;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
37 Salamanca;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
37 Salamanca;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
37 Salamanca;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
37 Salamanca;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
37 Salamanca;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
37 Salamanca;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
37 Salamanca;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;96,25
37 Salamanca;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
37 Salamanca;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
37 Salamanca;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
37 Salamanca;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;96,2
37 Salamanca;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
37 Salamanca;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
37 Salamanca;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
37 Salamanca;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;95,07
37 Salamanca;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
37 Salamanca;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
37 Salamanca;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;92,51
37 Salamanca;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
37 Salamanca;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
37 Salamanca;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
37 Salamanca;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;92,97
37 Salamanca;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
37 Salamanca;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
37 Salamanca;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
37 Salamanca;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;92
37 Salamanca;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
37 Salamanca;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
37 Salamanca;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
37 Salamanca;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
37 Salamanca;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
37 Salamanca;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
37 Salamanca;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;90,41
37 Salamanca;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
37 Salamanca;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
37 Salamanca;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
37 Salamanca;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;89,65
37 Salamanca;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
37 Salamanca;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
37 Salamanca;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
37 Salamanca;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
37 Salamanca;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
37 Salamanca;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
37 Salamanca;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;87,43
37 Salamanca;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
37 Salamanca;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
37 Salamanca;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
37 Salamanca;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;87,55
37 Salamanca;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
37 Salamanca;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
37 Salamanca;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
37 Salamanca;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
37 Salamanca;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
37 Salamanca;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QIV;3.193
37 Salamanca;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
37 Salamanca;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
37 Salamanca;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
37 Salamanca;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QIV;3.320
37 Salamanca;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
37 Salamanca;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
37 Salamanca;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
37 Salamanca;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QIV;3.412
37 Salamanca;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
37 Salamanca;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
37 Salamanca;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
37 Salamanca;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2022QIV;3.066
37 Salamanca;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
37 Salamanca;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2022QII;""
37 Salamanca;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2022QI;""
37 Salamanca;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2021QIV;3.197
37 Salamanca;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
37 Salamanca;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2021QII;""
37 Salamanca;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2021QI;""
37 Salamanca;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2020QIV;3.314
37 Salamanca;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
37 Salamanca;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2020QII;""
37 Salamanca;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2020QI;""
37 Salamanca;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
37 Salamanca;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
37 Salamanca;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2022QII;""
37 Salamanca;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2022QI;3.109
37 Salamanca;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
37 Salamanca;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
37 Salamanca;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2021QII;""
37 Salamanca;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2021QI;3.242
37 Salamanca;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
37 Salamanca;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
37 Salamanca;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2020QII;""
37 Salamanca;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2020QI;""
37 Salamanca;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
37 Salamanca;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
37 Salamanca;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QII;3.018
37 Salamanca;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QI;""
37 Salamanca;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
37 Salamanca;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
37 Salamanca;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QII;3.163
37 Salamanca;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QI;""
37 Salamanca;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
37 Salamanca;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
37 Salamanca;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QII;""
37 Salamanca;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QI;""
37 Salamanca;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
37 Salamanca;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QIII;2.948
37 Salamanca;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QII;""
37 Salamanca;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QI;""
37 Salamanca;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
37 Salamanca;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QIII;3.083
37 Salamanca;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QII;""
37 Salamanca;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QI;""
37 Salamanca;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
37 Salamanca;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
37 Salamanca;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QII;""
37 Salamanca;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QI;""
37 Salamanca;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
37 Salamanca;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
37 Salamanca;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
37 Salamanca;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
37 Salamanca;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
37 Salamanca;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
37 Salamanca;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
37 Salamanca;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
37 Salamanca;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
37 Salamanca;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
37 Salamanca;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
37 Salamanca;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
37 Salamanca;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;96,02
37 Salamanca;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
37 Salamanca;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
37 Salamanca;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
37 Salamanca;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;96,3
37 Salamanca;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
37 Salamanca;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
37 Salamanca;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
37 Salamanca;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;97,13
37 Salamanca;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
37 Salamanca;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
37 Salamanca;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
37 Salamanca;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
37 Salamanca;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
37 Salamanca;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
37 Salamanca;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;93,64
37 Salamanca;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
37 Salamanca;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
37 Salamanca;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
37 Salamanca;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;95,02
37 Salamanca;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
37 Salamanca;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
37 Salamanca;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
37 Salamanca;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
37 Salamanca;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
37 Salamanca;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
37 Salamanca;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;90,9
37 Salamanca;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
37 Salamanca;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
37 Salamanca;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
37 Salamanca;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;92,7
37 Salamanca;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
37 Salamanca;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
37 Salamanca;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
37 Salamanca;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
37 Salamanca;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
37 Salamanca;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
37 Salamanca;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;88,8
37 Salamanca;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
37 Salamanca;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
37 Salamanca;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
37 Salamanca;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;90,36
37 Salamanca;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
37 Salamanca;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
37 Salamanca;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
37 Salamanca;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
37 Salamanca;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
37 Salamanca;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
37 Salamanca;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QIV;1.971
37 Salamanca;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
37 Salamanca;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
37 Salamanca;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
37 Salamanca;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QIV;2.103
37 Salamanca;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
37 Salamanca;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
37 Salamanca;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
37 Salamanca;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QIV;2.180
37 Salamanca;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
37 Salamanca;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
37 Salamanca;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
37 Salamanca;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2022QIV;1.897
37 Salamanca;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
37 Salamanca;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2022QII;""
37 Salamanca;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2022QI;""
37 Salamanca;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2021QIV;2.021
37 Salamanca;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
37 Salamanca;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2021QII;""
37 Salamanca;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2021QI;""
37 Salamanca;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2020QIV;2.123
37 Salamanca;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
37 Salamanca;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2020QII;""
37 Salamanca;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2020QI;""
37 Salamanca;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
37 Salamanca;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
37 Salamanca;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2022QII;""
37 Salamanca;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2022QI;1.967
37 Salamanca;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
37 Salamanca;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
37 Salamanca;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2021QII;""
37 Salamanca;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2021QI;2.083
37 Salamanca;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
37 Salamanca;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
37 Salamanca;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2020QII;""
37 Salamanca;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2020QI;""
37 Salamanca;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
37 Salamanca;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
37 Salamanca;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QII;1.916
37 Salamanca;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QI;""
37 Salamanca;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
37 Salamanca;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
37 Salamanca;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QII;2.035
37 Salamanca;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QI;""
37 Salamanca;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
37 Salamanca;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
37 Salamanca;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QII;""
37 Salamanca;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QI;""
37 Salamanca;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
37 Salamanca;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QIII;1.873
37 Salamanca;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QII;""
37 Salamanca;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QI;""
37 Salamanca;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
37 Salamanca;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QIII;1.991
37 Salamanca;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QII;""
37 Salamanca;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QI;""
37 Salamanca;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
37 Salamanca;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
37 Salamanca;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QII;""
37 Salamanca;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QI;""
37 Salamanca;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
37 Salamanca;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
37 Salamanca;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
37 Salamanca;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
37 Salamanca;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
37 Salamanca;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
37 Salamanca;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
37 Salamanca;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
37 Salamanca;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
37 Salamanca;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
37 Salamanca;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
37 Salamanca;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
37 Salamanca;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;96,25
37 Salamanca;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
37 Salamanca;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
37 Salamanca;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
37 Salamanca;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;96,1
37 Salamanca;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
37 Salamanca;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
37 Salamanca;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
37 Salamanca;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;97,39
37 Salamanca;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
37 Salamanca;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
37 Salamanca;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
37 Salamanca;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
37 Salamanca;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
37 Salamanca;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
37 Salamanca;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;93,53
37 Salamanca;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
37 Salamanca;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
37 Salamanca;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
37 Salamanca;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;95,55
37 Salamanca;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
37 Salamanca;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
37 Salamanca;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
37 Salamanca;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
37 Salamanca;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
37 Salamanca;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
37 Salamanca;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;91,11
37 Salamanca;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
37 Salamanca;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
37 Salamanca;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
37 Salamanca;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;93,35
37 Salamanca;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
37 Salamanca;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
37 Salamanca;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
37 Salamanca;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
37 Salamanca;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
37 Salamanca;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
37 Salamanca;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;89,06
37 Salamanca;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
37 Salamanca;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
37 Salamanca;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
37 Salamanca;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;91,33
37 Salamanca;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
37 Salamanca;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
37 Salamanca;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
37 Salamanca;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
37 Salamanca;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
37 Salamanca;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
37 Salamanca;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QIV;1.222
37 Salamanca;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
37 Salamanca;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
37 Salamanca;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
37 Salamanca;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QIV;1.217
37 Salamanca;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
37 Salamanca;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
37 Salamanca;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
37 Salamanca;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QIV;1.232
37 Salamanca;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
37 Salamanca;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
37 Salamanca;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
37 Salamanca;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2022QIV;1.169
37 Salamanca;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
37 Salamanca;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2022QII;""
37 Salamanca;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2022QI;""
37 Salamanca;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2021QIV;1.176
37 Salamanca;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
37 Salamanca;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2021QII;""
37 Salamanca;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2021QI;""
37 Salamanca;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2020QIV;1.191
37 Salamanca;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
37 Salamanca;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2020QII;""
37 Salamanca;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2020QI;""
37 Salamanca;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
37 Salamanca;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
37 Salamanca;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2022QII;""
37 Salamanca;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2022QI;1.142
37 Salamanca;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
37 Salamanca;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
37 Salamanca;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2021QII;""
37 Salamanca;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2021QI;1.159
37 Salamanca;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
37 Salamanca;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
37 Salamanca;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2020QII;""
37 Salamanca;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2020QI;""
37 Salamanca;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
37 Salamanca;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
37 Salamanca;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QII;1.102
37 Salamanca;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QI;""
37 Salamanca;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
37 Salamanca;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
37 Salamanca;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QII;1.128
37 Salamanca;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QI;""
37 Salamanca;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
37 Salamanca;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
37 Salamanca;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QII;""
37 Salamanca;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QI;""
37 Salamanca;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
37 Salamanca;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QIII;1.075
37 Salamanca;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QII;""
37 Salamanca;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QI;""
37 Salamanca;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
37 Salamanca;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QIII;1.092
37 Salamanca;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QII;""
37 Salamanca;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QI;""
37 Salamanca;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
37 Salamanca;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
37 Salamanca;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QII;""
37 Salamanca;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QI;""
37 Salamanca;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
37 Salamanca;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
37 Salamanca;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
37 Salamanca;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
37 Salamanca;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
37 Salamanca;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
37 Salamanca;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
37 Salamanca;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
37 Salamanca;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
37 Salamanca;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
37 Salamanca;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
37 Salamanca;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
37 Salamanca;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;95,66
37 Salamanca;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
37 Salamanca;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
37 Salamanca;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
37 Salamanca;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;96,63
37 Salamanca;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
37 Salamanca;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
37 Salamanca;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
37 Salamanca;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;96,67
37 Salamanca;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
37 Salamanca;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
37 Salamanca;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
37 Salamanca;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
37 Salamanca;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
37 Salamanca;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
37 Salamanca;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;93,84
37 Salamanca;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
37 Salamanca;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
37 Salamanca;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
37 Salamanca;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;94,07
37 Salamanca;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
37 Salamanca;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
37 Salamanca;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
37 Salamanca;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
37 Salamanca;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
37 Salamanca;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
37 Salamanca;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;90,55
37 Salamanca;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
37 Salamanca;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
37 Salamanca;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
37 Salamanca;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;91,56
37 Salamanca;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
37 Salamanca;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
37 Salamanca;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
37 Salamanca;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
37 Salamanca;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
37 Salamanca;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
37 Salamanca;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;88,33
37 Salamanca;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
37 Salamanca;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
37 Salamanca;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
37 Salamanca;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;88,64
37 Salamanca;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
37 Salamanca;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
37 Salamanca;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
37 Salamanca;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
37 Salamanca;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
37 Salamanca;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
37 Salamanca;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
37 Salamanca;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
37 Salamanca;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
37 Salamanca;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QI;5.830
37 Salamanca;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
37 Salamanca;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
37 Salamanca;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
37 Salamanca;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QI;5.965
37 Salamanca;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
37 Salamanca;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
37 Salamanca;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
37 Salamanca;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QI;5.994
37 Salamanca;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
37 Salamanca;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
37 Salamanca;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2022QII;""
37 Salamanca;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2022QI;5.702
37 Salamanca;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
37 Salamanca;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
37 Salamanca;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2021QII;""
37 Salamanca;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2021QI;5.885
37 Salamanca;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
37 Salamanca;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
37 Salamanca;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2020QII;""
37 Salamanca;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2020QI;5.703
37 Salamanca;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
37 Salamanca;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
37 Salamanca;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2022QII;5.570
37 Salamanca;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2022QI;""
37 Salamanca;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
37 Salamanca;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
37 Salamanca;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2021QII;5.770
37 Salamanca;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2021QI;""
37 Salamanca;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
37 Salamanca;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
37 Salamanca;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2020QII;5.621
37 Salamanca;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2020QI;""
37 Salamanca;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
37 Salamanca;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QIII;5.461
37 Salamanca;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QII;""
37 Salamanca;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QI;""
37 Salamanca;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
37 Salamanca;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QIII;5.687
37 Salamanca;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QII;""
37 Salamanca;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QI;""
37 Salamanca;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
37 Salamanca;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QIII;5.520
37 Salamanca;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QII;""
37 Salamanca;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QI;""
37 Salamanca;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QIV;5.360
37 Salamanca;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
37 Salamanca;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QII;""
37 Salamanca;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QI;""
37 Salamanca;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QIV;5.581
37 Salamanca;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
37 Salamanca;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QII;""
37 Salamanca;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QI;""
37 Salamanca;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QIV;5.433
37 Salamanca;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
37 Salamanca;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QII;""
37 Salamanca;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QI;""
37 Salamanca;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
37 Salamanca;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
37 Salamanca;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
37 Salamanca;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
37 Salamanca;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
37 Salamanca;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
37 Salamanca;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
37 Salamanca;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
37 Salamanca;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
37 Salamanca;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
37 Salamanca;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
37 Salamanca;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
37 Salamanca;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
37 Salamanca;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
37 Salamanca;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
37 Salamanca;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;97,8
37 Salamanca;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
37 Salamanca;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
37 Salamanca;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
37 Salamanca;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;98,66
37 Salamanca;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
37 Salamanca;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
37 Salamanca;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
37 Salamanca;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;95,15
37 Salamanca;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
37 Salamanca;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
37 Salamanca;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;95,54
37 Salamanca;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
37 Salamanca;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
37 Salamanca;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
37 Salamanca;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;96,73
37 Salamanca;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
37 Salamanca;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
37 Salamanca;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
37 Salamanca;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;93,78
37 Salamanca;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
37 Salamanca;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
37 Salamanca;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;93,67
37 Salamanca;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
37 Salamanca;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
37 Salamanca;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
37 Salamanca;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;95,34
37 Salamanca;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
37 Salamanca;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
37 Salamanca;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
37 Salamanca;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;92,09
37 Salamanca;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
37 Salamanca;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
37 Salamanca;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;91,94
37 Salamanca;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
37 Salamanca;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
37 Salamanca;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
37 Salamanca;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;93,56
37 Salamanca;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
37 Salamanca;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
37 Salamanca;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
37 Salamanca;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;90,64
37 Salamanca;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
37 Salamanca;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
37 Salamanca;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
37 Salamanca;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
37 Salamanca;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
37 Salamanca;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
37 Salamanca;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QI;3.763
37 Salamanca;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
37 Salamanca;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
37 Salamanca;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
37 Salamanca;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QI;3.888
37 Salamanca;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
37 Salamanca;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
37 Salamanca;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
37 Salamanca;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QI;3.898
37 Salamanca;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
37 Salamanca;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
37 Salamanca;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2022QII;""
37 Salamanca;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2022QI;3.685
37 Salamanca;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
37 Salamanca;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
37 Salamanca;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2021QII;""
37 Salamanca;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2021QI;3.837
37 Salamanca;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
37 Salamanca;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
37 Salamanca;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2020QII;""
37 Salamanca;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2020QI;3.731
37 Salamanca;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
37 Salamanca;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
37 Salamanca;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2022QII;3.614
37 Salamanca;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2022QI;""
37 Salamanca;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
37 Salamanca;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
37 Salamanca;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2021QII;3.769
37 Salamanca;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2021QI;""
37 Salamanca;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
37 Salamanca;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
37 Salamanca;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2020QII;3.689
37 Salamanca;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2020QI;""
37 Salamanca;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
37 Salamanca;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QIII;3.546
37 Salamanca;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QII;""
37 Salamanca;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QI;""
37 Salamanca;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
37 Salamanca;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QIII;3.725
37 Salamanca;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QII;""
37 Salamanca;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QI;""
37 Salamanca;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
37 Salamanca;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QIII;3.639
37 Salamanca;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QII;""
37 Salamanca;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QI;""
37 Salamanca;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QIV;3.495
37 Salamanca;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
37 Salamanca;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QII;""
37 Salamanca;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QI;""
37 Salamanca;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QIV;3.653
37 Salamanca;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
37 Salamanca;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QII;""
37 Salamanca;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QI;""
37 Salamanca;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QIV;3.583
37 Salamanca;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
37 Salamanca;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QII;""
37 Salamanca;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QI;""
37 Salamanca;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
37 Salamanca;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
37 Salamanca;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
37 Salamanca;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
37 Salamanca;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
37 Salamanca;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
37 Salamanca;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
37 Salamanca;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
37 Salamanca;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
37 Salamanca;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
37 Salamanca;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
37 Salamanca;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
37 Salamanca;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
37 Salamanca;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
37 Salamanca;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
37 Salamanca;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;97,93
37 Salamanca;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
37 Salamanca;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
37 Salamanca;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
37 Salamanca;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;98,69
37 Salamanca;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
37 Salamanca;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
37 Salamanca;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
37 Salamanca;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;95,72
37 Salamanca;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
37 Salamanca;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
37 Salamanca;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;96,04
37 Salamanca;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
37 Salamanca;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
37 Salamanca;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
37 Salamanca;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;96,94
37 Salamanca;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
37 Salamanca;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
37 Salamanca;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
37 Salamanca;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;94,64
37 Salamanca;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
37 Salamanca;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
37 Salamanca;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;94,23
37 Salamanca;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
37 Salamanca;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
37 Salamanca;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
37 Salamanca;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;95,81
37 Salamanca;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
37 Salamanca;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
37 Salamanca;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
37 Salamanca;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;93,36
37 Salamanca;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
37 Salamanca;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
37 Salamanca;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;92,88
37 Salamanca;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
37 Salamanca;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
37 Salamanca;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
37 Salamanca;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;93,96
37 Salamanca;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
37 Salamanca;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
37 Salamanca;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
37 Salamanca;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;91,92
37 Salamanca;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
37 Salamanca;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
37 Salamanca;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
37 Salamanca;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
37 Salamanca;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
37 Salamanca;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
37 Salamanca;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QI;2.067
37 Salamanca;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
37 Salamanca;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
37 Salamanca;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
37 Salamanca;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QI;2.077
37 Salamanca;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
37 Salamanca;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
37 Salamanca;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
37 Salamanca;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QI;2.096
37 Salamanca;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
37 Salamanca;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
37 Salamanca;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2022QII;""
37 Salamanca;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2022QI;2.017
37 Salamanca;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
37 Salamanca;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
37 Salamanca;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2021QII;""
37 Salamanca;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2021QI;2.048
37 Salamanca;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
37 Salamanca;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
37 Salamanca;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2020QII;""
37 Salamanca;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2020QI;1.972
37 Salamanca;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
37 Salamanca;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
37 Salamanca;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2022QII;1.956
37 Salamanca;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2022QI;""
37 Salamanca;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
37 Salamanca;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
37 Salamanca;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2021QII;2.001
37 Salamanca;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2021QI;""
37 Salamanca;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
37 Salamanca;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
37 Salamanca;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2020QII;1.932
37 Salamanca;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2020QI;""
37 Salamanca;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
37 Salamanca;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QIII;1.915
37 Salamanca;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QII;""
37 Salamanca;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QI;""
37 Salamanca;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
37 Salamanca;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QIII;1.962
37 Salamanca;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QII;""
37 Salamanca;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QI;""
37 Salamanca;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
37 Salamanca;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QIII;1.881
37 Salamanca;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QII;""
37 Salamanca;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QI;""
37 Salamanca;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QIV;1.865
37 Salamanca;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
37 Salamanca;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QII;""
37 Salamanca;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QI;""
37 Salamanca;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QIV;1.928
37 Salamanca;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
37 Salamanca;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QII;""
37 Salamanca;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QI;""
37 Salamanca;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QIV;1.850
37 Salamanca;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
37 Salamanca;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QII;""
37 Salamanca;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QI;""
37 Salamanca;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
37 Salamanca;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
37 Salamanca;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
37 Salamanca;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
37 Salamanca;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
37 Salamanca;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
37 Salamanca;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
37 Salamanca;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
37 Salamanca;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
37 Salamanca;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
37 Salamanca;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
37 Salamanca;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
37 Salamanca;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
37 Salamanca;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
37 Salamanca;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
37 Salamanca;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;97,58
37 Salamanca;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
37 Salamanca;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
37 Salamanca;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
37 Salamanca;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;98,6
37 Salamanca;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
37 Salamanca;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
37 Salamanca;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
37 Salamanca;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;94,08
37 Salamanca;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
37 Salamanca;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
37 Salamanca;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;94,63
37 Salamanca;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
37 Salamanca;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
37 Salamanca;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
37 Salamanca;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;96,34
37 Salamanca;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
37 Salamanca;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
37 Salamanca;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
37 Salamanca;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;92,18
37 Salamanca;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
37 Salamanca;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
37 Salamanca;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;92,65
37 Salamanca;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
37 Salamanca;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
37 Salamanca;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
37 Salamanca;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;94,46
37 Salamanca;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
37 Salamanca;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
37 Salamanca;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
37 Salamanca;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;89,74
37 Salamanca;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
37 Salamanca;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
37 Salamanca;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;90,23
37 Salamanca;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
37 Salamanca;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
37 Salamanca;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
37 Salamanca;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;92,83
37 Salamanca;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
37 Salamanca;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
37 Salamanca;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
37 Salamanca;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;88,26
37 Salamanca;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
37 Salamanca;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
37 Salamanca;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
37 Salamanca;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
37 Salamanca;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
37 Salamanca;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QII;5.644
37 Salamanca;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
37 Salamanca;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
37 Salamanca;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
37 Salamanca;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QII;5.780
37 Salamanca;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
37 Salamanca;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
37 Salamanca;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
37 Salamanca;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QII;5.888
37 Salamanca;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
37 Salamanca;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
37 Salamanca;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
37 Salamanca;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2022QII;5.495
37 Salamanca;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2022QI;""
37 Salamanca;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
37 Salamanca;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
37 Salamanca;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2021QII;5.647
37 Salamanca;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2021QI;""
37 Salamanca;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
37 Salamanca;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
37 Salamanca;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2020QII;5.798
37 Salamanca;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2020QI;""
37 Salamanca;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
37 Salamanca;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2022QIII;5.380
37 Salamanca;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2022QII;""
37 Salamanca;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2022QI;""
37 Salamanca;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
37 Salamanca;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2021QIII;5.554
37 Salamanca;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2021QII;""
37 Salamanca;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2021QI;""
37 Salamanca;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
37 Salamanca;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2020QIII;5.685
37 Salamanca;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2020QII;""
37 Salamanca;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2020QI;""
37 Salamanca;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QIV;5.267
37 Salamanca;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
37 Salamanca;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QII;""
37 Salamanca;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QI;""
37 Salamanca;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QIV;5.448
37 Salamanca;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
37 Salamanca;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QII;""
37 Salamanca;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QI;""
37 Salamanca;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QIV;5.590
37 Salamanca;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
37 Salamanca;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QII;""
37 Salamanca;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QI;""
37 Salamanca;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
37 Salamanca;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
37 Salamanca;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QII;""
37 Salamanca;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QI;5.353
37 Salamanca;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
37 Salamanca;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
37 Salamanca;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QII;""
37 Salamanca;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QI;5.536
37 Salamanca;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
37 Salamanca;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
37 Salamanca;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QII;""
37 Salamanca;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QI;""
37 Salamanca;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
37 Salamanca;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
37 Salamanca;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
37 Salamanca;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
37 Salamanca;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
37 Salamanca;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
37 Salamanca;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
37 Salamanca;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
37 Salamanca;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
37 Salamanca;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
37 Salamanca;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
37 Salamanca;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
37 Salamanca;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
37 Salamanca;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
37 Salamanca;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;97,36
37 Salamanca;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
37 Salamanca;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
37 Salamanca;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
37 Salamanca;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;97,7
37 Salamanca;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
37 Salamanca;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
37 Salamanca;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
37 Salamanca;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;98,47
37 Salamanca;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
37 Salamanca;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
37 Salamanca;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;95,32
37 Salamanca;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
37 Salamanca;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
37 Salamanca;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
37 Salamanca;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;96,09
37 Salamanca;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
37 Salamanca;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
37 Salamanca;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
37 Salamanca;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;96,55
37 Salamanca;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
37 Salamanca;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
37 Salamanca;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;93,32
37 Salamanca;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
37 Salamanca;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
37 Salamanca;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
37 Salamanca;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;94,26
37 Salamanca;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
37 Salamanca;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
37 Salamanca;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
37 Salamanca;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;94,94
37 Salamanca;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
37 Salamanca;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
37 Salamanca;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
37 Salamanca;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
37 Salamanca;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
37 Salamanca;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
37 Salamanca;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;92,61
37 Salamanca;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
37 Salamanca;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
37 Salamanca;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
37 Salamanca;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;94,02
37 Salamanca;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
37 Salamanca;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
37 Salamanca;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
37 Salamanca;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
37 Salamanca;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
37 Salamanca;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
37 Salamanca;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QII;3.636
37 Salamanca;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
37 Salamanca;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
37 Salamanca;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
37 Salamanca;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QII;3.758
37 Salamanca;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
37 Salamanca;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
37 Salamanca;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
37 Salamanca;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QII;3.832
37 Salamanca;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
37 Salamanca;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
37 Salamanca;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
37 Salamanca;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2022QII;3.552
37 Salamanca;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2022QI;""
37 Salamanca;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
37 Salamanca;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
37 Salamanca;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2021QII;3.676
37 Salamanca;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2021QI;""
37 Salamanca;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
37 Salamanca;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
37 Salamanca;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2020QII;3.787
37 Salamanca;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2020QI;""
37 Salamanca;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
37 Salamanca;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2022QIII;3.476
37 Salamanca;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2022QII;""
37 Salamanca;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2022QI;""
37 Salamanca;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
37 Salamanca;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2021QIII;3.625
37 Salamanca;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2021QII;""
37 Salamanca;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2021QI;""
37 Salamanca;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
37 Salamanca;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2020QIII;3.728
37 Salamanca;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2020QII;""
37 Salamanca;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2020QI;""
37 Salamanca;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QIV;3.415
37 Salamanca;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
37 Salamanca;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QII;""
37 Salamanca;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QI;""
37 Salamanca;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QIV;3.556
37 Salamanca;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
37 Salamanca;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QII;""
37 Salamanca;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QI;""
37 Salamanca;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QIV;3.668
37 Salamanca;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
37 Salamanca;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QII;""
37 Salamanca;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QI;""
37 Salamanca;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
37 Salamanca;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
37 Salamanca;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QII;""
37 Salamanca;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QI;3.499
37 Salamanca;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
37 Salamanca;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
37 Salamanca;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QII;""
37 Salamanca;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QI;3.633
37 Salamanca;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
37 Salamanca;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
37 Salamanca;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QII;""
37 Salamanca;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QI;""
37 Salamanca;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
37 Salamanca;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
37 Salamanca;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
37 Salamanca;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
37 Salamanca;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
37 Salamanca;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
37 Salamanca;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
37 Salamanca;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
37 Salamanca;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
37 Salamanca;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
37 Salamanca;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
37 Salamanca;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
37 Salamanca;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
37 Salamanca;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
37 Salamanca;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;97,69
37 Salamanca;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
37 Salamanca;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
37 Salamanca;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
37 Salamanca;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;97,82
37 Salamanca;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
37 Salamanca;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
37 Salamanca;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
37 Salamanca;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;98,83
37 Salamanca;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
37 Salamanca;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
37 Salamanca;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;95,6
37 Salamanca;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
37 Salamanca;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
37 Salamanca;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
37 Salamanca;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;96,46
37 Salamanca;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
37 Salamanca;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
37 Salamanca;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
37 Salamanca;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;97,29
37 Salamanca;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
37 Salamanca;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
37 Salamanca;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;93,92
37 Salamanca;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
37 Salamanca;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
37 Salamanca;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
37 Salamanca;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;94,62
37 Salamanca;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
37 Salamanca;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
37 Salamanca;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
37 Salamanca;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;95,72
37 Salamanca;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
37 Salamanca;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
37 Salamanca;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
37 Salamanca;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
37 Salamanca;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
37 Salamanca;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
37 Salamanca;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;93,11
37 Salamanca;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
37 Salamanca;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
37 Salamanca;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
37 Salamanca;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;94,81
37 Salamanca;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
37 Salamanca;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
37 Salamanca;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
37 Salamanca;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
37 Salamanca;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
37 Salamanca;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
37 Salamanca;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QII;2.008
37 Salamanca;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
37 Salamanca;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
37 Salamanca;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
37 Salamanca;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QII;2.022
37 Salamanca;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
37 Salamanca;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
37 Salamanca;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
37 Salamanca;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QII;2.056
37 Salamanca;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
37 Salamanca;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
37 Salamanca;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
37 Salamanca;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2022QII;1.943
37 Salamanca;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2022QI;""
37 Salamanca;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
37 Salamanca;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
37 Salamanca;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2021QII;1.971
37 Salamanca;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2021QI;""
37 Salamanca;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
37 Salamanca;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
37 Salamanca;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2020QII;2.011
37 Salamanca;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2020QI;""
37 Salamanca;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
37 Salamanca;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2022QIII;1.904
37 Salamanca;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2022QII;""
37 Salamanca;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2022QI;""
37 Salamanca;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
37 Salamanca;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2021QIII;1.929
37 Salamanca;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2021QII;""
37 Salamanca;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2021QI;""
37 Salamanca;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
37 Salamanca;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2020QIII;1.957
37 Salamanca;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2020QII;""
37 Salamanca;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2020QI;""
37 Salamanca;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QIV;1.852
37 Salamanca;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
37 Salamanca;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QII;""
37 Salamanca;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QI;""
37 Salamanca;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QIV;1.892
37 Salamanca;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
37 Salamanca;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QII;""
37 Salamanca;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QI;""
37 Salamanca;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QIV;1.922
37 Salamanca;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
37 Salamanca;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QII;""
37 Salamanca;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QI;""
37 Salamanca;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
37 Salamanca;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
37 Salamanca;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QII;""
37 Salamanca;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QI;1.854
37 Salamanca;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
37 Salamanca;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
37 Salamanca;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QII;""
37 Salamanca;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QI;1.903
37 Salamanca;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
37 Salamanca;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
37 Salamanca;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QII;""
37 Salamanca;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QI;""
37 Salamanca;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
37 Salamanca;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
37 Salamanca;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
37 Salamanca;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
37 Salamanca;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
37 Salamanca;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
37 Salamanca;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
37 Salamanca;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
37 Salamanca;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
37 Salamanca;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
37 Salamanca;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
37 Salamanca;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
37 Salamanca;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
37 Salamanca;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
37 Salamanca;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;96,76
37 Salamanca;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
37 Salamanca;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
37 Salamanca;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
37 Salamanca;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;97,48
37 Salamanca;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
37 Salamanca;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
37 Salamanca;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
37 Salamanca;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;97,81
37 Salamanca;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
37 Salamanca;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
37 Salamanca;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;94,82
37 Salamanca;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
37 Salamanca;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
37 Salamanca;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
37 Salamanca;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;95,4
37 Salamanca;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
37 Salamanca;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
37 Salamanca;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
37 Salamanca;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;95,18
37 Salamanca;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
37 Salamanca;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
37 Salamanca;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;92,23
37 Salamanca;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
37 Salamanca;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
37 Salamanca;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
37 Salamanca;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;93,57
37 Salamanca;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
37 Salamanca;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
37 Salamanca;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
37 Salamanca;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;93,48
37 Salamanca;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
37 Salamanca;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
37 Salamanca;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
37 Salamanca;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
37 Salamanca;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
37 Salamanca;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
37 Salamanca;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;91,69
37 Salamanca;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
37 Salamanca;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
37 Salamanca;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
37 Salamanca;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;92,56
37 Salamanca;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
37 Salamanca;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
37 Salamanca;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
37 Salamanca;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
37 Salamanca;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
37 Salamanca;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QIII;5.644
37 Salamanca;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
37 Salamanca;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
37 Salamanca;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
37 Salamanca;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QIII;5.807
37 Salamanca;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
37 Salamanca;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
37 Salamanca;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
37 Salamanca;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QIII;5.918
37 Salamanca;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
37 Salamanca;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
37 Salamanca;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
37 Salamanca;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2022QIII;5.496
37 Salamanca;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2022QII;""
37 Salamanca;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2022QI;""
37 Salamanca;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
37 Salamanca;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2021QIII;5.688
37 Salamanca;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2021QII;""
37 Salamanca;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2021QI;""
37 Salamanca;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
37 Salamanca;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2020QIII;5.786
37 Salamanca;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2020QII;""
37 Salamanca;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2020QI;""
37 Salamanca;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2022QIV;5.357
37 Salamanca;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
37 Salamanca;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2022QII;""
37 Salamanca;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2022QI;""
37 Salamanca;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2021QIV;5.566
37 Salamanca;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
37 Salamanca;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2021QII;""
37 Salamanca;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2021QI;""
37 Salamanca;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2020QIV;5.681
37 Salamanca;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
37 Salamanca;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2020QII;""
37 Salamanca;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2020QI;""
37 Salamanca;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
37 Salamanca;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
37 Salamanca;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QII;""
37 Salamanca;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QI;5.464
37 Salamanca;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
37 Salamanca;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
37 Salamanca;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QII;""
37 Salamanca;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QI;5.624
37 Salamanca;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
37 Salamanca;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
37 Salamanca;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QII;""
37 Salamanca;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QI;""
37 Salamanca;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
37 Salamanca;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
37 Salamanca;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QII;5.359
37 Salamanca;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QI;""
37 Salamanca;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
37 Salamanca;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
37 Salamanca;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QII;5.532
37 Salamanca;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QI;""
37 Salamanca;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
37 Salamanca;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
37 Salamanca;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QII;""
37 Salamanca;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QI;""
37 Salamanca;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
37 Salamanca;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
37 Salamanca;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
37 Salamanca;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
37 Salamanca;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
37 Salamanca;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
37 Salamanca;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
37 Salamanca;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
37 Salamanca;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
37 Salamanca;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
37 Salamanca;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
37 Salamanca;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
37 Salamanca;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
37 Salamanca;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;97,38
37 Salamanca;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
37 Salamanca;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
37 Salamanca;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
37 Salamanca;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;97,95
37 Salamanca;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
37 Salamanca;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
37 Salamanca;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
37 Salamanca;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;97,77
37 Salamanca;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
37 Salamanca;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
37 Salamanca;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;94,91
37 Salamanca;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
37 Salamanca;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
37 Salamanca;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
37 Salamanca;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;95,85
37 Salamanca;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
37 Salamanca;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
37 Salamanca;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
37 Salamanca;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;96
37 Salamanca;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
37 Salamanca;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
37 Salamanca;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
37 Salamanca;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
37 Salamanca;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
37 Salamanca;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
37 Salamanca;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;94,09
37 Salamanca;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
37 Salamanca;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
37 Salamanca;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
37 Salamanca;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;95,03
37 Salamanca;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
37 Salamanca;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
37 Salamanca;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
37 Salamanca;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
37 Salamanca;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
37 Salamanca;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
37 Salamanca;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;92,29
37 Salamanca;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
37 Salamanca;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
37 Salamanca;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
37 Salamanca;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;93,48
37 Salamanca;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
37 Salamanca;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
37 Salamanca;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
37 Salamanca;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
37 Salamanca;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
37 Salamanca;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
37 Salamanca;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QIII;3.625
37 Salamanca;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
37 Salamanca;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
37 Salamanca;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
37 Salamanca;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QIII;3.764
37 Salamanca;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
37 Salamanca;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
37 Salamanca;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
37 Salamanca;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QIII;3.860
37 Salamanca;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
37 Salamanca;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
37 Salamanca;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
37 Salamanca;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2022QIII;3.535
37 Salamanca;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2022QII;""
37 Salamanca;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2022QI;""
37 Salamanca;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
37 Salamanca;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2021QIII;3.700
37 Salamanca;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2021QII;""
37 Salamanca;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2021QI;""
37 Salamanca;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
37 Salamanca;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2020QIII;3.792
37 Salamanca;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2020QII;""
37 Salamanca;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2020QI;""
37 Salamanca;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2022QIV;3.463
37 Salamanca;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
37 Salamanca;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2022QII;""
37 Salamanca;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2022QI;""
37 Salamanca;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2021QIV;3.624
37 Salamanca;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
37 Salamanca;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2021QII;""
37 Salamanca;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2021QI;""
37 Salamanca;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2020QIV;3.725
37 Salamanca;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
37 Salamanca;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2020QII;""
37 Salamanca;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2020QI;""
37 Salamanca;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
37 Salamanca;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
37 Salamanca;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QII;""
37 Salamanca;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QI;3.561
37 Salamanca;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
37 Salamanca;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
37 Salamanca;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QII;""
37 Salamanca;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QI;3.689
37 Salamanca;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
37 Salamanca;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
37 Salamanca;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QII;""
37 Salamanca;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QI;""
37 Salamanca;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
37 Salamanca;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
37 Salamanca;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QII;3.502
37 Salamanca;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QI;""
37 Salamanca;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
37 Salamanca;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
37 Salamanca;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QII;3.636
37 Salamanca;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QI;""
37 Salamanca;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
37 Salamanca;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
37 Salamanca;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QII;""
37 Salamanca;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QI;""
37 Salamanca;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
37 Salamanca;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
37 Salamanca;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
37 Salamanca;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
37 Salamanca;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
37 Salamanca;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
37 Salamanca;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
37 Salamanca;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
37 Salamanca;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
37 Salamanca;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
37 Salamanca;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
37 Salamanca;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
37 Salamanca;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
37 Salamanca;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;97,52
37 Salamanca;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
37 Salamanca;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
37 Salamanca;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
37 Salamanca;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;98,3
37 Salamanca;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
37 Salamanca;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
37 Salamanca;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
37 Salamanca;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;98,24
37 Salamanca;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
37 Salamanca;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
37 Salamanca;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;95,53
37 Salamanca;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
37 Salamanca;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
37 Salamanca;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
37 Salamanca;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;96,28
37 Salamanca;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
37 Salamanca;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
37 Salamanca;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
37 Salamanca;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;96,5
37 Salamanca;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
37 Salamanca;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
37 Salamanca;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
37 Salamanca;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
37 Salamanca;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
37 Salamanca;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
37 Salamanca;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;94,61
37 Salamanca;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
37 Salamanca;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
37 Salamanca;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
37 Salamanca;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;95,57
37 Salamanca;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
37 Salamanca;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
37 Salamanca;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
37 Salamanca;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
37 Salamanca;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
37 Salamanca;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
37 Salamanca;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;93,04
37 Salamanca;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
37 Salamanca;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
37 Salamanca;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
37 Salamanca;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;94,2
37 Salamanca;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
37 Salamanca;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
37 Salamanca;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
37 Salamanca;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
37 Salamanca;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
37 Salamanca;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
37 Salamanca;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QIII;2.019
37 Salamanca;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
37 Salamanca;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
37 Salamanca;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
37 Salamanca;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QIII;2.043
37 Salamanca;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
37 Salamanca;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
37 Salamanca;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
37 Salamanca;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QIII;2.058
37 Salamanca;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
37 Salamanca;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
37 Salamanca;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
37 Salamanca;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2022QIII;1.961
37 Salamanca;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2022QII;""
37 Salamanca;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2022QI;""
37 Salamanca;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
37 Salamanca;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2021QIII;1.988
37 Salamanca;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2021QII;""
37 Salamanca;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2021QI;""
37 Salamanca;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
37 Salamanca;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2020QIII;1.994
37 Salamanca;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2020QII;""
37 Salamanca;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2020QI;""
37 Salamanca;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2022QIV;1.894
37 Salamanca;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
37 Salamanca;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2022QII;""
37 Salamanca;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2022QI;""
37 Salamanca;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2021QIV;1.942
37 Salamanca;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
37 Salamanca;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2021QII;""
37 Salamanca;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2021QI;""
37 Salamanca;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2020QIV;1.956
37 Salamanca;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
37 Salamanca;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2020QII;""
37 Salamanca;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2020QI;""
37 Salamanca;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
37 Salamanca;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
37 Salamanca;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QII;""
37 Salamanca;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QI;1.903
37 Salamanca;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
37 Salamanca;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
37 Salamanca;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QII;""
37 Salamanca;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QI;1.935
37 Salamanca;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
37 Salamanca;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
37 Salamanca;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QII;""
37 Salamanca;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QI;""
37 Salamanca;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
37 Salamanca;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
37 Salamanca;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QII;1.857
37 Salamanca;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QI;""
37 Salamanca;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
37 Salamanca;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
37 Salamanca;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QII;1.896
37 Salamanca;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QI;""
37 Salamanca;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
37 Salamanca;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
37 Salamanca;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QII;""
37 Salamanca;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QI;""
37 Salamanca;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
37 Salamanca;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
37 Salamanca;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
37 Salamanca;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
37 Salamanca;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
37 Salamanca;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
37 Salamanca;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
37 Salamanca;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
37 Salamanca;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
37 Salamanca;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
37 Salamanca;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
37 Salamanca;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
37 Salamanca;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
37 Salamanca;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;97,13
37 Salamanca;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
37 Salamanca;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
37 Salamanca;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
37 Salamanca;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;97,31
37 Salamanca;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
37 Salamanca;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
37 Salamanca;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
37 Salamanca;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;96,89
37 Salamanca;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
37 Salamanca;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
37 Salamanca;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;93,81
37 Salamanca;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
37 Salamanca;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
37 Salamanca;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
37 Salamanca;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;95,06
37 Salamanca;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
37 Salamanca;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
37 Salamanca;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
37 Salamanca;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;95,04
37 Salamanca;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
37 Salamanca;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
37 Salamanca;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
37 Salamanca;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
37 Salamanca;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
37 Salamanca;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
37 Salamanca;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;93,15
37 Salamanca;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
37 Salamanca;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
37 Salamanca;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
37 Salamanca;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;94,02
37 Salamanca;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
37 Salamanca;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
37 Salamanca;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
37 Salamanca;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
37 Salamanca;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
37 Salamanca;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
37 Salamanca;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;90,9
37 Salamanca;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
37 Salamanca;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
37 Salamanca;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
37 Salamanca;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;92,13
37 Salamanca;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
37 Salamanca;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
37 Salamanca;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
37 Salamanca;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
37 Salamanca;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
37 Salamanca;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QIV;5.600
37 Salamanca;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
37 Salamanca;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
37 Salamanca;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
37 Salamanca;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QIV;5.839
37 Salamanca;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
37 Salamanca;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
37 Salamanca;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
37 Salamanca;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QIV;5.945
37 Salamanca;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
37 Salamanca;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
37 Salamanca;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
37 Salamanca;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2022QIV;5.451
37 Salamanca;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
37 Salamanca;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2022QII;""
37 Salamanca;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2022QI;""
37 Salamanca;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2021QIV;5.705
37 Salamanca;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
37 Salamanca;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2021QII;""
37 Salamanca;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2021QI;""
37 Salamanca;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2020QIV;5.820
37 Salamanca;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
37 Salamanca;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2020QII;""
37 Salamanca;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2020QI;""
37 Salamanca;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
37 Salamanca;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
37 Salamanca;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2022QII;""
37 Salamanca;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2022QI;5.591
37 Salamanca;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
37 Salamanca;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
37 Salamanca;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2021QII;""
37 Salamanca;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2021QI;5.754
37 Salamanca;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
37 Salamanca;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
37 Salamanca;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2020QII;""
37 Salamanca;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2020QI;""
37 Salamanca;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
37 Salamanca;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
37 Salamanca;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QII;5.476
37 Salamanca;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QI;""
37 Salamanca;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
37 Salamanca;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
37 Salamanca;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QII;5.649
37 Salamanca;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QI;""
37 Salamanca;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
37 Salamanca;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
37 Salamanca;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QII;""
37 Salamanca;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QI;""
37 Salamanca;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
37 Salamanca;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QIII;5.371
37 Salamanca;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QII;""
37 Salamanca;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QI;""
37 Salamanca;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
37 Salamanca;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QIII;5.571
37 Salamanca;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QII;""
37 Salamanca;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QI;""
37 Salamanca;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
37 Salamanca;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
37 Salamanca;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QII;""
37 Salamanca;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QI;""
37 Salamanca;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
37 Salamanca;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
37 Salamanca;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
37 Salamanca;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
37 Salamanca;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
37 Salamanca;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
37 Salamanca;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
37 Salamanca;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
37 Salamanca;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
37 Salamanca;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
37 Salamanca;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
37 Salamanca;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
37 Salamanca;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;97,34
37 Salamanca;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
37 Salamanca;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
37 Salamanca;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
37 Salamanca;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;97,71
37 Salamanca;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
37 Salamanca;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
37 Salamanca;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
37 Salamanca;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;97,9
37 Salamanca;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
37 Salamanca;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
37 Salamanca;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
37 Salamanca;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
37 Salamanca;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
37 Salamanca;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
37 Salamanca;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;95,75
37 Salamanca;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
37 Salamanca;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
37 Salamanca;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
37 Salamanca;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;96,79
37 Salamanca;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
37 Salamanca;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
37 Salamanca;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
37 Salamanca;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
37 Salamanca;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
37 Salamanca;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
37 Salamanca;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;93,78
37 Salamanca;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
37 Salamanca;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
37 Salamanca;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
37 Salamanca;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;95,02
37 Salamanca;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
37 Salamanca;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
37 Salamanca;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
37 Salamanca;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
37 Salamanca;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
37 Salamanca;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
37 Salamanca;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;91,98
37 Salamanca;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
37 Salamanca;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
37 Salamanca;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
37 Salamanca;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;93,71
37 Salamanca;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
37 Salamanca;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
37 Salamanca;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
37 Salamanca;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
37 Salamanca;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
37 Salamanca;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
37 Salamanca;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QIV;3.593
37 Salamanca;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
37 Salamanca;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
37 Salamanca;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
37 Salamanca;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QIV;3.789
37 Salamanca;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
37 Salamanca;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
37 Salamanca;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
37 Salamanca;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QIV;3.879
37 Salamanca;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
37 Salamanca;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
37 Salamanca;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
37 Salamanca;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2022QIV;3.515
37 Salamanca;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
37 Salamanca;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2022QII;""
37 Salamanca;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2022QI;""
37 Salamanca;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2021QIV;3.705
37 Salamanca;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
37 Salamanca;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2021QII;""
37 Salamanca;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2021QI;""
37 Salamanca;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2020QIV;3.798
37 Salamanca;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
37 Salamanca;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2020QII;""
37 Salamanca;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2020QI;""
37 Salamanca;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
37 Salamanca;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
37 Salamanca;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2022QII;""
37 Salamanca;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2022QI;3.635
37 Salamanca;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
37 Salamanca;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
37 Salamanca;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2021QII;""
37 Salamanca;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2021QI;3.757
37 Salamanca;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
37 Salamanca;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
37 Salamanca;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2020QII;""
37 Salamanca;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2020QI;""
37 Salamanca;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
37 Salamanca;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
37 Salamanca;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QII;3.571
37 Salamanca;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QI;""
37 Salamanca;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
37 Salamanca;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
37 Salamanca;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QII;3.695
37 Salamanca;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QI;""
37 Salamanca;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
37 Salamanca;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
37 Salamanca;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QII;""
37 Salamanca;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QI;""
37 Salamanca;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
37 Salamanca;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QIII;3.506
37 Salamanca;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QII;""
37 Salamanca;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QI;""
37 Salamanca;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
37 Salamanca;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QIII;3.655
37 Salamanca;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QII;""
37 Salamanca;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QI;""
37 Salamanca;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
37 Salamanca;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
37 Salamanca;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QII;""
37 Salamanca;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QI;""
37 Salamanca;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
37 Salamanca;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
37 Salamanca;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
37 Salamanca;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
37 Salamanca;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
37 Salamanca;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
37 Salamanca;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
37 Salamanca;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
37 Salamanca;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
37 Salamanca;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
37 Salamanca;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
37 Salamanca;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
37 Salamanca;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;97,83
37 Salamanca;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
37 Salamanca;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
37 Salamanca;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
37 Salamanca;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;97,78
37 Salamanca;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
37 Salamanca;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
37 Salamanca;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
37 Salamanca;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;97,91
37 Salamanca;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
37 Salamanca;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
37 Salamanca;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
37 Salamanca;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
37 Salamanca;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
37 Salamanca;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
37 Salamanca;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;95,94
37 Salamanca;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
37 Salamanca;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
37 Salamanca;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
37 Salamanca;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;96,85
37 Salamanca;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
37 Salamanca;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
37 Salamanca;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
37 Salamanca;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
37 Salamanca;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
37 Salamanca;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
37 Salamanca;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;94,25
37 Salamanca;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
37 Salamanca;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
37 Salamanca;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
37 Salamanca;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;95,26
37 Salamanca;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
37 Salamanca;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
37 Salamanca;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
37 Salamanca;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
37 Salamanca;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
37 Salamanca;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
37 Salamanca;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;92,53
37 Salamanca;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
37 Salamanca;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
37 Salamanca;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
37 Salamanca;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;94,23
37 Salamanca;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
37 Salamanca;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
37 Salamanca;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
37 Salamanca;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
37 Salamanca;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
37 Salamanca;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
37 Salamanca;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QIV;2.007
37 Salamanca;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
37 Salamanca;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
37 Salamanca;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
37 Salamanca;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QIV;2.050
37 Salamanca;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
37 Salamanca;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
37 Salamanca;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
37 Salamanca;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QIV;2.066
37 Salamanca;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
37 Salamanca;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
37 Salamanca;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
37 Salamanca;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2022QIV;1.936
37 Salamanca;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
37 Salamanca;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2022QII;""
37 Salamanca;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2022QI;""
37 Salamanca;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2021QIV;2.000
37 Salamanca;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
37 Salamanca;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2021QII;""
37 Salamanca;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2021QI;""
37 Salamanca;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2020QIV;2.022
37 Salamanca;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
37 Salamanca;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2020QII;""
37 Salamanca;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2020QI;""
37 Salamanca;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
37 Salamanca;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
37 Salamanca;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2022QII;""
37 Salamanca;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2022QI;1.956
37 Salamanca;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
37 Salamanca;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
37 Salamanca;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2021QII;""
37 Salamanca;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2021QI;1.997
37 Salamanca;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
37 Salamanca;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
37 Salamanca;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2020QII;""
37 Salamanca;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2020QI;""
37 Salamanca;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
37 Salamanca;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
37 Salamanca;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QII;1.905
37 Salamanca;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QI;""
37 Salamanca;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
37 Salamanca;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
37 Salamanca;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QII;1.954
37 Salamanca;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QI;""
37 Salamanca;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
37 Salamanca;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
37 Salamanca;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QII;""
37 Salamanca;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QI;""
37 Salamanca;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
37 Salamanca;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QIII;1.865
37 Salamanca;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QII;""
37 Salamanca;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QI;""
37 Salamanca;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
37 Salamanca;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QIII;1.916
37 Salamanca;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QII;""
37 Salamanca;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QI;""
37 Salamanca;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
37 Salamanca;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
37 Salamanca;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QII;""
37 Salamanca;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QI;""
37 Salamanca;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
37 Salamanca;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
37 Salamanca;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
37 Salamanca;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
37 Salamanca;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
37 Salamanca;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
37 Salamanca;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
37 Salamanca;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
37 Salamanca;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
37 Salamanca;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
37 Salamanca;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
37 Salamanca;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
37 Salamanca;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;96,46
37 Salamanca;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
37 Salamanca;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
37 Salamanca;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
37 Salamanca;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;97,56
37 Salamanca;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
37 Salamanca;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
37 Salamanca;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
37 Salamanca;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;97,87
37 Salamanca;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
37 Salamanca;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
37 Salamanca;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
37 Salamanca;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
37 Salamanca;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
37 Salamanca;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
37 Salamanca;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;95,41
37 Salamanca;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
37 Salamanca;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
37 Salamanca;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
37 Salamanca;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;96,66
37 Salamanca;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
37 Salamanca;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
37 Salamanca;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
37 Salamanca;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
37 Salamanca;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
37 Salamanca;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
37 Salamanca;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;92,93
37 Salamanca;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
37 Salamanca;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
37 Salamanca;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
37 Salamanca;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;94,58
37 Salamanca;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
37 Salamanca;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
37 Salamanca;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
37 Salamanca;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
37 Salamanca;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
37 Salamanca;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
37 Salamanca;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;90,98
37 Salamanca;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
37 Salamanca;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
37 Salamanca;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
37 Salamanca;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;92,74
37 Salamanca;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
37 Salamanca;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
37 Salamanca;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
37 Salamanca;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
37 Salamanca;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
37 Salamanca;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
37 Salamanca;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
37 Salamanca;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
37 Salamanca;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
37 Salamanca;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QI;6.745
37 Salamanca;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
37 Salamanca;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
37 Salamanca;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
37 Salamanca;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QI;6.750
37 Salamanca;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
37 Salamanca;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
37 Salamanca;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
37 Salamanca;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QI;6.921
37 Salamanca;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
37 Salamanca;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
37 Salamanca;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2022QII;""
37 Salamanca;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2022QI;6.654
37 Salamanca;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
37 Salamanca;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
37 Salamanca;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2021QII;""
37 Salamanca;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2021QI;6.664
37 Salamanca;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
37 Salamanca;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
37 Salamanca;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2020QII;""
37 Salamanca;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2020QI;6.698
37 Salamanca;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
37 Salamanca;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
37 Salamanca;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2022QII;6.549
37 Salamanca;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2022QI;""
37 Salamanca;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
37 Salamanca;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
37 Salamanca;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2021QII;6.563
37 Salamanca;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2021QI;""
37 Salamanca;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
37 Salamanca;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
37 Salamanca;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2020QII;6.606
37 Salamanca;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2020QI;""
37 Salamanca;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
37 Salamanca;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QIII;6.478
37 Salamanca;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QII;""
37 Salamanca;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QI;""
37 Salamanca;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
37 Salamanca;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QIII;6.473
37 Salamanca;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QII;""
37 Salamanca;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QI;""
37 Salamanca;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
37 Salamanca;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QIII;6.516
37 Salamanca;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QII;""
37 Salamanca;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QI;""
37 Salamanca;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QIV;6.386
37 Salamanca;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
37 Salamanca;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QII;""
37 Salamanca;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QI;""
37 Salamanca;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QIV;6.396
37 Salamanca;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
37 Salamanca;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QII;""
37 Salamanca;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QI;""
37 Salamanca;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QIV;6.429
37 Salamanca;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
37 Salamanca;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QII;""
37 Salamanca;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QI;""
37 Salamanca;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
37 Salamanca;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
37 Salamanca;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
37 Salamanca;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
37 Salamanca;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
37 Salamanca;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
37 Salamanca;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
37 Salamanca;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
37 Salamanca;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
37 Salamanca;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
37 Salamanca;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
37 Salamanca;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
37 Salamanca;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
37 Salamanca;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
37 Salamanca;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
37 Salamanca;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;98,65
37 Salamanca;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
37 Salamanca;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
37 Salamanca;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
37 Salamanca;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;98,73
37 Salamanca;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
37 Salamanca;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
37 Salamanca;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
37 Salamanca;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;96,78
37 Salamanca;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
37 Salamanca;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
37 Salamanca;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;97,09
37 Salamanca;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
37 Salamanca;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
37 Salamanca;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
37 Salamanca;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;97,23
37 Salamanca;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
37 Salamanca;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
37 Salamanca;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
37 Salamanca;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;95,45
37 Salamanca;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
37 Salamanca;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
37 Salamanca;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;96,04
37 Salamanca;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
37 Salamanca;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
37 Salamanca;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
37 Salamanca;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;95,9
37 Salamanca;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
37 Salamanca;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
37 Salamanca;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
37 Salamanca;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;94,15
37 Salamanca;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
37 Salamanca;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
37 Salamanca;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;94,68
37 Salamanca;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
37 Salamanca;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
37 Salamanca;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
37 Salamanca;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;94,76
37 Salamanca;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
37 Salamanca;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
37 Salamanca;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
37 Salamanca;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;92,89
37 Salamanca;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
37 Salamanca;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
37 Salamanca;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
37 Salamanca;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
37 Salamanca;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
37 Salamanca;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
37 Salamanca;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QI;4.454
37 Salamanca;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
37 Salamanca;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
37 Salamanca;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
37 Salamanca;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QI;4.443
37 Salamanca;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
37 Salamanca;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
37 Salamanca;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
37 Salamanca;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QI;4.577
37 Salamanca;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
37 Salamanca;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
37 Salamanca;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2022QII;""
37 Salamanca;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2022QI;4.398
37 Salamanca;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
37 Salamanca;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
37 Salamanca;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2021QII;""
37 Salamanca;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2021QI;4.387
37 Salamanca;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
37 Salamanca;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
37 Salamanca;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2020QII;""
37 Salamanca;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2020QI;4.433
37 Salamanca;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
37 Salamanca;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
37 Salamanca;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2022QII;4.349
37 Salamanca;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2022QI;""
37 Salamanca;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
37 Salamanca;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
37 Salamanca;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2021QII;4.331
37 Salamanca;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2021QI;""
37 Salamanca;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
37 Salamanca;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
37 Salamanca;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2020QII;4.373
37 Salamanca;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2020QI;""
37 Salamanca;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
37 Salamanca;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QIII;4.300
37 Salamanca;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QII;""
37 Salamanca;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QI;""
37 Salamanca;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
37 Salamanca;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QIII;4.280
37 Salamanca;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QII;""
37 Salamanca;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QI;""
37 Salamanca;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
37 Salamanca;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QIII;4.321
37 Salamanca;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QII;""
37 Salamanca;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QI;""
37 Salamanca;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QIV;4.242
37 Salamanca;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
37 Salamanca;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QII;""
37 Salamanca;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QI;""
37 Salamanca;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QIV;4.235
37 Salamanca;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
37 Salamanca;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QII;""
37 Salamanca;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QI;""
37 Salamanca;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QIV;4.267
37 Salamanca;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
37 Salamanca;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QII;""
37 Salamanca;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QI;""
37 Salamanca;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
37 Salamanca;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
37 Salamanca;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
37 Salamanca;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
37 Salamanca;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
37 Salamanca;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
37 Salamanca;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
37 Salamanca;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
37 Salamanca;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
37 Salamanca;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
37 Salamanca;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
37 Salamanca;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
37 Salamanca;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
37 Salamanca;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
37 Salamanca;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
37 Salamanca;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;98,74
37 Salamanca;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
37 Salamanca;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
37 Salamanca;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
37 Salamanca;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;98,74
37 Salamanca;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
37 Salamanca;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
37 Salamanca;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
37 Salamanca;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;96,85
37 Salamanca;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
37 Salamanca;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
37 Salamanca;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;97,64
37 Salamanca;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
37 Salamanca;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
37 Salamanca;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
37 Salamanca;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;97,48
37 Salamanca;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
37 Salamanca;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
37 Salamanca;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
37 Salamanca;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;95,54
37 Salamanca;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
37 Salamanca;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
37 Salamanca;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;96,54
37 Salamanca;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
37 Salamanca;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
37 Salamanca;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
37 Salamanca;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;96,33
37 Salamanca;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
37 Salamanca;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
37 Salamanca;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
37 Salamanca;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;94,41
37 Salamanca;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
37 Salamanca;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
37 Salamanca;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;95,24
37 Salamanca;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
37 Salamanca;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
37 Salamanca;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
37 Salamanca;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;95,32
37 Salamanca;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
37 Salamanca;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
37 Salamanca;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
37 Salamanca;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;93,23
37 Salamanca;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
37 Salamanca;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
37 Salamanca;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
37 Salamanca;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
37 Salamanca;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
37 Salamanca;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
37 Salamanca;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QI;2.291
37 Salamanca;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
37 Salamanca;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
37 Salamanca;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
37 Salamanca;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QI;2.307
37 Salamanca;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
37 Salamanca;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
37 Salamanca;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
37 Salamanca;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QI;2.344
37 Salamanca;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
37 Salamanca;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
37 Salamanca;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2022QII;""
37 Salamanca;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2022QI;2.256
37 Salamanca;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
37 Salamanca;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
37 Salamanca;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2021QII;""
37 Salamanca;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2021QI;2.277
37 Salamanca;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
37 Salamanca;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
37 Salamanca;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2020QII;""
37 Salamanca;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2020QI;2.265
37 Salamanca;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
37 Salamanca;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
37 Salamanca;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2022QII;2.200
37 Salamanca;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2022QI;""
37 Salamanca;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
37 Salamanca;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
37 Salamanca;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2021QII;2.232
37 Salamanca;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2021QI;""
37 Salamanca;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
37 Salamanca;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
37 Salamanca;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2020QII;2.233
37 Salamanca;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2020QI;""
37 Salamanca;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
37 Salamanca;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QIII;2.178
37 Salamanca;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QII;""
37 Salamanca;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QI;""
37 Salamanca;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
37 Salamanca;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QIII;2.193
37 Salamanca;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QII;""
37 Salamanca;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QI;""
37 Salamanca;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
37 Salamanca;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QIII;2.195
37 Salamanca;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QII;""
37 Salamanca;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QI;""
37 Salamanca;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QIV;2.144
37 Salamanca;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
37 Salamanca;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QII;""
37 Salamanca;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QI;""
37 Salamanca;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QIV;2.161
37 Salamanca;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
37 Salamanca;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QII;""
37 Salamanca;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QI;""
37 Salamanca;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QIV;2.162
37 Salamanca;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
37 Salamanca;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QII;""
37 Salamanca;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QI;""
37 Salamanca;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
37 Salamanca;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
37 Salamanca;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
37 Salamanca;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
37 Salamanca;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
37 Salamanca;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
37 Salamanca;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
37 Salamanca;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
37 Salamanca;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
37 Salamanca;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
37 Salamanca;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
37 Salamanca;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
37 Salamanca;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
37 Salamanca;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
37 Salamanca;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
37 Salamanca;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;98,47
37 Salamanca;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
37 Salamanca;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
37 Salamanca;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
37 Salamanca;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;98,7
37 Salamanca;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
37 Salamanca;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
37 Salamanca;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
37 Salamanca;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;96,63
37 Salamanca;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
37 Salamanca;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
37 Salamanca;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;96,03
37 Salamanca;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
37 Salamanca;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
37 Salamanca;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
37 Salamanca;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;96,75
37 Salamanca;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
37 Salamanca;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
37 Salamanca;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
37 Salamanca;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;95,26
37 Salamanca;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
37 Salamanca;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
37 Salamanca;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;95,07
37 Salamanca;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
37 Salamanca;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
37 Salamanca;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
37 Salamanca;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;95,06
37 Salamanca;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
37 Salamanca;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
37 Salamanca;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
37 Salamanca;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;93,64
37 Salamanca;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
37 Salamanca;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
37 Salamanca;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;93,58
37 Salamanca;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
37 Salamanca;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
37 Salamanca;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
37 Salamanca;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;93,67
37 Salamanca;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
37 Salamanca;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
37 Salamanca;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
37 Salamanca;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;92,24
37 Salamanca;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
37 Salamanca;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
37 Salamanca;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
37 Salamanca;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
37 Salamanca;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
37 Salamanca;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QII;6.790
37 Salamanca;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
37 Salamanca;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
37 Salamanca;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
37 Salamanca;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QII;6.831
37 Salamanca;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
37 Salamanca;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
37 Salamanca;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
37 Salamanca;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QII;6.834
37 Salamanca;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
37 Salamanca;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
37 Salamanca;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
37 Salamanca;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2022QII;6.673
37 Salamanca;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2022QI;""
37 Salamanca;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
37 Salamanca;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
37 Salamanca;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2021QII;6.715
37 Salamanca;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2021QI;""
37 Salamanca;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
37 Salamanca;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
37 Salamanca;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2020QII;6.731
37 Salamanca;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2020QI;""
37 Salamanca;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
37 Salamanca;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2022QIII;6.594
37 Salamanca;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2022QII;""
37 Salamanca;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2022QI;""
37 Salamanca;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
37 Salamanca;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2021QIII;6.616
37 Salamanca;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2021QII;""
37 Salamanca;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2021QI;""
37 Salamanca;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
37 Salamanca;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2020QIII;6.627
37 Salamanca;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2020QII;""
37 Salamanca;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2020QI;""
37 Salamanca;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QIV;6.496
37 Salamanca;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
37 Salamanca;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QII;""
37 Salamanca;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QI;""
37 Salamanca;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QIV;6.521
37 Salamanca;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
37 Salamanca;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QII;""
37 Salamanca;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QI;""
37 Salamanca;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QIV;6.536
37 Salamanca;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
37 Salamanca;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QII;""
37 Salamanca;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QI;""
37 Salamanca;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
37 Salamanca;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
37 Salamanca;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QII;""
37 Salamanca;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QI;6.447
37 Salamanca;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
37 Salamanca;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
37 Salamanca;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QII;""
37 Salamanca;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QI;6.471
37 Salamanca;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
37 Salamanca;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
37 Salamanca;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QII;""
37 Salamanca;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QI;""
37 Salamanca;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
37 Salamanca;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
37 Salamanca;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
37 Salamanca;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
37 Salamanca;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
37 Salamanca;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
37 Salamanca;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
37 Salamanca;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
37 Salamanca;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
37 Salamanca;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
37 Salamanca;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
37 Salamanca;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
37 Salamanca;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
37 Salamanca;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
37 Salamanca;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;98,28
37 Salamanca;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
37 Salamanca;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
37 Salamanca;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
37 Salamanca;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;98,3
37 Salamanca;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
37 Salamanca;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
37 Salamanca;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
37 Salamanca;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;98,49
37 Salamanca;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
37 Salamanca;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
37 Salamanca;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;97,11
37 Salamanca;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
37 Salamanca;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
37 Salamanca;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
37 Salamanca;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;96,85
37 Salamanca;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
37 Salamanca;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
37 Salamanca;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
37 Salamanca;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;96,97
37 Salamanca;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
37 Salamanca;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
37 Salamanca;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;95,67
37 Salamanca;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
37 Salamanca;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
37 Salamanca;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
37 Salamanca;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;95,46
37 Salamanca;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
37 Salamanca;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
37 Salamanca;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
37 Salamanca;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;95,64
37 Salamanca;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
37 Salamanca;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
37 Salamanca;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
37 Salamanca;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
37 Salamanca;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
37 Salamanca;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
37 Salamanca;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;94,38
37 Salamanca;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
37 Salamanca;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
37 Salamanca;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
37 Salamanca;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;94,69
37 Salamanca;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
37 Salamanca;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
37 Salamanca;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
37 Salamanca;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
37 Salamanca;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
37 Salamanca;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
37 Salamanca;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QII;4.429
37 Salamanca;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
37 Salamanca;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
37 Salamanca;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
37 Salamanca;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QII;4.505
37 Salamanca;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
37 Salamanca;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
37 Salamanca;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
37 Salamanca;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QII;4.503
37 Salamanca;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
37 Salamanca;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
37 Salamanca;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
37 Salamanca;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2022QII;4.372
37 Salamanca;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2022QI;""
37 Salamanca;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
37 Salamanca;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
37 Salamanca;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2021QII;4.440
37 Salamanca;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2021QI;""
37 Salamanca;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
37 Salamanca;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
37 Salamanca;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2020QII;4.436
37 Salamanca;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2020QI;""
37 Salamanca;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
37 Salamanca;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2022QIII;4.321
37 Salamanca;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2022QII;""
37 Salamanca;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2022QI;""
37 Salamanca;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
37 Salamanca;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2021QIII;4.386
37 Salamanca;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2021QII;""
37 Salamanca;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2021QI;""
37 Salamanca;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
37 Salamanca;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2020QIII;4.376
37 Salamanca;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2020QII;""
37 Salamanca;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2020QI;""
37 Salamanca;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QIV;4.264
37 Salamanca;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
37 Salamanca;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QII;""
37 Salamanca;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QI;""
37 Salamanca;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QIV;4.328
37 Salamanca;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
37 Salamanca;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QII;""
37 Salamanca;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QI;""
37 Salamanca;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QIV;4.319
37 Salamanca;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
37 Salamanca;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QII;""
37 Salamanca;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QI;""
37 Salamanca;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
37 Salamanca;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
37 Salamanca;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QII;""
37 Salamanca;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QI;4.282
37 Salamanca;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
37 Salamanca;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
37 Salamanca;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QII;""
37 Salamanca;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QI;4.276
37 Salamanca;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
37 Salamanca;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
37 Salamanca;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QII;""
37 Salamanca;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QI;""
37 Salamanca;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
37 Salamanca;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
37 Salamanca;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
37 Salamanca;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
37 Salamanca;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
37 Salamanca;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
37 Salamanca;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
37 Salamanca;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
37 Salamanca;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
37 Salamanca;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
37 Salamanca;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
37 Salamanca;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
37 Salamanca;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
37 Salamanca;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
37 Salamanca;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;98,71
37 Salamanca;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
37 Salamanca;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
37 Salamanca;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
37 Salamanca;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;98,56
37 Salamanca;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
37 Salamanca;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
37 Salamanca;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
37 Salamanca;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;98,51
37 Salamanca;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
37 Salamanca;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
37 Salamanca;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;97,56
37 Salamanca;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
37 Salamanca;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
37 Salamanca;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
37 Salamanca;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;97,36
37 Salamanca;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
37 Salamanca;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
37 Salamanca;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
37 Salamanca;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;97,18
37 Salamanca;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
37 Salamanca;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
37 Salamanca;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;96,27
37 Salamanca;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
37 Salamanca;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
37 Salamanca;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
37 Salamanca;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;96,07
37 Salamanca;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
37 Salamanca;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
37 Salamanca;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
37 Salamanca;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;95,91
37 Salamanca;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
37 Salamanca;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
37 Salamanca;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
37 Salamanca;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
37 Salamanca;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
37 Salamanca;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
37 Salamanca;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;95,05
37 Salamanca;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
37 Salamanca;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
37 Salamanca;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
37 Salamanca;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;94,96
37 Salamanca;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
37 Salamanca;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
37 Salamanca;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
37 Salamanca;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
37 Salamanca;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
37 Salamanca;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
37 Salamanca;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QII;2.361
37 Salamanca;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
37 Salamanca;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
37 Salamanca;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
37 Salamanca;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QII;2.326
37 Salamanca;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
37 Salamanca;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
37 Salamanca;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
37 Salamanca;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QII;2.331
37 Salamanca;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
37 Salamanca;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
37 Salamanca;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
37 Salamanca;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2022QII;2.301
37 Salamanca;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2022QI;""
37 Salamanca;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
37 Salamanca;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
37 Salamanca;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2021QII;2.275
37 Salamanca;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2021QI;""
37 Salamanca;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
37 Salamanca;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
37 Salamanca;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2020QII;2.295
37 Salamanca;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2020QI;""
37 Salamanca;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
37 Salamanca;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2022QIII;2.273
37 Salamanca;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2022QII;""
37 Salamanca;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2022QI;""
37 Salamanca;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
37 Salamanca;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2021QIII;2.230
37 Salamanca;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2021QII;""
37 Salamanca;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2021QI;""
37 Salamanca;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
37 Salamanca;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2020QIII;2.251
37 Salamanca;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2020QII;""
37 Salamanca;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2020QI;""
37 Salamanca;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QIV;2.232
37 Salamanca;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
37 Salamanca;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QII;""
37 Salamanca;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QI;""
37 Salamanca;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QIV;2.193
37 Salamanca;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
37 Salamanca;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QII;""
37 Salamanca;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QI;""
37 Salamanca;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QIV;2.217
37 Salamanca;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
37 Salamanca;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QII;""
37 Salamanca;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QI;""
37 Salamanca;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
37 Salamanca;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
37 Salamanca;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QII;""
37 Salamanca;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QI;2.165
37 Salamanca;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
37 Salamanca;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
37 Salamanca;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QII;""
37 Salamanca;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QI;2.195
37 Salamanca;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
37 Salamanca;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
37 Salamanca;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QII;""
37 Salamanca;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QI;""
37 Salamanca;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
37 Salamanca;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
37 Salamanca;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
37 Salamanca;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
37 Salamanca;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
37 Salamanca;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
37 Salamanca;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
37 Salamanca;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
37 Salamanca;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
37 Salamanca;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
37 Salamanca;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
37 Salamanca;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
37 Salamanca;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
37 Salamanca;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
37 Salamanca;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;97,46
37 Salamanca;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
37 Salamanca;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
37 Salamanca;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
37 Salamanca;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;97,81
37 Salamanca;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
37 Salamanca;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
37 Salamanca;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
37 Salamanca;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;98,46
37 Salamanca;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
37 Salamanca;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
37 Salamanca;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;96,27
37 Salamanca;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
37 Salamanca;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
37 Salamanca;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
37 Salamanca;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;95,87
37 Salamanca;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
37 Salamanca;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
37 Salamanca;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
37 Salamanca;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;96,57
37 Salamanca;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
37 Salamanca;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
37 Salamanca;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;94,54
37 Salamanca;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
37 Salamanca;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
37 Salamanca;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
37 Salamanca;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;94,28
37 Salamanca;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
37 Salamanca;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
37 Salamanca;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
37 Salamanca;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;95,11
37 Salamanca;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
37 Salamanca;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
37 Salamanca;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
37 Salamanca;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
37 Salamanca;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
37 Salamanca;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
37 Salamanca;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;93,08
37 Salamanca;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
37 Salamanca;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
37 Salamanca;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
37 Salamanca;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;94,17
37 Salamanca;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
37 Salamanca;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
37 Salamanca;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
37 Salamanca;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
37 Salamanca;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
37 Salamanca;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QIII;6.786
37 Salamanca;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
37 Salamanca;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
37 Salamanca;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
37 Salamanca;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QIII;6.824
37 Salamanca;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
37 Salamanca;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
37 Salamanca;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
37 Salamanca;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QIII;6.807
37 Salamanca;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
37 Salamanca;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
37 Salamanca;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
37 Salamanca;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2022QIII;6.683
37 Salamanca;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2022QII;""
37 Salamanca;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2022QI;""
37 Salamanca;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
37 Salamanca;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2021QIII;6.698
37 Salamanca;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2021QII;""
37 Salamanca;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2021QI;""
37 Salamanca;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
37 Salamanca;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2020QIII;6.690
37 Salamanca;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2020QII;""
37 Salamanca;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2020QI;""
37 Salamanca;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2022QIV;6.572
37 Salamanca;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
37 Salamanca;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2022QII;""
37 Salamanca;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2022QI;""
37 Salamanca;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2021QIV;6.590
37 Salamanca;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
37 Salamanca;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2021QII;""
37 Salamanca;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2021QI;""
37 Salamanca;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2020QIV;6.589
37 Salamanca;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
37 Salamanca;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2020QII;""
37 Salamanca;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2020QI;""
37 Salamanca;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
37 Salamanca;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
37 Salamanca;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QII;""
37 Salamanca;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QI;6.511
37 Salamanca;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
37 Salamanca;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
37 Salamanca;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QII;""
37 Salamanca;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QI;6.522
37 Salamanca;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
37 Salamanca;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
37 Salamanca;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QII;""
37 Salamanca;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QI;""
37 Salamanca;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
37 Salamanca;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
37 Salamanca;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QII;6.427
37 Salamanca;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QI;""
37 Salamanca;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
37 Salamanca;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
37 Salamanca;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QII;6.437
37 Salamanca;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QI;""
37 Salamanca;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
37 Salamanca;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
37 Salamanca;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QII;""
37 Salamanca;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QI;""
37 Salamanca;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
37 Salamanca;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
37 Salamanca;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
37 Salamanca;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
37 Salamanca;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
37 Salamanca;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
37 Salamanca;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
37 Salamanca;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
37 Salamanca;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
37 Salamanca;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
37 Salamanca;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
37 Salamanca;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
37 Salamanca;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
37 Salamanca;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;98,48
37 Salamanca;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
37 Salamanca;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
37 Salamanca;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
37 Salamanca;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;98,15
37 Salamanca;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
37 Salamanca;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
37 Salamanca;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
37 Salamanca;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;98,28
37 Salamanca;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
37 Salamanca;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
37 Salamanca;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;96,85
37 Salamanca;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
37 Salamanca;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
37 Salamanca;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
37 Salamanca;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;96,57
37 Salamanca;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
37 Salamanca;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
37 Salamanca;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
37 Salamanca;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;96,8
37 Salamanca;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
37 Salamanca;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
37 Salamanca;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
37 Salamanca;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
37 Salamanca;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
37 Salamanca;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
37 Salamanca;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;95,41
37 Salamanca;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
37 Salamanca;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
37 Salamanca;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
37 Salamanca;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;95,81
37 Salamanca;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
37 Salamanca;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
37 Salamanca;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
37 Salamanca;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
37 Salamanca;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
37 Salamanca;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
37 Salamanca;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;94,18
37 Salamanca;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
37 Salamanca;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
37 Salamanca;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
37 Salamanca;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;94,56
37 Salamanca;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
37 Salamanca;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
37 Salamanca;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
37 Salamanca;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
37 Salamanca;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
37 Salamanca;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
37 Salamanca;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QIII;4.435
37 Salamanca;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
37 Salamanca;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
37 Salamanca;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
37 Salamanca;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QIII;4.508
37 Salamanca;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
37 Salamanca;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
37 Salamanca;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
37 Salamanca;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QIII;4.484
37 Salamanca;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
37 Salamanca;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
37 Salamanca;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
37 Salamanca;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2022QIII;4.368
37 Salamanca;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2022QII;""
37 Salamanca;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2022QI;""
37 Salamanca;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
37 Salamanca;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2021QIII;4.440
37 Salamanca;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2021QII;""
37 Salamanca;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2021QI;""
37 Salamanca;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
37 Salamanca;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2020QIII;4.420
37 Salamanca;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2020QII;""
37 Salamanca;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2020QI;""
37 Salamanca;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2022QIV;4.303
37 Salamanca;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
37 Salamanca;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2022QII;""
37 Salamanca;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2022QI;""
37 Salamanca;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2021QIV;4.376
37 Salamanca;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
37 Salamanca;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2021QII;""
37 Salamanca;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2021QI;""
37 Salamanca;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2020QIV;4.354
37 Salamanca;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
37 Salamanca;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2020QII;""
37 Salamanca;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2020QI;""
37 Salamanca;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
37 Salamanca;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
37 Salamanca;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QII;""
37 Salamanca;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QI;4.327
37 Salamanca;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
37 Salamanca;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
37 Salamanca;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QII;""
37 Salamanca;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QI;4.311
37 Salamanca;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
37 Salamanca;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
37 Salamanca;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QII;""
37 Salamanca;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QI;""
37 Salamanca;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
37 Salamanca;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
37 Salamanca;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QII;4.285
37 Salamanca;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QI;""
37 Salamanca;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
37 Salamanca;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
37 Salamanca;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QII;4.261
37 Salamanca;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QI;""
37 Salamanca;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
37 Salamanca;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
37 Salamanca;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QII;""
37 Salamanca;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QI;""
37 Salamanca;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
37 Salamanca;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
37 Salamanca;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
37 Salamanca;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
37 Salamanca;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
37 Salamanca;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
37 Salamanca;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
37 Salamanca;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
37 Salamanca;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
37 Salamanca;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
37 Salamanca;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
37 Salamanca;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
37 Salamanca;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
37 Salamanca;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;98,49
37 Salamanca;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
37 Salamanca;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
37 Salamanca;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
37 Salamanca;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;98,49
37 Salamanca;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
37 Salamanca;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
37 Salamanca;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
37 Salamanca;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;98,57
37 Salamanca;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
37 Salamanca;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
37 Salamanca;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;97,02
37 Salamanca;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
37 Salamanca;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
37 Salamanca;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
37 Salamanca;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;97,07
37 Salamanca;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
37 Salamanca;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
37 Salamanca;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
37 Salamanca;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;97,1
37 Salamanca;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
37 Salamanca;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
37 Salamanca;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
37 Salamanca;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
37 Salamanca;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
37 Salamanca;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
37 Salamanca;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;95,98
37 Salamanca;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
37 Salamanca;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
37 Salamanca;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
37 Salamanca;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;96,14
37 Salamanca;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
37 Salamanca;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
37 Salamanca;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
37 Salamanca;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
37 Salamanca;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
37 Salamanca;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
37 Salamanca;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;95,05
37 Salamanca;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
37 Salamanca;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
37 Salamanca;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
37 Salamanca;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;95,03
37 Salamanca;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
37 Salamanca;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
37 Salamanca;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
37 Salamanca;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
37 Salamanca;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
37 Salamanca;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
37 Salamanca;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QIII;2.351
37 Salamanca;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
37 Salamanca;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
37 Salamanca;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
37 Salamanca;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QIII;2.316
37 Salamanca;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
37 Salamanca;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
37 Salamanca;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
37 Salamanca;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QIII;2.323
37 Salamanca;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
37 Salamanca;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
37 Salamanca;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
37 Salamanca;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2022QIII;2.315
37 Salamanca;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2022QII;""
37 Salamanca;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2022QI;""
37 Salamanca;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
37 Salamanca;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2021QIII;2.258
37 Salamanca;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2021QII;""
37 Salamanca;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2021QI;""
37 Salamanca;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
37 Salamanca;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2020QIII;2.270
37 Salamanca;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2020QII;""
37 Salamanca;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2020QI;""
37 Salamanca;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2022QIV;2.269
37 Salamanca;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
37 Salamanca;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2022QII;""
37 Salamanca;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2022QI;""
37 Salamanca;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2021QIV;2.214
37 Salamanca;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
37 Salamanca;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2021QII;""
37 Salamanca;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2021QI;""
37 Salamanca;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2020QIV;2.235
37 Salamanca;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
37 Salamanca;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2020QII;""
37 Salamanca;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2020QI;""
37 Salamanca;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
37 Salamanca;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
37 Salamanca;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QII;""
37 Salamanca;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QI;2.184
37 Salamanca;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
37 Salamanca;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
37 Salamanca;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QII;""
37 Salamanca;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QI;2.211
37 Salamanca;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
37 Salamanca;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
37 Salamanca;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QII;""
37 Salamanca;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QI;""
37 Salamanca;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
37 Salamanca;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
37 Salamanca;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QII;2.142
37 Salamanca;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QI;""
37 Salamanca;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
37 Salamanca;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
37 Salamanca;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QII;2.176
37 Salamanca;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QI;""
37 Salamanca;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
37 Salamanca;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
37 Salamanca;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QII;""
37 Salamanca;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QI;""
37 Salamanca;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
37 Salamanca;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
37 Salamanca;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
37 Salamanca;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
37 Salamanca;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
37 Salamanca;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
37 Salamanca;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
37 Salamanca;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
37 Salamanca;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
37 Salamanca;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
37 Salamanca;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
37 Salamanca;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
37 Salamanca;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
37 Salamanca;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;98,47
37 Salamanca;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
37 Salamanca;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
37 Salamanca;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
37 Salamanca;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;97,5
37 Salamanca;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
37 Salamanca;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
37 Salamanca;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
37 Salamanca;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;97,72
37 Salamanca;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
37 Salamanca;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
37 Salamanca;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;96,51
37 Salamanca;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
37 Salamanca;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
37 Salamanca;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
37 Salamanca;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;95,6
37 Salamanca;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
37 Salamanca;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
37 Salamanca;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
37 Salamanca;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;96,21
37 Salamanca;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
37 Salamanca;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
37 Salamanca;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
37 Salamanca;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
37 Salamanca;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
37 Salamanca;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
37 Salamanca;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;94,3
37 Salamanca;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
37 Salamanca;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
37 Salamanca;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
37 Salamanca;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;95,18
37 Salamanca;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
37 Salamanca;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
37 Salamanca;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
37 Salamanca;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
37 Salamanca;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
37 Salamanca;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
37 Salamanca;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;92,49
37 Salamanca;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
37 Salamanca;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
37 Salamanca;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
37 Salamanca;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;93,67
37 Salamanca;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
37 Salamanca;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
37 Salamanca;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
37 Salamanca;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
37 Salamanca;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
37 Salamanca;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QIV;6.763
37 Salamanca;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
37 Salamanca;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
37 Salamanca;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
37 Salamanca;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QIV;6.774
37 Salamanca;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
37 Salamanca;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
37 Salamanca;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
37 Salamanca;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QIV;6.781
37 Salamanca;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
37 Salamanca;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
37 Salamanca;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
37 Salamanca;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2022QIV;6.642
37 Salamanca;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
37 Salamanca;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2022QII;""
37 Salamanca;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2022QI;""
37 Salamanca;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2021QIV;6.652
37 Salamanca;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
37 Salamanca;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2021QII;""
37 Salamanca;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2021QI;""
37 Salamanca;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2020QIV;6.664
37 Salamanca;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
37 Salamanca;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2020QII;""
37 Salamanca;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2020QI;""
37 Salamanca;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
37 Salamanca;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
37 Salamanca;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2022QII;""
37 Salamanca;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2022QI;6.571
37 Salamanca;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
37 Salamanca;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
37 Salamanca;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2021QII;""
37 Salamanca;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2021QI;6.593
37 Salamanca;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
37 Salamanca;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
37 Salamanca;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2020QII;""
37 Salamanca;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2020QI;""
37 Salamanca;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
37 Salamanca;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
37 Salamanca;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QII;6.481
37 Salamanca;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QI;""
37 Salamanca;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
37 Salamanca;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
37 Salamanca;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QII;6.504
37 Salamanca;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QI;""
37 Salamanca;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
37 Salamanca;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
37 Salamanca;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QII;""
37 Salamanca;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QI;""
37 Salamanca;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
37 Salamanca;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QIII;6.415
37 Salamanca;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QII;""
37 Salamanca;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QI;""
37 Salamanca;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
37 Salamanca;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QIII;6.419
37 Salamanca;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QII;""
37 Salamanca;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QI;""
37 Salamanca;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
37 Salamanca;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
37 Salamanca;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QII;""
37 Salamanca;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QI;""
37 Salamanca;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
37 Salamanca;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
37 Salamanca;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
37 Salamanca;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
37 Salamanca;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
37 Salamanca;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
37 Salamanca;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
37 Salamanca;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
37 Salamanca;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
37 Salamanca;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
37 Salamanca;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
37 Salamanca;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
37 Salamanca;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;98,21
37 Salamanca;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
37 Salamanca;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
37 Salamanca;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
37 Salamanca;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;98,2
37 Salamanca;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
37 Salamanca;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
37 Salamanca;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
37 Salamanca;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;98,27
37 Salamanca;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
37 Salamanca;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
37 Salamanca;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
37 Salamanca;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
37 Salamanca;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
37 Salamanca;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
37 Salamanca;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;97
37 Salamanca;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
37 Salamanca;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
37 Salamanca;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
37 Salamanca;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;97,23
37 Salamanca;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
37 Salamanca;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
37 Salamanca;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
37 Salamanca;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
37 Salamanca;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
37 Salamanca;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
37 Salamanca;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;95,67
37 Salamanca;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
37 Salamanca;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
37 Salamanca;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
37 Salamanca;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;95,92
37 Salamanca;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
37 Salamanca;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
37 Salamanca;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
37 Salamanca;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
37 Salamanca;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
37 Salamanca;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
37 Salamanca;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;94,7
37 Salamanca;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
37 Salamanca;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
37 Salamanca;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
37 Salamanca;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;94,66
37 Salamanca;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
37 Salamanca;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
37 Salamanca;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
37 Salamanca;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
37 Salamanca;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
37 Salamanca;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
37 Salamanca;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QIV;4.410
37 Salamanca;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
37 Salamanca;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
37 Salamanca;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
37 Salamanca;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QIV;4.480
37 Salamanca;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
37 Salamanca;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
37 Salamanca;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
37 Salamanca;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QIV;4.475
37 Salamanca;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
37 Salamanca;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
37 Salamanca;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
37 Salamanca;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2022QIV;4.338
37 Salamanca;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
37 Salamanca;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2022QII;""
37 Salamanca;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2022QI;""
37 Salamanca;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2021QIV;4.409
37 Salamanca;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
37 Salamanca;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2021QII;""
37 Salamanca;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2021QI;""
37 Salamanca;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2020QIV;4.398
37 Salamanca;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
37 Salamanca;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2020QII;""
37 Salamanca;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2020QI;""
37 Salamanca;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
37 Salamanca;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
37 Salamanca;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2022QII;""
37 Salamanca;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2022QI;4.359
37 Salamanca;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
37 Salamanca;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
37 Salamanca;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2021QII;""
37 Salamanca;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2021QI;4.352
37 Salamanca;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
37 Salamanca;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
37 Salamanca;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2020QII;""
37 Salamanca;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2020QI;""
37 Salamanca;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
37 Salamanca;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
37 Salamanca;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QII;4.315
37 Salamanca;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QI;""
37 Salamanca;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
37 Salamanca;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
37 Salamanca;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QII;4.300
37 Salamanca;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QI;""
37 Salamanca;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
37 Salamanca;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
37 Salamanca;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QII;""
37 Salamanca;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QI;""
37 Salamanca;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
37 Salamanca;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QIII;4.270
37 Salamanca;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QII;""
37 Salamanca;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QI;""
37 Salamanca;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
37 Salamanca;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QIII;4.252
37 Salamanca;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QII;""
37 Salamanca;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QI;""
37 Salamanca;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
37 Salamanca;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
37 Salamanca;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QII;""
37 Salamanca;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QI;""
37 Salamanca;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
37 Salamanca;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
37 Salamanca;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
37 Salamanca;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
37 Salamanca;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
37 Salamanca;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
37 Salamanca;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
37 Salamanca;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
37 Salamanca;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
37 Salamanca;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
37 Salamanca;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
37 Salamanca;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
37 Salamanca;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;98,37
37 Salamanca;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
37 Salamanca;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
37 Salamanca;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
37 Salamanca;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;98,42
37 Salamanca;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
37 Salamanca;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
37 Salamanca;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
37 Salamanca;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;98,28
37 Salamanca;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
37 Salamanca;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
37 Salamanca;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
37 Salamanca;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
37 Salamanca;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
37 Salamanca;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
37 Salamanca;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;97,3
37 Salamanca;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
37 Salamanca;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
37 Salamanca;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
37 Salamanca;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;97,25
37 Salamanca;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
37 Salamanca;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
37 Salamanca;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
37 Salamanca;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
37 Salamanca;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
37 Salamanca;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
37 Salamanca;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;96,32
37 Salamanca;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
37 Salamanca;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
37 Salamanca;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
37 Salamanca;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;96,09
37 Salamanca;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
37 Salamanca;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
37 Salamanca;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
37 Salamanca;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
37 Salamanca;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
37 Salamanca;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
37 Salamanca;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;95,31
37 Salamanca;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
37 Salamanca;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
37 Salamanca;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
37 Salamanca;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;95,02
37 Salamanca;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
37 Salamanca;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
37 Salamanca;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
37 Salamanca;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
37 Salamanca;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
37 Salamanca;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
37 Salamanca;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QIV;2.353
37 Salamanca;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
37 Salamanca;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
37 Salamanca;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
37 Salamanca;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QIV;2.294
37 Salamanca;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
37 Salamanca;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
37 Salamanca;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
37 Salamanca;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QIV;2.306
37 Salamanca;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
37 Salamanca;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
37 Salamanca;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
37 Salamanca;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2022QIV;2.304
37 Salamanca;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
37 Salamanca;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2022QII;""
37 Salamanca;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2022QI;""
37 Salamanca;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2021QIV;2.243
37 Salamanca;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
37 Salamanca;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2021QII;""
37 Salamanca;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2021QI;""
37 Salamanca;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2020QIV;2.266
37 Salamanca;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
37 Salamanca;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2020QII;""
37 Salamanca;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2020QI;""
37 Salamanca;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
37 Salamanca;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
37 Salamanca;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2022QII;""
37 Salamanca;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2022QI;2.212
37 Salamanca;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
37 Salamanca;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
37 Salamanca;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2021QII;""
37 Salamanca;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2021QI;2.241
37 Salamanca;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
37 Salamanca;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
37 Salamanca;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2020QII;""
37 Salamanca;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2020QI;""
37 Salamanca;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
37 Salamanca;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
37 Salamanca;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QII;2.166
37 Salamanca;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QI;""
37 Salamanca;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
37 Salamanca;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
37 Salamanca;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QII;2.204
37 Salamanca;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QI;""
37 Salamanca;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
37 Salamanca;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
37 Salamanca;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QII;""
37 Salamanca;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QI;""
37 Salamanca;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
37 Salamanca;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QIII;2.145
37 Salamanca;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QII;""
37 Salamanca;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QI;""
37 Salamanca;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
37 Salamanca;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QIII;2.167
37 Salamanca;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QII;""
37 Salamanca;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QI;""
37 Salamanca;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
37 Salamanca;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
37 Salamanca;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QII;""
37 Salamanca;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QI;""
37 Salamanca;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
37 Salamanca;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
37 Salamanca;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
37 Salamanca;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
37 Salamanca;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
37 Salamanca;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
37 Salamanca;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
37 Salamanca;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
37 Salamanca;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
37 Salamanca;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
37 Salamanca;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
37 Salamanca;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
37 Salamanca;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;97,92
37 Salamanca;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
37 Salamanca;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
37 Salamanca;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
37 Salamanca;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;97,78
37 Salamanca;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
37 Salamanca;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
37 Salamanca;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
37 Salamanca;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;98,27
37 Salamanca;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
37 Salamanca;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
37 Salamanca;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
37 Salamanca;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
37 Salamanca;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
37 Salamanca;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
37 Salamanca;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;96,43
37 Salamanca;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
37 Salamanca;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
37 Salamanca;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
37 Salamanca;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;97,18
37 Salamanca;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
37 Salamanca;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
37 Salamanca;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
37 Salamanca;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
37 Salamanca;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
37 Salamanca;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
37 Salamanca;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;94,42
37 Salamanca;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
37 Salamanca;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
37 Salamanca;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
37 Salamanca;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;95,58
37 Salamanca;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
37 Salamanca;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
37 Salamanca;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
37 Salamanca;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
37 Salamanca;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
37 Salamanca;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
37 Salamanca;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;93,5
37 Salamanca;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
37 Salamanca;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
37 Salamanca;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
37 Salamanca;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;93,97
37 Salamanca;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
37 Salamanca;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
37 Salamanca;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
37 Salamanca;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
37 Salamanca;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
37 Salamanca;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
37 Salamanca;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
37 Salamanca;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
37 Salamanca;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
37 Salamanca;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QI;3.581
37 Salamanca;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
37 Salamanca;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
37 Salamanca;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
37 Salamanca;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QI;3.369
37 Salamanca;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
37 Salamanca;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
37 Salamanca;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
37 Salamanca;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QI;3.893
37 Salamanca;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
37 Salamanca;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
37 Salamanca;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2022QII;""
37 Salamanca;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2022QI;3.459
37 Salamanca;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
37 Salamanca;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
37 Salamanca;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2021QII;""
37 Salamanca;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2021QI;3.240
37 Salamanca;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
37 Salamanca;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
37 Salamanca;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2020QII;""
37 Salamanca;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2020QI;3.668
37 Salamanca;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
37 Salamanca;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
37 Salamanca;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2022QII;3.343
37 Salamanca;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2022QI;""
37 Salamanca;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
37 Salamanca;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
37 Salamanca;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2021QII;3.130
37 Salamanca;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2021QI;""
37 Salamanca;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
37 Salamanca;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
37 Salamanca;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2020QII;3.551
37 Salamanca;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2020QI;""
37 Salamanca;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
37 Salamanca;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QIII;3.238
37 Salamanca;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QII;""
37 Salamanca;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QI;""
37 Salamanca;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
37 Salamanca;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QIII;3.041
37 Salamanca;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QII;""
37 Salamanca;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QI;""
37 Salamanca;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
37 Salamanca;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QIII;3.413
37 Salamanca;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QII;""
37 Salamanca;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QI;""
37 Salamanca;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QIV;3.036
37 Salamanca;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
37 Salamanca;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QII;""
37 Salamanca;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QI;""
37 Salamanca;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QIV;2.903
37 Salamanca;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
37 Salamanca;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QII;""
37 Salamanca;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QI;""
37 Salamanca;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QIV;3.262
37 Salamanca;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
37 Salamanca;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QII;""
37 Salamanca;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QI;""
37 Salamanca;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
37 Salamanca;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
37 Salamanca;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
37 Salamanca;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
37 Salamanca;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
37 Salamanca;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
37 Salamanca;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
37 Salamanca;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
37 Salamanca;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
37 Salamanca;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
37 Salamanca;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
37 Salamanca;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
37 Salamanca;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
37 Salamanca;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
37 Salamanca;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
37 Salamanca;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;96,59
37 Salamanca;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
37 Salamanca;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
37 Salamanca;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
37 Salamanca;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;96,17
37 Salamanca;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
37 Salamanca;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
37 Salamanca;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
37 Salamanca;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;94,22
37 Salamanca;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
37 Salamanca;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
37 Salamanca;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;93,35
37 Salamanca;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
37 Salamanca;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
37 Salamanca;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
37 Salamanca;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;92,91
37 Salamanca;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
37 Salamanca;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
37 Salamanca;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
37 Salamanca;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;91,22
37 Salamanca;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
37 Salamanca;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
37 Salamanca;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;90,42
37 Salamanca;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
37 Salamanca;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
37 Salamanca;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
37 Salamanca;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;90,26
37 Salamanca;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
37 Salamanca;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
37 Salamanca;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
37 Salamanca;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;87,67
37 Salamanca;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
37 Salamanca;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
37 Salamanca;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;84,78
37 Salamanca;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
37 Salamanca;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
37 Salamanca;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
37 Salamanca;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;86,17
37 Salamanca;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
37 Salamanca;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
37 Salamanca;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
37 Salamanca;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;83,79
37 Salamanca;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
37 Salamanca;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
37 Salamanca;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
37 Salamanca;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
37 Salamanca;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
37 Salamanca;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
37 Salamanca;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QI;2.450
37 Salamanca;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
37 Salamanca;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
37 Salamanca;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
37 Salamanca;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QI;2.295
37 Salamanca;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
37 Salamanca;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
37 Salamanca;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
37 Salamanca;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QI;2.637
37 Salamanca;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
37 Salamanca;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
37 Salamanca;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2022QII;""
37 Salamanca;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2022QI;2.370
37 Salamanca;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
37 Salamanca;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
37 Salamanca;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2021QII;""
37 Salamanca;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2021QI;2.207
37 Salamanca;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
37 Salamanca;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
37 Salamanca;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2020QII;""
37 Salamanca;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2020QI;2.491
37 Salamanca;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
37 Salamanca;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
37 Salamanca;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2022QII;2.292
37 Salamanca;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2022QI;""
37 Salamanca;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
37 Salamanca;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
37 Salamanca;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2021QII;2.141
37 Salamanca;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2021QI;""
37 Salamanca;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
37 Salamanca;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
37 Salamanca;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2020QII;2.417
37 Salamanca;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2020QI;""
37 Salamanca;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
37 Salamanca;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QIII;2.221
37 Salamanca;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QII;""
37 Salamanca;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QI;""
37 Salamanca;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
37 Salamanca;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QIII;2.087
37 Salamanca;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QII;""
37 Salamanca;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QI;""
37 Salamanca;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
37 Salamanca;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QIII;2.335
37 Salamanca;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QII;""
37 Salamanca;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QI;""
37 Salamanca;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QIV;2.076
37 Salamanca;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
37 Salamanca;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QII;""
37 Salamanca;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QI;""
37 Salamanca;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QIV;2.001
37 Salamanca;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
37 Salamanca;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QII;""
37 Salamanca;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QI;""
37 Salamanca;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QIV;2.235
37 Salamanca;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
37 Salamanca;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QII;""
37 Salamanca;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QI;""
37 Salamanca;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
37 Salamanca;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
37 Salamanca;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
37 Salamanca;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
37 Salamanca;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
37 Salamanca;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
37 Salamanca;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
37 Salamanca;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
37 Salamanca;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
37 Salamanca;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
37 Salamanca;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
37 Salamanca;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
37 Salamanca;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
37 Salamanca;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
37 Salamanca;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
37 Salamanca;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;96,73
37 Salamanca;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
37 Salamanca;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
37 Salamanca;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
37 Salamanca;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;96,17
37 Salamanca;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
37 Salamanca;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
37 Salamanca;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
37 Salamanca;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;94,46
37 Salamanca;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
37 Salamanca;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
37 Salamanca;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;93,55
37 Salamanca;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
37 Salamanca;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
37 Salamanca;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
37 Salamanca;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;93,29
37 Salamanca;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
37 Salamanca;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
37 Salamanca;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
37 Salamanca;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;91,66
37 Salamanca;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
37 Salamanca;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
37 Salamanca;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;90,65
37 Salamanca;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
37 Salamanca;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
37 Salamanca;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
37 Salamanca;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;90,94
37 Salamanca;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
37 Salamanca;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
37 Salamanca;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
37 Salamanca;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;88,55
37 Salamanca;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
37 Salamanca;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
37 Salamanca;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;84,73
37 Salamanca;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
37 Salamanca;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
37 Salamanca;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
37 Salamanca;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;87,19
37 Salamanca;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
37 Salamanca;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
37 Salamanca;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
37 Salamanca;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;84,76
37 Salamanca;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
37 Salamanca;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
37 Salamanca;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
37 Salamanca;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
37 Salamanca;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
37 Salamanca;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
37 Salamanca;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QI;1.131
37 Salamanca;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
37 Salamanca;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
37 Salamanca;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
37 Salamanca;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QI;1.074
37 Salamanca;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
37 Salamanca;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
37 Salamanca;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
37 Salamanca;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QI;1.256
37 Salamanca;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
37 Salamanca;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
37 Salamanca;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2022QII;""
37 Salamanca;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2022QI;1.089
37 Salamanca;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
37 Salamanca;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
37 Salamanca;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2021QII;""
37 Salamanca;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2021QI;1.033
37 Salamanca;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
37 Salamanca;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
37 Salamanca;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2020QII;""
37 Salamanca;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2020QI;1.177
37 Salamanca;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
37 Salamanca;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
37 Salamanca;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2022QII;1.051
37 Salamanca;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2022QI;""
37 Salamanca;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
37 Salamanca;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
37 Salamanca;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2021QII;989
37 Salamanca;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2021QI;""
37 Salamanca;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
37 Salamanca;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
37 Salamanca;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2020QII;1.134
37 Salamanca;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2020QI;""
37 Salamanca;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
37 Salamanca;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QIII;1.017
37 Salamanca;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QII;""
37 Salamanca;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QI;""
37 Salamanca;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
37 Salamanca;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QIII;954
37 Salamanca;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QII;""
37 Salamanca;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QI;""
37 Salamanca;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
37 Salamanca;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QIII;1.078
37 Salamanca;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QII;""
37 Salamanca;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QI;""
37 Salamanca;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QIV;960
37 Salamanca;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
37 Salamanca;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QII;""
37 Salamanca;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QI;""
37 Salamanca;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QIV;902
37 Salamanca;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
37 Salamanca;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QII;""
37 Salamanca;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QI;""
37 Salamanca;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QIV;1.027
37 Salamanca;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
37 Salamanca;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QII;""
37 Salamanca;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QI;""
37 Salamanca;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
37 Salamanca;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
37 Salamanca;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
37 Salamanca;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
37 Salamanca;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
37 Salamanca;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
37 Salamanca;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
37 Salamanca;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
37 Salamanca;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
37 Salamanca;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
37 Salamanca;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
37 Salamanca;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
37 Salamanca;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
37 Salamanca;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
37 Salamanca;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
37 Salamanca;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;96,29
37 Salamanca;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
37 Salamanca;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
37 Salamanca;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
37 Salamanca;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;96,18
37 Salamanca;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
37 Salamanca;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
37 Salamanca;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
37 Salamanca;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;93,71
37 Salamanca;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
37 Salamanca;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
37 Salamanca;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;92,93
37 Salamanca;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
37 Salamanca;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
37 Salamanca;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
37 Salamanca;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;92,09
37 Salamanca;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
37 Salamanca;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
37 Salamanca;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
37 Salamanca;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;90,29
37 Salamanca;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
37 Salamanca;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
37 Salamanca;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;89,92
37 Salamanca;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
37 Salamanca;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
37 Salamanca;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
37 Salamanca;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;88,83
37 Salamanca;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
37 Salamanca;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
37 Salamanca;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
37 Salamanca;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;85,83
37 Salamanca;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
37 Salamanca;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
37 Salamanca;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;84,88
37 Salamanca;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
37 Salamanca;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
37 Salamanca;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
37 Salamanca;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;83,99
37 Salamanca;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
37 Salamanca;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
37 Salamanca;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
37 Salamanca;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;81,77
37 Salamanca;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
37 Salamanca;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
37 Salamanca;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
37 Salamanca;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
37 Salamanca;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
37 Salamanca;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QII;4.117
37 Salamanca;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
37 Salamanca;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
37 Salamanca;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
37 Salamanca;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QII;3.875
37 Salamanca;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
37 Salamanca;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
37 Salamanca;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
37 Salamanca;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QII;3.724
37 Salamanca;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
37 Salamanca;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
37 Salamanca;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
37 Salamanca;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2022QII;3.985
37 Salamanca;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2022QI;""
37 Salamanca;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
37 Salamanca;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
37 Salamanca;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2021QII;3.759
37 Salamanca;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2021QI;""
37 Salamanca;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
37 Salamanca;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
37 Salamanca;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2020QII;3.604
37 Salamanca;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2020QI;""
37 Salamanca;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
37 Salamanca;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2022QIII;3.867
37 Salamanca;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2022QII;""
37 Salamanca;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2022QI;""
37 Salamanca;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
37 Salamanca;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2021QIII;3.660
37 Salamanca;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2021QII;""
37 Salamanca;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2021QI;""
37 Salamanca;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
37 Salamanca;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2020QIII;3.449
37 Salamanca;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2020QII;""
37 Salamanca;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2020QI;""
37 Salamanca;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QIV;3.650
37 Salamanca;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
37 Salamanca;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QII;""
37 Salamanca;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QI;""
37 Salamanca;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QIV;3.516
37 Salamanca;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
37 Salamanca;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QII;""
37 Salamanca;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QI;""
37 Salamanca;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QIV;3.296
37 Salamanca;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
37 Salamanca;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QII;""
37 Salamanca;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QI;""
37 Salamanca;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
37 Salamanca;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
37 Salamanca;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QII;""
37 Salamanca;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QI;3.400
37 Salamanca;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
37 Salamanca;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
37 Salamanca;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QII;""
37 Salamanca;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QI;3.176
37 Salamanca;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
37 Salamanca;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
37 Salamanca;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QII;""
37 Salamanca;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QI;""
37 Salamanca;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
37 Salamanca;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
37 Salamanca;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
37 Salamanca;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
37 Salamanca;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
37 Salamanca;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
37 Salamanca;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
37 Salamanca;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
37 Salamanca;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
37 Salamanca;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
37 Salamanca;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
37 Salamanca;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
37 Salamanca;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
37 Salamanca;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
37 Salamanca;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;96,79
37 Salamanca;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
37 Salamanca;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
37 Salamanca;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
37 Salamanca;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;97,01
37 Salamanca;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
37 Salamanca;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
37 Salamanca;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
37 Salamanca;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;96,78
37 Salamanca;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
37 Salamanca;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
37 Salamanca;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;93,93
37 Salamanca;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
37 Salamanca;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
37 Salamanca;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
37 Salamanca;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;94,45
37 Salamanca;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
37 Salamanca;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
37 Salamanca;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
37 Salamanca;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;92,62
37 Salamanca;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
37 Salamanca;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
37 Salamanca;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;88,66
37 Salamanca;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
37 Salamanca;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
37 Salamanca;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
37 Salamanca;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;90,74
37 Salamanca;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
37 Salamanca;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
37 Salamanca;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
37 Salamanca;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;88,51
37 Salamanca;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
37 Salamanca;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
37 Salamanca;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
37 Salamanca;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
37 Salamanca;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
37 Salamanca;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
37 Salamanca;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;87,74
37 Salamanca;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
37 Salamanca;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
37 Salamanca;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
37 Salamanca;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;85,28
37 Salamanca;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
37 Salamanca;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
37 Salamanca;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
37 Salamanca;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
37 Salamanca;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
37 Salamanca;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
37 Salamanca;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QII;2.834
37 Salamanca;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
37 Salamanca;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
37 Salamanca;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
37 Salamanca;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QII;2.630
37 Salamanca;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
37 Salamanca;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
37 Salamanca;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
37 Salamanca;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QII;2.523
37 Salamanca;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
37 Salamanca;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
37 Salamanca;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
37 Salamanca;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2022QII;2.749
37 Salamanca;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2022QI;""
37 Salamanca;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
37 Salamanca;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
37 Salamanca;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2021QII;2.561
37 Salamanca;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2021QI;""
37 Salamanca;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
37 Salamanca;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
37 Salamanca;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2020QII;2.447
37 Salamanca;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2020QI;""
37 Salamanca;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
37 Salamanca;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2022QIII;2.671
37 Salamanca;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2022QII;""
37 Salamanca;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2022QI;""
37 Salamanca;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
37 Salamanca;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2021QIII;2.499
37 Salamanca;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2021QII;""
37 Salamanca;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2021QI;""
37 Salamanca;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
37 Salamanca;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2020QIII;2.353
37 Salamanca;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2020QII;""
37 Salamanca;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2020QI;""
37 Salamanca;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QIV;2.514
37 Salamanca;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
37 Salamanca;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QII;""
37 Salamanca;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QI;""
37 Salamanca;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QIV;2.408
37 Salamanca;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
37 Salamanca;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QII;""
37 Salamanca;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QI;""
37 Salamanca;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QIV;2.253
37 Salamanca;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
37 Salamanca;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QII;""
37 Salamanca;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QI;""
37 Salamanca;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
37 Salamanca;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
37 Salamanca;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QII;""
37 Salamanca;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QI;2.332
37 Salamanca;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
37 Salamanca;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
37 Salamanca;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QII;""
37 Salamanca;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QI;2.167
37 Salamanca;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
37 Salamanca;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
37 Salamanca;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QII;""
37 Salamanca;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QI;""
37 Salamanca;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
37 Salamanca;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
37 Salamanca;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
37 Salamanca;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
37 Salamanca;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
37 Salamanca;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
37 Salamanca;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
37 Salamanca;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
37 Salamanca;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
37 Salamanca;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
37 Salamanca;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
37 Salamanca;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
37 Salamanca;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
37 Salamanca;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
37 Salamanca;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;97
37 Salamanca;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
37 Salamanca;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
37 Salamanca;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
37 Salamanca;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;97,38
37 Salamanca;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
37 Salamanca;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
37 Salamanca;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
37 Salamanca;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;96,99
37 Salamanca;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
37 Salamanca;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
37 Salamanca;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;94,25
37 Salamanca;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
37 Salamanca;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
37 Salamanca;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
37 Salamanca;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;95,02
37 Salamanca;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
37 Salamanca;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
37 Salamanca;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
37 Salamanca;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;93,26
37 Salamanca;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
37 Salamanca;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
37 Salamanca;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;88,71
37 Salamanca;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
37 Salamanca;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
37 Salamanca;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
37 Salamanca;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;91,56
37 Salamanca;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
37 Salamanca;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
37 Salamanca;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
37 Salamanca;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;89,3
37 Salamanca;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
37 Salamanca;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
37 Salamanca;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
37 Salamanca;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
37 Salamanca;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
37 Salamanca;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
37 Salamanca;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;88,67
37 Salamanca;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
37 Salamanca;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
37 Salamanca;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
37 Salamanca;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;85,89
37 Salamanca;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
37 Salamanca;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
37 Salamanca;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
37 Salamanca;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
37 Salamanca;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
37 Salamanca;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
37 Salamanca;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QII;1.283
37 Salamanca;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
37 Salamanca;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
37 Salamanca;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
37 Salamanca;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QII;1.245
37 Salamanca;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
37 Salamanca;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
37 Salamanca;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
37 Salamanca;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QII;1.201
37 Salamanca;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
37 Salamanca;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
37 Salamanca;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
37 Salamanca;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2022QII;1.236
37 Salamanca;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2022QI;""
37 Salamanca;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
37 Salamanca;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
37 Salamanca;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2021QII;1.198
37 Salamanca;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2021QI;""
37 Salamanca;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
37 Salamanca;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
37 Salamanca;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2020QII;1.157
37 Salamanca;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2020QI;""
37 Salamanca;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
37 Salamanca;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2022QIII;1.196
37 Salamanca;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2022QII;""
37 Salamanca;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2022QI;""
37 Salamanca;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
37 Salamanca;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2021QIII;1.161
37 Salamanca;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2021QII;""
37 Salamanca;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2021QI;""
37 Salamanca;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
37 Salamanca;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2020QIII;1.096
37 Salamanca;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2020QII;""
37 Salamanca;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2020QI;""
37 Salamanca;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QIV;1.136
37 Salamanca;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
37 Salamanca;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QII;""
37 Salamanca;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QI;""
37 Salamanca;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QIV;1.108
37 Salamanca;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
37 Salamanca;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QII;""
37 Salamanca;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QI;""
37 Salamanca;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QIV;1.043
37 Salamanca;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
37 Salamanca;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QII;""
37 Salamanca;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QI;""
37 Salamanca;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
37 Salamanca;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
37 Salamanca;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QII;""
37 Salamanca;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QI;1.068
37 Salamanca;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
37 Salamanca;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
37 Salamanca;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QII;""
37 Salamanca;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QI;1.009
37 Salamanca;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
37 Salamanca;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
37 Salamanca;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QII;""
37 Salamanca;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QI;""
37 Salamanca;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
37 Salamanca;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
37 Salamanca;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
37 Salamanca;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
37 Salamanca;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
37 Salamanca;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
37 Salamanca;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
37 Salamanca;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
37 Salamanca;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
37 Salamanca;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
37 Salamanca;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
37 Salamanca;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
37 Salamanca;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
37 Salamanca;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
37 Salamanca;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;96,34
37 Salamanca;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
37 Salamanca;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
37 Salamanca;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
37 Salamanca;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;96,22
37 Salamanca;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
37 Salamanca;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
37 Salamanca;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
37 Salamanca;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;96,34
37 Salamanca;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
37 Salamanca;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
37 Salamanca;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;93,22
37 Salamanca;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
37 Salamanca;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
37 Salamanca;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
37 Salamanca;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;93,25
37 Salamanca;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
37 Salamanca;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
37 Salamanca;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
37 Salamanca;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;91,26
37 Salamanca;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
37 Salamanca;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
37 Salamanca;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;88,54
37 Salamanca;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
37 Salamanca;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
37 Salamanca;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
37 Salamanca;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;89
37 Salamanca;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
37 Salamanca;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
37 Salamanca;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
37 Salamanca;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;86,84
37 Salamanca;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
37 Salamanca;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
37 Salamanca;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
37 Salamanca;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
37 Salamanca;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
37 Salamanca;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
37 Salamanca;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;85,78
37 Salamanca;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
37 Salamanca;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
37 Salamanca;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
37 Salamanca;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;84,01
37 Salamanca;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
37 Salamanca;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
37 Salamanca;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
37 Salamanca;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
37 Salamanca;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
37 Salamanca;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QIII;4.029
37 Salamanca;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
37 Salamanca;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
37 Salamanca;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
37 Salamanca;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QIII;3.798
37 Salamanca;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
37 Salamanca;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
37 Salamanca;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
37 Salamanca;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QIII;3.638
37 Salamanca;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
37 Salamanca;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
37 Salamanca;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
37 Salamanca;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2022QIII;3.900
37 Salamanca;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2022QII;""
37 Salamanca;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2022QI;""
37 Salamanca;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
37 Salamanca;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2021QIII;3.688
37 Salamanca;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2021QII;""
37 Salamanca;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2021QI;""
37 Salamanca;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
37 Salamanca;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2020QIII;3.477
37 Salamanca;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2020QII;""
37 Salamanca;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2020QI;""
37 Salamanca;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2022QIV;3.676
37 Salamanca;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
37 Salamanca;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2022QII;""
37 Salamanca;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2022QI;""
37 Salamanca;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2021QIV;3.543
37 Salamanca;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
37 Salamanca;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2021QII;""
37 Salamanca;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2021QI;""
37 Salamanca;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2020QIV;3.319
37 Salamanca;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
37 Salamanca;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2020QII;""
37 Salamanca;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2020QI;""
37 Salamanca;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
37 Salamanca;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
37 Salamanca;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QII;""
37 Salamanca;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QI;3.425
37 Salamanca;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
37 Salamanca;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
37 Salamanca;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QII;""
37 Salamanca;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QI;3.198
37 Salamanca;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
37 Salamanca;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
37 Salamanca;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QII;""
37 Salamanca;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QI;""
37 Salamanca;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
37 Salamanca;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
37 Salamanca;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QII;3.316
37 Salamanca;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QI;""
37 Salamanca;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
37 Salamanca;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
37 Salamanca;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QII;3.091
37 Salamanca;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QI;""
37 Salamanca;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
37 Salamanca;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
37 Salamanca;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QII;""
37 Salamanca;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QI;""
37 Salamanca;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
37 Salamanca;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
37 Salamanca;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
37 Salamanca;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
37 Salamanca;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
37 Salamanca;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
37 Salamanca;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
37 Salamanca;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
37 Salamanca;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
37 Salamanca;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
37 Salamanca;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
37 Salamanca;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
37 Salamanca;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
37 Salamanca;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;96,8
37 Salamanca;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
37 Salamanca;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
37 Salamanca;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
37 Salamanca;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;97,1
37 Salamanca;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
37 Salamanca;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
37 Salamanca;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
37 Salamanca;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;95,57
37 Salamanca;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
37 Salamanca;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
37 Salamanca;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;91,24
37 Salamanca;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
37 Salamanca;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
37 Salamanca;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
37 Salamanca;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;93,29
37 Salamanca;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
37 Salamanca;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
37 Salamanca;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
37 Salamanca;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;91,23
37 Salamanca;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
37 Salamanca;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
37 Salamanca;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
37 Salamanca;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
37 Salamanca;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
37 Salamanca;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
37 Salamanca;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;90,18
37 Salamanca;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
37 Salamanca;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
37 Salamanca;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
37 Salamanca;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;87,91
37 Salamanca;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
37 Salamanca;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
37 Salamanca;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
37 Salamanca;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
37 Salamanca;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
37 Salamanca;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
37 Salamanca;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;87,31
37 Salamanca;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
37 Salamanca;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
37 Salamanca;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
37 Salamanca;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;84,96
37 Salamanca;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
37 Salamanca;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
37 Salamanca;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
37 Salamanca;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
37 Salamanca;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
37 Salamanca;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
37 Salamanca;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QIII;2.778
37 Salamanca;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
37 Salamanca;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
37 Salamanca;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
37 Salamanca;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QIII;2.586
37 Salamanca;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
37 Salamanca;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
37 Salamanca;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
37 Salamanca;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QIII;2.469
37 Salamanca;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
37 Salamanca;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
37 Salamanca;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
37 Salamanca;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2022QIII;2.694
37 Salamanca;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2022QII;""
37 Salamanca;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2022QI;""
37 Salamanca;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
37 Salamanca;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2021QIII;2.517
37 Salamanca;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2021QII;""
37 Salamanca;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2021QI;""
37 Salamanca;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
37 Salamanca;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2020QIII;2.372
37 Salamanca;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2020QII;""
37 Salamanca;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2020QI;""
37 Salamanca;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2022QIV;2.531
37 Salamanca;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
37 Salamanca;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2022QII;""
37 Salamanca;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2022QI;""
37 Salamanca;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2021QIV;2.426
37 Salamanca;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
37 Salamanca;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2021QII;""
37 Salamanca;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2021QI;""
37 Salamanca;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2020QIV;2.268
37 Salamanca;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
37 Salamanca;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2020QII;""
37 Salamanca;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2020QI;""
37 Salamanca;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
37 Salamanca;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
37 Salamanca;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QII;""
37 Salamanca;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QI;2.349
37 Salamanca;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
37 Salamanca;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
37 Salamanca;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QII;""
37 Salamanca;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QI;2.182
37 Salamanca;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
37 Salamanca;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
37 Salamanca;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QII;""
37 Salamanca;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QI;""
37 Salamanca;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
37 Salamanca;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
37 Salamanca;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QII;2.274
37 Salamanca;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QI;""
37 Salamanca;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
37 Salamanca;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
37 Salamanca;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QII;2.117
37 Salamanca;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QI;""
37 Salamanca;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
37 Salamanca;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
37 Salamanca;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QII;""
37 Salamanca;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QI;""
37 Salamanca;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
37 Salamanca;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
37 Salamanca;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
37 Salamanca;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
37 Salamanca;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
37 Salamanca;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
37 Salamanca;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
37 Salamanca;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
37 Salamanca;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
37 Salamanca;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
37 Salamanca;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
37 Salamanca;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
37 Salamanca;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
37 Salamanca;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;96,98
37 Salamanca;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
37 Salamanca;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
37 Salamanca;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
37 Salamanca;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;97,33
37 Salamanca;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
37 Salamanca;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
37 Salamanca;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
37 Salamanca;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;96,07
37 Salamanca;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
37 Salamanca;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
37 Salamanca;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;91,11
37 Salamanca;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
37 Salamanca;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
37 Salamanca;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
37 Salamanca;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;93,81
37 Salamanca;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
37 Salamanca;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
37 Salamanca;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
37 Salamanca;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;91,86
37 Salamanca;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
37 Salamanca;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
37 Salamanca;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
37 Salamanca;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
37 Salamanca;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
37 Salamanca;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
37 Salamanca;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;90,84
37 Salamanca;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
37 Salamanca;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
37 Salamanca;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
37 Salamanca;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;88,38
37 Salamanca;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
37 Salamanca;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
37 Salamanca;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
37 Salamanca;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
37 Salamanca;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
37 Salamanca;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
37 Salamanca;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;87,94
37 Salamanca;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
37 Salamanca;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
37 Salamanca;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
37 Salamanca;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;85,74
37 Salamanca;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
37 Salamanca;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
37 Salamanca;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
37 Salamanca;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
37 Salamanca;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
37 Salamanca;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
37 Salamanca;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QIII;1.251
37 Salamanca;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
37 Salamanca;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
37 Salamanca;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
37 Salamanca;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QIII;1.212
37 Salamanca;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
37 Salamanca;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
37 Salamanca;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
37 Salamanca;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QIII;1.169
37 Salamanca;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
37 Salamanca;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
37 Salamanca;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
37 Salamanca;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2022QIII;1.206
37 Salamanca;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2022QII;""
37 Salamanca;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2022QI;""
37 Salamanca;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
37 Salamanca;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2021QIII;1.171
37 Salamanca;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2021QII;""
37 Salamanca;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2021QI;""
37 Salamanca;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
37 Salamanca;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2020QIII;1.105
37 Salamanca;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2020QII;""
37 Salamanca;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2020QI;""
37 Salamanca;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2022QIV;1.145
37 Salamanca;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
37 Salamanca;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2022QII;""
37 Salamanca;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2022QI;""
37 Salamanca;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2021QIV;1.117
37 Salamanca;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
37 Salamanca;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2021QII;""
37 Salamanca;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2021QI;""
37 Salamanca;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2020QIV;1.051
37 Salamanca;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
37 Salamanca;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2020QII;""
37 Salamanca;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2020QI;""
37 Salamanca;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
37 Salamanca;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
37 Salamanca;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QII;""
37 Salamanca;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QI;1.076
37 Salamanca;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
37 Salamanca;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
37 Salamanca;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QII;""
37 Salamanca;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QI;1.016
37 Salamanca;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
37 Salamanca;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
37 Salamanca;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QII;""
37 Salamanca;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QI;""
37 Salamanca;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
37 Salamanca;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
37 Salamanca;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QII;1.042
37 Salamanca;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QI;""
37 Salamanca;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
37 Salamanca;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
37 Salamanca;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QII;974
37 Salamanca;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QI;""
37 Salamanca;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
37 Salamanca;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
37 Salamanca;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QII;""
37 Salamanca;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QI;""
37 Salamanca;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
37 Salamanca;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
37 Salamanca;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
37 Salamanca;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
37 Salamanca;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
37 Salamanca;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
37 Salamanca;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
37 Salamanca;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
37 Salamanca;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
37 Salamanca;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
37 Salamanca;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
37 Salamanca;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
37 Salamanca;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
37 Salamanca;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;96,4
37 Salamanca;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
37 Salamanca;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
37 Salamanca;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
37 Salamanca;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;96,62
37 Salamanca;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
37 Salamanca;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
37 Salamanca;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
37 Salamanca;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;94,53
37 Salamanca;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
37 Salamanca;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
37 Salamanca;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;91,53
37 Salamanca;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
37 Salamanca;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
37 Salamanca;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
37 Salamanca;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;92,16
37 Salamanca;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
37 Salamanca;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
37 Salamanca;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
37 Salamanca;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;89,91
37 Salamanca;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
37 Salamanca;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
37 Salamanca;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
37 Salamanca;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
37 Salamanca;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
37 Salamanca;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
37 Salamanca;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;88,78
37 Salamanca;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
37 Salamanca;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
37 Salamanca;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
37 Salamanca;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;86,91
37 Salamanca;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
37 Salamanca;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
37 Salamanca;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
37 Salamanca;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
37 Salamanca;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
37 Salamanca;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
37 Salamanca;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;85,97
37 Salamanca;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
37 Salamanca;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
37 Salamanca;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
37 Salamanca;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;83,32
37 Salamanca;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
37 Salamanca;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
37 Salamanca;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
37 Salamanca;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
37 Salamanca;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
37 Salamanca;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QIV;3.926
37 Salamanca;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
37 Salamanca;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
37 Salamanca;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
37 Salamanca;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QIV;3.708
37 Salamanca;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
37 Salamanca;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
37 Salamanca;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
37 Salamanca;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QIV;3.510
37 Salamanca;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
37 Salamanca;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
37 Salamanca;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
37 Salamanca;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2022QIV;3.694
37 Salamanca;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
37 Salamanca;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2022QII;""
37 Salamanca;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2022QI;""
37 Salamanca;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2021QIV;3.560
37 Salamanca;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
37 Salamanca;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2021QII;""
37 Salamanca;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2021QI;""
37 Salamanca;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2020QIV;3.345
37 Salamanca;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
37 Salamanca;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2020QII;""
37 Salamanca;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2020QI;""
37 Salamanca;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
37 Salamanca;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
37 Salamanca;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2022QII;""
37 Salamanca;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2022QI;3.442
37 Salamanca;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
37 Salamanca;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
37 Salamanca;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2021QII;""
37 Salamanca;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2021QI;3.219
37 Salamanca;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
37 Salamanca;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
37 Salamanca;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2020QII;""
37 Salamanca;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2020QI;""
37 Salamanca;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
37 Salamanca;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
37 Salamanca;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QII;3.329
37 Salamanca;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QI;""
37 Salamanca;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
37 Salamanca;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
37 Salamanca;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QII;3.112
37 Salamanca;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QI;""
37 Salamanca;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
37 Salamanca;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
37 Salamanca;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QII;""
37 Salamanca;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QI;""
37 Salamanca;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
37 Salamanca;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QIII;3.224
37 Salamanca;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QII;""
37 Salamanca;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QI;""
37 Salamanca;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
37 Salamanca;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QIII;3.024
37 Salamanca;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QII;""
37 Salamanca;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QI;""
37 Salamanca;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
37 Salamanca;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
37 Salamanca;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QII;""
37 Salamanca;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QI;""
37 Salamanca;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
37 Salamanca;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
37 Salamanca;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
37 Salamanca;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
37 Salamanca;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
37 Salamanca;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
37 Salamanca;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
37 Salamanca;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
37 Salamanca;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
37 Salamanca;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
37 Salamanca;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
37 Salamanca;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
37 Salamanca;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;94,09
37 Salamanca;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
37 Salamanca;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
37 Salamanca;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
37 Salamanca;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;96,01
37 Salamanca;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
37 Salamanca;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
37 Salamanca;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
37 Salamanca;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;95,3
37 Salamanca;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
37 Salamanca;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
37 Salamanca;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
37 Salamanca;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
37 Salamanca;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
37 Salamanca;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
37 Salamanca;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;92,83
37 Salamanca;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
37 Salamanca;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
37 Salamanca;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
37 Salamanca;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;91,71
37 Salamanca;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
37 Salamanca;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
37 Salamanca;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
37 Salamanca;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
37 Salamanca;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
37 Salamanca;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
37 Salamanca;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;89,78
37 Salamanca;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
37 Salamanca;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
37 Salamanca;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
37 Salamanca;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;88,66
37 Salamanca;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
37 Salamanca;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
37 Salamanca;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
37 Salamanca;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
37 Salamanca;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
37 Salamanca;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
37 Salamanca;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;86,95
37 Salamanca;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
37 Salamanca;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
37 Salamanca;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
37 Salamanca;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;86,15
37 Salamanca;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
37 Salamanca;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
37 Salamanca;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
37 Salamanca;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
37 Salamanca;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
37 Salamanca;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
37 Salamanca;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QIV;2.703
37 Salamanca;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
37 Salamanca;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
37 Salamanca;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
37 Salamanca;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QIV;2.530
37 Salamanca;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
37 Salamanca;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
37 Salamanca;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
37 Salamanca;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QIV;2.392
37 Salamanca;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
37 Salamanca;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
37 Salamanca;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
37 Salamanca;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2022QIV;2.536
37 Salamanca;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
37 Salamanca;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2022QII;""
37 Salamanca;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2022QI;""
37 Salamanca;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2021QIV;2.437
37 Salamanca;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
37 Salamanca;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2021QII;""
37 Salamanca;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2021QI;""
37 Salamanca;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2020QIV;2.283
37 Salamanca;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
37 Salamanca;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2020QII;""
37 Salamanca;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2020QI;""
37 Salamanca;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
37 Salamanca;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
37 Salamanca;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2022QII;""
37 Salamanca;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2022QI;2.360
37 Salamanca;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
37 Salamanca;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
37 Salamanca;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2021QII;""
37 Salamanca;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2021QI;2.195
37 Salamanca;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
37 Salamanca;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
37 Salamanca;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2020QII;""
37 Salamanca;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2020QI;""
37 Salamanca;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
37 Salamanca;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
37 Salamanca;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QII;2.283
37 Salamanca;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QI;""
37 Salamanca;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
37 Salamanca;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
37 Salamanca;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QII;2.130
37 Salamanca;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QI;""
37 Salamanca;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
37 Salamanca;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
37 Salamanca;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QII;""
37 Salamanca;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QI;""
37 Salamanca;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
37 Salamanca;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QIII;2.212
37 Salamanca;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QII;""
37 Salamanca;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QI;""
37 Salamanca;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
37 Salamanca;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QIII;2.076
37 Salamanca;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QII;""
37 Salamanca;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QI;""
37 Salamanca;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
37 Salamanca;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
37 Salamanca;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QII;""
37 Salamanca;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QI;""
37 Salamanca;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
37 Salamanca;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
37 Salamanca;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
37 Salamanca;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
37 Salamanca;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
37 Salamanca;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
37 Salamanca;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
37 Salamanca;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
37 Salamanca;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
37 Salamanca;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
37 Salamanca;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
37 Salamanca;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
37 Salamanca;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;93,82
37 Salamanca;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
37 Salamanca;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
37 Salamanca;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
37 Salamanca;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;96,32
37 Salamanca;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
37 Salamanca;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
37 Salamanca;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
37 Salamanca;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;95,44
37 Salamanca;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
37 Salamanca;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
37 Salamanca;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
37 Salamanca;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
37 Salamanca;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
37 Salamanca;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
37 Salamanca;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;93,28
37 Salamanca;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
37 Salamanca;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
37 Salamanca;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
37 Salamanca;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;91,76
37 Salamanca;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
37 Salamanca;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
37 Salamanca;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
37 Salamanca;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
37 Salamanca;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
37 Salamanca;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
37 Salamanca;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;90,24
37 Salamanca;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
37 Salamanca;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
37 Salamanca;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
37 Salamanca;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;89,05
37 Salamanca;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
37 Salamanca;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
37 Salamanca;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
37 Salamanca;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
37 Salamanca;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
37 Salamanca;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
37 Salamanca;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;87,43
37 Salamanca;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
37 Salamanca;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
37 Salamanca;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
37 Salamanca;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;86,79
37 Salamanca;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
37 Salamanca;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
37 Salamanca;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
37 Salamanca;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
37 Salamanca;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
37 Salamanca;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
37 Salamanca;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QIV;1.223
37 Salamanca;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
37 Salamanca;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
37 Salamanca;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
37 Salamanca;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QIV;1.178
37 Salamanca;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
37 Salamanca;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
37 Salamanca;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
37 Salamanca;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QIV;1.118
37 Salamanca;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
37 Salamanca;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
37 Salamanca;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
37 Salamanca;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2022QIV;1.158
37 Salamanca;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
37 Salamanca;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2022QII;""
37 Salamanca;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2022QI;""
37 Salamanca;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2021QIV;1.123
37 Salamanca;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
37 Salamanca;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2021QII;""
37 Salamanca;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2021QI;""
37 Salamanca;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2020QIV;1.062
37 Salamanca;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
37 Salamanca;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2020QII;""
37 Salamanca;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2020QI;""
37 Salamanca;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
37 Salamanca;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
37 Salamanca;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2022QII;""
37 Salamanca;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2022QI;1.082
37 Salamanca;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
37 Salamanca;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
37 Salamanca;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2021QII;""
37 Salamanca;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2021QI;1.024
37 Salamanca;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
37 Salamanca;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
37 Salamanca;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2020QII;""
37 Salamanca;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2020QI;""
37 Salamanca;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
37 Salamanca;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
37 Salamanca;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QII;1.046
37 Salamanca;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QI;""
37 Salamanca;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
37 Salamanca;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
37 Salamanca;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QII;982
37 Salamanca;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QI;""
37 Salamanca;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
37 Salamanca;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
37 Salamanca;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QII;""
37 Salamanca;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QI;""
37 Salamanca;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
37 Salamanca;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QIII;1.012
37 Salamanca;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QII;""
37 Salamanca;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QI;""
37 Salamanca;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
37 Salamanca;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QIII;948
37 Salamanca;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QII;""
37 Salamanca;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QI;""
37 Salamanca;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
37 Salamanca;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
37 Salamanca;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QII;""
37 Salamanca;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QI;""
37 Salamanca;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
37 Salamanca;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
37 Salamanca;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
37 Salamanca;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
37 Salamanca;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
37 Salamanca;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
37 Salamanca;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
37 Salamanca;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
37 Salamanca;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
37 Salamanca;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
37 Salamanca;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
37 Salamanca;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
37 Salamanca;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;94,69
37 Salamanca;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
37 Salamanca;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
37 Salamanca;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
37 Salamanca;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;95,33
37 Salamanca;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
37 Salamanca;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
37 Salamanca;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
37 Salamanca;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;94,99
37 Salamanca;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
37 Salamanca;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
37 Salamanca;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
37 Salamanca;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
37 Salamanca;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
37 Salamanca;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
37 Salamanca;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;91,85
37 Salamanca;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
37 Salamanca;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
37 Salamanca;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
37 Salamanca;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;91,59
37 Salamanca;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
37 Salamanca;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
37 Salamanca;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
37 Salamanca;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
37 Salamanca;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
37 Salamanca;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
37 Salamanca;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;88,79
37 Salamanca;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
37 Salamanca;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
37 Salamanca;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
37 Salamanca;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;87,84
37 Salamanca;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
37 Salamanca;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
37 Salamanca;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
37 Salamanca;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
37 Salamanca;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
37 Salamanca;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
37 Salamanca;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;85,91
37 Salamanca;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
37 Salamanca;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
37 Salamanca;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
37 Salamanca;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;84,79
37 Salamanca;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
37 Salamanca;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
37 Salamanca;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
37 Salamanca;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
37 Salamanca;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
37 Salamanca;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QI;62.790
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QI;60.175
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QI;60.767
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Total;Survival in the first trimester;2022QII;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Total;Survival in the first trimester;2022QI;60.494
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Total;Survival in the first trimester;2021QII;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Total;Survival in the first trimester;2021QI;58.403
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Total;Survival in the first trimester;2020QII;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Total;Survival in the first trimester;2020QI;56.484
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Total;Survival in the second trimester;2022QII;58.406
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Total;Survival in the second trimester;2022QI;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Total;Survival in the second trimester;2021QII;56.559
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Total;Survival in the second trimester;2021QI;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Total;Survival in the second trimester;2020QII;55.087
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Total;Survival in the second trimester;2020QI;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Total;Survival in the third trimester;2022QIII;56.558
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Total;Survival in the third trimester;2022QII;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Total;Survival in the third trimester;2022QI;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Total;Survival in the third trimester;2021QIII;55.015
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Total;Survival in the third trimester;2021QII;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Total;Survival in the third trimester;2021QI;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Total;Survival in the third trimester;2020QIII;53.311
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Total;Survival in the third trimester;2020QII;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Total;Survival in the third trimester;2020QI;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Total;Survival in the third trimester;2022QIV;54.757
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Total;Survival in the third trimester;2022QII;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Total;Survival in the third trimester;2022QI;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Total;Survival in the third trimester;2021QIV;53.388
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Total;Survival in the third trimester;2021QII;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Total;Survival in the third trimester;2021QI;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Total;Survival in the third trimester;2020QIV;51.649
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Total;Survival in the third trimester;2020QII;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Total;Survival in the third trimester;2020QI;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;96,34
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;97,06
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;92,95
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;93,02
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;93,99
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;90,65
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;90,07
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;91,43
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;87,73
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;87,21
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;88,72
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;85
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QI;38.555
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QI;37.300
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QI;37.521
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Males;Survival in the first trimester;2022QII;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Males;Survival in the first trimester;2022QI;37.239
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Males;Survival in the first trimester;2021QII;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Males;Survival in the first trimester;2021QI;36.256
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Males;Survival in the first trimester;2020QII;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Males;Survival in the first trimester;2020QI;35.077
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Males;Survival in the second trimester;2022QII;36.069
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Males;Survival in the second trimester;2022QI;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Males;Survival in the second trimester;2021QII;35.181
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Males;Survival in the second trimester;2021QI;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Males;Survival in the second trimester;2020QII;34.274
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Males;Survival in the second trimester;2020QI;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Males;Survival in the third trimester;2022QIII;35.039
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Males;Survival in the third trimester;2022QII;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Males;Survival in the third trimester;2022QI;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Males;Survival in the third trimester;2021QIII;34.282
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Males;Survival in the third trimester;2021QII;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Males;Survival in the third trimester;2021QI;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Males;Survival in the third trimester;2020QIII;33.280
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Males;Survival in the third trimester;2020QII;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Males;Survival in the third trimester;2020QI;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Males;Survival in the third trimester;2022QIV;33.964
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Males;Survival in the third trimester;2022QII;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Males;Survival in the third trimester;2022QI;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Males;Survival in the third trimester;2021QIV;33.337
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Males;Survival in the third trimester;2021QII;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Males;Survival in the third trimester;2021QI;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Males;Survival in the third trimester;2020QIV;32.315
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Males;Survival in the third trimester;2020QII;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Males;Survival in the third trimester;2020QI;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;96,59
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;97,2
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;93,49
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;93,55
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;94,32
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;91,35
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;90,88
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;91,91
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;88,7
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;88,09
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;89,38
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;86,13
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QI;24.235
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QI;22.875
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QI;23.246
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Females;Survival in the first trimester;2022QII;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Females;Survival in the first trimester;2022QI;23.255
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Females;Survival in the first trimester;2021QII;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Females;Survival in the first trimester;2021QI;22.147
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Females;Survival in the first trimester;2020QII;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Females;Survival in the first trimester;2020QI;21.407
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Females;Survival in the second trimester;2022QII;22.337
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Females;Survival in the second trimester;2022QI;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Females;Survival in the second trimester;2021QII;21.378
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Females;Survival in the second trimester;2021QI;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Females;Survival in the second trimester;2020QII;20.813
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Females;Survival in the second trimester;2020QI;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Females;Survival in the third trimester;2022QIII;21.519
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Females;Survival in the third trimester;2022QII;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Females;Survival in the third trimester;2022QI;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Females;Survival in the third trimester;2021QIII;20.733
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Females;Survival in the third trimester;2021QII;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Females;Survival in the third trimester;2021QI;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Females;Survival in the third trimester;2020QIII;20.031
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Females;Survival in the third trimester;2020QII;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Females;Survival in the third trimester;2020QI;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Females;Survival in the third trimester;2022QIV;20.793
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Females;Survival in the third trimester;2022QII;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Females;Survival in the third trimester;2022QI;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Females;Survival in the third trimester;2021QIV;20.051
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Females;Survival in the third trimester;2021QII;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Females;Survival in the third trimester;2021QI;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Females;Survival in the third trimester;2020QIV;19.334
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Females;Survival in the third trimester;2020QII;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Females;Survival in the third trimester;2020QI;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;95,96
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;96,82
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;92,09
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;92,17
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;93,46
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;89,53
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;88,79
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;90,64
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;86,17
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;85,8
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;87,65
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;83,17
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QII;63.365
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QII;60.879
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QII;59.654
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Total;Survival in the first trimester;2022QII;61.034
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Total;Survival in the first trimester;2022QI;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Total;Survival in the first trimester;2021QII;58.803
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Total;Survival in the first trimester;2021QI;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Total;Survival in the first trimester;2020QII;58.100
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Total;Survival in the first trimester;2020QI;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Total;Survival in the second trimester;2022QIII;58.999
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Total;Survival in the second trimester;2022QII;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Total;Survival in the second trimester;2022QI;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Total;Survival in the second trimester;2021QIII;57.085
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Total;Survival in the second trimester;2021QII;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Total;Survival in the second trimester;2021QI;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Total;Survival in the second trimester;2020QIII;56.085
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Total;Survival in the second trimester;2020QII;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Total;Survival in the second trimester;2020QI;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Total;Survival in the third trimester;2022QIV;57.029
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Total;Survival in the third trimester;2022QII;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Total;Survival in the third trimester;2022QI;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Total;Survival in the third trimester;2021QIV;55.334
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Total;Survival in the third trimester;2021QII;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Total;Survival in the third trimester;2021QI;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Total;Survival in the third trimester;2020QIV;54.248
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Total;Survival in the third trimester;2020QII;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Total;Survival in the third trimester;2020QI;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Total;Survival in the third trimester;2022QII;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Total;Survival in the third trimester;2022QI;53.666
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Total;Survival in the third trimester;2021QII;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Total;Survival in the third trimester;2021QI;52.930
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Total;Survival in the third trimester;2020QII;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Total;Survival in the third trimester;2020QI;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;96,32
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;96,59
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;97,39
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;93,11
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;93,77
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;94,02
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;90
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;90,89
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;90,94
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;88,15
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;88,73
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QII;38.847
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QII;37.668
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QII;36.917
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Males;Survival in the first trimester;2022QII;37.538
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Males;Survival in the first trimester;2022QI;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Males;Survival in the first trimester;2021QII;36.450
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Males;Survival in the first trimester;2021QI;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Males;Survival in the first trimester;2020QII;36.027
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Males;Survival in the first trimester;2020QI;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Males;Survival in the second trimester;2022QIII;36.403
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Males;Survival in the second trimester;2022QII;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Males;Survival in the second trimester;2022QI;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Males;Survival in the second trimester;2021QIII;35.442
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Males;Survival in the second trimester;2021QII;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Males;Survival in the second trimester;2021QI;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Males;Survival in the second trimester;2020QIII;34.874
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Males;Survival in the second trimester;2020QII;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Males;Survival in the second trimester;2020QI;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Males;Survival in the third trimester;2022QIV;35.229
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Males;Survival in the third trimester;2022QII;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Males;Survival in the third trimester;2022QI;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Males;Survival in the third trimester;2021QIV;34.423
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Males;Survival in the third trimester;2021QII;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Males;Survival in the third trimester;2021QI;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Males;Survival in the third trimester;2020QIV;33.812
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Males;Survival in the third trimester;2020QII;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Males;Survival in the third trimester;2020QI;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Males;Survival in the third trimester;2022QII;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Males;Survival in the third trimester;2022QI;33.466
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Males;Survival in the third trimester;2021QII;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Males;Survival in the third trimester;2021QI;33.044
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Males;Survival in the third trimester;2020QII;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Males;Survival in the third trimester;2020QI;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;96,63
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;96,77
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;97,59
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;93,71
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;94,09
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;94,47
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;90,69
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;91,39
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;91,59
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;88,84
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;89,51
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QII;24.518
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QII;23.211
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QII;22.737
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Females;Survival in the first trimester;2022QII;23.496
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Females;Survival in the first trimester;2022QI;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Females;Survival in the first trimester;2021QII;22.353
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Females;Survival in the first trimester;2021QI;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Females;Survival in the first trimester;2020QII;22.073
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Females;Survival in the first trimester;2020QI;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Females;Survival in the second trimester;2022QIII;22.596
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Females;Survival in the second trimester;2022QII;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Females;Survival in the second trimester;2022QI;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Females;Survival in the second trimester;2021QIII;21.643
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Females;Survival in the second trimester;2021QII;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Females;Survival in the second trimester;2021QI;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Females;Survival in the second trimester;2020QIII;21.211
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Females;Survival in the second trimester;2020QII;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Females;Survival in the second trimester;2020QI;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Females;Survival in the third trimester;2022QIV;21.800
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Females;Survival in the third trimester;2022QII;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Females;Survival in the third trimester;2022QI;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Females;Survival in the third trimester;2021QIV;20.911
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Females;Survival in the third trimester;2021QII;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Females;Survival in the third trimester;2021QI;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Females;Survival in the third trimester;2020QIV;20.436
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Females;Survival in the third trimester;2020QII;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Females;Survival in the third trimester;2020QI;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Females;Survival in the third trimester;2022QII;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Females;Survival in the third trimester;2022QI;20.200
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Females;Survival in the third trimester;2021QII;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Females;Survival in the third trimester;2021QI;19.886
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Females;Survival in the third trimester;2020QII;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Females;Survival in the third trimester;2020QI;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;95,83
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;96,3
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;97,08
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;92,16
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;93,24
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;93,29
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;88,91
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;90,09
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;89,88
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;87,03
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;87,46
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QIII;63.942
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QIII;61.597
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QIII;59.641
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Total;Survival in the first trimester;2022QIII;61.673
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Total;Survival in the first trimester;2022QII;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Total;Survival in the first trimester;2022QI;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Total;Survival in the first trimester;2021QIII;59.637
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Total;Survival in the first trimester;2021QII;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Total;Survival in the first trimester;2021QI;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Total;Survival in the first trimester;2020QIII;57.457
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Total;Survival in the first trimester;2020QII;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Total;Survival in the first trimester;2020QI;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Total;Survival in the second trimester;2022QIV;59.495
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Total;Survival in the second trimester;2022QII;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Total;Survival in the second trimester;2022QI;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Total;Survival in the second trimester;2021QIV;57.683
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Total;Survival in the second trimester;2021QII;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Total;Survival in the second trimester;2021QI;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Total;Survival in the second trimester;2020QIV;55.498
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Total;Survival in the second trimester;2020QII;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Total;Survival in the second trimester;2020QI;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Total;Survival in the third trimester;2022QII;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Total;Survival in the third trimester;2022QI;55.843
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Total;Survival in the third trimester;2021QII;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Total;Survival in the third trimester;2021QI;54.101
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Total;Survival in the third trimester;2020QII;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Total;Survival in the third trimester;2020QI;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Total;Survival in the third trimester;2022QII;54.129
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Total;Survival in the third trimester;2022QI;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Total;Survival in the third trimester;2021QII;52.590
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Total;Survival in the third trimester;2021QI;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Total;Survival in the third trimester;2020QII;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Total;Survival in the third trimester;2020QI;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;96,45
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;96,82
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;96,34
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;93,05
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;93,65
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;93,05
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;90,66
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;90,71
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;87,88
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;88,18
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QIII;39.205
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QIII;38.009
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QIII;36.998
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Males;Survival in the first trimester;2022QIII;37.933
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Males;Survival in the first trimester;2022QII;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Males;Survival in the first trimester;2022QI;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Males;Survival in the first trimester;2021QIII;36.855
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Males;Survival in the first trimester;2021QII;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Males;Survival in the first trimester;2021QI;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Males;Survival in the first trimester;2020QIII;35.732
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Males;Survival in the first trimester;2020QII;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Males;Survival in the first trimester;2020QI;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Males;Survival in the second trimester;2022QIV;36.641
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Males;Survival in the second trimester;2022QII;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Males;Survival in the second trimester;2022QI;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Males;Survival in the second trimester;2021QIV;35.709
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Males;Survival in the second trimester;2021QII;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Males;Survival in the second trimester;2021QI;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Males;Survival in the second trimester;2020QIV;34.592
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Males;Survival in the second trimester;2020QII;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Males;Survival in the second trimester;2020QI;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Males;Survival in the third trimester;2022QII;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Males;Survival in the third trimester;2022QI;34.654
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Males;Survival in the third trimester;2021QII;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Males;Survival in the third trimester;2021QI;33.775
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Males;Survival in the third trimester;2020QII;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Males;Survival in the third trimester;2020QI;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Males;Survival in the third trimester;2022QII;33.692
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Males;Survival in the third trimester;2022QI;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Males;Survival in the third trimester;2021QII;32.894
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Males;Survival in the third trimester;2021QI;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Males;Survival in the third trimester;2020QII;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Males;Survival in the third trimester;2020QI;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;96,76
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;96,96
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;96,58
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;93,46
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;93,95
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;93,5
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;91,17
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;91,29
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;88,64
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;88,91
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QIII;24.737
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QIII;23.588
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QIII;22.643
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Females;Survival in the first trimester;2022QIII;23.740
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Females;Survival in the first trimester;2022QII;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Females;Survival in the first trimester;2022QI;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Females;Survival in the first trimester;2021QIII;22.782
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Females;Survival in the first trimester;2021QII;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Females;Survival in the first trimester;2021QI;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Females;Survival in the first trimester;2020QIII;21.725
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Females;Survival in the first trimester;2020QII;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Females;Survival in the first trimester;2020QI;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Females;Survival in the second trimester;2022QIV;22.854
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Females;Survival in the second trimester;2022QII;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Females;Survival in the second trimester;2022QI;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Females;Survival in the second trimester;2021QIV;21.974
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Females;Survival in the second trimester;2021QII;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Females;Survival in the second trimester;2021QI;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Females;Survival in the second trimester;2020QIV;20.906
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Females;Survival in the second trimester;2020QII;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Females;Survival in the second trimester;2020QI;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Females;Survival in the third trimester;2022QII;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Females;Survival in the third trimester;2022QI;21.189
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Females;Survival in the third trimester;2021QII;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Females;Survival in the third trimester;2021QI;20.326
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Females;Survival in the third trimester;2020QII;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Females;Survival in the third trimester;2020QI;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Females;Survival in the third trimester;2022QII;20.437
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Females;Survival in the third trimester;2022QI;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Females;Survival in the third trimester;2021QII;19.696
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Females;Survival in the third trimester;2021QI;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Females;Survival in the third trimester;2020QII;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Females;Survival in the third trimester;2020QI;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;95,97
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;96,58
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;95,95
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;92,39
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;93,16
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;92,33
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;89,83
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;89,77
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;86,64
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;86,98
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QIV;64.335
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QIV;62.258
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QIV;60.071
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Total;Survival in the first trimester;2022QIV;61.901
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Total;Survival in the first trimester;2022QII;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Total;Survival in the first trimester;2022QI;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Total;Survival in the first trimester;2021QIV;60.058
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Total;Survival in the first trimester;2021QII;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Total;Survival in the first trimester;2021QI;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Total;Survival in the first trimester;2020QIV;57.824
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Total;Survival in the first trimester;2020QII;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Total;Survival in the first trimester;2020QI;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Total;Survival in the second trimester;2022QII;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Total;Survival in the second trimester;2022QI;58.046
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Total;Survival in the second trimester;2021QII;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Total;Survival in the second trimester;2021QI;56.267
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Total;Survival in the second trimester;2020QII;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Total;Survival in the second trimester;2020QI;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Total;Survival in the third trimester;2022QII;56.170
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Total;Survival in the third trimester;2022QI;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Total;Survival in the third trimester;2021QII;54.611
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Total;Survival in the third trimester;2021QI;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Total;Survival in the third trimester;2020QII;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Total;Survival in the third trimester;2020QI;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Total;Survival in the third trimester;2022QIII;54.462
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Total;Survival in the third trimester;2022QII;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Total;Survival in the third trimester;2022QI;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Total;Survival in the third trimester;2021QIII;53.216
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Total;Survival in the third trimester;2021QII;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Total;Survival in the third trimester;2021QI;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Total;Survival in the third trimester;2020QII;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Total;Survival in the third trimester;2020QI;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;96,22
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;96,47
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;96,26
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;93,23
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;93,67
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;90,22
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;90,91
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;87,48
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;88,59
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QIV;39.450
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QIV;38.362
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QIV;37.238
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Males;Survival in the first trimester;2022QIV;38.021
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Males;Survival in the first trimester;2022QII;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Males;Survival in the first trimester;2022QI;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Males;Survival in the first trimester;2021QIV;37.073
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Males;Survival in the first trimester;2021QII;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Males;Survival in the first trimester;2021QI;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Males;Survival in the first trimester;2020QIV;35.938
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Males;Survival in the first trimester;2020QII;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Males;Survival in the first trimester;2020QI;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Males;Survival in the second trimester;2022QII;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Males;Survival in the second trimester;2022QI;35.921
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Males;Survival in the second trimester;2021QII;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Males;Survival in the second trimester;2021QI;35.025
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Males;Survival in the second trimester;2020QII;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Males;Survival in the second trimester;2020QI;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Males;Survival in the third trimester;2022QII;34.865
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Males;Survival in the third trimester;2022QI;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Males;Survival in the third trimester;2021QII;34.058
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Males;Survival in the third trimester;2021QI;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Males;Survival in the third trimester;2020QII;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Males;Survival in the third trimester;2020QI;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Males;Survival in the third trimester;2022QIII;33.901
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Males;Survival in the third trimester;2022QII;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Males;Survival in the third trimester;2022QI;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Males;Survival in the third trimester;2021QIII;33.249
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Males;Survival in the third trimester;2021QII;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Males;Survival in the third trimester;2021QI;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Males;Survival in the third trimester;2020QII;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Males;Survival in the third trimester;2020QI;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;96,38
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;96,64
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;96,51
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;93,64
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;94,06
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;90,88
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;91,46
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;88,37
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;89,29
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QIV;24.885
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QIV;23.896
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QIV;22.833
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Females;Survival in the first trimester;2022QIV;23.880
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Females;Survival in the first trimester;2022QII;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Females;Survival in the first trimester;2022QI;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Females;Survival in the first trimester;2021QIV;22.985
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Females;Survival in the first trimester;2021QII;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Females;Survival in the first trimester;2021QI;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Females;Survival in the first trimester;2020QIV;21.886
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Females;Survival in the first trimester;2020QII;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Females;Survival in the first trimester;2020QI;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Females;Survival in the second trimester;2022QII;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Females;Survival in the second trimester;2022QI;22.125
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Females;Survival in the second trimester;2021QII;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Females;Survival in the second trimester;2021QI;21.242
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Females;Survival in the second trimester;2020QII;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Females;Survival in the second trimester;2020QI;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Females;Survival in the third trimester;2022QII;21.305
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Females;Survival in the third trimester;2022QI;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Females;Survival in the third trimester;2021QII;20.553
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Females;Survival in the third trimester;2021QI;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Females;Survival in the third trimester;2020QII;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Females;Survival in the third trimester;2020QI;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Females;Survival in the third trimester;2022QIII;20.561
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Females;Survival in the third trimester;2022QII;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Females;Survival in the third trimester;2022QI;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Females;Survival in the third trimester;2021QIII;19.967
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Females;Survival in the third trimester;2021QII;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Females;Survival in the third trimester;2021QI;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Females;Survival in the third trimester;2020QII;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Females;Survival in the third trimester;2020QI;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;95,96
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;96,19
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;95,85
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;92,59
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;93,03
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;89,16
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;90,01
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;86,04
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;87,45
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QI;4.033
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QI;3.687
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QI;3.006
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2022QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2022QI;3.696
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2021QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2021QI;3.469
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2020QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2020QI;2.618
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2022QII;3.471
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2022QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2021QII;3.238
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2021QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2020QII;2.523
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2020QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QIII;3.249
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QIII;3.024
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QIII;2.376
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QIV;3.061
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QIV;2.838
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QIV;2.218
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;91,64
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;94,09
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;87,09
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;86,06
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;87,82
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;83,93
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;80,56
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;82,02
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;79,04
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;75,9
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;76,97
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;73,79
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QI;2.333
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QI;2.204
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QI;1.809
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2022QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2022QI;2.150
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2021QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2021QI;2.087
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2020QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2020QI;1.582
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2022QII;2.016
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2022QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2021QII;1.933
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2021QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2020QII;1.535
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2020QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QIII;1.900
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QIII;1.802
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QIII;1.458
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QIV;1.795
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QIV;1.713
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QIV;1.364
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;92,16
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;94,69
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;87,45
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;86,41
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;87,7
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;84,85
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;81,44
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;81,76
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;80,6
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;76,94
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;77,72
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;75,4
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QI;1.700
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QI;1.483
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QI;1.197
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2022QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2022QI;1.546
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2021QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2021QI;1.382
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2020QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2020QI;1.036
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2022QII;1.455
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2022QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2021QII;1.305
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2021QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2020QII;988
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2020QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QIII;1.349
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QIII;1.222
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QIII;918
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QIV;1.266
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QIV;1.125
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QIV;854
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;90,94
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;93,19
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;86,55
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;85,59
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;88
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;82,54
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;79,35
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;82,4
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;76,69
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;74,47
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;75,86
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;71,35
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QII;3.562
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QII;3.248
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QII;3.095
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2022QII;3.319
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2022QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2021QII;3.001
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2021QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2020QII;2.972
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2020QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2022QIII;3.081
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2022QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2022QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2021QIII;2.780
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2021QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2021QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2020QIII;2.776
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2020QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2020QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QIV;2.879
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QIV;2.599
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QIV;2.582
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QI;2.425
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QI;2.454
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;93,18
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;92,4
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;96,03
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;86,5
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;85,59
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;89,69
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;80,83
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;80,02
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;83,42
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;74,66
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;79,29
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QII;2.077
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QII;1.953
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QII;1.840
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2022QII;1.938
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2022QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2021QII;1.789
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2021QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2020QII;1.780
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2020QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2022QIII;1.813
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2022QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2022QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2021QIII;1.655
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2021QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2021QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2020QIII;1.675
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2020QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2020QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QIV;1.701
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QIV;1.570
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QIV;1.563
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QI;1.465
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QI;1.494
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;93,31
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;91,6
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;96,74
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;87,29
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;84,74
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;91,03
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;81,9
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;80,39
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;84,95
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;75,01
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;81,2
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QII;1.485
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QII;1.295
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QII;1.255
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2022QII;1.381
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2022QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2021QII;1.212
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2021QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2020QII;1.192
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2020QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2022QIII;1.268
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2022QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2022QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2021QIII;1.125
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2021QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2021QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2020QIII;1.101
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2020QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2020QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QIV;1.178
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QIV;1.029
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QIV;1.019
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QI;960
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QI;960
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;93
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;93,59
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;94,98
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;85,39
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;86,87
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;87,73
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;79,33
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;79,46
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;81,2
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;74,13
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;76,49
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QIII;3.818
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QIII;3.528
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QIII;3.230
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2022QIII;3.534
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2022QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2022QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2021QIII;3.242
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2021QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2021QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2020QIII;2.999
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2020QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2020QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2022QIV;3.295
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2022QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2022QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2021QIV;3.021
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2021QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2021QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2020QIV;2.782
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2020QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2020QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QI;2.803
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QI;2.637
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QII;2.652
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QII;2.483
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;92,56
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;91,89
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;92,85
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;86,3
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;85,63
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;86,13
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;79,45
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;81,64
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;75,17
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;76,87
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QIII;2.238
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QIII;2.052
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QIII;1.945
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2022QIII;2.086
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2022QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2022QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2021QIII;1.880
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2021QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2021QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2020QIII;1.815
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2020QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2020QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2022QIV;1.951
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2022QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2022QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2021QIV;1.776
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2021QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2021QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2020QIV;1.686
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2020QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2020QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QI;1.647
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QI;1.608
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QII;1.562
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QII;1.505
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;93,21
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;91,62
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;93,32
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;87,18
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;86,55
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;86,68
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;80,26
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;82,67
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;76,12
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;77,38
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QIII;1.580
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QIII;1.476
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QIII;1.285
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2022QIII;1.448
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2022QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2022QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2021QIII;1.362
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2021QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2021QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2020QIII;1.184
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2020QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2020QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2022QIV;1.344
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2022QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2022QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2021QIV;1.245
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2021QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2021QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2020QIV;1.096
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2020QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2020QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QI;1.156
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QI;1.029
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QII;1.090
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QII;978
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;91,65
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;92,28
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;92,14
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;85,06
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;84,35
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;85,29
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;78,32
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;80,08
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;73,85
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;76,11
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QIV;4.030
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QIV;3.791
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QIV;3.470
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2022QIV;3.741
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2022QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2022QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2021QIV;3.508
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2021QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2021QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2020QIV;3.200
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2020QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2020QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2022QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2022QI;3.237
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2021QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2021QI;3.020
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2020QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2020QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QII;3.059
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QII;2.834
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QIII;2.868
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QIII;2.669
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;92,83
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;92,53
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;92,22
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;85,39
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;87,03
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;80,69
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;81,67
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;75,65
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;76,92
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QIV;2.371
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QIV;2.189
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QIV;2.065
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2022QIV;2.207
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2022QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2022QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2021QIV;2.051
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2021QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2021QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2020QIV;1.910
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2020QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2020QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2022QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2022QI;1.898
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2021QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2021QI;1.815
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2020QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2020QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QII;1.793
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QII;1.692
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QIII;1.691
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QIII;1.592
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;93,08
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;93,7
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;92,49
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;86,71
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;87,89
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;81,91
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;81,94
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;77,25
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;77,09
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QIV;1.659
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QIV;1.602
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QIV;1.405
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2022QIV;1.534
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2022QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2022QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2021QIV;1.457
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2021QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2021QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2020QIV;1.290
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2020QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2020QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2022QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2022QI;1.339
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2021QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2021QI;1.205
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2020QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2020QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QII;1.266
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QII;1.142
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QIII;1.177
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QIII;1.077
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;92,47
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;90,95
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;91,81
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;83,58
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;85,77
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;79,03
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;81,28
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;73,47
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;76,65
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QI;12.261
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QI;11.957
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QI;11.647
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2022QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2022QI;11.705
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2021QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2021QI;11.560
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2020QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2020QI;10.647
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2022QII;11.176
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2022QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2021QII;11.129
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2021QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2020QII;10.317
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2020QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QIII;10.745
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QIII;10.757
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QIII;9.920
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QIV;10.354
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QIV;10.372
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QIV;9.556
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;95,47
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;96,68
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;91,41
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;91,15
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;93,08
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;88,58
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;87,64
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;89,96
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;85,17
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;84,45
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;86,74
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;82,05
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QI;6.926
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QI;6.837
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QI;6.573
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2022QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2022QI;6.626
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2021QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2021QI;6.608
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2020QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2020QI;6.063
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2022QII;6.357
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2022QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2021QII;6.381
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2021QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2020QII;5.888
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2020QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QIII;6.116
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QIII;6.179
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QIII;5.673
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QIV;5.898
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QIV;5.966
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QIV;5.484
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;95,67
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;96,65
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;92,24
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;91,78
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;93,33
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;89,58
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;88,3
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;90,38
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;86,31
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;85,16
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;87,26
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;83,43
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QI;5.335
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QI;5.120
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QI;5.074
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2022QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2022QI;5.079
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2021QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2021QI;4.952
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2020QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2020QI;4.584
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2022QII;4.819
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2022QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2021QII;4.748
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2021QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2020QII;4.429
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2020QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QIII;4.629
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QIII;4.578
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QIII;4.247
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QIV;4.456
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QIV;4.406
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QIV;4.072
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;95,2
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;96,72
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;90,34
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;90,33
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;92,73
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;87,29
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;86,77
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;89,41
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;83,7
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;83,52
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;86,05
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;80,25
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QII;11.660
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QII;11.409
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QII;11.493
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2022QII;11.108
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2022QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2021QII;10.932
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2021QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2020QII;11.118
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2020QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2022QIII;10.637
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2022QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2022QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2021QIII;10.511
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2021QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2021QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2020QIII;10.678
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2020QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2020QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QIV;10.222
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QIV;10.118
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QIV;10.273
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QI;9.716
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QI;9.982
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;95,27
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;95,82
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;96,74
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;91,23
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;92,13
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;92,91
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;87,67
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;88,68
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;89,38
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;85,16
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;86,85
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QII;6.538
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QII;6.487
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QII;6.544
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2022QII;6.257
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2022QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2021QII;6.233
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2021QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2020QII;6.346
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2020QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2022QIII;5.989
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2022QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2022QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2021QIII;5.997
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2021QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2021QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2020QIII;6.105
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2020QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2020QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QIV;5.757
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QIV;5.784
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QIV;5.896
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QI;5.577
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QI;5.726
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;95,7
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;96,08
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;96,97
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;91,6
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;92,45
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;93,29
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;88,05
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;89,16
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;90,1
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;85,97
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;87,5
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QII;5.122
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QII;4.922
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QII;4.949
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2022QII;4.851
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2022QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2021QII;4.699
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2021QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2020QII;4.772
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2020QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2022QIII;4.648
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2022QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2022QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2021QIII;4.514
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2021QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2021QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2020QIII;4.573
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2020QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2020QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QIV;4.465
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QIV;4.334
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QIV;4.377
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QI;4.139
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QI;4.256
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;94,71
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;95,47
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;96,42
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;90,75
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;91,71
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;92,4
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;87,17
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;88,05
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;88,44
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;84,09
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;86
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QIII;11.923
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QIII;11.753
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QIII;11.538
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2022QIII;11.392
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2022QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2022QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2021QIII;11.278
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2021QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2021QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2020QIII;11.052
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2020QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2020QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2022QIV;10.918
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2022QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2022QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2021QIV;10.832
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2021QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2021QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2020QIV;10.620
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2020QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2020QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QI;10.383
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QI;10.312
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QII;9.945
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QII;9.972
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;95,55
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;95,96
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;95,79
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;91,57
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;92,16
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;92,04
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;88,34
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;89,37
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;84,62
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;86,43
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QIII;6.686
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QIII;6.676
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QIII;6.577
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2022QIII;6.389
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2022QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2022QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2021QIII;6.406
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2021QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2021QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2020QIII;6.303
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2020QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2020QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2022QIV;6.127
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2022QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2022QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2021QIV;6.159
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2021QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2021QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2020QIV;6.084
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2020QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2020QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QI;5.927
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QI;5.906
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QII;5.707
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QII;5.724
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;95,56
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;95,96
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;95,83
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;91,64
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;92,26
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;92,5
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;88,78
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;89,8
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;85,49
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;87,03
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QIII;5.237
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QIII;5.077
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QIII;4.961
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2022QIII;5.003
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2022QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2022QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2021QIII;4.872
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2021QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2021QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2020QIII;4.749
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2020QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2020QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2022QIV;4.791
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2022QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2022QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2021QIV;4.673
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2021QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2021QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2020QIV;4.536
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2020QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2020QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QI;4.456
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QI;4.406
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QII;4.238
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QII;4.248
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;95,53
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;95,96
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;95,73
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;91,48
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;92,04
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;91,43
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;87,77
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;88,81
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;83,47
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;85,63
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QIV;12.148
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QIV;11.991
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QIV;11.807
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2022QIV;11.615
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2022QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2022QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2021QIV;11.482
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2021QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2021QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2020QIV;11.302
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2020QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2020QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2022QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2022QI;10.993
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2021QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2021QI;10.960
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2020QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2020QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QII;10.505
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QII;10.577
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QIII;10.108
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QIII;10.243
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;95,61
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;95,76
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;95,72
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;91,68
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;92,83
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;87,61
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;89,58
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;84,3
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;86,75
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QIV;6.789
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QIV;6.788
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QIV;6.735
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2022QIV;6.500
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2022QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2022QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2021QIV;6.508
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2021QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2021QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2020QIV;6.474
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2020QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2020QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2022QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2022QI;6.252
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2021QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2021QI;6.275
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2020QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2020QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QII;6.004
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QII;6.072
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QIII;5.775
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QIII;5.895
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;95,74
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;95,88
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;96,12
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;92,1
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;93,17
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;88,45
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;90,16
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;85,08
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;87,53
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QIV;5.359
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QIV;5.203
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QIV;5.072
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2022QIV;5.115
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2022QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2022QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2021QIV;4.974
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2021QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2021QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2020QIV;4.828
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2020QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2020QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2022QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2022QI;4.741
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2021QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2021QI;4.685
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2020QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2020QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QII;4.501
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QII;4.505
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QIII;4.333
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QIII;4.348
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;95,45
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;95,6
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;95,19
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;91,12
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;92,37
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;86,51
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;88,82
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;83,28
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;85,73
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QI;19.617
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QI;19.092
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QI;19.228
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2022QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2022QI;19.006
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2021QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2021QI;18.605
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2020QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2020QI;17.841
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2022QII;18.428
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2022QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2021QII;18.100
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2021QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2020QII;17.431
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2020QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QIII;17.934
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QIII;17.661
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QIII;16.920
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QIV;17.423
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QIV;17.239
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QIV;16.465
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;96,89
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;97,45
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;92,79
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;93,94
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;94,8
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;90,65
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;91,42
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;92,5
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;88
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;88,82
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;90,29
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;85,63
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QI;12.029
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QI;11.907
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QI;11.907
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2022QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2022QI;11.667
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2021QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2021QI;11.601
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2020QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2020QI;11.121
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2022QII;11.344
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2022QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2021QII;11.310
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2021QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2020QII;10.880
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2020QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QIII;11.076
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QIII;11.046
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QIII;10.610
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QIV;10.780
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QIV;10.799
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QIV;10.348
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;96,99
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;97,43
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;93,4
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;94,31
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;94,99
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;91,37
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;92,08
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;92,77
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;89,11
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;89,62
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;90,69
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;86,91
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QI;7.588
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QI;7.185
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QI;7.321
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2022QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2022QI;7.339
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2021QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2021QI;7.004
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2020QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2020QI;6.720
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2022QII;7.084
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2022QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2021QII;6.790
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2021QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2020QII;6.551
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2020QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QIII;6.858
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QIII;6.615
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QIII;6.310
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QIV;6.643
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QIV;6.440
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QIV;6.117
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;96,72
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;97,48
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;91,79
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;93,36
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;94,5
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;89,48
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;90,38
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;92,07
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;86,19
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;87,55
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;89,63
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;83,55
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QII;19.420
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QII;18.962
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QII;18.808
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2022QII;18.745
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2022QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2021QII;18.402
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2021QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2020QII;18.361
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2020QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2022QIII;18.203
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2022QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2022QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2021QIII;17.917
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2021QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2021QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2020QIII;17.792
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2020QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2020QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QIV;17.644
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QIV;17.439
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QIV;17.283
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QI;17.004
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QI;16.930
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;96,52
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;97,05
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;97,62
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;93,73
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;94,49
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;94,6
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;90,85
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;91,97
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;91,89
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;89,67
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;90,01
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QII;11.819
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QII;11.709
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QII;11.693
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2022QII;11.434
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2022QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2021QII;11.388
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2021QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2020QII;11.428
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2020QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2022QIII;11.140
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2022QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2022QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2021QIII;11.093
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2021QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2021QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2020QIII;11.116
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2020QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2020QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QIV;10.817
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QIV;10.808
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QIV;10.825
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QI;10.555
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QI;10.611
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;96,74
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;97,26
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;97,73
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;94,26
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;94,74
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;95,07
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;91,52
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;92,31
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;92,58
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;90,14
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;90,75
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QII;7.601
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QII;7.253
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QII;7.115
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2022QII;7.311
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2022QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2021QII;7.014
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2021QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2020QII;6.933
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2020QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2022QIII;7.063
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2022QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2022QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2021QIII;6.824
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2021QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2021QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2020QIII;6.676
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2020QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2020QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QIV;6.827
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QIV;6.631
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QIV;6.458
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QI;6.449
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QI;6.319
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;96,18
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;96,7
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;97,44
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;92,92
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;94,09
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;93,83
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;89,82
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;91,42
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;90,77
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;88,91
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;88,81
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QIII;19.640
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QIII;19.220
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QIII;18.845
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2022QIII;19.029
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2022QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2022QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2021QIII;18.670
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2021QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2021QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2020QIII;18.232
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2020QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2020QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2022QIV;18.411
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2022QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2022QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2021QIV;18.135
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2021QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2021QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2020QIV;17.685
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2020QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2020QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QI;17.646
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QI;17.309
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QII;17.160
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QII;16.884
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;96,89
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;97,14
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;96,75
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;93,74
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;94,35
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;93,84
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;91,81
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;91,85
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;89,28
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;89,59
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QIII;11.947
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QIII;11.857
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QIII;11.746
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2022QIII;11.613
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2022QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2022QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2021QIII;11.523
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2021QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2021QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2020QIII;11.405
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2020QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2020QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2022QIV;11.256
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2022QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2022QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2021QIV;11.199
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2021QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2021QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2020QIV;11.087
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2020QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2020QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QI;10.912
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QI;10.856
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QII;10.639
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QII;10.616
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;97,2
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;97,18
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;97,1
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;94,22
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;94,45
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;94,39
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;92,03
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;92,42
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;89,73
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;90,38
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QIII;7.693
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QIII;7.363
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QIII;7.099
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2022QIII;7.416
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2022QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2022QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2021QIII;7.147
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2021QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2021QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2020QIII;6.827
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2020QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2020QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2022QIV;7.155
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2022QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2022QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2021QIV;6.936
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2021QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2021QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2020QIV;6.598
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2020QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2020QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QI;6.734
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QI;6.453
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QII;6.521
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QII;6.268
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;96,4
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;97,07
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;96,17
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;93,01
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;94,2
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;92,94
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;91,46
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;90,9
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;88,56
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;88,29
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QIV;19.808
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QIV;19.400
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QIV;19.035
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2022QIV;19.112
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2022QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2022QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2021QIV;18.805
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2021QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2021QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2020QIV;18.400
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2020QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2020QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2022QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2022QI;18.274
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2021QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2021QI;17.978
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2020QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2020QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QII;17.754
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QII;17.514
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QIII;17.295
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QIII;17.110
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;96,49
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;96,93
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;96,66
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;94,2
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;94,45
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;91,52
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;92,01
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;89,15
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;89,89
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QIV;12.055
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QIV;11.958
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QIV;11.871
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2022QIV;11.659
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2022QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2022QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2021QIV;11.595
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2021QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2021QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2020QIV;11.503
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2020QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2020QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2022QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2022QI;11.283
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2021QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2021QI;11.241
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2020QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2020QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QII;10.989
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QII;10.971
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QIII;10.735
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QIII;10.730
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;96,72
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;96,96
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;96,9
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;94,36
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;94,69
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;91,9
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;92,42
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;89,77
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;90,39
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QIV;7.753
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QIV;7.442
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QIV;7.164
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2022QIV;7.453
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2022QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2022QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2021QIV;7.210
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2021QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2021QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2020QIV;6.897
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2020QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2020QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2022QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2022QI;6.991
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2021QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2021QI;6.737
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2020QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2020QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QII;6.765
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QII;6.543
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QIII;6.560
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QIII;6.380
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;96,13
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;96,88
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;96,27
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;93,94
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;94,04
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;90,9
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;91,33
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;88,15
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;89,06
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QI;17.830
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QI;17.048
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QI;17.462
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2022QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2022QI;17.355
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2021QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2021QI;16.670
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2020QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2020QI;16.520
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2022QII;16.905
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2022QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2021QII;16.320
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2021QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2020QII;16.230
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2020QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QIII;16.503
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QIII;16.042
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QIII;15.856
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QIV;16.111
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QIV;15.694
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QIV;15.503
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;97,34
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;97,78
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;94,61
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;94,81
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;95,73
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;92,94
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;92,56
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;94,1
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;90,8
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;90,36
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;92,06
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;88,78
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QI;11.267
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QI;10.780
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QI;11.026
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2022QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2022QI;10.985
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2021QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2021QI;10.556
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2020QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2020QI;10.466
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2022QII;10.736
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2022QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2021QII;10.354
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2021QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2020QII;10.301
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2020QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QIII;10.508
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QIII;10.196
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QIII;10.082
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QIV;10.266
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QIV;9.985
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QIV;9.865
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;97,5
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;97,92
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;94,92
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;95,29
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;96,05
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;93,42
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;93,26
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;94,58
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;91,44
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;91,12
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;92,63
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;89,47
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QI;6.563
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QI;6.268
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QI;6.436
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2022QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2022QI;6.370
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2021QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2021QI;6.114
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2020QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2020QI;6.054
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2022QII;6.169
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2022QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2021QII;5.966
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2021QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2020QII;5.929
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2020QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QIII;5.995
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QIII;5.846
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QIII;5.774
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QIV;5.845
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QIV;5.709
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QIV;5.638
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;97,06
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;97,54
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;94,06
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;94
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;95,18
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;92,12
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;91,35
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;93,27
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;89,71
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;89,06
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;91,08
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;87,6
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QII;18.419
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QII;17.638
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QII;17.155
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2022QII;17.914
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2022QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2021QII;17.222
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2021QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2020QII;16.830
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2020QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2022QIII;17.474
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2022QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2022QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2021QIII;16.902
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2021QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2021QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2020QIII;16.404
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2020QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2020QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QIV;17.032
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QIV;16.518
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QIV;16.018
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QI;16.143
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QI;15.734
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;97,26
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;97,64
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;98,11
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;94,87
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;95,83
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;95,62
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;92,47
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;93,65
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;93,37
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;91,52
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;91,72
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QII;11.607
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QII;11.158
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QII;10.838
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2022QII;11.331
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2022QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2021QII;10.909
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2021QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2020QII;10.653
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2020QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2022QIII;11.086
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2022QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2022QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2021QIII;10.727
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2021QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2021QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2020QIII;10.396
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2020QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2020QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QIV;10.817
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QIV;10.499
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QIV;10.159
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QI;10.277
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QI;9.993
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;97,62
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;97,77
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;98,29
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;95,51
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;96,14
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;95,92
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;93,19
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;94,09
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;93,74
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;92,1
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;92,2
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QII;6.812
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QII;6.480
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QII;6.317
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2022QII;6.583
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2022QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2021QII;6.313
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2021QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2020QII;6.177
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2020QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2022QIII;6.388
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2022QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2022QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2021QIII;6.175
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2021QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2021QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2020QIII;6.008
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2020QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2020QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QIV;6.215
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QIV;6.019
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QIV;5.859
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QI;5.866
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QI;5.741
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;96,64
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;97,42
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;97,78
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;93,78
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;95,29
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;95,11
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;91,24
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;92,89
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;92,75
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;90,52
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;90,88
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QIII;18.451
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QIII;17.706
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QIII;17.125
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2022QIII;17.968
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2022QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2022QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2021QIII;17.341
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2021QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2021QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2020QIII;16.666
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2020QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2020QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2022QIV;17.486
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2022QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2022QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2021QIV;16.919
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2021QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2021QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2020QIV;16.253
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2020QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2020QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QI;16.521
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QI;15.954
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QII;16.163
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QII;15.663
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;97,38
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;97,94
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;97,32
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;94,77
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;95,56
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;94,91
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;93,31
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;93,16
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;91,29
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;91,46
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QIII;11.650
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QIII;11.202
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QIII;10.850
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2022QIII;11.375
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2022QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2022QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2021QIII;10.991
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2021QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2021QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2020QIII;10.574
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2020QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2020QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2022QIV;11.084
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2022QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2022QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2021QIV;10.742
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2021QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2021QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2020QIV;10.319
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2020QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2020QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QI;10.507
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QI;10.142
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QII;10.306
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QII;9.971
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;97,64
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;98,12
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;97,46
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;95,14
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;95,89
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;95,11
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;93,8
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;93,47
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;92
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;91,9
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QIII;6.801
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QIII;6.504
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QIII;6.275
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2022QIII;6.593
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2022QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2022QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2021QIII;6.350
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2021QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2021QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2020QIII;6.092
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2020QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2020QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2022QIV;6.402
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2022QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2022QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2021QIV;6.177
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2021QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2021QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2020QIV;5.934
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2020QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2020QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QI;6.014
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QI;5.812
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QII;5.857
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QII;5.692
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;96,94
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;97,63
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;97,08
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;94,13
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;94,97
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;94,57
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;92,47
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;92,62
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;90,05
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;90,71
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QIV;18.471
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QIV;17.826
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QIV;17.117
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2022QIV;17.939
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2022QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2022QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2021QIV;17.361
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2021QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2021QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2020QIV;16.645
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2020QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2020QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2022QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2022QI;16.936
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2021QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2021QI;16.309
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2020QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2020QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QII;16.534
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QII;15.995
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QIII;16.163
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QIII;15.741
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;97,12
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;97,39
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;97,24
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;95,01
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;95,28
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;92,75
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;93,45
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;90,67
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;91,96
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QIV;11.682
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QIV;11.281
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QIV;10.843
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2022QIV;11.362
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2022QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2022QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2021QIV;11.004
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2021QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2021QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2020QIV;10.556
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2020QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2020QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2022QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2022QI;10.750
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2021QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2021QI;10.356
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2020QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2020QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QII;10.527
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QII;10.174
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QIII;10.319
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QIII;10.026
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;97,26
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;97,54
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;97,35
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;95,29
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;95,51
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;93,32
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;93,83
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;91,47
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;92,47
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QIV;6.789
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QIV;6.545
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QIV;6.274
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2022QIV;6.577
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2022QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2022QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2021QIV;6.357
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2021QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2021QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2020QIV;6.089
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2020QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2020QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2022QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2022QI;6.186
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2021QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2021QI;5.953
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2020QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2020QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QII;6.007
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QII;5.821
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QIII;5.844
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QIII;5.715
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;96,88
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;97,13
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;97,05
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;94,51
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;94,88
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;91,78
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;92,78
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;89,29
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;91,09
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QI;9.049
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QI;8.391
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QI;9.424
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2022QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2022QI;8.732
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2021QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2021QI;8.099
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2020QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2020QI;8.858
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2022QII;8.426
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2022QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2021QII;7.772
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2021QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2020QII;8.586
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2020QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QIII;8.127
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QIII;7.531
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QIII;8.239
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QIV;7.808
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QIV;7.245
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QIV;7.907
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;96,5
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;96,52
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;93,99
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;93,12
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;92,62
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;91,11
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;89,81
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;89,75
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;87,43
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;86,29
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;86,34
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;83,9
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QI;6.000
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QI;5.572
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QI;6.206
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2022QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2022QI;5.811
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2021QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2021QI;5.404
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2020QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2020QI;5.845
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2022QII;5.616
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2022QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2021QII;5.203
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2021QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2020QII;5.670
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2020QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QIII;5.439
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QIII;5.059
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QIII;5.457
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QIV;5.225
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QIV;4.874
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QIV;5.254
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;96,85
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;96,98
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;94,18
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;93,6
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;93,38
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;91,36
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;90,65
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;90,79
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;87,93
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;87,08
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;87,47
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;84,66
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QI;3.049
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QI;2.819
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QI;3.218
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2022QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2022QI;2.921
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2021QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2021QI;2.695
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2020QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2020QI;3.013
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2022QII;2.810
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2022QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2021QII;2.569
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2021QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2020QII;2.916
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2020QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QIII;2.688
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QIII;2.472
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QIII;2.782
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QIV;2.583
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QIV;2.371
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QIV;2.653
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;95,8
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;95,6
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;93,63
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;92,16
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;91,13
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;90,62
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;88,16
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;87,69
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;86,45
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;84,72
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;84,11
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;82,44
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QII;10.304
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QII;9.622
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QII;9.103
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2022QII;9.948
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2022QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2021QII;9.246
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2021QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2020QII;8.819
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2020QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2022QIII;9.604
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2022QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2022QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2021QIII;8.975
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2021QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2021QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2020QIII;8.435
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2020QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2020QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QIV;9.252
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QIV;8.660
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QIV;8.092
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QI;8.378
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QI;7.830
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;96,55
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;96,09
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;96,88
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;93,21
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;93,28
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;92,66
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;89,79
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;90
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;88,89
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;87,07
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;86,02
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QII;6.806
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QII;6.361
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QII;6.002
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2022QII;6.578
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2022QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2021QII;6.131
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2021QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2020QII;5.820
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2020QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2022QIII;6.375
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2022QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2022QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2021QIII;5.970
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2021QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2021QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2020QIII;5.582
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2020QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2020QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QIV;6.137
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QIV;5.762
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QIV;5.369
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QI;5.592
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QI;5.220
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;96,65
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;96,38
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;96,97
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;93,67
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;93,85
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;93
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;90,17
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;90,58
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;89,45
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;87,91
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;86,97
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QII;3.498
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QII;3.261
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QII;3.101
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2022QII;3.370
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2022QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2021QII;3.115
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2021QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2020QII;2.999
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2020QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2022QIII;3.229
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2022QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2022QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2021QIII;3.005
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2021QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2021QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2020QIII;2.853
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2020QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2020QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QIV;3.115
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QIV;2.898
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QIV;2.723
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QI;2.786
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QI;2.610
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;96,34
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;95,52
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;96,71
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;92,31
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;92,15
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;92
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;89,05
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;88,87
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;87,81
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;85,43
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;84,17
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QIII;10.110
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QIII;9.390
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QIII;8.903
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2022QIII;9.750
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2022QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2022QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2021QIII;9.106
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2021QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2021QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2020QIII;8.508
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2020QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2020QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2022QIV;9.385
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2022QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2022QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2021QIV;8.776
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2021QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2021QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2020QIV;8.158
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2020QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2020QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QI;8.490
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QI;7.889
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QII;8.209
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QII;7.588
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;96,44
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;96,98
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;95,56
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;92,83
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;93,46
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;91,63
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;90,42
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;88,61
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;87,42
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;85,23
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QIII;6.684
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QIII;6.222
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QIII;5.880
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2022QIII;6.470
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2022QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2022QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2021QIII;6.055
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2021QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2021QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2020QIII;5.635
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2020QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2020QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2022QIV;6.223
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2022QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2022QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2021QIV;5.833
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2021QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2021QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2020QIV;5.416
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2020QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2020QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QI;5.661
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QI;5.263
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QII;5.478
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QII;5.078
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;96,8
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;97,32
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;95,83
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;93,1
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;93,75
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;92,11
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;90,98
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;89,51
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;88,04
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;86,36
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QIII;3.426
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QIII;3.168
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QIII;3.023
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2022QIII;3.280
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2022QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2022QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2021QIII;3.051
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2021QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2021QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2020QIII;2.873
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2020QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2020QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2022QIV;3.162
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2022QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2022QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2021QIV;2.943
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2021QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2021QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2020QIV;2.742
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2020QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2020QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QI;2.829
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QI;2.626
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QII;2.731
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QII;2.510
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;95,74
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;96,31
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;95,04
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;92,29
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;92,9
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;90,7
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;89,3
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;86,87
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;86,21
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;83,03
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QIV;9.878
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QIV;9.250
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QIV;8.642
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2022QIV;9.494
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2022QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2022QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2021QIV;8.902
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2021QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2021QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2020QIV;8.277
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2020QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2020QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2022QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2022QI;8.606
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2021QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2021QI;8.000
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2020QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2020QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QII;8.318
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QII;7.691
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QIII;8.028
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QIII;7.453
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;96,11
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;96,24
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;95,78
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;93,04
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;92,57
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;89,92
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;89
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;86,79
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;86,24
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QIV;6.553
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QIV;6.146
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QIV;5.724
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2022QIV;6.293
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2022QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2022QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2021QIV;5.915
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2021QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2021QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2020QIV;5.495
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2020QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2020QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2022QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2022QI;5.738
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2021QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2021QI;5.338
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2020QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2020QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QII;5.552
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QII;5.149
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QIII;5.381
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QIII;5.006
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;96,03
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;96,24
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;96
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;93,36
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;93,26
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;90,34
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;89,95
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;87,55
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;87,46
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QIV;3.325
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QIV;3.104
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QIV;2.918
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2022QIV;3.201
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2022QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2022QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2021QIV;2.987
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2021QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2021QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2020QIV;2.782
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2020QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2020QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2022QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2022QI;2.868
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2021QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2021QI;2.662
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2020QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2020QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QII;2.766
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QII;2.542
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QIII;2.647
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QIII;2.447
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;96,27
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;96,23
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;95,34
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;92,4
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;91,23
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;89,11
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;87,11
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;85,28
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;83,86
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
40 Segovia;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
40 Segovia;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
40 Segovia;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
40 Segovia;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QI;10.963
40 Segovia;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
40 Segovia;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
40 Segovia;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
40 Segovia;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QI;10.900
40 Segovia;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
40 Segovia;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
40 Segovia;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
40 Segovia;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QI;11.062
40 Segovia;All ages;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
40 Segovia;All ages;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
40 Segovia;All ages;Cohort January 1;Total;Survival in the first trimester;2022QII;""
40 Segovia;All ages;Cohort January 1;Total;Survival in the first trimester;2022QI;10.678
40 Segovia;All ages;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
40 Segovia;All ages;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
40 Segovia;All ages;Cohort January 1;Total;Survival in the first trimester;2021QII;""
40 Segovia;All ages;Cohort January 1;Total;Survival in the first trimester;2021QI;10.667
40 Segovia;All ages;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
40 Segovia;All ages;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
40 Segovia;All ages;Cohort January 1;Total;Survival in the first trimester;2020QII;""
40 Segovia;All ages;Cohort January 1;Total;Survival in the first trimester;2020QI;10.536
40 Segovia;All ages;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
40 Segovia;All ages;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
40 Segovia;All ages;Cohort January 1;Total;Survival in the second trimester;2022QII;10.404
40 Segovia;All ages;Cohort January 1;Total;Survival in the second trimester;2022QI;""
40 Segovia;All ages;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
40 Segovia;All ages;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
40 Segovia;All ages;Cohort January 1;Total;Survival in the second trimester;2021QII;10.432
40 Segovia;All ages;Cohort January 1;Total;Survival in the second trimester;2021QI;""
40 Segovia;All ages;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
40 Segovia;All ages;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
40 Segovia;All ages;Cohort January 1;Total;Survival in the second trimester;2020QII;10.315
40 Segovia;All ages;Cohort January 1;Total;Survival in the second trimester;2020QI;""
40 Segovia;All ages;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
40 Segovia;All ages;Cohort January 1;Total;Survival in the third trimester;2022QIII;10.183
40 Segovia;All ages;Cohort January 1;Total;Survival in the third trimester;2022QII;""
40 Segovia;All ages;Cohort January 1;Total;Survival in the third trimester;2022QI;""
40 Segovia;All ages;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
40 Segovia;All ages;Cohort January 1;Total;Survival in the third trimester;2021QIII;10.191
40 Segovia;All ages;Cohort January 1;Total;Survival in the third trimester;2021QII;""
40 Segovia;All ages;Cohort January 1;Total;Survival in the third trimester;2021QI;""
40 Segovia;All ages;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
40 Segovia;All ages;Cohort January 1;Total;Survival in the third trimester;2020QIII;10.094
40 Segovia;All ages;Cohort January 1;Total;Survival in the third trimester;2020QII;""
40 Segovia;All ages;Cohort January 1;Total;Survival in the third trimester;2020QI;""
40 Segovia;All ages;Cohort January 1;Total;Survival in the third trimester;2022QIV;9.856
40 Segovia;All ages;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
40 Segovia;All ages;Cohort January 1;Total;Survival in the third trimester;2022QII;""
40 Segovia;All ages;Cohort January 1;Total;Survival in the third trimester;2022QI;""
40 Segovia;All ages;Cohort January 1;Total;Survival in the third trimester;2021QIV;9.956
40 Segovia;All ages;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
40 Segovia;All ages;Cohort January 1;Total;Survival in the third trimester;2021QII;""
40 Segovia;All ages;Cohort January 1;Total;Survival in the third trimester;2021QI;""
40 Segovia;All ages;Cohort January 1;Total;Survival in the third trimester;2020QIV;9.865
40 Segovia;All ages;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
40 Segovia;All ages;Cohort January 1;Total;Survival in the third trimester;2020QII;""
40 Segovia;All ages;Cohort January 1;Total;Survival in the third trimester;2020QI;""
40 Segovia;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
40 Segovia;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
40 Segovia;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
40 Segovia;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
40 Segovia;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
40 Segovia;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
40 Segovia;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
40 Segovia;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
40 Segovia;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
40 Segovia;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
40 Segovia;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
40 Segovia;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
40 Segovia;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
40 Segovia;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
40 Segovia;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
40 Segovia;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;97,4
40 Segovia;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
40 Segovia;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
40 Segovia;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
40 Segovia;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;97,86
40 Segovia;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
40 Segovia;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
40 Segovia;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
40 Segovia;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;95,24
40 Segovia;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
40 Segovia;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
40 Segovia;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;94,9
40 Segovia;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
40 Segovia;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
40 Segovia;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
40 Segovia;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;95,71
40 Segovia;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
40 Segovia;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
40 Segovia;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
40 Segovia;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;93,25
40 Segovia;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
40 Segovia;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
40 Segovia;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;92,89
40 Segovia;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
40 Segovia;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
40 Segovia;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
40 Segovia;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;93,5
40 Segovia;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
40 Segovia;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
40 Segovia;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
40 Segovia;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;91,25
40 Segovia;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
40 Segovia;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
40 Segovia;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;89,9
40 Segovia;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
40 Segovia;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
40 Segovia;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
40 Segovia;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;91,34
40 Segovia;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
40 Segovia;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
40 Segovia;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
40 Segovia;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;89,18
40 Segovia;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
40 Segovia;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
40 Segovia;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
40 Segovia;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
40 Segovia;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
40 Segovia;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
40 Segovia;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QI;7.200
40 Segovia;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
40 Segovia;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
40 Segovia;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
40 Segovia;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QI;7.192
40 Segovia;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
40 Segovia;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
40 Segovia;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
40 Segovia;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QI;7.278
40 Segovia;All ages;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
40 Segovia;All ages;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
40 Segovia;All ages;Cohort January 1;Males;Survival in the first trimester;2022QII;""
40 Segovia;All ages;Cohort January 1;Males;Survival in the first trimester;2022QI;7.023
40 Segovia;All ages;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
40 Segovia;All ages;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
40 Segovia;All ages;Cohort January 1;Males;Survival in the first trimester;2021QII;""
40 Segovia;All ages;Cohort January 1;Males;Survival in the first trimester;2021QI;7.053
40 Segovia;All ages;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
40 Segovia;All ages;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
40 Segovia;All ages;Cohort January 1;Males;Survival in the first trimester;2020QII;""
40 Segovia;All ages;Cohort January 1;Males;Survival in the first trimester;2020QI;6.970
40 Segovia;All ages;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
40 Segovia;All ages;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
40 Segovia;All ages;Cohort January 1;Males;Survival in the second trimester;2022QII;6.862
40 Segovia;All ages;Cohort January 1;Males;Survival in the second trimester;2022QI;""
40 Segovia;All ages;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
40 Segovia;All ages;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
40 Segovia;All ages;Cohort January 1;Males;Survival in the second trimester;2021QII;6.923
40 Segovia;All ages;Cohort January 1;Males;Survival in the second trimester;2021QI;""
40 Segovia;All ages;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
40 Segovia;All ages;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
40 Segovia;All ages;Cohort January 1;Males;Survival in the second trimester;2020QII;6.834
40 Segovia;All ages;Cohort January 1;Males;Survival in the second trimester;2020QI;""
40 Segovia;All ages;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
40 Segovia;All ages;Cohort January 1;Males;Survival in the third trimester;2022QIII;6.740
40 Segovia;All ages;Cohort January 1;Males;Survival in the third trimester;2022QII;""
40 Segovia;All ages;Cohort January 1;Males;Survival in the third trimester;2022QI;""
40 Segovia;All ages;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
40 Segovia;All ages;Cohort January 1;Males;Survival in the third trimester;2021QIII;6.781
40 Segovia;All ages;Cohort January 1;Males;Survival in the third trimester;2021QII;""
40 Segovia;All ages;Cohort January 1;Males;Survival in the third trimester;2021QI;""
40 Segovia;All ages;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
40 Segovia;All ages;Cohort January 1;Males;Survival in the third trimester;2020QIII;6.707
40 Segovia;All ages;Cohort January 1;Males;Survival in the third trimester;2020QII;""
40 Segovia;All ages;Cohort January 1;Males;Survival in the third trimester;2020QI;""
40 Segovia;All ages;Cohort January 1;Males;Survival in the third trimester;2022QIV;6.528
40 Segovia;All ages;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
40 Segovia;All ages;Cohort January 1;Males;Survival in the third trimester;2022QII;""
40 Segovia;All ages;Cohort January 1;Males;Survival in the third trimester;2022QI;""
40 Segovia;All ages;Cohort January 1;Males;Survival in the third trimester;2021QIV;6.624
40 Segovia;All ages;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
40 Segovia;All ages;Cohort January 1;Males;Survival in the third trimester;2021QII;""
40 Segovia;All ages;Cohort January 1;Males;Survival in the third trimester;2021QI;""
40 Segovia;All ages;Cohort January 1;Males;Survival in the third trimester;2020QIV;6.560
40 Segovia;All ages;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
40 Segovia;All ages;Cohort January 1;Males;Survival in the third trimester;2020QII;""
40 Segovia;All ages;Cohort January 1;Males;Survival in the third trimester;2020QI;""
40 Segovia;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
40 Segovia;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
40 Segovia;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
40 Segovia;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
40 Segovia;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
40 Segovia;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
40 Segovia;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
40 Segovia;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
40 Segovia;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
40 Segovia;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
40 Segovia;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
40 Segovia;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
40 Segovia;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
40 Segovia;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
40 Segovia;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
40 Segovia;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;97,54
40 Segovia;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
40 Segovia;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
40 Segovia;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
40 Segovia;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;98,07
40 Segovia;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
40 Segovia;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
40 Segovia;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
40 Segovia;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;95,77
40 Segovia;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
40 Segovia;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
40 Segovia;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;95,31
40 Segovia;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
40 Segovia;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
40 Segovia;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
40 Segovia;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;96,26
40 Segovia;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
40 Segovia;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
40 Segovia;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
40 Segovia;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;93,9
40 Segovia;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
40 Segovia;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
40 Segovia;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;93,61
40 Segovia;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
40 Segovia;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
40 Segovia;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
40 Segovia;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;94,29
40 Segovia;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
40 Segovia;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
40 Segovia;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
40 Segovia;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;92,15
40 Segovia;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
40 Segovia;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
40 Segovia;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;90,67
40 Segovia;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
40 Segovia;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
40 Segovia;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
40 Segovia;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;92,1
40 Segovia;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
40 Segovia;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
40 Segovia;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
40 Segovia;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;90,13
40 Segovia;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
40 Segovia;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
40 Segovia;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
40 Segovia;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
40 Segovia;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
40 Segovia;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
40 Segovia;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QI;3.763
40 Segovia;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
40 Segovia;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
40 Segovia;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
40 Segovia;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QI;3.708
40 Segovia;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
40 Segovia;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
40 Segovia;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
40 Segovia;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QI;3.784
40 Segovia;All ages;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
40 Segovia;All ages;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
40 Segovia;All ages;Cohort January 1;Females;Survival in the first trimester;2022QII;""
40 Segovia;All ages;Cohort January 1;Females;Survival in the first trimester;2022QI;3.655
40 Segovia;All ages;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
40 Segovia;All ages;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
40 Segovia;All ages;Cohort January 1;Females;Survival in the first trimester;2021QII;""
40 Segovia;All ages;Cohort January 1;Females;Survival in the first trimester;2021QI;3.614
40 Segovia;All ages;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
40 Segovia;All ages;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
40 Segovia;All ages;Cohort January 1;Females;Survival in the first trimester;2020QII;""
40 Segovia;All ages;Cohort January 1;Females;Survival in the first trimester;2020QI;3.566
40 Segovia;All ages;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
40 Segovia;All ages;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
40 Segovia;All ages;Cohort January 1;Females;Survival in the second trimester;2022QII;3.542
40 Segovia;All ages;Cohort January 1;Females;Survival in the second trimester;2022QI;""
40 Segovia;All ages;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
40 Segovia;All ages;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
40 Segovia;All ages;Cohort January 1;Females;Survival in the second trimester;2021QII;3.509
40 Segovia;All ages;Cohort January 1;Females;Survival in the second trimester;2021QI;""
40 Segovia;All ages;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
40 Segovia;All ages;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
40 Segovia;All ages;Cohort January 1;Females;Survival in the second trimester;2020QII;3.481
40 Segovia;All ages;Cohort January 1;Females;Survival in the second trimester;2020QI;""
40 Segovia;All ages;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
40 Segovia;All ages;Cohort January 1;Females;Survival in the third trimester;2022QIII;3.443
40 Segovia;All ages;Cohort January 1;Females;Survival in the third trimester;2022QII;""
40 Segovia;All ages;Cohort January 1;Females;Survival in the third trimester;2022QI;""
40 Segovia;All ages;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
40 Segovia;All ages;Cohort January 1;Females;Survival in the third trimester;2021QIII;3.410
40 Segovia;All ages;Cohort January 1;Females;Survival in the third trimester;2021QII;""
40 Segovia;All ages;Cohort January 1;Females;Survival in the third trimester;2021QI;""
40 Segovia;All ages;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
40 Segovia;All ages;Cohort January 1;Females;Survival in the third trimester;2020QIII;3.387
40 Segovia;All ages;Cohort January 1;Females;Survival in the third trimester;2020QII;""
40 Segovia;All ages;Cohort January 1;Females;Survival in the third trimester;2020QI;""
40 Segovia;All ages;Cohort January 1;Females;Survival in the third trimester;2022QIV;3.328
40 Segovia;All ages;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
40 Segovia;All ages;Cohort January 1;Females;Survival in the third trimester;2022QII;""
40 Segovia;All ages;Cohort January 1;Females;Survival in the third trimester;2022QI;""
40 Segovia;All ages;Cohort January 1;Females;Survival in the third trimester;2021QIV;3.332
40 Segovia;All ages;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
40 Segovia;All ages;Cohort January 1;Females;Survival in the third trimester;2021QII;""
40 Segovia;All ages;Cohort January 1;Females;Survival in the third trimester;2021QI;""
40 Segovia;All ages;Cohort January 1;Females;Survival in the third trimester;2020QIV;3.305
40 Segovia;All ages;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
40 Segovia;All ages;Cohort January 1;Females;Survival in the third trimester;2020QII;""
40 Segovia;All ages;Cohort January 1;Females;Survival in the third trimester;2020QI;""
40 Segovia;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
40 Segovia;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
40 Segovia;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
40 Segovia;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
40 Segovia;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
40 Segovia;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
40 Segovia;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
40 Segovia;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
40 Segovia;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
40 Segovia;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
40 Segovia;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
40 Segovia;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
40 Segovia;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
40 Segovia;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
40 Segovia;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
40 Segovia;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;97,13
40 Segovia;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
40 Segovia;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
40 Segovia;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
40 Segovia;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;97,46
40 Segovia;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
40 Segovia;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
40 Segovia;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
40 Segovia;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;94,24
40 Segovia;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
40 Segovia;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
40 Segovia;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;94,13
40 Segovia;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
40 Segovia;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
40 Segovia;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
40 Segovia;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;94,63
40 Segovia;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
40 Segovia;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
40 Segovia;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
40 Segovia;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;91,99
40 Segovia;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
40 Segovia;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
40 Segovia;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;91,5
40 Segovia;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
40 Segovia;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
40 Segovia;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
40 Segovia;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;91,96
40 Segovia;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
40 Segovia;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
40 Segovia;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
40 Segovia;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;89,51
40 Segovia;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
40 Segovia;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
40 Segovia;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;88,44
40 Segovia;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
40 Segovia;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
40 Segovia;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
40 Segovia;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;89,86
40 Segovia;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
40 Segovia;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
40 Segovia;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
40 Segovia;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;87,34
40 Segovia;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
40 Segovia;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
40 Segovia;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
40 Segovia;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
40 Segovia;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
40 Segovia;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QII;10.993
40 Segovia;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
40 Segovia;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
40 Segovia;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
40 Segovia;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QII;10.942
40 Segovia;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
40 Segovia;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
40 Segovia;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
40 Segovia;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QII;10.845
40 Segovia;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
40 Segovia;All ages;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
40 Segovia;All ages;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
40 Segovia;All ages;Cohort April 1;Total;Survival in the first trimester;2022QII;10.693
40 Segovia;All ages;Cohort April 1;Total;Survival in the first trimester;2022QI;""
40 Segovia;All ages;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
40 Segovia;All ages;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
40 Segovia;All ages;Cohort April 1;Total;Survival in the first trimester;2021QII;10.681
40 Segovia;All ages;Cohort April 1;Total;Survival in the first trimester;2021QI;""
40 Segovia;All ages;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
40 Segovia;All ages;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
40 Segovia;All ages;Cohort April 1;Total;Survival in the first trimester;2020QII;10.611
40 Segovia;All ages;Cohort April 1;Total;Survival in the first trimester;2020QI;""
40 Segovia;All ages;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
40 Segovia;All ages;Cohort April 1;Total;Survival in the second trimester;2022QIII;10.440
40 Segovia;All ages;Cohort April 1;Total;Survival in the second trimester;2022QII;""
40 Segovia;All ages;Cohort April 1;Total;Survival in the second trimester;2022QI;""
40 Segovia;All ages;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
40 Segovia;All ages;Cohort April 1;Total;Survival in the second trimester;2021QIII;10.421
40 Segovia;All ages;Cohort April 1;Total;Survival in the second trimester;2021QII;""
40 Segovia;All ages;Cohort April 1;Total;Survival in the second trimester;2021QI;""
40 Segovia;All ages;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
40 Segovia;All ages;Cohort April 1;Total;Survival in the second trimester;2020QIII;10.363
40 Segovia;All ages;Cohort April 1;Total;Survival in the second trimester;2020QII;""
40 Segovia;All ages;Cohort April 1;Total;Survival in the second trimester;2020QI;""
40 Segovia;All ages;Cohort April 1;Total;Survival in the third trimester;2022QIV;10.092
40 Segovia;All ages;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
40 Segovia;All ages;Cohort April 1;Total;Survival in the third trimester;2022QII;""
40 Segovia;All ages;Cohort April 1;Total;Survival in the third trimester;2022QI;""
40 Segovia;All ages;Cohort April 1;Total;Survival in the third trimester;2021QIV;10.170
40 Segovia;All ages;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
40 Segovia;All ages;Cohort April 1;Total;Survival in the third trimester;2021QII;""
40 Segovia;All ages;Cohort April 1;Total;Survival in the third trimester;2021QI;""
40 Segovia;All ages;Cohort April 1;Total;Survival in the third trimester;2020QIV;10.117
40 Segovia;All ages;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
40 Segovia;All ages;Cohort April 1;Total;Survival in the third trimester;2020QII;""
40 Segovia;All ages;Cohort April 1;Total;Survival in the third trimester;2020QI;""
40 Segovia;All ages;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
40 Segovia;All ages;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
40 Segovia;All ages;Cohort April 1;Total;Survival in the third trimester;2022QII;""
40 Segovia;All ages;Cohort April 1;Total;Survival in the third trimester;2022QI;9.952
40 Segovia;All ages;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
40 Segovia;All ages;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
40 Segovia;All ages;Cohort April 1;Total;Survival in the third trimester;2021QII;""
40 Segovia;All ages;Cohort April 1;Total;Survival in the third trimester;2021QI;9.939
40 Segovia;All ages;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
40 Segovia;All ages;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
40 Segovia;All ages;Cohort April 1;Total;Survival in the third trimester;2020QII;""
40 Segovia;All ages;Cohort April 1;Total;Survival in the third trimester;2020QI;""
40 Segovia;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
40 Segovia;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
40 Segovia;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
40 Segovia;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
40 Segovia;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
40 Segovia;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
40 Segovia;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
40 Segovia;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
40 Segovia;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
40 Segovia;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
40 Segovia;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
40 Segovia;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
40 Segovia;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
40 Segovia;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
40 Segovia;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;97,27
40 Segovia;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
40 Segovia;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
40 Segovia;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
40 Segovia;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;97,61
40 Segovia;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
40 Segovia;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
40 Segovia;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
40 Segovia;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;97,84
40 Segovia;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
40 Segovia;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
40 Segovia;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;94,97
40 Segovia;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
40 Segovia;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
40 Segovia;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
40 Segovia;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;95,24
40 Segovia;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
40 Segovia;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
40 Segovia;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
40 Segovia;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;95,56
40 Segovia;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
40 Segovia;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
40 Segovia;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;91,8
40 Segovia;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
40 Segovia;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
40 Segovia;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
40 Segovia;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;92,94
40 Segovia;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
40 Segovia;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
40 Segovia;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
40 Segovia;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;93,29
40 Segovia;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
40 Segovia;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
40 Segovia;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
40 Segovia;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
40 Segovia;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
40 Segovia;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
40 Segovia;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;90,95
40 Segovia;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
40 Segovia;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
40 Segovia;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
40 Segovia;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;91,65
40 Segovia;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
40 Segovia;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
40 Segovia;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
40 Segovia;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
40 Segovia;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
40 Segovia;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
40 Segovia;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QII;7.214
40 Segovia;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
40 Segovia;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
40 Segovia;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
40 Segovia;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QII;7.209
40 Segovia;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
40 Segovia;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
40 Segovia;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
40 Segovia;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QII;7.167
40 Segovia;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
40 Segovia;All ages;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
40 Segovia;All ages;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
40 Segovia;All ages;Cohort April 1;Males;Survival in the first trimester;2022QII;7.035
40 Segovia;All ages;Cohort April 1;Males;Survival in the first trimester;2022QI;""
40 Segovia;All ages;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
40 Segovia;All ages;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
40 Segovia;All ages;Cohort April 1;Males;Survival in the first trimester;2021QII;7.064
40 Segovia;All ages;Cohort April 1;Males;Survival in the first trimester;2021QI;""
40 Segovia;All ages;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
40 Segovia;All ages;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
40 Segovia;All ages;Cohort April 1;Males;Survival in the first trimester;2020QII;7.024
40 Segovia;All ages;Cohort April 1;Males;Survival in the first trimester;2020QI;""
40 Segovia;All ages;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
40 Segovia;All ages;Cohort April 1;Males;Survival in the second trimester;2022QIII;6.896
40 Segovia;All ages;Cohort April 1;Males;Survival in the second trimester;2022QII;""
40 Segovia;All ages;Cohort April 1;Males;Survival in the second trimester;2022QI;""
40 Segovia;All ages;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
40 Segovia;All ages;Cohort April 1;Males;Survival in the second trimester;2021QIII;6.907
40 Segovia;All ages;Cohort April 1;Males;Survival in the second trimester;2021QII;""
40 Segovia;All ages;Cohort April 1;Males;Survival in the second trimester;2021QI;""
40 Segovia;All ages;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
40 Segovia;All ages;Cohort April 1;Males;Survival in the second trimester;2020QIII;6.880
40 Segovia;All ages;Cohort April 1;Males;Survival in the second trimester;2020QII;""
40 Segovia;All ages;Cohort April 1;Males;Survival in the second trimester;2020QI;""
40 Segovia;All ages;Cohort April 1;Males;Survival in the third trimester;2022QIV;6.669
40 Segovia;All ages;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
40 Segovia;All ages;Cohort April 1;Males;Survival in the third trimester;2022QII;""
40 Segovia;All ages;Cohort April 1;Males;Survival in the third trimester;2022QI;""
40 Segovia;All ages;Cohort April 1;Males;Survival in the third trimester;2021QIV;6.740
40 Segovia;All ages;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
40 Segovia;All ages;Cohort April 1;Males;Survival in the third trimester;2021QII;""
40 Segovia;All ages;Cohort April 1;Males;Survival in the third trimester;2021QI;""
40 Segovia;All ages;Cohort April 1;Males;Survival in the third trimester;2020QIV;6.727
40 Segovia;All ages;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
40 Segovia;All ages;Cohort April 1;Males;Survival in the third trimester;2020QII;""
40 Segovia;All ages;Cohort April 1;Males;Survival in the third trimester;2020QI;""
40 Segovia;All ages;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
40 Segovia;All ages;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
40 Segovia;All ages;Cohort April 1;Males;Survival in the third trimester;2022QII;""
40 Segovia;All ages;Cohort April 1;Males;Survival in the third trimester;2022QI;6.604
40 Segovia;All ages;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
40 Segovia;All ages;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
40 Segovia;All ages;Cohort April 1;Males;Survival in the third trimester;2021QII;""
40 Segovia;All ages;Cohort April 1;Males;Survival in the third trimester;2021QI;6.623
40 Segovia;All ages;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
40 Segovia;All ages;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
40 Segovia;All ages;Cohort April 1;Males;Survival in the third trimester;2020QII;""
40 Segovia;All ages;Cohort April 1;Males;Survival in the third trimester;2020QI;""
40 Segovia;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
40 Segovia;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
40 Segovia;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
40 Segovia;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
40 Segovia;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
40 Segovia;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
40 Segovia;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
40 Segovia;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
40 Segovia;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
40 Segovia;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
40 Segovia;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
40 Segovia;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
40 Segovia;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
40 Segovia;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
40 Segovia;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;97,52
40 Segovia;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
40 Segovia;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
40 Segovia;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
40 Segovia;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;97,99
40 Segovia;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
40 Segovia;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
40 Segovia;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
40 Segovia;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;98
40 Segovia;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
40 Segovia;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
40 Segovia;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;95,59
40 Segovia;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
40 Segovia;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
40 Segovia;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
40 Segovia;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;95,81
40 Segovia;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
40 Segovia;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
40 Segovia;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
40 Segovia;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;96
40 Segovia;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
40 Segovia;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
40 Segovia;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;92,45
40 Segovia;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
40 Segovia;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
40 Segovia;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
40 Segovia;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;93,49
40 Segovia;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
40 Segovia;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
40 Segovia;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
40 Segovia;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;93,86
40 Segovia;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
40 Segovia;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
40 Segovia;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
40 Segovia;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
40 Segovia;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
40 Segovia;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
40 Segovia;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;91,61
40 Segovia;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
40 Segovia;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
40 Segovia;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
40 Segovia;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;92,41
40 Segovia;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
40 Segovia;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
40 Segovia;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
40 Segovia;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
40 Segovia;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
40 Segovia;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
40 Segovia;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QII;3.779
40 Segovia;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
40 Segovia;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
40 Segovia;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
40 Segovia;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QII;3.733
40 Segovia;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
40 Segovia;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
40 Segovia;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
40 Segovia;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QII;3.678
40 Segovia;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
40 Segovia;All ages;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
40 Segovia;All ages;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
40 Segovia;All ages;Cohort April 1;Females;Survival in the first trimester;2022QII;3.658
40 Segovia;All ages;Cohort April 1;Females;Survival in the first trimester;2022QI;""
40 Segovia;All ages;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
40 Segovia;All ages;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
40 Segovia;All ages;Cohort April 1;Females;Survival in the first trimester;2021QII;3.617
40 Segovia;All ages;Cohort April 1;Females;Survival in the first trimester;2021QI;""
40 Segovia;All ages;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
40 Segovia;All ages;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
40 Segovia;All ages;Cohort April 1;Females;Survival in the first trimester;2020QII;3.587
40 Segovia;All ages;Cohort April 1;Females;Survival in the first trimester;2020QI;""
40 Segovia;All ages;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
40 Segovia;All ages;Cohort April 1;Females;Survival in the second trimester;2022QIII;3.544
40 Segovia;All ages;Cohort April 1;Females;Survival in the second trimester;2022QII;""
40 Segovia;All ages;Cohort April 1;Females;Survival in the second trimester;2022QI;""
40 Segovia;All ages;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
40 Segovia;All ages;Cohort April 1;Females;Survival in the second trimester;2021QIII;3.514
40 Segovia;All ages;Cohort April 1;Females;Survival in the second trimester;2021QII;""
40 Segovia;All ages;Cohort April 1;Females;Survival in the second trimester;2021QI;""
40 Segovia;All ages;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
40 Segovia;All ages;Cohort April 1;Females;Survival in the second trimester;2020QIII;3.483
40 Segovia;All ages;Cohort April 1;Females;Survival in the second trimester;2020QII;""
40 Segovia;All ages;Cohort April 1;Females;Survival in the second trimester;2020QI;""
40 Segovia;All ages;Cohort April 1;Females;Survival in the third trimester;2022QIV;3.423
40 Segovia;All ages;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
40 Segovia;All ages;Cohort April 1;Females;Survival in the third trimester;2022QII;""
40 Segovia;All ages;Cohort April 1;Females;Survival in the third trimester;2022QI;""
40 Segovia;All ages;Cohort April 1;Females;Survival in the third trimester;2021QIV;3.430
40 Segovia;All ages;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
40 Segovia;All ages;Cohort April 1;Females;Survival in the third trimester;2021QII;""
40 Segovia;All ages;Cohort April 1;Females;Survival in the third trimester;2021QI;""
40 Segovia;All ages;Cohort April 1;Females;Survival in the third trimester;2020QIV;3.390
40 Segovia;All ages;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
40 Segovia;All ages;Cohort April 1;Females;Survival in the third trimester;2020QII;""
40 Segovia;All ages;Cohort April 1;Females;Survival in the third trimester;2020QI;""
40 Segovia;All ages;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
40 Segovia;All ages;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
40 Segovia;All ages;Cohort April 1;Females;Survival in the third trimester;2022QII;""
40 Segovia;All ages;Cohort April 1;Females;Survival in the third trimester;2022QI;3.348
40 Segovia;All ages;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
40 Segovia;All ages;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
40 Segovia;All ages;Cohort April 1;Females;Survival in the third trimester;2021QII;""
40 Segovia;All ages;Cohort April 1;Females;Survival in the third trimester;2021QI;3.316
40 Segovia;All ages;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
40 Segovia;All ages;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
40 Segovia;All ages;Cohort April 1;Females;Survival in the third trimester;2020QII;""
40 Segovia;All ages;Cohort April 1;Females;Survival in the third trimester;2020QI;""
40 Segovia;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
40 Segovia;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
40 Segovia;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
40 Segovia;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
40 Segovia;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
40 Segovia;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
40 Segovia;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
40 Segovia;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
40 Segovia;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
40 Segovia;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
40 Segovia;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
40 Segovia;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
40 Segovia;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
40 Segovia;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
40 Segovia;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;96,8
40 Segovia;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
40 Segovia;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
40 Segovia;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
40 Segovia;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;96,89
40 Segovia;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
40 Segovia;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
40 Segovia;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
40 Segovia;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;97,53
40 Segovia;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
40 Segovia;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
40 Segovia;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;93,78
40 Segovia;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
40 Segovia;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
40 Segovia;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
40 Segovia;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;94,13
40 Segovia;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
40 Segovia;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
40 Segovia;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
40 Segovia;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;94,7
40 Segovia;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
40 Segovia;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
40 Segovia;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;90,58
40 Segovia;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
40 Segovia;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
40 Segovia;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
40 Segovia;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;91,88
40 Segovia;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
40 Segovia;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
40 Segovia;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
40 Segovia;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;92,17
40 Segovia;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
40 Segovia;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
40 Segovia;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
40 Segovia;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
40 Segovia;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
40 Segovia;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
40 Segovia;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;89,69
40 Segovia;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
40 Segovia;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
40 Segovia;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
40 Segovia;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;90,16
40 Segovia;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
40 Segovia;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
40 Segovia;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
40 Segovia;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
40 Segovia;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
40 Segovia;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QIII;11.051
40 Segovia;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
40 Segovia;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
40 Segovia;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
40 Segovia;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QIII;11.051
40 Segovia;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
40 Segovia;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
40 Segovia;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
40 Segovia;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QIII;10.908
40 Segovia;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
40 Segovia;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
40 Segovia;All ages;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
40 Segovia;All ages;Cohort July 1;Total;Survival in the first trimester;2022QIII;10.719
40 Segovia;All ages;Cohort July 1;Total;Survival in the first trimester;2022QII;""
40 Segovia;All ages;Cohort July 1;Total;Survival in the first trimester;2022QI;""
40 Segovia;All ages;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
40 Segovia;All ages;Cohort July 1;Total;Survival in the first trimester;2021QIII;10.701
40 Segovia;All ages;Cohort July 1;Total;Survival in the first trimester;2021QII;""
40 Segovia;All ages;Cohort July 1;Total;Survival in the first trimester;2021QI;""
40 Segovia;All ages;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
40 Segovia;All ages;Cohort July 1;Total;Survival in the first trimester;2020QIII;10.598
40 Segovia;All ages;Cohort July 1;Total;Survival in the first trimester;2020QII;""
40 Segovia;All ages;Cohort July 1;Total;Survival in the first trimester;2020QI;""
40 Segovia;All ages;Cohort July 1;Total;Survival in the second trimester;2022QIV;10.341
40 Segovia;All ages;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
40 Segovia;All ages;Cohort July 1;Total;Survival in the second trimester;2022QII;""
40 Segovia;All ages;Cohort July 1;Total;Survival in the second trimester;2022QI;""
40 Segovia;All ages;Cohort July 1;Total;Survival in the second trimester;2021QIV;10.412
40 Segovia;All ages;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
40 Segovia;All ages;Cohort July 1;Total;Survival in the second trimester;2021QII;""
40 Segovia;All ages;Cohort July 1;Total;Survival in the second trimester;2021QI;""
40 Segovia;All ages;Cohort July 1;Total;Survival in the second trimester;2020QIV;10.327
40 Segovia;All ages;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
40 Segovia;All ages;Cohort July 1;Total;Survival in the second trimester;2020QII;""
40 Segovia;All ages;Cohort July 1;Total;Survival in the second trimester;2020QI;""
40 Segovia;All ages;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
40 Segovia;All ages;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
40 Segovia;All ages;Cohort July 1;Total;Survival in the third trimester;2022QII;""
40 Segovia;All ages;Cohort July 1;Total;Survival in the third trimester;2022QI;10.178
40 Segovia;All ages;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
40 Segovia;All ages;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
40 Segovia;All ages;Cohort July 1;Total;Survival in the third trimester;2021QII;""
40 Segovia;All ages;Cohort July 1;Total;Survival in the third trimester;2021QI;10.144
40 Segovia;All ages;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
40 Segovia;All ages;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
40 Segovia;All ages;Cohort July 1;Total;Survival in the third trimester;2020QII;""
40 Segovia;All ages;Cohort July 1;Total;Survival in the third trimester;2020QI;""
40 Segovia;All ages;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
40 Segovia;All ages;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
40 Segovia;All ages;Cohort July 1;Total;Survival in the third trimester;2022QII;9.959
40 Segovia;All ages;Cohort July 1;Total;Survival in the third trimester;2022QI;""
40 Segovia;All ages;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
40 Segovia;All ages;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
40 Segovia;All ages;Cohort July 1;Total;Survival in the third trimester;2021QII;9.957
40 Segovia;All ages;Cohort July 1;Total;Survival in the third trimester;2021QI;""
40 Segovia;All ages;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
40 Segovia;All ages;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
40 Segovia;All ages;Cohort July 1;Total;Survival in the third trimester;2020QII;""
40 Segovia;All ages;Cohort July 1;Total;Survival in the third trimester;2020QI;""
40 Segovia;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
40 Segovia;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
40 Segovia;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
40 Segovia;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
40 Segovia;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
40 Segovia;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
40 Segovia;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
40 Segovia;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
40 Segovia;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
40 Segovia;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
40 Segovia;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
40 Segovia;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
40 Segovia;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
40 Segovia;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;97
40 Segovia;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
40 Segovia;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
40 Segovia;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
40 Segovia;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;96,83
40 Segovia;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
40 Segovia;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
40 Segovia;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
40 Segovia;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;97,16
40 Segovia;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
40 Segovia;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
40 Segovia;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;93,58
40 Segovia;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
40 Segovia;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
40 Segovia;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
40 Segovia;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;94,22
40 Segovia;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
40 Segovia;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
40 Segovia;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
40 Segovia;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;94,67
40 Segovia;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
40 Segovia;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
40 Segovia;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
40 Segovia;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
40 Segovia;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
40 Segovia;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
40 Segovia;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;92,1
40 Segovia;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
40 Segovia;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
40 Segovia;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
40 Segovia;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;93
40 Segovia;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
40 Segovia;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
40 Segovia;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
40 Segovia;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
40 Segovia;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
40 Segovia;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
40 Segovia;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;90,12
40 Segovia;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
40 Segovia;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
40 Segovia;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
40 Segovia;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;91,28
40 Segovia;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
40 Segovia;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
40 Segovia;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
40 Segovia;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
40 Segovia;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
40 Segovia;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
40 Segovia;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QIII;7.261
40 Segovia;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
40 Segovia;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
40 Segovia;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
40 Segovia;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QIII;7.293
40 Segovia;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
40 Segovia;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
40 Segovia;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
40 Segovia;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QIII;7.217
40 Segovia;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
40 Segovia;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
40 Segovia;All ages;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
40 Segovia;All ages;Cohort July 1;Males;Survival in the first trimester;2022QIII;7.070
40 Segovia;All ages;Cohort July 1;Males;Survival in the first trimester;2022QII;""
40 Segovia;All ages;Cohort July 1;Males;Survival in the first trimester;2022QI;""
40 Segovia;All ages;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
40 Segovia;All ages;Cohort July 1;Males;Survival in the first trimester;2021QIII;7.081
40 Segovia;All ages;Cohort July 1;Males;Survival in the first trimester;2021QII;""
40 Segovia;All ages;Cohort July 1;Males;Survival in the first trimester;2021QI;""
40 Segovia;All ages;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
40 Segovia;All ages;Cohort July 1;Males;Survival in the first trimester;2020QIII;7.038
40 Segovia;All ages;Cohort July 1;Males;Survival in the first trimester;2020QII;""
40 Segovia;All ages;Cohort July 1;Males;Survival in the first trimester;2020QI;""
40 Segovia;All ages;Cohort July 1;Males;Survival in the second trimester;2022QIV;6.827
40 Segovia;All ages;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
40 Segovia;All ages;Cohort July 1;Males;Survival in the second trimester;2022QII;""
40 Segovia;All ages;Cohort July 1;Males;Survival in the second trimester;2022QI;""
40 Segovia;All ages;Cohort July 1;Males;Survival in the second trimester;2021QIV;6.888
40 Segovia;All ages;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
40 Segovia;All ages;Cohort July 1;Males;Survival in the second trimester;2021QII;""
40 Segovia;All ages;Cohort July 1;Males;Survival in the second trimester;2021QI;""
40 Segovia;All ages;Cohort July 1;Males;Survival in the second trimester;2020QIV;6.868
40 Segovia;All ages;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
40 Segovia;All ages;Cohort July 1;Males;Survival in the second trimester;2020QII;""
40 Segovia;All ages;Cohort July 1;Males;Survival in the second trimester;2020QI;""
40 Segovia;All ages;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
40 Segovia;All ages;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
40 Segovia;All ages;Cohort July 1;Males;Survival in the third trimester;2022QII;""
40 Segovia;All ages;Cohort July 1;Males;Survival in the third trimester;2022QI;6.741
40 Segovia;All ages;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
40 Segovia;All ages;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
40 Segovia;All ages;Cohort July 1;Males;Survival in the third trimester;2021QII;""
40 Segovia;All ages;Cohort July 1;Males;Survival in the third trimester;2021QI;6.762
40 Segovia;All ages;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
40 Segovia;All ages;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
40 Segovia;All ages;Cohort July 1;Males;Survival in the third trimester;2020QII;""
40 Segovia;All ages;Cohort July 1;Males;Survival in the third trimester;2020QI;""
40 Segovia;All ages;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
40 Segovia;All ages;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
40 Segovia;All ages;Cohort July 1;Males;Survival in the third trimester;2022QII;6.612
40 Segovia;All ages;Cohort July 1;Males;Survival in the third trimester;2022QI;""
40 Segovia;All ages;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
40 Segovia;All ages;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
40 Segovia;All ages;Cohort July 1;Males;Survival in the third trimester;2021QII;6.652
40 Segovia;All ages;Cohort July 1;Males;Survival in the third trimester;2021QI;""
40 Segovia;All ages;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
40 Segovia;All ages;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
40 Segovia;All ages;Cohort July 1;Males;Survival in the third trimester;2020QII;""
40 Segovia;All ages;Cohort July 1;Males;Survival in the third trimester;2020QI;""
40 Segovia;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
40 Segovia;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
40 Segovia;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
40 Segovia;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
40 Segovia;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
40 Segovia;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
40 Segovia;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
40 Segovia;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
40 Segovia;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
40 Segovia;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
40 Segovia;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
40 Segovia;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
40 Segovia;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
40 Segovia;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;97,37
40 Segovia;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
40 Segovia;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
40 Segovia;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
40 Segovia;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;97,09
40 Segovia;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
40 Segovia;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
40 Segovia;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
40 Segovia;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;97,52
40 Segovia;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
40 Segovia;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
40 Segovia;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;94,02
40 Segovia;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
40 Segovia;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
40 Segovia;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
40 Segovia;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;94,45
40 Segovia;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
40 Segovia;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
40 Segovia;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
40 Segovia;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;95,16
40 Segovia;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
40 Segovia;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
40 Segovia;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
40 Segovia;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
40 Segovia;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
40 Segovia;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
40 Segovia;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;92,43
40 Segovia;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
40 Segovia;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
40 Segovia;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
40 Segovia;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;93,7
40 Segovia;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
40 Segovia;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
40 Segovia;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
40 Segovia;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
40 Segovia;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
40 Segovia;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
40 Segovia;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;90,66
40 Segovia;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
40 Segovia;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
40 Segovia;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
40 Segovia;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;92,17
40 Segovia;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
40 Segovia;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
40 Segovia;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
40 Segovia;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
40 Segovia;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
40 Segovia;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
40 Segovia;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QIII;3.790
40 Segovia;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
40 Segovia;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
40 Segovia;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
40 Segovia;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QIII;3.758
40 Segovia;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
40 Segovia;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
40 Segovia;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
40 Segovia;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QIII;3.691
40 Segovia;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
40 Segovia;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
40 Segovia;All ages;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
40 Segovia;All ages;Cohort July 1;Females;Survival in the first trimester;2022QIII;3.649
40 Segovia;All ages;Cohort July 1;Females;Survival in the first trimester;2022QII;""
40 Segovia;All ages;Cohort July 1;Females;Survival in the first trimester;2022QI;""
40 Segovia;All ages;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
40 Segovia;All ages;Cohort July 1;Females;Survival in the first trimester;2021QIII;3.620
40 Segovia;All ages;Cohort July 1;Females;Survival in the first trimester;2021QII;""
40 Segovia;All ages;Cohort July 1;Females;Survival in the first trimester;2021QI;""
40 Segovia;All ages;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
40 Segovia;All ages;Cohort July 1;Females;Survival in the first trimester;2020QIII;3.560
40 Segovia;All ages;Cohort July 1;Females;Survival in the first trimester;2020QII;""
40 Segovia;All ages;Cohort July 1;Females;Survival in the first trimester;2020QI;""
40 Segovia;All ages;Cohort July 1;Females;Survival in the second trimester;2022QIV;3.514
40 Segovia;All ages;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
40 Segovia;All ages;Cohort July 1;Females;Survival in the second trimester;2022QII;""
40 Segovia;All ages;Cohort July 1;Females;Survival in the second trimester;2022QI;""
40 Segovia;All ages;Cohort July 1;Females;Survival in the second trimester;2021QIV;3.524
40 Segovia;All ages;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
40 Segovia;All ages;Cohort July 1;Females;Survival in the second trimester;2021QII;""
40 Segovia;All ages;Cohort July 1;Females;Survival in the second trimester;2021QI;""
40 Segovia;All ages;Cohort July 1;Females;Survival in the second trimester;2020QIV;3.459
40 Segovia;All ages;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
40 Segovia;All ages;Cohort July 1;Females;Survival in the second trimester;2020QII;""
40 Segovia;All ages;Cohort July 1;Females;Survival in the second trimester;2020QI;""
40 Segovia;All ages;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
40 Segovia;All ages;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
40 Segovia;All ages;Cohort July 1;Females;Survival in the third trimester;2022QII;""
40 Segovia;All ages;Cohort July 1;Females;Survival in the third trimester;2022QI;3.437
40 Segovia;All ages;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
40 Segovia;All ages;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
40 Segovia;All ages;Cohort July 1;Females;Survival in the third trimester;2021QII;""
40 Segovia;All ages;Cohort July 1;Females;Survival in the third trimester;2021QI;3.382
40 Segovia;All ages;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
40 Segovia;All ages;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
40 Segovia;All ages;Cohort July 1;Females;Survival in the third trimester;2020QII;""
40 Segovia;All ages;Cohort July 1;Females;Survival in the third trimester;2020QI;""
40 Segovia;All ages;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
40 Segovia;All ages;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
40 Segovia;All ages;Cohort July 1;Females;Survival in the third trimester;2022QII;3.347
40 Segovia;All ages;Cohort July 1;Females;Survival in the third trimester;2022QI;""
40 Segovia;All ages;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
40 Segovia;All ages;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
40 Segovia;All ages;Cohort July 1;Females;Survival in the third trimester;2021QII;3.305
40 Segovia;All ages;Cohort July 1;Females;Survival in the third trimester;2021QI;""
40 Segovia;All ages;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
40 Segovia;All ages;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
40 Segovia;All ages;Cohort July 1;Females;Survival in the third trimester;2020QII;""
40 Segovia;All ages;Cohort July 1;Females;Survival in the third trimester;2020QI;""
40 Segovia;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
40 Segovia;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
40 Segovia;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
40 Segovia;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
40 Segovia;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
40 Segovia;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
40 Segovia;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
40 Segovia;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
40 Segovia;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
40 Segovia;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
40 Segovia;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
40 Segovia;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
40 Segovia;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
40 Segovia;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;96,28
40 Segovia;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
40 Segovia;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
40 Segovia;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
40 Segovia;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;96,33
40 Segovia;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
40 Segovia;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
40 Segovia;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
40 Segovia;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;96,45
40 Segovia;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
40 Segovia;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
40 Segovia;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;92,72
40 Segovia;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
40 Segovia;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
40 Segovia;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
40 Segovia;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;93,77
40 Segovia;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
40 Segovia;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
40 Segovia;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
40 Segovia;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;93,71
40 Segovia;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
40 Segovia;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
40 Segovia;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
40 Segovia;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
40 Segovia;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
40 Segovia;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
40 Segovia;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;91,46
40 Segovia;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
40 Segovia;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
40 Segovia;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
40 Segovia;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;91,63
40 Segovia;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
40 Segovia;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
40 Segovia;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
40 Segovia;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
40 Segovia;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
40 Segovia;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
40 Segovia;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;89,06
40 Segovia;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
40 Segovia;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
40 Segovia;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
40 Segovia;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;89,54
40 Segovia;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
40 Segovia;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
40 Segovia;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
40 Segovia;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
40 Segovia;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
40 Segovia;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QIV;10.964
40 Segovia;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
40 Segovia;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
40 Segovia;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
40 Segovia;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QIV;10.990
40 Segovia;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
40 Segovia;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
40 Segovia;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
40 Segovia;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QIV;10.937
40 Segovia;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
40 Segovia;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
40 Segovia;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
40 Segovia;All ages;Cohort October 1;Total;Survival in the first trimester;2022QIV;10.550
40 Segovia;All ages;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
40 Segovia;All ages;Cohort October 1;Total;Survival in the first trimester;2022QII;""
40 Segovia;All ages;Cohort October 1;Total;Survival in the first trimester;2022QI;""
40 Segovia;All ages;Cohort October 1;Total;Survival in the first trimester;2021QIV;10.670
40 Segovia;All ages;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
40 Segovia;All ages;Cohort October 1;Total;Survival in the first trimester;2021QII;""
40 Segovia;All ages;Cohort October 1;Total;Survival in the first trimester;2021QI;""
40 Segovia;All ages;Cohort October 1;Total;Survival in the first trimester;2020QIV;10.619
40 Segovia;All ages;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
40 Segovia;All ages;Cohort October 1;Total;Survival in the first trimester;2020QII;""
40 Segovia;All ages;Cohort October 1;Total;Survival in the first trimester;2020QI;""
40 Segovia;All ages;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
40 Segovia;All ages;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
40 Segovia;All ages;Cohort October 1;Total;Survival in the second trimester;2022QII;""
40 Segovia;All ages;Cohort October 1;Total;Survival in the second trimester;2022QI;10.412
40 Segovia;All ages;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
40 Segovia;All ages;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
40 Segovia;All ages;Cohort October 1;Total;Survival in the second trimester;2021QII;""
40 Segovia;All ages;Cohort October 1;Total;Survival in the second trimester;2021QI;10.411
40 Segovia;All ages;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
40 Segovia;All ages;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
40 Segovia;All ages;Cohort October 1;Total;Survival in the second trimester;2020QII;""
40 Segovia;All ages;Cohort October 1;Total;Survival in the second trimester;2020QI;""
40 Segovia;All ages;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
40 Segovia;All ages;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
40 Segovia;All ages;Cohort October 1;Total;Survival in the third trimester;2022QII;10.170
40 Segovia;All ages;Cohort October 1;Total;Survival in the third trimester;2022QI;""
40 Segovia;All ages;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
40 Segovia;All ages;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
40 Segovia;All ages;Cohort October 1;Total;Survival in the third trimester;2021QII;10.208
40 Segovia;All ages;Cohort October 1;Total;Survival in the third trimester;2021QI;""
40 Segovia;All ages;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
40 Segovia;All ages;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
40 Segovia;All ages;Cohort October 1;Total;Survival in the third trimester;2020QII;""
40 Segovia;All ages;Cohort October 1;Total;Survival in the third trimester;2020QI;""
40 Segovia;All ages;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
40 Segovia;All ages;Cohort October 1;Total;Survival in the third trimester;2022QIII;9.973
40 Segovia;All ages;Cohort October 1;Total;Survival in the third trimester;2022QII;""
40 Segovia;All ages;Cohort October 1;Total;Survival in the third trimester;2022QI;""
40 Segovia;All ages;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
40 Segovia;All ages;Cohort October 1;Total;Survival in the third trimester;2021QIII;9.978
40 Segovia;All ages;Cohort October 1;Total;Survival in the third trimester;2021QII;""
40 Segovia;All ages;Cohort October 1;Total;Survival in the third trimester;2021QI;""
40 Segovia;All ages;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
40 Segovia;All ages;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
40 Segovia;All ages;Cohort October 1;Total;Survival in the third trimester;2020QII;""
40 Segovia;All ages;Cohort October 1;Total;Survival in the third trimester;2020QI;""
40 Segovia;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
40 Segovia;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
40 Segovia;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
40 Segovia;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
40 Segovia;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
40 Segovia;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
40 Segovia;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
40 Segovia;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
40 Segovia;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
40 Segovia;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
40 Segovia;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
40 Segovia;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
40 Segovia;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;96,22
40 Segovia;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
40 Segovia;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
40 Segovia;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
40 Segovia;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;97,09
40 Segovia;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
40 Segovia;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
40 Segovia;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
40 Segovia;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;97,09
40 Segovia;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
40 Segovia;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
40 Segovia;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
40 Segovia;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
40 Segovia;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
40 Segovia;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
40 Segovia;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;94,74
40 Segovia;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
40 Segovia;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
40 Segovia;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
40 Segovia;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;95,19
40 Segovia;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
40 Segovia;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
40 Segovia;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
40 Segovia;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
40 Segovia;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
40 Segovia;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
40 Segovia;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;92,54
40 Segovia;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
40 Segovia;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
40 Segovia;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
40 Segovia;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;93,33
40 Segovia;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
40 Segovia;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
40 Segovia;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
40 Segovia;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
40 Segovia;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
40 Segovia;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
40 Segovia;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;90,75
40 Segovia;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
40 Segovia;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
40 Segovia;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
40 Segovia;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;91,23
40 Segovia;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
40 Segovia;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
40 Segovia;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
40 Segovia;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
40 Segovia;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
40 Segovia;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
40 Segovia;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QIV;7.209
40 Segovia;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
40 Segovia;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
40 Segovia;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
40 Segovia;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QIV;7.242
40 Segovia;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
40 Segovia;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
40 Segovia;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
40 Segovia;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QIV;7.244
40 Segovia;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
40 Segovia;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
40 Segovia;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
40 Segovia;All ages;Cohort October 1;Males;Survival in the first trimester;2022QIV;6.944
40 Segovia;All ages;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
40 Segovia;All ages;Cohort October 1;Males;Survival in the first trimester;2022QII;""
40 Segovia;All ages;Cohort October 1;Males;Survival in the first trimester;2022QI;""
40 Segovia;All ages;Cohort October 1;Males;Survival in the first trimester;2021QIV;7.032
40 Segovia;All ages;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
40 Segovia;All ages;Cohort October 1;Males;Survival in the first trimester;2021QII;""
40 Segovia;All ages;Cohort October 1;Males;Survival in the first trimester;2021QI;""
40 Segovia;All ages;Cohort October 1;Males;Survival in the first trimester;2020QIV;7.042
40 Segovia;All ages;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
40 Segovia;All ages;Cohort October 1;Males;Survival in the first trimester;2020QII;""
40 Segovia;All ages;Cohort October 1;Males;Survival in the first trimester;2020QI;""
40 Segovia;All ages;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
40 Segovia;All ages;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
40 Segovia;All ages;Cohort October 1;Males;Survival in the second trimester;2022QII;""
40 Segovia;All ages;Cohort October 1;Males;Survival in the second trimester;2022QI;6.870
40 Segovia;All ages;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
40 Segovia;All ages;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
40 Segovia;All ages;Cohort October 1;Males;Survival in the second trimester;2021QII;""
40 Segovia;All ages;Cohort October 1;Males;Survival in the second trimester;2021QI;6.918
40 Segovia;All ages;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
40 Segovia;All ages;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
40 Segovia;All ages;Cohort October 1;Males;Survival in the second trimester;2020QII;""
40 Segovia;All ages;Cohort October 1;Males;Survival in the second trimester;2020QI;""
40 Segovia;All ages;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
40 Segovia;All ages;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
40 Segovia;All ages;Cohort October 1;Males;Survival in the third trimester;2022QII;6.728
40 Segovia;All ages;Cohort October 1;Males;Survival in the third trimester;2022QI;""
40 Segovia;All ages;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
40 Segovia;All ages;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
40 Segovia;All ages;Cohort October 1;Males;Survival in the third trimester;2021QII;6.801
40 Segovia;All ages;Cohort October 1;Males;Survival in the third trimester;2021QI;""
40 Segovia;All ages;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
40 Segovia;All ages;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
40 Segovia;All ages;Cohort October 1;Males;Survival in the third trimester;2020QII;""
40 Segovia;All ages;Cohort October 1;Males;Survival in the third trimester;2020QI;""
40 Segovia;All ages;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
40 Segovia;All ages;Cohort October 1;Males;Survival in the third trimester;2022QIII;6.616
40 Segovia;All ages;Cohort October 1;Males;Survival in the third trimester;2022QII;""
40 Segovia;All ages;Cohort October 1;Males;Survival in the third trimester;2022QI;""
40 Segovia;All ages;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
40 Segovia;All ages;Cohort October 1;Males;Survival in the third trimester;2021QIII;6.664
40 Segovia;All ages;Cohort October 1;Males;Survival in the third trimester;2021QII;""
40 Segovia;All ages;Cohort October 1;Males;Survival in the third trimester;2021QI;""
40 Segovia;All ages;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
40 Segovia;All ages;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
40 Segovia;All ages;Cohort October 1;Males;Survival in the third trimester;2020QII;""
40 Segovia;All ages;Cohort October 1;Males;Survival in the third trimester;2020QI;""
40 Segovia;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
40 Segovia;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
40 Segovia;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
40 Segovia;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
40 Segovia;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
40 Segovia;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
40 Segovia;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
40 Segovia;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
40 Segovia;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
40 Segovia;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
40 Segovia;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
40 Segovia;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
40 Segovia;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;96,32
40 Segovia;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
40 Segovia;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
40 Segovia;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
40 Segovia;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;97,1
40 Segovia;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
40 Segovia;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
40 Segovia;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
40 Segovia;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;97,21
40 Segovia;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
40 Segovia;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
40 Segovia;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
40 Segovia;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
40 Segovia;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
40 Segovia;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
40 Segovia;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;94,86
40 Segovia;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
40 Segovia;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
40 Segovia;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
40 Segovia;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;95,5
40 Segovia;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
40 Segovia;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
40 Segovia;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
40 Segovia;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
40 Segovia;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
40 Segovia;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
40 Segovia;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;92,9
40 Segovia;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
40 Segovia;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
40 Segovia;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
40 Segovia;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;93,88
40 Segovia;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
40 Segovia;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
40 Segovia;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
40 Segovia;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
40 Segovia;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
40 Segovia;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
40 Segovia;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;91,36
40 Segovia;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
40 Segovia;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
40 Segovia;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
40 Segovia;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;91,99
40 Segovia;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
40 Segovia;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
40 Segovia;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
40 Segovia;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
40 Segovia;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
40 Segovia;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
40 Segovia;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QIV;3.755
40 Segovia;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
40 Segovia;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
40 Segovia;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
40 Segovia;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QIV;3.748
40 Segovia;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
40 Segovia;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
40 Segovia;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
40 Segovia;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QIV;3.693
40 Segovia;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
40 Segovia;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
40 Segovia;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
40 Segovia;All ages;Cohort October 1;Females;Survival in the first trimester;2022QIV;3.606
40 Segovia;All ages;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
40 Segovia;All ages;Cohort October 1;Females;Survival in the first trimester;2022QII;""
40 Segovia;All ages;Cohort October 1;Females;Survival in the first trimester;2022QI;""
40 Segovia;All ages;Cohort October 1;Females;Survival in the first trimester;2021QIV;3.638
40 Segovia;All ages;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
40 Segovia;All ages;Cohort October 1;Females;Survival in the first trimester;2021QII;""
40 Segovia;All ages;Cohort October 1;Females;Survival in the first trimester;2021QI;""
40 Segovia;All ages;Cohort October 1;Females;Survival in the first trimester;2020QIV;3.577
40 Segovia;All ages;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
40 Segovia;All ages;Cohort October 1;Females;Survival in the first trimester;2020QII;""
40 Segovia;All ages;Cohort October 1;Females;Survival in the first trimester;2020QI;""
40 Segovia;All ages;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
40 Segovia;All ages;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
40 Segovia;All ages;Cohort October 1;Females;Survival in the second trimester;2022QII;""
40 Segovia;All ages;Cohort October 1;Females;Survival in the second trimester;2022QI;3.542
40 Segovia;All ages;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
40 Segovia;All ages;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
40 Segovia;All ages;Cohort October 1;Females;Survival in the second trimester;2021QII;""
40 Segovia;All ages;Cohort October 1;Females;Survival in the second trimester;2021QI;3.493
40 Segovia;All ages;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
40 Segovia;All ages;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
40 Segovia;All ages;Cohort October 1;Females;Survival in the second trimester;2020QII;""
40 Segovia;All ages;Cohort October 1;Females;Survival in the second trimester;2020QI;""
40 Segovia;All ages;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
40 Segovia;All ages;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
40 Segovia;All ages;Cohort October 1;Females;Survival in the third trimester;2022QII;3.442
40 Segovia;All ages;Cohort October 1;Females;Survival in the third trimester;2022QI;""
40 Segovia;All ages;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
40 Segovia;All ages;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
40 Segovia;All ages;Cohort October 1;Females;Survival in the third trimester;2021QII;3.407
40 Segovia;All ages;Cohort October 1;Females;Survival in the third trimester;2021QI;""
40 Segovia;All ages;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
40 Segovia;All ages;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
40 Segovia;All ages;Cohort October 1;Females;Survival in the third trimester;2020QII;""
40 Segovia;All ages;Cohort October 1;Females;Survival in the third trimester;2020QI;""
40 Segovia;All ages;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
40 Segovia;All ages;Cohort October 1;Females;Survival in the third trimester;2022QIII;3.357
40 Segovia;All ages;Cohort October 1;Females;Survival in the third trimester;2022QII;""
40 Segovia;All ages;Cohort October 1;Females;Survival in the third trimester;2022QI;""
40 Segovia;All ages;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
40 Segovia;All ages;Cohort October 1;Females;Survival in the third trimester;2021QIII;3.314
40 Segovia;All ages;Cohort October 1;Females;Survival in the third trimester;2021QII;""
40 Segovia;All ages;Cohort October 1;Females;Survival in the third trimester;2021QI;""
40 Segovia;All ages;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
40 Segovia;All ages;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
40 Segovia;All ages;Cohort October 1;Females;Survival in the third trimester;2020QII;""
40 Segovia;All ages;Cohort October 1;Females;Survival in the third trimester;2020QI;""
40 Segovia;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
40 Segovia;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
40 Segovia;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
40 Segovia;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
40 Segovia;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
40 Segovia;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
40 Segovia;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
40 Segovia;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
40 Segovia;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
40 Segovia;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
40 Segovia;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
40 Segovia;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
40 Segovia;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;96,03
40 Segovia;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
40 Segovia;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
40 Segovia;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
40 Segovia;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;97,07
40 Segovia;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
40 Segovia;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
40 Segovia;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
40 Segovia;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;96,86
40 Segovia;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
40 Segovia;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
40 Segovia;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
40 Segovia;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
40 Segovia;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
40 Segovia;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
40 Segovia;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;94,5
40 Segovia;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
40 Segovia;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
40 Segovia;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
40 Segovia;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;94,58
40 Segovia;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
40 Segovia;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
40 Segovia;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
40 Segovia;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
40 Segovia;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
40 Segovia;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
40 Segovia;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;91,84
40 Segovia;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
40 Segovia;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
40 Segovia;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
40 Segovia;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;92,26
40 Segovia;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
40 Segovia;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
40 Segovia;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
40 Segovia;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
40 Segovia;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
40 Segovia;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
40 Segovia;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;89,57
40 Segovia;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
40 Segovia;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
40 Segovia;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
40 Segovia;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;89,74
40 Segovia;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
40 Segovia;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
40 Segovia;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
40 Segovia;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
40 Segovia;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
40 Segovia;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
40 Segovia;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
40 Segovia;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
40 Segovia;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
40 Segovia;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QI;566
40 Segovia;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
40 Segovia;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
40 Segovia;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
40 Segovia;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QI;541
40 Segovia;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
40 Segovia;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
40 Segovia;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
40 Segovia;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QI;436
40 Segovia;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
40 Segovia;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
40 Segovia;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2022QII;""
40 Segovia;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2022QI;525
40 Segovia;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
40 Segovia;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
40 Segovia;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2021QII;""
40 Segovia;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2021QI;515
40 Segovia;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
40 Segovia;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
40 Segovia;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2020QII;""
40 Segovia;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2020QI;389
40 Segovia;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
40 Segovia;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
40 Segovia;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2022QII;493
40 Segovia;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2022QI;""
40 Segovia;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
40 Segovia;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
40 Segovia;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2021QII;489
40 Segovia;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2021QI;""
40 Segovia;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
40 Segovia;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
40 Segovia;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2020QII;374
40 Segovia;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2020QI;""
40 Segovia;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
40 Segovia;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QIII;468
40 Segovia;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QII;""
40 Segovia;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QI;""
40 Segovia;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
40 Segovia;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QIII;457
40 Segovia;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QII;""
40 Segovia;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QI;""
40 Segovia;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
40 Segovia;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QIII;351
40 Segovia;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QII;""
40 Segovia;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QI;""
40 Segovia;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QIV;440
40 Segovia;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
40 Segovia;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QII;""
40 Segovia;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QI;""
40 Segovia;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QIV;426
40 Segovia;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
40 Segovia;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QII;""
40 Segovia;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QI;""
40 Segovia;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QIV;339
40 Segovia;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
40 Segovia;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QII;""
40 Segovia;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QI;""
40 Segovia;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
40 Segovia;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
40 Segovia;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
40 Segovia;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
40 Segovia;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
40 Segovia;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
40 Segovia;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
40 Segovia;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
40 Segovia;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
40 Segovia;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
40 Segovia;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
40 Segovia;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
40 Segovia;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
40 Segovia;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
40 Segovia;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
40 Segovia;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;92,76
40 Segovia;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
40 Segovia;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
40 Segovia;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
40 Segovia;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;95,19
40 Segovia;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
40 Segovia;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
40 Segovia;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
40 Segovia;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;89,22
40 Segovia;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
40 Segovia;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
40 Segovia;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;87,1
40 Segovia;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
40 Segovia;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
40 Segovia;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
40 Segovia;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;90,39
40 Segovia;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
40 Segovia;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
40 Segovia;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
40 Segovia;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;85,78
40 Segovia;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
40 Segovia;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
40 Segovia;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;82,69
40 Segovia;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
40 Segovia;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
40 Segovia;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
40 Segovia;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;84,47
40 Segovia;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
40 Segovia;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
40 Segovia;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
40 Segovia;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;80,5
40 Segovia;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
40 Segovia;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
40 Segovia;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;77,74
40 Segovia;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
40 Segovia;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
40 Segovia;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
40 Segovia;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;78,74
40 Segovia;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
40 Segovia;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
40 Segovia;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
40 Segovia;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;77,75
40 Segovia;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
40 Segovia;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
40 Segovia;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
40 Segovia;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
40 Segovia;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
40 Segovia;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
40 Segovia;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QI;371
40 Segovia;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
40 Segovia;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
40 Segovia;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
40 Segovia;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QI;351
40 Segovia;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
40 Segovia;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
40 Segovia;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
40 Segovia;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QI;282
40 Segovia;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
40 Segovia;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
40 Segovia;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2022QII;""
40 Segovia;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2022QI;341
40 Segovia;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
40 Segovia;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
40 Segovia;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2021QII;""
40 Segovia;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2021QI;337
40 Segovia;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
40 Segovia;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
40 Segovia;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2020QII;""
40 Segovia;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2020QI;258
40 Segovia;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
40 Segovia;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
40 Segovia;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2022QII;321
40 Segovia;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2022QI;""
40 Segovia;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
40 Segovia;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
40 Segovia;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2021QII;322
40 Segovia;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2021QI;""
40 Segovia;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
40 Segovia;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
40 Segovia;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2020QII;247
40 Segovia;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2020QI;""
40 Segovia;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
40 Segovia;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QIII;303
40 Segovia;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QII;""
40 Segovia;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QI;""
40 Segovia;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
40 Segovia;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QIII;303
40 Segovia;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QII;""
40 Segovia;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QI;""
40 Segovia;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
40 Segovia;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QIII;236
40 Segovia;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QII;""
40 Segovia;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QI;""
40 Segovia;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QIV;285
40 Segovia;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
40 Segovia;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QII;""
40 Segovia;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QI;""
40 Segovia;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QIV;284
40 Segovia;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
40 Segovia;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QII;""
40 Segovia;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QI;""
40 Segovia;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QIV;229
40 Segovia;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
40 Segovia;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QII;""
40 Segovia;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QI;""
40 Segovia;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
40 Segovia;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
40 Segovia;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
40 Segovia;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
40 Segovia;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
40 Segovia;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
40 Segovia;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
40 Segovia;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
40 Segovia;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
40 Segovia;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
40 Segovia;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
40 Segovia;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
40 Segovia;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
40 Segovia;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
40 Segovia;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
40 Segovia;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;91,91
40 Segovia;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
40 Segovia;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
40 Segovia;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
40 Segovia;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;96,01
40 Segovia;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
40 Segovia;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
40 Segovia;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
40 Segovia;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;91,49
40 Segovia;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
40 Segovia;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
40 Segovia;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;86,52
40 Segovia;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
40 Segovia;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
40 Segovia;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
40 Segovia;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;91,74
40 Segovia;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
40 Segovia;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
40 Segovia;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
40 Segovia;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;87,59
40 Segovia;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
40 Segovia;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
40 Segovia;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;81,67
40 Segovia;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
40 Segovia;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
40 Segovia;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
40 Segovia;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;86,32
40 Segovia;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
40 Segovia;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
40 Segovia;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
40 Segovia;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;83,69
40 Segovia;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
40 Segovia;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
40 Segovia;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;76,82
40 Segovia;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
40 Segovia;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
40 Segovia;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
40 Segovia;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;80,91
40 Segovia;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
40 Segovia;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
40 Segovia;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
40 Segovia;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;81,21
40 Segovia;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
40 Segovia;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
40 Segovia;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
40 Segovia;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
40 Segovia;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
40 Segovia;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
40 Segovia;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QI;195
40 Segovia;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
40 Segovia;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
40 Segovia;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
40 Segovia;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QI;190
40 Segovia;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
40 Segovia;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
40 Segovia;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
40 Segovia;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QI;154
40 Segovia;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
40 Segovia;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
40 Segovia;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2022QII;""
40 Segovia;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2022QI;184
40 Segovia;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
40 Segovia;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
40 Segovia;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2021QII;""
40 Segovia;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2021QI;178
40 Segovia;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
40 Segovia;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
40 Segovia;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2020QII;""
40 Segovia;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2020QI;131
40 Segovia;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
40 Segovia;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
40 Segovia;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2022QII;172
40 Segovia;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2022QI;""
40 Segovia;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
40 Segovia;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
40 Segovia;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2021QII;167
40 Segovia;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2021QI;""
40 Segovia;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
40 Segovia;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
40 Segovia;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2020QII;127
40 Segovia;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2020QI;""
40 Segovia;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
40 Segovia;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QIII;165
40 Segovia;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QII;""
40 Segovia;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QI;""
40 Segovia;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
40 Segovia;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QIII;154
40 Segovia;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QII;""
40 Segovia;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QI;""
40 Segovia;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
40 Segovia;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QIII;115
40 Segovia;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QII;""
40 Segovia;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QI;""
40 Segovia;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QIV;155
40 Segovia;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
40 Segovia;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QII;""
40 Segovia;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QI;""
40 Segovia;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QIV;142
40 Segovia;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
40 Segovia;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QII;""
40 Segovia;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QI;""
40 Segovia;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QIV;110
40 Segovia;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
40 Segovia;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QII;""
40 Segovia;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QI;""
40 Segovia;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
40 Segovia;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
40 Segovia;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
40 Segovia;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
40 Segovia;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
40 Segovia;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
40 Segovia;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
40 Segovia;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
40 Segovia;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
40 Segovia;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
40 Segovia;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
40 Segovia;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
40 Segovia;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
40 Segovia;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
40 Segovia;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
40 Segovia;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;94,36
40 Segovia;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
40 Segovia;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
40 Segovia;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
40 Segovia;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;93,68
40 Segovia;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
40 Segovia;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
40 Segovia;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
40 Segovia;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;85,06
40 Segovia;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
40 Segovia;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
40 Segovia;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;88,21
40 Segovia;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
40 Segovia;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
40 Segovia;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
40 Segovia;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;87,89
40 Segovia;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
40 Segovia;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
40 Segovia;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
40 Segovia;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;82,47
40 Segovia;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
40 Segovia;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
40 Segovia;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;84,62
40 Segovia;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
40 Segovia;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
40 Segovia;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
40 Segovia;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;81,05
40 Segovia;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
40 Segovia;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
40 Segovia;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
40 Segovia;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;74,68
40 Segovia;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
40 Segovia;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
40 Segovia;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;79,49
40 Segovia;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
40 Segovia;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
40 Segovia;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
40 Segovia;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;74,74
40 Segovia;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
40 Segovia;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
40 Segovia;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
40 Segovia;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;71,43
40 Segovia;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
40 Segovia;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
40 Segovia;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
40 Segovia;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
40 Segovia;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
40 Segovia;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QII;488
40 Segovia;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
40 Segovia;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
40 Segovia;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
40 Segovia;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QII;486
40 Segovia;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
40 Segovia;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
40 Segovia;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
40 Segovia;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QII;440
40 Segovia;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
40 Segovia;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
40 Segovia;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
40 Segovia;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2022QII;453
40 Segovia;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2022QI;""
40 Segovia;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
40 Segovia;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
40 Segovia;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2021QII;460
40 Segovia;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2021QI;""
40 Segovia;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
40 Segovia;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
40 Segovia;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2020QII;421
40 Segovia;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2020QI;""
40 Segovia;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
40 Segovia;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2022QIII;425
40 Segovia;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2022QII;""
40 Segovia;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2022QI;""
40 Segovia;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
40 Segovia;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2021QIII;430
40 Segovia;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2021QII;""
40 Segovia;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2021QI;""
40 Segovia;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
40 Segovia;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2020QIII;394
40 Segovia;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2020QII;""
40 Segovia;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2020QI;""
40 Segovia;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QIV;402
40 Segovia;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
40 Segovia;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QII;""
40 Segovia;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QI;""
40 Segovia;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QIV;398
40 Segovia;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
40 Segovia;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QII;""
40 Segovia;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QI;""
40 Segovia;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QIV;378
40 Segovia;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
40 Segovia;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QII;""
40 Segovia;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QI;""
40 Segovia;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
40 Segovia;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
40 Segovia;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QII;""
40 Segovia;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QI;380
40 Segovia;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
40 Segovia;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
40 Segovia;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QII;""
40 Segovia;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QI;365
40 Segovia;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
40 Segovia;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
40 Segovia;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QII;""
40 Segovia;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QI;""
40 Segovia;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
40 Segovia;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
40 Segovia;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
40 Segovia;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
40 Segovia;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
40 Segovia;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
40 Segovia;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
40 Segovia;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
40 Segovia;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
40 Segovia;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
40 Segovia;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
40 Segovia;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
40 Segovia;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
40 Segovia;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
40 Segovia;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;92,83
40 Segovia;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
40 Segovia;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
40 Segovia;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
40 Segovia;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;94,65
40 Segovia;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
40 Segovia;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
40 Segovia;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
40 Segovia;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;95,68
40 Segovia;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
40 Segovia;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
40 Segovia;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;87,09
40 Segovia;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
40 Segovia;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
40 Segovia;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
40 Segovia;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;88,48
40 Segovia;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
40 Segovia;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
40 Segovia;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
40 Segovia;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;89,55
40 Segovia;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
40 Segovia;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
40 Segovia;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;82,38
40 Segovia;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
40 Segovia;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
40 Segovia;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
40 Segovia;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;81,89
40 Segovia;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
40 Segovia;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
40 Segovia;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
40 Segovia;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;85,91
40 Segovia;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
40 Segovia;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
40 Segovia;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
40 Segovia;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
40 Segovia;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
40 Segovia;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
40 Segovia;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;78,19
40 Segovia;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
40 Segovia;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
40 Segovia;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
40 Segovia;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;82,95
40 Segovia;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
40 Segovia;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
40 Segovia;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
40 Segovia;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
40 Segovia;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
40 Segovia;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
40 Segovia;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QII;318
40 Segovia;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
40 Segovia;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
40 Segovia;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
40 Segovia;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QII;315
40 Segovia;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
40 Segovia;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
40 Segovia;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
40 Segovia;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QII;287
40 Segovia;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
40 Segovia;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
40 Segovia;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
40 Segovia;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2022QII;295
40 Segovia;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2022QI;""
40 Segovia;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
40 Segovia;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
40 Segovia;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2021QII;299
40 Segovia;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2021QI;""
40 Segovia;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
40 Segovia;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
40 Segovia;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2020QII;274
40 Segovia;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2020QI;""
40 Segovia;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
40 Segovia;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2022QIII;277
40 Segovia;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2022QII;""
40 Segovia;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2022QI;""
40 Segovia;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
40 Segovia;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2021QIII;284
40 Segovia;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2021QII;""
40 Segovia;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2021QI;""
40 Segovia;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
40 Segovia;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2020QIII;262
40 Segovia;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2020QII;""
40 Segovia;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2020QI;""
40 Segovia;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QIV;263
40 Segovia;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
40 Segovia;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QII;""
40 Segovia;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QI;""
40 Segovia;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QIV;264
40 Segovia;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
40 Segovia;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QII;""
40 Segovia;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QI;""
40 Segovia;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QIV;255
40 Segovia;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
40 Segovia;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QII;""
40 Segovia;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QI;""
40 Segovia;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
40 Segovia;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
40 Segovia;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QII;""
40 Segovia;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QI;251
40 Segovia;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
40 Segovia;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
40 Segovia;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QII;""
40 Segovia;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QI;248
40 Segovia;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
40 Segovia;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
40 Segovia;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QII;""
40 Segovia;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QI;""
40 Segovia;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
40 Segovia;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
40 Segovia;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
40 Segovia;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
40 Segovia;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
40 Segovia;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
40 Segovia;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
40 Segovia;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
40 Segovia;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
40 Segovia;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
40 Segovia;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
40 Segovia;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
40 Segovia;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
40 Segovia;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
40 Segovia;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;92,77
40 Segovia;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
40 Segovia;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
40 Segovia;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
40 Segovia;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;94,92
40 Segovia;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
40 Segovia;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
40 Segovia;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
40 Segovia;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;95,47
40 Segovia;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
40 Segovia;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
40 Segovia;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;87,11
40 Segovia;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
40 Segovia;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
40 Segovia;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
40 Segovia;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;90,16
40 Segovia;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
40 Segovia;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
40 Segovia;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
40 Segovia;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;91,29
40 Segovia;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
40 Segovia;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
40 Segovia;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;82,7
40 Segovia;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
40 Segovia;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
40 Segovia;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
40 Segovia;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;83,81
40 Segovia;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
40 Segovia;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
40 Segovia;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
40 Segovia;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;88,85
40 Segovia;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
40 Segovia;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
40 Segovia;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
40 Segovia;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
40 Segovia;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
40 Segovia;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
40 Segovia;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;79,68
40 Segovia;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
40 Segovia;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
40 Segovia;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
40 Segovia;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;86,41
40 Segovia;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
40 Segovia;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
40 Segovia;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
40 Segovia;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
40 Segovia;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
40 Segovia;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
40 Segovia;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QII;170
40 Segovia;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
40 Segovia;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
40 Segovia;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
40 Segovia;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QII;171
40 Segovia;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
40 Segovia;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
40 Segovia;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
40 Segovia;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QII;153
40 Segovia;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
40 Segovia;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
40 Segovia;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
40 Segovia;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2022QII;158
40 Segovia;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2022QI;""
40 Segovia;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
40 Segovia;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
40 Segovia;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2021QII;161
40 Segovia;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2021QI;""
40 Segovia;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
40 Segovia;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
40 Segovia;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2020QII;147
40 Segovia;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2020QI;""
40 Segovia;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
40 Segovia;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2022QIII;148
40 Segovia;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2022QII;""
40 Segovia;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2022QI;""
40 Segovia;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
40 Segovia;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2021QIII;146
40 Segovia;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2021QII;""
40 Segovia;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2021QI;""
40 Segovia;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
40 Segovia;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2020QIII;132
40 Segovia;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2020QII;""
40 Segovia;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2020QI;""
40 Segovia;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QIV;139
40 Segovia;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
40 Segovia;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QII;""
40 Segovia;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QI;""
40 Segovia;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QIV;134
40 Segovia;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
40 Segovia;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QII;""
40 Segovia;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QI;""
40 Segovia;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QIV;123
40 Segovia;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
40 Segovia;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QII;""
40 Segovia;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QI;""
40 Segovia;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
40 Segovia;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
40 Segovia;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QII;""
40 Segovia;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QI;129
40 Segovia;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
40 Segovia;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
40 Segovia;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QII;""
40 Segovia;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QI;117
40 Segovia;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
40 Segovia;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
40 Segovia;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QII;""
40 Segovia;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QI;""
40 Segovia;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
40 Segovia;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
40 Segovia;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
40 Segovia;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
40 Segovia;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
40 Segovia;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
40 Segovia;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
40 Segovia;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
40 Segovia;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
40 Segovia;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
40 Segovia;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
40 Segovia;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
40 Segovia;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
40 Segovia;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
40 Segovia;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;92,94
40 Segovia;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
40 Segovia;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
40 Segovia;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
40 Segovia;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;94,15
40 Segovia;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
40 Segovia;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
40 Segovia;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
40 Segovia;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;96,08
40 Segovia;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
40 Segovia;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
40 Segovia;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;87,06
40 Segovia;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
40 Segovia;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
40 Segovia;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
40 Segovia;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;85,38
40 Segovia;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
40 Segovia;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
40 Segovia;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
40 Segovia;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;86,27
40 Segovia;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
40 Segovia;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
40 Segovia;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;81,76
40 Segovia;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
40 Segovia;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
40 Segovia;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
40 Segovia;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;78,36
40 Segovia;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
40 Segovia;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
40 Segovia;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
40 Segovia;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;80,39
40 Segovia;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
40 Segovia;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
40 Segovia;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
40 Segovia;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
40 Segovia;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
40 Segovia;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
40 Segovia;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;75,44
40 Segovia;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
40 Segovia;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
40 Segovia;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
40 Segovia;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;76,47
40 Segovia;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
40 Segovia;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
40 Segovia;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
40 Segovia;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
40 Segovia;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
40 Segovia;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QIII;538
40 Segovia;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
40 Segovia;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
40 Segovia;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
40 Segovia;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QIII;547
40 Segovia;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
40 Segovia;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
40 Segovia;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
40 Segovia;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QIII;495
40 Segovia;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
40 Segovia;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
40 Segovia;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
40 Segovia;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2022QIII;480
40 Segovia;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2022QII;""
40 Segovia;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2022QI;""
40 Segovia;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
40 Segovia;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2021QIII;474
40 Segovia;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2021QII;""
40 Segovia;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2021QI;""
40 Segovia;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
40 Segovia;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2020QIII;442
40 Segovia;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2020QII;""
40 Segovia;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2020QI;""
40 Segovia;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2022QIV;454
40 Segovia;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
40 Segovia;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2022QII;""
40 Segovia;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2022QI;""
40 Segovia;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2021QIV;440
40 Segovia;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
40 Segovia;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2021QII;""
40 Segovia;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2021QI;""
40 Segovia;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2020QIV;420
40 Segovia;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
40 Segovia;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2020QII;""
40 Segovia;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2020QI;""
40 Segovia;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
40 Segovia;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
40 Segovia;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QII;""
40 Segovia;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QI;417
40 Segovia;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
40 Segovia;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
40 Segovia;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QII;""
40 Segovia;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QI;407
40 Segovia;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
40 Segovia;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
40 Segovia;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QII;""
40 Segovia;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QI;""
40 Segovia;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
40 Segovia;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
40 Segovia;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QII;396
40 Segovia;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QI;""
40 Segovia;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
40 Segovia;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
40 Segovia;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QII;390
40 Segovia;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QI;""
40 Segovia;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
40 Segovia;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
40 Segovia;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QII;""
40 Segovia;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QI;""
40 Segovia;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
40 Segovia;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
40 Segovia;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
40 Segovia;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
40 Segovia;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
40 Segovia;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
40 Segovia;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
40 Segovia;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
40 Segovia;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
40 Segovia;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
40 Segovia;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
40 Segovia;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
40 Segovia;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
40 Segovia;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;89,22
40 Segovia;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
40 Segovia;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
40 Segovia;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
40 Segovia;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;86,65
40 Segovia;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
40 Segovia;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
40 Segovia;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
40 Segovia;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;89,29
40 Segovia;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
40 Segovia;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
40 Segovia;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;84,39
40 Segovia;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
40 Segovia;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
40 Segovia;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
40 Segovia;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;80,44
40 Segovia;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
40 Segovia;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
40 Segovia;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
40 Segovia;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;84,85
40 Segovia;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
40 Segovia;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
40 Segovia;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
40 Segovia;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
40 Segovia;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
40 Segovia;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
40 Segovia;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;76,23
40 Segovia;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
40 Segovia;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
40 Segovia;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
40 Segovia;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;82,22
40 Segovia;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
40 Segovia;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
40 Segovia;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
40 Segovia;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
40 Segovia;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
40 Segovia;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
40 Segovia;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;72,39
40 Segovia;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
40 Segovia;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
40 Segovia;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
40 Segovia;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;78,79
40 Segovia;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
40 Segovia;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
40 Segovia;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
40 Segovia;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
40 Segovia;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
40 Segovia;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
40 Segovia;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QIII;345
40 Segovia;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
40 Segovia;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
40 Segovia;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
40 Segovia;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QIII;357
40 Segovia;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
40 Segovia;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
40 Segovia;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
40 Segovia;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QIII;324
40 Segovia;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
40 Segovia;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
40 Segovia;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
40 Segovia;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2022QIII;310
40 Segovia;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2022QII;""
40 Segovia;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2022QI;""
40 Segovia;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
40 Segovia;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2021QIII;313
40 Segovia;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2021QII;""
40 Segovia;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2021QI;""
40 Segovia;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
40 Segovia;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2020QIII;297
40 Segovia;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2020QII;""
40 Segovia;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2020QI;""
40 Segovia;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2022QIV;295
40 Segovia;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
40 Segovia;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2022QII;""
40 Segovia;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2022QI;""
40 Segovia;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2021QIV;292
40 Segovia;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
40 Segovia;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2021QII;""
40 Segovia;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2021QI;""
40 Segovia;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2020QIV;285
40 Segovia;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
40 Segovia;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2020QII;""
40 Segovia;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2020QI;""
40 Segovia;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
40 Segovia;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
40 Segovia;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QII;""
40 Segovia;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QI;277
40 Segovia;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
40 Segovia;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
40 Segovia;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QII;""
40 Segovia;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QI;278
40 Segovia;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
40 Segovia;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
40 Segovia;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QII;""
40 Segovia;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QI;""
40 Segovia;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
40 Segovia;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
40 Segovia;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QII;266
40 Segovia;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QI;""
40 Segovia;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
40 Segovia;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
40 Segovia;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QII;267
40 Segovia;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QI;""
40 Segovia;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
40 Segovia;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
40 Segovia;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QII;""
40 Segovia;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QI;""
40 Segovia;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
40 Segovia;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
40 Segovia;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
40 Segovia;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
40 Segovia;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
40 Segovia;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
40 Segovia;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
40 Segovia;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
40 Segovia;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
40 Segovia;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
40 Segovia;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
40 Segovia;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
40 Segovia;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
40 Segovia;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;89,86
40 Segovia;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
40 Segovia;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
40 Segovia;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
40 Segovia;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;87,68
40 Segovia;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
40 Segovia;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
40 Segovia;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
40 Segovia;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;91,67
40 Segovia;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
40 Segovia;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
40 Segovia;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;85,51
40 Segovia;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
40 Segovia;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
40 Segovia;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
40 Segovia;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;81,79
40 Segovia;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
40 Segovia;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
40 Segovia;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
40 Segovia;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;87,96
40 Segovia;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
40 Segovia;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
40 Segovia;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
40 Segovia;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
40 Segovia;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
40 Segovia;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
40 Segovia;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;77,59
40 Segovia;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
40 Segovia;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
40 Segovia;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
40 Segovia;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;85,8
40 Segovia;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
40 Segovia;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
40 Segovia;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
40 Segovia;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
40 Segovia;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
40 Segovia;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
40 Segovia;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;74,51
40 Segovia;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
40 Segovia;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
40 Segovia;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
40 Segovia;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;82,41
40 Segovia;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
40 Segovia;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
40 Segovia;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
40 Segovia;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
40 Segovia;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
40 Segovia;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
40 Segovia;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QIII;193
40 Segovia;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
40 Segovia;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
40 Segovia;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
40 Segovia;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QIII;190
40 Segovia;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
40 Segovia;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
40 Segovia;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
40 Segovia;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QIII;171
40 Segovia;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
40 Segovia;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
40 Segovia;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
40 Segovia;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2022QIII;170
40 Segovia;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2022QII;""
40 Segovia;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2022QI;""
40 Segovia;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
40 Segovia;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2021QIII;161
40 Segovia;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2021QII;""
40 Segovia;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2021QI;""
40 Segovia;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
40 Segovia;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2020QIII;145
40 Segovia;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2020QII;""
40 Segovia;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2020QI;""
40 Segovia;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2022QIV;159
40 Segovia;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
40 Segovia;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2022QII;""
40 Segovia;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2022QI;""
40 Segovia;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2021QIV;148
40 Segovia;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
40 Segovia;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2021QII;""
40 Segovia;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2021QI;""
40 Segovia;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2020QIV;135
40 Segovia;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
40 Segovia;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2020QII;""
40 Segovia;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2020QI;""
40 Segovia;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
40 Segovia;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
40 Segovia;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QII;""
40 Segovia;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QI;140
40 Segovia;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
40 Segovia;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
40 Segovia;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QII;""
40 Segovia;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QI;129
40 Segovia;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
40 Segovia;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
40 Segovia;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QII;""
40 Segovia;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QI;""
40 Segovia;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
40 Segovia;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
40 Segovia;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QII;130
40 Segovia;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QI;""
40 Segovia;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
40 Segovia;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
40 Segovia;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QII;123
40 Segovia;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QI;""
40 Segovia;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
40 Segovia;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
40 Segovia;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QII;""
40 Segovia;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QI;""
40 Segovia;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
40 Segovia;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
40 Segovia;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
40 Segovia;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
40 Segovia;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
40 Segovia;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
40 Segovia;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
40 Segovia;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
40 Segovia;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
40 Segovia;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
40 Segovia;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
40 Segovia;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
40 Segovia;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
40 Segovia;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;88,08
40 Segovia;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
40 Segovia;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
40 Segovia;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
40 Segovia;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;84,74
40 Segovia;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
40 Segovia;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
40 Segovia;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
40 Segovia;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;84,8
40 Segovia;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
40 Segovia;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
40 Segovia;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;82,38
40 Segovia;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
40 Segovia;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
40 Segovia;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
40 Segovia;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;77,89
40 Segovia;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
40 Segovia;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
40 Segovia;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
40 Segovia;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;78,95
40 Segovia;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
40 Segovia;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
40 Segovia;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
40 Segovia;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
40 Segovia;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
40 Segovia;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
40 Segovia;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;73,68
40 Segovia;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
40 Segovia;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
40 Segovia;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
40 Segovia;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;75,44
40 Segovia;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
40 Segovia;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
40 Segovia;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
40 Segovia;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
40 Segovia;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
40 Segovia;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
40 Segovia;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;68,42
40 Segovia;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
40 Segovia;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
40 Segovia;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
40 Segovia;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;71,93
40 Segovia;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
40 Segovia;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
40 Segovia;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
40 Segovia;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
40 Segovia;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
40 Segovia;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QIV;535
40 Segovia;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
40 Segovia;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
40 Segovia;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
40 Segovia;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QIV;541
40 Segovia;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
40 Segovia;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
40 Segovia;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
40 Segovia;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QIV;509
40 Segovia;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
40 Segovia;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
40 Segovia;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
40 Segovia;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2022QIV;500
40 Segovia;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
40 Segovia;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2022QII;""
40 Segovia;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2022QI;""
40 Segovia;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2021QIV;503
40 Segovia;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
40 Segovia;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2021QII;""
40 Segovia;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2021QI;""
40 Segovia;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2020QIV;474
40 Segovia;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
40 Segovia;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2020QII;""
40 Segovia;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2020QI;""
40 Segovia;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
40 Segovia;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
40 Segovia;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2022QII;""
40 Segovia;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2022QI;470
40 Segovia;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
40 Segovia;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
40 Segovia;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2021QII;""
40 Segovia;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2021QI;454
40 Segovia;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
40 Segovia;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
40 Segovia;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2020QII;""
40 Segovia;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2020QI;""
40 Segovia;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
40 Segovia;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
40 Segovia;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QII;445
40 Segovia;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QI;""
40 Segovia;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
40 Segovia;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
40 Segovia;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QII;435
40 Segovia;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QI;""
40 Segovia;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
40 Segovia;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
40 Segovia;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QII;""
40 Segovia;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QI;""
40 Segovia;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
40 Segovia;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QIII;425
40 Segovia;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QII;""
40 Segovia;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QI;""
40 Segovia;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
40 Segovia;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QIII;406
40 Segovia;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QII;""
40 Segovia;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QI;""
40 Segovia;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
40 Segovia;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
40 Segovia;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QII;""
40 Segovia;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QI;""
40 Segovia;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
40 Segovia;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
40 Segovia;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
40 Segovia;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
40 Segovia;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
40 Segovia;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
40 Segovia;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
40 Segovia;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
40 Segovia;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
40 Segovia;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
40 Segovia;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
40 Segovia;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
40 Segovia;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;93,46
40 Segovia;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
40 Segovia;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
40 Segovia;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
40 Segovia;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;92,98
40 Segovia;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
40 Segovia;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
40 Segovia;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
40 Segovia;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;93,12
40 Segovia;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
40 Segovia;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
40 Segovia;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
40 Segovia;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
40 Segovia;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
40 Segovia;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
40 Segovia;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;86,88
40 Segovia;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
40 Segovia;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
40 Segovia;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
40 Segovia;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;89,19
40 Segovia;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
40 Segovia;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
40 Segovia;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
40 Segovia;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
40 Segovia;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
40 Segovia;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
40 Segovia;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;82,26
40 Segovia;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
40 Segovia;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
40 Segovia;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
40 Segovia;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;85,46
40 Segovia;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
40 Segovia;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
40 Segovia;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
40 Segovia;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
40 Segovia;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
40 Segovia;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
40 Segovia;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;78,56
40 Segovia;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
40 Segovia;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
40 Segovia;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
40 Segovia;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;79,76
40 Segovia;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
40 Segovia;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
40 Segovia;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
40 Segovia;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
40 Segovia;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
40 Segovia;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
40 Segovia;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QIV;347
40 Segovia;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
40 Segovia;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
40 Segovia;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
40 Segovia;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QIV;354
40 Segovia;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
40 Segovia;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
40 Segovia;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
40 Segovia;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QIV;338
40 Segovia;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
40 Segovia;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
40 Segovia;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
40 Segovia;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2022QIV;326
40 Segovia;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
40 Segovia;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2022QII;""
40 Segovia;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2022QI;""
40 Segovia;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2021QIV;330
40 Segovia;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
40 Segovia;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2021QII;""
40 Segovia;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2021QI;""
40 Segovia;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2020QIV;316
40 Segovia;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
40 Segovia;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2020QII;""
40 Segovia;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2020QI;""
40 Segovia;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
40 Segovia;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
40 Segovia;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2022QII;""
40 Segovia;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2022QI;307
40 Segovia;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
40 Segovia;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
40 Segovia;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2021QII;""
40 Segovia;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2021QI;305
40 Segovia;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
40 Segovia;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
40 Segovia;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2020QII;""
40 Segovia;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2020QI;""
40 Segovia;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
40 Segovia;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
40 Segovia;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QII;294
40 Segovia;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QI;""
40 Segovia;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
40 Segovia;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
40 Segovia;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QII;293
40 Segovia;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QI;""
40 Segovia;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
40 Segovia;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
40 Segovia;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QII;""
40 Segovia;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QI;""
40 Segovia;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
40 Segovia;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QIII;279
40 Segovia;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QII;""
40 Segovia;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QI;""
40 Segovia;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
40 Segovia;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QIII;275
40 Segovia;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QII;""
40 Segovia;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QI;""
40 Segovia;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
40 Segovia;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
40 Segovia;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QII;""
40 Segovia;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QI;""
40 Segovia;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
40 Segovia;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
40 Segovia;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
40 Segovia;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
40 Segovia;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
40 Segovia;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
40 Segovia;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
40 Segovia;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
40 Segovia;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
40 Segovia;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
40 Segovia;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
40 Segovia;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
40 Segovia;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;93,95
40 Segovia;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
40 Segovia;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
40 Segovia;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
40 Segovia;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;93,22
40 Segovia;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
40 Segovia;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
40 Segovia;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
40 Segovia;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;93,49
40 Segovia;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
40 Segovia;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
40 Segovia;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
40 Segovia;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
40 Segovia;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
40 Segovia;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
40 Segovia;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;86,72
40 Segovia;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
40 Segovia;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
40 Segovia;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
40 Segovia;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;90,24
40 Segovia;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
40 Segovia;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
40 Segovia;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
40 Segovia;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
40 Segovia;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
40 Segovia;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
40 Segovia;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;83,05
40 Segovia;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
40 Segovia;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
40 Segovia;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
40 Segovia;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;86,69
40 Segovia;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
40 Segovia;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
40 Segovia;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
40 Segovia;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
40 Segovia;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
40 Segovia;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
40 Segovia;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;78,81
40 Segovia;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
40 Segovia;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
40 Segovia;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
40 Segovia;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;81,36
40 Segovia;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
40 Segovia;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
40 Segovia;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
40 Segovia;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
40 Segovia;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
40 Segovia;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
40 Segovia;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QIV;188
40 Segovia;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
40 Segovia;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
40 Segovia;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
40 Segovia;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QIV;187
40 Segovia;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
40 Segovia;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
40 Segovia;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
40 Segovia;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QIV;171
40 Segovia;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
40 Segovia;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
40 Segovia;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
40 Segovia;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2022QIV;174
40 Segovia;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
40 Segovia;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2022QII;""
40 Segovia;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2022QI;""
40 Segovia;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2021QIV;173
40 Segovia;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
40 Segovia;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2021QII;""
40 Segovia;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2021QI;""
40 Segovia;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2020QIV;158
40 Segovia;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
40 Segovia;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2020QII;""
40 Segovia;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2020QI;""
40 Segovia;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
40 Segovia;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
40 Segovia;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2022QII;""
40 Segovia;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2022QI;163
40 Segovia;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
40 Segovia;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
40 Segovia;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2021QII;""
40 Segovia;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2021QI;149
40 Segovia;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
40 Segovia;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
40 Segovia;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2020QII;""
40 Segovia;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2020QI;""
40 Segovia;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
40 Segovia;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
40 Segovia;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QII;151
40 Segovia;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QI;""
40 Segovia;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
40 Segovia;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
40 Segovia;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QII;142
40 Segovia;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QI;""
40 Segovia;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
40 Segovia;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
40 Segovia;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QII;""
40 Segovia;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QI;""
40 Segovia;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
40 Segovia;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QIII;146
40 Segovia;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QII;""
40 Segovia;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QI;""
40 Segovia;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
40 Segovia;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QIII;131
40 Segovia;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QII;""
40 Segovia;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QI;""
40 Segovia;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
40 Segovia;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
40 Segovia;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QII;""
40 Segovia;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QI;""
40 Segovia;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
40 Segovia;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
40 Segovia;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
40 Segovia;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
40 Segovia;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
40 Segovia;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
40 Segovia;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
40 Segovia;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
40 Segovia;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
40 Segovia;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
40 Segovia;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
40 Segovia;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
40 Segovia;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;92,55
40 Segovia;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
40 Segovia;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
40 Segovia;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
40 Segovia;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;92,51
40 Segovia;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
40 Segovia;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
40 Segovia;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
40 Segovia;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;92,4
40 Segovia;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
40 Segovia;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
40 Segovia;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
40 Segovia;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
40 Segovia;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
40 Segovia;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
40 Segovia;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;87,17
40 Segovia;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
40 Segovia;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
40 Segovia;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
40 Segovia;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;87,13
40 Segovia;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
40 Segovia;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
40 Segovia;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
40 Segovia;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
40 Segovia;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
40 Segovia;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
40 Segovia;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;80,75
40 Segovia;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
40 Segovia;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
40 Segovia;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
40 Segovia;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;83,04
40 Segovia;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
40 Segovia;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
40 Segovia;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
40 Segovia;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
40 Segovia;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
40 Segovia;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
40 Segovia;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;78,07
40 Segovia;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
40 Segovia;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
40 Segovia;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
40 Segovia;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;76,61
40 Segovia;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
40 Segovia;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
40 Segovia;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
40 Segovia;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
40 Segovia;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
40 Segovia;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
40 Segovia;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
40 Segovia;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
40 Segovia;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
40 Segovia;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QI;1.639
40 Segovia;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
40 Segovia;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
40 Segovia;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
40 Segovia;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QI;1.634
40 Segovia;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
40 Segovia;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
40 Segovia;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
40 Segovia;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QI;1.563
40 Segovia;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
40 Segovia;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
40 Segovia;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2022QII;""
40 Segovia;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2022QI;1.585
40 Segovia;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
40 Segovia;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
40 Segovia;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2021QII;""
40 Segovia;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2021QI;1.598
40 Segovia;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
40 Segovia;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
40 Segovia;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2020QII;""
40 Segovia;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2020QI;1.460
40 Segovia;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
40 Segovia;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
40 Segovia;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2022QII;1.519
40 Segovia;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2022QI;""
40 Segovia;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
40 Segovia;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
40 Segovia;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2021QII;1.551
40 Segovia;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2021QI;""
40 Segovia;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
40 Segovia;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
40 Segovia;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2020QII;1.428
40 Segovia;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2020QI;""
40 Segovia;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
40 Segovia;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QIII;1.471
40 Segovia;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QII;""
40 Segovia;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QI;""
40 Segovia;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
40 Segovia;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QIII;1.511
40 Segovia;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QII;""
40 Segovia;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QI;""
40 Segovia;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
40 Segovia;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QIII;1.390
40 Segovia;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QII;""
40 Segovia;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QI;""
40 Segovia;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QIV;1.422
40 Segovia;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
40 Segovia;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QII;""
40 Segovia;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QI;""
40 Segovia;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QIV;1.479
40 Segovia;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
40 Segovia;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QII;""
40 Segovia;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QI;""
40 Segovia;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QIV;1.349
40 Segovia;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
40 Segovia;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QII;""
40 Segovia;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QI;""
40 Segovia;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
40 Segovia;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
40 Segovia;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
40 Segovia;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
40 Segovia;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
40 Segovia;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
40 Segovia;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
40 Segovia;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
40 Segovia;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
40 Segovia;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
40 Segovia;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
40 Segovia;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
40 Segovia;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
40 Segovia;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
40 Segovia;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
40 Segovia;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;96,71
40 Segovia;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
40 Segovia;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
40 Segovia;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
40 Segovia;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;97,8
40 Segovia;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
40 Segovia;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
40 Segovia;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
40 Segovia;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;93,41
40 Segovia;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
40 Segovia;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
40 Segovia;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;92,68
40 Segovia;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
40 Segovia;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
40 Segovia;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
40 Segovia;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;94,92
40 Segovia;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
40 Segovia;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
40 Segovia;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
40 Segovia;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;91,36
40 Segovia;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
40 Segovia;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
40 Segovia;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;89,75
40 Segovia;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
40 Segovia;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
40 Segovia;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
40 Segovia;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;92,47
40 Segovia;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
40 Segovia;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
40 Segovia;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
40 Segovia;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;88,93
40 Segovia;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
40 Segovia;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
40 Segovia;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;86,76
40 Segovia;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
40 Segovia;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
40 Segovia;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
40 Segovia;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;90,51
40 Segovia;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
40 Segovia;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
40 Segovia;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
40 Segovia;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;86,31
40 Segovia;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
40 Segovia;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
40 Segovia;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
40 Segovia;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
40 Segovia;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
40 Segovia;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
40 Segovia;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QI;1.020
40 Segovia;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
40 Segovia;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
40 Segovia;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
40 Segovia;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QI;1.031
40 Segovia;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
40 Segovia;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
40 Segovia;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
40 Segovia;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QI;978
40 Segovia;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
40 Segovia;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
40 Segovia;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2022QII;""
40 Segovia;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2022QI;991
40 Segovia;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
40 Segovia;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
40 Segovia;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2021QII;""
40 Segovia;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2021QI;1.012
40 Segovia;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
40 Segovia;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
40 Segovia;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2020QII;""
40 Segovia;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2020QI;923
40 Segovia;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
40 Segovia;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
40 Segovia;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2022QII;951
40 Segovia;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2022QI;""
40 Segovia;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
40 Segovia;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
40 Segovia;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2021QII;988
40 Segovia;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2021QI;""
40 Segovia;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
40 Segovia;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
40 Segovia;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2020QII;898
40 Segovia;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2020QI;""
40 Segovia;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
40 Segovia;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QIII;926
40 Segovia;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QII;""
40 Segovia;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QI;""
40 Segovia;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
40 Segovia;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QIII;965
40 Segovia;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QII;""
40 Segovia;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QI;""
40 Segovia;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
40 Segovia;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QIII;881
40 Segovia;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QII;""
40 Segovia;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QI;""
40 Segovia;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QIV;892
40 Segovia;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
40 Segovia;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QII;""
40 Segovia;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QI;""
40 Segovia;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QIV;945
40 Segovia;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
40 Segovia;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QII;""
40 Segovia;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QI;""
40 Segovia;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QIV;856
40 Segovia;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
40 Segovia;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QII;""
40 Segovia;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QI;""
40 Segovia;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
40 Segovia;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
40 Segovia;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
40 Segovia;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
40 Segovia;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
40 Segovia;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
40 Segovia;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
40 Segovia;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
40 Segovia;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
40 Segovia;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
40 Segovia;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
40 Segovia;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
40 Segovia;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
40 Segovia;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
40 Segovia;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
40 Segovia;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;97,16
40 Segovia;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
40 Segovia;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
40 Segovia;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
40 Segovia;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;98,16
40 Segovia;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
40 Segovia;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
40 Segovia;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
40 Segovia;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;94,38
40 Segovia;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
40 Segovia;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
40 Segovia;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;93,24
40 Segovia;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
40 Segovia;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
40 Segovia;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
40 Segovia;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;95,83
40 Segovia;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
40 Segovia;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
40 Segovia;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
40 Segovia;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;91,82
40 Segovia;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
40 Segovia;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
40 Segovia;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;90,78
40 Segovia;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
40 Segovia;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
40 Segovia;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
40 Segovia;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;93,6
40 Segovia;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
40 Segovia;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
40 Segovia;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
40 Segovia;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;90,08
40 Segovia;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
40 Segovia;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
40 Segovia;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;87,45
40 Segovia;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
40 Segovia;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
40 Segovia;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
40 Segovia;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;91,66
40 Segovia;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
40 Segovia;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
40 Segovia;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
40 Segovia;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;87,53
40 Segovia;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
40 Segovia;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
40 Segovia;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
40 Segovia;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
40 Segovia;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
40 Segovia;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
40 Segovia;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QI;619
40 Segovia;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
40 Segovia;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
40 Segovia;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
40 Segovia;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QI;603
40 Segovia;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
40 Segovia;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
40 Segovia;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
40 Segovia;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QI;585
40 Segovia;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
40 Segovia;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
40 Segovia;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2022QII;""
40 Segovia;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2022QI;594
40 Segovia;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
40 Segovia;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
40 Segovia;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2021QII;""
40 Segovia;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2021QI;586
40 Segovia;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
40 Segovia;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
40 Segovia;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2020QII;""
40 Segovia;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2020QI;537
40 Segovia;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
40 Segovia;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
40 Segovia;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2022QII;568
40 Segovia;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2022QI;""
40 Segovia;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
40 Segovia;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
40 Segovia;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2021QII;563
40 Segovia;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2021QI;""
40 Segovia;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
40 Segovia;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
40 Segovia;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2020QII;530
40 Segovia;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2020QI;""
40 Segovia;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
40 Segovia;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QIII;545
40 Segovia;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QII;""
40 Segovia;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QI;""
40 Segovia;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
40 Segovia;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QIII;546
40 Segovia;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QII;""
40 Segovia;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QI;""
40 Segovia;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
40 Segovia;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QIII;509
40 Segovia;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QII;""
40 Segovia;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QI;""
40 Segovia;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QIV;530
40 Segovia;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
40 Segovia;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QII;""
40 Segovia;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QI;""
40 Segovia;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QIV;534
40 Segovia;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
40 Segovia;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QII;""
40 Segovia;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QI;""
40 Segovia;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QIV;493
40 Segovia;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
40 Segovia;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QII;""
40 Segovia;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QI;""
40 Segovia;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
40 Segovia;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
40 Segovia;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
40 Segovia;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
40 Segovia;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
40 Segovia;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
40 Segovia;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
40 Segovia;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
40 Segovia;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
40 Segovia;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
40 Segovia;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
40 Segovia;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
40 Segovia;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
40 Segovia;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
40 Segovia;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
40 Segovia;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;95,96
40 Segovia;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
40 Segovia;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
40 Segovia;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
40 Segovia;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;97,18
40 Segovia;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
40 Segovia;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
40 Segovia;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
40 Segovia;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;91,79
40 Segovia;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
40 Segovia;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
40 Segovia;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;91,76
40 Segovia;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
40 Segovia;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
40 Segovia;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
40 Segovia;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;93,37
40 Segovia;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
40 Segovia;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
40 Segovia;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
40 Segovia;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;90,6
40 Segovia;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
40 Segovia;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
40 Segovia;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;88,05
40 Segovia;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
40 Segovia;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
40 Segovia;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
40 Segovia;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;90,55
40 Segovia;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
40 Segovia;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
40 Segovia;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
40 Segovia;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;87,01
40 Segovia;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
40 Segovia;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
40 Segovia;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;85,62
40 Segovia;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
40 Segovia;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
40 Segovia;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
40 Segovia;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;88,56
40 Segovia;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
40 Segovia;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
40 Segovia;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
40 Segovia;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;84,27
40 Segovia;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
40 Segovia;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
40 Segovia;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
40 Segovia;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
40 Segovia;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
40 Segovia;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QII;1.542
40 Segovia;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
40 Segovia;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
40 Segovia;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
40 Segovia;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QII;1.525
40 Segovia;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
40 Segovia;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
40 Segovia;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
40 Segovia;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QII;1.531
40 Segovia;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
40 Segovia;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
40 Segovia;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
40 Segovia;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2022QII;1.480
40 Segovia;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2022QI;""
40 Segovia;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
40 Segovia;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
40 Segovia;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2021QII;1.469
40 Segovia;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2021QI;""
40 Segovia;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
40 Segovia;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
40 Segovia;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2020QII;1.496
40 Segovia;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2020QI;""
40 Segovia;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
40 Segovia;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2022QIII;1.429
40 Segovia;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2022QII;""
40 Segovia;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2022QI;""
40 Segovia;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
40 Segovia;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2021QIII;1.423
40 Segovia;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2021QII;""
40 Segovia;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2021QI;""
40 Segovia;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
40 Segovia;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2020QIII;1.452
40 Segovia;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2020QII;""
40 Segovia;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2020QI;""
40 Segovia;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QIV;1.374
40 Segovia;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
40 Segovia;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QII;""
40 Segovia;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QI;""
40 Segovia;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QIV;1.390
40 Segovia;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
40 Segovia;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QII;""
40 Segovia;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QI;""
40 Segovia;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QIV;1.407
40 Segovia;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
40 Segovia;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QII;""
40 Segovia;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QI;""
40 Segovia;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
40 Segovia;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
40 Segovia;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QII;""
40 Segovia;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QI;1.348
40 Segovia;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
40 Segovia;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
40 Segovia;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QII;""
40 Segovia;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QI;1.378
40 Segovia;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
40 Segovia;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
40 Segovia;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QII;""
40 Segovia;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QI;""
40 Segovia;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
40 Segovia;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
40 Segovia;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
40 Segovia;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
40 Segovia;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
40 Segovia;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
40 Segovia;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
40 Segovia;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
40 Segovia;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
40 Segovia;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
40 Segovia;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
40 Segovia;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
40 Segovia;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
40 Segovia;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
40 Segovia;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;95,98
40 Segovia;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
40 Segovia;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
40 Segovia;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
40 Segovia;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;96,33
40 Segovia;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
40 Segovia;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
40 Segovia;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
40 Segovia;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;97,71
40 Segovia;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
40 Segovia;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
40 Segovia;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;92,67
40 Segovia;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
40 Segovia;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
40 Segovia;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
40 Segovia;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;93,31
40 Segovia;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
40 Segovia;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
40 Segovia;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
40 Segovia;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;94,84
40 Segovia;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
40 Segovia;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
40 Segovia;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;89,11
40 Segovia;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
40 Segovia;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
40 Segovia;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
40 Segovia;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;91,15
40 Segovia;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
40 Segovia;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
40 Segovia;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
40 Segovia;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;91,9
40 Segovia;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
40 Segovia;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
40 Segovia;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
40 Segovia;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
40 Segovia;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
40 Segovia;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
40 Segovia;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;88,39
40 Segovia;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
40 Segovia;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
40 Segovia;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
40 Segovia;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;90,01
40 Segovia;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
40 Segovia;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
40 Segovia;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
40 Segovia;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
40 Segovia;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
40 Segovia;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
40 Segovia;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QII;967
40 Segovia;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
40 Segovia;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
40 Segovia;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
40 Segovia;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QII;962
40 Segovia;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
40 Segovia;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
40 Segovia;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
40 Segovia;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QII;970
40 Segovia;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
40 Segovia;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
40 Segovia;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
40 Segovia;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2022QII;933
40 Segovia;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2022QI;""
40 Segovia;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
40 Segovia;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
40 Segovia;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2021QII;932
40 Segovia;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2021QI;""
40 Segovia;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
40 Segovia;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
40 Segovia;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2020QII;943
40 Segovia;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2020QI;""
40 Segovia;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
40 Segovia;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2022QIII;906
40 Segovia;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2022QII;""
40 Segovia;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2022QI;""
40 Segovia;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
40 Segovia;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2021QIII;902
40 Segovia;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2021QII;""
40 Segovia;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2021QI;""
40 Segovia;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
40 Segovia;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2020QIII;923
40 Segovia;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2020QII;""
40 Segovia;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2020QI;""
40 Segovia;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QIV;866
40 Segovia;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
40 Segovia;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QII;""
40 Segovia;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QI;""
40 Segovia;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QIV;882
40 Segovia;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
40 Segovia;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QII;""
40 Segovia;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QI;""
40 Segovia;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QIV;895
40 Segovia;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
40 Segovia;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QII;""
40 Segovia;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QI;""
40 Segovia;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
40 Segovia;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
40 Segovia;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QII;""
40 Segovia;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QI;859
40 Segovia;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
40 Segovia;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
40 Segovia;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QII;""
40 Segovia;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QI;881
40 Segovia;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
40 Segovia;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
40 Segovia;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QII;""
40 Segovia;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QI;""
40 Segovia;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
40 Segovia;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
40 Segovia;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
40 Segovia;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
40 Segovia;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
40 Segovia;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
40 Segovia;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
40 Segovia;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
40 Segovia;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
40 Segovia;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
40 Segovia;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
40 Segovia;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
40 Segovia;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
40 Segovia;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
40 Segovia;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;96,48
40 Segovia;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
40 Segovia;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
40 Segovia;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
40 Segovia;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;96,88
40 Segovia;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
40 Segovia;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
40 Segovia;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
40 Segovia;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;97,22
40 Segovia;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
40 Segovia;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
40 Segovia;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;93,69
40 Segovia;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
40 Segovia;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
40 Segovia;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
40 Segovia;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;93,76
40 Segovia;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
40 Segovia;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
40 Segovia;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
40 Segovia;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;95,15
40 Segovia;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
40 Segovia;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
40 Segovia;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;89,56
40 Segovia;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
40 Segovia;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
40 Segovia;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
40 Segovia;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;91,68
40 Segovia;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
40 Segovia;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
40 Segovia;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
40 Segovia;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;92,27
40 Segovia;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
40 Segovia;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
40 Segovia;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
40 Segovia;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
40 Segovia;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
40 Segovia;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
40 Segovia;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;89,29
40 Segovia;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
40 Segovia;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
40 Segovia;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
40 Segovia;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;90,82
40 Segovia;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
40 Segovia;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
40 Segovia;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
40 Segovia;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
40 Segovia;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
40 Segovia;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
40 Segovia;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QII;575
40 Segovia;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
40 Segovia;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
40 Segovia;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
40 Segovia;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QII;563
40 Segovia;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
40 Segovia;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
40 Segovia;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
40 Segovia;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QII;561
40 Segovia;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
40 Segovia;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
40 Segovia;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
40 Segovia;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2022QII;547
40 Segovia;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2022QI;""
40 Segovia;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
40 Segovia;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
40 Segovia;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2021QII;537
40 Segovia;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2021QI;""
40 Segovia;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
40 Segovia;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
40 Segovia;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2020QII;553
40 Segovia;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2020QI;""
40 Segovia;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
40 Segovia;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2022QIII;523
40 Segovia;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2022QII;""
40 Segovia;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2022QI;""
40 Segovia;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
40 Segovia;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2021QIII;521
40 Segovia;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2021QII;""
40 Segovia;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2021QI;""
40 Segovia;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
40 Segovia;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2020QIII;529
40 Segovia;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2020QII;""
40 Segovia;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2020QI;""
40 Segovia;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QIV;508
40 Segovia;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
40 Segovia;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QII;""
40 Segovia;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QI;""
40 Segovia;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QIV;508
40 Segovia;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
40 Segovia;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QII;""
40 Segovia;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QI;""
40 Segovia;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QIV;512
40 Segovia;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
40 Segovia;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QII;""
40 Segovia;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QI;""
40 Segovia;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
40 Segovia;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
40 Segovia;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QII;""
40 Segovia;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QI;489
40 Segovia;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
40 Segovia;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
40 Segovia;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QII;""
40 Segovia;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QI;497
40 Segovia;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
40 Segovia;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
40 Segovia;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QII;""
40 Segovia;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QI;""
40 Segovia;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
40 Segovia;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
40 Segovia;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
40 Segovia;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
40 Segovia;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
40 Segovia;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
40 Segovia;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
40 Segovia;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
40 Segovia;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
40 Segovia;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
40 Segovia;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
40 Segovia;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
40 Segovia;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
40 Segovia;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
40 Segovia;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;95,13
40 Segovia;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
40 Segovia;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
40 Segovia;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
40 Segovia;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;95,38
40 Segovia;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
40 Segovia;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
40 Segovia;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
40 Segovia;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;98,57
40 Segovia;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
40 Segovia;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
40 Segovia;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;90,96
40 Segovia;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
40 Segovia;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
40 Segovia;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
40 Segovia;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;92,54
40 Segovia;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
40 Segovia;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
40 Segovia;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
40 Segovia;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;94,3
40 Segovia;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
40 Segovia;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
40 Segovia;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;88,35
40 Segovia;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
40 Segovia;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
40 Segovia;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
40 Segovia;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;90,23
40 Segovia;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
40 Segovia;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
40 Segovia;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
40 Segovia;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;91,27
40 Segovia;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
40 Segovia;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
40 Segovia;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
40 Segovia;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
40 Segovia;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
40 Segovia;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
40 Segovia;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;86,86
40 Segovia;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
40 Segovia;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
40 Segovia;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
40 Segovia;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;88,59
40 Segovia;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
40 Segovia;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
40 Segovia;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
40 Segovia;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
40 Segovia;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
40 Segovia;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QIII;1.580
40 Segovia;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
40 Segovia;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
40 Segovia;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
40 Segovia;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QIII;1.570
40 Segovia;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
40 Segovia;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
40 Segovia;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
40 Segovia;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QIII;1.564
40 Segovia;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
40 Segovia;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
40 Segovia;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
40 Segovia;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2022QIII;1.510
40 Segovia;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2022QII;""
40 Segovia;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2022QI;""
40 Segovia;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
40 Segovia;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2021QIII;1.510
40 Segovia;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2021QII;""
40 Segovia;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2021QI;""
40 Segovia;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
40 Segovia;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2020QIII;1.511
40 Segovia;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2020QII;""
40 Segovia;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2020QI;""
40 Segovia;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2022QIV;1.444
40 Segovia;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
40 Segovia;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2022QII;""
40 Segovia;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2022QI;""
40 Segovia;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2021QIV;1.465
40 Segovia;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
40 Segovia;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2021QII;""
40 Segovia;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2021QI;""
40 Segovia;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2020QIV;1.464
40 Segovia;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
40 Segovia;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2020QII;""
40 Segovia;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2020QI;""
40 Segovia;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
40 Segovia;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
40 Segovia;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QII;""
40 Segovia;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QI;1.421
40 Segovia;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
40 Segovia;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
40 Segovia;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QII;""
40 Segovia;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QI;1.435
40 Segovia;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
40 Segovia;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
40 Segovia;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QII;""
40 Segovia;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QI;""
40 Segovia;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
40 Segovia;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
40 Segovia;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QII;1.370
40 Segovia;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QI;""
40 Segovia;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
40 Segovia;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
40 Segovia;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QII;1.402
40 Segovia;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QI;""
40 Segovia;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
40 Segovia;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
40 Segovia;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QII;""
40 Segovia;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QI;""
40 Segovia;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
40 Segovia;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
40 Segovia;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
40 Segovia;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
40 Segovia;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
40 Segovia;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
40 Segovia;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
40 Segovia;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
40 Segovia;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
40 Segovia;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
40 Segovia;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
40 Segovia;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
40 Segovia;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
40 Segovia;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;95,57
40 Segovia;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
40 Segovia;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
40 Segovia;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
40 Segovia;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;96,18
40 Segovia;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
40 Segovia;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
40 Segovia;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
40 Segovia;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;96,61
40 Segovia;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
40 Segovia;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
40 Segovia;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;91,39
40 Segovia;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
40 Segovia;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
40 Segovia;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
40 Segovia;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;93,31
40 Segovia;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
40 Segovia;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
40 Segovia;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
40 Segovia;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;93,61
40 Segovia;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
40 Segovia;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
40 Segovia;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
40 Segovia;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
40 Segovia;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
40 Segovia;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
40 Segovia;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;90,51
40 Segovia;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
40 Segovia;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
40 Segovia;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
40 Segovia;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;91,75
40 Segovia;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
40 Segovia;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
40 Segovia;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
40 Segovia;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
40 Segovia;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
40 Segovia;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
40 Segovia;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;87,26
40 Segovia;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
40 Segovia;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
40 Segovia;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
40 Segovia;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;89,64
40 Segovia;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
40 Segovia;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
40 Segovia;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
40 Segovia;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
40 Segovia;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
40 Segovia;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
40 Segovia;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QIII;998
40 Segovia;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
40 Segovia;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
40 Segovia;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
40 Segovia;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QIII;996
40 Segovia;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
40 Segovia;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
40 Segovia;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
40 Segovia;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QIII;987
40 Segovia;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
40 Segovia;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
40 Segovia;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
40 Segovia;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2022QIII;957
40 Segovia;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2022QII;""
40 Segovia;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2022QI;""
40 Segovia;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
40 Segovia;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2021QIII;954
40 Segovia;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2021QII;""
40 Segovia;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2021QI;""
40 Segovia;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
40 Segovia;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2020QIII;963
40 Segovia;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2020QII;""
40 Segovia;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2020QI;""
40 Segovia;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2022QIV;911
40 Segovia;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
40 Segovia;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2022QII;""
40 Segovia;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2022QI;""
40 Segovia;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2021QIV;926
40 Segovia;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
40 Segovia;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2021QII;""
40 Segovia;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2021QI;""
40 Segovia;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2020QIV;935
40 Segovia;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
40 Segovia;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2020QII;""
40 Segovia;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2020QI;""
40 Segovia;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
40 Segovia;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
40 Segovia;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QII;""
40 Segovia;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QI;901
40 Segovia;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
40 Segovia;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
40 Segovia;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QII;""
40 Segovia;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QI;921
40 Segovia;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
40 Segovia;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
40 Segovia;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QII;""
40 Segovia;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QI;""
40 Segovia;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
40 Segovia;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
40 Segovia;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QII;871
40 Segovia;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QI;""
40 Segovia;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
40 Segovia;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
40 Segovia;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QII;905
40 Segovia;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QI;""
40 Segovia;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
40 Segovia;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
40 Segovia;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QII;""
40 Segovia;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QI;""
40 Segovia;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
40 Segovia;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
40 Segovia;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
40 Segovia;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
40 Segovia;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
40 Segovia;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
40 Segovia;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
40 Segovia;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
40 Segovia;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
40 Segovia;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
40 Segovia;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
40 Segovia;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
40 Segovia;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
40 Segovia;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;95,89
40 Segovia;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
40 Segovia;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
40 Segovia;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
40 Segovia;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;95,78
40 Segovia;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
40 Segovia;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
40 Segovia;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
40 Segovia;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;97,57
40 Segovia;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
40 Segovia;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
40 Segovia;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;91,28
40 Segovia;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
40 Segovia;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
40 Segovia;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
40 Segovia;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;92,97
40 Segovia;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
40 Segovia;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
40 Segovia;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
40 Segovia;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;94,73
40 Segovia;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
40 Segovia;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
40 Segovia;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
40 Segovia;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
40 Segovia;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
40 Segovia;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
40 Segovia;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;90,46
40 Segovia;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
40 Segovia;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
40 Segovia;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
40 Segovia;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;93,31
40 Segovia;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
40 Segovia;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
40 Segovia;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
40 Segovia;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
40 Segovia;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
40 Segovia;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
40 Segovia;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;87,45
40 Segovia;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
40 Segovia;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
40 Segovia;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
40 Segovia;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;91,69
40 Segovia;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
40 Segovia;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
40 Segovia;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
40 Segovia;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
40 Segovia;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
40 Segovia;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
40 Segovia;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QIII;582
40 Segovia;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
40 Segovia;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
40 Segovia;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
40 Segovia;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QIII;574
40 Segovia;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
40 Segovia;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
40 Segovia;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
40 Segovia;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QIII;577
40 Segovia;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
40 Segovia;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
40 Segovia;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
40 Segovia;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2022QIII;553
40 Segovia;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2022QII;""
40 Segovia;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2022QI;""
40 Segovia;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
40 Segovia;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2021QIII;556
40 Segovia;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2021QII;""
40 Segovia;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2021QI;""
40 Segovia;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
40 Segovia;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2020QIII;548
40 Segovia;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2020QII;""
40 Segovia;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2020QI;""
40 Segovia;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2022QIV;533
40 Segovia;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
40 Segovia;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2022QII;""
40 Segovia;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2022QI;""
40 Segovia;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2021QIV;539
40 Segovia;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
40 Segovia;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2021QII;""
40 Segovia;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2021QI;""
40 Segovia;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2020QIV;529
40 Segovia;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
40 Segovia;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2020QII;""
40 Segovia;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2020QI;""
40 Segovia;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
40 Segovia;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
40 Segovia;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QII;""
40 Segovia;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QI;520
40 Segovia;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
40 Segovia;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
40 Segovia;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QII;""
40 Segovia;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QI;514
40 Segovia;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
40 Segovia;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
40 Segovia;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QII;""
40 Segovia;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QI;""
40 Segovia;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
40 Segovia;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
40 Segovia;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QII;499
40 Segovia;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QI;""
40 Segovia;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
40 Segovia;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
40 Segovia;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QII;497
40 Segovia;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QI;""
40 Segovia;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
40 Segovia;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
40 Segovia;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QII;""
40 Segovia;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QI;""
40 Segovia;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
40 Segovia;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
40 Segovia;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
40 Segovia;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
40 Segovia;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
40 Segovia;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
40 Segovia;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
40 Segovia;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
40 Segovia;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
40 Segovia;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
40 Segovia;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
40 Segovia;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
40 Segovia;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
40 Segovia;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;95,02
40 Segovia;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
40 Segovia;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
40 Segovia;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
40 Segovia;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;96,86
40 Segovia;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
40 Segovia;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
40 Segovia;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
40 Segovia;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;94,97
40 Segovia;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
40 Segovia;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
40 Segovia;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;91,58
40 Segovia;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
40 Segovia;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
40 Segovia;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
40 Segovia;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;93,9
40 Segovia;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
40 Segovia;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
40 Segovia;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
40 Segovia;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;91,68
40 Segovia;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
40 Segovia;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
40 Segovia;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
40 Segovia;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
40 Segovia;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
40 Segovia;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
40 Segovia;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;90,59
40 Segovia;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
40 Segovia;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
40 Segovia;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
40 Segovia;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;89,08
40 Segovia;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
40 Segovia;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
40 Segovia;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
40 Segovia;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
40 Segovia;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
40 Segovia;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
40 Segovia;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;86,93
40 Segovia;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
40 Segovia;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
40 Segovia;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
40 Segovia;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;86,14
40 Segovia;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
40 Segovia;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
40 Segovia;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
40 Segovia;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
40 Segovia;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
40 Segovia;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QIV;1.562
40 Segovia;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
40 Segovia;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
40 Segovia;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
40 Segovia;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QIV;1.609
40 Segovia;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
40 Segovia;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
40 Segovia;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
40 Segovia;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QIV;1.604
40 Segovia;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
40 Segovia;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
40 Segovia;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
40 Segovia;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2022QIV;1.491
40 Segovia;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
40 Segovia;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2022QII;""
40 Segovia;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2022QI;""
40 Segovia;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2021QIV;1.552
40 Segovia;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
40 Segovia;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2021QII;""
40 Segovia;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2021QI;""
40 Segovia;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2020QIV;1.549
40 Segovia;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
40 Segovia;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2020QII;""
40 Segovia;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2020QI;""
40 Segovia;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
40 Segovia;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
40 Segovia;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2022QII;""
40 Segovia;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2022QI;1.504
40 Segovia;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
40 Segovia;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
40 Segovia;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2021QII;""
40 Segovia;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2021QI;1.517
40 Segovia;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
40 Segovia;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
40 Segovia;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2020QII;""
40 Segovia;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2020QI;""
40 Segovia;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
40 Segovia;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
40 Segovia;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QII;1.446
40 Segovia;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QI;""
40 Segovia;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
40 Segovia;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
40 Segovia;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QII;1.478
40 Segovia;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QI;""
40 Segovia;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
40 Segovia;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
40 Segovia;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QII;""
40 Segovia;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QI;""
40 Segovia;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
40 Segovia;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QIII;1.404
40 Segovia;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QII;""
40 Segovia;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QI;""
40 Segovia;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
40 Segovia;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QIII;1.441
40 Segovia;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QII;""
40 Segovia;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QI;""
40 Segovia;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
40 Segovia;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
40 Segovia;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QII;""
40 Segovia;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QI;""
40 Segovia;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
40 Segovia;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
40 Segovia;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
40 Segovia;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
40 Segovia;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
40 Segovia;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
40 Segovia;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
40 Segovia;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
40 Segovia;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
40 Segovia;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
40 Segovia;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
40 Segovia;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
40 Segovia;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;95,45
40 Segovia;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
40 Segovia;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
40 Segovia;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
40 Segovia;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;96,46
40 Segovia;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
40 Segovia;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
40 Segovia;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
40 Segovia;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;96,57
40 Segovia;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
40 Segovia;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
40 Segovia;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
40 Segovia;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
40 Segovia;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
40 Segovia;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
40 Segovia;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;93,47
40 Segovia;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
40 Segovia;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
40 Segovia;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
40 Segovia;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;94,58
40 Segovia;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
40 Segovia;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
40 Segovia;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
40 Segovia;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
40 Segovia;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
40 Segovia;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
40 Segovia;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;89,87
40 Segovia;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
40 Segovia;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
40 Segovia;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
40 Segovia;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;92,14
40 Segovia;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
40 Segovia;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
40 Segovia;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
40 Segovia;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
40 Segovia;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
40 Segovia;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
40 Segovia;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;87,26
40 Segovia;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
40 Segovia;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
40 Segovia;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
40 Segovia;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;89,84
40 Segovia;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
40 Segovia;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
40 Segovia;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
40 Segovia;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
40 Segovia;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
40 Segovia;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
40 Segovia;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QIV;981
40 Segovia;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
40 Segovia;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
40 Segovia;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
40 Segovia;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QIV;1.006
40 Segovia;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
40 Segovia;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
40 Segovia;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
40 Segovia;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QIV;1.022
40 Segovia;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
40 Segovia;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
40 Segovia;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
40 Segovia;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2022QIV;931
40 Segovia;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
40 Segovia;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2022QII;""
40 Segovia;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2022QI;""
40 Segovia;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2021QIV;974
40 Segovia;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
40 Segovia;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2021QII;""
40 Segovia;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2021QI;""
40 Segovia;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2020QIV;988
40 Segovia;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
40 Segovia;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2020QII;""
40 Segovia;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2020QI;""
40 Segovia;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
40 Segovia;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
40 Segovia;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2022QII;""
40 Segovia;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2022QI;948
40 Segovia;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
40 Segovia;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
40 Segovia;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2021QII;""
40 Segovia;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2021QI;972
40 Segovia;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
40 Segovia;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
40 Segovia;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2020QII;""
40 Segovia;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2020QI;""
40 Segovia;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
40 Segovia;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
40 Segovia;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QII;913
40 Segovia;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QI;""
40 Segovia;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
40 Segovia;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
40 Segovia;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QII;954
40 Segovia;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QI;""
40 Segovia;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
40 Segovia;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
40 Segovia;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QII;""
40 Segovia;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QI;""
40 Segovia;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
40 Segovia;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QIII;891
40 Segovia;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QII;""
40 Segovia;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QI;""
40 Segovia;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
40 Segovia;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QIII;933
40 Segovia;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QII;""
40 Segovia;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QI;""
40 Segovia;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
40 Segovia;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
40 Segovia;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QII;""
40 Segovia;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QI;""
40 Segovia;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
40 Segovia;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
40 Segovia;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
40 Segovia;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
40 Segovia;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
40 Segovia;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
40 Segovia;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
40 Segovia;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
40 Segovia;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
40 Segovia;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
40 Segovia;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
40 Segovia;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
40 Segovia;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;94,9
40 Segovia;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
40 Segovia;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
40 Segovia;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
40 Segovia;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;96,82
40 Segovia;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
40 Segovia;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
40 Segovia;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
40 Segovia;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;96,67
40 Segovia;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
40 Segovia;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
40 Segovia;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
40 Segovia;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
40 Segovia;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
40 Segovia;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
40 Segovia;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;94,23
40 Segovia;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
40 Segovia;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
40 Segovia;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
40 Segovia;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;95,11
40 Segovia;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
40 Segovia;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
40 Segovia;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
40 Segovia;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
40 Segovia;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
40 Segovia;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
40 Segovia;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;90,76
40 Segovia;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
40 Segovia;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
40 Segovia;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
40 Segovia;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;93,35
40 Segovia;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
40 Segovia;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
40 Segovia;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
40 Segovia;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
40 Segovia;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
40 Segovia;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
40 Segovia;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;88,57
40 Segovia;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
40 Segovia;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
40 Segovia;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
40 Segovia;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;91,29
40 Segovia;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
40 Segovia;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
40 Segovia;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
40 Segovia;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
40 Segovia;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
40 Segovia;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
40 Segovia;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QIV;581
40 Segovia;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
40 Segovia;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
40 Segovia;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
40 Segovia;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QIV;603
40 Segovia;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
40 Segovia;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
40 Segovia;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
40 Segovia;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QIV;582
40 Segovia;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
40 Segovia;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
40 Segovia;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
40 Segovia;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2022QIV;560
40 Segovia;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
40 Segovia;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2022QII;""
40 Segovia;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2022QI;""
40 Segovia;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2021QIV;578
40 Segovia;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
40 Segovia;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2021QII;""
40 Segovia;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2021QI;""
40 Segovia;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2020QIV;561
40 Segovia;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
40 Segovia;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2020QII;""
40 Segovia;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2020QI;""
40 Segovia;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
40 Segovia;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
40 Segovia;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2022QII;""
40 Segovia;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2022QI;556
40 Segovia;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
40 Segovia;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
40 Segovia;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2021QII;""
40 Segovia;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2021QI;545
40 Segovia;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
40 Segovia;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
40 Segovia;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2020QII;""
40 Segovia;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2020QI;""
40 Segovia;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
40 Segovia;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
40 Segovia;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QII;533
40 Segovia;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QI;""
40 Segovia;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
40 Segovia;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
40 Segovia;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QII;524
40 Segovia;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QI;""
40 Segovia;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
40 Segovia;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
40 Segovia;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QII;""
40 Segovia;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QI;""
40 Segovia;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
40 Segovia;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QIII;513
40 Segovia;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QII;""
40 Segovia;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QI;""
40 Segovia;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
40 Segovia;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QIII;508
40 Segovia;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QII;""
40 Segovia;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QI;""
40 Segovia;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
40 Segovia;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
40 Segovia;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QII;""
40 Segovia;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QI;""
40 Segovia;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
40 Segovia;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
40 Segovia;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
40 Segovia;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
40 Segovia;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
40 Segovia;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
40 Segovia;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
40 Segovia;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
40 Segovia;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
40 Segovia;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
40 Segovia;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
40 Segovia;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
40 Segovia;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;96,39
40 Segovia;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
40 Segovia;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
40 Segovia;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
40 Segovia;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;95,85
40 Segovia;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
40 Segovia;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
40 Segovia;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
40 Segovia;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;96,39
40 Segovia;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
40 Segovia;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
40 Segovia;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
40 Segovia;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
40 Segovia;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
40 Segovia;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
40 Segovia;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;92,21
40 Segovia;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
40 Segovia;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
40 Segovia;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
40 Segovia;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;93,64
40 Segovia;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
40 Segovia;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
40 Segovia;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
40 Segovia;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
40 Segovia;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
40 Segovia;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
40 Segovia;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;88,39
40 Segovia;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
40 Segovia;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
40 Segovia;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
40 Segovia;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;90,03
40 Segovia;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
40 Segovia;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
40 Segovia;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
40 Segovia;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
40 Segovia;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
40 Segovia;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
40 Segovia;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;85,07
40 Segovia;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
40 Segovia;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
40 Segovia;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
40 Segovia;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;87,29
40 Segovia;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
40 Segovia;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
40 Segovia;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
40 Segovia;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
40 Segovia;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
40 Segovia;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
40 Segovia;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
40 Segovia;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
40 Segovia;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
40 Segovia;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QI;3.176
40 Segovia;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
40 Segovia;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
40 Segovia;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
40 Segovia;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QI;3.285
40 Segovia;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
40 Segovia;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
40 Segovia;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
40 Segovia;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QI;3.270
40 Segovia;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
40 Segovia;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
40 Segovia;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2022QII;""
40 Segovia;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2022QI;3.097
40 Segovia;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
40 Segovia;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
40 Segovia;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2021QII;""
40 Segovia;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2021QI;3.223
40 Segovia;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
40 Segovia;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
40 Segovia;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2020QII;""
40 Segovia;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2020QI;3.129
40 Segovia;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
40 Segovia;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
40 Segovia;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2022QII;3.037
40 Segovia;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2022QI;""
40 Segovia;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
40 Segovia;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
40 Segovia;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2021QII;3.157
40 Segovia;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2021QI;""
40 Segovia;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
40 Segovia;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
40 Segovia;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2020QII;3.084
40 Segovia;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2020QI;""
40 Segovia;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
40 Segovia;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QIII;2.988
40 Segovia;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QII;""
40 Segovia;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QI;""
40 Segovia;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
40 Segovia;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QIII;3.094
40 Segovia;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QII;""
40 Segovia;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QI;""
40 Segovia;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
40 Segovia;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QIII;3.040
40 Segovia;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QII;""
40 Segovia;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QI;""
40 Segovia;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QIV;2.925
40 Segovia;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
40 Segovia;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QII;""
40 Segovia;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QI;""
40 Segovia;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QIV;3.044
40 Segovia;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
40 Segovia;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QII;""
40 Segovia;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QI;""
40 Segovia;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QIV;2.991
40 Segovia;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
40 Segovia;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QII;""
40 Segovia;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QI;""
40 Segovia;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
40 Segovia;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
40 Segovia;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
40 Segovia;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
40 Segovia;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
40 Segovia;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
40 Segovia;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
40 Segovia;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
40 Segovia;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
40 Segovia;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
40 Segovia;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
40 Segovia;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
40 Segovia;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
40 Segovia;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
40 Segovia;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
40 Segovia;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;97,51
40 Segovia;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
40 Segovia;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
40 Segovia;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
40 Segovia;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;98,11
40 Segovia;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
40 Segovia;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
40 Segovia;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
40 Segovia;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;95,69
40 Segovia;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
40 Segovia;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
40 Segovia;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;95,62
40 Segovia;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
40 Segovia;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
40 Segovia;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
40 Segovia;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;96,1
40 Segovia;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
40 Segovia;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
40 Segovia;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
40 Segovia;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;94,31
40 Segovia;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
40 Segovia;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
40 Segovia;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;94,08
40 Segovia;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
40 Segovia;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
40 Segovia;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
40 Segovia;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;94,19
40 Segovia;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
40 Segovia;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
40 Segovia;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
40 Segovia;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;92,97
40 Segovia;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
40 Segovia;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
40 Segovia;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;92,1
40 Segovia;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
40 Segovia;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
40 Segovia;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
40 Segovia;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;92,66
40 Segovia;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
40 Segovia;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
40 Segovia;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
40 Segovia;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;91,47
40 Segovia;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
40 Segovia;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
40 Segovia;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
40 Segovia;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
40 Segovia;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
40 Segovia;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
40 Segovia;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QI;2.058
40 Segovia;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
40 Segovia;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
40 Segovia;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
40 Segovia;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QI;2.142
40 Segovia;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
40 Segovia;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
40 Segovia;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
40 Segovia;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QI;2.107
40 Segovia;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
40 Segovia;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
40 Segovia;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2022QII;""
40 Segovia;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2022QI;2.014
40 Segovia;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
40 Segovia;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
40 Segovia;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2021QII;""
40 Segovia;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2021QI;2.105
40 Segovia;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
40 Segovia;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
40 Segovia;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2020QII;""
40 Segovia;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2020QI;2.033
40 Segovia;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
40 Segovia;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
40 Segovia;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2022QII;1.983
40 Segovia;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2022QI;""
40 Segovia;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
40 Segovia;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
40 Segovia;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2021QII;2.069
40 Segovia;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2021QI;""
40 Segovia;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
40 Segovia;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
40 Segovia;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2020QII;2.015
40 Segovia;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2020QI;""
40 Segovia;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
40 Segovia;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QIII;1.958
40 Segovia;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QII;""
40 Segovia;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QI;""
40 Segovia;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
40 Segovia;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QIII;2.036
40 Segovia;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QII;""
40 Segovia;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QI;""
40 Segovia;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
40 Segovia;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QIII;1.987
40 Segovia;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QII;""
40 Segovia;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QI;""
40 Segovia;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QIV;1.920
40 Segovia;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
40 Segovia;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QII;""
40 Segovia;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QI;""
40 Segovia;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QIV;2.005
40 Segovia;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
40 Segovia;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QII;""
40 Segovia;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QI;""
40 Segovia;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QIV;1.962
40 Segovia;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
40 Segovia;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QII;""
40 Segovia;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QI;""
40 Segovia;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
40 Segovia;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
40 Segovia;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
40 Segovia;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
40 Segovia;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
40 Segovia;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
40 Segovia;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
40 Segovia;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
40 Segovia;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
40 Segovia;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
40 Segovia;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
40 Segovia;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
40 Segovia;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
40 Segovia;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
40 Segovia;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
40 Segovia;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;97,86
40 Segovia;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
40 Segovia;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
40 Segovia;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
40 Segovia;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;98,27
40 Segovia;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
40 Segovia;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
40 Segovia;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
40 Segovia;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;96,49
40 Segovia;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
40 Segovia;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
40 Segovia;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;96,36
40 Segovia;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
40 Segovia;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
40 Segovia;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
40 Segovia;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;96,59
40 Segovia;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
40 Segovia;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
40 Segovia;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
40 Segovia;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;95,63
40 Segovia;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
40 Segovia;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
40 Segovia;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;95,14
40 Segovia;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
40 Segovia;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
40 Segovia;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
40 Segovia;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;95,05
40 Segovia;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
40 Segovia;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
40 Segovia;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
40 Segovia;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;94,3
40 Segovia;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
40 Segovia;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
40 Segovia;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;93,29
40 Segovia;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
40 Segovia;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
40 Segovia;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
40 Segovia;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;93,6
40 Segovia;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
40 Segovia;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
40 Segovia;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
40 Segovia;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;93,12
40 Segovia;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
40 Segovia;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
40 Segovia;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
40 Segovia;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
40 Segovia;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
40 Segovia;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
40 Segovia;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QI;1.118
40 Segovia;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
40 Segovia;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
40 Segovia;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
40 Segovia;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QI;1.143
40 Segovia;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
40 Segovia;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
40 Segovia;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
40 Segovia;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QI;1.163
40 Segovia;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
40 Segovia;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
40 Segovia;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2022QII;""
40 Segovia;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2022QI;1.083
40 Segovia;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
40 Segovia;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
40 Segovia;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2021QII;""
40 Segovia;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2021QI;1.118
40 Segovia;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
40 Segovia;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
40 Segovia;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2020QII;""
40 Segovia;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2020QI;1.096
40 Segovia;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
40 Segovia;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
40 Segovia;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2022QII;1.054
40 Segovia;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2022QI;""
40 Segovia;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
40 Segovia;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
40 Segovia;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2021QII;1.088
40 Segovia;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2021QI;""
40 Segovia;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
40 Segovia;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
40 Segovia;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2020QII;1.069
40 Segovia;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2020QI;""
40 Segovia;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
40 Segovia;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QIII;1.030
40 Segovia;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QII;""
40 Segovia;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QI;""
40 Segovia;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
40 Segovia;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QIII;1.058
40 Segovia;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QII;""
40 Segovia;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QI;""
40 Segovia;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
40 Segovia;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QIII;1.053
40 Segovia;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QII;""
40 Segovia;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QI;""
40 Segovia;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QIV;1.005
40 Segovia;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
40 Segovia;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QII;""
40 Segovia;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QI;""
40 Segovia;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QIV;1.039
40 Segovia;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
40 Segovia;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QII;""
40 Segovia;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QI;""
40 Segovia;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QIV;1.029
40 Segovia;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
40 Segovia;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QII;""
40 Segovia;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QI;""
40 Segovia;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
40 Segovia;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
40 Segovia;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
40 Segovia;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
40 Segovia;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
40 Segovia;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
40 Segovia;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
40 Segovia;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
40 Segovia;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
40 Segovia;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
40 Segovia;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
40 Segovia;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
40 Segovia;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
40 Segovia;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
40 Segovia;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
40 Segovia;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;96,87
40 Segovia;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
40 Segovia;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
40 Segovia;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
40 Segovia;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;97,81
40 Segovia;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
40 Segovia;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
40 Segovia;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
40 Segovia;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;94,24
40 Segovia;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
40 Segovia;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
40 Segovia;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;94,28
40 Segovia;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
40 Segovia;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
40 Segovia;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
40 Segovia;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;95,19
40 Segovia;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
40 Segovia;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
40 Segovia;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
40 Segovia;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;91,92
40 Segovia;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
40 Segovia;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
40 Segovia;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;92,13
40 Segovia;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
40 Segovia;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
40 Segovia;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
40 Segovia;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;92,56
40 Segovia;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
40 Segovia;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
40 Segovia;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
40 Segovia;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;90,54
40 Segovia;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
40 Segovia;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
40 Segovia;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;89,89
40 Segovia;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
40 Segovia;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
40 Segovia;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
40 Segovia;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;90,9
40 Segovia;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
40 Segovia;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
40 Segovia;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
40 Segovia;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;88,48
40 Segovia;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
40 Segovia;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
40 Segovia;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
40 Segovia;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
40 Segovia;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
40 Segovia;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QII;3.060
40 Segovia;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
40 Segovia;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
40 Segovia;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
40 Segovia;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QII;3.163
40 Segovia;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
40 Segovia;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
40 Segovia;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
40 Segovia;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QII;3.220
40 Segovia;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
40 Segovia;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
40 Segovia;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
40 Segovia;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2022QII;2.988
40 Segovia;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2022QI;""
40 Segovia;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
40 Segovia;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
40 Segovia;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2021QII;3.091
40 Segovia;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2021QI;""
40 Segovia;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
40 Segovia;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
40 Segovia;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2020QII;3.172
40 Segovia;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2020QI;""
40 Segovia;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
40 Segovia;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2022QIII;2.933
40 Segovia;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2022QII;""
40 Segovia;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2022QI;""
40 Segovia;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
40 Segovia;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2021QIII;3.025
40 Segovia;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2021QII;""
40 Segovia;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2021QI;""
40 Segovia;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
40 Segovia;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2020QIII;3.119
40 Segovia;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2020QII;""
40 Segovia;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2020QI;""
40 Segovia;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QIV;2.864
40 Segovia;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
40 Segovia;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QII;""
40 Segovia;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QI;""
40 Segovia;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QIV;2.966
40 Segovia;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
40 Segovia;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QII;""
40 Segovia;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QI;""
40 Segovia;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QIV;3.066
40 Segovia;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
40 Segovia;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QII;""
40 Segovia;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QI;""
40 Segovia;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
40 Segovia;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
40 Segovia;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QII;""
40 Segovia;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QI;2.904
40 Segovia;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
40 Segovia;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
40 Segovia;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QII;""
40 Segovia;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QI;3.024
40 Segovia;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
40 Segovia;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
40 Segovia;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QII;""
40 Segovia;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QI;""
40 Segovia;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
40 Segovia;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
40 Segovia;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
40 Segovia;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
40 Segovia;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
40 Segovia;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
40 Segovia;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
40 Segovia;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
40 Segovia;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
40 Segovia;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
40 Segovia;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
40 Segovia;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
40 Segovia;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
40 Segovia;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
40 Segovia;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;97,65
40 Segovia;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
40 Segovia;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
40 Segovia;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
40 Segovia;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;97,72
40 Segovia;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
40 Segovia;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
40 Segovia;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
40 Segovia;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;98,51
40 Segovia;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
40 Segovia;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
40 Segovia;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;95,85
40 Segovia;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
40 Segovia;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
40 Segovia;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
40 Segovia;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;95,64
40 Segovia;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
40 Segovia;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
40 Segovia;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
40 Segovia;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;96,86
40 Segovia;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
40 Segovia;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
40 Segovia;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;93,59
40 Segovia;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
40 Segovia;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
40 Segovia;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
40 Segovia;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;93,77
40 Segovia;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
40 Segovia;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
40 Segovia;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
40 Segovia;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;95,22
40 Segovia;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
40 Segovia;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
40 Segovia;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
40 Segovia;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
40 Segovia;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
40 Segovia;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
40 Segovia;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;91,81
40 Segovia;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
40 Segovia;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
40 Segovia;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
40 Segovia;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;93,91
40 Segovia;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
40 Segovia;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
40 Segovia;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
40 Segovia;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
40 Segovia;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
40 Segovia;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
40 Segovia;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QII;1.978
40 Segovia;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
40 Segovia;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
40 Segovia;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
40 Segovia;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QII;2.048
40 Segovia;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
40 Segovia;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
40 Segovia;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
40 Segovia;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QII;2.095
40 Segovia;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
40 Segovia;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
40 Segovia;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
40 Segovia;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2022QII;1.936
40 Segovia;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2022QI;""
40 Segovia;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
40 Segovia;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
40 Segovia;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2021QII;2.009
40 Segovia;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2021QI;""
40 Segovia;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
40 Segovia;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
40 Segovia;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2020QII;2.075
40 Segovia;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2020QI;""
40 Segovia;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
40 Segovia;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2022QIII;1.905
40 Segovia;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2022QII;""
40 Segovia;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2022QI;""
40 Segovia;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
40 Segovia;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2021QIII;1.973
40 Segovia;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2021QII;""
40 Segovia;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2021QI;""
40 Segovia;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
40 Segovia;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2020QIII;2.041
40 Segovia;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2020QII;""
40 Segovia;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2020QI;""
40 Segovia;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QIV;1.862
40 Segovia;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
40 Segovia;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QII;""
40 Segovia;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QI;""
40 Segovia;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QIV;1.937
40 Segovia;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
40 Segovia;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QII;""
40 Segovia;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QI;""
40 Segovia;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QIV;2.014
40 Segovia;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
40 Segovia;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QII;""
40 Segovia;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QI;""
40 Segovia;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
40 Segovia;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
40 Segovia;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QII;""
40 Segovia;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QI;1.902
40 Segovia;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
40 Segovia;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
40 Segovia;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QII;""
40 Segovia;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QI;1.992
40 Segovia;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
40 Segovia;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
40 Segovia;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QII;""
40 Segovia;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QI;""
40 Segovia;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
40 Segovia;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
40 Segovia;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
40 Segovia;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
40 Segovia;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
40 Segovia;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
40 Segovia;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
40 Segovia;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
40 Segovia;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
40 Segovia;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
40 Segovia;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
40 Segovia;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
40 Segovia;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
40 Segovia;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
40 Segovia;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;97,88
40 Segovia;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
40 Segovia;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
40 Segovia;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
40 Segovia;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;98,1
40 Segovia;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
40 Segovia;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
40 Segovia;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
40 Segovia;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;99,05
40 Segovia;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
40 Segovia;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
40 Segovia;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;96,31
40 Segovia;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
40 Segovia;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
40 Segovia;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
40 Segovia;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;96,34
40 Segovia;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
40 Segovia;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
40 Segovia;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
40 Segovia;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;97,42
40 Segovia;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
40 Segovia;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
40 Segovia;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;94,14
40 Segovia;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
40 Segovia;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
40 Segovia;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
40 Segovia;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;94,58
40 Segovia;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
40 Segovia;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
40 Segovia;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
40 Segovia;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;96,13
40 Segovia;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
40 Segovia;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
40 Segovia;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
40 Segovia;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
40 Segovia;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
40 Segovia;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
40 Segovia;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;92,87
40 Segovia;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
40 Segovia;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
40 Segovia;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
40 Segovia;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;95,08
40 Segovia;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
40 Segovia;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
40 Segovia;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
40 Segovia;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
40 Segovia;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
40 Segovia;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
40 Segovia;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QII;1.082
40 Segovia;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
40 Segovia;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
40 Segovia;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
40 Segovia;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QII;1.115
40 Segovia;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
40 Segovia;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
40 Segovia;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
40 Segovia;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QII;1.125
40 Segovia;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
40 Segovia;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
40 Segovia;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
40 Segovia;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2022QII;1.052
40 Segovia;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2022QI;""
40 Segovia;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
40 Segovia;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
40 Segovia;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2021QII;1.082
40 Segovia;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2021QI;""
40 Segovia;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
40 Segovia;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
40 Segovia;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2020QII;1.097
40 Segovia;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2020QI;""
40 Segovia;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
40 Segovia;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2022QIII;1.028
40 Segovia;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2022QII;""
40 Segovia;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2022QI;""
40 Segovia;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
40 Segovia;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2021QIII;1.052
40 Segovia;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2021QII;""
40 Segovia;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2021QI;""
40 Segovia;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
40 Segovia;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2020QIII;1.078
40 Segovia;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2020QII;""
40 Segovia;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2020QI;""
40 Segovia;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QIV;1.002
40 Segovia;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
40 Segovia;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QII;""
40 Segovia;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QI;""
40 Segovia;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QIV;1.029
40 Segovia;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
40 Segovia;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QII;""
40 Segovia;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QI;""
40 Segovia;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QIV;1.052
40 Segovia;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
40 Segovia;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QII;""
40 Segovia;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QI;""
40 Segovia;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
40 Segovia;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
40 Segovia;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QII;""
40 Segovia;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QI;1.002
40 Segovia;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
40 Segovia;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
40 Segovia;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QII;""
40 Segovia;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QI;1.032
40 Segovia;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
40 Segovia;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
40 Segovia;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QII;""
40 Segovia;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QI;""
40 Segovia;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
40 Segovia;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
40 Segovia;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
40 Segovia;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
40 Segovia;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
40 Segovia;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
40 Segovia;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
40 Segovia;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
40 Segovia;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
40 Segovia;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
40 Segovia;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
40 Segovia;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
40 Segovia;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
40 Segovia;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
40 Segovia;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;97,23
40 Segovia;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
40 Segovia;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
40 Segovia;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
40 Segovia;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;97,04
40 Segovia;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
40 Segovia;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
40 Segovia;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
40 Segovia;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;97,51
40 Segovia;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
40 Segovia;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
40 Segovia;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;95,01
40 Segovia;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
40 Segovia;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
40 Segovia;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
40 Segovia;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;94,35
40 Segovia;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
40 Segovia;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
40 Segovia;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
40 Segovia;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;95,82
40 Segovia;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
40 Segovia;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
40 Segovia;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;92,61
40 Segovia;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
40 Segovia;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
40 Segovia;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
40 Segovia;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;92,29
40 Segovia;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
40 Segovia;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
40 Segovia;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
40 Segovia;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;93,51
40 Segovia;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
40 Segovia;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
40 Segovia;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
40 Segovia;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
40 Segovia;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
40 Segovia;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
40 Segovia;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;89,87
40 Segovia;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
40 Segovia;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
40 Segovia;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
40 Segovia;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;91,73
40 Segovia;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
40 Segovia;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
40 Segovia;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
40 Segovia;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
40 Segovia;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
40 Segovia;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QIII;3.089
40 Segovia;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
40 Segovia;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
40 Segovia;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
40 Segovia;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QIII;3.182
40 Segovia;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
40 Segovia;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
40 Segovia;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
40 Segovia;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QIII;3.255
40 Segovia;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
40 Segovia;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
40 Segovia;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
40 Segovia;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2022QIII;3.020
40 Segovia;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2022QII;""
40 Segovia;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2022QI;""
40 Segovia;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
40 Segovia;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2021QIII;3.103
40 Segovia;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2021QII;""
40 Segovia;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2021QI;""
40 Segovia;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
40 Segovia;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2020QIII;3.191
40 Segovia;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2020QII;""
40 Segovia;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2020QI;""
40 Segovia;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2022QIV;2.941
40 Segovia;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
40 Segovia;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2022QII;""
40 Segovia;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2022QI;""
40 Segovia;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2021QIV;3.031
40 Segovia;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
40 Segovia;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2021QII;""
40 Segovia;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2021QI;""
40 Segovia;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2020QIV;3.129
40 Segovia;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
40 Segovia;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2020QII;""
40 Segovia;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2020QI;""
40 Segovia;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
40 Segovia;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
40 Segovia;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QII;""
40 Segovia;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QI;2.964
40 Segovia;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
40 Segovia;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
40 Segovia;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QII;""
40 Segovia;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QI;3.084
40 Segovia;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
40 Segovia;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
40 Segovia;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QII;""
40 Segovia;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QI;""
40 Segovia;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
40 Segovia;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
40 Segovia;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QII;2.918
40 Segovia;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QI;""
40 Segovia;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
40 Segovia;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
40 Segovia;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QII;3.033
40 Segovia;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QI;""
40 Segovia;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
40 Segovia;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
40 Segovia;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QII;""
40 Segovia;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QI;""
40 Segovia;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
40 Segovia;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
40 Segovia;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
40 Segovia;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
40 Segovia;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
40 Segovia;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
40 Segovia;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
40 Segovia;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
40 Segovia;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
40 Segovia;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
40 Segovia;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
40 Segovia;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
40 Segovia;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
40 Segovia;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;97,77
40 Segovia;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
40 Segovia;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
40 Segovia;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
40 Segovia;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;97,52
40 Segovia;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
40 Segovia;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
40 Segovia;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
40 Segovia;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;98,03
40 Segovia;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
40 Segovia;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
40 Segovia;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;95,21
40 Segovia;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
40 Segovia;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
40 Segovia;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
40 Segovia;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;95,25
40 Segovia;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
40 Segovia;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
40 Segovia;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
40 Segovia;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;96,13
40 Segovia;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
40 Segovia;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
40 Segovia;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
40 Segovia;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
40 Segovia;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
40 Segovia;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
40 Segovia;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;93,15
40 Segovia;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
40 Segovia;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
40 Segovia;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
40 Segovia;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;94,75
40 Segovia;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
40 Segovia;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
40 Segovia;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
40 Segovia;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
40 Segovia;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
40 Segovia;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
40 Segovia;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;91,7
40 Segovia;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
40 Segovia;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
40 Segovia;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
40 Segovia;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;93,18
40 Segovia;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
40 Segovia;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
40 Segovia;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
40 Segovia;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
40 Segovia;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
40 Segovia;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
40 Segovia;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QIII;1.997
40 Segovia;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
40 Segovia;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
40 Segovia;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
40 Segovia;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QIII;2.066
40 Segovia;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
40 Segovia;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
40 Segovia;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
40 Segovia;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QIII;2.131
40 Segovia;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
40 Segovia;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
40 Segovia;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
40 Segovia;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2022QIII;1.956
40 Segovia;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2022QII;""
40 Segovia;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2022QI;""
40 Segovia;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
40 Segovia;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2021QIII;2.024
40 Segovia;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2021QII;""
40 Segovia;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2021QI;""
40 Segovia;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
40 Segovia;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2020QIII;2.088
40 Segovia;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2020QII;""
40 Segovia;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2020QI;""
40 Segovia;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2022QIV;1.906
40 Segovia;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
40 Segovia;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2022QII;""
40 Segovia;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2022QI;""
40 Segovia;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2021QIV;1.976
40 Segovia;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
40 Segovia;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2021QII;""
40 Segovia;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2021QI;""
40 Segovia;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2020QIV;2.054
40 Segovia;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
40 Segovia;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2020QII;""
40 Segovia;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2020QI;""
40 Segovia;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
40 Segovia;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
40 Segovia;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QII;""
40 Segovia;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QI;1.937
40 Segovia;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
40 Segovia;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
40 Segovia;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QII;""
40 Segovia;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QI;2.030
40 Segovia;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
40 Segovia;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
40 Segovia;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QII;""
40 Segovia;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QI;""
40 Segovia;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
40 Segovia;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
40 Segovia;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QII;1.914
40 Segovia;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QI;""
40 Segovia;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
40 Segovia;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
40 Segovia;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QII;2.001
40 Segovia;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QI;""
40 Segovia;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
40 Segovia;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
40 Segovia;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QII;""
40 Segovia;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QI;""
40 Segovia;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
40 Segovia;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
40 Segovia;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
40 Segovia;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
40 Segovia;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
40 Segovia;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
40 Segovia;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
40 Segovia;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
40 Segovia;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
40 Segovia;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
40 Segovia;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
40 Segovia;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
40 Segovia;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
40 Segovia;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;97,95
40 Segovia;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
40 Segovia;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
40 Segovia;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
40 Segovia;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;97,97
40 Segovia;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
40 Segovia;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
40 Segovia;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
40 Segovia;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;97,98
40 Segovia;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
40 Segovia;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
40 Segovia;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;95,44
40 Segovia;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
40 Segovia;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
40 Segovia;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
40 Segovia;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;95,64
40 Segovia;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
40 Segovia;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
40 Segovia;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
40 Segovia;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;96,39
40 Segovia;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
40 Segovia;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
40 Segovia;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
40 Segovia;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
40 Segovia;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
40 Segovia;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
40 Segovia;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;93,76
40 Segovia;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
40 Segovia;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
40 Segovia;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
40 Segovia;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;95,26
40 Segovia;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
40 Segovia;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
40 Segovia;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
40 Segovia;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
40 Segovia;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
40 Segovia;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
40 Segovia;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;92,64
40 Segovia;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
40 Segovia;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
40 Segovia;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
40 Segovia;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;93,9
40 Segovia;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
40 Segovia;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
40 Segovia;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
40 Segovia;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
40 Segovia;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
40 Segovia;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
40 Segovia;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QIII;1.092
40 Segovia;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
40 Segovia;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
40 Segovia;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
40 Segovia;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QIII;1.116
40 Segovia;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
40 Segovia;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
40 Segovia;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
40 Segovia;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QIII;1.124
40 Segovia;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
40 Segovia;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
40 Segovia;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
40 Segovia;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2022QIII;1.064
40 Segovia;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2022QII;""
40 Segovia;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2022QI;""
40 Segovia;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
40 Segovia;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2021QIII;1.079
40 Segovia;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2021QII;""
40 Segovia;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2021QI;""
40 Segovia;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
40 Segovia;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2020QIII;1.103
40 Segovia;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2020QII;""
40 Segovia;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2020QI;""
40 Segovia;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2022QIV;1.035
40 Segovia;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
40 Segovia;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2022QII;""
40 Segovia;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2022QI;""
40 Segovia;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2021QIV;1.055
40 Segovia;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
40 Segovia;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2021QII;""
40 Segovia;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2021QI;""
40 Segovia;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2020QIV;1.075
40 Segovia;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
40 Segovia;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2020QII;""
40 Segovia;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2020QI;""
40 Segovia;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
40 Segovia;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
40 Segovia;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QII;""
40 Segovia;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QI;1.027
40 Segovia;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
40 Segovia;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
40 Segovia;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QII;""
40 Segovia;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QI;1.054
40 Segovia;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
40 Segovia;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
40 Segovia;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QII;""
40 Segovia;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QI;""
40 Segovia;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
40 Segovia;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
40 Segovia;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QII;1.004
40 Segovia;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QI;""
40 Segovia;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
40 Segovia;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
40 Segovia;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QII;1.032
40 Segovia;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QI;""
40 Segovia;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
40 Segovia;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
40 Segovia;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QII;""
40 Segovia;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QI;""
40 Segovia;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
40 Segovia;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
40 Segovia;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
40 Segovia;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
40 Segovia;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
40 Segovia;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
40 Segovia;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
40 Segovia;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
40 Segovia;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
40 Segovia;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
40 Segovia;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
40 Segovia;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
40 Segovia;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
40 Segovia;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;97,44
40 Segovia;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
40 Segovia;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
40 Segovia;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
40 Segovia;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;96,68
40 Segovia;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
40 Segovia;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
40 Segovia;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
40 Segovia;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;98,13
40 Segovia;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
40 Segovia;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
40 Segovia;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;94,78
40 Segovia;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
40 Segovia;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
40 Segovia;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
40 Segovia;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;94,53
40 Segovia;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
40 Segovia;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
40 Segovia;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
40 Segovia;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;95,64
40 Segovia;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
40 Segovia;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
40 Segovia;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
40 Segovia;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
40 Segovia;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
40 Segovia;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
40 Segovia;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;92,03
40 Segovia;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
40 Segovia;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
40 Segovia;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
40 Segovia;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;93,77
40 Segovia;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
40 Segovia;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
40 Segovia;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
40 Segovia;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
40 Segovia;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
40 Segovia;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
40 Segovia;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;89,96
40 Segovia;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
40 Segovia;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
40 Segovia;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
40 Segovia;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;91,81
40 Segovia;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
40 Segovia;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
40 Segovia;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
40 Segovia;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
40 Segovia;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
40 Segovia;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QIV;3.092
40 Segovia;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
40 Segovia;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
40 Segovia;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
40 Segovia;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QIV;3.173
40 Segovia;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
40 Segovia;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
40 Segovia;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
40 Segovia;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QIV;3.286
40 Segovia;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
40 Segovia;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
40 Segovia;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
40 Segovia;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2022QIV;2.999
40 Segovia;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
40 Segovia;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2022QII;""
40 Segovia;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2022QI;""
40 Segovia;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2021QIV;3.094
40 Segovia;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
40 Segovia;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2021QII;""
40 Segovia;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2021QI;""
40 Segovia;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2020QIV;3.211
40 Segovia;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
40 Segovia;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2020QII;""
40 Segovia;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2020QI;""
40 Segovia;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
40 Segovia;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
40 Segovia;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2022QII;""
40 Segovia;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2022QI;3.021
40 Segovia;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
40 Segovia;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
40 Segovia;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2021QII;""
40 Segovia;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2021QI;3.156
40 Segovia;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
40 Segovia;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
40 Segovia;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2020QII;""
40 Segovia;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2020QI;""
40 Segovia;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
40 Segovia;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
40 Segovia;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QII;2.969
40 Segovia;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QI;""
40 Segovia;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
40 Segovia;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
40 Segovia;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QII;3.100
40 Segovia;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QI;""
40 Segovia;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
40 Segovia;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
40 Segovia;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QII;""
40 Segovia;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QI;""
40 Segovia;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
40 Segovia;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QIII;2.927
40 Segovia;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QII;""
40 Segovia;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QI;""
40 Segovia;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
40 Segovia;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QIII;3.039
40 Segovia;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QII;""
40 Segovia;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QI;""
40 Segovia;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
40 Segovia;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
40 Segovia;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QII;""
40 Segovia;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QI;""
40 Segovia;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
40 Segovia;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
40 Segovia;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
40 Segovia;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
40 Segovia;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
40 Segovia;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
40 Segovia;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
40 Segovia;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
40 Segovia;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
40 Segovia;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
40 Segovia;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
40 Segovia;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
40 Segovia;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;96,99
40 Segovia;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
40 Segovia;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
40 Segovia;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
40 Segovia;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;97,51
40 Segovia;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
40 Segovia;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
40 Segovia;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
40 Segovia;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;97,72
40 Segovia;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
40 Segovia;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
40 Segovia;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
40 Segovia;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
40 Segovia;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
40 Segovia;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
40 Segovia;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;95,21
40 Segovia;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
40 Segovia;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
40 Segovia;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
40 Segovia;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;96,04
40 Segovia;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
40 Segovia;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
40 Segovia;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
40 Segovia;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
40 Segovia;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
40 Segovia;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
40 Segovia;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;93,57
40 Segovia;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
40 Segovia;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
40 Segovia;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
40 Segovia;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;94,34
40 Segovia;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
40 Segovia;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
40 Segovia;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
40 Segovia;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
40 Segovia;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
40 Segovia;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
40 Segovia;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;92,25
40 Segovia;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
40 Segovia;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
40 Segovia;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
40 Segovia;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;92,48
40 Segovia;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
40 Segovia;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
40 Segovia;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
40 Segovia;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
40 Segovia;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
40 Segovia;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
40 Segovia;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QIV;2.000
40 Segovia;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
40 Segovia;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
40 Segovia;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
40 Segovia;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QIV;2.063
40 Segovia;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
40 Segovia;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
40 Segovia;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
40 Segovia;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QIV;2.141
40 Segovia;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
40 Segovia;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
40 Segovia;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
40 Segovia;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2022QIV;1.942
40 Segovia;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
40 Segovia;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2022QII;""
40 Segovia;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2022QI;""
40 Segovia;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2021QIV;2.010
40 Segovia;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
40 Segovia;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2021QII;""
40 Segovia;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2021QI;""
40 Segovia;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2020QIV;2.098
40 Segovia;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
40 Segovia;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2020QII;""
40 Segovia;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2020QI;""
40 Segovia;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
40 Segovia;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
40 Segovia;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2022QII;""
40 Segovia;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2022QI;1.968
40 Segovia;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
40 Segovia;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
40 Segovia;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2021QII;""
40 Segovia;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2021QI;2.066
40 Segovia;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
40 Segovia;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
40 Segovia;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2020QII;""
40 Segovia;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2020QI;""
40 Segovia;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
40 Segovia;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
40 Segovia;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QII;1.942
40 Segovia;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QI;""
40 Segovia;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
40 Segovia;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
40 Segovia;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QII;2.034
40 Segovia;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QI;""
40 Segovia;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
40 Segovia;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
40 Segovia;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QII;""
40 Segovia;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QI;""
40 Segovia;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
40 Segovia;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QIII;1.919
40 Segovia;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QII;""
40 Segovia;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QI;""
40 Segovia;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
40 Segovia;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QIII;2.002
40 Segovia;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QII;""
40 Segovia;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QI;""
40 Segovia;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
40 Segovia;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
40 Segovia;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QII;""
40 Segovia;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QI;""
40 Segovia;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
40 Segovia;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
40 Segovia;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
40 Segovia;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
40 Segovia;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
40 Segovia;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
40 Segovia;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
40 Segovia;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
40 Segovia;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
40 Segovia;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
40 Segovia;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
40 Segovia;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
40 Segovia;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;97,1
40 Segovia;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
40 Segovia;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
40 Segovia;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
40 Segovia;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;97,43
40 Segovia;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
40 Segovia;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
40 Segovia;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
40 Segovia;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;97,99
40 Segovia;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
40 Segovia;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
40 Segovia;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
40 Segovia;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
40 Segovia;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
40 Segovia;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
40 Segovia;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;95,4
40 Segovia;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
40 Segovia;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
40 Segovia;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
40 Segovia;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;96,5
40 Segovia;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
40 Segovia;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
40 Segovia;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
40 Segovia;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
40 Segovia;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
40 Segovia;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
40 Segovia;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;94,13
40 Segovia;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
40 Segovia;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
40 Segovia;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
40 Segovia;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;95
40 Segovia;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
40 Segovia;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
40 Segovia;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
40 Segovia;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
40 Segovia;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
40 Segovia;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
40 Segovia;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;93,02
40 Segovia;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
40 Segovia;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
40 Segovia;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
40 Segovia;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;93,51
40 Segovia;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
40 Segovia;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
40 Segovia;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
40 Segovia;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
40 Segovia;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
40 Segovia;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
40 Segovia;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QIV;1.092
40 Segovia;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
40 Segovia;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
40 Segovia;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
40 Segovia;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QIV;1.110
40 Segovia;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
40 Segovia;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
40 Segovia;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
40 Segovia;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QIV;1.145
40 Segovia;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
40 Segovia;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
40 Segovia;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
40 Segovia;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2022QIV;1.057
40 Segovia;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
40 Segovia;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2022QII;""
40 Segovia;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2022QI;""
40 Segovia;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2021QIV;1.084
40 Segovia;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
40 Segovia;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2021QII;""
40 Segovia;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2021QI;""
40 Segovia;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2020QIV;1.113
40 Segovia;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
40 Segovia;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2020QII;""
40 Segovia;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2020QI;""
40 Segovia;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
40 Segovia;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
40 Segovia;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2022QII;""
40 Segovia;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2022QI;1.053
40 Segovia;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
40 Segovia;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
40 Segovia;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2021QII;""
40 Segovia;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2021QI;1.090
40 Segovia;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
40 Segovia;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
40 Segovia;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2020QII;""
40 Segovia;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2020QI;""
40 Segovia;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
40 Segovia;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
40 Segovia;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QII;1.027
40 Segovia;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QI;""
40 Segovia;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
40 Segovia;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
40 Segovia;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QII;1.066
40 Segovia;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QI;""
40 Segovia;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
40 Segovia;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
40 Segovia;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QII;""
40 Segovia;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QI;""
40 Segovia;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
40 Segovia;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QIII;1.008
40 Segovia;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QII;""
40 Segovia;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QI;""
40 Segovia;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
40 Segovia;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QIII;1.037
40 Segovia;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QII;""
40 Segovia;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QI;""
40 Segovia;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
40 Segovia;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
40 Segovia;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QII;""
40 Segovia;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QI;""
40 Segovia;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
40 Segovia;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
40 Segovia;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
40 Segovia;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
40 Segovia;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
40 Segovia;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
40 Segovia;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
40 Segovia;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
40 Segovia;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
40 Segovia;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
40 Segovia;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
40 Segovia;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
40 Segovia;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;96,79
40 Segovia;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
40 Segovia;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
40 Segovia;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
40 Segovia;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;97,66
40 Segovia;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
40 Segovia;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
40 Segovia;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
40 Segovia;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;97,21
40 Segovia;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
40 Segovia;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
40 Segovia;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
40 Segovia;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
40 Segovia;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
40 Segovia;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
40 Segovia;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;94,86
40 Segovia;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
40 Segovia;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
40 Segovia;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
40 Segovia;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;95,2
40 Segovia;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
40 Segovia;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
40 Segovia;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
40 Segovia;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
40 Segovia;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
40 Segovia;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
40 Segovia;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;92,52
40 Segovia;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
40 Segovia;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
40 Segovia;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
40 Segovia;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;93,1
40 Segovia;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
40 Segovia;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
40 Segovia;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
40 Segovia;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
40 Segovia;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
40 Segovia;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
40 Segovia;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;90,81
40 Segovia;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
40 Segovia;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
40 Segovia;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
40 Segovia;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;90,57
40 Segovia;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
40 Segovia;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
40 Segovia;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
40 Segovia;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
40 Segovia;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
40 Segovia;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
40 Segovia;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
40 Segovia;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
40 Segovia;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
40 Segovia;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QI;3.642
40 Segovia;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
40 Segovia;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
40 Segovia;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
40 Segovia;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QI;3.616
40 Segovia;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
40 Segovia;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
40 Segovia;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
40 Segovia;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QI;3.694
40 Segovia;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
40 Segovia;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
40 Segovia;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2022QII;""
40 Segovia;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2022QI;3.590
40 Segovia;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
40 Segovia;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
40 Segovia;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2021QII;""
40 Segovia;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2021QI;3.561
40 Segovia;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
40 Segovia;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
40 Segovia;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2020QII;""
40 Segovia;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2020QI;3.568
40 Segovia;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
40 Segovia;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
40 Segovia;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2022QII;3.542
40 Segovia;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2022QI;""
40 Segovia;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
40 Segovia;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
40 Segovia;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2021QII;3.514
40 Segovia;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2021QI;""
40 Segovia;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
40 Segovia;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
40 Segovia;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2020QII;3.505
40 Segovia;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2020QI;""
40 Segovia;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
40 Segovia;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QIII;3.497
40 Segovia;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QII;""
40 Segovia;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QI;""
40 Segovia;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
40 Segovia;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QIII;3.473
40 Segovia;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QII;""
40 Segovia;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QI;""
40 Segovia;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
40 Segovia;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QIII;3.450
40 Segovia;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QII;""
40 Segovia;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QI;""
40 Segovia;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QIV;3.437
40 Segovia;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
40 Segovia;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QII;""
40 Segovia;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QI;""
40 Segovia;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QIV;3.422
40 Segovia;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
40 Segovia;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QII;""
40 Segovia;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QI;""
40 Segovia;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QIV;3.412
40 Segovia;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
40 Segovia;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QII;""
40 Segovia;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QI;""
40 Segovia;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
40 Segovia;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
40 Segovia;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
40 Segovia;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
40 Segovia;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
40 Segovia;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
40 Segovia;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
40 Segovia;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
40 Segovia;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
40 Segovia;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
40 Segovia;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
40 Segovia;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
40 Segovia;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
40 Segovia;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
40 Segovia;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
40 Segovia;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;98,57
40 Segovia;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
40 Segovia;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
40 Segovia;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
40 Segovia;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;98,48
40 Segovia;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
40 Segovia;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
40 Segovia;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
40 Segovia;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;96,59
40 Segovia;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
40 Segovia;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
40 Segovia;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;97,25
40 Segovia;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
40 Segovia;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
40 Segovia;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
40 Segovia;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;97,18
40 Segovia;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
40 Segovia;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
40 Segovia;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
40 Segovia;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;94,88
40 Segovia;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
40 Segovia;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
40 Segovia;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;96,02
40 Segovia;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
40 Segovia;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
40 Segovia;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
40 Segovia;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;96,05
40 Segovia;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
40 Segovia;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
40 Segovia;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
40 Segovia;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;93,39
40 Segovia;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
40 Segovia;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
40 Segovia;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;94,37
40 Segovia;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
40 Segovia;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
40 Segovia;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
40 Segovia;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;94,63
40 Segovia;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
40 Segovia;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
40 Segovia;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
40 Segovia;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;92,37
40 Segovia;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
40 Segovia;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
40 Segovia;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
40 Segovia;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
40 Segovia;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
40 Segovia;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
40 Segovia;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QI;2.397
40 Segovia;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
40 Segovia;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
40 Segovia;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
40 Segovia;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QI;2.395
40 Segovia;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
40 Segovia;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
40 Segovia;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
40 Segovia;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QI;2.439
40 Segovia;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
40 Segovia;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
40 Segovia;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2022QII;""
40 Segovia;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2022QI;2.364
40 Segovia;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
40 Segovia;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
40 Segovia;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2021QII;""
40 Segovia;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2021QI;2.363
40 Segovia;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
40 Segovia;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
40 Segovia;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2020QII;""
40 Segovia;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2020QI;2.363
40 Segovia;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
40 Segovia;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
40 Segovia;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2022QII;2.335
40 Segovia;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2022QI;""
40 Segovia;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
40 Segovia;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
40 Segovia;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2021QII;2.337
40 Segovia;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2021QI;""
40 Segovia;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
40 Segovia;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
40 Segovia;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2020QII;2.329
40 Segovia;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2020QI;""
40 Segovia;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
40 Segovia;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QIII;2.315
40 Segovia;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QII;""
40 Segovia;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QI;""
40 Segovia;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
40 Segovia;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QIII;2.312
40 Segovia;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QII;""
40 Segovia;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QI;""
40 Segovia;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
40 Segovia;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QIII;2.300
40 Segovia;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QII;""
40 Segovia;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QI;""
40 Segovia;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QIV;2.279
40 Segovia;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
40 Segovia;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QII;""
40 Segovia;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QI;""
40 Segovia;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QIV;2.274
40 Segovia;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
40 Segovia;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QII;""
40 Segovia;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QI;""
40 Segovia;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QIV;2.273
40 Segovia;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
40 Segovia;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QII;""
40 Segovia;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QI;""
40 Segovia;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
40 Segovia;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
40 Segovia;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
40 Segovia;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
40 Segovia;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
40 Segovia;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
40 Segovia;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
40 Segovia;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
40 Segovia;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
40 Segovia;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
40 Segovia;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
40 Segovia;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
40 Segovia;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
40 Segovia;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
40 Segovia;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
40 Segovia;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;98,62
40 Segovia;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
40 Segovia;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
40 Segovia;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
40 Segovia;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;98,66
40 Segovia;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
40 Segovia;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
40 Segovia;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
40 Segovia;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;96,88
40 Segovia;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
40 Segovia;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
40 Segovia;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;97,41
40 Segovia;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
40 Segovia;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
40 Segovia;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
40 Segovia;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;97,58
40 Segovia;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
40 Segovia;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
40 Segovia;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
40 Segovia;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;95,49
40 Segovia;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
40 Segovia;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
40 Segovia;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;96,58
40 Segovia;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
40 Segovia;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
40 Segovia;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
40 Segovia;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;96,53
40 Segovia;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
40 Segovia;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
40 Segovia;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
40 Segovia;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;94,3
40 Segovia;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
40 Segovia;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
40 Segovia;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;95,08
40 Segovia;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
40 Segovia;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
40 Segovia;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
40 Segovia;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;94,95
40 Segovia;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
40 Segovia;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
40 Segovia;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
40 Segovia;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;93,19
40 Segovia;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
40 Segovia;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
40 Segovia;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
40 Segovia;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
40 Segovia;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
40 Segovia;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
40 Segovia;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QI;1.245
40 Segovia;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
40 Segovia;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
40 Segovia;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
40 Segovia;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QI;1.221
40 Segovia;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
40 Segovia;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
40 Segovia;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
40 Segovia;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QI;1.255
40 Segovia;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
40 Segovia;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
40 Segovia;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2022QII;""
40 Segovia;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2022QI;1.226
40 Segovia;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
40 Segovia;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
40 Segovia;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2021QII;""
40 Segovia;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2021QI;1.198
40 Segovia;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
40 Segovia;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
40 Segovia;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2020QII;""
40 Segovia;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2020QI;1.205
40 Segovia;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
40 Segovia;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
40 Segovia;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2022QII;1.207
40 Segovia;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2022QI;""
40 Segovia;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
40 Segovia;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
40 Segovia;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2021QII;1.177
40 Segovia;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2021QI;""
40 Segovia;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
40 Segovia;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
40 Segovia;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2020QII;1.176
40 Segovia;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2020QI;""
40 Segovia;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
40 Segovia;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QIII;1.182
40 Segovia;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QII;""
40 Segovia;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QI;""
40 Segovia;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
40 Segovia;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QIII;1.161
40 Segovia;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QII;""
40 Segovia;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QI;""
40 Segovia;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
40 Segovia;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QIII;1.150
40 Segovia;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QII;""
40 Segovia;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QI;""
40 Segovia;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QIV;1.158
40 Segovia;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
40 Segovia;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QII;""
40 Segovia;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QI;""
40 Segovia;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QIV;1.148
40 Segovia;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
40 Segovia;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QII;""
40 Segovia;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QI;""
40 Segovia;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QIV;1.139
40 Segovia;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
40 Segovia;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QII;""
40 Segovia;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QI;""
40 Segovia;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
40 Segovia;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
40 Segovia;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
40 Segovia;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
40 Segovia;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
40 Segovia;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
40 Segovia;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
40 Segovia;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
40 Segovia;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
40 Segovia;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
40 Segovia;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
40 Segovia;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
40 Segovia;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
40 Segovia;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
40 Segovia;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
40 Segovia;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;98,47
40 Segovia;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
40 Segovia;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
40 Segovia;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
40 Segovia;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;98,12
40 Segovia;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
40 Segovia;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
40 Segovia;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
40 Segovia;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;96,02
40 Segovia;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
40 Segovia;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
40 Segovia;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;96,95
40 Segovia;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
40 Segovia;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
40 Segovia;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
40 Segovia;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;96,4
40 Segovia;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
40 Segovia;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
40 Segovia;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
40 Segovia;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;93,71
40 Segovia;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
40 Segovia;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
40 Segovia;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;94,94
40 Segovia;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
40 Segovia;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
40 Segovia;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
40 Segovia;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;95,09
40 Segovia;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
40 Segovia;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
40 Segovia;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
40 Segovia;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;91,63
40 Segovia;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
40 Segovia;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
40 Segovia;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;93,01
40 Segovia;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
40 Segovia;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
40 Segovia;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
40 Segovia;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;94,02
40 Segovia;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
40 Segovia;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
40 Segovia;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
40 Segovia;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;90,76
40 Segovia;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
40 Segovia;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
40 Segovia;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
40 Segovia;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
40 Segovia;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
40 Segovia;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QII;3.672
40 Segovia;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
40 Segovia;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
40 Segovia;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
40 Segovia;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QII;3.658
40 Segovia;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
40 Segovia;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
40 Segovia;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
40 Segovia;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QII;3.642
40 Segovia;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
40 Segovia;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
40 Segovia;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
40 Segovia;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2022QII;3.615
40 Segovia;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2022QI;""
40 Segovia;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
40 Segovia;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
40 Segovia;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2021QII;3.606
40 Segovia;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2021QI;""
40 Segovia;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
40 Segovia;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
40 Segovia;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2020QII;3.576
40 Segovia;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2020QI;""
40 Segovia;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
40 Segovia;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2022QIII;3.555
40 Segovia;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2022QII;""
40 Segovia;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2022QI;""
40 Segovia;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
40 Segovia;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2021QIII;3.557
40 Segovia;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2021QII;""
40 Segovia;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2021QI;""
40 Segovia;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
40 Segovia;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2020QIII;3.516
40 Segovia;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2020QII;""
40 Segovia;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2020QI;""
40 Segovia;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QIV;3.490
40 Segovia;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
40 Segovia;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QII;""
40 Segovia;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QI;""
40 Segovia;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QIV;3.510
40 Segovia;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
40 Segovia;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QII;""
40 Segovia;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QI;""
40 Segovia;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QIV;3.473
40 Segovia;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
40 Segovia;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QII;""
40 Segovia;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QI;""
40 Segovia;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
40 Segovia;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
40 Segovia;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QII;""
40 Segovia;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QI;3.468
40 Segovia;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
40 Segovia;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
40 Segovia;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QII;""
40 Segovia;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QI;3.431
40 Segovia;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
40 Segovia;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
40 Segovia;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QII;""
40 Segovia;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QI;""
40 Segovia;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
40 Segovia;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
40 Segovia;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
40 Segovia;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
40 Segovia;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
40 Segovia;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
40 Segovia;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
40 Segovia;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
40 Segovia;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
40 Segovia;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
40 Segovia;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
40 Segovia;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
40 Segovia;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
40 Segovia;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
40 Segovia;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;98,45
40 Segovia;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
40 Segovia;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
40 Segovia;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
40 Segovia;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;98,58
40 Segovia;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
40 Segovia;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
40 Segovia;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
40 Segovia;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;98,19
40 Segovia;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
40 Segovia;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
40 Segovia;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;96,81
40 Segovia;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
40 Segovia;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
40 Segovia;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
40 Segovia;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;97,24
40 Segovia;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
40 Segovia;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
40 Segovia;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
40 Segovia;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;96,54
40 Segovia;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
40 Segovia;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
40 Segovia;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;95,04
40 Segovia;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
40 Segovia;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
40 Segovia;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
40 Segovia;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;95,95
40 Segovia;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
40 Segovia;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
40 Segovia;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
40 Segovia;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;95,36
40 Segovia;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
40 Segovia;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
40 Segovia;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
40 Segovia;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
40 Segovia;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
40 Segovia;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
40 Segovia;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;94,81
40 Segovia;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
40 Segovia;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
40 Segovia;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
40 Segovia;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;94,21
40 Segovia;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
40 Segovia;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
40 Segovia;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
40 Segovia;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
40 Segovia;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
40 Segovia;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
40 Segovia;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QII;2.415
40 Segovia;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
40 Segovia;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
40 Segovia;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
40 Segovia;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QII;2.418
40 Segovia;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
40 Segovia;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
40 Segovia;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
40 Segovia;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QII;2.410
40 Segovia;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
40 Segovia;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
40 Segovia;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
40 Segovia;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2022QII;2.379
40 Segovia;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2022QI;""
40 Segovia;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
40 Segovia;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
40 Segovia;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2021QII;2.390
40 Segovia;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2021QI;""
40 Segovia;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
40 Segovia;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
40 Segovia;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2020QII;2.375
40 Segovia;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2020QI;""
40 Segovia;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
40 Segovia;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2022QIII;2.351
40 Segovia;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2022QII;""
40 Segovia;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2022QI;""
40 Segovia;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
40 Segovia;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2021QIII;2.360
40 Segovia;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2021QII;""
40 Segovia;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2021QI;""
40 Segovia;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
40 Segovia;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2020QIII;2.341
40 Segovia;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2020QII;""
40 Segovia;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2020QI;""
40 Segovia;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QIV;2.313
40 Segovia;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
40 Segovia;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QII;""
40 Segovia;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QI;""
40 Segovia;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QIV;2.325
40 Segovia;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
40 Segovia;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QII;""
40 Segovia;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QI;""
40 Segovia;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QIV;2.313
40 Segovia;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
40 Segovia;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QII;""
40 Segovia;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QI;""
40 Segovia;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
40 Segovia;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
40 Segovia;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QII;""
40 Segovia;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QI;2.297
40 Segovia;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
40 Segovia;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
40 Segovia;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QII;""
40 Segovia;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QI;2.288
40 Segovia;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
40 Segovia;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
40 Segovia;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QII;""
40 Segovia;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QI;""
40 Segovia;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
40 Segovia;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
40 Segovia;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
40 Segovia;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
40 Segovia;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
40 Segovia;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
40 Segovia;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
40 Segovia;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
40 Segovia;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
40 Segovia;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
40 Segovia;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
40 Segovia;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
40 Segovia;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
40 Segovia;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
40 Segovia;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;98,51
40 Segovia;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
40 Segovia;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
40 Segovia;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
40 Segovia;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;98,84
40 Segovia;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
40 Segovia;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
40 Segovia;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
40 Segovia;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;98,55
40 Segovia;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
40 Segovia;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
40 Segovia;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;97,35
40 Segovia;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
40 Segovia;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
40 Segovia;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
40 Segovia;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;97,6
40 Segovia;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
40 Segovia;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
40 Segovia;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
40 Segovia;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;97,14
40 Segovia;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
40 Segovia;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
40 Segovia;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;95,78
40 Segovia;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
40 Segovia;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
40 Segovia;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
40 Segovia;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;96,15
40 Segovia;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
40 Segovia;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
40 Segovia;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
40 Segovia;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;95,98
40 Segovia;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
40 Segovia;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
40 Segovia;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
40 Segovia;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
40 Segovia;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
40 Segovia;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
40 Segovia;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;95
40 Segovia;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
40 Segovia;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
40 Segovia;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
40 Segovia;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;94,94
40 Segovia;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
40 Segovia;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
40 Segovia;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
40 Segovia;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
40 Segovia;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
40 Segovia;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
40 Segovia;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QII;1.257
40 Segovia;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
40 Segovia;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
40 Segovia;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
40 Segovia;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QII;1.240
40 Segovia;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
40 Segovia;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
40 Segovia;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
40 Segovia;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QII;1.232
40 Segovia;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
40 Segovia;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
40 Segovia;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
40 Segovia;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2022QII;1.236
40 Segovia;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2022QI;""
40 Segovia;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
40 Segovia;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
40 Segovia;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2021QII;1.216
40 Segovia;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2021QI;""
40 Segovia;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
40 Segovia;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
40 Segovia;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2020QII;1.201
40 Segovia;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2020QI;""
40 Segovia;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
40 Segovia;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2022QIII;1.204
40 Segovia;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2022QII;""
40 Segovia;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2022QI;""
40 Segovia;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
40 Segovia;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2021QIII;1.197
40 Segovia;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2021QII;""
40 Segovia;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2021QI;""
40 Segovia;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
40 Segovia;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2020QIII;1.175
40 Segovia;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2020QII;""
40 Segovia;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2020QI;""
40 Segovia;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QIV;1.177
40 Segovia;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
40 Segovia;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QII;""
40 Segovia;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QI;""
40 Segovia;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QIV;1.185
40 Segovia;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
40 Segovia;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QII;""
40 Segovia;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QI;""
40 Segovia;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QIV;1.160
40 Segovia;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
40 Segovia;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QII;""
40 Segovia;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QI;""
40 Segovia;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
40 Segovia;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
40 Segovia;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QII;""
40 Segovia;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QI;1.171
40 Segovia;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
40 Segovia;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
40 Segovia;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QII;""
40 Segovia;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QI;1.143
40 Segovia;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
40 Segovia;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
40 Segovia;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QII;""
40 Segovia;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QI;""
40 Segovia;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
40 Segovia;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
40 Segovia;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
40 Segovia;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
40 Segovia;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
40 Segovia;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
40 Segovia;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
40 Segovia;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
40 Segovia;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
40 Segovia;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
40 Segovia;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
40 Segovia;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
40 Segovia;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
40 Segovia;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
40 Segovia;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;98,33
40 Segovia;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
40 Segovia;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
40 Segovia;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
40 Segovia;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;98,06
40 Segovia;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
40 Segovia;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
40 Segovia;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
40 Segovia;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;97,48
40 Segovia;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
40 Segovia;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
40 Segovia;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;95,78
40 Segovia;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
40 Segovia;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
40 Segovia;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
40 Segovia;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;96,53
40 Segovia;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
40 Segovia;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
40 Segovia;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
40 Segovia;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;95,37
40 Segovia;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
40 Segovia;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
40 Segovia;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;93,64
40 Segovia;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
40 Segovia;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
40 Segovia;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
40 Segovia;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;95,56
40 Segovia;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
40 Segovia;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
40 Segovia;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
40 Segovia;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;94,16
40 Segovia;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
40 Segovia;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
40 Segovia;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
40 Segovia;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
40 Segovia;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
40 Segovia;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
40 Segovia;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;94,44
40 Segovia;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
40 Segovia;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
40 Segovia;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
40 Segovia;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;92,78
40 Segovia;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
40 Segovia;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
40 Segovia;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
40 Segovia;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
40 Segovia;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
40 Segovia;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QIII;3.662
40 Segovia;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
40 Segovia;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
40 Segovia;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
40 Segovia;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QIII;3.675
40 Segovia;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
40 Segovia;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
40 Segovia;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
40 Segovia;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QIII;3.632
40 Segovia;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
40 Segovia;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
40 Segovia;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
40 Segovia;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2022QIII;3.593
40 Segovia;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2022QII;""
40 Segovia;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2022QI;""
40 Segovia;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
40 Segovia;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2021QIII;3.612
40 Segovia;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2021QII;""
40 Segovia;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2021QI;""
40 Segovia;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
40 Segovia;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2020QIII;3.564
40 Segovia;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2020QII;""
40 Segovia;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2020QI;""
40 Segovia;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2022QIV;3.524
40 Segovia;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
40 Segovia;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2022QII;""
40 Segovia;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2022QI;""
40 Segovia;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2021QIV;3.557
40 Segovia;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
40 Segovia;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2021QII;""
40 Segovia;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2021QI;""
40 Segovia;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2020QIV;3.515
40 Segovia;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
40 Segovia;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2020QII;""
40 Segovia;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2020QI;""
40 Segovia;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
40 Segovia;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
40 Segovia;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QII;""
40 Segovia;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QI;3.513
40 Segovia;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
40 Segovia;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
40 Segovia;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QII;""
40 Segovia;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QI;3.471
40 Segovia;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
40 Segovia;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
40 Segovia;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QII;""
40 Segovia;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QI;""
40 Segovia;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
40 Segovia;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
40 Segovia;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QII;3.474
40 Segovia;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QI;""
40 Segovia;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
40 Segovia;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
40 Segovia;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QII;3.431
40 Segovia;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QI;""
40 Segovia;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
40 Segovia;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
40 Segovia;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QII;""
40 Segovia;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QI;""
40 Segovia;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
40 Segovia;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
40 Segovia;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
40 Segovia;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
40 Segovia;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
40 Segovia;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
40 Segovia;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
40 Segovia;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
40 Segovia;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
40 Segovia;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
40 Segovia;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
40 Segovia;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
40 Segovia;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
40 Segovia;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;98,12
40 Segovia;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
40 Segovia;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
40 Segovia;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
40 Segovia;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;98,29
40 Segovia;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
40 Segovia;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
40 Segovia;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
40 Segovia;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;98,13
40 Segovia;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
40 Segovia;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
40 Segovia;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;96,23
40 Segovia;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
40 Segovia;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
40 Segovia;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
40 Segovia;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;96,79
40 Segovia;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
40 Segovia;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
40 Segovia;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
40 Segovia;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;96,78
40 Segovia;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
40 Segovia;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
40 Segovia;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
40 Segovia;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
40 Segovia;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
40 Segovia;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
40 Segovia;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;95,59
40 Segovia;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
40 Segovia;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
40 Segovia;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
40 Segovia;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;95,57
40 Segovia;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
40 Segovia;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
40 Segovia;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
40 Segovia;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
40 Segovia;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
40 Segovia;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
40 Segovia;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;94,53
40 Segovia;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
40 Segovia;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
40 Segovia;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
40 Segovia;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;94,47
40 Segovia;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
40 Segovia;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
40 Segovia;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
40 Segovia;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
40 Segovia;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
40 Segovia;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
40 Segovia;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QIII;2.409
40 Segovia;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
40 Segovia;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
40 Segovia;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
40 Segovia;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QIII;2.427
40 Segovia;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
40 Segovia;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
40 Segovia;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
40 Segovia;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QIII;2.408
40 Segovia;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
40 Segovia;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
40 Segovia;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
40 Segovia;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2022QIII;2.375
40 Segovia;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2022QII;""
40 Segovia;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2022QI;""
40 Segovia;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
40 Segovia;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2021QIII;2.392
40 Segovia;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2021QII;""
40 Segovia;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2021QI;""
40 Segovia;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
40 Segovia;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2020QIII;2.369
40 Segovia;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2020QII;""
40 Segovia;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2020QI;""
40 Segovia;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2022QIV;2.336
40 Segovia;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
40 Segovia;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2022QII;""
40 Segovia;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2022QI;""
40 Segovia;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2021QIV;2.353
40 Segovia;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
40 Segovia;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2021QII;""
40 Segovia;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2021QI;""
40 Segovia;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2020QIV;2.338
40 Segovia;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
40 Segovia;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2020QII;""
40 Segovia;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2020QI;""
40 Segovia;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
40 Segovia;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
40 Segovia;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QII;""
40 Segovia;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QI;2.324
40 Segovia;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
40 Segovia;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
40 Segovia;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QII;""
40 Segovia;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QI;2.313
40 Segovia;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
40 Segovia;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
40 Segovia;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QII;""
40 Segovia;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QI;""
40 Segovia;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
40 Segovia;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
40 Segovia;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QII;2.298
40 Segovia;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QI;""
40 Segovia;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
40 Segovia;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
40 Segovia;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QII;2.288
40 Segovia;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QI;""
40 Segovia;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
40 Segovia;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
40 Segovia;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QII;""
40 Segovia;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QI;""
40 Segovia;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
40 Segovia;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
40 Segovia;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
40 Segovia;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
40 Segovia;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
40 Segovia;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
40 Segovia;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
40 Segovia;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
40 Segovia;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
40 Segovia;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
40 Segovia;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
40 Segovia;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
40 Segovia;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
40 Segovia;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;98,59
40 Segovia;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
40 Segovia;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
40 Segovia;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
40 Segovia;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;98,56
40 Segovia;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
40 Segovia;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
40 Segovia;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
40 Segovia;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;98,38
40 Segovia;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
40 Segovia;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
40 Segovia;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;96,97
40 Segovia;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
40 Segovia;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
40 Segovia;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
40 Segovia;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;96,95
40 Segovia;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
40 Segovia;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
40 Segovia;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
40 Segovia;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;97,09
40 Segovia;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
40 Segovia;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
40 Segovia;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
40 Segovia;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
40 Segovia;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
40 Segovia;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
40 Segovia;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;95,76
40 Segovia;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
40 Segovia;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
40 Segovia;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
40 Segovia;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;96,05
40 Segovia;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
40 Segovia;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
40 Segovia;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
40 Segovia;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
40 Segovia;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
40 Segovia;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
40 Segovia;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;94,68
40 Segovia;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
40 Segovia;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
40 Segovia;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
40 Segovia;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;95,02
40 Segovia;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
40 Segovia;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
40 Segovia;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
40 Segovia;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
40 Segovia;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
40 Segovia;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
40 Segovia;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QIII;1.253
40 Segovia;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
40 Segovia;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
40 Segovia;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
40 Segovia;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QIII;1.248
40 Segovia;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
40 Segovia;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
40 Segovia;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
40 Segovia;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QIII;1.224
40 Segovia;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
40 Segovia;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
40 Segovia;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
40 Segovia;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2022QIII;1.218
40 Segovia;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2022QII;""
40 Segovia;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2022QI;""
40 Segovia;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
40 Segovia;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2021QIII;1.220
40 Segovia;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2021QII;""
40 Segovia;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2021QI;""
40 Segovia;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
40 Segovia;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2020QIII;1.195
40 Segovia;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2020QII;""
40 Segovia;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2020QI;""
40 Segovia;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2022QIV;1.188
40 Segovia;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
40 Segovia;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2022QII;""
40 Segovia;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2022QI;""
40 Segovia;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2021QIV;1.204
40 Segovia;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
40 Segovia;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2021QII;""
40 Segovia;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2021QI;""
40 Segovia;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2020QIV;1.177
40 Segovia;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
40 Segovia;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2020QII;""
40 Segovia;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2020QI;""
40 Segovia;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
40 Segovia;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
40 Segovia;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QII;""
40 Segovia;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QI;1.189
40 Segovia;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
40 Segovia;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
40 Segovia;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QII;""
40 Segovia;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QI;1.158
40 Segovia;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
40 Segovia;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
40 Segovia;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QII;""
40 Segovia;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QI;""
40 Segovia;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
40 Segovia;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
40 Segovia;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QII;1.176
40 Segovia;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QI;""
40 Segovia;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
40 Segovia;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
40 Segovia;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QII;1.143
40 Segovia;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QI;""
40 Segovia;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
40 Segovia;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
40 Segovia;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QII;""
40 Segovia;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QI;""
40 Segovia;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
40 Segovia;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
40 Segovia;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
40 Segovia;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
40 Segovia;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
40 Segovia;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
40 Segovia;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
40 Segovia;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
40 Segovia;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
40 Segovia;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
40 Segovia;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
40 Segovia;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
40 Segovia;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
40 Segovia;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;97,21
40 Segovia;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
40 Segovia;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
40 Segovia;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
40 Segovia;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;97,76
40 Segovia;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
40 Segovia;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
40 Segovia;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
40 Segovia;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;97,63
40 Segovia;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
40 Segovia;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
40 Segovia;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;94,81
40 Segovia;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
40 Segovia;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
40 Segovia;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
40 Segovia;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;96,47
40 Segovia;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
40 Segovia;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
40 Segovia;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
40 Segovia;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;96,16
40 Segovia;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
40 Segovia;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
40 Segovia;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
40 Segovia;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
40 Segovia;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
40 Segovia;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
40 Segovia;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;95,27
40 Segovia;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
40 Segovia;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
40 Segovia;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
40 Segovia;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;94,61
40 Segovia;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
40 Segovia;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
40 Segovia;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
40 Segovia;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
40 Segovia;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
40 Segovia;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
40 Segovia;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;94,23
40 Segovia;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
40 Segovia;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
40 Segovia;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
40 Segovia;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;93,38
40 Segovia;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
40 Segovia;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
40 Segovia;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
40 Segovia;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
40 Segovia;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
40 Segovia;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QIV;3.640
40 Segovia;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
40 Segovia;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
40 Segovia;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
40 Segovia;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QIV;3.658
40 Segovia;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
40 Segovia;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
40 Segovia;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
40 Segovia;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QIV;3.629
40 Segovia;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
40 Segovia;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
40 Segovia;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
40 Segovia;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2022QIV;3.567
40 Segovia;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
40 Segovia;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2022QII;""
40 Segovia;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2022QI;""
40 Segovia;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2021QIV;3.595
40 Segovia;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
40 Segovia;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2021QII;""
40 Segovia;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2021QI;""
40 Segovia;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2020QIV;3.570
40 Segovia;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
40 Segovia;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2020QII;""
40 Segovia;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2020QI;""
40 Segovia;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
40 Segovia;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
40 Segovia;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2022QII;""
40 Segovia;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2022QI;3.548
40 Segovia;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
40 Segovia;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
40 Segovia;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2021QII;""
40 Segovia;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2021QI;3.522
40 Segovia;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
40 Segovia;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
40 Segovia;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2020QII;""
40 Segovia;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2020QI;""
40 Segovia;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
40 Segovia;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
40 Segovia;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QII;3.506
40 Segovia;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QI;""
40 Segovia;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
40 Segovia;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
40 Segovia;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QII;3.481
40 Segovia;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QI;""
40 Segovia;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
40 Segovia;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
40 Segovia;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QII;""
40 Segovia;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QI;""
40 Segovia;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
40 Segovia;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QIII;3.465
40 Segovia;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QII;""
40 Segovia;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QI;""
40 Segovia;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
40 Segovia;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QIII;3.443
40 Segovia;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QII;""
40 Segovia;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QI;""
40 Segovia;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
40 Segovia;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
40 Segovia;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QII;""
40 Segovia;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QI;""
40 Segovia;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
40 Segovia;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
40 Segovia;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
40 Segovia;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
40 Segovia;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
40 Segovia;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
40 Segovia;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
40 Segovia;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
40 Segovia;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
40 Segovia;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
40 Segovia;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
40 Segovia;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
40 Segovia;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;97,99
40 Segovia;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
40 Segovia;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
40 Segovia;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
40 Segovia;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;98,28
40 Segovia;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
40 Segovia;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
40 Segovia;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
40 Segovia;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;98,37
40 Segovia;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
40 Segovia;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
40 Segovia;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
40 Segovia;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
40 Segovia;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
40 Segovia;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
40 Segovia;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;96,99
40 Segovia;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
40 Segovia;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
40 Segovia;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
40 Segovia;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;97,05
40 Segovia;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
40 Segovia;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
40 Segovia;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
40 Segovia;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
40 Segovia;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
40 Segovia;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
40 Segovia;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;95,84
40 Segovia;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
40 Segovia;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
40 Segovia;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
40 Segovia;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;95,92
40 Segovia;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
40 Segovia;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
40 Segovia;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
40 Segovia;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
40 Segovia;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
40 Segovia;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
40 Segovia;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;94,72
40 Segovia;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
40 Segovia;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
40 Segovia;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
40 Segovia;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;94,87
40 Segovia;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
40 Segovia;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
40 Segovia;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
40 Segovia;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
40 Segovia;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
40 Segovia;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
40 Segovia;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QIV;2.401
40 Segovia;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
40 Segovia;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
40 Segovia;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
40 Segovia;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QIV;2.417
40 Segovia;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
40 Segovia;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
40 Segovia;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
40 Segovia;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QIV;2.408
40 Segovia;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
40 Segovia;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
40 Segovia;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
40 Segovia;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2022QIV;2.359
40 Segovia;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
40 Segovia;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2022QII;""
40 Segovia;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2022QI;""
40 Segovia;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2021QIV;2.373
40 Segovia;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
40 Segovia;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2021QII;""
40 Segovia;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2021QI;""
40 Segovia;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2020QIV;2.372
40 Segovia;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
40 Segovia;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2020QII;""
40 Segovia;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2020QI;""
40 Segovia;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
40 Segovia;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
40 Segovia;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2022QII;""
40 Segovia;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2022QI;2.342
40 Segovia;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
40 Segovia;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
40 Segovia;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2021QII;""
40 Segovia;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2021QI;2.344
40 Segovia;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
40 Segovia;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
40 Segovia;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2020QII;""
40 Segovia;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2020QI;""
40 Segovia;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
40 Segovia;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
40 Segovia;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QII;2.314
40 Segovia;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QI;""
40 Segovia;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
40 Segovia;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
40 Segovia;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QII;2.318
40 Segovia;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QI;""
40 Segovia;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
40 Segovia;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
40 Segovia;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QII;""
40 Segovia;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QI;""
40 Segovia;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
40 Segovia;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QIII;2.295
40 Segovia;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QII;""
40 Segovia;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QI;""
40 Segovia;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
40 Segovia;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QIII;2.294
40 Segovia;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QII;""
40 Segovia;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QI;""
40 Segovia;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
40 Segovia;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
40 Segovia;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QII;""
40 Segovia;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QI;""
40 Segovia;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
40 Segovia;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
40 Segovia;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
40 Segovia;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
40 Segovia;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
40 Segovia;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
40 Segovia;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
40 Segovia;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
40 Segovia;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
40 Segovia;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
40 Segovia;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
40 Segovia;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
40 Segovia;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;98,25
40 Segovia;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
40 Segovia;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
40 Segovia;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
40 Segovia;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;98,18
40 Segovia;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
40 Segovia;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
40 Segovia;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
40 Segovia;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;98,5
40 Segovia;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
40 Segovia;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
40 Segovia;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
40 Segovia;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
40 Segovia;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
40 Segovia;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
40 Segovia;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;96,9
40 Segovia;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
40 Segovia;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
40 Segovia;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
40 Segovia;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;97,34
40 Segovia;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
40 Segovia;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
40 Segovia;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
40 Segovia;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
40 Segovia;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
40 Segovia;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
40 Segovia;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;95,74
40 Segovia;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
40 Segovia;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
40 Segovia;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
40 Segovia;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;96,26
40 Segovia;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
40 Segovia;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
40 Segovia;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
40 Segovia;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
40 Segovia;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
40 Segovia;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
40 Segovia;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;94,95
40 Segovia;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
40 Segovia;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
40 Segovia;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
40 Segovia;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;95,27
40 Segovia;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
40 Segovia;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
40 Segovia;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
40 Segovia;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
40 Segovia;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
40 Segovia;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
40 Segovia;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QIV;1.239
40 Segovia;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
40 Segovia;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
40 Segovia;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
40 Segovia;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QIV;1.241
40 Segovia;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
40 Segovia;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
40 Segovia;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
40 Segovia;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QIV;1.221
40 Segovia;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
40 Segovia;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
40 Segovia;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
40 Segovia;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2022QIV;1.208
40 Segovia;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
40 Segovia;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2022QII;""
40 Segovia;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2022QI;""
40 Segovia;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2021QIV;1.222
40 Segovia;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
40 Segovia;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2021QII;""
40 Segovia;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2021QI;""
40 Segovia;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2020QIV;1.198
40 Segovia;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
40 Segovia;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2020QII;""
40 Segovia;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2020QI;""
40 Segovia;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
40 Segovia;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
40 Segovia;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2022QII;""
40 Segovia;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2022QI;1.206
40 Segovia;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
40 Segovia;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
40 Segovia;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2021QII;""
40 Segovia;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2021QI;1.178
40 Segovia;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
40 Segovia;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
40 Segovia;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2020QII;""
40 Segovia;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2020QI;""
40 Segovia;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
40 Segovia;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
40 Segovia;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QII;1.192
40 Segovia;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QI;""
40 Segovia;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
40 Segovia;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
40 Segovia;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QII;1.163
40 Segovia;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QI;""
40 Segovia;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
40 Segovia;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
40 Segovia;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QII;""
40 Segovia;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QI;""
40 Segovia;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
40 Segovia;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QIII;1.170
40 Segovia;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QII;""
40 Segovia;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QI;""
40 Segovia;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
40 Segovia;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QIII;1.149
40 Segovia;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QII;""
40 Segovia;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QI;""
40 Segovia;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
40 Segovia;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
40 Segovia;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QII;""
40 Segovia;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QI;""
40 Segovia;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
40 Segovia;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
40 Segovia;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
40 Segovia;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
40 Segovia;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
40 Segovia;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
40 Segovia;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
40 Segovia;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
40 Segovia;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
40 Segovia;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
40 Segovia;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
40 Segovia;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
40 Segovia;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;97,5
40 Segovia;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
40 Segovia;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
40 Segovia;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
40 Segovia;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;98,47
40 Segovia;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
40 Segovia;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
40 Segovia;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
40 Segovia;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;98,12
40 Segovia;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
40 Segovia;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
40 Segovia;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
40 Segovia;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
40 Segovia;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
40 Segovia;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
40 Segovia;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;97,18
40 Segovia;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
40 Segovia;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
40 Segovia;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
40 Segovia;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;96,48
40 Segovia;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
40 Segovia;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
40 Segovia;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
40 Segovia;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
40 Segovia;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
40 Segovia;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
40 Segovia;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;96,05
40 Segovia;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
40 Segovia;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
40 Segovia;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
40 Segovia;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;95,25
40 Segovia;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
40 Segovia;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
40 Segovia;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
40 Segovia;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
40 Segovia;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
40 Segovia;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
40 Segovia;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;94,28
40 Segovia;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
40 Segovia;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
40 Segovia;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
40 Segovia;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;94,1
40 Segovia;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
40 Segovia;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
40 Segovia;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
40 Segovia;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
40 Segovia;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
40 Segovia;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
40 Segovia;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
40 Segovia;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
40 Segovia;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
40 Segovia;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QI;1.940
40 Segovia;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
40 Segovia;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
40 Segovia;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
40 Segovia;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QI;1.824
40 Segovia;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
40 Segovia;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
40 Segovia;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
40 Segovia;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QI;2.099
40 Segovia;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
40 Segovia;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
40 Segovia;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2022QII;""
40 Segovia;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2022QI;1.881
40 Segovia;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
40 Segovia;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
40 Segovia;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2021QII;""
40 Segovia;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2021QI;1.770
40 Segovia;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
40 Segovia;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
40 Segovia;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2020QII;""
40 Segovia;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2020QI;1.990
40 Segovia;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
40 Segovia;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
40 Segovia;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2022QII;1.813
40 Segovia;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2022QI;""
40 Segovia;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
40 Segovia;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
40 Segovia;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2021QII;1.721
40 Segovia;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2021QI;""
40 Segovia;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
40 Segovia;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
40 Segovia;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2020QII;1.924
40 Segovia;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2020QI;""
40 Segovia;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
40 Segovia;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QIII;1.759
40 Segovia;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QII;""
40 Segovia;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QI;""
40 Segovia;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
40 Segovia;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QIII;1.656
40 Segovia;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QII;""
40 Segovia;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QI;""
40 Segovia;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
40 Segovia;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QIII;1.863
40 Segovia;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QII;""
40 Segovia;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QI;""
40 Segovia;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QIV;1.632
40 Segovia;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
40 Segovia;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QII;""
40 Segovia;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QI;""
40 Segovia;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QIV;1.585
40 Segovia;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
40 Segovia;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QII;""
40 Segovia;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QI;""
40 Segovia;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QIV;1.774
40 Segovia;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
40 Segovia;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QII;""
40 Segovia;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QI;""
40 Segovia;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
40 Segovia;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
40 Segovia;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
40 Segovia;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
40 Segovia;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
40 Segovia;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
40 Segovia;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
40 Segovia;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
40 Segovia;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
40 Segovia;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
40 Segovia;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
40 Segovia;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
40 Segovia;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
40 Segovia;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
40 Segovia;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
40 Segovia;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;96,96
40 Segovia;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
40 Segovia;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
40 Segovia;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
40 Segovia;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;97,04
40 Segovia;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
40 Segovia;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
40 Segovia;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
40 Segovia;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;94,81
40 Segovia;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
40 Segovia;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
40 Segovia;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;93,45
40 Segovia;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
40 Segovia;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
40 Segovia;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
40 Segovia;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;94,35
40 Segovia;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
40 Segovia;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
40 Segovia;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
40 Segovia;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;91,66
40 Segovia;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
40 Segovia;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
40 Segovia;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;90,67
40 Segovia;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
40 Segovia;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
40 Segovia;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
40 Segovia;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;90,79
40 Segovia;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
40 Segovia;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
40 Segovia;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
40 Segovia;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;88,76
40 Segovia;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
40 Segovia;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
40 Segovia;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;84,12
40 Segovia;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
40 Segovia;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
40 Segovia;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
40 Segovia;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;86,9
40 Segovia;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
40 Segovia;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
40 Segovia;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
40 Segovia;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;84,52
40 Segovia;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
40 Segovia;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
40 Segovia;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
40 Segovia;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
40 Segovia;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
40 Segovia;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
40 Segovia;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QI;1.354
40 Segovia;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
40 Segovia;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
40 Segovia;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
40 Segovia;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QI;1.273
40 Segovia;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
40 Segovia;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
40 Segovia;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
40 Segovia;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QI;1.472
40 Segovia;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
40 Segovia;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
40 Segovia;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2022QII;""
40 Segovia;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2022QI;1.313
40 Segovia;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
40 Segovia;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
40 Segovia;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2021QII;""
40 Segovia;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2021QI;1.236
40 Segovia;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
40 Segovia;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
40 Segovia;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2020QII;""
40 Segovia;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2020QI;1.393
40 Segovia;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
40 Segovia;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
40 Segovia;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2022QII;1.272
40 Segovia;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2022QI;""
40 Segovia;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
40 Segovia;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
40 Segovia;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2021QII;1.207
40 Segovia;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2021QI;""
40 Segovia;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
40 Segovia;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
40 Segovia;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2020QII;1.345
40 Segovia;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2020QI;""
40 Segovia;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
40 Segovia;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QIII;1.238
40 Segovia;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QII;""
40 Segovia;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QI;""
40 Segovia;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
40 Segovia;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QIII;1.165
40 Segovia;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QII;""
40 Segovia;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QI;""
40 Segovia;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
40 Segovia;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QIII;1.303
40 Segovia;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QII;""
40 Segovia;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QI;""
40 Segovia;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QIV;1.152
40 Segovia;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
40 Segovia;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QII;""
40 Segovia;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QI;""
40 Segovia;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QIV;1.116
40 Segovia;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
40 Segovia;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QII;""
40 Segovia;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QI;""
40 Segovia;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QIV;1.240
40 Segovia;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
40 Segovia;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QII;""
40 Segovia;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QI;""
40 Segovia;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
40 Segovia;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
40 Segovia;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
40 Segovia;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
40 Segovia;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
40 Segovia;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
40 Segovia;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
40 Segovia;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
40 Segovia;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
40 Segovia;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
40 Segovia;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
40 Segovia;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
40 Segovia;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
40 Segovia;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
40 Segovia;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
40 Segovia;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;96,97
40 Segovia;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
40 Segovia;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
40 Segovia;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
40 Segovia;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;97,09
40 Segovia;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
40 Segovia;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
40 Segovia;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
40 Segovia;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;94,63
40 Segovia;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
40 Segovia;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
40 Segovia;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;93,94
40 Segovia;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
40 Segovia;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
40 Segovia;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
40 Segovia;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;94,82
40 Segovia;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
40 Segovia;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
40 Segovia;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
40 Segovia;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;91,37
40 Segovia;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
40 Segovia;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
40 Segovia;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;91,43
40 Segovia;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
40 Segovia;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
40 Segovia;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
40 Segovia;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;91,52
40 Segovia;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
40 Segovia;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
40 Segovia;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
40 Segovia;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;88,52
40 Segovia;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
40 Segovia;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
40 Segovia;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;85,08
40 Segovia;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
40 Segovia;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
40 Segovia;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
40 Segovia;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;87,67
40 Segovia;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
40 Segovia;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
40 Segovia;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
40 Segovia;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;84,24
40 Segovia;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
40 Segovia;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
40 Segovia;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
40 Segovia;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
40 Segovia;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
40 Segovia;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
40 Segovia;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QI;586
40 Segovia;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
40 Segovia;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
40 Segovia;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
40 Segovia;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QI;551
40 Segovia;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
40 Segovia;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
40 Segovia;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
40 Segovia;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QI;627
40 Segovia;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
40 Segovia;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
40 Segovia;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2022QII;""
40 Segovia;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2022QI;568
40 Segovia;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
40 Segovia;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
40 Segovia;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2021QII;""
40 Segovia;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2021QI;534
40 Segovia;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
40 Segovia;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
40 Segovia;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2020QII;""
40 Segovia;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2020QI;597
40 Segovia;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
40 Segovia;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
40 Segovia;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2022QII;541
40 Segovia;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2022QI;""
40 Segovia;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
40 Segovia;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
40 Segovia;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2021QII;514
40 Segovia;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2021QI;""
40 Segovia;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
40 Segovia;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
40 Segovia;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2020QII;579
40 Segovia;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2020QI;""
40 Segovia;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
40 Segovia;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QIII;521
40 Segovia;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QII;""
40 Segovia;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QI;""
40 Segovia;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
40 Segovia;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QIII;491
40 Segovia;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QII;""
40 Segovia;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QI;""
40 Segovia;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
40 Segovia;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QIII;560
40 Segovia;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QII;""
40 Segovia;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QI;""
40 Segovia;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QIV;480
40 Segovia;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
40 Segovia;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QII;""
40 Segovia;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QI;""
40 Segovia;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QIV;469
40 Segovia;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
40 Segovia;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QII;""
40 Segovia;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QI;""
40 Segovia;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QIV;534
40 Segovia;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
40 Segovia;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QII;""
40 Segovia;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QI;""
40 Segovia;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
40 Segovia;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
40 Segovia;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
40 Segovia;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
40 Segovia;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
40 Segovia;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
40 Segovia;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
40 Segovia;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
40 Segovia;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
40 Segovia;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
40 Segovia;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
40 Segovia;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
40 Segovia;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
40 Segovia;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
40 Segovia;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
40 Segovia;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;96,93
40 Segovia;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
40 Segovia;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
40 Segovia;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
40 Segovia;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;96,91
40 Segovia;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
40 Segovia;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
40 Segovia;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
40 Segovia;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;95,22
40 Segovia;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
40 Segovia;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
40 Segovia;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;92,32
40 Segovia;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
40 Segovia;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
40 Segovia;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
40 Segovia;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;93,28
40 Segovia;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
40 Segovia;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
40 Segovia;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
40 Segovia;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;92,34
40 Segovia;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
40 Segovia;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
40 Segovia;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;88,91
40 Segovia;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
40 Segovia;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
40 Segovia;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
40 Segovia;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;89,11
40 Segovia;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
40 Segovia;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
40 Segovia;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
40 Segovia;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;89,31
40 Segovia;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
40 Segovia;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
40 Segovia;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;81,91
40 Segovia;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
40 Segovia;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
40 Segovia;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
40 Segovia;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;85,12
40 Segovia;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
40 Segovia;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
40 Segovia;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
40 Segovia;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;85,17
40 Segovia;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
40 Segovia;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
40 Segovia;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
40 Segovia;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
40 Segovia;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
40 Segovia;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QII;2.231
40 Segovia;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
40 Segovia;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
40 Segovia;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
40 Segovia;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QII;2.110
40 Segovia;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
40 Segovia;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
40 Segovia;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
40 Segovia;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QII;2.012
40 Segovia;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
40 Segovia;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
40 Segovia;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
40 Segovia;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2022QII;2.157
40 Segovia;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2022QI;""
40 Segovia;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
40 Segovia;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
40 Segovia;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2021QII;2.055
40 Segovia;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2021QI;""
40 Segovia;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
40 Segovia;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
40 Segovia;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2020QII;1.946
40 Segovia;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2020QI;""
40 Segovia;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
40 Segovia;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2022QIII;2.098
40 Segovia;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2022QII;""
40 Segovia;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2022QI;""
40 Segovia;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
40 Segovia;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2021QIII;1.986
40 Segovia;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2021QII;""
40 Segovia;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2021QI;""
40 Segovia;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
40 Segovia;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2020QIII;1.882
40 Segovia;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2020QII;""
40 Segovia;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2020QI;""
40 Segovia;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QIV;1.962
40 Segovia;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
40 Segovia;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QII;""
40 Segovia;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QI;""
40 Segovia;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QIV;1.906
40 Segovia;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
40 Segovia;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QII;""
40 Segovia;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QI;""
40 Segovia;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QIV;1.793
40 Segovia;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
40 Segovia;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QII;""
40 Segovia;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QI;""
40 Segovia;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
40 Segovia;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
40 Segovia;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QII;""
40 Segovia;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QI;1.852
40 Segovia;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
40 Segovia;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
40 Segovia;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QII;""
40 Segovia;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QI;1.741
40 Segovia;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
40 Segovia;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
40 Segovia;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QII;""
40 Segovia;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QI;""
40 Segovia;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
40 Segovia;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
40 Segovia;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
40 Segovia;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
40 Segovia;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
40 Segovia;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
40 Segovia;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
40 Segovia;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
40 Segovia;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
40 Segovia;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
40 Segovia;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
40 Segovia;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
40 Segovia;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
40 Segovia;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
40 Segovia;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;96,68
40 Segovia;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
40 Segovia;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
40 Segovia;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
40 Segovia;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;97,39
40 Segovia;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
40 Segovia;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
40 Segovia;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
40 Segovia;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;96,72
40 Segovia;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
40 Segovia;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
40 Segovia;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;94,04
40 Segovia;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
40 Segovia;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
40 Segovia;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
40 Segovia;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;94,12
40 Segovia;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
40 Segovia;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
40 Segovia;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
40 Segovia;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;93,54
40 Segovia;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
40 Segovia;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
40 Segovia;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;87,94
40 Segovia;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
40 Segovia;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
40 Segovia;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
40 Segovia;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;90,33
40 Segovia;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
40 Segovia;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
40 Segovia;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
40 Segovia;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;89,12
40 Segovia;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
40 Segovia;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
40 Segovia;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
40 Segovia;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
40 Segovia;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
40 Segovia;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
40 Segovia;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;87,77
40 Segovia;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
40 Segovia;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
40 Segovia;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
40 Segovia;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;86,53
40 Segovia;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
40 Segovia;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
40 Segovia;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
40 Segovia;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
40 Segovia;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
40 Segovia;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
40 Segovia;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QII;1.536
40 Segovia;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
40 Segovia;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
40 Segovia;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
40 Segovia;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QII;1.466
40 Segovia;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
40 Segovia;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
40 Segovia;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
40 Segovia;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QII;1.405
40 Segovia;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
40 Segovia;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
40 Segovia;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
40 Segovia;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2022QII;1.492
40 Segovia;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2022QI;""
40 Segovia;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
40 Segovia;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
40 Segovia;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2021QII;1.434
40 Segovia;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2021QI;""
40 Segovia;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
40 Segovia;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
40 Segovia;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2020QII;1.357
40 Segovia;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2020QI;""
40 Segovia;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
40 Segovia;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2022QIII;1.457
40 Segovia;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2022QII;""
40 Segovia;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2022QI;""
40 Segovia;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
40 Segovia;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2021QIII;1.388
40 Segovia;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2021QII;""
40 Segovia;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2021QI;""
40 Segovia;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
40 Segovia;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2020QIII;1.313
40 Segovia;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2020QII;""
40 Segovia;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2020QI;""
40 Segovia;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QIV;1.365
40 Segovia;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
40 Segovia;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QII;""
40 Segovia;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QI;""
40 Segovia;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QIV;1.332
40 Segovia;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
40 Segovia;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QII;""
40 Segovia;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QI;""
40 Segovia;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QIV;1.250
40 Segovia;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
40 Segovia;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QII;""
40 Segovia;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QI;""
40 Segovia;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
40 Segovia;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
40 Segovia;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QII;""
40 Segovia;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QI;1.295
40 Segovia;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
40 Segovia;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
40 Segovia;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QII;""
40 Segovia;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QI;1.214
40 Segovia;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
40 Segovia;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
40 Segovia;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QII;""
40 Segovia;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QI;""
40 Segovia;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
40 Segovia;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
40 Segovia;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
40 Segovia;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
40 Segovia;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
40 Segovia;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
40 Segovia;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
40 Segovia;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
40 Segovia;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
40 Segovia;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
40 Segovia;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
40 Segovia;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
40 Segovia;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
40 Segovia;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
40 Segovia;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;97,14
40 Segovia;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
40 Segovia;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
40 Segovia;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
40 Segovia;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;97,82
40 Segovia;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
40 Segovia;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
40 Segovia;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
40 Segovia;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;96,58
40 Segovia;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
40 Segovia;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
40 Segovia;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;94,86
40 Segovia;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
40 Segovia;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
40 Segovia;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
40 Segovia;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;94,68
40 Segovia;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
40 Segovia;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
40 Segovia;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
40 Segovia;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;93,45
40 Segovia;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
40 Segovia;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
40 Segovia;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;88,87
40 Segovia;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
40 Segovia;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
40 Segovia;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
40 Segovia;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;90,86
40 Segovia;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
40 Segovia;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
40 Segovia;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
40 Segovia;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;88,97
40 Segovia;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
40 Segovia;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
40 Segovia;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
40 Segovia;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
40 Segovia;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
40 Segovia;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
40 Segovia;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;88,34
40 Segovia;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
40 Segovia;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
40 Segovia;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
40 Segovia;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;86,41
40 Segovia;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
40 Segovia;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
40 Segovia;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
40 Segovia;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
40 Segovia;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
40 Segovia;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
40 Segovia;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QII;695
40 Segovia;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
40 Segovia;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
40 Segovia;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
40 Segovia;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QII;644
40 Segovia;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
40 Segovia;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
40 Segovia;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
40 Segovia;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QII;607
40 Segovia;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
40 Segovia;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
40 Segovia;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
40 Segovia;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2022QII;665
40 Segovia;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2022QI;""
40 Segovia;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
40 Segovia;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
40 Segovia;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2021QII;621
40 Segovia;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2021QI;""
40 Segovia;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
40 Segovia;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
40 Segovia;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2020QII;589
40 Segovia;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2020QI;""
40 Segovia;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
40 Segovia;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2022QIII;641
40 Segovia;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2022QII;""
40 Segovia;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2022QI;""
40 Segovia;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
40 Segovia;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2021QIII;598
40 Segovia;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2021QII;""
40 Segovia;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2021QI;""
40 Segovia;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
40 Segovia;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2020QIII;569
40 Segovia;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2020QII;""
40 Segovia;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2020QI;""
40 Segovia;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QIV;597
40 Segovia;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
40 Segovia;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QII;""
40 Segovia;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QI;""
40 Segovia;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QIV;574
40 Segovia;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
40 Segovia;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QII;""
40 Segovia;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QI;""
40 Segovia;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QIV;543
40 Segovia;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
40 Segovia;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QII;""
40 Segovia;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QI;""
40 Segovia;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
40 Segovia;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
40 Segovia;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QII;""
40 Segovia;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QI;557
40 Segovia;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
40 Segovia;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
40 Segovia;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QII;""
40 Segovia;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QI;527
40 Segovia;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
40 Segovia;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
40 Segovia;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QII;""
40 Segovia;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QI;""
40 Segovia;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
40 Segovia;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
40 Segovia;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
40 Segovia;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
40 Segovia;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
40 Segovia;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
40 Segovia;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
40 Segovia;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
40 Segovia;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
40 Segovia;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
40 Segovia;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
40 Segovia;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
40 Segovia;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
40 Segovia;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
40 Segovia;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;95,68
40 Segovia;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
40 Segovia;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
40 Segovia;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
40 Segovia;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;96,43
40 Segovia;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
40 Segovia;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
40 Segovia;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
40 Segovia;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;97,03
40 Segovia;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
40 Segovia;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
40 Segovia;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;92,23
40 Segovia;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
40 Segovia;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
40 Segovia;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
40 Segovia;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;92,86
40 Segovia;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
40 Segovia;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
40 Segovia;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
40 Segovia;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;93,74
40 Segovia;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
40 Segovia;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
40 Segovia;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;85,9
40 Segovia;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
40 Segovia;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
40 Segovia;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
40 Segovia;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;89,13
40 Segovia;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
40 Segovia;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
40 Segovia;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
40 Segovia;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;89,46
40 Segovia;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
40 Segovia;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
40 Segovia;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
40 Segovia;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
40 Segovia;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
40 Segovia;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
40 Segovia;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;86,49
40 Segovia;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
40 Segovia;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
40 Segovia;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
40 Segovia;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;86,82
40 Segovia;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
40 Segovia;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
40 Segovia;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
40 Segovia;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
40 Segovia;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
40 Segovia;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QIII;2.182
40 Segovia;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
40 Segovia;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
40 Segovia;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
40 Segovia;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QIII;2.077
40 Segovia;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
40 Segovia;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
40 Segovia;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
40 Segovia;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QIII;1.962
40 Segovia;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
40 Segovia;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
40 Segovia;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
40 Segovia;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2022QIII;2.116
40 Segovia;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2022QII;""
40 Segovia;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2022QI;""
40 Segovia;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
40 Segovia;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2021QIII;2.002
40 Segovia;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2021QII;""
40 Segovia;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2021QI;""
40 Segovia;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
40 Segovia;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2020QIII;1.890
40 Segovia;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2020QII;""
40 Segovia;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2020QI;""
40 Segovia;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2022QIV;1.978
40 Segovia;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
40 Segovia;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2022QII;""
40 Segovia;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2022QI;""
40 Segovia;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2021QIV;1.919
40 Segovia;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
40 Segovia;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2021QII;""
40 Segovia;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2021QI;""
40 Segovia;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2020QIV;1.799
40 Segovia;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
40 Segovia;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2020QII;""
40 Segovia;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2020QI;""
40 Segovia;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
40 Segovia;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
40 Segovia;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QII;""
40 Segovia;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QI;1.863
40 Segovia;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
40 Segovia;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
40 Segovia;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QII;""
40 Segovia;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QI;1.747
40 Segovia;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
40 Segovia;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
40 Segovia;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QII;""
40 Segovia;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QI;""
40 Segovia;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
40 Segovia;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
40 Segovia;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QII;1.801
40 Segovia;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QI;""
40 Segovia;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
40 Segovia;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
40 Segovia;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QII;1.701
40 Segovia;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QI;""
40 Segovia;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
40 Segovia;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
40 Segovia;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QII;""
40 Segovia;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QI;""
40 Segovia;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
40 Segovia;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
40 Segovia;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
40 Segovia;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
40 Segovia;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
40 Segovia;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
40 Segovia;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
40 Segovia;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
40 Segovia;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
40 Segovia;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
40 Segovia;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
40 Segovia;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
40 Segovia;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
40 Segovia;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;96,98
40 Segovia;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
40 Segovia;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
40 Segovia;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
40 Segovia;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;96,39
40 Segovia;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
40 Segovia;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
40 Segovia;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
40 Segovia;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;96,33
40 Segovia;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
40 Segovia;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
40 Segovia;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;90,65
40 Segovia;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
40 Segovia;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
40 Segovia;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
40 Segovia;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;92,39
40 Segovia;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
40 Segovia;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
40 Segovia;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
40 Segovia;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;91,69
40 Segovia;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
40 Segovia;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
40 Segovia;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
40 Segovia;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
40 Segovia;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
40 Segovia;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
40 Segovia;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;89,7
40 Segovia;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
40 Segovia;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
40 Segovia;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
40 Segovia;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;89,04
40 Segovia;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
40 Segovia;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
40 Segovia;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
40 Segovia;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
40 Segovia;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
40 Segovia;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
40 Segovia;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;86,71
40 Segovia;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
40 Segovia;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
40 Segovia;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
40 Segovia;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;86,7
40 Segovia;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
40 Segovia;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
40 Segovia;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
40 Segovia;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
40 Segovia;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
40 Segovia;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
40 Segovia;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QIII;1.512
40 Segovia;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
40 Segovia;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
40 Segovia;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
40 Segovia;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QIII;1.447
40 Segovia;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
40 Segovia;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
40 Segovia;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
40 Segovia;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QIII;1.367
40 Segovia;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
40 Segovia;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
40 Segovia;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
40 Segovia;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2022QIII;1.472
40 Segovia;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2022QII;""
40 Segovia;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2022QI;""
40 Segovia;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
40 Segovia;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2021QIII;1.398
40 Segovia;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2021QII;""
40 Segovia;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2021QI;""
40 Segovia;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
40 Segovia;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2020QIII;1.321
40 Segovia;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2020QII;""
40 Segovia;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2020QI;""
40 Segovia;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2022QIV;1.379
40 Segovia;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
40 Segovia;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2022QII;""
40 Segovia;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2022QI;""
40 Segovia;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2021QIV;1.341
40 Segovia;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
40 Segovia;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2021QII;""
40 Segovia;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2021QI;""
40 Segovia;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2020QIV;1.256
40 Segovia;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
40 Segovia;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2020QII;""
40 Segovia;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2020QI;""
40 Segovia;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
40 Segovia;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
40 Segovia;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QII;""
40 Segovia;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QI;1.302
40 Segovia;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
40 Segovia;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
40 Segovia;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QII;""
40 Segovia;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QI;1.220
40 Segovia;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
40 Segovia;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
40 Segovia;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QII;""
40 Segovia;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QI;""
40 Segovia;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
40 Segovia;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
40 Segovia;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QII;1.263
40 Segovia;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QI;""
40 Segovia;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
40 Segovia;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
40 Segovia;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QII;1.191
40 Segovia;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QI;""
40 Segovia;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
40 Segovia;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
40 Segovia;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QII;""
40 Segovia;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QI;""
40 Segovia;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
40 Segovia;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
40 Segovia;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
40 Segovia;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
40 Segovia;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
40 Segovia;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
40 Segovia;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
40 Segovia;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
40 Segovia;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
40 Segovia;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
40 Segovia;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
40 Segovia;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
40 Segovia;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
40 Segovia;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;97,35
40 Segovia;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
40 Segovia;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
40 Segovia;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
40 Segovia;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;96,61
40 Segovia;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
40 Segovia;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
40 Segovia;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
40 Segovia;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;96,63
40 Segovia;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
40 Segovia;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
40 Segovia;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;91,2
40 Segovia;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
40 Segovia;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
40 Segovia;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
40 Segovia;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;92,67
40 Segovia;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
40 Segovia;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
40 Segovia;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
40 Segovia;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;91,88
40 Segovia;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
40 Segovia;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
40 Segovia;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
40 Segovia;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
40 Segovia;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
40 Segovia;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
40 Segovia;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;89,98
40 Segovia;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
40 Segovia;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
40 Segovia;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
40 Segovia;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;89,25
40 Segovia;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
40 Segovia;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
40 Segovia;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
40 Segovia;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
40 Segovia;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
40 Segovia;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
40 Segovia;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;87,28
40 Segovia;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
40 Segovia;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
40 Segovia;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
40 Segovia;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;87,13
40 Segovia;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
40 Segovia;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
40 Segovia;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
40 Segovia;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
40 Segovia;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
40 Segovia;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
40 Segovia;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QIII;670
40 Segovia;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
40 Segovia;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
40 Segovia;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
40 Segovia;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QIII;630
40 Segovia;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
40 Segovia;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
40 Segovia;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
40 Segovia;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QIII;595
40 Segovia;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
40 Segovia;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
40 Segovia;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
40 Segovia;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2022QIII;644
40 Segovia;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2022QII;""
40 Segovia;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2022QI;""
40 Segovia;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
40 Segovia;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2021QIII;604
40 Segovia;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2021QII;""
40 Segovia;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2021QI;""
40 Segovia;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
40 Segovia;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2020QIII;569
40 Segovia;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2020QII;""
40 Segovia;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2020QI;""
40 Segovia;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2022QIV;599
40 Segovia;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
40 Segovia;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2022QII;""
40 Segovia;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2022QI;""
40 Segovia;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2021QIV;578
40 Segovia;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
40 Segovia;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2021QII;""
40 Segovia;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2021QI;""
40 Segovia;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2020QIV;543
40 Segovia;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
40 Segovia;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2020QII;""
40 Segovia;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2020QI;""
40 Segovia;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
40 Segovia;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
40 Segovia;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QII;""
40 Segovia;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QI;561
40 Segovia;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
40 Segovia;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
40 Segovia;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QII;""
40 Segovia;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QI;527
40 Segovia;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
40 Segovia;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
40 Segovia;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QII;""
40 Segovia;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QI;""
40 Segovia;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
40 Segovia;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
40 Segovia;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QII;538
40 Segovia;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QI;""
40 Segovia;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
40 Segovia;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
40 Segovia;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QII;510
40 Segovia;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QI;""
40 Segovia;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
40 Segovia;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
40 Segovia;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QII;""
40 Segovia;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QI;""
40 Segovia;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
40 Segovia;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
40 Segovia;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
40 Segovia;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
40 Segovia;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
40 Segovia;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
40 Segovia;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
40 Segovia;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
40 Segovia;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
40 Segovia;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
40 Segovia;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
40 Segovia;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
40 Segovia;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
40 Segovia;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;96,12
40 Segovia;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
40 Segovia;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
40 Segovia;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
40 Segovia;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;95,87
40 Segovia;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
40 Segovia;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
40 Segovia;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
40 Segovia;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;95,63
40 Segovia;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
40 Segovia;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
40 Segovia;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;89,4
40 Segovia;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
40 Segovia;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
40 Segovia;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
40 Segovia;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;91,75
40 Segovia;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
40 Segovia;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
40 Segovia;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
40 Segovia;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;91,26
40 Segovia;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
40 Segovia;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
40 Segovia;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
40 Segovia;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
40 Segovia;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
40 Segovia;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
40 Segovia;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;89,05
40 Segovia;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
40 Segovia;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
40 Segovia;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
40 Segovia;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;88,57
40 Segovia;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
40 Segovia;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
40 Segovia;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
40 Segovia;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
40 Segovia;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
40 Segovia;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
40 Segovia;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;85,4
40 Segovia;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
40 Segovia;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
40 Segovia;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
40 Segovia;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;85,71
40 Segovia;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
40 Segovia;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
40 Segovia;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
40 Segovia;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
40 Segovia;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
40 Segovia;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QIV;2.135
40 Segovia;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
40 Segovia;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
40 Segovia;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
40 Segovia;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QIV;2.009
40 Segovia;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
40 Segovia;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
40 Segovia;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
40 Segovia;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QIV;1.909
40 Segovia;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
40 Segovia;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
40 Segovia;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
40 Segovia;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2022QIV;1.993
40 Segovia;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
40 Segovia;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2022QII;""
40 Segovia;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2022QI;""
40 Segovia;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2021QIV;1.926
40 Segovia;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
40 Segovia;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2021QII;""
40 Segovia;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2021QI;""
40 Segovia;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2020QIV;1.815
40 Segovia;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
40 Segovia;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2020QII;""
40 Segovia;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2020QI;""
40 Segovia;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
40 Segovia;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
40 Segovia;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2022QII;""
40 Segovia;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2022QI;1.869
40 Segovia;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
40 Segovia;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
40 Segovia;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2021QII;""
40 Segovia;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2021QI;1.762
40 Segovia;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
40 Segovia;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
40 Segovia;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2020QII;""
40 Segovia;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2020QI;""
40 Segovia;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
40 Segovia;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
40 Segovia;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QII;1.804
40 Segovia;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QI;""
40 Segovia;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
40 Segovia;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
40 Segovia;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QII;1.714
40 Segovia;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QI;""
40 Segovia;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
40 Segovia;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
40 Segovia;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QII;""
40 Segovia;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QI;""
40 Segovia;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
40 Segovia;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QIII;1.752
40 Segovia;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QII;""
40 Segovia;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QI;""
40 Segovia;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
40 Segovia;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QIII;1.649
40 Segovia;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QII;""
40 Segovia;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QI;""
40 Segovia;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
40 Segovia;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
40 Segovia;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QII;""
40 Segovia;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QI;""
40 Segovia;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
40 Segovia;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
40 Segovia;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
40 Segovia;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
40 Segovia;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
40 Segovia;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
40 Segovia;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
40 Segovia;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
40 Segovia;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
40 Segovia;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
40 Segovia;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
40 Segovia;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
40 Segovia;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;93,35
40 Segovia;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
40 Segovia;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
40 Segovia;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
40 Segovia;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;95,87
40 Segovia;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
40 Segovia;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
40 Segovia;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
40 Segovia;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;95,08
40 Segovia;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
40 Segovia;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
40 Segovia;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
40 Segovia;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
40 Segovia;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
40 Segovia;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
40 Segovia;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;93,03
40 Segovia;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
40 Segovia;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
40 Segovia;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
40 Segovia;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;92,3
40 Segovia;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
40 Segovia;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
40 Segovia;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
40 Segovia;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
40 Segovia;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
40 Segovia;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
40 Segovia;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;89,8
40 Segovia;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
40 Segovia;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
40 Segovia;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
40 Segovia;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;89,79
40 Segovia;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
40 Segovia;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
40 Segovia;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
40 Segovia;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
40 Segovia;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
40 Segovia;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
40 Segovia;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;87,21
40 Segovia;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
40 Segovia;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
40 Segovia;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
40 Segovia;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;86,38
40 Segovia;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
40 Segovia;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
40 Segovia;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
40 Segovia;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
40 Segovia;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
40 Segovia;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
40 Segovia;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QIV;1.480
40 Segovia;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
40 Segovia;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
40 Segovia;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
40 Segovia;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QIV;1.402
40 Segovia;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
40 Segovia;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
40 Segovia;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
40 Segovia;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QIV;1.335
40 Segovia;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
40 Segovia;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
40 Segovia;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
40 Segovia;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2022QIV;1.386
40 Segovia;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
40 Segovia;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2022QII;""
40 Segovia;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2022QI;""
40 Segovia;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2021QIV;1.345
40 Segovia;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
40 Segovia;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2021QII;""
40 Segovia;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2021QI;""
40 Segovia;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2020QIV;1.268
40 Segovia;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
40 Segovia;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2020QII;""
40 Segovia;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2020QI;""
40 Segovia;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
40 Segovia;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
40 Segovia;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2022QII;""
40 Segovia;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2022QI;1.305
40 Segovia;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
40 Segovia;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
40 Segovia;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2021QII;""
40 Segovia;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2021QI;1.231
40 Segovia;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
40 Segovia;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
40 Segovia;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2020QII;""
40 Segovia;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2020QI;""
40 Segovia;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
40 Segovia;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
40 Segovia;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QII;1.265
40 Segovia;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QI;""
40 Segovia;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
40 Segovia;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
40 Segovia;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QII;1.202
40 Segovia;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QI;""
40 Segovia;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
40 Segovia;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
40 Segovia;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QII;""
40 Segovia;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QI;""
40 Segovia;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
40 Segovia;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QIII;1.232
40 Segovia;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QII;""
40 Segovia;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QI;""
40 Segovia;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
40 Segovia;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QIII;1.160
40 Segovia;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QII;""
40 Segovia;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QI;""
40 Segovia;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
40 Segovia;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
40 Segovia;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QII;""
40 Segovia;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QI;""
40 Segovia;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
40 Segovia;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
40 Segovia;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
40 Segovia;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
40 Segovia;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
40 Segovia;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
40 Segovia;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
40 Segovia;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
40 Segovia;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
40 Segovia;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
40 Segovia;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
40 Segovia;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
40 Segovia;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;93,65
40 Segovia;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
40 Segovia;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
40 Segovia;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
40 Segovia;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;95,93
40 Segovia;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
40 Segovia;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
40 Segovia;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
40 Segovia;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;94,98
40 Segovia;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
40 Segovia;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
40 Segovia;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
40 Segovia;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
40 Segovia;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
40 Segovia;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
40 Segovia;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;93,08
40 Segovia;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
40 Segovia;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
40 Segovia;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
40 Segovia;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;92,21
40 Segovia;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
40 Segovia;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
40 Segovia;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
40 Segovia;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
40 Segovia;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
40 Segovia;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
40 Segovia;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;90,23
40 Segovia;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
40 Segovia;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
40 Segovia;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
40 Segovia;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;90,04
40 Segovia;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
40 Segovia;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
40 Segovia;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
40 Segovia;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
40 Segovia;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
40 Segovia;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
40 Segovia;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;87,87
40 Segovia;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
40 Segovia;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
40 Segovia;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
40 Segovia;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;86,89
40 Segovia;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
40 Segovia;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
40 Segovia;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
40 Segovia;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
40 Segovia;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
40 Segovia;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
40 Segovia;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QIV;655
40 Segovia;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
40 Segovia;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
40 Segovia;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
40 Segovia;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QIV;607
40 Segovia;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
40 Segovia;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
40 Segovia;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
40 Segovia;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QIV;574
40 Segovia;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
40 Segovia;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
40 Segovia;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
40 Segovia;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2022QIV;607
40 Segovia;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
40 Segovia;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2022QII;""
40 Segovia;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2022QI;""
40 Segovia;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2021QIV;581
40 Segovia;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
40 Segovia;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2021QII;""
40 Segovia;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2021QI;""
40 Segovia;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2020QIV;547
40 Segovia;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
40 Segovia;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2020QII;""
40 Segovia;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2020QI;""
40 Segovia;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
40 Segovia;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
40 Segovia;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2022QII;""
40 Segovia;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2022QI;564
40 Segovia;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
40 Segovia;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
40 Segovia;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2021QII;""
40 Segovia;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2021QI;531
40 Segovia;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
40 Segovia;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
40 Segovia;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2020QII;""
40 Segovia;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2020QI;""
40 Segovia;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
40 Segovia;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
40 Segovia;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QII;539
40 Segovia;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QI;""
40 Segovia;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
40 Segovia;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
40 Segovia;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QII;512
40 Segovia;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QI;""
40 Segovia;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
40 Segovia;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
40 Segovia;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QII;""
40 Segovia;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QI;""
40 Segovia;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
40 Segovia;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QIII;520
40 Segovia;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QII;""
40 Segovia;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QI;""
40 Segovia;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
40 Segovia;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QIII;489
40 Segovia;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QII;""
40 Segovia;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QI;""
40 Segovia;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
40 Segovia;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
40 Segovia;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QII;""
40 Segovia;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QI;""
40 Segovia;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
40 Segovia;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
40 Segovia;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
40 Segovia;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
40 Segovia;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
40 Segovia;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
40 Segovia;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
40 Segovia;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
40 Segovia;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
40 Segovia;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
40 Segovia;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
40 Segovia;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
40 Segovia;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;92,67
40 Segovia;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
40 Segovia;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
40 Segovia;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
40 Segovia;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;95,72
40 Segovia;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
40 Segovia;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
40 Segovia;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
40 Segovia;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;95,3
40 Segovia;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
40 Segovia;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
40 Segovia;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
40 Segovia;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
40 Segovia;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
40 Segovia;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
40 Segovia;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;92,92
40 Segovia;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
40 Segovia;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
40 Segovia;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
40 Segovia;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;92,51
40 Segovia;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
40 Segovia;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
40 Segovia;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
40 Segovia;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
40 Segovia;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
40 Segovia;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
40 Segovia;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;88,8
40 Segovia;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
40 Segovia;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
40 Segovia;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
40 Segovia;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;89,2
40 Segovia;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
40 Segovia;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
40 Segovia;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
40 Segovia;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
40 Segovia;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
40 Segovia;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
40 Segovia;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;85,67
40 Segovia;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
40 Segovia;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
40 Segovia;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
40 Segovia;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;85,19
40 Segovia;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
40 Segovia;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
40 Segovia;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
40 Segovia;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
40 Segovia;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
40 Segovia;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
41 Sevilla;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
41 Sevilla;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
41 Sevilla;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
41 Sevilla;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QI;108.406
41 Sevilla;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
41 Sevilla;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
41 Sevilla;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
41 Sevilla;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QI;105.738
41 Sevilla;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
41 Sevilla;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
41 Sevilla;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
41 Sevilla;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QI;105.004
41 Sevilla;All ages;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
41 Sevilla;All ages;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
41 Sevilla;All ages;Cohort January 1;Total;Survival in the first trimester;2022QII;""
41 Sevilla;All ages;Cohort January 1;Total;Survival in the first trimester;2022QI;104.910
41 Sevilla;All ages;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
41 Sevilla;All ages;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
41 Sevilla;All ages;Cohort January 1;Total;Survival in the first trimester;2021QII;""
41 Sevilla;All ages;Cohort January 1;Total;Survival in the first trimester;2021QI;102.861
41 Sevilla;All ages;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
41 Sevilla;All ages;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
41 Sevilla;All ages;Cohort January 1;Total;Survival in the first trimester;2020QII;""
41 Sevilla;All ages;Cohort January 1;Total;Survival in the first trimester;2020QI;97.632
41 Sevilla;All ages;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
41 Sevilla;All ages;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
41 Sevilla;All ages;Cohort January 1;Total;Survival in the second trimester;2022QII;101.210
41 Sevilla;All ages;Cohort January 1;Total;Survival in the second trimester;2022QI;""
41 Sevilla;All ages;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
41 Sevilla;All ages;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
41 Sevilla;All ages;Cohort January 1;Total;Survival in the second trimester;2021QII;99.717
41 Sevilla;All ages;Cohort January 1;Total;Survival in the second trimester;2021QI;""
41 Sevilla;All ages;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
41 Sevilla;All ages;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
41 Sevilla;All ages;Cohort January 1;Total;Survival in the second trimester;2020QII;95.695
41 Sevilla;All ages;Cohort January 1;Total;Survival in the second trimester;2020QI;""
41 Sevilla;All ages;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
41 Sevilla;All ages;Cohort January 1;Total;Survival in the third trimester;2022QIII;98.189
41 Sevilla;All ages;Cohort January 1;Total;Survival in the third trimester;2022QII;""
41 Sevilla;All ages;Cohort January 1;Total;Survival in the third trimester;2022QI;""
41 Sevilla;All ages;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
41 Sevilla;All ages;Cohort January 1;Total;Survival in the third trimester;2021QIII;97.098
41 Sevilla;All ages;Cohort January 1;Total;Survival in the third trimester;2021QII;""
41 Sevilla;All ages;Cohort January 1;Total;Survival in the third trimester;2021QI;""
41 Sevilla;All ages;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
41 Sevilla;All ages;Cohort January 1;Total;Survival in the third trimester;2020QIII;93.159
41 Sevilla;All ages;Cohort January 1;Total;Survival in the third trimester;2020QII;""
41 Sevilla;All ages;Cohort January 1;Total;Survival in the third trimester;2020QI;""
41 Sevilla;All ages;Cohort January 1;Total;Survival in the third trimester;2022QIV;94.853
41 Sevilla;All ages;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
41 Sevilla;All ages;Cohort January 1;Total;Survival in the third trimester;2022QII;""
41 Sevilla;All ages;Cohort January 1;Total;Survival in the third trimester;2022QI;""
41 Sevilla;All ages;Cohort January 1;Total;Survival in the third trimester;2021QIV;94.410
41 Sevilla;All ages;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
41 Sevilla;All ages;Cohort January 1;Total;Survival in the third trimester;2021QII;""
41 Sevilla;All ages;Cohort January 1;Total;Survival in the third trimester;2021QI;""
41 Sevilla;All ages;Cohort January 1;Total;Survival in the third trimester;2020QIV;90.733
41 Sevilla;All ages;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
41 Sevilla;All ages;Cohort January 1;Total;Survival in the third trimester;2020QII;""
41 Sevilla;All ages;Cohort January 1;Total;Survival in the third trimester;2020QI;""
41 Sevilla;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
41 Sevilla;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
41 Sevilla;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
41 Sevilla;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
41 Sevilla;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
41 Sevilla;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
41 Sevilla;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
41 Sevilla;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
41 Sevilla;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
41 Sevilla;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
41 Sevilla;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
41 Sevilla;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
41 Sevilla;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
41 Sevilla;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
41 Sevilla;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
41 Sevilla;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;96,78
41 Sevilla;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
41 Sevilla;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
41 Sevilla;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
41 Sevilla;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;97,28
41 Sevilla;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
41 Sevilla;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
41 Sevilla;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
41 Sevilla;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;92,98
41 Sevilla;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
41 Sevilla;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
41 Sevilla;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;93,36
41 Sevilla;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
41 Sevilla;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
41 Sevilla;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
41 Sevilla;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;94,31
41 Sevilla;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
41 Sevilla;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
41 Sevilla;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
41 Sevilla;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;91,13
41 Sevilla;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
41 Sevilla;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
41 Sevilla;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;90,58
41 Sevilla;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
41 Sevilla;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
41 Sevilla;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
41 Sevilla;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;91,83
41 Sevilla;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
41 Sevilla;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
41 Sevilla;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
41 Sevilla;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;88,72
41 Sevilla;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
41 Sevilla;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
41 Sevilla;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;87,5
41 Sevilla;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
41 Sevilla;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
41 Sevilla;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
41 Sevilla;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;89,29
41 Sevilla;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
41 Sevilla;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
41 Sevilla;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
41 Sevilla;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;86,41
41 Sevilla;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
41 Sevilla;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
41 Sevilla;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
41 Sevilla;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
41 Sevilla;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
41 Sevilla;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
41 Sevilla;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QI;69.543
41 Sevilla;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
41 Sevilla;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
41 Sevilla;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
41 Sevilla;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QI;68.457
41 Sevilla;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
41 Sevilla;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
41 Sevilla;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
41 Sevilla;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QI;68.130
41 Sevilla;All ages;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
41 Sevilla;All ages;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
41 Sevilla;All ages;Cohort January 1;Males;Survival in the first trimester;2022QII;""
41 Sevilla;All ages;Cohort January 1;Males;Survival in the first trimester;2022QI;67.549
41 Sevilla;All ages;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
41 Sevilla;All ages;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
41 Sevilla;All ages;Cohort January 1;Males;Survival in the first trimester;2021QII;""
41 Sevilla;All ages;Cohort January 1;Males;Survival in the first trimester;2021QI;66.713
41 Sevilla;All ages;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
41 Sevilla;All ages;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
41 Sevilla;All ages;Cohort January 1;Males;Survival in the first trimester;2020QII;""
41 Sevilla;All ages;Cohort January 1;Males;Survival in the first trimester;2020QI;63.759
41 Sevilla;All ages;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
41 Sevilla;All ages;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
41 Sevilla;All ages;Cohort January 1;Males;Survival in the second trimester;2022QII;65.517
41 Sevilla;All ages;Cohort January 1;Males;Survival in the second trimester;2022QI;""
41 Sevilla;All ages;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
41 Sevilla;All ages;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
41 Sevilla;All ages;Cohort January 1;Males;Survival in the second trimester;2021QII;64.843
41 Sevilla;All ages;Cohort January 1;Males;Survival in the second trimester;2021QI;""
41 Sevilla;All ages;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
41 Sevilla;All ages;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
41 Sevilla;All ages;Cohort January 1;Males;Survival in the second trimester;2020QII;62.609
41 Sevilla;All ages;Cohort January 1;Males;Survival in the second trimester;2020QI;""
41 Sevilla;All ages;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
41 Sevilla;All ages;Cohort January 1;Males;Survival in the third trimester;2022QIII;63.769
41 Sevilla;All ages;Cohort January 1;Males;Survival in the third trimester;2022QII;""
41 Sevilla;All ages;Cohort January 1;Males;Survival in the third trimester;2022QI;""
41 Sevilla;All ages;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
41 Sevilla;All ages;Cohort January 1;Males;Survival in the third trimester;2021QIII;63.289
41 Sevilla;All ages;Cohort January 1;Males;Survival in the third trimester;2021QII;""
41 Sevilla;All ages;Cohort January 1;Males;Survival in the third trimester;2021QI;""
41 Sevilla;All ages;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
41 Sevilla;All ages;Cohort January 1;Males;Survival in the third trimester;2020QIII;61.161
41 Sevilla;All ages;Cohort January 1;Males;Survival in the third trimester;2020QII;""
41 Sevilla;All ages;Cohort January 1;Males;Survival in the third trimester;2020QI;""
41 Sevilla;All ages;Cohort January 1;Males;Survival in the third trimester;2022QIV;61.783
41 Sevilla;All ages;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
41 Sevilla;All ages;Cohort January 1;Males;Survival in the third trimester;2022QII;""
41 Sevilla;All ages;Cohort January 1;Males;Survival in the third trimester;2022QI;""
41 Sevilla;All ages;Cohort January 1;Males;Survival in the third trimester;2021QIV;61.679
41 Sevilla;All ages;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
41 Sevilla;All ages;Cohort January 1;Males;Survival in the third trimester;2021QII;""
41 Sevilla;All ages;Cohort January 1;Males;Survival in the third trimester;2021QI;""
41 Sevilla;All ages;Cohort January 1;Males;Survival in the third trimester;2020QIV;59.742
41 Sevilla;All ages;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
41 Sevilla;All ages;Cohort January 1;Males;Survival in the third trimester;2020QII;""
41 Sevilla;All ages;Cohort January 1;Males;Survival in the third trimester;2020QI;""
41 Sevilla;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
41 Sevilla;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
41 Sevilla;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
41 Sevilla;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
41 Sevilla;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
41 Sevilla;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
41 Sevilla;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
41 Sevilla;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
41 Sevilla;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
41 Sevilla;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
41 Sevilla;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
41 Sevilla;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
41 Sevilla;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
41 Sevilla;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
41 Sevilla;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
41 Sevilla;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;97,13
41 Sevilla;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
41 Sevilla;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
41 Sevilla;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
41 Sevilla;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;97,45
41 Sevilla;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
41 Sevilla;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
41 Sevilla;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
41 Sevilla;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;93,58
41 Sevilla;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
41 Sevilla;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
41 Sevilla;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;94,21
41 Sevilla;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
41 Sevilla;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
41 Sevilla;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
41 Sevilla;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;94,72
41 Sevilla;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
41 Sevilla;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
41 Sevilla;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
41 Sevilla;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;91,9
41 Sevilla;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
41 Sevilla;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
41 Sevilla;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;91,7
41 Sevilla;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
41 Sevilla;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
41 Sevilla;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
41 Sevilla;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;92,45
41 Sevilla;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
41 Sevilla;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
41 Sevilla;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
41 Sevilla;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;89,77
41 Sevilla;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
41 Sevilla;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
41 Sevilla;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;88,84
41 Sevilla;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
41 Sevilla;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
41 Sevilla;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
41 Sevilla;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;90,1
41 Sevilla;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
41 Sevilla;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
41 Sevilla;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
41 Sevilla;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;87,69
41 Sevilla;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
41 Sevilla;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
41 Sevilla;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
41 Sevilla;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
41 Sevilla;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
41 Sevilla;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
41 Sevilla;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QI;38.863
41 Sevilla;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
41 Sevilla;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
41 Sevilla;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
41 Sevilla;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QI;37.281
41 Sevilla;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
41 Sevilla;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
41 Sevilla;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
41 Sevilla;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QI;36.874
41 Sevilla;All ages;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
41 Sevilla;All ages;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
41 Sevilla;All ages;Cohort January 1;Females;Survival in the first trimester;2022QII;""
41 Sevilla;All ages;Cohort January 1;Females;Survival in the first trimester;2022QI;37.361
41 Sevilla;All ages;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
41 Sevilla;All ages;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
41 Sevilla;All ages;Cohort January 1;Females;Survival in the first trimester;2021QII;""
41 Sevilla;All ages;Cohort January 1;Females;Survival in the first trimester;2021QI;36.148
41 Sevilla;All ages;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
41 Sevilla;All ages;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
41 Sevilla;All ages;Cohort January 1;Females;Survival in the first trimester;2020QII;""
41 Sevilla;All ages;Cohort January 1;Females;Survival in the first trimester;2020QI;33.873
41 Sevilla;All ages;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
41 Sevilla;All ages;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
41 Sevilla;All ages;Cohort January 1;Females;Survival in the second trimester;2022QII;35.693
41 Sevilla;All ages;Cohort January 1;Females;Survival in the second trimester;2022QI;""
41 Sevilla;All ages;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
41 Sevilla;All ages;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
41 Sevilla;All ages;Cohort January 1;Females;Survival in the second trimester;2021QII;34.874
41 Sevilla;All ages;Cohort January 1;Females;Survival in the second trimester;2021QI;""
41 Sevilla;All ages;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
41 Sevilla;All ages;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
41 Sevilla;All ages;Cohort January 1;Females;Survival in the second trimester;2020QII;33.086
41 Sevilla;All ages;Cohort January 1;Females;Survival in the second trimester;2020QI;""
41 Sevilla;All ages;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
41 Sevilla;All ages;Cohort January 1;Females;Survival in the third trimester;2022QIII;34.420
41 Sevilla;All ages;Cohort January 1;Females;Survival in the third trimester;2022QII;""
41 Sevilla;All ages;Cohort January 1;Females;Survival in the third trimester;2022QI;""
41 Sevilla;All ages;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
41 Sevilla;All ages;Cohort January 1;Females;Survival in the third trimester;2021QIII;33.809
41 Sevilla;All ages;Cohort January 1;Females;Survival in the third trimester;2021QII;""
41 Sevilla;All ages;Cohort January 1;Females;Survival in the third trimester;2021QI;""
41 Sevilla;All ages;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
41 Sevilla;All ages;Cohort January 1;Females;Survival in the third trimester;2020QIII;31.998
41 Sevilla;All ages;Cohort January 1;Females;Survival in the third trimester;2020QII;""
41 Sevilla;All ages;Cohort January 1;Females;Survival in the third trimester;2020QI;""
41 Sevilla;All ages;Cohort January 1;Females;Survival in the third trimester;2022QIV;33.070
41 Sevilla;All ages;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
41 Sevilla;All ages;Cohort January 1;Females;Survival in the third trimester;2022QII;""
41 Sevilla;All ages;Cohort January 1;Females;Survival in the third trimester;2022QI;""
41 Sevilla;All ages;Cohort January 1;Females;Survival in the third trimester;2021QIV;32.731
41 Sevilla;All ages;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
41 Sevilla;All ages;Cohort January 1;Females;Survival in the third trimester;2021QII;""
41 Sevilla;All ages;Cohort January 1;Females;Survival in the third trimester;2021QI;""
41 Sevilla;All ages;Cohort January 1;Females;Survival in the third trimester;2020QIV;30.991
41 Sevilla;All ages;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
41 Sevilla;All ages;Cohort January 1;Females;Survival in the third trimester;2020QII;""
41 Sevilla;All ages;Cohort January 1;Females;Survival in the third trimester;2020QI;""
41 Sevilla;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
41 Sevilla;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
41 Sevilla;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
41 Sevilla;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
41 Sevilla;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
41 Sevilla;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
41 Sevilla;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
41 Sevilla;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
41 Sevilla;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
41 Sevilla;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
41 Sevilla;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
41 Sevilla;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
41 Sevilla;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
41 Sevilla;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
41 Sevilla;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
41 Sevilla;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;96,14
41 Sevilla;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
41 Sevilla;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
41 Sevilla;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
41 Sevilla;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;96,96
41 Sevilla;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
41 Sevilla;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
41 Sevilla;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
41 Sevilla;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;91,86
41 Sevilla;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
41 Sevilla;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
41 Sevilla;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;91,84
41 Sevilla;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
41 Sevilla;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
41 Sevilla;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
41 Sevilla;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;93,54
41 Sevilla;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
41 Sevilla;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
41 Sevilla;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
41 Sevilla;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;89,73
41 Sevilla;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
41 Sevilla;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
41 Sevilla;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;88,57
41 Sevilla;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
41 Sevilla;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
41 Sevilla;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
41 Sevilla;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;90,69
41 Sevilla;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
41 Sevilla;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
41 Sevilla;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
41 Sevilla;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;86,78
41 Sevilla;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
41 Sevilla;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
41 Sevilla;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;85,09
41 Sevilla;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
41 Sevilla;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
41 Sevilla;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
41 Sevilla;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;87,8
41 Sevilla;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
41 Sevilla;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
41 Sevilla;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
41 Sevilla;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;84,05
41 Sevilla;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
41 Sevilla;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
41 Sevilla;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
41 Sevilla;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
41 Sevilla;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
41 Sevilla;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QII;109.156
41 Sevilla;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
41 Sevilla;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
41 Sevilla;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
41 Sevilla;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QII;107.025
41 Sevilla;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
41 Sevilla;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
41 Sevilla;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
41 Sevilla;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QII;102.742
41 Sevilla;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
41 Sevilla;All ages;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
41 Sevilla;All ages;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
41 Sevilla;All ages;Cohort April 1;Total;Survival in the first trimester;2022QII;104.990
41 Sevilla;All ages;Cohort April 1;Total;Survival in the first trimester;2022QI;""
41 Sevilla;All ages;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
41 Sevilla;All ages;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
41 Sevilla;All ages;Cohort April 1;Total;Survival in the first trimester;2021QII;103.455
41 Sevilla;All ages;Cohort April 1;Total;Survival in the first trimester;2021QI;""
41 Sevilla;All ages;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
41 Sevilla;All ages;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
41 Sevilla;All ages;Cohort April 1;Total;Survival in the first trimester;2020QII;100.456
41 Sevilla;All ages;Cohort April 1;Total;Survival in the first trimester;2020QI;""
41 Sevilla;All ages;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
41 Sevilla;All ages;Cohort April 1;Total;Survival in the second trimester;2022QIII;101.724
41 Sevilla;All ages;Cohort April 1;Total;Survival in the second trimester;2022QII;""
41 Sevilla;All ages;Cohort April 1;Total;Survival in the second trimester;2022QI;""
41 Sevilla;All ages;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
41 Sevilla;All ages;Cohort April 1;Total;Survival in the second trimester;2021QIII;100.541
41 Sevilla;All ages;Cohort April 1;Total;Survival in the second trimester;2021QII;""
41 Sevilla;All ages;Cohort April 1;Total;Survival in the second trimester;2021QI;""
41 Sevilla;All ages;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
41 Sevilla;All ages;Cohort April 1;Total;Survival in the second trimester;2020QIII;97.510
41 Sevilla;All ages;Cohort April 1;Total;Survival in the second trimester;2020QII;""
41 Sevilla;All ages;Cohort April 1;Total;Survival in the second trimester;2020QI;""
41 Sevilla;All ages;Cohort April 1;Total;Survival in the third trimester;2022QIV;98.113
41 Sevilla;All ages;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
41 Sevilla;All ages;Cohort April 1;Total;Survival in the third trimester;2022QII;""
41 Sevilla;All ages;Cohort April 1;Total;Survival in the third trimester;2022QI;""
41 Sevilla;All ages;Cohort April 1;Total;Survival in the third trimester;2021QIV;97.602
41 Sevilla;All ages;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
41 Sevilla;All ages;Cohort April 1;Total;Survival in the third trimester;2021QII;""
41 Sevilla;All ages;Cohort April 1;Total;Survival in the third trimester;2021QI;""
41 Sevilla;All ages;Cohort April 1;Total;Survival in the third trimester;2020QIV;94.804
41 Sevilla;All ages;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
41 Sevilla;All ages;Cohort April 1;Total;Survival in the third trimester;2020QII;""
41 Sevilla;All ages;Cohort April 1;Total;Survival in the third trimester;2020QI;""
41 Sevilla;All ages;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
41 Sevilla;All ages;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
41 Sevilla;All ages;Cohort April 1;Total;Survival in the third trimester;2022QII;""
41 Sevilla;All ages;Cohort April 1;Total;Survival in the third trimester;2022QI;94.953
41 Sevilla;All ages;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
41 Sevilla;All ages;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
41 Sevilla;All ages;Cohort April 1;Total;Survival in the third trimester;2021QII;""
41 Sevilla;All ages;Cohort April 1;Total;Survival in the third trimester;2021QI;92.800
41 Sevilla;All ages;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
41 Sevilla;All ages;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
41 Sevilla;All ages;Cohort April 1;Total;Survival in the third trimester;2020QII;""
41 Sevilla;All ages;Cohort April 1;Total;Survival in the third trimester;2020QI;""
41 Sevilla;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
41 Sevilla;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
41 Sevilla;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
41 Sevilla;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
41 Sevilla;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
41 Sevilla;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
41 Sevilla;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
41 Sevilla;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
41 Sevilla;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
41 Sevilla;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
41 Sevilla;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
41 Sevilla;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
41 Sevilla;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
41 Sevilla;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
41 Sevilla;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;96,18
41 Sevilla;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
41 Sevilla;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
41 Sevilla;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
41 Sevilla;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;96,66
41 Sevilla;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
41 Sevilla;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
41 Sevilla;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
41 Sevilla;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;97,78
41 Sevilla;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
41 Sevilla;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
41 Sevilla;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;93,19
41 Sevilla;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
41 Sevilla;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
41 Sevilla;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
41 Sevilla;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;93,94
41 Sevilla;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
41 Sevilla;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
41 Sevilla;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
41 Sevilla;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;94,91
41 Sevilla;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
41 Sevilla;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
41 Sevilla;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;89,88
41 Sevilla;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
41 Sevilla;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
41 Sevilla;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
41 Sevilla;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;91,2
41 Sevilla;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
41 Sevilla;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
41 Sevilla;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
41 Sevilla;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;92,27
41 Sevilla;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
41 Sevilla;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
41 Sevilla;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
41 Sevilla;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
41 Sevilla;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
41 Sevilla;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
41 Sevilla;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;88,72
41 Sevilla;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
41 Sevilla;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
41 Sevilla;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
41 Sevilla;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;90,32
41 Sevilla;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
41 Sevilla;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
41 Sevilla;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
41 Sevilla;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
41 Sevilla;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
41 Sevilla;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
41 Sevilla;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QII;69.926
41 Sevilla;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
41 Sevilla;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
41 Sevilla;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
41 Sevilla;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QII;69.146
41 Sevilla;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
41 Sevilla;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
41 Sevilla;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
41 Sevilla;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QII;66.680
41 Sevilla;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
41 Sevilla;All ages;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
41 Sevilla;All ages;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
41 Sevilla;All ages;Cohort April 1;Males;Survival in the first trimester;2022QII;67.633
41 Sevilla;All ages;Cohort April 1;Males;Survival in the first trimester;2022QI;""
41 Sevilla;All ages;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
41 Sevilla;All ages;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
41 Sevilla;All ages;Cohort April 1;Males;Survival in the first trimester;2021QII;67.004
41 Sevilla;All ages;Cohort April 1;Males;Survival in the first trimester;2021QI;""
41 Sevilla;All ages;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
41 Sevilla;All ages;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
41 Sevilla;All ages;Cohort April 1;Males;Survival in the first trimester;2020QII;65.368
41 Sevilla;All ages;Cohort April 1;Males;Survival in the first trimester;2020QI;""
41 Sevilla;All ages;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
41 Sevilla;All ages;Cohort April 1;Males;Survival in the second trimester;2022QIII;65.736
41 Sevilla;All ages;Cohort April 1;Males;Survival in the second trimester;2022QII;""
41 Sevilla;All ages;Cohort April 1;Males;Survival in the second trimester;2022QI;""
41 Sevilla;All ages;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
41 Sevilla;All ages;Cohort April 1;Males;Survival in the second trimester;2021QIII;65.272
41 Sevilla;All ages;Cohort April 1;Males;Survival in the second trimester;2021QII;""
41 Sevilla;All ages;Cohort April 1;Males;Survival in the second trimester;2021QI;""
41 Sevilla;All ages;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
41 Sevilla;All ages;Cohort April 1;Males;Survival in the second trimester;2020QIII;63.688
41 Sevilla;All ages;Cohort April 1;Males;Survival in the second trimester;2020QII;""
41 Sevilla;All ages;Cohort April 1;Males;Survival in the second trimester;2020QI;""
41 Sevilla;All ages;Cohort April 1;Males;Survival in the third trimester;2022QIV;63.586
41 Sevilla;All ages;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
41 Sevilla;All ages;Cohort April 1;Males;Survival in the third trimester;2022QII;""
41 Sevilla;All ages;Cohort April 1;Males;Survival in the third trimester;2022QI;""
41 Sevilla;All ages;Cohort April 1;Males;Survival in the third trimester;2021QIV;63.521
41 Sevilla;All ages;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
41 Sevilla;All ages;Cohort April 1;Males;Survival in the third trimester;2021QII;""
41 Sevilla;All ages;Cohort April 1;Males;Survival in the third trimester;2021QI;""
41 Sevilla;All ages;Cohort April 1;Males;Survival in the third trimester;2020QIV;62.087
41 Sevilla;All ages;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
41 Sevilla;All ages;Cohort April 1;Males;Survival in the third trimester;2020QII;""
41 Sevilla;All ages;Cohort April 1;Males;Survival in the third trimester;2020QI;""
41 Sevilla;All ages;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
41 Sevilla;All ages;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
41 Sevilla;All ages;Cohort April 1;Males;Survival in the third trimester;2022QII;""
41 Sevilla;All ages;Cohort April 1;Males;Survival in the third trimester;2022QI;62.013
41 Sevilla;All ages;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
41 Sevilla;All ages;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
41 Sevilla;All ages;Cohort April 1;Males;Survival in the third trimester;2021QII;""
41 Sevilla;All ages;Cohort April 1;Males;Survival in the third trimester;2021QI;60.862
41 Sevilla;All ages;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
41 Sevilla;All ages;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
41 Sevilla;All ages;Cohort April 1;Males;Survival in the third trimester;2020QII;""
41 Sevilla;All ages;Cohort April 1;Males;Survival in the third trimester;2020QI;""
41 Sevilla;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
41 Sevilla;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
41 Sevilla;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
41 Sevilla;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
41 Sevilla;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
41 Sevilla;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
41 Sevilla;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
41 Sevilla;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
41 Sevilla;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
41 Sevilla;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
41 Sevilla;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
41 Sevilla;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
41 Sevilla;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
41 Sevilla;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
41 Sevilla;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;96,72
41 Sevilla;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
41 Sevilla;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
41 Sevilla;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
41 Sevilla;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;96,9
41 Sevilla;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
41 Sevilla;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
41 Sevilla;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
41 Sevilla;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;98,03
41 Sevilla;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
41 Sevilla;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
41 Sevilla;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;94,01
41 Sevilla;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
41 Sevilla;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
41 Sevilla;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
41 Sevilla;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;94,4
41 Sevilla;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
41 Sevilla;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
41 Sevilla;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
41 Sevilla;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;95,51
41 Sevilla;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
41 Sevilla;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
41 Sevilla;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;90,93
41 Sevilla;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
41 Sevilla;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
41 Sevilla;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
41 Sevilla;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;91,87
41 Sevilla;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
41 Sevilla;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
41 Sevilla;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
41 Sevilla;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;93,11
41 Sevilla;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
41 Sevilla;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
41 Sevilla;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
41 Sevilla;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
41 Sevilla;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
41 Sevilla;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
41 Sevilla;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;89,68
41 Sevilla;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
41 Sevilla;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
41 Sevilla;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
41 Sevilla;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;91,27
41 Sevilla;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
41 Sevilla;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
41 Sevilla;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
41 Sevilla;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
41 Sevilla;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
41 Sevilla;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
41 Sevilla;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QII;39.230
41 Sevilla;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
41 Sevilla;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
41 Sevilla;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
41 Sevilla;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QII;37.879
41 Sevilla;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
41 Sevilla;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
41 Sevilla;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
41 Sevilla;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QII;36.062
41 Sevilla;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
41 Sevilla;All ages;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
41 Sevilla;All ages;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
41 Sevilla;All ages;Cohort April 1;Females;Survival in the first trimester;2022QII;37.357
41 Sevilla;All ages;Cohort April 1;Females;Survival in the first trimester;2022QI;""
41 Sevilla;All ages;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
41 Sevilla;All ages;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
41 Sevilla;All ages;Cohort April 1;Females;Survival in the first trimester;2021QII;36.451
41 Sevilla;All ages;Cohort April 1;Females;Survival in the first trimester;2021QI;""
41 Sevilla;All ages;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
41 Sevilla;All ages;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
41 Sevilla;All ages;Cohort April 1;Females;Survival in the first trimester;2020QII;35.088
41 Sevilla;All ages;Cohort April 1;Females;Survival in the first trimester;2020QI;""
41 Sevilla;All ages;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
41 Sevilla;All ages;Cohort April 1;Females;Survival in the second trimester;2022QIII;35.988
41 Sevilla;All ages;Cohort April 1;Females;Survival in the second trimester;2022QII;""
41 Sevilla;All ages;Cohort April 1;Females;Survival in the second trimester;2022QI;""
41 Sevilla;All ages;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
41 Sevilla;All ages;Cohort April 1;Females;Survival in the second trimester;2021QIII;35.269
41 Sevilla;All ages;Cohort April 1;Females;Survival in the second trimester;2021QII;""
41 Sevilla;All ages;Cohort April 1;Females;Survival in the second trimester;2021QI;""
41 Sevilla;All ages;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
41 Sevilla;All ages;Cohort April 1;Females;Survival in the second trimester;2020QIII;33.822
41 Sevilla;All ages;Cohort April 1;Females;Survival in the second trimester;2020QII;""
41 Sevilla;All ages;Cohort April 1;Females;Survival in the second trimester;2020QI;""
41 Sevilla;All ages;Cohort April 1;Females;Survival in the third trimester;2022QIV;34.527
41 Sevilla;All ages;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
41 Sevilla;All ages;Cohort April 1;Females;Survival in the third trimester;2022QII;""
41 Sevilla;All ages;Cohort April 1;Females;Survival in the third trimester;2022QI;""
41 Sevilla;All ages;Cohort April 1;Females;Survival in the third trimester;2021QIV;34.081
41 Sevilla;All ages;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
41 Sevilla;All ages;Cohort April 1;Females;Survival in the third trimester;2021QII;""
41 Sevilla;All ages;Cohort April 1;Females;Survival in the third trimester;2021QI;""
41 Sevilla;All ages;Cohort April 1;Females;Survival in the third trimester;2020QIV;32.717
41 Sevilla;All ages;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
41 Sevilla;All ages;Cohort April 1;Females;Survival in the third trimester;2020QII;""
41 Sevilla;All ages;Cohort April 1;Females;Survival in the third trimester;2020QI;""
41 Sevilla;All ages;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
41 Sevilla;All ages;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
41 Sevilla;All ages;Cohort April 1;Females;Survival in the third trimester;2022QII;""
41 Sevilla;All ages;Cohort April 1;Females;Survival in the third trimester;2022QI;32.940
41 Sevilla;All ages;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
41 Sevilla;All ages;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
41 Sevilla;All ages;Cohort April 1;Females;Survival in the third trimester;2021QII;""
41 Sevilla;All ages;Cohort April 1;Females;Survival in the third trimester;2021QI;31.938
41 Sevilla;All ages;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
41 Sevilla;All ages;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
41 Sevilla;All ages;Cohort April 1;Females;Survival in the third trimester;2020QII;""
41 Sevilla;All ages;Cohort April 1;Females;Survival in the third trimester;2020QI;""
41 Sevilla;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
41 Sevilla;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
41 Sevilla;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
41 Sevilla;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
41 Sevilla;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
41 Sevilla;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
41 Sevilla;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
41 Sevilla;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
41 Sevilla;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
41 Sevilla;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
41 Sevilla;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
41 Sevilla;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
41 Sevilla;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
41 Sevilla;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
41 Sevilla;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;95,23
41 Sevilla;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
41 Sevilla;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
41 Sevilla;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
41 Sevilla;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;96,23
41 Sevilla;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
41 Sevilla;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
41 Sevilla;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
41 Sevilla;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;97,3
41 Sevilla;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
41 Sevilla;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
41 Sevilla;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;91,74
41 Sevilla;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
41 Sevilla;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
41 Sevilla;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
41 Sevilla;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;93,11
41 Sevilla;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
41 Sevilla;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
41 Sevilla;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
41 Sevilla;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;93,79
41 Sevilla;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
41 Sevilla;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
41 Sevilla;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;88,01
41 Sevilla;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
41 Sevilla;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
41 Sevilla;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
41 Sevilla;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;89,97
41 Sevilla;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
41 Sevilla;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
41 Sevilla;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
41 Sevilla;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;90,72
41 Sevilla;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
41 Sevilla;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
41 Sevilla;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
41 Sevilla;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
41 Sevilla;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
41 Sevilla;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
41 Sevilla;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;86,96
41 Sevilla;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
41 Sevilla;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
41 Sevilla;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
41 Sevilla;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;88,56
41 Sevilla;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
41 Sevilla;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
41 Sevilla;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
41 Sevilla;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
41 Sevilla;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
41 Sevilla;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QIII;108.711
41 Sevilla;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
41 Sevilla;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
41 Sevilla;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
41 Sevilla;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QIII;107.835
41 Sevilla;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
41 Sevilla;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
41 Sevilla;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
41 Sevilla;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QIII;104.364
41 Sevilla;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
41 Sevilla;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
41 Sevilla;All ages;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
41 Sevilla;All ages;Cohort July 1;Total;Survival in the first trimester;2022QIII;104.948
41 Sevilla;All ages;Cohort July 1;Total;Survival in the first trimester;2022QII;""
41 Sevilla;All ages;Cohort July 1;Total;Survival in the first trimester;2022QI;""
41 Sevilla;All ages;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
41 Sevilla;All ages;Cohort July 1;Total;Survival in the first trimester;2021QIII;104.422
41 Sevilla;All ages;Cohort July 1;Total;Survival in the first trimester;2021QII;""
41 Sevilla;All ages;Cohort July 1;Total;Survival in the first trimester;2021QI;""
41 Sevilla;All ages;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
41 Sevilla;All ages;Cohort July 1;Total;Survival in the first trimester;2020QIII;100.949
41 Sevilla;All ages;Cohort July 1;Total;Survival in the first trimester;2020QII;""
41 Sevilla;All ages;Cohort July 1;Total;Survival in the first trimester;2020QI;""
41 Sevilla;All ages;Cohort July 1;Total;Survival in the second trimester;2022QIV;100.988
41 Sevilla;All ages;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
41 Sevilla;All ages;Cohort July 1;Total;Survival in the second trimester;2022QII;""
41 Sevilla;All ages;Cohort July 1;Total;Survival in the second trimester;2022QI;""
41 Sevilla;All ages;Cohort July 1;Total;Survival in the second trimester;2021QIV;101.163
41 Sevilla;All ages;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
41 Sevilla;All ages;Cohort July 1;Total;Survival in the second trimester;2021QII;""
41 Sevilla;All ages;Cohort July 1;Total;Survival in the second trimester;2021QI;""
41 Sevilla;All ages;Cohort July 1;Total;Survival in the second trimester;2020QIV;97.978
41 Sevilla;All ages;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
41 Sevilla;All ages;Cohort July 1;Total;Survival in the second trimester;2020QII;""
41 Sevilla;All ages;Cohort July 1;Total;Survival in the second trimester;2020QI;""
41 Sevilla;All ages;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
41 Sevilla;All ages;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
41 Sevilla;All ages;Cohort July 1;Total;Survival in the third trimester;2022QII;""
41 Sevilla;All ages;Cohort July 1;Total;Survival in the third trimester;2022QI;98.299
41 Sevilla;All ages;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
41 Sevilla;All ages;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
41 Sevilla;All ages;Cohort July 1;Total;Survival in the third trimester;2021QII;""
41 Sevilla;All ages;Cohort July 1;Total;Survival in the third trimester;2021QI;95.794
41 Sevilla;All ages;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
41 Sevilla;All ages;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
41 Sevilla;All ages;Cohort July 1;Total;Survival in the third trimester;2020QII;""
41 Sevilla;All ages;Cohort July 1;Total;Survival in the third trimester;2020QI;""
41 Sevilla;All ages;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
41 Sevilla;All ages;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
41 Sevilla;All ages;Cohort July 1;Total;Survival in the third trimester;2022QII;95.223
41 Sevilla;All ages;Cohort July 1;Total;Survival in the third trimester;2022QI;""
41 Sevilla;All ages;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
41 Sevilla;All ages;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
41 Sevilla;All ages;Cohort July 1;Total;Survival in the third trimester;2021QII;93.375
41 Sevilla;All ages;Cohort July 1;Total;Survival in the third trimester;2021QI;""
41 Sevilla;All ages;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
41 Sevilla;All ages;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
41 Sevilla;All ages;Cohort July 1;Total;Survival in the third trimester;2020QII;""
41 Sevilla;All ages;Cohort July 1;Total;Survival in the third trimester;2020QI;""
41 Sevilla;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
41 Sevilla;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
41 Sevilla;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
41 Sevilla;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
41 Sevilla;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
41 Sevilla;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
41 Sevilla;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
41 Sevilla;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
41 Sevilla;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
41 Sevilla;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
41 Sevilla;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
41 Sevilla;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
41 Sevilla;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
41 Sevilla;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;96,54
41 Sevilla;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
41 Sevilla;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
41 Sevilla;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
41 Sevilla;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;96,83
41 Sevilla;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
41 Sevilla;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
41 Sevilla;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
41 Sevilla;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;96,73
41 Sevilla;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
41 Sevilla;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
41 Sevilla;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;92,9
41 Sevilla;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
41 Sevilla;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
41 Sevilla;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
41 Sevilla;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;93,81
41 Sevilla;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
41 Sevilla;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
41 Sevilla;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
41 Sevilla;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;93,88
41 Sevilla;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
41 Sevilla;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
41 Sevilla;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
41 Sevilla;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
41 Sevilla;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
41 Sevilla;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
41 Sevilla;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;91,16
41 Sevilla;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
41 Sevilla;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
41 Sevilla;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
41 Sevilla;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;91,79
41 Sevilla;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
41 Sevilla;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
41 Sevilla;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
41 Sevilla;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
41 Sevilla;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
41 Sevilla;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
41 Sevilla;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;88,3
41 Sevilla;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
41 Sevilla;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
41 Sevilla;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
41 Sevilla;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;89,47
41 Sevilla;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
41 Sevilla;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
41 Sevilla;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
41 Sevilla;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
41 Sevilla;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
41 Sevilla;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
41 Sevilla;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QIII;69.804
41 Sevilla;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
41 Sevilla;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
41 Sevilla;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
41 Sevilla;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QIII;69.563
41 Sevilla;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
41 Sevilla;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
41 Sevilla;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
41 Sevilla;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QIII;67.829
41 Sevilla;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
41 Sevilla;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
41 Sevilla;All ages;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
41 Sevilla;All ages;Cohort July 1;Males;Survival in the first trimester;2022QIII;67.599
41 Sevilla;All ages;Cohort July 1;Males;Survival in the first trimester;2022QII;""
41 Sevilla;All ages;Cohort July 1;Males;Survival in the first trimester;2022QI;""
41 Sevilla;All ages;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
41 Sevilla;All ages;Cohort July 1;Males;Survival in the first trimester;2021QIII;67.517
41 Sevilla;All ages;Cohort July 1;Males;Survival in the first trimester;2021QII;""
41 Sevilla;All ages;Cohort July 1;Males;Survival in the first trimester;2021QI;""
41 Sevilla;All ages;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
41 Sevilla;All ages;Cohort July 1;Males;Survival in the first trimester;2020QIII;65.847
41 Sevilla;All ages;Cohort July 1;Males;Survival in the first trimester;2020QII;""
41 Sevilla;All ages;Cohort July 1;Males;Survival in the first trimester;2020QI;""
41 Sevilla;All ages;Cohort July 1;Males;Survival in the second trimester;2022QIV;65.216
41 Sevilla;All ages;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
41 Sevilla;All ages;Cohort July 1;Males;Survival in the second trimester;2022QII;""
41 Sevilla;All ages;Cohort July 1;Males;Survival in the second trimester;2022QI;""
41 Sevilla;All ages;Cohort July 1;Males;Survival in the second trimester;2021QIV;65.568
41 Sevilla;All ages;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
41 Sevilla;All ages;Cohort July 1;Males;Survival in the second trimester;2021QII;""
41 Sevilla;All ages;Cohort July 1;Males;Survival in the second trimester;2021QI;""
41 Sevilla;All ages;Cohort July 1;Males;Survival in the second trimester;2020QIV;64.085
41 Sevilla;All ages;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
41 Sevilla;All ages;Cohort July 1;Males;Survival in the second trimester;2020QII;""
41 Sevilla;All ages;Cohort July 1;Males;Survival in the second trimester;2020QI;""
41 Sevilla;All ages;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
41 Sevilla;All ages;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
41 Sevilla;All ages;Cohort July 1;Males;Survival in the third trimester;2022QII;""
41 Sevilla;All ages;Cohort July 1;Males;Survival in the third trimester;2022QI;63.944
41 Sevilla;All ages;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
41 Sevilla;All ages;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
41 Sevilla;All ages;Cohort July 1;Males;Survival in the third trimester;2021QII;""
41 Sevilla;All ages;Cohort July 1;Males;Survival in the third trimester;2021QI;62.745
41 Sevilla;All ages;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
41 Sevilla;All ages;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
41 Sevilla;All ages;Cohort July 1;Males;Survival in the third trimester;2020QII;""
41 Sevilla;All ages;Cohort July 1;Males;Survival in the third trimester;2020QI;""
41 Sevilla;All ages;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
41 Sevilla;All ages;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
41 Sevilla;All ages;Cohort July 1;Males;Survival in the third trimester;2022QII;62.218
41 Sevilla;All ages;Cohort July 1;Males;Survival in the third trimester;2022QI;""
41 Sevilla;All ages;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
41 Sevilla;All ages;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
41 Sevilla;All ages;Cohort July 1;Males;Survival in the third trimester;2021QII;61.296
41 Sevilla;All ages;Cohort July 1;Males;Survival in the third trimester;2021QI;""
41 Sevilla;All ages;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
41 Sevilla;All ages;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
41 Sevilla;All ages;Cohort July 1;Males;Survival in the third trimester;2020QII;""
41 Sevilla;All ages;Cohort July 1;Males;Survival in the third trimester;2020QI;""
41 Sevilla;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
41 Sevilla;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
41 Sevilla;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
41 Sevilla;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
41 Sevilla;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
41 Sevilla;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
41 Sevilla;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
41 Sevilla;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
41 Sevilla;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
41 Sevilla;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
41 Sevilla;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
41 Sevilla;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
41 Sevilla;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
41 Sevilla;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;96,84
41 Sevilla;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
41 Sevilla;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
41 Sevilla;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
41 Sevilla;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;97,06
41 Sevilla;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
41 Sevilla;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
41 Sevilla;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
41 Sevilla;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;97,08
41 Sevilla;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
41 Sevilla;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
41 Sevilla;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;93,43
41 Sevilla;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
41 Sevilla;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
41 Sevilla;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
41 Sevilla;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;94,26
41 Sevilla;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
41 Sevilla;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
41 Sevilla;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
41 Sevilla;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;94,48
41 Sevilla;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
41 Sevilla;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
41 Sevilla;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
41 Sevilla;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
41 Sevilla;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
41 Sevilla;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
41 Sevilla;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;91,92
41 Sevilla;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
41 Sevilla;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
41 Sevilla;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
41 Sevilla;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;92,5
41 Sevilla;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
41 Sevilla;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
41 Sevilla;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
41 Sevilla;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
41 Sevilla;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
41 Sevilla;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
41 Sevilla;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;89,44
41 Sevilla;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
41 Sevilla;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
41 Sevilla;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
41 Sevilla;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;90,37
41 Sevilla;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
41 Sevilla;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
41 Sevilla;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
41 Sevilla;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
41 Sevilla;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
41 Sevilla;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
41 Sevilla;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QIII;38.907
41 Sevilla;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
41 Sevilla;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
41 Sevilla;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
41 Sevilla;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QIII;38.272
41 Sevilla;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
41 Sevilla;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
41 Sevilla;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
41 Sevilla;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QIII;36.535
41 Sevilla;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
41 Sevilla;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
41 Sevilla;All ages;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
41 Sevilla;All ages;Cohort July 1;Females;Survival in the first trimester;2022QIII;37.349
41 Sevilla;All ages;Cohort July 1;Females;Survival in the first trimester;2022QII;""
41 Sevilla;All ages;Cohort July 1;Females;Survival in the first trimester;2022QI;""
41 Sevilla;All ages;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
41 Sevilla;All ages;Cohort July 1;Females;Survival in the first trimester;2021QIII;36.905
41 Sevilla;All ages;Cohort July 1;Females;Survival in the first trimester;2021QII;""
41 Sevilla;All ages;Cohort July 1;Females;Survival in the first trimester;2021QI;""
41 Sevilla;All ages;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
41 Sevilla;All ages;Cohort July 1;Females;Survival in the first trimester;2020QIII;35.102
41 Sevilla;All ages;Cohort July 1;Females;Survival in the first trimester;2020QII;""
41 Sevilla;All ages;Cohort July 1;Females;Survival in the first trimester;2020QI;""
41 Sevilla;All ages;Cohort July 1;Females;Survival in the second trimester;2022QIV;35.772
41 Sevilla;All ages;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
41 Sevilla;All ages;Cohort July 1;Females;Survival in the second trimester;2022QII;""
41 Sevilla;All ages;Cohort July 1;Females;Survival in the second trimester;2022QI;""
41 Sevilla;All ages;Cohort July 1;Females;Survival in the second trimester;2021QIV;35.595
41 Sevilla;All ages;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
41 Sevilla;All ages;Cohort July 1;Females;Survival in the second trimester;2021QII;""
41 Sevilla;All ages;Cohort July 1;Females;Survival in the second trimester;2021QI;""
41 Sevilla;All ages;Cohort July 1;Females;Survival in the second trimester;2020QIV;33.893
41 Sevilla;All ages;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
41 Sevilla;All ages;Cohort July 1;Females;Survival in the second trimester;2020QII;""
41 Sevilla;All ages;Cohort July 1;Females;Survival in the second trimester;2020QI;""
41 Sevilla;All ages;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
41 Sevilla;All ages;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
41 Sevilla;All ages;Cohort July 1;Females;Survival in the third trimester;2022QII;""
41 Sevilla;All ages;Cohort July 1;Females;Survival in the third trimester;2022QI;34.355
41 Sevilla;All ages;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
41 Sevilla;All ages;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
41 Sevilla;All ages;Cohort July 1;Females;Survival in the third trimester;2021QII;""
41 Sevilla;All ages;Cohort July 1;Females;Survival in the third trimester;2021QI;33.049
41 Sevilla;All ages;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
41 Sevilla;All ages;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
41 Sevilla;All ages;Cohort July 1;Females;Survival in the third trimester;2020QII;""
41 Sevilla;All ages;Cohort July 1;Females;Survival in the third trimester;2020QI;""
41 Sevilla;All ages;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
41 Sevilla;All ages;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
41 Sevilla;All ages;Cohort July 1;Females;Survival in the third trimester;2022QII;33.005
41 Sevilla;All ages;Cohort July 1;Females;Survival in the third trimester;2022QI;""
41 Sevilla;All ages;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
41 Sevilla;All ages;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
41 Sevilla;All ages;Cohort July 1;Females;Survival in the third trimester;2021QII;32.079
41 Sevilla;All ages;Cohort July 1;Females;Survival in the third trimester;2021QI;""
41 Sevilla;All ages;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
41 Sevilla;All ages;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
41 Sevilla;All ages;Cohort July 1;Females;Survival in the third trimester;2020QII;""
41 Sevilla;All ages;Cohort July 1;Females;Survival in the third trimester;2020QI;""
41 Sevilla;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
41 Sevilla;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
41 Sevilla;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
41 Sevilla;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
41 Sevilla;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
41 Sevilla;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
41 Sevilla;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
41 Sevilla;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
41 Sevilla;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
41 Sevilla;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
41 Sevilla;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
41 Sevilla;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
41 Sevilla;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
41 Sevilla;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;96
41 Sevilla;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
41 Sevilla;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
41 Sevilla;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
41 Sevilla;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;96,43
41 Sevilla;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
41 Sevilla;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
41 Sevilla;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
41 Sevilla;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;96,08
41 Sevilla;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
41 Sevilla;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
41 Sevilla;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;91,94
41 Sevilla;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
41 Sevilla;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
41 Sevilla;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
41 Sevilla;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;93,01
41 Sevilla;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
41 Sevilla;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
41 Sevilla;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
41 Sevilla;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;92,77
41 Sevilla;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
41 Sevilla;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
41 Sevilla;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
41 Sevilla;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
41 Sevilla;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
41 Sevilla;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
41 Sevilla;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;89,77
41 Sevilla;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
41 Sevilla;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
41 Sevilla;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
41 Sevilla;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;90,46
41 Sevilla;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
41 Sevilla;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
41 Sevilla;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
41 Sevilla;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
41 Sevilla;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
41 Sevilla;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
41 Sevilla;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;86,24
41 Sevilla;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
41 Sevilla;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
41 Sevilla;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
41 Sevilla;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;87,8
41 Sevilla;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
41 Sevilla;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
41 Sevilla;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
41 Sevilla;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
41 Sevilla;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
41 Sevilla;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QIV;108.739
41 Sevilla;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
41 Sevilla;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
41 Sevilla;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
41 Sevilla;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QIV;108.010
41 Sevilla;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
41 Sevilla;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
41 Sevilla;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
41 Sevilla;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QIV;104.779
41 Sevilla;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
41 Sevilla;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
41 Sevilla;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
41 Sevilla;All ages;Cohort October 1;Total;Survival in the first trimester;2022QIV;104.395
41 Sevilla;All ages;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
41 Sevilla;All ages;Cohort October 1;Total;Survival in the first trimester;2022QII;""
41 Sevilla;All ages;Cohort October 1;Total;Survival in the first trimester;2022QI;""
41 Sevilla;All ages;Cohort October 1;Total;Survival in the first trimester;2021QIV;104.355
41 Sevilla;All ages;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
41 Sevilla;All ages;Cohort October 1;Total;Survival in the first trimester;2021QII;""
41 Sevilla;All ages;Cohort October 1;Total;Survival in the first trimester;2021QI;""
41 Sevilla;All ages;Cohort October 1;Total;Survival in the first trimester;2020QIV;101.385
41 Sevilla;All ages;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
41 Sevilla;All ages;Cohort October 1;Total;Survival in the first trimester;2020QII;""
41 Sevilla;All ages;Cohort October 1;Total;Survival in the first trimester;2020QI;""
41 Sevilla;All ages;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
41 Sevilla;All ages;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
41 Sevilla;All ages;Cohort October 1;Total;Survival in the second trimester;2022QII;""
41 Sevilla;All ages;Cohort October 1;Total;Survival in the second trimester;2022QI;101.267
41 Sevilla;All ages;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
41 Sevilla;All ages;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
41 Sevilla;All ages;Cohort October 1;Total;Survival in the second trimester;2021QII;""
41 Sevilla;All ages;Cohort October 1;Total;Survival in the second trimester;2021QI;98.951
41 Sevilla;All ages;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
41 Sevilla;All ages;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
41 Sevilla;All ages;Cohort October 1;Total;Survival in the second trimester;2020QII;""
41 Sevilla;All ages;Cohort October 1;Total;Survival in the second trimester;2020QI;""
41 Sevilla;All ages;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
41 Sevilla;All ages;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
41 Sevilla;All ages;Cohort October 1;Total;Survival in the third trimester;2022QII;97.942
41 Sevilla;All ages;Cohort October 1;Total;Survival in the third trimester;2022QI;""
41 Sevilla;All ages;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
41 Sevilla;All ages;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
41 Sevilla;All ages;Cohort October 1;Total;Survival in the third trimester;2021QII;96.259
41 Sevilla;All ages;Cohort October 1;Total;Survival in the third trimester;2021QI;""
41 Sevilla;All ages;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
41 Sevilla;All ages;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
41 Sevilla;All ages;Cohort October 1;Total;Survival in the third trimester;2020QII;""
41 Sevilla;All ages;Cohort October 1;Total;Survival in the third trimester;2020QI;""
41 Sevilla;All ages;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
41 Sevilla;All ages;Cohort October 1;Total;Survival in the third trimester;2022QIII;95.131
41 Sevilla;All ages;Cohort October 1;Total;Survival in the third trimester;2022QII;""
41 Sevilla;All ages;Cohort October 1;Total;Survival in the third trimester;2022QI;""
41 Sevilla;All ages;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
41 Sevilla;All ages;Cohort October 1;Total;Survival in the third trimester;2021QIII;93.856
41 Sevilla;All ages;Cohort October 1;Total;Survival in the third trimester;2021QII;""
41 Sevilla;All ages;Cohort October 1;Total;Survival in the third trimester;2021QI;""
41 Sevilla;All ages;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
41 Sevilla;All ages;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
41 Sevilla;All ages;Cohort October 1;Total;Survival in the third trimester;2020QII;""
41 Sevilla;All ages;Cohort October 1;Total;Survival in the third trimester;2020QI;""
41 Sevilla;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
41 Sevilla;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
41 Sevilla;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
41 Sevilla;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
41 Sevilla;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
41 Sevilla;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
41 Sevilla;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
41 Sevilla;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
41 Sevilla;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
41 Sevilla;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
41 Sevilla;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
41 Sevilla;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
41 Sevilla;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;96,01
41 Sevilla;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
41 Sevilla;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
41 Sevilla;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
41 Sevilla;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;96,62
41 Sevilla;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
41 Sevilla;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
41 Sevilla;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
41 Sevilla;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;96,76
41 Sevilla;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
41 Sevilla;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
41 Sevilla;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
41 Sevilla;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
41 Sevilla;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
41 Sevilla;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
41 Sevilla;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;93,76
41 Sevilla;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
41 Sevilla;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
41 Sevilla;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
41 Sevilla;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;94,44
41 Sevilla;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
41 Sevilla;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
41 Sevilla;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
41 Sevilla;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
41 Sevilla;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
41 Sevilla;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
41 Sevilla;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;90,68
41 Sevilla;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
41 Sevilla;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
41 Sevilla;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
41 Sevilla;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;91,87
41 Sevilla;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
41 Sevilla;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
41 Sevilla;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
41 Sevilla;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
41 Sevilla;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
41 Sevilla;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
41 Sevilla;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;88,08
41 Sevilla;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
41 Sevilla;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
41 Sevilla;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
41 Sevilla;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;89,58
41 Sevilla;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
41 Sevilla;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
41 Sevilla;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
41 Sevilla;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
41 Sevilla;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
41 Sevilla;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
41 Sevilla;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QIV;69.611
41 Sevilla;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
41 Sevilla;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
41 Sevilla;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
41 Sevilla;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QIV;69.519
41 Sevilla;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
41 Sevilla;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
41 Sevilla;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
41 Sevilla;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QIV;68.029
41 Sevilla;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
41 Sevilla;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
41 Sevilla;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
41 Sevilla;All ages;Cohort October 1;Males;Survival in the first trimester;2022QIV;67.003
41 Sevilla;All ages;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
41 Sevilla;All ages;Cohort October 1;Males;Survival in the first trimester;2022QII;""
41 Sevilla;All ages;Cohort October 1;Males;Survival in the first trimester;2022QI;""
41 Sevilla;All ages;Cohort October 1;Males;Survival in the first trimester;2021QIV;67.339
41 Sevilla;All ages;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
41 Sevilla;All ages;Cohort October 1;Males;Survival in the first trimester;2021QII;""
41 Sevilla;All ages;Cohort October 1;Males;Survival in the first trimester;2021QI;""
41 Sevilla;All ages;Cohort October 1;Males;Survival in the first trimester;2020QIV;65.997
41 Sevilla;All ages;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
41 Sevilla;All ages;Cohort October 1;Males;Survival in the first trimester;2020QII;""
41 Sevilla;All ages;Cohort October 1;Males;Survival in the first trimester;2020QI;""
41 Sevilla;All ages;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
41 Sevilla;All ages;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
41 Sevilla;All ages;Cohort October 1;Males;Survival in the second trimester;2022QII;""
41 Sevilla;All ages;Cohort October 1;Males;Survival in the second trimester;2022QI;65.589
41 Sevilla;All ages;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
41 Sevilla;All ages;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
41 Sevilla;All ages;Cohort October 1;Males;Survival in the second trimester;2021QII;""
41 Sevilla;All ages;Cohort October 1;Males;Survival in the second trimester;2021QI;64.522
41 Sevilla;All ages;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
41 Sevilla;All ages;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
41 Sevilla;All ages;Cohort October 1;Males;Survival in the second trimester;2020QII;""
41 Sevilla;All ages;Cohort October 1;Males;Survival in the second trimester;2020QI;""
41 Sevilla;All ages;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
41 Sevilla;All ages;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
41 Sevilla;All ages;Cohort October 1;Males;Survival in the third trimester;2022QII;63.751
41 Sevilla;All ages;Cohort October 1;Males;Survival in the third trimester;2022QI;""
41 Sevilla;All ages;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
41 Sevilla;All ages;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
41 Sevilla;All ages;Cohort October 1;Males;Survival in the third trimester;2021QII;62.921
41 Sevilla;All ages;Cohort October 1;Males;Survival in the third trimester;2021QI;""
41 Sevilla;All ages;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
41 Sevilla;All ages;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
41 Sevilla;All ages;Cohort October 1;Males;Survival in the third trimester;2020QII;""
41 Sevilla;All ages;Cohort October 1;Males;Survival in the third trimester;2020QI;""
41 Sevilla;All ages;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
41 Sevilla;All ages;Cohort October 1;Males;Survival in the third trimester;2022QIII;62.117
41 Sevilla;All ages;Cohort October 1;Males;Survival in the third trimester;2022QII;""
41 Sevilla;All ages;Cohort October 1;Males;Survival in the third trimester;2022QI;""
41 Sevilla;All ages;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
41 Sevilla;All ages;Cohort October 1;Males;Survival in the third trimester;2021QIII;61.483
41 Sevilla;All ages;Cohort October 1;Males;Survival in the third trimester;2021QII;""
41 Sevilla;All ages;Cohort October 1;Males;Survival in the third trimester;2021QI;""
41 Sevilla;All ages;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
41 Sevilla;All ages;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
41 Sevilla;All ages;Cohort October 1;Males;Survival in the third trimester;2020QII;""
41 Sevilla;All ages;Cohort October 1;Males;Survival in the third trimester;2020QI;""
41 Sevilla;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
41 Sevilla;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
41 Sevilla;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
41 Sevilla;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
41 Sevilla;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
41 Sevilla;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
41 Sevilla;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
41 Sevilla;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
41 Sevilla;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
41 Sevilla;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
41 Sevilla;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
41 Sevilla;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
41 Sevilla;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;96,25
41 Sevilla;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
41 Sevilla;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
41 Sevilla;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
41 Sevilla;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;96,86
41 Sevilla;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
41 Sevilla;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
41 Sevilla;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
41 Sevilla;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;97,01
41 Sevilla;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
41 Sevilla;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
41 Sevilla;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
41 Sevilla;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
41 Sevilla;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
41 Sevilla;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
41 Sevilla;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;94,35
41 Sevilla;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
41 Sevilla;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
41 Sevilla;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
41 Sevilla;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;94,84
41 Sevilla;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
41 Sevilla;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
41 Sevilla;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
41 Sevilla;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
41 Sevilla;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
41 Sevilla;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
41 Sevilla;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;91,7
41 Sevilla;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
41 Sevilla;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
41 Sevilla;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
41 Sevilla;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;92,49
41 Sevilla;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
41 Sevilla;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
41 Sevilla;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
41 Sevilla;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
41 Sevilla;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
41 Sevilla;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
41 Sevilla;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;89,35
41 Sevilla;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
41 Sevilla;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
41 Sevilla;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
41 Sevilla;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;90,38
41 Sevilla;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
41 Sevilla;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
41 Sevilla;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
41 Sevilla;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
41 Sevilla;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
41 Sevilla;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
41 Sevilla;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QIV;39.128
41 Sevilla;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
41 Sevilla;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
41 Sevilla;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
41 Sevilla;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QIV;38.491
41 Sevilla;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
41 Sevilla;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
41 Sevilla;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
41 Sevilla;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QIV;36.750
41 Sevilla;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
41 Sevilla;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
41 Sevilla;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
41 Sevilla;All ages;Cohort October 1;Females;Survival in the first trimester;2022QIV;37.392
41 Sevilla;All ages;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
41 Sevilla;All ages;Cohort October 1;Females;Survival in the first trimester;2022QII;""
41 Sevilla;All ages;Cohort October 1;Females;Survival in the first trimester;2022QI;""
41 Sevilla;All ages;Cohort October 1;Females;Survival in the first trimester;2021QIV;37.016
41 Sevilla;All ages;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
41 Sevilla;All ages;Cohort October 1;Females;Survival in the first trimester;2021QII;""
41 Sevilla;All ages;Cohort October 1;Females;Survival in the first trimester;2021QI;""
41 Sevilla;All ages;Cohort October 1;Females;Survival in the first trimester;2020QIV;35.388
41 Sevilla;All ages;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
41 Sevilla;All ages;Cohort October 1;Females;Survival in the first trimester;2020QII;""
41 Sevilla;All ages;Cohort October 1;Females;Survival in the first trimester;2020QI;""
41 Sevilla;All ages;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
41 Sevilla;All ages;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
41 Sevilla;All ages;Cohort October 1;Females;Survival in the second trimester;2022QII;""
41 Sevilla;All ages;Cohort October 1;Females;Survival in the second trimester;2022QI;35.678
41 Sevilla;All ages;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
41 Sevilla;All ages;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
41 Sevilla;All ages;Cohort October 1;Females;Survival in the second trimester;2021QII;""
41 Sevilla;All ages;Cohort October 1;Females;Survival in the second trimester;2021QI;34.429
41 Sevilla;All ages;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
41 Sevilla;All ages;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
41 Sevilla;All ages;Cohort October 1;Females;Survival in the second trimester;2020QII;""
41 Sevilla;All ages;Cohort October 1;Females;Survival in the second trimester;2020QI;""
41 Sevilla;All ages;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
41 Sevilla;All ages;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
41 Sevilla;All ages;Cohort October 1;Females;Survival in the third trimester;2022QII;34.191
41 Sevilla;All ages;Cohort October 1;Females;Survival in the third trimester;2022QI;""
41 Sevilla;All ages;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
41 Sevilla;All ages;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
41 Sevilla;All ages;Cohort October 1;Females;Survival in the third trimester;2021QII;33.338
41 Sevilla;All ages;Cohort October 1;Females;Survival in the third trimester;2021QI;""
41 Sevilla;All ages;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
41 Sevilla;All ages;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
41 Sevilla;All ages;Cohort October 1;Females;Survival in the third trimester;2020QII;""
41 Sevilla;All ages;Cohort October 1;Females;Survival in the third trimester;2020QI;""
41 Sevilla;All ages;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
41 Sevilla;All ages;Cohort October 1;Females;Survival in the third trimester;2022QIII;33.014
41 Sevilla;All ages;Cohort October 1;Females;Survival in the third trimester;2022QII;""
41 Sevilla;All ages;Cohort October 1;Females;Survival in the third trimester;2022QI;""
41 Sevilla;All ages;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
41 Sevilla;All ages;Cohort October 1;Females;Survival in the third trimester;2021QIII;32.373
41 Sevilla;All ages;Cohort October 1;Females;Survival in the third trimester;2021QII;""
41 Sevilla;All ages;Cohort October 1;Females;Survival in the third trimester;2021QI;""
41 Sevilla;All ages;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
41 Sevilla;All ages;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
41 Sevilla;All ages;Cohort October 1;Females;Survival in the third trimester;2020QII;""
41 Sevilla;All ages;Cohort October 1;Females;Survival in the third trimester;2020QI;""
41 Sevilla;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
41 Sevilla;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
41 Sevilla;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
41 Sevilla;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
41 Sevilla;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
41 Sevilla;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
41 Sevilla;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
41 Sevilla;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
41 Sevilla;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
41 Sevilla;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
41 Sevilla;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
41 Sevilla;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
41 Sevilla;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;95,56
41 Sevilla;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
41 Sevilla;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
41 Sevilla;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
41 Sevilla;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;96,17
41 Sevilla;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
41 Sevilla;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
41 Sevilla;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
41 Sevilla;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;96,29
41 Sevilla;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
41 Sevilla;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
41 Sevilla;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
41 Sevilla;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
41 Sevilla;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
41 Sevilla;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
41 Sevilla;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;92,69
41 Sevilla;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
41 Sevilla;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
41 Sevilla;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
41 Sevilla;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;93,68
41 Sevilla;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
41 Sevilla;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
41 Sevilla;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
41 Sevilla;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
41 Sevilla;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
41 Sevilla;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
41 Sevilla;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;88,83
41 Sevilla;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
41 Sevilla;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
41 Sevilla;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
41 Sevilla;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;90,72
41 Sevilla;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
41 Sevilla;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
41 Sevilla;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
41 Sevilla;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
41 Sevilla;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
41 Sevilla;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
41 Sevilla;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;85,77
41 Sevilla;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
41 Sevilla;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
41 Sevilla;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
41 Sevilla;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;88,09
41 Sevilla;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
41 Sevilla;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
41 Sevilla;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
41 Sevilla;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
41 Sevilla;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
41 Sevilla;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
41 Sevilla;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
41 Sevilla;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
41 Sevilla;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
41 Sevilla;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QI;8.195
41 Sevilla;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
41 Sevilla;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
41 Sevilla;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
41 Sevilla;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QI;7.910
41 Sevilla;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
41 Sevilla;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
41 Sevilla;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
41 Sevilla;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QI;6.363
41 Sevilla;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
41 Sevilla;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
41 Sevilla;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2022QII;""
41 Sevilla;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2022QI;7.622
41 Sevilla;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
41 Sevilla;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
41 Sevilla;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2021QII;""
41 Sevilla;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2021QI;7.458
41 Sevilla;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
41 Sevilla;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
41 Sevilla;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2020QII;""
41 Sevilla;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2020QI;5.570
41 Sevilla;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
41 Sevilla;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
41 Sevilla;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2022QII;7.084
41 Sevilla;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2022QI;""
41 Sevilla;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
41 Sevilla;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
41 Sevilla;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2021QII;6.954
41 Sevilla;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2021QI;""
41 Sevilla;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
41 Sevilla;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
41 Sevilla;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2020QII;5.378
41 Sevilla;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2020QI;""
41 Sevilla;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
41 Sevilla;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QIII;6.622
41 Sevilla;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QII;""
41 Sevilla;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QI;""
41 Sevilla;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
41 Sevilla;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QIII;6.536
41 Sevilla;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QII;""
41 Sevilla;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QI;""
41 Sevilla;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
41 Sevilla;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QIII;5.079
41 Sevilla;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QII;""
41 Sevilla;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QI;""
41 Sevilla;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QIV;6.187
41 Sevilla;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
41 Sevilla;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QII;""
41 Sevilla;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QI;""
41 Sevilla;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QIV;6.176
41 Sevilla;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
41 Sevilla;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QII;""
41 Sevilla;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QI;""
41 Sevilla;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QIV;4.818
41 Sevilla;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
41 Sevilla;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QII;""
41 Sevilla;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QI;""
41 Sevilla;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
41 Sevilla;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
41 Sevilla;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
41 Sevilla;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
41 Sevilla;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
41 Sevilla;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
41 Sevilla;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
41 Sevilla;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
41 Sevilla;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
41 Sevilla;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
41 Sevilla;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
41 Sevilla;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
41 Sevilla;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
41 Sevilla;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
41 Sevilla;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
41 Sevilla;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;93,01
41 Sevilla;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
41 Sevilla;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
41 Sevilla;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
41 Sevilla;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;94,29
41 Sevilla;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
41 Sevilla;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
41 Sevilla;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
41 Sevilla;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;87,54
41 Sevilla;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
41 Sevilla;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
41 Sevilla;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;86,44
41 Sevilla;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
41 Sevilla;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
41 Sevilla;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
41 Sevilla;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;87,91
41 Sevilla;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
41 Sevilla;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
41 Sevilla;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
41 Sevilla;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;84,52
41 Sevilla;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
41 Sevilla;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
41 Sevilla;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;80,81
41 Sevilla;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
41 Sevilla;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
41 Sevilla;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
41 Sevilla;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;82,63
41 Sevilla;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
41 Sevilla;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
41 Sevilla;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
41 Sevilla;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;79,82
41 Sevilla;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
41 Sevilla;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
41 Sevilla;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;75,5
41 Sevilla;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
41 Sevilla;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
41 Sevilla;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
41 Sevilla;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;78,08
41 Sevilla;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
41 Sevilla;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
41 Sevilla;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
41 Sevilla;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;75,72
41 Sevilla;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
41 Sevilla;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
41 Sevilla;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
41 Sevilla;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
41 Sevilla;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
41 Sevilla;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
41 Sevilla;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QI;4.788
41 Sevilla;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
41 Sevilla;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
41 Sevilla;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
41 Sevilla;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QI;4.775
41 Sevilla;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
41 Sevilla;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
41 Sevilla;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
41 Sevilla;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QI;3.851
41 Sevilla;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
41 Sevilla;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
41 Sevilla;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2022QII;""
41 Sevilla;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2022QI;4.472
41 Sevilla;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
41 Sevilla;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
41 Sevilla;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2021QII;""
41 Sevilla;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2021QI;4.503
41 Sevilla;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
41 Sevilla;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
41 Sevilla;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2020QII;""
41 Sevilla;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2020QI;3.385
41 Sevilla;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
41 Sevilla;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
41 Sevilla;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2022QII;4.183
41 Sevilla;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2022QI;""
41 Sevilla;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
41 Sevilla;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
41 Sevilla;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2021QII;4.201
41 Sevilla;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2021QI;""
41 Sevilla;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
41 Sevilla;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
41 Sevilla;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2020QII;3.267
41 Sevilla;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2020QI;""
41 Sevilla;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
41 Sevilla;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QIII;3.929
41 Sevilla;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QII;""
41 Sevilla;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QI;""
41 Sevilla;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
41 Sevilla;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QIII;3.945
41 Sevilla;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QII;""
41 Sevilla;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QI;""
41 Sevilla;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
41 Sevilla;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QIII;3.113
41 Sevilla;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QII;""
41 Sevilla;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QI;""
41 Sevilla;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QIV;3.678
41 Sevilla;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
41 Sevilla;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QII;""
41 Sevilla;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QI;""
41 Sevilla;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QIV;3.750
41 Sevilla;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
41 Sevilla;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QII;""
41 Sevilla;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QI;""
41 Sevilla;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QIV;2.972
41 Sevilla;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
41 Sevilla;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QII;""
41 Sevilla;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QI;""
41 Sevilla;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
41 Sevilla;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
41 Sevilla;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
41 Sevilla;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
41 Sevilla;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
41 Sevilla;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
41 Sevilla;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
41 Sevilla;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
41 Sevilla;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
41 Sevilla;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
41 Sevilla;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
41 Sevilla;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
41 Sevilla;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
41 Sevilla;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
41 Sevilla;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
41 Sevilla;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;93,4
41 Sevilla;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
41 Sevilla;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
41 Sevilla;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
41 Sevilla;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;94,3
41 Sevilla;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
41 Sevilla;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
41 Sevilla;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
41 Sevilla;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;87,9
41 Sevilla;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
41 Sevilla;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
41 Sevilla;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;87,36
41 Sevilla;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
41 Sevilla;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
41 Sevilla;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
41 Sevilla;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;87,98
41 Sevilla;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
41 Sevilla;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
41 Sevilla;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
41 Sevilla;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;84,84
41 Sevilla;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
41 Sevilla;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
41 Sevilla;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;82,06
41 Sevilla;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
41 Sevilla;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
41 Sevilla;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
41 Sevilla;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;82,62
41 Sevilla;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
41 Sevilla;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
41 Sevilla;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
41 Sevilla;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;80,84
41 Sevilla;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
41 Sevilla;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
41 Sevilla;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;76,82
41 Sevilla;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
41 Sevilla;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
41 Sevilla;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
41 Sevilla;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;78,53
41 Sevilla;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
41 Sevilla;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
41 Sevilla;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
41 Sevilla;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;77,17
41 Sevilla;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
41 Sevilla;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
41 Sevilla;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
41 Sevilla;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
41 Sevilla;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
41 Sevilla;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
41 Sevilla;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QI;3.407
41 Sevilla;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
41 Sevilla;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
41 Sevilla;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
41 Sevilla;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QI;3.135
41 Sevilla;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
41 Sevilla;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
41 Sevilla;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
41 Sevilla;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QI;2.512
41 Sevilla;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
41 Sevilla;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
41 Sevilla;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2022QII;""
41 Sevilla;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2022QI;3.150
41 Sevilla;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
41 Sevilla;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
41 Sevilla;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2021QII;""
41 Sevilla;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2021QI;2.955
41 Sevilla;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
41 Sevilla;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
41 Sevilla;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2020QII;""
41 Sevilla;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2020QI;2.185
41 Sevilla;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
41 Sevilla;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
41 Sevilla;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2022QII;2.901
41 Sevilla;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2022QI;""
41 Sevilla;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
41 Sevilla;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
41 Sevilla;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2021QII;2.753
41 Sevilla;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2021QI;""
41 Sevilla;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
41 Sevilla;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
41 Sevilla;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2020QII;2.111
41 Sevilla;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2020QI;""
41 Sevilla;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
41 Sevilla;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QIII;2.693
41 Sevilla;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QII;""
41 Sevilla;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QI;""
41 Sevilla;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
41 Sevilla;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QIII;2.591
41 Sevilla;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QII;""
41 Sevilla;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QI;""
41 Sevilla;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
41 Sevilla;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QIII;1.966
41 Sevilla;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QII;""
41 Sevilla;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QI;""
41 Sevilla;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QIV;2.509
41 Sevilla;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
41 Sevilla;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QII;""
41 Sevilla;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QI;""
41 Sevilla;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QIV;2.426
41 Sevilla;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
41 Sevilla;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QII;""
41 Sevilla;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QI;""
41 Sevilla;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QIV;1.846
41 Sevilla;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
41 Sevilla;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QII;""
41 Sevilla;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QI;""
41 Sevilla;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
41 Sevilla;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
41 Sevilla;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
41 Sevilla;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
41 Sevilla;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
41 Sevilla;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
41 Sevilla;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
41 Sevilla;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
41 Sevilla;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
41 Sevilla;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
41 Sevilla;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
41 Sevilla;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
41 Sevilla;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
41 Sevilla;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
41 Sevilla;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
41 Sevilla;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;92,46
41 Sevilla;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
41 Sevilla;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
41 Sevilla;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
41 Sevilla;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;94,26
41 Sevilla;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
41 Sevilla;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
41 Sevilla;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
41 Sevilla;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;86,98
41 Sevilla;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
41 Sevilla;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
41 Sevilla;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;85,15
41 Sevilla;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
41 Sevilla;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
41 Sevilla;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
41 Sevilla;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;87,81
41 Sevilla;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
41 Sevilla;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
41 Sevilla;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
41 Sevilla;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;84,04
41 Sevilla;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
41 Sevilla;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
41 Sevilla;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;79,04
41 Sevilla;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
41 Sevilla;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
41 Sevilla;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
41 Sevilla;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;82,65
41 Sevilla;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
41 Sevilla;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
41 Sevilla;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
41 Sevilla;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;78,26
41 Sevilla;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
41 Sevilla;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
41 Sevilla;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;73,64
41 Sevilla;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
41 Sevilla;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
41 Sevilla;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
41 Sevilla;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;77,38
41 Sevilla;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
41 Sevilla;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
41 Sevilla;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
41 Sevilla;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;73,49
41 Sevilla;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
41 Sevilla;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
41 Sevilla;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
41 Sevilla;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
41 Sevilla;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
41 Sevilla;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QII;7.119
41 Sevilla;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
41 Sevilla;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
41 Sevilla;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
41 Sevilla;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QII;7.012
41 Sevilla;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
41 Sevilla;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
41 Sevilla;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
41 Sevilla;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QII;6.533
41 Sevilla;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
41 Sevilla;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
41 Sevilla;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
41 Sevilla;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2022QII;6.567
41 Sevilla;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2022QI;""
41 Sevilla;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
41 Sevilla;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
41 Sevilla;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2021QII;6.469
41 Sevilla;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2021QI;""
41 Sevilla;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
41 Sevilla;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
41 Sevilla;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2020QII;6.289
41 Sevilla;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2020QI;""
41 Sevilla;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
41 Sevilla;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2022QIII;6.107
41 Sevilla;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2022QII;""
41 Sevilla;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2022QI;""
41 Sevilla;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
41 Sevilla;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2021QIII;6.037
41 Sevilla;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2021QII;""
41 Sevilla;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2021QI;""
41 Sevilla;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
41 Sevilla;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2020QIII;5.904
41 Sevilla;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2020QII;""
41 Sevilla;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2020QI;""
41 Sevilla;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QIV;5.679
41 Sevilla;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
41 Sevilla;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QII;""
41 Sevilla;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QI;""
41 Sevilla;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QIV;5.667
41 Sevilla;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
41 Sevilla;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QII;""
41 Sevilla;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QI;""
41 Sevilla;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QIV;5.583
41 Sevilla;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
41 Sevilla;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QII;""
41 Sevilla;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QI;""
41 Sevilla;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
41 Sevilla;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
41 Sevilla;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QII;""
41 Sevilla;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QI;5.325
41 Sevilla;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
41 Sevilla;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
41 Sevilla;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QII;""
41 Sevilla;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QI;5.360
41 Sevilla;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
41 Sevilla;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
41 Sevilla;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QII;""
41 Sevilla;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QI;""
41 Sevilla;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
41 Sevilla;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
41 Sevilla;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
41 Sevilla;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
41 Sevilla;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
41 Sevilla;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
41 Sevilla;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
41 Sevilla;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
41 Sevilla;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
41 Sevilla;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
41 Sevilla;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
41 Sevilla;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
41 Sevilla;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
41 Sevilla;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
41 Sevilla;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;92,25
41 Sevilla;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
41 Sevilla;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
41 Sevilla;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
41 Sevilla;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;92,26
41 Sevilla;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
41 Sevilla;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
41 Sevilla;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
41 Sevilla;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;96,27
41 Sevilla;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
41 Sevilla;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
41 Sevilla;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;85,78
41 Sevilla;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
41 Sevilla;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
41 Sevilla;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
41 Sevilla;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;86,1
41 Sevilla;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
41 Sevilla;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
41 Sevilla;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
41 Sevilla;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;90,37
41 Sevilla;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
41 Sevilla;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
41 Sevilla;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;79,77
41 Sevilla;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
41 Sevilla;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
41 Sevilla;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
41 Sevilla;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;80,82
41 Sevilla;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
41 Sevilla;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
41 Sevilla;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
41 Sevilla;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;85,46
41 Sevilla;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
41 Sevilla;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
41 Sevilla;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
41 Sevilla;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
41 Sevilla;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
41 Sevilla;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
41 Sevilla;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;75,94
41 Sevilla;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
41 Sevilla;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
41 Sevilla;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
41 Sevilla;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;82,05
41 Sevilla;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
41 Sevilla;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
41 Sevilla;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
41 Sevilla;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
41 Sevilla;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
41 Sevilla;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
41 Sevilla;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QII;4.161
41 Sevilla;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
41 Sevilla;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
41 Sevilla;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
41 Sevilla;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QII;4.198
41 Sevilla;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
41 Sevilla;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
41 Sevilla;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
41 Sevilla;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QII;3.939
41 Sevilla;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
41 Sevilla;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
41 Sevilla;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
41 Sevilla;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2022QII;3.867
41 Sevilla;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2022QI;""
41 Sevilla;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
41 Sevilla;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
41 Sevilla;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2021QII;3.855
41 Sevilla;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2021QI;""
41 Sevilla;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
41 Sevilla;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
41 Sevilla;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2020QII;3.793
41 Sevilla;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2020QI;""
41 Sevilla;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
41 Sevilla;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2022QIII;3.615
41 Sevilla;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2022QII;""
41 Sevilla;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2022QI;""
41 Sevilla;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
41 Sevilla;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2021QIII;3.589
41 Sevilla;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2021QII;""
41 Sevilla;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2021QI;""
41 Sevilla;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
41 Sevilla;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2020QIII;3.599
41 Sevilla;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2020QII;""
41 Sevilla;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2020QI;""
41 Sevilla;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QIV;3.367
41 Sevilla;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
41 Sevilla;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QII;""
41 Sevilla;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QI;""
41 Sevilla;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QIV;3.384
41 Sevilla;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
41 Sevilla;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QII;""
41 Sevilla;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QI;""
41 Sevilla;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QIV;3.420
41 Sevilla;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
41 Sevilla;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QII;""
41 Sevilla;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QI;""
41 Sevilla;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
41 Sevilla;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
41 Sevilla;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QII;""
41 Sevilla;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QI;3.189
41 Sevilla;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
41 Sevilla;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
41 Sevilla;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QII;""
41 Sevilla;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QI;3.279
41 Sevilla;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
41 Sevilla;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
41 Sevilla;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QII;""
41 Sevilla;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QI;""
41 Sevilla;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
41 Sevilla;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
41 Sevilla;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
41 Sevilla;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
41 Sevilla;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
41 Sevilla;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
41 Sevilla;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
41 Sevilla;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
41 Sevilla;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
41 Sevilla;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
41 Sevilla;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
41 Sevilla;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
41 Sevilla;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
41 Sevilla;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
41 Sevilla;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;92,93
41 Sevilla;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
41 Sevilla;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
41 Sevilla;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
41 Sevilla;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;91,83
41 Sevilla;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
41 Sevilla;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
41 Sevilla;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
41 Sevilla;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;96,29
41 Sevilla;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
41 Sevilla;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
41 Sevilla;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;86,88
41 Sevilla;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
41 Sevilla;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
41 Sevilla;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
41 Sevilla;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;85,49
41 Sevilla;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
41 Sevilla;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
41 Sevilla;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
41 Sevilla;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;91,37
41 Sevilla;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
41 Sevilla;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
41 Sevilla;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;80,92
41 Sevilla;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
41 Sevilla;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
41 Sevilla;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
41 Sevilla;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;80,61
41 Sevilla;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
41 Sevilla;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
41 Sevilla;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
41 Sevilla;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;86,82
41 Sevilla;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
41 Sevilla;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
41 Sevilla;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
41 Sevilla;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
41 Sevilla;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
41 Sevilla;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
41 Sevilla;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;75,96
41 Sevilla;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
41 Sevilla;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
41 Sevilla;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
41 Sevilla;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;83,24
41 Sevilla;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
41 Sevilla;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
41 Sevilla;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
41 Sevilla;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
41 Sevilla;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
41 Sevilla;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
41 Sevilla;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QII;2.958
41 Sevilla;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
41 Sevilla;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
41 Sevilla;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
41 Sevilla;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QII;2.814
41 Sevilla;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
41 Sevilla;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
41 Sevilla;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
41 Sevilla;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QII;2.594
41 Sevilla;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
41 Sevilla;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
41 Sevilla;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
41 Sevilla;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2022QII;2.700
41 Sevilla;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2022QI;""
41 Sevilla;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
41 Sevilla;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
41 Sevilla;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2021QII;2.614
41 Sevilla;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2021QI;""
41 Sevilla;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
41 Sevilla;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
41 Sevilla;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2020QII;2.496
41 Sevilla;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2020QI;""
41 Sevilla;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
41 Sevilla;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2022QIII;2.492
41 Sevilla;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2022QII;""
41 Sevilla;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2022QI;""
41 Sevilla;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
41 Sevilla;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2021QIII;2.448
41 Sevilla;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2021QII;""
41 Sevilla;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2021QI;""
41 Sevilla;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
41 Sevilla;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2020QIII;2.305
41 Sevilla;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2020QII;""
41 Sevilla;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2020QI;""
41 Sevilla;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QIV;2.312
41 Sevilla;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
41 Sevilla;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QII;""
41 Sevilla;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QI;""
41 Sevilla;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QIV;2.283
41 Sevilla;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
41 Sevilla;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QII;""
41 Sevilla;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QI;""
41 Sevilla;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QIV;2.163
41 Sevilla;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
41 Sevilla;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QII;""
41 Sevilla;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QI;""
41 Sevilla;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
41 Sevilla;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
41 Sevilla;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QII;""
41 Sevilla;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QI;2.136
41 Sevilla;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
41 Sevilla;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
41 Sevilla;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QII;""
41 Sevilla;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QI;2.081
41 Sevilla;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
41 Sevilla;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
41 Sevilla;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QII;""
41 Sevilla;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QI;""
41 Sevilla;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
41 Sevilla;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
41 Sevilla;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
41 Sevilla;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
41 Sevilla;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
41 Sevilla;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
41 Sevilla;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
41 Sevilla;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
41 Sevilla;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
41 Sevilla;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
41 Sevilla;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
41 Sevilla;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
41 Sevilla;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
41 Sevilla;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
41 Sevilla;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;91,28
41 Sevilla;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
41 Sevilla;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
41 Sevilla;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
41 Sevilla;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;92,89
41 Sevilla;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
41 Sevilla;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
41 Sevilla;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
41 Sevilla;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;96,22
41 Sevilla;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
41 Sevilla;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
41 Sevilla;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;84,25
41 Sevilla;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
41 Sevilla;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
41 Sevilla;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
41 Sevilla;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;86,99
41 Sevilla;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
41 Sevilla;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
41 Sevilla;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
41 Sevilla;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;88,86
41 Sevilla;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
41 Sevilla;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
41 Sevilla;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;78,16
41 Sevilla;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
41 Sevilla;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
41 Sevilla;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
41 Sevilla;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;81,13
41 Sevilla;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
41 Sevilla;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
41 Sevilla;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
41 Sevilla;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;83,38
41 Sevilla;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
41 Sevilla;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
41 Sevilla;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
41 Sevilla;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
41 Sevilla;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
41 Sevilla;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
41 Sevilla;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;75,91
41 Sevilla;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
41 Sevilla;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
41 Sevilla;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
41 Sevilla;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;80,22
41 Sevilla;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
41 Sevilla;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
41 Sevilla;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
41 Sevilla;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
41 Sevilla;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
41 Sevilla;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QIII;7.368
41 Sevilla;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
41 Sevilla;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
41 Sevilla;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
41 Sevilla;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QIII;7.500
41 Sevilla;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
41 Sevilla;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
41 Sevilla;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
41 Sevilla;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QIII;6.963
41 Sevilla;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
41 Sevilla;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
41 Sevilla;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
41 Sevilla;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2022QIII;6.797
41 Sevilla;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2022QII;""
41 Sevilla;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2022QI;""
41 Sevilla;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
41 Sevilla;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2021QIII;6.921
41 Sevilla;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2021QII;""
41 Sevilla;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2021QI;""
41 Sevilla;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
41 Sevilla;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2020QIII;6.459
41 Sevilla;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2020QII;""
41 Sevilla;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2020QI;""
41 Sevilla;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2022QIV;6.316
41 Sevilla;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
41 Sevilla;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2022QII;""
41 Sevilla;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2022QI;""
41 Sevilla;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2021QIV;6.468
41 Sevilla;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
41 Sevilla;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2021QII;""
41 Sevilla;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2021QI;""
41 Sevilla;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2020QIV;6.083
41 Sevilla;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
41 Sevilla;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2020QII;""
41 Sevilla;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2020QI;""
41 Sevilla;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
41 Sevilla;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
41 Sevilla;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QII;""
41 Sevilla;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QI;6.068
41 Sevilla;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
41 Sevilla;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
41 Sevilla;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QII;""
41 Sevilla;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QI;5.824
41 Sevilla;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
41 Sevilla;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
41 Sevilla;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QII;""
41 Sevilla;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QI;""
41 Sevilla;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
41 Sevilla;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
41 Sevilla;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QII;5.653
41 Sevilla;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QI;""
41 Sevilla;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
41 Sevilla;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
41 Sevilla;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QII;5.518
41 Sevilla;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QI;""
41 Sevilla;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
41 Sevilla;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
41 Sevilla;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QII;""
41 Sevilla;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QI;""
41 Sevilla;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
41 Sevilla;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
41 Sevilla;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
41 Sevilla;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
41 Sevilla;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
41 Sevilla;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
41 Sevilla;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
41 Sevilla;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
41 Sevilla;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
41 Sevilla;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
41 Sevilla;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
41 Sevilla;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
41 Sevilla;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
41 Sevilla;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;92,25
41 Sevilla;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
41 Sevilla;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
41 Sevilla;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
41 Sevilla;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;92,28
41 Sevilla;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
41 Sevilla;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
41 Sevilla;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
41 Sevilla;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;92,76
41 Sevilla;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
41 Sevilla;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
41 Sevilla;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;85,72
41 Sevilla;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
41 Sevilla;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
41 Sevilla;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
41 Sevilla;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;86,24
41 Sevilla;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
41 Sevilla;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
41 Sevilla;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
41 Sevilla;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;87,36
41 Sevilla;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
41 Sevilla;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
41 Sevilla;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
41 Sevilla;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
41 Sevilla;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
41 Sevilla;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
41 Sevilla;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;80,91
41 Sevilla;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
41 Sevilla;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
41 Sevilla;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
41 Sevilla;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;83,64
41 Sevilla;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
41 Sevilla;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
41 Sevilla;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
41 Sevilla;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
41 Sevilla;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
41 Sevilla;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
41 Sevilla;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;75,37
41 Sevilla;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
41 Sevilla;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
41 Sevilla;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
41 Sevilla;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;79,25
41 Sevilla;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
41 Sevilla;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
41 Sevilla;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
41 Sevilla;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
41 Sevilla;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
41 Sevilla;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
41 Sevilla;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QIII;4.352
41 Sevilla;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
41 Sevilla;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
41 Sevilla;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
41 Sevilla;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QIII;4.443
41 Sevilla;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
41 Sevilla;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
41 Sevilla;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
41 Sevilla;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QIII;4.215
41 Sevilla;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
41 Sevilla;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
41 Sevilla;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
41 Sevilla;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2022QIII;4.028
41 Sevilla;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2022QII;""
41 Sevilla;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2022QI;""
41 Sevilla;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
41 Sevilla;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2021QIII;4.085
41 Sevilla;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2021QII;""
41 Sevilla;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2021QI;""
41 Sevilla;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
41 Sevilla;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2020QIII;3.947
41 Sevilla;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2020QII;""
41 Sevilla;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2020QI;""
41 Sevilla;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2022QIV;3.745
41 Sevilla;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
41 Sevilla;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2022QII;""
41 Sevilla;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2022QI;""
41 Sevilla;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2021QIV;3.834
41 Sevilla;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
41 Sevilla;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2021QII;""
41 Sevilla;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2021QI;""
41 Sevilla;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2020QIV;3.730
41 Sevilla;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
41 Sevilla;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2020QII;""
41 Sevilla;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2020QI;""
41 Sevilla;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
41 Sevilla;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
41 Sevilla;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QII;""
41 Sevilla;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QI;3.615
41 Sevilla;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
41 Sevilla;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
41 Sevilla;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QII;""
41 Sevilla;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QI;3.568
41 Sevilla;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
41 Sevilla;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
41 Sevilla;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QII;""
41 Sevilla;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QI;""
41 Sevilla;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
41 Sevilla;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
41 Sevilla;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QII;3.388
41 Sevilla;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QI;""
41 Sevilla;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
41 Sevilla;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
41 Sevilla;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QII;3.389
41 Sevilla;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QI;""
41 Sevilla;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
41 Sevilla;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
41 Sevilla;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QII;""
41 Sevilla;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QI;""
41 Sevilla;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
41 Sevilla;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
41 Sevilla;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
41 Sevilla;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
41 Sevilla;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
41 Sevilla;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
41 Sevilla;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
41 Sevilla;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
41 Sevilla;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
41 Sevilla;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
41 Sevilla;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
41 Sevilla;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
41 Sevilla;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
41 Sevilla;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;92,56
41 Sevilla;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
41 Sevilla;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
41 Sevilla;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
41 Sevilla;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;91,94
41 Sevilla;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
41 Sevilla;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
41 Sevilla;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
41 Sevilla;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;93,64
41 Sevilla;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
41 Sevilla;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
41 Sevilla;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;86,05
41 Sevilla;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
41 Sevilla;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
41 Sevilla;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
41 Sevilla;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;86,29
41 Sevilla;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
41 Sevilla;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
41 Sevilla;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
41 Sevilla;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;88,49
41 Sevilla;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
41 Sevilla;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
41 Sevilla;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
41 Sevilla;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
41 Sevilla;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
41 Sevilla;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
41 Sevilla;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;81,36
41 Sevilla;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
41 Sevilla;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
41 Sevilla;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
41 Sevilla;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;84,65
41 Sevilla;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
41 Sevilla;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
41 Sevilla;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
41 Sevilla;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
41 Sevilla;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
41 Sevilla;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
41 Sevilla;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;76,25
41 Sevilla;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
41 Sevilla;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
41 Sevilla;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
41 Sevilla;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;80,4
41 Sevilla;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
41 Sevilla;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
41 Sevilla;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
41 Sevilla;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
41 Sevilla;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
41 Sevilla;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
41 Sevilla;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QIII;3.016
41 Sevilla;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
41 Sevilla;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
41 Sevilla;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
41 Sevilla;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QIII;3.057
41 Sevilla;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
41 Sevilla;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
41 Sevilla;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
41 Sevilla;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QIII;2.748
41 Sevilla;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
41 Sevilla;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
41 Sevilla;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
41 Sevilla;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2022QIII;2.769
41 Sevilla;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2022QII;""
41 Sevilla;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2022QI;""
41 Sevilla;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
41 Sevilla;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2021QIII;2.836
41 Sevilla;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2021QII;""
41 Sevilla;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2021QI;""
41 Sevilla;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
41 Sevilla;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2020QIII;2.512
41 Sevilla;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2020QII;""
41 Sevilla;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2020QI;""
41 Sevilla;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2022QIV;2.571
41 Sevilla;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
41 Sevilla;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2022QII;""
41 Sevilla;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2022QI;""
41 Sevilla;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2021QIV;2.634
41 Sevilla;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
41 Sevilla;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2021QII;""
41 Sevilla;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2021QI;""
41 Sevilla;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2020QIV;2.353
41 Sevilla;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
41 Sevilla;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2020QII;""
41 Sevilla;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2020QI;""
41 Sevilla;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
41 Sevilla;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
41 Sevilla;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QII;""
41 Sevilla;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QI;2.453
41 Sevilla;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
41 Sevilla;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
41 Sevilla;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QII;""
41 Sevilla;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QI;2.256
41 Sevilla;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
41 Sevilla;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
41 Sevilla;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QII;""
41 Sevilla;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QI;""
41 Sevilla;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
41 Sevilla;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
41 Sevilla;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QII;2.265
41 Sevilla;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QI;""
41 Sevilla;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
41 Sevilla;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
41 Sevilla;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QII;2.129
41 Sevilla;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QI;""
41 Sevilla;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
41 Sevilla;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
41 Sevilla;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QII;""
41 Sevilla;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QI;""
41 Sevilla;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
41 Sevilla;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
41 Sevilla;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
41 Sevilla;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
41 Sevilla;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
41 Sevilla;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
41 Sevilla;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
41 Sevilla;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
41 Sevilla;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
41 Sevilla;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
41 Sevilla;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
41 Sevilla;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
41 Sevilla;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
41 Sevilla;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;91,81
41 Sevilla;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
41 Sevilla;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
41 Sevilla;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
41 Sevilla;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;92,77
41 Sevilla;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
41 Sevilla;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
41 Sevilla;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
41 Sevilla;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;91,41
41 Sevilla;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
41 Sevilla;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
41 Sevilla;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;85,25
41 Sevilla;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
41 Sevilla;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
41 Sevilla;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
41 Sevilla;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;86,16
41 Sevilla;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
41 Sevilla;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
41 Sevilla;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
41 Sevilla;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;85,63
41 Sevilla;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
41 Sevilla;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
41 Sevilla;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
41 Sevilla;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
41 Sevilla;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
41 Sevilla;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
41 Sevilla;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;80,24
41 Sevilla;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
41 Sevilla;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
41 Sevilla;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
41 Sevilla;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;82,1
41 Sevilla;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
41 Sevilla;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
41 Sevilla;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
41 Sevilla;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
41 Sevilla;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
41 Sevilla;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
41 Sevilla;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;74,09
41 Sevilla;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
41 Sevilla;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
41 Sevilla;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
41 Sevilla;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;77,47
41 Sevilla;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
41 Sevilla;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
41 Sevilla;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
41 Sevilla;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
41 Sevilla;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
41 Sevilla;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QIV;7.701
41 Sevilla;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
41 Sevilla;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
41 Sevilla;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
41 Sevilla;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QIV;7.814
41 Sevilla;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
41 Sevilla;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
41 Sevilla;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
41 Sevilla;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QIV;7.318
41 Sevilla;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
41 Sevilla;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
41 Sevilla;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
41 Sevilla;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2022QIV;7.144
41 Sevilla;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
41 Sevilla;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2022QII;""
41 Sevilla;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2022QI;""
41 Sevilla;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2021QIV;7.281
41 Sevilla;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
41 Sevilla;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2021QII;""
41 Sevilla;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2021QI;""
41 Sevilla;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2020QIV;6.853
41 Sevilla;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
41 Sevilla;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2020QII;""
41 Sevilla;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2020QI;""
41 Sevilla;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
41 Sevilla;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
41 Sevilla;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2022QII;""
41 Sevilla;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2022QI;6.825
41 Sevilla;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
41 Sevilla;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
41 Sevilla;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2021QII;""
41 Sevilla;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2021QI;6.520
41 Sevilla;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
41 Sevilla;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
41 Sevilla;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2020QII;""
41 Sevilla;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2020QI;""
41 Sevilla;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
41 Sevilla;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
41 Sevilla;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QII;6.352
41 Sevilla;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QI;""
41 Sevilla;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
41 Sevilla;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
41 Sevilla;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QII;6.147
41 Sevilla;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QI;""
41 Sevilla;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
41 Sevilla;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
41 Sevilla;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QII;""
41 Sevilla;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QI;""
41 Sevilla;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
41 Sevilla;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QIII;5.950
41 Sevilla;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QII;""
41 Sevilla;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QI;""
41 Sevilla;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
41 Sevilla;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QIII;5.802
41 Sevilla;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QII;""
41 Sevilla;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QI;""
41 Sevilla;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
41 Sevilla;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
41 Sevilla;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QII;""
41 Sevilla;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QI;""
41 Sevilla;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
41 Sevilla;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
41 Sevilla;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
41 Sevilla;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
41 Sevilla;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
41 Sevilla;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
41 Sevilla;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
41 Sevilla;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
41 Sevilla;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
41 Sevilla;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
41 Sevilla;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
41 Sevilla;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
41 Sevilla;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;92,77
41 Sevilla;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
41 Sevilla;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
41 Sevilla;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
41 Sevilla;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;93,18
41 Sevilla;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
41 Sevilla;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
41 Sevilla;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
41 Sevilla;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;93,65
41 Sevilla;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
41 Sevilla;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
41 Sevilla;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
41 Sevilla;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
41 Sevilla;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
41 Sevilla;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
41 Sevilla;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;87,34
41 Sevilla;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
41 Sevilla;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
41 Sevilla;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
41 Sevilla;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;89,1
41 Sevilla;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
41 Sevilla;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
41 Sevilla;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
41 Sevilla;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
41 Sevilla;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
41 Sevilla;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
41 Sevilla;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;81,29
41 Sevilla;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
41 Sevilla;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
41 Sevilla;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
41 Sevilla;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;84
41 Sevilla;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
41 Sevilla;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
41 Sevilla;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
41 Sevilla;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
41 Sevilla;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
41 Sevilla;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
41 Sevilla;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;76,15
41 Sevilla;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
41 Sevilla;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
41 Sevilla;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
41 Sevilla;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;79,28
41 Sevilla;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
41 Sevilla;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
41 Sevilla;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
41 Sevilla;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
41 Sevilla;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
41 Sevilla;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
41 Sevilla;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QIV;4.514
41 Sevilla;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
41 Sevilla;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
41 Sevilla;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
41 Sevilla;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QIV;4.579
41 Sevilla;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
41 Sevilla;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
41 Sevilla;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
41 Sevilla;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QIV;4.437
41 Sevilla;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
41 Sevilla;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
41 Sevilla;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
41 Sevilla;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2022QIV;4.191
41 Sevilla;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
41 Sevilla;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2022QII;""
41 Sevilla;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2022QI;""
41 Sevilla;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2021QIV;4.282
41 Sevilla;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
41 Sevilla;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2021QII;""
41 Sevilla;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2021QI;""
41 Sevilla;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2020QIV;4.164
41 Sevilla;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
41 Sevilla;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2020QII;""
41 Sevilla;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2020QI;""
41 Sevilla;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
41 Sevilla;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
41 Sevilla;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2022QII;""
41 Sevilla;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2022QI;4.033
41 Sevilla;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
41 Sevilla;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
41 Sevilla;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2021QII;""
41 Sevilla;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2021QI;3.962
41 Sevilla;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
41 Sevilla;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
41 Sevilla;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2020QII;""
41 Sevilla;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2020QI;""
41 Sevilla;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
41 Sevilla;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
41 Sevilla;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QII;3.777
41 Sevilla;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QI;""
41 Sevilla;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
41 Sevilla;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
41 Sevilla;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QII;3.741
41 Sevilla;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QI;""
41 Sevilla;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
41 Sevilla;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
41 Sevilla;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QII;""
41 Sevilla;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QI;""
41 Sevilla;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
41 Sevilla;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QIII;3.555
41 Sevilla;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QII;""
41 Sevilla;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QI;""
41 Sevilla;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
41 Sevilla;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QIII;3.526
41 Sevilla;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QII;""
41 Sevilla;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QI;""
41 Sevilla;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
41 Sevilla;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
41 Sevilla;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QII;""
41 Sevilla;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QI;""
41 Sevilla;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
41 Sevilla;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
41 Sevilla;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
41 Sevilla;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
41 Sevilla;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
41 Sevilla;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
41 Sevilla;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
41 Sevilla;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
41 Sevilla;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
41 Sevilla;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
41 Sevilla;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
41 Sevilla;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
41 Sevilla;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;92,84
41 Sevilla;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
41 Sevilla;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
41 Sevilla;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
41 Sevilla;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;93,51
41 Sevilla;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
41 Sevilla;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
41 Sevilla;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
41 Sevilla;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;93,85
41 Sevilla;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
41 Sevilla;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
41 Sevilla;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
41 Sevilla;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
41 Sevilla;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
41 Sevilla;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
41 Sevilla;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;88,08
41 Sevilla;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
41 Sevilla;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
41 Sevilla;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
41 Sevilla;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;89,29
41 Sevilla;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
41 Sevilla;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
41 Sevilla;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
41 Sevilla;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
41 Sevilla;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
41 Sevilla;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
41 Sevilla;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;82,49
41 Sevilla;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
41 Sevilla;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
41 Sevilla;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
41 Sevilla;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;84,31
41 Sevilla;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
41 Sevilla;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
41 Sevilla;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
41 Sevilla;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
41 Sevilla;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
41 Sevilla;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
41 Sevilla;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;77,64
41 Sevilla;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
41 Sevilla;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
41 Sevilla;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
41 Sevilla;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;79,47
41 Sevilla;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
41 Sevilla;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
41 Sevilla;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
41 Sevilla;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
41 Sevilla;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
41 Sevilla;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
41 Sevilla;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QIV;3.187
41 Sevilla;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
41 Sevilla;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
41 Sevilla;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
41 Sevilla;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QIV;3.235
41 Sevilla;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
41 Sevilla;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
41 Sevilla;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
41 Sevilla;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QIV;2.881
41 Sevilla;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
41 Sevilla;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
41 Sevilla;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
41 Sevilla;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2022QIV;2.953
41 Sevilla;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
41 Sevilla;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2022QII;""
41 Sevilla;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2022QI;""
41 Sevilla;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2021QIV;2.999
41 Sevilla;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
41 Sevilla;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2021QII;""
41 Sevilla;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2021QI;""
41 Sevilla;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2020QIV;2.689
41 Sevilla;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
41 Sevilla;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2020QII;""
41 Sevilla;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2020QI;""
41 Sevilla;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
41 Sevilla;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
41 Sevilla;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2022QII;""
41 Sevilla;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2022QI;2.792
41 Sevilla;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
41 Sevilla;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
41 Sevilla;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2021QII;""
41 Sevilla;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2021QI;2.558
41 Sevilla;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
41 Sevilla;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
41 Sevilla;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2020QII;""
41 Sevilla;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2020QI;""
41 Sevilla;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
41 Sevilla;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
41 Sevilla;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QII;2.575
41 Sevilla;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QI;""
41 Sevilla;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
41 Sevilla;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
41 Sevilla;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QII;2.406
41 Sevilla;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QI;""
41 Sevilla;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
41 Sevilla;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
41 Sevilla;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QII;""
41 Sevilla;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QI;""
41 Sevilla;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
41 Sevilla;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QIII;2.395
41 Sevilla;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QII;""
41 Sevilla;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QI;""
41 Sevilla;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
41 Sevilla;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QIII;2.276
41 Sevilla;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QII;""
41 Sevilla;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QI;""
41 Sevilla;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
41 Sevilla;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
41 Sevilla;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QII;""
41 Sevilla;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QI;""
41 Sevilla;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
41 Sevilla;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
41 Sevilla;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
41 Sevilla;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
41 Sevilla;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
41 Sevilla;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
41 Sevilla;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
41 Sevilla;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
41 Sevilla;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
41 Sevilla;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
41 Sevilla;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
41 Sevilla;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
41 Sevilla;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;92,66
41 Sevilla;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
41 Sevilla;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
41 Sevilla;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
41 Sevilla;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;92,7
41 Sevilla;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
41 Sevilla;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
41 Sevilla;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
41 Sevilla;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;93,34
41 Sevilla;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
41 Sevilla;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
41 Sevilla;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
41 Sevilla;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
41 Sevilla;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
41 Sevilla;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
41 Sevilla;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;86,31
41 Sevilla;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
41 Sevilla;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
41 Sevilla;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
41 Sevilla;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;88,79
41 Sevilla;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
41 Sevilla;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
41 Sevilla;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
41 Sevilla;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
41 Sevilla;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
41 Sevilla;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
41 Sevilla;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;79,6
41 Sevilla;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
41 Sevilla;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
41 Sevilla;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
41 Sevilla;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;83,51
41 Sevilla;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
41 Sevilla;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
41 Sevilla;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
41 Sevilla;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
41 Sevilla;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
41 Sevilla;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
41 Sevilla;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;74,03
41 Sevilla;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
41 Sevilla;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
41 Sevilla;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
41 Sevilla;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;79
41 Sevilla;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
41 Sevilla;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
41 Sevilla;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
41 Sevilla;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
41 Sevilla;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
41 Sevilla;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
41 Sevilla;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
41 Sevilla;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
41 Sevilla;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
41 Sevilla;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QI;22.258
41 Sevilla;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
41 Sevilla;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
41 Sevilla;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
41 Sevilla;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QI;22.426
41 Sevilla;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
41 Sevilla;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
41 Sevilla;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
41 Sevilla;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QI;21.706
41 Sevilla;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
41 Sevilla;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
41 Sevilla;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2022QII;""
41 Sevilla;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2022QI;21.416
41 Sevilla;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
41 Sevilla;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
41 Sevilla;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2021QII;""
41 Sevilla;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2021QI;21.703
41 Sevilla;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
41 Sevilla;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
41 Sevilla;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2020QII;""
41 Sevilla;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2020QI;19.813
41 Sevilla;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
41 Sevilla;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
41 Sevilla;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2022QII;20.476
41 Sevilla;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2022QI;""
41 Sevilla;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
41 Sevilla;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
41 Sevilla;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2021QII;20.948
41 Sevilla;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2021QI;""
41 Sevilla;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
41 Sevilla;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
41 Sevilla;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2020QII;19.369
41 Sevilla;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2020QI;""
41 Sevilla;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
41 Sevilla;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QIII;19.744
41 Sevilla;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QII;""
41 Sevilla;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QI;""
41 Sevilla;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
41 Sevilla;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QIII;20.287
41 Sevilla;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QII;""
41 Sevilla;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QI;""
41 Sevilla;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
41 Sevilla;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QIII;18.725
41 Sevilla;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QII;""
41 Sevilla;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QI;""
41 Sevilla;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QIV;19.010
41 Sevilla;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
41 Sevilla;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QII;""
41 Sevilla;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QI;""
41 Sevilla;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QIV;19.648
41 Sevilla;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
41 Sevilla;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QII;""
41 Sevilla;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QI;""
41 Sevilla;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QIV;18.162
41 Sevilla;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
41 Sevilla;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QII;""
41 Sevilla;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QI;""
41 Sevilla;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
41 Sevilla;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
41 Sevilla;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
41 Sevilla;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
41 Sevilla;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
41 Sevilla;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
41 Sevilla;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
41 Sevilla;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
41 Sevilla;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
41 Sevilla;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
41 Sevilla;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
41 Sevilla;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
41 Sevilla;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
41 Sevilla;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
41 Sevilla;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
41 Sevilla;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;96,22
41 Sevilla;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
41 Sevilla;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
41 Sevilla;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
41 Sevilla;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;96,78
41 Sevilla;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
41 Sevilla;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
41 Sevilla;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
41 Sevilla;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;91,28
41 Sevilla;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
41 Sevilla;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
41 Sevilla;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;91,99
41 Sevilla;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
41 Sevilla;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
41 Sevilla;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
41 Sevilla;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;93,41
41 Sevilla;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
41 Sevilla;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
41 Sevilla;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
41 Sevilla;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;89,23
41 Sevilla;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
41 Sevilla;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
41 Sevilla;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;88,71
41 Sevilla;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
41 Sevilla;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
41 Sevilla;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
41 Sevilla;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;90,46
41 Sevilla;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
41 Sevilla;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
41 Sevilla;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
41 Sevilla;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;86,27
41 Sevilla;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
41 Sevilla;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
41 Sevilla;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;85,41
41 Sevilla;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
41 Sevilla;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
41 Sevilla;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
41 Sevilla;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;87,61
41 Sevilla;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
41 Sevilla;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
41 Sevilla;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
41 Sevilla;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;83,67
41 Sevilla;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
41 Sevilla;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
41 Sevilla;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
41 Sevilla;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
41 Sevilla;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
41 Sevilla;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
41 Sevilla;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QI;13.258
41 Sevilla;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
41 Sevilla;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
41 Sevilla;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
41 Sevilla;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QI;13.491
41 Sevilla;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
41 Sevilla;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
41 Sevilla;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
41 Sevilla;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QI;13.043
41 Sevilla;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
41 Sevilla;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
41 Sevilla;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2022QII;""
41 Sevilla;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2022QI;12.802
41 Sevilla;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
41 Sevilla;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
41 Sevilla;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2021QII;""
41 Sevilla;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2021QI;13.082
41 Sevilla;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
41 Sevilla;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
41 Sevilla;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2020QII;""
41 Sevilla;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2020QI;11.991
41 Sevilla;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
41 Sevilla;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
41 Sevilla;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2022QII;12.303
41 Sevilla;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2022QI;""
41 Sevilla;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
41 Sevilla;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
41 Sevilla;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2021QII;12.655
41 Sevilla;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2021QI;""
41 Sevilla;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
41 Sevilla;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
41 Sevilla;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2020QII;11.766
41 Sevilla;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2020QI;""
41 Sevilla;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
41 Sevilla;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QIII;11.893
41 Sevilla;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QII;""
41 Sevilla;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QI;""
41 Sevilla;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
41 Sevilla;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QIII;12.281
41 Sevilla;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QII;""
41 Sevilla;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QI;""
41 Sevilla;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
41 Sevilla;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QIII;11.413
41 Sevilla;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QII;""
41 Sevilla;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QI;""
41 Sevilla;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QIV;11.502
41 Sevilla;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
41 Sevilla;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QII;""
41 Sevilla;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QI;""
41 Sevilla;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QIV;11.920
41 Sevilla;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
41 Sevilla;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QII;""
41 Sevilla;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QI;""
41 Sevilla;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QIV;11.095
41 Sevilla;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
41 Sevilla;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QII;""
41 Sevilla;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QI;""
41 Sevilla;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
41 Sevilla;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
41 Sevilla;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
41 Sevilla;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
41 Sevilla;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
41 Sevilla;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
41 Sevilla;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
41 Sevilla;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
41 Sevilla;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
41 Sevilla;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
41 Sevilla;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
41 Sevilla;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
41 Sevilla;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
41 Sevilla;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
41 Sevilla;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
41 Sevilla;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;96,56
41 Sevilla;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
41 Sevilla;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
41 Sevilla;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
41 Sevilla;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;96,97
41 Sevilla;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
41 Sevilla;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
41 Sevilla;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
41 Sevilla;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;91,93
41 Sevilla;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
41 Sevilla;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
41 Sevilla;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;92,8
41 Sevilla;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
41 Sevilla;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
41 Sevilla;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
41 Sevilla;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;93,8
41 Sevilla;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
41 Sevilla;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
41 Sevilla;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
41 Sevilla;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;90,21
41 Sevilla;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
41 Sevilla;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
41 Sevilla;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;89,7
41 Sevilla;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
41 Sevilla;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
41 Sevilla;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
41 Sevilla;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;91,03
41 Sevilla;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
41 Sevilla;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
41 Sevilla;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
41 Sevilla;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;87,5
41 Sevilla;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
41 Sevilla;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
41 Sevilla;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;86,76
41 Sevilla;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
41 Sevilla;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
41 Sevilla;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
41 Sevilla;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;88,36
41 Sevilla;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
41 Sevilla;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
41 Sevilla;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
41 Sevilla;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;85,06
41 Sevilla;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
41 Sevilla;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
41 Sevilla;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
41 Sevilla;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
41 Sevilla;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
41 Sevilla;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
41 Sevilla;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QI;9.000
41 Sevilla;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
41 Sevilla;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
41 Sevilla;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
41 Sevilla;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QI;8.935
41 Sevilla;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
41 Sevilla;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
41 Sevilla;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
41 Sevilla;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QI;8.663
41 Sevilla;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
41 Sevilla;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
41 Sevilla;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2022QII;""
41 Sevilla;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2022QI;8.614
41 Sevilla;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
41 Sevilla;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
41 Sevilla;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2021QII;""
41 Sevilla;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2021QI;8.621
41 Sevilla;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
41 Sevilla;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
41 Sevilla;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2020QII;""
41 Sevilla;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2020QI;7.822
41 Sevilla;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
41 Sevilla;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
41 Sevilla;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2022QII;8.173
41 Sevilla;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2022QI;""
41 Sevilla;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
41 Sevilla;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
41 Sevilla;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2021QII;8.293
41 Sevilla;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2021QI;""
41 Sevilla;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
41 Sevilla;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
41 Sevilla;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2020QII;7.603
41 Sevilla;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2020QI;""
41 Sevilla;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
41 Sevilla;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QIII;7.851
41 Sevilla;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QII;""
41 Sevilla;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QI;""
41 Sevilla;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
41 Sevilla;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QIII;8.006
41 Sevilla;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QII;""
41 Sevilla;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QI;""
41 Sevilla;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
41 Sevilla;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QIII;7.312
41 Sevilla;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QII;""
41 Sevilla;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QI;""
41 Sevilla;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QIV;7.508
41 Sevilla;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
41 Sevilla;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QII;""
41 Sevilla;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QI;""
41 Sevilla;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QIV;7.728
41 Sevilla;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
41 Sevilla;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QII;""
41 Sevilla;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QI;""
41 Sevilla;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QIV;7.067
41 Sevilla;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
41 Sevilla;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QII;""
41 Sevilla;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QI;""
41 Sevilla;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
41 Sevilla;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
41 Sevilla;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
41 Sevilla;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
41 Sevilla;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
41 Sevilla;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
41 Sevilla;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
41 Sevilla;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
41 Sevilla;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
41 Sevilla;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
41 Sevilla;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
41 Sevilla;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
41 Sevilla;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
41 Sevilla;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
41 Sevilla;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
41 Sevilla;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;95,71
41 Sevilla;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
41 Sevilla;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
41 Sevilla;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
41 Sevilla;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;96,49
41 Sevilla;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
41 Sevilla;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
41 Sevilla;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
41 Sevilla;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;90,29
41 Sevilla;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
41 Sevilla;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
41 Sevilla;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;90,81
41 Sevilla;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
41 Sevilla;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
41 Sevilla;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
41 Sevilla;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;92,81
41 Sevilla;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
41 Sevilla;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
41 Sevilla;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
41 Sevilla;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;87,76
41 Sevilla;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
41 Sevilla;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
41 Sevilla;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;87,23
41 Sevilla;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
41 Sevilla;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
41 Sevilla;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
41 Sevilla;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;89,6
41 Sevilla;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
41 Sevilla;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
41 Sevilla;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
41 Sevilla;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;84,4
41 Sevilla;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
41 Sevilla;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
41 Sevilla;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;83,42
41 Sevilla;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
41 Sevilla;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
41 Sevilla;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
41 Sevilla;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;86,49
41 Sevilla;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
41 Sevilla;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
41 Sevilla;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
41 Sevilla;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;81,58
41 Sevilla;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
41 Sevilla;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
41 Sevilla;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
41 Sevilla;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
41 Sevilla;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
41 Sevilla;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QII;20.978
41 Sevilla;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
41 Sevilla;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
41 Sevilla;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
41 Sevilla;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QII;21.371
41 Sevilla;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
41 Sevilla;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
41 Sevilla;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
41 Sevilla;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QII;21.266
41 Sevilla;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
41 Sevilla;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
41 Sevilla;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
41 Sevilla;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2022QII;19.957
41 Sevilla;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2022QI;""
41 Sevilla;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
41 Sevilla;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
41 Sevilla;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2021QII;20.521
41 Sevilla;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2021QI;""
41 Sevilla;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
41 Sevilla;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
41 Sevilla;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2020QII;20.724
41 Sevilla;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2020QI;""
41 Sevilla;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
41 Sevilla;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2022QIII;19.207
41 Sevilla;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2022QII;""
41 Sevilla;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2022QI;""
41 Sevilla;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
41 Sevilla;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2021QIII;19.774
41 Sevilla;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2021QII;""
41 Sevilla;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2021QI;""
41 Sevilla;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
41 Sevilla;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2020QIII;19.981
41 Sevilla;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2020QII;""
41 Sevilla;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2020QI;""
41 Sevilla;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QIV;18.427
41 Sevilla;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
41 Sevilla;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QII;""
41 Sevilla;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QI;""
41 Sevilla;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QIV;19.089
41 Sevilla;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
41 Sevilla;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QII;""
41 Sevilla;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QI;""
41 Sevilla;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QIV;19.349
41 Sevilla;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
41 Sevilla;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QII;""
41 Sevilla;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QI;""
41 Sevilla;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
41 Sevilla;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
41 Sevilla;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QII;""
41 Sevilla;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QI;18.457
41 Sevilla;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
41 Sevilla;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
41 Sevilla;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QII;""
41 Sevilla;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QI;18.876
41 Sevilla;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
41 Sevilla;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
41 Sevilla;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QII;""
41 Sevilla;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QI;""
41 Sevilla;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
41 Sevilla;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
41 Sevilla;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
41 Sevilla;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
41 Sevilla;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
41 Sevilla;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
41 Sevilla;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
41 Sevilla;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
41 Sevilla;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
41 Sevilla;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
41 Sevilla;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
41 Sevilla;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
41 Sevilla;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
41 Sevilla;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
41 Sevilla;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;95,13
41 Sevilla;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
41 Sevilla;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
41 Sevilla;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
41 Sevilla;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;96,02
41 Sevilla;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
41 Sevilla;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
41 Sevilla;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
41 Sevilla;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;97,45
41 Sevilla;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
41 Sevilla;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
41 Sevilla;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;91,56
41 Sevilla;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
41 Sevilla;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
41 Sevilla;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
41 Sevilla;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;92,53
41 Sevilla;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
41 Sevilla;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
41 Sevilla;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
41 Sevilla;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;93,96
41 Sevilla;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
41 Sevilla;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
41 Sevilla;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;87,84
41 Sevilla;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
41 Sevilla;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
41 Sevilla;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
41 Sevilla;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;89,32
41 Sevilla;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
41 Sevilla;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
41 Sevilla;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
41 Sevilla;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;90,99
41 Sevilla;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
41 Sevilla;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
41 Sevilla;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
41 Sevilla;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
41 Sevilla;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
41 Sevilla;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
41 Sevilla;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;86,36
41 Sevilla;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
41 Sevilla;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
41 Sevilla;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
41 Sevilla;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;88,76
41 Sevilla;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
41 Sevilla;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
41 Sevilla;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
41 Sevilla;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
41 Sevilla;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
41 Sevilla;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
41 Sevilla;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QII;12.406
41 Sevilla;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
41 Sevilla;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
41 Sevilla;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
41 Sevilla;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QII;12.769
41 Sevilla;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
41 Sevilla;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
41 Sevilla;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
41 Sevilla;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QII;12.808
41 Sevilla;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
41 Sevilla;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
41 Sevilla;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
41 Sevilla;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2022QII;11.860
41 Sevilla;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2022QI;""
41 Sevilla;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
41 Sevilla;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
41 Sevilla;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2021QII;12.298
41 Sevilla;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2021QI;""
41 Sevilla;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
41 Sevilla;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
41 Sevilla;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2020QII;12.528
41 Sevilla;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2020QI;""
41 Sevilla;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
41 Sevilla;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2022QIII;11.434
41 Sevilla;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2022QII;""
41 Sevilla;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2022QI;""
41 Sevilla;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
41 Sevilla;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2021QIII;11.873
41 Sevilla;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2021QII;""
41 Sevilla;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2021QI;""
41 Sevilla;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
41 Sevilla;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2020QIII;12.119
41 Sevilla;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2020QII;""
41 Sevilla;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2020QI;""
41 Sevilla;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QIV;11.007
41 Sevilla;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
41 Sevilla;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QII;""
41 Sevilla;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QI;""
41 Sevilla;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QIV;11.496
41 Sevilla;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
41 Sevilla;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QII;""
41 Sevilla;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QI;""
41 Sevilla;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QIV;11.754
41 Sevilla;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
41 Sevilla;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QII;""
41 Sevilla;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QI;""
41 Sevilla;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
41 Sevilla;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
41 Sevilla;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QII;""
41 Sevilla;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QI;11.158
41 Sevilla;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
41 Sevilla;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
41 Sevilla;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QII;""
41 Sevilla;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QI;11.491
41 Sevilla;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
41 Sevilla;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
41 Sevilla;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QII;""
41 Sevilla;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QI;""
41 Sevilla;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
41 Sevilla;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
41 Sevilla;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
41 Sevilla;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
41 Sevilla;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
41 Sevilla;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
41 Sevilla;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
41 Sevilla;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
41 Sevilla;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
41 Sevilla;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
41 Sevilla;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
41 Sevilla;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
41 Sevilla;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
41 Sevilla;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
41 Sevilla;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;95,6
41 Sevilla;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
41 Sevilla;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
41 Sevilla;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
41 Sevilla;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;96,31
41 Sevilla;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
41 Sevilla;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
41 Sevilla;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
41 Sevilla;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;97,81
41 Sevilla;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
41 Sevilla;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
41 Sevilla;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;92,17
41 Sevilla;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
41 Sevilla;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
41 Sevilla;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
41 Sevilla;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;92,98
41 Sevilla;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
41 Sevilla;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
41 Sevilla;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
41 Sevilla;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;94,62
41 Sevilla;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
41 Sevilla;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
41 Sevilla;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;88,72
41 Sevilla;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
41 Sevilla;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
41 Sevilla;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
41 Sevilla;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;90,03
41 Sevilla;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
41 Sevilla;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
41 Sevilla;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
41 Sevilla;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;91,77
41 Sevilla;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
41 Sevilla;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
41 Sevilla;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
41 Sevilla;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
41 Sevilla;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
41 Sevilla;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
41 Sevilla;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;87,38
41 Sevilla;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
41 Sevilla;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
41 Sevilla;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
41 Sevilla;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;89,72
41 Sevilla;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
41 Sevilla;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
41 Sevilla;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
41 Sevilla;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
41 Sevilla;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
41 Sevilla;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
41 Sevilla;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QII;8.572
41 Sevilla;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
41 Sevilla;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
41 Sevilla;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
41 Sevilla;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QII;8.602
41 Sevilla;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
41 Sevilla;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
41 Sevilla;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
41 Sevilla;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QII;8.458
41 Sevilla;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
41 Sevilla;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
41 Sevilla;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
41 Sevilla;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2022QII;8.097
41 Sevilla;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2022QI;""
41 Sevilla;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
41 Sevilla;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
41 Sevilla;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2021QII;8.223
41 Sevilla;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2021QI;""
41 Sevilla;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
41 Sevilla;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
41 Sevilla;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2020QII;8.196
41 Sevilla;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2020QI;""
41 Sevilla;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
41 Sevilla;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2022QIII;7.773
41 Sevilla;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2022QII;""
41 Sevilla;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2022QI;""
41 Sevilla;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
41 Sevilla;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2021QIII;7.901
41 Sevilla;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2021QII;""
41 Sevilla;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2021QI;""
41 Sevilla;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
41 Sevilla;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2020QIII;7.862
41 Sevilla;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2020QII;""
41 Sevilla;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2020QI;""
41 Sevilla;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QIV;7.420
41 Sevilla;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
41 Sevilla;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QII;""
41 Sevilla;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QI;""
41 Sevilla;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QIV;7.593
41 Sevilla;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
41 Sevilla;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QII;""
41 Sevilla;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QI;""
41 Sevilla;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QIV;7.595
41 Sevilla;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
41 Sevilla;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QII;""
41 Sevilla;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QI;""
41 Sevilla;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
41 Sevilla;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
41 Sevilla;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QII;""
41 Sevilla;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QI;7.299
41 Sevilla;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
41 Sevilla;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
41 Sevilla;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QII;""
41 Sevilla;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QI;7.385
41 Sevilla;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
41 Sevilla;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
41 Sevilla;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QII;""
41 Sevilla;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QI;""
41 Sevilla;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
41 Sevilla;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
41 Sevilla;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
41 Sevilla;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
41 Sevilla;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
41 Sevilla;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
41 Sevilla;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
41 Sevilla;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
41 Sevilla;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
41 Sevilla;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
41 Sevilla;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
41 Sevilla;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
41 Sevilla;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
41 Sevilla;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
41 Sevilla;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;94,46
41 Sevilla;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
41 Sevilla;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
41 Sevilla;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
41 Sevilla;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;95,59
41 Sevilla;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
41 Sevilla;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
41 Sevilla;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
41 Sevilla;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;96,9
41 Sevilla;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
41 Sevilla;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
41 Sevilla;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;90,68
41 Sevilla;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
41 Sevilla;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
41 Sevilla;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
41 Sevilla;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;91,85
41 Sevilla;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
41 Sevilla;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
41 Sevilla;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
41 Sevilla;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;92,95
41 Sevilla;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
41 Sevilla;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
41 Sevilla;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;86,56
41 Sevilla;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
41 Sevilla;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
41 Sevilla;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
41 Sevilla;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;88,27
41 Sevilla;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
41 Sevilla;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
41 Sevilla;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
41 Sevilla;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;89,8
41 Sevilla;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
41 Sevilla;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
41 Sevilla;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
41 Sevilla;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
41 Sevilla;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
41 Sevilla;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
41 Sevilla;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;84,85
41 Sevilla;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
41 Sevilla;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
41 Sevilla;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
41 Sevilla;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;87,31
41 Sevilla;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
41 Sevilla;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
41 Sevilla;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
41 Sevilla;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
41 Sevilla;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
41 Sevilla;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QIII;21.026
41 Sevilla;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
41 Sevilla;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
41 Sevilla;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
41 Sevilla;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QIII;21.784
41 Sevilla;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
41 Sevilla;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
41 Sevilla;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
41 Sevilla;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QIII;21.793
41 Sevilla;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
41 Sevilla;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
41 Sevilla;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
41 Sevilla;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2022QIII;20.149
41 Sevilla;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2022QII;""
41 Sevilla;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2022QI;""
41 Sevilla;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
41 Sevilla;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2021QIII;20.916
41 Sevilla;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2021QII;""
41 Sevilla;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2021QI;""
41 Sevilla;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
41 Sevilla;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2020QIII;20.938
41 Sevilla;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2020QII;""
41 Sevilla;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2020QI;""
41 Sevilla;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2022QIV;19.263
41 Sevilla;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
41 Sevilla;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2022QII;""
41 Sevilla;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2022QI;""
41 Sevilla;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2021QIV;20.146
41 Sevilla;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
41 Sevilla;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2021QII;""
41 Sevilla;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2021QI;""
41 Sevilla;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2020QIV;20.220
41 Sevilla;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
41 Sevilla;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2020QII;""
41 Sevilla;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2020QI;""
41 Sevilla;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
41 Sevilla;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
41 Sevilla;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QII;""
41 Sevilla;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QI;19.466
41 Sevilla;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
41 Sevilla;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
41 Sevilla;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QII;""
41 Sevilla;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QI;19.684
41 Sevilla;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
41 Sevilla;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
41 Sevilla;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QII;""
41 Sevilla;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QI;""
41 Sevilla;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
41 Sevilla;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
41 Sevilla;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QII;18.692
41 Sevilla;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QI;""
41 Sevilla;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
41 Sevilla;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
41 Sevilla;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QII;19.125
41 Sevilla;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QI;""
41 Sevilla;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
41 Sevilla;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
41 Sevilla;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QII;""
41 Sevilla;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QI;""
41 Sevilla;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
41 Sevilla;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
41 Sevilla;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
41 Sevilla;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
41 Sevilla;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
41 Sevilla;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
41 Sevilla;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
41 Sevilla;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
41 Sevilla;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
41 Sevilla;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
41 Sevilla;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
41 Sevilla;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
41 Sevilla;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
41 Sevilla;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;95,83
41 Sevilla;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
41 Sevilla;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
41 Sevilla;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
41 Sevilla;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;96,02
41 Sevilla;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
41 Sevilla;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
41 Sevilla;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
41 Sevilla;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;96,08
41 Sevilla;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
41 Sevilla;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
41 Sevilla;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;91,62
41 Sevilla;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
41 Sevilla;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
41 Sevilla;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
41 Sevilla;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;92,48
41 Sevilla;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
41 Sevilla;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
41 Sevilla;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
41 Sevilla;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;92,78
41 Sevilla;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
41 Sevilla;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
41 Sevilla;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
41 Sevilla;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
41 Sevilla;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
41 Sevilla;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
41 Sevilla;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;89,36
41 Sevilla;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
41 Sevilla;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
41 Sevilla;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
41 Sevilla;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;90,32
41 Sevilla;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
41 Sevilla;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
41 Sevilla;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
41 Sevilla;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
41 Sevilla;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
41 Sevilla;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
41 Sevilla;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;85,81
41 Sevilla;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
41 Sevilla;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
41 Sevilla;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
41 Sevilla;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;87,76
41 Sevilla;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
41 Sevilla;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
41 Sevilla;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
41 Sevilla;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
41 Sevilla;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
41 Sevilla;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
41 Sevilla;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QIII;12.445
41 Sevilla;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
41 Sevilla;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
41 Sevilla;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
41 Sevilla;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QIII;13.038
41 Sevilla;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
41 Sevilla;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
41 Sevilla;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
41 Sevilla;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QIII;13.154
41 Sevilla;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
41 Sevilla;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
41 Sevilla;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
41 Sevilla;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2022QIII;11.950
41 Sevilla;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2022QII;""
41 Sevilla;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2022QI;""
41 Sevilla;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
41 Sevilla;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2021QIII;12.532
41 Sevilla;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2021QII;""
41 Sevilla;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2021QI;""
41 Sevilla;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
41 Sevilla;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2020QIII;12.679
41 Sevilla;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2020QII;""
41 Sevilla;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2020QI;""
41 Sevilla;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2022QIV;11.460
41 Sevilla;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
41 Sevilla;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2022QII;""
41 Sevilla;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2022QI;""
41 Sevilla;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2021QIV;12.101
41 Sevilla;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
41 Sevilla;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2021QII;""
41 Sevilla;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2021QI;""
41 Sevilla;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2020QIV;12.263
41 Sevilla;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
41 Sevilla;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2020QII;""
41 Sevilla;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2020QI;""
41 Sevilla;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
41 Sevilla;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
41 Sevilla;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QII;""
41 Sevilla;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QI;11.737
41 Sevilla;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
41 Sevilla;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
41 Sevilla;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QII;""
41 Sevilla;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QI;11.960
41 Sevilla;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
41 Sevilla;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
41 Sevilla;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QII;""
41 Sevilla;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QI;""
41 Sevilla;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
41 Sevilla;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
41 Sevilla;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QII;11.324
41 Sevilla;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QI;""
41 Sevilla;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
41 Sevilla;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
41 Sevilla;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QII;11.650
41 Sevilla;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QI;""
41 Sevilla;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
41 Sevilla;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
41 Sevilla;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QII;""
41 Sevilla;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QI;""
41 Sevilla;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
41 Sevilla;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
41 Sevilla;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
41 Sevilla;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
41 Sevilla;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
41 Sevilla;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
41 Sevilla;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
41 Sevilla;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
41 Sevilla;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
41 Sevilla;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
41 Sevilla;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
41 Sevilla;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
41 Sevilla;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
41 Sevilla;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;96,02
41 Sevilla;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
41 Sevilla;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
41 Sevilla;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
41 Sevilla;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;96,12
41 Sevilla;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
41 Sevilla;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
41 Sevilla;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
41 Sevilla;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;96,39
41 Sevilla;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
41 Sevilla;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
41 Sevilla;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;92,09
41 Sevilla;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
41 Sevilla;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
41 Sevilla;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
41 Sevilla;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;92,81
41 Sevilla;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
41 Sevilla;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
41 Sevilla;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
41 Sevilla;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;93,23
41 Sevilla;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
41 Sevilla;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
41 Sevilla;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
41 Sevilla;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
41 Sevilla;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
41 Sevilla;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
41 Sevilla;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;90,02
41 Sevilla;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
41 Sevilla;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
41 Sevilla;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
41 Sevilla;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;90,92
41 Sevilla;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
41 Sevilla;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
41 Sevilla;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
41 Sevilla;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
41 Sevilla;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
41 Sevilla;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
41 Sevilla;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;86,85
41 Sevilla;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
41 Sevilla;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
41 Sevilla;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
41 Sevilla;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;88,57
41 Sevilla;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
41 Sevilla;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
41 Sevilla;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
41 Sevilla;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
41 Sevilla;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
41 Sevilla;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
41 Sevilla;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QIII;8.581
41 Sevilla;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
41 Sevilla;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
41 Sevilla;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
41 Sevilla;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QIII;8.746
41 Sevilla;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
41 Sevilla;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
41 Sevilla;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
41 Sevilla;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QIII;8.639
41 Sevilla;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
41 Sevilla;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
41 Sevilla;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
41 Sevilla;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2022QIII;8.199
41 Sevilla;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2022QII;""
41 Sevilla;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2022QI;""
41 Sevilla;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
41 Sevilla;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2021QIII;8.384
41 Sevilla;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2021QII;""
41 Sevilla;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2021QI;""
41 Sevilla;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
41 Sevilla;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2020QIII;8.259
41 Sevilla;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2020QII;""
41 Sevilla;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2020QI;""
41 Sevilla;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2022QIV;7.803
41 Sevilla;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
41 Sevilla;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2022QII;""
41 Sevilla;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2022QI;""
41 Sevilla;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2021QIV;8.045
41 Sevilla;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
41 Sevilla;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2021QII;""
41 Sevilla;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2021QI;""
41 Sevilla;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2020QIV;7.957
41 Sevilla;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
41 Sevilla;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2020QII;""
41 Sevilla;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2020QI;""
41 Sevilla;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
41 Sevilla;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
41 Sevilla;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QII;""
41 Sevilla;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QI;7.729
41 Sevilla;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
41 Sevilla;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
41 Sevilla;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QII;""
41 Sevilla;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QI;7.724
41 Sevilla;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
41 Sevilla;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
41 Sevilla;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QII;""
41 Sevilla;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QI;""
41 Sevilla;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
41 Sevilla;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
41 Sevilla;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QII;7.368
41 Sevilla;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QI;""
41 Sevilla;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
41 Sevilla;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
41 Sevilla;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QII;7.475
41 Sevilla;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QI;""
41 Sevilla;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
41 Sevilla;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
41 Sevilla;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QII;""
41 Sevilla;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QI;""
41 Sevilla;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
41 Sevilla;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
41 Sevilla;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
41 Sevilla;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
41 Sevilla;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
41 Sevilla;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
41 Sevilla;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
41 Sevilla;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
41 Sevilla;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
41 Sevilla;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
41 Sevilla;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
41 Sevilla;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
41 Sevilla;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
41 Sevilla;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;95,55
41 Sevilla;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
41 Sevilla;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
41 Sevilla;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
41 Sevilla;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;95,86
41 Sevilla;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
41 Sevilla;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
41 Sevilla;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
41 Sevilla;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;95,6
41 Sevilla;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
41 Sevilla;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
41 Sevilla;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;90,93
41 Sevilla;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
41 Sevilla;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
41 Sevilla;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
41 Sevilla;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;91,98
41 Sevilla;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
41 Sevilla;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
41 Sevilla;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
41 Sevilla;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;92,11
41 Sevilla;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
41 Sevilla;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
41 Sevilla;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
41 Sevilla;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
41 Sevilla;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
41 Sevilla;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
41 Sevilla;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;88,37
41 Sevilla;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
41 Sevilla;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
41 Sevilla;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
41 Sevilla;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;89,41
41 Sevilla;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
41 Sevilla;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
41 Sevilla;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
41 Sevilla;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
41 Sevilla;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
41 Sevilla;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
41 Sevilla;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;84,24
41 Sevilla;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
41 Sevilla;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
41 Sevilla;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
41 Sevilla;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;86,53
41 Sevilla;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
41 Sevilla;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
41 Sevilla;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
41 Sevilla;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
41 Sevilla;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
41 Sevilla;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QIV;21.177
41 Sevilla;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
41 Sevilla;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
41 Sevilla;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
41 Sevilla;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QIV;21.915
41 Sevilla;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
41 Sevilla;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
41 Sevilla;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
41 Sevilla;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QIV;22.015
41 Sevilla;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
41 Sevilla;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
41 Sevilla;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
41 Sevilla;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2022QIV;20.207
41 Sevilla;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
41 Sevilla;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2022QII;""
41 Sevilla;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2022QI;""
41 Sevilla;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2021QIV;21.054
41 Sevilla;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
41 Sevilla;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2021QII;""
41 Sevilla;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2021QI;""
41 Sevilla;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2020QIV;21.204
41 Sevilla;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
41 Sevilla;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2020QII;""
41 Sevilla;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2020QI;""
41 Sevilla;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
41 Sevilla;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
41 Sevilla;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2022QII;""
41 Sevilla;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2022QI;20.306
41 Sevilla;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
41 Sevilla;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
41 Sevilla;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2021QII;""
41 Sevilla;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2021QI;20.594
41 Sevilla;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
41 Sevilla;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
41 Sevilla;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2020QII;""
41 Sevilla;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2020QI;""
41 Sevilla;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
41 Sevilla;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
41 Sevilla;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QII;19.469
41 Sevilla;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QI;""
41 Sevilla;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
41 Sevilla;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
41 Sevilla;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QII;19.967
41 Sevilla;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QI;""
41 Sevilla;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
41 Sevilla;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
41 Sevilla;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QII;""
41 Sevilla;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QI;""
41 Sevilla;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
41 Sevilla;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QIII;18.786
41 Sevilla;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QII;""
41 Sevilla;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QI;""
41 Sevilla;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
41 Sevilla;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QIII;19.367
41 Sevilla;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QII;""
41 Sevilla;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QI;""
41 Sevilla;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
41 Sevilla;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
41 Sevilla;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QII;""
41 Sevilla;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QI;""
41 Sevilla;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
41 Sevilla;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
41 Sevilla;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
41 Sevilla;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
41 Sevilla;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
41 Sevilla;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
41 Sevilla;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
41 Sevilla;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
41 Sevilla;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
41 Sevilla;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
41 Sevilla;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
41 Sevilla;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
41 Sevilla;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;95,42
41 Sevilla;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
41 Sevilla;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
41 Sevilla;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
41 Sevilla;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;96,07
41 Sevilla;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
41 Sevilla;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
41 Sevilla;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
41 Sevilla;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;96,32
41 Sevilla;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
41 Sevilla;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
41 Sevilla;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
41 Sevilla;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
41 Sevilla;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
41 Sevilla;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
41 Sevilla;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;92,66
41 Sevilla;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
41 Sevilla;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
41 Sevilla;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
41 Sevilla;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;93,55
41 Sevilla;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
41 Sevilla;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
41 Sevilla;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
41 Sevilla;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
41 Sevilla;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
41 Sevilla;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
41 Sevilla;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;88,84
41 Sevilla;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
41 Sevilla;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
41 Sevilla;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
41 Sevilla;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;90,7
41 Sevilla;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
41 Sevilla;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
41 Sevilla;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
41 Sevilla;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
41 Sevilla;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
41 Sevilla;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
41 Sevilla;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;85,72
41 Sevilla;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
41 Sevilla;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
41 Sevilla;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
41 Sevilla;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;87,97
41 Sevilla;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
41 Sevilla;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
41 Sevilla;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
41 Sevilla;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
41 Sevilla;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
41 Sevilla;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
41 Sevilla;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QIV;12.505
41 Sevilla;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
41 Sevilla;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
41 Sevilla;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
41 Sevilla;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QIV;13.102
41 Sevilla;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
41 Sevilla;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
41 Sevilla;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
41 Sevilla;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QIV;13.284
41 Sevilla;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
41 Sevilla;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
41 Sevilla;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
41 Sevilla;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2022QIV;11.961
41 Sevilla;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
41 Sevilla;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2022QII;""
41 Sevilla;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2022QI;""
41 Sevilla;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2021QIV;12.623
41 Sevilla;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
41 Sevilla;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2021QII;""
41 Sevilla;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2021QI;""
41 Sevilla;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2020QIV;12.805
41 Sevilla;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
41 Sevilla;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2020QII;""
41 Sevilla;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2020QI;""
41 Sevilla;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
41 Sevilla;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
41 Sevilla;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2022QII;""
41 Sevilla;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2022QI;12.222
41 Sevilla;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
41 Sevilla;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
41 Sevilla;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2021QII;""
41 Sevilla;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2021QI;12.462
41 Sevilla;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
41 Sevilla;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
41 Sevilla;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2020QII;""
41 Sevilla;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2020QI;""
41 Sevilla;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
41 Sevilla;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
41 Sevilla;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QII;11.777
41 Sevilla;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QI;""
41 Sevilla;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
41 Sevilla;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
41 Sevilla;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QII;12.113
41 Sevilla;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QI;""
41 Sevilla;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
41 Sevilla;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
41 Sevilla;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QII;""
41 Sevilla;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QI;""
41 Sevilla;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
41 Sevilla;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QIII;11.391
41 Sevilla;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QII;""
41 Sevilla;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QI;""
41 Sevilla;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
41 Sevilla;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QIII;11.775
41 Sevilla;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QII;""
41 Sevilla;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QI;""
41 Sevilla;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
41 Sevilla;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
41 Sevilla;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QII;""
41 Sevilla;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QI;""
41 Sevilla;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
41 Sevilla;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
41 Sevilla;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
41 Sevilla;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
41 Sevilla;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
41 Sevilla;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
41 Sevilla;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
41 Sevilla;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
41 Sevilla;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
41 Sevilla;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
41 Sevilla;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
41 Sevilla;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
41 Sevilla;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;95,65
41 Sevilla;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
41 Sevilla;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
41 Sevilla;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
41 Sevilla;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;96,34
41 Sevilla;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
41 Sevilla;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
41 Sevilla;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
41 Sevilla;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;96,39
41 Sevilla;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
41 Sevilla;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
41 Sevilla;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
41 Sevilla;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
41 Sevilla;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
41 Sevilla;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
41 Sevilla;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;93,28
41 Sevilla;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
41 Sevilla;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
41 Sevilla;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
41 Sevilla;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;93,81
41 Sevilla;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
41 Sevilla;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
41 Sevilla;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
41 Sevilla;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
41 Sevilla;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
41 Sevilla;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
41 Sevilla;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;89,89
41 Sevilla;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
41 Sevilla;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
41 Sevilla;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
41 Sevilla;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;91,18
41 Sevilla;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
41 Sevilla;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
41 Sevilla;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
41 Sevilla;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
41 Sevilla;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
41 Sevilla;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
41 Sevilla;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;86,94
41 Sevilla;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
41 Sevilla;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
41 Sevilla;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
41 Sevilla;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;88,64
41 Sevilla;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
41 Sevilla;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
41 Sevilla;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
41 Sevilla;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
41 Sevilla;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
41 Sevilla;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
41 Sevilla;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QIV;8.672
41 Sevilla;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
41 Sevilla;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
41 Sevilla;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
41 Sevilla;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QIV;8.813
41 Sevilla;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
41 Sevilla;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
41 Sevilla;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
41 Sevilla;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QIV;8.731
41 Sevilla;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
41 Sevilla;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
41 Sevilla;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
41 Sevilla;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2022QIV;8.246
41 Sevilla;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
41 Sevilla;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2022QII;""
41 Sevilla;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2022QI;""
41 Sevilla;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2021QIV;8.431
41 Sevilla;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
41 Sevilla;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2021QII;""
41 Sevilla;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2021QI;""
41 Sevilla;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2020QIV;8.399
41 Sevilla;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
41 Sevilla;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2020QII;""
41 Sevilla;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2020QI;""
41 Sevilla;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
41 Sevilla;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
41 Sevilla;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2022QII;""
41 Sevilla;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2022QI;8.084
41 Sevilla;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
41 Sevilla;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
41 Sevilla;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2021QII;""
41 Sevilla;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2021QI;8.132
41 Sevilla;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
41 Sevilla;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
41 Sevilla;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2020QII;""
41 Sevilla;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2020QI;""
41 Sevilla;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
41 Sevilla;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
41 Sevilla;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QII;7.692
41 Sevilla;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QI;""
41 Sevilla;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
41 Sevilla;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
41 Sevilla;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QII;7.854
41 Sevilla;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QI;""
41 Sevilla;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
41 Sevilla;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
41 Sevilla;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QII;""
41 Sevilla;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QI;""
41 Sevilla;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
41 Sevilla;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QIII;7.395
41 Sevilla;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QII;""
41 Sevilla;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QI;""
41 Sevilla;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
41 Sevilla;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QIII;7.592
41 Sevilla;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QII;""
41 Sevilla;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QI;""
41 Sevilla;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
41 Sevilla;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
41 Sevilla;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QII;""
41 Sevilla;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QI;""
41 Sevilla;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
41 Sevilla;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
41 Sevilla;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
41 Sevilla;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
41 Sevilla;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
41 Sevilla;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
41 Sevilla;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
41 Sevilla;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
41 Sevilla;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
41 Sevilla;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
41 Sevilla;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
41 Sevilla;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
41 Sevilla;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;95,09
41 Sevilla;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
41 Sevilla;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
41 Sevilla;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
41 Sevilla;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;95,67
41 Sevilla;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
41 Sevilla;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
41 Sevilla;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
41 Sevilla;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;96,2
41 Sevilla;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
41 Sevilla;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
41 Sevilla;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
41 Sevilla;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
41 Sevilla;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
41 Sevilla;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
41 Sevilla;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;91,73
41 Sevilla;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
41 Sevilla;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
41 Sevilla;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
41 Sevilla;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;93,14
41 Sevilla;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
41 Sevilla;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
41 Sevilla;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
41 Sevilla;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
41 Sevilla;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
41 Sevilla;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
41 Sevilla;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;87,28
41 Sevilla;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
41 Sevilla;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
41 Sevilla;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
41 Sevilla;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;89,96
41 Sevilla;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
41 Sevilla;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
41 Sevilla;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
41 Sevilla;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
41 Sevilla;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
41 Sevilla;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
41 Sevilla;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;83,91
41 Sevilla;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
41 Sevilla;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
41 Sevilla;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
41 Sevilla;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;86,95
41 Sevilla;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
41 Sevilla;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
41 Sevilla;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
41 Sevilla;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
41 Sevilla;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
41 Sevilla;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
41 Sevilla;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
41 Sevilla;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
41 Sevilla;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
41 Sevilla;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QI;36.511
41 Sevilla;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
41 Sevilla;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
41 Sevilla;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
41 Sevilla;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QI;36.200
41 Sevilla;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
41 Sevilla;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
41 Sevilla;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
41 Sevilla;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QI;36.044
41 Sevilla;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
41 Sevilla;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
41 Sevilla;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2022QII;""
41 Sevilla;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2022QI;35.533
41 Sevilla;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
41 Sevilla;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
41 Sevilla;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2021QII;""
41 Sevilla;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2021QI;35.440
41 Sevilla;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
41 Sevilla;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
41 Sevilla;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2020QII;""
41 Sevilla;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2020QI;33.584
41 Sevilla;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
41 Sevilla;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
41 Sevilla;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2022QII;34.421
41 Sevilla;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2022QI;""
41 Sevilla;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
41 Sevilla;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
41 Sevilla;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2021QII;34.537
41 Sevilla;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2021QI;""
41 Sevilla;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
41 Sevilla;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
41 Sevilla;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2020QII;33.019
41 Sevilla;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2020QI;""
41 Sevilla;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
41 Sevilla;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QIII;33.570
41 Sevilla;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QII;""
41 Sevilla;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QI;""
41 Sevilla;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
41 Sevilla;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QIII;33.841
41 Sevilla;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QII;""
41 Sevilla;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QI;""
41 Sevilla;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
41 Sevilla;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QIII;32.271
41 Sevilla;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QII;""
41 Sevilla;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QI;""
41 Sevilla;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QIV;32.666
41 Sevilla;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
41 Sevilla;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QII;""
41 Sevilla;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QI;""
41 Sevilla;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QIV;33.083
41 Sevilla;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
41 Sevilla;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QII;""
41 Sevilla;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QI;""
41 Sevilla;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QIV;31.623
41 Sevilla;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
41 Sevilla;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QII;""
41 Sevilla;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QI;""
41 Sevilla;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
41 Sevilla;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
41 Sevilla;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
41 Sevilla;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
41 Sevilla;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
41 Sevilla;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
41 Sevilla;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
41 Sevilla;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
41 Sevilla;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
41 Sevilla;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
41 Sevilla;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
41 Sevilla;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
41 Sevilla;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
41 Sevilla;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
41 Sevilla;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
41 Sevilla;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;97,32
41 Sevilla;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
41 Sevilla;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
41 Sevilla;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
41 Sevilla;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;97,9
41 Sevilla;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
41 Sevilla;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
41 Sevilla;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
41 Sevilla;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;93,18
41 Sevilla;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
41 Sevilla;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
41 Sevilla;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;94,28
41 Sevilla;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
41 Sevilla;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
41 Sevilla;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
41 Sevilla;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;95,41
41 Sevilla;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
41 Sevilla;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
41 Sevilla;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
41 Sevilla;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;91,61
41 Sevilla;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
41 Sevilla;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
41 Sevilla;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;91,94
41 Sevilla;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
41 Sevilla;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
41 Sevilla;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
41 Sevilla;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;93,48
41 Sevilla;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
41 Sevilla;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
41 Sevilla;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
41 Sevilla;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;89,53
41 Sevilla;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
41 Sevilla;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
41 Sevilla;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;89,47
41 Sevilla;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
41 Sevilla;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
41 Sevilla;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
41 Sevilla;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;91,39
41 Sevilla;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
41 Sevilla;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
41 Sevilla;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
41 Sevilla;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;87,73
41 Sevilla;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
41 Sevilla;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
41 Sevilla;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
41 Sevilla;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
41 Sevilla;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
41 Sevilla;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
41 Sevilla;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QI;23.659
41 Sevilla;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
41 Sevilla;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
41 Sevilla;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
41 Sevilla;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QI;23.718
41 Sevilla;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
41 Sevilla;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
41 Sevilla;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
41 Sevilla;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QI;23.655
41 Sevilla;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
41 Sevilla;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
41 Sevilla;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2022QII;""
41 Sevilla;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2022QI;23.085
41 Sevilla;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
41 Sevilla;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
41 Sevilla;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2021QII;""
41 Sevilla;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2021QI;23.257
41 Sevilla;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
41 Sevilla;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
41 Sevilla;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2020QII;""
41 Sevilla;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2020QI;22.196
41 Sevilla;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
41 Sevilla;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
41 Sevilla;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2022QII;22.501
41 Sevilla;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2022QI;""
41 Sevilla;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
41 Sevilla;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
41 Sevilla;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2021QII;22.706
41 Sevilla;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2021QI;""
41 Sevilla;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
41 Sevilla;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
41 Sevilla;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2020QII;21.868
41 Sevilla;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2020QI;""
41 Sevilla;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
41 Sevilla;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QIII;22.034
41 Sevilla;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QII;""
41 Sevilla;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QI;""
41 Sevilla;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
41 Sevilla;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QIII;22.314
41 Sevilla;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QII;""
41 Sevilla;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QI;""
41 Sevilla;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
41 Sevilla;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QIII;21.450
41 Sevilla;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QII;""
41 Sevilla;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QI;""
41 Sevilla;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QIV;21.507
41 Sevilla;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
41 Sevilla;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QII;""
41 Sevilla;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QI;""
41 Sevilla;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QIV;21.861
41 Sevilla;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
41 Sevilla;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QII;""
41 Sevilla;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QI;""
41 Sevilla;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QIV;21.069
41 Sevilla;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
41 Sevilla;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QII;""
41 Sevilla;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QI;""
41 Sevilla;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
41 Sevilla;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
41 Sevilla;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
41 Sevilla;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
41 Sevilla;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
41 Sevilla;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
41 Sevilla;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
41 Sevilla;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
41 Sevilla;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
41 Sevilla;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
41 Sevilla;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
41 Sevilla;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
41 Sevilla;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
41 Sevilla;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
41 Sevilla;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
41 Sevilla;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;97,57
41 Sevilla;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
41 Sevilla;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
41 Sevilla;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
41 Sevilla;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;98,06
41 Sevilla;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
41 Sevilla;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
41 Sevilla;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
41 Sevilla;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;93,83
41 Sevilla;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
41 Sevilla;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
41 Sevilla;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;95,11
41 Sevilla;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
41 Sevilla;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
41 Sevilla;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
41 Sevilla;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;95,73
41 Sevilla;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
41 Sevilla;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
41 Sevilla;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
41 Sevilla;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;92,45
41 Sevilla;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
41 Sevilla;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
41 Sevilla;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;93,13
41 Sevilla;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
41 Sevilla;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
41 Sevilla;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
41 Sevilla;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;94,08
41 Sevilla;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
41 Sevilla;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
41 Sevilla;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
41 Sevilla;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;90,68
41 Sevilla;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
41 Sevilla;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
41 Sevilla;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;90,9
41 Sevilla;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
41 Sevilla;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
41 Sevilla;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
41 Sevilla;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;92,17
41 Sevilla;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
41 Sevilla;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
41 Sevilla;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
41 Sevilla;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;89,07
41 Sevilla;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
41 Sevilla;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
41 Sevilla;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
41 Sevilla;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
41 Sevilla;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
41 Sevilla;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
41 Sevilla;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QI;12.852
41 Sevilla;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
41 Sevilla;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
41 Sevilla;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
41 Sevilla;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QI;12.482
41 Sevilla;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
41 Sevilla;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
41 Sevilla;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
41 Sevilla;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QI;12.389
41 Sevilla;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
41 Sevilla;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
41 Sevilla;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2022QII;""
41 Sevilla;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2022QI;12.448
41 Sevilla;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
41 Sevilla;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
41 Sevilla;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2021QII;""
41 Sevilla;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2021QI;12.183
41 Sevilla;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
41 Sevilla;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
41 Sevilla;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2020QII;""
41 Sevilla;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2020QI;11.388
41 Sevilla;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
41 Sevilla;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
41 Sevilla;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2022QII;11.920
41 Sevilla;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2022QI;""
41 Sevilla;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
41 Sevilla;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
41 Sevilla;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2021QII;11.831
41 Sevilla;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2021QI;""
41 Sevilla;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
41 Sevilla;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
41 Sevilla;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2020QII;11.151
41 Sevilla;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2020QI;""
41 Sevilla;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
41 Sevilla;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QIII;11.536
41 Sevilla;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QII;""
41 Sevilla;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QI;""
41 Sevilla;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
41 Sevilla;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QIII;11.527
41 Sevilla;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QII;""
41 Sevilla;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QI;""
41 Sevilla;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
41 Sevilla;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QIII;10.821
41 Sevilla;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QII;""
41 Sevilla;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QI;""
41 Sevilla;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QIV;11.159
41 Sevilla;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
41 Sevilla;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QII;""
41 Sevilla;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QI;""
41 Sevilla;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QIV;11.222
41 Sevilla;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
41 Sevilla;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QII;""
41 Sevilla;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QI;""
41 Sevilla;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QIV;10.554
41 Sevilla;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
41 Sevilla;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QII;""
41 Sevilla;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QI;""
41 Sevilla;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
41 Sevilla;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
41 Sevilla;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
41 Sevilla;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
41 Sevilla;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
41 Sevilla;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
41 Sevilla;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
41 Sevilla;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
41 Sevilla;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
41 Sevilla;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
41 Sevilla;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
41 Sevilla;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
41 Sevilla;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
41 Sevilla;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
41 Sevilla;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
41 Sevilla;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;96,86
41 Sevilla;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
41 Sevilla;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
41 Sevilla;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
41 Sevilla;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;97,6
41 Sevilla;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
41 Sevilla;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
41 Sevilla;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
41 Sevilla;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;91,92
41 Sevilla;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
41 Sevilla;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
41 Sevilla;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;92,75
41 Sevilla;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
41 Sevilla;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
41 Sevilla;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
41 Sevilla;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;94,78
41 Sevilla;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
41 Sevilla;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
41 Sevilla;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
41 Sevilla;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;90,01
41 Sevilla;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
41 Sevilla;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
41 Sevilla;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;89,76
41 Sevilla;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
41 Sevilla;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
41 Sevilla;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
41 Sevilla;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;92,35
41 Sevilla;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
41 Sevilla;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
41 Sevilla;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
41 Sevilla;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;87,34
41 Sevilla;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
41 Sevilla;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
41 Sevilla;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;86,83
41 Sevilla;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
41 Sevilla;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
41 Sevilla;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
41 Sevilla;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;89,91
41 Sevilla;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
41 Sevilla;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
41 Sevilla;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
41 Sevilla;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;85,19
41 Sevilla;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
41 Sevilla;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
41 Sevilla;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
41 Sevilla;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
41 Sevilla;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
41 Sevilla;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QII;36.283
41 Sevilla;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
41 Sevilla;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
41 Sevilla;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
41 Sevilla;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QII;36.112
41 Sevilla;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
41 Sevilla;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
41 Sevilla;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
41 Sevilla;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QII;35.087
41 Sevilla;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
41 Sevilla;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
41 Sevilla;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
41 Sevilla;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2022QII;35.010
41 Sevilla;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2022QI;""
41 Sevilla;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
41 Sevilla;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
41 Sevilla;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2021QII;35.076
41 Sevilla;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2021QI;""
41 Sevilla;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
41 Sevilla;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
41 Sevilla;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2020QII;34.421
41 Sevilla;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2020QI;""
41 Sevilla;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
41 Sevilla;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2022QIII;34.052
41 Sevilla;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2022QII;""
41 Sevilla;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2022QI;""
41 Sevilla;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
41 Sevilla;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2021QIII;34.286
41 Sevilla;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2021QII;""
41 Sevilla;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2021QI;""
41 Sevilla;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
41 Sevilla;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2020QIII;33.576
41 Sevilla;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2020QII;""
41 Sevilla;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2020QI;""
41 Sevilla;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QIV;33.024
41 Sevilla;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
41 Sevilla;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QII;""
41 Sevilla;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QI;""
41 Sevilla;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QIV;33.449
41 Sevilla;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
41 Sevilla;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QII;""
41 Sevilla;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QI;""
41 Sevilla;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QIV;32.830
41 Sevilla;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
41 Sevilla;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QII;""
41 Sevilla;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QI;""
41 Sevilla;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
41 Sevilla;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
41 Sevilla;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QII;""
41 Sevilla;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QI;32.703
41 Sevilla;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
41 Sevilla;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
41 Sevilla;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QII;""
41 Sevilla;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QI;32.307
41 Sevilla;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
41 Sevilla;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
41 Sevilla;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QII;""
41 Sevilla;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QI;""
41 Sevilla;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
41 Sevilla;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
41 Sevilla;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
41 Sevilla;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
41 Sevilla;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
41 Sevilla;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
41 Sevilla;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
41 Sevilla;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
41 Sevilla;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
41 Sevilla;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
41 Sevilla;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
41 Sevilla;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
41 Sevilla;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
41 Sevilla;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
41 Sevilla;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;96,49
41 Sevilla;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
41 Sevilla;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
41 Sevilla;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
41 Sevilla;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;97,13
41 Sevilla;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
41 Sevilla;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
41 Sevilla;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
41 Sevilla;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;98,1
41 Sevilla;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
41 Sevilla;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
41 Sevilla;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;93,85
41 Sevilla;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
41 Sevilla;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
41 Sevilla;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
41 Sevilla;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;94,94
41 Sevilla;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
41 Sevilla;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
41 Sevilla;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
41 Sevilla;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;95,69
41 Sevilla;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
41 Sevilla;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
41 Sevilla;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;91,02
41 Sevilla;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
41 Sevilla;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
41 Sevilla;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
41 Sevilla;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;92,63
41 Sevilla;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
41 Sevilla;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
41 Sevilla;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
41 Sevilla;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;93,57
41 Sevilla;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
41 Sevilla;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
41 Sevilla;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
41 Sevilla;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
41 Sevilla;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
41 Sevilla;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
41 Sevilla;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;90,56
41 Sevilla;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
41 Sevilla;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
41 Sevilla;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
41 Sevilla;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;92,08
41 Sevilla;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
41 Sevilla;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
41 Sevilla;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
41 Sevilla;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
41 Sevilla;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
41 Sevilla;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
41 Sevilla;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QII;23.417
41 Sevilla;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
41 Sevilla;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
41 Sevilla;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
41 Sevilla;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QII;23.505
41 Sevilla;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
41 Sevilla;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
41 Sevilla;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
41 Sevilla;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QII;23.029
41 Sevilla;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
41 Sevilla;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
41 Sevilla;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
41 Sevilla;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2022QII;22.736
41 Sevilla;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2022QI;""
41 Sevilla;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
41 Sevilla;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
41 Sevilla;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2021QII;22.875
41 Sevilla;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2021QI;""
41 Sevilla;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
41 Sevilla;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
41 Sevilla;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2020QII;22.667
41 Sevilla;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2020QI;""
41 Sevilla;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
41 Sevilla;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2022QIII;22.204
41 Sevilla;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2022QII;""
41 Sevilla;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2022QI;""
41 Sevilla;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
41 Sevilla;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2021QIII;22.429
41 Sevilla;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2021QII;""
41 Sevilla;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2021QI;""
41 Sevilla;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
41 Sevilla;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2020QIII;22.194
41 Sevilla;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2020QII;""
41 Sevilla;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2020QI;""
41 Sevilla;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QIV;21.616
41 Sevilla;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
41 Sevilla;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QII;""
41 Sevilla;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QI;""
41 Sevilla;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QIV;21.937
41 Sevilla;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
41 Sevilla;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QII;""
41 Sevilla;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QI;""
41 Sevilla;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QIV;21.751
41 Sevilla;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
41 Sevilla;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QII;""
41 Sevilla;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QI;""
41 Sevilla;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
41 Sevilla;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
41 Sevilla;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QII;""
41 Sevilla;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QI;21.501
41 Sevilla;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
41 Sevilla;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
41 Sevilla;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QII;""
41 Sevilla;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QI;21.437
41 Sevilla;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
41 Sevilla;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
41 Sevilla;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QII;""
41 Sevilla;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QI;""
41 Sevilla;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
41 Sevilla;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
41 Sevilla;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
41 Sevilla;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
41 Sevilla;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
41 Sevilla;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
41 Sevilla;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
41 Sevilla;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
41 Sevilla;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
41 Sevilla;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
41 Sevilla;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
41 Sevilla;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
41 Sevilla;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
41 Sevilla;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
41 Sevilla;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;97,09
41 Sevilla;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
41 Sevilla;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
41 Sevilla;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
41 Sevilla;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;97,32
41 Sevilla;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
41 Sevilla;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
41 Sevilla;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
41 Sevilla;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;98,43
41 Sevilla;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
41 Sevilla;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
41 Sevilla;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;94,82
41 Sevilla;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
41 Sevilla;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
41 Sevilla;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
41 Sevilla;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;95,42
41 Sevilla;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
41 Sevilla;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
41 Sevilla;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
41 Sevilla;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;96,37
41 Sevilla;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
41 Sevilla;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
41 Sevilla;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;92,31
41 Sevilla;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
41 Sevilla;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
41 Sevilla;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
41 Sevilla;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;93,33
41 Sevilla;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
41 Sevilla;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
41 Sevilla;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
41 Sevilla;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;94,45
41 Sevilla;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
41 Sevilla;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
41 Sevilla;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
41 Sevilla;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
41 Sevilla;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
41 Sevilla;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
41 Sevilla;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;91,47
41 Sevilla;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
41 Sevilla;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
41 Sevilla;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
41 Sevilla;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;93,09
41 Sevilla;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
41 Sevilla;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
41 Sevilla;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
41 Sevilla;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
41 Sevilla;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
41 Sevilla;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
41 Sevilla;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QII;12.866
41 Sevilla;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
41 Sevilla;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
41 Sevilla;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
41 Sevilla;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QII;12.607
41 Sevilla;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
41 Sevilla;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
41 Sevilla;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
41 Sevilla;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QII;12.058
41 Sevilla;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
41 Sevilla;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
41 Sevilla;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
41 Sevilla;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2022QII;12.274
41 Sevilla;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2022QI;""
41 Sevilla;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
41 Sevilla;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
41 Sevilla;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2021QII;12.201
41 Sevilla;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2021QI;""
41 Sevilla;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
41 Sevilla;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
41 Sevilla;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2020QII;11.754
41 Sevilla;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2020QI;""
41 Sevilla;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
41 Sevilla;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2022QIII;11.848
41 Sevilla;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2022QII;""
41 Sevilla;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2022QI;""
41 Sevilla;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
41 Sevilla;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2021QIII;11.857
41 Sevilla;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2021QII;""
41 Sevilla;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2021QI;""
41 Sevilla;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
41 Sevilla;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2020QIII;11.382
41 Sevilla;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2020QII;""
41 Sevilla;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2020QI;""
41 Sevilla;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QIV;11.408
41 Sevilla;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
41 Sevilla;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QII;""
41 Sevilla;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QI;""
41 Sevilla;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QIV;11.512
41 Sevilla;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
41 Sevilla;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QII;""
41 Sevilla;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QI;""
41 Sevilla;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QIV;11.079
41 Sevilla;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
41 Sevilla;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QII;""
41 Sevilla;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QI;""
41 Sevilla;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
41 Sevilla;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
41 Sevilla;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QII;""
41 Sevilla;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QI;11.202
41 Sevilla;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
41 Sevilla;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
41 Sevilla;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QII;""
41 Sevilla;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QI;10.870
41 Sevilla;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
41 Sevilla;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
41 Sevilla;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QII;""
41 Sevilla;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QI;""
41 Sevilla;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
41 Sevilla;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
41 Sevilla;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
41 Sevilla;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
41 Sevilla;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
41 Sevilla;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
41 Sevilla;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
41 Sevilla;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
41 Sevilla;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
41 Sevilla;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
41 Sevilla;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
41 Sevilla;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
41 Sevilla;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
41 Sevilla;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
41 Sevilla;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;95,4
41 Sevilla;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
41 Sevilla;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
41 Sevilla;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
41 Sevilla;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;96,78
41 Sevilla;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
41 Sevilla;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
41 Sevilla;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
41 Sevilla;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;97,48
41 Sevilla;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
41 Sevilla;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
41 Sevilla;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;92,09
41 Sevilla;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
41 Sevilla;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
41 Sevilla;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
41 Sevilla;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;94,05
41 Sevilla;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
41 Sevilla;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
41 Sevilla;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
41 Sevilla;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;94,39
41 Sevilla;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
41 Sevilla;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
41 Sevilla;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;88,67
41 Sevilla;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
41 Sevilla;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
41 Sevilla;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
41 Sevilla;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;91,31
41 Sevilla;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
41 Sevilla;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
41 Sevilla;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
41 Sevilla;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;91,88
41 Sevilla;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
41 Sevilla;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
41 Sevilla;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
41 Sevilla;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
41 Sevilla;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
41 Sevilla;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
41 Sevilla;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;88,86
41 Sevilla;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
41 Sevilla;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
41 Sevilla;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
41 Sevilla;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;90,15
41 Sevilla;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
41 Sevilla;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
41 Sevilla;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
41 Sevilla;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
41 Sevilla;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
41 Sevilla;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QIII;36.047
41 Sevilla;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
41 Sevilla;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
41 Sevilla;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
41 Sevilla;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QIII;36.296
41 Sevilla;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
41 Sevilla;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
41 Sevilla;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
41 Sevilla;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QIII;35.738
41 Sevilla;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
41 Sevilla;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
41 Sevilla;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
41 Sevilla;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2022QIII;34.968
41 Sevilla;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2022QII;""
41 Sevilla;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2022QI;""
41 Sevilla;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
41 Sevilla;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2021QIII;35.369
41 Sevilla;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2021QII;""
41 Sevilla;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2021QI;""
41 Sevilla;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
41 Sevilla;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2020QIII;34.755
41 Sevilla;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2020QII;""
41 Sevilla;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2020QI;""
41 Sevilla;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2022QIV;33.844
41 Sevilla;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
41 Sevilla;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2022QII;""
41 Sevilla;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2022QI;""
41 Sevilla;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2021QIV;34.447
41 Sevilla;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
41 Sevilla;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2021QII;""
41 Sevilla;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2021QI;""
41 Sevilla;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2020QIV;33.936
41 Sevilla;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
41 Sevilla;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2020QII;""
41 Sevilla;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2020QI;""
41 Sevilla;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
41 Sevilla;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
41 Sevilla;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QII;""
41 Sevilla;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QI;33.635
41 Sevilla;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
41 Sevilla;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
41 Sevilla;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QII;""
41 Sevilla;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QI;33.365
41 Sevilla;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
41 Sevilla;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
41 Sevilla;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QII;""
41 Sevilla;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QI;""
41 Sevilla;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
41 Sevilla;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
41 Sevilla;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QII;32.739
41 Sevilla;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QI;""
41 Sevilla;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
41 Sevilla;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
41 Sevilla;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QII;32.673
41 Sevilla;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QI;""
41 Sevilla;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
41 Sevilla;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
41 Sevilla;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QII;""
41 Sevilla;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QI;""
41 Sevilla;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
41 Sevilla;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
41 Sevilla;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
41 Sevilla;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
41 Sevilla;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
41 Sevilla;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
41 Sevilla;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
41 Sevilla;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
41 Sevilla;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
41 Sevilla;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
41 Sevilla;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
41 Sevilla;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
41 Sevilla;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
41 Sevilla;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;97,01
41 Sevilla;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
41 Sevilla;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
41 Sevilla;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
41 Sevilla;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;97,45
41 Sevilla;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
41 Sevilla;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
41 Sevilla;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
41 Sevilla;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;97,25
41 Sevilla;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
41 Sevilla;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
41 Sevilla;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;93,89
41 Sevilla;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
41 Sevilla;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
41 Sevilla;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
41 Sevilla;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;94,91
41 Sevilla;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
41 Sevilla;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
41 Sevilla;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
41 Sevilla;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;94,96
41 Sevilla;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
41 Sevilla;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
41 Sevilla;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
41 Sevilla;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
41 Sevilla;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
41 Sevilla;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
41 Sevilla;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;92,67
41 Sevilla;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
41 Sevilla;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
41 Sevilla;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
41 Sevilla;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;93,36
41 Sevilla;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
41 Sevilla;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
41 Sevilla;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
41 Sevilla;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
41 Sevilla;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
41 Sevilla;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
41 Sevilla;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;90,2
41 Sevilla;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
41 Sevilla;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
41 Sevilla;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
41 Sevilla;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;91,42
41 Sevilla;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
41 Sevilla;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
41 Sevilla;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
41 Sevilla;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
41 Sevilla;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
41 Sevilla;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
41 Sevilla;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QIII;23.345
41 Sevilla;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
41 Sevilla;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
41 Sevilla;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
41 Sevilla;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QIII;23.588
41 Sevilla;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
41 Sevilla;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
41 Sevilla;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
41 Sevilla;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QIII;23.501
41 Sevilla;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
41 Sevilla;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
41 Sevilla;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
41 Sevilla;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2022QIII;22.742
41 Sevilla;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2022QII;""
41 Sevilla;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2022QI;""
41 Sevilla;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
41 Sevilla;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2021QIII;23.062
41 Sevilla;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2021QII;""
41 Sevilla;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2021QI;""
41 Sevilla;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
41 Sevilla;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2020QIII;22.938
41 Sevilla;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2020QII;""
41 Sevilla;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2020QI;""
41 Sevilla;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2022QIV;22.080
41 Sevilla;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
41 Sevilla;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2022QII;""
41 Sevilla;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2022QI;""
41 Sevilla;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2021QIV;22.516
41 Sevilla;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
41 Sevilla;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2021QII;""
41 Sevilla;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2021QI;""
41 Sevilla;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2020QIV;22.454
41 Sevilla;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
41 Sevilla;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2020QII;""
41 Sevilla;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2020QI;""
41 Sevilla;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
41 Sevilla;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
41 Sevilla;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QII;""
41 Sevilla;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QI;22.039
41 Sevilla;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
41 Sevilla;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
41 Sevilla;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QII;""
41 Sevilla;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QI;22.109
41 Sevilla;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
41 Sevilla;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
41 Sevilla;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QII;""
41 Sevilla;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QI;""
41 Sevilla;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
41 Sevilla;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
41 Sevilla;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QII;21.555
41 Sevilla;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QI;""
41 Sevilla;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
41 Sevilla;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
41 Sevilla;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QII;21.680
41 Sevilla;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QI;""
41 Sevilla;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
41 Sevilla;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
41 Sevilla;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QII;""
41 Sevilla;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QI;""
41 Sevilla;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
41 Sevilla;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
41 Sevilla;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
41 Sevilla;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
41 Sevilla;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
41 Sevilla;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
41 Sevilla;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
41 Sevilla;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
41 Sevilla;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
41 Sevilla;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
41 Sevilla;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
41 Sevilla;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
41 Sevilla;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
41 Sevilla;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;97,42
41 Sevilla;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
41 Sevilla;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
41 Sevilla;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
41 Sevilla;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;97,77
41 Sevilla;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
41 Sevilla;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
41 Sevilla;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
41 Sevilla;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;97,6
41 Sevilla;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
41 Sevilla;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
41 Sevilla;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;94,58
41 Sevilla;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
41 Sevilla;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
41 Sevilla;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
41 Sevilla;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;95,46
41 Sevilla;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
41 Sevilla;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
41 Sevilla;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
41 Sevilla;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;95,54
41 Sevilla;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
41 Sevilla;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
41 Sevilla;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
41 Sevilla;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
41 Sevilla;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
41 Sevilla;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
41 Sevilla;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;93,43
41 Sevilla;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
41 Sevilla;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
41 Sevilla;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
41 Sevilla;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;94,08
41 Sevilla;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
41 Sevilla;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
41 Sevilla;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
41 Sevilla;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
41 Sevilla;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
41 Sevilla;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
41 Sevilla;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;91,38
41 Sevilla;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
41 Sevilla;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
41 Sevilla;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
41 Sevilla;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;92,25
41 Sevilla;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
41 Sevilla;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
41 Sevilla;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
41 Sevilla;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
41 Sevilla;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
41 Sevilla;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
41 Sevilla;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QIII;12.702
41 Sevilla;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
41 Sevilla;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
41 Sevilla;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
41 Sevilla;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QIII;12.708
41 Sevilla;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
41 Sevilla;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
41 Sevilla;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
41 Sevilla;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QIII;12.237
41 Sevilla;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
41 Sevilla;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
41 Sevilla;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
41 Sevilla;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2022QIII;12.226
41 Sevilla;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2022QII;""
41 Sevilla;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2022QI;""
41 Sevilla;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
41 Sevilla;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2021QIII;12.307
41 Sevilla;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2021QII;""
41 Sevilla;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2021QI;""
41 Sevilla;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
41 Sevilla;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2020QIII;11.817
41 Sevilla;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2020QII;""
41 Sevilla;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2020QI;""
41 Sevilla;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2022QIV;11.764
41 Sevilla;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
41 Sevilla;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2022QII;""
41 Sevilla;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2022QI;""
41 Sevilla;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2021QIV;11.931
41 Sevilla;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
41 Sevilla;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2021QII;""
41 Sevilla;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2021QI;""
41 Sevilla;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2020QIV;11.482
41 Sevilla;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
41 Sevilla;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2020QII;""
41 Sevilla;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2020QI;""
41 Sevilla;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
41 Sevilla;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
41 Sevilla;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QII;""
41 Sevilla;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QI;11.596
41 Sevilla;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
41 Sevilla;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
41 Sevilla;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QII;""
41 Sevilla;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QI;11.256
41 Sevilla;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
41 Sevilla;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
41 Sevilla;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QII;""
41 Sevilla;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QI;""
41 Sevilla;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
41 Sevilla;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
41 Sevilla;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QII;11.184
41 Sevilla;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QI;""
41 Sevilla;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
41 Sevilla;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
41 Sevilla;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QII;10.993
41 Sevilla;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QI;""
41 Sevilla;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
41 Sevilla;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
41 Sevilla;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QII;""
41 Sevilla;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QI;""
41 Sevilla;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
41 Sevilla;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
41 Sevilla;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
41 Sevilla;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
41 Sevilla;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
41 Sevilla;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
41 Sevilla;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
41 Sevilla;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
41 Sevilla;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
41 Sevilla;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
41 Sevilla;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
41 Sevilla;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
41 Sevilla;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
41 Sevilla;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;96,25
41 Sevilla;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
41 Sevilla;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
41 Sevilla;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
41 Sevilla;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;96,84
41 Sevilla;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
41 Sevilla;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
41 Sevilla;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
41 Sevilla;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;96,57
41 Sevilla;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
41 Sevilla;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
41 Sevilla;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;92,62
41 Sevilla;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
41 Sevilla;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
41 Sevilla;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
41 Sevilla;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;93,89
41 Sevilla;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
41 Sevilla;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
41 Sevilla;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
41 Sevilla;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;93,83
41 Sevilla;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
41 Sevilla;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
41 Sevilla;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
41 Sevilla;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
41 Sevilla;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
41 Sevilla;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
41 Sevilla;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;91,25
41 Sevilla;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
41 Sevilla;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
41 Sevilla;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
41 Sevilla;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;91,98
41 Sevilla;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
41 Sevilla;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
41 Sevilla;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
41 Sevilla;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
41 Sevilla;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
41 Sevilla;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
41 Sevilla;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;88,01
41 Sevilla;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
41 Sevilla;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
41 Sevilla;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
41 Sevilla;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;89,83
41 Sevilla;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
41 Sevilla;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
41 Sevilla;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
41 Sevilla;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
41 Sevilla;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
41 Sevilla;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QIV;36.089
41 Sevilla;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
41 Sevilla;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
41 Sevilla;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
41 Sevilla;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QIV;36.377
41 Sevilla;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
41 Sevilla;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
41 Sevilla;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
41 Sevilla;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QIV;35.888
41 Sevilla;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
41 Sevilla;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
41 Sevilla;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
41 Sevilla;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2022QIV;34.842
41 Sevilla;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
41 Sevilla;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2022QII;""
41 Sevilla;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2022QI;""
41 Sevilla;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2021QIV;35.333
41 Sevilla;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
41 Sevilla;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2021QII;""
41 Sevilla;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2021QI;""
41 Sevilla;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2020QIV;34.927
41 Sevilla;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
41 Sevilla;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2020QII;""
41 Sevilla;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2020QI;""
41 Sevilla;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
41 Sevilla;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
41 Sevilla;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2022QII;""
41 Sevilla;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2022QI;34.475
41 Sevilla;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
41 Sevilla;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
41 Sevilla;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2021QII;""
41 Sevilla;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2021QI;34.296
41 Sevilla;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
41 Sevilla;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
41 Sevilla;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2020QII;""
41 Sevilla;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2020QI;""
41 Sevilla;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
41 Sevilla;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
41 Sevilla;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QII;33.491
41 Sevilla;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QI;""
41 Sevilla;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
41 Sevilla;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
41 Sevilla;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QII;33.513
41 Sevilla;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QI;""
41 Sevilla;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
41 Sevilla;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
41 Sevilla;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QII;""
41 Sevilla;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QI;""
41 Sevilla;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
41 Sevilla;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QIII;32.706
41 Sevilla;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QII;""
41 Sevilla;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QI;""
41 Sevilla;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
41 Sevilla;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QIII;32.866
41 Sevilla;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QII;""
41 Sevilla;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QI;""
41 Sevilla;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
41 Sevilla;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
41 Sevilla;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QII;""
41 Sevilla;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QI;""
41 Sevilla;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
41 Sevilla;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
41 Sevilla;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
41 Sevilla;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
41 Sevilla;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
41 Sevilla;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
41 Sevilla;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
41 Sevilla;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
41 Sevilla;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
41 Sevilla;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
41 Sevilla;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
41 Sevilla;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
41 Sevilla;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;96,54
41 Sevilla;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
41 Sevilla;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
41 Sevilla;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
41 Sevilla;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;97,13
41 Sevilla;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
41 Sevilla;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
41 Sevilla;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
41 Sevilla;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;97,32
41 Sevilla;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
41 Sevilla;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
41 Sevilla;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
41 Sevilla;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
41 Sevilla;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
41 Sevilla;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
41 Sevilla;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;94,77
41 Sevilla;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
41 Sevilla;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
41 Sevilla;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
41 Sevilla;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;95,56
41 Sevilla;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
41 Sevilla;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
41 Sevilla;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
41 Sevilla;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
41 Sevilla;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
41 Sevilla;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
41 Sevilla;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;92,07
41 Sevilla;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
41 Sevilla;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
41 Sevilla;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
41 Sevilla;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;93,38
41 Sevilla;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
41 Sevilla;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
41 Sevilla;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
41 Sevilla;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
41 Sevilla;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
41 Sevilla;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
41 Sevilla;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;89,91
41 Sevilla;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
41 Sevilla;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
41 Sevilla;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
41 Sevilla;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;91,58
41 Sevilla;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
41 Sevilla;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
41 Sevilla;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
41 Sevilla;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
41 Sevilla;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
41 Sevilla;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
41 Sevilla;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QIV;23.333
41 Sevilla;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
41 Sevilla;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
41 Sevilla;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
41 Sevilla;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QIV;23.635
41 Sevilla;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
41 Sevilla;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
41 Sevilla;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
41 Sevilla;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QIV;23.588
41 Sevilla;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
41 Sevilla;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
41 Sevilla;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
41 Sevilla;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2022QIV;22.600
41 Sevilla;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
41 Sevilla;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2022QII;""
41 Sevilla;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2022QI;""
41 Sevilla;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2021QIV;23.007
41 Sevilla;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
41 Sevilla;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2021QII;""
41 Sevilla;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2021QI;""
41 Sevilla;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2020QIV;23.015
41 Sevilla;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
41 Sevilla;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2020QII;""
41 Sevilla;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2020QI;""
41 Sevilla;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
41 Sevilla;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
41 Sevilla;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2022QII;""
41 Sevilla;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2022QI;22.503
41 Sevilla;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
41 Sevilla;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
41 Sevilla;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2021QII;""
41 Sevilla;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2021QI;22.637
41 Sevilla;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
41 Sevilla;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
41 Sevilla;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2020QII;""
41 Sevilla;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2020QI;""
41 Sevilla;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
41 Sevilla;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
41 Sevilla;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QII;21.983
41 Sevilla;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QI;""
41 Sevilla;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
41 Sevilla;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
41 Sevilla;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QII;22.153
41 Sevilla;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QI;""
41 Sevilla;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
41 Sevilla;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
41 Sevilla;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QII;""
41 Sevilla;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QI;""
41 Sevilla;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
41 Sevilla;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QIII;21.553
41 Sevilla;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QII;""
41 Sevilla;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QI;""
41 Sevilla;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
41 Sevilla;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QIII;21.785
41 Sevilla;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QII;""
41 Sevilla;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QI;""
41 Sevilla;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
41 Sevilla;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
41 Sevilla;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QII;""
41 Sevilla;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QI;""
41 Sevilla;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
41 Sevilla;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
41 Sevilla;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
41 Sevilla;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
41 Sevilla;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
41 Sevilla;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
41 Sevilla;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
41 Sevilla;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
41 Sevilla;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
41 Sevilla;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
41 Sevilla;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
41 Sevilla;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
41 Sevilla;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;96,86
41 Sevilla;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
41 Sevilla;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
41 Sevilla;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
41 Sevilla;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;97,34
41 Sevilla;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
41 Sevilla;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
41 Sevilla;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
41 Sevilla;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;97,57
41 Sevilla;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
41 Sevilla;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
41 Sevilla;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
41 Sevilla;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
41 Sevilla;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
41 Sevilla;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
41 Sevilla;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;95,21
41 Sevilla;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
41 Sevilla;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
41 Sevilla;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
41 Sevilla;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;95,97
41 Sevilla;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
41 Sevilla;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
41 Sevilla;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
41 Sevilla;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
41 Sevilla;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
41 Sevilla;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
41 Sevilla;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;93,01
41 Sevilla;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
41 Sevilla;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
41 Sevilla;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
41 Sevilla;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;93,92
41 Sevilla;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
41 Sevilla;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
41 Sevilla;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
41 Sevilla;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
41 Sevilla;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
41 Sevilla;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
41 Sevilla;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;91,19
41 Sevilla;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
41 Sevilla;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
41 Sevilla;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
41 Sevilla;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;92,36
41 Sevilla;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
41 Sevilla;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
41 Sevilla;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
41 Sevilla;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
41 Sevilla;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
41 Sevilla;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
41 Sevilla;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QIV;12.756
41 Sevilla;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
41 Sevilla;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
41 Sevilla;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
41 Sevilla;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QIV;12.742
41 Sevilla;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
41 Sevilla;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
41 Sevilla;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
41 Sevilla;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QIV;12.300
41 Sevilla;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
41 Sevilla;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
41 Sevilla;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
41 Sevilla;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2022QIV;12.242
41 Sevilla;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
41 Sevilla;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2022QII;""
41 Sevilla;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2022QI;""
41 Sevilla;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2021QIV;12.326
41 Sevilla;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
41 Sevilla;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2021QII;""
41 Sevilla;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2021QI;""
41 Sevilla;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2020QIV;11.912
41 Sevilla;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
41 Sevilla;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2020QII;""
41 Sevilla;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2020QI;""
41 Sevilla;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
41 Sevilla;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
41 Sevilla;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2022QII;""
41 Sevilla;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2022QI;11.972
41 Sevilla;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
41 Sevilla;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
41 Sevilla;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2021QII;""
41 Sevilla;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2021QI;11.659
41 Sevilla;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
41 Sevilla;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
41 Sevilla;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2020QII;""
41 Sevilla;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2020QI;""
41 Sevilla;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
41 Sevilla;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
41 Sevilla;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QII;11.508
41 Sevilla;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QI;""
41 Sevilla;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
41 Sevilla;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
41 Sevilla;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QII;11.360
41 Sevilla;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QI;""
41 Sevilla;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
41 Sevilla;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
41 Sevilla;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QII;""
41 Sevilla;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QI;""
41 Sevilla;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
41 Sevilla;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QIII;11.153
41 Sevilla;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QII;""
41 Sevilla;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QI;""
41 Sevilla;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
41 Sevilla;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QIII;11.081
41 Sevilla;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QII;""
41 Sevilla;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QI;""
41 Sevilla;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
41 Sevilla;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
41 Sevilla;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QII;""
41 Sevilla;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QI;""
41 Sevilla;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
41 Sevilla;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
41 Sevilla;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
41 Sevilla;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
41 Sevilla;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
41 Sevilla;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
41 Sevilla;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
41 Sevilla;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
41 Sevilla;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
41 Sevilla;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
41 Sevilla;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
41 Sevilla;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
41 Sevilla;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;95,97
41 Sevilla;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
41 Sevilla;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
41 Sevilla;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
41 Sevilla;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;96,74
41 Sevilla;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
41 Sevilla;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
41 Sevilla;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
41 Sevilla;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;96,85
41 Sevilla;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
41 Sevilla;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
41 Sevilla;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
41 Sevilla;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
41 Sevilla;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
41 Sevilla;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
41 Sevilla;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;93,96
41 Sevilla;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
41 Sevilla;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
41 Sevilla;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
41 Sevilla;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;94,79
41 Sevilla;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
41 Sevilla;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
41 Sevilla;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
41 Sevilla;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
41 Sevilla;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
41 Sevilla;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
41 Sevilla;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;90,32
41 Sevilla;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
41 Sevilla;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
41 Sevilla;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
41 Sevilla;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;92,36
41 Sevilla;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
41 Sevilla;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
41 Sevilla;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
41 Sevilla;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
41 Sevilla;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
41 Sevilla;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
41 Sevilla;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;87,53
41 Sevilla;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
41 Sevilla;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
41 Sevilla;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
41 Sevilla;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;90,09
41 Sevilla;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
41 Sevilla;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
41 Sevilla;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
41 Sevilla;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
41 Sevilla;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
41 Sevilla;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
41 Sevilla;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
41 Sevilla;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
41 Sevilla;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
41 Sevilla;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QI;29.662
41 Sevilla;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
41 Sevilla;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
41 Sevilla;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
41 Sevilla;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QI;28.151
41 Sevilla;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
41 Sevilla;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
41 Sevilla;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
41 Sevilla;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QI;28.322
41 Sevilla;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
41 Sevilla;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
41 Sevilla;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2022QII;""
41 Sevilla;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2022QI;29.003
41 Sevilla;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
41 Sevilla;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
41 Sevilla;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2021QII;""
41 Sevilla;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2021QI;27.630
41 Sevilla;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
41 Sevilla;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
41 Sevilla;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2020QII;""
41 Sevilla;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2020QI;26.937
41 Sevilla;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
41 Sevilla;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
41 Sevilla;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2022QII;28.312
41 Sevilla;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2022QI;""
41 Sevilla;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
41 Sevilla;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
41 Sevilla;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2021QII;27.055
41 Sevilla;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2021QI;""
41 Sevilla;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
41 Sevilla;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
41 Sevilla;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2020QII;26.570
41 Sevilla;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2020QI;""
41 Sevilla;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
41 Sevilla;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QIII;27.761
41 Sevilla;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QII;""
41 Sevilla;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QI;""
41 Sevilla;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
41 Sevilla;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QIII;26.593
41 Sevilla;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QII;""
41 Sevilla;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QI;""
41 Sevilla;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
41 Sevilla;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QIII;26.159
41 Sevilla;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QII;""
41 Sevilla;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QI;""
41 Sevilla;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QIV;27.091
41 Sevilla;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
41 Sevilla;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QII;""
41 Sevilla;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QI;""
41 Sevilla;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QIV;26.125
41 Sevilla;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
41 Sevilla;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QII;""
41 Sevilla;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QI;""
41 Sevilla;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QIV;25.696
41 Sevilla;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
41 Sevilla;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QII;""
41 Sevilla;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QI;""
41 Sevilla;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
41 Sevilla;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
41 Sevilla;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
41 Sevilla;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
41 Sevilla;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
41 Sevilla;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
41 Sevilla;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
41 Sevilla;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
41 Sevilla;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
41 Sevilla;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
41 Sevilla;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
41 Sevilla;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
41 Sevilla;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
41 Sevilla;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
41 Sevilla;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
41 Sevilla;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;97,78
41 Sevilla;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
41 Sevilla;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
41 Sevilla;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
41 Sevilla;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;98,15
41 Sevilla;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
41 Sevilla;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
41 Sevilla;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
41 Sevilla;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;95,11
41 Sevilla;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
41 Sevilla;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
41 Sevilla;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;95,45
41 Sevilla;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
41 Sevilla;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
41 Sevilla;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
41 Sevilla;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;96,11
41 Sevilla;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
41 Sevilla;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
41 Sevilla;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
41 Sevilla;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;93,81
41 Sevilla;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
41 Sevilla;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
41 Sevilla;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;93,59
41 Sevilla;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
41 Sevilla;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
41 Sevilla;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
41 Sevilla;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;94,47
41 Sevilla;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
41 Sevilla;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
41 Sevilla;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
41 Sevilla;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;92,36
41 Sevilla;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
41 Sevilla;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
41 Sevilla;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;91,33
41 Sevilla;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
41 Sevilla;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
41 Sevilla;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
41 Sevilla;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;92,8
41 Sevilla;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
41 Sevilla;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
41 Sevilla;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
41 Sevilla;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;90,73
41 Sevilla;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
41 Sevilla;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
41 Sevilla;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
41 Sevilla;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
41 Sevilla;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
41 Sevilla;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
41 Sevilla;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QI;19.909
41 Sevilla;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
41 Sevilla;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
41 Sevilla;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
41 Sevilla;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QI;19.076
41 Sevilla;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
41 Sevilla;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
41 Sevilla;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
41 Sevilla;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QI;19.192
41 Sevilla;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
41 Sevilla;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
41 Sevilla;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2022QII;""
41 Sevilla;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2022QI;19.544
41 Sevilla;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
41 Sevilla;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
41 Sevilla;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2021QII;""
41 Sevilla;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2021QI;18.748
41 Sevilla;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
41 Sevilla;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
41 Sevilla;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2020QII;""
41 Sevilla;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2020QI;18.338
41 Sevilla;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
41 Sevilla;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
41 Sevilla;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2022QII;19.147
41 Sevilla;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2022QI;""
41 Sevilla;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
41 Sevilla;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
41 Sevilla;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2021QII;18.406
41 Sevilla;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2021QI;""
41 Sevilla;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
41 Sevilla;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
41 Sevilla;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2020QII;18.106
41 Sevilla;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2020QI;""
41 Sevilla;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
41 Sevilla;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QIII;18.813
41 Sevilla;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QII;""
41 Sevilla;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QI;""
41 Sevilla;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
41 Sevilla;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QIII;18.110
41 Sevilla;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QII;""
41 Sevilla;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QI;""
41 Sevilla;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
41 Sevilla;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QIII;17.859
41 Sevilla;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QII;""
41 Sevilla;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QI;""
41 Sevilla;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QIV;18.396
41 Sevilla;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
41 Sevilla;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QII;""
41 Sevilla;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QI;""
41 Sevilla;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QIV;17.814
41 Sevilla;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
41 Sevilla;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QII;""
41 Sevilla;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QI;""
41 Sevilla;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QIV;17.594
41 Sevilla;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
41 Sevilla;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QII;""
41 Sevilla;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QI;""
41 Sevilla;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
41 Sevilla;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
41 Sevilla;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
41 Sevilla;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
41 Sevilla;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
41 Sevilla;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
41 Sevilla;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
41 Sevilla;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
41 Sevilla;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
41 Sevilla;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
41 Sevilla;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
41 Sevilla;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
41 Sevilla;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
41 Sevilla;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
41 Sevilla;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
41 Sevilla;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;98,17
41 Sevilla;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
41 Sevilla;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
41 Sevilla;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
41 Sevilla;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;98,28
41 Sevilla;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
41 Sevilla;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
41 Sevilla;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
41 Sevilla;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;95,55
41 Sevilla;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
41 Sevilla;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
41 Sevilla;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;96,17
41 Sevilla;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
41 Sevilla;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
41 Sevilla;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
41 Sevilla;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;96,49
41 Sevilla;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
41 Sevilla;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
41 Sevilla;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
41 Sevilla;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;94,34
41 Sevilla;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
41 Sevilla;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
41 Sevilla;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;94,49
41 Sevilla;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
41 Sevilla;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
41 Sevilla;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
41 Sevilla;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;94,94
41 Sevilla;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
41 Sevilla;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
41 Sevilla;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
41 Sevilla;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;93,05
41 Sevilla;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
41 Sevilla;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
41 Sevilla;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;92,4
41 Sevilla;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
41 Sevilla;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
41 Sevilla;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
41 Sevilla;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;93,38
41 Sevilla;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
41 Sevilla;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
41 Sevilla;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
41 Sevilla;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;91,67
41 Sevilla;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
41 Sevilla;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
41 Sevilla;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
41 Sevilla;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
41 Sevilla;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
41 Sevilla;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
41 Sevilla;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QI;9.753
41 Sevilla;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
41 Sevilla;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
41 Sevilla;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
41 Sevilla;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QI;9.075
41 Sevilla;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
41 Sevilla;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
41 Sevilla;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
41 Sevilla;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QI;9.130
41 Sevilla;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
41 Sevilla;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
41 Sevilla;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2022QII;""
41 Sevilla;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2022QI;9.459
41 Sevilla;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
41 Sevilla;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
41 Sevilla;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2021QII;""
41 Sevilla;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2021QI;8.882
41 Sevilla;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
41 Sevilla;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
41 Sevilla;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2020QII;""
41 Sevilla;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2020QI;8.599
41 Sevilla;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
41 Sevilla;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
41 Sevilla;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2022QII;9.165
41 Sevilla;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2022QI;""
41 Sevilla;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
41 Sevilla;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
41 Sevilla;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2021QII;8.649
41 Sevilla;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2021QI;""
41 Sevilla;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
41 Sevilla;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
41 Sevilla;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2020QII;8.464
41 Sevilla;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2020QI;""
41 Sevilla;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
41 Sevilla;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QIII;8.948
41 Sevilla;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QII;""
41 Sevilla;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QI;""
41 Sevilla;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
41 Sevilla;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QIII;8.483
41 Sevilla;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QII;""
41 Sevilla;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QI;""
41 Sevilla;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
41 Sevilla;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QIII;8.300
41 Sevilla;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QII;""
41 Sevilla;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QI;""
41 Sevilla;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QIV;8.695
41 Sevilla;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
41 Sevilla;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QII;""
41 Sevilla;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QI;""
41 Sevilla;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QIV;8.311
41 Sevilla;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
41 Sevilla;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QII;""
41 Sevilla;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QI;""
41 Sevilla;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QIV;8.102
41 Sevilla;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
41 Sevilla;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QII;""
41 Sevilla;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QI;""
41 Sevilla;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
41 Sevilla;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
41 Sevilla;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
41 Sevilla;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
41 Sevilla;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
41 Sevilla;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
41 Sevilla;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
41 Sevilla;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
41 Sevilla;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
41 Sevilla;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
41 Sevilla;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
41 Sevilla;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
41 Sevilla;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
41 Sevilla;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
41 Sevilla;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
41 Sevilla;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;96,99
41 Sevilla;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
41 Sevilla;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
41 Sevilla;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
41 Sevilla;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;97,87
41 Sevilla;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
41 Sevilla;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
41 Sevilla;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
41 Sevilla;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;94,18
41 Sevilla;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
41 Sevilla;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
41 Sevilla;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;93,97
41 Sevilla;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
41 Sevilla;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
41 Sevilla;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
41 Sevilla;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;95,31
41 Sevilla;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
41 Sevilla;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
41 Sevilla;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
41 Sevilla;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;92,71
41 Sevilla;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
41 Sevilla;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
41 Sevilla;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;91,75
41 Sevilla;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
41 Sevilla;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
41 Sevilla;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
41 Sevilla;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;93,48
41 Sevilla;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
41 Sevilla;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
41 Sevilla;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
41 Sevilla;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;90,91
41 Sevilla;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
41 Sevilla;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
41 Sevilla;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;89,15
41 Sevilla;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
41 Sevilla;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
41 Sevilla;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
41 Sevilla;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;91,58
41 Sevilla;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
41 Sevilla;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
41 Sevilla;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
41 Sevilla;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;88,74
41 Sevilla;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
41 Sevilla;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
41 Sevilla;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
41 Sevilla;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
41 Sevilla;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
41 Sevilla;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QII;31.172
41 Sevilla;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
41 Sevilla;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
41 Sevilla;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
41 Sevilla;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QII;29.766
41 Sevilla;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
41 Sevilla;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
41 Sevilla;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
41 Sevilla;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QII;27.833
41 Sevilla;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
41 Sevilla;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
41 Sevilla;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
41 Sevilla;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2022QII;30.352
41 Sevilla;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2022QI;""
41 Sevilla;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
41 Sevilla;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
41 Sevilla;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2021QII;29.086
41 Sevilla;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2021QI;""
41 Sevilla;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
41 Sevilla;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
41 Sevilla;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2020QII;27.397
41 Sevilla;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2020QI;""
41 Sevilla;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
41 Sevilla;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2022QIII;29.720
41 Sevilla;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2022QII;""
41 Sevilla;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2022QI;""
41 Sevilla;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
41 Sevilla;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2021QIII;28.555
41 Sevilla;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2021QII;""
41 Sevilla;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2021QI;""
41 Sevilla;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
41 Sevilla;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2020QIII;26.905
41 Sevilla;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2020QII;""
41 Sevilla;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2020QI;""
41 Sevilla;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QIV;29.006
41 Sevilla;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
41 Sevilla;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QII;""
41 Sevilla;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QI;""
41 Sevilla;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QIV;28.011
41 Sevilla;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
41 Sevilla;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QII;""
41 Sevilla;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QI;""
41 Sevilla;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QIV;26.400
41 Sevilla;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
41 Sevilla;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QII;""
41 Sevilla;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QI;""
41 Sevilla;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
41 Sevilla;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
41 Sevilla;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QII;""
41 Sevilla;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QI;27.490
41 Sevilla;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
41 Sevilla;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
41 Sevilla;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QII;""
41 Sevilla;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QI;25.996
41 Sevilla;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
41 Sevilla;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
41 Sevilla;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QII;""
41 Sevilla;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QI;""
41 Sevilla;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
41 Sevilla;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
41 Sevilla;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
41 Sevilla;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
41 Sevilla;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
41 Sevilla;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
41 Sevilla;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
41 Sevilla;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
41 Sevilla;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
41 Sevilla;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
41 Sevilla;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
41 Sevilla;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
41 Sevilla;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
41 Sevilla;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
41 Sevilla;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;97,37
41 Sevilla;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
41 Sevilla;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
41 Sevilla;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
41 Sevilla;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;97,72
41 Sevilla;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
41 Sevilla;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
41 Sevilla;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
41 Sevilla;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;98,43
41 Sevilla;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
41 Sevilla;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
41 Sevilla;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;95,34
41 Sevilla;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
41 Sevilla;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
41 Sevilla;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
41 Sevilla;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;95,93
41 Sevilla;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
41 Sevilla;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
41 Sevilla;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
41 Sevilla;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;96,67
41 Sevilla;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
41 Sevilla;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
41 Sevilla;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;93,05
41 Sevilla;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
41 Sevilla;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
41 Sevilla;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
41 Sevilla;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;94,1
41 Sevilla;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
41 Sevilla;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
41 Sevilla;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
41 Sevilla;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;94,85
41 Sevilla;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
41 Sevilla;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
41 Sevilla;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
41 Sevilla;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
41 Sevilla;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
41 Sevilla;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
41 Sevilla;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;92,35
41 Sevilla;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
41 Sevilla;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
41 Sevilla;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
41 Sevilla;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;93,4
41 Sevilla;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
41 Sevilla;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
41 Sevilla;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
41 Sevilla;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
41 Sevilla;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
41 Sevilla;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
41 Sevilla;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QII;20.765
41 Sevilla;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
41 Sevilla;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
41 Sevilla;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
41 Sevilla;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QII;20.089
41 Sevilla;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
41 Sevilla;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
41 Sevilla;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
41 Sevilla;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QII;18.864
41 Sevilla;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
41 Sevilla;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
41 Sevilla;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
41 Sevilla;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2022QII;20.305
41 Sevilla;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2022QI;""
41 Sevilla;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
41 Sevilla;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
41 Sevilla;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2021QII;19.671
41 Sevilla;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2021QI;""
41 Sevilla;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
41 Sevilla;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
41 Sevilla;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2020QII;18.603
41 Sevilla;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2020QI;""
41 Sevilla;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
41 Sevilla;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2022QIII;19.924
41 Sevilla;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2022QII;""
41 Sevilla;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2022QI;""
41 Sevilla;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
41 Sevilla;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2021QIII;19.331
41 Sevilla;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2021QII;""
41 Sevilla;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2021QI;""
41 Sevilla;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
41 Sevilla;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2020QIII;18.311
41 Sevilla;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2020QII;""
41 Sevilla;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2020QI;""
41 Sevilla;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QIV;19.479
41 Sevilla;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
41 Sevilla;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QII;""
41 Sevilla;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QI;""
41 Sevilla;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QIV;18.984
41 Sevilla;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
41 Sevilla;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QII;""
41 Sevilla;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QI;""
41 Sevilla;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QIV;18.017
41 Sevilla;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
41 Sevilla;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QII;""
41 Sevilla;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QI;""
41 Sevilla;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
41 Sevilla;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
41 Sevilla;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QII;""
41 Sevilla;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QI;18.705
41 Sevilla;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
41 Sevilla;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
41 Sevilla;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QII;""
41 Sevilla;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QI;17.756
41 Sevilla;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
41 Sevilla;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
41 Sevilla;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QII;""
41 Sevilla;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QI;""
41 Sevilla;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
41 Sevilla;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
41 Sevilla;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
41 Sevilla;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
41 Sevilla;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
41 Sevilla;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
41 Sevilla;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
41 Sevilla;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
41 Sevilla;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
41 Sevilla;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
41 Sevilla;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
41 Sevilla;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
41 Sevilla;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
41 Sevilla;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
41 Sevilla;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;97,78
41 Sevilla;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
41 Sevilla;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
41 Sevilla;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
41 Sevilla;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;97,92
41 Sevilla;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
41 Sevilla;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
41 Sevilla;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
41 Sevilla;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;98,62
41 Sevilla;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
41 Sevilla;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
41 Sevilla;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;95,95
41 Sevilla;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
41 Sevilla;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
41 Sevilla;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
41 Sevilla;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;96,23
41 Sevilla;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
41 Sevilla;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
41 Sevilla;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
41 Sevilla;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;97,07
41 Sevilla;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
41 Sevilla;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
41 Sevilla;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;93,81
41 Sevilla;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
41 Sevilla;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
41 Sevilla;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
41 Sevilla;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;94,5
41 Sevilla;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
41 Sevilla;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
41 Sevilla;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
41 Sevilla;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;95,51
41 Sevilla;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
41 Sevilla;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
41 Sevilla;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
41 Sevilla;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
41 Sevilla;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
41 Sevilla;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
41 Sevilla;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;93,11
41 Sevilla;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
41 Sevilla;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
41 Sevilla;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
41 Sevilla;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;94,13
41 Sevilla;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
41 Sevilla;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
41 Sevilla;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
41 Sevilla;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
41 Sevilla;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
41 Sevilla;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
41 Sevilla;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QII;10.407
41 Sevilla;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
41 Sevilla;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
41 Sevilla;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
41 Sevilla;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QII;9.677
41 Sevilla;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
41 Sevilla;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
41 Sevilla;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
41 Sevilla;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QII;8.969
41 Sevilla;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
41 Sevilla;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
41 Sevilla;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
41 Sevilla;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2022QII;10.047
41 Sevilla;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2022QI;""
41 Sevilla;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
41 Sevilla;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
41 Sevilla;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2021QII;9.415
41 Sevilla;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2021QI;""
41 Sevilla;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
41 Sevilla;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
41 Sevilla;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2020QII;8.794
41 Sevilla;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2020QI;""
41 Sevilla;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
41 Sevilla;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2022QIII;9.796
41 Sevilla;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2022QII;""
41 Sevilla;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2022QI;""
41 Sevilla;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
41 Sevilla;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2021QIII;9.224
41 Sevilla;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2021QII;""
41 Sevilla;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2021QI;""
41 Sevilla;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
41 Sevilla;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2020QIII;8.594
41 Sevilla;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2020QII;""
41 Sevilla;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2020QI;""
41 Sevilla;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QIV;9.527
41 Sevilla;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
41 Sevilla;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QII;""
41 Sevilla;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QI;""
41 Sevilla;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QIV;9.027
41 Sevilla;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
41 Sevilla;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QII;""
41 Sevilla;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QI;""
41 Sevilla;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QIV;8.383
41 Sevilla;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
41 Sevilla;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QII;""
41 Sevilla;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QI;""
41 Sevilla;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
41 Sevilla;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
41 Sevilla;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QII;""
41 Sevilla;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QI;8.785
41 Sevilla;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
41 Sevilla;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
41 Sevilla;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QII;""
41 Sevilla;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QI;8.240
41 Sevilla;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
41 Sevilla;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
41 Sevilla;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QII;""
41 Sevilla;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QI;""
41 Sevilla;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
41 Sevilla;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
41 Sevilla;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
41 Sevilla;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
41 Sevilla;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
41 Sevilla;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
41 Sevilla;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
41 Sevilla;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
41 Sevilla;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
41 Sevilla;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
41 Sevilla;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
41 Sevilla;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
41 Sevilla;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
41 Sevilla;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
41 Sevilla;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;96,54
41 Sevilla;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
41 Sevilla;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
41 Sevilla;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
41 Sevilla;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;97,29
41 Sevilla;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
41 Sevilla;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
41 Sevilla;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
41 Sevilla;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;98,05
41 Sevilla;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
41 Sevilla;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
41 Sevilla;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;94,13
41 Sevilla;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
41 Sevilla;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
41 Sevilla;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
41 Sevilla;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;95,32
41 Sevilla;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
41 Sevilla;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
41 Sevilla;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
41 Sevilla;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;95,82
41 Sevilla;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
41 Sevilla;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
41 Sevilla;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;91,54
41 Sevilla;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
41 Sevilla;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
41 Sevilla;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
41 Sevilla;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;93,28
41 Sevilla;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
41 Sevilla;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
41 Sevilla;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
41 Sevilla;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;93,47
41 Sevilla;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
41 Sevilla;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
41 Sevilla;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
41 Sevilla;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
41 Sevilla;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
41 Sevilla;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
41 Sevilla;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;90,78
41 Sevilla;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
41 Sevilla;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
41 Sevilla;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
41 Sevilla;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;91,87
41 Sevilla;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
41 Sevilla;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
41 Sevilla;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
41 Sevilla;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
41 Sevilla;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
41 Sevilla;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QIII;30.994
41 Sevilla;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
41 Sevilla;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
41 Sevilla;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
41 Sevilla;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QIII;29.785
41 Sevilla;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
41 Sevilla;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
41 Sevilla;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
41 Sevilla;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QIII;28.087
41 Sevilla;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
41 Sevilla;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
41 Sevilla;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
41 Sevilla;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2022QIII;30.262
41 Sevilla;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2022QII;""
41 Sevilla;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2022QI;""
41 Sevilla;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
41 Sevilla;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2021QIII;29.185
41 Sevilla;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2021QII;""
41 Sevilla;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2021QI;""
41 Sevilla;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
41 Sevilla;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2020QIII;27.519
41 Sevilla;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2020QII;""
41 Sevilla;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2020QI;""
41 Sevilla;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2022QIV;29.481
41 Sevilla;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
41 Sevilla;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2022QII;""
41 Sevilla;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2022QI;""
41 Sevilla;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2021QIV;28.583
41 Sevilla;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
41 Sevilla;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2021QII;""
41 Sevilla;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2021QI;""
41 Sevilla;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2020QIV;26.975
41 Sevilla;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
41 Sevilla;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2020QII;""
41 Sevilla;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2020QI;""
41 Sevilla;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
41 Sevilla;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
41 Sevilla;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QII;""
41 Sevilla;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QI;28.024
41 Sevilla;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
41 Sevilla;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
41 Sevilla;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QII;""
41 Sevilla;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QI;26.546
41 Sevilla;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
41 Sevilla;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
41 Sevilla;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QII;""
41 Sevilla;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QI;""
41 Sevilla;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
41 Sevilla;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
41 Sevilla;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QII;27.427
41 Sevilla;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QI;""
41 Sevilla;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
41 Sevilla;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
41 Sevilla;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QII;26.065
41 Sevilla;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QI;""
41 Sevilla;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
41 Sevilla;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
41 Sevilla;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QII;""
41 Sevilla;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QI;""
41 Sevilla;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
41 Sevilla;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
41 Sevilla;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
41 Sevilla;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
41 Sevilla;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
41 Sevilla;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
41 Sevilla;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
41 Sevilla;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
41 Sevilla;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
41 Sevilla;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
41 Sevilla;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
41 Sevilla;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
41 Sevilla;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
41 Sevilla;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;97,64
41 Sevilla;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
41 Sevilla;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
41 Sevilla;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
41 Sevilla;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;97,99
41 Sevilla;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
41 Sevilla;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
41 Sevilla;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
41 Sevilla;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;97,98
41 Sevilla;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
41 Sevilla;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
41 Sevilla;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;95,12
41 Sevilla;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
41 Sevilla;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
41 Sevilla;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
41 Sevilla;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;95,96
41 Sevilla;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
41 Sevilla;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
41 Sevilla;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
41 Sevilla;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;96,04
41 Sevilla;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
41 Sevilla;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
41 Sevilla;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
41 Sevilla;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
41 Sevilla;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
41 Sevilla;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
41 Sevilla;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;94,09
41 Sevilla;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
41 Sevilla;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
41 Sevilla;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
41 Sevilla;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;94,51
41 Sevilla;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
41 Sevilla;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
41 Sevilla;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
41 Sevilla;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
41 Sevilla;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
41 Sevilla;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
41 Sevilla;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;92,08
41 Sevilla;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
41 Sevilla;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
41 Sevilla;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
41 Sevilla;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;92,8
41 Sevilla;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
41 Sevilla;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
41 Sevilla;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
41 Sevilla;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
41 Sevilla;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
41 Sevilla;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
41 Sevilla;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QIII;20.701
41 Sevilla;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
41 Sevilla;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
41 Sevilla;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
41 Sevilla;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QIII;20.092
41 Sevilla;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
41 Sevilla;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
41 Sevilla;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
41 Sevilla;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QIII;19.075
41 Sevilla;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
41 Sevilla;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
41 Sevilla;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
41 Sevilla;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2022QIII;20.252
41 Sevilla;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2022QII;""
41 Sevilla;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2022QI;""
41 Sevilla;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
41 Sevilla;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2021QIII;19.705
41 Sevilla;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2021QII;""
41 Sevilla;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2021QI;""
41 Sevilla;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
41 Sevilla;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2020QIII;18.728
41 Sevilla;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2020QII;""
41 Sevilla;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2020QI;""
41 Sevilla;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2022QIV;19.762
41 Sevilla;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
41 Sevilla;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2022QII;""
41 Sevilla;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2022QI;""
41 Sevilla;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2021QIV;19.321
41 Sevilla;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
41 Sevilla;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2021QII;""
41 Sevilla;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2021QI;""
41 Sevilla;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2020QIV;18.409
41 Sevilla;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
41 Sevilla;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2020QII;""
41 Sevilla;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2020QI;""
41 Sevilla;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
41 Sevilla;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
41 Sevilla;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QII;""
41 Sevilla;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QI;19.021
41 Sevilla;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
41 Sevilla;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
41 Sevilla;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QII;""
41 Sevilla;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QI;18.131
41 Sevilla;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
41 Sevilla;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
41 Sevilla;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QII;""
41 Sevilla;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QI;""
41 Sevilla;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
41 Sevilla;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
41 Sevilla;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QII;18.674
41 Sevilla;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QI;""
41 Sevilla;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
41 Sevilla;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
41 Sevilla;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QII;17.834
41 Sevilla;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QI;""
41 Sevilla;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
41 Sevilla;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
41 Sevilla;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QII;""
41 Sevilla;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QI;""
41 Sevilla;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
41 Sevilla;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
41 Sevilla;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
41 Sevilla;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
41 Sevilla;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
41 Sevilla;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
41 Sevilla;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
41 Sevilla;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
41 Sevilla;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
41 Sevilla;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
41 Sevilla;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
41 Sevilla;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
41 Sevilla;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
41 Sevilla;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;97,83
41 Sevilla;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
41 Sevilla;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
41 Sevilla;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
41 Sevilla;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;98,07
41 Sevilla;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
41 Sevilla;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
41 Sevilla;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
41 Sevilla;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;98,18
41 Sevilla;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
41 Sevilla;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
41 Sevilla;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;95,46
41 Sevilla;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
41 Sevilla;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
41 Sevilla;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
41 Sevilla;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;96,16
41 Sevilla;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
41 Sevilla;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
41 Sevilla;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
41 Sevilla;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;96,51
41 Sevilla;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
41 Sevilla;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
41 Sevilla;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
41 Sevilla;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
41 Sevilla;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
41 Sevilla;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
41 Sevilla;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;94,67
41 Sevilla;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
41 Sevilla;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
41 Sevilla;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
41 Sevilla;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;95,05
41 Sevilla;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
41 Sevilla;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
41 Sevilla;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
41 Sevilla;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
41 Sevilla;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
41 Sevilla;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
41 Sevilla;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;92,94
41 Sevilla;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
41 Sevilla;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
41 Sevilla;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
41 Sevilla;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;93,49
41 Sevilla;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
41 Sevilla;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
41 Sevilla;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
41 Sevilla;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
41 Sevilla;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
41 Sevilla;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
41 Sevilla;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QIII;10.293
41 Sevilla;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
41 Sevilla;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
41 Sevilla;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
41 Sevilla;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QIII;9.693
41 Sevilla;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
41 Sevilla;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
41 Sevilla;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
41 Sevilla;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QIII;9.012
41 Sevilla;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
41 Sevilla;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
41 Sevilla;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
41 Sevilla;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2022QIII;10.010
41 Sevilla;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2022QII;""
41 Sevilla;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2022QI;""
41 Sevilla;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
41 Sevilla;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2021QIII;9.480
41 Sevilla;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2021QII;""
41 Sevilla;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2021QI;""
41 Sevilla;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
41 Sevilla;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2020QIII;8.791
41 Sevilla;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2020QII;""
41 Sevilla;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2020QI;""
41 Sevilla;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2022QIV;9.719
41 Sevilla;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
41 Sevilla;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2022QII;""
41 Sevilla;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2022QI;""
41 Sevilla;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2021QIV;9.262
41 Sevilla;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
41 Sevilla;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2021QII;""
41 Sevilla;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2021QI;""
41 Sevilla;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2020QIV;8.566
41 Sevilla;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
41 Sevilla;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2020QII;""
41 Sevilla;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2020QI;""
41 Sevilla;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
41 Sevilla;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
41 Sevilla;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QII;""
41 Sevilla;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QI;9.003
41 Sevilla;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
41 Sevilla;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
41 Sevilla;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QII;""
41 Sevilla;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QI;8.415
41 Sevilla;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
41 Sevilla;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
41 Sevilla;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QII;""
41 Sevilla;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QI;""
41 Sevilla;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
41 Sevilla;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
41 Sevilla;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QII;8.753
41 Sevilla;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QI;""
41 Sevilla;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
41 Sevilla;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
41 Sevilla;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QII;8.231
41 Sevilla;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QI;""
41 Sevilla;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
41 Sevilla;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
41 Sevilla;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QII;""
41 Sevilla;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QI;""
41 Sevilla;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
41 Sevilla;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
41 Sevilla;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
41 Sevilla;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
41 Sevilla;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
41 Sevilla;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
41 Sevilla;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
41 Sevilla;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
41 Sevilla;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
41 Sevilla;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
41 Sevilla;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
41 Sevilla;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
41 Sevilla;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
41 Sevilla;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;97,25
41 Sevilla;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
41 Sevilla;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
41 Sevilla;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
41 Sevilla;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;97,8
41 Sevilla;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
41 Sevilla;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
41 Sevilla;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
41 Sevilla;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;97,55
41 Sevilla;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
41 Sevilla;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
41 Sevilla;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;94,42
41 Sevilla;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
41 Sevilla;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
41 Sevilla;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
41 Sevilla;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;95,55
41 Sevilla;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
41 Sevilla;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
41 Sevilla;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
41 Sevilla;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;95,05
41 Sevilla;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
41 Sevilla;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
41 Sevilla;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
41 Sevilla;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
41 Sevilla;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
41 Sevilla;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
41 Sevilla;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;92,88
41 Sevilla;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
41 Sevilla;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
41 Sevilla;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
41 Sevilla;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;93,38
41 Sevilla;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
41 Sevilla;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
41 Sevilla;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
41 Sevilla;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
41 Sevilla;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
41 Sevilla;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
41 Sevilla;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;90,3
41 Sevilla;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
41 Sevilla;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
41 Sevilla;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
41 Sevilla;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;91,33
41 Sevilla;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
41 Sevilla;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
41 Sevilla;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
41 Sevilla;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
41 Sevilla;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
41 Sevilla;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QIV;30.854
41 Sevilla;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
41 Sevilla;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
41 Sevilla;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
41 Sevilla;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QIV;29.732
41 Sevilla;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
41 Sevilla;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
41 Sevilla;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
41 Sevilla;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QIV;28.119
41 Sevilla;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
41 Sevilla;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
41 Sevilla;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
41 Sevilla;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2022QIV;29.998
41 Sevilla;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
41 Sevilla;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2022QII;""
41 Sevilla;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2022QI;""
41 Sevilla;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2021QIV;29.058
41 Sevilla;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
41 Sevilla;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2021QII;""
41 Sevilla;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2021QI;""
41 Sevilla;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2020QIV;27.508
41 Sevilla;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
41 Sevilla;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2020QII;""
41 Sevilla;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2020QI;""
41 Sevilla;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
41 Sevilla;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
41 Sevilla;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2022QII;""
41 Sevilla;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2022QI;28.457
41 Sevilla;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
41 Sevilla;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
41 Sevilla;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2021QII;""
41 Sevilla;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2021QI;27.049
41 Sevilla;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
41 Sevilla;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
41 Sevilla;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2020QII;""
41 Sevilla;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2020QI;""
41 Sevilla;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
41 Sevilla;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
41 Sevilla;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QII;27.830
41 Sevilla;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QI;""
41 Sevilla;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
41 Sevilla;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
41 Sevilla;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QII;26.529
41 Sevilla;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QI;""
41 Sevilla;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
41 Sevilla;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
41 Sevilla;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QII;""
41 Sevilla;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QI;""
41 Sevilla;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
41 Sevilla;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QIII;27.302
41 Sevilla;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QII;""
41 Sevilla;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QI;""
41 Sevilla;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
41 Sevilla;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QIII;26.089
41 Sevilla;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QII;""
41 Sevilla;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QI;""
41 Sevilla;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
41 Sevilla;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
41 Sevilla;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QII;""
41 Sevilla;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QI;""
41 Sevilla;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
41 Sevilla;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
41 Sevilla;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
41 Sevilla;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
41 Sevilla;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
41 Sevilla;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
41 Sevilla;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
41 Sevilla;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
41 Sevilla;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
41 Sevilla;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
41 Sevilla;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
41 Sevilla;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
41 Sevilla;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;97,23
41 Sevilla;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
41 Sevilla;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
41 Sevilla;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
41 Sevilla;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;97,73
41 Sevilla;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
41 Sevilla;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
41 Sevilla;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
41 Sevilla;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;97,83
41 Sevilla;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
41 Sevilla;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
41 Sevilla;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
41 Sevilla;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
41 Sevilla;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
41 Sevilla;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
41 Sevilla;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;95,71
41 Sevilla;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
41 Sevilla;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
41 Sevilla;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
41 Sevilla;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;96,19
41 Sevilla;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
41 Sevilla;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
41 Sevilla;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
41 Sevilla;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
41 Sevilla;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
41 Sevilla;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
41 Sevilla;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;93,6
41 Sevilla;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
41 Sevilla;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
41 Sevilla;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
41 Sevilla;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;94,35
41 Sevilla;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
41 Sevilla;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
41 Sevilla;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
41 Sevilla;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
41 Sevilla;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
41 Sevilla;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
41 Sevilla;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;91,83
41 Sevilla;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
41 Sevilla;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
41 Sevilla;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
41 Sevilla;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;92,78
41 Sevilla;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
41 Sevilla;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
41 Sevilla;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
41 Sevilla;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
41 Sevilla;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
41 Sevilla;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
41 Sevilla;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QIV;20.559
41 Sevilla;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
41 Sevilla;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
41 Sevilla;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
41 Sevilla;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QIV;19.994
41 Sevilla;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
41 Sevilla;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
41 Sevilla;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
41 Sevilla;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QIV;19.062
41 Sevilla;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
41 Sevilla;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
41 Sevilla;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
41 Sevilla;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2022QIV;20.024
41 Sevilla;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
41 Sevilla;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2022QII;""
41 Sevilla;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2022QI;""
41 Sevilla;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2021QIV;19.574
41 Sevilla;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
41 Sevilla;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2021QII;""
41 Sevilla;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2021QI;""
41 Sevilla;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2020QIV;18.703
41 Sevilla;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
41 Sevilla;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2020QII;""
41 Sevilla;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2020QI;""
41 Sevilla;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
41 Sevilla;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
41 Sevilla;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2022QII;""
41 Sevilla;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2022QI;19.249
41 Sevilla;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
41 Sevilla;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
41 Sevilla;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2021QII;""
41 Sevilla;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2021QI;18.413
41 Sevilla;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
41 Sevilla;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
41 Sevilla;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2020QII;""
41 Sevilla;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2020QI;""
41 Sevilla;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
41 Sevilla;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
41 Sevilla;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QII;18.890
41 Sevilla;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QI;""
41 Sevilla;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
41 Sevilla;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
41 Sevilla;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QII;18.103
41 Sevilla;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QI;""
41 Sevilla;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
41 Sevilla;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
41 Sevilla;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QII;""
41 Sevilla;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QI;""
41 Sevilla;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
41 Sevilla;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QIII;18.571
41 Sevilla;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QII;""
41 Sevilla;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QI;""
41 Sevilla;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
41 Sevilla;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QIII;17.816
41 Sevilla;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QII;""
41 Sevilla;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QI;""
41 Sevilla;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
41 Sevilla;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
41 Sevilla;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QII;""
41 Sevilla;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QI;""
41 Sevilla;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
41 Sevilla;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
41 Sevilla;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
41 Sevilla;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
41 Sevilla;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
41 Sevilla;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
41 Sevilla;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
41 Sevilla;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
41 Sevilla;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
41 Sevilla;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
41 Sevilla;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
41 Sevilla;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
41 Sevilla;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;97,4
41 Sevilla;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
41 Sevilla;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
41 Sevilla;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
41 Sevilla;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;97,9
41 Sevilla;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
41 Sevilla;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
41 Sevilla;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
41 Sevilla;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;98,12
41 Sevilla;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
41 Sevilla;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
41 Sevilla;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
41 Sevilla;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
41 Sevilla;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
41 Sevilla;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
41 Sevilla;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;96,27
41 Sevilla;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
41 Sevilla;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
41 Sevilla;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
41 Sevilla;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;96,6
41 Sevilla;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
41 Sevilla;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
41 Sevilla;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
41 Sevilla;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
41 Sevilla;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
41 Sevilla;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
41 Sevilla;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;94,48
41 Sevilla;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
41 Sevilla;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
41 Sevilla;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
41 Sevilla;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;94,97
41 Sevilla;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
41 Sevilla;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
41 Sevilla;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
41 Sevilla;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
41 Sevilla;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
41 Sevilla;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
41 Sevilla;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;92,88
41 Sevilla;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
41 Sevilla;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
41 Sevilla;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
41 Sevilla;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;93,46
41 Sevilla;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
41 Sevilla;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
41 Sevilla;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
41 Sevilla;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
41 Sevilla;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
41 Sevilla;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
41 Sevilla;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QIV;10.295
41 Sevilla;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
41 Sevilla;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
41 Sevilla;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
41 Sevilla;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QIV;9.738
41 Sevilla;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
41 Sevilla;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
41 Sevilla;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
41 Sevilla;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QIV;9.057
41 Sevilla;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
41 Sevilla;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
41 Sevilla;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
41 Sevilla;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2022QIV;9.974
41 Sevilla;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
41 Sevilla;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2022QII;""
41 Sevilla;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2022QI;""
41 Sevilla;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2021QIV;9.484
41 Sevilla;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
41 Sevilla;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2021QII;""
41 Sevilla;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2021QI;""
41 Sevilla;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2020QIV;8.805
41 Sevilla;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
41 Sevilla;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2020QII;""
41 Sevilla;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2020QI;""
41 Sevilla;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
41 Sevilla;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
41 Sevilla;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2022QII;""
41 Sevilla;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2022QI;9.208
41 Sevilla;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
41 Sevilla;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
41 Sevilla;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2021QII;""
41 Sevilla;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2021QI;8.636
41 Sevilla;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
41 Sevilla;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
41 Sevilla;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2020QII;""
41 Sevilla;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2020QI;""
41 Sevilla;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
41 Sevilla;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
41 Sevilla;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QII;8.940
41 Sevilla;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QI;""
41 Sevilla;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
41 Sevilla;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
41 Sevilla;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QII;8.426
41 Sevilla;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QI;""
41 Sevilla;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
41 Sevilla;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
41 Sevilla;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QII;""
41 Sevilla;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QI;""
41 Sevilla;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
41 Sevilla;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QIII;8.731
41 Sevilla;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QII;""
41 Sevilla;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QI;""
41 Sevilla;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
41 Sevilla;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QIII;8.273
41 Sevilla;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QII;""
41 Sevilla;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QI;""
41 Sevilla;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
41 Sevilla;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
41 Sevilla;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QII;""
41 Sevilla;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QI;""
41 Sevilla;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
41 Sevilla;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
41 Sevilla;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
41 Sevilla;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
41 Sevilla;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
41 Sevilla;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
41 Sevilla;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
41 Sevilla;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
41 Sevilla;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
41 Sevilla;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
41 Sevilla;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
41 Sevilla;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
41 Sevilla;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;96,88
41 Sevilla;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
41 Sevilla;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
41 Sevilla;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
41 Sevilla;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;97,39
41 Sevilla;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
41 Sevilla;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
41 Sevilla;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
41 Sevilla;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;97,22
41 Sevilla;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
41 Sevilla;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
41 Sevilla;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
41 Sevilla;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
41 Sevilla;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
41 Sevilla;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
41 Sevilla;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;94,56
41 Sevilla;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
41 Sevilla;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
41 Sevilla;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
41 Sevilla;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;95,35
41 Sevilla;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
41 Sevilla;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
41 Sevilla;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
41 Sevilla;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
41 Sevilla;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
41 Sevilla;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
41 Sevilla;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;91,81
41 Sevilla;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
41 Sevilla;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
41 Sevilla;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
41 Sevilla;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;93,03
41 Sevilla;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
41 Sevilla;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
41 Sevilla;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
41 Sevilla;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
41 Sevilla;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
41 Sevilla;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
41 Sevilla;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;89,66
41 Sevilla;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
41 Sevilla;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
41 Sevilla;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
41 Sevilla;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;91,34
41 Sevilla;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
41 Sevilla;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
41 Sevilla;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
41 Sevilla;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
41 Sevilla;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
41 Sevilla;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
41 Sevilla;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
41 Sevilla;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
41 Sevilla;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
41 Sevilla;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QI;11.780
41 Sevilla;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
41 Sevilla;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
41 Sevilla;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
41 Sevilla;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QI;11.051
41 Sevilla;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
41 Sevilla;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
41 Sevilla;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
41 Sevilla;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QI;12.569
41 Sevilla;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
41 Sevilla;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
41 Sevilla;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2022QII;""
41 Sevilla;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2022QI;11.336
41 Sevilla;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
41 Sevilla;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
41 Sevilla;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2021QII;""
41 Sevilla;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2021QI;10.630
41 Sevilla;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
41 Sevilla;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
41 Sevilla;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2020QII;""
41 Sevilla;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2020QI;11.728
41 Sevilla;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
41 Sevilla;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
41 Sevilla;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2022QII;10.917
41 Sevilla;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2022QI;""
41 Sevilla;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
41 Sevilla;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
41 Sevilla;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2021QII;10.223
41 Sevilla;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2021QI;""
41 Sevilla;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
41 Sevilla;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
41 Sevilla;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2020QII;11.359
41 Sevilla;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2020QI;""
41 Sevilla;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
41 Sevilla;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QIII;10.492
41 Sevilla;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QII;""
41 Sevilla;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QI;""
41 Sevilla;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
41 Sevilla;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QIII;9.841
41 Sevilla;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QII;""
41 Sevilla;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QI;""
41 Sevilla;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
41 Sevilla;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QIII;10.925
41 Sevilla;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QII;""
41 Sevilla;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QI;""
41 Sevilla;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QIV;9.899
41 Sevilla;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
41 Sevilla;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QII;""
41 Sevilla;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QI;""
41 Sevilla;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QIV;9.378
41 Sevilla;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
41 Sevilla;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QII;""
41 Sevilla;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QI;""
41 Sevilla;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QIV;10.434
41 Sevilla;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
41 Sevilla;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QII;""
41 Sevilla;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QI;""
41 Sevilla;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
41 Sevilla;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
41 Sevilla;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
41 Sevilla;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
41 Sevilla;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
41 Sevilla;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
41 Sevilla;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
41 Sevilla;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
41 Sevilla;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
41 Sevilla;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
41 Sevilla;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
41 Sevilla;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
41 Sevilla;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
41 Sevilla;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
41 Sevilla;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
41 Sevilla;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;96,23
41 Sevilla;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
41 Sevilla;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
41 Sevilla;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
41 Sevilla;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;96,19
41 Sevilla;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
41 Sevilla;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
41 Sevilla;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
41 Sevilla;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;93,31
41 Sevilla;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
41 Sevilla;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
41 Sevilla;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;92,67
41 Sevilla;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
41 Sevilla;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
41 Sevilla;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
41 Sevilla;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;92,51
41 Sevilla;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
41 Sevilla;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
41 Sevilla;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
41 Sevilla;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;90,37
41 Sevilla;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
41 Sevilla;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
41 Sevilla;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;89,07
41 Sevilla;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
41 Sevilla;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
41 Sevilla;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
41 Sevilla;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;89,05
41 Sevilla;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
41 Sevilla;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
41 Sevilla;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
41 Sevilla;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;86,92
41 Sevilla;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
41 Sevilla;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
41 Sevilla;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;84,03
41 Sevilla;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
41 Sevilla;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
41 Sevilla;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
41 Sevilla;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;84,86
41 Sevilla;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
41 Sevilla;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
41 Sevilla;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
41 Sevilla;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;83,01
41 Sevilla;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
41 Sevilla;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
41 Sevilla;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
41 Sevilla;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
41 Sevilla;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
41 Sevilla;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
41 Sevilla;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QI;7.929
41 Sevilla;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
41 Sevilla;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
41 Sevilla;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
41 Sevilla;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QI;7.397
41 Sevilla;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
41 Sevilla;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
41 Sevilla;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
41 Sevilla;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QI;8.389
41 Sevilla;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
41 Sevilla;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
41 Sevilla;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2022QII;""
41 Sevilla;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2022QI;7.646
41 Sevilla;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
41 Sevilla;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
41 Sevilla;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2021QII;""
41 Sevilla;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2021QI;7.123
41 Sevilla;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
41 Sevilla;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
41 Sevilla;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2020QII;""
41 Sevilla;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2020QI;7.849
41 Sevilla;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
41 Sevilla;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
41 Sevilla;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2022QII;7.383
41 Sevilla;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2022QI;""
41 Sevilla;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
41 Sevilla;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
41 Sevilla;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2021QII;6.875
41 Sevilla;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2021QI;""
41 Sevilla;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
41 Sevilla;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
41 Sevilla;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2020QII;7.602
41 Sevilla;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2020QI;""
41 Sevilla;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
41 Sevilla;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QIII;7.100
41 Sevilla;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QII;""
41 Sevilla;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QI;""
41 Sevilla;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
41 Sevilla;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QIII;6.639
41 Sevilla;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QII;""
41 Sevilla;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QI;""
41 Sevilla;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
41 Sevilla;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QIII;7.326
41 Sevilla;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QII;""
41 Sevilla;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QI;""
41 Sevilla;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QIV;6.700
41 Sevilla;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
41 Sevilla;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QII;""
41 Sevilla;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QI;""
41 Sevilla;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QIV;6.334
41 Sevilla;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
41 Sevilla;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QII;""
41 Sevilla;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QI;""
41 Sevilla;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QIV;7.012
41 Sevilla;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
41 Sevilla;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QII;""
41 Sevilla;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QI;""
41 Sevilla;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
41 Sevilla;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
41 Sevilla;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
41 Sevilla;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
41 Sevilla;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
41 Sevilla;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
41 Sevilla;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
41 Sevilla;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
41 Sevilla;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
41 Sevilla;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
41 Sevilla;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
41 Sevilla;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
41 Sevilla;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
41 Sevilla;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
41 Sevilla;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
41 Sevilla;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;96,43
41 Sevilla;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
41 Sevilla;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
41 Sevilla;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
41 Sevilla;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;96,3
41 Sevilla;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
41 Sevilla;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
41 Sevilla;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
41 Sevilla;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;93,56
41 Sevilla;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
41 Sevilla;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
41 Sevilla;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;93,11
41 Sevilla;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
41 Sevilla;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
41 Sevilla;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
41 Sevilla;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;92,94
41 Sevilla;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
41 Sevilla;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
41 Sevilla;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
41 Sevilla;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;90,62
41 Sevilla;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
41 Sevilla;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
41 Sevilla;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;89,54
41 Sevilla;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
41 Sevilla;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
41 Sevilla;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
41 Sevilla;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;89,75
41 Sevilla;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
41 Sevilla;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
41 Sevilla;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
41 Sevilla;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;87,33
41 Sevilla;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
41 Sevilla;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
41 Sevilla;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;84,5
41 Sevilla;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
41 Sevilla;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
41 Sevilla;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
41 Sevilla;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;85,63
41 Sevilla;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
41 Sevilla;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
41 Sevilla;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
41 Sevilla;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;83,59
41 Sevilla;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
41 Sevilla;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
41 Sevilla;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
41 Sevilla;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
41 Sevilla;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
41 Sevilla;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
41 Sevilla;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QI;3.851
41 Sevilla;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
41 Sevilla;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
41 Sevilla;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
41 Sevilla;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QI;3.654
41 Sevilla;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
41 Sevilla;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
41 Sevilla;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
41 Sevilla;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QI;4.180
41 Sevilla;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
41 Sevilla;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
41 Sevilla;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2022QII;""
41 Sevilla;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2022QI;3.690
41 Sevilla;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
41 Sevilla;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
41 Sevilla;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2021QII;""
41 Sevilla;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2021QI;3.507
41 Sevilla;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
41 Sevilla;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
41 Sevilla;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2020QII;""
41 Sevilla;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2020QI;3.879
41 Sevilla;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
41 Sevilla;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
41 Sevilla;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2022QII;3.534
41 Sevilla;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2022QI;""
41 Sevilla;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
41 Sevilla;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
41 Sevilla;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2021QII;3.348
41 Sevilla;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2021QI;""
41 Sevilla;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
41 Sevilla;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
41 Sevilla;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2020QII;3.757
41 Sevilla;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2020QI;""
41 Sevilla;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
41 Sevilla;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QIII;3.392
41 Sevilla;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QII;""
41 Sevilla;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QI;""
41 Sevilla;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
41 Sevilla;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QIII;3.202
41 Sevilla;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QII;""
41 Sevilla;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QI;""
41 Sevilla;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
41 Sevilla;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QIII;3.599
41 Sevilla;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QII;""
41 Sevilla;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QI;""
41 Sevilla;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QIV;3.199
41 Sevilla;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
41 Sevilla;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QII;""
41 Sevilla;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QI;""
41 Sevilla;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QIV;3.044
41 Sevilla;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
41 Sevilla;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QII;""
41 Sevilla;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QI;""
41 Sevilla;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QIV;3.422
41 Sevilla;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
41 Sevilla;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QII;""
41 Sevilla;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QI;""
41 Sevilla;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
41 Sevilla;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
41 Sevilla;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
41 Sevilla;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
41 Sevilla;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
41 Sevilla;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
41 Sevilla;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
41 Sevilla;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
41 Sevilla;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
41 Sevilla;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
41 Sevilla;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
41 Sevilla;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
41 Sevilla;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
41 Sevilla;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
41 Sevilla;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
41 Sevilla;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;95,82
41 Sevilla;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
41 Sevilla;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
41 Sevilla;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
41 Sevilla;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;95,98
41 Sevilla;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
41 Sevilla;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
41 Sevilla;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
41 Sevilla;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;92,8
41 Sevilla;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
41 Sevilla;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
41 Sevilla;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;91,77
41 Sevilla;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
41 Sevilla;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
41 Sevilla;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
41 Sevilla;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;91,63
41 Sevilla;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
41 Sevilla;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
41 Sevilla;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
41 Sevilla;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;89,88
41 Sevilla;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
41 Sevilla;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
41 Sevilla;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;88,08
41 Sevilla;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
41 Sevilla;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
41 Sevilla;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
41 Sevilla;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;87,63
41 Sevilla;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
41 Sevilla;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
41 Sevilla;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
41 Sevilla;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;86,1
41 Sevilla;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
41 Sevilla;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
41 Sevilla;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;83,07
41 Sevilla;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
41 Sevilla;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
41 Sevilla;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
41 Sevilla;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;83,31
41 Sevilla;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
41 Sevilla;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
41 Sevilla;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
41 Sevilla;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;81,87
41 Sevilla;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
41 Sevilla;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
41 Sevilla;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
41 Sevilla;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
41 Sevilla;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
41 Sevilla;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QII;13.604
41 Sevilla;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
41 Sevilla;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
41 Sevilla;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
41 Sevilla;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QII;12.764
41 Sevilla;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
41 Sevilla;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
41 Sevilla;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
41 Sevilla;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QII;12.023
41 Sevilla;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
41 Sevilla;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
41 Sevilla;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
41 Sevilla;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2022QII;13.104
41 Sevilla;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2022QI;""
41 Sevilla;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
41 Sevilla;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
41 Sevilla;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2021QII;12.303
41 Sevilla;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2021QI;""
41 Sevilla;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
41 Sevilla;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
41 Sevilla;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2020QII;11.625
41 Sevilla;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2020QI;""
41 Sevilla;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
41 Sevilla;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2022QIII;12.638
41 Sevilla;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2022QII;""
41 Sevilla;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2022QI;""
41 Sevilla;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
41 Sevilla;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2021QIII;11.889
41 Sevilla;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2021QII;""
41 Sevilla;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2021QI;""
41 Sevilla;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
41 Sevilla;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2020QIII;11.144
41 Sevilla;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2020QII;""
41 Sevilla;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2020QI;""
41 Sevilla;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QIV;11.977
41 Sevilla;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
41 Sevilla;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QII;""
41 Sevilla;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QI;""
41 Sevilla;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QIV;11.386
41 Sevilla;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
41 Sevilla;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QII;""
41 Sevilla;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QI;""
41 Sevilla;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QIV;10.642
41 Sevilla;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
41 Sevilla;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QII;""
41 Sevilla;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QI;""
41 Sevilla;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
41 Sevilla;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
41 Sevilla;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QII;""
41 Sevilla;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QI;10.978
41 Sevilla;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
41 Sevilla;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
41 Sevilla;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QII;""
41 Sevilla;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QI;10.261
41 Sevilla;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
41 Sevilla;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
41 Sevilla;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QII;""
41 Sevilla;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QI;""
41 Sevilla;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
41 Sevilla;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
41 Sevilla;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
41 Sevilla;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
41 Sevilla;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
41 Sevilla;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
41 Sevilla;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
41 Sevilla;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
41 Sevilla;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
41 Sevilla;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
41 Sevilla;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
41 Sevilla;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
41 Sevilla;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
41 Sevilla;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
41 Sevilla;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;96,32
41 Sevilla;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
41 Sevilla;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
41 Sevilla;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
41 Sevilla;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;96,39
41 Sevilla;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
41 Sevilla;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
41 Sevilla;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
41 Sevilla;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;96,69
41 Sevilla;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
41 Sevilla;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
41 Sevilla;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;92,9
41 Sevilla;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
41 Sevilla;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
41 Sevilla;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
41 Sevilla;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;93,14
41 Sevilla;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
41 Sevilla;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
41 Sevilla;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
41 Sevilla;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;92,69
41 Sevilla;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
41 Sevilla;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
41 Sevilla;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;88,04
41 Sevilla;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
41 Sevilla;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
41 Sevilla;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
41 Sevilla;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;89,2
41 Sevilla;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
41 Sevilla;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
41 Sevilla;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
41 Sevilla;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;88,51
41 Sevilla;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
41 Sevilla;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
41 Sevilla;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
41 Sevilla;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
41 Sevilla;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
41 Sevilla;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
41 Sevilla;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;86,01
41 Sevilla;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
41 Sevilla;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
41 Sevilla;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
41 Sevilla;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;85,34
41 Sevilla;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
41 Sevilla;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
41 Sevilla;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
41 Sevilla;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
41 Sevilla;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
41 Sevilla;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
41 Sevilla;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QII;9.177
41 Sevilla;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
41 Sevilla;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
41 Sevilla;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
41 Sevilla;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QII;8.585
41 Sevilla;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
41 Sevilla;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
41 Sevilla;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
41 Sevilla;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QII;8.040
41 Sevilla;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
41 Sevilla;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
41 Sevilla;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
41 Sevilla;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2022QII;8.865
41 Sevilla;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2022QI;""
41 Sevilla;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
41 Sevilla;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
41 Sevilla;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2021QII;8.305
41 Sevilla;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2021QI;""
41 Sevilla;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
41 Sevilla;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
41 Sevilla;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2020QII;7.777
41 Sevilla;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2020QI;""
41 Sevilla;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
41 Sevilla;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2022QIII;8.559
41 Sevilla;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2022QII;""
41 Sevilla;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2022QI;""
41 Sevilla;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
41 Sevilla;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2021QIII;8.050
41 Sevilla;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2021QII;""
41 Sevilla;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2021QI;""
41 Sevilla;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
41 Sevilla;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2020QIII;7.465
41 Sevilla;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2020QII;""
41 Sevilla;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2020QI;""
41 Sevilla;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QIV;8.117
41 Sevilla;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
41 Sevilla;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QII;""
41 Sevilla;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QI;""
41 Sevilla;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QIV;7.720
41 Sevilla;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
41 Sevilla;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QII;""
41 Sevilla;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QI;""
41 Sevilla;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QIV;7.145
41 Sevilla;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
41 Sevilla;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QII;""
41 Sevilla;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QI;""
41 Sevilla;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
41 Sevilla;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
41 Sevilla;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QII;""
41 Sevilla;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QI;7.460
41 Sevilla;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
41 Sevilla;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
41 Sevilla;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QII;""
41 Sevilla;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QI;6.899
41 Sevilla;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
41 Sevilla;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
41 Sevilla;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QII;""
41 Sevilla;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QI;""
41 Sevilla;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
41 Sevilla;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
41 Sevilla;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
41 Sevilla;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
41 Sevilla;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
41 Sevilla;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
41 Sevilla;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
41 Sevilla;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
41 Sevilla;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
41 Sevilla;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
41 Sevilla;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
41 Sevilla;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
41 Sevilla;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
41 Sevilla;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
41 Sevilla;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;96,6
41 Sevilla;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
41 Sevilla;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
41 Sevilla;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
41 Sevilla;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;96,74
41 Sevilla;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
41 Sevilla;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
41 Sevilla;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
41 Sevilla;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;96,73
41 Sevilla;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
41 Sevilla;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
41 Sevilla;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;93,27
41 Sevilla;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
41 Sevilla;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
41 Sevilla;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
41 Sevilla;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;93,77
41 Sevilla;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
41 Sevilla;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
41 Sevilla;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
41 Sevilla;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;92,85
41 Sevilla;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
41 Sevilla;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
41 Sevilla;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;88,45
41 Sevilla;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
41 Sevilla;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
41 Sevilla;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
41 Sevilla;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;89,92
41 Sevilla;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
41 Sevilla;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
41 Sevilla;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
41 Sevilla;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;88,87
41 Sevilla;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
41 Sevilla;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
41 Sevilla;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
41 Sevilla;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
41 Sevilla;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
41 Sevilla;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
41 Sevilla;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;86,9
41 Sevilla;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
41 Sevilla;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
41 Sevilla;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
41 Sevilla;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;85,81
41 Sevilla;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
41 Sevilla;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
41 Sevilla;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
41 Sevilla;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
41 Sevilla;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
41 Sevilla;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
41 Sevilla;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QII;4.427
41 Sevilla;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
41 Sevilla;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
41 Sevilla;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
41 Sevilla;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QII;4.179
41 Sevilla;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
41 Sevilla;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
41 Sevilla;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
41 Sevilla;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QII;3.983
41 Sevilla;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
41 Sevilla;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
41 Sevilla;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
41 Sevilla;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2022QII;4.239
41 Sevilla;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2022QI;""
41 Sevilla;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
41 Sevilla;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
41 Sevilla;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2021QII;3.998
41 Sevilla;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2021QI;""
41 Sevilla;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
41 Sevilla;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
41 Sevilla;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2020QII;3.848
41 Sevilla;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2020QI;""
41 Sevilla;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
41 Sevilla;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2022QIII;4.079
41 Sevilla;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2022QII;""
41 Sevilla;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2022QI;""
41 Sevilla;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
41 Sevilla;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2021QIII;3.839
41 Sevilla;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2021QII;""
41 Sevilla;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2021QI;""
41 Sevilla;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
41 Sevilla;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2020QIII;3.679
41 Sevilla;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2020QII;""
41 Sevilla;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2020QI;""
41 Sevilla;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QIV;3.860
41 Sevilla;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
41 Sevilla;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QII;""
41 Sevilla;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QI;""
41 Sevilla;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QIV;3.666
41 Sevilla;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
41 Sevilla;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QII;""
41 Sevilla;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QI;""
41 Sevilla;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QIV;3.497
41 Sevilla;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
41 Sevilla;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QII;""
41 Sevilla;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QI;""
41 Sevilla;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
41 Sevilla;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
41 Sevilla;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QII;""
41 Sevilla;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QI;3.518
41 Sevilla;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
41 Sevilla;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
41 Sevilla;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QII;""
41 Sevilla;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QI;3.362
41 Sevilla;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
41 Sevilla;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
41 Sevilla;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QII;""
41 Sevilla;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QI;""
41 Sevilla;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
41 Sevilla;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
41 Sevilla;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
41 Sevilla;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
41 Sevilla;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
41 Sevilla;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
41 Sevilla;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
41 Sevilla;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
41 Sevilla;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
41 Sevilla;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
41 Sevilla;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
41 Sevilla;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
41 Sevilla;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
41 Sevilla;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
41 Sevilla;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;95,75
41 Sevilla;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
41 Sevilla;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
41 Sevilla;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
41 Sevilla;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;95,67
41 Sevilla;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
41 Sevilla;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
41 Sevilla;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
41 Sevilla;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;96,61
41 Sevilla;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
41 Sevilla;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
41 Sevilla;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;92,14
41 Sevilla;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
41 Sevilla;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
41 Sevilla;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
41 Sevilla;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;91,86
41 Sevilla;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
41 Sevilla;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
41 Sevilla;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
41 Sevilla;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;92,37
41 Sevilla;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
41 Sevilla;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
41 Sevilla;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;87,19
41 Sevilla;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
41 Sevilla;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
41 Sevilla;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
41 Sevilla;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;87,72
41 Sevilla;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
41 Sevilla;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
41 Sevilla;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
41 Sevilla;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;87,8
41 Sevilla;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
41 Sevilla;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
41 Sevilla;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
41 Sevilla;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
41 Sevilla;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
41 Sevilla;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
41 Sevilla;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;84,18
41 Sevilla;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
41 Sevilla;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
41 Sevilla;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
41 Sevilla;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;84,41
41 Sevilla;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
41 Sevilla;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
41 Sevilla;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
41 Sevilla;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
41 Sevilla;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
41 Sevilla;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QIII;13.276
41 Sevilla;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
41 Sevilla;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
41 Sevilla;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
41 Sevilla;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QIII;12.470
41 Sevilla;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
41 Sevilla;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
41 Sevilla;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
41 Sevilla;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QIII;11.783
41 Sevilla;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
41 Sevilla;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
41 Sevilla;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
41 Sevilla;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2022QIII;12.772
41 Sevilla;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2022QII;""
41 Sevilla;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2022QI;""
41 Sevilla;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
41 Sevilla;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2021QIII;12.031
41 Sevilla;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2021QII;""
41 Sevilla;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2021QI;""
41 Sevilla;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
41 Sevilla;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2020QIII;11.278
41 Sevilla;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2020QII;""
41 Sevilla;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2020QI;""
41 Sevilla;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2022QIV;12.084
41 Sevilla;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
41 Sevilla;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2022QII;""
41 Sevilla;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2022QI;""
41 Sevilla;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2021QIV;11.519
41 Sevilla;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
41 Sevilla;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2021QII;""
41 Sevilla;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2021QI;""
41 Sevilla;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2020QIV;10.764
41 Sevilla;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
41 Sevilla;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2020QII;""
41 Sevilla;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2020QI;""
41 Sevilla;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
41 Sevilla;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
41 Sevilla;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QII;""
41 Sevilla;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QI;11.106
41 Sevilla;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
41 Sevilla;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
41 Sevilla;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QII;""
41 Sevilla;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QI;10.375
41 Sevilla;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
41 Sevilla;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
41 Sevilla;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QII;""
41 Sevilla;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QI;""
41 Sevilla;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
41 Sevilla;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
41 Sevilla;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QII;10.712
41 Sevilla;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QI;""
41 Sevilla;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
41 Sevilla;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
41 Sevilla;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QII;9.994
41 Sevilla;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QI;""
41 Sevilla;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
41 Sevilla;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
41 Sevilla;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QII;""
41 Sevilla;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QI;""
41 Sevilla;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
41 Sevilla;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
41 Sevilla;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
41 Sevilla;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
41 Sevilla;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
41 Sevilla;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
41 Sevilla;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
41 Sevilla;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
41 Sevilla;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
41 Sevilla;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
41 Sevilla;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
41 Sevilla;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
41 Sevilla;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
41 Sevilla;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;96,2
41 Sevilla;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
41 Sevilla;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
41 Sevilla;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
41 Sevilla;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;96,48
41 Sevilla;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
41 Sevilla;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
41 Sevilla;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
41 Sevilla;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;95,71
41 Sevilla;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
41 Sevilla;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
41 Sevilla;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;91,02
41 Sevilla;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
41 Sevilla;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
41 Sevilla;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
41 Sevilla;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;92,37
41 Sevilla;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
41 Sevilla;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
41 Sevilla;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
41 Sevilla;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;91,35
41 Sevilla;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
41 Sevilla;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
41 Sevilla;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
41 Sevilla;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
41 Sevilla;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
41 Sevilla;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
41 Sevilla;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;89,06
41 Sevilla;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
41 Sevilla;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
41 Sevilla;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
41 Sevilla;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;88,05
41 Sevilla;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
41 Sevilla;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
41 Sevilla;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
41 Sevilla;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
41 Sevilla;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
41 Sevilla;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
41 Sevilla;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;85,9
41 Sevilla;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
41 Sevilla;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
41 Sevilla;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
41 Sevilla;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;84,82
41 Sevilla;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
41 Sevilla;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
41 Sevilla;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
41 Sevilla;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
41 Sevilla;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
41 Sevilla;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
41 Sevilla;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QIII;8.961
41 Sevilla;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
41 Sevilla;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
41 Sevilla;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
41 Sevilla;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QIII;8.402
41 Sevilla;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
41 Sevilla;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
41 Sevilla;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
41 Sevilla;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QIII;7.884
41 Sevilla;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
41 Sevilla;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
41 Sevilla;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
41 Sevilla;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2022QIII;8.627
41 Sevilla;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2022QII;""
41 Sevilla;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2022QI;""
41 Sevilla;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
41 Sevilla;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2021QIII;8.133
41 Sevilla;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2021QII;""
41 Sevilla;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2021QI;""
41 Sevilla;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
41 Sevilla;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2020QIII;7.555
41 Sevilla;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2020QII;""
41 Sevilla;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2020QI;""
41 Sevilla;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2022QIV;8.169
41 Sevilla;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
41 Sevilla;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2022QII;""
41 Sevilla;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2022QI;""
41 Sevilla;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2021QIV;7.796
41 Sevilla;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
41 Sevilla;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2021QII;""
41 Sevilla;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2021QI;""
41 Sevilla;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2020QIV;7.229
41 Sevilla;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
41 Sevilla;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2020QII;""
41 Sevilla;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2020QI;""
41 Sevilla;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
41 Sevilla;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
41 Sevilla;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QII;""
41 Sevilla;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QI;7.532
41 Sevilla;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
41 Sevilla;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
41 Sevilla;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QII;""
41 Sevilla;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QI;6.977
41 Sevilla;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
41 Sevilla;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
41 Sevilla;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QII;""
41 Sevilla;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QI;""
41 Sevilla;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
41 Sevilla;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
41 Sevilla;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QII;7.277
41 Sevilla;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QI;""
41 Sevilla;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
41 Sevilla;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
41 Sevilla;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QII;6.743
41 Sevilla;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QI;""
41 Sevilla;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
41 Sevilla;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
41 Sevilla;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QII;""
41 Sevilla;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QI;""
41 Sevilla;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
41 Sevilla;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
41 Sevilla;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
41 Sevilla;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
41 Sevilla;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
41 Sevilla;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
41 Sevilla;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
41 Sevilla;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
41 Sevilla;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
41 Sevilla;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
41 Sevilla;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
41 Sevilla;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
41 Sevilla;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
41 Sevilla;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;96,27
41 Sevilla;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
41 Sevilla;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
41 Sevilla;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
41 Sevilla;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;96,8
41 Sevilla;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
41 Sevilla;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
41 Sevilla;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
41 Sevilla;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;95,83
41 Sevilla;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
41 Sevilla;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
41 Sevilla;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;91,16
41 Sevilla;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
41 Sevilla;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
41 Sevilla;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
41 Sevilla;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;92,79
41 Sevilla;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
41 Sevilla;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
41 Sevilla;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
41 Sevilla;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;91,69
41 Sevilla;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
41 Sevilla;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
41 Sevilla;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
41 Sevilla;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
41 Sevilla;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
41 Sevilla;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
41 Sevilla;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;89,65
41 Sevilla;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
41 Sevilla;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
41 Sevilla;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
41 Sevilla;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;88,5
41 Sevilla;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
41 Sevilla;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
41 Sevilla;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
41 Sevilla;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
41 Sevilla;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
41 Sevilla;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
41 Sevilla;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;86,61
41 Sevilla;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
41 Sevilla;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
41 Sevilla;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
41 Sevilla;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;85,53
41 Sevilla;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
41 Sevilla;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
41 Sevilla;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
41 Sevilla;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
41 Sevilla;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
41 Sevilla;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
41 Sevilla;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QIII;4.315
41 Sevilla;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
41 Sevilla;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
41 Sevilla;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
41 Sevilla;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QIII;4.068
41 Sevilla;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
41 Sevilla;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
41 Sevilla;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
41 Sevilla;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QIII;3.899
41 Sevilla;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
41 Sevilla;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
41 Sevilla;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
41 Sevilla;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2022QIII;4.145
41 Sevilla;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2022QII;""
41 Sevilla;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2022QI;""
41 Sevilla;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
41 Sevilla;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2021QIII;3.898
41 Sevilla;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2021QII;""
41 Sevilla;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2021QI;""
41 Sevilla;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
41 Sevilla;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2020QIII;3.723
41 Sevilla;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2020QII;""
41 Sevilla;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2020QI;""
41 Sevilla;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2022QIV;3.915
41 Sevilla;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
41 Sevilla;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2022QII;""
41 Sevilla;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2022QI;""
41 Sevilla;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2021QIV;3.723
41 Sevilla;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
41 Sevilla;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2021QII;""
41 Sevilla;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2021QI;""
41 Sevilla;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2020QIV;3.535
41 Sevilla;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
41 Sevilla;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2020QII;""
41 Sevilla;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2020QI;""
41 Sevilla;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
41 Sevilla;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
41 Sevilla;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QII;""
41 Sevilla;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QI;3.574
41 Sevilla;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
41 Sevilla;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
41 Sevilla;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QII;""
41 Sevilla;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QI;3.398
41 Sevilla;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
41 Sevilla;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
41 Sevilla;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QII;""
41 Sevilla;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QI;""
41 Sevilla;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
41 Sevilla;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
41 Sevilla;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QII;3.435
41 Sevilla;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QI;""
41 Sevilla;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
41 Sevilla;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
41 Sevilla;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QII;3.251
41 Sevilla;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QI;""
41 Sevilla;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
41 Sevilla;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
41 Sevilla;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QII;""
41 Sevilla;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QI;""
41 Sevilla;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
41 Sevilla;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
41 Sevilla;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
41 Sevilla;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
41 Sevilla;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
41 Sevilla;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
41 Sevilla;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
41 Sevilla;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
41 Sevilla;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
41 Sevilla;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
41 Sevilla;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
41 Sevilla;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
41 Sevilla;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
41 Sevilla;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;96,06
41 Sevilla;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
41 Sevilla;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
41 Sevilla;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
41 Sevilla;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;95,82
41 Sevilla;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
41 Sevilla;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
41 Sevilla;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
41 Sevilla;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;95,49
41 Sevilla;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
41 Sevilla;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
41 Sevilla;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;90,73
41 Sevilla;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
41 Sevilla;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
41 Sevilla;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
41 Sevilla;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;91,52
41 Sevilla;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
41 Sevilla;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
41 Sevilla;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
41 Sevilla;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;90,66
41 Sevilla;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
41 Sevilla;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
41 Sevilla;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
41 Sevilla;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
41 Sevilla;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
41 Sevilla;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
41 Sevilla;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;87,86
41 Sevilla;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
41 Sevilla;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
41 Sevilla;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
41 Sevilla;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;87,15
41 Sevilla;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
41 Sevilla;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
41 Sevilla;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
41 Sevilla;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
41 Sevilla;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
41 Sevilla;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
41 Sevilla;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;84,44
41 Sevilla;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
41 Sevilla;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
41 Sevilla;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
41 Sevilla;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;83,38
41 Sevilla;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
41 Sevilla;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
41 Sevilla;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
41 Sevilla;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
41 Sevilla;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
41 Sevilla;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QIV;12.918
41 Sevilla;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
41 Sevilla;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
41 Sevilla;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
41 Sevilla;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QIV;12.172
41 Sevilla;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
41 Sevilla;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
41 Sevilla;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
41 Sevilla;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QIV;11.439
41 Sevilla;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
41 Sevilla;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
41 Sevilla;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
41 Sevilla;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2022QIV;12.204
41 Sevilla;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
41 Sevilla;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2022QII;""
41 Sevilla;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2022QI;""
41 Sevilla;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2021QIV;11.629
41 Sevilla;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
41 Sevilla;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2021QII;""
41 Sevilla;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2021QI;""
41 Sevilla;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2020QIV;10.893
41 Sevilla;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
41 Sevilla;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2020QII;""
41 Sevilla;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2020QI;""
41 Sevilla;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
41 Sevilla;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
41 Sevilla;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2022QII;""
41 Sevilla;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2022QI;11.204
41 Sevilla;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
41 Sevilla;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
41 Sevilla;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2021QII;""
41 Sevilla;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2021QI;10.492
41 Sevilla;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
41 Sevilla;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
41 Sevilla;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2020QII;""
41 Sevilla;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2020QI;""
41 Sevilla;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
41 Sevilla;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
41 Sevilla;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QII;10.800
41 Sevilla;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QI;""
41 Sevilla;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
41 Sevilla;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
41 Sevilla;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QII;10.103
41 Sevilla;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QI;""
41 Sevilla;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
41 Sevilla;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
41 Sevilla;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QII;""
41 Sevilla;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QI;""
41 Sevilla;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
41 Sevilla;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QIII;10.387
41 Sevilla;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QII;""
41 Sevilla;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QI;""
41 Sevilla;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
41 Sevilla;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QIII;9.732
41 Sevilla;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QII;""
41 Sevilla;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QI;""
41 Sevilla;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
41 Sevilla;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
41 Sevilla;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QII;""
41 Sevilla;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QI;""
41 Sevilla;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
41 Sevilla;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
41 Sevilla;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
41 Sevilla;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
41 Sevilla;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
41 Sevilla;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
41 Sevilla;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
41 Sevilla;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
41 Sevilla;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
41 Sevilla;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
41 Sevilla;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
41 Sevilla;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
41 Sevilla;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;94,47
41 Sevilla;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
41 Sevilla;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
41 Sevilla;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
41 Sevilla;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;95,54
41 Sevilla;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
41 Sevilla;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
41 Sevilla;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
41 Sevilla;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;95,23
41 Sevilla;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
41 Sevilla;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
41 Sevilla;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
41 Sevilla;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
41 Sevilla;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
41 Sevilla;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
41 Sevilla;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;92,05
41 Sevilla;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
41 Sevilla;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
41 Sevilla;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
41 Sevilla;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;91,72
41 Sevilla;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
41 Sevilla;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
41 Sevilla;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
41 Sevilla;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
41 Sevilla;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
41 Sevilla;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
41 Sevilla;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;88,73
41 Sevilla;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
41 Sevilla;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
41 Sevilla;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
41 Sevilla;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;88,32
41 Sevilla;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
41 Sevilla;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
41 Sevilla;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
41 Sevilla;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
41 Sevilla;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
41 Sevilla;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
41 Sevilla;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;85,34
41 Sevilla;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
41 Sevilla;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
41 Sevilla;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
41 Sevilla;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;85,08
41 Sevilla;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
41 Sevilla;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
41 Sevilla;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
41 Sevilla;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
41 Sevilla;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
41 Sevilla;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
41 Sevilla;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QIV;8.700
41 Sevilla;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
41 Sevilla;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
41 Sevilla;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
41 Sevilla;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QIV;8.209
41 Sevilla;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
41 Sevilla;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
41 Sevilla;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
41 Sevilla;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QIV;7.658
41 Sevilla;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
41 Sevilla;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
41 Sevilla;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
41 Sevilla;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2022QIV;8.227
41 Sevilla;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
41 Sevilla;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2022QII;""
41 Sevilla;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2022QI;""
41 Sevilla;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2021QIV;7.853
41 Sevilla;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
41 Sevilla;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2021QII;""
41 Sevilla;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2021QI;""
41 Sevilla;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2020QIV;7.310
41 Sevilla;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
41 Sevilla;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2020QII;""
41 Sevilla;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2020QI;""
41 Sevilla;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
41 Sevilla;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
41 Sevilla;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2022QII;""
41 Sevilla;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2022QI;7.582
41 Sevilla;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
41 Sevilla;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
41 Sevilla;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2021QII;""
41 Sevilla;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2021QI;7.048
41 Sevilla;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
41 Sevilla;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
41 Sevilla;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2020QII;""
41 Sevilla;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2020QI;""
41 Sevilla;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
41 Sevilla;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
41 Sevilla;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QII;7.324
41 Sevilla;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QI;""
41 Sevilla;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
41 Sevilla;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
41 Sevilla;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QII;6.811
41 Sevilla;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QI;""
41 Sevilla;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
41 Sevilla;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
41 Sevilla;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QII;""
41 Sevilla;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QI;""
41 Sevilla;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
41 Sevilla;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QIII;7.047
41 Sevilla;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QII;""
41 Sevilla;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QI;""
41 Sevilla;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
41 Sevilla;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QIII;6.581
41 Sevilla;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QII;""
41 Sevilla;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QI;""
41 Sevilla;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
41 Sevilla;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
41 Sevilla;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QII;""
41 Sevilla;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QI;""
41 Sevilla;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
41 Sevilla;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
41 Sevilla;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
41 Sevilla;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
41 Sevilla;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
41 Sevilla;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
41 Sevilla;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
41 Sevilla;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
41 Sevilla;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
41 Sevilla;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
41 Sevilla;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
41 Sevilla;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
41 Sevilla;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;94,56
41 Sevilla;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
41 Sevilla;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
41 Sevilla;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
41 Sevilla;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;95,66
41 Sevilla;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
41 Sevilla;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
41 Sevilla;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
41 Sevilla;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;95,46
41 Sevilla;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
41 Sevilla;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
41 Sevilla;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
41 Sevilla;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
41 Sevilla;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
41 Sevilla;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
41 Sevilla;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;92,36
41 Sevilla;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
41 Sevilla;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
41 Sevilla;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
41 Sevilla;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;92,03
41 Sevilla;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
41 Sevilla;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
41 Sevilla;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
41 Sevilla;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
41 Sevilla;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
41 Sevilla;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
41 Sevilla;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;89,22
41 Sevilla;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
41 Sevilla;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
41 Sevilla;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
41 Sevilla;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;88,94
41 Sevilla;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
41 Sevilla;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
41 Sevilla;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
41 Sevilla;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
41 Sevilla;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
41 Sevilla;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
41 Sevilla;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;85,84
41 Sevilla;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
41 Sevilla;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
41 Sevilla;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
41 Sevilla;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;85,94
41 Sevilla;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
41 Sevilla;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
41 Sevilla;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
41 Sevilla;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
41 Sevilla;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
41 Sevilla;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
41 Sevilla;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QIV;4.218
41 Sevilla;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
41 Sevilla;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
41 Sevilla;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
41 Sevilla;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QIV;3.963
41 Sevilla;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
41 Sevilla;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
41 Sevilla;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
41 Sevilla;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QIV;3.781
41 Sevilla;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
41 Sevilla;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
41 Sevilla;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
41 Sevilla;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2022QIV;3.977
41 Sevilla;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
41 Sevilla;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2022QII;""
41 Sevilla;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2022QI;""
41 Sevilla;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2021QIV;3.776
41 Sevilla;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
41 Sevilla;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2021QII;""
41 Sevilla;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2021QI;""
41 Sevilla;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2020QIV;3.583
41 Sevilla;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
41 Sevilla;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2020QII;""
41 Sevilla;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2020QI;""
41 Sevilla;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
41 Sevilla;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
41 Sevilla;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2022QII;""
41 Sevilla;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2022QI;3.622
41 Sevilla;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
41 Sevilla;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
41 Sevilla;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2021QII;""
41 Sevilla;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2021QI;3.444
41 Sevilla;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
41 Sevilla;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
41 Sevilla;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2020QII;""
41 Sevilla;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2020QI;""
41 Sevilla;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
41 Sevilla;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
41 Sevilla;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QII;3.476
41 Sevilla;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QI;""
41 Sevilla;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
41 Sevilla;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
41 Sevilla;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QII;3.292
41 Sevilla;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QI;""
41 Sevilla;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
41 Sevilla;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
41 Sevilla;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QII;""
41 Sevilla;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QI;""
41 Sevilla;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
41 Sevilla;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QIII;3.340
41 Sevilla;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QII;""
41 Sevilla;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QI;""
41 Sevilla;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
41 Sevilla;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QIII;3.151
41 Sevilla;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QII;""
41 Sevilla;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QI;""
41 Sevilla;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
41 Sevilla;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
41 Sevilla;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QII;""
41 Sevilla;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QI;""
41 Sevilla;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
41 Sevilla;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
41 Sevilla;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
41 Sevilla;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
41 Sevilla;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
41 Sevilla;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
41 Sevilla;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
41 Sevilla;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
41 Sevilla;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
41 Sevilla;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
41 Sevilla;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
41 Sevilla;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
41 Sevilla;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;94,29
41 Sevilla;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
41 Sevilla;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
41 Sevilla;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
41 Sevilla;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;95,28
41 Sevilla;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
41 Sevilla;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
41 Sevilla;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
41 Sevilla;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;94,76
41 Sevilla;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
41 Sevilla;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
41 Sevilla;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
41 Sevilla;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
41 Sevilla;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
41 Sevilla;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
41 Sevilla;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;91,4
41 Sevilla;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
41 Sevilla;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
41 Sevilla;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
41 Sevilla;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;91,09
41 Sevilla;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
41 Sevilla;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
41 Sevilla;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
41 Sevilla;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
41 Sevilla;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
41 Sevilla;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
41 Sevilla;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;87,71
41 Sevilla;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
41 Sevilla;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
41 Sevilla;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
41 Sevilla;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;87,07
41 Sevilla;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
41 Sevilla;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
41 Sevilla;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
41 Sevilla;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
41 Sevilla;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
41 Sevilla;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
41 Sevilla;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;84,28
41 Sevilla;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
41 Sevilla;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
41 Sevilla;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
41 Sevilla;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;83,34
41 Sevilla;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
41 Sevilla;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
41 Sevilla;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
41 Sevilla;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
41 Sevilla;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
41 Sevilla;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
42 Soria;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
42 Soria;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
42 Soria;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
42 Soria;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QI;5.401
42 Soria;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
42 Soria;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
42 Soria;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
42 Soria;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QI;5.384
42 Soria;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
42 Soria;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
42 Soria;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
42 Soria;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QI;5.498
42 Soria;All ages;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
42 Soria;All ages;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
42 Soria;All ages;Cohort January 1;Total;Survival in the first trimester;2022QII;""
42 Soria;All ages;Cohort January 1;Total;Survival in the first trimester;2022QI;5.283
42 Soria;All ages;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
42 Soria;All ages;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
42 Soria;All ages;Cohort January 1;Total;Survival in the first trimester;2021QII;""
42 Soria;All ages;Cohort January 1;Total;Survival in the first trimester;2021QI;5.284
42 Soria;All ages;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
42 Soria;All ages;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
42 Soria;All ages;Cohort January 1;Total;Survival in the first trimester;2020QII;""
42 Soria;All ages;Cohort January 1;Total;Survival in the first trimester;2020QI;5.234
42 Soria;All ages;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
42 Soria;All ages;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
42 Soria;All ages;Cohort January 1;Total;Survival in the second trimester;2022QII;5.160
42 Soria;All ages;Cohort January 1;Total;Survival in the second trimester;2022QI;""
42 Soria;All ages;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
42 Soria;All ages;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
42 Soria;All ages;Cohort January 1;Total;Survival in the second trimester;2021QII;5.178
42 Soria;All ages;Cohort January 1;Total;Survival in the second trimester;2021QI;""
42 Soria;All ages;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
42 Soria;All ages;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
42 Soria;All ages;Cohort January 1;Total;Survival in the second trimester;2020QII;5.150
42 Soria;All ages;Cohort January 1;Total;Survival in the second trimester;2020QI;""
42 Soria;All ages;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
42 Soria;All ages;Cohort January 1;Total;Survival in the third trimester;2022QIII;5.037
42 Soria;All ages;Cohort January 1;Total;Survival in the third trimester;2022QII;""
42 Soria;All ages;Cohort January 1;Total;Survival in the third trimester;2022QI;""
42 Soria;All ages;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
42 Soria;All ages;Cohort January 1;Total;Survival in the third trimester;2021QIII;5.073
42 Soria;All ages;Cohort January 1;Total;Survival in the third trimester;2021QII;""
42 Soria;All ages;Cohort January 1;Total;Survival in the third trimester;2021QI;""
42 Soria;All ages;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
42 Soria;All ages;Cohort January 1;Total;Survival in the third trimester;2020QIII;5.056
42 Soria;All ages;Cohort January 1;Total;Survival in the third trimester;2020QII;""
42 Soria;All ages;Cohort January 1;Total;Survival in the third trimester;2020QI;""
42 Soria;All ages;Cohort January 1;Total;Survival in the third trimester;2022QIV;4.880
42 Soria;All ages;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
42 Soria;All ages;Cohort January 1;Total;Survival in the third trimester;2022QII;""
42 Soria;All ages;Cohort January 1;Total;Survival in the third trimester;2022QI;""
42 Soria;All ages;Cohort January 1;Total;Survival in the third trimester;2021QIV;4.967
42 Soria;All ages;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
42 Soria;All ages;Cohort January 1;Total;Survival in the third trimester;2021QII;""
42 Soria;All ages;Cohort January 1;Total;Survival in the third trimester;2021QI;""
42 Soria;All ages;Cohort January 1;Total;Survival in the third trimester;2020QIV;4.932
42 Soria;All ages;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
42 Soria;All ages;Cohort January 1;Total;Survival in the third trimester;2020QII;""
42 Soria;All ages;Cohort January 1;Total;Survival in the third trimester;2020QI;""
42 Soria;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
42 Soria;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
42 Soria;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
42 Soria;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
42 Soria;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
42 Soria;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
42 Soria;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
42 Soria;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
42 Soria;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
42 Soria;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
42 Soria;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
42 Soria;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
42 Soria;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
42 Soria;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
42 Soria;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
42 Soria;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;97,82
42 Soria;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
42 Soria;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
42 Soria;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
42 Soria;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;98,14
42 Soria;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
42 Soria;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
42 Soria;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
42 Soria;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;95,2
42 Soria;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
42 Soria;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
42 Soria;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;95,54
42 Soria;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
42 Soria;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
42 Soria;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
42 Soria;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;96,17
42 Soria;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
42 Soria;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
42 Soria;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
42 Soria;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;93,67
42 Soria;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
42 Soria;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
42 Soria;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;93,26
42 Soria;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
42 Soria;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
42 Soria;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
42 Soria;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;94,22
42 Soria;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
42 Soria;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
42 Soria;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
42 Soria;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;91,96
42 Soria;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
42 Soria;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
42 Soria;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;90,35
42 Soria;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
42 Soria;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
42 Soria;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
42 Soria;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;92,25
42 Soria;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
42 Soria;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
42 Soria;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
42 Soria;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;89,71
42 Soria;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
42 Soria;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
42 Soria;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
42 Soria;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
42 Soria;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
42 Soria;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
42 Soria;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QI;3.485
42 Soria;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
42 Soria;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
42 Soria;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
42 Soria;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QI;3.484
42 Soria;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
42 Soria;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
42 Soria;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
42 Soria;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QI;3.546
42 Soria;All ages;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
42 Soria;All ages;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
42 Soria;All ages;Cohort January 1;Males;Survival in the first trimester;2022QII;""
42 Soria;All ages;Cohort January 1;Males;Survival in the first trimester;2022QI;3.411
42 Soria;All ages;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
42 Soria;All ages;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
42 Soria;All ages;Cohort January 1;Males;Survival in the first trimester;2021QII;""
42 Soria;All ages;Cohort January 1;Males;Survival in the first trimester;2021QI;3.429
42 Soria;All ages;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
42 Soria;All ages;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
42 Soria;All ages;Cohort January 1;Males;Survival in the first trimester;2020QII;""
42 Soria;All ages;Cohort January 1;Males;Survival in the first trimester;2020QI;3.400
42 Soria;All ages;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
42 Soria;All ages;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
42 Soria;All ages;Cohort January 1;Males;Survival in the second trimester;2022QII;3.340
42 Soria;All ages;Cohort January 1;Males;Survival in the second trimester;2022QI;""
42 Soria;All ages;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
42 Soria;All ages;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
42 Soria;All ages;Cohort January 1;Males;Survival in the second trimester;2021QII;3.368
42 Soria;All ages;Cohort January 1;Males;Survival in the second trimester;2021QI;""
42 Soria;All ages;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
42 Soria;All ages;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
42 Soria;All ages;Cohort January 1;Males;Survival in the second trimester;2020QII;3.355
42 Soria;All ages;Cohort January 1;Males;Survival in the second trimester;2020QI;""
42 Soria;All ages;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
42 Soria;All ages;Cohort January 1;Males;Survival in the third trimester;2022QIII;3.275
42 Soria;All ages;Cohort January 1;Males;Survival in the third trimester;2022QII;""
42 Soria;All ages;Cohort January 1;Males;Survival in the third trimester;2022QI;""
42 Soria;All ages;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
42 Soria;All ages;Cohort January 1;Males;Survival in the third trimester;2021QIII;3.309
42 Soria;All ages;Cohort January 1;Males;Survival in the third trimester;2021QII;""
42 Soria;All ages;Cohort January 1;Males;Survival in the third trimester;2021QI;""
42 Soria;All ages;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
42 Soria;All ages;Cohort January 1;Males;Survival in the third trimester;2020QIII;3.304
42 Soria;All ages;Cohort January 1;Males;Survival in the third trimester;2020QII;""
42 Soria;All ages;Cohort January 1;Males;Survival in the third trimester;2020QI;""
42 Soria;All ages;Cohort January 1;Males;Survival in the third trimester;2022QIV;3.185
42 Soria;All ages;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
42 Soria;All ages;Cohort January 1;Males;Survival in the third trimester;2022QII;""
42 Soria;All ages;Cohort January 1;Males;Survival in the third trimester;2022QI;""
42 Soria;All ages;Cohort January 1;Males;Survival in the third trimester;2021QIV;3.241
42 Soria;All ages;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
42 Soria;All ages;Cohort January 1;Males;Survival in the third trimester;2021QII;""
42 Soria;All ages;Cohort January 1;Males;Survival in the third trimester;2021QI;""
42 Soria;All ages;Cohort January 1;Males;Survival in the third trimester;2020QIV;3.222
42 Soria;All ages;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
42 Soria;All ages;Cohort January 1;Males;Survival in the third trimester;2020QII;""
42 Soria;All ages;Cohort January 1;Males;Survival in the third trimester;2020QI;""
42 Soria;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
42 Soria;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
42 Soria;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
42 Soria;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
42 Soria;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
42 Soria;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
42 Soria;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
42 Soria;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
42 Soria;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
42 Soria;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
42 Soria;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
42 Soria;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
42 Soria;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
42 Soria;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
42 Soria;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
42 Soria;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;97,88
42 Soria;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
42 Soria;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
42 Soria;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
42 Soria;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;98,42
42 Soria;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
42 Soria;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
42 Soria;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
42 Soria;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;95,88
42 Soria;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
42 Soria;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
42 Soria;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;95,84
42 Soria;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
42 Soria;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
42 Soria;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
42 Soria;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;96,67
42 Soria;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
42 Soria;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
42 Soria;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
42 Soria;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;94,61
42 Soria;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
42 Soria;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
42 Soria;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;93,97
42 Soria;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
42 Soria;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
42 Soria;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
42 Soria;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;94,98
42 Soria;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
42 Soria;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
42 Soria;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
42 Soria;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;93,18
42 Soria;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
42 Soria;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
42 Soria;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;91,39
42 Soria;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
42 Soria;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
42 Soria;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
42 Soria;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;93,03
42 Soria;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
42 Soria;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
42 Soria;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
42 Soria;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;90,86
42 Soria;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
42 Soria;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
42 Soria;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
42 Soria;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
42 Soria;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
42 Soria;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
42 Soria;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QI;1.916
42 Soria;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
42 Soria;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
42 Soria;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
42 Soria;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QI;1.900
42 Soria;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
42 Soria;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
42 Soria;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
42 Soria;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QI;1.952
42 Soria;All ages;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
42 Soria;All ages;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
42 Soria;All ages;Cohort January 1;Females;Survival in the first trimester;2022QII;""
42 Soria;All ages;Cohort January 1;Females;Survival in the first trimester;2022QI;1.872
42 Soria;All ages;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
42 Soria;All ages;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
42 Soria;All ages;Cohort January 1;Females;Survival in the first trimester;2021QII;""
42 Soria;All ages;Cohort January 1;Females;Survival in the first trimester;2021QI;1.855
42 Soria;All ages;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
42 Soria;All ages;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
42 Soria;All ages;Cohort January 1;Females;Survival in the first trimester;2020QII;""
42 Soria;All ages;Cohort January 1;Females;Survival in the first trimester;2020QI;1.834
42 Soria;All ages;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
42 Soria;All ages;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
42 Soria;All ages;Cohort January 1;Females;Survival in the second trimester;2022QII;1.820
42 Soria;All ages;Cohort January 1;Females;Survival in the second trimester;2022QI;""
42 Soria;All ages;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
42 Soria;All ages;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
42 Soria;All ages;Cohort January 1;Females;Survival in the second trimester;2021QII;1.810
42 Soria;All ages;Cohort January 1;Females;Survival in the second trimester;2021QI;""
42 Soria;All ages;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
42 Soria;All ages;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
42 Soria;All ages;Cohort January 1;Females;Survival in the second trimester;2020QII;1.795
42 Soria;All ages;Cohort January 1;Females;Survival in the second trimester;2020QI;""
42 Soria;All ages;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
42 Soria;All ages;Cohort January 1;Females;Survival in the third trimester;2022QIII;1.762
42 Soria;All ages;Cohort January 1;Females;Survival in the third trimester;2022QII;""
42 Soria;All ages;Cohort January 1;Females;Survival in the third trimester;2022QI;""
42 Soria;All ages;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
42 Soria;All ages;Cohort January 1;Females;Survival in the third trimester;2021QIII;1.764
42 Soria;All ages;Cohort January 1;Females;Survival in the third trimester;2021QII;""
42 Soria;All ages;Cohort January 1;Females;Survival in the third trimester;2021QI;""
42 Soria;All ages;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
42 Soria;All ages;Cohort January 1;Females;Survival in the third trimester;2020QIII;1.752
42 Soria;All ages;Cohort January 1;Females;Survival in the third trimester;2020QII;""
42 Soria;All ages;Cohort January 1;Females;Survival in the third trimester;2020QI;""
42 Soria;All ages;Cohort January 1;Females;Survival in the third trimester;2022QIV;1.695
42 Soria;All ages;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
42 Soria;All ages;Cohort January 1;Females;Survival in the third trimester;2022QII;""
42 Soria;All ages;Cohort January 1;Females;Survival in the third trimester;2022QI;""
42 Soria;All ages;Cohort January 1;Females;Survival in the third trimester;2021QIV;1.726
42 Soria;All ages;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
42 Soria;All ages;Cohort January 1;Females;Survival in the third trimester;2021QII;""
42 Soria;All ages;Cohort January 1;Females;Survival in the third trimester;2021QI;""
42 Soria;All ages;Cohort January 1;Females;Survival in the third trimester;2020QIV;1.710
42 Soria;All ages;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
42 Soria;All ages;Cohort January 1;Females;Survival in the third trimester;2020QII;""
42 Soria;All ages;Cohort January 1;Females;Survival in the third trimester;2020QI;""
42 Soria;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
42 Soria;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
42 Soria;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
42 Soria;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
42 Soria;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
42 Soria;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
42 Soria;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
42 Soria;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
42 Soria;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
42 Soria;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
42 Soria;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
42 Soria;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
42 Soria;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
42 Soria;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
42 Soria;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
42 Soria;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;97,7
42 Soria;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
42 Soria;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
42 Soria;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
42 Soria;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;97,63
42 Soria;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
42 Soria;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
42 Soria;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
42 Soria;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;93,95
42 Soria;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
42 Soria;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
42 Soria;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;94,99
42 Soria;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
42 Soria;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
42 Soria;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
42 Soria;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;95,26
42 Soria;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
42 Soria;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
42 Soria;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
42 Soria;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;91,96
42 Soria;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
42 Soria;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
42 Soria;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;91,96
42 Soria;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
42 Soria;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
42 Soria;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
42 Soria;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;92,84
42 Soria;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
42 Soria;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
42 Soria;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
42 Soria;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;89,75
42 Soria;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
42 Soria;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
42 Soria;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;88,47
42 Soria;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
42 Soria;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
42 Soria;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
42 Soria;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;90,84
42 Soria;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
42 Soria;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
42 Soria;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
42 Soria;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;87,6
42 Soria;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
42 Soria;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
42 Soria;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
42 Soria;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
42 Soria;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
42 Soria;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QII;5.412
42 Soria;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
42 Soria;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
42 Soria;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
42 Soria;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QII;5.395
42 Soria;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
42 Soria;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
42 Soria;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
42 Soria;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QII;5.388
42 Soria;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
42 Soria;All ages;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
42 Soria;All ages;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
42 Soria;All ages;Cohort April 1;Total;Survival in the first trimester;2022QII;5.279
42 Soria;All ages;Cohort April 1;Total;Survival in the first trimester;2022QI;""
42 Soria;All ages;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
42 Soria;All ages;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
42 Soria;All ages;Cohort April 1;Total;Survival in the first trimester;2021QII;5.272
42 Soria;All ages;Cohort April 1;Total;Survival in the first trimester;2021QI;""
42 Soria;All ages;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
42 Soria;All ages;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
42 Soria;All ages;Cohort April 1;Total;Survival in the first trimester;2020QII;5.293
42 Soria;All ages;Cohort April 1;Total;Survival in the first trimester;2020QI;""
42 Soria;All ages;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
42 Soria;All ages;Cohort April 1;Total;Survival in the second trimester;2022QIII;5.150
42 Soria;All ages;Cohort April 1;Total;Survival in the second trimester;2022QII;""
42 Soria;All ages;Cohort April 1;Total;Survival in the second trimester;2022QI;""
42 Soria;All ages;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
42 Soria;All ages;Cohort April 1;Total;Survival in the second trimester;2021QIII;5.157
42 Soria;All ages;Cohort April 1;Total;Survival in the second trimester;2021QII;""
42 Soria;All ages;Cohort April 1;Total;Survival in the second trimester;2021QI;""
42 Soria;All ages;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
42 Soria;All ages;Cohort April 1;Total;Survival in the second trimester;2020QIII;5.172
42 Soria;All ages;Cohort April 1;Total;Survival in the second trimester;2020QII;""
42 Soria;All ages;Cohort April 1;Total;Survival in the second trimester;2020QI;""
42 Soria;All ages;Cohort April 1;Total;Survival in the third trimester;2022QIV;4.981
42 Soria;All ages;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
42 Soria;All ages;Cohort April 1;Total;Survival in the third trimester;2022QII;""
42 Soria;All ages;Cohort April 1;Total;Survival in the third trimester;2022QI;""
42 Soria;All ages;Cohort April 1;Total;Survival in the third trimester;2021QIV;5.047
42 Soria;All ages;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
42 Soria;All ages;Cohort April 1;Total;Survival in the third trimester;2021QII;""
42 Soria;All ages;Cohort April 1;Total;Survival in the third trimester;2021QI;""
42 Soria;All ages;Cohort April 1;Total;Survival in the third trimester;2020QIV;5.035
42 Soria;All ages;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
42 Soria;All ages;Cohort April 1;Total;Survival in the third trimester;2020QII;""
42 Soria;All ages;Cohort April 1;Total;Survival in the third trimester;2020QI;""
42 Soria;All ages;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
42 Soria;All ages;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
42 Soria;All ages;Cohort April 1;Total;Survival in the third trimester;2022QII;""
42 Soria;All ages;Cohort April 1;Total;Survival in the third trimester;2022QI;4.954
42 Soria;All ages;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
42 Soria;All ages;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
42 Soria;All ages;Cohort April 1;Total;Survival in the third trimester;2021QII;""
42 Soria;All ages;Cohort April 1;Total;Survival in the third trimester;2021QI;4.970
42 Soria;All ages;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
42 Soria;All ages;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
42 Soria;All ages;Cohort April 1;Total;Survival in the third trimester;2020QII;""
42 Soria;All ages;Cohort April 1;Total;Survival in the third trimester;2020QI;""
42 Soria;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
42 Soria;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
42 Soria;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
42 Soria;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
42 Soria;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
42 Soria;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
42 Soria;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
42 Soria;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
42 Soria;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
42 Soria;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
42 Soria;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
42 Soria;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
42 Soria;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
42 Soria;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
42 Soria;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;97,54
42 Soria;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
42 Soria;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
42 Soria;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
42 Soria;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;97,72
42 Soria;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
42 Soria;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
42 Soria;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
42 Soria;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;98,24
42 Soria;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
42 Soria;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
42 Soria;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;95,16
42 Soria;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
42 Soria;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
42 Soria;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
42 Soria;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;95,59
42 Soria;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
42 Soria;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
42 Soria;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
42 Soria;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;95,99
42 Soria;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
42 Soria;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
42 Soria;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;92,04
42 Soria;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
42 Soria;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
42 Soria;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
42 Soria;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;93,55
42 Soria;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
42 Soria;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
42 Soria;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
42 Soria;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;93,45
42 Soria;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
42 Soria;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
42 Soria;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
42 Soria;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
42 Soria;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
42 Soria;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
42 Soria;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;91,83
42 Soria;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
42 Soria;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
42 Soria;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
42 Soria;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;92,24
42 Soria;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
42 Soria;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
42 Soria;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
42 Soria;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
42 Soria;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
42 Soria;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
42 Soria;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QII;3.488
42 Soria;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
42 Soria;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
42 Soria;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
42 Soria;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QII;3.495
42 Soria;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
42 Soria;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
42 Soria;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
42 Soria;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QII;3.490
42 Soria;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
42 Soria;All ages;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
42 Soria;All ages;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
42 Soria;All ages;Cohort April 1;Males;Survival in the first trimester;2022QII;3.409
42 Soria;All ages;Cohort April 1;Males;Survival in the first trimester;2022QI;""
42 Soria;All ages;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
42 Soria;All ages;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
42 Soria;All ages;Cohort April 1;Males;Survival in the first trimester;2021QII;3.427
42 Soria;All ages;Cohort April 1;Males;Survival in the first trimester;2021QI;""
42 Soria;All ages;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
42 Soria;All ages;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
42 Soria;All ages;Cohort April 1;Males;Survival in the first trimester;2020QII;3.438
42 Soria;All ages;Cohort April 1;Males;Survival in the first trimester;2020QI;""
42 Soria;All ages;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
42 Soria;All ages;Cohort April 1;Males;Survival in the second trimester;2022QIII;3.342
42 Soria;All ages;Cohort April 1;Males;Survival in the second trimester;2022QII;""
42 Soria;All ages;Cohort April 1;Males;Survival in the second trimester;2022QI;""
42 Soria;All ages;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
42 Soria;All ages;Cohort April 1;Males;Survival in the second trimester;2021QIII;3.361
42 Soria;All ages;Cohort April 1;Males;Survival in the second trimester;2021QII;""
42 Soria;All ages;Cohort April 1;Males;Survival in the second trimester;2021QI;""
42 Soria;All ages;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
42 Soria;All ages;Cohort April 1;Males;Survival in the second trimester;2020QIII;3.368
42 Soria;All ages;Cohort April 1;Males;Survival in the second trimester;2020QII;""
42 Soria;All ages;Cohort April 1;Males;Survival in the second trimester;2020QI;""
42 Soria;All ages;Cohort April 1;Males;Survival in the third trimester;2022QIV;3.242
42 Soria;All ages;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
42 Soria;All ages;Cohort April 1;Males;Survival in the third trimester;2022QII;""
42 Soria;All ages;Cohort April 1;Males;Survival in the third trimester;2022QI;""
42 Soria;All ages;Cohort April 1;Males;Survival in the third trimester;2021QIV;3.291
42 Soria;All ages;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
42 Soria;All ages;Cohort April 1;Males;Survival in the third trimester;2021QII;""
42 Soria;All ages;Cohort April 1;Males;Survival in the third trimester;2021QI;""
42 Soria;All ages;Cohort April 1;Males;Survival in the third trimester;2020QIV;3.282
42 Soria;All ages;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
42 Soria;All ages;Cohort April 1;Males;Survival in the third trimester;2020QII;""
42 Soria;All ages;Cohort April 1;Males;Survival in the third trimester;2020QI;""
42 Soria;All ages;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
42 Soria;All ages;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
42 Soria;All ages;Cohort April 1;Males;Survival in the third trimester;2022QII;""
42 Soria;All ages;Cohort April 1;Males;Survival in the third trimester;2022QI;3.235
42 Soria;All ages;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
42 Soria;All ages;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
42 Soria;All ages;Cohort April 1;Males;Survival in the third trimester;2021QII;""
42 Soria;All ages;Cohort April 1;Males;Survival in the third trimester;2021QI;3.246
42 Soria;All ages;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
42 Soria;All ages;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
42 Soria;All ages;Cohort April 1;Males;Survival in the third trimester;2020QII;""
42 Soria;All ages;Cohort April 1;Males;Survival in the third trimester;2020QI;""
42 Soria;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
42 Soria;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
42 Soria;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
42 Soria;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
42 Soria;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
42 Soria;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
42 Soria;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
42 Soria;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
42 Soria;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
42 Soria;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
42 Soria;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
42 Soria;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
42 Soria;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
42 Soria;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
42 Soria;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;97,74
42 Soria;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
42 Soria;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
42 Soria;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
42 Soria;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;98,05
42 Soria;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
42 Soria;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
42 Soria;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
42 Soria;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;98,51
42 Soria;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
42 Soria;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
42 Soria;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;95,81
42 Soria;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
42 Soria;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
42 Soria;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
42 Soria;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;96,17
42 Soria;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
42 Soria;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
42 Soria;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
42 Soria;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;96,5
42 Soria;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
42 Soria;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
42 Soria;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;92,95
42 Soria;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
42 Soria;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
42 Soria;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
42 Soria;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;94,16
42 Soria;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
42 Soria;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
42 Soria;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
42 Soria;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;94,04
42 Soria;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
42 Soria;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
42 Soria;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
42 Soria;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
42 Soria;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
42 Soria;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
42 Soria;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;92,56
42 Soria;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
42 Soria;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
42 Soria;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
42 Soria;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;93,01
42 Soria;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
42 Soria;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
42 Soria;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
42 Soria;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
42 Soria;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
42 Soria;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
42 Soria;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QII;1.924
42 Soria;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
42 Soria;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
42 Soria;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
42 Soria;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QII;1.900
42 Soria;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
42 Soria;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
42 Soria;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
42 Soria;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QII;1.898
42 Soria;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
42 Soria;All ages;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
42 Soria;All ages;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
42 Soria;All ages;Cohort April 1;Females;Survival in the first trimester;2022QII;1.870
42 Soria;All ages;Cohort April 1;Females;Survival in the first trimester;2022QI;""
42 Soria;All ages;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
42 Soria;All ages;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
42 Soria;All ages;Cohort April 1;Females;Survival in the first trimester;2021QII;1.845
42 Soria;All ages;Cohort April 1;Females;Survival in the first trimester;2021QI;""
42 Soria;All ages;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
42 Soria;All ages;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
42 Soria;All ages;Cohort April 1;Females;Survival in the first trimester;2020QII;1.855
42 Soria;All ages;Cohort April 1;Females;Survival in the first trimester;2020QI;""
42 Soria;All ages;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
42 Soria;All ages;Cohort April 1;Females;Survival in the second trimester;2022QIII;1.808
42 Soria;All ages;Cohort April 1;Females;Survival in the second trimester;2022QII;""
42 Soria;All ages;Cohort April 1;Females;Survival in the second trimester;2022QI;""
42 Soria;All ages;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
42 Soria;All ages;Cohort April 1;Females;Survival in the second trimester;2021QIII;1.796
42 Soria;All ages;Cohort April 1;Females;Survival in the second trimester;2021QII;""
42 Soria;All ages;Cohort April 1;Females;Survival in the second trimester;2021QI;""
42 Soria;All ages;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
42 Soria;All ages;Cohort April 1;Females;Survival in the second trimester;2020QIII;1.804
42 Soria;All ages;Cohort April 1;Females;Survival in the second trimester;2020QII;""
42 Soria;All ages;Cohort April 1;Females;Survival in the second trimester;2020QI;""
42 Soria;All ages;Cohort April 1;Females;Survival in the third trimester;2022QIV;1.739
42 Soria;All ages;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
42 Soria;All ages;Cohort April 1;Females;Survival in the third trimester;2022QII;""
42 Soria;All ages;Cohort April 1;Females;Survival in the third trimester;2022QI;""
42 Soria;All ages;Cohort April 1;Females;Survival in the third trimester;2021QIV;1.756
42 Soria;All ages;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
42 Soria;All ages;Cohort April 1;Females;Survival in the third trimester;2021QII;""
42 Soria;All ages;Cohort April 1;Females;Survival in the third trimester;2021QI;""
42 Soria;All ages;Cohort April 1;Females;Survival in the third trimester;2020QIV;1.753
42 Soria;All ages;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
42 Soria;All ages;Cohort April 1;Females;Survival in the third trimester;2020QII;""
42 Soria;All ages;Cohort April 1;Females;Survival in the third trimester;2020QI;""
42 Soria;All ages;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
42 Soria;All ages;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
42 Soria;All ages;Cohort April 1;Females;Survival in the third trimester;2022QII;""
42 Soria;All ages;Cohort April 1;Females;Survival in the third trimester;2022QI;1.719
42 Soria;All ages;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
42 Soria;All ages;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
42 Soria;All ages;Cohort April 1;Females;Survival in the third trimester;2021QII;""
42 Soria;All ages;Cohort April 1;Females;Survival in the third trimester;2021QI;1.724
42 Soria;All ages;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
42 Soria;All ages;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
42 Soria;All ages;Cohort April 1;Females;Survival in the third trimester;2020QII;""
42 Soria;All ages;Cohort April 1;Females;Survival in the third trimester;2020QI;""
42 Soria;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
42 Soria;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
42 Soria;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
42 Soria;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
42 Soria;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
42 Soria;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
42 Soria;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
42 Soria;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
42 Soria;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
42 Soria;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
42 Soria;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
42 Soria;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
42 Soria;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
42 Soria;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
42 Soria;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;97,19
42 Soria;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
42 Soria;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
42 Soria;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
42 Soria;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;97,11
42 Soria;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
42 Soria;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
42 Soria;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
42 Soria;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;97,73
42 Soria;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
42 Soria;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
42 Soria;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;93,97
42 Soria;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
42 Soria;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
42 Soria;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
42 Soria;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;94,53
42 Soria;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
42 Soria;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
42 Soria;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
42 Soria;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;95,05
42 Soria;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
42 Soria;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
42 Soria;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;90,38
42 Soria;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
42 Soria;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
42 Soria;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
42 Soria;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;92,42
42 Soria;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
42 Soria;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
42 Soria;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
42 Soria;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;92,36
42 Soria;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
42 Soria;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
42 Soria;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
42 Soria;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
42 Soria;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
42 Soria;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
42 Soria;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;90,47
42 Soria;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
42 Soria;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
42 Soria;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
42 Soria;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;90,83
42 Soria;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
42 Soria;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
42 Soria;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
42 Soria;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
42 Soria;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
42 Soria;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QIII;5.448
42 Soria;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
42 Soria;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
42 Soria;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
42 Soria;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QIII;5.454
42 Soria;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
42 Soria;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
42 Soria;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
42 Soria;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QIII;5.405
42 Soria;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
42 Soria;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
42 Soria;All ages;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
42 Soria;All ages;Cohort July 1;Total;Survival in the first trimester;2022QIII;5.280
42 Soria;All ages;Cohort July 1;Total;Survival in the first trimester;2022QII;""
42 Soria;All ages;Cohort July 1;Total;Survival in the first trimester;2022QI;""
42 Soria;All ages;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
42 Soria;All ages;Cohort July 1;Total;Survival in the first trimester;2021QIII;5.313
42 Soria;All ages;Cohort July 1;Total;Survival in the first trimester;2021QII;""
42 Soria;All ages;Cohort July 1;Total;Survival in the first trimester;2021QI;""
42 Soria;All ages;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
42 Soria;All ages;Cohort July 1;Total;Survival in the first trimester;2020QIII;5.270
42 Soria;All ages;Cohort July 1;Total;Survival in the first trimester;2020QII;""
42 Soria;All ages;Cohort July 1;Total;Survival in the first trimester;2020QI;""
42 Soria;All ages;Cohort July 1;Total;Survival in the second trimester;2022QIV;5.090
42 Soria;All ages;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
42 Soria;All ages;Cohort July 1;Total;Survival in the second trimester;2022QII;""
42 Soria;All ages;Cohort July 1;Total;Survival in the second trimester;2022QI;""
42 Soria;All ages;Cohort July 1;Total;Survival in the second trimester;2021QIV;5.180
42 Soria;All ages;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
42 Soria;All ages;Cohort July 1;Total;Survival in the second trimester;2021QII;""
42 Soria;All ages;Cohort July 1;Total;Survival in the second trimester;2021QI;""
42 Soria;All ages;Cohort July 1;Total;Survival in the second trimester;2020QIV;5.113
42 Soria;All ages;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
42 Soria;All ages;Cohort July 1;Total;Survival in the second trimester;2020QII;""
42 Soria;All ages;Cohort July 1;Total;Survival in the second trimester;2020QI;""
42 Soria;All ages;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
42 Soria;All ages;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
42 Soria;All ages;Cohort July 1;Total;Survival in the third trimester;2022QII;""
42 Soria;All ages;Cohort July 1;Total;Survival in the third trimester;2022QI;5.081
42 Soria;All ages;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
42 Soria;All ages;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
42 Soria;All ages;Cohort July 1;Total;Survival in the third trimester;2021QII;""
42 Soria;All ages;Cohort July 1;Total;Survival in the third trimester;2021QI;5.042
42 Soria;All ages;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
42 Soria;All ages;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
42 Soria;All ages;Cohort July 1;Total;Survival in the third trimester;2020QII;""
42 Soria;All ages;Cohort July 1;Total;Survival in the third trimester;2020QI;""
42 Soria;All ages;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
42 Soria;All ages;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
42 Soria;All ages;Cohort July 1;Total;Survival in the third trimester;2022QII;4.981
42 Soria;All ages;Cohort July 1;Total;Survival in the third trimester;2022QI;""
42 Soria;All ages;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
42 Soria;All ages;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
42 Soria;All ages;Cohort July 1;Total;Survival in the third trimester;2021QII;4.954
42 Soria;All ages;Cohort July 1;Total;Survival in the third trimester;2021QI;""
42 Soria;All ages;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
42 Soria;All ages;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
42 Soria;All ages;Cohort July 1;Total;Survival in the third trimester;2020QII;""
42 Soria;All ages;Cohort July 1;Total;Survival in the third trimester;2020QI;""
42 Soria;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
42 Soria;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
42 Soria;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
42 Soria;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
42 Soria;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
42 Soria;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
42 Soria;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
42 Soria;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
42 Soria;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
42 Soria;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
42 Soria;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
42 Soria;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
42 Soria;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
42 Soria;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;96,92
42 Soria;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
42 Soria;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
42 Soria;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
42 Soria;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;97,41
42 Soria;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
42 Soria;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
42 Soria;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
42 Soria;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;97,5
42 Soria;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
42 Soria;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
42 Soria;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;93,43
42 Soria;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
42 Soria;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
42 Soria;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
42 Soria;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;94,98
42 Soria;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
42 Soria;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
42 Soria;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
42 Soria;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;94,6
42 Soria;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
42 Soria;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
42 Soria;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
42 Soria;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
42 Soria;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
42 Soria;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
42 Soria;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;93,16
42 Soria;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
42 Soria;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
42 Soria;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
42 Soria;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;93,28
42 Soria;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
42 Soria;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
42 Soria;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
42 Soria;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
42 Soria;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
42 Soria;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
42 Soria;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;91,33
42 Soria;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
42 Soria;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
42 Soria;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
42 Soria;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;91,66
42 Soria;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
42 Soria;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
42 Soria;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
42 Soria;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
42 Soria;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
42 Soria;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
42 Soria;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QIII;3.514
42 Soria;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
42 Soria;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
42 Soria;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
42 Soria;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QIII;3.537
42 Soria;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
42 Soria;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
42 Soria;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
42 Soria;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QIII;3.512
42 Soria;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
42 Soria;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
42 Soria;All ages;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
42 Soria;All ages;Cohort July 1;Males;Survival in the first trimester;2022QIII;3.427
42 Soria;All ages;Cohort July 1;Males;Survival in the first trimester;2022QII;""
42 Soria;All ages;Cohort July 1;Males;Survival in the first trimester;2022QI;""
42 Soria;All ages;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
42 Soria;All ages;Cohort July 1;Males;Survival in the first trimester;2021QIII;3.456
42 Soria;All ages;Cohort July 1;Males;Survival in the first trimester;2021QII;""
42 Soria;All ages;Cohort July 1;Males;Survival in the first trimester;2021QI;""
42 Soria;All ages;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
42 Soria;All ages;Cohort July 1;Males;Survival in the first trimester;2020QIII;3.432
42 Soria;All ages;Cohort July 1;Males;Survival in the first trimester;2020QII;""
42 Soria;All ages;Cohort July 1;Males;Survival in the first trimester;2020QI;""
42 Soria;All ages;Cohort July 1;Males;Survival in the second trimester;2022QIV;3.312
42 Soria;All ages;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
42 Soria;All ages;Cohort July 1;Males;Survival in the second trimester;2022QII;""
42 Soria;All ages;Cohort July 1;Males;Survival in the second trimester;2022QI;""
42 Soria;All ages;Cohort July 1;Males;Survival in the second trimester;2021QIV;3.371
42 Soria;All ages;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
42 Soria;All ages;Cohort July 1;Males;Survival in the second trimester;2021QII;""
42 Soria;All ages;Cohort July 1;Males;Survival in the second trimester;2021QI;""
42 Soria;All ages;Cohort July 1;Males;Survival in the second trimester;2020QIV;3.332
42 Soria;All ages;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
42 Soria;All ages;Cohort July 1;Males;Survival in the second trimester;2020QII;""
42 Soria;All ages;Cohort July 1;Males;Survival in the second trimester;2020QI;""
42 Soria;All ages;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
42 Soria;All ages;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
42 Soria;All ages;Cohort July 1;Males;Survival in the third trimester;2022QII;""
42 Soria;All ages;Cohort July 1;Males;Survival in the third trimester;2022QI;3.311
42 Soria;All ages;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
42 Soria;All ages;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
42 Soria;All ages;Cohort July 1;Males;Survival in the third trimester;2021QII;""
42 Soria;All ages;Cohort July 1;Males;Survival in the third trimester;2021QI;3.291
42 Soria;All ages;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
42 Soria;All ages;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
42 Soria;All ages;Cohort July 1;Males;Survival in the third trimester;2020QII;""
42 Soria;All ages;Cohort July 1;Males;Survival in the third trimester;2020QI;""
42 Soria;All ages;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
42 Soria;All ages;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
42 Soria;All ages;Cohort July 1;Males;Survival in the third trimester;2022QII;3.252
42 Soria;All ages;Cohort July 1;Males;Survival in the third trimester;2022QI;""
42 Soria;All ages;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
42 Soria;All ages;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
42 Soria;All ages;Cohort July 1;Males;Survival in the third trimester;2021QII;3.240
42 Soria;All ages;Cohort July 1;Males;Survival in the third trimester;2021QI;""
42 Soria;All ages;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
42 Soria;All ages;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
42 Soria;All ages;Cohort July 1;Males;Survival in the third trimester;2020QII;""
42 Soria;All ages;Cohort July 1;Males;Survival in the third trimester;2020QI;""
42 Soria;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
42 Soria;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
42 Soria;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
42 Soria;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
42 Soria;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
42 Soria;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
42 Soria;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
42 Soria;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
42 Soria;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
42 Soria;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
42 Soria;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
42 Soria;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
42 Soria;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
42 Soria;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;97,52
42 Soria;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
42 Soria;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
42 Soria;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
42 Soria;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;97,71
42 Soria;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
42 Soria;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
42 Soria;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
42 Soria;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;97,72
42 Soria;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
42 Soria;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
42 Soria;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;94,25
42 Soria;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
42 Soria;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
42 Soria;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
42 Soria;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;95,31
42 Soria;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
42 Soria;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
42 Soria;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
42 Soria;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;94,87
42 Soria;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
42 Soria;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
42 Soria;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
42 Soria;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
42 Soria;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
42 Soria;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
42 Soria;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;93,61
42 Soria;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
42 Soria;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
42 Soria;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
42 Soria;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;93,71
42 Soria;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
42 Soria;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
42 Soria;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
42 Soria;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
42 Soria;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
42 Soria;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
42 Soria;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;91,94
42 Soria;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
42 Soria;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
42 Soria;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
42 Soria;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;92,26
42 Soria;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
42 Soria;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
42 Soria;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
42 Soria;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
42 Soria;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
42 Soria;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
42 Soria;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QIII;1.934
42 Soria;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
42 Soria;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
42 Soria;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
42 Soria;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QIII;1.917
42 Soria;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
42 Soria;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
42 Soria;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
42 Soria;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QIII;1.893
42 Soria;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
42 Soria;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
42 Soria;All ages;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
42 Soria;All ages;Cohort July 1;Females;Survival in the first trimester;2022QIII;1.853
42 Soria;All ages;Cohort July 1;Females;Survival in the first trimester;2022QII;""
42 Soria;All ages;Cohort July 1;Females;Survival in the first trimester;2022QI;""
42 Soria;All ages;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
42 Soria;All ages;Cohort July 1;Females;Survival in the first trimester;2021QIII;1.857
42 Soria;All ages;Cohort July 1;Females;Survival in the first trimester;2021QII;""
42 Soria;All ages;Cohort July 1;Females;Survival in the first trimester;2021QI;""
42 Soria;All ages;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
42 Soria;All ages;Cohort July 1;Females;Survival in the first trimester;2020QIII;1.838
42 Soria;All ages;Cohort July 1;Females;Survival in the first trimester;2020QII;""
42 Soria;All ages;Cohort July 1;Females;Survival in the first trimester;2020QI;""
42 Soria;All ages;Cohort July 1;Females;Survival in the second trimester;2022QIV;1.778
42 Soria;All ages;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
42 Soria;All ages;Cohort July 1;Females;Survival in the second trimester;2022QII;""
42 Soria;All ages;Cohort July 1;Females;Survival in the second trimester;2022QI;""
42 Soria;All ages;Cohort July 1;Females;Survival in the second trimester;2021QIV;1.809
42 Soria;All ages;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
42 Soria;All ages;Cohort July 1;Females;Survival in the second trimester;2021QII;""
42 Soria;All ages;Cohort July 1;Females;Survival in the second trimester;2021QI;""
42 Soria;All ages;Cohort July 1;Females;Survival in the second trimester;2020QIV;1.781
42 Soria;All ages;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
42 Soria;All ages;Cohort July 1;Females;Survival in the second trimester;2020QII;""
42 Soria;All ages;Cohort July 1;Females;Survival in the second trimester;2020QI;""
42 Soria;All ages;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
42 Soria;All ages;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
42 Soria;All ages;Cohort July 1;Females;Survival in the third trimester;2022QII;""
42 Soria;All ages;Cohort July 1;Females;Survival in the third trimester;2022QI;1.770
42 Soria;All ages;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
42 Soria;All ages;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
42 Soria;All ages;Cohort July 1;Females;Survival in the third trimester;2021QII;""
42 Soria;All ages;Cohort July 1;Females;Survival in the third trimester;2021QI;1.751
42 Soria;All ages;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
42 Soria;All ages;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
42 Soria;All ages;Cohort July 1;Females;Survival in the third trimester;2020QII;""
42 Soria;All ages;Cohort July 1;Females;Survival in the third trimester;2020QI;""
42 Soria;All ages;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
42 Soria;All ages;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
42 Soria;All ages;Cohort July 1;Females;Survival in the third trimester;2022QII;1.729
42 Soria;All ages;Cohort July 1;Females;Survival in the third trimester;2022QI;""
42 Soria;All ages;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
42 Soria;All ages;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
42 Soria;All ages;Cohort July 1;Females;Survival in the third trimester;2021QII;1.714
42 Soria;All ages;Cohort July 1;Females;Survival in the third trimester;2021QI;""
42 Soria;All ages;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
42 Soria;All ages;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
42 Soria;All ages;Cohort July 1;Females;Survival in the third trimester;2020QII;""
42 Soria;All ages;Cohort July 1;Females;Survival in the third trimester;2020QI;""
42 Soria;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
42 Soria;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
42 Soria;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
42 Soria;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
42 Soria;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
42 Soria;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
42 Soria;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
42 Soria;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
42 Soria;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
42 Soria;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
42 Soria;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
42 Soria;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
42 Soria;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
42 Soria;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;95,81
42 Soria;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
42 Soria;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
42 Soria;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
42 Soria;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;96,87
42 Soria;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
42 Soria;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
42 Soria;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
42 Soria;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;97,09
42 Soria;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
42 Soria;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
42 Soria;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;91,93
42 Soria;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
42 Soria;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
42 Soria;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
42 Soria;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;94,37
42 Soria;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
42 Soria;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
42 Soria;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
42 Soria;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;94,08
42 Soria;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
42 Soria;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
42 Soria;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
42 Soria;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
42 Soria;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
42 Soria;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
42 Soria;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;92,33
42 Soria;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
42 Soria;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
42 Soria;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
42 Soria;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;92,5
42 Soria;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
42 Soria;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
42 Soria;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
42 Soria;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
42 Soria;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
42 Soria;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
42 Soria;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;90,19
42 Soria;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
42 Soria;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
42 Soria;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
42 Soria;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;90,54
42 Soria;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
42 Soria;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
42 Soria;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
42 Soria;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
42 Soria;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
42 Soria;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QIV;5.421
42 Soria;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
42 Soria;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
42 Soria;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
42 Soria;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QIV;5.429
42 Soria;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
42 Soria;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
42 Soria;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
42 Soria;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QIV;5.439
42 Soria;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
42 Soria;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
42 Soria;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
42 Soria;All ages;Cohort October 1;Total;Survival in the first trimester;2022QIV;5.217
42 Soria;All ages;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
42 Soria;All ages;Cohort October 1;Total;Survival in the first trimester;2022QII;""
42 Soria;All ages;Cohort October 1;Total;Survival in the first trimester;2022QI;""
42 Soria;All ages;Cohort October 1;Total;Survival in the first trimester;2021QIV;5.280
42 Soria;All ages;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
42 Soria;All ages;Cohort October 1;Total;Survival in the first trimester;2021QII;""
42 Soria;All ages;Cohort October 1;Total;Survival in the first trimester;2021QI;""
42 Soria;All ages;Cohort October 1;Total;Survival in the first trimester;2020QIV;5.262
42 Soria;All ages;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
42 Soria;All ages;Cohort October 1;Total;Survival in the first trimester;2020QII;""
42 Soria;All ages;Cohort October 1;Total;Survival in the first trimester;2020QI;""
42 Soria;All ages;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
42 Soria;All ages;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
42 Soria;All ages;Cohort October 1;Total;Survival in the second trimester;2022QII;""
42 Soria;All ages;Cohort October 1;Total;Survival in the second trimester;2022QI;5.175
42 Soria;All ages;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
42 Soria;All ages;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
42 Soria;All ages;Cohort October 1;Total;Survival in the second trimester;2021QII;""
42 Soria;All ages;Cohort October 1;Total;Survival in the second trimester;2021QI;5.177
42 Soria;All ages;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
42 Soria;All ages;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
42 Soria;All ages;Cohort October 1;Total;Survival in the second trimester;2020QII;""
42 Soria;All ages;Cohort October 1;Total;Survival in the second trimester;2020QI;""
42 Soria;All ages;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
42 Soria;All ages;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
42 Soria;All ages;Cohort October 1;Total;Survival in the third trimester;2022QII;5.064
42 Soria;All ages;Cohort October 1;Total;Survival in the third trimester;2022QI;""
42 Soria;All ages;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
42 Soria;All ages;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
42 Soria;All ages;Cohort October 1;Total;Survival in the third trimester;2021QII;5.080
42 Soria;All ages;Cohort October 1;Total;Survival in the third trimester;2021QI;""
42 Soria;All ages;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
42 Soria;All ages;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
42 Soria;All ages;Cohort October 1;Total;Survival in the third trimester;2020QII;""
42 Soria;All ages;Cohort October 1;Total;Survival in the third trimester;2020QI;""
42 Soria;All ages;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
42 Soria;All ages;Cohort October 1;Total;Survival in the third trimester;2022QIII;4.944
42 Soria;All ages;Cohort October 1;Total;Survival in the third trimester;2022QII;""
42 Soria;All ages;Cohort October 1;Total;Survival in the third trimester;2022QI;""
42 Soria;All ages;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
42 Soria;All ages;Cohort October 1;Total;Survival in the third trimester;2021QIII;4.980
42 Soria;All ages;Cohort October 1;Total;Survival in the third trimester;2021QII;""
42 Soria;All ages;Cohort October 1;Total;Survival in the third trimester;2021QI;""
42 Soria;All ages;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
42 Soria;All ages;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
42 Soria;All ages;Cohort October 1;Total;Survival in the third trimester;2020QII;""
42 Soria;All ages;Cohort October 1;Total;Survival in the third trimester;2020QI;""
42 Soria;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
42 Soria;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
42 Soria;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
42 Soria;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
42 Soria;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
42 Soria;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
42 Soria;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
42 Soria;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
42 Soria;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
42 Soria;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
42 Soria;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
42 Soria;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
42 Soria;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;96,24
42 Soria;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
42 Soria;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
42 Soria;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
42 Soria;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;97,26
42 Soria;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
42 Soria;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
42 Soria;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
42 Soria;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;96,75
42 Soria;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
42 Soria;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
42 Soria;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
42 Soria;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
42 Soria;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
42 Soria;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
42 Soria;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;95,32
42 Soria;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
42 Soria;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
42 Soria;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
42 Soria;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;95,18
42 Soria;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
42 Soria;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
42 Soria;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
42 Soria;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
42 Soria;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
42 Soria;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
42 Soria;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;93,28
42 Soria;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
42 Soria;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
42 Soria;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
42 Soria;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;93,4
42 Soria;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
42 Soria;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
42 Soria;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
42 Soria;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
42 Soria;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
42 Soria;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
42 Soria;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;91,07
42 Soria;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
42 Soria;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
42 Soria;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
42 Soria;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;91,56
42 Soria;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
42 Soria;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
42 Soria;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
42 Soria;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
42 Soria;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
42 Soria;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
42 Soria;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QIV;3.507
42 Soria;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
42 Soria;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
42 Soria;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
42 Soria;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QIV;3.515
42 Soria;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
42 Soria;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
42 Soria;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
42 Soria;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QIV;3.526
42 Soria;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
42 Soria;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
42 Soria;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
42 Soria;All ages;Cohort October 1;Males;Survival in the first trimester;2022QIV;3.388
42 Soria;All ages;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
42 Soria;All ages;Cohort October 1;Males;Survival in the first trimester;2022QII;""
42 Soria;All ages;Cohort October 1;Males;Survival in the first trimester;2022QI;""
42 Soria;All ages;Cohort October 1;Males;Survival in the first trimester;2021QIV;3.425
42 Soria;All ages;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
42 Soria;All ages;Cohort October 1;Males;Survival in the first trimester;2021QII;""
42 Soria;All ages;Cohort October 1;Males;Survival in the first trimester;2021QI;""
42 Soria;All ages;Cohort October 1;Males;Survival in the first trimester;2020QIV;3.413
42 Soria;All ages;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
42 Soria;All ages;Cohort October 1;Males;Survival in the first trimester;2020QII;""
42 Soria;All ages;Cohort October 1;Males;Survival in the first trimester;2020QI;""
42 Soria;All ages;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
42 Soria;All ages;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
42 Soria;All ages;Cohort October 1;Males;Survival in the second trimester;2022QII;""
42 Soria;All ages;Cohort October 1;Males;Survival in the second trimester;2022QI;3.360
42 Soria;All ages;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
42 Soria;All ages;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
42 Soria;All ages;Cohort October 1;Males;Survival in the second trimester;2021QII;""
42 Soria;All ages;Cohort October 1;Males;Survival in the second trimester;2021QI;3.366
42 Soria;All ages;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
42 Soria;All ages;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
42 Soria;All ages;Cohort October 1;Males;Survival in the second trimester;2020QII;""
42 Soria;All ages;Cohort October 1;Males;Survival in the second trimester;2020QI;""
42 Soria;All ages;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
42 Soria;All ages;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
42 Soria;All ages;Cohort October 1;Males;Survival in the third trimester;2022QII;3.294
42 Soria;All ages;Cohort October 1;Males;Survival in the third trimester;2022QI;""
42 Soria;All ages;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
42 Soria;All ages;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
42 Soria;All ages;Cohort October 1;Males;Survival in the third trimester;2021QII;3.309
42 Soria;All ages;Cohort October 1;Males;Survival in the third trimester;2021QI;""
42 Soria;All ages;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
42 Soria;All ages;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
42 Soria;All ages;Cohort October 1;Males;Survival in the third trimester;2020QII;""
42 Soria;All ages;Cohort October 1;Males;Survival in the third trimester;2020QI;""
42 Soria;All ages;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
42 Soria;All ages;Cohort October 1;Males;Survival in the third trimester;2022QIII;3.230
42 Soria;All ages;Cohort October 1;Males;Survival in the third trimester;2022QII;""
42 Soria;All ages;Cohort October 1;Males;Survival in the third trimester;2022QI;""
42 Soria;All ages;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
42 Soria;All ages;Cohort October 1;Males;Survival in the third trimester;2021QIII;3.254
42 Soria;All ages;Cohort October 1;Males;Survival in the third trimester;2021QII;""
42 Soria;All ages;Cohort October 1;Males;Survival in the third trimester;2021QI;""
42 Soria;All ages;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
42 Soria;All ages;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
42 Soria;All ages;Cohort October 1;Males;Survival in the third trimester;2020QII;""
42 Soria;All ages;Cohort October 1;Males;Survival in the third trimester;2020QI;""
42 Soria;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
42 Soria;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
42 Soria;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
42 Soria;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
42 Soria;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
42 Soria;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
42 Soria;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
42 Soria;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
42 Soria;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
42 Soria;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
42 Soria;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
42 Soria;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
42 Soria;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;96,61
42 Soria;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
42 Soria;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
42 Soria;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
42 Soria;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;97,44
42 Soria;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
42 Soria;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
42 Soria;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
42 Soria;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;96,8
42 Soria;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
42 Soria;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
42 Soria;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
42 Soria;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
42 Soria;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
42 Soria;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
42 Soria;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;95,59
42 Soria;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
42 Soria;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
42 Soria;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
42 Soria;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;95,46
42 Soria;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
42 Soria;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
42 Soria;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
42 Soria;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
42 Soria;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
42 Soria;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
42 Soria;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;93,71
42 Soria;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
42 Soria;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
42 Soria;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
42 Soria;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;93,85
42 Soria;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
42 Soria;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
42 Soria;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
42 Soria;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
42 Soria;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
42 Soria;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
42 Soria;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;91,89
42 Soria;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
42 Soria;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
42 Soria;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
42 Soria;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;92,29
42 Soria;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
42 Soria;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
42 Soria;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
42 Soria;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
42 Soria;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
42 Soria;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
42 Soria;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QIV;1.914
42 Soria;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
42 Soria;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
42 Soria;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
42 Soria;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QIV;1.914
42 Soria;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
42 Soria;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
42 Soria;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
42 Soria;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QIV;1.913
42 Soria;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
42 Soria;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
42 Soria;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
42 Soria;All ages;Cohort October 1;Females;Survival in the first trimester;2022QIV;1.829
42 Soria;All ages;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
42 Soria;All ages;Cohort October 1;Females;Survival in the first trimester;2022QII;""
42 Soria;All ages;Cohort October 1;Females;Survival in the first trimester;2022QI;""
42 Soria;All ages;Cohort October 1;Females;Survival in the first trimester;2021QIV;1.855
42 Soria;All ages;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
42 Soria;All ages;Cohort October 1;Females;Survival in the first trimester;2021QII;""
42 Soria;All ages;Cohort October 1;Females;Survival in the first trimester;2021QI;""
42 Soria;All ages;Cohort October 1;Females;Survival in the first trimester;2020QIV;1.849
42 Soria;All ages;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
42 Soria;All ages;Cohort October 1;Females;Survival in the first trimester;2020QII;""
42 Soria;All ages;Cohort October 1;Females;Survival in the first trimester;2020QI;""
42 Soria;All ages;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
42 Soria;All ages;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
42 Soria;All ages;Cohort October 1;Females;Survival in the second trimester;2022QII;""
42 Soria;All ages;Cohort October 1;Females;Survival in the second trimester;2022QI;1.815
42 Soria;All ages;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
42 Soria;All ages;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
42 Soria;All ages;Cohort October 1;Females;Survival in the second trimester;2021QII;""
42 Soria;All ages;Cohort October 1;Females;Survival in the second trimester;2021QI;1.811
42 Soria;All ages;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
42 Soria;All ages;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
42 Soria;All ages;Cohort October 1;Females;Survival in the second trimester;2020QII;""
42 Soria;All ages;Cohort October 1;Females;Survival in the second trimester;2020QI;""
42 Soria;All ages;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
42 Soria;All ages;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
42 Soria;All ages;Cohort October 1;Females;Survival in the third trimester;2022QII;1.770
42 Soria;All ages;Cohort October 1;Females;Survival in the third trimester;2022QI;""
42 Soria;All ages;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
42 Soria;All ages;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
42 Soria;All ages;Cohort October 1;Females;Survival in the third trimester;2021QII;1.771
42 Soria;All ages;Cohort October 1;Females;Survival in the third trimester;2021QI;""
42 Soria;All ages;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
42 Soria;All ages;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
42 Soria;All ages;Cohort October 1;Females;Survival in the third trimester;2020QII;""
42 Soria;All ages;Cohort October 1;Females;Survival in the third trimester;2020QI;""
42 Soria;All ages;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
42 Soria;All ages;Cohort October 1;Females;Survival in the third trimester;2022QIII;1.714
42 Soria;All ages;Cohort October 1;Females;Survival in the third trimester;2022QII;""
42 Soria;All ages;Cohort October 1;Females;Survival in the third trimester;2022QI;""
42 Soria;All ages;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
42 Soria;All ages;Cohort October 1;Females;Survival in the third trimester;2021QIII;1.726
42 Soria;All ages;Cohort October 1;Females;Survival in the third trimester;2021QII;""
42 Soria;All ages;Cohort October 1;Females;Survival in the third trimester;2021QI;""
42 Soria;All ages;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
42 Soria;All ages;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
42 Soria;All ages;Cohort October 1;Females;Survival in the third trimester;2020QII;""
42 Soria;All ages;Cohort October 1;Females;Survival in the third trimester;2020QI;""
42 Soria;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
42 Soria;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
42 Soria;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
42 Soria;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
42 Soria;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
42 Soria;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
42 Soria;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
42 Soria;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
42 Soria;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
42 Soria;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
42 Soria;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
42 Soria;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
42 Soria;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;95,56
42 Soria;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
42 Soria;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
42 Soria;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
42 Soria;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;96,92
42 Soria;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
42 Soria;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
42 Soria;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
42 Soria;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;96,65
42 Soria;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
42 Soria;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
42 Soria;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
42 Soria;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
42 Soria;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
42 Soria;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
42 Soria;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;94,83
42 Soria;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
42 Soria;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
42 Soria;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
42 Soria;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;94,67
42 Soria;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
42 Soria;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
42 Soria;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
42 Soria;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
42 Soria;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
42 Soria;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
42 Soria;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;92,48
42 Soria;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
42 Soria;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
42 Soria;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
42 Soria;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;92,58
42 Soria;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
42 Soria;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
42 Soria;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
42 Soria;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
42 Soria;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
42 Soria;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
42 Soria;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;89,55
42 Soria;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
42 Soria;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
42 Soria;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
42 Soria;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;90,22
42 Soria;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
42 Soria;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
42 Soria;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
42 Soria;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
42 Soria;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
42 Soria;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
42 Soria;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
42 Soria;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
42 Soria;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
42 Soria;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QI;283
42 Soria;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
42 Soria;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
42 Soria;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
42 Soria;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QI;292
42 Soria;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
42 Soria;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
42 Soria;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
42 Soria;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QI;221
42 Soria;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
42 Soria;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
42 Soria;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2022QII;""
42 Soria;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2022QI;263
42 Soria;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
42 Soria;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
42 Soria;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2021QII;""
42 Soria;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2021QI;276
42 Soria;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
42 Soria;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
42 Soria;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2020QII;""
42 Soria;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2020QI;198
42 Soria;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
42 Soria;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
42 Soria;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2022QII;250
42 Soria;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2022QI;""
42 Soria;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
42 Soria;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
42 Soria;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2021QII;262
42 Soria;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2021QI;""
42 Soria;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
42 Soria;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
42 Soria;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2020QII;191
42 Soria;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2020QI;""
42 Soria;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
42 Soria;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QIII;242
42 Soria;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QII;""
42 Soria;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QI;""
42 Soria;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
42 Soria;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QIII;246
42 Soria;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QII;""
42 Soria;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QI;""
42 Soria;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
42 Soria;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QIII;183
42 Soria;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QII;""
42 Soria;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QI;""
42 Soria;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QIV;235
42 Soria;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
42 Soria;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QII;""
42 Soria;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QI;""
42 Soria;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QIV;233
42 Soria;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
42 Soria;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QII;""
42 Soria;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QI;""
42 Soria;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QIV;177
42 Soria;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
42 Soria;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QII;""
42 Soria;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QI;""
42 Soria;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
42 Soria;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
42 Soria;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
42 Soria;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
42 Soria;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
42 Soria;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
42 Soria;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
42 Soria;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
42 Soria;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
42 Soria;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
42 Soria;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
42 Soria;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
42 Soria;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
42 Soria;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
42 Soria;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
42 Soria;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;92,93
42 Soria;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
42 Soria;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
42 Soria;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
42 Soria;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;94,52
42 Soria;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
42 Soria;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
42 Soria;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
42 Soria;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;89,59
42 Soria;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
42 Soria;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
42 Soria;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;88,34
42 Soria;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
42 Soria;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
42 Soria;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
42 Soria;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;89,73
42 Soria;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
42 Soria;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
42 Soria;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
42 Soria;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;86,43
42 Soria;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
42 Soria;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
42 Soria;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;85,51
42 Soria;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
42 Soria;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
42 Soria;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
42 Soria;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;84,25
42 Soria;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
42 Soria;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
42 Soria;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
42 Soria;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;82,81
42 Soria;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
42 Soria;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
42 Soria;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;83,04
42 Soria;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
42 Soria;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
42 Soria;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
42 Soria;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;79,79
42 Soria;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
42 Soria;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
42 Soria;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
42 Soria;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;80,09
42 Soria;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
42 Soria;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
42 Soria;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
42 Soria;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
42 Soria;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
42 Soria;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
42 Soria;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QI;177
42 Soria;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
42 Soria;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
42 Soria;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
42 Soria;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QI;179
42 Soria;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
42 Soria;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
42 Soria;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
42 Soria;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QI;136
42 Soria;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
42 Soria;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
42 Soria;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2022QII;""
42 Soria;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2022QI;161
42 Soria;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
42 Soria;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
42 Soria;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2021QII;""
42 Soria;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2021QI;171
42 Soria;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
42 Soria;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
42 Soria;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2020QII;""
42 Soria;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2020QI;122
42 Soria;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
42 Soria;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
42 Soria;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2022QII;154
42 Soria;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2022QI;""
42 Soria;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
42 Soria;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
42 Soria;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2021QII;165
42 Soria;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2021QI;""
42 Soria;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
42 Soria;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
42 Soria;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2020QII;119
42 Soria;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2020QI;""
42 Soria;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
42 Soria;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QIII;151
42 Soria;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QII;""
42 Soria;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QI;""
42 Soria;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
42 Soria;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QIII;158
42 Soria;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QII;""
42 Soria;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QI;""
42 Soria;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
42 Soria;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QIII;113
42 Soria;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QII;""
42 Soria;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QI;""
42 Soria;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QIV;147
42 Soria;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
42 Soria;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QII;""
42 Soria;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QI;""
42 Soria;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QIV;149
42 Soria;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
42 Soria;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QII;""
42 Soria;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QI;""
42 Soria;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QIV;110
42 Soria;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
42 Soria;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QII;""
42 Soria;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QI;""
42 Soria;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
42 Soria;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
42 Soria;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
42 Soria;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
42 Soria;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
42 Soria;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
42 Soria;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
42 Soria;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
42 Soria;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
42 Soria;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
42 Soria;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
42 Soria;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
42 Soria;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
42 Soria;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
42 Soria;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
42 Soria;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;90,96
42 Soria;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
42 Soria;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
42 Soria;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
42 Soria;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;95,53
42 Soria;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
42 Soria;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
42 Soria;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
42 Soria;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;89,71
42 Soria;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
42 Soria;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
42 Soria;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;87,01
42 Soria;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
42 Soria;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
42 Soria;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
42 Soria;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;92,18
42 Soria;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
42 Soria;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
42 Soria;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
42 Soria;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;87,5
42 Soria;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
42 Soria;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
42 Soria;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;85,31
42 Soria;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
42 Soria;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
42 Soria;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
42 Soria;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;88,27
42 Soria;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
42 Soria;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
42 Soria;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
42 Soria;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;83,09
42 Soria;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
42 Soria;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
42 Soria;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;83,05
42 Soria;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
42 Soria;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
42 Soria;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
42 Soria;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;83,24
42 Soria;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
42 Soria;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
42 Soria;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
42 Soria;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;80,88
42 Soria;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
42 Soria;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
42 Soria;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
42 Soria;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
42 Soria;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
42 Soria;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
42 Soria;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QI;106
42 Soria;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
42 Soria;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
42 Soria;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
42 Soria;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QI;113
42 Soria;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
42 Soria;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
42 Soria;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
42 Soria;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QI;85
42 Soria;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
42 Soria;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
42 Soria;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2022QII;""
42 Soria;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2022QI;102
42 Soria;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
42 Soria;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
42 Soria;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2021QII;""
42 Soria;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2021QI;105
42 Soria;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
42 Soria;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
42 Soria;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2020QII;""
42 Soria;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2020QI;76
42 Soria;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
42 Soria;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
42 Soria;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2022QII;96
42 Soria;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2022QI;""
42 Soria;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
42 Soria;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
42 Soria;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2021QII;97
42 Soria;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2021QI;""
42 Soria;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
42 Soria;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
42 Soria;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2020QII;72
42 Soria;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2020QI;""
42 Soria;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
42 Soria;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QIII;91
42 Soria;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QII;""
42 Soria;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QI;""
42 Soria;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
42 Soria;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QIII;88
42 Soria;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QII;""
42 Soria;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QI;""
42 Soria;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
42 Soria;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QIII;70
42 Soria;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QII;""
42 Soria;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QI;""
42 Soria;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QIV;88
42 Soria;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
42 Soria;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QII;""
42 Soria;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QI;""
42 Soria;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QIV;84
42 Soria;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
42 Soria;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QII;""
42 Soria;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QI;""
42 Soria;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QIV;67
42 Soria;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
42 Soria;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QII;""
42 Soria;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QI;""
42 Soria;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
42 Soria;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
42 Soria;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
42 Soria;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
42 Soria;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
42 Soria;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
42 Soria;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
42 Soria;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
42 Soria;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
42 Soria;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
42 Soria;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
42 Soria;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
42 Soria;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
42 Soria;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
42 Soria;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
42 Soria;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;96,23
42 Soria;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
42 Soria;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
42 Soria;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
42 Soria;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;92,92
42 Soria;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
42 Soria;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
42 Soria;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
42 Soria;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;89,41
42 Soria;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
42 Soria;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
42 Soria;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;90,57
42 Soria;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
42 Soria;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
42 Soria;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
42 Soria;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;85,84
42 Soria;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
42 Soria;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
42 Soria;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
42 Soria;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;84,71
42 Soria;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
42 Soria;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
42 Soria;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;85,85
42 Soria;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
42 Soria;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
42 Soria;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
42 Soria;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;77,88
42 Soria;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
42 Soria;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
42 Soria;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
42 Soria;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;82,35
42 Soria;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
42 Soria;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
42 Soria;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;83,02
42 Soria;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
42 Soria;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
42 Soria;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
42 Soria;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;74,34
42 Soria;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
42 Soria;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
42 Soria;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
42 Soria;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;78,82
42 Soria;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
42 Soria;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
42 Soria;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
42 Soria;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
42 Soria;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
42 Soria;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QII;238
42 Soria;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
42 Soria;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
42 Soria;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
42 Soria;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QII;254
42 Soria;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
42 Soria;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
42 Soria;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
42 Soria;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QII;239
42 Soria;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
42 Soria;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
42 Soria;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
42 Soria;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2022QII;225
42 Soria;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2022QI;""
42 Soria;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
42 Soria;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
42 Soria;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2021QII;238
42 Soria;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2021QI;""
42 Soria;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
42 Soria;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
42 Soria;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2020QII;227
42 Soria;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2020QI;""
42 Soria;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
42 Soria;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2022QIII;214
42 Soria;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2022QII;""
42 Soria;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2022QI;""
42 Soria;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
42 Soria;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2021QIII;224
42 Soria;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2021QII;""
42 Soria;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2021QI;""
42 Soria;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
42 Soria;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2020QIII;215
42 Soria;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2020QII;""
42 Soria;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2020QI;""
42 Soria;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QIV;206
42 Soria;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
42 Soria;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QII;""
42 Soria;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QI;""
42 Soria;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QIV;213
42 Soria;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
42 Soria;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QII;""
42 Soria;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QI;""
42 Soria;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QIV;206
42 Soria;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
42 Soria;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QII;""
42 Soria;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QI;""
42 Soria;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
42 Soria;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
42 Soria;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QII;""
42 Soria;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QI;196
42 Soria;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
42 Soria;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
42 Soria;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QII;""
42 Soria;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QI;200
42 Soria;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
42 Soria;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
42 Soria;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QII;""
42 Soria;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QI;""
42 Soria;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
42 Soria;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
42 Soria;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
42 Soria;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
42 Soria;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
42 Soria;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
42 Soria;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
42 Soria;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
42 Soria;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
42 Soria;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
42 Soria;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
42 Soria;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
42 Soria;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
42 Soria;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
42 Soria;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;94,54
42 Soria;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
42 Soria;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
42 Soria;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
42 Soria;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;93,7
42 Soria;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
42 Soria;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
42 Soria;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
42 Soria;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;94,98
42 Soria;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
42 Soria;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
42 Soria;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;89,92
42 Soria;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
42 Soria;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
42 Soria;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
42 Soria;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;88,19
42 Soria;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
42 Soria;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
42 Soria;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
42 Soria;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;89,96
42 Soria;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
42 Soria;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
42 Soria;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;86,55
42 Soria;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
42 Soria;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
42 Soria;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
42 Soria;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;83,86
42 Soria;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
42 Soria;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
42 Soria;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
42 Soria;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;86,19
42 Soria;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
42 Soria;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
42 Soria;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
42 Soria;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
42 Soria;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
42 Soria;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
42 Soria;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;77,17
42 Soria;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
42 Soria;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
42 Soria;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
42 Soria;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;83,68
42 Soria;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
42 Soria;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
42 Soria;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
42 Soria;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
42 Soria;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
42 Soria;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
42 Soria;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QII;142
42 Soria;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
42 Soria;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
42 Soria;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
42 Soria;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QII;162
42 Soria;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
42 Soria;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
42 Soria;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
42 Soria;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QII;149
42 Soria;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
42 Soria;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
42 Soria;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
42 Soria;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2022QII;136
42 Soria;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2022QI;""
42 Soria;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
42 Soria;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
42 Soria;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2021QII;155
42 Soria;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2021QI;""
42 Soria;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
42 Soria;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
42 Soria;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2020QII;142
42 Soria;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2020QI;""
42 Soria;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
42 Soria;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2022QIII;132
42 Soria;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2022QII;""
42 Soria;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2022QI;""
42 Soria;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
42 Soria;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2021QIII;147
42 Soria;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2021QII;""
42 Soria;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2021QI;""
42 Soria;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
42 Soria;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2020QIII;133
42 Soria;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2020QII;""
42 Soria;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2020QI;""
42 Soria;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QIV;127
42 Soria;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
42 Soria;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QII;""
42 Soria;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QI;""
42 Soria;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QIV;141
42 Soria;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
42 Soria;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QII;""
42 Soria;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QI;""
42 Soria;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QIV;129
42 Soria;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
42 Soria;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QII;""
42 Soria;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QI;""
42 Soria;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
42 Soria;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
42 Soria;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QII;""
42 Soria;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QI;128
42 Soria;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
42 Soria;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
42 Soria;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QII;""
42 Soria;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QI;127
42 Soria;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
42 Soria;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
42 Soria;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QII;""
42 Soria;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QI;""
42 Soria;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
42 Soria;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
42 Soria;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
42 Soria;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
42 Soria;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
42 Soria;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
42 Soria;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
42 Soria;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
42 Soria;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
42 Soria;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
42 Soria;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
42 Soria;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
42 Soria;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
42 Soria;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
42 Soria;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;95,77
42 Soria;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
42 Soria;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
42 Soria;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
42 Soria;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;95,68
42 Soria;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
42 Soria;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
42 Soria;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
42 Soria;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;95,3
42 Soria;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
42 Soria;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
42 Soria;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;92,96
42 Soria;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
42 Soria;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
42 Soria;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
42 Soria;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;90,74
42 Soria;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
42 Soria;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
42 Soria;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
42 Soria;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;89,26
42 Soria;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
42 Soria;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
42 Soria;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;89,44
42 Soria;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
42 Soria;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
42 Soria;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
42 Soria;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;87,04
42 Soria;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
42 Soria;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
42 Soria;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
42 Soria;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;86,58
42 Soria;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
42 Soria;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
42 Soria;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
42 Soria;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
42 Soria;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
42 Soria;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
42 Soria;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;79,01
42 Soria;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
42 Soria;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
42 Soria;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
42 Soria;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;85,23
42 Soria;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
42 Soria;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
42 Soria;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
42 Soria;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
42 Soria;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
42 Soria;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
42 Soria;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QII;96
42 Soria;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
42 Soria;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
42 Soria;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
42 Soria;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QII;92
42 Soria;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
42 Soria;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
42 Soria;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
42 Soria;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QII;90
42 Soria;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
42 Soria;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
42 Soria;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
42 Soria;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2022QII;89
42 Soria;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2022QI;""
42 Soria;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
42 Soria;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
42 Soria;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2021QII;83
42 Soria;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2021QI;""
42 Soria;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
42 Soria;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
42 Soria;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2020QII;85
42 Soria;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2020QI;""
42 Soria;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
42 Soria;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2022QIII;82
42 Soria;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2022QII;""
42 Soria;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2022QI;""
42 Soria;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
42 Soria;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2021QIII;77
42 Soria;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2021QII;""
42 Soria;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2021QI;""
42 Soria;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
42 Soria;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2020QIII;82
42 Soria;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2020QII;""
42 Soria;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2020QI;""
42 Soria;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QIV;79
42 Soria;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
42 Soria;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QII;""
42 Soria;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QI;""
42 Soria;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QIV;72
42 Soria;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
42 Soria;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QII;""
42 Soria;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QI;""
42 Soria;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QIV;77
42 Soria;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
42 Soria;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QII;""
42 Soria;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QI;""
42 Soria;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
42 Soria;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
42 Soria;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QII;""
42 Soria;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QI;68
42 Soria;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
42 Soria;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
42 Soria;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QII;""
42 Soria;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QI;73
42 Soria;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
42 Soria;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
42 Soria;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QII;""
42 Soria;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QI;""
42 Soria;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
42 Soria;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
42 Soria;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
42 Soria;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
42 Soria;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
42 Soria;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
42 Soria;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
42 Soria;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
42 Soria;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
42 Soria;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
42 Soria;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
42 Soria;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
42 Soria;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
42 Soria;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
42 Soria;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;92,71
42 Soria;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
42 Soria;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
42 Soria;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
42 Soria;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;90,22
42 Soria;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
42 Soria;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
42 Soria;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
42 Soria;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;94,44
42 Soria;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
42 Soria;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
42 Soria;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;85,42
42 Soria;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
42 Soria;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
42 Soria;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
42 Soria;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;83,7
42 Soria;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
42 Soria;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
42 Soria;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
42 Soria;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;91,11
42 Soria;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
42 Soria;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
42 Soria;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;82,29
42 Soria;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
42 Soria;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
42 Soria;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
42 Soria;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;78,26
42 Soria;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
42 Soria;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
42 Soria;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
42 Soria;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;85,56
42 Soria;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
42 Soria;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
42 Soria;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
42 Soria;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
42 Soria;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
42 Soria;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
42 Soria;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;73,91
42 Soria;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
42 Soria;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
42 Soria;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
42 Soria;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;81,11
42 Soria;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
42 Soria;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
42 Soria;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
42 Soria;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
42 Soria;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
42 Soria;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QIII;258
42 Soria;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
42 Soria;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
42 Soria;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
42 Soria;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QIII;281
42 Soria;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
42 Soria;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
42 Soria;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
42 Soria;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QIII;257
42 Soria;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
42 Soria;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
42 Soria;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
42 Soria;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2022QIII;234
42 Soria;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2022QII;""
42 Soria;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2022QI;""
42 Soria;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
42 Soria;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2021QIII;256
42 Soria;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2021QII;""
42 Soria;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2021QI;""
42 Soria;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
42 Soria;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2020QIII;239
42 Soria;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2020QII;""
42 Soria;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2020QI;""
42 Soria;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2022QIV;224
42 Soria;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
42 Soria;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2022QII;""
42 Soria;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2022QI;""
42 Soria;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2021QIV;240
42 Soria;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
42 Soria;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2021QII;""
42 Soria;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2021QI;""
42 Soria;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2020QIV;223
42 Soria;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
42 Soria;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2020QII;""
42 Soria;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2020QI;""
42 Soria;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
42 Soria;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
42 Soria;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QII;""
42 Soria;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QI;223
42 Soria;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
42 Soria;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
42 Soria;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QII;""
42 Soria;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QI;215
42 Soria;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
42 Soria;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
42 Soria;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QII;""
42 Soria;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QI;""
42 Soria;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
42 Soria;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
42 Soria;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QII;214
42 Soria;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QI;""
42 Soria;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
42 Soria;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
42 Soria;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QII;206
42 Soria;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QI;""
42 Soria;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
42 Soria;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
42 Soria;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QII;""
42 Soria;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QI;""
42 Soria;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
42 Soria;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
42 Soria;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
42 Soria;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
42 Soria;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
42 Soria;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
42 Soria;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
42 Soria;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
42 Soria;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
42 Soria;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
42 Soria;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
42 Soria;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
42 Soria;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
42 Soria;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;90,7
42 Soria;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
42 Soria;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
42 Soria;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
42 Soria;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;91,1
42 Soria;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
42 Soria;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
42 Soria;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
42 Soria;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;93
42 Soria;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
42 Soria;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
42 Soria;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;86,82
42 Soria;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
42 Soria;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
42 Soria;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
42 Soria;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;85,41
42 Soria;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
42 Soria;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
42 Soria;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
42 Soria;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;86,77
42 Soria;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
42 Soria;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
42 Soria;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
42 Soria;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
42 Soria;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
42 Soria;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
42 Soria;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;79,36
42 Soria;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
42 Soria;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
42 Soria;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
42 Soria;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;83,66
42 Soria;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
42 Soria;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
42 Soria;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
42 Soria;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
42 Soria;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
42 Soria;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
42 Soria;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;76,16
42 Soria;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
42 Soria;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
42 Soria;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
42 Soria;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;80,16
42 Soria;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
42 Soria;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
42 Soria;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
42 Soria;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
42 Soria;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
42 Soria;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
42 Soria;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QIII;153
42 Soria;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
42 Soria;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
42 Soria;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
42 Soria;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QIII;179
42 Soria;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
42 Soria;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
42 Soria;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
42 Soria;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QIII;160
42 Soria;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
42 Soria;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
42 Soria;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
42 Soria;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2022QIII;144
42 Soria;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2022QII;""
42 Soria;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2022QI;""
42 Soria;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
42 Soria;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2021QIII;166
42 Soria;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2021QII;""
42 Soria;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2021QI;""
42 Soria;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
42 Soria;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2020QIII;146
42 Soria;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2020QII;""
42 Soria;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2020QI;""
42 Soria;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2022QIV;138
42 Soria;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
42 Soria;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2022QII;""
42 Soria;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2022QI;""
42 Soria;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2021QIV;156
42 Soria;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
42 Soria;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2021QII;""
42 Soria;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2021QI;""
42 Soria;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2020QIV;139
42 Soria;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
42 Soria;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2020QII;""
42 Soria;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2020QI;""
42 Soria;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
42 Soria;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
42 Soria;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QII;""
42 Soria;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QI;143
42 Soria;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
42 Soria;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
42 Soria;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QII;""
42 Soria;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QI;135
42 Soria;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
42 Soria;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
42 Soria;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QII;""
42 Soria;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QI;""
42 Soria;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
42 Soria;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
42 Soria;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QII;137
42 Soria;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QI;""
42 Soria;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
42 Soria;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
42 Soria;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QII;133
42 Soria;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QI;""
42 Soria;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
42 Soria;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
42 Soria;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QII;""
42 Soria;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QI;""
42 Soria;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
42 Soria;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
42 Soria;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
42 Soria;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
42 Soria;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
42 Soria;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
42 Soria;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
42 Soria;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
42 Soria;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
42 Soria;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
42 Soria;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
42 Soria;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
42 Soria;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
42 Soria;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;94,12
42 Soria;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
42 Soria;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
42 Soria;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
42 Soria;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;92,74
42 Soria;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
42 Soria;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
42 Soria;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
42 Soria;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;91,25
42 Soria;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
42 Soria;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
42 Soria;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;90,2
42 Soria;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
42 Soria;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
42 Soria;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
42 Soria;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;87,15
42 Soria;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
42 Soria;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
42 Soria;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
42 Soria;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;86,88
42 Soria;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
42 Soria;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
42 Soria;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
42 Soria;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
42 Soria;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
42 Soria;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
42 Soria;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;79,89
42 Soria;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
42 Soria;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
42 Soria;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
42 Soria;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;84,38
42 Soria;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
42 Soria;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
42 Soria;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
42 Soria;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
42 Soria;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
42 Soria;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
42 Soria;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;76,54
42 Soria;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
42 Soria;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
42 Soria;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
42 Soria;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;83,13
42 Soria;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
42 Soria;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
42 Soria;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
42 Soria;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
42 Soria;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
42 Soria;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
42 Soria;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QIII;105
42 Soria;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
42 Soria;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
42 Soria;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
42 Soria;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QIII;102
42 Soria;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
42 Soria;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
42 Soria;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
42 Soria;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QIII;97
42 Soria;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
42 Soria;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
42 Soria;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
42 Soria;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2022QIII;90
42 Soria;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2022QII;""
42 Soria;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2022QI;""
42 Soria;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
42 Soria;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2021QIII;90
42 Soria;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2021QII;""
42 Soria;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2021QI;""
42 Soria;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
42 Soria;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2020QIII;93
42 Soria;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2020QII;""
42 Soria;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2020QI;""
42 Soria;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2022QIV;86
42 Soria;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
42 Soria;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2022QII;""
42 Soria;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2022QI;""
42 Soria;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2021QIV;84
42 Soria;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
42 Soria;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2021QII;""
42 Soria;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2021QI;""
42 Soria;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2020QIV;84
42 Soria;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
42 Soria;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2020QII;""
42 Soria;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2020QI;""
42 Soria;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
42 Soria;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
42 Soria;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QII;""
42 Soria;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QI;80
42 Soria;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
42 Soria;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
42 Soria;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QII;""
42 Soria;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QI;80
42 Soria;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
42 Soria;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
42 Soria;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QII;""
42 Soria;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QI;""
42 Soria;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
42 Soria;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
42 Soria;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QII;77
42 Soria;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QI;""
42 Soria;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
42 Soria;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
42 Soria;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QII;73
42 Soria;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QI;""
42 Soria;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
42 Soria;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
42 Soria;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QII;""
42 Soria;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QI;""
42 Soria;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
42 Soria;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
42 Soria;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
42 Soria;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
42 Soria;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
42 Soria;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
42 Soria;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
42 Soria;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
42 Soria;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
42 Soria;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
42 Soria;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
42 Soria;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
42 Soria;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
42 Soria;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;85,71
42 Soria;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
42 Soria;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
42 Soria;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
42 Soria;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;88,24
42 Soria;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
42 Soria;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
42 Soria;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
42 Soria;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;95,88
42 Soria;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
42 Soria;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
42 Soria;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;81,9
42 Soria;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
42 Soria;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
42 Soria;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
42 Soria;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;82,35
42 Soria;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
42 Soria;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
42 Soria;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
42 Soria;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;86,6
42 Soria;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
42 Soria;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
42 Soria;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
42 Soria;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
42 Soria;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
42 Soria;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
42 Soria;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;78,43
42 Soria;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
42 Soria;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
42 Soria;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
42 Soria;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;82,47
42 Soria;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
42 Soria;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
42 Soria;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
42 Soria;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
42 Soria;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
42 Soria;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
42 Soria;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;75,49
42 Soria;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
42 Soria;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
42 Soria;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
42 Soria;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;75,26
42 Soria;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
42 Soria;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
42 Soria;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
42 Soria;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
42 Soria;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
42 Soria;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QIV;270
42 Soria;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
42 Soria;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
42 Soria;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
42 Soria;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QIV;283
42 Soria;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
42 Soria;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
42 Soria;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
42 Soria;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QIV;283
42 Soria;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
42 Soria;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
42 Soria;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
42 Soria;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2022QIV;258
42 Soria;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
42 Soria;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2022QII;""
42 Soria;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2022QI;""
42 Soria;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2021QIV;263
42 Soria;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
42 Soria;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2021QII;""
42 Soria;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2021QI;""
42 Soria;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2020QIV;262
42 Soria;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
42 Soria;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2020QII;""
42 Soria;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2020QI;""
42 Soria;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
42 Soria;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
42 Soria;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2022QII;""
42 Soria;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2022QI;244
42 Soria;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
42 Soria;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
42 Soria;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2021QII;""
42 Soria;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2021QI;249
42 Soria;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
42 Soria;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
42 Soria;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2020QII;""
42 Soria;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2020QI;""
42 Soria;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
42 Soria;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
42 Soria;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QII;233
42 Soria;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QI;""
42 Soria;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
42 Soria;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
42 Soria;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QII;238
42 Soria;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QI;""
42 Soria;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
42 Soria;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
42 Soria;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QII;""
42 Soria;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QI;""
42 Soria;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
42 Soria;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QIII;225
42 Soria;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QII;""
42 Soria;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QI;""
42 Soria;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
42 Soria;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QIII;224
42 Soria;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QII;""
42 Soria;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QI;""
42 Soria;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
42 Soria;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
42 Soria;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QII;""
42 Soria;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QI;""
42 Soria;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
42 Soria;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
42 Soria;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
42 Soria;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
42 Soria;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
42 Soria;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
42 Soria;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
42 Soria;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
42 Soria;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
42 Soria;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
42 Soria;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
42 Soria;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
42 Soria;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;95,56
42 Soria;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
42 Soria;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
42 Soria;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
42 Soria;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;92,93
42 Soria;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
42 Soria;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
42 Soria;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
42 Soria;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;92,58
42 Soria;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
42 Soria;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
42 Soria;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
42 Soria;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
42 Soria;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
42 Soria;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
42 Soria;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;86,22
42 Soria;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
42 Soria;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
42 Soria;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
42 Soria;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;87,99
42 Soria;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
42 Soria;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
42 Soria;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
42 Soria;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
42 Soria;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
42 Soria;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
42 Soria;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;82,33
42 Soria;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
42 Soria;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
42 Soria;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
42 Soria;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;84,1
42 Soria;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
42 Soria;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
42 Soria;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
42 Soria;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
42 Soria;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
42 Soria;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
42 Soria;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;79,51
42 Soria;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
42 Soria;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
42 Soria;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
42 Soria;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;79,15
42 Soria;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
42 Soria;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
42 Soria;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
42 Soria;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
42 Soria;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
42 Soria;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
42 Soria;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QIV;168
42 Soria;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
42 Soria;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
42 Soria;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
42 Soria;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QIV;178
42 Soria;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
42 Soria;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
42 Soria;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
42 Soria;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QIV;171
42 Soria;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
42 Soria;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
42 Soria;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
42 Soria;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2022QIV;161
42 Soria;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
42 Soria;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2022QII;""
42 Soria;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2022QI;""
42 Soria;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2021QIV;167
42 Soria;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
42 Soria;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2021QII;""
42 Soria;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2021QI;""
42 Soria;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2020QIV;159
42 Soria;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
42 Soria;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2020QII;""
42 Soria;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2020QI;""
42 Soria;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
42 Soria;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
42 Soria;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2022QII;""
42 Soria;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2022QI;152
42 Soria;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
42 Soria;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
42 Soria;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2021QII;""
42 Soria;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2021QI;152
42 Soria;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
42 Soria;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
42 Soria;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2020QII;""
42 Soria;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2020QI;""
42 Soria;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
42 Soria;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
42 Soria;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QII;145
42 Soria;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QI;""
42 Soria;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
42 Soria;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
42 Soria;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QII;148
42 Soria;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QI;""
42 Soria;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
42 Soria;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
42 Soria;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QII;""
42 Soria;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QI;""
42 Soria;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
42 Soria;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QIII;142
42 Soria;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QII;""
42 Soria;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QI;""
42 Soria;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
42 Soria;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QIII;142
42 Soria;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QII;""
42 Soria;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QI;""
42 Soria;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
42 Soria;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
42 Soria;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QII;""
42 Soria;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QI;""
42 Soria;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
42 Soria;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
42 Soria;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
42 Soria;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
42 Soria;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
42 Soria;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
42 Soria;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
42 Soria;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
42 Soria;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
42 Soria;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
42 Soria;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
42 Soria;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
42 Soria;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;95,83
42 Soria;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
42 Soria;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
42 Soria;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
42 Soria;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;93,82
42 Soria;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
42 Soria;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
42 Soria;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
42 Soria;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;92,98
42 Soria;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
42 Soria;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
42 Soria;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
42 Soria;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
42 Soria;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
42 Soria;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
42 Soria;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;85,39
42 Soria;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
42 Soria;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
42 Soria;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
42 Soria;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;88,89
42 Soria;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
42 Soria;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
42 Soria;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
42 Soria;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
42 Soria;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
42 Soria;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
42 Soria;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;81,46
42 Soria;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
42 Soria;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
42 Soria;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
42 Soria;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;86,55
42 Soria;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
42 Soria;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
42 Soria;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
42 Soria;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
42 Soria;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
42 Soria;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
42 Soria;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;79,78
42 Soria;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
42 Soria;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
42 Soria;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
42 Soria;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;83,04
42 Soria;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
42 Soria;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
42 Soria;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
42 Soria;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
42 Soria;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
42 Soria;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
42 Soria;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QIV;102
42 Soria;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
42 Soria;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
42 Soria;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
42 Soria;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QIV;105
42 Soria;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
42 Soria;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
42 Soria;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
42 Soria;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QIV;112
42 Soria;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
42 Soria;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
42 Soria;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
42 Soria;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2022QIV;97
42 Soria;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
42 Soria;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2022QII;""
42 Soria;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2022QI;""
42 Soria;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2021QIV;96
42 Soria;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
42 Soria;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2021QII;""
42 Soria;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2021QI;""
42 Soria;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2020QIV;103
42 Soria;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
42 Soria;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2020QII;""
42 Soria;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2020QI;""
42 Soria;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
42 Soria;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
42 Soria;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2022QII;""
42 Soria;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2022QI;92
42 Soria;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
42 Soria;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
42 Soria;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2021QII;""
42 Soria;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2021QI;97
42 Soria;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
42 Soria;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
42 Soria;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2020QII;""
42 Soria;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2020QI;""
42 Soria;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
42 Soria;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
42 Soria;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QII;88
42 Soria;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QI;""
42 Soria;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
42 Soria;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
42 Soria;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QII;90
42 Soria;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QI;""
42 Soria;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
42 Soria;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
42 Soria;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QII;""
42 Soria;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QI;""
42 Soria;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
42 Soria;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QIII;83
42 Soria;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QII;""
42 Soria;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QI;""
42 Soria;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
42 Soria;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QIII;82
42 Soria;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QII;""
42 Soria;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QI;""
42 Soria;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
42 Soria;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
42 Soria;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QII;""
42 Soria;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QI;""
42 Soria;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
42 Soria;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
42 Soria;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
42 Soria;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
42 Soria;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
42 Soria;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
42 Soria;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
42 Soria;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
42 Soria;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
42 Soria;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
42 Soria;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
42 Soria;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
42 Soria;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;95,1
42 Soria;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
42 Soria;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
42 Soria;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
42 Soria;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;91,43
42 Soria;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
42 Soria;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
42 Soria;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
42 Soria;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;91,96
42 Soria;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
42 Soria;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
42 Soria;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
42 Soria;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
42 Soria;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
42 Soria;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
42 Soria;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;87,62
42 Soria;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
42 Soria;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
42 Soria;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
42 Soria;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;86,61
42 Soria;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
42 Soria;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
42 Soria;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
42 Soria;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
42 Soria;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
42 Soria;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
42 Soria;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;83,81
42 Soria;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
42 Soria;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
42 Soria;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
42 Soria;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;80,36
42 Soria;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
42 Soria;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
42 Soria;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
42 Soria;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
42 Soria;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
42 Soria;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
42 Soria;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;79,05
42 Soria;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
42 Soria;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
42 Soria;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
42 Soria;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;73,21
42 Soria;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
42 Soria;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
42 Soria;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
42 Soria;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
42 Soria;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
42 Soria;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
42 Soria;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
42 Soria;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
42 Soria;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
42 Soria;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QI;841
42 Soria;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
42 Soria;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
42 Soria;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
42 Soria;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QI;844
42 Soria;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
42 Soria;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
42 Soria;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
42 Soria;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QI;833
42 Soria;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
42 Soria;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
42 Soria;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2022QII;""
42 Soria;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2022QI;819
42 Soria;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
42 Soria;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
42 Soria;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2021QII;""
42 Soria;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2021QI;827
42 Soria;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
42 Soria;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
42 Soria;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2020QII;""
42 Soria;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2020QI;784
42 Soria;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
42 Soria;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
42 Soria;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2022QII;797
42 Soria;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2022QI;""
42 Soria;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
42 Soria;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
42 Soria;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2021QII;808
42 Soria;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2021QI;""
42 Soria;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
42 Soria;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
42 Soria;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2020QII;771
42 Soria;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2020QI;""
42 Soria;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
42 Soria;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QIII;772
42 Soria;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QII;""
42 Soria;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QI;""
42 Soria;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
42 Soria;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QIII;790
42 Soria;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QII;""
42 Soria;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QI;""
42 Soria;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
42 Soria;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QIII;746
42 Soria;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QII;""
42 Soria;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QI;""
42 Soria;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QIV;743
42 Soria;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
42 Soria;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QII;""
42 Soria;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QI;""
42 Soria;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QIV;773
42 Soria;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
42 Soria;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QII;""
42 Soria;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QI;""
42 Soria;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QIV;733
42 Soria;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
42 Soria;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QII;""
42 Soria;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QI;""
42 Soria;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
42 Soria;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
42 Soria;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
42 Soria;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
42 Soria;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
42 Soria;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
42 Soria;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
42 Soria;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
42 Soria;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
42 Soria;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
42 Soria;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
42 Soria;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
42 Soria;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
42 Soria;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
42 Soria;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
42 Soria;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;97,38
42 Soria;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
42 Soria;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
42 Soria;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
42 Soria;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;97,99
42 Soria;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
42 Soria;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
42 Soria;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
42 Soria;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;94,12
42 Soria;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
42 Soria;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
42 Soria;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;94,77
42 Soria;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
42 Soria;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
42 Soria;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
42 Soria;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;95,73
42 Soria;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
42 Soria;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
42 Soria;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
42 Soria;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;92,56
42 Soria;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
42 Soria;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
42 Soria;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;91,8
42 Soria;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
42 Soria;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
42 Soria;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
42 Soria;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;93,6
42 Soria;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
42 Soria;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
42 Soria;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
42 Soria;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;89,56
42 Soria;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
42 Soria;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
42 Soria;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;88,35
42 Soria;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
42 Soria;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
42 Soria;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
42 Soria;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;91,59
42 Soria;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
42 Soria;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
42 Soria;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
42 Soria;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;88
42 Soria;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
42 Soria;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
42 Soria;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
42 Soria;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
42 Soria;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
42 Soria;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
42 Soria;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QI;499
42 Soria;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
42 Soria;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
42 Soria;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
42 Soria;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QI;498
42 Soria;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
42 Soria;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
42 Soria;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
42 Soria;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QI;491
42 Soria;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
42 Soria;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
42 Soria;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2022QII;""
42 Soria;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2022QI;481
42 Soria;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
42 Soria;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
42 Soria;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2021QII;""
42 Soria;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2021QI;490
42 Soria;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
42 Soria;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
42 Soria;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2020QII;""
42 Soria;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2020QI;465
42 Soria;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
42 Soria;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
42 Soria;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2022QII;466
42 Soria;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2022QI;""
42 Soria;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
42 Soria;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
42 Soria;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2021QII;478
42 Soria;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2021QI;""
42 Soria;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
42 Soria;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
42 Soria;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2020QII;457
42 Soria;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2020QI;""
42 Soria;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
42 Soria;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QIII;453
42 Soria;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QII;""
42 Soria;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QI;""
42 Soria;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
42 Soria;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QIII;469
42 Soria;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QII;""
42 Soria;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QI;""
42 Soria;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
42 Soria;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QIII;442
42 Soria;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QII;""
42 Soria;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QI;""
42 Soria;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QIV;441
42 Soria;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
42 Soria;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QII;""
42 Soria;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QI;""
42 Soria;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QIV;462
42 Soria;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
42 Soria;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QII;""
42 Soria;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QI;""
42 Soria;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QIV;433
42 Soria;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
42 Soria;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QII;""
42 Soria;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QI;""
42 Soria;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
42 Soria;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
42 Soria;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
42 Soria;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
42 Soria;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
42 Soria;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
42 Soria;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
42 Soria;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
42 Soria;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
42 Soria;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
42 Soria;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
42 Soria;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
42 Soria;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
42 Soria;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
42 Soria;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
42 Soria;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;96,39
42 Soria;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
42 Soria;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
42 Soria;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
42 Soria;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;98,39
42 Soria;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
42 Soria;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
42 Soria;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
42 Soria;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;94,7
42 Soria;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
42 Soria;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
42 Soria;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;93,39
42 Soria;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
42 Soria;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
42 Soria;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
42 Soria;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;95,98
42 Soria;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
42 Soria;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
42 Soria;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
42 Soria;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;93,08
42 Soria;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
42 Soria;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
42 Soria;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;90,78
42 Soria;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
42 Soria;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
42 Soria;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
42 Soria;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;94,18
42 Soria;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
42 Soria;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
42 Soria;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
42 Soria;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;90,02
42 Soria;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
42 Soria;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
42 Soria;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;88,38
42 Soria;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
42 Soria;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
42 Soria;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
42 Soria;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;92,77
42 Soria;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
42 Soria;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
42 Soria;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
42 Soria;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;88,19
42 Soria;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
42 Soria;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
42 Soria;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
42 Soria;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
42 Soria;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
42 Soria;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
42 Soria;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QI;342
42 Soria;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
42 Soria;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
42 Soria;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
42 Soria;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QI;346
42 Soria;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
42 Soria;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
42 Soria;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
42 Soria;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QI;342
42 Soria;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
42 Soria;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
42 Soria;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2022QII;""
42 Soria;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2022QI;338
42 Soria;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
42 Soria;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
42 Soria;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2021QII;""
42 Soria;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2021QI;337
42 Soria;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
42 Soria;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
42 Soria;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2020QII;""
42 Soria;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2020QI;319
42 Soria;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
42 Soria;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
42 Soria;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2022QII;331
42 Soria;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2022QI;""
42 Soria;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
42 Soria;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
42 Soria;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2021QII;330
42 Soria;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2021QI;""
42 Soria;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
42 Soria;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
42 Soria;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2020QII;314
42 Soria;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2020QI;""
42 Soria;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
42 Soria;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QIII;319
42 Soria;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QII;""
42 Soria;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QI;""
42 Soria;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
42 Soria;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QIII;321
42 Soria;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QII;""
42 Soria;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QI;""
42 Soria;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
42 Soria;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QIII;304
42 Soria;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QII;""
42 Soria;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QI;""
42 Soria;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QIV;302
42 Soria;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
42 Soria;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QII;""
42 Soria;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QI;""
42 Soria;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QIV;311
42 Soria;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
42 Soria;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QII;""
42 Soria;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QI;""
42 Soria;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QIV;300
42 Soria;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
42 Soria;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QII;""
42 Soria;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QI;""
42 Soria;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
42 Soria;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
42 Soria;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
42 Soria;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
42 Soria;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
42 Soria;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
42 Soria;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
42 Soria;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
42 Soria;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
42 Soria;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
42 Soria;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
42 Soria;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
42 Soria;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
42 Soria;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
42 Soria;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
42 Soria;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;98,83
42 Soria;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
42 Soria;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
42 Soria;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
42 Soria;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;97,4
42 Soria;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
42 Soria;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
42 Soria;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
42 Soria;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;93,27
42 Soria;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
42 Soria;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
42 Soria;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;96,78
42 Soria;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
42 Soria;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
42 Soria;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
42 Soria;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;95,38
42 Soria;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
42 Soria;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
42 Soria;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
42 Soria;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;91,81
42 Soria;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
42 Soria;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
42 Soria;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;93,27
42 Soria;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
42 Soria;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
42 Soria;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
42 Soria;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;92,77
42 Soria;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
42 Soria;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
42 Soria;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
42 Soria;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;88,89
42 Soria;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
42 Soria;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
42 Soria;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;88,3
42 Soria;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
42 Soria;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
42 Soria;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
42 Soria;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;89,88
42 Soria;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
42 Soria;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
42 Soria;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
42 Soria;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;87,72
42 Soria;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
42 Soria;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
42 Soria;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
42 Soria;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
42 Soria;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
42 Soria;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QII;802
42 Soria;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
42 Soria;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
42 Soria;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
42 Soria;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QII;805
42 Soria;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
42 Soria;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
42 Soria;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
42 Soria;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QII;825
42 Soria;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
42 Soria;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
42 Soria;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
42 Soria;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2022QII;778
42 Soria;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2022QI;""
42 Soria;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
42 Soria;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
42 Soria;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2021QII;781
42 Soria;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2021QI;""
42 Soria;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
42 Soria;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
42 Soria;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2020QII;809
42 Soria;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2020QI;""
42 Soria;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
42 Soria;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2022QIII;753
42 Soria;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2022QII;""
42 Soria;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2022QI;""
42 Soria;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
42 Soria;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2021QIII;756
42 Soria;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2021QII;""
42 Soria;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2021QI;""
42 Soria;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
42 Soria;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2020QIII;778
42 Soria;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2020QII;""
42 Soria;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2020QI;""
42 Soria;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QIV;725
42 Soria;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
42 Soria;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QII;""
42 Soria;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QI;""
42 Soria;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QIV;737
42 Soria;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
42 Soria;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QII;""
42 Soria;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QI;""
42 Soria;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QIV;760
42 Soria;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
42 Soria;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QII;""
42 Soria;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QI;""
42 Soria;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
42 Soria;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
42 Soria;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QII;""
42 Soria;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QI;723
42 Soria;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
42 Soria;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
42 Soria;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QII;""
42 Soria;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QI;746
42 Soria;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
42 Soria;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
42 Soria;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QII;""
42 Soria;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QI;""
42 Soria;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
42 Soria;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
42 Soria;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
42 Soria;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
42 Soria;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
42 Soria;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
42 Soria;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
42 Soria;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
42 Soria;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
42 Soria;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
42 Soria;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
42 Soria;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
42 Soria;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
42 Soria;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
42 Soria;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;97,01
42 Soria;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
42 Soria;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
42 Soria;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
42 Soria;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;97,02
42 Soria;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
42 Soria;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
42 Soria;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
42 Soria;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;98,06
42 Soria;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
42 Soria;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
42 Soria;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;93,89
42 Soria;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
42 Soria;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
42 Soria;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
42 Soria;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;93,91
42 Soria;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
42 Soria;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
42 Soria;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
42 Soria;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;94,3
42 Soria;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
42 Soria;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
42 Soria;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;90,4
42 Soria;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
42 Soria;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
42 Soria;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
42 Soria;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;91,55
42 Soria;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
42 Soria;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
42 Soria;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
42 Soria;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;92,12
42 Soria;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
42 Soria;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
42 Soria;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
42 Soria;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
42 Soria;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
42 Soria;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
42 Soria;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;89,81
42 Soria;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
42 Soria;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
42 Soria;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
42 Soria;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;90,42
42 Soria;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
42 Soria;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
42 Soria;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
42 Soria;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
42 Soria;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
42 Soria;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
42 Soria;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QII;464
42 Soria;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
42 Soria;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
42 Soria;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
42 Soria;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QII;470
42 Soria;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
42 Soria;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
42 Soria;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
42 Soria;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QII;484
42 Soria;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
42 Soria;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
42 Soria;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
42 Soria;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2022QII;448
42 Soria;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2022QI;""
42 Soria;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
42 Soria;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
42 Soria;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2021QII;458
42 Soria;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2021QI;""
42 Soria;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
42 Soria;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
42 Soria;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2020QII;475
42 Soria;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2020QI;""
42 Soria;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
42 Soria;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2022QIII;434
42 Soria;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2022QII;""
42 Soria;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2022QI;""
42 Soria;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
42 Soria;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2021QIII;447
42 Soria;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2021QII;""
42 Soria;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2021QI;""
42 Soria;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
42 Soria;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2020QIII;457
42 Soria;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2020QII;""
42 Soria;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2020QI;""
42 Soria;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QIV;419
42 Soria;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
42 Soria;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QII;""
42 Soria;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QI;""
42 Soria;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QIV;437
42 Soria;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
42 Soria;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QII;""
42 Soria;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QI;""
42 Soria;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QIV;448
42 Soria;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
42 Soria;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QII;""
42 Soria;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QI;""
42 Soria;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
42 Soria;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
42 Soria;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QII;""
42 Soria;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QI;426
42 Soria;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
42 Soria;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
42 Soria;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QII;""
42 Soria;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QI;441
42 Soria;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
42 Soria;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
42 Soria;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QII;""
42 Soria;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QI;""
42 Soria;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
42 Soria;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
42 Soria;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
42 Soria;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
42 Soria;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
42 Soria;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
42 Soria;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
42 Soria;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
42 Soria;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
42 Soria;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
42 Soria;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
42 Soria;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
42 Soria;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
42 Soria;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
42 Soria;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;96,55
42 Soria;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
42 Soria;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
42 Soria;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
42 Soria;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;97,45
42 Soria;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
42 Soria;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
42 Soria;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
42 Soria;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;98,14
42 Soria;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
42 Soria;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
42 Soria;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;93,53
42 Soria;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
42 Soria;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
42 Soria;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
42 Soria;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;95,11
42 Soria;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
42 Soria;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
42 Soria;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
42 Soria;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;94,42
42 Soria;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
42 Soria;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
42 Soria;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;90,3
42 Soria;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
42 Soria;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
42 Soria;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
42 Soria;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;92,98
42 Soria;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
42 Soria;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
42 Soria;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
42 Soria;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;92,56
42 Soria;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
42 Soria;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
42 Soria;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
42 Soria;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
42 Soria;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
42 Soria;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
42 Soria;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;90,64
42 Soria;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
42 Soria;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
42 Soria;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
42 Soria;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;91,12
42 Soria;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
42 Soria;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
42 Soria;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
42 Soria;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
42 Soria;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
42 Soria;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
42 Soria;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QII;338
42 Soria;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
42 Soria;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
42 Soria;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
42 Soria;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QII;335
42 Soria;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
42 Soria;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
42 Soria;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
42 Soria;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QII;341
42 Soria;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
42 Soria;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
42 Soria;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
42 Soria;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2022QII;330
42 Soria;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2022QI;""
42 Soria;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
42 Soria;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
42 Soria;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2021QII;323
42 Soria;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2021QI;""
42 Soria;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
42 Soria;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
42 Soria;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2020QII;334
42 Soria;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2020QI;""
42 Soria;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
42 Soria;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2022QIII;319
42 Soria;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2022QII;""
42 Soria;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2022QI;""
42 Soria;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
42 Soria;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2021QIII;309
42 Soria;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2021QII;""
42 Soria;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2021QI;""
42 Soria;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
42 Soria;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2020QIII;321
42 Soria;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2020QII;""
42 Soria;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2020QI;""
42 Soria;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QIV;306
42 Soria;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
42 Soria;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QII;""
42 Soria;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QI;""
42 Soria;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QIV;300
42 Soria;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
42 Soria;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QII;""
42 Soria;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QI;""
42 Soria;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QIV;312
42 Soria;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
42 Soria;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QII;""
42 Soria;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QI;""
42 Soria;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
42 Soria;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
42 Soria;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QII;""
42 Soria;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QI;297
42 Soria;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
42 Soria;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
42 Soria;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QII;""
42 Soria;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QI;305
42 Soria;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
42 Soria;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
42 Soria;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QII;""
42 Soria;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QI;""
42 Soria;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
42 Soria;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
42 Soria;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
42 Soria;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
42 Soria;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
42 Soria;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
42 Soria;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
42 Soria;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
42 Soria;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
42 Soria;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
42 Soria;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
42 Soria;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
42 Soria;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
42 Soria;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
42 Soria;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;97,63
42 Soria;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
42 Soria;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
42 Soria;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
42 Soria;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;96,42
42 Soria;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
42 Soria;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
42 Soria;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
42 Soria;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;97,95
42 Soria;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
42 Soria;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
42 Soria;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;94,38
42 Soria;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
42 Soria;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
42 Soria;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
42 Soria;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;92,24
42 Soria;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
42 Soria;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
42 Soria;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
42 Soria;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;94,13
42 Soria;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
42 Soria;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
42 Soria;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;90,53
42 Soria;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
42 Soria;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
42 Soria;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
42 Soria;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;89,55
42 Soria;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
42 Soria;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
42 Soria;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
42 Soria;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;91,5
42 Soria;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
42 Soria;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
42 Soria;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
42 Soria;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
42 Soria;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
42 Soria;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
42 Soria;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;88,66
42 Soria;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
42 Soria;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
42 Soria;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
42 Soria;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;89,44
42 Soria;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
42 Soria;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
42 Soria;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
42 Soria;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
42 Soria;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
42 Soria;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QIII;832
42 Soria;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
42 Soria;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
42 Soria;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
42 Soria;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QIII;828
42 Soria;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
42 Soria;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
42 Soria;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
42 Soria;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QIII;833
42 Soria;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
42 Soria;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
42 Soria;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
42 Soria;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2022QIII;795
42 Soria;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2022QII;""
42 Soria;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2022QI;""
42 Soria;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
42 Soria;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2021QIII;800
42 Soria;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2021QII;""
42 Soria;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2021QI;""
42 Soria;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
42 Soria;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2020QIII;802
42 Soria;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2020QII;""
42 Soria;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2020QI;""
42 Soria;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2022QIV;758
42 Soria;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
42 Soria;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2022QII;""
42 Soria;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2022QI;""
42 Soria;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2021QIV;773
42 Soria;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
42 Soria;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2021QII;""
42 Soria;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2021QI;""
42 Soria;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2020QIV;782
42 Soria;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
42 Soria;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2020QII;""
42 Soria;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2020QI;""
42 Soria;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
42 Soria;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
42 Soria;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QII;""
42 Soria;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QI;756
42 Soria;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
42 Soria;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
42 Soria;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QII;""
42 Soria;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QI;768
42 Soria;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
42 Soria;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
42 Soria;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QII;""
42 Soria;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QI;""
42 Soria;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
42 Soria;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
42 Soria;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QII;741
42 Soria;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QI;""
42 Soria;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
42 Soria;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
42 Soria;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QII;753
42 Soria;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QI;""
42 Soria;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
42 Soria;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
42 Soria;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QII;""
42 Soria;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QI;""
42 Soria;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
42 Soria;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
42 Soria;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
42 Soria;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
42 Soria;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
42 Soria;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
42 Soria;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
42 Soria;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
42 Soria;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
42 Soria;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
42 Soria;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
42 Soria;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
42 Soria;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
42 Soria;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;95,55
42 Soria;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
42 Soria;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
42 Soria;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
42 Soria;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;96,62
42 Soria;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
42 Soria;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
42 Soria;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
42 Soria;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;96,28
42 Soria;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
42 Soria;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
42 Soria;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;91,11
42 Soria;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
42 Soria;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
42 Soria;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
42 Soria;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;93,36
42 Soria;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
42 Soria;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
42 Soria;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
42 Soria;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;93,88
42 Soria;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
42 Soria;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
42 Soria;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
42 Soria;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
42 Soria;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
42 Soria;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
42 Soria;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;91,3
42 Soria;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
42 Soria;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
42 Soria;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
42 Soria;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;92,2
42 Soria;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
42 Soria;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
42 Soria;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
42 Soria;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
42 Soria;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
42 Soria;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
42 Soria;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;89,49
42 Soria;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
42 Soria;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
42 Soria;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
42 Soria;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;90,4
42 Soria;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
42 Soria;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
42 Soria;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
42 Soria;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
42 Soria;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
42 Soria;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
42 Soria;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QIII;488
42 Soria;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
42 Soria;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
42 Soria;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
42 Soria;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QIII;486
42 Soria;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
42 Soria;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
42 Soria;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
42 Soria;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QIII;489
42 Soria;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
42 Soria;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
42 Soria;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
42 Soria;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2022QIII;466
42 Soria;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2022QII;""
42 Soria;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2022QI;""
42 Soria;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
42 Soria;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2021QIII;473
42 Soria;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2021QII;""
42 Soria;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2021QI;""
42 Soria;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
42 Soria;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2020QIII;471
42 Soria;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2020QII;""
42 Soria;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2020QI;""
42 Soria;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2022QIV;443
42 Soria;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
42 Soria;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2022QII;""
42 Soria;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2022QI;""
42 Soria;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2021QIV;459
42 Soria;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
42 Soria;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2021QII;""
42 Soria;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2021QI;""
42 Soria;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2020QIV;460
42 Soria;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
42 Soria;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2020QII;""
42 Soria;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2020QI;""
42 Soria;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
42 Soria;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
42 Soria;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QII;""
42 Soria;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QI;445
42 Soria;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
42 Soria;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
42 Soria;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QII;""
42 Soria;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QI;453
42 Soria;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
42 Soria;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
42 Soria;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QII;""
42 Soria;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QI;""
42 Soria;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
42 Soria;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
42 Soria;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QII;436
42 Soria;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QI;""
42 Soria;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
42 Soria;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
42 Soria;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QII;443
42 Soria;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QI;""
42 Soria;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
42 Soria;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
42 Soria;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QII;""
42 Soria;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QI;""
42 Soria;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
42 Soria;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
42 Soria;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
42 Soria;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
42 Soria;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
42 Soria;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
42 Soria;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
42 Soria;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
42 Soria;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
42 Soria;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
42 Soria;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
42 Soria;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
42 Soria;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
42 Soria;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;95,49
42 Soria;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
42 Soria;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
42 Soria;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
42 Soria;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;97,33
42 Soria;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
42 Soria;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
42 Soria;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
42 Soria;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;96,32
42 Soria;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
42 Soria;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
42 Soria;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;90,78
42 Soria;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
42 Soria;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
42 Soria;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
42 Soria;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;94,44
42 Soria;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
42 Soria;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
42 Soria;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
42 Soria;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;94,07
42 Soria;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
42 Soria;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
42 Soria;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
42 Soria;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
42 Soria;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
42 Soria;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
42 Soria;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;91,56
42 Soria;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
42 Soria;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
42 Soria;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
42 Soria;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;92,64
42 Soria;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
42 Soria;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
42 Soria;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
42 Soria;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
42 Soria;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
42 Soria;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
42 Soria;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;89,71
42 Soria;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
42 Soria;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
42 Soria;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
42 Soria;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;90,59
42 Soria;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
42 Soria;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
42 Soria;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
42 Soria;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
42 Soria;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
42 Soria;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
42 Soria;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QIII;344
42 Soria;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
42 Soria;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
42 Soria;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
42 Soria;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QIII;342
42 Soria;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
42 Soria;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
42 Soria;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
42 Soria;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QIII;344
42 Soria;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
42 Soria;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
42 Soria;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
42 Soria;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2022QIII;329
42 Soria;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2022QII;""
42 Soria;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2022QI;""
42 Soria;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
42 Soria;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2021QIII;327
42 Soria;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2021QII;""
42 Soria;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2021QI;""
42 Soria;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
42 Soria;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2020QIII;331
42 Soria;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2020QII;""
42 Soria;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2020QI;""
42 Soria;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2022QIV;315
42 Soria;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
42 Soria;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2022QII;""
42 Soria;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2022QI;""
42 Soria;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2021QIV;314
42 Soria;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
42 Soria;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2021QII;""
42 Soria;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2021QI;""
42 Soria;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2020QIV;322
42 Soria;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
42 Soria;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2020QII;""
42 Soria;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2020QI;""
42 Soria;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
42 Soria;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
42 Soria;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QII;""
42 Soria;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QI;311
42 Soria;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
42 Soria;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
42 Soria;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QII;""
42 Soria;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QI;315
42 Soria;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
42 Soria;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
42 Soria;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QII;""
42 Soria;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QI;""
42 Soria;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
42 Soria;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
42 Soria;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QII;305
42 Soria;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QI;""
42 Soria;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
42 Soria;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
42 Soria;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QII;310
42 Soria;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QI;""
42 Soria;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
42 Soria;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
42 Soria;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QII;""
42 Soria;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QI;""
42 Soria;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
42 Soria;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
42 Soria;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
42 Soria;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
42 Soria;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
42 Soria;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
42 Soria;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
42 Soria;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
42 Soria;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
42 Soria;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
42 Soria;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
42 Soria;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
42 Soria;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
42 Soria;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;95,64
42 Soria;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
42 Soria;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
42 Soria;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
42 Soria;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;95,61
42 Soria;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
42 Soria;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
42 Soria;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
42 Soria;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;96,22
42 Soria;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
42 Soria;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
42 Soria;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;91,57
42 Soria;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
42 Soria;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
42 Soria;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
42 Soria;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;91,81
42 Soria;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
42 Soria;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
42 Soria;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
42 Soria;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;93,6
42 Soria;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
42 Soria;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
42 Soria;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
42 Soria;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
42 Soria;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
42 Soria;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
42 Soria;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;90,94
42 Soria;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
42 Soria;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
42 Soria;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
42 Soria;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;91,57
42 Soria;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
42 Soria;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
42 Soria;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
42 Soria;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
42 Soria;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
42 Soria;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
42 Soria;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;89,18
42 Soria;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
42 Soria;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
42 Soria;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
42 Soria;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;90,12
42 Soria;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
42 Soria;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
42 Soria;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
42 Soria;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
42 Soria;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
42 Soria;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QIV;830
42 Soria;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
42 Soria;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
42 Soria;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
42 Soria;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QIV;831
42 Soria;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
42 Soria;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
42 Soria;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
42 Soria;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QIV;837
42 Soria;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
42 Soria;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
42 Soria;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
42 Soria;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2022QIV;790
42 Soria;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
42 Soria;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2022QII;""
42 Soria;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2022QI;""
42 Soria;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2021QIV;801
42 Soria;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
42 Soria;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2021QII;""
42 Soria;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2021QI;""
42 Soria;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2020QIV;815
42 Soria;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
42 Soria;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2020QII;""
42 Soria;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2020QI;""
42 Soria;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
42 Soria;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
42 Soria;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2022QII;""
42 Soria;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2022QI;782
42 Soria;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
42 Soria;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
42 Soria;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2021QII;""
42 Soria;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2021QI;799
42 Soria;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
42 Soria;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
42 Soria;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2020QII;""
42 Soria;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2020QI;""
42 Soria;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
42 Soria;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
42 Soria;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QII;764
42 Soria;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QI;""
42 Soria;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
42 Soria;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
42 Soria;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QII;781
42 Soria;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QI;""
42 Soria;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
42 Soria;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
42 Soria;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QII;""
42 Soria;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QI;""
42 Soria;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
42 Soria;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QIII;742
42 Soria;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QII;""
42 Soria;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QI;""
42 Soria;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
42 Soria;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QIII;764
42 Soria;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QII;""
42 Soria;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QI;""
42 Soria;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
42 Soria;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
42 Soria;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QII;""
42 Soria;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QI;""
42 Soria;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
42 Soria;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
42 Soria;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
42 Soria;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
42 Soria;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
42 Soria;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
42 Soria;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
42 Soria;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
42 Soria;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
42 Soria;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
42 Soria;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
42 Soria;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
42 Soria;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;95,18
42 Soria;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
42 Soria;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
42 Soria;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
42 Soria;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;96,39
42 Soria;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
42 Soria;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
42 Soria;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
42 Soria;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;97,37
42 Soria;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
42 Soria;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
42 Soria;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
42 Soria;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
42 Soria;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
42 Soria;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
42 Soria;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;94,1
42 Soria;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
42 Soria;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
42 Soria;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
42 Soria;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;95,46
42 Soria;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
42 Soria;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
42 Soria;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
42 Soria;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
42 Soria;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
42 Soria;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
42 Soria;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;91,94
42 Soria;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
42 Soria;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
42 Soria;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
42 Soria;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;93,31
42 Soria;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
42 Soria;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
42 Soria;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
42 Soria;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
42 Soria;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
42 Soria;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
42 Soria;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;89,29
42 Soria;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
42 Soria;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
42 Soria;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
42 Soria;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;91,28
42 Soria;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
42 Soria;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
42 Soria;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
42 Soria;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
42 Soria;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
42 Soria;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
42 Soria;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QIV;485
42 Soria;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
42 Soria;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
42 Soria;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
42 Soria;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QIV;490
42 Soria;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
42 Soria;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
42 Soria;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
42 Soria;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QIV;492
42 Soria;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
42 Soria;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
42 Soria;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
42 Soria;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2022QIV;462
42 Soria;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
42 Soria;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2022QII;""
42 Soria;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2022QI;""
42 Soria;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2021QIV;476
42 Soria;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
42 Soria;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2021QII;""
42 Soria;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2021QI;""
42 Soria;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2020QIV;480
42 Soria;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
42 Soria;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2020QII;""
42 Soria;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2020QI;""
42 Soria;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
42 Soria;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
42 Soria;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2022QII;""
42 Soria;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2022QI;461
42 Soria;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
42 Soria;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
42 Soria;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2021QII;""
42 Soria;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2021QI;473
42 Soria;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
42 Soria;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
42 Soria;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2020QII;""
42 Soria;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2020QI;""
42 Soria;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
42 Soria;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
42 Soria;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QII;449
42 Soria;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QI;""
42 Soria;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
42 Soria;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
42 Soria;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QII;461
42 Soria;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QI;""
42 Soria;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
42 Soria;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
42 Soria;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QII;""
42 Soria;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QI;""
42 Soria;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
42 Soria;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QIII;437
42 Soria;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QII;""
42 Soria;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QI;""
42 Soria;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
42 Soria;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QIII;453
42 Soria;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QII;""
42 Soria;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QI;""
42 Soria;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
42 Soria;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
42 Soria;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QII;""
42 Soria;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QI;""
42 Soria;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
42 Soria;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
42 Soria;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
42 Soria;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
42 Soria;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
42 Soria;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
42 Soria;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
42 Soria;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
42 Soria;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
42 Soria;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
42 Soria;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
42 Soria;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
42 Soria;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;95,26
42 Soria;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
42 Soria;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
42 Soria;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
42 Soria;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;97,14
42 Soria;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
42 Soria;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
42 Soria;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
42 Soria;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;97,56
42 Soria;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
42 Soria;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
42 Soria;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
42 Soria;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
42 Soria;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
42 Soria;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
42 Soria;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;94,08
42 Soria;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
42 Soria;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
42 Soria;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
42 Soria;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;96,14
42 Soria;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
42 Soria;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
42 Soria;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
42 Soria;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
42 Soria;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
42 Soria;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
42 Soria;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;91,63
42 Soria;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
42 Soria;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
42 Soria;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
42 Soria;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;93,7
42 Soria;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
42 Soria;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
42 Soria;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
42 Soria;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
42 Soria;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
42 Soria;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
42 Soria;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;89,18
42 Soria;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
42 Soria;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
42 Soria;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
42 Soria;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;92,07
42 Soria;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
42 Soria;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
42 Soria;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
42 Soria;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
42 Soria;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
42 Soria;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
42 Soria;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QIV;345
42 Soria;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
42 Soria;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
42 Soria;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
42 Soria;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QIV;341
42 Soria;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
42 Soria;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
42 Soria;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
42 Soria;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QIV;345
42 Soria;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
42 Soria;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
42 Soria;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
42 Soria;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2022QIV;328
42 Soria;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
42 Soria;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2022QII;""
42 Soria;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2022QI;""
42 Soria;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2021QIV;325
42 Soria;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
42 Soria;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2021QII;""
42 Soria;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2021QI;""
42 Soria;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2020QIV;335
42 Soria;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
42 Soria;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2020QII;""
42 Soria;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2020QI;""
42 Soria;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
42 Soria;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
42 Soria;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2022QII;""
42 Soria;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2022QI;321
42 Soria;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
42 Soria;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
42 Soria;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2021QII;""
42 Soria;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2021QI;326
42 Soria;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
42 Soria;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
42 Soria;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2020QII;""
42 Soria;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2020QI;""
42 Soria;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
42 Soria;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
42 Soria;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QII;315
42 Soria;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QI;""
42 Soria;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
42 Soria;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
42 Soria;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QII;320
42 Soria;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QI;""
42 Soria;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
42 Soria;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
42 Soria;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QII;""
42 Soria;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QI;""
42 Soria;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
42 Soria;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QIII;305
42 Soria;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QII;""
42 Soria;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QI;""
42 Soria;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
42 Soria;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QIII;311
42 Soria;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QII;""
42 Soria;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QI;""
42 Soria;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
42 Soria;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
42 Soria;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QII;""
42 Soria;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QI;""
42 Soria;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
42 Soria;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
42 Soria;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
42 Soria;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
42 Soria;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
42 Soria;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
42 Soria;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
42 Soria;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
42 Soria;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
42 Soria;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
42 Soria;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
42 Soria;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
42 Soria;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;95,07
42 Soria;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
42 Soria;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
42 Soria;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
42 Soria;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;95,31
42 Soria;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
42 Soria;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
42 Soria;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
42 Soria;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;97,1
42 Soria;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
42 Soria;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
42 Soria;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
42 Soria;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
42 Soria;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
42 Soria;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
42 Soria;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;94,13
42 Soria;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
42 Soria;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
42 Soria;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
42 Soria;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;94,49
42 Soria;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
42 Soria;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
42 Soria;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
42 Soria;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
42 Soria;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
42 Soria;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
42 Soria;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;92,38
42 Soria;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
42 Soria;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
42 Soria;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
42 Soria;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;92,75
42 Soria;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
42 Soria;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
42 Soria;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
42 Soria;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
42 Soria;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
42 Soria;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
42 Soria;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;89,44
42 Soria;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
42 Soria;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
42 Soria;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
42 Soria;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;90,14
42 Soria;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
42 Soria;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
42 Soria;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
42 Soria;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
42 Soria;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
42 Soria;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
42 Soria;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
42 Soria;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
42 Soria;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
42 Soria;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QI;1.531
42 Soria;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
42 Soria;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
42 Soria;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
42 Soria;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QI;1.561
42 Soria;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
42 Soria;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
42 Soria;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
42 Soria;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QI;1.548
42 Soria;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
42 Soria;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
42 Soria;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2022QII;""
42 Soria;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2022QI;1.497
42 Soria;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
42 Soria;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
42 Soria;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2021QII;""
42 Soria;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2021QI;1.532
42 Soria;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
42 Soria;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
42 Soria;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2020QII;""
42 Soria;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2020QI;1.488
42 Soria;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
42 Soria;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
42 Soria;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2022QII;1.469
42 Soria;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2022QI;""
42 Soria;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
42 Soria;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
42 Soria;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2021QII;1.513
42 Soria;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2021QI;""
42 Soria;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
42 Soria;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
42 Soria;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2020QII;1.473
42 Soria;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2020QI;""
42 Soria;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
42 Soria;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QIII;1.434
42 Soria;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QII;""
42 Soria;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QI;""
42 Soria;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
42 Soria;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QIII;1.488
42 Soria;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QII;""
42 Soria;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QI;""
42 Soria;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
42 Soria;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QIII;1.456
42 Soria;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QII;""
42 Soria;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QI;""
42 Soria;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QIV;1.411
42 Soria;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
42 Soria;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QII;""
42 Soria;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QI;""
42 Soria;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QIV;1.471
42 Soria;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
42 Soria;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QII;""
42 Soria;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QI;""
42 Soria;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QIV;1.426
42 Soria;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
42 Soria;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QII;""
42 Soria;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QI;""
42 Soria;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
42 Soria;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
42 Soria;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
42 Soria;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
42 Soria;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
42 Soria;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
42 Soria;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
42 Soria;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
42 Soria;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
42 Soria;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
42 Soria;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
42 Soria;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
42 Soria;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
42 Soria;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
42 Soria;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
42 Soria;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;97,78
42 Soria;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
42 Soria;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
42 Soria;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
42 Soria;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;98,14
42 Soria;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
42 Soria;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
42 Soria;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
42 Soria;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;96,12
42 Soria;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
42 Soria;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
42 Soria;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;95,95
42 Soria;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
42 Soria;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
42 Soria;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
42 Soria;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;96,93
42 Soria;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
42 Soria;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
42 Soria;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
42 Soria;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;95,16
42 Soria;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
42 Soria;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
42 Soria;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;93,66
42 Soria;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
42 Soria;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
42 Soria;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
42 Soria;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;95,32
42 Soria;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
42 Soria;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
42 Soria;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
42 Soria;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;94,06
42 Soria;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
42 Soria;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
42 Soria;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;92,16
42 Soria;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
42 Soria;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
42 Soria;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
42 Soria;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;94,23
42 Soria;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
42 Soria;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
42 Soria;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
42 Soria;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;92,12
42 Soria;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
42 Soria;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
42 Soria;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
42 Soria;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
42 Soria;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
42 Soria;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
42 Soria;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QI;973
42 Soria;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
42 Soria;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
42 Soria;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
42 Soria;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QI;998
42 Soria;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
42 Soria;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
42 Soria;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
42 Soria;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QI;996
42 Soria;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
42 Soria;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
42 Soria;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2022QII;""
42 Soria;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2022QI;958
42 Soria;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
42 Soria;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
42 Soria;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2021QII;""
42 Soria;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2021QI;985
42 Soria;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
42 Soria;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
42 Soria;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2020QII;""
42 Soria;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2020QI;962
42 Soria;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
42 Soria;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
42 Soria;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2022QII;943
42 Soria;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2022QI;""
42 Soria;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
42 Soria;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
42 Soria;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2021QII;976
42 Soria;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2021QI;""
42 Soria;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
42 Soria;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
42 Soria;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2020QII;956
42 Soria;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2020QI;""
42 Soria;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
42 Soria;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QIII;927
42 Soria;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QII;""
42 Soria;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QI;""
42 Soria;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
42 Soria;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QIII;963
42 Soria;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QII;""
42 Soria;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QI;""
42 Soria;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
42 Soria;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QIII;946
42 Soria;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QII;""
42 Soria;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QI;""
42 Soria;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QIV;914
42 Soria;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
42 Soria;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QII;""
42 Soria;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QI;""
42 Soria;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QIV;948
42 Soria;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
42 Soria;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QII;""
42 Soria;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QI;""
42 Soria;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QIV;925
42 Soria;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
42 Soria;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QII;""
42 Soria;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QI;""
42 Soria;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
42 Soria;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
42 Soria;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
42 Soria;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
42 Soria;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
42 Soria;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
42 Soria;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
42 Soria;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
42 Soria;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
42 Soria;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
42 Soria;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
42 Soria;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
42 Soria;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
42 Soria;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
42 Soria;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
42 Soria;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;98,46
42 Soria;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
42 Soria;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
42 Soria;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
42 Soria;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;98,7
42 Soria;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
42 Soria;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
42 Soria;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
42 Soria;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;96,59
42 Soria;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
42 Soria;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
42 Soria;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;96,92
42 Soria;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
42 Soria;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
42 Soria;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
42 Soria;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;97,8
42 Soria;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
42 Soria;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
42 Soria;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
42 Soria;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;95,98
42 Soria;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
42 Soria;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
42 Soria;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;95,27
42 Soria;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
42 Soria;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
42 Soria;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
42 Soria;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;96,49
42 Soria;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
42 Soria;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
42 Soria;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
42 Soria;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;94,98
42 Soria;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
42 Soria;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
42 Soria;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;93,94
42 Soria;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
42 Soria;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
42 Soria;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
42 Soria;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;94,99
42 Soria;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
42 Soria;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
42 Soria;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
42 Soria;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;92,87
42 Soria;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
42 Soria;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
42 Soria;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
42 Soria;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
42 Soria;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
42 Soria;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
42 Soria;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QI;558
42 Soria;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
42 Soria;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
42 Soria;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
42 Soria;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QI;563
42 Soria;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
42 Soria;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
42 Soria;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
42 Soria;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QI;552
42 Soria;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
42 Soria;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
42 Soria;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2022QII;""
42 Soria;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2022QI;539
42 Soria;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
42 Soria;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
42 Soria;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2021QII;""
42 Soria;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2021QI;547
42 Soria;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
42 Soria;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
42 Soria;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2020QII;""
42 Soria;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2020QI;526
42 Soria;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
42 Soria;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
42 Soria;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2022QII;526
42 Soria;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2022QI;""
42 Soria;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
42 Soria;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
42 Soria;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2021QII;537
42 Soria;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2021QI;""
42 Soria;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
42 Soria;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
42 Soria;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2020QII;517
42 Soria;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2020QI;""
42 Soria;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
42 Soria;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QIII;507
42 Soria;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QII;""
42 Soria;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QI;""
42 Soria;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
42 Soria;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QIII;525
42 Soria;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QII;""
42 Soria;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QI;""
42 Soria;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
42 Soria;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QIII;510
42 Soria;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QII;""
42 Soria;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QI;""
42 Soria;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QIV;497
42 Soria;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
42 Soria;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QII;""
42 Soria;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QI;""
42 Soria;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QIV;523
42 Soria;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
42 Soria;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QII;""
42 Soria;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QI;""
42 Soria;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QIV;501
42 Soria;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
42 Soria;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QII;""
42 Soria;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QI;""
42 Soria;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
42 Soria;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
42 Soria;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
42 Soria;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
42 Soria;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
42 Soria;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
42 Soria;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
42 Soria;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
42 Soria;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
42 Soria;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
42 Soria;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
42 Soria;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
42 Soria;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
42 Soria;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
42 Soria;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
42 Soria;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;96,59
42 Soria;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
42 Soria;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
42 Soria;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
42 Soria;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;97,16
42 Soria;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
42 Soria;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
42 Soria;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
42 Soria;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;95,29
42 Soria;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
42 Soria;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
42 Soria;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;94,27
42 Soria;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
42 Soria;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
42 Soria;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
42 Soria;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;95,38
42 Soria;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
42 Soria;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
42 Soria;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
42 Soria;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;93,66
42 Soria;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
42 Soria;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
42 Soria;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;90,86
42 Soria;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
42 Soria;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
42 Soria;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
42 Soria;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;93,25
42 Soria;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
42 Soria;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
42 Soria;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
42 Soria;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;92,39
42 Soria;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
42 Soria;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
42 Soria;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;89,07
42 Soria;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
42 Soria;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
42 Soria;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
42 Soria;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;92,9
42 Soria;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
42 Soria;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
42 Soria;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
42 Soria;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;90,76
42 Soria;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
42 Soria;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
42 Soria;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
42 Soria;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
42 Soria;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
42 Soria;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QII;1.466
42 Soria;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
42 Soria;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
42 Soria;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
42 Soria;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QII;1.500
42 Soria;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
42 Soria;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
42 Soria;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
42 Soria;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QII;1.522
42 Soria;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
42 Soria;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
42 Soria;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
42 Soria;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2022QII;1.436
42 Soria;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2022QI;""
42 Soria;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
42 Soria;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
42 Soria;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2021QII;1.476
42 Soria;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2021QI;""
42 Soria;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
42 Soria;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
42 Soria;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2020QII;1.505
42 Soria;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2020QI;""
42 Soria;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
42 Soria;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2022QIII;1.400
42 Soria;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2022QII;""
42 Soria;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2022QI;""
42 Soria;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
42 Soria;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2021QIII;1.454
42 Soria;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2021QII;""
42 Soria;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2021QI;""
42 Soria;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
42 Soria;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2020QIII;1.483
42 Soria;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2020QII;""
42 Soria;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2020QI;""
42 Soria;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QIV;1.369
42 Soria;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
42 Soria;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QII;""
42 Soria;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QI;""
42 Soria;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QIV;1.434
42 Soria;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
42 Soria;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QII;""
42 Soria;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QI;""
42 Soria;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QIV;1.452
42 Soria;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
42 Soria;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QII;""
42 Soria;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QI;""
42 Soria;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
42 Soria;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
42 Soria;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QII;""
42 Soria;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QI;1.409
42 Soria;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
42 Soria;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
42 Soria;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QII;""
42 Soria;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QI;1.436
42 Soria;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
42 Soria;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
42 Soria;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QII;""
42 Soria;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QI;""
42 Soria;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
42 Soria;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
42 Soria;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
42 Soria;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
42 Soria;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
42 Soria;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
42 Soria;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
42 Soria;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
42 Soria;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
42 Soria;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
42 Soria;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
42 Soria;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
42 Soria;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
42 Soria;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
42 Soria;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;97,95
42 Soria;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
42 Soria;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
42 Soria;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
42 Soria;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;98,4
42 Soria;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
42 Soria;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
42 Soria;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
42 Soria;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;98,88
42 Soria;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
42 Soria;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
42 Soria;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;95,5
42 Soria;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
42 Soria;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
42 Soria;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
42 Soria;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;96,93
42 Soria;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
42 Soria;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
42 Soria;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
42 Soria;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;97,44
42 Soria;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
42 Soria;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
42 Soria;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;93,38
42 Soria;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
42 Soria;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
42 Soria;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
42 Soria;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;95,6
42 Soria;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
42 Soria;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
42 Soria;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
42 Soria;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;95,4
42 Soria;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
42 Soria;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
42 Soria;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
42 Soria;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
42 Soria;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
42 Soria;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
42 Soria;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;93,93
42 Soria;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
42 Soria;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
42 Soria;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
42 Soria;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;94,35
42 Soria;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
42 Soria;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
42 Soria;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
42 Soria;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
42 Soria;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
42 Soria;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
42 Soria;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QII;941
42 Soria;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
42 Soria;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
42 Soria;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
42 Soria;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QII;961
42 Soria;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
42 Soria;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
42 Soria;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
42 Soria;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QII;981
42 Soria;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
42 Soria;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
42 Soria;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
42 Soria;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2022QII;923
42 Soria;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2022QI;""
42 Soria;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
42 Soria;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
42 Soria;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2021QII;948
42 Soria;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2021QI;""
42 Soria;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
42 Soria;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
42 Soria;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2020QII;974
42 Soria;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2020QI;""
42 Soria;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
42 Soria;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2022QIII;908
42 Soria;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2022QII;""
42 Soria;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2022QI;""
42 Soria;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
42 Soria;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2021QIII;935
42 Soria;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2021QII;""
42 Soria;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2021QI;""
42 Soria;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
42 Soria;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2020QIII;961
42 Soria;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2020QII;""
42 Soria;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2020QI;""
42 Soria;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QIV;891
42 Soria;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
42 Soria;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QII;""
42 Soria;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QI;""
42 Soria;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QIV;919
42 Soria;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
42 Soria;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QII;""
42 Soria;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QI;""
42 Soria;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QIV;939
42 Soria;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
42 Soria;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QII;""
42 Soria;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QI;""
42 Soria;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
42 Soria;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
42 Soria;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QII;""
42 Soria;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QI;909
42 Soria;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
42 Soria;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
42 Soria;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QII;""
42 Soria;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QI;933
42 Soria;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
42 Soria;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
42 Soria;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QII;""
42 Soria;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QI;""
42 Soria;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
42 Soria;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
42 Soria;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
42 Soria;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
42 Soria;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
42 Soria;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
42 Soria;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
42 Soria;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
42 Soria;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
42 Soria;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
42 Soria;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
42 Soria;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
42 Soria;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
42 Soria;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
42 Soria;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;98,09
42 Soria;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
42 Soria;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
42 Soria;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
42 Soria;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;98,65
42 Soria;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
42 Soria;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
42 Soria;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
42 Soria;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;99,29
42 Soria;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
42 Soria;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
42 Soria;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;96,49
42 Soria;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
42 Soria;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
42 Soria;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
42 Soria;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;97,29
42 Soria;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
42 Soria;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
42 Soria;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
42 Soria;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;97,96
42 Soria;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
42 Soria;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
42 Soria;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;94,69
42 Soria;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
42 Soria;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
42 Soria;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
42 Soria;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;95,63
42 Soria;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
42 Soria;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
42 Soria;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
42 Soria;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;95,72
42 Soria;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
42 Soria;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
42 Soria;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
42 Soria;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
42 Soria;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
42 Soria;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
42 Soria;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;94,59
42 Soria;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
42 Soria;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
42 Soria;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
42 Soria;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;95,11
42 Soria;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
42 Soria;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
42 Soria;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
42 Soria;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
42 Soria;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
42 Soria;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
42 Soria;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QII;525
42 Soria;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
42 Soria;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
42 Soria;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
42 Soria;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QII;539
42 Soria;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
42 Soria;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
42 Soria;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
42 Soria;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QII;541
42 Soria;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
42 Soria;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
42 Soria;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
42 Soria;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2022QII;513
42 Soria;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2022QI;""
42 Soria;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
42 Soria;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
42 Soria;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2021QII;528
42 Soria;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2021QI;""
42 Soria;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
42 Soria;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
42 Soria;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2020QII;531
42 Soria;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2020QI;""
42 Soria;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
42 Soria;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2022QIII;492
42 Soria;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2022QII;""
42 Soria;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2022QI;""
42 Soria;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
42 Soria;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2021QIII;519
42 Soria;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2021QII;""
42 Soria;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2021QI;""
42 Soria;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
42 Soria;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2020QIII;522
42 Soria;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2020QII;""
42 Soria;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2020QI;""
42 Soria;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QIV;478
42 Soria;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
42 Soria;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QII;""
42 Soria;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QI;""
42 Soria;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QIV;515
42 Soria;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
42 Soria;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QII;""
42 Soria;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QI;""
42 Soria;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QIV;513
42 Soria;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
42 Soria;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QII;""
42 Soria;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QI;""
42 Soria;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
42 Soria;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
42 Soria;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QII;""
42 Soria;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QI;500
42 Soria;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
42 Soria;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
42 Soria;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QII;""
42 Soria;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QI;503
42 Soria;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
42 Soria;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
42 Soria;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QII;""
42 Soria;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QI;""
42 Soria;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
42 Soria;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
42 Soria;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
42 Soria;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
42 Soria;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
42 Soria;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
42 Soria;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
42 Soria;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
42 Soria;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
42 Soria;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
42 Soria;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
42 Soria;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
42 Soria;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
42 Soria;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
42 Soria;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;97,71
42 Soria;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
42 Soria;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
42 Soria;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
42 Soria;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;97,96
42 Soria;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
42 Soria;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
42 Soria;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
42 Soria;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;98,15
42 Soria;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
42 Soria;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
42 Soria;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;93,71
42 Soria;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
42 Soria;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
42 Soria;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
42 Soria;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;96,29
42 Soria;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
42 Soria;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
42 Soria;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
42 Soria;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;96,49
42 Soria;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
42 Soria;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
42 Soria;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;91,05
42 Soria;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
42 Soria;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
42 Soria;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
42 Soria;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;95,55
42 Soria;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
42 Soria;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
42 Soria;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
42 Soria;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;94,82
42 Soria;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
42 Soria;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
42 Soria;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
42 Soria;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
42 Soria;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
42 Soria;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
42 Soria;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;92,76
42 Soria;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
42 Soria;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
42 Soria;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
42 Soria;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;92,98
42 Soria;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
42 Soria;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
42 Soria;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
42 Soria;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
42 Soria;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
42 Soria;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QIII;1.476
42 Soria;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
42 Soria;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
42 Soria;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
42 Soria;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QIII;1.520
42 Soria;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
42 Soria;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
42 Soria;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
42 Soria;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QIII;1.530
42 Soria;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
42 Soria;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
42 Soria;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
42 Soria;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2022QIII;1.433
42 Soria;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2022QII;""
42 Soria;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2022QI;""
42 Soria;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
42 Soria;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2021QIII;1.490
42 Soria;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2021QII;""
42 Soria;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2021QI;""
42 Soria;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
42 Soria;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2020QIII;1.501
42 Soria;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2020QII;""
42 Soria;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2020QI;""
42 Soria;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2022QIV;1.400
42 Soria;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
42 Soria;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2022QII;""
42 Soria;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2022QI;""
42 Soria;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2021QIV;1.468
42 Soria;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
42 Soria;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2021QII;""
42 Soria;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2021QI;""
42 Soria;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2020QIV;1.466
42 Soria;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
42 Soria;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2020QII;""
42 Soria;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2020QI;""
42 Soria;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
42 Soria;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
42 Soria;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QII;""
42 Soria;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QI;1.442
42 Soria;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
42 Soria;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
42 Soria;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QII;""
42 Soria;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QI;1.447
42 Soria;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
42 Soria;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
42 Soria;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QII;""
42 Soria;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QI;""
42 Soria;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
42 Soria;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
42 Soria;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QII;1.420
42 Soria;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QI;""
42 Soria;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
42 Soria;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
42 Soria;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QII;1.435
42 Soria;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QI;""
42 Soria;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
42 Soria;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
42 Soria;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QII;""
42 Soria;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QI;""
42 Soria;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
42 Soria;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
42 Soria;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
42 Soria;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
42 Soria;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
42 Soria;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
42 Soria;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
42 Soria;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
42 Soria;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
42 Soria;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
42 Soria;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
42 Soria;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
42 Soria;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
42 Soria;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;97,09
42 Soria;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
42 Soria;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
42 Soria;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
42 Soria;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;98,03
42 Soria;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
42 Soria;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
42 Soria;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
42 Soria;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;98,1
42 Soria;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
42 Soria;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
42 Soria;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;94,85
42 Soria;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
42 Soria;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
42 Soria;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
42 Soria;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;96,58
42 Soria;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
42 Soria;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
42 Soria;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
42 Soria;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;95,82
42 Soria;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
42 Soria;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
42 Soria;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
42 Soria;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
42 Soria;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
42 Soria;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
42 Soria;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;94,87
42 Soria;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
42 Soria;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
42 Soria;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
42 Soria;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;94,58
42 Soria;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
42 Soria;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
42 Soria;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
42 Soria;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
42 Soria;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
42 Soria;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
42 Soria;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;93,42
42 Soria;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
42 Soria;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
42 Soria;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
42 Soria;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;93,79
42 Soria;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
42 Soria;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
42 Soria;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
42 Soria;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
42 Soria;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
42 Soria;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
42 Soria;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QIII;948
42 Soria;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
42 Soria;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
42 Soria;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
42 Soria;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QIII;976
42 Soria;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
42 Soria;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
42 Soria;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
42 Soria;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QIII;993
42 Soria;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
42 Soria;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
42 Soria;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
42 Soria;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2022QIII;929
42 Soria;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2022QII;""
42 Soria;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2022QI;""
42 Soria;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
42 Soria;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2021QIII;958
42 Soria;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2021QII;""
42 Soria;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2021QI;""
42 Soria;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
42 Soria;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2020QIII;975
42 Soria;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2020QII;""
42 Soria;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2020QI;""
42 Soria;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2022QIV;910
42 Soria;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
42 Soria;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2022QII;""
42 Soria;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2022QI;""
42 Soria;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2021QIV;941
42 Soria;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
42 Soria;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2021QII;""
42 Soria;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2021QI;""
42 Soria;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2020QIV;950
42 Soria;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
42 Soria;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2020QII;""
42 Soria;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2020QI;""
42 Soria;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
42 Soria;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
42 Soria;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QII;""
42 Soria;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QI;931
42 Soria;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
42 Soria;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
42 Soria;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QII;""
42 Soria;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QI;941
42 Soria;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
42 Soria;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
42 Soria;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QII;""
42 Soria;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QI;""
42 Soria;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
42 Soria;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
42 Soria;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QII;920
42 Soria;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QI;""
42 Soria;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
42 Soria;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
42 Soria;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QII;936
42 Soria;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QI;""
42 Soria;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
42 Soria;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
42 Soria;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QII;""
42 Soria;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QI;""
42 Soria;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
42 Soria;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
42 Soria;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
42 Soria;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
42 Soria;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
42 Soria;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
42 Soria;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
42 Soria;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
42 Soria;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
42 Soria;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
42 Soria;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
42 Soria;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
42 Soria;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
42 Soria;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;98
42 Soria;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
42 Soria;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
42 Soria;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
42 Soria;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;98,16
42 Soria;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
42 Soria;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
42 Soria;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
42 Soria;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;98,19
42 Soria;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
42 Soria;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
42 Soria;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;95,99
42 Soria;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
42 Soria;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
42 Soria;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
42 Soria;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;96,41
42 Soria;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
42 Soria;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
42 Soria;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
42 Soria;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;95,67
42 Soria;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
42 Soria;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
42 Soria;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
42 Soria;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
42 Soria;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
42 Soria;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
42 Soria;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;95,39
42 Soria;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
42 Soria;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
42 Soria;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
42 Soria;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;94,76
42 Soria;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
42 Soria;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
42 Soria;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
42 Soria;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
42 Soria;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
42 Soria;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
42 Soria;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;94,26
42 Soria;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
42 Soria;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
42 Soria;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
42 Soria;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;94,26
42 Soria;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
42 Soria;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
42 Soria;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
42 Soria;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
42 Soria;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
42 Soria;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
42 Soria;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QIII;528
42 Soria;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
42 Soria;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
42 Soria;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
42 Soria;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QIII;544
42 Soria;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
42 Soria;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
42 Soria;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
42 Soria;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QIII;537
42 Soria;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
42 Soria;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
42 Soria;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
42 Soria;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2022QIII;504
42 Soria;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2022QII;""
42 Soria;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2022QI;""
42 Soria;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
42 Soria;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2021QIII;532
42 Soria;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2021QII;""
42 Soria;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2021QI;""
42 Soria;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
42 Soria;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2020QIII;526
42 Soria;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2020QII;""
42 Soria;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2020QI;""
42 Soria;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2022QIV;490
42 Soria;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
42 Soria;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2022QII;""
42 Soria;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2022QI;""
42 Soria;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2021QIV;527
42 Soria;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
42 Soria;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2021QII;""
42 Soria;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2021QI;""
42 Soria;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2020QIV;516
42 Soria;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
42 Soria;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2020QII;""
42 Soria;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2020QI;""
42 Soria;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
42 Soria;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
42 Soria;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QII;""
42 Soria;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QI;511
42 Soria;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
42 Soria;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
42 Soria;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QII;""
42 Soria;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QI;506
42 Soria;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
42 Soria;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
42 Soria;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QII;""
42 Soria;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QI;""
42 Soria;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
42 Soria;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
42 Soria;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QII;500
42 Soria;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QI;""
42 Soria;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
42 Soria;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
42 Soria;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QII;499
42 Soria;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QI;""
42 Soria;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
42 Soria;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
42 Soria;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QII;""
42 Soria;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QI;""
42 Soria;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
42 Soria;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
42 Soria;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
42 Soria;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
42 Soria;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
42 Soria;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
42 Soria;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
42 Soria;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
42 Soria;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
42 Soria;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
42 Soria;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
42 Soria;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
42 Soria;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
42 Soria;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;95,45
42 Soria;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
42 Soria;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
42 Soria;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
42 Soria;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;97,79
42 Soria;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
42 Soria;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
42 Soria;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
42 Soria;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;97,95
42 Soria;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
42 Soria;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
42 Soria;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;92,8
42 Soria;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
42 Soria;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
42 Soria;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
42 Soria;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;96,88
42 Soria;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
42 Soria;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
42 Soria;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
42 Soria;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;96,09
42 Soria;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
42 Soria;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
42 Soria;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
42 Soria;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
42 Soria;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
42 Soria;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
42 Soria;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;93,93
42 Soria;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
42 Soria;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
42 Soria;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
42 Soria;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;94,23
42 Soria;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
42 Soria;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
42 Soria;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
42 Soria;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
42 Soria;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
42 Soria;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
42 Soria;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;91,91
42 Soria;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
42 Soria;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
42 Soria;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
42 Soria;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;92,92
42 Soria;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
42 Soria;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
42 Soria;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
42 Soria;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
42 Soria;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
42 Soria;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QIV;1.474
42 Soria;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
42 Soria;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
42 Soria;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
42 Soria;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QIV;1.519
42 Soria;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
42 Soria;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
42 Soria;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
42 Soria;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QIV;1.560
42 Soria;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
42 Soria;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
42 Soria;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
42 Soria;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2022QIV;1.436
42 Soria;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
42 Soria;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2022QII;""
42 Soria;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2022QI;""
42 Soria;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2021QIV;1.494
42 Soria;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
42 Soria;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2021QII;""
42 Soria;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2021QI;""
42 Soria;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2020QIV;1.518
42 Soria;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
42 Soria;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2020QII;""
42 Soria;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2020QI;""
42 Soria;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
42 Soria;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
42 Soria;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2022QII;""
42 Soria;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2022QI;1.467
42 Soria;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
42 Soria;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
42 Soria;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2021QII;""
42 Soria;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2021QI;1.495
42 Soria;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
42 Soria;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
42 Soria;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2020QII;""
42 Soria;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2020QI;""
42 Soria;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
42 Soria;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
42 Soria;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QII;1.443
42 Soria;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QI;""
42 Soria;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
42 Soria;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
42 Soria;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QII;1.479
42 Soria;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QI;""
42 Soria;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
42 Soria;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
42 Soria;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QII;""
42 Soria;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QI;""
42 Soria;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
42 Soria;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QIII;1.408
42 Soria;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QII;""
42 Soria;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QI;""
42 Soria;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
42 Soria;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QIII;1.456
42 Soria;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QII;""
42 Soria;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QI;""
42 Soria;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
42 Soria;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
42 Soria;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QII;""
42 Soria;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QI;""
42 Soria;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
42 Soria;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
42 Soria;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
42 Soria;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
42 Soria;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
42 Soria;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
42 Soria;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
42 Soria;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
42 Soria;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
42 Soria;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
42 Soria;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
42 Soria;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
42 Soria;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;97,42
42 Soria;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
42 Soria;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
42 Soria;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
42 Soria;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;98,35
42 Soria;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
42 Soria;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
42 Soria;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
42 Soria;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;97,31
42 Soria;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
42 Soria;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
42 Soria;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
42 Soria;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
42 Soria;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
42 Soria;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
42 Soria;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;96,58
42 Soria;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
42 Soria;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
42 Soria;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
42 Soria;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;95,83
42 Soria;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
42 Soria;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
42 Soria;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
42 Soria;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
42 Soria;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
42 Soria;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
42 Soria;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;95
42 Soria;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
42 Soria;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
42 Soria;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
42 Soria;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;94,81
42 Soria;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
42 Soria;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
42 Soria;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
42 Soria;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
42 Soria;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
42 Soria;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
42 Soria;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;92,69
42 Soria;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
42 Soria;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
42 Soria;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
42 Soria;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;93,33
42 Soria;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
42 Soria;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
42 Soria;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
42 Soria;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
42 Soria;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
42 Soria;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
42 Soria;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QIV;950
42 Soria;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
42 Soria;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
42 Soria;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
42 Soria;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QIV;974
42 Soria;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
42 Soria;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
42 Soria;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
42 Soria;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QIV;1.005
42 Soria;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
42 Soria;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
42 Soria;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
42 Soria;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2022QIV;930
42 Soria;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
42 Soria;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2022QII;""
42 Soria;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2022QI;""
42 Soria;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2021QIV;956
42 Soria;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
42 Soria;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2021QII;""
42 Soria;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2021QI;""
42 Soria;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2020QIV;976
42 Soria;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
42 Soria;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2020QII;""
42 Soria;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2020QI;""
42 Soria;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
42 Soria;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
42 Soria;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2022QII;""
42 Soria;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2022QI;945
42 Soria;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
42 Soria;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
42 Soria;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2021QII;""
42 Soria;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2021QI;966
42 Soria;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
42 Soria;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
42 Soria;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2020QII;""
42 Soria;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2020QI;""
42 Soria;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
42 Soria;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
42 Soria;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QII;932
42 Soria;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QI;""
42 Soria;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
42 Soria;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
42 Soria;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QII;959
42 Soria;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QI;""
42 Soria;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
42 Soria;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
42 Soria;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QII;""
42 Soria;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QI;""
42 Soria;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
42 Soria;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QIII;916
42 Soria;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QII;""
42 Soria;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QI;""
42 Soria;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
42 Soria;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QIII;948
42 Soria;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QII;""
42 Soria;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QI;""
42 Soria;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
42 Soria;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
42 Soria;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QII;""
42 Soria;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QI;""
42 Soria;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
42 Soria;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
42 Soria;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
42 Soria;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
42 Soria;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
42 Soria;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
42 Soria;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
42 Soria;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
42 Soria;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
42 Soria;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
42 Soria;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
42 Soria;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
42 Soria;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;97,89
42 Soria;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
42 Soria;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
42 Soria;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
42 Soria;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;98,15
42 Soria;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
42 Soria;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
42 Soria;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
42 Soria;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;97,11
42 Soria;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
42 Soria;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
42 Soria;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
42 Soria;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
42 Soria;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
42 Soria;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
42 Soria;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;97,02
42 Soria;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
42 Soria;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
42 Soria;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
42 Soria;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;96,12
42 Soria;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
42 Soria;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
42 Soria;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
42 Soria;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
42 Soria;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
42 Soria;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
42 Soria;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;95,69
42 Soria;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
42 Soria;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
42 Soria;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
42 Soria;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;95,42
42 Soria;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
42 Soria;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
42 Soria;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
42 Soria;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
42 Soria;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
42 Soria;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
42 Soria;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;94,05
42 Soria;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
42 Soria;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
42 Soria;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
42 Soria;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;94,33
42 Soria;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
42 Soria;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
42 Soria;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
42 Soria;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
42 Soria;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
42 Soria;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
42 Soria;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QIV;524
42 Soria;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
42 Soria;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
42 Soria;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
42 Soria;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QIV;545
42 Soria;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
42 Soria;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
42 Soria;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
42 Soria;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QIV;555
42 Soria;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
42 Soria;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
42 Soria;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
42 Soria;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2022QIV;506
42 Soria;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
42 Soria;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2022QII;""
42 Soria;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2022QI;""
42 Soria;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2021QIV;538
42 Soria;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
42 Soria;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2021QII;""
42 Soria;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2021QI;""
42 Soria;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2020QIV;542
42 Soria;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
42 Soria;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2020QII;""
42 Soria;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2020QI;""
42 Soria;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
42 Soria;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
42 Soria;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2022QII;""
42 Soria;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2022QI;522
42 Soria;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
42 Soria;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
42 Soria;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2021QII;""
42 Soria;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2021QI;529
42 Soria;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
42 Soria;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
42 Soria;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2020QII;""
42 Soria;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2020QI;""
42 Soria;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
42 Soria;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
42 Soria;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QII;511
42 Soria;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QI;""
42 Soria;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
42 Soria;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
42 Soria;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QII;520
42 Soria;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QI;""
42 Soria;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
42 Soria;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
42 Soria;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QII;""
42 Soria;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QI;""
42 Soria;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
42 Soria;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QIII;492
42 Soria;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QII;""
42 Soria;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QI;""
42 Soria;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
42 Soria;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QIII;508
42 Soria;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QII;""
42 Soria;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QI;""
42 Soria;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
42 Soria;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
42 Soria;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QII;""
42 Soria;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QI;""
42 Soria;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
42 Soria;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
42 Soria;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
42 Soria;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
42 Soria;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
42 Soria;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
42 Soria;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
42 Soria;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
42 Soria;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
42 Soria;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
42 Soria;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
42 Soria;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
42 Soria;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;96,56
42 Soria;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
42 Soria;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
42 Soria;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
42 Soria;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;98,72
42 Soria;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
42 Soria;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
42 Soria;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
42 Soria;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;97,66
42 Soria;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
42 Soria;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
42 Soria;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
42 Soria;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
42 Soria;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
42 Soria;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
42 Soria;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;95,78
42 Soria;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
42 Soria;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
42 Soria;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
42 Soria;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;95,32
42 Soria;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
42 Soria;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
42 Soria;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
42 Soria;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
42 Soria;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
42 Soria;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
42 Soria;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;93,76
42 Soria;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
42 Soria;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
42 Soria;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
42 Soria;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;93,69
42 Soria;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
42 Soria;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
42 Soria;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
42 Soria;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
42 Soria;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
42 Soria;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
42 Soria;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;90,28
42 Soria;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
42 Soria;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
42 Soria;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
42 Soria;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;91,53
42 Soria;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
42 Soria;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
42 Soria;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
42 Soria;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
42 Soria;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
42 Soria;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
42 Soria;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
42 Soria;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
42 Soria;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
42 Soria;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QI;1.755
42 Soria;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
42 Soria;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
42 Soria;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
42 Soria;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QI;1.764
42 Soria;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
42 Soria;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
42 Soria;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
42 Soria;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QI;1.833
42 Soria;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
42 Soria;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
42 Soria;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2022QII;""
42 Soria;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2022QI;1.734
42 Soria;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
42 Soria;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
42 Soria;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2021QII;""
42 Soria;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2021QI;1.752
42 Soria;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
42 Soria;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
42 Soria;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2020QII;""
42 Soria;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2020QI;1.760
42 Soria;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
42 Soria;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
42 Soria;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2022QII;1.708
42 Soria;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2022QI;""
42 Soria;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
42 Soria;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
42 Soria;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2021QII;1.727
42 Soria;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2021QI;""
42 Soria;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
42 Soria;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
42 Soria;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2020QII;1.735
42 Soria;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2020QI;""
42 Soria;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
42 Soria;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QIII;1.683
42 Soria;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QII;""
42 Soria;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QI;""
42 Soria;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
42 Soria;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QIII;1.708
42 Soria;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QII;""
42 Soria;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QI;""
42 Soria;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
42 Soria;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QIII;1.715
42 Soria;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QII;""
42 Soria;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QI;""
42 Soria;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QIV;1.651
42 Soria;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
42 Soria;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QII;""
42 Soria;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QI;""
42 Soria;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QIV;1.687
42 Soria;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
42 Soria;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QII;""
42 Soria;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QI;""
42 Soria;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QIV;1.692
42 Soria;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
42 Soria;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QII;""
42 Soria;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QI;""
42 Soria;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
42 Soria;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
42 Soria;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
42 Soria;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
42 Soria;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
42 Soria;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
42 Soria;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
42 Soria;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
42 Soria;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
42 Soria;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
42 Soria;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
42 Soria;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
42 Soria;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
42 Soria;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
42 Soria;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
42 Soria;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;98,8
42 Soria;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
42 Soria;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
42 Soria;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
42 Soria;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;99,32
42 Soria;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
42 Soria;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
42 Soria;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
42 Soria;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;96,02
42 Soria;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
42 Soria;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
42 Soria;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;97,32
42 Soria;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
42 Soria;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
42 Soria;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
42 Soria;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;97,9
42 Soria;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
42 Soria;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
42 Soria;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
42 Soria;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;94,65
42 Soria;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
42 Soria;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
42 Soria;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;95,9
42 Soria;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
42 Soria;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
42 Soria;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
42 Soria;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;96,83
42 Soria;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
42 Soria;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
42 Soria;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
42 Soria;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;93,56
42 Soria;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
42 Soria;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
42 Soria;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;94,07
42 Soria;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
42 Soria;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
42 Soria;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
42 Soria;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;95,63
42 Soria;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
42 Soria;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
42 Soria;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
42 Soria;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;92,31
42 Soria;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
42 Soria;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
42 Soria;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
42 Soria;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
42 Soria;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
42 Soria;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
42 Soria;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QI;1.145
42 Soria;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
42 Soria;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
42 Soria;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
42 Soria;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QI;1.160
42 Soria;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
42 Soria;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
42 Soria;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
42 Soria;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QI;1.182
42 Soria;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
42 Soria;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
42 Soria;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2022QII;""
42 Soria;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2022QI;1.133
42 Soria;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
42 Soria;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
42 Soria;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2021QII;""
42 Soria;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2021QI;1.153
42 Soria;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
42 Soria;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
42 Soria;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2020QII;""
42 Soria;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2020QI;1.151
42 Soria;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
42 Soria;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
42 Soria;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2022QII;1.123
42 Soria;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2022QI;""
42 Soria;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
42 Soria;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
42 Soria;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2021QII;1.139
42 Soria;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2021QI;""
42 Soria;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
42 Soria;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
42 Soria;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2020QII;1.140
42 Soria;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2020QI;""
42 Soria;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
42 Soria;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QIII;1.109
42 Soria;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QII;""
42 Soria;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QI;""
42 Soria;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
42 Soria;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QIII;1.127
42 Soria;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QII;""
42 Soria;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QI;""
42 Soria;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
42 Soria;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QIII;1.133
42 Soria;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QII;""
42 Soria;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QI;""
42 Soria;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QIV;1.089
42 Soria;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
42 Soria;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QII;""
42 Soria;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QI;""
42 Soria;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QIV;1.115
42 Soria;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
42 Soria;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QII;""
42 Soria;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QI;""
42 Soria;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QIV;1.119
42 Soria;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
42 Soria;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QII;""
42 Soria;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QI;""
42 Soria;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
42 Soria;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
42 Soria;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
42 Soria;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
42 Soria;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
42 Soria;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
42 Soria;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
42 Soria;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
42 Soria;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
42 Soria;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
42 Soria;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
42 Soria;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
42 Soria;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
42 Soria;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
42 Soria;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
42 Soria;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;98,95
42 Soria;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
42 Soria;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
42 Soria;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
42 Soria;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;99,4
42 Soria;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
42 Soria;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
42 Soria;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
42 Soria;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;97,38
42 Soria;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
42 Soria;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
42 Soria;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;98,08
42 Soria;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
42 Soria;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
42 Soria;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
42 Soria;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;98,19
42 Soria;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
42 Soria;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
42 Soria;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
42 Soria;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;96,45
42 Soria;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
42 Soria;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
42 Soria;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;96,86
42 Soria;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
42 Soria;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
42 Soria;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
42 Soria;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;97,16
42 Soria;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
42 Soria;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
42 Soria;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
42 Soria;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;95,85
42 Soria;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
42 Soria;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
42 Soria;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;95,11
42 Soria;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
42 Soria;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
42 Soria;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
42 Soria;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;96,12
42 Soria;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
42 Soria;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
42 Soria;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
42 Soria;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;94,67
42 Soria;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
42 Soria;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
42 Soria;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
42 Soria;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
42 Soria;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
42 Soria;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
42 Soria;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QI;610
42 Soria;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
42 Soria;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
42 Soria;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
42 Soria;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QI;604
42 Soria;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
42 Soria;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
42 Soria;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
42 Soria;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QI;651
42 Soria;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
42 Soria;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
42 Soria;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2022QII;""
42 Soria;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2022QI;601
42 Soria;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
42 Soria;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
42 Soria;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2021QII;""
42 Soria;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2021QI;599
42 Soria;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
42 Soria;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
42 Soria;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2020QII;""
42 Soria;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2020QI;609
42 Soria;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
42 Soria;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
42 Soria;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2022QII;585
42 Soria;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2022QI;""
42 Soria;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
42 Soria;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
42 Soria;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2021QII;588
42 Soria;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2021QI;""
42 Soria;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
42 Soria;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
42 Soria;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2020QII;595
42 Soria;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2020QI;""
42 Soria;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
42 Soria;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QIII;574
42 Soria;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QII;""
42 Soria;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QI;""
42 Soria;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
42 Soria;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QIII;581
42 Soria;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QII;""
42 Soria;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QI;""
42 Soria;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
42 Soria;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QIII;582
42 Soria;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QII;""
42 Soria;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QI;""
42 Soria;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QIV;562
42 Soria;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
42 Soria;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QII;""
42 Soria;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QI;""
42 Soria;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QIV;572
42 Soria;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
42 Soria;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QII;""
42 Soria;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QI;""
42 Soria;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QIV;573
42 Soria;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
42 Soria;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QII;""
42 Soria;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QI;""
42 Soria;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
42 Soria;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
42 Soria;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
42 Soria;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
42 Soria;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
42 Soria;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
42 Soria;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
42 Soria;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
42 Soria;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
42 Soria;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
42 Soria;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
42 Soria;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
42 Soria;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
42 Soria;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
42 Soria;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
42 Soria;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;98,52
42 Soria;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
42 Soria;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
42 Soria;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
42 Soria;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;99,17
42 Soria;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
42 Soria;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
42 Soria;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
42 Soria;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;93,55
42 Soria;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
42 Soria;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
42 Soria;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;95,9
42 Soria;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
42 Soria;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
42 Soria;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
42 Soria;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;97,35
42 Soria;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
42 Soria;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
42 Soria;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
42 Soria;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;91,4
42 Soria;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
42 Soria;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
42 Soria;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;94,1
42 Soria;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
42 Soria;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
42 Soria;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
42 Soria;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;96,19
42 Soria;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
42 Soria;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
42 Soria;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
42 Soria;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;89,4
42 Soria;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
42 Soria;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
42 Soria;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;92,13
42 Soria;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
42 Soria;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
42 Soria;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
42 Soria;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;94,7
42 Soria;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
42 Soria;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
42 Soria;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
42 Soria;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;88,02
42 Soria;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
42 Soria;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
42 Soria;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
42 Soria;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
42 Soria;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
42 Soria;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QII;1.762
42 Soria;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
42 Soria;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
42 Soria;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
42 Soria;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QII;1.766
42 Soria;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
42 Soria;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
42 Soria;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
42 Soria;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QII;1.789
42 Soria;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
42 Soria;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
42 Soria;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
42 Soria;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2022QII;1.733
42 Soria;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2022QI;""
42 Soria;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
42 Soria;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
42 Soria;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2021QII;1.737
42 Soria;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2021QI;""
42 Soria;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
42 Soria;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
42 Soria;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2020QII;1.764
42 Soria;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2020QI;""
42 Soria;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
42 Soria;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2022QIII;1.708
42 Soria;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2022QII;""
42 Soria;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2022QI;""
42 Soria;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
42 Soria;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2021QIII;1.714
42 Soria;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2021QII;""
42 Soria;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2021QI;""
42 Soria;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
42 Soria;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2020QIII;1.734
42 Soria;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2020QII;""
42 Soria;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2020QI;""
42 Soria;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QIV;1.678
42 Soria;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
42 Soria;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QII;""
42 Soria;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QI;""
42 Soria;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QIV;1.693
42 Soria;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
42 Soria;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QII;""
42 Soria;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QI;""
42 Soria;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QIV;1.708
42 Soria;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
42 Soria;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QII;""
42 Soria;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QI;""
42 Soria;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
42 Soria;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
42 Soria;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QII;""
42 Soria;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QI;1.676
42 Soria;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
42 Soria;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
42 Soria;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QII;""
42 Soria;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QI;1.703
42 Soria;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
42 Soria;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
42 Soria;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QII;""
42 Soria;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QI;""
42 Soria;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
42 Soria;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
42 Soria;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
42 Soria;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
42 Soria;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
42 Soria;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
42 Soria;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
42 Soria;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
42 Soria;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
42 Soria;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
42 Soria;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
42 Soria;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
42 Soria;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
42 Soria;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
42 Soria;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;98,35
42 Soria;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
42 Soria;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
42 Soria;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
42 Soria;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;98,36
42 Soria;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
42 Soria;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
42 Soria;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
42 Soria;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;98,6
42 Soria;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
42 Soria;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
42 Soria;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;96,94
42 Soria;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
42 Soria;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
42 Soria;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
42 Soria;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;97,06
42 Soria;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
42 Soria;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
42 Soria;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
42 Soria;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;96,93
42 Soria;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
42 Soria;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
42 Soria;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;95,23
42 Soria;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
42 Soria;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
42 Soria;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
42 Soria;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;95,87
42 Soria;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
42 Soria;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
42 Soria;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
42 Soria;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;95,47
42 Soria;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
42 Soria;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
42 Soria;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
42 Soria;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
42 Soria;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
42 Soria;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
42 Soria;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;94,9
42 Soria;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
42 Soria;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
42 Soria;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
42 Soria;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;95,19
42 Soria;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
42 Soria;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
42 Soria;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
42 Soria;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
42 Soria;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
42 Soria;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
42 Soria;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QII;1.152
42 Soria;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
42 Soria;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
42 Soria;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
42 Soria;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QII;1.154
42 Soria;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
42 Soria;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
42 Soria;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
42 Soria;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QII;1.171
42 Soria;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
42 Soria;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
42 Soria;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
42 Soria;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2022QII;1.140
42 Soria;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2022QI;""
42 Soria;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
42 Soria;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
42 Soria;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2021QII;1.139
42 Soria;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2021QI;""
42 Soria;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
42 Soria;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
42 Soria;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2020QII;1.160
42 Soria;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2020QI;""
42 Soria;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
42 Soria;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2022QIII;1.126
42 Soria;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2022QII;""
42 Soria;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2022QI;""
42 Soria;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
42 Soria;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2021QIII;1.127
42 Soria;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2021QII;""
42 Soria;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2021QI;""
42 Soria;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
42 Soria;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2020QIII;1.144
42 Soria;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2020QII;""
42 Soria;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2020QI;""
42 Soria;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QIV;1.109
42 Soria;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
42 Soria;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QII;""
42 Soria;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QI;""
42 Soria;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QIV;1.115
42 Soria;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
42 Soria;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QII;""
42 Soria;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QI;""
42 Soria;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QIV;1.128
42 Soria;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
42 Soria;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QII;""
42 Soria;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QI;""
42 Soria;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
42 Soria;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
42 Soria;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QII;""
42 Soria;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QI;1.105
42 Soria;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
42 Soria;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
42 Soria;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QII;""
42 Soria;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QI;1.124
42 Soria;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
42 Soria;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
42 Soria;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QII;""
42 Soria;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QI;""
42 Soria;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
42 Soria;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
42 Soria;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
42 Soria;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
42 Soria;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
42 Soria;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
42 Soria;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
42 Soria;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
42 Soria;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
42 Soria;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
42 Soria;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
42 Soria;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
42 Soria;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
42 Soria;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
42 Soria;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;98,96
42 Soria;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
42 Soria;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
42 Soria;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
42 Soria;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;98,7
42 Soria;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
42 Soria;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
42 Soria;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
42 Soria;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;99,06
42 Soria;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
42 Soria;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
42 Soria;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;97,74
42 Soria;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
42 Soria;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
42 Soria;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
42 Soria;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;97,66
42 Soria;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
42 Soria;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
42 Soria;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
42 Soria;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;97,69
42 Soria;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
42 Soria;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
42 Soria;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;96,27
42 Soria;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
42 Soria;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
42 Soria;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
42 Soria;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;96,62
42 Soria;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
42 Soria;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
42 Soria;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
42 Soria;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;96,33
42 Soria;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
42 Soria;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
42 Soria;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
42 Soria;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
42 Soria;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
42 Soria;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
42 Soria;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;95,75
42 Soria;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
42 Soria;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
42 Soria;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
42 Soria;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;95,99
42 Soria;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
42 Soria;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
42 Soria;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
42 Soria;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
42 Soria;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
42 Soria;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
42 Soria;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QII;610
42 Soria;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
42 Soria;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
42 Soria;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
42 Soria;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QII;612
42 Soria;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
42 Soria;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
42 Soria;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
42 Soria;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QII;618
42 Soria;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
42 Soria;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
42 Soria;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
42 Soria;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2022QII;593
42 Soria;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2022QI;""
42 Soria;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
42 Soria;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
42 Soria;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2021QII;598
42 Soria;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2021QI;""
42 Soria;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
42 Soria;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
42 Soria;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2020QII;604
42 Soria;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2020QI;""
42 Soria;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
42 Soria;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2022QIII;582
42 Soria;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2022QII;""
42 Soria;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2022QI;""
42 Soria;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
42 Soria;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2021QIII;587
42 Soria;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2021QII;""
42 Soria;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2021QI;""
42 Soria;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
42 Soria;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2020QIII;590
42 Soria;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2020QII;""
42 Soria;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2020QI;""
42 Soria;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QIV;569
42 Soria;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
42 Soria;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QII;""
42 Soria;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QI;""
42 Soria;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QIV;578
42 Soria;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
42 Soria;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QII;""
42 Soria;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QI;""
42 Soria;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QIV;580
42 Soria;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
42 Soria;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QII;""
42 Soria;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QI;""
42 Soria;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
42 Soria;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
42 Soria;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QII;""
42 Soria;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QI;571
42 Soria;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
42 Soria;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
42 Soria;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QII;""
42 Soria;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QI;579
42 Soria;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
42 Soria;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
42 Soria;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QII;""
42 Soria;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QI;""
42 Soria;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
42 Soria;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
42 Soria;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
42 Soria;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
42 Soria;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
42 Soria;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
42 Soria;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
42 Soria;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
42 Soria;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
42 Soria;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
42 Soria;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
42 Soria;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
42 Soria;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
42 Soria;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
42 Soria;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;97,21
42 Soria;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
42 Soria;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
42 Soria;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
42 Soria;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;97,71
42 Soria;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
42 Soria;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
42 Soria;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
42 Soria;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;97,73
42 Soria;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
42 Soria;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
42 Soria;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;95,41
42 Soria;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
42 Soria;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
42 Soria;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
42 Soria;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;95,92
42 Soria;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
42 Soria;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
42 Soria;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
42 Soria;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;95,47
42 Soria;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
42 Soria;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
42 Soria;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;93,28
42 Soria;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
42 Soria;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
42 Soria;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
42 Soria;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;94,44
42 Soria;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
42 Soria;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
42 Soria;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
42 Soria;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;93,85
42 Soria;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
42 Soria;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
42 Soria;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
42 Soria;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
42 Soria;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
42 Soria;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
42 Soria;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;93,3
42 Soria;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
42 Soria;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
42 Soria;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
42 Soria;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;93,69
42 Soria;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
42 Soria;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
42 Soria;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
42 Soria;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
42 Soria;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
42 Soria;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QIII;1.766
42 Soria;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
42 Soria;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
42 Soria;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
42 Soria;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QIII;1.770
42 Soria;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
42 Soria;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
42 Soria;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
42 Soria;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QIII;1.793
42 Soria;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
42 Soria;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
42 Soria;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
42 Soria;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2022QIII;1.734
42 Soria;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2022QII;""
42 Soria;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2022QI;""
42 Soria;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
42 Soria;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2021QIII;1.744
42 Soria;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2021QII;""
42 Soria;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2021QI;""
42 Soria;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
42 Soria;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2020QIII;1.762
42 Soria;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2020QII;""
42 Soria;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2020QI;""
42 Soria;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2022QIV;1.697
42 Soria;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
42 Soria;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2022QII;""
42 Soria;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2022QI;""
42 Soria;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2021QIV;1.717
42 Soria;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
42 Soria;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2021QII;""
42 Soria;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2021QI;""
42 Soria;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2020QIV;1.730
42 Soria;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
42 Soria;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2020QII;""
42 Soria;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2020QI;""
42 Soria;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
42 Soria;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
42 Soria;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QII;""
42 Soria;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QI;1.698
42 Soria;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
42 Soria;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
42 Soria;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QII;""
42 Soria;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QI;1.724
42 Soria;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
42 Soria;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
42 Soria;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QII;""
42 Soria;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QI;""
42 Soria;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
42 Soria;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
42 Soria;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QII;1.678
42 Soria;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QI;""
42 Soria;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
42 Soria;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
42 Soria;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QII;1.701
42 Soria;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QI;""
42 Soria;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
42 Soria;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
42 Soria;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QII;""
42 Soria;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QI;""
42 Soria;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
42 Soria;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
42 Soria;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
42 Soria;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
42 Soria;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
42 Soria;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
42 Soria;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
42 Soria;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
42 Soria;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
42 Soria;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
42 Soria;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
42 Soria;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
42 Soria;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
42 Soria;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;98,19
42 Soria;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
42 Soria;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
42 Soria;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
42 Soria;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;98,53
42 Soria;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
42 Soria;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
42 Soria;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
42 Soria;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;98,27
42 Soria;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
42 Soria;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
42 Soria;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;96,09
42 Soria;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
42 Soria;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
42 Soria;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
42 Soria;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;97,01
42 Soria;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
42 Soria;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
42 Soria;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
42 Soria;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;96,49
42 Soria;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
42 Soria;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
42 Soria;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
42 Soria;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
42 Soria;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
42 Soria;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
42 Soria;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;95,93
42 Soria;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
42 Soria;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
42 Soria;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
42 Soria;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;96,15
42 Soria;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
42 Soria;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
42 Soria;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
42 Soria;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
42 Soria;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
42 Soria;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
42 Soria;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;94,8
42 Soria;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
42 Soria;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
42 Soria;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
42 Soria;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;94,87
42 Soria;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
42 Soria;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
42 Soria;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
42 Soria;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
42 Soria;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
42 Soria;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
42 Soria;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QIII;1.156
42 Soria;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
42 Soria;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
42 Soria;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
42 Soria;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QIII;1.158
42 Soria;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
42 Soria;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
42 Soria;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
42 Soria;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QIII;1.180
42 Soria;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
42 Soria;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
42 Soria;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
42 Soria;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2022QIII;1.139
42 Soria;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2022QII;""
42 Soria;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2022QI;""
42 Soria;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
42 Soria;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2021QIII;1.144
42 Soria;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2021QII;""
42 Soria;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2021QI;""
42 Soria;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
42 Soria;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2020QIII;1.164
42 Soria;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2020QII;""
42 Soria;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2020QI;""
42 Soria;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2022QIV;1.118
42 Soria;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
42 Soria;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2022QII;""
42 Soria;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2022QI;""
42 Soria;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2021QIV;1.128
42 Soria;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
42 Soria;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2021QII;""
42 Soria;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2021QI;""
42 Soria;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2020QIV;1.143
42 Soria;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
42 Soria;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2020QII;""
42 Soria;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2020QI;""
42 Soria;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
42 Soria;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
42 Soria;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QII;""
42 Soria;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QI;1.117
42 Soria;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
42 Soria;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
42 Soria;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QII;""
42 Soria;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QI;1.139
42 Soria;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
42 Soria;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
42 Soria;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QII;""
42 Soria;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QI;""
42 Soria;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
42 Soria;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
42 Soria;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QII;1.108
42 Soria;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QI;""
42 Soria;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
42 Soria;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
42 Soria;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QII;1.125
42 Soria;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QI;""
42 Soria;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
42 Soria;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
42 Soria;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QII;""
42 Soria;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QI;""
42 Soria;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
42 Soria;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
42 Soria;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
42 Soria;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
42 Soria;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
42 Soria;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
42 Soria;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
42 Soria;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
42 Soria;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
42 Soria;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
42 Soria;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
42 Soria;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
42 Soria;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
42 Soria;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;98,53
42 Soria;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
42 Soria;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
42 Soria;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
42 Soria;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;98,79
42 Soria;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
42 Soria;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
42 Soria;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
42 Soria;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;98,64
42 Soria;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
42 Soria;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
42 Soria;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;96,71
42 Soria;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
42 Soria;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
42 Soria;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
42 Soria;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;97,41
42 Soria;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
42 Soria;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
42 Soria;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
42 Soria;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;96,86
42 Soria;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
42 Soria;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
42 Soria;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
42 Soria;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
42 Soria;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
42 Soria;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
42 Soria;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;96,46
42 Soria;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
42 Soria;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
42 Soria;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
42 Soria;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;96,53
42 Soria;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
42 Soria;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
42 Soria;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
42 Soria;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
42 Soria;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
42 Soria;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
42 Soria;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;95,68
42 Soria;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
42 Soria;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
42 Soria;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
42 Soria;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;95,34
42 Soria;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
42 Soria;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
42 Soria;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
42 Soria;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
42 Soria;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
42 Soria;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
42 Soria;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QIII;610
42 Soria;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
42 Soria;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
42 Soria;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
42 Soria;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QIII;612
42 Soria;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
42 Soria;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
42 Soria;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
42 Soria;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QIII;613
42 Soria;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
42 Soria;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
42 Soria;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
42 Soria;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2022QIII;595
42 Soria;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2022QII;""
42 Soria;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2022QI;""
42 Soria;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
42 Soria;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2021QIII;600
42 Soria;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2021QII;""
42 Soria;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2021QI;""
42 Soria;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
42 Soria;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2020QIII;598
42 Soria;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2020QII;""
42 Soria;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2020QI;""
42 Soria;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2022QIV;579
42 Soria;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
42 Soria;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2022QII;""
42 Soria;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2022QI;""
42 Soria;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2021QIV;589
42 Soria;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
42 Soria;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2021QII;""
42 Soria;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2021QI;""
42 Soria;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2020QIV;587
42 Soria;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
42 Soria;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2020QII;""
42 Soria;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2020QI;""
42 Soria;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
42 Soria;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
42 Soria;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QII;""
42 Soria;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QI;581
42 Soria;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
42 Soria;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
42 Soria;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QII;""
42 Soria;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QI;585
42 Soria;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
42 Soria;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
42 Soria;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QII;""
42 Soria;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QI;""
42 Soria;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
42 Soria;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
42 Soria;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QII;570
42 Soria;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QI;""
42 Soria;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
42 Soria;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
42 Soria;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QII;576
42 Soria;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QI;""
42 Soria;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
42 Soria;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
42 Soria;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QII;""
42 Soria;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QI;""
42 Soria;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
42 Soria;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
42 Soria;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
42 Soria;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
42 Soria;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
42 Soria;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
42 Soria;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
42 Soria;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
42 Soria;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
42 Soria;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
42 Soria;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
42 Soria;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
42 Soria;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
42 Soria;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;97,54
42 Soria;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
42 Soria;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
42 Soria;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
42 Soria;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;98,04
42 Soria;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
42 Soria;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
42 Soria;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
42 Soria;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;97,55
42 Soria;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
42 Soria;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
42 Soria;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;94,92
42 Soria;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
42 Soria;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
42 Soria;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
42 Soria;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;96,24
42 Soria;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
42 Soria;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
42 Soria;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
42 Soria;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;95,76
42 Soria;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
42 Soria;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
42 Soria;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
42 Soria;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
42 Soria;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
42 Soria;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
42 Soria;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;94,93
42 Soria;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
42 Soria;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
42 Soria;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
42 Soria;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;95,43
42 Soria;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
42 Soria;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
42 Soria;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
42 Soria;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
42 Soria;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
42 Soria;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
42 Soria;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;93,14
42 Soria;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
42 Soria;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
42 Soria;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
42 Soria;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;93,96
42 Soria;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
42 Soria;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
42 Soria;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
42 Soria;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
42 Soria;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
42 Soria;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QIV;1.755
42 Soria;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
42 Soria;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
42 Soria;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
42 Soria;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QIV;1.770
42 Soria;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
42 Soria;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
42 Soria;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
42 Soria;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QIV;1.784
42 Soria;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
42 Soria;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
42 Soria;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
42 Soria;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2022QIV;1.716
42 Soria;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
42 Soria;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2022QII;""
42 Soria;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2022QI;""
42 Soria;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2021QIV;1.739
42 Soria;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
42 Soria;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2021QII;""
42 Soria;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2021QI;""
42 Soria;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2020QIV;1.751
42 Soria;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
42 Soria;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2020QII;""
42 Soria;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2020QI;""
42 Soria;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
42 Soria;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
42 Soria;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2022QII;""
42 Soria;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2022QI;1.719
42 Soria;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
42 Soria;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
42 Soria;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2021QII;""
42 Soria;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2021QI;1.742
42 Soria;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
42 Soria;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
42 Soria;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2020QII;""
42 Soria;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2020QI;""
42 Soria;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
42 Soria;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
42 Soria;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QII;1.695
42 Soria;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QI;""
42 Soria;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
42 Soria;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
42 Soria;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QII;1.719
42 Soria;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QI;""
42 Soria;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
42 Soria;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
42 Soria;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QII;""
42 Soria;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QI;""
42 Soria;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
42 Soria;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QIII;1.670
42 Soria;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QII;""
42 Soria;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QI;""
42 Soria;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
42 Soria;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QIII;1.700
42 Soria;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QII;""
42 Soria;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QI;""
42 Soria;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
42 Soria;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
42 Soria;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QII;""
42 Soria;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QI;""
42 Soria;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
42 Soria;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
42 Soria;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
42 Soria;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
42 Soria;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
42 Soria;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
42 Soria;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
42 Soria;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
42 Soria;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
42 Soria;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
42 Soria;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
42 Soria;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
42 Soria;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;97,78
42 Soria;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
42 Soria;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
42 Soria;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
42 Soria;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;98,25
42 Soria;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
42 Soria;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
42 Soria;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
42 Soria;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;98,15
42 Soria;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
42 Soria;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
42 Soria;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
42 Soria;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
42 Soria;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
42 Soria;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
42 Soria;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;97,12
42 Soria;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
42 Soria;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
42 Soria;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
42 Soria;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;97,65
42 Soria;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
42 Soria;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
42 Soria;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
42 Soria;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
42 Soria;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
42 Soria;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
42 Soria;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;95,76
42 Soria;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
42 Soria;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
42 Soria;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
42 Soria;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;96,36
42 Soria;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
42 Soria;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
42 Soria;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
42 Soria;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
42 Soria;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
42 Soria;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
42 Soria;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;94,35
42 Soria;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
42 Soria;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
42 Soria;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
42 Soria;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;95,29
42 Soria;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
42 Soria;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
42 Soria;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
42 Soria;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
42 Soria;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
42 Soria;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
42 Soria;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QIV;1.148
42 Soria;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
42 Soria;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
42 Soria;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
42 Soria;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QIV;1.157
42 Soria;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
42 Soria;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
42 Soria;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
42 Soria;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QIV;1.175
42 Soria;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
42 Soria;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
42 Soria;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
42 Soria;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2022QIV;1.127
42 Soria;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
42 Soria;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2022QII;""
42 Soria;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2022QI;""
42 Soria;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2021QIV;1.139
42 Soria;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
42 Soria;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2021QII;""
42 Soria;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2021QI;""
42 Soria;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2020QIV;1.154
42 Soria;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
42 Soria;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2020QII;""
42 Soria;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2020QI;""
42 Soria;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
42 Soria;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
42 Soria;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2022QII;""
42 Soria;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2022QI;1.127
42 Soria;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
42 Soria;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
42 Soria;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2021QII;""
42 Soria;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2021QI;1.148
42 Soria;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
42 Soria;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
42 Soria;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2020QII;""
42 Soria;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2020QI;""
42 Soria;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
42 Soria;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
42 Soria;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QII;1.117
42 Soria;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QI;""
42 Soria;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
42 Soria;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
42 Soria;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QII;1.134
42 Soria;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QI;""
42 Soria;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
42 Soria;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
42 Soria;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QII;""
42 Soria;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QI;""
42 Soria;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
42 Soria;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QIII;1.103
42 Soria;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QII;""
42 Soria;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QI;""
42 Soria;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
42 Soria;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QIII;1.122
42 Soria;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QII;""
42 Soria;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QI;""
42 Soria;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
42 Soria;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
42 Soria;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QII;""
42 Soria;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QI;""
42 Soria;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
42 Soria;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
42 Soria;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
42 Soria;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
42 Soria;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
42 Soria;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
42 Soria;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
42 Soria;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
42 Soria;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
42 Soria;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
42 Soria;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
42 Soria;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
42 Soria;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;98,17
42 Soria;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
42 Soria;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
42 Soria;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
42 Soria;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;98,44
42 Soria;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
42 Soria;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
42 Soria;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
42 Soria;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;98,21
42 Soria;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
42 Soria;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
42 Soria;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
42 Soria;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
42 Soria;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
42 Soria;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
42 Soria;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;97,41
42 Soria;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
42 Soria;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
42 Soria;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
42 Soria;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;97,7
42 Soria;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
42 Soria;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
42 Soria;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
42 Soria;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
42 Soria;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
42 Soria;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
42 Soria;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;96,54
42 Soria;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
42 Soria;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
42 Soria;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
42 Soria;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;96,51
42 Soria;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
42 Soria;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
42 Soria;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
42 Soria;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
42 Soria;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
42 Soria;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
42 Soria;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;95,33
42 Soria;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
42 Soria;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
42 Soria;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
42 Soria;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;95,49
42 Soria;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
42 Soria;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
42 Soria;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
42 Soria;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
42 Soria;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
42 Soria;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
42 Soria;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QIV;607
42 Soria;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
42 Soria;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
42 Soria;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
42 Soria;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QIV;613
42 Soria;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
42 Soria;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
42 Soria;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
42 Soria;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QIV;609
42 Soria;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
42 Soria;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
42 Soria;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
42 Soria;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2022QIV;589
42 Soria;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
42 Soria;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2022QII;""
42 Soria;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2022QI;""
42 Soria;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2021QIV;600
42 Soria;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
42 Soria;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2021QII;""
42 Soria;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2021QI;""
42 Soria;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2020QIV;597
42 Soria;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
42 Soria;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2020QII;""
42 Soria;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2020QI;""
42 Soria;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
42 Soria;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
42 Soria;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2022QII;""
42 Soria;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2022QI;592
42 Soria;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
42 Soria;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
42 Soria;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2021QII;""
42 Soria;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2021QI;594
42 Soria;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
42 Soria;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
42 Soria;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2020QII;""
42 Soria;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2020QI;""
42 Soria;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
42 Soria;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
42 Soria;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QII;578
42 Soria;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QI;""
42 Soria;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
42 Soria;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
42 Soria;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QII;585
42 Soria;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QI;""
42 Soria;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
42 Soria;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
42 Soria;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QII;""
42 Soria;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QI;""
42 Soria;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
42 Soria;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QIII;567
42 Soria;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QII;""
42 Soria;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QI;""
42 Soria;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
42 Soria;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QIII;578
42 Soria;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QII;""
42 Soria;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QI;""
42 Soria;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
42 Soria;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
42 Soria;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QII;""
42 Soria;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QI;""
42 Soria;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
42 Soria;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
42 Soria;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
42 Soria;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
42 Soria;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
42 Soria;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
42 Soria;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
42 Soria;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
42 Soria;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
42 Soria;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
42 Soria;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
42 Soria;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
42 Soria;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;97,03
42 Soria;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
42 Soria;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
42 Soria;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
42 Soria;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;97,88
42 Soria;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
42 Soria;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
42 Soria;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
42 Soria;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;98,03
42 Soria;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
42 Soria;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
42 Soria;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
42 Soria;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
42 Soria;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
42 Soria;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
42 Soria;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;96,57
42 Soria;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
42 Soria;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
42 Soria;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
42 Soria;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;97,54
42 Soria;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
42 Soria;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
42 Soria;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
42 Soria;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
42 Soria;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
42 Soria;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
42 Soria;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;94,29
42 Soria;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
42 Soria;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
42 Soria;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
42 Soria;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;96,06
42 Soria;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
42 Soria;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
42 Soria;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
42 Soria;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
42 Soria;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
42 Soria;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
42 Soria;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;92,5
42 Soria;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
42 Soria;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
42 Soria;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
42 Soria;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;94,91
42 Soria;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
42 Soria;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
42 Soria;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
42 Soria;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
42 Soria;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
42 Soria;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
42 Soria;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
42 Soria;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
42 Soria;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
42 Soria;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QI;991
42 Soria;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
42 Soria;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
42 Soria;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
42 Soria;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QI;923
42 Soria;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
42 Soria;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
42 Soria;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
42 Soria;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QI;1.063
42 Soria;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
42 Soria;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
42 Soria;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2022QII;""
42 Soria;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2022QI;970
42 Soria;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
42 Soria;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
42 Soria;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2021QII;""
42 Soria;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2021QI;897
42 Soria;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
42 Soria;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
42 Soria;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2020QII;""
42 Soria;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2020QI;1.004
42 Soria;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
42 Soria;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
42 Soria;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2022QII;936
42 Soria;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2022QI;""
42 Soria;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
42 Soria;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
42 Soria;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2021QII;868
42 Soria;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2021QI;""
42 Soria;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
42 Soria;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
42 Soria;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2020QII;980
42 Soria;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2020QI;""
42 Soria;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
42 Soria;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QIII;906
42 Soria;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QII;""
42 Soria;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QI;""
42 Soria;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
42 Soria;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QIII;841
42 Soria;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QII;""
42 Soria;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QI;""
42 Soria;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
42 Soria;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QIII;956
42 Soria;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QII;""
42 Soria;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QI;""
42 Soria;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QIV;840
42 Soria;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
42 Soria;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QII;""
42 Soria;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QI;""
42 Soria;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QIV;803
42 Soria;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
42 Soria;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QII;""
42 Soria;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QI;""
42 Soria;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QIV;904
42 Soria;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
42 Soria;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QII;""
42 Soria;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QI;""
42 Soria;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
42 Soria;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
42 Soria;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
42 Soria;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
42 Soria;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
42 Soria;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
42 Soria;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
42 Soria;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
42 Soria;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
42 Soria;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
42 Soria;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
42 Soria;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
42 Soria;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
42 Soria;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
42 Soria;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
42 Soria;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;97,88
42 Soria;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
42 Soria;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
42 Soria;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
42 Soria;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;97,18
42 Soria;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
42 Soria;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
42 Soria;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
42 Soria;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;94,45
42 Soria;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
42 Soria;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
42 Soria;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;94,45
42 Soria;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
42 Soria;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
42 Soria;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
42 Soria;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;94,04
42 Soria;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
42 Soria;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
42 Soria;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
42 Soria;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;92,19
42 Soria;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
42 Soria;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
42 Soria;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;91,42
42 Soria;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
42 Soria;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
42 Soria;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
42 Soria;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;91,12
42 Soria;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
42 Soria;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
42 Soria;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
42 Soria;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;89,93
42 Soria;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
42 Soria;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
42 Soria;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;84,76
42 Soria;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
42 Soria;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
42 Soria;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
42 Soria;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;87
42 Soria;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
42 Soria;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
42 Soria;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
42 Soria;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;85,04
42 Soria;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
42 Soria;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
42 Soria;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
42 Soria;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
42 Soria;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
42 Soria;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
42 Soria;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QI;691
42 Soria;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
42 Soria;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
42 Soria;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
42 Soria;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QI;649
42 Soria;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
42 Soria;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
42 Soria;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
42 Soria;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QI;741
42 Soria;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
42 Soria;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
42 Soria;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2022QII;""
42 Soria;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2022QI;678
42 Soria;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
42 Soria;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
42 Soria;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2021QII;""
42 Soria;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2021QI;630
42 Soria;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
42 Soria;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
42 Soria;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2020QII;""
42 Soria;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2020QI;700
42 Soria;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
42 Soria;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
42 Soria;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2022QII;654
42 Soria;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2022QI;""
42 Soria;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
42 Soria;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
42 Soria;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2021QII;610
42 Soria;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2021QI;""
42 Soria;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
42 Soria;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
42 Soria;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2020QII;683
42 Soria;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2020QI;""
42 Soria;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
42 Soria;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QIII;635
42 Soria;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QII;""
42 Soria;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QI;""
42 Soria;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
42 Soria;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QIII;592
42 Soria;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QII;""
42 Soria;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QI;""
42 Soria;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
42 Soria;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QIII;670
42 Soria;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QII;""
42 Soria;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QI;""
42 Soria;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QIV;594
42 Soria;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
42 Soria;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QII;""
42 Soria;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QI;""
42 Soria;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QIV;567
42 Soria;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
42 Soria;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QII;""
42 Soria;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QI;""
42 Soria;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QIV;635
42 Soria;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
42 Soria;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QII;""
42 Soria;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QI;""
42 Soria;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
42 Soria;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
42 Soria;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
42 Soria;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
42 Soria;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
42 Soria;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
42 Soria;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
42 Soria;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
42 Soria;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
42 Soria;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
42 Soria;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
42 Soria;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
42 Soria;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
42 Soria;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
42 Soria;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
42 Soria;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;98,12
42 Soria;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
42 Soria;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
42 Soria;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
42 Soria;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;97,07
42 Soria;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
42 Soria;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
42 Soria;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
42 Soria;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;94,47
42 Soria;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
42 Soria;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
42 Soria;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;94,65
42 Soria;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
42 Soria;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
42 Soria;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
42 Soria;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;93,99
42 Soria;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
42 Soria;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
42 Soria;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
42 Soria;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;92,17
42 Soria;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
42 Soria;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
42 Soria;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;91,9
42 Soria;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
42 Soria;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
42 Soria;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
42 Soria;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;91,22
42 Soria;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
42 Soria;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
42 Soria;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
42 Soria;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;90,42
42 Soria;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
42 Soria;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
42 Soria;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;85,96
42 Soria;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
42 Soria;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
42 Soria;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
42 Soria;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;87,37
42 Soria;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
42 Soria;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
42 Soria;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
42 Soria;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;85,7
42 Soria;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
42 Soria;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
42 Soria;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
42 Soria;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
42 Soria;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
42 Soria;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
42 Soria;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QI;300
42 Soria;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
42 Soria;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
42 Soria;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
42 Soria;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QI;274
42 Soria;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
42 Soria;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
42 Soria;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
42 Soria;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QI;322
42 Soria;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
42 Soria;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
42 Soria;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2022QII;""
42 Soria;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2022QI;292
42 Soria;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
42 Soria;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
42 Soria;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2021QII;""
42 Soria;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2021QI;267
42 Soria;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
42 Soria;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
42 Soria;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2020QII;""
42 Soria;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2020QI;304
42 Soria;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
42 Soria;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
42 Soria;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2022QII;282
42 Soria;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2022QI;""
42 Soria;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
42 Soria;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
42 Soria;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2021QII;258
42 Soria;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2021QI;""
42 Soria;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
42 Soria;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
42 Soria;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2020QII;297
42 Soria;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2020QI;""
42 Soria;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
42 Soria;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QIII;271
42 Soria;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QII;""
42 Soria;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QI;""
42 Soria;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
42 Soria;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QIII;249
42 Soria;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QII;""
42 Soria;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QI;""
42 Soria;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
42 Soria;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QIII;286
42 Soria;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QII;""
42 Soria;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QI;""
42 Soria;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QIV;246
42 Soria;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
42 Soria;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QII;""
42 Soria;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QI;""
42 Soria;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QIV;236
42 Soria;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
42 Soria;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QII;""
42 Soria;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QI;""
42 Soria;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QIV;269
42 Soria;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
42 Soria;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QII;""
42 Soria;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QI;""
42 Soria;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
42 Soria;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
42 Soria;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
42 Soria;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
42 Soria;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
42 Soria;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
42 Soria;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
42 Soria;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
42 Soria;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
42 Soria;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
42 Soria;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
42 Soria;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
42 Soria;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
42 Soria;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
42 Soria;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
42 Soria;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;97,33
42 Soria;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
42 Soria;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
42 Soria;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
42 Soria;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;97,45
42 Soria;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
42 Soria;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
42 Soria;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
42 Soria;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;94,41
42 Soria;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
42 Soria;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
42 Soria;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;94
42 Soria;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
42 Soria;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
42 Soria;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
42 Soria;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;94,16
42 Soria;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
42 Soria;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
42 Soria;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
42 Soria;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;92,24
42 Soria;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
42 Soria;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
42 Soria;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;90,33
42 Soria;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
42 Soria;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
42 Soria;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
42 Soria;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;90,88
42 Soria;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
42 Soria;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
42 Soria;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
42 Soria;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;88,82
42 Soria;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
42 Soria;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
42 Soria;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;82
42 Soria;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
42 Soria;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
42 Soria;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
42 Soria;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;86,13
42 Soria;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
42 Soria;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
42 Soria;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
42 Soria;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;83,54
42 Soria;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
42 Soria;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
42 Soria;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
42 Soria;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
42 Soria;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
42 Soria;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QII;1.144
42 Soria;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
42 Soria;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
42 Soria;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
42 Soria;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QII;1.070
42 Soria;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
42 Soria;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
42 Soria;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
42 Soria;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QII;1.013
42 Soria;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
42 Soria;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
42 Soria;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
42 Soria;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2022QII;1.107
42 Soria;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2022QI;""
42 Soria;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
42 Soria;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
42 Soria;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2021QII;1.040
42 Soria;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2021QI;""
42 Soria;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
42 Soria;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
42 Soria;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2020QII;988
42 Soria;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2020QI;""
42 Soria;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
42 Soria;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2022QIII;1.075
42 Soria;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2022QII;""
42 Soria;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2022QI;""
42 Soria;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
42 Soria;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2021QIII;1.009
42 Soria;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2021QII;""
42 Soria;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2021QI;""
42 Soria;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
42 Soria;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2020QIII;962
42 Soria;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2020QII;""
42 Soria;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2020QI;""
42 Soria;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QIV;1.003
42 Soria;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
42 Soria;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QII;""
42 Soria;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QI;""
42 Soria;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QIV;970
42 Soria;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
42 Soria;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QII;""
42 Soria;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QI;""
42 Soria;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QIV;909
42 Soria;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
42 Soria;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QII;""
42 Soria;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QI;""
42 Soria;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
42 Soria;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
42 Soria;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QII;""
42 Soria;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QI;950
42 Soria;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
42 Soria;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
42 Soria;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QII;""
42 Soria;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QI;885
42 Soria;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
42 Soria;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
42 Soria;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QII;""
42 Soria;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QI;""
42 Soria;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
42 Soria;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
42 Soria;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
42 Soria;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
42 Soria;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
42 Soria;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
42 Soria;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
42 Soria;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
42 Soria;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
42 Soria;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
42 Soria;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
42 Soria;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
42 Soria;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
42 Soria;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
42 Soria;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;96,77
42 Soria;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
42 Soria;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
42 Soria;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
42 Soria;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;97,2
42 Soria;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
42 Soria;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
42 Soria;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
42 Soria;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;97,53
42 Soria;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
42 Soria;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
42 Soria;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;93,97
42 Soria;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
42 Soria;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
42 Soria;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
42 Soria;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;94,3
42 Soria;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
42 Soria;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
42 Soria;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
42 Soria;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;94,97
42 Soria;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
42 Soria;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
42 Soria;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;87,67
42 Soria;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
42 Soria;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
42 Soria;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
42 Soria;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;90,65
42 Soria;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
42 Soria;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
42 Soria;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
42 Soria;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;89,73
42 Soria;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
42 Soria;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
42 Soria;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
42 Soria;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
42 Soria;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
42 Soria;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
42 Soria;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;88,79
42 Soria;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
42 Soria;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
42 Soria;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
42 Soria;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;87,36
42 Soria;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
42 Soria;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
42 Soria;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
42 Soria;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
42 Soria;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
42 Soria;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
42 Soria;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QII;789
42 Soria;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
42 Soria;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
42 Soria;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
42 Soria;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QII;748
42 Soria;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
42 Soria;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
42 Soria;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
42 Soria;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QII;705
42 Soria;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
42 Soria;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
42 Soria;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
42 Soria;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2022QII;762
42 Soria;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2022QI;""
42 Soria;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
42 Soria;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
42 Soria;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2021QII;727
42 Soria;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2021QI;""
42 Soria;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
42 Soria;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
42 Soria;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2020QII;687
42 Soria;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2020QI;""
42 Soria;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
42 Soria;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2022QIII;742
42 Soria;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2022QII;""
42 Soria;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2022QI;""
42 Soria;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
42 Soria;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2021QIII;705
42 Soria;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2021QII;""
42 Soria;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2021QI;""
42 Soria;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
42 Soria;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2020QIII;673
42 Soria;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2020QII;""
42 Soria;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2020QI;""
42 Soria;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QIV;696
42 Soria;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
42 Soria;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QII;""
42 Soria;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QI;""
42 Soria;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QIV;679
42 Soria;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
42 Soria;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QII;""
42 Soria;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QI;""
42 Soria;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QIV;638
42 Soria;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
42 Soria;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QII;""
42 Soria;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QI;""
42 Soria;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
42 Soria;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
42 Soria;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QII;""
42 Soria;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QI;667
42 Soria;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
42 Soria;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
42 Soria;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QII;""
42 Soria;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QI;621
42 Soria;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
42 Soria;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
42 Soria;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QII;""
42 Soria;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QI;""
42 Soria;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
42 Soria;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
42 Soria;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
42 Soria;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
42 Soria;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
42 Soria;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
42 Soria;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
42 Soria;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
42 Soria;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
42 Soria;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
42 Soria;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
42 Soria;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
42 Soria;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
42 Soria;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
42 Soria;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;96,58
42 Soria;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
42 Soria;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
42 Soria;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
42 Soria;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;97,19
42 Soria;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
42 Soria;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
42 Soria;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
42 Soria;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;97,45
42 Soria;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
42 Soria;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
42 Soria;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;94,04
42 Soria;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
42 Soria;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
42 Soria;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
42 Soria;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;94,25
42 Soria;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
42 Soria;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
42 Soria;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
42 Soria;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;95,46
42 Soria;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
42 Soria;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
42 Soria;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;88,21
42 Soria;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
42 Soria;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
42 Soria;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
42 Soria;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;90,78
42 Soria;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
42 Soria;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
42 Soria;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
42 Soria;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;90,5
42 Soria;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
42 Soria;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
42 Soria;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
42 Soria;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
42 Soria;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
42 Soria;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
42 Soria;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;89,17
42 Soria;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
42 Soria;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
42 Soria;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
42 Soria;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;88,09
42 Soria;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
42 Soria;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
42 Soria;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
42 Soria;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
42 Soria;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
42 Soria;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
42 Soria;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QII;355
42 Soria;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
42 Soria;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
42 Soria;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
42 Soria;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QII;322
42 Soria;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
42 Soria;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
42 Soria;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
42 Soria;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QII;308
42 Soria;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
42 Soria;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
42 Soria;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
42 Soria;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2022QII;345
42 Soria;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2022QI;""
42 Soria;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
42 Soria;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
42 Soria;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2021QII;313
42 Soria;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2021QI;""
42 Soria;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
42 Soria;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
42 Soria;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2020QII;301
42 Soria;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2020QI;""
42 Soria;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
42 Soria;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2022QIII;333
42 Soria;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2022QII;""
42 Soria;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2022QI;""
42 Soria;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
42 Soria;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2021QIII;304
42 Soria;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2021QII;""
42 Soria;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2021QI;""
42 Soria;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
42 Soria;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2020QIII;289
42 Soria;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2020QII;""
42 Soria;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2020QI;""
42 Soria;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QIV;307
42 Soria;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
42 Soria;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QII;""
42 Soria;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QI;""
42 Soria;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QIV;291
42 Soria;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
42 Soria;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QII;""
42 Soria;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QI;""
42 Soria;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QIV;271
42 Soria;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
42 Soria;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QII;""
42 Soria;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QI;""
42 Soria;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
42 Soria;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
42 Soria;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QII;""
42 Soria;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QI;283
42 Soria;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
42 Soria;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
42 Soria;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QII;""
42 Soria;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QI;264
42 Soria;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
42 Soria;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
42 Soria;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QII;""
42 Soria;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QI;""
42 Soria;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
42 Soria;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
42 Soria;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
42 Soria;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
42 Soria;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
42 Soria;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
42 Soria;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
42 Soria;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
42 Soria;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
42 Soria;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
42 Soria;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
42 Soria;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
42 Soria;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
42 Soria;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
42 Soria;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;97,18
42 Soria;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
42 Soria;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
42 Soria;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
42 Soria;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;97,2
42 Soria;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
42 Soria;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
42 Soria;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
42 Soria;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;97,73
42 Soria;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
42 Soria;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
42 Soria;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;93,8
42 Soria;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
42 Soria;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
42 Soria;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
42 Soria;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;94,41
42 Soria;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
42 Soria;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
42 Soria;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
42 Soria;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;93,83
42 Soria;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
42 Soria;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
42 Soria;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;86,48
42 Soria;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
42 Soria;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
42 Soria;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
42 Soria;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;90,37
42 Soria;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
42 Soria;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
42 Soria;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
42 Soria;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;87,99
42 Soria;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
42 Soria;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
42 Soria;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
42 Soria;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
42 Soria;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
42 Soria;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
42 Soria;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;87,89
42 Soria;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
42 Soria;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
42 Soria;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
42 Soria;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;85,71
42 Soria;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
42 Soria;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
42 Soria;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
42 Soria;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
42 Soria;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
42 Soria;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QIII;1.116
42 Soria;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
42 Soria;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
42 Soria;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
42 Soria;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QIII;1.055
42 Soria;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
42 Soria;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
42 Soria;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
42 Soria;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QIII;992
42 Soria;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
42 Soria;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
42 Soria;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
42 Soria;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2022QIII;1.084
42 Soria;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2022QII;""
42 Soria;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2022QI;""
42 Soria;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
42 Soria;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2021QIII;1.023
42 Soria;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2021QII;""
42 Soria;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2021QI;""
42 Soria;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
42 Soria;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2020QIII;966
42 Soria;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2020QII;""
42 Soria;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2020QI;""
42 Soria;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2022QIV;1.011
42 Soria;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
42 Soria;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2022QII;""
42 Soria;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2022QI;""
42 Soria;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2021QIV;982
42 Soria;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
42 Soria;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2021QII;""
42 Soria;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2021QI;""
42 Soria;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2020QIV;912
42 Soria;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
42 Soria;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2020QII;""
42 Soria;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2020QI;""
42 Soria;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
42 Soria;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
42 Soria;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QII;""
42 Soria;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QI;962
42 Soria;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
42 Soria;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
42 Soria;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QII;""
42 Soria;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QI;888
42 Soria;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
42 Soria;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
42 Soria;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QII;""
42 Soria;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QI;""
42 Soria;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
42 Soria;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
42 Soria;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QII;928
42 Soria;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QI;""
42 Soria;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
42 Soria;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
42 Soria;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QII;859
42 Soria;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QI;""
42 Soria;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
42 Soria;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
42 Soria;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QII;""
42 Soria;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QI;""
42 Soria;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
42 Soria;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
42 Soria;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
42 Soria;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
42 Soria;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
42 Soria;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
42 Soria;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
42 Soria;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
42 Soria;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
42 Soria;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
42 Soria;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
42 Soria;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
42 Soria;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
42 Soria;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;97,13
42 Soria;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
42 Soria;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
42 Soria;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
42 Soria;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;96,97
42 Soria;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
42 Soria;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
42 Soria;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
42 Soria;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;97,38
42 Soria;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
42 Soria;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
42 Soria;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;90,59
42 Soria;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
42 Soria;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
42 Soria;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
42 Soria;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;93,08
42 Soria;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
42 Soria;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
42 Soria;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
42 Soria;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;91,94
42 Soria;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
42 Soria;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
42 Soria;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
42 Soria;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
42 Soria;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
42 Soria;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
42 Soria;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;91,18
42 Soria;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
42 Soria;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
42 Soria;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
42 Soria;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;89,52
42 Soria;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
42 Soria;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
42 Soria;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
42 Soria;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
42 Soria;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
42 Soria;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
42 Soria;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;87,96
42 Soria;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
42 Soria;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
42 Soria;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
42 Soria;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;86,59
42 Soria;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
42 Soria;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
42 Soria;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
42 Soria;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
42 Soria;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
42 Soria;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
42 Soria;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QIII;769
42 Soria;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
42 Soria;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
42 Soria;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
42 Soria;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QIII;738
42 Soria;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
42 Soria;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
42 Soria;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
42 Soria;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QIII;690
42 Soria;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
42 Soria;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
42 Soria;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
42 Soria;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2022QIII;749
42 Soria;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2022QII;""
42 Soria;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2022QI;""
42 Soria;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
42 Soria;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2021QIII;715
42 Soria;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2021QII;""
42 Soria;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2021QI;""
42 Soria;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
42 Soria;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2020QIII;676
42 Soria;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2020QII;""
42 Soria;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2020QI;""
42 Soria;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2022QIV;703
42 Soria;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
42 Soria;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2022QII;""
42 Soria;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2022QI;""
42 Soria;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2021QIV;687
42 Soria;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
42 Soria;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2021QII;""
42 Soria;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2021QI;""
42 Soria;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2020QIV;640
42 Soria;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
42 Soria;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2020QII;""
42 Soria;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2020QI;""
42 Soria;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
42 Soria;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
42 Soria;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QII;""
42 Soria;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QI;675
42 Soria;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
42 Soria;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
42 Soria;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QII;""
42 Soria;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QI;623
42 Soria;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
42 Soria;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
42 Soria;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QII;""
42 Soria;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QI;""
42 Soria;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
42 Soria;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
42 Soria;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QII;651
42 Soria;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QI;""
42 Soria;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
42 Soria;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
42 Soria;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QII;603
42 Soria;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QI;""
42 Soria;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
42 Soria;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
42 Soria;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QII;""
42 Soria;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QI;""
42 Soria;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
42 Soria;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
42 Soria;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
42 Soria;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
42 Soria;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
42 Soria;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
42 Soria;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
42 Soria;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
42 Soria;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
42 Soria;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
42 Soria;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
42 Soria;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
42 Soria;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
42 Soria;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;97,4
42 Soria;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
42 Soria;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
42 Soria;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
42 Soria;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;96,88
42 Soria;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
42 Soria;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
42 Soria;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
42 Soria;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;97,97
42 Soria;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
42 Soria;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
42 Soria;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;91,42
42 Soria;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
42 Soria;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
42 Soria;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
42 Soria;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;93,09
42 Soria;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
42 Soria;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
42 Soria;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
42 Soria;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;92,75
42 Soria;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
42 Soria;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
42 Soria;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
42 Soria;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
42 Soria;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
42 Soria;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
42 Soria;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;91,46
42 Soria;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
42 Soria;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
42 Soria;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
42 Soria;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;90,29
42 Soria;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
42 Soria;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
42 Soria;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
42 Soria;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
42 Soria;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
42 Soria;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
42 Soria;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;88,21
42 Soria;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
42 Soria;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
42 Soria;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
42 Soria;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;87,39
42 Soria;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
42 Soria;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
42 Soria;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
42 Soria;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
42 Soria;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
42 Soria;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
42 Soria;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QIII;347
42 Soria;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
42 Soria;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
42 Soria;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
42 Soria;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QIII;317
42 Soria;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
42 Soria;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
42 Soria;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
42 Soria;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QIII;302
42 Soria;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
42 Soria;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
42 Soria;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
42 Soria;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2022QIII;335
42 Soria;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2022QII;""
42 Soria;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2022QI;""
42 Soria;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
42 Soria;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2021QIII;308
42 Soria;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2021QII;""
42 Soria;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2021QI;""
42 Soria;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
42 Soria;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2020QIII;290
42 Soria;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2020QII;""
42 Soria;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2020QI;""
42 Soria;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2022QIV;308
42 Soria;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
42 Soria;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2022QII;""
42 Soria;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2022QI;""
42 Soria;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2021QIV;295
42 Soria;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
42 Soria;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2021QII;""
42 Soria;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2021QI;""
42 Soria;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2020QIV;272
42 Soria;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
42 Soria;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2020QII;""
42 Soria;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2020QI;""
42 Soria;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
42 Soria;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
42 Soria;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QII;""
42 Soria;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QI;287
42 Soria;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
42 Soria;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
42 Soria;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QII;""
42 Soria;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QI;265
42 Soria;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
42 Soria;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
42 Soria;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QII;""
42 Soria;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QI;""
42 Soria;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
42 Soria;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
42 Soria;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QII;277
42 Soria;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QI;""
42 Soria;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
42 Soria;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
42 Soria;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QII;256
42 Soria;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QI;""
42 Soria;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
42 Soria;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
42 Soria;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QII;""
42 Soria;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QI;""
42 Soria;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
42 Soria;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
42 Soria;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
42 Soria;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
42 Soria;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
42 Soria;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
42 Soria;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
42 Soria;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
42 Soria;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
42 Soria;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
42 Soria;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
42 Soria;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
42 Soria;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
42 Soria;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;96,54
42 Soria;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
42 Soria;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
42 Soria;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
42 Soria;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;97,16
42 Soria;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
42 Soria;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
42 Soria;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
42 Soria;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;96,03
42 Soria;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
42 Soria;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
42 Soria;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;88,76
42 Soria;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
42 Soria;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
42 Soria;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
42 Soria;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;93,06
42 Soria;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
42 Soria;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
42 Soria;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
42 Soria;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;90,07
42 Soria;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
42 Soria;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
42 Soria;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
42 Soria;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
42 Soria;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
42 Soria;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
42 Soria;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;90,54
42 Soria;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
42 Soria;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
42 Soria;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
42 Soria;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;87,75
42 Soria;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
42 Soria;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
42 Soria;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
42 Soria;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
42 Soria;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
42 Soria;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
42 Soria;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;87,38
42 Soria;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
42 Soria;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
42 Soria;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
42 Soria;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;84,77
42 Soria;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
42 Soria;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
42 Soria;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
42 Soria;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
42 Soria;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
42 Soria;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QIV;1.092
42 Soria;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
42 Soria;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
42 Soria;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
42 Soria;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QIV;1.026
42 Soria;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
42 Soria;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
42 Soria;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
42 Soria;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QIV;975
42 Soria;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
42 Soria;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
42 Soria;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
42 Soria;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2022QIV;1.017
42 Soria;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
42 Soria;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2022QII;""
42 Soria;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2022QI;""
42 Soria;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2021QIV;983
42 Soria;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
42 Soria;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2021QII;""
42 Soria;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2021QI;""
42 Soria;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2020QIV;916
42 Soria;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
42 Soria;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2020QII;""
42 Soria;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2020QI;""
42 Soria;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
42 Soria;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
42 Soria;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2022QII;""
42 Soria;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2022QI;963
42 Soria;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
42 Soria;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
42 Soria;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2021QII;""
42 Soria;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2021QI;892
42 Soria;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
42 Soria;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
42 Soria;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2020QII;""
42 Soria;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2020QI;""
42 Soria;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
42 Soria;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
42 Soria;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QII;929
42 Soria;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QI;""
42 Soria;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
42 Soria;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
42 Soria;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QII;863
42 Soria;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QI;""
42 Soria;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
42 Soria;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
42 Soria;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QII;""
42 Soria;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QI;""
42 Soria;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
42 Soria;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QIII;899
42 Soria;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QII;""
42 Soria;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QI;""
42 Soria;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
42 Soria;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QIII;836
42 Soria;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QII;""
42 Soria;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QI;""
42 Soria;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
42 Soria;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
42 Soria;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QII;""
42 Soria;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QI;""
42 Soria;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
42 Soria;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
42 Soria;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
42 Soria;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
42 Soria;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
42 Soria;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
42 Soria;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
42 Soria;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
42 Soria;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
42 Soria;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
42 Soria;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
42 Soria;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
42 Soria;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;93,13
42 Soria;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
42 Soria;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
42 Soria;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
42 Soria;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;95,81
42 Soria;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
42 Soria;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
42 Soria;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
42 Soria;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;93,95
42 Soria;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
42 Soria;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
42 Soria;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
42 Soria;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
42 Soria;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
42 Soria;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
42 Soria;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;93,86
42 Soria;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
42 Soria;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
42 Soria;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
42 Soria;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;91,49
42 Soria;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
42 Soria;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
42 Soria;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
42 Soria;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
42 Soria;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
42 Soria;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
42 Soria;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;90,55
42 Soria;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
42 Soria;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
42 Soria;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
42 Soria;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;88,51
42 Soria;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
42 Soria;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
42 Soria;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
42 Soria;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
42 Soria;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
42 Soria;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
42 Soria;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;87,62
42 Soria;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
42 Soria;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
42 Soria;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
42 Soria;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;85,74
42 Soria;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
42 Soria;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
42 Soria;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
42 Soria;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
42 Soria;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
42 Soria;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
42 Soria;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QIV;756
42 Soria;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
42 Soria;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
42 Soria;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
42 Soria;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QIV;716
42 Soria;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
42 Soria;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
42 Soria;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
42 Soria;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QIV;683
42 Soria;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
42 Soria;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
42 Soria;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
42 Soria;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2022QIV;708
42 Soria;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
42 Soria;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2022QII;""
42 Soria;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2022QI;""
42 Soria;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2021QIV;687
42 Soria;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
42 Soria;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2021QII;""
42 Soria;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2021QI;""
42 Soria;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2020QIV;644
42 Soria;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
42 Soria;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2020QII;""
42 Soria;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2020QI;""
42 Soria;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
42 Soria;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
42 Soria;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2022QII;""
42 Soria;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2022QI;675
42 Soria;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
42 Soria;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
42 Soria;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2021QII;""
42 Soria;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2021QI;627
42 Soria;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
42 Soria;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
42 Soria;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2020QII;""
42 Soria;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2020QI;""
42 Soria;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
42 Soria;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
42 Soria;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QII;651
42 Soria;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QI;""
42 Soria;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
42 Soria;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
42 Soria;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QII;607
42 Soria;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QI;""
42 Soria;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
42 Soria;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
42 Soria;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QII;""
42 Soria;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QI;""
42 Soria;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
42 Soria;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QIII;632
42 Soria;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QII;""
42 Soria;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QI;""
42 Soria;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
42 Soria;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QIII;589
42 Soria;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QII;""
42 Soria;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QI;""
42 Soria;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
42 Soria;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
42 Soria;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QII;""
42 Soria;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QI;""
42 Soria;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
42 Soria;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
42 Soria;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
42 Soria;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
42 Soria;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
42 Soria;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
42 Soria;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
42 Soria;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
42 Soria;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
42 Soria;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
42 Soria;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
42 Soria;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
42 Soria;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;93,65
42 Soria;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
42 Soria;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
42 Soria;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
42 Soria;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;95,95
42 Soria;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
42 Soria;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
42 Soria;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
42 Soria;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;94,29
42 Soria;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
42 Soria;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
42 Soria;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
42 Soria;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
42 Soria;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
42 Soria;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
42 Soria;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;94,27
42 Soria;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
42 Soria;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
42 Soria;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
42 Soria;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;91,8
42 Soria;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
42 Soria;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
42 Soria;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
42 Soria;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
42 Soria;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
42 Soria;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
42 Soria;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;90,92
42 Soria;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
42 Soria;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
42 Soria;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
42 Soria;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;88,87
42 Soria;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
42 Soria;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
42 Soria;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
42 Soria;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
42 Soria;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
42 Soria;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
42 Soria;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;88,27
42 Soria;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
42 Soria;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
42 Soria;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
42 Soria;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;86,24
42 Soria;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
42 Soria;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
42 Soria;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
42 Soria;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
42 Soria;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
42 Soria;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
42 Soria;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QIV;336
42 Soria;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
42 Soria;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
42 Soria;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
42 Soria;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QIV;310
42 Soria;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
42 Soria;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
42 Soria;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
42 Soria;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QIV;292
42 Soria;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
42 Soria;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
42 Soria;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
42 Soria;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2022QIV;309
42 Soria;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
42 Soria;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2022QII;""
42 Soria;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2022QI;""
42 Soria;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2021QIV;296
42 Soria;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
42 Soria;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2021QII;""
42 Soria;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2021QI;""
42 Soria;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2020QIV;272
42 Soria;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
42 Soria;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2020QII;""
42 Soria;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2020QI;""
42 Soria;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
42 Soria;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
42 Soria;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2022QII;""
42 Soria;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2022QI;288
42 Soria;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
42 Soria;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
42 Soria;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2021QII;""
42 Soria;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2021QI;265
42 Soria;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
42 Soria;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
42 Soria;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2020QII;""
42 Soria;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2020QI;""
42 Soria;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
42 Soria;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
42 Soria;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QII;278
42 Soria;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QI;""
42 Soria;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
42 Soria;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
42 Soria;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QII;256
42 Soria;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QI;""
42 Soria;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
42 Soria;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
42 Soria;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QII;""
42 Soria;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QI;""
42 Soria;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
42 Soria;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QIII;267
42 Soria;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QII;""
42 Soria;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QI;""
42 Soria;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
42 Soria;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QIII;247
42 Soria;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QII;""
42 Soria;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QI;""
42 Soria;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
42 Soria;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
42 Soria;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QII;""
42 Soria;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QI;""
42 Soria;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
42 Soria;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
42 Soria;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
42 Soria;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
42 Soria;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
42 Soria;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
42 Soria;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
42 Soria;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
42 Soria;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
42 Soria;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
42 Soria;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
42 Soria;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
42 Soria;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;91,96
42 Soria;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
42 Soria;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
42 Soria;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
42 Soria;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;95,48
42 Soria;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
42 Soria;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
42 Soria;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
42 Soria;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;93,15
42 Soria;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
42 Soria;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
42 Soria;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
42 Soria;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
42 Soria;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
42 Soria;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
42 Soria;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;92,9
42 Soria;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
42 Soria;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
42 Soria;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
42 Soria;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;90,75
42 Soria;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
42 Soria;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
42 Soria;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
42 Soria;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
42 Soria;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
42 Soria;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
42 Soria;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;89,68
42 Soria;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
42 Soria;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
42 Soria;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
42 Soria;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;87,67
42 Soria;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
42 Soria;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
42 Soria;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
42 Soria;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
42 Soria;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
42 Soria;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
42 Soria;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;86,13
42 Soria;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
42 Soria;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
42 Soria;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
42 Soria;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;84,59
42 Soria;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
42 Soria;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
42 Soria;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
42 Soria;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
42 Soria;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
42 Soria;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
43 Tarragona;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
43 Tarragona;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
43 Tarragona;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
43 Tarragona;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QI;49.202
43 Tarragona;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
43 Tarragona;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
43 Tarragona;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
43 Tarragona;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QI;48.180
43 Tarragona;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
43 Tarragona;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
43 Tarragona;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
43 Tarragona;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QI;48.914
43 Tarragona;All ages;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
43 Tarragona;All ages;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
43 Tarragona;All ages;Cohort January 1;Total;Survival in the first trimester;2022QII;""
43 Tarragona;All ages;Cohort January 1;Total;Survival in the first trimester;2022QI;47.334
43 Tarragona;All ages;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
43 Tarragona;All ages;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
43 Tarragona;All ages;Cohort January 1;Total;Survival in the first trimester;2021QII;""
43 Tarragona;All ages;Cohort January 1;Total;Survival in the first trimester;2021QI;46.966
43 Tarragona;All ages;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
43 Tarragona;All ages;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
43 Tarragona;All ages;Cohort January 1;Total;Survival in the first trimester;2020QII;""
43 Tarragona;All ages;Cohort January 1;Total;Survival in the first trimester;2020QI;45.730
43 Tarragona;All ages;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
43 Tarragona;All ages;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
43 Tarragona;All ages;Cohort January 1;Total;Survival in the second trimester;2022QII;45.753
43 Tarragona;All ages;Cohort January 1;Total;Survival in the second trimester;2022QI;""
43 Tarragona;All ages;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
43 Tarragona;All ages;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
43 Tarragona;All ages;Cohort January 1;Total;Survival in the second trimester;2021QII;45.588
43 Tarragona;All ages;Cohort January 1;Total;Survival in the second trimester;2021QI;""
43 Tarragona;All ages;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
43 Tarragona;All ages;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
43 Tarragona;All ages;Cohort January 1;Total;Survival in the second trimester;2020QII;44.723
43 Tarragona;All ages;Cohort January 1;Total;Survival in the second trimester;2020QI;""
43 Tarragona;All ages;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
43 Tarragona;All ages;Cohort January 1;Total;Survival in the third trimester;2022QIII;44.392
43 Tarragona;All ages;Cohort January 1;Total;Survival in the third trimester;2022QII;""
43 Tarragona;All ages;Cohort January 1;Total;Survival in the third trimester;2022QI;""
43 Tarragona;All ages;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
43 Tarragona;All ages;Cohort January 1;Total;Survival in the third trimester;2021QIII;44.418
43 Tarragona;All ages;Cohort January 1;Total;Survival in the third trimester;2021QII;""
43 Tarragona;All ages;Cohort January 1;Total;Survival in the third trimester;2021QI;""
43 Tarragona;All ages;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
43 Tarragona;All ages;Cohort January 1;Total;Survival in the third trimester;2020QIII;43.306
43 Tarragona;All ages;Cohort January 1;Total;Survival in the third trimester;2020QII;""
43 Tarragona;All ages;Cohort January 1;Total;Survival in the third trimester;2020QI;""
43 Tarragona;All ages;Cohort January 1;Total;Survival in the third trimester;2022QIV;42.767
43 Tarragona;All ages;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
43 Tarragona;All ages;Cohort January 1;Total;Survival in the third trimester;2022QII;""
43 Tarragona;All ages;Cohort January 1;Total;Survival in the third trimester;2022QI;""
43 Tarragona;All ages;Cohort January 1;Total;Survival in the third trimester;2021QIV;43.018
43 Tarragona;All ages;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
43 Tarragona;All ages;Cohort January 1;Total;Survival in the third trimester;2021QII;""
43 Tarragona;All ages;Cohort January 1;Total;Survival in the third trimester;2021QI;""
43 Tarragona;All ages;Cohort January 1;Total;Survival in the third trimester;2020QIV;41.919
43 Tarragona;All ages;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
43 Tarragona;All ages;Cohort January 1;Total;Survival in the third trimester;2020QII;""
43 Tarragona;All ages;Cohort January 1;Total;Survival in the third trimester;2020QI;""
43 Tarragona;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
43 Tarragona;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
43 Tarragona;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
43 Tarragona;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
43 Tarragona;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
43 Tarragona;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
43 Tarragona;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
43 Tarragona;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
43 Tarragona;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
43 Tarragona;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
43 Tarragona;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
43 Tarragona;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
43 Tarragona;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
43 Tarragona;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
43 Tarragona;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
43 Tarragona;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;96,2
43 Tarragona;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
43 Tarragona;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
43 Tarragona;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
43 Tarragona;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;97,48
43 Tarragona;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
43 Tarragona;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
43 Tarragona;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
43 Tarragona;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;93,49
43 Tarragona;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
43 Tarragona;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
43 Tarragona;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;92,99
43 Tarragona;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
43 Tarragona;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
43 Tarragona;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
43 Tarragona;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;94,62
43 Tarragona;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
43 Tarragona;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
43 Tarragona;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
43 Tarragona;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;91,43
43 Tarragona;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
43 Tarragona;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
43 Tarragona;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;90,22
43 Tarragona;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
43 Tarragona;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
43 Tarragona;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
43 Tarragona;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;92,19
43 Tarragona;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
43 Tarragona;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
43 Tarragona;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
43 Tarragona;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;88,53
43 Tarragona;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
43 Tarragona;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
43 Tarragona;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;86,92
43 Tarragona;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
43 Tarragona;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
43 Tarragona;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
43 Tarragona;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;89,29
43 Tarragona;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
43 Tarragona;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
43 Tarragona;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
43 Tarragona;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;85,7
43 Tarragona;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
43 Tarragona;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
43 Tarragona;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
43 Tarragona;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
43 Tarragona;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
43 Tarragona;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
43 Tarragona;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QI;30.742
43 Tarragona;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
43 Tarragona;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
43 Tarragona;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
43 Tarragona;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QI;30.209
43 Tarragona;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
43 Tarragona;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
43 Tarragona;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
43 Tarragona;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QI;30.550
43 Tarragona;All ages;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
43 Tarragona;All ages;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
43 Tarragona;All ages;Cohort January 1;Males;Survival in the first trimester;2022QII;""
43 Tarragona;All ages;Cohort January 1;Males;Survival in the first trimester;2022QI;29.645
43 Tarragona;All ages;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
43 Tarragona;All ages;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
43 Tarragona;All ages;Cohort January 1;Males;Survival in the first trimester;2021QII;""
43 Tarragona;All ages;Cohort January 1;Males;Survival in the first trimester;2021QI;29.440
43 Tarragona;All ages;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
43 Tarragona;All ages;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
43 Tarragona;All ages;Cohort January 1;Males;Survival in the first trimester;2020QII;""
43 Tarragona;All ages;Cohort January 1;Males;Survival in the first trimester;2020QI;28.656
43 Tarragona;All ages;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
43 Tarragona;All ages;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
43 Tarragona;All ages;Cohort January 1;Males;Survival in the second trimester;2022QII;28.714
43 Tarragona;All ages;Cohort January 1;Males;Survival in the second trimester;2022QI;""
43 Tarragona;All ages;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
43 Tarragona;All ages;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
43 Tarragona;All ages;Cohort January 1;Males;Survival in the second trimester;2021QII;28.590
43 Tarragona;All ages;Cohort January 1;Males;Survival in the second trimester;2021QI;""
43 Tarragona;All ages;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
43 Tarragona;All ages;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
43 Tarragona;All ages;Cohort January 1;Males;Survival in the second trimester;2020QII;28.094
43 Tarragona;All ages;Cohort January 1;Males;Survival in the second trimester;2020QI;""
43 Tarragona;All ages;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
43 Tarragona;All ages;Cohort January 1;Males;Survival in the third trimester;2022QIII;27.919
43 Tarragona;All ages;Cohort January 1;Males;Survival in the third trimester;2022QII;""
43 Tarragona;All ages;Cohort January 1;Males;Survival in the third trimester;2022QI;""
43 Tarragona;All ages;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
43 Tarragona;All ages;Cohort January 1;Males;Survival in the third trimester;2021QIII;27.918
43 Tarragona;All ages;Cohort January 1;Males;Survival in the third trimester;2021QII;""
43 Tarragona;All ages;Cohort January 1;Males;Survival in the third trimester;2021QI;""
43 Tarragona;All ages;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
43 Tarragona;All ages;Cohort January 1;Males;Survival in the third trimester;2020QIII;27.260
43 Tarragona;All ages;Cohort January 1;Males;Survival in the third trimester;2020QII;""
43 Tarragona;All ages;Cohort January 1;Males;Survival in the third trimester;2020QI;""
43 Tarragona;All ages;Cohort January 1;Males;Survival in the third trimester;2022QIV;26.986
43 Tarragona;All ages;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
43 Tarragona;All ages;Cohort January 1;Males;Survival in the third trimester;2022QII;""
43 Tarragona;All ages;Cohort January 1;Males;Survival in the third trimester;2022QI;""
43 Tarragona;All ages;Cohort January 1;Males;Survival in the third trimester;2021QIV;27.075
43 Tarragona;All ages;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
43 Tarragona;All ages;Cohort January 1;Males;Survival in the third trimester;2021QII;""
43 Tarragona;All ages;Cohort January 1;Males;Survival in the third trimester;2021QI;""
43 Tarragona;All ages;Cohort January 1;Males;Survival in the third trimester;2020QIV;26.406
43 Tarragona;All ages;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
43 Tarragona;All ages;Cohort January 1;Males;Survival in the third trimester;2020QII;""
43 Tarragona;All ages;Cohort January 1;Males;Survival in the third trimester;2020QI;""
43 Tarragona;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
43 Tarragona;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
43 Tarragona;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
43 Tarragona;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
43 Tarragona;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
43 Tarragona;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
43 Tarragona;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
43 Tarragona;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
43 Tarragona;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
43 Tarragona;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
43 Tarragona;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
43 Tarragona;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
43 Tarragona;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
43 Tarragona;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
43 Tarragona;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
43 Tarragona;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;96,43
43 Tarragona;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
43 Tarragona;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
43 Tarragona;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
43 Tarragona;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;97,45
43 Tarragona;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
43 Tarragona;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
43 Tarragona;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
43 Tarragona;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;93,8
43 Tarragona;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
43 Tarragona;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
43 Tarragona;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;93,4
43 Tarragona;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
43 Tarragona;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
43 Tarragona;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
43 Tarragona;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;94,64
43 Tarragona;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
43 Tarragona;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
43 Tarragona;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
43 Tarragona;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;91,96
43 Tarragona;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
43 Tarragona;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
43 Tarragona;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;90,82
43 Tarragona;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
43 Tarragona;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
43 Tarragona;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
43 Tarragona;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;92,42
43 Tarragona;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
43 Tarragona;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
43 Tarragona;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
43 Tarragona;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;89,23
43 Tarragona;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
43 Tarragona;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
43 Tarragona;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;87,78
43 Tarragona;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
43 Tarragona;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
43 Tarragona;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
43 Tarragona;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;89,63
43 Tarragona;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
43 Tarragona;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
43 Tarragona;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
43 Tarragona;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;86,44
43 Tarragona;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
43 Tarragona;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
43 Tarragona;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
43 Tarragona;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
43 Tarragona;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
43 Tarragona;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
43 Tarragona;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QI;18.460
43 Tarragona;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
43 Tarragona;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
43 Tarragona;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
43 Tarragona;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QI;17.971
43 Tarragona;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
43 Tarragona;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
43 Tarragona;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
43 Tarragona;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QI;18.364
43 Tarragona;All ages;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
43 Tarragona;All ages;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
43 Tarragona;All ages;Cohort January 1;Females;Survival in the first trimester;2022QII;""
43 Tarragona;All ages;Cohort January 1;Females;Survival in the first trimester;2022QI;17.689
43 Tarragona;All ages;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
43 Tarragona;All ages;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
43 Tarragona;All ages;Cohort January 1;Females;Survival in the first trimester;2021QII;""
43 Tarragona;All ages;Cohort January 1;Females;Survival in the first trimester;2021QI;17.526
43 Tarragona;All ages;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
43 Tarragona;All ages;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
43 Tarragona;All ages;Cohort January 1;Females;Survival in the first trimester;2020QII;""
43 Tarragona;All ages;Cohort January 1;Females;Survival in the first trimester;2020QI;17.074
43 Tarragona;All ages;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
43 Tarragona;All ages;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
43 Tarragona;All ages;Cohort January 1;Females;Survival in the second trimester;2022QII;17.039
43 Tarragona;All ages;Cohort January 1;Females;Survival in the second trimester;2022QI;""
43 Tarragona;All ages;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
43 Tarragona;All ages;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
43 Tarragona;All ages;Cohort January 1;Females;Survival in the second trimester;2021QII;16.998
43 Tarragona;All ages;Cohort January 1;Females;Survival in the second trimester;2021QI;""
43 Tarragona;All ages;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
43 Tarragona;All ages;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
43 Tarragona;All ages;Cohort January 1;Females;Survival in the second trimester;2020QII;16.629
43 Tarragona;All ages;Cohort January 1;Females;Survival in the second trimester;2020QI;""
43 Tarragona;All ages;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
43 Tarragona;All ages;Cohort January 1;Females;Survival in the third trimester;2022QIII;16.473
43 Tarragona;All ages;Cohort January 1;Females;Survival in the third trimester;2022QII;""
43 Tarragona;All ages;Cohort January 1;Females;Survival in the third trimester;2022QI;""
43 Tarragona;All ages;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
43 Tarragona;All ages;Cohort January 1;Females;Survival in the third trimester;2021QIII;16.500
43 Tarragona;All ages;Cohort January 1;Females;Survival in the third trimester;2021QII;""
43 Tarragona;All ages;Cohort January 1;Females;Survival in the third trimester;2021QI;""
43 Tarragona;All ages;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
43 Tarragona;All ages;Cohort January 1;Females;Survival in the third trimester;2020QIII;16.046
43 Tarragona;All ages;Cohort January 1;Females;Survival in the third trimester;2020QII;""
43 Tarragona;All ages;Cohort January 1;Females;Survival in the third trimester;2020QI;""
43 Tarragona;All ages;Cohort January 1;Females;Survival in the third trimester;2022QIV;15.781
43 Tarragona;All ages;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
43 Tarragona;All ages;Cohort January 1;Females;Survival in the third trimester;2022QII;""
43 Tarragona;All ages;Cohort January 1;Females;Survival in the third trimester;2022QI;""
43 Tarragona;All ages;Cohort January 1;Females;Survival in the third trimester;2021QIV;15.943
43 Tarragona;All ages;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
43 Tarragona;All ages;Cohort January 1;Females;Survival in the third trimester;2021QII;""
43 Tarragona;All ages;Cohort January 1;Females;Survival in the third trimester;2021QI;""
43 Tarragona;All ages;Cohort January 1;Females;Survival in the third trimester;2020QIV;15.513
43 Tarragona;All ages;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
43 Tarragona;All ages;Cohort January 1;Females;Survival in the third trimester;2020QII;""
43 Tarragona;All ages;Cohort January 1;Females;Survival in the third trimester;2020QI;""
43 Tarragona;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
43 Tarragona;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
43 Tarragona;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
43 Tarragona;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
43 Tarragona;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
43 Tarragona;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
43 Tarragona;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
43 Tarragona;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
43 Tarragona;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
43 Tarragona;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
43 Tarragona;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
43 Tarragona;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
43 Tarragona;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
43 Tarragona;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
43 Tarragona;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
43 Tarragona;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;95,82
43 Tarragona;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
43 Tarragona;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
43 Tarragona;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
43 Tarragona;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;97,52
43 Tarragona;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
43 Tarragona;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
43 Tarragona;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
43 Tarragona;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;92,98
43 Tarragona;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
43 Tarragona;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
43 Tarragona;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;92,3
43 Tarragona;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
43 Tarragona;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
43 Tarragona;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
43 Tarragona;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;94,59
43 Tarragona;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
43 Tarragona;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
43 Tarragona;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
43 Tarragona;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;90,55
43 Tarragona;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
43 Tarragona;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
43 Tarragona;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;89,24
43 Tarragona;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
43 Tarragona;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
43 Tarragona;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
43 Tarragona;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;91,81
43 Tarragona;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
43 Tarragona;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
43 Tarragona;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
43 Tarragona;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;87,38
43 Tarragona;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
43 Tarragona;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
43 Tarragona;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;85,49
43 Tarragona;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
43 Tarragona;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
43 Tarragona;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
43 Tarragona;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;88,72
43 Tarragona;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
43 Tarragona;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
43 Tarragona;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
43 Tarragona;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;84,48
43 Tarragona;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
43 Tarragona;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
43 Tarragona;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
43 Tarragona;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
43 Tarragona;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
43 Tarragona;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QII;49.295
43 Tarragona;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
43 Tarragona;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
43 Tarragona;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
43 Tarragona;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QII;48.978
43 Tarragona;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
43 Tarragona;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
43 Tarragona;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
43 Tarragona;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QII;47.887
43 Tarragona;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
43 Tarragona;All ages;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
43 Tarragona;All ages;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
43 Tarragona;All ages;Cohort April 1;Total;Survival in the first trimester;2022QII;47.529
43 Tarragona;All ages;Cohort April 1;Total;Survival in the first trimester;2022QI;""
43 Tarragona;All ages;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
43 Tarragona;All ages;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
43 Tarragona;All ages;Cohort April 1;Total;Survival in the first trimester;2021QII;47.405
43 Tarragona;All ages;Cohort April 1;Total;Survival in the first trimester;2021QI;""
43 Tarragona;All ages;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
43 Tarragona;All ages;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
43 Tarragona;All ages;Cohort April 1;Total;Survival in the first trimester;2020QII;46.761
43 Tarragona;All ages;Cohort April 1;Total;Survival in the first trimester;2020QI;""
43 Tarragona;All ages;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
43 Tarragona;All ages;Cohort April 1;Total;Survival in the second trimester;2022QIII;46.016
43 Tarragona;All ages;Cohort April 1;Total;Survival in the second trimester;2022QII;""
43 Tarragona;All ages;Cohort April 1;Total;Survival in the second trimester;2022QI;""
43 Tarragona;All ages;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
43 Tarragona;All ages;Cohort April 1;Total;Survival in the second trimester;2021QIII;46.050
43 Tarragona;All ages;Cohort April 1;Total;Survival in the second trimester;2021QII;""
43 Tarragona;All ages;Cohort April 1;Total;Survival in the second trimester;2021QI;""
43 Tarragona;All ages;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
43 Tarragona;All ages;Cohort April 1;Total;Survival in the second trimester;2020QIII;45.174
43 Tarragona;All ages;Cohort April 1;Total;Survival in the second trimester;2020QII;""
43 Tarragona;All ages;Cohort April 1;Total;Survival in the second trimester;2020QI;""
43 Tarragona;All ages;Cohort April 1;Total;Survival in the third trimester;2022QIV;44.190
43 Tarragona;All ages;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
43 Tarragona;All ages;Cohort April 1;Total;Survival in the third trimester;2022QII;""
43 Tarragona;All ages;Cohort April 1;Total;Survival in the third trimester;2022QI;""
43 Tarragona;All ages;Cohort April 1;Total;Survival in the third trimester;2021QIV;44.432
43 Tarragona;All ages;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
43 Tarragona;All ages;Cohort April 1;Total;Survival in the third trimester;2021QII;""
43 Tarragona;All ages;Cohort April 1;Total;Survival in the third trimester;2021QI;""
43 Tarragona;All ages;Cohort April 1;Total;Survival in the third trimester;2020QIV;43.611
43 Tarragona;All ages;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
43 Tarragona;All ages;Cohort April 1;Total;Survival in the third trimester;2020QII;""
43 Tarragona;All ages;Cohort April 1;Total;Survival in the third trimester;2020QI;""
43 Tarragona;All ages;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
43 Tarragona;All ages;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
43 Tarragona;All ages;Cohort April 1;Total;Survival in the third trimester;2022QII;""
43 Tarragona;All ages;Cohort April 1;Total;Survival in the third trimester;2022QI;43.026
43 Tarragona;All ages;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
43 Tarragona;All ages;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
43 Tarragona;All ages;Cohort April 1;Total;Survival in the third trimester;2021QII;""
43 Tarragona;All ages;Cohort April 1;Total;Survival in the third trimester;2021QI;42.709
43 Tarragona;All ages;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
43 Tarragona;All ages;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
43 Tarragona;All ages;Cohort April 1;Total;Survival in the third trimester;2020QII;""
43 Tarragona;All ages;Cohort April 1;Total;Survival in the third trimester;2020QI;""
43 Tarragona;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
43 Tarragona;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
43 Tarragona;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
43 Tarragona;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
43 Tarragona;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
43 Tarragona;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
43 Tarragona;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
43 Tarragona;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
43 Tarragona;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
43 Tarragona;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
43 Tarragona;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
43 Tarragona;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
43 Tarragona;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
43 Tarragona;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
43 Tarragona;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;96,42
43 Tarragona;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
43 Tarragona;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
43 Tarragona;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
43 Tarragona;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;96,79
43 Tarragona;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
43 Tarragona;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
43 Tarragona;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
43 Tarragona;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;97,65
43 Tarragona;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
43 Tarragona;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
43 Tarragona;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;93,35
43 Tarragona;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
43 Tarragona;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
43 Tarragona;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
43 Tarragona;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;94,02
43 Tarragona;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
43 Tarragona;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
43 Tarragona;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
43 Tarragona;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;94,33
43 Tarragona;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
43 Tarragona;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
43 Tarragona;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;89,64
43 Tarragona;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
43 Tarragona;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
43 Tarragona;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
43 Tarragona;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;90,72
43 Tarragona;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
43 Tarragona;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
43 Tarragona;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
43 Tarragona;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;91,07
43 Tarragona;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
43 Tarragona;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
43 Tarragona;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
43 Tarragona;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
43 Tarragona;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
43 Tarragona;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
43 Tarragona;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;87,85
43 Tarragona;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
43 Tarragona;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
43 Tarragona;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
43 Tarragona;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;89,19
43 Tarragona;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
43 Tarragona;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
43 Tarragona;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
43 Tarragona;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
43 Tarragona;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
43 Tarragona;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
43 Tarragona;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QII;30.817
43 Tarragona;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
43 Tarragona;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
43 Tarragona;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
43 Tarragona;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QII;30.697
43 Tarragona;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
43 Tarragona;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
43 Tarragona;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
43 Tarragona;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QII;30.006
43 Tarragona;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
43 Tarragona;All ages;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
43 Tarragona;All ages;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
43 Tarragona;All ages;Cohort April 1;Males;Survival in the first trimester;2022QII;29.764
43 Tarragona;All ages;Cohort April 1;Males;Survival in the first trimester;2022QI;""
43 Tarragona;All ages;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
43 Tarragona;All ages;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
43 Tarragona;All ages;Cohort April 1;Males;Survival in the first trimester;2021QII;29.719
43 Tarragona;All ages;Cohort April 1;Males;Survival in the first trimester;2021QI;""
43 Tarragona;All ages;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
43 Tarragona;All ages;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
43 Tarragona;All ages;Cohort April 1;Males;Survival in the first trimester;2020QII;29.370
43 Tarragona;All ages;Cohort April 1;Males;Survival in the first trimester;2020QI;""
43 Tarragona;All ages;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
43 Tarragona;All ages;Cohort April 1;Males;Survival in the second trimester;2022QIII;28.876
43 Tarragona;All ages;Cohort April 1;Males;Survival in the second trimester;2022QII;""
43 Tarragona;All ages;Cohort April 1;Males;Survival in the second trimester;2022QI;""
43 Tarragona;All ages;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
43 Tarragona;All ages;Cohort April 1;Males;Survival in the second trimester;2021QIII;28.927
43 Tarragona;All ages;Cohort April 1;Males;Survival in the second trimester;2021QII;""
43 Tarragona;All ages;Cohort April 1;Males;Survival in the second trimester;2021QI;""
43 Tarragona;All ages;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
43 Tarragona;All ages;Cohort April 1;Males;Survival in the second trimester;2020QIII;28.425
43 Tarragona;All ages;Cohort April 1;Males;Survival in the second trimester;2020QII;""
43 Tarragona;All ages;Cohort April 1;Males;Survival in the second trimester;2020QI;""
43 Tarragona;All ages;Cohort April 1;Males;Survival in the third trimester;2022QIV;27.834
43 Tarragona;All ages;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
43 Tarragona;All ages;Cohort April 1;Males;Survival in the third trimester;2022QII;""
43 Tarragona;All ages;Cohort April 1;Males;Survival in the third trimester;2022QI;""
43 Tarragona;All ages;Cohort April 1;Males;Survival in the third trimester;2021QIV;27.965
43 Tarragona;All ages;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
43 Tarragona;All ages;Cohort April 1;Males;Survival in the third trimester;2021QII;""
43 Tarragona;All ages;Cohort April 1;Males;Survival in the third trimester;2021QI;""
43 Tarragona;All ages;Cohort April 1;Males;Survival in the third trimester;2020QIV;27.455
43 Tarragona;All ages;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
43 Tarragona;All ages;Cohort April 1;Males;Survival in the third trimester;2020QII;""
43 Tarragona;All ages;Cohort April 1;Males;Survival in the third trimester;2020QI;""
43 Tarragona;All ages;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
43 Tarragona;All ages;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
43 Tarragona;All ages;Cohort April 1;Males;Survival in the third trimester;2022QII;""
43 Tarragona;All ages;Cohort April 1;Males;Survival in the third trimester;2022QI;27.138
43 Tarragona;All ages;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
43 Tarragona;All ages;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
43 Tarragona;All ages;Cohort April 1;Males;Survival in the third trimester;2021QII;""
43 Tarragona;All ages;Cohort April 1;Males;Survival in the third trimester;2021QI;26.878
43 Tarragona;All ages;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
43 Tarragona;All ages;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
43 Tarragona;All ages;Cohort April 1;Males;Survival in the third trimester;2020QII;""
43 Tarragona;All ages;Cohort April 1;Males;Survival in the third trimester;2020QI;""
43 Tarragona;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
43 Tarragona;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
43 Tarragona;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
43 Tarragona;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
43 Tarragona;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
43 Tarragona;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
43 Tarragona;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
43 Tarragona;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
43 Tarragona;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
43 Tarragona;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
43 Tarragona;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
43 Tarragona;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
43 Tarragona;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
43 Tarragona;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
43 Tarragona;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;96,58
43 Tarragona;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
43 Tarragona;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
43 Tarragona;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
43 Tarragona;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;96,81
43 Tarragona;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
43 Tarragona;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
43 Tarragona;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
43 Tarragona;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;97,88
43 Tarragona;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
43 Tarragona;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
43 Tarragona;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;93,7
43 Tarragona;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
43 Tarragona;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
43 Tarragona;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
43 Tarragona;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;94,23
43 Tarragona;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
43 Tarragona;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
43 Tarragona;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
43 Tarragona;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;94,73
43 Tarragona;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
43 Tarragona;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
43 Tarragona;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;90,32
43 Tarragona;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
43 Tarragona;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
43 Tarragona;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
43 Tarragona;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;91,1
43 Tarragona;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
43 Tarragona;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
43 Tarragona;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
43 Tarragona;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;91,5
43 Tarragona;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
43 Tarragona;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
43 Tarragona;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
43 Tarragona;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
43 Tarragona;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
43 Tarragona;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
43 Tarragona;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;88,41
43 Tarragona;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
43 Tarragona;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
43 Tarragona;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
43 Tarragona;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;89,58
43 Tarragona;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
43 Tarragona;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
43 Tarragona;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
43 Tarragona;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
43 Tarragona;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
43 Tarragona;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
43 Tarragona;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QII;18.478
43 Tarragona;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
43 Tarragona;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
43 Tarragona;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
43 Tarragona;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QII;18.281
43 Tarragona;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
43 Tarragona;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
43 Tarragona;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
43 Tarragona;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QII;17.881
43 Tarragona;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
43 Tarragona;All ages;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
43 Tarragona;All ages;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
43 Tarragona;All ages;Cohort April 1;Females;Survival in the first trimester;2022QII;17.765
43 Tarragona;All ages;Cohort April 1;Females;Survival in the first trimester;2022QI;""
43 Tarragona;All ages;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
43 Tarragona;All ages;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
43 Tarragona;All ages;Cohort April 1;Females;Survival in the first trimester;2021QII;17.686
43 Tarragona;All ages;Cohort April 1;Females;Survival in the first trimester;2021QI;""
43 Tarragona;All ages;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
43 Tarragona;All ages;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
43 Tarragona;All ages;Cohort April 1;Females;Survival in the first trimester;2020QII;17.391
43 Tarragona;All ages;Cohort April 1;Females;Survival in the first trimester;2020QI;""
43 Tarragona;All ages;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
43 Tarragona;All ages;Cohort April 1;Females;Survival in the second trimester;2022QIII;17.140
43 Tarragona;All ages;Cohort April 1;Females;Survival in the second trimester;2022QII;""
43 Tarragona;All ages;Cohort April 1;Females;Survival in the second trimester;2022QI;""
43 Tarragona;All ages;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
43 Tarragona;All ages;Cohort April 1;Females;Survival in the second trimester;2021QIII;17.123
43 Tarragona;All ages;Cohort April 1;Females;Survival in the second trimester;2021QII;""
43 Tarragona;All ages;Cohort April 1;Females;Survival in the second trimester;2021QI;""
43 Tarragona;All ages;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
43 Tarragona;All ages;Cohort April 1;Females;Survival in the second trimester;2020QIII;16.749
43 Tarragona;All ages;Cohort April 1;Females;Survival in the second trimester;2020QII;""
43 Tarragona;All ages;Cohort April 1;Females;Survival in the second trimester;2020QI;""
43 Tarragona;All ages;Cohort April 1;Females;Survival in the third trimester;2022QIV;16.356
43 Tarragona;All ages;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
43 Tarragona;All ages;Cohort April 1;Females;Survival in the third trimester;2022QII;""
43 Tarragona;All ages;Cohort April 1;Females;Survival in the third trimester;2022QI;""
43 Tarragona;All ages;Cohort April 1;Females;Survival in the third trimester;2021QIV;16.467
43 Tarragona;All ages;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
43 Tarragona;All ages;Cohort April 1;Females;Survival in the third trimester;2021QII;""
43 Tarragona;All ages;Cohort April 1;Females;Survival in the third trimester;2021QI;""
43 Tarragona;All ages;Cohort April 1;Females;Survival in the third trimester;2020QIV;16.156
43 Tarragona;All ages;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
43 Tarragona;All ages;Cohort April 1;Females;Survival in the third trimester;2020QII;""
43 Tarragona;All ages;Cohort April 1;Females;Survival in the third trimester;2020QI;""
43 Tarragona;All ages;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
43 Tarragona;All ages;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
43 Tarragona;All ages;Cohort April 1;Females;Survival in the third trimester;2022QII;""
43 Tarragona;All ages;Cohort April 1;Females;Survival in the third trimester;2022QI;15.888
43 Tarragona;All ages;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
43 Tarragona;All ages;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
43 Tarragona;All ages;Cohort April 1;Females;Survival in the third trimester;2021QII;""
43 Tarragona;All ages;Cohort April 1;Females;Survival in the third trimester;2021QI;15.831
43 Tarragona;All ages;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
43 Tarragona;All ages;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
43 Tarragona;All ages;Cohort April 1;Females;Survival in the third trimester;2020QII;""
43 Tarragona;All ages;Cohort April 1;Females;Survival in the third trimester;2020QI;""
43 Tarragona;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
43 Tarragona;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
43 Tarragona;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
43 Tarragona;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
43 Tarragona;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
43 Tarragona;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
43 Tarragona;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
43 Tarragona;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
43 Tarragona;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
43 Tarragona;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
43 Tarragona;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
43 Tarragona;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
43 Tarragona;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
43 Tarragona;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
43 Tarragona;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;96,14
43 Tarragona;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
43 Tarragona;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
43 Tarragona;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
43 Tarragona;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;96,75
43 Tarragona;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
43 Tarragona;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
43 Tarragona;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
43 Tarragona;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;97,26
43 Tarragona;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
43 Tarragona;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
43 Tarragona;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;92,76
43 Tarragona;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
43 Tarragona;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
43 Tarragona;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
43 Tarragona;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;93,67
43 Tarragona;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
43 Tarragona;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
43 Tarragona;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
43 Tarragona;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;93,67
43 Tarragona;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
43 Tarragona;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
43 Tarragona;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;88,52
43 Tarragona;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
43 Tarragona;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
43 Tarragona;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
43 Tarragona;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;90,08
43 Tarragona;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
43 Tarragona;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
43 Tarragona;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
43 Tarragona;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;90,35
43 Tarragona;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
43 Tarragona;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
43 Tarragona;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
43 Tarragona;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
43 Tarragona;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
43 Tarragona;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
43 Tarragona;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;86,91
43 Tarragona;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
43 Tarragona;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
43 Tarragona;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
43 Tarragona;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;88,54
43 Tarragona;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
43 Tarragona;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
43 Tarragona;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
43 Tarragona;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
43 Tarragona;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
43 Tarragona;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QIII;49.966
43 Tarragona;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
43 Tarragona;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
43 Tarragona;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
43 Tarragona;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QIII;49.795
43 Tarragona;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
43 Tarragona;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
43 Tarragona;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
43 Tarragona;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QIII;48.669
43 Tarragona;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
43 Tarragona;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
43 Tarragona;All ages;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
43 Tarragona;All ages;Cohort July 1;Total;Survival in the first trimester;2022QIII;47.962
43 Tarragona;All ages;Cohort July 1;Total;Survival in the first trimester;2022QII;""
43 Tarragona;All ages;Cohort July 1;Total;Survival in the first trimester;2022QI;""
43 Tarragona;All ages;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
43 Tarragona;All ages;Cohort July 1;Total;Survival in the first trimester;2021QIII;47.948
43 Tarragona;All ages;Cohort July 1;Total;Survival in the first trimester;2021QII;""
43 Tarragona;All ages;Cohort July 1;Total;Survival in the first trimester;2021QI;""
43 Tarragona;All ages;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
43 Tarragona;All ages;Cohort July 1;Total;Survival in the first trimester;2020QIII;46.648
43 Tarragona;All ages;Cohort July 1;Total;Survival in the first trimester;2020QII;""
43 Tarragona;All ages;Cohort July 1;Total;Survival in the first trimester;2020QI;""
43 Tarragona;All ages;Cohort July 1;Total;Survival in the second trimester;2022QIV;45.699
43 Tarragona;All ages;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
43 Tarragona;All ages;Cohort July 1;Total;Survival in the second trimester;2022QII;""
43 Tarragona;All ages;Cohort July 1;Total;Survival in the second trimester;2022QI;""
43 Tarragona;All ages;Cohort July 1;Total;Survival in the second trimester;2021QIV;45.992
43 Tarragona;All ages;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
43 Tarragona;All ages;Cohort July 1;Total;Survival in the second trimester;2021QII;""
43 Tarragona;All ages;Cohort July 1;Total;Survival in the second trimester;2021QI;""
43 Tarragona;All ages;Cohort July 1;Total;Survival in the second trimester;2020QIV;44.856
43 Tarragona;All ages;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
43 Tarragona;All ages;Cohort July 1;Total;Survival in the second trimester;2020QII;""
43 Tarragona;All ages;Cohort July 1;Total;Survival in the second trimester;2020QI;""
43 Tarragona;All ages;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
43 Tarragona;All ages;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
43 Tarragona;All ages;Cohort July 1;Total;Survival in the third trimester;2022QII;""
43 Tarragona;All ages;Cohort July 1;Total;Survival in the third trimester;2022QI;44.457
43 Tarragona;All ages;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
43 Tarragona;All ages;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
43 Tarragona;All ages;Cohort July 1;Total;Survival in the third trimester;2021QII;""
43 Tarragona;All ages;Cohort July 1;Total;Survival in the third trimester;2021QI;43.901
43 Tarragona;All ages;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
43 Tarragona;All ages;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
43 Tarragona;All ages;Cohort July 1;Total;Survival in the third trimester;2020QII;""
43 Tarragona;All ages;Cohort July 1;Total;Survival in the third trimester;2020QI;""
43 Tarragona;All ages;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
43 Tarragona;All ages;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
43 Tarragona;All ages;Cohort July 1;Total;Survival in the third trimester;2022QII;43.170
43 Tarragona;All ages;Cohort July 1;Total;Survival in the third trimester;2022QI;""
43 Tarragona;All ages;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
43 Tarragona;All ages;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
43 Tarragona;All ages;Cohort July 1;Total;Survival in the third trimester;2021QII;42.823
43 Tarragona;All ages;Cohort July 1;Total;Survival in the third trimester;2021QI;""
43 Tarragona;All ages;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
43 Tarragona;All ages;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
43 Tarragona;All ages;Cohort July 1;Total;Survival in the third trimester;2020QII;""
43 Tarragona;All ages;Cohort July 1;Total;Survival in the third trimester;2020QI;""
43 Tarragona;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
43 Tarragona;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
43 Tarragona;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
43 Tarragona;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
43 Tarragona;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
43 Tarragona;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
43 Tarragona;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
43 Tarragona;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
43 Tarragona;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
43 Tarragona;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
43 Tarragona;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
43 Tarragona;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
43 Tarragona;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
43 Tarragona;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;95,99
43 Tarragona;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
43 Tarragona;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
43 Tarragona;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
43 Tarragona;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;96,29
43 Tarragona;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
43 Tarragona;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
43 Tarragona;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
43 Tarragona;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;95,85
43 Tarragona;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
43 Tarragona;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
43 Tarragona;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;91,46
43 Tarragona;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
43 Tarragona;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
43 Tarragona;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
43 Tarragona;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;92,36
43 Tarragona;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
43 Tarragona;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
43 Tarragona;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
43 Tarragona;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;92,17
43 Tarragona;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
43 Tarragona;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
43 Tarragona;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
43 Tarragona;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
43 Tarragona;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
43 Tarragona;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
43 Tarragona;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;89,28
43 Tarragona;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
43 Tarragona;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
43 Tarragona;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
43 Tarragona;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;90,2
43 Tarragona;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
43 Tarragona;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
43 Tarragona;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
43 Tarragona;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
43 Tarragona;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
43 Tarragona;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
43 Tarragona;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;86,7
43 Tarragona;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
43 Tarragona;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
43 Tarragona;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
43 Tarragona;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;87,99
43 Tarragona;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
43 Tarragona;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
43 Tarragona;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
43 Tarragona;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
43 Tarragona;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
43 Tarragona;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
43 Tarragona;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QIII;31.163
43 Tarragona;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
43 Tarragona;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
43 Tarragona;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
43 Tarragona;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QIII;31.152
43 Tarragona;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
43 Tarragona;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
43 Tarragona;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
43 Tarragona;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QIII;30.528
43 Tarragona;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
43 Tarragona;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
43 Tarragona;All ages;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
43 Tarragona;All ages;Cohort July 1;Males;Survival in the first trimester;2022QIII;30.013
43 Tarragona;All ages;Cohort July 1;Males;Survival in the first trimester;2022QII;""
43 Tarragona;All ages;Cohort July 1;Males;Survival in the first trimester;2022QI;""
43 Tarragona;All ages;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
43 Tarragona;All ages;Cohort July 1;Males;Survival in the first trimester;2021QIII;30.077
43 Tarragona;All ages;Cohort July 1;Males;Survival in the first trimester;2021QII;""
43 Tarragona;All ages;Cohort July 1;Males;Survival in the first trimester;2021QI;""
43 Tarragona;All ages;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
43 Tarragona;All ages;Cohort July 1;Males;Survival in the first trimester;2020QIII;29.347
43 Tarragona;All ages;Cohort July 1;Males;Survival in the first trimester;2020QII;""
43 Tarragona;All ages;Cohort July 1;Males;Survival in the first trimester;2020QI;""
43 Tarragona;All ages;Cohort July 1;Males;Survival in the second trimester;2022QIV;28.718
43 Tarragona;All ages;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
43 Tarragona;All ages;Cohort July 1;Males;Survival in the second trimester;2022QII;""
43 Tarragona;All ages;Cohort July 1;Males;Survival in the second trimester;2022QI;""
43 Tarragona;All ages;Cohort July 1;Males;Survival in the second trimester;2021QIV;28.920
43 Tarragona;All ages;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
43 Tarragona;All ages;Cohort July 1;Males;Survival in the second trimester;2021QII;""
43 Tarragona;All ages;Cohort July 1;Males;Survival in the second trimester;2021QI;""
43 Tarragona;All ages;Cohort July 1;Males;Survival in the second trimester;2020QIV;28.238
43 Tarragona;All ages;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
43 Tarragona;All ages;Cohort July 1;Males;Survival in the second trimester;2020QII;""
43 Tarragona;All ages;Cohort July 1;Males;Survival in the second trimester;2020QI;""
43 Tarragona;All ages;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
43 Tarragona;All ages;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
43 Tarragona;All ages;Cohort July 1;Males;Survival in the third trimester;2022QII;""
43 Tarragona;All ages;Cohort July 1;Males;Survival in the third trimester;2022QI;28.012
43 Tarragona;All ages;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
43 Tarragona;All ages;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
43 Tarragona;All ages;Cohort July 1;Males;Survival in the third trimester;2021QII;""
43 Tarragona;All ages;Cohort July 1;Males;Survival in the third trimester;2021QI;27.624
43 Tarragona;All ages;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
43 Tarragona;All ages;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
43 Tarragona;All ages;Cohort July 1;Males;Survival in the third trimester;2020QII;""
43 Tarragona;All ages;Cohort July 1;Males;Survival in the third trimester;2020QI;""
43 Tarragona;All ages;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
43 Tarragona;All ages;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
43 Tarragona;All ages;Cohort July 1;Males;Survival in the third trimester;2022QII;27.252
43 Tarragona;All ages;Cohort July 1;Males;Survival in the third trimester;2022QI;""
43 Tarragona;All ages;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
43 Tarragona;All ages;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
43 Tarragona;All ages;Cohort July 1;Males;Survival in the third trimester;2021QII;26.968
43 Tarragona;All ages;Cohort July 1;Males;Survival in the third trimester;2021QI;""
43 Tarragona;All ages;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
43 Tarragona;All ages;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
43 Tarragona;All ages;Cohort July 1;Males;Survival in the third trimester;2020QII;""
43 Tarragona;All ages;Cohort July 1;Males;Survival in the third trimester;2020QI;""
43 Tarragona;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
43 Tarragona;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
43 Tarragona;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
43 Tarragona;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
43 Tarragona;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
43 Tarragona;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
43 Tarragona;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
43 Tarragona;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
43 Tarragona;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
43 Tarragona;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
43 Tarragona;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
43 Tarragona;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
43 Tarragona;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
43 Tarragona;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;96,31
43 Tarragona;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
43 Tarragona;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
43 Tarragona;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
43 Tarragona;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;96,55
43 Tarragona;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
43 Tarragona;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
43 Tarragona;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
43 Tarragona;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;96,13
43 Tarragona;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
43 Tarragona;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
43 Tarragona;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;92,15
43 Tarragona;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
43 Tarragona;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
43 Tarragona;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
43 Tarragona;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;92,84
43 Tarragona;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
43 Tarragona;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
43 Tarragona;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
43 Tarragona;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;92,5
43 Tarragona;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
43 Tarragona;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
43 Tarragona;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
43 Tarragona;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
43 Tarragona;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
43 Tarragona;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
43 Tarragona;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;89,92
43 Tarragona;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
43 Tarragona;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
43 Tarragona;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
43 Tarragona;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;90,49
43 Tarragona;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
43 Tarragona;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
43 Tarragona;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
43 Tarragona;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
43 Tarragona;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
43 Tarragona;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
43 Tarragona;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;87,48
43 Tarragona;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
43 Tarragona;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
43 Tarragona;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
43 Tarragona;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;88,34
43 Tarragona;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
43 Tarragona;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
43 Tarragona;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
43 Tarragona;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
43 Tarragona;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
43 Tarragona;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
43 Tarragona;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QIII;18.803
43 Tarragona;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
43 Tarragona;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
43 Tarragona;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
43 Tarragona;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QIII;18.643
43 Tarragona;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
43 Tarragona;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
43 Tarragona;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
43 Tarragona;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QIII;18.141
43 Tarragona;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
43 Tarragona;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
43 Tarragona;All ages;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
43 Tarragona;All ages;Cohort July 1;Females;Survival in the first trimester;2022QIII;17.949
43 Tarragona;All ages;Cohort July 1;Females;Survival in the first trimester;2022QII;""
43 Tarragona;All ages;Cohort July 1;Females;Survival in the first trimester;2022QI;""
43 Tarragona;All ages;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
43 Tarragona;All ages;Cohort July 1;Females;Survival in the first trimester;2021QIII;17.871
43 Tarragona;All ages;Cohort July 1;Females;Survival in the first trimester;2021QII;""
43 Tarragona;All ages;Cohort July 1;Females;Survival in the first trimester;2021QI;""
43 Tarragona;All ages;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
43 Tarragona;All ages;Cohort July 1;Females;Survival in the first trimester;2020QIII;17.301
43 Tarragona;All ages;Cohort July 1;Females;Survival in the first trimester;2020QII;""
43 Tarragona;All ages;Cohort July 1;Females;Survival in the first trimester;2020QI;""
43 Tarragona;All ages;Cohort July 1;Females;Survival in the second trimester;2022QIV;16.981
43 Tarragona;All ages;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
43 Tarragona;All ages;Cohort July 1;Females;Survival in the second trimester;2022QII;""
43 Tarragona;All ages;Cohort July 1;Females;Survival in the second trimester;2022QI;""
43 Tarragona;All ages;Cohort July 1;Females;Survival in the second trimester;2021QIV;17.072
43 Tarragona;All ages;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
43 Tarragona;All ages;Cohort July 1;Females;Survival in the second trimester;2021QII;""
43 Tarragona;All ages;Cohort July 1;Females;Survival in the second trimester;2021QI;""
43 Tarragona;All ages;Cohort July 1;Females;Survival in the second trimester;2020QIV;16.618
43 Tarragona;All ages;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
43 Tarragona;All ages;Cohort July 1;Females;Survival in the second trimester;2020QII;""
43 Tarragona;All ages;Cohort July 1;Females;Survival in the second trimester;2020QI;""
43 Tarragona;All ages;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
43 Tarragona;All ages;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
43 Tarragona;All ages;Cohort July 1;Females;Survival in the third trimester;2022QII;""
43 Tarragona;All ages;Cohort July 1;Females;Survival in the third trimester;2022QI;16.445
43 Tarragona;All ages;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
43 Tarragona;All ages;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
43 Tarragona;All ages;Cohort July 1;Females;Survival in the third trimester;2021QII;""
43 Tarragona;All ages;Cohort July 1;Females;Survival in the third trimester;2021QI;16.277
43 Tarragona;All ages;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
43 Tarragona;All ages;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
43 Tarragona;All ages;Cohort July 1;Females;Survival in the third trimester;2020QII;""
43 Tarragona;All ages;Cohort July 1;Females;Survival in the third trimester;2020QI;""
43 Tarragona;All ages;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
43 Tarragona;All ages;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
43 Tarragona;All ages;Cohort July 1;Females;Survival in the third trimester;2022QII;15.918
43 Tarragona;All ages;Cohort July 1;Females;Survival in the third trimester;2022QI;""
43 Tarragona;All ages;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
43 Tarragona;All ages;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
43 Tarragona;All ages;Cohort July 1;Females;Survival in the third trimester;2021QII;15.855
43 Tarragona;All ages;Cohort July 1;Females;Survival in the third trimester;2021QI;""
43 Tarragona;All ages;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
43 Tarragona;All ages;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
43 Tarragona;All ages;Cohort July 1;Females;Survival in the third trimester;2020QII;""
43 Tarragona;All ages;Cohort July 1;Females;Survival in the third trimester;2020QI;""
43 Tarragona;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
43 Tarragona;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
43 Tarragona;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
43 Tarragona;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
43 Tarragona;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
43 Tarragona;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
43 Tarragona;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
43 Tarragona;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
43 Tarragona;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
43 Tarragona;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
43 Tarragona;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
43 Tarragona;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
43 Tarragona;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
43 Tarragona;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;95,46
43 Tarragona;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
43 Tarragona;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
43 Tarragona;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
43 Tarragona;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;95,86
43 Tarragona;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
43 Tarragona;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
43 Tarragona;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
43 Tarragona;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;95,37
43 Tarragona;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
43 Tarragona;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
43 Tarragona;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;90,31
43 Tarragona;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
43 Tarragona;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
43 Tarragona;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
43 Tarragona;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;91,57
43 Tarragona;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
43 Tarragona;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
43 Tarragona;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
43 Tarragona;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;91,6
43 Tarragona;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
43 Tarragona;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
43 Tarragona;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
43 Tarragona;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
43 Tarragona;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
43 Tarragona;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
43 Tarragona;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;88,21
43 Tarragona;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
43 Tarragona;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
43 Tarragona;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
43 Tarragona;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;89,72
43 Tarragona;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
43 Tarragona;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
43 Tarragona;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
43 Tarragona;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
43 Tarragona;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
43 Tarragona;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
43 Tarragona;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;85,38
43 Tarragona;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
43 Tarragona;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
43 Tarragona;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
43 Tarragona;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;87,4
43 Tarragona;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
43 Tarragona;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
43 Tarragona;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
43 Tarragona;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
43 Tarragona;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
43 Tarragona;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QIV;49.671
43 Tarragona;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
43 Tarragona;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
43 Tarragona;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
43 Tarragona;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QIV;49.536
43 Tarragona;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
43 Tarragona;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
43 Tarragona;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
43 Tarragona;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QIV;48.536
43 Tarragona;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
43 Tarragona;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
43 Tarragona;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
43 Tarragona;All ages;Cohort October 1;Total;Survival in the first trimester;2022QIV;47.188
43 Tarragona;All ages;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
43 Tarragona;All ages;Cohort October 1;Total;Survival in the first trimester;2022QII;""
43 Tarragona;All ages;Cohort October 1;Total;Survival in the first trimester;2022QI;""
43 Tarragona;All ages;Cohort October 1;Total;Survival in the first trimester;2021QIV;47.357
43 Tarragona;All ages;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
43 Tarragona;All ages;Cohort October 1;Total;Survival in the first trimester;2021QII;""
43 Tarragona;All ages;Cohort October 1;Total;Survival in the first trimester;2021QI;""
43 Tarragona;All ages;Cohort October 1;Total;Survival in the first trimester;2020QIV;46.476
43 Tarragona;All ages;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
43 Tarragona;All ages;Cohort October 1;Total;Survival in the first trimester;2020QII;""
43 Tarragona;All ages;Cohort October 1;Total;Survival in the first trimester;2020QI;""
43 Tarragona;All ages;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
43 Tarragona;All ages;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
43 Tarragona;All ages;Cohort October 1;Total;Survival in the second trimester;2022QII;""
43 Tarragona;All ages;Cohort October 1;Total;Survival in the second trimester;2022QI;45.692
43 Tarragona;All ages;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
43 Tarragona;All ages;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
43 Tarragona;All ages;Cohort October 1;Total;Survival in the second trimester;2021QII;""
43 Tarragona;All ages;Cohort October 1;Total;Survival in the second trimester;2021QI;45.417
43 Tarragona;All ages;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
43 Tarragona;All ages;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
43 Tarragona;All ages;Cohort October 1;Total;Survival in the second trimester;2020QII;""
43 Tarragona;All ages;Cohort October 1;Total;Survival in the second trimester;2020QI;""
43 Tarragona;All ages;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
43 Tarragona;All ages;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
43 Tarragona;All ages;Cohort October 1;Total;Survival in the third trimester;2022QII;44.297
43 Tarragona;All ages;Cohort October 1;Total;Survival in the third trimester;2022QI;""
43 Tarragona;All ages;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
43 Tarragona;All ages;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
43 Tarragona;All ages;Cohort October 1;Total;Survival in the third trimester;2021QII;44.219
43 Tarragona;All ages;Cohort October 1;Total;Survival in the third trimester;2021QI;""
43 Tarragona;All ages;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
43 Tarragona;All ages;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
43 Tarragona;All ages;Cohort October 1;Total;Survival in the third trimester;2020QII;""
43 Tarragona;All ages;Cohort October 1;Total;Survival in the third trimester;2020QI;""
43 Tarragona;All ages;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
43 Tarragona;All ages;Cohort October 1;Total;Survival in the third trimester;2022QIII;43.049
43 Tarragona;All ages;Cohort October 1;Total;Survival in the third trimester;2022QII;""
43 Tarragona;All ages;Cohort October 1;Total;Survival in the third trimester;2022QI;""
43 Tarragona;All ages;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
43 Tarragona;All ages;Cohort October 1;Total;Survival in the third trimester;2021QIII;43.173
43 Tarragona;All ages;Cohort October 1;Total;Survival in the third trimester;2021QII;""
43 Tarragona;All ages;Cohort October 1;Total;Survival in the third trimester;2021QI;""
43 Tarragona;All ages;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
43 Tarragona;All ages;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
43 Tarragona;All ages;Cohort October 1;Total;Survival in the third trimester;2020QII;""
43 Tarragona;All ages;Cohort October 1;Total;Survival in the third trimester;2020QI;""
43 Tarragona;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
43 Tarragona;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
43 Tarragona;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
43 Tarragona;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
43 Tarragona;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
43 Tarragona;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
43 Tarragona;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
43 Tarragona;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
43 Tarragona;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
43 Tarragona;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
43 Tarragona;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
43 Tarragona;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
43 Tarragona;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;95
43 Tarragona;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
43 Tarragona;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
43 Tarragona;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
43 Tarragona;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;95,6
43 Tarragona;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
43 Tarragona;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
43 Tarragona;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
43 Tarragona;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;95,76
43 Tarragona;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
43 Tarragona;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
43 Tarragona;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
43 Tarragona;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
43 Tarragona;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
43 Tarragona;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
43 Tarragona;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;92,24
43 Tarragona;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
43 Tarragona;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
43 Tarragona;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
43 Tarragona;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;93,57
43 Tarragona;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
43 Tarragona;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
43 Tarragona;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
43 Tarragona;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
43 Tarragona;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
43 Tarragona;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
43 Tarragona;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;89,42
43 Tarragona;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
43 Tarragona;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
43 Tarragona;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
43 Tarragona;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;91,11
43 Tarragona;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
43 Tarragona;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
43 Tarragona;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
43 Tarragona;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
43 Tarragona;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
43 Tarragona;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
43 Tarragona;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;86,9
43 Tarragona;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
43 Tarragona;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
43 Tarragona;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
43 Tarragona;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;88,95
43 Tarragona;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
43 Tarragona;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
43 Tarragona;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
43 Tarragona;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
43 Tarragona;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
43 Tarragona;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
43 Tarragona;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QIV;30.994
43 Tarragona;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
43 Tarragona;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
43 Tarragona;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
43 Tarragona;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QIV;30.971
43 Tarragona;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
43 Tarragona;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
43 Tarragona;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
43 Tarragona;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QIV;30.493
43 Tarragona;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
43 Tarragona;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
43 Tarragona;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
43 Tarragona;All ages;Cohort October 1;Males;Survival in the first trimester;2022QIV;29.554
43 Tarragona;All ages;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
43 Tarragona;All ages;Cohort October 1;Males;Survival in the first trimester;2022QII;""
43 Tarragona;All ages;Cohort October 1;Males;Survival in the first trimester;2022QI;""
43 Tarragona;All ages;Cohort October 1;Males;Survival in the first trimester;2021QIV;29.687
43 Tarragona;All ages;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
43 Tarragona;All ages;Cohort October 1;Males;Survival in the first trimester;2021QII;""
43 Tarragona;All ages;Cohort October 1;Males;Survival in the first trimester;2021QI;""
43 Tarragona;All ages;Cohort October 1;Males;Survival in the first trimester;2020QIV;29.217
43 Tarragona;All ages;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
43 Tarragona;All ages;Cohort October 1;Males;Survival in the first trimester;2020QII;""
43 Tarragona;All ages;Cohort October 1;Males;Survival in the first trimester;2020QI;""
43 Tarragona;All ages;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
43 Tarragona;All ages;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
43 Tarragona;All ages;Cohort October 1;Males;Survival in the second trimester;2022QII;""
43 Tarragona;All ages;Cohort October 1;Males;Survival in the second trimester;2022QI;28.707
43 Tarragona;All ages;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
43 Tarragona;All ages;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
43 Tarragona;All ages;Cohort October 1;Males;Survival in the second trimester;2021QII;""
43 Tarragona;All ages;Cohort October 1;Males;Survival in the second trimester;2021QI;28.547
43 Tarragona;All ages;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
43 Tarragona;All ages;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
43 Tarragona;All ages;Cohort October 1;Males;Survival in the second trimester;2020QII;""
43 Tarragona;All ages;Cohort October 1;Males;Survival in the second trimester;2020QI;""
43 Tarragona;All ages;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
43 Tarragona;All ages;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
43 Tarragona;All ages;Cohort October 1;Males;Survival in the third trimester;2022QII;27.884
43 Tarragona;All ages;Cohort October 1;Males;Survival in the third trimester;2022QI;""
43 Tarragona;All ages;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
43 Tarragona;All ages;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
43 Tarragona;All ages;Cohort October 1;Males;Survival in the third trimester;2021QII;27.816
43 Tarragona;All ages;Cohort October 1;Males;Survival in the third trimester;2021QI;""
43 Tarragona;All ages;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
43 Tarragona;All ages;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
43 Tarragona;All ages;Cohort October 1;Males;Survival in the third trimester;2020QII;""
43 Tarragona;All ages;Cohort October 1;Males;Survival in the third trimester;2020QI;""
43 Tarragona;All ages;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
43 Tarragona;All ages;Cohort October 1;Males;Survival in the third trimester;2022QIII;27.161
43 Tarragona;All ages;Cohort October 1;Males;Survival in the third trimester;2022QII;""
43 Tarragona;All ages;Cohort October 1;Males;Survival in the third trimester;2022QI;""
43 Tarragona;All ages;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
43 Tarragona;All ages;Cohort October 1;Males;Survival in the third trimester;2021QIII;27.215
43 Tarragona;All ages;Cohort October 1;Males;Survival in the third trimester;2021QII;""
43 Tarragona;All ages;Cohort October 1;Males;Survival in the third trimester;2021QI;""
43 Tarragona;All ages;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
43 Tarragona;All ages;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
43 Tarragona;All ages;Cohort October 1;Males;Survival in the third trimester;2020QII;""
43 Tarragona;All ages;Cohort October 1;Males;Survival in the third trimester;2020QI;""
43 Tarragona;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
43 Tarragona;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
43 Tarragona;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
43 Tarragona;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
43 Tarragona;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
43 Tarragona;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
43 Tarragona;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
43 Tarragona;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
43 Tarragona;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
43 Tarragona;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
43 Tarragona;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
43 Tarragona;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
43 Tarragona;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;95,35
43 Tarragona;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
43 Tarragona;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
43 Tarragona;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
43 Tarragona;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;95,85
43 Tarragona;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
43 Tarragona;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
43 Tarragona;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
43 Tarragona;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;95,82
43 Tarragona;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
43 Tarragona;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
43 Tarragona;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
43 Tarragona;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
43 Tarragona;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
43 Tarragona;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
43 Tarragona;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;92,69
43 Tarragona;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
43 Tarragona;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
43 Tarragona;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
43 Tarragona;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;93,62
43 Tarragona;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
43 Tarragona;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
43 Tarragona;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
43 Tarragona;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
43 Tarragona;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
43 Tarragona;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
43 Tarragona;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;90,03
43 Tarragona;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
43 Tarragona;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
43 Tarragona;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
43 Tarragona;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;91,22
43 Tarragona;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
43 Tarragona;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
43 Tarragona;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
43 Tarragona;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
43 Tarragona;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
43 Tarragona;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
43 Tarragona;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;87,7
43 Tarragona;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
43 Tarragona;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
43 Tarragona;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
43 Tarragona;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;89,25
43 Tarragona;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
43 Tarragona;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
43 Tarragona;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
43 Tarragona;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
43 Tarragona;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
43 Tarragona;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
43 Tarragona;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QIV;18.677
43 Tarragona;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
43 Tarragona;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
43 Tarragona;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
43 Tarragona;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QIV;18.565
43 Tarragona;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
43 Tarragona;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
43 Tarragona;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
43 Tarragona;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QIV;18.043
43 Tarragona;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
43 Tarragona;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
43 Tarragona;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
43 Tarragona;All ages;Cohort October 1;Females;Survival in the first trimester;2022QIV;17.634
43 Tarragona;All ages;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
43 Tarragona;All ages;Cohort October 1;Females;Survival in the first trimester;2022QII;""
43 Tarragona;All ages;Cohort October 1;Females;Survival in the first trimester;2022QI;""
43 Tarragona;All ages;Cohort October 1;Females;Survival in the first trimester;2021QIV;17.670
43 Tarragona;All ages;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
43 Tarragona;All ages;Cohort October 1;Females;Survival in the first trimester;2021QII;""
43 Tarragona;All ages;Cohort October 1;Females;Survival in the first trimester;2021QI;""
43 Tarragona;All ages;Cohort October 1;Females;Survival in the first trimester;2020QIV;17.259
43 Tarragona;All ages;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
43 Tarragona;All ages;Cohort October 1;Females;Survival in the first trimester;2020QII;""
43 Tarragona;All ages;Cohort October 1;Females;Survival in the first trimester;2020QI;""
43 Tarragona;All ages;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
43 Tarragona;All ages;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
43 Tarragona;All ages;Cohort October 1;Females;Survival in the second trimester;2022QII;""
43 Tarragona;All ages;Cohort October 1;Females;Survival in the second trimester;2022QI;16.985
43 Tarragona;All ages;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
43 Tarragona;All ages;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
43 Tarragona;All ages;Cohort October 1;Females;Survival in the second trimester;2021QII;""
43 Tarragona;All ages;Cohort October 1;Females;Survival in the second trimester;2021QI;16.870
43 Tarragona;All ages;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
43 Tarragona;All ages;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
43 Tarragona;All ages;Cohort October 1;Females;Survival in the second trimester;2020QII;""
43 Tarragona;All ages;Cohort October 1;Females;Survival in the second trimester;2020QI;""
43 Tarragona;All ages;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
43 Tarragona;All ages;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
43 Tarragona;All ages;Cohort October 1;Females;Survival in the third trimester;2022QII;16.413
43 Tarragona;All ages;Cohort October 1;Females;Survival in the third trimester;2022QI;""
43 Tarragona;All ages;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
43 Tarragona;All ages;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
43 Tarragona;All ages;Cohort October 1;Females;Survival in the third trimester;2021QII;16.403
43 Tarragona;All ages;Cohort October 1;Females;Survival in the third trimester;2021QI;""
43 Tarragona;All ages;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
43 Tarragona;All ages;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
43 Tarragona;All ages;Cohort October 1;Females;Survival in the third trimester;2020QII;""
43 Tarragona;All ages;Cohort October 1;Females;Survival in the third trimester;2020QI;""
43 Tarragona;All ages;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
43 Tarragona;All ages;Cohort October 1;Females;Survival in the third trimester;2022QIII;15.888
43 Tarragona;All ages;Cohort October 1;Females;Survival in the third trimester;2022QII;""
43 Tarragona;All ages;Cohort October 1;Females;Survival in the third trimester;2022QI;""
43 Tarragona;All ages;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
43 Tarragona;All ages;Cohort October 1;Females;Survival in the third trimester;2021QIII;15.958
43 Tarragona;All ages;Cohort October 1;Females;Survival in the third trimester;2021QII;""
43 Tarragona;All ages;Cohort October 1;Females;Survival in the third trimester;2021QI;""
43 Tarragona;All ages;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
43 Tarragona;All ages;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
43 Tarragona;All ages;Cohort October 1;Females;Survival in the third trimester;2020QII;""
43 Tarragona;All ages;Cohort October 1;Females;Survival in the third trimester;2020QI;""
43 Tarragona;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
43 Tarragona;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
43 Tarragona;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
43 Tarragona;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
43 Tarragona;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
43 Tarragona;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
43 Tarragona;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
43 Tarragona;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
43 Tarragona;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
43 Tarragona;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
43 Tarragona;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
43 Tarragona;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
43 Tarragona;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;94,42
43 Tarragona;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
43 Tarragona;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
43 Tarragona;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
43 Tarragona;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;95,18
43 Tarragona;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
43 Tarragona;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
43 Tarragona;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
43 Tarragona;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;95,65
43 Tarragona;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
43 Tarragona;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
43 Tarragona;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
43 Tarragona;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
43 Tarragona;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
43 Tarragona;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
43 Tarragona;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;91,49
43 Tarragona;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
43 Tarragona;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
43 Tarragona;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
43 Tarragona;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;93,5
43 Tarragona;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
43 Tarragona;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
43 Tarragona;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
43 Tarragona;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
43 Tarragona;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
43 Tarragona;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
43 Tarragona;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;88,41
43 Tarragona;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
43 Tarragona;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
43 Tarragona;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
43 Tarragona;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;90,91
43 Tarragona;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
43 Tarragona;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
43 Tarragona;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
43 Tarragona;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
43 Tarragona;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
43 Tarragona;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
43 Tarragona;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;85,58
43 Tarragona;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
43 Tarragona;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
43 Tarragona;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
43 Tarragona;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;88,44
43 Tarragona;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
43 Tarragona;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
43 Tarragona;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
43 Tarragona;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
43 Tarragona;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
43 Tarragona;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
43 Tarragona;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
43 Tarragona;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
43 Tarragona;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
43 Tarragona;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QI;3.426
43 Tarragona;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
43 Tarragona;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
43 Tarragona;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
43 Tarragona;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QI;3.237
43 Tarragona;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
43 Tarragona;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
43 Tarragona;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
43 Tarragona;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QI;2.625
43 Tarragona;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
43 Tarragona;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
43 Tarragona;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2022QII;""
43 Tarragona;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2022QI;3.138
43 Tarragona;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
43 Tarragona;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
43 Tarragona;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2021QII;""
43 Tarragona;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2021QI;3.087
43 Tarragona;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
43 Tarragona;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
43 Tarragona;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2020QII;""
43 Tarragona;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2020QI;2.298
43 Tarragona;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
43 Tarragona;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
43 Tarragona;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2022QII;2.903
43 Tarragona;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2022QI;""
43 Tarragona;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
43 Tarragona;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
43 Tarragona;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2021QII;2.893
43 Tarragona;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2021QI;""
43 Tarragona;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
43 Tarragona;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
43 Tarragona;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2020QII;2.210
43 Tarragona;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2020QI;""
43 Tarragona;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
43 Tarragona;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QIII;2.724
43 Tarragona;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QII;""
43 Tarragona;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QI;""
43 Tarragona;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
43 Tarragona;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QIII;2.689
43 Tarragona;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QII;""
43 Tarragona;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QI;""
43 Tarragona;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
43 Tarragona;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QIII;2.083
43 Tarragona;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QII;""
43 Tarragona;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QI;""
43 Tarragona;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QIV;2.542
43 Tarragona;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
43 Tarragona;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QII;""
43 Tarragona;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QI;""
43 Tarragona;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QIV;2.507
43 Tarragona;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
43 Tarragona;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QII;""
43 Tarragona;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QI;""
43 Tarragona;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QIV;1.947
43 Tarragona;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
43 Tarragona;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QII;""
43 Tarragona;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QI;""
43 Tarragona;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
43 Tarragona;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
43 Tarragona;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
43 Tarragona;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
43 Tarragona;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
43 Tarragona;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
43 Tarragona;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
43 Tarragona;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
43 Tarragona;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
43 Tarragona;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
43 Tarragona;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
43 Tarragona;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
43 Tarragona;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
43 Tarragona;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
43 Tarragona;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
43 Tarragona;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;91,59
43 Tarragona;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
43 Tarragona;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
43 Tarragona;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
43 Tarragona;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;95,37
43 Tarragona;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
43 Tarragona;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
43 Tarragona;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
43 Tarragona;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;87,54
43 Tarragona;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
43 Tarragona;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
43 Tarragona;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;84,73
43 Tarragona;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
43 Tarragona;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
43 Tarragona;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
43 Tarragona;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;89,37
43 Tarragona;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
43 Tarragona;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
43 Tarragona;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
43 Tarragona;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;84,19
43 Tarragona;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
43 Tarragona;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
43 Tarragona;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;79,51
43 Tarragona;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
43 Tarragona;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
43 Tarragona;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
43 Tarragona;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;83,07
43 Tarragona;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
43 Tarragona;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
43 Tarragona;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
43 Tarragona;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;79,35
43 Tarragona;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
43 Tarragona;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
43 Tarragona;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;74,2
43 Tarragona;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
43 Tarragona;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
43 Tarragona;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
43 Tarragona;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;77,45
43 Tarragona;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
43 Tarragona;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
43 Tarragona;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
43 Tarragona;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;74,17
43 Tarragona;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
43 Tarragona;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
43 Tarragona;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
43 Tarragona;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
43 Tarragona;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
43 Tarragona;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
43 Tarragona;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QI;2.169
43 Tarragona;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
43 Tarragona;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
43 Tarragona;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
43 Tarragona;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QI;2.055
43 Tarragona;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
43 Tarragona;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
43 Tarragona;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
43 Tarragona;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QI;1.675
43 Tarragona;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
43 Tarragona;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
43 Tarragona;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2022QII;""
43 Tarragona;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2022QI;1.991
43 Tarragona;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
43 Tarragona;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
43 Tarragona;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2021QII;""
43 Tarragona;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2021QI;1.958
43 Tarragona;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
43 Tarragona;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
43 Tarragona;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2020QII;""
43 Tarragona;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2020QI;1.467
43 Tarragona;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
43 Tarragona;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
43 Tarragona;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2022QII;1.843
43 Tarragona;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2022QI;""
43 Tarragona;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
43 Tarragona;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
43 Tarragona;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2021QII;1.829
43 Tarragona;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2021QI;""
43 Tarragona;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
43 Tarragona;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
43 Tarragona;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2020QII;1.409
43 Tarragona;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2020QI;""
43 Tarragona;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
43 Tarragona;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QIII;1.743
43 Tarragona;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QII;""
43 Tarragona;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QI;""
43 Tarragona;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
43 Tarragona;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QIII;1.702
43 Tarragona;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QII;""
43 Tarragona;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QI;""
43 Tarragona;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
43 Tarragona;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QIII;1.341
43 Tarragona;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QII;""
43 Tarragona;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QI;""
43 Tarragona;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QIV;1.643
43 Tarragona;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
43 Tarragona;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QII;""
43 Tarragona;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QI;""
43 Tarragona;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QIV;1.600
43 Tarragona;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
43 Tarragona;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QII;""
43 Tarragona;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QI;""
43 Tarragona;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QIV;1.263
43 Tarragona;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
43 Tarragona;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QII;""
43 Tarragona;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QI;""
43 Tarragona;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
43 Tarragona;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
43 Tarragona;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
43 Tarragona;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
43 Tarragona;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
43 Tarragona;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
43 Tarragona;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
43 Tarragona;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
43 Tarragona;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
43 Tarragona;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
43 Tarragona;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
43 Tarragona;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
43 Tarragona;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
43 Tarragona;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
43 Tarragona;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
43 Tarragona;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;91,79
43 Tarragona;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
43 Tarragona;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
43 Tarragona;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
43 Tarragona;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;95,28
43 Tarragona;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
43 Tarragona;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
43 Tarragona;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
43 Tarragona;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;87,58
43 Tarragona;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
43 Tarragona;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
43 Tarragona;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;84,97
43 Tarragona;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
43 Tarragona;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
43 Tarragona;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
43 Tarragona;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;89
43 Tarragona;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
43 Tarragona;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
43 Tarragona;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
43 Tarragona;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;84,12
43 Tarragona;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
43 Tarragona;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
43 Tarragona;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;80,36
43 Tarragona;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
43 Tarragona;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
43 Tarragona;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
43 Tarragona;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;82,82
43 Tarragona;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
43 Tarragona;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
43 Tarragona;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
43 Tarragona;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;80,06
43 Tarragona;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
43 Tarragona;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
43 Tarragona;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;75,75
43 Tarragona;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
43 Tarragona;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
43 Tarragona;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
43 Tarragona;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;77,86
43 Tarragona;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
43 Tarragona;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
43 Tarragona;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
43 Tarragona;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;75,4
43 Tarragona;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
43 Tarragona;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
43 Tarragona;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
43 Tarragona;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
43 Tarragona;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
43 Tarragona;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
43 Tarragona;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QI;1.257
43 Tarragona;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
43 Tarragona;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
43 Tarragona;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
43 Tarragona;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QI;1.182
43 Tarragona;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
43 Tarragona;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
43 Tarragona;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
43 Tarragona;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QI;950
43 Tarragona;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
43 Tarragona;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
43 Tarragona;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2022QII;""
43 Tarragona;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2022QI;1.147
43 Tarragona;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
43 Tarragona;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
43 Tarragona;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2021QII;""
43 Tarragona;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2021QI;1.129
43 Tarragona;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
43 Tarragona;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
43 Tarragona;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2020QII;""
43 Tarragona;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2020QI;831
43 Tarragona;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
43 Tarragona;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
43 Tarragona;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2022QII;1.060
43 Tarragona;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2022QI;""
43 Tarragona;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
43 Tarragona;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
43 Tarragona;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2021QII;1.064
43 Tarragona;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2021QI;""
43 Tarragona;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
43 Tarragona;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
43 Tarragona;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2020QII;801
43 Tarragona;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2020QI;""
43 Tarragona;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
43 Tarragona;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QIII;981
43 Tarragona;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QII;""
43 Tarragona;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QI;""
43 Tarragona;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
43 Tarragona;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QIII;987
43 Tarragona;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QII;""
43 Tarragona;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QI;""
43 Tarragona;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
43 Tarragona;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QIII;742
43 Tarragona;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QII;""
43 Tarragona;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QI;""
43 Tarragona;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QIV;899
43 Tarragona;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
43 Tarragona;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QII;""
43 Tarragona;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QI;""
43 Tarragona;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QIV;907
43 Tarragona;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
43 Tarragona;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QII;""
43 Tarragona;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QI;""
43 Tarragona;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QIV;684
43 Tarragona;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
43 Tarragona;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QII;""
43 Tarragona;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QI;""
43 Tarragona;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
43 Tarragona;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
43 Tarragona;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
43 Tarragona;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
43 Tarragona;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
43 Tarragona;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
43 Tarragona;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
43 Tarragona;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
43 Tarragona;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
43 Tarragona;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
43 Tarragona;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
43 Tarragona;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
43 Tarragona;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
43 Tarragona;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
43 Tarragona;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
43 Tarragona;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;91,25
43 Tarragona;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
43 Tarragona;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
43 Tarragona;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
43 Tarragona;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;95,52
43 Tarragona;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
43 Tarragona;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
43 Tarragona;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
43 Tarragona;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;87,47
43 Tarragona;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
43 Tarragona;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
43 Tarragona;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;84,33
43 Tarragona;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
43 Tarragona;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
43 Tarragona;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
43 Tarragona;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;90,02
43 Tarragona;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
43 Tarragona;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
43 Tarragona;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
43 Tarragona;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;84,32
43 Tarragona;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
43 Tarragona;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
43 Tarragona;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;78,04
43 Tarragona;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
43 Tarragona;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
43 Tarragona;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
43 Tarragona;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;83,5
43 Tarragona;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
43 Tarragona;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
43 Tarragona;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
43 Tarragona;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;78,11
43 Tarragona;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
43 Tarragona;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
43 Tarragona;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;71,52
43 Tarragona;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
43 Tarragona;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
43 Tarragona;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
43 Tarragona;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;76,73
43 Tarragona;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
43 Tarragona;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
43 Tarragona;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
43 Tarragona;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;72
43 Tarragona;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
43 Tarragona;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
43 Tarragona;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
43 Tarragona;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
43 Tarragona;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
43 Tarragona;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QII;3.046
43 Tarragona;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
43 Tarragona;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
43 Tarragona;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
43 Tarragona;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QII;2.984
43 Tarragona;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
43 Tarragona;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
43 Tarragona;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
43 Tarragona;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QII;2.675
43 Tarragona;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
43 Tarragona;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
43 Tarragona;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
43 Tarragona;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2022QII;2.789
43 Tarragona;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2022QI;""
43 Tarragona;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
43 Tarragona;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
43 Tarragona;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2021QII;2.761
43 Tarragona;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2021QI;""
43 Tarragona;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
43 Tarragona;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
43 Tarragona;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2020QII;2.559
43 Tarragona;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2020QI;""
43 Tarragona;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
43 Tarragona;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2022QIII;2.599
43 Tarragona;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2022QII;""
43 Tarragona;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2022QI;""
43 Tarragona;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
43 Tarragona;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2021QIII;2.529
43 Tarragona;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2021QII;""
43 Tarragona;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2021QI;""
43 Tarragona;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
43 Tarragona;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2020QIII;2.398
43 Tarragona;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2020QII;""
43 Tarragona;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2020QI;""
43 Tarragona;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QIV;2.409
43 Tarragona;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
43 Tarragona;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QII;""
43 Tarragona;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QI;""
43 Tarragona;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QIV;2.328
43 Tarragona;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
43 Tarragona;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QII;""
43 Tarragona;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QI;""
43 Tarragona;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QIV;2.234
43 Tarragona;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
43 Tarragona;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QII;""
43 Tarragona;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QI;""
43 Tarragona;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
43 Tarragona;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
43 Tarragona;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QII;""
43 Tarragona;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QI;2.151
43 Tarragona;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
43 Tarragona;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
43 Tarragona;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QII;""
43 Tarragona;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QI;2.147
43 Tarragona;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
43 Tarragona;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
43 Tarragona;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QII;""
43 Tarragona;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QI;""
43 Tarragona;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
43 Tarragona;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
43 Tarragona;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
43 Tarragona;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
43 Tarragona;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
43 Tarragona;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
43 Tarragona;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
43 Tarragona;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
43 Tarragona;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
43 Tarragona;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
43 Tarragona;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
43 Tarragona;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
43 Tarragona;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
43 Tarragona;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
43 Tarragona;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;91,56
43 Tarragona;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
43 Tarragona;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
43 Tarragona;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
43 Tarragona;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;92,53
43 Tarragona;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
43 Tarragona;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
43 Tarragona;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
43 Tarragona;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;95,66
43 Tarragona;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
43 Tarragona;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
43 Tarragona;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;85,33
43 Tarragona;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
43 Tarragona;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
43 Tarragona;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
43 Tarragona;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;84,75
43 Tarragona;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
43 Tarragona;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
43 Tarragona;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
43 Tarragona;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;89,64
43 Tarragona;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
43 Tarragona;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
43 Tarragona;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;79,09
43 Tarragona;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
43 Tarragona;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
43 Tarragona;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
43 Tarragona;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;78,02
43 Tarragona;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
43 Tarragona;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
43 Tarragona;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
43 Tarragona;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;83,51
43 Tarragona;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
43 Tarragona;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
43 Tarragona;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
43 Tarragona;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
43 Tarragona;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
43 Tarragona;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
43 Tarragona;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;72,08
43 Tarragona;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
43 Tarragona;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
43 Tarragona;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
43 Tarragona;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;80,26
43 Tarragona;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
43 Tarragona;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
43 Tarragona;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
43 Tarragona;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
43 Tarragona;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
43 Tarragona;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
43 Tarragona;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QII;1.952
43 Tarragona;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
43 Tarragona;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
43 Tarragona;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
43 Tarragona;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QII;1.907
43 Tarragona;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
43 Tarragona;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
43 Tarragona;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
43 Tarragona;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QII;1.708
43 Tarragona;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
43 Tarragona;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
43 Tarragona;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
43 Tarragona;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2022QII;1.787
43 Tarragona;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2022QI;""
43 Tarragona;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
43 Tarragona;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
43 Tarragona;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2021QII;1.760
43 Tarragona;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2021QI;""
43 Tarragona;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
43 Tarragona;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
43 Tarragona;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2020QII;1.629
43 Tarragona;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2020QI;""
43 Tarragona;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
43 Tarragona;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2022QIII;1.678
43 Tarragona;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2022QII;""
43 Tarragona;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2022QI;""
43 Tarragona;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
43 Tarragona;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2021QIII;1.613
43 Tarragona;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2021QII;""
43 Tarragona;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2021QI;""
43 Tarragona;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
43 Tarragona;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2020QIII;1.540
43 Tarragona;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2020QII;""
43 Tarragona;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2020QI;""
43 Tarragona;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QIV;1.572
43 Tarragona;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
43 Tarragona;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QII;""
43 Tarragona;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QI;""
43 Tarragona;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QIV;1.498
43 Tarragona;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
43 Tarragona;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QII;""
43 Tarragona;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QI;""
43 Tarragona;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QIV;1.444
43 Tarragona;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
43 Tarragona;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QII;""
43 Tarragona;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QI;""
43 Tarragona;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
43 Tarragona;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
43 Tarragona;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QII;""
43 Tarragona;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QI;1.393
43 Tarragona;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
43 Tarragona;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
43 Tarragona;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QII;""
43 Tarragona;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QI;1.384
43 Tarragona;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
43 Tarragona;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
43 Tarragona;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QII;""
43 Tarragona;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QI;""
43 Tarragona;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
43 Tarragona;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
43 Tarragona;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
43 Tarragona;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
43 Tarragona;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
43 Tarragona;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
43 Tarragona;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
43 Tarragona;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
43 Tarragona;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
43 Tarragona;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
43 Tarragona;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
43 Tarragona;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
43 Tarragona;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
43 Tarragona;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
43 Tarragona;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;91,55
43 Tarragona;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
43 Tarragona;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
43 Tarragona;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
43 Tarragona;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;92,29
43 Tarragona;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
43 Tarragona;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
43 Tarragona;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
43 Tarragona;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;95,37
43 Tarragona;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
43 Tarragona;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
43 Tarragona;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;85,96
43 Tarragona;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
43 Tarragona;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
43 Tarragona;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
43 Tarragona;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;84,58
43 Tarragona;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
43 Tarragona;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
43 Tarragona;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
43 Tarragona;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;90,16
43 Tarragona;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
43 Tarragona;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
43 Tarragona;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;80,53
43 Tarragona;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
43 Tarragona;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
43 Tarragona;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
43 Tarragona;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;78,55
43 Tarragona;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
43 Tarragona;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
43 Tarragona;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
43 Tarragona;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;84,54
43 Tarragona;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
43 Tarragona;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
43 Tarragona;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
43 Tarragona;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
43 Tarragona;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
43 Tarragona;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
43 Tarragona;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;73,05
43 Tarragona;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
43 Tarragona;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
43 Tarragona;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
43 Tarragona;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;81,03
43 Tarragona;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
43 Tarragona;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
43 Tarragona;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
43 Tarragona;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
43 Tarragona;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
43 Tarragona;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
43 Tarragona;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QII;1.094
43 Tarragona;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
43 Tarragona;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
43 Tarragona;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
43 Tarragona;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QII;1.077
43 Tarragona;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
43 Tarragona;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
43 Tarragona;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
43 Tarragona;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QII;967
43 Tarragona;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
43 Tarragona;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
43 Tarragona;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
43 Tarragona;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2022QII;1.002
43 Tarragona;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2022QI;""
43 Tarragona;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
43 Tarragona;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
43 Tarragona;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2021QII;1.001
43 Tarragona;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2021QI;""
43 Tarragona;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
43 Tarragona;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
43 Tarragona;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2020QII;930
43 Tarragona;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2020QI;""
43 Tarragona;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
43 Tarragona;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2022QIII;921
43 Tarragona;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2022QII;""
43 Tarragona;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2022QI;""
43 Tarragona;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
43 Tarragona;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2021QIII;916
43 Tarragona;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2021QII;""
43 Tarragona;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2021QI;""
43 Tarragona;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
43 Tarragona;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2020QIII;858
43 Tarragona;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2020QII;""
43 Tarragona;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2020QI;""
43 Tarragona;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QIV;837
43 Tarragona;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
43 Tarragona;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QII;""
43 Tarragona;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QI;""
43 Tarragona;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QIV;830
43 Tarragona;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
43 Tarragona;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QII;""
43 Tarragona;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QI;""
43 Tarragona;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QIV;790
43 Tarragona;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
43 Tarragona;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QII;""
43 Tarragona;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QI;""
43 Tarragona;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
43 Tarragona;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
43 Tarragona;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QII;""
43 Tarragona;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QI;758
43 Tarragona;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
43 Tarragona;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
43 Tarragona;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QII;""
43 Tarragona;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QI;763
43 Tarragona;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
43 Tarragona;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
43 Tarragona;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QII;""
43 Tarragona;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QI;""
43 Tarragona;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
43 Tarragona;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
43 Tarragona;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
43 Tarragona;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
43 Tarragona;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
43 Tarragona;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
43 Tarragona;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
43 Tarragona;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
43 Tarragona;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
43 Tarragona;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
43 Tarragona;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
43 Tarragona;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
43 Tarragona;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
43 Tarragona;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
43 Tarragona;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;91,59
43 Tarragona;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
43 Tarragona;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
43 Tarragona;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
43 Tarragona;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;92,94
43 Tarragona;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
43 Tarragona;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
43 Tarragona;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
43 Tarragona;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;96,17
43 Tarragona;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
43 Tarragona;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
43 Tarragona;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;84,19
43 Tarragona;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
43 Tarragona;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
43 Tarragona;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
43 Tarragona;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;85,05
43 Tarragona;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
43 Tarragona;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
43 Tarragona;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
43 Tarragona;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;88,73
43 Tarragona;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
43 Tarragona;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
43 Tarragona;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;76,51
43 Tarragona;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
43 Tarragona;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
43 Tarragona;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
43 Tarragona;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;77,07
43 Tarragona;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
43 Tarragona;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
43 Tarragona;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
43 Tarragona;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;81,7
43 Tarragona;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
43 Tarragona;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
43 Tarragona;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
43 Tarragona;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
43 Tarragona;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
43 Tarragona;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
43 Tarragona;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;70,38
43 Tarragona;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
43 Tarragona;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
43 Tarragona;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
43 Tarragona;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;78,9
43 Tarragona;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
43 Tarragona;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
43 Tarragona;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
43 Tarragona;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
43 Tarragona;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
43 Tarragona;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QIII;3.315
43 Tarragona;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
43 Tarragona;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
43 Tarragona;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
43 Tarragona;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QIII;3.254
43 Tarragona;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
43 Tarragona;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
43 Tarragona;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
43 Tarragona;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QIII;2.908
43 Tarragona;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
43 Tarragona;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
43 Tarragona;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
43 Tarragona;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2022QIII;3.002
43 Tarragona;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2022QII;""
43 Tarragona;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2022QI;""
43 Tarragona;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
43 Tarragona;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2021QIII;2.902
43 Tarragona;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2021QII;""
43 Tarragona;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2021QI;""
43 Tarragona;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
43 Tarragona;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2020QIII;2.654
43 Tarragona;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2020QII;""
43 Tarragona;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2020QI;""
43 Tarragona;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2022QIV;2.743
43 Tarragona;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
43 Tarragona;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2022QII;""
43 Tarragona;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2022QI;""
43 Tarragona;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2021QIV;2.661
43 Tarragona;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
43 Tarragona;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2021QII;""
43 Tarragona;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2021QI;""
43 Tarragona;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2020QIV;2.453
43 Tarragona;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
43 Tarragona;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2020QII;""
43 Tarragona;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2020QI;""
43 Tarragona;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
43 Tarragona;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
43 Tarragona;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QII;""
43 Tarragona;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QI;2.456
43 Tarragona;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
43 Tarragona;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
43 Tarragona;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QII;""
43 Tarragona;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QI;2.349
43 Tarragona;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
43 Tarragona;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
43 Tarragona;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QII;""
43 Tarragona;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QI;""
43 Tarragona;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
43 Tarragona;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
43 Tarragona;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QII;2.286
43 Tarragona;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QI;""
43 Tarragona;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
43 Tarragona;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
43 Tarragona;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QII;2.233
43 Tarragona;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QI;""
43 Tarragona;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
43 Tarragona;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
43 Tarragona;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QII;""
43 Tarragona;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QI;""
43 Tarragona;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
43 Tarragona;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
43 Tarragona;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
43 Tarragona;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
43 Tarragona;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
43 Tarragona;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
43 Tarragona;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
43 Tarragona;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
43 Tarragona;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
43 Tarragona;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
43 Tarragona;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
43 Tarragona;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
43 Tarragona;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
43 Tarragona;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;90,56
43 Tarragona;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
43 Tarragona;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
43 Tarragona;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
43 Tarragona;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;89,18
43 Tarragona;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
43 Tarragona;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
43 Tarragona;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
43 Tarragona;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;91,27
43 Tarragona;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
43 Tarragona;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
43 Tarragona;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;82,75
43 Tarragona;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
43 Tarragona;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
43 Tarragona;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
43 Tarragona;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;81,78
43 Tarragona;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
43 Tarragona;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
43 Tarragona;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
43 Tarragona;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;84,35
43 Tarragona;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
43 Tarragona;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
43 Tarragona;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
43 Tarragona;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
43 Tarragona;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
43 Tarragona;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
43 Tarragona;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;75,48
43 Tarragona;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
43 Tarragona;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
43 Tarragona;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
43 Tarragona;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;80,78
43 Tarragona;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
43 Tarragona;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
43 Tarragona;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
43 Tarragona;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
43 Tarragona;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
43 Tarragona;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
43 Tarragona;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;70,25
43 Tarragona;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
43 Tarragona;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
43 Tarragona;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
43 Tarragona;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;76,79
43 Tarragona;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
43 Tarragona;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
43 Tarragona;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
43 Tarragona;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
43 Tarragona;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
43 Tarragona;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
43 Tarragona;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QIII;2.118
43 Tarragona;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
43 Tarragona;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
43 Tarragona;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
43 Tarragona;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QIII;2.070
43 Tarragona;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
43 Tarragona;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
43 Tarragona;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
43 Tarragona;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QIII;1.836
43 Tarragona;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
43 Tarragona;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
43 Tarragona;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
43 Tarragona;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2022QIII;1.935
43 Tarragona;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2022QII;""
43 Tarragona;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2022QI;""
43 Tarragona;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
43 Tarragona;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2021QIII;1.853
43 Tarragona;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2021QII;""
43 Tarragona;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2021QI;""
43 Tarragona;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
43 Tarragona;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2020QIII;1.703
43 Tarragona;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2020QII;""
43 Tarragona;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2020QI;""
43 Tarragona;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2022QIV;1.782
43 Tarragona;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
43 Tarragona;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2022QII;""
43 Tarragona;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2022QI;""
43 Tarragona;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2021QIV;1.711
43 Tarragona;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
43 Tarragona;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2021QII;""
43 Tarragona;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2021QI;""
43 Tarragona;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2020QIV;1.580
43 Tarragona;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
43 Tarragona;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2020QII;""
43 Tarragona;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2020QI;""
43 Tarragona;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
43 Tarragona;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
43 Tarragona;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QII;""
43 Tarragona;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QI;1.587
43 Tarragona;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
43 Tarragona;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
43 Tarragona;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QII;""
43 Tarragona;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QI;1.512
43 Tarragona;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
43 Tarragona;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
43 Tarragona;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QII;""
43 Tarragona;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QI;""
43 Tarragona;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
43 Tarragona;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
43 Tarragona;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QII;1.480
43 Tarragona;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QI;""
43 Tarragona;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
43 Tarragona;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
43 Tarragona;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QII;1.436
43 Tarragona;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QI;""
43 Tarragona;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
43 Tarragona;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
43 Tarragona;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QII;""
43 Tarragona;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QI;""
43 Tarragona;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
43 Tarragona;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
43 Tarragona;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
43 Tarragona;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
43 Tarragona;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
43 Tarragona;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
43 Tarragona;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
43 Tarragona;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
43 Tarragona;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
43 Tarragona;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
43 Tarragona;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
43 Tarragona;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
43 Tarragona;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
43 Tarragona;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;91,36
43 Tarragona;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
43 Tarragona;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
43 Tarragona;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
43 Tarragona;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;89,52
43 Tarragona;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
43 Tarragona;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
43 Tarragona;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
43 Tarragona;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;92,76
43 Tarragona;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
43 Tarragona;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
43 Tarragona;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;84,14
43 Tarragona;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
43 Tarragona;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
43 Tarragona;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
43 Tarragona;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;82,66
43 Tarragona;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
43 Tarragona;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
43 Tarragona;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
43 Tarragona;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;86,06
43 Tarragona;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
43 Tarragona;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
43 Tarragona;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
43 Tarragona;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
43 Tarragona;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
43 Tarragona;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
43 Tarragona;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;76,67
43 Tarragona;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
43 Tarragona;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
43 Tarragona;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
43 Tarragona;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;82,35
43 Tarragona;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
43 Tarragona;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
43 Tarragona;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
43 Tarragona;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
43 Tarragona;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
43 Tarragona;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
43 Tarragona;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;71,5
43 Tarragona;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
43 Tarragona;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
43 Tarragona;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
43 Tarragona;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;78,21
43 Tarragona;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
43 Tarragona;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
43 Tarragona;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
43 Tarragona;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
43 Tarragona;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
43 Tarragona;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
43 Tarragona;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QIII;1.197
43 Tarragona;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
43 Tarragona;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
43 Tarragona;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
43 Tarragona;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QIII;1.184
43 Tarragona;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
43 Tarragona;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
43 Tarragona;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
43 Tarragona;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QIII;1.072
43 Tarragona;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
43 Tarragona;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
43 Tarragona;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
43 Tarragona;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2022QIII;1.067
43 Tarragona;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2022QII;""
43 Tarragona;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2022QI;""
43 Tarragona;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
43 Tarragona;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2021QIII;1.049
43 Tarragona;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2021QII;""
43 Tarragona;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2021QI;""
43 Tarragona;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
43 Tarragona;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2020QIII;951
43 Tarragona;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2020QII;""
43 Tarragona;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2020QI;""
43 Tarragona;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2022QIV;961
43 Tarragona;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
43 Tarragona;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2022QII;""
43 Tarragona;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2022QI;""
43 Tarragona;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2021QIV;950
43 Tarragona;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
43 Tarragona;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2021QII;""
43 Tarragona;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2021QI;""
43 Tarragona;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2020QIV;873
43 Tarragona;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
43 Tarragona;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2020QII;""
43 Tarragona;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2020QI;""
43 Tarragona;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
43 Tarragona;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
43 Tarragona;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QII;""
43 Tarragona;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QI;869
43 Tarragona;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
43 Tarragona;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
43 Tarragona;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QII;""
43 Tarragona;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QI;837
43 Tarragona;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
43 Tarragona;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
43 Tarragona;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QII;""
43 Tarragona;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QI;""
43 Tarragona;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
43 Tarragona;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
43 Tarragona;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QII;806
43 Tarragona;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QI;""
43 Tarragona;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
43 Tarragona;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
43 Tarragona;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QII;797
43 Tarragona;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QI;""
43 Tarragona;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
43 Tarragona;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
43 Tarragona;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QII;""
43 Tarragona;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QI;""
43 Tarragona;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
43 Tarragona;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
43 Tarragona;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
43 Tarragona;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
43 Tarragona;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
43 Tarragona;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
43 Tarragona;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
43 Tarragona;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
43 Tarragona;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
43 Tarragona;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
43 Tarragona;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
43 Tarragona;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
43 Tarragona;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
43 Tarragona;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;89,14
43 Tarragona;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
43 Tarragona;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
43 Tarragona;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
43 Tarragona;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;88,6
43 Tarragona;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
43 Tarragona;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
43 Tarragona;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
43 Tarragona;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;88,71
43 Tarragona;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
43 Tarragona;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
43 Tarragona;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;80,28
43 Tarragona;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
43 Tarragona;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
43 Tarragona;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
43 Tarragona;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;80,24
43 Tarragona;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
43 Tarragona;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
43 Tarragona;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
43 Tarragona;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;81,44
43 Tarragona;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
43 Tarragona;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
43 Tarragona;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
43 Tarragona;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
43 Tarragona;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
43 Tarragona;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
43 Tarragona;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;73,4
43 Tarragona;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
43 Tarragona;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
43 Tarragona;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
43 Tarragona;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;78,08
43 Tarragona;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
43 Tarragona;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
43 Tarragona;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
43 Tarragona;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
43 Tarragona;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
43 Tarragona;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
43 Tarragona;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;68,07
43 Tarragona;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
43 Tarragona;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
43 Tarragona;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
43 Tarragona;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;74,35
43 Tarragona;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
43 Tarragona;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
43 Tarragona;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
43 Tarragona;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
43 Tarragona;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
43 Tarragona;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QIV;3.415
43 Tarragona;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
43 Tarragona;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
43 Tarragona;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
43 Tarragona;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QIV;3.275
43 Tarragona;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
43 Tarragona;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
43 Tarragona;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
43 Tarragona;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QIV;3.099
43 Tarragona;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
43 Tarragona;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
43 Tarragona;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
43 Tarragona;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2022QIV;3.101
43 Tarragona;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
43 Tarragona;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2022QII;""
43 Tarragona;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2022QI;""
43 Tarragona;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2021QIV;2.975
43 Tarragona;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
43 Tarragona;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2021QII;""
43 Tarragona;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2021QI;""
43 Tarragona;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2020QIV;2.831
43 Tarragona;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
43 Tarragona;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2020QII;""
43 Tarragona;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2020QI;""
43 Tarragona;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
43 Tarragona;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
43 Tarragona;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2022QII;""
43 Tarragona;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2022QI;2.740
43 Tarragona;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
43 Tarragona;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
43 Tarragona;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2021QII;""
43 Tarragona;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2021QI;2.710
43 Tarragona;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
43 Tarragona;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
43 Tarragona;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2020QII;""
43 Tarragona;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2020QI;""
43 Tarragona;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
43 Tarragona;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
43 Tarragona;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QII;2.546
43 Tarragona;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QI;""
43 Tarragona;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
43 Tarragona;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
43 Tarragona;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QII;2.565
43 Tarragona;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QI;""
43 Tarragona;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
43 Tarragona;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
43 Tarragona;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QII;""
43 Tarragona;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QI;""
43 Tarragona;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
43 Tarragona;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QIII;2.397
43 Tarragona;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QII;""
43 Tarragona;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QI;""
43 Tarragona;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
43 Tarragona;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QIII;2.403
43 Tarragona;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QII;""
43 Tarragona;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QI;""
43 Tarragona;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
43 Tarragona;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
43 Tarragona;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QII;""
43 Tarragona;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QI;""
43 Tarragona;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
43 Tarragona;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
43 Tarragona;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
43 Tarragona;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
43 Tarragona;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
43 Tarragona;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
43 Tarragona;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
43 Tarragona;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
43 Tarragona;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
43 Tarragona;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
43 Tarragona;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
43 Tarragona;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
43 Tarragona;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;90,81
43 Tarragona;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
43 Tarragona;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
43 Tarragona;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
43 Tarragona;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;90,84
43 Tarragona;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
43 Tarragona;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
43 Tarragona;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
43 Tarragona;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;91,35
43 Tarragona;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
43 Tarragona;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
43 Tarragona;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
43 Tarragona;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
43 Tarragona;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
43 Tarragona;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
43 Tarragona;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;83,66
43 Tarragona;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
43 Tarragona;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
43 Tarragona;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
43 Tarragona;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;87,45
43 Tarragona;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
43 Tarragona;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
43 Tarragona;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
43 Tarragona;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
43 Tarragona;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
43 Tarragona;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
43 Tarragona;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;77,74
43 Tarragona;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
43 Tarragona;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
43 Tarragona;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
43 Tarragona;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;82,77
43 Tarragona;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
43 Tarragona;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
43 Tarragona;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
43 Tarragona;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
43 Tarragona;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
43 Tarragona;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
43 Tarragona;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;73,19
43 Tarragona;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
43 Tarragona;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
43 Tarragona;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
43 Tarragona;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;77,54
43 Tarragona;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
43 Tarragona;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
43 Tarragona;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
43 Tarragona;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
43 Tarragona;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
43 Tarragona;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
43 Tarragona;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QIV;2.173
43 Tarragona;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
43 Tarragona;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
43 Tarragona;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
43 Tarragona;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QIV;2.067
43 Tarragona;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
43 Tarragona;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
43 Tarragona;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
43 Tarragona;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QIV;1.966
43 Tarragona;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
43 Tarragona;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
43 Tarragona;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
43 Tarragona;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2022QIV;1.983
43 Tarragona;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
43 Tarragona;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2022QII;""
43 Tarragona;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2022QI;""
43 Tarragona;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2021QIV;1.888
43 Tarragona;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
43 Tarragona;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2021QII;""
43 Tarragona;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2021QI;""
43 Tarragona;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2020QIV;1.804
43 Tarragona;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
43 Tarragona;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2020QII;""
43 Tarragona;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2020QI;""
43 Tarragona;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
43 Tarragona;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
43 Tarragona;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2022QII;""
43 Tarragona;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2022QI;1.746
43 Tarragona;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
43 Tarragona;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
43 Tarragona;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2021QII;""
43 Tarragona;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2021QI;1.727
43 Tarragona;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
43 Tarragona;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
43 Tarragona;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2020QII;""
43 Tarragona;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2020QI;""
43 Tarragona;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
43 Tarragona;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
43 Tarragona;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QII;1.627
43 Tarragona;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QI;""
43 Tarragona;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
43 Tarragona;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
43 Tarragona;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QII;1.633
43 Tarragona;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QI;""
43 Tarragona;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
43 Tarragona;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
43 Tarragona;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QII;""
43 Tarragona;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QI;""
43 Tarragona;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
43 Tarragona;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QIII;1.547
43 Tarragona;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QII;""
43 Tarragona;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QI;""
43 Tarragona;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
43 Tarragona;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QIII;1.534
43 Tarragona;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QII;""
43 Tarragona;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QI;""
43 Tarragona;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
43 Tarragona;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
43 Tarragona;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QII;""
43 Tarragona;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QI;""
43 Tarragona;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
43 Tarragona;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
43 Tarragona;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
43 Tarragona;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
43 Tarragona;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
43 Tarragona;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
43 Tarragona;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
43 Tarragona;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
43 Tarragona;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
43 Tarragona;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
43 Tarragona;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
43 Tarragona;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
43 Tarragona;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;91,26
43 Tarragona;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
43 Tarragona;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
43 Tarragona;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
43 Tarragona;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;91,34
43 Tarragona;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
43 Tarragona;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
43 Tarragona;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
43 Tarragona;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;91,76
43 Tarragona;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
43 Tarragona;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
43 Tarragona;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
43 Tarragona;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
43 Tarragona;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
43 Tarragona;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
43 Tarragona;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;84,47
43 Tarragona;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
43 Tarragona;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
43 Tarragona;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
43 Tarragona;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;87,84
43 Tarragona;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
43 Tarragona;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
43 Tarragona;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
43 Tarragona;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
43 Tarragona;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
43 Tarragona;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
43 Tarragona;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;78,71
43 Tarragona;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
43 Tarragona;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
43 Tarragona;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
43 Tarragona;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;83,06
43 Tarragona;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
43 Tarragona;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
43 Tarragona;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
43 Tarragona;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
43 Tarragona;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
43 Tarragona;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
43 Tarragona;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;74,84
43 Tarragona;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
43 Tarragona;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
43 Tarragona;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
43 Tarragona;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;78,03
43 Tarragona;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
43 Tarragona;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
43 Tarragona;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
43 Tarragona;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
43 Tarragona;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
43 Tarragona;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
43 Tarragona;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QIV;1.242
43 Tarragona;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
43 Tarragona;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
43 Tarragona;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
43 Tarragona;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QIV;1.208
43 Tarragona;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
43 Tarragona;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
43 Tarragona;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
43 Tarragona;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QIV;1.133
43 Tarragona;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
43 Tarragona;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
43 Tarragona;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
43 Tarragona;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2022QIV;1.118
43 Tarragona;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
43 Tarragona;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2022QII;""
43 Tarragona;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2022QI;""
43 Tarragona;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2021QIV;1.087
43 Tarragona;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
43 Tarragona;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2021QII;""
43 Tarragona;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2021QI;""
43 Tarragona;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2020QIV;1.027
43 Tarragona;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
43 Tarragona;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2020QII;""
43 Tarragona;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2020QI;""
43 Tarragona;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
43 Tarragona;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
43 Tarragona;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2022QII;""
43 Tarragona;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2022QI;994
43 Tarragona;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
43 Tarragona;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
43 Tarragona;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2021QII;""
43 Tarragona;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2021QI;983
43 Tarragona;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
43 Tarragona;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
43 Tarragona;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2020QII;""
43 Tarragona;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2020QI;""
43 Tarragona;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
43 Tarragona;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
43 Tarragona;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QII;919
43 Tarragona;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QI;""
43 Tarragona;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
43 Tarragona;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
43 Tarragona;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QII;932
43 Tarragona;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QI;""
43 Tarragona;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
43 Tarragona;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
43 Tarragona;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QII;""
43 Tarragona;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QI;""
43 Tarragona;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
43 Tarragona;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QIII;850
43 Tarragona;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QII;""
43 Tarragona;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QI;""
43 Tarragona;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
43 Tarragona;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QIII;869
43 Tarragona;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QII;""
43 Tarragona;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QI;""
43 Tarragona;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
43 Tarragona;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
43 Tarragona;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QII;""
43 Tarragona;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QI;""
43 Tarragona;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
43 Tarragona;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
43 Tarragona;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
43 Tarragona;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
43 Tarragona;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
43 Tarragona;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
43 Tarragona;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
43 Tarragona;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
43 Tarragona;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
43 Tarragona;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
43 Tarragona;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
43 Tarragona;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
43 Tarragona;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;90,02
43 Tarragona;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
43 Tarragona;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
43 Tarragona;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
43 Tarragona;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;89,98
43 Tarragona;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
43 Tarragona;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
43 Tarragona;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
43 Tarragona;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;90,64
43 Tarragona;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
43 Tarragona;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
43 Tarragona;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
43 Tarragona;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
43 Tarragona;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
43 Tarragona;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
43 Tarragona;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;82,28
43 Tarragona;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
43 Tarragona;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
43 Tarragona;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
43 Tarragona;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;86,76
43 Tarragona;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
43 Tarragona;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
43 Tarragona;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
43 Tarragona;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
43 Tarragona;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
43 Tarragona;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
43 Tarragona;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;76,08
43 Tarragona;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
43 Tarragona;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
43 Tarragona;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
43 Tarragona;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;82,26
43 Tarragona;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
43 Tarragona;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
43 Tarragona;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
43 Tarragona;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
43 Tarragona;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
43 Tarragona;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
43 Tarragona;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;70,36
43 Tarragona;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
43 Tarragona;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
43 Tarragona;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
43 Tarragona;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;76,7
43 Tarragona;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
43 Tarragona;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
43 Tarragona;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
43 Tarragona;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
43 Tarragona;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
43 Tarragona;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
43 Tarragona;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
43 Tarragona;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
43 Tarragona;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
43 Tarragona;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QI;8.516
43 Tarragona;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
43 Tarragona;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
43 Tarragona;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
43 Tarragona;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QI;8.594
43 Tarragona;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
43 Tarragona;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
43 Tarragona;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
43 Tarragona;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QI;8.351
43 Tarragona;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
43 Tarragona;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
43 Tarragona;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2022QII;""
43 Tarragona;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2022QI;8.142
43 Tarragona;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
43 Tarragona;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
43 Tarragona;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2021QII;""
43 Tarragona;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2021QI;8.357
43 Tarragona;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
43 Tarragona;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
43 Tarragona;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2020QII;""
43 Tarragona;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2020QI;7.743
43 Tarragona;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
43 Tarragona;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
43 Tarragona;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2022QII;7.797
43 Tarragona;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2022QI;""
43 Tarragona;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
43 Tarragona;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
43 Tarragona;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2021QII;8.069
43 Tarragona;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2021QI;""
43 Tarragona;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
43 Tarragona;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
43 Tarragona;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2020QII;7.541
43 Tarragona;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2020QI;""
43 Tarragona;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
43 Tarragona;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QIII;7.518
43 Tarragona;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QII;""
43 Tarragona;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QI;""
43 Tarragona;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
43 Tarragona;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QIII;7.807
43 Tarragona;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QII;""
43 Tarragona;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QI;""
43 Tarragona;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
43 Tarragona;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QIII;7.235
43 Tarragona;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QII;""
43 Tarragona;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QI;""
43 Tarragona;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QIV;7.224
43 Tarragona;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
43 Tarragona;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QII;""
43 Tarragona;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QI;""
43 Tarragona;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QIV;7.526
43 Tarragona;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
43 Tarragona;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QII;""
43 Tarragona;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QI;""
43 Tarragona;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QIV;6.951
43 Tarragona;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
43 Tarragona;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QII;""
43 Tarragona;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QI;""
43 Tarragona;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
43 Tarragona;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
43 Tarragona;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
43 Tarragona;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
43 Tarragona;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
43 Tarragona;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
43 Tarragona;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
43 Tarragona;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
43 Tarragona;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
43 Tarragona;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
43 Tarragona;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
43 Tarragona;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
43 Tarragona;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
43 Tarragona;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
43 Tarragona;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
43 Tarragona;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;95,61
43 Tarragona;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
43 Tarragona;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
43 Tarragona;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
43 Tarragona;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;97,24
43 Tarragona;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
43 Tarragona;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
43 Tarragona;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
43 Tarragona;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;92,72
43 Tarragona;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
43 Tarragona;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
43 Tarragona;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;91,56
43 Tarragona;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
43 Tarragona;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
43 Tarragona;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
43 Tarragona;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;93,89
43 Tarragona;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
43 Tarragona;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
43 Tarragona;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
43 Tarragona;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;90,3
43 Tarragona;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
43 Tarragona;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
43 Tarragona;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;88,28
43 Tarragona;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
43 Tarragona;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
43 Tarragona;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
43 Tarragona;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;90,84
43 Tarragona;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
43 Tarragona;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
43 Tarragona;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
43 Tarragona;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;86,64
43 Tarragona;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
43 Tarragona;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
43 Tarragona;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;84,83
43 Tarragona;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
43 Tarragona;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
43 Tarragona;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
43 Tarragona;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;87,57
43 Tarragona;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
43 Tarragona;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
43 Tarragona;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
43 Tarragona;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;83,24
43 Tarragona;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
43 Tarragona;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
43 Tarragona;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
43 Tarragona;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
43 Tarragona;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
43 Tarragona;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
43 Tarragona;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QI;5.124
43 Tarragona;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
43 Tarragona;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
43 Tarragona;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
43 Tarragona;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QI;5.216
43 Tarragona;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
43 Tarragona;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
43 Tarragona;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
43 Tarragona;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QI;4.999
43 Tarragona;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
43 Tarragona;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
43 Tarragona;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2022QII;""
43 Tarragona;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2022QI;4.920
43 Tarragona;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
43 Tarragona;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
43 Tarragona;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2021QII;""
43 Tarragona;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2021QI;5.071
43 Tarragona;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
43 Tarragona;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
43 Tarragona;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2020QII;""
43 Tarragona;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2020QI;4.656
43 Tarragona;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
43 Tarragona;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
43 Tarragona;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2022QII;4.727
43 Tarragona;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2022QI;""
43 Tarragona;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
43 Tarragona;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
43 Tarragona;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2021QII;4.888
43 Tarragona;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2021QI;""
43 Tarragona;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
43 Tarragona;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
43 Tarragona;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2020QII;4.560
43 Tarragona;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2020QI;""
43 Tarragona;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
43 Tarragona;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QIII;4.576
43 Tarragona;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QII;""
43 Tarragona;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QI;""
43 Tarragona;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
43 Tarragona;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QIII;4.744
43 Tarragona;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QII;""
43 Tarragona;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QI;""
43 Tarragona;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
43 Tarragona;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QIII;4.388
43 Tarragona;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QII;""
43 Tarragona;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QI;""
43 Tarragona;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QIV;4.413
43 Tarragona;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
43 Tarragona;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QII;""
43 Tarragona;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QI;""
43 Tarragona;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QIV;4.578
43 Tarragona;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
43 Tarragona;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QII;""
43 Tarragona;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QI;""
43 Tarragona;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QIV;4.218
43 Tarragona;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
43 Tarragona;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QII;""
43 Tarragona;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QI;""
43 Tarragona;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
43 Tarragona;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
43 Tarragona;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
43 Tarragona;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
43 Tarragona;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
43 Tarragona;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
43 Tarragona;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
43 Tarragona;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
43 Tarragona;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
43 Tarragona;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
43 Tarragona;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
43 Tarragona;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
43 Tarragona;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
43 Tarragona;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
43 Tarragona;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
43 Tarragona;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;96,02
43 Tarragona;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
43 Tarragona;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
43 Tarragona;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
43 Tarragona;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;97,22
43 Tarragona;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
43 Tarragona;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
43 Tarragona;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
43 Tarragona;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;93,14
43 Tarragona;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
43 Tarragona;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
43 Tarragona;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;92,25
43 Tarragona;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
43 Tarragona;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
43 Tarragona;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
43 Tarragona;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;93,71
43 Tarragona;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
43 Tarragona;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
43 Tarragona;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
43 Tarragona;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;91,22
43 Tarragona;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
43 Tarragona;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
43 Tarragona;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;89,31
43 Tarragona;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
43 Tarragona;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
43 Tarragona;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
43 Tarragona;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;90,95
43 Tarragona;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
43 Tarragona;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
43 Tarragona;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
43 Tarragona;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;87,78
43 Tarragona;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
43 Tarragona;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
43 Tarragona;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;86,12
43 Tarragona;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
43 Tarragona;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
43 Tarragona;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
43 Tarragona;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;87,77
43 Tarragona;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
43 Tarragona;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
43 Tarragona;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
43 Tarragona;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;84,38
43 Tarragona;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
43 Tarragona;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
43 Tarragona;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
43 Tarragona;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
43 Tarragona;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
43 Tarragona;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
43 Tarragona;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QI;3.392
43 Tarragona;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
43 Tarragona;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
43 Tarragona;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
43 Tarragona;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QI;3.378
43 Tarragona;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
43 Tarragona;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
43 Tarragona;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
43 Tarragona;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QI;3.352
43 Tarragona;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
43 Tarragona;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
43 Tarragona;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2022QII;""
43 Tarragona;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2022QI;3.222
43 Tarragona;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
43 Tarragona;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
43 Tarragona;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2021QII;""
43 Tarragona;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2021QI;3.286
43 Tarragona;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
43 Tarragona;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
43 Tarragona;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2020QII;""
43 Tarragona;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2020QI;3.087
43 Tarragona;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
43 Tarragona;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
43 Tarragona;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2022QII;3.070
43 Tarragona;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2022QI;""
43 Tarragona;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
43 Tarragona;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
43 Tarragona;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2021QII;3.181
43 Tarragona;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2021QI;""
43 Tarragona;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
43 Tarragona;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
43 Tarragona;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2020QII;2.981
43 Tarragona;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2020QI;""
43 Tarragona;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
43 Tarragona;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QIII;2.942
43 Tarragona;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QII;""
43 Tarragona;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QI;""
43 Tarragona;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
43 Tarragona;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QIII;3.063
43 Tarragona;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QII;""
43 Tarragona;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QI;""
43 Tarragona;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
43 Tarragona;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QIII;2.847
43 Tarragona;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QII;""
43 Tarragona;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QI;""
43 Tarragona;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QIV;2.811
43 Tarragona;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
43 Tarragona;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QII;""
43 Tarragona;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QI;""
43 Tarragona;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QIV;2.948
43 Tarragona;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
43 Tarragona;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QII;""
43 Tarragona;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QI;""
43 Tarragona;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QIV;2.733
43 Tarragona;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
43 Tarragona;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QII;""
43 Tarragona;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QI;""
43 Tarragona;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
43 Tarragona;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
43 Tarragona;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
43 Tarragona;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
43 Tarragona;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
43 Tarragona;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
43 Tarragona;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
43 Tarragona;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
43 Tarragona;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
43 Tarragona;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
43 Tarragona;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
43 Tarragona;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
43 Tarragona;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
43 Tarragona;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
43 Tarragona;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
43 Tarragona;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;94,99
43 Tarragona;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
43 Tarragona;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
43 Tarragona;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
43 Tarragona;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;97,28
43 Tarragona;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
43 Tarragona;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
43 Tarragona;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
43 Tarragona;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;92,09
43 Tarragona;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
43 Tarragona;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
43 Tarragona;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;90,51
43 Tarragona;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
43 Tarragona;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
43 Tarragona;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
43 Tarragona;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;94,17
43 Tarragona;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
43 Tarragona;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
43 Tarragona;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
43 Tarragona;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;88,93
43 Tarragona;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
43 Tarragona;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
43 Tarragona;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;86,73
43 Tarragona;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
43 Tarragona;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
43 Tarragona;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
43 Tarragona;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;90,67
43 Tarragona;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
43 Tarragona;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
43 Tarragona;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
43 Tarragona;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;84,93
43 Tarragona;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
43 Tarragona;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
43 Tarragona;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;82,87
43 Tarragona;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
43 Tarragona;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
43 Tarragona;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
43 Tarragona;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;87,27
43 Tarragona;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
43 Tarragona;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
43 Tarragona;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
43 Tarragona;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;81,53
43 Tarragona;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
43 Tarragona;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
43 Tarragona;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
43 Tarragona;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
43 Tarragona;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
43 Tarragona;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QII;7.998
43 Tarragona;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
43 Tarragona;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
43 Tarragona;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
43 Tarragona;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QII;8.164
43 Tarragona;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
43 Tarragona;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
43 Tarragona;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
43 Tarragona;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QII;8.294
43 Tarragona;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
43 Tarragona;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
43 Tarragona;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
43 Tarragona;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2022QII;7.615
43 Tarragona;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2022QI;""
43 Tarragona;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
43 Tarragona;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
43 Tarragona;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2021QII;7.833
43 Tarragona;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2021QI;""
43 Tarragona;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
43 Tarragona;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
43 Tarragona;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2020QII;8.065
43 Tarragona;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2020QI;""
43 Tarragona;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
43 Tarragona;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2022QIII;7.311
43 Tarragona;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2022QII;""
43 Tarragona;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2022QI;""
43 Tarragona;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
43 Tarragona;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2021QIII;7.537
43 Tarragona;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2021QII;""
43 Tarragona;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2021QI;""
43 Tarragona;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
43 Tarragona;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2020QIII;7.726
43 Tarragona;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2020QII;""
43 Tarragona;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2020QI;""
43 Tarragona;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QIV;6.968
43 Tarragona;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
43 Tarragona;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QII;""
43 Tarragona;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QI;""
43 Tarragona;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QIV;7.214
43 Tarragona;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
43 Tarragona;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QII;""
43 Tarragona;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QI;""
43 Tarragona;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QIV;7.396
43 Tarragona;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
43 Tarragona;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QII;""
43 Tarragona;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QI;""
43 Tarragona;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
43 Tarragona;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
43 Tarragona;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QII;""
43 Tarragona;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QI;6.948
43 Tarragona;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
43 Tarragona;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
43 Tarragona;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QII;""
43 Tarragona;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QI;7.238
43 Tarragona;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
43 Tarragona;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
43 Tarragona;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QII;""
43 Tarragona;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QI;""
43 Tarragona;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
43 Tarragona;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
43 Tarragona;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
43 Tarragona;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
43 Tarragona;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
43 Tarragona;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
43 Tarragona;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
43 Tarragona;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
43 Tarragona;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
43 Tarragona;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
43 Tarragona;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
43 Tarragona;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
43 Tarragona;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
43 Tarragona;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
43 Tarragona;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;95,21
43 Tarragona;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
43 Tarragona;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
43 Tarragona;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
43 Tarragona;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;95,95
43 Tarragona;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
43 Tarragona;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
43 Tarragona;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
43 Tarragona;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;97,24
43 Tarragona;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
43 Tarragona;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
43 Tarragona;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;91,41
43 Tarragona;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
43 Tarragona;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
43 Tarragona;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
43 Tarragona;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;92,32
43 Tarragona;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
43 Tarragona;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
43 Tarragona;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
43 Tarragona;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;93,15
43 Tarragona;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
43 Tarragona;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
43 Tarragona;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;87,12
43 Tarragona;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
43 Tarragona;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
43 Tarragona;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
43 Tarragona;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;88,36
43 Tarragona;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
43 Tarragona;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
43 Tarragona;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
43 Tarragona;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;89,17
43 Tarragona;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
43 Tarragona;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
43 Tarragona;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
43 Tarragona;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
43 Tarragona;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
43 Tarragona;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
43 Tarragona;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;85,11
43 Tarragona;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
43 Tarragona;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
43 Tarragona;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
43 Tarragona;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;87,27
43 Tarragona;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
43 Tarragona;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
43 Tarragona;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
43 Tarragona;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
43 Tarragona;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
43 Tarragona;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
43 Tarragona;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QII;4.806
43 Tarragona;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
43 Tarragona;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
43 Tarragona;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
43 Tarragona;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QII;4.936
43 Tarragona;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
43 Tarragona;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
43 Tarragona;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
43 Tarragona;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QII;5.000
43 Tarragona;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
43 Tarragona;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
43 Tarragona;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
43 Tarragona;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2022QII;4.581
43 Tarragona;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2022QI;""
43 Tarragona;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
43 Tarragona;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
43 Tarragona;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2021QII;4.727
43 Tarragona;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2021QI;""
43 Tarragona;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
43 Tarragona;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
43 Tarragona;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2020QII;4.891
43 Tarragona;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2020QI;""
43 Tarragona;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
43 Tarragona;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2022QIII;4.417
43 Tarragona;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2022QII;""
43 Tarragona;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2022QI;""
43 Tarragona;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
43 Tarragona;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2021QIII;4.560
43 Tarragona;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2021QII;""
43 Tarragona;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2021QI;""
43 Tarragona;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
43 Tarragona;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2020QIII;4.701
43 Tarragona;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2020QII;""
43 Tarragona;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2020QI;""
43 Tarragona;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QIV;4.231
43 Tarragona;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
43 Tarragona;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QII;""
43 Tarragona;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QI;""
43 Tarragona;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QIV;4.370
43 Tarragona;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
43 Tarragona;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QII;""
43 Tarragona;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QI;""
43 Tarragona;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QIV;4.501
43 Tarragona;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
43 Tarragona;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QII;""
43 Tarragona;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QI;""
43 Tarragona;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
43 Tarragona;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
43 Tarragona;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QII;""
43 Tarragona;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QI;4.224
43 Tarragona;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
43 Tarragona;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
43 Tarragona;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QII;""
43 Tarragona;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QI;4.403
43 Tarragona;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
43 Tarragona;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
43 Tarragona;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QII;""
43 Tarragona;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QI;""
43 Tarragona;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
43 Tarragona;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
43 Tarragona;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
43 Tarragona;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
43 Tarragona;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
43 Tarragona;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
43 Tarragona;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
43 Tarragona;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
43 Tarragona;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
43 Tarragona;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
43 Tarragona;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
43 Tarragona;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
43 Tarragona;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
43 Tarragona;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
43 Tarragona;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;95,32
43 Tarragona;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
43 Tarragona;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
43 Tarragona;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
43 Tarragona;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;95,77
43 Tarragona;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
43 Tarragona;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
43 Tarragona;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
43 Tarragona;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;97,82
43 Tarragona;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
43 Tarragona;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
43 Tarragona;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;91,91
43 Tarragona;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
43 Tarragona;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
43 Tarragona;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
43 Tarragona;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;92,38
43 Tarragona;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
43 Tarragona;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
43 Tarragona;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
43 Tarragona;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;94,02
43 Tarragona;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
43 Tarragona;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
43 Tarragona;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;88,04
43 Tarragona;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
43 Tarragona;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
43 Tarragona;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
43 Tarragona;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;88,53
43 Tarragona;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
43 Tarragona;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
43 Tarragona;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
43 Tarragona;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;90,02
43 Tarragona;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
43 Tarragona;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
43 Tarragona;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
43 Tarragona;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
43 Tarragona;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
43 Tarragona;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
43 Tarragona;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;85,58
43 Tarragona;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
43 Tarragona;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
43 Tarragona;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
43 Tarragona;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;88,06
43 Tarragona;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
43 Tarragona;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
43 Tarragona;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
43 Tarragona;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
43 Tarragona;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
43 Tarragona;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
43 Tarragona;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QII;3.192
43 Tarragona;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
43 Tarragona;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
43 Tarragona;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
43 Tarragona;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QII;3.228
43 Tarragona;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
43 Tarragona;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
43 Tarragona;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
43 Tarragona;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QII;3.294
43 Tarragona;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
43 Tarragona;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
43 Tarragona;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
43 Tarragona;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2022QII;3.034
43 Tarragona;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2022QI;""
43 Tarragona;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
43 Tarragona;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
43 Tarragona;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2021QII;3.106
43 Tarragona;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2021QI;""
43 Tarragona;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
43 Tarragona;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
43 Tarragona;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2020QII;3.174
43 Tarragona;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2020QI;""
43 Tarragona;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
43 Tarragona;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2022QIII;2.894
43 Tarragona;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2022QII;""
43 Tarragona;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2022QI;""
43 Tarragona;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
43 Tarragona;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2021QIII;2.977
43 Tarragona;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2021QII;""
43 Tarragona;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2021QI;""
43 Tarragona;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
43 Tarragona;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2020QIII;3.025
43 Tarragona;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2020QII;""
43 Tarragona;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2020QI;""
43 Tarragona;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QIV;2.737
43 Tarragona;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
43 Tarragona;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QII;""
43 Tarragona;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QI;""
43 Tarragona;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QIV;2.844
43 Tarragona;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
43 Tarragona;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QII;""
43 Tarragona;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QI;""
43 Tarragona;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QIV;2.895
43 Tarragona;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
43 Tarragona;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QII;""
43 Tarragona;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QI;""
43 Tarragona;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
43 Tarragona;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
43 Tarragona;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QII;""
43 Tarragona;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QI;2.724
43 Tarragona;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
43 Tarragona;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
43 Tarragona;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QII;""
43 Tarragona;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QI;2.835
43 Tarragona;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
43 Tarragona;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
43 Tarragona;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QII;""
43 Tarragona;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QI;""
43 Tarragona;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
43 Tarragona;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
43 Tarragona;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
43 Tarragona;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
43 Tarragona;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
43 Tarragona;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
43 Tarragona;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
43 Tarragona;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
43 Tarragona;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
43 Tarragona;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
43 Tarragona;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
43 Tarragona;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
43 Tarragona;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
43 Tarragona;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
43 Tarragona;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;95,05
43 Tarragona;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
43 Tarragona;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
43 Tarragona;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
43 Tarragona;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;96,22
43 Tarragona;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
43 Tarragona;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
43 Tarragona;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
43 Tarragona;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;96,36
43 Tarragona;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
43 Tarragona;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
43 Tarragona;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;90,66
43 Tarragona;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
43 Tarragona;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
43 Tarragona;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
43 Tarragona;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;92,22
43 Tarragona;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
43 Tarragona;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
43 Tarragona;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
43 Tarragona;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;91,83
43 Tarragona;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
43 Tarragona;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
43 Tarragona;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;85,75
43 Tarragona;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
43 Tarragona;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
43 Tarragona;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
43 Tarragona;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;88,1
43 Tarragona;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
43 Tarragona;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
43 Tarragona;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
43 Tarragona;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;87,89
43 Tarragona;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
43 Tarragona;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
43 Tarragona;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
43 Tarragona;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
43 Tarragona;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
43 Tarragona;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
43 Tarragona;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;84,39
43 Tarragona;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
43 Tarragona;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
43 Tarragona;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
43 Tarragona;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;86,07
43 Tarragona;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
43 Tarragona;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
43 Tarragona;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
43 Tarragona;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
43 Tarragona;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
43 Tarragona;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QIII;8.180
43 Tarragona;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
43 Tarragona;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
43 Tarragona;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
43 Tarragona;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QIII;8.427
43 Tarragona;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
43 Tarragona;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
43 Tarragona;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
43 Tarragona;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QIII;8.501
43 Tarragona;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
43 Tarragona;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
43 Tarragona;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
43 Tarragona;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2022QIII;7.784
43 Tarragona;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2022QII;""
43 Tarragona;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2022QI;""
43 Tarragona;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
43 Tarragona;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2021QIII;8.037
43 Tarragona;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2021QII;""
43 Tarragona;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2021QI;""
43 Tarragona;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
43 Tarragona;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2020QIII;8.078
43 Tarragona;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2020QII;""
43 Tarragona;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2020QI;""
43 Tarragona;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2022QIV;7.369
43 Tarragona;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
43 Tarragona;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2022QII;""
43 Tarragona;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2022QI;""
43 Tarragona;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2021QIV;7.652
43 Tarragona;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
43 Tarragona;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2021QII;""
43 Tarragona;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2021QI;""
43 Tarragona;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2020QIV;7.706
43 Tarragona;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
43 Tarragona;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2020QII;""
43 Tarragona;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2020QI;""
43 Tarragona;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
43 Tarragona;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
43 Tarragona;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QII;""
43 Tarragona;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QI;7.359
43 Tarragona;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
43 Tarragona;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
43 Tarragona;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QII;""
43 Tarragona;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QI;7.537
43 Tarragona;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
43 Tarragona;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
43 Tarragona;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QII;""
43 Tarragona;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QI;""
43 Tarragona;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
43 Tarragona;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
43 Tarragona;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QII;7.101
43 Tarragona;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QI;""
43 Tarragona;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
43 Tarragona;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
43 Tarragona;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QII;7.336
43 Tarragona;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QI;""
43 Tarragona;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
43 Tarragona;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
43 Tarragona;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QII;""
43 Tarragona;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QI;""
43 Tarragona;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
43 Tarragona;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
43 Tarragona;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
43 Tarragona;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
43 Tarragona;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
43 Tarragona;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
43 Tarragona;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
43 Tarragona;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
43 Tarragona;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
43 Tarragona;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
43 Tarragona;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
43 Tarragona;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
43 Tarragona;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
43 Tarragona;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;95,16
43 Tarragona;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
43 Tarragona;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
43 Tarragona;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
43 Tarragona;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;95,37
43 Tarragona;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
43 Tarragona;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
43 Tarragona;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
43 Tarragona;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;95,02
43 Tarragona;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
43 Tarragona;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
43 Tarragona;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;90,09
43 Tarragona;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
43 Tarragona;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
43 Tarragona;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
43 Tarragona;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;90,8
43 Tarragona;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
43 Tarragona;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
43 Tarragona;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
43 Tarragona;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;90,65
43 Tarragona;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
43 Tarragona;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
43 Tarragona;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
43 Tarragona;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
43 Tarragona;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
43 Tarragona;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
43 Tarragona;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;87,33
43 Tarragona;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
43 Tarragona;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
43 Tarragona;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
43 Tarragona;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;88,66
43 Tarragona;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
43 Tarragona;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
43 Tarragona;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
43 Tarragona;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
43 Tarragona;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
43 Tarragona;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
43 Tarragona;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;84,26
43 Tarragona;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
43 Tarragona;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
43 Tarragona;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
43 Tarragona;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;86,3
43 Tarragona;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
43 Tarragona;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
43 Tarragona;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
43 Tarragona;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
43 Tarragona;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
43 Tarragona;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
43 Tarragona;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QIII;4.893
43 Tarragona;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
43 Tarragona;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
43 Tarragona;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
43 Tarragona;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QIII;5.087
43 Tarragona;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
43 Tarragona;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
43 Tarragona;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
43 Tarragona;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QIII;5.168
43 Tarragona;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
43 Tarragona;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
43 Tarragona;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
43 Tarragona;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2022QIII;4.682
43 Tarragona;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2022QII;""
43 Tarragona;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2022QI;""
43 Tarragona;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
43 Tarragona;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2021QIII;4.866
43 Tarragona;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2021QII;""
43 Tarragona;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2021QI;""
43 Tarragona;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
43 Tarragona;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2020QIII;4.932
43 Tarragona;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2020QII;""
43 Tarragona;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2020QI;""
43 Tarragona;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2022QIV;4.454
43 Tarragona;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
43 Tarragona;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2022QII;""
43 Tarragona;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2022QI;""
43 Tarragona;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2021QIV;4.637
43 Tarragona;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
43 Tarragona;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2021QII;""
43 Tarragona;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2021QI;""
43 Tarragona;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2020QIV;4.705
43 Tarragona;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
43 Tarragona;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2020QII;""
43 Tarragona;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2020QI;""
43 Tarragona;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
43 Tarragona;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
43 Tarragona;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QII;""
43 Tarragona;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QI;4.473
43 Tarragona;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
43 Tarragona;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
43 Tarragona;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QII;""
43 Tarragona;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QI;4.598
43 Tarragona;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
43 Tarragona;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
43 Tarragona;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QII;""
43 Tarragona;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QI;""
43 Tarragona;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
43 Tarragona;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
43 Tarragona;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QII;4.329
43 Tarragona;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QI;""
43 Tarragona;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
43 Tarragona;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
43 Tarragona;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QII;4.475
43 Tarragona;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QI;""
43 Tarragona;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
43 Tarragona;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
43 Tarragona;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QII;""
43 Tarragona;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QI;""
43 Tarragona;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
43 Tarragona;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
43 Tarragona;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
43 Tarragona;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
43 Tarragona;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
43 Tarragona;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
43 Tarragona;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
43 Tarragona;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
43 Tarragona;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
43 Tarragona;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
43 Tarragona;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
43 Tarragona;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
43 Tarragona;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
43 Tarragona;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;95,69
43 Tarragona;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
43 Tarragona;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
43 Tarragona;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
43 Tarragona;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;95,66
43 Tarragona;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
43 Tarragona;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
43 Tarragona;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
43 Tarragona;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;95,43
43 Tarragona;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
43 Tarragona;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
43 Tarragona;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;91,03
43 Tarragona;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
43 Tarragona;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
43 Tarragona;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
43 Tarragona;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;91,15
43 Tarragona;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
43 Tarragona;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
43 Tarragona;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
43 Tarragona;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;91,04
43 Tarragona;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
43 Tarragona;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
43 Tarragona;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
43 Tarragona;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
43 Tarragona;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
43 Tarragona;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
43 Tarragona;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;87,93
43 Tarragona;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
43 Tarragona;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
43 Tarragona;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
43 Tarragona;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;88,97
43 Tarragona;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
43 Tarragona;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
43 Tarragona;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
43 Tarragona;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
43 Tarragona;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
43 Tarragona;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
43 Tarragona;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;85,1
43 Tarragona;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
43 Tarragona;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
43 Tarragona;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
43 Tarragona;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;86,59
43 Tarragona;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
43 Tarragona;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
43 Tarragona;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
43 Tarragona;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
43 Tarragona;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
43 Tarragona;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
43 Tarragona;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QIII;3.287
43 Tarragona;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
43 Tarragona;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
43 Tarragona;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
43 Tarragona;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QIII;3.340
43 Tarragona;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
43 Tarragona;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
43 Tarragona;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
43 Tarragona;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QIII;3.333
43 Tarragona;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
43 Tarragona;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
43 Tarragona;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
43 Tarragona;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2022QIII;3.102
43 Tarragona;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2022QII;""
43 Tarragona;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2022QI;""
43 Tarragona;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
43 Tarragona;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2021QIII;3.171
43 Tarragona;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2021QII;""
43 Tarragona;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2021QI;""
43 Tarragona;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
43 Tarragona;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2020QIII;3.146
43 Tarragona;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2020QII;""
43 Tarragona;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2020QI;""
43 Tarragona;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2022QIV;2.915
43 Tarragona;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
43 Tarragona;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2022QII;""
43 Tarragona;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2022QI;""
43 Tarragona;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2021QIV;3.015
43 Tarragona;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
43 Tarragona;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2021QII;""
43 Tarragona;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2021QI;""
43 Tarragona;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2020QIV;3.001
43 Tarragona;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
43 Tarragona;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2020QII;""
43 Tarragona;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2020QI;""
43 Tarragona;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
43 Tarragona;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
43 Tarragona;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QII;""
43 Tarragona;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QI;2.886
43 Tarragona;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
43 Tarragona;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
43 Tarragona;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QII;""
43 Tarragona;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QI;2.939
43 Tarragona;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
43 Tarragona;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
43 Tarragona;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QII;""
43 Tarragona;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QI;""
43 Tarragona;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
43 Tarragona;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
43 Tarragona;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QII;2.772
43 Tarragona;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QI;""
43 Tarragona;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
43 Tarragona;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
43 Tarragona;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QII;2.861
43 Tarragona;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QI;""
43 Tarragona;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
43 Tarragona;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
43 Tarragona;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QII;""
43 Tarragona;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QI;""
43 Tarragona;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
43 Tarragona;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
43 Tarragona;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
43 Tarragona;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
43 Tarragona;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
43 Tarragona;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
43 Tarragona;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
43 Tarragona;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
43 Tarragona;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
43 Tarragona;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
43 Tarragona;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
43 Tarragona;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
43 Tarragona;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
43 Tarragona;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;94,37
43 Tarragona;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
43 Tarragona;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
43 Tarragona;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
43 Tarragona;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;94,94
43 Tarragona;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
43 Tarragona;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
43 Tarragona;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
43 Tarragona;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;94,39
43 Tarragona;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
43 Tarragona;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
43 Tarragona;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;88,68
43 Tarragona;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
43 Tarragona;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
43 Tarragona;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
43 Tarragona;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;90,27
43 Tarragona;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
43 Tarragona;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
43 Tarragona;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
43 Tarragona;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;90,04
43 Tarragona;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
43 Tarragona;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
43 Tarragona;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
43 Tarragona;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
43 Tarragona;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
43 Tarragona;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
43 Tarragona;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;86,41
43 Tarragona;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
43 Tarragona;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
43 Tarragona;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
43 Tarragona;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;88,18
43 Tarragona;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
43 Tarragona;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
43 Tarragona;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
43 Tarragona;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
43 Tarragona;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
43 Tarragona;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
43 Tarragona;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;82,99
43 Tarragona;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
43 Tarragona;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
43 Tarragona;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
43 Tarragona;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;85,84
43 Tarragona;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
43 Tarragona;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
43 Tarragona;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
43 Tarragona;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
43 Tarragona;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
43 Tarragona;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QIV;8.215
43 Tarragona;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
43 Tarragona;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
43 Tarragona;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
43 Tarragona;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QIV;8.464
43 Tarragona;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
43 Tarragona;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
43 Tarragona;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
43 Tarragona;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QIV;8.548
43 Tarragona;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
43 Tarragona;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
43 Tarragona;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
43 Tarragona;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2022QIV;7.755
43 Tarragona;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
43 Tarragona;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2022QII;""
43 Tarragona;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2022QI;""
43 Tarragona;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2021QIV;8.028
43 Tarragona;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
43 Tarragona;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2021QII;""
43 Tarragona;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2021QI;""
43 Tarragona;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2020QIV;8.127
43 Tarragona;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
43 Tarragona;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2020QII;""
43 Tarragona;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2020QI;""
43 Tarragona;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
43 Tarragona;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
43 Tarragona;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2022QII;""
43 Tarragona;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2022QI;7.702
43 Tarragona;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
43 Tarragona;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
43 Tarragona;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2021QII;""
43 Tarragona;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2021QI;7.929
43 Tarragona;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
43 Tarragona;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
43 Tarragona;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2020QII;""
43 Tarragona;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2020QI;""
43 Tarragona;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
43 Tarragona;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
43 Tarragona;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QII;7.411
43 Tarragona;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QI;""
43 Tarragona;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
43 Tarragona;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
43 Tarragona;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QII;7.691
43 Tarragona;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QI;""
43 Tarragona;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
43 Tarragona;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
43 Tarragona;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QII;""
43 Tarragona;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QI;""
43 Tarragona;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
43 Tarragona;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QIII;7.154
43 Tarragona;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QII;""
43 Tarragona;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QI;""
43 Tarragona;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
43 Tarragona;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QIII;7.459
43 Tarragona;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QII;""
43 Tarragona;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QI;""
43 Tarragona;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
43 Tarragona;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
43 Tarragona;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QII;""
43 Tarragona;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QI;""
43 Tarragona;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
43 Tarragona;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
43 Tarragona;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
43 Tarragona;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
43 Tarragona;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
43 Tarragona;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
43 Tarragona;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
43 Tarragona;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
43 Tarragona;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
43 Tarragona;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
43 Tarragona;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
43 Tarragona;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
43 Tarragona;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;94,4
43 Tarragona;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
43 Tarragona;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
43 Tarragona;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
43 Tarragona;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;94,85
43 Tarragona;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
43 Tarragona;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
43 Tarragona;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
43 Tarragona;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;95,07
43 Tarragona;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
43 Tarragona;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
43 Tarragona;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
43 Tarragona;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
43 Tarragona;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
43 Tarragona;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
43 Tarragona;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;91
43 Tarragona;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
43 Tarragona;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
43 Tarragona;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
43 Tarragona;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;92,76
43 Tarragona;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
43 Tarragona;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
43 Tarragona;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
43 Tarragona;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
43 Tarragona;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
43 Tarragona;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
43 Tarragona;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;87,56
43 Tarragona;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
43 Tarragona;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
43 Tarragona;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
43 Tarragona;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;89,97
43 Tarragona;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
43 Tarragona;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
43 Tarragona;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
43 Tarragona;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
43 Tarragona;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
43 Tarragona;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
43 Tarragona;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;84,52
43 Tarragona;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
43 Tarragona;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
43 Tarragona;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
43 Tarragona;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;87,26
43 Tarragona;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
43 Tarragona;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
43 Tarragona;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
43 Tarragona;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
43 Tarragona;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
43 Tarragona;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
43 Tarragona;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QIV;4.934
43 Tarragona;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
43 Tarragona;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
43 Tarragona;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
43 Tarragona;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QIV;5.109
43 Tarragona;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
43 Tarragona;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
43 Tarragona;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
43 Tarragona;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QIV;5.215
43 Tarragona;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
43 Tarragona;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
43 Tarragona;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
43 Tarragona;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2022QIV;4.678
43 Tarragona;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
43 Tarragona;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2022QII;""
43 Tarragona;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2022QI;""
43 Tarragona;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2021QIV;4.850
43 Tarragona;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
43 Tarragona;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2021QII;""
43 Tarragona;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2021QI;""
43 Tarragona;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2020QIV;4.954
43 Tarragona;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
43 Tarragona;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2020QII;""
43 Tarragona;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2020QI;""
43 Tarragona;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
43 Tarragona;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
43 Tarragona;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2022QII;""
43 Tarragona;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2022QI;4.672
43 Tarragona;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
43 Tarragona;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
43 Tarragona;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2021QII;""
43 Tarragona;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2021QI;4.830
43 Tarragona;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
43 Tarragona;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
43 Tarragona;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2020QII;""
43 Tarragona;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2020QI;""
43 Tarragona;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
43 Tarragona;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
43 Tarragona;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QII;4.510
43 Tarragona;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QI;""
43 Tarragona;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
43 Tarragona;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
43 Tarragona;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QII;4.684
43 Tarragona;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QI;""
43 Tarragona;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
43 Tarragona;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
43 Tarragona;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QII;""
43 Tarragona;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QI;""
43 Tarragona;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
43 Tarragona;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QIII;4.372
43 Tarragona;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QII;""
43 Tarragona;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QI;""
43 Tarragona;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
43 Tarragona;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QIII;4.555
43 Tarragona;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QII;""
43 Tarragona;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QI;""
43 Tarragona;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
43 Tarragona;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
43 Tarragona;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QII;""
43 Tarragona;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QI;""
43 Tarragona;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
43 Tarragona;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
43 Tarragona;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
43 Tarragona;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
43 Tarragona;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
43 Tarragona;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
43 Tarragona;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
43 Tarragona;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
43 Tarragona;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
43 Tarragona;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
43 Tarragona;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
43 Tarragona;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
43 Tarragona;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;94,81
43 Tarragona;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
43 Tarragona;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
43 Tarragona;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
43 Tarragona;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;94,93
43 Tarragona;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
43 Tarragona;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
43 Tarragona;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
43 Tarragona;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;95
43 Tarragona;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
43 Tarragona;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
43 Tarragona;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
43 Tarragona;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
43 Tarragona;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
43 Tarragona;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
43 Tarragona;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;91,45
43 Tarragona;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
43 Tarragona;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
43 Tarragona;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
43 Tarragona;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;92,62
43 Tarragona;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
43 Tarragona;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
43 Tarragona;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
43 Tarragona;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
43 Tarragona;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
43 Tarragona;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
43 Tarragona;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;88,28
43 Tarragona;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
43 Tarragona;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
43 Tarragona;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
43 Tarragona;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;89,82
43 Tarragona;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
43 Tarragona;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
43 Tarragona;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
43 Tarragona;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
43 Tarragona;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
43 Tarragona;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
43 Tarragona;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;85,57
43 Tarragona;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
43 Tarragona;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
43 Tarragona;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
43 Tarragona;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;87,34
43 Tarragona;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
43 Tarragona;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
43 Tarragona;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
43 Tarragona;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
43 Tarragona;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
43 Tarragona;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
43 Tarragona;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QIV;3.281
43 Tarragona;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
43 Tarragona;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
43 Tarragona;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
43 Tarragona;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QIV;3.355
43 Tarragona;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
43 Tarragona;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
43 Tarragona;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
43 Tarragona;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QIV;3.333
43 Tarragona;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
43 Tarragona;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
43 Tarragona;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
43 Tarragona;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2022QIV;3.077
43 Tarragona;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
43 Tarragona;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2022QII;""
43 Tarragona;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2022QI;""
43 Tarragona;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2021QIV;3.178
43 Tarragona;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
43 Tarragona;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2021QII;""
43 Tarragona;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2021QI;""
43 Tarragona;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2020QIV;3.173
43 Tarragona;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
43 Tarragona;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2020QII;""
43 Tarragona;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2020QI;""
43 Tarragona;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
43 Tarragona;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
43 Tarragona;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2022QII;""
43 Tarragona;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2022QI;3.030
43 Tarragona;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
43 Tarragona;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
43 Tarragona;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2021QII;""
43 Tarragona;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2021QI;3.099
43 Tarragona;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
43 Tarragona;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
43 Tarragona;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2020QII;""
43 Tarragona;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2020QI;""
43 Tarragona;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
43 Tarragona;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
43 Tarragona;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QII;2.901
43 Tarragona;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QI;""
43 Tarragona;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
43 Tarragona;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
43 Tarragona;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QII;3.007
43 Tarragona;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QI;""
43 Tarragona;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
43 Tarragona;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
43 Tarragona;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QII;""
43 Tarragona;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QI;""
43 Tarragona;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
43 Tarragona;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QIII;2.782
43 Tarragona;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QII;""
43 Tarragona;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QI;""
43 Tarragona;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
43 Tarragona;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QIII;2.904
43 Tarragona;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QII;""
43 Tarragona;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QI;""
43 Tarragona;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
43 Tarragona;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
43 Tarragona;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QII;""
43 Tarragona;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QI;""
43 Tarragona;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
43 Tarragona;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
43 Tarragona;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
43 Tarragona;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
43 Tarragona;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
43 Tarragona;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
43 Tarragona;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
43 Tarragona;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
43 Tarragona;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
43 Tarragona;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
43 Tarragona;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
43 Tarragona;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
43 Tarragona;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;93,78
43 Tarragona;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
43 Tarragona;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
43 Tarragona;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
43 Tarragona;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;94,72
43 Tarragona;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
43 Tarragona;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
43 Tarragona;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
43 Tarragona;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;95,2
43 Tarragona;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
43 Tarragona;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
43 Tarragona;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
43 Tarragona;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
43 Tarragona;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
43 Tarragona;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
43 Tarragona;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;90,31
43 Tarragona;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
43 Tarragona;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
43 Tarragona;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
43 Tarragona;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;92,98
43 Tarragona;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
43 Tarragona;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
43 Tarragona;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
43 Tarragona;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
43 Tarragona;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
43 Tarragona;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
43 Tarragona;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;86,47
43 Tarragona;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
43 Tarragona;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
43 Tarragona;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
43 Tarragona;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;90,22
43 Tarragona;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
43 Tarragona;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
43 Tarragona;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
43 Tarragona;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
43 Tarragona;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
43 Tarragona;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
43 Tarragona;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;82,92
43 Tarragona;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
43 Tarragona;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
43 Tarragona;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
43 Tarragona;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;87,13
43 Tarragona;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
43 Tarragona;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
43 Tarragona;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
43 Tarragona;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
43 Tarragona;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
43 Tarragona;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
43 Tarragona;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
43 Tarragona;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
43 Tarragona;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
43 Tarragona;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QI;15.613
43 Tarragona;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
43 Tarragona;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
43 Tarragona;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
43 Tarragona;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QI;15.405
43 Tarragona;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
43 Tarragona;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
43 Tarragona;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
43 Tarragona;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QI;15.504
43 Tarragona;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
43 Tarragona;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
43 Tarragona;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2022QII;""
43 Tarragona;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2022QI;15.093
43 Tarragona;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
43 Tarragona;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
43 Tarragona;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2021QII;""
43 Tarragona;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2021QI;15.087
43 Tarragona;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
43 Tarragona;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
43 Tarragona;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2020QII;""
43 Tarragona;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2020QI;14.520
43 Tarragona;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
43 Tarragona;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
43 Tarragona;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2022QII;14.668
43 Tarragona;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2022QI;""
43 Tarragona;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
43 Tarragona;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
43 Tarragona;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2021QII;14.708
43 Tarragona;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2021QI;""
43 Tarragona;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
43 Tarragona;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
43 Tarragona;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2020QII;14.270
43 Tarragona;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2020QI;""
43 Tarragona;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
43 Tarragona;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QIII;14.318
43 Tarragona;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QII;""
43 Tarragona;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QI;""
43 Tarragona;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
43 Tarragona;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QIII;14.402
43 Tarragona;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QII;""
43 Tarragona;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QI;""
43 Tarragona;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
43 Tarragona;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QIII;13.880
43 Tarragona;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QII;""
43 Tarragona;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QI;""
43 Tarragona;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QIV;13.889
43 Tarragona;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
43 Tarragona;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QII;""
43 Tarragona;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QI;""
43 Tarragona;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QIV;14.065
43 Tarragona;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
43 Tarragona;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QII;""
43 Tarragona;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QI;""
43 Tarragona;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QIV;13.489
43 Tarragona;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
43 Tarragona;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QII;""
43 Tarragona;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QI;""
43 Tarragona;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
43 Tarragona;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
43 Tarragona;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
43 Tarragona;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
43 Tarragona;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
43 Tarragona;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
43 Tarragona;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
43 Tarragona;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
43 Tarragona;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
43 Tarragona;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
43 Tarragona;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
43 Tarragona;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
43 Tarragona;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
43 Tarragona;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
43 Tarragona;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
43 Tarragona;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;96,67
43 Tarragona;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
43 Tarragona;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
43 Tarragona;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
43 Tarragona;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;97,94
43 Tarragona;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
43 Tarragona;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
43 Tarragona;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
43 Tarragona;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;93,65
43 Tarragona;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
43 Tarragona;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
43 Tarragona;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;93,95
43 Tarragona;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
43 Tarragona;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
43 Tarragona;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
43 Tarragona;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;95,48
43 Tarragona;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
43 Tarragona;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
43 Tarragona;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
43 Tarragona;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;92,04
43 Tarragona;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
43 Tarragona;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
43 Tarragona;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;91,71
43 Tarragona;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
43 Tarragona;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
43 Tarragona;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
43 Tarragona;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;93,49
43 Tarragona;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
43 Tarragona;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
43 Tarragona;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
43 Tarragona;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;89,53
43 Tarragona;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
43 Tarragona;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
43 Tarragona;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;88,96
43 Tarragona;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
43 Tarragona;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
43 Tarragona;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
43 Tarragona;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;91,3
43 Tarragona;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
43 Tarragona;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
43 Tarragona;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
43 Tarragona;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;87
43 Tarragona;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
43 Tarragona;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
43 Tarragona;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
43 Tarragona;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
43 Tarragona;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
43 Tarragona;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
43 Tarragona;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QI;9.782
43 Tarragona;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
43 Tarragona;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
43 Tarragona;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
43 Tarragona;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QI;9.692
43 Tarragona;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
43 Tarragona;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
43 Tarragona;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
43 Tarragona;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QI;9.720
43 Tarragona;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
43 Tarragona;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
43 Tarragona;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2022QII;""
43 Tarragona;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2022QI;9.485
43 Tarragona;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
43 Tarragona;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
43 Tarragona;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2021QII;""
43 Tarragona;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2021QI;9.496
43 Tarragona;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
43 Tarragona;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
43 Tarragona;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2020QII;""
43 Tarragona;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2020QI;9.156
43 Tarragona;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
43 Tarragona;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
43 Tarragona;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2022QII;9.236
43 Tarragona;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2022QI;""
43 Tarragona;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
43 Tarragona;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
43 Tarragona;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2021QII;9.277
43 Tarragona;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2021QI;""
43 Tarragona;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
43 Tarragona;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
43 Tarragona;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2020QII;9.012
43 Tarragona;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2020QI;""
43 Tarragona;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
43 Tarragona;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QIII;9.037
43 Tarragona;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QII;""
43 Tarragona;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QI;""
43 Tarragona;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
43 Tarragona;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QIII;9.106
43 Tarragona;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QII;""
43 Tarragona;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QI;""
43 Tarragona;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
43 Tarragona;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QIII;8.784
43 Tarragona;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QII;""
43 Tarragona;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QI;""
43 Tarragona;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QIV;8.784
43 Tarragona;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
43 Tarragona;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QII;""
43 Tarragona;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QI;""
43 Tarragona;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QIV;8.904
43 Tarragona;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
43 Tarragona;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QII;""
43 Tarragona;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QI;""
43 Tarragona;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QIV;8.538
43 Tarragona;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
43 Tarragona;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QII;""
43 Tarragona;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QI;""
43 Tarragona;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
43 Tarragona;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
43 Tarragona;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
43 Tarragona;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
43 Tarragona;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
43 Tarragona;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
43 Tarragona;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
43 Tarragona;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
43 Tarragona;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
43 Tarragona;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
43 Tarragona;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
43 Tarragona;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
43 Tarragona;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
43 Tarragona;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
43 Tarragona;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
43 Tarragona;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;96,96
43 Tarragona;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
43 Tarragona;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
43 Tarragona;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
43 Tarragona;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;97,98
43 Tarragona;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
43 Tarragona;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
43 Tarragona;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
43 Tarragona;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;94,2
43 Tarragona;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
43 Tarragona;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
43 Tarragona;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;94,42
43 Tarragona;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
43 Tarragona;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
43 Tarragona;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
43 Tarragona;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;95,72
43 Tarragona;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
43 Tarragona;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
43 Tarragona;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
43 Tarragona;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;92,72
43 Tarragona;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
43 Tarragona;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
43 Tarragona;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;92,38
43 Tarragona;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
43 Tarragona;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
43 Tarragona;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
43 Tarragona;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;93,95
43 Tarragona;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
43 Tarragona;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
43 Tarragona;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
43 Tarragona;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;90,37
43 Tarragona;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
43 Tarragona;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
43 Tarragona;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;89,8
43 Tarragona;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
43 Tarragona;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
43 Tarragona;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
43 Tarragona;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;91,87
43 Tarragona;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
43 Tarragona;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
43 Tarragona;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
43 Tarragona;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;87,84
43 Tarragona;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
43 Tarragona;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
43 Tarragona;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
43 Tarragona;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
43 Tarragona;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
43 Tarragona;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
43 Tarragona;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QI;5.831
43 Tarragona;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
43 Tarragona;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
43 Tarragona;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
43 Tarragona;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QI;5.713
43 Tarragona;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
43 Tarragona;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
43 Tarragona;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
43 Tarragona;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QI;5.784
43 Tarragona;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
43 Tarragona;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
43 Tarragona;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2022QII;""
43 Tarragona;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2022QI;5.608
43 Tarragona;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
43 Tarragona;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
43 Tarragona;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2021QII;""
43 Tarragona;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2021QI;5.591
43 Tarragona;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
43 Tarragona;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
43 Tarragona;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2020QII;""
43 Tarragona;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2020QI;5.364
43 Tarragona;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
43 Tarragona;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
43 Tarragona;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2022QII;5.432
43 Tarragona;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2022QI;""
43 Tarragona;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
43 Tarragona;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
43 Tarragona;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2021QII;5.431
43 Tarragona;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2021QI;""
43 Tarragona;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
43 Tarragona;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
43 Tarragona;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2020QII;5.258
43 Tarragona;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2020QI;""
43 Tarragona;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
43 Tarragona;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QIII;5.281
43 Tarragona;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QII;""
43 Tarragona;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QI;""
43 Tarragona;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
43 Tarragona;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QIII;5.296
43 Tarragona;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QII;""
43 Tarragona;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QI;""
43 Tarragona;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
43 Tarragona;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QIII;5.096
43 Tarragona;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QII;""
43 Tarragona;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QI;""
43 Tarragona;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QIV;5.105
43 Tarragona;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
43 Tarragona;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QII;""
43 Tarragona;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QI;""
43 Tarragona;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QIV;5.161
43 Tarragona;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
43 Tarragona;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QII;""
43 Tarragona;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QI;""
43 Tarragona;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QIV;4.951
43 Tarragona;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
43 Tarragona;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QII;""
43 Tarragona;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QI;""
43 Tarragona;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
43 Tarragona;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
43 Tarragona;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
43 Tarragona;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
43 Tarragona;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
43 Tarragona;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
43 Tarragona;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
43 Tarragona;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
43 Tarragona;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
43 Tarragona;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
43 Tarragona;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
43 Tarragona;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
43 Tarragona;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
43 Tarragona;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
43 Tarragona;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
43 Tarragona;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;96,18
43 Tarragona;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
43 Tarragona;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
43 Tarragona;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
43 Tarragona;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;97,86
43 Tarragona;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
43 Tarragona;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
43 Tarragona;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
43 Tarragona;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;92,74
43 Tarragona;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
43 Tarragona;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
43 Tarragona;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;93,16
43 Tarragona;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
43 Tarragona;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
43 Tarragona;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
43 Tarragona;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;95,06
43 Tarragona;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
43 Tarragona;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
43 Tarragona;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
43 Tarragona;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;90,91
43 Tarragona;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
43 Tarragona;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
43 Tarragona;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;90,57
43 Tarragona;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
43 Tarragona;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
43 Tarragona;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
43 Tarragona;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;92,7
43 Tarragona;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
43 Tarragona;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
43 Tarragona;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
43 Tarragona;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;88,11
43 Tarragona;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
43 Tarragona;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
43 Tarragona;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;87,55
43 Tarragona;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
43 Tarragona;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
43 Tarragona;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
43 Tarragona;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;90,34
43 Tarragona;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
43 Tarragona;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
43 Tarragona;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
43 Tarragona;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;85,6
43 Tarragona;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
43 Tarragona;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
43 Tarragona;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
43 Tarragona;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
43 Tarragona;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
43 Tarragona;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QII;15.263
43 Tarragona;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
43 Tarragona;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
43 Tarragona;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
43 Tarragona;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QII;15.345
43 Tarragona;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
43 Tarragona;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
43 Tarragona;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
43 Tarragona;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QII;15.172
43 Tarragona;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
43 Tarragona;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
43 Tarragona;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
43 Tarragona;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2022QII;14.787
43 Tarragona;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2022QI;""
43 Tarragona;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
43 Tarragona;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
43 Tarragona;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2021QII;14.916
43 Tarragona;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2021QI;""
43 Tarragona;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
43 Tarragona;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
43 Tarragona;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2020QII;14.886
43 Tarragona;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2020QI;""
43 Tarragona;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
43 Tarragona;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2022QIII;14.393
43 Tarragona;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2022QII;""
43 Tarragona;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2022QI;""
43 Tarragona;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
43 Tarragona;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2021QIII;14.559
43 Tarragona;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2021QII;""
43 Tarragona;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2021QI;""
43 Tarragona;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
43 Tarragona;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2020QIII;14.460
43 Tarragona;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2020QII;""
43 Tarragona;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2020QI;""
43 Tarragona;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QIV;13.927
43 Tarragona;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
43 Tarragona;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QII;""
43 Tarragona;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QI;""
43 Tarragona;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QIV;14.184
43 Tarragona;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
43 Tarragona;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QII;""
43 Tarragona;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QI;""
43 Tarragona;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QIV;14.024
43 Tarragona;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
43 Tarragona;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QII;""
43 Tarragona;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QI;""
43 Tarragona;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
43 Tarragona;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
43 Tarragona;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QII;""
43 Tarragona;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QI;13.805
43 Tarragona;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
43 Tarragona;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
43 Tarragona;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QII;""
43 Tarragona;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QI;13.807
43 Tarragona;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
43 Tarragona;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
43 Tarragona;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QII;""
43 Tarragona;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QI;""
43 Tarragona;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
43 Tarragona;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
43 Tarragona;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
43 Tarragona;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
43 Tarragona;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
43 Tarragona;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
43 Tarragona;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
43 Tarragona;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
43 Tarragona;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
43 Tarragona;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
43 Tarragona;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
43 Tarragona;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
43 Tarragona;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
43 Tarragona;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
43 Tarragona;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;96,88
43 Tarragona;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
43 Tarragona;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
43 Tarragona;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
43 Tarragona;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;97,2
43 Tarragona;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
43 Tarragona;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
43 Tarragona;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
43 Tarragona;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;98,11
43 Tarragona;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
43 Tarragona;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
43 Tarragona;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;94,3
43 Tarragona;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
43 Tarragona;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
43 Tarragona;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
43 Tarragona;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;94,88
43 Tarragona;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
43 Tarragona;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
43 Tarragona;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
43 Tarragona;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;95,31
43 Tarragona;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
43 Tarragona;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
43 Tarragona;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;91,25
43 Tarragona;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
43 Tarragona;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
43 Tarragona;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
43 Tarragona;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;92,43
43 Tarragona;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
43 Tarragona;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
43 Tarragona;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
43 Tarragona;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;92,43
43 Tarragona;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
43 Tarragona;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
43 Tarragona;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
43 Tarragona;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
43 Tarragona;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
43 Tarragona;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
43 Tarragona;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;89,96
43 Tarragona;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
43 Tarragona;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
43 Tarragona;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
43 Tarragona;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;91
43 Tarragona;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
43 Tarragona;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
43 Tarragona;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
43 Tarragona;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
43 Tarragona;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
43 Tarragona;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
43 Tarragona;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QII;9.561
43 Tarragona;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
43 Tarragona;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
43 Tarragona;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
43 Tarragona;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QII;9.663
43 Tarragona;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
43 Tarragona;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
43 Tarragona;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
43 Tarragona;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QII;9.558
43 Tarragona;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
43 Tarragona;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
43 Tarragona;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
43 Tarragona;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2022QII;9.283
43 Tarragona;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2022QI;""
43 Tarragona;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
43 Tarragona;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
43 Tarragona;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2021QII;9.403
43 Tarragona;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2021QI;""
43 Tarragona;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
43 Tarragona;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
43 Tarragona;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2020QII;9.392
43 Tarragona;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2020QI;""
43 Tarragona;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
43 Tarragona;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2022QIII;9.053
43 Tarragona;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2022QII;""
43 Tarragona;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2022QI;""
43 Tarragona;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
43 Tarragona;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2021QIII;9.195
43 Tarragona;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2021QII;""
43 Tarragona;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2021QI;""
43 Tarragona;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
43 Tarragona;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2020QIII;9.140
43 Tarragona;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2020QII;""
43 Tarragona;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2020QI;""
43 Tarragona;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QIV;8.780
43 Tarragona;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
43 Tarragona;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QII;""
43 Tarragona;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QI;""
43 Tarragona;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QIV;8.980
43 Tarragona;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
43 Tarragona;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QII;""
43 Tarragona;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QI;""
43 Tarragona;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QIV;8.863
43 Tarragona;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
43 Tarragona;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QII;""
43 Tarragona;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QI;""
43 Tarragona;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
43 Tarragona;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
43 Tarragona;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QII;""
43 Tarragona;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QI;8.762
43 Tarragona;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
43 Tarragona;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
43 Tarragona;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QII;""
43 Tarragona;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QI;8.724
43 Tarragona;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
43 Tarragona;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
43 Tarragona;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QII;""
43 Tarragona;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QI;""
43 Tarragona;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
43 Tarragona;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
43 Tarragona;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
43 Tarragona;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
43 Tarragona;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
43 Tarragona;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
43 Tarragona;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
43 Tarragona;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
43 Tarragona;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
43 Tarragona;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
43 Tarragona;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
43 Tarragona;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
43 Tarragona;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
43 Tarragona;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
43 Tarragona;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;97,09
43 Tarragona;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
43 Tarragona;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
43 Tarragona;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
43 Tarragona;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;97,31
43 Tarragona;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
43 Tarragona;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
43 Tarragona;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
43 Tarragona;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;98,26
43 Tarragona;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
43 Tarragona;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
43 Tarragona;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;94,69
43 Tarragona;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
43 Tarragona;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
43 Tarragona;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
43 Tarragona;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;95,16
43 Tarragona;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
43 Tarragona;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
43 Tarragona;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
43 Tarragona;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;95,63
43 Tarragona;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
43 Tarragona;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
43 Tarragona;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;91,83
43 Tarragona;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
43 Tarragona;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
43 Tarragona;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
43 Tarragona;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;92,93
43 Tarragona;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
43 Tarragona;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
43 Tarragona;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
43 Tarragona;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;92,73
43 Tarragona;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
43 Tarragona;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
43 Tarragona;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
43 Tarragona;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
43 Tarragona;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
43 Tarragona;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
43 Tarragona;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;90,68
43 Tarragona;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
43 Tarragona;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
43 Tarragona;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
43 Tarragona;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;91,27
43 Tarragona;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
43 Tarragona;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
43 Tarragona;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
43 Tarragona;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
43 Tarragona;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
43 Tarragona;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
43 Tarragona;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QII;5.702
43 Tarragona;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
43 Tarragona;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
43 Tarragona;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
43 Tarragona;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QII;5.682
43 Tarragona;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
43 Tarragona;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
43 Tarragona;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
43 Tarragona;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QII;5.614
43 Tarragona;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
43 Tarragona;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
43 Tarragona;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
43 Tarragona;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2022QII;5.504
43 Tarragona;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2022QI;""
43 Tarragona;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
43 Tarragona;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
43 Tarragona;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2021QII;5.513
43 Tarragona;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2021QI;""
43 Tarragona;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
43 Tarragona;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
43 Tarragona;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2020QII;5.494
43 Tarragona;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2020QI;""
43 Tarragona;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
43 Tarragona;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2022QIII;5.340
43 Tarragona;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2022QII;""
43 Tarragona;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2022QI;""
43 Tarragona;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
43 Tarragona;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2021QIII;5.364
43 Tarragona;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2021QII;""
43 Tarragona;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2021QI;""
43 Tarragona;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
43 Tarragona;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2020QIII;5.320
43 Tarragona;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2020QII;""
43 Tarragona;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2020QI;""
43 Tarragona;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QIV;5.147
43 Tarragona;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
43 Tarragona;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QII;""
43 Tarragona;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QI;""
43 Tarragona;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QIV;5.204
43 Tarragona;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
43 Tarragona;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QII;""
43 Tarragona;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QI;""
43 Tarragona;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QIV;5.161
43 Tarragona;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
43 Tarragona;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QII;""
43 Tarragona;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QI;""
43 Tarragona;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
43 Tarragona;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
43 Tarragona;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QII;""
43 Tarragona;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QI;5.043
43 Tarragona;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
43 Tarragona;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
43 Tarragona;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QII;""
43 Tarragona;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QI;5.083
43 Tarragona;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
43 Tarragona;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
43 Tarragona;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QII;""
43 Tarragona;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QI;""
43 Tarragona;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
43 Tarragona;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
43 Tarragona;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
43 Tarragona;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
43 Tarragona;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
43 Tarragona;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
43 Tarragona;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
43 Tarragona;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
43 Tarragona;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
43 Tarragona;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
43 Tarragona;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
43 Tarragona;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
43 Tarragona;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
43 Tarragona;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
43 Tarragona;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;96,53
43 Tarragona;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
43 Tarragona;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
43 Tarragona;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
43 Tarragona;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;97,03
43 Tarragona;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
43 Tarragona;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
43 Tarragona;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
43 Tarragona;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;97,86
43 Tarragona;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
43 Tarragona;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
43 Tarragona;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;93,65
43 Tarragona;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
43 Tarragona;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
43 Tarragona;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
43 Tarragona;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;94,4
43 Tarragona;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
43 Tarragona;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
43 Tarragona;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
43 Tarragona;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;94,76
43 Tarragona;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
43 Tarragona;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
43 Tarragona;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;90,27
43 Tarragona;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
43 Tarragona;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
43 Tarragona;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
43 Tarragona;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;91,59
43 Tarragona;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
43 Tarragona;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
43 Tarragona;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
43 Tarragona;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;91,93
43 Tarragona;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
43 Tarragona;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
43 Tarragona;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
43 Tarragona;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
43 Tarragona;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
43 Tarragona;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
43 Tarragona;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;88,75
43 Tarragona;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
43 Tarragona;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
43 Tarragona;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
43 Tarragona;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;90,54
43 Tarragona;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
43 Tarragona;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
43 Tarragona;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
43 Tarragona;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
43 Tarragona;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
43 Tarragona;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QIII;15.495
43 Tarragona;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
43 Tarragona;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
43 Tarragona;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
43 Tarragona;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QIII;15.643
43 Tarragona;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
43 Tarragona;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
43 Tarragona;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
43 Tarragona;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QIII;15.466
43 Tarragona;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
43 Tarragona;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
43 Tarragona;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
43 Tarragona;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2022QIII;14.968
43 Tarragona;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2022QII;""
43 Tarragona;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2022QI;""
43 Tarragona;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
43 Tarragona;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2021QIII;15.147
43 Tarragona;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2021QII;""
43 Tarragona;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2021QI;""
43 Tarragona;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
43 Tarragona;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2020QIII;14.923
43 Tarragona;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2020QII;""
43 Tarragona;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2020QI;""
43 Tarragona;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2022QIV;14.377
43 Tarragona;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
43 Tarragona;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2022QII;""
43 Tarragona;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2022QI;""
43 Tarragona;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2021QIV;14.671
43 Tarragona;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
43 Tarragona;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2021QII;""
43 Tarragona;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2021QI;""
43 Tarragona;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2020QIV;14.420
43 Tarragona;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
43 Tarragona;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2020QII;""
43 Tarragona;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2020QI;""
43 Tarragona;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
43 Tarragona;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
43 Tarragona;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QII;""
43 Tarragona;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QI;14.248
43 Tarragona;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
43 Tarragona;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
43 Tarragona;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QII;""
43 Tarragona;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QI;14.187
43 Tarragona;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
43 Tarragona;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
43 Tarragona;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QII;""
43 Tarragona;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QI;""
43 Tarragona;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
43 Tarragona;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
43 Tarragona;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QII;13.894
43 Tarragona;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QI;""
43 Tarragona;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
43 Tarragona;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
43 Tarragona;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QII;13.883
43 Tarragona;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QI;""
43 Tarragona;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
43 Tarragona;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
43 Tarragona;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QII;""
43 Tarragona;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QI;""
43 Tarragona;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
43 Tarragona;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
43 Tarragona;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
43 Tarragona;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
43 Tarragona;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
43 Tarragona;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
43 Tarragona;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
43 Tarragona;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
43 Tarragona;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
43 Tarragona;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
43 Tarragona;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
43 Tarragona;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
43 Tarragona;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
43 Tarragona;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;96,6
43 Tarragona;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
43 Tarragona;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
43 Tarragona;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
43 Tarragona;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;96,83
43 Tarragona;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
43 Tarragona;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
43 Tarragona;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
43 Tarragona;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;96,49
43 Tarragona;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
43 Tarragona;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
43 Tarragona;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;92,78
43 Tarragona;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
43 Tarragona;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
43 Tarragona;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
43 Tarragona;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;93,79
43 Tarragona;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
43 Tarragona;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
43 Tarragona;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
43 Tarragona;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;93,24
43 Tarragona;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
43 Tarragona;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
43 Tarragona;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
43 Tarragona;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
43 Tarragona;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
43 Tarragona;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
43 Tarragona;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;91,08
43 Tarragona;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
43 Tarragona;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
43 Tarragona;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
43 Tarragona;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;91,73
43 Tarragona;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
43 Tarragona;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
43 Tarragona;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
43 Tarragona;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
43 Tarragona;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
43 Tarragona;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
43 Tarragona;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;88,82
43 Tarragona;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
43 Tarragona;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
43 Tarragona;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
43 Tarragona;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;89,76
43 Tarragona;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
43 Tarragona;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
43 Tarragona;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
43 Tarragona;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
43 Tarragona;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
43 Tarragona;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
43 Tarragona;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QIII;9.693
43 Tarragona;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
43 Tarragona;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
43 Tarragona;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
43 Tarragona;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QIII;9.835
43 Tarragona;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
43 Tarragona;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
43 Tarragona;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
43 Tarragona;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QIII;9.749
43 Tarragona;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
43 Tarragona;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
43 Tarragona;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
43 Tarragona;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2022QIII;9.392
43 Tarragona;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2022QII;""
43 Tarragona;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2022QI;""
43 Tarragona;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
43 Tarragona;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2021QIII;9.548
43 Tarragona;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2021QII;""
43 Tarragona;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2021QI;""
43 Tarragona;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
43 Tarragona;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2020QIII;9.424
43 Tarragona;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2020QII;""
43 Tarragona;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2020QI;""
43 Tarragona;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2022QIV;9.044
43 Tarragona;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
43 Tarragona;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2022QII;""
43 Tarragona;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2022QI;""
43 Tarragona;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2021QIV;9.274
43 Tarragona;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
43 Tarragona;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2021QII;""
43 Tarragona;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2021QI;""
43 Tarragona;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2020QIV;9.109
43 Tarragona;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
43 Tarragona;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2020QII;""
43 Tarragona;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2020QI;""
43 Tarragona;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
43 Tarragona;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
43 Tarragona;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QII;""
43 Tarragona;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QI;9.032
43 Tarragona;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
43 Tarragona;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
43 Tarragona;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QII;""
43 Tarragona;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QI;8.957
43 Tarragona;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
43 Tarragona;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
43 Tarragona;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QII;""
43 Tarragona;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QI;""
43 Tarragona;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
43 Tarragona;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
43 Tarragona;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QII;8.818
43 Tarragona;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QI;""
43 Tarragona;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
43 Tarragona;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
43 Tarragona;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QII;8.782
43 Tarragona;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QI;""
43 Tarragona;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
43 Tarragona;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
43 Tarragona;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QII;""
43 Tarragona;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QI;""
43 Tarragona;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
43 Tarragona;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
43 Tarragona;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
43 Tarragona;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
43 Tarragona;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
43 Tarragona;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
43 Tarragona;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
43 Tarragona;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
43 Tarragona;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
43 Tarragona;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
43 Tarragona;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
43 Tarragona;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
43 Tarragona;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
43 Tarragona;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;96,89
43 Tarragona;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
43 Tarragona;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
43 Tarragona;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
43 Tarragona;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;97,08
43 Tarragona;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
43 Tarragona;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
43 Tarragona;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
43 Tarragona;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;96,67
43 Tarragona;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
43 Tarragona;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
43 Tarragona;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;93,3
43 Tarragona;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
43 Tarragona;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
43 Tarragona;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
43 Tarragona;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;94,3
43 Tarragona;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
43 Tarragona;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
43 Tarragona;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
43 Tarragona;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;93,44
43 Tarragona;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
43 Tarragona;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
43 Tarragona;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
43 Tarragona;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
43 Tarragona;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
43 Tarragona;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
43 Tarragona;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;91,84
43 Tarragona;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
43 Tarragona;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
43 Tarragona;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
43 Tarragona;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;91,88
43 Tarragona;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
43 Tarragona;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
43 Tarragona;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
43 Tarragona;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
43 Tarragona;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
43 Tarragona;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
43 Tarragona;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;89,66
43 Tarragona;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
43 Tarragona;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
43 Tarragona;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
43 Tarragona;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;90,08
43 Tarragona;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
43 Tarragona;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
43 Tarragona;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
43 Tarragona;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
43 Tarragona;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
43 Tarragona;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
43 Tarragona;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QIII;5.802
43 Tarragona;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
43 Tarragona;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
43 Tarragona;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
43 Tarragona;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QIII;5.808
43 Tarragona;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
43 Tarragona;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
43 Tarragona;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
43 Tarragona;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QIII;5.717
43 Tarragona;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
43 Tarragona;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
43 Tarragona;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
43 Tarragona;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2022QIII;5.576
43 Tarragona;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2022QII;""
43 Tarragona;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2022QI;""
43 Tarragona;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
43 Tarragona;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2021QIII;5.599
43 Tarragona;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2021QII;""
43 Tarragona;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2021QI;""
43 Tarragona;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
43 Tarragona;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2020QIII;5.499
43 Tarragona;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2020QII;""
43 Tarragona;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2020QI;""
43 Tarragona;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2022QIV;5.333
43 Tarragona;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
43 Tarragona;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2022QII;""
43 Tarragona;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2022QI;""
43 Tarragona;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2021QIV;5.397
43 Tarragona;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
43 Tarragona;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2021QII;""
43 Tarragona;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2021QI;""
43 Tarragona;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2020QIV;5.311
43 Tarragona;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
43 Tarragona;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2020QII;""
43 Tarragona;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2020QI;""
43 Tarragona;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
43 Tarragona;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
43 Tarragona;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QII;""
43 Tarragona;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QI;5.216
43 Tarragona;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
43 Tarragona;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
43 Tarragona;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QII;""
43 Tarragona;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QI;5.230
43 Tarragona;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
43 Tarragona;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
43 Tarragona;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QII;""
43 Tarragona;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QI;""
43 Tarragona;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
43 Tarragona;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
43 Tarragona;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QII;5.076
43 Tarragona;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QI;""
43 Tarragona;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
43 Tarragona;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
43 Tarragona;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QII;5.101
43 Tarragona;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QI;""
43 Tarragona;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
43 Tarragona;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
43 Tarragona;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QII;""
43 Tarragona;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QI;""
43 Tarragona;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
43 Tarragona;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
43 Tarragona;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
43 Tarragona;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
43 Tarragona;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
43 Tarragona;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
43 Tarragona;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
43 Tarragona;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
43 Tarragona;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
43 Tarragona;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
43 Tarragona;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
43 Tarragona;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
43 Tarragona;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
43 Tarragona;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;96,1
43 Tarragona;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
43 Tarragona;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
43 Tarragona;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
43 Tarragona;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;96,4
43 Tarragona;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
43 Tarragona;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
43 Tarragona;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
43 Tarragona;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;96,19
43 Tarragona;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
43 Tarragona;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
43 Tarragona;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;91,92
43 Tarragona;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
43 Tarragona;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
43 Tarragona;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
43 Tarragona;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;92,92
43 Tarragona;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
43 Tarragona;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
43 Tarragona;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
43 Tarragona;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;92,9
43 Tarragona;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
43 Tarragona;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
43 Tarragona;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
43 Tarragona;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
43 Tarragona;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
43 Tarragona;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
43 Tarragona;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;89,81
43 Tarragona;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
43 Tarragona;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
43 Tarragona;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
43 Tarragona;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;91,48
43 Tarragona;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
43 Tarragona;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
43 Tarragona;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
43 Tarragona;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
43 Tarragona;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
43 Tarragona;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
43 Tarragona;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;87,4
43 Tarragona;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
43 Tarragona;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
43 Tarragona;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
43 Tarragona;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;89,23
43 Tarragona;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
43 Tarragona;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
43 Tarragona;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
43 Tarragona;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
43 Tarragona;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
43 Tarragona;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QIV;15.442
43 Tarragona;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
43 Tarragona;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
43 Tarragona;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
43 Tarragona;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QIV;15.617
43 Tarragona;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
43 Tarragona;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
43 Tarragona;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
43 Tarragona;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QIV;15.485
43 Tarragona;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
43 Tarragona;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
43 Tarragona;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
43 Tarragona;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2022QIV;14.798
43 Tarragona;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
43 Tarragona;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2022QII;""
43 Tarragona;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2022QI;""
43 Tarragona;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2021QIV;15.080
43 Tarragona;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
43 Tarragona;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2021QII;""
43 Tarragona;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2021QI;""
43 Tarragona;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2020QIV;14.902
43 Tarragona;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
43 Tarragona;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2020QII;""
43 Tarragona;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2020QI;""
43 Tarragona;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
43 Tarragona;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
43 Tarragona;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2022QII;""
43 Tarragona;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2022QI;14.615
43 Tarragona;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
43 Tarragona;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
43 Tarragona;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2021QII;""
43 Tarragona;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2021QI;14.638
43 Tarragona;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
43 Tarragona;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
43 Tarragona;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2020QII;""
43 Tarragona;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2020QI;""
43 Tarragona;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
43 Tarragona;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
43 Tarragona;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QII;14.236
43 Tarragona;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QI;""
43 Tarragona;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
43 Tarragona;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
43 Tarragona;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QII;14.303
43 Tarragona;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QI;""
43 Tarragona;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
43 Tarragona;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
43 Tarragona;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QII;""
43 Tarragona;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QI;""
43 Tarragona;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
43 Tarragona;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QIII;13.921
43 Tarragona;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QII;""
43 Tarragona;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QI;""
43 Tarragona;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
43 Tarragona;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QIII;14.033
43 Tarragona;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QII;""
43 Tarragona;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QI;""
43 Tarragona;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
43 Tarragona;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
43 Tarragona;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QII;""
43 Tarragona;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QI;""
43 Tarragona;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
43 Tarragona;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
43 Tarragona;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
43 Tarragona;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
43 Tarragona;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
43 Tarragona;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
43 Tarragona;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
43 Tarragona;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
43 Tarragona;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
43 Tarragona;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
43 Tarragona;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
43 Tarragona;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
43 Tarragona;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;95,83
43 Tarragona;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
43 Tarragona;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
43 Tarragona;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
43 Tarragona;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;96,56
43 Tarragona;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
43 Tarragona;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
43 Tarragona;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
43 Tarragona;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;96,24
43 Tarragona;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
43 Tarragona;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
43 Tarragona;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
43 Tarragona;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
43 Tarragona;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
43 Tarragona;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
43 Tarragona;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;93,58
43 Tarragona;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
43 Tarragona;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
43 Tarragona;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
43 Tarragona;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;94,53
43 Tarragona;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
43 Tarragona;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
43 Tarragona;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
43 Tarragona;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
43 Tarragona;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
43 Tarragona;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
43 Tarragona;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;91,16
43 Tarragona;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
43 Tarragona;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
43 Tarragona;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
43 Tarragona;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;92,37
43 Tarragona;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
43 Tarragona;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
43 Tarragona;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
43 Tarragona;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
43 Tarragona;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
43 Tarragona;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
43 Tarragona;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;89,14
43 Tarragona;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
43 Tarragona;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
43 Tarragona;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
43 Tarragona;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;90,62
43 Tarragona;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
43 Tarragona;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
43 Tarragona;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
43 Tarragona;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
43 Tarragona;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
43 Tarragona;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
43 Tarragona;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QIV;9.651
43 Tarragona;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
43 Tarragona;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
43 Tarragona;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
43 Tarragona;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QIV;9.801
43 Tarragona;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
43 Tarragona;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
43 Tarragona;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
43 Tarragona;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QIV;9.773
43 Tarragona;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
43 Tarragona;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
43 Tarragona;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
43 Tarragona;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2022QIV;9.267
43 Tarragona;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
43 Tarragona;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2022QII;""
43 Tarragona;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2022QI;""
43 Tarragona;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2021QIV;9.497
43 Tarragona;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
43 Tarragona;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2021QII;""
43 Tarragona;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2021QI;""
43 Tarragona;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2020QIV;9.408
43 Tarragona;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
43 Tarragona;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2020QII;""
43 Tarragona;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2020QI;""
43 Tarragona;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
43 Tarragona;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
43 Tarragona;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2022QII;""
43 Tarragona;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2022QI;9.228
43 Tarragona;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
43 Tarragona;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
43 Tarragona;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2021QII;""
43 Tarragona;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2021QI;9.243
43 Tarragona;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
43 Tarragona;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
43 Tarragona;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2020QII;""
43 Tarragona;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2020QI;""
43 Tarragona;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
43 Tarragona;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
43 Tarragona;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QII;9.001
43 Tarragona;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QI;""
43 Tarragona;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
43 Tarragona;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
43 Tarragona;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QII;9.049
43 Tarragona;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QI;""
43 Tarragona;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
43 Tarragona;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
43 Tarragona;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QII;""
43 Tarragona;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QI;""
43 Tarragona;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
43 Tarragona;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QIII;8.823
43 Tarragona;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QII;""
43 Tarragona;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QI;""
43 Tarragona;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
43 Tarragona;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QIII;8.897
43 Tarragona;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QII;""
43 Tarragona;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QI;""
43 Tarragona;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
43 Tarragona;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
43 Tarragona;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QII;""
43 Tarragona;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QI;""
43 Tarragona;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
43 Tarragona;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
43 Tarragona;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
43 Tarragona;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
43 Tarragona;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
43 Tarragona;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
43 Tarragona;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
43 Tarragona;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
43 Tarragona;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
43 Tarragona;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
43 Tarragona;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
43 Tarragona;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
43 Tarragona;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;96,02
43 Tarragona;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
43 Tarragona;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
43 Tarragona;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
43 Tarragona;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;96,9
43 Tarragona;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
43 Tarragona;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
43 Tarragona;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
43 Tarragona;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;96,27
43 Tarragona;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
43 Tarragona;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
43 Tarragona;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
43 Tarragona;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
43 Tarragona;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
43 Tarragona;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
43 Tarragona;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;94,15
43 Tarragona;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
43 Tarragona;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
43 Tarragona;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
43 Tarragona;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;94,58
43 Tarragona;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
43 Tarragona;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
43 Tarragona;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
43 Tarragona;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
43 Tarragona;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
43 Tarragona;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
43 Tarragona;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;91,84
43 Tarragona;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
43 Tarragona;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
43 Tarragona;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
43 Tarragona;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;92,59
43 Tarragona;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
43 Tarragona;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
43 Tarragona;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
43 Tarragona;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
43 Tarragona;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
43 Tarragona;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
43 Tarragona;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;90,02
43 Tarragona;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
43 Tarragona;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
43 Tarragona;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
43 Tarragona;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;91,04
43 Tarragona;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
43 Tarragona;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
43 Tarragona;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
43 Tarragona;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
43 Tarragona;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
43 Tarragona;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
43 Tarragona;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QIV;5.791
43 Tarragona;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
43 Tarragona;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
43 Tarragona;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
43 Tarragona;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QIV;5.816
43 Tarragona;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
43 Tarragona;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
43 Tarragona;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
43 Tarragona;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QIV;5.712
43 Tarragona;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
43 Tarragona;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
43 Tarragona;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
43 Tarragona;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2022QIV;5.531
43 Tarragona;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
43 Tarragona;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2022QII;""
43 Tarragona;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2022QI;""
43 Tarragona;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2021QIV;5.583
43 Tarragona;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
43 Tarragona;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2021QII;""
43 Tarragona;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2021QI;""
43 Tarragona;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2020QIV;5.494
43 Tarragona;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
43 Tarragona;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2020QII;""
43 Tarragona;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2020QI;""
43 Tarragona;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
43 Tarragona;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
43 Tarragona;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2022QII;""
43 Tarragona;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2022QI;5.387
43 Tarragona;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
43 Tarragona;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
43 Tarragona;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2021QII;""
43 Tarragona;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2021QI;5.395
43 Tarragona;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
43 Tarragona;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
43 Tarragona;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2020QII;""
43 Tarragona;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2020QI;""
43 Tarragona;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
43 Tarragona;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
43 Tarragona;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QII;5.235
43 Tarragona;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QI;""
43 Tarragona;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
43 Tarragona;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
43 Tarragona;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QII;5.254
43 Tarragona;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QI;""
43 Tarragona;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
43 Tarragona;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
43 Tarragona;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QII;""
43 Tarragona;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QI;""
43 Tarragona;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
43 Tarragona;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QIII;5.098
43 Tarragona;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QII;""
43 Tarragona;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QI;""
43 Tarragona;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
43 Tarragona;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QIII;5.136
43 Tarragona;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QII;""
43 Tarragona;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QI;""
43 Tarragona;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
43 Tarragona;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
43 Tarragona;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QII;""
43 Tarragona;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QI;""
43 Tarragona;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
43 Tarragona;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
43 Tarragona;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
43 Tarragona;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
43 Tarragona;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
43 Tarragona;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
43 Tarragona;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
43 Tarragona;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
43 Tarragona;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
43 Tarragona;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
43 Tarragona;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
43 Tarragona;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
43 Tarragona;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;95,51
43 Tarragona;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
43 Tarragona;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
43 Tarragona;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
43 Tarragona;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;95,99
43 Tarragona;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
43 Tarragona;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
43 Tarragona;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
43 Tarragona;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;96,18
43 Tarragona;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
43 Tarragona;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
43 Tarragona;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
43 Tarragona;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
43 Tarragona;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
43 Tarragona;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
43 Tarragona;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;92,62
43 Tarragona;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
43 Tarragona;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
43 Tarragona;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
43 Tarragona;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;94,45
43 Tarragona;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
43 Tarragona;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
43 Tarragona;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
43 Tarragona;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
43 Tarragona;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
43 Tarragona;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
43 Tarragona;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;90,01
43 Tarragona;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
43 Tarragona;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
43 Tarragona;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
43 Tarragona;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;91,98
43 Tarragona;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
43 Tarragona;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
43 Tarragona;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
43 Tarragona;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
43 Tarragona;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
43 Tarragona;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
43 Tarragona;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;87,65
43 Tarragona;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
43 Tarragona;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
43 Tarragona;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
43 Tarragona;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;89,92
43 Tarragona;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
43 Tarragona;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
43 Tarragona;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
43 Tarragona;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
43 Tarragona;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
43 Tarragona;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
43 Tarragona;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
43 Tarragona;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
43 Tarragona;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
43 Tarragona;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QI;14.313
43 Tarragona;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
43 Tarragona;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
43 Tarragona;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
43 Tarragona;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QI;13.944
43 Tarragona;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
43 Tarragona;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
43 Tarragona;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
43 Tarragona;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QI;14.290
43 Tarragona;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
43 Tarragona;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
43 Tarragona;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2022QII;""
43 Tarragona;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2022QI;13.947
43 Tarragona;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
43 Tarragona;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
43 Tarragona;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2021QII;""
43 Tarragona;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2021QI;13.700
43 Tarragona;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
43 Tarragona;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
43 Tarragona;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2020QII;""
43 Tarragona;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2020QI;13.622
43 Tarragona;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
43 Tarragona;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
43 Tarragona;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2022QII;13.642
43 Tarragona;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2022QI;""
43 Tarragona;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
43 Tarragona;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
43 Tarragona;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2021QII;13.454
43 Tarragona;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2021QI;""
43 Tarragona;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
43 Tarragona;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
43 Tarragona;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2020QII;13.406
43 Tarragona;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2020QI;""
43 Tarragona;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
43 Tarragona;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QIII;13.337
43 Tarragona;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QII;""
43 Tarragona;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QI;""
43 Tarragona;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
43 Tarragona;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QIII;13.265
43 Tarragona;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QII;""
43 Tarragona;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QI;""
43 Tarragona;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
43 Tarragona;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QIII;13.153
43 Tarragona;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QII;""
43 Tarragona;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QI;""
43 Tarragona;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QIV;13.026
43 Tarragona;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
43 Tarragona;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QII;""
43 Tarragona;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QI;""
43 Tarragona;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QIV;12.999
43 Tarragona;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
43 Tarragona;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QII;""
43 Tarragona;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QI;""
43 Tarragona;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QIV;12.881
43 Tarragona;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
43 Tarragona;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QII;""
43 Tarragona;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QI;""
43 Tarragona;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
43 Tarragona;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
43 Tarragona;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
43 Tarragona;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
43 Tarragona;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
43 Tarragona;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
43 Tarragona;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
43 Tarragona;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
43 Tarragona;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
43 Tarragona;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
43 Tarragona;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
43 Tarragona;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
43 Tarragona;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
43 Tarragona;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
43 Tarragona;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
43 Tarragona;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;97,44
43 Tarragona;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
43 Tarragona;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
43 Tarragona;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
43 Tarragona;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;98,25
43 Tarragona;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
43 Tarragona;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
43 Tarragona;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
43 Tarragona;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;95,33
43 Tarragona;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
43 Tarragona;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
43 Tarragona;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;95,31
43 Tarragona;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
43 Tarragona;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
43 Tarragona;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
43 Tarragona;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;96,49
43 Tarragona;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
43 Tarragona;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
43 Tarragona;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
43 Tarragona;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;93,81
43 Tarragona;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
43 Tarragona;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
43 Tarragona;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;93,18
43 Tarragona;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
43 Tarragona;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
43 Tarragona;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
43 Tarragona;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;95,13
43 Tarragona;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
43 Tarragona;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
43 Tarragona;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
43 Tarragona;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;92,04
43 Tarragona;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
43 Tarragona;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
43 Tarragona;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;91,01
43 Tarragona;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
43 Tarragona;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
43 Tarragona;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
43 Tarragona;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;93,22
43 Tarragona;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
43 Tarragona;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
43 Tarragona;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
43 Tarragona;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;90,14
43 Tarragona;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
43 Tarragona;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
43 Tarragona;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
43 Tarragona;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
43 Tarragona;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
43 Tarragona;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
43 Tarragona;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QI;9.028
43 Tarragona;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
43 Tarragona;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
43 Tarragona;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
43 Tarragona;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QI;8.816
43 Tarragona;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
43 Tarragona;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
43 Tarragona;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
43 Tarragona;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QI;9.032
43 Tarragona;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
43 Tarragona;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
43 Tarragona;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2022QII;""
43 Tarragona;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2022QI;8.818
43 Tarragona;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
43 Tarragona;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
43 Tarragona;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2021QII;""
43 Tarragona;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2021QI;8.665
43 Tarragona;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
43 Tarragona;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
43 Tarragona;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2020QII;""
43 Tarragona;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2020QI;8.624
43 Tarragona;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
43 Tarragona;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
43 Tarragona;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2022QII;8.642
43 Tarragona;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2022QI;""
43 Tarragona;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
43 Tarragona;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
43 Tarragona;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2021QII;8.512
43 Tarragona;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2021QI;""
43 Tarragona;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
43 Tarragona;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
43 Tarragona;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2020QII;8.505
43 Tarragona;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2020QI;""
43 Tarragona;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
43 Tarragona;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QIII;8.460
43 Tarragona;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QII;""
43 Tarragona;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QI;""
43 Tarragona;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
43 Tarragona;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QIII;8.394
43 Tarragona;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QII;""
43 Tarragona;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QI;""
43 Tarragona;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
43 Tarragona;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QIII;8.353
43 Tarragona;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QII;""
43 Tarragona;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QI;""
43 Tarragona;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QIV;8.290
43 Tarragona;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
43 Tarragona;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QII;""
43 Tarragona;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QI;""
43 Tarragona;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QIV;8.228
43 Tarragona;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
43 Tarragona;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QII;""
43 Tarragona;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QI;""
43 Tarragona;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QIV;8.175
43 Tarragona;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
43 Tarragona;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QII;""
43 Tarragona;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QI;""
43 Tarragona;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
43 Tarragona;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
43 Tarragona;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
43 Tarragona;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
43 Tarragona;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
43 Tarragona;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
43 Tarragona;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
43 Tarragona;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
43 Tarragona;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
43 Tarragona;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
43 Tarragona;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
43 Tarragona;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
43 Tarragona;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
43 Tarragona;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
43 Tarragona;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
43 Tarragona;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;97,67
43 Tarragona;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
43 Tarragona;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
43 Tarragona;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
43 Tarragona;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;98,29
43 Tarragona;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
43 Tarragona;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
43 Tarragona;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
43 Tarragona;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;95,48
43 Tarragona;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
43 Tarragona;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
43 Tarragona;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;95,72
43 Tarragona;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
43 Tarragona;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
43 Tarragona;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
43 Tarragona;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;96,55
43 Tarragona;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
43 Tarragona;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
43 Tarragona;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
43 Tarragona;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;94,17
43 Tarragona;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
43 Tarragona;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
43 Tarragona;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;93,71
43 Tarragona;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
43 Tarragona;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
43 Tarragona;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
43 Tarragona;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;95,21
43 Tarragona;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
43 Tarragona;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
43 Tarragona;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
43 Tarragona;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;92,48
43 Tarragona;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
43 Tarragona;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
43 Tarragona;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;91,83
43 Tarragona;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
43 Tarragona;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
43 Tarragona;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
43 Tarragona;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;93,33
43 Tarragona;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
43 Tarragona;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
43 Tarragona;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
43 Tarragona;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;90,51
43 Tarragona;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
43 Tarragona;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
43 Tarragona;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
43 Tarragona;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
43 Tarragona;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
43 Tarragona;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
43 Tarragona;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QI;5.285
43 Tarragona;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
43 Tarragona;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
43 Tarragona;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
43 Tarragona;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QI;5.128
43 Tarragona;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
43 Tarragona;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
43 Tarragona;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
43 Tarragona;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QI;5.258
43 Tarragona;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
43 Tarragona;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
43 Tarragona;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2022QII;""
43 Tarragona;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2022QI;5.129
43 Tarragona;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
43 Tarragona;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
43 Tarragona;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2021QII;""
43 Tarragona;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2021QI;5.035
43 Tarragona;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
43 Tarragona;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
43 Tarragona;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2020QII;""
43 Tarragona;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2020QI;4.998
43 Tarragona;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
43 Tarragona;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
43 Tarragona;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2022QII;5.000
43 Tarragona;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2022QI;""
43 Tarragona;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
43 Tarragona;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
43 Tarragona;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2021QII;4.942
43 Tarragona;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2021QI;""
43 Tarragona;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
43 Tarragona;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
43 Tarragona;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2020QII;4.901
43 Tarragona;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2020QI;""
43 Tarragona;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
43 Tarragona;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QIII;4.877
43 Tarragona;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QII;""
43 Tarragona;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QI;""
43 Tarragona;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
43 Tarragona;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QIII;4.871
43 Tarragona;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QII;""
43 Tarragona;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QI;""
43 Tarragona;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
43 Tarragona;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QIII;4.800
43 Tarragona;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QII;""
43 Tarragona;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QI;""
43 Tarragona;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QIV;4.736
43 Tarragona;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
43 Tarragona;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QII;""
43 Tarragona;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QI;""
43 Tarragona;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QIV;4.771
43 Tarragona;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
43 Tarragona;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QII;""
43 Tarragona;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QI;""
43 Tarragona;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QIV;4.706
43 Tarragona;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
43 Tarragona;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QII;""
43 Tarragona;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QI;""
43 Tarragona;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
43 Tarragona;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
43 Tarragona;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
43 Tarragona;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
43 Tarragona;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
43 Tarragona;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
43 Tarragona;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
43 Tarragona;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
43 Tarragona;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
43 Tarragona;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
43 Tarragona;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
43 Tarragona;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
43 Tarragona;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
43 Tarragona;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
43 Tarragona;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
43 Tarragona;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;97,05
43 Tarragona;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
43 Tarragona;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
43 Tarragona;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
43 Tarragona;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;98,19
43 Tarragona;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
43 Tarragona;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
43 Tarragona;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
43 Tarragona;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;95,06
43 Tarragona;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
43 Tarragona;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
43 Tarragona;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;94,61
43 Tarragona;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
43 Tarragona;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
43 Tarragona;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
43 Tarragona;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;96,37
43 Tarragona;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
43 Tarragona;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
43 Tarragona;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
43 Tarragona;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;93,21
43 Tarragona;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
43 Tarragona;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
43 Tarragona;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;92,28
43 Tarragona;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
43 Tarragona;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
43 Tarragona;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
43 Tarragona;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;94,99
43 Tarragona;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
43 Tarragona;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
43 Tarragona;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
43 Tarragona;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;91,29
43 Tarragona;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
43 Tarragona;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
43 Tarragona;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;89,61
43 Tarragona;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
43 Tarragona;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
43 Tarragona;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
43 Tarragona;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;93,04
43 Tarragona;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
43 Tarragona;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
43 Tarragona;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
43 Tarragona;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;89,5
43 Tarragona;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
43 Tarragona;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
43 Tarragona;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
43 Tarragona;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
43 Tarragona;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
43 Tarragona;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QII;14.668
43 Tarragona;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
43 Tarragona;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
43 Tarragona;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
43 Tarragona;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QII;14.444
43 Tarragona;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
43 Tarragona;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
43 Tarragona;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
43 Tarragona;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QII;14.028
43 Tarragona;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
43 Tarragona;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
43 Tarragona;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
43 Tarragona;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2022QII;14.321
43 Tarragona;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2022QI;""
43 Tarragona;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
43 Tarragona;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
43 Tarragona;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2021QII;14.154
43 Tarragona;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2021QI;""
43 Tarragona;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
43 Tarragona;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
43 Tarragona;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2020QII;13.795
43 Tarragona;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2020QI;""
43 Tarragona;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
43 Tarragona;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2022QIII;13.973
43 Tarragona;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2022QII;""
43 Tarragona;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2022QI;""
43 Tarragona;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
43 Tarragona;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2021QIII;13.916
43 Tarragona;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2021QII;""
43 Tarragona;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2021QI;""
43 Tarragona;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
43 Tarragona;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2020QIII;13.504
43 Tarragona;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2020QII;""
43 Tarragona;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2020QI;""
43 Tarragona;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QIV;13.611
43 Tarragona;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
43 Tarragona;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QII;""
43 Tarragona;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QI;""
43 Tarragona;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QIV;13.581
43 Tarragona;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
43 Tarragona;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QII;""
43 Tarragona;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QI;""
43 Tarragona;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QIV;13.194
43 Tarragona;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
43 Tarragona;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QII;""
43 Tarragona;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QI;""
43 Tarragona;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
43 Tarragona;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
43 Tarragona;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QII;""
43 Tarragona;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QI;13.291
43 Tarragona;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
43 Tarragona;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
43 Tarragona;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QII;""
43 Tarragona;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QI;13.004
43 Tarragona;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
43 Tarragona;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
43 Tarragona;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QII;""
43 Tarragona;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QI;""
43 Tarragona;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
43 Tarragona;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
43 Tarragona;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
43 Tarragona;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
43 Tarragona;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
43 Tarragona;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
43 Tarragona;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
43 Tarragona;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
43 Tarragona;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
43 Tarragona;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
43 Tarragona;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
43 Tarragona;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
43 Tarragona;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
43 Tarragona;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
43 Tarragona;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;97,63
43 Tarragona;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
43 Tarragona;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
43 Tarragona;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
43 Tarragona;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;97,99
43 Tarragona;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
43 Tarragona;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
43 Tarragona;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
43 Tarragona;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;98,34
43 Tarragona;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
43 Tarragona;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
43 Tarragona;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;95,26
43 Tarragona;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
43 Tarragona;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
43 Tarragona;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
43 Tarragona;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;96,34
43 Tarragona;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
43 Tarragona;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
43 Tarragona;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
43 Tarragona;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;96,26
43 Tarragona;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
43 Tarragona;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
43 Tarragona;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;92,79
43 Tarragona;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
43 Tarragona;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
43 Tarragona;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
43 Tarragona;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;94,03
43 Tarragona;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
43 Tarragona;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
43 Tarragona;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
43 Tarragona;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;94,05
43 Tarragona;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
43 Tarragona;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
43 Tarragona;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
43 Tarragona;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
43 Tarragona;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
43 Tarragona;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
43 Tarragona;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;92,02
43 Tarragona;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
43 Tarragona;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
43 Tarragona;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
43 Tarragona;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;92,7
43 Tarragona;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
43 Tarragona;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
43 Tarragona;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
43 Tarragona;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
43 Tarragona;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
43 Tarragona;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
43 Tarragona;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QII;9.252
43 Tarragona;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
43 Tarragona;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
43 Tarragona;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
43 Tarragona;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QII;9.132
43 Tarragona;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
43 Tarragona;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
43 Tarragona;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
43 Tarragona;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QII;8.876
43 Tarragona;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
43 Tarragona;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
43 Tarragona;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
43 Tarragona;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2022QII;9.053
43 Tarragona;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2022QI;""
43 Tarragona;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
43 Tarragona;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
43 Tarragona;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2021QII;8.954
43 Tarragona;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2021QI;""
43 Tarragona;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
43 Tarragona;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
43 Tarragona;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2020QII;8.745
43 Tarragona;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2020QI;""
43 Tarragona;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
43 Tarragona;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2022QIII;8.848
43 Tarragona;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2022QII;""
43 Tarragona;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2022QI;""
43 Tarragona;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
43 Tarragona;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2021QIII;8.809
43 Tarragona;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2021QII;""
43 Tarragona;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2021QI;""
43 Tarragona;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
43 Tarragona;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2020QIII;8.568
43 Tarragona;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2020QII;""
43 Tarragona;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2020QI;""
43 Tarragona;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QIV;8.649
43 Tarragona;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
43 Tarragona;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QII;""
43 Tarragona;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QI;""
43 Tarragona;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QIV;8.600
43 Tarragona;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
43 Tarragona;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QII;""
43 Tarragona;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QI;""
43 Tarragona;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QIV;8.364
43 Tarragona;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
43 Tarragona;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QII;""
43 Tarragona;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QI;""
43 Tarragona;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
43 Tarragona;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
43 Tarragona;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QII;""
43 Tarragona;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QI;8.436
43 Tarragona;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
43 Tarragona;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
43 Tarragona;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QII;""
43 Tarragona;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QI;8.253
43 Tarragona;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
43 Tarragona;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
43 Tarragona;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QII;""
43 Tarragona;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QI;""
43 Tarragona;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
43 Tarragona;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
43 Tarragona;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
43 Tarragona;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
43 Tarragona;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
43 Tarragona;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
43 Tarragona;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
43 Tarragona;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
43 Tarragona;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
43 Tarragona;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
43 Tarragona;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
43 Tarragona;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
43 Tarragona;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
43 Tarragona;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
43 Tarragona;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;97,85
43 Tarragona;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
43 Tarragona;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
43 Tarragona;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
43 Tarragona;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;98,05
43 Tarragona;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
43 Tarragona;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
43 Tarragona;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
43 Tarragona;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;98,52
43 Tarragona;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
43 Tarragona;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
43 Tarragona;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;95,63
43 Tarragona;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
43 Tarragona;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
43 Tarragona;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
43 Tarragona;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;96,46
43 Tarragona;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
43 Tarragona;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
43 Tarragona;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
43 Tarragona;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;96,53
43 Tarragona;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
43 Tarragona;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
43 Tarragona;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;93,48
43 Tarragona;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
43 Tarragona;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
43 Tarragona;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
43 Tarragona;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;94,17
43 Tarragona;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
43 Tarragona;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
43 Tarragona;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
43 Tarragona;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;94,23
43 Tarragona;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
43 Tarragona;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
43 Tarragona;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
43 Tarragona;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
43 Tarragona;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
43 Tarragona;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
43 Tarragona;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;92,38
43 Tarragona;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
43 Tarragona;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
43 Tarragona;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
43 Tarragona;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;92,98
43 Tarragona;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
43 Tarragona;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
43 Tarragona;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
43 Tarragona;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
43 Tarragona;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
43 Tarragona;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
43 Tarragona;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QII;5.416
43 Tarragona;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
43 Tarragona;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
43 Tarragona;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
43 Tarragona;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QII;5.312
43 Tarragona;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
43 Tarragona;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
43 Tarragona;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
43 Tarragona;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QII;5.152
43 Tarragona;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
43 Tarragona;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
43 Tarragona;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
43 Tarragona;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2022QII;5.268
43 Tarragona;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2022QI;""
43 Tarragona;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
43 Tarragona;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
43 Tarragona;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2021QII;5.200
43 Tarragona;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2021QI;""
43 Tarragona;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
43 Tarragona;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
43 Tarragona;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2020QII;5.050
43 Tarragona;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2020QI;""
43 Tarragona;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
43 Tarragona;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2022QIII;5.125
43 Tarragona;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2022QII;""
43 Tarragona;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2022QI;""
43 Tarragona;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
43 Tarragona;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2021QIII;5.107
43 Tarragona;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2021QII;""
43 Tarragona;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2021QI;""
43 Tarragona;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
43 Tarragona;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2020QIII;4.936
43 Tarragona;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2020QII;""
43 Tarragona;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2020QI;""
43 Tarragona;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QIV;4.962
43 Tarragona;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
43 Tarragona;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QII;""
43 Tarragona;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QI;""
43 Tarragona;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QIV;4.981
43 Tarragona;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
43 Tarragona;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QII;""
43 Tarragona;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QI;""
43 Tarragona;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QIV;4.830
43 Tarragona;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
43 Tarragona;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QII;""
43 Tarragona;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QI;""
43 Tarragona;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
43 Tarragona;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
43 Tarragona;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QII;""
43 Tarragona;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QI;4.855
43 Tarragona;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
43 Tarragona;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
43 Tarragona;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QII;""
43 Tarragona;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QI;4.751
43 Tarragona;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
43 Tarragona;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
43 Tarragona;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QII;""
43 Tarragona;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QI;""
43 Tarragona;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
43 Tarragona;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
43 Tarragona;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
43 Tarragona;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
43 Tarragona;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
43 Tarragona;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
43 Tarragona;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
43 Tarragona;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
43 Tarragona;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
43 Tarragona;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
43 Tarragona;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
43 Tarragona;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
43 Tarragona;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
43 Tarragona;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
43 Tarragona;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;97,27
43 Tarragona;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
43 Tarragona;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
43 Tarragona;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
43 Tarragona;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;97,89
43 Tarragona;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
43 Tarragona;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
43 Tarragona;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
43 Tarragona;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;98,02
43 Tarragona;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
43 Tarragona;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
43 Tarragona;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;94,63
43 Tarragona;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
43 Tarragona;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
43 Tarragona;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
43 Tarragona;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;96,14
43 Tarragona;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
43 Tarragona;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
43 Tarragona;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
43 Tarragona;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;95,81
43 Tarragona;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
43 Tarragona;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
43 Tarragona;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;91,62
43 Tarragona;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
43 Tarragona;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
43 Tarragona;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
43 Tarragona;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;93,77
43 Tarragona;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
43 Tarragona;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
43 Tarragona;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
43 Tarragona;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;93,75
43 Tarragona;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
43 Tarragona;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
43 Tarragona;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
43 Tarragona;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
43 Tarragona;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
43 Tarragona;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
43 Tarragona;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;91,4
43 Tarragona;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
43 Tarragona;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
43 Tarragona;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
43 Tarragona;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;92,22
43 Tarragona;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
43 Tarragona;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
43 Tarragona;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
43 Tarragona;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
43 Tarragona;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
43 Tarragona;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QIII;14.777
43 Tarragona;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
43 Tarragona;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
43 Tarragona;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
43 Tarragona;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QIII;14.558
43 Tarragona;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
43 Tarragona;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
43 Tarragona;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
43 Tarragona;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QIII;14.169
43 Tarragona;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
43 Tarragona;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
43 Tarragona;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
43 Tarragona;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2022QIII;14.334
43 Tarragona;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2022QII;""
43 Tarragona;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2022QI;""
43 Tarragona;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
43 Tarragona;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2021QIII;14.235
43 Tarragona;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2021QII;""
43 Tarragona;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2021QI;""
43 Tarragona;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
43 Tarragona;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2020QIII;13.795
43 Tarragona;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2020QII;""
43 Tarragona;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2020QI;""
43 Tarragona;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2022QIV;13.863
43 Tarragona;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
43 Tarragona;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2022QII;""
43 Tarragona;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2022QI;""
43 Tarragona;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2021QIV;13.821
43 Tarragona;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
43 Tarragona;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2021QII;""
43 Tarragona;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2021QI;""
43 Tarragona;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2020QIV;13.436
43 Tarragona;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
43 Tarragona;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2020QII;""
43 Tarragona;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2020QI;""
43 Tarragona;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
43 Tarragona;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
43 Tarragona;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QII;""
43 Tarragona;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QI;13.507
43 Tarragona;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
43 Tarragona;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
43 Tarragona;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QII;""
43 Tarragona;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QI;13.239
43 Tarragona;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
43 Tarragona;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
43 Tarragona;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QII;""
43 Tarragona;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QI;""
43 Tarragona;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
43 Tarragona;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
43 Tarragona;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QII;13.244
43 Tarragona;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QI;""
43 Tarragona;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
43 Tarragona;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
43 Tarragona;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QII;13.029
43 Tarragona;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QI;""
43 Tarragona;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
43 Tarragona;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
43 Tarragona;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QII;""
43 Tarragona;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QI;""
43 Tarragona;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
43 Tarragona;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
43 Tarragona;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
43 Tarragona;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
43 Tarragona;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
43 Tarragona;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
43 Tarragona;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
43 Tarragona;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
43 Tarragona;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
43 Tarragona;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
43 Tarragona;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
43 Tarragona;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
43 Tarragona;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
43 Tarragona;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;97
43 Tarragona;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
43 Tarragona;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
43 Tarragona;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
43 Tarragona;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;97,78
43 Tarragona;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
43 Tarragona;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
43 Tarragona;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
43 Tarragona;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;97,36
43 Tarragona;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
43 Tarragona;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
43 Tarragona;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;93,81
43 Tarragona;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
43 Tarragona;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
43 Tarragona;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
43 Tarragona;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;94,94
43 Tarragona;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
43 Tarragona;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
43 Tarragona;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
43 Tarragona;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;94,83
43 Tarragona;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
43 Tarragona;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
43 Tarragona;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
43 Tarragona;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
43 Tarragona;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
43 Tarragona;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
43 Tarragona;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;92,78
43 Tarragona;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
43 Tarragona;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
43 Tarragona;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
43 Tarragona;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;93,44
43 Tarragona;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
43 Tarragona;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
43 Tarragona;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
43 Tarragona;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
43 Tarragona;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
43 Tarragona;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
43 Tarragona;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;90,97
43 Tarragona;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
43 Tarragona;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
43 Tarragona;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
43 Tarragona;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;91,95
43 Tarragona;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
43 Tarragona;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
43 Tarragona;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
43 Tarragona;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
43 Tarragona;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
43 Tarragona;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
43 Tarragona;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QIII;9.302
43 Tarragona;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
43 Tarragona;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
43 Tarragona;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
43 Tarragona;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QIII;9.195
43 Tarragona;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
43 Tarragona;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
43 Tarragona;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
43 Tarragona;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QIII;8.968
43 Tarragona;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
43 Tarragona;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
43 Tarragona;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
43 Tarragona;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2022QIII;9.049
43 Tarragona;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2022QII;""
43 Tarragona;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2022QI;""
43 Tarragona;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
43 Tarragona;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2021QIII;8.998
43 Tarragona;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2021QII;""
43 Tarragona;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2021QI;""
43 Tarragona;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
43 Tarragona;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2020QIII;8.747
43 Tarragona;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2020QII;""
43 Tarragona;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2020QI;""
43 Tarragona;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2022QIV;8.792
43 Tarragona;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
43 Tarragona;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2022QII;""
43 Tarragona;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2022QI;""
43 Tarragona;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2021QIV;8.748
43 Tarragona;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
43 Tarragona;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2021QII;""
43 Tarragona;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2021QI;""
43 Tarragona;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2020QIV;8.513
43 Tarragona;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
43 Tarragona;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2020QII;""
43 Tarragona;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2020QI;""
43 Tarragona;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
43 Tarragona;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
43 Tarragona;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QII;""
43 Tarragona;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QI;8.568
43 Tarragona;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
43 Tarragona;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
43 Tarragona;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QII;""
43 Tarragona;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QI;8.396
43 Tarragona;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
43 Tarragona;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
43 Tarragona;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QII;""
43 Tarragona;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QI;""
43 Tarragona;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
43 Tarragona;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
43 Tarragona;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QII;8.419
43 Tarragona;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QI;""
43 Tarragona;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
43 Tarragona;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
43 Tarragona;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QII;8.264
43 Tarragona;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QI;""
43 Tarragona;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
43 Tarragona;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
43 Tarragona;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QII;""
43 Tarragona;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QI;""
43 Tarragona;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
43 Tarragona;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
43 Tarragona;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
43 Tarragona;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
43 Tarragona;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
43 Tarragona;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
43 Tarragona;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
43 Tarragona;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
43 Tarragona;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
43 Tarragona;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
43 Tarragona;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
43 Tarragona;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
43 Tarragona;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
43 Tarragona;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;97,28
43 Tarragona;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
43 Tarragona;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
43 Tarragona;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
43 Tarragona;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;97,86
43 Tarragona;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
43 Tarragona;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
43 Tarragona;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
43 Tarragona;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;97,54
43 Tarragona;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
43 Tarragona;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
43 Tarragona;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;94,52
43 Tarragona;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
43 Tarragona;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
43 Tarragona;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
43 Tarragona;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;95,14
43 Tarragona;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
43 Tarragona;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
43 Tarragona;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
43 Tarragona;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;94,93
43 Tarragona;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
43 Tarragona;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
43 Tarragona;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
43 Tarragona;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
43 Tarragona;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
43 Tarragona;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
43 Tarragona;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;93,18
43 Tarragona;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
43 Tarragona;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
43 Tarragona;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
43 Tarragona;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;93,62
43 Tarragona;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
43 Tarragona;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
43 Tarragona;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
43 Tarragona;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
43 Tarragona;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
43 Tarragona;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
43 Tarragona;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;91,56
43 Tarragona;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
43 Tarragona;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
43 Tarragona;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
43 Tarragona;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;92,15
43 Tarragona;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
43 Tarragona;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
43 Tarragona;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
43 Tarragona;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
43 Tarragona;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
43 Tarragona;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
43 Tarragona;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QIII;5.475
43 Tarragona;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
43 Tarragona;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
43 Tarragona;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
43 Tarragona;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QIII;5.363
43 Tarragona;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
43 Tarragona;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
43 Tarragona;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
43 Tarragona;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QIII;5.201
43 Tarragona;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
43 Tarragona;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
43 Tarragona;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
43 Tarragona;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2022QIII;5.285
43 Tarragona;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2022QII;""
43 Tarragona;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2022QI;""
43 Tarragona;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
43 Tarragona;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2021QIII;5.237
43 Tarragona;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2021QII;""
43 Tarragona;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2021QI;""
43 Tarragona;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
43 Tarragona;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2020QIII;5.048
43 Tarragona;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2020QII;""
43 Tarragona;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2020QI;""
43 Tarragona;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2022QIV;5.071
43 Tarragona;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
43 Tarragona;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2022QII;""
43 Tarragona;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2022QI;""
43 Tarragona;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2021QIV;5.073
43 Tarragona;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
43 Tarragona;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2021QII;""
43 Tarragona;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2021QI;""
43 Tarragona;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2020QIV;4.923
43 Tarragona;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
43 Tarragona;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2020QII;""
43 Tarragona;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2020QI;""
43 Tarragona;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
43 Tarragona;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
43 Tarragona;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QII;""
43 Tarragona;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QI;4.939
43 Tarragona;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
43 Tarragona;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
43 Tarragona;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QII;""
43 Tarragona;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QI;4.843
43 Tarragona;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
43 Tarragona;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
43 Tarragona;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QII;""
43 Tarragona;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QI;""
43 Tarragona;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
43 Tarragona;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
43 Tarragona;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QII;4.825
43 Tarragona;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QI;""
43 Tarragona;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
43 Tarragona;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
43 Tarragona;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QII;4.765
43 Tarragona;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QI;""
43 Tarragona;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
43 Tarragona;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
43 Tarragona;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QII;""
43 Tarragona;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QI;""
43 Tarragona;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
43 Tarragona;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
43 Tarragona;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
43 Tarragona;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
43 Tarragona;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
43 Tarragona;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
43 Tarragona;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
43 Tarragona;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
43 Tarragona;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
43 Tarragona;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
43 Tarragona;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
43 Tarragona;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
43 Tarragona;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
43 Tarragona;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;96,53
43 Tarragona;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
43 Tarragona;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
43 Tarragona;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
43 Tarragona;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;97,65
43 Tarragona;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
43 Tarragona;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
43 Tarragona;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
43 Tarragona;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;97,06
43 Tarragona;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
43 Tarragona;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
43 Tarragona;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;92,62
43 Tarragona;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
43 Tarragona;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
43 Tarragona;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
43 Tarragona;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;94,59
43 Tarragona;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
43 Tarragona;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
43 Tarragona;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
43 Tarragona;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;94,65
43 Tarragona;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
43 Tarragona;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
43 Tarragona;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
43 Tarragona;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
43 Tarragona;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
43 Tarragona;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
43 Tarragona;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;92,09
43 Tarragona;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
43 Tarragona;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
43 Tarragona;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
43 Tarragona;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;93,12
43 Tarragona;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
43 Tarragona;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
43 Tarragona;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
43 Tarragona;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
43 Tarragona;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
43 Tarragona;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
43 Tarragona;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;89,97
43 Tarragona;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
43 Tarragona;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
43 Tarragona;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
43 Tarragona;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;91,62
43 Tarragona;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
43 Tarragona;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
43 Tarragona;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
43 Tarragona;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
43 Tarragona;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
43 Tarragona;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QIV;14.629
43 Tarragona;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
43 Tarragona;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
43 Tarragona;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
43 Tarragona;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QIV;14.481
43 Tarragona;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
43 Tarragona;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
43 Tarragona;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
43 Tarragona;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QIV;14.101
43 Tarragona;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
43 Tarragona;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
43 Tarragona;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
43 Tarragona;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2022QIV;14.111
43 Tarragona;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
43 Tarragona;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2022QII;""
43 Tarragona;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2022QI;""
43 Tarragona;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2021QIV;14.031
43 Tarragona;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
43 Tarragona;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2021QII;""
43 Tarragona;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2021QI;""
43 Tarragona;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2020QIV;13.695
43 Tarragona;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
43 Tarragona;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2020QII;""
43 Tarragona;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2020QI;""
43 Tarragona;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
43 Tarragona;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
43 Tarragona;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2022QII;""
43 Tarragona;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2022QI;13.697
43 Tarragona;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
43 Tarragona;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
43 Tarragona;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2021QII;""
43 Tarragona;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2021QI;13.476
43 Tarragona;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
43 Tarragona;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
43 Tarragona;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2020QII;""
43 Tarragona;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2020QI;""
43 Tarragona;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
43 Tarragona;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
43 Tarragona;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QII;13.416
43 Tarragona;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QI;""
43 Tarragona;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
43 Tarragona;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
43 Tarragona;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QII;13.252
43 Tarragona;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QI;""
43 Tarragona;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
43 Tarragona;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
43 Tarragona;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QII;""
43 Tarragona;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QI;""
43 Tarragona;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
43 Tarragona;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QIII;13.135
43 Tarragona;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QII;""
43 Tarragona;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QI;""
43 Tarragona;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
43 Tarragona;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QIII;13.074
43 Tarragona;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QII;""
43 Tarragona;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QI;""
43 Tarragona;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
43 Tarragona;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
43 Tarragona;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QII;""
43 Tarragona;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QI;""
43 Tarragona;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
43 Tarragona;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
43 Tarragona;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
43 Tarragona;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
43 Tarragona;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
43 Tarragona;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
43 Tarragona;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
43 Tarragona;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
43 Tarragona;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
43 Tarragona;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
43 Tarragona;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
43 Tarragona;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
43 Tarragona;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;96,46
43 Tarragona;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
43 Tarragona;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
43 Tarragona;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
43 Tarragona;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;96,89
43 Tarragona;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
43 Tarragona;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
43 Tarragona;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
43 Tarragona;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;97,12
43 Tarragona;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
43 Tarragona;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
43 Tarragona;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
43 Tarragona;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
43 Tarragona;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
43 Tarragona;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
43 Tarragona;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;94,59
43 Tarragona;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
43 Tarragona;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
43 Tarragona;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
43 Tarragona;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;95,57
43 Tarragona;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
43 Tarragona;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
43 Tarragona;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
43 Tarragona;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
43 Tarragona;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
43 Tarragona;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
43 Tarragona;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;92,65
43 Tarragona;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
43 Tarragona;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
43 Tarragona;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
43 Tarragona;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;93,98
43 Tarragona;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
43 Tarragona;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
43 Tarragona;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
43 Tarragona;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
43 Tarragona;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
43 Tarragona;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
43 Tarragona;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;90,71
43 Tarragona;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
43 Tarragona;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
43 Tarragona;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
43 Tarragona;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;92,72
43 Tarragona;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
43 Tarragona;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
43 Tarragona;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
43 Tarragona;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
43 Tarragona;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
43 Tarragona;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
43 Tarragona;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QIV;9.218
43 Tarragona;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
43 Tarragona;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
43 Tarragona;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
43 Tarragona;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QIV;9.137
43 Tarragona;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
43 Tarragona;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
43 Tarragona;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
43 Tarragona;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QIV;8.929
43 Tarragona;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
43 Tarragona;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
43 Tarragona;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
43 Tarragona;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2022QIV;8.934
43 Tarragona;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
43 Tarragona;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2022QII;""
43 Tarragona;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2022QI;""
43 Tarragona;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2021QIV;8.868
43 Tarragona;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
43 Tarragona;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2021QII;""
43 Tarragona;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2021QI;""
43 Tarragona;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2020QIV;8.670
43 Tarragona;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
43 Tarragona;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2020QII;""
43 Tarragona;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2020QI;""
43 Tarragona;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
43 Tarragona;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
43 Tarragona;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2022QII;""
43 Tarragona;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2022QI;8.677
43 Tarragona;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
43 Tarragona;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
43 Tarragona;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2021QII;""
43 Tarragona;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2021QI;8.539
43 Tarragona;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
43 Tarragona;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
43 Tarragona;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2020QII;""
43 Tarragona;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2020QI;""
43 Tarragona;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
43 Tarragona;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
43 Tarragona;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QII;8.514
43 Tarragona;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QI;""
43 Tarragona;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
43 Tarragona;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
43 Tarragona;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QII;8.398
43 Tarragona;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QI;""
43 Tarragona;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
43 Tarragona;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
43 Tarragona;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QII;""
43 Tarragona;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QI;""
43 Tarragona;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
43 Tarragona;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QIII;8.349
43 Tarragona;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QII;""
43 Tarragona;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QI;""
43 Tarragona;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
43 Tarragona;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QIII;8.286
43 Tarragona;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QII;""
43 Tarragona;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QI;""
43 Tarragona;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
43 Tarragona;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
43 Tarragona;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QII;""
43 Tarragona;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QI;""
43 Tarragona;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
43 Tarragona;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
43 Tarragona;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
43 Tarragona;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
43 Tarragona;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
43 Tarragona;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
43 Tarragona;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
43 Tarragona;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
43 Tarragona;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
43 Tarragona;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
43 Tarragona;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
43 Tarragona;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
43 Tarragona;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;96,92
43 Tarragona;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
43 Tarragona;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
43 Tarragona;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
43 Tarragona;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;97,06
43 Tarragona;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
43 Tarragona;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
43 Tarragona;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
43 Tarragona;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;97,1
43 Tarragona;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
43 Tarragona;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
43 Tarragona;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
43 Tarragona;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
43 Tarragona;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
43 Tarragona;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
43 Tarragona;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;94,97
43 Tarragona;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
43 Tarragona;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
43 Tarragona;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
43 Tarragona;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;95,63
43 Tarragona;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
43 Tarragona;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
43 Tarragona;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
43 Tarragona;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
43 Tarragona;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
43 Tarragona;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
43 Tarragona;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;93,18
43 Tarragona;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
43 Tarragona;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
43 Tarragona;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
43 Tarragona;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;94,05
43 Tarragona;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
43 Tarragona;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
43 Tarragona;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
43 Tarragona;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
43 Tarragona;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
43 Tarragona;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
43 Tarragona;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;91,38
43 Tarragona;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
43 Tarragona;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
43 Tarragona;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
43 Tarragona;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;92,8
43 Tarragona;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
43 Tarragona;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
43 Tarragona;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
43 Tarragona;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
43 Tarragona;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
43 Tarragona;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
43 Tarragona;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QIV;5.411
43 Tarragona;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
43 Tarragona;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
43 Tarragona;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
43 Tarragona;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QIV;5.344
43 Tarragona;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
43 Tarragona;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
43 Tarragona;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
43 Tarragona;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QIV;5.172
43 Tarragona;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
43 Tarragona;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
43 Tarragona;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
43 Tarragona;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2022QIV;5.177
43 Tarragona;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
43 Tarragona;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2022QII;""
43 Tarragona;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2022QI;""
43 Tarragona;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2021QIV;5.163
43 Tarragona;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
43 Tarragona;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2021QII;""
43 Tarragona;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2021QI;""
43 Tarragona;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2020QIV;5.025
43 Tarragona;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
43 Tarragona;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2020QII;""
43 Tarragona;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2020QI;""
43 Tarragona;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
43 Tarragona;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
43 Tarragona;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2022QII;""
43 Tarragona;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2022QI;5.020
43 Tarragona;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
43 Tarragona;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
43 Tarragona;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2021QII;""
43 Tarragona;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2021QI;4.937
43 Tarragona;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
43 Tarragona;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
43 Tarragona;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2020QII;""
43 Tarragona;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2020QI;""
43 Tarragona;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
43 Tarragona;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
43 Tarragona;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QII;4.902
43 Tarragona;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QI;""
43 Tarragona;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
43 Tarragona;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
43 Tarragona;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QII;4.854
43 Tarragona;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QI;""
43 Tarragona;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
43 Tarragona;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
43 Tarragona;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QII;""
43 Tarragona;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QI;""
43 Tarragona;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
43 Tarragona;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QIII;4.786
43 Tarragona;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QII;""
43 Tarragona;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QI;""
43 Tarragona;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
43 Tarragona;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QIII;4.788
43 Tarragona;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QII;""
43 Tarragona;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QI;""
43 Tarragona;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
43 Tarragona;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
43 Tarragona;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QII;""
43 Tarragona;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QI;""
43 Tarragona;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
43 Tarragona;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
43 Tarragona;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
43 Tarragona;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
43 Tarragona;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
43 Tarragona;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
43 Tarragona;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
43 Tarragona;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
43 Tarragona;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
43 Tarragona;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
43 Tarragona;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
43 Tarragona;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
43 Tarragona;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;95,68
43 Tarragona;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
43 Tarragona;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
43 Tarragona;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
43 Tarragona;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;96,61
43 Tarragona;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
43 Tarragona;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
43 Tarragona;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
43 Tarragona;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;97,16
43 Tarragona;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
43 Tarragona;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
43 Tarragona;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
43 Tarragona;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
43 Tarragona;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
43 Tarragona;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
43 Tarragona;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;93,94
43 Tarragona;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
43 Tarragona;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
43 Tarragona;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
43 Tarragona;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;95,46
43 Tarragona;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
43 Tarragona;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
43 Tarragona;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
43 Tarragona;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
43 Tarragona;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
43 Tarragona;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
43 Tarragona;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;91,73
43 Tarragona;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
43 Tarragona;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
43 Tarragona;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
43 Tarragona;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;93,85
43 Tarragona;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
43 Tarragona;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
43 Tarragona;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
43 Tarragona;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
43 Tarragona;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
43 Tarragona;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
43 Tarragona;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;89,56
43 Tarragona;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
43 Tarragona;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
43 Tarragona;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
43 Tarragona;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;92,58
43 Tarragona;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
43 Tarragona;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
43 Tarragona;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
43 Tarragona;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
43 Tarragona;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
43 Tarragona;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
43 Tarragona;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
43 Tarragona;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
43 Tarragona;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
43 Tarragona;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QI;7.334
43 Tarragona;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
43 Tarragona;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
43 Tarragona;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
43 Tarragona;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QI;7.000
43 Tarragona;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
43 Tarragona;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
43 Tarragona;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
43 Tarragona;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QI;8.144
43 Tarragona;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
43 Tarragona;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
43 Tarragona;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2022QII;""
43 Tarragona;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2022QI;7.014
43 Tarragona;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
43 Tarragona;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
43 Tarragona;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2021QII;""
43 Tarragona;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2021QI;6.735
43 Tarragona;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
43 Tarragona;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
43 Tarragona;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2020QII;""
43 Tarragona;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2020QI;7.547
43 Tarragona;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
43 Tarragona;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
43 Tarragona;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2022QII;6.743
43 Tarragona;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2022QI;""
43 Tarragona;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
43 Tarragona;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
43 Tarragona;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2021QII;6.464
43 Tarragona;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2021QI;""
43 Tarragona;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
43 Tarragona;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
43 Tarragona;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2020QII;7.296
43 Tarragona;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2020QI;""
43 Tarragona;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
43 Tarragona;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QIII;6.495
43 Tarragona;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QII;""
43 Tarragona;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QI;""
43 Tarragona;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
43 Tarragona;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QIII;6.255
43 Tarragona;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QII;""
43 Tarragona;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QI;""
43 Tarragona;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
43 Tarragona;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QIII;6.955
43 Tarragona;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QII;""
43 Tarragona;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QI;""
43 Tarragona;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QIV;6.086
43 Tarragona;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
43 Tarragona;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QII;""
43 Tarragona;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QI;""
43 Tarragona;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QIV;5.921
43 Tarragona;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
43 Tarragona;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QII;""
43 Tarragona;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QI;""
43 Tarragona;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QIV;6.651
43 Tarragona;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
43 Tarragona;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QII;""
43 Tarragona;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QI;""
43 Tarragona;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
43 Tarragona;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
43 Tarragona;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
43 Tarragona;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
43 Tarragona;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
43 Tarragona;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
43 Tarragona;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
43 Tarragona;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
43 Tarragona;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
43 Tarragona;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
43 Tarragona;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
43 Tarragona;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
43 Tarragona;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
43 Tarragona;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
43 Tarragona;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
43 Tarragona;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;95,64
43 Tarragona;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
43 Tarragona;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
43 Tarragona;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
43 Tarragona;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;96,21
43 Tarragona;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
43 Tarragona;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
43 Tarragona;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
43 Tarragona;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;92,67
43 Tarragona;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
43 Tarragona;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
43 Tarragona;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;91,94
43 Tarragona;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
43 Tarragona;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
43 Tarragona;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
43 Tarragona;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;92,34
43 Tarragona;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
43 Tarragona;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
43 Tarragona;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
43 Tarragona;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;89,59
43 Tarragona;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
43 Tarragona;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
43 Tarragona;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;88,56
43 Tarragona;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
43 Tarragona;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
43 Tarragona;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
43 Tarragona;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;89,36
43 Tarragona;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
43 Tarragona;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
43 Tarragona;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
43 Tarragona;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;85,4
43 Tarragona;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
43 Tarragona;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
43 Tarragona;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;82,98
43 Tarragona;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
43 Tarragona;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
43 Tarragona;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
43 Tarragona;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;84,59
43 Tarragona;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
43 Tarragona;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
43 Tarragona;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
43 Tarragona;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;81,67
43 Tarragona;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
43 Tarragona;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
43 Tarragona;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
43 Tarragona;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
43 Tarragona;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
43 Tarragona;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
43 Tarragona;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QI;4.639
43 Tarragona;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
43 Tarragona;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
43 Tarragona;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
43 Tarragona;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QI;4.430
43 Tarragona;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
43 Tarragona;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
43 Tarragona;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
43 Tarragona;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QI;5.124
43 Tarragona;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
43 Tarragona;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
43 Tarragona;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2022QII;""
43 Tarragona;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2022QI;4.431
43 Tarragona;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
43 Tarragona;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
43 Tarragona;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2021QII;""
43 Tarragona;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2021QI;4.250
43 Tarragona;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
43 Tarragona;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
43 Tarragona;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2020QII;""
43 Tarragona;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2020QI;4.753
43 Tarragona;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
43 Tarragona;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
43 Tarragona;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2022QII;4.266
43 Tarragona;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2022QI;""
43 Tarragona;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
43 Tarragona;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
43 Tarragona;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2021QII;4.084
43 Tarragona;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2021QI;""
43 Tarragona;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
43 Tarragona;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
43 Tarragona;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2020QII;4.608
43 Tarragona;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2020QI;""
43 Tarragona;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
43 Tarragona;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QIII;4.103
43 Tarragona;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QII;""
43 Tarragona;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QI;""
43 Tarragona;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
43 Tarragona;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QIII;3.972
43 Tarragona;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QII;""
43 Tarragona;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QI;""
43 Tarragona;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
43 Tarragona;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QIII;4.394
43 Tarragona;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QII;""
43 Tarragona;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QI;""
43 Tarragona;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QIV;3.856
43 Tarragona;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
43 Tarragona;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QII;""
43 Tarragona;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QI;""
43 Tarragona;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QIV;3.765
43 Tarragona;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
43 Tarragona;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QII;""
43 Tarragona;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QI;""
43 Tarragona;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QIV;4.212
43 Tarragona;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
43 Tarragona;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QII;""
43 Tarragona;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QI;""
43 Tarragona;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
43 Tarragona;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
43 Tarragona;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
43 Tarragona;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
43 Tarragona;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
43 Tarragona;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
43 Tarragona;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
43 Tarragona;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
43 Tarragona;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
43 Tarragona;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
43 Tarragona;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
43 Tarragona;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
43 Tarragona;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
43 Tarragona;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
43 Tarragona;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
43 Tarragona;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;95,52
43 Tarragona;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
43 Tarragona;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
43 Tarragona;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
43 Tarragona;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;95,94
43 Tarragona;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
43 Tarragona;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
43 Tarragona;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
43 Tarragona;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;92,76
43 Tarragona;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
43 Tarragona;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
43 Tarragona;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;91,96
43 Tarragona;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
43 Tarragona;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
43 Tarragona;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
43 Tarragona;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;92,19
43 Tarragona;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
43 Tarragona;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
43 Tarragona;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
43 Tarragona;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;89,93
43 Tarragona;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
43 Tarragona;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
43 Tarragona;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;88,45
43 Tarragona;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
43 Tarragona;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
43 Tarragona;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
43 Tarragona;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;89,66
43 Tarragona;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
43 Tarragona;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
43 Tarragona;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
43 Tarragona;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;85,75
43 Tarragona;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
43 Tarragona;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
43 Tarragona;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;83,12
43 Tarragona;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
43 Tarragona;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
43 Tarragona;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
43 Tarragona;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;84,99
43 Tarragona;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
43 Tarragona;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
43 Tarragona;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
43 Tarragona;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;82,2
43 Tarragona;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
43 Tarragona;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
43 Tarragona;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
43 Tarragona;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
43 Tarragona;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
43 Tarragona;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
43 Tarragona;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QI;2.695
43 Tarragona;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
43 Tarragona;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
43 Tarragona;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
43 Tarragona;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QI;2.570
43 Tarragona;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
43 Tarragona;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
43 Tarragona;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
43 Tarragona;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QI;3.020
43 Tarragona;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
43 Tarragona;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
43 Tarragona;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2022QII;""
43 Tarragona;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2022QI;2.583
43 Tarragona;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
43 Tarragona;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
43 Tarragona;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2021QII;""
43 Tarragona;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2021QI;2.485
43 Tarragona;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
43 Tarragona;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
43 Tarragona;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2020QII;""
43 Tarragona;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2020QI;2.794
43 Tarragona;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
43 Tarragona;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
43 Tarragona;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2022QII;2.477
43 Tarragona;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2022QI;""
43 Tarragona;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
43 Tarragona;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
43 Tarragona;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2021QII;2.380
43 Tarragona;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2021QI;""
43 Tarragona;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
43 Tarragona;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
43 Tarragona;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2020QII;2.688
43 Tarragona;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2020QI;""
43 Tarragona;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
43 Tarragona;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QIII;2.392
43 Tarragona;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QII;""
43 Tarragona;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QI;""
43 Tarragona;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
43 Tarragona;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QIII;2.283
43 Tarragona;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QII;""
43 Tarragona;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QI;""
43 Tarragona;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
43 Tarragona;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QIII;2.561
43 Tarragona;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QII;""
43 Tarragona;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QI;""
43 Tarragona;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QIV;2.230
43 Tarragona;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
43 Tarragona;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QII;""
43 Tarragona;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QI;""
43 Tarragona;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QIV;2.156
43 Tarragona;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
43 Tarragona;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QII;""
43 Tarragona;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QI;""
43 Tarragona;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QIV;2.439
43 Tarragona;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
43 Tarragona;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QII;""
43 Tarragona;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QI;""
43 Tarragona;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
43 Tarragona;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
43 Tarragona;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
43 Tarragona;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
43 Tarragona;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
43 Tarragona;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
43 Tarragona;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
43 Tarragona;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
43 Tarragona;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
43 Tarragona;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
43 Tarragona;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
43 Tarragona;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
43 Tarragona;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
43 Tarragona;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
43 Tarragona;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
43 Tarragona;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;95,84
43 Tarragona;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
43 Tarragona;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
43 Tarragona;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
43 Tarragona;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;96,69
43 Tarragona;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
43 Tarragona;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
43 Tarragona;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
43 Tarragona;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;92,52
43 Tarragona;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
43 Tarragona;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
43 Tarragona;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;91,91
43 Tarragona;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
43 Tarragona;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
43 Tarragona;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
43 Tarragona;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;92,61
43 Tarragona;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
43 Tarragona;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
43 Tarragona;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
43 Tarragona;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;89,01
43 Tarragona;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
43 Tarragona;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
43 Tarragona;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;88,76
43 Tarragona;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
43 Tarragona;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
43 Tarragona;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
43 Tarragona;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;88,83
43 Tarragona;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
43 Tarragona;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
43 Tarragona;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
43 Tarragona;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;84,8
43 Tarragona;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
43 Tarragona;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
43 Tarragona;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;82,75
43 Tarragona;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
43 Tarragona;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
43 Tarragona;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
43 Tarragona;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;83,89
43 Tarragona;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
43 Tarragona;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
43 Tarragona;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
43 Tarragona;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;80,76
43 Tarragona;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
43 Tarragona;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
43 Tarragona;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
43 Tarragona;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
43 Tarragona;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
43 Tarragona;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QII;8.320
43 Tarragona;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
43 Tarragona;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
43 Tarragona;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
43 Tarragona;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QII;8.041
43 Tarragona;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
43 Tarragona;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
43 Tarragona;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
43 Tarragona;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QII;7.718
43 Tarragona;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
43 Tarragona;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
43 Tarragona;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
43 Tarragona;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2022QII;8.017
43 Tarragona;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2022QI;""
43 Tarragona;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
43 Tarragona;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
43 Tarragona;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2021QII;7.741
43 Tarragona;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2021QI;""
43 Tarragona;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
43 Tarragona;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
43 Tarragona;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2020QII;7.456
43 Tarragona;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2020QI;""
43 Tarragona;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
43 Tarragona;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2022QIII;7.740
43 Tarragona;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2022QII;""
43 Tarragona;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2022QI;""
43 Tarragona;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
43 Tarragona;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2021QIII;7.509
43 Tarragona;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2021QII;""
43 Tarragona;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2021QI;""
43 Tarragona;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
43 Tarragona;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2020QIII;7.086
43 Tarragona;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2020QII;""
43 Tarragona;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2020QI;""
43 Tarragona;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QIV;7.275
43 Tarragona;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
43 Tarragona;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QII;""
43 Tarragona;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QI;""
43 Tarragona;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QIV;7.125
43 Tarragona;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
43 Tarragona;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QII;""
43 Tarragona;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QI;""
43 Tarragona;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QIV;6.763
43 Tarragona;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
43 Tarragona;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QII;""
43 Tarragona;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QI;""
43 Tarragona;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
43 Tarragona;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
43 Tarragona;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QII;""
43 Tarragona;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QI;6.831
43 Tarragona;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
43 Tarragona;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
43 Tarragona;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QII;""
43 Tarragona;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QI;6.513
43 Tarragona;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
43 Tarragona;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
43 Tarragona;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QII;""
43 Tarragona;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QI;""
43 Tarragona;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
43 Tarragona;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
43 Tarragona;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
43 Tarragona;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
43 Tarragona;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
43 Tarragona;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
43 Tarragona;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
43 Tarragona;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
43 Tarragona;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
43 Tarragona;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
43 Tarragona;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
43 Tarragona;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
43 Tarragona;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
43 Tarragona;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
43 Tarragona;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;96,36
43 Tarragona;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
43 Tarragona;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
43 Tarragona;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
43 Tarragona;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;96,27
43 Tarragona;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
43 Tarragona;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
43 Tarragona;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
43 Tarragona;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;96,61
43 Tarragona;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
43 Tarragona;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
43 Tarragona;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;93,03
43 Tarragona;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
43 Tarragona;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
43 Tarragona;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
43 Tarragona;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;93,38
43 Tarragona;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
43 Tarragona;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
43 Tarragona;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
43 Tarragona;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;91,81
43 Tarragona;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
43 Tarragona;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
43 Tarragona;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;87,44
43 Tarragona;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
43 Tarragona;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
43 Tarragona;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
43 Tarragona;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;88,61
43 Tarragona;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
43 Tarragona;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
43 Tarragona;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
43 Tarragona;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;87,63
43 Tarragona;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
43 Tarragona;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
43 Tarragona;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
43 Tarragona;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
43 Tarragona;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
43 Tarragona;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
43 Tarragona;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;84,95
43 Tarragona;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
43 Tarragona;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
43 Tarragona;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
43 Tarragona;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;84,39
43 Tarragona;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
43 Tarragona;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
43 Tarragona;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
43 Tarragona;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
43 Tarragona;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
43 Tarragona;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
43 Tarragona;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QII;5.246
43 Tarragona;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
43 Tarragona;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
43 Tarragona;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
43 Tarragona;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QII;5.059
43 Tarragona;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
43 Tarragona;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
43 Tarragona;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
43 Tarragona;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QII;4.864
43 Tarragona;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
43 Tarragona;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
43 Tarragona;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
43 Tarragona;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2022QII;5.060
43 Tarragona;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2022QI;""
43 Tarragona;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
43 Tarragona;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
43 Tarragona;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2021QII;4.875
43 Tarragona;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2021QI;""
43 Tarragona;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
43 Tarragona;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
43 Tarragona;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2020QII;4.713
43 Tarragona;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2020QI;""
43 Tarragona;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
43 Tarragona;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2022QIII;4.880
43 Tarragona;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2022QII;""
43 Tarragona;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2022QI;""
43 Tarragona;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
43 Tarragona;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2021QIII;4.750
43 Tarragona;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2021QII;""
43 Tarragona;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2021QI;""
43 Tarragona;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
43 Tarragona;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2020QIII;4.476
43 Tarragona;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2020QII;""
43 Tarragona;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2020QI;""
43 Tarragona;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QIV;4.602
43 Tarragona;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
43 Tarragona;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QII;""
43 Tarragona;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QI;""
43 Tarragona;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QIV;4.517
43 Tarragona;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
43 Tarragona;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QII;""
43 Tarragona;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QI;""
43 Tarragona;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QIV;4.283
43 Tarragona;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
43 Tarragona;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QII;""
43 Tarragona;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QI;""
43 Tarragona;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
43 Tarragona;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
43 Tarragona;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QII;""
43 Tarragona;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QI;4.323
43 Tarragona;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
43 Tarragona;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
43 Tarragona;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QII;""
43 Tarragona;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QI;4.114
43 Tarragona;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
43 Tarragona;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
43 Tarragona;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QII;""
43 Tarragona;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QI;""
43 Tarragona;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
43 Tarragona;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
43 Tarragona;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
43 Tarragona;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
43 Tarragona;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
43 Tarragona;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
43 Tarragona;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
43 Tarragona;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
43 Tarragona;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
43 Tarragona;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
43 Tarragona;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
43 Tarragona;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
43 Tarragona;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
43 Tarragona;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
43 Tarragona;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;96,45
43 Tarragona;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
43 Tarragona;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
43 Tarragona;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
43 Tarragona;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;96,36
43 Tarragona;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
43 Tarragona;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
43 Tarragona;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
43 Tarragona;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;96,9
43 Tarragona;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
43 Tarragona;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
43 Tarragona;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;93,02
43 Tarragona;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
43 Tarragona;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
43 Tarragona;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
43 Tarragona;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;93,89
43 Tarragona;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
43 Tarragona;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
43 Tarragona;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
43 Tarragona;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;92,02
43 Tarragona;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
43 Tarragona;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
43 Tarragona;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;87,72
43 Tarragona;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
43 Tarragona;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
43 Tarragona;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
43 Tarragona;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;89,29
43 Tarragona;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
43 Tarragona;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
43 Tarragona;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
43 Tarragona;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;88,06
43 Tarragona;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
43 Tarragona;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
43 Tarragona;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
43 Tarragona;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
43 Tarragona;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
43 Tarragona;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
43 Tarragona;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;85,45
43 Tarragona;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
43 Tarragona;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
43 Tarragona;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
43 Tarragona;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;84,58
43 Tarragona;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
43 Tarragona;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
43 Tarragona;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
43 Tarragona;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
43 Tarragona;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
43 Tarragona;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
43 Tarragona;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QII;3.074
43 Tarragona;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
43 Tarragona;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
43 Tarragona;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
43 Tarragona;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QII;2.982
43 Tarragona;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
43 Tarragona;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
43 Tarragona;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
43 Tarragona;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QII;2.854
43 Tarragona;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
43 Tarragona;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
43 Tarragona;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
43 Tarragona;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2022QII;2.957
43 Tarragona;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2022QI;""
43 Tarragona;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
43 Tarragona;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
43 Tarragona;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2021QII;2.866
43 Tarragona;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2021QI;""
43 Tarragona;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
43 Tarragona;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
43 Tarragona;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2020QII;2.743
43 Tarragona;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2020QI;""
43 Tarragona;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
43 Tarragona;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2022QIII;2.860
43 Tarragona;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2022QII;""
43 Tarragona;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2022QI;""
43 Tarragona;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
43 Tarragona;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2021QIII;2.759
43 Tarragona;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2021QII;""
43 Tarragona;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2021QI;""
43 Tarragona;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
43 Tarragona;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2020QIII;2.610
43 Tarragona;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2020QII;""
43 Tarragona;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2020QI;""
43 Tarragona;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QIV;2.673
43 Tarragona;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
43 Tarragona;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QII;""
43 Tarragona;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QI;""
43 Tarragona;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QIV;2.608
43 Tarragona;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
43 Tarragona;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QII;""
43 Tarragona;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QI;""
43 Tarragona;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QIV;2.480
43 Tarragona;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
43 Tarragona;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QII;""
43 Tarragona;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QI;""
43 Tarragona;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
43 Tarragona;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
43 Tarragona;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QII;""
43 Tarragona;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QI;2.508
43 Tarragona;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
43 Tarragona;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
43 Tarragona;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QII;""
43 Tarragona;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QI;2.399
43 Tarragona;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
43 Tarragona;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
43 Tarragona;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QII;""
43 Tarragona;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QI;""
43 Tarragona;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
43 Tarragona;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
43 Tarragona;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
43 Tarragona;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
43 Tarragona;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
43 Tarragona;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
43 Tarragona;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
43 Tarragona;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
43 Tarragona;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
43 Tarragona;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
43 Tarragona;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
43 Tarragona;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
43 Tarragona;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
43 Tarragona;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
43 Tarragona;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;96,19
43 Tarragona;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
43 Tarragona;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
43 Tarragona;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
43 Tarragona;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;96,11
43 Tarragona;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
43 Tarragona;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
43 Tarragona;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
43 Tarragona;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;96,11
43 Tarragona;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
43 Tarragona;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
43 Tarragona;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;93,04
43 Tarragona;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
43 Tarragona;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
43 Tarragona;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
43 Tarragona;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;92,52
43 Tarragona;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
43 Tarragona;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
43 Tarragona;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
43 Tarragona;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;91,45
43 Tarragona;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
43 Tarragona;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
43 Tarragona;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;86,96
43 Tarragona;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
43 Tarragona;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
43 Tarragona;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
43 Tarragona;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;87,46
43 Tarragona;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
43 Tarragona;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
43 Tarragona;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
43 Tarragona;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;86,9
43 Tarragona;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
43 Tarragona;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
43 Tarragona;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
43 Tarragona;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
43 Tarragona;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
43 Tarragona;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
43 Tarragona;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;84,1
43 Tarragona;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
43 Tarragona;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
43 Tarragona;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
43 Tarragona;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;84,06
43 Tarragona;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
43 Tarragona;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
43 Tarragona;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
43 Tarragona;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
43 Tarragona;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
43 Tarragona;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QIII;8.199
43 Tarragona;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
43 Tarragona;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
43 Tarragona;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
43 Tarragona;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QIII;7.913
43 Tarragona;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
43 Tarragona;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
43 Tarragona;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
43 Tarragona;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QIII;7.625
43 Tarragona;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
43 Tarragona;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
43 Tarragona;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
43 Tarragona;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2022QIII;7.874
43 Tarragona;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2022QII;""
43 Tarragona;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2022QI;""
43 Tarragona;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
43 Tarragona;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2021QIII;7.627
43 Tarragona;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2021QII;""
43 Tarragona;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2021QI;""
43 Tarragona;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
43 Tarragona;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2020QIII;7.198
43 Tarragona;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2020QII;""
43 Tarragona;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2020QI;""
43 Tarragona;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2022QIV;7.347
43 Tarragona;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
43 Tarragona;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2022QII;""
43 Tarragona;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2022QI;""
43 Tarragona;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2021QIV;7.187
43 Tarragona;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
43 Tarragona;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2021QII;""
43 Tarragona;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2021QI;""
43 Tarragona;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2020QIV;6.841
43 Tarragona;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
43 Tarragona;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2020QII;""
43 Tarragona;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2020QI;""
43 Tarragona;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
43 Tarragona;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
43 Tarragona;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QII;""
43 Tarragona;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QI;6.887
43 Tarragona;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
43 Tarragona;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
43 Tarragona;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QII;""
43 Tarragona;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QI;6.589
43 Tarragona;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
43 Tarragona;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
43 Tarragona;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QII;""
43 Tarragona;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QI;""
43 Tarragona;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
43 Tarragona;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
43 Tarragona;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QII;6.645
43 Tarragona;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QI;""
43 Tarragona;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
43 Tarragona;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
43 Tarragona;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QII;6.342
43 Tarragona;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QI;""
43 Tarragona;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
43 Tarragona;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
43 Tarragona;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QII;""
43 Tarragona;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QI;""
43 Tarragona;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
43 Tarragona;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
43 Tarragona;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
43 Tarragona;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
43 Tarragona;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
43 Tarragona;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
43 Tarragona;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
43 Tarragona;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
43 Tarragona;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
43 Tarragona;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
43 Tarragona;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
43 Tarragona;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
43 Tarragona;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
43 Tarragona;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;96,04
43 Tarragona;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
43 Tarragona;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
43 Tarragona;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
43 Tarragona;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;96,39
43 Tarragona;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
43 Tarragona;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
43 Tarragona;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
43 Tarragona;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;94,4
43 Tarragona;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
43 Tarragona;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
43 Tarragona;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;89,61
43 Tarragona;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
43 Tarragona;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
43 Tarragona;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
43 Tarragona;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;90,83
43 Tarragona;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
43 Tarragona;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
43 Tarragona;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
43 Tarragona;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;89,72
43 Tarragona;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
43 Tarragona;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
43 Tarragona;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
43 Tarragona;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
43 Tarragona;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
43 Tarragona;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
43 Tarragona;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;87,03
43 Tarragona;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
43 Tarragona;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
43 Tarragona;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
43 Tarragona;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;86,41
43 Tarragona;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
43 Tarragona;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
43 Tarragona;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
43 Tarragona;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
43 Tarragona;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
43 Tarragona;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
43 Tarragona;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;83,98
43 Tarragona;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
43 Tarragona;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
43 Tarragona;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
43 Tarragona;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;83,17
43 Tarragona;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
43 Tarragona;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
43 Tarragona;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
43 Tarragona;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
43 Tarragona;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
43 Tarragona;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
43 Tarragona;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QIII;5.157
43 Tarragona;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
43 Tarragona;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
43 Tarragona;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
43 Tarragona;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QIII;4.965
43 Tarragona;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
43 Tarragona;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
43 Tarragona;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
43 Tarragona;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QIII;4.807
43 Tarragona;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
43 Tarragona;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
43 Tarragona;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
43 Tarragona;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2022QIII;4.955
43 Tarragona;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2022QII;""
43 Tarragona;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2022QI;""
43 Tarragona;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
43 Tarragona;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2021QIII;4.812
43 Tarragona;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2021QII;""
43 Tarragona;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2021QI;""
43 Tarragona;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
43 Tarragona;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2020QIII;4.541
43 Tarragona;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2020QII;""
43 Tarragona;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2020QI;""
43 Tarragona;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2022QIV;4.646
43 Tarragona;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
43 Tarragona;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2022QII;""
43 Tarragona;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2022QI;""
43 Tarragona;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2021QIV;4.550
43 Tarragona;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
43 Tarragona;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2021QII;""
43 Tarragona;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2021QI;""
43 Tarragona;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2020QIV;4.331
43 Tarragona;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
43 Tarragona;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2020QII;""
43 Tarragona;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2020QI;""
43 Tarragona;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
43 Tarragona;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
43 Tarragona;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QII;""
43 Tarragona;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QI;4.352
43 Tarragona;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
43 Tarragona;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
43 Tarragona;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QII;""
43 Tarragona;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QI;4.161
43 Tarragona;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
43 Tarragona;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
43 Tarragona;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QII;""
43 Tarragona;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QI;""
43 Tarragona;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
43 Tarragona;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
43 Tarragona;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QII;4.206
43 Tarragona;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QI;""
43 Tarragona;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
43 Tarragona;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
43 Tarragona;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QII;4.011
43 Tarragona;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QI;""
43 Tarragona;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
43 Tarragona;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
43 Tarragona;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QII;""
43 Tarragona;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QI;""
43 Tarragona;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
43 Tarragona;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
43 Tarragona;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
43 Tarragona;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
43 Tarragona;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
43 Tarragona;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
43 Tarragona;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
43 Tarragona;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
43 Tarragona;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
43 Tarragona;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
43 Tarragona;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
43 Tarragona;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
43 Tarragona;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
43 Tarragona;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;96,08
43 Tarragona;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
43 Tarragona;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
43 Tarragona;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
43 Tarragona;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;96,92
43 Tarragona;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
43 Tarragona;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
43 Tarragona;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
43 Tarragona;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;94,47
43 Tarragona;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
43 Tarragona;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
43 Tarragona;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;90,09
43 Tarragona;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
43 Tarragona;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
43 Tarragona;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
43 Tarragona;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;91,64
43 Tarragona;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
43 Tarragona;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
43 Tarragona;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
43 Tarragona;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;90,1
43 Tarragona;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
43 Tarragona;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
43 Tarragona;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
43 Tarragona;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
43 Tarragona;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
43 Tarragona;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
43 Tarragona;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;87,65
43 Tarragona;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
43 Tarragona;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
43 Tarragona;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
43 Tarragona;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;86,56
43 Tarragona;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
43 Tarragona;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
43 Tarragona;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
43 Tarragona;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
43 Tarragona;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
43 Tarragona;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
43 Tarragona;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;84,71
43 Tarragona;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
43 Tarragona;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
43 Tarragona;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
43 Tarragona;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;83,44
43 Tarragona;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
43 Tarragona;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
43 Tarragona;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
43 Tarragona;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
43 Tarragona;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
43 Tarragona;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
43 Tarragona;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QIII;3.042
43 Tarragona;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
43 Tarragona;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
43 Tarragona;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
43 Tarragona;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QIII;2.948
43 Tarragona;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
43 Tarragona;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
43 Tarragona;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
43 Tarragona;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QIII;2.818
43 Tarragona;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
43 Tarragona;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
43 Tarragona;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
43 Tarragona;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2022QIII;2.919
43 Tarragona;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2022QII;""
43 Tarragona;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2022QI;""
43 Tarragona;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
43 Tarragona;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2021QIII;2.815
43 Tarragona;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2021QII;""
43 Tarragona;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2021QI;""
43 Tarragona;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
43 Tarragona;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2020QIII;2.657
43 Tarragona;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2020QII;""
43 Tarragona;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2020QI;""
43 Tarragona;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2022QIV;2.701
43 Tarragona;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
43 Tarragona;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2022QII;""
43 Tarragona;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2022QI;""
43 Tarragona;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2021QIV;2.637
43 Tarragona;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
43 Tarragona;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2021QII;""
43 Tarragona;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2021QI;""
43 Tarragona;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2020QIV;2.510
43 Tarragona;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
43 Tarragona;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2020QII;""
43 Tarragona;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2020QI;""
43 Tarragona;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
43 Tarragona;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
43 Tarragona;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QII;""
43 Tarragona;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QI;2.535
43 Tarragona;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
43 Tarragona;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
43 Tarragona;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QII;""
43 Tarragona;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QI;2.428
43 Tarragona;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
43 Tarragona;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
43 Tarragona;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QII;""
43 Tarragona;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QI;""
43 Tarragona;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
43 Tarragona;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
43 Tarragona;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QII;2.439
43 Tarragona;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QI;""
43 Tarragona;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
43 Tarragona;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
43 Tarragona;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QII;2.331
43 Tarragona;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QI;""
43 Tarragona;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
43 Tarragona;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
43 Tarragona;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QII;""
43 Tarragona;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QI;""
43 Tarragona;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
43 Tarragona;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
43 Tarragona;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
43 Tarragona;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
43 Tarragona;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
43 Tarragona;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
43 Tarragona;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
43 Tarragona;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
43 Tarragona;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
43 Tarragona;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
43 Tarragona;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
43 Tarragona;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
43 Tarragona;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
43 Tarragona;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;95,96
43 Tarragona;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
43 Tarragona;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
43 Tarragona;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
43 Tarragona;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;95,49
43 Tarragona;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
43 Tarragona;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
43 Tarragona;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
43 Tarragona;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;94,29
43 Tarragona;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
43 Tarragona;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
43 Tarragona;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;88,79
43 Tarragona;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
43 Tarragona;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
43 Tarragona;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
43 Tarragona;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;89,45
43 Tarragona;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
43 Tarragona;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
43 Tarragona;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
43 Tarragona;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;89,07
43 Tarragona;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
43 Tarragona;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
43 Tarragona;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
43 Tarragona;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
43 Tarragona;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
43 Tarragona;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
43 Tarragona;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;85,99
43 Tarragona;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
43 Tarragona;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
43 Tarragona;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
43 Tarragona;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;86,16
43 Tarragona;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
43 Tarragona;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
43 Tarragona;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
43 Tarragona;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
43 Tarragona;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
43 Tarragona;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
43 Tarragona;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;82,73
43 Tarragona;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
43 Tarragona;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
43 Tarragona;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
43 Tarragona;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;82,72
43 Tarragona;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
43 Tarragona;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
43 Tarragona;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
43 Tarragona;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
43 Tarragona;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
43 Tarragona;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QIV;7.970
43 Tarragona;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
43 Tarragona;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
43 Tarragona;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
43 Tarragona;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QIV;7.699
43 Tarragona;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
43 Tarragona;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
43 Tarragona;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
43 Tarragona;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QIV;7.303
43 Tarragona;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
43 Tarragona;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
43 Tarragona;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
43 Tarragona;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2022QIV;7.423
43 Tarragona;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
43 Tarragona;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2022QII;""
43 Tarragona;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2022QI;""
43 Tarragona;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2021QIV;7.243
43 Tarragona;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
43 Tarragona;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2021QII;""
43 Tarragona;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2021QI;""
43 Tarragona;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2020QIV;6.921
43 Tarragona;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
43 Tarragona;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2020QII;""
43 Tarragona;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2020QI;""
43 Tarragona;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
43 Tarragona;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
43 Tarragona;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2022QII;""
43 Tarragona;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2022QI;6.938
43 Tarragona;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
43 Tarragona;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
43 Tarragona;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2021QII;""
43 Tarragona;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2021QI;6.664
43 Tarragona;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
43 Tarragona;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
43 Tarragona;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2020QII;""
43 Tarragona;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2020QI;""
43 Tarragona;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
43 Tarragona;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
43 Tarragona;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QII;6.688
43 Tarragona;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QI;""
43 Tarragona;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
43 Tarragona;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
43 Tarragona;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QII;6.408
43 Tarragona;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QI;""
43 Tarragona;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
43 Tarragona;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
43 Tarragona;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QII;""
43 Tarragona;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QI;""
43 Tarragona;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
43 Tarragona;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QIII;6.442
43 Tarragona;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QII;""
43 Tarragona;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QI;""
43 Tarragona;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
43 Tarragona;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QIII;6.204
43 Tarragona;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QII;""
43 Tarragona;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QI;""
43 Tarragona;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
43 Tarragona;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
43 Tarragona;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QII;""
43 Tarragona;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QI;""
43 Tarragona;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
43 Tarragona;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
43 Tarragona;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
43 Tarragona;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
43 Tarragona;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
43 Tarragona;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
43 Tarragona;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
43 Tarragona;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
43 Tarragona;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
43 Tarragona;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
43 Tarragona;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
43 Tarragona;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
43 Tarragona;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;93,14
43 Tarragona;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
43 Tarragona;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
43 Tarragona;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
43 Tarragona;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;94,08
43 Tarragona;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
43 Tarragona;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
43 Tarragona;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
43 Tarragona;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;94,77
43 Tarragona;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
43 Tarragona;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
43 Tarragona;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
43 Tarragona;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
43 Tarragona;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
43 Tarragona;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
43 Tarragona;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;90,12
43 Tarragona;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
43 Tarragona;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
43 Tarragona;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
43 Tarragona;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;91,25
43 Tarragona;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
43 Tarragona;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
43 Tarragona;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
43 Tarragona;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
43 Tarragona;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
43 Tarragona;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
43 Tarragona;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;86,87
43 Tarragona;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
43 Tarragona;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
43 Tarragona;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
43 Tarragona;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;87,74
43 Tarragona;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
43 Tarragona;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
43 Tarragona;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
43 Tarragona;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
43 Tarragona;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
43 Tarragona;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
43 Tarragona;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;83,67
43 Tarragona;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
43 Tarragona;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
43 Tarragona;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
43 Tarragona;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;84,95
43 Tarragona;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
43 Tarragona;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
43 Tarragona;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
43 Tarragona;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
43 Tarragona;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
43 Tarragona;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
43 Tarragona;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QIV;5.018
43 Tarragona;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
43 Tarragona;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
43 Tarragona;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
43 Tarragona;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QIV;4.857
43 Tarragona;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
43 Tarragona;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
43 Tarragona;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
43 Tarragona;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QIV;4.610
43 Tarragona;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
43 Tarragona;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
43 Tarragona;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
43 Tarragona;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2022QIV;4.692
43 Tarragona;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
43 Tarragona;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2022QII;""
43 Tarragona;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2022QI;""
43 Tarragona;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2021QIV;4.584
43 Tarragona;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
43 Tarragona;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2021QII;""
43 Tarragona;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2021QI;""
43 Tarragona;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2020QIV;4.381
43 Tarragona;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
43 Tarragona;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2020QII;""
43 Tarragona;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2020QI;""
43 Tarragona;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
43 Tarragona;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
43 Tarragona;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2022QII;""
43 Tarragona;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2022QI;4.384
43 Tarragona;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
43 Tarragona;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
43 Tarragona;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2021QII;""
43 Tarragona;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2021QI;4.208
43 Tarragona;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
43 Tarragona;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
43 Tarragona;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2020QII;""
43 Tarragona;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2020QI;""
43 Tarragona;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
43 Tarragona;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
43 Tarragona;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QII;4.232
43 Tarragona;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QI;""
43 Tarragona;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
43 Tarragona;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
43 Tarragona;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QII;4.052
43 Tarragona;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QI;""
43 Tarragona;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
43 Tarragona;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
43 Tarragona;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QII;""
43 Tarragona;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QI;""
43 Tarragona;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
43 Tarragona;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QIII;4.070
43 Tarragona;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QII;""
43 Tarragona;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QI;""
43 Tarragona;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
43 Tarragona;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QIII;3.943
43 Tarragona;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QII;""
43 Tarragona;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QI;""
43 Tarragona;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
43 Tarragona;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
43 Tarragona;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QII;""
43 Tarragona;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QI;""
43 Tarragona;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
43 Tarragona;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
43 Tarragona;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
43 Tarragona;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
43 Tarragona;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
43 Tarragona;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
43 Tarragona;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
43 Tarragona;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
43 Tarragona;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
43 Tarragona;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
43 Tarragona;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
43 Tarragona;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
43 Tarragona;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;93,5
43 Tarragona;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
43 Tarragona;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
43 Tarragona;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
43 Tarragona;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;94,38
43 Tarragona;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
43 Tarragona;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
43 Tarragona;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
43 Tarragona;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;95,03
43 Tarragona;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
43 Tarragona;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
43 Tarragona;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
43 Tarragona;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
43 Tarragona;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
43 Tarragona;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
43 Tarragona;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;90,26
43 Tarragona;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
43 Tarragona;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
43 Tarragona;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
43 Tarragona;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;91,28
43 Tarragona;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
43 Tarragona;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
43 Tarragona;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
43 Tarragona;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
43 Tarragona;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
43 Tarragona;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
43 Tarragona;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;87,13
43 Tarragona;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
43 Tarragona;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
43 Tarragona;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
43 Tarragona;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;87,9
43 Tarragona;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
43 Tarragona;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
43 Tarragona;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
43 Tarragona;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
43 Tarragona;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
43 Tarragona;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
43 Tarragona;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;83,8
43 Tarragona;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
43 Tarragona;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
43 Tarragona;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
43 Tarragona;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;85,53
43 Tarragona;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
43 Tarragona;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
43 Tarragona;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
43 Tarragona;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
43 Tarragona;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
43 Tarragona;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
43 Tarragona;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QIV;2.952
43 Tarragona;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
43 Tarragona;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
43 Tarragona;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
43 Tarragona;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QIV;2.842
43 Tarragona;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
43 Tarragona;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
43 Tarragona;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
43 Tarragona;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QIV;2.693
43 Tarragona;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
43 Tarragona;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
43 Tarragona;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
43 Tarragona;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2022QIV;2.731
43 Tarragona;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
43 Tarragona;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2022QII;""
43 Tarragona;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2022QI;""
43 Tarragona;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2021QIV;2.659
43 Tarragona;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
43 Tarragona;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2021QII;""
43 Tarragona;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2021QI;""
43 Tarragona;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2020QIV;2.540
43 Tarragona;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
43 Tarragona;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2020QII;""
43 Tarragona;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2020QI;""
43 Tarragona;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
43 Tarragona;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
43 Tarragona;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2022QII;""
43 Tarragona;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2022QI;2.554
43 Tarragona;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
43 Tarragona;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
43 Tarragona;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2021QII;""
43 Tarragona;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2021QI;2.456
43 Tarragona;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
43 Tarragona;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
43 Tarragona;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2020QII;""
43 Tarragona;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2020QI;""
43 Tarragona;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
43 Tarragona;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
43 Tarragona;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QII;2.456
43 Tarragona;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QI;""
43 Tarragona;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
43 Tarragona;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
43 Tarragona;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QII;2.356
43 Tarragona;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QI;""
43 Tarragona;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
43 Tarragona;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
43 Tarragona;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QII;""
43 Tarragona;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QI;""
43 Tarragona;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
43 Tarragona;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QIII;2.372
43 Tarragona;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QII;""
43 Tarragona;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QI;""
43 Tarragona;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
43 Tarragona;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QIII;2.261
43 Tarragona;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QII;""
43 Tarragona;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QI;""
43 Tarragona;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
43 Tarragona;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
43 Tarragona;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QII;""
43 Tarragona;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QI;""
43 Tarragona;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
43 Tarragona;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
43 Tarragona;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
43 Tarragona;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
43 Tarragona;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
43 Tarragona;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
43 Tarragona;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
43 Tarragona;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
43 Tarragona;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
43 Tarragona;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
43 Tarragona;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
43 Tarragona;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
43 Tarragona;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;92,51
43 Tarragona;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
43 Tarragona;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
43 Tarragona;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
43 Tarragona;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;93,56
43 Tarragona;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
43 Tarragona;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
43 Tarragona;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
43 Tarragona;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;94,32
43 Tarragona;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
43 Tarragona;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
43 Tarragona;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
43 Tarragona;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
43 Tarragona;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
43 Tarragona;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
43 Tarragona;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;89,87
43 Tarragona;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
43 Tarragona;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
43 Tarragona;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
43 Tarragona;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;91,2
43 Tarragona;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
43 Tarragona;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
43 Tarragona;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
43 Tarragona;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
43 Tarragona;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
43 Tarragona;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
43 Tarragona;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;86,42
43 Tarragona;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
43 Tarragona;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
43 Tarragona;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
43 Tarragona;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;87,49
43 Tarragona;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
43 Tarragona;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
43 Tarragona;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
43 Tarragona;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
43 Tarragona;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
43 Tarragona;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
43 Tarragona;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;83,46
43 Tarragona;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
43 Tarragona;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
43 Tarragona;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
43 Tarragona;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;83,96
43 Tarragona;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
43 Tarragona;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
43 Tarragona;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
43 Tarragona;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
43 Tarragona;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
43 Tarragona;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
44 Teruel;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
44 Teruel;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
44 Teruel;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
44 Teruel;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QI;8.891
44 Teruel;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
44 Teruel;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
44 Teruel;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
44 Teruel;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QI;8.858
44 Teruel;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
44 Teruel;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
44 Teruel;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
44 Teruel;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QI;9.106
44 Teruel;All ages;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
44 Teruel;All ages;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
44 Teruel;All ages;Cohort January 1;Total;Survival in the first trimester;2022QII;""
44 Teruel;All ages;Cohort January 1;Total;Survival in the first trimester;2022QI;8.661
44 Teruel;All ages;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
44 Teruel;All ages;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
44 Teruel;All ages;Cohort January 1;Total;Survival in the first trimester;2021QII;""
44 Teruel;All ages;Cohort January 1;Total;Survival in the first trimester;2021QI;8.658
44 Teruel;All ages;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
44 Teruel;All ages;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
44 Teruel;All ages;Cohort January 1;Total;Survival in the first trimester;2020QII;""
44 Teruel;All ages;Cohort January 1;Total;Survival in the first trimester;2020QI;8.649
44 Teruel;All ages;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
44 Teruel;All ages;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
44 Teruel;All ages;Cohort January 1;Total;Survival in the second trimester;2022QII;8.430
44 Teruel;All ages;Cohort January 1;Total;Survival in the second trimester;2022QI;""
44 Teruel;All ages;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
44 Teruel;All ages;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
44 Teruel;All ages;Cohort January 1;Total;Survival in the second trimester;2021QII;8.465
44 Teruel;All ages;Cohort January 1;Total;Survival in the second trimester;2021QI;""
44 Teruel;All ages;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
44 Teruel;All ages;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
44 Teruel;All ages;Cohort January 1;Total;Survival in the second trimester;2020QII;8.477
44 Teruel;All ages;Cohort January 1;Total;Survival in the second trimester;2020QI;""
44 Teruel;All ages;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
44 Teruel;All ages;Cohort January 1;Total;Survival in the third trimester;2022QIII;8.270
44 Teruel;All ages;Cohort January 1;Total;Survival in the third trimester;2022QII;""
44 Teruel;All ages;Cohort January 1;Total;Survival in the third trimester;2022QI;""
44 Teruel;All ages;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
44 Teruel;All ages;Cohort January 1;Total;Survival in the third trimester;2021QIII;8.297
44 Teruel;All ages;Cohort January 1;Total;Survival in the third trimester;2021QII;""
44 Teruel;All ages;Cohort January 1;Total;Survival in the third trimester;2021QI;""
44 Teruel;All ages;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
44 Teruel;All ages;Cohort January 1;Total;Survival in the third trimester;2020QIII;8.271
44 Teruel;All ages;Cohort January 1;Total;Survival in the third trimester;2020QII;""
44 Teruel;All ages;Cohort January 1;Total;Survival in the third trimester;2020QI;""
44 Teruel;All ages;Cohort January 1;Total;Survival in the third trimester;2022QIV;7.959
44 Teruel;All ages;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
44 Teruel;All ages;Cohort January 1;Total;Survival in the third trimester;2022QII;""
44 Teruel;All ages;Cohort January 1;Total;Survival in the third trimester;2022QI;""
44 Teruel;All ages;Cohort January 1;Total;Survival in the third trimester;2021QIV;8.104
44 Teruel;All ages;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
44 Teruel;All ages;Cohort January 1;Total;Survival in the third trimester;2021QII;""
44 Teruel;All ages;Cohort January 1;Total;Survival in the third trimester;2021QI;""
44 Teruel;All ages;Cohort January 1;Total;Survival in the third trimester;2020QIV;8.070
44 Teruel;All ages;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
44 Teruel;All ages;Cohort January 1;Total;Survival in the third trimester;2020QII;""
44 Teruel;All ages;Cohort January 1;Total;Survival in the third trimester;2020QI;""
44 Teruel;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
44 Teruel;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
44 Teruel;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
44 Teruel;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
44 Teruel;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
44 Teruel;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
44 Teruel;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
44 Teruel;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
44 Teruel;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
44 Teruel;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
44 Teruel;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
44 Teruel;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
44 Teruel;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
44 Teruel;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
44 Teruel;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
44 Teruel;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;97,41
44 Teruel;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
44 Teruel;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
44 Teruel;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
44 Teruel;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;97,74
44 Teruel;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
44 Teruel;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
44 Teruel;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
44 Teruel;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;94,98
44 Teruel;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
44 Teruel;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
44 Teruel;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;94,81
44 Teruel;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
44 Teruel;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
44 Teruel;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
44 Teruel;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;95,56
44 Teruel;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
44 Teruel;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
44 Teruel;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
44 Teruel;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;93,09
44 Teruel;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
44 Teruel;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
44 Teruel;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;93,02
44 Teruel;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
44 Teruel;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
44 Teruel;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
44 Teruel;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;93,67
44 Teruel;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
44 Teruel;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
44 Teruel;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
44 Teruel;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;90,83
44 Teruel;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
44 Teruel;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
44 Teruel;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;89,52
44 Teruel;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
44 Teruel;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
44 Teruel;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
44 Teruel;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;91,49
44 Teruel;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
44 Teruel;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
44 Teruel;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
44 Teruel;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;88,62
44 Teruel;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
44 Teruel;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
44 Teruel;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
44 Teruel;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
44 Teruel;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
44 Teruel;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
44 Teruel;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QI;5.584
44 Teruel;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
44 Teruel;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
44 Teruel;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
44 Teruel;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QI;5.585
44 Teruel;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
44 Teruel;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
44 Teruel;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
44 Teruel;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QI;5.728
44 Teruel;All ages;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
44 Teruel;All ages;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
44 Teruel;All ages;Cohort January 1;Males;Survival in the first trimester;2022QII;""
44 Teruel;All ages;Cohort January 1;Males;Survival in the first trimester;2022QI;5.445
44 Teruel;All ages;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
44 Teruel;All ages;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
44 Teruel;All ages;Cohort January 1;Males;Survival in the first trimester;2021QII;""
44 Teruel;All ages;Cohort January 1;Males;Survival in the first trimester;2021QI;5.467
44 Teruel;All ages;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
44 Teruel;All ages;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
44 Teruel;All ages;Cohort January 1;Males;Survival in the first trimester;2020QII;""
44 Teruel;All ages;Cohort January 1;Males;Survival in the first trimester;2020QI;5.459
44 Teruel;All ages;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
44 Teruel;All ages;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
44 Teruel;All ages;Cohort January 1;Males;Survival in the second trimester;2022QII;5.324
44 Teruel;All ages;Cohort January 1;Males;Survival in the second trimester;2022QI;""
44 Teruel;All ages;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
44 Teruel;All ages;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
44 Teruel;All ages;Cohort January 1;Males;Survival in the second trimester;2021QII;5.370
44 Teruel;All ages;Cohort January 1;Males;Survival in the second trimester;2021QI;""
44 Teruel;All ages;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
44 Teruel;All ages;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
44 Teruel;All ages;Cohort January 1;Males;Survival in the second trimester;2020QII;5.367
44 Teruel;All ages;Cohort January 1;Males;Survival in the second trimester;2020QI;""
44 Teruel;All ages;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
44 Teruel;All ages;Cohort January 1;Males;Survival in the third trimester;2022QIII;5.229
44 Teruel;All ages;Cohort January 1;Males;Survival in the third trimester;2022QII;""
44 Teruel;All ages;Cohort January 1;Males;Survival in the third trimester;2022QI;""
44 Teruel;All ages;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
44 Teruel;All ages;Cohort January 1;Males;Survival in the third trimester;2021QIII;5.265
44 Teruel;All ages;Cohort January 1;Males;Survival in the third trimester;2021QII;""
44 Teruel;All ages;Cohort January 1;Males;Survival in the third trimester;2021QI;""
44 Teruel;All ages;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
44 Teruel;All ages;Cohort January 1;Males;Survival in the third trimester;2020QIII;5.257
44 Teruel;All ages;Cohort January 1;Males;Survival in the third trimester;2020QII;""
44 Teruel;All ages;Cohort January 1;Males;Survival in the third trimester;2020QI;""
44 Teruel;All ages;Cohort January 1;Males;Survival in the third trimester;2022QIV;5.040
44 Teruel;All ages;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
44 Teruel;All ages;Cohort January 1;Males;Survival in the third trimester;2022QII;""
44 Teruel;All ages;Cohort January 1;Males;Survival in the third trimester;2022QI;""
44 Teruel;All ages;Cohort January 1;Males;Survival in the third trimester;2021QIV;5.154
44 Teruel;All ages;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
44 Teruel;All ages;Cohort January 1;Males;Survival in the third trimester;2021QII;""
44 Teruel;All ages;Cohort January 1;Males;Survival in the third trimester;2021QI;""
44 Teruel;All ages;Cohort January 1;Males;Survival in the third trimester;2020QIV;5.142
44 Teruel;All ages;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
44 Teruel;All ages;Cohort January 1;Males;Survival in the third trimester;2020QII;""
44 Teruel;All ages;Cohort January 1;Males;Survival in the third trimester;2020QI;""
44 Teruel;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
44 Teruel;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
44 Teruel;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
44 Teruel;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
44 Teruel;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
44 Teruel;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
44 Teruel;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
44 Teruel;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
44 Teruel;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
44 Teruel;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
44 Teruel;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
44 Teruel;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
44 Teruel;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
44 Teruel;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
44 Teruel;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
44 Teruel;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;97,51
44 Teruel;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
44 Teruel;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
44 Teruel;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
44 Teruel;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;97,89
44 Teruel;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
44 Teruel;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
44 Teruel;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
44 Teruel;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;95,3
44 Teruel;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
44 Teruel;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
44 Teruel;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;95,34
44 Teruel;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
44 Teruel;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
44 Teruel;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
44 Teruel;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;96,15
44 Teruel;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
44 Teruel;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
44 Teruel;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
44 Teruel;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;93,7
44 Teruel;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
44 Teruel;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
44 Teruel;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;93,64
44 Teruel;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
44 Teruel;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
44 Teruel;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
44 Teruel;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;94,27
44 Teruel;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
44 Teruel;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
44 Teruel;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
44 Teruel;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;91,78
44 Teruel;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
44 Teruel;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
44 Teruel;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;90,26
44 Teruel;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
44 Teruel;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
44 Teruel;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
44 Teruel;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;92,28
44 Teruel;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
44 Teruel;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
44 Teruel;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
44 Teruel;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;89,77
44 Teruel;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
44 Teruel;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
44 Teruel;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
44 Teruel;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
44 Teruel;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
44 Teruel;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
44 Teruel;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QI;3.307
44 Teruel;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
44 Teruel;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
44 Teruel;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
44 Teruel;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QI;3.273
44 Teruel;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
44 Teruel;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
44 Teruel;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
44 Teruel;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QI;3.378
44 Teruel;All ages;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
44 Teruel;All ages;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
44 Teruel;All ages;Cohort January 1;Females;Survival in the first trimester;2022QII;""
44 Teruel;All ages;Cohort January 1;Females;Survival in the first trimester;2022QI;3.216
44 Teruel;All ages;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
44 Teruel;All ages;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
44 Teruel;All ages;Cohort January 1;Females;Survival in the first trimester;2021QII;""
44 Teruel;All ages;Cohort January 1;Females;Survival in the first trimester;2021QI;3.191
44 Teruel;All ages;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
44 Teruel;All ages;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
44 Teruel;All ages;Cohort January 1;Females;Survival in the first trimester;2020QII;""
44 Teruel;All ages;Cohort January 1;Females;Survival in the first trimester;2020QI;3.190
44 Teruel;All ages;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
44 Teruel;All ages;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
44 Teruel;All ages;Cohort January 1;Females;Survival in the second trimester;2022QII;3.106
44 Teruel;All ages;Cohort January 1;Females;Survival in the second trimester;2022QI;""
44 Teruel;All ages;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
44 Teruel;All ages;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
44 Teruel;All ages;Cohort January 1;Females;Survival in the second trimester;2021QII;3.095
44 Teruel;All ages;Cohort January 1;Females;Survival in the second trimester;2021QI;""
44 Teruel;All ages;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
44 Teruel;All ages;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
44 Teruel;All ages;Cohort January 1;Females;Survival in the second trimester;2020QII;3.110
44 Teruel;All ages;Cohort January 1;Females;Survival in the second trimester;2020QI;""
44 Teruel;All ages;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
44 Teruel;All ages;Cohort January 1;Females;Survival in the third trimester;2022QIII;3.041
44 Teruel;All ages;Cohort January 1;Females;Survival in the third trimester;2022QII;""
44 Teruel;All ages;Cohort January 1;Females;Survival in the third trimester;2022QI;""
44 Teruel;All ages;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
44 Teruel;All ages;Cohort January 1;Females;Survival in the third trimester;2021QIII;3.032
44 Teruel;All ages;Cohort January 1;Females;Survival in the third trimester;2021QII;""
44 Teruel;All ages;Cohort January 1;Females;Survival in the third trimester;2021QI;""
44 Teruel;All ages;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
44 Teruel;All ages;Cohort January 1;Females;Survival in the third trimester;2020QIII;3.014
44 Teruel;All ages;Cohort January 1;Females;Survival in the third trimester;2020QII;""
44 Teruel;All ages;Cohort January 1;Females;Survival in the third trimester;2020QI;""
44 Teruel;All ages;Cohort January 1;Females;Survival in the third trimester;2022QIV;2.919
44 Teruel;All ages;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
44 Teruel;All ages;Cohort January 1;Females;Survival in the third trimester;2022QII;""
44 Teruel;All ages;Cohort January 1;Females;Survival in the third trimester;2022QI;""
44 Teruel;All ages;Cohort January 1;Females;Survival in the third trimester;2021QIV;2.950
44 Teruel;All ages;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
44 Teruel;All ages;Cohort January 1;Females;Survival in the third trimester;2021QII;""
44 Teruel;All ages;Cohort January 1;Females;Survival in the third trimester;2021QI;""
44 Teruel;All ages;Cohort January 1;Females;Survival in the third trimester;2020QIV;2.928
44 Teruel;All ages;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
44 Teruel;All ages;Cohort January 1;Females;Survival in the third trimester;2020QII;""
44 Teruel;All ages;Cohort January 1;Females;Survival in the third trimester;2020QI;""
44 Teruel;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
44 Teruel;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
44 Teruel;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
44 Teruel;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
44 Teruel;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
44 Teruel;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
44 Teruel;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
44 Teruel;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
44 Teruel;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
44 Teruel;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
44 Teruel;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
44 Teruel;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
44 Teruel;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
44 Teruel;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
44 Teruel;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
44 Teruel;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;97,25
44 Teruel;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
44 Teruel;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
44 Teruel;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
44 Teruel;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;97,49
44 Teruel;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
44 Teruel;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
44 Teruel;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
44 Teruel;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;94,43
44 Teruel;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
44 Teruel;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
44 Teruel;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;93,92
44 Teruel;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
44 Teruel;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
44 Teruel;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
44 Teruel;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;94,56
44 Teruel;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
44 Teruel;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
44 Teruel;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
44 Teruel;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;92,07
44 Teruel;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
44 Teruel;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
44 Teruel;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;91,96
44 Teruel;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
44 Teruel;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
44 Teruel;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
44 Teruel;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;92,64
44 Teruel;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
44 Teruel;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
44 Teruel;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
44 Teruel;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;89,22
44 Teruel;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
44 Teruel;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
44 Teruel;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;88,27
44 Teruel;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
44 Teruel;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
44 Teruel;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
44 Teruel;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;90,13
44 Teruel;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
44 Teruel;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
44 Teruel;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
44 Teruel;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;86,68
44 Teruel;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
44 Teruel;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
44 Teruel;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
44 Teruel;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
44 Teruel;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
44 Teruel;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QII;8.901
44 Teruel;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
44 Teruel;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
44 Teruel;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
44 Teruel;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QII;8.839
44 Teruel;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
44 Teruel;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
44 Teruel;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
44 Teruel;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QII;8.943
44 Teruel;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
44 Teruel;All ages;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
44 Teruel;All ages;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
44 Teruel;All ages;Cohort April 1;Total;Survival in the first trimester;2022QII;8.647
44 Teruel;All ages;Cohort April 1;Total;Survival in the first trimester;2022QI;""
44 Teruel;All ages;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
44 Teruel;All ages;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
44 Teruel;All ages;Cohort April 1;Total;Survival in the first trimester;2021QII;8.622
44 Teruel;All ages;Cohort April 1;Total;Survival in the first trimester;2021QI;""
44 Teruel;All ages;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
44 Teruel;All ages;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
44 Teruel;All ages;Cohort April 1;Total;Survival in the first trimester;2020QII;8.754
44 Teruel;All ages;Cohort April 1;Total;Survival in the first trimester;2020QI;""
44 Teruel;All ages;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
44 Teruel;All ages;Cohort April 1;Total;Survival in the second trimester;2022QIII;8.474
44 Teruel;All ages;Cohort April 1;Total;Survival in the second trimester;2022QII;""
44 Teruel;All ages;Cohort April 1;Total;Survival in the second trimester;2022QI;""
44 Teruel;All ages;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
44 Teruel;All ages;Cohort April 1;Total;Survival in the second trimester;2021QIII;8.442
44 Teruel;All ages;Cohort April 1;Total;Survival in the second trimester;2021QII;""
44 Teruel;All ages;Cohort April 1;Total;Survival in the second trimester;2021QI;""
44 Teruel;All ages;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
44 Teruel;All ages;Cohort April 1;Total;Survival in the second trimester;2020QIII;8.511
44 Teruel;All ages;Cohort April 1;Total;Survival in the second trimester;2020QII;""
44 Teruel;All ages;Cohort April 1;Total;Survival in the second trimester;2020QI;""
44 Teruel;All ages;Cohort April 1;Total;Survival in the third trimester;2022QIV;8.149
44 Teruel;All ages;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
44 Teruel;All ages;Cohort April 1;Total;Survival in the third trimester;2022QII;""
44 Teruel;All ages;Cohort April 1;Total;Survival in the third trimester;2022QI;""
44 Teruel;All ages;Cohort April 1;Total;Survival in the third trimester;2021QIV;8.238
44 Teruel;All ages;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
44 Teruel;All ages;Cohort April 1;Total;Survival in the third trimester;2021QII;""
44 Teruel;All ages;Cohort April 1;Total;Survival in the third trimester;2021QI;""
44 Teruel;All ages;Cohort April 1;Total;Survival in the third trimester;2020QIV;8.289
44 Teruel;All ages;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
44 Teruel;All ages;Cohort April 1;Total;Survival in the third trimester;2020QII;""
44 Teruel;All ages;Cohort April 1;Total;Survival in the third trimester;2020QI;""
44 Teruel;All ages;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
44 Teruel;All ages;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
44 Teruel;All ages;Cohort April 1;Total;Survival in the third trimester;2022QII;""
44 Teruel;All ages;Cohort April 1;Total;Survival in the third trimester;2022QI;8.065
44 Teruel;All ages;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
44 Teruel;All ages;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
44 Teruel;All ages;Cohort April 1;Total;Survival in the third trimester;2021QII;""
44 Teruel;All ages;Cohort April 1;Total;Survival in the third trimester;2021QI;8.136
44 Teruel;All ages;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
44 Teruel;All ages;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
44 Teruel;All ages;Cohort April 1;Total;Survival in the third trimester;2020QII;""
44 Teruel;All ages;Cohort April 1;Total;Survival in the third trimester;2020QI;""
44 Teruel;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
44 Teruel;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
44 Teruel;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
44 Teruel;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
44 Teruel;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
44 Teruel;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
44 Teruel;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
44 Teruel;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
44 Teruel;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
44 Teruel;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
44 Teruel;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
44 Teruel;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
44 Teruel;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
44 Teruel;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
44 Teruel;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;97,15
44 Teruel;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
44 Teruel;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
44 Teruel;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
44 Teruel;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;97,54
44 Teruel;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
44 Teruel;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
44 Teruel;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
44 Teruel;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;97,89
44 Teruel;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
44 Teruel;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
44 Teruel;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;95,2
44 Teruel;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
44 Teruel;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
44 Teruel;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
44 Teruel;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;95,51
44 Teruel;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
44 Teruel;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
44 Teruel;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
44 Teruel;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;95,17
44 Teruel;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
44 Teruel;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
44 Teruel;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;91,55
44 Teruel;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
44 Teruel;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
44 Teruel;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
44 Teruel;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;93,2
44 Teruel;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
44 Teruel;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
44 Teruel;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
44 Teruel;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;92,69
44 Teruel;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
44 Teruel;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
44 Teruel;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
44 Teruel;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
44 Teruel;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
44 Teruel;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
44 Teruel;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;91,24
44 Teruel;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
44 Teruel;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
44 Teruel;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
44 Teruel;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;90,98
44 Teruel;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
44 Teruel;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
44 Teruel;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
44 Teruel;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
44 Teruel;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
44 Teruel;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
44 Teruel;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QII;5.567
44 Teruel;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
44 Teruel;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
44 Teruel;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
44 Teruel;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QII;5.578
44 Teruel;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
44 Teruel;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
44 Teruel;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
44 Teruel;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QII;5.622
44 Teruel;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
44 Teruel;All ages;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
44 Teruel;All ages;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
44 Teruel;All ages;Cohort April 1;Males;Survival in the first trimester;2022QII;5.436
44 Teruel;All ages;Cohort April 1;Males;Survival in the first trimester;2022QI;""
44 Teruel;All ages;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
44 Teruel;All ages;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
44 Teruel;All ages;Cohort April 1;Males;Survival in the first trimester;2021QII;5.463
44 Teruel;All ages;Cohort April 1;Males;Survival in the first trimester;2021QI;""
44 Teruel;All ages;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
44 Teruel;All ages;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
44 Teruel;All ages;Cohort April 1;Males;Survival in the first trimester;2020QII;5.522
44 Teruel;All ages;Cohort April 1;Males;Survival in the first trimester;2020QI;""
44 Teruel;All ages;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
44 Teruel;All ages;Cohort April 1;Males;Survival in the second trimester;2022QIII;5.335
44 Teruel;All ages;Cohort April 1;Males;Survival in the second trimester;2022QII;""
44 Teruel;All ages;Cohort April 1;Males;Survival in the second trimester;2022QI;""
44 Teruel;All ages;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
44 Teruel;All ages;Cohort April 1;Males;Survival in the second trimester;2021QIII;5.350
44 Teruel;All ages;Cohort April 1;Males;Survival in the second trimester;2021QII;""
44 Teruel;All ages;Cohort April 1;Males;Survival in the second trimester;2021QI;""
44 Teruel;All ages;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
44 Teruel;All ages;Cohort April 1;Males;Survival in the second trimester;2020QIII;5.390
44 Teruel;All ages;Cohort April 1;Males;Survival in the second trimester;2020QII;""
44 Teruel;All ages;Cohort April 1;Males;Survival in the second trimester;2020QI;""
44 Teruel;All ages;Cohort April 1;Males;Survival in the third trimester;2022QIV;5.139
44 Teruel;All ages;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
44 Teruel;All ages;Cohort April 1;Males;Survival in the third trimester;2022QII;""
44 Teruel;All ages;Cohort April 1;Males;Survival in the third trimester;2022QI;""
44 Teruel;All ages;Cohort April 1;Males;Survival in the third trimester;2021QIV;5.232
44 Teruel;All ages;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
44 Teruel;All ages;Cohort April 1;Males;Survival in the third trimester;2021QII;""
44 Teruel;All ages;Cohort April 1;Males;Survival in the third trimester;2021QI;""
44 Teruel;All ages;Cohort April 1;Males;Survival in the third trimester;2020QIV;5.264
44 Teruel;All ages;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
44 Teruel;All ages;Cohort April 1;Males;Survival in the third trimester;2020QII;""
44 Teruel;All ages;Cohort April 1;Males;Survival in the third trimester;2020QI;""
44 Teruel;All ages;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
44 Teruel;All ages;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
44 Teruel;All ages;Cohort April 1;Males;Survival in the third trimester;2022QII;""
44 Teruel;All ages;Cohort April 1;Males;Survival in the third trimester;2022QI;5.127
44 Teruel;All ages;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
44 Teruel;All ages;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
44 Teruel;All ages;Cohort April 1;Males;Survival in the third trimester;2021QII;""
44 Teruel;All ages;Cohort April 1;Males;Survival in the third trimester;2021QI;5.176
44 Teruel;All ages;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
44 Teruel;All ages;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
44 Teruel;All ages;Cohort April 1;Males;Survival in the third trimester;2020QII;""
44 Teruel;All ages;Cohort April 1;Males;Survival in the third trimester;2020QI;""
44 Teruel;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
44 Teruel;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
44 Teruel;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
44 Teruel;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
44 Teruel;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
44 Teruel;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
44 Teruel;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
44 Teruel;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
44 Teruel;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
44 Teruel;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
44 Teruel;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
44 Teruel;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
44 Teruel;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
44 Teruel;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
44 Teruel;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;97,65
44 Teruel;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
44 Teruel;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
44 Teruel;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
44 Teruel;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;97,94
44 Teruel;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
44 Teruel;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
44 Teruel;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
44 Teruel;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;98,22
44 Teruel;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
44 Teruel;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
44 Teruel;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;95,83
44 Teruel;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
44 Teruel;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
44 Teruel;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
44 Teruel;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;95,91
44 Teruel;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
44 Teruel;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
44 Teruel;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
44 Teruel;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;95,87
44 Teruel;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
44 Teruel;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
44 Teruel;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;92,31
44 Teruel;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
44 Teruel;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
44 Teruel;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
44 Teruel;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;93,8
44 Teruel;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
44 Teruel;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
44 Teruel;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
44 Teruel;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;93,63
44 Teruel;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
44 Teruel;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
44 Teruel;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
44 Teruel;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
44 Teruel;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
44 Teruel;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
44 Teruel;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;91,91
44 Teruel;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
44 Teruel;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
44 Teruel;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
44 Teruel;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;92,07
44 Teruel;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
44 Teruel;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
44 Teruel;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
44 Teruel;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
44 Teruel;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
44 Teruel;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
44 Teruel;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QII;3.334
44 Teruel;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
44 Teruel;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
44 Teruel;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
44 Teruel;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QII;3.261
44 Teruel;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
44 Teruel;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
44 Teruel;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
44 Teruel;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QII;3.321
44 Teruel;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
44 Teruel;All ages;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
44 Teruel;All ages;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
44 Teruel;All ages;Cohort April 1;Females;Survival in the first trimester;2022QII;3.211
44 Teruel;All ages;Cohort April 1;Females;Survival in the first trimester;2022QI;""
44 Teruel;All ages;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
44 Teruel;All ages;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
44 Teruel;All ages;Cohort April 1;Females;Survival in the first trimester;2021QII;3.159
44 Teruel;All ages;Cohort April 1;Females;Survival in the first trimester;2021QI;""
44 Teruel;All ages;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
44 Teruel;All ages;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
44 Teruel;All ages;Cohort April 1;Females;Survival in the first trimester;2020QII;3.232
44 Teruel;All ages;Cohort April 1;Females;Survival in the first trimester;2020QI;""
44 Teruel;All ages;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
44 Teruel;All ages;Cohort April 1;Females;Survival in the second trimester;2022QIII;3.139
44 Teruel;All ages;Cohort April 1;Females;Survival in the second trimester;2022QII;""
44 Teruel;All ages;Cohort April 1;Females;Survival in the second trimester;2022QI;""
44 Teruel;All ages;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
44 Teruel;All ages;Cohort April 1;Females;Survival in the second trimester;2021QIII;3.092
44 Teruel;All ages;Cohort April 1;Females;Survival in the second trimester;2021QII;""
44 Teruel;All ages;Cohort April 1;Females;Survival in the second trimester;2021QI;""
44 Teruel;All ages;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
44 Teruel;All ages;Cohort April 1;Females;Survival in the second trimester;2020QIII;3.121
44 Teruel;All ages;Cohort April 1;Females;Survival in the second trimester;2020QII;""
44 Teruel;All ages;Cohort April 1;Females;Survival in the second trimester;2020QI;""
44 Teruel;All ages;Cohort April 1;Females;Survival in the third trimester;2022QIV;3.010
44 Teruel;All ages;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
44 Teruel;All ages;Cohort April 1;Females;Survival in the third trimester;2022QII;""
44 Teruel;All ages;Cohort April 1;Females;Survival in the third trimester;2022QI;""
44 Teruel;All ages;Cohort April 1;Females;Survival in the third trimester;2021QIV;3.006
44 Teruel;All ages;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
44 Teruel;All ages;Cohort April 1;Females;Survival in the third trimester;2021QII;""
44 Teruel;All ages;Cohort April 1;Females;Survival in the third trimester;2021QI;""
44 Teruel;All ages;Cohort April 1;Females;Survival in the third trimester;2020QIV;3.025
44 Teruel;All ages;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
44 Teruel;All ages;Cohort April 1;Females;Survival in the third trimester;2020QII;""
44 Teruel;All ages;Cohort April 1;Females;Survival in the third trimester;2020QI;""
44 Teruel;All ages;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
44 Teruel;All ages;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
44 Teruel;All ages;Cohort April 1;Females;Survival in the third trimester;2022QII;""
44 Teruel;All ages;Cohort April 1;Females;Survival in the third trimester;2022QI;2.938
44 Teruel;All ages;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
44 Teruel;All ages;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
44 Teruel;All ages;Cohort April 1;Females;Survival in the third trimester;2021QII;""
44 Teruel;All ages;Cohort April 1;Females;Survival in the third trimester;2021QI;2.960
44 Teruel;All ages;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
44 Teruel;All ages;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
44 Teruel;All ages;Cohort April 1;Females;Survival in the third trimester;2020QII;""
44 Teruel;All ages;Cohort April 1;Females;Survival in the third trimester;2020QI;""
44 Teruel;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
44 Teruel;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
44 Teruel;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
44 Teruel;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
44 Teruel;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
44 Teruel;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
44 Teruel;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
44 Teruel;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
44 Teruel;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
44 Teruel;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
44 Teruel;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
44 Teruel;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
44 Teruel;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
44 Teruel;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
44 Teruel;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;96,31
44 Teruel;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
44 Teruel;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
44 Teruel;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
44 Teruel;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;96,87
44 Teruel;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
44 Teruel;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
44 Teruel;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
44 Teruel;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;97,32
44 Teruel;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
44 Teruel;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
44 Teruel;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;94,15
44 Teruel;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
44 Teruel;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
44 Teruel;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
44 Teruel;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;94,82
44 Teruel;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
44 Teruel;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
44 Teruel;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
44 Teruel;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;93,98
44 Teruel;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
44 Teruel;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
44 Teruel;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;90,28
44 Teruel;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
44 Teruel;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
44 Teruel;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
44 Teruel;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;92,18
44 Teruel;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
44 Teruel;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
44 Teruel;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
44 Teruel;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;91,09
44 Teruel;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
44 Teruel;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
44 Teruel;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
44 Teruel;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
44 Teruel;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
44 Teruel;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
44 Teruel;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;90,1
44 Teruel;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
44 Teruel;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
44 Teruel;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
44 Teruel;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;89,13
44 Teruel;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
44 Teruel;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
44 Teruel;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
44 Teruel;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
44 Teruel;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
44 Teruel;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QIII;8.939
44 Teruel;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
44 Teruel;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
44 Teruel;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
44 Teruel;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QIII;8.928
44 Teruel;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
44 Teruel;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
44 Teruel;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
44 Teruel;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QIII;8.987
44 Teruel;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
44 Teruel;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
44 Teruel;All ages;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
44 Teruel;All ages;Cohort July 1;Total;Survival in the first trimester;2022QIII;8.696
44 Teruel;All ages;Cohort July 1;Total;Survival in the first trimester;2022QII;""
44 Teruel;All ages;Cohort July 1;Total;Survival in the first trimester;2022QI;""
44 Teruel;All ages;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
44 Teruel;All ages;Cohort July 1;Total;Survival in the first trimester;2021QIII;8.681
44 Teruel;All ages;Cohort July 1;Total;Survival in the first trimester;2021QII;""
44 Teruel;All ages;Cohort July 1;Total;Survival in the first trimester;2021QI;""
44 Teruel;All ages;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
44 Teruel;All ages;Cohort July 1;Total;Survival in the first trimester;2020QIII;8.693
44 Teruel;All ages;Cohort July 1;Total;Survival in the first trimester;2020QII;""
44 Teruel;All ages;Cohort July 1;Total;Survival in the first trimester;2020QI;""
44 Teruel;All ages;Cohort July 1;Total;Survival in the second trimester;2022QIV;8.333
44 Teruel;All ages;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
44 Teruel;All ages;Cohort July 1;Total;Survival in the second trimester;2022QII;""
44 Teruel;All ages;Cohort July 1;Total;Survival in the second trimester;2022QI;""
44 Teruel;All ages;Cohort July 1;Total;Survival in the second trimester;2021QIV;8.452
44 Teruel;All ages;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
44 Teruel;All ages;Cohort July 1;Total;Survival in the second trimester;2021QII;""
44 Teruel;All ages;Cohort July 1;Total;Survival in the second trimester;2021QI;""
44 Teruel;All ages;Cohort July 1;Total;Survival in the second trimester;2020QIV;8.451
44 Teruel;All ages;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
44 Teruel;All ages;Cohort July 1;Total;Survival in the second trimester;2020QII;""
44 Teruel;All ages;Cohort July 1;Total;Survival in the second trimester;2020QI;""
44 Teruel;All ages;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
44 Teruel;All ages;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
44 Teruel;All ages;Cohort July 1;Total;Survival in the third trimester;2022QII;""
44 Teruel;All ages;Cohort July 1;Total;Survival in the third trimester;2022QI;8.261
44 Teruel;All ages;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
44 Teruel;All ages;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
44 Teruel;All ages;Cohort July 1;Total;Survival in the third trimester;2021QII;""
44 Teruel;All ages;Cohort July 1;Total;Survival in the third trimester;2021QI;8.289
44 Teruel;All ages;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
44 Teruel;All ages;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
44 Teruel;All ages;Cohort July 1;Total;Survival in the third trimester;2020QII;""
44 Teruel;All ages;Cohort July 1;Total;Survival in the third trimester;2020QI;""
44 Teruel;All ages;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
44 Teruel;All ages;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
44 Teruel;All ages;Cohort July 1;Total;Survival in the third trimester;2022QII;8.065
44 Teruel;All ages;Cohort July 1;Total;Survival in the third trimester;2022QI;""
44 Teruel;All ages;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
44 Teruel;All ages;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
44 Teruel;All ages;Cohort July 1;Total;Survival in the third trimester;2021QII;8.130
44 Teruel;All ages;Cohort July 1;Total;Survival in the third trimester;2021QI;""
44 Teruel;All ages;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
44 Teruel;All ages;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
44 Teruel;All ages;Cohort July 1;Total;Survival in the third trimester;2020QII;""
44 Teruel;All ages;Cohort July 1;Total;Survival in the third trimester;2020QI;""
44 Teruel;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
44 Teruel;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
44 Teruel;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
44 Teruel;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
44 Teruel;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
44 Teruel;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
44 Teruel;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
44 Teruel;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
44 Teruel;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
44 Teruel;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
44 Teruel;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
44 Teruel;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
44 Teruel;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
44 Teruel;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;97,28
44 Teruel;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
44 Teruel;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
44 Teruel;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
44 Teruel;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;97,23
44 Teruel;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
44 Teruel;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
44 Teruel;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
44 Teruel;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;96,73
44 Teruel;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
44 Teruel;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
44 Teruel;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;93,22
44 Teruel;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
44 Teruel;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
44 Teruel;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
44 Teruel;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;94,67
44 Teruel;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
44 Teruel;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
44 Teruel;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
44 Teruel;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;94,04
44 Teruel;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
44 Teruel;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
44 Teruel;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
44 Teruel;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
44 Teruel;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
44 Teruel;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
44 Teruel;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;92,53
44 Teruel;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
44 Teruel;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
44 Teruel;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
44 Teruel;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;92,23
44 Teruel;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
44 Teruel;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
44 Teruel;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
44 Teruel;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
44 Teruel;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
44 Teruel;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
44 Teruel;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;90,33
44 Teruel;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
44 Teruel;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
44 Teruel;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
44 Teruel;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;90,46
44 Teruel;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
44 Teruel;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
44 Teruel;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
44 Teruel;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
44 Teruel;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
44 Teruel;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
44 Teruel;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QIII;5.596
44 Teruel;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
44 Teruel;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
44 Teruel;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
44 Teruel;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QIII;5.630
44 Teruel;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
44 Teruel;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
44 Teruel;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
44 Teruel;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QIII;5.660
44 Teruel;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
44 Teruel;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
44 Teruel;All ages;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
44 Teruel;All ages;Cohort July 1;Males;Survival in the first trimester;2022QIII;5.461
44 Teruel;All ages;Cohort July 1;Males;Survival in the first trimester;2022QII;""
44 Teruel;All ages;Cohort July 1;Males;Survival in the first trimester;2022QI;""
44 Teruel;All ages;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
44 Teruel;All ages;Cohort July 1;Males;Survival in the first trimester;2021QIII;5.483
44 Teruel;All ages;Cohort July 1;Males;Survival in the first trimester;2021QII;""
44 Teruel;All ages;Cohort July 1;Males;Survival in the first trimester;2021QI;""
44 Teruel;All ages;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
44 Teruel;All ages;Cohort July 1;Males;Survival in the first trimester;2020QIII;5.498
44 Teruel;All ages;Cohort July 1;Males;Survival in the first trimester;2020QII;""
44 Teruel;All ages;Cohort July 1;Males;Survival in the first trimester;2020QI;""
44 Teruel;All ages;Cohort July 1;Males;Survival in the second trimester;2022QIV;5.245
44 Teruel;All ages;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
44 Teruel;All ages;Cohort July 1;Males;Survival in the second trimester;2022QII;""
44 Teruel;All ages;Cohort July 1;Males;Survival in the second trimester;2022QI;""
44 Teruel;All ages;Cohort July 1;Males;Survival in the second trimester;2021QIV;5.353
44 Teruel;All ages;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
44 Teruel;All ages;Cohort July 1;Males;Survival in the second trimester;2021QII;""
44 Teruel;All ages;Cohort July 1;Males;Survival in the second trimester;2021QI;""
44 Teruel;All ages;Cohort July 1;Males;Survival in the second trimester;2020QIV;5.358
44 Teruel;All ages;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
44 Teruel;All ages;Cohort July 1;Males;Survival in the second trimester;2020QII;""
44 Teruel;All ages;Cohort July 1;Males;Survival in the second trimester;2020QI;""
44 Teruel;All ages;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
44 Teruel;All ages;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
44 Teruel;All ages;Cohort July 1;Males;Survival in the third trimester;2022QII;""
44 Teruel;All ages;Cohort July 1;Males;Survival in the third trimester;2022QI;5.238
44 Teruel;All ages;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
44 Teruel;All ages;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
44 Teruel;All ages;Cohort July 1;Males;Survival in the third trimester;2021QII;""
44 Teruel;All ages;Cohort July 1;Males;Survival in the third trimester;2021QI;5.264
44 Teruel;All ages;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
44 Teruel;All ages;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
44 Teruel;All ages;Cohort July 1;Males;Survival in the third trimester;2020QII;""
44 Teruel;All ages;Cohort July 1;Males;Survival in the third trimester;2020QI;""
44 Teruel;All ages;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
44 Teruel;All ages;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
44 Teruel;All ages;Cohort July 1;Males;Survival in the third trimester;2022QII;5.131
44 Teruel;All ages;Cohort July 1;Males;Survival in the third trimester;2022QI;""
44 Teruel;All ages;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
44 Teruel;All ages;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
44 Teruel;All ages;Cohort July 1;Males;Survival in the third trimester;2021QII;5.187
44 Teruel;All ages;Cohort July 1;Males;Survival in the third trimester;2021QI;""
44 Teruel;All ages;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
44 Teruel;All ages;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
44 Teruel;All ages;Cohort July 1;Males;Survival in the third trimester;2020QII;""
44 Teruel;All ages;Cohort July 1;Males;Survival in the third trimester;2020QI;""
44 Teruel;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
44 Teruel;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
44 Teruel;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
44 Teruel;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
44 Teruel;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
44 Teruel;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
44 Teruel;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
44 Teruel;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
44 Teruel;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
44 Teruel;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
44 Teruel;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
44 Teruel;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
44 Teruel;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
44 Teruel;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;97,59
44 Teruel;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
44 Teruel;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
44 Teruel;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
44 Teruel;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;97,39
44 Teruel;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
44 Teruel;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
44 Teruel;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
44 Teruel;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;97,14
44 Teruel;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
44 Teruel;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
44 Teruel;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;93,73
44 Teruel;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
44 Teruel;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
44 Teruel;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
44 Teruel;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;95,08
44 Teruel;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
44 Teruel;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
44 Teruel;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
44 Teruel;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;94,66
44 Teruel;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
44 Teruel;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
44 Teruel;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
44 Teruel;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
44 Teruel;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
44 Teruel;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
44 Teruel;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;93,04
44 Teruel;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
44 Teruel;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
44 Teruel;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
44 Teruel;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;93
44 Teruel;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
44 Teruel;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
44 Teruel;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
44 Teruel;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
44 Teruel;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
44 Teruel;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
44 Teruel;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;91,14
44 Teruel;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
44 Teruel;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
44 Teruel;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
44 Teruel;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;91,64
44 Teruel;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
44 Teruel;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
44 Teruel;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
44 Teruel;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
44 Teruel;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
44 Teruel;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
44 Teruel;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QIII;3.343
44 Teruel;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
44 Teruel;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
44 Teruel;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
44 Teruel;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QIII;3.298
44 Teruel;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
44 Teruel;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
44 Teruel;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
44 Teruel;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QIII;3.327
44 Teruel;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
44 Teruel;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
44 Teruel;All ages;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
44 Teruel;All ages;Cohort July 1;Females;Survival in the first trimester;2022QIII;3.235
44 Teruel;All ages;Cohort July 1;Females;Survival in the first trimester;2022QII;""
44 Teruel;All ages;Cohort July 1;Females;Survival in the first trimester;2022QI;""
44 Teruel;All ages;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
44 Teruel;All ages;Cohort July 1;Females;Survival in the first trimester;2021QIII;3.198
44 Teruel;All ages;Cohort July 1;Females;Survival in the first trimester;2021QII;""
44 Teruel;All ages;Cohort July 1;Females;Survival in the first trimester;2021QI;""
44 Teruel;All ages;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
44 Teruel;All ages;Cohort July 1;Females;Survival in the first trimester;2020QIII;3.195
44 Teruel;All ages;Cohort July 1;Females;Survival in the first trimester;2020QII;""
44 Teruel;All ages;Cohort July 1;Females;Survival in the first trimester;2020QI;""
44 Teruel;All ages;Cohort July 1;Females;Survival in the second trimester;2022QIV;3.088
44 Teruel;All ages;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
44 Teruel;All ages;Cohort July 1;Females;Survival in the second trimester;2022QII;""
44 Teruel;All ages;Cohort July 1;Females;Survival in the second trimester;2022QI;""
44 Teruel;All ages;Cohort July 1;Females;Survival in the second trimester;2021QIV;3.099
44 Teruel;All ages;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
44 Teruel;All ages;Cohort July 1;Females;Survival in the second trimester;2021QII;""
44 Teruel;All ages;Cohort July 1;Females;Survival in the second trimester;2021QI;""
44 Teruel;All ages;Cohort July 1;Females;Survival in the second trimester;2020QIV;3.093
44 Teruel;All ages;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
44 Teruel;All ages;Cohort July 1;Females;Survival in the second trimester;2020QII;""
44 Teruel;All ages;Cohort July 1;Females;Survival in the second trimester;2020QI;""
44 Teruel;All ages;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
44 Teruel;All ages;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
44 Teruel;All ages;Cohort July 1;Females;Survival in the third trimester;2022QII;""
44 Teruel;All ages;Cohort July 1;Females;Survival in the third trimester;2022QI;3.023
44 Teruel;All ages;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
44 Teruel;All ages;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
44 Teruel;All ages;Cohort July 1;Females;Survival in the third trimester;2021QII;""
44 Teruel;All ages;Cohort July 1;Females;Survival in the third trimester;2021QI;3.025
44 Teruel;All ages;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
44 Teruel;All ages;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
44 Teruel;All ages;Cohort July 1;Females;Survival in the third trimester;2020QII;""
44 Teruel;All ages;Cohort July 1;Females;Survival in the third trimester;2020QI;""
44 Teruel;All ages;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
44 Teruel;All ages;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
44 Teruel;All ages;Cohort July 1;Females;Survival in the third trimester;2022QII;2.934
44 Teruel;All ages;Cohort July 1;Females;Survival in the third trimester;2022QI;""
44 Teruel;All ages;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
44 Teruel;All ages;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
44 Teruel;All ages;Cohort July 1;Females;Survival in the third trimester;2021QII;2.943
44 Teruel;All ages;Cohort July 1;Females;Survival in the third trimester;2021QI;""
44 Teruel;All ages;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
44 Teruel;All ages;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
44 Teruel;All ages;Cohort July 1;Females;Survival in the third trimester;2020QII;""
44 Teruel;All ages;Cohort July 1;Females;Survival in the third trimester;2020QI;""
44 Teruel;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
44 Teruel;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
44 Teruel;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
44 Teruel;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
44 Teruel;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
44 Teruel;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
44 Teruel;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
44 Teruel;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
44 Teruel;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
44 Teruel;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
44 Teruel;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
44 Teruel;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
44 Teruel;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
44 Teruel;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;96,77
44 Teruel;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
44 Teruel;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
44 Teruel;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
44 Teruel;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;96,97
44 Teruel;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
44 Teruel;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
44 Teruel;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
44 Teruel;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;96,03
44 Teruel;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
44 Teruel;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
44 Teruel;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;92,37
44 Teruel;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
44 Teruel;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
44 Teruel;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
44 Teruel;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;93,97
44 Teruel;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
44 Teruel;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
44 Teruel;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
44 Teruel;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;92,97
44 Teruel;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
44 Teruel;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
44 Teruel;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
44 Teruel;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
44 Teruel;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
44 Teruel;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
44 Teruel;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;91,66
44 Teruel;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
44 Teruel;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
44 Teruel;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
44 Teruel;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;90,92
44 Teruel;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
44 Teruel;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
44 Teruel;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
44 Teruel;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
44 Teruel;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
44 Teruel;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
44 Teruel;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;88,96
44 Teruel;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
44 Teruel;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
44 Teruel;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
44 Teruel;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;88,46
44 Teruel;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
44 Teruel;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
44 Teruel;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
44 Teruel;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
44 Teruel;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
44 Teruel;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QIV;8.884
44 Teruel;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
44 Teruel;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
44 Teruel;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
44 Teruel;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QIV;8.927
44 Teruel;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
44 Teruel;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
44 Teruel;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
44 Teruel;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QIV;8.929
44 Teruel;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
44 Teruel;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
44 Teruel;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
44 Teruel;All ages;Cohort October 1;Total;Survival in the first trimester;2022QIV;8.497
44 Teruel;All ages;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
44 Teruel;All ages;Cohort October 1;Total;Survival in the first trimester;2022QII;""
44 Teruel;All ages;Cohort October 1;Total;Survival in the first trimester;2022QI;""
44 Teruel;All ages;Cohort October 1;Total;Survival in the first trimester;2021QIV;8.663
44 Teruel;All ages;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
44 Teruel;All ages;Cohort October 1;Total;Survival in the first trimester;2021QII;""
44 Teruel;All ages;Cohort October 1;Total;Survival in the first trimester;2021QI;""
44 Teruel;All ages;Cohort October 1;Total;Survival in the first trimester;2020QIV;8.651
44 Teruel;All ages;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
44 Teruel;All ages;Cohort October 1;Total;Survival in the first trimester;2020QII;""
44 Teruel;All ages;Cohort October 1;Total;Survival in the first trimester;2020QI;""
44 Teruel;All ages;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
44 Teruel;All ages;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
44 Teruel;All ages;Cohort October 1;Total;Survival in the second trimester;2022QII;""
44 Teruel;All ages;Cohort October 1;Total;Survival in the second trimester;2022QI;8.463
44 Teruel;All ages;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
44 Teruel;All ages;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
44 Teruel;All ages;Cohort October 1;Total;Survival in the second trimester;2021QII;""
44 Teruel;All ages;Cohort October 1;Total;Survival in the second trimester;2021QI;8.470
44 Teruel;All ages;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
44 Teruel;All ages;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
44 Teruel;All ages;Cohort October 1;Total;Survival in the second trimester;2020QII;""
44 Teruel;All ages;Cohort October 1;Total;Survival in the second trimester;2020QI;""
44 Teruel;All ages;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
44 Teruel;All ages;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
44 Teruel;All ages;Cohort October 1;Total;Survival in the third trimester;2022QII;8.253
44 Teruel;All ages;Cohort October 1;Total;Survival in the third trimester;2022QI;""
44 Teruel;All ages;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
44 Teruel;All ages;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
44 Teruel;All ages;Cohort October 1;Total;Survival in the third trimester;2021QII;8.293
44 Teruel;All ages;Cohort October 1;Total;Survival in the third trimester;2021QI;""
44 Teruel;All ages;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
44 Teruel;All ages;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
44 Teruel;All ages;Cohort October 1;Total;Survival in the third trimester;2020QII;""
44 Teruel;All ages;Cohort October 1;Total;Survival in the third trimester;2020QI;""
44 Teruel;All ages;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
44 Teruel;All ages;Cohort October 1;Total;Survival in the third trimester;2022QIII;8.100
44 Teruel;All ages;Cohort October 1;Total;Survival in the third trimester;2022QII;""
44 Teruel;All ages;Cohort October 1;Total;Survival in the third trimester;2022QI;""
44 Teruel;All ages;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
44 Teruel;All ages;Cohort October 1;Total;Survival in the third trimester;2021QIII;8.144
44 Teruel;All ages;Cohort October 1;Total;Survival in the third trimester;2021QII;""
44 Teruel;All ages;Cohort October 1;Total;Survival in the third trimester;2021QI;""
44 Teruel;All ages;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
44 Teruel;All ages;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
44 Teruel;All ages;Cohort October 1;Total;Survival in the third trimester;2020QII;""
44 Teruel;All ages;Cohort October 1;Total;Survival in the third trimester;2020QI;""
44 Teruel;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
44 Teruel;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
44 Teruel;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
44 Teruel;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
44 Teruel;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
44 Teruel;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
44 Teruel;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
44 Teruel;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
44 Teruel;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
44 Teruel;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
44 Teruel;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
44 Teruel;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
44 Teruel;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;95,64
44 Teruel;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
44 Teruel;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
44 Teruel;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
44 Teruel;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;97,04
44 Teruel;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
44 Teruel;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
44 Teruel;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
44 Teruel;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;96,89
44 Teruel;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
44 Teruel;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
44 Teruel;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
44 Teruel;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
44 Teruel;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
44 Teruel;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
44 Teruel;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;94,8
44 Teruel;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
44 Teruel;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
44 Teruel;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
44 Teruel;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;94,86
44 Teruel;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
44 Teruel;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
44 Teruel;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
44 Teruel;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
44 Teruel;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
44 Teruel;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
44 Teruel;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;92,45
44 Teruel;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
44 Teruel;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
44 Teruel;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
44 Teruel;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;92,88
44 Teruel;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
44 Teruel;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
44 Teruel;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
44 Teruel;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
44 Teruel;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
44 Teruel;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
44 Teruel;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;90,74
44 Teruel;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
44 Teruel;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
44 Teruel;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
44 Teruel;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;91,21
44 Teruel;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
44 Teruel;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
44 Teruel;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
44 Teruel;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
44 Teruel;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
44 Teruel;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
44 Teruel;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QIV;5.558
44 Teruel;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
44 Teruel;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
44 Teruel;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
44 Teruel;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QIV;5.607
44 Teruel;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
44 Teruel;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
44 Teruel;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
44 Teruel;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QIV;5.627
44 Teruel;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
44 Teruel;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
44 Teruel;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
44 Teruel;All ages;Cohort October 1;Males;Survival in the first trimester;2022QIV;5.328
44 Teruel;All ages;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
44 Teruel;All ages;Cohort October 1;Males;Survival in the first trimester;2022QII;""
44 Teruel;All ages;Cohort October 1;Males;Survival in the first trimester;2022QI;""
44 Teruel;All ages;Cohort October 1;Males;Survival in the first trimester;2021QIV;5.459
44 Teruel;All ages;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
44 Teruel;All ages;Cohort October 1;Males;Survival in the first trimester;2021QII;""
44 Teruel;All ages;Cohort October 1;Males;Survival in the first trimester;2021QI;""
44 Teruel;All ages;Cohort October 1;Males;Survival in the first trimester;2020QIV;5.466
44 Teruel;All ages;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
44 Teruel;All ages;Cohort October 1;Males;Survival in the first trimester;2020QII;""
44 Teruel;All ages;Cohort October 1;Males;Survival in the first trimester;2020QI;""
44 Teruel;All ages;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
44 Teruel;All ages;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
44 Teruel;All ages;Cohort October 1;Males;Survival in the second trimester;2022QII;""
44 Teruel;All ages;Cohort October 1;Males;Survival in the second trimester;2022QI;5.339
44 Teruel;All ages;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
44 Teruel;All ages;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
44 Teruel;All ages;Cohort October 1;Males;Survival in the second trimester;2021QII;""
44 Teruel;All ages;Cohort October 1;Males;Survival in the second trimester;2021QI;5.360
44 Teruel;All ages;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
44 Teruel;All ages;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
44 Teruel;All ages;Cohort October 1;Males;Survival in the second trimester;2020QII;""
44 Teruel;All ages;Cohort October 1;Males;Survival in the second trimester;2020QI;""
44 Teruel;All ages;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
44 Teruel;All ages;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
44 Teruel;All ages;Cohort October 1;Males;Survival in the third trimester;2022QII;5.228
44 Teruel;All ages;Cohort October 1;Males;Survival in the third trimester;2022QI;""
44 Teruel;All ages;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
44 Teruel;All ages;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
44 Teruel;All ages;Cohort October 1;Males;Survival in the third trimester;2021QII;5.271
44 Teruel;All ages;Cohort October 1;Males;Survival in the third trimester;2021QI;""
44 Teruel;All ages;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
44 Teruel;All ages;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
44 Teruel;All ages;Cohort October 1;Males;Survival in the third trimester;2020QII;""
44 Teruel;All ages;Cohort October 1;Males;Survival in the third trimester;2020QI;""
44 Teruel;All ages;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
44 Teruel;All ages;Cohort October 1;Males;Survival in the third trimester;2022QIII;5.137
44 Teruel;All ages;Cohort October 1;Males;Survival in the third trimester;2022QII;""
44 Teruel;All ages;Cohort October 1;Males;Survival in the third trimester;2022QI;""
44 Teruel;All ages;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
44 Teruel;All ages;Cohort October 1;Males;Survival in the third trimester;2021QIII;5.176
44 Teruel;All ages;Cohort October 1;Males;Survival in the third trimester;2021QII;""
44 Teruel;All ages;Cohort October 1;Males;Survival in the third trimester;2021QI;""
44 Teruel;All ages;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
44 Teruel;All ages;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
44 Teruel;All ages;Cohort October 1;Males;Survival in the third trimester;2020QII;""
44 Teruel;All ages;Cohort October 1;Males;Survival in the third trimester;2020QI;""
44 Teruel;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
44 Teruel;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
44 Teruel;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
44 Teruel;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
44 Teruel;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
44 Teruel;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
44 Teruel;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
44 Teruel;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
44 Teruel;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
44 Teruel;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
44 Teruel;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
44 Teruel;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
44 Teruel;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;95,86
44 Teruel;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
44 Teruel;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
44 Teruel;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
44 Teruel;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;97,36
44 Teruel;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
44 Teruel;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
44 Teruel;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
44 Teruel;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;97,14
44 Teruel;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
44 Teruel;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
44 Teruel;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
44 Teruel;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
44 Teruel;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
44 Teruel;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
44 Teruel;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;95,22
44 Teruel;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
44 Teruel;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
44 Teruel;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
44 Teruel;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;95,26
44 Teruel;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
44 Teruel;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
44 Teruel;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
44 Teruel;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
44 Teruel;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
44 Teruel;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
44 Teruel;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;93,24
44 Teruel;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
44 Teruel;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
44 Teruel;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
44 Teruel;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;93,67
44 Teruel;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
44 Teruel;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
44 Teruel;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
44 Teruel;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
44 Teruel;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
44 Teruel;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
44 Teruel;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;91,62
44 Teruel;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
44 Teruel;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
44 Teruel;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
44 Teruel;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;91,99
44 Teruel;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
44 Teruel;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
44 Teruel;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
44 Teruel;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
44 Teruel;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
44 Teruel;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
44 Teruel;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QIV;3.326
44 Teruel;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
44 Teruel;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
44 Teruel;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
44 Teruel;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QIV;3.320
44 Teruel;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
44 Teruel;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
44 Teruel;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
44 Teruel;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QIV;3.302
44 Teruel;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
44 Teruel;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
44 Teruel;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
44 Teruel;All ages;Cohort October 1;Females;Survival in the first trimester;2022QIV;3.169
44 Teruel;All ages;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
44 Teruel;All ages;Cohort October 1;Females;Survival in the first trimester;2022QII;""
44 Teruel;All ages;Cohort October 1;Females;Survival in the first trimester;2022QI;""
44 Teruel;All ages;Cohort October 1;Females;Survival in the first trimester;2021QIV;3.204
44 Teruel;All ages;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
44 Teruel;All ages;Cohort October 1;Females;Survival in the first trimester;2021QII;""
44 Teruel;All ages;Cohort October 1;Females;Survival in the first trimester;2021QI;""
44 Teruel;All ages;Cohort October 1;Females;Survival in the first trimester;2020QIV;3.185
44 Teruel;All ages;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
44 Teruel;All ages;Cohort October 1;Females;Survival in the first trimester;2020QII;""
44 Teruel;All ages;Cohort October 1;Females;Survival in the first trimester;2020QI;""
44 Teruel;All ages;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
44 Teruel;All ages;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
44 Teruel;All ages;Cohort October 1;Females;Survival in the second trimester;2022QII;""
44 Teruel;All ages;Cohort October 1;Females;Survival in the second trimester;2022QI;3.124
44 Teruel;All ages;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
44 Teruel;All ages;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
44 Teruel;All ages;Cohort October 1;Females;Survival in the second trimester;2021QII;""
44 Teruel;All ages;Cohort October 1;Females;Survival in the second trimester;2021QI;3.110
44 Teruel;All ages;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
44 Teruel;All ages;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
44 Teruel;All ages;Cohort October 1;Females;Survival in the second trimester;2020QII;""
44 Teruel;All ages;Cohort October 1;Females;Survival in the second trimester;2020QI;""
44 Teruel;All ages;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
44 Teruel;All ages;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
44 Teruel;All ages;Cohort October 1;Females;Survival in the third trimester;2022QII;3.025
44 Teruel;All ages;Cohort October 1;Females;Survival in the third trimester;2022QI;""
44 Teruel;All ages;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
44 Teruel;All ages;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
44 Teruel;All ages;Cohort October 1;Females;Survival in the third trimester;2021QII;3.022
44 Teruel;All ages;Cohort October 1;Females;Survival in the third trimester;2021QI;""
44 Teruel;All ages;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
44 Teruel;All ages;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
44 Teruel;All ages;Cohort October 1;Females;Survival in the third trimester;2020QII;""
44 Teruel;All ages;Cohort October 1;Females;Survival in the third trimester;2020QI;""
44 Teruel;All ages;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
44 Teruel;All ages;Cohort October 1;Females;Survival in the third trimester;2022QIII;2.963
44 Teruel;All ages;Cohort October 1;Females;Survival in the third trimester;2022QII;""
44 Teruel;All ages;Cohort October 1;Females;Survival in the third trimester;2022QI;""
44 Teruel;All ages;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
44 Teruel;All ages;Cohort October 1;Females;Survival in the third trimester;2021QIII;2.968
44 Teruel;All ages;Cohort October 1;Females;Survival in the third trimester;2021QII;""
44 Teruel;All ages;Cohort October 1;Females;Survival in the third trimester;2021QI;""
44 Teruel;All ages;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
44 Teruel;All ages;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
44 Teruel;All ages;Cohort October 1;Females;Survival in the third trimester;2020QII;""
44 Teruel;All ages;Cohort October 1;Females;Survival in the third trimester;2020QI;""
44 Teruel;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
44 Teruel;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
44 Teruel;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
44 Teruel;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
44 Teruel;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
44 Teruel;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
44 Teruel;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
44 Teruel;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
44 Teruel;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
44 Teruel;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
44 Teruel;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
44 Teruel;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
44 Teruel;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;95,28
44 Teruel;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
44 Teruel;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
44 Teruel;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
44 Teruel;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;96,51
44 Teruel;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
44 Teruel;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
44 Teruel;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
44 Teruel;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;96,46
44 Teruel;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
44 Teruel;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
44 Teruel;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
44 Teruel;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
44 Teruel;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
44 Teruel;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
44 Teruel;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;94,1
44 Teruel;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
44 Teruel;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
44 Teruel;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
44 Teruel;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;94,19
44 Teruel;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
44 Teruel;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
44 Teruel;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
44 Teruel;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
44 Teruel;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
44 Teruel;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
44 Teruel;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;91,11
44 Teruel;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
44 Teruel;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
44 Teruel;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
44 Teruel;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;91,52
44 Teruel;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
44 Teruel;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
44 Teruel;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
44 Teruel;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
44 Teruel;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
44 Teruel;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
44 Teruel;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;89,25
44 Teruel;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
44 Teruel;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
44 Teruel;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
44 Teruel;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;89,88
44 Teruel;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
44 Teruel;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
44 Teruel;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
44 Teruel;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
44 Teruel;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
44 Teruel;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
44 Teruel;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
44 Teruel;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
44 Teruel;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
44 Teruel;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QI;546
44 Teruel;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
44 Teruel;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
44 Teruel;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
44 Teruel;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QI;538
44 Teruel;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
44 Teruel;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
44 Teruel;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
44 Teruel;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QI;480
44 Teruel;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
44 Teruel;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
44 Teruel;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2022QII;""
44 Teruel;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2022QI;508
44 Teruel;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
44 Teruel;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
44 Teruel;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2021QII;""
44 Teruel;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2021QI;507
44 Teruel;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
44 Teruel;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
44 Teruel;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2020QII;""
44 Teruel;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2020QI;436
44 Teruel;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
44 Teruel;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
44 Teruel;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2022QII;485
44 Teruel;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2022QI;""
44 Teruel;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
44 Teruel;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
44 Teruel;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2021QII;487
44 Teruel;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2021QI;""
44 Teruel;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
44 Teruel;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
44 Teruel;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2020QII;417
44 Teruel;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2020QI;""
44 Teruel;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
44 Teruel;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QIII;469
44 Teruel;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QII;""
44 Teruel;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QI;""
44 Teruel;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
44 Teruel;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QIII;457
44 Teruel;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QII;""
44 Teruel;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QI;""
44 Teruel;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
44 Teruel;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QIII;396
44 Teruel;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QII;""
44 Teruel;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QI;""
44 Teruel;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QIV;447
44 Teruel;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
44 Teruel;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QII;""
44 Teruel;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QI;""
44 Teruel;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QIV;433
44 Teruel;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
44 Teruel;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QII;""
44 Teruel;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QI;""
44 Teruel;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QIV;377
44 Teruel;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
44 Teruel;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QII;""
44 Teruel;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QI;""
44 Teruel;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
44 Teruel;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
44 Teruel;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
44 Teruel;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
44 Teruel;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
44 Teruel;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
44 Teruel;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
44 Teruel;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
44 Teruel;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
44 Teruel;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
44 Teruel;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
44 Teruel;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
44 Teruel;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
44 Teruel;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
44 Teruel;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
44 Teruel;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;93,04
44 Teruel;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
44 Teruel;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
44 Teruel;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
44 Teruel;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;94,24
44 Teruel;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
44 Teruel;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
44 Teruel;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
44 Teruel;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;90,83
44 Teruel;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
44 Teruel;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
44 Teruel;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;88,83
44 Teruel;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
44 Teruel;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
44 Teruel;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
44 Teruel;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;90,52
44 Teruel;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
44 Teruel;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
44 Teruel;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
44 Teruel;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;86,88
44 Teruel;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
44 Teruel;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
44 Teruel;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;85,9
44 Teruel;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
44 Teruel;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
44 Teruel;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
44 Teruel;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;84,94
44 Teruel;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
44 Teruel;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
44 Teruel;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
44 Teruel;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;82,5
44 Teruel;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
44 Teruel;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
44 Teruel;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;81,87
44 Teruel;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
44 Teruel;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
44 Teruel;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
44 Teruel;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;80,48
44 Teruel;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
44 Teruel;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
44 Teruel;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
44 Teruel;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;78,54
44 Teruel;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
44 Teruel;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
44 Teruel;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
44 Teruel;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
44 Teruel;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
44 Teruel;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
44 Teruel;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QI;351
44 Teruel;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
44 Teruel;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
44 Teruel;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
44 Teruel;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QI;343
44 Teruel;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
44 Teruel;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
44 Teruel;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
44 Teruel;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QI;309
44 Teruel;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
44 Teruel;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
44 Teruel;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2022QII;""
44 Teruel;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2022QI;328
44 Teruel;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
44 Teruel;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
44 Teruel;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2021QII;""
44 Teruel;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2021QI;324
44 Teruel;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
44 Teruel;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
44 Teruel;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2020QII;""
44 Teruel;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2020QI;284
44 Teruel;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
44 Teruel;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
44 Teruel;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2022QII;314
44 Teruel;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2022QI;""
44 Teruel;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
44 Teruel;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
44 Teruel;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2021QII;311
44 Teruel;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2021QI;""
44 Teruel;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
44 Teruel;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
44 Teruel;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2020QII;271
44 Teruel;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2020QI;""
44 Teruel;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
44 Teruel;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QIII;303
44 Teruel;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QII;""
44 Teruel;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QI;""
44 Teruel;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
44 Teruel;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QIII;294
44 Teruel;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QII;""
44 Teruel;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QI;""
44 Teruel;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
44 Teruel;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QIII;261
44 Teruel;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QII;""
44 Teruel;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QI;""
44 Teruel;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QIV;288
44 Teruel;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
44 Teruel;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QII;""
44 Teruel;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QI;""
44 Teruel;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QIV;280
44 Teruel;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
44 Teruel;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QII;""
44 Teruel;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QI;""
44 Teruel;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QIV;248
44 Teruel;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
44 Teruel;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QII;""
44 Teruel;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QI;""
44 Teruel;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
44 Teruel;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
44 Teruel;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
44 Teruel;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
44 Teruel;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
44 Teruel;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
44 Teruel;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
44 Teruel;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
44 Teruel;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
44 Teruel;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
44 Teruel;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
44 Teruel;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
44 Teruel;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
44 Teruel;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
44 Teruel;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
44 Teruel;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;93,45
44 Teruel;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
44 Teruel;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
44 Teruel;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
44 Teruel;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;94,46
44 Teruel;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
44 Teruel;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
44 Teruel;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
44 Teruel;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;91,91
44 Teruel;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
44 Teruel;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
44 Teruel;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;89,46
44 Teruel;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
44 Teruel;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
44 Teruel;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
44 Teruel;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;90,67
44 Teruel;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
44 Teruel;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
44 Teruel;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
44 Teruel;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;87,7
44 Teruel;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
44 Teruel;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
44 Teruel;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;86,32
44 Teruel;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
44 Teruel;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
44 Teruel;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
44 Teruel;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;85,71
44 Teruel;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
44 Teruel;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
44 Teruel;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
44 Teruel;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;84,47
44 Teruel;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
44 Teruel;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
44 Teruel;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;82,05
44 Teruel;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
44 Teruel;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
44 Teruel;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
44 Teruel;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;81,63
44 Teruel;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
44 Teruel;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
44 Teruel;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
44 Teruel;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;80,26
44 Teruel;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
44 Teruel;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
44 Teruel;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
44 Teruel;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
44 Teruel;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
44 Teruel;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
44 Teruel;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QI;195
44 Teruel;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
44 Teruel;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
44 Teruel;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
44 Teruel;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QI;195
44 Teruel;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
44 Teruel;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
44 Teruel;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
44 Teruel;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QI;171
44 Teruel;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
44 Teruel;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
44 Teruel;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2022QII;""
44 Teruel;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2022QI;180
44 Teruel;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
44 Teruel;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
44 Teruel;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2021QII;""
44 Teruel;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2021QI;183
44 Teruel;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
44 Teruel;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
44 Teruel;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2020QII;""
44 Teruel;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2020QI;152
44 Teruel;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
44 Teruel;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
44 Teruel;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2022QII;171
44 Teruel;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2022QI;""
44 Teruel;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
44 Teruel;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
44 Teruel;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2021QII;176
44 Teruel;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2021QI;""
44 Teruel;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
44 Teruel;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
44 Teruel;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2020QII;146
44 Teruel;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2020QI;""
44 Teruel;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
44 Teruel;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QIII;166
44 Teruel;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QII;""
44 Teruel;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QI;""
44 Teruel;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
44 Teruel;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QIII;163
44 Teruel;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QII;""
44 Teruel;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QI;""
44 Teruel;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
44 Teruel;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QIII;135
44 Teruel;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QII;""
44 Teruel;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QI;""
44 Teruel;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QIV;159
44 Teruel;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
44 Teruel;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QII;""
44 Teruel;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QI;""
44 Teruel;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QIV;153
44 Teruel;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
44 Teruel;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QII;""
44 Teruel;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QI;""
44 Teruel;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QIV;129
44 Teruel;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
44 Teruel;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QII;""
44 Teruel;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QI;""
44 Teruel;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
44 Teruel;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
44 Teruel;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
44 Teruel;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
44 Teruel;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
44 Teruel;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
44 Teruel;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
44 Teruel;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
44 Teruel;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
44 Teruel;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
44 Teruel;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
44 Teruel;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
44 Teruel;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
44 Teruel;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
44 Teruel;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
44 Teruel;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;92,31
44 Teruel;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
44 Teruel;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
44 Teruel;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
44 Teruel;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;93,85
44 Teruel;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
44 Teruel;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
44 Teruel;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
44 Teruel;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;88,89
44 Teruel;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
44 Teruel;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
44 Teruel;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;87,69
44 Teruel;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
44 Teruel;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
44 Teruel;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
44 Teruel;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;90,26
44 Teruel;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
44 Teruel;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
44 Teruel;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
44 Teruel;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;85,38
44 Teruel;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
44 Teruel;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
44 Teruel;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;85,13
44 Teruel;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
44 Teruel;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
44 Teruel;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
44 Teruel;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;83,59
44 Teruel;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
44 Teruel;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
44 Teruel;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
44 Teruel;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;78,95
44 Teruel;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
44 Teruel;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
44 Teruel;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;81,54
44 Teruel;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
44 Teruel;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
44 Teruel;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
44 Teruel;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;78,46
44 Teruel;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
44 Teruel;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
44 Teruel;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
44 Teruel;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;75,44
44 Teruel;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
44 Teruel;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
44 Teruel;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
44 Teruel;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
44 Teruel;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
44 Teruel;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QII;477
44 Teruel;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
44 Teruel;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
44 Teruel;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
44 Teruel;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QII;472
44 Teruel;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
44 Teruel;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
44 Teruel;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
44 Teruel;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QII;491
44 Teruel;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
44 Teruel;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
44 Teruel;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
44 Teruel;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2022QII;452
44 Teruel;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2022QI;""
44 Teruel;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
44 Teruel;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
44 Teruel;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2021QII;446
44 Teruel;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2021QI;""
44 Teruel;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
44 Teruel;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
44 Teruel;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2020QII;469
44 Teruel;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2020QI;""
44 Teruel;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
44 Teruel;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2022QIII;435
44 Teruel;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2022QII;""
44 Teruel;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2022QI;""
44 Teruel;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
44 Teruel;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2021QIII;416
44 Teruel;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2021QII;""
44 Teruel;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2021QI;""
44 Teruel;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
44 Teruel;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2020QIII;440
44 Teruel;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2020QII;""
44 Teruel;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2020QI;""
44 Teruel;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QIV;413
44 Teruel;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
44 Teruel;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QII;""
44 Teruel;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QI;""
44 Teruel;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QIV;389
44 Teruel;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
44 Teruel;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QII;""
44 Teruel;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QI;""
44 Teruel;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QIV;417
44 Teruel;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
44 Teruel;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QII;""
44 Teruel;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QI;""
44 Teruel;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
44 Teruel;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
44 Teruel;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QII;""
44 Teruel;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QI;368
44 Teruel;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
44 Teruel;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
44 Teruel;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QII;""
44 Teruel;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QI;401
44 Teruel;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
44 Teruel;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
44 Teruel;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QII;""
44 Teruel;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QI;""
44 Teruel;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
44 Teruel;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
44 Teruel;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
44 Teruel;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
44 Teruel;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
44 Teruel;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
44 Teruel;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
44 Teruel;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
44 Teruel;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
44 Teruel;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
44 Teruel;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
44 Teruel;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
44 Teruel;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
44 Teruel;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
44 Teruel;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;94,76
44 Teruel;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
44 Teruel;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
44 Teruel;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
44 Teruel;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;94,49
44 Teruel;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
44 Teruel;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
44 Teruel;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
44 Teruel;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;95,52
44 Teruel;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
44 Teruel;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
44 Teruel;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;91,19
44 Teruel;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
44 Teruel;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
44 Teruel;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
44 Teruel;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;88,14
44 Teruel;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
44 Teruel;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
44 Teruel;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
44 Teruel;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;89,61
44 Teruel;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
44 Teruel;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
44 Teruel;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;86,58
44 Teruel;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
44 Teruel;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
44 Teruel;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
44 Teruel;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;82,42
44 Teruel;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
44 Teruel;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
44 Teruel;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
44 Teruel;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;84,93
44 Teruel;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
44 Teruel;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
44 Teruel;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
44 Teruel;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
44 Teruel;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
44 Teruel;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
44 Teruel;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;77,97
44 Teruel;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
44 Teruel;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
44 Teruel;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
44 Teruel;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;81,67
44 Teruel;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
44 Teruel;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
44 Teruel;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
44 Teruel;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
44 Teruel;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
44 Teruel;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
44 Teruel;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QII;310
44 Teruel;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
44 Teruel;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
44 Teruel;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
44 Teruel;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QII;310
44 Teruel;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
44 Teruel;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
44 Teruel;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
44 Teruel;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QII;317
44 Teruel;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
44 Teruel;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
44 Teruel;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
44 Teruel;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2022QII;295
44 Teruel;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2022QI;""
44 Teruel;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
44 Teruel;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
44 Teruel;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2021QII;293
44 Teruel;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2021QI;""
44 Teruel;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
44 Teruel;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
44 Teruel;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2020QII;303
44 Teruel;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2020QI;""
44 Teruel;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
44 Teruel;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2022QIII;283
44 Teruel;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2022QII;""
44 Teruel;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2022QI;""
44 Teruel;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
44 Teruel;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2021QIII;276
44 Teruel;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2021QII;""
44 Teruel;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2021QI;""
44 Teruel;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
44 Teruel;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2020QIII;288
44 Teruel;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2020QII;""
44 Teruel;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2020QI;""
44 Teruel;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QIV;268
44 Teruel;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
44 Teruel;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QII;""
44 Teruel;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QI;""
44 Teruel;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QIV;260
44 Teruel;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
44 Teruel;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QII;""
44 Teruel;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QI;""
44 Teruel;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QIV;273
44 Teruel;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
44 Teruel;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QII;""
44 Teruel;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QI;""
44 Teruel;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
44 Teruel;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
44 Teruel;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QII;""
44 Teruel;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QI;244
44 Teruel;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
44 Teruel;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
44 Teruel;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QII;""
44 Teruel;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QI;264
44 Teruel;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
44 Teruel;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
44 Teruel;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QII;""
44 Teruel;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QI;""
44 Teruel;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
44 Teruel;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
44 Teruel;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
44 Teruel;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
44 Teruel;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
44 Teruel;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
44 Teruel;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
44 Teruel;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
44 Teruel;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
44 Teruel;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
44 Teruel;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
44 Teruel;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
44 Teruel;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
44 Teruel;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
44 Teruel;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;95,16
44 Teruel;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
44 Teruel;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
44 Teruel;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
44 Teruel;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;94,52
44 Teruel;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
44 Teruel;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
44 Teruel;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
44 Teruel;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;95,58
44 Teruel;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
44 Teruel;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
44 Teruel;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;91,29
44 Teruel;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
44 Teruel;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
44 Teruel;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
44 Teruel;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;89,03
44 Teruel;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
44 Teruel;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
44 Teruel;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
44 Teruel;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;90,85
44 Teruel;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
44 Teruel;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
44 Teruel;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;86,45
44 Teruel;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
44 Teruel;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
44 Teruel;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
44 Teruel;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;83,87
44 Teruel;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
44 Teruel;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
44 Teruel;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
44 Teruel;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;86,12
44 Teruel;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
44 Teruel;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
44 Teruel;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
44 Teruel;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
44 Teruel;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
44 Teruel;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
44 Teruel;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;78,71
44 Teruel;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
44 Teruel;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
44 Teruel;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
44 Teruel;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;83,28
44 Teruel;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
44 Teruel;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
44 Teruel;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
44 Teruel;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
44 Teruel;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
44 Teruel;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
44 Teruel;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QII;167
44 Teruel;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
44 Teruel;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
44 Teruel;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
44 Teruel;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QII;162
44 Teruel;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
44 Teruel;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
44 Teruel;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
44 Teruel;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QII;174
44 Teruel;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
44 Teruel;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
44 Teruel;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
44 Teruel;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2022QII;157
44 Teruel;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2022QI;""
44 Teruel;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
44 Teruel;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
44 Teruel;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2021QII;153
44 Teruel;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2021QI;""
44 Teruel;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
44 Teruel;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
44 Teruel;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2020QII;166
44 Teruel;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2020QI;""
44 Teruel;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
44 Teruel;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2022QIII;152
44 Teruel;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2022QII;""
44 Teruel;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2022QI;""
44 Teruel;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
44 Teruel;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2021QIII;140
44 Teruel;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2021QII;""
44 Teruel;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2021QI;""
44 Teruel;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
44 Teruel;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2020QIII;152
44 Teruel;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2020QII;""
44 Teruel;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2020QI;""
44 Teruel;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QIV;145
44 Teruel;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
44 Teruel;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QII;""
44 Teruel;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QI;""
44 Teruel;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QIV;129
44 Teruel;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
44 Teruel;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QII;""
44 Teruel;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QI;""
44 Teruel;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QIV;144
44 Teruel;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
44 Teruel;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QII;""
44 Teruel;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QI;""
44 Teruel;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
44 Teruel;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
44 Teruel;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QII;""
44 Teruel;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QI;124
44 Teruel;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
44 Teruel;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
44 Teruel;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QII;""
44 Teruel;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QI;137
44 Teruel;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
44 Teruel;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
44 Teruel;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QII;""
44 Teruel;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QI;""
44 Teruel;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
44 Teruel;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
44 Teruel;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
44 Teruel;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
44 Teruel;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
44 Teruel;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
44 Teruel;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
44 Teruel;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
44 Teruel;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
44 Teruel;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
44 Teruel;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
44 Teruel;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
44 Teruel;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
44 Teruel;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
44 Teruel;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;94,01
44 Teruel;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
44 Teruel;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
44 Teruel;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
44 Teruel;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;94,44
44 Teruel;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
44 Teruel;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
44 Teruel;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
44 Teruel;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;95,4
44 Teruel;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
44 Teruel;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
44 Teruel;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;91,02
44 Teruel;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
44 Teruel;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
44 Teruel;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
44 Teruel;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;86,42
44 Teruel;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
44 Teruel;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
44 Teruel;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
44 Teruel;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;87,36
44 Teruel;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
44 Teruel;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
44 Teruel;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;86,83
44 Teruel;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
44 Teruel;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
44 Teruel;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
44 Teruel;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;79,63
44 Teruel;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
44 Teruel;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
44 Teruel;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
44 Teruel;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;82,76
44 Teruel;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
44 Teruel;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
44 Teruel;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
44 Teruel;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
44 Teruel;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
44 Teruel;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
44 Teruel;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;76,54
44 Teruel;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
44 Teruel;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
44 Teruel;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
44 Teruel;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;78,74
44 Teruel;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
44 Teruel;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
44 Teruel;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
44 Teruel;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
44 Teruel;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
44 Teruel;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QIII;514
44 Teruel;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
44 Teruel;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
44 Teruel;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
44 Teruel;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QIII;544
44 Teruel;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
44 Teruel;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
44 Teruel;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
44 Teruel;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QIII;522
44 Teruel;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
44 Teruel;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
44 Teruel;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
44 Teruel;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2022QIII;471
44 Teruel;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2022QII;""
44 Teruel;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2022QI;""
44 Teruel;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
44 Teruel;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2021QIII;477
44 Teruel;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2021QII;""
44 Teruel;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2021QI;""
44 Teruel;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
44 Teruel;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2020QIII;469
44 Teruel;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2020QII;""
44 Teruel;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2020QI;""
44 Teruel;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2022QIV;445
44 Teruel;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
44 Teruel;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2022QII;""
44 Teruel;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2022QI;""
44 Teruel;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2021QIV;441
44 Teruel;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
44 Teruel;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2021QII;""
44 Teruel;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2021QI;""
44 Teruel;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2020QIV;440
44 Teruel;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
44 Teruel;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2020QII;""
44 Teruel;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2020QI;""
44 Teruel;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
44 Teruel;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
44 Teruel;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QII;""
44 Teruel;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QI;417
44 Teruel;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
44 Teruel;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
44 Teruel;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QII;""
44 Teruel;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QI;422
44 Teruel;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
44 Teruel;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
44 Teruel;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QII;""
44 Teruel;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QI;""
44 Teruel;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
44 Teruel;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
44 Teruel;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QII;398
44 Teruel;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QI;""
44 Teruel;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
44 Teruel;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
44 Teruel;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QII;407
44 Teruel;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QI;""
44 Teruel;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
44 Teruel;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
44 Teruel;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QII;""
44 Teruel;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QI;""
44 Teruel;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
44 Teruel;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
44 Teruel;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
44 Teruel;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
44 Teruel;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
44 Teruel;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
44 Teruel;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
44 Teruel;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
44 Teruel;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
44 Teruel;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
44 Teruel;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
44 Teruel;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
44 Teruel;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
44 Teruel;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;91,63
44 Teruel;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
44 Teruel;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
44 Teruel;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
44 Teruel;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;87,68
44 Teruel;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
44 Teruel;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
44 Teruel;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
44 Teruel;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;89,85
44 Teruel;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
44 Teruel;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
44 Teruel;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;86,58
44 Teruel;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
44 Teruel;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
44 Teruel;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
44 Teruel;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;81,07
44 Teruel;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
44 Teruel;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
44 Teruel;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
44 Teruel;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;84,29
44 Teruel;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
44 Teruel;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
44 Teruel;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
44 Teruel;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
44 Teruel;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
44 Teruel;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
44 Teruel;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;76,65
44 Teruel;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
44 Teruel;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
44 Teruel;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
44 Teruel;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;80,84
44 Teruel;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
44 Teruel;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
44 Teruel;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
44 Teruel;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
44 Teruel;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
44 Teruel;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
44 Teruel;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;73,16
44 Teruel;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
44 Teruel;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
44 Teruel;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
44 Teruel;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;77,97
44 Teruel;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
44 Teruel;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
44 Teruel;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
44 Teruel;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
44 Teruel;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
44 Teruel;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
44 Teruel;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QIII;332
44 Teruel;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
44 Teruel;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
44 Teruel;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
44 Teruel;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QIII;352
44 Teruel;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
44 Teruel;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
44 Teruel;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
44 Teruel;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QIII;336
44 Teruel;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
44 Teruel;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
44 Teruel;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
44 Teruel;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2022QIII;304
44 Teruel;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2022QII;""
44 Teruel;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2022QI;""
44 Teruel;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
44 Teruel;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2021QIII;314
44 Teruel;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2021QII;""
44 Teruel;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2021QI;""
44 Teruel;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
44 Teruel;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2020QIII;303
44 Teruel;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2020QII;""
44 Teruel;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2020QI;""
44 Teruel;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2022QIV;287
44 Teruel;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
44 Teruel;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2022QII;""
44 Teruel;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2022QI;""
44 Teruel;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2021QIV;293
44 Teruel;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
44 Teruel;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2021QII;""
44 Teruel;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2021QI;""
44 Teruel;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2020QIV;285
44 Teruel;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
44 Teruel;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2020QII;""
44 Teruel;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2020QI;""
44 Teruel;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
44 Teruel;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
44 Teruel;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QII;""
44 Teruel;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QI;277
44 Teruel;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
44 Teruel;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
44 Teruel;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QII;""
44 Teruel;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QI;275
44 Teruel;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
44 Teruel;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
44 Teruel;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QII;""
44 Teruel;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QI;""
44 Teruel;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
44 Teruel;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
44 Teruel;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QII;266
44 Teruel;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QI;""
44 Teruel;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
44 Teruel;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
44 Teruel;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QII;265
44 Teruel;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QI;""
44 Teruel;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
44 Teruel;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
44 Teruel;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QII;""
44 Teruel;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QI;""
44 Teruel;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
44 Teruel;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
44 Teruel;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
44 Teruel;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
44 Teruel;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
44 Teruel;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
44 Teruel;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
44 Teruel;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
44 Teruel;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
44 Teruel;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
44 Teruel;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
44 Teruel;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
44 Teruel;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
44 Teruel;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;91,57
44 Teruel;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
44 Teruel;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
44 Teruel;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
44 Teruel;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;89,2
44 Teruel;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
44 Teruel;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
44 Teruel;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
44 Teruel;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;90,18
44 Teruel;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
44 Teruel;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
44 Teruel;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;86,45
44 Teruel;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
44 Teruel;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
44 Teruel;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
44 Teruel;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;83,24
44 Teruel;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
44 Teruel;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
44 Teruel;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
44 Teruel;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;84,82
44 Teruel;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
44 Teruel;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
44 Teruel;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
44 Teruel;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
44 Teruel;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
44 Teruel;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
44 Teruel;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;78,69
44 Teruel;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
44 Teruel;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
44 Teruel;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
44 Teruel;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;81,85
44 Teruel;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
44 Teruel;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
44 Teruel;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
44 Teruel;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
44 Teruel;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
44 Teruel;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
44 Teruel;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;75,57
44 Teruel;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
44 Teruel;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
44 Teruel;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
44 Teruel;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;78,87
44 Teruel;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
44 Teruel;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
44 Teruel;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
44 Teruel;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
44 Teruel;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
44 Teruel;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
44 Teruel;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QIII;182
44 Teruel;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
44 Teruel;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
44 Teruel;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
44 Teruel;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QIII;192
44 Teruel;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
44 Teruel;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
44 Teruel;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
44 Teruel;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QIII;186
44 Teruel;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
44 Teruel;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
44 Teruel;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
44 Teruel;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2022QIII;167
44 Teruel;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2022QII;""
44 Teruel;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2022QI;""
44 Teruel;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
44 Teruel;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2021QIII;163
44 Teruel;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2021QII;""
44 Teruel;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2021QI;""
44 Teruel;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
44 Teruel;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2020QIII;166
44 Teruel;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2020QII;""
44 Teruel;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2020QI;""
44 Teruel;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2022QIV;158
44 Teruel;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
44 Teruel;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2022QII;""
44 Teruel;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2022QI;""
44 Teruel;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2021QIV;148
44 Teruel;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
44 Teruel;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2021QII;""
44 Teruel;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2021QI;""
44 Teruel;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2020QIV;155
44 Teruel;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
44 Teruel;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2020QII;""
44 Teruel;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2020QI;""
44 Teruel;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
44 Teruel;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
44 Teruel;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QII;""
44 Teruel;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QI;140
44 Teruel;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
44 Teruel;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
44 Teruel;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QII;""
44 Teruel;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QI;147
44 Teruel;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
44 Teruel;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
44 Teruel;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QII;""
44 Teruel;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QI;""
44 Teruel;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
44 Teruel;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
44 Teruel;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QII;132
44 Teruel;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QI;""
44 Teruel;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
44 Teruel;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
44 Teruel;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QII;142
44 Teruel;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QI;""
44 Teruel;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
44 Teruel;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
44 Teruel;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QII;""
44 Teruel;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QI;""
44 Teruel;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
44 Teruel;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
44 Teruel;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
44 Teruel;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
44 Teruel;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
44 Teruel;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
44 Teruel;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
44 Teruel;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
44 Teruel;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
44 Teruel;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
44 Teruel;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
44 Teruel;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
44 Teruel;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
44 Teruel;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;91,76
44 Teruel;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
44 Teruel;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
44 Teruel;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
44 Teruel;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;84,9
44 Teruel;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
44 Teruel;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
44 Teruel;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
44 Teruel;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;89,25
44 Teruel;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
44 Teruel;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
44 Teruel;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;86,81
44 Teruel;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
44 Teruel;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
44 Teruel;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
44 Teruel;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;77,08
44 Teruel;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
44 Teruel;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
44 Teruel;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
44 Teruel;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;83,33
44 Teruel;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
44 Teruel;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
44 Teruel;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
44 Teruel;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
44 Teruel;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
44 Teruel;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
44 Teruel;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;72,92
44 Teruel;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
44 Teruel;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
44 Teruel;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
44 Teruel;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;79,03
44 Teruel;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
44 Teruel;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
44 Teruel;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
44 Teruel;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
44 Teruel;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
44 Teruel;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
44 Teruel;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;68,75
44 Teruel;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
44 Teruel;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
44 Teruel;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
44 Teruel;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;76,34
44 Teruel;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
44 Teruel;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
44 Teruel;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
44 Teruel;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
44 Teruel;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
44 Teruel;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QIV;506
44 Teruel;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
44 Teruel;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
44 Teruel;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
44 Teruel;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QIV;537
44 Teruel;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
44 Teruel;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
44 Teruel;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
44 Teruel;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QIV;531
44 Teruel;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
44 Teruel;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
44 Teruel;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
44 Teruel;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2022QIV;478
44 Teruel;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
44 Teruel;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2022QII;""
44 Teruel;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2022QI;""
44 Teruel;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2021QIV;494
44 Teruel;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
44 Teruel;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2021QII;""
44 Teruel;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2021QI;""
44 Teruel;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2020QIV;493
44 Teruel;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
44 Teruel;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2020QII;""
44 Teruel;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2020QI;""
44 Teruel;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
44 Teruel;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
44 Teruel;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2022QII;""
44 Teruel;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2022QI;464
44 Teruel;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
44 Teruel;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
44 Teruel;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2021QII;""
44 Teruel;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2021QI;469
44 Teruel;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
44 Teruel;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
44 Teruel;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2020QII;""
44 Teruel;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2020QI;""
44 Teruel;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
44 Teruel;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
44 Teruel;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QII;444
44 Teruel;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QI;""
44 Teruel;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
44 Teruel;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
44 Teruel;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QII;454
44 Teruel;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QI;""
44 Teruel;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
44 Teruel;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
44 Teruel;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QII;""
44 Teruel;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QI;""
44 Teruel;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
44 Teruel;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QIII;431
44 Teruel;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QII;""
44 Teruel;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QI;""
44 Teruel;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
44 Teruel;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QIII;425
44 Teruel;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QII;""
44 Teruel;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QI;""
44 Teruel;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
44 Teruel;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
44 Teruel;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QII;""
44 Teruel;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QI;""
44 Teruel;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
44 Teruel;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
44 Teruel;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
44 Teruel;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
44 Teruel;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
44 Teruel;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
44 Teruel;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
44 Teruel;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
44 Teruel;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
44 Teruel;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
44 Teruel;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
44 Teruel;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
44 Teruel;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;94,47
44 Teruel;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
44 Teruel;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
44 Teruel;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
44 Teruel;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;91,99
44 Teruel;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
44 Teruel;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
44 Teruel;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
44 Teruel;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;92,84
44 Teruel;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
44 Teruel;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
44 Teruel;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
44 Teruel;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
44 Teruel;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
44 Teruel;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
44 Teruel;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;86,41
44 Teruel;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
44 Teruel;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
44 Teruel;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
44 Teruel;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;88,32
44 Teruel;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
44 Teruel;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
44 Teruel;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
44 Teruel;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
44 Teruel;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
44 Teruel;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
44 Teruel;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;82,68
44 Teruel;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
44 Teruel;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
44 Teruel;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
44 Teruel;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;85,5
44 Teruel;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
44 Teruel;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
44 Teruel;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
44 Teruel;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
44 Teruel;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
44 Teruel;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
44 Teruel;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;80,26
44 Teruel;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
44 Teruel;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
44 Teruel;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
44 Teruel;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;80,04
44 Teruel;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
44 Teruel;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
44 Teruel;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
44 Teruel;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
44 Teruel;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
44 Teruel;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
44 Teruel;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QIV;322
44 Teruel;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
44 Teruel;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
44 Teruel;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
44 Teruel;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QIV;344
44 Teruel;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
44 Teruel;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
44 Teruel;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
44 Teruel;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QIV;336
44 Teruel;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
44 Teruel;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
44 Teruel;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
44 Teruel;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2022QIV;303
44 Teruel;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
44 Teruel;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2022QII;""
44 Teruel;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2022QI;""
44 Teruel;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2021QIV;320
44 Teruel;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
44 Teruel;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2021QII;""
44 Teruel;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2021QI;""
44 Teruel;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2020QIV;314
44 Teruel;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
44 Teruel;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2020QII;""
44 Teruel;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2020QI;""
44 Teruel;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
44 Teruel;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
44 Teruel;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2022QII;""
44 Teruel;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2022QI;302
44 Teruel;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
44 Teruel;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
44 Teruel;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2021QII;""
44 Teruel;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2021QI;300
44 Teruel;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
44 Teruel;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
44 Teruel;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2020QII;""
44 Teruel;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2020QI;""
44 Teruel;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
44 Teruel;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
44 Teruel;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QII;291
44 Teruel;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QI;""
44 Teruel;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
44 Teruel;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
44 Teruel;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QII;290
44 Teruel;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QI;""
44 Teruel;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
44 Teruel;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
44 Teruel;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QII;""
44 Teruel;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QI;""
44 Teruel;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
44 Teruel;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QIII;282
44 Teruel;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QII;""
44 Teruel;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QI;""
44 Teruel;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
44 Teruel;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QIII;273
44 Teruel;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QII;""
44 Teruel;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QI;""
44 Teruel;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
44 Teruel;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
44 Teruel;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QII;""
44 Teruel;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QI;""
44 Teruel;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
44 Teruel;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
44 Teruel;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
44 Teruel;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
44 Teruel;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
44 Teruel;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
44 Teruel;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
44 Teruel;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
44 Teruel;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
44 Teruel;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
44 Teruel;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
44 Teruel;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
44 Teruel;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;94,1
44 Teruel;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
44 Teruel;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
44 Teruel;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
44 Teruel;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;93,02
44 Teruel;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
44 Teruel;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
44 Teruel;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
44 Teruel;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;93,45
44 Teruel;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
44 Teruel;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
44 Teruel;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
44 Teruel;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
44 Teruel;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
44 Teruel;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
44 Teruel;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;87,79
44 Teruel;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
44 Teruel;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
44 Teruel;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
44 Teruel;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;89,29
44 Teruel;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
44 Teruel;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
44 Teruel;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
44 Teruel;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
44 Teruel;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
44 Teruel;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
44 Teruel;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;84,59
44 Teruel;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
44 Teruel;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
44 Teruel;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
44 Teruel;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;86,31
44 Teruel;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
44 Teruel;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
44 Teruel;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
44 Teruel;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
44 Teruel;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
44 Teruel;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
44 Teruel;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;81,98
44 Teruel;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
44 Teruel;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
44 Teruel;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
44 Teruel;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;81,25
44 Teruel;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
44 Teruel;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
44 Teruel;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
44 Teruel;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
44 Teruel;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
44 Teruel;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
44 Teruel;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QIV;184
44 Teruel;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
44 Teruel;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
44 Teruel;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
44 Teruel;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QIV;193
44 Teruel;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
44 Teruel;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
44 Teruel;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
44 Teruel;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QIV;195
44 Teruel;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
44 Teruel;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
44 Teruel;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
44 Teruel;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2022QIV;175
44 Teruel;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
44 Teruel;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2022QII;""
44 Teruel;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2022QI;""
44 Teruel;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2021QIV;174
44 Teruel;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
44 Teruel;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2021QII;""
44 Teruel;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2021QI;""
44 Teruel;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2020QIV;179
44 Teruel;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
44 Teruel;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2020QII;""
44 Teruel;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2020QI;""
44 Teruel;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
44 Teruel;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
44 Teruel;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2022QII;""
44 Teruel;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2022QI;162
44 Teruel;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
44 Teruel;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
44 Teruel;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2021QII;""
44 Teruel;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2021QI;169
44 Teruel;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
44 Teruel;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
44 Teruel;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2020QII;""
44 Teruel;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2020QI;""
44 Teruel;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
44 Teruel;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
44 Teruel;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QII;153
44 Teruel;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QI;""
44 Teruel;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
44 Teruel;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
44 Teruel;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QII;164
44 Teruel;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QI;""
44 Teruel;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
44 Teruel;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
44 Teruel;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QII;""
44 Teruel;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QI;""
44 Teruel;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
44 Teruel;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QIII;149
44 Teruel;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QII;""
44 Teruel;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QI;""
44 Teruel;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
44 Teruel;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QIII;152
44 Teruel;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QII;""
44 Teruel;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QI;""
44 Teruel;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
44 Teruel;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
44 Teruel;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QII;""
44 Teruel;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QI;""
44 Teruel;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
44 Teruel;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
44 Teruel;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
44 Teruel;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
44 Teruel;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
44 Teruel;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
44 Teruel;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
44 Teruel;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
44 Teruel;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
44 Teruel;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
44 Teruel;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
44 Teruel;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
44 Teruel;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;95,11
44 Teruel;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
44 Teruel;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
44 Teruel;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
44 Teruel;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;90,16
44 Teruel;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
44 Teruel;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
44 Teruel;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
44 Teruel;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;91,79
44 Teruel;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
44 Teruel;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
44 Teruel;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
44 Teruel;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
44 Teruel;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
44 Teruel;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
44 Teruel;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;83,94
44 Teruel;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
44 Teruel;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
44 Teruel;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
44 Teruel;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;86,67
44 Teruel;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
44 Teruel;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
44 Teruel;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
44 Teruel;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
44 Teruel;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
44 Teruel;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
44 Teruel;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;79,27
44 Teruel;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
44 Teruel;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
44 Teruel;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
44 Teruel;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;84,1
44 Teruel;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
44 Teruel;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
44 Teruel;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
44 Teruel;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
44 Teruel;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
44 Teruel;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
44 Teruel;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;77,2
44 Teruel;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
44 Teruel;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
44 Teruel;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
44 Teruel;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;77,95
44 Teruel;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
44 Teruel;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
44 Teruel;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
44 Teruel;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
44 Teruel;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
44 Teruel;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
44 Teruel;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
44 Teruel;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
44 Teruel;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
44 Teruel;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QI;1.541
44 Teruel;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
44 Teruel;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
44 Teruel;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
44 Teruel;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QI;1.631
44 Teruel;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
44 Teruel;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
44 Teruel;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
44 Teruel;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QI;1.595
44 Teruel;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
44 Teruel;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
44 Teruel;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2022QII;""
44 Teruel;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2022QI;1.510
44 Teruel;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
44 Teruel;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
44 Teruel;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2021QII;""
44 Teruel;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2021QI;1.590
44 Teruel;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
44 Teruel;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
44 Teruel;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2020QII;""
44 Teruel;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2020QI;1.499
44 Teruel;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
44 Teruel;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
44 Teruel;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2022QII;1.460
44 Teruel;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2022QI;""
44 Teruel;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
44 Teruel;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
44 Teruel;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2021QII;1.539
44 Teruel;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2021QI;""
44 Teruel;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
44 Teruel;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
44 Teruel;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2020QII;1.466
44 Teruel;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2020QI;""
44 Teruel;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
44 Teruel;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QIII;1.429
44 Teruel;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QII;""
44 Teruel;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QI;""
44 Teruel;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
44 Teruel;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QIII;1.509
44 Teruel;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QII;""
44 Teruel;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QI;""
44 Teruel;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
44 Teruel;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QIII;1.422
44 Teruel;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QII;""
44 Teruel;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QI;""
44 Teruel;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QIV;1.381
44 Teruel;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
44 Teruel;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QII;""
44 Teruel;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QI;""
44 Teruel;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QIV;1.474
44 Teruel;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
44 Teruel;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QII;""
44 Teruel;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QI;""
44 Teruel;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QIV;1.389
44 Teruel;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
44 Teruel;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QII;""
44 Teruel;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QI;""
44 Teruel;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
44 Teruel;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
44 Teruel;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
44 Teruel;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
44 Teruel;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
44 Teruel;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
44 Teruel;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
44 Teruel;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
44 Teruel;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
44 Teruel;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
44 Teruel;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
44 Teruel;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
44 Teruel;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
44 Teruel;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
44 Teruel;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
44 Teruel;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;97,99
44 Teruel;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
44 Teruel;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
44 Teruel;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
44 Teruel;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;97,49
44 Teruel;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
44 Teruel;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
44 Teruel;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
44 Teruel;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;93,98
44 Teruel;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
44 Teruel;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
44 Teruel;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;94,74
44 Teruel;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
44 Teruel;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
44 Teruel;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
44 Teruel;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;94,36
44 Teruel;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
44 Teruel;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
44 Teruel;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
44 Teruel;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;91,91
44 Teruel;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
44 Teruel;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
44 Teruel;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;92,73
44 Teruel;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
44 Teruel;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
44 Teruel;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
44 Teruel;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;92,52
44 Teruel;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
44 Teruel;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
44 Teruel;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
44 Teruel;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;89,15
44 Teruel;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
44 Teruel;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
44 Teruel;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;89,62
44 Teruel;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
44 Teruel;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
44 Teruel;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
44 Teruel;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;90,37
44 Teruel;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
44 Teruel;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
44 Teruel;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
44 Teruel;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;87,08
44 Teruel;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
44 Teruel;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
44 Teruel;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
44 Teruel;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
44 Teruel;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
44 Teruel;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
44 Teruel;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QI;921
44 Teruel;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
44 Teruel;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
44 Teruel;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
44 Teruel;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QI;965
44 Teruel;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
44 Teruel;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
44 Teruel;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
44 Teruel;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QI;936
44 Teruel;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
44 Teruel;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
44 Teruel;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2022QII;""
44 Teruel;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2022QI;904
44 Teruel;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
44 Teruel;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
44 Teruel;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2021QII;""
44 Teruel;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2021QI;941
44 Teruel;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
44 Teruel;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
44 Teruel;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2020QII;""
44 Teruel;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2020QI;883
44 Teruel;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
44 Teruel;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
44 Teruel;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2022QII;883
44 Teruel;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2022QI;""
44 Teruel;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
44 Teruel;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
44 Teruel;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2021QII;919
44 Teruel;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2021QI;""
44 Teruel;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
44 Teruel;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
44 Teruel;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2020QII;869
44 Teruel;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2020QI;""
44 Teruel;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
44 Teruel;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QIII;865
44 Teruel;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QII;""
44 Teruel;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QI;""
44 Teruel;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
44 Teruel;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QIII;906
44 Teruel;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QII;""
44 Teruel;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QI;""
44 Teruel;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
44 Teruel;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QIII;850
44 Teruel;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QII;""
44 Teruel;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QI;""
44 Teruel;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QIV;841
44 Teruel;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
44 Teruel;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QII;""
44 Teruel;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QI;""
44 Teruel;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QIV;890
44 Teruel;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
44 Teruel;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QII;""
44 Teruel;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QI;""
44 Teruel;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QIV;834
44 Teruel;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
44 Teruel;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QII;""
44 Teruel;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QI;""
44 Teruel;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
44 Teruel;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
44 Teruel;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
44 Teruel;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
44 Teruel;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
44 Teruel;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
44 Teruel;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
44 Teruel;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
44 Teruel;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
44 Teruel;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
44 Teruel;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
44 Teruel;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
44 Teruel;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
44 Teruel;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
44 Teruel;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
44 Teruel;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;98,15
44 Teruel;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
44 Teruel;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
44 Teruel;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
44 Teruel;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;97,51
44 Teruel;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
44 Teruel;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
44 Teruel;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
44 Teruel;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;94,34
44 Teruel;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
44 Teruel;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
44 Teruel;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;95,87
44 Teruel;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
44 Teruel;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
44 Teruel;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
44 Teruel;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;95,23
44 Teruel;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
44 Teruel;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
44 Teruel;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
44 Teruel;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;92,84
44 Teruel;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
44 Teruel;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
44 Teruel;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;93,92
44 Teruel;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
44 Teruel;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
44 Teruel;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
44 Teruel;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;93,89
44 Teruel;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
44 Teruel;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
44 Teruel;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
44 Teruel;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;90,81
44 Teruel;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
44 Teruel;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
44 Teruel;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;91,31
44 Teruel;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
44 Teruel;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
44 Teruel;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
44 Teruel;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;92,23
44 Teruel;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
44 Teruel;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
44 Teruel;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
44 Teruel;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;89,1
44 Teruel;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
44 Teruel;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
44 Teruel;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
44 Teruel;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
44 Teruel;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
44 Teruel;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
44 Teruel;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QI;620
44 Teruel;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
44 Teruel;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
44 Teruel;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
44 Teruel;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QI;666
44 Teruel;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
44 Teruel;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
44 Teruel;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
44 Teruel;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QI;659
44 Teruel;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
44 Teruel;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
44 Teruel;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2022QII;""
44 Teruel;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2022QI;606
44 Teruel;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
44 Teruel;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
44 Teruel;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2021QII;""
44 Teruel;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2021QI;649
44 Teruel;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
44 Teruel;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
44 Teruel;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2020QII;""
44 Teruel;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2020QI;616
44 Teruel;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
44 Teruel;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
44 Teruel;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2022QII;577
44 Teruel;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2022QI;""
44 Teruel;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
44 Teruel;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
44 Teruel;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2021QII;620
44 Teruel;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2021QI;""
44 Teruel;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
44 Teruel;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
44 Teruel;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2020QII;597
44 Teruel;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2020QI;""
44 Teruel;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
44 Teruel;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QIII;564
44 Teruel;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QII;""
44 Teruel;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QI;""
44 Teruel;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
44 Teruel;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QIII;603
44 Teruel;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QII;""
44 Teruel;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QI;""
44 Teruel;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
44 Teruel;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QIII;572
44 Teruel;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QII;""
44 Teruel;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QI;""
44 Teruel;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QIV;540
44 Teruel;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
44 Teruel;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QII;""
44 Teruel;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QI;""
44 Teruel;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QIV;584
44 Teruel;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
44 Teruel;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QII;""
44 Teruel;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QI;""
44 Teruel;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QIV;555
44 Teruel;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
44 Teruel;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QII;""
44 Teruel;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QI;""
44 Teruel;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
44 Teruel;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
44 Teruel;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
44 Teruel;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
44 Teruel;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
44 Teruel;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
44 Teruel;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
44 Teruel;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
44 Teruel;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
44 Teruel;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
44 Teruel;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
44 Teruel;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
44 Teruel;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
44 Teruel;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
44 Teruel;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
44 Teruel;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;97,74
44 Teruel;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
44 Teruel;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
44 Teruel;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
44 Teruel;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;97,45
44 Teruel;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
44 Teruel;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
44 Teruel;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
44 Teruel;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;93,47
44 Teruel;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
44 Teruel;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
44 Teruel;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;93,06
44 Teruel;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
44 Teruel;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
44 Teruel;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
44 Teruel;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;93,09
44 Teruel;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
44 Teruel;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
44 Teruel;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
44 Teruel;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;90,59
44 Teruel;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
44 Teruel;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
44 Teruel;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;90,97
44 Teruel;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
44 Teruel;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
44 Teruel;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
44 Teruel;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;90,54
44 Teruel;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
44 Teruel;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
44 Teruel;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
44 Teruel;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;86,8
44 Teruel;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
44 Teruel;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
44 Teruel;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;87,1
44 Teruel;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
44 Teruel;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
44 Teruel;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
44 Teruel;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;87,69
44 Teruel;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
44 Teruel;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
44 Teruel;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
44 Teruel;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;84,22
44 Teruel;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
44 Teruel;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
44 Teruel;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
44 Teruel;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
44 Teruel;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
44 Teruel;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QII;1.469
44 Teruel;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
44 Teruel;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
44 Teruel;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
44 Teruel;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QII;1.502
44 Teruel;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
44 Teruel;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
44 Teruel;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
44 Teruel;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QII;1.576
44 Teruel;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
44 Teruel;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
44 Teruel;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
44 Teruel;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2022QII;1.421
44 Teruel;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2022QI;""
44 Teruel;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
44 Teruel;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
44 Teruel;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2021QII;1.449
44 Teruel;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2021QI;""
44 Teruel;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
44 Teruel;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
44 Teruel;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2020QII;1.538
44 Teruel;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2020QI;""
44 Teruel;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
44 Teruel;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2022QIII;1.388
44 Teruel;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2022QII;""
44 Teruel;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2022QI;""
44 Teruel;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
44 Teruel;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2021QIII;1.415
44 Teruel;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2021QII;""
44 Teruel;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2021QI;""
44 Teruel;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
44 Teruel;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2020QIII;1.487
44 Teruel;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2020QII;""
44 Teruel;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2020QI;""
44 Teruel;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QIV;1.340
44 Teruel;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
44 Teruel;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QII;""
44 Teruel;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QI;""
44 Teruel;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QIV;1.381
44 Teruel;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
44 Teruel;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QII;""
44 Teruel;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QI;""
44 Teruel;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QIV;1.452
44 Teruel;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
44 Teruel;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QII;""
44 Teruel;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QI;""
44 Teruel;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
44 Teruel;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
44 Teruel;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QII;""
44 Teruel;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QI;1.359
44 Teruel;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
44 Teruel;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
44 Teruel;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QII;""
44 Teruel;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QI;1.427
44 Teruel;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
44 Teruel;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
44 Teruel;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QII;""
44 Teruel;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QI;""
44 Teruel;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
44 Teruel;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
44 Teruel;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
44 Teruel;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
44 Teruel;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
44 Teruel;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
44 Teruel;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
44 Teruel;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
44 Teruel;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
44 Teruel;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
44 Teruel;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
44 Teruel;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
44 Teruel;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
44 Teruel;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
44 Teruel;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;96,73
44 Teruel;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
44 Teruel;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
44 Teruel;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
44 Teruel;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;96,47
44 Teruel;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
44 Teruel;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
44 Teruel;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
44 Teruel;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;97,59
44 Teruel;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
44 Teruel;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
44 Teruel;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;94,49
44 Teruel;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
44 Teruel;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
44 Teruel;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
44 Teruel;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;94,21
44 Teruel;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
44 Teruel;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
44 Teruel;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
44 Teruel;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;94,35
44 Teruel;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
44 Teruel;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
44 Teruel;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;91,22
44 Teruel;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
44 Teruel;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
44 Teruel;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
44 Teruel;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;91,94
44 Teruel;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
44 Teruel;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
44 Teruel;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
44 Teruel;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;92,13
44 Teruel;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
44 Teruel;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
44 Teruel;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
44 Teruel;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
44 Teruel;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
44 Teruel;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
44 Teruel;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;90,48
44 Teruel;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
44 Teruel;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
44 Teruel;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
44 Teruel;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;90,55
44 Teruel;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
44 Teruel;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
44 Teruel;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
44 Teruel;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
44 Teruel;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
44 Teruel;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
44 Teruel;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QII;874
44 Teruel;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
44 Teruel;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
44 Teruel;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
44 Teruel;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QII;894
44 Teruel;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
44 Teruel;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
44 Teruel;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
44 Teruel;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QII;928
44 Teruel;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
44 Teruel;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
44 Teruel;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
44 Teruel;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2022QII;852
44 Teruel;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2022QI;""
44 Teruel;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
44 Teruel;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
44 Teruel;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2021QII;868
44 Teruel;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2021QI;""
44 Teruel;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
44 Teruel;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
44 Teruel;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2020QII;911
44 Teruel;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2020QI;""
44 Teruel;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
44 Teruel;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2022QIII;834
44 Teruel;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2022QII;""
44 Teruel;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2022QI;""
44 Teruel;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
44 Teruel;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2021QIII;854
44 Teruel;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2021QII;""
44 Teruel;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2021QI;""
44 Teruel;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
44 Teruel;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2020QIII;888
44 Teruel;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2020QII;""
44 Teruel;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2020QI;""
44 Teruel;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QIV;809
44 Teruel;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
44 Teruel;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QII;""
44 Teruel;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QI;""
44 Teruel;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QIV;836
44 Teruel;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
44 Teruel;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QII;""
44 Teruel;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QI;""
44 Teruel;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QIV;870
44 Teruel;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
44 Teruel;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QII;""
44 Teruel;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QI;""
44 Teruel;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
44 Teruel;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
44 Teruel;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QII;""
44 Teruel;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QI;823
44 Teruel;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
44 Teruel;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
44 Teruel;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QII;""
44 Teruel;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QI;856
44 Teruel;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
44 Teruel;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
44 Teruel;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QII;""
44 Teruel;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QI;""
44 Teruel;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
44 Teruel;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
44 Teruel;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
44 Teruel;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
44 Teruel;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
44 Teruel;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
44 Teruel;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
44 Teruel;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
44 Teruel;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
44 Teruel;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
44 Teruel;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
44 Teruel;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
44 Teruel;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
44 Teruel;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
44 Teruel;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;97,48
44 Teruel;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
44 Teruel;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
44 Teruel;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
44 Teruel;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;97,09
44 Teruel;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
44 Teruel;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
44 Teruel;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
44 Teruel;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;98,17
44 Teruel;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
44 Teruel;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
44 Teruel;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;95,42
44 Teruel;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
44 Teruel;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
44 Teruel;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
44 Teruel;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;95,53
44 Teruel;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
44 Teruel;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
44 Teruel;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
44 Teruel;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;95,69
44 Teruel;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
44 Teruel;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
44 Teruel;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;92,56
44 Teruel;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
44 Teruel;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
44 Teruel;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
44 Teruel;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;93,51
44 Teruel;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
44 Teruel;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
44 Teruel;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
44 Teruel;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;93,75
44 Teruel;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
44 Teruel;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
44 Teruel;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
44 Teruel;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
44 Teruel;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
44 Teruel;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
44 Teruel;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;92,06
44 Teruel;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
44 Teruel;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
44 Teruel;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
44 Teruel;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;92,24
44 Teruel;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
44 Teruel;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
44 Teruel;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
44 Teruel;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
44 Teruel;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
44 Teruel;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
44 Teruel;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QII;595
44 Teruel;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
44 Teruel;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
44 Teruel;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
44 Teruel;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QII;608
44 Teruel;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
44 Teruel;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
44 Teruel;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
44 Teruel;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QII;648
44 Teruel;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
44 Teruel;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
44 Teruel;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
44 Teruel;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2022QII;569
44 Teruel;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2022QI;""
44 Teruel;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
44 Teruel;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
44 Teruel;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2021QII;581
44 Teruel;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2021QI;""
44 Teruel;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
44 Teruel;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
44 Teruel;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2020QII;627
44 Teruel;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2020QI;""
44 Teruel;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
44 Teruel;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2022QIII;554
44 Teruel;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2022QII;""
44 Teruel;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2022QI;""
44 Teruel;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
44 Teruel;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2021QIII;561
44 Teruel;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2021QII;""
44 Teruel;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2021QI;""
44 Teruel;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
44 Teruel;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2020QIII;599
44 Teruel;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2020QII;""
44 Teruel;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2020QI;""
44 Teruel;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QIV;531
44 Teruel;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
44 Teruel;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QII;""
44 Teruel;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QI;""
44 Teruel;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QIV;545
44 Teruel;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
44 Teruel;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QII;""
44 Teruel;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QI;""
44 Teruel;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QIV;582
44 Teruel;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
44 Teruel;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QII;""
44 Teruel;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QI;""
44 Teruel;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
44 Teruel;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
44 Teruel;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QII;""
44 Teruel;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QI;536
44 Teruel;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
44 Teruel;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
44 Teruel;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QII;""
44 Teruel;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QI;571
44 Teruel;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
44 Teruel;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
44 Teruel;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QII;""
44 Teruel;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QI;""
44 Teruel;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
44 Teruel;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
44 Teruel;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
44 Teruel;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
44 Teruel;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
44 Teruel;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
44 Teruel;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
44 Teruel;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
44 Teruel;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
44 Teruel;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
44 Teruel;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
44 Teruel;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
44 Teruel;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
44 Teruel;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
44 Teruel;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;95,63
44 Teruel;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
44 Teruel;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
44 Teruel;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
44 Teruel;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;95,56
44 Teruel;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
44 Teruel;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
44 Teruel;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
44 Teruel;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;96,76
44 Teruel;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
44 Teruel;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
44 Teruel;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;93,11
44 Teruel;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
44 Teruel;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
44 Teruel;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
44 Teruel;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;92,27
44 Teruel;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
44 Teruel;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
44 Teruel;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
44 Teruel;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;92,44
44 Teruel;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
44 Teruel;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
44 Teruel;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;89,24
44 Teruel;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
44 Teruel;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
44 Teruel;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
44 Teruel;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;89,64
44 Teruel;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
44 Teruel;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
44 Teruel;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
44 Teruel;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;89,81
44 Teruel;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
44 Teruel;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
44 Teruel;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
44 Teruel;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
44 Teruel;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
44 Teruel;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
44 Teruel;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;88,16
44 Teruel;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
44 Teruel;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
44 Teruel;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
44 Teruel;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;88,12
44 Teruel;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
44 Teruel;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
44 Teruel;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
44 Teruel;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
44 Teruel;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
44 Teruel;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QIII;1.507
44 Teruel;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
44 Teruel;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
44 Teruel;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
44 Teruel;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QIII;1.509
44 Teruel;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
44 Teruel;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
44 Teruel;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
44 Teruel;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QIII;1.605
44 Teruel;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
44 Teruel;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
44 Teruel;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
44 Teruel;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2022QIII;1.456
44 Teruel;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2022QII;""
44 Teruel;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2022QI;""
44 Teruel;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
44 Teruel;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2021QIII;1.467
44 Teruel;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2021QII;""
44 Teruel;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2021QI;""
44 Teruel;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
44 Teruel;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2020QIII;1.545
44 Teruel;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2020QII;""
44 Teruel;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2020QI;""
44 Teruel;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2022QIV;1.395
44 Teruel;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
44 Teruel;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2022QII;""
44 Teruel;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2022QI;""
44 Teruel;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2021QIV;1.427
44 Teruel;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
44 Teruel;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2021QII;""
44 Teruel;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2021QI;""
44 Teruel;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2020QIV;1.506
44 Teruel;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
44 Teruel;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2020QII;""
44 Teruel;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2020QI;""
44 Teruel;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
44 Teruel;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
44 Teruel;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QII;""
44 Teruel;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QI;1.401
44 Teruel;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
44 Teruel;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
44 Teruel;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QII;""
44 Teruel;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QI;1.477
44 Teruel;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
44 Teruel;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
44 Teruel;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QII;""
44 Teruel;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QI;""
44 Teruel;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
44 Teruel;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
44 Teruel;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QII;1.359
44 Teruel;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QI;""
44 Teruel;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
44 Teruel;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
44 Teruel;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QII;1.437
44 Teruel;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QI;""
44 Teruel;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
44 Teruel;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
44 Teruel;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QII;""
44 Teruel;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QI;""
44 Teruel;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
44 Teruel;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
44 Teruel;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
44 Teruel;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
44 Teruel;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
44 Teruel;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
44 Teruel;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
44 Teruel;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
44 Teruel;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
44 Teruel;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
44 Teruel;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
44 Teruel;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
44 Teruel;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
44 Teruel;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;96,62
44 Teruel;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
44 Teruel;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
44 Teruel;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
44 Teruel;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;97,22
44 Teruel;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
44 Teruel;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
44 Teruel;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
44 Teruel;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;96,26
44 Teruel;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
44 Teruel;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
44 Teruel;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;92,57
44 Teruel;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
44 Teruel;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
44 Teruel;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
44 Teruel;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;94,57
44 Teruel;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
44 Teruel;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
44 Teruel;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
44 Teruel;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;93,83
44 Teruel;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
44 Teruel;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
44 Teruel;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
44 Teruel;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
44 Teruel;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
44 Teruel;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
44 Teruel;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;92,84
44 Teruel;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
44 Teruel;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
44 Teruel;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
44 Teruel;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;92,02
44 Teruel;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
44 Teruel;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
44 Teruel;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
44 Teruel;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
44 Teruel;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
44 Teruel;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
44 Teruel;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;90,06
44 Teruel;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
44 Teruel;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
44 Teruel;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
44 Teruel;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;89,53
44 Teruel;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
44 Teruel;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
44 Teruel;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
44 Teruel;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
44 Teruel;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
44 Teruel;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
44 Teruel;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QIII;893
44 Teruel;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
44 Teruel;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
44 Teruel;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
44 Teruel;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QIII;903
44 Teruel;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
44 Teruel;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
44 Teruel;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
44 Teruel;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QIII;950
44 Teruel;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
44 Teruel;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
44 Teruel;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
44 Teruel;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2022QIII;869
44 Teruel;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2022QII;""
44 Teruel;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2022QI;""
44 Teruel;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
44 Teruel;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2021QIII;884
44 Teruel;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2021QII;""
44 Teruel;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2021QI;""
44 Teruel;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
44 Teruel;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2020QIII;922
44 Teruel;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2020QII;""
44 Teruel;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2020QI;""
44 Teruel;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2022QIV;838
44 Teruel;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
44 Teruel;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2022QII;""
44 Teruel;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2022QI;""
44 Teruel;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2021QIV;862
44 Teruel;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
44 Teruel;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2021QII;""
44 Teruel;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2021QI;""
44 Teruel;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2020QIV;901
44 Teruel;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
44 Teruel;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2020QII;""
44 Teruel;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2020QI;""
44 Teruel;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
44 Teruel;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
44 Teruel;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QII;""
44 Teruel;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QI;847
44 Teruel;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
44 Teruel;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
44 Teruel;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QII;""
44 Teruel;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QI;884
44 Teruel;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
44 Teruel;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
44 Teruel;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QII;""
44 Teruel;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QI;""
44 Teruel;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
44 Teruel;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
44 Teruel;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QII;829
44 Teruel;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QI;""
44 Teruel;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
44 Teruel;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
44 Teruel;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QII;867
44 Teruel;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QI;""
44 Teruel;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
44 Teruel;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
44 Teruel;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QII;""
44 Teruel;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QI;""
44 Teruel;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
44 Teruel;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
44 Teruel;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
44 Teruel;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
44 Teruel;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
44 Teruel;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
44 Teruel;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
44 Teruel;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
44 Teruel;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
44 Teruel;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
44 Teruel;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
44 Teruel;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
44 Teruel;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
44 Teruel;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;97,31
44 Teruel;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
44 Teruel;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
44 Teruel;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
44 Teruel;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;97,9
44 Teruel;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
44 Teruel;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
44 Teruel;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
44 Teruel;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;97,05
44 Teruel;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
44 Teruel;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
44 Teruel;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;93,84
44 Teruel;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
44 Teruel;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
44 Teruel;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
44 Teruel;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;95,46
44 Teruel;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
44 Teruel;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
44 Teruel;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
44 Teruel;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;94,84
44 Teruel;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
44 Teruel;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
44 Teruel;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
44 Teruel;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
44 Teruel;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
44 Teruel;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
44 Teruel;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;93,8
44 Teruel;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
44 Teruel;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
44 Teruel;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
44 Teruel;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;93,05
44 Teruel;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
44 Teruel;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
44 Teruel;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
44 Teruel;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
44 Teruel;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
44 Teruel;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
44 Teruel;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;91,81
44 Teruel;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
44 Teruel;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
44 Teruel;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
44 Teruel;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;91,26
44 Teruel;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
44 Teruel;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
44 Teruel;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
44 Teruel;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
44 Teruel;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
44 Teruel;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
44 Teruel;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QIII;614
44 Teruel;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
44 Teruel;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
44 Teruel;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
44 Teruel;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QIII;606
44 Teruel;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
44 Teruel;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
44 Teruel;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
44 Teruel;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QIII;655
44 Teruel;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
44 Teruel;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
44 Teruel;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
44 Teruel;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2022QIII;587
44 Teruel;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2022QII;""
44 Teruel;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2022QI;""
44 Teruel;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
44 Teruel;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2021QIII;583
44 Teruel;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2021QII;""
44 Teruel;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2021QI;""
44 Teruel;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
44 Teruel;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2020QIII;623
44 Teruel;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2020QII;""
44 Teruel;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2020QI;""
44 Teruel;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2022QIV;557
44 Teruel;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
44 Teruel;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2022QII;""
44 Teruel;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2022QI;""
44 Teruel;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2021QIV;565
44 Teruel;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
44 Teruel;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2021QII;""
44 Teruel;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2021QI;""
44 Teruel;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2020QIV;605
44 Teruel;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
44 Teruel;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2020QII;""
44 Teruel;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2020QI;""
44 Teruel;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
44 Teruel;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
44 Teruel;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QII;""
44 Teruel;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QI;554
44 Teruel;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
44 Teruel;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
44 Teruel;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QII;""
44 Teruel;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QI;593
44 Teruel;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
44 Teruel;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
44 Teruel;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QII;""
44 Teruel;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QI;""
44 Teruel;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
44 Teruel;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
44 Teruel;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QII;530
44 Teruel;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QI;""
44 Teruel;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
44 Teruel;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
44 Teruel;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QII;570
44 Teruel;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QI;""
44 Teruel;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
44 Teruel;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
44 Teruel;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QII;""
44 Teruel;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QI;""
44 Teruel;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
44 Teruel;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
44 Teruel;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
44 Teruel;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
44 Teruel;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
44 Teruel;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
44 Teruel;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
44 Teruel;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
44 Teruel;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
44 Teruel;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
44 Teruel;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
44 Teruel;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
44 Teruel;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
44 Teruel;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;95,6
44 Teruel;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
44 Teruel;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
44 Teruel;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
44 Teruel;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;96,2
44 Teruel;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
44 Teruel;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
44 Teruel;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
44 Teruel;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;95,11
44 Teruel;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
44 Teruel;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
44 Teruel;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;90,72
44 Teruel;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
44 Teruel;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
44 Teruel;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
44 Teruel;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;93,23
44 Teruel;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
44 Teruel;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
44 Teruel;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
44 Teruel;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;92,37
44 Teruel;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
44 Teruel;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
44 Teruel;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
44 Teruel;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
44 Teruel;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
44 Teruel;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
44 Teruel;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;91,42
44 Teruel;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
44 Teruel;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
44 Teruel;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
44 Teruel;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;90,53
44 Teruel;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
44 Teruel;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
44 Teruel;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
44 Teruel;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
44 Teruel;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
44 Teruel;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
44 Teruel;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;87,46
44 Teruel;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
44 Teruel;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
44 Teruel;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
44 Teruel;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;87,02
44 Teruel;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
44 Teruel;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
44 Teruel;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
44 Teruel;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
44 Teruel;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
44 Teruel;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QIV;1.515
44 Teruel;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
44 Teruel;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
44 Teruel;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
44 Teruel;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QIV;1.528
44 Teruel;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
44 Teruel;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
44 Teruel;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
44 Teruel;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QIV;1.610
44 Teruel;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
44 Teruel;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
44 Teruel;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
44 Teruel;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2022QIV;1.452
44 Teruel;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
44 Teruel;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2022QII;""
44 Teruel;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2022QI;""
44 Teruel;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2021QIV;1.477
44 Teruel;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
44 Teruel;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2021QII;""
44 Teruel;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2021QI;""
44 Teruel;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2020QIV;1.567
44 Teruel;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
44 Teruel;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2020QII;""
44 Teruel;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2020QI;""
44 Teruel;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
44 Teruel;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
44 Teruel;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2022QII;""
44 Teruel;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2022QI;1.451
44 Teruel;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
44 Teruel;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
44 Teruel;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2021QII;""
44 Teruel;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2021QI;1.530
44 Teruel;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
44 Teruel;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
44 Teruel;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2020QII;""
44 Teruel;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2020QI;""
44 Teruel;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
44 Teruel;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
44 Teruel;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QII;1.407
44 Teruel;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QI;""
44 Teruel;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
44 Teruel;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
44 Teruel;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QII;1.484
44 Teruel;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QI;""
44 Teruel;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
44 Teruel;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
44 Teruel;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QII;""
44 Teruel;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QI;""
44 Teruel;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
44 Teruel;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QIII;1.379
44 Teruel;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QII;""
44 Teruel;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QI;""
44 Teruel;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
44 Teruel;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QIII;1.462
44 Teruel;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QII;""
44 Teruel;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QI;""
44 Teruel;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
44 Teruel;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
44 Teruel;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QII;""
44 Teruel;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QI;""
44 Teruel;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
44 Teruel;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
44 Teruel;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
44 Teruel;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
44 Teruel;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
44 Teruel;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
44 Teruel;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
44 Teruel;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
44 Teruel;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
44 Teruel;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
44 Teruel;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
44 Teruel;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
44 Teruel;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;95,84
44 Teruel;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
44 Teruel;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
44 Teruel;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
44 Teruel;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;96,66
44 Teruel;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
44 Teruel;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
44 Teruel;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
44 Teruel;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;97,33
44 Teruel;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
44 Teruel;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
44 Teruel;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
44 Teruel;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
44 Teruel;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
44 Teruel;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
44 Teruel;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;94,96
44 Teruel;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
44 Teruel;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
44 Teruel;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
44 Teruel;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;95,03
44 Teruel;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
44 Teruel;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
44 Teruel;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
44 Teruel;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
44 Teruel;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
44 Teruel;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
44 Teruel;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;92,08
44 Teruel;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
44 Teruel;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
44 Teruel;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
44 Teruel;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;92,17
44 Teruel;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
44 Teruel;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
44 Teruel;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
44 Teruel;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
44 Teruel;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
44 Teruel;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
44 Teruel;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;90,25
44 Teruel;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
44 Teruel;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
44 Teruel;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
44 Teruel;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;90,81
44 Teruel;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
44 Teruel;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
44 Teruel;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
44 Teruel;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
44 Teruel;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
44 Teruel;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
44 Teruel;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QIV;900
44 Teruel;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
44 Teruel;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
44 Teruel;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
44 Teruel;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QIV;911
44 Teruel;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
44 Teruel;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
44 Teruel;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
44 Teruel;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QIV;959
44 Teruel;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
44 Teruel;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
44 Teruel;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
44 Teruel;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2022QIV;868
44 Teruel;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
44 Teruel;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2022QII;""
44 Teruel;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2022QI;""
44 Teruel;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2021QIV;884
44 Teruel;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
44 Teruel;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2021QII;""
44 Teruel;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2021QI;""
44 Teruel;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2020QIV;935
44 Teruel;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
44 Teruel;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2020QII;""
44 Teruel;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2020QI;""
44 Teruel;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
44 Teruel;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
44 Teruel;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2022QII;""
44 Teruel;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2022QI;869
44 Teruel;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
44 Teruel;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
44 Teruel;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2021QII;""
44 Teruel;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2021QI;913
44 Teruel;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
44 Teruel;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
44 Teruel;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2020QII;""
44 Teruel;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2020QI;""
44 Teruel;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
44 Teruel;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
44 Teruel;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QII;851
44 Teruel;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QI;""
44 Teruel;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
44 Teruel;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
44 Teruel;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QII;893
44 Teruel;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QI;""
44 Teruel;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
44 Teruel;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
44 Teruel;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QII;""
44 Teruel;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QI;""
44 Teruel;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
44 Teruel;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QIII;835
44 Teruel;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QII;""
44 Teruel;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QI;""
44 Teruel;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
44 Teruel;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QIII;883
44 Teruel;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QII;""
44 Teruel;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QI;""
44 Teruel;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
44 Teruel;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
44 Teruel;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QII;""
44 Teruel;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QI;""
44 Teruel;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
44 Teruel;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
44 Teruel;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
44 Teruel;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
44 Teruel;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
44 Teruel;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
44 Teruel;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
44 Teruel;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
44 Teruel;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
44 Teruel;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
44 Teruel;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
44 Teruel;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
44 Teruel;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;96,44
44 Teruel;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
44 Teruel;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
44 Teruel;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
44 Teruel;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;97,04
44 Teruel;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
44 Teruel;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
44 Teruel;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
44 Teruel;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;97,5
44 Teruel;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
44 Teruel;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
44 Teruel;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
44 Teruel;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
44 Teruel;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
44 Teruel;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
44 Teruel;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;95,39
44 Teruel;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
44 Teruel;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
44 Teruel;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
44 Teruel;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;95,2
44 Teruel;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
44 Teruel;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
44 Teruel;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
44 Teruel;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
44 Teruel;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
44 Teruel;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
44 Teruel;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;93,41
44 Teruel;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
44 Teruel;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
44 Teruel;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
44 Teruel;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;93,12
44 Teruel;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
44 Teruel;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
44 Teruel;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
44 Teruel;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
44 Teruel;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
44 Teruel;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
44 Teruel;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;91,66
44 Teruel;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
44 Teruel;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
44 Teruel;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
44 Teruel;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;92,08
44 Teruel;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
44 Teruel;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
44 Teruel;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
44 Teruel;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
44 Teruel;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
44 Teruel;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
44 Teruel;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QIV;615
44 Teruel;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
44 Teruel;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
44 Teruel;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
44 Teruel;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QIV;617
44 Teruel;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
44 Teruel;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
44 Teruel;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
44 Teruel;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QIV;651
44 Teruel;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
44 Teruel;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
44 Teruel;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
44 Teruel;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2022QIV;584
44 Teruel;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
44 Teruel;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2022QII;""
44 Teruel;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2022QI;""
44 Teruel;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2021QIV;593
44 Teruel;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
44 Teruel;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2021QII;""
44 Teruel;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2021QI;""
44 Teruel;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2020QIV;632
44 Teruel;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
44 Teruel;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2020QII;""
44 Teruel;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2020QI;""
44 Teruel;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
44 Teruel;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
44 Teruel;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2022QII;""
44 Teruel;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2022QI;582
44 Teruel;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
44 Teruel;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
44 Teruel;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2021QII;""
44 Teruel;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2021QI;617
44 Teruel;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
44 Teruel;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
44 Teruel;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2020QII;""
44 Teruel;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2020QI;""
44 Teruel;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
44 Teruel;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
44 Teruel;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QII;556
44 Teruel;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QI;""
44 Teruel;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
44 Teruel;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
44 Teruel;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QII;591
44 Teruel;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QI;""
44 Teruel;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
44 Teruel;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
44 Teruel;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QII;""
44 Teruel;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QI;""
44 Teruel;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
44 Teruel;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QIII;544
44 Teruel;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QII;""
44 Teruel;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QI;""
44 Teruel;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
44 Teruel;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QIII;579
44 Teruel;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QII;""
44 Teruel;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QI;""
44 Teruel;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
44 Teruel;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
44 Teruel;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QII;""
44 Teruel;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QI;""
44 Teruel;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
44 Teruel;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
44 Teruel;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
44 Teruel;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
44 Teruel;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
44 Teruel;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
44 Teruel;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
44 Teruel;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
44 Teruel;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
44 Teruel;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
44 Teruel;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
44 Teruel;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
44 Teruel;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;94,96
44 Teruel;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
44 Teruel;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
44 Teruel;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
44 Teruel;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;96,11
44 Teruel;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
44 Teruel;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
44 Teruel;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
44 Teruel;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;97,08
44 Teruel;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
44 Teruel;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
44 Teruel;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
44 Teruel;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
44 Teruel;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
44 Teruel;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
44 Teruel;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;94,33
44 Teruel;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
44 Teruel;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
44 Teruel;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
44 Teruel;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;94,78
44 Teruel;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
44 Teruel;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
44 Teruel;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
44 Teruel;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
44 Teruel;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
44 Teruel;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
44 Teruel;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;90,11
44 Teruel;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
44 Teruel;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
44 Teruel;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
44 Teruel;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;90,78
44 Teruel;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
44 Teruel;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
44 Teruel;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
44 Teruel;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
44 Teruel;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
44 Teruel;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
44 Teruel;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;88,17
44 Teruel;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
44 Teruel;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
44 Teruel;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
44 Teruel;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;88,94
44 Teruel;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
44 Teruel;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
44 Teruel;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
44 Teruel;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
44 Teruel;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
44 Teruel;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
44 Teruel;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
44 Teruel;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
44 Teruel;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
44 Teruel;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QI;2.569
44 Teruel;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
44 Teruel;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
44 Teruel;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
44 Teruel;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QI;2.589
44 Teruel;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
44 Teruel;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
44 Teruel;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
44 Teruel;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QI;2.618
44 Teruel;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
44 Teruel;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
44 Teruel;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2022QII;""
44 Teruel;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2022QI;2.515
44 Teruel;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
44 Teruel;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
44 Teruel;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2021QII;""
44 Teruel;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2021QI;2.535
44 Teruel;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
44 Teruel;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
44 Teruel;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2020QII;""
44 Teruel;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2020QI;2.482
44 Teruel;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
44 Teruel;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
44 Teruel;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2022QII;2.452
44 Teruel;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2022QI;""
44 Teruel;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
44 Teruel;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
44 Teruel;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2021QII;2.496
44 Teruel;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2021QI;""
44 Teruel;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
44 Teruel;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
44 Teruel;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2020QII;2.449
44 Teruel;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2020QI;""
44 Teruel;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
44 Teruel;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QIII;2.417
44 Teruel;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QII;""
44 Teruel;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QI;""
44 Teruel;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
44 Teruel;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QIII;2.452
44 Teruel;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QII;""
44 Teruel;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QI;""
44 Teruel;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
44 Teruel;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QIII;2.400
44 Teruel;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QII;""
44 Teruel;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QI;""
44 Teruel;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QIV;2.357
44 Teruel;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
44 Teruel;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QII;""
44 Teruel;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QI;""
44 Teruel;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QIV;2.403
44 Teruel;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
44 Teruel;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QII;""
44 Teruel;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QI;""
44 Teruel;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QIV;2.358
44 Teruel;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
44 Teruel;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QII;""
44 Teruel;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QI;""
44 Teruel;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
44 Teruel;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
44 Teruel;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
44 Teruel;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
44 Teruel;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
44 Teruel;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
44 Teruel;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
44 Teruel;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
44 Teruel;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
44 Teruel;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
44 Teruel;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
44 Teruel;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
44 Teruel;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
44 Teruel;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
44 Teruel;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
44 Teruel;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;97,9
44 Teruel;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
44 Teruel;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
44 Teruel;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
44 Teruel;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;97,91
44 Teruel;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
44 Teruel;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
44 Teruel;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
44 Teruel;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;94,81
44 Teruel;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
44 Teruel;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
44 Teruel;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;95,45
44 Teruel;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
44 Teruel;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
44 Teruel;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
44 Teruel;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;96,41
44 Teruel;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
44 Teruel;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
44 Teruel;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
44 Teruel;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;93,54
44 Teruel;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
44 Teruel;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
44 Teruel;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;94,08
44 Teruel;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
44 Teruel;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
44 Teruel;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
44 Teruel;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;94,71
44 Teruel;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
44 Teruel;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
44 Teruel;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
44 Teruel;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;91,67
44 Teruel;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
44 Teruel;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
44 Teruel;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;91,75
44 Teruel;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
44 Teruel;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
44 Teruel;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
44 Teruel;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;92,82
44 Teruel;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
44 Teruel;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
44 Teruel;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
44 Teruel;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;90,07
44 Teruel;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
44 Teruel;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
44 Teruel;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
44 Teruel;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
44 Teruel;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
44 Teruel;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
44 Teruel;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QI;1.620
44 Teruel;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
44 Teruel;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
44 Teruel;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
44 Teruel;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QI;1.664
44 Teruel;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
44 Teruel;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
44 Teruel;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
44 Teruel;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QI;1.664
44 Teruel;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
44 Teruel;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
44 Teruel;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2022QII;""
44 Teruel;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2022QI;1.589
44 Teruel;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
44 Teruel;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
44 Teruel;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2021QII;""
44 Teruel;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2021QI;1.633
44 Teruel;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
44 Teruel;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
44 Teruel;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2020QII;""
44 Teruel;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2020QI;1.589
44 Teruel;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
44 Teruel;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
44 Teruel;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2022QII;1.552
44 Teruel;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2022QI;""
44 Teruel;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
44 Teruel;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
44 Teruel;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2021QII;1.613
44 Teruel;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2021QI;""
44 Teruel;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
44 Teruel;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
44 Teruel;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2020QII;1.578
44 Teruel;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2020QI;""
44 Teruel;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
44 Teruel;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QIII;1.534
44 Teruel;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QII;""
44 Teruel;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QI;""
44 Teruel;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
44 Teruel;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QIII;1.583
44 Teruel;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QII;""
44 Teruel;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QI;""
44 Teruel;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
44 Teruel;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QIII;1.550
44 Teruel;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QII;""
44 Teruel;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QI;""
44 Teruel;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QIV;1.504
44 Teruel;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
44 Teruel;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QII;""
44 Teruel;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QI;""
44 Teruel;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QIV;1.551
44 Teruel;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
44 Teruel;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QII;""
44 Teruel;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QI;""
44 Teruel;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QIV;1.530
44 Teruel;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
44 Teruel;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QII;""
44 Teruel;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QI;""
44 Teruel;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
44 Teruel;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
44 Teruel;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
44 Teruel;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
44 Teruel;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
44 Teruel;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
44 Teruel;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
44 Teruel;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
44 Teruel;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
44 Teruel;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
44 Teruel;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
44 Teruel;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
44 Teruel;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
44 Teruel;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
44 Teruel;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
44 Teruel;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;98,09
44 Teruel;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
44 Teruel;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
44 Teruel;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
44 Teruel;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;98,14
44 Teruel;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
44 Teruel;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
44 Teruel;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
44 Teruel;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;95,49
44 Teruel;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
44 Teruel;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
44 Teruel;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;95,8
44 Teruel;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
44 Teruel;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
44 Teruel;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
44 Teruel;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;96,94
44 Teruel;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
44 Teruel;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
44 Teruel;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
44 Teruel;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;94,83
44 Teruel;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
44 Teruel;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
44 Teruel;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;94,69
44 Teruel;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
44 Teruel;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
44 Teruel;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
44 Teruel;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;95,13
44 Teruel;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
44 Teruel;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
44 Teruel;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
44 Teruel;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;93,15
44 Teruel;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
44 Teruel;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
44 Teruel;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;92,84
44 Teruel;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
44 Teruel;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
44 Teruel;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
44 Teruel;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;93,21
44 Teruel;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
44 Teruel;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
44 Teruel;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
44 Teruel;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;91,95
44 Teruel;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
44 Teruel;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
44 Teruel;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
44 Teruel;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
44 Teruel;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
44 Teruel;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
44 Teruel;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QI;949
44 Teruel;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
44 Teruel;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
44 Teruel;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
44 Teruel;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QI;925
44 Teruel;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
44 Teruel;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
44 Teruel;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
44 Teruel;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QI;954
44 Teruel;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
44 Teruel;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
44 Teruel;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2022QII;""
44 Teruel;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2022QI;926
44 Teruel;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
44 Teruel;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
44 Teruel;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2021QII;""
44 Teruel;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2021QI;902
44 Teruel;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
44 Teruel;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
44 Teruel;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2020QII;""
44 Teruel;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2020QI;893
44 Teruel;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
44 Teruel;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
44 Teruel;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2022QII;900
44 Teruel;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2022QI;""
44 Teruel;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
44 Teruel;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
44 Teruel;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2021QII;883
44 Teruel;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2021QI;""
44 Teruel;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
44 Teruel;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
44 Teruel;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2020QII;871
44 Teruel;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2020QI;""
44 Teruel;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
44 Teruel;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QIII;883
44 Teruel;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QII;""
44 Teruel;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QI;""
44 Teruel;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
44 Teruel;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QIII;869
44 Teruel;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QII;""
44 Teruel;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QI;""
44 Teruel;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
44 Teruel;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QIII;850
44 Teruel;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QII;""
44 Teruel;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QI;""
44 Teruel;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QIV;853
44 Teruel;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
44 Teruel;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QII;""
44 Teruel;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QI;""
44 Teruel;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QIV;852
44 Teruel;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
44 Teruel;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QII;""
44 Teruel;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QI;""
44 Teruel;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QIV;828
44 Teruel;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
44 Teruel;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QII;""
44 Teruel;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QI;""
44 Teruel;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
44 Teruel;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
44 Teruel;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
44 Teruel;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
44 Teruel;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
44 Teruel;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
44 Teruel;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
44 Teruel;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
44 Teruel;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
44 Teruel;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
44 Teruel;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
44 Teruel;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
44 Teruel;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
44 Teruel;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
44 Teruel;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
44 Teruel;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;97,58
44 Teruel;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
44 Teruel;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
44 Teruel;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
44 Teruel;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;97,51
44 Teruel;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
44 Teruel;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
44 Teruel;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
44 Teruel;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;93,61
44 Teruel;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
44 Teruel;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
44 Teruel;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;94,84
44 Teruel;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
44 Teruel;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
44 Teruel;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
44 Teruel;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;95,46
44 Teruel;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
44 Teruel;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
44 Teruel;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
44 Teruel;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;91,3
44 Teruel;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
44 Teruel;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
44 Teruel;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;93,05
44 Teruel;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
44 Teruel;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
44 Teruel;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
44 Teruel;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;93,95
44 Teruel;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
44 Teruel;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
44 Teruel;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
44 Teruel;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;89,1
44 Teruel;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
44 Teruel;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
44 Teruel;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;89,88
44 Teruel;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
44 Teruel;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
44 Teruel;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
44 Teruel;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;92,11
44 Teruel;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
44 Teruel;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
44 Teruel;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
44 Teruel;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;86,79
44 Teruel;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
44 Teruel;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
44 Teruel;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
44 Teruel;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
44 Teruel;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
44 Teruel;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QII;2.510
44 Teruel;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
44 Teruel;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
44 Teruel;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
44 Teruel;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QII;2.514
44 Teruel;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
44 Teruel;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
44 Teruel;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
44 Teruel;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QII;2.585
44 Teruel;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
44 Teruel;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
44 Teruel;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
44 Teruel;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2022QII;2.437
44 Teruel;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2022QI;""
44 Teruel;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
44 Teruel;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
44 Teruel;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2021QII;2.466
44 Teruel;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2021QI;""
44 Teruel;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
44 Teruel;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
44 Teruel;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2020QII;2.547
44 Teruel;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2020QI;""
44 Teruel;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
44 Teruel;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2022QIII;2.402
44 Teruel;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2022QII;""
44 Teruel;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2022QI;""
44 Teruel;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
44 Teruel;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2021QIII;2.422
44 Teruel;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2021QII;""
44 Teruel;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2021QI;""
44 Teruel;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
44 Teruel;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2020QIII;2.484
44 Teruel;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2020QII;""
44 Teruel;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2020QI;""
44 Teruel;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QIV;2.338
44 Teruel;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
44 Teruel;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QII;""
44 Teruel;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QI;""
44 Teruel;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QIV;2.371
44 Teruel;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
44 Teruel;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QII;""
44 Teruel;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QI;""
44 Teruel;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QIV;2.436
44 Teruel;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
44 Teruel;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QII;""
44 Teruel;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QI;""
44 Teruel;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
44 Teruel;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
44 Teruel;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QII;""
44 Teruel;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QI;2.332
44 Teruel;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
44 Teruel;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
44 Teruel;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QII;""
44 Teruel;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QI;2.394
44 Teruel;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
44 Teruel;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
44 Teruel;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QII;""
44 Teruel;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QI;""
44 Teruel;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
44 Teruel;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
44 Teruel;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
44 Teruel;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
44 Teruel;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
44 Teruel;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
44 Teruel;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
44 Teruel;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
44 Teruel;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
44 Teruel;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
44 Teruel;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
44 Teruel;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
44 Teruel;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
44 Teruel;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
44 Teruel;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;97,09
44 Teruel;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
44 Teruel;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
44 Teruel;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
44 Teruel;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;98,09
44 Teruel;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
44 Teruel;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
44 Teruel;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
44 Teruel;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;98,53
44 Teruel;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
44 Teruel;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
44 Teruel;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;95,7
44 Teruel;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
44 Teruel;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
44 Teruel;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
44 Teruel;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;96,34
44 Teruel;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
44 Teruel;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
44 Teruel;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
44 Teruel;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;96,09
44 Teruel;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
44 Teruel;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
44 Teruel;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;93,15
44 Teruel;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
44 Teruel;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
44 Teruel;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
44 Teruel;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;94,31
44 Teruel;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
44 Teruel;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
44 Teruel;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
44 Teruel;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;94,24
44 Teruel;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
44 Teruel;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
44 Teruel;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
44 Teruel;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
44 Teruel;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
44 Teruel;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
44 Teruel;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;92,76
44 Teruel;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
44 Teruel;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
44 Teruel;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
44 Teruel;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;92,61
44 Teruel;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
44 Teruel;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
44 Teruel;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
44 Teruel;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
44 Teruel;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
44 Teruel;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
44 Teruel;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QII;1.567
44 Teruel;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
44 Teruel;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
44 Teruel;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
44 Teruel;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QII;1.599
44 Teruel;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
44 Teruel;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
44 Teruel;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
44 Teruel;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QII;1.641
44 Teruel;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
44 Teruel;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
44 Teruel;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
44 Teruel;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2022QII;1.527
44 Teruel;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2022QI;""
44 Teruel;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
44 Teruel;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
44 Teruel;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2021QII;1.573
44 Teruel;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2021QI;""
44 Teruel;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
44 Teruel;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
44 Teruel;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2020QII;1.628
44 Teruel;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2020QI;""
44 Teruel;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
44 Teruel;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2022QIII;1.508
44 Teruel;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2022QII;""
44 Teruel;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2022QI;""
44 Teruel;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
44 Teruel;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2021QIII;1.543
44 Teruel;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2021QII;""
44 Teruel;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2021QI;""
44 Teruel;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
44 Teruel;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2020QIII;1.593
44 Teruel;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2020QII;""
44 Teruel;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2020QI;""
44 Teruel;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QIV;1.478
44 Teruel;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
44 Teruel;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QII;""
44 Teruel;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QI;""
44 Teruel;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QIV;1.512
44 Teruel;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
44 Teruel;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QII;""
44 Teruel;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QI;""
44 Teruel;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QIV;1.570
44 Teruel;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
44 Teruel;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QII;""
44 Teruel;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QI;""
44 Teruel;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
44 Teruel;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
44 Teruel;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QII;""
44 Teruel;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QI;1.492
44 Teruel;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
44 Teruel;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
44 Teruel;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QII;""
44 Teruel;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QI;1.547
44 Teruel;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
44 Teruel;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
44 Teruel;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QII;""
44 Teruel;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QI;""
44 Teruel;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
44 Teruel;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
44 Teruel;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
44 Teruel;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
44 Teruel;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
44 Teruel;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
44 Teruel;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
44 Teruel;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
44 Teruel;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
44 Teruel;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
44 Teruel;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
44 Teruel;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
44 Teruel;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
44 Teruel;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
44 Teruel;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;97,45
44 Teruel;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
44 Teruel;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
44 Teruel;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
44 Teruel;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;98,37
44 Teruel;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
44 Teruel;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
44 Teruel;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
44 Teruel;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;99,21
44 Teruel;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
44 Teruel;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
44 Teruel;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;96,23
44 Teruel;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
44 Teruel;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
44 Teruel;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
44 Teruel;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;96,5
44 Teruel;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
44 Teruel;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
44 Teruel;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
44 Teruel;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;97,07
44 Teruel;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
44 Teruel;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
44 Teruel;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;94,32
44 Teruel;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
44 Teruel;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
44 Teruel;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
44 Teruel;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;94,56
44 Teruel;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
44 Teruel;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
44 Teruel;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
44 Teruel;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;95,67
44 Teruel;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
44 Teruel;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
44 Teruel;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
44 Teruel;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
44 Teruel;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
44 Teruel;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
44 Teruel;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;93,31
44 Teruel;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
44 Teruel;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
44 Teruel;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
44 Teruel;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;94,27
44 Teruel;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
44 Teruel;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
44 Teruel;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
44 Teruel;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
44 Teruel;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
44 Teruel;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
44 Teruel;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QII;943
44 Teruel;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
44 Teruel;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
44 Teruel;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
44 Teruel;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QII;915
44 Teruel;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
44 Teruel;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
44 Teruel;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
44 Teruel;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QII;944
44 Teruel;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
44 Teruel;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
44 Teruel;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
44 Teruel;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2022QII;910
44 Teruel;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2022QI;""
44 Teruel;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
44 Teruel;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
44 Teruel;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2021QII;893
44 Teruel;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2021QI;""
44 Teruel;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
44 Teruel;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
44 Teruel;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2020QII;919
44 Teruel;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2020QI;""
44 Teruel;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
44 Teruel;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2022QIII;894
44 Teruel;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2022QII;""
44 Teruel;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2022QI;""
44 Teruel;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
44 Teruel;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2021QIII;879
44 Teruel;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2021QII;""
44 Teruel;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2021QI;""
44 Teruel;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
44 Teruel;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2020QIII;891
44 Teruel;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2020QII;""
44 Teruel;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2020QI;""
44 Teruel;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QIV;860
44 Teruel;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
44 Teruel;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QII;""
44 Teruel;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QI;""
44 Teruel;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QIV;859
44 Teruel;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
44 Teruel;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QII;""
44 Teruel;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QI;""
44 Teruel;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QIV;866
44 Teruel;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
44 Teruel;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QII;""
44 Teruel;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QI;""
44 Teruel;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
44 Teruel;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
44 Teruel;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QII;""
44 Teruel;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QI;840
44 Teruel;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
44 Teruel;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
44 Teruel;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QII;""
44 Teruel;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QI;847
44 Teruel;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
44 Teruel;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
44 Teruel;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QII;""
44 Teruel;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QI;""
44 Teruel;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
44 Teruel;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
44 Teruel;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
44 Teruel;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
44 Teruel;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
44 Teruel;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
44 Teruel;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
44 Teruel;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
44 Teruel;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
44 Teruel;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
44 Teruel;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
44 Teruel;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
44 Teruel;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
44 Teruel;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
44 Teruel;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;96,5
44 Teruel;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
44 Teruel;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
44 Teruel;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
44 Teruel;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;97,6
44 Teruel;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
44 Teruel;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
44 Teruel;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
44 Teruel;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;97,35
44 Teruel;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
44 Teruel;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
44 Teruel;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;94,8
44 Teruel;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
44 Teruel;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
44 Teruel;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
44 Teruel;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;96,07
44 Teruel;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
44 Teruel;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
44 Teruel;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
44 Teruel;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;94,39
44 Teruel;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
44 Teruel;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
44 Teruel;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;91,2
44 Teruel;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
44 Teruel;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
44 Teruel;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
44 Teruel;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;93,88
44 Teruel;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
44 Teruel;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
44 Teruel;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
44 Teruel;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;91,74
44 Teruel;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
44 Teruel;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
44 Teruel;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
44 Teruel;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
44 Teruel;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
44 Teruel;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
44 Teruel;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;91,8
44 Teruel;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
44 Teruel;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
44 Teruel;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
44 Teruel;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;89,72
44 Teruel;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
44 Teruel;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
44 Teruel;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
44 Teruel;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
44 Teruel;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
44 Teruel;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QIII;2.515
44 Teruel;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
44 Teruel;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
44 Teruel;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
44 Teruel;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QIII;2.557
44 Teruel;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
44 Teruel;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
44 Teruel;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
44 Teruel;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QIII;2.606
44 Teruel;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
44 Teruel;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
44 Teruel;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
44 Teruel;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2022QIII;2.469
44 Teruel;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2022QII;""
44 Teruel;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2022QI;""
44 Teruel;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
44 Teruel;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2021QIII;2.502
44 Teruel;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2021QII;""
44 Teruel;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2021QI;""
44 Teruel;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
44 Teruel;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2020QIII;2.535
44 Teruel;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2020QII;""
44 Teruel;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2020QI;""
44 Teruel;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2022QIV;2.396
44 Teruel;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
44 Teruel;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2022QII;""
44 Teruel;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2022QI;""
44 Teruel;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2021QIV;2.444
44 Teruel;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
44 Teruel;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2021QII;""
44 Teruel;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2021QI;""
44 Teruel;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2020QIV;2.481
44 Teruel;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
44 Teruel;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2020QII;""
44 Teruel;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2020QI;""
44 Teruel;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
44 Teruel;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
44 Teruel;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QII;""
44 Teruel;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QI;2.400
44 Teruel;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
44 Teruel;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
44 Teruel;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QII;""
44 Teruel;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QI;2.438
44 Teruel;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
44 Teruel;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
44 Teruel;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QII;""
44 Teruel;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QI;""
44 Teruel;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
44 Teruel;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
44 Teruel;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QII;2.345
44 Teruel;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QI;""
44 Teruel;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
44 Teruel;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
44 Teruel;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QII;2.405
44 Teruel;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QI;""
44 Teruel;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
44 Teruel;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
44 Teruel;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QII;""
44 Teruel;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QI;""
44 Teruel;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
44 Teruel;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
44 Teruel;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
44 Teruel;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
44 Teruel;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
44 Teruel;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
44 Teruel;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
44 Teruel;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
44 Teruel;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
44 Teruel;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
44 Teruel;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
44 Teruel;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
44 Teruel;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
44 Teruel;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;98,17
44 Teruel;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
44 Teruel;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
44 Teruel;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
44 Teruel;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;97,85
44 Teruel;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
44 Teruel;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
44 Teruel;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
44 Teruel;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;97,28
44 Teruel;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
44 Teruel;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
44 Teruel;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;95,27
44 Teruel;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
44 Teruel;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
44 Teruel;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
44 Teruel;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;95,58
44 Teruel;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
44 Teruel;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
44 Teruel;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
44 Teruel;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;95,2
44 Teruel;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
44 Teruel;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
44 Teruel;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
44 Teruel;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
44 Teruel;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
44 Teruel;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
44 Teruel;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;93,86
44 Teruel;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
44 Teruel;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
44 Teruel;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
44 Teruel;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;93,55
44 Teruel;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
44 Teruel;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
44 Teruel;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
44 Teruel;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
44 Teruel;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
44 Teruel;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
44 Teruel;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;91,71
44 Teruel;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
44 Teruel;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
44 Teruel;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
44 Teruel;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;92,29
44 Teruel;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
44 Teruel;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
44 Teruel;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
44 Teruel;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
44 Teruel;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
44 Teruel;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
44 Teruel;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QIII;1.570
44 Teruel;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
44 Teruel;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
44 Teruel;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
44 Teruel;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QIII;1.619
44 Teruel;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
44 Teruel;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
44 Teruel;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
44 Teruel;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QIII;1.665
44 Teruel;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
44 Teruel;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
44 Teruel;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
44 Teruel;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2022QIII;1.545
44 Teruel;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2022QII;""
44 Teruel;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2022QI;""
44 Teruel;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
44 Teruel;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2021QIII;1.586
44 Teruel;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2021QII;""
44 Teruel;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2021QI;""
44 Teruel;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
44 Teruel;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2020QIII;1.628
44 Teruel;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2020QII;""
44 Teruel;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2020QI;""
44 Teruel;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2022QIV;1.510
44 Teruel;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
44 Teruel;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2022QII;""
44 Teruel;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2022QI;""
44 Teruel;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2021QIV;1.553
44 Teruel;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
44 Teruel;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2021QII;""
44 Teruel;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2021QI;""
44 Teruel;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2020QIV;1.600
44 Teruel;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
44 Teruel;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2020QII;""
44 Teruel;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2020QI;""
44 Teruel;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
44 Teruel;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
44 Teruel;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QII;""
44 Teruel;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QI;1.529
44 Teruel;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
44 Teruel;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
44 Teruel;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QII;""
44 Teruel;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QI;1.576
44 Teruel;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
44 Teruel;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
44 Teruel;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QII;""
44 Teruel;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QI;""
44 Teruel;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
44 Teruel;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
44 Teruel;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QII;1.496
44 Teruel;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QI;""
44 Teruel;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
44 Teruel;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
44 Teruel;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QII;1.560
44 Teruel;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QI;""
44 Teruel;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
44 Teruel;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
44 Teruel;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QII;""
44 Teruel;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QI;""
44 Teruel;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
44 Teruel;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
44 Teruel;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
44 Teruel;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
44 Teruel;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
44 Teruel;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
44 Teruel;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
44 Teruel;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
44 Teruel;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
44 Teruel;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
44 Teruel;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
44 Teruel;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
44 Teruel;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
44 Teruel;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;98,41
44 Teruel;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
44 Teruel;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
44 Teruel;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
44 Teruel;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;97,96
44 Teruel;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
44 Teruel;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
44 Teruel;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
44 Teruel;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;97,78
44 Teruel;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
44 Teruel;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
44 Teruel;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;96,18
44 Teruel;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
44 Teruel;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
44 Teruel;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
44 Teruel;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;95,92
44 Teruel;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
44 Teruel;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
44 Teruel;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
44 Teruel;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;96,1
44 Teruel;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
44 Teruel;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
44 Teruel;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
44 Teruel;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
44 Teruel;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
44 Teruel;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
44 Teruel;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;94,44
44 Teruel;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
44 Teruel;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
44 Teruel;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
44 Teruel;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;94,65
44 Teruel;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
44 Teruel;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
44 Teruel;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
44 Teruel;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
44 Teruel;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
44 Teruel;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
44 Teruel;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;92,4
44 Teruel;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
44 Teruel;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
44 Teruel;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
44 Teruel;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;93,69
44 Teruel;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
44 Teruel;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
44 Teruel;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
44 Teruel;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
44 Teruel;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
44 Teruel;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
44 Teruel;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QIII;945
44 Teruel;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
44 Teruel;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
44 Teruel;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
44 Teruel;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QIII;938
44 Teruel;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
44 Teruel;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
44 Teruel;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
44 Teruel;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QIII;941
44 Teruel;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
44 Teruel;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
44 Teruel;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
44 Teruel;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2022QIII;924
44 Teruel;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2022QII;""
44 Teruel;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2022QI;""
44 Teruel;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
44 Teruel;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2021QIII;916
44 Teruel;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2021QII;""
44 Teruel;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2021QI;""
44 Teruel;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
44 Teruel;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2020QIII;907
44 Teruel;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2020QII;""
44 Teruel;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2020QI;""
44 Teruel;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2022QIV;886
44 Teruel;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
44 Teruel;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2022QII;""
44 Teruel;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2022QI;""
44 Teruel;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2021QIV;891
44 Teruel;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
44 Teruel;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2021QII;""
44 Teruel;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2021QI;""
44 Teruel;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2020QIV;881
44 Teruel;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
44 Teruel;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2020QII;""
44 Teruel;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2020QI;""
44 Teruel;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
44 Teruel;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
44 Teruel;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QII;""
44 Teruel;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QI;871
44 Teruel;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
44 Teruel;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
44 Teruel;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QII;""
44 Teruel;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QI;862
44 Teruel;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
44 Teruel;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
44 Teruel;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QII;""
44 Teruel;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QI;""
44 Teruel;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
44 Teruel;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
44 Teruel;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QII;849
44 Teruel;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QI;""
44 Teruel;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
44 Teruel;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
44 Teruel;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QII;845
44 Teruel;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QI;""
44 Teruel;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
44 Teruel;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
44 Teruel;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QII;""
44 Teruel;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QI;""
44 Teruel;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
44 Teruel;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
44 Teruel;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
44 Teruel;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
44 Teruel;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
44 Teruel;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
44 Teruel;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
44 Teruel;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
44 Teruel;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
44 Teruel;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
44 Teruel;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
44 Teruel;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
44 Teruel;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
44 Teruel;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;97,78
44 Teruel;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
44 Teruel;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
44 Teruel;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
44 Teruel;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;97,65
44 Teruel;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
44 Teruel;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
44 Teruel;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
44 Teruel;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;96,39
44 Teruel;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
44 Teruel;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
44 Teruel;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;93,76
44 Teruel;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
44 Teruel;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
44 Teruel;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
44 Teruel;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;94,99
44 Teruel;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
44 Teruel;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
44 Teruel;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
44 Teruel;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;93,62
44 Teruel;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
44 Teruel;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
44 Teruel;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
44 Teruel;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
44 Teruel;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
44 Teruel;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
44 Teruel;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;92,86
44 Teruel;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
44 Teruel;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
44 Teruel;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
44 Teruel;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;91,6
44 Teruel;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
44 Teruel;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
44 Teruel;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
44 Teruel;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
44 Teruel;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
44 Teruel;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
44 Teruel;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;90,51
44 Teruel;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
44 Teruel;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
44 Teruel;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
44 Teruel;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;89,8
44 Teruel;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
44 Teruel;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
44 Teruel;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
44 Teruel;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
44 Teruel;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
44 Teruel;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QIV;2.519
44 Teruel;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
44 Teruel;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
44 Teruel;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
44 Teruel;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QIV;2.567
44 Teruel;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
44 Teruel;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
44 Teruel;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
44 Teruel;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QIV;2.590
44 Teruel;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
44 Teruel;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
44 Teruel;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
44 Teruel;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2022QIV;2.435
44 Teruel;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
44 Teruel;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2022QII;""
44 Teruel;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2022QI;""
44 Teruel;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2021QIV;2.501
44 Teruel;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
44 Teruel;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2021QII;""
44 Teruel;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2021QI;""
44 Teruel;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2020QIV;2.523
44 Teruel;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
44 Teruel;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2020QII;""
44 Teruel;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2020QI;""
44 Teruel;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
44 Teruel;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
44 Teruel;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2022QII;""
44 Teruel;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2022QI;2.455
44 Teruel;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
44 Teruel;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
44 Teruel;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2021QII;""
44 Teruel;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2021QI;2.476
44 Teruel;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
44 Teruel;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
44 Teruel;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2020QII;""
44 Teruel;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2020QI;""
44 Teruel;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
44 Teruel;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
44 Teruel;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QII;2.397
44 Teruel;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QI;""
44 Teruel;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
44 Teruel;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
44 Teruel;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QII;2.440
44 Teruel;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QI;""
44 Teruel;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
44 Teruel;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
44 Teruel;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QII;""
44 Teruel;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QI;""
44 Teruel;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
44 Teruel;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QIII;2.363
44 Teruel;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QII;""
44 Teruel;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QI;""
44 Teruel;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
44 Teruel;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QIII;2.405
44 Teruel;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QII;""
44 Teruel;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QI;""
44 Teruel;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
44 Teruel;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
44 Teruel;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QII;""
44 Teruel;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QI;""
44 Teruel;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
44 Teruel;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
44 Teruel;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
44 Teruel;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
44 Teruel;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
44 Teruel;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
44 Teruel;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
44 Teruel;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
44 Teruel;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
44 Teruel;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
44 Teruel;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
44 Teruel;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
44 Teruel;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;96,67
44 Teruel;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
44 Teruel;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
44 Teruel;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
44 Teruel;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;97,43
44 Teruel;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
44 Teruel;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
44 Teruel;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
44 Teruel;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;97,41
44 Teruel;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
44 Teruel;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
44 Teruel;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
44 Teruel;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
44 Teruel;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
44 Teruel;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
44 Teruel;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;95,64
44 Teruel;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
44 Teruel;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
44 Teruel;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
44 Teruel;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;95,6
44 Teruel;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
44 Teruel;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
44 Teruel;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
44 Teruel;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
44 Teruel;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
44 Teruel;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
44 Teruel;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;93,38
44 Teruel;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
44 Teruel;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
44 Teruel;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
44 Teruel;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;94,21
44 Teruel;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
44 Teruel;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
44 Teruel;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
44 Teruel;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
44 Teruel;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
44 Teruel;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
44 Teruel;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;92,05
44 Teruel;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
44 Teruel;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
44 Teruel;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
44 Teruel;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;92,86
44 Teruel;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
44 Teruel;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
44 Teruel;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
44 Teruel;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
44 Teruel;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
44 Teruel;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
44 Teruel;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QIV;1.572
44 Teruel;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
44 Teruel;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
44 Teruel;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
44 Teruel;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QIV;1.620
44 Teruel;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
44 Teruel;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
44 Teruel;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
44 Teruel;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QIV;1.657
44 Teruel;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
44 Teruel;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
44 Teruel;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
44 Teruel;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2022QIV;1.530
44 Teruel;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
44 Teruel;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2022QII;""
44 Teruel;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2022QI;""
44 Teruel;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2021QIV;1.583
44 Teruel;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
44 Teruel;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2021QII;""
44 Teruel;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2021QI;""
44 Teruel;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2020QIV;1.622
44 Teruel;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
44 Teruel;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2020QII;""
44 Teruel;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2020QI;""
44 Teruel;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
44 Teruel;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
44 Teruel;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2022QII;""
44 Teruel;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2022QI;1.557
44 Teruel;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
44 Teruel;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
44 Teruel;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2021QII;""
44 Teruel;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2021QI;1.595
44 Teruel;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
44 Teruel;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
44 Teruel;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2020QII;""
44 Teruel;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2020QI;""
44 Teruel;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
44 Teruel;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
44 Teruel;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QII;1.523
44 Teruel;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QI;""
44 Teruel;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
44 Teruel;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
44 Teruel;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QII;1.576
44 Teruel;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QI;""
44 Teruel;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
44 Teruel;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
44 Teruel;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QII;""
44 Teruel;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QI;""
44 Teruel;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
44 Teruel;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QIII;1.505
44 Teruel;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QII;""
44 Teruel;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QI;""
44 Teruel;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
44 Teruel;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QIII;1.552
44 Teruel;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QII;""
44 Teruel;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QI;""
44 Teruel;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
44 Teruel;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
44 Teruel;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QII;""
44 Teruel;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QI;""
44 Teruel;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
44 Teruel;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
44 Teruel;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
44 Teruel;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
44 Teruel;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
44 Teruel;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
44 Teruel;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
44 Teruel;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
44 Teruel;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
44 Teruel;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
44 Teruel;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
44 Teruel;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
44 Teruel;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;97,33
44 Teruel;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
44 Teruel;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
44 Teruel;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
44 Teruel;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;97,72
44 Teruel;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
44 Teruel;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
44 Teruel;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
44 Teruel;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;97,89
44 Teruel;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
44 Teruel;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
44 Teruel;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
44 Teruel;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
44 Teruel;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
44 Teruel;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
44 Teruel;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;96,11
44 Teruel;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
44 Teruel;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
44 Teruel;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
44 Teruel;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;96,26
44 Teruel;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
44 Teruel;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
44 Teruel;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
44 Teruel;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
44 Teruel;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
44 Teruel;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
44 Teruel;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;94,01
44 Teruel;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
44 Teruel;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
44 Teruel;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
44 Teruel;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;95,11
44 Teruel;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
44 Teruel;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
44 Teruel;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
44 Teruel;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
44 Teruel;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
44 Teruel;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
44 Teruel;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;92,9
44 Teruel;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
44 Teruel;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
44 Teruel;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
44 Teruel;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;93,66
44 Teruel;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
44 Teruel;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
44 Teruel;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
44 Teruel;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
44 Teruel;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
44 Teruel;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
44 Teruel;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QIV;947
44 Teruel;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
44 Teruel;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
44 Teruel;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
44 Teruel;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QIV;947
44 Teruel;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
44 Teruel;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
44 Teruel;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
44 Teruel;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QIV;933
44 Teruel;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
44 Teruel;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
44 Teruel;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
44 Teruel;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2022QIV;905
44 Teruel;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
44 Teruel;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2022QII;""
44 Teruel;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2022QI;""
44 Teruel;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2021QIV;918
44 Teruel;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
44 Teruel;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2021QII;""
44 Teruel;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2021QI;""
44 Teruel;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2020QIV;901
44 Teruel;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
44 Teruel;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2020QII;""
44 Teruel;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2020QI;""
44 Teruel;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
44 Teruel;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
44 Teruel;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2022QII;""
44 Teruel;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2022QI;898
44 Teruel;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
44 Teruel;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
44 Teruel;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2021QII;""
44 Teruel;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2021QI;881
44 Teruel;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
44 Teruel;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
44 Teruel;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2020QII;""
44 Teruel;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2020QI;""
44 Teruel;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
44 Teruel;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
44 Teruel;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QII;874
44 Teruel;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QI;""
44 Teruel;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
44 Teruel;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
44 Teruel;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QII;864
44 Teruel;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QI;""
44 Teruel;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
44 Teruel;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
44 Teruel;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QII;""
44 Teruel;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QI;""
44 Teruel;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
44 Teruel;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QIII;858
44 Teruel;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QII;""
44 Teruel;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QI;""
44 Teruel;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
44 Teruel;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QIII;853
44 Teruel;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QII;""
44 Teruel;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QI;""
44 Teruel;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
44 Teruel;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
44 Teruel;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QII;""
44 Teruel;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QI;""
44 Teruel;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
44 Teruel;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
44 Teruel;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
44 Teruel;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
44 Teruel;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
44 Teruel;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
44 Teruel;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
44 Teruel;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
44 Teruel;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
44 Teruel;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
44 Teruel;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
44 Teruel;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
44 Teruel;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;95,56
44 Teruel;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
44 Teruel;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
44 Teruel;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
44 Teruel;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;96,94
44 Teruel;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
44 Teruel;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
44 Teruel;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
44 Teruel;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;96,57
44 Teruel;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
44 Teruel;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
44 Teruel;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
44 Teruel;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
44 Teruel;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
44 Teruel;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
44 Teruel;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;94,83
44 Teruel;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
44 Teruel;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
44 Teruel;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
44 Teruel;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;94,43
44 Teruel;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
44 Teruel;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
44 Teruel;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
44 Teruel;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
44 Teruel;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
44 Teruel;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
44 Teruel;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;92,29
44 Teruel;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
44 Teruel;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
44 Teruel;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
44 Teruel;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;92,6
44 Teruel;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
44 Teruel;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
44 Teruel;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
44 Teruel;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
44 Teruel;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
44 Teruel;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
44 Teruel;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;90,6
44 Teruel;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
44 Teruel;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
44 Teruel;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
44 Teruel;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;91,43
44 Teruel;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
44 Teruel;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
44 Teruel;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
44 Teruel;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
44 Teruel;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
44 Teruel;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
44 Teruel;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
44 Teruel;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
44 Teruel;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
44 Teruel;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QI;2.899
44 Teruel;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
44 Teruel;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
44 Teruel;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
44 Teruel;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QI;2.891
44 Teruel;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
44 Teruel;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
44 Teruel;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
44 Teruel;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QI;2.977
44 Teruel;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
44 Teruel;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
44 Teruel;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2022QII;""
44 Teruel;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2022QI;2.841
44 Teruel;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
44 Teruel;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
44 Teruel;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2021QII;""
44 Teruel;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2021QI;2.862
44 Teruel;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
44 Teruel;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
44 Teruel;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2020QII;""
44 Teruel;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2020QI;2.876
44 Teruel;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
44 Teruel;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
44 Teruel;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2022QII;2.792
44 Teruel;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2022QI;""
44 Teruel;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
44 Teruel;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
44 Teruel;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2021QII;2.818
44 Teruel;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2021QI;""
44 Teruel;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
44 Teruel;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
44 Teruel;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2020QII;2.842
44 Teruel;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2020QI;""
44 Teruel;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
44 Teruel;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QIII;2.758
44 Teruel;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QII;""
44 Teruel;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QI;""
44 Teruel;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
44 Teruel;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QIII;2.793
44 Teruel;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QII;""
44 Teruel;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QI;""
44 Teruel;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
44 Teruel;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QIII;2.805
44 Teruel;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QII;""
44 Teruel;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QI;""
44 Teruel;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QIV;2.701
44 Teruel;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
44 Teruel;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QII;""
44 Teruel;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QI;""
44 Teruel;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QIV;2.754
44 Teruel;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
44 Teruel;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QII;""
44 Teruel;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QI;""
44 Teruel;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QIV;2.764
44 Teruel;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
44 Teruel;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QII;""
44 Teruel;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QI;""
44 Teruel;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
44 Teruel;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
44 Teruel;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
44 Teruel;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
44 Teruel;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
44 Teruel;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
44 Teruel;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
44 Teruel;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
44 Teruel;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
44 Teruel;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
44 Teruel;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
44 Teruel;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
44 Teruel;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
44 Teruel;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
44 Teruel;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
44 Teruel;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;98
44 Teruel;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
44 Teruel;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
44 Teruel;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
44 Teruel;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;99
44 Teruel;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
44 Teruel;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
44 Teruel;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
44 Teruel;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;96,61
44 Teruel;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
44 Teruel;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
44 Teruel;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;96,31
44 Teruel;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
44 Teruel;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
44 Teruel;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
44 Teruel;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;97,47
44 Teruel;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
44 Teruel;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
44 Teruel;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
44 Teruel;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;95,47
44 Teruel;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
44 Teruel;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
44 Teruel;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;95,14
44 Teruel;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
44 Teruel;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
44 Teruel;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
44 Teruel;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;96,61
44 Teruel;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
44 Teruel;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
44 Teruel;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
44 Teruel;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;94,22
44 Teruel;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
44 Teruel;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
44 Teruel;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;93,17
44 Teruel;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
44 Teruel;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
44 Teruel;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
44 Teruel;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;95,26
44 Teruel;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
44 Teruel;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
44 Teruel;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
44 Teruel;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;92,85
44 Teruel;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
44 Teruel;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
44 Teruel;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
44 Teruel;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
44 Teruel;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
44 Teruel;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
44 Teruel;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QI;1.813
44 Teruel;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
44 Teruel;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
44 Teruel;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
44 Teruel;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QI;1.813
44 Teruel;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
44 Teruel;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
44 Teruel;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
44 Teruel;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QI;1.871
44 Teruel;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
44 Teruel;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
44 Teruel;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2022QII;""
44 Teruel;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2022QI;1.777
44 Teruel;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
44 Teruel;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
44 Teruel;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2021QII;""
44 Teruel;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2021QI;1.796
44 Teruel;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
44 Teruel;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
44 Teruel;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2020QII;""
44 Teruel;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2020QI;1.809
44 Teruel;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
44 Teruel;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
44 Teruel;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2022QII;1.756
44 Teruel;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2022QI;""
44 Teruel;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
44 Teruel;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
44 Teruel;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2021QII;1.779
44 Teruel;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2021QI;""
44 Teruel;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
44 Teruel;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
44 Teruel;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2020QII;1.789
44 Teruel;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2020QI;""
44 Teruel;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
44 Teruel;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QIII;1.735
44 Teruel;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QII;""
44 Teruel;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QI;""
44 Teruel;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
44 Teruel;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QIII;1.763
44 Teruel;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QII;""
44 Teruel;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QI;""
44 Teruel;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
44 Teruel;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QIII;1.770
44 Teruel;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QII;""
44 Teruel;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QI;""
44 Teruel;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QIV;1.703
44 Teruel;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
44 Teruel;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QII;""
44 Teruel;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QI;""
44 Teruel;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QIV;1.744
44 Teruel;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
44 Teruel;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QII;""
44 Teruel;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QI;""
44 Teruel;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QIV;1.746
44 Teruel;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
44 Teruel;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QII;""
44 Teruel;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QI;""
44 Teruel;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
44 Teruel;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
44 Teruel;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
44 Teruel;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
44 Teruel;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
44 Teruel;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
44 Teruel;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
44 Teruel;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
44 Teruel;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
44 Teruel;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
44 Teruel;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
44 Teruel;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
44 Teruel;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
44 Teruel;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
44 Teruel;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
44 Teruel;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;98,01
44 Teruel;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
44 Teruel;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
44 Teruel;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
44 Teruel;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;99,06
44 Teruel;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
44 Teruel;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
44 Teruel;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
44 Teruel;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;96,69
44 Teruel;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
44 Teruel;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
44 Teruel;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;96,86
44 Teruel;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
44 Teruel;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
44 Teruel;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
44 Teruel;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;98,12
44 Teruel;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
44 Teruel;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
44 Teruel;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
44 Teruel;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;95,62
44 Teruel;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
44 Teruel;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
44 Teruel;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;95,7
44 Teruel;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
44 Teruel;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
44 Teruel;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
44 Teruel;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;97,24
44 Teruel;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
44 Teruel;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
44 Teruel;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
44 Teruel;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;94,6
44 Teruel;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
44 Teruel;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
44 Teruel;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;93,93
44 Teruel;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
44 Teruel;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
44 Teruel;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
44 Teruel;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;96,19
44 Teruel;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
44 Teruel;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
44 Teruel;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
44 Teruel;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;93,32
44 Teruel;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
44 Teruel;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
44 Teruel;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
44 Teruel;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
44 Teruel;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
44 Teruel;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
44 Teruel;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QI;1.086
44 Teruel;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
44 Teruel;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
44 Teruel;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
44 Teruel;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QI;1.078
44 Teruel;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
44 Teruel;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
44 Teruel;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
44 Teruel;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QI;1.106
44 Teruel;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
44 Teruel;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
44 Teruel;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2022QII;""
44 Teruel;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2022QI;1.064
44 Teruel;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
44 Teruel;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
44 Teruel;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2021QII;""
44 Teruel;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2021QI;1.066
44 Teruel;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
44 Teruel;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
44 Teruel;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2020QII;""
44 Teruel;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2020QI;1.067
44 Teruel;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
44 Teruel;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
44 Teruel;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2022QII;1.036
44 Teruel;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2022QI;""
44 Teruel;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
44 Teruel;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
44 Teruel;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2021QII;1.039
44 Teruel;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2021QI;""
44 Teruel;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
44 Teruel;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
44 Teruel;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2020QII;1.053
44 Teruel;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2020QI;""
44 Teruel;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
44 Teruel;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QIII;1.023
44 Teruel;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QII;""
44 Teruel;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QI;""
44 Teruel;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
44 Teruel;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QIII;1.030
44 Teruel;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QII;""
44 Teruel;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QI;""
44 Teruel;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
44 Teruel;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QIII;1.035
44 Teruel;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QII;""
44 Teruel;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QI;""
44 Teruel;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QIV;998
44 Teruel;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
44 Teruel;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QII;""
44 Teruel;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QI;""
44 Teruel;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QIV;1.010
44 Teruel;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
44 Teruel;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QII;""
44 Teruel;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QI;""
44 Teruel;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QIV;1.018
44 Teruel;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
44 Teruel;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QII;""
44 Teruel;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QI;""
44 Teruel;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
44 Teruel;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
44 Teruel;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
44 Teruel;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
44 Teruel;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
44 Teruel;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
44 Teruel;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
44 Teruel;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
44 Teruel;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
44 Teruel;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
44 Teruel;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
44 Teruel;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
44 Teruel;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
44 Teruel;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
44 Teruel;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
44 Teruel;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;97,97
44 Teruel;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
44 Teruel;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
44 Teruel;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
44 Teruel;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;98,89
44 Teruel;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
44 Teruel;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
44 Teruel;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
44 Teruel;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;96,47
44 Teruel;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
44 Teruel;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
44 Teruel;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;95,4
44 Teruel;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
44 Teruel;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
44 Teruel;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
44 Teruel;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;96,38
44 Teruel;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
44 Teruel;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
44 Teruel;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
44 Teruel;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;95,21
44 Teruel;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
44 Teruel;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
44 Teruel;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;94,2
44 Teruel;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
44 Teruel;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
44 Teruel;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
44 Teruel;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;95,55
44 Teruel;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
44 Teruel;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
44 Teruel;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
44 Teruel;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;93,58
44 Teruel;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
44 Teruel;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
44 Teruel;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;91,9
44 Teruel;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
44 Teruel;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
44 Teruel;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
44 Teruel;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;93,69
44 Teruel;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
44 Teruel;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
44 Teruel;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
44 Teruel;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;92,04
44 Teruel;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
44 Teruel;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
44 Teruel;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
44 Teruel;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
44 Teruel;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
44 Teruel;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QII;2.903
44 Teruel;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
44 Teruel;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
44 Teruel;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
44 Teruel;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QII;2.909
44 Teruel;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
44 Teruel;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
44 Teruel;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
44 Teruel;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QII;2.923
44 Teruel;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
44 Teruel;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
44 Teruel;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
44 Teruel;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2022QII;2.847
44 Teruel;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2022QI;""
44 Teruel;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
44 Teruel;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
44 Teruel;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2021QII;2.863
44 Teruel;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2021QI;""
44 Teruel;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
44 Teruel;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
44 Teruel;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2020QII;2.886
44 Teruel;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2020QI;""
44 Teruel;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
44 Teruel;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2022QIII;2.806
44 Teruel;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2022QII;""
44 Teruel;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2022QI;""
44 Teruel;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
44 Teruel;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2021QIII;2.834
44 Teruel;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2021QII;""
44 Teruel;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2021QI;""
44 Teruel;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
44 Teruel;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2020QIII;2.844
44 Teruel;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2020QII;""
44 Teruel;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2020QI;""
44 Teruel;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QIV;2.747
44 Teruel;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
44 Teruel;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QII;""
44 Teruel;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QI;""
44 Teruel;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QIV;2.791
44 Teruel;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
44 Teruel;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QII;""
44 Teruel;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QI;""
44 Teruel;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QIV;2.795
44 Teruel;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
44 Teruel;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QII;""
44 Teruel;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QI;""
44 Teruel;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
44 Teruel;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
44 Teruel;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QII;""
44 Teruel;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QI;2.746
44 Teruel;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
44 Teruel;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
44 Teruel;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QII;""
44 Teruel;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QI;2.770
44 Teruel;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
44 Teruel;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
44 Teruel;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QII;""
44 Teruel;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QI;""
44 Teruel;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
44 Teruel;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
44 Teruel;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
44 Teruel;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
44 Teruel;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
44 Teruel;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
44 Teruel;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
44 Teruel;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
44 Teruel;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
44 Teruel;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
44 Teruel;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
44 Teruel;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
44 Teruel;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
44 Teruel;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
44 Teruel;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;98,07
44 Teruel;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
44 Teruel;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
44 Teruel;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
44 Teruel;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;98,42
44 Teruel;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
44 Teruel;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
44 Teruel;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
44 Teruel;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;98,73
44 Teruel;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
44 Teruel;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
44 Teruel;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;96,66
44 Teruel;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
44 Teruel;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
44 Teruel;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
44 Teruel;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;97,42
44 Teruel;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
44 Teruel;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
44 Teruel;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
44 Teruel;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;97,3
44 Teruel;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
44 Teruel;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
44 Teruel;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;94,63
44 Teruel;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
44 Teruel;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
44 Teruel;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
44 Teruel;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;95,94
44 Teruel;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
44 Teruel;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
44 Teruel;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
44 Teruel;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;95,62
44 Teruel;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
44 Teruel;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
44 Teruel;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
44 Teruel;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
44 Teruel;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
44 Teruel;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
44 Teruel;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;94,4
44 Teruel;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
44 Teruel;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
44 Teruel;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
44 Teruel;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;94,77
44 Teruel;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
44 Teruel;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
44 Teruel;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
44 Teruel;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
44 Teruel;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
44 Teruel;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
44 Teruel;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QII;1.817
44 Teruel;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
44 Teruel;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
44 Teruel;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
44 Teruel;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QII;1.826
44 Teruel;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
44 Teruel;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
44 Teruel;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
44 Teruel;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QII;1.833
44 Teruel;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
44 Teruel;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
44 Teruel;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
44 Teruel;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2022QII;1.794
44 Teruel;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2022QI;""
44 Teruel;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
44 Teruel;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
44 Teruel;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2021QII;1.807
44 Teruel;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2021QI;""
44 Teruel;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
44 Teruel;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
44 Teruel;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2020QII;1.811
44 Teruel;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2020QI;""
44 Teruel;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
44 Teruel;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2022QIII;1.772
44 Teruel;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2022QII;""
44 Teruel;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2022QI;""
44 Teruel;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
44 Teruel;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2021QIII;1.787
44 Teruel;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2021QII;""
44 Teruel;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2021QI;""
44 Teruel;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
44 Teruel;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2020QIII;1.789
44 Teruel;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2020QII;""
44 Teruel;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2020QI;""
44 Teruel;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QIV;1.739
44 Teruel;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
44 Teruel;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QII;""
44 Teruel;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QI;""
44 Teruel;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QIV;1.765
44 Teruel;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
44 Teruel;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QII;""
44 Teruel;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QI;""
44 Teruel;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QIV;1.762
44 Teruel;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
44 Teruel;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QII;""
44 Teruel;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QI;""
44 Teruel;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
44 Teruel;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
44 Teruel;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QII;""
44 Teruel;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QI;1.739
44 Teruel;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
44 Teruel;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
44 Teruel;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QII;""
44 Teruel;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QI;1.747
44 Teruel;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
44 Teruel;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
44 Teruel;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QII;""
44 Teruel;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QI;""
44 Teruel;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
44 Teruel;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
44 Teruel;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
44 Teruel;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
44 Teruel;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
44 Teruel;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
44 Teruel;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
44 Teruel;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
44 Teruel;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
44 Teruel;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
44 Teruel;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
44 Teruel;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
44 Teruel;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
44 Teruel;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
44 Teruel;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;98,73
44 Teruel;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
44 Teruel;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
44 Teruel;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
44 Teruel;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;98,96
44 Teruel;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
44 Teruel;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
44 Teruel;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
44 Teruel;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;98,8
44 Teruel;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
44 Teruel;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
44 Teruel;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;97,52
44 Teruel;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
44 Teruel;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
44 Teruel;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
44 Teruel;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;97,86
44 Teruel;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
44 Teruel;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
44 Teruel;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
44 Teruel;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;97,6
44 Teruel;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
44 Teruel;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
44 Teruel;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;95,71
44 Teruel;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
44 Teruel;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
44 Teruel;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
44 Teruel;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;96,66
44 Teruel;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
44 Teruel;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
44 Teruel;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
44 Teruel;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;96,13
44 Teruel;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
44 Teruel;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
44 Teruel;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
44 Teruel;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
44 Teruel;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
44 Teruel;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
44 Teruel;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;95,24
44 Teruel;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
44 Teruel;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
44 Teruel;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
44 Teruel;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;95,31
44 Teruel;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
44 Teruel;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
44 Teruel;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
44 Teruel;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
44 Teruel;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
44 Teruel;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
44 Teruel;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QII;1.086
44 Teruel;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
44 Teruel;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
44 Teruel;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
44 Teruel;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QII;1.083
44 Teruel;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
44 Teruel;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
44 Teruel;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
44 Teruel;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QII;1.090
44 Teruel;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
44 Teruel;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
44 Teruel;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
44 Teruel;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2022QII;1.053
44 Teruel;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2022QI;""
44 Teruel;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
44 Teruel;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
44 Teruel;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2021QII;1.056
44 Teruel;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2021QI;""
44 Teruel;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
44 Teruel;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
44 Teruel;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2020QII;1.075
44 Teruel;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2020QI;""
44 Teruel;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
44 Teruel;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2022QIII;1.034
44 Teruel;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2022QII;""
44 Teruel;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2022QI;""
44 Teruel;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
44 Teruel;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2021QIII;1.047
44 Teruel;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2021QII;""
44 Teruel;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2021QI;""
44 Teruel;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
44 Teruel;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2020QIII;1.055
44 Teruel;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2020QII;""
44 Teruel;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2020QI;""
44 Teruel;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QIV;1.008
44 Teruel;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
44 Teruel;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QII;""
44 Teruel;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QI;""
44 Teruel;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QIV;1.026
44 Teruel;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
44 Teruel;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QII;""
44 Teruel;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QI;""
44 Teruel;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QIV;1.033
44 Teruel;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
44 Teruel;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QII;""
44 Teruel;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QI;""
44 Teruel;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
44 Teruel;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
44 Teruel;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QII;""
44 Teruel;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QI;1.007
44 Teruel;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
44 Teruel;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
44 Teruel;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QII;""
44 Teruel;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QI;1.023
44 Teruel;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
44 Teruel;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
44 Teruel;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QII;""
44 Teruel;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QI;""
44 Teruel;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
44 Teruel;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
44 Teruel;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
44 Teruel;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
44 Teruel;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
44 Teruel;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
44 Teruel;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
44 Teruel;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
44 Teruel;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
44 Teruel;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
44 Teruel;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
44 Teruel;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
44 Teruel;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
44 Teruel;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
44 Teruel;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;96,96
44 Teruel;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
44 Teruel;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
44 Teruel;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
44 Teruel;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;97,51
44 Teruel;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
44 Teruel;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
44 Teruel;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
44 Teruel;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;98,62
44 Teruel;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
44 Teruel;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
44 Teruel;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;95,21
44 Teruel;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
44 Teruel;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
44 Teruel;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
44 Teruel;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;96,68
44 Teruel;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
44 Teruel;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
44 Teruel;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
44 Teruel;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;96,79
44 Teruel;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
44 Teruel;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
44 Teruel;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;92,82
44 Teruel;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
44 Teruel;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
44 Teruel;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
44 Teruel;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;94,74
44 Teruel;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
44 Teruel;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
44 Teruel;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
44 Teruel;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;94,77
44 Teruel;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
44 Teruel;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
44 Teruel;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
44 Teruel;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
44 Teruel;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
44 Teruel;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
44 Teruel;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;92,98
44 Teruel;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
44 Teruel;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
44 Teruel;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
44 Teruel;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;93,85
44 Teruel;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
44 Teruel;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
44 Teruel;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
44 Teruel;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
44 Teruel;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
44 Teruel;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QIII;2.896
44 Teruel;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
44 Teruel;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
44 Teruel;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
44 Teruel;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QIII;2.906
44 Teruel;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
44 Teruel;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
44 Teruel;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
44 Teruel;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QIII;2.932
44 Teruel;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
44 Teruel;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
44 Teruel;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
44 Teruel;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2022QIII;2.845
44 Teruel;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2022QII;""
44 Teruel;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2022QI;""
44 Teruel;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
44 Teruel;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2021QIII;2.870
44 Teruel;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2021QII;""
44 Teruel;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2021QI;""
44 Teruel;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
44 Teruel;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2020QIII;2.883
44 Teruel;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2020QII;""
44 Teruel;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2020QI;""
44 Teruel;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2022QIV;2.779
44 Teruel;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
44 Teruel;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2022QII;""
44 Teruel;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2022QI;""
44 Teruel;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2021QIV;2.826
44 Teruel;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
44 Teruel;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2021QII;""
44 Teruel;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2021QI;""
44 Teruel;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2020QIV;2.831
44 Teruel;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
44 Teruel;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2020QII;""
44 Teruel;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2020QI;""
44 Teruel;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
44 Teruel;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
44 Teruel;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QII;""
44 Teruel;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QI;2.775
44 Teruel;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
44 Teruel;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
44 Teruel;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QII;""
44 Teruel;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QI;2.804
44 Teruel;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
44 Teruel;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
44 Teruel;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QII;""
44 Teruel;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QI;""
44 Teruel;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
44 Teruel;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
44 Teruel;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QII;2.739
44 Teruel;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QI;""
44 Teruel;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
44 Teruel;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
44 Teruel;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QII;2.771
44 Teruel;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QI;""
44 Teruel;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
44 Teruel;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
44 Teruel;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QII;""
44 Teruel;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QI;""
44 Teruel;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
44 Teruel;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
44 Teruel;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
44 Teruel;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
44 Teruel;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
44 Teruel;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
44 Teruel;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
44 Teruel;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
44 Teruel;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
44 Teruel;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
44 Teruel;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
44 Teruel;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
44 Teruel;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
44 Teruel;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;98,24
44 Teruel;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
44 Teruel;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
44 Teruel;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
44 Teruel;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;98,76
44 Teruel;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
44 Teruel;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
44 Teruel;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
44 Teruel;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;98,33
44 Teruel;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
44 Teruel;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
44 Teruel;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;95,96
44 Teruel;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
44 Teruel;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
44 Teruel;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
44 Teruel;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;97,25
44 Teruel;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
44 Teruel;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
44 Teruel;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
44 Teruel;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;96,56
44 Teruel;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
44 Teruel;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
44 Teruel;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
44 Teruel;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
44 Teruel;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
44 Teruel;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
44 Teruel;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;95,49
44 Teruel;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
44 Teruel;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
44 Teruel;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
44 Teruel;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;95,63
44 Teruel;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
44 Teruel;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
44 Teruel;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
44 Teruel;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
44 Teruel;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
44 Teruel;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
44 Teruel;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;94,25
44 Teruel;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
44 Teruel;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
44 Teruel;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
44 Teruel;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;94,51
44 Teruel;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
44 Teruel;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
44 Teruel;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
44 Teruel;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
44 Teruel;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
44 Teruel;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
44 Teruel;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QIII;1.825
44 Teruel;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
44 Teruel;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
44 Teruel;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
44 Teruel;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QIII;1.826
44 Teruel;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
44 Teruel;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
44 Teruel;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
44 Teruel;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QIII;1.835
44 Teruel;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
44 Teruel;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
44 Teruel;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
44 Teruel;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2022QIII;1.799
44 Teruel;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2022QII;""
44 Teruel;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2022QI;""
44 Teruel;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
44 Teruel;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2021QIII;1.804
44 Teruel;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2021QII;""
44 Teruel;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2021QI;""
44 Teruel;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
44 Teruel;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2020QIII;1.810
44 Teruel;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2020QII;""
44 Teruel;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2020QI;""
44 Teruel;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2022QIV;1.762
44 Teruel;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
44 Teruel;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2022QII;""
44 Teruel;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2022QI;""
44 Teruel;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2021QIV;1.782
44 Teruel;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
44 Teruel;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2021QII;""
44 Teruel;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2021QI;""
44 Teruel;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2020QIV;1.781
44 Teruel;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
44 Teruel;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2020QII;""
44 Teruel;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2020QI;""
44 Teruel;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
44 Teruel;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
44 Teruel;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QII;""
44 Teruel;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QI;1.752
44 Teruel;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
44 Teruel;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
44 Teruel;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QII;""
44 Teruel;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QI;1.765
44 Teruel;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
44 Teruel;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
44 Teruel;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QII;""
44 Teruel;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QI;""
44 Teruel;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
44 Teruel;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
44 Teruel;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QII;1.734
44 Teruel;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QI;""
44 Teruel;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
44 Teruel;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
44 Teruel;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QII;1.755
44 Teruel;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QI;""
44 Teruel;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
44 Teruel;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
44 Teruel;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QII;""
44 Teruel;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QI;""
44 Teruel;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
44 Teruel;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
44 Teruel;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
44 Teruel;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
44 Teruel;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
44 Teruel;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
44 Teruel;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
44 Teruel;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
44 Teruel;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
44 Teruel;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
44 Teruel;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
44 Teruel;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
44 Teruel;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
44 Teruel;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;98,58
44 Teruel;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
44 Teruel;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
44 Teruel;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
44 Teruel;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;98,8
44 Teruel;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
44 Teruel;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
44 Teruel;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
44 Teruel;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;98,64
44 Teruel;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
44 Teruel;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
44 Teruel;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;96,55
44 Teruel;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
44 Teruel;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
44 Teruel;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
44 Teruel;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;97,59
44 Teruel;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
44 Teruel;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
44 Teruel;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
44 Teruel;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;97,06
44 Teruel;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
44 Teruel;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
44 Teruel;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
44 Teruel;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
44 Teruel;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
44 Teruel;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
44 Teruel;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;95,95
44 Teruel;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
44 Teruel;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
44 Teruel;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
44 Teruel;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;96,19
44 Teruel;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
44 Teruel;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
44 Teruel;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
44 Teruel;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
44 Teruel;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
44 Teruel;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
44 Teruel;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;94,96
44 Teruel;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
44 Teruel;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
44 Teruel;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
44 Teruel;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;95,64
44 Teruel;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
44 Teruel;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
44 Teruel;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
44 Teruel;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
44 Teruel;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
44 Teruel;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
44 Teruel;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QIII;1.071
44 Teruel;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
44 Teruel;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
44 Teruel;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
44 Teruel;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QIII;1.080
44 Teruel;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
44 Teruel;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
44 Teruel;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
44 Teruel;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QIII;1.097
44 Teruel;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
44 Teruel;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
44 Teruel;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
44 Teruel;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2022QIII;1.046
44 Teruel;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2022QII;""
44 Teruel;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2022QI;""
44 Teruel;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
44 Teruel;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2021QIII;1.066
44 Teruel;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2021QII;""
44 Teruel;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2021QI;""
44 Teruel;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
44 Teruel;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2020QIII;1.073
44 Teruel;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2020QII;""
44 Teruel;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2020QI;""
44 Teruel;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2022QIV;1.017
44 Teruel;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
44 Teruel;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2022QII;""
44 Teruel;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2022QI;""
44 Teruel;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2021QIV;1.044
44 Teruel;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
44 Teruel;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2021QII;""
44 Teruel;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2021QI;""
44 Teruel;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2020QIV;1.050
44 Teruel;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
44 Teruel;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2020QII;""
44 Teruel;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2020QI;""
44 Teruel;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
44 Teruel;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
44 Teruel;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QII;""
44 Teruel;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QI;1.023
44 Teruel;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
44 Teruel;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
44 Teruel;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QII;""
44 Teruel;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QI;1.039
44 Teruel;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
44 Teruel;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
44 Teruel;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QII;""
44 Teruel;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QI;""
44 Teruel;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
44 Teruel;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
44 Teruel;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QII;1.005
44 Teruel;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QI;""
44 Teruel;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
44 Teruel;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
44 Teruel;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QII;1.016
44 Teruel;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QI;""
44 Teruel;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
44 Teruel;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
44 Teruel;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QII;""
44 Teruel;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QI;""
44 Teruel;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
44 Teruel;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
44 Teruel;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
44 Teruel;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
44 Teruel;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
44 Teruel;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
44 Teruel;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
44 Teruel;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
44 Teruel;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
44 Teruel;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
44 Teruel;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
44 Teruel;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
44 Teruel;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
44 Teruel;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;97,67
44 Teruel;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
44 Teruel;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
44 Teruel;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
44 Teruel;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;98,7
44 Teruel;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
44 Teruel;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
44 Teruel;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
44 Teruel;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;97,81
44 Teruel;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
44 Teruel;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
44 Teruel;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;94,96
44 Teruel;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
44 Teruel;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
44 Teruel;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
44 Teruel;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;96,67
44 Teruel;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
44 Teruel;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
44 Teruel;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
44 Teruel;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;95,72
44 Teruel;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
44 Teruel;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
44 Teruel;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
44 Teruel;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
44 Teruel;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
44 Teruel;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
44 Teruel;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;94,72
44 Teruel;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
44 Teruel;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
44 Teruel;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
44 Teruel;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;94,71
44 Teruel;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
44 Teruel;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
44 Teruel;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
44 Teruel;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
44 Teruel;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
44 Teruel;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
44 Teruel;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;93,06
44 Teruel;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
44 Teruel;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
44 Teruel;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
44 Teruel;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;92,62
44 Teruel;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
44 Teruel;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
44 Teruel;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
44 Teruel;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
44 Teruel;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
44 Teruel;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QIV;2.880
44 Teruel;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
44 Teruel;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
44 Teruel;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
44 Teruel;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QIV;2.916
44 Teruel;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
44 Teruel;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
44 Teruel;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
44 Teruel;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QIV;2.928
44 Teruel;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
44 Teruel;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
44 Teruel;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
44 Teruel;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2022QIV;2.806
44 Teruel;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
44 Teruel;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2022QII;""
44 Teruel;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2022QI;""
44 Teruel;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2021QIV;2.863
44 Teruel;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
44 Teruel;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2021QII;""
44 Teruel;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2021QI;""
44 Teruel;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2020QIV;2.866
44 Teruel;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
44 Teruel;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2020QII;""
44 Teruel;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2020QI;""
44 Teruel;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
44 Teruel;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
44 Teruel;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2022QII;""
44 Teruel;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2022QI;2.811
44 Teruel;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
44 Teruel;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
44 Teruel;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2021QII;""
44 Teruel;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2021QI;2.838
44 Teruel;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
44 Teruel;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
44 Teruel;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2020QII;""
44 Teruel;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2020QI;""
44 Teruel;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
44 Teruel;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
44 Teruel;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QII;2.769
44 Teruel;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QI;""
44 Teruel;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
44 Teruel;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
44 Teruel;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QII;2.796
44 Teruel;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QI;""
44 Teruel;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
44 Teruel;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
44 Teruel;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QII;""
44 Teruel;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QI;""
44 Teruel;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
44 Teruel;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QIII;2.735
44 Teruel;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QII;""
44 Teruel;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QI;""
44 Teruel;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
44 Teruel;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QIII;2.772
44 Teruel;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QII;""
44 Teruel;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QI;""
44 Teruel;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
44 Teruel;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
44 Teruel;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QII;""
44 Teruel;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QI;""
44 Teruel;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
44 Teruel;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
44 Teruel;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
44 Teruel;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
44 Teruel;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
44 Teruel;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
44 Teruel;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
44 Teruel;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
44 Teruel;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
44 Teruel;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
44 Teruel;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
44 Teruel;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
44 Teruel;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;97,43
44 Teruel;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
44 Teruel;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
44 Teruel;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
44 Teruel;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;98,18
44 Teruel;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
44 Teruel;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
44 Teruel;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
44 Teruel;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;97,88
44 Teruel;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
44 Teruel;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
44 Teruel;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
44 Teruel;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
44 Teruel;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
44 Teruel;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
44 Teruel;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;96,4
44 Teruel;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
44 Teruel;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
44 Teruel;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
44 Teruel;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;96,93
44 Teruel;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
44 Teruel;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
44 Teruel;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
44 Teruel;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
44 Teruel;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
44 Teruel;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
44 Teruel;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;94,96
44 Teruel;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
44 Teruel;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
44 Teruel;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
44 Teruel;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;95,49
44 Teruel;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
44 Teruel;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
44 Teruel;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
44 Teruel;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
44 Teruel;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
44 Teruel;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
44 Teruel;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;93,79
44 Teruel;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
44 Teruel;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
44 Teruel;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
44 Teruel;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;94,67
44 Teruel;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
44 Teruel;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
44 Teruel;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
44 Teruel;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
44 Teruel;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
44 Teruel;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
44 Teruel;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QIV;1.816
44 Teruel;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
44 Teruel;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
44 Teruel;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
44 Teruel;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QIV;1.827
44 Teruel;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
44 Teruel;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
44 Teruel;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
44 Teruel;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QIV;1.835
44 Teruel;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
44 Teruel;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
44 Teruel;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
44 Teruel;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2022QIV;1.775
44 Teruel;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
44 Teruel;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2022QII;""
44 Teruel;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2022QI;""
44 Teruel;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2021QIV;1.799
44 Teruel;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
44 Teruel;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2021QII;""
44 Teruel;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2021QI;""
44 Teruel;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2020QIV;1.799
44 Teruel;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
44 Teruel;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2020QII;""
44 Teruel;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2020QI;""
44 Teruel;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
44 Teruel;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
44 Teruel;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2022QII;""
44 Teruel;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2022QI;1.768
44 Teruel;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
44 Teruel;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
44 Teruel;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2021QII;""
44 Teruel;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2021QI;1.783
44 Teruel;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
44 Teruel;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
44 Teruel;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2020QII;""
44 Teruel;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2020QI;""
44 Teruel;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
44 Teruel;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
44 Teruel;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QII;1.748
44 Teruel;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QI;""
44 Teruel;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
44 Teruel;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
44 Teruel;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QII;1.767
44 Teruel;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QI;""
44 Teruel;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
44 Teruel;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
44 Teruel;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QII;""
44 Teruel;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QI;""
44 Teruel;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
44 Teruel;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QIII;1.727
44 Teruel;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QII;""
44 Teruel;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QI;""
44 Teruel;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
44 Teruel;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QIII;1.752
44 Teruel;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QII;""
44 Teruel;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QI;""
44 Teruel;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
44 Teruel;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
44 Teruel;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QII;""
44 Teruel;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QI;""
44 Teruel;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
44 Teruel;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
44 Teruel;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
44 Teruel;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
44 Teruel;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
44 Teruel;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
44 Teruel;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
44 Teruel;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
44 Teruel;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
44 Teruel;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
44 Teruel;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
44 Teruel;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
44 Teruel;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;97,74
44 Teruel;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
44 Teruel;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
44 Teruel;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
44 Teruel;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;98,47
44 Teruel;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
44 Teruel;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
44 Teruel;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
44 Teruel;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;98,04
44 Teruel;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
44 Teruel;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
44 Teruel;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
44 Teruel;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
44 Teruel;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
44 Teruel;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
44 Teruel;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;96,77
44 Teruel;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
44 Teruel;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
44 Teruel;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
44 Teruel;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;97,17
44 Teruel;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
44 Teruel;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
44 Teruel;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
44 Teruel;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
44 Teruel;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
44 Teruel;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
44 Teruel;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;95,68
44 Teruel;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
44 Teruel;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
44 Teruel;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
44 Teruel;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;96,29
44 Teruel;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
44 Teruel;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
44 Teruel;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
44 Teruel;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
44 Teruel;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
44 Teruel;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
44 Teruel;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;94,53
44 Teruel;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
44 Teruel;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
44 Teruel;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
44 Teruel;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;95,48
44 Teruel;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
44 Teruel;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
44 Teruel;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
44 Teruel;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
44 Teruel;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
44 Teruel;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
44 Teruel;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QIV;1.064
44 Teruel;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
44 Teruel;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
44 Teruel;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
44 Teruel;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QIV;1.089
44 Teruel;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
44 Teruel;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
44 Teruel;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
44 Teruel;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QIV;1.093
44 Teruel;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
44 Teruel;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
44 Teruel;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
44 Teruel;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2022QIV;1.031
44 Teruel;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
44 Teruel;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2022QII;""
44 Teruel;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2022QI;""
44 Teruel;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2021QIV;1.064
44 Teruel;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
44 Teruel;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2021QII;""
44 Teruel;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2021QI;""
44 Teruel;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2020QIV;1.067
44 Teruel;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
44 Teruel;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2020QII;""
44 Teruel;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2020QI;""
44 Teruel;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
44 Teruel;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
44 Teruel;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2022QII;""
44 Teruel;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2022QI;1.043
44 Teruel;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
44 Teruel;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
44 Teruel;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2021QII;""
44 Teruel;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2021QI;1.055
44 Teruel;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
44 Teruel;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
44 Teruel;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2020QII;""
44 Teruel;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2020QI;""
44 Teruel;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
44 Teruel;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
44 Teruel;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QII;1.021
44 Teruel;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QI;""
44 Teruel;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
44 Teruel;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
44 Teruel;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QII;1.029
44 Teruel;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QI;""
44 Teruel;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
44 Teruel;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
44 Teruel;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QII;""
44 Teruel;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QI;""
44 Teruel;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
44 Teruel;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QIII;1.008
44 Teruel;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QII;""
44 Teruel;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QI;""
44 Teruel;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
44 Teruel;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QIII;1.020
44 Teruel;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QII;""
44 Teruel;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QI;""
44 Teruel;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
44 Teruel;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
44 Teruel;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QII;""
44 Teruel;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QI;""
44 Teruel;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
44 Teruel;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
44 Teruel;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
44 Teruel;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
44 Teruel;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
44 Teruel;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
44 Teruel;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
44 Teruel;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
44 Teruel;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
44 Teruel;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
44 Teruel;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
44 Teruel;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
44 Teruel;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;96,9
44 Teruel;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
44 Teruel;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
44 Teruel;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
44 Teruel;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;97,7
44 Teruel;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
44 Teruel;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
44 Teruel;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
44 Teruel;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;97,62
44 Teruel;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
44 Teruel;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
44 Teruel;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
44 Teruel;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
44 Teruel;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
44 Teruel;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
44 Teruel;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;95,78
44 Teruel;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
44 Teruel;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
44 Teruel;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
44 Teruel;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;96,52
44 Teruel;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
44 Teruel;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
44 Teruel;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
44 Teruel;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
44 Teruel;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
44 Teruel;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
44 Teruel;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;93,76
44 Teruel;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
44 Teruel;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
44 Teruel;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
44 Teruel;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;94,14
44 Teruel;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
44 Teruel;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
44 Teruel;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
44 Teruel;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
44 Teruel;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
44 Teruel;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
44 Teruel;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;92,56
44 Teruel;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
44 Teruel;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
44 Teruel;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
44 Teruel;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;93,32
44 Teruel;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
44 Teruel;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
44 Teruel;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
44 Teruel;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
44 Teruel;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
44 Teruel;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
44 Teruel;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
44 Teruel;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
44 Teruel;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
44 Teruel;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QI;1.336
44 Teruel;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
44 Teruel;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
44 Teruel;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
44 Teruel;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QI;1.209
44 Teruel;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
44 Teruel;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
44 Teruel;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
44 Teruel;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QI;1.436
44 Teruel;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
44 Teruel;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
44 Teruel;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2022QII;""
44 Teruel;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2022QI;1.287
44 Teruel;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
44 Teruel;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
44 Teruel;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2021QII;""
44 Teruel;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2021QI;1.164
44 Teruel;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
44 Teruel;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
44 Teruel;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2020QII;""
44 Teruel;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2020QI;1.356
44 Teruel;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
44 Teruel;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
44 Teruel;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2022QII;1.241
44 Teruel;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2022QI;""
44 Teruel;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
44 Teruel;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
44 Teruel;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2021QII;1.125
44 Teruel;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2021QI;""
44 Teruel;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
44 Teruel;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
44 Teruel;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2020QII;1.303
44 Teruel;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2020QI;""
44 Teruel;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
44 Teruel;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QIII;1.197
44 Teruel;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QII;""
44 Teruel;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QI;""
44 Teruel;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
44 Teruel;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QIII;1.086
44 Teruel;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QII;""
44 Teruel;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QI;""
44 Teruel;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
44 Teruel;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QIII;1.248
44 Teruel;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QII;""
44 Teruel;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QI;""
44 Teruel;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QIV;1.073
44 Teruel;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
44 Teruel;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QII;""
44 Teruel;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QI;""
44 Teruel;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QIV;1.040
44 Teruel;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
44 Teruel;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QII;""
44 Teruel;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QI;""
44 Teruel;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QIV;1.182
44 Teruel;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
44 Teruel;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QII;""
44 Teruel;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QI;""
44 Teruel;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
44 Teruel;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
44 Teruel;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
44 Teruel;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
44 Teruel;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
44 Teruel;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
44 Teruel;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
44 Teruel;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
44 Teruel;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
44 Teruel;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
44 Teruel;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
44 Teruel;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
44 Teruel;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
44 Teruel;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
44 Teruel;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
44 Teruel;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;96,33
44 Teruel;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
44 Teruel;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
44 Teruel;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
44 Teruel;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;96,28
44 Teruel;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
44 Teruel;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
44 Teruel;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
44 Teruel;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;94,43
44 Teruel;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
44 Teruel;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
44 Teruel;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;92,89
44 Teruel;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
44 Teruel;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
44 Teruel;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
44 Teruel;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;93,05
44 Teruel;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
44 Teruel;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
44 Teruel;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
44 Teruel;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;90,74
44 Teruel;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
44 Teruel;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
44 Teruel;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;89,6
44 Teruel;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
44 Teruel;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
44 Teruel;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
44 Teruel;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;89,83
44 Teruel;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
44 Teruel;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
44 Teruel;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
44 Teruel;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;86,91
44 Teruel;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
44 Teruel;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
44 Teruel;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;80,31
44 Teruel;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
44 Teruel;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
44 Teruel;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
44 Teruel;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;86,02
44 Teruel;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
44 Teruel;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
44 Teruel;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
44 Teruel;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;82,31
44 Teruel;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
44 Teruel;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
44 Teruel;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
44 Teruel;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
44 Teruel;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
44 Teruel;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
44 Teruel;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QI;879
44 Teruel;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
44 Teruel;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
44 Teruel;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
44 Teruel;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QI;800
44 Teruel;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
44 Teruel;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
44 Teruel;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
44 Teruel;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QI;948
44 Teruel;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
44 Teruel;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
44 Teruel;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2022QII;""
44 Teruel;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2022QI;847
44 Teruel;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
44 Teruel;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
44 Teruel;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2021QII;""
44 Teruel;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2021QI;773
44 Teruel;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
44 Teruel;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
44 Teruel;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2020QII;""
44 Teruel;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2020QI;894
44 Teruel;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
44 Teruel;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
44 Teruel;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2022QII;819
44 Teruel;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2022QI;""
44 Teruel;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
44 Teruel;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
44 Teruel;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2021QII;748
44 Teruel;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2021QI;""
44 Teruel;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
44 Teruel;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
44 Teruel;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2020QII;860
44 Teruel;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2020QI;""
44 Teruel;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
44 Teruel;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QIII;792
44 Teruel;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QII;""
44 Teruel;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QI;""
44 Teruel;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
44 Teruel;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QIII;719
44 Teruel;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QII;""
44 Teruel;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QI;""
44 Teruel;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
44 Teruel;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QIII;826
44 Teruel;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QII;""
44 Teruel;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QI;""
44 Teruel;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QIV;704
44 Teruel;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
44 Teruel;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QII;""
44 Teruel;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QI;""
44 Teruel;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QIV;689
44 Teruel;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
44 Teruel;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QII;""
44 Teruel;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QI;""
44 Teruel;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QIV;784
44 Teruel;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
44 Teruel;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QII;""
44 Teruel;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QI;""
44 Teruel;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
44 Teruel;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
44 Teruel;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
44 Teruel;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
44 Teruel;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
44 Teruel;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
44 Teruel;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
44 Teruel;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
44 Teruel;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
44 Teruel;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
44 Teruel;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
44 Teruel;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
44 Teruel;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
44 Teruel;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
44 Teruel;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
44 Teruel;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;96,36
44 Teruel;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
44 Teruel;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
44 Teruel;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
44 Teruel;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;96,63
44 Teruel;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
44 Teruel;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
44 Teruel;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
44 Teruel;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;94,3
44 Teruel;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
44 Teruel;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
44 Teruel;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;93,17
44 Teruel;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
44 Teruel;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
44 Teruel;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
44 Teruel;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;93,5
44 Teruel;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
44 Teruel;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
44 Teruel;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
44 Teruel;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;90,72
44 Teruel;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
44 Teruel;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
44 Teruel;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;90,1
44 Teruel;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
44 Teruel;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
44 Teruel;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
44 Teruel;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;89,88
44 Teruel;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
44 Teruel;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
44 Teruel;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
44 Teruel;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;87,13
44 Teruel;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
44 Teruel;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
44 Teruel;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;80,09
44 Teruel;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
44 Teruel;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
44 Teruel;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
44 Teruel;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;86,13
44 Teruel;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
44 Teruel;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
44 Teruel;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
44 Teruel;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;82,7
44 Teruel;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
44 Teruel;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
44 Teruel;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
44 Teruel;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
44 Teruel;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
44 Teruel;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
44 Teruel;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QI;457
44 Teruel;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
44 Teruel;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
44 Teruel;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
44 Teruel;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QI;409
44 Teruel;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
44 Teruel;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
44 Teruel;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
44 Teruel;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QI;488
44 Teruel;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
44 Teruel;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
44 Teruel;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2022QII;""
44 Teruel;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2022QI;440
44 Teruel;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
44 Teruel;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
44 Teruel;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2021QII;""
44 Teruel;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2021QI;391
44 Teruel;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
44 Teruel;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
44 Teruel;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2020QII;""
44 Teruel;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2020QI;462
44 Teruel;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
44 Teruel;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
44 Teruel;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2022QII;422
44 Teruel;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2022QI;""
44 Teruel;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
44 Teruel;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
44 Teruel;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2021QII;377
44 Teruel;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2021QI;""
44 Teruel;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
44 Teruel;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
44 Teruel;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2020QII;443
44 Teruel;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2020QI;""
44 Teruel;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
44 Teruel;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QIII;405
44 Teruel;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QII;""
44 Teruel;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QI;""
44 Teruel;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
44 Teruel;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QIII;367
44 Teruel;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QII;""
44 Teruel;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QI;""
44 Teruel;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
44 Teruel;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QIII;422
44 Teruel;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QII;""
44 Teruel;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QI;""
44 Teruel;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QIV;369
44 Teruel;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
44 Teruel;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QII;""
44 Teruel;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QI;""
44 Teruel;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QIV;351
44 Teruel;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
44 Teruel;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QII;""
44 Teruel;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QI;""
44 Teruel;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QIV;398
44 Teruel;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
44 Teruel;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QII;""
44 Teruel;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QI;""
44 Teruel;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
44 Teruel;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
44 Teruel;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
44 Teruel;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
44 Teruel;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
44 Teruel;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
44 Teruel;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
44 Teruel;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
44 Teruel;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
44 Teruel;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
44 Teruel;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
44 Teruel;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
44 Teruel;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
44 Teruel;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
44 Teruel;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
44 Teruel;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;96,28
44 Teruel;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
44 Teruel;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
44 Teruel;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
44 Teruel;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;95,6
44 Teruel;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
44 Teruel;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
44 Teruel;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
44 Teruel;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;94,67
44 Teruel;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
44 Teruel;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
44 Teruel;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;92,34
44 Teruel;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
44 Teruel;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
44 Teruel;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
44 Teruel;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;92,18
44 Teruel;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
44 Teruel;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
44 Teruel;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
44 Teruel;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;90,78
44 Teruel;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
44 Teruel;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
44 Teruel;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;88,62
44 Teruel;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
44 Teruel;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
44 Teruel;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
44 Teruel;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;89,73
44 Teruel;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
44 Teruel;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
44 Teruel;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
44 Teruel;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;86,48
44 Teruel;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
44 Teruel;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
44 Teruel;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;80,74
44 Teruel;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
44 Teruel;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
44 Teruel;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
44 Teruel;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;85,82
44 Teruel;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
44 Teruel;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
44 Teruel;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
44 Teruel;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;81,56
44 Teruel;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
44 Teruel;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
44 Teruel;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
44 Teruel;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
44 Teruel;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
44 Teruel;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QII;1.542
44 Teruel;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
44 Teruel;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
44 Teruel;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
44 Teruel;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QII;1.442
44 Teruel;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
44 Teruel;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
44 Teruel;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
44 Teruel;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QII;1.368
44 Teruel;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
44 Teruel;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
44 Teruel;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
44 Teruel;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2022QII;1.490
44 Teruel;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2022QI;""
44 Teruel;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
44 Teruel;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
44 Teruel;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2021QII;1.398
44 Teruel;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2021QI;""
44 Teruel;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
44 Teruel;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
44 Teruel;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2020QII;1.314
44 Teruel;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2020QI;""
44 Teruel;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
44 Teruel;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2022QIII;1.443
44 Teruel;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2022QII;""
44 Teruel;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2022QI;""
44 Teruel;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
44 Teruel;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2021QIII;1.355
44 Teruel;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2021QII;""
44 Teruel;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2021QI;""
44 Teruel;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
44 Teruel;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2020QIII;1.256
44 Teruel;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2020QII;""
44 Teruel;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2020QI;""
44 Teruel;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QIV;1.311
44 Teruel;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
44 Teruel;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QII;""
44 Teruel;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QI;""
44 Teruel;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QIV;1.306
44 Teruel;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
44 Teruel;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QII;""
44 Teruel;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QI;""
44 Teruel;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QIV;1.189
44 Teruel;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
44 Teruel;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QII;""
44 Teruel;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QI;""
44 Teruel;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
44 Teruel;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
44 Teruel;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QII;""
44 Teruel;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QI;1.260
44 Teruel;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
44 Teruel;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
44 Teruel;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QII;""
44 Teruel;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QI;1.144
44 Teruel;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
44 Teruel;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
44 Teruel;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QII;""
44 Teruel;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QI;""
44 Teruel;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
44 Teruel;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
44 Teruel;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
44 Teruel;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
44 Teruel;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
44 Teruel;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
44 Teruel;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
44 Teruel;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
44 Teruel;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
44 Teruel;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
44 Teruel;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
44 Teruel;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
44 Teruel;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
44 Teruel;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
44 Teruel;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;96,63
44 Teruel;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
44 Teruel;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
44 Teruel;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
44 Teruel;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;96,95
44 Teruel;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
44 Teruel;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
44 Teruel;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
44 Teruel;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;96,05
44 Teruel;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
44 Teruel;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
44 Teruel;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;93,58
44 Teruel;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
44 Teruel;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
44 Teruel;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
44 Teruel;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;93,97
44 Teruel;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
44 Teruel;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
44 Teruel;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
44 Teruel;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;91,81
44 Teruel;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
44 Teruel;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
44 Teruel;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;85,02
44 Teruel;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
44 Teruel;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
44 Teruel;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
44 Teruel;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;90,57
44 Teruel;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
44 Teruel;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
44 Teruel;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
44 Teruel;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;86,92
44 Teruel;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
44 Teruel;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
44 Teruel;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
44 Teruel;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
44 Teruel;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
44 Teruel;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
44 Teruel;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;87,38
44 Teruel;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
44 Teruel;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
44 Teruel;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
44 Teruel;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;83,63
44 Teruel;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
44 Teruel;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
44 Teruel;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
44 Teruel;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
44 Teruel;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
44 Teruel;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
44 Teruel;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QII;999
44 Teruel;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
44 Teruel;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
44 Teruel;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
44 Teruel;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QII;949
44 Teruel;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
44 Teruel;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
44 Teruel;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
44 Teruel;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QII;903
44 Teruel;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
44 Teruel;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
44 Teruel;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
44 Teruel;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2022QII;968
44 Teruel;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2022QI;""
44 Teruel;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
44 Teruel;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
44 Teruel;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2021QII;922
44 Teruel;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2021QI;""
44 Teruel;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
44 Teruel;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
44 Teruel;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2020QII;869
44 Teruel;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2020QI;""
44 Teruel;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
44 Teruel;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2022QIII;938
44 Teruel;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2022QII;""
44 Teruel;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2022QI;""
44 Teruel;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
44 Teruel;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2021QIII;890
44 Teruel;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2021QII;""
44 Teruel;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2021QI;""
44 Teruel;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
44 Teruel;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2020QIII;832
44 Teruel;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2020QII;""
44 Teruel;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2020QI;""
44 Teruel;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QIV;845
44 Teruel;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
44 Teruel;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QII;""
44 Teruel;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QI;""
44 Teruel;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QIV;859
44 Teruel;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
44 Teruel;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QII;""
44 Teruel;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QI;""
44 Teruel;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QIV;789
44 Teruel;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
44 Teruel;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QII;""
44 Teruel;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QI;""
44 Teruel;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
44 Teruel;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
44 Teruel;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QII;""
44 Teruel;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QI;829
44 Teruel;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
44 Teruel;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
44 Teruel;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QII;""
44 Teruel;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QI;762
44 Teruel;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
44 Teruel;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
44 Teruel;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QII;""
44 Teruel;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QI;""
44 Teruel;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
44 Teruel;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
44 Teruel;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
44 Teruel;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
44 Teruel;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
44 Teruel;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
44 Teruel;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
44 Teruel;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
44 Teruel;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
44 Teruel;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
44 Teruel;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
44 Teruel;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
44 Teruel;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
44 Teruel;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
44 Teruel;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;96,9
44 Teruel;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
44 Teruel;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
44 Teruel;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
44 Teruel;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;97,15
44 Teruel;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
44 Teruel;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
44 Teruel;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
44 Teruel;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;96,23
44 Teruel;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
44 Teruel;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
44 Teruel;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;93,89
44 Teruel;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
44 Teruel;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
44 Teruel;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
44 Teruel;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;93,78
44 Teruel;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
44 Teruel;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
44 Teruel;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
44 Teruel;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;92,14
44 Teruel;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
44 Teruel;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
44 Teruel;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;84,58
44 Teruel;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
44 Teruel;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
44 Teruel;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
44 Teruel;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;90,52
44 Teruel;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
44 Teruel;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
44 Teruel;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
44 Teruel;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;87,38
44 Teruel;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
44 Teruel;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
44 Teruel;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
44 Teruel;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
44 Teruel;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
44 Teruel;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
44 Teruel;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;87,36
44 Teruel;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
44 Teruel;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
44 Teruel;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
44 Teruel;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;84,39
44 Teruel;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
44 Teruel;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
44 Teruel;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
44 Teruel;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
44 Teruel;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
44 Teruel;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
44 Teruel;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QII;543
44 Teruel;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
44 Teruel;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
44 Teruel;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
44 Teruel;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QII;493
44 Teruel;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
44 Teruel;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
44 Teruel;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
44 Teruel;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QII;465
44 Teruel;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
44 Teruel;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
44 Teruel;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
44 Teruel;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2022QII;522
44 Teruel;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2022QI;""
44 Teruel;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
44 Teruel;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
44 Teruel;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2021QII;476
44 Teruel;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2021QI;""
44 Teruel;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
44 Teruel;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
44 Teruel;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2020QII;445
44 Teruel;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2020QI;""
44 Teruel;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
44 Teruel;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2022QIII;505
44 Teruel;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2022QII;""
44 Teruel;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2022QI;""
44 Teruel;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
44 Teruel;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2021QIII;465
44 Teruel;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2021QII;""
44 Teruel;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2021QI;""
44 Teruel;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
44 Teruel;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2020QIII;424
44 Teruel;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2020QII;""
44 Teruel;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2020QI;""
44 Teruel;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QIV;466
44 Teruel;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
44 Teruel;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QII;""
44 Teruel;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QI;""
44 Teruel;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QIV;447
44 Teruel;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
44 Teruel;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QII;""
44 Teruel;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QI;""
44 Teruel;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QIV;400
44 Teruel;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
44 Teruel;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QII;""
44 Teruel;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QI;""
44 Teruel;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
44 Teruel;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
44 Teruel;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QII;""
44 Teruel;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QI;431
44 Teruel;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
44 Teruel;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
44 Teruel;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QII;""
44 Teruel;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QI;382
44 Teruel;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
44 Teruel;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
44 Teruel;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QII;""
44 Teruel;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QI;""
44 Teruel;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
44 Teruel;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
44 Teruel;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
44 Teruel;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
44 Teruel;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
44 Teruel;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
44 Teruel;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
44 Teruel;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
44 Teruel;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
44 Teruel;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
44 Teruel;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
44 Teruel;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
44 Teruel;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
44 Teruel;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
44 Teruel;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;96,13
44 Teruel;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
44 Teruel;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
44 Teruel;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
44 Teruel;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;96,55
44 Teruel;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
44 Teruel;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
44 Teruel;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
44 Teruel;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;95,7
44 Teruel;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
44 Teruel;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
44 Teruel;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;93
44 Teruel;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
44 Teruel;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
44 Teruel;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
44 Teruel;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;94,32
44 Teruel;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
44 Teruel;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
44 Teruel;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
44 Teruel;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;91,18
44 Teruel;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
44 Teruel;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
44 Teruel;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;85,82
44 Teruel;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
44 Teruel;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
44 Teruel;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
44 Teruel;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;90,67
44 Teruel;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
44 Teruel;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
44 Teruel;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
44 Teruel;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;86,02
44 Teruel;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
44 Teruel;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
44 Teruel;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
44 Teruel;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
44 Teruel;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
44 Teruel;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
44 Teruel;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;87,42
44 Teruel;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
44 Teruel;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
44 Teruel;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
44 Teruel;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;82,15
44 Teruel;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
44 Teruel;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
44 Teruel;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
44 Teruel;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
44 Teruel;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
44 Teruel;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QIII;1.507
44 Teruel;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
44 Teruel;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
44 Teruel;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
44 Teruel;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QIII;1.412
44 Teruel;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
44 Teruel;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
44 Teruel;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
44 Teruel;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QIII;1.322
44 Teruel;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
44 Teruel;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
44 Teruel;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
44 Teruel;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2022QIII;1.455
44 Teruel;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2022QII;""
44 Teruel;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2022QI;""
44 Teruel;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
44 Teruel;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2021QIII;1.365
44 Teruel;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2021QII;""
44 Teruel;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2021QI;""
44 Teruel;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
44 Teruel;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2020QIII;1.261
44 Teruel;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2020QII;""
44 Teruel;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2020QI;""
44 Teruel;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2022QIV;1.318
44 Teruel;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
44 Teruel;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2022QII;""
44 Teruel;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2022QI;""
44 Teruel;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2021QIV;1.314
44 Teruel;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
44 Teruel;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2021QII;""
44 Teruel;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2021QI;""
44 Teruel;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2020QIV;1.193
44 Teruel;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
44 Teruel;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2020QII;""
44 Teruel;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2020QI;""
44 Teruel;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
44 Teruel;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
44 Teruel;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QII;""
44 Teruel;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QI;1.268
44 Teruel;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
44 Teruel;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
44 Teruel;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QII;""
44 Teruel;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QI;1.148
44 Teruel;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
44 Teruel;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
44 Teruel;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QII;""
44 Teruel;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QI;""
44 Teruel;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
44 Teruel;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
44 Teruel;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QII;1.224
44 Teruel;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QI;""
44 Teruel;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
44 Teruel;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
44 Teruel;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QII;1.110
44 Teruel;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QI;""
44 Teruel;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
44 Teruel;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
44 Teruel;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QII;""
44 Teruel;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QI;""
44 Teruel;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
44 Teruel;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
44 Teruel;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
44 Teruel;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
44 Teruel;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
44 Teruel;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
44 Teruel;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
44 Teruel;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
44 Teruel;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
44 Teruel;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
44 Teruel;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
44 Teruel;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
44 Teruel;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
44 Teruel;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;96,55
44 Teruel;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
44 Teruel;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
44 Teruel;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
44 Teruel;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;96,67
44 Teruel;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
44 Teruel;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
44 Teruel;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
44 Teruel;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;95,39
44 Teruel;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
44 Teruel;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
44 Teruel;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;87,46
44 Teruel;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
44 Teruel;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
44 Teruel;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
44 Teruel;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;93,06
44 Teruel;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
44 Teruel;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
44 Teruel;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
44 Teruel;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;90,24
44 Teruel;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
44 Teruel;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
44 Teruel;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
44 Teruel;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
44 Teruel;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
44 Teruel;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
44 Teruel;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;89,8
44 Teruel;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
44 Teruel;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
44 Teruel;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
44 Teruel;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;86,84
44 Teruel;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
44 Teruel;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
44 Teruel;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
44 Teruel;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
44 Teruel;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
44 Teruel;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
44 Teruel;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;86,69
44 Teruel;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
44 Teruel;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
44 Teruel;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
44 Teruel;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;83,96
44 Teruel;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
44 Teruel;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
44 Teruel;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
44 Teruel;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
44 Teruel;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
44 Teruel;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
44 Teruel;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QIII;976
44 Teruel;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
44 Teruel;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
44 Teruel;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
44 Teruel;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QIII;930
44 Teruel;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
44 Teruel;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
44 Teruel;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
44 Teruel;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QIII;874
44 Teruel;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
44 Teruel;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
44 Teruel;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
44 Teruel;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2022QIII;944
44 Teruel;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2022QII;""
44 Teruel;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2022QI;""
44 Teruel;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
44 Teruel;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2021QIII;895
44 Teruel;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2021QII;""
44 Teruel;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2021QI;""
44 Teruel;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
44 Teruel;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2020QIII;835
44 Teruel;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2020QII;""
44 Teruel;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2020QI;""
44 Teruel;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2022QIV;848
44 Teruel;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
44 Teruel;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2022QII;""
44 Teruel;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2022QI;""
44 Teruel;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2021QIV;863
44 Teruel;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
44 Teruel;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2021QII;""
44 Teruel;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2021QI;""
44 Teruel;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2020QIV;791
44 Teruel;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
44 Teruel;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2020QII;""
44 Teruel;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2020QI;""
44 Teruel;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
44 Teruel;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
44 Teruel;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QII;""
44 Teruel;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QI;833
44 Teruel;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
44 Teruel;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
44 Teruel;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QII;""
44 Teruel;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QI;764
44 Teruel;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
44 Teruel;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
44 Teruel;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QII;""
44 Teruel;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QI;""
44 Teruel;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
44 Teruel;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
44 Teruel;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QII;806
44 Teruel;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QI;""
44 Teruel;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
44 Teruel;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
44 Teruel;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QII;740
44 Teruel;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QI;""
44 Teruel;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
44 Teruel;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
44 Teruel;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QII;""
44 Teruel;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QI;""
44 Teruel;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
44 Teruel;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
44 Teruel;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
44 Teruel;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
44 Teruel;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
44 Teruel;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
44 Teruel;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
44 Teruel;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
44 Teruel;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
44 Teruel;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
44 Teruel;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
44 Teruel;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
44 Teruel;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
44 Teruel;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;96,72
44 Teruel;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
44 Teruel;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
44 Teruel;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
44 Teruel;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;96,24
44 Teruel;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
44 Teruel;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
44 Teruel;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
44 Teruel;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;95,54
44 Teruel;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
44 Teruel;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
44 Teruel;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;86,89
44 Teruel;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
44 Teruel;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
44 Teruel;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
44 Teruel;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;92,8
44 Teruel;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
44 Teruel;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
44 Teruel;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
44 Teruel;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;90,5
44 Teruel;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
44 Teruel;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
44 Teruel;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
44 Teruel;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
44 Teruel;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
44 Teruel;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
44 Teruel;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;89,57
44 Teruel;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
44 Teruel;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
44 Teruel;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
44 Teruel;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;87,41
44 Teruel;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
44 Teruel;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
44 Teruel;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
44 Teruel;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
44 Teruel;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
44 Teruel;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
44 Teruel;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;86,67
44 Teruel;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
44 Teruel;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
44 Teruel;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
44 Teruel;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;84,67
44 Teruel;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
44 Teruel;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
44 Teruel;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
44 Teruel;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
44 Teruel;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
44 Teruel;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
44 Teruel;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QIII;531
44 Teruel;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
44 Teruel;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
44 Teruel;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
44 Teruel;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QIII;482
44 Teruel;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
44 Teruel;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
44 Teruel;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
44 Teruel;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QIII;448
44 Teruel;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
44 Teruel;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
44 Teruel;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
44 Teruel;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2022QIII;511
44 Teruel;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2022QII;""
44 Teruel;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2022QI;""
44 Teruel;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
44 Teruel;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2021QIII;470
44 Teruel;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2021QII;""
44 Teruel;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2021QI;""
44 Teruel;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
44 Teruel;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2020QIII;426
44 Teruel;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2020QII;""
44 Teruel;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2020QI;""
44 Teruel;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2022QIV;470
44 Teruel;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
44 Teruel;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2022QII;""
44 Teruel;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2022QI;""
44 Teruel;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2021QIV;451
44 Teruel;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
44 Teruel;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2021QII;""
44 Teruel;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2021QI;""
44 Teruel;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2020QIV;402
44 Teruel;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
44 Teruel;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2020QII;""
44 Teruel;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2020QI;""
44 Teruel;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
44 Teruel;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
44 Teruel;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QII;""
44 Teruel;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QI;435
44 Teruel;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
44 Teruel;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
44 Teruel;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QII;""
44 Teruel;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QI;384
44 Teruel;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
44 Teruel;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
44 Teruel;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QII;""
44 Teruel;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QI;""
44 Teruel;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
44 Teruel;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
44 Teruel;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QII;418
44 Teruel;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QI;""
44 Teruel;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
44 Teruel;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
44 Teruel;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QII;370
44 Teruel;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QI;""
44 Teruel;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
44 Teruel;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
44 Teruel;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QII;""
44 Teruel;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QI;""
44 Teruel;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
44 Teruel;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
44 Teruel;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
44 Teruel;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
44 Teruel;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
44 Teruel;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
44 Teruel;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
44 Teruel;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
44 Teruel;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
44 Teruel;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
44 Teruel;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
44 Teruel;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
44 Teruel;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
44 Teruel;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;96,23
44 Teruel;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
44 Teruel;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
44 Teruel;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
44 Teruel;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;97,51
44 Teruel;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
44 Teruel;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
44 Teruel;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
44 Teruel;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;95,09
44 Teruel;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
44 Teruel;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
44 Teruel;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;88,51
44 Teruel;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
44 Teruel;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
44 Teruel;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
44 Teruel;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;93,57
44 Teruel;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
44 Teruel;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
44 Teruel;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
44 Teruel;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;89,73
44 Teruel;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
44 Teruel;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
44 Teruel;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
44 Teruel;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
44 Teruel;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
44 Teruel;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
44 Teruel;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;90,25
44 Teruel;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
44 Teruel;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
44 Teruel;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
44 Teruel;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;85,71
44 Teruel;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
44 Teruel;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
44 Teruel;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
44 Teruel;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
44 Teruel;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
44 Teruel;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
44 Teruel;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;86,72
44 Teruel;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
44 Teruel;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
44 Teruel;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
44 Teruel;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;82,59
44 Teruel;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
44 Teruel;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
44 Teruel;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
44 Teruel;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
44 Teruel;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
44 Teruel;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QIV;1.464
44 Teruel;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
44 Teruel;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
44 Teruel;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
44 Teruel;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QIV;1.379
44 Teruel;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
44 Teruel;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
44 Teruel;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
44 Teruel;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QIV;1.270
44 Teruel;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
44 Teruel;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
44 Teruel;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
44 Teruel;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2022QIV;1.326
44 Teruel;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
44 Teruel;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2022QII;""
44 Teruel;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2022QI;""
44 Teruel;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2021QIV;1.328
44 Teruel;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
44 Teruel;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2021QII;""
44 Teruel;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2021QI;""
44 Teruel;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2020QIV;1.202
44 Teruel;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
44 Teruel;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2020QII;""
44 Teruel;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2020QI;""
44 Teruel;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
44 Teruel;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
44 Teruel;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2022QII;""
44 Teruel;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2022QI;1.282
44 Teruel;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
44 Teruel;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
44 Teruel;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2021QII;""
44 Teruel;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2021QI;1.157
44 Teruel;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
44 Teruel;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
44 Teruel;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2020QII;""
44 Teruel;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2020QI;""
44 Teruel;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
44 Teruel;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
44 Teruel;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QII;1.236
44 Teruel;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QI;""
44 Teruel;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
44 Teruel;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
44 Teruel;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QII;1.119
44 Teruel;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QI;""
44 Teruel;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
44 Teruel;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
44 Teruel;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QII;""
44 Teruel;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QI;""
44 Teruel;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
44 Teruel;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QIII;1.192
44 Teruel;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QII;""
44 Teruel;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QI;""
44 Teruel;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
44 Teruel;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QIII;1.080
44 Teruel;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QII;""
44 Teruel;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QI;""
44 Teruel;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
44 Teruel;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
44 Teruel;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QII;""
44 Teruel;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QI;""
44 Teruel;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
44 Teruel;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
44 Teruel;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
44 Teruel;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
44 Teruel;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
44 Teruel;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
44 Teruel;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
44 Teruel;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
44 Teruel;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
44 Teruel;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
44 Teruel;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
44 Teruel;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
44 Teruel;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;90,57
44 Teruel;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
44 Teruel;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
44 Teruel;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
44 Teruel;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;96,3
44 Teruel;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
44 Teruel;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
44 Teruel;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
44 Teruel;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;94,65
44 Teruel;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
44 Teruel;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
44 Teruel;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
44 Teruel;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
44 Teruel;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
44 Teruel;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
44 Teruel;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;92,97
44 Teruel;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
44 Teruel;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
44 Teruel;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
44 Teruel;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;91,1
44 Teruel;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
44 Teruel;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
44 Teruel;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
44 Teruel;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
44 Teruel;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
44 Teruel;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
44 Teruel;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;89,63
44 Teruel;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
44 Teruel;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
44 Teruel;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
44 Teruel;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;88,11
44 Teruel;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
44 Teruel;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
44 Teruel;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
44 Teruel;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
44 Teruel;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
44 Teruel;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
44 Teruel;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;86,44
44 Teruel;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
44 Teruel;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
44 Teruel;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
44 Teruel;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;85,04
44 Teruel;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
44 Teruel;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
44 Teruel;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
44 Teruel;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
44 Teruel;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
44 Teruel;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
44 Teruel;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QIV;948
44 Teruel;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
44 Teruel;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
44 Teruel;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
44 Teruel;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QIV;905
44 Teruel;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
44 Teruel;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
44 Teruel;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
44 Teruel;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QIV;840
44 Teruel;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
44 Teruel;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
44 Teruel;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
44 Teruel;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2022QIV;852
44 Teruel;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
44 Teruel;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2022QII;""
44 Teruel;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2022QI;""
44 Teruel;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2021QIV;873
44 Teruel;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
44 Teruel;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2021QII;""
44 Teruel;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2021QI;""
44 Teruel;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2020QIV;796
44 Teruel;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
44 Teruel;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2020QII;""
44 Teruel;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2020QI;""
44 Teruel;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
44 Teruel;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
44 Teruel;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2022QII;""
44 Teruel;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2022QI;843
44 Teruel;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
44 Teruel;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
44 Teruel;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2021QII;""
44 Teruel;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2021QI;769
44 Teruel;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
44 Teruel;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
44 Teruel;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2020QII;""
44 Teruel;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2020QI;""
44 Teruel;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
44 Teruel;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
44 Teruel;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QII;815
44 Teruel;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QI;""
44 Teruel;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
44 Teruel;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
44 Teruel;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QII;745
44 Teruel;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QI;""
44 Teruel;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
44 Teruel;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
44 Teruel;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QII;""
44 Teruel;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QI;""
44 Teruel;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
44 Teruel;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QIII;788
44 Teruel;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QII;""
44 Teruel;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QI;""
44 Teruel;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
44 Teruel;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QIII;716
44 Teruel;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QII;""
44 Teruel;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QI;""
44 Teruel;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
44 Teruel;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
44 Teruel;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QII;""
44 Teruel;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QI;""
44 Teruel;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
44 Teruel;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
44 Teruel;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
44 Teruel;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
44 Teruel;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
44 Teruel;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
44 Teruel;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
44 Teruel;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
44 Teruel;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
44 Teruel;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
44 Teruel;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
44 Teruel;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
44 Teruel;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;89,87
44 Teruel;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
44 Teruel;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
44 Teruel;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
44 Teruel;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;96,46
44 Teruel;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
44 Teruel;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
44 Teruel;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
44 Teruel;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;94,76
44 Teruel;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
44 Teruel;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
44 Teruel;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
44 Teruel;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
44 Teruel;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
44 Teruel;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
44 Teruel;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;93,15
44 Teruel;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
44 Teruel;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
44 Teruel;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
44 Teruel;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;91,55
44 Teruel;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
44 Teruel;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
44 Teruel;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
44 Teruel;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
44 Teruel;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
44 Teruel;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
44 Teruel;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;90,06
44 Teruel;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
44 Teruel;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
44 Teruel;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
44 Teruel;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;88,69
44 Teruel;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
44 Teruel;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
44 Teruel;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
44 Teruel;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
44 Teruel;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
44 Teruel;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
44 Teruel;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;87,07
44 Teruel;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
44 Teruel;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
44 Teruel;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
44 Teruel;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;85,24
44 Teruel;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
44 Teruel;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
44 Teruel;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
44 Teruel;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
44 Teruel;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
44 Teruel;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
44 Teruel;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QIV;516
44 Teruel;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
44 Teruel;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
44 Teruel;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
44 Teruel;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QIV;474
44 Teruel;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
44 Teruel;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
44 Teruel;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
44 Teruel;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QIV;430
44 Teruel;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
44 Teruel;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
44 Teruel;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
44 Teruel;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2022QIV;474
44 Teruel;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
44 Teruel;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2022QII;""
44 Teruel;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2022QI;""
44 Teruel;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2021QIV;455
44 Teruel;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
44 Teruel;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2021QII;""
44 Teruel;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2021QI;""
44 Teruel;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2020QIV;406
44 Teruel;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
44 Teruel;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2020QII;""
44 Teruel;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2020QI;""
44 Teruel;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
44 Teruel;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
44 Teruel;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2022QII;""
44 Teruel;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2022QI;439
44 Teruel;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
44 Teruel;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
44 Teruel;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2021QII;""
44 Teruel;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2021QI;388
44 Teruel;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
44 Teruel;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
44 Teruel;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2020QII;""
44 Teruel;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2020QI;""
44 Teruel;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
44 Teruel;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
44 Teruel;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QII;421
44 Teruel;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QI;""
44 Teruel;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
44 Teruel;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
44 Teruel;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QII;374
44 Teruel;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QI;""
44 Teruel;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
44 Teruel;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
44 Teruel;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QII;""
44 Teruel;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QI;""
44 Teruel;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
44 Teruel;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QIII;404
44 Teruel;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QII;""
44 Teruel;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QI;""
44 Teruel;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
44 Teruel;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QIII;364
44 Teruel;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QII;""
44 Teruel;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QI;""
44 Teruel;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
44 Teruel;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
44 Teruel;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QII;""
44 Teruel;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QI;""
44 Teruel;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
44 Teruel;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
44 Teruel;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
44 Teruel;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
44 Teruel;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
44 Teruel;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
44 Teruel;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
44 Teruel;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
44 Teruel;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
44 Teruel;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
44 Teruel;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
44 Teruel;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
44 Teruel;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;91,86
44 Teruel;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
44 Teruel;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
44 Teruel;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
44 Teruel;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;95,99
44 Teruel;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
44 Teruel;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
44 Teruel;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
44 Teruel;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;94,42
44 Teruel;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
44 Teruel;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
44 Teruel;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
44 Teruel;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
44 Teruel;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
44 Teruel;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
44 Teruel;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;92,62
44 Teruel;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
44 Teruel;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
44 Teruel;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
44 Teruel;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;90,23
44 Teruel;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
44 Teruel;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
44 Teruel;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
44 Teruel;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
44 Teruel;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
44 Teruel;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
44 Teruel;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;88,82
44 Teruel;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
44 Teruel;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
44 Teruel;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
44 Teruel;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;86,98
44 Teruel;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
44 Teruel;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
44 Teruel;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
44 Teruel;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
44 Teruel;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
44 Teruel;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
44 Teruel;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;85,23
44 Teruel;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
44 Teruel;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
44 Teruel;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
44 Teruel;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;84,65
44 Teruel;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
44 Teruel;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
44 Teruel;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
44 Teruel;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
44 Teruel;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
44 Teruel;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
45 Toledo;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
45 Toledo;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
45 Toledo;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
45 Toledo;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QI;44.114
45 Toledo;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
45 Toledo;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
45 Toledo;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
45 Toledo;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QI;43.439
45 Toledo;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
45 Toledo;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
45 Toledo;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
45 Toledo;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QI;43.809
45 Toledo;All ages;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
45 Toledo;All ages;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
45 Toledo;All ages;Cohort January 1;Total;Survival in the first trimester;2022QII;""
45 Toledo;All ages;Cohort January 1;Total;Survival in the first trimester;2022QI;42.728
45 Toledo;All ages;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
45 Toledo;All ages;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
45 Toledo;All ages;Cohort January 1;Total;Survival in the first trimester;2021QII;""
45 Toledo;All ages;Cohort January 1;Total;Survival in the first trimester;2021QI;42.408
45 Toledo;All ages;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
45 Toledo;All ages;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
45 Toledo;All ages;Cohort January 1;Total;Survival in the first trimester;2020QII;""
45 Toledo;All ages;Cohort January 1;Total;Survival in the first trimester;2020QI;40.904
45 Toledo;All ages;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
45 Toledo;All ages;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
45 Toledo;All ages;Cohort January 1;Total;Survival in the second trimester;2022QII;41.419
45 Toledo;All ages;Cohort January 1;Total;Survival in the second trimester;2022QI;""
45 Toledo;All ages;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
45 Toledo;All ages;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
45 Toledo;All ages;Cohort January 1;Total;Survival in the second trimester;2021QII;41.071
45 Toledo;All ages;Cohort January 1;Total;Survival in the second trimester;2021QI;""
45 Toledo;All ages;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
45 Toledo;All ages;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
45 Toledo;All ages;Cohort January 1;Total;Survival in the second trimester;2020QII;40.147
45 Toledo;All ages;Cohort January 1;Total;Survival in the second trimester;2020QI;""
45 Toledo;All ages;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
45 Toledo;All ages;Cohort January 1;Total;Survival in the third trimester;2022QIII;40.376
45 Toledo;All ages;Cohort January 1;Total;Survival in the third trimester;2022QII;""
45 Toledo;All ages;Cohort January 1;Total;Survival in the third trimester;2022QI;""
45 Toledo;All ages;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
45 Toledo;All ages;Cohort January 1;Total;Survival in the third trimester;2021QIII;40.091
45 Toledo;All ages;Cohort January 1;Total;Survival in the third trimester;2021QII;""
45 Toledo;All ages;Cohort January 1;Total;Survival in the third trimester;2021QI;""
45 Toledo;All ages;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
45 Toledo;All ages;Cohort January 1;Total;Survival in the third trimester;2020QIII;39.225
45 Toledo;All ages;Cohort January 1;Total;Survival in the third trimester;2020QII;""
45 Toledo;All ages;Cohort January 1;Total;Survival in the third trimester;2020QI;""
45 Toledo;All ages;Cohort January 1;Total;Survival in the third trimester;2022QIV;39.071
45 Toledo;All ages;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
45 Toledo;All ages;Cohort January 1;Total;Survival in the third trimester;2022QII;""
45 Toledo;All ages;Cohort January 1;Total;Survival in the third trimester;2022QI;""
45 Toledo;All ages;Cohort January 1;Total;Survival in the third trimester;2021QIV;39.025
45 Toledo;All ages;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
45 Toledo;All ages;Cohort January 1;Total;Survival in the third trimester;2021QII;""
45 Toledo;All ages;Cohort January 1;Total;Survival in the third trimester;2021QI;""
45 Toledo;All ages;Cohort January 1;Total;Survival in the third trimester;2020QIV;38.350
45 Toledo;All ages;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
45 Toledo;All ages;Cohort January 1;Total;Survival in the third trimester;2020QII;""
45 Toledo;All ages;Cohort January 1;Total;Survival in the third trimester;2020QI;""
45 Toledo;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
45 Toledo;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
45 Toledo;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
45 Toledo;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
45 Toledo;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
45 Toledo;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
45 Toledo;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
45 Toledo;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
45 Toledo;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
45 Toledo;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
45 Toledo;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
45 Toledo;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
45 Toledo;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
45 Toledo;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
45 Toledo;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
45 Toledo;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;96,86
45 Toledo;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
45 Toledo;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
45 Toledo;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
45 Toledo;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;97,63
45 Toledo;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
45 Toledo;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
45 Toledo;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
45 Toledo;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;93,37
45 Toledo;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
45 Toledo;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
45 Toledo;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;93,89
45 Toledo;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
45 Toledo;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
45 Toledo;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
45 Toledo;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;94,55
45 Toledo;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
45 Toledo;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
45 Toledo;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
45 Toledo;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;91,64
45 Toledo;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
45 Toledo;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
45 Toledo;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;91,53
45 Toledo;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
45 Toledo;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
45 Toledo;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
45 Toledo;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;92,29
45 Toledo;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
45 Toledo;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
45 Toledo;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
45 Toledo;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;89,54
45 Toledo;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
45 Toledo;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
45 Toledo;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;88,57
45 Toledo;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
45 Toledo;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
45 Toledo;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
45 Toledo;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;89,84
45 Toledo;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
45 Toledo;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
45 Toledo;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
45 Toledo;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;87,54
45 Toledo;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
45 Toledo;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
45 Toledo;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
45 Toledo;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
45 Toledo;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
45 Toledo;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
45 Toledo;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QI;29.372
45 Toledo;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
45 Toledo;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
45 Toledo;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
45 Toledo;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QI;29.151
45 Toledo;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
45 Toledo;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
45 Toledo;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
45 Toledo;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QI;29.444
45 Toledo;All ages;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
45 Toledo;All ages;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
45 Toledo;All ages;Cohort January 1;Males;Survival in the first trimester;2022QII;""
45 Toledo;All ages;Cohort January 1;Males;Survival in the first trimester;2022QI;28.527
45 Toledo;All ages;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
45 Toledo;All ages;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
45 Toledo;All ages;Cohort January 1;Males;Survival in the first trimester;2021QII;""
45 Toledo;All ages;Cohort January 1;Males;Survival in the first trimester;2021QI;28.506
45 Toledo;All ages;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
45 Toledo;All ages;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
45 Toledo;All ages;Cohort January 1;Males;Survival in the first trimester;2020QII;""
45 Toledo;All ages;Cohort January 1;Males;Survival in the first trimester;2020QI;27.623
45 Toledo;All ages;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
45 Toledo;All ages;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
45 Toledo;All ages;Cohort January 1;Males;Survival in the second trimester;2022QII;27.769
45 Toledo;All ages;Cohort January 1;Males;Survival in the second trimester;2022QI;""
45 Toledo;All ages;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
45 Toledo;All ages;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
45 Toledo;All ages;Cohort January 1;Males;Survival in the second trimester;2021QII;27.669
45 Toledo;All ages;Cohort January 1;Males;Survival in the second trimester;2021QI;""
45 Toledo;All ages;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
45 Toledo;All ages;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
45 Toledo;All ages;Cohort January 1;Males;Survival in the second trimester;2020QII;27.180
45 Toledo;All ages;Cohort January 1;Males;Survival in the second trimester;2020QI;""
45 Toledo;All ages;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
45 Toledo;All ages;Cohort January 1;Males;Survival in the third trimester;2022QIII;27.135
45 Toledo;All ages;Cohort January 1;Males;Survival in the third trimester;2022QII;""
45 Toledo;All ages;Cohort January 1;Males;Survival in the third trimester;2022QI;""
45 Toledo;All ages;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
45 Toledo;All ages;Cohort January 1;Males;Survival in the third trimester;2021QIII;27.066
45 Toledo;All ages;Cohort January 1;Males;Survival in the third trimester;2021QII;""
45 Toledo;All ages;Cohort January 1;Males;Survival in the third trimester;2021QI;""
45 Toledo;All ages;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
45 Toledo;All ages;Cohort January 1;Males;Survival in the third trimester;2020QIII;26.597
45 Toledo;All ages;Cohort January 1;Males;Survival in the third trimester;2020QII;""
45 Toledo;All ages;Cohort January 1;Males;Survival in the third trimester;2020QI;""
45 Toledo;All ages;Cohort January 1;Males;Survival in the third trimester;2022QIV;26.320
45 Toledo;All ages;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
45 Toledo;All ages;Cohort January 1;Males;Survival in the third trimester;2022QII;""
45 Toledo;All ages;Cohort January 1;Males;Survival in the third trimester;2022QI;""
45 Toledo;All ages;Cohort January 1;Males;Survival in the third trimester;2021QIV;26.377
45 Toledo;All ages;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
45 Toledo;All ages;Cohort January 1;Males;Survival in the third trimester;2021QII;""
45 Toledo;All ages;Cohort January 1;Males;Survival in the third trimester;2021QI;""
45 Toledo;All ages;Cohort January 1;Males;Survival in the third trimester;2020QIV;26.041
45 Toledo;All ages;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
45 Toledo;All ages;Cohort January 1;Males;Survival in the third trimester;2020QII;""
45 Toledo;All ages;Cohort January 1;Males;Survival in the third trimester;2020QI;""
45 Toledo;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
45 Toledo;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
45 Toledo;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
45 Toledo;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
45 Toledo;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
45 Toledo;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
45 Toledo;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
45 Toledo;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
45 Toledo;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
45 Toledo;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
45 Toledo;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
45 Toledo;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
45 Toledo;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
45 Toledo;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
45 Toledo;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
45 Toledo;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;97,12
45 Toledo;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
45 Toledo;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
45 Toledo;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
45 Toledo;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;97,79
45 Toledo;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
45 Toledo;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
45 Toledo;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
45 Toledo;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;93,82
45 Toledo;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
45 Toledo;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
45 Toledo;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;94,54
45 Toledo;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
45 Toledo;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
45 Toledo;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
45 Toledo;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;94,92
45 Toledo;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
45 Toledo;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
45 Toledo;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
45 Toledo;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;92,31
45 Toledo;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
45 Toledo;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
45 Toledo;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;92,38
45 Toledo;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
45 Toledo;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
45 Toledo;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
45 Toledo;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;92,85
45 Toledo;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
45 Toledo;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
45 Toledo;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
45 Toledo;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;90,33
45 Toledo;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
45 Toledo;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
45 Toledo;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;89,61
45 Toledo;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
45 Toledo;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
45 Toledo;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
45 Toledo;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;90,48
45 Toledo;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
45 Toledo;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
45 Toledo;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
45 Toledo;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;88,44
45 Toledo;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
45 Toledo;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
45 Toledo;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
45 Toledo;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
45 Toledo;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
45 Toledo;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
45 Toledo;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QI;14.742
45 Toledo;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
45 Toledo;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
45 Toledo;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
45 Toledo;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QI;14.288
45 Toledo;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
45 Toledo;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
45 Toledo;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
45 Toledo;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QI;14.365
45 Toledo;All ages;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
45 Toledo;All ages;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
45 Toledo;All ages;Cohort January 1;Females;Survival in the first trimester;2022QII;""
45 Toledo;All ages;Cohort January 1;Females;Survival in the first trimester;2022QI;14.201
45 Toledo;All ages;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
45 Toledo;All ages;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
45 Toledo;All ages;Cohort January 1;Females;Survival in the first trimester;2021QII;""
45 Toledo;All ages;Cohort January 1;Females;Survival in the first trimester;2021QI;13.902
45 Toledo;All ages;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
45 Toledo;All ages;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
45 Toledo;All ages;Cohort January 1;Females;Survival in the first trimester;2020QII;""
45 Toledo;All ages;Cohort January 1;Females;Survival in the first trimester;2020QI;13.281
45 Toledo;All ages;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
45 Toledo;All ages;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
45 Toledo;All ages;Cohort January 1;Females;Survival in the second trimester;2022QII;13.650
45 Toledo;All ages;Cohort January 1;Females;Survival in the second trimester;2022QI;""
45 Toledo;All ages;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
45 Toledo;All ages;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
45 Toledo;All ages;Cohort January 1;Females;Survival in the second trimester;2021QII;13.402
45 Toledo;All ages;Cohort January 1;Females;Survival in the second trimester;2021QI;""
45 Toledo;All ages;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
45 Toledo;All ages;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
45 Toledo;All ages;Cohort January 1;Females;Survival in the second trimester;2020QII;12.967
45 Toledo;All ages;Cohort January 1;Females;Survival in the second trimester;2020QI;""
45 Toledo;All ages;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
45 Toledo;All ages;Cohort January 1;Females;Survival in the third trimester;2022QIII;13.241
45 Toledo;All ages;Cohort January 1;Females;Survival in the third trimester;2022QII;""
45 Toledo;All ages;Cohort January 1;Females;Survival in the third trimester;2022QI;""
45 Toledo;All ages;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
45 Toledo;All ages;Cohort January 1;Females;Survival in the third trimester;2021QIII;13.025
45 Toledo;All ages;Cohort January 1;Females;Survival in the third trimester;2021QII;""
45 Toledo;All ages;Cohort January 1;Females;Survival in the third trimester;2021QI;""
45 Toledo;All ages;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
45 Toledo;All ages;Cohort January 1;Females;Survival in the third trimester;2020QIII;12.628
45 Toledo;All ages;Cohort January 1;Females;Survival in the third trimester;2020QII;""
45 Toledo;All ages;Cohort January 1;Females;Survival in the third trimester;2020QI;""
45 Toledo;All ages;Cohort January 1;Females;Survival in the third trimester;2022QIV;12.751
45 Toledo;All ages;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
45 Toledo;All ages;Cohort January 1;Females;Survival in the third trimester;2022QII;""
45 Toledo;All ages;Cohort January 1;Females;Survival in the third trimester;2022QI;""
45 Toledo;All ages;Cohort January 1;Females;Survival in the third trimester;2021QIV;12.648
45 Toledo;All ages;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
45 Toledo;All ages;Cohort January 1;Females;Survival in the third trimester;2021QII;""
45 Toledo;All ages;Cohort January 1;Females;Survival in the third trimester;2021QI;""
45 Toledo;All ages;Cohort January 1;Females;Survival in the third trimester;2020QIV;12.309
45 Toledo;All ages;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
45 Toledo;All ages;Cohort January 1;Females;Survival in the third trimester;2020QII;""
45 Toledo;All ages;Cohort January 1;Females;Survival in the third trimester;2020QI;""
45 Toledo;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
45 Toledo;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
45 Toledo;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
45 Toledo;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
45 Toledo;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
45 Toledo;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
45 Toledo;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
45 Toledo;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
45 Toledo;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
45 Toledo;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
45 Toledo;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
45 Toledo;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
45 Toledo;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
45 Toledo;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
45 Toledo;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
45 Toledo;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;96,33
45 Toledo;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
45 Toledo;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
45 Toledo;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
45 Toledo;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;97,3
45 Toledo;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
45 Toledo;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
45 Toledo;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
45 Toledo;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;92,45
45 Toledo;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
45 Toledo;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
45 Toledo;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;92,59
45 Toledo;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
45 Toledo;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
45 Toledo;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
45 Toledo;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;93,8
45 Toledo;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
45 Toledo;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
45 Toledo;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
45 Toledo;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;90,27
45 Toledo;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
45 Toledo;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
45 Toledo;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;89,82
45 Toledo;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
45 Toledo;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
45 Toledo;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
45 Toledo;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;91,16
45 Toledo;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
45 Toledo;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
45 Toledo;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
45 Toledo;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;87,91
45 Toledo;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
45 Toledo;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
45 Toledo;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;86,49
45 Toledo;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
45 Toledo;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
45 Toledo;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
45 Toledo;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;88,52
45 Toledo;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
45 Toledo;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
45 Toledo;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
45 Toledo;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;85,69
45 Toledo;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
45 Toledo;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
45 Toledo;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
45 Toledo;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
45 Toledo;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
45 Toledo;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QII;44.204
45 Toledo;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
45 Toledo;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
45 Toledo;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
45 Toledo;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QII;43.903
45 Toledo;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
45 Toledo;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
45 Toledo;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
45 Toledo;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QII;42.553
45 Toledo;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
45 Toledo;All ages;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
45 Toledo;All ages;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
45 Toledo;All ages;Cohort April 1;Total;Survival in the first trimester;2022QII;42.748
45 Toledo;All ages;Cohort April 1;Total;Survival in the first trimester;2022QI;""
45 Toledo;All ages;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
45 Toledo;All ages;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
45 Toledo;All ages;Cohort April 1;Total;Survival in the first trimester;2021QII;42.409
45 Toledo;All ages;Cohort April 1;Total;Survival in the first trimester;2021QI;""
45 Toledo;All ages;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
45 Toledo;All ages;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
45 Toledo;All ages;Cohort April 1;Total;Survival in the first trimester;2020QII;41.691
45 Toledo;All ages;Cohort April 1;Total;Survival in the first trimester;2020QI;""
45 Toledo;All ages;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
45 Toledo;All ages;Cohort April 1;Total;Survival in the second trimester;2022QIII;41.612
45 Toledo;All ages;Cohort April 1;Total;Survival in the second trimester;2022QII;""
45 Toledo;All ages;Cohort April 1;Total;Survival in the second trimester;2022QI;""
45 Toledo;All ages;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
45 Toledo;All ages;Cohort April 1;Total;Survival in the second trimester;2021QIII;41.318
45 Toledo;All ages;Cohort April 1;Total;Survival in the second trimester;2021QII;""
45 Toledo;All ages;Cohort April 1;Total;Survival in the second trimester;2021QI;""
45 Toledo;All ages;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
45 Toledo;All ages;Cohort April 1;Total;Survival in the second trimester;2020QIII;40.652
45 Toledo;All ages;Cohort April 1;Total;Survival in the second trimester;2020QII;""
45 Toledo;All ages;Cohort April 1;Total;Survival in the second trimester;2020QI;""
45 Toledo;All ages;Cohort April 1;Total;Survival in the third trimester;2022QIV;40.219
45 Toledo;All ages;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
45 Toledo;All ages;Cohort April 1;Total;Survival in the third trimester;2022QII;""
45 Toledo;All ages;Cohort April 1;Total;Survival in the third trimester;2022QI;""
45 Toledo;All ages;Cohort April 1;Total;Survival in the third trimester;2021QIV;40.174
45 Toledo;All ages;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
45 Toledo;All ages;Cohort April 1;Total;Survival in the third trimester;2021QII;""
45 Toledo;All ages;Cohort April 1;Total;Survival in the third trimester;2021QI;""
45 Toledo;All ages;Cohort April 1;Total;Survival in the third trimester;2020QIV;39.695
45 Toledo;All ages;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
45 Toledo;All ages;Cohort April 1;Total;Survival in the third trimester;2020QII;""
45 Toledo;All ages;Cohort April 1;Total;Survival in the third trimester;2020QI;""
45 Toledo;All ages;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
45 Toledo;All ages;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
45 Toledo;All ages;Cohort April 1;Total;Survival in the third trimester;2022QII;""
45 Toledo;All ages;Cohort April 1;Total;Survival in the third trimester;2022QI;39.137
45 Toledo;All ages;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
45 Toledo;All ages;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
45 Toledo;All ages;Cohort April 1;Total;Survival in the third trimester;2021QII;""
45 Toledo;All ages;Cohort April 1;Total;Survival in the third trimester;2021QI;38.949
45 Toledo;All ages;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
45 Toledo;All ages;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
45 Toledo;All ages;Cohort April 1;Total;Survival in the third trimester;2020QII;""
45 Toledo;All ages;Cohort April 1;Total;Survival in the third trimester;2020QI;""
45 Toledo;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
45 Toledo;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
45 Toledo;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
45 Toledo;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
45 Toledo;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
45 Toledo;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
45 Toledo;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
45 Toledo;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
45 Toledo;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
45 Toledo;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
45 Toledo;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
45 Toledo;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
45 Toledo;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
45 Toledo;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
45 Toledo;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;96,71
45 Toledo;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
45 Toledo;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
45 Toledo;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
45 Toledo;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;96,6
45 Toledo;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
45 Toledo;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
45 Toledo;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
45 Toledo;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;97,97
45 Toledo;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
45 Toledo;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
45 Toledo;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;94,14
45 Toledo;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
45 Toledo;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
45 Toledo;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
45 Toledo;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;94,11
45 Toledo;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
45 Toledo;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
45 Toledo;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
45 Toledo;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;95,53
45 Toledo;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
45 Toledo;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
45 Toledo;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;90,98
45 Toledo;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
45 Toledo;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
45 Toledo;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
45 Toledo;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;91,51
45 Toledo;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
45 Toledo;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
45 Toledo;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
45 Toledo;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;93,28
45 Toledo;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
45 Toledo;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
45 Toledo;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
45 Toledo;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
45 Toledo;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
45 Toledo;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
45 Toledo;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;89,14
45 Toledo;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
45 Toledo;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
45 Toledo;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
45 Toledo;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;91,53
45 Toledo;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
45 Toledo;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
45 Toledo;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
45 Toledo;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
45 Toledo;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
45 Toledo;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
45 Toledo;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QII;29.410
45 Toledo;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
45 Toledo;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
45 Toledo;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
45 Toledo;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QII;29.436
45 Toledo;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
45 Toledo;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
45 Toledo;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
45 Toledo;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QII;28.622
45 Toledo;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
45 Toledo;All ages;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
45 Toledo;All ages;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
45 Toledo;All ages;Cohort April 1;Males;Survival in the first trimester;2022QII;28.565
45 Toledo;All ages;Cohort April 1;Males;Survival in the first trimester;2022QI;""
45 Toledo;All ages;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
45 Toledo;All ages;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
45 Toledo;All ages;Cohort April 1;Males;Survival in the first trimester;2021QII;28.494
45 Toledo;All ages;Cohort April 1;Males;Survival in the first trimester;2021QI;""
45 Toledo;All ages;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
45 Toledo;All ages;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
45 Toledo;All ages;Cohort April 1;Males;Survival in the first trimester;2020QII;28.116
45 Toledo;All ages;Cohort April 1;Males;Survival in the first trimester;2020QI;""
45 Toledo;All ages;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
45 Toledo;All ages;Cohort April 1;Males;Survival in the second trimester;2022QIII;27.871
45 Toledo;All ages;Cohort April 1;Males;Survival in the second trimester;2022QII;""
45 Toledo;All ages;Cohort April 1;Males;Survival in the second trimester;2022QI;""
45 Toledo;All ages;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
45 Toledo;All ages;Cohort April 1;Males;Survival in the second trimester;2021QIII;27.822
45 Toledo;All ages;Cohort April 1;Males;Survival in the second trimester;2021QII;""
45 Toledo;All ages;Cohort April 1;Males;Survival in the second trimester;2021QI;""
45 Toledo;All ages;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
45 Toledo;All ages;Cohort April 1;Males;Survival in the second trimester;2020QIII;27.451
45 Toledo;All ages;Cohort April 1;Males;Survival in the second trimester;2020QII;""
45 Toledo;All ages;Cohort April 1;Males;Survival in the second trimester;2020QI;""
45 Toledo;All ages;Cohort April 1;Males;Survival in the third trimester;2022QIV;27.002
45 Toledo;All ages;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
45 Toledo;All ages;Cohort April 1;Males;Survival in the third trimester;2022QII;""
45 Toledo;All ages;Cohort April 1;Males;Survival in the third trimester;2022QI;""
45 Toledo;All ages;Cohort April 1;Males;Survival in the third trimester;2021QIV;27.086
45 Toledo;All ages;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
45 Toledo;All ages;Cohort April 1;Males;Survival in the third trimester;2021QII;""
45 Toledo;All ages;Cohort April 1;Males;Survival in the third trimester;2021QI;""
45 Toledo;All ages;Cohort April 1;Males;Survival in the third trimester;2020QIV;26.846
45 Toledo;All ages;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
45 Toledo;All ages;Cohort April 1;Males;Survival in the third trimester;2020QII;""
45 Toledo;All ages;Cohort April 1;Males;Survival in the third trimester;2020QI;""
45 Toledo;All ages;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
45 Toledo;All ages;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
45 Toledo;All ages;Cohort April 1;Males;Survival in the third trimester;2022QII;""
45 Toledo;All ages;Cohort April 1;Males;Survival in the third trimester;2022QI;26.467
45 Toledo;All ages;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
45 Toledo;All ages;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
45 Toledo;All ages;Cohort April 1;Males;Survival in the third trimester;2021QII;""
45 Toledo;All ages;Cohort April 1;Males;Survival in the third trimester;2021QI;26.373
45 Toledo;All ages;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
45 Toledo;All ages;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
45 Toledo;All ages;Cohort April 1;Males;Survival in the third trimester;2020QII;""
45 Toledo;All ages;Cohort April 1;Males;Survival in the third trimester;2020QI;""
45 Toledo;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
45 Toledo;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
45 Toledo;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
45 Toledo;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
45 Toledo;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
45 Toledo;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
45 Toledo;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
45 Toledo;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
45 Toledo;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
45 Toledo;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
45 Toledo;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
45 Toledo;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
45 Toledo;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
45 Toledo;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
45 Toledo;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;97,13
45 Toledo;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
45 Toledo;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
45 Toledo;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
45 Toledo;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;96,8
45 Toledo;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
45 Toledo;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
45 Toledo;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
45 Toledo;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;98,23
45 Toledo;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
45 Toledo;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
45 Toledo;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;94,77
45 Toledo;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
45 Toledo;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
45 Toledo;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
45 Toledo;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;94,52
45 Toledo;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
45 Toledo;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
45 Toledo;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
45 Toledo;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;95,91
45 Toledo;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
45 Toledo;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
45 Toledo;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;91,81
45 Toledo;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
45 Toledo;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
45 Toledo;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
45 Toledo;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;92,02
45 Toledo;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
45 Toledo;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
45 Toledo;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
45 Toledo;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;93,79
45 Toledo;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
45 Toledo;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
45 Toledo;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
45 Toledo;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
45 Toledo;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
45 Toledo;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
45 Toledo;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;89,91
45 Toledo;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
45 Toledo;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
45 Toledo;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
45 Toledo;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;92,14
45 Toledo;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
45 Toledo;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
45 Toledo;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
45 Toledo;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
45 Toledo;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
45 Toledo;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
45 Toledo;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QII;14.794
45 Toledo;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
45 Toledo;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
45 Toledo;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
45 Toledo;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QII;14.467
45 Toledo;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
45 Toledo;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
45 Toledo;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
45 Toledo;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QII;13.931
45 Toledo;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
45 Toledo;All ages;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
45 Toledo;All ages;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
45 Toledo;All ages;Cohort April 1;Females;Survival in the first trimester;2022QII;14.183
45 Toledo;All ages;Cohort April 1;Females;Survival in the first trimester;2022QI;""
45 Toledo;All ages;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
45 Toledo;All ages;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
45 Toledo;All ages;Cohort April 1;Females;Survival in the first trimester;2021QII;13.915
45 Toledo;All ages;Cohort April 1;Females;Survival in the first trimester;2021QI;""
45 Toledo;All ages;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
45 Toledo;All ages;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
45 Toledo;All ages;Cohort April 1;Females;Survival in the first trimester;2020QII;13.575
45 Toledo;All ages;Cohort April 1;Females;Survival in the first trimester;2020QI;""
45 Toledo;All ages;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
45 Toledo;All ages;Cohort April 1;Females;Survival in the second trimester;2022QIII;13.741
45 Toledo;All ages;Cohort April 1;Females;Survival in the second trimester;2022QII;""
45 Toledo;All ages;Cohort April 1;Females;Survival in the second trimester;2022QI;""
45 Toledo;All ages;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
45 Toledo;All ages;Cohort April 1;Females;Survival in the second trimester;2021QIII;13.496
45 Toledo;All ages;Cohort April 1;Females;Survival in the second trimester;2021QII;""
45 Toledo;All ages;Cohort April 1;Females;Survival in the second trimester;2021QI;""
45 Toledo;All ages;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
45 Toledo;All ages;Cohort April 1;Females;Survival in the second trimester;2020QIII;13.201
45 Toledo;All ages;Cohort April 1;Females;Survival in the second trimester;2020QII;""
45 Toledo;All ages;Cohort April 1;Females;Survival in the second trimester;2020QI;""
45 Toledo;All ages;Cohort April 1;Females;Survival in the third trimester;2022QIV;13.217
45 Toledo;All ages;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
45 Toledo;All ages;Cohort April 1;Females;Survival in the third trimester;2022QII;""
45 Toledo;All ages;Cohort April 1;Females;Survival in the third trimester;2022QI;""
45 Toledo;All ages;Cohort April 1;Females;Survival in the third trimester;2021QIV;13.088
45 Toledo;All ages;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
45 Toledo;All ages;Cohort April 1;Females;Survival in the third trimester;2021QII;""
45 Toledo;All ages;Cohort April 1;Females;Survival in the third trimester;2021QI;""
45 Toledo;All ages;Cohort April 1;Females;Survival in the third trimester;2020QIV;12.849
45 Toledo;All ages;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
45 Toledo;All ages;Cohort April 1;Females;Survival in the third trimester;2020QII;""
45 Toledo;All ages;Cohort April 1;Females;Survival in the third trimester;2020QI;""
45 Toledo;All ages;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
45 Toledo;All ages;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
45 Toledo;All ages;Cohort April 1;Females;Survival in the third trimester;2022QII;""
45 Toledo;All ages;Cohort April 1;Females;Survival in the third trimester;2022QI;12.670
45 Toledo;All ages;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
45 Toledo;All ages;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
45 Toledo;All ages;Cohort April 1;Females;Survival in the third trimester;2021QII;""
45 Toledo;All ages;Cohort April 1;Females;Survival in the third trimester;2021QI;12.576
45 Toledo;All ages;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
45 Toledo;All ages;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
45 Toledo;All ages;Cohort April 1;Females;Survival in the third trimester;2020QII;""
45 Toledo;All ages;Cohort April 1;Females;Survival in the third trimester;2020QI;""
45 Toledo;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
45 Toledo;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
45 Toledo;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
45 Toledo;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
45 Toledo;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
45 Toledo;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
45 Toledo;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
45 Toledo;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
45 Toledo;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
45 Toledo;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
45 Toledo;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
45 Toledo;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
45 Toledo;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
45 Toledo;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
45 Toledo;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;95,87
45 Toledo;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
45 Toledo;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
45 Toledo;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
45 Toledo;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;96,18
45 Toledo;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
45 Toledo;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
45 Toledo;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
45 Toledo;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;97,44
45 Toledo;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
45 Toledo;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
45 Toledo;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;92,88
45 Toledo;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
45 Toledo;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
45 Toledo;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
45 Toledo;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;93,29
45 Toledo;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
45 Toledo;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
45 Toledo;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
45 Toledo;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;94,76
45 Toledo;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
45 Toledo;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
45 Toledo;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;89,34
45 Toledo;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
45 Toledo;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
45 Toledo;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
45 Toledo;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;90,47
45 Toledo;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
45 Toledo;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
45 Toledo;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
45 Toledo;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;92,23
45 Toledo;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
45 Toledo;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
45 Toledo;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
45 Toledo;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
45 Toledo;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
45 Toledo;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
45 Toledo;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;87,58
45 Toledo;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
45 Toledo;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
45 Toledo;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
45 Toledo;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;90,27
45 Toledo;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
45 Toledo;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
45 Toledo;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
45 Toledo;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
45 Toledo;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
45 Toledo;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QIII;44.374
45 Toledo;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
45 Toledo;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
45 Toledo;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
45 Toledo;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QIII;44.029
45 Toledo;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
45 Toledo;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
45 Toledo;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
45 Toledo;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QIII;43.146
45 Toledo;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
45 Toledo;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
45 Toledo;All ages;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
45 Toledo;All ages;Cohort July 1;Total;Survival in the first trimester;2022QIII;42.951
45 Toledo;All ages;Cohort July 1;Total;Survival in the first trimester;2022QII;""
45 Toledo;All ages;Cohort July 1;Total;Survival in the first trimester;2022QI;""
45 Toledo;All ages;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
45 Toledo;All ages;Cohort July 1;Total;Survival in the first trimester;2021QIII;42.699
45 Toledo;All ages;Cohort July 1;Total;Survival in the first trimester;2021QII;""
45 Toledo;All ages;Cohort July 1;Total;Survival in the first trimester;2021QI;""
45 Toledo;All ages;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
45 Toledo;All ages;Cohort July 1;Total;Survival in the first trimester;2020QIII;41.887
45 Toledo;All ages;Cohort July 1;Total;Survival in the first trimester;2020QII;""
45 Toledo;All ages;Cohort July 1;Total;Survival in the first trimester;2020QI;""
45 Toledo;All ages;Cohort July 1;Total;Survival in the second trimester;2022QIV;41.419
45 Toledo;All ages;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
45 Toledo;All ages;Cohort July 1;Total;Survival in the second trimester;2022QII;""
45 Toledo;All ages;Cohort July 1;Total;Survival in the second trimester;2022QI;""
45 Toledo;All ages;Cohort July 1;Total;Survival in the second trimester;2021QIV;41.415
45 Toledo;All ages;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
45 Toledo;All ages;Cohort July 1;Total;Survival in the second trimester;2021QII;""
45 Toledo;All ages;Cohort July 1;Total;Survival in the second trimester;2021QI;""
45 Toledo;All ages;Cohort July 1;Total;Survival in the second trimester;2020QIV;40.815
45 Toledo;All ages;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
45 Toledo;All ages;Cohort July 1;Total;Survival in the second trimester;2020QII;""
45 Toledo;All ages;Cohort July 1;Total;Survival in the second trimester;2020QI;""
45 Toledo;All ages;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
45 Toledo;All ages;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
45 Toledo;All ages;Cohort July 1;Total;Survival in the third trimester;2022QII;""
45 Toledo;All ages;Cohort July 1;Total;Survival in the third trimester;2022QI;40.306
45 Toledo;All ages;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
45 Toledo;All ages;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
45 Toledo;All ages;Cohort July 1;Total;Survival in the third trimester;2021QII;""
45 Toledo;All ages;Cohort July 1;Total;Survival in the third trimester;2021QI;40.016
45 Toledo;All ages;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
45 Toledo;All ages;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
45 Toledo;All ages;Cohort July 1;Total;Survival in the third trimester;2020QII;""
45 Toledo;All ages;Cohort July 1;Total;Survival in the third trimester;2020QI;""
45 Toledo;All ages;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
45 Toledo;All ages;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
45 Toledo;All ages;Cohort July 1;Total;Survival in the third trimester;2022QII;39.247
45 Toledo;All ages;Cohort July 1;Total;Survival in the third trimester;2022QI;""
45 Toledo;All ages;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
45 Toledo;All ages;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
45 Toledo;All ages;Cohort July 1;Total;Survival in the third trimester;2021QII;38.930
45 Toledo;All ages;Cohort July 1;Total;Survival in the third trimester;2021QI;""
45 Toledo;All ages;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
45 Toledo;All ages;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
45 Toledo;All ages;Cohort July 1;Total;Survival in the third trimester;2020QII;""
45 Toledo;All ages;Cohort July 1;Total;Survival in the third trimester;2020QI;""
45 Toledo;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
45 Toledo;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
45 Toledo;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
45 Toledo;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
45 Toledo;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
45 Toledo;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
45 Toledo;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
45 Toledo;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
45 Toledo;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
45 Toledo;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
45 Toledo;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
45 Toledo;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
45 Toledo;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
45 Toledo;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;96,79
45 Toledo;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
45 Toledo;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
45 Toledo;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
45 Toledo;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;96,98
45 Toledo;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
45 Toledo;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
45 Toledo;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
45 Toledo;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;97,08
45 Toledo;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
45 Toledo;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
45 Toledo;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;93,34
45 Toledo;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
45 Toledo;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
45 Toledo;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
45 Toledo;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;94,06
45 Toledo;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
45 Toledo;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
45 Toledo;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
45 Toledo;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;94,6
45 Toledo;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
45 Toledo;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
45 Toledo;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
45 Toledo;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
45 Toledo;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
45 Toledo;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
45 Toledo;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;91,54
45 Toledo;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
45 Toledo;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
45 Toledo;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
45 Toledo;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;92,75
45 Toledo;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
45 Toledo;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
45 Toledo;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
45 Toledo;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
45 Toledo;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
45 Toledo;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
45 Toledo;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;89,14
45 Toledo;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
45 Toledo;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
45 Toledo;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
45 Toledo;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;90,23
45 Toledo;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
45 Toledo;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
45 Toledo;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
45 Toledo;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
45 Toledo;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
45 Toledo;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
45 Toledo;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QIII;29.512
45 Toledo;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
45 Toledo;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
45 Toledo;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
45 Toledo;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QIII;29.450
45 Toledo;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
45 Toledo;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
45 Toledo;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
45 Toledo;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QIII;29.092
45 Toledo;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
45 Toledo;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
45 Toledo;All ages;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
45 Toledo;All ages;Cohort July 1;Males;Survival in the first trimester;2022QIII;28.650
45 Toledo;All ages;Cohort July 1;Males;Survival in the first trimester;2022QII;""
45 Toledo;All ages;Cohort July 1;Males;Survival in the first trimester;2022QI;""
45 Toledo;All ages;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
45 Toledo;All ages;Cohort July 1;Males;Survival in the first trimester;2021QIII;28.627
45 Toledo;All ages;Cohort July 1;Males;Survival in the first trimester;2021QII;""
45 Toledo;All ages;Cohort July 1;Males;Survival in the first trimester;2021QI;""
45 Toledo;All ages;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
45 Toledo;All ages;Cohort July 1;Males;Survival in the first trimester;2020QIII;28.278
45 Toledo;All ages;Cohort July 1;Males;Survival in the first trimester;2020QII;""
45 Toledo;All ages;Cohort July 1;Males;Survival in the first trimester;2020QI;""
45 Toledo;All ages;Cohort July 1;Males;Survival in the second trimester;2022QIV;27.695
45 Toledo;All ages;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
45 Toledo;All ages;Cohort July 1;Males;Survival in the second trimester;2022QII;""
45 Toledo;All ages;Cohort July 1;Males;Survival in the second trimester;2022QI;""
45 Toledo;All ages;Cohort July 1;Males;Survival in the second trimester;2021QIV;27.804
45 Toledo;All ages;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
45 Toledo;All ages;Cohort July 1;Males;Survival in the second trimester;2021QII;""
45 Toledo;All ages;Cohort July 1;Males;Survival in the second trimester;2021QI;""
45 Toledo;All ages;Cohort July 1;Males;Survival in the second trimester;2020QIV;27.590
45 Toledo;All ages;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
45 Toledo;All ages;Cohort July 1;Males;Survival in the second trimester;2020QII;""
45 Toledo;All ages;Cohort July 1;Males;Survival in the second trimester;2020QI;""
45 Toledo;All ages;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
45 Toledo;All ages;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
45 Toledo;All ages;Cohort July 1;Males;Survival in the third trimester;2022QII;""
45 Toledo;All ages;Cohort July 1;Males;Survival in the third trimester;2022QI;27.140
45 Toledo;All ages;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
45 Toledo;All ages;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
45 Toledo;All ages;Cohort July 1;Males;Survival in the third trimester;2021QII;""
45 Toledo;All ages;Cohort July 1;Males;Survival in the third trimester;2021QI;27.078
45 Toledo;All ages;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
45 Toledo;All ages;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
45 Toledo;All ages;Cohort July 1;Males;Survival in the third trimester;2020QII;""
45 Toledo;All ages;Cohort July 1;Males;Survival in the third trimester;2020QI;""
45 Toledo;All ages;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
45 Toledo;All ages;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
45 Toledo;All ages;Cohort July 1;Males;Survival in the third trimester;2022QII;26.515
45 Toledo;All ages;Cohort July 1;Males;Survival in the third trimester;2022QI;""
45 Toledo;All ages;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
45 Toledo;All ages;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
45 Toledo;All ages;Cohort July 1;Males;Survival in the third trimester;2021QII;26.389
45 Toledo;All ages;Cohort July 1;Males;Survival in the third trimester;2021QI;""
45 Toledo;All ages;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
45 Toledo;All ages;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
45 Toledo;All ages;Cohort July 1;Males;Survival in the third trimester;2020QII;""
45 Toledo;All ages;Cohort July 1;Males;Survival in the third trimester;2020QI;""
45 Toledo;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
45 Toledo;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
45 Toledo;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
45 Toledo;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
45 Toledo;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
45 Toledo;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
45 Toledo;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
45 Toledo;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
45 Toledo;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
45 Toledo;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
45 Toledo;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
45 Toledo;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
45 Toledo;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
45 Toledo;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;97,08
45 Toledo;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
45 Toledo;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
45 Toledo;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
45 Toledo;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;97,21
45 Toledo;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
45 Toledo;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
45 Toledo;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
45 Toledo;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;97,2
45 Toledo;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
45 Toledo;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
45 Toledo;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;93,84
45 Toledo;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
45 Toledo;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
45 Toledo;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
45 Toledo;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;94,41
45 Toledo;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
45 Toledo;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
45 Toledo;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
45 Toledo;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;94,84
45 Toledo;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
45 Toledo;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
45 Toledo;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
45 Toledo;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
45 Toledo;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
45 Toledo;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
45 Toledo;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;92,16
45 Toledo;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
45 Toledo;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
45 Toledo;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
45 Toledo;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;93,08
45 Toledo;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
45 Toledo;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
45 Toledo;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
45 Toledo;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
45 Toledo;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
45 Toledo;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
45 Toledo;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;90,03
45 Toledo;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
45 Toledo;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
45 Toledo;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
45 Toledo;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;90,71
45 Toledo;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
45 Toledo;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
45 Toledo;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
45 Toledo;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
45 Toledo;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
45 Toledo;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
45 Toledo;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QIII;14.862
45 Toledo;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
45 Toledo;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
45 Toledo;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
45 Toledo;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QIII;14.579
45 Toledo;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
45 Toledo;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
45 Toledo;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
45 Toledo;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QIII;14.054
45 Toledo;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
45 Toledo;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
45 Toledo;All ages;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
45 Toledo;All ages;Cohort July 1;Females;Survival in the first trimester;2022QIII;14.301
45 Toledo;All ages;Cohort July 1;Females;Survival in the first trimester;2022QII;""
45 Toledo;All ages;Cohort July 1;Females;Survival in the first trimester;2022QI;""
45 Toledo;All ages;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
45 Toledo;All ages;Cohort July 1;Females;Survival in the first trimester;2021QIII;14.072
45 Toledo;All ages;Cohort July 1;Females;Survival in the first trimester;2021QII;""
45 Toledo;All ages;Cohort July 1;Females;Survival in the first trimester;2021QI;""
45 Toledo;All ages;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
45 Toledo;All ages;Cohort July 1;Females;Survival in the first trimester;2020QIII;13.609
45 Toledo;All ages;Cohort July 1;Females;Survival in the first trimester;2020QII;""
45 Toledo;All ages;Cohort July 1;Females;Survival in the first trimester;2020QI;""
45 Toledo;All ages;Cohort July 1;Females;Survival in the second trimester;2022QIV;13.724
45 Toledo;All ages;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
45 Toledo;All ages;Cohort July 1;Females;Survival in the second trimester;2022QII;""
45 Toledo;All ages;Cohort July 1;Females;Survival in the second trimester;2022QI;""
45 Toledo;All ages;Cohort July 1;Females;Survival in the second trimester;2021QIV;13.611
45 Toledo;All ages;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
45 Toledo;All ages;Cohort July 1;Females;Survival in the second trimester;2021QII;""
45 Toledo;All ages;Cohort July 1;Females;Survival in the second trimester;2021QI;""
45 Toledo;All ages;Cohort July 1;Females;Survival in the second trimester;2020QIV;13.225
45 Toledo;All ages;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
45 Toledo;All ages;Cohort July 1;Females;Survival in the second trimester;2020QII;""
45 Toledo;All ages;Cohort July 1;Females;Survival in the second trimester;2020QI;""
45 Toledo;All ages;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
45 Toledo;All ages;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
45 Toledo;All ages;Cohort July 1;Females;Survival in the third trimester;2022QII;""
45 Toledo;All ages;Cohort July 1;Females;Survival in the third trimester;2022QI;13.166
45 Toledo;All ages;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
45 Toledo;All ages;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
45 Toledo;All ages;Cohort July 1;Females;Survival in the third trimester;2021QII;""
45 Toledo;All ages;Cohort July 1;Females;Survival in the third trimester;2021QI;12.938
45 Toledo;All ages;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
45 Toledo;All ages;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
45 Toledo;All ages;Cohort July 1;Females;Survival in the third trimester;2020QII;""
45 Toledo;All ages;Cohort July 1;Females;Survival in the third trimester;2020QI;""
45 Toledo;All ages;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
45 Toledo;All ages;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
45 Toledo;All ages;Cohort July 1;Females;Survival in the third trimester;2022QII;12.732
45 Toledo;All ages;Cohort July 1;Females;Survival in the third trimester;2022QI;""
45 Toledo;All ages;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
45 Toledo;All ages;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
45 Toledo;All ages;Cohort July 1;Females;Survival in the third trimester;2021QII;12.541
45 Toledo;All ages;Cohort July 1;Females;Survival in the third trimester;2021QI;""
45 Toledo;All ages;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
45 Toledo;All ages;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
45 Toledo;All ages;Cohort July 1;Females;Survival in the third trimester;2020QII;""
45 Toledo;All ages;Cohort July 1;Females;Survival in the third trimester;2020QI;""
45 Toledo;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
45 Toledo;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
45 Toledo;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
45 Toledo;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
45 Toledo;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
45 Toledo;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
45 Toledo;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
45 Toledo;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
45 Toledo;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
45 Toledo;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
45 Toledo;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
45 Toledo;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
45 Toledo;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
45 Toledo;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;96,23
45 Toledo;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
45 Toledo;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
45 Toledo;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
45 Toledo;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;96,52
45 Toledo;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
45 Toledo;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
45 Toledo;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
45 Toledo;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;96,83
45 Toledo;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
45 Toledo;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
45 Toledo;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;92,34
45 Toledo;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
45 Toledo;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
45 Toledo;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
45 Toledo;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;93,36
45 Toledo;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
45 Toledo;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
45 Toledo;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
45 Toledo;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;94,1
45 Toledo;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
45 Toledo;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
45 Toledo;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
45 Toledo;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
45 Toledo;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
45 Toledo;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
45 Toledo;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;90,31
45 Toledo;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
45 Toledo;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
45 Toledo;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
45 Toledo;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;92,06
45 Toledo;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
45 Toledo;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
45 Toledo;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
45 Toledo;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
45 Toledo;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
45 Toledo;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
45 Toledo;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;87,33
45 Toledo;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
45 Toledo;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
45 Toledo;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
45 Toledo;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;89,23
45 Toledo;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
45 Toledo;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
45 Toledo;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
45 Toledo;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
45 Toledo;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
45 Toledo;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QIV;44.113
45 Toledo;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
45 Toledo;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
45 Toledo;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
45 Toledo;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QIV;44.060
45 Toledo;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
45 Toledo;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
45 Toledo;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
45 Toledo;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QIV;43.310
45 Toledo;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
45 Toledo;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
45 Toledo;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
45 Toledo;All ages;Cohort October 1;Total;Survival in the first trimester;2022QIV;42.433
45 Toledo;All ages;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
45 Toledo;All ages;Cohort October 1;Total;Survival in the first trimester;2022QII;""
45 Toledo;All ages;Cohort October 1;Total;Survival in the first trimester;2022QI;""
45 Toledo;All ages;Cohort October 1;Total;Survival in the first trimester;2021QIV;42.608
45 Toledo;All ages;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
45 Toledo;All ages;Cohort October 1;Total;Survival in the first trimester;2021QII;""
45 Toledo;All ages;Cohort October 1;Total;Survival in the first trimester;2021QI;""
45 Toledo;All ages;Cohort October 1;Total;Survival in the first trimester;2020QIV;42.056
45 Toledo;All ages;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
45 Toledo;All ages;Cohort October 1;Total;Survival in the first trimester;2020QII;""
45 Toledo;All ages;Cohort October 1;Total;Survival in the first trimester;2020QI;""
45 Toledo;All ages;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
45 Toledo;All ages;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
45 Toledo;All ages;Cohort October 1;Total;Survival in the second trimester;2022QII;""
45 Toledo;All ages;Cohort October 1;Total;Survival in the second trimester;2022QI;41.389
45 Toledo;All ages;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
45 Toledo;All ages;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
45 Toledo;All ages;Cohort October 1;Total;Survival in the second trimester;2021QII;""
45 Toledo;All ages;Cohort October 1;Total;Survival in the second trimester;2021QI;41.166
45 Toledo;All ages;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
45 Toledo;All ages;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
45 Toledo;All ages;Cohort October 1;Total;Survival in the second trimester;2020QII;""
45 Toledo;All ages;Cohort October 1;Total;Survival in the second trimester;2020QI;""
45 Toledo;All ages;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
45 Toledo;All ages;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
45 Toledo;All ages;Cohort October 1;Total;Survival in the third trimester;2022QII;40.229
45 Toledo;All ages;Cohort October 1;Total;Survival in the third trimester;2022QI;""
45 Toledo;All ages;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
45 Toledo;All ages;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
45 Toledo;All ages;Cohort October 1;Total;Survival in the third trimester;2021QII;39.981
45 Toledo;All ages;Cohort October 1;Total;Survival in the third trimester;2021QI;""
45 Toledo;All ages;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
45 Toledo;All ages;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
45 Toledo;All ages;Cohort October 1;Total;Survival in the third trimester;2020QII;""
45 Toledo;All ages;Cohort October 1;Total;Survival in the third trimester;2020QI;""
45 Toledo;All ages;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
45 Toledo;All ages;Cohort October 1;Total;Survival in the third trimester;2022QIII;39.269
45 Toledo;All ages;Cohort October 1;Total;Survival in the third trimester;2022QII;""
45 Toledo;All ages;Cohort October 1;Total;Survival in the third trimester;2022QI;""
45 Toledo;All ages;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
45 Toledo;All ages;Cohort October 1;Total;Survival in the third trimester;2021QIII;39.078
45 Toledo;All ages;Cohort October 1;Total;Survival in the third trimester;2021QII;""
45 Toledo;All ages;Cohort October 1;Total;Survival in the third trimester;2021QI;""
45 Toledo;All ages;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
45 Toledo;All ages;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
45 Toledo;All ages;Cohort October 1;Total;Survival in the third trimester;2020QII;""
45 Toledo;All ages;Cohort October 1;Total;Survival in the third trimester;2020QI;""
45 Toledo;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
45 Toledo;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
45 Toledo;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
45 Toledo;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
45 Toledo;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
45 Toledo;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
45 Toledo;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
45 Toledo;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
45 Toledo;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
45 Toledo;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
45 Toledo;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
45 Toledo;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
45 Toledo;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;96,19
45 Toledo;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
45 Toledo;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
45 Toledo;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
45 Toledo;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;96,7
45 Toledo;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
45 Toledo;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
45 Toledo;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
45 Toledo;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;97,1
45 Toledo;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
45 Toledo;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
45 Toledo;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
45 Toledo;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
45 Toledo;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
45 Toledo;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
45 Toledo;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;93,94
45 Toledo;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
45 Toledo;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
45 Toledo;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
45 Toledo;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;95,05
45 Toledo;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
45 Toledo;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
45 Toledo;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
45 Toledo;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
45 Toledo;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
45 Toledo;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
45 Toledo;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;91,31
45 Toledo;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
45 Toledo;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
45 Toledo;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
45 Toledo;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;92,31
45 Toledo;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
45 Toledo;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
45 Toledo;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
45 Toledo;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
45 Toledo;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
45 Toledo;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
45 Toledo;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;89,13
45 Toledo;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
45 Toledo;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
45 Toledo;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
45 Toledo;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;90,23
45 Toledo;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
45 Toledo;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
45 Toledo;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
45 Toledo;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
45 Toledo;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
45 Toledo;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
45 Toledo;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QIV;29.330
45 Toledo;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
45 Toledo;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
45 Toledo;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
45 Toledo;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QIV;29.444
45 Toledo;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
45 Toledo;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
45 Toledo;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
45 Toledo;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QIV;29.155
45 Toledo;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
45 Toledo;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
45 Toledo;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
45 Toledo;All ages;Cohort October 1;Males;Survival in the first trimester;2022QIV;28.280
45 Toledo;All ages;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
45 Toledo;All ages;Cohort October 1;Males;Survival in the first trimester;2022QII;""
45 Toledo;All ages;Cohort October 1;Males;Survival in the first trimester;2022QI;""
45 Toledo;All ages;Cohort October 1;Males;Survival in the first trimester;2021QIV;28.521
45 Toledo;All ages;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
45 Toledo;All ages;Cohort October 1;Males;Survival in the first trimester;2021QII;""
45 Toledo;All ages;Cohort October 1;Males;Survival in the first trimester;2021QI;""
45 Toledo;All ages;Cohort October 1;Males;Survival in the first trimester;2020QIV;28.354
45 Toledo;All ages;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
45 Toledo;All ages;Cohort October 1;Males;Survival in the first trimester;2020QII;""
45 Toledo;All ages;Cohort October 1;Males;Survival in the first trimester;2020QI;""
45 Toledo;All ages;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
45 Toledo;All ages;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
45 Toledo;All ages;Cohort October 1;Males;Survival in the second trimester;2022QII;""
45 Toledo;All ages;Cohort October 1;Males;Survival in the second trimester;2022QI;27.789
45 Toledo;All ages;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
45 Toledo;All ages;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
45 Toledo;All ages;Cohort October 1;Males;Survival in the second trimester;2021QII;""
45 Toledo;All ages;Cohort October 1;Males;Survival in the second trimester;2021QI;27.792
45 Toledo;All ages;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
45 Toledo;All ages;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
45 Toledo;All ages;Cohort October 1;Males;Survival in the second trimester;2020QII;""
45 Toledo;All ages;Cohort October 1;Males;Survival in the second trimester;2020QI;""
45 Toledo;All ages;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
45 Toledo;All ages;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
45 Toledo;All ages;Cohort October 1;Males;Survival in the third trimester;2022QII;27.106
45 Toledo;All ages;Cohort October 1;Males;Survival in the third trimester;2022QI;""
45 Toledo;All ages;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
45 Toledo;All ages;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
45 Toledo;All ages;Cohort October 1;Males;Survival in the third trimester;2021QII;27.042
45 Toledo;All ages;Cohort October 1;Males;Survival in the third trimester;2021QI;""
45 Toledo;All ages;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
45 Toledo;All ages;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
45 Toledo;All ages;Cohort October 1;Males;Survival in the third trimester;2020QII;""
45 Toledo;All ages;Cohort October 1;Males;Survival in the third trimester;2020QI;""
45 Toledo;All ages;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
45 Toledo;All ages;Cohort October 1;Males;Survival in the third trimester;2022QIII;26.517
45 Toledo;All ages;Cohort October 1;Males;Survival in the third trimester;2022QII;""
45 Toledo;All ages;Cohort October 1;Males;Survival in the third trimester;2022QI;""
45 Toledo;All ages;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
45 Toledo;All ages;Cohort October 1;Males;Survival in the third trimester;2021QIII;26.473
45 Toledo;All ages;Cohort October 1;Males;Survival in the third trimester;2021QII;""
45 Toledo;All ages;Cohort October 1;Males;Survival in the third trimester;2021QI;""
45 Toledo;All ages;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
45 Toledo;All ages;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
45 Toledo;All ages;Cohort October 1;Males;Survival in the third trimester;2020QII;""
45 Toledo;All ages;Cohort October 1;Males;Survival in the third trimester;2020QI;""
45 Toledo;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
45 Toledo;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
45 Toledo;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
45 Toledo;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
45 Toledo;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
45 Toledo;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
45 Toledo;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
45 Toledo;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
45 Toledo;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
45 Toledo;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
45 Toledo;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
45 Toledo;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
45 Toledo;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;96,42
45 Toledo;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
45 Toledo;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
45 Toledo;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
45 Toledo;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;96,87
45 Toledo;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
45 Toledo;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
45 Toledo;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
45 Toledo;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;97,25
45 Toledo;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
45 Toledo;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
45 Toledo;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
45 Toledo;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
45 Toledo;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
45 Toledo;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
45 Toledo;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;94,38
45 Toledo;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
45 Toledo;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
45 Toledo;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
45 Toledo;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;95,32
45 Toledo;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
45 Toledo;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
45 Toledo;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
45 Toledo;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
45 Toledo;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
45 Toledo;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
45 Toledo;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;92,06
45 Toledo;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
45 Toledo;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
45 Toledo;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
45 Toledo;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;92,75
45 Toledo;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
45 Toledo;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
45 Toledo;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
45 Toledo;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
45 Toledo;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
45 Toledo;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
45 Toledo;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;90,06
45 Toledo;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
45 Toledo;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
45 Toledo;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
45 Toledo;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;90,8
45 Toledo;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
45 Toledo;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
45 Toledo;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
45 Toledo;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
45 Toledo;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
45 Toledo;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
45 Toledo;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QIV;14.783
45 Toledo;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
45 Toledo;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
45 Toledo;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
45 Toledo;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QIV;14.616
45 Toledo;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
45 Toledo;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
45 Toledo;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
45 Toledo;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QIV;14.155
45 Toledo;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
45 Toledo;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
45 Toledo;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
45 Toledo;All ages;Cohort October 1;Females;Survival in the first trimester;2022QIV;14.153
45 Toledo;All ages;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
45 Toledo;All ages;Cohort October 1;Females;Survival in the first trimester;2022QII;""
45 Toledo;All ages;Cohort October 1;Females;Survival in the first trimester;2022QI;""
45 Toledo;All ages;Cohort October 1;Females;Survival in the first trimester;2021QIV;14.087
45 Toledo;All ages;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
45 Toledo;All ages;Cohort October 1;Females;Survival in the first trimester;2021QII;""
45 Toledo;All ages;Cohort October 1;Females;Survival in the first trimester;2021QI;""
45 Toledo;All ages;Cohort October 1;Females;Survival in the first trimester;2020QIV;13.702
45 Toledo;All ages;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
45 Toledo;All ages;Cohort October 1;Females;Survival in the first trimester;2020QII;""
45 Toledo;All ages;Cohort October 1;Females;Survival in the first trimester;2020QI;""
45 Toledo;All ages;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
45 Toledo;All ages;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
45 Toledo;All ages;Cohort October 1;Females;Survival in the second trimester;2022QII;""
45 Toledo;All ages;Cohort October 1;Females;Survival in the second trimester;2022QI;13.600
45 Toledo;All ages;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
45 Toledo;All ages;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
45 Toledo;All ages;Cohort October 1;Females;Survival in the second trimester;2021QII;""
45 Toledo;All ages;Cohort October 1;Females;Survival in the second trimester;2021QI;13.374
45 Toledo;All ages;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
45 Toledo;All ages;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
45 Toledo;All ages;Cohort October 1;Females;Survival in the second trimester;2020QII;""
45 Toledo;All ages;Cohort October 1;Females;Survival in the second trimester;2020QI;""
45 Toledo;All ages;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
45 Toledo;All ages;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
45 Toledo;All ages;Cohort October 1;Females;Survival in the third trimester;2022QII;13.123
45 Toledo;All ages;Cohort October 1;Females;Survival in the third trimester;2022QI;""
45 Toledo;All ages;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
45 Toledo;All ages;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
45 Toledo;All ages;Cohort October 1;Females;Survival in the third trimester;2021QII;12.939
45 Toledo;All ages;Cohort October 1;Females;Survival in the third trimester;2021QI;""
45 Toledo;All ages;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
45 Toledo;All ages;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
45 Toledo;All ages;Cohort October 1;Females;Survival in the third trimester;2020QII;""
45 Toledo;All ages;Cohort October 1;Females;Survival in the third trimester;2020QI;""
45 Toledo;All ages;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
45 Toledo;All ages;Cohort October 1;Females;Survival in the third trimester;2022QIII;12.752
45 Toledo;All ages;Cohort October 1;Females;Survival in the third trimester;2022QII;""
45 Toledo;All ages;Cohort October 1;Females;Survival in the third trimester;2022QI;""
45 Toledo;All ages;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
45 Toledo;All ages;Cohort October 1;Females;Survival in the third trimester;2021QIII;12.605
45 Toledo;All ages;Cohort October 1;Females;Survival in the third trimester;2021QII;""
45 Toledo;All ages;Cohort October 1;Females;Survival in the third trimester;2021QI;""
45 Toledo;All ages;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
45 Toledo;All ages;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
45 Toledo;All ages;Cohort October 1;Females;Survival in the third trimester;2020QII;""
45 Toledo;All ages;Cohort October 1;Females;Survival in the third trimester;2020QI;""
45 Toledo;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
45 Toledo;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
45 Toledo;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
45 Toledo;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
45 Toledo;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
45 Toledo;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
45 Toledo;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
45 Toledo;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
45 Toledo;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
45 Toledo;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
45 Toledo;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
45 Toledo;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
45 Toledo;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;95,74
45 Toledo;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
45 Toledo;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
45 Toledo;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
45 Toledo;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;96,38
45 Toledo;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
45 Toledo;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
45 Toledo;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
45 Toledo;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;96,8
45 Toledo;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
45 Toledo;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
45 Toledo;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
45 Toledo;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
45 Toledo;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
45 Toledo;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
45 Toledo;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;93,05
45 Toledo;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
45 Toledo;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
45 Toledo;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
45 Toledo;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;94,48
45 Toledo;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
45 Toledo;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
45 Toledo;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
45 Toledo;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
45 Toledo;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
45 Toledo;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
45 Toledo;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;89,79
45 Toledo;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
45 Toledo;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
45 Toledo;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
45 Toledo;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;91,41
45 Toledo;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
45 Toledo;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
45 Toledo;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
45 Toledo;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
45 Toledo;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
45 Toledo;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
45 Toledo;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;87,25
45 Toledo;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
45 Toledo;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
45 Toledo;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
45 Toledo;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;89,05
45 Toledo;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
45 Toledo;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
45 Toledo;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
45 Toledo;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
45 Toledo;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
45 Toledo;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
45 Toledo;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
45 Toledo;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
45 Toledo;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
45 Toledo;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QI;2.839
45 Toledo;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
45 Toledo;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
45 Toledo;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
45 Toledo;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QI;2.694
45 Toledo;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
45 Toledo;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
45 Toledo;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
45 Toledo;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QI;2.300
45 Toledo;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
45 Toledo;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
45 Toledo;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2022QII;""
45 Toledo;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2022QI;2.640
45 Toledo;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
45 Toledo;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
45 Toledo;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2021QII;""
45 Toledo;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2021QI;2.529
45 Toledo;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
45 Toledo;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
45 Toledo;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2020QII;""
45 Toledo;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2020QI;1.979
45 Toledo;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
45 Toledo;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
45 Toledo;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2022QII;2.480
45 Toledo;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2022QI;""
45 Toledo;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
45 Toledo;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
45 Toledo;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2021QII;2.373
45 Toledo;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2021QI;""
45 Toledo;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
45 Toledo;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
45 Toledo;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2020QII;1.911
45 Toledo;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2020QI;""
45 Toledo;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
45 Toledo;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QIII;2.319
45 Toledo;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QII;""
45 Toledo;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QI;""
45 Toledo;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
45 Toledo;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QIII;2.241
45 Toledo;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QII;""
45 Toledo;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QI;""
45 Toledo;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
45 Toledo;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QIII;1.825
45 Toledo;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QII;""
45 Toledo;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QI;""
45 Toledo;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QIV;2.172
45 Toledo;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
45 Toledo;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QII;""
45 Toledo;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QI;""
45 Toledo;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QIV;2.122
45 Toledo;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
45 Toledo;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QII;""
45 Toledo;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QI;""
45 Toledo;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QIV;1.740
45 Toledo;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
45 Toledo;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QII;""
45 Toledo;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QI;""
45 Toledo;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
45 Toledo;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
45 Toledo;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
45 Toledo;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
45 Toledo;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
45 Toledo;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
45 Toledo;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
45 Toledo;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
45 Toledo;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
45 Toledo;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
45 Toledo;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
45 Toledo;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
45 Toledo;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
45 Toledo;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
45 Toledo;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
45 Toledo;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;92,99
45 Toledo;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
45 Toledo;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
45 Toledo;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
45 Toledo;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;93,88
45 Toledo;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
45 Toledo;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
45 Toledo;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
45 Toledo;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;86,04
45 Toledo;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
45 Toledo;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
45 Toledo;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;87,35
45 Toledo;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
45 Toledo;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
45 Toledo;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
45 Toledo;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;88,08
45 Toledo;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
45 Toledo;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
45 Toledo;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
45 Toledo;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;83,09
45 Toledo;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
45 Toledo;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
45 Toledo;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;81,68
45 Toledo;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
45 Toledo;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
45 Toledo;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
45 Toledo;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;83,18
45 Toledo;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
45 Toledo;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
45 Toledo;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
45 Toledo;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;79,35
45 Toledo;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
45 Toledo;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
45 Toledo;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;76,51
45 Toledo;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
45 Toledo;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
45 Toledo;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
45 Toledo;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;78,77
45 Toledo;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
45 Toledo;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
45 Toledo;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
45 Toledo;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;75,65
45 Toledo;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
45 Toledo;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
45 Toledo;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
45 Toledo;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
45 Toledo;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
45 Toledo;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
45 Toledo;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QI;1.839
45 Toledo;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
45 Toledo;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
45 Toledo;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
45 Toledo;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QI;1.744
45 Toledo;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
45 Toledo;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
45 Toledo;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
45 Toledo;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QI;1.518
45 Toledo;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
45 Toledo;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
45 Toledo;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2022QII;""
45 Toledo;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2022QI;1.715
45 Toledo;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
45 Toledo;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
45 Toledo;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2021QII;""
45 Toledo;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2021QI;1.644
45 Toledo;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
45 Toledo;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
45 Toledo;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2020QII;""
45 Toledo;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2020QI;1.300
45 Toledo;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
45 Toledo;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
45 Toledo;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2022QII;1.611
45 Toledo;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2022QI;""
45 Toledo;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
45 Toledo;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
45 Toledo;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2021QII;1.536
45 Toledo;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2021QI;""
45 Toledo;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
45 Toledo;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
45 Toledo;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2020QII;1.254
45 Toledo;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2020QI;""
45 Toledo;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
45 Toledo;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QIII;1.511
45 Toledo;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QII;""
45 Toledo;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QI;""
45 Toledo;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
45 Toledo;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QIII;1.451
45 Toledo;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QII;""
45 Toledo;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QI;""
45 Toledo;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
45 Toledo;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QIII;1.202
45 Toledo;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QII;""
45 Toledo;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QI;""
45 Toledo;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QIV;1.427
45 Toledo;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
45 Toledo;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QII;""
45 Toledo;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QI;""
45 Toledo;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QIV;1.378
45 Toledo;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
45 Toledo;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QII;""
45 Toledo;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QI;""
45 Toledo;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QIV;1.145
45 Toledo;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
45 Toledo;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QII;""
45 Toledo;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QI;""
45 Toledo;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
45 Toledo;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
45 Toledo;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
45 Toledo;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
45 Toledo;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
45 Toledo;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
45 Toledo;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
45 Toledo;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
45 Toledo;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
45 Toledo;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
45 Toledo;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
45 Toledo;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
45 Toledo;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
45 Toledo;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
45 Toledo;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
45 Toledo;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;93,26
45 Toledo;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
45 Toledo;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
45 Toledo;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
45 Toledo;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;94,27
45 Toledo;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
45 Toledo;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
45 Toledo;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
45 Toledo;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;85,64
45 Toledo;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
45 Toledo;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
45 Toledo;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;87,6
45 Toledo;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
45 Toledo;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
45 Toledo;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
45 Toledo;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;88,07
45 Toledo;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
45 Toledo;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
45 Toledo;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
45 Toledo;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;82,61
45 Toledo;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
45 Toledo;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
45 Toledo;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;82,16
45 Toledo;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
45 Toledo;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
45 Toledo;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
45 Toledo;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;83,2
45 Toledo;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
45 Toledo;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
45 Toledo;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
45 Toledo;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;79,18
45 Toledo;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
45 Toledo;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
45 Toledo;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;77,6
45 Toledo;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
45 Toledo;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
45 Toledo;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
45 Toledo;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;79,01
45 Toledo;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
45 Toledo;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
45 Toledo;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
45 Toledo;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;75,43
45 Toledo;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
45 Toledo;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
45 Toledo;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
45 Toledo;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
45 Toledo;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
45 Toledo;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
45 Toledo;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QI;1.000
45 Toledo;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
45 Toledo;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
45 Toledo;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
45 Toledo;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QI;950
45 Toledo;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
45 Toledo;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
45 Toledo;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
45 Toledo;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QI;782
45 Toledo;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
45 Toledo;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
45 Toledo;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2022QII;""
45 Toledo;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2022QI;925
45 Toledo;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
45 Toledo;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
45 Toledo;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2021QII;""
45 Toledo;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2021QI;885
45 Toledo;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
45 Toledo;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
45 Toledo;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2020QII;""
45 Toledo;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2020QI;679
45 Toledo;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
45 Toledo;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
45 Toledo;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2022QII;869
45 Toledo;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2022QI;""
45 Toledo;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
45 Toledo;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
45 Toledo;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2021QII;837
45 Toledo;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2021QI;""
45 Toledo;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
45 Toledo;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
45 Toledo;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2020QII;657
45 Toledo;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2020QI;""
45 Toledo;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
45 Toledo;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QIII;808
45 Toledo;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QII;""
45 Toledo;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QI;""
45 Toledo;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
45 Toledo;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QIII;790
45 Toledo;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QII;""
45 Toledo;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QI;""
45 Toledo;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
45 Toledo;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QIII;623
45 Toledo;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QII;""
45 Toledo;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QI;""
45 Toledo;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QIV;745
45 Toledo;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
45 Toledo;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QII;""
45 Toledo;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QI;""
45 Toledo;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QIV;744
45 Toledo;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
45 Toledo;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QII;""
45 Toledo;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QI;""
45 Toledo;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QIV;595
45 Toledo;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
45 Toledo;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QII;""
45 Toledo;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QI;""
45 Toledo;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
45 Toledo;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
45 Toledo;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
45 Toledo;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
45 Toledo;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
45 Toledo;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
45 Toledo;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
45 Toledo;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
45 Toledo;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
45 Toledo;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
45 Toledo;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
45 Toledo;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
45 Toledo;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
45 Toledo;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
45 Toledo;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
45 Toledo;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;92,5
45 Toledo;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
45 Toledo;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
45 Toledo;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
45 Toledo;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;93,16
45 Toledo;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
45 Toledo;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
45 Toledo;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
45 Toledo;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;86,83
45 Toledo;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
45 Toledo;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
45 Toledo;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;86,9
45 Toledo;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
45 Toledo;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
45 Toledo;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
45 Toledo;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;88,11
45 Toledo;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
45 Toledo;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
45 Toledo;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
45 Toledo;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;84,02
45 Toledo;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
45 Toledo;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
45 Toledo;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;80,8
45 Toledo;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
45 Toledo;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
45 Toledo;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
45 Toledo;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;83,16
45 Toledo;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
45 Toledo;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
45 Toledo;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
45 Toledo;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;79,67
45 Toledo;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
45 Toledo;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
45 Toledo;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;74,5
45 Toledo;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
45 Toledo;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
45 Toledo;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
45 Toledo;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;78,32
45 Toledo;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
45 Toledo;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
45 Toledo;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
45 Toledo;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;76,09
45 Toledo;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
45 Toledo;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
45 Toledo;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
45 Toledo;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
45 Toledo;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
45 Toledo;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QII;2.503
45 Toledo;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
45 Toledo;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
45 Toledo;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
45 Toledo;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QII;2.395
45 Toledo;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
45 Toledo;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
45 Toledo;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
45 Toledo;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QII;2.299
45 Toledo;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
45 Toledo;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
45 Toledo;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
45 Toledo;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2022QII;2.310
45 Toledo;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2022QI;""
45 Toledo;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
45 Toledo;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
45 Toledo;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2021QII;2.218
45 Toledo;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2021QI;""
45 Toledo;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
45 Toledo;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
45 Toledo;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2020QII;2.197
45 Toledo;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2020QI;""
45 Toledo;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
45 Toledo;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2022QIII;2.146
45 Toledo;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2022QII;""
45 Toledo;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2022QI;""
45 Toledo;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
45 Toledo;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2021QIII;2.077
45 Toledo;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2021QII;""
45 Toledo;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2021QI;""
45 Toledo;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
45 Toledo;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2020QIII;2.084
45 Toledo;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2020QII;""
45 Toledo;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2020QI;""
45 Toledo;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QIV;2.001
45 Toledo;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
45 Toledo;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QII;""
45 Toledo;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QI;""
45 Toledo;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QIV;1.965
45 Toledo;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
45 Toledo;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QII;""
45 Toledo;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QI;""
45 Toledo;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QIV;1.975
45 Toledo;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
45 Toledo;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QII;""
45 Toledo;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QI;""
45 Toledo;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
45 Toledo;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
45 Toledo;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QII;""
45 Toledo;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QI;1.855
45 Toledo;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
45 Toledo;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
45 Toledo;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QII;""
45 Toledo;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QI;1.887
45 Toledo;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
45 Toledo;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
45 Toledo;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QII;""
45 Toledo;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QI;""
45 Toledo;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
45 Toledo;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
45 Toledo;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
45 Toledo;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
45 Toledo;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
45 Toledo;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
45 Toledo;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
45 Toledo;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
45 Toledo;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
45 Toledo;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
45 Toledo;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
45 Toledo;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
45 Toledo;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
45 Toledo;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
45 Toledo;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;92,29
45 Toledo;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
45 Toledo;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
45 Toledo;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
45 Toledo;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;92,61
45 Toledo;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
45 Toledo;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
45 Toledo;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
45 Toledo;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;95,56
45 Toledo;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
45 Toledo;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
45 Toledo;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;85,74
45 Toledo;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
45 Toledo;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
45 Toledo;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
45 Toledo;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;86,72
45 Toledo;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
45 Toledo;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
45 Toledo;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
45 Toledo;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;90,65
45 Toledo;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
45 Toledo;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
45 Toledo;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;79,94
45 Toledo;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
45 Toledo;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
45 Toledo;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
45 Toledo;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;82,05
45 Toledo;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
45 Toledo;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
45 Toledo;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
45 Toledo;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;85,91
45 Toledo;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
45 Toledo;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
45 Toledo;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
45 Toledo;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
45 Toledo;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
45 Toledo;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
45 Toledo;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;77,45
45 Toledo;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
45 Toledo;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
45 Toledo;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
45 Toledo;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;82,08
45 Toledo;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
45 Toledo;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
45 Toledo;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
45 Toledo;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
45 Toledo;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
45 Toledo;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
45 Toledo;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QII;1.644
45 Toledo;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
45 Toledo;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
45 Toledo;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
45 Toledo;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QII;1.581
45 Toledo;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
45 Toledo;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
45 Toledo;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
45 Toledo;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QII;1.491
45 Toledo;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
45 Toledo;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
45 Toledo;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
45 Toledo;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2022QII;1.519
45 Toledo;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2022QI;""
45 Toledo;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
45 Toledo;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
45 Toledo;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2021QII;1.461
45 Toledo;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2021QI;""
45 Toledo;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
45 Toledo;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
45 Toledo;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2020QII;1.423
45 Toledo;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2020QI;""
45 Toledo;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
45 Toledo;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2022QIII;1.414
45 Toledo;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2022QII;""
45 Toledo;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2022QI;""
45 Toledo;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
45 Toledo;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2021QIII;1.372
45 Toledo;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2021QII;""
45 Toledo;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2021QI;""
45 Toledo;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
45 Toledo;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2020QIII;1.352
45 Toledo;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2020QII;""
45 Toledo;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2020QI;""
45 Toledo;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QIV;1.332
45 Toledo;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
45 Toledo;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QII;""
45 Toledo;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QI;""
45 Toledo;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QIV;1.305
45 Toledo;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
45 Toledo;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QII;""
45 Toledo;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QI;""
45 Toledo;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QIV;1.283
45 Toledo;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
45 Toledo;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QII;""
45 Toledo;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QI;""
45 Toledo;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
45 Toledo;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
45 Toledo;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QII;""
45 Toledo;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QI;1.236
45 Toledo;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
45 Toledo;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
45 Toledo;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QII;""
45 Toledo;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QI;1.232
45 Toledo;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
45 Toledo;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
45 Toledo;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QII;""
45 Toledo;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QI;""
45 Toledo;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
45 Toledo;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
45 Toledo;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
45 Toledo;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
45 Toledo;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
45 Toledo;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
45 Toledo;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
45 Toledo;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
45 Toledo;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
45 Toledo;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
45 Toledo;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
45 Toledo;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
45 Toledo;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
45 Toledo;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
45 Toledo;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;92,4
45 Toledo;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
45 Toledo;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
45 Toledo;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
45 Toledo;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;92,41
45 Toledo;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
45 Toledo;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
45 Toledo;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
45 Toledo;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;95,44
45 Toledo;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
45 Toledo;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
45 Toledo;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;86,01
45 Toledo;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
45 Toledo;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
45 Toledo;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
45 Toledo;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;86,78
45 Toledo;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
45 Toledo;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
45 Toledo;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
45 Toledo;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;90,68
45 Toledo;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
45 Toledo;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
45 Toledo;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;81,02
45 Toledo;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
45 Toledo;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
45 Toledo;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
45 Toledo;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;82,54
45 Toledo;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
45 Toledo;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
45 Toledo;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
45 Toledo;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;86,05
45 Toledo;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
45 Toledo;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
45 Toledo;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
45 Toledo;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
45 Toledo;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
45 Toledo;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
45 Toledo;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;78,18
45 Toledo;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
45 Toledo;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
45 Toledo;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
45 Toledo;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;82,63
45 Toledo;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
45 Toledo;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
45 Toledo;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
45 Toledo;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
45 Toledo;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
45 Toledo;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
45 Toledo;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QII;859
45 Toledo;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
45 Toledo;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
45 Toledo;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
45 Toledo;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QII;814
45 Toledo;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
45 Toledo;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
45 Toledo;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
45 Toledo;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QII;808
45 Toledo;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
45 Toledo;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
45 Toledo;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
45 Toledo;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2022QII;791
45 Toledo;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2022QI;""
45 Toledo;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
45 Toledo;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
45 Toledo;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2021QII;757
45 Toledo;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2021QI;""
45 Toledo;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
45 Toledo;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
45 Toledo;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2020QII;774
45 Toledo;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2020QI;""
45 Toledo;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
45 Toledo;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2022QIII;732
45 Toledo;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2022QII;""
45 Toledo;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2022QI;""
45 Toledo;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
45 Toledo;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2021QIII;705
45 Toledo;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2021QII;""
45 Toledo;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2021QI;""
45 Toledo;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
45 Toledo;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2020QIII;732
45 Toledo;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2020QII;""
45 Toledo;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2020QI;""
45 Toledo;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QIV;669
45 Toledo;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
45 Toledo;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QII;""
45 Toledo;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QI;""
45 Toledo;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QIV;660
45 Toledo;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
45 Toledo;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QII;""
45 Toledo;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QI;""
45 Toledo;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QIV;692
45 Toledo;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
45 Toledo;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QII;""
45 Toledo;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QI;""
45 Toledo;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
45 Toledo;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
45 Toledo;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QII;""
45 Toledo;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QI;619
45 Toledo;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
45 Toledo;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
45 Toledo;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QII;""
45 Toledo;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QI;655
45 Toledo;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
45 Toledo;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
45 Toledo;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QII;""
45 Toledo;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QI;""
45 Toledo;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
45 Toledo;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
45 Toledo;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
45 Toledo;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
45 Toledo;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
45 Toledo;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
45 Toledo;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
45 Toledo;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
45 Toledo;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
45 Toledo;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
45 Toledo;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
45 Toledo;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
45 Toledo;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
45 Toledo;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
45 Toledo;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;92,08
45 Toledo;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
45 Toledo;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
45 Toledo;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
45 Toledo;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;93
45 Toledo;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
45 Toledo;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
45 Toledo;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
45 Toledo;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;95,79
45 Toledo;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
45 Toledo;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
45 Toledo;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;85,22
45 Toledo;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
45 Toledo;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
45 Toledo;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
45 Toledo;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;86,61
45 Toledo;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
45 Toledo;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
45 Toledo;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
45 Toledo;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;90,59
45 Toledo;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
45 Toledo;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
45 Toledo;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;77,88
45 Toledo;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
45 Toledo;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
45 Toledo;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
45 Toledo;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;81,08
45 Toledo;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
45 Toledo;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
45 Toledo;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
45 Toledo;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;85,64
45 Toledo;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
45 Toledo;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
45 Toledo;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
45 Toledo;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
45 Toledo;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
45 Toledo;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
45 Toledo;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;76,04
45 Toledo;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
45 Toledo;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
45 Toledo;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
45 Toledo;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;81,06
45 Toledo;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
45 Toledo;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
45 Toledo;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
45 Toledo;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
45 Toledo;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
45 Toledo;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QIII;2.657
45 Toledo;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
45 Toledo;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
45 Toledo;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
45 Toledo;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QIII;2.590
45 Toledo;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
45 Toledo;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
45 Toledo;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
45 Toledo;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QIII;2.430
45 Toledo;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
45 Toledo;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
45 Toledo;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
45 Toledo;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2022QIII;2.411
45 Toledo;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2022QII;""
45 Toledo;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2022QI;""
45 Toledo;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
45 Toledo;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2021QIII;2.373
45 Toledo;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2021QII;""
45 Toledo;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2021QI;""
45 Toledo;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
45 Toledo;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2020QIII;2.263
45 Toledo;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2020QII;""
45 Toledo;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2020QI;""
45 Toledo;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2022QIV;2.238
45 Toledo;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
45 Toledo;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2022QII;""
45 Toledo;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2022QI;""
45 Toledo;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2021QIV;2.231
45 Toledo;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
45 Toledo;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2021QII;""
45 Toledo;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2021QI;""
45 Toledo;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2020QIV;2.134
45 Toledo;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
45 Toledo;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2020QII;""
45 Toledo;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2020QI;""
45 Toledo;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
45 Toledo;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
45 Toledo;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QII;""
45 Toledo;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QI;2.098
45 Toledo;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
45 Toledo;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
45 Toledo;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QII;""
45 Toledo;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QI;2.034
45 Toledo;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
45 Toledo;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
45 Toledo;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QII;""
45 Toledo;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QI;""
45 Toledo;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
45 Toledo;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
45 Toledo;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QII;1.990
45 Toledo;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QI;""
45 Toledo;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
45 Toledo;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
45 Toledo;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QII;1.934
45 Toledo;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QI;""
45 Toledo;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
45 Toledo;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
45 Toledo;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QII;""
45 Toledo;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QI;""
45 Toledo;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
45 Toledo;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
45 Toledo;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
45 Toledo;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
45 Toledo;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
45 Toledo;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
45 Toledo;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
45 Toledo;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
45 Toledo;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
45 Toledo;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
45 Toledo;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
45 Toledo;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
45 Toledo;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
45 Toledo;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;90,74
45 Toledo;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
45 Toledo;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
45 Toledo;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
45 Toledo;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;91,62
45 Toledo;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
45 Toledo;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
45 Toledo;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
45 Toledo;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;93,13
45 Toledo;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
45 Toledo;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
45 Toledo;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;84,23
45 Toledo;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
45 Toledo;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
45 Toledo;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
45 Toledo;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;86,14
45 Toledo;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
45 Toledo;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
45 Toledo;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
45 Toledo;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;87,82
45 Toledo;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
45 Toledo;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
45 Toledo;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
45 Toledo;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
45 Toledo;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
45 Toledo;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
45 Toledo;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;81
45 Toledo;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
45 Toledo;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
45 Toledo;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
45 Toledo;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;83,7
45 Toledo;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
45 Toledo;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
45 Toledo;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
45 Toledo;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
45 Toledo;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
45 Toledo;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
45 Toledo;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;76,83
45 Toledo;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
45 Toledo;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
45 Toledo;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
45 Toledo;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;79,59
45 Toledo;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
45 Toledo;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
45 Toledo;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
45 Toledo;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
45 Toledo;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
45 Toledo;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
45 Toledo;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QIII;1.723
45 Toledo;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
45 Toledo;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
45 Toledo;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
45 Toledo;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QIII;1.689
45 Toledo;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
45 Toledo;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
45 Toledo;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
45 Toledo;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QIII;1.598
45 Toledo;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
45 Toledo;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
45 Toledo;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
45 Toledo;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2022QIII;1.567
45 Toledo;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2022QII;""
45 Toledo;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2022QI;""
45 Toledo;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
45 Toledo;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2021QIII;1.550
45 Toledo;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2021QII;""
45 Toledo;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2021QI;""
45 Toledo;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
45 Toledo;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2020QIII;1.487
45 Toledo;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2020QII;""
45 Toledo;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2020QI;""
45 Toledo;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2022QIV;1.465
45 Toledo;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
45 Toledo;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2022QII;""
45 Toledo;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2022QI;""
45 Toledo;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2021QIV;1.462
45 Toledo;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
45 Toledo;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2021QII;""
45 Toledo;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2021QI;""
45 Toledo;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2020QIV;1.402
45 Toledo;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
45 Toledo;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2020QII;""
45 Toledo;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2020QI;""
45 Toledo;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
45 Toledo;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
45 Toledo;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QII;""
45 Toledo;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QI;1.377
45 Toledo;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
45 Toledo;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
45 Toledo;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QII;""
45 Toledo;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QI;1.340
45 Toledo;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
45 Toledo;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
45 Toledo;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QII;""
45 Toledo;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QI;""
45 Toledo;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
45 Toledo;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
45 Toledo;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QII;1.310
45 Toledo;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QI;""
45 Toledo;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
45 Toledo;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
45 Toledo;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QII;1.269
45 Toledo;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QI;""
45 Toledo;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
45 Toledo;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
45 Toledo;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QII;""
45 Toledo;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QI;""
45 Toledo;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
45 Toledo;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
45 Toledo;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
45 Toledo;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
45 Toledo;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
45 Toledo;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
45 Toledo;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
45 Toledo;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
45 Toledo;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
45 Toledo;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
45 Toledo;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
45 Toledo;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
45 Toledo;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
45 Toledo;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;90,95
45 Toledo;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
45 Toledo;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
45 Toledo;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
45 Toledo;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;91,77
45 Toledo;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
45 Toledo;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
45 Toledo;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
45 Toledo;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;93,05
45 Toledo;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
45 Toledo;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
45 Toledo;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;85,03
45 Toledo;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
45 Toledo;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
45 Toledo;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
45 Toledo;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;86,56
45 Toledo;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
45 Toledo;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
45 Toledo;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
45 Toledo;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;87,73
45 Toledo;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
45 Toledo;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
45 Toledo;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
45 Toledo;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
45 Toledo;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
45 Toledo;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
45 Toledo;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;81,53
45 Toledo;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
45 Toledo;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
45 Toledo;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
45 Toledo;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;83,85
45 Toledo;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
45 Toledo;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
45 Toledo;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
45 Toledo;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
45 Toledo;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
45 Toledo;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
45 Toledo;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;77,56
45 Toledo;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
45 Toledo;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
45 Toledo;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
45 Toledo;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;79,41
45 Toledo;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
45 Toledo;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
45 Toledo;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
45 Toledo;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
45 Toledo;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
45 Toledo;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
45 Toledo;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QIII;934
45 Toledo;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
45 Toledo;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
45 Toledo;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
45 Toledo;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QIII;901
45 Toledo;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
45 Toledo;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
45 Toledo;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
45 Toledo;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QIII;832
45 Toledo;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
45 Toledo;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
45 Toledo;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
45 Toledo;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2022QIII;844
45 Toledo;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2022QII;""
45 Toledo;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2022QI;""
45 Toledo;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
45 Toledo;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2021QIII;823
45 Toledo;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2021QII;""
45 Toledo;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2021QI;""
45 Toledo;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
45 Toledo;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2020QIII;776
45 Toledo;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2020QII;""
45 Toledo;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2020QI;""
45 Toledo;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2022QIV;773
45 Toledo;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
45 Toledo;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2022QII;""
45 Toledo;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2022QI;""
45 Toledo;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2021QIV;769
45 Toledo;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
45 Toledo;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2021QII;""
45 Toledo;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2021QI;""
45 Toledo;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2020QIV;732
45 Toledo;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
45 Toledo;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2020QII;""
45 Toledo;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2020QI;""
45 Toledo;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
45 Toledo;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
45 Toledo;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QII;""
45 Toledo;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QI;721
45 Toledo;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
45 Toledo;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
45 Toledo;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QII;""
45 Toledo;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QI;694
45 Toledo;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
45 Toledo;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
45 Toledo;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QII;""
45 Toledo;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QI;""
45 Toledo;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
45 Toledo;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
45 Toledo;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QII;680
45 Toledo;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QI;""
45 Toledo;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
45 Toledo;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
45 Toledo;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QII;665
45 Toledo;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QI;""
45 Toledo;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
45 Toledo;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
45 Toledo;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QII;""
45 Toledo;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QI;""
45 Toledo;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
45 Toledo;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
45 Toledo;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
45 Toledo;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
45 Toledo;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
45 Toledo;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
45 Toledo;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
45 Toledo;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
45 Toledo;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
45 Toledo;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
45 Toledo;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
45 Toledo;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
45 Toledo;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
45 Toledo;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;90,36
45 Toledo;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
45 Toledo;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
45 Toledo;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
45 Toledo;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;91,34
45 Toledo;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
45 Toledo;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
45 Toledo;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
45 Toledo;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;93,27
45 Toledo;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
45 Toledo;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
45 Toledo;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;82,76
45 Toledo;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
45 Toledo;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
45 Toledo;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
45 Toledo;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;85,35
45 Toledo;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
45 Toledo;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
45 Toledo;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
45 Toledo;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;87,98
45 Toledo;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
45 Toledo;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
45 Toledo;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
45 Toledo;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
45 Toledo;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
45 Toledo;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
45 Toledo;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;80,02
45 Toledo;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
45 Toledo;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
45 Toledo;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
45 Toledo;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;83,41
45 Toledo;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
45 Toledo;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
45 Toledo;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
45 Toledo;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
45 Toledo;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
45 Toledo;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
45 Toledo;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;75,47
45 Toledo;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
45 Toledo;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
45 Toledo;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
45 Toledo;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;79,93
45 Toledo;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
45 Toledo;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
45 Toledo;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
45 Toledo;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
45 Toledo;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
45 Toledo;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QIV;2.690
45 Toledo;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
45 Toledo;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
45 Toledo;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
45 Toledo;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QIV;2.662
45 Toledo;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
45 Toledo;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
45 Toledo;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
45 Toledo;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QIV;2.564
45 Toledo;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
45 Toledo;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
45 Toledo;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
45 Toledo;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2022QIV;2.482
45 Toledo;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
45 Toledo;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2022QII;""
45 Toledo;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2022QI;""
45 Toledo;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2021QIV;2.484
45 Toledo;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
45 Toledo;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2021QII;""
45 Toledo;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2021QI;""
45 Toledo;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2020QIV;2.394
45 Toledo;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
45 Toledo;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2020QII;""
45 Toledo;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2020QI;""
45 Toledo;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
45 Toledo;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
45 Toledo;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2022QII;""
45 Toledo;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2022QI;2.328
45 Toledo;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
45 Toledo;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
45 Toledo;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2021QII;""
45 Toledo;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2021QI;2.270
45 Toledo;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
45 Toledo;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
45 Toledo;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2020QII;""
45 Toledo;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2020QI;""
45 Toledo;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
45 Toledo;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
45 Toledo;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QII;2.200
45 Toledo;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QI;""
45 Toledo;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
45 Toledo;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
45 Toledo;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QII;2.146
45 Toledo;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QI;""
45 Toledo;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
45 Toledo;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
45 Toledo;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QII;""
45 Toledo;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QI;""
45 Toledo;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
45 Toledo;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QIII;2.069
45 Toledo;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QII;""
45 Toledo;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QI;""
45 Toledo;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
45 Toledo;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QIII;2.033
45 Toledo;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QII;""
45 Toledo;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QI;""
45 Toledo;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
45 Toledo;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
45 Toledo;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QII;""
45 Toledo;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QI;""
45 Toledo;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
45 Toledo;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
45 Toledo;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
45 Toledo;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
45 Toledo;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
45 Toledo;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
45 Toledo;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
45 Toledo;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
45 Toledo;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
45 Toledo;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
45 Toledo;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
45 Toledo;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
45 Toledo;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;92,27
45 Toledo;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
45 Toledo;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
45 Toledo;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
45 Toledo;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;93,31
45 Toledo;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
45 Toledo;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
45 Toledo;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
45 Toledo;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;93,37
45 Toledo;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
45 Toledo;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
45 Toledo;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
45 Toledo;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
45 Toledo;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
45 Toledo;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
45 Toledo;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;87,45
45 Toledo;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
45 Toledo;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
45 Toledo;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
45 Toledo;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;88,53
45 Toledo;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
45 Toledo;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
45 Toledo;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
45 Toledo;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
45 Toledo;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
45 Toledo;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
45 Toledo;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;82,64
45 Toledo;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
45 Toledo;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
45 Toledo;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
45 Toledo;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;83,7
45 Toledo;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
45 Toledo;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
45 Toledo;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
45 Toledo;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
45 Toledo;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
45 Toledo;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
45 Toledo;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;77,72
45 Toledo;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
45 Toledo;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
45 Toledo;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
45 Toledo;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;79,29
45 Toledo;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
45 Toledo;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
45 Toledo;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
45 Toledo;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
45 Toledo;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
45 Toledo;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
45 Toledo;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QIV;1.736
45 Toledo;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
45 Toledo;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
45 Toledo;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
45 Toledo;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QIV;1.735
45 Toledo;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
45 Toledo;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
45 Toledo;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
45 Toledo;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QIV;1.682
45 Toledo;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
45 Toledo;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
45 Toledo;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
45 Toledo;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2022QIV;1.609
45 Toledo;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
45 Toledo;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2022QII;""
45 Toledo;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2022QI;""
45 Toledo;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2021QIV;1.626
45 Toledo;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
45 Toledo;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2021QII;""
45 Toledo;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2021QI;""
45 Toledo;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2020QIV;1.572
45 Toledo;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
45 Toledo;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2020QII;""
45 Toledo;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2020QI;""
45 Toledo;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
45 Toledo;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
45 Toledo;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2022QII;""
45 Toledo;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2022QI;1.529
45 Toledo;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
45 Toledo;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
45 Toledo;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2021QII;""
45 Toledo;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2021QI;1.495
45 Toledo;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
45 Toledo;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
45 Toledo;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2020QII;""
45 Toledo;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2020QI;""
45 Toledo;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
45 Toledo;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
45 Toledo;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QII;1.447
45 Toledo;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QI;""
45 Toledo;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
45 Toledo;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
45 Toledo;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QII;1.409
45 Toledo;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QI;""
45 Toledo;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
45 Toledo;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
45 Toledo;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QII;""
45 Toledo;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QI;""
45 Toledo;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
45 Toledo;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QIII;1.362
45 Toledo;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QII;""
45 Toledo;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QI;""
45 Toledo;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
45 Toledo;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QIII;1.331
45 Toledo;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QII;""
45 Toledo;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QI;""
45 Toledo;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
45 Toledo;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
45 Toledo;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QII;""
45 Toledo;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QI;""
45 Toledo;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
45 Toledo;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
45 Toledo;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
45 Toledo;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
45 Toledo;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
45 Toledo;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
45 Toledo;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
45 Toledo;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
45 Toledo;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
45 Toledo;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
45 Toledo;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
45 Toledo;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
45 Toledo;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;92,68
45 Toledo;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
45 Toledo;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
45 Toledo;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
45 Toledo;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;93,72
45 Toledo;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
45 Toledo;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
45 Toledo;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
45 Toledo;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;93,46
45 Toledo;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
45 Toledo;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
45 Toledo;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
45 Toledo;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
45 Toledo;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
45 Toledo;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
45 Toledo;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;88,13
45 Toledo;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
45 Toledo;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
45 Toledo;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
45 Toledo;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;88,88
45 Toledo;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
45 Toledo;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
45 Toledo;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
45 Toledo;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
45 Toledo;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
45 Toledo;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
45 Toledo;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;83,4
45 Toledo;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
45 Toledo;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
45 Toledo;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
45 Toledo;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;83,77
45 Toledo;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
45 Toledo;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
45 Toledo;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
45 Toledo;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
45 Toledo;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
45 Toledo;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
45 Toledo;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;78,5
45 Toledo;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
45 Toledo;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
45 Toledo;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
45 Toledo;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;79,13
45 Toledo;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
45 Toledo;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
45 Toledo;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
45 Toledo;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
45 Toledo;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
45 Toledo;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
45 Toledo;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QIV;954
45 Toledo;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
45 Toledo;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
45 Toledo;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
45 Toledo;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QIV;927
45 Toledo;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
45 Toledo;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
45 Toledo;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
45 Toledo;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QIV;882
45 Toledo;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
45 Toledo;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
45 Toledo;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
45 Toledo;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2022QIV;873
45 Toledo;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
45 Toledo;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2022QII;""
45 Toledo;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2022QI;""
45 Toledo;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2021QIV;858
45 Toledo;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
45 Toledo;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2021QII;""
45 Toledo;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2021QI;""
45 Toledo;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2020QIV;822
45 Toledo;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
45 Toledo;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2020QII;""
45 Toledo;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2020QI;""
45 Toledo;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
45 Toledo;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
45 Toledo;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2022QII;""
45 Toledo;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2022QI;799
45 Toledo;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
45 Toledo;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
45 Toledo;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2021QII;""
45 Toledo;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2021QI;775
45 Toledo;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
45 Toledo;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
45 Toledo;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2020QII;""
45 Toledo;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2020QI;""
45 Toledo;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
45 Toledo;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
45 Toledo;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QII;753
45 Toledo;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QI;""
45 Toledo;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
45 Toledo;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
45 Toledo;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QII;737
45 Toledo;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QI;""
45 Toledo;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
45 Toledo;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
45 Toledo;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QII;""
45 Toledo;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QI;""
45 Toledo;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
45 Toledo;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QIII;707
45 Toledo;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QII;""
45 Toledo;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QI;""
45 Toledo;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
45 Toledo;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QIII;702
45 Toledo;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QII;""
45 Toledo;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QI;""
45 Toledo;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
45 Toledo;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
45 Toledo;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QII;""
45 Toledo;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QI;""
45 Toledo;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
45 Toledo;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
45 Toledo;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
45 Toledo;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
45 Toledo;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
45 Toledo;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
45 Toledo;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
45 Toledo;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
45 Toledo;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
45 Toledo;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
45 Toledo;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
45 Toledo;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
45 Toledo;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;91,51
45 Toledo;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
45 Toledo;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
45 Toledo;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
45 Toledo;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;92,56
45 Toledo;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
45 Toledo;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
45 Toledo;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
45 Toledo;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;93,2
45 Toledo;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
45 Toledo;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
45 Toledo;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
45 Toledo;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
45 Toledo;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
45 Toledo;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
45 Toledo;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;86,19
45 Toledo;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
45 Toledo;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
45 Toledo;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
45 Toledo;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;87,87
45 Toledo;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
45 Toledo;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
45 Toledo;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
45 Toledo;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
45 Toledo;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
45 Toledo;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
45 Toledo;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;81,23
45 Toledo;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
45 Toledo;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
45 Toledo;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
45 Toledo;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;83,56
45 Toledo;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
45 Toledo;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
45 Toledo;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
45 Toledo;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
45 Toledo;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
45 Toledo;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
45 Toledo;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;76,27
45 Toledo;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
45 Toledo;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
45 Toledo;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
45 Toledo;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;79,59
45 Toledo;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
45 Toledo;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
45 Toledo;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
45 Toledo;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
45 Toledo;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
45 Toledo;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
45 Toledo;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
45 Toledo;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
45 Toledo;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
45 Toledo;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QI;7.931
45 Toledo;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
45 Toledo;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
45 Toledo;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
45 Toledo;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QI;8.140
45 Toledo;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
45 Toledo;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
45 Toledo;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
45 Toledo;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QI;7.960
45 Toledo;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
45 Toledo;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
45 Toledo;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2022QII;""
45 Toledo;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2022QI;7.631
45 Toledo;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
45 Toledo;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
45 Toledo;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2021QII;""
45 Toledo;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2021QI;7.935
45 Toledo;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
45 Toledo;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
45 Toledo;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2020QII;""
45 Toledo;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2020QI;7.252
45 Toledo;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
45 Toledo;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
45 Toledo;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2022QII;7.331
45 Toledo;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2022QI;""
45 Toledo;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
45 Toledo;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
45 Toledo;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2021QII;7.639
45 Toledo;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2021QI;""
45 Toledo;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
45 Toledo;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
45 Toledo;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2020QII;7.113
45 Toledo;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2020QI;""
45 Toledo;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
45 Toledo;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QIII;7.120
45 Toledo;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QII;""
45 Toledo;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QI;""
45 Toledo;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
45 Toledo;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QIII;7.416
45 Toledo;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QII;""
45 Toledo;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QI;""
45 Toledo;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
45 Toledo;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QIII;6.893
45 Toledo;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QII;""
45 Toledo;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QI;""
45 Toledo;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QIV;6.882
45 Toledo;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
45 Toledo;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QII;""
45 Toledo;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QI;""
45 Toledo;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QIV;7.197
45 Toledo;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
45 Toledo;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QII;""
45 Toledo;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QI;""
45 Toledo;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QIV;6.735
45 Toledo;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
45 Toledo;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QII;""
45 Toledo;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QI;""
45 Toledo;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
45 Toledo;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
45 Toledo;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
45 Toledo;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
45 Toledo;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
45 Toledo;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
45 Toledo;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
45 Toledo;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
45 Toledo;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
45 Toledo;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
45 Toledo;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
45 Toledo;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
45 Toledo;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
45 Toledo;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
45 Toledo;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
45 Toledo;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;96,22
45 Toledo;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
45 Toledo;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
45 Toledo;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
45 Toledo;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;97,48
45 Toledo;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
45 Toledo;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
45 Toledo;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
45 Toledo;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;91,11
45 Toledo;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
45 Toledo;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
45 Toledo;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;92,43
45 Toledo;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
45 Toledo;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
45 Toledo;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
45 Toledo;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;93,85
45 Toledo;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
45 Toledo;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
45 Toledo;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
45 Toledo;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;89,36
45 Toledo;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
45 Toledo;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
45 Toledo;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;89,77
45 Toledo;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
45 Toledo;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
45 Toledo;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
45 Toledo;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;91,11
45 Toledo;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
45 Toledo;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
45 Toledo;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
45 Toledo;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;86,6
45 Toledo;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
45 Toledo;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
45 Toledo;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;86,77
45 Toledo;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
45 Toledo;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
45 Toledo;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
45 Toledo;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;88,42
45 Toledo;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
45 Toledo;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
45 Toledo;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
45 Toledo;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;84,61
45 Toledo;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
45 Toledo;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
45 Toledo;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
45 Toledo;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
45 Toledo;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
45 Toledo;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
45 Toledo;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QI;4.956
45 Toledo;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
45 Toledo;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
45 Toledo;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
45 Toledo;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QI;5.182
45 Toledo;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
45 Toledo;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
45 Toledo;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
45 Toledo;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QI;5.041
45 Toledo;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
45 Toledo;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
45 Toledo;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2022QII;""
45 Toledo;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2022QI;4.786
45 Toledo;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
45 Toledo;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
45 Toledo;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2021QII;""
45 Toledo;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2021QI;5.067
45 Toledo;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
45 Toledo;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
45 Toledo;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2020QII;""
45 Toledo;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2020QI;4.629
45 Toledo;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
45 Toledo;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
45 Toledo;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2022QII;4.623
45 Toledo;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2022QI;""
45 Toledo;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
45 Toledo;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
45 Toledo;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2021QII;4.891
45 Toledo;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2021QI;""
45 Toledo;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
45 Toledo;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
45 Toledo;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2020QII;4.554
45 Toledo;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2020QI;""
45 Toledo;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
45 Toledo;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QIII;4.507
45 Toledo;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QII;""
45 Toledo;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QI;""
45 Toledo;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
45 Toledo;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QIII;4.767
45 Toledo;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QII;""
45 Toledo;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QI;""
45 Toledo;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
45 Toledo;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QIII;4.415
45 Toledo;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QII;""
45 Toledo;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QI;""
45 Toledo;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QIV;4.361
45 Toledo;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
45 Toledo;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QII;""
45 Toledo;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QI;""
45 Toledo;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QIV;4.631
45 Toledo;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
45 Toledo;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QII;""
45 Toledo;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QI;""
45 Toledo;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QIV;4.321
45 Toledo;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
45 Toledo;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QII;""
45 Toledo;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QI;""
45 Toledo;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
45 Toledo;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
45 Toledo;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
45 Toledo;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
45 Toledo;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
45 Toledo;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
45 Toledo;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
45 Toledo;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
45 Toledo;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
45 Toledo;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
45 Toledo;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
45 Toledo;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
45 Toledo;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
45 Toledo;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
45 Toledo;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
45 Toledo;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;96,57
45 Toledo;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
45 Toledo;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
45 Toledo;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
45 Toledo;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;97,78
45 Toledo;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
45 Toledo;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
45 Toledo;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
45 Toledo;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;91,83
45 Toledo;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
45 Toledo;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
45 Toledo;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;93,28
45 Toledo;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
45 Toledo;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
45 Toledo;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
45 Toledo;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;94,38
45 Toledo;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
45 Toledo;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
45 Toledo;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
45 Toledo;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;90,34
45 Toledo;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
45 Toledo;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
45 Toledo;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;90,94
45 Toledo;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
45 Toledo;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
45 Toledo;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
45 Toledo;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;91,99
45 Toledo;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
45 Toledo;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
45 Toledo;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
45 Toledo;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;87,58
45 Toledo;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
45 Toledo;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
45 Toledo;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;87,99
45 Toledo;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
45 Toledo;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
45 Toledo;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
45 Toledo;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;89,37
45 Toledo;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
45 Toledo;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
45 Toledo;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
45 Toledo;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;85,72
45 Toledo;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
45 Toledo;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
45 Toledo;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
45 Toledo;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
45 Toledo;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
45 Toledo;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
45 Toledo;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QI;2.975
45 Toledo;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
45 Toledo;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
45 Toledo;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
45 Toledo;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QI;2.958
45 Toledo;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
45 Toledo;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
45 Toledo;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
45 Toledo;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QI;2.919
45 Toledo;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
45 Toledo;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
45 Toledo;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2022QII;""
45 Toledo;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2022QI;2.845
45 Toledo;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
45 Toledo;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
45 Toledo;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2021QII;""
45 Toledo;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2021QI;2.868
45 Toledo;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
45 Toledo;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
45 Toledo;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2020QII;""
45 Toledo;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2020QI;2.623
45 Toledo;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
45 Toledo;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
45 Toledo;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2022QII;2.708
45 Toledo;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2022QI;""
45 Toledo;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
45 Toledo;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
45 Toledo;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2021QII;2.748
45 Toledo;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2021QI;""
45 Toledo;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
45 Toledo;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
45 Toledo;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2020QII;2.559
45 Toledo;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2020QI;""
45 Toledo;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
45 Toledo;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QIII;2.613
45 Toledo;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QII;""
45 Toledo;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QI;""
45 Toledo;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
45 Toledo;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QIII;2.649
45 Toledo;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QII;""
45 Toledo;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QI;""
45 Toledo;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
45 Toledo;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QIII;2.478
45 Toledo;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QII;""
45 Toledo;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QI;""
45 Toledo;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QIV;2.521
45 Toledo;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
45 Toledo;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QII;""
45 Toledo;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QI;""
45 Toledo;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QIV;2.566
45 Toledo;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
45 Toledo;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QII;""
45 Toledo;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QI;""
45 Toledo;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QIV;2.414
45 Toledo;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
45 Toledo;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QII;""
45 Toledo;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QI;""
45 Toledo;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
45 Toledo;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
45 Toledo;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
45 Toledo;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
45 Toledo;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
45 Toledo;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
45 Toledo;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
45 Toledo;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
45 Toledo;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
45 Toledo;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
45 Toledo;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
45 Toledo;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
45 Toledo;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
45 Toledo;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
45 Toledo;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
45 Toledo;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;95,63
45 Toledo;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
45 Toledo;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
45 Toledo;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
45 Toledo;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;96,96
45 Toledo;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
45 Toledo;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
45 Toledo;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
45 Toledo;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;89,86
45 Toledo;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
45 Toledo;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
45 Toledo;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;91,03
45 Toledo;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
45 Toledo;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
45 Toledo;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
45 Toledo;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;92,9
45 Toledo;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
45 Toledo;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
45 Toledo;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
45 Toledo;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;87,67
45 Toledo;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
45 Toledo;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
45 Toledo;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;87,83
45 Toledo;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
45 Toledo;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
45 Toledo;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
45 Toledo;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;89,55
45 Toledo;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
45 Toledo;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
45 Toledo;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
45 Toledo;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;84,89
45 Toledo;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
45 Toledo;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
45 Toledo;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;84,74
45 Toledo;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
45 Toledo;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
45 Toledo;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
45 Toledo;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;86,75
45 Toledo;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
45 Toledo;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
45 Toledo;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
45 Toledo;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;82,7
45 Toledo;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
45 Toledo;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
45 Toledo;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
45 Toledo;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
45 Toledo;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
45 Toledo;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QII;7.329
45 Toledo;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
45 Toledo;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
45 Toledo;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
45 Toledo;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QII;7.652
45 Toledo;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
45 Toledo;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
45 Toledo;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
45 Toledo;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QII;7.695
45 Toledo;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
45 Toledo;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
45 Toledo;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
45 Toledo;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2022QII;7.035
45 Toledo;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2022QI;""
45 Toledo;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
45 Toledo;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
45 Toledo;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2021QII;7.339
45 Toledo;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2021QI;""
45 Toledo;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
45 Toledo;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
45 Toledo;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2020QII;7.535
45 Toledo;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2020QI;""
45 Toledo;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
45 Toledo;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2022QIII;6.819
45 Toledo;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2022QII;""
45 Toledo;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2022QI;""
45 Toledo;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
45 Toledo;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2021QIII;7.080
45 Toledo;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2021QII;""
45 Toledo;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2021QI;""
45 Toledo;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
45 Toledo;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2020QIII;7.292
45 Toledo;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2020QII;""
45 Toledo;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2020QI;""
45 Toledo;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QIV;6.564
45 Toledo;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
45 Toledo;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QII;""
45 Toledo;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QI;""
45 Toledo;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QIV;6.852
45 Toledo;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
45 Toledo;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QII;""
45 Toledo;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QI;""
45 Toledo;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QIV;7.110
45 Toledo;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
45 Toledo;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QII;""
45 Toledo;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QI;""
45 Toledo;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
45 Toledo;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
45 Toledo;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QII;""
45 Toledo;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QI;6.639
45 Toledo;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
45 Toledo;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
45 Toledo;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QII;""
45 Toledo;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QI;6.968
45 Toledo;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
45 Toledo;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
45 Toledo;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QII;""
45 Toledo;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QI;""
45 Toledo;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
45 Toledo;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
45 Toledo;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
45 Toledo;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
45 Toledo;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
45 Toledo;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
45 Toledo;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
45 Toledo;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
45 Toledo;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
45 Toledo;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
45 Toledo;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
45 Toledo;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
45 Toledo;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
45 Toledo;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
45 Toledo;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;95,99
45 Toledo;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
45 Toledo;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
45 Toledo;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
45 Toledo;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;95,91
45 Toledo;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
45 Toledo;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
45 Toledo;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
45 Toledo;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;97,92
45 Toledo;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
45 Toledo;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
45 Toledo;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;93,04
45 Toledo;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
45 Toledo;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
45 Toledo;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
45 Toledo;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;92,52
45 Toledo;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
45 Toledo;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
45 Toledo;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
45 Toledo;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;94,76
45 Toledo;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
45 Toledo;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
45 Toledo;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;89,56
45 Toledo;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
45 Toledo;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
45 Toledo;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
45 Toledo;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;89,55
45 Toledo;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
45 Toledo;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
45 Toledo;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
45 Toledo;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;92,4
45 Toledo;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
45 Toledo;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
45 Toledo;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
45 Toledo;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
45 Toledo;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
45 Toledo;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
45 Toledo;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;86,76
45 Toledo;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
45 Toledo;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
45 Toledo;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
45 Toledo;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;90,55
45 Toledo;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
45 Toledo;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
45 Toledo;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
45 Toledo;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
45 Toledo;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
45 Toledo;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
45 Toledo;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QII;4.543
45 Toledo;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
45 Toledo;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
45 Toledo;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
45 Toledo;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QII;4.804
45 Toledo;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
45 Toledo;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
45 Toledo;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
45 Toledo;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QII;4.907
45 Toledo;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
45 Toledo;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
45 Toledo;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
45 Toledo;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2022QII;4.382
45 Toledo;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2022QI;""
45 Toledo;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
45 Toledo;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
45 Toledo;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2021QII;4.613
45 Toledo;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2021QI;""
45 Toledo;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
45 Toledo;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
45 Toledo;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2020QII;4.819
45 Toledo;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2020QI;""
45 Toledo;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
45 Toledo;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2022QIII;4.262
45 Toledo;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2022QII;""
45 Toledo;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2022QI;""
45 Toledo;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
45 Toledo;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2021QIII;4.467
45 Toledo;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2021QII;""
45 Toledo;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2021QI;""
45 Toledo;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
45 Toledo;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2020QIII;4.666
45 Toledo;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2020QII;""
45 Toledo;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2020QI;""
45 Toledo;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QIV;4.102
45 Toledo;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
45 Toledo;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QII;""
45 Toledo;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QI;""
45 Toledo;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QIV;4.322
45 Toledo;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
45 Toledo;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QII;""
45 Toledo;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QI;""
45 Toledo;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QIV;4.557
45 Toledo;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
45 Toledo;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QII;""
45 Toledo;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QI;""
45 Toledo;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
45 Toledo;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
45 Toledo;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QII;""
45 Toledo;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QI;4.208
45 Toledo;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
45 Toledo;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
45 Toledo;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QII;""
45 Toledo;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QI;4.475
45 Toledo;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
45 Toledo;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
45 Toledo;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QII;""
45 Toledo;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QI;""
45 Toledo;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
45 Toledo;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
45 Toledo;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
45 Toledo;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
45 Toledo;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
45 Toledo;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
45 Toledo;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
45 Toledo;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
45 Toledo;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
45 Toledo;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
45 Toledo;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
45 Toledo;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
45 Toledo;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
45 Toledo;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
45 Toledo;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;96,46
45 Toledo;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
45 Toledo;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
45 Toledo;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
45 Toledo;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;96,02
45 Toledo;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
45 Toledo;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
45 Toledo;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
45 Toledo;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;98,21
45 Toledo;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
45 Toledo;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
45 Toledo;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;93,81
45 Toledo;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
45 Toledo;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
45 Toledo;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
45 Toledo;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;92,99
45 Toledo;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
45 Toledo;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
45 Toledo;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
45 Toledo;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;95,09
45 Toledo;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
45 Toledo;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
45 Toledo;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;90,29
45 Toledo;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
45 Toledo;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
45 Toledo;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
45 Toledo;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;89,97
45 Toledo;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
45 Toledo;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
45 Toledo;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
45 Toledo;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;92,87
45 Toledo;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
45 Toledo;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
45 Toledo;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
45 Toledo;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
45 Toledo;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
45 Toledo;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
45 Toledo;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;87,59
45 Toledo;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
45 Toledo;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
45 Toledo;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
45 Toledo;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;91,2
45 Toledo;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
45 Toledo;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
45 Toledo;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
45 Toledo;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
45 Toledo;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
45 Toledo;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
45 Toledo;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QII;2.786
45 Toledo;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
45 Toledo;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
45 Toledo;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
45 Toledo;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QII;2.848
45 Toledo;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
45 Toledo;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
45 Toledo;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
45 Toledo;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QII;2.788
45 Toledo;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
45 Toledo;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
45 Toledo;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
45 Toledo;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2022QII;2.653
45 Toledo;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2022QI;""
45 Toledo;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
45 Toledo;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
45 Toledo;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2021QII;2.726
45 Toledo;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2021QI;""
45 Toledo;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
45 Toledo;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
45 Toledo;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2020QII;2.716
45 Toledo;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2020QI;""
45 Toledo;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
45 Toledo;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2022QIII;2.557
45 Toledo;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2022QII;""
45 Toledo;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2022QI;""
45 Toledo;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
45 Toledo;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2021QIII;2.613
45 Toledo;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2021QII;""
45 Toledo;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2021QI;""
45 Toledo;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
45 Toledo;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2020QIII;2.626
45 Toledo;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2020QII;""
45 Toledo;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2020QI;""
45 Toledo;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QIV;2.462
45 Toledo;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
45 Toledo;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QII;""
45 Toledo;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QI;""
45 Toledo;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QIV;2.530
45 Toledo;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
45 Toledo;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QII;""
45 Toledo;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QI;""
45 Toledo;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QIV;2.553
45 Toledo;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
45 Toledo;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QII;""
45 Toledo;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QI;""
45 Toledo;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
45 Toledo;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
45 Toledo;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QII;""
45 Toledo;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QI;2.431
45 Toledo;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
45 Toledo;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
45 Toledo;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QII;""
45 Toledo;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QI;2.493
45 Toledo;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
45 Toledo;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
45 Toledo;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QII;""
45 Toledo;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QI;""
45 Toledo;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
45 Toledo;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
45 Toledo;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
45 Toledo;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
45 Toledo;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
45 Toledo;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
45 Toledo;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
45 Toledo;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
45 Toledo;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
45 Toledo;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
45 Toledo;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
45 Toledo;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
45 Toledo;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
45 Toledo;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
45 Toledo;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;95,23
45 Toledo;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
45 Toledo;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
45 Toledo;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
45 Toledo;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;95,72
45 Toledo;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
45 Toledo;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
45 Toledo;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
45 Toledo;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;97,42
45 Toledo;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
45 Toledo;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
45 Toledo;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;91,78
45 Toledo;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
45 Toledo;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
45 Toledo;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
45 Toledo;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;91,75
45 Toledo;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
45 Toledo;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
45 Toledo;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
45 Toledo;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;94,19
45 Toledo;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
45 Toledo;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
45 Toledo;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;88,37
45 Toledo;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
45 Toledo;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
45 Toledo;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
45 Toledo;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;88,83
45 Toledo;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
45 Toledo;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
45 Toledo;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
45 Toledo;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;91,57
45 Toledo;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
45 Toledo;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
45 Toledo;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
45 Toledo;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
45 Toledo;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
45 Toledo;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
45 Toledo;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;85,36
45 Toledo;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
45 Toledo;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
45 Toledo;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
45 Toledo;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;89,42
45 Toledo;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
45 Toledo;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
45 Toledo;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
45 Toledo;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
45 Toledo;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
45 Toledo;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QIII;7.454
45 Toledo;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
45 Toledo;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
45 Toledo;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
45 Toledo;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QIII;7.778
45 Toledo;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
45 Toledo;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
45 Toledo;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
45 Toledo;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QIII;7.933
45 Toledo;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
45 Toledo;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
45 Toledo;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
45 Toledo;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2022QIII;7.190
45 Toledo;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2022QII;""
45 Toledo;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2022QI;""
45 Toledo;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
45 Toledo;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2021QIII;7.470
45 Toledo;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2021QII;""
45 Toledo;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2021QI;""
45 Toledo;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
45 Toledo;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2020QIII;7.646
45 Toledo;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2020QII;""
45 Toledo;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2020QI;""
45 Toledo;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2022QIV;6.907
45 Toledo;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
45 Toledo;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2022QII;""
45 Toledo;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2022QI;""
45 Toledo;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2021QIV;7.208
45 Toledo;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
45 Toledo;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2021QII;""
45 Toledo;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2021QI;""
45 Toledo;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2020QIV;7.435
45 Toledo;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
45 Toledo;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2020QII;""
45 Toledo;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2020QI;""
45 Toledo;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
45 Toledo;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
45 Toledo;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QII;""
45 Toledo;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QI;6.978
45 Toledo;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
45 Toledo;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
45 Toledo;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QII;""
45 Toledo;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QI;7.280
45 Toledo;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
45 Toledo;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
45 Toledo;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QII;""
45 Toledo;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QI;""
45 Toledo;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
45 Toledo;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
45 Toledo;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QII;6.730
45 Toledo;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QI;""
45 Toledo;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
45 Toledo;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
45 Toledo;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QII;7.043
45 Toledo;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QI;""
45 Toledo;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
45 Toledo;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
45 Toledo;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QII;""
45 Toledo;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QI;""
45 Toledo;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
45 Toledo;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
45 Toledo;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
45 Toledo;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
45 Toledo;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
45 Toledo;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
45 Toledo;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
45 Toledo;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
45 Toledo;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
45 Toledo;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
45 Toledo;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
45 Toledo;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
45 Toledo;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
45 Toledo;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;96,46
45 Toledo;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
45 Toledo;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
45 Toledo;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
45 Toledo;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;96,04
45 Toledo;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
45 Toledo;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
45 Toledo;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
45 Toledo;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;96,38
45 Toledo;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
45 Toledo;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
45 Toledo;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;92,66
45 Toledo;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
45 Toledo;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
45 Toledo;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
45 Toledo;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;92,67
45 Toledo;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
45 Toledo;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
45 Toledo;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
45 Toledo;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;93,72
45 Toledo;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
45 Toledo;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
45 Toledo;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
45 Toledo;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
45 Toledo;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
45 Toledo;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
45 Toledo;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;89,71
45 Toledo;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
45 Toledo;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
45 Toledo;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
45 Toledo;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;91,77
45 Toledo;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
45 Toledo;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
45 Toledo;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
45 Toledo;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
45 Toledo;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
45 Toledo;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
45 Toledo;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;86,53
45 Toledo;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
45 Toledo;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
45 Toledo;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
45 Toledo;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;88,78
45 Toledo;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
45 Toledo;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
45 Toledo;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
45 Toledo;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
45 Toledo;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
45 Toledo;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
45 Toledo;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QIII;4.627
45 Toledo;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
45 Toledo;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
45 Toledo;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
45 Toledo;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QIII;4.876
45 Toledo;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
45 Toledo;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
45 Toledo;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
45 Toledo;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QIII;5.077
45 Toledo;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
45 Toledo;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
45 Toledo;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
45 Toledo;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2022QIII;4.477
45 Toledo;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2022QII;""
45 Toledo;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2022QI;""
45 Toledo;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
45 Toledo;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2021QIII;4.698
45 Toledo;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2021QII;""
45 Toledo;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2021QI;""
45 Toledo;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
45 Toledo;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2020QIII;4.891
45 Toledo;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2020QII;""
45 Toledo;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2020QI;""
45 Toledo;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2022QIV;4.301
45 Toledo;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
45 Toledo;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2022QII;""
45 Toledo;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2022QI;""
45 Toledo;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2021QIV;4.531
45 Toledo;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
45 Toledo;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2021QII;""
45 Toledo;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2021QI;""
45 Toledo;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2020QIV;4.764
45 Toledo;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
45 Toledo;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2020QII;""
45 Toledo;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2020QI;""
45 Toledo;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
45 Toledo;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
45 Toledo;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QII;""
45 Toledo;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QI;4.408
45 Toledo;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
45 Toledo;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
45 Toledo;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QII;""
45 Toledo;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QI;4.674
45 Toledo;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
45 Toledo;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
45 Toledo;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QII;""
45 Toledo;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QI;""
45 Toledo;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
45 Toledo;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
45 Toledo;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QII;4.274
45 Toledo;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QI;""
45 Toledo;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
45 Toledo;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
45 Toledo;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QII;4.536
45 Toledo;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QI;""
45 Toledo;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
45 Toledo;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
45 Toledo;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QII;""
45 Toledo;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QI;""
45 Toledo;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
45 Toledo;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
45 Toledo;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
45 Toledo;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
45 Toledo;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
45 Toledo;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
45 Toledo;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
45 Toledo;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
45 Toledo;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
45 Toledo;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
45 Toledo;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
45 Toledo;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
45 Toledo;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
45 Toledo;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;96,76
45 Toledo;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
45 Toledo;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
45 Toledo;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
45 Toledo;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;96,35
45 Toledo;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
45 Toledo;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
45 Toledo;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
45 Toledo;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;96,34
45 Toledo;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
45 Toledo;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
45 Toledo;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;92,95
45 Toledo;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
45 Toledo;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
45 Toledo;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
45 Toledo;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;92,92
45 Toledo;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
45 Toledo;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
45 Toledo;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
45 Toledo;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;93,83
45 Toledo;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
45 Toledo;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
45 Toledo;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
45 Toledo;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
45 Toledo;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
45 Toledo;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
45 Toledo;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;90,4
45 Toledo;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
45 Toledo;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
45 Toledo;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
45 Toledo;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;92,06
45 Toledo;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
45 Toledo;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
45 Toledo;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
45 Toledo;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
45 Toledo;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
45 Toledo;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
45 Toledo;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;87,65
45 Toledo;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
45 Toledo;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
45 Toledo;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
45 Toledo;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;89,34
45 Toledo;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
45 Toledo;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
45 Toledo;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
45 Toledo;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
45 Toledo;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
45 Toledo;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
45 Toledo;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QIII;2.827
45 Toledo;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
45 Toledo;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
45 Toledo;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
45 Toledo;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QIII;2.902
45 Toledo;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
45 Toledo;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
45 Toledo;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
45 Toledo;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QIII;2.856
45 Toledo;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
45 Toledo;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
45 Toledo;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
45 Toledo;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2022QIII;2.713
45 Toledo;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2022QII;""
45 Toledo;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2022QI;""
45 Toledo;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
45 Toledo;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2021QIII;2.772
45 Toledo;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2021QII;""
45 Toledo;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2021QI;""
45 Toledo;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
45 Toledo;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2020QIII;2.755
45 Toledo;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2020QII;""
45 Toledo;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2020QI;""
45 Toledo;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2022QIV;2.606
45 Toledo;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
45 Toledo;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2022QII;""
45 Toledo;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2022QI;""
45 Toledo;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2021QIV;2.677
45 Toledo;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
45 Toledo;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2021QII;""
45 Toledo;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2021QI;""
45 Toledo;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2020QIV;2.671
45 Toledo;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
45 Toledo;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2020QII;""
45 Toledo;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2020QI;""
45 Toledo;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
45 Toledo;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
45 Toledo;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QII;""
45 Toledo;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QI;2.570
45 Toledo;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
45 Toledo;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
45 Toledo;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QII;""
45 Toledo;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QI;2.606
45 Toledo;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
45 Toledo;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
45 Toledo;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QII;""
45 Toledo;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QI;""
45 Toledo;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
45 Toledo;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
45 Toledo;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QII;2.456
45 Toledo;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QI;""
45 Toledo;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
45 Toledo;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
45 Toledo;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QII;2.507
45 Toledo;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QI;""
45 Toledo;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
45 Toledo;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
45 Toledo;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QII;""
45 Toledo;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QI;""
45 Toledo;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
45 Toledo;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
45 Toledo;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
45 Toledo;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
45 Toledo;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
45 Toledo;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
45 Toledo;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
45 Toledo;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
45 Toledo;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
45 Toledo;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
45 Toledo;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
45 Toledo;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
45 Toledo;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
45 Toledo;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;95,97
45 Toledo;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
45 Toledo;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
45 Toledo;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
45 Toledo;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;95,52
45 Toledo;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
45 Toledo;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
45 Toledo;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
45 Toledo;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;96,46
45 Toledo;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
45 Toledo;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
45 Toledo;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;92,18
45 Toledo;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
45 Toledo;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
45 Toledo;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
45 Toledo;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;92,25
45 Toledo;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
45 Toledo;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
45 Toledo;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
45 Toledo;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;93,52
45 Toledo;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
45 Toledo;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
45 Toledo;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
45 Toledo;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
45 Toledo;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
45 Toledo;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
45 Toledo;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;88,56
45 Toledo;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
45 Toledo;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
45 Toledo;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
45 Toledo;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;91,25
45 Toledo;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
45 Toledo;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
45 Toledo;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
45 Toledo;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
45 Toledo;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
45 Toledo;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
45 Toledo;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;84,63
45 Toledo;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
45 Toledo;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
45 Toledo;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
45 Toledo;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;87,78
45 Toledo;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
45 Toledo;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
45 Toledo;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
45 Toledo;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
45 Toledo;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
45 Toledo;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QIV;7.483
45 Toledo;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
45 Toledo;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
45 Toledo;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
45 Toledo;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QIV;7.838
45 Toledo;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
45 Toledo;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
45 Toledo;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
45 Toledo;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QIV;8.017
45 Toledo;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
45 Toledo;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
45 Toledo;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
45 Toledo;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2022QIV;7.170
45 Toledo;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
45 Toledo;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2022QII;""
45 Toledo;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2022QI;""
45 Toledo;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2021QIV;7.537
45 Toledo;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
45 Toledo;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2021QII;""
45 Toledo;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2021QI;""
45 Toledo;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2020QIV;7.767
45 Toledo;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
45 Toledo;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2020QII;""
45 Toledo;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2020QI;""
45 Toledo;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
45 Toledo;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
45 Toledo;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2022QII;""
45 Toledo;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2022QI;7.277
45 Toledo;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
45 Toledo;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
45 Toledo;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2021QII;""
45 Toledo;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2021QI;7.591
45 Toledo;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
45 Toledo;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
45 Toledo;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2020QII;""
45 Toledo;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2020QI;""
45 Toledo;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
45 Toledo;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
45 Toledo;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QII;7.008
45 Toledo;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QI;""
45 Toledo;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
45 Toledo;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
45 Toledo;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QII;7.330
45 Toledo;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QI;""
45 Toledo;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
45 Toledo;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
45 Toledo;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QII;""
45 Toledo;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QI;""
45 Toledo;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
45 Toledo;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QIII;6.814
45 Toledo;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QII;""
45 Toledo;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QI;""
45 Toledo;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
45 Toledo;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QIII;7.128
45 Toledo;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QII;""
45 Toledo;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QI;""
45 Toledo;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
45 Toledo;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
45 Toledo;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QII;""
45 Toledo;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QI;""
45 Toledo;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
45 Toledo;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
45 Toledo;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
45 Toledo;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
45 Toledo;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
45 Toledo;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
45 Toledo;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
45 Toledo;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
45 Toledo;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
45 Toledo;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
45 Toledo;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
45 Toledo;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
45 Toledo;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;95,82
45 Toledo;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
45 Toledo;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
45 Toledo;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
45 Toledo;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;96,16
45 Toledo;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
45 Toledo;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
45 Toledo;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
45 Toledo;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;96,88
45 Toledo;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
45 Toledo;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
45 Toledo;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
45 Toledo;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
45 Toledo;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
45 Toledo;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
45 Toledo;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;92,84
45 Toledo;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
45 Toledo;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
45 Toledo;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
45 Toledo;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;94,69
45 Toledo;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
45 Toledo;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
45 Toledo;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
45 Toledo;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
45 Toledo;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
45 Toledo;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
45 Toledo;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;89,41
45 Toledo;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
45 Toledo;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
45 Toledo;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
45 Toledo;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;91,43
45 Toledo;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
45 Toledo;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
45 Toledo;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
45 Toledo;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
45 Toledo;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
45 Toledo;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
45 Toledo;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;86,94
45 Toledo;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
45 Toledo;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
45 Toledo;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
45 Toledo;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;88,91
45 Toledo;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
45 Toledo;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
45 Toledo;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
45 Toledo;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
45 Toledo;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
45 Toledo;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
45 Toledo;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QIV;4.646
45 Toledo;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
45 Toledo;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
45 Toledo;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
45 Toledo;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QIV;4.919
45 Toledo;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
45 Toledo;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
45 Toledo;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
45 Toledo;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QIV;5.118
45 Toledo;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
45 Toledo;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
45 Toledo;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
45 Toledo;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2022QIV;4.454
45 Toledo;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
45 Toledo;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2022QII;""
45 Toledo;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2022QI;""
45 Toledo;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2021QIV;4.729
45 Toledo;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
45 Toledo;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2021QII;""
45 Toledo;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2021QI;""
45 Toledo;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2020QIV;4.966
45 Toledo;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
45 Toledo;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2020QII;""
45 Toledo;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2020QI;""
45 Toledo;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
45 Toledo;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
45 Toledo;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2022QII;""
45 Toledo;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2022QI;4.587
45 Toledo;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
45 Toledo;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
45 Toledo;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2021QII;""
45 Toledo;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2021QI;4.868
45 Toledo;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
45 Toledo;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
45 Toledo;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2020QII;""
45 Toledo;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2020QI;""
45 Toledo;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
45 Toledo;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
45 Toledo;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QII;4.441
45 Toledo;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QI;""
45 Toledo;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
45 Toledo;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
45 Toledo;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QII;4.713
45 Toledo;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QI;""
45 Toledo;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
45 Toledo;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
45 Toledo;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QII;""
45 Toledo;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QI;""
45 Toledo;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
45 Toledo;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QIII;4.335
45 Toledo;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QII;""
45 Toledo;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QI;""
45 Toledo;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
45 Toledo;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QIII;4.598
45 Toledo;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QII;""
45 Toledo;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QI;""
45 Toledo;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
45 Toledo;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
45 Toledo;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QII;""
45 Toledo;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QI;""
45 Toledo;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
45 Toledo;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
45 Toledo;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
45 Toledo;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
45 Toledo;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
45 Toledo;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
45 Toledo;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
45 Toledo;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
45 Toledo;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
45 Toledo;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
45 Toledo;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
45 Toledo;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
45 Toledo;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;95,87
45 Toledo;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
45 Toledo;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
45 Toledo;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
45 Toledo;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;96,14
45 Toledo;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
45 Toledo;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
45 Toledo;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
45 Toledo;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;97,03
45 Toledo;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
45 Toledo;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
45 Toledo;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
45 Toledo;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
45 Toledo;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
45 Toledo;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
45 Toledo;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;93,25
45 Toledo;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
45 Toledo;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
45 Toledo;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
45 Toledo;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;95,12
45 Toledo;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
45 Toledo;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
45 Toledo;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
45 Toledo;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
45 Toledo;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
45 Toledo;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
45 Toledo;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;90,28
45 Toledo;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
45 Toledo;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
45 Toledo;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
45 Toledo;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;92,09
45 Toledo;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
45 Toledo;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
45 Toledo;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
45 Toledo;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
45 Toledo;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
45 Toledo;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
45 Toledo;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;88,13
45 Toledo;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
45 Toledo;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
45 Toledo;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
45 Toledo;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;89,84
45 Toledo;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
45 Toledo;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
45 Toledo;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
45 Toledo;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
45 Toledo;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
45 Toledo;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
45 Toledo;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QIV;2.837
45 Toledo;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
45 Toledo;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
45 Toledo;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
45 Toledo;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QIV;2.919
45 Toledo;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
45 Toledo;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
45 Toledo;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
45 Toledo;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QIV;2.899
45 Toledo;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
45 Toledo;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
45 Toledo;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
45 Toledo;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2022QIV;2.716
45 Toledo;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
45 Toledo;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2022QII;""
45 Toledo;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2022QI;""
45 Toledo;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2021QIV;2.808
45 Toledo;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
45 Toledo;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2021QII;""
45 Toledo;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2021QI;""
45 Toledo;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2020QIV;2.801
45 Toledo;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
45 Toledo;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2020QII;""
45 Toledo;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2020QI;""
45 Toledo;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
45 Toledo;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
45 Toledo;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2022QII;""
45 Toledo;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2022QI;2.690
45 Toledo;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
45 Toledo;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
45 Toledo;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2021QII;""
45 Toledo;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2021QI;2.723
45 Toledo;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
45 Toledo;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
45 Toledo;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2020QII;""
45 Toledo;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2020QI;""
45 Toledo;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
45 Toledo;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
45 Toledo;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QII;2.567
45 Toledo;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QI;""
45 Toledo;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
45 Toledo;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
45 Toledo;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QII;2.617
45 Toledo;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QI;""
45 Toledo;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
45 Toledo;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
45 Toledo;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QII;""
45 Toledo;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QI;""
45 Toledo;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
45 Toledo;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QIII;2.479
45 Toledo;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QII;""
45 Toledo;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QI;""
45 Toledo;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
45 Toledo;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QIII;2.530
45 Toledo;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QII;""
45 Toledo;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QI;""
45 Toledo;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
45 Toledo;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
45 Toledo;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QII;""
45 Toledo;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QI;""
45 Toledo;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
45 Toledo;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
45 Toledo;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
45 Toledo;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
45 Toledo;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
45 Toledo;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
45 Toledo;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
45 Toledo;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
45 Toledo;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
45 Toledo;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
45 Toledo;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
45 Toledo;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
45 Toledo;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;95,73
45 Toledo;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
45 Toledo;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
45 Toledo;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
45 Toledo;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;96,2
45 Toledo;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
45 Toledo;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
45 Toledo;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
45 Toledo;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;96,62
45 Toledo;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
45 Toledo;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
45 Toledo;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
45 Toledo;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
45 Toledo;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
45 Toledo;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
45 Toledo;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;92,15
45 Toledo;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
45 Toledo;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
45 Toledo;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
45 Toledo;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;93,93
45 Toledo;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
45 Toledo;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
45 Toledo;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
45 Toledo;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
45 Toledo;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
45 Toledo;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
45 Toledo;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;87,94
45 Toledo;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
45 Toledo;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
45 Toledo;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
45 Toledo;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;90,27
45 Toledo;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
45 Toledo;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
45 Toledo;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
45 Toledo;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
45 Toledo;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
45 Toledo;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
45 Toledo;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;84,93
45 Toledo;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
45 Toledo;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
45 Toledo;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
45 Toledo;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;87,27
45 Toledo;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
45 Toledo;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
45 Toledo;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
45 Toledo;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
45 Toledo;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
45 Toledo;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
45 Toledo;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
45 Toledo;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
45 Toledo;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
45 Toledo;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QI;14.145
45 Toledo;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
45 Toledo;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
45 Toledo;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
45 Toledo;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QI;14.045
45 Toledo;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
45 Toledo;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
45 Toledo;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
45 Toledo;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QI;13.969
45 Toledo;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
45 Toledo;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
45 Toledo;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2022QII;""
45 Toledo;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2022QI;13.747
45 Toledo;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
45 Toledo;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
45 Toledo;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2021QII;""
45 Toledo;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2021QI;13.769
45 Toledo;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
45 Toledo;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
45 Toledo;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2020QII;""
45 Toledo;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2020QI;13.133
45 Toledo;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
45 Toledo;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
45 Toledo;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2022QII;13.355
45 Toledo;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2022QI;""
45 Toledo;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
45 Toledo;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
45 Toledo;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2021QII;13.400
45 Toledo;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2021QI;""
45 Toledo;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
45 Toledo;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
45 Toledo;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2020QII;12.917
45 Toledo;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2020QI;""
45 Toledo;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
45 Toledo;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QIII;13.073
45 Toledo;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QII;""
45 Toledo;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QI;""
45 Toledo;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
45 Toledo;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QIII;13.131
45 Toledo;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QII;""
45 Toledo;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QI;""
45 Toledo;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
45 Toledo;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QIII;12.682
45 Toledo;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QII;""
45 Toledo;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QI;""
45 Toledo;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QIV;12.726
45 Toledo;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
45 Toledo;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QII;""
45 Toledo;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QI;""
45 Toledo;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QIV;12.860
45 Toledo;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
45 Toledo;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QII;""
45 Toledo;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QI;""
45 Toledo;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QIV;12.475
45 Toledo;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
45 Toledo;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QII;""
45 Toledo;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QI;""
45 Toledo;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
45 Toledo;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
45 Toledo;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
45 Toledo;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
45 Toledo;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
45 Toledo;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
45 Toledo;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
45 Toledo;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
45 Toledo;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
45 Toledo;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
45 Toledo;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
45 Toledo;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
45 Toledo;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
45 Toledo;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
45 Toledo;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
45 Toledo;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;97,19
45 Toledo;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
45 Toledo;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
45 Toledo;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
45 Toledo;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;98,03
45 Toledo;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
45 Toledo;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
45 Toledo;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
45 Toledo;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;94,02
45 Toledo;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
45 Toledo;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
45 Toledo;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;94,41
45 Toledo;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
45 Toledo;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
45 Toledo;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
45 Toledo;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;95,41
45 Toledo;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
45 Toledo;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
45 Toledo;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
45 Toledo;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;92,47
45 Toledo;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
45 Toledo;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
45 Toledo;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;92,42
45 Toledo;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
45 Toledo;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
45 Toledo;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
45 Toledo;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;93,49
45 Toledo;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
45 Toledo;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
45 Toledo;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
45 Toledo;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;90,79
45 Toledo;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
45 Toledo;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
45 Toledo;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;89,97
45 Toledo;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
45 Toledo;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
45 Toledo;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
45 Toledo;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;91,56
45 Toledo;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
45 Toledo;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
45 Toledo;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
45 Toledo;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;89,3
45 Toledo;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
45 Toledo;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
45 Toledo;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
45 Toledo;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
45 Toledo;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
45 Toledo;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
45 Toledo;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QI;9.493
45 Toledo;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
45 Toledo;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
45 Toledo;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
45 Toledo;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QI;9.520
45 Toledo;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
45 Toledo;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
45 Toledo;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
45 Toledo;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QI;9.511
45 Toledo;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
45 Toledo;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
45 Toledo;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2022QII;""
45 Toledo;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2022QI;9.245
45 Toledo;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
45 Toledo;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
45 Toledo;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2021QII;""
45 Toledo;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2021QI;9.346
45 Toledo;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
45 Toledo;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
45 Toledo;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2020QII;""
45 Toledo;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2020QI;8.985
45 Toledo;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
45 Toledo;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
45 Toledo;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2022QII;9.037
45 Toledo;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2022QI;""
45 Toledo;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
45 Toledo;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
45 Toledo;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2021QII;9.119
45 Toledo;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2021QI;""
45 Toledo;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
45 Toledo;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
45 Toledo;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2020QII;8.874
45 Toledo;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2020QI;""
45 Toledo;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
45 Toledo;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QIII;8.857
45 Toledo;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QII;""
45 Toledo;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QI;""
45 Toledo;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
45 Toledo;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QIII;8.956
45 Toledo;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QII;""
45 Toledo;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QI;""
45 Toledo;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
45 Toledo;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QIII;8.718
45 Toledo;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QII;""
45 Toledo;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QI;""
45 Toledo;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QIV;8.653
45 Toledo;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
45 Toledo;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QII;""
45 Toledo;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QI;""
45 Toledo;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QIV;8.775
45 Toledo;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
45 Toledo;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QII;""
45 Toledo;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QI;""
45 Toledo;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QIV;8.584
45 Toledo;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
45 Toledo;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QII;""
45 Toledo;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QI;""
45 Toledo;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
45 Toledo;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
45 Toledo;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
45 Toledo;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
45 Toledo;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
45 Toledo;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
45 Toledo;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
45 Toledo;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
45 Toledo;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
45 Toledo;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
45 Toledo;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
45 Toledo;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
45 Toledo;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
45 Toledo;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
45 Toledo;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
45 Toledo;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;97,39
45 Toledo;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
45 Toledo;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
45 Toledo;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
45 Toledo;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;98,17
45 Toledo;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
45 Toledo;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
45 Toledo;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
45 Toledo;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;94,47
45 Toledo;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
45 Toledo;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
45 Toledo;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;95,2
45 Toledo;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
45 Toledo;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
45 Toledo;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
45 Toledo;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;95,79
45 Toledo;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
45 Toledo;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
45 Toledo;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
45 Toledo;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;93,3
45 Toledo;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
45 Toledo;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
45 Toledo;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;93,3
45 Toledo;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
45 Toledo;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
45 Toledo;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
45 Toledo;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;94,08
45 Toledo;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
45 Toledo;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
45 Toledo;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
45 Toledo;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;91,66
45 Toledo;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
45 Toledo;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
45 Toledo;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;91,15
45 Toledo;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
45 Toledo;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
45 Toledo;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
45 Toledo;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;92,17
45 Toledo;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
45 Toledo;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
45 Toledo;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
45 Toledo;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;90,25
45 Toledo;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
45 Toledo;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
45 Toledo;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
45 Toledo;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
45 Toledo;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
45 Toledo;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
45 Toledo;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QI;4.652
45 Toledo;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
45 Toledo;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
45 Toledo;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
45 Toledo;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QI;4.525
45 Toledo;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
45 Toledo;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
45 Toledo;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
45 Toledo;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QI;4.458
45 Toledo;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
45 Toledo;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
45 Toledo;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2022QII;""
45 Toledo;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2022QI;4.502
45 Toledo;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
45 Toledo;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
45 Toledo;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2021QII;""
45 Toledo;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2021QI;4.423
45 Toledo;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
45 Toledo;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
45 Toledo;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2020QII;""
45 Toledo;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2020QI;4.148
45 Toledo;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
45 Toledo;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
45 Toledo;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2022QII;4.318
45 Toledo;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2022QI;""
45 Toledo;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
45 Toledo;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
45 Toledo;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2021QII;4.281
45 Toledo;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2021QI;""
45 Toledo;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
45 Toledo;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
45 Toledo;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2020QII;4.043
45 Toledo;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2020QI;""
45 Toledo;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
45 Toledo;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QIII;4.216
45 Toledo;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QII;""
45 Toledo;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QI;""
45 Toledo;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
45 Toledo;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QIII;4.175
45 Toledo;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QII;""
45 Toledo;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QI;""
45 Toledo;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
45 Toledo;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QIII;3.964
45 Toledo;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QII;""
45 Toledo;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QI;""
45 Toledo;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QIV;4.073
45 Toledo;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
45 Toledo;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QII;""
45 Toledo;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QI;""
45 Toledo;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QIV;4.085
45 Toledo;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
45 Toledo;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QII;""
45 Toledo;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QI;""
45 Toledo;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QIV;3.891
45 Toledo;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
45 Toledo;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QII;""
45 Toledo;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QI;""
45 Toledo;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
45 Toledo;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
45 Toledo;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
45 Toledo;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
45 Toledo;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
45 Toledo;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
45 Toledo;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
45 Toledo;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
45 Toledo;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
45 Toledo;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
45 Toledo;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
45 Toledo;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
45 Toledo;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
45 Toledo;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
45 Toledo;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
45 Toledo;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;96,78
45 Toledo;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
45 Toledo;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
45 Toledo;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
45 Toledo;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;97,75
45 Toledo;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
45 Toledo;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
45 Toledo;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
45 Toledo;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;93,05
45 Toledo;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
45 Toledo;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
45 Toledo;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;92,82
45 Toledo;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
45 Toledo;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
45 Toledo;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
45 Toledo;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;94,61
45 Toledo;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
45 Toledo;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
45 Toledo;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
45 Toledo;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;90,69
45 Toledo;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
45 Toledo;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
45 Toledo;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;90,63
45 Toledo;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
45 Toledo;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
45 Toledo;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
45 Toledo;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;92,27
45 Toledo;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
45 Toledo;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
45 Toledo;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
45 Toledo;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;88,92
45 Toledo;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
45 Toledo;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
45 Toledo;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;87,55
45 Toledo;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
45 Toledo;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
45 Toledo;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
45 Toledo;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;90,28
45 Toledo;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
45 Toledo;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
45 Toledo;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
45 Toledo;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;87,28
45 Toledo;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
45 Toledo;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
45 Toledo;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
45 Toledo;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
45 Toledo;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
45 Toledo;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QII;13.932
45 Toledo;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
45 Toledo;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
45 Toledo;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
45 Toledo;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QII;13.971
45 Toledo;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
45 Toledo;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
45 Toledo;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
45 Toledo;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QII;13.650
45 Toledo;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
45 Toledo;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
45 Toledo;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
45 Toledo;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2022QII;13.485
45 Toledo;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2022QI;""
45 Toledo;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
45 Toledo;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
45 Toledo;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2021QII;13.557
45 Toledo;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2021QI;""
45 Toledo;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
45 Toledo;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
45 Toledo;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2020QII;13.403
45 Toledo;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2020QI;""
45 Toledo;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
45 Toledo;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2022QIII;13.160
45 Toledo;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2022QII;""
45 Toledo;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2022QI;""
45 Toledo;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
45 Toledo;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2021QIII;13.263
45 Toledo;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2021QII;""
45 Toledo;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2021QI;""
45 Toledo;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
45 Toledo;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2020QIII;13.138
45 Toledo;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2020QII;""
45 Toledo;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2020QI;""
45 Toledo;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QIV;12.808
45 Toledo;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
45 Toledo;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QII;""
45 Toledo;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QI;""
45 Toledo;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QIV;12.977
45 Toledo;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
45 Toledo;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QII;""
45 Toledo;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QI;""
45 Toledo;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QIV;12.912
45 Toledo;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
45 Toledo;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QII;""
45 Toledo;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QI;""
45 Toledo;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
45 Toledo;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
45 Toledo;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QII;""
45 Toledo;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QI;12.675
45 Toledo;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
45 Toledo;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
45 Toledo;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QII;""
45 Toledo;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QI;12.722
45 Toledo;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
45 Toledo;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
45 Toledo;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QII;""
45 Toledo;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QI;""
45 Toledo;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
45 Toledo;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
45 Toledo;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
45 Toledo;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
45 Toledo;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
45 Toledo;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
45 Toledo;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
45 Toledo;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
45 Toledo;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
45 Toledo;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
45 Toledo;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
45 Toledo;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
45 Toledo;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
45 Toledo;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
45 Toledo;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;96,79
45 Toledo;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
45 Toledo;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
45 Toledo;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
45 Toledo;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;97,04
45 Toledo;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
45 Toledo;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
45 Toledo;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
45 Toledo;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;98,19
45 Toledo;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
45 Toledo;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
45 Toledo;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;94,46
45 Toledo;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
45 Toledo;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
45 Toledo;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
45 Toledo;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;94,93
45 Toledo;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
45 Toledo;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
45 Toledo;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
45 Toledo;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;96,25
45 Toledo;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
45 Toledo;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
45 Toledo;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;91,93
45 Toledo;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
45 Toledo;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
45 Toledo;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
45 Toledo;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;92,89
45 Toledo;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
45 Toledo;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
45 Toledo;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
45 Toledo;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;94,59
45 Toledo;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
45 Toledo;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
45 Toledo;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
45 Toledo;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
45 Toledo;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
45 Toledo;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
45 Toledo;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;90,72
45 Toledo;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
45 Toledo;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
45 Toledo;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
45 Toledo;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;93,2
45 Toledo;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
45 Toledo;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
45 Toledo;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
45 Toledo;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
45 Toledo;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
45 Toledo;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
45 Toledo;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QII;9.303
45 Toledo;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
45 Toledo;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
45 Toledo;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
45 Toledo;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QII;9.440
45 Toledo;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
45 Toledo;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
45 Toledo;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
45 Toledo;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QII;9.284
45 Toledo;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
45 Toledo;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
45 Toledo;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
45 Toledo;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2022QII;9.068
45 Toledo;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2022QI;""
45 Toledo;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
45 Toledo;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
45 Toledo;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2021QII;9.182
45 Toledo;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2021QI;""
45 Toledo;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
45 Toledo;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
45 Toledo;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2020QII;9.158
45 Toledo;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2020QI;""
45 Toledo;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
45 Toledo;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2022QIII;8.856
45 Toledo;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2022QII;""
45 Toledo;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2022QI;""
45 Toledo;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
45 Toledo;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2021QIII;9.004
45 Toledo;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2021QII;""
45 Toledo;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2021QI;""
45 Toledo;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
45 Toledo;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2020QIII;8.981
45 Toledo;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2020QII;""
45 Toledo;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2020QI;""
45 Toledo;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QIV;8.654
45 Toledo;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
45 Toledo;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QII;""
45 Toledo;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QI;""
45 Toledo;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QIV;8.822
45 Toledo;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
45 Toledo;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QII;""
45 Toledo;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QI;""
45 Toledo;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QIV;8.833
45 Toledo;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
45 Toledo;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QII;""
45 Toledo;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QI;""
45 Toledo;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
45 Toledo;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
45 Toledo;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QII;""
45 Toledo;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QI;8.638
45 Toledo;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
45 Toledo;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
45 Toledo;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QII;""
45 Toledo;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QI;8.715
45 Toledo;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
45 Toledo;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
45 Toledo;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QII;""
45 Toledo;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QI;""
45 Toledo;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
45 Toledo;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
45 Toledo;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
45 Toledo;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
45 Toledo;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
45 Toledo;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
45 Toledo;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
45 Toledo;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
45 Toledo;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
45 Toledo;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
45 Toledo;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
45 Toledo;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
45 Toledo;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
45 Toledo;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
45 Toledo;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;97,47
45 Toledo;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
45 Toledo;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
45 Toledo;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
45 Toledo;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;97,27
45 Toledo;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
45 Toledo;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
45 Toledo;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
45 Toledo;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;98,64
45 Toledo;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
45 Toledo;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
45 Toledo;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;95,2
45 Toledo;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
45 Toledo;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
45 Toledo;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
45 Toledo;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;95,38
45 Toledo;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
45 Toledo;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
45 Toledo;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
45 Toledo;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;96,74
45 Toledo;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
45 Toledo;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
45 Toledo;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;93,02
45 Toledo;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
45 Toledo;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
45 Toledo;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
45 Toledo;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;93,45
45 Toledo;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
45 Toledo;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
45 Toledo;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
45 Toledo;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;95,14
45 Toledo;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
45 Toledo;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
45 Toledo;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
45 Toledo;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
45 Toledo;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
45 Toledo;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
45 Toledo;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;91,5
45 Toledo;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
45 Toledo;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
45 Toledo;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
45 Toledo;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;93,87
45 Toledo;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
45 Toledo;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
45 Toledo;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
45 Toledo;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
45 Toledo;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
45 Toledo;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
45 Toledo;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QII;4.629
45 Toledo;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
45 Toledo;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
45 Toledo;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
45 Toledo;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QII;4.531
45 Toledo;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
45 Toledo;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
45 Toledo;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
45 Toledo;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QII;4.366
45 Toledo;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
45 Toledo;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
45 Toledo;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
45 Toledo;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2022QII;4.417
45 Toledo;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2022QI;""
45 Toledo;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
45 Toledo;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
45 Toledo;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2021QII;4.375
45 Toledo;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2021QI;""
45 Toledo;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
45 Toledo;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
45 Toledo;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2020QII;4.245
45 Toledo;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2020QI;""
45 Toledo;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
45 Toledo;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2022QIII;4.304
45 Toledo;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2022QII;""
45 Toledo;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2022QI;""
45 Toledo;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
45 Toledo;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2021QIII;4.259
45 Toledo;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2021QII;""
45 Toledo;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2021QI;""
45 Toledo;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
45 Toledo;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2020QIII;4.157
45 Toledo;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2020QII;""
45 Toledo;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2020QI;""
45 Toledo;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QIV;4.154
45 Toledo;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
45 Toledo;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QII;""
45 Toledo;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QI;""
45 Toledo;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QIV;4.155
45 Toledo;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
45 Toledo;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QII;""
45 Toledo;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QI;""
45 Toledo;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QIV;4.079
45 Toledo;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
45 Toledo;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QII;""
45 Toledo;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QI;""
45 Toledo;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
45 Toledo;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
45 Toledo;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QII;""
45 Toledo;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QI;4.037
45 Toledo;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
45 Toledo;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
45 Toledo;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QII;""
45 Toledo;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QI;4.007
45 Toledo;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
45 Toledo;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
45 Toledo;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QII;""
45 Toledo;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QI;""
45 Toledo;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
45 Toledo;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
45 Toledo;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
45 Toledo;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
45 Toledo;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
45 Toledo;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
45 Toledo;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
45 Toledo;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
45 Toledo;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
45 Toledo;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
45 Toledo;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
45 Toledo;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
45 Toledo;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
45 Toledo;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
45 Toledo;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;95,42
45 Toledo;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
45 Toledo;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
45 Toledo;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
45 Toledo;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;96,56
45 Toledo;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
45 Toledo;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
45 Toledo;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
45 Toledo;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;97,23
45 Toledo;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
45 Toledo;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
45 Toledo;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;92,98
45 Toledo;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
45 Toledo;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
45 Toledo;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
45 Toledo;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;94
45 Toledo;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
45 Toledo;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
45 Toledo;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
45 Toledo;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;95,21
45 Toledo;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
45 Toledo;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
45 Toledo;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;89,74
45 Toledo;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
45 Toledo;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
45 Toledo;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
45 Toledo;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;91,7
45 Toledo;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
45 Toledo;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
45 Toledo;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
45 Toledo;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;93,43
45 Toledo;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
45 Toledo;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
45 Toledo;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
45 Toledo;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
45 Toledo;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
45 Toledo;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
45 Toledo;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;89,1
45 Toledo;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
45 Toledo;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
45 Toledo;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
45 Toledo;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;91,78
45 Toledo;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
45 Toledo;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
45 Toledo;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
45 Toledo;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
45 Toledo;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
45 Toledo;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QIII;13.962
45 Toledo;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
45 Toledo;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
45 Toledo;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
45 Toledo;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QIII;14.015
45 Toledo;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
45 Toledo;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
45 Toledo;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
45 Toledo;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QIII;13.854
45 Toledo;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
45 Toledo;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
45 Toledo;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
45 Toledo;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2022QIII;13.563
45 Toledo;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2022QII;""
45 Toledo;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2022QI;""
45 Toledo;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
45 Toledo;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2021QIII;13.665
45 Toledo;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2021QII;""
45 Toledo;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2021QI;""
45 Toledo;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
45 Toledo;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2020QIII;13.532
45 Toledo;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2020QII;""
45 Toledo;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2020QI;""
45 Toledo;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2022QIV;13.168
45 Toledo;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
45 Toledo;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2022QII;""
45 Toledo;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2022QI;""
45 Toledo;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2021QIV;13.343
45 Toledo;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
45 Toledo;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2021QII;""
45 Toledo;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2021QI;""
45 Toledo;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2020QIV;13.270
45 Toledo;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
45 Toledo;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2020QII;""
45 Toledo;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2020QI;""
45 Toledo;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
45 Toledo;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
45 Toledo;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QII;""
45 Toledo;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QI;13.022
45 Toledo;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
45 Toledo;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
45 Toledo;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QII;""
45 Toledo;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QI;13.060
45 Toledo;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
45 Toledo;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
45 Toledo;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QII;""
45 Toledo;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QI;""
45 Toledo;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
45 Toledo;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
45 Toledo;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QII;12.713
45 Toledo;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QI;""
45 Toledo;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
45 Toledo;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
45 Toledo;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QII;12.760
45 Toledo;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QI;""
45 Toledo;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
45 Toledo;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
45 Toledo;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QII;""
45 Toledo;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QI;""
45 Toledo;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
45 Toledo;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
45 Toledo;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
45 Toledo;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
45 Toledo;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
45 Toledo;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
45 Toledo;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
45 Toledo;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
45 Toledo;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
45 Toledo;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
45 Toledo;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
45 Toledo;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
45 Toledo;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
45 Toledo;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;97,14
45 Toledo;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
45 Toledo;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
45 Toledo;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
45 Toledo;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;97,5
45 Toledo;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
45 Toledo;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
45 Toledo;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
45 Toledo;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;97,68
45 Toledo;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
45 Toledo;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
45 Toledo;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;94,31
45 Toledo;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
45 Toledo;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
45 Toledo;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
45 Toledo;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;95,21
45 Toledo;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
45 Toledo;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
45 Toledo;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
45 Toledo;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;95,78
45 Toledo;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
45 Toledo;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
45 Toledo;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
45 Toledo;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
45 Toledo;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
45 Toledo;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
45 Toledo;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;92,91
45 Toledo;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
45 Toledo;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
45 Toledo;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
45 Toledo;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;94,27
45 Toledo;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
45 Toledo;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
45 Toledo;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
45 Toledo;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
45 Toledo;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
45 Toledo;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
45 Toledo;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;90,71
45 Toledo;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
45 Toledo;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
45 Toledo;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
45 Toledo;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;92,1
45 Toledo;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
45 Toledo;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
45 Toledo;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
45 Toledo;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
45 Toledo;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
45 Toledo;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
45 Toledo;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QIII;9.359
45 Toledo;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
45 Toledo;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
45 Toledo;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
45 Toledo;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QIII;9.452
45 Toledo;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
45 Toledo;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
45 Toledo;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
45 Toledo;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QIII;9.449
45 Toledo;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
45 Toledo;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
45 Toledo;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
45 Toledo;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2022QIII;9.100
45 Toledo;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2022QII;""
45 Toledo;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2022QI;""
45 Toledo;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
45 Toledo;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2021QIII;9.243
45 Toledo;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2021QII;""
45 Toledo;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2021QI;""
45 Toledo;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
45 Toledo;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2020QIII;9.236
45 Toledo;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2020QII;""
45 Toledo;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2020QI;""
45 Toledo;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2022QIV;8.872
45 Toledo;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
45 Toledo;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2022QII;""
45 Toledo;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2022QI;""
45 Toledo;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2021QIV;9.041
45 Toledo;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
45 Toledo;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2021QII;""
45 Toledo;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2021QI;""
45 Toledo;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2020QIV;9.061
45 Toledo;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
45 Toledo;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2020QII;""
45 Toledo;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2020QI;""
45 Toledo;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
45 Toledo;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
45 Toledo;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QII;""
45 Toledo;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QI;8.841
45 Toledo;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
45 Toledo;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
45 Toledo;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QII;""
45 Toledo;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QI;8.929
45 Toledo;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
45 Toledo;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
45 Toledo;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QII;""
45 Toledo;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QI;""
45 Toledo;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
45 Toledo;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
45 Toledo;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QII;8.673
45 Toledo;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QI;""
45 Toledo;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
45 Toledo;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
45 Toledo;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QII;8.738
45 Toledo;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QI;""
45 Toledo;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
45 Toledo;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
45 Toledo;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QII;""
45 Toledo;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QI;""
45 Toledo;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
45 Toledo;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
45 Toledo;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
45 Toledo;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
45 Toledo;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
45 Toledo;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
45 Toledo;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
45 Toledo;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
45 Toledo;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
45 Toledo;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
45 Toledo;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
45 Toledo;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
45 Toledo;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
45 Toledo;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;97,23
45 Toledo;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
45 Toledo;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
45 Toledo;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
45 Toledo;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;97,79
45 Toledo;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
45 Toledo;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
45 Toledo;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
45 Toledo;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;97,75
45 Toledo;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
45 Toledo;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
45 Toledo;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;94,8
45 Toledo;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
45 Toledo;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
45 Toledo;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
45 Toledo;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;95,65
45 Toledo;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
45 Toledo;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
45 Toledo;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
45 Toledo;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;95,89
45 Toledo;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
45 Toledo;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
45 Toledo;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
45 Toledo;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
45 Toledo;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
45 Toledo;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
45 Toledo;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;93,54
45 Toledo;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
45 Toledo;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
45 Toledo;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
45 Toledo;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;94,5
45 Toledo;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
45 Toledo;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
45 Toledo;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
45 Toledo;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
45 Toledo;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
45 Toledo;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
45 Toledo;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;91,76
45 Toledo;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
45 Toledo;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
45 Toledo;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
45 Toledo;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;92,48
45 Toledo;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
45 Toledo;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
45 Toledo;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
45 Toledo;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
45 Toledo;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
45 Toledo;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
45 Toledo;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QIII;4.603
45 Toledo;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
45 Toledo;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
45 Toledo;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
45 Toledo;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QIII;4.563
45 Toledo;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
45 Toledo;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
45 Toledo;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
45 Toledo;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QIII;4.405
45 Toledo;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
45 Toledo;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
45 Toledo;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
45 Toledo;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2022QIII;4.463
45 Toledo;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2022QII;""
45 Toledo;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2022QI;""
45 Toledo;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
45 Toledo;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2021QIII;4.422
45 Toledo;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2021QII;""
45 Toledo;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2021QI;""
45 Toledo;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
45 Toledo;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2020QIII;4.296
45 Toledo;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2020QII;""
45 Toledo;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2020QI;""
45 Toledo;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2022QIV;4.296
45 Toledo;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
45 Toledo;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2022QII;""
45 Toledo;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2022QI;""
45 Toledo;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2021QIV;4.302
45 Toledo;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
45 Toledo;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2021QII;""
45 Toledo;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2021QI;""
45 Toledo;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2020QIV;4.209
45 Toledo;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
45 Toledo;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2020QII;""
45 Toledo;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2020QI;""
45 Toledo;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
45 Toledo;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
45 Toledo;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QII;""
45 Toledo;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QI;4.181
45 Toledo;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
45 Toledo;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
45 Toledo;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QII;""
45 Toledo;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QI;4.131
45 Toledo;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
45 Toledo;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
45 Toledo;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QII;""
45 Toledo;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QI;""
45 Toledo;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
45 Toledo;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
45 Toledo;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QII;4.040
45 Toledo;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QI;""
45 Toledo;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
45 Toledo;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
45 Toledo;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QII;4.022
45 Toledo;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QI;""
45 Toledo;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
45 Toledo;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
45 Toledo;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QII;""
45 Toledo;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QI;""
45 Toledo;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
45 Toledo;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
45 Toledo;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
45 Toledo;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
45 Toledo;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
45 Toledo;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
45 Toledo;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
45 Toledo;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
45 Toledo;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
45 Toledo;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
45 Toledo;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
45 Toledo;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
45 Toledo;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
45 Toledo;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;96,96
45 Toledo;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
45 Toledo;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
45 Toledo;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
45 Toledo;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;96,91
45 Toledo;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
45 Toledo;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
45 Toledo;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
45 Toledo;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;97,53
45 Toledo;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
45 Toledo;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
45 Toledo;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;93,33
45 Toledo;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
45 Toledo;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
45 Toledo;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
45 Toledo;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;94,28
45 Toledo;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
45 Toledo;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
45 Toledo;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
45 Toledo;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;95,55
45 Toledo;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
45 Toledo;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
45 Toledo;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
45 Toledo;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
45 Toledo;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
45 Toledo;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
45 Toledo;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;91,63
45 Toledo;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
45 Toledo;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
45 Toledo;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
45 Toledo;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;93,78
45 Toledo;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
45 Toledo;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
45 Toledo;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
45 Toledo;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
45 Toledo;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
45 Toledo;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
45 Toledo;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;88,54
45 Toledo;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
45 Toledo;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
45 Toledo;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
45 Toledo;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;91,31
45 Toledo;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
45 Toledo;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
45 Toledo;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
45 Toledo;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
45 Toledo;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
45 Toledo;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QIV;13.892
45 Toledo;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
45 Toledo;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
45 Toledo;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
45 Toledo;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QIV;14.079
45 Toledo;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
45 Toledo;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
45 Toledo;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
45 Toledo;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QIV;13.933
45 Toledo;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
45 Toledo;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
45 Toledo;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
45 Toledo;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2022QIV;13.459
45 Toledo;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
45 Toledo;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2022QII;""
45 Toledo;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2022QI;""
45 Toledo;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2021QIV;13.702
45 Toledo;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
45 Toledo;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2021QII;""
45 Toledo;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2021QI;""
45 Toledo;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2020QIV;13.633
45 Toledo;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
45 Toledo;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2020QII;""
45 Toledo;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2020QI;""
45 Toledo;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
45 Toledo;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
45 Toledo;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2022QII;""
45 Toledo;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2022QI;13.353
45 Toledo;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
45 Toledo;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
45 Toledo;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2021QII;""
45 Toledo;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2021QI;13.399
45 Toledo;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
45 Toledo;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
45 Toledo;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2020QII;""
45 Toledo;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2020QI;""
45 Toledo;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
45 Toledo;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
45 Toledo;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QII;13.004
45 Toledo;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QI;""
45 Toledo;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
45 Toledo;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
45 Toledo;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QII;13.071
45 Toledo;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QI;""
45 Toledo;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
45 Toledo;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
45 Toledo;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QII;""
45 Toledo;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QI;""
45 Toledo;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
45 Toledo;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QIII;12.749
45 Toledo;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QII;""
45 Toledo;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QI;""
45 Toledo;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
45 Toledo;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QIII;12.822
45 Toledo;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QII;""
45 Toledo;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QI;""
45 Toledo;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
45 Toledo;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
45 Toledo;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QII;""
45 Toledo;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QI;""
45 Toledo;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
45 Toledo;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
45 Toledo;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
45 Toledo;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
45 Toledo;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
45 Toledo;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
45 Toledo;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
45 Toledo;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
45 Toledo;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
45 Toledo;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
45 Toledo;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
45 Toledo;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
45 Toledo;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;96,88
45 Toledo;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
45 Toledo;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
45 Toledo;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
45 Toledo;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;97,32
45 Toledo;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
45 Toledo;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
45 Toledo;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
45 Toledo;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;97,85
45 Toledo;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
45 Toledo;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
45 Toledo;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
45 Toledo;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
45 Toledo;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
45 Toledo;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
45 Toledo;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;94,84
45 Toledo;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
45 Toledo;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
45 Toledo;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
45 Toledo;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;96,17
45 Toledo;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
45 Toledo;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
45 Toledo;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
45 Toledo;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
45 Toledo;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
45 Toledo;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
45 Toledo;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;92,36
45 Toledo;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
45 Toledo;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
45 Toledo;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
45 Toledo;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;93,81
45 Toledo;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
45 Toledo;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
45 Toledo;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
45 Toledo;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
45 Toledo;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
45 Toledo;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
45 Toledo;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;90,55
45 Toledo;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
45 Toledo;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
45 Toledo;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
45 Toledo;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;92,03
45 Toledo;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
45 Toledo;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
45 Toledo;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
45 Toledo;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
45 Toledo;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
45 Toledo;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
45 Toledo;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QIV;9.299
45 Toledo;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
45 Toledo;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
45 Toledo;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
45 Toledo;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QIV;9.485
45 Toledo;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
45 Toledo;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
45 Toledo;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
45 Toledo;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QIV;9.476
45 Toledo;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
45 Toledo;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
45 Toledo;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
45 Toledo;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2022QIV;9.047
45 Toledo;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
45 Toledo;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2022QII;""
45 Toledo;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2022QI;""
45 Toledo;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2021QIV;9.251
45 Toledo;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
45 Toledo;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2021QII;""
45 Toledo;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2021QI;""
45 Toledo;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2020QIV;9.277
45 Toledo;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
45 Toledo;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2020QII;""
45 Toledo;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2020QI;""
45 Toledo;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
45 Toledo;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
45 Toledo;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2022QII;""
45 Toledo;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2022QI;9.034
45 Toledo;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
45 Toledo;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
45 Toledo;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2021QII;""
45 Toledo;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2021QI;9.132
45 Toledo;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
45 Toledo;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
45 Toledo;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2020QII;""
45 Toledo;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2020QI;""
45 Toledo;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
45 Toledo;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
45 Toledo;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QII;8.844
45 Toledo;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QI;""
45 Toledo;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
45 Toledo;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
45 Toledo;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QII;8.928
45 Toledo;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QI;""
45 Toledo;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
45 Toledo;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
45 Toledo;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QII;""
45 Toledo;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QI;""
45 Toledo;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
45 Toledo;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QIII;8.678
45 Toledo;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QII;""
45 Toledo;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QI;""
45 Toledo;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
45 Toledo;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QIII;8.772
45 Toledo;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QII;""
45 Toledo;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QI;""
45 Toledo;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
45 Toledo;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
45 Toledo;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QII;""
45 Toledo;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QI;""
45 Toledo;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
45 Toledo;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
45 Toledo;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
45 Toledo;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
45 Toledo;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
45 Toledo;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
45 Toledo;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
45 Toledo;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
45 Toledo;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
45 Toledo;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
45 Toledo;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
45 Toledo;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
45 Toledo;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;97,29
45 Toledo;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
45 Toledo;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
45 Toledo;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
45 Toledo;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;97,53
45 Toledo;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
45 Toledo;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
45 Toledo;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
45 Toledo;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;97,9
45 Toledo;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
45 Toledo;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
45 Toledo;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
45 Toledo;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
45 Toledo;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
45 Toledo;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
45 Toledo;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;95,25
45 Toledo;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
45 Toledo;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
45 Toledo;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
45 Toledo;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;96,37
45 Toledo;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
45 Toledo;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
45 Toledo;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
45 Toledo;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
45 Toledo;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
45 Toledo;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
45 Toledo;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;93,24
45 Toledo;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
45 Toledo;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
45 Toledo;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
45 Toledo;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;94,22
45 Toledo;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
45 Toledo;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
45 Toledo;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
45 Toledo;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
45 Toledo;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
45 Toledo;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
45 Toledo;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;91,49
45 Toledo;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
45 Toledo;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
45 Toledo;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
45 Toledo;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;92,57
45 Toledo;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
45 Toledo;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
45 Toledo;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
45 Toledo;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
45 Toledo;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
45 Toledo;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
45 Toledo;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QIV;4.593
45 Toledo;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
45 Toledo;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
45 Toledo;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
45 Toledo;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QIV;4.594
45 Toledo;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
45 Toledo;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
45 Toledo;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
45 Toledo;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QIV;4.457
45 Toledo;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
45 Toledo;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
45 Toledo;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
45 Toledo;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2022QIV;4.412
45 Toledo;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
45 Toledo;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2022QII;""
45 Toledo;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2022QI;""
45 Toledo;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2021QIV;4.451
45 Toledo;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
45 Toledo;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2021QII;""
45 Toledo;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2021QI;""
45 Toledo;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2020QIV;4.356
45 Toledo;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
45 Toledo;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2020QII;""
45 Toledo;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2020QI;""
45 Toledo;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
45 Toledo;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
45 Toledo;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2022QII;""
45 Toledo;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2022QI;4.319
45 Toledo;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
45 Toledo;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
45 Toledo;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2021QII;""
45 Toledo;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2021QI;4.267
45 Toledo;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
45 Toledo;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
45 Toledo;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2020QII;""
45 Toledo;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2020QI;""
45 Toledo;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
45 Toledo;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
45 Toledo;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QII;4.160
45 Toledo;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QI;""
45 Toledo;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
45 Toledo;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
45 Toledo;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QII;4.143
45 Toledo;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QI;""
45 Toledo;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
45 Toledo;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
45 Toledo;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QII;""
45 Toledo;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QI;""
45 Toledo;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
45 Toledo;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QIII;4.071
45 Toledo;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QII;""
45 Toledo;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QI;""
45 Toledo;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
45 Toledo;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QIII;4.050
45 Toledo;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QII;""
45 Toledo;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QI;""
45 Toledo;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
45 Toledo;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
45 Toledo;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QII;""
45 Toledo;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QI;""
45 Toledo;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
45 Toledo;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
45 Toledo;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
45 Toledo;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
45 Toledo;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
45 Toledo;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
45 Toledo;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
45 Toledo;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
45 Toledo;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
45 Toledo;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
45 Toledo;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
45 Toledo;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
45 Toledo;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;96,06
45 Toledo;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
45 Toledo;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
45 Toledo;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
45 Toledo;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;96,89
45 Toledo;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
45 Toledo;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
45 Toledo;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
45 Toledo;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;97,73
45 Toledo;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
45 Toledo;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
45 Toledo;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
45 Toledo;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
45 Toledo;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
45 Toledo;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
45 Toledo;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;94,01
45 Toledo;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
45 Toledo;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
45 Toledo;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
45 Toledo;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;95,74
45 Toledo;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
45 Toledo;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
45 Toledo;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
45 Toledo;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
45 Toledo;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
45 Toledo;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
45 Toledo;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;90,55
45 Toledo;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
45 Toledo;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
45 Toledo;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
45 Toledo;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;92,95
45 Toledo;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
45 Toledo;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
45 Toledo;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
45 Toledo;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
45 Toledo;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
45 Toledo;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
45 Toledo;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;88,62
45 Toledo;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
45 Toledo;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
45 Toledo;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
45 Toledo;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;90,87
45 Toledo;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
45 Toledo;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
45 Toledo;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
45 Toledo;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
45 Toledo;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
45 Toledo;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
45 Toledo;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
45 Toledo;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
45 Toledo;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
45 Toledo;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QI;12.937
45 Toledo;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
45 Toledo;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
45 Toledo;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
45 Toledo;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QI;12.672
45 Toledo;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
45 Toledo;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
45 Toledo;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
45 Toledo;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QI;12.892
45 Toledo;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
45 Toledo;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
45 Toledo;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2022QII;""
45 Toledo;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2022QI;12.670
45 Toledo;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
45 Toledo;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
45 Toledo;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2021QII;""
45 Toledo;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2021QI;12.496
45 Toledo;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
45 Toledo;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
45 Toledo;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2020QII;""
45 Toledo;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2020QI;12.282
45 Toledo;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
45 Toledo;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
45 Toledo;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2022QII;12.439
45 Toledo;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2022QI;""
45 Toledo;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
45 Toledo;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
45 Toledo;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2021QII;12.203
45 Toledo;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2021QI;""
45 Toledo;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
45 Toledo;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
45 Toledo;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2020QII;12.130
45 Toledo;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2020QI;""
45 Toledo;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
45 Toledo;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QIII;12.242
45 Toledo;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QII;""
45 Toledo;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QI;""
45 Toledo;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
45 Toledo;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QIII;12.038
45 Toledo;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QII;""
45 Toledo;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QI;""
45 Toledo;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
45 Toledo;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QIII;11.960
45 Toledo;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QII;""
45 Toledo;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QI;""
45 Toledo;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QIV;12.007
45 Toledo;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
45 Toledo;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QII;""
45 Toledo;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QI;""
45 Toledo;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QIV;11.813
45 Toledo;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
45 Toledo;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QII;""
45 Toledo;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QI;""
45 Toledo;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QIV;11.783
45 Toledo;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
45 Toledo;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QII;""
45 Toledo;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QI;""
45 Toledo;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
45 Toledo;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
45 Toledo;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
45 Toledo;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
45 Toledo;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
45 Toledo;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
45 Toledo;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
45 Toledo;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
45 Toledo;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
45 Toledo;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
45 Toledo;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
45 Toledo;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
45 Toledo;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
45 Toledo;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
45 Toledo;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
45 Toledo;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;97,94
45 Toledo;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
45 Toledo;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
45 Toledo;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
45 Toledo;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;98,61
45 Toledo;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
45 Toledo;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
45 Toledo;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
45 Toledo;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;95,27
45 Toledo;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
45 Toledo;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
45 Toledo;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;96,15
45 Toledo;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
45 Toledo;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
45 Toledo;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
45 Toledo;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;96,3
45 Toledo;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
45 Toledo;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
45 Toledo;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
45 Toledo;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;94,09
45 Toledo;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
45 Toledo;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
45 Toledo;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;94,63
45 Toledo;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
45 Toledo;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
45 Toledo;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
45 Toledo;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;95
45 Toledo;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
45 Toledo;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
45 Toledo;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
45 Toledo;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;92,77
45 Toledo;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
45 Toledo;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
45 Toledo;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;92,81
45 Toledo;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
45 Toledo;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
45 Toledo;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
45 Toledo;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;93,22
45 Toledo;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
45 Toledo;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
45 Toledo;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
45 Toledo;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;91,4
45 Toledo;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
45 Toledo;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
45 Toledo;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
45 Toledo;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
45 Toledo;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
45 Toledo;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
45 Toledo;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QI;8.703
45 Toledo;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
45 Toledo;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
45 Toledo;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
45 Toledo;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QI;8.583
45 Toledo;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
45 Toledo;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
45 Toledo;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
45 Toledo;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QI;8.728
45 Toledo;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
45 Toledo;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
45 Toledo;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2022QII;""
45 Toledo;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2022QI;8.549
45 Toledo;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
45 Toledo;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
45 Toledo;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2021QII;""
45 Toledo;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2021QI;8.468
45 Toledo;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
45 Toledo;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
45 Toledo;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2020QII;""
45 Toledo;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2020QI;8.344
45 Toledo;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
45 Toledo;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
45 Toledo;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2022QII;8.415
45 Toledo;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2022QI;""
45 Toledo;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
45 Toledo;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
45 Toledo;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2021QII;8.279
45 Toledo;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2021QI;""
45 Toledo;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
45 Toledo;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
45 Toledo;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2020QII;8.255
45 Toledo;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2020QI;""
45 Toledo;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
45 Toledo;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QIII;8.296
45 Toledo;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QII;""
45 Toledo;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QI;""
45 Toledo;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
45 Toledo;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QIII;8.180
45 Toledo;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QII;""
45 Toledo;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QI;""
45 Toledo;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
45 Toledo;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QIII;8.152
45 Toledo;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QII;""
45 Toledo;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QI;""
45 Toledo;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QIV;8.145
45 Toledo;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
45 Toledo;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QII;""
45 Toledo;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QI;""
45 Toledo;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QIV;8.037
45 Toledo;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
45 Toledo;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QII;""
45 Toledo;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QI;""
45 Toledo;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QIV;8.041
45 Toledo;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
45 Toledo;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QII;""
45 Toledo;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QI;""
45 Toledo;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
45 Toledo;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
45 Toledo;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
45 Toledo;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
45 Toledo;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
45 Toledo;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
45 Toledo;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
45 Toledo;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
45 Toledo;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
45 Toledo;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
45 Toledo;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
45 Toledo;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
45 Toledo;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
45 Toledo;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
45 Toledo;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
45 Toledo;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;98,23
45 Toledo;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
45 Toledo;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
45 Toledo;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
45 Toledo;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;98,66
45 Toledo;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
45 Toledo;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
45 Toledo;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
45 Toledo;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;95,6
45 Toledo;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
45 Toledo;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
45 Toledo;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;96,69
45 Toledo;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
45 Toledo;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
45 Toledo;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
45 Toledo;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;96,46
45 Toledo;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
45 Toledo;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
45 Toledo;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
45 Toledo;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;94,58
45 Toledo;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
45 Toledo;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
45 Toledo;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;95,32
45 Toledo;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
45 Toledo;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
45 Toledo;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
45 Toledo;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;95,3
45 Toledo;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
45 Toledo;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
45 Toledo;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
45 Toledo;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;93,4
45 Toledo;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
45 Toledo;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
45 Toledo;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;93,59
45 Toledo;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
45 Toledo;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
45 Toledo;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
45 Toledo;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;93,64
45 Toledo;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
45 Toledo;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
45 Toledo;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
45 Toledo;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;92,13
45 Toledo;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
45 Toledo;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
45 Toledo;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
45 Toledo;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
45 Toledo;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
45 Toledo;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
45 Toledo;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QI;4.234
45 Toledo;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
45 Toledo;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
45 Toledo;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
45 Toledo;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QI;4.089
45 Toledo;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
45 Toledo;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
45 Toledo;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
45 Toledo;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QI;4.164
45 Toledo;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
45 Toledo;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
45 Toledo;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2022QII;""
45 Toledo;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2022QI;4.121
45 Toledo;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
45 Toledo;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
45 Toledo;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2021QII;""
45 Toledo;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2021QI;4.028
45 Toledo;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
45 Toledo;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
45 Toledo;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2020QII;""
45 Toledo;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2020QI;3.938
45 Toledo;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
45 Toledo;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
45 Toledo;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2022QII;4.024
45 Toledo;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2022QI;""
45 Toledo;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
45 Toledo;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
45 Toledo;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2021QII;3.924
45 Toledo;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2021QI;""
45 Toledo;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
45 Toledo;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
45 Toledo;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2020QII;3.875
45 Toledo;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2020QI;""
45 Toledo;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
45 Toledo;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QIII;3.946
45 Toledo;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QII;""
45 Toledo;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QI;""
45 Toledo;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
45 Toledo;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QIII;3.858
45 Toledo;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QII;""
45 Toledo;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QI;""
45 Toledo;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
45 Toledo;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QIII;3.808
45 Toledo;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QII;""
45 Toledo;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QI;""
45 Toledo;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QIV;3.862
45 Toledo;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
45 Toledo;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QII;""
45 Toledo;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QI;""
45 Toledo;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QIV;3.776
45 Toledo;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
45 Toledo;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QII;""
45 Toledo;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QI;""
45 Toledo;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QIV;3.742
45 Toledo;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
45 Toledo;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QII;""
45 Toledo;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QI;""
45 Toledo;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
45 Toledo;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
45 Toledo;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
45 Toledo;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
45 Toledo;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
45 Toledo;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
45 Toledo;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
45 Toledo;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
45 Toledo;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
45 Toledo;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
45 Toledo;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
45 Toledo;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
45 Toledo;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
45 Toledo;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
45 Toledo;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
45 Toledo;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;97,33
45 Toledo;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
45 Toledo;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
45 Toledo;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
45 Toledo;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;98,51
45 Toledo;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
45 Toledo;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
45 Toledo;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
45 Toledo;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;94,57
45 Toledo;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
45 Toledo;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
45 Toledo;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;95,04
45 Toledo;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
45 Toledo;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
45 Toledo;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
45 Toledo;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;95,96
45 Toledo;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
45 Toledo;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
45 Toledo;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
45 Toledo;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;93,06
45 Toledo;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
45 Toledo;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
45 Toledo;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;93,2
45 Toledo;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
45 Toledo;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
45 Toledo;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
45 Toledo;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;94,35
45 Toledo;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
45 Toledo;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
45 Toledo;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
45 Toledo;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;91,45
45 Toledo;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
45 Toledo;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
45 Toledo;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;91,21
45 Toledo;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
45 Toledo;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
45 Toledo;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
45 Toledo;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;92,35
45 Toledo;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
45 Toledo;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
45 Toledo;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
45 Toledo;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;89,87
45 Toledo;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
45 Toledo;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
45 Toledo;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
45 Toledo;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
45 Toledo;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
45 Toledo;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QII;13.198
45 Toledo;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
45 Toledo;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
45 Toledo;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
45 Toledo;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QII;13.086
45 Toledo;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
45 Toledo;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
45 Toledo;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
45 Toledo;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QII;12.552
45 Toledo;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
45 Toledo;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
45 Toledo;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
45 Toledo;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2022QII;12.926
45 Toledo;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2022QI;""
45 Toledo;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
45 Toledo;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
45 Toledo;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2021QII;12.751
45 Toledo;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2021QI;""
45 Toledo;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
45 Toledo;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
45 Toledo;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2020QII;12.384
45 Toledo;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2020QI;""
45 Toledo;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
45 Toledo;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2022QIII;12.709
45 Toledo;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2022QII;""
45 Toledo;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2022QI;""
45 Toledo;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
45 Toledo;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2021QIII;12.558
45 Toledo;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2021QII;""
45 Toledo;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2021QI;""
45 Toledo;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
45 Toledo;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2020QIII;12.188
45 Toledo;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2020QII;""
45 Toledo;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2020QI;""
45 Toledo;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QIV;12.437
45 Toledo;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
45 Toledo;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QII;""
45 Toledo;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QI;""
45 Toledo;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QIV;12.295
45 Toledo;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
45 Toledo;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QII;""
45 Toledo;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QI;""
45 Toledo;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QIV;12.005
45 Toledo;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
45 Toledo;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QII;""
45 Toledo;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QI;""
45 Toledo;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
45 Toledo;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
45 Toledo;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QII;""
45 Toledo;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QI;12.093
45 Toledo;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
45 Toledo;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
45 Toledo;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QII;""
45 Toledo;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QI;11.873
45 Toledo;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
45 Toledo;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
45 Toledo;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QII;""
45 Toledo;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QI;""
45 Toledo;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
45 Toledo;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
45 Toledo;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
45 Toledo;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
45 Toledo;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
45 Toledo;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
45 Toledo;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
45 Toledo;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
45 Toledo;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
45 Toledo;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
45 Toledo;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
45 Toledo;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
45 Toledo;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
45 Toledo;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
45 Toledo;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;97,94
45 Toledo;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
45 Toledo;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
45 Toledo;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
45 Toledo;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;97,44
45 Toledo;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
45 Toledo;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
45 Toledo;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
45 Toledo;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;98,66
45 Toledo;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
45 Toledo;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
45 Toledo;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;96,29
45 Toledo;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
45 Toledo;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
45 Toledo;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
45 Toledo;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;95,97
45 Toledo;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
45 Toledo;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
45 Toledo;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
45 Toledo;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;97,1
45 Toledo;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
45 Toledo;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
45 Toledo;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;94,23
45 Toledo;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
45 Toledo;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
45 Toledo;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
45 Toledo;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;93,96
45 Toledo;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
45 Toledo;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
45 Toledo;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
45 Toledo;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;95,64
45 Toledo;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
45 Toledo;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
45 Toledo;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
45 Toledo;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
45 Toledo;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
45 Toledo;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
45 Toledo;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;92,41
45 Toledo;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
45 Toledo;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
45 Toledo;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
45 Toledo;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;94,59
45 Toledo;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
45 Toledo;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
45 Toledo;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
45 Toledo;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
45 Toledo;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
45 Toledo;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
45 Toledo;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QII;8.862
45 Toledo;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
45 Toledo;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
45 Toledo;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
45 Toledo;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QII;8.864
45 Toledo;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
45 Toledo;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
45 Toledo;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
45 Toledo;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QII;8.509
45 Toledo;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
45 Toledo;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
45 Toledo;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
45 Toledo;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2022QII;8.699
45 Toledo;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2022QI;""
45 Toledo;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
45 Toledo;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
45 Toledo;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2021QII;8.644
45 Toledo;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2021QI;""
45 Toledo;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
45 Toledo;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
45 Toledo;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2020QII;8.410
45 Toledo;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2020QI;""
45 Toledo;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
45 Toledo;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2022QIII;8.573
45 Toledo;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2022QII;""
45 Toledo;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2022QI;""
45 Toledo;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
45 Toledo;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2021QIII;8.525
45 Toledo;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2021QII;""
45 Toledo;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2021QI;""
45 Toledo;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
45 Toledo;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2020QIII;8.286
45 Toledo;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2020QII;""
45 Toledo;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2020QI;""
45 Toledo;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QIV;8.395
45 Toledo;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
45 Toledo;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QII;""
45 Toledo;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QI;""
45 Toledo;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QIV;8.355
45 Toledo;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
45 Toledo;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QII;""
45 Toledo;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QI;""
45 Toledo;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QIV;8.173
45 Toledo;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
45 Toledo;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QII;""
45 Toledo;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QI;""
45 Toledo;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
45 Toledo;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
45 Toledo;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QII;""
45 Toledo;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QI;8.241
45 Toledo;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
45 Toledo;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
45 Toledo;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QII;""
45 Toledo;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QI;8.084
45 Toledo;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
45 Toledo;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
45 Toledo;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QII;""
45 Toledo;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QI;""
45 Toledo;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
45 Toledo;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
45 Toledo;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
45 Toledo;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
45 Toledo;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
45 Toledo;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
45 Toledo;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
45 Toledo;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
45 Toledo;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
45 Toledo;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
45 Toledo;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
45 Toledo;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
45 Toledo;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
45 Toledo;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
45 Toledo;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;98,16
45 Toledo;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
45 Toledo;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
45 Toledo;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
45 Toledo;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;97,52
45 Toledo;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
45 Toledo;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
45 Toledo;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
45 Toledo;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;98,84
45 Toledo;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
45 Toledo;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
45 Toledo;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;96,74
45 Toledo;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
45 Toledo;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
45 Toledo;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
45 Toledo;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;96,18
45 Toledo;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
45 Toledo;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
45 Toledo;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
45 Toledo;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;97,38
45 Toledo;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
45 Toledo;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
45 Toledo;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;94,73
45 Toledo;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
45 Toledo;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
45 Toledo;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
45 Toledo;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;94,26
45 Toledo;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
45 Toledo;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
45 Toledo;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
45 Toledo;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;96,05
45 Toledo;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
45 Toledo;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
45 Toledo;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
45 Toledo;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
45 Toledo;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
45 Toledo;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
45 Toledo;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;92,97
45 Toledo;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
45 Toledo;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
45 Toledo;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
45 Toledo;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;95,01
45 Toledo;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
45 Toledo;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
45 Toledo;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
45 Toledo;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
45 Toledo;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
45 Toledo;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
45 Toledo;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QII;4.336
45 Toledo;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
45 Toledo;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
45 Toledo;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
45 Toledo;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QII;4.222
45 Toledo;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
45 Toledo;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
45 Toledo;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
45 Toledo;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QII;4.043
45 Toledo;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
45 Toledo;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
45 Toledo;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
45 Toledo;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2022QII;4.227
45 Toledo;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2022QI;""
45 Toledo;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
45 Toledo;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
45 Toledo;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2021QII;4.107
45 Toledo;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2021QI;""
45 Toledo;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
45 Toledo;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
45 Toledo;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2020QII;3.974
45 Toledo;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2020QI;""
45 Toledo;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
45 Toledo;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2022QIII;4.136
45 Toledo;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2022QII;""
45 Toledo;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2022QI;""
45 Toledo;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
45 Toledo;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2021QIII;4.033
45 Toledo;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2021QII;""
45 Toledo;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2021QI;""
45 Toledo;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
45 Toledo;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2020QIII;3.902
45 Toledo;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2020QII;""
45 Toledo;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2020QI;""
45 Toledo;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QIV;4.042
45 Toledo;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
45 Toledo;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QII;""
45 Toledo;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QI;""
45 Toledo;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QIV;3.940
45 Toledo;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
45 Toledo;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QII;""
45 Toledo;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QI;""
45 Toledo;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QIV;3.832
45 Toledo;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
45 Toledo;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QII;""
45 Toledo;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QI;""
45 Toledo;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
45 Toledo;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
45 Toledo;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QII;""
45 Toledo;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QI;3.852
45 Toledo;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
45 Toledo;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
45 Toledo;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QII;""
45 Toledo;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QI;3.789
45 Toledo;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
45 Toledo;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
45 Toledo;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QII;""
45 Toledo;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QI;""
45 Toledo;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
45 Toledo;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
45 Toledo;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
45 Toledo;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
45 Toledo;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
45 Toledo;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
45 Toledo;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
45 Toledo;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
45 Toledo;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
45 Toledo;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
45 Toledo;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
45 Toledo;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
45 Toledo;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
45 Toledo;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
45 Toledo;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;97,49
45 Toledo;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
45 Toledo;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
45 Toledo;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
45 Toledo;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;97,28
45 Toledo;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
45 Toledo;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
45 Toledo;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
45 Toledo;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;98,29
45 Toledo;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
45 Toledo;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
45 Toledo;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;95,39
45 Toledo;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
45 Toledo;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
45 Toledo;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
45 Toledo;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;95,52
45 Toledo;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
45 Toledo;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
45 Toledo;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
45 Toledo;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;96,51
45 Toledo;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
45 Toledo;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
45 Toledo;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;93,22
45 Toledo;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
45 Toledo;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
45 Toledo;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
45 Toledo;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;93,32
45 Toledo;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
45 Toledo;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
45 Toledo;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
45 Toledo;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;94,78
45 Toledo;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
45 Toledo;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
45 Toledo;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
45 Toledo;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
45 Toledo;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
45 Toledo;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
45 Toledo;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;91,24
45 Toledo;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
45 Toledo;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
45 Toledo;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
45 Toledo;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;93,72
45 Toledo;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
45 Toledo;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
45 Toledo;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
45 Toledo;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
45 Toledo;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
45 Toledo;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QIII;13.224
45 Toledo;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
45 Toledo;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
45 Toledo;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
45 Toledo;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QIII;13.008
45 Toledo;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
45 Toledo;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
45 Toledo;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
45 Toledo;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QIII;12.664
45 Toledo;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
45 Toledo;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
45 Toledo;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
45 Toledo;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2022QIII;12.949
45 Toledo;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2022QII;""
45 Toledo;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2022QI;""
45 Toledo;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
45 Toledo;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2021QIII;12.780
45 Toledo;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2021QII;""
45 Toledo;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2021QI;""
45 Toledo;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
45 Toledo;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2020QIII;12.425
45 Toledo;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2020QII;""
45 Toledo;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2020QI;""
45 Toledo;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2022QIV;12.646
45 Toledo;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
45 Toledo;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2022QII;""
45 Toledo;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2022QI;""
45 Toledo;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2021QIV;12.489
45 Toledo;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
45 Toledo;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2021QII;""
45 Toledo;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2021QI;""
45 Toledo;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2020QIV;12.223
45 Toledo;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
45 Toledo;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2020QII;""
45 Toledo;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2020QI;""
45 Toledo;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
45 Toledo;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
45 Toledo;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QII;""
45 Toledo;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QI;12.276
45 Toledo;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
45 Toledo;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
45 Toledo;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QII;""
45 Toledo;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QI;12.086
45 Toledo;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
45 Toledo;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
45 Toledo;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QII;""
45 Toledo;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QI;""
45 Toledo;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
45 Toledo;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
45 Toledo;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QII;12.092
45 Toledo;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QI;""
45 Toledo;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
45 Toledo;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
45 Toledo;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QII;11.844
45 Toledo;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QI;""
45 Toledo;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
45 Toledo;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
45 Toledo;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QII;""
45 Toledo;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QI;""
45 Toledo;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
45 Toledo;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
45 Toledo;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
45 Toledo;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
45 Toledo;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
45 Toledo;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
45 Toledo;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
45 Toledo;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
45 Toledo;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
45 Toledo;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
45 Toledo;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
45 Toledo;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
45 Toledo;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
45 Toledo;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;97,92
45 Toledo;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
45 Toledo;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
45 Toledo;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
45 Toledo;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;98,25
45 Toledo;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
45 Toledo;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
45 Toledo;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
45 Toledo;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;98,11
45 Toledo;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
45 Toledo;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
45 Toledo;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;95,63
45 Toledo;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
45 Toledo;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
45 Toledo;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
45 Toledo;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;96,01
45 Toledo;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
45 Toledo;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
45 Toledo;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
45 Toledo;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;96,52
45 Toledo;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
45 Toledo;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
45 Toledo;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
45 Toledo;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
45 Toledo;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
45 Toledo;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
45 Toledo;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;94,37
45 Toledo;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
45 Toledo;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
45 Toledo;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
45 Toledo;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;95,44
45 Toledo;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
45 Toledo;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
45 Toledo;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
45 Toledo;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
45 Toledo;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
45 Toledo;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
45 Toledo;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;92,96
45 Toledo;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
45 Toledo;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
45 Toledo;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
45 Toledo;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;93,52
45 Toledo;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
45 Toledo;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
45 Toledo;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
45 Toledo;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
45 Toledo;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
45 Toledo;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
45 Toledo;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QIII;8.865
45 Toledo;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
45 Toledo;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
45 Toledo;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
45 Toledo;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QIII;8.783
45 Toledo;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
45 Toledo;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
45 Toledo;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
45 Toledo;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QIII;8.595
45 Toledo;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
45 Toledo;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
45 Toledo;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
45 Toledo;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2022QIII;8.707
45 Toledo;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2022QII;""
45 Toledo;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2022QI;""
45 Toledo;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
45 Toledo;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2021QIII;8.641
45 Toledo;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2021QII;""
45 Toledo;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2021QI;""
45 Toledo;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
45 Toledo;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2020QIII;8.447
45 Toledo;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2020QII;""
45 Toledo;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2020QI;""
45 Toledo;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2022QIV;8.512
45 Toledo;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
45 Toledo;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2022QII;""
45 Toledo;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2022QI;""
45 Toledo;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2021QIV;8.455
45 Toledo;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
45 Toledo;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2021QII;""
45 Toledo;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2021QI;""
45 Toledo;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2020QIV;8.321
45 Toledo;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
45 Toledo;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2020QII;""
45 Toledo;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2020QI;""
45 Toledo;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
45 Toledo;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
45 Toledo;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QII;""
45 Toledo;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QI;8.339
45 Toledo;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
45 Toledo;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
45 Toledo;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QII;""
45 Toledo;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QI;8.227
45 Toledo;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
45 Toledo;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
45 Toledo;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QII;""
45 Toledo;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QI;""
45 Toledo;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
45 Toledo;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
45 Toledo;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QII;8.227
45 Toledo;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QI;""
45 Toledo;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
45 Toledo;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
45 Toledo;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QII;8.067
45 Toledo;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QI;""
45 Toledo;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
45 Toledo;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
45 Toledo;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QII;""
45 Toledo;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QI;""
45 Toledo;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
45 Toledo;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
45 Toledo;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
45 Toledo;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
45 Toledo;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
45 Toledo;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
45 Toledo;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
45 Toledo;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
45 Toledo;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
45 Toledo;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
45 Toledo;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
45 Toledo;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
45 Toledo;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
45 Toledo;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;98,22
45 Toledo;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
45 Toledo;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
45 Toledo;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
45 Toledo;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;98,38
45 Toledo;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
45 Toledo;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
45 Toledo;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
45 Toledo;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;98,28
45 Toledo;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
45 Toledo;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
45 Toledo;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;96,02
45 Toledo;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
45 Toledo;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
45 Toledo;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
45 Toledo;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;96,27
45 Toledo;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
45 Toledo;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
45 Toledo;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
45 Toledo;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;96,81
45 Toledo;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
45 Toledo;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
45 Toledo;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
45 Toledo;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
45 Toledo;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
45 Toledo;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
45 Toledo;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;94,94
45 Toledo;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
45 Toledo;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
45 Toledo;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
45 Toledo;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;95,72
45 Toledo;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
45 Toledo;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
45 Toledo;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
45 Toledo;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
45 Toledo;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
45 Toledo;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
45 Toledo;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;93,67
45 Toledo;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
45 Toledo;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
45 Toledo;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
45 Toledo;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;93,86
45 Toledo;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
45 Toledo;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
45 Toledo;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
45 Toledo;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
45 Toledo;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
45 Toledo;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
45 Toledo;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QIII;4.359
45 Toledo;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
45 Toledo;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
45 Toledo;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
45 Toledo;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QIII;4.225
45 Toledo;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
45 Toledo;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
45 Toledo;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
45 Toledo;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QIII;4.069
45 Toledo;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
45 Toledo;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
45 Toledo;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
45 Toledo;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2022QIII;4.242
45 Toledo;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2022QII;""
45 Toledo;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2022QI;""
45 Toledo;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
45 Toledo;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2021QIII;4.139
45 Toledo;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2021QII;""
45 Toledo;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2021QI;""
45 Toledo;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
45 Toledo;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2020QIII;3.978
45 Toledo;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2020QII;""
45 Toledo;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2020QI;""
45 Toledo;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2022QIV;4.134
45 Toledo;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
45 Toledo;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2022QII;""
45 Toledo;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2022QI;""
45 Toledo;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2021QIV;4.034
45 Toledo;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
45 Toledo;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2021QII;""
45 Toledo;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2021QI;""
45 Toledo;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2020QIV;3.902
45 Toledo;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
45 Toledo;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2020QII;""
45 Toledo;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2020QI;""
45 Toledo;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
45 Toledo;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
45 Toledo;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QII;""
45 Toledo;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QI;3.937
45 Toledo;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
45 Toledo;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
45 Toledo;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QII;""
45 Toledo;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QI;3.859
45 Toledo;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
45 Toledo;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
45 Toledo;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QII;""
45 Toledo;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QI;""
45 Toledo;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
45 Toledo;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
45 Toledo;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QII;3.865
45 Toledo;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QI;""
45 Toledo;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
45 Toledo;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
45 Toledo;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QII;3.777
45 Toledo;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QI;""
45 Toledo;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
45 Toledo;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
45 Toledo;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QII;""
45 Toledo;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QI;""
45 Toledo;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
45 Toledo;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
45 Toledo;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
45 Toledo;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
45 Toledo;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
45 Toledo;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
45 Toledo;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
45 Toledo;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
45 Toledo;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
45 Toledo;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
45 Toledo;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
45 Toledo;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
45 Toledo;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
45 Toledo;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;97,32
45 Toledo;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
45 Toledo;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
45 Toledo;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
45 Toledo;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;97,96
45 Toledo;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
45 Toledo;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
45 Toledo;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
45 Toledo;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;97,76
45 Toledo;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
45 Toledo;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
45 Toledo;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;94,84
45 Toledo;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
45 Toledo;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
45 Toledo;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
45 Toledo;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;95,48
45 Toledo;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
45 Toledo;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
45 Toledo;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
45 Toledo;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;95,9
45 Toledo;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
45 Toledo;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
45 Toledo;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
45 Toledo;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
45 Toledo;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
45 Toledo;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
45 Toledo;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;93,18
45 Toledo;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
45 Toledo;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
45 Toledo;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
45 Toledo;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;94,84
45 Toledo;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
45 Toledo;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
45 Toledo;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
45 Toledo;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
45 Toledo;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
45 Toledo;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
45 Toledo;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;91,48
45 Toledo;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
45 Toledo;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
45 Toledo;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
45 Toledo;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;92,82
45 Toledo;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
45 Toledo;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
45 Toledo;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
45 Toledo;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
45 Toledo;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
45 Toledo;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QIV;13.147
45 Toledo;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
45 Toledo;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
45 Toledo;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
45 Toledo;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QIV;13.002
45 Toledo;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
45 Toledo;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
45 Toledo;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
45 Toledo;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QIV;12.676
45 Toledo;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
45 Toledo;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
45 Toledo;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
45 Toledo;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2022QIV;12.809
45 Toledo;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
45 Toledo;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2022QII;""
45 Toledo;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2022QI;""
45 Toledo;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2021QIV;12.685
45 Toledo;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
45 Toledo;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2021QII;""
45 Toledo;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2021QI;""
45 Toledo;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2020QIV;12.430
45 Toledo;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
45 Toledo;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2020QII;""
45 Toledo;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2020QI;""
45 Toledo;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
45 Toledo;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
45 Toledo;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2022QII;""
45 Toledo;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2022QI;12.449
45 Toledo;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
45 Toledo;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
45 Toledo;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2021QII;""
45 Toledo;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2021QI;12.279
45 Toledo;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
45 Toledo;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
45 Toledo;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2020QII;""
45 Toledo;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2020QI;""
45 Toledo;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
45 Toledo;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
45 Toledo;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QII;12.251
45 Toledo;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QI;""
45 Toledo;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
45 Toledo;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
45 Toledo;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QII;12.021
45 Toledo;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QI;""
45 Toledo;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
45 Toledo;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
45 Toledo;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QII;""
45 Toledo;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QI;""
45 Toledo;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
45 Toledo;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QIII;12.062
45 Toledo;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QII;""
45 Toledo;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QI;""
45 Toledo;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
45 Toledo;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QIII;11.870
45 Toledo;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QII;""
45 Toledo;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QI;""
45 Toledo;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
45 Toledo;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
45 Toledo;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QII;""
45 Toledo;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QI;""
45 Toledo;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
45 Toledo;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
45 Toledo;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
45 Toledo;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
45 Toledo;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
45 Toledo;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
45 Toledo;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
45 Toledo;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
45 Toledo;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
45 Toledo;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
45 Toledo;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
45 Toledo;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
45 Toledo;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;97,43
45 Toledo;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
45 Toledo;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
45 Toledo;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
45 Toledo;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;97,56
45 Toledo;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
45 Toledo;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
45 Toledo;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
45 Toledo;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;98,06
45 Toledo;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
45 Toledo;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
45 Toledo;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
45 Toledo;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
45 Toledo;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
45 Toledo;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
45 Toledo;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;95,75
45 Toledo;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
45 Toledo;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
45 Toledo;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
45 Toledo;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;96,87
45 Toledo;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
45 Toledo;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
45 Toledo;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
45 Toledo;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
45 Toledo;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
45 Toledo;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
45 Toledo;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;94,22
45 Toledo;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
45 Toledo;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
45 Toledo;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
45 Toledo;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;94,83
45 Toledo;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
45 Toledo;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
45 Toledo;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
45 Toledo;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
45 Toledo;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
45 Toledo;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
45 Toledo;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;92,77
45 Toledo;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
45 Toledo;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
45 Toledo;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
45 Toledo;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;93,64
45 Toledo;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
45 Toledo;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
45 Toledo;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
45 Toledo;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
45 Toledo;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
45 Toledo;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
45 Toledo;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QIV;8.817
45 Toledo;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
45 Toledo;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
45 Toledo;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
45 Toledo;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QIV;8.770
45 Toledo;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
45 Toledo;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
45 Toledo;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
45 Toledo;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QIV;8.599
45 Toledo;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
45 Toledo;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
45 Toledo;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
45 Toledo;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2022QIV;8.597
45 Toledo;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
45 Toledo;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2022QII;""
45 Toledo;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2022QI;""
45 Toledo;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2021QIV;8.565
45 Toledo;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
45 Toledo;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2021QII;""
45 Toledo;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2021QI;""
45 Toledo;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2020QIV;8.444
45 Toledo;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
45 Toledo;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2020QII;""
45 Toledo;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2020QI;""
45 Toledo;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
45 Toledo;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
45 Toledo;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2022QII;""
45 Toledo;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2022QI;8.434
45 Toledo;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
45 Toledo;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
45 Toledo;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2021QII;""
45 Toledo;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2021QI;8.342
45 Toledo;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
45 Toledo;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
45 Toledo;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2020QII;""
45 Toledo;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2020QI;""
45 Toledo;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
45 Toledo;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
45 Toledo;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QII;8.316
45 Toledo;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QI;""
45 Toledo;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
45 Toledo;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
45 Toledo;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QII;8.170
45 Toledo;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QI;""
45 Toledo;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
45 Toledo;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
45 Toledo;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QII;""
45 Toledo;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QI;""
45 Toledo;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
45 Toledo;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QIII;8.202
45 Toledo;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QII;""
45 Toledo;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QI;""
45 Toledo;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
45 Toledo;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QIII;8.080
45 Toledo;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QII;""
45 Toledo;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QI;""
45 Toledo;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
45 Toledo;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
45 Toledo;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QII;""
45 Toledo;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QI;""
45 Toledo;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
45 Toledo;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
45 Toledo;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
45 Toledo;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
45 Toledo;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
45 Toledo;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
45 Toledo;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
45 Toledo;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
45 Toledo;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
45 Toledo;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
45 Toledo;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
45 Toledo;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
45 Toledo;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;97,5
45 Toledo;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
45 Toledo;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
45 Toledo;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
45 Toledo;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;97,66
45 Toledo;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
45 Toledo;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
45 Toledo;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
45 Toledo;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;98,2
45 Toledo;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
45 Toledo;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
45 Toledo;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
45 Toledo;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
45 Toledo;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
45 Toledo;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
45 Toledo;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;96,17
45 Toledo;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
45 Toledo;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
45 Toledo;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
45 Toledo;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;97,01
45 Toledo;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
45 Toledo;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
45 Toledo;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
45 Toledo;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
45 Toledo;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
45 Toledo;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
45 Toledo;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;94,82
45 Toledo;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
45 Toledo;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
45 Toledo;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
45 Toledo;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;95,01
45 Toledo;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
45 Toledo;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
45 Toledo;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
45 Toledo;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
45 Toledo;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
45 Toledo;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
45 Toledo;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;93,52
45 Toledo;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
45 Toledo;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
45 Toledo;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
45 Toledo;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;93,96
45 Toledo;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
45 Toledo;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
45 Toledo;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
45 Toledo;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
45 Toledo;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
45 Toledo;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
45 Toledo;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QIV;4.330
45 Toledo;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
45 Toledo;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
45 Toledo;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
45 Toledo;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QIV;4.232
45 Toledo;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
45 Toledo;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
45 Toledo;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
45 Toledo;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QIV;4.077
45 Toledo;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
45 Toledo;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
45 Toledo;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
45 Toledo;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2022QIV;4.212
45 Toledo;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
45 Toledo;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2022QII;""
45 Toledo;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2022QI;""
45 Toledo;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2021QIV;4.120
45 Toledo;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
45 Toledo;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2021QII;""
45 Toledo;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2021QI;""
45 Toledo;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2020QIV;3.986
45 Toledo;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
45 Toledo;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2020QII;""
45 Toledo;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2020QI;""
45 Toledo;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
45 Toledo;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
45 Toledo;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2022QII;""
45 Toledo;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2022QI;4.015
45 Toledo;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
45 Toledo;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
45 Toledo;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2021QII;""
45 Toledo;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2021QI;3.937
45 Toledo;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
45 Toledo;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
45 Toledo;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2020QII;""
45 Toledo;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2020QI;""
45 Toledo;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
45 Toledo;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
45 Toledo;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QII;3.935
45 Toledo;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QI;""
45 Toledo;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
45 Toledo;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
45 Toledo;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QII;3.851
45 Toledo;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QI;""
45 Toledo;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
45 Toledo;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
45 Toledo;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QII;""
45 Toledo;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QI;""
45 Toledo;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
45 Toledo;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QIII;3.860
45 Toledo;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QII;""
45 Toledo;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QI;""
45 Toledo;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
45 Toledo;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QIII;3.790
45 Toledo;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QII;""
45 Toledo;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QI;""
45 Toledo;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
45 Toledo;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
45 Toledo;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QII;""
45 Toledo;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QI;""
45 Toledo;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
45 Toledo;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
45 Toledo;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
45 Toledo;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
45 Toledo;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
45 Toledo;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
45 Toledo;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
45 Toledo;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
45 Toledo;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
45 Toledo;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
45 Toledo;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
45 Toledo;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
45 Toledo;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;97,27
45 Toledo;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
45 Toledo;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
45 Toledo;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
45 Toledo;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;97,35
45 Toledo;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
45 Toledo;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
45 Toledo;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
45 Toledo;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;97,77
45 Toledo;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
45 Toledo;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
45 Toledo;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
45 Toledo;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
45 Toledo;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
45 Toledo;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
45 Toledo;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;94,87
45 Toledo;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
45 Toledo;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
45 Toledo;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
45 Toledo;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;96,57
45 Toledo;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
45 Toledo;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
45 Toledo;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
45 Toledo;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
45 Toledo;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
45 Toledo;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
45 Toledo;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;92,98
45 Toledo;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
45 Toledo;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
45 Toledo;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
45 Toledo;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;94,46
45 Toledo;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
45 Toledo;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
45 Toledo;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
45 Toledo;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
45 Toledo;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
45 Toledo;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
45 Toledo;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;91,21
45 Toledo;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
45 Toledo;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
45 Toledo;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
45 Toledo;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;92,96
45 Toledo;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
45 Toledo;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
45 Toledo;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
45 Toledo;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
45 Toledo;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
45 Toledo;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
45 Toledo;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
45 Toledo;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
45 Toledo;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
45 Toledo;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QI;6.262
45 Toledo;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
45 Toledo;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
45 Toledo;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
45 Toledo;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QI;5.888
45 Toledo;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
45 Toledo;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
45 Toledo;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
45 Toledo;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QI;6.688
45 Toledo;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
45 Toledo;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
45 Toledo;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2022QII;""
45 Toledo;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2022QI;6.040
45 Toledo;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
45 Toledo;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
45 Toledo;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2021QII;""
45 Toledo;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2021QI;5.679
45 Toledo;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
45 Toledo;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
45 Toledo;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2020QII;""
45 Toledo;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2020QI;6.258
45 Toledo;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
45 Toledo;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
45 Toledo;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2022QII;5.814
45 Toledo;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2022QI;""
45 Toledo;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
45 Toledo;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
45 Toledo;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2021QII;5.456
45 Toledo;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2021QI;""
45 Toledo;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
45 Toledo;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
45 Toledo;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2020QII;6.076
45 Toledo;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2020QI;""
45 Toledo;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
45 Toledo;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QIII;5.622
45 Toledo;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QII;""
45 Toledo;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QI;""
45 Toledo;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
45 Toledo;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QIII;5.265
45 Toledo;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QII;""
45 Toledo;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QI;""
45 Toledo;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
45 Toledo;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QIII;5.865
45 Toledo;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QII;""
45 Toledo;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QI;""
45 Toledo;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QIV;5.284
45 Toledo;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
45 Toledo;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QII;""
45 Toledo;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QI;""
45 Toledo;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QIV;5.033
45 Toledo;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
45 Toledo;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QII;""
45 Toledo;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QI;""
45 Toledo;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QIV;5.617
45 Toledo;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
45 Toledo;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QII;""
45 Toledo;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QI;""
45 Toledo;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
45 Toledo;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
45 Toledo;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
45 Toledo;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
45 Toledo;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
45 Toledo;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
45 Toledo;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
45 Toledo;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
45 Toledo;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
45 Toledo;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
45 Toledo;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
45 Toledo;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
45 Toledo;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
45 Toledo;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
45 Toledo;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
45 Toledo;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;96,45
45 Toledo;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
45 Toledo;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
45 Toledo;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
45 Toledo;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;96,45
45 Toledo;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
45 Toledo;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
45 Toledo;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
45 Toledo;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;93,57
45 Toledo;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
45 Toledo;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
45 Toledo;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;92,85
45 Toledo;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
45 Toledo;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
45 Toledo;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
45 Toledo;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;92,66
45 Toledo;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
45 Toledo;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
45 Toledo;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
45 Toledo;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;90,85
45 Toledo;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
45 Toledo;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
45 Toledo;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;89,78
45 Toledo;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
45 Toledo;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
45 Toledo;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
45 Toledo;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;89,42
45 Toledo;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
45 Toledo;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
45 Toledo;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
45 Toledo;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;87,69
45 Toledo;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
45 Toledo;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
45 Toledo;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;84,38
45 Toledo;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
45 Toledo;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
45 Toledo;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
45 Toledo;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;85,48
45 Toledo;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
45 Toledo;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
45 Toledo;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
45 Toledo;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;83,99
45 Toledo;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
45 Toledo;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
45 Toledo;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
45 Toledo;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
45 Toledo;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
45 Toledo;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
45 Toledo;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QI;4.381
45 Toledo;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
45 Toledo;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
45 Toledo;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
45 Toledo;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QI;4.122
45 Toledo;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
45 Toledo;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
45 Toledo;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
45 Toledo;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QI;4.646
45 Toledo;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
45 Toledo;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
45 Toledo;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2022QII;""
45 Toledo;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2022QI;4.232
45 Toledo;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
45 Toledo;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
45 Toledo;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2021QII;""
45 Toledo;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2021QI;3.981
45 Toledo;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
45 Toledo;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
45 Toledo;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2020QII;""
45 Toledo;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2020QI;4.365
45 Toledo;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
45 Toledo;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
45 Toledo;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2022QII;4.083
45 Toledo;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2022QI;""
45 Toledo;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
45 Toledo;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
45 Toledo;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2021QII;3.844
45 Toledo;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2021QI;""
45 Toledo;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
45 Toledo;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
45 Toledo;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2020QII;4.243
45 Toledo;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2020QI;""
45 Toledo;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
45 Toledo;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QIII;3.964
45 Toledo;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QII;""
45 Toledo;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QI;""
45 Toledo;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
45 Toledo;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QIII;3.712
45 Toledo;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QII;""
45 Toledo;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QI;""
45 Toledo;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
45 Toledo;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QIII;4.110
45 Toledo;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QII;""
45 Toledo;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QI;""
45 Toledo;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QIV;3.734
45 Toledo;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
45 Toledo;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QII;""
45 Toledo;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QI;""
45 Toledo;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QIV;3.556
45 Toledo;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
45 Toledo;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QII;""
45 Toledo;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QI;""
45 Toledo;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QIV;3.950
45 Toledo;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
45 Toledo;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QII;""
45 Toledo;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QI;""
45 Toledo;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
45 Toledo;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
45 Toledo;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
45 Toledo;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
45 Toledo;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
45 Toledo;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
45 Toledo;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
45 Toledo;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
45 Toledo;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
45 Toledo;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
45 Toledo;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
45 Toledo;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
45 Toledo;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
45 Toledo;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
45 Toledo;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
45 Toledo;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;96,6
45 Toledo;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
45 Toledo;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
45 Toledo;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
45 Toledo;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;96,58
45 Toledo;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
45 Toledo;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
45 Toledo;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
45 Toledo;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;93,95
45 Toledo;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
45 Toledo;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
45 Toledo;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;93,2
45 Toledo;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
45 Toledo;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
45 Toledo;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
45 Toledo;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;93,26
45 Toledo;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
45 Toledo;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
45 Toledo;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
45 Toledo;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;91,33
45 Toledo;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
45 Toledo;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
45 Toledo;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;90,48
45 Toledo;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
45 Toledo;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
45 Toledo;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
45 Toledo;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;90,05
45 Toledo;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
45 Toledo;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
45 Toledo;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
45 Toledo;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;88,46
45 Toledo;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
45 Toledo;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
45 Toledo;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;85,23
45 Toledo;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
45 Toledo;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
45 Toledo;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
45 Toledo;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;86,27
45 Toledo;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
45 Toledo;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
45 Toledo;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
45 Toledo;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;85,02
45 Toledo;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
45 Toledo;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
45 Toledo;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
45 Toledo;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
45 Toledo;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
45 Toledo;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
45 Toledo;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QI;1.881
45 Toledo;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
45 Toledo;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
45 Toledo;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
45 Toledo;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QI;1.766
45 Toledo;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
45 Toledo;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
45 Toledo;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
45 Toledo;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QI;2.042
45 Toledo;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
45 Toledo;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
45 Toledo;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2022QII;""
45 Toledo;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2022QI;1.808
45 Toledo;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
45 Toledo;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
45 Toledo;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2021QII;""
45 Toledo;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2021QI;1.698
45 Toledo;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
45 Toledo;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
45 Toledo;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2020QII;""
45 Toledo;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2020QI;1.893
45 Toledo;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
45 Toledo;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
45 Toledo;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2022QII;1.731
45 Toledo;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2022QI;""
45 Toledo;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
45 Toledo;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
45 Toledo;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2021QII;1.612
45 Toledo;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2021QI;""
45 Toledo;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
45 Toledo;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
45 Toledo;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2020QII;1.833
45 Toledo;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2020QI;""
45 Toledo;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
45 Toledo;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QIII;1.658
45 Toledo;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QII;""
45 Toledo;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QI;""
45 Toledo;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
45 Toledo;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QIII;1.553
45 Toledo;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QII;""
45 Toledo;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QI;""
45 Toledo;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
45 Toledo;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QIII;1.755
45 Toledo;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QII;""
45 Toledo;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QI;""
45 Toledo;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QIV;1.550
45 Toledo;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
45 Toledo;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QII;""
45 Toledo;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QI;""
45 Toledo;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QIV;1.477
45 Toledo;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
45 Toledo;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QII;""
45 Toledo;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QI;""
45 Toledo;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QIV;1.667
45 Toledo;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
45 Toledo;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QII;""
45 Toledo;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QI;""
45 Toledo;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
45 Toledo;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
45 Toledo;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
45 Toledo;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
45 Toledo;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
45 Toledo;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
45 Toledo;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
45 Toledo;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
45 Toledo;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
45 Toledo;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
45 Toledo;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
45 Toledo;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
45 Toledo;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
45 Toledo;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
45 Toledo;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
45 Toledo;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;96,12
45 Toledo;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
45 Toledo;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
45 Toledo;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
45 Toledo;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;96,15
45 Toledo;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
45 Toledo;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
45 Toledo;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
45 Toledo;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;92,7
45 Toledo;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
45 Toledo;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
45 Toledo;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;92,03
45 Toledo;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
45 Toledo;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
45 Toledo;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
45 Toledo;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;91,28
45 Toledo;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
45 Toledo;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
45 Toledo;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
45 Toledo;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;89,76
45 Toledo;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
45 Toledo;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
45 Toledo;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;88,14
45 Toledo;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
45 Toledo;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
45 Toledo;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
45 Toledo;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;87,94
45 Toledo;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
45 Toledo;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
45 Toledo;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
45 Toledo;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;85,95
45 Toledo;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
45 Toledo;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
45 Toledo;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;82,4
45 Toledo;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
45 Toledo;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
45 Toledo;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
45 Toledo;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;83,64
45 Toledo;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
45 Toledo;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
45 Toledo;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
45 Toledo;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;81,64
45 Toledo;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
45 Toledo;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
45 Toledo;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
45 Toledo;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
45 Toledo;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
45 Toledo;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QII;7.242
45 Toledo;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
45 Toledo;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
45 Toledo;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
45 Toledo;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QII;6.799
45 Toledo;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
45 Toledo;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
45 Toledo;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
45 Toledo;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QII;6.357
45 Toledo;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
45 Toledo;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
45 Toledo;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
45 Toledo;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2022QII;6.992
45 Toledo;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2022QI;""
45 Toledo;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
45 Toledo;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
45 Toledo;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2021QII;6.544
45 Toledo;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2021QI;""
45 Toledo;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
45 Toledo;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
45 Toledo;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2020QII;6.172
45 Toledo;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2020QI;""
45 Toledo;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
45 Toledo;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2022QIII;6.778
45 Toledo;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2022QII;""
45 Toledo;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2022QI;""
45 Toledo;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
45 Toledo;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2021QIII;6.340
45 Toledo;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2021QII;""
45 Toledo;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2021QI;""
45 Toledo;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
45 Toledo;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2020QIII;5.950
45 Toledo;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2020QII;""
45 Toledo;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2020QI;""
45 Toledo;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QIV;6.409
45 Toledo;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
45 Toledo;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QII;""
45 Toledo;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QI;""
45 Toledo;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QIV;6.085
45 Toledo;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
45 Toledo;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QII;""
45 Toledo;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QI;""
45 Toledo;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QIV;5.693
45 Toledo;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
45 Toledo;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QII;""
45 Toledo;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QI;""
45 Toledo;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
45 Toledo;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
45 Toledo;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QII;""
45 Toledo;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QI;5.875
45 Toledo;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
45 Toledo;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
45 Toledo;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QII;""
45 Toledo;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QI;5.499
45 Toledo;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
45 Toledo;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
45 Toledo;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QII;""
45 Toledo;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QI;""
45 Toledo;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
45 Toledo;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
45 Toledo;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
45 Toledo;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
45 Toledo;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
45 Toledo;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
45 Toledo;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
45 Toledo;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
45 Toledo;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
45 Toledo;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
45 Toledo;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
45 Toledo;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
45 Toledo;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
45 Toledo;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
45 Toledo;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;96,55
45 Toledo;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
45 Toledo;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
45 Toledo;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
45 Toledo;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;96,25
45 Toledo;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
45 Toledo;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
45 Toledo;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
45 Toledo;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;97,09
45 Toledo;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
45 Toledo;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
45 Toledo;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;93,59
45 Toledo;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
45 Toledo;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
45 Toledo;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
45 Toledo;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;93,25
45 Toledo;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
45 Toledo;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
45 Toledo;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
45 Toledo;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;93,6
45 Toledo;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
45 Toledo;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
45 Toledo;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;88,5
45 Toledo;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
45 Toledo;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
45 Toledo;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
45 Toledo;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;89,5
45 Toledo;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
45 Toledo;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
45 Toledo;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
45 Toledo;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;89,55
45 Toledo;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
45 Toledo;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
45 Toledo;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
45 Toledo;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
45 Toledo;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
45 Toledo;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
45 Toledo;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;86,41
45 Toledo;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
45 Toledo;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
45 Toledo;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
45 Toledo;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;86,5
45 Toledo;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
45 Toledo;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
45 Toledo;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
45 Toledo;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
45 Toledo;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
45 Toledo;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
45 Toledo;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QII;5.058
45 Toledo;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
45 Toledo;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
45 Toledo;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
45 Toledo;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QII;4.747
45 Toledo;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
45 Toledo;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
45 Toledo;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
45 Toledo;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QII;4.431
45 Toledo;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
45 Toledo;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
45 Toledo;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
45 Toledo;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2022QII;4.897
45 Toledo;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2022QI;""
45 Toledo;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
45 Toledo;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
45 Toledo;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2021QII;4.594
45 Toledo;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2021QI;""
45 Toledo;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
45 Toledo;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
45 Toledo;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2020QII;4.306
45 Toledo;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2020QI;""
45 Toledo;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
45 Toledo;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2022QIII;4.766
45 Toledo;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2022QII;""
45 Toledo;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2022QI;""
45 Toledo;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
45 Toledo;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2021QIII;4.454
45 Toledo;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2021QII;""
45 Toledo;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2021QI;""
45 Toledo;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
45 Toledo;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2020QIII;4.166
45 Toledo;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2020QII;""
45 Toledo;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2020QI;""
45 Toledo;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QIV;4.519
45 Toledo;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
45 Toledo;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QII;""
45 Toledo;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QI;""
45 Toledo;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QIV;4.282
45 Toledo;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
45 Toledo;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QII;""
45 Toledo;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QI;""
45 Toledo;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QIV;4.000
45 Toledo;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
45 Toledo;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QII;""
45 Toledo;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QI;""
45 Toledo;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
45 Toledo;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
45 Toledo;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QII;""
45 Toledo;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QI;4.144
45 Toledo;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
45 Toledo;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
45 Toledo;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QII;""
45 Toledo;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QI;3.867
45 Toledo;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
45 Toledo;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
45 Toledo;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QII;""
45 Toledo;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QI;""
45 Toledo;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
45 Toledo;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
45 Toledo;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
45 Toledo;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
45 Toledo;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
45 Toledo;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
45 Toledo;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
45 Toledo;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
45 Toledo;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
45 Toledo;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
45 Toledo;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
45 Toledo;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
45 Toledo;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
45 Toledo;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
45 Toledo;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;96,82
45 Toledo;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
45 Toledo;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
45 Toledo;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
45 Toledo;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;96,78
45 Toledo;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
45 Toledo;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
45 Toledo;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
45 Toledo;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;97,18
45 Toledo;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
45 Toledo;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
45 Toledo;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;94,23
45 Toledo;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
45 Toledo;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
45 Toledo;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
45 Toledo;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;93,83
45 Toledo;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
45 Toledo;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
45 Toledo;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
45 Toledo;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;94,02
45 Toledo;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
45 Toledo;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
45 Toledo;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;89,34
45 Toledo;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
45 Toledo;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
45 Toledo;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
45 Toledo;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;90,2
45 Toledo;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
45 Toledo;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
45 Toledo;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
45 Toledo;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;90,27
45 Toledo;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
45 Toledo;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
45 Toledo;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
45 Toledo;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
45 Toledo;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
45 Toledo;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
45 Toledo;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;87,3
45 Toledo;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
45 Toledo;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
45 Toledo;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
45 Toledo;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;87,27
45 Toledo;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
45 Toledo;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
45 Toledo;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
45 Toledo;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
45 Toledo;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
45 Toledo;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
45 Toledo;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QII;2.184
45 Toledo;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
45 Toledo;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
45 Toledo;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
45 Toledo;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QII;2.052
45 Toledo;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
45 Toledo;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
45 Toledo;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
45 Toledo;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QII;1.926
45 Toledo;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
45 Toledo;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
45 Toledo;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
45 Toledo;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2022QII;2.095
45 Toledo;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2022QI;""
45 Toledo;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
45 Toledo;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
45 Toledo;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2021QII;1.950
45 Toledo;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2021QI;""
45 Toledo;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
45 Toledo;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
45 Toledo;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2020QII;1.866
45 Toledo;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2020QI;""
45 Toledo;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
45 Toledo;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2022QIII;2.012
45 Toledo;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2022QII;""
45 Toledo;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2022QI;""
45 Toledo;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
45 Toledo;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2021QIII;1.886
45 Toledo;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2021QII;""
45 Toledo;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2021QI;""
45 Toledo;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
45 Toledo;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2020QIII;1.784
45 Toledo;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2020QII;""
45 Toledo;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2020QI;""
45 Toledo;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QIV;1.890
45 Toledo;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
45 Toledo;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QII;""
45 Toledo;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QI;""
45 Toledo;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QIV;1.803
45 Toledo;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
45 Toledo;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QII;""
45 Toledo;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QI;""
45 Toledo;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QIV;1.693
45 Toledo;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
45 Toledo;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QII;""
45 Toledo;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QI;""
45 Toledo;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
45 Toledo;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
45 Toledo;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QII;""
45 Toledo;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QI;1.731
45 Toledo;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
45 Toledo;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
45 Toledo;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QII;""
45 Toledo;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QI;1.632
45 Toledo;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
45 Toledo;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
45 Toledo;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QII;""
45 Toledo;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QI;""
45 Toledo;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
45 Toledo;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
45 Toledo;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
45 Toledo;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
45 Toledo;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
45 Toledo;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
45 Toledo;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
45 Toledo;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
45 Toledo;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
45 Toledo;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
45 Toledo;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
45 Toledo;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
45 Toledo;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
45 Toledo;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
45 Toledo;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;95,92
45 Toledo;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
45 Toledo;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
45 Toledo;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
45 Toledo;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;95,03
45 Toledo;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
45 Toledo;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
45 Toledo;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
45 Toledo;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;96,88
45 Toledo;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
45 Toledo;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
45 Toledo;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;92,12
45 Toledo;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
45 Toledo;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
45 Toledo;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
45 Toledo;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;91,91
45 Toledo;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
45 Toledo;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
45 Toledo;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
45 Toledo;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;92,63
45 Toledo;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
45 Toledo;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
45 Toledo;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;86,54
45 Toledo;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
45 Toledo;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
45 Toledo;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
45 Toledo;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;87,87
45 Toledo;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
45 Toledo;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
45 Toledo;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
45 Toledo;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;87,9
45 Toledo;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
45 Toledo;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
45 Toledo;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
45 Toledo;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
45 Toledo;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
45 Toledo;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
45 Toledo;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;84,36
45 Toledo;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
45 Toledo;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
45 Toledo;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
45 Toledo;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;84,74
45 Toledo;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
45 Toledo;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
45 Toledo;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
45 Toledo;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
45 Toledo;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
45 Toledo;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QIII;7.077
45 Toledo;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
45 Toledo;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
45 Toledo;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
45 Toledo;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QIII;6.638
45 Toledo;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
45 Toledo;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
45 Toledo;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
45 Toledo;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QIII;6.265
45 Toledo;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
45 Toledo;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
45 Toledo;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
45 Toledo;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2022QIII;6.838
45 Toledo;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2022QII;""
45 Toledo;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2022QI;""
45 Toledo;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
45 Toledo;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2021QIII;6.411
45 Toledo;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2021QII;""
45 Toledo;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2021QI;""
45 Toledo;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
45 Toledo;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2020QIII;6.021
45 Toledo;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2020QII;""
45 Toledo;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2020QI;""
45 Toledo;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2022QIV;6.460
45 Toledo;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
45 Toledo;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2022QII;""
45 Toledo;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2022QI;""
45 Toledo;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2021QIV;6.144
45 Toledo;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
45 Toledo;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2021QII;""
45 Toledo;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2021QI;""
45 Toledo;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2020QIV;5.753
45 Toledo;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
45 Toledo;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2020QII;""
45 Toledo;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2020QI;""
45 Toledo;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
45 Toledo;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
45 Toledo;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QII;""
45 Toledo;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QI;5.932
45 Toledo;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
45 Toledo;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
45 Toledo;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QII;""
45 Toledo;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QI;5.556
45 Toledo;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
45 Toledo;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
45 Toledo;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QII;""
45 Toledo;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QI;""
45 Toledo;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
45 Toledo;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
45 Toledo;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QII;5.722
45 Toledo;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QI;""
45 Toledo;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
45 Toledo;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
45 Toledo;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QII;5.349
45 Toledo;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QI;""
45 Toledo;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
45 Toledo;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
45 Toledo;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QII;""
45 Toledo;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QI;""
45 Toledo;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
45 Toledo;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
45 Toledo;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
45 Toledo;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
45 Toledo;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
45 Toledo;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
45 Toledo;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
45 Toledo;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
45 Toledo;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
45 Toledo;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
45 Toledo;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
45 Toledo;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
45 Toledo;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
45 Toledo;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;96,62
45 Toledo;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
45 Toledo;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
45 Toledo;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
45 Toledo;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;96,58
45 Toledo;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
45 Toledo;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
45 Toledo;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
45 Toledo;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;96,11
45 Toledo;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
45 Toledo;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
45 Toledo;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;91,28
45 Toledo;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
45 Toledo;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
45 Toledo;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
45 Toledo;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;92,56
45 Toledo;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
45 Toledo;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
45 Toledo;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
45 Toledo;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;91,83
45 Toledo;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
45 Toledo;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
45 Toledo;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
45 Toledo;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
45 Toledo;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
45 Toledo;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
45 Toledo;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;89,36
45 Toledo;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
45 Toledo;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
45 Toledo;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
45 Toledo;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;88,68
45 Toledo;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
45 Toledo;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
45 Toledo;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
45 Toledo;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
45 Toledo;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
45 Toledo;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
45 Toledo;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;86,2
45 Toledo;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
45 Toledo;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
45 Toledo;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
45 Toledo;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;85,38
45 Toledo;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
45 Toledo;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
45 Toledo;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
45 Toledo;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
45 Toledo;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
45 Toledo;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
45 Toledo;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QIII;4.938
45 Toledo;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
45 Toledo;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
45 Toledo;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
45 Toledo;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QIII;4.650
45 Toledo;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
45 Toledo;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
45 Toledo;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
45 Toledo;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QIII;4.373
45 Toledo;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
45 Toledo;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
45 Toledo;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
45 Toledo;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2022QIII;4.799
45 Toledo;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2022QII;""
45 Toledo;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2022QI;""
45 Toledo;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
45 Toledo;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2021QIII;4.495
45 Toledo;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2021QII;""
45 Toledo;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2021QI;""
45 Toledo;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
45 Toledo;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2020QIII;4.217
45 Toledo;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2020QII;""
45 Toledo;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2020QI;""
45 Toledo;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2022QIV;4.545
45 Toledo;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
45 Toledo;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2022QII;""
45 Toledo;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2022QI;""
45 Toledo;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2021QIV;4.315
45 Toledo;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
45 Toledo;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2021QII;""
45 Toledo;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2021QI;""
45 Toledo;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2020QIV;4.042
45 Toledo;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
45 Toledo;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2020QII;""
45 Toledo;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2020QI;""
45 Toledo;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
45 Toledo;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
45 Toledo;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QII;""
45 Toledo;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QI;4.175
45 Toledo;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
45 Toledo;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
45 Toledo;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QII;""
45 Toledo;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QI;3.908
45 Toledo;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
45 Toledo;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
45 Toledo;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QII;""
45 Toledo;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QI;""
45 Toledo;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
45 Toledo;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
45 Toledo;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QII;4.031
45 Toledo;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QI;""
45 Toledo;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
45 Toledo;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
45 Toledo;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QII;3.779
45 Toledo;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QI;""
45 Toledo;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
45 Toledo;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
45 Toledo;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QII;""
45 Toledo;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QI;""
45 Toledo;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
45 Toledo;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
45 Toledo;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
45 Toledo;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
45 Toledo;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
45 Toledo;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
45 Toledo;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
45 Toledo;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
45 Toledo;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
45 Toledo;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
45 Toledo;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
45 Toledo;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
45 Toledo;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
45 Toledo;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;97,19
45 Toledo;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
45 Toledo;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
45 Toledo;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
45 Toledo;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;96,67
45 Toledo;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
45 Toledo;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
45 Toledo;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
45 Toledo;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;96,43
45 Toledo;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
45 Toledo;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
45 Toledo;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;92,04
45 Toledo;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
45 Toledo;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
45 Toledo;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
45 Toledo;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;92,8
45 Toledo;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
45 Toledo;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
45 Toledo;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
45 Toledo;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;92,43
45 Toledo;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
45 Toledo;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
45 Toledo;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
45 Toledo;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
45 Toledo;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
45 Toledo;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
45 Toledo;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;89,78
45 Toledo;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
45 Toledo;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
45 Toledo;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
45 Toledo;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;89,37
45 Toledo;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
45 Toledo;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
45 Toledo;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
45 Toledo;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
45 Toledo;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
45 Toledo;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
45 Toledo;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;86,69
45 Toledo;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
45 Toledo;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
45 Toledo;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
45 Toledo;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;86,42
45 Toledo;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
45 Toledo;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
45 Toledo;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
45 Toledo;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
45 Toledo;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
45 Toledo;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
45 Toledo;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QIII;2.139
45 Toledo;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
45 Toledo;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
45 Toledo;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
45 Toledo;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QIII;1.988
45 Toledo;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
45 Toledo;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
45 Toledo;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
45 Toledo;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QIII;1.892
45 Toledo;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
45 Toledo;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
45 Toledo;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
45 Toledo;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2022QIII;2.039
45 Toledo;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2022QII;""
45 Toledo;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2022QI;""
45 Toledo;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
45 Toledo;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2021QIII;1.916
45 Toledo;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2021QII;""
45 Toledo;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2021QI;""
45 Toledo;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
45 Toledo;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2020QIII;1.804
45 Toledo;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2020QII;""
45 Toledo;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2020QI;""
45 Toledo;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2022QIV;1.915
45 Toledo;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
45 Toledo;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2022QII;""
45 Toledo;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2022QI;""
45 Toledo;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2021QIV;1.829
45 Toledo;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
45 Toledo;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2021QII;""
45 Toledo;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2021QI;""
45 Toledo;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2020QIV;1.711
45 Toledo;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
45 Toledo;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2020QII;""
45 Toledo;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2020QI;""
45 Toledo;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
45 Toledo;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
45 Toledo;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QII;""
45 Toledo;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QI;1.757
45 Toledo;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
45 Toledo;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
45 Toledo;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QII;""
45 Toledo;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QI;1.648
45 Toledo;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
45 Toledo;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
45 Toledo;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QII;""
45 Toledo;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QI;""
45 Toledo;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
45 Toledo;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
45 Toledo;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QII;1.691
45 Toledo;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QI;""
45 Toledo;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
45 Toledo;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
45 Toledo;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QII;1.570
45 Toledo;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QI;""
45 Toledo;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
45 Toledo;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
45 Toledo;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QII;""
45 Toledo;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QI;""
45 Toledo;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
45 Toledo;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
45 Toledo;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
45 Toledo;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
45 Toledo;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
45 Toledo;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
45 Toledo;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
45 Toledo;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
45 Toledo;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
45 Toledo;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
45 Toledo;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
45 Toledo;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
45 Toledo;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
45 Toledo;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;95,32
45 Toledo;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
45 Toledo;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
45 Toledo;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
45 Toledo;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;96,38
45 Toledo;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
45 Toledo;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
45 Toledo;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
45 Toledo;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;95,35
45 Toledo;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
45 Toledo;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
45 Toledo;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;89,53
45 Toledo;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
45 Toledo;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
45 Toledo;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
45 Toledo;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;92
45 Toledo;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
45 Toledo;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
45 Toledo;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
45 Toledo;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;90,43
45 Toledo;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
45 Toledo;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
45 Toledo;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
45 Toledo;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
45 Toledo;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
45 Toledo;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
45 Toledo;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;88,38
45 Toledo;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
45 Toledo;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
45 Toledo;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
45 Toledo;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;87,1
45 Toledo;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
45 Toledo;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
45 Toledo;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
45 Toledo;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
45 Toledo;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
45 Toledo;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
45 Toledo;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;85,06
45 Toledo;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
45 Toledo;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
45 Toledo;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
45 Toledo;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;82,98
45 Toledo;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
45 Toledo;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
45 Toledo;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
45 Toledo;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
45 Toledo;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
45 Toledo;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QIV;6.901
45 Toledo;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
45 Toledo;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
45 Toledo;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
45 Toledo;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QIV;6.479
45 Toledo;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
45 Toledo;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
45 Toledo;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
45 Toledo;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QIV;6.120
45 Toledo;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
45 Toledo;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
45 Toledo;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
45 Toledo;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2022QIV;6.513
45 Toledo;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
45 Toledo;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2022QII;""
45 Toledo;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2022QI;""
45 Toledo;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2021QIV;6.200
45 Toledo;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
45 Toledo;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2021QII;""
45 Toledo;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2021QI;""
45 Toledo;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2020QIV;5.832
45 Toledo;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
45 Toledo;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2020QII;""
45 Toledo;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2020QI;""
45 Toledo;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
45 Toledo;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
45 Toledo;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2022QII;""
45 Toledo;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2022QI;5.982
45 Toledo;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
45 Toledo;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
45 Toledo;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2021QII;""
45 Toledo;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2021QI;5.627
45 Toledo;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
45 Toledo;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
45 Toledo;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2020QII;""
45 Toledo;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2020QI;""
45 Toledo;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
45 Toledo;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
45 Toledo;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QII;5.766
45 Toledo;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QI;""
45 Toledo;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
45 Toledo;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
45 Toledo;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QII;5.413
45 Toledo;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QI;""
45 Toledo;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
45 Toledo;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
45 Toledo;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QII;""
45 Toledo;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QI;""
45 Toledo;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
45 Toledo;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QIII;5.575
45 Toledo;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QII;""
45 Toledo;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QI;""
45 Toledo;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
45 Toledo;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QIII;5.225
45 Toledo;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QII;""
45 Toledo;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QI;""
45 Toledo;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
45 Toledo;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
45 Toledo;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QII;""
45 Toledo;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QI;""
45 Toledo;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
45 Toledo;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
45 Toledo;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
45 Toledo;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
45 Toledo;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
45 Toledo;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
45 Toledo;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
45 Toledo;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
45 Toledo;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
45 Toledo;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
45 Toledo;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
45 Toledo;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
45 Toledo;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;94,38
45 Toledo;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
45 Toledo;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
45 Toledo;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
45 Toledo;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;95,69
45 Toledo;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
45 Toledo;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
45 Toledo;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
45 Toledo;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;95,29
45 Toledo;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
45 Toledo;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
45 Toledo;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
45 Toledo;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
45 Toledo;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
45 Toledo;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
45 Toledo;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;92,33
45 Toledo;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
45 Toledo;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
45 Toledo;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
45 Toledo;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;91,94
45 Toledo;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
45 Toledo;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
45 Toledo;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
45 Toledo;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
45 Toledo;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
45 Toledo;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
45 Toledo;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;89
45 Toledo;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
45 Toledo;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
45 Toledo;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
45 Toledo;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;88,45
45 Toledo;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
45 Toledo;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
45 Toledo;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
45 Toledo;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
45 Toledo;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
45 Toledo;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
45 Toledo;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;86,05
45 Toledo;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
45 Toledo;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
45 Toledo;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
45 Toledo;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;85,38
45 Toledo;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
45 Toledo;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
45 Toledo;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
45 Toledo;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
45 Toledo;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
45 Toledo;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
45 Toledo;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QIV;4.832
45 Toledo;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
45 Toledo;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
45 Toledo;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
45 Toledo;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QIV;4.535
45 Toledo;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
45 Toledo;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
45 Toledo;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
45 Toledo;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QIV;4.280
45 Toledo;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
45 Toledo;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
45 Toledo;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
45 Toledo;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2022QIV;4.573
45 Toledo;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
45 Toledo;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2022QII;""
45 Toledo;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2022QI;""
45 Toledo;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2021QIV;4.350
45 Toledo;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
45 Toledo;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2021QII;""
45 Toledo;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2021QI;""
45 Toledo;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2020QIV;4.095
45 Toledo;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
45 Toledo;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2020QII;""
45 Toledo;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2020QI;""
45 Toledo;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
45 Toledo;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
45 Toledo;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2022QII;""
45 Toledo;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2022QI;4.205
45 Toledo;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
45 Toledo;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
45 Toledo;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2021QII;""
45 Toledo;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2021QI;3.955
45 Toledo;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
45 Toledo;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
45 Toledo;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2020QII;""
45 Toledo;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2020QI;""
45 Toledo;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
45 Toledo;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
45 Toledo;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QII;4.058
45 Toledo;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QI;""
45 Toledo;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
45 Toledo;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
45 Toledo;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QII;3.822
45 Toledo;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QI;""
45 Toledo;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
45 Toledo;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
45 Toledo;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QII;""
45 Toledo;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QI;""
45 Toledo;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
45 Toledo;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QIII;3.940
45 Toledo;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QII;""
45 Toledo;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QI;""
45 Toledo;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
45 Toledo;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QIII;3.692
45 Toledo;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QII;""
45 Toledo;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QI;""
45 Toledo;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
45 Toledo;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
45 Toledo;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QII;""
45 Toledo;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QI;""
45 Toledo;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
45 Toledo;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
45 Toledo;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
45 Toledo;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
45 Toledo;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
45 Toledo;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
45 Toledo;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
45 Toledo;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
45 Toledo;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
45 Toledo;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
45 Toledo;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
45 Toledo;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
45 Toledo;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;94,64
45 Toledo;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
45 Toledo;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
45 Toledo;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
45 Toledo;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;95,92
45 Toledo;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
45 Toledo;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
45 Toledo;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
45 Toledo;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;95,68
45 Toledo;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
45 Toledo;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
45 Toledo;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
45 Toledo;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
45 Toledo;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
45 Toledo;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
45 Toledo;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;92,72
45 Toledo;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
45 Toledo;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
45 Toledo;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
45 Toledo;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;92,41
45 Toledo;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
45 Toledo;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
45 Toledo;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
45 Toledo;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
45 Toledo;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
45 Toledo;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
45 Toledo;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;89,48
45 Toledo;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
45 Toledo;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
45 Toledo;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
45 Toledo;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;89,3
45 Toledo;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
45 Toledo;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
45 Toledo;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
45 Toledo;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
45 Toledo;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
45 Toledo;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
45 Toledo;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;86,88
45 Toledo;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
45 Toledo;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
45 Toledo;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
45 Toledo;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;86,26
45 Toledo;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
45 Toledo;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
45 Toledo;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
45 Toledo;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
45 Toledo;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
45 Toledo;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
45 Toledo;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QIV;2.069
45 Toledo;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
45 Toledo;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
45 Toledo;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
45 Toledo;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QIV;1.944
45 Toledo;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
45 Toledo;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
45 Toledo;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
45 Toledo;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QIV;1.840
45 Toledo;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
45 Toledo;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
45 Toledo;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
45 Toledo;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2022QIV;1.940
45 Toledo;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
45 Toledo;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2022QII;""
45 Toledo;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2022QI;""
45 Toledo;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2021QIV;1.850
45 Toledo;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
45 Toledo;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2021QII;""
45 Toledo;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2021QI;""
45 Toledo;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2020QIV;1.737
45 Toledo;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
45 Toledo;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2020QII;""
45 Toledo;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2020QI;""
45 Toledo;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
45 Toledo;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
45 Toledo;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2022QII;""
45 Toledo;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2022QI;1.777
45 Toledo;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
45 Toledo;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
45 Toledo;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2021QII;""
45 Toledo;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2021QI;1.672
45 Toledo;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
45 Toledo;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
45 Toledo;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2020QII;""
45 Toledo;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2020QI;""
45 Toledo;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
45 Toledo;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
45 Toledo;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QII;1.708
45 Toledo;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QI;""
45 Toledo;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
45 Toledo;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
45 Toledo;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QII;1.591
45 Toledo;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QI;""
45 Toledo;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
45 Toledo;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
45 Toledo;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QII;""
45 Toledo;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QI;""
45 Toledo;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
45 Toledo;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QIII;1.635
45 Toledo;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QII;""
45 Toledo;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QI;""
45 Toledo;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
45 Toledo;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QIII;1.533
45 Toledo;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QII;""
45 Toledo;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QI;""
45 Toledo;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
45 Toledo;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
45 Toledo;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QII;""
45 Toledo;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QI;""
45 Toledo;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
45 Toledo;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
45 Toledo;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
45 Toledo;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
45 Toledo;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
45 Toledo;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
45 Toledo;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
45 Toledo;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
45 Toledo;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
45 Toledo;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
45 Toledo;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
45 Toledo;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
45 Toledo;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;93,77
45 Toledo;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
45 Toledo;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
45 Toledo;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
45 Toledo;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;95,16
45 Toledo;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
45 Toledo;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
45 Toledo;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
45 Toledo;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;94,4
45 Toledo;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
45 Toledo;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
45 Toledo;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
45 Toledo;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
45 Toledo;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
45 Toledo;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
45 Toledo;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;91,41
45 Toledo;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
45 Toledo;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
45 Toledo;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
45 Toledo;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;90,87
45 Toledo;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
45 Toledo;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
45 Toledo;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
45 Toledo;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
45 Toledo;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
45 Toledo;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
45 Toledo;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;87,86
45 Toledo;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
45 Toledo;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
45 Toledo;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
45 Toledo;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;86,47
45 Toledo;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
45 Toledo;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
45 Toledo;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
45 Toledo;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
45 Toledo;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
45 Toledo;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
45 Toledo;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;84,1
45 Toledo;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
45 Toledo;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
45 Toledo;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
45 Toledo;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;83,32
45 Toledo;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
45 Toledo;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
45 Toledo;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
45 Toledo;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
45 Toledo;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
45 Toledo;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
46 Valencia/València;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
46 Valencia/València;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
46 Valencia/València;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
46 Valencia/València;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QI;172.514
46 Valencia/València;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
46 Valencia/València;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
46 Valencia/València;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
46 Valencia/València;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QI;169.530
46 Valencia/València;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
46 Valencia/València;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
46 Valencia/València;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
46 Valencia/València;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QI;171.654
46 Valencia/València;All ages;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
46 Valencia/València;All ages;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
46 Valencia/València;All ages;Cohort January 1;Total;Survival in the first trimester;2022QII;""
46 Valencia/València;All ages;Cohort January 1;Total;Survival in the first trimester;2022QI;166.365
46 Valencia/València;All ages;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
46 Valencia/València;All ages;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
46 Valencia/València;All ages;Cohort January 1;Total;Survival in the first trimester;2021QII;""
46 Valencia/València;All ages;Cohort January 1;Total;Survival in the first trimester;2021QI;164.674
46 Valencia/València;All ages;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
46 Valencia/València;All ages;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
46 Valencia/València;All ages;Cohort January 1;Total;Survival in the first trimester;2020QII;""
46 Valencia/València;All ages;Cohort January 1;Total;Survival in the first trimester;2020QI;160.451
46 Valencia/València;All ages;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
46 Valencia/València;All ages;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
46 Valencia/València;All ages;Cohort January 1;Total;Survival in the second trimester;2022QII;160.574
46 Valencia/València;All ages;Cohort January 1;Total;Survival in the second trimester;2022QI;""
46 Valencia/València;All ages;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
46 Valencia/València;All ages;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
46 Valencia/València;All ages;Cohort January 1;Total;Survival in the second trimester;2021QII;159.615
46 Valencia/València;All ages;Cohort January 1;Total;Survival in the second trimester;2021QI;""
46 Valencia/València;All ages;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
46 Valencia/València;All ages;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
46 Valencia/València;All ages;Cohort January 1;Total;Survival in the second trimester;2020QII;157.026
46 Valencia/València;All ages;Cohort January 1;Total;Survival in the second trimester;2020QI;""
46 Valencia/València;All ages;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
46 Valencia/València;All ages;Cohort January 1;Total;Survival in the third trimester;2022QIII;155.658
46 Valencia/València;All ages;Cohort January 1;Total;Survival in the third trimester;2022QII;""
46 Valencia/València;All ages;Cohort January 1;Total;Survival in the third trimester;2022QI;""
46 Valencia/València;All ages;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
46 Valencia/València;All ages;Cohort January 1;Total;Survival in the third trimester;2021QIII;155.161
46 Valencia/València;All ages;Cohort January 1;Total;Survival in the third trimester;2021QII;""
46 Valencia/València;All ages;Cohort January 1;Total;Survival in the third trimester;2021QI;""
46 Valencia/València;All ages;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
46 Valencia/València;All ages;Cohort January 1;Total;Survival in the third trimester;2020QIII;152.586
46 Valencia/València;All ages;Cohort January 1;Total;Survival in the third trimester;2020QII;""
46 Valencia/València;All ages;Cohort January 1;Total;Survival in the third trimester;2020QI;""
46 Valencia/València;All ages;Cohort January 1;Total;Survival in the third trimester;2022QIV;150.244
46 Valencia/València;All ages;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
46 Valencia/València;All ages;Cohort January 1;Total;Survival in the third trimester;2022QII;""
46 Valencia/València;All ages;Cohort January 1;Total;Survival in the third trimester;2022QI;""
46 Valencia/València;All ages;Cohort January 1;Total;Survival in the third trimester;2021QIV;150.538
46 Valencia/València;All ages;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
46 Valencia/València;All ages;Cohort January 1;Total;Survival in the third trimester;2021QII;""
46 Valencia/València;All ages;Cohort January 1;Total;Survival in the third trimester;2021QI;""
46 Valencia/València;All ages;Cohort January 1;Total;Survival in the third trimester;2020QIV;147.845
46 Valencia/València;All ages;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
46 Valencia/València;All ages;Cohort January 1;Total;Survival in the third trimester;2020QII;""
46 Valencia/València;All ages;Cohort January 1;Total;Survival in the third trimester;2020QI;""
46 Valencia/València;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
46 Valencia/València;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
46 Valencia/València;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
46 Valencia/València;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
46 Valencia/València;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
46 Valencia/València;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
46 Valencia/València;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
46 Valencia/València;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
46 Valencia/València;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
46 Valencia/València;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
46 Valencia/València;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
46 Valencia/València;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
46 Valencia/València;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
46 Valencia/València;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
46 Valencia/València;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
46 Valencia/València;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;96,44
46 Valencia/València;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
46 Valencia/València;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
46 Valencia/València;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
46 Valencia/València;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;97,14
46 Valencia/València;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
46 Valencia/València;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
46 Valencia/València;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
46 Valencia/València;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;93,47
46 Valencia/València;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
46 Valencia/València;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
46 Valencia/València;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;93,08
46 Valencia/València;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
46 Valencia/València;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
46 Valencia/València;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
46 Valencia/València;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;94,15
46 Valencia/València;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
46 Valencia/València;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
46 Valencia/València;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
46 Valencia/València;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;91,48
46 Valencia/València;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
46 Valencia/València;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
46 Valencia/València;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;90,23
46 Valencia/València;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
46 Valencia/València;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
46 Valencia/València;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
46 Valencia/València;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;91,52
46 Valencia/València;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
46 Valencia/València;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
46 Valencia/València;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
46 Valencia/València;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;88,89
46 Valencia/València;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
46 Valencia/València;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
46 Valencia/València;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;87,09
46 Valencia/València;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
46 Valencia/València;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
46 Valencia/València;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
46 Valencia/València;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;88,8
46 Valencia/València;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
46 Valencia/València;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
46 Valencia/València;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
46 Valencia/València;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;86,13
46 Valencia/València;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
46 Valencia/València;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
46 Valencia/València;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
46 Valencia/València;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
46 Valencia/València;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
46 Valencia/València;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
46 Valencia/València;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QI;108.266
46 Valencia/València;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
46 Valencia/València;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
46 Valencia/València;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
46 Valencia/València;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QI;106.833
46 Valencia/València;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
46 Valencia/València;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
46 Valencia/València;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
46 Valencia/València;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QI;107.932
46 Valencia/València;All ages;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
46 Valencia/València;All ages;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
46 Valencia/València;All ages;Cohort January 1;Males;Survival in the first trimester;2022QII;""
46 Valencia/València;All ages;Cohort January 1;Males;Survival in the first trimester;2022QI;104.582
46 Valencia/València;All ages;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
46 Valencia/València;All ages;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
46 Valencia/València;All ages;Cohort January 1;Males;Survival in the first trimester;2021QII;""
46 Valencia/València;All ages;Cohort January 1;Males;Survival in the first trimester;2021QI;103.837
46 Valencia/València;All ages;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
46 Valencia/València;All ages;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
46 Valencia/València;All ages;Cohort January 1;Males;Survival in the first trimester;2020QII;""
46 Valencia/València;All ages;Cohort January 1;Males;Survival in the first trimester;2020QI;101.376
46 Valencia/València;All ages;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
46 Valencia/València;All ages;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
46 Valencia/València;All ages;Cohort January 1;Males;Survival in the second trimester;2022QII;101.250
46 Valencia/València;All ages;Cohort January 1;Males;Survival in the second trimester;2022QI;""
46 Valencia/València;All ages;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
46 Valencia/València;All ages;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
46 Valencia/València;All ages;Cohort January 1;Males;Survival in the second trimester;2021QII;100.827
46 Valencia/València;All ages;Cohort January 1;Males;Survival in the second trimester;2021QI;""
46 Valencia/València;All ages;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
46 Valencia/València;All ages;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
46 Valencia/València;All ages;Cohort January 1;Males;Survival in the second trimester;2020QII;99.390
46 Valencia/València;All ages;Cohort January 1;Males;Survival in the second trimester;2020QI;""
46 Valencia/València;All ages;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
46 Valencia/València;All ages;Cohort January 1;Males;Survival in the third trimester;2022QIII;98.386
46 Valencia/València;All ages;Cohort January 1;Males;Survival in the third trimester;2022QII;""
46 Valencia/València;All ages;Cohort January 1;Males;Survival in the third trimester;2022QI;""
46 Valencia/València;All ages;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
46 Valencia/València;All ages;Cohort January 1;Males;Survival in the third trimester;2021QIII;98.217
46 Valencia/València;All ages;Cohort January 1;Males;Survival in the third trimester;2021QII;""
46 Valencia/València;All ages;Cohort January 1;Males;Survival in the third trimester;2021QI;""
46 Valencia/València;All ages;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
46 Valencia/València;All ages;Cohort January 1;Males;Survival in the third trimester;2020QIII;96.853
46 Valencia/València;All ages;Cohort January 1;Males;Survival in the third trimester;2020QII;""
46 Valencia/València;All ages;Cohort January 1;Males;Survival in the third trimester;2020QI;""
46 Valencia/València;All ages;Cohort January 1;Males;Survival in the third trimester;2022QIV;95.099
46 Valencia/València;All ages;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
46 Valencia/València;All ages;Cohort January 1;Males;Survival in the third trimester;2022QII;""
46 Valencia/València;All ages;Cohort January 1;Males;Survival in the third trimester;2022QI;""
46 Valencia/València;All ages;Cohort January 1;Males;Survival in the third trimester;2021QIV;95.450
46 Valencia/València;All ages;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
46 Valencia/València;All ages;Cohort January 1;Males;Survival in the third trimester;2021QII;""
46 Valencia/València;All ages;Cohort January 1;Males;Survival in the third trimester;2021QI;""
46 Valencia/València;All ages;Cohort January 1;Males;Survival in the third trimester;2020QIV;94.053
46 Valencia/València;All ages;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
46 Valencia/València;All ages;Cohort January 1;Males;Survival in the third trimester;2020QII;""
46 Valencia/València;All ages;Cohort January 1;Males;Survival in the third trimester;2020QI;""
46 Valencia/València;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
46 Valencia/València;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
46 Valencia/València;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
46 Valencia/València;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
46 Valencia/València;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
46 Valencia/València;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
46 Valencia/València;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
46 Valencia/València;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
46 Valencia/València;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
46 Valencia/València;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
46 Valencia/València;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
46 Valencia/València;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
46 Valencia/València;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
46 Valencia/València;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
46 Valencia/València;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
46 Valencia/València;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;96,6
46 Valencia/València;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
46 Valencia/València;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
46 Valencia/València;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
46 Valencia/València;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;97,2
46 Valencia/València;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
46 Valencia/València;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
46 Valencia/València;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
46 Valencia/València;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;93,93
46 Valencia/València;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
46 Valencia/València;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
46 Valencia/València;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;93,52
46 Valencia/València;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
46 Valencia/València;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
46 Valencia/València;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
46 Valencia/València;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;94,38
46 Valencia/València;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
46 Valencia/València;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
46 Valencia/València;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
46 Valencia/València;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;92,09
46 Valencia/València;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
46 Valencia/València;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
46 Valencia/València;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;90,87
46 Valencia/València;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
46 Valencia/València;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
46 Valencia/València;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
46 Valencia/València;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;91,94
46 Valencia/València;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
46 Valencia/València;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
46 Valencia/València;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
46 Valencia/València;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;89,74
46 Valencia/València;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
46 Valencia/València;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
46 Valencia/València;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;87,84
46 Valencia/València;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
46 Valencia/València;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
46 Valencia/València;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
46 Valencia/València;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;89,35
46 Valencia/València;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
46 Valencia/València;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
46 Valencia/València;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
46 Valencia/València;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;87,14
46 Valencia/València;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
46 Valencia/València;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
46 Valencia/València;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
46 Valencia/València;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
46 Valencia/València;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
46 Valencia/València;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
46 Valencia/València;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QI;64.248
46 Valencia/València;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
46 Valencia/València;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
46 Valencia/València;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
46 Valencia/València;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QI;62.697
46 Valencia/València;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
46 Valencia/València;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
46 Valencia/València;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
46 Valencia/València;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QI;63.722
46 Valencia/València;All ages;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
46 Valencia/València;All ages;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
46 Valencia/València;All ages;Cohort January 1;Females;Survival in the first trimester;2022QII;""
46 Valencia/València;All ages;Cohort January 1;Females;Survival in the first trimester;2022QI;61.783
46 Valencia/València;All ages;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
46 Valencia/València;All ages;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
46 Valencia/València;All ages;Cohort January 1;Females;Survival in the first trimester;2021QII;""
46 Valencia/València;All ages;Cohort January 1;Females;Survival in the first trimester;2021QI;60.837
46 Valencia/València;All ages;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
46 Valencia/València;All ages;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
46 Valencia/València;All ages;Cohort January 1;Females;Survival in the first trimester;2020QII;""
46 Valencia/València;All ages;Cohort January 1;Females;Survival in the first trimester;2020QI;59.075
46 Valencia/València;All ages;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
46 Valencia/València;All ages;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
46 Valencia/València;All ages;Cohort January 1;Females;Survival in the second trimester;2022QII;59.324
46 Valencia/València;All ages;Cohort January 1;Females;Survival in the second trimester;2022QI;""
46 Valencia/València;All ages;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
46 Valencia/València;All ages;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
46 Valencia/València;All ages;Cohort January 1;Females;Survival in the second trimester;2021QII;58.788
46 Valencia/València;All ages;Cohort January 1;Females;Survival in the second trimester;2021QI;""
46 Valencia/València;All ages;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
46 Valencia/València;All ages;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
46 Valencia/València;All ages;Cohort January 1;Females;Survival in the second trimester;2020QII;57.636
46 Valencia/València;All ages;Cohort January 1;Females;Survival in the second trimester;2020QI;""
46 Valencia/València;All ages;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
46 Valencia/València;All ages;Cohort January 1;Females;Survival in the third trimester;2022QIII;57.272
46 Valencia/València;All ages;Cohort January 1;Females;Survival in the third trimester;2022QII;""
46 Valencia/València;All ages;Cohort January 1;Females;Survival in the third trimester;2022QI;""
46 Valencia/València;All ages;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
46 Valencia/València;All ages;Cohort January 1;Females;Survival in the third trimester;2021QIII;56.944
46 Valencia/València;All ages;Cohort January 1;Females;Survival in the third trimester;2021QII;""
46 Valencia/València;All ages;Cohort January 1;Females;Survival in the third trimester;2021QI;""
46 Valencia/València;All ages;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
46 Valencia/València;All ages;Cohort January 1;Females;Survival in the third trimester;2020QIII;55.733
46 Valencia/València;All ages;Cohort January 1;Females;Survival in the third trimester;2020QII;""
46 Valencia/València;All ages;Cohort January 1;Females;Survival in the third trimester;2020QI;""
46 Valencia/València;All ages;Cohort January 1;Females;Survival in the third trimester;2022QIV;55.145
46 Valencia/València;All ages;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
46 Valencia/València;All ages;Cohort January 1;Females;Survival in the third trimester;2022QII;""
46 Valencia/València;All ages;Cohort January 1;Females;Survival in the third trimester;2022QI;""
46 Valencia/València;All ages;Cohort January 1;Females;Survival in the third trimester;2021QIV;55.088
46 Valencia/València;All ages;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
46 Valencia/València;All ages;Cohort January 1;Females;Survival in the third trimester;2021QII;""
46 Valencia/València;All ages;Cohort January 1;Females;Survival in the third trimester;2021QI;""
46 Valencia/València;All ages;Cohort January 1;Females;Survival in the third trimester;2020QIV;53.792
46 Valencia/València;All ages;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
46 Valencia/València;All ages;Cohort January 1;Females;Survival in the third trimester;2020QII;""
46 Valencia/València;All ages;Cohort January 1;Females;Survival in the third trimester;2020QI;""
46 Valencia/València;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
46 Valencia/València;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
46 Valencia/València;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
46 Valencia/València;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
46 Valencia/València;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
46 Valencia/València;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
46 Valencia/València;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
46 Valencia/València;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
46 Valencia/València;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
46 Valencia/València;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
46 Valencia/València;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
46 Valencia/València;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
46 Valencia/València;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
46 Valencia/València;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
46 Valencia/València;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
46 Valencia/València;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;96,16
46 Valencia/València;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
46 Valencia/València;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
46 Valencia/València;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
46 Valencia/València;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;97,03
46 Valencia/València;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
46 Valencia/València;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
46 Valencia/València;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
46 Valencia/València;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;92,71
46 Valencia/València;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
46 Valencia/València;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
46 Valencia/València;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;92,34
46 Valencia/València;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
46 Valencia/València;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
46 Valencia/València;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
46 Valencia/València;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;93,77
46 Valencia/València;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
46 Valencia/València;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
46 Valencia/València;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
46 Valencia/València;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;90,45
46 Valencia/València;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
46 Valencia/València;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
46 Valencia/València;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;89,14
46 Valencia/València;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
46 Valencia/València;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
46 Valencia/València;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
46 Valencia/València;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;90,82
46 Valencia/València;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
46 Valencia/València;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
46 Valencia/València;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
46 Valencia/València;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;87,46
46 Valencia/València;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
46 Valencia/València;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
46 Valencia/València;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;85,83
46 Valencia/València;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
46 Valencia/València;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
46 Valencia/València;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
46 Valencia/València;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;87,86
46 Valencia/València;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
46 Valencia/València;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
46 Valencia/València;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
46 Valencia/València;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;84,42
46 Valencia/València;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
46 Valencia/València;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
46 Valencia/València;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
46 Valencia/València;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
46 Valencia/València;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
46 Valencia/València;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QII;173.305
46 Valencia/València;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
46 Valencia/València;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
46 Valencia/València;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
46 Valencia/València;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QII;171.261
46 Valencia/València;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
46 Valencia/València;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
46 Valencia/València;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
46 Valencia/València;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QII;168.129
46 Valencia/València;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
46 Valencia/València;All ages;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
46 Valencia/València;All ages;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
46 Valencia/València;All ages;Cohort April 1;Total;Survival in the first trimester;2022QII;166.787
46 Valencia/València;All ages;Cohort April 1;Total;Survival in the first trimester;2022QI;""
46 Valencia/València;All ages;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
46 Valencia/València;All ages;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
46 Valencia/València;All ages;Cohort April 1;Total;Survival in the first trimester;2021QII;165.515
46 Valencia/València;All ages;Cohort April 1;Total;Survival in the first trimester;2021QI;""
46 Valencia/València;All ages;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
46 Valencia/València;All ages;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
46 Valencia/València;All ages;Cohort April 1;Total;Survival in the first trimester;2020QII;164.226
46 Valencia/València;All ages;Cohort April 1;Total;Survival in the first trimester;2020QI;""
46 Valencia/València;All ages;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
46 Valencia/València;All ages;Cohort April 1;Total;Survival in the second trimester;2022QIII;161.368
46 Valencia/València;All ages;Cohort April 1;Total;Survival in the second trimester;2022QII;""
46 Valencia/València;All ages;Cohort April 1;Total;Survival in the second trimester;2022QI;""
46 Valencia/València;All ages;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
46 Valencia/València;All ages;Cohort April 1;Total;Survival in the second trimester;2021QIII;160.509
46 Valencia/València;All ages;Cohort April 1;Total;Survival in the second trimester;2021QII;""
46 Valencia/València;All ages;Cohort April 1;Total;Survival in the second trimester;2021QI;""
46 Valencia/València;All ages;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
46 Valencia/València;All ages;Cohort April 1;Total;Survival in the second trimester;2020QIII;159.113
46 Valencia/València;All ages;Cohort April 1;Total;Survival in the second trimester;2020QII;""
46 Valencia/València;All ages;Cohort April 1;Total;Survival in the second trimester;2020QI;""
46 Valencia/València;All ages;Cohort April 1;Total;Survival in the third trimester;2022QIV;155.434
46 Valencia/València;All ages;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
46 Valencia/València;All ages;Cohort April 1;Total;Survival in the third trimester;2022QII;""
46 Valencia/València;All ages;Cohort April 1;Total;Survival in the third trimester;2022QI;""
46 Valencia/València;All ages;Cohort April 1;Total;Survival in the third trimester;2021QIV;155.406
46 Valencia/València;All ages;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
46 Valencia/València;All ages;Cohort April 1;Total;Survival in the third trimester;2021QII;""
46 Valencia/València;All ages;Cohort April 1;Total;Survival in the third trimester;2021QI;""
46 Valencia/València;All ages;Cohort April 1;Total;Survival in the third trimester;2020QIV;153.843
46 Valencia/València;All ages;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
46 Valencia/València;All ages;Cohort April 1;Total;Survival in the third trimester;2020QII;""
46 Valencia/València;All ages;Cohort April 1;Total;Survival in the third trimester;2020QI;""
46 Valencia/València;All ages;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
46 Valencia/València;All ages;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
46 Valencia/València;All ages;Cohort April 1;Total;Survival in the third trimester;2022QII;""
46 Valencia/València;All ages;Cohort April 1;Total;Survival in the third trimester;2022QI;150.777
46 Valencia/València;All ages;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
46 Valencia/València;All ages;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
46 Valencia/València;All ages;Cohort April 1;Total;Survival in the third trimester;2021QII;""
46 Valencia/València;All ages;Cohort April 1;Total;Survival in the third trimester;2021QI;150.254
46 Valencia/València;All ages;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
46 Valencia/València;All ages;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
46 Valencia/València;All ages;Cohort April 1;Total;Survival in the third trimester;2020QII;""
46 Valencia/València;All ages;Cohort April 1;Total;Survival in the third trimester;2020QI;""
46 Valencia/València;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
46 Valencia/València;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
46 Valencia/València;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
46 Valencia/València;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
46 Valencia/València;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
46 Valencia/València;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
46 Valencia/València;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
46 Valencia/València;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
46 Valencia/València;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
46 Valencia/València;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
46 Valencia/València;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
46 Valencia/València;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
46 Valencia/València;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
46 Valencia/València;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
46 Valencia/València;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;96,24
46 Valencia/València;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
46 Valencia/València;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
46 Valencia/València;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
46 Valencia/València;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;96,64
46 Valencia/València;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
46 Valencia/València;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
46 Valencia/València;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
46 Valencia/València;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;97,68
46 Valencia/València;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
46 Valencia/València;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
46 Valencia/València;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;93,11
46 Valencia/València;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
46 Valencia/València;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
46 Valencia/València;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
46 Valencia/València;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;93,72
46 Valencia/València;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
46 Valencia/València;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
46 Valencia/València;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
46 Valencia/València;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;94,64
46 Valencia/València;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
46 Valencia/València;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
46 Valencia/València;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;89,69
46 Valencia/València;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
46 Valencia/València;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
46 Valencia/València;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
46 Valencia/València;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;90,74
46 Valencia/València;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
46 Valencia/València;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
46 Valencia/València;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
46 Valencia/València;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;91,5
46 Valencia/València;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
46 Valencia/València;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
46 Valencia/València;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
46 Valencia/València;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
46 Valencia/València;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
46 Valencia/València;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
46 Valencia/València;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;88,04
46 Valencia/València;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
46 Valencia/València;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
46 Valencia/València;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
46 Valencia/València;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;89,37
46 Valencia/València;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
46 Valencia/València;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
46 Valencia/València;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
46 Valencia/València;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
46 Valencia/València;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
46 Valencia/València;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
46 Valencia/València;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QII;108.639
46 Valencia/València;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
46 Valencia/València;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
46 Valencia/València;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
46 Valencia/València;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QII;107.772
46 Valencia/València;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
46 Valencia/València;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
46 Valencia/València;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
46 Valencia/València;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QII;105.913
46 Valencia/València;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
46 Valencia/València;All ages;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
46 Valencia/València;All ages;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
46 Valencia/València;All ages;Cohort April 1;Males;Survival in the first trimester;2022QII;104.896
46 Valencia/València;All ages;Cohort April 1;Males;Survival in the first trimester;2022QI;""
46 Valencia/València;All ages;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
46 Valencia/València;All ages;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
46 Valencia/València;All ages;Cohort April 1;Males;Survival in the first trimester;2021QII;104.330
46 Valencia/València;All ages;Cohort April 1;Males;Survival in the first trimester;2021QI;""
46 Valencia/València;All ages;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
46 Valencia/València;All ages;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
46 Valencia/València;All ages;Cohort April 1;Males;Survival in the first trimester;2020QII;103.677
46 Valencia/València;All ages;Cohort April 1;Males;Survival in the first trimester;2020QI;""
46 Valencia/València;All ages;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
46 Valencia/València;All ages;Cohort April 1;Males;Survival in the second trimester;2022QIII;101.740
46 Valencia/València;All ages;Cohort April 1;Males;Survival in the second trimester;2022QII;""
46 Valencia/València;All ages;Cohort April 1;Males;Survival in the second trimester;2022QI;""
46 Valencia/València;All ages;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
46 Valencia/València;All ages;Cohort April 1;Males;Survival in the second trimester;2021QIII;101.380
46 Valencia/València;All ages;Cohort April 1;Males;Survival in the second trimester;2021QII;""
46 Valencia/València;All ages;Cohort April 1;Males;Survival in the second trimester;2021QI;""
46 Valencia/València;All ages;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
46 Valencia/València;All ages;Cohort April 1;Males;Survival in the second trimester;2020QIII;100.716
46 Valencia/València;All ages;Cohort April 1;Males;Survival in the second trimester;2020QII;""
46 Valencia/València;All ages;Cohort April 1;Males;Survival in the second trimester;2020QI;""
46 Valencia/València;All ages;Cohort April 1;Males;Survival in the third trimester;2022QIV;98.129
46 Valencia/València;All ages;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
46 Valencia/València;All ages;Cohort April 1;Males;Survival in the third trimester;2022QII;""
46 Valencia/València;All ages;Cohort April 1;Males;Survival in the third trimester;2022QI;""
46 Valencia/València;All ages;Cohort April 1;Males;Survival in the third trimester;2021QIV;98.328
46 Valencia/València;All ages;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
46 Valencia/València;All ages;Cohort April 1;Males;Survival in the third trimester;2021QII;""
46 Valencia/València;All ages;Cohort April 1;Males;Survival in the third trimester;2021QI;""
46 Valencia/València;All ages;Cohort April 1;Males;Survival in the third trimester;2020QIV;97.583
46 Valencia/València;All ages;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
46 Valencia/València;All ages;Cohort April 1;Males;Survival in the third trimester;2020QII;""
46 Valencia/València;All ages;Cohort April 1;Males;Survival in the third trimester;2020QI;""
46 Valencia/València;All ages;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
46 Valencia/València;All ages;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
46 Valencia/València;All ages;Cohort April 1;Males;Survival in the third trimester;2022QII;""
46 Valencia/València;All ages;Cohort April 1;Males;Survival in the third trimester;2022QI;95.583
46 Valencia/València;All ages;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
46 Valencia/València;All ages;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
46 Valencia/València;All ages;Cohort April 1;Males;Survival in the third trimester;2021QII;""
46 Valencia/València;All ages;Cohort April 1;Males;Survival in the third trimester;2021QI;95.369
46 Valencia/València;All ages;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
46 Valencia/València;All ages;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
46 Valencia/València;All ages;Cohort April 1;Males;Survival in the third trimester;2020QII;""
46 Valencia/València;All ages;Cohort April 1;Males;Survival in the third trimester;2020QI;""
46 Valencia/València;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
46 Valencia/València;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
46 Valencia/València;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
46 Valencia/València;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
46 Valencia/València;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
46 Valencia/València;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
46 Valencia/València;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
46 Valencia/València;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
46 Valencia/València;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
46 Valencia/València;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
46 Valencia/València;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
46 Valencia/València;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
46 Valencia/València;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
46 Valencia/València;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
46 Valencia/València;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;96,55
46 Valencia/València;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
46 Valencia/València;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
46 Valencia/València;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
46 Valencia/València;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;96,81
46 Valencia/València;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
46 Valencia/València;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
46 Valencia/València;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
46 Valencia/València;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;97,89
46 Valencia/València;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
46 Valencia/València;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
46 Valencia/València;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;93,65
46 Valencia/València;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
46 Valencia/València;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
46 Valencia/València;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
46 Valencia/València;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;94,07
46 Valencia/València;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
46 Valencia/València;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
46 Valencia/València;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
46 Valencia/València;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;95,09
46 Valencia/València;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
46 Valencia/València;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
46 Valencia/València;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;90,33
46 Valencia/València;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
46 Valencia/València;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
46 Valencia/València;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
46 Valencia/València;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;91,24
46 Valencia/València;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
46 Valencia/València;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
46 Valencia/València;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
46 Valencia/València;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;92,14
46 Valencia/València;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
46 Valencia/València;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
46 Valencia/València;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
46 Valencia/València;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
46 Valencia/València;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
46 Valencia/València;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
46 Valencia/València;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;88,69
46 Valencia/València;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
46 Valencia/València;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
46 Valencia/València;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
46 Valencia/València;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;90,04
46 Valencia/València;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
46 Valencia/València;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
46 Valencia/València;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
46 Valencia/València;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
46 Valencia/València;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
46 Valencia/València;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
46 Valencia/València;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QII;64.666
46 Valencia/València;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
46 Valencia/València;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
46 Valencia/València;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
46 Valencia/València;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QII;63.489
46 Valencia/València;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
46 Valencia/València;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
46 Valencia/València;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
46 Valencia/València;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QII;62.216
46 Valencia/València;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
46 Valencia/València;All ages;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
46 Valencia/València;All ages;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
46 Valencia/València;All ages;Cohort April 1;Females;Survival in the first trimester;2022QII;61.891
46 Valencia/València;All ages;Cohort April 1;Females;Survival in the first trimester;2022QI;""
46 Valencia/València;All ages;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
46 Valencia/València;All ages;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
46 Valencia/València;All ages;Cohort April 1;Females;Survival in the first trimester;2021QII;61.185
46 Valencia/València;All ages;Cohort April 1;Females;Survival in the first trimester;2021QI;""
46 Valencia/València;All ages;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
46 Valencia/València;All ages;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
46 Valencia/València;All ages;Cohort April 1;Females;Survival in the first trimester;2020QII;60.549
46 Valencia/València;All ages;Cohort April 1;Females;Survival in the first trimester;2020QI;""
46 Valencia/València;All ages;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
46 Valencia/València;All ages;Cohort April 1;Females;Survival in the second trimester;2022QIII;59.628
46 Valencia/València;All ages;Cohort April 1;Females;Survival in the second trimester;2022QII;""
46 Valencia/València;All ages;Cohort April 1;Females;Survival in the second trimester;2022QI;""
46 Valencia/València;All ages;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
46 Valencia/València;All ages;Cohort April 1;Females;Survival in the second trimester;2021QIII;59.129
46 Valencia/València;All ages;Cohort April 1;Females;Survival in the second trimester;2021QII;""
46 Valencia/València;All ages;Cohort April 1;Females;Survival in the second trimester;2021QI;""
46 Valencia/València;All ages;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
46 Valencia/València;All ages;Cohort April 1;Females;Survival in the second trimester;2020QIII;58.397
46 Valencia/València;All ages;Cohort April 1;Females;Survival in the second trimester;2020QII;""
46 Valencia/València;All ages;Cohort April 1;Females;Survival in the second trimester;2020QI;""
46 Valencia/València;All ages;Cohort April 1;Females;Survival in the third trimester;2022QIV;57.305
46 Valencia/València;All ages;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
46 Valencia/València;All ages;Cohort April 1;Females;Survival in the third trimester;2022QII;""
46 Valencia/València;All ages;Cohort April 1;Females;Survival in the third trimester;2022QI;""
46 Valencia/València;All ages;Cohort April 1;Females;Survival in the third trimester;2021QIV;57.078
46 Valencia/València;All ages;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
46 Valencia/València;All ages;Cohort April 1;Females;Survival in the third trimester;2021QII;""
46 Valencia/València;All ages;Cohort April 1;Females;Survival in the third trimester;2021QI;""
46 Valencia/València;All ages;Cohort April 1;Females;Survival in the third trimester;2020QIV;56.260
46 Valencia/València;All ages;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
46 Valencia/València;All ages;Cohort April 1;Females;Survival in the third trimester;2020QII;""
46 Valencia/València;All ages;Cohort April 1;Females;Survival in the third trimester;2020QI;""
46 Valencia/València;All ages;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
46 Valencia/València;All ages;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
46 Valencia/València;All ages;Cohort April 1;Females;Survival in the third trimester;2022QII;""
46 Valencia/València;All ages;Cohort April 1;Females;Survival in the third trimester;2022QI;55.194
46 Valencia/València;All ages;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
46 Valencia/València;All ages;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
46 Valencia/València;All ages;Cohort April 1;Females;Survival in the third trimester;2021QII;""
46 Valencia/València;All ages;Cohort April 1;Females;Survival in the third trimester;2021QI;54.885
46 Valencia/València;All ages;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
46 Valencia/València;All ages;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
46 Valencia/València;All ages;Cohort April 1;Females;Survival in the third trimester;2020QII;""
46 Valencia/València;All ages;Cohort April 1;Females;Survival in the third trimester;2020QI;""
46 Valencia/València;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
46 Valencia/València;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
46 Valencia/València;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
46 Valencia/València;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
46 Valencia/València;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
46 Valencia/València;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
46 Valencia/València;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
46 Valencia/València;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
46 Valencia/València;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
46 Valencia/València;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
46 Valencia/València;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
46 Valencia/València;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
46 Valencia/València;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
46 Valencia/València;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
46 Valencia/València;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;95,71
46 Valencia/València;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
46 Valencia/València;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
46 Valencia/València;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
46 Valencia/València;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;96,37
46 Valencia/València;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
46 Valencia/València;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
46 Valencia/València;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
46 Valencia/València;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;97,32
46 Valencia/València;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
46 Valencia/València;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
46 Valencia/València;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;92,21
46 Valencia/València;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
46 Valencia/València;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
46 Valencia/València;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
46 Valencia/València;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;93,13
46 Valencia/València;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
46 Valencia/València;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
46 Valencia/València;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
46 Valencia/València;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;93,86
46 Valencia/València;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
46 Valencia/València;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
46 Valencia/València;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;88,62
46 Valencia/València;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
46 Valencia/València;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
46 Valencia/València;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
46 Valencia/València;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;89,9
46 Valencia/València;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
46 Valencia/València;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
46 Valencia/València;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
46 Valencia/València;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;90,43
46 Valencia/València;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
46 Valencia/València;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
46 Valencia/València;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
46 Valencia/València;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
46 Valencia/València;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
46 Valencia/València;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
46 Valencia/València;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;86,93
46 Valencia/València;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
46 Valencia/València;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
46 Valencia/València;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
46 Valencia/València;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;88,22
46 Valencia/València;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
46 Valencia/València;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
46 Valencia/València;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
46 Valencia/València;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
46 Valencia/València;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
46 Valencia/València;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QIII;173.708
46 Valencia/València;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
46 Valencia/València;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
46 Valencia/València;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
46 Valencia/València;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QIII;172.473
46 Valencia/València;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
46 Valencia/València;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
46 Valencia/València;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
46 Valencia/València;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QIII;169.413
46 Valencia/València;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
46 Valencia/València;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
46 Valencia/València;All ages;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
46 Valencia/València;All ages;Cohort July 1;Total;Survival in the first trimester;2022QIII;167.210
46 Valencia/València;All ages;Cohort July 1;Total;Survival in the first trimester;2022QII;""
46 Valencia/València;All ages;Cohort July 1;Total;Survival in the first trimester;2022QI;""
46 Valencia/València;All ages;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
46 Valencia/València;All ages;Cohort July 1;Total;Survival in the first trimester;2021QIII;166.361
46 Valencia/València;All ages;Cohort July 1;Total;Survival in the first trimester;2021QII;""
46 Valencia/València;All ages;Cohort July 1;Total;Survival in the first trimester;2021QI;""
46 Valencia/València;All ages;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
46 Valencia/València;All ages;Cohort July 1;Total;Survival in the first trimester;2020QIII;163.464
46 Valencia/València;All ages;Cohort July 1;Total;Survival in the first trimester;2020QII;""
46 Valencia/València;All ages;Cohort July 1;Total;Survival in the first trimester;2020QI;""
46 Valencia/València;All ages;Cohort July 1;Total;Survival in the second trimester;2022QIV;160.640
46 Valencia/València;All ages;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
46 Valencia/València;All ages;Cohort July 1;Total;Survival in the second trimester;2022QII;""
46 Valencia/València;All ages;Cohort July 1;Total;Survival in the second trimester;2022QI;""
46 Valencia/València;All ages;Cohort July 1;Total;Survival in the second trimester;2021QIV;160.633
46 Valencia/València;All ages;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
46 Valencia/València;All ages;Cohort July 1;Total;Survival in the second trimester;2021QII;""
46 Valencia/València;All ages;Cohort July 1;Total;Survival in the second trimester;2021QI;""
46 Valencia/València;All ages;Cohort July 1;Total;Survival in the second trimester;2020QIV;157.713
46 Valencia/València;All ages;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
46 Valencia/València;All ages;Cohort July 1;Total;Survival in the second trimester;2020QII;""
46 Valencia/València;All ages;Cohort July 1;Total;Survival in the second trimester;2020QI;""
46 Valencia/València;All ages;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
46 Valencia/València;All ages;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
46 Valencia/València;All ages;Cohort July 1;Total;Survival in the third trimester;2022QII;""
46 Valencia/València;All ages;Cohort July 1;Total;Survival in the third trimester;2022QI;155.581
46 Valencia/València;All ages;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
46 Valencia/València;All ages;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
46 Valencia/València;All ages;Cohort July 1;Total;Survival in the third trimester;2021QII;""
46 Valencia/València;All ages;Cohort July 1;Total;Survival in the third trimester;2021QI;153.891
46 Valencia/València;All ages;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
46 Valencia/València;All ages;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
46 Valencia/València;All ages;Cohort July 1;Total;Survival in the third trimester;2020QII;""
46 Valencia/València;All ages;Cohort July 1;Total;Survival in the third trimester;2020QI;""
46 Valencia/València;All ages;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
46 Valencia/València;All ages;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
46 Valencia/València;All ages;Cohort July 1;Total;Survival in the third trimester;2022QII;150.914
46 Valencia/València;All ages;Cohort July 1;Total;Survival in the third trimester;2022QI;""
46 Valencia/València;All ages;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
46 Valencia/València;All ages;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
46 Valencia/València;All ages;Cohort July 1;Total;Survival in the third trimester;2021QII;149.939
46 Valencia/València;All ages;Cohort July 1;Total;Survival in the third trimester;2021QI;""
46 Valencia/València;All ages;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
46 Valencia/València;All ages;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
46 Valencia/València;All ages;Cohort July 1;Total;Survival in the third trimester;2020QII;""
46 Valencia/València;All ages;Cohort July 1;Total;Survival in the third trimester;2020QI;""
46 Valencia/València;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
46 Valencia/València;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
46 Valencia/València;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
46 Valencia/València;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
46 Valencia/València;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
46 Valencia/València;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
46 Valencia/València;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
46 Valencia/València;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
46 Valencia/València;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
46 Valencia/València;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
46 Valencia/València;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
46 Valencia/València;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
46 Valencia/València;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
46 Valencia/València;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;96,26
46 Valencia/València;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
46 Valencia/València;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
46 Valencia/València;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
46 Valencia/València;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;96,46
46 Valencia/València;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
46 Valencia/València;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
46 Valencia/València;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
46 Valencia/València;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;96,49
46 Valencia/València;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
46 Valencia/València;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
46 Valencia/València;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;92,48
46 Valencia/València;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
46 Valencia/València;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
46 Valencia/València;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
46 Valencia/València;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;93,14
46 Valencia/València;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
46 Valencia/València;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
46 Valencia/València;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
46 Valencia/València;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;93,09
46 Valencia/València;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
46 Valencia/València;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
46 Valencia/València;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
46 Valencia/València;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
46 Valencia/València;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
46 Valencia/València;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
46 Valencia/València;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;90,21
46 Valencia/València;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
46 Valencia/València;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
46 Valencia/València;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
46 Valencia/València;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;90,84
46 Valencia/València;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
46 Valencia/València;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
46 Valencia/València;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
46 Valencia/València;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
46 Valencia/València;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
46 Valencia/València;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
46 Valencia/València;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;87,5
46 Valencia/València;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
46 Valencia/València;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
46 Valencia/València;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
46 Valencia/València;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;88,51
46 Valencia/València;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
46 Valencia/València;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
46 Valencia/València;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
46 Valencia/València;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
46 Valencia/València;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
46 Valencia/València;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
46 Valencia/València;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QIII;108.903
46 Valencia/València;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
46 Valencia/València;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
46 Valencia/València;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
46 Valencia/València;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QIII;108.425
46 Valencia/València;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
46 Valencia/València;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
46 Valencia/València;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
46 Valencia/València;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QIII;106.889
46 Valencia/València;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
46 Valencia/València;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
46 Valencia/València;All ages;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
46 Valencia/València;All ages;Cohort July 1;Males;Survival in the first trimester;2022QIII;105.118
46 Valencia/València;All ages;Cohort July 1;Males;Survival in the first trimester;2022QII;""
46 Valencia/València;All ages;Cohort July 1;Males;Survival in the first trimester;2022QI;""
46 Valencia/València;All ages;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
46 Valencia/València;All ages;Cohort July 1;Males;Survival in the first trimester;2021QIII;104.824
46 Valencia/València;All ages;Cohort July 1;Males;Survival in the first trimester;2021QII;""
46 Valencia/València;All ages;Cohort July 1;Males;Survival in the first trimester;2021QI;""
46 Valencia/València;All ages;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
46 Valencia/València;All ages;Cohort July 1;Males;Survival in the first trimester;2020QIII;103.415
46 Valencia/València;All ages;Cohort July 1;Males;Survival in the first trimester;2020QII;""
46 Valencia/València;All ages;Cohort July 1;Males;Survival in the first trimester;2020QI;""
46 Valencia/València;All ages;Cohort July 1;Males;Survival in the second trimester;2022QIV;101.116
46 Valencia/València;All ages;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
46 Valencia/València;All ages;Cohort July 1;Males;Survival in the second trimester;2022QII;""
46 Valencia/València;All ages;Cohort July 1;Males;Survival in the second trimester;2022QI;""
46 Valencia/València;All ages;Cohort July 1;Males;Survival in the second trimester;2021QIV;101.417
46 Valencia/València;All ages;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
46 Valencia/València;All ages;Cohort July 1;Males;Survival in the second trimester;2021QII;""
46 Valencia/València;All ages;Cohort July 1;Males;Survival in the second trimester;2021QI;""
46 Valencia/València;All ages;Cohort July 1;Males;Survival in the second trimester;2020QIV;99.975
46 Valencia/València;All ages;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
46 Valencia/València;All ages;Cohort July 1;Males;Survival in the second trimester;2020QII;""
46 Valencia/València;All ages;Cohort July 1;Males;Survival in the second trimester;2020QI;""
46 Valencia/València;All ages;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
46 Valencia/València;All ages;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
46 Valencia/València;All ages;Cohort July 1;Males;Survival in the third trimester;2022QII;""
46 Valencia/València;All ages;Cohort July 1;Males;Survival in the third trimester;2022QI;98.418
46 Valencia/València;All ages;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
46 Valencia/València;All ages;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
46 Valencia/València;All ages;Cohort July 1;Males;Survival in the third trimester;2021QII;""
46 Valencia/València;All ages;Cohort July 1;Males;Survival in the third trimester;2021QI;97.619
46 Valencia/València;All ages;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
46 Valencia/València;All ages;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
46 Valencia/València;All ages;Cohort July 1;Males;Survival in the third trimester;2020QII;""
46 Valencia/València;All ages;Cohort July 1;Males;Survival in the third trimester;2020QI;""
46 Valencia/València;All ages;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
46 Valencia/València;All ages;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
46 Valencia/València;All ages;Cohort July 1;Males;Survival in the third trimester;2022QII;95.724
46 Valencia/València;All ages;Cohort July 1;Males;Survival in the third trimester;2022QI;""
46 Valencia/València;All ages;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
46 Valencia/València;All ages;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
46 Valencia/València;All ages;Cohort July 1;Males;Survival in the third trimester;2021QII;95.292
46 Valencia/València;All ages;Cohort July 1;Males;Survival in the third trimester;2021QI;""
46 Valencia/València;All ages;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
46 Valencia/València;All ages;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
46 Valencia/València;All ages;Cohort July 1;Males;Survival in the third trimester;2020QII;""
46 Valencia/València;All ages;Cohort July 1;Males;Survival in the third trimester;2020QI;""
46 Valencia/València;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
46 Valencia/València;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
46 Valencia/València;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
46 Valencia/València;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
46 Valencia/València;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
46 Valencia/València;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
46 Valencia/València;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
46 Valencia/València;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
46 Valencia/València;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
46 Valencia/València;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
46 Valencia/València;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
46 Valencia/València;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
46 Valencia/València;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
46 Valencia/València;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;96,52
46 Valencia/València;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
46 Valencia/València;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
46 Valencia/València;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
46 Valencia/València;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;96,68
46 Valencia/València;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
46 Valencia/València;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
46 Valencia/València;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
46 Valencia/València;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;96,75
46 Valencia/València;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
46 Valencia/València;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
46 Valencia/València;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;92,85
46 Valencia/València;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
46 Valencia/València;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
46 Valencia/València;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
46 Valencia/València;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;93,54
46 Valencia/València;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
46 Valencia/València;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
46 Valencia/València;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
46 Valencia/València;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;93,53
46 Valencia/València;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
46 Valencia/València;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
46 Valencia/València;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
46 Valencia/València;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
46 Valencia/València;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
46 Valencia/València;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
46 Valencia/València;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;90,77
46 Valencia/València;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
46 Valencia/València;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
46 Valencia/València;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
46 Valencia/València;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;91,33
46 Valencia/València;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
46 Valencia/València;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
46 Valencia/València;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
46 Valencia/València;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
46 Valencia/València;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
46 Valencia/València;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
46 Valencia/València;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;88,29
46 Valencia/València;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
46 Valencia/València;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
46 Valencia/València;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
46 Valencia/València;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;89,15
46 Valencia/València;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
46 Valencia/València;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
46 Valencia/València;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
46 Valencia/València;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
46 Valencia/València;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
46 Valencia/València;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
46 Valencia/València;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QIII;64.805
46 Valencia/València;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
46 Valencia/València;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
46 Valencia/València;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
46 Valencia/València;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QIII;64.048
46 Valencia/València;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
46 Valencia/València;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
46 Valencia/València;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
46 Valencia/València;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QIII;62.524
46 Valencia/València;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
46 Valencia/València;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
46 Valencia/València;All ages;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
46 Valencia/València;All ages;Cohort July 1;Females;Survival in the first trimester;2022QIII;62.092
46 Valencia/València;All ages;Cohort July 1;Females;Survival in the first trimester;2022QII;""
46 Valencia/València;All ages;Cohort July 1;Females;Survival in the first trimester;2022QI;""
46 Valencia/València;All ages;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
46 Valencia/València;All ages;Cohort July 1;Females;Survival in the first trimester;2021QIII;61.537
46 Valencia/València;All ages;Cohort July 1;Females;Survival in the first trimester;2021QII;""
46 Valencia/València;All ages;Cohort July 1;Females;Survival in the first trimester;2021QI;""
46 Valencia/València;All ages;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
46 Valencia/València;All ages;Cohort July 1;Females;Survival in the first trimester;2020QIII;60.049
46 Valencia/València;All ages;Cohort July 1;Females;Survival in the first trimester;2020QII;""
46 Valencia/València;All ages;Cohort July 1;Females;Survival in the first trimester;2020QI;""
46 Valencia/València;All ages;Cohort July 1;Females;Survival in the second trimester;2022QIV;59.524
46 Valencia/València;All ages;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
46 Valencia/València;All ages;Cohort July 1;Females;Survival in the second trimester;2022QII;""
46 Valencia/València;All ages;Cohort July 1;Females;Survival in the second trimester;2022QI;""
46 Valencia/València;All ages;Cohort July 1;Females;Survival in the second trimester;2021QIV;59.216
46 Valencia/València;All ages;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
46 Valencia/València;All ages;Cohort July 1;Females;Survival in the second trimester;2021QII;""
46 Valencia/València;All ages;Cohort July 1;Females;Survival in the second trimester;2021QI;""
46 Valencia/València;All ages;Cohort July 1;Females;Survival in the second trimester;2020QIV;57.738
46 Valencia/València;All ages;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
46 Valencia/València;All ages;Cohort July 1;Females;Survival in the second trimester;2020QII;""
46 Valencia/València;All ages;Cohort July 1;Females;Survival in the second trimester;2020QI;""
46 Valencia/València;All ages;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
46 Valencia/València;All ages;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
46 Valencia/València;All ages;Cohort July 1;Females;Survival in the third trimester;2022QII;""
46 Valencia/València;All ages;Cohort July 1;Females;Survival in the third trimester;2022QI;57.163
46 Valencia/València;All ages;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
46 Valencia/València;All ages;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
46 Valencia/València;All ages;Cohort July 1;Females;Survival in the third trimester;2021QII;""
46 Valencia/València;All ages;Cohort July 1;Females;Survival in the third trimester;2021QI;56.272
46 Valencia/València;All ages;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
46 Valencia/València;All ages;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
46 Valencia/València;All ages;Cohort July 1;Females;Survival in the third trimester;2020QII;""
46 Valencia/València;All ages;Cohort July 1;Females;Survival in the third trimester;2020QI;""
46 Valencia/València;All ages;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
46 Valencia/València;All ages;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
46 Valencia/València;All ages;Cohort July 1;Females;Survival in the third trimester;2022QII;55.190
46 Valencia/València;All ages;Cohort July 1;Females;Survival in the third trimester;2022QI;""
46 Valencia/València;All ages;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
46 Valencia/València;All ages;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
46 Valencia/València;All ages;Cohort July 1;Females;Survival in the third trimester;2021QII;54.647
46 Valencia/València;All ages;Cohort July 1;Females;Survival in the third trimester;2021QI;""
46 Valencia/València;All ages;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
46 Valencia/València;All ages;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
46 Valencia/València;All ages;Cohort July 1;Females;Survival in the third trimester;2020QII;""
46 Valencia/València;All ages;Cohort July 1;Females;Survival in the third trimester;2020QI;""
46 Valencia/València;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
46 Valencia/València;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
46 Valencia/València;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
46 Valencia/València;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
46 Valencia/València;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
46 Valencia/València;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
46 Valencia/València;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
46 Valencia/València;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
46 Valencia/València;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
46 Valencia/València;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
46 Valencia/València;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
46 Valencia/València;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
46 Valencia/València;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
46 Valencia/València;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;95,81
46 Valencia/València;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
46 Valencia/València;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
46 Valencia/València;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
46 Valencia/València;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;96,08
46 Valencia/València;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
46 Valencia/València;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
46 Valencia/València;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
46 Valencia/València;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;96,04
46 Valencia/València;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
46 Valencia/València;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
46 Valencia/València;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;91,85
46 Valencia/València;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
46 Valencia/València;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
46 Valencia/València;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
46 Valencia/València;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;92,46
46 Valencia/València;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
46 Valencia/València;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
46 Valencia/València;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
46 Valencia/València;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;92,35
46 Valencia/València;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
46 Valencia/València;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
46 Valencia/València;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
46 Valencia/València;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
46 Valencia/València;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
46 Valencia/València;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
46 Valencia/València;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;89,25
46 Valencia/València;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
46 Valencia/València;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
46 Valencia/València;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
46 Valencia/València;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;90
46 Valencia/València;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
46 Valencia/València;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
46 Valencia/València;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
46 Valencia/València;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
46 Valencia/València;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
46 Valencia/València;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
46 Valencia/València;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;86,17
46 Valencia/València;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
46 Valencia/València;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
46 Valencia/València;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
46 Valencia/València;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;87,4
46 Valencia/València;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
46 Valencia/València;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
46 Valencia/València;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
46 Valencia/València;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
46 Valencia/València;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
46 Valencia/València;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QIV;172.940
46 Valencia/València;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
46 Valencia/València;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
46 Valencia/València;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
46 Valencia/València;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QIV;172.090
46 Valencia/València;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
46 Valencia/València;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
46 Valencia/València;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
46 Valencia/València;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QIV;169.526
46 Valencia/València;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
46 Valencia/València;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
46 Valencia/València;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
46 Valencia/València;All ages;Cohort October 1;Total;Survival in the first trimester;2022QIV;165.735
46 Valencia/València;All ages;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
46 Valencia/València;All ages;Cohort October 1;Total;Survival in the first trimester;2022QII;""
46 Valencia/València;All ages;Cohort October 1;Total;Survival in the first trimester;2022QI;""
46 Valencia/València;All ages;Cohort October 1;Total;Survival in the first trimester;2021QIV;165.672
46 Valencia/València;All ages;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
46 Valencia/València;All ages;Cohort October 1;Total;Survival in the first trimester;2021QII;""
46 Valencia/València;All ages;Cohort October 1;Total;Survival in the first trimester;2021QI;""
46 Valencia/València;All ages;Cohort October 1;Total;Survival in the first trimester;2020QIV;163.038
46 Valencia/València;All ages;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
46 Valencia/València;All ages;Cohort October 1;Total;Survival in the first trimester;2020QII;""
46 Valencia/València;All ages;Cohort October 1;Total;Survival in the first trimester;2020QI;""
46 Valencia/València;All ages;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
46 Valencia/València;All ages;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
46 Valencia/València;All ages;Cohort October 1;Total;Survival in the second trimester;2022QII;""
46 Valencia/València;All ages;Cohort October 1;Total;Survival in the second trimester;2022QI;160.216
46 Valencia/València;All ages;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
46 Valencia/València;All ages;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
46 Valencia/València;All ages;Cohort October 1;Total;Survival in the second trimester;2021QII;""
46 Valencia/València;All ages;Cohort October 1;Total;Survival in the second trimester;2021QI;158.832
46 Valencia/València;All ages;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
46 Valencia/València;All ages;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
46 Valencia/València;All ages;Cohort October 1;Total;Survival in the second trimester;2020QII;""
46 Valencia/València;All ages;Cohort October 1;Total;Survival in the second trimester;2020QI;""
46 Valencia/València;All ages;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
46 Valencia/València;All ages;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
46 Valencia/València;All ages;Cohort October 1;Total;Survival in the third trimester;2022QII;155.093
46 Valencia/València;All ages;Cohort October 1;Total;Survival in the third trimester;2022QI;""
46 Valencia/València;All ages;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
46 Valencia/València;All ages;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
46 Valencia/València;All ages;Cohort October 1;Total;Survival in the third trimester;2021QII;154.466
46 Valencia/València;All ages;Cohort October 1;Total;Survival in the third trimester;2021QI;""
46 Valencia/València;All ages;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
46 Valencia/València;All ages;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
46 Valencia/València;All ages;Cohort October 1;Total;Survival in the third trimester;2020QII;""
46 Valencia/València;All ages;Cohort October 1;Total;Survival in the third trimester;2020QI;""
46 Valencia/València;All ages;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
46 Valencia/València;All ages;Cohort October 1;Total;Survival in the third trimester;2022QIII;150.605
46 Valencia/València;All ages;Cohort October 1;Total;Survival in the third trimester;2022QII;""
46 Valencia/València;All ages;Cohort October 1;Total;Survival in the third trimester;2022QI;""
46 Valencia/València;All ages;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
46 Valencia/València;All ages;Cohort October 1;Total;Survival in the third trimester;2021QIII;150.451
46 Valencia/València;All ages;Cohort October 1;Total;Survival in the third trimester;2021QII;""
46 Valencia/València;All ages;Cohort October 1;Total;Survival in the third trimester;2021QI;""
46 Valencia/València;All ages;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
46 Valencia/València;All ages;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
46 Valencia/València;All ages;Cohort October 1;Total;Survival in the third trimester;2020QII;""
46 Valencia/València;All ages;Cohort October 1;Total;Survival in the third trimester;2020QI;""
46 Valencia/València;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
46 Valencia/València;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
46 Valencia/València;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
46 Valencia/València;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
46 Valencia/València;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
46 Valencia/València;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
46 Valencia/València;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
46 Valencia/València;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
46 Valencia/València;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
46 Valencia/València;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
46 Valencia/València;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
46 Valencia/València;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
46 Valencia/València;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;95,83
46 Valencia/València;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
46 Valencia/València;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
46 Valencia/València;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
46 Valencia/València;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;96,27
46 Valencia/València;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
46 Valencia/València;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
46 Valencia/València;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
46 Valencia/València;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;96,17
46 Valencia/València;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
46 Valencia/València;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
46 Valencia/València;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
46 Valencia/València;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
46 Valencia/València;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
46 Valencia/València;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
46 Valencia/València;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;93,1
46 Valencia/València;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
46 Valencia/València;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
46 Valencia/València;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
46 Valencia/València;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;93,69
46 Valencia/València;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
46 Valencia/València;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
46 Valencia/València;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
46 Valencia/València;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
46 Valencia/València;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
46 Valencia/València;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
46 Valencia/València;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;90,12
46 Valencia/València;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
46 Valencia/València;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
46 Valencia/València;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
46 Valencia/València;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;91,12
46 Valencia/València;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
46 Valencia/València;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
46 Valencia/València;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
46 Valencia/València;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
46 Valencia/València;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
46 Valencia/València;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
46 Valencia/València;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;87,52
46 Valencia/València;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
46 Valencia/València;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
46 Valencia/València;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
46 Valencia/València;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;88,75
46 Valencia/València;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
46 Valencia/València;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
46 Valencia/València;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
46 Valencia/València;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
46 Valencia/València;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
46 Valencia/València;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
46 Valencia/València;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QIV;108.453
46 Valencia/València;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
46 Valencia/València;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
46 Valencia/València;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
46 Valencia/València;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QIV;108.138
46 Valencia/València;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
46 Valencia/València;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
46 Valencia/València;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
46 Valencia/València;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QIV;106.987
46 Valencia/València;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
46 Valencia/València;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
46 Valencia/València;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
46 Valencia/València;All ages;Cohort October 1;Males;Survival in the first trimester;2022QIV;104.073
46 Valencia/València;All ages;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
46 Valencia/València;All ages;Cohort October 1;Males;Survival in the first trimester;2022QII;""
46 Valencia/València;All ages;Cohort October 1;Males;Survival in the first trimester;2022QI;""
46 Valencia/València;All ages;Cohort October 1;Males;Survival in the first trimester;2021QIV;104.323
46 Valencia/València;All ages;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
46 Valencia/València;All ages;Cohort October 1;Males;Survival in the first trimester;2021QII;""
46 Valencia/València;All ages;Cohort October 1;Males;Survival in the first trimester;2021QI;""
46 Valencia/València;All ages;Cohort October 1;Males;Survival in the first trimester;2020QIV;103.098
46 Valencia/València;All ages;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
46 Valencia/València;All ages;Cohort October 1;Males;Survival in the first trimester;2020QII;""
46 Valencia/València;All ages;Cohort October 1;Males;Survival in the first trimester;2020QI;""
46 Valencia/València;All ages;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
46 Valencia/València;All ages;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
46 Valencia/València;All ages;Cohort October 1;Males;Survival in the second trimester;2022QII;""
46 Valencia/València;All ages;Cohort October 1;Males;Survival in the second trimester;2022QI;101.082
46 Valencia/València;All ages;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
46 Valencia/València;All ages;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
46 Valencia/València;All ages;Cohort October 1;Males;Survival in the second trimester;2021QII;""
46 Valencia/València;All ages;Cohort October 1;Males;Survival in the second trimester;2021QI;100.513
46 Valencia/València;All ages;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
46 Valencia/València;All ages;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
46 Valencia/València;All ages;Cohort October 1;Males;Survival in the second trimester;2020QII;""
46 Valencia/València;All ages;Cohort October 1;Males;Survival in the second trimester;2020QI;""
46 Valencia/València;All ages;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
46 Valencia/València;All ages;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
46 Valencia/València;All ages;Cohort October 1;Males;Survival in the third trimester;2022QII;98.133
46 Valencia/València;All ages;Cohort October 1;Males;Survival in the third trimester;2022QI;""
46 Valencia/València;All ages;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
46 Valencia/València;All ages;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
46 Valencia/València;All ages;Cohort October 1;Males;Survival in the third trimester;2021QII;97.931
46 Valencia/València;All ages;Cohort October 1;Males;Survival in the third trimester;2021QI;""
46 Valencia/València;All ages;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
46 Valencia/València;All ages;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
46 Valencia/València;All ages;Cohort October 1;Males;Survival in the third trimester;2020QII;""
46 Valencia/València;All ages;Cohort October 1;Males;Survival in the third trimester;2020QI;""
46 Valencia/València;All ages;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
46 Valencia/València;All ages;Cohort October 1;Males;Survival in the third trimester;2022QIII;95.505
46 Valencia/València;All ages;Cohort October 1;Males;Survival in the third trimester;2022QII;""
46 Valencia/València;All ages;Cohort October 1;Males;Survival in the third trimester;2022QI;""
46 Valencia/València;All ages;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
46 Valencia/València;All ages;Cohort October 1;Males;Survival in the third trimester;2021QIII;95.574
46 Valencia/València;All ages;Cohort October 1;Males;Survival in the third trimester;2021QII;""
46 Valencia/València;All ages;Cohort October 1;Males;Survival in the third trimester;2021QI;""
46 Valencia/València;All ages;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
46 Valencia/València;All ages;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
46 Valencia/València;All ages;Cohort October 1;Males;Survival in the third trimester;2020QII;""
46 Valencia/València;All ages;Cohort October 1;Males;Survival in the third trimester;2020QI;""
46 Valencia/València;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
46 Valencia/València;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
46 Valencia/València;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
46 Valencia/València;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
46 Valencia/València;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
46 Valencia/València;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
46 Valencia/València;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
46 Valencia/València;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
46 Valencia/València;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
46 Valencia/València;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
46 Valencia/València;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
46 Valencia/València;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
46 Valencia/València;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;95,96
46 Valencia/València;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
46 Valencia/València;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
46 Valencia/València;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
46 Valencia/València;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;96,47
46 Valencia/València;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
46 Valencia/València;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
46 Valencia/València;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
46 Valencia/València;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;96,36
46 Valencia/València;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
46 Valencia/València;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
46 Valencia/València;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
46 Valencia/València;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
46 Valencia/València;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
46 Valencia/València;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
46 Valencia/València;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;93,48
46 Valencia/València;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
46 Valencia/València;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
46 Valencia/València;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
46 Valencia/València;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;93,95
46 Valencia/València;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
46 Valencia/València;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
46 Valencia/València;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
46 Valencia/València;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
46 Valencia/València;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
46 Valencia/València;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
46 Valencia/València;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;90,75
46 Valencia/València;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
46 Valencia/València;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
46 Valencia/València;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
46 Valencia/València;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;91,54
46 Valencia/València;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
46 Valencia/València;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
46 Valencia/València;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
46 Valencia/València;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
46 Valencia/València;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
46 Valencia/València;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
46 Valencia/València;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;88,32
46 Valencia/València;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
46 Valencia/València;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
46 Valencia/València;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
46 Valencia/València;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;89,33
46 Valencia/València;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
46 Valencia/València;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
46 Valencia/València;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
46 Valencia/València;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
46 Valencia/València;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
46 Valencia/València;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
46 Valencia/València;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QIV;64.487
46 Valencia/València;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
46 Valencia/València;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
46 Valencia/València;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
46 Valencia/València;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QIV;63.952
46 Valencia/València;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
46 Valencia/València;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
46 Valencia/València;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
46 Valencia/València;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QIV;62.539
46 Valencia/València;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
46 Valencia/València;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
46 Valencia/València;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
46 Valencia/València;All ages;Cohort October 1;Females;Survival in the first trimester;2022QIV;61.662
46 Valencia/València;All ages;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
46 Valencia/València;All ages;Cohort October 1;Females;Survival in the first trimester;2022QII;""
46 Valencia/València;All ages;Cohort October 1;Females;Survival in the first trimester;2022QI;""
46 Valencia/València;All ages;Cohort October 1;Females;Survival in the first trimester;2021QIV;61.349
46 Valencia/València;All ages;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
46 Valencia/València;All ages;Cohort October 1;Females;Survival in the first trimester;2021QII;""
46 Valencia/València;All ages;Cohort October 1;Females;Survival in the first trimester;2021QI;""
46 Valencia/València;All ages;Cohort October 1;Females;Survival in the first trimester;2020QIV;59.940
46 Valencia/València;All ages;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
46 Valencia/València;All ages;Cohort October 1;Females;Survival in the first trimester;2020QII;""
46 Valencia/València;All ages;Cohort October 1;Females;Survival in the first trimester;2020QI;""
46 Valencia/València;All ages;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
46 Valencia/València;All ages;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
46 Valencia/València;All ages;Cohort October 1;Females;Survival in the second trimester;2022QII;""
46 Valencia/València;All ages;Cohort October 1;Females;Survival in the second trimester;2022QI;59.134
46 Valencia/València;All ages;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
46 Valencia/València;All ages;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
46 Valencia/València;All ages;Cohort October 1;Females;Survival in the second trimester;2021QII;""
46 Valencia/València;All ages;Cohort October 1;Females;Survival in the second trimester;2021QI;58.319
46 Valencia/València;All ages;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
46 Valencia/València;All ages;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
46 Valencia/València;All ages;Cohort October 1;Females;Survival in the second trimester;2020QII;""
46 Valencia/València;All ages;Cohort October 1;Females;Survival in the second trimester;2020QI;""
46 Valencia/València;All ages;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
46 Valencia/València;All ages;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
46 Valencia/València;All ages;Cohort October 1;Females;Survival in the third trimester;2022QII;56.960
46 Valencia/València;All ages;Cohort October 1;Females;Survival in the third trimester;2022QI;""
46 Valencia/València;All ages;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
46 Valencia/València;All ages;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
46 Valencia/València;All ages;Cohort October 1;Females;Survival in the third trimester;2021QII;56.535
46 Valencia/València;All ages;Cohort October 1;Females;Survival in the third trimester;2021QI;""
46 Valencia/València;All ages;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
46 Valencia/València;All ages;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
46 Valencia/València;All ages;Cohort October 1;Females;Survival in the third trimester;2020QII;""
46 Valencia/València;All ages;Cohort October 1;Females;Survival in the third trimester;2020QI;""
46 Valencia/València;All ages;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
46 Valencia/València;All ages;Cohort October 1;Females;Survival in the third trimester;2022QIII;55.100
46 Valencia/València;All ages;Cohort October 1;Females;Survival in the third trimester;2022QII;""
46 Valencia/València;All ages;Cohort October 1;Females;Survival in the third trimester;2022QI;""
46 Valencia/València;All ages;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
46 Valencia/València;All ages;Cohort October 1;Females;Survival in the third trimester;2021QIII;54.877
46 Valencia/València;All ages;Cohort October 1;Females;Survival in the third trimester;2021QII;""
46 Valencia/València;All ages;Cohort October 1;Females;Survival in the third trimester;2021QI;""
46 Valencia/València;All ages;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
46 Valencia/València;All ages;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
46 Valencia/València;All ages;Cohort October 1;Females;Survival in the third trimester;2020QII;""
46 Valencia/València;All ages;Cohort October 1;Females;Survival in the third trimester;2020QI;""
46 Valencia/València;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
46 Valencia/València;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
46 Valencia/València;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
46 Valencia/València;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
46 Valencia/València;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
46 Valencia/València;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
46 Valencia/València;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
46 Valencia/València;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
46 Valencia/València;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
46 Valencia/València;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
46 Valencia/València;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
46 Valencia/València;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
46 Valencia/València;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;95,62
46 Valencia/València;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
46 Valencia/València;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
46 Valencia/València;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
46 Valencia/València;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;95,93
46 Valencia/València;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
46 Valencia/València;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
46 Valencia/València;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
46 Valencia/València;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;95,84
46 Valencia/València;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
46 Valencia/València;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
46 Valencia/València;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
46 Valencia/València;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
46 Valencia/València;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
46 Valencia/València;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
46 Valencia/València;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;92,47
46 Valencia/València;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
46 Valencia/València;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
46 Valencia/València;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
46 Valencia/València;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;93,25
46 Valencia/València;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
46 Valencia/València;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
46 Valencia/València;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
46 Valencia/València;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
46 Valencia/València;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
46 Valencia/València;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
46 Valencia/València;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;89,07
46 Valencia/València;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
46 Valencia/València;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
46 Valencia/València;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
46 Valencia/València;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;90,4
46 Valencia/València;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
46 Valencia/València;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
46 Valencia/València;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
46 Valencia/València;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
46 Valencia/València;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
46 Valencia/València;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
46 Valencia/València;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;86,16
46 Valencia/València;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
46 Valencia/València;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
46 Valencia/València;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
46 Valencia/València;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;87,75
46 Valencia/València;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
46 Valencia/València;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
46 Valencia/València;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
46 Valencia/València;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
46 Valencia/València;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
46 Valencia/València;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
46 Valencia/València;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
46 Valencia/València;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
46 Valencia/València;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
46 Valencia/València;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QI;11.860
46 Valencia/València;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
46 Valencia/València;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
46 Valencia/València;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
46 Valencia/València;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QI;11.284
46 Valencia/València;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
46 Valencia/València;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
46 Valencia/València;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
46 Valencia/València;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QI;9.431
46 Valencia/València;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
46 Valencia/València;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
46 Valencia/València;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2022QII;""
46 Valencia/València;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2022QI;10.953
46 Valencia/València;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
46 Valencia/València;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
46 Valencia/València;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2021QII;""
46 Valencia/València;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2021QI;10.581
46 Valencia/València;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
46 Valencia/València;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
46 Valencia/València;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2020QII;""
46 Valencia/València;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2020QI;8.160
46 Valencia/València;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
46 Valencia/València;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
46 Valencia/València;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2022QII;10.122
46 Valencia/València;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2022QI;""
46 Valencia/València;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
46 Valencia/València;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
46 Valencia/València;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2021QII;9.846
46 Valencia/València;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2021QI;""
46 Valencia/València;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
46 Valencia/València;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
46 Valencia/València;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2020QII;7.832
46 Valencia/València;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2020QI;""
46 Valencia/València;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
46 Valencia/València;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QIII;9.471
46 Valencia/València;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QII;""
46 Valencia/València;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QI;""
46 Valencia/València;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
46 Valencia/València;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QIII;9.198
46 Valencia/València;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QII;""
46 Valencia/València;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QI;""
46 Valencia/València;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
46 Valencia/València;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QIII;7.414
46 Valencia/València;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QII;""
46 Valencia/València;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QI;""
46 Valencia/València;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QIV;8.794
46 Valencia/València;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
46 Valencia/València;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QII;""
46 Valencia/València;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QI;""
46 Valencia/València;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QIV;8.621
46 Valencia/València;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
46 Valencia/València;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QII;""
46 Valencia/València;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QI;""
46 Valencia/València;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QIV;6.958
46 Valencia/València;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
46 Valencia/València;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QII;""
46 Valencia/València;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QI;""
46 Valencia/València;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
46 Valencia/València;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
46 Valencia/València;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
46 Valencia/València;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
46 Valencia/València;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
46 Valencia/València;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
46 Valencia/València;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
46 Valencia/València;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
46 Valencia/València;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
46 Valencia/València;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
46 Valencia/València;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
46 Valencia/València;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
46 Valencia/València;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
46 Valencia/València;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
46 Valencia/València;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
46 Valencia/València;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;92,35
46 Valencia/València;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
46 Valencia/València;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
46 Valencia/València;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
46 Valencia/València;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;93,77
46 Valencia/València;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
46 Valencia/València;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
46 Valencia/València;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
46 Valencia/València;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;86,52
46 Valencia/València;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
46 Valencia/València;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
46 Valencia/València;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;85,35
46 Valencia/València;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
46 Valencia/València;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
46 Valencia/València;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
46 Valencia/València;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;87,26
46 Valencia/València;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
46 Valencia/València;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
46 Valencia/València;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
46 Valencia/València;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;83,05
46 Valencia/València;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
46 Valencia/València;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
46 Valencia/València;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;79,86
46 Valencia/València;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
46 Valencia/València;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
46 Valencia/València;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
46 Valencia/València;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;81,51
46 Valencia/València;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
46 Valencia/València;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
46 Valencia/València;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
46 Valencia/València;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;78,61
46 Valencia/València;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
46 Valencia/València;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
46 Valencia/València;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;74,15
46 Valencia/València;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
46 Valencia/València;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
46 Valencia/València;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
46 Valencia/València;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;76,4
46 Valencia/València;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
46 Valencia/València;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
46 Valencia/València;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
46 Valencia/València;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;73,78
46 Valencia/València;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
46 Valencia/València;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
46 Valencia/València;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
46 Valencia/València;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
46 Valencia/València;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
46 Valencia/València;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
46 Valencia/València;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QI;7.226
46 Valencia/València;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
46 Valencia/València;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
46 Valencia/València;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
46 Valencia/València;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QI;6.888
46 Valencia/València;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
46 Valencia/València;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
46 Valencia/València;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
46 Valencia/València;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QI;5.741
46 Valencia/València;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
46 Valencia/València;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
46 Valencia/València;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2022QII;""
46 Valencia/València;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2022QI;6.671
46 Valencia/València;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
46 Valencia/València;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
46 Valencia/València;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2021QII;""
46 Valencia/València;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2021QI;6.437
46 Valencia/València;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
46 Valencia/València;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
46 Valencia/València;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2020QII;""
46 Valencia/València;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2020QI;5.003
46 Valencia/València;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
46 Valencia/València;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
46 Valencia/València;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2022QII;6.195
46 Valencia/València;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2022QI;""
46 Valencia/València;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
46 Valencia/València;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
46 Valencia/València;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2021QII;5.999
46 Valencia/València;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2021QI;""
46 Valencia/València;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
46 Valencia/València;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
46 Valencia/València;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2020QII;4.801
46 Valencia/València;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2020QI;""
46 Valencia/València;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
46 Valencia/València;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QIII;5.790
46 Valencia/València;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QII;""
46 Valencia/València;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QI;""
46 Valencia/València;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
46 Valencia/València;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QIII;5.627
46 Valencia/València;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QII;""
46 Valencia/València;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QI;""
46 Valencia/València;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
46 Valencia/València;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QIII;4.569
46 Valencia/València;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QII;""
46 Valencia/València;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QI;""
46 Valencia/València;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QIV;5.368
46 Valencia/València;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
46 Valencia/València;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QII;""
46 Valencia/València;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QI;""
46 Valencia/València;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QIV;5.275
46 Valencia/València;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
46 Valencia/València;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QII;""
46 Valencia/València;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QI;""
46 Valencia/València;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QIV;4.304
46 Valencia/València;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
46 Valencia/València;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QII;""
46 Valencia/València;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QI;""
46 Valencia/València;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
46 Valencia/València;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
46 Valencia/València;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
46 Valencia/València;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
46 Valencia/València;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
46 Valencia/València;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
46 Valencia/València;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
46 Valencia/València;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
46 Valencia/València;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
46 Valencia/València;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
46 Valencia/València;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
46 Valencia/València;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
46 Valencia/València;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
46 Valencia/València;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
46 Valencia/València;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
46 Valencia/València;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;92,32
46 Valencia/València;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
46 Valencia/València;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
46 Valencia/València;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
46 Valencia/València;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;93,45
46 Valencia/València;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
46 Valencia/València;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
46 Valencia/València;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
46 Valencia/València;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;87,15
46 Valencia/València;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
46 Valencia/València;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
46 Valencia/València;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;85,73
46 Valencia/València;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
46 Valencia/València;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
46 Valencia/València;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
46 Valencia/València;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;87,09
46 Valencia/València;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
46 Valencia/València;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
46 Valencia/València;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
46 Valencia/València;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;83,63
46 Valencia/València;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
46 Valencia/València;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
46 Valencia/València;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;80,13
46 Valencia/València;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
46 Valencia/València;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
46 Valencia/València;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
46 Valencia/València;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;81,69
46 Valencia/València;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
46 Valencia/València;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
46 Valencia/València;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
46 Valencia/València;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;79,59
46 Valencia/València;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
46 Valencia/València;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
46 Valencia/València;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;74,29
46 Valencia/València;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
46 Valencia/València;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
46 Valencia/València;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
46 Valencia/València;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;76,58
46 Valencia/València;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
46 Valencia/València;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
46 Valencia/València;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
46 Valencia/València;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;74,97
46 Valencia/València;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
46 Valencia/València;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
46 Valencia/València;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
46 Valencia/València;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
46 Valencia/València;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
46 Valencia/València;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
46 Valencia/València;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QI;4.634
46 Valencia/València;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
46 Valencia/València;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
46 Valencia/València;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
46 Valencia/València;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QI;4.396
46 Valencia/València;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
46 Valencia/València;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
46 Valencia/València;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
46 Valencia/València;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QI;3.690
46 Valencia/València;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
46 Valencia/València;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
46 Valencia/València;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2022QII;""
46 Valencia/València;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2022QI;4.282
46 Valencia/València;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
46 Valencia/València;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
46 Valencia/València;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2021QII;""
46 Valencia/València;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2021QI;4.144
46 Valencia/València;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
46 Valencia/València;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
46 Valencia/València;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2020QII;""
46 Valencia/València;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2020QI;3.157
46 Valencia/València;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
46 Valencia/València;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
46 Valencia/València;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2022QII;3.927
46 Valencia/València;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2022QI;""
46 Valencia/València;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
46 Valencia/València;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
46 Valencia/València;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2021QII;3.847
46 Valencia/València;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2021QI;""
46 Valencia/València;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
46 Valencia/València;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
46 Valencia/València;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2020QII;3.031
46 Valencia/València;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2020QI;""
46 Valencia/València;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
46 Valencia/València;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QIII;3.681
46 Valencia/València;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QII;""
46 Valencia/València;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QI;""
46 Valencia/València;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
46 Valencia/València;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QIII;3.571
46 Valencia/València;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QII;""
46 Valencia/València;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QI;""
46 Valencia/València;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
46 Valencia/València;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QIII;2.845
46 Valencia/València;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QII;""
46 Valencia/València;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QI;""
46 Valencia/València;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QIV;3.426
46 Valencia/València;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
46 Valencia/València;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QII;""
46 Valencia/València;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QI;""
46 Valencia/València;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QIV;3.346
46 Valencia/València;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
46 Valencia/València;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QII;""
46 Valencia/València;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QI;""
46 Valencia/València;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QIV;2.654
46 Valencia/València;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
46 Valencia/València;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QII;""
46 Valencia/València;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QI;""
46 Valencia/València;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
46 Valencia/València;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
46 Valencia/València;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
46 Valencia/València;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
46 Valencia/València;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
46 Valencia/València;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
46 Valencia/València;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
46 Valencia/València;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
46 Valencia/València;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
46 Valencia/València;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
46 Valencia/València;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
46 Valencia/València;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
46 Valencia/València;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
46 Valencia/València;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
46 Valencia/València;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
46 Valencia/València;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;92,4
46 Valencia/València;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
46 Valencia/València;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
46 Valencia/València;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
46 Valencia/València;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;94,27
46 Valencia/València;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
46 Valencia/València;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
46 Valencia/València;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
46 Valencia/València;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;85,56
46 Valencia/València;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
46 Valencia/València;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
46 Valencia/València;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;84,74
46 Valencia/València;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
46 Valencia/València;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
46 Valencia/València;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
46 Valencia/València;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;87,51
46 Valencia/València;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
46 Valencia/València;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
46 Valencia/València;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
46 Valencia/València;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;82,14
46 Valencia/València;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
46 Valencia/València;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
46 Valencia/València;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;79,43
46 Valencia/València;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
46 Valencia/València;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
46 Valencia/València;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
46 Valencia/València;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;81,23
46 Valencia/València;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
46 Valencia/València;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
46 Valencia/València;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
46 Valencia/València;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;77,1
46 Valencia/València;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
46 Valencia/València;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
46 Valencia/València;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;73,93
46 Valencia/València;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
46 Valencia/València;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
46 Valencia/València;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
46 Valencia/València;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;76,11
46 Valencia/València;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
46 Valencia/València;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
46 Valencia/València;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
46 Valencia/València;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;71,92
46 Valencia/València;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
46 Valencia/València;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
46 Valencia/València;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
46 Valencia/València;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
46 Valencia/València;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
46 Valencia/València;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QII;10.611
46 Valencia/València;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
46 Valencia/València;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
46 Valencia/València;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
46 Valencia/València;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QII;10.184
46 Valencia/València;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
46 Valencia/València;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
46 Valencia/València;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
46 Valencia/València;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QII;9.409
46 Valencia/València;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
46 Valencia/València;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
46 Valencia/València;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
46 Valencia/València;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2022QII;9.706
46 Valencia/València;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2022QI;""
46 Valencia/València;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
46 Valencia/València;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
46 Valencia/València;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2021QII;9.338
46 Valencia/València;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2021QI;""
46 Valencia/València;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
46 Valencia/València;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
46 Valencia/València;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2020QII;8.983
46 Valencia/València;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2020QI;""
46 Valencia/València;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
46 Valencia/València;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2022QIII;9.028
46 Valencia/València;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2022QII;""
46 Valencia/València;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2022QI;""
46 Valencia/València;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
46 Valencia/València;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2021QIII;8.621
46 Valencia/València;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2021QII;""
46 Valencia/València;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2021QI;""
46 Valencia/València;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
46 Valencia/València;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2020QIII;8.451
46 Valencia/València;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2020QII;""
46 Valencia/València;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2020QI;""
46 Valencia/València;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QIV;8.305
46 Valencia/València;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
46 Valencia/València;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QII;""
46 Valencia/València;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QI;""
46 Valencia/València;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QIV;8.008
46 Valencia/València;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
46 Valencia/València;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QII;""
46 Valencia/València;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QI;""
46 Valencia/València;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QIV;7.882
46 Valencia/València;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
46 Valencia/València;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QII;""
46 Valencia/València;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QI;""
46 Valencia/València;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
46 Valencia/València;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
46 Valencia/València;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QII;""
46 Valencia/València;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QI;7.487
46 Valencia/València;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
46 Valencia/València;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
46 Valencia/València;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QII;""
46 Valencia/València;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QI;7.500
46 Valencia/València;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
46 Valencia/València;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
46 Valencia/València;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QII;""
46 Valencia/València;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QI;""
46 Valencia/València;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
46 Valencia/València;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
46 Valencia/València;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
46 Valencia/València;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
46 Valencia/València;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
46 Valencia/València;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
46 Valencia/València;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
46 Valencia/València;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
46 Valencia/València;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
46 Valencia/València;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
46 Valencia/València;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
46 Valencia/València;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
46 Valencia/València;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
46 Valencia/València;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
46 Valencia/València;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;91,47
46 Valencia/València;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
46 Valencia/València;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
46 Valencia/València;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
46 Valencia/València;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;91,69
46 Valencia/València;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
46 Valencia/València;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
46 Valencia/València;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
46 Valencia/València;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;95,47
46 Valencia/València;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
46 Valencia/València;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
46 Valencia/València;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;85,08
46 Valencia/València;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
46 Valencia/València;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
46 Valencia/València;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
46 Valencia/València;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;84,65
46 Valencia/València;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
46 Valencia/València;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
46 Valencia/València;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
46 Valencia/València;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;89,82
46 Valencia/València;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
46 Valencia/València;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
46 Valencia/València;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;78,27
46 Valencia/València;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
46 Valencia/València;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
46 Valencia/València;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
46 Valencia/València;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;78,63
46 Valencia/València;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
46 Valencia/València;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
46 Valencia/València;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
46 Valencia/València;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;83,77
46 Valencia/València;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
46 Valencia/València;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
46 Valencia/València;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
46 Valencia/València;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
46 Valencia/València;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
46 Valencia/València;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
46 Valencia/València;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;73,52
46 Valencia/València;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
46 Valencia/València;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
46 Valencia/València;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
46 Valencia/València;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;79,71
46 Valencia/València;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
46 Valencia/València;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
46 Valencia/València;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
46 Valencia/València;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
46 Valencia/València;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
46 Valencia/València;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
46 Valencia/València;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QII;6.502
46 Valencia/València;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
46 Valencia/València;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
46 Valencia/València;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
46 Valencia/València;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QII;6.219
46 Valencia/València;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
46 Valencia/València;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
46 Valencia/València;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
46 Valencia/València;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QII;5.770
46 Valencia/València;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
46 Valencia/València;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
46 Valencia/València;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
46 Valencia/València;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2022QII;5.976
46 Valencia/València;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2022QI;""
46 Valencia/València;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
46 Valencia/València;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
46 Valencia/València;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2021QII;5.703
46 Valencia/València;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2021QI;""
46 Valencia/València;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
46 Valencia/València;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
46 Valencia/València;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2020QII;5.510
46 Valencia/València;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2020QI;""
46 Valencia/València;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
46 Valencia/València;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2022QIII;5.563
46 Valencia/València;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2022QII;""
46 Valencia/València;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2022QI;""
46 Valencia/València;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
46 Valencia/València;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2021QIII;5.286
46 Valencia/València;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2021QII;""
46 Valencia/València;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2021QI;""
46 Valencia/València;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
46 Valencia/València;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2020QIII;5.198
46 Valencia/València;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2020QII;""
46 Valencia/València;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2020QI;""
46 Valencia/València;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QIV;5.103
46 Valencia/València;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
46 Valencia/València;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QII;""
46 Valencia/València;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QI;""
46 Valencia/València;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QIV;4.919
46 Valencia/València;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
46 Valencia/València;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QII;""
46 Valencia/València;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QI;""
46 Valencia/València;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QIV;4.860
46 Valencia/València;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
46 Valencia/València;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QII;""
46 Valencia/València;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QI;""
46 Valencia/València;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
46 Valencia/València;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
46 Valencia/València;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QII;""
46 Valencia/València;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QI;4.600
46 Valencia/València;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
46 Valencia/València;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
46 Valencia/València;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QII;""
46 Valencia/València;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QI;4.608
46 Valencia/València;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
46 Valencia/València;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
46 Valencia/València;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QII;""
46 Valencia/València;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QI;""
46 Valencia/València;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
46 Valencia/València;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
46 Valencia/València;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
46 Valencia/València;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
46 Valencia/València;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
46 Valencia/València;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
46 Valencia/València;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
46 Valencia/València;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
46 Valencia/València;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
46 Valencia/València;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
46 Valencia/València;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
46 Valencia/València;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
46 Valencia/València;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
46 Valencia/València;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
46 Valencia/València;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;91,91
46 Valencia/València;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
46 Valencia/València;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
46 Valencia/València;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
46 Valencia/València;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;91,7
46 Valencia/València;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
46 Valencia/València;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
46 Valencia/València;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
46 Valencia/València;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;95,49
46 Valencia/València;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
46 Valencia/València;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
46 Valencia/València;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;85,56
46 Valencia/València;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
46 Valencia/València;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
46 Valencia/València;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
46 Valencia/València;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;85
46 Valencia/València;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
46 Valencia/València;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
46 Valencia/València;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
46 Valencia/València;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;90,09
46 Valencia/València;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
46 Valencia/València;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
46 Valencia/València;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;78,48
46 Valencia/València;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
46 Valencia/València;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
46 Valencia/València;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
46 Valencia/València;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;79,1
46 Valencia/València;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
46 Valencia/València;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
46 Valencia/València;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
46 Valencia/València;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;84,23
46 Valencia/València;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
46 Valencia/València;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
46 Valencia/València;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
46 Valencia/València;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
46 Valencia/València;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
46 Valencia/València;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
46 Valencia/València;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;73,97
46 Valencia/València;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
46 Valencia/València;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
46 Valencia/València;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
46 Valencia/València;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;79,86
46 Valencia/València;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
46 Valencia/València;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
46 Valencia/València;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
46 Valencia/València;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
46 Valencia/València;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
46 Valencia/València;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
46 Valencia/València;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QII;4.109
46 Valencia/València;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
46 Valencia/València;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
46 Valencia/València;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
46 Valencia/València;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QII;3.965
46 Valencia/València;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
46 Valencia/València;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
46 Valencia/València;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
46 Valencia/València;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QII;3.639
46 Valencia/València;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
46 Valencia/València;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
46 Valencia/València;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
46 Valencia/València;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2022QII;3.730
46 Valencia/València;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2022QI;""
46 Valencia/València;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
46 Valencia/València;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
46 Valencia/València;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2021QII;3.635
46 Valencia/València;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2021QI;""
46 Valencia/València;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
46 Valencia/València;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
46 Valencia/València;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2020QII;3.473
46 Valencia/València;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2020QI;""
46 Valencia/València;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
46 Valencia/València;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2022QIII;3.465
46 Valencia/València;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2022QII;""
46 Valencia/València;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2022QI;""
46 Valencia/València;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
46 Valencia/València;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2021QIII;3.335
46 Valencia/València;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2021QII;""
46 Valencia/València;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2021QI;""
46 Valencia/València;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
46 Valencia/València;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2020QIII;3.253
46 Valencia/València;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2020QII;""
46 Valencia/València;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2020QI;""
46 Valencia/València;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QIV;3.202
46 Valencia/València;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
46 Valencia/València;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QII;""
46 Valencia/València;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QI;""
46 Valencia/València;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QIV;3.089
46 Valencia/València;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
46 Valencia/València;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QII;""
46 Valencia/València;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QI;""
46 Valencia/València;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QIV;3.022
46 Valencia/València;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
46 Valencia/València;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QII;""
46 Valencia/València;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QI;""
46 Valencia/València;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
46 Valencia/València;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
46 Valencia/València;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QII;""
46 Valencia/València;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QI;2.887
46 Valencia/València;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
46 Valencia/València;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
46 Valencia/València;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QII;""
46 Valencia/València;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QI;2.892
46 Valencia/València;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
46 Valencia/València;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
46 Valencia/València;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QII;""
46 Valencia/València;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QI;""
46 Valencia/València;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
46 Valencia/València;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
46 Valencia/València;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
46 Valencia/València;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
46 Valencia/València;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
46 Valencia/València;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
46 Valencia/València;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
46 Valencia/València;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
46 Valencia/València;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
46 Valencia/València;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
46 Valencia/València;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
46 Valencia/València;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
46 Valencia/València;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
46 Valencia/València;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
46 Valencia/València;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;90,78
46 Valencia/València;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
46 Valencia/València;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
46 Valencia/València;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
46 Valencia/València;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;91,68
46 Valencia/València;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
46 Valencia/València;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
46 Valencia/València;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
46 Valencia/València;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;95,44
46 Valencia/València;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
46 Valencia/València;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
46 Valencia/València;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;84,33
46 Valencia/València;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
46 Valencia/València;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
46 Valencia/València;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
46 Valencia/València;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;84,11
46 Valencia/València;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
46 Valencia/València;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
46 Valencia/València;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
46 Valencia/València;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;89,39
46 Valencia/València;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
46 Valencia/València;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
46 Valencia/València;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;77,93
46 Valencia/València;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
46 Valencia/València;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
46 Valencia/València;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
46 Valencia/València;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;77,91
46 Valencia/València;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
46 Valencia/València;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
46 Valencia/València;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
46 Valencia/València;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;83,04
46 Valencia/València;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
46 Valencia/València;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
46 Valencia/València;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
46 Valencia/València;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
46 Valencia/València;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
46 Valencia/València;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
46 Valencia/València;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;72,81
46 Valencia/València;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
46 Valencia/València;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
46 Valencia/València;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
46 Valencia/València;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;79,47
46 Valencia/València;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
46 Valencia/València;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
46 Valencia/València;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
46 Valencia/València;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
46 Valencia/València;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
46 Valencia/València;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QIII;11.190
46 Valencia/València;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
46 Valencia/València;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
46 Valencia/València;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
46 Valencia/València;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QIII;10.840
46 Valencia/València;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
46 Valencia/València;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
46 Valencia/València;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
46 Valencia/València;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QIII;10.004
46 Valencia/València;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
46 Valencia/València;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
46 Valencia/València;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
46 Valencia/València;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2022QIII;10.265
46 Valencia/València;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2022QII;""
46 Valencia/València;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2022QI;""
46 Valencia/València;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
46 Valencia/València;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2021QIII;9.841
46 Valencia/València;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2021QII;""
46 Valencia/València;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2021QI;""
46 Valencia/València;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
46 Valencia/València;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2020QIII;9.250
46 Valencia/València;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2020QII;""
46 Valencia/València;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2020QI;""
46 Valencia/València;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2022QIV;9.411
46 Valencia/València;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
46 Valencia/València;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2022QII;""
46 Valencia/València;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2022QI;""
46 Valencia/València;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2021QIV;9.089
46 Valencia/València;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
46 Valencia/València;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2021QII;""
46 Valencia/València;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2021QI;""
46 Valencia/València;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2020QIV;8.583
46 Valencia/València;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
46 Valencia/València;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2020QII;""
46 Valencia/València;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2020QI;""
46 Valencia/València;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
46 Valencia/València;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
46 Valencia/València;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QII;""
46 Valencia/València;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QI;8.447
46 Valencia/València;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
46 Valencia/València;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
46 Valencia/València;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QII;""
46 Valencia/València;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QI;8.150
46 Valencia/València;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
46 Valencia/València;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
46 Valencia/València;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QII;""
46 Valencia/València;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QI;""
46 Valencia/València;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
46 Valencia/València;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
46 Valencia/València;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QII;7.863
46 Valencia/València;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QI;""
46 Valencia/València;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
46 Valencia/València;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
46 Valencia/València;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QII;7.688
46 Valencia/València;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QI;""
46 Valencia/València;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
46 Valencia/València;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
46 Valencia/València;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QII;""
46 Valencia/València;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QI;""
46 Valencia/València;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
46 Valencia/València;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
46 Valencia/València;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
46 Valencia/València;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
46 Valencia/València;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
46 Valencia/València;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
46 Valencia/València;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
46 Valencia/València;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
46 Valencia/València;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
46 Valencia/València;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
46 Valencia/València;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
46 Valencia/València;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
46 Valencia/València;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
46 Valencia/València;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;91,73
46 Valencia/València;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
46 Valencia/València;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
46 Valencia/València;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
46 Valencia/València;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;90,78
46 Valencia/València;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
46 Valencia/València;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
46 Valencia/València;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
46 Valencia/València;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;92,46
46 Valencia/València;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
46 Valencia/València;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
46 Valencia/València;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;84,1
46 Valencia/València;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
46 Valencia/València;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
46 Valencia/València;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
46 Valencia/València;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;83,85
46 Valencia/València;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
46 Valencia/València;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
46 Valencia/València;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
46 Valencia/València;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;85,8
46 Valencia/València;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
46 Valencia/València;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
46 Valencia/València;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
46 Valencia/València;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
46 Valencia/València;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
46 Valencia/València;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
46 Valencia/València;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;77,92
46 Valencia/València;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
46 Valencia/València;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
46 Valencia/València;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
46 Valencia/València;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;81,47
46 Valencia/València;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
46 Valencia/València;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
46 Valencia/València;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
46 Valencia/València;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
46 Valencia/València;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
46 Valencia/València;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
46 Valencia/València;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;72,54
46 Valencia/València;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
46 Valencia/València;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
46 Valencia/València;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
46 Valencia/València;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;76,85
46 Valencia/València;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
46 Valencia/València;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
46 Valencia/València;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
46 Valencia/València;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
46 Valencia/València;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
46 Valencia/València;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
46 Valencia/València;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QIII;6.886
46 Valencia/València;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
46 Valencia/València;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
46 Valencia/València;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
46 Valencia/València;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QIII;6.623
46 Valencia/València;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
46 Valencia/València;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
46 Valencia/València;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
46 Valencia/València;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QIII;6.163
46 Valencia/València;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
46 Valencia/València;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
46 Valencia/València;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
46 Valencia/València;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2022QIII;6.319
46 Valencia/València;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2022QII;""
46 Valencia/València;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2022QI;""
46 Valencia/València;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
46 Valencia/València;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2021QIII;6.037
46 Valencia/València;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2021QII;""
46 Valencia/València;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2021QI;""
46 Valencia/València;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
46 Valencia/València;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2020QIII;5.702
46 Valencia/València;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2020QII;""
46 Valencia/València;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2020QI;""
46 Valencia/València;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2022QIV;5.775
46 Valencia/València;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
46 Valencia/València;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2022QII;""
46 Valencia/València;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2022QI;""
46 Valencia/València;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2021QIV;5.594
46 Valencia/València;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
46 Valencia/València;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2021QII;""
46 Valencia/València;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2021QI;""
46 Valencia/València;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2020QIV;5.298
46 Valencia/València;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
46 Valencia/València;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2020QII;""
46 Valencia/València;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2020QI;""
46 Valencia/València;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
46 Valencia/València;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
46 Valencia/València;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QII;""
46 Valencia/València;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QI;5.200
46 Valencia/València;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
46 Valencia/València;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
46 Valencia/València;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QII;""
46 Valencia/València;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QI;5.017
46 Valencia/València;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
46 Valencia/València;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
46 Valencia/València;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QII;""
46 Valencia/València;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QI;""
46 Valencia/València;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
46 Valencia/València;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
46 Valencia/València;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QII;4.872
46 Valencia/València;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QI;""
46 Valencia/València;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
46 Valencia/València;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
46 Valencia/València;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QII;4.757
46 Valencia/València;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QI;""
46 Valencia/València;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
46 Valencia/València;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
46 Valencia/València;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QII;""
46 Valencia/València;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QI;""
46 Valencia/València;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
46 Valencia/València;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
46 Valencia/València;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
46 Valencia/València;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
46 Valencia/València;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
46 Valencia/València;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
46 Valencia/València;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
46 Valencia/València;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
46 Valencia/València;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
46 Valencia/València;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
46 Valencia/València;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
46 Valencia/València;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
46 Valencia/València;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
46 Valencia/València;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;91,77
46 Valencia/València;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
46 Valencia/València;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
46 Valencia/València;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
46 Valencia/València;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;91,15
46 Valencia/València;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
46 Valencia/València;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
46 Valencia/València;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
46 Valencia/València;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;92,52
46 Valencia/València;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
46 Valencia/València;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
46 Valencia/València;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;83,87
46 Valencia/València;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
46 Valencia/València;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
46 Valencia/València;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
46 Valencia/València;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;84,46
46 Valencia/València;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
46 Valencia/València;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
46 Valencia/València;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
46 Valencia/València;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;85,96
46 Valencia/València;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
46 Valencia/València;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
46 Valencia/València;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
46 Valencia/València;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
46 Valencia/València;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
46 Valencia/València;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
46 Valencia/València;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;78,51
46 Valencia/València;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
46 Valencia/València;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
46 Valencia/València;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
46 Valencia/València;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;81,41
46 Valencia/València;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
46 Valencia/València;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
46 Valencia/València;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
46 Valencia/València;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
46 Valencia/València;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
46 Valencia/València;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
46 Valencia/València;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;73,56
46 Valencia/València;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
46 Valencia/València;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
46 Valencia/València;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
46 Valencia/València;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;77,19
46 Valencia/València;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
46 Valencia/València;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
46 Valencia/València;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
46 Valencia/València;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
46 Valencia/València;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
46 Valencia/València;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
46 Valencia/València;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QIII;4.304
46 Valencia/València;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
46 Valencia/València;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
46 Valencia/València;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
46 Valencia/València;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QIII;4.217
46 Valencia/València;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
46 Valencia/València;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
46 Valencia/València;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
46 Valencia/València;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QIII;3.841
46 Valencia/València;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
46 Valencia/València;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
46 Valencia/València;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
46 Valencia/València;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2022QIII;3.946
46 Valencia/València;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2022QII;""
46 Valencia/València;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2022QI;""
46 Valencia/València;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
46 Valencia/València;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2021QIII;3.804
46 Valencia/València;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2021QII;""
46 Valencia/València;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2021QI;""
46 Valencia/València;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
46 Valencia/València;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2020QIII;3.548
46 Valencia/València;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2020QII;""
46 Valencia/València;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2020QI;""
46 Valencia/València;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2022QIV;3.636
46 Valencia/València;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
46 Valencia/València;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2022QII;""
46 Valencia/València;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2022QI;""
46 Valencia/València;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2021QIV;3.495
46 Valencia/València;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
46 Valencia/València;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2021QII;""
46 Valencia/València;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2021QI;""
46 Valencia/València;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2020QIV;3.285
46 Valencia/València;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
46 Valencia/València;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2020QII;""
46 Valencia/València;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2020QI;""
46 Valencia/València;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
46 Valencia/València;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
46 Valencia/València;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QII;""
46 Valencia/València;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QI;3.247
46 Valencia/València;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
46 Valencia/València;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
46 Valencia/València;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QII;""
46 Valencia/València;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QI;3.133
46 Valencia/València;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
46 Valencia/València;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
46 Valencia/València;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QII;""
46 Valencia/València;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QI;""
46 Valencia/València;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
46 Valencia/València;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
46 Valencia/València;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QII;2.991
46 Valencia/València;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QI;""
46 Valencia/València;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
46 Valencia/València;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
46 Valencia/València;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QII;2.931
46 Valencia/València;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QI;""
46 Valencia/València;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
46 Valencia/València;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
46 Valencia/València;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QII;""
46 Valencia/València;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QI;""
46 Valencia/València;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
46 Valencia/València;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
46 Valencia/València;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
46 Valencia/València;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
46 Valencia/València;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
46 Valencia/València;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
46 Valencia/València;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
46 Valencia/València;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
46 Valencia/València;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
46 Valencia/València;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
46 Valencia/València;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
46 Valencia/València;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
46 Valencia/València;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
46 Valencia/València;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;91,68
46 Valencia/València;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
46 Valencia/València;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
46 Valencia/València;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
46 Valencia/València;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;90,21
46 Valencia/València;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
46 Valencia/València;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
46 Valencia/València;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
46 Valencia/València;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;92,37
46 Valencia/València;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
46 Valencia/València;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
46 Valencia/València;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;84,48
46 Valencia/València;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
46 Valencia/València;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
46 Valencia/València;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
46 Valencia/València;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;82,88
46 Valencia/València;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
46 Valencia/València;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
46 Valencia/València;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
46 Valencia/València;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;85,52
46 Valencia/València;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
46 Valencia/València;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
46 Valencia/València;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
46 Valencia/València;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
46 Valencia/València;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
46 Valencia/València;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
46 Valencia/València;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;77
46 Valencia/València;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
46 Valencia/València;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
46 Valencia/València;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
46 Valencia/València;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;81,57
46 Valencia/València;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
46 Valencia/València;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
46 Valencia/València;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
46 Valencia/València;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
46 Valencia/València;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
46 Valencia/València;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
46 Valencia/València;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;70,93
46 Valencia/València;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
46 Valencia/València;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
46 Valencia/València;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
46 Valencia/València;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;76,31
46 Valencia/València;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
46 Valencia/València;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
46 Valencia/València;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
46 Valencia/València;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
46 Valencia/València;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
46 Valencia/València;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QIV;11.568
46 Valencia/València;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
46 Valencia/València;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
46 Valencia/València;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
46 Valencia/València;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QIV;11.160
46 Valencia/València;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
46 Valencia/València;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
46 Valencia/València;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
46 Valencia/València;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QIV;10.550
46 Valencia/València;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
46 Valencia/València;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
46 Valencia/València;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
46 Valencia/València;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2022QIV;10.568
46 Valencia/València;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
46 Valencia/València;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2022QII;""
46 Valencia/València;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2022QI;""
46 Valencia/València;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2021QIV;10.242
46 Valencia/València;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
46 Valencia/València;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2021QII;""
46 Valencia/València;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2021QI;""
46 Valencia/València;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2020QIV;9.722
46 Valencia/València;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
46 Valencia/València;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2020QII;""
46 Valencia/València;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2020QI;""
46 Valencia/València;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
46 Valencia/València;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
46 Valencia/València;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2022QII;""
46 Valencia/València;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2022QI;9.500
46 Valencia/València;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
46 Valencia/València;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
46 Valencia/València;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2021QII;""
46 Valencia/València;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2021QI;9.205
46 Valencia/València;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
46 Valencia/València;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
46 Valencia/València;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2020QII;""
46 Valencia/València;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2020QI;""
46 Valencia/València;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
46 Valencia/València;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
46 Valencia/València;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QII;8.813
46 Valencia/València;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QI;""
46 Valencia/València;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
46 Valencia/València;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
46 Valencia/València;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QII;8.646
46 Valencia/València;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QI;""
46 Valencia/València;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
46 Valencia/València;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
46 Valencia/València;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QII;""
46 Valencia/València;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QI;""
46 Valencia/València;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
46 Valencia/València;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QIII;8.282
46 Valencia/València;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QII;""
46 Valencia/València;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QI;""
46 Valencia/València;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
46 Valencia/València;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QIII;8.141
46 Valencia/València;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QII;""
46 Valencia/València;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QI;""
46 Valencia/València;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
46 Valencia/València;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
46 Valencia/València;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QII;""
46 Valencia/València;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QI;""
46 Valencia/València;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
46 Valencia/València;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
46 Valencia/València;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
46 Valencia/València;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
46 Valencia/València;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
46 Valencia/València;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
46 Valencia/València;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
46 Valencia/València;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
46 Valencia/València;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
46 Valencia/València;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
46 Valencia/València;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
46 Valencia/València;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
46 Valencia/València;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;91,36
46 Valencia/València;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
46 Valencia/València;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
46 Valencia/València;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
46 Valencia/València;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;91,77
46 Valencia/València;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
46 Valencia/València;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
46 Valencia/València;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
46 Valencia/València;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;92,15
46 Valencia/València;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
46 Valencia/València;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
46 Valencia/València;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
46 Valencia/València;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
46 Valencia/València;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
46 Valencia/València;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
46 Valencia/València;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;85,13
46 Valencia/València;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
46 Valencia/València;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
46 Valencia/València;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
46 Valencia/València;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;87,25
46 Valencia/València;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
46 Valencia/València;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
46 Valencia/València;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
46 Valencia/València;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
46 Valencia/València;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
46 Valencia/València;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
46 Valencia/València;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;78,97
46 Valencia/València;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
46 Valencia/València;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
46 Valencia/València;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
46 Valencia/València;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;81,95
46 Valencia/València;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
46 Valencia/València;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
46 Valencia/València;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
46 Valencia/València;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
46 Valencia/València;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
46 Valencia/València;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
46 Valencia/València;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;74,21
46 Valencia/València;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
46 Valencia/València;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
46 Valencia/València;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
46 Valencia/València;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;77,17
46 Valencia/València;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
46 Valencia/València;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
46 Valencia/València;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
46 Valencia/València;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
46 Valencia/València;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
46 Valencia/València;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
46 Valencia/València;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QIV;7.083
46 Valencia/València;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
46 Valencia/València;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
46 Valencia/València;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
46 Valencia/València;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QIV;6.808
46 Valencia/València;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
46 Valencia/València;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
46 Valencia/València;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
46 Valencia/València;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QIV;6.464
46 Valencia/València;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
46 Valencia/València;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
46 Valencia/València;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
46 Valencia/València;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2022QIV;6.452
46 Valencia/València;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
46 Valencia/València;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2022QII;""
46 Valencia/València;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2022QI;""
46 Valencia/València;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2021QIV;6.264
46 Valencia/València;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
46 Valencia/València;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2021QII;""
46 Valencia/València;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2021QI;""
46 Valencia/València;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2020QIV;5.964
46 Valencia/València;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
46 Valencia/València;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2020QII;""
46 Valencia/València;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2020QI;""
46 Valencia/València;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
46 Valencia/València;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
46 Valencia/València;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2022QII;""
46 Valencia/València;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2022QI;5.818
46 Valencia/València;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
46 Valencia/València;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
46 Valencia/València;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2021QII;""
46 Valencia/València;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2021QI;5.634
46 Valencia/València;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
46 Valencia/València;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
46 Valencia/València;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2020QII;""
46 Valencia/València;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2020QI;""
46 Valencia/València;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
46 Valencia/València;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
46 Valencia/València;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QII;5.422
46 Valencia/València;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QI;""
46 Valencia/València;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
46 Valencia/València;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
46 Valencia/València;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QII;5.309
46 Valencia/València;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QI;""
46 Valencia/València;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
46 Valencia/València;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
46 Valencia/València;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QII;""
46 Valencia/València;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QI;""
46 Valencia/València;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
46 Valencia/València;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QIII;5.092
46 Valencia/València;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QII;""
46 Valencia/València;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QI;""
46 Valencia/València;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
46 Valencia/València;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QIII;5.010
46 Valencia/València;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QII;""
46 Valencia/València;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QI;""
46 Valencia/València;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
46 Valencia/València;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
46 Valencia/València;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QII;""
46 Valencia/València;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QI;""
46 Valencia/València;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
46 Valencia/València;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
46 Valencia/València;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
46 Valencia/València;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
46 Valencia/València;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
46 Valencia/València;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
46 Valencia/València;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
46 Valencia/València;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
46 Valencia/València;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
46 Valencia/València;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
46 Valencia/València;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
46 Valencia/València;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
46 Valencia/València;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;91,09
46 Valencia/València;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
46 Valencia/València;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
46 Valencia/València;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
46 Valencia/València;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;92,01
46 Valencia/València;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
46 Valencia/València;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
46 Valencia/València;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
46 Valencia/València;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;92,26
46 Valencia/València;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
46 Valencia/València;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
46 Valencia/València;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
46 Valencia/València;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
46 Valencia/València;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
46 Valencia/València;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
46 Valencia/València;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;85,46
46 Valencia/València;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
46 Valencia/València;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
46 Valencia/València;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
46 Valencia/València;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;87,16
46 Valencia/València;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
46 Valencia/València;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
46 Valencia/València;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
46 Valencia/València;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
46 Valencia/València;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
46 Valencia/València;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
46 Valencia/València;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;79,64
46 Valencia/València;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
46 Valencia/València;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
46 Valencia/València;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
46 Valencia/València;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;82,13
46 Valencia/València;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
46 Valencia/València;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
46 Valencia/València;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
46 Valencia/València;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
46 Valencia/València;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
46 Valencia/València;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
46 Valencia/València;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;74,79
46 Valencia/València;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
46 Valencia/València;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
46 Valencia/València;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
46 Valencia/València;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;77,51
46 Valencia/València;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
46 Valencia/València;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
46 Valencia/València;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
46 Valencia/València;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
46 Valencia/València;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
46 Valencia/València;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
46 Valencia/València;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QIV;4.485
46 Valencia/València;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
46 Valencia/València;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
46 Valencia/València;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
46 Valencia/València;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QIV;4.352
46 Valencia/València;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
46 Valencia/València;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
46 Valencia/València;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
46 Valencia/València;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QIV;4.086
46 Valencia/València;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
46 Valencia/València;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
46 Valencia/València;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
46 Valencia/València;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2022QIV;4.116
46 Valencia/València;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
46 Valencia/València;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2022QII;""
46 Valencia/València;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2022QI;""
46 Valencia/València;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2021QIV;3.978
46 Valencia/València;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
46 Valencia/València;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2021QII;""
46 Valencia/València;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2021QI;""
46 Valencia/València;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2020QIV;3.758
46 Valencia/València;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
46 Valencia/València;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2020QII;""
46 Valencia/València;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2020QI;""
46 Valencia/València;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
46 Valencia/València;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
46 Valencia/València;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2022QII;""
46 Valencia/València;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2022QI;3.682
46 Valencia/València;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
46 Valencia/València;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
46 Valencia/València;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2021QII;""
46 Valencia/València;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2021QI;3.571
46 Valencia/València;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
46 Valencia/València;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
46 Valencia/València;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2020QII;""
46 Valencia/València;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2020QI;""
46 Valencia/València;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
46 Valencia/València;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
46 Valencia/València;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QII;3.391
46 Valencia/València;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QI;""
46 Valencia/València;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
46 Valencia/València;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
46 Valencia/València;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QII;3.337
46 Valencia/València;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QI;""
46 Valencia/València;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
46 Valencia/València;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
46 Valencia/València;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QII;""
46 Valencia/València;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QI;""
46 Valencia/València;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
46 Valencia/València;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QIII;3.190
46 Valencia/València;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QII;""
46 Valencia/València;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QI;""
46 Valencia/València;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
46 Valencia/València;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QIII;3.131
46 Valencia/València;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QII;""
46 Valencia/València;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QI;""
46 Valencia/València;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
46 Valencia/València;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
46 Valencia/València;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QII;""
46 Valencia/València;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QI;""
46 Valencia/València;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
46 Valencia/València;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
46 Valencia/València;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
46 Valencia/València;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
46 Valencia/València;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
46 Valencia/València;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
46 Valencia/València;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
46 Valencia/València;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
46 Valencia/València;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
46 Valencia/València;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
46 Valencia/València;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
46 Valencia/València;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
46 Valencia/València;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;91,77
46 Valencia/València;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
46 Valencia/València;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
46 Valencia/València;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
46 Valencia/València;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;91,41
46 Valencia/València;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
46 Valencia/València;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
46 Valencia/València;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
46 Valencia/València;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;91,97
46 Valencia/València;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
46 Valencia/València;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
46 Valencia/València;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
46 Valencia/València;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
46 Valencia/València;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
46 Valencia/València;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
46 Valencia/València;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;84,6
46 Valencia/València;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
46 Valencia/València;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
46 Valencia/València;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
46 Valencia/València;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;87,4
46 Valencia/València;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
46 Valencia/València;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
46 Valencia/València;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
46 Valencia/València;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
46 Valencia/València;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
46 Valencia/València;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
46 Valencia/València;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;77,92
46 Valencia/València;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
46 Valencia/València;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
46 Valencia/València;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
46 Valencia/València;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;81,67
46 Valencia/València;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
46 Valencia/València;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
46 Valencia/València;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
46 Valencia/València;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
46 Valencia/València;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
46 Valencia/València;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
46 Valencia/València;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;73,3
46 Valencia/València;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
46 Valencia/València;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
46 Valencia/València;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
46 Valencia/València;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;76,63
46 Valencia/València;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
46 Valencia/València;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
46 Valencia/València;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
46 Valencia/València;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
46 Valencia/València;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
46 Valencia/València;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
46 Valencia/València;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
46 Valencia/València;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
46 Valencia/València;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
46 Valencia/València;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QI;31.770
46 Valencia/València;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
46 Valencia/València;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
46 Valencia/València;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
46 Valencia/València;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QI;32.076
46 Valencia/València;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
46 Valencia/València;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
46 Valencia/València;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
46 Valencia/València;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QI;31.240
46 Valencia/València;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
46 Valencia/València;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
46 Valencia/València;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2022QII;""
46 Valencia/València;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2022QI;30.326
46 Valencia/València;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
46 Valencia/València;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
46 Valencia/València;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2021QII;""
46 Valencia/València;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2021QI;30.966
46 Valencia/València;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
46 Valencia/València;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
46 Valencia/València;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2020QII;""
46 Valencia/València;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2020QI;28.752
46 Valencia/València;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
46 Valencia/València;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
46 Valencia/València;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2022QII;29.002
46 Valencia/València;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2022QI;""
46 Valencia/València;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
46 Valencia/València;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
46 Valencia/València;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2021QII;29.815
46 Valencia/València;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2021QI;""
46 Valencia/València;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
46 Valencia/València;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
46 Valencia/València;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2020QII;28.033
46 Valencia/València;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2020QI;""
46 Valencia/València;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
46 Valencia/València;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QIII;27.917
46 Valencia/València;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QII;""
46 Valencia/València;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QI;""
46 Valencia/València;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
46 Valencia/València;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QIII;28.826
46 Valencia/València;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QII;""
46 Valencia/València;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QI;""
46 Valencia/València;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
46 Valencia/València;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QIII;27.057
46 Valencia/València;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QII;""
46 Valencia/València;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QI;""
46 Valencia/València;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QIV;26.883
46 Valencia/València;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
46 Valencia/València;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QII;""
46 Valencia/València;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QI;""
46 Valencia/València;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QIV;27.827
46 Valencia/València;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
46 Valencia/València;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QII;""
46 Valencia/València;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QI;""
46 Valencia/València;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QIV;26.063
46 Valencia/València;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
46 Valencia/València;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QII;""
46 Valencia/València;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QI;""
46 Valencia/València;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
46 Valencia/València;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
46 Valencia/València;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
46 Valencia/València;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
46 Valencia/València;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
46 Valencia/València;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
46 Valencia/València;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
46 Valencia/València;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
46 Valencia/València;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
46 Valencia/València;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
46 Valencia/València;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
46 Valencia/València;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
46 Valencia/València;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
46 Valencia/València;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
46 Valencia/València;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
46 Valencia/València;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;95,45
46 Valencia/València;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
46 Valencia/València;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
46 Valencia/València;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
46 Valencia/València;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;96,54
46 Valencia/València;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
46 Valencia/València;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
46 Valencia/València;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
46 Valencia/València;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;92,04
46 Valencia/València;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
46 Valencia/València;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
46 Valencia/València;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;91,29
46 Valencia/València;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
46 Valencia/València;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
46 Valencia/València;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
46 Valencia/València;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;92,95
46 Valencia/València;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
46 Valencia/València;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
46 Valencia/València;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
46 Valencia/València;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;89,73
46 Valencia/València;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
46 Valencia/València;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
46 Valencia/València;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;87,87
46 Valencia/València;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
46 Valencia/València;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
46 Valencia/València;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
46 Valencia/València;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;89,87
46 Valencia/València;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
46 Valencia/València;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
46 Valencia/València;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
46 Valencia/València;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;86,61
46 Valencia/València;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
46 Valencia/València;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
46 Valencia/València;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;84,62
46 Valencia/València;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
46 Valencia/València;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
46 Valencia/València;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
46 Valencia/València;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;86,75
46 Valencia/València;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
46 Valencia/València;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
46 Valencia/València;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
46 Valencia/València;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;83,43
46 Valencia/València;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
46 Valencia/València;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
46 Valencia/València;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
46 Valencia/València;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
46 Valencia/València;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
46 Valencia/València;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
46 Valencia/València;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QI;18.710
46 Valencia/València;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
46 Valencia/València;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
46 Valencia/València;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
46 Valencia/València;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QI;19.137
46 Valencia/València;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
46 Valencia/València;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
46 Valencia/València;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
46 Valencia/València;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QI;18.556
46 Valencia/València;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
46 Valencia/València;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
46 Valencia/València;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2022QII;""
46 Valencia/València;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2022QI;17.888
46 Valencia/València;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
46 Valencia/València;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
46 Valencia/València;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2021QII;""
46 Valencia/València;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2021QI;18.491
46 Valencia/València;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
46 Valencia/València;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
46 Valencia/València;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2020QII;""
46 Valencia/València;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2020QI;17.177
46 Valencia/València;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
46 Valencia/València;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
46 Valencia/València;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2022QII;17.143
46 Valencia/València;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2022QI;""
46 Valencia/València;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
46 Valencia/València;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
46 Valencia/València;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2021QII;17.838
46 Valencia/València;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2021QI;""
46 Valencia/València;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
46 Valencia/València;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
46 Valencia/València;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2020QII;16.767
46 Valencia/València;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2020QI;""
46 Valencia/València;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
46 Valencia/València;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QIII;16.554
46 Valencia/València;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QII;""
46 Valencia/València;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QI;""
46 Valencia/València;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
46 Valencia/València;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QIII;17.290
46 Valencia/València;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QII;""
46 Valencia/València;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QI;""
46 Valencia/València;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
46 Valencia/València;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QIII;16.233
46 Valencia/València;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QII;""
46 Valencia/València;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QI;""
46 Valencia/València;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QIV;15.988
46 Valencia/València;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
46 Valencia/València;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QII;""
46 Valencia/València;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QI;""
46 Valencia/València;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QIV;16.708
46 Valencia/València;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
46 Valencia/València;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QII;""
46 Valencia/València;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QI;""
46 Valencia/València;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QIV;15.671
46 Valencia/València;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
46 Valencia/València;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QII;""
46 Valencia/València;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QI;""
46 Valencia/València;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
46 Valencia/València;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
46 Valencia/València;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
46 Valencia/València;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
46 Valencia/València;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
46 Valencia/València;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
46 Valencia/València;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
46 Valencia/València;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
46 Valencia/València;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
46 Valencia/València;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
46 Valencia/València;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
46 Valencia/València;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
46 Valencia/València;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
46 Valencia/València;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
46 Valencia/València;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
46 Valencia/València;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;95,61
46 Valencia/València;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
46 Valencia/València;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
46 Valencia/València;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
46 Valencia/València;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;96,62
46 Valencia/València;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
46 Valencia/València;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
46 Valencia/València;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
46 Valencia/València;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;92,57
46 Valencia/València;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
46 Valencia/València;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
46 Valencia/València;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;91,62
46 Valencia/València;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
46 Valencia/València;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
46 Valencia/València;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
46 Valencia/València;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;93,21
46 Valencia/València;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
46 Valencia/València;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
46 Valencia/València;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
46 Valencia/València;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;90,36
46 Valencia/València;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
46 Valencia/València;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
46 Valencia/València;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;88,48
46 Valencia/València;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
46 Valencia/València;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
46 Valencia/València;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
46 Valencia/València;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;90,35
46 Valencia/València;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
46 Valencia/València;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
46 Valencia/València;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
46 Valencia/València;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;87,48
46 Valencia/València;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
46 Valencia/València;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
46 Valencia/València;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;85,45
46 Valencia/València;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
46 Valencia/València;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
46 Valencia/València;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
46 Valencia/València;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;87,31
46 Valencia/València;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
46 Valencia/València;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
46 Valencia/València;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
46 Valencia/València;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;84,45
46 Valencia/València;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
46 Valencia/València;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
46 Valencia/València;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
46 Valencia/València;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
46 Valencia/València;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
46 Valencia/València;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
46 Valencia/València;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QI;13.060
46 Valencia/València;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
46 Valencia/València;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
46 Valencia/València;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
46 Valencia/València;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QI;12.939
46 Valencia/València;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
46 Valencia/València;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
46 Valencia/València;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
46 Valencia/València;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QI;12.684
46 Valencia/València;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
46 Valencia/València;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
46 Valencia/València;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2022QII;""
46 Valencia/València;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2022QI;12.438
46 Valencia/València;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
46 Valencia/València;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
46 Valencia/València;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2021QII;""
46 Valencia/València;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2021QI;12.475
46 Valencia/València;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
46 Valencia/València;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
46 Valencia/València;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2020QII;""
46 Valencia/València;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2020QI;11.575
46 Valencia/València;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
46 Valencia/València;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
46 Valencia/València;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2022QII;11.859
46 Valencia/València;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2022QI;""
46 Valencia/València;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
46 Valencia/València;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
46 Valencia/València;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2021QII;11.977
46 Valencia/València;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2021QI;""
46 Valencia/València;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
46 Valencia/València;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
46 Valencia/València;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2020QII;11.266
46 Valencia/València;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2020QI;""
46 Valencia/València;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
46 Valencia/València;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QIII;11.363
46 Valencia/València;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QII;""
46 Valencia/València;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QI;""
46 Valencia/València;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
46 Valencia/València;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QIII;11.536
46 Valencia/València;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QII;""
46 Valencia/València;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QI;""
46 Valencia/València;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
46 Valencia/València;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QIII;10.824
46 Valencia/València;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QII;""
46 Valencia/València;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QI;""
46 Valencia/València;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QIV;10.895
46 Valencia/València;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
46 Valencia/València;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QII;""
46 Valencia/València;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QI;""
46 Valencia/València;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QIV;11.119
46 Valencia/València;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
46 Valencia/València;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QII;""
46 Valencia/València;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QI;""
46 Valencia/València;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QIV;10.392
46 Valencia/València;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
46 Valencia/València;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QII;""
46 Valencia/València;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QI;""
46 Valencia/València;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
46 Valencia/València;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
46 Valencia/València;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
46 Valencia/València;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
46 Valencia/València;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
46 Valencia/València;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
46 Valencia/València;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
46 Valencia/València;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
46 Valencia/València;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
46 Valencia/València;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
46 Valencia/València;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
46 Valencia/València;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
46 Valencia/València;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
46 Valencia/València;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
46 Valencia/València;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
46 Valencia/València;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;95,24
46 Valencia/València;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
46 Valencia/València;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
46 Valencia/València;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
46 Valencia/València;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;96,41
46 Valencia/València;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
46 Valencia/València;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
46 Valencia/València;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
46 Valencia/València;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;91,26
46 Valencia/València;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
46 Valencia/València;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
46 Valencia/València;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;90,8
46 Valencia/València;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
46 Valencia/València;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
46 Valencia/València;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
46 Valencia/València;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;92,57
46 Valencia/València;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
46 Valencia/València;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
46 Valencia/València;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
46 Valencia/València;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;88,82
46 Valencia/València;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
46 Valencia/València;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
46 Valencia/València;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;87,01
46 Valencia/València;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
46 Valencia/València;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
46 Valencia/València;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
46 Valencia/València;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;89,16
46 Valencia/València;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
46 Valencia/València;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
46 Valencia/València;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
46 Valencia/València;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;85,34
46 Valencia/València;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
46 Valencia/València;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
46 Valencia/València;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;83,42
46 Valencia/València;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
46 Valencia/València;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
46 Valencia/València;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
46 Valencia/València;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;85,93
46 Valencia/València;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
46 Valencia/València;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
46 Valencia/València;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
46 Valencia/València;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;81,93
46 Valencia/València;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
46 Valencia/València;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
46 Valencia/València;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
46 Valencia/València;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
46 Valencia/València;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
46 Valencia/València;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QII;29.927
46 Valencia/València;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
46 Valencia/València;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
46 Valencia/València;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
46 Valencia/València;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QII;30.458
46 Valencia/València;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
46 Valencia/València;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
46 Valencia/València;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
46 Valencia/València;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QII;30.852
46 Valencia/València;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
46 Valencia/València;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
46 Valencia/València;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
46 Valencia/València;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2022QII;28.473
46 Valencia/València;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2022QI;""
46 Valencia/València;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
46 Valencia/València;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
46 Valencia/València;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2021QII;29.139
46 Valencia/València;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2021QI;""
46 Valencia/València;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
46 Valencia/València;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
46 Valencia/València;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2020QII;30.008
46 Valencia/València;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2020QI;""
46 Valencia/València;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
46 Valencia/València;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2022QIII;27.324
46 Valencia/València;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2022QII;""
46 Valencia/València;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2022QI;""
46 Valencia/València;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
46 Valencia/València;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2021QIII;28.010
46 Valencia/València;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2021QII;""
46 Valencia/València;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2021QI;""
46 Valencia/València;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
46 Valencia/València;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2020QIII;28.852
46 Valencia/València;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2020QII;""
46 Valencia/València;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2020QI;""
46 Valencia/València;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QIV;26.174
46 Valencia/València;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
46 Valencia/València;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QII;""
46 Valencia/València;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QI;""
46 Valencia/València;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QIV;26.930
46 Valencia/València;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
46 Valencia/València;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QII;""
46 Valencia/València;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QI;""
46 Valencia/València;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QIV;27.718
46 Valencia/València;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
46 Valencia/València;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QII;""
46 Valencia/València;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QI;""
46 Valencia/València;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
46 Valencia/València;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
46 Valencia/València;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QII;""
46 Valencia/València;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QI;25.891
46 Valencia/València;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
46 Valencia/València;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
46 Valencia/València;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QII;""
46 Valencia/València;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QI;26.933
46 Valencia/València;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
46 Valencia/València;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
46 Valencia/València;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QII;""
46 Valencia/València;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QI;""
46 Valencia/València;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
46 Valencia/València;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
46 Valencia/València;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
46 Valencia/València;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
46 Valencia/València;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
46 Valencia/València;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
46 Valencia/València;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
46 Valencia/València;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
46 Valencia/València;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
46 Valencia/València;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
46 Valencia/València;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
46 Valencia/València;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
46 Valencia/València;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
46 Valencia/València;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
46 Valencia/València;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;95,14
46 Valencia/València;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
46 Valencia/València;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
46 Valencia/València;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
46 Valencia/València;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;95,67
46 Valencia/València;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
46 Valencia/València;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
46 Valencia/València;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
46 Valencia/València;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;97,26
46 Valencia/València;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
46 Valencia/València;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
46 Valencia/València;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;91,3
46 Valencia/València;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
46 Valencia/València;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
46 Valencia/València;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
46 Valencia/València;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;91,96
46 Valencia/València;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
46 Valencia/València;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
46 Valencia/València;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
46 Valencia/València;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;93,52
46 Valencia/València;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
46 Valencia/València;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
46 Valencia/València;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;87,46
46 Valencia/València;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
46 Valencia/València;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
46 Valencia/València;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
46 Valencia/València;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;88,42
46 Valencia/València;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
46 Valencia/València;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
46 Valencia/València;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
46 Valencia/València;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;89,84
46 Valencia/València;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
46 Valencia/València;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
46 Valencia/València;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
46 Valencia/València;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
46 Valencia/València;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
46 Valencia/València;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
46 Valencia/València;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;85,01
46 Valencia/València;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
46 Valencia/València;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
46 Valencia/València;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
46 Valencia/València;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;87,3
46 Valencia/València;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
46 Valencia/València;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
46 Valencia/València;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
46 Valencia/València;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
46 Valencia/València;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
46 Valencia/València;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
46 Valencia/València;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QII;17.543
46 Valencia/València;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
46 Valencia/València;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
46 Valencia/València;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
46 Valencia/València;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QII;18.001
46 Valencia/València;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
46 Valencia/València;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
46 Valencia/València;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
46 Valencia/València;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QII;18.382
46 Valencia/València;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
46 Valencia/València;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
46 Valencia/València;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
46 Valencia/València;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2022QII;16.729
46 Valencia/València;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2022QI;""
46 Valencia/València;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
46 Valencia/València;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
46 Valencia/València;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2021QII;17.249
46 Valencia/València;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2021QI;""
46 Valencia/València;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
46 Valencia/València;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
46 Valencia/València;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2020QII;17.911
46 Valencia/València;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2020QI;""
46 Valencia/València;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
46 Valencia/València;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2022QIII;16.098
46 Valencia/València;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2022QII;""
46 Valencia/València;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2022QI;""
46 Valencia/València;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
46 Valencia/València;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2021QIII;16.612
46 Valencia/València;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2021QII;""
46 Valencia/València;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2021QI;""
46 Valencia/València;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
46 Valencia/València;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2020QIII;17.271
46 Valencia/València;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2020QII;""
46 Valencia/València;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2020QI;""
46 Valencia/València;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QIV;15.464
46 Valencia/València;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
46 Valencia/València;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QII;""
46 Valencia/València;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QI;""
46 Valencia/València;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QIV;15.987
46 Valencia/València;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
46 Valencia/València;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QII;""
46 Valencia/València;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QI;""
46 Valencia/València;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QIV;16.624
46 Valencia/València;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
46 Valencia/València;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QII;""
46 Valencia/València;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QI;""
46 Valencia/València;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
46 Valencia/València;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
46 Valencia/València;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QII;""
46 Valencia/València;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QI;15.412
46 Valencia/València;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
46 Valencia/València;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
46 Valencia/València;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QII;""
46 Valencia/València;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QI;16.170
46 Valencia/València;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
46 Valencia/València;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
46 Valencia/València;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QII;""
46 Valencia/València;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QI;""
46 Valencia/València;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
46 Valencia/València;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
46 Valencia/València;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
46 Valencia/València;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
46 Valencia/València;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
46 Valencia/València;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
46 Valencia/València;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
46 Valencia/València;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
46 Valencia/València;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
46 Valencia/València;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
46 Valencia/València;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
46 Valencia/València;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
46 Valencia/València;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
46 Valencia/València;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
46 Valencia/València;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;95,36
46 Valencia/València;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
46 Valencia/València;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
46 Valencia/València;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
46 Valencia/València;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;95,82
46 Valencia/València;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
46 Valencia/València;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
46 Valencia/València;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
46 Valencia/València;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;97,44
46 Valencia/València;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
46 Valencia/València;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
46 Valencia/València;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;91,76
46 Valencia/València;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
46 Valencia/València;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
46 Valencia/València;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
46 Valencia/València;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;92,28
46 Valencia/València;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
46 Valencia/València;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
46 Valencia/València;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
46 Valencia/València;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;93,96
46 Valencia/València;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
46 Valencia/València;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
46 Valencia/València;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;88,15
46 Valencia/València;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
46 Valencia/València;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
46 Valencia/València;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
46 Valencia/València;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;88,81
46 Valencia/València;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
46 Valencia/València;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
46 Valencia/València;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
46 Valencia/València;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;90,44
46 Valencia/València;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
46 Valencia/València;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
46 Valencia/València;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
46 Valencia/València;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
46 Valencia/València;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
46 Valencia/València;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
46 Valencia/València;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;85,62
46 Valencia/València;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
46 Valencia/València;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
46 Valencia/València;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
46 Valencia/València;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;87,97
46 Valencia/València;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
46 Valencia/València;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
46 Valencia/València;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
46 Valencia/València;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
46 Valencia/València;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
46 Valencia/València;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
46 Valencia/València;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QII;12.384
46 Valencia/València;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
46 Valencia/València;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
46 Valencia/València;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
46 Valencia/València;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QII;12.457
46 Valencia/València;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
46 Valencia/València;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
46 Valencia/València;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
46 Valencia/València;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QII;12.470
46 Valencia/València;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
46 Valencia/València;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
46 Valencia/València;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
46 Valencia/València;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2022QII;11.744
46 Valencia/València;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2022QI;""
46 Valencia/València;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
46 Valencia/València;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
46 Valencia/València;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2021QII;11.890
46 Valencia/València;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2021QI;""
46 Valencia/València;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
46 Valencia/València;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
46 Valencia/València;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2020QII;12.097
46 Valencia/València;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2020QI;""
46 Valencia/València;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
46 Valencia/València;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2022QIII;11.226
46 Valencia/València;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2022QII;""
46 Valencia/València;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2022QI;""
46 Valencia/València;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
46 Valencia/València;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2021QIII;11.398
46 Valencia/València;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2021QII;""
46 Valencia/València;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2021QI;""
46 Valencia/València;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
46 Valencia/València;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2020QIII;11.581
46 Valencia/València;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2020QII;""
46 Valencia/València;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2020QI;""
46 Valencia/València;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QIV;10.710
46 Valencia/València;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
46 Valencia/València;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QII;""
46 Valencia/València;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QI;""
46 Valencia/València;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QIV;10.943
46 Valencia/València;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
46 Valencia/València;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QII;""
46 Valencia/València;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QI;""
46 Valencia/València;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QIV;11.094
46 Valencia/València;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
46 Valencia/València;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QII;""
46 Valencia/València;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QI;""
46 Valencia/València;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
46 Valencia/València;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
46 Valencia/València;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QII;""
46 Valencia/València;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QI;10.479
46 Valencia/València;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
46 Valencia/València;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
46 Valencia/València;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QII;""
46 Valencia/València;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QI;10.763
46 Valencia/València;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
46 Valencia/València;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
46 Valencia/València;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QII;""
46 Valencia/València;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QI;""
46 Valencia/València;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
46 Valencia/València;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
46 Valencia/València;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
46 Valencia/València;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
46 Valencia/València;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
46 Valencia/València;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
46 Valencia/València;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
46 Valencia/València;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
46 Valencia/València;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
46 Valencia/València;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
46 Valencia/València;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
46 Valencia/València;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
46 Valencia/València;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
46 Valencia/València;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
46 Valencia/València;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;94,83
46 Valencia/València;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
46 Valencia/València;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
46 Valencia/València;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
46 Valencia/València;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;95,45
46 Valencia/València;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
46 Valencia/València;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
46 Valencia/València;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
46 Valencia/València;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;97,01
46 Valencia/València;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
46 Valencia/València;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
46 Valencia/València;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;90,65
46 Valencia/València;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
46 Valencia/València;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
46 Valencia/València;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
46 Valencia/València;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;91,5
46 Valencia/València;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
46 Valencia/València;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
46 Valencia/València;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
46 Valencia/València;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;92,87
46 Valencia/València;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
46 Valencia/València;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
46 Valencia/València;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;86,48
46 Valencia/València;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
46 Valencia/València;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
46 Valencia/València;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
46 Valencia/València;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;87,85
46 Valencia/València;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
46 Valencia/València;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
46 Valencia/València;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
46 Valencia/València;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;88,97
46 Valencia/València;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
46 Valencia/València;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
46 Valencia/València;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
46 Valencia/València;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
46 Valencia/València;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
46 Valencia/València;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
46 Valencia/València;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;84,12
46 Valencia/València;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
46 Valencia/València;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
46 Valencia/València;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
46 Valencia/València;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;86,31
46 Valencia/València;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
46 Valencia/València;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
46 Valencia/València;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
46 Valencia/València;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
46 Valencia/València;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
46 Valencia/València;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QIII;30.352
46 Valencia/València;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
46 Valencia/València;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
46 Valencia/València;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
46 Valencia/València;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QIII;31.043
46 Valencia/València;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
46 Valencia/València;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
46 Valencia/València;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
46 Valencia/València;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QIII;31.352
46 Valencia/València;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
46 Valencia/València;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
46 Valencia/València;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
46 Valencia/València;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2022QIII;28.962
46 Valencia/València;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2022QII;""
46 Valencia/València;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2022QI;""
46 Valencia/València;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
46 Valencia/València;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2021QIII;29.661
46 Valencia/València;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2021QII;""
46 Valencia/València;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2021QI;""
46 Valencia/València;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
46 Valencia/València;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2020QIII;30.024
46 Valencia/València;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2020QII;""
46 Valencia/València;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2020QI;""
46 Valencia/València;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2022QIV;27.650
46 Valencia/València;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
46 Valencia/València;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2022QII;""
46 Valencia/València;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2022QI;""
46 Valencia/València;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2021QIV;28.410
46 Valencia/València;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
46 Valencia/València;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2021QII;""
46 Valencia/València;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2021QI;""
46 Valencia/València;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2020QIV;28.750
46 Valencia/València;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
46 Valencia/València;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2020QII;""
46 Valencia/València;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2020QI;""
46 Valencia/València;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
46 Valencia/València;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
46 Valencia/València;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QII;""
46 Valencia/València;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QI;27.251
46 Valencia/València;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
46 Valencia/València;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
46 Valencia/València;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QII;""
46 Valencia/València;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QI;27.901
46 Valencia/València;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
46 Valencia/València;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
46 Valencia/València;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QII;""
46 Valencia/València;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QI;""
46 Valencia/València;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
46 Valencia/València;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
46 Valencia/València;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QII;26.242
46 Valencia/València;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QI;""
46 Valencia/València;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
46 Valencia/València;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
46 Valencia/València;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QII;27.041
46 Valencia/València;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QI;""
46 Valencia/València;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
46 Valencia/València;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
46 Valencia/València;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QII;""
46 Valencia/València;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QI;""
46 Valencia/València;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
46 Valencia/València;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
46 Valencia/València;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
46 Valencia/València;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
46 Valencia/València;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
46 Valencia/València;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
46 Valencia/València;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
46 Valencia/València;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
46 Valencia/València;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
46 Valencia/València;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
46 Valencia/València;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
46 Valencia/València;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
46 Valencia/València;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
46 Valencia/València;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;95,42
46 Valencia/València;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
46 Valencia/València;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
46 Valencia/València;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
46 Valencia/València;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;95,55
46 Valencia/València;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
46 Valencia/València;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
46 Valencia/València;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
46 Valencia/València;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;95,76
46 Valencia/València;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
46 Valencia/València;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
46 Valencia/València;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;91,1
46 Valencia/València;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
46 Valencia/València;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
46 Valencia/València;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
46 Valencia/València;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;91,52
46 Valencia/València;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
46 Valencia/València;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
46 Valencia/València;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
46 Valencia/València;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;91,7
46 Valencia/València;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
46 Valencia/València;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
46 Valencia/València;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
46 Valencia/València;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
46 Valencia/València;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
46 Valencia/València;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
46 Valencia/València;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;87,78
46 Valencia/València;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
46 Valencia/València;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
46 Valencia/València;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
46 Valencia/València;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;88,99
46 Valencia/València;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
46 Valencia/València;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
46 Valencia/València;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
46 Valencia/València;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
46 Valencia/València;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
46 Valencia/València;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
46 Valencia/València;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;84,53
46 Valencia/València;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
46 Valencia/València;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
46 Valencia/València;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
46 Valencia/València;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;86,25
46 Valencia/València;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
46 Valencia/València;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
46 Valencia/València;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
46 Valencia/València;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
46 Valencia/València;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
46 Valencia/València;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
46 Valencia/València;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QIII;17.782
46 Valencia/València;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
46 Valencia/València;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
46 Valencia/València;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
46 Valencia/València;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QIII;18.357
46 Valencia/València;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
46 Valencia/València;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
46 Valencia/València;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
46 Valencia/València;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QIII;18.740
46 Valencia/València;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
46 Valencia/València;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
46 Valencia/València;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
46 Valencia/València;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2022QIII;17.012
46 Valencia/València;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2022QII;""
46 Valencia/València;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2022QI;""
46 Valencia/València;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
46 Valencia/València;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2021QIII;17.565
46 Valencia/València;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2021QII;""
46 Valencia/València;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2021QI;""
46 Valencia/València;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
46 Valencia/València;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2020QIII;17.992
46 Valencia/València;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2020QII;""
46 Valencia/València;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2020QI;""
46 Valencia/València;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2022QIV;16.290
46 Valencia/València;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
46 Valencia/València;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2022QII;""
46 Valencia/València;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2022QI;""
46 Valencia/València;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2021QIV;16.845
46 Valencia/València;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
46 Valencia/València;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2021QII;""
46 Valencia/València;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2021QI;""
46 Valencia/València;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2020QIV;17.258
46 Valencia/València;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
46 Valencia/València;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2020QII;""
46 Valencia/València;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2020QI;""
46 Valencia/València;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
46 Valencia/València;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
46 Valencia/València;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QII;""
46 Valencia/València;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QI;16.202
46 Valencia/València;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
46 Valencia/València;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
46 Valencia/València;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QII;""
46 Valencia/València;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QI;16.765
46 Valencia/València;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
46 Valencia/València;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
46 Valencia/València;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QII;""
46 Valencia/València;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QI;""
46 Valencia/València;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
46 Valencia/València;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
46 Valencia/València;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QII;15.633
46 Valencia/València;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QI;""
46 Valencia/València;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
46 Valencia/València;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
46 Valencia/València;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QII;16.275
46 Valencia/València;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QI;""
46 Valencia/València;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
46 Valencia/València;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
46 Valencia/València;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QII;""
46 Valencia/València;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QI;""
46 Valencia/València;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
46 Valencia/València;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
46 Valencia/València;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
46 Valencia/València;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
46 Valencia/València;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
46 Valencia/València;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
46 Valencia/València;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
46 Valencia/València;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
46 Valencia/València;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
46 Valencia/València;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
46 Valencia/València;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
46 Valencia/València;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
46 Valencia/València;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
46 Valencia/València;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;95,67
46 Valencia/València;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
46 Valencia/València;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
46 Valencia/València;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
46 Valencia/València;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;95,69
46 Valencia/València;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
46 Valencia/València;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
46 Valencia/València;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
46 Valencia/València;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;96,01
46 Valencia/València;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
46 Valencia/València;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
46 Valencia/València;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;91,61
46 Valencia/València;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
46 Valencia/València;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
46 Valencia/València;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
46 Valencia/València;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;91,76
46 Valencia/València;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
46 Valencia/València;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
46 Valencia/València;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
46 Valencia/València;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;92,09
46 Valencia/València;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
46 Valencia/València;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
46 Valencia/València;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
46 Valencia/València;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
46 Valencia/València;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
46 Valencia/València;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
46 Valencia/València;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;88,26
46 Valencia/València;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
46 Valencia/València;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
46 Valencia/València;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
46 Valencia/València;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;89,46
46 Valencia/València;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
46 Valencia/València;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
46 Valencia/València;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
46 Valencia/València;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
46 Valencia/València;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
46 Valencia/València;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
46 Valencia/València;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;85,16
46 Valencia/València;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
46 Valencia/València;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
46 Valencia/València;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
46 Valencia/València;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;86,85
46 Valencia/València;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
46 Valencia/València;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
46 Valencia/València;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
46 Valencia/València;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
46 Valencia/València;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
46 Valencia/València;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
46 Valencia/València;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QIII;12.570
46 Valencia/València;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
46 Valencia/València;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
46 Valencia/València;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
46 Valencia/València;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QIII;12.686
46 Valencia/València;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
46 Valencia/València;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
46 Valencia/València;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
46 Valencia/València;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QIII;12.612
46 Valencia/València;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
46 Valencia/València;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
46 Valencia/València;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
46 Valencia/València;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2022QIII;11.950
46 Valencia/València;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2022QII;""
46 Valencia/València;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2022QI;""
46 Valencia/València;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
46 Valencia/València;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2021QIII;12.096
46 Valencia/València;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2021QII;""
46 Valencia/València;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2021QI;""
46 Valencia/València;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
46 Valencia/València;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2020QIII;12.032
46 Valencia/València;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2020QII;""
46 Valencia/València;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2020QI;""
46 Valencia/València;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2022QIV;11.360
46 Valencia/València;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
46 Valencia/València;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2022QII;""
46 Valencia/València;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2022QI;""
46 Valencia/València;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2021QIV;11.565
46 Valencia/València;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
46 Valencia/València;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2021QII;""
46 Valencia/València;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2021QI;""
46 Valencia/València;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2020QIV;11.492
46 Valencia/València;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
46 Valencia/València;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2020QII;""
46 Valencia/València;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2020QI;""
46 Valencia/València;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
46 Valencia/València;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
46 Valencia/València;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QII;""
46 Valencia/València;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QI;11.049
46 Valencia/València;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
46 Valencia/València;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
46 Valencia/València;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QII;""
46 Valencia/València;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QI;11.136
46 Valencia/València;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
46 Valencia/València;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
46 Valencia/València;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QII;""
46 Valencia/València;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QI;""
46 Valencia/València;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
46 Valencia/València;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
46 Valencia/València;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QII;10.609
46 Valencia/València;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QI;""
46 Valencia/València;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
46 Valencia/València;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
46 Valencia/València;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QII;10.766
46 Valencia/València;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QI;""
46 Valencia/València;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
46 Valencia/València;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
46 Valencia/València;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QII;""
46 Valencia/València;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QI;""
46 Valencia/València;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
46 Valencia/València;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
46 Valencia/València;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
46 Valencia/València;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
46 Valencia/València;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
46 Valencia/València;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
46 Valencia/València;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
46 Valencia/València;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
46 Valencia/València;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
46 Valencia/València;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
46 Valencia/València;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
46 Valencia/València;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
46 Valencia/València;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
46 Valencia/València;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;95,07
46 Valencia/València;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
46 Valencia/València;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
46 Valencia/València;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
46 Valencia/València;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;95,35
46 Valencia/València;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
46 Valencia/València;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
46 Valencia/València;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
46 Valencia/València;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;95,4
46 Valencia/València;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
46 Valencia/València;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
46 Valencia/València;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;90,37
46 Valencia/València;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
46 Valencia/València;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
46 Valencia/València;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
46 Valencia/València;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;91,16
46 Valencia/València;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
46 Valencia/València;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
46 Valencia/València;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
46 Valencia/València;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;91,12
46 Valencia/València;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
46 Valencia/València;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
46 Valencia/València;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
46 Valencia/València;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
46 Valencia/València;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
46 Valencia/València;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
46 Valencia/València;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;87,1
46 Valencia/València;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
46 Valencia/València;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
46 Valencia/València;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
46 Valencia/València;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;88,3
46 Valencia/València;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
46 Valencia/València;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
46 Valencia/València;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
46 Valencia/València;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
46 Valencia/València;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
46 Valencia/València;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
46 Valencia/València;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;83,63
46 Valencia/València;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
46 Valencia/València;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
46 Valencia/València;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
46 Valencia/València;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;85,36
46 Valencia/València;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
46 Valencia/València;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
46 Valencia/València;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
46 Valencia/València;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
46 Valencia/València;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
46 Valencia/València;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QIV;30.532
46 Valencia/València;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
46 Valencia/València;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
46 Valencia/València;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
46 Valencia/València;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QIV;31.246
46 Valencia/València;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
46 Valencia/València;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
46 Valencia/València;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
46 Valencia/València;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QIV;31.730
46 Valencia/València;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
46 Valencia/València;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
46 Valencia/València;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
46 Valencia/València;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2022QIV;29.055
46 Valencia/València;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
46 Valencia/València;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2022QII;""
46 Valencia/València;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2022QI;""
46 Valencia/València;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2021QIV;29.820
46 Valencia/València;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
46 Valencia/València;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2021QII;""
46 Valencia/València;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2021QI;""
46 Valencia/València;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2020QIV;30.270
46 Valencia/València;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
46 Valencia/València;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2020QII;""
46 Valencia/València;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2020QI;""
46 Valencia/València;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
46 Valencia/València;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
46 Valencia/València;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2022QII;""
46 Valencia/València;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2022QI;28.558
46 Valencia/València;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
46 Valencia/València;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
46 Valencia/València;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2021QII;""
46 Valencia/València;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2021QI;29.320
46 Valencia/València;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
46 Valencia/València;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
46 Valencia/València;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2020QII;""
46 Valencia/València;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2020QI;""
46 Valencia/València;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
46 Valencia/València;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
46 Valencia/València;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QII;27.421
46 Valencia/València;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QI;""
46 Valencia/València;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
46 Valencia/València;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
46 Valencia/València;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QII;28.347
46 Valencia/València;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QI;""
46 Valencia/València;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
46 Valencia/València;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
46 Valencia/València;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QII;""
46 Valencia/València;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QI;""
46 Valencia/València;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
46 Valencia/València;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QIII;26.451
46 Valencia/València;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QII;""
46 Valencia/València;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QI;""
46 Valencia/València;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
46 Valencia/València;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QIII;27.484
46 Valencia/València;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QII;""
46 Valencia/València;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QI;""
46 Valencia/València;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
46 Valencia/València;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
46 Valencia/València;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QII;""
46 Valencia/València;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QI;""
46 Valencia/València;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
46 Valencia/València;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
46 Valencia/València;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
46 Valencia/València;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
46 Valencia/València;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
46 Valencia/València;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
46 Valencia/València;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
46 Valencia/València;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
46 Valencia/València;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
46 Valencia/València;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
46 Valencia/València;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
46 Valencia/València;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
46 Valencia/València;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;95,16
46 Valencia/València;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
46 Valencia/València;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
46 Valencia/València;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
46 Valencia/València;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;95,44
46 Valencia/València;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
46 Valencia/València;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
46 Valencia/València;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
46 Valencia/València;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;95,4
46 Valencia/València;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
46 Valencia/València;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
46 Valencia/València;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
46 Valencia/València;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
46 Valencia/València;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
46 Valencia/València;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
46 Valencia/València;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;91,4
46 Valencia/València;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
46 Valencia/València;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
46 Valencia/València;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
46 Valencia/València;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;92,4
46 Valencia/València;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
46 Valencia/València;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
46 Valencia/València;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
46 Valencia/València;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
46 Valencia/València;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
46 Valencia/València;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
46 Valencia/València;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;87,76
46 Valencia/València;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
46 Valencia/València;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
46 Valencia/València;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
46 Valencia/València;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;89,34
46 Valencia/València;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
46 Valencia/València;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
46 Valencia/València;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
46 Valencia/València;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
46 Valencia/València;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
46 Valencia/València;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
46 Valencia/València;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;84,65
46 Valencia/València;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
46 Valencia/València;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
46 Valencia/València;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
46 Valencia/València;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;86,62
46 Valencia/València;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
46 Valencia/València;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
46 Valencia/València;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
46 Valencia/València;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
46 Valencia/València;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
46 Valencia/València;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
46 Valencia/València;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QIV;17.918
46 Valencia/València;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
46 Valencia/València;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
46 Valencia/València;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
46 Valencia/València;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QIV;18.465
46 Valencia/València;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
46 Valencia/València;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
46 Valencia/València;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
46 Valencia/València;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QIV;18.962
46 Valencia/València;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
46 Valencia/València;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
46 Valencia/València;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
46 Valencia/València;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2022QIV;17.098
46 Valencia/València;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
46 Valencia/València;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2022QII;""
46 Valencia/València;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2022QI;""
46 Valencia/València;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2021QIV;17.645
46 Valencia/València;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
46 Valencia/València;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2021QII;""
46 Valencia/València;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2021QI;""
46 Valencia/València;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2020QIV;18.119
46 Valencia/València;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
46 Valencia/València;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2020QII;""
46 Valencia/València;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2020QI;""
46 Valencia/València;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
46 Valencia/València;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
46 Valencia/València;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2022QII;""
46 Valencia/València;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2022QI;16.935
46 Valencia/València;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
46 Valencia/València;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
46 Valencia/València;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2021QII;""
46 Valencia/València;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2021QI;17.567
46 Valencia/València;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
46 Valencia/València;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
46 Valencia/València;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2020QII;""
46 Valencia/València;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2020QI;""
46 Valencia/València;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
46 Valencia/València;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
46 Valencia/València;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QII;16.293
46 Valencia/València;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QI;""
46 Valencia/València;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
46 Valencia/València;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
46 Valencia/València;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QII;17.017
46 Valencia/València;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QI;""
46 Valencia/València;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
46 Valencia/València;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
46 Valencia/València;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QII;""
46 Valencia/València;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QI;""
46 Valencia/València;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
46 Valencia/València;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QIII;15.759
46 Valencia/València;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QII;""
46 Valencia/València;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QI;""
46 Valencia/València;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
46 Valencia/València;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QIII;16.536
46 Valencia/València;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QII;""
46 Valencia/València;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QI;""
46 Valencia/València;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
46 Valencia/València;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
46 Valencia/València;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QII;""
46 Valencia/València;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QI;""
46 Valencia/València;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
46 Valencia/València;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
46 Valencia/València;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
46 Valencia/València;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
46 Valencia/València;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
46 Valencia/València;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
46 Valencia/València;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
46 Valencia/València;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
46 Valencia/València;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
46 Valencia/València;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
46 Valencia/València;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
46 Valencia/València;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
46 Valencia/València;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;95,42
46 Valencia/València;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
46 Valencia/València;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
46 Valencia/València;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
46 Valencia/València;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;95,56
46 Valencia/València;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
46 Valencia/València;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
46 Valencia/València;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
46 Valencia/València;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;95,55
46 Valencia/València;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
46 Valencia/València;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
46 Valencia/València;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
46 Valencia/València;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
46 Valencia/València;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
46 Valencia/València;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
46 Valencia/València;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;91,71
46 Valencia/València;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
46 Valencia/València;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
46 Valencia/València;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
46 Valencia/València;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;92,64
46 Valencia/València;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
46 Valencia/València;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
46 Valencia/València;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
46 Valencia/València;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
46 Valencia/València;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
46 Valencia/València;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
46 Valencia/València;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;88,24
46 Valencia/València;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
46 Valencia/València;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
46 Valencia/València;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
46 Valencia/València;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;89,74
46 Valencia/València;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
46 Valencia/València;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
46 Valencia/València;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
46 Valencia/València;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
46 Valencia/València;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
46 Valencia/València;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
46 Valencia/València;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;85,35
46 Valencia/València;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
46 Valencia/València;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
46 Valencia/València;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
46 Valencia/València;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;87,21
46 Valencia/València;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
46 Valencia/València;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
46 Valencia/València;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
46 Valencia/València;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
46 Valencia/València;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
46 Valencia/València;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
46 Valencia/València;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QIV;12.614
46 Valencia/València;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
46 Valencia/València;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
46 Valencia/València;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
46 Valencia/València;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QIV;12.781
46 Valencia/València;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
46 Valencia/València;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
46 Valencia/València;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
46 Valencia/València;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QIV;12.768
46 Valencia/València;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
46 Valencia/València;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
46 Valencia/València;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
46 Valencia/València;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2022QIV;11.957
46 Valencia/València;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
46 Valencia/València;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2022QII;""
46 Valencia/València;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2022QI;""
46 Valencia/València;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2021QIV;12.175
46 Valencia/València;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
46 Valencia/València;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2021QII;""
46 Valencia/València;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2021QI;""
46 Valencia/València;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2020QIV;12.151
46 Valencia/València;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
46 Valencia/València;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2020QII;""
46 Valencia/València;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2020QI;""
46 Valencia/València;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
46 Valencia/València;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
46 Valencia/València;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2022QII;""
46 Valencia/València;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2022QI;11.623
46 Valencia/València;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
46 Valencia/València;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
46 Valencia/València;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2021QII;""
46 Valencia/València;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2021QI;11.753
46 Valencia/València;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
46 Valencia/València;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
46 Valencia/València;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2020QII;""
46 Valencia/València;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2020QI;""
46 Valencia/València;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
46 Valencia/València;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
46 Valencia/València;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QII;11.128
46 Valencia/València;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QI;""
46 Valencia/València;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
46 Valencia/València;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
46 Valencia/València;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QII;11.330
46 Valencia/València;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QI;""
46 Valencia/València;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
46 Valencia/València;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
46 Valencia/València;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QII;""
46 Valencia/València;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QI;""
46 Valencia/València;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
46 Valencia/València;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QIII;10.692
46 Valencia/València;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QII;""
46 Valencia/València;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QI;""
46 Valencia/València;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
46 Valencia/València;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QIII;10.948
46 Valencia/València;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QII;""
46 Valencia/València;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QI;""
46 Valencia/València;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
46 Valencia/València;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
46 Valencia/València;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QII;""
46 Valencia/València;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QI;""
46 Valencia/València;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
46 Valencia/València;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
46 Valencia/València;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
46 Valencia/València;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
46 Valencia/València;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
46 Valencia/València;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
46 Valencia/València;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
46 Valencia/València;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
46 Valencia/València;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
46 Valencia/València;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
46 Valencia/València;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
46 Valencia/València;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
46 Valencia/València;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;94,79
46 Valencia/València;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
46 Valencia/València;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
46 Valencia/València;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
46 Valencia/València;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;95,26
46 Valencia/València;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
46 Valencia/València;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
46 Valencia/València;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
46 Valencia/València;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;95,17
46 Valencia/València;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
46 Valencia/València;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
46 Valencia/València;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
46 Valencia/València;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
46 Valencia/València;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
46 Valencia/València;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
46 Valencia/València;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;90,94
46 Valencia/València;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
46 Valencia/València;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
46 Valencia/València;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
46 Valencia/València;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;92,05
46 Valencia/València;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
46 Valencia/València;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
46 Valencia/València;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
46 Valencia/València;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
46 Valencia/València;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
46 Valencia/València;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
46 Valencia/València;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;87,07
46 Valencia/València;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
46 Valencia/València;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
46 Valencia/València;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
46 Valencia/València;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;88,74
46 Valencia/València;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
46 Valencia/València;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
46 Valencia/València;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
46 Valencia/València;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
46 Valencia/València;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
46 Valencia/València;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
46 Valencia/València;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;83,66
46 Valencia/València;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
46 Valencia/València;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
46 Valencia/València;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
46 Valencia/València;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;85,75
46 Valencia/València;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
46 Valencia/València;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
46 Valencia/València;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
46 Valencia/València;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
46 Valencia/València;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
46 Valencia/València;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
46 Valencia/València;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
46 Valencia/València;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
46 Valencia/València;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
46 Valencia/València;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QI;55.861
46 Valencia/València;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
46 Valencia/València;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
46 Valencia/València;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
46 Valencia/València;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QI;55.892
46 Valencia/València;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
46 Valencia/València;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
46 Valencia/València;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
46 Valencia/València;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QI;56.175
46 Valencia/València;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
46 Valencia/València;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
46 Valencia/València;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2022QII;""
46 Valencia/València;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2022QI;54.192
46 Valencia/València;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
46 Valencia/València;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
46 Valencia/València;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2021QII;""
46 Valencia/València;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2021QI;54.577
46 Valencia/València;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
46 Valencia/València;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
46 Valencia/València;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2020QII;""
46 Valencia/València;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2020QI;52.797
46 Valencia/València;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
46 Valencia/València;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
46 Valencia/València;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2022QII;52.567
46 Valencia/València;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2022QI;""
46 Valencia/València;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
46 Valencia/València;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
46 Valencia/València;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2021QII;53.195
46 Valencia/València;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2021QI;""
46 Valencia/València;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
46 Valencia/València;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
46 Valencia/València;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2020QII;51.867
46 Valencia/València;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2020QI;""
46 Valencia/València;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
46 Valencia/València;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QIII;51.217
46 Valencia/València;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QII;""
46 Valencia/València;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QI;""
46 Valencia/València;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
46 Valencia/València;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QIII;52.009
46 Valencia/València;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QII;""
46 Valencia/València;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QI;""
46 Valencia/València;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
46 Valencia/València;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QIII;50.671
46 Valencia/València;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QII;""
46 Valencia/València;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QI;""
46 Valencia/València;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QIV;49.868
46 Valencia/València;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
46 Valencia/València;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QII;""
46 Valencia/València;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QI;""
46 Valencia/València;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QIV;50.756
46 Valencia/València;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
46 Valencia/València;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QII;""
46 Valencia/València;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QI;""
46 Valencia/València;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QIV;49.406
46 Valencia/València;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
46 Valencia/València;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QII;""
46 Valencia/València;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QI;""
46 Valencia/València;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
46 Valencia/València;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
46 Valencia/València;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
46 Valencia/València;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
46 Valencia/València;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
46 Valencia/València;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
46 Valencia/València;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
46 Valencia/València;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
46 Valencia/València;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
46 Valencia/València;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
46 Valencia/València;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
46 Valencia/València;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
46 Valencia/València;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
46 Valencia/València;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
46 Valencia/València;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
46 Valencia/València;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;97,01
46 Valencia/València;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
46 Valencia/València;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
46 Valencia/València;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
46 Valencia/València;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;97,65
46 Valencia/València;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
46 Valencia/València;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
46 Valencia/València;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
46 Valencia/València;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;93,99
46 Valencia/València;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
46 Valencia/València;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
46 Valencia/València;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;94,1
46 Valencia/València;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
46 Valencia/València;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
46 Valencia/València;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
46 Valencia/València;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;95,17
46 Valencia/València;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
46 Valencia/València;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
46 Valencia/València;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
46 Valencia/València;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;92,33
46 Valencia/València;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
46 Valencia/València;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
46 Valencia/València;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;91,69
46 Valencia/València;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
46 Valencia/València;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
46 Valencia/València;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
46 Valencia/València;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;93,05
46 Valencia/València;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
46 Valencia/València;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
46 Valencia/València;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
46 Valencia/València;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;90,2
46 Valencia/València;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
46 Valencia/València;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
46 Valencia/València;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;89,27
46 Valencia/València;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
46 Valencia/València;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
46 Valencia/València;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
46 Valencia/València;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;90,81
46 Valencia/València;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
46 Valencia/València;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
46 Valencia/València;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
46 Valencia/València;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;87,95
46 Valencia/València;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
46 Valencia/València;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
46 Valencia/València;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
46 Valencia/València;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
46 Valencia/València;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
46 Valencia/València;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
46 Valencia/València;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QI;35.377
46 Valencia/València;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
46 Valencia/València;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
46 Valencia/València;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
46 Valencia/València;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QI;35.518
46 Valencia/València;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
46 Valencia/València;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
46 Valencia/València;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
46 Valencia/València;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QI;35.630
46 Valencia/València;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
46 Valencia/València;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
46 Valencia/València;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2022QII;""
46 Valencia/València;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2022QI;34.404
46 Valencia/València;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
46 Valencia/València;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
46 Valencia/València;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2021QII;""
46 Valencia/València;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2021QI;34.726
46 Valencia/València;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
46 Valencia/València;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
46 Valencia/València;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2020QII;""
46 Valencia/València;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2020QI;33.649
46 Valencia/València;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
46 Valencia/València;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
46 Valencia/València;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2022QII;33.483
46 Valencia/València;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2022QI;""
46 Valencia/València;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
46 Valencia/València;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
46 Valencia/València;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2021QII;33.926
46 Valencia/València;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2021QI;""
46 Valencia/València;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
46 Valencia/València;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
46 Valencia/València;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2020QII;33.119
46 Valencia/València;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2020QI;""
46 Valencia/València;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
46 Valencia/València;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QIII;32.708
46 Valencia/València;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QII;""
46 Valencia/València;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QI;""
46 Valencia/València;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
46 Valencia/València;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QIII;33.225
46 Valencia/València;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QII;""
46 Valencia/València;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QI;""
46 Valencia/València;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
46 Valencia/València;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QIII;32.434
46 Valencia/València;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QII;""
46 Valencia/València;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QI;""
46 Valencia/València;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QIV;31.898
46 Valencia/València;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
46 Valencia/València;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QII;""
46 Valencia/València;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QI;""
46 Valencia/València;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QIV;32.493
46 Valencia/València;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
46 Valencia/València;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QII;""
46 Valencia/València;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QI;""
46 Valencia/València;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QIV;31.709
46 Valencia/València;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
46 Valencia/València;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QII;""
46 Valencia/València;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QI;""
46 Valencia/València;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
46 Valencia/València;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
46 Valencia/València;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
46 Valencia/València;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
46 Valencia/València;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
46 Valencia/València;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
46 Valencia/València;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
46 Valencia/València;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
46 Valencia/València;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
46 Valencia/València;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
46 Valencia/València;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
46 Valencia/València;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
46 Valencia/València;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
46 Valencia/València;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
46 Valencia/València;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
46 Valencia/València;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;97,25
46 Valencia/València;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
46 Valencia/València;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
46 Valencia/València;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
46 Valencia/València;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;97,77
46 Valencia/València;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
46 Valencia/València;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
46 Valencia/València;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
46 Valencia/València;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;94,44
46 Valencia/València;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
46 Valencia/València;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
46 Valencia/València;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;94,65
46 Valencia/València;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
46 Valencia/València;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
46 Valencia/València;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
46 Valencia/València;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;95,52
46 Valencia/València;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
46 Valencia/València;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
46 Valencia/València;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
46 Valencia/València;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;92,95
46 Valencia/València;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
46 Valencia/València;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
46 Valencia/València;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;92,46
46 Valencia/València;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
46 Valencia/València;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
46 Valencia/València;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
46 Valencia/València;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;93,54
46 Valencia/València;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
46 Valencia/València;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
46 Valencia/València;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
46 Valencia/València;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;91,03
46 Valencia/València;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
46 Valencia/València;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
46 Valencia/València;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;90,17
46 Valencia/València;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
46 Valencia/València;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
46 Valencia/València;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
46 Valencia/València;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;91,48
46 Valencia/València;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
46 Valencia/València;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
46 Valencia/València;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
46 Valencia/València;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;89
46 Valencia/València;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
46 Valencia/València;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
46 Valencia/València;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
46 Valencia/València;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
46 Valencia/València;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
46 Valencia/València;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
46 Valencia/València;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QI;20.484
46 Valencia/València;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
46 Valencia/València;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
46 Valencia/València;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
46 Valencia/València;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QI;20.374
46 Valencia/València;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
46 Valencia/València;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
46 Valencia/València;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
46 Valencia/València;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QI;20.545
46 Valencia/València;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
46 Valencia/València;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
46 Valencia/València;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2022QII;""
46 Valencia/València;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2022QI;19.788
46 Valencia/València;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
46 Valencia/València;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
46 Valencia/València;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2021QII;""
46 Valencia/València;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2021QI;19.851
46 Valencia/València;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
46 Valencia/València;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
46 Valencia/València;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2020QII;""
46 Valencia/València;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2020QI;19.148
46 Valencia/València;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
46 Valencia/València;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
46 Valencia/València;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2022QII;19.084
46 Valencia/València;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2022QI;""
46 Valencia/València;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
46 Valencia/València;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
46 Valencia/València;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2021QII;19.269
46 Valencia/València;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2021QI;""
46 Valencia/València;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
46 Valencia/València;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
46 Valencia/València;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2020QII;18.748
46 Valencia/València;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2020QI;""
46 Valencia/València;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
46 Valencia/València;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QIII;18.509
46 Valencia/València;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QII;""
46 Valencia/València;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QI;""
46 Valencia/València;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
46 Valencia/València;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QIII;18.784
46 Valencia/València;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QII;""
46 Valencia/València;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QI;""
46 Valencia/València;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
46 Valencia/València;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QIII;18.237
46 Valencia/València;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QII;""
46 Valencia/València;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QI;""
46 Valencia/València;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QIV;17.970
46 Valencia/València;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
46 Valencia/València;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QII;""
46 Valencia/València;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QI;""
46 Valencia/València;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QIV;18.263
46 Valencia/València;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
46 Valencia/València;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QII;""
46 Valencia/València;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QI;""
46 Valencia/València;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QIV;17.697
46 Valencia/València;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
46 Valencia/València;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QII;""
46 Valencia/València;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QI;""
46 Valencia/València;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
46 Valencia/València;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
46 Valencia/València;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
46 Valencia/València;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
46 Valencia/València;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
46 Valencia/València;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
46 Valencia/València;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
46 Valencia/València;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
46 Valencia/València;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
46 Valencia/València;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
46 Valencia/València;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
46 Valencia/València;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
46 Valencia/València;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
46 Valencia/València;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
46 Valencia/València;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
46 Valencia/València;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;96,6
46 Valencia/València;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
46 Valencia/València;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
46 Valencia/València;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
46 Valencia/València;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;97,43
46 Valencia/València;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
46 Valencia/València;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
46 Valencia/València;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
46 Valencia/València;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;93,2
46 Valencia/València;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
46 Valencia/València;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
46 Valencia/València;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;93,17
46 Valencia/València;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
46 Valencia/València;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
46 Valencia/València;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
46 Valencia/València;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;94,58
46 Valencia/València;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
46 Valencia/València;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
46 Valencia/València;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
46 Valencia/València;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;91,25
46 Valencia/València;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
46 Valencia/València;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
46 Valencia/València;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;90,36
46 Valencia/València;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
46 Valencia/València;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
46 Valencia/València;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
46 Valencia/València;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;92,2
46 Valencia/València;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
46 Valencia/València;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
46 Valencia/València;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
46 Valencia/València;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;88,77
46 Valencia/València;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
46 Valencia/València;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
46 Valencia/València;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;87,73
46 Valencia/València;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
46 Valencia/València;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
46 Valencia/València;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
46 Valencia/València;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;89,64
46 Valencia/València;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
46 Valencia/València;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
46 Valencia/València;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
46 Valencia/València;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;86,14
46 Valencia/València;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
46 Valencia/València;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
46 Valencia/València;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
46 Valencia/València;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
46 Valencia/València;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
46 Valencia/València;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QII;54.731
46 Valencia/València;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
46 Valencia/València;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
46 Valencia/València;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
46 Valencia/València;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QII;55.188
46 Valencia/València;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
46 Valencia/València;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
46 Valencia/València;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
46 Valencia/València;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QII;55.137
46 Valencia/València;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
46 Valencia/València;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
46 Valencia/València;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
46 Valencia/València;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2022QII;52.884
46 Valencia/València;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2022QI;""
46 Valencia/València;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
46 Valencia/València;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
46 Valencia/València;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2021QII;53.635
46 Valencia/València;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2021QI;""
46 Valencia/València;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
46 Valencia/València;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
46 Valencia/València;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2020QII;54.070
46 Valencia/València;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2020QI;""
46 Valencia/València;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
46 Valencia/València;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2022QIII;51.366
46 Valencia/València;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2022QII;""
46 Valencia/València;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2022QI;""
46 Valencia/València;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
46 Valencia/València;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2021QIII;52.334
46 Valencia/València;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2021QII;""
46 Valencia/València;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2021QI;""
46 Valencia/València;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
46 Valencia/València;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2020QIII;52.715
46 Valencia/València;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2020QII;""
46 Valencia/València;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2020QI;""
46 Valencia/València;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QIV;49.914
46 Valencia/València;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
46 Valencia/València;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QII;""
46 Valencia/València;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QI;""
46 Valencia/València;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QIV;50.923
46 Valencia/València;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
46 Valencia/València;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QII;""
46 Valencia/València;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QI;""
46 Valencia/València;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QIV;51.298
46 Valencia/València;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
46 Valencia/València;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QII;""
46 Valencia/València;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QI;""
46 Valencia/València;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
46 Valencia/València;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
46 Valencia/València;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QII;""
46 Valencia/València;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QI;49.656
46 Valencia/València;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
46 Valencia/València;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
46 Valencia/València;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QII;""
46 Valencia/València;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QI;50.328
46 Valencia/València;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
46 Valencia/València;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
46 Valencia/València;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QII;""
46 Valencia/València;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QI;""
46 Valencia/València;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
46 Valencia/València;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
46 Valencia/València;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
46 Valencia/València;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
46 Valencia/València;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
46 Valencia/València;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
46 Valencia/València;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
46 Valencia/València;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
46 Valencia/València;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
46 Valencia/València;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
46 Valencia/València;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
46 Valencia/València;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
46 Valencia/València;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
46 Valencia/València;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
46 Valencia/València;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;96,63
46 Valencia/València;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
46 Valencia/València;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
46 Valencia/València;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
46 Valencia/València;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;97,19
46 Valencia/València;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
46 Valencia/València;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
46 Valencia/València;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
46 Valencia/València;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;98,06
46 Valencia/València;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
46 Valencia/València;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
46 Valencia/València;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;93,85
46 Valencia/València;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
46 Valencia/València;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
46 Valencia/València;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
46 Valencia/València;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;94,83
46 Valencia/València;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
46 Valencia/València;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
46 Valencia/València;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
46 Valencia/València;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;95,61
46 Valencia/València;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
46 Valencia/València;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
46 Valencia/València;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;91,2
46 Valencia/València;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
46 Valencia/València;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
46 Valencia/València;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
46 Valencia/València;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;92,27
46 Valencia/València;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
46 Valencia/València;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
46 Valencia/València;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
46 Valencia/València;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;93,04
46 Valencia/València;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
46 Valencia/València;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
46 Valencia/València;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
46 Valencia/València;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
46 Valencia/València;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
46 Valencia/València;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
46 Valencia/València;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;89,98
46 Valencia/València;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
46 Valencia/València;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
46 Valencia/València;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
46 Valencia/València;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;91,28
46 Valencia/València;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
46 Valencia/València;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
46 Valencia/València;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
46 Valencia/València;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
46 Valencia/València;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
46 Valencia/València;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
46 Valencia/València;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QII;34.441
46 Valencia/València;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
46 Valencia/València;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
46 Valencia/València;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
46 Valencia/València;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QII;34.988
46 Valencia/València;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
46 Valencia/València;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
46 Valencia/València;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
46 Valencia/València;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QII;34.976
46 Valencia/València;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
46 Valencia/València;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
46 Valencia/València;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
46 Valencia/València;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2022QII;33.411
46 Valencia/València;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2022QI;""
46 Valencia/València;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
46 Valencia/València;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
46 Valencia/València;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2021QII;34.068
46 Valencia/València;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2021QI;""
46 Valencia/València;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
46 Valencia/València;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
46 Valencia/València;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2020QII;34.374
46 Valencia/València;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2020QI;""
46 Valencia/València;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
46 Valencia/València;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2022QIII;32.534
46 Valencia/València;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2022QII;""
46 Valencia/València;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2022QI;""
46 Valencia/València;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
46 Valencia/València;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2021QIII;33.299
46 Valencia/València;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2021QII;""
46 Valencia/València;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2021QI;""
46 Valencia/València;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
46 Valencia/València;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2020QIII;33.599
46 Valencia/València;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2020QII;""
46 Valencia/València;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2020QI;""
46 Valencia/València;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QIV;31.663
46 Valencia/València;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
46 Valencia/València;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QII;""
46 Valencia/València;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QI;""
46 Valencia/València;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QIV;32.467
46 Valencia/València;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
46 Valencia/València;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QII;""
46 Valencia/València;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QI;""
46 Valencia/València;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QIV;32.782
46 Valencia/València;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
46 Valencia/València;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QII;""
46 Valencia/València;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QI;""
46 Valencia/València;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
46 Valencia/València;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
46 Valencia/València;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QII;""
46 Valencia/València;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QI;31.739
46 Valencia/València;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
46 Valencia/València;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
46 Valencia/València;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QII;""
46 Valencia/València;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QI;32.207
46 Valencia/València;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
46 Valencia/València;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
46 Valencia/València;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QII;""
46 Valencia/València;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QI;""
46 Valencia/València;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
46 Valencia/València;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
46 Valencia/València;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
46 Valencia/València;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
46 Valencia/València;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
46 Valencia/València;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
46 Valencia/València;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
46 Valencia/València;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
46 Valencia/València;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
46 Valencia/València;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
46 Valencia/València;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
46 Valencia/València;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
46 Valencia/València;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
46 Valencia/València;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
46 Valencia/València;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;97,01
46 Valencia/València;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
46 Valencia/València;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
46 Valencia/València;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
46 Valencia/València;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;97,37
46 Valencia/València;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
46 Valencia/València;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
46 Valencia/València;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
46 Valencia/València;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;98,28
46 Valencia/València;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
46 Valencia/València;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
46 Valencia/València;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;94,46
46 Valencia/València;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
46 Valencia/València;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
46 Valencia/València;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
46 Valencia/València;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;95,17
46 Valencia/València;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
46 Valencia/València;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
46 Valencia/València;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
46 Valencia/València;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;96,06
46 Valencia/València;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
46 Valencia/València;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
46 Valencia/València;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;91,93
46 Valencia/València;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
46 Valencia/València;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
46 Valencia/València;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
46 Valencia/València;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;92,79
46 Valencia/València;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
46 Valencia/València;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
46 Valencia/València;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
46 Valencia/València;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;93,73
46 Valencia/València;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
46 Valencia/València;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
46 Valencia/València;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
46 Valencia/València;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
46 Valencia/València;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
46 Valencia/València;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
46 Valencia/València;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;90,71
46 Valencia/València;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
46 Valencia/València;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
46 Valencia/València;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
46 Valencia/València;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;92,08
46 Valencia/València;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
46 Valencia/València;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
46 Valencia/València;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
46 Valencia/València;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
46 Valencia/València;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
46 Valencia/València;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
46 Valencia/València;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QII;20.290
46 Valencia/València;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
46 Valencia/València;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
46 Valencia/València;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
46 Valencia/València;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QII;20.200
46 Valencia/València;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
46 Valencia/València;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
46 Valencia/València;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
46 Valencia/València;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QII;20.161
46 Valencia/València;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
46 Valencia/València;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
46 Valencia/València;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
46 Valencia/València;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2022QII;19.473
46 Valencia/València;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2022QI;""
46 Valencia/València;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
46 Valencia/València;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
46 Valencia/València;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2021QII;19.567
46 Valencia/València;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2021QI;""
46 Valencia/València;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
46 Valencia/València;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
46 Valencia/València;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2020QII;19.696
46 Valencia/València;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2020QI;""
46 Valencia/València;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
46 Valencia/València;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2022QIII;18.832
46 Valencia/València;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2022QII;""
46 Valencia/València;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2022QI;""
46 Valencia/València;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
46 Valencia/València;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2021QIII;19.035
46 Valencia/València;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2021QII;""
46 Valencia/València;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2021QI;""
46 Valencia/València;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
46 Valencia/València;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2020QIII;19.116
46 Valencia/València;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2020QII;""
46 Valencia/València;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2020QI;""
46 Valencia/València;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QIV;18.251
46 Valencia/València;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
46 Valencia/València;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QII;""
46 Valencia/València;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QI;""
46 Valencia/València;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QIV;18.456
46 Valencia/València;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
46 Valencia/València;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QII;""
46 Valencia/València;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QI;""
46 Valencia/València;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QIV;18.516
46 Valencia/València;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
46 Valencia/València;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QII;""
46 Valencia/València;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QI;""
46 Valencia/València;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
46 Valencia/València;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
46 Valencia/València;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QII;""
46 Valencia/València;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QI;17.917
46 Valencia/València;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
46 Valencia/València;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
46 Valencia/València;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QII;""
46 Valencia/València;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QI;18.121
46 Valencia/València;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
46 Valencia/València;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
46 Valencia/València;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QII;""
46 Valencia/València;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QI;""
46 Valencia/València;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
46 Valencia/València;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
46 Valencia/València;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
46 Valencia/València;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
46 Valencia/València;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
46 Valencia/València;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
46 Valencia/València;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
46 Valencia/València;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
46 Valencia/València;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
46 Valencia/València;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
46 Valencia/València;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
46 Valencia/València;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
46 Valencia/València;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
46 Valencia/València;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
46 Valencia/València;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;95,97
46 Valencia/València;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
46 Valencia/València;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
46 Valencia/València;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
46 Valencia/València;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;96,87
46 Valencia/València;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
46 Valencia/València;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
46 Valencia/València;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
46 Valencia/València;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;97,69
46 Valencia/València;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
46 Valencia/València;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
46 Valencia/València;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;92,81
46 Valencia/València;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
46 Valencia/València;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
46 Valencia/València;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
46 Valencia/València;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;94,23
46 Valencia/València;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
46 Valencia/València;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
46 Valencia/València;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
46 Valencia/València;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;94,82
46 Valencia/València;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
46 Valencia/València;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
46 Valencia/València;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;89,95
46 Valencia/València;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
46 Valencia/València;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
46 Valencia/València;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
46 Valencia/València;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;91,37
46 Valencia/València;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
46 Valencia/València;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
46 Valencia/València;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
46 Valencia/València;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;91,84
46 Valencia/València;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
46 Valencia/València;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
46 Valencia/València;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
46 Valencia/València;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
46 Valencia/València;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
46 Valencia/València;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
46 Valencia/València;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;88,7
46 Valencia/València;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
46 Valencia/València;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
46 Valencia/València;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
46 Valencia/València;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;89,88
46 Valencia/València;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
46 Valencia/València;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
46 Valencia/València;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
46 Valencia/València;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
46 Valencia/València;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
46 Valencia/València;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QIII;54.846
46 Valencia/València;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
46 Valencia/València;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
46 Valencia/València;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
46 Valencia/València;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QIII;55.687
46 Valencia/València;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
46 Valencia/València;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
46 Valencia/València;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
46 Valencia/València;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QIII;55.620
46 Valencia/València;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
46 Valencia/València;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
46 Valencia/València;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
46 Valencia/València;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2022QIII;53.050
46 Valencia/València;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2022QII;""
46 Valencia/València;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2022QI;""
46 Valencia/València;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
46 Valencia/València;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2021QIII;54.090
46 Valencia/València;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2021QII;""
46 Valencia/València;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2021QI;""
46 Valencia/València;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
46 Valencia/València;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2020QIII;54.052
46 Valencia/València;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2020QII;""
46 Valencia/València;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2020QI;""
46 Valencia/València;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2022QIV;51.422
46 Valencia/València;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
46 Valencia/València;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2022QII;""
46 Valencia/València;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2022QI;""
46 Valencia/València;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2021QIV;52.506
46 Valencia/València;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
46 Valencia/València;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2021QII;""
46 Valencia/València;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2021QI;""
46 Valencia/València;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2020QIV;52.510
46 Valencia/València;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
46 Valencia/València;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2020QII;""
46 Valencia/València;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2020QI;""
46 Valencia/València;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
46 Valencia/València;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
46 Valencia/València;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QII;""
46 Valencia/València;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QI;51.138
46 Valencia/València;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
46 Valencia/València;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
46 Valencia/València;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QII;""
46 Valencia/València;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QI;51.478
46 Valencia/València;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
46 Valencia/València;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
46 Valencia/València;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QII;""
46 Valencia/València;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QI;""
46 Valencia/València;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
46 Valencia/València;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
46 Valencia/València;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QII;49.814
46 Valencia/València;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QI;""
46 Valencia/València;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
46 Valencia/València;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
46 Valencia/València;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QII;50.400
46 Valencia/València;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QI;""
46 Valencia/València;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
46 Valencia/València;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
46 Valencia/València;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QII;""
46 Valencia/València;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QI;""
46 Valencia/València;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
46 Valencia/València;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
46 Valencia/València;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
46 Valencia/València;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
46 Valencia/València;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
46 Valencia/València;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
46 Valencia/València;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
46 Valencia/València;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
46 Valencia/València;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
46 Valencia/València;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
46 Valencia/València;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
46 Valencia/València;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
46 Valencia/València;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
46 Valencia/València;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;96,73
46 Valencia/València;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
46 Valencia/València;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
46 Valencia/València;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
46 Valencia/València;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;97,13
46 Valencia/València;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
46 Valencia/València;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
46 Valencia/València;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
46 Valencia/València;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;97,18
46 Valencia/València;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
46 Valencia/València;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
46 Valencia/València;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;93,76
46 Valencia/València;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
46 Valencia/València;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
46 Valencia/València;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
46 Valencia/València;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;94,29
46 Valencia/València;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
46 Valencia/València;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
46 Valencia/València;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
46 Valencia/València;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;94,41
46 Valencia/València;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
46 Valencia/València;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
46 Valencia/València;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
46 Valencia/València;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
46 Valencia/València;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
46 Valencia/València;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
46 Valencia/València;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;91,83
46 Valencia/València;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
46 Valencia/València;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
46 Valencia/València;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
46 Valencia/València;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;92,55
46 Valencia/València;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
46 Valencia/València;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
46 Valencia/València;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
46 Valencia/València;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
46 Valencia/València;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
46 Valencia/València;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
46 Valencia/València;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;89,45
46 Valencia/València;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
46 Valencia/València;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
46 Valencia/València;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
46 Valencia/València;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;90,61
46 Valencia/València;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
46 Valencia/València;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
46 Valencia/València;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
46 Valencia/València;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
46 Valencia/València;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
46 Valencia/València;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
46 Valencia/València;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QIII;34.536
46 Valencia/València;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
46 Valencia/València;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
46 Valencia/València;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
46 Valencia/València;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QIII;35.287
46 Valencia/València;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
46 Valencia/València;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
46 Valencia/València;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
46 Valencia/València;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QIII;35.353
46 Valencia/València;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
46 Valencia/València;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
46 Valencia/València;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
46 Valencia/València;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2022QIII;33.492
46 Valencia/València;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2022QII;""
46 Valencia/València;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2022QI;""
46 Valencia/València;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
46 Valencia/València;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2021QIII;34.340
46 Valencia/València;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2021QII;""
46 Valencia/València;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2021QI;""
46 Valencia/València;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
46 Valencia/València;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2020QIII;34.452
46 Valencia/València;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2020QII;""
46 Valencia/València;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2020QI;""
46 Valencia/València;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2022QIV;32.519
46 Valencia/València;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
46 Valencia/València;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2022QII;""
46 Valencia/València;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2022QI;""
46 Valencia/València;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2021QIV;33.407
46 Valencia/València;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
46 Valencia/València;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2021QII;""
46 Valencia/València;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2021QI;""
46 Valencia/València;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2020QIV;33.552
46 Valencia/València;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
46 Valencia/València;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2020QII;""
46 Valencia/València;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2020QI;""
46 Valencia/València;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
46 Valencia/València;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
46 Valencia/València;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QII;""
46 Valencia/València;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QI;32.618
46 Valencia/València;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
46 Valencia/València;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
46 Valencia/València;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QII;""
46 Valencia/València;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QI;32.940
46 Valencia/València;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
46 Valencia/València;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
46 Valencia/València;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QII;""
46 Valencia/València;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QI;""
46 Valencia/València;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
46 Valencia/València;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
46 Valencia/València;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QII;31.869
46 Valencia/València;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QI;""
46 Valencia/València;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
46 Valencia/València;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
46 Valencia/València;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QII;32.325
46 Valencia/València;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QI;""
46 Valencia/València;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
46 Valencia/València;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
46 Valencia/València;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QII;""
46 Valencia/València;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QI;""
46 Valencia/València;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
46 Valencia/València;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
46 Valencia/València;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
46 Valencia/València;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
46 Valencia/València;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
46 Valencia/València;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
46 Valencia/València;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
46 Valencia/València;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
46 Valencia/València;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
46 Valencia/València;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
46 Valencia/València;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
46 Valencia/València;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
46 Valencia/València;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
46 Valencia/València;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;96,98
46 Valencia/València;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
46 Valencia/València;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
46 Valencia/València;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
46 Valencia/València;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;97,32
46 Valencia/València;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
46 Valencia/València;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
46 Valencia/València;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
46 Valencia/València;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;97,45
46 Valencia/València;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
46 Valencia/València;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
46 Valencia/València;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;94,16
46 Valencia/València;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
46 Valencia/València;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
46 Valencia/València;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
46 Valencia/València;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;94,67
46 Valencia/València;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
46 Valencia/València;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
46 Valencia/València;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
46 Valencia/València;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;94,91
46 Valencia/València;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
46 Valencia/València;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
46 Valencia/València;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
46 Valencia/València;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
46 Valencia/València;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
46 Valencia/València;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
46 Valencia/València;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;92,44
46 Valencia/València;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
46 Valencia/València;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
46 Valencia/València;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
46 Valencia/València;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;93,17
46 Valencia/València;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
46 Valencia/València;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
46 Valencia/València;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
46 Valencia/València;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
46 Valencia/València;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
46 Valencia/València;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
46 Valencia/València;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;90,31
46 Valencia/València;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
46 Valencia/València;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
46 Valencia/València;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
46 Valencia/València;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;91,43
46 Valencia/València;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
46 Valencia/València;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
46 Valencia/València;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
46 Valencia/València;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
46 Valencia/València;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
46 Valencia/València;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
46 Valencia/València;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QIII;20.310
46 Valencia/València;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
46 Valencia/València;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
46 Valencia/València;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
46 Valencia/València;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QIII;20.400
46 Valencia/València;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
46 Valencia/València;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
46 Valencia/València;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
46 Valencia/València;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QIII;20.267
46 Valencia/València;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
46 Valencia/València;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
46 Valencia/València;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
46 Valencia/València;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2022QIII;19.558
46 Valencia/València;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2022QII;""
46 Valencia/València;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2022QI;""
46 Valencia/València;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
46 Valencia/València;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2021QIII;19.750
46 Valencia/València;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2021QII;""
46 Valencia/València;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2021QI;""
46 Valencia/València;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
46 Valencia/València;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2020QIII;19.600
46 Valencia/València;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2020QII;""
46 Valencia/València;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2020QI;""
46 Valencia/València;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2022QIV;18.903
46 Valencia/València;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
46 Valencia/València;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2022QII;""
46 Valencia/València;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2022QI;""
46 Valencia/València;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2021QIV;19.099
46 Valencia/València;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
46 Valencia/València;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2021QII;""
46 Valencia/València;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2021QI;""
46 Valencia/València;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2020QIV;18.958
46 Valencia/València;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
46 Valencia/València;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2020QII;""
46 Valencia/València;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2020QI;""
46 Valencia/València;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
46 Valencia/València;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
46 Valencia/València;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QII;""
46 Valencia/València;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QI;18.520
46 Valencia/València;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
46 Valencia/València;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
46 Valencia/València;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QII;""
46 Valencia/València;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QI;18.538
46 Valencia/València;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
46 Valencia/València;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
46 Valencia/València;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QII;""
46 Valencia/València;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QI;""
46 Valencia/València;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
46 Valencia/València;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
46 Valencia/València;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QII;17.945
46 Valencia/València;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QI;""
46 Valencia/València;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
46 Valencia/València;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
46 Valencia/València;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QII;18.075
46 Valencia/València;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QI;""
46 Valencia/València;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
46 Valencia/València;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
46 Valencia/València;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QII;""
46 Valencia/València;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QI;""
46 Valencia/València;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
46 Valencia/València;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
46 Valencia/València;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
46 Valencia/València;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
46 Valencia/València;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
46 Valencia/València;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
46 Valencia/València;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
46 Valencia/València;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
46 Valencia/València;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
46 Valencia/València;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
46 Valencia/València;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
46 Valencia/València;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
46 Valencia/València;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
46 Valencia/València;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;96,3
46 Valencia/València;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
46 Valencia/València;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
46 Valencia/València;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
46 Valencia/València;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;96,81
46 Valencia/València;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
46 Valencia/València;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
46 Valencia/València;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
46 Valencia/València;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;96,71
46 Valencia/València;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
46 Valencia/València;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
46 Valencia/València;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;93,07
46 Valencia/València;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
46 Valencia/València;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
46 Valencia/València;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
46 Valencia/València;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;93,62
46 Valencia/València;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
46 Valencia/València;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
46 Valencia/València;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
46 Valencia/València;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;93,54
46 Valencia/València;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
46 Valencia/València;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
46 Valencia/València;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
46 Valencia/València;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
46 Valencia/València;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
46 Valencia/València;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
46 Valencia/València;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;90,78
46 Valencia/València;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
46 Valencia/València;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
46 Valencia/València;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
46 Valencia/València;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;91,47
46 Valencia/València;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
46 Valencia/València;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
46 Valencia/València;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
46 Valencia/València;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
46 Valencia/València;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
46 Valencia/València;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
46 Valencia/València;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;87,97
46 Valencia/València;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
46 Valencia/València;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
46 Valencia/València;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
46 Valencia/València;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;89,18
46 Valencia/València;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
46 Valencia/València;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
46 Valencia/València;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
46 Valencia/València;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
46 Valencia/València;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
46 Valencia/València;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QIV;54.641
46 Valencia/València;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
46 Valencia/València;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
46 Valencia/València;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
46 Valencia/València;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QIV;55.727
46 Valencia/València;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
46 Valencia/València;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
46 Valencia/València;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
46 Valencia/València;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QIV;55.815
46 Valencia/València;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
46 Valencia/València;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
46 Valencia/València;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
46 Valencia/València;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2022QIV;52.866
46 Valencia/València;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
46 Valencia/València;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2022QII;""
46 Valencia/València;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2022QI;""
46 Valencia/València;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2021QIV;53.970
46 Valencia/València;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
46 Valencia/València;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2021QII;""
46 Valencia/València;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2021QI;""
46 Valencia/València;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2020QIV;54.061
46 Valencia/València;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
46 Valencia/València;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2020QII;""
46 Valencia/València;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2020QI;""
46 Valencia/València;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
46 Valencia/València;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
46 Valencia/València;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2022QII;""
46 Valencia/València;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2022QI;52.493
46 Valencia/València;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
46 Valencia/València;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
46 Valencia/València;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2021QII;""
46 Valencia/València;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2021QI;52.910
46 Valencia/València;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
46 Valencia/València;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
46 Valencia/València;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2020QII;""
46 Valencia/València;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2020QI;""
46 Valencia/València;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
46 Valencia/València;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
46 Valencia/València;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QII;51.039
46 Valencia/València;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QI;""
46 Valencia/València;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
46 Valencia/València;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
46 Valencia/València;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QII;51.719
46 Valencia/València;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QI;""
46 Valencia/València;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
46 Valencia/València;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
46 Valencia/València;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QII;""
46 Valencia/València;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QI;""
46 Valencia/València;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
46 Valencia/València;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QIII;49.795
46 Valencia/València;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QII;""
46 Valencia/València;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QI;""
46 Valencia/València;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
46 Valencia/València;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QIII;50.633
46 Valencia/València;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QII;""
46 Valencia/València;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QI;""
46 Valencia/València;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
46 Valencia/València;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
46 Valencia/València;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QII;""
46 Valencia/València;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QI;""
46 Valencia/València;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
46 Valencia/València;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
46 Valencia/València;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
46 Valencia/València;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
46 Valencia/València;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
46 Valencia/València;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
46 Valencia/València;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
46 Valencia/València;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
46 Valencia/València;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
46 Valencia/València;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
46 Valencia/València;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
46 Valencia/València;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
46 Valencia/València;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;96,75
46 Valencia/València;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
46 Valencia/València;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
46 Valencia/València;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
46 Valencia/València;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;96,85
46 Valencia/València;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
46 Valencia/València;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
46 Valencia/València;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
46 Valencia/València;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;96,86
46 Valencia/València;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
46 Valencia/València;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
46 Valencia/València;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
46 Valencia/València;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
46 Valencia/València;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
46 Valencia/València;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
46 Valencia/València;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;94,2
46 Valencia/València;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
46 Valencia/València;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
46 Valencia/València;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
46 Valencia/València;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;94,8
46 Valencia/València;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
46 Valencia/València;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
46 Valencia/València;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
46 Valencia/València;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
46 Valencia/València;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
46 Valencia/València;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
46 Valencia/València;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;91,59
46 Valencia/València;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
46 Valencia/València;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
46 Valencia/València;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
46 Valencia/València;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;92,66
46 Valencia/València;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
46 Valencia/València;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
46 Valencia/València;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
46 Valencia/València;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
46 Valencia/València;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
46 Valencia/València;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
46 Valencia/València;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;89,36
46 Valencia/València;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
46 Valencia/València;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
46 Valencia/València;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
46 Valencia/València;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;90,72
46 Valencia/València;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
46 Valencia/València;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
46 Valencia/València;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
46 Valencia/València;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
46 Valencia/València;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
46 Valencia/València;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
46 Valencia/València;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QIV;34.386
46 Valencia/València;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
46 Valencia/València;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
46 Valencia/València;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
46 Valencia/València;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QIV;35.299
46 Valencia/València;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
46 Valencia/València;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
46 Valencia/València;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
46 Valencia/València;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QIV;35.511
46 Valencia/València;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
46 Valencia/València;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
46 Valencia/València;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
46 Valencia/València;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2022QIV;33.333
46 Valencia/València;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
46 Valencia/València;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2022QII;""
46 Valencia/València;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2022QI;""
46 Valencia/València;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2021QIV;34.265
46 Valencia/València;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
46 Valencia/València;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2021QII;""
46 Valencia/València;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2021QI;""
46 Valencia/València;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2020QIV;34.474
46 Valencia/València;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
46 Valencia/València;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2020QII;""
46 Valencia/València;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2020QI;""
46 Valencia/València;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
46 Valencia/València;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
46 Valencia/València;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2022QII;""
46 Valencia/València;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2022QI;33.409
46 Valencia/València;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
46 Valencia/València;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
46 Valencia/València;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2021QII;""
46 Valencia/València;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2021QI;33.790
46 Valencia/València;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
46 Valencia/València;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
46 Valencia/València;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2020QII;""
46 Valencia/València;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2020QI;""
46 Valencia/València;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
46 Valencia/València;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
46 Valencia/València;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QII;32.592
46 Valencia/València;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QI;""
46 Valencia/València;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
46 Valencia/València;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
46 Valencia/València;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QII;33.103
46 Valencia/València;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QI;""
46 Valencia/València;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
46 Valencia/València;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
46 Valencia/València;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QII;""
46 Valencia/València;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QI;""
46 Valencia/València;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
46 Valencia/València;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QIII;31.871
46 Valencia/València;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QII;""
46 Valencia/València;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QI;""
46 Valencia/València;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
46 Valencia/València;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QIII;32.470
46 Valencia/València;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QII;""
46 Valencia/València;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QI;""
46 Valencia/València;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
46 Valencia/València;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
46 Valencia/València;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QII;""
46 Valencia/València;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QI;""
46 Valencia/València;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
46 Valencia/València;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
46 Valencia/València;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
46 Valencia/València;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
46 Valencia/València;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
46 Valencia/València;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
46 Valencia/València;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
46 Valencia/València;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
46 Valencia/València;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
46 Valencia/València;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
46 Valencia/València;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
46 Valencia/València;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
46 Valencia/València;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;96,94
46 Valencia/València;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
46 Valencia/València;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
46 Valencia/València;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
46 Valencia/València;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;97,07
46 Valencia/València;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
46 Valencia/València;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
46 Valencia/València;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
46 Valencia/València;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;97,08
46 Valencia/València;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
46 Valencia/València;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
46 Valencia/València;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
46 Valencia/València;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
46 Valencia/València;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
46 Valencia/València;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
46 Valencia/València;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;94,65
46 Valencia/València;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
46 Valencia/València;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
46 Valencia/València;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
46 Valencia/València;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;95,15
46 Valencia/València;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
46 Valencia/València;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
46 Valencia/València;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
46 Valencia/València;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
46 Valencia/València;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
46 Valencia/València;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
46 Valencia/València;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;92,33
46 Valencia/València;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
46 Valencia/València;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
46 Valencia/València;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
46 Valencia/València;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;93,22
46 Valencia/València;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
46 Valencia/València;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
46 Valencia/València;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
46 Valencia/València;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
46 Valencia/València;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
46 Valencia/València;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
46 Valencia/València;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;90,29
46 Valencia/València;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
46 Valencia/València;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
46 Valencia/València;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
46 Valencia/València;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;91,44
46 Valencia/València;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
46 Valencia/València;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
46 Valencia/València;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
46 Valencia/València;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
46 Valencia/València;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
46 Valencia/València;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
46 Valencia/València;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QIV;20.255
46 Valencia/València;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
46 Valencia/València;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
46 Valencia/València;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
46 Valencia/València;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QIV;20.428
46 Valencia/València;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
46 Valencia/València;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
46 Valencia/València;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
46 Valencia/València;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QIV;20.304
46 Valencia/València;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
46 Valencia/València;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
46 Valencia/València;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
46 Valencia/València;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2022QIV;19.533
46 Valencia/València;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
46 Valencia/València;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2022QII;""
46 Valencia/València;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2022QI;""
46 Valencia/València;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2021QIV;19.705
46 Valencia/València;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
46 Valencia/València;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2021QII;""
46 Valencia/València;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2021QI;""
46 Valencia/València;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2020QIV;19.587
46 Valencia/València;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
46 Valencia/València;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2020QII;""
46 Valencia/València;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2020QI;""
46 Valencia/València;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
46 Valencia/València;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
46 Valencia/València;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2022QII;""
46 Valencia/València;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2022QI;19.084
46 Valencia/València;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
46 Valencia/València;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
46 Valencia/València;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2021QII;""
46 Valencia/València;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2021QI;19.120
46 Valencia/València;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
46 Valencia/València;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
46 Valencia/València;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2020QII;""
46 Valencia/València;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2020QI;""
46 Valencia/València;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
46 Valencia/València;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
46 Valencia/València;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QII;18.447
46 Valencia/València;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QI;""
46 Valencia/València;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
46 Valencia/València;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
46 Valencia/València;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QII;18.616
46 Valencia/València;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QI;""
46 Valencia/València;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
46 Valencia/València;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
46 Valencia/València;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QII;""
46 Valencia/València;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QI;""
46 Valencia/València;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
46 Valencia/València;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QIII;17.924
46 Valencia/València;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QII;""
46 Valencia/València;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QI;""
46 Valencia/València;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
46 Valencia/València;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QIII;18.163
46 Valencia/València;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QII;""
46 Valencia/València;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QI;""
46 Valencia/València;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
46 Valencia/València;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
46 Valencia/València;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QII;""
46 Valencia/València;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QI;""
46 Valencia/València;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
46 Valencia/València;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
46 Valencia/València;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
46 Valencia/València;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
46 Valencia/València;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
46 Valencia/València;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
46 Valencia/València;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
46 Valencia/València;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
46 Valencia/València;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
46 Valencia/València;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
46 Valencia/València;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
46 Valencia/València;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
46 Valencia/València;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;96,44
46 Valencia/València;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
46 Valencia/València;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
46 Valencia/València;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
46 Valencia/València;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;96,46
46 Valencia/València;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
46 Valencia/València;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
46 Valencia/València;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
46 Valencia/València;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;96,47
46 Valencia/València;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
46 Valencia/València;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
46 Valencia/València;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
46 Valencia/València;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
46 Valencia/València;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
46 Valencia/València;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
46 Valencia/València;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;93,42
46 Valencia/València;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
46 Valencia/València;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
46 Valencia/València;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
46 Valencia/València;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;94,17
46 Valencia/València;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
46 Valencia/València;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
46 Valencia/València;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
46 Valencia/València;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
46 Valencia/València;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
46 Valencia/València;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
46 Valencia/València;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;90,3
46 Valencia/València;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
46 Valencia/València;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
46 Valencia/València;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
46 Valencia/València;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;91,69
46 Valencia/València;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
46 Valencia/València;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
46 Valencia/València;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
46 Valencia/València;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
46 Valencia/València;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
46 Valencia/València;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
46 Valencia/València;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;87,74
46 Valencia/València;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
46 Valencia/València;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
46 Valencia/València;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
46 Valencia/València;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;89,46
46 Valencia/València;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
46 Valencia/València;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
46 Valencia/València;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
46 Valencia/València;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
46 Valencia/València;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
46 Valencia/València;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
46 Valencia/València;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
46 Valencia/València;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
46 Valencia/València;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
46 Valencia/València;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QI;50.526
46 Valencia/València;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
46 Valencia/València;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
46 Valencia/València;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
46 Valencia/València;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QI;48.931
46 Valencia/València;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
46 Valencia/València;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
46 Valencia/València;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
46 Valencia/València;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QI;50.076
46 Valencia/València;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
46 Valencia/València;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
46 Valencia/València;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2022QII;""
46 Valencia/València;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2022QI;49.322
46 Valencia/València;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
46 Valencia/València;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
46 Valencia/València;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2021QII;""
46 Valencia/València;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2021QI;48.055
46 Valencia/València;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
46 Valencia/València;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
46 Valencia/València;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2020QII;""
46 Valencia/València;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2020QI;47.710
46 Valencia/València;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
46 Valencia/València;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
46 Valencia/València;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2022QII;48.177
46 Valencia/València;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2022QI;""
46 Valencia/València;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
46 Valencia/València;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
46 Valencia/València;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2021QII;47.105
46 Valencia/València;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2021QI;""
46 Valencia/València;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
46 Valencia/València;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
46 Valencia/València;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2020QII;46.983
46 Valencia/València;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2020QI;""
46 Valencia/València;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
46 Valencia/València;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QIII;47.240
46 Valencia/València;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QII;""
46 Valencia/València;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QI;""
46 Valencia/València;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
46 Valencia/València;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QIII;46.300
46 Valencia/València;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QII;""
46 Valencia/València;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QI;""
46 Valencia/València;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
46 Valencia/València;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QIII;46.092
46 Valencia/València;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QII;""
46 Valencia/València;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QI;""
46 Valencia/València;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QIV;46.163
46 Valencia/València;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
46 Valencia/València;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QII;""
46 Valencia/València;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QI;""
46 Valencia/València;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QIV;45.458
46 Valencia/València;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
46 Valencia/València;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QII;""
46 Valencia/València;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QI;""
46 Valencia/València;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QIV;45.206
46 Valencia/València;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
46 Valencia/València;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QII;""
46 Valencia/València;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QI;""
46 Valencia/València;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
46 Valencia/València;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
46 Valencia/València;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
46 Valencia/València;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
46 Valencia/València;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
46 Valencia/València;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
46 Valencia/València;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
46 Valencia/València;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
46 Valencia/València;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
46 Valencia/València;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
46 Valencia/València;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
46 Valencia/València;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
46 Valencia/València;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
46 Valencia/València;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
46 Valencia/València;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
46 Valencia/València;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;97,62
46 Valencia/València;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
46 Valencia/València;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
46 Valencia/València;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
46 Valencia/València;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;98,21
46 Valencia/València;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
46 Valencia/València;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
46 Valencia/València;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
46 Valencia/València;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;95,28
46 Valencia/València;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
46 Valencia/València;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
46 Valencia/València;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;95,35
46 Valencia/València;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
46 Valencia/València;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
46 Valencia/València;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
46 Valencia/València;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;96,27
46 Valencia/València;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
46 Valencia/València;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
46 Valencia/València;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
46 Valencia/València;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;93,82
46 Valencia/València;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
46 Valencia/València;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
46 Valencia/València;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;93,5
46 Valencia/València;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
46 Valencia/València;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
46 Valencia/València;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
46 Valencia/València;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;94,62
46 Valencia/València;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
46 Valencia/València;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
46 Valencia/València;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
46 Valencia/València;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;92,04
46 Valencia/València;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
46 Valencia/València;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
46 Valencia/València;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;91,36
46 Valencia/València;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
46 Valencia/València;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
46 Valencia/València;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
46 Valencia/València;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;92,9
46 Valencia/València;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
46 Valencia/València;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
46 Valencia/València;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
46 Valencia/València;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;90,27
46 Valencia/València;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
46 Valencia/València;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
46 Valencia/València;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
46 Valencia/València;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
46 Valencia/València;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
46 Valencia/València;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
46 Valencia/València;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QI;32.376
46 Valencia/València;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
46 Valencia/València;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
46 Valencia/València;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
46 Valencia/València;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QI;31.407
46 Valencia/València;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
46 Valencia/València;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
46 Valencia/València;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
46 Valencia/València;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QI;32.063
46 Valencia/València;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
46 Valencia/València;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
46 Valencia/València;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2022QII;""
46 Valencia/València;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2022QI;31.645
46 Valencia/València;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
46 Valencia/València;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
46 Valencia/València;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2021QII;""
46 Valencia/València;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2021QI;30.875
46 Valencia/València;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
46 Valencia/València;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
46 Valencia/València;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2020QII;""
46 Valencia/València;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2020QI;30.661
46 Valencia/València;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
46 Valencia/València;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
46 Valencia/València;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2022QII;30.996
46 Valencia/València;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2022QI;""
46 Valencia/València;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
46 Valencia/València;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
46 Valencia/València;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2021QII;30.278
46 Valencia/València;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2021QI;""
46 Valencia/València;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
46 Valencia/València;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
46 Valencia/València;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2020QII;30.237
46 Valencia/València;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2020QI;""
46 Valencia/València;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
46 Valencia/València;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QIII;30.451
46 Valencia/València;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QII;""
46 Valencia/València;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QI;""
46 Valencia/València;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
46 Valencia/València;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QIII;29.793
46 Valencia/València;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QII;""
46 Valencia/València;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QI;""
46 Valencia/València;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
46 Valencia/València;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QIII;29.726
46 Valencia/València;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QII;""
46 Valencia/València;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QI;""
46 Valencia/València;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QIV;29.790
46 Valencia/València;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
46 Valencia/València;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QII;""
46 Valencia/València;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QI;""
46 Valencia/València;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QIV;29.285
46 Valencia/València;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
46 Valencia/València;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QII;""
46 Valencia/València;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QI;""
46 Valencia/València;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QIV;29.190
46 Valencia/València;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
46 Valencia/València;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QII;""
46 Valencia/València;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QI;""
46 Valencia/València;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
46 Valencia/València;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
46 Valencia/València;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
46 Valencia/València;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
46 Valencia/València;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
46 Valencia/València;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
46 Valencia/València;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
46 Valencia/València;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
46 Valencia/València;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
46 Valencia/València;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
46 Valencia/València;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
46 Valencia/València;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
46 Valencia/València;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
46 Valencia/València;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
46 Valencia/València;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
46 Valencia/València;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;97,74
46 Valencia/València;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
46 Valencia/València;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
46 Valencia/València;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
46 Valencia/València;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;98,31
46 Valencia/València;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
46 Valencia/València;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
46 Valencia/València;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
46 Valencia/València;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;95,63
46 Valencia/València;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
46 Valencia/València;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
46 Valencia/València;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;95,74
46 Valencia/València;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
46 Valencia/València;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
46 Valencia/València;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
46 Valencia/València;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;96,41
46 Valencia/València;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
46 Valencia/València;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
46 Valencia/València;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
46 Valencia/València;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;94,3
46 Valencia/València;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
46 Valencia/València;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
46 Valencia/València;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;94,05
46 Valencia/València;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
46 Valencia/València;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
46 Valencia/València;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
46 Valencia/València;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;94,86
46 Valencia/València;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
46 Valencia/València;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
46 Valencia/València;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
46 Valencia/València;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;92,71
46 Valencia/València;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
46 Valencia/València;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
46 Valencia/València;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;92,01
46 Valencia/València;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
46 Valencia/València;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
46 Valencia/València;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
46 Valencia/València;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;93,24
46 Valencia/València;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
46 Valencia/València;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
46 Valencia/València;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
46 Valencia/València;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;91,04
46 Valencia/València;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
46 Valencia/València;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
46 Valencia/València;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
46 Valencia/València;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
46 Valencia/València;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
46 Valencia/València;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
46 Valencia/València;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QI;18.150
46 Valencia/València;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
46 Valencia/València;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
46 Valencia/València;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
46 Valencia/València;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QI;17.524
46 Valencia/València;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
46 Valencia/València;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
46 Valencia/València;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
46 Valencia/València;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QI;18.013
46 Valencia/València;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
46 Valencia/València;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
46 Valencia/València;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2022QII;""
46 Valencia/València;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2022QI;17.677
46 Valencia/València;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
46 Valencia/València;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
46 Valencia/València;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2021QII;""
46 Valencia/València;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2021QI;17.180
46 Valencia/València;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
46 Valencia/València;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
46 Valencia/València;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2020QII;""
46 Valencia/València;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2020QI;17.049
46 Valencia/València;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
46 Valencia/València;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
46 Valencia/València;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2022QII;17.181
46 Valencia/València;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2022QI;""
46 Valencia/València;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
46 Valencia/València;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
46 Valencia/València;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2021QII;16.827
46 Valencia/València;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2021QI;""
46 Valencia/València;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
46 Valencia/València;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
46 Valencia/València;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2020QII;16.746
46 Valencia/València;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2020QI;""
46 Valencia/València;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
46 Valencia/València;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QIII;16.789
46 Valencia/València;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QII;""
46 Valencia/València;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QI;""
46 Valencia/València;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
46 Valencia/València;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QIII;16.507
46 Valencia/València;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QII;""
46 Valencia/València;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QI;""
46 Valencia/València;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
46 Valencia/València;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QIII;16.366
46 Valencia/València;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QII;""
46 Valencia/València;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QI;""
46 Valencia/València;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QIV;16.373
46 Valencia/València;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
46 Valencia/València;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QII;""
46 Valencia/València;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QI;""
46 Valencia/València;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QIV;16.173
46 Valencia/València;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
46 Valencia/València;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QII;""
46 Valencia/València;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QI;""
46 Valencia/València;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QIV;16.016
46 Valencia/València;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
46 Valencia/València;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QII;""
46 Valencia/València;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QI;""
46 Valencia/València;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
46 Valencia/València;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
46 Valencia/València;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
46 Valencia/València;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
46 Valencia/València;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
46 Valencia/València;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
46 Valencia/València;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
46 Valencia/València;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
46 Valencia/València;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
46 Valencia/València;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
46 Valencia/València;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
46 Valencia/València;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
46 Valencia/València;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
46 Valencia/València;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
46 Valencia/València;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
46 Valencia/València;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;97,39
46 Valencia/València;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
46 Valencia/València;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
46 Valencia/València;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
46 Valencia/València;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;98,04
46 Valencia/València;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
46 Valencia/València;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
46 Valencia/València;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
46 Valencia/València;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;94,65
46 Valencia/València;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
46 Valencia/València;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
46 Valencia/València;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;94,66
46 Valencia/València;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
46 Valencia/València;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
46 Valencia/València;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
46 Valencia/València;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;96,02
46 Valencia/València;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
46 Valencia/València;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
46 Valencia/València;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
46 Valencia/València;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;92,97
46 Valencia/València;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
46 Valencia/València;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
46 Valencia/València;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;92,5
46 Valencia/València;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
46 Valencia/València;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
46 Valencia/València;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
46 Valencia/València;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;94,2
46 Valencia/València;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
46 Valencia/València;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
46 Valencia/València;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
46 Valencia/València;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;90,86
46 Valencia/València;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
46 Valencia/València;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
46 Valencia/València;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;90,21
46 Valencia/València;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
46 Valencia/València;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
46 Valencia/València;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
46 Valencia/València;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;92,29
46 Valencia/València;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
46 Valencia/València;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
46 Valencia/València;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
46 Valencia/València;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;88,91
46 Valencia/València;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
46 Valencia/València;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
46 Valencia/València;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
46 Valencia/València;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
46 Valencia/València;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
46 Valencia/València;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QII;52.164
46 Valencia/València;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
46 Valencia/València;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
46 Valencia/València;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
46 Valencia/València;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QII;50.853
46 Valencia/València;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
46 Valencia/València;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
46 Valencia/València;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
46 Valencia/València;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QII;49.133
46 Valencia/València;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
46 Valencia/València;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
46 Valencia/València;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
46 Valencia/València;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2022QII;50.845
46 Valencia/València;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2022QI;""
46 Valencia/València;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
46 Valencia/València;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
46 Valencia/València;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2021QII;49.768
46 Valencia/València;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2021QI;""
46 Valencia/València;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
46 Valencia/València;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
46 Valencia/València;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2020QII;48.325
46 Valencia/València;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2020QI;""
46 Valencia/València;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
46 Valencia/València;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2022QIII;49.778
46 Valencia/València;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2022QII;""
46 Valencia/València;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2022QI;""
46 Valencia/València;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
46 Valencia/València;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2021QIII;48.832
46 Valencia/València;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2021QII;""
46 Valencia/València;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2021QI;""
46 Valencia/València;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
46 Valencia/València;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2020QIII;47.304
46 Valencia/València;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2020QII;""
46 Valencia/València;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2020QI;""
46 Valencia/València;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QIV;48.549
46 Valencia/València;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
46 Valencia/València;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QII;""
46 Valencia/València;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QI;""
46 Valencia/València;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QIV;47.866
46 Valencia/València;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
46 Valencia/València;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QII;""
46 Valencia/València;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QI;""
46 Valencia/València;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QIV;46.330
46 Valencia/València;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
46 Valencia/València;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QII;""
46 Valencia/València;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QI;""
46 Valencia/València;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
46 Valencia/València;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
46 Valencia/València;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QII;""
46 Valencia/València;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QI;46.906
46 Valencia/València;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
46 Valencia/València;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
46 Valencia/València;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QII;""
46 Valencia/València;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QI;45.649
46 Valencia/València;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
46 Valencia/València;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
46 Valencia/València;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QII;""
46 Valencia/València;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QI;""
46 Valencia/València;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
46 Valencia/València;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
46 Valencia/València;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
46 Valencia/València;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
46 Valencia/València;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
46 Valencia/València;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
46 Valencia/València;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
46 Valencia/València;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
46 Valencia/València;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
46 Valencia/València;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
46 Valencia/València;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
46 Valencia/València;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
46 Valencia/València;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
46 Valencia/València;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
46 Valencia/València;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;97,47
46 Valencia/València;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
46 Valencia/València;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
46 Valencia/València;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
46 Valencia/València;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;97,87
46 Valencia/València;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
46 Valencia/València;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
46 Valencia/València;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
46 Valencia/València;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;98,36
46 Valencia/València;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
46 Valencia/València;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
46 Valencia/València;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;95,43
46 Valencia/València;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
46 Valencia/València;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
46 Valencia/València;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
46 Valencia/València;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;96,03
46 Valencia/València;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
46 Valencia/València;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
46 Valencia/València;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
46 Valencia/València;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;96,28
46 Valencia/València;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
46 Valencia/València;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
46 Valencia/València;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;93,07
46 Valencia/València;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
46 Valencia/València;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
46 Valencia/València;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
46 Valencia/València;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;94,13
46 Valencia/València;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
46 Valencia/València;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
46 Valencia/València;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
46 Valencia/València;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;94,3
46 Valencia/València;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
46 Valencia/València;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
46 Valencia/València;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
46 Valencia/València;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
46 Valencia/València;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
46 Valencia/València;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
46 Valencia/València;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;92,24
46 Valencia/València;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
46 Valencia/València;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
46 Valencia/València;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
46 Valencia/València;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;92,91
46 Valencia/València;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
46 Valencia/València;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
46 Valencia/València;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
46 Valencia/València;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
46 Valencia/València;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
46 Valencia/València;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
46 Valencia/València;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QII;33.441
46 Valencia/València;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
46 Valencia/València;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
46 Valencia/València;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
46 Valencia/València;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QII;32.641
46 Valencia/València;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
46 Valencia/València;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
46 Valencia/València;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
46 Valencia/València;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QII;31.536
46 Valencia/València;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
46 Valencia/València;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
46 Valencia/València;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
46 Valencia/València;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2022QII;32.686
46 Valencia/València;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2022QI;""
46 Valencia/València;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
46 Valencia/València;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
46 Valencia/València;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2021QII;31.977
46 Valencia/València;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2021QI;""
46 Valencia/València;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
46 Valencia/València;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
46 Valencia/València;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2020QII;31.073
46 Valencia/València;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2020QI;""
46 Valencia/València;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
46 Valencia/València;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2022QIII;32.069
46 Valencia/València;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2022QII;""
46 Valencia/València;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2022QI;""
46 Valencia/València;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
46 Valencia/València;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2021QIII;31.415
46 Valencia/València;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2021QII;""
46 Valencia/València;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2021QI;""
46 Valencia/València;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
46 Valencia/València;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2020QIII;30.472
46 Valencia/València;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2020QII;""
46 Valencia/València;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2020QI;""
46 Valencia/València;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QIV;31.317
46 Valencia/València;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
46 Valencia/València;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QII;""
46 Valencia/València;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QI;""
46 Valencia/València;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QIV;30.833
46 Valencia/València;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
46 Valencia/València;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QII;""
46 Valencia/València;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QI;""
46 Valencia/València;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QIV;29.877
46 Valencia/València;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
46 Valencia/València;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QII;""
46 Valencia/València;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QI;""
46 Valencia/València;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
46 Valencia/València;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
46 Valencia/València;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QII;""
46 Valencia/València;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QI;30.256
46 Valencia/València;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
46 Valencia/València;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
46 Valencia/València;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QII;""
46 Valencia/València;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QI;29.460
46 Valencia/València;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
46 Valencia/València;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
46 Valencia/València;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QII;""
46 Valencia/València;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QI;""
46 Valencia/València;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
46 Valencia/València;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
46 Valencia/València;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
46 Valencia/València;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
46 Valencia/València;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
46 Valencia/València;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
46 Valencia/València;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
46 Valencia/València;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
46 Valencia/València;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
46 Valencia/València;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
46 Valencia/València;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
46 Valencia/València;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
46 Valencia/València;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
46 Valencia/València;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
46 Valencia/València;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;97,74
46 Valencia/València;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
46 Valencia/València;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
46 Valencia/València;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
46 Valencia/València;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;97,97
46 Valencia/València;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
46 Valencia/València;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
46 Valencia/València;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
46 Valencia/València;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;98,53
46 Valencia/València;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
46 Valencia/València;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
46 Valencia/València;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;95,9
46 Valencia/València;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
46 Valencia/València;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
46 Valencia/València;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
46 Valencia/València;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;96,24
46 Valencia/València;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
46 Valencia/València;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
46 Valencia/València;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
46 Valencia/València;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;96,63
46 Valencia/València;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
46 Valencia/València;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
46 Valencia/València;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;93,65
46 Valencia/València;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
46 Valencia/València;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
46 Valencia/València;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
46 Valencia/València;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;94,46
46 Valencia/València;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
46 Valencia/València;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
46 Valencia/València;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
46 Valencia/València;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;94,74
46 Valencia/València;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
46 Valencia/València;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
46 Valencia/València;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
46 Valencia/València;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
46 Valencia/València;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
46 Valencia/València;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
46 Valencia/València;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;92,69
46 Valencia/València;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
46 Valencia/València;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
46 Valencia/València;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
46 Valencia/València;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;93,42
46 Valencia/València;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
46 Valencia/València;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
46 Valencia/València;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
46 Valencia/València;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
46 Valencia/València;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
46 Valencia/València;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
46 Valencia/València;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QII;18.723
46 Valencia/València;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
46 Valencia/València;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
46 Valencia/València;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
46 Valencia/València;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QII;18.212
46 Valencia/València;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
46 Valencia/València;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
46 Valencia/València;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
46 Valencia/València;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QII;17.597
46 Valencia/València;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
46 Valencia/València;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
46 Valencia/València;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
46 Valencia/València;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2022QII;18.159
46 Valencia/València;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2022QI;""
46 Valencia/València;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
46 Valencia/València;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
46 Valencia/València;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2021QII;17.791
46 Valencia/València;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2021QI;""
46 Valencia/València;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
46 Valencia/València;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
46 Valencia/València;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2020QII;17.252
46 Valencia/València;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2020QI;""
46 Valencia/València;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
46 Valencia/València;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2022QIII;17.709
46 Valencia/València;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2022QII;""
46 Valencia/València;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2022QI;""
46 Valencia/València;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
46 Valencia/València;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2021QIII;17.417
46 Valencia/València;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2021QII;""
46 Valencia/València;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2021QI;""
46 Valencia/València;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
46 Valencia/València;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2020QIII;16.832
46 Valencia/València;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2020QII;""
46 Valencia/València;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2020QI;""
46 Valencia/València;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QIV;17.232
46 Valencia/València;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
46 Valencia/València;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QII;""
46 Valencia/València;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QI;""
46 Valencia/València;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QIV;17.033
46 Valencia/València;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
46 Valencia/València;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QII;""
46 Valencia/València;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QI;""
46 Valencia/València;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QIV;16.453
46 Valencia/València;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
46 Valencia/València;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QII;""
46 Valencia/València;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QI;""
46 Valencia/València;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
46 Valencia/València;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
46 Valencia/València;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QII;""
46 Valencia/València;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QI;16.650
46 Valencia/València;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
46 Valencia/València;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
46 Valencia/València;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QII;""
46 Valencia/València;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QI;16.189
46 Valencia/València;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
46 Valencia/València;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
46 Valencia/València;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QII;""
46 Valencia/València;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QI;""
46 Valencia/València;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
46 Valencia/València;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
46 Valencia/València;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
46 Valencia/València;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
46 Valencia/València;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
46 Valencia/València;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
46 Valencia/València;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
46 Valencia/València;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
46 Valencia/València;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
46 Valencia/València;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
46 Valencia/València;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
46 Valencia/València;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
46 Valencia/València;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
46 Valencia/València;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
46 Valencia/València;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;96,99
46 Valencia/València;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
46 Valencia/València;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
46 Valencia/València;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
46 Valencia/València;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;97,69
46 Valencia/València;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
46 Valencia/València;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
46 Valencia/València;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
46 Valencia/València;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;98,04
46 Valencia/València;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
46 Valencia/València;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
46 Valencia/València;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;94,58
46 Valencia/València;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
46 Valencia/València;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
46 Valencia/València;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
46 Valencia/València;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;95,63
46 Valencia/València;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
46 Valencia/València;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
46 Valencia/València;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
46 Valencia/València;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;95,65
46 Valencia/València;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
46 Valencia/València;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
46 Valencia/València;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;92,04
46 Valencia/València;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
46 Valencia/València;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
46 Valencia/València;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
46 Valencia/València;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;93,53
46 Valencia/València;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
46 Valencia/València;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
46 Valencia/València;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
46 Valencia/València;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;93,5
46 Valencia/València;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
46 Valencia/València;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
46 Valencia/València;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
46 Valencia/València;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
46 Valencia/València;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
46 Valencia/València;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
46 Valencia/València;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;91,42
46 Valencia/València;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
46 Valencia/València;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
46 Valencia/València;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
46 Valencia/València;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;92
46 Valencia/València;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
46 Valencia/València;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
46 Valencia/València;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
46 Valencia/València;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
46 Valencia/València;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
46 Valencia/València;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QIII;52.055
46 Valencia/València;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
46 Valencia/València;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
46 Valencia/València;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
46 Valencia/València;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QIII;50.893
46 Valencia/València;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
46 Valencia/València;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
46 Valencia/València;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
46 Valencia/València;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QIII;49.284
46 Valencia/València;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
46 Valencia/València;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
46 Valencia/València;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
46 Valencia/València;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2022QIII;50.777
46 Valencia/València;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2022QII;""
46 Valencia/València;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2022QI;""
46 Valencia/València;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
46 Valencia/València;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2021QIII;49.754
46 Valencia/València;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2021QII;""
46 Valencia/València;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2021QI;""
46 Valencia/València;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
46 Valencia/València;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2020QIII;48.104
46 Valencia/València;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2020QII;""
46 Valencia/València;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2020QI;""
46 Valencia/València;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2022QIV;49.421
46 Valencia/València;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
46 Valencia/València;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2022QII;""
46 Valencia/València;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2022QI;""
46 Valencia/València;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2021QIV;48.688
46 Valencia/València;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
46 Valencia/València;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2021QII;""
46 Valencia/València;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2021QI;""
46 Valencia/València;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2020QIV;47.042
46 Valencia/València;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
46 Valencia/València;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2020QII;""
46 Valencia/València;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2020QI;""
46 Valencia/València;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
46 Valencia/València;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
46 Valencia/València;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QII;""
46 Valencia/València;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QI;47.668
46 Valencia/València;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
46 Valencia/València;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
46 Valencia/València;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QII;""
46 Valencia/València;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QI;46.326
46 Valencia/València;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
46 Valencia/València;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
46 Valencia/València;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QII;""
46 Valencia/València;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QI;""
46 Valencia/València;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
46 Valencia/València;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
46 Valencia/València;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QII;46.729
46 Valencia/València;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QI;""
46 Valencia/València;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
46 Valencia/València;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
46 Valencia/València;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QII;45.560
46 Valencia/València;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QI;""
46 Valencia/València;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
46 Valencia/València;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
46 Valencia/València;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QII;""
46 Valencia/València;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QI;""
46 Valencia/València;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
46 Valencia/València;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
46 Valencia/València;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
46 Valencia/València;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
46 Valencia/València;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
46 Valencia/València;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
46 Valencia/València;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
46 Valencia/València;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
46 Valencia/València;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
46 Valencia/València;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
46 Valencia/València;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
46 Valencia/València;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
46 Valencia/València;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
46 Valencia/València;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;97,54
46 Valencia/València;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
46 Valencia/València;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
46 Valencia/València;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
46 Valencia/València;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;97,76
46 Valencia/València;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
46 Valencia/València;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
46 Valencia/València;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
46 Valencia/València;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;97,61
46 Valencia/València;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
46 Valencia/València;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
46 Valencia/València;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;94,94
46 Valencia/València;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
46 Valencia/València;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
46 Valencia/València;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
46 Valencia/València;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;95,67
46 Valencia/València;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
46 Valencia/València;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
46 Valencia/València;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
46 Valencia/València;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;95,45
46 Valencia/València;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
46 Valencia/València;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
46 Valencia/València;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
46 Valencia/València;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
46 Valencia/València;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
46 Valencia/València;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
46 Valencia/València;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;93,66
46 Valencia/València;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
46 Valencia/València;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
46 Valencia/València;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
46 Valencia/València;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;94
46 Valencia/València;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
46 Valencia/València;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
46 Valencia/València;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
46 Valencia/València;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
46 Valencia/València;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
46 Valencia/València;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
46 Valencia/València;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;91,82
46 Valencia/València;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
46 Valencia/València;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
46 Valencia/València;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
46 Valencia/València;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;92,44
46 Valencia/València;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
46 Valencia/València;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
46 Valencia/València;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
46 Valencia/València;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
46 Valencia/València;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
46 Valencia/València;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
46 Valencia/València;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QIII;33.390
46 Valencia/València;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
46 Valencia/València;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
46 Valencia/València;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
46 Valencia/València;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QIII;32.612
46 Valencia/València;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
46 Valencia/València;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
46 Valencia/València;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
46 Valencia/València;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QIII;31.636
46 Valencia/València;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
46 Valencia/València;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
46 Valencia/València;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
46 Valencia/València;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2022QIII;32.660
46 Valencia/València;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2022QII;""
46 Valencia/València;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2022QI;""
46 Valencia/València;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
46 Valencia/València;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2021QIII;31.944
46 Valencia/València;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2021QII;""
46 Valencia/València;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2021QI;""
46 Valencia/València;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
46 Valencia/València;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2020QIII;30.947
46 Valencia/València;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2020QII;""
46 Valencia/València;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2020QI;""
46 Valencia/València;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2022QIV;31.816
46 Valencia/València;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
46 Valencia/València;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2022QII;""
46 Valencia/València;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2022QI;""
46 Valencia/València;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2021QIV;31.298
46 Valencia/València;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
46 Valencia/València;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2021QII;""
46 Valencia/València;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2021QI;""
46 Valencia/València;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2020QIV;30.294
46 Valencia/València;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
46 Valencia/València;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2020QII;""
46 Valencia/València;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2020QI;""
46 Valencia/València;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
46 Valencia/València;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
46 Valencia/València;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QII;""
46 Valencia/València;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QI;30.686
46 Valencia/València;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
46 Valencia/València;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
46 Valencia/València;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QII;""
46 Valencia/València;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QI;29.857
46 Valencia/València;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
46 Valencia/València;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
46 Valencia/València;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QII;""
46 Valencia/València;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QI;""
46 Valencia/València;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
46 Valencia/València;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
46 Valencia/València;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QII;30.146
46 Valencia/València;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QI;""
46 Valencia/València;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
46 Valencia/València;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
46 Valencia/València;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QII;29.383
46 Valencia/València;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QI;""
46 Valencia/València;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
46 Valencia/València;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
46 Valencia/València;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QII;""
46 Valencia/València;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QI;""
46 Valencia/València;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
46 Valencia/València;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
46 Valencia/València;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
46 Valencia/València;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
46 Valencia/València;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
46 Valencia/València;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
46 Valencia/València;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
46 Valencia/València;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
46 Valencia/València;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
46 Valencia/València;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
46 Valencia/València;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
46 Valencia/València;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
46 Valencia/València;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
46 Valencia/València;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;97,81
46 Valencia/València;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
46 Valencia/València;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
46 Valencia/València;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
46 Valencia/València;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;97,95
46 Valencia/València;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
46 Valencia/València;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
46 Valencia/València;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
46 Valencia/València;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;97,82
46 Valencia/València;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
46 Valencia/València;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
46 Valencia/València;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;95,29
46 Valencia/València;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
46 Valencia/València;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
46 Valencia/València;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
46 Valencia/València;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;95,97
46 Valencia/València;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
46 Valencia/València;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
46 Valencia/València;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
46 Valencia/València;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;95,76
46 Valencia/València;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
46 Valencia/València;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
46 Valencia/València;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
46 Valencia/València;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
46 Valencia/València;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
46 Valencia/València;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
46 Valencia/València;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;94,09
46 Valencia/València;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
46 Valencia/València;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
46 Valencia/València;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
46 Valencia/València;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;94,38
46 Valencia/València;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
46 Valencia/València;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
46 Valencia/València;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
46 Valencia/València;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
46 Valencia/València;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
46 Valencia/València;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
46 Valencia/València;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;92,44
46 Valencia/València;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
46 Valencia/València;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
46 Valencia/València;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
46 Valencia/València;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;92,88
46 Valencia/València;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
46 Valencia/València;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
46 Valencia/València;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
46 Valencia/València;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
46 Valencia/València;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
46 Valencia/València;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
46 Valencia/València;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QIII;18.665
46 Valencia/València;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
46 Valencia/València;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
46 Valencia/València;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
46 Valencia/València;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QIII;18.281
46 Valencia/València;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
46 Valencia/València;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
46 Valencia/València;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
46 Valencia/València;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QIII;17.648
46 Valencia/València;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
46 Valencia/València;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
46 Valencia/València;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
46 Valencia/València;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2022QIII;18.117
46 Valencia/València;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2022QII;""
46 Valencia/València;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2022QI;""
46 Valencia/València;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
46 Valencia/València;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2021QIII;17.810
46 Valencia/València;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2021QII;""
46 Valencia/València;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2021QI;""
46 Valencia/València;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
46 Valencia/València;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2020QIII;17.157
46 Valencia/València;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2020QII;""
46 Valencia/València;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2020QI;""
46 Valencia/València;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2022QIV;17.605
46 Valencia/València;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
46 Valencia/València;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2022QII;""
46 Valencia/València;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2022QI;""
46 Valencia/València;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2021QIV;17.390
46 Valencia/València;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
46 Valencia/València;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2021QII;""
46 Valencia/València;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2021QI;""
46 Valencia/València;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2020QIV;16.748
46 Valencia/València;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
46 Valencia/València;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2020QII;""
46 Valencia/València;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2020QI;""
46 Valencia/València;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
46 Valencia/València;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
46 Valencia/València;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QII;""
46 Valencia/València;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QI;16.982
46 Valencia/València;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
46 Valencia/València;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
46 Valencia/València;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QII;""
46 Valencia/València;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QI;16.469
46 Valencia/València;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
46 Valencia/València;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
46 Valencia/València;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QII;""
46 Valencia/València;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QI;""
46 Valencia/València;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
46 Valencia/València;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
46 Valencia/València;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QII;16.583
46 Valencia/València;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QI;""
46 Valencia/València;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
46 Valencia/València;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
46 Valencia/València;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QII;16.177
46 Valencia/València;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QI;""
46 Valencia/València;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
46 Valencia/València;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
46 Valencia/València;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QII;""
46 Valencia/València;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QI;""
46 Valencia/València;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
46 Valencia/València;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
46 Valencia/València;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
46 Valencia/València;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
46 Valencia/València;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
46 Valencia/València;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
46 Valencia/València;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
46 Valencia/València;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
46 Valencia/València;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
46 Valencia/València;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
46 Valencia/València;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
46 Valencia/València;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
46 Valencia/València;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
46 Valencia/València;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;97,06
46 Valencia/València;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
46 Valencia/València;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
46 Valencia/València;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
46 Valencia/València;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;97,42
46 Valencia/València;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
46 Valencia/València;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
46 Valencia/València;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
46 Valencia/València;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;97,22
46 Valencia/València;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
46 Valencia/València;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
46 Valencia/València;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;94,32
46 Valencia/València;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
46 Valencia/València;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
46 Valencia/València;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
46 Valencia/València;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;95,13
46 Valencia/València;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
46 Valencia/València;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
46 Valencia/València;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
46 Valencia/València;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;94,9
46 Valencia/València;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
46 Valencia/València;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
46 Valencia/València;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
46 Valencia/València;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
46 Valencia/València;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
46 Valencia/València;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
46 Valencia/València;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;92,89
46 Valencia/València;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
46 Valencia/València;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
46 Valencia/València;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
46 Valencia/València;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;93,32
46 Valencia/València;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
46 Valencia/València;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
46 Valencia/València;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
46 Valencia/València;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
46 Valencia/València;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
46 Valencia/València;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
46 Valencia/València;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;90,71
46 Valencia/València;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
46 Valencia/València;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
46 Valencia/València;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
46 Valencia/València;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;91,66
46 Valencia/València;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
46 Valencia/València;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
46 Valencia/València;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
46 Valencia/València;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
46 Valencia/València;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
46 Valencia/València;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QIV;51.767
46 Valencia/València;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
46 Valencia/València;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
46 Valencia/València;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
46 Valencia/València;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QIV;50.653
46 Valencia/València;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
46 Valencia/València;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
46 Valencia/València;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
46 Valencia/València;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QIV;49.116
46 Valencia/València;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
46 Valencia/València;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
46 Valencia/València;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
46 Valencia/València;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2022QIV;50.272
46 Valencia/València;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
46 Valencia/València;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2022QII;""
46 Valencia/València;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2022QI;""
46 Valencia/València;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2021QIV;49.464
46 Valencia/València;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
46 Valencia/València;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2021QII;""
46 Valencia/València;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2021QI;""
46 Valencia/València;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2020QIV;47.923
46 Valencia/València;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
46 Valencia/València;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2020QII;""
46 Valencia/València;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2020QI;""
46 Valencia/València;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
46 Valencia/València;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
46 Valencia/València;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2022QII;""
46 Valencia/València;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2022QI;48.374
46 Valencia/València;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
46 Valencia/València;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
46 Valencia/València;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2021QII;""
46 Valencia/València;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2021QI;47.145
46 Valencia/València;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
46 Valencia/València;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
46 Valencia/València;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2020QII;""
46 Valencia/València;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2020QI;""
46 Valencia/València;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
46 Valencia/València;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
46 Valencia/València;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QII;47.358
46 Valencia/València;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QI;""
46 Valencia/València;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
46 Valencia/València;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
46 Valencia/València;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QII;46.311
46 Valencia/València;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QI;""
46 Valencia/València;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
46 Valencia/València;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
46 Valencia/València;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QII;""
46 Valencia/València;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QI;""
46 Valencia/València;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
46 Valencia/València;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QIII;46.488
46 Valencia/València;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QII;""
46 Valencia/València;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QI;""
46 Valencia/València;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
46 Valencia/València;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QIII;45.562
46 Valencia/València;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QII;""
46 Valencia/València;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QI;""
46 Valencia/València;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
46 Valencia/València;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
46 Valencia/València;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QII;""
46 Valencia/València;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QI;""
46 Valencia/València;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
46 Valencia/València;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
46 Valencia/València;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
46 Valencia/València;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
46 Valencia/València;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
46 Valencia/València;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
46 Valencia/València;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
46 Valencia/València;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
46 Valencia/València;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
46 Valencia/València;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
46 Valencia/València;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
46 Valencia/València;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
46 Valencia/València;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;97,11
46 Valencia/València;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
46 Valencia/València;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
46 Valencia/València;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
46 Valencia/València;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;97,65
46 Valencia/València;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
46 Valencia/València;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
46 Valencia/València;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
46 Valencia/València;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;97,57
46 Valencia/València;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
46 Valencia/València;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
46 Valencia/València;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
46 Valencia/València;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
46 Valencia/València;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
46 Valencia/València;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
46 Valencia/València;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;95,5
46 Valencia/València;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
46 Valencia/València;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
46 Valencia/València;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
46 Valencia/València;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;95,99
46 Valencia/València;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
46 Valencia/València;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
46 Valencia/València;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
46 Valencia/València;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
46 Valencia/València;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
46 Valencia/València;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
46 Valencia/València;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;93,49
46 Valencia/València;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
46 Valencia/València;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
46 Valencia/València;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
46 Valencia/València;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;94,29
46 Valencia/València;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
46 Valencia/València;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
46 Valencia/València;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
46 Valencia/València;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
46 Valencia/València;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
46 Valencia/València;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
46 Valencia/València;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;91,78
46 Valencia/València;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
46 Valencia/València;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
46 Valencia/València;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
46 Valencia/València;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;92,76
46 Valencia/València;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
46 Valencia/València;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
46 Valencia/València;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
46 Valencia/València;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
46 Valencia/València;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
46 Valencia/València;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
46 Valencia/València;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QIV;33.267
46 Valencia/València;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
46 Valencia/València;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
46 Valencia/València;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
46 Valencia/València;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QIV;32.462
46 Valencia/València;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
46 Valencia/València;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
46 Valencia/València;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
46 Valencia/València;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QIV;31.546
46 Valencia/València;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
46 Valencia/València;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
46 Valencia/València;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
46 Valencia/València;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2022QIV;32.336
46 Valencia/València;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
46 Valencia/València;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2022QII;""
46 Valencia/València;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2022QI;""
46 Valencia/València;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2021QIV;31.742
46 Valencia/València;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
46 Valencia/València;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2021QII;""
46 Valencia/València;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2021QI;""
46 Valencia/València;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2020QIV;30.813
46 Valencia/València;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
46 Valencia/València;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2020QII;""
46 Valencia/València;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2020QI;""
46 Valencia/València;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
46 Valencia/València;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
46 Valencia/València;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2022QII;""
46 Valencia/València;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2022QI;31.087
46 Valencia/València;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
46 Valencia/València;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
46 Valencia/València;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2021QII;""
46 Valencia/València;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2021QI;30.341
46 Valencia/València;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
46 Valencia/València;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
46 Valencia/València;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2020QII;""
46 Valencia/València;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2020QI;""
46 Valencia/València;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
46 Valencia/València;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
46 Valencia/València;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QII;30.511
46 Valencia/València;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QI;""
46 Valencia/València;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
46 Valencia/València;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
46 Valencia/València;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QII;29.824
46 Valencia/València;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QI;""
46 Valencia/València;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
46 Valencia/València;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
46 Valencia/València;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QII;""
46 Valencia/València;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QI;""
46 Valencia/València;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
46 Valencia/València;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QIII;30.010
46 Valencia/València;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QII;""
46 Valencia/València;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QI;""
46 Valencia/València;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
46 Valencia/València;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QIII;29.375
46 Valencia/València;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QII;""
46 Valencia/València;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QI;""
46 Valencia/València;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
46 Valencia/València;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
46 Valencia/València;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QII;""
46 Valencia/València;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QI;""
46 Valencia/València;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
46 Valencia/València;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
46 Valencia/València;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
46 Valencia/València;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
46 Valencia/València;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
46 Valencia/València;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
46 Valencia/València;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
46 Valencia/València;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
46 Valencia/València;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
46 Valencia/València;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
46 Valencia/València;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
46 Valencia/València;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
46 Valencia/València;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;97,2
46 Valencia/València;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
46 Valencia/València;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
46 Valencia/València;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
46 Valencia/València;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;97,78
46 Valencia/València;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
46 Valencia/València;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
46 Valencia/València;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
46 Valencia/València;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;97,68
46 Valencia/València;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
46 Valencia/València;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
46 Valencia/València;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
46 Valencia/València;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
46 Valencia/València;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
46 Valencia/València;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
46 Valencia/València;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;95,76
46 Valencia/València;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
46 Valencia/València;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
46 Valencia/València;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
46 Valencia/València;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;96,18
46 Valencia/València;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
46 Valencia/València;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
46 Valencia/València;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
46 Valencia/València;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
46 Valencia/València;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
46 Valencia/València;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
46 Valencia/València;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;93,99
46 Valencia/València;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
46 Valencia/València;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
46 Valencia/València;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
46 Valencia/València;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;94,54
46 Valencia/València;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
46 Valencia/València;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
46 Valencia/València;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
46 Valencia/València;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
46 Valencia/València;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
46 Valencia/València;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
46 Valencia/València;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;92,45
46 Valencia/València;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
46 Valencia/València;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
46 Valencia/València;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
46 Valencia/València;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;93,12
46 Valencia/València;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
46 Valencia/València;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
46 Valencia/València;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
46 Valencia/València;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
46 Valencia/València;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
46 Valencia/València;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
46 Valencia/València;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QIV;18.500
46 Valencia/València;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
46 Valencia/València;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
46 Valencia/València;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
46 Valencia/València;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QIV;18.191
46 Valencia/València;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
46 Valencia/València;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
46 Valencia/València;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
46 Valencia/València;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QIV;17.570
46 Valencia/València;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
46 Valencia/València;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
46 Valencia/València;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
46 Valencia/València;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2022QIV;17.936
46 Valencia/València;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
46 Valencia/València;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2022QII;""
46 Valencia/València;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2022QI;""
46 Valencia/València;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2021QIV;17.722
46 Valencia/València;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
46 Valencia/València;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2021QII;""
46 Valencia/València;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2021QI;""
46 Valencia/València;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2020QIV;17.110
46 Valencia/València;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
46 Valencia/València;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2020QII;""
46 Valencia/València;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2020QI;""
46 Valencia/València;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
46 Valencia/València;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
46 Valencia/València;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2022QII;""
46 Valencia/València;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2022QI;17.287
46 Valencia/València;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
46 Valencia/València;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
46 Valencia/València;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2021QII;""
46 Valencia/València;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2021QI;16.804
46 Valencia/València;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
46 Valencia/València;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
46 Valencia/València;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2020QII;""
46 Valencia/València;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2020QI;""
46 Valencia/València;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
46 Valencia/València;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
46 Valencia/València;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QII;16.847
46 Valencia/València;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QI;""
46 Valencia/València;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
46 Valencia/València;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
46 Valencia/València;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QII;16.487
46 Valencia/València;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QI;""
46 Valencia/València;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
46 Valencia/València;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
46 Valencia/València;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QII;""
46 Valencia/València;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QI;""
46 Valencia/València;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
46 Valencia/València;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QIII;16.478
46 Valencia/València;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QII;""
46 Valencia/València;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QI;""
46 Valencia/València;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
46 Valencia/València;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QIII;16.187
46 Valencia/València;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QII;""
46 Valencia/València;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QI;""
46 Valencia/València;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
46 Valencia/València;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
46 Valencia/València;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QII;""
46 Valencia/València;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QI;""
46 Valencia/València;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
46 Valencia/València;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
46 Valencia/València;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
46 Valencia/València;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
46 Valencia/València;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
46 Valencia/València;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
46 Valencia/València;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
46 Valencia/València;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
46 Valencia/València;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
46 Valencia/València;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
46 Valencia/València;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
46 Valencia/València;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
46 Valencia/València;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;96,95
46 Valencia/València;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
46 Valencia/València;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
46 Valencia/València;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
46 Valencia/València;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;97,42
46 Valencia/València;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
46 Valencia/València;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
46 Valencia/València;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
46 Valencia/València;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;97,38
46 Valencia/València;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
46 Valencia/València;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
46 Valencia/València;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
46 Valencia/València;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
46 Valencia/València;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
46 Valencia/València;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
46 Valencia/València;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;95,03
46 Valencia/València;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
46 Valencia/València;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
46 Valencia/València;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
46 Valencia/València;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;95,64
46 Valencia/València;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
46 Valencia/València;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
46 Valencia/València;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
46 Valencia/València;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
46 Valencia/València;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
46 Valencia/València;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
46 Valencia/València;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;92,61
46 Valencia/València;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
46 Valencia/València;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
46 Valencia/València;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
46 Valencia/València;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;93,84
46 Valencia/València;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
46 Valencia/València;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
46 Valencia/València;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
46 Valencia/València;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
46 Valencia/València;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
46 Valencia/València;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
46 Valencia/València;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;90,58
46 Valencia/València;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
46 Valencia/València;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
46 Valencia/València;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
46 Valencia/València;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;92,13
46 Valencia/València;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
46 Valencia/València;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
46 Valencia/València;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
46 Valencia/València;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
46 Valencia/València;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
46 Valencia/València;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
46 Valencia/València;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
46 Valencia/València;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
46 Valencia/València;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
46 Valencia/València;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QI;22.497
46 Valencia/València;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
46 Valencia/València;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
46 Valencia/València;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
46 Valencia/València;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QI;21.347
46 Valencia/València;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
46 Valencia/València;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
46 Valencia/València;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
46 Valencia/València;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QI;24.732
46 Valencia/València;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
46 Valencia/València;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
46 Valencia/València;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2022QII;""
46 Valencia/València;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2022QI;21.572
46 Valencia/València;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
46 Valencia/València;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
46 Valencia/València;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2021QII;""
46 Valencia/València;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2021QI;20.495
46 Valencia/València;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
46 Valencia/València;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
46 Valencia/València;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2020QII;""
46 Valencia/València;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2020QI;23.032
46 Valencia/València;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
46 Valencia/València;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
46 Valencia/València;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2022QII;20.706
46 Valencia/València;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2022QI;""
46 Valencia/València;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
46 Valencia/València;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
46 Valencia/València;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2021QII;19.654
46 Valencia/València;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2021QI;""
46 Valencia/València;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
46 Valencia/València;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
46 Valencia/València;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2020QII;22.311
46 Valencia/València;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2020QI;""
46 Valencia/València;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
46 Valencia/València;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QIII;19.813
46 Valencia/València;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QII;""
46 Valencia/València;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QI;""
46 Valencia/València;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
46 Valencia/València;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QIII;18.828
46 Valencia/València;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QII;""
46 Valencia/València;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QI;""
46 Valencia/València;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
46 Valencia/València;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QIII;21.352
46 Valencia/València;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QII;""
46 Valencia/València;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QI;""
46 Valencia/València;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QIV;18.536
46 Valencia/València;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
46 Valencia/València;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QII;""
46 Valencia/València;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QI;""
46 Valencia/València;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QIV;17.876
46 Valencia/València;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
46 Valencia/València;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QII;""
46 Valencia/València;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QI;""
46 Valencia/València;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QIV;20.212
46 Valencia/València;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
46 Valencia/València;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QII;""
46 Valencia/València;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QI;""
46 Valencia/València;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
46 Valencia/València;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
46 Valencia/València;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
46 Valencia/València;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
46 Valencia/València;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
46 Valencia/València;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
46 Valencia/València;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
46 Valencia/València;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
46 Valencia/València;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
46 Valencia/València;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
46 Valencia/València;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
46 Valencia/València;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
46 Valencia/València;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
46 Valencia/València;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
46 Valencia/València;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
46 Valencia/València;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;95,89
46 Valencia/València;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
46 Valencia/València;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
46 Valencia/València;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
46 Valencia/València;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;96,01
46 Valencia/València;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
46 Valencia/València;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
46 Valencia/València;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
46 Valencia/València;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;93,13
46 Valencia/València;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
46 Valencia/València;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
46 Valencia/València;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;92,04
46 Valencia/València;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
46 Valencia/València;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
46 Valencia/València;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
46 Valencia/València;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;92,07
46 Valencia/València;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
46 Valencia/València;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
46 Valencia/València;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
46 Valencia/València;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;90,21
46 Valencia/València;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
46 Valencia/València;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
46 Valencia/València;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;88,07
46 Valencia/València;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
46 Valencia/València;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
46 Valencia/València;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
46 Valencia/València;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;88,2
46 Valencia/València;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
46 Valencia/València;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
46 Valencia/València;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
46 Valencia/València;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;86,33
46 Valencia/València;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
46 Valencia/València;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
46 Valencia/València;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;82,39
46 Valencia/València;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
46 Valencia/València;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
46 Valencia/València;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
46 Valencia/València;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;83,74
46 Valencia/València;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
46 Valencia/València;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
46 Valencia/València;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
46 Valencia/València;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;81,72
46 Valencia/València;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
46 Valencia/València;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
46 Valencia/València;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
46 Valencia/València;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
46 Valencia/València;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
46 Valencia/València;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
46 Valencia/València;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QI;14.577
46 Valencia/València;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
46 Valencia/València;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
46 Valencia/València;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
46 Valencia/València;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QI;13.883
46 Valencia/València;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
46 Valencia/València;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
46 Valencia/València;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
46 Valencia/València;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QI;15.942
46 Valencia/València;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
46 Valencia/València;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
46 Valencia/València;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2022QII;""
46 Valencia/València;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2022QI;13.974
46 Valencia/València;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
46 Valencia/València;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
46 Valencia/València;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2021QII;""
46 Valencia/València;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2021QI;13.308
46 Valencia/València;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
46 Valencia/València;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
46 Valencia/València;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2020QII;""
46 Valencia/València;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2020QI;14.886
46 Valencia/València;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
46 Valencia/València;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
46 Valencia/València;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2022QII;13.433
46 Valencia/València;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2022QI;""
46 Valencia/València;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
46 Valencia/València;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
46 Valencia/València;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2021QII;12.786
46 Valencia/València;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2021QI;""
46 Valencia/València;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
46 Valencia/València;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
46 Valencia/València;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2020QII;14.466
46 Valencia/València;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2020QI;""
46 Valencia/València;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
46 Valencia/València;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QIII;12.883
46 Valencia/València;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QII;""
46 Valencia/València;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QI;""
46 Valencia/València;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
46 Valencia/València;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QIII;12.282
46 Valencia/València;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QII;""
46 Valencia/València;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QI;""
46 Valencia/València;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
46 Valencia/València;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QIII;13.891
46 Valencia/València;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QII;""
46 Valencia/València;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QI;""
46 Valencia/València;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QIV;12.055
46 Valencia/València;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
46 Valencia/València;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QII;""
46 Valencia/València;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QI;""
46 Valencia/València;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QIV;11.689
46 Valencia/València;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
46 Valencia/València;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QII;""
46 Valencia/València;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QI;""
46 Valencia/València;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QIV;13.179
46 Valencia/València;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
46 Valencia/València;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QII;""
46 Valencia/València;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QI;""
46 Valencia/València;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
46 Valencia/València;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
46 Valencia/València;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
46 Valencia/València;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
46 Valencia/València;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
46 Valencia/València;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
46 Valencia/València;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
46 Valencia/València;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
46 Valencia/València;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
46 Valencia/València;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
46 Valencia/València;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
46 Valencia/València;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
46 Valencia/València;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
46 Valencia/València;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
46 Valencia/València;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
46 Valencia/València;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;95,86
46 Valencia/València;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
46 Valencia/València;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
46 Valencia/València;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
46 Valencia/València;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;95,86
46 Valencia/València;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
46 Valencia/València;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
46 Valencia/València;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
46 Valencia/València;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;93,38
46 Valencia/València;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
46 Valencia/València;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
46 Valencia/València;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;92,15
46 Valencia/València;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
46 Valencia/València;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
46 Valencia/València;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
46 Valencia/València;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;92,1
46 Valencia/València;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
46 Valencia/València;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
46 Valencia/València;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
46 Valencia/València;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;90,74
46 Valencia/València;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
46 Valencia/València;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
46 Valencia/València;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;88,38
46 Valencia/València;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
46 Valencia/València;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
46 Valencia/València;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
46 Valencia/València;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;88,47
46 Valencia/València;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
46 Valencia/València;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
46 Valencia/València;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
46 Valencia/València;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;87,13
46 Valencia/València;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
46 Valencia/València;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
46 Valencia/València;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;82,7
46 Valencia/València;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
46 Valencia/València;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
46 Valencia/València;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
46 Valencia/València;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;84,2
46 Valencia/València;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
46 Valencia/València;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
46 Valencia/València;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
46 Valencia/València;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;82,67
46 Valencia/València;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
46 Valencia/València;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
46 Valencia/València;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
46 Valencia/València;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
46 Valencia/València;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
46 Valencia/València;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
46 Valencia/València;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QI;7.920
46 Valencia/València;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
46 Valencia/València;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
46 Valencia/València;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
46 Valencia/València;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QI;7.464
46 Valencia/València;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
46 Valencia/València;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
46 Valencia/València;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
46 Valencia/València;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QI;8.790
46 Valencia/València;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
46 Valencia/València;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
46 Valencia/València;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2022QII;""
46 Valencia/València;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2022QI;7.598
46 Valencia/València;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
46 Valencia/València;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
46 Valencia/València;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2021QII;""
46 Valencia/València;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2021QI;7.187
46 Valencia/València;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
46 Valencia/València;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
46 Valencia/València;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2020QII;""
46 Valencia/València;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2020QI;8.146
46 Valencia/València;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
46 Valencia/València;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
46 Valencia/València;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2022QII;7.273
46 Valencia/València;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2022QI;""
46 Valencia/València;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
46 Valencia/València;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
46 Valencia/València;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2021QII;6.868
46 Valencia/València;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2021QI;""
46 Valencia/València;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
46 Valencia/València;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
46 Valencia/València;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2020QII;7.845
46 Valencia/València;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2020QI;""
46 Valencia/València;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
46 Valencia/València;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QIII;6.930
46 Valencia/València;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QII;""
46 Valencia/València;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QI;""
46 Valencia/València;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
46 Valencia/València;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QIII;6.546
46 Valencia/València;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QII;""
46 Valencia/València;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QI;""
46 Valencia/València;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
46 Valencia/València;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QIII;7.461
46 Valencia/València;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QII;""
46 Valencia/València;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QI;""
46 Valencia/València;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QIV;6.481
46 Valencia/València;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
46 Valencia/València;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QII;""
46 Valencia/València;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QI;""
46 Valencia/València;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QIV;6.187
46 Valencia/València;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
46 Valencia/València;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QII;""
46 Valencia/València;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QI;""
46 Valencia/València;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QIV;7.033
46 Valencia/València;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
46 Valencia/València;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QII;""
46 Valencia/València;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QI;""
46 Valencia/València;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
46 Valencia/València;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
46 Valencia/València;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
46 Valencia/València;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
46 Valencia/València;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
46 Valencia/València;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
46 Valencia/València;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
46 Valencia/València;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
46 Valencia/València;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
46 Valencia/València;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
46 Valencia/València;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
46 Valencia/València;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
46 Valencia/València;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
46 Valencia/València;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
46 Valencia/València;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
46 Valencia/València;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;95,93
46 Valencia/València;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
46 Valencia/València;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
46 Valencia/València;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
46 Valencia/València;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;96,29
46 Valencia/València;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
46 Valencia/València;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
46 Valencia/València;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
46 Valencia/València;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;92,67
46 Valencia/València;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
46 Valencia/València;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
46 Valencia/València;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;91,83
46 Valencia/València;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
46 Valencia/València;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
46 Valencia/València;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
46 Valencia/València;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;92,02
46 Valencia/València;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
46 Valencia/València;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
46 Valencia/València;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
46 Valencia/València;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;89,25
46 Valencia/València;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
46 Valencia/València;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
46 Valencia/València;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;87,5
46 Valencia/València;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
46 Valencia/València;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
46 Valencia/València;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
46 Valencia/València;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;87,7
46 Valencia/València;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
46 Valencia/València;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
46 Valencia/València;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
46 Valencia/València;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;84,88
46 Valencia/València;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
46 Valencia/València;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
46 Valencia/València;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;81,83
46 Valencia/València;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
46 Valencia/València;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
46 Valencia/València;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
46 Valencia/València;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;82,89
46 Valencia/València;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
46 Valencia/València;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
46 Valencia/València;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
46 Valencia/València;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;80,01
46 Valencia/València;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
46 Valencia/València;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
46 Valencia/València;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
46 Valencia/València;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
46 Valencia/València;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
46 Valencia/València;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QII;25.872
46 Valencia/València;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
46 Valencia/València;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
46 Valencia/València;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
46 Valencia/València;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QII;24.578
46 Valencia/València;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
46 Valencia/València;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
46 Valencia/València;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
46 Valencia/València;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QII;23.598
46 Valencia/València;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
46 Valencia/València;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
46 Valencia/València;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
46 Valencia/València;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2022QII;24.879
46 Valencia/València;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2022QI;""
46 Valencia/València;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
46 Valencia/València;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
46 Valencia/València;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2021QII;23.635
46 Valencia/València;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2021QI;""
46 Valencia/València;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
46 Valencia/València;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
46 Valencia/València;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2020QII;22.840
46 Valencia/València;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2020QI;""
46 Valencia/València;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
46 Valencia/València;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2022QIII;23.872
46 Valencia/València;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2022QII;""
46 Valencia/València;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2022QI;""
46 Valencia/València;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
46 Valencia/València;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2021QIII;22.712
46 Valencia/València;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2021QII;""
46 Valencia/València;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2021QI;""
46 Valencia/València;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
46 Valencia/València;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2020QIII;21.791
46 Valencia/València;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2020QII;""
46 Valencia/València;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2020QI;""
46 Valencia/València;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QIV;22.492
46 Valencia/València;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
46 Valencia/València;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QII;""
46 Valencia/València;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QI;""
46 Valencia/València;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QIV;21.679
46 Valencia/València;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
46 Valencia/València;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QII;""
46 Valencia/València;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QI;""
46 Valencia/València;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QIV;20.615
46 Valencia/València;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
46 Valencia/València;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QII;""
46 Valencia/València;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QI;""
46 Valencia/València;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
46 Valencia/València;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
46 Valencia/València;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QII;""
46 Valencia/València;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QI;20.837
46 Valencia/València;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
46 Valencia/València;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
46 Valencia/València;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QII;""
46 Valencia/València;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QI;19.844
46 Valencia/València;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
46 Valencia/València;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
46 Valencia/València;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QII;""
46 Valencia/València;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QI;""
46 Valencia/València;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
46 Valencia/València;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
46 Valencia/València;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
46 Valencia/València;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
46 Valencia/València;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
46 Valencia/València;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
46 Valencia/València;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
46 Valencia/València;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
46 Valencia/València;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
46 Valencia/València;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
46 Valencia/València;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
46 Valencia/València;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
46 Valencia/València;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
46 Valencia/València;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
46 Valencia/València;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;96,16
46 Valencia/València;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
46 Valencia/València;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
46 Valencia/València;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
46 Valencia/València;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;96,16
46 Valencia/València;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
46 Valencia/València;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
46 Valencia/València;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
46 Valencia/València;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;96,79
46 Valencia/València;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
46 Valencia/València;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
46 Valencia/València;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;92,27
46 Valencia/València;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
46 Valencia/València;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
46 Valencia/València;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
46 Valencia/València;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;92,41
46 Valencia/València;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
46 Valencia/València;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
46 Valencia/València;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
46 Valencia/València;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;92,34
46 Valencia/València;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
46 Valencia/València;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
46 Valencia/València;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;86,94
46 Valencia/València;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
46 Valencia/València;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
46 Valencia/València;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
46 Valencia/València;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;88,2
46 Valencia/València;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
46 Valencia/València;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
46 Valencia/València;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
46 Valencia/València;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;87,36
46 Valencia/València;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
46 Valencia/València;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
46 Valencia/València;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
46 Valencia/València;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
46 Valencia/València;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
46 Valencia/València;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
46 Valencia/València;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;84,78
46 Valencia/València;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
46 Valencia/València;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
46 Valencia/València;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
46 Valencia/València;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;84,09
46 Valencia/València;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
46 Valencia/València;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
46 Valencia/València;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
46 Valencia/València;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
46 Valencia/València;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
46 Valencia/València;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
46 Valencia/València;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QII;16.712
46 Valencia/València;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
46 Valencia/València;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
46 Valencia/València;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
46 Valencia/València;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QII;15.923
46 Valencia/València;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
46 Valencia/València;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
46 Valencia/València;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
46 Valencia/València;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QII;15.249
46 Valencia/València;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
46 Valencia/València;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
46 Valencia/València;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
46 Valencia/València;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2022QII;16.094
46 Valencia/València;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2022QI;""
46 Valencia/València;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
46 Valencia/València;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
46 Valencia/València;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2021QII;15.333
46 Valencia/València;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2021QI;""
46 Valencia/València;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
46 Valencia/València;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
46 Valencia/València;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2020QII;14.809
46 Valencia/València;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2020QI;""
46 Valencia/València;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
46 Valencia/València;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2022QIII;15.476
46 Valencia/València;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2022QII;""
46 Valencia/València;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2022QI;""
46 Valencia/València;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
46 Valencia/València;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2021QIII;14.768
46 Valencia/València;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2021QII;""
46 Valencia/València;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2021QI;""
46 Valencia/València;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
46 Valencia/València;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2020QIII;14.176
46 Valencia/València;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2020QII;""
46 Valencia/València;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2020QI;""
46 Valencia/València;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QIV;14.582
46 Valencia/València;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
46 Valencia/València;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QII;""
46 Valencia/València;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QI;""
46 Valencia/València;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QIV;14.122
46 Valencia/València;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
46 Valencia/València;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QII;""
46 Valencia/València;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QI;""
46 Valencia/València;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QIV;13.440
46 Valencia/València;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
46 Valencia/València;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QII;""
46 Valencia/València;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QI;""
46 Valencia/València;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
46 Valencia/València;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
46 Valencia/València;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QII;""
46 Valencia/València;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QI;13.576
46 Valencia/València;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
46 Valencia/València;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
46 Valencia/València;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QII;""
46 Valencia/València;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QI;12.924
46 Valencia/València;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
46 Valencia/València;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
46 Valencia/València;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QII;""
46 Valencia/València;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QI;""
46 Valencia/València;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
46 Valencia/València;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
46 Valencia/València;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
46 Valencia/València;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
46 Valencia/València;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
46 Valencia/València;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
46 Valencia/València;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
46 Valencia/València;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
46 Valencia/València;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
46 Valencia/València;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
46 Valencia/València;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
46 Valencia/València;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
46 Valencia/València;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
46 Valencia/València;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
46 Valencia/València;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;96,3
46 Valencia/València;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
46 Valencia/València;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
46 Valencia/València;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
46 Valencia/València;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;96,29
46 Valencia/València;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
46 Valencia/València;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
46 Valencia/València;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
46 Valencia/València;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;97,11
46 Valencia/València;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
46 Valencia/València;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
46 Valencia/València;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;92,6
46 Valencia/València;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
46 Valencia/València;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
46 Valencia/València;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
46 Valencia/València;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;92,75
46 Valencia/València;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
46 Valencia/València;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
46 Valencia/València;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
46 Valencia/València;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;92,96
46 Valencia/València;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
46 Valencia/València;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
46 Valencia/València;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;87,25
46 Valencia/València;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
46 Valencia/València;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
46 Valencia/València;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
46 Valencia/València;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;88,69
46 Valencia/València;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
46 Valencia/València;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
46 Valencia/València;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
46 Valencia/València;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;88,14
46 Valencia/València;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
46 Valencia/València;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
46 Valencia/València;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
46 Valencia/València;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
46 Valencia/València;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
46 Valencia/València;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
46 Valencia/València;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;85,26
46 Valencia/València;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
46 Valencia/València;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
46 Valencia/València;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
46 Valencia/València;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;84,75
46 Valencia/València;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
46 Valencia/València;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
46 Valencia/València;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
46 Valencia/València;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
46 Valencia/València;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
46 Valencia/València;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
46 Valencia/València;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QII;9.160
46 Valencia/València;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
46 Valencia/València;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
46 Valencia/València;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
46 Valencia/València;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QII;8.655
46 Valencia/València;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
46 Valencia/València;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
46 Valencia/València;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
46 Valencia/València;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QII;8.349
46 Valencia/València;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
46 Valencia/València;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
46 Valencia/València;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
46 Valencia/València;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2022QII;8.785
46 Valencia/València;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2022QI;""
46 Valencia/València;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
46 Valencia/València;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
46 Valencia/València;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2021QII;8.302
46 Valencia/València;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2021QI;""
46 Valencia/València;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
46 Valencia/València;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
46 Valencia/València;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2020QII;8.031
46 Valencia/València;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2020QI;""
46 Valencia/València;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
46 Valencia/València;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2022QIII;8.396
46 Valencia/València;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2022QII;""
46 Valencia/València;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2022QI;""
46 Valencia/València;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
46 Valencia/València;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2021QIII;7.944
46 Valencia/València;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2021QII;""
46 Valencia/València;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2021QI;""
46 Valencia/València;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
46 Valencia/València;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2020QIII;7.615
46 Valencia/València;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2020QII;""
46 Valencia/València;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2020QI;""
46 Valencia/València;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QIV;7.910
46 Valencia/València;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
46 Valencia/València;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QII;""
46 Valencia/València;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QI;""
46 Valencia/València;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QIV;7.557
46 Valencia/València;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
46 Valencia/València;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QII;""
46 Valencia/València;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QI;""
46 Valencia/València;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QIV;7.175
46 Valencia/València;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
46 Valencia/València;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QII;""
46 Valencia/València;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QI;""
46 Valencia/València;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
46 Valencia/València;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
46 Valencia/València;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QII;""
46 Valencia/València;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QI;7.261
46 Valencia/València;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
46 Valencia/València;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
46 Valencia/València;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QII;""
46 Valencia/València;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QI;6.920
46 Valencia/València;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
46 Valencia/València;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
46 Valencia/València;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QII;""
46 Valencia/València;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QI;""
46 Valencia/València;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
46 Valencia/València;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
46 Valencia/València;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
46 Valencia/València;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
46 Valencia/València;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
46 Valencia/València;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
46 Valencia/València;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
46 Valencia/València;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
46 Valencia/València;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
46 Valencia/València;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
46 Valencia/València;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
46 Valencia/València;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
46 Valencia/València;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
46 Valencia/València;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
46 Valencia/València;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;95,91
46 Valencia/València;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
46 Valencia/València;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
46 Valencia/València;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
46 Valencia/València;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;95,92
46 Valencia/València;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
46 Valencia/València;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
46 Valencia/València;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
46 Valencia/València;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;96,19
46 Valencia/València;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
46 Valencia/València;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
46 Valencia/València;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;91,66
46 Valencia/València;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
46 Valencia/València;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
46 Valencia/València;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
46 Valencia/València;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;91,79
46 Valencia/València;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
46 Valencia/València;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
46 Valencia/València;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
46 Valencia/València;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;91,21
46 Valencia/València;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
46 Valencia/València;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
46 Valencia/València;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;86,35
46 Valencia/València;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
46 Valencia/València;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
46 Valencia/València;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
46 Valencia/València;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;87,31
46 Valencia/València;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
46 Valencia/València;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
46 Valencia/València;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
46 Valencia/València;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;85,94
46 Valencia/València;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
46 Valencia/València;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
46 Valencia/València;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
46 Valencia/València;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
46 Valencia/València;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
46 Valencia/València;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
46 Valencia/València;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;83,89
46 Valencia/València;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
46 Valencia/València;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
46 Valencia/València;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
46 Valencia/València;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;82,88
46 Valencia/València;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
46 Valencia/València;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
46 Valencia/València;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
46 Valencia/València;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
46 Valencia/València;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
46 Valencia/València;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QIII;25.265
46 Valencia/València;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
46 Valencia/València;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
46 Valencia/València;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
46 Valencia/València;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QIII;24.010
46 Valencia/València;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
46 Valencia/València;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
46 Valencia/València;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
46 Valencia/València;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QIII;23.153
46 Valencia/València;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
46 Valencia/València;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
46 Valencia/València;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
46 Valencia/València;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2022QIII;24.156
46 Valencia/València;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2022QII;""
46 Valencia/València;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2022QI;""
46 Valencia/València;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
46 Valencia/València;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2021QIII;23.015
46 Valencia/València;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2021QII;""
46 Valencia/València;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2021QI;""
46 Valencia/València;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
46 Valencia/València;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2020QIII;22.034
46 Valencia/València;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2020QII;""
46 Valencia/València;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2020QI;""
46 Valencia/València;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2022QIV;22.736
46 Valencia/València;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
46 Valencia/València;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2022QII;""
46 Valencia/València;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2022QI;""
46 Valencia/València;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2021QIV;21.940
46 Valencia/València;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
46 Valencia/València;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2021QII;""
46 Valencia/València;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2021QI;""
46 Valencia/València;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2020QIV;20.828
46 Valencia/València;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
46 Valencia/València;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2020QII;""
46 Valencia/València;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2020QI;""
46 Valencia/València;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
46 Valencia/València;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
46 Valencia/València;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QII;""
46 Valencia/València;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QI;21.077
46 Valencia/València;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
46 Valencia/València;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
46 Valencia/València;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QII;""
46 Valencia/València;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QI;20.036
46 Valencia/València;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
46 Valencia/València;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
46 Valencia/València;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QII;""
46 Valencia/València;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QI;""
46 Valencia/València;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
46 Valencia/València;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
46 Valencia/València;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QII;20.266
46 Valencia/València;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QI;""
46 Valencia/València;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
46 Valencia/València;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
46 Valencia/València;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QII;19.250
46 Valencia/València;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QI;""
46 Valencia/València;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
46 Valencia/València;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
46 Valencia/València;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QII;""
46 Valencia/València;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QI;""
46 Valencia/València;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
46 Valencia/València;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
46 Valencia/València;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
46 Valencia/València;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
46 Valencia/València;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
46 Valencia/València;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
46 Valencia/València;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
46 Valencia/València;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
46 Valencia/València;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
46 Valencia/València;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
46 Valencia/València;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
46 Valencia/València;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
46 Valencia/València;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
46 Valencia/València;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;95,61
46 Valencia/València;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
46 Valencia/València;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
46 Valencia/València;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
46 Valencia/València;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;95,86
46 Valencia/València;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
46 Valencia/València;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
46 Valencia/València;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
46 Valencia/València;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;95,17
46 Valencia/València;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
46 Valencia/València;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
46 Valencia/València;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;89,99
46 Valencia/València;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
46 Valencia/València;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
46 Valencia/València;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
46 Valencia/València;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;91,38
46 Valencia/València;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
46 Valencia/València;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
46 Valencia/València;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
46 Valencia/València;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;89,96
46 Valencia/València;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
46 Valencia/València;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
46 Valencia/València;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
46 Valencia/València;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
46 Valencia/València;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
46 Valencia/València;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
46 Valencia/València;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;87,78
46 Valencia/València;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
46 Valencia/València;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
46 Valencia/València;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
46 Valencia/València;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;86,54
46 Valencia/València;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
46 Valencia/València;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
46 Valencia/València;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
46 Valencia/València;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
46 Valencia/València;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
46 Valencia/València;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
46 Valencia/València;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;84,41
46 Valencia/València;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
46 Valencia/València;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
46 Valencia/València;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
46 Valencia/València;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;83,14
46 Valencia/València;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
46 Valencia/València;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
46 Valencia/València;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
46 Valencia/València;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
46 Valencia/València;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
46 Valencia/València;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
46 Valencia/València;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QIII;16.309
46 Valencia/València;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
46 Valencia/València;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
46 Valencia/València;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
46 Valencia/València;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QIII;15.546
46 Valencia/València;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
46 Valencia/València;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
46 Valencia/València;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
46 Valencia/València;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QIII;14.997
46 Valencia/València;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
46 Valencia/València;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
46 Valencia/València;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
46 Valencia/València;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2022QIII;15.635
46 Valencia/València;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2022QII;""
46 Valencia/València;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2022QI;""
46 Valencia/València;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
46 Valencia/València;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2021QIII;14.938
46 Valencia/València;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2021QII;""
46 Valencia/València;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2021QI;""
46 Valencia/València;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
46 Valencia/València;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2020QIII;14.322
46 Valencia/València;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2020QII;""
46 Valencia/València;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2020QI;""
46 Valencia/València;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2022QIV;14.716
46 Valencia/València;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
46 Valencia/València;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2022QII;""
46 Valencia/València;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2022QI;""
46 Valencia/València;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2021QIV;14.273
46 Valencia/València;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
46 Valencia/València;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2021QII;""
46 Valencia/València;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2021QI;""
46 Valencia/València;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2020QIV;13.573
46 Valencia/València;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
46 Valencia/València;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2020QII;""
46 Valencia/València;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2020QI;""
46 Valencia/València;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
46 Valencia/València;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
46 Valencia/València;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QII;""
46 Valencia/València;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QI;13.712
46 Valencia/València;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
46 Valencia/València;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
46 Valencia/València;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QII;""
46 Valencia/València;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QI;13.040
46 Valencia/València;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
46 Valencia/València;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
46 Valencia/València;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QII;""
46 Valencia/València;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QI;""
46 Valencia/València;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
46 Valencia/València;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
46 Valencia/València;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QII;13.204
46 Valencia/València;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QI;""
46 Valencia/València;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
46 Valencia/València;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
46 Valencia/València;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QII;12.552
46 Valencia/València;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QI;""
46 Valencia/València;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
46 Valencia/València;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
46 Valencia/València;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QII;""
46 Valencia/València;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QI;""
46 Valencia/València;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
46 Valencia/València;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
46 Valencia/València;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
46 Valencia/València;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
46 Valencia/València;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
46 Valencia/València;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
46 Valencia/València;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
46 Valencia/València;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
46 Valencia/València;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
46 Valencia/València;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
46 Valencia/València;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
46 Valencia/València;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
46 Valencia/València;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
46 Valencia/València;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;95,87
46 Valencia/València;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
46 Valencia/València;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
46 Valencia/València;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
46 Valencia/València;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;96,09
46 Valencia/València;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
46 Valencia/València;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
46 Valencia/València;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
46 Valencia/València;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;95,5
46 Valencia/València;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
46 Valencia/València;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
46 Valencia/València;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;90,23
46 Valencia/València;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
46 Valencia/València;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
46 Valencia/València;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
46 Valencia/València;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;91,81
46 Valencia/València;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
46 Valencia/València;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
46 Valencia/València;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
46 Valencia/València;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;90,5
46 Valencia/València;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
46 Valencia/València;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
46 Valencia/València;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
46 Valencia/València;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
46 Valencia/València;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
46 Valencia/València;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
46 Valencia/València;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;88,2
46 Valencia/València;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
46 Valencia/València;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
46 Valencia/València;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
46 Valencia/València;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;86,95
46 Valencia/València;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
46 Valencia/València;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
46 Valencia/València;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
46 Valencia/València;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
46 Valencia/València;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
46 Valencia/València;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
46 Valencia/València;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;84,94
46 Valencia/València;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
46 Valencia/València;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
46 Valencia/València;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
46 Valencia/València;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;83,7
46 Valencia/València;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
46 Valencia/València;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
46 Valencia/València;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
46 Valencia/València;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
46 Valencia/València;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
46 Valencia/València;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
46 Valencia/València;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QIII;8.956
46 Valencia/València;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
46 Valencia/València;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
46 Valencia/València;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
46 Valencia/València;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QIII;8.464
46 Valencia/València;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
46 Valencia/València;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
46 Valencia/València;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
46 Valencia/València;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QIII;8.156
46 Valencia/València;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
46 Valencia/València;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
46 Valencia/València;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
46 Valencia/València;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2022QIII;8.521
46 Valencia/València;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2022QII;""
46 Valencia/València;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2022QI;""
46 Valencia/València;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
46 Valencia/València;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2021QIII;8.077
46 Valencia/València;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2021QII;""
46 Valencia/València;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2021QI;""
46 Valencia/València;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
46 Valencia/València;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2020QIII;7.712
46 Valencia/València;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2020QII;""
46 Valencia/València;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2020QI;""
46 Valencia/València;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2022QIV;8.020
46 Valencia/València;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
46 Valencia/València;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2022QII;""
46 Valencia/València;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2022QI;""
46 Valencia/València;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2021QIV;7.667
46 Valencia/València;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
46 Valencia/València;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2021QII;""
46 Valencia/València;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2021QI;""
46 Valencia/València;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2020QIV;7.255
46 Valencia/València;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
46 Valencia/València;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2020QII;""
46 Valencia/València;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2020QI;""
46 Valencia/València;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
46 Valencia/València;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
46 Valencia/València;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QII;""
46 Valencia/València;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QI;7.365
46 Valencia/València;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
46 Valencia/València;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
46 Valencia/València;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QII;""
46 Valencia/València;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QI;6.996
46 Valencia/València;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
46 Valencia/València;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
46 Valencia/València;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QII;""
46 Valencia/València;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QI;""
46 Valencia/València;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
46 Valencia/València;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
46 Valencia/València;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QII;7.062
46 Valencia/València;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QI;""
46 Valencia/València;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
46 Valencia/València;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
46 Valencia/València;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QII;6.698
46 Valencia/València;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QI;""
46 Valencia/València;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
46 Valencia/València;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
46 Valencia/València;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QII;""
46 Valencia/València;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QI;""
46 Valencia/València;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
46 Valencia/València;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
46 Valencia/València;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
46 Valencia/València;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
46 Valencia/València;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
46 Valencia/València;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
46 Valencia/València;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
46 Valencia/València;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
46 Valencia/València;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
46 Valencia/València;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
46 Valencia/València;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
46 Valencia/València;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
46 Valencia/València;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
46 Valencia/València;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;95,14
46 Valencia/València;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
46 Valencia/València;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
46 Valencia/València;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
46 Valencia/València;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;95,43
46 Valencia/València;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
46 Valencia/València;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
46 Valencia/València;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
46 Valencia/València;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;94,56
46 Valencia/València;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
46 Valencia/València;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
46 Valencia/València;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;89,55
46 Valencia/València;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
46 Valencia/València;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
46 Valencia/València;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
46 Valencia/València;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;90,58
46 Valencia/València;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
46 Valencia/València;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
46 Valencia/València;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
46 Valencia/València;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;88,95
46 Valencia/València;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
46 Valencia/València;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
46 Valencia/València;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
46 Valencia/València;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
46 Valencia/València;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
46 Valencia/València;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
46 Valencia/València;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;87,02
46 Valencia/València;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
46 Valencia/València;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
46 Valencia/València;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
46 Valencia/València;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;85,78
46 Valencia/València;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
46 Valencia/València;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
46 Valencia/València;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
46 Valencia/València;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
46 Valencia/València;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
46 Valencia/València;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
46 Valencia/València;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;83,44
46 Valencia/València;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
46 Valencia/València;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
46 Valencia/València;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
46 Valencia/València;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;82,12
46 Valencia/València;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
46 Valencia/València;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
46 Valencia/València;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
46 Valencia/València;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
46 Valencia/València;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
46 Valencia/València;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QIV;24.432
46 Valencia/València;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
46 Valencia/València;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
46 Valencia/València;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
46 Valencia/València;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QIV;23.304
46 Valencia/València;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
46 Valencia/València;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
46 Valencia/València;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
46 Valencia/València;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QIV;22.315
46 Valencia/València;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
46 Valencia/València;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
46 Valencia/València;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
46 Valencia/València;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2022QIV;22.974
46 Valencia/València;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
46 Valencia/València;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2022QII;""
46 Valencia/València;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2022QI;""
46 Valencia/València;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2021QIV;22.176
46 Valencia/València;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
46 Valencia/València;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2021QII;""
46 Valencia/València;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2021QI;""
46 Valencia/València;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2020QIV;21.062
46 Valencia/València;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
46 Valencia/València;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2020QII;""
46 Valencia/València;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2020QI;""
46 Valencia/València;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
46 Valencia/València;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
46 Valencia/València;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2022QII;""
46 Valencia/València;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2022QI;21.291
46 Valencia/València;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
46 Valencia/València;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
46 Valencia/València;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2021QII;""
46 Valencia/València;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2021QI;20.252
46 Valencia/València;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
46 Valencia/València;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
46 Valencia/València;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2020QII;""
46 Valencia/València;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2020QI;""
46 Valencia/València;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
46 Valencia/València;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
46 Valencia/València;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QII;20.462
46 Valencia/València;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QI;""
46 Valencia/València;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
46 Valencia/València;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
46 Valencia/València;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QII;19.443
46 Valencia/València;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QI;""
46 Valencia/València;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
46 Valencia/València;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
46 Valencia/València;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QII;""
46 Valencia/València;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QI;""
46 Valencia/València;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
46 Valencia/València;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QIII;19.589
46 Valencia/València;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QII;""
46 Valencia/València;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QI;""
46 Valencia/València;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
46 Valencia/València;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QIII;18.631
46 Valencia/València;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QII;""
46 Valencia/València;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QI;""
46 Valencia/València;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
46 Valencia/València;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
46 Valencia/València;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QII;""
46 Valencia/València;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QI;""
46 Valencia/València;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
46 Valencia/València;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
46 Valencia/València;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
46 Valencia/València;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
46 Valencia/València;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
46 Valencia/València;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
46 Valencia/València;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
46 Valencia/València;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
46 Valencia/València;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
46 Valencia/València;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
46 Valencia/València;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
46 Valencia/València;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
46 Valencia/València;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;94,03
46 Valencia/València;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
46 Valencia/València;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
46 Valencia/València;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
46 Valencia/València;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;95,16
46 Valencia/València;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
46 Valencia/València;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
46 Valencia/València;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
46 Valencia/València;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;94,38
46 Valencia/València;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
46 Valencia/València;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
46 Valencia/València;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
46 Valencia/València;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
46 Valencia/València;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
46 Valencia/València;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
46 Valencia/València;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;91,36
46 Valencia/València;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
46 Valencia/València;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
46 Valencia/València;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
46 Valencia/València;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;90,76
46 Valencia/València;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
46 Valencia/València;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
46 Valencia/València;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
46 Valencia/València;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
46 Valencia/València;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
46 Valencia/València;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
46 Valencia/València;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;87,8
46 Valencia/València;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
46 Valencia/València;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
46 Valencia/València;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
46 Valencia/València;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;87,13
46 Valencia/València;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
46 Valencia/València;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
46 Valencia/València;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
46 Valencia/València;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
46 Valencia/València;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
46 Valencia/València;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
46 Valencia/València;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;84,06
46 Valencia/València;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
46 Valencia/València;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
46 Valencia/València;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
46 Valencia/València;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;83,49
46 Valencia/València;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
46 Valencia/València;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
46 Valencia/València;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
46 Valencia/València;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
46 Valencia/València;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
46 Valencia/València;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
46 Valencia/València;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QIV;15.799
46 Valencia/València;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
46 Valencia/València;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
46 Valencia/València;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
46 Valencia/València;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QIV;15.104
46 Valencia/València;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
46 Valencia/València;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
46 Valencia/València;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
46 Valencia/València;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QIV;14.504
46 Valencia/València;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
46 Valencia/València;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
46 Valencia/València;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
46 Valencia/València;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2022QIV;14.854
46 Valencia/València;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
46 Valencia/València;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2022QII;""
46 Valencia/València;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2022QI;""
46 Valencia/València;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2021QIV;14.407
46 Valencia/València;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
46 Valencia/València;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2021QII;""
46 Valencia/València;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2021QI;""
46 Valencia/València;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2020QIV;13.728
46 Valencia/València;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
46 Valencia/València;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2020QII;""
46 Valencia/València;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2020QI;""
46 Valencia/València;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
46 Valencia/València;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
46 Valencia/València;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2022QII;""
46 Valencia/València;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2022QI;13.833
46 Valencia/València;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
46 Valencia/València;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
46 Valencia/València;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2021QII;""
46 Valencia/València;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2021QI;13.181
46 Valencia/València;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
46 Valencia/València;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
46 Valencia/València;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2020QII;""
46 Valencia/València;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2020QI;""
46 Valencia/València;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
46 Valencia/València;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
46 Valencia/València;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QII;13.315
46 Valencia/València;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QI;""
46 Valencia/València;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
46 Valencia/València;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
46 Valencia/València;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QII;12.678
46 Valencia/València;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QI;""
46 Valencia/València;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
46 Valencia/València;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
46 Valencia/València;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QII;""
46 Valencia/València;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QI;""
46 Valencia/València;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
46 Valencia/València;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QIII;12.773
46 Valencia/València;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QII;""
46 Valencia/València;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QI;""
46 Valencia/València;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
46 Valencia/València;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QIII;12.183
46 Valencia/València;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QII;""
46 Valencia/València;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QI;""
46 Valencia/València;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
46 Valencia/València;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
46 Valencia/València;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QII;""
46 Valencia/València;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QI;""
46 Valencia/València;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
46 Valencia/València;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
46 Valencia/València;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
46 Valencia/València;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
46 Valencia/València;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
46 Valencia/València;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
46 Valencia/València;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
46 Valencia/València;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
46 Valencia/València;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
46 Valencia/València;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
46 Valencia/València;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
46 Valencia/València;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
46 Valencia/València;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;94,02
46 Valencia/València;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
46 Valencia/València;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
46 Valencia/València;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
46 Valencia/València;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;95,39
46 Valencia/València;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
46 Valencia/València;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
46 Valencia/València;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
46 Valencia/València;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;94,65
46 Valencia/València;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
46 Valencia/València;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
46 Valencia/València;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
46 Valencia/València;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
46 Valencia/València;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
46 Valencia/València;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
46 Valencia/València;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;91,59
46 Valencia/València;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
46 Valencia/València;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
46 Valencia/València;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
46 Valencia/València;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;90,88
46 Valencia/València;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
46 Valencia/València;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
46 Valencia/València;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
46 Valencia/València;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
46 Valencia/València;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
46 Valencia/València;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
46 Valencia/València;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;88,16
46 Valencia/València;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
46 Valencia/València;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
46 Valencia/València;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
46 Valencia/València;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;87,41
46 Valencia/València;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
46 Valencia/València;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
46 Valencia/València;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
46 Valencia/València;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
46 Valencia/València;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
46 Valencia/València;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
46 Valencia/València;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;84,57
46 Valencia/València;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
46 Valencia/València;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
46 Valencia/València;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
46 Valencia/València;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;84
46 Valencia/València;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
46 Valencia/València;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
46 Valencia/València;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
46 Valencia/València;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
46 Valencia/València;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
46 Valencia/València;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
46 Valencia/València;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QIV;8.633
46 Valencia/València;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
46 Valencia/València;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
46 Valencia/València;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
46 Valencia/València;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QIV;8.200
46 Valencia/València;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
46 Valencia/València;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
46 Valencia/València;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
46 Valencia/València;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QIV;7.811
46 Valencia/València;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
46 Valencia/València;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
46 Valencia/València;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
46 Valencia/València;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2022QIV;8.120
46 Valencia/València;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
46 Valencia/València;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2022QII;""
46 Valencia/València;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2022QI;""
46 Valencia/València;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2021QIV;7.769
46 Valencia/València;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
46 Valencia/València;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2021QII;""
46 Valencia/València;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2021QI;""
46 Valencia/València;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2020QIV;7.334
46 Valencia/València;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
46 Valencia/València;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2020QII;""
46 Valencia/València;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2020QI;""
46 Valencia/València;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
46 Valencia/València;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
46 Valencia/València;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2022QII;""
46 Valencia/València;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2022QI;7.458
46 Valencia/València;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
46 Valencia/València;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
46 Valencia/València;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2021QII;""
46 Valencia/València;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2021QI;7.071
46 Valencia/València;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
46 Valencia/València;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
46 Valencia/València;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2020QII;""
46 Valencia/València;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2020QI;""
46 Valencia/València;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
46 Valencia/València;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
46 Valencia/València;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QII;7.147
46 Valencia/València;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QI;""
46 Valencia/València;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
46 Valencia/València;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
46 Valencia/València;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QII;6.765
46 Valencia/València;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QI;""
46 Valencia/València;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
46 Valencia/València;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
46 Valencia/València;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QII;""
46 Valencia/València;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QI;""
46 Valencia/València;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
46 Valencia/València;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QIII;6.816
46 Valencia/València;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QII;""
46 Valencia/València;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QI;""
46 Valencia/València;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
46 Valencia/València;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QIII;6.448
46 Valencia/València;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QII;""
46 Valencia/València;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QI;""
46 Valencia/València;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
46 Valencia/València;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
46 Valencia/València;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QII;""
46 Valencia/València;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QI;""
46 Valencia/València;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
46 Valencia/València;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
46 Valencia/València;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
46 Valencia/València;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
46 Valencia/València;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
46 Valencia/València;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
46 Valencia/València;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
46 Valencia/València;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
46 Valencia/València;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
46 Valencia/València;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
46 Valencia/València;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
46 Valencia/València;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
46 Valencia/València;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;94,06
46 Valencia/València;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
46 Valencia/València;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
46 Valencia/València;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
46 Valencia/València;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;94,74
46 Valencia/València;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
46 Valencia/València;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
46 Valencia/València;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
46 Valencia/València;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;93,89
46 Valencia/València;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
46 Valencia/València;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
46 Valencia/València;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
46 Valencia/València;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
46 Valencia/València;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
46 Valencia/València;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
46 Valencia/València;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;90,95
46 Valencia/València;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
46 Valencia/València;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
46 Valencia/València;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
46 Valencia/València;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;90,53
46 Valencia/València;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
46 Valencia/València;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
46 Valencia/València;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
46 Valencia/València;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
46 Valencia/València;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
46 Valencia/València;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
46 Valencia/València;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;87,16
46 Valencia/València;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
46 Valencia/València;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
46 Valencia/València;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
46 Valencia/València;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;86,61
46 Valencia/València;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
46 Valencia/València;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
46 Valencia/València;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
46 Valencia/València;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
46 Valencia/València;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
46 Valencia/València;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
46 Valencia/València;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;83,12
46 Valencia/València;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
46 Valencia/València;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
46 Valencia/València;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
46 Valencia/València;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;82,55
46 Valencia/València;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
46 Valencia/València;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
46 Valencia/València;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
46 Valencia/València;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
46 Valencia/València;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
46 Valencia/València;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
47 Valladolid;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
47 Valladolid;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
47 Valladolid;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
47 Valladolid;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QI;30.535
47 Valladolid;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
47 Valladolid;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
47 Valladolid;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
47 Valladolid;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QI;30.374
47 Valladolid;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
47 Valladolid;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
47 Valladolid;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
47 Valladolid;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QI;31.150
47 Valladolid;All ages;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
47 Valladolid;All ages;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
47 Valladolid;All ages;Cohort January 1;Total;Survival in the first trimester;2022QII;""
47 Valladolid;All ages;Cohort January 1;Total;Survival in the first trimester;2022QI;29.712
47 Valladolid;All ages;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
47 Valladolid;All ages;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
47 Valladolid;All ages;Cohort January 1;Total;Survival in the first trimester;2021QII;""
47 Valladolid;All ages;Cohort January 1;Total;Survival in the first trimester;2021QI;29.708
47 Valladolid;All ages;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
47 Valladolid;All ages;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
47 Valladolid;All ages;Cohort January 1;Total;Survival in the first trimester;2020QII;""
47 Valladolid;All ages;Cohort January 1;Total;Survival in the first trimester;2020QI;29.554
47 Valladolid;All ages;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
47 Valladolid;All ages;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
47 Valladolid;All ages;Cohort January 1;Total;Survival in the second trimester;2022QII;28.901
47 Valladolid;All ages;Cohort January 1;Total;Survival in the second trimester;2022QI;""
47 Valladolid;All ages;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
47 Valladolid;All ages;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
47 Valladolid;All ages;Cohort January 1;Total;Survival in the second trimester;2021QII;29.033
47 Valladolid;All ages;Cohort January 1;Total;Survival in the second trimester;2021QI;""
47 Valladolid;All ages;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
47 Valladolid;All ages;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
47 Valladolid;All ages;Cohort January 1;Total;Survival in the second trimester;2020QII;28.979
47 Valladolid;All ages;Cohort January 1;Total;Survival in the second trimester;2020QI;""
47 Valladolid;All ages;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
47 Valladolid;All ages;Cohort January 1;Total;Survival in the third trimester;2022QIII;28.179
47 Valladolid;All ages;Cohort January 1;Total;Survival in the third trimester;2022QII;""
47 Valladolid;All ages;Cohort January 1;Total;Survival in the third trimester;2022QI;""
47 Valladolid;All ages;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
47 Valladolid;All ages;Cohort January 1;Total;Survival in the third trimester;2021QIII;28.411
47 Valladolid;All ages;Cohort January 1;Total;Survival in the third trimester;2021QII;""
47 Valladolid;All ages;Cohort January 1;Total;Survival in the third trimester;2021QI;""
47 Valladolid;All ages;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
47 Valladolid;All ages;Cohort January 1;Total;Survival in the third trimester;2020QIII;28.332
47 Valladolid;All ages;Cohort January 1;Total;Survival in the third trimester;2020QII;""
47 Valladolid;All ages;Cohort January 1;Total;Survival in the third trimester;2020QI;""
47 Valladolid;All ages;Cohort January 1;Total;Survival in the third trimester;2022QIV;27.359
47 Valladolid;All ages;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
47 Valladolid;All ages;Cohort January 1;Total;Survival in the third trimester;2022QII;""
47 Valladolid;All ages;Cohort January 1;Total;Survival in the third trimester;2022QI;""
47 Valladolid;All ages;Cohort January 1;Total;Survival in the third trimester;2021QIV;27.772
47 Valladolid;All ages;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
47 Valladolid;All ages;Cohort January 1;Total;Survival in the third trimester;2021QII;""
47 Valladolid;All ages;Cohort January 1;Total;Survival in the third trimester;2021QI;""
47 Valladolid;All ages;Cohort January 1;Total;Survival in the third trimester;2020QIV;27.618
47 Valladolid;All ages;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
47 Valladolid;All ages;Cohort January 1;Total;Survival in the third trimester;2020QII;""
47 Valladolid;All ages;Cohort January 1;Total;Survival in the third trimester;2020QI;""
47 Valladolid;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
47 Valladolid;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
47 Valladolid;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
47 Valladolid;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
47 Valladolid;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
47 Valladolid;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
47 Valladolid;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
47 Valladolid;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
47 Valladolid;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
47 Valladolid;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
47 Valladolid;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
47 Valladolid;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
47 Valladolid;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
47 Valladolid;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
47 Valladolid;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
47 Valladolid;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;97,3
47 Valladolid;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
47 Valladolid;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
47 Valladolid;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
47 Valladolid;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;97,81
47 Valladolid;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
47 Valladolid;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
47 Valladolid;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
47 Valladolid;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;94,88
47 Valladolid;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
47 Valladolid;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
47 Valladolid;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;94,65
47 Valladolid;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
47 Valladolid;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
47 Valladolid;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
47 Valladolid;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;95,59
47 Valladolid;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
47 Valladolid;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
47 Valladolid;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
47 Valladolid;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;93,03
47 Valladolid;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
47 Valladolid;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
47 Valladolid;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;92,28
47 Valladolid;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
47 Valladolid;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
47 Valladolid;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
47 Valladolid;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;93,54
47 Valladolid;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
47 Valladolid;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
47 Valladolid;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
47 Valladolid;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;90,95
47 Valladolid;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
47 Valladolid;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
47 Valladolid;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;89,6
47 Valladolid;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
47 Valladolid;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
47 Valladolid;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
47 Valladolid;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;91,43
47 Valladolid;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
47 Valladolid;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
47 Valladolid;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
47 Valladolid;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;88,66
47 Valladolid;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
47 Valladolid;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
47 Valladolid;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
47 Valladolid;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
47 Valladolid;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
47 Valladolid;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
47 Valladolid;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QI;19.399
47 Valladolid;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
47 Valladolid;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
47 Valladolid;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
47 Valladolid;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QI;19.351
47 Valladolid;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
47 Valladolid;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
47 Valladolid;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
47 Valladolid;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QI;19.839
47 Valladolid;All ages;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
47 Valladolid;All ages;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
47 Valladolid;All ages;Cohort January 1;Males;Survival in the first trimester;2022QII;""
47 Valladolid;All ages;Cohort January 1;Males;Survival in the first trimester;2022QI;18.926
47 Valladolid;All ages;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
47 Valladolid;All ages;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
47 Valladolid;All ages;Cohort January 1;Males;Survival in the first trimester;2021QII;""
47 Valladolid;All ages;Cohort January 1;Males;Survival in the first trimester;2021QI;18.935
47 Valladolid;All ages;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
47 Valladolid;All ages;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
47 Valladolid;All ages;Cohort January 1;Males;Survival in the first trimester;2020QII;""
47 Valladolid;All ages;Cohort January 1;Males;Survival in the first trimester;2020QI;18.871
47 Valladolid;All ages;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
47 Valladolid;All ages;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
47 Valladolid;All ages;Cohort January 1;Males;Survival in the second trimester;2022QII;18.467
47 Valladolid;All ages;Cohort January 1;Males;Survival in the second trimester;2022QI;""
47 Valladolid;All ages;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
47 Valladolid;All ages;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
47 Valladolid;All ages;Cohort January 1;Males;Survival in the second trimester;2021QII;18.579
47 Valladolid;All ages;Cohort January 1;Males;Survival in the second trimester;2021QI;""
47 Valladolid;All ages;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
47 Valladolid;All ages;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
47 Valladolid;All ages;Cohort January 1;Males;Survival in the second trimester;2020QII;18.538
47 Valladolid;All ages;Cohort January 1;Males;Survival in the second trimester;2020QI;""
47 Valladolid;All ages;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
47 Valladolid;All ages;Cohort January 1;Males;Survival in the third trimester;2022QIII;18.055
47 Valladolid;All ages;Cohort January 1;Males;Survival in the third trimester;2022QII;""
47 Valladolid;All ages;Cohort January 1;Males;Survival in the third trimester;2022QI;""
47 Valladolid;All ages;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
47 Valladolid;All ages;Cohort January 1;Males;Survival in the third trimester;2021QIII;18.209
47 Valladolid;All ages;Cohort January 1;Males;Survival in the third trimester;2021QII;""
47 Valladolid;All ages;Cohort January 1;Males;Survival in the third trimester;2021QI;""
47 Valladolid;All ages;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
47 Valladolid;All ages;Cohort January 1;Males;Survival in the third trimester;2020QIII;18.170
47 Valladolid;All ages;Cohort January 1;Males;Survival in the third trimester;2020QII;""
47 Valladolid;All ages;Cohort January 1;Males;Survival in the third trimester;2020QI;""
47 Valladolid;All ages;Cohort January 1;Males;Survival in the third trimester;2022QIV;17.524
47 Valladolid;All ages;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
47 Valladolid;All ages;Cohort January 1;Males;Survival in the third trimester;2022QII;""
47 Valladolid;All ages;Cohort January 1;Males;Survival in the third trimester;2022QI;""
47 Valladolid;All ages;Cohort January 1;Males;Survival in the third trimester;2021QIV;17.834
47 Valladolid;All ages;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
47 Valladolid;All ages;Cohort January 1;Males;Survival in the third trimester;2021QII;""
47 Valladolid;All ages;Cohort January 1;Males;Survival in the third trimester;2021QI;""
47 Valladolid;All ages;Cohort January 1;Males;Survival in the third trimester;2020QIV;17.743
47 Valladolid;All ages;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
47 Valladolid;All ages;Cohort January 1;Males;Survival in the third trimester;2020QII;""
47 Valladolid;All ages;Cohort January 1;Males;Survival in the third trimester;2020QI;""
47 Valladolid;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
47 Valladolid;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
47 Valladolid;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
47 Valladolid;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
47 Valladolid;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
47 Valladolid;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
47 Valladolid;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
47 Valladolid;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
47 Valladolid;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
47 Valladolid;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
47 Valladolid;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
47 Valladolid;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
47 Valladolid;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
47 Valladolid;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
47 Valladolid;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
47 Valladolid;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;97,56
47 Valladolid;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
47 Valladolid;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
47 Valladolid;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
47 Valladolid;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;97,85
47 Valladolid;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
47 Valladolid;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
47 Valladolid;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
47 Valladolid;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;95,12
47 Valladolid;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
47 Valladolid;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
47 Valladolid;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;95,2
47 Valladolid;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
47 Valladolid;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
47 Valladolid;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
47 Valladolid;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;96,01
47 Valladolid;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
47 Valladolid;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
47 Valladolid;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
47 Valladolid;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;93,44
47 Valladolid;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
47 Valladolid;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
47 Valladolid;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;93,07
47 Valladolid;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
47 Valladolid;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
47 Valladolid;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
47 Valladolid;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;94,1
47 Valladolid;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
47 Valladolid;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
47 Valladolid;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
47 Valladolid;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;91,59
47 Valladolid;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
47 Valladolid;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
47 Valladolid;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;90,33
47 Valladolid;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
47 Valladolid;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
47 Valladolid;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
47 Valladolid;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;92,16
47 Valladolid;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
47 Valladolid;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
47 Valladolid;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
47 Valladolid;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;89,43
47 Valladolid;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
47 Valladolid;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
47 Valladolid;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
47 Valladolid;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
47 Valladolid;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
47 Valladolid;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
47 Valladolid;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QI;11.136
47 Valladolid;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
47 Valladolid;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
47 Valladolid;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
47 Valladolid;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QI;11.023
47 Valladolid;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
47 Valladolid;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
47 Valladolid;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
47 Valladolid;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QI;11.311
47 Valladolid;All ages;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
47 Valladolid;All ages;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
47 Valladolid;All ages;Cohort January 1;Females;Survival in the first trimester;2022QII;""
47 Valladolid;All ages;Cohort January 1;Females;Survival in the first trimester;2022QI;10.786
47 Valladolid;All ages;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
47 Valladolid;All ages;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
47 Valladolid;All ages;Cohort January 1;Females;Survival in the first trimester;2021QII;""
47 Valladolid;All ages;Cohort January 1;Females;Survival in the first trimester;2021QI;10.773
47 Valladolid;All ages;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
47 Valladolid;All ages;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
47 Valladolid;All ages;Cohort January 1;Females;Survival in the first trimester;2020QII;""
47 Valladolid;All ages;Cohort January 1;Females;Survival in the first trimester;2020QI;10.683
47 Valladolid;All ages;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
47 Valladolid;All ages;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
47 Valladolid;All ages;Cohort January 1;Females;Survival in the second trimester;2022QII;10.434
47 Valladolid;All ages;Cohort January 1;Females;Survival in the second trimester;2022QI;""
47 Valladolid;All ages;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
47 Valladolid;All ages;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
47 Valladolid;All ages;Cohort January 1;Females;Survival in the second trimester;2021QII;10.454
47 Valladolid;All ages;Cohort January 1;Females;Survival in the second trimester;2021QI;""
47 Valladolid;All ages;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
47 Valladolid;All ages;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
47 Valladolid;All ages;Cohort January 1;Females;Survival in the second trimester;2020QII;10.441
47 Valladolid;All ages;Cohort January 1;Females;Survival in the second trimester;2020QI;""
47 Valladolid;All ages;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
47 Valladolid;All ages;Cohort January 1;Females;Survival in the third trimester;2022QIII;10.124
47 Valladolid;All ages;Cohort January 1;Females;Survival in the third trimester;2022QII;""
47 Valladolid;All ages;Cohort January 1;Females;Survival in the third trimester;2022QI;""
47 Valladolid;All ages;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
47 Valladolid;All ages;Cohort January 1;Females;Survival in the third trimester;2021QIII;10.202
47 Valladolid;All ages;Cohort January 1;Females;Survival in the third trimester;2021QII;""
47 Valladolid;All ages;Cohort January 1;Females;Survival in the third trimester;2021QI;""
47 Valladolid;All ages;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
47 Valladolid;All ages;Cohort January 1;Females;Survival in the third trimester;2020QIII;10.162
47 Valladolid;All ages;Cohort January 1;Females;Survival in the third trimester;2020QII;""
47 Valladolid;All ages;Cohort January 1;Females;Survival in the third trimester;2020QI;""
47 Valladolid;All ages;Cohort January 1;Females;Survival in the third trimester;2022QIV;9.835
47 Valladolid;All ages;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
47 Valladolid;All ages;Cohort January 1;Females;Survival in the third trimester;2022QII;""
47 Valladolid;All ages;Cohort January 1;Females;Survival in the third trimester;2022QI;""
47 Valladolid;All ages;Cohort January 1;Females;Survival in the third trimester;2021QIV;9.938
47 Valladolid;All ages;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
47 Valladolid;All ages;Cohort January 1;Females;Survival in the third trimester;2021QII;""
47 Valladolid;All ages;Cohort January 1;Females;Survival in the third trimester;2021QI;""
47 Valladolid;All ages;Cohort January 1;Females;Survival in the third trimester;2020QIV;9.875
47 Valladolid;All ages;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
47 Valladolid;All ages;Cohort January 1;Females;Survival in the third trimester;2020QII;""
47 Valladolid;All ages;Cohort January 1;Females;Survival in the third trimester;2020QI;""
47 Valladolid;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
47 Valladolid;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
47 Valladolid;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
47 Valladolid;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
47 Valladolid;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
47 Valladolid;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
47 Valladolid;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
47 Valladolid;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
47 Valladolid;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
47 Valladolid;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
47 Valladolid;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
47 Valladolid;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
47 Valladolid;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
47 Valladolid;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
47 Valladolid;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
47 Valladolid;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;96,86
47 Valladolid;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
47 Valladolid;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
47 Valladolid;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
47 Valladolid;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;97,73
47 Valladolid;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
47 Valladolid;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
47 Valladolid;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
47 Valladolid;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;94,45
47 Valladolid;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
47 Valladolid;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
47 Valladolid;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;93,7
47 Valladolid;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
47 Valladolid;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
47 Valladolid;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
47 Valladolid;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;94,84
47 Valladolid;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
47 Valladolid;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
47 Valladolid;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
47 Valladolid;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;92,31
47 Valladolid;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
47 Valladolid;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
47 Valladolid;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;90,91
47 Valladolid;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
47 Valladolid;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
47 Valladolid;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
47 Valladolid;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;92,55
47 Valladolid;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
47 Valladolid;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
47 Valladolid;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
47 Valladolid;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;89,84
47 Valladolid;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
47 Valladolid;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
47 Valladolid;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;88,32
47 Valladolid;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
47 Valladolid;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
47 Valladolid;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
47 Valladolid;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;90,16
47 Valladolid;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
47 Valladolid;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
47 Valladolid;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
47 Valladolid;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;87,3
47 Valladolid;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
47 Valladolid;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
47 Valladolid;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
47 Valladolid;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
47 Valladolid;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
47 Valladolid;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QII;30.539
47 Valladolid;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
47 Valladolid;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
47 Valladolid;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
47 Valladolid;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QII;30.524
47 Valladolid;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
47 Valladolid;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
47 Valladolid;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
47 Valladolid;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QII;30.541
47 Valladolid;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
47 Valladolid;All ages;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
47 Valladolid;All ages;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
47 Valladolid;All ages;Cohort April 1;Total;Survival in the first trimester;2022QII;29.613
47 Valladolid;All ages;Cohort April 1;Total;Survival in the first trimester;2022QI;""
47 Valladolid;All ages;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
47 Valladolid;All ages;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
47 Valladolid;All ages;Cohort April 1;Total;Survival in the first trimester;2021QII;29.765
47 Valladolid;All ages;Cohort April 1;Total;Survival in the first trimester;2021QI;""
47 Valladolid;All ages;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
47 Valladolid;All ages;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
47 Valladolid;All ages;Cohort April 1;Total;Survival in the first trimester;2020QII;29.922
47 Valladolid;All ages;Cohort April 1;Total;Survival in the first trimester;2020QI;""
47 Valladolid;All ages;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
47 Valladolid;All ages;Cohort April 1;Total;Survival in the second trimester;2022QIII;28.843
47 Valladolid;All ages;Cohort April 1;Total;Survival in the second trimester;2022QII;""
47 Valladolid;All ages;Cohort April 1;Total;Survival in the second trimester;2022QI;""
47 Valladolid;All ages;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
47 Valladolid;All ages;Cohort April 1;Total;Survival in the second trimester;2021QIII;29.094
47 Valladolid;All ages;Cohort April 1;Total;Survival in the second trimester;2021QII;""
47 Valladolid;All ages;Cohort April 1;Total;Survival in the second trimester;2021QI;""
47 Valladolid;All ages;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
47 Valladolid;All ages;Cohort April 1;Total;Survival in the second trimester;2020QIII;29.184
47 Valladolid;All ages;Cohort April 1;Total;Survival in the second trimester;2020QII;""
47 Valladolid;All ages;Cohort April 1;Total;Survival in the second trimester;2020QI;""
47 Valladolid;All ages;Cohort April 1;Total;Survival in the third trimester;2022QIV;27.975
47 Valladolid;All ages;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
47 Valladolid;All ages;Cohort April 1;Total;Survival in the third trimester;2022QII;""
47 Valladolid;All ages;Cohort April 1;Total;Survival in the third trimester;2022QI;""
47 Valladolid;All ages;Cohort April 1;Total;Survival in the third trimester;2021QIV;28.395
47 Valladolid;All ages;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
47 Valladolid;All ages;Cohort April 1;Total;Survival in the third trimester;2021QII;""
47 Valladolid;All ages;Cohort April 1;Total;Survival in the third trimester;2021QI;""
47 Valladolid;All ages;Cohort April 1;Total;Survival in the third trimester;2020QIV;28.406
47 Valladolid;All ages;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
47 Valladolid;All ages;Cohort April 1;Total;Survival in the third trimester;2020QII;""
47 Valladolid;All ages;Cohort April 1;Total;Survival in the third trimester;2020QI;""
47 Valladolid;All ages;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
47 Valladolid;All ages;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
47 Valladolid;All ages;Cohort April 1;Total;Survival in the third trimester;2022QII;""
47 Valladolid;All ages;Cohort April 1;Total;Survival in the third trimester;2022QI;27.751
47 Valladolid;All ages;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
47 Valladolid;All ages;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
47 Valladolid;All ages;Cohort April 1;Total;Survival in the third trimester;2021QII;""
47 Valladolid;All ages;Cohort April 1;Total;Survival in the third trimester;2021QI;27.905
47 Valladolid;All ages;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
47 Valladolid;All ages;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
47 Valladolid;All ages;Cohort April 1;Total;Survival in the third trimester;2020QII;""
47 Valladolid;All ages;Cohort April 1;Total;Survival in the third trimester;2020QI;""
47 Valladolid;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
47 Valladolid;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
47 Valladolid;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
47 Valladolid;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
47 Valladolid;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
47 Valladolid;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
47 Valladolid;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
47 Valladolid;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
47 Valladolid;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
47 Valladolid;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
47 Valladolid;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
47 Valladolid;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
47 Valladolid;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
47 Valladolid;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
47 Valladolid;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;96,97
47 Valladolid;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
47 Valladolid;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
47 Valladolid;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
47 Valladolid;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;97,51
47 Valladolid;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
47 Valladolid;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
47 Valladolid;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
47 Valladolid;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;97,97
47 Valladolid;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
47 Valladolid;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
47 Valladolid;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;94,45
47 Valladolid;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
47 Valladolid;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
47 Valladolid;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
47 Valladolid;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;95,32
47 Valladolid;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
47 Valladolid;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
47 Valladolid;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
47 Valladolid;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;95,56
47 Valladolid;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
47 Valladolid;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
47 Valladolid;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;91,6
47 Valladolid;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
47 Valladolid;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
47 Valladolid;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
47 Valladolid;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;93,03
47 Valladolid;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
47 Valladolid;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
47 Valladolid;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
47 Valladolid;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;93,01
47 Valladolid;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
47 Valladolid;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
47 Valladolid;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
47 Valladolid;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
47 Valladolid;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
47 Valladolid;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
47 Valladolid;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;90,92
47 Valladolid;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
47 Valladolid;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
47 Valladolid;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
47 Valladolid;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;91,37
47 Valladolid;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
47 Valladolid;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
47 Valladolid;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
47 Valladolid;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
47 Valladolid;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
47 Valladolid;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
47 Valladolid;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QII;19.411
47 Valladolid;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
47 Valladolid;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
47 Valladolid;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
47 Valladolid;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QII;19.435
47 Valladolid;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
47 Valladolid;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
47 Valladolid;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
47 Valladolid;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QII;19.431
47 Valladolid;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
47 Valladolid;All ages;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
47 Valladolid;All ages;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
47 Valladolid;All ages;Cohort April 1;Males;Survival in the first trimester;2022QII;18.881
47 Valladolid;All ages;Cohort April 1;Males;Survival in the first trimester;2022QI;""
47 Valladolid;All ages;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
47 Valladolid;All ages;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
47 Valladolid;All ages;Cohort April 1;Males;Survival in the first trimester;2021QII;19.034
47 Valladolid;All ages;Cohort April 1;Males;Survival in the first trimester;2021QI;""
47 Valladolid;All ages;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
47 Valladolid;All ages;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
47 Valladolid;All ages;Cohort April 1;Males;Survival in the first trimester;2020QII;19.074
47 Valladolid;All ages;Cohort April 1;Males;Survival in the first trimester;2020QI;""
47 Valladolid;All ages;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
47 Valladolid;All ages;Cohort April 1;Males;Survival in the second trimester;2022QIII;18.439
47 Valladolid;All ages;Cohort April 1;Males;Survival in the second trimester;2022QII;""
47 Valladolid;All ages;Cohort April 1;Males;Survival in the second trimester;2022QI;""
47 Valladolid;All ages;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
47 Valladolid;All ages;Cohort April 1;Males;Survival in the second trimester;2021QIII;18.628
47 Valladolid;All ages;Cohort April 1;Males;Survival in the second trimester;2021QII;""
47 Valladolid;All ages;Cohort April 1;Males;Survival in the second trimester;2021QI;""
47 Valladolid;All ages;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
47 Valladolid;All ages;Cohort April 1;Males;Survival in the second trimester;2020QIII;18.648
47 Valladolid;All ages;Cohort April 1;Males;Survival in the second trimester;2020QII;""
47 Valladolid;All ages;Cohort April 1;Males;Survival in the second trimester;2020QI;""
47 Valladolid;All ages;Cohort April 1;Males;Survival in the third trimester;2022QIV;17.878
47 Valladolid;All ages;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
47 Valladolid;All ages;Cohort April 1;Males;Survival in the third trimester;2022QII;""
47 Valladolid;All ages;Cohort April 1;Males;Survival in the third trimester;2022QI;""
47 Valladolid;All ages;Cohort April 1;Males;Survival in the third trimester;2021QIV;18.221
47 Valladolid;All ages;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
47 Valladolid;All ages;Cohort April 1;Males;Survival in the third trimester;2021QII;""
47 Valladolid;All ages;Cohort April 1;Males;Survival in the third trimester;2021QI;""
47 Valladolid;All ages;Cohort April 1;Males;Survival in the third trimester;2020QIV;18.181
47 Valladolid;All ages;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
47 Valladolid;All ages;Cohort April 1;Males;Survival in the third trimester;2020QII;""
47 Valladolid;All ages;Cohort April 1;Males;Survival in the third trimester;2020QI;""
47 Valladolid;All ages;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
47 Valladolid;All ages;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
47 Valladolid;All ages;Cohort April 1;Males;Survival in the third trimester;2022QII;""
47 Valladolid;All ages;Cohort April 1;Males;Survival in the third trimester;2022QI;17.856
47 Valladolid;All ages;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
47 Valladolid;All ages;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
47 Valladolid;All ages;Cohort April 1;Males;Survival in the third trimester;2021QII;""
47 Valladolid;All ages;Cohort April 1;Males;Survival in the third trimester;2021QI;17.870
47 Valladolid;All ages;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
47 Valladolid;All ages;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
47 Valladolid;All ages;Cohort April 1;Males;Survival in the third trimester;2020QII;""
47 Valladolid;All ages;Cohort April 1;Males;Survival in the third trimester;2020QI;""
47 Valladolid;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
47 Valladolid;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
47 Valladolid;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
47 Valladolid;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
47 Valladolid;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
47 Valladolid;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
47 Valladolid;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
47 Valladolid;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
47 Valladolid;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
47 Valladolid;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
47 Valladolid;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
47 Valladolid;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
47 Valladolid;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
47 Valladolid;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
47 Valladolid;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;97,27
47 Valladolid;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
47 Valladolid;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
47 Valladolid;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
47 Valladolid;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;97,94
47 Valladolid;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
47 Valladolid;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
47 Valladolid;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
47 Valladolid;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;98,16
47 Valladolid;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
47 Valladolid;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
47 Valladolid;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;94,99
47 Valladolid;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
47 Valladolid;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
47 Valladolid;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
47 Valladolid;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;95,85
47 Valladolid;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
47 Valladolid;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
47 Valladolid;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
47 Valladolid;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;95,97
47 Valladolid;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
47 Valladolid;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
47 Valladolid;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;92,1
47 Valladolid;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
47 Valladolid;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
47 Valladolid;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
47 Valladolid;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;93,75
47 Valladolid;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
47 Valladolid;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
47 Valladolid;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
47 Valladolid;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;93,57
47 Valladolid;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
47 Valladolid;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
47 Valladolid;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
47 Valladolid;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
47 Valladolid;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
47 Valladolid;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
47 Valladolid;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;91,88
47 Valladolid;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
47 Valladolid;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
47 Valladolid;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
47 Valladolid;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;91,97
47 Valladolid;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
47 Valladolid;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
47 Valladolid;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
47 Valladolid;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
47 Valladolid;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
47 Valladolid;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
47 Valladolid;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QII;11.128
47 Valladolid;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
47 Valladolid;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
47 Valladolid;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
47 Valladolid;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QII;11.089
47 Valladolid;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
47 Valladolid;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
47 Valladolid;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
47 Valladolid;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QII;11.110
47 Valladolid;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
47 Valladolid;All ages;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
47 Valladolid;All ages;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
47 Valladolid;All ages;Cohort April 1;Females;Survival in the first trimester;2022QII;10.732
47 Valladolid;All ages;Cohort April 1;Females;Survival in the first trimester;2022QI;""
47 Valladolid;All ages;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
47 Valladolid;All ages;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
47 Valladolid;All ages;Cohort April 1;Females;Survival in the first trimester;2021QII;10.731
47 Valladolid;All ages;Cohort April 1;Females;Survival in the first trimester;2021QI;""
47 Valladolid;All ages;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
47 Valladolid;All ages;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
47 Valladolid;All ages;Cohort April 1;Females;Survival in the first trimester;2020QII;10.848
47 Valladolid;All ages;Cohort April 1;Females;Survival in the first trimester;2020QI;""
47 Valladolid;All ages;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
47 Valladolid;All ages;Cohort April 1;Females;Survival in the second trimester;2022QIII;10.404
47 Valladolid;All ages;Cohort April 1;Females;Survival in the second trimester;2022QII;""
47 Valladolid;All ages;Cohort April 1;Females;Survival in the second trimester;2022QI;""
47 Valladolid;All ages;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
47 Valladolid;All ages;Cohort April 1;Females;Survival in the second trimester;2021QIII;10.466
47 Valladolid;All ages;Cohort April 1;Females;Survival in the second trimester;2021QII;""
47 Valladolid;All ages;Cohort April 1;Females;Survival in the second trimester;2021QI;""
47 Valladolid;All ages;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
47 Valladolid;All ages;Cohort April 1;Females;Survival in the second trimester;2020QIII;10.536
47 Valladolid;All ages;Cohort April 1;Females;Survival in the second trimester;2020QII;""
47 Valladolid;All ages;Cohort April 1;Females;Survival in the second trimester;2020QI;""
47 Valladolid;All ages;Cohort April 1;Females;Survival in the third trimester;2022QIV;10.097
47 Valladolid;All ages;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
47 Valladolid;All ages;Cohort April 1;Females;Survival in the third trimester;2022QII;""
47 Valladolid;All ages;Cohort April 1;Females;Survival in the third trimester;2022QI;""
47 Valladolid;All ages;Cohort April 1;Females;Survival in the third trimester;2021QIV;10.174
47 Valladolid;All ages;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
47 Valladolid;All ages;Cohort April 1;Females;Survival in the third trimester;2021QII;""
47 Valladolid;All ages;Cohort April 1;Females;Survival in the third trimester;2021QI;""
47 Valladolid;All ages;Cohort April 1;Females;Survival in the third trimester;2020QIV;10.225
47 Valladolid;All ages;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
47 Valladolid;All ages;Cohort April 1;Females;Survival in the third trimester;2020QII;""
47 Valladolid;All ages;Cohort April 1;Females;Survival in the third trimester;2020QI;""
47 Valladolid;All ages;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
47 Valladolid;All ages;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
47 Valladolid;All ages;Cohort April 1;Females;Survival in the third trimester;2022QII;""
47 Valladolid;All ages;Cohort April 1;Females;Survival in the third trimester;2022QI;9.895
47 Valladolid;All ages;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
47 Valladolid;All ages;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
47 Valladolid;All ages;Cohort April 1;Females;Survival in the third trimester;2021QII;""
47 Valladolid;All ages;Cohort April 1;Females;Survival in the third trimester;2021QI;10.035
47 Valladolid;All ages;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
47 Valladolid;All ages;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
47 Valladolid;All ages;Cohort April 1;Females;Survival in the third trimester;2020QII;""
47 Valladolid;All ages;Cohort April 1;Females;Survival in the third trimester;2020QI;""
47 Valladolid;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
47 Valladolid;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
47 Valladolid;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
47 Valladolid;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
47 Valladolid;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
47 Valladolid;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
47 Valladolid;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
47 Valladolid;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
47 Valladolid;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
47 Valladolid;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
47 Valladolid;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
47 Valladolid;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
47 Valladolid;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
47 Valladolid;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
47 Valladolid;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;96,44
47 Valladolid;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
47 Valladolid;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
47 Valladolid;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
47 Valladolid;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;96,77
47 Valladolid;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
47 Valladolid;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
47 Valladolid;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
47 Valladolid;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;97,64
47 Valladolid;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
47 Valladolid;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
47 Valladolid;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;93,49
47 Valladolid;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
47 Valladolid;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
47 Valladolid;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
47 Valladolid;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;94,38
47 Valladolid;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
47 Valladolid;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
47 Valladolid;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
47 Valladolid;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;94,83
47 Valladolid;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
47 Valladolid;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
47 Valladolid;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;90,74
47 Valladolid;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
47 Valladolid;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
47 Valladolid;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
47 Valladolid;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;91,75
47 Valladolid;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
47 Valladolid;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
47 Valladolid;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
47 Valladolid;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;92,03
47 Valladolid;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
47 Valladolid;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
47 Valladolid;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
47 Valladolid;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
47 Valladolid;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
47 Valladolid;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
47 Valladolid;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;89,23
47 Valladolid;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
47 Valladolid;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
47 Valladolid;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
47 Valladolid;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;90,32
47 Valladolid;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
47 Valladolid;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
47 Valladolid;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
47 Valladolid;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
47 Valladolid;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
47 Valladolid;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QIII;30.500
47 Valladolid;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
47 Valladolid;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
47 Valladolid;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
47 Valladolid;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QIII;30.738
47 Valladolid;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
47 Valladolid;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
47 Valladolid;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
47 Valladolid;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QIII;30.586
47 Valladolid;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
47 Valladolid;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
47 Valladolid;All ages;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
47 Valladolid;All ages;Cohort July 1;Total;Survival in the first trimester;2022QIII;29.560
47 Valladolid;All ages;Cohort July 1;Total;Survival in the first trimester;2022QII;""
47 Valladolid;All ages;Cohort July 1;Total;Survival in the first trimester;2022QI;""
47 Valladolid;All ages;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
47 Valladolid;All ages;Cohort July 1;Total;Survival in the first trimester;2021QIII;29.910
47 Valladolid;All ages;Cohort July 1;Total;Survival in the first trimester;2021QII;""
47 Valladolid;All ages;Cohort July 1;Total;Survival in the first trimester;2021QI;""
47 Valladolid;All ages;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
47 Valladolid;All ages;Cohort July 1;Total;Survival in the first trimester;2020QIII;29.747
47 Valladolid;All ages;Cohort July 1;Total;Survival in the first trimester;2020QII;""
47 Valladolid;All ages;Cohort July 1;Total;Survival in the first trimester;2020QI;""
47 Valladolid;All ages;Cohort July 1;Total;Survival in the second trimester;2022QIV;28.614
47 Valladolid;All ages;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
47 Valladolid;All ages;Cohort July 1;Total;Survival in the second trimester;2022QII;""
47 Valladolid;All ages;Cohort July 1;Total;Survival in the second trimester;2022QI;""
47 Valladolid;All ages;Cohort July 1;Total;Survival in the second trimester;2021QIV;29.115
47 Valladolid;All ages;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
47 Valladolid;All ages;Cohort July 1;Total;Survival in the second trimester;2021QII;""
47 Valladolid;All ages;Cohort July 1;Total;Survival in the second trimester;2021QI;""
47 Valladolid;All ages;Cohort July 1;Total;Survival in the second trimester;2020QIV;28.923
47 Valladolid;All ages;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
47 Valladolid;All ages;Cohort July 1;Total;Survival in the second trimester;2020QII;""
47 Valladolid;All ages;Cohort July 1;Total;Survival in the second trimester;2020QI;""
47 Valladolid;All ages;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
47 Valladolid;All ages;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
47 Valladolid;All ages;Cohort July 1;Total;Survival in the third trimester;2022QII;""
47 Valladolid;All ages;Cohort July 1;Total;Survival in the third trimester;2022QI;28.421
47 Valladolid;All ages;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
47 Valladolid;All ages;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
47 Valladolid;All ages;Cohort July 1;Total;Survival in the third trimester;2021QII;""
47 Valladolid;All ages;Cohort July 1;Total;Survival in the third trimester;2021QI;28.390
47 Valladolid;All ages;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
47 Valladolid;All ages;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
47 Valladolid;All ages;Cohort July 1;Total;Survival in the third trimester;2020QII;""
47 Valladolid;All ages;Cohort July 1;Total;Survival in the third trimester;2020QI;""
47 Valladolid;All ages;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
47 Valladolid;All ages;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
47 Valladolid;All ages;Cohort July 1;Total;Survival in the third trimester;2022QII;27.740
47 Valladolid;All ages;Cohort July 1;Total;Survival in the third trimester;2022QI;""
47 Valladolid;All ages;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
47 Valladolid;All ages;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
47 Valladolid;All ages;Cohort July 1;Total;Survival in the third trimester;2021QII;27.830
47 Valladolid;All ages;Cohort July 1;Total;Survival in the third trimester;2021QI;""
47 Valladolid;All ages;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
47 Valladolid;All ages;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
47 Valladolid;All ages;Cohort July 1;Total;Survival in the third trimester;2020QII;""
47 Valladolid;All ages;Cohort July 1;Total;Survival in the third trimester;2020QI;""
47 Valladolid;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
47 Valladolid;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
47 Valladolid;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
47 Valladolid;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
47 Valladolid;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
47 Valladolid;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
47 Valladolid;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
47 Valladolid;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
47 Valladolid;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
47 Valladolid;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
47 Valladolid;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
47 Valladolid;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
47 Valladolid;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
47 Valladolid;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;96,92
47 Valladolid;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
47 Valladolid;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
47 Valladolid;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
47 Valladolid;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;97,31
47 Valladolid;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
47 Valladolid;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
47 Valladolid;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
47 Valladolid;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;97,26
47 Valladolid;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
47 Valladolid;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
47 Valladolid;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;93,82
47 Valladolid;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
47 Valladolid;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
47 Valladolid;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
47 Valladolid;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;94,72
47 Valladolid;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
47 Valladolid;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
47 Valladolid;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
47 Valladolid;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;94,56
47 Valladolid;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
47 Valladolid;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
47 Valladolid;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
47 Valladolid;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
47 Valladolid;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
47 Valladolid;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
47 Valladolid;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;92,46
47 Valladolid;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
47 Valladolid;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
47 Valladolid;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
47 Valladolid;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;92,82
47 Valladolid;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
47 Valladolid;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
47 Valladolid;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
47 Valladolid;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
47 Valladolid;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
47 Valladolid;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
47 Valladolid;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;90,25
47 Valladolid;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
47 Valladolid;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
47 Valladolid;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
47 Valladolid;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;90,99
47 Valladolid;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
47 Valladolid;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
47 Valladolid;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
47 Valladolid;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
47 Valladolid;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
47 Valladolid;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
47 Valladolid;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QIII;19.400
47 Valladolid;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
47 Valladolid;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
47 Valladolid;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
47 Valladolid;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QIII;19.602
47 Valladolid;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
47 Valladolid;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
47 Valladolid;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
47 Valladolid;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QIII;19.501
47 Valladolid;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
47 Valladolid;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
47 Valladolid;All ages;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
47 Valladolid;All ages;Cohort July 1;Males;Survival in the first trimester;2022QIII;18.850
47 Valladolid;All ages;Cohort July 1;Males;Survival in the first trimester;2022QII;""
47 Valladolid;All ages;Cohort July 1;Males;Survival in the first trimester;2022QI;""
47 Valladolid;All ages;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
47 Valladolid;All ages;Cohort July 1;Males;Survival in the first trimester;2021QIII;19.104
47 Valladolid;All ages;Cohort July 1;Males;Survival in the first trimester;2021QII;""
47 Valladolid;All ages;Cohort July 1;Males;Survival in the first trimester;2021QI;""
47 Valladolid;All ages;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
47 Valladolid;All ages;Cohort July 1;Males;Survival in the first trimester;2020QIII;19.009
47 Valladolid;All ages;Cohort July 1;Males;Survival in the first trimester;2020QII;""
47 Valladolid;All ages;Cohort July 1;Males;Survival in the first trimester;2020QI;""
47 Valladolid;All ages;Cohort July 1;Males;Survival in the second trimester;2022QIV;18.242
47 Valladolid;All ages;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
47 Valladolid;All ages;Cohort July 1;Males;Survival in the second trimester;2022QII;""
47 Valladolid;All ages;Cohort July 1;Males;Survival in the second trimester;2022QI;""
47 Valladolid;All ages;Cohort July 1;Males;Survival in the second trimester;2021QIV;18.632
47 Valladolid;All ages;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
47 Valladolid;All ages;Cohort July 1;Males;Survival in the second trimester;2021QII;""
47 Valladolid;All ages;Cohort July 1;Males;Survival in the second trimester;2021QI;""
47 Valladolid;All ages;Cohort July 1;Males;Survival in the second trimester;2020QIV;18.510
47 Valladolid;All ages;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
47 Valladolid;All ages;Cohort July 1;Males;Survival in the second trimester;2020QII;""
47 Valladolid;All ages;Cohort July 1;Males;Survival in the second trimester;2020QI;""
47 Valladolid;All ages;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
47 Valladolid;All ages;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
47 Valladolid;All ages;Cohort July 1;Males;Survival in the third trimester;2022QII;""
47 Valladolid;All ages;Cohort July 1;Males;Survival in the third trimester;2022QI;18.236
47 Valladolid;All ages;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
47 Valladolid;All ages;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
47 Valladolid;All ages;Cohort July 1;Males;Survival in the third trimester;2021QII;""
47 Valladolid;All ages;Cohort July 1;Males;Survival in the third trimester;2021QI;18.177
47 Valladolid;All ages;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
47 Valladolid;All ages;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
47 Valladolid;All ages;Cohort July 1;Males;Survival in the third trimester;2020QII;""
47 Valladolid;All ages;Cohort July 1;Males;Survival in the third trimester;2020QI;""
47 Valladolid;All ages;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
47 Valladolid;All ages;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
47 Valladolid;All ages;Cohort July 1;Males;Survival in the third trimester;2022QII;17.836
47 Valladolid;All ages;Cohort July 1;Males;Survival in the third trimester;2022QI;""
47 Valladolid;All ages;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
47 Valladolid;All ages;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
47 Valladolid;All ages;Cohort July 1;Males;Survival in the third trimester;2021QII;17.878
47 Valladolid;All ages;Cohort July 1;Males;Survival in the third trimester;2021QI;""
47 Valladolid;All ages;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
47 Valladolid;All ages;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
47 Valladolid;All ages;Cohort July 1;Males;Survival in the third trimester;2020QII;""
47 Valladolid;All ages;Cohort July 1;Males;Survival in the third trimester;2020QI;""
47 Valladolid;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
47 Valladolid;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
47 Valladolid;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
47 Valladolid;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
47 Valladolid;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
47 Valladolid;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
47 Valladolid;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
47 Valladolid;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
47 Valladolid;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
47 Valladolid;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
47 Valladolid;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
47 Valladolid;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
47 Valladolid;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
47 Valladolid;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;97,16
47 Valladolid;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
47 Valladolid;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
47 Valladolid;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
47 Valladolid;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;97,46
47 Valladolid;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
47 Valladolid;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
47 Valladolid;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
47 Valladolid;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;97,48
47 Valladolid;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
47 Valladolid;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
47 Valladolid;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;94,03
47 Valladolid;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
47 Valladolid;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
47 Valladolid;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
47 Valladolid;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;95,05
47 Valladolid;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
47 Valladolid;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
47 Valladolid;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
47 Valladolid;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;94,92
47 Valladolid;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
47 Valladolid;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
47 Valladolid;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
47 Valladolid;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
47 Valladolid;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
47 Valladolid;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
47 Valladolid;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;93,03
47 Valladolid;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
47 Valladolid;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
47 Valladolid;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
47 Valladolid;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;93,21
47 Valladolid;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
47 Valladolid;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
47 Valladolid;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
47 Valladolid;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
47 Valladolid;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
47 Valladolid;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
47 Valladolid;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;90,99
47 Valladolid;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
47 Valladolid;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
47 Valladolid;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
47 Valladolid;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;91,68
47 Valladolid;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
47 Valladolid;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
47 Valladolid;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
47 Valladolid;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
47 Valladolid;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
47 Valladolid;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
47 Valladolid;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QIII;11.100
47 Valladolid;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
47 Valladolid;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
47 Valladolid;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
47 Valladolid;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QIII;11.136
47 Valladolid;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
47 Valladolid;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
47 Valladolid;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
47 Valladolid;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QIII;11.085
47 Valladolid;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
47 Valladolid;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
47 Valladolid;All ages;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
47 Valladolid;All ages;Cohort July 1;Females;Survival in the first trimester;2022QIII;10.710
47 Valladolid;All ages;Cohort July 1;Females;Survival in the first trimester;2022QII;""
47 Valladolid;All ages;Cohort July 1;Females;Survival in the first trimester;2022QI;""
47 Valladolid;All ages;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
47 Valladolid;All ages;Cohort July 1;Females;Survival in the first trimester;2021QIII;10.806
47 Valladolid;All ages;Cohort July 1;Females;Survival in the first trimester;2021QII;""
47 Valladolid;All ages;Cohort July 1;Females;Survival in the first trimester;2021QI;""
47 Valladolid;All ages;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
47 Valladolid;All ages;Cohort July 1;Females;Survival in the first trimester;2020QIII;10.738
47 Valladolid;All ages;Cohort July 1;Females;Survival in the first trimester;2020QII;""
47 Valladolid;All ages;Cohort July 1;Females;Survival in the first trimester;2020QI;""
47 Valladolid;All ages;Cohort July 1;Females;Survival in the second trimester;2022QIV;10.372
47 Valladolid;All ages;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
47 Valladolid;All ages;Cohort July 1;Females;Survival in the second trimester;2022QII;""
47 Valladolid;All ages;Cohort July 1;Females;Survival in the second trimester;2022QI;""
47 Valladolid;All ages;Cohort July 1;Females;Survival in the second trimester;2021QIV;10.483
47 Valladolid;All ages;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
47 Valladolid;All ages;Cohort July 1;Females;Survival in the second trimester;2021QII;""
47 Valladolid;All ages;Cohort July 1;Females;Survival in the second trimester;2021QI;""
47 Valladolid;All ages;Cohort July 1;Females;Survival in the second trimester;2020QIV;10.413
47 Valladolid;All ages;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
47 Valladolid;All ages;Cohort July 1;Females;Survival in the second trimester;2020QII;""
47 Valladolid;All ages;Cohort July 1;Females;Survival in the second trimester;2020QI;""
47 Valladolid;All ages;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
47 Valladolid;All ages;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
47 Valladolid;All ages;Cohort July 1;Females;Survival in the third trimester;2022QII;""
47 Valladolid;All ages;Cohort July 1;Females;Survival in the third trimester;2022QI;10.185
47 Valladolid;All ages;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
47 Valladolid;All ages;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
47 Valladolid;All ages;Cohort July 1;Females;Survival in the third trimester;2021QII;""
47 Valladolid;All ages;Cohort July 1;Females;Survival in the third trimester;2021QI;10.213
47 Valladolid;All ages;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
47 Valladolid;All ages;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
47 Valladolid;All ages;Cohort July 1;Females;Survival in the third trimester;2020QII;""
47 Valladolid;All ages;Cohort July 1;Females;Survival in the third trimester;2020QI;""
47 Valladolid;All ages;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
47 Valladolid;All ages;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
47 Valladolid;All ages;Cohort July 1;Females;Survival in the third trimester;2022QII;9.904
47 Valladolid;All ages;Cohort July 1;Females;Survival in the third trimester;2022QI;""
47 Valladolid;All ages;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
47 Valladolid;All ages;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
47 Valladolid;All ages;Cohort July 1;Females;Survival in the third trimester;2021QII;9.952
47 Valladolid;All ages;Cohort July 1;Females;Survival in the third trimester;2021QI;""
47 Valladolid;All ages;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
47 Valladolid;All ages;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
47 Valladolid;All ages;Cohort July 1;Females;Survival in the third trimester;2020QII;""
47 Valladolid;All ages;Cohort July 1;Females;Survival in the third trimester;2020QI;""
47 Valladolid;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
47 Valladolid;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
47 Valladolid;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
47 Valladolid;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
47 Valladolid;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
47 Valladolid;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
47 Valladolid;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
47 Valladolid;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
47 Valladolid;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
47 Valladolid;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
47 Valladolid;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
47 Valladolid;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
47 Valladolid;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
47 Valladolid;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;96,49
47 Valladolid;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
47 Valladolid;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
47 Valladolid;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
47 Valladolid;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;97,04
47 Valladolid;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
47 Valladolid;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
47 Valladolid;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
47 Valladolid;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;96,87
47 Valladolid;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
47 Valladolid;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
47 Valladolid;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;93,44
47 Valladolid;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
47 Valladolid;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
47 Valladolid;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
47 Valladolid;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;94,14
47 Valladolid;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
47 Valladolid;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
47 Valladolid;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
47 Valladolid;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;93,94
47 Valladolid;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
47 Valladolid;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
47 Valladolid;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
47 Valladolid;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
47 Valladolid;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
47 Valladolid;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
47 Valladolid;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;91,46
47 Valladolid;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
47 Valladolid;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
47 Valladolid;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
47 Valladolid;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;92,13
47 Valladolid;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
47 Valladolid;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
47 Valladolid;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
47 Valladolid;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
47 Valladolid;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
47 Valladolid;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
47 Valladolid;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;88,94
47 Valladolid;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
47 Valladolid;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
47 Valladolid;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
47 Valladolid;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;89,78
47 Valladolid;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
47 Valladolid;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
47 Valladolid;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
47 Valladolid;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
47 Valladolid;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
47 Valladolid;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QIV;30.222
47 Valladolid;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
47 Valladolid;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
47 Valladolid;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
47 Valladolid;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QIV;30.623
47 Valladolid;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
47 Valladolid;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
47 Valladolid;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
47 Valladolid;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QIV;30.519
47 Valladolid;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
47 Valladolid;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
47 Valladolid;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
47 Valladolid;All ages;Cohort October 1;Total;Survival in the first trimester;2022QIV;29.198
47 Valladolid;All ages;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
47 Valladolid;All ages;Cohort October 1;Total;Survival in the first trimester;2022QII;""
47 Valladolid;All ages;Cohort October 1;Total;Survival in the first trimester;2022QI;""
47 Valladolid;All ages;Cohort October 1;Total;Survival in the first trimester;2021QIV;29.744
47 Valladolid;All ages;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
47 Valladolid;All ages;Cohort October 1;Total;Survival in the first trimester;2021QII;""
47 Valladolid;All ages;Cohort October 1;Total;Survival in the first trimester;2021QI;""
47 Valladolid;All ages;Cohort October 1;Total;Survival in the first trimester;2020QIV;29.610
47 Valladolid;All ages;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
47 Valladolid;All ages;Cohort October 1;Total;Survival in the first trimester;2020QII;""
47 Valladolid;All ages;Cohort October 1;Total;Survival in the first trimester;2020QI;""
47 Valladolid;All ages;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
47 Valladolid;All ages;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
47 Valladolid;All ages;Cohort October 1;Total;Survival in the second trimester;2022QII;""
47 Valladolid;All ages;Cohort October 1;Total;Survival in the second trimester;2022QI;29.010
47 Valladolid;All ages;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
47 Valladolid;All ages;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
47 Valladolid;All ages;Cohort October 1;Total;Survival in the second trimester;2021QII;""
47 Valladolid;All ages;Cohort October 1;Total;Survival in the second trimester;2021QI;29.030
47 Valladolid;All ages;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
47 Valladolid;All ages;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
47 Valladolid;All ages;Cohort October 1;Total;Survival in the second trimester;2020QII;""
47 Valladolid;All ages;Cohort October 1;Total;Survival in the second trimester;2020QI;""
47 Valladolid;All ages;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
47 Valladolid;All ages;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
47 Valladolid;All ages;Cohort October 1;Total;Survival in the third trimester;2022QII;28.286
47 Valladolid;All ages;Cohort October 1;Total;Survival in the third trimester;2022QI;""
47 Valladolid;All ages;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
47 Valladolid;All ages;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
47 Valladolid;All ages;Cohort October 1;Total;Survival in the third trimester;2021QII;28.422
47 Valladolid;All ages;Cohort October 1;Total;Survival in the third trimester;2021QI;""
47 Valladolid;All ages;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
47 Valladolid;All ages;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
47 Valladolid;All ages;Cohort October 1;Total;Survival in the third trimester;2020QII;""
47 Valladolid;All ages;Cohort October 1;Total;Survival in the third trimester;2020QI;""
47 Valladolid;All ages;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
47 Valladolid;All ages;Cohort October 1;Total;Survival in the third trimester;2022QIII;27.602
47 Valladolid;All ages;Cohort October 1;Total;Survival in the third trimester;2022QII;""
47 Valladolid;All ages;Cohort October 1;Total;Survival in the third trimester;2022QI;""
47 Valladolid;All ages;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
47 Valladolid;All ages;Cohort October 1;Total;Survival in the third trimester;2021QIII;27.845
47 Valladolid;All ages;Cohort October 1;Total;Survival in the third trimester;2021QII;""
47 Valladolid;All ages;Cohort October 1;Total;Survival in the third trimester;2021QI;""
47 Valladolid;All ages;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
47 Valladolid;All ages;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
47 Valladolid;All ages;Cohort October 1;Total;Survival in the third trimester;2020QII;""
47 Valladolid;All ages;Cohort October 1;Total;Survival in the third trimester;2020QI;""
47 Valladolid;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
47 Valladolid;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
47 Valladolid;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
47 Valladolid;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
47 Valladolid;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
47 Valladolid;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
47 Valladolid;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
47 Valladolid;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
47 Valladolid;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
47 Valladolid;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
47 Valladolid;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
47 Valladolid;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
47 Valladolid;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;96,61
47 Valladolid;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
47 Valladolid;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
47 Valladolid;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
47 Valladolid;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;97,13
47 Valladolid;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
47 Valladolid;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
47 Valladolid;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
47 Valladolid;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;97,02
47 Valladolid;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
47 Valladolid;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
47 Valladolid;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
47 Valladolid;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
47 Valladolid;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
47 Valladolid;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
47 Valladolid;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;94,73
47 Valladolid;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
47 Valladolid;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
47 Valladolid;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
47 Valladolid;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;95,12
47 Valladolid;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
47 Valladolid;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
47 Valladolid;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
47 Valladolid;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
47 Valladolid;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
47 Valladolid;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
47 Valladolid;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;92,37
47 Valladolid;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
47 Valladolid;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
47 Valladolid;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
47 Valladolid;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;93,13
47 Valladolid;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
47 Valladolid;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
47 Valladolid;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
47 Valladolid;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
47 Valladolid;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
47 Valladolid;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
47 Valladolid;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;90,13
47 Valladolid;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
47 Valladolid;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
47 Valladolid;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
47 Valladolid;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;91,24
47 Valladolid;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
47 Valladolid;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
47 Valladolid;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
47 Valladolid;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
47 Valladolid;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
47 Valladolid;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
47 Valladolid;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QIV;19.224
47 Valladolid;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
47 Valladolid;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
47 Valladolid;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
47 Valladolid;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QIV;19.485
47 Valladolid;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
47 Valladolid;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
47 Valladolid;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
47 Valladolid;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QIV;19.463
47 Valladolid;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
47 Valladolid;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
47 Valladolid;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
47 Valladolid;All ages;Cohort October 1;Males;Survival in the first trimester;2022QIV;18.572
47 Valladolid;All ages;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
47 Valladolid;All ages;Cohort October 1;Males;Survival in the first trimester;2022QII;""
47 Valladolid;All ages;Cohort October 1;Males;Survival in the first trimester;2022QI;""
47 Valladolid;All ages;Cohort October 1;Males;Survival in the first trimester;2021QIV;18.960
47 Valladolid;All ages;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
47 Valladolid;All ages;Cohort October 1;Males;Survival in the first trimester;2021QII;""
47 Valladolid;All ages;Cohort October 1;Males;Survival in the first trimester;2021QI;""
47 Valladolid;All ages;Cohort October 1;Males;Survival in the first trimester;2020QIV;18.910
47 Valladolid;All ages;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
47 Valladolid;All ages;Cohort October 1;Males;Survival in the first trimester;2020QII;""
47 Valladolid;All ages;Cohort October 1;Males;Survival in the first trimester;2020QI;""
47 Valladolid;All ages;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
47 Valladolid;All ages;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
47 Valladolid;All ages;Cohort October 1;Males;Survival in the second trimester;2022QII;""
47 Valladolid;All ages;Cohort October 1;Males;Survival in the second trimester;2022QI;18.546
47 Valladolid;All ages;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
47 Valladolid;All ages;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
47 Valladolid;All ages;Cohort October 1;Males;Survival in the second trimester;2021QII;""
47 Valladolid;All ages;Cohort October 1;Males;Survival in the second trimester;2021QI;18.546
47 Valladolid;All ages;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
47 Valladolid;All ages;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
47 Valladolid;All ages;Cohort October 1;Males;Survival in the second trimester;2020QII;""
47 Valladolid;All ages;Cohort October 1;Males;Survival in the second trimester;2020QI;""
47 Valladolid;All ages;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
47 Valladolid;All ages;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
47 Valladolid;All ages;Cohort October 1;Males;Survival in the third trimester;2022QII;18.123
47 Valladolid;All ages;Cohort October 1;Males;Survival in the third trimester;2022QI;""
47 Valladolid;All ages;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
47 Valladolid;All ages;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
47 Valladolid;All ages;Cohort October 1;Males;Survival in the third trimester;2021QII;18.221
47 Valladolid;All ages;Cohort October 1;Males;Survival in the third trimester;2021QI;""
47 Valladolid;All ages;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
47 Valladolid;All ages;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
47 Valladolid;All ages;Cohort October 1;Males;Survival in the third trimester;2020QII;""
47 Valladolid;All ages;Cohort October 1;Males;Survival in the third trimester;2020QI;""
47 Valladolid;All ages;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
47 Valladolid;All ages;Cohort October 1;Males;Survival in the third trimester;2022QIII;17.730
47 Valladolid;All ages;Cohort October 1;Males;Survival in the third trimester;2022QII;""
47 Valladolid;All ages;Cohort October 1;Males;Survival in the third trimester;2022QI;""
47 Valladolid;All ages;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
47 Valladolid;All ages;Cohort October 1;Males;Survival in the third trimester;2021QIII;17.878
47 Valladolid;All ages;Cohort October 1;Males;Survival in the third trimester;2021QII;""
47 Valladolid;All ages;Cohort October 1;Males;Survival in the third trimester;2021QI;""
47 Valladolid;All ages;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
47 Valladolid;All ages;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
47 Valladolid;All ages;Cohort October 1;Males;Survival in the third trimester;2020QII;""
47 Valladolid;All ages;Cohort October 1;Males;Survival in the third trimester;2020QI;""
47 Valladolid;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
47 Valladolid;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
47 Valladolid;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
47 Valladolid;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
47 Valladolid;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
47 Valladolid;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
47 Valladolid;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
47 Valladolid;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
47 Valladolid;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
47 Valladolid;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
47 Valladolid;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
47 Valladolid;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
47 Valladolid;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;96,61
47 Valladolid;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
47 Valladolid;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
47 Valladolid;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
47 Valladolid;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;97,31
47 Valladolid;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
47 Valladolid;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
47 Valladolid;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
47 Valladolid;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;97,16
47 Valladolid;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
47 Valladolid;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
47 Valladolid;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
47 Valladolid;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
47 Valladolid;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
47 Valladolid;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
47 Valladolid;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;95,18
47 Valladolid;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
47 Valladolid;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
47 Valladolid;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
47 Valladolid;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;95,29
47 Valladolid;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
47 Valladolid;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
47 Valladolid;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
47 Valladolid;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
47 Valladolid;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
47 Valladolid;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
47 Valladolid;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;93,01
47 Valladolid;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
47 Valladolid;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
47 Valladolid;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
47 Valladolid;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;93,62
47 Valladolid;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
47 Valladolid;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
47 Valladolid;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
47 Valladolid;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
47 Valladolid;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
47 Valladolid;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
47 Valladolid;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;90,99
47 Valladolid;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
47 Valladolid;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
47 Valladolid;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
47 Valladolid;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;91,86
47 Valladolid;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
47 Valladolid;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
47 Valladolid;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
47 Valladolid;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
47 Valladolid;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
47 Valladolid;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
47 Valladolid;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QIV;10.998
47 Valladolid;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
47 Valladolid;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
47 Valladolid;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
47 Valladolid;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QIV;11.138
47 Valladolid;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
47 Valladolid;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
47 Valladolid;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
47 Valladolid;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QIV;11.056
47 Valladolid;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
47 Valladolid;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
47 Valladolid;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
47 Valladolid;All ages;Cohort October 1;Females;Survival in the first trimester;2022QIV;10.626
47 Valladolid;All ages;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
47 Valladolid;All ages;Cohort October 1;Females;Survival in the first trimester;2022QII;""
47 Valladolid;All ages;Cohort October 1;Females;Survival in the first trimester;2022QI;""
47 Valladolid;All ages;Cohort October 1;Females;Survival in the first trimester;2021QIV;10.784
47 Valladolid;All ages;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
47 Valladolid;All ages;Cohort October 1;Females;Survival in the first trimester;2021QII;""
47 Valladolid;All ages;Cohort October 1;Females;Survival in the first trimester;2021QI;""
47 Valladolid;All ages;Cohort October 1;Females;Survival in the first trimester;2020QIV;10.700
47 Valladolid;All ages;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
47 Valladolid;All ages;Cohort October 1;Females;Survival in the first trimester;2020QII;""
47 Valladolid;All ages;Cohort October 1;Females;Survival in the first trimester;2020QI;""
47 Valladolid;All ages;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
47 Valladolid;All ages;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
47 Valladolid;All ages;Cohort October 1;Females;Survival in the second trimester;2022QII;""
47 Valladolid;All ages;Cohort October 1;Females;Survival in the second trimester;2022QI;10.464
47 Valladolid;All ages;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
47 Valladolid;All ages;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
47 Valladolid;All ages;Cohort October 1;Females;Survival in the second trimester;2021QII;""
47 Valladolid;All ages;Cohort October 1;Females;Survival in the second trimester;2021QI;10.484
47 Valladolid;All ages;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
47 Valladolid;All ages;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
47 Valladolid;All ages;Cohort October 1;Females;Survival in the second trimester;2020QII;""
47 Valladolid;All ages;Cohort October 1;Females;Survival in the second trimester;2020QI;""
47 Valladolid;All ages;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
47 Valladolid;All ages;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
47 Valladolid;All ages;Cohort October 1;Females;Survival in the third trimester;2022QII;10.163
47 Valladolid;All ages;Cohort October 1;Females;Survival in the third trimester;2022QI;""
47 Valladolid;All ages;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
47 Valladolid;All ages;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
47 Valladolid;All ages;Cohort October 1;Females;Survival in the third trimester;2021QII;10.201
47 Valladolid;All ages;Cohort October 1;Females;Survival in the third trimester;2021QI;""
47 Valladolid;All ages;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
47 Valladolid;All ages;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
47 Valladolid;All ages;Cohort October 1;Females;Survival in the third trimester;2020QII;""
47 Valladolid;All ages;Cohort October 1;Females;Survival in the third trimester;2020QI;""
47 Valladolid;All ages;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
47 Valladolid;All ages;Cohort October 1;Females;Survival in the third trimester;2022QIII;9.872
47 Valladolid;All ages;Cohort October 1;Females;Survival in the third trimester;2022QII;""
47 Valladolid;All ages;Cohort October 1;Females;Survival in the third trimester;2022QI;""
47 Valladolid;All ages;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
47 Valladolid;All ages;Cohort October 1;Females;Survival in the third trimester;2021QIII;9.967
47 Valladolid;All ages;Cohort October 1;Females;Survival in the third trimester;2021QII;""
47 Valladolid;All ages;Cohort October 1;Females;Survival in the third trimester;2021QI;""
47 Valladolid;All ages;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
47 Valladolid;All ages;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
47 Valladolid;All ages;Cohort October 1;Females;Survival in the third trimester;2020QII;""
47 Valladolid;All ages;Cohort October 1;Females;Survival in the third trimester;2020QI;""
47 Valladolid;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
47 Valladolid;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
47 Valladolid;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
47 Valladolid;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
47 Valladolid;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
47 Valladolid;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
47 Valladolid;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
47 Valladolid;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
47 Valladolid;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
47 Valladolid;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
47 Valladolid;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
47 Valladolid;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
47 Valladolid;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;96,62
47 Valladolid;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
47 Valladolid;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
47 Valladolid;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
47 Valladolid;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;96,82
47 Valladolid;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
47 Valladolid;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
47 Valladolid;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
47 Valladolid;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;96,78
47 Valladolid;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
47 Valladolid;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
47 Valladolid;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
47 Valladolid;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
47 Valladolid;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
47 Valladolid;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
47 Valladolid;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;93,95
47 Valladolid;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
47 Valladolid;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
47 Valladolid;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
47 Valladolid;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;94,83
47 Valladolid;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
47 Valladolid;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
47 Valladolid;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
47 Valladolid;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
47 Valladolid;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
47 Valladolid;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
47 Valladolid;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;91,25
47 Valladolid;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
47 Valladolid;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
47 Valladolid;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
47 Valladolid;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;92,27
47 Valladolid;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
47 Valladolid;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
47 Valladolid;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
47 Valladolid;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
47 Valladolid;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
47 Valladolid;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
47 Valladolid;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;88,63
47 Valladolid;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
47 Valladolid;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
47 Valladolid;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
47 Valladolid;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;90,15
47 Valladolid;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
47 Valladolid;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
47 Valladolid;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
47 Valladolid;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
47 Valladolid;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
47 Valladolid;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
47 Valladolid;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
47 Valladolid;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
47 Valladolid;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
47 Valladolid;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QI;1.529
47 Valladolid;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
47 Valladolid;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
47 Valladolid;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
47 Valladolid;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QI;1.487
47 Valladolid;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
47 Valladolid;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
47 Valladolid;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
47 Valladolid;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QI;1.273
47 Valladolid;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
47 Valladolid;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
47 Valladolid;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2022QII;""
47 Valladolid;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2022QI;1.410
47 Valladolid;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
47 Valladolid;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
47 Valladolid;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2021QII;""
47 Valladolid;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2021QI;1.400
47 Valladolid;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
47 Valladolid;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
47 Valladolid;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2020QII;""
47 Valladolid;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2020QI;1.131
47 Valladolid;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
47 Valladolid;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
47 Valladolid;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2022QII;1.308
47 Valladolid;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2022QI;""
47 Valladolid;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
47 Valladolid;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
47 Valladolid;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2021QII;1.309
47 Valladolid;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2021QI;""
47 Valladolid;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
47 Valladolid;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
47 Valladolid;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2020QII;1.076
47 Valladolid;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2020QI;""
47 Valladolid;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
47 Valladolid;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QIII;1.221
47 Valladolid;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QII;""
47 Valladolid;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QI;""
47 Valladolid;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
47 Valladolid;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QIII;1.244
47 Valladolid;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QII;""
47 Valladolid;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QI;""
47 Valladolid;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
47 Valladolid;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QIII;1.019
47 Valladolid;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QII;""
47 Valladolid;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QI;""
47 Valladolid;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QIV;1.159
47 Valladolid;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
47 Valladolid;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QII;""
47 Valladolid;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QI;""
47 Valladolid;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QIV;1.175
47 Valladolid;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
47 Valladolid;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QII;""
47 Valladolid;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QI;""
47 Valladolid;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QIV;961
47 Valladolid;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
47 Valladolid;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QII;""
47 Valladolid;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QI;""
47 Valladolid;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
47 Valladolid;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
47 Valladolid;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
47 Valladolid;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
47 Valladolid;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
47 Valladolid;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
47 Valladolid;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
47 Valladolid;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
47 Valladolid;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
47 Valladolid;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
47 Valladolid;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
47 Valladolid;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
47 Valladolid;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
47 Valladolid;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
47 Valladolid;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
47 Valladolid;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;92,22
47 Valladolid;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
47 Valladolid;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
47 Valladolid;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
47 Valladolid;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;94,15
47 Valladolid;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
47 Valladolid;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
47 Valladolid;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
47 Valladolid;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;88,85
47 Valladolid;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
47 Valladolid;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
47 Valladolid;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;85,55
47 Valladolid;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
47 Valladolid;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
47 Valladolid;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
47 Valladolid;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;88,03
47 Valladolid;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
47 Valladolid;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
47 Valladolid;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
47 Valladolid;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;84,52
47 Valladolid;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
47 Valladolid;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
47 Valladolid;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;79,86
47 Valladolid;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
47 Valladolid;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
47 Valladolid;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
47 Valladolid;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;83,66
47 Valladolid;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
47 Valladolid;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
47 Valladolid;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
47 Valladolid;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;80,05
47 Valladolid;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
47 Valladolid;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
47 Valladolid;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;75,8
47 Valladolid;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
47 Valladolid;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
47 Valladolid;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
47 Valladolid;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;79,02
47 Valladolid;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
47 Valladolid;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
47 Valladolid;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
47 Valladolid;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;75,49
47 Valladolid;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
47 Valladolid;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
47 Valladolid;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
47 Valladolid;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
47 Valladolid;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
47 Valladolid;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
47 Valladolid;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QI;947
47 Valladolid;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
47 Valladolid;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
47 Valladolid;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
47 Valladolid;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QI;901
47 Valladolid;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
47 Valladolid;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
47 Valladolid;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
47 Valladolid;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QI;776
47 Valladolid;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
47 Valladolid;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
47 Valladolid;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2022QII;""
47 Valladolid;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2022QI;874
47 Valladolid;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
47 Valladolid;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
47 Valladolid;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2021QII;""
47 Valladolid;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2021QI;848
47 Valladolid;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
47 Valladolid;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
47 Valladolid;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2020QII;""
47 Valladolid;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2020QI;695
47 Valladolid;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
47 Valladolid;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
47 Valladolid;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2022QII;808
47 Valladolid;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2022QI;""
47 Valladolid;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
47 Valladolid;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
47 Valladolid;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2021QII;802
47 Valladolid;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2021QI;""
47 Valladolid;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
47 Valladolid;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
47 Valladolid;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2020QII;662
47 Valladolid;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2020QI;""
47 Valladolid;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
47 Valladolid;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QIII;754
47 Valladolid;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QII;""
47 Valladolid;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QI;""
47 Valladolid;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
47 Valladolid;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QIII;762
47 Valladolid;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QII;""
47 Valladolid;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QI;""
47 Valladolid;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
47 Valladolid;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QIII;635
47 Valladolid;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QII;""
47 Valladolid;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QI;""
47 Valladolid;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QIV;713
47 Valladolid;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
47 Valladolid;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QII;""
47 Valladolid;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QI;""
47 Valladolid;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QIV;719
47 Valladolid;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
47 Valladolid;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QII;""
47 Valladolid;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QI;""
47 Valladolid;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QIV;596
47 Valladolid;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
47 Valladolid;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QII;""
47 Valladolid;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QI;""
47 Valladolid;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
47 Valladolid;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
47 Valladolid;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
47 Valladolid;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
47 Valladolid;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
47 Valladolid;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
47 Valladolid;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
47 Valladolid;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
47 Valladolid;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
47 Valladolid;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
47 Valladolid;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
47 Valladolid;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
47 Valladolid;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
47 Valladolid;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
47 Valladolid;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
47 Valladolid;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;92,29
47 Valladolid;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
47 Valladolid;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
47 Valladolid;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
47 Valladolid;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;94,12
47 Valladolid;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
47 Valladolid;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
47 Valladolid;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
47 Valladolid;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;89,56
47 Valladolid;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
47 Valladolid;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
47 Valladolid;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;85,32
47 Valladolid;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
47 Valladolid;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
47 Valladolid;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
47 Valladolid;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;89,01
47 Valladolid;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
47 Valladolid;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
47 Valladolid;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
47 Valladolid;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;85,31
47 Valladolid;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
47 Valladolid;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
47 Valladolid;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;79,62
47 Valladolid;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
47 Valladolid;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
47 Valladolid;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
47 Valladolid;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;84,57
47 Valladolid;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
47 Valladolid;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
47 Valladolid;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
47 Valladolid;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;81,83
47 Valladolid;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
47 Valladolid;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
47 Valladolid;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;75,29
47 Valladolid;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
47 Valladolid;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
47 Valladolid;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
47 Valladolid;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;79,8
47 Valladolid;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
47 Valladolid;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
47 Valladolid;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
47 Valladolid;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;76,8
47 Valladolid;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
47 Valladolid;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
47 Valladolid;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
47 Valladolid;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
47 Valladolid;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
47 Valladolid;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
47 Valladolid;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QI;582
47 Valladolid;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
47 Valladolid;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
47 Valladolid;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
47 Valladolid;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QI;586
47 Valladolid;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
47 Valladolid;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
47 Valladolid;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
47 Valladolid;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QI;497
47 Valladolid;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
47 Valladolid;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
47 Valladolid;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2022QII;""
47 Valladolid;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2022QI;536
47 Valladolid;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
47 Valladolid;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
47 Valladolid;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2021QII;""
47 Valladolid;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2021QI;552
47 Valladolid;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
47 Valladolid;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
47 Valladolid;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2020QII;""
47 Valladolid;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2020QI;436
47 Valladolid;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
47 Valladolid;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
47 Valladolid;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2022QII;500
47 Valladolid;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2022QI;""
47 Valladolid;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
47 Valladolid;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
47 Valladolid;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2021QII;507
47 Valladolid;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2021QI;""
47 Valladolid;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
47 Valladolid;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
47 Valladolid;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2020QII;414
47 Valladolid;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2020QI;""
47 Valladolid;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
47 Valladolid;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QIII;467
47 Valladolid;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QII;""
47 Valladolid;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QI;""
47 Valladolid;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
47 Valladolid;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QIII;482
47 Valladolid;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QII;""
47 Valladolid;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QI;""
47 Valladolid;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
47 Valladolid;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QIII;384
47 Valladolid;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QII;""
47 Valladolid;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QI;""
47 Valladolid;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QIV;446
47 Valladolid;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
47 Valladolid;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QII;""
47 Valladolid;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QI;""
47 Valladolid;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QIV;456
47 Valladolid;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
47 Valladolid;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QII;""
47 Valladolid;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QI;""
47 Valladolid;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QIV;365
47 Valladolid;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
47 Valladolid;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QII;""
47 Valladolid;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QI;""
47 Valladolid;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
47 Valladolid;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
47 Valladolid;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
47 Valladolid;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
47 Valladolid;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
47 Valladolid;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
47 Valladolid;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
47 Valladolid;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
47 Valladolid;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
47 Valladolid;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
47 Valladolid;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
47 Valladolid;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
47 Valladolid;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
47 Valladolid;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
47 Valladolid;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
47 Valladolid;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;92,1
47 Valladolid;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
47 Valladolid;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
47 Valladolid;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
47 Valladolid;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;94,2
47 Valladolid;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
47 Valladolid;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
47 Valladolid;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
47 Valladolid;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;87,73
47 Valladolid;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
47 Valladolid;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
47 Valladolid;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;85,91
47 Valladolid;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
47 Valladolid;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
47 Valladolid;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
47 Valladolid;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;86,52
47 Valladolid;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
47 Valladolid;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
47 Valladolid;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
47 Valladolid;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;83,3
47 Valladolid;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
47 Valladolid;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
47 Valladolid;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;80,24
47 Valladolid;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
47 Valladolid;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
47 Valladolid;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
47 Valladolid;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;82,25
47 Valladolid;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
47 Valladolid;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
47 Valladolid;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
47 Valladolid;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;77,26
47 Valladolid;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
47 Valladolid;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
47 Valladolid;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;76,63
47 Valladolid;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
47 Valladolid;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
47 Valladolid;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
47 Valladolid;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;77,82
47 Valladolid;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
47 Valladolid;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
47 Valladolid;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
47 Valladolid;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;73,44
47 Valladolid;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
47 Valladolid;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
47 Valladolid;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
47 Valladolid;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
47 Valladolid;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
47 Valladolid;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QII;1.340
47 Valladolid;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
47 Valladolid;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
47 Valladolid;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
47 Valladolid;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QII;1.310
47 Valladolid;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
47 Valladolid;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
47 Valladolid;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
47 Valladolid;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QII;1.281
47 Valladolid;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
47 Valladolid;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
47 Valladolid;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
47 Valladolid;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2022QII;1.216
47 Valladolid;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2022QI;""
47 Valladolid;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
47 Valladolid;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
47 Valladolid;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2021QII;1.203
47 Valladolid;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2021QI;""
47 Valladolid;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
47 Valladolid;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
47 Valladolid;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2020QII;1.220
47 Valladolid;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2020QI;""
47 Valladolid;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
47 Valladolid;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2022QIII;1.129
47 Valladolid;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2022QII;""
47 Valladolid;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2022QI;""
47 Valladolid;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
47 Valladolid;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2021QIII;1.144
47 Valladolid;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2021QII;""
47 Valladolid;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2021QI;""
47 Valladolid;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
47 Valladolid;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2020QIII;1.149
47 Valladolid;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2020QII;""
47 Valladolid;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2020QI;""
47 Valladolid;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QIV;1.066
47 Valladolid;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
47 Valladolid;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QII;""
47 Valladolid;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QI;""
47 Valladolid;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QIV;1.068
47 Valladolid;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
47 Valladolid;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QII;""
47 Valladolid;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QI;""
47 Valladolid;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QIV;1.076
47 Valladolid;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
47 Valladolid;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QII;""
47 Valladolid;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QI;""
47 Valladolid;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
47 Valladolid;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
47 Valladolid;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QII;""
47 Valladolid;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QI;1.006
47 Valladolid;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
47 Valladolid;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
47 Valladolid;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QII;""
47 Valladolid;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QI;1.027
47 Valladolid;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
47 Valladolid;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
47 Valladolid;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QII;""
47 Valladolid;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QI;""
47 Valladolid;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
47 Valladolid;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
47 Valladolid;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
47 Valladolid;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
47 Valladolid;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
47 Valladolid;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
47 Valladolid;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
47 Valladolid;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
47 Valladolid;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
47 Valladolid;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
47 Valladolid;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
47 Valladolid;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
47 Valladolid;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
47 Valladolid;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
47 Valladolid;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;90,75
47 Valladolid;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
47 Valladolid;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
47 Valladolid;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
47 Valladolid;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;91,83
47 Valladolid;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
47 Valladolid;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
47 Valladolid;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
47 Valladolid;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;95,24
47 Valladolid;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
47 Valladolid;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
47 Valladolid;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;84,25
47 Valladolid;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
47 Valladolid;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
47 Valladolid;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
47 Valladolid;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;87,33
47 Valladolid;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
47 Valladolid;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
47 Valladolid;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
47 Valladolid;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;89,7
47 Valladolid;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
47 Valladolid;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
47 Valladolid;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;79,55
47 Valladolid;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
47 Valladolid;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
47 Valladolid;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
47 Valladolid;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;81,53
47 Valladolid;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
47 Valladolid;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
47 Valladolid;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
47 Valladolid;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;84
47 Valladolid;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
47 Valladolid;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
47 Valladolid;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
47 Valladolid;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
47 Valladolid;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
47 Valladolid;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
47 Valladolid;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;76,79
47 Valladolid;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
47 Valladolid;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
47 Valladolid;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
47 Valladolid;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;80,17
47 Valladolid;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
47 Valladolid;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
47 Valladolid;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
47 Valladolid;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
47 Valladolid;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
47 Valladolid;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
47 Valladolid;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QII;829
47 Valladolid;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
47 Valladolid;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
47 Valladolid;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
47 Valladolid;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QII;808
47 Valladolid;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
47 Valladolid;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
47 Valladolid;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
47 Valladolid;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QII;780
47 Valladolid;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
47 Valladolid;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
47 Valladolid;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
47 Valladolid;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2022QII;749
47 Valladolid;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2022QI;""
47 Valladolid;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
47 Valladolid;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
47 Valladolid;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2021QII;755
47 Valladolid;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2021QI;""
47 Valladolid;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
47 Valladolid;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
47 Valladolid;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2020QII;745
47 Valladolid;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2020QI;""
47 Valladolid;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
47 Valladolid;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2022QIII;693
47 Valladolid;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2022QII;""
47 Valladolid;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2022QI;""
47 Valladolid;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
47 Valladolid;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2021QIII;719
47 Valladolid;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2021QII;""
47 Valladolid;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2021QI;""
47 Valladolid;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
47 Valladolid;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2020QIII;710
47 Valladolid;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2020QII;""
47 Valladolid;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2020QI;""
47 Valladolid;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QIV;650
47 Valladolid;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
47 Valladolid;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QII;""
47 Valladolid;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QI;""
47 Valladolid;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QIV;671
47 Valladolid;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
47 Valladolid;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QII;""
47 Valladolid;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QI;""
47 Valladolid;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QIV;663
47 Valladolid;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
47 Valladolid;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QII;""
47 Valladolid;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QI;""
47 Valladolid;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
47 Valladolid;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
47 Valladolid;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QII;""
47 Valladolid;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QI;632
47 Valladolid;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
47 Valladolid;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
47 Valladolid;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QII;""
47 Valladolid;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QI;633
47 Valladolid;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
47 Valladolid;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
47 Valladolid;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QII;""
47 Valladolid;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QI;""
47 Valladolid;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
47 Valladolid;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
47 Valladolid;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
47 Valladolid;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
47 Valladolid;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
47 Valladolid;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
47 Valladolid;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
47 Valladolid;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
47 Valladolid;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
47 Valladolid;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
47 Valladolid;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
47 Valladolid;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
47 Valladolid;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
47 Valladolid;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
47 Valladolid;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;90,35
47 Valladolid;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
47 Valladolid;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
47 Valladolid;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
47 Valladolid;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;93,44
47 Valladolid;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
47 Valladolid;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
47 Valladolid;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
47 Valladolid;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;95,51
47 Valladolid;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
47 Valladolid;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
47 Valladolid;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;83,59
47 Valladolid;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
47 Valladolid;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
47 Valladolid;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
47 Valladolid;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;88,99
47 Valladolid;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
47 Valladolid;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
47 Valladolid;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
47 Valladolid;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;91,03
47 Valladolid;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
47 Valladolid;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
47 Valladolid;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;78,41
47 Valladolid;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
47 Valladolid;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
47 Valladolid;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
47 Valladolid;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;83,04
47 Valladolid;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
47 Valladolid;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
47 Valladolid;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
47 Valladolid;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;85
47 Valladolid;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
47 Valladolid;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
47 Valladolid;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
47 Valladolid;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
47 Valladolid;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
47 Valladolid;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
47 Valladolid;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;78,22
47 Valladolid;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
47 Valladolid;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
47 Valladolid;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
47 Valladolid;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;81,15
47 Valladolid;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
47 Valladolid;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
47 Valladolid;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
47 Valladolid;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
47 Valladolid;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
47 Valladolid;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
47 Valladolid;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QII;511
47 Valladolid;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
47 Valladolid;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
47 Valladolid;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
47 Valladolid;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QII;502
47 Valladolid;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
47 Valladolid;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
47 Valladolid;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
47 Valladolid;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QII;501
47 Valladolid;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
47 Valladolid;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
47 Valladolid;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
47 Valladolid;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2022QII;467
47 Valladolid;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2022QI;""
47 Valladolid;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
47 Valladolid;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
47 Valladolid;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2021QII;448
47 Valladolid;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2021QI;""
47 Valladolid;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
47 Valladolid;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
47 Valladolid;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2020QII;475
47 Valladolid;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2020QI;""
47 Valladolid;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
47 Valladolid;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2022QIII;436
47 Valladolid;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2022QII;""
47 Valladolid;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2022QI;""
47 Valladolid;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
47 Valladolid;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2021QIII;425
47 Valladolid;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2021QII;""
47 Valladolid;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2021QI;""
47 Valladolid;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
47 Valladolid;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2020QIII;439
47 Valladolid;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2020QII;""
47 Valladolid;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2020QI;""
47 Valladolid;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QIV;416
47 Valladolid;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
47 Valladolid;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QII;""
47 Valladolid;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QI;""
47 Valladolid;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QIV;397
47 Valladolid;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
47 Valladolid;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QII;""
47 Valladolid;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QI;""
47 Valladolid;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QIV;413
47 Valladolid;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
47 Valladolid;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QII;""
47 Valladolid;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QI;""
47 Valladolid;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
47 Valladolid;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
47 Valladolid;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QII;""
47 Valladolid;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QI;374
47 Valladolid;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
47 Valladolid;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
47 Valladolid;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QII;""
47 Valladolid;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QI;394
47 Valladolid;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
47 Valladolid;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
47 Valladolid;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QII;""
47 Valladolid;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QI;""
47 Valladolid;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
47 Valladolid;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
47 Valladolid;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
47 Valladolid;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
47 Valladolid;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
47 Valladolid;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
47 Valladolid;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
47 Valladolid;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
47 Valladolid;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
47 Valladolid;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
47 Valladolid;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
47 Valladolid;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
47 Valladolid;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
47 Valladolid;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
47 Valladolid;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;91,39
47 Valladolid;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
47 Valladolid;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
47 Valladolid;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
47 Valladolid;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;89,24
47 Valladolid;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
47 Valladolid;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
47 Valladolid;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
47 Valladolid;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;94,81
47 Valladolid;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
47 Valladolid;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
47 Valladolid;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;85,32
47 Valladolid;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
47 Valladolid;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
47 Valladolid;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
47 Valladolid;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;84,66
47 Valladolid;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
47 Valladolid;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
47 Valladolid;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
47 Valladolid;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;87,62
47 Valladolid;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
47 Valladolid;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
47 Valladolid;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;81,41
47 Valladolid;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
47 Valladolid;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
47 Valladolid;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
47 Valladolid;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;79,08
47 Valladolid;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
47 Valladolid;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
47 Valladolid;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
47 Valladolid;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;82,44
47 Valladolid;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
47 Valladolid;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
47 Valladolid;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
47 Valladolid;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
47 Valladolid;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
47 Valladolid;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
47 Valladolid;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;74,5
47 Valladolid;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
47 Valladolid;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
47 Valladolid;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
47 Valladolid;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;78,64
47 Valladolid;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
47 Valladolid;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
47 Valladolid;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
47 Valladolid;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
47 Valladolid;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
47 Valladolid;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QIII;1.422
47 Valladolid;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
47 Valladolid;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
47 Valladolid;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
47 Valladolid;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QIII;1.405
47 Valladolid;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
47 Valladolid;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
47 Valladolid;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
47 Valladolid;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QIII;1.336
47 Valladolid;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
47 Valladolid;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
47 Valladolid;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
47 Valladolid;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2022QIII;1.287
47 Valladolid;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2022QII;""
47 Valladolid;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2022QI;""
47 Valladolid;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
47 Valladolid;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2021QIII;1.296
47 Valladolid;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2021QII;""
47 Valladolid;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2021QI;""
47 Valladolid;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
47 Valladolid;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2020QIII;1.234
47 Valladolid;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2020QII;""
47 Valladolid;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2020QI;""
47 Valladolid;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2022QIV;1.204
47 Valladolid;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
47 Valladolid;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2022QII;""
47 Valladolid;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2022QI;""
47 Valladolid;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2021QIV;1.198
47 Valladolid;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
47 Valladolid;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2021QII;""
47 Valladolid;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2021QI;""
47 Valladolid;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2020QIV;1.155
47 Valladolid;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
47 Valladolid;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2020QII;""
47 Valladolid;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2020QI;""
47 Valladolid;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
47 Valladolid;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
47 Valladolid;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QII;""
47 Valladolid;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QI;1.119
47 Valladolid;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
47 Valladolid;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
47 Valladolid;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QII;""
47 Valladolid;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QI;1.100
47 Valladolid;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
47 Valladolid;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
47 Valladolid;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QII;""
47 Valladolid;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QI;""
47 Valladolid;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
47 Valladolid;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
47 Valladolid;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QII;1.047
47 Valladolid;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QI;""
47 Valladolid;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
47 Valladolid;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
47 Valladolid;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QII;1.038
47 Valladolid;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QI;""
47 Valladolid;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
47 Valladolid;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
47 Valladolid;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QII;""
47 Valladolid;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QI;""
47 Valladolid;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
47 Valladolid;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
47 Valladolid;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
47 Valladolid;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
47 Valladolid;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
47 Valladolid;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
47 Valladolid;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
47 Valladolid;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
47 Valladolid;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
47 Valladolid;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
47 Valladolid;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
47 Valladolid;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
47 Valladolid;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
47 Valladolid;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;90,51
47 Valladolid;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
47 Valladolid;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
47 Valladolid;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
47 Valladolid;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;92,24
47 Valladolid;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
47 Valladolid;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
47 Valladolid;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
47 Valladolid;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;92,37
47 Valladolid;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
47 Valladolid;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
47 Valladolid;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;84,67
47 Valladolid;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
47 Valladolid;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
47 Valladolid;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
47 Valladolid;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;85,27
47 Valladolid;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
47 Valladolid;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
47 Valladolid;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
47 Valladolid;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;86,45
47 Valladolid;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
47 Valladolid;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
47 Valladolid;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
47 Valladolid;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
47 Valladolid;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
47 Valladolid;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
47 Valladolid;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;79,64
47 Valladolid;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
47 Valladolid;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
47 Valladolid;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
47 Valladolid;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;82,34
47 Valladolid;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
47 Valladolid;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
47 Valladolid;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
47 Valladolid;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
47 Valladolid;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
47 Valladolid;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
47 Valladolid;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;74,52
47 Valladolid;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
47 Valladolid;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
47 Valladolid;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
47 Valladolid;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;77,69
47 Valladolid;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
47 Valladolid;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
47 Valladolid;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
47 Valladolid;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
47 Valladolid;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
47 Valladolid;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
47 Valladolid;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QIII;879
47 Valladolid;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
47 Valladolid;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
47 Valladolid;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
47 Valladolid;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QIII;871
47 Valladolid;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
47 Valladolid;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
47 Valladolid;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
47 Valladolid;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QIII;822
47 Valladolid;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
47 Valladolid;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
47 Valladolid;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
47 Valladolid;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2022QIII;792
47 Valladolid;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2022QII;""
47 Valladolid;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2022QI;""
47 Valladolid;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
47 Valladolid;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2021QIII;807
47 Valladolid;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2021QII;""
47 Valladolid;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2021QI;""
47 Valladolid;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
47 Valladolid;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2020QIII;765
47 Valladolid;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2020QII;""
47 Valladolid;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2020QI;""
47 Valladolid;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2022QIV;736
47 Valladolid;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
47 Valladolid;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2022QII;""
47 Valladolid;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2022QI;""
47 Valladolid;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2021QIV;749
47 Valladolid;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
47 Valladolid;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2021QII;""
47 Valladolid;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2021QI;""
47 Valladolid;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2020QIV;714
47 Valladolid;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
47 Valladolid;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2020QII;""
47 Valladolid;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2020QI;""
47 Valladolid;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
47 Valladolid;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
47 Valladolid;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QII;""
47 Valladolid;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QI;699
47 Valladolid;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
47 Valladolid;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
47 Valladolid;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QII;""
47 Valladolid;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QI;679
47 Valladolid;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
47 Valladolid;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
47 Valladolid;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QII;""
47 Valladolid;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QI;""
47 Valladolid;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
47 Valladolid;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
47 Valladolid;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QII;650
47 Valladolid;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QI;""
47 Valladolid;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
47 Valladolid;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
47 Valladolid;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QII;646
47 Valladolid;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QI;""
47 Valladolid;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
47 Valladolid;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
47 Valladolid;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QII;""
47 Valladolid;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QI;""
47 Valladolid;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
47 Valladolid;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
47 Valladolid;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
47 Valladolid;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
47 Valladolid;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
47 Valladolid;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
47 Valladolid;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
47 Valladolid;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
47 Valladolid;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
47 Valladolid;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
47 Valladolid;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
47 Valladolid;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
47 Valladolid;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
47 Valladolid;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;90,1
47 Valladolid;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
47 Valladolid;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
47 Valladolid;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
47 Valladolid;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;92,65
47 Valladolid;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
47 Valladolid;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
47 Valladolid;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
47 Valladolid;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;93,07
47 Valladolid;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
47 Valladolid;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
47 Valladolid;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;83,73
47 Valladolid;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
47 Valladolid;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
47 Valladolid;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
47 Valladolid;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;85,99
47 Valladolid;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
47 Valladolid;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
47 Valladolid;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
47 Valladolid;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;86,86
47 Valladolid;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
47 Valladolid;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
47 Valladolid;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
47 Valladolid;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
47 Valladolid;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
47 Valladolid;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
47 Valladolid;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;80,25
47 Valladolid;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
47 Valladolid;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
47 Valladolid;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
47 Valladolid;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;82,6
47 Valladolid;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
47 Valladolid;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
47 Valladolid;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
47 Valladolid;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
47 Valladolid;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
47 Valladolid;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
47 Valladolid;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;74,63
47 Valladolid;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
47 Valladolid;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
47 Valladolid;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
47 Valladolid;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;78,59
47 Valladolid;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
47 Valladolid;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
47 Valladolid;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
47 Valladolid;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
47 Valladolid;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
47 Valladolid;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
47 Valladolid;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QIII;543
47 Valladolid;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
47 Valladolid;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
47 Valladolid;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
47 Valladolid;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QIII;534
47 Valladolid;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
47 Valladolid;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
47 Valladolid;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
47 Valladolid;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QIII;514
47 Valladolid;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
47 Valladolid;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
47 Valladolid;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
47 Valladolid;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2022QIII;495
47 Valladolid;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2022QII;""
47 Valladolid;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2022QI;""
47 Valladolid;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
47 Valladolid;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2021QIII;489
47 Valladolid;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2021QII;""
47 Valladolid;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2021QI;""
47 Valladolid;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
47 Valladolid;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2020QIII;469
47 Valladolid;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2020QII;""
47 Valladolid;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2020QI;""
47 Valladolid;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2022QIV;468
47 Valladolid;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
47 Valladolid;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2022QII;""
47 Valladolid;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2022QI;""
47 Valladolid;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2021QIV;449
47 Valladolid;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
47 Valladolid;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2021QII;""
47 Valladolid;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2021QI;""
47 Valladolid;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2020QIV;441
47 Valladolid;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
47 Valladolid;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2020QII;""
47 Valladolid;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2020QI;""
47 Valladolid;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
47 Valladolid;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
47 Valladolid;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QII;""
47 Valladolid;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QI;420
47 Valladolid;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
47 Valladolid;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
47 Valladolid;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QII;""
47 Valladolid;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QI;421
47 Valladolid;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
47 Valladolid;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
47 Valladolid;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QII;""
47 Valladolid;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QI;""
47 Valladolid;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
47 Valladolid;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
47 Valladolid;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QII;397
47 Valladolid;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QI;""
47 Valladolid;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
47 Valladolid;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
47 Valladolid;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QII;392
47 Valladolid;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QI;""
47 Valladolid;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
47 Valladolid;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
47 Valladolid;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QII;""
47 Valladolid;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QI;""
47 Valladolid;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
47 Valladolid;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
47 Valladolid;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
47 Valladolid;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
47 Valladolid;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
47 Valladolid;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
47 Valladolid;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
47 Valladolid;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
47 Valladolid;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
47 Valladolid;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
47 Valladolid;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
47 Valladolid;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
47 Valladolid;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
47 Valladolid;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;91,16
47 Valladolid;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
47 Valladolid;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
47 Valladolid;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
47 Valladolid;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;91,57
47 Valladolid;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
47 Valladolid;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
47 Valladolid;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
47 Valladolid;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;91,25
47 Valladolid;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
47 Valladolid;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
47 Valladolid;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;86,19
47 Valladolid;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
47 Valladolid;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
47 Valladolid;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
47 Valladolid;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;84,08
47 Valladolid;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
47 Valladolid;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
47 Valladolid;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
47 Valladolid;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;85,8
47 Valladolid;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
47 Valladolid;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
47 Valladolid;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
47 Valladolid;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
47 Valladolid;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
47 Valladolid;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
47 Valladolid;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;78,65
47 Valladolid;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
47 Valladolid;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
47 Valladolid;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
47 Valladolid;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;81,91
47 Valladolid;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
47 Valladolid;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
47 Valladolid;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
47 Valladolid;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
47 Valladolid;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
47 Valladolid;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
47 Valladolid;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;74,34
47 Valladolid;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
47 Valladolid;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
47 Valladolid;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
47 Valladolid;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;76,26
47 Valladolid;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
47 Valladolid;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
47 Valladolid;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
47 Valladolid;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
47 Valladolid;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
47 Valladolid;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QIV;1.447
47 Valladolid;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
47 Valladolid;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
47 Valladolid;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
47 Valladolid;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QIV;1.470
47 Valladolid;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
47 Valladolid;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
47 Valladolid;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
47 Valladolid;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QIV;1.401
47 Valladolid;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
47 Valladolid;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
47 Valladolid;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
47 Valladolid;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2022QIV;1.338
47 Valladolid;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
47 Valladolid;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2022QII;""
47 Valladolid;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2022QI;""
47 Valladolid;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2021QIV;1.353
47 Valladolid;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
47 Valladolid;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2021QII;""
47 Valladolid;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2021QI;""
47 Valladolid;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2020QIV;1.305
47 Valladolid;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
47 Valladolid;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2020QII;""
47 Valladolid;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2020QI;""
47 Valladolid;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
47 Valladolid;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
47 Valladolid;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2022QII;""
47 Valladolid;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2022QI;1.259
47 Valladolid;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
47 Valladolid;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
47 Valladolid;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2021QII;""
47 Valladolid;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2021QI;1.238
47 Valladolid;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
47 Valladolid;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
47 Valladolid;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2020QII;""
47 Valladolid;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2020QI;""
47 Valladolid;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
47 Valladolid;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
47 Valladolid;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QII;1.177
47 Valladolid;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QI;""
47 Valladolid;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
47 Valladolid;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
47 Valladolid;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QII;1.162
47 Valladolid;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QI;""
47 Valladolid;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
47 Valladolid;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
47 Valladolid;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QII;""
47 Valladolid;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QI;""
47 Valladolid;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
47 Valladolid;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QIII;1.103
47 Valladolid;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QII;""
47 Valladolid;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QI;""
47 Valladolid;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
47 Valladolid;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QIII;1.111
47 Valladolid;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QII;""
47 Valladolid;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QI;""
47 Valladolid;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
47 Valladolid;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
47 Valladolid;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QII;""
47 Valladolid;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QI;""
47 Valladolid;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
47 Valladolid;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
47 Valladolid;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
47 Valladolid;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
47 Valladolid;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
47 Valladolid;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
47 Valladolid;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
47 Valladolid;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
47 Valladolid;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
47 Valladolid;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
47 Valladolid;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
47 Valladolid;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
47 Valladolid;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;92,47
47 Valladolid;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
47 Valladolid;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
47 Valladolid;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
47 Valladolid;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;92,04
47 Valladolid;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
47 Valladolid;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
47 Valladolid;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
47 Valladolid;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;93,15
47 Valladolid;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
47 Valladolid;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
47 Valladolid;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
47 Valladolid;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
47 Valladolid;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
47 Valladolid;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
47 Valladolid;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;85,65
47 Valladolid;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
47 Valladolid;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
47 Valladolid;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
47 Valladolid;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;88,37
47 Valladolid;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
47 Valladolid;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
47 Valladolid;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
47 Valladolid;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
47 Valladolid;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
47 Valladolid;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
47 Valladolid;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;80,07
47 Valladolid;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
47 Valladolid;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
47 Valladolid;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
47 Valladolid;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;82,94
47 Valladolid;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
47 Valladolid;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
47 Valladolid;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
47 Valladolid;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
47 Valladolid;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
47 Valladolid;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
47 Valladolid;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;75,03
47 Valladolid;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
47 Valladolid;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
47 Valladolid;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
47 Valladolid;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;79,3
47 Valladolid;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
47 Valladolid;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
47 Valladolid;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
47 Valladolid;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
47 Valladolid;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
47 Valladolid;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
47 Valladolid;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QIV;893
47 Valladolid;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
47 Valladolid;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
47 Valladolid;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
47 Valladolid;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QIV;908
47 Valladolid;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
47 Valladolid;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
47 Valladolid;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
47 Valladolid;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QIV;860
47 Valladolid;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
47 Valladolid;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
47 Valladolid;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
47 Valladolid;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2022QIV;826
47 Valladolid;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
47 Valladolid;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2022QII;""
47 Valladolid;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2022QI;""
47 Valladolid;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2021QIV;840
47 Valladolid;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
47 Valladolid;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2021QII;""
47 Valladolid;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2021QI;""
47 Valladolid;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2020QIV;796
47 Valladolid;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
47 Valladolid;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2020QII;""
47 Valladolid;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2020QI;""
47 Valladolid;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
47 Valladolid;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
47 Valladolid;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2022QII;""
47 Valladolid;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2022QI;783
47 Valladolid;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
47 Valladolid;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
47 Valladolid;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2021QII;""
47 Valladolid;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2021QI;754
47 Valladolid;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
47 Valladolid;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
47 Valladolid;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2020QII;""
47 Valladolid;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2020QI;""
47 Valladolid;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
47 Valladolid;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
47 Valladolid;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QII;729
47 Valladolid;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QI;""
47 Valladolid;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
47 Valladolid;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
47 Valladolid;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QII;714
47 Valladolid;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QI;""
47 Valladolid;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
47 Valladolid;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
47 Valladolid;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QII;""
47 Valladolid;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QI;""
47 Valladolid;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
47 Valladolid;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QIII;684
47 Valladolid;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QII;""
47 Valladolid;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QI;""
47 Valladolid;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
47 Valladolid;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QIII;682
47 Valladolid;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QII;""
47 Valladolid;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QI;""
47 Valladolid;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
47 Valladolid;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
47 Valladolid;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QII;""
47 Valladolid;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QI;""
47 Valladolid;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
47 Valladolid;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
47 Valladolid;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
47 Valladolid;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
47 Valladolid;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
47 Valladolid;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
47 Valladolid;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
47 Valladolid;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
47 Valladolid;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
47 Valladolid;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
47 Valladolid;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
47 Valladolid;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
47 Valladolid;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;92,5
47 Valladolid;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
47 Valladolid;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
47 Valladolid;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
47 Valladolid;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;92,51
47 Valladolid;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
47 Valladolid;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
47 Valladolid;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
47 Valladolid;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;92,56
47 Valladolid;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
47 Valladolid;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
47 Valladolid;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
47 Valladolid;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
47 Valladolid;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
47 Valladolid;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
47 Valladolid;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;86,23
47 Valladolid;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
47 Valladolid;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
47 Valladolid;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
47 Valladolid;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;87,67
47 Valladolid;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
47 Valladolid;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
47 Valladolid;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
47 Valladolid;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
47 Valladolid;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
47 Valladolid;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
47 Valladolid;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;80,29
47 Valladolid;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
47 Valladolid;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
47 Valladolid;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
47 Valladolid;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;83,02
47 Valladolid;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
47 Valladolid;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
47 Valladolid;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
47 Valladolid;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
47 Valladolid;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
47 Valladolid;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
47 Valladolid;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;75,33
47 Valladolid;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
47 Valladolid;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
47 Valladolid;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
47 Valladolid;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;79,3
47 Valladolid;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
47 Valladolid;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
47 Valladolid;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
47 Valladolid;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
47 Valladolid;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
47 Valladolid;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
47 Valladolid;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QIV;554
47 Valladolid;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
47 Valladolid;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
47 Valladolid;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
47 Valladolid;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QIV;562
47 Valladolid;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
47 Valladolid;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
47 Valladolid;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
47 Valladolid;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QIV;541
47 Valladolid;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
47 Valladolid;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
47 Valladolid;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
47 Valladolid;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2022QIV;512
47 Valladolid;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
47 Valladolid;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2022QII;""
47 Valladolid;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2022QI;""
47 Valladolid;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2021QIV;513
47 Valladolid;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
47 Valladolid;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2021QII;""
47 Valladolid;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2021QI;""
47 Valladolid;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2020QIV;509
47 Valladolid;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
47 Valladolid;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2020QII;""
47 Valladolid;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2020QI;""
47 Valladolid;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
47 Valladolid;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
47 Valladolid;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2022QII;""
47 Valladolid;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2022QI;476
47 Valladolid;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
47 Valladolid;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
47 Valladolid;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2021QII;""
47 Valladolid;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2021QI;484
47 Valladolid;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
47 Valladolid;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
47 Valladolid;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2020QII;""
47 Valladolid;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2020QI;""
47 Valladolid;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
47 Valladolid;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
47 Valladolid;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QII;448
47 Valladolid;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QI;""
47 Valladolid;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
47 Valladolid;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
47 Valladolid;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QII;448
47 Valladolid;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QI;""
47 Valladolid;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
47 Valladolid;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
47 Valladolid;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QII;""
47 Valladolid;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QI;""
47 Valladolid;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
47 Valladolid;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QIII;419
47 Valladolid;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QII;""
47 Valladolid;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QI;""
47 Valladolid;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
47 Valladolid;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QIII;429
47 Valladolid;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QII;""
47 Valladolid;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QI;""
47 Valladolid;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
47 Valladolid;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
47 Valladolid;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QII;""
47 Valladolid;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QI;""
47 Valladolid;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
47 Valladolid;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
47 Valladolid;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
47 Valladolid;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
47 Valladolid;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
47 Valladolid;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
47 Valladolid;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
47 Valladolid;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
47 Valladolid;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
47 Valladolid;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
47 Valladolid;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
47 Valladolid;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
47 Valladolid;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;92,42
47 Valladolid;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
47 Valladolid;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
47 Valladolid;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
47 Valladolid;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;91,28
47 Valladolid;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
47 Valladolid;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
47 Valladolid;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
47 Valladolid;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;94,09
47 Valladolid;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
47 Valladolid;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
47 Valladolid;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
47 Valladolid;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
47 Valladolid;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
47 Valladolid;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
47 Valladolid;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;84,7
47 Valladolid;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
47 Valladolid;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
47 Valladolid;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
47 Valladolid;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;89,46
47 Valladolid;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
47 Valladolid;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
47 Valladolid;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
47 Valladolid;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
47 Valladolid;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
47 Valladolid;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
47 Valladolid;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;79,72
47 Valladolid;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
47 Valladolid;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
47 Valladolid;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
47 Valladolid;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;82,81
47 Valladolid;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
47 Valladolid;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
47 Valladolid;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
47 Valladolid;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
47 Valladolid;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
47 Valladolid;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
47 Valladolid;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;74,56
47 Valladolid;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
47 Valladolid;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
47 Valladolid;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
47 Valladolid;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;79,3
47 Valladolid;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
47 Valladolid;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
47 Valladolid;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
47 Valladolid;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
47 Valladolid;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
47 Valladolid;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
47 Valladolid;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
47 Valladolid;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
47 Valladolid;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
47 Valladolid;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QI;4.768
47 Valladolid;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
47 Valladolid;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
47 Valladolid;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
47 Valladolid;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QI;4.845
47 Valladolid;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
47 Valladolid;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
47 Valladolid;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
47 Valladolid;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QI;4.778
47 Valladolid;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
47 Valladolid;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
47 Valladolid;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2022QII;""
47 Valladolid;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2022QI;4.607
47 Valladolid;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
47 Valladolid;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
47 Valladolid;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2021QII;""
47 Valladolid;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2021QI;4.718
47 Valladolid;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
47 Valladolid;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
47 Valladolid;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2020QII;""
47 Valladolid;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2020QI;4.457
47 Valladolid;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
47 Valladolid;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
47 Valladolid;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2022QII;4.457
47 Valladolid;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2022QI;""
47 Valladolid;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
47 Valladolid;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
47 Valladolid;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2021QII;4.587
47 Valladolid;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2021QI;""
47 Valladolid;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
47 Valladolid;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
47 Valladolid;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2020QII;4.363
47 Valladolid;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2020QI;""
47 Valladolid;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
47 Valladolid;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QIII;4.327
47 Valladolid;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QII;""
47 Valladolid;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QI;""
47 Valladolid;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
47 Valladolid;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QIII;4.471
47 Valladolid;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QII;""
47 Valladolid;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QI;""
47 Valladolid;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
47 Valladolid;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QIII;4.242
47 Valladolid;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QII;""
47 Valladolid;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QI;""
47 Valladolid;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QIV;4.199
47 Valladolid;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
47 Valladolid;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QII;""
47 Valladolid;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QI;""
47 Valladolid;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QIV;4.357
47 Valladolid;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
47 Valladolid;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QII;""
47 Valladolid;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QI;""
47 Valladolid;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QIV;4.126
47 Valladolid;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
47 Valladolid;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QII;""
47 Valladolid;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QI;""
47 Valladolid;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
47 Valladolid;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
47 Valladolid;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
47 Valladolid;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
47 Valladolid;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
47 Valladolid;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
47 Valladolid;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
47 Valladolid;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
47 Valladolid;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
47 Valladolid;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
47 Valladolid;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
47 Valladolid;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
47 Valladolid;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
47 Valladolid;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
47 Valladolid;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
47 Valladolid;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;96,62
47 Valladolid;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
47 Valladolid;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
47 Valladolid;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
47 Valladolid;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;97,38
47 Valladolid;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
47 Valladolid;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
47 Valladolid;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
47 Valladolid;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;93,28
47 Valladolid;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
47 Valladolid;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
47 Valladolid;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;93,48
47 Valladolid;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
47 Valladolid;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
47 Valladolid;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
47 Valladolid;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;94,67
47 Valladolid;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
47 Valladolid;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
47 Valladolid;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
47 Valladolid;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;91,31
47 Valladolid;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
47 Valladolid;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
47 Valladolid;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;90,75
47 Valladolid;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
47 Valladolid;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
47 Valladolid;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
47 Valladolid;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;92,28
47 Valladolid;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
47 Valladolid;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
47 Valladolid;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
47 Valladolid;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;88,78
47 Valladolid;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
47 Valladolid;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
47 Valladolid;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;88,07
47 Valladolid;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
47 Valladolid;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
47 Valladolid;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
47 Valladolid;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;89,93
47 Valladolid;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
47 Valladolid;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
47 Valladolid;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
47 Valladolid;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;86,35
47 Valladolid;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
47 Valladolid;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
47 Valladolid;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
47 Valladolid;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
47 Valladolid;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
47 Valladolid;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
47 Valladolid;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QI;2.797
47 Valladolid;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
47 Valladolid;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
47 Valladolid;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
47 Valladolid;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QI;2.868
47 Valladolid;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
47 Valladolid;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
47 Valladolid;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
47 Valladolid;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QI;2.808
47 Valladolid;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
47 Valladolid;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
47 Valladolid;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2022QII;""
47 Valladolid;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2022QI;2.716
47 Valladolid;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
47 Valladolid;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
47 Valladolid;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2021QII;""
47 Valladolid;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2021QI;2.794
47 Valladolid;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
47 Valladolid;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
47 Valladolid;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2020QII;""
47 Valladolid;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2020QI;2.633
47 Valladolid;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
47 Valladolid;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
47 Valladolid;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2022QII;2.637
47 Valladolid;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2022QI;""
47 Valladolid;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
47 Valladolid;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
47 Valladolid;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2021QII;2.732
47 Valladolid;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2021QI;""
47 Valladolid;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
47 Valladolid;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
47 Valladolid;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2020QII;2.593
47 Valladolid;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2020QI;""
47 Valladolid;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
47 Valladolid;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QIII;2.569
47 Valladolid;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QII;""
47 Valladolid;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QI;""
47 Valladolid;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
47 Valladolid;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QIII;2.670
47 Valladolid;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QII;""
47 Valladolid;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QI;""
47 Valladolid;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
47 Valladolid;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QIII;2.532
47 Valladolid;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QII;""
47 Valladolid;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QI;""
47 Valladolid;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QIV;2.506
47 Valladolid;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
47 Valladolid;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QII;""
47 Valladolid;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QI;""
47 Valladolid;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QIV;2.609
47 Valladolid;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
47 Valladolid;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QII;""
47 Valladolid;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QI;""
47 Valladolid;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QIV;2.469
47 Valladolid;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
47 Valladolid;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QII;""
47 Valladolid;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QI;""
47 Valladolid;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
47 Valladolid;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
47 Valladolid;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
47 Valladolid;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
47 Valladolid;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
47 Valladolid;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
47 Valladolid;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
47 Valladolid;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
47 Valladolid;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
47 Valladolid;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
47 Valladolid;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
47 Valladolid;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
47 Valladolid;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
47 Valladolid;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
47 Valladolid;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
47 Valladolid;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;97,1
47 Valladolid;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
47 Valladolid;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
47 Valladolid;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
47 Valladolid;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;97,42
47 Valladolid;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
47 Valladolid;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
47 Valladolid;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
47 Valladolid;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;93,77
47 Valladolid;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
47 Valladolid;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
47 Valladolid;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;94,28
47 Valladolid;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
47 Valladolid;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
47 Valladolid;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
47 Valladolid;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;95,26
47 Valladolid;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
47 Valladolid;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
47 Valladolid;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
47 Valladolid;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;92,34
47 Valladolid;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
47 Valladolid;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
47 Valladolid;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;91,85
47 Valladolid;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
47 Valladolid;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
47 Valladolid;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
47 Valladolid;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;93,1
47 Valladolid;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
47 Valladolid;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
47 Valladolid;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
47 Valladolid;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;90,17
47 Valladolid;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
47 Valladolid;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
47 Valladolid;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;89,6
47 Valladolid;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
47 Valladolid;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
47 Valladolid;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
47 Valladolid;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;90,97
47 Valladolid;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
47 Valladolid;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
47 Valladolid;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
47 Valladolid;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;87,93
47 Valladolid;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
47 Valladolid;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
47 Valladolid;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
47 Valladolid;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
47 Valladolid;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
47 Valladolid;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
47 Valladolid;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QI;1.971
47 Valladolid;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
47 Valladolid;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
47 Valladolid;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
47 Valladolid;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QI;1.977
47 Valladolid;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
47 Valladolid;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
47 Valladolid;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
47 Valladolid;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QI;1.970
47 Valladolid;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
47 Valladolid;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
47 Valladolid;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2022QII;""
47 Valladolid;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2022QI;1.891
47 Valladolid;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
47 Valladolid;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
47 Valladolid;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2021QII;""
47 Valladolid;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2021QI;1.924
47 Valladolid;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
47 Valladolid;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
47 Valladolid;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2020QII;""
47 Valladolid;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2020QI;1.824
47 Valladolid;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
47 Valladolid;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
47 Valladolid;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2022QII;1.820
47 Valladolid;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2022QI;""
47 Valladolid;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
47 Valladolid;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
47 Valladolid;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2021QII;1.855
47 Valladolid;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2021QI;""
47 Valladolid;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
47 Valladolid;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
47 Valladolid;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2020QII;1.770
47 Valladolid;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2020QI;""
47 Valladolid;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
47 Valladolid;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QIII;1.758
47 Valladolid;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QII;""
47 Valladolid;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QI;""
47 Valladolid;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
47 Valladolid;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QIII;1.801
47 Valladolid;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QII;""
47 Valladolid;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QI;""
47 Valladolid;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
47 Valladolid;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QIII;1.710
47 Valladolid;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QII;""
47 Valladolid;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QI;""
47 Valladolid;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QIV;1.693
47 Valladolid;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
47 Valladolid;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QII;""
47 Valladolid;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QI;""
47 Valladolid;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QIV;1.748
47 Valladolid;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
47 Valladolid;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QII;""
47 Valladolid;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QI;""
47 Valladolid;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QIV;1.657
47 Valladolid;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
47 Valladolid;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QII;""
47 Valladolid;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QI;""
47 Valladolid;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
47 Valladolid;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
47 Valladolid;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
47 Valladolid;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
47 Valladolid;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
47 Valladolid;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
47 Valladolid;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
47 Valladolid;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
47 Valladolid;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
47 Valladolid;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
47 Valladolid;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
47 Valladolid;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
47 Valladolid;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
47 Valladolid;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
47 Valladolid;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
47 Valladolid;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;95,94
47 Valladolid;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
47 Valladolid;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
47 Valladolid;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
47 Valladolid;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;97,32
47 Valladolid;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
47 Valladolid;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
47 Valladolid;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
47 Valladolid;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;92,59
47 Valladolid;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
47 Valladolid;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
47 Valladolid;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;92,34
47 Valladolid;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
47 Valladolid;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
47 Valladolid;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
47 Valladolid;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;93,83
47 Valladolid;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
47 Valladolid;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
47 Valladolid;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
47 Valladolid;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;89,85
47 Valladolid;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
47 Valladolid;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
47 Valladolid;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;89,19
47 Valladolid;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
47 Valladolid;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
47 Valladolid;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
47 Valladolid;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;91,1
47 Valladolid;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
47 Valladolid;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
47 Valladolid;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
47 Valladolid;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;86,8
47 Valladolid;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
47 Valladolid;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
47 Valladolid;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;85,9
47 Valladolid;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
47 Valladolid;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
47 Valladolid;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
47 Valladolid;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;88,42
47 Valladolid;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
47 Valladolid;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
47 Valladolid;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
47 Valladolid;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;84,11
47 Valladolid;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
47 Valladolid;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
47 Valladolid;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
47 Valladolid;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
47 Valladolid;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
47 Valladolid;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QII;4.389
47 Valladolid;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
47 Valladolid;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
47 Valladolid;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
47 Valladolid;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QII;4.578
47 Valladolid;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
47 Valladolid;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
47 Valladolid;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
47 Valladolid;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QII;4.696
47 Valladolid;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
47 Valladolid;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
47 Valladolid;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
47 Valladolid;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2022QII;4.219
47 Valladolid;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2022QI;""
47 Valladolid;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
47 Valladolid;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
47 Valladolid;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2021QII;4.438
47 Valladolid;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2021QI;""
47 Valladolid;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
47 Valladolid;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
47 Valladolid;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2020QII;4.592
47 Valladolid;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2020QI;""
47 Valladolid;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
47 Valladolid;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2022QIII;4.075
47 Valladolid;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2022QII;""
47 Valladolid;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2022QI;""
47 Valladolid;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
47 Valladolid;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2021QIII;4.303
47 Valladolid;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2021QII;""
47 Valladolid;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2021QI;""
47 Valladolid;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
47 Valladolid;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2020QIII;4.460
47 Valladolid;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2020QII;""
47 Valladolid;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2020QI;""
47 Valladolid;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QIV;3.944
47 Valladolid;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
47 Valladolid;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QII;""
47 Valladolid;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QI;""
47 Valladolid;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QIV;4.183
47 Valladolid;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
47 Valladolid;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QII;""
47 Valladolid;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QI;""
47 Valladolid;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QIV;4.330
47 Valladolid;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
47 Valladolid;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QII;""
47 Valladolid;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QI;""
47 Valladolid;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
47 Valladolid;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
47 Valladolid;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QII;""
47 Valladolid;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QI;4.062
47 Valladolid;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
47 Valladolid;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
47 Valladolid;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QII;""
47 Valladolid;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QI;4.251
47 Valladolid;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
47 Valladolid;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
47 Valladolid;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QII;""
47 Valladolid;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QI;""
47 Valladolid;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
47 Valladolid;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
47 Valladolid;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
47 Valladolid;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
47 Valladolid;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
47 Valladolid;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
47 Valladolid;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
47 Valladolid;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
47 Valladolid;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
47 Valladolid;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
47 Valladolid;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
47 Valladolid;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
47 Valladolid;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
47 Valladolid;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
47 Valladolid;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;96,13
47 Valladolid;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
47 Valladolid;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
47 Valladolid;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
47 Valladolid;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;96,94
47 Valladolid;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
47 Valladolid;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
47 Valladolid;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
47 Valladolid;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;97,79
47 Valladolid;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
47 Valladolid;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
47 Valladolid;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;92,85
47 Valladolid;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
47 Valladolid;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
47 Valladolid;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
47 Valladolid;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;93,99
47 Valladolid;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
47 Valladolid;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
47 Valladolid;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
47 Valladolid;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;94,97
47 Valladolid;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
47 Valladolid;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
47 Valladolid;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;89,86
47 Valladolid;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
47 Valladolid;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
47 Valladolid;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
47 Valladolid;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;91,37
47 Valladolid;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
47 Valladolid;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
47 Valladolid;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
47 Valladolid;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;92,21
47 Valladolid;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
47 Valladolid;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
47 Valladolid;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
47 Valladolid;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
47 Valladolid;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
47 Valladolid;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
47 Valladolid;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;88,73
47 Valladolid;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
47 Valladolid;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
47 Valladolid;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
47 Valladolid;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;90,52
47 Valladolid;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
47 Valladolid;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
47 Valladolid;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
47 Valladolid;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
47 Valladolid;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
47 Valladolid;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
47 Valladolid;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QII;2.585
47 Valladolid;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
47 Valladolid;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
47 Valladolid;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
47 Valladolid;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QII;2.695
47 Valladolid;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
47 Valladolid;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
47 Valladolid;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
47 Valladolid;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QII;2.764
47 Valladolid;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
47 Valladolid;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
47 Valladolid;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
47 Valladolid;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2022QII;2.494
47 Valladolid;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2022QI;""
47 Valladolid;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
47 Valladolid;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
47 Valladolid;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2021QII;2.626
47 Valladolid;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2021QI;""
47 Valladolid;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
47 Valladolid;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
47 Valladolid;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2020QII;2.717
47 Valladolid;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2020QI;""
47 Valladolid;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
47 Valladolid;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2022QIII;2.419
47 Valladolid;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2022QII;""
47 Valladolid;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2022QI;""
47 Valladolid;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
47 Valladolid;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2021QIII;2.550
47 Valladolid;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2021QII;""
47 Valladolid;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2021QI;""
47 Valladolid;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
47 Valladolid;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2020QIII;2.647
47 Valladolid;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2020QII;""
47 Valladolid;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2020QI;""
47 Valladolid;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QIV;2.352
47 Valladolid;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
47 Valladolid;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QII;""
47 Valladolid;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QI;""
47 Valladolid;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QIV;2.483
47 Valladolid;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
47 Valladolid;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QII;""
47 Valladolid;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QI;""
47 Valladolid;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QIV;2.575
47 Valladolid;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
47 Valladolid;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QII;""
47 Valladolid;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QI;""
47 Valladolid;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
47 Valladolid;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
47 Valladolid;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QII;""
47 Valladolid;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QI;2.424
47 Valladolid;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
47 Valladolid;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
47 Valladolid;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QII;""
47 Valladolid;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QI;2.529
47 Valladolid;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
47 Valladolid;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
47 Valladolid;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QII;""
47 Valladolid;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QI;""
47 Valladolid;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
47 Valladolid;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
47 Valladolid;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
47 Valladolid;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
47 Valladolid;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
47 Valladolid;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
47 Valladolid;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
47 Valladolid;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
47 Valladolid;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
47 Valladolid;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
47 Valladolid;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
47 Valladolid;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
47 Valladolid;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
47 Valladolid;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
47 Valladolid;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;96,48
47 Valladolid;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
47 Valladolid;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
47 Valladolid;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
47 Valladolid;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;97,44
47 Valladolid;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
47 Valladolid;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
47 Valladolid;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
47 Valladolid;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;98,3
47 Valladolid;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
47 Valladolid;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
47 Valladolid;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;93,58
47 Valladolid;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
47 Valladolid;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
47 Valladolid;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
47 Valladolid;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;94,62
47 Valladolid;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
47 Valladolid;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
47 Valladolid;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
47 Valladolid;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;95,77
47 Valladolid;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
47 Valladolid;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
47 Valladolid;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;90,99
47 Valladolid;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
47 Valladolid;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
47 Valladolid;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
47 Valladolid;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;92,13
47 Valladolid;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
47 Valladolid;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
47 Valladolid;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
47 Valladolid;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;93,16
47 Valladolid;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
47 Valladolid;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
47 Valladolid;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
47 Valladolid;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
47 Valladolid;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
47 Valladolid;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
47 Valladolid;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;89,94
47 Valladolid;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
47 Valladolid;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
47 Valladolid;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
47 Valladolid;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;91,5
47 Valladolid;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
47 Valladolid;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
47 Valladolid;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
47 Valladolid;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
47 Valladolid;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
47 Valladolid;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
47 Valladolid;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QII;1.804
47 Valladolid;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
47 Valladolid;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
47 Valladolid;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
47 Valladolid;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QII;1.883
47 Valladolid;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
47 Valladolid;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
47 Valladolid;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
47 Valladolid;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QII;1.932
47 Valladolid;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
47 Valladolid;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
47 Valladolid;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
47 Valladolid;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2022QII;1.725
47 Valladolid;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2022QI;""
47 Valladolid;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
47 Valladolid;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
47 Valladolid;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2021QII;1.812
47 Valladolid;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2021QI;""
47 Valladolid;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
47 Valladolid;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
47 Valladolid;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2020QII;1.875
47 Valladolid;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2020QI;""
47 Valladolid;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
47 Valladolid;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2022QIII;1.656
47 Valladolid;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2022QII;""
47 Valladolid;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2022QI;""
47 Valladolid;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
47 Valladolid;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2021QIII;1.753
47 Valladolid;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2021QII;""
47 Valladolid;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2021QI;""
47 Valladolid;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
47 Valladolid;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2020QIII;1.813
47 Valladolid;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2020QII;""
47 Valladolid;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2020QI;""
47 Valladolid;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QIV;1.592
47 Valladolid;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
47 Valladolid;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QII;""
47 Valladolid;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QI;""
47 Valladolid;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QIV;1.700
47 Valladolid;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
47 Valladolid;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QII;""
47 Valladolid;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QI;""
47 Valladolid;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QIV;1.755
47 Valladolid;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
47 Valladolid;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QII;""
47 Valladolid;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QI;""
47 Valladolid;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
47 Valladolid;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
47 Valladolid;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QII;""
47 Valladolid;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QI;1.638
47 Valladolid;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
47 Valladolid;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
47 Valladolid;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QII;""
47 Valladolid;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QI;1.722
47 Valladolid;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
47 Valladolid;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
47 Valladolid;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QII;""
47 Valladolid;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QI;""
47 Valladolid;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
47 Valladolid;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
47 Valladolid;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
47 Valladolid;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
47 Valladolid;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
47 Valladolid;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
47 Valladolid;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
47 Valladolid;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
47 Valladolid;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
47 Valladolid;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
47 Valladolid;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
47 Valladolid;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
47 Valladolid;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
47 Valladolid;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
47 Valladolid;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;95,62
47 Valladolid;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
47 Valladolid;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
47 Valladolid;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
47 Valladolid;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;96,23
47 Valladolid;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
47 Valladolid;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
47 Valladolid;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
47 Valladolid;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;97,05
47 Valladolid;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
47 Valladolid;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
47 Valladolid;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;91,8
47 Valladolid;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
47 Valladolid;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
47 Valladolid;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
47 Valladolid;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;93,1
47 Valladolid;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
47 Valladolid;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
47 Valladolid;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
47 Valladolid;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;93,84
47 Valladolid;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
47 Valladolid;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
47 Valladolid;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;88,25
47 Valladolid;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
47 Valladolid;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
47 Valladolid;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
47 Valladolid;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;90,28
47 Valladolid;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
47 Valladolid;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
47 Valladolid;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
47 Valladolid;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;90,84
47 Valladolid;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
47 Valladolid;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
47 Valladolid;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
47 Valladolid;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
47 Valladolid;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
47 Valladolid;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
47 Valladolid;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;86,99
47 Valladolid;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
47 Valladolid;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
47 Valladolid;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
47 Valladolid;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;89,13
47 Valladolid;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
47 Valladolid;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
47 Valladolid;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
47 Valladolid;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
47 Valladolid;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
47 Valladolid;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QIII;4.446
47 Valladolid;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
47 Valladolid;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
47 Valladolid;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
47 Valladolid;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QIII;4.702
47 Valladolid;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
47 Valladolid;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
47 Valladolid;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
47 Valladolid;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QIII;4.756
47 Valladolid;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
47 Valladolid;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
47 Valladolid;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
47 Valladolid;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2022QIII;4.268
47 Valladolid;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2022QII;""
47 Valladolid;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2022QI;""
47 Valladolid;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
47 Valladolid;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2021QIII;4.534
47 Valladolid;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2021QII;""
47 Valladolid;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2021QI;""
47 Valladolid;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
47 Valladolid;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2020QIII;4.602
47 Valladolid;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2020QII;""
47 Valladolid;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2020QI;""
47 Valladolid;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2022QIV;4.121
47 Valladolid;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
47 Valladolid;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2022QII;""
47 Valladolid;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2022QI;""
47 Valladolid;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2021QIV;4.389
47 Valladolid;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
47 Valladolid;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2021QII;""
47 Valladolid;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2021QI;""
47 Valladolid;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2020QIV;4.464
47 Valladolid;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
47 Valladolid;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2020QII;""
47 Valladolid;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2020QI;""
47 Valladolid;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
47 Valladolid;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
47 Valladolid;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QII;""
47 Valladolid;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QI;4.258
47 Valladolid;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
47 Valladolid;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
47 Valladolid;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QII;""
47 Valladolid;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QI;4.373
47 Valladolid;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
47 Valladolid;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
47 Valladolid;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QII;""
47 Valladolid;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QI;""
47 Valladolid;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
47 Valladolid;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
47 Valladolid;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QII;4.136
47 Valladolid;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QI;""
47 Valladolid;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
47 Valladolid;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
47 Valladolid;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QII;4.267
47 Valladolid;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QI;""
47 Valladolid;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
47 Valladolid;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
47 Valladolid;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QII;""
47 Valladolid;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QI;""
47 Valladolid;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
47 Valladolid;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
47 Valladolid;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
47 Valladolid;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
47 Valladolid;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
47 Valladolid;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
47 Valladolid;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
47 Valladolid;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
47 Valladolid;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
47 Valladolid;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
47 Valladolid;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
47 Valladolid;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
47 Valladolid;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
47 Valladolid;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;96
47 Valladolid;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
47 Valladolid;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
47 Valladolid;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
47 Valladolid;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;96,43
47 Valladolid;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
47 Valladolid;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
47 Valladolid;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
47 Valladolid;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;96,76
47 Valladolid;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
47 Valladolid;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
47 Valladolid;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;92,69
47 Valladolid;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
47 Valladolid;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
47 Valladolid;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
47 Valladolid;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;93,34
47 Valladolid;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
47 Valladolid;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
47 Valladolid;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
47 Valladolid;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;93,86
47 Valladolid;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
47 Valladolid;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
47 Valladolid;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
47 Valladolid;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
47 Valladolid;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
47 Valladolid;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
47 Valladolid;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;90,56
47 Valladolid;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
47 Valladolid;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
47 Valladolid;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
47 Valladolid;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;91,95
47 Valladolid;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
47 Valladolid;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
47 Valladolid;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
47 Valladolid;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
47 Valladolid;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
47 Valladolid;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
47 Valladolid;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;87,96
47 Valladolid;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
47 Valladolid;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
47 Valladolid;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
47 Valladolid;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;89,72
47 Valladolid;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
47 Valladolid;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
47 Valladolid;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
47 Valladolid;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
47 Valladolid;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
47 Valladolid;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
47 Valladolid;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QIII;2.617
47 Valladolid;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
47 Valladolid;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
47 Valladolid;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
47 Valladolid;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QIII;2.788
47 Valladolid;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
47 Valladolid;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
47 Valladolid;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
47 Valladolid;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QIII;2.822
47 Valladolid;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
47 Valladolid;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
47 Valladolid;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
47 Valladolid;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2022QIII;2.518
47 Valladolid;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2022QII;""
47 Valladolid;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2022QI;""
47 Valladolid;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
47 Valladolid;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2021QIII;2.689
47 Valladolid;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2021QII;""
47 Valladolid;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2021QI;""
47 Valladolid;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
47 Valladolid;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2020QIII;2.736
47 Valladolid;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2020QII;""
47 Valladolid;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2020QI;""
47 Valladolid;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2022QIV;2.441
47 Valladolid;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
47 Valladolid;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2022QII;""
47 Valladolid;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2022QI;""
47 Valladolid;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2021QIV;2.603
47 Valladolid;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
47 Valladolid;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2021QII;""
47 Valladolid;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2021QI;""
47 Valladolid;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2020QIV;2.658
47 Valladolid;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
47 Valladolid;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2020QII;""
47 Valladolid;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2020QI;""
47 Valladolid;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
47 Valladolid;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
47 Valladolid;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QII;""
47 Valladolid;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QI;2.540
47 Valladolid;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
47 Valladolid;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
47 Valladolid;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QII;""
47 Valladolid;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QI;2.605
47 Valladolid;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
47 Valladolid;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
47 Valladolid;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QII;""
47 Valladolid;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QI;""
47 Valladolid;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
47 Valladolid;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
47 Valladolid;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QII;2.475
47 Valladolid;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QI;""
47 Valladolid;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
47 Valladolid;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
47 Valladolid;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QII;2.552
47 Valladolid;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QI;""
47 Valladolid;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
47 Valladolid;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
47 Valladolid;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QII;""
47 Valladolid;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QI;""
47 Valladolid;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
47 Valladolid;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
47 Valladolid;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
47 Valladolid;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
47 Valladolid;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
47 Valladolid;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
47 Valladolid;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
47 Valladolid;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
47 Valladolid;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
47 Valladolid;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
47 Valladolid;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
47 Valladolid;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
47 Valladolid;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
47 Valladolid;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;96,22
47 Valladolid;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
47 Valladolid;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
47 Valladolid;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
47 Valladolid;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;96,45
47 Valladolid;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
47 Valladolid;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
47 Valladolid;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
47 Valladolid;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;96,95
47 Valladolid;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
47 Valladolid;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
47 Valladolid;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;93,27
47 Valladolid;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
47 Valladolid;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
47 Valladolid;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
47 Valladolid;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;93,36
47 Valladolid;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
47 Valladolid;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
47 Valladolid;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
47 Valladolid;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;94,19
47 Valladolid;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
47 Valladolid;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
47 Valladolid;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
47 Valladolid;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
47 Valladolid;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
47 Valladolid;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
47 Valladolid;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;91,1
47 Valladolid;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
47 Valladolid;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
47 Valladolid;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
47 Valladolid;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;92,31
47 Valladolid;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
47 Valladolid;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
47 Valladolid;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
47 Valladolid;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
47 Valladolid;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
47 Valladolid;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
47 Valladolid;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;88,77
47 Valladolid;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
47 Valladolid;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
47 Valladolid;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
47 Valladolid;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;90,43
47 Valladolid;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
47 Valladolid;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
47 Valladolid;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
47 Valladolid;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
47 Valladolid;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
47 Valladolid;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
47 Valladolid;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QIII;1.829
47 Valladolid;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
47 Valladolid;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
47 Valladolid;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
47 Valladolid;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QIII;1.914
47 Valladolid;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
47 Valladolid;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
47 Valladolid;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
47 Valladolid;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QIII;1.934
47 Valladolid;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
47 Valladolid;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
47 Valladolid;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
47 Valladolid;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2022QIII;1.750
47 Valladolid;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2022QII;""
47 Valladolid;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2022QI;""
47 Valladolid;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
47 Valladolid;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2021QIII;1.845
47 Valladolid;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2021QII;""
47 Valladolid;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2021QI;""
47 Valladolid;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
47 Valladolid;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2020QIII;1.866
47 Valladolid;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2020QII;""
47 Valladolid;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2020QI;""
47 Valladolid;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2022QIV;1.680
47 Valladolid;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
47 Valladolid;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2022QII;""
47 Valladolid;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2022QI;""
47 Valladolid;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2021QIV;1.786
47 Valladolid;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
47 Valladolid;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2021QII;""
47 Valladolid;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2021QI;""
47 Valladolid;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2020QIV;1.806
47 Valladolid;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
47 Valladolid;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2020QII;""
47 Valladolid;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2020QI;""
47 Valladolid;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
47 Valladolid;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
47 Valladolid;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QII;""
47 Valladolid;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QI;1.718
47 Valladolid;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
47 Valladolid;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
47 Valladolid;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QII;""
47 Valladolid;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QI;1.768
47 Valladolid;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
47 Valladolid;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
47 Valladolid;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QII;""
47 Valladolid;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QI;""
47 Valladolid;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
47 Valladolid;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
47 Valladolid;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QII;1.661
47 Valladolid;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QI;""
47 Valladolid;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
47 Valladolid;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
47 Valladolid;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QII;1.715
47 Valladolid;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QI;""
47 Valladolid;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
47 Valladolid;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
47 Valladolid;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QII;""
47 Valladolid;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QI;""
47 Valladolid;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
47 Valladolid;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
47 Valladolid;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
47 Valladolid;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
47 Valladolid;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
47 Valladolid;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
47 Valladolid;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
47 Valladolid;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
47 Valladolid;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
47 Valladolid;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
47 Valladolid;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
47 Valladolid;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
47 Valladolid;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
47 Valladolid;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;95,68
47 Valladolid;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
47 Valladolid;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
47 Valladolid;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
47 Valladolid;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;96,39
47 Valladolid;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
47 Valladolid;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
47 Valladolid;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
47 Valladolid;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;96,48
47 Valladolid;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
47 Valladolid;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
47 Valladolid;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;91,85
47 Valladolid;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
47 Valladolid;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
47 Valladolid;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
47 Valladolid;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;93,31
47 Valladolid;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
47 Valladolid;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
47 Valladolid;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
47 Valladolid;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;93,38
47 Valladolid;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
47 Valladolid;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
47 Valladolid;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
47 Valladolid;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
47 Valladolid;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
47 Valladolid;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
47 Valladolid;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;89,76
47 Valladolid;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
47 Valladolid;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
47 Valladolid;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
47 Valladolid;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;91,42
47 Valladolid;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
47 Valladolid;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
47 Valladolid;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
47 Valladolid;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
47 Valladolid;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
47 Valladolid;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
47 Valladolid;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;86,78
47 Valladolid;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
47 Valladolid;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
47 Valladolid;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
47 Valladolid;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;88,68
47 Valladolid;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
47 Valladolid;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
47 Valladolid;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
47 Valladolid;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
47 Valladolid;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
47 Valladolid;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QIV;4.460
47 Valladolid;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
47 Valladolid;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
47 Valladolid;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
47 Valladolid;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QIV;4.716
47 Valladolid;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
47 Valladolid;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
47 Valladolid;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
47 Valladolid;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QIV;4.801
47 Valladolid;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
47 Valladolid;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
47 Valladolid;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
47 Valladolid;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2022QIV;4.298
47 Valladolid;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
47 Valladolid;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2022QII;""
47 Valladolid;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2022QI;""
47 Valladolid;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2021QIV;4.550
47 Valladolid;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
47 Valladolid;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2021QII;""
47 Valladolid;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2021QI;""
47 Valladolid;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2020QIV;4.643
47 Valladolid;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
47 Valladolid;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2020QII;""
47 Valladolid;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2020QI;""
47 Valladolid;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
47 Valladolid;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
47 Valladolid;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2022QII;""
47 Valladolid;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2022QI;4.410
47 Valladolid;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
47 Valladolid;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
47 Valladolid;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2021QII;""
47 Valladolid;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2021QI;4.543
47 Valladolid;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
47 Valladolid;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
47 Valladolid;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2020QII;""
47 Valladolid;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2020QI;""
47 Valladolid;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
47 Valladolid;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
47 Valladolid;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QII;4.279
47 Valladolid;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QI;""
47 Valladolid;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
47 Valladolid;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
47 Valladolid;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QII;4.425
47 Valladolid;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QI;""
47 Valladolid;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
47 Valladolid;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
47 Valladolid;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QII;""
47 Valladolid;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QI;""
47 Valladolid;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
47 Valladolid;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QIII;4.160
47 Valladolid;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QII;""
47 Valladolid;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QI;""
47 Valladolid;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
47 Valladolid;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QIII;4.316
47 Valladolid;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QII;""
47 Valladolid;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QI;""
47 Valladolid;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
47 Valladolid;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
47 Valladolid;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QII;""
47 Valladolid;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QI;""
47 Valladolid;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
47 Valladolid;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
47 Valladolid;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
47 Valladolid;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
47 Valladolid;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
47 Valladolid;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
47 Valladolid;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
47 Valladolid;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
47 Valladolid;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
47 Valladolid;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
47 Valladolid;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
47 Valladolid;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
47 Valladolid;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;96,37
47 Valladolid;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
47 Valladolid;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
47 Valladolid;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
47 Valladolid;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;96,48
47 Valladolid;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
47 Valladolid;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
47 Valladolid;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
47 Valladolid;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;96,71
47 Valladolid;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
47 Valladolid;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
47 Valladolid;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
47 Valladolid;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
47 Valladolid;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
47 Valladolid;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
47 Valladolid;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;93,51
47 Valladolid;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
47 Valladolid;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
47 Valladolid;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
47 Valladolid;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;94,63
47 Valladolid;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
47 Valladolid;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
47 Valladolid;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
47 Valladolid;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
47 Valladolid;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
47 Valladolid;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
47 Valladolid;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;90,73
47 Valladolid;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
47 Valladolid;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
47 Valladolid;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
47 Valladolid;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;92,17
47 Valladolid;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
47 Valladolid;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
47 Valladolid;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
47 Valladolid;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
47 Valladolid;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
47 Valladolid;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
47 Valladolid;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;88,21
47 Valladolid;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
47 Valladolid;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
47 Valladolid;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
47 Valladolid;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;89,9
47 Valladolid;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
47 Valladolid;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
47 Valladolid;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
47 Valladolid;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
47 Valladolid;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
47 Valladolid;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
47 Valladolid;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QIV;2.617
47 Valladolid;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
47 Valladolid;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
47 Valladolid;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
47 Valladolid;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QIV;2.784
47 Valladolid;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
47 Valladolid;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
47 Valladolid;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
47 Valladolid;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QIV;2.844
47 Valladolid;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
47 Valladolid;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
47 Valladolid;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
47 Valladolid;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2022QIV;2.532
47 Valladolid;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
47 Valladolid;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2022QII;""
47 Valladolid;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2022QI;""
47 Valladolid;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2021QIV;2.685
47 Valladolid;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
47 Valladolid;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2021QII;""
47 Valladolid;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2021QI;""
47 Valladolid;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2020QIV;2.755
47 Valladolid;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
47 Valladolid;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2020QII;""
47 Valladolid;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2020QI;""
47 Valladolid;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
47 Valladolid;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
47 Valladolid;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2022QII;""
47 Valladolid;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2022QI;2.617
47 Valladolid;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
47 Valladolid;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
47 Valladolid;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2021QII;""
47 Valladolid;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2021QI;2.698
47 Valladolid;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
47 Valladolid;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
47 Valladolid;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2020QII;""
47 Valladolid;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2020QI;""
47 Valladolid;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
47 Valladolid;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
47 Valladolid;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QII;2.545
47 Valladolid;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QI;""
47 Valladolid;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
47 Valladolid;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
47 Valladolid;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QII;2.641
47 Valladolid;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QI;""
47 Valladolid;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
47 Valladolid;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
47 Valladolid;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QII;""
47 Valladolid;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QI;""
47 Valladolid;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
47 Valladolid;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QIII;2.483
47 Valladolid;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QII;""
47 Valladolid;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QI;""
47 Valladolid;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
47 Valladolid;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QIII;2.582
47 Valladolid;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QII;""
47 Valladolid;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QI;""
47 Valladolid;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
47 Valladolid;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
47 Valladolid;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QII;""
47 Valladolid;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QI;""
47 Valladolid;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
47 Valladolid;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
47 Valladolid;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
47 Valladolid;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
47 Valladolid;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
47 Valladolid;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
47 Valladolid;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
47 Valladolid;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
47 Valladolid;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
47 Valladolid;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
47 Valladolid;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
47 Valladolid;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
47 Valladolid;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;96,75
47 Valladolid;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
47 Valladolid;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
47 Valladolid;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
47 Valladolid;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;96,44
47 Valladolid;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
47 Valladolid;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
47 Valladolid;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
47 Valladolid;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;96,87
47 Valladolid;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
47 Valladolid;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
47 Valladolid;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
47 Valladolid;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
47 Valladolid;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
47 Valladolid;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
47 Valladolid;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;94
47 Valladolid;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
47 Valladolid;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
47 Valladolid;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
47 Valladolid;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;94,87
47 Valladolid;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
47 Valladolid;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
47 Valladolid;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
47 Valladolid;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
47 Valladolid;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
47 Valladolid;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
47 Valladolid;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;91,42
47 Valladolid;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
47 Valladolid;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
47 Valladolid;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
47 Valladolid;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;92,86
47 Valladolid;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
47 Valladolid;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
47 Valladolid;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
47 Valladolid;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
47 Valladolid;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
47 Valladolid;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
47 Valladolid;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;89,19
47 Valladolid;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
47 Valladolid;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
47 Valladolid;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
47 Valladolid;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;90,79
47 Valladolid;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
47 Valladolid;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
47 Valladolid;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
47 Valladolid;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
47 Valladolid;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
47 Valladolid;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
47 Valladolid;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QIV;1.843
47 Valladolid;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
47 Valladolid;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
47 Valladolid;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
47 Valladolid;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QIV;1.932
47 Valladolid;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
47 Valladolid;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
47 Valladolid;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
47 Valladolid;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QIV;1.957
47 Valladolid;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
47 Valladolid;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
47 Valladolid;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
47 Valladolid;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2022QIV;1.766
47 Valladolid;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
47 Valladolid;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2022QII;""
47 Valladolid;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2022QI;""
47 Valladolid;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2021QIV;1.865
47 Valladolid;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
47 Valladolid;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2021QII;""
47 Valladolid;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2021QI;""
47 Valladolid;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2020QIV;1.888
47 Valladolid;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
47 Valladolid;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2020QII;""
47 Valladolid;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2020QI;""
47 Valladolid;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
47 Valladolid;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
47 Valladolid;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2022QII;""
47 Valladolid;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2022QI;1.793
47 Valladolid;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
47 Valladolid;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
47 Valladolid;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2021QII;""
47 Valladolid;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2021QI;1.845
47 Valladolid;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
47 Valladolid;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
47 Valladolid;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2020QII;""
47 Valladolid;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2020QI;""
47 Valladolid;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
47 Valladolid;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
47 Valladolid;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QII;1.734
47 Valladolid;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QI;""
47 Valladolid;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
47 Valladolid;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
47 Valladolid;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QII;1.784
47 Valladolid;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QI;""
47 Valladolid;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
47 Valladolid;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
47 Valladolid;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QII;""
47 Valladolid;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QI;""
47 Valladolid;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
47 Valladolid;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QIII;1.677
47 Valladolid;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QII;""
47 Valladolid;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QI;""
47 Valladolid;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
47 Valladolid;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QIII;1.734
47 Valladolid;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QII;""
47 Valladolid;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QI;""
47 Valladolid;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
47 Valladolid;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
47 Valladolid;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QII;""
47 Valladolid;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QI;""
47 Valladolid;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
47 Valladolid;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
47 Valladolid;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
47 Valladolid;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
47 Valladolid;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
47 Valladolid;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
47 Valladolid;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
47 Valladolid;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
47 Valladolid;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
47 Valladolid;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
47 Valladolid;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
47 Valladolid;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
47 Valladolid;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;95,82
47 Valladolid;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
47 Valladolid;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
47 Valladolid;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
47 Valladolid;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;96,53
47 Valladolid;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
47 Valladolid;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
47 Valladolid;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
47 Valladolid;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;96,47
47 Valladolid;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
47 Valladolid;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
47 Valladolid;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
47 Valladolid;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
47 Valladolid;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
47 Valladolid;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
47 Valladolid;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;92,81
47 Valladolid;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
47 Valladolid;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
47 Valladolid;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
47 Valladolid;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;94,28
47 Valladolid;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
47 Valladolid;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
47 Valladolid;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
47 Valladolid;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
47 Valladolid;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
47 Valladolid;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
47 Valladolid;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;89,75
47 Valladolid;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
47 Valladolid;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
47 Valladolid;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
47 Valladolid;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;91,16
47 Valladolid;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
47 Valladolid;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
47 Valladolid;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
47 Valladolid;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
47 Valladolid;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
47 Valladolid;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
47 Valladolid;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;86,8
47 Valladolid;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
47 Valladolid;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
47 Valladolid;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
47 Valladolid;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;88,61
47 Valladolid;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
47 Valladolid;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
47 Valladolid;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
47 Valladolid;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
47 Valladolid;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
47 Valladolid;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
47 Valladolid;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
47 Valladolid;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
47 Valladolid;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
47 Valladolid;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QI;9.107
47 Valladolid;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
47 Valladolid;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
47 Valladolid;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
47 Valladolid;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QI;9.252
47 Valladolid;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
47 Valladolid;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
47 Valladolid;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
47 Valladolid;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QI;9.352
47 Valladolid;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
47 Valladolid;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
47 Valladolid;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2022QII;""
47 Valladolid;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2022QI;8.899
47 Valladolid;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
47 Valladolid;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
47 Valladolid;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2021QII;""
47 Valladolid;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2021QI;9.102
47 Valladolid;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
47 Valladolid;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
47 Valladolid;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2020QII;""
47 Valladolid;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2020QI;8.902
47 Valladolid;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
47 Valladolid;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
47 Valladolid;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2022QII;8.697
47 Valladolid;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2022QI;""
47 Valladolid;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
47 Valladolid;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
47 Valladolid;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2021QII;8.944
47 Valladolid;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2021QI;""
47 Valladolid;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
47 Valladolid;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
47 Valladolid;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2020QII;8.757
47 Valladolid;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2020QI;""
47 Valladolid;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
47 Valladolid;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QIII;8.520
47 Valladolid;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QII;""
47 Valladolid;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QI;""
47 Valladolid;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
47 Valladolid;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QIII;8.803
47 Valladolid;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QII;""
47 Valladolid;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QI;""
47 Valladolid;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
47 Valladolid;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QIII;8.597
47 Valladolid;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QII;""
47 Valladolid;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QI;""
47 Valladolid;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QIV;8.346
47 Valladolid;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
47 Valladolid;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QII;""
47 Valladolid;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QI;""
47 Valladolid;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QIV;8.658
47 Valladolid;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
47 Valladolid;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QII;""
47 Valladolid;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QI;""
47 Valladolid;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QIV;8.435
47 Valladolid;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
47 Valladolid;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QII;""
47 Valladolid;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QI;""
47 Valladolid;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
47 Valladolid;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
47 Valladolid;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
47 Valladolid;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
47 Valladolid;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
47 Valladolid;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
47 Valladolid;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
47 Valladolid;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
47 Valladolid;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
47 Valladolid;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
47 Valladolid;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
47 Valladolid;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
47 Valladolid;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
47 Valladolid;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
47 Valladolid;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
47 Valladolid;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;97,72
47 Valladolid;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
47 Valladolid;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
47 Valladolid;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
47 Valladolid;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;98,38
47 Valladolid;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
47 Valladolid;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
47 Valladolid;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
47 Valladolid;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;95,19
47 Valladolid;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
47 Valladolid;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
47 Valladolid;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;95,5
47 Valladolid;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
47 Valladolid;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
47 Valladolid;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
47 Valladolid;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;96,67
47 Valladolid;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
47 Valladolid;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
47 Valladolid;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
47 Valladolid;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;93,64
47 Valladolid;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
47 Valladolid;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
47 Valladolid;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;93,55
47 Valladolid;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
47 Valladolid;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
47 Valladolid;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
47 Valladolid;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;95,15
47 Valladolid;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
47 Valladolid;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
47 Valladolid;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
47 Valladolid;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;91,93
47 Valladolid;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
47 Valladolid;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
47 Valladolid;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;91,64
47 Valladolid;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
47 Valladolid;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
47 Valladolid;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
47 Valladolid;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;93,58
47 Valladolid;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
47 Valladolid;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
47 Valladolid;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
47 Valladolid;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;90,19
47 Valladolid;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
47 Valladolid;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
47 Valladolid;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
47 Valladolid;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
47 Valladolid;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
47 Valladolid;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
47 Valladolid;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QI;5.813
47 Valladolid;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
47 Valladolid;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
47 Valladolid;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
47 Valladolid;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QI;5.947
47 Valladolid;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
47 Valladolid;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
47 Valladolid;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
47 Valladolid;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QI;6.002
47 Valladolid;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
47 Valladolid;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
47 Valladolid;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2022QII;""
47 Valladolid;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2022QI;5.702
47 Valladolid;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
47 Valladolid;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
47 Valladolid;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2021QII;""
47 Valladolid;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2021QI;5.852
47 Valladolid;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
47 Valladolid;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
47 Valladolid;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2020QII;""
47 Valladolid;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2020QI;5.726
47 Valladolid;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
47 Valladolid;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
47 Valladolid;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2022QII;5.595
47 Valladolid;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2022QI;""
47 Valladolid;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
47 Valladolid;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
47 Valladolid;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2021QII;5.776
47 Valladolid;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2021QI;""
47 Valladolid;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
47 Valladolid;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
47 Valladolid;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2020QII;5.641
47 Valladolid;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2020QI;""
47 Valladolid;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
47 Valladolid;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QIII;5.500
47 Valladolid;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QII;""
47 Valladolid;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QI;""
47 Valladolid;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
47 Valladolid;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QIII;5.693
47 Valladolid;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QII;""
47 Valladolid;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QI;""
47 Valladolid;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
47 Valladolid;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QIII;5.552
47 Valladolid;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QII;""
47 Valladolid;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QI;""
47 Valladolid;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QIV;5.381
47 Valladolid;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
47 Valladolid;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QII;""
47 Valladolid;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QI;""
47 Valladolid;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QIV;5.612
47 Valladolid;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
47 Valladolid;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QII;""
47 Valladolid;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QI;""
47 Valladolid;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QIV;5.457
47 Valladolid;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
47 Valladolid;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QII;""
47 Valladolid;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QI;""
47 Valladolid;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
47 Valladolid;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
47 Valladolid;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
47 Valladolid;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
47 Valladolid;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
47 Valladolid;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
47 Valladolid;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
47 Valladolid;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
47 Valladolid;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
47 Valladolid;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
47 Valladolid;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
47 Valladolid;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
47 Valladolid;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
47 Valladolid;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
47 Valladolid;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
47 Valladolid;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;98,09
47 Valladolid;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
47 Valladolid;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
47 Valladolid;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
47 Valladolid;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;98,4
47 Valladolid;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
47 Valladolid;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
47 Valladolid;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
47 Valladolid;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;95,4
47 Valladolid;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
47 Valladolid;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
47 Valladolid;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;96,25
47 Valladolid;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
47 Valladolid;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
47 Valladolid;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
47 Valladolid;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;97,12
47 Valladolid;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
47 Valladolid;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
47 Valladolid;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
47 Valladolid;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;93,99
47 Valladolid;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
47 Valladolid;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
47 Valladolid;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;94,62
47 Valladolid;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
47 Valladolid;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
47 Valladolid;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
47 Valladolid;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;95,73
47 Valladolid;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
47 Valladolid;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
47 Valladolid;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
47 Valladolid;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;92,5
47 Valladolid;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
47 Valladolid;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
47 Valladolid;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;92,57
47 Valladolid;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
47 Valladolid;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
47 Valladolid;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
47 Valladolid;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;94,37
47 Valladolid;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
47 Valladolid;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
47 Valladolid;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
47 Valladolid;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;90,92
47 Valladolid;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
47 Valladolid;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
47 Valladolid;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
47 Valladolid;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
47 Valladolid;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
47 Valladolid;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
47 Valladolid;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QI;3.294
47 Valladolid;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
47 Valladolid;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
47 Valladolid;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
47 Valladolid;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QI;3.305
47 Valladolid;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
47 Valladolid;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
47 Valladolid;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
47 Valladolid;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QI;3.350
47 Valladolid;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
47 Valladolid;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
47 Valladolid;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2022QII;""
47 Valladolid;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2022QI;3.197
47 Valladolid;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
47 Valladolid;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
47 Valladolid;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2021QII;""
47 Valladolid;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2021QI;3.250
47 Valladolid;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
47 Valladolid;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
47 Valladolid;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2020QII;""
47 Valladolid;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2020QI;3.176
47 Valladolid;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
47 Valladolid;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
47 Valladolid;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2022QII;3.102
47 Valladolid;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2022QI;""
47 Valladolid;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
47 Valladolid;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
47 Valladolid;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2021QII;3.168
47 Valladolid;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2021QI;""
47 Valladolid;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
47 Valladolid;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
47 Valladolid;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2020QII;3.116
47 Valladolid;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2020QI;""
47 Valladolid;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
47 Valladolid;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QIII;3.020
47 Valladolid;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QII;""
47 Valladolid;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QI;""
47 Valladolid;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
47 Valladolid;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QIII;3.110
47 Valladolid;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QII;""
47 Valladolid;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QI;""
47 Valladolid;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
47 Valladolid;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QIII;3.045
47 Valladolid;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QII;""
47 Valladolid;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QI;""
47 Valladolid;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QIV;2.965
47 Valladolid;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
47 Valladolid;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QII;""
47 Valladolid;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QI;""
47 Valladolid;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QIV;3.046
47 Valladolid;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
47 Valladolid;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QII;""
47 Valladolid;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QI;""
47 Valladolid;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QIV;2.978
47 Valladolid;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
47 Valladolid;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QII;""
47 Valladolid;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QI;""
47 Valladolid;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
47 Valladolid;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
47 Valladolid;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
47 Valladolid;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
47 Valladolid;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
47 Valladolid;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
47 Valladolid;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
47 Valladolid;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
47 Valladolid;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
47 Valladolid;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
47 Valladolid;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
47 Valladolid;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
47 Valladolid;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
47 Valladolid;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
47 Valladolid;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
47 Valladolid;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;97,06
47 Valladolid;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
47 Valladolid;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
47 Valladolid;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
47 Valladolid;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;98,34
47 Valladolid;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
47 Valladolid;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
47 Valladolid;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
47 Valladolid;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;94,81
47 Valladolid;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
47 Valladolid;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
47 Valladolid;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;94,17
47 Valladolid;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
47 Valladolid;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
47 Valladolid;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
47 Valladolid;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;95,85
47 Valladolid;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
47 Valladolid;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
47 Valladolid;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
47 Valladolid;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;93,01
47 Valladolid;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
47 Valladolid;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
47 Valladolid;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;91,68
47 Valladolid;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
47 Valladolid;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
47 Valladolid;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
47 Valladolid;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;94,1
47 Valladolid;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
47 Valladolid;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
47 Valladolid;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
47 Valladolid;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;90,9
47 Valladolid;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
47 Valladolid;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
47 Valladolid;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;90,01
47 Valladolid;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
47 Valladolid;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
47 Valladolid;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
47 Valladolid;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;92,16
47 Valladolid;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
47 Valladolid;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
47 Valladolid;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
47 Valladolid;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;88,9
47 Valladolid;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
47 Valladolid;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
47 Valladolid;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
47 Valladolid;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
47 Valladolid;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
47 Valladolid;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QII;8.831
47 Valladolid;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
47 Valladolid;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
47 Valladolid;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
47 Valladolid;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QII;8.966
47 Valladolid;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
47 Valladolid;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
47 Valladolid;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
47 Valladolid;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QII;9.203
47 Valladolid;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
47 Valladolid;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
47 Valladolid;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
47 Valladolid;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2022QII;8.595
47 Valladolid;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2022QI;""
47 Valladolid;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
47 Valladolid;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
47 Valladolid;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2021QII;8.788
47 Valladolid;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2021QI;""
47 Valladolid;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
47 Valladolid;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
47 Valladolid;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2020QII;9.037
47 Valladolid;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2020QI;""
47 Valladolid;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
47 Valladolid;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2022QIII;8.413
47 Valladolid;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2022QII;""
47 Valladolid;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2022QI;""
47 Valladolid;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
47 Valladolid;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2021QIII;8.632
47 Valladolid;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2021QII;""
47 Valladolid;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2021QI;""
47 Valladolid;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
47 Valladolid;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2020QIII;8.855
47 Valladolid;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2020QII;""
47 Valladolid;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2020QI;""
47 Valladolid;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QIV;8.234
47 Valladolid;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
47 Valladolid;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QII;""
47 Valladolid;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QI;""
47 Valladolid;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QIV;8.478
47 Valladolid;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
47 Valladolid;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QII;""
47 Valladolid;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QI;""
47 Valladolid;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QIV;8.668
47 Valladolid;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
47 Valladolid;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QII;""
47 Valladolid;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QI;""
47 Valladolid;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
47 Valladolid;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
47 Valladolid;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QII;""
47 Valladolid;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QI;8.314
47 Valladolid;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
47 Valladolid;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
47 Valladolid;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QII;""
47 Valladolid;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QI;8.554
47 Valladolid;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
47 Valladolid;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
47 Valladolid;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QII;""
47 Valladolid;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QI;""
47 Valladolid;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
47 Valladolid;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
47 Valladolid;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
47 Valladolid;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
47 Valladolid;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
47 Valladolid;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
47 Valladolid;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
47 Valladolid;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
47 Valladolid;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
47 Valladolid;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
47 Valladolid;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
47 Valladolid;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
47 Valladolid;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
47 Valladolid;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
47 Valladolid;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;97,33
47 Valladolid;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
47 Valladolid;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
47 Valladolid;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
47 Valladolid;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;98,01
47 Valladolid;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
47 Valladolid;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
47 Valladolid;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
47 Valladolid;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;98,2
47 Valladolid;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
47 Valladolid;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
47 Valladolid;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;95,27
47 Valladolid;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
47 Valladolid;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
47 Valladolid;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
47 Valladolid;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;96,27
47 Valladolid;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
47 Valladolid;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
47 Valladolid;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
47 Valladolid;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;96,22
47 Valladolid;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
47 Valladolid;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
47 Valladolid;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;93,24
47 Valladolid;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
47 Valladolid;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
47 Valladolid;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
47 Valladolid;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;94,56
47 Valladolid;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
47 Valladolid;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
47 Valladolid;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
47 Valladolid;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;94,19
47 Valladolid;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
47 Valladolid;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
47 Valladolid;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
47 Valladolid;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
47 Valladolid;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
47 Valladolid;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
47 Valladolid;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;92,73
47 Valladolid;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
47 Valladolid;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
47 Valladolid;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
47 Valladolid;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;92,95
47 Valladolid;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
47 Valladolid;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
47 Valladolid;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
47 Valladolid;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
47 Valladolid;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
47 Valladolid;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
47 Valladolid;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QII;5.614
47 Valladolid;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
47 Valladolid;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
47 Valladolid;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
47 Valladolid;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QII;5.736
47 Valladolid;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
47 Valladolid;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
47 Valladolid;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
47 Valladolid;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QII;5.896
47 Valladolid;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
47 Valladolid;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
47 Valladolid;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
47 Valladolid;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2022QII;5.486
47 Valladolid;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2022QI;""
47 Valladolid;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
47 Valladolid;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
47 Valladolid;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2021QII;5.650
47 Valladolid;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2021QI;""
47 Valladolid;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
47 Valladolid;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
47 Valladolid;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2020QII;5.801
47 Valladolid;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2020QI;""
47 Valladolid;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
47 Valladolid;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2022QIII;5.387
47 Valladolid;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2022QII;""
47 Valladolid;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2022QI;""
47 Valladolid;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
47 Valladolid;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2021QIII;5.555
47 Valladolid;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2021QII;""
47 Valladolid;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2021QI;""
47 Valladolid;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
47 Valladolid;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2020QIII;5.701
47 Valladolid;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2020QII;""
47 Valladolid;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2020QI;""
47 Valladolid;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QIV;5.270
47 Valladolid;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
47 Valladolid;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QII;""
47 Valladolid;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QI;""
47 Valladolid;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QIV;5.477
47 Valladolid;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
47 Valladolid;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QII;""
47 Valladolid;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QI;""
47 Valladolid;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QIV;5.590
47 Valladolid;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
47 Valladolid;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QII;""
47 Valladolid;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QI;""
47 Valladolid;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
47 Valladolid;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
47 Valladolid;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QII;""
47 Valladolid;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QI;5.392
47 Valladolid;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
47 Valladolid;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
47 Valladolid;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QII;""
47 Valladolid;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QI;5.520
47 Valladolid;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
47 Valladolid;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
47 Valladolid;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QII;""
47 Valladolid;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QI;""
47 Valladolid;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
47 Valladolid;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
47 Valladolid;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
47 Valladolid;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
47 Valladolid;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
47 Valladolid;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
47 Valladolid;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
47 Valladolid;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
47 Valladolid;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
47 Valladolid;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
47 Valladolid;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
47 Valladolid;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
47 Valladolid;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
47 Valladolid;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
47 Valladolid;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;97,72
47 Valladolid;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
47 Valladolid;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
47 Valladolid;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
47 Valladolid;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;98,5
47 Valladolid;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
47 Valladolid;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
47 Valladolid;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
47 Valladolid;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;98,39
47 Valladolid;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
47 Valladolid;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
47 Valladolid;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;95,96
47 Valladolid;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
47 Valladolid;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
47 Valladolid;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
47 Valladolid;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;96,84
47 Valladolid;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
47 Valladolid;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
47 Valladolid;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
47 Valladolid;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;96,69
47 Valladolid;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
47 Valladolid;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
47 Valladolid;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;93,87
47 Valladolid;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
47 Valladolid;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
47 Valladolid;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
47 Valladolid;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;95,48
47 Valladolid;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
47 Valladolid;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
47 Valladolid;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
47 Valladolid;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;94,81
47 Valladolid;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
47 Valladolid;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
47 Valladolid;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
47 Valladolid;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
47 Valladolid;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
47 Valladolid;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
47 Valladolid;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;94
47 Valladolid;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
47 Valladolid;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
47 Valladolid;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
47 Valladolid;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;93,62
47 Valladolid;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
47 Valladolid;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
47 Valladolid;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
47 Valladolid;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
47 Valladolid;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
47 Valladolid;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
47 Valladolid;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QII;3.217
47 Valladolid;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
47 Valladolid;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
47 Valladolid;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
47 Valladolid;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QII;3.230
47 Valladolid;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
47 Valladolid;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
47 Valladolid;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
47 Valladolid;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QII;3.307
47 Valladolid;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
47 Valladolid;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
47 Valladolid;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
47 Valladolid;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2022QII;3.109
47 Valladolid;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2022QI;""
47 Valladolid;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
47 Valladolid;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
47 Valladolid;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2021QII;3.138
47 Valladolid;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2021QI;""
47 Valladolid;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
47 Valladolid;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
47 Valladolid;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2020QII;3.236
47 Valladolid;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2020QI;""
47 Valladolid;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
47 Valladolid;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2022QIII;3.026
47 Valladolid;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2022QII;""
47 Valladolid;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2022QI;""
47 Valladolid;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
47 Valladolid;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2021QIII;3.077
47 Valladolid;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2021QII;""
47 Valladolid;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2021QI;""
47 Valladolid;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
47 Valladolid;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2020QIII;3.154
47 Valladolid;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2020QII;""
47 Valladolid;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2020QI;""
47 Valladolid;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QIV;2.964
47 Valladolid;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
47 Valladolid;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QII;""
47 Valladolid;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QI;""
47 Valladolid;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QIV;3.001
47 Valladolid;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
47 Valladolid;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QII;""
47 Valladolid;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QI;""
47 Valladolid;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QIV;3.078
47 Valladolid;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
47 Valladolid;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QII;""
47 Valladolid;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QI;""
47 Valladolid;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
47 Valladolid;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
47 Valladolid;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QII;""
47 Valladolid;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QI;2.922
47 Valladolid;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
47 Valladolid;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
47 Valladolid;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QII;""
47 Valladolid;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QI;3.034
47 Valladolid;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
47 Valladolid;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
47 Valladolid;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QII;""
47 Valladolid;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QI;""
47 Valladolid;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
47 Valladolid;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
47 Valladolid;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
47 Valladolid;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
47 Valladolid;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
47 Valladolid;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
47 Valladolid;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
47 Valladolid;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
47 Valladolid;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
47 Valladolid;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
47 Valladolid;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
47 Valladolid;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
47 Valladolid;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
47 Valladolid;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
47 Valladolid;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;96,64
47 Valladolid;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
47 Valladolid;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
47 Valladolid;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
47 Valladolid;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;97,15
47 Valladolid;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
47 Valladolid;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
47 Valladolid;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
47 Valladolid;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;97,85
47 Valladolid;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
47 Valladolid;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
47 Valladolid;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;94,06
47 Valladolid;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
47 Valladolid;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
47 Valladolid;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
47 Valladolid;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;95,26
47 Valladolid;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
47 Valladolid;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
47 Valladolid;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
47 Valladolid;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;95,37
47 Valladolid;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
47 Valladolid;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
47 Valladolid;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;92,14
47 Valladolid;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
47 Valladolid;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
47 Valladolid;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
47 Valladolid;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;92,91
47 Valladolid;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
47 Valladolid;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
47 Valladolid;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
47 Valladolid;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;93,08
47 Valladolid;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
47 Valladolid;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
47 Valladolid;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
47 Valladolid;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
47 Valladolid;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
47 Valladolid;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
47 Valladolid;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;90,46
47 Valladolid;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
47 Valladolid;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
47 Valladolid;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
47 Valladolid;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;91,74
47 Valladolid;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
47 Valladolid;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
47 Valladolid;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
47 Valladolid;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
47 Valladolid;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
47 Valladolid;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QIII;8.853
47 Valladolid;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
47 Valladolid;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
47 Valladolid;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
47 Valladolid;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QIII;9.064
47 Valladolid;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
47 Valladolid;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
47 Valladolid;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
47 Valladolid;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QIII;9.257
47 Valladolid;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
47 Valladolid;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
47 Valladolid;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
47 Valladolid;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2022QIII;8.630
47 Valladolid;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2022QII;""
47 Valladolid;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2022QI;""
47 Valladolid;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
47 Valladolid;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2021QIII;8.869
47 Valladolid;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2021QII;""
47 Valladolid;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2021QI;""
47 Valladolid;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
47 Valladolid;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2020QIII;9.049
47 Valladolid;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2020QII;""
47 Valladolid;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2020QI;""
47 Valladolid;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2022QIV;8.427
47 Valladolid;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
47 Valladolid;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2022QII;""
47 Valladolid;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2022QI;""
47 Valladolid;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2021QIV;8.691
47 Valladolid;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
47 Valladolid;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2021QII;""
47 Valladolid;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2021QI;""
47 Valladolid;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2020QIV;8.845
47 Valladolid;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
47 Valladolid;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2020QII;""
47 Valladolid;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2020QI;""
47 Valladolid;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
47 Valladolid;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
47 Valladolid;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QII;""
47 Valladolid;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QI;8.516
47 Valladolid;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
47 Valladolid;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
47 Valladolid;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QII;""
47 Valladolid;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QI;8.723
47 Valladolid;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
47 Valladolid;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
47 Valladolid;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QII;""
47 Valladolid;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QI;""
47 Valladolid;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
47 Valladolid;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
47 Valladolid;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QII;8.342
47 Valladolid;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QI;""
47 Valladolid;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
47 Valladolid;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
47 Valladolid;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QII;8.594
47 Valladolid;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QI;""
47 Valladolid;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
47 Valladolid;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
47 Valladolid;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QII;""
47 Valladolid;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QI;""
47 Valladolid;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
47 Valladolid;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
47 Valladolid;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
47 Valladolid;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
47 Valladolid;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
47 Valladolid;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
47 Valladolid;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
47 Valladolid;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
47 Valladolid;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
47 Valladolid;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
47 Valladolid;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
47 Valladolid;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
47 Valladolid;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
47 Valladolid;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;97,48
47 Valladolid;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
47 Valladolid;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
47 Valladolid;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
47 Valladolid;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;97,85
47 Valladolid;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
47 Valladolid;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
47 Valladolid;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
47 Valladolid;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;97,75
47 Valladolid;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
47 Valladolid;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
47 Valladolid;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;95,19
47 Valladolid;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
47 Valladolid;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
47 Valladolid;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
47 Valladolid;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;95,88
47 Valladolid;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
47 Valladolid;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
47 Valladolid;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
47 Valladolid;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;95,55
47 Valladolid;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
47 Valladolid;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
47 Valladolid;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
47 Valladolid;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
47 Valladolid;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
47 Valladolid;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
47 Valladolid;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;93,95
47 Valladolid;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
47 Valladolid;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
47 Valladolid;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
47 Valladolid;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;94,23
47 Valladolid;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
47 Valladolid;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
47 Valladolid;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
47 Valladolid;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
47 Valladolid;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
47 Valladolid;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
47 Valladolid;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;92,03
47 Valladolid;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
47 Valladolid;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
47 Valladolid;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
47 Valladolid;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;92,84
47 Valladolid;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
47 Valladolid;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
47 Valladolid;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
47 Valladolid;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
47 Valladolid;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
47 Valladolid;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
47 Valladolid;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QIII;5.636
47 Valladolid;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
47 Valladolid;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
47 Valladolid;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
47 Valladolid;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QIII;5.803
47 Valladolid;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
47 Valladolid;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
47 Valladolid;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
47 Valladolid;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QIII;5.947
47 Valladolid;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
47 Valladolid;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
47 Valladolid;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
47 Valladolid;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2022QIII;5.508
47 Valladolid;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2022QII;""
47 Valladolid;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2022QI;""
47 Valladolid;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
47 Valladolid;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2021QIII;5.684
47 Valladolid;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2021QII;""
47 Valladolid;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2021QI;""
47 Valladolid;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
47 Valladolid;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2020QIII;5.832
47 Valladolid;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2020QII;""
47 Valladolid;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2020QI;""
47 Valladolid;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2022QIV;5.378
47 Valladolid;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
47 Valladolid;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2022QII;""
47 Valladolid;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2022QI;""
47 Valladolid;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2021QIV;5.591
47 Valladolid;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
47 Valladolid;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2021QII;""
47 Valladolid;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2021QI;""
47 Valladolid;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2020QIV;5.709
47 Valladolid;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
47 Valladolid;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2020QII;""
47 Valladolid;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2020QI;""
47 Valladolid;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
47 Valladolid;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
47 Valladolid;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QII;""
47 Valladolid;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QI;5.499
47 Valladolid;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
47 Valladolid;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
47 Valladolid;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QII;""
47 Valladolid;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QI;5.634
47 Valladolid;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
47 Valladolid;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
47 Valladolid;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QII;""
47 Valladolid;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QI;""
47 Valladolid;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
47 Valladolid;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
47 Valladolid;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QII;5.406
47 Valladolid;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QI;""
47 Valladolid;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
47 Valladolid;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
47 Valladolid;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QII;5.574
47 Valladolid;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QI;""
47 Valladolid;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
47 Valladolid;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
47 Valladolid;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QII;""
47 Valladolid;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QI;""
47 Valladolid;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
47 Valladolid;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
47 Valladolid;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
47 Valladolid;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
47 Valladolid;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
47 Valladolid;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
47 Valladolid;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
47 Valladolid;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
47 Valladolid;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
47 Valladolid;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
47 Valladolid;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
47 Valladolid;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
47 Valladolid;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
47 Valladolid;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;97,73
47 Valladolid;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
47 Valladolid;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
47 Valladolid;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
47 Valladolid;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;97,95
47 Valladolid;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
47 Valladolid;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
47 Valladolid;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
47 Valladolid;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;98,07
47 Valladolid;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
47 Valladolid;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
47 Valladolid;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;95,42
47 Valladolid;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
47 Valladolid;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
47 Valladolid;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
47 Valladolid;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;96,35
47 Valladolid;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
47 Valladolid;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
47 Valladolid;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
47 Valladolid;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;96
47 Valladolid;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
47 Valladolid;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
47 Valladolid;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
47 Valladolid;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
47 Valladolid;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
47 Valladolid;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
47 Valladolid;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;94,76
47 Valladolid;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
47 Valladolid;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
47 Valladolid;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
47 Valladolid;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;94,74
47 Valladolid;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
47 Valladolid;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
47 Valladolid;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
47 Valladolid;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
47 Valladolid;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
47 Valladolid;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
47 Valladolid;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;93,16
47 Valladolid;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
47 Valladolid;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
47 Valladolid;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
47 Valladolid;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;93,73
47 Valladolid;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
47 Valladolid;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
47 Valladolid;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
47 Valladolid;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
47 Valladolid;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
47 Valladolid;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
47 Valladolid;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QIII;3.217
47 Valladolid;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
47 Valladolid;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
47 Valladolid;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
47 Valladolid;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QIII;3.261
47 Valladolid;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
47 Valladolid;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
47 Valladolid;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
47 Valladolid;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QIII;3.310
47 Valladolid;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
47 Valladolid;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
47 Valladolid;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
47 Valladolid;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2022QIII;3.122
47 Valladolid;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2022QII;""
47 Valladolid;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2022QI;""
47 Valladolid;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
47 Valladolid;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2021QIII;3.185
47 Valladolid;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2021QII;""
47 Valladolid;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2021QI;""
47 Valladolid;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
47 Valladolid;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2020QIII;3.217
47 Valladolid;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2020QII;""
47 Valladolid;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2020QI;""
47 Valladolid;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2022QIV;3.049
47 Valladolid;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
47 Valladolid;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2022QII;""
47 Valladolid;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2022QI;""
47 Valladolid;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2021QIV;3.100
47 Valladolid;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
47 Valladolid;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2021QII;""
47 Valladolid;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2021QI;""
47 Valladolid;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2020QIV;3.136
47 Valladolid;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
47 Valladolid;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2020QII;""
47 Valladolid;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2020QI;""
47 Valladolid;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
47 Valladolid;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
47 Valladolid;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QII;""
47 Valladolid;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QI;3.017
47 Valladolid;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
47 Valladolid;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
47 Valladolid;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QII;""
47 Valladolid;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QI;3.089
47 Valladolid;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
47 Valladolid;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
47 Valladolid;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QII;""
47 Valladolid;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QI;""
47 Valladolid;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
47 Valladolid;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
47 Valladolid;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QII;2.936
47 Valladolid;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QI;""
47 Valladolid;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
47 Valladolid;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
47 Valladolid;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QII;3.020
47 Valladolid;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QI;""
47 Valladolid;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
47 Valladolid;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
47 Valladolid;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QII;""
47 Valladolid;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QI;""
47 Valladolid;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
47 Valladolid;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
47 Valladolid;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
47 Valladolid;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
47 Valladolid;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
47 Valladolid;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
47 Valladolid;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
47 Valladolid;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
47 Valladolid;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
47 Valladolid;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
47 Valladolid;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
47 Valladolid;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
47 Valladolid;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
47 Valladolid;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;97,05
47 Valladolid;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
47 Valladolid;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
47 Valladolid;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
47 Valladolid;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;97,67
47 Valladolid;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
47 Valladolid;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
47 Valladolid;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
47 Valladolid;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;97,19
47 Valladolid;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
47 Valladolid;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
47 Valladolid;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;94,78
47 Valladolid;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
47 Valladolid;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
47 Valladolid;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
47 Valladolid;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;95,06
47 Valladolid;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
47 Valladolid;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
47 Valladolid;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
47 Valladolid;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;94,74
47 Valladolid;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
47 Valladolid;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
47 Valladolid;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
47 Valladolid;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
47 Valladolid;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
47 Valladolid;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
47 Valladolid;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;92,52
47 Valladolid;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
47 Valladolid;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
47 Valladolid;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
47 Valladolid;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;93,32
47 Valladolid;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
47 Valladolid;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
47 Valladolid;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
47 Valladolid;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
47 Valladolid;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
47 Valladolid;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
47 Valladolid;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;90,03
47 Valladolid;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
47 Valladolid;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
47 Valladolid;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
47 Valladolid;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;91,24
47 Valladolid;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
47 Valladolid;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
47 Valladolid;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
47 Valladolid;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
47 Valladolid;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
47 Valladolid;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QIV;8.800
47 Valladolid;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
47 Valladolid;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
47 Valladolid;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
47 Valladolid;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QIV;9.078
47 Valladolid;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
47 Valladolid;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
47 Valladolid;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
47 Valladolid;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QIV;9.265
47 Valladolid;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
47 Valladolid;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
47 Valladolid;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
47 Valladolid;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2022QIV;8.583
47 Valladolid;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
47 Valladolid;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2022QII;""
47 Valladolid;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2022QI;""
47 Valladolid;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2021QIV;8.878
47 Valladolid;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
47 Valladolid;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2021QII;""
47 Valladolid;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2021QI;""
47 Valladolid;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2020QIV;9.041
47 Valladolid;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
47 Valladolid;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2020QII;""
47 Valladolid;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2020QI;""
47 Valladolid;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
47 Valladolid;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
47 Valladolid;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2022QII;""
47 Valladolid;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2022QI;8.696
47 Valladolid;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
47 Valladolid;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
47 Valladolid;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2021QII;""
47 Valladolid;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2021QI;8.907
47 Valladolid;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
47 Valladolid;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
47 Valladolid;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2020QII;""
47 Valladolid;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2020QI;""
47 Valladolid;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
47 Valladolid;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
47 Valladolid;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QII;8.514
47 Valladolid;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QI;""
47 Valladolid;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
47 Valladolid;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
47 Valladolid;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QII;8.765
47 Valladolid;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QI;""
47 Valladolid;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
47 Valladolid;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
47 Valladolid;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QII;""
47 Valladolid;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QI;""
47 Valladolid;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
47 Valladolid;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QIII;8.350
47 Valladolid;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QII;""
47 Valladolid;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QI;""
47 Valladolid;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
47 Valladolid;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QIII;8.635
47 Valladolid;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QII;""
47 Valladolid;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QI;""
47 Valladolid;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
47 Valladolid;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
47 Valladolid;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QII;""
47 Valladolid;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QI;""
47 Valladolid;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
47 Valladolid;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
47 Valladolid;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
47 Valladolid;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
47 Valladolid;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
47 Valladolid;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
47 Valladolid;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
47 Valladolid;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
47 Valladolid;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
47 Valladolid;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
47 Valladolid;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
47 Valladolid;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
47 Valladolid;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;97,53
47 Valladolid;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
47 Valladolid;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
47 Valladolid;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
47 Valladolid;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;97,8
47 Valladolid;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
47 Valladolid;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
47 Valladolid;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
47 Valladolid;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;97,58
47 Valladolid;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
47 Valladolid;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
47 Valladolid;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
47 Valladolid;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
47 Valladolid;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
47 Valladolid;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
47 Valladolid;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;95,79
47 Valladolid;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
47 Valladolid;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
47 Valladolid;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
47 Valladolid;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;96,14
47 Valladolid;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
47 Valladolid;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
47 Valladolid;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
47 Valladolid;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
47 Valladolid;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
47 Valladolid;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
47 Valladolid;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;93,79
47 Valladolid;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
47 Valladolid;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
47 Valladolid;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
47 Valladolid;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;94,6
47 Valladolid;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
47 Valladolid;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
47 Valladolid;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
47 Valladolid;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
47 Valladolid;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
47 Valladolid;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
47 Valladolid;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;91,98
47 Valladolid;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
47 Valladolid;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
47 Valladolid;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
47 Valladolid;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;93,2
47 Valladolid;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
47 Valladolid;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
47 Valladolid;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
47 Valladolid;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
47 Valladolid;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
47 Valladolid;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
47 Valladolid;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QIV;5.601
47 Valladolid;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
47 Valladolid;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
47 Valladolid;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
47 Valladolid;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QIV;5.798
47 Valladolid;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
47 Valladolid;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
47 Valladolid;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
47 Valladolid;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QIV;5.967
47 Valladolid;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
47 Valladolid;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
47 Valladolid;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
47 Valladolid;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2022QIV;5.463
47 Valladolid;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
47 Valladolid;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2022QII;""
47 Valladolid;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2022QI;""
47 Valladolid;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2021QIV;5.686
47 Valladolid;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
47 Valladolid;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2021QII;""
47 Valladolid;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2021QI;""
47 Valladolid;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2020QIV;5.832
47 Valladolid;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
47 Valladolid;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2020QII;""
47 Valladolid;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2020QI;""
47 Valladolid;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
47 Valladolid;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
47 Valladolid;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2022QII;""
47 Valladolid;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2022QI;5.592
47 Valladolid;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
47 Valladolid;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
47 Valladolid;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2021QII;""
47 Valladolid;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2021QI;5.748
47 Valladolid;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
47 Valladolid;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
47 Valladolid;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2020QII;""
47 Valladolid;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2020QI;""
47 Valladolid;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
47 Valladolid;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
47 Valladolid;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QII;5.493
47 Valladolid;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QI;""
47 Valladolid;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
47 Valladolid;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
47 Valladolid;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QII;5.680
47 Valladolid;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QI;""
47 Valladolid;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
47 Valladolid;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
47 Valladolid;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QII;""
47 Valladolid;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QI;""
47 Valladolid;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
47 Valladolid;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QIII;5.402
47 Valladolid;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QII;""
47 Valladolid;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QI;""
47 Valladolid;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
47 Valladolid;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QIII;5.604
47 Valladolid;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QII;""
47 Valladolid;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QI;""
47 Valladolid;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
47 Valladolid;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
47 Valladolid;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QII;""
47 Valladolid;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QI;""
47 Valladolid;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
47 Valladolid;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
47 Valladolid;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
47 Valladolid;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
47 Valladolid;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
47 Valladolid;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
47 Valladolid;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
47 Valladolid;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
47 Valladolid;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
47 Valladolid;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
47 Valladolid;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
47 Valladolid;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
47 Valladolid;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;97,54
47 Valladolid;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
47 Valladolid;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
47 Valladolid;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
47 Valladolid;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;98,07
47 Valladolid;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
47 Valladolid;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
47 Valladolid;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
47 Valladolid;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;97,74
47 Valladolid;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
47 Valladolid;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
47 Valladolid;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
47 Valladolid;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
47 Valladolid;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
47 Valladolid;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
47 Valladolid;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;96,45
47 Valladolid;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
47 Valladolid;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
47 Valladolid;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
47 Valladolid;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;96,33
47 Valladolid;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
47 Valladolid;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
47 Valladolid;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
47 Valladolid;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
47 Valladolid;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
47 Valladolid;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
47 Valladolid;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;94,74
47 Valladolid;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
47 Valladolid;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
47 Valladolid;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
47 Valladolid;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;95,19
47 Valladolid;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
47 Valladolid;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
47 Valladolid;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
47 Valladolid;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
47 Valladolid;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
47 Valladolid;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
47 Valladolid;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;93,17
47 Valladolid;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
47 Valladolid;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
47 Valladolid;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
47 Valladolid;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;93,92
47 Valladolid;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
47 Valladolid;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
47 Valladolid;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
47 Valladolid;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
47 Valladolid;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
47 Valladolid;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
47 Valladolid;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QIV;3.199
47 Valladolid;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
47 Valladolid;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
47 Valladolid;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
47 Valladolid;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QIV;3.280
47 Valladolid;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
47 Valladolid;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
47 Valladolid;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
47 Valladolid;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QIV;3.298
47 Valladolid;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
47 Valladolid;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
47 Valladolid;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
47 Valladolid;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2022QIV;3.120
47 Valladolid;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
47 Valladolid;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2022QII;""
47 Valladolid;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2022QI;""
47 Valladolid;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2021QIV;3.192
47 Valladolid;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
47 Valladolid;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2021QII;""
47 Valladolid;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2021QI;""
47 Valladolid;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2020QIV;3.209
47 Valladolid;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
47 Valladolid;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2020QII;""
47 Valladolid;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2020QI;""
47 Valladolid;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
47 Valladolid;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
47 Valladolid;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2022QII;""
47 Valladolid;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2022QI;3.104
47 Valladolid;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
47 Valladolid;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
47 Valladolid;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2021QII;""
47 Valladolid;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2021QI;3.159
47 Valladolid;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
47 Valladolid;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
47 Valladolid;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2020QII;""
47 Valladolid;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2020QI;""
47 Valladolid;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
47 Valladolid;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
47 Valladolid;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QII;3.021
47 Valladolid;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QI;""
47 Valladolid;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
47 Valladolid;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
47 Valladolid;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QII;3.085
47 Valladolid;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QI;""
47 Valladolid;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
47 Valladolid;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
47 Valladolid;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QII;""
47 Valladolid;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QI;""
47 Valladolid;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
47 Valladolid;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QIII;2.948
47 Valladolid;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QII;""
47 Valladolid;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QI;""
47 Valladolid;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
47 Valladolid;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QIII;3.031
47 Valladolid;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QII;""
47 Valladolid;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QI;""
47 Valladolid;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
47 Valladolid;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
47 Valladolid;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QII;""
47 Valladolid;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QI;""
47 Valladolid;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
47 Valladolid;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
47 Valladolid;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
47 Valladolid;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
47 Valladolid;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
47 Valladolid;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
47 Valladolid;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
47 Valladolid;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
47 Valladolid;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
47 Valladolid;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
47 Valladolid;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
47 Valladolid;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
47 Valladolid;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;97,53
47 Valladolid;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
47 Valladolid;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
47 Valladolid;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
47 Valladolid;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;97,32
47 Valladolid;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
47 Valladolid;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
47 Valladolid;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
47 Valladolid;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;97,3
47 Valladolid;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
47 Valladolid;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
47 Valladolid;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
47 Valladolid;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
47 Valladolid;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
47 Valladolid;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
47 Valladolid;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;94,63
47 Valladolid;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
47 Valladolid;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
47 Valladolid;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
47 Valladolid;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;95,79
47 Valladolid;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
47 Valladolid;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
47 Valladolid;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
47 Valladolid;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
47 Valladolid;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
47 Valladolid;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
47 Valladolid;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;92,1
47 Valladolid;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
47 Valladolid;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
47 Valladolid;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
47 Valladolid;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;93,54
47 Valladolid;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
47 Valladolid;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
47 Valladolid;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
47 Valladolid;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
47 Valladolid;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
47 Valladolid;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
47 Valladolid;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;89,88
47 Valladolid;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
47 Valladolid;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
47 Valladolid;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
47 Valladolid;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;91,9
47 Valladolid;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
47 Valladolid;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
47 Valladolid;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
47 Valladolid;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
47 Valladolid;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
47 Valladolid;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
47 Valladolid;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
47 Valladolid;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
47 Valladolid;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
47 Valladolid;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QI;9.870
47 Valladolid;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
47 Valladolid;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
47 Valladolid;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
47 Valladolid;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QI;9.837
47 Valladolid;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
47 Valladolid;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
47 Valladolid;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
47 Valladolid;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QI;10.010
47 Valladolid;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
47 Valladolid;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
47 Valladolid;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2022QII;""
47 Valladolid;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2022QI;9.707
47 Valladolid;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
47 Valladolid;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
47 Valladolid;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2021QII;""
47 Valladolid;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2021QI;9.698
47 Valladolid;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
47 Valladolid;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
47 Valladolid;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2020QII;""
47 Valladolid;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2020QI;9.667
47 Valladolid;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
47 Valladolid;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
47 Valladolid;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2022QII;9.537
47 Valladolid;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2022QI;""
47 Valladolid;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
47 Valladolid;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
47 Valladolid;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2021QII;9.543
47 Valladolid;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2021QI;""
47 Valladolid;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
47 Valladolid;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
47 Valladolid;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2020QII;9.550
47 Valladolid;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2020QI;""
47 Valladolid;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
47 Valladolid;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QIII;9.404
47 Valladolid;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QII;""
47 Valladolid;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QI;""
47 Valladolid;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
47 Valladolid;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QIII;9.422
47 Valladolid;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QII;""
47 Valladolid;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QI;""
47 Valladolid;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
47 Valladolid;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QIII;9.446
47 Valladolid;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QII;""
47 Valladolid;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QI;""
47 Valladolid;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QIV;9.259
47 Valladolid;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
47 Valladolid;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QII;""
47 Valladolid;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QI;""
47 Valladolid;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QIV;9.288
47 Valladolid;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
47 Valladolid;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QII;""
47 Valladolid;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QI;""
47 Valladolid;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QIV;9.307
47 Valladolid;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
47 Valladolid;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QII;""
47 Valladolid;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QI;""
47 Valladolid;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
47 Valladolid;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
47 Valladolid;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
47 Valladolid;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
47 Valladolid;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
47 Valladolid;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
47 Valladolid;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
47 Valladolid;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
47 Valladolid;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
47 Valladolid;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
47 Valladolid;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
47 Valladolid;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
47 Valladolid;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
47 Valladolid;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
47 Valladolid;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
47 Valladolid;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;98,35
47 Valladolid;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
47 Valladolid;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
47 Valladolid;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
47 Valladolid;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;98,59
47 Valladolid;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
47 Valladolid;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
47 Valladolid;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
47 Valladolid;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;96,57
47 Valladolid;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
47 Valladolid;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
47 Valladolid;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;96,63
47 Valladolid;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
47 Valladolid;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
47 Valladolid;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
47 Valladolid;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;97,01
47 Valladolid;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
47 Valladolid;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
47 Valladolid;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
47 Valladolid;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;95,4
47 Valladolid;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
47 Valladolid;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
47 Valladolid;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;95,28
47 Valladolid;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
47 Valladolid;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
47 Valladolid;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
47 Valladolid;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;95,78
47 Valladolid;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
47 Valladolid;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
47 Valladolid;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
47 Valladolid;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;94,37
47 Valladolid;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
47 Valladolid;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
47 Valladolid;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;93,81
47 Valladolid;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
47 Valladolid;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
47 Valladolid;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
47 Valladolid;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;94,42
47 Valladolid;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
47 Valladolid;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
47 Valladolid;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
47 Valladolid;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;92,98
47 Valladolid;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
47 Valladolid;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
47 Valladolid;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
47 Valladolid;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
47 Valladolid;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
47 Valladolid;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
47 Valladolid;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QI;6.360
47 Valladolid;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
47 Valladolid;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
47 Valladolid;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
47 Valladolid;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QI;6.367
47 Valladolid;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
47 Valladolid;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
47 Valladolid;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
47 Valladolid;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QI;6.456
47 Valladolid;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
47 Valladolid;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
47 Valladolid;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2022QII;""
47 Valladolid;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2022QI;6.261
47 Valladolid;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
47 Valladolid;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
47 Valladolid;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2021QII;""
47 Valladolid;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2021QI;6.283
47 Valladolid;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
47 Valladolid;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
47 Valladolid;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2020QII;""
47 Valladolid;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2020QI;6.249
47 Valladolid;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
47 Valladolid;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
47 Valladolid;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2022QII;6.179
47 Valladolid;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2022QI;""
47 Valladolid;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
47 Valladolid;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
47 Valladolid;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2021QII;6.198
47 Valladolid;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2021QI;""
47 Valladolid;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
47 Valladolid;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
47 Valladolid;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2020QII;6.185
47 Valladolid;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2020QI;""
47 Valladolid;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
47 Valladolid;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QIII;6.103
47 Valladolid;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QII;""
47 Valladolid;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QI;""
47 Valladolid;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
47 Valladolid;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QIII;6.131
47 Valladolid;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QII;""
47 Valladolid;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QI;""
47 Valladolid;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
47 Valladolid;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QIII;6.131
47 Valladolid;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QII;""
47 Valladolid;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QI;""
47 Valladolid;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QIV;6.011
47 Valladolid;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
47 Valladolid;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QII;""
47 Valladolid;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QI;""
47 Valladolid;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QIV;6.052
47 Valladolid;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
47 Valladolid;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QII;""
47 Valladolid;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QI;""
47 Valladolid;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QIV;6.044
47 Valladolid;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
47 Valladolid;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QII;""
47 Valladolid;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QI;""
47 Valladolid;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
47 Valladolid;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
47 Valladolid;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
47 Valladolid;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
47 Valladolid;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
47 Valladolid;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
47 Valladolid;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
47 Valladolid;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
47 Valladolid;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
47 Valladolid;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
47 Valladolid;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
47 Valladolid;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
47 Valladolid;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
47 Valladolid;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
47 Valladolid;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
47 Valladolid;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;98,44
47 Valladolid;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
47 Valladolid;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
47 Valladolid;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
47 Valladolid;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;98,68
47 Valladolid;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
47 Valladolid;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
47 Valladolid;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
47 Valladolid;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;96,79
47 Valladolid;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
47 Valladolid;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
47 Valladolid;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;97,15
47 Valladolid;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
47 Valladolid;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
47 Valladolid;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
47 Valladolid;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;97,35
47 Valladolid;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
47 Valladolid;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
47 Valladolid;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
47 Valladolid;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;95,8
47 Valladolid;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
47 Valladolid;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
47 Valladolid;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;95,96
47 Valladolid;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
47 Valladolid;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
47 Valladolid;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
47 Valladolid;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;96,29
47 Valladolid;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
47 Valladolid;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
47 Valladolid;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
47 Valladolid;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;94,97
47 Valladolid;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
47 Valladolid;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
47 Valladolid;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;94,51
47 Valladolid;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
47 Valladolid;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
47 Valladolid;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
47 Valladolid;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;95,05
47 Valladolid;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
47 Valladolid;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
47 Valladolid;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
47 Valladolid;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;93,62
47 Valladolid;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
47 Valladolid;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
47 Valladolid;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
47 Valladolid;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
47 Valladolid;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
47 Valladolid;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
47 Valladolid;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QI;3.510
47 Valladolid;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
47 Valladolid;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
47 Valladolid;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
47 Valladolid;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QI;3.470
47 Valladolid;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
47 Valladolid;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
47 Valladolid;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
47 Valladolid;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QI;3.554
47 Valladolid;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
47 Valladolid;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
47 Valladolid;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2022QII;""
47 Valladolid;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2022QI;3.446
47 Valladolid;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
47 Valladolid;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
47 Valladolid;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2021QII;""
47 Valladolid;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2021QI;3.415
47 Valladolid;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
47 Valladolid;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
47 Valladolid;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2020QII;""
47 Valladolid;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2020QI;3.418
47 Valladolid;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
47 Valladolid;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
47 Valladolid;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2022QII;3.358
47 Valladolid;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2022QI;""
47 Valladolid;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
47 Valladolid;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
47 Valladolid;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2021QII;3.345
47 Valladolid;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2021QI;""
47 Valladolid;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
47 Valladolid;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
47 Valladolid;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2020QII;3.365
47 Valladolid;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2020QI;""
47 Valladolid;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
47 Valladolid;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QIII;3.301
47 Valladolid;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QII;""
47 Valladolid;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QI;""
47 Valladolid;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
47 Valladolid;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QIII;3.291
47 Valladolid;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QII;""
47 Valladolid;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QI;""
47 Valladolid;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
47 Valladolid;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QIII;3.315
47 Valladolid;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QII;""
47 Valladolid;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QI;""
47 Valladolid;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QIV;3.248
47 Valladolid;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
47 Valladolid;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QII;""
47 Valladolid;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QI;""
47 Valladolid;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QIV;3.236
47 Valladolid;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
47 Valladolid;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QII;""
47 Valladolid;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QI;""
47 Valladolid;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QIV;3.263
47 Valladolid;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
47 Valladolid;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QII;""
47 Valladolid;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QI;""
47 Valladolid;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
47 Valladolid;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
47 Valladolid;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
47 Valladolid;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
47 Valladolid;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
47 Valladolid;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
47 Valladolid;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
47 Valladolid;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
47 Valladolid;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
47 Valladolid;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
47 Valladolid;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
47 Valladolid;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
47 Valladolid;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
47 Valladolid;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
47 Valladolid;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
47 Valladolid;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;98,18
47 Valladolid;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
47 Valladolid;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
47 Valladolid;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
47 Valladolid;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;98,41
47 Valladolid;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
47 Valladolid;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
47 Valladolid;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
47 Valladolid;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;96,17
47 Valladolid;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
47 Valladolid;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
47 Valladolid;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;95,67
47 Valladolid;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
47 Valladolid;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
47 Valladolid;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
47 Valladolid;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;96,4
47 Valladolid;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
47 Valladolid;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
47 Valladolid;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
47 Valladolid;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;94,68
47 Valladolid;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
47 Valladolid;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
47 Valladolid;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;94,05
47 Valladolid;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
47 Valladolid;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
47 Valladolid;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
47 Valladolid;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;94,84
47 Valladolid;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
47 Valladolid;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
47 Valladolid;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
47 Valladolid;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;93,28
47 Valladolid;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
47 Valladolid;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
47 Valladolid;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;92,54
47 Valladolid;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
47 Valladolid;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
47 Valladolid;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
47 Valladolid;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;93,26
47 Valladolid;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
47 Valladolid;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
47 Valladolid;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
47 Valladolid;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;91,81
47 Valladolid;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
47 Valladolid;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
47 Valladolid;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
47 Valladolid;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
47 Valladolid;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
47 Valladolid;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QII;10.001
47 Valladolid;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
47 Valladolid;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
47 Valladolid;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
47 Valladolid;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QII;9.977
47 Valladolid;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
47 Valladolid;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
47 Valladolid;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
47 Valladolid;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QII;9.870
47 Valladolid;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
47 Valladolid;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
47 Valladolid;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
47 Valladolid;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2022QII;9.812
47 Valladolid;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2022QI;""
47 Valladolid;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
47 Valladolid;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
47 Valladolid;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2021QII;9.798
47 Valladolid;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2021QI;""
47 Valladolid;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
47 Valladolid;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
47 Valladolid;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2020QII;9.748
47 Valladolid;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2020QI;""
47 Valladolid;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
47 Valladolid;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2022QIII;9.659
47 Valladolid;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2022QII;""
47 Valladolid;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2022QI;""
47 Valladolid;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
47 Valladolid;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2021QIII;9.668
47 Valladolid;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2021QII;""
47 Valladolid;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2021QI;""
47 Valladolid;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
47 Valladolid;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2020QIII;9.626
47 Valladolid;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2020QII;""
47 Valladolid;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2020QI;""
47 Valladolid;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QIV;9.499
47 Valladolid;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
47 Valladolid;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QII;""
47 Valladolid;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QI;""
47 Valladolid;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QIV;9.510
47 Valladolid;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
47 Valladolid;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QII;""
47 Valladolid;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QI;""
47 Valladolid;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QIV;9.479
47 Valladolid;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
47 Valladolid;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QII;""
47 Valladolid;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QI;""
47 Valladolid;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
47 Valladolid;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
47 Valladolid;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QII;""
47 Valladolid;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QI;9.372
47 Valladolid;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
47 Valladolid;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
47 Valladolid;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QII;""
47 Valladolid;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QI;9.367
47 Valladolid;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
47 Valladolid;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
47 Valladolid;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QII;""
47 Valladolid;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QI;""
47 Valladolid;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
47 Valladolid;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
47 Valladolid;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
47 Valladolid;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
47 Valladolid;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
47 Valladolid;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
47 Valladolid;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
47 Valladolid;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
47 Valladolid;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
47 Valladolid;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
47 Valladolid;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
47 Valladolid;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
47 Valladolid;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
47 Valladolid;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
47 Valladolid;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;98,11
47 Valladolid;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
47 Valladolid;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
47 Valladolid;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
47 Valladolid;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;98,21
47 Valladolid;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
47 Valladolid;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
47 Valladolid;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
47 Valladolid;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;98,76
47 Valladolid;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
47 Valladolid;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
47 Valladolid;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;96,58
47 Valladolid;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
47 Valladolid;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
47 Valladolid;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
47 Valladolid;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;96,9
47 Valladolid;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
47 Valladolid;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
47 Valladolid;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
47 Valladolid;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;97,53
47 Valladolid;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
47 Valladolid;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
47 Valladolid;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;94,98
47 Valladolid;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
47 Valladolid;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
47 Valladolid;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
47 Valladolid;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;95,32
47 Valladolid;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
47 Valladolid;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
47 Valladolid;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
47 Valladolid;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;96,04
47 Valladolid;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
47 Valladolid;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
47 Valladolid;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
47 Valladolid;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
47 Valladolid;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
47 Valladolid;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
47 Valladolid;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;93,94
47 Valladolid;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
47 Valladolid;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
47 Valladolid;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
47 Valladolid;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;94,9
47 Valladolid;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
47 Valladolid;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
47 Valladolid;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
47 Valladolid;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
47 Valladolid;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
47 Valladolid;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
47 Valladolid;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QII;6.444
47 Valladolid;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
47 Valladolid;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
47 Valladolid;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
47 Valladolid;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QII;6.427
47 Valladolid;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
47 Valladolid;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
47 Valladolid;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
47 Valladolid;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QII;6.369
47 Valladolid;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
47 Valladolid;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
47 Valladolid;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
47 Valladolid;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2022QII;6.349
47 Valladolid;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2022QI;""
47 Valladolid;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
47 Valladolid;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
47 Valladolid;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2021QII;6.331
47 Valladolid;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2021QI;""
47 Valladolid;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
47 Valladolid;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
47 Valladolid;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2020QII;6.302
47 Valladolid;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2020QI;""
47 Valladolid;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
47 Valladolid;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2022QIII;6.262
47 Valladolid;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2022QII;""
47 Valladolid;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2022QI;""
47 Valladolid;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
47 Valladolid;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2021QIII;6.258
47 Valladolid;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2021QII;""
47 Valladolid;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2021QI;""
47 Valladolid;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
47 Valladolid;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2020QIII;6.234
47 Valladolid;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2020QII;""
47 Valladolid;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2020QI;""
47 Valladolid;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QIV;6.160
47 Valladolid;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
47 Valladolid;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QII;""
47 Valladolid;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QI;""
47 Valladolid;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QIV;6.164
47 Valladolid;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
47 Valladolid;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QII;""
47 Valladolid;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QI;""
47 Valladolid;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QIV;6.140
47 Valladolid;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
47 Valladolid;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QII;""
47 Valladolid;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QI;""
47 Valladolid;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
47 Valladolid;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
47 Valladolid;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QII;""
47 Valladolid;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QI;6.083
47 Valladolid;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
47 Valladolid;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
47 Valladolid;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QII;""
47 Valladolid;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QI;6.074
47 Valladolid;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
47 Valladolid;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
47 Valladolid;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QII;""
47 Valladolid;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QI;""
47 Valladolid;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
47 Valladolid;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
47 Valladolid;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
47 Valladolid;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
47 Valladolid;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
47 Valladolid;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
47 Valladolid;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
47 Valladolid;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
47 Valladolid;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
47 Valladolid;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
47 Valladolid;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
47 Valladolid;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
47 Valladolid;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
47 Valladolid;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
47 Valladolid;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;98,53
47 Valladolid;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
47 Valladolid;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
47 Valladolid;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
47 Valladolid;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;98,51
47 Valladolid;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
47 Valladolid;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
47 Valladolid;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
47 Valladolid;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;98,95
47 Valladolid;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
47 Valladolid;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
47 Valladolid;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;97,18
47 Valladolid;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
47 Valladolid;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
47 Valladolid;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
47 Valladolid;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;97,37
47 Valladolid;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
47 Valladolid;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
47 Valladolid;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
47 Valladolid;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;97,88
47 Valladolid;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
47 Valladolid;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
47 Valladolid;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;95,59
47 Valladolid;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
47 Valladolid;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
47 Valladolid;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
47 Valladolid;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;95,91
47 Valladolid;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
47 Valladolid;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
47 Valladolid;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
47 Valladolid;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;96,4
47 Valladolid;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
47 Valladolid;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
47 Valladolid;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
47 Valladolid;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
47 Valladolid;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
47 Valladolid;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
47 Valladolid;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;94,65
47 Valladolid;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
47 Valladolid;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
47 Valladolid;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
47 Valladolid;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;95,37
47 Valladolid;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
47 Valladolid;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
47 Valladolid;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
47 Valladolid;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
47 Valladolid;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
47 Valladolid;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
47 Valladolid;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QII;3.557
47 Valladolid;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
47 Valladolid;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
47 Valladolid;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
47 Valladolid;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QII;3.550
47 Valladolid;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
47 Valladolid;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
47 Valladolid;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
47 Valladolid;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QII;3.501
47 Valladolid;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
47 Valladolid;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
47 Valladolid;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
47 Valladolid;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2022QII;3.463
47 Valladolid;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2022QI;""
47 Valladolid;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
47 Valladolid;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
47 Valladolid;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2021QII;3.467
47 Valladolid;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2021QI;""
47 Valladolid;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
47 Valladolid;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
47 Valladolid;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2020QII;3.446
47 Valladolid;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2020QI;""
47 Valladolid;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
47 Valladolid;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2022QIII;3.397
47 Valladolid;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2022QII;""
47 Valladolid;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2022QI;""
47 Valladolid;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
47 Valladolid;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2021QIII;3.410
47 Valladolid;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2021QII;""
47 Valladolid;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2021QI;""
47 Valladolid;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
47 Valladolid;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2020QIII;3.392
47 Valladolid;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2020QII;""
47 Valladolid;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2020QI;""
47 Valladolid;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QIV;3.339
47 Valladolid;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
47 Valladolid;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QII;""
47 Valladolid;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QI;""
47 Valladolid;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QIV;3.346
47 Valladolid;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
47 Valladolid;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QII;""
47 Valladolid;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QI;""
47 Valladolid;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QIV;3.339
47 Valladolid;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
47 Valladolid;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QII;""
47 Valladolid;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QI;""
47 Valladolid;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
47 Valladolid;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
47 Valladolid;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QII;""
47 Valladolid;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QI;3.289
47 Valladolid;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
47 Valladolid;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
47 Valladolid;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QII;""
47 Valladolid;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QI;3.293
47 Valladolid;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
47 Valladolid;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
47 Valladolid;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QII;""
47 Valladolid;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QI;""
47 Valladolid;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
47 Valladolid;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
47 Valladolid;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
47 Valladolid;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
47 Valladolid;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
47 Valladolid;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
47 Valladolid;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
47 Valladolid;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
47 Valladolid;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
47 Valladolid;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
47 Valladolid;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
47 Valladolid;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
47 Valladolid;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
47 Valladolid;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
47 Valladolid;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;97,36
47 Valladolid;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
47 Valladolid;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
47 Valladolid;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
47 Valladolid;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;97,66
47 Valladolid;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
47 Valladolid;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
47 Valladolid;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
47 Valladolid;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;98,43
47 Valladolid;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
47 Valladolid;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
47 Valladolid;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;95,5
47 Valladolid;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
47 Valladolid;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
47 Valladolid;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
47 Valladolid;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;96,06
47 Valladolid;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
47 Valladolid;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
47 Valladolid;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
47 Valladolid;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;96,89
47 Valladolid;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
47 Valladolid;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
47 Valladolid;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;93,87
47 Valladolid;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
47 Valladolid;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
47 Valladolid;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
47 Valladolid;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;94,25
47 Valladolid;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
47 Valladolid;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
47 Valladolid;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
47 Valladolid;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;95,37
47 Valladolid;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
47 Valladolid;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
47 Valladolid;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
47 Valladolid;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
47 Valladolid;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
47 Valladolid;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
47 Valladolid;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;92,65
47 Valladolid;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
47 Valladolid;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
47 Valladolid;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
47 Valladolid;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;94,06
47 Valladolid;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
47 Valladolid;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
47 Valladolid;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
47 Valladolid;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
47 Valladolid;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
47 Valladolid;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QIII;9.964
47 Valladolid;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
47 Valladolid;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
47 Valladolid;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
47 Valladolid;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QIII;9.983
47 Valladolid;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
47 Valladolid;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
47 Valladolid;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
47 Valladolid;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QIII;9.881
47 Valladolid;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
47 Valladolid;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
47 Valladolid;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
47 Valladolid;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2022QIII;9.777
47 Valladolid;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2022QII;""
47 Valladolid;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2022QI;""
47 Valladolid;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
47 Valladolid;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2021QIII;9.823
47 Valladolid;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2021QII;""
47 Valladolid;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2021QI;""
47 Valladolid;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
47 Valladolid;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2020QIII;9.745
47 Valladolid;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2020QII;""
47 Valladolid;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2020QI;""
47 Valladolid;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2022QIV;9.601
47 Valladolid;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
47 Valladolid;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2022QII;""
47 Valladolid;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2022QI;""
47 Valladolid;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2021QIV;9.645
47 Valladolid;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
47 Valladolid;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2021QII;""
47 Valladolid;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2021QI;""
47 Valladolid;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2020QIV;9.585
47 Valladolid;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
47 Valladolid;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2020QII;""
47 Valladolid;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2020QI;""
47 Valladolid;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
47 Valladolid;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
47 Valladolid;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QII;""
47 Valladolid;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QI;9.500
47 Valladolid;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
47 Valladolid;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
47 Valladolid;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QII;""
47 Valladolid;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QI;9.469
47 Valladolid;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
47 Valladolid;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
47 Valladolid;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QII;""
47 Valladolid;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QI;""
47 Valladolid;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
47 Valladolid;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
47 Valladolid;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QII;9.364
47 Valladolid;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QI;""
47 Valladolid;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
47 Valladolid;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
47 Valladolid;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QII;9.342
47 Valladolid;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QI;""
47 Valladolid;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
47 Valladolid;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
47 Valladolid;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QII;""
47 Valladolid;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QI;""
47 Valladolid;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
47 Valladolid;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
47 Valladolid;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
47 Valladolid;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
47 Valladolid;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
47 Valladolid;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
47 Valladolid;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
47 Valladolid;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
47 Valladolid;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
47 Valladolid;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
47 Valladolid;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
47 Valladolid;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
47 Valladolid;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
47 Valladolid;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;98,12
47 Valladolid;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
47 Valladolid;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
47 Valladolid;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
47 Valladolid;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;98,4
47 Valladolid;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
47 Valladolid;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
47 Valladolid;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
47 Valladolid;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;98,62
47 Valladolid;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
47 Valladolid;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
47 Valladolid;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;96,36
47 Valladolid;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
47 Valladolid;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
47 Valladolid;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
47 Valladolid;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;96,61
47 Valladolid;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
47 Valladolid;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
47 Valladolid;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
47 Valladolid;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;97
47 Valladolid;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
47 Valladolid;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
47 Valladolid;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
47 Valladolid;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
47 Valladolid;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
47 Valladolid;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
47 Valladolid;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;95,16
47 Valladolid;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
47 Valladolid;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
47 Valladolid;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
47 Valladolid;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;95,83
47 Valladolid;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
47 Valladolid;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
47 Valladolid;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
47 Valladolid;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
47 Valladolid;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
47 Valladolid;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
47 Valladolid;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;93,8
47 Valladolid;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
47 Valladolid;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
47 Valladolid;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
47 Valladolid;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;94,55
47 Valladolid;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
47 Valladolid;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
47 Valladolid;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
47 Valladolid;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
47 Valladolid;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
47 Valladolid;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
47 Valladolid;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QIII;6.435
47 Valladolid;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
47 Valladolid;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
47 Valladolid;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
47 Valladolid;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QIII;6.440
47 Valladolid;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
47 Valladolid;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
47 Valladolid;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
47 Valladolid;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QIII;6.381
47 Valladolid;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
47 Valladolid;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
47 Valladolid;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
47 Valladolid;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2022QIII;6.334
47 Valladolid;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2022QII;""
47 Valladolid;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2022QI;""
47 Valladolid;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
47 Valladolid;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2021QIII;6.353
47 Valladolid;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2021QII;""
47 Valladolid;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2021QI;""
47 Valladolid;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
47 Valladolid;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2020QIII;6.305
47 Valladolid;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2020QII;""
47 Valladolid;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2020QI;""
47 Valladolid;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2022QIV;6.221
47 Valladolid;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
47 Valladolid;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2022QII;""
47 Valladolid;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2022QI;""
47 Valladolid;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2021QIV;6.241
47 Valladolid;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
47 Valladolid;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2021QII;""
47 Valladolid;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2021QI;""
47 Valladolid;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2020QIV;6.202
47 Valladolid;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
47 Valladolid;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2020QII;""
47 Valladolid;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2020QI;""
47 Valladolid;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
47 Valladolid;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
47 Valladolid;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QII;""
47 Valladolid;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QI;6.155
47 Valladolid;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
47 Valladolid;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
47 Valladolid;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QII;""
47 Valladolid;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QI;6.133
47 Valladolid;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
47 Valladolid;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
47 Valladolid;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QII;""
47 Valladolid;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QI;""
47 Valladolid;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
47 Valladolid;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
47 Valladolid;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QII;6.082
47 Valladolid;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QI;""
47 Valladolid;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
47 Valladolid;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
47 Valladolid;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QII;6.065
47 Valladolid;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QI;""
47 Valladolid;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
47 Valladolid;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
47 Valladolid;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QII;""
47 Valladolid;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QI;""
47 Valladolid;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
47 Valladolid;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
47 Valladolid;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
47 Valladolid;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
47 Valladolid;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
47 Valladolid;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
47 Valladolid;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
47 Valladolid;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
47 Valladolid;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
47 Valladolid;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
47 Valladolid;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
47 Valladolid;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
47 Valladolid;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
47 Valladolid;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;98,43
47 Valladolid;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
47 Valladolid;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
47 Valladolid;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
47 Valladolid;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;98,65
47 Valladolid;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
47 Valladolid;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
47 Valladolid;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
47 Valladolid;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;98,81
47 Valladolid;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
47 Valladolid;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
47 Valladolid;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;96,67
47 Valladolid;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
47 Valladolid;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
47 Valladolid;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
47 Valladolid;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;96,91
47 Valladolid;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
47 Valladolid;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
47 Valladolid;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
47 Valladolid;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;97,19
47 Valladolid;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
47 Valladolid;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
47 Valladolid;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
47 Valladolid;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
47 Valladolid;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
47 Valladolid;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
47 Valladolid;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;95,57
47 Valladolid;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
47 Valladolid;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
47 Valladolid;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
47 Valladolid;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;96,11
47 Valladolid;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
47 Valladolid;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
47 Valladolid;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
47 Valladolid;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
47 Valladolid;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
47 Valladolid;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
47 Valladolid;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;94,44
47 Valladolid;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
47 Valladolid;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
47 Valladolid;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
47 Valladolid;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;95,05
47 Valladolid;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
47 Valladolid;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
47 Valladolid;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
47 Valladolid;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
47 Valladolid;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
47 Valladolid;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
47 Valladolid;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QIII;3.529
47 Valladolid;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
47 Valladolid;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
47 Valladolid;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
47 Valladolid;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QIII;3.543
47 Valladolid;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
47 Valladolid;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
47 Valladolid;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
47 Valladolid;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QIII;3.500
47 Valladolid;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
47 Valladolid;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
47 Valladolid;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
47 Valladolid;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2022QIII;3.443
47 Valladolid;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2022QII;""
47 Valladolid;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2022QI;""
47 Valladolid;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
47 Valladolid;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2021QIII;3.470
47 Valladolid;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2021QII;""
47 Valladolid;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2021QI;""
47 Valladolid;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
47 Valladolid;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2020QIII;3.440
47 Valladolid;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2020QII;""
47 Valladolid;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2020QI;""
47 Valladolid;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2022QIV;3.380
47 Valladolid;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
47 Valladolid;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2022QII;""
47 Valladolid;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2022QI;""
47 Valladolid;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2021QIV;3.404
47 Valladolid;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
47 Valladolid;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2021QII;""
47 Valladolid;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2021QI;""
47 Valladolid;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2020QIV;3.383
47 Valladolid;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
47 Valladolid;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2020QII;""
47 Valladolid;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2020QI;""
47 Valladolid;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
47 Valladolid;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
47 Valladolid;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QII;""
47 Valladolid;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QI;3.345
47 Valladolid;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
47 Valladolid;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
47 Valladolid;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QII;""
47 Valladolid;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QI;3.336
47 Valladolid;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
47 Valladolid;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
47 Valladolid;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QII;""
47 Valladolid;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QI;""
47 Valladolid;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
47 Valladolid;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
47 Valladolid;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QII;3.282
47 Valladolid;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QI;""
47 Valladolid;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
47 Valladolid;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
47 Valladolid;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QII;3.277
47 Valladolid;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QI;""
47 Valladolid;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
47 Valladolid;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
47 Valladolid;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QII;""
47 Valladolid;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QI;""
47 Valladolid;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
47 Valladolid;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
47 Valladolid;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
47 Valladolid;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
47 Valladolid;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
47 Valladolid;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
47 Valladolid;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
47 Valladolid;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
47 Valladolid;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
47 Valladolid;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
47 Valladolid;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
47 Valladolid;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
47 Valladolid;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
47 Valladolid;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;97,56
47 Valladolid;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
47 Valladolid;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
47 Valladolid;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
47 Valladolid;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;97,94
47 Valladolid;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
47 Valladolid;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
47 Valladolid;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
47 Valladolid;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;98,29
47 Valladolid;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
47 Valladolid;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
47 Valladolid;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;95,78
47 Valladolid;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
47 Valladolid;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
47 Valladolid;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
47 Valladolid;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;96,08
47 Valladolid;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
47 Valladolid;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
47 Valladolid;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
47 Valladolid;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;96,66
47 Valladolid;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
47 Valladolid;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
47 Valladolid;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
47 Valladolid;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
47 Valladolid;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
47 Valladolid;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
47 Valladolid;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;94,41
47 Valladolid;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
47 Valladolid;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
47 Valladolid;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
47 Valladolid;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;95,31
47 Valladolid;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
47 Valladolid;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
47 Valladolid;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
47 Valladolid;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
47 Valladolid;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
47 Valladolid;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
47 Valladolid;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;92,63
47 Valladolid;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
47 Valladolid;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
47 Valladolid;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
47 Valladolid;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;93,63
47 Valladolid;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
47 Valladolid;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
47 Valladolid;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
47 Valladolid;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
47 Valladolid;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
47 Valladolid;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QIV;9.878
47 Valladolid;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
47 Valladolid;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
47 Valladolid;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
47 Valladolid;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QIV;9.935
47 Valladolid;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
47 Valladolid;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
47 Valladolid;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
47 Valladolid;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QIV;9.890
47 Valladolid;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
47 Valladolid;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
47 Valladolid;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
47 Valladolid;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2022QIV;9.689
47 Valladolid;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
47 Valladolid;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2022QII;""
47 Valladolid;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2022QI;""
47 Valladolid;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2021QIV;9.741
47 Valladolid;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
47 Valladolid;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2021QII;""
47 Valladolid;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2021QI;""
47 Valladolid;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2020QIV;9.706
47 Valladolid;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
47 Valladolid;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2020QII;""
47 Valladolid;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2020QI;""
47 Valladolid;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
47 Valladolid;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
47 Valladolid;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2022QII;""
47 Valladolid;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2022QI;9.589
47 Valladolid;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
47 Valladolid;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
47 Valladolid;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2021QII;""
47 Valladolid;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2021QI;9.582
47 Valladolid;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
47 Valladolid;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
47 Valladolid;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2020QII;""
47 Valladolid;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2020QI;""
47 Valladolid;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
47 Valladolid;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
47 Valladolid;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QII;9.442
47 Valladolid;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QI;""
47 Valladolid;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
47 Valladolid;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
47 Valladolid;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QII;9.447
47 Valladolid;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QI;""
47 Valladolid;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
47 Valladolid;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
47 Valladolid;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QII;""
47 Valladolid;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QI;""
47 Valladolid;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
47 Valladolid;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QIII;9.309
47 Valladolid;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QII;""
47 Valladolid;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QI;""
47 Valladolid;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
47 Valladolid;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QIII;9.332
47 Valladolid;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QII;""
47 Valladolid;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QI;""
47 Valladolid;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
47 Valladolid;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
47 Valladolid;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QII;""
47 Valladolid;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QI;""
47 Valladolid;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
47 Valladolid;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
47 Valladolid;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
47 Valladolid;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
47 Valladolid;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
47 Valladolid;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
47 Valladolid;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
47 Valladolid;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
47 Valladolid;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
47 Valladolid;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
47 Valladolid;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
47 Valladolid;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
47 Valladolid;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;98,09
47 Valladolid;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
47 Valladolid;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
47 Valladolid;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
47 Valladolid;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;98,05
47 Valladolid;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
47 Valladolid;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
47 Valladolid;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
47 Valladolid;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;98,14
47 Valladolid;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
47 Valladolid;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
47 Valladolid;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
47 Valladolid;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
47 Valladolid;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
47 Valladolid;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
47 Valladolid;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;96,52
47 Valladolid;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
47 Valladolid;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
47 Valladolid;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
47 Valladolid;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;96,89
47 Valladolid;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
47 Valladolid;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
47 Valladolid;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
47 Valladolid;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
47 Valladolid;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
47 Valladolid;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
47 Valladolid;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;95,04
47 Valladolid;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
47 Valladolid;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
47 Valladolid;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
47 Valladolid;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;95,52
47 Valladolid;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
47 Valladolid;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
47 Valladolid;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
47 Valladolid;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
47 Valladolid;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
47 Valladolid;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
47 Valladolid;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;93,7
47 Valladolid;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
47 Valladolid;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
47 Valladolid;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
47 Valladolid;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;94,36
47 Valladolid;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
47 Valladolid;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
47 Valladolid;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
47 Valladolid;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
47 Valladolid;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
47 Valladolid;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
47 Valladolid;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QIV;6.394
47 Valladolid;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
47 Valladolid;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
47 Valladolid;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
47 Valladolid;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QIV;6.408
47 Valladolid;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
47 Valladolid;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
47 Valladolid;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
47 Valladolid;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QIV;6.398
47 Valladolid;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
47 Valladolid;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
47 Valladolid;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
47 Valladolid;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2022QIV;6.272
47 Valladolid;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
47 Valladolid;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2022QII;""
47 Valladolid;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2022QI;""
47 Valladolid;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2021QIV;6.289
47 Valladolid;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
47 Valladolid;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2021QII;""
47 Valladolid;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2021QI;""
47 Valladolid;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2020QIV;6.280
47 Valladolid;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
47 Valladolid;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2020QII;""
47 Valladolid;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2020QI;""
47 Valladolid;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
47 Valladolid;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
47 Valladolid;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2022QII;""
47 Valladolid;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2022QI;6.199
47 Valladolid;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
47 Valladolid;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
47 Valladolid;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2021QII;""
47 Valladolid;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2021QI;6.204
47 Valladolid;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
47 Valladolid;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
47 Valladolid;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2020QII;""
47 Valladolid;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2020QI;""
47 Valladolid;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
47 Valladolid;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
47 Valladolid;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QII;6.123
47 Valladolid;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QI;""
47 Valladolid;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
47 Valladolid;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
47 Valladolid;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QII;6.129
47 Valladolid;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QI;""
47 Valladolid;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
47 Valladolid;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
47 Valladolid;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QII;""
47 Valladolid;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QI;""
47 Valladolid;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
47 Valladolid;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QIII;6.047
47 Valladolid;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QII;""
47 Valladolid;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QI;""
47 Valladolid;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
47 Valladolid;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QIII;6.065
47 Valladolid;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QII;""
47 Valladolid;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QI;""
47 Valladolid;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
47 Valladolid;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
47 Valladolid;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QII;""
47 Valladolid;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QI;""
47 Valladolid;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
47 Valladolid;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
47 Valladolid;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
47 Valladolid;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
47 Valladolid;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
47 Valladolid;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
47 Valladolid;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
47 Valladolid;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
47 Valladolid;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
47 Valladolid;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
47 Valladolid;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
47 Valladolid;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
47 Valladolid;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;98,09
47 Valladolid;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
47 Valladolid;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
47 Valladolid;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
47 Valladolid;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;98,14
47 Valladolid;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
47 Valladolid;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
47 Valladolid;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
47 Valladolid;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;98,16
47 Valladolid;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
47 Valladolid;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
47 Valladolid;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
47 Valladolid;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
47 Valladolid;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
47 Valladolid;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
47 Valladolid;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;96,74
47 Valladolid;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
47 Valladolid;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
47 Valladolid;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
47 Valladolid;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;96,97
47 Valladolid;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
47 Valladolid;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
47 Valladolid;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
47 Valladolid;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
47 Valladolid;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
47 Valladolid;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
47 Valladolid;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;95,55
47 Valladolid;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
47 Valladolid;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
47 Valladolid;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
47 Valladolid;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;95,8
47 Valladolid;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
47 Valladolid;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
47 Valladolid;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
47 Valladolid;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
47 Valladolid;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
47 Valladolid;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
47 Valladolid;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;94,37
47 Valladolid;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
47 Valladolid;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
47 Valladolid;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
47 Valladolid;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;94,8
47 Valladolid;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
47 Valladolid;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
47 Valladolid;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
47 Valladolid;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
47 Valladolid;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
47 Valladolid;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
47 Valladolid;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QIV;3.484
47 Valladolid;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
47 Valladolid;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
47 Valladolid;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
47 Valladolid;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QIV;3.527
47 Valladolid;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
47 Valladolid;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
47 Valladolid;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
47 Valladolid;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QIV;3.492
47 Valladolid;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
47 Valladolid;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
47 Valladolid;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
47 Valladolid;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2022QIV;3.417
47 Valladolid;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
47 Valladolid;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2022QII;""
47 Valladolid;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2022QI;""
47 Valladolid;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2021QIV;3.452
47 Valladolid;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
47 Valladolid;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2021QII;""
47 Valladolid;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2021QI;""
47 Valladolid;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2020QIV;3.426
47 Valladolid;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
47 Valladolid;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2020QII;""
47 Valladolid;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2020QI;""
47 Valladolid;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
47 Valladolid;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
47 Valladolid;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2022QII;""
47 Valladolid;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2022QI;3.390
47 Valladolid;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
47 Valladolid;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
47 Valladolid;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2021QII;""
47 Valladolid;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2021QI;3.378
47 Valladolid;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
47 Valladolid;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
47 Valladolid;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2020QII;""
47 Valladolid;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2020QI;""
47 Valladolid;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
47 Valladolid;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
47 Valladolid;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QII;3.319
47 Valladolid;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QI;""
47 Valladolid;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
47 Valladolid;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
47 Valladolid;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QII;3.318
47 Valladolid;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QI;""
47 Valladolid;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
47 Valladolid;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
47 Valladolid;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QII;""
47 Valladolid;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QI;""
47 Valladolid;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
47 Valladolid;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QIII;3.262
47 Valladolid;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QII;""
47 Valladolid;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QI;""
47 Valladolid;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
47 Valladolid;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QIII;3.267
47 Valladolid;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QII;""
47 Valladolid;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QI;""
47 Valladolid;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
47 Valladolid;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
47 Valladolid;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QII;""
47 Valladolid;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QI;""
47 Valladolid;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
47 Valladolid;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
47 Valladolid;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
47 Valladolid;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
47 Valladolid;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
47 Valladolid;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
47 Valladolid;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
47 Valladolid;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
47 Valladolid;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
47 Valladolid;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
47 Valladolid;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
47 Valladolid;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
47 Valladolid;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;98,08
47 Valladolid;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
47 Valladolid;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
47 Valladolid;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
47 Valladolid;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;97,87
47 Valladolid;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
47 Valladolid;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
47 Valladolid;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
47 Valladolid;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;98,11
47 Valladolid;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
47 Valladolid;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
47 Valladolid;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
47 Valladolid;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
47 Valladolid;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
47 Valladolid;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
47 Valladolid;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;96,12
47 Valladolid;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
47 Valladolid;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
47 Valladolid;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
47 Valladolid;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;96,74
47 Valladolid;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
47 Valladolid;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
47 Valladolid;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
47 Valladolid;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
47 Valladolid;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
47 Valladolid;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
47 Valladolid;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;94,1
47 Valladolid;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
47 Valladolid;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
47 Valladolid;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
47 Valladolid;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;95,02
47 Valladolid;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
47 Valladolid;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
47 Valladolid;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
47 Valladolid;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
47 Valladolid;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
47 Valladolid;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
47 Valladolid;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;92,49
47 Valladolid;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
47 Valladolid;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
47 Valladolid;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
47 Valladolid;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;93,56
47 Valladolid;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
47 Valladolid;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
47 Valladolid;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
47 Valladolid;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
47 Valladolid;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
47 Valladolid;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
47 Valladolid;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
47 Valladolid;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
47 Valladolid;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
47 Valladolid;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QI;5.261
47 Valladolid;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
47 Valladolid;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
47 Valladolid;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
47 Valladolid;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QI;4.953
47 Valladolid;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
47 Valladolid;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
47 Valladolid;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
47 Valladolid;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QI;5.737
47 Valladolid;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
47 Valladolid;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
47 Valladolid;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2022QII;""
47 Valladolid;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2022QI;5.089
47 Valladolid;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
47 Valladolid;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
47 Valladolid;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2021QII;""
47 Valladolid;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2021QI;4.790
47 Valladolid;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
47 Valladolid;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
47 Valladolid;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2020QII;""
47 Valladolid;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2020QI;5.397
47 Valladolid;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
47 Valladolid;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
47 Valladolid;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2022QII;4.902
47 Valladolid;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2022QI;""
47 Valladolid;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
47 Valladolid;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
47 Valladolid;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2021QII;4.650
47 Valladolid;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2021QI;""
47 Valladolid;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
47 Valladolid;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
47 Valladolid;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2020QII;5.233
47 Valladolid;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2020QI;""
47 Valladolid;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
47 Valladolid;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QIII;4.707
47 Valladolid;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QII;""
47 Valladolid;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QI;""
47 Valladolid;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
47 Valladolid;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QIII;4.471
47 Valladolid;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QII;""
47 Valladolid;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QI;""
47 Valladolid;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
47 Valladolid;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QIII;5.028
47 Valladolid;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QII;""
47 Valladolid;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QI;""
47 Valladolid;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QIV;4.396
47 Valladolid;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
47 Valladolid;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QII;""
47 Valladolid;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QI;""
47 Valladolid;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QIV;4.294
47 Valladolid;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
47 Valladolid;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QII;""
47 Valladolid;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QI;""
47 Valladolid;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QIV;4.789
47 Valladolid;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
47 Valladolid;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QII;""
47 Valladolid;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QI;""
47 Valladolid;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
47 Valladolid;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
47 Valladolid;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
47 Valladolid;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
47 Valladolid;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
47 Valladolid;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
47 Valladolid;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
47 Valladolid;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
47 Valladolid;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
47 Valladolid;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
47 Valladolid;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
47 Valladolid;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
47 Valladolid;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
47 Valladolid;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
47 Valladolid;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
47 Valladolid;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;96,73
47 Valladolid;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
47 Valladolid;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
47 Valladolid;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
47 Valladolid;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;96,71
47 Valladolid;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
47 Valladolid;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
47 Valladolid;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
47 Valladolid;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;94,07
47 Valladolid;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
47 Valladolid;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
47 Valladolid;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;93,18
47 Valladolid;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
47 Valladolid;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
47 Valladolid;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
47 Valladolid;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;93,88
47 Valladolid;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
47 Valladolid;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
47 Valladolid;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
47 Valladolid;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;91,21
47 Valladolid;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
47 Valladolid;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
47 Valladolid;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;89,47
47 Valladolid;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
47 Valladolid;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
47 Valladolid;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
47 Valladolid;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;90,27
47 Valladolid;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
47 Valladolid;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
47 Valladolid;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
47 Valladolid;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;87,64
47 Valladolid;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
47 Valladolid;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
47 Valladolid;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;83,56
47 Valladolid;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
47 Valladolid;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
47 Valladolid;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
47 Valladolid;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;86,69
47 Valladolid;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
47 Valladolid;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
47 Valladolid;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
47 Valladolid;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;83,48
47 Valladolid;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
47 Valladolid;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
47 Valladolid;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
47 Valladolid;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
47 Valladolid;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
47 Valladolid;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
47 Valladolid;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QI;3.482
47 Valladolid;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
47 Valladolid;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
47 Valladolid;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
47 Valladolid;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QI;3.268
47 Valladolid;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
47 Valladolid;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
47 Valladolid;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
47 Valladolid;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QI;3.797
47 Valladolid;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
47 Valladolid;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
47 Valladolid;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2022QII;""
47 Valladolid;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2022QI;3.373
47 Valladolid;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
47 Valladolid;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
47 Valladolid;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2021QII;""
47 Valladolid;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2021QI;3.158
47 Valladolid;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
47 Valladolid;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
47 Valladolid;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2020QII;""
47 Valladolid;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2020QI;3.568
47 Valladolid;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
47 Valladolid;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
47 Valladolid;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2022QII;3.248
47 Valladolid;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2022QI;""
47 Valladolid;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
47 Valladolid;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
47 Valladolid;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2021QII;3.071
47 Valladolid;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2021QI;""
47 Valladolid;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
47 Valladolid;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
47 Valladolid;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2020QII;3.457
47 Valladolid;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2020QI;""
47 Valladolid;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
47 Valladolid;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QIII;3.129
47 Valladolid;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QII;""
47 Valladolid;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QI;""
47 Valladolid;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
47 Valladolid;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QIII;2.953
47 Valladolid;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QII;""
47 Valladolid;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QI;""
47 Valladolid;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
47 Valladolid;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QIII;3.320
47 Valladolid;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QII;""
47 Valladolid;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QI;""
47 Valladolid;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QIV;2.913
47 Valladolid;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
47 Valladolid;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QII;""
47 Valladolid;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QI;""
47 Valladolid;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QIV;2.842
47 Valladolid;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
47 Valladolid;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QII;""
47 Valladolid;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QI;""
47 Valladolid;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QIV;3.177
47 Valladolid;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
47 Valladolid;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QII;""
47 Valladolid;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QI;""
47 Valladolid;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
47 Valladolid;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
47 Valladolid;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
47 Valladolid;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
47 Valladolid;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
47 Valladolid;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
47 Valladolid;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
47 Valladolid;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
47 Valladolid;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
47 Valladolid;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
47 Valladolid;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
47 Valladolid;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
47 Valladolid;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
47 Valladolid;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
47 Valladolid;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
47 Valladolid;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;96,87
47 Valladolid;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
47 Valladolid;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
47 Valladolid;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
47 Valladolid;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;96,63
47 Valladolid;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
47 Valladolid;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
47 Valladolid;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
47 Valladolid;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;93,97
47 Valladolid;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
47 Valladolid;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
47 Valladolid;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;93,28
47 Valladolid;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
47 Valladolid;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
47 Valladolid;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
47 Valladolid;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;93,97
47 Valladolid;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
47 Valladolid;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
47 Valladolid;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
47 Valladolid;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;91,05
47 Valladolid;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
47 Valladolid;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
47 Valladolid;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;89,86
47 Valladolid;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
47 Valladolid;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
47 Valladolid;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
47 Valladolid;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;90,36
47 Valladolid;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
47 Valladolid;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
47 Valladolid;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
47 Valladolid;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;87,44
47 Valladolid;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
47 Valladolid;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
47 Valladolid;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;83,66
47 Valladolid;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
47 Valladolid;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
47 Valladolid;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
47 Valladolid;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;86,96
47 Valladolid;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
47 Valladolid;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
47 Valladolid;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
47 Valladolid;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;83,67
47 Valladolid;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
47 Valladolid;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
47 Valladolid;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
47 Valladolid;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
47 Valladolid;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
47 Valladolid;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
47 Valladolid;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QI;1.779
47 Valladolid;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
47 Valladolid;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
47 Valladolid;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
47 Valladolid;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QI;1.685
47 Valladolid;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
47 Valladolid;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
47 Valladolid;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
47 Valladolid;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QI;1.940
47 Valladolid;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
47 Valladolid;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
47 Valladolid;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2022QII;""
47 Valladolid;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2022QI;1.716
47 Valladolid;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
47 Valladolid;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
47 Valladolid;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2021QII;""
47 Valladolid;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2021QI;1.632
47 Valladolid;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
47 Valladolid;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
47 Valladolid;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2020QII;""
47 Valladolid;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2020QI;1.829
47 Valladolid;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
47 Valladolid;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
47 Valladolid;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2022QII;1.654
47 Valladolid;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2022QI;""
47 Valladolid;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
47 Valladolid;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
47 Valladolid;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2021QII;1.579
47 Valladolid;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2021QI;""
47 Valladolid;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
47 Valladolid;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
47 Valladolid;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2020QII;1.776
47 Valladolid;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2020QI;""
47 Valladolid;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
47 Valladolid;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QIII;1.578
47 Valladolid;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QII;""
47 Valladolid;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QI;""
47 Valladolid;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
47 Valladolid;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QIII;1.518
47 Valladolid;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QII;""
47 Valladolid;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QI;""
47 Valladolid;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
47 Valladolid;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QIII;1.708
47 Valladolid;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QII;""
47 Valladolid;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QI;""
47 Valladolid;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QIV;1.483
47 Valladolid;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
47 Valladolid;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QII;""
47 Valladolid;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QI;""
47 Valladolid;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QIV;1.452
47 Valladolid;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
47 Valladolid;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QII;""
47 Valladolid;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QI;""
47 Valladolid;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QIV;1.612
47 Valladolid;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
47 Valladolid;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QII;""
47 Valladolid;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QI;""
47 Valladolid;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
47 Valladolid;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
47 Valladolid;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
47 Valladolid;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
47 Valladolid;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
47 Valladolid;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
47 Valladolid;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
47 Valladolid;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
47 Valladolid;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
47 Valladolid;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
47 Valladolid;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
47 Valladolid;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
47 Valladolid;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
47 Valladolid;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
47 Valladolid;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
47 Valladolid;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;96,46
47 Valladolid;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
47 Valladolid;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
47 Valladolid;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
47 Valladolid;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;96,85
47 Valladolid;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
47 Valladolid;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
47 Valladolid;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
47 Valladolid;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;94,28
47 Valladolid;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
47 Valladolid;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
47 Valladolid;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;92,97
47 Valladolid;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
47 Valladolid;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
47 Valladolid;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
47 Valladolid;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;93,71
47 Valladolid;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
47 Valladolid;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
47 Valladolid;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
47 Valladolid;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;91,55
47 Valladolid;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
47 Valladolid;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
47 Valladolid;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;88,7
47 Valladolid;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
47 Valladolid;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
47 Valladolid;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
47 Valladolid;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;90,09
47 Valladolid;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
47 Valladolid;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
47 Valladolid;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
47 Valladolid;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;88,04
47 Valladolid;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
47 Valladolid;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
47 Valladolid;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;83,36
47 Valladolid;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
47 Valladolid;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
47 Valladolid;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
47 Valladolid;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;86,17
47 Valladolid;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
47 Valladolid;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
47 Valladolid;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
47 Valladolid;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;83,09
47 Valladolid;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
47 Valladolid;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
47 Valladolid;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
47 Valladolid;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
47 Valladolid;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
47 Valladolid;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QII;5.978
47 Valladolid;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
47 Valladolid;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
47 Valladolid;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
47 Valladolid;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QII;5.693
47 Valladolid;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
47 Valladolid;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
47 Valladolid;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
47 Valladolid;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QII;5.491
47 Valladolid;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
47 Valladolid;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
47 Valladolid;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
47 Valladolid;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2022QII;5.771
47 Valladolid;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2022QI;""
47 Valladolid;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
47 Valladolid;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
47 Valladolid;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2021QII;5.538
47 Valladolid;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2021QI;""
47 Valladolid;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
47 Valladolid;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
47 Valladolid;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2020QII;5.325
47 Valladolid;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2020QI;""
47 Valladolid;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
47 Valladolid;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2022QIII;5.567
47 Valladolid;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2022QII;""
47 Valladolid;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2022QI;""
47 Valladolid;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
47 Valladolid;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2021QIII;5.347
47 Valladolid;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2021QII;""
47 Valladolid;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2021QI;""
47 Valladolid;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
47 Valladolid;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2020QIII;5.094
47 Valladolid;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2020QII;""
47 Valladolid;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2020QI;""
47 Valladolid;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QIV;5.232
47 Valladolid;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
47 Valladolid;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QII;""
47 Valladolid;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QI;""
47 Valladolid;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QIV;5.156
47 Valladolid;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
47 Valladolid;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QII;""
47 Valladolid;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QI;""
47 Valladolid;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QIV;4.853
47 Valladolid;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
47 Valladolid;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QII;""
47 Valladolid;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QI;""
47 Valladolid;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
47 Valladolid;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
47 Valladolid;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QII;""
47 Valladolid;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QI;4.997
47 Valladolid;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
47 Valladolid;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
47 Valladolid;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QII;""
47 Valladolid;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QI;4.706
47 Valladolid;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
47 Valladolid;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
47 Valladolid;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QII;""
47 Valladolid;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QI;""
47 Valladolid;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
47 Valladolid;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
47 Valladolid;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
47 Valladolid;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
47 Valladolid;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
47 Valladolid;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
47 Valladolid;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
47 Valladolid;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
47 Valladolid;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
47 Valladolid;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
47 Valladolid;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
47 Valladolid;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
47 Valladolid;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
47 Valladolid;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
47 Valladolid;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;96,54
47 Valladolid;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
47 Valladolid;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
47 Valladolid;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
47 Valladolid;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;97,28
47 Valladolid;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
47 Valladolid;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
47 Valladolid;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
47 Valladolid;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;96,98
47 Valladolid;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
47 Valladolid;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
47 Valladolid;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;93,12
47 Valladolid;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
47 Valladolid;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
47 Valladolid;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
47 Valladolid;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;93,92
47 Valladolid;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
47 Valladolid;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
47 Valladolid;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
47 Valladolid;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;92,77
47 Valladolid;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
47 Valladolid;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
47 Valladolid;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;87,52
47 Valladolid;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
47 Valladolid;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
47 Valladolid;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
47 Valladolid;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;90,57
47 Valladolid;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
47 Valladolid;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
47 Valladolid;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
47 Valladolid;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;88,38
47 Valladolid;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
47 Valladolid;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
47 Valladolid;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
47 Valladolid;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
47 Valladolid;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
47 Valladolid;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
47 Valladolid;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;87,77
47 Valladolid;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
47 Valladolid;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
47 Valladolid;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
47 Valladolid;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;85,7
47 Valladolid;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
47 Valladolid;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
47 Valladolid;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
47 Valladolid;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
47 Valladolid;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
47 Valladolid;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
47 Valladolid;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QII;3.939
47 Valladolid;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
47 Valladolid;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
47 Valladolid;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
47 Valladolid;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QII;3.769
47 Valladolid;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
47 Valladolid;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
47 Valladolid;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
47 Valladolid;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QII;3.622
47 Valladolid;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
47 Valladolid;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
47 Valladolid;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
47 Valladolid;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2022QII;3.803
47 Valladolid;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2022QI;""
47 Valladolid;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
47 Valladolid;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
47 Valladolid;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2021QII;3.672
47 Valladolid;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2021QI;""
47 Valladolid;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
47 Valladolid;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
47 Valladolid;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2020QII;3.509
47 Valladolid;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2020QI;""
47 Valladolid;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
47 Valladolid;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2022QIII;3.678
47 Valladolid;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2022QII;""
47 Valladolid;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2022QI;""
47 Valladolid;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
47 Valladolid;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2021QIII;3.546
47 Valladolid;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2021QII;""
47 Valladolid;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2021QI;""
47 Valladolid;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
47 Valladolid;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2020QIII;3.356
47 Valladolid;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2020QII;""
47 Valladolid;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2020QI;""
47 Valladolid;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QIV;3.446
47 Valladolid;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
47 Valladolid;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QII;""
47 Valladolid;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QI;""
47 Valladolid;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QIV;3.426
47 Valladolid;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
47 Valladolid;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QII;""
47 Valladolid;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QI;""
47 Valladolid;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QIV;3.213
47 Valladolid;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
47 Valladolid;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QII;""
47 Valladolid;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QI;""
47 Valladolid;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
47 Valladolid;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
47 Valladolid;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QII;""
47 Valladolid;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QI;3.325
47 Valladolid;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
47 Valladolid;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
47 Valladolid;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QII;""
47 Valladolid;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QI;3.114
47 Valladolid;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
47 Valladolid;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
47 Valladolid;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QII;""
47 Valladolid;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QI;""
47 Valladolid;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
47 Valladolid;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
47 Valladolid;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
47 Valladolid;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
47 Valladolid;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
47 Valladolid;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
47 Valladolid;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
47 Valladolid;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
47 Valladolid;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
47 Valladolid;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
47 Valladolid;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
47 Valladolid;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
47 Valladolid;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
47 Valladolid;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
47 Valladolid;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;96,55
47 Valladolid;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
47 Valladolid;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
47 Valladolid;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
47 Valladolid;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;97,43
47 Valladolid;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
47 Valladolid;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
47 Valladolid;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
47 Valladolid;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;96,88
47 Valladolid;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
47 Valladolid;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
47 Valladolid;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;93,37
47 Valladolid;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
47 Valladolid;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
47 Valladolid;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
47 Valladolid;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;94,08
47 Valladolid;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
47 Valladolid;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
47 Valladolid;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
47 Valladolid;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;92,66
47 Valladolid;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
47 Valladolid;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
47 Valladolid;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;87,48
47 Valladolid;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
47 Valladolid;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
47 Valladolid;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
47 Valladolid;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;90,9
47 Valladolid;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
47 Valladolid;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
47 Valladolid;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
47 Valladolid;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;88,71
47 Valladolid;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
47 Valladolid;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
47 Valladolid;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
47 Valladolid;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
47 Valladolid;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
47 Valladolid;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
47 Valladolid;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;88,22
47 Valladolid;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
47 Valladolid;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
47 Valladolid;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
47 Valladolid;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;85,97
47 Valladolid;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
47 Valladolid;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
47 Valladolid;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
47 Valladolid;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
47 Valladolid;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
47 Valladolid;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
47 Valladolid;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QII;2.039
47 Valladolid;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
47 Valladolid;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
47 Valladolid;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
47 Valladolid;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QII;1.924
47 Valladolid;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
47 Valladolid;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
47 Valladolid;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
47 Valladolid;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QII;1.869
47 Valladolid;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
47 Valladolid;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
47 Valladolid;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
47 Valladolid;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2022QII;1.968
47 Valladolid;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2022QI;""
47 Valladolid;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
47 Valladolid;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
47 Valladolid;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2021QII;1.866
47 Valladolid;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2021QI;""
47 Valladolid;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
47 Valladolid;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
47 Valladolid;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2020QII;1.816
47 Valladolid;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2020QI;""
47 Valladolid;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
47 Valladolid;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2022QIII;1.889
47 Valladolid;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2022QII;""
47 Valladolid;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2022QI;""
47 Valladolid;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
47 Valladolid;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2021QIII;1.801
47 Valladolid;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2021QII;""
47 Valladolid;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2021QI;""
47 Valladolid;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
47 Valladolid;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2020QIII;1.738
47 Valladolid;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2020QII;""
47 Valladolid;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2020QI;""
47 Valladolid;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QIV;1.786
47 Valladolid;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
47 Valladolid;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QII;""
47 Valladolid;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QI;""
47 Valladolid;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QIV;1.730
47 Valladolid;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
47 Valladolid;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QII;""
47 Valladolid;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QI;""
47 Valladolid;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QIV;1.640
47 Valladolid;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
47 Valladolid;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QII;""
47 Valladolid;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QI;""
47 Valladolid;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
47 Valladolid;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
47 Valladolid;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QII;""
47 Valladolid;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QI;1.672
47 Valladolid;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
47 Valladolid;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
47 Valladolid;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QII;""
47 Valladolid;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QI;1.592
47 Valladolid;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
47 Valladolid;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
47 Valladolid;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QII;""
47 Valladolid;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QI;""
47 Valladolid;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
47 Valladolid;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
47 Valladolid;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
47 Valladolid;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
47 Valladolid;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
47 Valladolid;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
47 Valladolid;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
47 Valladolid;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
47 Valladolid;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
47 Valladolid;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
47 Valladolid;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
47 Valladolid;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
47 Valladolid;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
47 Valladolid;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
47 Valladolid;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;96,52
47 Valladolid;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
47 Valladolid;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
47 Valladolid;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
47 Valladolid;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;96,99
47 Valladolid;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
47 Valladolid;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
47 Valladolid;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
47 Valladolid;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;97,16
47 Valladolid;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
47 Valladolid;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
47 Valladolid;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;92,64
47 Valladolid;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
47 Valladolid;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
47 Valladolid;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
47 Valladolid;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;93,61
47 Valladolid;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
47 Valladolid;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
47 Valladolid;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
47 Valladolid;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;92,99
47 Valladolid;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
47 Valladolid;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
47 Valladolid;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;87,59
47 Valladolid;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
47 Valladolid;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
47 Valladolid;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
47 Valladolid;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;89,92
47 Valladolid;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
47 Valladolid;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
47 Valladolid;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
47 Valladolid;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;87,75
47 Valladolid;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
47 Valladolid;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
47 Valladolid;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
47 Valladolid;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
47 Valladolid;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
47 Valladolid;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
47 Valladolid;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;86,9
47 Valladolid;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
47 Valladolid;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
47 Valladolid;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
47 Valladolid;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;85,18
47 Valladolid;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
47 Valladolid;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
47 Valladolid;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
47 Valladolid;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
47 Valladolid;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
47 Valladolid;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QIII;5.815
47 Valladolid;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
47 Valladolid;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
47 Valladolid;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
47 Valladolid;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QIII;5.584
47 Valladolid;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
47 Valladolid;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
47 Valladolid;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
47 Valladolid;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QIII;5.356
47 Valladolid;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
47 Valladolid;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
47 Valladolid;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
47 Valladolid;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2022QIII;5.598
47 Valladolid;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2022QII;""
47 Valladolid;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2022QI;""
47 Valladolid;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
47 Valladolid;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2021QIII;5.388
47 Valladolid;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2021QII;""
47 Valladolid;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2021QI;""
47 Valladolid;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
47 Valladolid;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2020QIII;5.117
47 Valladolid;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2020QII;""
47 Valladolid;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2020QI;""
47 Valladolid;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2022QIV;5.261
47 Valladolid;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
47 Valladolid;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2022QII;""
47 Valladolid;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2022QI;""
47 Valladolid;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2021QIV;5.192
47 Valladolid;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
47 Valladolid;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2021QII;""
47 Valladolid;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2021QI;""
47 Valladolid;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2020QIV;4.874
47 Valladolid;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
47 Valladolid;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2020QII;""
47 Valladolid;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2020QI;""
47 Valladolid;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
47 Valladolid;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
47 Valladolid;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QII;""
47 Valladolid;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QI;5.028
47 Valladolid;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
47 Valladolid;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
47 Valladolid;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QII;""
47 Valladolid;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QI;4.725
47 Valladolid;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
47 Valladolid;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
47 Valladolid;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QII;""
47 Valladolid;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QI;""
47 Valladolid;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
47 Valladolid;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
47 Valladolid;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QII;4.851
47 Valladolid;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QI;""
47 Valladolid;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
47 Valladolid;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
47 Valladolid;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QII;4.589
47 Valladolid;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QI;""
47 Valladolid;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
47 Valladolid;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
47 Valladolid;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QII;""
47 Valladolid;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QI;""
47 Valladolid;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
47 Valladolid;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
47 Valladolid;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
47 Valladolid;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
47 Valladolid;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
47 Valladolid;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
47 Valladolid;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
47 Valladolid;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
47 Valladolid;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
47 Valladolid;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
47 Valladolid;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
47 Valladolid;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
47 Valladolid;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
47 Valladolid;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;96,27
47 Valladolid;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
47 Valladolid;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
47 Valladolid;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
47 Valladolid;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;96,49
47 Valladolid;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
47 Valladolid;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
47 Valladolid;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
47 Valladolid;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;95,54
47 Valladolid;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
47 Valladolid;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
47 Valladolid;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;90,47
47 Valladolid;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
47 Valladolid;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
47 Valladolid;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
47 Valladolid;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;92,98
47 Valladolid;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
47 Valladolid;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
47 Valladolid;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
47 Valladolid;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;91
47 Valladolid;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
47 Valladolid;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
47 Valladolid;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
47 Valladolid;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
47 Valladolid;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
47 Valladolid;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
47 Valladolid;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;90,04
47 Valladolid;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
47 Valladolid;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
47 Valladolid;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
47 Valladolid;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;88,22
47 Valladolid;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
47 Valladolid;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
47 Valladolid;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
47 Valladolid;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
47 Valladolid;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
47 Valladolid;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
47 Valladolid;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;86,87
47 Valladolid;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
47 Valladolid;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
47 Valladolid;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
47 Valladolid;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;85,68
47 Valladolid;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
47 Valladolid;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
47 Valladolid;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
47 Valladolid;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
47 Valladolid;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
47 Valladolid;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
47 Valladolid;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QIII;3.833
47 Valladolid;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
47 Valladolid;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
47 Valladolid;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
47 Valladolid;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QIII;3.700
47 Valladolid;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
47 Valladolid;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
47 Valladolid;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
47 Valladolid;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QIII;3.529
47 Valladolid;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
47 Valladolid;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
47 Valladolid;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
47 Valladolid;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2022QIII;3.698
47 Valladolid;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2022QII;""
47 Valladolid;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2022QI;""
47 Valladolid;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
47 Valladolid;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2021QIII;3.571
47 Valladolid;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2021QII;""
47 Valladolid;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2021QI;""
47 Valladolid;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
47 Valladolid;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2020QIII;3.371
47 Valladolid;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2020QII;""
47 Valladolid;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2020QI;""
47 Valladolid;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2022QIV;3.466
47 Valladolid;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
47 Valladolid;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2022QII;""
47 Valladolid;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2022QI;""
47 Valladolid;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2021QIV;3.448
47 Valladolid;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
47 Valladolid;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2021QII;""
47 Valladolid;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2021QI;""
47 Valladolid;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2020QIV;3.227
47 Valladolid;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
47 Valladolid;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2020QII;""
47 Valladolid;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2020QI;""
47 Valladolid;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
47 Valladolid;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
47 Valladolid;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QII;""
47 Valladolid;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QI;3.343
47 Valladolid;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
47 Valladolid;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
47 Valladolid;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QII;""
47 Valladolid;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QI;3.126
47 Valladolid;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
47 Valladolid;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
47 Valladolid;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QII;""
47 Valladolid;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QI;""
47 Valladolid;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
47 Valladolid;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
47 Valladolid;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QII;3.223
47 Valladolid;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QI;""
47 Valladolid;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
47 Valladolid;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
47 Valladolid;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QII;3.041
47 Valladolid;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QI;""
47 Valladolid;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
47 Valladolid;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
47 Valladolid;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QII;""
47 Valladolid;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QI;""
47 Valladolid;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
47 Valladolid;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
47 Valladolid;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
47 Valladolid;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
47 Valladolid;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
47 Valladolid;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
47 Valladolid;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
47 Valladolid;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
47 Valladolid;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
47 Valladolid;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
47 Valladolid;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
47 Valladolid;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
47 Valladolid;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
47 Valladolid;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;96,48
47 Valladolid;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
47 Valladolid;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
47 Valladolid;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
47 Valladolid;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;96,51
47 Valladolid;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
47 Valladolid;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
47 Valladolid;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
47 Valladolid;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;95,52
47 Valladolid;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
47 Valladolid;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
47 Valladolid;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;90,43
47 Valladolid;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
47 Valladolid;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
47 Valladolid;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
47 Valladolid;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;93,19
47 Valladolid;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
47 Valladolid;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
47 Valladolid;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
47 Valladolid;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;91,44
47 Valladolid;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
47 Valladolid;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
47 Valladolid;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
47 Valladolid;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
47 Valladolid;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
47 Valladolid;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
47 Valladolid;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;90,35
47 Valladolid;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
47 Valladolid;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
47 Valladolid;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
47 Valladolid;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;88,58
47 Valladolid;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
47 Valladolid;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
47 Valladolid;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
47 Valladolid;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
47 Valladolid;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
47 Valladolid;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
47 Valladolid;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;87,11
47 Valladolid;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
47 Valladolid;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
47 Valladolid;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
47 Valladolid;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;86,17
47 Valladolid;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
47 Valladolid;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
47 Valladolid;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
47 Valladolid;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
47 Valladolid;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
47 Valladolid;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
47 Valladolid;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QIII;1.982
47 Valladolid;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
47 Valladolid;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
47 Valladolid;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
47 Valladolid;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QIII;1.884
47 Valladolid;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
47 Valladolid;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
47 Valladolid;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
47 Valladolid;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QIII;1.827
47 Valladolid;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
47 Valladolid;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
47 Valladolid;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
47 Valladolid;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2022QIII;1.900
47 Valladolid;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2022QII;""
47 Valladolid;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2022QI;""
47 Valladolid;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
47 Valladolid;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2021QIII;1.817
47 Valladolid;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2021QII;""
47 Valladolid;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2021QI;""
47 Valladolid;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
47 Valladolid;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2020QIII;1.746
47 Valladolid;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2020QII;""
47 Valladolid;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2020QI;""
47 Valladolid;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2022QIV;1.795
47 Valladolid;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
47 Valladolid;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2022QII;""
47 Valladolid;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2022QI;""
47 Valladolid;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2021QIV;1.744
47 Valladolid;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
47 Valladolid;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2021QII;""
47 Valladolid;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2021QI;""
47 Valladolid;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2020QIV;1.647
47 Valladolid;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
47 Valladolid;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2020QII;""
47 Valladolid;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2020QI;""
47 Valladolid;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
47 Valladolid;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
47 Valladolid;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QII;""
47 Valladolid;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QI;1.685
47 Valladolid;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
47 Valladolid;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
47 Valladolid;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QII;""
47 Valladolid;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QI;1.599
47 Valladolid;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
47 Valladolid;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
47 Valladolid;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QII;""
47 Valladolid;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QI;""
47 Valladolid;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
47 Valladolid;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
47 Valladolid;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QII;1.628
47 Valladolid;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QI;""
47 Valladolid;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
47 Valladolid;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
47 Valladolid;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QII;1.548
47 Valladolid;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QI;""
47 Valladolid;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
47 Valladolid;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
47 Valladolid;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QII;""
47 Valladolid;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QI;""
47 Valladolid;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
47 Valladolid;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
47 Valladolid;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
47 Valladolid;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
47 Valladolid;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
47 Valladolid;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
47 Valladolid;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
47 Valladolid;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
47 Valladolid;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
47 Valladolid;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
47 Valladolid;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
47 Valladolid;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
47 Valladolid;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
47 Valladolid;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;95,86
47 Valladolid;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
47 Valladolid;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
47 Valladolid;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
47 Valladolid;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;96,44
47 Valladolid;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
47 Valladolid;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
47 Valladolid;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
47 Valladolid;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;95,57
47 Valladolid;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
47 Valladolid;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
47 Valladolid;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;90,57
47 Valladolid;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
47 Valladolid;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
47 Valladolid;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
47 Valladolid;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;92,57
47 Valladolid;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
47 Valladolid;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
47 Valladolid;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
47 Valladolid;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;90,15
47 Valladolid;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
47 Valladolid;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
47 Valladolid;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
47 Valladolid;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
47 Valladolid;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
47 Valladolid;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
47 Valladolid;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;89,44
47 Valladolid;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
47 Valladolid;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
47 Valladolid;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
47 Valladolid;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;87,52
47 Valladolid;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
47 Valladolid;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
47 Valladolid;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
47 Valladolid;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
47 Valladolid;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
47 Valladolid;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
47 Valladolid;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;86,41
47 Valladolid;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
47 Valladolid;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
47 Valladolid;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
47 Valladolid;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;84,73
47 Valladolid;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
47 Valladolid;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
47 Valladolid;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
47 Valladolid;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
47 Valladolid;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
47 Valladolid;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QIV;5.637
47 Valladolid;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
47 Valladolid;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
47 Valladolid;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
47 Valladolid;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QIV;5.424
47 Valladolid;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
47 Valladolid;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
47 Valladolid;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
47 Valladolid;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QIV;5.162
47 Valladolid;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
47 Valladolid;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
47 Valladolid;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
47 Valladolid;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2022QIV;5.290
47 Valladolid;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
47 Valladolid;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2022QII;""
47 Valladolid;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2022QI;""
47 Valladolid;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2021QIV;5.222
47 Valladolid;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
47 Valladolid;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2021QII;""
47 Valladolid;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2021QI;""
47 Valladolid;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2020QIV;4.915
47 Valladolid;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
47 Valladolid;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2020QII;""
47 Valladolid;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2020QI;""
47 Valladolid;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
47 Valladolid;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
47 Valladolid;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2022QII;""
47 Valladolid;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2022QI;5.056
47 Valladolid;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
47 Valladolid;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
47 Valladolid;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2021QII;""
47 Valladolid;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2021QI;4.760
47 Valladolid;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
47 Valladolid;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
47 Valladolid;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2020QII;""
47 Valladolid;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2020QI;""
47 Valladolid;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
47 Valladolid;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
47 Valladolid;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QII;4.874
47 Valladolid;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QI;""
47 Valladolid;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
47 Valladolid;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
47 Valladolid;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QII;4.623
47 Valladolid;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QI;""
47 Valladolid;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
47 Valladolid;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
47 Valladolid;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QII;""
47 Valladolid;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QI;""
47 Valladolid;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
47 Valladolid;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QIII;4.680
47 Valladolid;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QII;""
47 Valladolid;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QI;""
47 Valladolid;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
47 Valladolid;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QIII;4.451
47 Valladolid;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QII;""
47 Valladolid;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QI;""
47 Valladolid;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
47 Valladolid;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
47 Valladolid;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QII;""
47 Valladolid;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QI;""
47 Valladolid;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
47 Valladolid;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
47 Valladolid;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
47 Valladolid;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
47 Valladolid;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
47 Valladolid;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
47 Valladolid;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
47 Valladolid;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
47 Valladolid;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
47 Valladolid;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
47 Valladolid;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
47 Valladolid;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
47 Valladolid;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;93,84
47 Valladolid;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
47 Valladolid;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
47 Valladolid;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
47 Valladolid;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;96,28
47 Valladolid;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
47 Valladolid;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
47 Valladolid;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
47 Valladolid;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;95,22
47 Valladolid;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
47 Valladolid;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
47 Valladolid;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
47 Valladolid;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
47 Valladolid;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
47 Valladolid;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
47 Valladolid;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;93,22
47 Valladolid;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
47 Valladolid;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
47 Valladolid;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
47 Valladolid;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;92,21
47 Valladolid;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
47 Valladolid;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
47 Valladolid;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
47 Valladolid;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
47 Valladolid;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
47 Valladolid;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
47 Valladolid;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;89,86
47 Valladolid;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
47 Valladolid;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
47 Valladolid;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
47 Valladolid;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;89,56
47 Valladolid;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
47 Valladolid;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
47 Valladolid;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
47 Valladolid;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
47 Valladolid;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
47 Valladolid;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
47 Valladolid;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;86,28
47 Valladolid;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
47 Valladolid;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
47 Valladolid;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
47 Valladolid;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;86,23
47 Valladolid;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
47 Valladolid;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
47 Valladolid;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
47 Valladolid;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
47 Valladolid;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
47 Valladolid;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
47 Valladolid;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QIV;3.719
47 Valladolid;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
47 Valladolid;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
47 Valladolid;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
47 Valladolid;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QIV;3.587
47 Valladolid;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
47 Valladolid;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
47 Valladolid;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
47 Valladolid;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QIV;3.394
47 Valladolid;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
47 Valladolid;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
47 Valladolid;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
47 Valladolid;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2022QIV;3.479
47 Valladolid;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
47 Valladolid;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2022QII;""
47 Valladolid;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2022QI;""
47 Valladolid;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2021QIV;3.460
47 Valladolid;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
47 Valladolid;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2021QII;""
47 Valladolid;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2021QI;""
47 Valladolid;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2020QIV;3.247
47 Valladolid;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
47 Valladolid;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2020QII;""
47 Valladolid;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2020QI;""
47 Valladolid;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
47 Valladolid;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
47 Valladolid;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2022QII;""
47 Valladolid;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2022QI;3.355
47 Valladolid;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
47 Valladolid;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
47 Valladolid;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2021QII;""
47 Valladolid;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2021QI;3.142
47 Valladolid;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
47 Valladolid;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
47 Valladolid;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2020QII;""
47 Valladolid;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2020QI;""
47 Valladolid;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
47 Valladolid;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
47 Valladolid;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QII;3.233
47 Valladolid;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QI;""
47 Valladolid;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
47 Valladolid;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
47 Valladolid;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QII;3.057
47 Valladolid;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QI;""
47 Valladolid;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
47 Valladolid;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
47 Valladolid;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QII;""
47 Valladolid;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QI;""
47 Valladolid;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
47 Valladolid;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QIII;3.114
47 Valladolid;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QII;""
47 Valladolid;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QI;""
47 Valladolid;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
47 Valladolid;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QIII;2.945
47 Valladolid;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QII;""
47 Valladolid;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QI;""
47 Valladolid;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
47 Valladolid;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
47 Valladolid;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QII;""
47 Valladolid;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QI;""
47 Valladolid;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
47 Valladolid;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
47 Valladolid;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
47 Valladolid;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
47 Valladolid;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
47 Valladolid;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
47 Valladolid;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
47 Valladolid;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
47 Valladolid;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
47 Valladolid;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
47 Valladolid;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
47 Valladolid;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
47 Valladolid;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;93,55
47 Valladolid;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
47 Valladolid;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
47 Valladolid;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
47 Valladolid;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;96,46
47 Valladolid;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
47 Valladolid;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
47 Valladolid;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
47 Valladolid;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;95,67
47 Valladolid;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
47 Valladolid;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
47 Valladolid;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
47 Valladolid;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
47 Valladolid;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
47 Valladolid;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
47 Valladolid;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;93,53
47 Valladolid;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
47 Valladolid;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
47 Valladolid;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
47 Valladolid;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;92,58
47 Valladolid;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
47 Valladolid;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
47 Valladolid;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
47 Valladolid;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
47 Valladolid;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
47 Valladolid;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
47 Valladolid;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;90,13
47 Valladolid;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
47 Valladolid;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
47 Valladolid;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
47 Valladolid;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;90,07
47 Valladolid;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
47 Valladolid;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
47 Valladolid;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
47 Valladolid;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
47 Valladolid;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
47 Valladolid;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
47 Valladolid;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;86,81
47 Valladolid;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
47 Valladolid;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
47 Valladolid;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
47 Valladolid;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;86,77
47 Valladolid;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
47 Valladolid;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
47 Valladolid;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
47 Valladolid;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
47 Valladolid;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
47 Valladolid;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
47 Valladolid;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QIV;1.918
47 Valladolid;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
47 Valladolid;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
47 Valladolid;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
47 Valladolid;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QIV;1.837
47 Valladolid;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
47 Valladolid;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
47 Valladolid;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
47 Valladolid;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QIV;1.768
47 Valladolid;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
47 Valladolid;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
47 Valladolid;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
47 Valladolid;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2022QIV;1.811
47 Valladolid;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
47 Valladolid;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2022QII;""
47 Valladolid;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2022QI;""
47 Valladolid;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2021QIV;1.762
47 Valladolid;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
47 Valladolid;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2021QII;""
47 Valladolid;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2021QI;""
47 Valladolid;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2020QIV;1.668
47 Valladolid;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
47 Valladolid;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2020QII;""
47 Valladolid;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2020QI;""
47 Valladolid;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
47 Valladolid;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
47 Valladolid;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2022QII;""
47 Valladolid;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2022QI;1.701
47 Valladolid;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
47 Valladolid;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
47 Valladolid;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2021QII;""
47 Valladolid;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2021QI;1.618
47 Valladolid;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
47 Valladolid;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
47 Valladolid;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2020QII;""
47 Valladolid;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2020QI;""
47 Valladolid;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
47 Valladolid;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
47 Valladolid;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QII;1.641
47 Valladolid;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QI;""
47 Valladolid;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
47 Valladolid;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
47 Valladolid;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QII;1.566
47 Valladolid;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QI;""
47 Valladolid;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
47 Valladolid;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
47 Valladolid;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QII;""
47 Valladolid;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QI;""
47 Valladolid;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
47 Valladolid;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QIII;1.566
47 Valladolid;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QII;""
47 Valladolid;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QI;""
47 Valladolid;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
47 Valladolid;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QIII;1.506
47 Valladolid;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QII;""
47 Valladolid;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QI;""
47 Valladolid;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
47 Valladolid;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
47 Valladolid;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QII;""
47 Valladolid;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QI;""
47 Valladolid;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
47 Valladolid;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
47 Valladolid;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
47 Valladolid;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
47 Valladolid;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
47 Valladolid;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
47 Valladolid;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
47 Valladolid;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
47 Valladolid;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
47 Valladolid;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
47 Valladolid;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
47 Valladolid;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
47 Valladolid;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;94,42
47 Valladolid;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
47 Valladolid;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
47 Valladolid;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
47 Valladolid;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;95,92
47 Valladolid;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
47 Valladolid;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
47 Valladolid;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
47 Valladolid;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;94,34
47 Valladolid;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
47 Valladolid;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
47 Valladolid;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
47 Valladolid;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
47 Valladolid;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
47 Valladolid;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
47 Valladolid;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;92,6
47 Valladolid;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
47 Valladolid;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
47 Valladolid;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
47 Valladolid;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;91,52
47 Valladolid;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
47 Valladolid;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
47 Valladolid;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
47 Valladolid;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
47 Valladolid;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
47 Valladolid;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
47 Valladolid;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;89,33
47 Valladolid;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
47 Valladolid;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
47 Valladolid;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
47 Valladolid;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;88,57
47 Valladolid;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
47 Valladolid;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
47 Valladolid;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
47 Valladolid;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
47 Valladolid;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
47 Valladolid;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
47 Valladolid;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;85,25
47 Valladolid;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
47 Valladolid;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
47 Valladolid;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
47 Valladolid;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;85,18
47 Valladolid;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
47 Valladolid;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
47 Valladolid;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
47 Valladolid;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
47 Valladolid;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
47 Valladolid;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
49 Zamora;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
49 Zamora;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
49 Zamora;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
49 Zamora;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QI;11.446
49 Zamora;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
49 Zamora;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
49 Zamora;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
49 Zamora;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QI;11.473
49 Zamora;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
49 Zamora;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
49 Zamora;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
49 Zamora;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QI;11.891
49 Zamora;All ages;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
49 Zamora;All ages;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
49 Zamora;All ages;Cohort January 1;Total;Survival in the first trimester;2022QII;""
49 Zamora;All ages;Cohort January 1;Total;Survival in the first trimester;2022QI;11.178
49 Zamora;All ages;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
49 Zamora;All ages;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
49 Zamora;All ages;Cohort January 1;Total;Survival in the first trimester;2021QII;""
49 Zamora;All ages;Cohort January 1;Total;Survival in the first trimester;2021QI;11.230
49 Zamora;All ages;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
49 Zamora;All ages;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
49 Zamora;All ages;Cohort January 1;Total;Survival in the first trimester;2020QII;""
49 Zamora;All ages;Cohort January 1;Total;Survival in the first trimester;2020QI;11.255
49 Zamora;All ages;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
49 Zamora;All ages;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
49 Zamora;All ages;Cohort January 1;Total;Survival in the second trimester;2022QII;10.901
49 Zamora;All ages;Cohort January 1;Total;Survival in the second trimester;2022QI;""
49 Zamora;All ages;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
49 Zamora;All ages;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
49 Zamora;All ages;Cohort January 1;Total;Survival in the second trimester;2021QII;11.024
49 Zamora;All ages;Cohort January 1;Total;Survival in the second trimester;2021QI;""
49 Zamora;All ages;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
49 Zamora;All ages;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
49 Zamora;All ages;Cohort January 1;Total;Survival in the second trimester;2020QII;11.045
49 Zamora;All ages;Cohort January 1;Total;Survival in the second trimester;2020QI;""
49 Zamora;All ages;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
49 Zamora;All ages;Cohort January 1;Total;Survival in the third trimester;2022QIII;10.655
49 Zamora;All ages;Cohort January 1;Total;Survival in the third trimester;2022QII;""
49 Zamora;All ages;Cohort January 1;Total;Survival in the third trimester;2022QI;""
49 Zamora;All ages;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
49 Zamora;All ages;Cohort January 1;Total;Survival in the third trimester;2021QIII;10.798
49 Zamora;All ages;Cohort January 1;Total;Survival in the third trimester;2021QII;""
49 Zamora;All ages;Cohort January 1;Total;Survival in the third trimester;2021QI;""
49 Zamora;All ages;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
49 Zamora;All ages;Cohort January 1;Total;Survival in the third trimester;2020QIII;10.782
49 Zamora;All ages;Cohort January 1;Total;Survival in the third trimester;2020QII;""
49 Zamora;All ages;Cohort January 1;Total;Survival in the third trimester;2020QI;""
49 Zamora;All ages;Cohort January 1;Total;Survival in the third trimester;2022QIV;10.320
49 Zamora;All ages;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
49 Zamora;All ages;Cohort January 1;Total;Survival in the third trimester;2022QII;""
49 Zamora;All ages;Cohort January 1;Total;Survival in the third trimester;2022QI;""
49 Zamora;All ages;Cohort January 1;Total;Survival in the third trimester;2021QIV;10.563
49 Zamora;All ages;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
49 Zamora;All ages;Cohort January 1;Total;Survival in the third trimester;2021QII;""
49 Zamora;All ages;Cohort January 1;Total;Survival in the third trimester;2021QI;""
49 Zamora;All ages;Cohort January 1;Total;Survival in the third trimester;2020QIV;10.525
49 Zamora;All ages;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
49 Zamora;All ages;Cohort January 1;Total;Survival in the third trimester;2020QII;""
49 Zamora;All ages;Cohort January 1;Total;Survival in the third trimester;2020QI;""
49 Zamora;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
49 Zamora;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
49 Zamora;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
49 Zamora;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
49 Zamora;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
49 Zamora;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
49 Zamora;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
49 Zamora;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
49 Zamora;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
49 Zamora;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
49 Zamora;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
49 Zamora;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
49 Zamora;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
49 Zamora;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
49 Zamora;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
49 Zamora;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;97,66
49 Zamora;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
49 Zamora;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
49 Zamora;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
49 Zamora;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;97,88
49 Zamora;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
49 Zamora;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
49 Zamora;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
49 Zamora;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;94,65
49 Zamora;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
49 Zamora;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
49 Zamora;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;95,24
49 Zamora;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
49 Zamora;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
49 Zamora;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
49 Zamora;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;96,09
49 Zamora;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
49 Zamora;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
49 Zamora;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
49 Zamora;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;92,89
49 Zamora;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
49 Zamora;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
49 Zamora;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;93,09
49 Zamora;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
49 Zamora;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
49 Zamora;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
49 Zamora;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;94,12
49 Zamora;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
49 Zamora;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
49 Zamora;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
49 Zamora;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;90,67
49 Zamora;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
49 Zamora;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
49 Zamora;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;90,16
49 Zamora;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
49 Zamora;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
49 Zamora;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
49 Zamora;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;92,07
49 Zamora;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
49 Zamora;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
49 Zamora;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
49 Zamora;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;88,51
49 Zamora;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
49 Zamora;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
49 Zamora;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
49 Zamora;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
49 Zamora;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
49 Zamora;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
49 Zamora;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QI;7.405
49 Zamora;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
49 Zamora;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
49 Zamora;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
49 Zamora;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QI;7.448
49 Zamora;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
49 Zamora;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
49 Zamora;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
49 Zamora;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QI;7.703
49 Zamora;All ages;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
49 Zamora;All ages;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
49 Zamora;All ages;Cohort January 1;Males;Survival in the first trimester;2022QII;""
49 Zamora;All ages;Cohort January 1;Males;Survival in the first trimester;2022QI;7.251
49 Zamora;All ages;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
49 Zamora;All ages;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
49 Zamora;All ages;Cohort January 1;Males;Survival in the first trimester;2021QII;""
49 Zamora;All ages;Cohort January 1;Males;Survival in the first trimester;2021QI;7.297
49 Zamora;All ages;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
49 Zamora;All ages;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
49 Zamora;All ages;Cohort January 1;Males;Survival in the first trimester;2020QII;""
49 Zamora;All ages;Cohort January 1;Males;Survival in the first trimester;2020QI;7.325
49 Zamora;All ages;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
49 Zamora;All ages;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
49 Zamora;All ages;Cohort January 1;Males;Survival in the second trimester;2022QII;7.087
49 Zamora;All ages;Cohort January 1;Males;Survival in the second trimester;2022QI;""
49 Zamora;All ages;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
49 Zamora;All ages;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
49 Zamora;All ages;Cohort January 1;Males;Survival in the second trimester;2021QII;7.181
49 Zamora;All ages;Cohort January 1;Males;Survival in the second trimester;2021QI;""
49 Zamora;All ages;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
49 Zamora;All ages;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
49 Zamora;All ages;Cohort January 1;Males;Survival in the second trimester;2020QII;7.205
49 Zamora;All ages;Cohort January 1;Males;Survival in the second trimester;2020QI;""
49 Zamora;All ages;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
49 Zamora;All ages;Cohort January 1;Males;Survival in the third trimester;2022QIII;6.947
49 Zamora;All ages;Cohort January 1;Males;Survival in the third trimester;2022QII;""
49 Zamora;All ages;Cohort January 1;Males;Survival in the third trimester;2022QI;""
49 Zamora;All ages;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
49 Zamora;All ages;Cohort January 1;Males;Survival in the third trimester;2021QIII;7.059
49 Zamora;All ages;Cohort January 1;Males;Survival in the third trimester;2021QII;""
49 Zamora;All ages;Cohort January 1;Males;Survival in the third trimester;2021QI;""
49 Zamora;All ages;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
49 Zamora;All ages;Cohort January 1;Males;Survival in the third trimester;2020QIII;7.047
49 Zamora;All ages;Cohort January 1;Males;Survival in the third trimester;2020QII;""
49 Zamora;All ages;Cohort January 1;Males;Survival in the third trimester;2020QI;""
49 Zamora;All ages;Cohort January 1;Males;Survival in the third trimester;2022QIV;6.730
49 Zamora;All ages;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
49 Zamora;All ages;Cohort January 1;Males;Survival in the third trimester;2022QII;""
49 Zamora;All ages;Cohort January 1;Males;Survival in the third trimester;2022QI;""
49 Zamora;All ages;Cohort January 1;Males;Survival in the third trimester;2021QIV;6.905
49 Zamora;All ages;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
49 Zamora;All ages;Cohort January 1;Males;Survival in the third trimester;2021QII;""
49 Zamora;All ages;Cohort January 1;Males;Survival in the third trimester;2021QI;""
49 Zamora;All ages;Cohort January 1;Males;Survival in the third trimester;2020QIV;6.897
49 Zamora;All ages;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
49 Zamora;All ages;Cohort January 1;Males;Survival in the third trimester;2020QII;""
49 Zamora;All ages;Cohort January 1;Males;Survival in the third trimester;2020QI;""
49 Zamora;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
49 Zamora;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
49 Zamora;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
49 Zamora;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
49 Zamora;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
49 Zamora;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
49 Zamora;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
49 Zamora;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
49 Zamora;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
49 Zamora;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
49 Zamora;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
49 Zamora;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
49 Zamora;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
49 Zamora;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
49 Zamora;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
49 Zamora;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;97,92
49 Zamora;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
49 Zamora;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
49 Zamora;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
49 Zamora;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;97,97
49 Zamora;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
49 Zamora;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
49 Zamora;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
49 Zamora;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;95,09
49 Zamora;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
49 Zamora;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
49 Zamora;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;95,71
49 Zamora;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
49 Zamora;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
49 Zamora;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
49 Zamora;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;96,42
49 Zamora;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
49 Zamora;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
49 Zamora;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
49 Zamora;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;93,53
49 Zamora;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
49 Zamora;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
49 Zamora;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;93,81
49 Zamora;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
49 Zamora;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
49 Zamora;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
49 Zamora;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;94,78
49 Zamora;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
49 Zamora;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
49 Zamora;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
49 Zamora;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;91,48
49 Zamora;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
49 Zamora;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
49 Zamora;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;90,88
49 Zamora;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
49 Zamora;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
49 Zamora;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
49 Zamora;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;92,71
49 Zamora;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
49 Zamora;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
49 Zamora;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
49 Zamora;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;89,54
49 Zamora;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
49 Zamora;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
49 Zamora;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
49 Zamora;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
49 Zamora;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
49 Zamora;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
49 Zamora;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QI;4.041
49 Zamora;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
49 Zamora;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
49 Zamora;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
49 Zamora;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QI;4.025
49 Zamora;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
49 Zamora;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
49 Zamora;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
49 Zamora;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QI;4.188
49 Zamora;All ages;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
49 Zamora;All ages;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
49 Zamora;All ages;Cohort January 1;Females;Survival in the first trimester;2022QII;""
49 Zamora;All ages;Cohort January 1;Females;Survival in the first trimester;2022QI;3.927
49 Zamora;All ages;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
49 Zamora;All ages;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
49 Zamora;All ages;Cohort January 1;Females;Survival in the first trimester;2021QII;""
49 Zamora;All ages;Cohort January 1;Females;Survival in the first trimester;2021QI;3.933
49 Zamora;All ages;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
49 Zamora;All ages;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
49 Zamora;All ages;Cohort January 1;Females;Survival in the first trimester;2020QII;""
49 Zamora;All ages;Cohort January 1;Females;Survival in the first trimester;2020QI;3.930
49 Zamora;All ages;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
49 Zamora;All ages;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
49 Zamora;All ages;Cohort January 1;Females;Survival in the second trimester;2022QII;3.814
49 Zamora;All ages;Cohort January 1;Females;Survival in the second trimester;2022QI;""
49 Zamora;All ages;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
49 Zamora;All ages;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
49 Zamora;All ages;Cohort January 1;Females;Survival in the second trimester;2021QII;3.843
49 Zamora;All ages;Cohort January 1;Females;Survival in the second trimester;2021QI;""
49 Zamora;All ages;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
49 Zamora;All ages;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
49 Zamora;All ages;Cohort January 1;Females;Survival in the second trimester;2020QII;3.840
49 Zamora;All ages;Cohort January 1;Females;Survival in the second trimester;2020QI;""
49 Zamora;All ages;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
49 Zamora;All ages;Cohort January 1;Females;Survival in the third trimester;2022QIII;3.708
49 Zamora;All ages;Cohort January 1;Females;Survival in the third trimester;2022QII;""
49 Zamora;All ages;Cohort January 1;Females;Survival in the third trimester;2022QI;""
49 Zamora;All ages;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
49 Zamora;All ages;Cohort January 1;Females;Survival in the third trimester;2021QIII;3.739
49 Zamora;All ages;Cohort January 1;Females;Survival in the third trimester;2021QII;""
49 Zamora;All ages;Cohort January 1;Females;Survival in the third trimester;2021QI;""
49 Zamora;All ages;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
49 Zamora;All ages;Cohort January 1;Females;Survival in the third trimester;2020QIII;3.735
49 Zamora;All ages;Cohort January 1;Females;Survival in the third trimester;2020QII;""
49 Zamora;All ages;Cohort January 1;Females;Survival in the third trimester;2020QI;""
49 Zamora;All ages;Cohort January 1;Females;Survival in the third trimester;2022QIV;3.590
49 Zamora;All ages;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
49 Zamora;All ages;Cohort January 1;Females;Survival in the third trimester;2022QII;""
49 Zamora;All ages;Cohort January 1;Females;Survival in the third trimester;2022QI;""
49 Zamora;All ages;Cohort January 1;Females;Survival in the third trimester;2021QIV;3.658
49 Zamora;All ages;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
49 Zamora;All ages;Cohort January 1;Females;Survival in the third trimester;2021QII;""
49 Zamora;All ages;Cohort January 1;Females;Survival in the third trimester;2021QI;""
49 Zamora;All ages;Cohort January 1;Females;Survival in the third trimester;2020QIV;3.628
49 Zamora;All ages;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
49 Zamora;All ages;Cohort January 1;Females;Survival in the third trimester;2020QII;""
49 Zamora;All ages;Cohort January 1;Females;Survival in the third trimester;2020QI;""
49 Zamora;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
49 Zamora;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
49 Zamora;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
49 Zamora;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
49 Zamora;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
49 Zamora;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
49 Zamora;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
49 Zamora;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
49 Zamora;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
49 Zamora;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
49 Zamora;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
49 Zamora;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
49 Zamora;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
49 Zamora;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
49 Zamora;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
49 Zamora;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;97,18
49 Zamora;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
49 Zamora;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
49 Zamora;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
49 Zamora;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;97,71
49 Zamora;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
49 Zamora;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
49 Zamora;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
49 Zamora;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;93,84
49 Zamora;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
49 Zamora;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
49 Zamora;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;94,38
49 Zamora;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
49 Zamora;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
49 Zamora;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
49 Zamora;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;95,48
49 Zamora;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
49 Zamora;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
49 Zamora;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
49 Zamora;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;91,69
49 Zamora;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
49 Zamora;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
49 Zamora;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;91,76
49 Zamora;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
49 Zamora;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
49 Zamora;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
49 Zamora;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;92,89
49 Zamora;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
49 Zamora;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
49 Zamora;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
49 Zamora;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;89,18
49 Zamora;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
49 Zamora;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
49 Zamora;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;88,84
49 Zamora;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
49 Zamora;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
49 Zamora;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
49 Zamora;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;90,88
49 Zamora;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
49 Zamora;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
49 Zamora;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
49 Zamora;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;86,63
49 Zamora;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
49 Zamora;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
49 Zamora;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
49 Zamora;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
49 Zamora;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
49 Zamora;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QII;11.444
49 Zamora;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
49 Zamora;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
49 Zamora;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
49 Zamora;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QII;11.493
49 Zamora;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
49 Zamora;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
49 Zamora;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
49 Zamora;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QII;11.559
49 Zamora;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
49 Zamora;All ages;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
49 Zamora;All ages;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
49 Zamora;All ages;Cohort April 1;Total;Survival in the first trimester;2022QII;11.155
49 Zamora;All ages;Cohort April 1;Total;Survival in the first trimester;2022QI;""
49 Zamora;All ages;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
49 Zamora;All ages;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
49 Zamora;All ages;Cohort April 1;Total;Survival in the first trimester;2021QII;11.252
49 Zamora;All ages;Cohort April 1;Total;Survival in the first trimester;2021QI;""
49 Zamora;All ages;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
49 Zamora;All ages;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
49 Zamora;All ages;Cohort April 1;Total;Survival in the first trimester;2020QII;11.330
49 Zamora;All ages;Cohort April 1;Total;Survival in the first trimester;2020QI;""
49 Zamora;All ages;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
49 Zamora;All ages;Cohort April 1;Total;Survival in the second trimester;2022QIII;10.884
49 Zamora;All ages;Cohort April 1;Total;Survival in the second trimester;2022QII;""
49 Zamora;All ages;Cohort April 1;Total;Survival in the second trimester;2022QI;""
49 Zamora;All ages;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
49 Zamora;All ages;Cohort April 1;Total;Survival in the second trimester;2021QIII;11.012
49 Zamora;All ages;Cohort April 1;Total;Survival in the second trimester;2021QII;""
49 Zamora;All ages;Cohort April 1;Total;Survival in the second trimester;2021QI;""
49 Zamora;All ages;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
49 Zamora;All ages;Cohort April 1;Total;Survival in the second trimester;2020QIII;11.048
49 Zamora;All ages;Cohort April 1;Total;Survival in the second trimester;2020QII;""
49 Zamora;All ages;Cohort April 1;Total;Survival in the second trimester;2020QI;""
49 Zamora;All ages;Cohort April 1;Total;Survival in the third trimester;2022QIV;10.519
49 Zamora;All ages;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
49 Zamora;All ages;Cohort April 1;Total;Survival in the third trimester;2022QII;""
49 Zamora;All ages;Cohort April 1;Total;Survival in the third trimester;2022QI;""
49 Zamora;All ages;Cohort April 1;Total;Survival in the third trimester;2021QIV;10.759
49 Zamora;All ages;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
49 Zamora;All ages;Cohort April 1;Total;Survival in the third trimester;2021QII;""
49 Zamora;All ages;Cohort April 1;Total;Survival in the third trimester;2021QI;""
49 Zamora;All ages;Cohort April 1;Total;Survival in the third trimester;2020QIV;10.770
49 Zamora;All ages;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
49 Zamora;All ages;Cohort April 1;Total;Survival in the third trimester;2020QII;""
49 Zamora;All ages;Cohort April 1;Total;Survival in the third trimester;2020QI;""
49 Zamora;All ages;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
49 Zamora;All ages;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
49 Zamora;All ages;Cohort April 1;Total;Survival in the third trimester;2022QII;""
49 Zamora;All ages;Cohort April 1;Total;Survival in the third trimester;2022QI;10.548
49 Zamora;All ages;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
49 Zamora;All ages;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
49 Zamora;All ages;Cohort April 1;Total;Survival in the third trimester;2021QII;""
49 Zamora;All ages;Cohort April 1;Total;Survival in the third trimester;2021QI;10.581
49 Zamora;All ages;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
49 Zamora;All ages;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
49 Zamora;All ages;Cohort April 1;Total;Survival in the third trimester;2020QII;""
49 Zamora;All ages;Cohort April 1;Total;Survival in the third trimester;2020QI;""
49 Zamora;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
49 Zamora;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
49 Zamora;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
49 Zamora;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
49 Zamora;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
49 Zamora;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
49 Zamora;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
49 Zamora;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
49 Zamora;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
49 Zamora;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
49 Zamora;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
49 Zamora;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
49 Zamora;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
49 Zamora;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
49 Zamora;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;97,47
49 Zamora;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
49 Zamora;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
49 Zamora;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
49 Zamora;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;97,9
49 Zamora;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
49 Zamora;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
49 Zamora;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
49 Zamora;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;98,02
49 Zamora;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
49 Zamora;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
49 Zamora;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;95,11
49 Zamora;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
49 Zamora;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
49 Zamora;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
49 Zamora;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;95,81
49 Zamora;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
49 Zamora;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
49 Zamora;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
49 Zamora;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;95,58
49 Zamora;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
49 Zamora;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
49 Zamora;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;91,92
49 Zamora;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
49 Zamora;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
49 Zamora;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
49 Zamora;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;93,61
49 Zamora;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
49 Zamora;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
49 Zamora;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
49 Zamora;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;93,17
49 Zamora;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
49 Zamora;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
49 Zamora;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
49 Zamora;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
49 Zamora;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
49 Zamora;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
49 Zamora;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;91,78
49 Zamora;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
49 Zamora;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
49 Zamora;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
49 Zamora;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;91,54
49 Zamora;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
49 Zamora;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
49 Zamora;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
49 Zamora;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
49 Zamora;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
49 Zamora;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
49 Zamora;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QII;7.410
49 Zamora;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
49 Zamora;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
49 Zamora;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
49 Zamora;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QII;7.451
49 Zamora;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
49 Zamora;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
49 Zamora;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
49 Zamora;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QII;7.498
49 Zamora;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
49 Zamora;All ages;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
49 Zamora;All ages;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
49 Zamora;All ages;Cohort April 1;Males;Survival in the first trimester;2022QII;7.240
49 Zamora;All ages;Cohort April 1;Males;Survival in the first trimester;2022QI;""
49 Zamora;All ages;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
49 Zamora;All ages;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
49 Zamora;All ages;Cohort April 1;Males;Survival in the first trimester;2021QII;7.318
49 Zamora;All ages;Cohort April 1;Males;Survival in the first trimester;2021QI;""
49 Zamora;All ages;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
49 Zamora;All ages;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
49 Zamora;All ages;Cohort April 1;Males;Survival in the first trimester;2020QII;7.370
49 Zamora;All ages;Cohort April 1;Males;Survival in the first trimester;2020QI;""
49 Zamora;All ages;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
49 Zamora;All ages;Cohort April 1;Males;Survival in the second trimester;2022QIII;7.085
49 Zamora;All ages;Cohort April 1;Males;Survival in the second trimester;2022QII;""
49 Zamora;All ages;Cohort April 1;Males;Survival in the second trimester;2022QI;""
49 Zamora;All ages;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
49 Zamora;All ages;Cohort April 1;Males;Survival in the second trimester;2021QIII;7.188
49 Zamora;All ages;Cohort April 1;Males;Survival in the second trimester;2021QII;""
49 Zamora;All ages;Cohort April 1;Males;Survival in the second trimester;2021QI;""
49 Zamora;All ages;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
49 Zamora;All ages;Cohort April 1;Males;Survival in the second trimester;2020QIII;7.200
49 Zamora;All ages;Cohort April 1;Males;Survival in the second trimester;2020QII;""
49 Zamora;All ages;Cohort April 1;Males;Survival in the second trimester;2020QI;""
49 Zamora;All ages;Cohort April 1;Males;Survival in the third trimester;2022QIV;6.849
49 Zamora;All ages;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
49 Zamora;All ages;Cohort April 1;Males;Survival in the third trimester;2022QII;""
49 Zamora;All ages;Cohort April 1;Males;Survival in the third trimester;2022QI;""
49 Zamora;All ages;Cohort April 1;Males;Survival in the third trimester;2021QIV;7.023
49 Zamora;All ages;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
49 Zamora;All ages;Cohort April 1;Males;Survival in the third trimester;2021QII;""
49 Zamora;All ages;Cohort April 1;Males;Survival in the third trimester;2021QI;""
49 Zamora;All ages;Cohort April 1;Males;Survival in the third trimester;2020QIV;7.034
49 Zamora;All ages;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
49 Zamora;All ages;Cohort April 1;Males;Survival in the third trimester;2020QII;""
49 Zamora;All ages;Cohort April 1;Males;Survival in the third trimester;2020QI;""
49 Zamora;All ages;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
49 Zamora;All ages;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
49 Zamora;All ages;Cohort April 1;Males;Survival in the third trimester;2022QII;""
49 Zamora;All ages;Cohort April 1;Males;Survival in the third trimester;2022QI;6.900
49 Zamora;All ages;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
49 Zamora;All ages;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
49 Zamora;All ages;Cohort April 1;Males;Survival in the third trimester;2021QII;""
49 Zamora;All ages;Cohort April 1;Males;Survival in the third trimester;2021QI;6.915
49 Zamora;All ages;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
49 Zamora;All ages;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
49 Zamora;All ages;Cohort April 1;Males;Survival in the third trimester;2020QII;""
49 Zamora;All ages;Cohort April 1;Males;Survival in the third trimester;2020QI;""
49 Zamora;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
49 Zamora;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
49 Zamora;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
49 Zamora;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
49 Zamora;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
49 Zamora;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
49 Zamora;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
49 Zamora;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
49 Zamora;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
49 Zamora;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
49 Zamora;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
49 Zamora;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
49 Zamora;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
49 Zamora;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
49 Zamora;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;97,71
49 Zamora;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
49 Zamora;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
49 Zamora;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
49 Zamora;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;98,22
49 Zamora;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
49 Zamora;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
49 Zamora;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
49 Zamora;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;98,29
49 Zamora;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
49 Zamora;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
49 Zamora;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;95,61
49 Zamora;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
49 Zamora;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
49 Zamora;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
49 Zamora;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;96,47
49 Zamora;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
49 Zamora;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
49 Zamora;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
49 Zamora;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;96,03
49 Zamora;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
49 Zamora;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
49 Zamora;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;92,43
49 Zamora;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
49 Zamora;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
49 Zamora;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
49 Zamora;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;94,26
49 Zamora;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
49 Zamora;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
49 Zamora;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
49 Zamora;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;93,81
49 Zamora;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
49 Zamora;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
49 Zamora;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
49 Zamora;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
49 Zamora;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
49 Zamora;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
49 Zamora;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;92,61
49 Zamora;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
49 Zamora;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
49 Zamora;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
49 Zamora;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;92,22
49 Zamora;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
49 Zamora;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
49 Zamora;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
49 Zamora;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
49 Zamora;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
49 Zamora;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
49 Zamora;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QII;4.034
49 Zamora;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
49 Zamora;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
49 Zamora;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
49 Zamora;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QII;4.042
49 Zamora;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
49 Zamora;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
49 Zamora;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
49 Zamora;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QII;4.061
49 Zamora;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
49 Zamora;All ages;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
49 Zamora;All ages;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
49 Zamora;All ages;Cohort April 1;Females;Survival in the first trimester;2022QII;3.915
49 Zamora;All ages;Cohort April 1;Females;Survival in the first trimester;2022QI;""
49 Zamora;All ages;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
49 Zamora;All ages;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
49 Zamora;All ages;Cohort April 1;Females;Survival in the first trimester;2021QII;3.934
49 Zamora;All ages;Cohort April 1;Females;Survival in the first trimester;2021QI;""
49 Zamora;All ages;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
49 Zamora;All ages;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
49 Zamora;All ages;Cohort April 1;Females;Survival in the first trimester;2020QII;3.960
49 Zamora;All ages;Cohort April 1;Females;Survival in the first trimester;2020QI;""
49 Zamora;All ages;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
49 Zamora;All ages;Cohort April 1;Females;Survival in the second trimester;2022QIII;3.799
49 Zamora;All ages;Cohort April 1;Females;Survival in the second trimester;2022QII;""
49 Zamora;All ages;Cohort April 1;Females;Survival in the second trimester;2022QI;""
49 Zamora;All ages;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
49 Zamora;All ages;Cohort April 1;Females;Survival in the second trimester;2021QIII;3.824
49 Zamora;All ages;Cohort April 1;Females;Survival in the second trimester;2021QII;""
49 Zamora;All ages;Cohort April 1;Females;Survival in the second trimester;2021QI;""
49 Zamora;All ages;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
49 Zamora;All ages;Cohort April 1;Females;Survival in the second trimester;2020QIII;3.848
49 Zamora;All ages;Cohort April 1;Females;Survival in the second trimester;2020QII;""
49 Zamora;All ages;Cohort April 1;Females;Survival in the second trimester;2020QI;""
49 Zamora;All ages;Cohort April 1;Females;Survival in the third trimester;2022QIV;3.670
49 Zamora;All ages;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
49 Zamora;All ages;Cohort April 1;Females;Survival in the third trimester;2022QII;""
49 Zamora;All ages;Cohort April 1;Females;Survival in the third trimester;2022QI;""
49 Zamora;All ages;Cohort April 1;Females;Survival in the third trimester;2021QIV;3.736
49 Zamora;All ages;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
49 Zamora;All ages;Cohort April 1;Females;Survival in the third trimester;2021QII;""
49 Zamora;All ages;Cohort April 1;Females;Survival in the third trimester;2021QI;""
49 Zamora;All ages;Cohort April 1;Females;Survival in the third trimester;2020QIV;3.736
49 Zamora;All ages;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
49 Zamora;All ages;Cohort April 1;Females;Survival in the third trimester;2020QII;""
49 Zamora;All ages;Cohort April 1;Females;Survival in the third trimester;2020QI;""
49 Zamora;All ages;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
49 Zamora;All ages;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
49 Zamora;All ages;Cohort April 1;Females;Survival in the third trimester;2022QII;""
49 Zamora;All ages;Cohort April 1;Females;Survival in the third trimester;2022QI;3.648
49 Zamora;All ages;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
49 Zamora;All ages;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
49 Zamora;All ages;Cohort April 1;Females;Survival in the third trimester;2021QII;""
49 Zamora;All ages;Cohort April 1;Females;Survival in the third trimester;2021QI;3.666
49 Zamora;All ages;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
49 Zamora;All ages;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
49 Zamora;All ages;Cohort April 1;Females;Survival in the third trimester;2020QII;""
49 Zamora;All ages;Cohort April 1;Females;Survival in the third trimester;2020QI;""
49 Zamora;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
49 Zamora;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
49 Zamora;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
49 Zamora;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
49 Zamora;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
49 Zamora;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
49 Zamora;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
49 Zamora;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
49 Zamora;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
49 Zamora;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
49 Zamora;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
49 Zamora;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
49 Zamora;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
49 Zamora;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
49 Zamora;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;97,05
49 Zamora;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
49 Zamora;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
49 Zamora;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
49 Zamora;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;97,33
49 Zamora;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
49 Zamora;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
49 Zamora;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
49 Zamora;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;97,51
49 Zamora;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
49 Zamora;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
49 Zamora;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;94,17
49 Zamora;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
49 Zamora;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
49 Zamora;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
49 Zamora;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;94,61
49 Zamora;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
49 Zamora;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
49 Zamora;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
49 Zamora;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;94,75
49 Zamora;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
49 Zamora;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
49 Zamora;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;90,98
49 Zamora;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
49 Zamora;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
49 Zamora;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
49 Zamora;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;92,43
49 Zamora;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
49 Zamora;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
49 Zamora;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
49 Zamora;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;92
49 Zamora;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
49 Zamora;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
49 Zamora;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
49 Zamora;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
49 Zamora;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
49 Zamora;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
49 Zamora;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;90,25
49 Zamora;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
49 Zamora;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
49 Zamora;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
49 Zamora;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;90,27
49 Zamora;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
49 Zamora;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
49 Zamora;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
49 Zamora;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
49 Zamora;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
49 Zamora;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QIII;11.455
49 Zamora;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
49 Zamora;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
49 Zamora;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
49 Zamora;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QIII;11.591
49 Zamora;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
49 Zamora;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
49 Zamora;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
49 Zamora;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QIII;11.597
49 Zamora;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
49 Zamora;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
49 Zamora;All ages;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
49 Zamora;All ages;Cohort July 1;Total;Survival in the first trimester;2022QIII;11.113
49 Zamora;All ages;Cohort July 1;Total;Survival in the first trimester;2022QII;""
49 Zamora;All ages;Cohort July 1;Total;Survival in the first trimester;2022QI;""
49 Zamora;All ages;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
49 Zamora;All ages;Cohort July 1;Total;Survival in the first trimester;2021QIII;11.284
49 Zamora;All ages;Cohort July 1;Total;Survival in the first trimester;2021QII;""
49 Zamora;All ages;Cohort July 1;Total;Survival in the first trimester;2021QI;""
49 Zamora;All ages;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
49 Zamora;All ages;Cohort July 1;Total;Survival in the first trimester;2020QIII;11.273
49 Zamora;All ages;Cohort July 1;Total;Survival in the first trimester;2020QII;""
49 Zamora;All ages;Cohort July 1;Total;Survival in the first trimester;2020QI;""
49 Zamora;All ages;Cohort July 1;Total;Survival in the second trimester;2022QIV;10.707
49 Zamora;All ages;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
49 Zamora;All ages;Cohort July 1;Total;Survival in the second trimester;2022QII;""
49 Zamora;All ages;Cohort July 1;Total;Survival in the second trimester;2022QI;""
49 Zamora;All ages;Cohort July 1;Total;Survival in the second trimester;2021QIV;10.996
49 Zamora;All ages;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
49 Zamora;All ages;Cohort July 1;Total;Survival in the second trimester;2021QII;""
49 Zamora;All ages;Cohort July 1;Total;Survival in the second trimester;2021QI;""
49 Zamora;All ages;Cohort July 1;Total;Survival in the second trimester;2020QIV;10.970
49 Zamora;All ages;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
49 Zamora;All ages;Cohort July 1;Total;Survival in the second trimester;2020QII;""
49 Zamora;All ages;Cohort July 1;Total;Survival in the second trimester;2020QI;""
49 Zamora;All ages;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
49 Zamora;All ages;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
49 Zamora;All ages;Cohort July 1;Total;Survival in the third trimester;2022QII;""
49 Zamora;All ages;Cohort July 1;Total;Survival in the third trimester;2022QI;10.772
49 Zamora;All ages;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
49 Zamora;All ages;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
49 Zamora;All ages;Cohort July 1;Total;Survival in the third trimester;2021QII;""
49 Zamora;All ages;Cohort July 1;Total;Survival in the third trimester;2021QI;10.769
49 Zamora;All ages;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
49 Zamora;All ages;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
49 Zamora;All ages;Cohort July 1;Total;Survival in the third trimester;2020QII;""
49 Zamora;All ages;Cohort July 1;Total;Survival in the third trimester;2020QI;""
49 Zamora;All ages;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
49 Zamora;All ages;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
49 Zamora;All ages;Cohort July 1;Total;Survival in the third trimester;2022QII;10.534
49 Zamora;All ages;Cohort July 1;Total;Survival in the third trimester;2022QI;""
49 Zamora;All ages;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
49 Zamora;All ages;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
49 Zamora;All ages;Cohort July 1;Total;Survival in the third trimester;2021QII;10.600
49 Zamora;All ages;Cohort July 1;Total;Survival in the third trimester;2021QI;""
49 Zamora;All ages;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
49 Zamora;All ages;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
49 Zamora;All ages;Cohort July 1;Total;Survival in the third trimester;2020QII;""
49 Zamora;All ages;Cohort July 1;Total;Survival in the third trimester;2020QI;""
49 Zamora;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
49 Zamora;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
49 Zamora;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
49 Zamora;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
49 Zamora;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
49 Zamora;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
49 Zamora;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
49 Zamora;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
49 Zamora;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
49 Zamora;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
49 Zamora;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
49 Zamora;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
49 Zamora;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
49 Zamora;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;97,01
49 Zamora;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
49 Zamora;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
49 Zamora;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
49 Zamora;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;97,35
49 Zamora;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
49 Zamora;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
49 Zamora;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
49 Zamora;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;97,21
49 Zamora;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
49 Zamora;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
49 Zamora;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;93,47
49 Zamora;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
49 Zamora;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
49 Zamora;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
49 Zamora;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;94,87
49 Zamora;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
49 Zamora;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
49 Zamora;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
49 Zamora;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;94,59
49 Zamora;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
49 Zamora;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
49 Zamora;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
49 Zamora;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
49 Zamora;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
49 Zamora;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
49 Zamora;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;92,93
49 Zamora;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
49 Zamora;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
49 Zamora;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
49 Zamora;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;92,86
49 Zamora;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
49 Zamora;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
49 Zamora;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
49 Zamora;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
49 Zamora;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
49 Zamora;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
49 Zamora;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;90,88
49 Zamora;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
49 Zamora;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
49 Zamora;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
49 Zamora;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;91,4
49 Zamora;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
49 Zamora;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
49 Zamora;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
49 Zamora;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
49 Zamora;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
49 Zamora;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
49 Zamora;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QIII;7.415
49 Zamora;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
49 Zamora;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
49 Zamora;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
49 Zamora;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QIII;7.532
49 Zamora;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
49 Zamora;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
49 Zamora;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
49 Zamora;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QIII;7.552
49 Zamora;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
49 Zamora;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
49 Zamora;All ages;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
49 Zamora;All ages;Cohort July 1;Males;Survival in the first trimester;2022QIII;7.218
49 Zamora;All ages;Cohort July 1;Males;Survival in the first trimester;2022QII;""
49 Zamora;All ages;Cohort July 1;Males;Survival in the first trimester;2022QI;""
49 Zamora;All ages;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
49 Zamora;All ages;Cohort July 1;Males;Survival in the first trimester;2021QIII;7.356
49 Zamora;All ages;Cohort July 1;Males;Survival in the first trimester;2021QII;""
49 Zamora;All ages;Cohort July 1;Males;Survival in the first trimester;2021QI;""
49 Zamora;All ages;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
49 Zamora;All ages;Cohort July 1;Males;Survival in the first trimester;2020QIII;7.353
49 Zamora;All ages;Cohort July 1;Males;Survival in the first trimester;2020QII;""
49 Zamora;All ages;Cohort July 1;Males;Survival in the first trimester;2020QI;""
49 Zamora;All ages;Cohort July 1;Males;Survival in the second trimester;2022QIV;6.955
49 Zamora;All ages;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
49 Zamora;All ages;Cohort July 1;Males;Survival in the second trimester;2022QII;""
49 Zamora;All ages;Cohort July 1;Males;Survival in the second trimester;2022QI;""
49 Zamora;All ages;Cohort July 1;Males;Survival in the second trimester;2021QIV;7.165
49 Zamora;All ages;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
49 Zamora;All ages;Cohort July 1;Males;Survival in the second trimester;2021QII;""
49 Zamora;All ages;Cohort July 1;Males;Survival in the second trimester;2021QI;""
49 Zamora;All ages;Cohort July 1;Males;Survival in the second trimester;2020QIV;7.170
49 Zamora;All ages;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
49 Zamora;All ages;Cohort July 1;Males;Survival in the second trimester;2020QII;""
49 Zamora;All ages;Cohort July 1;Males;Survival in the second trimester;2020QI;""
49 Zamora;All ages;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
49 Zamora;All ages;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
49 Zamora;All ages;Cohort July 1;Males;Survival in the third trimester;2022QII;""
49 Zamora;All ages;Cohort July 1;Males;Survival in the third trimester;2022QI;7.035
49 Zamora;All ages;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
49 Zamora;All ages;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
49 Zamora;All ages;Cohort July 1;Males;Survival in the third trimester;2021QII;""
49 Zamora;All ages;Cohort July 1;Males;Survival in the third trimester;2021QI;7.042
49 Zamora;All ages;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
49 Zamora;All ages;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
49 Zamora;All ages;Cohort July 1;Males;Survival in the third trimester;2020QII;""
49 Zamora;All ages;Cohort July 1;Males;Survival in the third trimester;2020QI;""
49 Zamora;All ages;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
49 Zamora;All ages;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
49 Zamora;All ages;Cohort July 1;Males;Survival in the third trimester;2022QII;6.883
49 Zamora;All ages;Cohort July 1;Males;Survival in the third trimester;2022QI;""
49 Zamora;All ages;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
49 Zamora;All ages;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
49 Zamora;All ages;Cohort July 1;Males;Survival in the third trimester;2021QII;6.946
49 Zamora;All ages;Cohort July 1;Males;Survival in the third trimester;2021QI;""
49 Zamora;All ages;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
49 Zamora;All ages;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
49 Zamora;All ages;Cohort July 1;Males;Survival in the third trimester;2020QII;""
49 Zamora;All ages;Cohort July 1;Males;Survival in the third trimester;2020QI;""
49 Zamora;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
49 Zamora;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
49 Zamora;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
49 Zamora;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
49 Zamora;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
49 Zamora;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
49 Zamora;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
49 Zamora;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
49 Zamora;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
49 Zamora;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
49 Zamora;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
49 Zamora;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
49 Zamora;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
49 Zamora;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;97,34
49 Zamora;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
49 Zamora;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
49 Zamora;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
49 Zamora;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;97,66
49 Zamora;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
49 Zamora;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
49 Zamora;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
49 Zamora;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;97,36
49 Zamora;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
49 Zamora;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
49 Zamora;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;93,8
49 Zamora;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
49 Zamora;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
49 Zamora;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
49 Zamora;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;95,13
49 Zamora;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
49 Zamora;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
49 Zamora;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
49 Zamora;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;94,94
49 Zamora;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
49 Zamora;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
49 Zamora;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
49 Zamora;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
49 Zamora;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
49 Zamora;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
49 Zamora;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;93,4
49 Zamora;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
49 Zamora;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
49 Zamora;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
49 Zamora;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;93,25
49 Zamora;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
49 Zamora;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
49 Zamora;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
49 Zamora;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
49 Zamora;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
49 Zamora;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
49 Zamora;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;91,38
49 Zamora;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
49 Zamora;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
49 Zamora;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
49 Zamora;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;91,98
49 Zamora;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
49 Zamora;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
49 Zamora;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
49 Zamora;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
49 Zamora;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
49 Zamora;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
49 Zamora;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QIII;4.040
49 Zamora;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
49 Zamora;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
49 Zamora;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
49 Zamora;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QIII;4.059
49 Zamora;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
49 Zamora;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
49 Zamora;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
49 Zamora;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QIII;4.045
49 Zamora;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
49 Zamora;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
49 Zamora;All ages;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
49 Zamora;All ages;Cohort July 1;Females;Survival in the first trimester;2022QIII;3.895
49 Zamora;All ages;Cohort July 1;Females;Survival in the first trimester;2022QII;""
49 Zamora;All ages;Cohort July 1;Females;Survival in the first trimester;2022QI;""
49 Zamora;All ages;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
49 Zamora;All ages;Cohort July 1;Females;Survival in the first trimester;2021QIII;3.928
49 Zamora;All ages;Cohort July 1;Females;Survival in the first trimester;2021QII;""
49 Zamora;All ages;Cohort July 1;Females;Survival in the first trimester;2021QI;""
49 Zamora;All ages;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
49 Zamora;All ages;Cohort July 1;Females;Survival in the first trimester;2020QIII;3.920
49 Zamora;All ages;Cohort July 1;Females;Survival in the first trimester;2020QII;""
49 Zamora;All ages;Cohort July 1;Females;Survival in the first trimester;2020QI;""
49 Zamora;All ages;Cohort July 1;Females;Survival in the second trimester;2022QIV;3.752
49 Zamora;All ages;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
49 Zamora;All ages;Cohort July 1;Females;Survival in the second trimester;2022QII;""
49 Zamora;All ages;Cohort July 1;Females;Survival in the second trimester;2022QI;""
49 Zamora;All ages;Cohort July 1;Females;Survival in the second trimester;2021QIV;3.831
49 Zamora;All ages;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
49 Zamora;All ages;Cohort July 1;Females;Survival in the second trimester;2021QII;""
49 Zamora;All ages;Cohort July 1;Females;Survival in the second trimester;2021QI;""
49 Zamora;All ages;Cohort July 1;Females;Survival in the second trimester;2020QIV;3.800
49 Zamora;All ages;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
49 Zamora;All ages;Cohort July 1;Females;Survival in the second trimester;2020QII;""
49 Zamora;All ages;Cohort July 1;Females;Survival in the second trimester;2020QI;""
49 Zamora;All ages;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
49 Zamora;All ages;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
49 Zamora;All ages;Cohort July 1;Females;Survival in the third trimester;2022QII;""
49 Zamora;All ages;Cohort July 1;Females;Survival in the third trimester;2022QI;3.737
49 Zamora;All ages;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
49 Zamora;All ages;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
49 Zamora;All ages;Cohort July 1;Females;Survival in the third trimester;2021QII;""
49 Zamora;All ages;Cohort July 1;Females;Survival in the third trimester;2021QI;3.727
49 Zamora;All ages;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
49 Zamora;All ages;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
49 Zamora;All ages;Cohort July 1;Females;Survival in the third trimester;2020QII;""
49 Zamora;All ages;Cohort July 1;Females;Survival in the third trimester;2020QI;""
49 Zamora;All ages;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
49 Zamora;All ages;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
49 Zamora;All ages;Cohort July 1;Females;Survival in the third trimester;2022QII;3.651
49 Zamora;All ages;Cohort July 1;Females;Survival in the third trimester;2022QI;""
49 Zamora;All ages;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
49 Zamora;All ages;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
49 Zamora;All ages;Cohort July 1;Females;Survival in the third trimester;2021QII;3.654
49 Zamora;All ages;Cohort July 1;Females;Survival in the third trimester;2021QI;""
49 Zamora;All ages;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
49 Zamora;All ages;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
49 Zamora;All ages;Cohort July 1;Females;Survival in the third trimester;2020QII;""
49 Zamora;All ages;Cohort July 1;Females;Survival in the third trimester;2020QI;""
49 Zamora;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
49 Zamora;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
49 Zamora;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
49 Zamora;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
49 Zamora;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
49 Zamora;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
49 Zamora;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
49 Zamora;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
49 Zamora;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
49 Zamora;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
49 Zamora;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
49 Zamora;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
49 Zamora;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
49 Zamora;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;96,41
49 Zamora;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
49 Zamora;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
49 Zamora;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
49 Zamora;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;96,77
49 Zamora;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
49 Zamora;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
49 Zamora;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
49 Zamora;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;96,91
49 Zamora;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
49 Zamora;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
49 Zamora;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;92,87
49 Zamora;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
49 Zamora;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
49 Zamora;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
49 Zamora;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;94,38
49 Zamora;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
49 Zamora;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
49 Zamora;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
49 Zamora;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;93,94
49 Zamora;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
49 Zamora;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
49 Zamora;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
49 Zamora;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
49 Zamora;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
49 Zamora;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
49 Zamora;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;92,07
49 Zamora;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
49 Zamora;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
49 Zamora;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
49 Zamora;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;92,14
49 Zamora;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
49 Zamora;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
49 Zamora;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
49 Zamora;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
49 Zamora;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
49 Zamora;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
49 Zamora;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;89,95
49 Zamora;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
49 Zamora;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
49 Zamora;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
49 Zamora;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;90,33
49 Zamora;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
49 Zamora;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
49 Zamora;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
49 Zamora;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
49 Zamora;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
49 Zamora;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QIV;11.342
49 Zamora;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
49 Zamora;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
49 Zamora;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
49 Zamora;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QIV;11.536
49 Zamora;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
49 Zamora;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
49 Zamora;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
49 Zamora;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QIV;11.583
49 Zamora;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
49 Zamora;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
49 Zamora;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
49 Zamora;All ages;Cohort October 1;Total;Survival in the first trimester;2022QIV;10.893
49 Zamora;All ages;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
49 Zamora;All ages;Cohort October 1;Total;Survival in the first trimester;2022QII;""
49 Zamora;All ages;Cohort October 1;Total;Survival in the first trimester;2022QI;""
49 Zamora;All ages;Cohort October 1;Total;Survival in the first trimester;2021QIV;11.209
49 Zamora;All ages;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
49 Zamora;All ages;Cohort October 1;Total;Survival in the first trimester;2021QII;""
49 Zamora;All ages;Cohort October 1;Total;Survival in the first trimester;2021QI;""
49 Zamora;All ages;Cohort October 1;Total;Survival in the first trimester;2020QIV;11.238
49 Zamora;All ages;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
49 Zamora;All ages;Cohort October 1;Total;Survival in the first trimester;2020QII;""
49 Zamora;All ages;Cohort October 1;Total;Survival in the first trimester;2020QI;""
49 Zamora;All ages;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
49 Zamora;All ages;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
49 Zamora;All ages;Cohort October 1;Total;Survival in the second trimester;2022QII;""
49 Zamora;All ages;Cohort October 1;Total;Survival in the second trimester;2022QI;10.970
49 Zamora;All ages;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
49 Zamora;All ages;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
49 Zamora;All ages;Cohort October 1;Total;Survival in the second trimester;2021QII;""
49 Zamora;All ages;Cohort October 1;Total;Survival in the second trimester;2021QI;11.018
49 Zamora;All ages;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
49 Zamora;All ages;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
49 Zamora;All ages;Cohort October 1;Total;Survival in the second trimester;2020QII;""
49 Zamora;All ages;Cohort October 1;Total;Survival in the second trimester;2020QI;""
49 Zamora;All ages;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
49 Zamora;All ages;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
49 Zamora;All ages;Cohort October 1;Total;Survival in the third trimester;2022QII;10.718
49 Zamora;All ages;Cohort October 1;Total;Survival in the third trimester;2022QI;""
49 Zamora;All ages;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
49 Zamora;All ages;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
49 Zamora;All ages;Cohort October 1;Total;Survival in the third trimester;2021QII;10.836
49 Zamora;All ages;Cohort October 1;Total;Survival in the third trimester;2021QI;""
49 Zamora;All ages;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
49 Zamora;All ages;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
49 Zamora;All ages;Cohort October 1;Total;Survival in the third trimester;2020QII;""
49 Zamora;All ages;Cohort October 1;Total;Survival in the third trimester;2020QI;""
49 Zamora;All ages;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
49 Zamora;All ages;Cohort October 1;Total;Survival in the third trimester;2022QIII;10.485
49 Zamora;All ages;Cohort October 1;Total;Survival in the third trimester;2022QII;""
49 Zamora;All ages;Cohort October 1;Total;Survival in the third trimester;2022QI;""
49 Zamora;All ages;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
49 Zamora;All ages;Cohort October 1;Total;Survival in the third trimester;2021QIII;10.622
49 Zamora;All ages;Cohort October 1;Total;Survival in the third trimester;2021QII;""
49 Zamora;All ages;Cohort October 1;Total;Survival in the third trimester;2021QI;""
49 Zamora;All ages;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
49 Zamora;All ages;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
49 Zamora;All ages;Cohort October 1;Total;Survival in the third trimester;2020QII;""
49 Zamora;All ages;Cohort October 1;Total;Survival in the third trimester;2020QI;""
49 Zamora;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
49 Zamora;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
49 Zamora;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
49 Zamora;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
49 Zamora;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
49 Zamora;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
49 Zamora;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
49 Zamora;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
49 Zamora;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
49 Zamora;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
49 Zamora;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
49 Zamora;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
49 Zamora;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;96,04
49 Zamora;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
49 Zamora;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
49 Zamora;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
49 Zamora;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;97,17
49 Zamora;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
49 Zamora;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
49 Zamora;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
49 Zamora;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;97,02
49 Zamora;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
49 Zamora;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
49 Zamora;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
49 Zamora;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
49 Zamora;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
49 Zamora;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
49 Zamora;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;95,09
49 Zamora;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
49 Zamora;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
49 Zamora;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
49 Zamora;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;95,12
49 Zamora;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
49 Zamora;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
49 Zamora;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
49 Zamora;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
49 Zamora;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
49 Zamora;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
49 Zamora;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;92,91
49 Zamora;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
49 Zamora;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
49 Zamora;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
49 Zamora;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;93,55
49 Zamora;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
49 Zamora;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
49 Zamora;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
49 Zamora;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
49 Zamora;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
49 Zamora;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
49 Zamora;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;90,89
49 Zamora;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
49 Zamora;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
49 Zamora;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
49 Zamora;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;91,7
49 Zamora;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
49 Zamora;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
49 Zamora;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
49 Zamora;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
49 Zamora;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
49 Zamora;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
49 Zamora;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QIV;7.350
49 Zamora;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
49 Zamora;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
49 Zamora;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
49 Zamora;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QIV;7.487
49 Zamora;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
49 Zamora;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
49 Zamora;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
49 Zamora;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QIV;7.530
49 Zamora;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
49 Zamora;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
49 Zamora;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
49 Zamora;All ages;Cohort October 1;Males;Survival in the first trimester;2022QIV;7.056
49 Zamora;All ages;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
49 Zamora;All ages;Cohort October 1;Males;Survival in the first trimester;2022QII;""
49 Zamora;All ages;Cohort October 1;Males;Survival in the first trimester;2022QI;""
49 Zamora;All ages;Cohort October 1;Males;Survival in the first trimester;2021QIV;7.274
49 Zamora;All ages;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
49 Zamora;All ages;Cohort October 1;Males;Survival in the first trimester;2021QII;""
49 Zamora;All ages;Cohort October 1;Males;Survival in the first trimester;2021QI;""
49 Zamora;All ages;Cohort October 1;Males;Survival in the first trimester;2020QIV;7.319
49 Zamora;All ages;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
49 Zamora;All ages;Cohort October 1;Males;Survival in the first trimester;2020QII;""
49 Zamora;All ages;Cohort October 1;Males;Survival in the first trimester;2020QI;""
49 Zamora;All ages;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
49 Zamora;All ages;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
49 Zamora;All ages;Cohort October 1;Males;Survival in the second trimester;2022QII;""
49 Zamora;All ages;Cohort October 1;Males;Survival in the second trimester;2022QI;7.136
49 Zamora;All ages;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
49 Zamora;All ages;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
49 Zamora;All ages;Cohort October 1;Males;Survival in the second trimester;2021QII;""
49 Zamora;All ages;Cohort October 1;Males;Survival in the second trimester;2021QI;7.181
49 Zamora;All ages;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
49 Zamora;All ages;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
49 Zamora;All ages;Cohort October 1;Males;Survival in the second trimester;2020QII;""
49 Zamora;All ages;Cohort October 1;Males;Survival in the second trimester;2020QI;""
49 Zamora;All ages;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
49 Zamora;All ages;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
49 Zamora;All ages;Cohort October 1;Males;Survival in the third trimester;2022QII;6.979
49 Zamora;All ages;Cohort October 1;Males;Survival in the third trimester;2022QI;""
49 Zamora;All ages;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
49 Zamora;All ages;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
49 Zamora;All ages;Cohort October 1;Males;Survival in the third trimester;2021QII;7.080
49 Zamora;All ages;Cohort October 1;Males;Survival in the third trimester;2021QI;""
49 Zamora;All ages;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
49 Zamora;All ages;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
49 Zamora;All ages;Cohort October 1;Males;Survival in the third trimester;2020QII;""
49 Zamora;All ages;Cohort October 1;Males;Survival in the third trimester;2020QI;""
49 Zamora;All ages;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
49 Zamora;All ages;Cohort October 1;Males;Survival in the third trimester;2022QIII;6.844
49 Zamora;All ages;Cohort October 1;Males;Survival in the third trimester;2022QII;""
49 Zamora;All ages;Cohort October 1;Males;Survival in the third trimester;2022QI;""
49 Zamora;All ages;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
49 Zamora;All ages;Cohort October 1;Males;Survival in the third trimester;2021QIII;6.967
49 Zamora;All ages;Cohort October 1;Males;Survival in the third trimester;2021QII;""
49 Zamora;All ages;Cohort October 1;Males;Survival in the third trimester;2021QI;""
49 Zamora;All ages;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
49 Zamora;All ages;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
49 Zamora;All ages;Cohort October 1;Males;Survival in the third trimester;2020QII;""
49 Zamora;All ages;Cohort October 1;Males;Survival in the third trimester;2020QI;""
49 Zamora;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
49 Zamora;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
49 Zamora;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
49 Zamora;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
49 Zamora;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
49 Zamora;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
49 Zamora;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
49 Zamora;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
49 Zamora;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
49 Zamora;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
49 Zamora;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
49 Zamora;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
49 Zamora;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;96
49 Zamora;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
49 Zamora;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
49 Zamora;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
49 Zamora;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;97,16
49 Zamora;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
49 Zamora;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
49 Zamora;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
49 Zamora;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;97,2
49 Zamora;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
49 Zamora;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
49 Zamora;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
49 Zamora;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
49 Zamora;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
49 Zamora;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
49 Zamora;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;95,31
49 Zamora;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
49 Zamora;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
49 Zamora;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
49 Zamora;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;95,37
49 Zamora;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
49 Zamora;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
49 Zamora;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
49 Zamora;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
49 Zamora;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
49 Zamora;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
49 Zamora;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;93,21
49 Zamora;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
49 Zamora;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
49 Zamora;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
49 Zamora;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;94,02
49 Zamora;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
49 Zamora;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
49 Zamora;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
49 Zamora;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
49 Zamora;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
49 Zamora;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
49 Zamora;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;91,41
49 Zamora;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
49 Zamora;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
49 Zamora;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
49 Zamora;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;92,52
49 Zamora;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
49 Zamora;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
49 Zamora;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
49 Zamora;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
49 Zamora;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
49 Zamora;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
49 Zamora;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QIV;3.992
49 Zamora;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
49 Zamora;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
49 Zamora;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
49 Zamora;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QIV;4.049
49 Zamora;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
49 Zamora;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
49 Zamora;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
49 Zamora;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QIV;4.053
49 Zamora;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
49 Zamora;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
49 Zamora;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
49 Zamora;All ages;Cohort October 1;Females;Survival in the first trimester;2022QIV;3.837
49 Zamora;All ages;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
49 Zamora;All ages;Cohort October 1;Females;Survival in the first trimester;2022QII;""
49 Zamora;All ages;Cohort October 1;Females;Survival in the first trimester;2022QI;""
49 Zamora;All ages;Cohort October 1;Females;Survival in the first trimester;2021QIV;3.935
49 Zamora;All ages;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
49 Zamora;All ages;Cohort October 1;Females;Survival in the first trimester;2021QII;""
49 Zamora;All ages;Cohort October 1;Females;Survival in the first trimester;2021QI;""
49 Zamora;All ages;Cohort October 1;Females;Survival in the first trimester;2020QIV;3.919
49 Zamora;All ages;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
49 Zamora;All ages;Cohort October 1;Females;Survival in the first trimester;2020QII;""
49 Zamora;All ages;Cohort October 1;Females;Survival in the first trimester;2020QI;""
49 Zamora;All ages;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
49 Zamora;All ages;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
49 Zamora;All ages;Cohort October 1;Females;Survival in the second trimester;2022QII;""
49 Zamora;All ages;Cohort October 1;Females;Survival in the second trimester;2022QI;3.834
49 Zamora;All ages;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
49 Zamora;All ages;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
49 Zamora;All ages;Cohort October 1;Females;Survival in the second trimester;2021QII;""
49 Zamora;All ages;Cohort October 1;Females;Survival in the second trimester;2021QI;3.837
49 Zamora;All ages;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
49 Zamora;All ages;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
49 Zamora;All ages;Cohort October 1;Females;Survival in the second trimester;2020QII;""
49 Zamora;All ages;Cohort October 1;Females;Survival in the second trimester;2020QI;""
49 Zamora;All ages;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
49 Zamora;All ages;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
49 Zamora;All ages;Cohort October 1;Females;Survival in the third trimester;2022QII;3.739
49 Zamora;All ages;Cohort October 1;Females;Survival in the third trimester;2022QI;""
49 Zamora;All ages;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
49 Zamora;All ages;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
49 Zamora;All ages;Cohort October 1;Females;Survival in the third trimester;2021QII;3.756
49 Zamora;All ages;Cohort October 1;Females;Survival in the third trimester;2021QI;""
49 Zamora;All ages;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
49 Zamora;All ages;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
49 Zamora;All ages;Cohort October 1;Females;Survival in the third trimester;2020QII;""
49 Zamora;All ages;Cohort October 1;Females;Survival in the third trimester;2020QI;""
49 Zamora;All ages;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
49 Zamora;All ages;Cohort October 1;Females;Survival in the third trimester;2022QIII;3.641
49 Zamora;All ages;Cohort October 1;Females;Survival in the third trimester;2022QII;""
49 Zamora;All ages;Cohort October 1;Females;Survival in the third trimester;2022QI;""
49 Zamora;All ages;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
49 Zamora;All ages;Cohort October 1;Females;Survival in the third trimester;2021QIII;3.655
49 Zamora;All ages;Cohort October 1;Females;Survival in the third trimester;2021QII;""
49 Zamora;All ages;Cohort October 1;Females;Survival in the third trimester;2021QI;""
49 Zamora;All ages;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
49 Zamora;All ages;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
49 Zamora;All ages;Cohort October 1;Females;Survival in the third trimester;2020QII;""
49 Zamora;All ages;Cohort October 1;Females;Survival in the third trimester;2020QI;""
49 Zamora;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
49 Zamora;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
49 Zamora;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
49 Zamora;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
49 Zamora;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
49 Zamora;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
49 Zamora;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
49 Zamora;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
49 Zamora;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
49 Zamora;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
49 Zamora;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
49 Zamora;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
49 Zamora;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;96,12
49 Zamora;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
49 Zamora;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
49 Zamora;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
49 Zamora;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;97,18
49 Zamora;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
49 Zamora;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
49 Zamora;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
49 Zamora;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;96,69
49 Zamora;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
49 Zamora;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
49 Zamora;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
49 Zamora;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
49 Zamora;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
49 Zamora;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
49 Zamora;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;94,69
49 Zamora;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
49 Zamora;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
49 Zamora;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
49 Zamora;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;94,67
49 Zamora;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
49 Zamora;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
49 Zamora;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
49 Zamora;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
49 Zamora;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
49 Zamora;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
49 Zamora;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;92,34
49 Zamora;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
49 Zamora;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
49 Zamora;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
49 Zamora;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;92,67
49 Zamora;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
49 Zamora;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
49 Zamora;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
49 Zamora;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
49 Zamora;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
49 Zamora;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
49 Zamora;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;89,92
49 Zamora;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
49 Zamora;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
49 Zamora;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
49 Zamora;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;90,18
49 Zamora;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
49 Zamora;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
49 Zamora;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
49 Zamora;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
49 Zamora;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
49 Zamora;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
49 Zamora;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
49 Zamora;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
49 Zamora;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
49 Zamora;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QI;588
49 Zamora;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
49 Zamora;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
49 Zamora;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
49 Zamora;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QI;592
49 Zamora;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
49 Zamora;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
49 Zamora;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
49 Zamora;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QI;494
49 Zamora;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
49 Zamora;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
49 Zamora;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2022QII;""
49 Zamora;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2022QI;550
49 Zamora;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
49 Zamora;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
49 Zamora;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2021QII;""
49 Zamora;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2021QI;549
49 Zamora;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
49 Zamora;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
49 Zamora;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2020QII;""
49 Zamora;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2020QI;452
49 Zamora;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
49 Zamora;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
49 Zamora;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2022QII;520
49 Zamora;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2022QI;""
49 Zamora;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
49 Zamora;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
49 Zamora;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2021QII;517
49 Zamora;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2021QI;""
49 Zamora;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
49 Zamora;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
49 Zamora;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2020QII;430
49 Zamora;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2020QI;""
49 Zamora;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
49 Zamora;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QIII;492
49 Zamora;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QII;""
49 Zamora;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QI;""
49 Zamora;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
49 Zamora;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QIII;490
49 Zamora;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QII;""
49 Zamora;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QI;""
49 Zamora;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
49 Zamora;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QIII;404
49 Zamora;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QII;""
49 Zamora;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QI;""
49 Zamora;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QIV;458
49 Zamora;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
49 Zamora;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QII;""
49 Zamora;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QI;""
49 Zamora;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QIV;467
49 Zamora;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
49 Zamora;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QII;""
49 Zamora;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QI;""
49 Zamora;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QIV;384
49 Zamora;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
49 Zamora;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QII;""
49 Zamora;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QI;""
49 Zamora;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
49 Zamora;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
49 Zamora;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
49 Zamora;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
49 Zamora;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
49 Zamora;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
49 Zamora;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
49 Zamora;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
49 Zamora;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
49 Zamora;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
49 Zamora;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
49 Zamora;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
49 Zamora;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
49 Zamora;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
49 Zamora;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
49 Zamora;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;93,54
49 Zamora;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
49 Zamora;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
49 Zamora;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
49 Zamora;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;92,74
49 Zamora;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
49 Zamora;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
49 Zamora;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
49 Zamora;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;91,5
49 Zamora;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
49 Zamora;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
49 Zamora;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;88,44
49 Zamora;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
49 Zamora;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
49 Zamora;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
49 Zamora;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;87,33
49 Zamora;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
49 Zamora;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
49 Zamora;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
49 Zamora;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;87,04
49 Zamora;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
49 Zamora;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
49 Zamora;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;83,67
49 Zamora;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
49 Zamora;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
49 Zamora;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
49 Zamora;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;82,77
49 Zamora;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
49 Zamora;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
49 Zamora;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
49 Zamora;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;81,78
49 Zamora;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
49 Zamora;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
49 Zamora;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;77,89
49 Zamora;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
49 Zamora;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
49 Zamora;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
49 Zamora;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;78,89
49 Zamora;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
49 Zamora;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
49 Zamora;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
49 Zamora;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;77,73
49 Zamora;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
49 Zamora;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
49 Zamora;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
49 Zamora;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
49 Zamora;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
49 Zamora;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
49 Zamora;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QI;369
49 Zamora;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
49 Zamora;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
49 Zamora;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
49 Zamora;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QI;391
49 Zamora;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
49 Zamora;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
49 Zamora;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
49 Zamora;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QI;324
49 Zamora;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
49 Zamora;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
49 Zamora;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2022QII;""
49 Zamora;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2022QI;350
49 Zamora;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
49 Zamora;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
49 Zamora;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2021QII;""
49 Zamora;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2021QI;363
49 Zamora;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
49 Zamora;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
49 Zamora;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2020QII;""
49 Zamora;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2020QI;294
49 Zamora;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
49 Zamora;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
49 Zamora;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2022QII;332
49 Zamora;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2022QI;""
49 Zamora;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
49 Zamora;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
49 Zamora;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2021QII;344
49 Zamora;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2021QI;""
49 Zamora;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
49 Zamora;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
49 Zamora;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2020QII;281
49 Zamora;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2020QI;""
49 Zamora;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
49 Zamora;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QIII;314
49 Zamora;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QII;""
49 Zamora;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QI;""
49 Zamora;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
49 Zamora;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QIII;326
49 Zamora;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QII;""
49 Zamora;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QI;""
49 Zamora;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
49 Zamora;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QIII;263
49 Zamora;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QII;""
49 Zamora;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QI;""
49 Zamora;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QIV;293
49 Zamora;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
49 Zamora;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QII;""
49 Zamora;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QI;""
49 Zamora;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QIV;308
49 Zamora;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
49 Zamora;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QII;""
49 Zamora;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QI;""
49 Zamora;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QIV;254
49 Zamora;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
49 Zamora;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QII;""
49 Zamora;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QI;""
49 Zamora;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
49 Zamora;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
49 Zamora;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
49 Zamora;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
49 Zamora;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
49 Zamora;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
49 Zamora;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
49 Zamora;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
49 Zamora;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
49 Zamora;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
49 Zamora;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
49 Zamora;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
49 Zamora;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
49 Zamora;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
49 Zamora;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
49 Zamora;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;94,85
49 Zamora;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
49 Zamora;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
49 Zamora;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
49 Zamora;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;92,84
49 Zamora;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
49 Zamora;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
49 Zamora;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
49 Zamora;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;90,74
49 Zamora;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
49 Zamora;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
49 Zamora;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;89,97
49 Zamora;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
49 Zamora;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
49 Zamora;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
49 Zamora;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;87,98
49 Zamora;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
49 Zamora;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
49 Zamora;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
49 Zamora;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;86,73
49 Zamora;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
49 Zamora;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
49 Zamora;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;85,09
49 Zamora;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
49 Zamora;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
49 Zamora;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
49 Zamora;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;83,38
49 Zamora;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
49 Zamora;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
49 Zamora;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
49 Zamora;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;81,17
49 Zamora;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
49 Zamora;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
49 Zamora;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;79,4
49 Zamora;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
49 Zamora;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
49 Zamora;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
49 Zamora;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;78,77
49 Zamora;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
49 Zamora;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
49 Zamora;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
49 Zamora;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;78,4
49 Zamora;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
49 Zamora;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
49 Zamora;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
49 Zamora;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
49 Zamora;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
49 Zamora;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
49 Zamora;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QI;219
49 Zamora;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
49 Zamora;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
49 Zamora;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
49 Zamora;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QI;201
49 Zamora;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
49 Zamora;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
49 Zamora;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
49 Zamora;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QI;170
49 Zamora;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
49 Zamora;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
49 Zamora;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2022QII;""
49 Zamora;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2022QI;200
49 Zamora;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
49 Zamora;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
49 Zamora;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2021QII;""
49 Zamora;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2021QI;186
49 Zamora;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
49 Zamora;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
49 Zamora;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2020QII;""
49 Zamora;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2020QI;158
49 Zamora;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
49 Zamora;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
49 Zamora;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2022QII;188
49 Zamora;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2022QI;""
49 Zamora;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
49 Zamora;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
49 Zamora;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2021QII;173
49 Zamora;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2021QI;""
49 Zamora;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
49 Zamora;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
49 Zamora;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2020QII;149
49 Zamora;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2020QI;""
49 Zamora;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
49 Zamora;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QIII;178
49 Zamora;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QII;""
49 Zamora;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QI;""
49 Zamora;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
49 Zamora;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QIII;164
49 Zamora;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QII;""
49 Zamora;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QI;""
49 Zamora;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
49 Zamora;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QIII;141
49 Zamora;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QII;""
49 Zamora;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QI;""
49 Zamora;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QIV;165
49 Zamora;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
49 Zamora;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QII;""
49 Zamora;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QI;""
49 Zamora;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QIV;159
49 Zamora;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
49 Zamora;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QII;""
49 Zamora;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QI;""
49 Zamora;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QIV;130
49 Zamora;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
49 Zamora;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QII;""
49 Zamora;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QI;""
49 Zamora;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
49 Zamora;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
49 Zamora;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
49 Zamora;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
49 Zamora;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
49 Zamora;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
49 Zamora;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
49 Zamora;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
49 Zamora;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
49 Zamora;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
49 Zamora;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
49 Zamora;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
49 Zamora;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
49 Zamora;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
49 Zamora;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
49 Zamora;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;91,32
49 Zamora;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
49 Zamora;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
49 Zamora;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
49 Zamora;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;92,54
49 Zamora;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
49 Zamora;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
49 Zamora;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
49 Zamora;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;92,94
49 Zamora;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
49 Zamora;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
49 Zamora;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;85,84
49 Zamora;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
49 Zamora;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
49 Zamora;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
49 Zamora;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;86,07
49 Zamora;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
49 Zamora;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
49 Zamora;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
49 Zamora;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;87,65
49 Zamora;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
49 Zamora;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
49 Zamora;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;81,28
49 Zamora;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
49 Zamora;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
49 Zamora;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
49 Zamora;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;81,59
49 Zamora;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
49 Zamora;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
49 Zamora;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
49 Zamora;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;82,94
49 Zamora;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
49 Zamora;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
49 Zamora;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;75,34
49 Zamora;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
49 Zamora;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
49 Zamora;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
49 Zamora;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;79,1
49 Zamora;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
49 Zamora;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
49 Zamora;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
49 Zamora;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;76,47
49 Zamora;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
49 Zamora;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
49 Zamora;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
49 Zamora;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
49 Zamora;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
49 Zamora;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QII;513
49 Zamora;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
49 Zamora;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
49 Zamora;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
49 Zamora;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QII;522
49 Zamora;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
49 Zamora;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
49 Zamora;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
49 Zamora;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QII;500
49 Zamora;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
49 Zamora;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
49 Zamora;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
49 Zamora;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2022QII;482
49 Zamora;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2022QI;""
49 Zamora;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
49 Zamora;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
49 Zamora;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2021QII;486
49 Zamora;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2021QI;""
49 Zamora;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
49 Zamora;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
49 Zamora;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2020QII;474
49 Zamora;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2020QI;""
49 Zamora;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
49 Zamora;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2022QIII;451
49 Zamora;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2022QII;""
49 Zamora;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2022QI;""
49 Zamora;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
49 Zamora;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2021QIII;458
49 Zamora;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2021QII;""
49 Zamora;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2021QI;""
49 Zamora;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
49 Zamora;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2020QIII;443
49 Zamora;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2020QII;""
49 Zamora;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2020QI;""
49 Zamora;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QIV;416
49 Zamora;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
49 Zamora;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QII;""
49 Zamora;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QI;""
49 Zamora;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QIV;435
49 Zamora;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
49 Zamora;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QII;""
49 Zamora;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QI;""
49 Zamora;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QIV;421
49 Zamora;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
49 Zamora;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QII;""
49 Zamora;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QI;""
49 Zamora;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
49 Zamora;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
49 Zamora;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QII;""
49 Zamora;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QI;412
49 Zamora;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
49 Zamora;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
49 Zamora;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QII;""
49 Zamora;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QI;396
49 Zamora;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
49 Zamora;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
49 Zamora;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QII;""
49 Zamora;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QI;""
49 Zamora;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
49 Zamora;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
49 Zamora;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
49 Zamora;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
49 Zamora;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
49 Zamora;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
49 Zamora;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
49 Zamora;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
49 Zamora;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
49 Zamora;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
49 Zamora;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
49 Zamora;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
49 Zamora;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
49 Zamora;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
49 Zamora;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;93,96
49 Zamora;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
49 Zamora;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
49 Zamora;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
49 Zamora;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;93,1
49 Zamora;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
49 Zamora;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
49 Zamora;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
49 Zamora;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;94,8
49 Zamora;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
49 Zamora;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
49 Zamora;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;87,91
49 Zamora;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
49 Zamora;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
49 Zamora;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
49 Zamora;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;87,74
49 Zamora;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
49 Zamora;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
49 Zamora;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
49 Zamora;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;88,6
49 Zamora;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
49 Zamora;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
49 Zamora;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;81,09
49 Zamora;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
49 Zamora;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
49 Zamora;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
49 Zamora;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;83,33
49 Zamora;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
49 Zamora;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
49 Zamora;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
49 Zamora;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;84,2
49 Zamora;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
49 Zamora;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
49 Zamora;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
49 Zamora;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
49 Zamora;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
49 Zamora;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
49 Zamora;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;78,93
49 Zamora;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
49 Zamora;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
49 Zamora;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
49 Zamora;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;79,2
49 Zamora;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
49 Zamora;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
49 Zamora;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
49 Zamora;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
49 Zamora;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
49 Zamora;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
49 Zamora;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QII;327
49 Zamora;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
49 Zamora;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
49 Zamora;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
49 Zamora;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QII;344
49 Zamora;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
49 Zamora;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
49 Zamora;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
49 Zamora;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QII;327
49 Zamora;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
49 Zamora;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
49 Zamora;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
49 Zamora;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2022QII;309
49 Zamora;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2022QI;""
49 Zamora;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
49 Zamora;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
49 Zamora;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2021QII;324
49 Zamora;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2021QI;""
49 Zamora;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
49 Zamora;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
49 Zamora;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2020QII;312
49 Zamora;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2020QI;""
49 Zamora;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
49 Zamora;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2022QIII;286
49 Zamora;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2022QII;""
49 Zamora;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2022QI;""
49 Zamora;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
49 Zamora;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2021QIII;305
49 Zamora;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2021QII;""
49 Zamora;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2021QI;""
49 Zamora;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
49 Zamora;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2020QIII;289
49 Zamora;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2020QII;""
49 Zamora;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2020QI;""
49 Zamora;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QIV;264
49 Zamora;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
49 Zamora;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QII;""
49 Zamora;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QI;""
49 Zamora;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QIV;288
49 Zamora;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
49 Zamora;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QII;""
49 Zamora;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QI;""
49 Zamora;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QIV;279
49 Zamora;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
49 Zamora;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QII;""
49 Zamora;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QI;""
49 Zamora;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
49 Zamora;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
49 Zamora;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QII;""
49 Zamora;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QI;274
49 Zamora;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
49 Zamora;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
49 Zamora;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QII;""
49 Zamora;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QI;262
49 Zamora;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
49 Zamora;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
49 Zamora;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QII;""
49 Zamora;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QI;""
49 Zamora;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
49 Zamora;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
49 Zamora;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
49 Zamora;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
49 Zamora;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
49 Zamora;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
49 Zamora;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
49 Zamora;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
49 Zamora;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
49 Zamora;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
49 Zamora;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
49 Zamora;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
49 Zamora;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
49 Zamora;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
49 Zamora;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;94,5
49 Zamora;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
49 Zamora;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
49 Zamora;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
49 Zamora;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;94,19
49 Zamora;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
49 Zamora;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
49 Zamora;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
49 Zamora;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;95,41
49 Zamora;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
49 Zamora;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
49 Zamora;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;87,46
49 Zamora;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
49 Zamora;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
49 Zamora;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
49 Zamora;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;88,66
49 Zamora;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
49 Zamora;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
49 Zamora;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
49 Zamora;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;88,38
49 Zamora;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
49 Zamora;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
49 Zamora;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;80,73
49 Zamora;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
49 Zamora;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
49 Zamora;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
49 Zamora;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;83,72
49 Zamora;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
49 Zamora;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
49 Zamora;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
49 Zamora;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;85,32
49 Zamora;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
49 Zamora;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
49 Zamora;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
49 Zamora;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
49 Zamora;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
49 Zamora;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
49 Zamora;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;79,65
49 Zamora;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
49 Zamora;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
49 Zamora;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
49 Zamora;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;80,12
49 Zamora;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
49 Zamora;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
49 Zamora;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
49 Zamora;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
49 Zamora;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
49 Zamora;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
49 Zamora;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QII;186
49 Zamora;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
49 Zamora;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
49 Zamora;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
49 Zamora;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QII;178
49 Zamora;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
49 Zamora;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
49 Zamora;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
49 Zamora;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QII;173
49 Zamora;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
49 Zamora;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
49 Zamora;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
49 Zamora;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2022QII;173
49 Zamora;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2022QI;""
49 Zamora;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
49 Zamora;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
49 Zamora;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2021QII;162
49 Zamora;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2021QI;""
49 Zamora;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
49 Zamora;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
49 Zamora;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2020QII;162
49 Zamora;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2020QI;""
49 Zamora;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
49 Zamora;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2022QIII;165
49 Zamora;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2022QII;""
49 Zamora;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2022QI;""
49 Zamora;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
49 Zamora;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2021QIII;153
49 Zamora;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2021QII;""
49 Zamora;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2021QI;""
49 Zamora;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
49 Zamora;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2020QIII;154
49 Zamora;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2020QII;""
49 Zamora;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2020QI;""
49 Zamora;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QIV;152
49 Zamora;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
49 Zamora;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QII;""
49 Zamora;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QI;""
49 Zamora;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QIV;147
49 Zamora;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
49 Zamora;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QII;""
49 Zamora;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QI;""
49 Zamora;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QIV;142
49 Zamora;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
49 Zamora;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QII;""
49 Zamora;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QI;""
49 Zamora;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
49 Zamora;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
49 Zamora;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QII;""
49 Zamora;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QI;138
49 Zamora;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
49 Zamora;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
49 Zamora;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QII;""
49 Zamora;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QI;134
49 Zamora;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
49 Zamora;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
49 Zamora;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QII;""
49 Zamora;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QI;""
49 Zamora;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
49 Zamora;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
49 Zamora;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
49 Zamora;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
49 Zamora;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
49 Zamora;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
49 Zamora;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
49 Zamora;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
49 Zamora;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
49 Zamora;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
49 Zamora;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
49 Zamora;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
49 Zamora;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
49 Zamora;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
49 Zamora;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;93,01
49 Zamora;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
49 Zamora;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
49 Zamora;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
49 Zamora;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;91,01
49 Zamora;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
49 Zamora;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
49 Zamora;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
49 Zamora;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;93,64
49 Zamora;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
49 Zamora;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
49 Zamora;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;88,71
49 Zamora;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
49 Zamora;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
49 Zamora;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
49 Zamora;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;85,96
49 Zamora;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
49 Zamora;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
49 Zamora;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
49 Zamora;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;89,02
49 Zamora;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
49 Zamora;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
49 Zamora;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;81,72
49 Zamora;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
49 Zamora;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
49 Zamora;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
49 Zamora;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;82,58
49 Zamora;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
49 Zamora;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
49 Zamora;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
49 Zamora;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;82,08
49 Zamora;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
49 Zamora;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
49 Zamora;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
49 Zamora;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
49 Zamora;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
49 Zamora;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
49 Zamora;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;77,53
49 Zamora;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
49 Zamora;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
49 Zamora;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
49 Zamora;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;77,46
49 Zamora;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
49 Zamora;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
49 Zamora;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
49 Zamora;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
49 Zamora;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
49 Zamora;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QIII;555
49 Zamora;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
49 Zamora;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
49 Zamora;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
49 Zamora;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QIII;550
49 Zamora;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
49 Zamora;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
49 Zamora;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
49 Zamora;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QIII;528
49 Zamora;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
49 Zamora;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
49 Zamora;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
49 Zamora;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2022QIII;505
49 Zamora;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2022QII;""
49 Zamora;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2022QI;""
49 Zamora;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
49 Zamora;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2021QIII;505
49 Zamora;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2021QII;""
49 Zamora;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2021QI;""
49 Zamora;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
49 Zamora;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2020QIII;482
49 Zamora;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2020QII;""
49 Zamora;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2020QI;""
49 Zamora;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2022QIV;460
49 Zamora;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
49 Zamora;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2022QII;""
49 Zamora;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2022QI;""
49 Zamora;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2021QIV;478
49 Zamora;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
49 Zamora;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2021QII;""
49 Zamora;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2021QI;""
49 Zamora;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2020QIV;459
49 Zamora;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
49 Zamora;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2020QII;""
49 Zamora;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2020QI;""
49 Zamora;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
49 Zamora;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
49 Zamora;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QII;""
49 Zamora;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QI;452
49 Zamora;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
49 Zamora;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
49 Zamora;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QII;""
49 Zamora;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QI;432
49 Zamora;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
49 Zamora;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
49 Zamora;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QII;""
49 Zamora;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QI;""
49 Zamora;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
49 Zamora;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
49 Zamora;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QII;428
49 Zamora;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QI;""
49 Zamora;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
49 Zamora;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
49 Zamora;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QII;414
49 Zamora;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QI;""
49 Zamora;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
49 Zamora;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
49 Zamora;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QII;""
49 Zamora;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QI;""
49 Zamora;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
49 Zamora;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
49 Zamora;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
49 Zamora;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
49 Zamora;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
49 Zamora;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
49 Zamora;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
49 Zamora;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
49 Zamora;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
49 Zamora;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
49 Zamora;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
49 Zamora;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
49 Zamora;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
49 Zamora;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;90,99
49 Zamora;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
49 Zamora;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
49 Zamora;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
49 Zamora;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;91,82
49 Zamora;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
49 Zamora;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
49 Zamora;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
49 Zamora;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;91,29
49 Zamora;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
49 Zamora;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
49 Zamora;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;82,88
49 Zamora;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
49 Zamora;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
49 Zamora;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
49 Zamora;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;86,91
49 Zamora;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
49 Zamora;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
49 Zamora;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
49 Zamora;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;86,93
49 Zamora;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
49 Zamora;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
49 Zamora;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
49 Zamora;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
49 Zamora;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
49 Zamora;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
49 Zamora;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;82,18
49 Zamora;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
49 Zamora;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
49 Zamora;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
49 Zamora;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;81,82
49 Zamora;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
49 Zamora;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
49 Zamora;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
49 Zamora;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
49 Zamora;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
49 Zamora;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
49 Zamora;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;77,82
49 Zamora;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
49 Zamora;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
49 Zamora;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
49 Zamora;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;78,41
49 Zamora;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
49 Zamora;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
49 Zamora;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
49 Zamora;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
49 Zamora;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
49 Zamora;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
49 Zamora;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QIII;352
49 Zamora;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
49 Zamora;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
49 Zamora;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
49 Zamora;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QIII;362
49 Zamora;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
49 Zamora;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
49 Zamora;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
49 Zamora;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QIII;353
49 Zamora;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
49 Zamora;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
49 Zamora;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
49 Zamora;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2022QIII;318
49 Zamora;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2022QII;""
49 Zamora;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2022QI;""
49 Zamora;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
49 Zamora;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2021QIII;330
49 Zamora;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2021QII;""
49 Zamora;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2021QI;""
49 Zamora;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
49 Zamora;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2020QIII;318
49 Zamora;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2020QII;""
49 Zamora;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2020QI;""
49 Zamora;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2022QIV;292
49 Zamora;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
49 Zamora;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2022QII;""
49 Zamora;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2022QI;""
49 Zamora;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2021QIV;310
49 Zamora;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
49 Zamora;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2021QII;""
49 Zamora;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2021QI;""
49 Zamora;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2020QIV;307
49 Zamora;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
49 Zamora;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2020QII;""
49 Zamora;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2020QI;""
49 Zamora;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
49 Zamora;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
49 Zamora;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QII;""
49 Zamora;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QI;295
49 Zamora;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
49 Zamora;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
49 Zamora;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QII;""
49 Zamora;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QI;289
49 Zamora;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
49 Zamora;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
49 Zamora;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QII;""
49 Zamora;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QI;""
49 Zamora;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
49 Zamora;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
49 Zamora;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QII;280
49 Zamora;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QI;""
49 Zamora;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
49 Zamora;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
49 Zamora;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QII;279
49 Zamora;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QI;""
49 Zamora;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
49 Zamora;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
49 Zamora;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QII;""
49 Zamora;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QI;""
49 Zamora;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
49 Zamora;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
49 Zamora;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
49 Zamora;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
49 Zamora;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
49 Zamora;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
49 Zamora;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
49 Zamora;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
49 Zamora;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
49 Zamora;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
49 Zamora;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
49 Zamora;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
49 Zamora;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
49 Zamora;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;90,34
49 Zamora;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
49 Zamora;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
49 Zamora;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
49 Zamora;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;91,16
49 Zamora;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
49 Zamora;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
49 Zamora;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
49 Zamora;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;90,08
49 Zamora;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
49 Zamora;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
49 Zamora;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;82,95
49 Zamora;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
49 Zamora;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
49 Zamora;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
49 Zamora;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;85,64
49 Zamora;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
49 Zamora;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
49 Zamora;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
49 Zamora;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;86,97
49 Zamora;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
49 Zamora;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
49 Zamora;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
49 Zamora;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
49 Zamora;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
49 Zamora;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
49 Zamora;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;81,49
49 Zamora;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
49 Zamora;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
49 Zamora;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
49 Zamora;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;81,87
49 Zamora;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
49 Zamora;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
49 Zamora;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
49 Zamora;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
49 Zamora;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
49 Zamora;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
49 Zamora;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;77,35
49 Zamora;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
49 Zamora;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
49 Zamora;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
49 Zamora;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;79,04
49 Zamora;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
49 Zamora;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
49 Zamora;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
49 Zamora;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
49 Zamora;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
49 Zamora;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
49 Zamora;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QIII;203
49 Zamora;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
49 Zamora;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
49 Zamora;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
49 Zamora;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QIII;188
49 Zamora;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
49 Zamora;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
49 Zamora;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
49 Zamora;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QIII;175
49 Zamora;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
49 Zamora;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
49 Zamora;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
49 Zamora;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2022QIII;187
49 Zamora;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2022QII;""
49 Zamora;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2022QI;""
49 Zamora;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
49 Zamora;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2021QIII;175
49 Zamora;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2021QII;""
49 Zamora;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2021QI;""
49 Zamora;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
49 Zamora;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2020QIII;164
49 Zamora;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2020QII;""
49 Zamora;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2020QI;""
49 Zamora;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2022QIV;168
49 Zamora;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
49 Zamora;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2022QII;""
49 Zamora;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2022QI;""
49 Zamora;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2021QIV;168
49 Zamora;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
49 Zamora;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2021QII;""
49 Zamora;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2021QI;""
49 Zamora;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2020QIV;152
49 Zamora;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
49 Zamora;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2020QII;""
49 Zamora;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2020QI;""
49 Zamora;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
49 Zamora;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
49 Zamora;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QII;""
49 Zamora;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QI;157
49 Zamora;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
49 Zamora;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
49 Zamora;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QII;""
49 Zamora;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QI;143
49 Zamora;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
49 Zamora;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
49 Zamora;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QII;""
49 Zamora;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QI;""
49 Zamora;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
49 Zamora;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
49 Zamora;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QII;148
49 Zamora;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QI;""
49 Zamora;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
49 Zamora;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
49 Zamora;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QII;135
49 Zamora;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QI;""
49 Zamora;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
49 Zamora;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
49 Zamora;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QII;""
49 Zamora;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QI;""
49 Zamora;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
49 Zamora;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
49 Zamora;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
49 Zamora;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
49 Zamora;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
49 Zamora;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
49 Zamora;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
49 Zamora;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
49 Zamora;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
49 Zamora;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
49 Zamora;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
49 Zamora;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
49 Zamora;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
49 Zamora;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;92,12
49 Zamora;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
49 Zamora;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
49 Zamora;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
49 Zamora;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;93,09
49 Zamora;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
49 Zamora;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
49 Zamora;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
49 Zamora;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;93,71
49 Zamora;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
49 Zamora;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
49 Zamora;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;82,76
49 Zamora;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
49 Zamora;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
49 Zamora;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
49 Zamora;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;89,36
49 Zamora;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
49 Zamora;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
49 Zamora;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
49 Zamora;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;86,86
49 Zamora;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
49 Zamora;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
49 Zamora;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
49 Zamora;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
49 Zamora;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
49 Zamora;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
49 Zamora;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;83,51
49 Zamora;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
49 Zamora;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
49 Zamora;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
49 Zamora;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;81,71
49 Zamora;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
49 Zamora;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
49 Zamora;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
49 Zamora;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
49 Zamora;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
49 Zamora;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
49 Zamora;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;78,72
49 Zamora;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
49 Zamora;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
49 Zamora;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
49 Zamora;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;77,14
49 Zamora;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
49 Zamora;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
49 Zamora;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
49 Zamora;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
49 Zamora;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
49 Zamora;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QIV;551
49 Zamora;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
49 Zamora;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
49 Zamora;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
49 Zamora;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QIV;565
49 Zamora;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
49 Zamora;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
49 Zamora;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
49 Zamora;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QIV;548
49 Zamora;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
49 Zamora;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
49 Zamora;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
49 Zamora;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2022QIV;497
49 Zamora;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
49 Zamora;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2022QII;""
49 Zamora;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2022QI;""
49 Zamora;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2021QIV;529
49 Zamora;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
49 Zamora;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2021QII;""
49 Zamora;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2021QI;""
49 Zamora;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2020QIV;520
49 Zamora;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
49 Zamora;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2020QII;""
49 Zamora;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2020QI;""
49 Zamora;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
49 Zamora;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
49 Zamora;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2022QII;""
49 Zamora;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2022QI;500
49 Zamora;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
49 Zamora;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
49 Zamora;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2021QII;""
49 Zamora;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2021QI;488
49 Zamora;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
49 Zamora;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
49 Zamora;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2020QII;""
49 Zamora;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2020QI;""
49 Zamora;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
49 Zamora;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
49 Zamora;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QII;474
49 Zamora;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QI;""
49 Zamora;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
49 Zamora;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
49 Zamora;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QII;465
49 Zamora;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QI;""
49 Zamora;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
49 Zamora;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
49 Zamora;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QII;""
49 Zamora;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QI;""
49 Zamora;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
49 Zamora;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QIII;449
49 Zamora;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QII;""
49 Zamora;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QI;""
49 Zamora;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
49 Zamora;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QIII;443
49 Zamora;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QII;""
49 Zamora;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QI;""
49 Zamora;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
49 Zamora;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
49 Zamora;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QII;""
49 Zamora;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QI;""
49 Zamora;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
49 Zamora;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
49 Zamora;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
49 Zamora;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
49 Zamora;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
49 Zamora;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
49 Zamora;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
49 Zamora;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
49 Zamora;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
49 Zamora;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
49 Zamora;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
49 Zamora;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
49 Zamora;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;90,2
49 Zamora;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
49 Zamora;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
49 Zamora;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
49 Zamora;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;93,63
49 Zamora;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
49 Zamora;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
49 Zamora;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
49 Zamora;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;94,89
49 Zamora;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
49 Zamora;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
49 Zamora;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
49 Zamora;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
49 Zamora;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
49 Zamora;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
49 Zamora;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;88,5
49 Zamora;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
49 Zamora;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
49 Zamora;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
49 Zamora;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;89,05
49 Zamora;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
49 Zamora;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
49 Zamora;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
49 Zamora;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
49 Zamora;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
49 Zamora;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
49 Zamora;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;83,89
49 Zamora;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
49 Zamora;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
49 Zamora;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
49 Zamora;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;84,85
49 Zamora;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
49 Zamora;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
49 Zamora;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
49 Zamora;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
49 Zamora;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
49 Zamora;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
49 Zamora;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;79,47
49 Zamora;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
49 Zamora;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
49 Zamora;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
49 Zamora;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;80,84
49 Zamora;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
49 Zamora;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
49 Zamora;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
49 Zamora;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
49 Zamora;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
49 Zamora;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
49 Zamora;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QIV;346
49 Zamora;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
49 Zamora;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
49 Zamora;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
49 Zamora;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QIV;361
49 Zamora;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
49 Zamora;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
49 Zamora;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
49 Zamora;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QIV;360
49 Zamora;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
49 Zamora;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
49 Zamora;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
49 Zamora;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2022QIV;313
49 Zamora;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
49 Zamora;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2022QII;""
49 Zamora;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2022QI;""
49 Zamora;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2021QIV;336
49 Zamora;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
49 Zamora;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2021QII;""
49 Zamora;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2021QI;""
49 Zamora;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2020QIV;346
49 Zamora;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
49 Zamora;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2020QII;""
49 Zamora;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2020QI;""
49 Zamora;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
49 Zamora;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
49 Zamora;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2022QII;""
49 Zamora;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2022QI;320
49 Zamora;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
49 Zamora;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
49 Zamora;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2021QII;""
49 Zamora;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2021QI;325
49 Zamora;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
49 Zamora;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
49 Zamora;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2020QII;""
49 Zamora;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2020QI;""
49 Zamora;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
49 Zamora;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
49 Zamora;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QII;303
49 Zamora;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QI;""
49 Zamora;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
49 Zamora;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
49 Zamora;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QII;313
49 Zamora;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QI;""
49 Zamora;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
49 Zamora;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
49 Zamora;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QII;""
49 Zamora;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QI;""
49 Zamora;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
49 Zamora;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QIII;287
49 Zamora;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QII;""
49 Zamora;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QI;""
49 Zamora;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
49 Zamora;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QIII;299
49 Zamora;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QII;""
49 Zamora;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QI;""
49 Zamora;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
49 Zamora;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
49 Zamora;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QII;""
49 Zamora;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QI;""
49 Zamora;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
49 Zamora;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
49 Zamora;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
49 Zamora;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
49 Zamora;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
49 Zamora;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
49 Zamora;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
49 Zamora;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
49 Zamora;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
49 Zamora;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
49 Zamora;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
49 Zamora;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
49 Zamora;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;90,46
49 Zamora;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
49 Zamora;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
49 Zamora;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
49 Zamora;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;93,07
49 Zamora;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
49 Zamora;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
49 Zamora;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
49 Zamora;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;96,11
49 Zamora;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
49 Zamora;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
49 Zamora;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
49 Zamora;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
49 Zamora;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
49 Zamora;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
49 Zamora;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;88,64
49 Zamora;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
49 Zamora;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
49 Zamora;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
49 Zamora;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;90,28
49 Zamora;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
49 Zamora;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
49 Zamora;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
49 Zamora;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
49 Zamora;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
49 Zamora;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
49 Zamora;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;83,93
49 Zamora;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
49 Zamora;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
49 Zamora;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
49 Zamora;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;86,94
49 Zamora;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
49 Zamora;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
49 Zamora;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
49 Zamora;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
49 Zamora;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
49 Zamora;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
49 Zamora;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;79,5
49 Zamora;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
49 Zamora;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
49 Zamora;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
49 Zamora;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;83,06
49 Zamora;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
49 Zamora;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
49 Zamora;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
49 Zamora;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
49 Zamora;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
49 Zamora;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
49 Zamora;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QIV;205
49 Zamora;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
49 Zamora;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
49 Zamora;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
49 Zamora;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QIV;204
49 Zamora;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
49 Zamora;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
49 Zamora;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
49 Zamora;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QIV;188
49 Zamora;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
49 Zamora;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
49 Zamora;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
49 Zamora;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2022QIV;184
49 Zamora;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
49 Zamora;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2022QII;""
49 Zamora;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2022QI;""
49 Zamora;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2021QIV;193
49 Zamora;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
49 Zamora;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2021QII;""
49 Zamora;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2021QI;""
49 Zamora;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2020QIV;174
49 Zamora;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
49 Zamora;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2020QII;""
49 Zamora;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2020QI;""
49 Zamora;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
49 Zamora;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
49 Zamora;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2022QII;""
49 Zamora;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2022QI;180
49 Zamora;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
49 Zamora;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
49 Zamora;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2021QII;""
49 Zamora;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2021QI;163
49 Zamora;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
49 Zamora;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
49 Zamora;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2020QII;""
49 Zamora;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2020QI;""
49 Zamora;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
49 Zamora;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
49 Zamora;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QII;171
49 Zamora;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QI;""
49 Zamora;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
49 Zamora;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
49 Zamora;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QII;152
49 Zamora;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QI;""
49 Zamora;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
49 Zamora;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
49 Zamora;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QII;""
49 Zamora;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QI;""
49 Zamora;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
49 Zamora;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QIII;162
49 Zamora;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QII;""
49 Zamora;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QI;""
49 Zamora;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
49 Zamora;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QIII;144
49 Zamora;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QII;""
49 Zamora;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QI;""
49 Zamora;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
49 Zamora;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
49 Zamora;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QII;""
49 Zamora;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QI;""
49 Zamora;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
49 Zamora;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
49 Zamora;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
49 Zamora;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
49 Zamora;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
49 Zamora;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
49 Zamora;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
49 Zamora;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
49 Zamora;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
49 Zamora;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
49 Zamora;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
49 Zamora;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
49 Zamora;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;89,76
49 Zamora;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
49 Zamora;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
49 Zamora;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
49 Zamora;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;94,61
49 Zamora;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
49 Zamora;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
49 Zamora;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
49 Zamora;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;92,55
49 Zamora;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
49 Zamora;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
49 Zamora;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
49 Zamora;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
49 Zamora;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
49 Zamora;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
49 Zamora;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;88,24
49 Zamora;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
49 Zamora;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
49 Zamora;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
49 Zamora;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;86,7
49 Zamora;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
49 Zamora;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
49 Zamora;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
49 Zamora;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
49 Zamora;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
49 Zamora;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
49 Zamora;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;83,82
49 Zamora;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
49 Zamora;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
49 Zamora;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
49 Zamora;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;80,85
49 Zamora;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
49 Zamora;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
49 Zamora;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
49 Zamora;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
49 Zamora;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
49 Zamora;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
49 Zamora;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;79,41
49 Zamora;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
49 Zamora;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
49 Zamora;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
49 Zamora;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;76,6
49 Zamora;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
49 Zamora;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
49 Zamora;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
49 Zamora;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
49 Zamora;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
49 Zamora;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
49 Zamora;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
49 Zamora;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
49 Zamora;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
49 Zamora;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QI;1.779
49 Zamora;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
49 Zamora;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
49 Zamora;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
49 Zamora;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QI;1.812
49 Zamora;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
49 Zamora;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
49 Zamora;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
49 Zamora;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QI;1.813
49 Zamora;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
49 Zamora;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
49 Zamora;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2022QII;""
49 Zamora;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2022QI;1.717
49 Zamora;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
49 Zamora;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
49 Zamora;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2021QII;""
49 Zamora;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2021QI;1.772
49 Zamora;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
49 Zamora;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
49 Zamora;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2020QII;""
49 Zamora;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2020QI;1.695
49 Zamora;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
49 Zamora;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
49 Zamora;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2022QII;1.679
49 Zamora;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2022QI;""
49 Zamora;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
49 Zamora;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
49 Zamora;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2021QII;1.740
49 Zamora;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2021QI;""
49 Zamora;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
49 Zamora;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
49 Zamora;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2020QII;1.661
49 Zamora;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2020QI;""
49 Zamora;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
49 Zamora;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QIII;1.637
49 Zamora;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QII;""
49 Zamora;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QI;""
49 Zamora;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
49 Zamora;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QIII;1.709
49 Zamora;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QII;""
49 Zamora;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QI;""
49 Zamora;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
49 Zamora;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QIII;1.625
49 Zamora;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QII;""
49 Zamora;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QI;""
49 Zamora;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QIV;1.585
49 Zamora;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
49 Zamora;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QII;""
49 Zamora;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QI;""
49 Zamora;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QIV;1.667
49 Zamora;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
49 Zamora;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QII;""
49 Zamora;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QI;""
49 Zamora;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QIV;1.588
49 Zamora;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
49 Zamora;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QII;""
49 Zamora;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QI;""
49 Zamora;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
49 Zamora;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
49 Zamora;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
49 Zamora;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
49 Zamora;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
49 Zamora;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
49 Zamora;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
49 Zamora;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
49 Zamora;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
49 Zamora;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
49 Zamora;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
49 Zamora;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
49 Zamora;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
49 Zamora;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
49 Zamora;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
49 Zamora;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;96,51
49 Zamora;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
49 Zamora;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
49 Zamora;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
49 Zamora;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;97,79
49 Zamora;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
49 Zamora;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
49 Zamora;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
49 Zamora;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;93,49
49 Zamora;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
49 Zamora;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
49 Zamora;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;94,38
49 Zamora;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
49 Zamora;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
49 Zamora;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
49 Zamora;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;96,03
49 Zamora;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
49 Zamora;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
49 Zamora;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
49 Zamora;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;91,62
49 Zamora;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
49 Zamora;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
49 Zamora;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;92,02
49 Zamora;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
49 Zamora;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
49 Zamora;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
49 Zamora;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;94,32
49 Zamora;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
49 Zamora;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
49 Zamora;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
49 Zamora;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;89,63
49 Zamora;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
49 Zamora;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
49 Zamora;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;89,09
49 Zamora;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
49 Zamora;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
49 Zamora;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
49 Zamora;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;92
49 Zamora;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
49 Zamora;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
49 Zamora;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
49 Zamora;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;87,59
49 Zamora;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
49 Zamora;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
49 Zamora;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
49 Zamora;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
49 Zamora;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
49 Zamora;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
49 Zamora;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QI;1.092
49 Zamora;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
49 Zamora;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
49 Zamora;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
49 Zamora;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QI;1.140
49 Zamora;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
49 Zamora;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
49 Zamora;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
49 Zamora;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QI;1.134
49 Zamora;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
49 Zamora;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
49 Zamora;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2022QII;""
49 Zamora;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2022QI;1.058
49 Zamora;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
49 Zamora;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
49 Zamora;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2021QII;""
49 Zamora;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2021QI;1.116
49 Zamora;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
49 Zamora;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
49 Zamora;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2020QII;""
49 Zamora;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2020QI;1.071
49 Zamora;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
49 Zamora;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
49 Zamora;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2022QII;1.041
49 Zamora;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2022QI;""
49 Zamora;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
49 Zamora;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
49 Zamora;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2021QII;1.096
49 Zamora;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2021QI;""
49 Zamora;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
49 Zamora;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
49 Zamora;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2020QII;1.053
49 Zamora;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2020QI;""
49 Zamora;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
49 Zamora;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QIII;1.020
49 Zamora;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QII;""
49 Zamora;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QI;""
49 Zamora;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
49 Zamora;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QIII;1.080
49 Zamora;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QII;""
49 Zamora;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QI;""
49 Zamora;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
49 Zamora;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QIII;1.035
49 Zamora;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QII;""
49 Zamora;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QI;""
49 Zamora;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QIV;988
49 Zamora;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
49 Zamora;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QII;""
49 Zamora;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QI;""
49 Zamora;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QIV;1.053
49 Zamora;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
49 Zamora;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QII;""
49 Zamora;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QI;""
49 Zamora;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QIV;1.014
49 Zamora;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
49 Zamora;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QII;""
49 Zamora;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QI;""
49 Zamora;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
49 Zamora;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
49 Zamora;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
49 Zamora;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
49 Zamora;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
49 Zamora;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
49 Zamora;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
49 Zamora;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
49 Zamora;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
49 Zamora;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
49 Zamora;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
49 Zamora;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
49 Zamora;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
49 Zamora;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
49 Zamora;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
49 Zamora;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;96,89
49 Zamora;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
49 Zamora;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
49 Zamora;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
49 Zamora;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;97,89
49 Zamora;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
49 Zamora;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
49 Zamora;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
49 Zamora;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;94,44
49 Zamora;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
49 Zamora;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
49 Zamora;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;95,33
49 Zamora;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
49 Zamora;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
49 Zamora;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
49 Zamora;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;96,14
49 Zamora;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
49 Zamora;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
49 Zamora;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
49 Zamora;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;92,86
49 Zamora;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
49 Zamora;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
49 Zamora;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;93,41
49 Zamora;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
49 Zamora;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
49 Zamora;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
49 Zamora;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;94,74
49 Zamora;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
49 Zamora;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
49 Zamora;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
49 Zamora;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;91,27
49 Zamora;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
49 Zamora;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
49 Zamora;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;90,48
49 Zamora;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
49 Zamora;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
49 Zamora;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
49 Zamora;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;92,37
49 Zamora;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
49 Zamora;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
49 Zamora;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
49 Zamora;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;89,42
49 Zamora;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
49 Zamora;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
49 Zamora;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
49 Zamora;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
49 Zamora;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
49 Zamora;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
49 Zamora;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QI;687
49 Zamora;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
49 Zamora;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
49 Zamora;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
49 Zamora;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QI;672
49 Zamora;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
49 Zamora;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
49 Zamora;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
49 Zamora;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QI;679
49 Zamora;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
49 Zamora;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
49 Zamora;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2022QII;""
49 Zamora;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2022QI;659
49 Zamora;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
49 Zamora;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
49 Zamora;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2021QII;""
49 Zamora;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2021QI;656
49 Zamora;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
49 Zamora;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
49 Zamora;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2020QII;""
49 Zamora;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2020QI;624
49 Zamora;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
49 Zamora;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
49 Zamora;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2022QII;638
49 Zamora;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2022QI;""
49 Zamora;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
49 Zamora;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
49 Zamora;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2021QII;644
49 Zamora;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2021QI;""
49 Zamora;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
49 Zamora;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
49 Zamora;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2020QII;608
49 Zamora;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2020QI;""
49 Zamora;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
49 Zamora;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QIII;617
49 Zamora;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QII;""
49 Zamora;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QI;""
49 Zamora;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
49 Zamora;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QIII;629
49 Zamora;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QII;""
49 Zamora;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QI;""
49 Zamora;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
49 Zamora;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QIII;590
49 Zamora;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QII;""
49 Zamora;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QI;""
49 Zamora;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QIV;597
49 Zamora;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
49 Zamora;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QII;""
49 Zamora;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QI;""
49 Zamora;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QIV;614
49 Zamora;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
49 Zamora;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QII;""
49 Zamora;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QI;""
49 Zamora;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QIV;574
49 Zamora;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
49 Zamora;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QII;""
49 Zamora;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QI;""
49 Zamora;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
49 Zamora;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
49 Zamora;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
49 Zamora;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
49 Zamora;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
49 Zamora;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
49 Zamora;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
49 Zamora;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
49 Zamora;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
49 Zamora;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
49 Zamora;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
49 Zamora;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
49 Zamora;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
49 Zamora;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
49 Zamora;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
49 Zamora;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;95,92
49 Zamora;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
49 Zamora;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
49 Zamora;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
49 Zamora;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;97,62
49 Zamora;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
49 Zamora;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
49 Zamora;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
49 Zamora;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;91,9
49 Zamora;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
49 Zamora;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
49 Zamora;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;92,87
49 Zamora;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
49 Zamora;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
49 Zamora;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
49 Zamora;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;95,83
49 Zamora;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
49 Zamora;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
49 Zamora;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
49 Zamora;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;89,54
49 Zamora;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
49 Zamora;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
49 Zamora;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;89,81
49 Zamora;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
49 Zamora;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
49 Zamora;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
49 Zamora;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;93,6
49 Zamora;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
49 Zamora;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
49 Zamora;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
49 Zamora;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;86,89
49 Zamora;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
49 Zamora;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
49 Zamora;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;86,9
49 Zamora;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
49 Zamora;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
49 Zamora;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
49 Zamora;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;91,37
49 Zamora;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
49 Zamora;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
49 Zamora;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
49 Zamora;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;84,54
49 Zamora;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
49 Zamora;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
49 Zamora;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
49 Zamora;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
49 Zamora;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
49 Zamora;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QII;1.648
49 Zamora;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
49 Zamora;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
49 Zamora;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
49 Zamora;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QII;1.695
49 Zamora;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
49 Zamora;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
49 Zamora;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
49 Zamora;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QII;1.773
49 Zamora;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
49 Zamora;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
49 Zamora;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
49 Zamora;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2022QII;1.611
49 Zamora;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2022QI;""
49 Zamora;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
49 Zamora;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
49 Zamora;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2021QII;1.656
49 Zamora;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2021QI;""
49 Zamora;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
49 Zamora;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
49 Zamora;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2020QII;1.736
49 Zamora;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2020QI;""
49 Zamora;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
49 Zamora;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2022QIII;1.566
49 Zamora;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2022QII;""
49 Zamora;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2022QI;""
49 Zamora;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
49 Zamora;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2021QIII;1.620
49 Zamora;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2021QII;""
49 Zamora;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2021QI;""
49 Zamora;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
49 Zamora;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2020QIII;1.698
49 Zamora;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2020QII;""
49 Zamora;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2020QI;""
49 Zamora;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QIV;1.510
49 Zamora;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
49 Zamora;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QII;""
49 Zamora;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QI;""
49 Zamora;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QIV;1.573
49 Zamora;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
49 Zamora;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QII;""
49 Zamora;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QI;""
49 Zamora;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QIV;1.658
49 Zamora;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
49 Zamora;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QII;""
49 Zamora;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QI;""
49 Zamora;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
49 Zamora;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
49 Zamora;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QII;""
49 Zamora;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QI;1.528
49 Zamora;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
49 Zamora;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
49 Zamora;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QII;""
49 Zamora;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QI;1.629
49 Zamora;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
49 Zamora;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
49 Zamora;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QII;""
49 Zamora;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QI;""
49 Zamora;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
49 Zamora;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
49 Zamora;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
49 Zamora;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
49 Zamora;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
49 Zamora;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
49 Zamora;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
49 Zamora;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
49 Zamora;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
49 Zamora;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
49 Zamora;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
49 Zamora;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
49 Zamora;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
49 Zamora;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
49 Zamora;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;97,75
49 Zamora;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
49 Zamora;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
49 Zamora;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
49 Zamora;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;97,7
49 Zamora;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
49 Zamora;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
49 Zamora;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
49 Zamora;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;97,91
49 Zamora;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
49 Zamora;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
49 Zamora;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;95,02
49 Zamora;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
49 Zamora;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
49 Zamora;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
49 Zamora;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;95,58
49 Zamora;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
49 Zamora;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
49 Zamora;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
49 Zamora;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;95,77
49 Zamora;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
49 Zamora;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
49 Zamora;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;91,63
49 Zamora;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
49 Zamora;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
49 Zamora;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
49 Zamora;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;92,8
49 Zamora;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
49 Zamora;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
49 Zamora;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
49 Zamora;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;93,51
49 Zamora;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
49 Zamora;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
49 Zamora;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
49 Zamora;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
49 Zamora;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
49 Zamora;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
49 Zamora;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;90,15
49 Zamora;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
49 Zamora;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
49 Zamora;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
49 Zamora;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;91,88
49 Zamora;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
49 Zamora;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
49 Zamora;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
49 Zamora;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
49 Zamora;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
49 Zamora;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
49 Zamora;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QII;1.028
49 Zamora;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
49 Zamora;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
49 Zamora;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
49 Zamora;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QII;1.053
49 Zamora;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
49 Zamora;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
49 Zamora;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
49 Zamora;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QII;1.116
49 Zamora;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
49 Zamora;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
49 Zamora;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
49 Zamora;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2022QII;1.011
49 Zamora;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2022QI;""
49 Zamora;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
49 Zamora;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
49 Zamora;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2021QII;1.028
49 Zamora;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2021QI;""
49 Zamora;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
49 Zamora;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
49 Zamora;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2020QII;1.097
49 Zamora;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2020QI;""
49 Zamora;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
49 Zamora;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2022QIII;988
49 Zamora;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2022QII;""
49 Zamora;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2022QI;""
49 Zamora;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
49 Zamora;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2021QIII;1.009
49 Zamora;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2021QII;""
49 Zamora;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2021QI;""
49 Zamora;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
49 Zamora;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2020QIII;1.078
49 Zamora;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2020QII;""
49 Zamora;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2020QI;""
49 Zamora;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QIV;955
49 Zamora;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
49 Zamora;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QII;""
49 Zamora;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QI;""
49 Zamora;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QIV;978
49 Zamora;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
49 Zamora;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QII;""
49 Zamora;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QI;""
49 Zamora;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QIV;1.054
49 Zamora;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
49 Zamora;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QII;""
49 Zamora;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QI;""
49 Zamora;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
49 Zamora;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
49 Zamora;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QII;""
49 Zamora;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QI;957
49 Zamora;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
49 Zamora;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
49 Zamora;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QII;""
49 Zamora;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QI;1.037
49 Zamora;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
49 Zamora;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
49 Zamora;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QII;""
49 Zamora;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QI;""
49 Zamora;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
49 Zamora;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
49 Zamora;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
49 Zamora;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
49 Zamora;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
49 Zamora;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
49 Zamora;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
49 Zamora;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
49 Zamora;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
49 Zamora;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
49 Zamora;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
49 Zamora;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
49 Zamora;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
49 Zamora;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
49 Zamora;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;98,35
49 Zamora;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
49 Zamora;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
49 Zamora;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
49 Zamora;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;97,63
49 Zamora;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
49 Zamora;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
49 Zamora;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
49 Zamora;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;98,3
49 Zamora;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
49 Zamora;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
49 Zamora;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;96,11
49 Zamora;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
49 Zamora;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
49 Zamora;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
49 Zamora;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;95,82
49 Zamora;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
49 Zamora;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
49 Zamora;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
49 Zamora;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;96,59
49 Zamora;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
49 Zamora;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
49 Zamora;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;92,9
49 Zamora;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
49 Zamora;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
49 Zamora;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
49 Zamora;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;92,88
49 Zamora;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
49 Zamora;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
49 Zamora;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
49 Zamora;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;94,44
49 Zamora;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
49 Zamora;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
49 Zamora;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
49 Zamora;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
49 Zamora;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
49 Zamora;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
49 Zamora;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;90,88
49 Zamora;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
49 Zamora;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
49 Zamora;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
49 Zamora;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;92,92
49 Zamora;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
49 Zamora;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
49 Zamora;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
49 Zamora;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
49 Zamora;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
49 Zamora;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
49 Zamora;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QII;620
49 Zamora;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
49 Zamora;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
49 Zamora;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
49 Zamora;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QII;642
49 Zamora;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
49 Zamora;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
49 Zamora;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
49 Zamora;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QII;657
49 Zamora;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
49 Zamora;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
49 Zamora;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
49 Zamora;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2022QII;600
49 Zamora;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2022QI;""
49 Zamora;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
49 Zamora;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
49 Zamora;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2021QII;628
49 Zamora;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2021QI;""
49 Zamora;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
49 Zamora;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
49 Zamora;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2020QII;639
49 Zamora;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2020QI;""
49 Zamora;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
49 Zamora;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2022QIII;578
49 Zamora;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2022QII;""
49 Zamora;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2022QI;""
49 Zamora;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
49 Zamora;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2021QIII;611
49 Zamora;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2021QII;""
49 Zamora;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2021QI;""
49 Zamora;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
49 Zamora;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2020QIII;620
49 Zamora;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2020QII;""
49 Zamora;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2020QI;""
49 Zamora;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QIV;555
49 Zamora;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
49 Zamora;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QII;""
49 Zamora;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QI;""
49 Zamora;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QIV;595
49 Zamora;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
49 Zamora;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QII;""
49 Zamora;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QI;""
49 Zamora;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QIV;604
49 Zamora;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
49 Zamora;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QII;""
49 Zamora;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QI;""
49 Zamora;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
49 Zamora;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
49 Zamora;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QII;""
49 Zamora;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QI;571
49 Zamora;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
49 Zamora;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
49 Zamora;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QII;""
49 Zamora;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QI;592
49 Zamora;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
49 Zamora;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
49 Zamora;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QII;""
49 Zamora;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QI;""
49 Zamora;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
49 Zamora;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
49 Zamora;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
49 Zamora;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
49 Zamora;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
49 Zamora;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
49 Zamora;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
49 Zamora;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
49 Zamora;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
49 Zamora;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
49 Zamora;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
49 Zamora;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
49 Zamora;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
49 Zamora;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
49 Zamora;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;96,77
49 Zamora;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
49 Zamora;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
49 Zamora;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
49 Zamora;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;97,82
49 Zamora;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
49 Zamora;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
49 Zamora;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
49 Zamora;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;97,26
49 Zamora;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
49 Zamora;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
49 Zamora;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;93,23
49 Zamora;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
49 Zamora;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
49 Zamora;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
49 Zamora;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;95,17
49 Zamora;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
49 Zamora;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
49 Zamora;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
49 Zamora;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;94,37
49 Zamora;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
49 Zamora;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
49 Zamora;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;89,52
49 Zamora;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
49 Zamora;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
49 Zamora;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
49 Zamora;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;92,68
49 Zamora;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
49 Zamora;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
49 Zamora;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
49 Zamora;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;91,93
49 Zamora;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
49 Zamora;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
49 Zamora;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
49 Zamora;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
49 Zamora;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
49 Zamora;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
49 Zamora;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;88,94
49 Zamora;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
49 Zamora;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
49 Zamora;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
49 Zamora;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;90,11
49 Zamora;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
49 Zamora;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
49 Zamora;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
49 Zamora;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
49 Zamora;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
49 Zamora;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QIII;1.701
49 Zamora;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
49 Zamora;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
49 Zamora;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
49 Zamora;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QIII;1.754
49 Zamora;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
49 Zamora;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
49 Zamora;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
49 Zamora;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QIII;1.790
49 Zamora;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
49 Zamora;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
49 Zamora;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
49 Zamora;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2022QIII;1.636
49 Zamora;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2022QII;""
49 Zamora;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2022QI;""
49 Zamora;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
49 Zamora;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2021QIII;1.704
49 Zamora;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2021QII;""
49 Zamora;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2021QI;""
49 Zamora;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
49 Zamora;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2020QIII;1.743
49 Zamora;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2020QII;""
49 Zamora;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2020QI;""
49 Zamora;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2022QIV;1.572
49 Zamora;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
49 Zamora;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2022QII;""
49 Zamora;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2022QI;""
49 Zamora;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2021QIV;1.651
49 Zamora;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
49 Zamora;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2021QII;""
49 Zamora;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2021QI;""
49 Zamora;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2020QIV;1.699
49 Zamora;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
49 Zamora;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2020QII;""
49 Zamora;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2020QI;""
49 Zamora;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
49 Zamora;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
49 Zamora;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QII;""
49 Zamora;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QI;1.600
49 Zamora;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
49 Zamora;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
49 Zamora;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QII;""
49 Zamora;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QI;1.668
49 Zamora;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
49 Zamora;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
49 Zamora;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QII;""
49 Zamora;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QI;""
49 Zamora;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
49 Zamora;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
49 Zamora;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QII;1.569
49 Zamora;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QI;""
49 Zamora;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
49 Zamora;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
49 Zamora;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QII;1.641
49 Zamora;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QI;""
49 Zamora;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
49 Zamora;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
49 Zamora;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QII;""
49 Zamora;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QI;""
49 Zamora;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
49 Zamora;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
49 Zamora;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
49 Zamora;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
49 Zamora;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
49 Zamora;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
49 Zamora;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
49 Zamora;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
49 Zamora;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
49 Zamora;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
49 Zamora;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
49 Zamora;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
49 Zamora;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
49 Zamora;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;96,18
49 Zamora;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
49 Zamora;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
49 Zamora;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
49 Zamora;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;97,15
49 Zamora;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
49 Zamora;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
49 Zamora;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
49 Zamora;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;97,37
49 Zamora;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
49 Zamora;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
49 Zamora;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;92,42
49 Zamora;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
49 Zamora;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
49 Zamora;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
49 Zamora;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;94,13
49 Zamora;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
49 Zamora;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
49 Zamora;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
49 Zamora;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;94,92
49 Zamora;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
49 Zamora;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
49 Zamora;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
49 Zamora;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
49 Zamora;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
49 Zamora;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
49 Zamora;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;91,22
49 Zamora;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
49 Zamora;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
49 Zamora;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
49 Zamora;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;93,18
49 Zamora;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
49 Zamora;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
49 Zamora;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
49 Zamora;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
49 Zamora;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
49 Zamora;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
49 Zamora;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;89,45
49 Zamora;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
49 Zamora;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
49 Zamora;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
49 Zamora;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;91,68
49 Zamora;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
49 Zamora;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
49 Zamora;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
49 Zamora;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
49 Zamora;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
49 Zamora;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
49 Zamora;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QIII;1.062
49 Zamora;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
49 Zamora;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
49 Zamora;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
49 Zamora;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QIII;1.086
49 Zamora;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
49 Zamora;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
49 Zamora;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
49 Zamora;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QIII;1.136
49 Zamora;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
49 Zamora;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
49 Zamora;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
49 Zamora;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2022QIII;1.029
49 Zamora;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2022QII;""
49 Zamora;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2022QI;""
49 Zamora;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
49 Zamora;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2021QIII;1.059
49 Zamora;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2021QII;""
49 Zamora;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2021QI;""
49 Zamora;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
49 Zamora;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2020QIII;1.109
49 Zamora;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2020QII;""
49 Zamora;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2020QI;""
49 Zamora;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2022QIV;990
49 Zamora;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
49 Zamora;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2022QII;""
49 Zamora;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2022QI;""
49 Zamora;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2021QIV;1.023
49 Zamora;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
49 Zamora;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2021QII;""
49 Zamora;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2021QI;""
49 Zamora;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2020QIV;1.081
49 Zamora;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
49 Zamora;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2020QII;""
49 Zamora;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2020QI;""
49 Zamora;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
49 Zamora;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
49 Zamora;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QII;""
49 Zamora;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QI;998
49 Zamora;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
49 Zamora;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
49 Zamora;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QII;""
49 Zamora;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QI;1.062
49 Zamora;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
49 Zamora;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
49 Zamora;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QII;""
49 Zamora;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QI;""
49 Zamora;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
49 Zamora;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
49 Zamora;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QII;982
49 Zamora;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QI;""
49 Zamora;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
49 Zamora;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
49 Zamora;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QII;1.045
49 Zamora;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QI;""
49 Zamora;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
49 Zamora;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
49 Zamora;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QII;""
49 Zamora;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QI;""
49 Zamora;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
49 Zamora;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
49 Zamora;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
49 Zamora;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
49 Zamora;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
49 Zamora;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
49 Zamora;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
49 Zamora;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
49 Zamora;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
49 Zamora;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
49 Zamora;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
49 Zamora;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
49 Zamora;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
49 Zamora;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;96,89
49 Zamora;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
49 Zamora;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
49 Zamora;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
49 Zamora;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;97,51
49 Zamora;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
49 Zamora;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
49 Zamora;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
49 Zamora;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;97,62
49 Zamora;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
49 Zamora;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
49 Zamora;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;93,22
49 Zamora;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
49 Zamora;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
49 Zamora;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
49 Zamora;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;94,2
49 Zamora;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
49 Zamora;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
49 Zamora;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
49 Zamora;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;95,16
49 Zamora;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
49 Zamora;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
49 Zamora;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
49 Zamora;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
49 Zamora;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
49 Zamora;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
49 Zamora;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;91,9
49 Zamora;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
49 Zamora;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
49 Zamora;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
49 Zamora;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;93,49
49 Zamora;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
49 Zamora;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
49 Zamora;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
49 Zamora;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
49 Zamora;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
49 Zamora;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
49 Zamora;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;90,42
49 Zamora;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
49 Zamora;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
49 Zamora;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
49 Zamora;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;91,99
49 Zamora;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
49 Zamora;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
49 Zamora;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
49 Zamora;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
49 Zamora;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
49 Zamora;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
49 Zamora;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QIII;639
49 Zamora;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
49 Zamora;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
49 Zamora;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
49 Zamora;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QIII;668
49 Zamora;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
49 Zamora;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
49 Zamora;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
49 Zamora;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QIII;654
49 Zamora;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
49 Zamora;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
49 Zamora;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
49 Zamora;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2022QIII;607
49 Zamora;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2022QII;""
49 Zamora;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2022QI;""
49 Zamora;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
49 Zamora;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2021QIII;645
49 Zamora;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2021QII;""
49 Zamora;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2021QI;""
49 Zamora;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
49 Zamora;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2020QIII;634
49 Zamora;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2020QII;""
49 Zamora;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2020QI;""
49 Zamora;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2022QIV;582
49 Zamora;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
49 Zamora;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2022QII;""
49 Zamora;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2022QI;""
49 Zamora;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2021QIV;628
49 Zamora;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
49 Zamora;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2021QII;""
49 Zamora;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2021QI;""
49 Zamora;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2020QIV;618
49 Zamora;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
49 Zamora;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2020QII;""
49 Zamora;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2020QI;""
49 Zamora;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
49 Zamora;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
49 Zamora;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QII;""
49 Zamora;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QI;602
49 Zamora;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
49 Zamora;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
49 Zamora;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QII;""
49 Zamora;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QI;606
49 Zamora;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
49 Zamora;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
49 Zamora;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QII;""
49 Zamora;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QI;""
49 Zamora;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
49 Zamora;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
49 Zamora;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QII;587
49 Zamora;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QI;""
49 Zamora;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
49 Zamora;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
49 Zamora;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QII;596
49 Zamora;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QI;""
49 Zamora;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
49 Zamora;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
49 Zamora;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QII;""
49 Zamora;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QI;""
49 Zamora;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
49 Zamora;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
49 Zamora;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
49 Zamora;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
49 Zamora;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
49 Zamora;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
49 Zamora;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
49 Zamora;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
49 Zamora;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
49 Zamora;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
49 Zamora;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
49 Zamora;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
49 Zamora;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
49 Zamora;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;94,99
49 Zamora;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
49 Zamora;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
49 Zamora;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
49 Zamora;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;96,56
49 Zamora;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
49 Zamora;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
49 Zamora;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
49 Zamora;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;96,94
49 Zamora;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
49 Zamora;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
49 Zamora;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;91,08
49 Zamora;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
49 Zamora;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
49 Zamora;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
49 Zamora;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;94,01
49 Zamora;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
49 Zamora;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
49 Zamora;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
49 Zamora;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;94,5
49 Zamora;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
49 Zamora;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
49 Zamora;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
49 Zamora;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
49 Zamora;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
49 Zamora;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
49 Zamora;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;90,12
49 Zamora;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
49 Zamora;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
49 Zamora;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
49 Zamora;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;92,66
49 Zamora;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
49 Zamora;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
49 Zamora;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
49 Zamora;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
49 Zamora;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
49 Zamora;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
49 Zamora;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;87,87
49 Zamora;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
49 Zamora;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
49 Zamora;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
49 Zamora;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;91,13
49 Zamora;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
49 Zamora;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
49 Zamora;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
49 Zamora;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
49 Zamora;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
49 Zamora;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QIV;1.692
49 Zamora;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
49 Zamora;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
49 Zamora;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
49 Zamora;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QIV;1.777
49 Zamora;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
49 Zamora;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
49 Zamora;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
49 Zamora;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QIV;1.812
49 Zamora;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
49 Zamora;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
49 Zamora;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
49 Zamora;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2022QIV;1.620
49 Zamora;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
49 Zamora;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2022QII;""
49 Zamora;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2022QI;""
49 Zamora;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2021QIV;1.714
49 Zamora;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
49 Zamora;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2021QII;""
49 Zamora;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2021QI;""
49 Zamora;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2020QIV;1.760
49 Zamora;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
49 Zamora;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2020QII;""
49 Zamora;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2020QI;""
49 Zamora;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
49 Zamora;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
49 Zamora;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2022QII;""
49 Zamora;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2022QI;1.657
49 Zamora;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
49 Zamora;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
49 Zamora;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2021QII;""
49 Zamora;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2021QI;1.726
49 Zamora;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
49 Zamora;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
49 Zamora;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2020QII;""
49 Zamora;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2020QI;""
49 Zamora;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
49 Zamora;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
49 Zamora;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QII;1.621
49 Zamora;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QI;""
49 Zamora;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
49 Zamora;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
49 Zamora;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QII;1.697
49 Zamora;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QI;""
49 Zamora;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
49 Zamora;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
49 Zamora;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QII;""
49 Zamora;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QI;""
49 Zamora;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
49 Zamora;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QIII;1.583
49 Zamora;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QII;""
49 Zamora;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QI;""
49 Zamora;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
49 Zamora;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QIII;1.668
49 Zamora;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QII;""
49 Zamora;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QI;""
49 Zamora;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
49 Zamora;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
49 Zamora;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QII;""
49 Zamora;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QI;""
49 Zamora;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
49 Zamora;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
49 Zamora;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
49 Zamora;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
49 Zamora;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
49 Zamora;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
49 Zamora;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
49 Zamora;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
49 Zamora;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
49 Zamora;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
49 Zamora;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
49 Zamora;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
49 Zamora;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;95,74
49 Zamora;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
49 Zamora;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
49 Zamora;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
49 Zamora;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;96,45
49 Zamora;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
49 Zamora;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
49 Zamora;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
49 Zamora;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;97,13
49 Zamora;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
49 Zamora;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
49 Zamora;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
49 Zamora;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
49 Zamora;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
49 Zamora;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
49 Zamora;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;93,25
49 Zamora;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
49 Zamora;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
49 Zamora;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
49 Zamora;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;95,25
49 Zamora;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
49 Zamora;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
49 Zamora;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
49 Zamora;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
49 Zamora;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
49 Zamora;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
49 Zamora;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;91,22
49 Zamora;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
49 Zamora;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
49 Zamora;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
49 Zamora;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;93,65
49 Zamora;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
49 Zamora;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
49 Zamora;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
49 Zamora;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
49 Zamora;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
49 Zamora;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
49 Zamora;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;89,08
49 Zamora;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
49 Zamora;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
49 Zamora;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
49 Zamora;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;92,05
49 Zamora;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
49 Zamora;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
49 Zamora;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
49 Zamora;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
49 Zamora;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
49 Zamora;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
49 Zamora;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QIV;1.057
49 Zamora;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
49 Zamora;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
49 Zamora;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
49 Zamora;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QIV;1.096
49 Zamora;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
49 Zamora;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
49 Zamora;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
49 Zamora;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QIV;1.151
49 Zamora;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
49 Zamora;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
49 Zamora;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
49 Zamora;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2022QIV;1.013
49 Zamora;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
49 Zamora;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2022QII;""
49 Zamora;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2022QI;""
49 Zamora;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2021QIV;1.053
49 Zamora;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
49 Zamora;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2021QII;""
49 Zamora;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2021QI;""
49 Zamora;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2020QIV;1.117
49 Zamora;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
49 Zamora;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2020QII;""
49 Zamora;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2020QI;""
49 Zamora;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
49 Zamora;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
49 Zamora;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2022QII;""
49 Zamora;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2022QI;1.023
49 Zamora;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
49 Zamora;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
49 Zamora;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2021QII;""
49 Zamora;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2021QI;1.096
49 Zamora;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
49 Zamora;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
49 Zamora;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2020QII;""
49 Zamora;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2020QI;""
49 Zamora;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
49 Zamora;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
49 Zamora;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QII;1.006
49 Zamora;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QI;""
49 Zamora;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
49 Zamora;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
49 Zamora;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QII;1.078
49 Zamora;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QI;""
49 Zamora;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
49 Zamora;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
49 Zamora;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QII;""
49 Zamora;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QI;""
49 Zamora;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
49 Zamora;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QIII;986
49 Zamora;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QII;""
49 Zamora;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QI;""
49 Zamora;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
49 Zamora;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QIII;1.064
49 Zamora;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QII;""
49 Zamora;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QI;""
49 Zamora;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
49 Zamora;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
49 Zamora;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QII;""
49 Zamora;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QI;""
49 Zamora;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
49 Zamora;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
49 Zamora;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
49 Zamora;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
49 Zamora;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
49 Zamora;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
49 Zamora;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
49 Zamora;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
49 Zamora;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
49 Zamora;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
49 Zamora;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
49 Zamora;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
49 Zamora;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;95,84
49 Zamora;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
49 Zamora;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
49 Zamora;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
49 Zamora;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;96,08
49 Zamora;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
49 Zamora;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
49 Zamora;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
49 Zamora;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;97,05
49 Zamora;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
49 Zamora;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
49 Zamora;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
49 Zamora;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
49 Zamora;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
49 Zamora;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
49 Zamora;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;93,34
49 Zamora;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
49 Zamora;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
49 Zamora;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
49 Zamora;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;95,22
49 Zamora;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
49 Zamora;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
49 Zamora;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
49 Zamora;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
49 Zamora;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
49 Zamora;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
49 Zamora;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;91,79
49 Zamora;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
49 Zamora;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
49 Zamora;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
49 Zamora;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;93,66
49 Zamora;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
49 Zamora;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
49 Zamora;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
49 Zamora;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
49 Zamora;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
49 Zamora;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
49 Zamora;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;89,96
49 Zamora;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
49 Zamora;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
49 Zamora;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
49 Zamora;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;92,44
49 Zamora;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
49 Zamora;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
49 Zamora;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
49 Zamora;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
49 Zamora;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
49 Zamora;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
49 Zamora;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QIV;635
49 Zamora;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
49 Zamora;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
49 Zamora;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
49 Zamora;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QIV;681
49 Zamora;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
49 Zamora;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
49 Zamora;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
49 Zamora;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QIV;661
49 Zamora;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
49 Zamora;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
49 Zamora;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
49 Zamora;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2022QIV;607
49 Zamora;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
49 Zamora;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2022QII;""
49 Zamora;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2022QI;""
49 Zamora;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2021QIV;661
49 Zamora;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
49 Zamora;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2021QII;""
49 Zamora;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2021QI;""
49 Zamora;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2020QIV;643
49 Zamora;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
49 Zamora;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2020QII;""
49 Zamora;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2020QI;""
49 Zamora;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
49 Zamora;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
49 Zamora;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2022QII;""
49 Zamora;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2022QI;634
49 Zamora;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
49 Zamora;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
49 Zamora;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2021QII;""
49 Zamora;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2021QI;630
49 Zamora;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
49 Zamora;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
49 Zamora;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2020QII;""
49 Zamora;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2020QI;""
49 Zamora;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
49 Zamora;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
49 Zamora;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QII;615
49 Zamora;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QI;""
49 Zamora;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
49 Zamora;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
49 Zamora;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QII;619
49 Zamora;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QI;""
49 Zamora;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
49 Zamora;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
49 Zamora;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QII;""
49 Zamora;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QI;""
49 Zamora;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
49 Zamora;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QIII;597
49 Zamora;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QII;""
49 Zamora;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QI;""
49 Zamora;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
49 Zamora;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QIII;604
49 Zamora;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QII;""
49 Zamora;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QI;""
49 Zamora;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
49 Zamora;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
49 Zamora;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QII;""
49 Zamora;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QI;""
49 Zamora;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
49 Zamora;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
49 Zamora;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
49 Zamora;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
49 Zamora;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
49 Zamora;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
49 Zamora;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
49 Zamora;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
49 Zamora;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
49 Zamora;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
49 Zamora;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
49 Zamora;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
49 Zamora;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;95,59
49 Zamora;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
49 Zamora;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
49 Zamora;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
49 Zamora;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;97,06
49 Zamora;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
49 Zamora;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
49 Zamora;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
49 Zamora;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;97,28
49 Zamora;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
49 Zamora;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
49 Zamora;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
49 Zamora;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
49 Zamora;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
49 Zamora;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
49 Zamora;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;93,1
49 Zamora;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
49 Zamora;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
49 Zamora;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
49 Zamora;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;95,31
49 Zamora;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
49 Zamora;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
49 Zamora;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
49 Zamora;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
49 Zamora;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
49 Zamora;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
49 Zamora;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;90,31
49 Zamora;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
49 Zamora;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
49 Zamora;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
49 Zamora;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;93,65
49 Zamora;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
49 Zamora;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
49 Zamora;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
49 Zamora;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
49 Zamora;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
49 Zamora;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
49 Zamora;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;87,67
49 Zamora;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
49 Zamora;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
49 Zamora;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
49 Zamora;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;91,38
49 Zamora;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
49 Zamora;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
49 Zamora;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
49 Zamora;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
49 Zamora;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
49 Zamora;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
49 Zamora;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
49 Zamora;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
49 Zamora;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
49 Zamora;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QI;3.226
49 Zamora;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
49 Zamora;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
49 Zamora;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
49 Zamora;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QI;3.285
49 Zamora;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
49 Zamora;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
49 Zamora;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
49 Zamora;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QI;3.345
49 Zamora;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
49 Zamora;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
49 Zamora;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2022QII;""
49 Zamora;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2022QI;3.164
49 Zamora;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
49 Zamora;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
49 Zamora;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2021QII;""
49 Zamora;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2021QI;3.249
49 Zamora;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
49 Zamora;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
49 Zamora;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2020QII;""
49 Zamora;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2020QI;3.168
49 Zamora;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
49 Zamora;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
49 Zamora;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2022QII;3.084
49 Zamora;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2022QI;""
49 Zamora;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
49 Zamora;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
49 Zamora;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2021QII;3.212
49 Zamora;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2021QI;""
49 Zamora;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
49 Zamora;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
49 Zamora;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2020QII;3.112
49 Zamora;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2020QI;""
49 Zamora;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
49 Zamora;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QIII;3.025
49 Zamora;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QII;""
49 Zamora;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QI;""
49 Zamora;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
49 Zamora;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QIII;3.159
49 Zamora;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QII;""
49 Zamora;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QI;""
49 Zamora;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
49 Zamora;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QIII;3.050
49 Zamora;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QII;""
49 Zamora;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QI;""
49 Zamora;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QIV;2.975
49 Zamora;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
49 Zamora;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QII;""
49 Zamora;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QI;""
49 Zamora;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QIV;3.113
49 Zamora;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
49 Zamora;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QII;""
49 Zamora;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QI;""
49 Zamora;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QIV;3.004
49 Zamora;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
49 Zamora;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QII;""
49 Zamora;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QI;""
49 Zamora;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
49 Zamora;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
49 Zamora;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
49 Zamora;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
49 Zamora;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
49 Zamora;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
49 Zamora;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
49 Zamora;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
49 Zamora;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
49 Zamora;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
49 Zamora;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
49 Zamora;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
49 Zamora;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
49 Zamora;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
49 Zamora;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
49 Zamora;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;98,08
49 Zamora;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
49 Zamora;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
49 Zamora;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
49 Zamora;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;98,9
49 Zamora;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
49 Zamora;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
49 Zamora;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
49 Zamora;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;94,71
49 Zamora;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
49 Zamora;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
49 Zamora;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;95,6
49 Zamora;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
49 Zamora;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
49 Zamora;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
49 Zamora;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;97,78
49 Zamora;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
49 Zamora;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
49 Zamora;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
49 Zamora;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;93,03
49 Zamora;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
49 Zamora;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
49 Zamora;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;93,77
49 Zamora;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
49 Zamora;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
49 Zamora;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
49 Zamora;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;96,16
49 Zamora;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
49 Zamora;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
49 Zamora;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
49 Zamora;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;91,18
49 Zamora;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
49 Zamora;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
49 Zamora;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;92,22
49 Zamora;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
49 Zamora;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
49 Zamora;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
49 Zamora;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;94,76
49 Zamora;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
49 Zamora;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
49 Zamora;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
49 Zamora;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;89,81
49 Zamora;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
49 Zamora;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
49 Zamora;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
49 Zamora;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
49 Zamora;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
49 Zamora;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
49 Zamora;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QI;2.073
49 Zamora;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
49 Zamora;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
49 Zamora;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
49 Zamora;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QI;2.098
49 Zamora;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
49 Zamora;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
49 Zamora;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
49 Zamora;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QI;2.125
49 Zamora;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
49 Zamora;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
49 Zamora;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2022QII;""
49 Zamora;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2022QI;2.032
49 Zamora;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
49 Zamora;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
49 Zamora;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2021QII;""
49 Zamora;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2021QI;2.073
49 Zamora;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
49 Zamora;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
49 Zamora;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2020QII;""
49 Zamora;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2020QI;2.025
49 Zamora;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
49 Zamora;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
49 Zamora;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2022QII;1.985
49 Zamora;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2022QI;""
49 Zamora;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
49 Zamora;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
49 Zamora;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2021QII;2.059
49 Zamora;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2021QI;""
49 Zamora;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
49 Zamora;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
49 Zamora;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2020QII;1.993
49 Zamora;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2020QI;""
49 Zamora;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
49 Zamora;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QIII;1.954
49 Zamora;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QII;""
49 Zamora;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QI;""
49 Zamora;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
49 Zamora;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QIII;2.032
49 Zamora;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QII;""
49 Zamora;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QI;""
49 Zamora;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
49 Zamora;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QIII;1.962
49 Zamora;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QII;""
49 Zamora;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QI;""
49 Zamora;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QIV;1.923
49 Zamora;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
49 Zamora;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QII;""
49 Zamora;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QI;""
49 Zamora;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QIV;2.005
49 Zamora;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
49 Zamora;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QII;""
49 Zamora;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QI;""
49 Zamora;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QIV;1.943
49 Zamora;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
49 Zamora;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QII;""
49 Zamora;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QI;""
49 Zamora;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
49 Zamora;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
49 Zamora;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
49 Zamora;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
49 Zamora;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
49 Zamora;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
49 Zamora;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
49 Zamora;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
49 Zamora;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
49 Zamora;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
49 Zamora;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
49 Zamora;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
49 Zamora;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
49 Zamora;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
49 Zamora;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
49 Zamora;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;98,02
49 Zamora;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
49 Zamora;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
49 Zamora;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
49 Zamora;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;98,81
49 Zamora;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
49 Zamora;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
49 Zamora;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
49 Zamora;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;95,29
49 Zamora;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
49 Zamora;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
49 Zamora;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;95,75
49 Zamora;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
49 Zamora;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
49 Zamora;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
49 Zamora;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;98,14
49 Zamora;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
49 Zamora;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
49 Zamora;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
49 Zamora;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;93,79
49 Zamora;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
49 Zamora;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
49 Zamora;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;94,26
49 Zamora;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
49 Zamora;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
49 Zamora;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
49 Zamora;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;96,85
49 Zamora;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
49 Zamora;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
49 Zamora;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
49 Zamora;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;92,33
49 Zamora;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
49 Zamora;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
49 Zamora;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;92,76
49 Zamora;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
49 Zamora;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
49 Zamora;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
49 Zamora;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;95,57
49 Zamora;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
49 Zamora;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
49 Zamora;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
49 Zamora;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;91,44
49 Zamora;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
49 Zamora;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
49 Zamora;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
49 Zamora;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
49 Zamora;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
49 Zamora;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
49 Zamora;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QI;1.153
49 Zamora;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
49 Zamora;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
49 Zamora;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
49 Zamora;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QI;1.187
49 Zamora;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
49 Zamora;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
49 Zamora;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
49 Zamora;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QI;1.220
49 Zamora;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
49 Zamora;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
49 Zamora;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2022QII;""
49 Zamora;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2022QI;1.132
49 Zamora;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
49 Zamora;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
49 Zamora;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2021QII;""
49 Zamora;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2021QI;1.176
49 Zamora;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
49 Zamora;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
49 Zamora;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2020QII;""
49 Zamora;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2020QI;1.143
49 Zamora;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
49 Zamora;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
49 Zamora;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2022QII;1.099
49 Zamora;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2022QI;""
49 Zamora;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
49 Zamora;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
49 Zamora;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2021QII;1.153
49 Zamora;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2021QI;""
49 Zamora;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
49 Zamora;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
49 Zamora;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2020QII;1.119
49 Zamora;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2020QI;""
49 Zamora;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
49 Zamora;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QIII;1.071
49 Zamora;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QII;""
49 Zamora;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QI;""
49 Zamora;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
49 Zamora;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QIII;1.127
49 Zamora;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QII;""
49 Zamora;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QI;""
49 Zamora;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
49 Zamora;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QIII;1.088
49 Zamora;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QII;""
49 Zamora;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QI;""
49 Zamora;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QIV;1.052
49 Zamora;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
49 Zamora;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QII;""
49 Zamora;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QI;""
49 Zamora;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QIV;1.108
49 Zamora;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
49 Zamora;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QII;""
49 Zamora;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QI;""
49 Zamora;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QIV;1.061
49 Zamora;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
49 Zamora;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QII;""
49 Zamora;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QI;""
49 Zamora;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
49 Zamora;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
49 Zamora;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
49 Zamora;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
49 Zamora;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
49 Zamora;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
49 Zamora;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
49 Zamora;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
49 Zamora;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
49 Zamora;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
49 Zamora;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
49 Zamora;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
49 Zamora;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
49 Zamora;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
49 Zamora;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
49 Zamora;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;98,18
49 Zamora;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
49 Zamora;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
49 Zamora;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
49 Zamora;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;99,07
49 Zamora;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
49 Zamora;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
49 Zamora;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
49 Zamora;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;93,69
49 Zamora;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
49 Zamora;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
49 Zamora;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;95,32
49 Zamora;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
49 Zamora;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
49 Zamora;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
49 Zamora;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;97,14
49 Zamora;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
49 Zamora;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
49 Zamora;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
49 Zamora;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;91,72
49 Zamora;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
49 Zamora;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
49 Zamora;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;92,89
49 Zamora;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
49 Zamora;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
49 Zamora;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
49 Zamora;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;94,95
49 Zamora;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
49 Zamora;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
49 Zamora;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
49 Zamora;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;89,18
49 Zamora;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
49 Zamora;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
49 Zamora;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;91,24
49 Zamora;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
49 Zamora;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
49 Zamora;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
49 Zamora;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;93,34
49 Zamora;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
49 Zamora;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
49 Zamora;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
49 Zamora;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;86,97
49 Zamora;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
49 Zamora;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
49 Zamora;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
49 Zamora;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
49 Zamora;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
49 Zamora;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QII;3.105
49 Zamora;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
49 Zamora;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
49 Zamora;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
49 Zamora;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QII;3.200
49 Zamora;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
49 Zamora;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
49 Zamora;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
49 Zamora;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QII;3.257
49 Zamora;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
49 Zamora;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
49 Zamora;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
49 Zamora;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2022QII;3.028
49 Zamora;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2022QI;""
49 Zamora;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
49 Zamora;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
49 Zamora;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2021QII;3.156
49 Zamora;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2021QI;""
49 Zamora;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
49 Zamora;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
49 Zamora;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2020QII;3.198
49 Zamora;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2020QI;""
49 Zamora;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
49 Zamora;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2022QIII;2.964
49 Zamora;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2022QII;""
49 Zamora;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2022QI;""
49 Zamora;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
49 Zamora;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2021QIII;3.100
49 Zamora;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2021QII;""
49 Zamora;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2021QI;""
49 Zamora;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
49 Zamora;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2020QIII;3.133
49 Zamora;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2020QII;""
49 Zamora;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2020QI;""
49 Zamora;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QIV;2.903
49 Zamora;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
49 Zamora;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QII;""
49 Zamora;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QI;""
49 Zamora;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QIV;3.054
49 Zamora;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
49 Zamora;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QII;""
49 Zamora;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QI;""
49 Zamora;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QIV;3.079
49 Zamora;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
49 Zamora;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QII;""
49 Zamora;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QI;""
49 Zamora;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
49 Zamora;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
49 Zamora;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QII;""
49 Zamora;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QI;3.001
49 Zamora;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
49 Zamora;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
49 Zamora;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QII;""
49 Zamora;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QI;3.051
49 Zamora;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
49 Zamora;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
49 Zamora;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QII;""
49 Zamora;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QI;""
49 Zamora;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
49 Zamora;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
49 Zamora;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
49 Zamora;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
49 Zamora;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
49 Zamora;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
49 Zamora;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
49 Zamora;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
49 Zamora;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
49 Zamora;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
49 Zamora;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
49 Zamora;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
49 Zamora;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
49 Zamora;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
49 Zamora;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;97,52
49 Zamora;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
49 Zamora;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
49 Zamora;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
49 Zamora;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;98,63
49 Zamora;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
49 Zamora;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
49 Zamora;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
49 Zamora;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;98,19
49 Zamora;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
49 Zamora;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
49 Zamora;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;95,46
49 Zamora;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
49 Zamora;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
49 Zamora;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
49 Zamora;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;96,88
49 Zamora;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
49 Zamora;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
49 Zamora;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
49 Zamora;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;96,19
49 Zamora;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
49 Zamora;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
49 Zamora;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;93,49
49 Zamora;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
49 Zamora;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
49 Zamora;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
49 Zamora;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;95,44
49 Zamora;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
49 Zamora;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
49 Zamora;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
49 Zamora;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;94,53
49 Zamora;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
49 Zamora;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
49 Zamora;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
49 Zamora;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
49 Zamora;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
49 Zamora;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
49 Zamora;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;93,78
49 Zamora;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
49 Zamora;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
49 Zamora;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
49 Zamora;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;93,68
49 Zamora;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
49 Zamora;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
49 Zamora;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
49 Zamora;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
49 Zamora;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
49 Zamora;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
49 Zamora;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QII;1.971
49 Zamora;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
49 Zamora;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
49 Zamora;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
49 Zamora;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QII;2.047
49 Zamora;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
49 Zamora;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
49 Zamora;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
49 Zamora;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QII;2.078
49 Zamora;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
49 Zamora;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
49 Zamora;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
49 Zamora;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2022QII;1.925
49 Zamora;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2022QI;""
49 Zamora;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
49 Zamora;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
49 Zamora;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2021QII;2.029
49 Zamora;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2021QI;""
49 Zamora;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
49 Zamora;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
49 Zamora;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2020QII;2.044
49 Zamora;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2020QI;""
49 Zamora;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
49 Zamora;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2022QIII;1.894
49 Zamora;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2022QII;""
49 Zamora;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2022QI;""
49 Zamora;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
49 Zamora;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2021QIII;2.001
49 Zamora;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2021QII;""
49 Zamora;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2021QI;""
49 Zamora;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
49 Zamora;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2020QIII;2.011
49 Zamora;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2020QII;""
49 Zamora;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2020QI;""
49 Zamora;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QIV;1.855
49 Zamora;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
49 Zamora;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QII;""
49 Zamora;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QI;""
49 Zamora;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QIV;1.974
49 Zamora;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
49 Zamora;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QII;""
49 Zamora;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QI;""
49 Zamora;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QIV;1.986
49 Zamora;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
49 Zamora;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QII;""
49 Zamora;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QI;""
49 Zamora;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
49 Zamora;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
49 Zamora;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QII;""
49 Zamora;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QI;1.939
49 Zamora;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
49 Zamora;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
49 Zamora;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QII;""
49 Zamora;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QI;1.967
49 Zamora;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
49 Zamora;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
49 Zamora;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QII;""
49 Zamora;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QI;""
49 Zamora;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
49 Zamora;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
49 Zamora;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
49 Zamora;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
49 Zamora;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
49 Zamora;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
49 Zamora;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
49 Zamora;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
49 Zamora;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
49 Zamora;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
49 Zamora;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
49 Zamora;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
49 Zamora;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
49 Zamora;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
49 Zamora;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;97,67
49 Zamora;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
49 Zamora;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
49 Zamora;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
49 Zamora;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;99,12
49 Zamora;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
49 Zamora;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
49 Zamora;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
49 Zamora;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;98,36
49 Zamora;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
49 Zamora;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
49 Zamora;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;96,09
49 Zamora;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
49 Zamora;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
49 Zamora;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
49 Zamora;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;97,75
49 Zamora;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
49 Zamora;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
49 Zamora;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
49 Zamora;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;96,78
49 Zamora;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
49 Zamora;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
49 Zamora;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;94,11
49 Zamora;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
49 Zamora;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
49 Zamora;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
49 Zamora;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;96,43
49 Zamora;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
49 Zamora;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
49 Zamora;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
49 Zamora;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;95,57
49 Zamora;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
49 Zamora;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
49 Zamora;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
49 Zamora;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
49 Zamora;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
49 Zamora;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
49 Zamora;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;94,72
49 Zamora;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
49 Zamora;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
49 Zamora;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
49 Zamora;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;94,66
49 Zamora;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
49 Zamora;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
49 Zamora;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
49 Zamora;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
49 Zamora;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
49 Zamora;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
49 Zamora;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QII;1.134
49 Zamora;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
49 Zamora;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
49 Zamora;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
49 Zamora;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QII;1.153
49 Zamora;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
49 Zamora;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
49 Zamora;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
49 Zamora;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QII;1.179
49 Zamora;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
49 Zamora;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
49 Zamora;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
49 Zamora;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2022QII;1.103
49 Zamora;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2022QI;""
49 Zamora;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
49 Zamora;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
49 Zamora;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2021QII;1.127
49 Zamora;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2021QI;""
49 Zamora;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
49 Zamora;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
49 Zamora;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2020QII;1.154
49 Zamora;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2020QI;""
49 Zamora;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
49 Zamora;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2022QIII;1.070
49 Zamora;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2022QII;""
49 Zamora;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2022QI;""
49 Zamora;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
49 Zamora;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2021QIII;1.099
49 Zamora;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2021QII;""
49 Zamora;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2021QI;""
49 Zamora;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
49 Zamora;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2020QIII;1.122
49 Zamora;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2020QII;""
49 Zamora;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2020QI;""
49 Zamora;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QIV;1.048
49 Zamora;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
49 Zamora;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QII;""
49 Zamora;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QI;""
49 Zamora;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QIV;1.080
49 Zamora;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
49 Zamora;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QII;""
49 Zamora;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QI;""
49 Zamora;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QIV;1.093
49 Zamora;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
49 Zamora;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QII;""
49 Zamora;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QI;""
49 Zamora;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
49 Zamora;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
49 Zamora;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QII;""
49 Zamora;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QI;1.062
49 Zamora;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
49 Zamora;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
49 Zamora;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QII;""
49 Zamora;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QI;1.084
49 Zamora;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
49 Zamora;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
49 Zamora;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QII;""
49 Zamora;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QI;""
49 Zamora;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
49 Zamora;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
49 Zamora;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
49 Zamora;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
49 Zamora;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
49 Zamora;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
49 Zamora;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
49 Zamora;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
49 Zamora;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
49 Zamora;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
49 Zamora;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
49 Zamora;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
49 Zamora;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
49 Zamora;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
49 Zamora;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;97,27
49 Zamora;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
49 Zamora;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
49 Zamora;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
49 Zamora;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;97,75
49 Zamora;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
49 Zamora;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
49 Zamora;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
49 Zamora;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;97,88
49 Zamora;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
49 Zamora;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
49 Zamora;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;94,36
49 Zamora;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
49 Zamora;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
49 Zamora;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
49 Zamora;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;95,32
49 Zamora;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
49 Zamora;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
49 Zamora;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
49 Zamora;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;95,17
49 Zamora;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
49 Zamora;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
49 Zamora;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;92,42
49 Zamora;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
49 Zamora;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
49 Zamora;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
49 Zamora;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;93,67
49 Zamora;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
49 Zamora;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
49 Zamora;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
49 Zamora;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;92,71
49 Zamora;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
49 Zamora;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
49 Zamora;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
49 Zamora;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
49 Zamora;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
49 Zamora;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
49 Zamora;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;92,11
49 Zamora;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
49 Zamora;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
49 Zamora;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
49 Zamora;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;91,94
49 Zamora;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
49 Zamora;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
49 Zamora;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
49 Zamora;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
49 Zamora;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
49 Zamora;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QIII;3.094
49 Zamora;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
49 Zamora;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
49 Zamora;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
49 Zamora;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QIII;3.239
49 Zamora;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
49 Zamora;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
49 Zamora;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
49 Zamora;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QIII;3.277
49 Zamora;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
49 Zamora;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
49 Zamora;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
49 Zamora;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2022QIII;3.019
49 Zamora;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2022QII;""
49 Zamora;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2022QI;""
49 Zamora;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
49 Zamora;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2021QIII;3.169
49 Zamora;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2021QII;""
49 Zamora;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2021QI;""
49 Zamora;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
49 Zamora;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2020QIII;3.205
49 Zamora;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2020QII;""
49 Zamora;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2020QI;""
49 Zamora;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2022QIV;2.948
49 Zamora;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
49 Zamora;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2022QII;""
49 Zamora;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2022QI;""
49 Zamora;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2021QIV;3.114
49 Zamora;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
49 Zamora;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2021QII;""
49 Zamora;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2021QI;""
49 Zamora;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2020QIV;3.141
49 Zamora;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
49 Zamora;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2020QII;""
49 Zamora;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2020QI;""
49 Zamora;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
49 Zamora;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
49 Zamora;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QII;""
49 Zamora;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QI;3.059
49 Zamora;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
49 Zamora;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
49 Zamora;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QII;""
49 Zamora;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QI;3.112
49 Zamora;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
49 Zamora;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
49 Zamora;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QII;""
49 Zamora;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QI;""
49 Zamora;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
49 Zamora;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
49 Zamora;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QII;2.992
49 Zamora;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QI;""
49 Zamora;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
49 Zamora;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
49 Zamora;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QII;3.084
49 Zamora;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QI;""
49 Zamora;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
49 Zamora;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
49 Zamora;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QII;""
49 Zamora;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QI;""
49 Zamora;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
49 Zamora;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
49 Zamora;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
49 Zamora;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
49 Zamora;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
49 Zamora;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
49 Zamora;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
49 Zamora;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
49 Zamora;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
49 Zamora;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
49 Zamora;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
49 Zamora;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
49 Zamora;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
49 Zamora;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;97,58
49 Zamora;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
49 Zamora;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
49 Zamora;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
49 Zamora;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;97,84
49 Zamora;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
49 Zamora;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
49 Zamora;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
49 Zamora;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;97,8
49 Zamora;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
49 Zamora;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
49 Zamora;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;95,28
49 Zamora;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
49 Zamora;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
49 Zamora;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
49 Zamora;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;96,14
49 Zamora;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
49 Zamora;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
49 Zamora;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
49 Zamora;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;95,85
49 Zamora;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
49 Zamora;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
49 Zamora;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
49 Zamora;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
49 Zamora;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
49 Zamora;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
49 Zamora;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;94,44
49 Zamora;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
49 Zamora;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
49 Zamora;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
49 Zamora;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;94,96
49 Zamora;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
49 Zamora;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
49 Zamora;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
49 Zamora;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
49 Zamora;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
49 Zamora;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
49 Zamora;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;92,37
49 Zamora;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
49 Zamora;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
49 Zamora;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
49 Zamora;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;94,11
49 Zamora;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
49 Zamora;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
49 Zamora;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
49 Zamora;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
49 Zamora;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
49 Zamora;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
49 Zamora;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QIII;1.959
49 Zamora;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
49 Zamora;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
49 Zamora;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
49 Zamora;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QIII;2.078
49 Zamora;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
49 Zamora;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
49 Zamora;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
49 Zamora;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QIII;2.089
49 Zamora;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
49 Zamora;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
49 Zamora;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
49 Zamora;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2022QIII;1.921
49 Zamora;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2022QII;""
49 Zamora;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2022QI;""
49 Zamora;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
49 Zamora;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2021QIII;2.041
49 Zamora;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2021QII;""
49 Zamora;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2021QI;""
49 Zamora;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
49 Zamora;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2020QIII;2.054
49 Zamora;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2020QII;""
49 Zamora;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2020QI;""
49 Zamora;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2022QIV;1.875
49 Zamora;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
49 Zamora;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2022QII;""
49 Zamora;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2022QI;""
49 Zamora;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2021QIV;2.009
49 Zamora;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
49 Zamora;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2021QII;""
49 Zamora;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2021QI;""
49 Zamora;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2020QIV;2.024
49 Zamora;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
49 Zamora;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2020QII;""
49 Zamora;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2020QI;""
49 Zamora;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
49 Zamora;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
49 Zamora;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QII;""
49 Zamora;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QI;1.974
49 Zamora;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
49 Zamora;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
49 Zamora;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QII;""
49 Zamora;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QI;2.004
49 Zamora;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
49 Zamora;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
49 Zamora;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QII;""
49 Zamora;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QI;""
49 Zamora;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
49 Zamora;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
49 Zamora;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QII;1.929
49 Zamora;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QI;""
49 Zamora;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
49 Zamora;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
49 Zamora;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QII;1.994
49 Zamora;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QI;""
49 Zamora;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
49 Zamora;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
49 Zamora;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QII;""
49 Zamora;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QI;""
49 Zamora;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
49 Zamora;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
49 Zamora;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
49 Zamora;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
49 Zamora;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
49 Zamora;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
49 Zamora;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
49 Zamora;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
49 Zamora;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
49 Zamora;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
49 Zamora;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
49 Zamora;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
49 Zamora;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
49 Zamora;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;98,06
49 Zamora;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
49 Zamora;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
49 Zamora;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
49 Zamora;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;98,22
49 Zamora;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
49 Zamora;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
49 Zamora;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
49 Zamora;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;98,32
49 Zamora;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
49 Zamora;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
49 Zamora;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;95,71
49 Zamora;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
49 Zamora;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
49 Zamora;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
49 Zamora;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;96,68
49 Zamora;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
49 Zamora;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
49 Zamora;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
49 Zamora;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;96,89
49 Zamora;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
49 Zamora;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
49 Zamora;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
49 Zamora;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
49 Zamora;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
49 Zamora;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
49 Zamora;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;95
49 Zamora;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
49 Zamora;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
49 Zamora;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
49 Zamora;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;95,93
49 Zamora;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
49 Zamora;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
49 Zamora;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
49 Zamora;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
49 Zamora;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
49 Zamora;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
49 Zamora;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;92,83
49 Zamora;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
49 Zamora;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
49 Zamora;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
49 Zamora;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;95,45
49 Zamora;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
49 Zamora;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
49 Zamora;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
49 Zamora;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
49 Zamora;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
49 Zamora;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
49 Zamora;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QIII;1.135
49 Zamora;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
49 Zamora;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
49 Zamora;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
49 Zamora;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QIII;1.161
49 Zamora;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
49 Zamora;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
49 Zamora;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
49 Zamora;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QIII;1.188
49 Zamora;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
49 Zamora;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
49 Zamora;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
49 Zamora;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2022QIII;1.098
49 Zamora;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2022QII;""
49 Zamora;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2022QI;""
49 Zamora;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
49 Zamora;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2021QIII;1.128
49 Zamora;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2021QII;""
49 Zamora;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2021QI;""
49 Zamora;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
49 Zamora;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2020QIII;1.151
49 Zamora;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2020QII;""
49 Zamora;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2020QI;""
49 Zamora;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2022QIV;1.073
49 Zamora;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
49 Zamora;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2022QII;""
49 Zamora;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2022QI;""
49 Zamora;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2021QIV;1.105
49 Zamora;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
49 Zamora;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2021QII;""
49 Zamora;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2021QI;""
49 Zamora;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2020QIV;1.117
49 Zamora;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
49 Zamora;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2020QII;""
49 Zamora;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2020QI;""
49 Zamora;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
49 Zamora;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
49 Zamora;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QII;""
49 Zamora;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QI;1.085
49 Zamora;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
49 Zamora;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
49 Zamora;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QII;""
49 Zamora;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QI;1.108
49 Zamora;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
49 Zamora;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
49 Zamora;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QII;""
49 Zamora;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QI;""
49 Zamora;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
49 Zamora;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
49 Zamora;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QII;1.063
49 Zamora;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QI;""
49 Zamora;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
49 Zamora;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
49 Zamora;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QII;1.090
49 Zamora;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QI;""
49 Zamora;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
49 Zamora;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
49 Zamora;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QII;""
49 Zamora;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QI;""
49 Zamora;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
49 Zamora;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
49 Zamora;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
49 Zamora;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
49 Zamora;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
49 Zamora;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
49 Zamora;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
49 Zamora;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
49 Zamora;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
49 Zamora;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
49 Zamora;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
49 Zamora;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
49 Zamora;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
49 Zamora;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;96,74
49 Zamora;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
49 Zamora;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
49 Zamora;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
49 Zamora;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;97,16
49 Zamora;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
49 Zamora;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
49 Zamora;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
49 Zamora;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;96,89
49 Zamora;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
49 Zamora;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
49 Zamora;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;94,54
49 Zamora;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
49 Zamora;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
49 Zamora;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
49 Zamora;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;95,18
49 Zamora;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
49 Zamora;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
49 Zamora;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
49 Zamora;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;94,02
49 Zamora;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
49 Zamora;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
49 Zamora;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
49 Zamora;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
49 Zamora;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
49 Zamora;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
49 Zamora;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;93,45
49 Zamora;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
49 Zamora;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
49 Zamora;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
49 Zamora;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;93,27
49 Zamora;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
49 Zamora;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
49 Zamora;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
49 Zamora;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
49 Zamora;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
49 Zamora;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
49 Zamora;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;91,56
49 Zamora;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
49 Zamora;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
49 Zamora;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
49 Zamora;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;91,75
49 Zamora;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
49 Zamora;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
49 Zamora;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
49 Zamora;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
49 Zamora;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
49 Zamora;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QIV;3.085
49 Zamora;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
49 Zamora;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
49 Zamora;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
49 Zamora;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QIV;3.223
49 Zamora;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
49 Zamora;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
49 Zamora;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
49 Zamora;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QIV;3.300
49 Zamora;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
49 Zamora;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
49 Zamora;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
49 Zamora;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2022QIV;3.005
49 Zamora;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
49 Zamora;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2022QII;""
49 Zamora;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2022QI;""
49 Zamora;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2021QIV;3.160
49 Zamora;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
49 Zamora;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2021QII;""
49 Zamora;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2021QI;""
49 Zamora;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2020QIV;3.222
49 Zamora;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
49 Zamora;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2020QII;""
49 Zamora;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2020QI;""
49 Zamora;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
49 Zamora;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
49 Zamora;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2022QII;""
49 Zamora;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2022QI;3.104
49 Zamora;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
49 Zamora;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
49 Zamora;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2021QII;""
49 Zamora;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2021QI;3.189
49 Zamora;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
49 Zamora;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
49 Zamora;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2020QII;""
49 Zamora;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2020QI;""
49 Zamora;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
49 Zamora;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
49 Zamora;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QII;3.032
49 Zamora;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QI;""
49 Zamora;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
49 Zamora;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
49 Zamora;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QII;3.157
49 Zamora;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QI;""
49 Zamora;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
49 Zamora;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
49 Zamora;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QII;""
49 Zamora;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QI;""
49 Zamora;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
49 Zamora;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QIII;2.976
49 Zamora;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QII;""
49 Zamora;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QI;""
49 Zamora;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
49 Zamora;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QIII;3.107
49 Zamora;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QII;""
49 Zamora;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QI;""
49 Zamora;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
49 Zamora;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
49 Zamora;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QII;""
49 Zamora;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QI;""
49 Zamora;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
49 Zamora;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
49 Zamora;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
49 Zamora;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
49 Zamora;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
49 Zamora;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
49 Zamora;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
49 Zamora;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
49 Zamora;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
49 Zamora;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
49 Zamora;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
49 Zamora;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
49 Zamora;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;97,41
49 Zamora;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
49 Zamora;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
49 Zamora;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
49 Zamora;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;98,05
49 Zamora;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
49 Zamora;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
49 Zamora;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
49 Zamora;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;97,64
49 Zamora;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
49 Zamora;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
49 Zamora;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
49 Zamora;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
49 Zamora;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
49 Zamora;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
49 Zamora;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;96,31
49 Zamora;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
49 Zamora;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
49 Zamora;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
49 Zamora;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;96,64
49 Zamora;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
49 Zamora;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
49 Zamora;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
49 Zamora;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
49 Zamora;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
49 Zamora;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
49 Zamora;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;94,07
49 Zamora;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
49 Zamora;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
49 Zamora;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
49 Zamora;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;95,67
49 Zamora;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
49 Zamora;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
49 Zamora;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
49 Zamora;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
49 Zamora;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
49 Zamora;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
49 Zamora;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;92,34
49 Zamora;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
49 Zamora;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
49 Zamora;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
49 Zamora;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;94,15
49 Zamora;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
49 Zamora;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
49 Zamora;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
49 Zamora;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
49 Zamora;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
49 Zamora;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
49 Zamora;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QIV;1.956
49 Zamora;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
49 Zamora;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
49 Zamora;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
49 Zamora;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QIV;2.075
49 Zamora;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
49 Zamora;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
49 Zamora;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
49 Zamora;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QIV;2.105
49 Zamora;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
49 Zamora;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
49 Zamora;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
49 Zamora;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2022QIV;1.905
49 Zamora;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
49 Zamora;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2022QII;""
49 Zamora;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2022QI;""
49 Zamora;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2021QIV;2.038
49 Zamora;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
49 Zamora;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2021QII;""
49 Zamora;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2021QI;""
49 Zamora;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2020QIV;2.066
49 Zamora;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
49 Zamora;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2020QII;""
49 Zamora;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2020QI;""
49 Zamora;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
49 Zamora;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
49 Zamora;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2022QII;""
49 Zamora;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2022QI;2.002
49 Zamora;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
49 Zamora;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
49 Zamora;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2021QII;""
49 Zamora;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2021QI;2.043
49 Zamora;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
49 Zamora;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
49 Zamora;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2020QII;""
49 Zamora;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2020QI;""
49 Zamora;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
49 Zamora;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
49 Zamora;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QII;1.956
49 Zamora;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QI;""
49 Zamora;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
49 Zamora;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
49 Zamora;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QII;2.031
49 Zamora;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QI;""
49 Zamora;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
49 Zamora;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
49 Zamora;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QII;""
49 Zamora;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QI;""
49 Zamora;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
49 Zamora;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QIII;1.926
49 Zamora;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QII;""
49 Zamora;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QI;""
49 Zamora;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
49 Zamora;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QIII;2.006
49 Zamora;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QII;""
49 Zamora;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QI;""
49 Zamora;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
49 Zamora;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
49 Zamora;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QII;""
49 Zamora;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QI;""
49 Zamora;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
49 Zamora;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
49 Zamora;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
49 Zamora;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
49 Zamora;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
49 Zamora;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
49 Zamora;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
49 Zamora;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
49 Zamora;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
49 Zamora;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
49 Zamora;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
49 Zamora;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
49 Zamora;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;97,39
49 Zamora;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
49 Zamora;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
49 Zamora;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
49 Zamora;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;98,22
49 Zamora;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
49 Zamora;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
49 Zamora;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
49 Zamora;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;98,15
49 Zamora;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
49 Zamora;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
49 Zamora;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
49 Zamora;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
49 Zamora;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
49 Zamora;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
49 Zamora;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;96,48
49 Zamora;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
49 Zamora;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
49 Zamora;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
49 Zamora;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;97,05
49 Zamora;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
49 Zamora;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
49 Zamora;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
49 Zamora;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
49 Zamora;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
49 Zamora;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
49 Zamora;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;94,27
49 Zamora;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
49 Zamora;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
49 Zamora;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
49 Zamora;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;96,48
49 Zamora;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
49 Zamora;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
49 Zamora;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
49 Zamora;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
49 Zamora;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
49 Zamora;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
49 Zamora;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;92,82
49 Zamora;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
49 Zamora;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
49 Zamora;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
49 Zamora;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;95,3
49 Zamora;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
49 Zamora;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
49 Zamora;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
49 Zamora;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
49 Zamora;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
49 Zamora;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
49 Zamora;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QIV;1.129
49 Zamora;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
49 Zamora;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
49 Zamora;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
49 Zamora;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QIV;1.148
49 Zamora;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
49 Zamora;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
49 Zamora;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
49 Zamora;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QIV;1.195
49 Zamora;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
49 Zamora;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
49 Zamora;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
49 Zamora;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2022QIV;1.100
49 Zamora;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
49 Zamora;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2022QII;""
49 Zamora;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2022QI;""
49 Zamora;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2021QIV;1.122
49 Zamora;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
49 Zamora;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2021QII;""
49 Zamora;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2021QI;""
49 Zamora;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2020QIV;1.156
49 Zamora;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
49 Zamora;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2020QII;""
49 Zamora;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2020QI;""
49 Zamora;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
49 Zamora;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
49 Zamora;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2022QII;""
49 Zamora;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2022QI;1.102
49 Zamora;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
49 Zamora;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
49 Zamora;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2021QII;""
49 Zamora;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2021QI;1.146
49 Zamora;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
49 Zamora;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
49 Zamora;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2020QII;""
49 Zamora;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2020QI;""
49 Zamora;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
49 Zamora;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
49 Zamora;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QII;1.076
49 Zamora;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QI;""
49 Zamora;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
49 Zamora;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
49 Zamora;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QII;1.126
49 Zamora;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QI;""
49 Zamora;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
49 Zamora;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
49 Zamora;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QII;""
49 Zamora;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QI;""
49 Zamora;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
49 Zamora;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QIII;1.050
49 Zamora;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QII;""
49 Zamora;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QI;""
49 Zamora;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
49 Zamora;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QIII;1.101
49 Zamora;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QII;""
49 Zamora;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QI;""
49 Zamora;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
49 Zamora;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
49 Zamora;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QII;""
49 Zamora;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QI;""
49 Zamora;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
49 Zamora;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
49 Zamora;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
49 Zamora;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
49 Zamora;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
49 Zamora;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
49 Zamora;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
49 Zamora;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
49 Zamora;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
49 Zamora;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
49 Zamora;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
49 Zamora;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
49 Zamora;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;97,43
49 Zamora;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
49 Zamora;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
49 Zamora;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
49 Zamora;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;97,74
49 Zamora;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
49 Zamora;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
49 Zamora;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
49 Zamora;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;96,74
49 Zamora;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
49 Zamora;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
49 Zamora;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
49 Zamora;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
49 Zamora;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
49 Zamora;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
49 Zamora;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;95,99
49 Zamora;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
49 Zamora;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
49 Zamora;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
49 Zamora;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;95,9
49 Zamora;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
49 Zamora;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
49 Zamora;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
49 Zamora;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
49 Zamora;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
49 Zamora;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
49 Zamora;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;93,73
49 Zamora;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
49 Zamora;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
49 Zamora;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
49 Zamora;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;94,23
49 Zamora;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
49 Zamora;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
49 Zamora;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
49 Zamora;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
49 Zamora;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
49 Zamora;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
49 Zamora;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;91,46
49 Zamora;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
49 Zamora;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
49 Zamora;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
49 Zamora;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;92,13
49 Zamora;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
49 Zamora;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
49 Zamora;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
49 Zamora;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
49 Zamora;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
49 Zamora;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
49 Zamora;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
49 Zamora;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
49 Zamora;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
49 Zamora;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QI;3.737
49 Zamora;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
49 Zamora;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
49 Zamora;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
49 Zamora;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QI;3.777
49 Zamora;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
49 Zamora;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
49 Zamora;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
49 Zamora;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QI;3.866
49 Zamora;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
49 Zamora;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
49 Zamora;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2022QII;""
49 Zamora;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2022QI;3.688
49 Zamora;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
49 Zamora;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
49 Zamora;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2021QII;""
49 Zamora;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2021QI;3.734
49 Zamora;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
49 Zamora;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
49 Zamora;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2020QII;""
49 Zamora;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2020QI;3.739
49 Zamora;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
49 Zamora;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
49 Zamora;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2022QII;3.644
49 Zamora;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2022QI;""
49 Zamora;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
49 Zamora;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
49 Zamora;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2021QII;3.702
49 Zamora;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2021QI;""
49 Zamora;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
49 Zamora;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
49 Zamora;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2020QII;3.700
49 Zamora;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2020QI;""
49 Zamora;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
49 Zamora;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QIII;3.596
49 Zamora;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QII;""
49 Zamora;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QI;""
49 Zamora;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
49 Zamora;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QIII;3.661
49 Zamora;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QII;""
49 Zamora;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QI;""
49 Zamora;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
49 Zamora;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QIII;3.657
49 Zamora;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QII;""
49 Zamora;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QI;""
49 Zamora;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QIV;3.527
49 Zamora;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
49 Zamora;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QII;""
49 Zamora;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QI;""
49 Zamora;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QIV;3.616
49 Zamora;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
49 Zamora;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QII;""
49 Zamora;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QI;""
49 Zamora;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QIV;3.614
49 Zamora;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
49 Zamora;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QII;""
49 Zamora;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QI;""
49 Zamora;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
49 Zamora;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
49 Zamora;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
49 Zamora;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
49 Zamora;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
49 Zamora;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
49 Zamora;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
49 Zamora;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
49 Zamora;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
49 Zamora;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
49 Zamora;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
49 Zamora;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
49 Zamora;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
49 Zamora;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
49 Zamora;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
49 Zamora;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;98,69
49 Zamora;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
49 Zamora;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
49 Zamora;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
49 Zamora;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;98,86
49 Zamora;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
49 Zamora;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
49 Zamora;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
49 Zamora;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;96,71
49 Zamora;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
49 Zamora;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
49 Zamora;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;97,51
49 Zamora;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
49 Zamora;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
49 Zamora;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
49 Zamora;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;98,01
49 Zamora;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
49 Zamora;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
49 Zamora;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
49 Zamora;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;95,71
49 Zamora;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
49 Zamora;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
49 Zamora;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;96,23
49 Zamora;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
49 Zamora;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
49 Zamora;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
49 Zamora;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;96,93
49 Zamora;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
49 Zamora;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
49 Zamora;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
49 Zamora;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;94,59
49 Zamora;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
49 Zamora;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
49 Zamora;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;94,38
49 Zamora;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
49 Zamora;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
49 Zamora;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
49 Zamora;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;95,74
49 Zamora;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
49 Zamora;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
49 Zamora;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
49 Zamora;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;93,48
49 Zamora;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
49 Zamora;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
49 Zamora;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
49 Zamora;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
49 Zamora;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
49 Zamora;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
49 Zamora;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QI;2.448
49 Zamora;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
49 Zamora;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
49 Zamora;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
49 Zamora;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QI;2.483
49 Zamora;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
49 Zamora;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
49 Zamora;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
49 Zamora;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QI;2.543
49 Zamora;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
49 Zamora;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
49 Zamora;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2022QII;""
49 Zamora;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2022QI;2.422
49 Zamora;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
49 Zamora;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
49 Zamora;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2021QII;""
49 Zamora;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2021QI;2.458
49 Zamora;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
49 Zamora;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
49 Zamora;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2020QII;""
49 Zamora;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2020QI;2.463
49 Zamora;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
49 Zamora;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
49 Zamora;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2022QII;2.393
49 Zamora;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2022QI;""
49 Zamora;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
49 Zamora;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
49 Zamora;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2021QII;2.441
49 Zamora;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2021QI;""
49 Zamora;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
49 Zamora;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
49 Zamora;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2020QII;2.442
49 Zamora;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2020QI;""
49 Zamora;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
49 Zamora;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QIII;2.364
49 Zamora;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QII;""
49 Zamora;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QI;""
49 Zamora;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
49 Zamora;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QIII;2.420
49 Zamora;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QII;""
49 Zamora;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QI;""
49 Zamora;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
49 Zamora;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QIII;2.415
49 Zamora;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QII;""
49 Zamora;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QI;""
49 Zamora;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QIV;2.320
49 Zamora;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
49 Zamora;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QII;""
49 Zamora;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QI;""
49 Zamora;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QIV;2.391
49 Zamora;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
49 Zamora;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QII;""
49 Zamora;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QI;""
49 Zamora;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QIV;2.386
49 Zamora;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
49 Zamora;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QII;""
49 Zamora;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QI;""
49 Zamora;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
49 Zamora;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
49 Zamora;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
49 Zamora;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
49 Zamora;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
49 Zamora;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
49 Zamora;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
49 Zamora;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
49 Zamora;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
49 Zamora;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
49 Zamora;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
49 Zamora;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
49 Zamora;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
49 Zamora;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
49 Zamora;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
49 Zamora;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;98,94
49 Zamora;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
49 Zamora;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
49 Zamora;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
49 Zamora;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;98,99
49 Zamora;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
49 Zamora;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
49 Zamora;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
49 Zamora;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;96,85
49 Zamora;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
49 Zamora;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
49 Zamora;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;97,75
49 Zamora;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
49 Zamora;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
49 Zamora;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
49 Zamora;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;98,31
49 Zamora;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
49 Zamora;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
49 Zamora;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
49 Zamora;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;96,03
49 Zamora;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
49 Zamora;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
49 Zamora;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;96,57
49 Zamora;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
49 Zamora;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
49 Zamora;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
49 Zamora;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;97,46
49 Zamora;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
49 Zamora;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
49 Zamora;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
49 Zamora;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;94,97
49 Zamora;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
49 Zamora;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
49 Zamora;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;94,77
49 Zamora;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
49 Zamora;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
49 Zamora;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
49 Zamora;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;96,29
49 Zamora;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
49 Zamora;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
49 Zamora;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
49 Zamora;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;93,83
49 Zamora;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
49 Zamora;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
49 Zamora;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
49 Zamora;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
49 Zamora;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
49 Zamora;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
49 Zamora;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QI;1.289
49 Zamora;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
49 Zamora;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
49 Zamora;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
49 Zamora;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QI;1.294
49 Zamora;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
49 Zamora;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
49 Zamora;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
49 Zamora;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QI;1.323
49 Zamora;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
49 Zamora;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
49 Zamora;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2022QII;""
49 Zamora;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2022QI;1.266
49 Zamora;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
49 Zamora;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
49 Zamora;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2021QII;""
49 Zamora;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2021QI;1.276
49 Zamora;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
49 Zamora;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
49 Zamora;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2020QII;""
49 Zamora;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2020QI;1.276
49 Zamora;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
49 Zamora;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
49 Zamora;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2022QII;1.251
49 Zamora;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2022QI;""
49 Zamora;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
49 Zamora;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
49 Zamora;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2021QII;1.261
49 Zamora;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2021QI;""
49 Zamora;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
49 Zamora;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
49 Zamora;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2020QII;1.258
49 Zamora;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2020QI;""
49 Zamora;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
49 Zamora;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QIII;1.232
49 Zamora;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QII;""
49 Zamora;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QI;""
49 Zamora;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
49 Zamora;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QIII;1.241
49 Zamora;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QII;""
49 Zamora;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QI;""
49 Zamora;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
49 Zamora;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QIII;1.242
49 Zamora;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QII;""
49 Zamora;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QI;""
49 Zamora;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QIV;1.207
49 Zamora;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
49 Zamora;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QII;""
49 Zamora;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QI;""
49 Zamora;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QIV;1.225
49 Zamora;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
49 Zamora;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QII;""
49 Zamora;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QI;""
49 Zamora;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QIV;1.228
49 Zamora;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
49 Zamora;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QII;""
49 Zamora;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QI;""
49 Zamora;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
49 Zamora;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
49 Zamora;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
49 Zamora;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
49 Zamora;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
49 Zamora;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
49 Zamora;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
49 Zamora;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
49 Zamora;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
49 Zamora;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
49 Zamora;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
49 Zamora;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
49 Zamora;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
49 Zamora;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
49 Zamora;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
49 Zamora;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;98,22
49 Zamora;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
49 Zamora;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
49 Zamora;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
49 Zamora;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;98,61
49 Zamora;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
49 Zamora;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
49 Zamora;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
49 Zamora;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;96,45
49 Zamora;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
49 Zamora;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
49 Zamora;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;97,05
49 Zamora;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
49 Zamora;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
49 Zamora;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
49 Zamora;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;97,45
49 Zamora;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
49 Zamora;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
49 Zamora;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
49 Zamora;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;95,09
49 Zamora;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
49 Zamora;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
49 Zamora;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;95,58
49 Zamora;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
49 Zamora;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
49 Zamora;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
49 Zamora;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;95,9
49 Zamora;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
49 Zamora;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
49 Zamora;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
49 Zamora;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;93,88
49 Zamora;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
49 Zamora;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
49 Zamora;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;93,64
49 Zamora;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
49 Zamora;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
49 Zamora;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
49 Zamora;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;94,67
49 Zamora;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
49 Zamora;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
49 Zamora;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
49 Zamora;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;92,82
49 Zamora;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
49 Zamora;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
49 Zamora;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
49 Zamora;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
49 Zamora;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
49 Zamora;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QII;3.726
49 Zamora;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
49 Zamora;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
49 Zamora;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
49 Zamora;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QII;3.757
49 Zamora;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
49 Zamora;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
49 Zamora;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
49 Zamora;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QII;3.800
49 Zamora;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
49 Zamora;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
49 Zamora;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
49 Zamora;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2022QII;3.674
49 Zamora;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2022QI;""
49 Zamora;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
49 Zamora;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
49 Zamora;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2021QII;3.717
49 Zamora;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2021QI;""
49 Zamora;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
49 Zamora;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
49 Zamora;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2020QII;3.756
49 Zamora;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2020QI;""
49 Zamora;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
49 Zamora;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2022QIII;3.617
49 Zamora;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2022QII;""
49 Zamora;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2022QI;""
49 Zamora;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
49 Zamora;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2021QIII;3.675
49 Zamora;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2021QII;""
49 Zamora;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2021QI;""
49 Zamora;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
49 Zamora;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2020QIII;3.709
49 Zamora;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2020QII;""
49 Zamora;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2020QI;""
49 Zamora;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QIV;3.545
49 Zamora;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
49 Zamora;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QII;""
49 Zamora;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QI;""
49 Zamora;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QIV;3.621
49 Zamora;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
49 Zamora;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QII;""
49 Zamora;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QI;""
49 Zamora;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QIV;3.659
49 Zamora;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
49 Zamora;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QII;""
49 Zamora;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QI;""
49 Zamora;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
49 Zamora;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
49 Zamora;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QII;""
49 Zamora;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QI;3.582
49 Zamora;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
49 Zamora;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
49 Zamora;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QII;""
49 Zamora;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QI;3.626
49 Zamora;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
49 Zamora;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
49 Zamora;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QII;""
49 Zamora;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QI;""
49 Zamora;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
49 Zamora;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
49 Zamora;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
49 Zamora;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
49 Zamora;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
49 Zamora;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
49 Zamora;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
49 Zamora;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
49 Zamora;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
49 Zamora;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
49 Zamora;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
49 Zamora;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
49 Zamora;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
49 Zamora;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
49 Zamora;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;98,6
49 Zamora;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
49 Zamora;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
49 Zamora;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
49 Zamora;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;98,94
49 Zamora;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
49 Zamora;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
49 Zamora;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
49 Zamora;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;98,84
49 Zamora;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
49 Zamora;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
49 Zamora;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;97,07
49 Zamora;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
49 Zamora;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
49 Zamora;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
49 Zamora;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;97,82
49 Zamora;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
49 Zamora;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
49 Zamora;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
49 Zamora;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;97,61
49 Zamora;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
49 Zamora;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
49 Zamora;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;95,14
49 Zamora;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
49 Zamora;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
49 Zamora;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
49 Zamora;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;96,38
49 Zamora;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
49 Zamora;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
49 Zamora;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
49 Zamora;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;96,29
49 Zamora;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
49 Zamora;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
49 Zamora;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
49 Zamora;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
49 Zamora;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
49 Zamora;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
49 Zamora;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;95,34
49 Zamora;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
49 Zamora;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
49 Zamora;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
49 Zamora;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;95,42
49 Zamora;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
49 Zamora;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
49 Zamora;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
49 Zamora;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
49 Zamora;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
49 Zamora;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
49 Zamora;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QII;2.429
49 Zamora;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
49 Zamora;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
49 Zamora;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
49 Zamora;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QII;2.454
49 Zamora;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
49 Zamora;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
49 Zamora;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
49 Zamora;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QII;2.492
49 Zamora;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
49 Zamora;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
49 Zamora;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
49 Zamora;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2022QII;2.396
49 Zamora;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2022QI;""
49 Zamora;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
49 Zamora;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
49 Zamora;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2021QII;2.434
49 Zamora;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2021QI;""
49 Zamora;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
49 Zamora;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
49 Zamora;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2020QII;2.469
49 Zamora;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2020QI;""
49 Zamora;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
49 Zamora;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2022QIII;2.362
49 Zamora;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2022QII;""
49 Zamora;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2022QI;""
49 Zamora;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
49 Zamora;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2021QIII;2.413
49 Zamora;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2021QII;""
49 Zamora;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2021QI;""
49 Zamora;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
49 Zamora;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2020QIII;2.441
49 Zamora;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2020QII;""
49 Zamora;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2020QI;""
49 Zamora;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QIV;2.315
49 Zamora;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
49 Zamora;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QII;""
49 Zamora;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QI;""
49 Zamora;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QIV;2.379
49 Zamora;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
49 Zamora;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QII;""
49 Zamora;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QI;""
49 Zamora;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QIV;2.406
49 Zamora;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
49 Zamora;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QII;""
49 Zamora;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QI;""
49 Zamora;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
49 Zamora;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
49 Zamora;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QII;""
49 Zamora;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QI;2.356
49 Zamora;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
49 Zamora;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
49 Zamora;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QII;""
49 Zamora;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QI;2.386
49 Zamora;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
49 Zamora;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
49 Zamora;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QII;""
49 Zamora;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QI;""
49 Zamora;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
49 Zamora;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
49 Zamora;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
49 Zamora;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
49 Zamora;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
49 Zamora;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
49 Zamora;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
49 Zamora;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
49 Zamora;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
49 Zamora;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
49 Zamora;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
49 Zamora;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
49 Zamora;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
49 Zamora;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
49 Zamora;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;98,64
49 Zamora;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
49 Zamora;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
49 Zamora;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
49 Zamora;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;99,19
49 Zamora;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
49 Zamora;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
49 Zamora;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
49 Zamora;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;99,08
49 Zamora;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
49 Zamora;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
49 Zamora;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;97,24
49 Zamora;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
49 Zamora;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
49 Zamora;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
49 Zamora;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;98,33
49 Zamora;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
49 Zamora;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
49 Zamora;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
49 Zamora;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;97,95
49 Zamora;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
49 Zamora;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
49 Zamora;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;95,31
49 Zamora;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
49 Zamora;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
49 Zamora;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
49 Zamora;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;96,94
49 Zamora;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
49 Zamora;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
49 Zamora;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
49 Zamora;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;96,55
49 Zamora;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
49 Zamora;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
49 Zamora;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
49 Zamora;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
49 Zamora;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
49 Zamora;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
49 Zamora;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;96,01
49 Zamora;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
49 Zamora;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
49 Zamora;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
49 Zamora;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;95,75
49 Zamora;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
49 Zamora;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
49 Zamora;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
49 Zamora;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
49 Zamora;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
49 Zamora;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
49 Zamora;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QII;1.297
49 Zamora;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
49 Zamora;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
49 Zamora;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
49 Zamora;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QII;1.303
49 Zamora;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
49 Zamora;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
49 Zamora;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
49 Zamora;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QII;1.308
49 Zamora;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
49 Zamora;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
49 Zamora;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
49 Zamora;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2022QII;1.278
49 Zamora;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2022QI;""
49 Zamora;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
49 Zamora;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
49 Zamora;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2021QII;1.283
49 Zamora;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2021QI;""
49 Zamora;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
49 Zamora;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
49 Zamora;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2020QII;1.287
49 Zamora;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2020QI;""
49 Zamora;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
49 Zamora;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2022QIII;1.255
49 Zamora;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2022QII;""
49 Zamora;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2022QI;""
49 Zamora;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
49 Zamora;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2021QIII;1.262
49 Zamora;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2021QII;""
49 Zamora;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2021QI;""
49 Zamora;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
49 Zamora;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2020QIII;1.268
49 Zamora;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2020QII;""
49 Zamora;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2020QI;""
49 Zamora;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QIV;1.230
49 Zamora;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
49 Zamora;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QII;""
49 Zamora;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QI;""
49 Zamora;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QIV;1.242
49 Zamora;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
49 Zamora;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QII;""
49 Zamora;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QI;""
49 Zamora;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QIV;1.253
49 Zamora;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
49 Zamora;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QII;""
49 Zamora;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QI;""
49 Zamora;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
49 Zamora;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
49 Zamora;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QII;""
49 Zamora;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QI;1.226
49 Zamora;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
49 Zamora;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
49 Zamora;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QII;""
49 Zamora;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QI;1.240
49 Zamora;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
49 Zamora;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
49 Zamora;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QII;""
49 Zamora;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QI;""
49 Zamora;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
49 Zamora;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
49 Zamora;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
49 Zamora;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
49 Zamora;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
49 Zamora;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
49 Zamora;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
49 Zamora;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
49 Zamora;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
49 Zamora;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
49 Zamora;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
49 Zamora;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
49 Zamora;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
49 Zamora;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
49 Zamora;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;98,54
49 Zamora;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
49 Zamora;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
49 Zamora;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
49 Zamora;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;98,47
49 Zamora;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
49 Zamora;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
49 Zamora;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
49 Zamora;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;98,39
49 Zamora;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
49 Zamora;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
49 Zamora;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;96,76
49 Zamora;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
49 Zamora;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
49 Zamora;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
49 Zamora;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;96,85
49 Zamora;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
49 Zamora;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
49 Zamora;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
49 Zamora;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;96,94
49 Zamora;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
49 Zamora;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
49 Zamora;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;94,83
49 Zamora;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
49 Zamora;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
49 Zamora;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
49 Zamora;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;95,32
49 Zamora;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
49 Zamora;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
49 Zamora;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
49 Zamora;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;95,8
49 Zamora;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
49 Zamora;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
49 Zamora;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
49 Zamora;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
49 Zamora;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
49 Zamora;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
49 Zamora;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;94,09
49 Zamora;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
49 Zamora;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
49 Zamora;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
49 Zamora;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;94,8
49 Zamora;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
49 Zamora;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
49 Zamora;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
49 Zamora;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
49 Zamora;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
49 Zamora;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QIII;3.724
49 Zamora;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
49 Zamora;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
49 Zamora;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
49 Zamora;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QIII;3.789
49 Zamora;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
49 Zamora;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
49 Zamora;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
49 Zamora;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QIII;3.812
49 Zamora;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
49 Zamora;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
49 Zamora;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
49 Zamora;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2022QIII;3.653
49 Zamora;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2022QII;""
49 Zamora;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2022QI;""
49 Zamora;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
49 Zamora;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2021QIII;3.733
49 Zamora;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2021QII;""
49 Zamora;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2021QI;""
49 Zamora;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
49 Zamora;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2020QIII;3.757
49 Zamora;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2020QII;""
49 Zamora;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2020QI;""
49 Zamora;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2022QIV;3.571
49 Zamora;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
49 Zamora;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2022QII;""
49 Zamora;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2022QI;""
49 Zamora;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2021QIV;3.666
49 Zamora;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
49 Zamora;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2021QII;""
49 Zamora;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2021QI;""
49 Zamora;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2020QIV;3.702
49 Zamora;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
49 Zamora;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2020QII;""
49 Zamora;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2020QI;""
49 Zamora;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
49 Zamora;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
49 Zamora;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QII;""
49 Zamora;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QI;3.626
49 Zamora;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
49 Zamora;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
49 Zamora;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QII;""
49 Zamora;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QI;3.666
49 Zamora;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
49 Zamora;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
49 Zamora;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QII;""
49 Zamora;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QI;""
49 Zamora;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
49 Zamora;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
49 Zamora;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QII;3.588
49 Zamora;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QI;""
49 Zamora;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
49 Zamora;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
49 Zamora;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QII;3.639
49 Zamora;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QI;""
49 Zamora;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
49 Zamora;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
49 Zamora;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QII;""
49 Zamora;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QI;""
49 Zamora;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
49 Zamora;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
49 Zamora;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
49 Zamora;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
49 Zamora;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
49 Zamora;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
49 Zamora;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
49 Zamora;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
49 Zamora;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
49 Zamora;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
49 Zamora;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
49 Zamora;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
49 Zamora;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
49 Zamora;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;98,09
49 Zamora;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
49 Zamora;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
49 Zamora;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
49 Zamora;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;98,52
49 Zamora;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
49 Zamora;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
49 Zamora;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
49 Zamora;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;98,56
49 Zamora;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
49 Zamora;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
49 Zamora;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;95,89
49 Zamora;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
49 Zamora;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
49 Zamora;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
49 Zamora;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;96,75
49 Zamora;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
49 Zamora;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
49 Zamora;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
49 Zamora;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;97,11
49 Zamora;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
49 Zamora;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
49 Zamora;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
49 Zamora;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
49 Zamora;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
49 Zamora;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
49 Zamora;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;95,7
49 Zamora;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
49 Zamora;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
49 Zamora;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
49 Zamora;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;96,17
49 Zamora;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
49 Zamora;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
49 Zamora;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
49 Zamora;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
49 Zamora;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
49 Zamora;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
49 Zamora;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;94,7
49 Zamora;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
49 Zamora;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
49 Zamora;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
49 Zamora;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;95,46
49 Zamora;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
49 Zamora;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
49 Zamora;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
49 Zamora;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
49 Zamora;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
49 Zamora;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
49 Zamora;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QIII;2.429
49 Zamora;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
49 Zamora;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
49 Zamora;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
49 Zamora;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QIII;2.487
49 Zamora;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
49 Zamora;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
49 Zamora;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
49 Zamora;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QIII;2.510
49 Zamora;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
49 Zamora;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
49 Zamora;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
49 Zamora;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2022QIII;2.386
49 Zamora;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2022QII;""
49 Zamora;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2022QI;""
49 Zamora;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
49 Zamora;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2021QIII;2.456
49 Zamora;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2021QII;""
49 Zamora;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2021QI;""
49 Zamora;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
49 Zamora;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2020QIII;2.476
49 Zamora;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2020QII;""
49 Zamora;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2020QI;""
49 Zamora;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2022QIV;2.331
49 Zamora;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
49 Zamora;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2022QII;""
49 Zamora;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2022QI;""
49 Zamora;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2021QIV;2.411
49 Zamora;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
49 Zamora;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2021QII;""
49 Zamora;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2021QI;""
49 Zamora;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2020QIV;2.439
49 Zamora;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
49 Zamora;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2020QII;""
49 Zamora;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2020QI;""
49 Zamora;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
49 Zamora;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
49 Zamora;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QII;""
49 Zamora;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QI;2.387
49 Zamora;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
49 Zamora;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
49 Zamora;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QII;""
49 Zamora;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QI;2.417
49 Zamora;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
49 Zamora;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
49 Zamora;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QII;""
49 Zamora;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QI;""
49 Zamora;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
49 Zamora;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
49 Zamora;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QII;2.362
49 Zamora;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QI;""
49 Zamora;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
49 Zamora;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
49 Zamora;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QII;2.402
49 Zamora;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QI;""
49 Zamora;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
49 Zamora;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
49 Zamora;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QII;""
49 Zamora;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QI;""
49 Zamora;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
49 Zamora;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
49 Zamora;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
49 Zamora;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
49 Zamora;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
49 Zamora;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
49 Zamora;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
49 Zamora;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
49 Zamora;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
49 Zamora;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
49 Zamora;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
49 Zamora;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
49 Zamora;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
49 Zamora;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;98,23
49 Zamora;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
49 Zamora;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
49 Zamora;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
49 Zamora;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;98,75
49 Zamora;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
49 Zamora;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
49 Zamora;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
49 Zamora;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;98,65
49 Zamora;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
49 Zamora;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
49 Zamora;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;95,97
49 Zamora;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
49 Zamora;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
49 Zamora;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
49 Zamora;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;96,94
49 Zamora;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
49 Zamora;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
49 Zamora;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
49 Zamora;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;97,17
49 Zamora;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
49 Zamora;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
49 Zamora;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
49 Zamora;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
49 Zamora;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
49 Zamora;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
49 Zamora;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;95,98
49 Zamora;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
49 Zamora;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
49 Zamora;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
49 Zamora;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;96,29
49 Zamora;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
49 Zamora;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
49 Zamora;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
49 Zamora;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
49 Zamora;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
49 Zamora;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
49 Zamora;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;94,97
49 Zamora;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
49 Zamora;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
49 Zamora;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
49 Zamora;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;95,7
49 Zamora;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
49 Zamora;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
49 Zamora;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
49 Zamora;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
49 Zamora;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
49 Zamora;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
49 Zamora;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QIII;1.295
49 Zamora;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
49 Zamora;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
49 Zamora;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
49 Zamora;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QIII;1.302
49 Zamora;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
49 Zamora;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
49 Zamora;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
49 Zamora;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QIII;1.302
49 Zamora;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
49 Zamora;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
49 Zamora;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
49 Zamora;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2022QIII;1.267
49 Zamora;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2022QII;""
49 Zamora;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2022QI;""
49 Zamora;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
49 Zamora;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2021QIII;1.277
49 Zamora;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2021QII;""
49 Zamora;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2021QI;""
49 Zamora;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
49 Zamora;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2020QIII;1.281
49 Zamora;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2020QII;""
49 Zamora;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2020QI;""
49 Zamora;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2022QIV;1.240
49 Zamora;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
49 Zamora;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2022QII;""
49 Zamora;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2022QI;""
49 Zamora;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2021QIV;1.255
49 Zamora;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
49 Zamora;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2021QII;""
49 Zamora;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2021QI;""
49 Zamora;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2020QIV;1.263
49 Zamora;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
49 Zamora;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2020QII;""
49 Zamora;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2020QI;""
49 Zamora;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
49 Zamora;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
49 Zamora;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QII;""
49 Zamora;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QI;1.239
49 Zamora;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
49 Zamora;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
49 Zamora;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QII;""
49 Zamora;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QI;1.249
49 Zamora;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
49 Zamora;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
49 Zamora;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QII;""
49 Zamora;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QI;""
49 Zamora;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
49 Zamora;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
49 Zamora;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QII;1.226
49 Zamora;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QI;""
49 Zamora;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
49 Zamora;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
49 Zamora;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QII;1.237
49 Zamora;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QI;""
49 Zamora;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
49 Zamora;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
49 Zamora;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QII;""
49 Zamora;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QI;""
49 Zamora;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
49 Zamora;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
49 Zamora;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
49 Zamora;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
49 Zamora;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
49 Zamora;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
49 Zamora;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
49 Zamora;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
49 Zamora;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
49 Zamora;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
49 Zamora;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
49 Zamora;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
49 Zamora;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
49 Zamora;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;97,84
49 Zamora;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
49 Zamora;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
49 Zamora;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
49 Zamora;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;98,08
49 Zamora;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
49 Zamora;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
49 Zamora;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
49 Zamora;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;98,39
49 Zamora;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
49 Zamora;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
49 Zamora;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;95,75
49 Zamora;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
49 Zamora;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
49 Zamora;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
49 Zamora;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;96,39
49 Zamora;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
49 Zamora;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
49 Zamora;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
49 Zamora;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;97
49 Zamora;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
49 Zamora;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
49 Zamora;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
49 Zamora;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
49 Zamora;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
49 Zamora;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
49 Zamora;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;95,16
49 Zamora;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
49 Zamora;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
49 Zamora;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
49 Zamora;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;95,93
49 Zamora;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
49 Zamora;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
49 Zamora;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
49 Zamora;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
49 Zamora;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
49 Zamora;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
49 Zamora;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;94,16
49 Zamora;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
49 Zamora;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
49 Zamora;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
49 Zamora;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;95,01
49 Zamora;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
49 Zamora;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
49 Zamora;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
49 Zamora;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
49 Zamora;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
49 Zamora;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QIV;3.694
49 Zamora;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
49 Zamora;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
49 Zamora;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
49 Zamora;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QIV;3.784
49 Zamora;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
49 Zamora;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
49 Zamora;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
49 Zamora;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QIV;3.809
49 Zamora;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
49 Zamora;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
49 Zamora;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
49 Zamora;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2022QIV;3.604
49 Zamora;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
49 Zamora;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2022QII;""
49 Zamora;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2022QI;""
49 Zamora;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2021QIV;3.708
49 Zamora;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
49 Zamora;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2021QII;""
49 Zamora;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2021QI;""
49 Zamora;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2020QIV;3.747
49 Zamora;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
49 Zamora;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2020QII;""
49 Zamora;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2020QI;""
49 Zamora;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
49 Zamora;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
49 Zamora;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2022QII;""
49 Zamora;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2022QI;3.665
49 Zamora;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
49 Zamora;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
49 Zamora;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2021QII;""
49 Zamora;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2021QI;3.706
49 Zamora;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
49 Zamora;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
49 Zamora;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2020QII;""
49 Zamora;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2020QI;""
49 Zamora;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
49 Zamora;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
49 Zamora;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QII;3.625
49 Zamora;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QI;""
49 Zamora;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
49 Zamora;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
49 Zamora;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QII;3.677
49 Zamora;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QI;""
49 Zamora;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
49 Zamora;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
49 Zamora;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QII;""
49 Zamora;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QI;""
49 Zamora;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
49 Zamora;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QIII;3.579
49 Zamora;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QII;""
49 Zamora;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QI;""
49 Zamora;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
49 Zamora;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QIII;3.637
49 Zamora;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QII;""
49 Zamora;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QI;""
49 Zamora;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
49 Zamora;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
49 Zamora;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QII;""
49 Zamora;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QI;""
49 Zamora;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
49 Zamora;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
49 Zamora;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
49 Zamora;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
49 Zamora;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
49 Zamora;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
49 Zamora;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
49 Zamora;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
49 Zamora;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
49 Zamora;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
49 Zamora;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
49 Zamora;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
49 Zamora;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;97,56
49 Zamora;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
49 Zamora;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
49 Zamora;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
49 Zamora;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;97,99
49 Zamora;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
49 Zamora;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
49 Zamora;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
49 Zamora;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;98,37
49 Zamora;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
49 Zamora;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
49 Zamora;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
49 Zamora;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
49 Zamora;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
49 Zamora;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
49 Zamora;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;96,86
49 Zamora;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
49 Zamora;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
49 Zamora;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
49 Zamora;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;97,3
49 Zamora;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
49 Zamora;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
49 Zamora;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
49 Zamora;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
49 Zamora;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
49 Zamora;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
49 Zamora;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;95,8
49 Zamora;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
49 Zamora;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
49 Zamora;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
49 Zamora;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;96,53
49 Zamora;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
49 Zamora;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
49 Zamora;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
49 Zamora;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
49 Zamora;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
49 Zamora;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
49 Zamora;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;94,58
49 Zamora;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
49 Zamora;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
49 Zamora;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
49 Zamora;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;95,48
49 Zamora;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
49 Zamora;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
49 Zamora;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
49 Zamora;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
49 Zamora;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
49 Zamora;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
49 Zamora;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QIV;2.412
49 Zamora;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
49 Zamora;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
49 Zamora;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
49 Zamora;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QIV;2.479
49 Zamora;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
49 Zamora;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
49 Zamora;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
49 Zamora;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QIV;2.504
49 Zamora;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
49 Zamora;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
49 Zamora;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
49 Zamora;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2022QIV;2.352
49 Zamora;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
49 Zamora;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2022QII;""
49 Zamora;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2022QI;""
49 Zamora;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2021QIV;2.431
49 Zamora;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
49 Zamora;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2021QII;""
49 Zamora;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2021QI;""
49 Zamora;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2020QIV;2.463
49 Zamora;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
49 Zamora;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2020QII;""
49 Zamora;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2020QI;""
49 Zamora;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
49 Zamora;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
49 Zamora;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2022QII;""
49 Zamora;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2022QI;2.407
49 Zamora;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
49 Zamora;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
49 Zamora;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2021QII;""
49 Zamora;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2021QI;2.439
49 Zamora;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
49 Zamora;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
49 Zamora;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2020QII;""
49 Zamora;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2020QI;""
49 Zamora;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
49 Zamora;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
49 Zamora;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QII;2.381
49 Zamora;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QI;""
49 Zamora;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
49 Zamora;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
49 Zamora;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QII;2.424
49 Zamora;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QI;""
49 Zamora;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
49 Zamora;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
49 Zamora;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QII;""
49 Zamora;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QI;""
49 Zamora;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
49 Zamora;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QIII;2.353
49 Zamora;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QII;""
49 Zamora;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QI;""
49 Zamora;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
49 Zamora;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QIII;2.403
49 Zamora;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QII;""
49 Zamora;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QI;""
49 Zamora;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
49 Zamora;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
49 Zamora;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QII;""
49 Zamora;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QI;""
49 Zamora;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
49 Zamora;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
49 Zamora;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
49 Zamora;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
49 Zamora;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
49 Zamora;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
49 Zamora;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
49 Zamora;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
49 Zamora;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
49 Zamora;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
49 Zamora;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
49 Zamora;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
49 Zamora;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;97,51
49 Zamora;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
49 Zamora;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
49 Zamora;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
49 Zamora;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;98,06
49 Zamora;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
49 Zamora;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
49 Zamora;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
49 Zamora;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;98,36
49 Zamora;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
49 Zamora;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
49 Zamora;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
49 Zamora;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
49 Zamora;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
49 Zamora;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
49 Zamora;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;97,1
49 Zamora;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
49 Zamora;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
49 Zamora;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
49 Zamora;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;97,4
49 Zamora;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
49 Zamora;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
49 Zamora;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
49 Zamora;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
49 Zamora;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
49 Zamora;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
49 Zamora;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;96,05
49 Zamora;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
49 Zamora;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
49 Zamora;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
49 Zamora;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;96,81
49 Zamora;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
49 Zamora;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
49 Zamora;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
49 Zamora;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
49 Zamora;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
49 Zamora;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
49 Zamora;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;94,92
49 Zamora;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
49 Zamora;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
49 Zamora;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
49 Zamora;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;95,97
49 Zamora;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
49 Zamora;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
49 Zamora;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
49 Zamora;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
49 Zamora;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
49 Zamora;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
49 Zamora;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QIV;1.282
49 Zamora;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
49 Zamora;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
49 Zamora;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
49 Zamora;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QIV;1.305
49 Zamora;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
49 Zamora;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
49 Zamora;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
49 Zamora;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QIV;1.305
49 Zamora;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
49 Zamora;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
49 Zamora;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
49 Zamora;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2022QIV;1.252
49 Zamora;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
49 Zamora;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2022QII;""
49 Zamora;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2022QI;""
49 Zamora;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2021QIV;1.277
49 Zamora;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
49 Zamora;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2021QII;""
49 Zamora;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2021QI;""
49 Zamora;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2020QIV;1.284
49 Zamora;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
49 Zamora;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2020QII;""
49 Zamora;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2020QI;""
49 Zamora;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
49 Zamora;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
49 Zamora;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2022QII;""
49 Zamora;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2022QI;1.258
49 Zamora;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
49 Zamora;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
49 Zamora;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2021QII;""
49 Zamora;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2021QI;1.267
49 Zamora;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
49 Zamora;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
49 Zamora;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2020QII;""
49 Zamora;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2020QI;""
49 Zamora;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
49 Zamora;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
49 Zamora;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QII;1.244
49 Zamora;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QI;""
49 Zamora;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
49 Zamora;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
49 Zamora;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QII;1.253
49 Zamora;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QI;""
49 Zamora;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
49 Zamora;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
49 Zamora;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QII;""
49 Zamora;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QI;""
49 Zamora;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
49 Zamora;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QIII;1.226
49 Zamora;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QII;""
49 Zamora;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QI;""
49 Zamora;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
49 Zamora;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QIII;1.234
49 Zamora;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QII;""
49 Zamora;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QI;""
49 Zamora;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
49 Zamora;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
49 Zamora;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QII;""
49 Zamora;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QI;""
49 Zamora;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
49 Zamora;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
49 Zamora;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
49 Zamora;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
49 Zamora;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
49 Zamora;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
49 Zamora;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
49 Zamora;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
49 Zamora;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
49 Zamora;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
49 Zamora;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
49 Zamora;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
49 Zamora;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;97,66
49 Zamora;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
49 Zamora;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
49 Zamora;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
49 Zamora;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;97,85
49 Zamora;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
49 Zamora;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
49 Zamora;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
49 Zamora;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;98,39
49 Zamora;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
49 Zamora;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
49 Zamora;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
49 Zamora;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
49 Zamora;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
49 Zamora;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
49 Zamora;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;96,4
49 Zamora;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
49 Zamora;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
49 Zamora;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
49 Zamora;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;97,09
49 Zamora;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
49 Zamora;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
49 Zamora;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
49 Zamora;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
49 Zamora;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
49 Zamora;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
49 Zamora;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;95,33
49 Zamora;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
49 Zamora;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
49 Zamora;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
49 Zamora;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;96,02
49 Zamora;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
49 Zamora;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
49 Zamora;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
49 Zamora;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
49 Zamora;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
49 Zamora;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
49 Zamora;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;93,95
49 Zamora;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
49 Zamora;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
49 Zamora;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
49 Zamora;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;94,56
49 Zamora;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
49 Zamora;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
49 Zamora;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
49 Zamora;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
49 Zamora;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
49 Zamora;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
49 Zamora;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
49 Zamora;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
49 Zamora;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
49 Zamora;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QI;2.116
49 Zamora;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
49 Zamora;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
49 Zamora;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
49 Zamora;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QI;2.007
49 Zamora;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
49 Zamora;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
49 Zamora;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
49 Zamora;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QI;2.373
49 Zamora;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
49 Zamora;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
49 Zamora;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2022QII;""
49 Zamora;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2022QI;2.059
49 Zamora;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
49 Zamora;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
49 Zamora;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2021QII;""
49 Zamora;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2021QI;1.926
49 Zamora;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
49 Zamora;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
49 Zamora;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2020QII;""
49 Zamora;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2020QI;2.201
49 Zamora;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
49 Zamora;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
49 Zamora;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2022QII;1.974
49 Zamora;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2022QI;""
49 Zamora;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
49 Zamora;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
49 Zamora;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2021QII;1.853
49 Zamora;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2021QI;""
49 Zamora;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
49 Zamora;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
49 Zamora;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2020QII;2.142
49 Zamora;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2020QI;""
49 Zamora;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
49 Zamora;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QIII;1.905
49 Zamora;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QII;""
49 Zamora;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QI;""
49 Zamora;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
49 Zamora;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QIII;1.779
49 Zamora;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QII;""
49 Zamora;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QI;""
49 Zamora;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
49 Zamora;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QIII;2.046
49 Zamora;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QII;""
49 Zamora;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QI;""
49 Zamora;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QIV;1.775
49 Zamora;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
49 Zamora;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QII;""
49 Zamora;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QI;""
49 Zamora;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QIV;1.700
49 Zamora;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
49 Zamora;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QII;""
49 Zamora;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QI;""
49 Zamora;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QIV;1.935
49 Zamora;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
49 Zamora;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QII;""
49 Zamora;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QI;""
49 Zamora;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
49 Zamora;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
49 Zamora;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
49 Zamora;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
49 Zamora;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
49 Zamora;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
49 Zamora;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
49 Zamora;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
49 Zamora;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
49 Zamora;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
49 Zamora;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
49 Zamora;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
49 Zamora;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
49 Zamora;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
49 Zamora;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
49 Zamora;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;97,31
49 Zamora;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
49 Zamora;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
49 Zamora;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
49 Zamora;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;95,96
49 Zamora;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
49 Zamora;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
49 Zamora;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
49 Zamora;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;92,75
49 Zamora;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
49 Zamora;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
49 Zamora;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;93,29
49 Zamora;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
49 Zamora;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
49 Zamora;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
49 Zamora;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;92,33
49 Zamora;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
49 Zamora;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
49 Zamora;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
49 Zamora;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;90,27
49 Zamora;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
49 Zamora;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
49 Zamora;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;90,03
49 Zamora;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
49 Zamora;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
49 Zamora;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
49 Zamora;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;88,64
49 Zamora;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
49 Zamora;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
49 Zamora;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
49 Zamora;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;86,22
49 Zamora;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
49 Zamora;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
49 Zamora;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;83,88
49 Zamora;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
49 Zamora;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
49 Zamora;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
49 Zamora;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;84,7
49 Zamora;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
49 Zamora;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
49 Zamora;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
49 Zamora;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;81,54
49 Zamora;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
49 Zamora;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
49 Zamora;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
49 Zamora;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
49 Zamora;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
49 Zamora;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
49 Zamora;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QI;1.423
49 Zamora;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
49 Zamora;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
49 Zamora;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
49 Zamora;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QI;1.336
49 Zamora;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
49 Zamora;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
49 Zamora;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
49 Zamora;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QI;1.577
49 Zamora;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
49 Zamora;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
49 Zamora;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2022QII;""
49 Zamora;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2022QI;1.389
49 Zamora;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
49 Zamora;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
49 Zamora;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2021QII;""
49 Zamora;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2021QI;1.287
49 Zamora;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
49 Zamora;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
49 Zamora;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2020QII;""
49 Zamora;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2020QI;1.472
49 Zamora;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
49 Zamora;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
49 Zamora;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2022QII;1.336
49 Zamora;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2022QI;""
49 Zamora;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
49 Zamora;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
49 Zamora;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2021QII;1.241
49 Zamora;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2021QI;""
49 Zamora;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
49 Zamora;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
49 Zamora;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2020QII;1.436
49 Zamora;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2020QI;""
49 Zamora;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
49 Zamora;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QIII;1.295
49 Zamora;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QII;""
49 Zamora;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QI;""
49 Zamora;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
49 Zamora;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QIII;1.201
49 Zamora;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QII;""
49 Zamora;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QI;""
49 Zamora;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
49 Zamora;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QIII;1.372
49 Zamora;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QII;""
49 Zamora;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QI;""
49 Zamora;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QIV;1.206
49 Zamora;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
49 Zamora;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QII;""
49 Zamora;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QI;""
49 Zamora;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QIV;1.148
49 Zamora;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
49 Zamora;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QII;""
49 Zamora;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QI;""
49 Zamora;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QIV;1.300
49 Zamora;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
49 Zamora;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QII;""
49 Zamora;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QI;""
49 Zamora;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
49 Zamora;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
49 Zamora;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
49 Zamora;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
49 Zamora;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
49 Zamora;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
49 Zamora;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
49 Zamora;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
49 Zamora;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
49 Zamora;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
49 Zamora;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
49 Zamora;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
49 Zamora;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
49 Zamora;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
49 Zamora;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
49 Zamora;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;97,61
49 Zamora;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
49 Zamora;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
49 Zamora;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
49 Zamora;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;96,33
49 Zamora;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
49 Zamora;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
49 Zamora;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
49 Zamora;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;93,34
49 Zamora;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
49 Zamora;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
49 Zamora;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;93,89
49 Zamora;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
49 Zamora;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
49 Zamora;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
49 Zamora;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;92,89
49 Zamora;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
49 Zamora;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
49 Zamora;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
49 Zamora;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;91,06
49 Zamora;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
49 Zamora;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
49 Zamora;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;91
49 Zamora;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
49 Zamora;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
49 Zamora;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
49 Zamora;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;89,9
49 Zamora;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
49 Zamora;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
49 Zamora;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
49 Zamora;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;87
49 Zamora;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
49 Zamora;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
49 Zamora;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;84,75
49 Zamora;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
49 Zamora;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
49 Zamora;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
49 Zamora;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;85,93
49 Zamora;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
49 Zamora;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
49 Zamora;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
49 Zamora;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;82,44
49 Zamora;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
49 Zamora;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
49 Zamora;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
49 Zamora;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
49 Zamora;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
49 Zamora;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
49 Zamora;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QI;693
49 Zamora;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
49 Zamora;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
49 Zamora;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
49 Zamora;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QI;671
49 Zamora;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
49 Zamora;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
49 Zamora;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
49 Zamora;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QI;796
49 Zamora;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
49 Zamora;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
49 Zamora;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2022QII;""
49 Zamora;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2022QI;670
49 Zamora;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
49 Zamora;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
49 Zamora;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2021QII;""
49 Zamora;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2021QI;639
49 Zamora;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
49 Zamora;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
49 Zamora;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2020QII;""
49 Zamora;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2020QI;729
49 Zamora;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
49 Zamora;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
49 Zamora;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2022QII;638
49 Zamora;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2022QI;""
49 Zamora;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
49 Zamora;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
49 Zamora;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2021QII;612
49 Zamora;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2021QI;""
49 Zamora;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
49 Zamora;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
49 Zamora;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2020QII;706
49 Zamora;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2020QI;""
49 Zamora;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
49 Zamora;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QIII;610
49 Zamora;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QII;""
49 Zamora;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QI;""
49 Zamora;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
49 Zamora;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QIII;578
49 Zamora;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QII;""
49 Zamora;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QI;""
49 Zamora;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
49 Zamora;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QIII;674
49 Zamora;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QII;""
49 Zamora;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QI;""
49 Zamora;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QIV;569
49 Zamora;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
49 Zamora;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QII;""
49 Zamora;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QI;""
49 Zamora;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QIV;552
49 Zamora;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
49 Zamora;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QII;""
49 Zamora;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QI;""
49 Zamora;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QIV;635
49 Zamora;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
49 Zamora;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QII;""
49 Zamora;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QI;""
49 Zamora;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
49 Zamora;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
49 Zamora;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
49 Zamora;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
49 Zamora;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
49 Zamora;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
49 Zamora;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
49 Zamora;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
49 Zamora;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
49 Zamora;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
49 Zamora;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
49 Zamora;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
49 Zamora;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
49 Zamora;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
49 Zamora;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
49 Zamora;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;96,68
49 Zamora;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
49 Zamora;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
49 Zamora;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
49 Zamora;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;95,23
49 Zamora;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
49 Zamora;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
49 Zamora;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
49 Zamora;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;91,58
49 Zamora;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
49 Zamora;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
49 Zamora;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;92,06
49 Zamora;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
49 Zamora;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
49 Zamora;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
49 Zamora;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;91,21
49 Zamora;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
49 Zamora;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
49 Zamora;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
49 Zamora;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;88,69
49 Zamora;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
49 Zamora;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
49 Zamora;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;88,02
49 Zamora;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
49 Zamora;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
49 Zamora;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
49 Zamora;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;86,14
49 Zamora;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
49 Zamora;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
49 Zamora;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
49 Zamora;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;84,67
49 Zamora;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
49 Zamora;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
49 Zamora;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;82,11
49 Zamora;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
49 Zamora;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
49 Zamora;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
49 Zamora;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;82,27
49 Zamora;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
49 Zamora;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
49 Zamora;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
49 Zamora;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;79,77
49 Zamora;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
49 Zamora;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
49 Zamora;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
49 Zamora;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
49 Zamora;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
49 Zamora;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QII;2.452
49 Zamora;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
49 Zamora;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
49 Zamora;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
49 Zamora;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QII;2.319
49 Zamora;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
49 Zamora;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
49 Zamora;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
49 Zamora;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QII;2.229
49 Zamora;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
49 Zamora;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
49 Zamora;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
49 Zamora;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2022QII;2.360
49 Zamora;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2022QI;""
49 Zamora;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
49 Zamora;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
49 Zamora;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2021QII;2.237
49 Zamora;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2021QI;""
49 Zamora;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
49 Zamora;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
49 Zamora;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2020QII;2.166
49 Zamora;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2020QI;""
49 Zamora;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
49 Zamora;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2022QIII;2.286
49 Zamora;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2022QII;""
49 Zamora;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2022QI;""
49 Zamora;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
49 Zamora;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2021QIII;2.159
49 Zamora;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2021QII;""
49 Zamora;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2021QI;""
49 Zamora;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
49 Zamora;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2020QIII;2.065
49 Zamora;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2020QII;""
49 Zamora;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2020QI;""
49 Zamora;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QIV;2.145
49 Zamora;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
49 Zamora;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QII;""
49 Zamora;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QI;""
49 Zamora;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QIV;2.076
49 Zamora;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
49 Zamora;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QII;""
49 Zamora;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QI;""
49 Zamora;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QIV;1.953
49 Zamora;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
49 Zamora;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QII;""
49 Zamora;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QI;""
49 Zamora;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
49 Zamora;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
49 Zamora;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QII;""
49 Zamora;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QI;2.025
49 Zamora;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
49 Zamora;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
49 Zamora;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QII;""
49 Zamora;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QI;1.879
49 Zamora;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
49 Zamora;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
49 Zamora;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QII;""
49 Zamora;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QI;""
49 Zamora;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
49 Zamora;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
49 Zamora;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
49 Zamora;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
49 Zamora;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
49 Zamora;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
49 Zamora;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
49 Zamora;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
49 Zamora;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
49 Zamora;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
49 Zamora;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
49 Zamora;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
49 Zamora;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
49 Zamora;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
49 Zamora;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;96,25
49 Zamora;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
49 Zamora;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
49 Zamora;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
49 Zamora;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;96,46
49 Zamora;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
49 Zamora;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
49 Zamora;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
49 Zamora;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;97,17
49 Zamora;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
49 Zamora;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
49 Zamora;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;93,23
49 Zamora;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
49 Zamora;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
49 Zamora;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
49 Zamora;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;93,1
49 Zamora;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
49 Zamora;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
49 Zamora;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
49 Zamora;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;92,64
49 Zamora;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
49 Zamora;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
49 Zamora;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;87,48
49 Zamora;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
49 Zamora;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
49 Zamora;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
49 Zamora;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;89,52
49 Zamora;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
49 Zamora;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
49 Zamora;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
49 Zamora;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;87,62
49 Zamora;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
49 Zamora;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
49 Zamora;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
49 Zamora;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
49 Zamora;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
49 Zamora;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
49 Zamora;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;87,32
49 Zamora;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
49 Zamora;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
49 Zamora;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
49 Zamora;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;84,3
49 Zamora;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
49 Zamora;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
49 Zamora;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
49 Zamora;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
49 Zamora;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
49 Zamora;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
49 Zamora;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QII;1.655
49 Zamora;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
49 Zamora;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
49 Zamora;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
49 Zamora;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QII;1.553
49 Zamora;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
49 Zamora;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
49 Zamora;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
49 Zamora;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QII;1.485
49 Zamora;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
49 Zamora;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
49 Zamora;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
49 Zamora;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2022QII;1.599
49 Zamora;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2022QI;""
49 Zamora;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
49 Zamora;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
49 Zamora;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2021QII;1.503
49 Zamora;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2021QI;""
49 Zamora;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
49 Zamora;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
49 Zamora;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2020QII;1.448
49 Zamora;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2020QI;""
49 Zamora;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
49 Zamora;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2022QIII;1.555
49 Zamora;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2022QII;""
49 Zamora;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2022QI;""
49 Zamora;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
49 Zamora;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2021QIII;1.460
49 Zamora;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2021QII;""
49 Zamora;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2021QI;""
49 Zamora;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
49 Zamora;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2020QIII;1.381
49 Zamora;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2020QII;""
49 Zamora;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2020QI;""
49 Zamora;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QIV;1.460
49 Zamora;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
49 Zamora;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QII;""
49 Zamora;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QI;""
49 Zamora;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QIV;1.404
49 Zamora;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
49 Zamora;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QII;""
49 Zamora;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QI;""
49 Zamora;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QIV;1.309
49 Zamora;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
49 Zamora;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QII;""
49 Zamora;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QI;""
49 Zamora;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
49 Zamora;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
49 Zamora;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QII;""
49 Zamora;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QI;1.374
49 Zamora;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
49 Zamora;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
49 Zamora;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QII;""
49 Zamora;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QI;1.263
49 Zamora;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
49 Zamora;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
49 Zamora;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QII;""
49 Zamora;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QI;""
49 Zamora;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
49 Zamora;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
49 Zamora;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
49 Zamora;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
49 Zamora;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
49 Zamora;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
49 Zamora;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
49 Zamora;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
49 Zamora;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
49 Zamora;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
49 Zamora;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
49 Zamora;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
49 Zamora;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
49 Zamora;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
49 Zamora;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;96,62
49 Zamora;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
49 Zamora;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
49 Zamora;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
49 Zamora;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;96,78
49 Zamora;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
49 Zamora;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
49 Zamora;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
49 Zamora;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;97,51
49 Zamora;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
49 Zamora;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
49 Zamora;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;93,96
49 Zamora;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
49 Zamora;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
49 Zamora;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
49 Zamora;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;94,01
49 Zamora;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
49 Zamora;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
49 Zamora;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
49 Zamora;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;93
49 Zamora;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
49 Zamora;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
49 Zamora;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;88,22
49 Zamora;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
49 Zamora;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
49 Zamora;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
49 Zamora;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;90,41
49 Zamora;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
49 Zamora;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
49 Zamora;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
49 Zamora;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;88,15
49 Zamora;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
49 Zamora;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
49 Zamora;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
49 Zamora;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
49 Zamora;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
49 Zamora;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
49 Zamora;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;88,47
49 Zamora;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
49 Zamora;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
49 Zamora;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
49 Zamora;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;85,05
49 Zamora;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
49 Zamora;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
49 Zamora;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
49 Zamora;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
49 Zamora;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
49 Zamora;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
49 Zamora;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QII;797
49 Zamora;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
49 Zamora;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
49 Zamora;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
49 Zamora;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QII;766
49 Zamora;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
49 Zamora;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
49 Zamora;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
49 Zamora;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QII;744
49 Zamora;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
49 Zamora;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
49 Zamora;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
49 Zamora;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2022QII;761
49 Zamora;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2022QI;""
49 Zamora;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
49 Zamora;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
49 Zamora;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2021QII;734
49 Zamora;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2021QI;""
49 Zamora;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
49 Zamora;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
49 Zamora;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2020QII;718
49 Zamora;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2020QI;""
49 Zamora;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
49 Zamora;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2022QIII;731
49 Zamora;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2022QII;""
49 Zamora;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2022QI;""
49 Zamora;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
49 Zamora;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2021QIII;699
49 Zamora;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2021QII;""
49 Zamora;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2021QI;""
49 Zamora;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
49 Zamora;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2020QIII;684
49 Zamora;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2020QII;""
49 Zamora;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2020QI;""
49 Zamora;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QIV;685
49 Zamora;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
49 Zamora;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QII;""
49 Zamora;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QI;""
49 Zamora;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QIV;672
49 Zamora;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
49 Zamora;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QII;""
49 Zamora;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QI;""
49 Zamora;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QIV;644
49 Zamora;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
49 Zamora;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QII;""
49 Zamora;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QI;""
49 Zamora;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
49 Zamora;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
49 Zamora;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QII;""
49 Zamora;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QI;651
49 Zamora;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
49 Zamora;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
49 Zamora;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QII;""
49 Zamora;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QI;616
49 Zamora;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
49 Zamora;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
49 Zamora;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QII;""
49 Zamora;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QI;""
49 Zamora;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
49 Zamora;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
49 Zamora;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
49 Zamora;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
49 Zamora;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
49 Zamora;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
49 Zamora;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
49 Zamora;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
49 Zamora;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
49 Zamora;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
49 Zamora;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
49 Zamora;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
49 Zamora;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
49 Zamora;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
49 Zamora;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;95,48
49 Zamora;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
49 Zamora;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
49 Zamora;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
49 Zamora;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;95,82
49 Zamora;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
49 Zamora;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
49 Zamora;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
49 Zamora;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;96,51
49 Zamora;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
49 Zamora;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
49 Zamora;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;91,72
49 Zamora;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
49 Zamora;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
49 Zamora;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
49 Zamora;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;91,25
49 Zamora;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
49 Zamora;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
49 Zamora;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
49 Zamora;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;91,94
49 Zamora;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
49 Zamora;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
49 Zamora;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;85,95
49 Zamora;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
49 Zamora;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
49 Zamora;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
49 Zamora;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;87,73
49 Zamora;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
49 Zamora;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
49 Zamora;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
49 Zamora;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;86,56
49 Zamora;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
49 Zamora;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
49 Zamora;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
49 Zamora;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
49 Zamora;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
49 Zamora;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
49 Zamora;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;84,99
49 Zamora;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
49 Zamora;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
49 Zamora;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
49 Zamora;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;82,8
49 Zamora;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
49 Zamora;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
49 Zamora;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
49 Zamora;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
49 Zamora;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
49 Zamora;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QIII;2.381
49 Zamora;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
49 Zamora;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
49 Zamora;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
49 Zamora;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QIII;2.259
49 Zamora;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
49 Zamora;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
49 Zamora;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
49 Zamora;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QIII;2.190
49 Zamora;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
49 Zamora;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
49 Zamora;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
49 Zamora;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2022QIII;2.300
49 Zamora;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2022QII;""
49 Zamora;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2022QI;""
49 Zamora;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
49 Zamora;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2021QIII;2.173
49 Zamora;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2021QII;""
49 Zamora;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2021QI;""
49 Zamora;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
49 Zamora;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2020QIII;2.086
49 Zamora;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2020QII;""
49 Zamora;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2020QI;""
49 Zamora;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2022QIV;2.156
49 Zamora;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
49 Zamora;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2022QII;""
49 Zamora;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2022QI;""
49 Zamora;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2021QIV;2.087
49 Zamora;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
49 Zamora;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2021QII;""
49 Zamora;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2021QI;""
49 Zamora;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2020QIV;1.969
49 Zamora;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
49 Zamora;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2020QII;""
49 Zamora;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2020QI;""
49 Zamora;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
49 Zamora;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
49 Zamora;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QII;""
49 Zamora;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QI;2.035
49 Zamora;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
49 Zamora;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
49 Zamora;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QII;""
49 Zamora;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QI;1.891
49 Zamora;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
49 Zamora;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
49 Zamora;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QII;""
49 Zamora;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QI;""
49 Zamora;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
49 Zamora;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
49 Zamora;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QII;1.957
49 Zamora;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QI;""
49 Zamora;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
49 Zamora;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
49 Zamora;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QII;1.822
49 Zamora;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QI;""
49 Zamora;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
49 Zamora;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
49 Zamora;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QII;""
49 Zamora;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QI;""
49 Zamora;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
49 Zamora;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
49 Zamora;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
49 Zamora;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
49 Zamora;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
49 Zamora;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
49 Zamora;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
49 Zamora;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
49 Zamora;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
49 Zamora;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
49 Zamora;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
49 Zamora;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
49 Zamora;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
49 Zamora;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;96,6
49 Zamora;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
49 Zamora;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
49 Zamora;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
49 Zamora;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;96,19
49 Zamora;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
49 Zamora;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
49 Zamora;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
49 Zamora;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;95,25
49 Zamora;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
49 Zamora;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
49 Zamora;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;90,55
49 Zamora;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
49 Zamora;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
49 Zamora;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
49 Zamora;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;92,39
49 Zamora;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
49 Zamora;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
49 Zamora;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
49 Zamora;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;89,91
49 Zamora;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
49 Zamora;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
49 Zamora;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
49 Zamora;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
49 Zamora;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
49 Zamora;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
49 Zamora;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;90,08
49 Zamora;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
49 Zamora;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
49 Zamora;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
49 Zamora;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;86,35
49 Zamora;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
49 Zamora;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
49 Zamora;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
49 Zamora;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
49 Zamora;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
49 Zamora;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
49 Zamora;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;86,63
49 Zamora;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
49 Zamora;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
49 Zamora;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
49 Zamora;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;83,2
49 Zamora;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
49 Zamora;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
49 Zamora;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
49 Zamora;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
49 Zamora;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
49 Zamora;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
49 Zamora;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QIII;1.613
49 Zamora;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
49 Zamora;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
49 Zamora;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
49 Zamora;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QIII;1.519
49 Zamora;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
49 Zamora;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
49 Zamora;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
49 Zamora;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QIII;1.464
49 Zamora;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
49 Zamora;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
49 Zamora;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
49 Zamora;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2022QIII;1.564
49 Zamora;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2022QII;""
49 Zamora;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2022QI;""
49 Zamora;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
49 Zamora;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2021QIII;1.470
49 Zamora;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2021QII;""
49 Zamora;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2021QI;""
49 Zamora;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
49 Zamora;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2020QIII;1.396
49 Zamora;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2020QII;""
49 Zamora;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2020QI;""
49 Zamora;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2022QIV;1.467
49 Zamora;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
49 Zamora;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2022QII;""
49 Zamora;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2022QI;""
49 Zamora;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2021QIV;1.412
49 Zamora;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
49 Zamora;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2021QII;""
49 Zamora;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2021QI;""
49 Zamora;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2020QIV;1.319
49 Zamora;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
49 Zamora;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2020QII;""
49 Zamora;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2020QI;""
49 Zamora;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
49 Zamora;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
49 Zamora;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QII;""
49 Zamora;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QI;1.381
49 Zamora;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
49 Zamora;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
49 Zamora;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QII;""
49 Zamora;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QI;1.270
49 Zamora;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
49 Zamora;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
49 Zamora;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QII;""
49 Zamora;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QI;""
49 Zamora;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
49 Zamora;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
49 Zamora;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QII;1.330
49 Zamora;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QI;""
49 Zamora;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
49 Zamora;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
49 Zamora;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QII;1.226
49 Zamora;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QI;""
49 Zamora;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
49 Zamora;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
49 Zamora;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QII;""
49 Zamora;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QI;""
49 Zamora;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
49 Zamora;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
49 Zamora;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
49 Zamora;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
49 Zamora;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
49 Zamora;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
49 Zamora;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
49 Zamora;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
49 Zamora;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
49 Zamora;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
49 Zamora;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
49 Zamora;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
49 Zamora;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
49 Zamora;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;96,96
49 Zamora;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
49 Zamora;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
49 Zamora;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
49 Zamora;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;96,77
49 Zamora;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
49 Zamora;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
49 Zamora;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
49 Zamora;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;95,36
49 Zamora;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
49 Zamora;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
49 Zamora;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;90,95
49 Zamora;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
49 Zamora;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
49 Zamora;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
49 Zamora;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;92,96
49 Zamora;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
49 Zamora;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
49 Zamora;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
49 Zamora;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;90,1
49 Zamora;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
49 Zamora;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
49 Zamora;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
49 Zamora;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
49 Zamora;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
49 Zamora;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
49 Zamora;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;90,92
49 Zamora;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
49 Zamora;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
49 Zamora;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
49 Zamora;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;86,75
49 Zamora;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
49 Zamora;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
49 Zamora;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
49 Zamora;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
49 Zamora;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
49 Zamora;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
49 Zamora;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;87,56
49 Zamora;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
49 Zamora;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
49 Zamora;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
49 Zamora;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;83,74
49 Zamora;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
49 Zamora;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
49 Zamora;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
49 Zamora;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
49 Zamora;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
49 Zamora;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
49 Zamora;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QIII;768
49 Zamora;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
49 Zamora;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
49 Zamora;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
49 Zamora;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QIII;740
49 Zamora;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
49 Zamora;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
49 Zamora;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
49 Zamora;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QIII;726
49 Zamora;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
49 Zamora;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
49 Zamora;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
49 Zamora;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2022QIII;736
49 Zamora;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2022QII;""
49 Zamora;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2022QI;""
49 Zamora;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
49 Zamora;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2021QIII;703
49 Zamora;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2021QII;""
49 Zamora;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2021QI;""
49 Zamora;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
49 Zamora;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2020QIII;690
49 Zamora;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2020QII;""
49 Zamora;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2020QI;""
49 Zamora;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2022QIV;689
49 Zamora;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
49 Zamora;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2022QII;""
49 Zamora;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2022QI;""
49 Zamora;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2021QIV;675
49 Zamora;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
49 Zamora;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2021QII;""
49 Zamora;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2021QI;""
49 Zamora;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2020QIV;650
49 Zamora;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
49 Zamora;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2020QII;""
49 Zamora;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2020QI;""
49 Zamora;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
49 Zamora;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
49 Zamora;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QII;""
49 Zamora;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QI;654
49 Zamora;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
49 Zamora;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
49 Zamora;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QII;""
49 Zamora;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QI;621
49 Zamora;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
49 Zamora;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
49 Zamora;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QII;""
49 Zamora;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QI;""
49 Zamora;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
49 Zamora;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
49 Zamora;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QII;627
49 Zamora;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QI;""
49 Zamora;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
49 Zamora;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
49 Zamora;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QII;596
49 Zamora;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QI;""
49 Zamora;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
49 Zamora;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
49 Zamora;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QII;""
49 Zamora;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QI;""
49 Zamora;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
49 Zamora;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
49 Zamora;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
49 Zamora;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
49 Zamora;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
49 Zamora;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
49 Zamora;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
49 Zamora;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
49 Zamora;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
49 Zamora;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
49 Zamora;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
49 Zamora;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
49 Zamora;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
49 Zamora;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;95,83
49 Zamora;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
49 Zamora;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
49 Zamora;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
49 Zamora;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;95
49 Zamora;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
49 Zamora;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
49 Zamora;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
49 Zamora;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;95,04
49 Zamora;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
49 Zamora;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
49 Zamora;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;89,71
49 Zamora;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
49 Zamora;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
49 Zamora;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
49 Zamora;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;91,22
49 Zamora;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
49 Zamora;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
49 Zamora;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
49 Zamora;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;89,53
49 Zamora;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
49 Zamora;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
49 Zamora;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
49 Zamora;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
49 Zamora;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
49 Zamora;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
49 Zamora;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;88,38
49 Zamora;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
49 Zamora;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
49 Zamora;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
49 Zamora;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;85,54
49 Zamora;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
49 Zamora;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
49 Zamora;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
49 Zamora;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
49 Zamora;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
49 Zamora;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
49 Zamora;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;84,73
49 Zamora;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
49 Zamora;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
49 Zamora;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
49 Zamora;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;82,09
49 Zamora;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
49 Zamora;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
49 Zamora;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
49 Zamora;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
49 Zamora;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
49 Zamora;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QIV;2.320
49 Zamora;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
49 Zamora;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
49 Zamora;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
49 Zamora;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QIV;2.187
49 Zamora;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
49 Zamora;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
49 Zamora;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
49 Zamora;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QIV;2.114
49 Zamora;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
49 Zamora;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
49 Zamora;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
49 Zamora;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2022QIV;2.167
49 Zamora;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
49 Zamora;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2022QII;""
49 Zamora;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2022QI;""
49 Zamora;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2021QIV;2.098
49 Zamora;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
49 Zamora;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2021QII;""
49 Zamora;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2021QI;""
49 Zamora;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2020QIV;1.989
49 Zamora;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
49 Zamora;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2020QII;""
49 Zamora;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2020QI;""
49 Zamora;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
49 Zamora;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
49 Zamora;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2022QII;""
49 Zamora;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2022QI;2.044
49 Zamora;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
49 Zamora;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
49 Zamora;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2021QII;""
49 Zamora;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2021QI;1.909
49 Zamora;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
49 Zamora;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
49 Zamora;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2020QII;""
49 Zamora;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2020QI;""
49 Zamora;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
49 Zamora;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
49 Zamora;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QII;1.966
49 Zamora;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QI;""
49 Zamora;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
49 Zamora;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
49 Zamora;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QII;1.840
49 Zamora;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QI;""
49 Zamora;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
49 Zamora;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
49 Zamora;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QII;""
49 Zamora;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QI;""
49 Zamora;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
49 Zamora;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QIII;1.898
49 Zamora;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QII;""
49 Zamora;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QI;""
49 Zamora;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
49 Zamora;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QIII;1.767
49 Zamora;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QII;""
49 Zamora;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QI;""
49 Zamora;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
49 Zamora;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
49 Zamora;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QII;""
49 Zamora;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QI;""
49 Zamora;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
49 Zamora;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
49 Zamora;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
49 Zamora;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
49 Zamora;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
49 Zamora;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
49 Zamora;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
49 Zamora;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
49 Zamora;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
49 Zamora;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
49 Zamora;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
49 Zamora;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
49 Zamora;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;93,41
49 Zamora;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
49 Zamora;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
49 Zamora;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
49 Zamora;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;95,93
49 Zamora;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
49 Zamora;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
49 Zamora;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
49 Zamora;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;94,09
49 Zamora;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
49 Zamora;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
49 Zamora;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
49 Zamora;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
49 Zamora;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
49 Zamora;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
49 Zamora;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;93,46
49 Zamora;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
49 Zamora;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
49 Zamora;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
49 Zamora;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;90,3
49 Zamora;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
49 Zamora;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
49 Zamora;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
49 Zamora;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
49 Zamora;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
49 Zamora;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
49 Zamora;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;89,89
49 Zamora;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
49 Zamora;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
49 Zamora;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
49 Zamora;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;87,04
49 Zamora;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
49 Zamora;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
49 Zamora;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
49 Zamora;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
49 Zamora;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
49 Zamora;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
49 Zamora;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;86,79
49 Zamora;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
49 Zamora;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
49 Zamora;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
49 Zamora;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;83,59
49 Zamora;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
49 Zamora;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
49 Zamora;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
49 Zamora;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
49 Zamora;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
49 Zamora;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
49 Zamora;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QIV;1.579
49 Zamora;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
49 Zamora;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
49 Zamora;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
49 Zamora;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QIV;1.476
49 Zamora;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
49 Zamora;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
49 Zamora;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
49 Zamora;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QIV;1.410
49 Zamora;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
49 Zamora;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
49 Zamora;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
49 Zamora;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2022QIV;1.473
49 Zamora;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
49 Zamora;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2022QII;""
49 Zamora;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2022QI;""
49 Zamora;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2021QIV;1.416
49 Zamora;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
49 Zamora;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2021QII;""
49 Zamora;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2021QI;""
49 Zamora;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2020QIV;1.327
49 Zamora;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
49 Zamora;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2020QII;""
49 Zamora;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2020QI;""
49 Zamora;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
49 Zamora;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
49 Zamora;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2022QII;""
49 Zamora;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2022QI;1.384
49 Zamora;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
49 Zamora;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
49 Zamora;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2021QII;""
49 Zamora;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2021QI;1.278
49 Zamora;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
49 Zamora;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
49 Zamora;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2020QII;""
49 Zamora;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2020QI;""
49 Zamora;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
49 Zamora;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
49 Zamora;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QII;1.333
49 Zamora;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QI;""
49 Zamora;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
49 Zamora;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
49 Zamora;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QII;1.234
49 Zamora;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QI;""
49 Zamora;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
49 Zamora;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
49 Zamora;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QII;""
49 Zamora;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QI;""
49 Zamora;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
49 Zamora;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QIII;1.292
49 Zamora;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QII;""
49 Zamora;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QI;""
49 Zamora;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
49 Zamora;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QIII;1.195
49 Zamora;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QII;""
49 Zamora;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QI;""
49 Zamora;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
49 Zamora;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
49 Zamora;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QII;""
49 Zamora;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QI;""
49 Zamora;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
49 Zamora;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
49 Zamora;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
49 Zamora;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
49 Zamora;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
49 Zamora;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
49 Zamora;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
49 Zamora;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
49 Zamora;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
49 Zamora;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
49 Zamora;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
49 Zamora;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
49 Zamora;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;93,29
49 Zamora;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
49 Zamora;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
49 Zamora;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
49 Zamora;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;95,93
49 Zamora;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
49 Zamora;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
49 Zamora;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
49 Zamora;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;94,11
49 Zamora;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
49 Zamora;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
49 Zamora;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
49 Zamora;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
49 Zamora;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
49 Zamora;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
49 Zamora;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;93,77
49 Zamora;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
49 Zamora;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
49 Zamora;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
49 Zamora;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;90,64
49 Zamora;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
49 Zamora;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
49 Zamora;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
49 Zamora;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
49 Zamora;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
49 Zamora;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
49 Zamora;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;90,31
49 Zamora;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
49 Zamora;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
49 Zamora;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
49 Zamora;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;87,52
49 Zamora;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
49 Zamora;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
49 Zamora;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
49 Zamora;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
49 Zamora;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
49 Zamora;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
49 Zamora;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;87,53
49 Zamora;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
49 Zamora;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
49 Zamora;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
49 Zamora;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;84,75
49 Zamora;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
49 Zamora;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
49 Zamora;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
49 Zamora;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
49 Zamora;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
49 Zamora;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
49 Zamora;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QIV;741
49 Zamora;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
49 Zamora;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
49 Zamora;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
49 Zamora;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QIV;711
49 Zamora;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
49 Zamora;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
49 Zamora;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
49 Zamora;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QIV;704
49 Zamora;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
49 Zamora;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
49 Zamora;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
49 Zamora;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2022QIV;694
49 Zamora;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
49 Zamora;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2022QII;""
49 Zamora;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2022QI;""
49 Zamora;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2021QIV;682
49 Zamora;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
49 Zamora;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2021QII;""
49 Zamora;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2021QI;""
49 Zamora;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2020QIV;662
49 Zamora;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
49 Zamora;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2020QII;""
49 Zamora;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2020QI;""
49 Zamora;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
49 Zamora;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
49 Zamora;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2022QII;""
49 Zamora;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2022QI;660
49 Zamora;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
49 Zamora;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
49 Zamora;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2021QII;""
49 Zamora;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2021QI;631
49 Zamora;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
49 Zamora;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
49 Zamora;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2020QII;""
49 Zamora;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2020QI;""
49 Zamora;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
49 Zamora;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
49 Zamora;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QII;633
49 Zamora;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QI;""
49 Zamora;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
49 Zamora;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
49 Zamora;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QII;606
49 Zamora;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QI;""
49 Zamora;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
49 Zamora;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
49 Zamora;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QII;""
49 Zamora;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QI;""
49 Zamora;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
49 Zamora;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QIII;606
49 Zamora;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QII;""
49 Zamora;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QI;""
49 Zamora;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
49 Zamora;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QIII;572
49 Zamora;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QII;""
49 Zamora;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QI;""
49 Zamora;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
49 Zamora;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
49 Zamora;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QII;""
49 Zamora;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QI;""
49 Zamora;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
49 Zamora;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
49 Zamora;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
49 Zamora;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
49 Zamora;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
49 Zamora;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
49 Zamora;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
49 Zamora;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
49 Zamora;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
49 Zamora;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
49 Zamora;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
49 Zamora;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
49 Zamora;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;93,66
49 Zamora;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
49 Zamora;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
49 Zamora;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
49 Zamora;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;95,92
49 Zamora;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
49 Zamora;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
49 Zamora;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
49 Zamora;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;94,03
49 Zamora;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
49 Zamora;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
49 Zamora;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
49 Zamora;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
49 Zamora;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
49 Zamora;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
49 Zamora;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;92,83
49 Zamora;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
49 Zamora;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
49 Zamora;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
49 Zamora;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;89,63
49 Zamora;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
49 Zamora;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
49 Zamora;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
49 Zamora;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
49 Zamora;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
49 Zamora;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
49 Zamora;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;89,03
49 Zamora;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
49 Zamora;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
49 Zamora;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
49 Zamora;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;86,08
49 Zamora;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
49 Zamora;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
49 Zamora;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
49 Zamora;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
49 Zamora;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
49 Zamora;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
49 Zamora;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;85,23
49 Zamora;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
49 Zamora;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
49 Zamora;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
49 Zamora;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;81,25
49 Zamora;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
49 Zamora;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
49 Zamora;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
49 Zamora;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
49 Zamora;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
49 Zamora;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
50 Zaragoza;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
50 Zaragoza;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
50 Zaragoza;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
50 Zaragoza;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QI;57.387
50 Zaragoza;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
50 Zaragoza;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
50 Zaragoza;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
50 Zaragoza;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QI;57.028
50 Zaragoza;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
50 Zaragoza;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
50 Zaragoza;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
50 Zaragoza;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QI;58.598
50 Zaragoza;All ages;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
50 Zaragoza;All ages;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
50 Zaragoza;All ages;Cohort January 1;Total;Survival in the first trimester;2022QII;""
50 Zaragoza;All ages;Cohort January 1;Total;Survival in the first trimester;2022QI;55.535
50 Zaragoza;All ages;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
50 Zaragoza;All ages;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
50 Zaragoza;All ages;Cohort January 1;Total;Survival in the first trimester;2021QII;""
50 Zaragoza;All ages;Cohort January 1;Total;Survival in the first trimester;2021QI;55.513
50 Zaragoza;All ages;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
50 Zaragoza;All ages;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
50 Zaragoza;All ages;Cohort January 1;Total;Survival in the first trimester;2020QII;""
50 Zaragoza;All ages;Cohort January 1;Total;Survival in the first trimester;2020QI;54.729
50 Zaragoza;All ages;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
50 Zaragoza;All ages;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
50 Zaragoza;All ages;Cohort January 1;Total;Survival in the second trimester;2022QII;53.868
50 Zaragoza;All ages;Cohort January 1;Total;Survival in the second trimester;2022QI;""
50 Zaragoza;All ages;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
50 Zaragoza;All ages;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
50 Zaragoza;All ages;Cohort January 1;Total;Survival in the second trimester;2021QII;53.988
50 Zaragoza;All ages;Cohort January 1;Total;Survival in the second trimester;2021QI;""
50 Zaragoza;All ages;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
50 Zaragoza;All ages;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
50 Zaragoza;All ages;Cohort January 1;Total;Survival in the second trimester;2020QII;53.649
50 Zaragoza;All ages;Cohort January 1;Total;Survival in the second trimester;2020QI;""
50 Zaragoza;All ages;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
50 Zaragoza;All ages;Cohort January 1;Total;Survival in the third trimester;2022QIII;52.469
50 Zaragoza;All ages;Cohort January 1;Total;Survival in the third trimester;2022QII;""
50 Zaragoza;All ages;Cohort January 1;Total;Survival in the third trimester;2022QI;""
50 Zaragoza;All ages;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
50 Zaragoza;All ages;Cohort January 1;Total;Survival in the third trimester;2021QIII;52.734
50 Zaragoza;All ages;Cohort January 1;Total;Survival in the third trimester;2021QII;""
50 Zaragoza;All ages;Cohort January 1;Total;Survival in the third trimester;2021QI;""
50 Zaragoza;All ages;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
50 Zaragoza;All ages;Cohort January 1;Total;Survival in the third trimester;2020QIII;52.204
50 Zaragoza;All ages;Cohort January 1;Total;Survival in the third trimester;2020QII;""
50 Zaragoza;All ages;Cohort January 1;Total;Survival in the third trimester;2020QI;""
50 Zaragoza;All ages;Cohort January 1;Total;Survival in the third trimester;2022QIV;50.713
50 Zaragoza;All ages;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
50 Zaragoza;All ages;Cohort January 1;Total;Survival in the third trimester;2022QII;""
50 Zaragoza;All ages;Cohort January 1;Total;Survival in the third trimester;2022QI;""
50 Zaragoza;All ages;Cohort January 1;Total;Survival in the third trimester;2021QIV;51.329
50 Zaragoza;All ages;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
50 Zaragoza;All ages;Cohort January 1;Total;Survival in the third trimester;2021QII;""
50 Zaragoza;All ages;Cohort January 1;Total;Survival in the third trimester;2021QI;""
50 Zaragoza;All ages;Cohort January 1;Total;Survival in the third trimester;2020QIV;50.706
50 Zaragoza;All ages;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
50 Zaragoza;All ages;Cohort January 1;Total;Survival in the third trimester;2020QII;""
50 Zaragoza;All ages;Cohort January 1;Total;Survival in the third trimester;2020QI;""
50 Zaragoza;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
50 Zaragoza;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
50 Zaragoza;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
50 Zaragoza;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
50 Zaragoza;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
50 Zaragoza;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
50 Zaragoza;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
50 Zaragoza;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
50 Zaragoza;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
50 Zaragoza;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
50 Zaragoza;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
50 Zaragoza;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
50 Zaragoza;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
50 Zaragoza;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
50 Zaragoza;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
50 Zaragoza;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;96,77
50 Zaragoza;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
50 Zaragoza;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
50 Zaragoza;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
50 Zaragoza;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;97,34
50 Zaragoza;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
50 Zaragoza;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
50 Zaragoza;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
50 Zaragoza;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;93,4
50 Zaragoza;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
50 Zaragoza;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
50 Zaragoza;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;93,87
50 Zaragoza;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
50 Zaragoza;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
50 Zaragoza;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
50 Zaragoza;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;94,67
50 Zaragoza;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
50 Zaragoza;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
50 Zaragoza;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
50 Zaragoza;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;91,55
50 Zaragoza;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
50 Zaragoza;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
50 Zaragoza;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;91,43
50 Zaragoza;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
50 Zaragoza;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
50 Zaragoza;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
50 Zaragoza;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;92,47
50 Zaragoza;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
50 Zaragoza;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
50 Zaragoza;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
50 Zaragoza;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;89,09
50 Zaragoza;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
50 Zaragoza;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
50 Zaragoza;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;88,37
50 Zaragoza;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
50 Zaragoza;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
50 Zaragoza;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
50 Zaragoza;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;90,01
50 Zaragoza;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
50 Zaragoza;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
50 Zaragoza;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
50 Zaragoza;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;86,53
50 Zaragoza;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
50 Zaragoza;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
50 Zaragoza;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
50 Zaragoza;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
50 Zaragoza;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
50 Zaragoza;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
50 Zaragoza;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QI;36.054
50 Zaragoza;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
50 Zaragoza;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
50 Zaragoza;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
50 Zaragoza;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QI;35.988
50 Zaragoza;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
50 Zaragoza;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
50 Zaragoza;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
50 Zaragoza;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QI;36.878
50 Zaragoza;All ages;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
50 Zaragoza;All ages;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
50 Zaragoza;All ages;Cohort January 1;Males;Survival in the first trimester;2022QII;""
50 Zaragoza;All ages;Cohort January 1;Males;Survival in the first trimester;2022QI;34.934
50 Zaragoza;All ages;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
50 Zaragoza;All ages;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
50 Zaragoza;All ages;Cohort January 1;Males;Survival in the first trimester;2021QII;""
50 Zaragoza;All ages;Cohort January 1;Males;Survival in the first trimester;2021QI;35.081
50 Zaragoza;All ages;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
50 Zaragoza;All ages;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
50 Zaragoza;All ages;Cohort January 1;Males;Survival in the first trimester;2020QII;""
50 Zaragoza;All ages;Cohort January 1;Males;Survival in the first trimester;2020QI;34.659
50 Zaragoza;All ages;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
50 Zaragoza;All ages;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
50 Zaragoza;All ages;Cohort January 1;Males;Survival in the second trimester;2022QII;33.949
50 Zaragoza;All ages;Cohort January 1;Males;Survival in the second trimester;2022QI;""
50 Zaragoza;All ages;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
50 Zaragoza;All ages;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
50 Zaragoza;All ages;Cohort January 1;Males;Survival in the second trimester;2021QII;34.149
50 Zaragoza;All ages;Cohort January 1;Males;Survival in the second trimester;2021QI;""
50 Zaragoza;All ages;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
50 Zaragoza;All ages;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
50 Zaragoza;All ages;Cohort January 1;Males;Survival in the second trimester;2020QII;34.052
50 Zaragoza;All ages;Cohort January 1;Males;Survival in the second trimester;2020QI;""
50 Zaragoza;All ages;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
50 Zaragoza;All ages;Cohort January 1;Males;Survival in the third trimester;2022QIII;33.142
50 Zaragoza;All ages;Cohort January 1;Males;Survival in the third trimester;2022QII;""
50 Zaragoza;All ages;Cohort January 1;Males;Survival in the third trimester;2022QI;""
50 Zaragoza;All ages;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
50 Zaragoza;All ages;Cohort January 1;Males;Survival in the third trimester;2021QIII;33.389
50 Zaragoza;All ages;Cohort January 1;Males;Survival in the third trimester;2021QII;""
50 Zaragoza;All ages;Cohort January 1;Males;Survival in the third trimester;2021QI;""
50 Zaragoza;All ages;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
50 Zaragoza;All ages;Cohort January 1;Males;Survival in the third trimester;2020QIII;33.180
50 Zaragoza;All ages;Cohort January 1;Males;Survival in the third trimester;2020QII;""
50 Zaragoza;All ages;Cohort January 1;Males;Survival in the third trimester;2020QI;""
50 Zaragoza;All ages;Cohort January 1;Males;Survival in the third trimester;2022QIV;32.070
50 Zaragoza;All ages;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
50 Zaragoza;All ages;Cohort January 1;Males;Survival in the third trimester;2022QII;""
50 Zaragoza;All ages;Cohort January 1;Males;Survival in the third trimester;2022QI;""
50 Zaragoza;All ages;Cohort January 1;Males;Survival in the third trimester;2021QIV;32.537
50 Zaragoza;All ages;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
50 Zaragoza;All ages;Cohort January 1;Males;Survival in the third trimester;2021QII;""
50 Zaragoza;All ages;Cohort January 1;Males;Survival in the third trimester;2021QI;""
50 Zaragoza;All ages;Cohort January 1;Males;Survival in the third trimester;2020QIV;32.272
50 Zaragoza;All ages;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
50 Zaragoza;All ages;Cohort January 1;Males;Survival in the third trimester;2020QII;""
50 Zaragoza;All ages;Cohort January 1;Males;Survival in the third trimester;2020QI;""
50 Zaragoza;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
50 Zaragoza;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
50 Zaragoza;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
50 Zaragoza;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
50 Zaragoza;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
50 Zaragoza;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
50 Zaragoza;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
50 Zaragoza;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
50 Zaragoza;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
50 Zaragoza;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
50 Zaragoza;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
50 Zaragoza;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
50 Zaragoza;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
50 Zaragoza;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
50 Zaragoza;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
50 Zaragoza;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;96,89
50 Zaragoza;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
50 Zaragoza;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
50 Zaragoza;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
50 Zaragoza;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;97,48
50 Zaragoza;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
50 Zaragoza;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
50 Zaragoza;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
50 Zaragoza;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;93,98
50 Zaragoza;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
50 Zaragoza;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
50 Zaragoza;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;94,16
50 Zaragoza;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
50 Zaragoza;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
50 Zaragoza;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
50 Zaragoza;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;94,89
50 Zaragoza;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
50 Zaragoza;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
50 Zaragoza;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
50 Zaragoza;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;92,34
50 Zaragoza;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
50 Zaragoza;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
50 Zaragoza;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;91,92
50 Zaragoza;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
50 Zaragoza;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
50 Zaragoza;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
50 Zaragoza;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;92,78
50 Zaragoza;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
50 Zaragoza;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
50 Zaragoza;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
50 Zaragoza;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;89,97
50 Zaragoza;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
50 Zaragoza;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
50 Zaragoza;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;88,95
50 Zaragoza;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
50 Zaragoza;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
50 Zaragoza;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
50 Zaragoza;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;90,41
50 Zaragoza;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
50 Zaragoza;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
50 Zaragoza;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
50 Zaragoza;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;87,51
50 Zaragoza;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
50 Zaragoza;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
50 Zaragoza;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
50 Zaragoza;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
50 Zaragoza;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
50 Zaragoza;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
50 Zaragoza;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QI;21.333
50 Zaragoza;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
50 Zaragoza;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
50 Zaragoza;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
50 Zaragoza;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QI;21.040
50 Zaragoza;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
50 Zaragoza;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
50 Zaragoza;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
50 Zaragoza;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QI;21.720
50 Zaragoza;All ages;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
50 Zaragoza;All ages;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
50 Zaragoza;All ages;Cohort January 1;Females;Survival in the first trimester;2022QII;""
50 Zaragoza;All ages;Cohort January 1;Females;Survival in the first trimester;2022QI;20.601
50 Zaragoza;All ages;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
50 Zaragoza;All ages;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
50 Zaragoza;All ages;Cohort January 1;Females;Survival in the first trimester;2021QII;""
50 Zaragoza;All ages;Cohort January 1;Females;Survival in the first trimester;2021QI;20.432
50 Zaragoza;All ages;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
50 Zaragoza;All ages;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
50 Zaragoza;All ages;Cohort January 1;Females;Survival in the first trimester;2020QII;""
50 Zaragoza;All ages;Cohort January 1;Females;Survival in the first trimester;2020QI;20.070
50 Zaragoza;All ages;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
50 Zaragoza;All ages;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
50 Zaragoza;All ages;Cohort January 1;Females;Survival in the second trimester;2022QII;19.919
50 Zaragoza;All ages;Cohort January 1;Females;Survival in the second trimester;2022QI;""
50 Zaragoza;All ages;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
50 Zaragoza;All ages;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
50 Zaragoza;All ages;Cohort January 1;Females;Survival in the second trimester;2021QII;19.839
50 Zaragoza;All ages;Cohort January 1;Females;Survival in the second trimester;2021QI;""
50 Zaragoza;All ages;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
50 Zaragoza;All ages;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
50 Zaragoza;All ages;Cohort January 1;Females;Survival in the second trimester;2020QII;19.597
50 Zaragoza;All ages;Cohort January 1;Females;Survival in the second trimester;2020QI;""
50 Zaragoza;All ages;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
50 Zaragoza;All ages;Cohort January 1;Females;Survival in the third trimester;2022QIII;19.327
50 Zaragoza;All ages;Cohort January 1;Females;Survival in the third trimester;2022QII;""
50 Zaragoza;All ages;Cohort January 1;Females;Survival in the third trimester;2022QI;""
50 Zaragoza;All ages;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
50 Zaragoza;All ages;Cohort January 1;Females;Survival in the third trimester;2021QIII;19.345
50 Zaragoza;All ages;Cohort January 1;Females;Survival in the third trimester;2021QII;""
50 Zaragoza;All ages;Cohort January 1;Females;Survival in the third trimester;2021QI;""
50 Zaragoza;All ages;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
50 Zaragoza;All ages;Cohort January 1;Females;Survival in the third trimester;2020QIII;19.024
50 Zaragoza;All ages;Cohort January 1;Females;Survival in the third trimester;2020QII;""
50 Zaragoza;All ages;Cohort January 1;Females;Survival in the third trimester;2020QI;""
50 Zaragoza;All ages;Cohort January 1;Females;Survival in the third trimester;2022QIV;18.643
50 Zaragoza;All ages;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
50 Zaragoza;All ages;Cohort January 1;Females;Survival in the third trimester;2022QII;""
50 Zaragoza;All ages;Cohort January 1;Females;Survival in the third trimester;2022QI;""
50 Zaragoza;All ages;Cohort January 1;Females;Survival in the third trimester;2021QIV;18.792
50 Zaragoza;All ages;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
50 Zaragoza;All ages;Cohort January 1;Females;Survival in the third trimester;2021QII;""
50 Zaragoza;All ages;Cohort January 1;Females;Survival in the third trimester;2021QI;""
50 Zaragoza;All ages;Cohort January 1;Females;Survival in the third trimester;2020QIV;18.434
50 Zaragoza;All ages;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
50 Zaragoza;All ages;Cohort January 1;Females;Survival in the third trimester;2020QII;""
50 Zaragoza;All ages;Cohort January 1;Females;Survival in the third trimester;2020QI;""
50 Zaragoza;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
50 Zaragoza;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
50 Zaragoza;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
50 Zaragoza;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
50 Zaragoza;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
50 Zaragoza;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
50 Zaragoza;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
50 Zaragoza;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
50 Zaragoza;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
50 Zaragoza;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
50 Zaragoza;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
50 Zaragoza;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
50 Zaragoza;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
50 Zaragoza;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
50 Zaragoza;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
50 Zaragoza;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;96,57
50 Zaragoza;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
50 Zaragoza;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
50 Zaragoza;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
50 Zaragoza;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;97,11
50 Zaragoza;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
50 Zaragoza;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
50 Zaragoza;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
50 Zaragoza;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;92,4
50 Zaragoza;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
50 Zaragoza;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
50 Zaragoza;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;93,37
50 Zaragoza;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
50 Zaragoza;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
50 Zaragoza;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
50 Zaragoza;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;94,29
50 Zaragoza;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
50 Zaragoza;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
50 Zaragoza;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
50 Zaragoza;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;90,23
50 Zaragoza;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
50 Zaragoza;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
50 Zaragoza;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;90,6
50 Zaragoza;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
50 Zaragoza;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
50 Zaragoza;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
50 Zaragoza;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;91,94
50 Zaragoza;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
50 Zaragoza;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
50 Zaragoza;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
50 Zaragoza;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;87,59
50 Zaragoza;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
50 Zaragoza;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
50 Zaragoza;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;87,39
50 Zaragoza;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
50 Zaragoza;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
50 Zaragoza;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
50 Zaragoza;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;89,32
50 Zaragoza;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
50 Zaragoza;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
50 Zaragoza;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
50 Zaragoza;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;84,87
50 Zaragoza;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
50 Zaragoza;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
50 Zaragoza;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
50 Zaragoza;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
50 Zaragoza;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
50 Zaragoza;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QII;57.363
50 Zaragoza;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
50 Zaragoza;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
50 Zaragoza;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
50 Zaragoza;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QII;57.404
50 Zaragoza;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
50 Zaragoza;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
50 Zaragoza;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
50 Zaragoza;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QII;56.829
50 Zaragoza;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
50 Zaragoza;All ages;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
50 Zaragoza;All ages;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
50 Zaragoza;All ages;Cohort April 1;Total;Survival in the first trimester;2022QII;55.475
50 Zaragoza;All ages;Cohort April 1;Total;Survival in the first trimester;2022QI;""
50 Zaragoza;All ages;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
50 Zaragoza;All ages;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
50 Zaragoza;All ages;Cohort April 1;Total;Survival in the first trimester;2021QII;55.647
50 Zaragoza;All ages;Cohort April 1;Total;Survival in the first trimester;2021QI;""
50 Zaragoza;All ages;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
50 Zaragoza;All ages;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
50 Zaragoza;All ages;Cohort April 1;Total;Survival in the first trimester;2020QII;55.546
50 Zaragoza;All ages;Cohort April 1;Total;Survival in the first trimester;2020QI;""
50 Zaragoza;All ages;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
50 Zaragoza;All ages;Cohort April 1;Total;Survival in the second trimester;2022QIII;53.948
50 Zaragoza;All ages;Cohort April 1;Total;Survival in the second trimester;2022QII;""
50 Zaragoza;All ages;Cohort April 1;Total;Survival in the second trimester;2022QI;""
50 Zaragoza;All ages;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
50 Zaragoza;All ages;Cohort April 1;Total;Survival in the second trimester;2021QIII;54.233
50 Zaragoza;All ages;Cohort April 1;Total;Survival in the second trimester;2021QII;""
50 Zaragoza;All ages;Cohort April 1;Total;Survival in the second trimester;2021QI;""
50 Zaragoza;All ages;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
50 Zaragoza;All ages;Cohort April 1;Total;Survival in the second trimester;2020QIII;53.856
50 Zaragoza;All ages;Cohort April 1;Total;Survival in the second trimester;2020QII;""
50 Zaragoza;All ages;Cohort April 1;Total;Survival in the second trimester;2020QI;""
50 Zaragoza;All ages;Cohort April 1;Total;Survival in the third trimester;2022QIV;52.072
50 Zaragoza;All ages;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
50 Zaragoza;All ages;Cohort April 1;Total;Survival in the third trimester;2022QII;""
50 Zaragoza;All ages;Cohort April 1;Total;Survival in the third trimester;2022QI;""
50 Zaragoza;All ages;Cohort April 1;Total;Survival in the third trimester;2021QIV;52.717
50 Zaragoza;All ages;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
50 Zaragoza;All ages;Cohort April 1;Total;Survival in the third trimester;2021QII;""
50 Zaragoza;All ages;Cohort April 1;Total;Survival in the third trimester;2021QI;""
50 Zaragoza;All ages;Cohort April 1;Total;Survival in the third trimester;2020QIV;52.240
50 Zaragoza;All ages;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
50 Zaragoza;All ages;Cohort April 1;Total;Survival in the third trimester;2020QII;""
50 Zaragoza;All ages;Cohort April 1;Total;Survival in the third trimester;2020QI;""
50 Zaragoza;All ages;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
50 Zaragoza;All ages;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
50 Zaragoza;All ages;Cohort April 1;Total;Survival in the third trimester;2022QII;""
50 Zaragoza;All ages;Cohort April 1;Total;Survival in the third trimester;2022QI;51.306
50 Zaragoza;All ages;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
50 Zaragoza;All ages;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
50 Zaragoza;All ages;Cohort April 1;Total;Survival in the third trimester;2021QII;""
50 Zaragoza;All ages;Cohort April 1;Total;Survival in the third trimester;2021QI;51.147
50 Zaragoza;All ages;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
50 Zaragoza;All ages;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
50 Zaragoza;All ages;Cohort April 1;Total;Survival in the third trimester;2020QII;""
50 Zaragoza;All ages;Cohort April 1;Total;Survival in the third trimester;2020QI;""
50 Zaragoza;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
50 Zaragoza;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
50 Zaragoza;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
50 Zaragoza;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
50 Zaragoza;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
50 Zaragoza;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
50 Zaragoza;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
50 Zaragoza;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
50 Zaragoza;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
50 Zaragoza;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
50 Zaragoza;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
50 Zaragoza;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
50 Zaragoza;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
50 Zaragoza;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
50 Zaragoza;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;96,71
50 Zaragoza;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
50 Zaragoza;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
50 Zaragoza;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
50 Zaragoza;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;96,94
50 Zaragoza;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
50 Zaragoza;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
50 Zaragoza;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
50 Zaragoza;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;97,74
50 Zaragoza;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
50 Zaragoza;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
50 Zaragoza;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;94,05
50 Zaragoza;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
50 Zaragoza;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
50 Zaragoza;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
50 Zaragoza;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;94,48
50 Zaragoza;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
50 Zaragoza;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
50 Zaragoza;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
50 Zaragoza;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;94,77
50 Zaragoza;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
50 Zaragoza;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
50 Zaragoza;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;90,78
50 Zaragoza;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
50 Zaragoza;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
50 Zaragoza;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
50 Zaragoza;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;91,84
50 Zaragoza;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
50 Zaragoza;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
50 Zaragoza;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
50 Zaragoza;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;91,92
50 Zaragoza;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
50 Zaragoza;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
50 Zaragoza;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
50 Zaragoza;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
50 Zaragoza;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
50 Zaragoza;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
50 Zaragoza;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;89,38
50 Zaragoza;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
50 Zaragoza;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
50 Zaragoza;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
50 Zaragoza;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;90
50 Zaragoza;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
50 Zaragoza;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
50 Zaragoza;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
50 Zaragoza;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
50 Zaragoza;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
50 Zaragoza;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
50 Zaragoza;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QII;36.014
50 Zaragoza;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
50 Zaragoza;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
50 Zaragoza;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
50 Zaragoza;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QII;36.220
50 Zaragoza;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
50 Zaragoza;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
50 Zaragoza;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
50 Zaragoza;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QII;35.879
50 Zaragoza;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
50 Zaragoza;All ages;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
50 Zaragoza;All ages;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
50 Zaragoza;All ages;Cohort April 1;Males;Survival in the first trimester;2022QII;34.901
50 Zaragoza;All ages;Cohort April 1;Males;Survival in the first trimester;2022QI;""
50 Zaragoza;All ages;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
50 Zaragoza;All ages;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
50 Zaragoza;All ages;Cohort April 1;Males;Survival in the first trimester;2021QII;35.141
50 Zaragoza;All ages;Cohort April 1;Males;Survival in the first trimester;2021QI;""
50 Zaragoza;All ages;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
50 Zaragoza;All ages;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
50 Zaragoza;All ages;Cohort April 1;Males;Survival in the first trimester;2020QII;35.194
50 Zaragoza;All ages;Cohort April 1;Males;Survival in the first trimester;2020QI;""
50 Zaragoza;All ages;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
50 Zaragoza;All ages;Cohort April 1;Males;Survival in the second trimester;2022QIII;34.021
50 Zaragoza;All ages;Cohort April 1;Males;Survival in the second trimester;2022QII;""
50 Zaragoza;All ages;Cohort April 1;Males;Survival in the second trimester;2022QI;""
50 Zaragoza;All ages;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
50 Zaragoza;All ages;Cohort April 1;Males;Survival in the second trimester;2021QIII;34.273
50 Zaragoza;All ages;Cohort April 1;Males;Survival in the second trimester;2021QII;""
50 Zaragoza;All ages;Cohort April 1;Males;Survival in the second trimester;2021QI;""
50 Zaragoza;All ages;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
50 Zaragoza;All ages;Cohort April 1;Males;Survival in the second trimester;2020QIII;34.167
50 Zaragoza;All ages;Cohort April 1;Males;Survival in the second trimester;2020QII;""
50 Zaragoza;All ages;Cohort April 1;Males;Survival in the second trimester;2020QI;""
50 Zaragoza;All ages;Cohort April 1;Males;Survival in the third trimester;2022QIV;32.873
50 Zaragoza;All ages;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
50 Zaragoza;All ages;Cohort April 1;Males;Survival in the third trimester;2022QII;""
50 Zaragoza;All ages;Cohort April 1;Males;Survival in the third trimester;2022QI;""
50 Zaragoza;All ages;Cohort April 1;Males;Survival in the third trimester;2021QIV;33.354
50 Zaragoza;All ages;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
50 Zaragoza;All ages;Cohort April 1;Males;Survival in the third trimester;2021QII;""
50 Zaragoza;All ages;Cohort April 1;Males;Survival in the third trimester;2021QI;""
50 Zaragoza;All ages;Cohort April 1;Males;Survival in the third trimester;2020QIV;33.175
50 Zaragoza;All ages;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
50 Zaragoza;All ages;Cohort April 1;Males;Survival in the third trimester;2020QII;""
50 Zaragoza;All ages;Cohort April 1;Males;Survival in the third trimester;2020QI;""
50 Zaragoza;All ages;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
50 Zaragoza;All ages;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
50 Zaragoza;All ages;Cohort April 1;Males;Survival in the third trimester;2022QII;""
50 Zaragoza;All ages;Cohort April 1;Males;Survival in the third trimester;2022QI;32.509
50 Zaragoza;All ages;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
50 Zaragoza;All ages;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
50 Zaragoza;All ages;Cohort April 1;Males;Survival in the third trimester;2021QII;""
50 Zaragoza;All ages;Cohort April 1;Males;Survival in the third trimester;2021QI;32.536
50 Zaragoza;All ages;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
50 Zaragoza;All ages;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
50 Zaragoza;All ages;Cohort April 1;Males;Survival in the third trimester;2020QII;""
50 Zaragoza;All ages;Cohort April 1;Males;Survival in the third trimester;2020QI;""
50 Zaragoza;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
50 Zaragoza;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
50 Zaragoza;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
50 Zaragoza;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
50 Zaragoza;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
50 Zaragoza;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
50 Zaragoza;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
50 Zaragoza;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
50 Zaragoza;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
50 Zaragoza;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
50 Zaragoza;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
50 Zaragoza;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
50 Zaragoza;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
50 Zaragoza;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
50 Zaragoza;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;96,91
50 Zaragoza;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
50 Zaragoza;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
50 Zaragoza;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
50 Zaragoza;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;97,02
50 Zaragoza;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
50 Zaragoza;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
50 Zaragoza;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
50 Zaragoza;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;98,09
50 Zaragoza;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
50 Zaragoza;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
50 Zaragoza;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;94,47
50 Zaragoza;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
50 Zaragoza;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
50 Zaragoza;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
50 Zaragoza;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;94,62
50 Zaragoza;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
50 Zaragoza;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
50 Zaragoza;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
50 Zaragoza;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;95,23
50 Zaragoza;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
50 Zaragoza;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
50 Zaragoza;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;91,28
50 Zaragoza;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
50 Zaragoza;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
50 Zaragoza;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
50 Zaragoza;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;92,09
50 Zaragoza;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
50 Zaragoza;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
50 Zaragoza;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
50 Zaragoza;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;92,46
50 Zaragoza;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
50 Zaragoza;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
50 Zaragoza;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
50 Zaragoza;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
50 Zaragoza;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
50 Zaragoza;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
50 Zaragoza;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;89,75
50 Zaragoza;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
50 Zaragoza;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
50 Zaragoza;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
50 Zaragoza;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;90,68
50 Zaragoza;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
50 Zaragoza;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
50 Zaragoza;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
50 Zaragoza;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
50 Zaragoza;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
50 Zaragoza;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
50 Zaragoza;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QII;21.349
50 Zaragoza;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
50 Zaragoza;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
50 Zaragoza;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
50 Zaragoza;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QII;21.184
50 Zaragoza;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
50 Zaragoza;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
50 Zaragoza;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
50 Zaragoza;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QII;20.950
50 Zaragoza;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
50 Zaragoza;All ages;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
50 Zaragoza;All ages;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
50 Zaragoza;All ages;Cohort April 1;Females;Survival in the first trimester;2022QII;20.574
50 Zaragoza;All ages;Cohort April 1;Females;Survival in the first trimester;2022QI;""
50 Zaragoza;All ages;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
50 Zaragoza;All ages;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
50 Zaragoza;All ages;Cohort April 1;Females;Survival in the first trimester;2021QII;20.506
50 Zaragoza;All ages;Cohort April 1;Females;Survival in the first trimester;2021QI;""
50 Zaragoza;All ages;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
50 Zaragoza;All ages;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
50 Zaragoza;All ages;Cohort April 1;Females;Survival in the first trimester;2020QII;20.352
50 Zaragoza;All ages;Cohort April 1;Females;Survival in the first trimester;2020QI;""
50 Zaragoza;All ages;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
50 Zaragoza;All ages;Cohort April 1;Females;Survival in the second trimester;2022QIII;19.927
50 Zaragoza;All ages;Cohort April 1;Females;Survival in the second trimester;2022QII;""
50 Zaragoza;All ages;Cohort April 1;Females;Survival in the second trimester;2022QI;""
50 Zaragoza;All ages;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
50 Zaragoza;All ages;Cohort April 1;Females;Survival in the second trimester;2021QIII;19.960
50 Zaragoza;All ages;Cohort April 1;Females;Survival in the second trimester;2021QII;""
50 Zaragoza;All ages;Cohort April 1;Females;Survival in the second trimester;2021QI;""
50 Zaragoza;All ages;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
50 Zaragoza;All ages;Cohort April 1;Females;Survival in the second trimester;2020QIII;19.689
50 Zaragoza;All ages;Cohort April 1;Females;Survival in the second trimester;2020QII;""
50 Zaragoza;All ages;Cohort April 1;Females;Survival in the second trimester;2020QI;""
50 Zaragoza;All ages;Cohort April 1;Females;Survival in the third trimester;2022QIV;19.199
50 Zaragoza;All ages;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
50 Zaragoza;All ages;Cohort April 1;Females;Survival in the third trimester;2022QII;""
50 Zaragoza;All ages;Cohort April 1;Females;Survival in the third trimester;2022QI;""
50 Zaragoza;All ages;Cohort April 1;Females;Survival in the third trimester;2021QIV;19.363
50 Zaragoza;All ages;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
50 Zaragoza;All ages;Cohort April 1;Females;Survival in the third trimester;2021QII;""
50 Zaragoza;All ages;Cohort April 1;Females;Survival in the third trimester;2021QI;""
50 Zaragoza;All ages;Cohort April 1;Females;Survival in the third trimester;2020QIV;19.065
50 Zaragoza;All ages;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
50 Zaragoza;All ages;Cohort April 1;Females;Survival in the third trimester;2020QII;""
50 Zaragoza;All ages;Cohort April 1;Females;Survival in the third trimester;2020QI;""
50 Zaragoza;All ages;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
50 Zaragoza;All ages;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
50 Zaragoza;All ages;Cohort April 1;Females;Survival in the third trimester;2022QII;""
50 Zaragoza;All ages;Cohort April 1;Females;Survival in the third trimester;2022QI;18.797
50 Zaragoza;All ages;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
50 Zaragoza;All ages;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
50 Zaragoza;All ages;Cohort April 1;Females;Survival in the third trimester;2021QII;""
50 Zaragoza;All ages;Cohort April 1;Females;Survival in the third trimester;2021QI;18.611
50 Zaragoza;All ages;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
50 Zaragoza;All ages;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
50 Zaragoza;All ages;Cohort April 1;Females;Survival in the third trimester;2020QII;""
50 Zaragoza;All ages;Cohort April 1;Females;Survival in the third trimester;2020QI;""
50 Zaragoza;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
50 Zaragoza;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
50 Zaragoza;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
50 Zaragoza;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
50 Zaragoza;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
50 Zaragoza;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
50 Zaragoza;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
50 Zaragoza;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
50 Zaragoza;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
50 Zaragoza;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
50 Zaragoza;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
50 Zaragoza;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
50 Zaragoza;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
50 Zaragoza;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
50 Zaragoza;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;96,37
50 Zaragoza;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
50 Zaragoza;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
50 Zaragoza;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
50 Zaragoza;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;96,8
50 Zaragoza;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
50 Zaragoza;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
50 Zaragoza;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
50 Zaragoza;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;97,15
50 Zaragoza;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
50 Zaragoza;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
50 Zaragoza;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;93,34
50 Zaragoza;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
50 Zaragoza;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
50 Zaragoza;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
50 Zaragoza;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;94,22
50 Zaragoza;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
50 Zaragoza;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
50 Zaragoza;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
50 Zaragoza;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;93,98
50 Zaragoza;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
50 Zaragoza;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
50 Zaragoza;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;89,93
50 Zaragoza;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
50 Zaragoza;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
50 Zaragoza;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
50 Zaragoza;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;91,4
50 Zaragoza;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
50 Zaragoza;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
50 Zaragoza;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
50 Zaragoza;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;91
50 Zaragoza;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
50 Zaragoza;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
50 Zaragoza;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
50 Zaragoza;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
50 Zaragoza;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
50 Zaragoza;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
50 Zaragoza;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;88,73
50 Zaragoza;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
50 Zaragoza;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
50 Zaragoza;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
50 Zaragoza;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;88,84
50 Zaragoza;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
50 Zaragoza;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
50 Zaragoza;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
50 Zaragoza;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
50 Zaragoza;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
50 Zaragoza;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QIII;57.389
50 Zaragoza;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
50 Zaragoza;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
50 Zaragoza;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
50 Zaragoza;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QIII;57.661
50 Zaragoza;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
50 Zaragoza;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
50 Zaragoza;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
50 Zaragoza;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QIII;57.431
50 Zaragoza;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
50 Zaragoza;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
50 Zaragoza;All ages;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
50 Zaragoza;All ages;Cohort July 1;Total;Survival in the first trimester;2022QIII;55.515
50 Zaragoza;All ages;Cohort July 1;Total;Survival in the first trimester;2022QII;""
50 Zaragoza;All ages;Cohort July 1;Total;Survival in the first trimester;2022QI;""
50 Zaragoza;All ages;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
50 Zaragoza;All ages;Cohort July 1;Total;Survival in the first trimester;2021QIII;55.875
50 Zaragoza;All ages;Cohort July 1;Total;Survival in the first trimester;2021QII;""
50 Zaragoza;All ages;Cohort July 1;Total;Survival in the first trimester;2021QI;""
50 Zaragoza;All ages;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
50 Zaragoza;All ages;Cohort July 1;Total;Survival in the first trimester;2020QIII;55.479
50 Zaragoza;All ages;Cohort July 1;Total;Survival in the first trimester;2020QII;""
50 Zaragoza;All ages;Cohort July 1;Total;Survival in the first trimester;2020QI;""
50 Zaragoza;All ages;Cohort July 1;Total;Survival in the second trimester;2022QIV;53.459
50 Zaragoza;All ages;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
50 Zaragoza;All ages;Cohort July 1;Total;Survival in the second trimester;2022QII;""
50 Zaragoza;All ages;Cohort July 1;Total;Survival in the second trimester;2022QI;""
50 Zaragoza;All ages;Cohort July 1;Total;Survival in the second trimester;2021QIV;54.177
50 Zaragoza;All ages;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
50 Zaragoza;All ages;Cohort July 1;Total;Survival in the second trimester;2021QII;""
50 Zaragoza;All ages;Cohort July 1;Total;Survival in the second trimester;2021QI;""
50 Zaragoza;All ages;Cohort July 1;Total;Survival in the second trimester;2020QIV;53.729
50 Zaragoza;All ages;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
50 Zaragoza;All ages;Cohort July 1;Total;Survival in the second trimester;2020QII;""
50 Zaragoza;All ages;Cohort July 1;Total;Survival in the second trimester;2020QI;""
50 Zaragoza;All ages;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
50 Zaragoza;All ages;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
50 Zaragoza;All ages;Cohort July 1;Total;Survival in the third trimester;2022QII;""
50 Zaragoza;All ages;Cohort July 1;Total;Survival in the third trimester;2022QI;52.657
50 Zaragoza;All ages;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
50 Zaragoza;All ages;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
50 Zaragoza;All ages;Cohort July 1;Total;Survival in the third trimester;2021QII;""
50 Zaragoza;All ages;Cohort July 1;Total;Survival in the third trimester;2021QI;52.549
50 Zaragoza;All ages;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
50 Zaragoza;All ages;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
50 Zaragoza;All ages;Cohort July 1;Total;Survival in the third trimester;2020QII;""
50 Zaragoza;All ages;Cohort July 1;Total;Survival in the third trimester;2020QI;""
50 Zaragoza;All ages;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
50 Zaragoza;All ages;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
50 Zaragoza;All ages;Cohort July 1;Total;Survival in the third trimester;2022QII;51.282
50 Zaragoza;All ages;Cohort July 1;Total;Survival in the third trimester;2022QI;""
50 Zaragoza;All ages;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
50 Zaragoza;All ages;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
50 Zaragoza;All ages;Cohort July 1;Total;Survival in the third trimester;2021QII;51.375
50 Zaragoza;All ages;Cohort July 1;Total;Survival in the third trimester;2021QI;""
50 Zaragoza;All ages;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
50 Zaragoza;All ages;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
50 Zaragoza;All ages;Cohort July 1;Total;Survival in the third trimester;2020QII;""
50 Zaragoza;All ages;Cohort July 1;Total;Survival in the third trimester;2020QI;""
50 Zaragoza;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
50 Zaragoza;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
50 Zaragoza;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
50 Zaragoza;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
50 Zaragoza;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
50 Zaragoza;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
50 Zaragoza;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
50 Zaragoza;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
50 Zaragoza;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
50 Zaragoza;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
50 Zaragoza;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
50 Zaragoza;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
50 Zaragoza;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
50 Zaragoza;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;96,73
50 Zaragoza;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
50 Zaragoza;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
50 Zaragoza;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
50 Zaragoza;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;96,9
50 Zaragoza;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
50 Zaragoza;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
50 Zaragoza;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
50 Zaragoza;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;96,6
50 Zaragoza;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
50 Zaragoza;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
50 Zaragoza;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;93,15
50 Zaragoza;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
50 Zaragoza;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
50 Zaragoza;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
50 Zaragoza;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;93,96
50 Zaragoza;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
50 Zaragoza;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
50 Zaragoza;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
50 Zaragoza;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;93,55
50 Zaragoza;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
50 Zaragoza;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
50 Zaragoza;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
50 Zaragoza;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
50 Zaragoza;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
50 Zaragoza;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
50 Zaragoza;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;91,32
50 Zaragoza;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
50 Zaragoza;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
50 Zaragoza;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
50 Zaragoza;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;91,5
50 Zaragoza;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
50 Zaragoza;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
50 Zaragoza;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
50 Zaragoza;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
50 Zaragoza;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
50 Zaragoza;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
50 Zaragoza;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;88,94
50 Zaragoza;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
50 Zaragoza;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
50 Zaragoza;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
50 Zaragoza;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;89,46
50 Zaragoza;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
50 Zaragoza;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
50 Zaragoza;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
50 Zaragoza;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
50 Zaragoza;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
50 Zaragoza;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
50 Zaragoza;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QIII;36.013
50 Zaragoza;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
50 Zaragoza;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
50 Zaragoza;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
50 Zaragoza;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QIII;36.350
50 Zaragoza;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
50 Zaragoza;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
50 Zaragoza;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
50 Zaragoza;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QIII;36.330
50 Zaragoza;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
50 Zaragoza;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
50 Zaragoza;All ages;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
50 Zaragoza;All ages;Cohort July 1;Males;Survival in the first trimester;2022QIII;34.958
50 Zaragoza;All ages;Cohort July 1;Males;Survival in the first trimester;2022QII;""
50 Zaragoza;All ages;Cohort July 1;Males;Survival in the first trimester;2022QI;""
50 Zaragoza;All ages;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
50 Zaragoza;All ages;Cohort July 1;Males;Survival in the first trimester;2021QIII;35.258
50 Zaragoza;All ages;Cohort July 1;Males;Survival in the first trimester;2021QII;""
50 Zaragoza;All ages;Cohort July 1;Males;Survival in the first trimester;2021QI;""
50 Zaragoza;All ages;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
50 Zaragoza;All ages;Cohort July 1;Males;Survival in the first trimester;2020QIII;35.124
50 Zaragoza;All ages;Cohort July 1;Males;Survival in the first trimester;2020QII;""
50 Zaragoza;All ages;Cohort July 1;Males;Survival in the first trimester;2020QI;""
50 Zaragoza;All ages;Cohort July 1;Males;Survival in the second trimester;2022QIV;33.703
50 Zaragoza;All ages;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
50 Zaragoza;All ages;Cohort July 1;Males;Survival in the second trimester;2022QII;""
50 Zaragoza;All ages;Cohort July 1;Males;Survival in the second trimester;2022QI;""
50 Zaragoza;All ages;Cohort July 1;Males;Survival in the second trimester;2021QIV;34.233
50 Zaragoza;All ages;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
50 Zaragoza;All ages;Cohort July 1;Males;Survival in the second trimester;2021QII;""
50 Zaragoza;All ages;Cohort July 1;Males;Survival in the second trimester;2021QI;""
50 Zaragoza;All ages;Cohort July 1;Males;Survival in the second trimester;2020QIV;34.055
50 Zaragoza;All ages;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
50 Zaragoza;All ages;Cohort July 1;Males;Survival in the second trimester;2020QII;""
50 Zaragoza;All ages;Cohort July 1;Males;Survival in the second trimester;2020QI;""
50 Zaragoza;All ages;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
50 Zaragoza;All ages;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
50 Zaragoza;All ages;Cohort July 1;Males;Survival in the third trimester;2022QII;""
50 Zaragoza;All ages;Cohort July 1;Males;Survival in the third trimester;2022QI;33.323
50 Zaragoza;All ages;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
50 Zaragoza;All ages;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
50 Zaragoza;All ages;Cohort July 1;Males;Survival in the third trimester;2021QII;""
50 Zaragoza;All ages;Cohort July 1;Males;Survival in the third trimester;2021QI;33.367
50 Zaragoza;All ages;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
50 Zaragoza;All ages;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
50 Zaragoza;All ages;Cohort July 1;Males;Survival in the third trimester;2020QII;""
50 Zaragoza;All ages;Cohort July 1;Males;Survival in the third trimester;2020QI;""
50 Zaragoza;All ages;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
50 Zaragoza;All ages;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
50 Zaragoza;All ages;Cohort July 1;Males;Survival in the third trimester;2022QII;32.502
50 Zaragoza;All ages;Cohort July 1;Males;Survival in the third trimester;2022QI;""
50 Zaragoza;All ages;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
50 Zaragoza;All ages;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
50 Zaragoza;All ages;Cohort July 1;Males;Survival in the third trimester;2021QII;32.649
50 Zaragoza;All ages;Cohort July 1;Males;Survival in the third trimester;2021QI;""
50 Zaragoza;All ages;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
50 Zaragoza;All ages;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
50 Zaragoza;All ages;Cohort July 1;Males;Survival in the third trimester;2020QII;""
50 Zaragoza;All ages;Cohort July 1;Males;Survival in the third trimester;2020QI;""
50 Zaragoza;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
50 Zaragoza;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
50 Zaragoza;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
50 Zaragoza;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
50 Zaragoza;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
50 Zaragoza;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
50 Zaragoza;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
50 Zaragoza;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
50 Zaragoza;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
50 Zaragoza;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
50 Zaragoza;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
50 Zaragoza;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
50 Zaragoza;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
50 Zaragoza;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;97,07
50 Zaragoza;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
50 Zaragoza;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
50 Zaragoza;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
50 Zaragoza;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;97
50 Zaragoza;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
50 Zaragoza;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
50 Zaragoza;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
50 Zaragoza;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;96,68
50 Zaragoza;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
50 Zaragoza;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
50 Zaragoza;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;93,59
50 Zaragoza;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
50 Zaragoza;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
50 Zaragoza;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
50 Zaragoza;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;94,18
50 Zaragoza;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
50 Zaragoza;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
50 Zaragoza;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
50 Zaragoza;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;93,74
50 Zaragoza;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
50 Zaragoza;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
50 Zaragoza;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
50 Zaragoza;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
50 Zaragoza;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
50 Zaragoza;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
50 Zaragoza;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;91,67
50 Zaragoza;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
50 Zaragoza;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
50 Zaragoza;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
50 Zaragoza;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;91,84
50 Zaragoza;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
50 Zaragoza;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
50 Zaragoza;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
50 Zaragoza;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
50 Zaragoza;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
50 Zaragoza;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
50 Zaragoza;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;89,41
50 Zaragoza;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
50 Zaragoza;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
50 Zaragoza;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
50 Zaragoza;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;89,87
50 Zaragoza;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
50 Zaragoza;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
50 Zaragoza;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
50 Zaragoza;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
50 Zaragoza;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
50 Zaragoza;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
50 Zaragoza;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QIII;21.376
50 Zaragoza;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
50 Zaragoza;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
50 Zaragoza;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
50 Zaragoza;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QIII;21.311
50 Zaragoza;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
50 Zaragoza;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
50 Zaragoza;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
50 Zaragoza;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QIII;21.101
50 Zaragoza;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
50 Zaragoza;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
50 Zaragoza;All ages;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
50 Zaragoza;All ages;Cohort July 1;Females;Survival in the first trimester;2022QIII;20.557
50 Zaragoza;All ages;Cohort July 1;Females;Survival in the first trimester;2022QII;""
50 Zaragoza;All ages;Cohort July 1;Females;Survival in the first trimester;2022QI;""
50 Zaragoza;All ages;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
50 Zaragoza;All ages;Cohort July 1;Females;Survival in the first trimester;2021QIII;20.617
50 Zaragoza;All ages;Cohort July 1;Females;Survival in the first trimester;2021QII;""
50 Zaragoza;All ages;Cohort July 1;Females;Survival in the first trimester;2021QI;""
50 Zaragoza;All ages;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
50 Zaragoza;All ages;Cohort July 1;Females;Survival in the first trimester;2020QIII;20.355
50 Zaragoza;All ages;Cohort July 1;Females;Survival in the first trimester;2020QII;""
50 Zaragoza;All ages;Cohort July 1;Females;Survival in the first trimester;2020QI;""
50 Zaragoza;All ages;Cohort July 1;Females;Survival in the second trimester;2022QIV;19.756
50 Zaragoza;All ages;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
50 Zaragoza;All ages;Cohort July 1;Females;Survival in the second trimester;2022QII;""
50 Zaragoza;All ages;Cohort July 1;Females;Survival in the second trimester;2022QI;""
50 Zaragoza;All ages;Cohort July 1;Females;Survival in the second trimester;2021QIV;19.944
50 Zaragoza;All ages;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
50 Zaragoza;All ages;Cohort July 1;Females;Survival in the second trimester;2021QII;""
50 Zaragoza;All ages;Cohort July 1;Females;Survival in the second trimester;2021QI;""
50 Zaragoza;All ages;Cohort July 1;Females;Survival in the second trimester;2020QIV;19.674
50 Zaragoza;All ages;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
50 Zaragoza;All ages;Cohort July 1;Females;Survival in the second trimester;2020QII;""
50 Zaragoza;All ages;Cohort July 1;Females;Survival in the second trimester;2020QI;""
50 Zaragoza;All ages;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
50 Zaragoza;All ages;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
50 Zaragoza;All ages;Cohort July 1;Females;Survival in the third trimester;2022QII;""
50 Zaragoza;All ages;Cohort July 1;Females;Survival in the third trimester;2022QI;19.334
50 Zaragoza;All ages;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
50 Zaragoza;All ages;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
50 Zaragoza;All ages;Cohort July 1;Females;Survival in the third trimester;2021QII;""
50 Zaragoza;All ages;Cohort July 1;Females;Survival in the third trimester;2021QI;19.182
50 Zaragoza;All ages;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
50 Zaragoza;All ages;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
50 Zaragoza;All ages;Cohort July 1;Females;Survival in the third trimester;2020QII;""
50 Zaragoza;All ages;Cohort July 1;Females;Survival in the third trimester;2020QI;""
50 Zaragoza;All ages;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
50 Zaragoza;All ages;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
50 Zaragoza;All ages;Cohort July 1;Females;Survival in the third trimester;2022QII;18.780
50 Zaragoza;All ages;Cohort July 1;Females;Survival in the third trimester;2022QI;""
50 Zaragoza;All ages;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
50 Zaragoza;All ages;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
50 Zaragoza;All ages;Cohort July 1;Females;Survival in the third trimester;2021QII;18.726
50 Zaragoza;All ages;Cohort July 1;Females;Survival in the third trimester;2021QI;""
50 Zaragoza;All ages;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
50 Zaragoza;All ages;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
50 Zaragoza;All ages;Cohort July 1;Females;Survival in the third trimester;2020QII;""
50 Zaragoza;All ages;Cohort July 1;Females;Survival in the third trimester;2020QI;""
50 Zaragoza;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
50 Zaragoza;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
50 Zaragoza;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
50 Zaragoza;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
50 Zaragoza;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
50 Zaragoza;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
50 Zaragoza;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
50 Zaragoza;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
50 Zaragoza;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
50 Zaragoza;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
50 Zaragoza;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
50 Zaragoza;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
50 Zaragoza;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
50 Zaragoza;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;96,17
50 Zaragoza;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
50 Zaragoza;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
50 Zaragoza;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
50 Zaragoza;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;96,74
50 Zaragoza;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
50 Zaragoza;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
50 Zaragoza;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
50 Zaragoza;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;96,46
50 Zaragoza;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
50 Zaragoza;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
50 Zaragoza;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;92,42
50 Zaragoza;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
50 Zaragoza;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
50 Zaragoza;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
50 Zaragoza;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;93,59
50 Zaragoza;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
50 Zaragoza;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
50 Zaragoza;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
50 Zaragoza;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;93,24
50 Zaragoza;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
50 Zaragoza;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
50 Zaragoza;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
50 Zaragoza;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
50 Zaragoza;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
50 Zaragoza;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
50 Zaragoza;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;90,72
50 Zaragoza;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
50 Zaragoza;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
50 Zaragoza;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
50 Zaragoza;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;90,91
50 Zaragoza;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
50 Zaragoza;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
50 Zaragoza;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
50 Zaragoza;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
50 Zaragoza;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
50 Zaragoza;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
50 Zaragoza;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;88,12
50 Zaragoza;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
50 Zaragoza;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
50 Zaragoza;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
50 Zaragoza;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;88,74
50 Zaragoza;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
50 Zaragoza;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
50 Zaragoza;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
50 Zaragoza;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
50 Zaragoza;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
50 Zaragoza;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QIV;57.223
50 Zaragoza;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
50 Zaragoza;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
50 Zaragoza;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
50 Zaragoza;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QIV;57.507
50 Zaragoza;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
50 Zaragoza;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
50 Zaragoza;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
50 Zaragoza;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QIV;57.182
50 Zaragoza;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
50 Zaragoza;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
50 Zaragoza;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
50 Zaragoza;All ages;Cohort October 1;Total;Survival in the first trimester;2022QIV;54.922
50 Zaragoza;All ages;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
50 Zaragoza;All ages;Cohort October 1;Total;Survival in the first trimester;2022QII;""
50 Zaragoza;All ages;Cohort October 1;Total;Survival in the first trimester;2022QI;""
50 Zaragoza;All ages;Cohort October 1;Total;Survival in the first trimester;2021QIV;55.600
50 Zaragoza;All ages;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
50 Zaragoza;All ages;Cohort October 1;Total;Survival in the first trimester;2021QII;""
50 Zaragoza;All ages;Cohort October 1;Total;Survival in the first trimester;2021QI;""
50 Zaragoza;All ages;Cohort October 1;Total;Survival in the first trimester;2020QIV;55.188
50 Zaragoza;All ages;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
50 Zaragoza;All ages;Cohort October 1;Total;Survival in the first trimester;2020QII;""
50 Zaragoza;All ages;Cohort October 1;Total;Survival in the first trimester;2020QI;""
50 Zaragoza;All ages;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
50 Zaragoza;All ages;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
50 Zaragoza;All ages;Cohort October 1;Total;Survival in the second trimester;2022QII;""
50 Zaragoza;All ages;Cohort October 1;Total;Survival in the second trimester;2022QI;53.961
50 Zaragoza;All ages;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
50 Zaragoza;All ages;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
50 Zaragoza;All ages;Cohort October 1;Total;Survival in the second trimester;2021QII;""
50 Zaragoza;All ages;Cohort October 1;Total;Survival in the second trimester;2021QI;53.893
50 Zaragoza;All ages;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
50 Zaragoza;All ages;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
50 Zaragoza;All ages;Cohort October 1;Total;Survival in the second trimester;2020QII;""
50 Zaragoza;All ages;Cohort October 1;Total;Survival in the second trimester;2020QI;""
50 Zaragoza;All ages;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
50 Zaragoza;All ages;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
50 Zaragoza;All ages;Cohort October 1;Total;Survival in the third trimester;2022QII;52.480
50 Zaragoza;All ages;Cohort October 1;Total;Survival in the third trimester;2022QI;""
50 Zaragoza;All ages;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
50 Zaragoza;All ages;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
50 Zaragoza;All ages;Cohort October 1;Total;Survival in the third trimester;2021QII;52.593
50 Zaragoza;All ages;Cohort October 1;Total;Survival in the third trimester;2021QI;""
50 Zaragoza;All ages;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
50 Zaragoza;All ages;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
50 Zaragoza;All ages;Cohort October 1;Total;Survival in the third trimester;2020QII;""
50 Zaragoza;All ages;Cohort October 1;Total;Survival in the third trimester;2020QI;""
50 Zaragoza;All ages;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
50 Zaragoza;All ages;Cohort October 1;Total;Survival in the third trimester;2022QIII;51.175
50 Zaragoza;All ages;Cohort October 1;Total;Survival in the third trimester;2022QII;""
50 Zaragoza;All ages;Cohort October 1;Total;Survival in the third trimester;2022QI;""
50 Zaragoza;All ages;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
50 Zaragoza;All ages;Cohort October 1;Total;Survival in the third trimester;2021QIII;51.464
50 Zaragoza;All ages;Cohort October 1;Total;Survival in the third trimester;2021QII;""
50 Zaragoza;All ages;Cohort October 1;Total;Survival in the third trimester;2021QI;""
50 Zaragoza;All ages;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
50 Zaragoza;All ages;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
50 Zaragoza;All ages;Cohort October 1;Total;Survival in the third trimester;2020QII;""
50 Zaragoza;All ages;Cohort October 1;Total;Survival in the third trimester;2020QI;""
50 Zaragoza;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
50 Zaragoza;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
50 Zaragoza;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
50 Zaragoza;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
50 Zaragoza;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
50 Zaragoza;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
50 Zaragoza;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
50 Zaragoza;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
50 Zaragoza;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
50 Zaragoza;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
50 Zaragoza;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
50 Zaragoza;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
50 Zaragoza;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;95,98
50 Zaragoza;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
50 Zaragoza;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
50 Zaragoza;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
50 Zaragoza;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;96,68
50 Zaragoza;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
50 Zaragoza;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
50 Zaragoza;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
50 Zaragoza;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;96,51
50 Zaragoza;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
50 Zaragoza;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
50 Zaragoza;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
50 Zaragoza;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
50 Zaragoza;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
50 Zaragoza;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
50 Zaragoza;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;93,83
50 Zaragoza;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
50 Zaragoza;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
50 Zaragoza;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
50 Zaragoza;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;94,25
50 Zaragoza;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
50 Zaragoza;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
50 Zaragoza;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
50 Zaragoza;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
50 Zaragoza;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
50 Zaragoza;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
50 Zaragoza;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;91,26
50 Zaragoza;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
50 Zaragoza;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
50 Zaragoza;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
50 Zaragoza;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;91,97
50 Zaragoza;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
50 Zaragoza;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
50 Zaragoza;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
50 Zaragoza;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
50 Zaragoza;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
50 Zaragoza;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
50 Zaragoza;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;88,99
50 Zaragoza;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
50 Zaragoza;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
50 Zaragoza;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
50 Zaragoza;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;90
50 Zaragoza;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
50 Zaragoza;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
50 Zaragoza;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
50 Zaragoza;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
50 Zaragoza;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
50 Zaragoza;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
50 Zaragoza;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QIV;35.933
50 Zaragoza;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
50 Zaragoza;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
50 Zaragoza;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
50 Zaragoza;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QIV;36.190
50 Zaragoza;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
50 Zaragoza;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
50 Zaragoza;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
50 Zaragoza;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QIV;36.157
50 Zaragoza;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
50 Zaragoza;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
50 Zaragoza;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
50 Zaragoza;All ages;Cohort October 1;Males;Survival in the first trimester;2022QIV;34.532
50 Zaragoza;All ages;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
50 Zaragoza;All ages;Cohort October 1;Males;Survival in the first trimester;2022QII;""
50 Zaragoza;All ages;Cohort October 1;Males;Survival in the first trimester;2022QI;""
50 Zaragoza;All ages;Cohort October 1;Males;Survival in the first trimester;2021QIV;35.033
50 Zaragoza;All ages;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
50 Zaragoza;All ages;Cohort October 1;Males;Survival in the first trimester;2021QII;""
50 Zaragoza;All ages;Cohort October 1;Males;Survival in the first trimester;2021QI;""
50 Zaragoza;All ages;Cohort October 1;Males;Survival in the first trimester;2020QIV;34.942
50 Zaragoza;All ages;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
50 Zaragoza;All ages;Cohort October 1;Males;Survival in the first trimester;2020QII;""
50 Zaragoza;All ages;Cohort October 1;Males;Survival in the first trimester;2020QI;""
50 Zaragoza;All ages;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
50 Zaragoza;All ages;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
50 Zaragoza;All ages;Cohort October 1;Males;Survival in the second trimester;2022QII;""
50 Zaragoza;All ages;Cohort October 1;Males;Survival in the second trimester;2022QI;34.051
50 Zaragoza;All ages;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
50 Zaragoza;All ages;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
50 Zaragoza;All ages;Cohort October 1;Males;Survival in the second trimester;2021QII;""
50 Zaragoza;All ages;Cohort October 1;Males;Survival in the second trimester;2021QI;34.175
50 Zaragoza;All ages;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
50 Zaragoza;All ages;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
50 Zaragoza;All ages;Cohort October 1;Males;Survival in the second trimester;2020QII;""
50 Zaragoza;All ages;Cohort October 1;Males;Survival in the second trimester;2020QI;""
50 Zaragoza;All ages;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
50 Zaragoza;All ages;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
50 Zaragoza;All ages;Cohort October 1;Males;Survival in the third trimester;2022QII;33.167
50 Zaragoza;All ages;Cohort October 1;Males;Survival in the third trimester;2022QI;""
50 Zaragoza;All ages;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
50 Zaragoza;All ages;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
50 Zaragoza;All ages;Cohort October 1;Males;Survival in the third trimester;2021QII;33.379
50 Zaragoza;All ages;Cohort October 1;Males;Survival in the third trimester;2021QI;""
50 Zaragoza;All ages;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
50 Zaragoza;All ages;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
50 Zaragoza;All ages;Cohort October 1;Males;Survival in the third trimester;2020QII;""
50 Zaragoza;All ages;Cohort October 1;Males;Survival in the third trimester;2020QI;""
50 Zaragoza;All ages;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
50 Zaragoza;All ages;Cohort October 1;Males;Survival in the third trimester;2022QIII;32.406
50 Zaragoza;All ages;Cohort October 1;Males;Survival in the third trimester;2022QII;""
50 Zaragoza;All ages;Cohort October 1;Males;Survival in the third trimester;2022QI;""
50 Zaragoza;All ages;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
50 Zaragoza;All ages;Cohort October 1;Males;Survival in the third trimester;2021QIII;32.701
50 Zaragoza;All ages;Cohort October 1;Males;Survival in the third trimester;2021QII;""
50 Zaragoza;All ages;Cohort October 1;Males;Survival in the third trimester;2021QI;""
50 Zaragoza;All ages;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
50 Zaragoza;All ages;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
50 Zaragoza;All ages;Cohort October 1;Males;Survival in the third trimester;2020QII;""
50 Zaragoza;All ages;Cohort October 1;Males;Survival in the third trimester;2020QI;""
50 Zaragoza;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
50 Zaragoza;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
50 Zaragoza;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
50 Zaragoza;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
50 Zaragoza;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
50 Zaragoza;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
50 Zaragoza;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
50 Zaragoza;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
50 Zaragoza;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
50 Zaragoza;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
50 Zaragoza;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
50 Zaragoza;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
50 Zaragoza;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;96,1
50 Zaragoza;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
50 Zaragoza;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
50 Zaragoza;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
50 Zaragoza;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;96,8
50 Zaragoza;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
50 Zaragoza;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
50 Zaragoza;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
50 Zaragoza;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;96,64
50 Zaragoza;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
50 Zaragoza;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
50 Zaragoza;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
50 Zaragoza;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
50 Zaragoza;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
50 Zaragoza;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
50 Zaragoza;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;94,09
50 Zaragoza;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
50 Zaragoza;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
50 Zaragoza;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
50 Zaragoza;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;94,52
50 Zaragoza;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
50 Zaragoza;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
50 Zaragoza;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
50 Zaragoza;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
50 Zaragoza;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
50 Zaragoza;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
50 Zaragoza;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;91,65
50 Zaragoza;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
50 Zaragoza;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
50 Zaragoza;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
50 Zaragoza;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;92,32
50 Zaragoza;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
50 Zaragoza;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
50 Zaragoza;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
50 Zaragoza;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
50 Zaragoza;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
50 Zaragoza;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
50 Zaragoza;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;89,54
50 Zaragoza;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
50 Zaragoza;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
50 Zaragoza;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
50 Zaragoza;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;90,44
50 Zaragoza;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
50 Zaragoza;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
50 Zaragoza;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
50 Zaragoza;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
50 Zaragoza;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
50 Zaragoza;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
50 Zaragoza;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QIV;21.290
50 Zaragoza;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
50 Zaragoza;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
50 Zaragoza;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
50 Zaragoza;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QIV;21.317
50 Zaragoza;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
50 Zaragoza;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
50 Zaragoza;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
50 Zaragoza;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QIV;21.025
50 Zaragoza;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
50 Zaragoza;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
50 Zaragoza;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
50 Zaragoza;All ages;Cohort October 1;Females;Survival in the first trimester;2022QIV;20.390
50 Zaragoza;All ages;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
50 Zaragoza;All ages;Cohort October 1;Females;Survival in the first trimester;2022QII;""
50 Zaragoza;All ages;Cohort October 1;Females;Survival in the first trimester;2022QI;""
50 Zaragoza;All ages;Cohort October 1;Females;Survival in the first trimester;2021QIV;20.567
50 Zaragoza;All ages;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
50 Zaragoza;All ages;Cohort October 1;Females;Survival in the first trimester;2021QII;""
50 Zaragoza;All ages;Cohort October 1;Females;Survival in the first trimester;2021QI;""
50 Zaragoza;All ages;Cohort October 1;Females;Survival in the first trimester;2020QIV;20.246
50 Zaragoza;All ages;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
50 Zaragoza;All ages;Cohort October 1;Females;Survival in the first trimester;2020QII;""
50 Zaragoza;All ages;Cohort October 1;Females;Survival in the first trimester;2020QI;""
50 Zaragoza;All ages;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
50 Zaragoza;All ages;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
50 Zaragoza;All ages;Cohort October 1;Females;Survival in the second trimester;2022QII;""
50 Zaragoza;All ages;Cohort October 1;Females;Survival in the second trimester;2022QI;19.910
50 Zaragoza;All ages;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
50 Zaragoza;All ages;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
50 Zaragoza;All ages;Cohort October 1;Females;Survival in the second trimester;2021QII;""
50 Zaragoza;All ages;Cohort October 1;Females;Survival in the second trimester;2021QI;19.718
50 Zaragoza;All ages;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
50 Zaragoza;All ages;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
50 Zaragoza;All ages;Cohort October 1;Females;Survival in the second trimester;2020QII;""
50 Zaragoza;All ages;Cohort October 1;Females;Survival in the second trimester;2020QI;""
50 Zaragoza;All ages;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
50 Zaragoza;All ages;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
50 Zaragoza;All ages;Cohort October 1;Females;Survival in the third trimester;2022QII;19.313
50 Zaragoza;All ages;Cohort October 1;Females;Survival in the third trimester;2022QI;""
50 Zaragoza;All ages;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
50 Zaragoza;All ages;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
50 Zaragoza;All ages;Cohort October 1;Females;Survival in the third trimester;2021QII;19.214
50 Zaragoza;All ages;Cohort October 1;Females;Survival in the third trimester;2021QI;""
50 Zaragoza;All ages;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
50 Zaragoza;All ages;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
50 Zaragoza;All ages;Cohort October 1;Females;Survival in the third trimester;2020QII;""
50 Zaragoza;All ages;Cohort October 1;Females;Survival in the third trimester;2020QI;""
50 Zaragoza;All ages;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
50 Zaragoza;All ages;Cohort October 1;Females;Survival in the third trimester;2022QIII;18.769
50 Zaragoza;All ages;Cohort October 1;Females;Survival in the third trimester;2022QII;""
50 Zaragoza;All ages;Cohort October 1;Females;Survival in the third trimester;2022QI;""
50 Zaragoza;All ages;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
50 Zaragoza;All ages;Cohort October 1;Females;Survival in the third trimester;2021QIII;18.763
50 Zaragoza;All ages;Cohort October 1;Females;Survival in the third trimester;2021QII;""
50 Zaragoza;All ages;Cohort October 1;Females;Survival in the third trimester;2021QI;""
50 Zaragoza;All ages;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
50 Zaragoza;All ages;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
50 Zaragoza;All ages;Cohort October 1;Females;Survival in the third trimester;2020QII;""
50 Zaragoza;All ages;Cohort October 1;Females;Survival in the third trimester;2020QI;""
50 Zaragoza;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
50 Zaragoza;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
50 Zaragoza;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
50 Zaragoza;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
50 Zaragoza;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
50 Zaragoza;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
50 Zaragoza;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
50 Zaragoza;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
50 Zaragoza;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
50 Zaragoza;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
50 Zaragoza;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
50 Zaragoza;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
50 Zaragoza;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;95,77
50 Zaragoza;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
50 Zaragoza;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
50 Zaragoza;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
50 Zaragoza;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;96,48
50 Zaragoza;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
50 Zaragoza;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
50 Zaragoza;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
50 Zaragoza;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;96,29
50 Zaragoza;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
50 Zaragoza;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
50 Zaragoza;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
50 Zaragoza;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
50 Zaragoza;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
50 Zaragoza;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
50 Zaragoza;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;93,4
50 Zaragoza;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
50 Zaragoza;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
50 Zaragoza;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
50 Zaragoza;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;93,78
50 Zaragoza;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
50 Zaragoza;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
50 Zaragoza;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
50 Zaragoza;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
50 Zaragoza;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
50 Zaragoza;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
50 Zaragoza;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;90,6
50 Zaragoza;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
50 Zaragoza;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
50 Zaragoza;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
50 Zaragoza;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;91,39
50 Zaragoza;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
50 Zaragoza;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
50 Zaragoza;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
50 Zaragoza;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
50 Zaragoza;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
50 Zaragoza;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
50 Zaragoza;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;88,05
50 Zaragoza;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
50 Zaragoza;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
50 Zaragoza;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
50 Zaragoza;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;89,24
50 Zaragoza;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
50 Zaragoza;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
50 Zaragoza;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
50 Zaragoza;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
50 Zaragoza;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
50 Zaragoza;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
50 Zaragoza;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
50 Zaragoza;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
50 Zaragoza;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
50 Zaragoza;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QI;3.632
50 Zaragoza;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
50 Zaragoza;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
50 Zaragoza;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
50 Zaragoza;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QI;3.485
50 Zaragoza;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
50 Zaragoza;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
50 Zaragoza;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
50 Zaragoza;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QI;2.937
50 Zaragoza;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
50 Zaragoza;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
50 Zaragoza;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2022QII;""
50 Zaragoza;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2022QI;3.345
50 Zaragoza;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
50 Zaragoza;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
50 Zaragoza;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2021QII;""
50 Zaragoza;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2021QI;3.245
50 Zaragoza;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
50 Zaragoza;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
50 Zaragoza;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2020QII;""
50 Zaragoza;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2020QI;2.453
50 Zaragoza;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
50 Zaragoza;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
50 Zaragoza;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2022QII;3.122
50 Zaragoza;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2022QI;""
50 Zaragoza;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
50 Zaragoza;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
50 Zaragoza;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2021QII;3.006
50 Zaragoza;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2021QI;""
50 Zaragoza;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
50 Zaragoza;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
50 Zaragoza;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2020QII;2.370
50 Zaragoza;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2020QI;""
50 Zaragoza;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
50 Zaragoza;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QIII;2.924
50 Zaragoza;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QII;""
50 Zaragoza;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QI;""
50 Zaragoza;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
50 Zaragoza;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QIII;2.836
50 Zaragoza;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QII;""
50 Zaragoza;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QI;""
50 Zaragoza;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
50 Zaragoza;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QIII;2.214
50 Zaragoza;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QII;""
50 Zaragoza;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QI;""
50 Zaragoza;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QIV;2.763
50 Zaragoza;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
50 Zaragoza;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QII;""
50 Zaragoza;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QI;""
50 Zaragoza;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QIV;2.679
50 Zaragoza;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
50 Zaragoza;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QII;""
50 Zaragoza;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QI;""
50 Zaragoza;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QIV;2.095
50 Zaragoza;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
50 Zaragoza;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QII;""
50 Zaragoza;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QI;""
50 Zaragoza;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
50 Zaragoza;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
50 Zaragoza;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
50 Zaragoza;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
50 Zaragoza;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
50 Zaragoza;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
50 Zaragoza;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
50 Zaragoza;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
50 Zaragoza;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
50 Zaragoza;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
50 Zaragoza;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
50 Zaragoza;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
50 Zaragoza;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
50 Zaragoza;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
50 Zaragoza;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
50 Zaragoza;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;92,1
50 Zaragoza;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
50 Zaragoza;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
50 Zaragoza;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
50 Zaragoza;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;93,11
50 Zaragoza;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
50 Zaragoza;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
50 Zaragoza;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
50 Zaragoza;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;83,52
50 Zaragoza;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
50 Zaragoza;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
50 Zaragoza;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;85,96
50 Zaragoza;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
50 Zaragoza;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
50 Zaragoza;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
50 Zaragoza;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;86,26
50 Zaragoza;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
50 Zaragoza;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
50 Zaragoza;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
50 Zaragoza;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;80,69
50 Zaragoza;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
50 Zaragoza;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
50 Zaragoza;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;80,51
50 Zaragoza;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
50 Zaragoza;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
50 Zaragoza;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
50 Zaragoza;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;81,38
50 Zaragoza;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
50 Zaragoza;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
50 Zaragoza;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
50 Zaragoza;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;75,38
50 Zaragoza;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
50 Zaragoza;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
50 Zaragoza;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;76,07
50 Zaragoza;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
50 Zaragoza;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
50 Zaragoza;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
50 Zaragoza;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;76,87
50 Zaragoza;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
50 Zaragoza;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
50 Zaragoza;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
50 Zaragoza;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;71,33
50 Zaragoza;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
50 Zaragoza;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
50 Zaragoza;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
50 Zaragoza;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
50 Zaragoza;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
50 Zaragoza;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
50 Zaragoza;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QI;2.227
50 Zaragoza;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
50 Zaragoza;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
50 Zaragoza;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
50 Zaragoza;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QI;2.214
50 Zaragoza;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
50 Zaragoza;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
50 Zaragoza;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
50 Zaragoza;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QI;1.841
50 Zaragoza;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
50 Zaragoza;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
50 Zaragoza;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2022QII;""
50 Zaragoza;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2022QI;2.048
50 Zaragoza;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
50 Zaragoza;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
50 Zaragoza;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2021QII;""
50 Zaragoza;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2021QI;2.047
50 Zaragoza;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
50 Zaragoza;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
50 Zaragoza;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2020QII;""
50 Zaragoza;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2020QI;1.534
50 Zaragoza;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
50 Zaragoza;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
50 Zaragoza;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2022QII;1.916
50 Zaragoza;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2022QI;""
50 Zaragoza;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
50 Zaragoza;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
50 Zaragoza;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2021QII;1.885
50 Zaragoza;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2021QI;""
50 Zaragoza;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
50 Zaragoza;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
50 Zaragoza;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2020QII;1.489
50 Zaragoza;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2020QI;""
50 Zaragoza;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
50 Zaragoza;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QIII;1.801
50 Zaragoza;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QII;""
50 Zaragoza;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QI;""
50 Zaragoza;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
50 Zaragoza;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QIII;1.783
50 Zaragoza;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QII;""
50 Zaragoza;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QI;""
50 Zaragoza;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
50 Zaragoza;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QIII;1.392
50 Zaragoza;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QII;""
50 Zaragoza;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QI;""
50 Zaragoza;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QIV;1.708
50 Zaragoza;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
50 Zaragoza;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QII;""
50 Zaragoza;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QI;""
50 Zaragoza;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QIV;1.678
50 Zaragoza;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
50 Zaragoza;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QII;""
50 Zaragoza;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QI;""
50 Zaragoza;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QIV;1.315
50 Zaragoza;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
50 Zaragoza;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QII;""
50 Zaragoza;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QI;""
50 Zaragoza;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
50 Zaragoza;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
50 Zaragoza;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
50 Zaragoza;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
50 Zaragoza;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
50 Zaragoza;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
50 Zaragoza;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
50 Zaragoza;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
50 Zaragoza;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
50 Zaragoza;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
50 Zaragoza;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
50 Zaragoza;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
50 Zaragoza;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
50 Zaragoza;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
50 Zaragoza;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
50 Zaragoza;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;91,96
50 Zaragoza;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
50 Zaragoza;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
50 Zaragoza;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
50 Zaragoza;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;92,46
50 Zaragoza;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
50 Zaragoza;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
50 Zaragoza;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
50 Zaragoza;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;83,32
50 Zaragoza;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
50 Zaragoza;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
50 Zaragoza;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;86,04
50 Zaragoza;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
50 Zaragoza;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
50 Zaragoza;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
50 Zaragoza;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;85,14
50 Zaragoza;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
50 Zaragoza;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
50 Zaragoza;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
50 Zaragoza;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;80,88
50 Zaragoza;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
50 Zaragoza;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
50 Zaragoza;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;80,87
50 Zaragoza;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
50 Zaragoza;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
50 Zaragoza;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
50 Zaragoza;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;80,53
50 Zaragoza;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
50 Zaragoza;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
50 Zaragoza;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
50 Zaragoza;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;75,61
50 Zaragoza;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
50 Zaragoza;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
50 Zaragoza;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;76,7
50 Zaragoza;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
50 Zaragoza;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
50 Zaragoza;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
50 Zaragoza;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;75,79
50 Zaragoza;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
50 Zaragoza;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
50 Zaragoza;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
50 Zaragoza;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;71,43
50 Zaragoza;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
50 Zaragoza;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
50 Zaragoza;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
50 Zaragoza;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
50 Zaragoza;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
50 Zaragoza;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
50 Zaragoza;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QI;1.405
50 Zaragoza;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
50 Zaragoza;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
50 Zaragoza;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
50 Zaragoza;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QI;1.271
50 Zaragoza;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
50 Zaragoza;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
50 Zaragoza;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
50 Zaragoza;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QI;1.096
50 Zaragoza;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
50 Zaragoza;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
50 Zaragoza;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2022QII;""
50 Zaragoza;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2022QI;1.297
50 Zaragoza;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
50 Zaragoza;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
50 Zaragoza;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2021QII;""
50 Zaragoza;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2021QI;1.198
50 Zaragoza;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
50 Zaragoza;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
50 Zaragoza;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2020QII;""
50 Zaragoza;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2020QI;919
50 Zaragoza;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
50 Zaragoza;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
50 Zaragoza;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2022QII;1.206
50 Zaragoza;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2022QI;""
50 Zaragoza;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
50 Zaragoza;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
50 Zaragoza;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2021QII;1.121
50 Zaragoza;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2021QI;""
50 Zaragoza;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
50 Zaragoza;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
50 Zaragoza;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2020QII;881
50 Zaragoza;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2020QI;""
50 Zaragoza;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
50 Zaragoza;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QIII;1.123
50 Zaragoza;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QII;""
50 Zaragoza;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QI;""
50 Zaragoza;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
50 Zaragoza;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QIII;1.053
50 Zaragoza;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QII;""
50 Zaragoza;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QI;""
50 Zaragoza;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
50 Zaragoza;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QIII;822
50 Zaragoza;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QII;""
50 Zaragoza;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QI;""
50 Zaragoza;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QIV;1.055
50 Zaragoza;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
50 Zaragoza;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QII;""
50 Zaragoza;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QI;""
50 Zaragoza;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QIV;1.001
50 Zaragoza;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
50 Zaragoza;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QII;""
50 Zaragoza;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QI;""
50 Zaragoza;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QIV;780
50 Zaragoza;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
50 Zaragoza;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QII;""
50 Zaragoza;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QI;""
50 Zaragoza;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
50 Zaragoza;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
50 Zaragoza;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
50 Zaragoza;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
50 Zaragoza;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
50 Zaragoza;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
50 Zaragoza;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
50 Zaragoza;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
50 Zaragoza;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
50 Zaragoza;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
50 Zaragoza;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
50 Zaragoza;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
50 Zaragoza;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
50 Zaragoza;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
50 Zaragoza;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
50 Zaragoza;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;92,31
50 Zaragoza;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
50 Zaragoza;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
50 Zaragoza;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
50 Zaragoza;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;94,26
50 Zaragoza;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
50 Zaragoza;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
50 Zaragoza;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
50 Zaragoza;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;83,85
50 Zaragoza;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
50 Zaragoza;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
50 Zaragoza;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;85,84
50 Zaragoza;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
50 Zaragoza;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
50 Zaragoza;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
50 Zaragoza;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;88,2
50 Zaragoza;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
50 Zaragoza;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
50 Zaragoza;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
50 Zaragoza;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;80,38
50 Zaragoza;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
50 Zaragoza;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
50 Zaragoza;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;79,93
50 Zaragoza;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
50 Zaragoza;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
50 Zaragoza;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
50 Zaragoza;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;82,85
50 Zaragoza;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
50 Zaragoza;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
50 Zaragoza;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
50 Zaragoza;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;75
50 Zaragoza;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
50 Zaragoza;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
50 Zaragoza;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;75,09
50 Zaragoza;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
50 Zaragoza;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
50 Zaragoza;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
50 Zaragoza;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;78,76
50 Zaragoza;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
50 Zaragoza;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
50 Zaragoza;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
50 Zaragoza;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;71,17
50 Zaragoza;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
50 Zaragoza;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
50 Zaragoza;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
50 Zaragoza;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
50 Zaragoza;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
50 Zaragoza;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QII;3.217
50 Zaragoza;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
50 Zaragoza;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
50 Zaragoza;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
50 Zaragoza;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QII;3.168
50 Zaragoza;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
50 Zaragoza;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
50 Zaragoza;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
50 Zaragoza;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QII;2.824
50 Zaragoza;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
50 Zaragoza;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
50 Zaragoza;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
50 Zaragoza;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2022QII;2.958
50 Zaragoza;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2022QI;""
50 Zaragoza;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
50 Zaragoza;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
50 Zaragoza;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2021QII;2.878
50 Zaragoza;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2021QI;""
50 Zaragoza;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
50 Zaragoza;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
50 Zaragoza;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2020QII;2.710
50 Zaragoza;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2020QI;""
50 Zaragoza;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
50 Zaragoza;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2022QIII;2.748
50 Zaragoza;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2022QII;""
50 Zaragoza;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2022QI;""
50 Zaragoza;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
50 Zaragoza;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2021QIII;2.666
50 Zaragoza;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2021QII;""
50 Zaragoza;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2021QI;""
50 Zaragoza;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
50 Zaragoza;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2020QIII;2.505
50 Zaragoza;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2020QII;""
50 Zaragoza;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2020QI;""
50 Zaragoza;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QIV;2.573
50 Zaragoza;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
50 Zaragoza;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QII;""
50 Zaragoza;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QI;""
50 Zaragoza;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QIV;2.514
50 Zaragoza;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
50 Zaragoza;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QII;""
50 Zaragoza;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QI;""
50 Zaragoza;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QIV;2.349
50 Zaragoza;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
50 Zaragoza;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QII;""
50 Zaragoza;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QI;""
50 Zaragoza;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
50 Zaragoza;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
50 Zaragoza;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QII;""
50 Zaragoza;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QI;2.343
50 Zaragoza;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
50 Zaragoza;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
50 Zaragoza;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QII;""
50 Zaragoza;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QI;2.245
50 Zaragoza;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
50 Zaragoza;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
50 Zaragoza;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QII;""
50 Zaragoza;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QI;""
50 Zaragoza;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
50 Zaragoza;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
50 Zaragoza;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
50 Zaragoza;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
50 Zaragoza;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
50 Zaragoza;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
50 Zaragoza;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
50 Zaragoza;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
50 Zaragoza;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
50 Zaragoza;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
50 Zaragoza;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
50 Zaragoza;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
50 Zaragoza;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
50 Zaragoza;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
50 Zaragoza;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;91,95
50 Zaragoza;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
50 Zaragoza;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
50 Zaragoza;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
50 Zaragoza;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;90,85
50 Zaragoza;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
50 Zaragoza;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
50 Zaragoza;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
50 Zaragoza;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;95,96
50 Zaragoza;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
50 Zaragoza;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
50 Zaragoza;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;85,42
50 Zaragoza;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
50 Zaragoza;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
50 Zaragoza;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
50 Zaragoza;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;84,15
50 Zaragoza;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
50 Zaragoza;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
50 Zaragoza;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
50 Zaragoza;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;88,7
50 Zaragoza;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
50 Zaragoza;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
50 Zaragoza;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;79,98
50 Zaragoza;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
50 Zaragoza;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
50 Zaragoza;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
50 Zaragoza;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;79,36
50 Zaragoza;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
50 Zaragoza;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
50 Zaragoza;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
50 Zaragoza;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;83,18
50 Zaragoza;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
50 Zaragoza;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
50 Zaragoza;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
50 Zaragoza;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
50 Zaragoza;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
50 Zaragoza;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
50 Zaragoza;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;73,96
50 Zaragoza;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
50 Zaragoza;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
50 Zaragoza;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
50 Zaragoza;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;79,5
50 Zaragoza;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
50 Zaragoza;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
50 Zaragoza;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
50 Zaragoza;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
50 Zaragoza;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
50 Zaragoza;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
50 Zaragoza;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QII;1.981
50 Zaragoza;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
50 Zaragoza;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
50 Zaragoza;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
50 Zaragoza;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QII;2.006
50 Zaragoza;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
50 Zaragoza;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
50 Zaragoza;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
50 Zaragoza;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QII;1.773
50 Zaragoza;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
50 Zaragoza;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
50 Zaragoza;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
50 Zaragoza;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2022QII;1.830
50 Zaragoza;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2022QI;""
50 Zaragoza;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
50 Zaragoza;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
50 Zaragoza;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2021QII;1.803
50 Zaragoza;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2021QI;""
50 Zaragoza;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
50 Zaragoza;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
50 Zaragoza;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2020QII;1.712
50 Zaragoza;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2020QI;""
50 Zaragoza;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
50 Zaragoza;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2022QIII;1.701
50 Zaragoza;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2022QII;""
50 Zaragoza;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2022QI;""
50 Zaragoza;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
50 Zaragoza;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2021QIII;1.673
50 Zaragoza;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2021QII;""
50 Zaragoza;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2021QI;""
50 Zaragoza;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
50 Zaragoza;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2020QIII;1.583
50 Zaragoza;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2020QII;""
50 Zaragoza;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2020QI;""
50 Zaragoza;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QIV;1.598
50 Zaragoza;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
50 Zaragoza;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QII;""
50 Zaragoza;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QI;""
50 Zaragoza;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QIV;1.572
50 Zaragoza;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
50 Zaragoza;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QII;""
50 Zaragoza;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QI;""
50 Zaragoza;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QIV;1.479
50 Zaragoza;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
50 Zaragoza;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QII;""
50 Zaragoza;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QI;""
50 Zaragoza;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
50 Zaragoza;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
50 Zaragoza;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QII;""
50 Zaragoza;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QI;1.462
50 Zaragoza;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
50 Zaragoza;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
50 Zaragoza;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QII;""
50 Zaragoza;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QI;1.410
50 Zaragoza;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
50 Zaragoza;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
50 Zaragoza;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QII;""
50 Zaragoza;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QI;""
50 Zaragoza;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
50 Zaragoza;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
50 Zaragoza;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
50 Zaragoza;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
50 Zaragoza;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
50 Zaragoza;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
50 Zaragoza;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
50 Zaragoza;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
50 Zaragoza;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
50 Zaragoza;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
50 Zaragoza;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
50 Zaragoza;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
50 Zaragoza;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
50 Zaragoza;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
50 Zaragoza;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;92,38
50 Zaragoza;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
50 Zaragoza;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
50 Zaragoza;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
50 Zaragoza;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;89,88
50 Zaragoza;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
50 Zaragoza;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
50 Zaragoza;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
50 Zaragoza;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;96,56
50 Zaragoza;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
50 Zaragoza;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
50 Zaragoza;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;85,87
50 Zaragoza;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
50 Zaragoza;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
50 Zaragoza;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
50 Zaragoza;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;83,4
50 Zaragoza;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
50 Zaragoza;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
50 Zaragoza;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
50 Zaragoza;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;89,28
50 Zaragoza;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
50 Zaragoza;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
50 Zaragoza;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;80,67
50 Zaragoza;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
50 Zaragoza;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
50 Zaragoza;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
50 Zaragoza;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;78,36
50 Zaragoza;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
50 Zaragoza;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
50 Zaragoza;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
50 Zaragoza;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;83,42
50 Zaragoza;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
50 Zaragoza;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
50 Zaragoza;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
50 Zaragoza;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
50 Zaragoza;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
50 Zaragoza;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
50 Zaragoza;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;72,88
50 Zaragoza;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
50 Zaragoza;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
50 Zaragoza;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
50 Zaragoza;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;79,53
50 Zaragoza;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
50 Zaragoza;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
50 Zaragoza;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
50 Zaragoza;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
50 Zaragoza;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
50 Zaragoza;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
50 Zaragoza;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QII;1.236
50 Zaragoza;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
50 Zaragoza;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
50 Zaragoza;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
50 Zaragoza;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QII;1.162
50 Zaragoza;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
50 Zaragoza;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
50 Zaragoza;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
50 Zaragoza;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QII;1.051
50 Zaragoza;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
50 Zaragoza;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
50 Zaragoza;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
50 Zaragoza;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2022QII;1.128
50 Zaragoza;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2022QI;""
50 Zaragoza;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
50 Zaragoza;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
50 Zaragoza;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2021QII;1.075
50 Zaragoza;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2021QI;""
50 Zaragoza;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
50 Zaragoza;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
50 Zaragoza;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2020QII;998
50 Zaragoza;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2020QI;""
50 Zaragoza;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
50 Zaragoza;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2022QIII;1.047
50 Zaragoza;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2022QII;""
50 Zaragoza;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2022QI;""
50 Zaragoza;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
50 Zaragoza;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2021QIII;993
50 Zaragoza;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2021QII;""
50 Zaragoza;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2021QI;""
50 Zaragoza;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
50 Zaragoza;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2020QIII;922
50 Zaragoza;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2020QII;""
50 Zaragoza;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2020QI;""
50 Zaragoza;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QIV;975
50 Zaragoza;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
50 Zaragoza;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QII;""
50 Zaragoza;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QI;""
50 Zaragoza;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QIV;942
50 Zaragoza;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
50 Zaragoza;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QII;""
50 Zaragoza;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QI;""
50 Zaragoza;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QIV;870
50 Zaragoza;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
50 Zaragoza;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QII;""
50 Zaragoza;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QI;""
50 Zaragoza;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
50 Zaragoza;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
50 Zaragoza;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QII;""
50 Zaragoza;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QI;881
50 Zaragoza;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
50 Zaragoza;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
50 Zaragoza;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QII;""
50 Zaragoza;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QI;835
50 Zaragoza;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
50 Zaragoza;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
50 Zaragoza;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QII;""
50 Zaragoza;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QI;""
50 Zaragoza;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
50 Zaragoza;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
50 Zaragoza;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
50 Zaragoza;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
50 Zaragoza;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
50 Zaragoza;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
50 Zaragoza;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
50 Zaragoza;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
50 Zaragoza;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
50 Zaragoza;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
50 Zaragoza;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
50 Zaragoza;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
50 Zaragoza;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
50 Zaragoza;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
50 Zaragoza;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;91,26
50 Zaragoza;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
50 Zaragoza;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
50 Zaragoza;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
50 Zaragoza;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;92,51
50 Zaragoza;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
50 Zaragoza;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
50 Zaragoza;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
50 Zaragoza;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;94,96
50 Zaragoza;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
50 Zaragoza;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
50 Zaragoza;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;84,71
50 Zaragoza;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
50 Zaragoza;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
50 Zaragoza;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
50 Zaragoza;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;85,46
50 Zaragoza;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
50 Zaragoza;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
50 Zaragoza;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
50 Zaragoza;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;87,73
50 Zaragoza;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
50 Zaragoza;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
50 Zaragoza;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;78,88
50 Zaragoza;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
50 Zaragoza;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
50 Zaragoza;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
50 Zaragoza;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;81,07
50 Zaragoza;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
50 Zaragoza;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
50 Zaragoza;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
50 Zaragoza;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;82,78
50 Zaragoza;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
50 Zaragoza;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
50 Zaragoza;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
50 Zaragoza;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
50 Zaragoza;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
50 Zaragoza;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
50 Zaragoza;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;75,82
50 Zaragoza;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
50 Zaragoza;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
50 Zaragoza;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
50 Zaragoza;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;79,45
50 Zaragoza;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
50 Zaragoza;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
50 Zaragoza;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
50 Zaragoza;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
50 Zaragoza;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
50 Zaragoza;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QIII;3.392
50 Zaragoza;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
50 Zaragoza;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
50 Zaragoza;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
50 Zaragoza;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QIII;3.354
50 Zaragoza;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
50 Zaragoza;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
50 Zaragoza;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
50 Zaragoza;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QIII;3.117
50 Zaragoza;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
50 Zaragoza;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
50 Zaragoza;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
50 Zaragoza;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2022QIII;3.098
50 Zaragoza;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2022QII;""
50 Zaragoza;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2022QI;""
50 Zaragoza;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
50 Zaragoza;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2021QIII;3.037
50 Zaragoza;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2021QII;""
50 Zaragoza;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2021QI;""
50 Zaragoza;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
50 Zaragoza;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2020QIII;2.813
50 Zaragoza;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2020QII;""
50 Zaragoza;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2020QI;""
50 Zaragoza;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2022QIV;2.884
50 Zaragoza;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
50 Zaragoza;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2022QII;""
50 Zaragoza;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2022QI;""
50 Zaragoza;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2021QIV;2.847
50 Zaragoza;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
50 Zaragoza;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2021QII;""
50 Zaragoza;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2021QI;""
50 Zaragoza;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2020QIV;2.632
50 Zaragoza;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
50 Zaragoza;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2020QII;""
50 Zaragoza;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2020QI;""
50 Zaragoza;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
50 Zaragoza;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
50 Zaragoza;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QII;""
50 Zaragoza;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QI;2.648
50 Zaragoza;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
50 Zaragoza;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
50 Zaragoza;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QII;""
50 Zaragoza;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QI;2.504
50 Zaragoza;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
50 Zaragoza;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
50 Zaragoza;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QII;""
50 Zaragoza;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QI;""
50 Zaragoza;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
50 Zaragoza;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
50 Zaragoza;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QII;2.492
50 Zaragoza;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QI;""
50 Zaragoza;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
50 Zaragoza;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
50 Zaragoza;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QII;2.376
50 Zaragoza;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QI;""
50 Zaragoza;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
50 Zaragoza;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
50 Zaragoza;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QII;""
50 Zaragoza;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QI;""
50 Zaragoza;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
50 Zaragoza;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
50 Zaragoza;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
50 Zaragoza;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
50 Zaragoza;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
50 Zaragoza;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
50 Zaragoza;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
50 Zaragoza;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
50 Zaragoza;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
50 Zaragoza;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
50 Zaragoza;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
50 Zaragoza;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
50 Zaragoza;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
50 Zaragoza;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;91,33
50 Zaragoza;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
50 Zaragoza;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
50 Zaragoza;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
50 Zaragoza;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;90,55
50 Zaragoza;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
50 Zaragoza;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
50 Zaragoza;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
50 Zaragoza;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;90,25
50 Zaragoza;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
50 Zaragoza;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
50 Zaragoza;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;85,02
50 Zaragoza;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
50 Zaragoza;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
50 Zaragoza;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
50 Zaragoza;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;84,88
50 Zaragoza;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
50 Zaragoza;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
50 Zaragoza;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
50 Zaragoza;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;84,44
50 Zaragoza;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
50 Zaragoza;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
50 Zaragoza;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
50 Zaragoza;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
50 Zaragoza;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
50 Zaragoza;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
50 Zaragoza;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;78,95
50 Zaragoza;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
50 Zaragoza;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
50 Zaragoza;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
50 Zaragoza;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;80,33
50 Zaragoza;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
50 Zaragoza;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
50 Zaragoza;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
50 Zaragoza;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
50 Zaragoza;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
50 Zaragoza;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
50 Zaragoza;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;74,3
50 Zaragoza;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
50 Zaragoza;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
50 Zaragoza;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
50 Zaragoza;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;76,23
50 Zaragoza;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
50 Zaragoza;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
50 Zaragoza;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
50 Zaragoza;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
50 Zaragoza;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
50 Zaragoza;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
50 Zaragoza;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QIII;2.111
50 Zaragoza;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
50 Zaragoza;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
50 Zaragoza;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
50 Zaragoza;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QIII;2.092
50 Zaragoza;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
50 Zaragoza;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
50 Zaragoza;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
50 Zaragoza;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QIII;1.986
50 Zaragoza;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
50 Zaragoza;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
50 Zaragoza;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
50 Zaragoza;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2022QIII;1.942
50 Zaragoza;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2022QII;""
50 Zaragoza;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2022QI;""
50 Zaragoza;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
50 Zaragoza;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2021QIII;1.895
50 Zaragoza;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2021QII;""
50 Zaragoza;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2021QI;""
50 Zaragoza;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
50 Zaragoza;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2020QIII;1.786
50 Zaragoza;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2020QII;""
50 Zaragoza;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2020QI;""
50 Zaragoza;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2022QIV;1.814
50 Zaragoza;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
50 Zaragoza;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2022QII;""
50 Zaragoza;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2022QI;""
50 Zaragoza;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2021QIV;1.773
50 Zaragoza;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
50 Zaragoza;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2021QII;""
50 Zaragoza;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2021QI;""
50 Zaragoza;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2020QIV;1.666
50 Zaragoza;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
50 Zaragoza;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2020QII;""
50 Zaragoza;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2020QI;""
50 Zaragoza;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
50 Zaragoza;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
50 Zaragoza;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QII;""
50 Zaragoza;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QI;1.650
50 Zaragoza;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
50 Zaragoza;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
50 Zaragoza;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QII;""
50 Zaragoza;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QI;1.580
50 Zaragoza;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
50 Zaragoza;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
50 Zaragoza;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QII;""
50 Zaragoza;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QI;""
50 Zaragoza;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
50 Zaragoza;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
50 Zaragoza;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QII;1.557
50 Zaragoza;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QI;""
50 Zaragoza;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
50 Zaragoza;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
50 Zaragoza;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QII;1.498
50 Zaragoza;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QI;""
50 Zaragoza;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
50 Zaragoza;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
50 Zaragoza;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QII;""
50 Zaragoza;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QI;""
50 Zaragoza;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
50 Zaragoza;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
50 Zaragoza;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
50 Zaragoza;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
50 Zaragoza;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
50 Zaragoza;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
50 Zaragoza;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
50 Zaragoza;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
50 Zaragoza;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
50 Zaragoza;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
50 Zaragoza;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
50 Zaragoza;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
50 Zaragoza;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
50 Zaragoza;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;91,99
50 Zaragoza;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
50 Zaragoza;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
50 Zaragoza;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
50 Zaragoza;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;90,58
50 Zaragoza;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
50 Zaragoza;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
50 Zaragoza;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
50 Zaragoza;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;89,93
50 Zaragoza;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
50 Zaragoza;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
50 Zaragoza;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;85,93
50 Zaragoza;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
50 Zaragoza;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
50 Zaragoza;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
50 Zaragoza;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;84,75
50 Zaragoza;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
50 Zaragoza;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
50 Zaragoza;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
50 Zaragoza;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;83,89
50 Zaragoza;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
50 Zaragoza;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
50 Zaragoza;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
50 Zaragoza;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
50 Zaragoza;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
50 Zaragoza;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
50 Zaragoza;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;78,87
50 Zaragoza;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
50 Zaragoza;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
50 Zaragoza;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
50 Zaragoza;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;79,56
50 Zaragoza;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
50 Zaragoza;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
50 Zaragoza;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
50 Zaragoza;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
50 Zaragoza;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
50 Zaragoza;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
50 Zaragoza;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;74,43
50 Zaragoza;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
50 Zaragoza;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
50 Zaragoza;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
50 Zaragoza;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;75,43
50 Zaragoza;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
50 Zaragoza;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
50 Zaragoza;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
50 Zaragoza;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
50 Zaragoza;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
50 Zaragoza;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
50 Zaragoza;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QIII;1.281
50 Zaragoza;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
50 Zaragoza;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
50 Zaragoza;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
50 Zaragoza;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QIII;1.262
50 Zaragoza;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
50 Zaragoza;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
50 Zaragoza;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
50 Zaragoza;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QIII;1.131
50 Zaragoza;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
50 Zaragoza;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
50 Zaragoza;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
50 Zaragoza;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2022QIII;1.156
50 Zaragoza;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2022QII;""
50 Zaragoza;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2022QI;""
50 Zaragoza;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
50 Zaragoza;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2021QIII;1.142
50 Zaragoza;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2021QII;""
50 Zaragoza;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2021QI;""
50 Zaragoza;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
50 Zaragoza;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2020QIII;1.027
50 Zaragoza;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2020QII;""
50 Zaragoza;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2020QI;""
50 Zaragoza;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2022QIV;1.070
50 Zaragoza;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
50 Zaragoza;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2022QII;""
50 Zaragoza;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2022QI;""
50 Zaragoza;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2021QIV;1.074
50 Zaragoza;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
50 Zaragoza;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2021QII;""
50 Zaragoza;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2021QI;""
50 Zaragoza;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2020QIV;966
50 Zaragoza;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
50 Zaragoza;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2020QII;""
50 Zaragoza;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2020QI;""
50 Zaragoza;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
50 Zaragoza;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
50 Zaragoza;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QII;""
50 Zaragoza;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QI;998
50 Zaragoza;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
50 Zaragoza;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
50 Zaragoza;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QII;""
50 Zaragoza;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QI;924
50 Zaragoza;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
50 Zaragoza;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
50 Zaragoza;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QII;""
50 Zaragoza;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QI;""
50 Zaragoza;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
50 Zaragoza;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
50 Zaragoza;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QII;935
50 Zaragoza;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QI;""
50 Zaragoza;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
50 Zaragoza;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
50 Zaragoza;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QII;878
50 Zaragoza;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QI;""
50 Zaragoza;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
50 Zaragoza;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
50 Zaragoza;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QII;""
50 Zaragoza;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QI;""
50 Zaragoza;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
50 Zaragoza;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
50 Zaragoza;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
50 Zaragoza;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
50 Zaragoza;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
50 Zaragoza;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
50 Zaragoza;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
50 Zaragoza;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
50 Zaragoza;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
50 Zaragoza;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
50 Zaragoza;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
50 Zaragoza;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
50 Zaragoza;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
50 Zaragoza;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;90,24
50 Zaragoza;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
50 Zaragoza;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
50 Zaragoza;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
50 Zaragoza;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;90,49
50 Zaragoza;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
50 Zaragoza;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
50 Zaragoza;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
50 Zaragoza;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;90,8
50 Zaragoza;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
50 Zaragoza;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
50 Zaragoza;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;83,53
50 Zaragoza;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
50 Zaragoza;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
50 Zaragoza;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
50 Zaragoza;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;85,1
50 Zaragoza;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
50 Zaragoza;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
50 Zaragoza;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
50 Zaragoza;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;85,41
50 Zaragoza;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
50 Zaragoza;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
50 Zaragoza;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
50 Zaragoza;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
50 Zaragoza;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
50 Zaragoza;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
50 Zaragoza;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;79,08
50 Zaragoza;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
50 Zaragoza;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
50 Zaragoza;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
50 Zaragoza;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;81,7
50 Zaragoza;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
50 Zaragoza;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
50 Zaragoza;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
50 Zaragoza;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
50 Zaragoza;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
50 Zaragoza;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
50 Zaragoza;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;74,09
50 Zaragoza;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
50 Zaragoza;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
50 Zaragoza;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
50 Zaragoza;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;77,63
50 Zaragoza;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
50 Zaragoza;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
50 Zaragoza;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
50 Zaragoza;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
50 Zaragoza;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
50 Zaragoza;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QIV;3.481
50 Zaragoza;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
50 Zaragoza;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
50 Zaragoza;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
50 Zaragoza;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QIV;3.452
50 Zaragoza;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
50 Zaragoza;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
50 Zaragoza;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
50 Zaragoza;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QIV;3.242
50 Zaragoza;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
50 Zaragoza;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
50 Zaragoza;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
50 Zaragoza;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2022QIV;3.205
50 Zaragoza;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
50 Zaragoza;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2022QII;""
50 Zaragoza;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2022QI;""
50 Zaragoza;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2021QIV;3.199
50 Zaragoza;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
50 Zaragoza;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2021QII;""
50 Zaragoza;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2021QI;""
50 Zaragoza;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2020QIV;3.003
50 Zaragoza;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
50 Zaragoza;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2020QII;""
50 Zaragoza;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2020QI;""
50 Zaragoza;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
50 Zaragoza;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
50 Zaragoza;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2022QII;""
50 Zaragoza;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2022QI;2.967
50 Zaragoza;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
50 Zaragoza;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
50 Zaragoza;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2021QII;""
50 Zaragoza;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2021QI;2.837
50 Zaragoza;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
50 Zaragoza;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
50 Zaragoza;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2020QII;""
50 Zaragoza;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2020QI;""
50 Zaragoza;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
50 Zaragoza;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
50 Zaragoza;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QII;2.786
50 Zaragoza;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QI;""
50 Zaragoza;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
50 Zaragoza;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
50 Zaragoza;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QII;2.671
50 Zaragoza;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QI;""
50 Zaragoza;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
50 Zaragoza;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
50 Zaragoza;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QII;""
50 Zaragoza;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QI;""
50 Zaragoza;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
50 Zaragoza;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QIII;2.617
50 Zaragoza;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QII;""
50 Zaragoza;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QI;""
50 Zaragoza;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
50 Zaragoza;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QIII;2.543
50 Zaragoza;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QII;""
50 Zaragoza;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QI;""
50 Zaragoza;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
50 Zaragoza;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
50 Zaragoza;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QII;""
50 Zaragoza;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QI;""
50 Zaragoza;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
50 Zaragoza;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
50 Zaragoza;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
50 Zaragoza;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
50 Zaragoza;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
50 Zaragoza;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
50 Zaragoza;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
50 Zaragoza;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
50 Zaragoza;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
50 Zaragoza;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
50 Zaragoza;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
50 Zaragoza;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
50 Zaragoza;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;92,07
50 Zaragoza;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
50 Zaragoza;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
50 Zaragoza;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
50 Zaragoza;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;92,67
50 Zaragoza;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
50 Zaragoza;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
50 Zaragoza;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
50 Zaragoza;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;92,63
50 Zaragoza;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
50 Zaragoza;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
50 Zaragoza;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
50 Zaragoza;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
50 Zaragoza;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
50 Zaragoza;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
50 Zaragoza;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;85,95
50 Zaragoza;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
50 Zaragoza;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
50 Zaragoza;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
50 Zaragoza;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;87,51
50 Zaragoza;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
50 Zaragoza;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
50 Zaragoza;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
50 Zaragoza;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
50 Zaragoza;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
50 Zaragoza;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
50 Zaragoza;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;80,71
50 Zaragoza;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
50 Zaragoza;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
50 Zaragoza;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
50 Zaragoza;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;82,39
50 Zaragoza;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
50 Zaragoza;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
50 Zaragoza;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
50 Zaragoza;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
50 Zaragoza;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
50 Zaragoza;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
50 Zaragoza;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;75,81
50 Zaragoza;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
50 Zaragoza;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
50 Zaragoza;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
50 Zaragoza;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;78,44
50 Zaragoza;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
50 Zaragoza;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
50 Zaragoza;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
50 Zaragoza;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
50 Zaragoza;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
50 Zaragoza;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
50 Zaragoza;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QIV;2.156
50 Zaragoza;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
50 Zaragoza;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
50 Zaragoza;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
50 Zaragoza;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QIV;2.131
50 Zaragoza;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
50 Zaragoza;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
50 Zaragoza;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
50 Zaragoza;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QIV;2.087
50 Zaragoza;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
50 Zaragoza;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
50 Zaragoza;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
50 Zaragoza;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2022QIV;1.992
50 Zaragoza;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
50 Zaragoza;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2022QII;""
50 Zaragoza;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2022QI;""
50 Zaragoza;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2021QIV;1.970
50 Zaragoza;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
50 Zaragoza;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2021QII;""
50 Zaragoza;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2021QI;""
50 Zaragoza;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2020QIV;1.924
50 Zaragoza;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
50 Zaragoza;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2020QII;""
50 Zaragoza;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2020QI;""
50 Zaragoza;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
50 Zaragoza;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
50 Zaragoza;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2022QII;""
50 Zaragoza;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2022QI;1.830
50 Zaragoza;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
50 Zaragoza;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
50 Zaragoza;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2021QII;""
50 Zaragoza;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2021QI;1.807
50 Zaragoza;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
50 Zaragoza;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
50 Zaragoza;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2020QII;""
50 Zaragoza;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2020QI;""
50 Zaragoza;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
50 Zaragoza;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
50 Zaragoza;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QII;1.721
50 Zaragoza;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QI;""
50 Zaragoza;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
50 Zaragoza;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
50 Zaragoza;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QII;1.698
50 Zaragoza;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QI;""
50 Zaragoza;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
50 Zaragoza;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
50 Zaragoza;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QII;""
50 Zaragoza;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QI;""
50 Zaragoza;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
50 Zaragoza;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QIII;1.618
50 Zaragoza;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QII;""
50 Zaragoza;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QI;""
50 Zaragoza;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
50 Zaragoza;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QIII;1.624
50 Zaragoza;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QII;""
50 Zaragoza;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QI;""
50 Zaragoza;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
50 Zaragoza;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
50 Zaragoza;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QII;""
50 Zaragoza;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QI;""
50 Zaragoza;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
50 Zaragoza;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
50 Zaragoza;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
50 Zaragoza;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
50 Zaragoza;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
50 Zaragoza;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
50 Zaragoza;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
50 Zaragoza;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
50 Zaragoza;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
50 Zaragoza;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
50 Zaragoza;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
50 Zaragoza;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
50 Zaragoza;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;92,39
50 Zaragoza;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
50 Zaragoza;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
50 Zaragoza;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
50 Zaragoza;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;92,44
50 Zaragoza;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
50 Zaragoza;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
50 Zaragoza;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
50 Zaragoza;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;92,19
50 Zaragoza;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
50 Zaragoza;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
50 Zaragoza;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
50 Zaragoza;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
50 Zaragoza;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
50 Zaragoza;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
50 Zaragoza;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;85,88
50 Zaragoza;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
50 Zaragoza;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
50 Zaragoza;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
50 Zaragoza;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;86,58
50 Zaragoza;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
50 Zaragoza;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
50 Zaragoza;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
50 Zaragoza;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
50 Zaragoza;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
50 Zaragoza;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
50 Zaragoza;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;80,76
50 Zaragoza;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
50 Zaragoza;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
50 Zaragoza;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
50 Zaragoza;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;81,36
50 Zaragoza;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
50 Zaragoza;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
50 Zaragoza;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
50 Zaragoza;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
50 Zaragoza;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
50 Zaragoza;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
50 Zaragoza;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;75,93
50 Zaragoza;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
50 Zaragoza;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
50 Zaragoza;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
50 Zaragoza;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;77,82
50 Zaragoza;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
50 Zaragoza;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
50 Zaragoza;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
50 Zaragoza;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
50 Zaragoza;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
50 Zaragoza;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
50 Zaragoza;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QIV;1.325
50 Zaragoza;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
50 Zaragoza;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
50 Zaragoza;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
50 Zaragoza;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QIV;1.321
50 Zaragoza;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
50 Zaragoza;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
50 Zaragoza;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
50 Zaragoza;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QIV;1.155
50 Zaragoza;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
50 Zaragoza;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
50 Zaragoza;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
50 Zaragoza;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2022QIV;1.213
50 Zaragoza;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
50 Zaragoza;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2022QII;""
50 Zaragoza;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2022QI;""
50 Zaragoza;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2021QIV;1.229
50 Zaragoza;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
50 Zaragoza;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2021QII;""
50 Zaragoza;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2021QI;""
50 Zaragoza;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2020QIV;1.079
50 Zaragoza;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
50 Zaragoza;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2020QII;""
50 Zaragoza;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2020QI;""
50 Zaragoza;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
50 Zaragoza;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
50 Zaragoza;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2022QII;""
50 Zaragoza;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2022QI;1.137
50 Zaragoza;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
50 Zaragoza;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
50 Zaragoza;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2021QII;""
50 Zaragoza;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2021QI;1.030
50 Zaragoza;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
50 Zaragoza;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
50 Zaragoza;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2020QII;""
50 Zaragoza;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2020QI;""
50 Zaragoza;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
50 Zaragoza;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
50 Zaragoza;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QII;1.065
50 Zaragoza;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QI;""
50 Zaragoza;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
50 Zaragoza;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
50 Zaragoza;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QII;973
50 Zaragoza;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QI;""
50 Zaragoza;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
50 Zaragoza;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
50 Zaragoza;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QII;""
50 Zaragoza;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QI;""
50 Zaragoza;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
50 Zaragoza;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QIII;999
50 Zaragoza;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QII;""
50 Zaragoza;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QI;""
50 Zaragoza;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
50 Zaragoza;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QIII;919
50 Zaragoza;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QII;""
50 Zaragoza;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QI;""
50 Zaragoza;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
50 Zaragoza;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
50 Zaragoza;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QII;""
50 Zaragoza;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QI;""
50 Zaragoza;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
50 Zaragoza;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
50 Zaragoza;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
50 Zaragoza;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
50 Zaragoza;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
50 Zaragoza;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
50 Zaragoza;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
50 Zaragoza;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
50 Zaragoza;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
50 Zaragoza;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
50 Zaragoza;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
50 Zaragoza;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
50 Zaragoza;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;91,55
50 Zaragoza;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
50 Zaragoza;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
50 Zaragoza;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
50 Zaragoza;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;93,04
50 Zaragoza;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
50 Zaragoza;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
50 Zaragoza;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
50 Zaragoza;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;93,42
50 Zaragoza;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
50 Zaragoza;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
50 Zaragoza;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
50 Zaragoza;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
50 Zaragoza;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
50 Zaragoza;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
50 Zaragoza;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;86,07
50 Zaragoza;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
50 Zaragoza;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
50 Zaragoza;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
50 Zaragoza;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;89,18
50 Zaragoza;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
50 Zaragoza;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
50 Zaragoza;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
50 Zaragoza;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
50 Zaragoza;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
50 Zaragoza;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
50 Zaragoza;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;80,62
50 Zaragoza;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
50 Zaragoza;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
50 Zaragoza;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
50 Zaragoza;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;84,24
50 Zaragoza;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
50 Zaragoza;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
50 Zaragoza;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
50 Zaragoza;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
50 Zaragoza;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
50 Zaragoza;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
50 Zaragoza;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;75,62
50 Zaragoza;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
50 Zaragoza;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
50 Zaragoza;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
50 Zaragoza;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;79,57
50 Zaragoza;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
50 Zaragoza;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
50 Zaragoza;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
50 Zaragoza;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
50 Zaragoza;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
50 Zaragoza;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
50 Zaragoza;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
50 Zaragoza;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
50 Zaragoza;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
50 Zaragoza;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QI;9.474
50 Zaragoza;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
50 Zaragoza;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
50 Zaragoza;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
50 Zaragoza;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QI;9.722
50 Zaragoza;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
50 Zaragoza;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
50 Zaragoza;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
50 Zaragoza;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QI;9.590
50 Zaragoza;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
50 Zaragoza;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
50 Zaragoza;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2022QII;""
50 Zaragoza;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2022QI;9.089
50 Zaragoza;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
50 Zaragoza;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
50 Zaragoza;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2021QII;""
50 Zaragoza;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2021QI;9.379
50 Zaragoza;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
50 Zaragoza;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
50 Zaragoza;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2020QII;""
50 Zaragoza;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2020QI;8.777
50 Zaragoza;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
50 Zaragoza;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
50 Zaragoza;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2022QII;8.771
50 Zaragoza;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2022QI;""
50 Zaragoza;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
50 Zaragoza;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
50 Zaragoza;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2021QII;9.057
50 Zaragoza;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2021QI;""
50 Zaragoza;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
50 Zaragoza;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
50 Zaragoza;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2020QII;8.562
50 Zaragoza;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2020QI;""
50 Zaragoza;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
50 Zaragoza;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QIII;8.513
50 Zaragoza;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QII;""
50 Zaragoza;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QI;""
50 Zaragoza;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
50 Zaragoza;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QIII;8.804
50 Zaragoza;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QII;""
50 Zaragoza;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QI;""
50 Zaragoza;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
50 Zaragoza;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QIII;8.262
50 Zaragoza;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QII;""
50 Zaragoza;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QI;""
50 Zaragoza;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QIV;8.221
50 Zaragoza;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
50 Zaragoza;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QII;""
50 Zaragoza;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QI;""
50 Zaragoza;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QIV;8.555
50 Zaragoza;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
50 Zaragoza;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QII;""
50 Zaragoza;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QI;""
50 Zaragoza;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QIV;7.971
50 Zaragoza;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
50 Zaragoza;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QII;""
50 Zaragoza;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QI;""
50 Zaragoza;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
50 Zaragoza;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
50 Zaragoza;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
50 Zaragoza;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
50 Zaragoza;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
50 Zaragoza;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
50 Zaragoza;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
50 Zaragoza;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
50 Zaragoza;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
50 Zaragoza;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
50 Zaragoza;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
50 Zaragoza;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
50 Zaragoza;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
50 Zaragoza;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
50 Zaragoza;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
50 Zaragoza;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;95,94
50 Zaragoza;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
50 Zaragoza;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
50 Zaragoza;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
50 Zaragoza;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;96,47
50 Zaragoza;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
50 Zaragoza;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
50 Zaragoza;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
50 Zaragoza;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;91,52
50 Zaragoza;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
50 Zaragoza;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
50 Zaragoza;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;92,58
50 Zaragoza;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
50 Zaragoza;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
50 Zaragoza;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
50 Zaragoza;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;93,16
50 Zaragoza;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
50 Zaragoza;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
50 Zaragoza;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
50 Zaragoza;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;89,28
50 Zaragoza;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
50 Zaragoza;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
50 Zaragoza;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;89,86
50 Zaragoza;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
50 Zaragoza;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
50 Zaragoza;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
50 Zaragoza;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;90,56
50 Zaragoza;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
50 Zaragoza;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
50 Zaragoza;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
50 Zaragoza;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;86,15
50 Zaragoza;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
50 Zaragoza;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
50 Zaragoza;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;86,77
50 Zaragoza;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
50 Zaragoza;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
50 Zaragoza;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
50 Zaragoza;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;88
50 Zaragoza;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
50 Zaragoza;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
50 Zaragoza;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
50 Zaragoza;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;83,12
50 Zaragoza;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
50 Zaragoza;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
50 Zaragoza;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
50 Zaragoza;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
50 Zaragoza;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
50 Zaragoza;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
50 Zaragoza;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QI;5.602
50 Zaragoza;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
50 Zaragoza;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
50 Zaragoza;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
50 Zaragoza;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QI;5.830
50 Zaragoza;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
50 Zaragoza;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
50 Zaragoza;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
50 Zaragoza;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QI;5.711
50 Zaragoza;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
50 Zaragoza;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
50 Zaragoza;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2022QII;""
50 Zaragoza;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2022QI;5.388
50 Zaragoza;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
50 Zaragoza;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
50 Zaragoza;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2021QII;""
50 Zaragoza;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2021QI;5.624
50 Zaragoza;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
50 Zaragoza;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
50 Zaragoza;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2020QII;""
50 Zaragoza;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2020QI;5.263
50 Zaragoza;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
50 Zaragoza;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
50 Zaragoza;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2022QII;5.217
50 Zaragoza;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2022QI;""
50 Zaragoza;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
50 Zaragoza;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
50 Zaragoza;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2021QII;5.424
50 Zaragoza;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2021QI;""
50 Zaragoza;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
50 Zaragoza;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
50 Zaragoza;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2020QII;5.154
50 Zaragoza;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2020QI;""
50 Zaragoza;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
50 Zaragoza;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QIII;5.082
50 Zaragoza;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QII;""
50 Zaragoza;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QI;""
50 Zaragoza;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
50 Zaragoza;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QIII;5.274
50 Zaragoza;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QII;""
50 Zaragoza;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QI;""
50 Zaragoza;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
50 Zaragoza;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QIII;4.998
50 Zaragoza;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QII;""
50 Zaragoza;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QI;""
50 Zaragoza;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QIV;4.911
50 Zaragoza;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
50 Zaragoza;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QII;""
50 Zaragoza;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QI;""
50 Zaragoza;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QIV;5.132
50 Zaragoza;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
50 Zaragoza;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QII;""
50 Zaragoza;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QI;""
50 Zaragoza;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QIV;4.832
50 Zaragoza;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
50 Zaragoza;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QII;""
50 Zaragoza;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QI;""
50 Zaragoza;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
50 Zaragoza;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
50 Zaragoza;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
50 Zaragoza;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
50 Zaragoza;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
50 Zaragoza;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
50 Zaragoza;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
50 Zaragoza;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
50 Zaragoza;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
50 Zaragoza;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
50 Zaragoza;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
50 Zaragoza;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
50 Zaragoza;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
50 Zaragoza;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
50 Zaragoza;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
50 Zaragoza;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;96,18
50 Zaragoza;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
50 Zaragoza;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
50 Zaragoza;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
50 Zaragoza;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;96,47
50 Zaragoza;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
50 Zaragoza;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
50 Zaragoza;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
50 Zaragoza;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;92,16
50 Zaragoza;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
50 Zaragoza;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
50 Zaragoza;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;93,13
50 Zaragoza;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
50 Zaragoza;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
50 Zaragoza;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
50 Zaragoza;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;93,04
50 Zaragoza;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
50 Zaragoza;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
50 Zaragoza;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
50 Zaragoza;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;90,25
50 Zaragoza;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
50 Zaragoza;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
50 Zaragoza;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;90,72
50 Zaragoza;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
50 Zaragoza;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
50 Zaragoza;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
50 Zaragoza;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;90,46
50 Zaragoza;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
50 Zaragoza;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
50 Zaragoza;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
50 Zaragoza;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;87,52
50 Zaragoza;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
50 Zaragoza;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
50 Zaragoza;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;87,67
50 Zaragoza;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
50 Zaragoza;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
50 Zaragoza;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
50 Zaragoza;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;88,03
50 Zaragoza;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
50 Zaragoza;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
50 Zaragoza;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
50 Zaragoza;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;84,61
50 Zaragoza;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
50 Zaragoza;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
50 Zaragoza;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
50 Zaragoza;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
50 Zaragoza;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
50 Zaragoza;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
50 Zaragoza;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QI;3.872
50 Zaragoza;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
50 Zaragoza;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
50 Zaragoza;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
50 Zaragoza;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QI;3.892
50 Zaragoza;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
50 Zaragoza;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
50 Zaragoza;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
50 Zaragoza;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QI;3.879
50 Zaragoza;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
50 Zaragoza;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
50 Zaragoza;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2022QII;""
50 Zaragoza;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2022QI;3.701
50 Zaragoza;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
50 Zaragoza;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
50 Zaragoza;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2021QII;""
50 Zaragoza;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2021QI;3.755
50 Zaragoza;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
50 Zaragoza;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
50 Zaragoza;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2020QII;""
50 Zaragoza;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2020QI;3.514
50 Zaragoza;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
50 Zaragoza;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
50 Zaragoza;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2022QII;3.554
50 Zaragoza;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2022QI;""
50 Zaragoza;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
50 Zaragoza;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
50 Zaragoza;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2021QII;3.633
50 Zaragoza;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2021QI;""
50 Zaragoza;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
50 Zaragoza;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
50 Zaragoza;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2020QII;3.408
50 Zaragoza;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2020QI;""
50 Zaragoza;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
50 Zaragoza;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QIII;3.431
50 Zaragoza;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QII;""
50 Zaragoza;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QI;""
50 Zaragoza;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
50 Zaragoza;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QIII;3.530
50 Zaragoza;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QII;""
50 Zaragoza;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QI;""
50 Zaragoza;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
50 Zaragoza;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QIII;3.264
50 Zaragoza;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QII;""
50 Zaragoza;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QI;""
50 Zaragoza;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QIV;3.310
50 Zaragoza;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
50 Zaragoza;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QII;""
50 Zaragoza;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QI;""
50 Zaragoza;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QIV;3.423
50 Zaragoza;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
50 Zaragoza;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QII;""
50 Zaragoza;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QI;""
50 Zaragoza;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QIV;3.139
50 Zaragoza;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
50 Zaragoza;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QII;""
50 Zaragoza;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QI;""
50 Zaragoza;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
50 Zaragoza;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
50 Zaragoza;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
50 Zaragoza;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
50 Zaragoza;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
50 Zaragoza;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
50 Zaragoza;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
50 Zaragoza;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
50 Zaragoza;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
50 Zaragoza;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
50 Zaragoza;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
50 Zaragoza;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
50 Zaragoza;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
50 Zaragoza;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
50 Zaragoza;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
50 Zaragoza;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;95,58
50 Zaragoza;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
50 Zaragoza;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
50 Zaragoza;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
50 Zaragoza;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;96,48
50 Zaragoza;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
50 Zaragoza;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
50 Zaragoza;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
50 Zaragoza;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;90,59
50 Zaragoza;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
50 Zaragoza;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
50 Zaragoza;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;91,79
50 Zaragoza;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
50 Zaragoza;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
50 Zaragoza;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
50 Zaragoza;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;93,35
50 Zaragoza;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
50 Zaragoza;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
50 Zaragoza;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
50 Zaragoza;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;87,86
50 Zaragoza;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
50 Zaragoza;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
50 Zaragoza;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;88,61
50 Zaragoza;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
50 Zaragoza;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
50 Zaragoza;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
50 Zaragoza;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;90,7
50 Zaragoza;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
50 Zaragoza;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
50 Zaragoza;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
50 Zaragoza;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;84,15
50 Zaragoza;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
50 Zaragoza;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
50 Zaragoza;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;85,49
50 Zaragoza;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
50 Zaragoza;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
50 Zaragoza;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
50 Zaragoza;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;87,95
50 Zaragoza;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
50 Zaragoza;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
50 Zaragoza;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
50 Zaragoza;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;80,92
50 Zaragoza;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
50 Zaragoza;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
50 Zaragoza;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
50 Zaragoza;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
50 Zaragoza;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
50 Zaragoza;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QII;8.845
50 Zaragoza;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
50 Zaragoza;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
50 Zaragoza;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
50 Zaragoza;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QII;9.122
50 Zaragoza;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
50 Zaragoza;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
50 Zaragoza;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
50 Zaragoza;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QII;9.320
50 Zaragoza;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
50 Zaragoza;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
50 Zaragoza;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
50 Zaragoza;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2022QII;8.495
50 Zaragoza;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2022QI;""
50 Zaragoza;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
50 Zaragoza;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
50 Zaragoza;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2021QII;8.773
50 Zaragoza;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2021QI;""
50 Zaragoza;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
50 Zaragoza;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
50 Zaragoza;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2020QII;9.064
50 Zaragoza;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2020QI;""
50 Zaragoza;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
50 Zaragoza;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2022QIII;8.200
50 Zaragoza;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2022QII;""
50 Zaragoza;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2022QI;""
50 Zaragoza;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
50 Zaragoza;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2021QIII;8.492
50 Zaragoza;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2021QII;""
50 Zaragoza;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2021QI;""
50 Zaragoza;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
50 Zaragoza;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2020QIII;8.727
50 Zaragoza;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2020QII;""
50 Zaragoza;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2020QI;""
50 Zaragoza;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QIV;7.905
50 Zaragoza;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
50 Zaragoza;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QII;""
50 Zaragoza;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QI;""
50 Zaragoza;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QIV;8.198
50 Zaragoza;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
50 Zaragoza;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QII;""
50 Zaragoza;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QI;""
50 Zaragoza;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QIV;8.401
50 Zaragoza;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
50 Zaragoza;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QII;""
50 Zaragoza;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QI;""
50 Zaragoza;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
50 Zaragoza;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
50 Zaragoza;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QII;""
50 Zaragoza;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QI;7.922
50 Zaragoza;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
50 Zaragoza;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
50 Zaragoza;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QII;""
50 Zaragoza;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QI;8.178
50 Zaragoza;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
50 Zaragoza;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
50 Zaragoza;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QII;""
50 Zaragoza;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QI;""
50 Zaragoza;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
50 Zaragoza;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
50 Zaragoza;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
50 Zaragoza;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
50 Zaragoza;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
50 Zaragoza;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
50 Zaragoza;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
50 Zaragoza;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
50 Zaragoza;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
50 Zaragoza;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
50 Zaragoza;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
50 Zaragoza;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
50 Zaragoza;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
50 Zaragoza;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
50 Zaragoza;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;96,04
50 Zaragoza;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
50 Zaragoza;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
50 Zaragoza;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
50 Zaragoza;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;96,17
50 Zaragoza;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
50 Zaragoza;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
50 Zaragoza;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
50 Zaragoza;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;97,25
50 Zaragoza;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
50 Zaragoza;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
50 Zaragoza;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;92,71
50 Zaragoza;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
50 Zaragoza;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
50 Zaragoza;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
50 Zaragoza;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;93,09
50 Zaragoza;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
50 Zaragoza;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
50 Zaragoza;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
50 Zaragoza;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;93,64
50 Zaragoza;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
50 Zaragoza;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
50 Zaragoza;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;89,37
50 Zaragoza;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
50 Zaragoza;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
50 Zaragoza;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
50 Zaragoza;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;89,87
50 Zaragoza;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
50 Zaragoza;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
50 Zaragoza;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
50 Zaragoza;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;90,14
50 Zaragoza;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
50 Zaragoza;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
50 Zaragoza;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
50 Zaragoza;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
50 Zaragoza;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
50 Zaragoza;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
50 Zaragoza;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;86,84
50 Zaragoza;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
50 Zaragoza;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
50 Zaragoza;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
50 Zaragoza;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;87,75
50 Zaragoza;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
50 Zaragoza;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
50 Zaragoza;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
50 Zaragoza;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
50 Zaragoza;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
50 Zaragoza;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
50 Zaragoza;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QII;5.230
50 Zaragoza;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
50 Zaragoza;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
50 Zaragoza;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
50 Zaragoza;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QII;5.425
50 Zaragoza;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
50 Zaragoza;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
50 Zaragoza;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
50 Zaragoza;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QII;5.567
50 Zaragoza;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
50 Zaragoza;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
50 Zaragoza;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
50 Zaragoza;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2022QII;5.040
50 Zaragoza;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2022QI;""
50 Zaragoza;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
50 Zaragoza;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
50 Zaragoza;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2021QII;5.215
50 Zaragoza;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2021QI;""
50 Zaragoza;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
50 Zaragoza;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
50 Zaragoza;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2020QII;5.442
50 Zaragoza;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2020QI;""
50 Zaragoza;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
50 Zaragoza;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2022QIII;4.885
50 Zaragoza;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2022QII;""
50 Zaragoza;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2022QI;""
50 Zaragoza;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
50 Zaragoza;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2021QIII;5.047
50 Zaragoza;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2021QII;""
50 Zaragoza;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2021QI;""
50 Zaragoza;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
50 Zaragoza;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2020QIII;5.269
50 Zaragoza;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2020QII;""
50 Zaragoza;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2020QI;""
50 Zaragoza;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QIV;4.715
50 Zaragoza;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
50 Zaragoza;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QII;""
50 Zaragoza;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QI;""
50 Zaragoza;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QIV;4.878
50 Zaragoza;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
50 Zaragoza;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QII;""
50 Zaragoza;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QI;""
50 Zaragoza;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QIV;5.079
50 Zaragoza;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
50 Zaragoza;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QII;""
50 Zaragoza;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QI;""
50 Zaragoza;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
50 Zaragoza;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
50 Zaragoza;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QII;""
50 Zaragoza;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QI;4.726
50 Zaragoza;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
50 Zaragoza;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
50 Zaragoza;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QII;""
50 Zaragoza;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QI;4.949
50 Zaragoza;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
50 Zaragoza;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
50 Zaragoza;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QII;""
50 Zaragoza;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QI;""
50 Zaragoza;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
50 Zaragoza;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
50 Zaragoza;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
50 Zaragoza;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
50 Zaragoza;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
50 Zaragoza;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
50 Zaragoza;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
50 Zaragoza;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
50 Zaragoza;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
50 Zaragoza;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
50 Zaragoza;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
50 Zaragoza;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
50 Zaragoza;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
50 Zaragoza;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
50 Zaragoza;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;96,37
50 Zaragoza;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
50 Zaragoza;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
50 Zaragoza;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
50 Zaragoza;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;96,13
50 Zaragoza;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
50 Zaragoza;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
50 Zaragoza;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
50 Zaragoza;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;97,75
50 Zaragoza;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
50 Zaragoza;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
50 Zaragoza;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;93,4
50 Zaragoza;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
50 Zaragoza;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
50 Zaragoza;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
50 Zaragoza;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;93,03
50 Zaragoza;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
50 Zaragoza;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
50 Zaragoza;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
50 Zaragoza;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;94,65
50 Zaragoza;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
50 Zaragoza;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
50 Zaragoza;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;90,15
50 Zaragoza;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
50 Zaragoza;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
50 Zaragoza;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
50 Zaragoza;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;89,92
50 Zaragoza;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
50 Zaragoza;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
50 Zaragoza;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
50 Zaragoza;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;91,23
50 Zaragoza;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
50 Zaragoza;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
50 Zaragoza;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
50 Zaragoza;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
50 Zaragoza;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
50 Zaragoza;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
50 Zaragoza;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;87,12
50 Zaragoza;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
50 Zaragoza;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
50 Zaragoza;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
50 Zaragoza;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;88,9
50 Zaragoza;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
50 Zaragoza;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
50 Zaragoza;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
50 Zaragoza;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
50 Zaragoza;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
50 Zaragoza;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
50 Zaragoza;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QII;3.615
50 Zaragoza;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
50 Zaragoza;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
50 Zaragoza;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
50 Zaragoza;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QII;3.697
50 Zaragoza;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
50 Zaragoza;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
50 Zaragoza;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
50 Zaragoza;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QII;3.753
50 Zaragoza;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
50 Zaragoza;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
50 Zaragoza;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
50 Zaragoza;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2022QII;3.455
50 Zaragoza;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2022QI;""
50 Zaragoza;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
50 Zaragoza;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
50 Zaragoza;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2021QII;3.558
50 Zaragoza;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2021QI;""
50 Zaragoza;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
50 Zaragoza;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
50 Zaragoza;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2020QII;3.622
50 Zaragoza;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2020QI;""
50 Zaragoza;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
50 Zaragoza;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2022QIII;3.315
50 Zaragoza;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2022QII;""
50 Zaragoza;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2022QI;""
50 Zaragoza;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
50 Zaragoza;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2021QIII;3.445
50 Zaragoza;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2021QII;""
50 Zaragoza;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2021QI;""
50 Zaragoza;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
50 Zaragoza;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2020QIII;3.458
50 Zaragoza;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2020QII;""
50 Zaragoza;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2020QI;""
50 Zaragoza;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QIV;3.190
50 Zaragoza;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
50 Zaragoza;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QII;""
50 Zaragoza;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QI;""
50 Zaragoza;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QIV;3.320
50 Zaragoza;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
50 Zaragoza;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QII;""
50 Zaragoza;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QI;""
50 Zaragoza;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QIV;3.322
50 Zaragoza;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
50 Zaragoza;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QII;""
50 Zaragoza;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QI;""
50 Zaragoza;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
50 Zaragoza;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
50 Zaragoza;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QII;""
50 Zaragoza;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QI;3.196
50 Zaragoza;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
50 Zaragoza;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
50 Zaragoza;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QII;""
50 Zaragoza;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QI;3.229
50 Zaragoza;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
50 Zaragoza;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
50 Zaragoza;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QII;""
50 Zaragoza;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QI;""
50 Zaragoza;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
50 Zaragoza;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
50 Zaragoza;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
50 Zaragoza;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
50 Zaragoza;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
50 Zaragoza;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
50 Zaragoza;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
50 Zaragoza;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
50 Zaragoza;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
50 Zaragoza;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
50 Zaragoza;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
50 Zaragoza;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
50 Zaragoza;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
50 Zaragoza;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
50 Zaragoza;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;95,57
50 Zaragoza;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
50 Zaragoza;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
50 Zaragoza;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
50 Zaragoza;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;96,24
50 Zaragoza;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
50 Zaragoza;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
50 Zaragoza;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
50 Zaragoza;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;96,51
50 Zaragoza;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
50 Zaragoza;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
50 Zaragoza;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;91,7
50 Zaragoza;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
50 Zaragoza;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
50 Zaragoza;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
50 Zaragoza;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;93,18
50 Zaragoza;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
50 Zaragoza;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
50 Zaragoza;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
50 Zaragoza;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;92,14
50 Zaragoza;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
50 Zaragoza;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
50 Zaragoza;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;88,24
50 Zaragoza;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
50 Zaragoza;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
50 Zaragoza;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
50 Zaragoza;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;89,8
50 Zaragoza;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
50 Zaragoza;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
50 Zaragoza;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
50 Zaragoza;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;88,52
50 Zaragoza;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
50 Zaragoza;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
50 Zaragoza;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
50 Zaragoza;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
50 Zaragoza;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
50 Zaragoza;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
50 Zaragoza;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;86,45
50 Zaragoza;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
50 Zaragoza;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
50 Zaragoza;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
50 Zaragoza;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;86,04
50 Zaragoza;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
50 Zaragoza;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
50 Zaragoza;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
50 Zaragoza;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
50 Zaragoza;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
50 Zaragoza;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QIII;8.969
50 Zaragoza;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
50 Zaragoza;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
50 Zaragoza;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
50 Zaragoza;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QIII;9.284
50 Zaragoza;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
50 Zaragoza;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
50 Zaragoza;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
50 Zaragoza;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QIII;9.574
50 Zaragoza;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
50 Zaragoza;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
50 Zaragoza;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
50 Zaragoza;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2022QIII;8.618
50 Zaragoza;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2022QII;""
50 Zaragoza;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2022QI;""
50 Zaragoza;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
50 Zaragoza;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2021QIII;8.917
50 Zaragoza;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2021QII;""
50 Zaragoza;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2021QI;""
50 Zaragoza;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
50 Zaragoza;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2020QIII;9.186
50 Zaragoza;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2020QII;""
50 Zaragoza;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2020QI;""
50 Zaragoza;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2022QIV;8.275
50 Zaragoza;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
50 Zaragoza;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2022QII;""
50 Zaragoza;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2022QI;""
50 Zaragoza;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2021QIV;8.577
50 Zaragoza;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
50 Zaragoza;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2021QII;""
50 Zaragoza;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2021QI;""
50 Zaragoza;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2020QIV;8.822
50 Zaragoza;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
50 Zaragoza;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2020QII;""
50 Zaragoza;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2020QI;""
50 Zaragoza;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
50 Zaragoza;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
50 Zaragoza;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QII;""
50 Zaragoza;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QI;8.272
50 Zaragoza;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
50 Zaragoza;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
50 Zaragoza;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QII;""
50 Zaragoza;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QI;8.568
50 Zaragoza;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
50 Zaragoza;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
50 Zaragoza;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QII;""
50 Zaragoza;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QI;""
50 Zaragoza;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
50 Zaragoza;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
50 Zaragoza;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QII;8.024
50 Zaragoza;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QI;""
50 Zaragoza;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
50 Zaragoza;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
50 Zaragoza;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QII;8.327
50 Zaragoza;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QI;""
50 Zaragoza;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
50 Zaragoza;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
50 Zaragoza;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QII;""
50 Zaragoza;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QI;""
50 Zaragoza;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
50 Zaragoza;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
50 Zaragoza;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
50 Zaragoza;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
50 Zaragoza;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
50 Zaragoza;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
50 Zaragoza;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
50 Zaragoza;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
50 Zaragoza;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
50 Zaragoza;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
50 Zaragoza;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
50 Zaragoza;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
50 Zaragoza;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
50 Zaragoza;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;96,09
50 Zaragoza;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
50 Zaragoza;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
50 Zaragoza;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
50 Zaragoza;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;96,05
50 Zaragoza;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
50 Zaragoza;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
50 Zaragoza;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
50 Zaragoza;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;95,95
50 Zaragoza;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
50 Zaragoza;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
50 Zaragoza;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;92,26
50 Zaragoza;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
50 Zaragoza;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
50 Zaragoza;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
50 Zaragoza;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;92,38
50 Zaragoza;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
50 Zaragoza;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
50 Zaragoza;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
50 Zaragoza;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;92,15
50 Zaragoza;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
50 Zaragoza;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
50 Zaragoza;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
50 Zaragoza;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
50 Zaragoza;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
50 Zaragoza;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
50 Zaragoza;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;89,1
50 Zaragoza;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
50 Zaragoza;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
50 Zaragoza;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
50 Zaragoza;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;89,49
50 Zaragoza;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
50 Zaragoza;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
50 Zaragoza;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
50 Zaragoza;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
50 Zaragoza;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
50 Zaragoza;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
50 Zaragoza;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;86,43
50 Zaragoza;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
50 Zaragoza;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
50 Zaragoza;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
50 Zaragoza;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;86,98
50 Zaragoza;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
50 Zaragoza;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
50 Zaragoza;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
50 Zaragoza;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
50 Zaragoza;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
50 Zaragoza;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
50 Zaragoza;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QIII;5.309
50 Zaragoza;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
50 Zaragoza;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
50 Zaragoza;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
50 Zaragoza;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QIII;5.526
50 Zaragoza;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
50 Zaragoza;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
50 Zaragoza;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
50 Zaragoza;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QIII;5.741
50 Zaragoza;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
50 Zaragoza;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
50 Zaragoza;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
50 Zaragoza;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2022QIII;5.127
50 Zaragoza;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2022QII;""
50 Zaragoza;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2022QI;""
50 Zaragoza;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
50 Zaragoza;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2021QIII;5.307
50 Zaragoza;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2021QII;""
50 Zaragoza;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2021QI;""
50 Zaragoza;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
50 Zaragoza;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2020QIII;5.537
50 Zaragoza;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2020QII;""
50 Zaragoza;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2020QI;""
50 Zaragoza;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2022QIV;4.931
50 Zaragoza;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
50 Zaragoza;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2022QII;""
50 Zaragoza;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2022QI;""
50 Zaragoza;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2021QIV;5.113
50 Zaragoza;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
50 Zaragoza;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2021QII;""
50 Zaragoza;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2021QI;""
50 Zaragoza;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2020QIV;5.321
50 Zaragoza;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
50 Zaragoza;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2020QII;""
50 Zaragoza;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2020QI;""
50 Zaragoza;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
50 Zaragoza;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
50 Zaragoza;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QII;""
50 Zaragoza;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QI;4.943
50 Zaragoza;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
50 Zaragoza;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
50 Zaragoza;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QII;""
50 Zaragoza;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QI;5.175
50 Zaragoza;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
50 Zaragoza;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
50 Zaragoza;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QII;""
50 Zaragoza;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QI;""
50 Zaragoza;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
50 Zaragoza;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
50 Zaragoza;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QII;4.805
50 Zaragoza;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QI;""
50 Zaragoza;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
50 Zaragoza;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
50 Zaragoza;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QII;5.028
50 Zaragoza;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QI;""
50 Zaragoza;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
50 Zaragoza;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
50 Zaragoza;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QII;""
50 Zaragoza;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QI;""
50 Zaragoza;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
50 Zaragoza;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
50 Zaragoza;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
50 Zaragoza;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
50 Zaragoza;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
50 Zaragoza;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
50 Zaragoza;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
50 Zaragoza;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
50 Zaragoza;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
50 Zaragoza;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
50 Zaragoza;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
50 Zaragoza;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
50 Zaragoza;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
50 Zaragoza;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;96,57
50 Zaragoza;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
50 Zaragoza;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
50 Zaragoza;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
50 Zaragoza;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;96,04
50 Zaragoza;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
50 Zaragoza;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
50 Zaragoza;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
50 Zaragoza;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;96,45
50 Zaragoza;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
50 Zaragoza;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
50 Zaragoza;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;92,88
50 Zaragoza;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
50 Zaragoza;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
50 Zaragoza;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
50 Zaragoza;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;92,53
50 Zaragoza;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
50 Zaragoza;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
50 Zaragoza;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
50 Zaragoza;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;92,68
50 Zaragoza;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
50 Zaragoza;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
50 Zaragoza;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
50 Zaragoza;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
50 Zaragoza;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
50 Zaragoza;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
50 Zaragoza;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;89,45
50 Zaragoza;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
50 Zaragoza;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
50 Zaragoza;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
50 Zaragoza;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;90,14
50 Zaragoza;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
50 Zaragoza;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
50 Zaragoza;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
50 Zaragoza;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
50 Zaragoza;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
50 Zaragoza;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
50 Zaragoza;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;86,95
50 Zaragoza;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
50 Zaragoza;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
50 Zaragoza;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
50 Zaragoza;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;87,58
50 Zaragoza;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
50 Zaragoza;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
50 Zaragoza;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
50 Zaragoza;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
50 Zaragoza;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
50 Zaragoza;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
50 Zaragoza;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QIII;3.660
50 Zaragoza;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
50 Zaragoza;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
50 Zaragoza;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
50 Zaragoza;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QIII;3.758
50 Zaragoza;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
50 Zaragoza;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
50 Zaragoza;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
50 Zaragoza;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QIII;3.833
50 Zaragoza;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
50 Zaragoza;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
50 Zaragoza;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
50 Zaragoza;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2022QIII;3.491
50 Zaragoza;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2022QII;""
50 Zaragoza;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2022QI;""
50 Zaragoza;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
50 Zaragoza;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2021QIII;3.610
50 Zaragoza;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2021QII;""
50 Zaragoza;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2021QI;""
50 Zaragoza;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
50 Zaragoza;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2020QIII;3.649
50 Zaragoza;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2020QII;""
50 Zaragoza;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2020QI;""
50 Zaragoza;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2022QIV;3.344
50 Zaragoza;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
50 Zaragoza;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2022QII;""
50 Zaragoza;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2022QI;""
50 Zaragoza;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2021QIV;3.464
50 Zaragoza;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
50 Zaragoza;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2021QII;""
50 Zaragoza;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2021QI;""
50 Zaragoza;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2020QIV;3.501
50 Zaragoza;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
50 Zaragoza;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2020QII;""
50 Zaragoza;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2020QI;""
50 Zaragoza;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
50 Zaragoza;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
50 Zaragoza;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QII;""
50 Zaragoza;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QI;3.329
50 Zaragoza;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
50 Zaragoza;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
50 Zaragoza;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QII;""
50 Zaragoza;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QI;3.393
50 Zaragoza;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
50 Zaragoza;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
50 Zaragoza;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QII;""
50 Zaragoza;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QI;""
50 Zaragoza;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
50 Zaragoza;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
50 Zaragoza;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QII;3.219
50 Zaragoza;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QI;""
50 Zaragoza;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
50 Zaragoza;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
50 Zaragoza;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QII;3.299
50 Zaragoza;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QI;""
50 Zaragoza;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
50 Zaragoza;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
50 Zaragoza;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QII;""
50 Zaragoza;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QI;""
50 Zaragoza;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
50 Zaragoza;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
50 Zaragoza;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
50 Zaragoza;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
50 Zaragoza;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
50 Zaragoza;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
50 Zaragoza;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
50 Zaragoza;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
50 Zaragoza;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
50 Zaragoza;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
50 Zaragoza;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
50 Zaragoza;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
50 Zaragoza;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
50 Zaragoza;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;95,38
50 Zaragoza;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
50 Zaragoza;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
50 Zaragoza;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
50 Zaragoza;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;96,06
50 Zaragoza;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
50 Zaragoza;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
50 Zaragoza;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
50 Zaragoza;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;95,2
50 Zaragoza;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
50 Zaragoza;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
50 Zaragoza;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;91,37
50 Zaragoza;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
50 Zaragoza;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
50 Zaragoza;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
50 Zaragoza;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;92,18
50 Zaragoza;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
50 Zaragoza;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
50 Zaragoza;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
50 Zaragoza;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;91,34
50 Zaragoza;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
50 Zaragoza;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
50 Zaragoza;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
50 Zaragoza;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
50 Zaragoza;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
50 Zaragoza;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
50 Zaragoza;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;88,58
50 Zaragoza;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
50 Zaragoza;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
50 Zaragoza;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
50 Zaragoza;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;88,52
50 Zaragoza;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
50 Zaragoza;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
50 Zaragoza;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
50 Zaragoza;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
50 Zaragoza;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
50 Zaragoza;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
50 Zaragoza;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;85,66
50 Zaragoza;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
50 Zaragoza;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
50 Zaragoza;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
50 Zaragoza;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;86,07
50 Zaragoza;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
50 Zaragoza;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
50 Zaragoza;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
50 Zaragoza;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
50 Zaragoza;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
50 Zaragoza;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QIV;9.079
50 Zaragoza;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
50 Zaragoza;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
50 Zaragoza;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
50 Zaragoza;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QIV;9.362
50 Zaragoza;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
50 Zaragoza;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
50 Zaragoza;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
50 Zaragoza;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QIV;9.608
50 Zaragoza;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
50 Zaragoza;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
50 Zaragoza;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
50 Zaragoza;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2022QIV;8.688
50 Zaragoza;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
50 Zaragoza;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2022QII;""
50 Zaragoza;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2022QI;""
50 Zaragoza;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2021QIV;8.978
50 Zaragoza;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
50 Zaragoza;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2021QII;""
50 Zaragoza;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2021QI;""
50 Zaragoza;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2020QIV;9.195
50 Zaragoza;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
50 Zaragoza;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2020QII;""
50 Zaragoza;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2020QI;""
50 Zaragoza;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
50 Zaragoza;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
50 Zaragoza;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2022QII;""
50 Zaragoza;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2022QI;8.647
50 Zaragoza;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
50 Zaragoza;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
50 Zaragoza;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2021QII;""
50 Zaragoza;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2021QI;8.906
50 Zaragoza;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
50 Zaragoza;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
50 Zaragoza;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2020QII;""
50 Zaragoza;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2020QI;""
50 Zaragoza;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
50 Zaragoza;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
50 Zaragoza;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QII;8.377
50 Zaragoza;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QI;""
50 Zaragoza;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
50 Zaragoza;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
50 Zaragoza;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QII;8.632
50 Zaragoza;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QI;""
50 Zaragoza;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
50 Zaragoza;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
50 Zaragoza;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QII;""
50 Zaragoza;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QI;""
50 Zaragoza;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
50 Zaragoza;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QIII;8.142
50 Zaragoza;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QII;""
50 Zaragoza;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QI;""
50 Zaragoza;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
50 Zaragoza;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QIII;8.410
50 Zaragoza;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QII;""
50 Zaragoza;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QI;""
50 Zaragoza;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
50 Zaragoza;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
50 Zaragoza;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QII;""
50 Zaragoza;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QI;""
50 Zaragoza;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
50 Zaragoza;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
50 Zaragoza;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
50 Zaragoza;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
50 Zaragoza;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
50 Zaragoza;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
50 Zaragoza;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
50 Zaragoza;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
50 Zaragoza;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
50 Zaragoza;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
50 Zaragoza;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
50 Zaragoza;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
50 Zaragoza;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;95,69
50 Zaragoza;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
50 Zaragoza;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
50 Zaragoza;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
50 Zaragoza;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;95,9
50 Zaragoza;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
50 Zaragoza;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
50 Zaragoza;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
50 Zaragoza;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;95,7
50 Zaragoza;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
50 Zaragoza;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
50 Zaragoza;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
50 Zaragoza;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
50 Zaragoza;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
50 Zaragoza;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
50 Zaragoza;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;92,36
50 Zaragoza;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
50 Zaragoza;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
50 Zaragoza;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
50 Zaragoza;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;92,69
50 Zaragoza;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
50 Zaragoza;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
50 Zaragoza;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
50 Zaragoza;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
50 Zaragoza;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
50 Zaragoza;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
50 Zaragoza;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;89,48
50 Zaragoza;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
50 Zaragoza;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
50 Zaragoza;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
50 Zaragoza;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;89,84
50 Zaragoza;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
50 Zaragoza;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
50 Zaragoza;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
50 Zaragoza;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
50 Zaragoza;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
50 Zaragoza;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
50 Zaragoza;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;86,97
50 Zaragoza;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
50 Zaragoza;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
50 Zaragoza;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
50 Zaragoza;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;87,53
50 Zaragoza;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
50 Zaragoza;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
50 Zaragoza;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
50 Zaragoza;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
50 Zaragoza;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
50 Zaragoza;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
50 Zaragoza;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QIV;5.402
50 Zaragoza;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
50 Zaragoza;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
50 Zaragoza;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
50 Zaragoza;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QIV;5.564
50 Zaragoza;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
50 Zaragoza;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
50 Zaragoza;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
50 Zaragoza;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QIV;5.784
50 Zaragoza;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
50 Zaragoza;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
50 Zaragoza;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
50 Zaragoza;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2022QIV;5.178
50 Zaragoza;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
50 Zaragoza;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2022QII;""
50 Zaragoza;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2022QI;""
50 Zaragoza;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2021QIV;5.341
50 Zaragoza;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
50 Zaragoza;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2021QII;""
50 Zaragoza;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2021QI;""
50 Zaragoza;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2020QIV;5.542
50 Zaragoza;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
50 Zaragoza;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2020QII;""
50 Zaragoza;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2020QI;""
50 Zaragoza;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
50 Zaragoza;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
50 Zaragoza;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2022QII;""
50 Zaragoza;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2022QI;5.156
50 Zaragoza;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
50 Zaragoza;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
50 Zaragoza;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2021QII;""
50 Zaragoza;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2021QI;5.373
50 Zaragoza;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
50 Zaragoza;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
50 Zaragoza;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2020QII;""
50 Zaragoza;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2020QI;""
50 Zaragoza;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
50 Zaragoza;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
50 Zaragoza;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QII;5.006
50 Zaragoza;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QI;""
50 Zaragoza;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
50 Zaragoza;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
50 Zaragoza;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QII;5.201
50 Zaragoza;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QI;""
50 Zaragoza;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
50 Zaragoza;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
50 Zaragoza;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QII;""
50 Zaragoza;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QI;""
50 Zaragoza;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
50 Zaragoza;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QIII;4.879
50 Zaragoza;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QII;""
50 Zaragoza;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QI;""
50 Zaragoza;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
50 Zaragoza;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QIII;5.072
50 Zaragoza;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QII;""
50 Zaragoza;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QI;""
50 Zaragoza;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
50 Zaragoza;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
50 Zaragoza;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QII;""
50 Zaragoza;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QI;""
50 Zaragoza;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
50 Zaragoza;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
50 Zaragoza;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
50 Zaragoza;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
50 Zaragoza;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
50 Zaragoza;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
50 Zaragoza;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
50 Zaragoza;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
50 Zaragoza;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
50 Zaragoza;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
50 Zaragoza;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
50 Zaragoza;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
50 Zaragoza;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;95,85
50 Zaragoza;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
50 Zaragoza;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
50 Zaragoza;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
50 Zaragoza;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;95,99
50 Zaragoza;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
50 Zaragoza;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
50 Zaragoza;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
50 Zaragoza;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;95,82
50 Zaragoza;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
50 Zaragoza;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
50 Zaragoza;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
50 Zaragoza;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
50 Zaragoza;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
50 Zaragoza;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
50 Zaragoza;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;92,67
50 Zaragoza;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
50 Zaragoza;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
50 Zaragoza;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
50 Zaragoza;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;92,89
50 Zaragoza;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
50 Zaragoza;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
50 Zaragoza;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
50 Zaragoza;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
50 Zaragoza;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
50 Zaragoza;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
50 Zaragoza;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;89,97
50 Zaragoza;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
50 Zaragoza;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
50 Zaragoza;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
50 Zaragoza;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;89,92
50 Zaragoza;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
50 Zaragoza;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
50 Zaragoza;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
50 Zaragoza;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
50 Zaragoza;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
50 Zaragoza;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
50 Zaragoza;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;87,69
50 Zaragoza;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
50 Zaragoza;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
50 Zaragoza;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
50 Zaragoza;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;87,69
50 Zaragoza;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
50 Zaragoza;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
50 Zaragoza;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
50 Zaragoza;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
50 Zaragoza;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
50 Zaragoza;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
50 Zaragoza;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QIV;3.677
50 Zaragoza;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
50 Zaragoza;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
50 Zaragoza;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
50 Zaragoza;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QIV;3.798
50 Zaragoza;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
50 Zaragoza;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
50 Zaragoza;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
50 Zaragoza;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QIV;3.824
50 Zaragoza;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
50 Zaragoza;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
50 Zaragoza;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
50 Zaragoza;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2022QIV;3.510
50 Zaragoza;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
50 Zaragoza;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2022QII;""
50 Zaragoza;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2022QI;""
50 Zaragoza;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2021QIV;3.637
50 Zaragoza;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
50 Zaragoza;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2021QII;""
50 Zaragoza;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2021QI;""
50 Zaragoza;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2020QIV;3.653
50 Zaragoza;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
50 Zaragoza;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2020QII;""
50 Zaragoza;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2020QI;""
50 Zaragoza;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
50 Zaragoza;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
50 Zaragoza;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2022QII;""
50 Zaragoza;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2022QI;3.491
50 Zaragoza;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
50 Zaragoza;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
50 Zaragoza;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2021QII;""
50 Zaragoza;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2021QI;3.533
50 Zaragoza;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
50 Zaragoza;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
50 Zaragoza;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2020QII;""
50 Zaragoza;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2020QI;""
50 Zaragoza;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
50 Zaragoza;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
50 Zaragoza;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QII;3.371
50 Zaragoza;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QI;""
50 Zaragoza;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
50 Zaragoza;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
50 Zaragoza;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QII;3.431
50 Zaragoza;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QI;""
50 Zaragoza;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
50 Zaragoza;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
50 Zaragoza;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QII;""
50 Zaragoza;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QI;""
50 Zaragoza;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
50 Zaragoza;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QIII;3.263
50 Zaragoza;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QII;""
50 Zaragoza;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QI;""
50 Zaragoza;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
50 Zaragoza;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QIII;3.338
50 Zaragoza;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QII;""
50 Zaragoza;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QI;""
50 Zaragoza;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
50 Zaragoza;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
50 Zaragoza;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QII;""
50 Zaragoza;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QI;""
50 Zaragoza;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
50 Zaragoza;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
50 Zaragoza;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
50 Zaragoza;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
50 Zaragoza;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
50 Zaragoza;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
50 Zaragoza;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
50 Zaragoza;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
50 Zaragoza;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
50 Zaragoza;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
50 Zaragoza;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
50 Zaragoza;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
50 Zaragoza;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;95,46
50 Zaragoza;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
50 Zaragoza;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
50 Zaragoza;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
50 Zaragoza;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;95,76
50 Zaragoza;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
50 Zaragoza;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
50 Zaragoza;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
50 Zaragoza;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;95,53
50 Zaragoza;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
50 Zaragoza;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
50 Zaragoza;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
50 Zaragoza;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
50 Zaragoza;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
50 Zaragoza;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
50 Zaragoza;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;91,92
50 Zaragoza;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
50 Zaragoza;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
50 Zaragoza;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
50 Zaragoza;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;92,39
50 Zaragoza;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
50 Zaragoza;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
50 Zaragoza;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
50 Zaragoza;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
50 Zaragoza;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
50 Zaragoza;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
50 Zaragoza;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;88,76
50 Zaragoza;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
50 Zaragoza;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
50 Zaragoza;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
50 Zaragoza;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;89,72
50 Zaragoza;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
50 Zaragoza;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
50 Zaragoza;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
50 Zaragoza;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
50 Zaragoza;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
50 Zaragoza;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
50 Zaragoza;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;85,91
50 Zaragoza;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
50 Zaragoza;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
50 Zaragoza;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
50 Zaragoza;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;87,29
50 Zaragoza;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
50 Zaragoza;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
50 Zaragoza;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
50 Zaragoza;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
50 Zaragoza;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
50 Zaragoza;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
50 Zaragoza;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
50 Zaragoza;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
50 Zaragoza;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
50 Zaragoza;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QI;17.600
50 Zaragoza;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
50 Zaragoza;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
50 Zaragoza;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
50 Zaragoza;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QI;17.884
50 Zaragoza;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
50 Zaragoza;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
50 Zaragoza;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
50 Zaragoza;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QI;18.178
50 Zaragoza;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
50 Zaragoza;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
50 Zaragoza;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2022QII;""
50 Zaragoza;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2022QI;17.130
50 Zaragoza;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
50 Zaragoza;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
50 Zaragoza;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2021QII;""
50 Zaragoza;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2021QI;17.492
50 Zaragoza;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
50 Zaragoza;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
50 Zaragoza;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2020QII;""
50 Zaragoza;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2020QI;17.082
50 Zaragoza;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
50 Zaragoza;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
50 Zaragoza;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2022QII;16.677
50 Zaragoza;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2022QI;""
50 Zaragoza;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
50 Zaragoza;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
50 Zaragoza;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2021QII;17.115
50 Zaragoza;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2021QI;""
50 Zaragoza;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
50 Zaragoza;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
50 Zaragoza;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2020QII;16.818
50 Zaragoza;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2020QI;""
50 Zaragoza;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
50 Zaragoza;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QIII;16.304
50 Zaragoza;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QII;""
50 Zaragoza;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QI;""
50 Zaragoza;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
50 Zaragoza;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QIII;16.784
50 Zaragoza;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QII;""
50 Zaragoza;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QI;""
50 Zaragoza;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
50 Zaragoza;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QIII;16.448
50 Zaragoza;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QII;""
50 Zaragoza;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QI;""
50 Zaragoza;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QIV;15.948
50 Zaragoza;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
50 Zaragoza;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QII;""
50 Zaragoza;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QI;""
50 Zaragoza;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QIV;16.463
50 Zaragoza;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
50 Zaragoza;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QII;""
50 Zaragoza;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QI;""
50 Zaragoza;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QIV;16.090
50 Zaragoza;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
50 Zaragoza;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QII;""
50 Zaragoza;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QI;""
50 Zaragoza;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
50 Zaragoza;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
50 Zaragoza;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
50 Zaragoza;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
50 Zaragoza;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
50 Zaragoza;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
50 Zaragoza;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
50 Zaragoza;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
50 Zaragoza;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
50 Zaragoza;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
50 Zaragoza;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
50 Zaragoza;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
50 Zaragoza;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
50 Zaragoza;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
50 Zaragoza;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
50 Zaragoza;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;97,33
50 Zaragoza;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
50 Zaragoza;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
50 Zaragoza;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
50 Zaragoza;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;97,81
50 Zaragoza;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
50 Zaragoza;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
50 Zaragoza;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
50 Zaragoza;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;93,97
50 Zaragoza;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
50 Zaragoza;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
50 Zaragoza;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;94,76
50 Zaragoza;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
50 Zaragoza;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
50 Zaragoza;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
50 Zaragoza;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;95,7
50 Zaragoza;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
50 Zaragoza;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
50 Zaragoza;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
50 Zaragoza;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;92,52
50 Zaragoza;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
50 Zaragoza;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
50 Zaragoza;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;92,64
50 Zaragoza;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
50 Zaragoza;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
50 Zaragoza;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
50 Zaragoza;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;93,85
50 Zaragoza;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
50 Zaragoza;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
50 Zaragoza;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
50 Zaragoza;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;90,48
50 Zaragoza;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
50 Zaragoza;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
50 Zaragoza;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;90,61
50 Zaragoza;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
50 Zaragoza;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
50 Zaragoza;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
50 Zaragoza;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;92,05
50 Zaragoza;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
50 Zaragoza;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
50 Zaragoza;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
50 Zaragoza;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;88,51
50 Zaragoza;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
50 Zaragoza;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
50 Zaragoza;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
50 Zaragoza;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
50 Zaragoza;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
50 Zaragoza;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
50 Zaragoza;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QI;11.195
50 Zaragoza;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
50 Zaragoza;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
50 Zaragoza;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
50 Zaragoza;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QI;11.386
50 Zaragoza;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
50 Zaragoza;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
50 Zaragoza;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
50 Zaragoza;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QI;11.544
50 Zaragoza;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
50 Zaragoza;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
50 Zaragoza;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2022QII;""
50 Zaragoza;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2022QI;10.910
50 Zaragoza;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
50 Zaragoza;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
50 Zaragoza;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2021QII;""
50 Zaragoza;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2021QI;11.159
50 Zaragoza;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
50 Zaragoza;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
50 Zaragoza;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2020QII;""
50 Zaragoza;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2020QI;10.959
50 Zaragoza;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
50 Zaragoza;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
50 Zaragoza;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2022QII;10.636
50 Zaragoza;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2022QI;""
50 Zaragoza;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
50 Zaragoza;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
50 Zaragoza;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2021QII;10.937
50 Zaragoza;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2021QI;""
50 Zaragoza;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
50 Zaragoza;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
50 Zaragoza;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2020QII;10.805
50 Zaragoza;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2020QI;""
50 Zaragoza;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
50 Zaragoza;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QIII;10.413
50 Zaragoza;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QII;""
50 Zaragoza;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QI;""
50 Zaragoza;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
50 Zaragoza;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QIII;10.731
50 Zaragoza;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QII;""
50 Zaragoza;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QI;""
50 Zaragoza;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
50 Zaragoza;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QIII;10.578
50 Zaragoza;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QII;""
50 Zaragoza;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QI;""
50 Zaragoza;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QIV;10.210
50 Zaragoza;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
50 Zaragoza;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QII;""
50 Zaragoza;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QI;""
50 Zaragoza;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QIV;10.531
50 Zaragoza;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
50 Zaragoza;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QII;""
50 Zaragoza;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QI;""
50 Zaragoza;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QIV;10.362
50 Zaragoza;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
50 Zaragoza;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QII;""
50 Zaragoza;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QI;""
50 Zaragoza;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
50 Zaragoza;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
50 Zaragoza;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
50 Zaragoza;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
50 Zaragoza;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
50 Zaragoza;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
50 Zaragoza;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
50 Zaragoza;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
50 Zaragoza;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
50 Zaragoza;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
50 Zaragoza;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
50 Zaragoza;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
50 Zaragoza;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
50 Zaragoza;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
50 Zaragoza;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
50 Zaragoza;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;97,45
50 Zaragoza;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
50 Zaragoza;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
50 Zaragoza;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
50 Zaragoza;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;98,01
50 Zaragoza;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
50 Zaragoza;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
50 Zaragoza;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
50 Zaragoza;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;94,93
50 Zaragoza;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
50 Zaragoza;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
50 Zaragoza;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;95,01
50 Zaragoza;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
50 Zaragoza;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
50 Zaragoza;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
50 Zaragoza;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;96,06
50 Zaragoza;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
50 Zaragoza;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
50 Zaragoza;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
50 Zaragoza;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;93,6
50 Zaragoza;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
50 Zaragoza;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
50 Zaragoza;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;93,01
50 Zaragoza;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
50 Zaragoza;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
50 Zaragoza;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
50 Zaragoza;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;94,25
50 Zaragoza;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
50 Zaragoza;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
50 Zaragoza;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
50 Zaragoza;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;91,63
50 Zaragoza;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
50 Zaragoza;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
50 Zaragoza;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;91,2
50 Zaragoza;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
50 Zaragoza;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
50 Zaragoza;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
50 Zaragoza;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;92,49
50 Zaragoza;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
50 Zaragoza;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
50 Zaragoza;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
50 Zaragoza;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;89,76
50 Zaragoza;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
50 Zaragoza;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
50 Zaragoza;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
50 Zaragoza;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
50 Zaragoza;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
50 Zaragoza;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
50 Zaragoza;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QI;6.405
50 Zaragoza;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
50 Zaragoza;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
50 Zaragoza;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
50 Zaragoza;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QI;6.498
50 Zaragoza;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
50 Zaragoza;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
50 Zaragoza;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
50 Zaragoza;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QI;6.634
50 Zaragoza;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
50 Zaragoza;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
50 Zaragoza;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2022QII;""
50 Zaragoza;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2022QI;6.220
50 Zaragoza;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
50 Zaragoza;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
50 Zaragoza;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2021QII;""
50 Zaragoza;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2021QI;6.333
50 Zaragoza;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
50 Zaragoza;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
50 Zaragoza;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2020QII;""
50 Zaragoza;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2020QI;6.123
50 Zaragoza;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
50 Zaragoza;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
50 Zaragoza;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2022QII;6.041
50 Zaragoza;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2022QI;""
50 Zaragoza;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
50 Zaragoza;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
50 Zaragoza;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2021QII;6.178
50 Zaragoza;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2021QI;""
50 Zaragoza;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
50 Zaragoza;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
50 Zaragoza;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2020QII;6.013
50 Zaragoza;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2020QI;""
50 Zaragoza;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
50 Zaragoza;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QIII;5.891
50 Zaragoza;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QII;""
50 Zaragoza;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QI;""
50 Zaragoza;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
50 Zaragoza;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QIII;6.053
50 Zaragoza;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QII;""
50 Zaragoza;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QI;""
50 Zaragoza;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
50 Zaragoza;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QIII;5.870
50 Zaragoza;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QII;""
50 Zaragoza;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QI;""
50 Zaragoza;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QIV;5.738
50 Zaragoza;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
50 Zaragoza;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QII;""
50 Zaragoza;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QI;""
50 Zaragoza;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QIV;5.932
50 Zaragoza;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
50 Zaragoza;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QII;""
50 Zaragoza;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QI;""
50 Zaragoza;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QIV;5.728
50 Zaragoza;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
50 Zaragoza;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QII;""
50 Zaragoza;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QI;""
50 Zaragoza;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
50 Zaragoza;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
50 Zaragoza;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
50 Zaragoza;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
50 Zaragoza;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
50 Zaragoza;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
50 Zaragoza;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
50 Zaragoza;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
50 Zaragoza;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
50 Zaragoza;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
50 Zaragoza;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
50 Zaragoza;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
50 Zaragoza;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
50 Zaragoza;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
50 Zaragoza;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
50 Zaragoza;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;97,11
50 Zaragoza;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
50 Zaragoza;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
50 Zaragoza;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
50 Zaragoza;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;97,46
50 Zaragoza;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
50 Zaragoza;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
50 Zaragoza;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
50 Zaragoza;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;92,3
50 Zaragoza;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
50 Zaragoza;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
50 Zaragoza;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;94,32
50 Zaragoza;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
50 Zaragoza;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
50 Zaragoza;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
50 Zaragoza;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;95,08
50 Zaragoza;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
50 Zaragoza;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
50 Zaragoza;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
50 Zaragoza;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;90,64
50 Zaragoza;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
50 Zaragoza;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
50 Zaragoza;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;91,98
50 Zaragoza;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
50 Zaragoza;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
50 Zaragoza;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
50 Zaragoza;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;93,15
50 Zaragoza;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
50 Zaragoza;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
50 Zaragoza;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
50 Zaragoza;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;88,48
50 Zaragoza;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
50 Zaragoza;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
50 Zaragoza;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;89,59
50 Zaragoza;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
50 Zaragoza;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
50 Zaragoza;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
50 Zaragoza;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;91,29
50 Zaragoza;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
50 Zaragoza;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
50 Zaragoza;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
50 Zaragoza;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;86,34
50 Zaragoza;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
50 Zaragoza;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
50 Zaragoza;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
50 Zaragoza;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
50 Zaragoza;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
50 Zaragoza;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QII;17.012
50 Zaragoza;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
50 Zaragoza;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
50 Zaragoza;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
50 Zaragoza;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QII;17.433
50 Zaragoza;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
50 Zaragoza;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
50 Zaragoza;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
50 Zaragoza;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QII;17.701
50 Zaragoza;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
50 Zaragoza;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
50 Zaragoza;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
50 Zaragoza;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2022QII;16.506
50 Zaragoza;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2022QI;""
50 Zaragoza;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
50 Zaragoza;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
50 Zaragoza;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2021QII;16.987
50 Zaragoza;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2021QI;""
50 Zaragoza;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
50 Zaragoza;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
50 Zaragoza;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2020QII;17.374
50 Zaragoza;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2020QI;""
50 Zaragoza;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
50 Zaragoza;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2022QIII;16.105
50 Zaragoza;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2022QII;""
50 Zaragoza;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2022QI;""
50 Zaragoza;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
50 Zaragoza;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2021QIII;16.629
50 Zaragoza;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2021QII;""
50 Zaragoza;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2021QI;""
50 Zaragoza;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
50 Zaragoza;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2020QIII;16.948
50 Zaragoza;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2020QII;""
50 Zaragoza;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2020QI;""
50 Zaragoza;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QIV;15.708
50 Zaragoza;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
50 Zaragoza;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QII;""
50 Zaragoza;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QI;""
50 Zaragoza;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QIV;16.296
50 Zaragoza;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
50 Zaragoza;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QII;""
50 Zaragoza;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QI;""
50 Zaragoza;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QIV;16.563
50 Zaragoza;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
50 Zaragoza;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QII;""
50 Zaragoza;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QI;""
50 Zaragoza;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
50 Zaragoza;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
50 Zaragoza;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QII;""
50 Zaragoza;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QI;15.946
50 Zaragoza;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
50 Zaragoza;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
50 Zaragoza;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QII;""
50 Zaragoza;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QI;16.269
50 Zaragoza;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
50 Zaragoza;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
50 Zaragoza;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QII;""
50 Zaragoza;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QI;""
50 Zaragoza;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
50 Zaragoza;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
50 Zaragoza;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
50 Zaragoza;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
50 Zaragoza;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
50 Zaragoza;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
50 Zaragoza;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
50 Zaragoza;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
50 Zaragoza;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
50 Zaragoza;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
50 Zaragoza;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
50 Zaragoza;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
50 Zaragoza;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
50 Zaragoza;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
50 Zaragoza;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;97,03
50 Zaragoza;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
50 Zaragoza;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
50 Zaragoza;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
50 Zaragoza;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;97,44
50 Zaragoza;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
50 Zaragoza;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
50 Zaragoza;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
50 Zaragoza;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;98,15
50 Zaragoza;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
50 Zaragoza;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
50 Zaragoza;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;94,67
50 Zaragoza;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
50 Zaragoza;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
50 Zaragoza;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
50 Zaragoza;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;95,39
50 Zaragoza;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
50 Zaragoza;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
50 Zaragoza;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
50 Zaragoza;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;95,75
50 Zaragoza;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
50 Zaragoza;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
50 Zaragoza;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;92,33
50 Zaragoza;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
50 Zaragoza;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
50 Zaragoza;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
50 Zaragoza;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;93,48
50 Zaragoza;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
50 Zaragoza;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
50 Zaragoza;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
50 Zaragoza;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;93,57
50 Zaragoza;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
50 Zaragoza;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
50 Zaragoza;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
50 Zaragoza;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
50 Zaragoza;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
50 Zaragoza;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
50 Zaragoza;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;91,47
50 Zaragoza;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
50 Zaragoza;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
50 Zaragoza;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
50 Zaragoza;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;91,91
50 Zaragoza;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
50 Zaragoza;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
50 Zaragoza;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
50 Zaragoza;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
50 Zaragoza;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
50 Zaragoza;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
50 Zaragoza;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QII;10.730
50 Zaragoza;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
50 Zaragoza;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
50 Zaragoza;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
50 Zaragoza;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QII;11.142
50 Zaragoza;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
50 Zaragoza;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
50 Zaragoza;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
50 Zaragoza;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QII;11.316
50 Zaragoza;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
50 Zaragoza;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
50 Zaragoza;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
50 Zaragoza;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2022QII;10.421
50 Zaragoza;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2022QI;""
50 Zaragoza;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
50 Zaragoza;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
50 Zaragoza;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2021QII;10.873
50 Zaragoza;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2021QI;""
50 Zaragoza;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
50 Zaragoza;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
50 Zaragoza;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2020QII;11.142
50 Zaragoza;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2020QI;""
50 Zaragoza;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
50 Zaragoza;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2022QIII;10.184
50 Zaragoza;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2022QII;""
50 Zaragoza;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2022QI;""
50 Zaragoza;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
50 Zaragoza;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2021QIII;10.644
50 Zaragoza;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2021QII;""
50 Zaragoza;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2021QI;""
50 Zaragoza;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
50 Zaragoza;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2020QIII;10.879
50 Zaragoza;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2020QII;""
50 Zaragoza;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2020QI;""
50 Zaragoza;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QIV;9.951
50 Zaragoza;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
50 Zaragoza;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QII;""
50 Zaragoza;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QI;""
50 Zaragoza;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QIV;10.438
50 Zaragoza;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
50 Zaragoza;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QII;""
50 Zaragoza;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QI;""
50 Zaragoza;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QIV;10.644
50 Zaragoza;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
50 Zaragoza;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QII;""
50 Zaragoza;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QI;""
50 Zaragoza;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
50 Zaragoza;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
50 Zaragoza;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QII;""
50 Zaragoza;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QI;10.226
50 Zaragoza;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
50 Zaragoza;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
50 Zaragoza;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QII;""
50 Zaragoza;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QI;10.466
50 Zaragoza;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
50 Zaragoza;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
50 Zaragoza;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QII;""
50 Zaragoza;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QI;""
50 Zaragoza;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
50 Zaragoza;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
50 Zaragoza;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
50 Zaragoza;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
50 Zaragoza;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
50 Zaragoza;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
50 Zaragoza;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
50 Zaragoza;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
50 Zaragoza;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
50 Zaragoza;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
50 Zaragoza;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
50 Zaragoza;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
50 Zaragoza;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
50 Zaragoza;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
50 Zaragoza;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;97,12
50 Zaragoza;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
50 Zaragoza;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
50 Zaragoza;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
50 Zaragoza;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;97,59
50 Zaragoza;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
50 Zaragoza;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
50 Zaragoza;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
50 Zaragoza;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;98,46
50 Zaragoza;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
50 Zaragoza;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
50 Zaragoza;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;94,91
50 Zaragoza;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
50 Zaragoza;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
50 Zaragoza;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
50 Zaragoza;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;95,53
50 Zaragoza;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
50 Zaragoza;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
50 Zaragoza;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
50 Zaragoza;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;96,14
50 Zaragoza;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
50 Zaragoza;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
50 Zaragoza;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;92,74
50 Zaragoza;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
50 Zaragoza;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
50 Zaragoza;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
50 Zaragoza;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;93,68
50 Zaragoza;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
50 Zaragoza;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
50 Zaragoza;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
50 Zaragoza;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;94,06
50 Zaragoza;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
50 Zaragoza;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
50 Zaragoza;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
50 Zaragoza;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
50 Zaragoza;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
50 Zaragoza;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
50 Zaragoza;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;91,78
50 Zaragoza;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
50 Zaragoza;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
50 Zaragoza;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
50 Zaragoza;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;92,49
50 Zaragoza;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
50 Zaragoza;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
50 Zaragoza;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
50 Zaragoza;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
50 Zaragoza;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
50 Zaragoza;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
50 Zaragoza;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QII;6.282
50 Zaragoza;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
50 Zaragoza;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
50 Zaragoza;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
50 Zaragoza;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QII;6.291
50 Zaragoza;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
50 Zaragoza;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
50 Zaragoza;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
50 Zaragoza;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QII;6.385
50 Zaragoza;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
50 Zaragoza;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
50 Zaragoza;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
50 Zaragoza;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2022QII;6.085
50 Zaragoza;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2022QI;""
50 Zaragoza;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
50 Zaragoza;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
50 Zaragoza;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2021QII;6.114
50 Zaragoza;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2021QI;""
50 Zaragoza;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
50 Zaragoza;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
50 Zaragoza;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2020QII;6.232
50 Zaragoza;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2020QI;""
50 Zaragoza;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
50 Zaragoza;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2022QIII;5.921
50 Zaragoza;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2022QII;""
50 Zaragoza;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2022QI;""
50 Zaragoza;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
50 Zaragoza;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2021QIII;5.985
50 Zaragoza;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2021QII;""
50 Zaragoza;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2021QI;""
50 Zaragoza;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
50 Zaragoza;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2020QIII;6.069
50 Zaragoza;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2020QII;""
50 Zaragoza;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2020QI;""
50 Zaragoza;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QIV;5.757
50 Zaragoza;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
50 Zaragoza;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QII;""
50 Zaragoza;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QI;""
50 Zaragoza;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QIV;5.858
50 Zaragoza;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
50 Zaragoza;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QII;""
50 Zaragoza;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QI;""
50 Zaragoza;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QIV;5.919
50 Zaragoza;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
50 Zaragoza;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QII;""
50 Zaragoza;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QI;""
50 Zaragoza;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
50 Zaragoza;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
50 Zaragoza;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QII;""
50 Zaragoza;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QI;5.720
50 Zaragoza;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
50 Zaragoza;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
50 Zaragoza;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QII;""
50 Zaragoza;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QI;5.803
50 Zaragoza;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
50 Zaragoza;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
50 Zaragoza;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QII;""
50 Zaragoza;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QI;""
50 Zaragoza;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
50 Zaragoza;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
50 Zaragoza;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
50 Zaragoza;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
50 Zaragoza;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
50 Zaragoza;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
50 Zaragoza;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
50 Zaragoza;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
50 Zaragoza;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
50 Zaragoza;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
50 Zaragoza;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
50 Zaragoza;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
50 Zaragoza;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
50 Zaragoza;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
50 Zaragoza;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;96,86
50 Zaragoza;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
50 Zaragoza;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
50 Zaragoza;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
50 Zaragoza;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;97,19
50 Zaragoza;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
50 Zaragoza;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
50 Zaragoza;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
50 Zaragoza;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;97,6
50 Zaragoza;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
50 Zaragoza;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
50 Zaragoza;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;94,25
50 Zaragoza;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
50 Zaragoza;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
50 Zaragoza;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
50 Zaragoza;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;95,14
50 Zaragoza;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
50 Zaragoza;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
50 Zaragoza;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
50 Zaragoza;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;95,05
50 Zaragoza;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
50 Zaragoza;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
50 Zaragoza;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;91,64
50 Zaragoza;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
50 Zaragoza;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
50 Zaragoza;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
50 Zaragoza;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;93,12
50 Zaragoza;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
50 Zaragoza;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
50 Zaragoza;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
50 Zaragoza;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;92,7
50 Zaragoza;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
50 Zaragoza;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
50 Zaragoza;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
50 Zaragoza;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
50 Zaragoza;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
50 Zaragoza;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
50 Zaragoza;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;90,92
50 Zaragoza;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
50 Zaragoza;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
50 Zaragoza;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
50 Zaragoza;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;90,88
50 Zaragoza;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
50 Zaragoza;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
50 Zaragoza;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
50 Zaragoza;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
50 Zaragoza;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
50 Zaragoza;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QIII;17.067
50 Zaragoza;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
50 Zaragoza;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
50 Zaragoza;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
50 Zaragoza;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QIII;17.576
50 Zaragoza;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
50 Zaragoza;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
50 Zaragoza;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
50 Zaragoza;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QIII;17.916
50 Zaragoza;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
50 Zaragoza;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
50 Zaragoza;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
50 Zaragoza;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2022QIII;16.566
50 Zaragoza;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2022QII;""
50 Zaragoza;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2022QI;""
50 Zaragoza;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
50 Zaragoza;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2021QIII;17.121
50 Zaragoza;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2021QII;""
50 Zaragoza;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2021QI;""
50 Zaragoza;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
50 Zaragoza;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2020QIII;17.441
50 Zaragoza;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2020QII;""
50 Zaragoza;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2020QI;""
50 Zaragoza;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2022QIV;16.119
50 Zaragoza;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
50 Zaragoza;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2022QII;""
50 Zaragoza;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2022QI;""
50 Zaragoza;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2021QIV;16.730
50 Zaragoza;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
50 Zaragoza;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2021QII;""
50 Zaragoza;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2021QI;""
50 Zaragoza;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2020QIV;17.022
50 Zaragoza;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
50 Zaragoza;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2020QII;""
50 Zaragoza;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2020QI;""
50 Zaragoza;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
50 Zaragoza;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
50 Zaragoza;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QII;""
50 Zaragoza;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QI;16.347
50 Zaragoza;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
50 Zaragoza;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
50 Zaragoza;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QII;""
50 Zaragoza;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QI;16.713
50 Zaragoza;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
50 Zaragoza;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
50 Zaragoza;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QII;""
50 Zaragoza;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QI;""
50 Zaragoza;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
50 Zaragoza;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
50 Zaragoza;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QII;15.975
50 Zaragoza;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QI;""
50 Zaragoza;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
50 Zaragoza;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
50 Zaragoza;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QII;16.421
50 Zaragoza;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QI;""
50 Zaragoza;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
50 Zaragoza;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
50 Zaragoza;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QII;""
50 Zaragoza;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QI;""
50 Zaragoza;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
50 Zaragoza;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
50 Zaragoza;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
50 Zaragoza;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
50 Zaragoza;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
50 Zaragoza;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
50 Zaragoza;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
50 Zaragoza;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
50 Zaragoza;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
50 Zaragoza;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
50 Zaragoza;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
50 Zaragoza;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
50 Zaragoza;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
50 Zaragoza;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;97,06
50 Zaragoza;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
50 Zaragoza;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
50 Zaragoza;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
50 Zaragoza;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;97,41
50 Zaragoza;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
50 Zaragoza;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
50 Zaragoza;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
50 Zaragoza;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;97,35
50 Zaragoza;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
50 Zaragoza;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
50 Zaragoza;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;94,45
50 Zaragoza;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
50 Zaragoza;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
50 Zaragoza;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
50 Zaragoza;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;95,19
50 Zaragoza;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
50 Zaragoza;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
50 Zaragoza;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
50 Zaragoza;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;95,01
50 Zaragoza;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
50 Zaragoza;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
50 Zaragoza;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
50 Zaragoza;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
50 Zaragoza;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
50 Zaragoza;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
50 Zaragoza;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;93,01
50 Zaragoza;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
50 Zaragoza;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
50 Zaragoza;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
50 Zaragoza;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;93,29
50 Zaragoza;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
50 Zaragoza;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
50 Zaragoza;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
50 Zaragoza;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
50 Zaragoza;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
50 Zaragoza;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
50 Zaragoza;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;90,89
50 Zaragoza;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
50 Zaragoza;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
50 Zaragoza;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
50 Zaragoza;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;91,66
50 Zaragoza;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
50 Zaragoza;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
50 Zaragoza;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
50 Zaragoza;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
50 Zaragoza;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
50 Zaragoza;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
50 Zaragoza;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QIII;10.741
50 Zaragoza;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
50 Zaragoza;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
50 Zaragoza;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
50 Zaragoza;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QIII;11.232
50 Zaragoza;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
50 Zaragoza;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
50 Zaragoza;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
50 Zaragoza;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QIII;11.449
50 Zaragoza;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
50 Zaragoza;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
50 Zaragoza;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
50 Zaragoza;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2022QIII;10.447
50 Zaragoza;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2022QII;""
50 Zaragoza;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2022QI;""
50 Zaragoza;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
50 Zaragoza;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2021QIII;10.946
50 Zaragoza;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2021QII;""
50 Zaragoza;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2021QI;""
50 Zaragoza;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
50 Zaragoza;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2020QIII;11.152
50 Zaragoza;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2020QII;""
50 Zaragoza;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2020QI;""
50 Zaragoza;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2022QIV;10.190
50 Zaragoza;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
50 Zaragoza;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2022QII;""
50 Zaragoza;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2022QI;""
50 Zaragoza;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2021QIV;10.703
50 Zaragoza;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
50 Zaragoza;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2021QII;""
50 Zaragoza;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2021QI;""
50 Zaragoza;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2020QIV;10.899
50 Zaragoza;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
50 Zaragoza;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2020QII;""
50 Zaragoza;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2020QI;""
50 Zaragoza;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
50 Zaragoza;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
50 Zaragoza;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QII;""
50 Zaragoza;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QI;10.473
50 Zaragoza;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
50 Zaragoza;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
50 Zaragoza;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QII;""
50 Zaragoza;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QI;10.712
50 Zaragoza;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
50 Zaragoza;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
50 Zaragoza;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QII;""
50 Zaragoza;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QI;""
50 Zaragoza;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
50 Zaragoza;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
50 Zaragoza;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QII;10.247
50 Zaragoza;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QI;""
50 Zaragoza;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
50 Zaragoza;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
50 Zaragoza;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QII;10.533
50 Zaragoza;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QI;""
50 Zaragoza;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
50 Zaragoza;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
50 Zaragoza;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QII;""
50 Zaragoza;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QI;""
50 Zaragoza;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
50 Zaragoza;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
50 Zaragoza;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
50 Zaragoza;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
50 Zaragoza;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
50 Zaragoza;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
50 Zaragoza;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
50 Zaragoza;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
50 Zaragoza;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
50 Zaragoza;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
50 Zaragoza;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
50 Zaragoza;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
50 Zaragoza;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
50 Zaragoza;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;97,26
50 Zaragoza;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
50 Zaragoza;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
50 Zaragoza;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
50 Zaragoza;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;97,45
50 Zaragoza;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
50 Zaragoza;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
50 Zaragoza;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
50 Zaragoza;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;97,41
50 Zaragoza;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
50 Zaragoza;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
50 Zaragoza;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;94,87
50 Zaragoza;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
50 Zaragoza;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
50 Zaragoza;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
50 Zaragoza;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;95,29
50 Zaragoza;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
50 Zaragoza;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
50 Zaragoza;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
50 Zaragoza;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;95,2
50 Zaragoza;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
50 Zaragoza;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
50 Zaragoza;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
50 Zaragoza;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
50 Zaragoza;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
50 Zaragoza;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
50 Zaragoza;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;93,24
50 Zaragoza;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
50 Zaragoza;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
50 Zaragoza;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
50 Zaragoza;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;93,56
50 Zaragoza;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
50 Zaragoza;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
50 Zaragoza;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
50 Zaragoza;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
50 Zaragoza;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
50 Zaragoza;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
50 Zaragoza;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;91,23
50 Zaragoza;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
50 Zaragoza;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
50 Zaragoza;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
50 Zaragoza;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;92
50 Zaragoza;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
50 Zaragoza;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
50 Zaragoza;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
50 Zaragoza;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
50 Zaragoza;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
50 Zaragoza;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
50 Zaragoza;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QIII;6.326
50 Zaragoza;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
50 Zaragoza;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
50 Zaragoza;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
50 Zaragoza;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QIII;6.344
50 Zaragoza;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
50 Zaragoza;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
50 Zaragoza;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
50 Zaragoza;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QIII;6.467
50 Zaragoza;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
50 Zaragoza;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
50 Zaragoza;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
50 Zaragoza;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2022QIII;6.119
50 Zaragoza;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2022QII;""
50 Zaragoza;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2022QI;""
50 Zaragoza;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
50 Zaragoza;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2021QIII;6.175
50 Zaragoza;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2021QII;""
50 Zaragoza;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2021QI;""
50 Zaragoza;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
50 Zaragoza;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2020QIII;6.289
50 Zaragoza;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2020QII;""
50 Zaragoza;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2020QI;""
50 Zaragoza;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2022QIV;5.929
50 Zaragoza;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
50 Zaragoza;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2022QII;""
50 Zaragoza;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2022QI;""
50 Zaragoza;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2021QIV;6.027
50 Zaragoza;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
50 Zaragoza;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2021QII;""
50 Zaragoza;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2021QI;""
50 Zaragoza;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2020QIV;6.123
50 Zaragoza;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
50 Zaragoza;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2020QII;""
50 Zaragoza;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2020QI;""
50 Zaragoza;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
50 Zaragoza;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
50 Zaragoza;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QII;""
50 Zaragoza;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QI;5.874
50 Zaragoza;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
50 Zaragoza;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
50 Zaragoza;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QII;""
50 Zaragoza;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QI;6.001
50 Zaragoza;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
50 Zaragoza;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
50 Zaragoza;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QII;""
50 Zaragoza;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QI;""
50 Zaragoza;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
50 Zaragoza;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
50 Zaragoza;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QII;5.728
50 Zaragoza;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QI;""
50 Zaragoza;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
50 Zaragoza;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
50 Zaragoza;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QII;5.888
50 Zaragoza;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QI;""
50 Zaragoza;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
50 Zaragoza;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
50 Zaragoza;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QII;""
50 Zaragoza;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QI;""
50 Zaragoza;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
50 Zaragoza;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
50 Zaragoza;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
50 Zaragoza;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
50 Zaragoza;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
50 Zaragoza;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
50 Zaragoza;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
50 Zaragoza;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
50 Zaragoza;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
50 Zaragoza;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
50 Zaragoza;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
50 Zaragoza;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
50 Zaragoza;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
50 Zaragoza;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;96,73
50 Zaragoza;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
50 Zaragoza;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
50 Zaragoza;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
50 Zaragoza;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;97,34
50 Zaragoza;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
50 Zaragoza;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
50 Zaragoza;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
50 Zaragoza;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;97,25
50 Zaragoza;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
50 Zaragoza;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
50 Zaragoza;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;93,72
50 Zaragoza;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
50 Zaragoza;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
50 Zaragoza;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
50 Zaragoza;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;95
50 Zaragoza;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
50 Zaragoza;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
50 Zaragoza;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
50 Zaragoza;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;94,68
50 Zaragoza;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
50 Zaragoza;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
50 Zaragoza;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
50 Zaragoza;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
50 Zaragoza;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
50 Zaragoza;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
50 Zaragoza;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;92,59
50 Zaragoza;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
50 Zaragoza;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
50 Zaragoza;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
50 Zaragoza;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;92,79
50 Zaragoza;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
50 Zaragoza;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
50 Zaragoza;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
50 Zaragoza;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
50 Zaragoza;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
50 Zaragoza;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
50 Zaragoza;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;90,29
50 Zaragoza;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
50 Zaragoza;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
50 Zaragoza;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
50 Zaragoza;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;91,05
50 Zaragoza;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
50 Zaragoza;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
50 Zaragoza;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
50 Zaragoza;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
50 Zaragoza;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
50 Zaragoza;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QIV;17.029
50 Zaragoza;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
50 Zaragoza;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
50 Zaragoza;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
50 Zaragoza;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QIV;17.580
50 Zaragoza;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
50 Zaragoza;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
50 Zaragoza;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
50 Zaragoza;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QIV;17.887
50 Zaragoza;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
50 Zaragoza;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
50 Zaragoza;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
50 Zaragoza;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2022QIV;16.513
50 Zaragoza;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
50 Zaragoza;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2022QII;""
50 Zaragoza;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2022QI;""
50 Zaragoza;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2021QIV;17.124
50 Zaragoza;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
50 Zaragoza;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2021QII;""
50 Zaragoza;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2021QI;""
50 Zaragoza;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2020QIV;17.388
50 Zaragoza;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
50 Zaragoza;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2020QII;""
50 Zaragoza;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2020QI;""
50 Zaragoza;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
50 Zaragoza;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
50 Zaragoza;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2022QII;""
50 Zaragoza;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2022QI;16.708
50 Zaragoza;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
50 Zaragoza;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
50 Zaragoza;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2021QII;""
50 Zaragoza;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2021QI;17.060
50 Zaragoza;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
50 Zaragoza;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
50 Zaragoza;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2020QII;""
50 Zaragoza;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2020QI;""
50 Zaragoza;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
50 Zaragoza;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
50 Zaragoza;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QII;16.305
50 Zaragoza;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QI;""
50 Zaragoza;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
50 Zaragoza;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
50 Zaragoza;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QII;16.741
50 Zaragoza;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QI;""
50 Zaragoza;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
50 Zaragoza;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
50 Zaragoza;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QII;""
50 Zaragoza;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QI;""
50 Zaragoza;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
50 Zaragoza;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QIII;15.959
50 Zaragoza;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QII;""
50 Zaragoza;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QI;""
50 Zaragoza;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
50 Zaragoza;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QIII;16.445
50 Zaragoza;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QII;""
50 Zaragoza;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QI;""
50 Zaragoza;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
50 Zaragoza;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
50 Zaragoza;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QII;""
50 Zaragoza;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QI;""
50 Zaragoza;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
50 Zaragoza;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
50 Zaragoza;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
50 Zaragoza;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
50 Zaragoza;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
50 Zaragoza;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
50 Zaragoza;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
50 Zaragoza;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
50 Zaragoza;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
50 Zaragoza;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
50 Zaragoza;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
50 Zaragoza;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
50 Zaragoza;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;96,97
50 Zaragoza;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
50 Zaragoza;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
50 Zaragoza;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
50 Zaragoza;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;97,41
50 Zaragoza;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
50 Zaragoza;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
50 Zaragoza;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
50 Zaragoza;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;97,21
50 Zaragoza;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
50 Zaragoza;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
50 Zaragoza;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
50 Zaragoza;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
50 Zaragoza;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
50 Zaragoza;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
50 Zaragoza;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;95,04
50 Zaragoza;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
50 Zaragoza;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
50 Zaragoza;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
50 Zaragoza;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;95,38
50 Zaragoza;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
50 Zaragoza;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
50 Zaragoza;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
50 Zaragoza;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
50 Zaragoza;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
50 Zaragoza;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
50 Zaragoza;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;92,75
50 Zaragoza;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
50 Zaragoza;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
50 Zaragoza;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
50 Zaragoza;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;93,59
50 Zaragoza;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
50 Zaragoza;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
50 Zaragoza;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
50 Zaragoza;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
50 Zaragoza;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
50 Zaragoza;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
50 Zaragoza;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;90,78
50 Zaragoza;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
50 Zaragoza;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
50 Zaragoza;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
50 Zaragoza;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;91,94
50 Zaragoza;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
50 Zaragoza;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
50 Zaragoza;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
50 Zaragoza;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
50 Zaragoza;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
50 Zaragoza;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
50 Zaragoza;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QIV;10.709
50 Zaragoza;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
50 Zaragoza;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
50 Zaragoza;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
50 Zaragoza;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QIV;11.212
50 Zaragoza;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
50 Zaragoza;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
50 Zaragoza;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
50 Zaragoza;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QIV;11.402
50 Zaragoza;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
50 Zaragoza;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
50 Zaragoza;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
50 Zaragoza;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2022QIV;10.406
50 Zaragoza;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
50 Zaragoza;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2022QII;""
50 Zaragoza;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2022QI;""
50 Zaragoza;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2021QIV;10.931
50 Zaragoza;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
50 Zaragoza;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2021QII;""
50 Zaragoza;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2021QI;""
50 Zaragoza;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2020QIV;11.106
50 Zaragoza;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
50 Zaragoza;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2020QII;""
50 Zaragoza;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2020QI;""
50 Zaragoza;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
50 Zaragoza;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
50 Zaragoza;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2022QII;""
50 Zaragoza;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2022QI;10.678
50 Zaragoza;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
50 Zaragoza;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
50 Zaragoza;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2021QII;""
50 Zaragoza;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2021QI;10.910
50 Zaragoza;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
50 Zaragoza;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
50 Zaragoza;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2020QII;""
50 Zaragoza;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2020QI;""
50 Zaragoza;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
50 Zaragoza;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
50 Zaragoza;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QII;10.431
50 Zaragoza;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QI;""
50 Zaragoza;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
50 Zaragoza;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
50 Zaragoza;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QII;10.719
50 Zaragoza;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QI;""
50 Zaragoza;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
50 Zaragoza;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
50 Zaragoza;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QII;""
50 Zaragoza;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QI;""
50 Zaragoza;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
50 Zaragoza;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QIII;10.223
50 Zaragoza;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QII;""
50 Zaragoza;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QI;""
50 Zaragoza;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
50 Zaragoza;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QIII;10.537
50 Zaragoza;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QII;""
50 Zaragoza;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QI;""
50 Zaragoza;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
50 Zaragoza;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
50 Zaragoza;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QII;""
50 Zaragoza;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QI;""
50 Zaragoza;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
50 Zaragoza;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
50 Zaragoza;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
50 Zaragoza;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
50 Zaragoza;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
50 Zaragoza;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
50 Zaragoza;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
50 Zaragoza;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
50 Zaragoza;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
50 Zaragoza;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
50 Zaragoza;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
50 Zaragoza;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
50 Zaragoza;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;97,17
50 Zaragoza;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
50 Zaragoza;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
50 Zaragoza;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
50 Zaragoza;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;97,49
50 Zaragoza;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
50 Zaragoza;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
50 Zaragoza;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
50 Zaragoza;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;97,4
50 Zaragoza;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
50 Zaragoza;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
50 Zaragoza;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
50 Zaragoza;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
50 Zaragoza;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
50 Zaragoza;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
50 Zaragoza;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;95,24
50 Zaragoza;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
50 Zaragoza;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
50 Zaragoza;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
50 Zaragoza;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;95,68
50 Zaragoza;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
50 Zaragoza;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
50 Zaragoza;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
50 Zaragoza;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
50 Zaragoza;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
50 Zaragoza;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
50 Zaragoza;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;93,03
50 Zaragoza;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
50 Zaragoza;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
50 Zaragoza;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
50 Zaragoza;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;94,01
50 Zaragoza;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
50 Zaragoza;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
50 Zaragoza;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
50 Zaragoza;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
50 Zaragoza;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
50 Zaragoza;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
50 Zaragoza;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;91,18
50 Zaragoza;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
50 Zaragoza;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
50 Zaragoza;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
50 Zaragoza;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;92,41
50 Zaragoza;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
50 Zaragoza;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
50 Zaragoza;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
50 Zaragoza;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
50 Zaragoza;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
50 Zaragoza;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
50 Zaragoza;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QIV;6.320
50 Zaragoza;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
50 Zaragoza;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
50 Zaragoza;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
50 Zaragoza;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QIV;6.368
50 Zaragoza;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
50 Zaragoza;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
50 Zaragoza;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
50 Zaragoza;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QIV;6.485
50 Zaragoza;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
50 Zaragoza;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
50 Zaragoza;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
50 Zaragoza;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2022QIV;6.107
50 Zaragoza;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
50 Zaragoza;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2022QII;""
50 Zaragoza;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2022QI;""
50 Zaragoza;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2021QIV;6.193
50 Zaragoza;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
50 Zaragoza;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2021QII;""
50 Zaragoza;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2021QI;""
50 Zaragoza;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2020QIV;6.282
50 Zaragoza;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
50 Zaragoza;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2020QII;""
50 Zaragoza;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2020QI;""
50 Zaragoza;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
50 Zaragoza;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
50 Zaragoza;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2022QII;""
50 Zaragoza;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2022QI;6.030
50 Zaragoza;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
50 Zaragoza;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
50 Zaragoza;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2021QII;""
50 Zaragoza;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2021QI;6.150
50 Zaragoza;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
50 Zaragoza;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
50 Zaragoza;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2020QII;""
50 Zaragoza;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2020QI;""
50 Zaragoza;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
50 Zaragoza;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
50 Zaragoza;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QII;5.874
50 Zaragoza;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QI;""
50 Zaragoza;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
50 Zaragoza;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
50 Zaragoza;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QII;6.022
50 Zaragoza;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QI;""
50 Zaragoza;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
50 Zaragoza;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
50 Zaragoza;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QII;""
50 Zaragoza;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QI;""
50 Zaragoza;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
50 Zaragoza;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QIII;5.736
50 Zaragoza;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QII;""
50 Zaragoza;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QI;""
50 Zaragoza;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
50 Zaragoza;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QIII;5.908
50 Zaragoza;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QII;""
50 Zaragoza;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QI;""
50 Zaragoza;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
50 Zaragoza;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
50 Zaragoza;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QII;""
50 Zaragoza;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QI;""
50 Zaragoza;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
50 Zaragoza;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
50 Zaragoza;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
50 Zaragoza;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
50 Zaragoza;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
50 Zaragoza;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
50 Zaragoza;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
50 Zaragoza;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
50 Zaragoza;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
50 Zaragoza;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
50 Zaragoza;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
50 Zaragoza;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
50 Zaragoza;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;96,63
50 Zaragoza;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
50 Zaragoza;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
50 Zaragoza;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
50 Zaragoza;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;97,25
50 Zaragoza;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
50 Zaragoza;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
50 Zaragoza;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
50 Zaragoza;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;96,87
50 Zaragoza;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
50 Zaragoza;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
50 Zaragoza;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
50 Zaragoza;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
50 Zaragoza;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
50 Zaragoza;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
50 Zaragoza;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;94,69
50 Zaragoza;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
50 Zaragoza;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
50 Zaragoza;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
50 Zaragoza;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;94,83
50 Zaragoza;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
50 Zaragoza;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
50 Zaragoza;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
50 Zaragoza;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
50 Zaragoza;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
50 Zaragoza;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
50 Zaragoza;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;92,24
50 Zaragoza;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
50 Zaragoza;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
50 Zaragoza;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
50 Zaragoza;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;92,86
50 Zaragoza;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
50 Zaragoza;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
50 Zaragoza;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
50 Zaragoza;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
50 Zaragoza;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
50 Zaragoza;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
50 Zaragoza;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;90,08
50 Zaragoza;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
50 Zaragoza;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
50 Zaragoza;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
50 Zaragoza;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;91,1
50 Zaragoza;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
50 Zaragoza;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
50 Zaragoza;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
50 Zaragoza;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
50 Zaragoza;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
50 Zaragoza;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
50 Zaragoza;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
50 Zaragoza;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
50 Zaragoza;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
50 Zaragoza;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QI;18.003
50 Zaragoza;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
50 Zaragoza;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
50 Zaragoza;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
50 Zaragoza;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QI;17.672
50 Zaragoza;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
50 Zaragoza;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
50 Zaragoza;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
50 Zaragoza;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QI;18.252
50 Zaragoza;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
50 Zaragoza;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
50 Zaragoza;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2022QII;""
50 Zaragoza;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2022QI;17.661
50 Zaragoza;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
50 Zaragoza;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
50 Zaragoza;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2021QII;""
50 Zaragoza;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2021QI;17.407
50 Zaragoza;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
50 Zaragoza;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
50 Zaragoza;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2020QII;""
50 Zaragoza;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2020QI;17.428
50 Zaragoza;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
50 Zaragoza;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
50 Zaragoza;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2022QII;17.322
50 Zaragoza;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2022QI;""
50 Zaragoza;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
50 Zaragoza;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
50 Zaragoza;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2021QII;17.115
50 Zaragoza;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2021QI;""
50 Zaragoza;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
50 Zaragoza;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
50 Zaragoza;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2020QII;17.203
50 Zaragoza;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2020QI;""
50 Zaragoza;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
50 Zaragoza;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QIII;17.019
50 Zaragoza;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QII;""
50 Zaragoza;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QI;""
50 Zaragoza;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
50 Zaragoza;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QIII;16.863
50 Zaragoza;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QII;""
50 Zaragoza;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QI;""
50 Zaragoza;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
50 Zaragoza;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QIII;16.917
50 Zaragoza;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QII;""
50 Zaragoza;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QI;""
50 Zaragoza;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QIV;16.694
50 Zaragoza;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
50 Zaragoza;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QII;""
50 Zaragoza;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QI;""
50 Zaragoza;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QIV;16.610
50 Zaragoza;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
50 Zaragoza;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QII;""
50 Zaragoza;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QI;""
50 Zaragoza;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QIV;16.625
50 Zaragoza;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
50 Zaragoza;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QII;""
50 Zaragoza;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QI;""
50 Zaragoza;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
50 Zaragoza;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
50 Zaragoza;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
50 Zaragoza;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
50 Zaragoza;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
50 Zaragoza;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
50 Zaragoza;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
50 Zaragoza;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
50 Zaragoza;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
50 Zaragoza;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
50 Zaragoza;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
50 Zaragoza;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
50 Zaragoza;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
50 Zaragoza;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
50 Zaragoza;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
50 Zaragoza;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;98,1
50 Zaragoza;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
50 Zaragoza;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
50 Zaragoza;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
50 Zaragoza;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;98,5
50 Zaragoza;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
50 Zaragoza;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
50 Zaragoza;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
50 Zaragoza;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;95,49
50 Zaragoza;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
50 Zaragoza;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
50 Zaragoza;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;96,22
50 Zaragoza;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
50 Zaragoza;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
50 Zaragoza;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
50 Zaragoza;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;96,85
50 Zaragoza;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
50 Zaragoza;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
50 Zaragoza;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
50 Zaragoza;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;94,25
50 Zaragoza;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
50 Zaragoza;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
50 Zaragoza;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;94,53
50 Zaragoza;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
50 Zaragoza;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
50 Zaragoza;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
50 Zaragoza;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;95,42
50 Zaragoza;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
50 Zaragoza;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
50 Zaragoza;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
50 Zaragoza;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;92,69
50 Zaragoza;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
50 Zaragoza;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
50 Zaragoza;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;92,73
50 Zaragoza;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
50 Zaragoza;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
50 Zaragoza;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
50 Zaragoza;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;93,99
50 Zaragoza;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
50 Zaragoza;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
50 Zaragoza;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
50 Zaragoza;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;91,09
50 Zaragoza;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
50 Zaragoza;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
50 Zaragoza;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
50 Zaragoza;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
50 Zaragoza;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
50 Zaragoza;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
50 Zaragoza;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QI;11.413
50 Zaragoza;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
50 Zaragoza;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
50 Zaragoza;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
50 Zaragoza;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QI;11.248
50 Zaragoza;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
50 Zaragoza;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
50 Zaragoza;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
50 Zaragoza;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QI;11.599
50 Zaragoza;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
50 Zaragoza;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
50 Zaragoza;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2022QII;""
50 Zaragoza;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2022QI;11.209
50 Zaragoza;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
50 Zaragoza;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
50 Zaragoza;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2021QII;""
50 Zaragoza;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2021QI;11.103
50 Zaragoza;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
50 Zaragoza;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
50 Zaragoza;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2020QII;""
50 Zaragoza;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2020QI;11.120
50 Zaragoza;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
50 Zaragoza;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
50 Zaragoza;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2022QII;11.004
50 Zaragoza;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2022QI;""
50 Zaragoza;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
50 Zaragoza;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
50 Zaragoza;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2021QII;10.930
50 Zaragoza;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2021QI;""
50 Zaragoza;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
50 Zaragoza;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
50 Zaragoza;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2020QII;11.000
50 Zaragoza;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2020QI;""
50 Zaragoza;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
50 Zaragoza;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QIII;10.835
50 Zaragoza;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QII;""
50 Zaragoza;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QI;""
50 Zaragoza;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
50 Zaragoza;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QIII;10.780
50 Zaragoza;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QII;""
50 Zaragoza;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QI;""
50 Zaragoza;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
50 Zaragoza;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QIII;10.828
50 Zaragoza;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QII;""
50 Zaragoza;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QI;""
50 Zaragoza;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QIV;10.657
50 Zaragoza;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
50 Zaragoza;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QII;""
50 Zaragoza;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QI;""
50 Zaragoza;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QIV;10.626
50 Zaragoza;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
50 Zaragoza;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QII;""
50 Zaragoza;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QI;""
50 Zaragoza;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QIV;10.655
50 Zaragoza;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
50 Zaragoza;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QII;""
50 Zaragoza;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QI;""
50 Zaragoza;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
50 Zaragoza;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
50 Zaragoza;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
50 Zaragoza;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
50 Zaragoza;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
50 Zaragoza;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
50 Zaragoza;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
50 Zaragoza;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
50 Zaragoza;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
50 Zaragoza;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
50 Zaragoza;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
50 Zaragoza;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
50 Zaragoza;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
50 Zaragoza;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
50 Zaragoza;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
50 Zaragoza;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;98,21
50 Zaragoza;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
50 Zaragoza;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
50 Zaragoza;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
50 Zaragoza;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;98,71
50 Zaragoza;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
50 Zaragoza;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
50 Zaragoza;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
50 Zaragoza;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;95,87
50 Zaragoza;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
50 Zaragoza;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
50 Zaragoza;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;96,42
50 Zaragoza;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
50 Zaragoza;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
50 Zaragoza;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
50 Zaragoza;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;97,17
50 Zaragoza;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
50 Zaragoza;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
50 Zaragoza;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
50 Zaragoza;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;94,84
50 Zaragoza;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
50 Zaragoza;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
50 Zaragoza;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;94,94
50 Zaragoza;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
50 Zaragoza;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
50 Zaragoza;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
50 Zaragoza;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;95,84
50 Zaragoza;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
50 Zaragoza;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
50 Zaragoza;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
50 Zaragoza;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;93,35
50 Zaragoza;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
50 Zaragoza;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
50 Zaragoza;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;93,38
50 Zaragoza;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
50 Zaragoza;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
50 Zaragoza;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
50 Zaragoza;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;94,47
50 Zaragoza;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
50 Zaragoza;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
50 Zaragoza;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
50 Zaragoza;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;91,86
50 Zaragoza;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
50 Zaragoza;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
50 Zaragoza;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
50 Zaragoza;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
50 Zaragoza;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
50 Zaragoza;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
50 Zaragoza;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QI;6.590
50 Zaragoza;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
50 Zaragoza;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
50 Zaragoza;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
50 Zaragoza;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QI;6.424
50 Zaragoza;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
50 Zaragoza;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
50 Zaragoza;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
50 Zaragoza;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QI;6.653
50 Zaragoza;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
50 Zaragoza;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
50 Zaragoza;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2022QII;""
50 Zaragoza;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2022QI;6.452
50 Zaragoza;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
50 Zaragoza;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
50 Zaragoza;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2021QII;""
50 Zaragoza;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2021QI;6.304
50 Zaragoza;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
50 Zaragoza;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
50 Zaragoza;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2020QII;""
50 Zaragoza;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2020QI;6.308
50 Zaragoza;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
50 Zaragoza;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
50 Zaragoza;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2022QII;6.318
50 Zaragoza;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2022QI;""
50 Zaragoza;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
50 Zaragoza;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
50 Zaragoza;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2021QII;6.185
50 Zaragoza;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2021QI;""
50 Zaragoza;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
50 Zaragoza;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
50 Zaragoza;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2020QII;6.203
50 Zaragoza;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2020QI;""
50 Zaragoza;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
50 Zaragoza;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QIII;6.184
50 Zaragoza;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QII;""
50 Zaragoza;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QI;""
50 Zaragoza;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
50 Zaragoza;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QIII;6.083
50 Zaragoza;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QII;""
50 Zaragoza;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QI;""
50 Zaragoza;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
50 Zaragoza;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QIII;6.089
50 Zaragoza;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QII;""
50 Zaragoza;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QI;""
50 Zaragoza;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QIV;6.037
50 Zaragoza;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
50 Zaragoza;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QII;""
50 Zaragoza;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QI;""
50 Zaragoza;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QIV;5.984
50 Zaragoza;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
50 Zaragoza;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QII;""
50 Zaragoza;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QI;""
50 Zaragoza;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QIV;5.970
50 Zaragoza;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
50 Zaragoza;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QII;""
50 Zaragoza;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QI;""
50 Zaragoza;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
50 Zaragoza;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
50 Zaragoza;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
50 Zaragoza;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
50 Zaragoza;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
50 Zaragoza;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
50 Zaragoza;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
50 Zaragoza;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
50 Zaragoza;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
50 Zaragoza;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
50 Zaragoza;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
50 Zaragoza;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
50 Zaragoza;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
50 Zaragoza;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
50 Zaragoza;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
50 Zaragoza;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;97,91
50 Zaragoza;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
50 Zaragoza;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
50 Zaragoza;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
50 Zaragoza;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;98,13
50 Zaragoza;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
50 Zaragoza;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
50 Zaragoza;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
50 Zaragoza;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;94,81
50 Zaragoza;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
50 Zaragoza;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
50 Zaragoza;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;95,87
50 Zaragoza;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
50 Zaragoza;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
50 Zaragoza;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
50 Zaragoza;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;96,28
50 Zaragoza;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
50 Zaragoza;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
50 Zaragoza;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
50 Zaragoza;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;93,24
50 Zaragoza;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
50 Zaragoza;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
50 Zaragoza;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;93,84
50 Zaragoza;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
50 Zaragoza;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
50 Zaragoza;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
50 Zaragoza;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;94,69
50 Zaragoza;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
50 Zaragoza;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
50 Zaragoza;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
50 Zaragoza;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;91,52
50 Zaragoza;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
50 Zaragoza;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
50 Zaragoza;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;91,61
50 Zaragoza;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
50 Zaragoza;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
50 Zaragoza;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
50 Zaragoza;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;93,15
50 Zaragoza;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
50 Zaragoza;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
50 Zaragoza;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
50 Zaragoza;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;89,73
50 Zaragoza;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
50 Zaragoza;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
50 Zaragoza;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
50 Zaragoza;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
50 Zaragoza;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
50 Zaragoza;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QII;18.421
50 Zaragoza;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
50 Zaragoza;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
50 Zaragoza;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
50 Zaragoza;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QII;18.157
50 Zaragoza;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
50 Zaragoza;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
50 Zaragoza;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
50 Zaragoza;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QII;17.822
50 Zaragoza;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
50 Zaragoza;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
50 Zaragoza;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
50 Zaragoza;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2022QII;18.007
50 Zaragoza;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2022QI;""
50 Zaragoza;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
50 Zaragoza;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
50 Zaragoza;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2021QII;17.825
50 Zaragoza;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2021QI;""
50 Zaragoza;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
50 Zaragoza;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
50 Zaragoza;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2020QII;17.548
50 Zaragoza;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2020QI;""
50 Zaragoza;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
50 Zaragoza;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2022QIII;17.682
50 Zaragoza;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2022QII;""
50 Zaragoza;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2022QI;""
50 Zaragoza;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
50 Zaragoza;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2021QIII;17.530
50 Zaragoza;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2021QII;""
50 Zaragoza;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2021QI;""
50 Zaragoza;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
50 Zaragoza;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2020QIII;17.203
50 Zaragoza;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2020QII;""
50 Zaragoza;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2020QI;""
50 Zaragoza;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QIV;17.322
50 Zaragoza;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
50 Zaragoza;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QII;""
50 Zaragoza;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QI;""
50 Zaragoza;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QIV;17.239
50 Zaragoza;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
50 Zaragoza;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QII;""
50 Zaragoza;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QI;""
50 Zaragoza;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QIV;16.898
50 Zaragoza;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
50 Zaragoza;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QII;""
50 Zaragoza;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QI;""
50 Zaragoza;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
50 Zaragoza;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
50 Zaragoza;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QII;""
50 Zaragoza;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QI;16.972
50 Zaragoza;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
50 Zaragoza;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
50 Zaragoza;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QII;""
50 Zaragoza;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QI;16.684
50 Zaragoza;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
50 Zaragoza;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
50 Zaragoza;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QII;""
50 Zaragoza;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QI;""
50 Zaragoza;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
50 Zaragoza;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
50 Zaragoza;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
50 Zaragoza;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
50 Zaragoza;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
50 Zaragoza;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
50 Zaragoza;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
50 Zaragoza;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
50 Zaragoza;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
50 Zaragoza;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
50 Zaragoza;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
50 Zaragoza;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
50 Zaragoza;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
50 Zaragoza;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
50 Zaragoza;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;97,75
50 Zaragoza;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
50 Zaragoza;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
50 Zaragoza;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
50 Zaragoza;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;98,17
50 Zaragoza;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
50 Zaragoza;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
50 Zaragoza;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
50 Zaragoza;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;98,46
50 Zaragoza;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
50 Zaragoza;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
50 Zaragoza;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;95,99
50 Zaragoza;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
50 Zaragoza;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
50 Zaragoza;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
50 Zaragoza;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;96,55
50 Zaragoza;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
50 Zaragoza;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
50 Zaragoza;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
50 Zaragoza;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;96,53
50 Zaragoza;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
50 Zaragoza;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
50 Zaragoza;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;94,03
50 Zaragoza;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
50 Zaragoza;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
50 Zaragoza;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
50 Zaragoza;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;94,94
50 Zaragoza;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
50 Zaragoza;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
50 Zaragoza;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
50 Zaragoza;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;94,82
50 Zaragoza;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
50 Zaragoza;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
50 Zaragoza;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
50 Zaragoza;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
50 Zaragoza;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
50 Zaragoza;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
50 Zaragoza;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;93,47
50 Zaragoza;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
50 Zaragoza;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
50 Zaragoza;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
50 Zaragoza;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;93,61
50 Zaragoza;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
50 Zaragoza;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
50 Zaragoza;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
50 Zaragoza;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
50 Zaragoza;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
50 Zaragoza;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
50 Zaragoza;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QII;11.665
50 Zaragoza;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
50 Zaragoza;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
50 Zaragoza;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
50 Zaragoza;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QII;11.521
50 Zaragoza;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
50 Zaragoza;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
50 Zaragoza;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
50 Zaragoza;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QII;11.328
50 Zaragoza;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
50 Zaragoza;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
50 Zaragoza;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
50 Zaragoza;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2022QII;11.421
50 Zaragoza;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2022QI;""
50 Zaragoza;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
50 Zaragoza;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
50 Zaragoza;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2021QII;11.325
50 Zaragoza;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2021QI;""
50 Zaragoza;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
50 Zaragoza;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
50 Zaragoza;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2020QII;11.195
50 Zaragoza;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2020QI;""
50 Zaragoza;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
50 Zaragoza;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2022QIII;11.244
50 Zaragoza;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2022QII;""
50 Zaragoza;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2022QI;""
50 Zaragoza;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
50 Zaragoza;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2021QIII;11.151
50 Zaragoza;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2021QII;""
50 Zaragoza;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2021QI;""
50 Zaragoza;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
50 Zaragoza;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2020QIII;10.986
50 Zaragoza;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2020QII;""
50 Zaragoza;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2020QI;""
50 Zaragoza;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QIV;11.049
50 Zaragoza;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
50 Zaragoza;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QII;""
50 Zaragoza;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QI;""
50 Zaragoza;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QIV;10.973
50 Zaragoza;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
50 Zaragoza;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QII;""
50 Zaragoza;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QI;""
50 Zaragoza;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QIV;10.805
50 Zaragoza;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
50 Zaragoza;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QII;""
50 Zaragoza;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QI;""
50 Zaragoza;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
50 Zaragoza;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
50 Zaragoza;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QII;""
50 Zaragoza;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QI;10.820
50 Zaragoza;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
50 Zaragoza;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
50 Zaragoza;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QII;""
50 Zaragoza;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QI;10.691
50 Zaragoza;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
50 Zaragoza;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
50 Zaragoza;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QII;""
50 Zaragoza;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QI;""
50 Zaragoza;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
50 Zaragoza;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
50 Zaragoza;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
50 Zaragoza;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
50 Zaragoza;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
50 Zaragoza;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
50 Zaragoza;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
50 Zaragoza;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
50 Zaragoza;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
50 Zaragoza;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
50 Zaragoza;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
50 Zaragoza;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
50 Zaragoza;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
50 Zaragoza;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
50 Zaragoza;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;97,91
50 Zaragoza;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
50 Zaragoza;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
50 Zaragoza;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
50 Zaragoza;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;98,3
50 Zaragoza;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
50 Zaragoza;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
50 Zaragoza;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
50 Zaragoza;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;98,83
50 Zaragoza;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
50 Zaragoza;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
50 Zaragoza;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;96,39
50 Zaragoza;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
50 Zaragoza;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
50 Zaragoza;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
50 Zaragoza;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;96,79
50 Zaragoza;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
50 Zaragoza;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
50 Zaragoza;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
50 Zaragoza;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;96,98
50 Zaragoza;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
50 Zaragoza;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
50 Zaragoza;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;94,72
50 Zaragoza;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
50 Zaragoza;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
50 Zaragoza;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
50 Zaragoza;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;95,24
50 Zaragoza;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
50 Zaragoza;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
50 Zaragoza;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
50 Zaragoza;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;95,38
50 Zaragoza;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
50 Zaragoza;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
50 Zaragoza;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
50 Zaragoza;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
50 Zaragoza;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
50 Zaragoza;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
50 Zaragoza;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;93,92
50 Zaragoza;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
50 Zaragoza;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
50 Zaragoza;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
50 Zaragoza;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;94,38
50 Zaragoza;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
50 Zaragoza;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
50 Zaragoza;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
50 Zaragoza;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
50 Zaragoza;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
50 Zaragoza;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
50 Zaragoza;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QII;6.756
50 Zaragoza;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
50 Zaragoza;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
50 Zaragoza;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
50 Zaragoza;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QII;6.636
50 Zaragoza;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
50 Zaragoza;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
50 Zaragoza;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
50 Zaragoza;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QII;6.494
50 Zaragoza;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
50 Zaragoza;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
50 Zaragoza;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
50 Zaragoza;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2022QII;6.586
50 Zaragoza;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2022QI;""
50 Zaragoza;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
50 Zaragoza;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
50 Zaragoza;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2021QII;6.500
50 Zaragoza;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2021QI;""
50 Zaragoza;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
50 Zaragoza;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
50 Zaragoza;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2020QII;6.353
50 Zaragoza;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2020QI;""
50 Zaragoza;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
50 Zaragoza;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2022QIII;6.438
50 Zaragoza;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2022QII;""
50 Zaragoza;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2022QI;""
50 Zaragoza;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
50 Zaragoza;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2021QIII;6.379
50 Zaragoza;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2021QII;""
50 Zaragoza;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2021QI;""
50 Zaragoza;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
50 Zaragoza;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2020QIII;6.217
50 Zaragoza;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2020QII;""
50 Zaragoza;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2020QI;""
50 Zaragoza;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QIV;6.273
50 Zaragoza;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
50 Zaragoza;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QII;""
50 Zaragoza;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QI;""
50 Zaragoza;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QIV;6.266
50 Zaragoza;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
50 Zaragoza;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QII;""
50 Zaragoza;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QI;""
50 Zaragoza;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QIV;6.093
50 Zaragoza;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
50 Zaragoza;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QII;""
50 Zaragoza;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QI;""
50 Zaragoza;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
50 Zaragoza;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
50 Zaragoza;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QII;""
50 Zaragoza;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QI;6.152
50 Zaragoza;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
50 Zaragoza;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
50 Zaragoza;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QII;""
50 Zaragoza;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QI;5.993
50 Zaragoza;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
50 Zaragoza;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
50 Zaragoza;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QII;""
50 Zaragoza;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QI;""
50 Zaragoza;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
50 Zaragoza;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
50 Zaragoza;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
50 Zaragoza;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
50 Zaragoza;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
50 Zaragoza;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
50 Zaragoza;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
50 Zaragoza;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
50 Zaragoza;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
50 Zaragoza;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
50 Zaragoza;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
50 Zaragoza;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
50 Zaragoza;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
50 Zaragoza;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
50 Zaragoza;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;97,48
50 Zaragoza;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
50 Zaragoza;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
50 Zaragoza;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
50 Zaragoza;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;97,95
50 Zaragoza;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
50 Zaragoza;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
50 Zaragoza;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
50 Zaragoza;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;97,83
50 Zaragoza;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
50 Zaragoza;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
50 Zaragoza;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;95,29
50 Zaragoza;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
50 Zaragoza;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
50 Zaragoza;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
50 Zaragoza;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;96,13
50 Zaragoza;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
50 Zaragoza;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
50 Zaragoza;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
50 Zaragoza;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;95,73
50 Zaragoza;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
50 Zaragoza;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
50 Zaragoza;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;92,85
50 Zaragoza;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
50 Zaragoza;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
50 Zaragoza;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
50 Zaragoza;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;94,42
50 Zaragoza;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
50 Zaragoza;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
50 Zaragoza;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
50 Zaragoza;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;93,83
50 Zaragoza;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
50 Zaragoza;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
50 Zaragoza;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
50 Zaragoza;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
50 Zaragoza;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
50 Zaragoza;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
50 Zaragoza;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;92,71
50 Zaragoza;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
50 Zaragoza;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
50 Zaragoza;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
50 Zaragoza;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;92,29
50 Zaragoza;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
50 Zaragoza;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
50 Zaragoza;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
50 Zaragoza;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
50 Zaragoza;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
50 Zaragoza;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QIII;18.329
50 Zaragoza;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
50 Zaragoza;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
50 Zaragoza;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
50 Zaragoza;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QIII;18.163
50 Zaragoza;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
50 Zaragoza;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
50 Zaragoza;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
50 Zaragoza;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QIII;17.890
50 Zaragoza;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
50 Zaragoza;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
50 Zaragoza;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
50 Zaragoza;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2022QIII;17.932
50 Zaragoza;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2022QII;""
50 Zaragoza;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2022QI;""
50 Zaragoza;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
50 Zaragoza;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2021QIII;17.807
50 Zaragoza;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2021QII;""
50 Zaragoza;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2021QI;""
50 Zaragoza;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
50 Zaragoza;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2020QIII;17.496
50 Zaragoza;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2020QII;""
50 Zaragoza;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2020QI;""
50 Zaragoza;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2022QIV;17.543
50 Zaragoza;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
50 Zaragoza;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2022QII;""
50 Zaragoza;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2022QI;""
50 Zaragoza;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2021QIV;17.484
50 Zaragoza;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
50 Zaragoza;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2021QII;""
50 Zaragoza;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2021QI;""
50 Zaragoza;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2020QIV;17.166
50 Zaragoza;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
50 Zaragoza;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2020QII;""
50 Zaragoza;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2020QI;""
50 Zaragoza;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
50 Zaragoza;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
50 Zaragoza;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QII;""
50 Zaragoza;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QI;17.202
50 Zaragoza;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
50 Zaragoza;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
50 Zaragoza;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QII;""
50 Zaragoza;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QI;16.938
50 Zaragoza;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
50 Zaragoza;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
50 Zaragoza;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QII;""
50 Zaragoza;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QI;""
50 Zaragoza;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
50 Zaragoza;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
50 Zaragoza;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QII;16.912
50 Zaragoza;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QI;""
50 Zaragoza;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
50 Zaragoza;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
50 Zaragoza;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QII;16.697
50 Zaragoza;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QI;""
50 Zaragoza;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
50 Zaragoza;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
50 Zaragoza;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QII;""
50 Zaragoza;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QI;""
50 Zaragoza;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
50 Zaragoza;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
50 Zaragoza;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
50 Zaragoza;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
50 Zaragoza;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
50 Zaragoza;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
50 Zaragoza;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
50 Zaragoza;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
50 Zaragoza;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
50 Zaragoza;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
50 Zaragoza;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
50 Zaragoza;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
50 Zaragoza;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
50 Zaragoza;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;97,83
50 Zaragoza;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
50 Zaragoza;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
50 Zaragoza;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
50 Zaragoza;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;98,04
50 Zaragoza;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
50 Zaragoza;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
50 Zaragoza;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
50 Zaragoza;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;97,8
50 Zaragoza;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
50 Zaragoza;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
50 Zaragoza;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;95,71
50 Zaragoza;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
50 Zaragoza;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
50 Zaragoza;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
50 Zaragoza;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;96,26
50 Zaragoza;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
50 Zaragoza;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
50 Zaragoza;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
50 Zaragoza;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;95,95
50 Zaragoza;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
50 Zaragoza;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
50 Zaragoza;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
50 Zaragoza;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
50 Zaragoza;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
50 Zaragoza;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
50 Zaragoza;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;94,71
50 Zaragoza;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
50 Zaragoza;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
50 Zaragoza;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
50 Zaragoza;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;94,68
50 Zaragoza;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
50 Zaragoza;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
50 Zaragoza;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
50 Zaragoza;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
50 Zaragoza;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
50 Zaragoza;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
50 Zaragoza;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;93,11
50 Zaragoza;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
50 Zaragoza;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
50 Zaragoza;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
50 Zaragoza;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;93,33
50 Zaragoza;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
50 Zaragoza;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
50 Zaragoza;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
50 Zaragoza;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
50 Zaragoza;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
50 Zaragoza;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
50 Zaragoza;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QIII;11.590
50 Zaragoza;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
50 Zaragoza;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
50 Zaragoza;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
50 Zaragoza;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QIII;11.517
50 Zaragoza;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
50 Zaragoza;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
50 Zaragoza;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
50 Zaragoza;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QIII;11.397
50 Zaragoza;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
50 Zaragoza;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
50 Zaragoza;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
50 Zaragoza;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2022QIII;11.380
50 Zaragoza;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2022QII;""
50 Zaragoza;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2022QI;""
50 Zaragoza;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
50 Zaragoza;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2021QIII;11.303
50 Zaragoza;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2021QII;""
50 Zaragoza;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2021QI;""
50 Zaragoza;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
50 Zaragoza;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2020QIII;11.156
50 Zaragoza;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2020QII;""
50 Zaragoza;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2020QI;""
50 Zaragoza;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2022QIV;11.164
50 Zaragoza;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
50 Zaragoza;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2022QII;""
50 Zaragoza;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2022QI;""
50 Zaragoza;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2021QIV;11.108
50 Zaragoza;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
50 Zaragoza;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2021QII;""
50 Zaragoza;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2021QI;""
50 Zaragoza;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2020QIV;10.963
50 Zaragoza;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
50 Zaragoza;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2020QII;""
50 Zaragoza;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2020QI;""
50 Zaragoza;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
50 Zaragoza;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
50 Zaragoza;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QII;""
50 Zaragoza;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QI;10.943
50 Zaragoza;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
50 Zaragoza;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
50 Zaragoza;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QII;""
50 Zaragoza;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QI;10.844
50 Zaragoza;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
50 Zaragoza;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
50 Zaragoza;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QII;""
50 Zaragoza;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QI;""
50 Zaragoza;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
50 Zaragoza;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
50 Zaragoza;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QII;10.771
50 Zaragoza;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QI;""
50 Zaragoza;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
50 Zaragoza;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
50 Zaragoza;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QII;10.696
50 Zaragoza;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QI;""
50 Zaragoza;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
50 Zaragoza;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
50 Zaragoza;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QII;""
50 Zaragoza;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QI;""
50 Zaragoza;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
50 Zaragoza;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
50 Zaragoza;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
50 Zaragoza;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
50 Zaragoza;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
50 Zaragoza;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
50 Zaragoza;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
50 Zaragoza;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
50 Zaragoza;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
50 Zaragoza;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
50 Zaragoza;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
50 Zaragoza;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
50 Zaragoza;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
50 Zaragoza;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;98,19
50 Zaragoza;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
50 Zaragoza;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
50 Zaragoza;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
50 Zaragoza;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;98,14
50 Zaragoza;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
50 Zaragoza;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
50 Zaragoza;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
50 Zaragoza;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;97,89
50 Zaragoza;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
50 Zaragoza;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
50 Zaragoza;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;96,32
50 Zaragoza;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
50 Zaragoza;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
50 Zaragoza;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
50 Zaragoza;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;96,45
50 Zaragoza;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
50 Zaragoza;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
50 Zaragoza;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
50 Zaragoza;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;96,19
50 Zaragoza;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
50 Zaragoza;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
50 Zaragoza;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
50 Zaragoza;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
50 Zaragoza;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
50 Zaragoza;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
50 Zaragoza;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;95,02
50 Zaragoza;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
50 Zaragoza;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
50 Zaragoza;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
50 Zaragoza;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;95,15
50 Zaragoza;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
50 Zaragoza;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
50 Zaragoza;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
50 Zaragoza;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
50 Zaragoza;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
50 Zaragoza;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
50 Zaragoza;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;93,52
50 Zaragoza;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
50 Zaragoza;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
50 Zaragoza;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
50 Zaragoza;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;93,85
50 Zaragoza;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
50 Zaragoza;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
50 Zaragoza;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
50 Zaragoza;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
50 Zaragoza;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
50 Zaragoza;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
50 Zaragoza;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QIII;6.739
50 Zaragoza;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
50 Zaragoza;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
50 Zaragoza;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
50 Zaragoza;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QIII;6.646
50 Zaragoza;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
50 Zaragoza;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
50 Zaragoza;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
50 Zaragoza;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QIII;6.493
50 Zaragoza;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
50 Zaragoza;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
50 Zaragoza;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
50 Zaragoza;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2022QIII;6.552
50 Zaragoza;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2022QII;""
50 Zaragoza;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2022QI;""
50 Zaragoza;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
50 Zaragoza;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2021QIII;6.504
50 Zaragoza;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2021QII;""
50 Zaragoza;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2021QI;""
50 Zaragoza;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
50 Zaragoza;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2020QIII;6.340
50 Zaragoza;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2020QII;""
50 Zaragoza;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2020QI;""
50 Zaragoza;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2022QIV;6.379
50 Zaragoza;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
50 Zaragoza;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2022QII;""
50 Zaragoza;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2022QI;""
50 Zaragoza;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2021QIV;6.376
50 Zaragoza;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
50 Zaragoza;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2021QII;""
50 Zaragoza;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2021QI;""
50 Zaragoza;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2020QIV;6.203
50 Zaragoza;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
50 Zaragoza;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2020QII;""
50 Zaragoza;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2020QI;""
50 Zaragoza;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
50 Zaragoza;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
50 Zaragoza;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QII;""
50 Zaragoza;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QI;6.259
50 Zaragoza;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
50 Zaragoza;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
50 Zaragoza;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QII;""
50 Zaragoza;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QI;6.094
50 Zaragoza;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
50 Zaragoza;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
50 Zaragoza;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QII;""
50 Zaragoza;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QI;""
50 Zaragoza;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
50 Zaragoza;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
50 Zaragoza;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QII;6.141
50 Zaragoza;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QI;""
50 Zaragoza;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
50 Zaragoza;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
50 Zaragoza;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QII;6.001
50 Zaragoza;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QI;""
50 Zaragoza;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
50 Zaragoza;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
50 Zaragoza;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QII;""
50 Zaragoza;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QI;""
50 Zaragoza;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
50 Zaragoza;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
50 Zaragoza;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
50 Zaragoza;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
50 Zaragoza;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
50 Zaragoza;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
50 Zaragoza;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
50 Zaragoza;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
50 Zaragoza;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
50 Zaragoza;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
50 Zaragoza;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
50 Zaragoza;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
50 Zaragoza;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
50 Zaragoza;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;97,23
50 Zaragoza;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
50 Zaragoza;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
50 Zaragoza;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
50 Zaragoza;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;97,86
50 Zaragoza;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
50 Zaragoza;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
50 Zaragoza;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
50 Zaragoza;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;97,64
50 Zaragoza;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
50 Zaragoza;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
50 Zaragoza;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;94,66
50 Zaragoza;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
50 Zaragoza;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
50 Zaragoza;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
50 Zaragoza;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;95,94
50 Zaragoza;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
50 Zaragoza;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
50 Zaragoza;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
50 Zaragoza;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;95,53
50 Zaragoza;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
50 Zaragoza;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
50 Zaragoza;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
50 Zaragoza;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
50 Zaragoza;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
50 Zaragoza;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
50 Zaragoza;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;94,18
50 Zaragoza;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
50 Zaragoza;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
50 Zaragoza;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
50 Zaragoza;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;93,85
50 Zaragoza;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
50 Zaragoza;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
50 Zaragoza;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
50 Zaragoza;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
50 Zaragoza;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
50 Zaragoza;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
50 Zaragoza;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;92,4
50 Zaragoza;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
50 Zaragoza;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
50 Zaragoza;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
50 Zaragoza;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;92,42
50 Zaragoza;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
50 Zaragoza;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
50 Zaragoza;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
50 Zaragoza;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
50 Zaragoza;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
50 Zaragoza;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QIV;18.242
50 Zaragoza;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
50 Zaragoza;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
50 Zaragoza;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
50 Zaragoza;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QIV;18.061
50 Zaragoza;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
50 Zaragoza;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
50 Zaragoza;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
50 Zaragoza;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QIV;17.791
50 Zaragoza;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
50 Zaragoza;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
50 Zaragoza;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
50 Zaragoza;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2022QIV;17.806
50 Zaragoza;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
50 Zaragoza;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2022QII;""
50 Zaragoza;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2022QI;""
50 Zaragoza;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2021QIV;17.709
50 Zaragoza;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
50 Zaragoza;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2021QII;""
50 Zaragoza;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2021QI;""
50 Zaragoza;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2020QIV;17.418
50 Zaragoza;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
50 Zaragoza;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2020QII;""
50 Zaragoza;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2020QI;""
50 Zaragoza;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
50 Zaragoza;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
50 Zaragoza;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2022QII;""
50 Zaragoza;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2022QI;17.405
50 Zaragoza;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
50 Zaragoza;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
50 Zaragoza;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2021QII;""
50 Zaragoza;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2021QI;17.173
50 Zaragoza;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
50 Zaragoza;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
50 Zaragoza;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2020QII;""
50 Zaragoza;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2020QI;""
50 Zaragoza;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
50 Zaragoza;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
50 Zaragoza;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QII;17.097
50 Zaragoza;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QI;""
50 Zaragoza;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
50 Zaragoza;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
50 Zaragoza;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QII;16.914
50 Zaragoza;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QI;""
50 Zaragoza;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
50 Zaragoza;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
50 Zaragoza;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QII;""
50 Zaragoza;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QI;""
50 Zaragoza;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
50 Zaragoza;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QIII;16.808
50 Zaragoza;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QII;""
50 Zaragoza;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QI;""
50 Zaragoza;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
50 Zaragoza;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QIII;16.676
50 Zaragoza;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QII;""
50 Zaragoza;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QI;""
50 Zaragoza;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
50 Zaragoza;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
50 Zaragoza;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QII;""
50 Zaragoza;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QI;""
50 Zaragoza;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
50 Zaragoza;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
50 Zaragoza;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
50 Zaragoza;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
50 Zaragoza;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
50 Zaragoza;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
50 Zaragoza;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
50 Zaragoza;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
50 Zaragoza;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
50 Zaragoza;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
50 Zaragoza;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
50 Zaragoza;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
50 Zaragoza;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;97,61
50 Zaragoza;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
50 Zaragoza;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
50 Zaragoza;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
50 Zaragoza;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;98,05
50 Zaragoza;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
50 Zaragoza;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
50 Zaragoza;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
50 Zaragoza;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;97,9
50 Zaragoza;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
50 Zaragoza;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
50 Zaragoza;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
50 Zaragoza;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
50 Zaragoza;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
50 Zaragoza;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
50 Zaragoza;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;96,37
50 Zaragoza;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
50 Zaragoza;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
50 Zaragoza;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
50 Zaragoza;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;96,53
50 Zaragoza;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
50 Zaragoza;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
50 Zaragoza;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
50 Zaragoza;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
50 Zaragoza;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
50 Zaragoza;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
50 Zaragoza;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;94,66
50 Zaragoza;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
50 Zaragoza;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
50 Zaragoza;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
50 Zaragoza;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;95,07
50 Zaragoza;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
50 Zaragoza;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
50 Zaragoza;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
50 Zaragoza;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
50 Zaragoza;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
50 Zaragoza;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
50 Zaragoza;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;93,06
50 Zaragoza;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
50 Zaragoza;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
50 Zaragoza;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
50 Zaragoza;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;93,73
50 Zaragoza;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
50 Zaragoza;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
50 Zaragoza;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
50 Zaragoza;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
50 Zaragoza;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
50 Zaragoza;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
50 Zaragoza;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QIV;11.557
50 Zaragoza;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
50 Zaragoza;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
50 Zaragoza;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
50 Zaragoza;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QIV;11.442
50 Zaragoza;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
50 Zaragoza;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
50 Zaragoza;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
50 Zaragoza;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QIV;11.321
50 Zaragoza;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
50 Zaragoza;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
50 Zaragoza;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
50 Zaragoza;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2022QIV;11.312
50 Zaragoza;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
50 Zaragoza;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2022QII;""
50 Zaragoza;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2022QI;""
50 Zaragoza;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2021QIV;11.227
50 Zaragoza;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
50 Zaragoza;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2021QII;""
50 Zaragoza;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2021QI;""
50 Zaragoza;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2020QIV;11.106
50 Zaragoza;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
50 Zaragoza;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2020QII;""
50 Zaragoza;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2020QI;""
50 Zaragoza;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
50 Zaragoza;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
50 Zaragoza;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2022QII;""
50 Zaragoza;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2022QI;11.050
50 Zaragoza;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
50 Zaragoza;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
50 Zaragoza;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2021QII;""
50 Zaragoza;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2021QI;10.975
50 Zaragoza;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
50 Zaragoza;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
50 Zaragoza;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2020QII;""
50 Zaragoza;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2020QI;""
50 Zaragoza;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
50 Zaragoza;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
50 Zaragoza;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QII;10.869
50 Zaragoza;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QI;""
50 Zaragoza;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
50 Zaragoza;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
50 Zaragoza;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QII;10.817
50 Zaragoza;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QI;""
50 Zaragoza;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
50 Zaragoza;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
50 Zaragoza;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QII;""
50 Zaragoza;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QI;""
50 Zaragoza;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
50 Zaragoza;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QIII;10.710
50 Zaragoza;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QII;""
50 Zaragoza;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QI;""
50 Zaragoza;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
50 Zaragoza;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QIII;10.675
50 Zaragoza;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QII;""
50 Zaragoza;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QI;""
50 Zaragoza;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
50 Zaragoza;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
50 Zaragoza;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QII;""
50 Zaragoza;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QI;""
50 Zaragoza;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
50 Zaragoza;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
50 Zaragoza;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
50 Zaragoza;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
50 Zaragoza;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
50 Zaragoza;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
50 Zaragoza;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
50 Zaragoza;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
50 Zaragoza;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
50 Zaragoza;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
50 Zaragoza;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
50 Zaragoza;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
50 Zaragoza;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;97,88
50 Zaragoza;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
50 Zaragoza;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
50 Zaragoza;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
50 Zaragoza;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;98,12
50 Zaragoza;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
50 Zaragoza;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
50 Zaragoza;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
50 Zaragoza;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;98,1
50 Zaragoza;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
50 Zaragoza;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
50 Zaragoza;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
50 Zaragoza;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
50 Zaragoza;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
50 Zaragoza;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
50 Zaragoza;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;96,57
50 Zaragoza;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
50 Zaragoza;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
50 Zaragoza;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
50 Zaragoza;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;96,94
50 Zaragoza;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
50 Zaragoza;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
50 Zaragoza;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
50 Zaragoza;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
50 Zaragoza;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
50 Zaragoza;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
50 Zaragoza;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;94,99
50 Zaragoza;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
50 Zaragoza;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
50 Zaragoza;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
50 Zaragoza;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;95,55
50 Zaragoza;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
50 Zaragoza;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
50 Zaragoza;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
50 Zaragoza;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
50 Zaragoza;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
50 Zaragoza;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
50 Zaragoza;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;93,6
50 Zaragoza;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
50 Zaragoza;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
50 Zaragoza;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
50 Zaragoza;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;94,29
50 Zaragoza;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
50 Zaragoza;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
50 Zaragoza;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
50 Zaragoza;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
50 Zaragoza;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
50 Zaragoza;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
50 Zaragoza;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QIV;6.685
50 Zaragoza;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
50 Zaragoza;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
50 Zaragoza;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
50 Zaragoza;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QIV;6.619
50 Zaragoza;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
50 Zaragoza;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
50 Zaragoza;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
50 Zaragoza;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QIV;6.470
50 Zaragoza;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
50 Zaragoza;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
50 Zaragoza;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
50 Zaragoza;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2022QIV;6.494
50 Zaragoza;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
50 Zaragoza;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2022QII;""
50 Zaragoza;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2022QI;""
50 Zaragoza;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2021QIV;6.482
50 Zaragoza;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
50 Zaragoza;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2021QII;""
50 Zaragoza;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2021QI;""
50 Zaragoza;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2020QIV;6.312
50 Zaragoza;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
50 Zaragoza;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2020QII;""
50 Zaragoza;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2020QI;""
50 Zaragoza;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
50 Zaragoza;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
50 Zaragoza;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2022QII;""
50 Zaragoza;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2022QI;6.355
50 Zaragoza;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
50 Zaragoza;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
50 Zaragoza;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2021QII;""
50 Zaragoza;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2021QI;6.198
50 Zaragoza;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
50 Zaragoza;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
50 Zaragoza;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2020QII;""
50 Zaragoza;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2020QI;""
50 Zaragoza;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
50 Zaragoza;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
50 Zaragoza;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QII;6.228
50 Zaragoza;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QI;""
50 Zaragoza;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
50 Zaragoza;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
50 Zaragoza;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QII;6.097
50 Zaragoza;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QI;""
50 Zaragoza;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
50 Zaragoza;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
50 Zaragoza;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QII;""
50 Zaragoza;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QI;""
50 Zaragoza;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
50 Zaragoza;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QIII;6.098
50 Zaragoza;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QII;""
50 Zaragoza;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QI;""
50 Zaragoza;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
50 Zaragoza;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QIII;6.001
50 Zaragoza;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QII;""
50 Zaragoza;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QI;""
50 Zaragoza;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
50 Zaragoza;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
50 Zaragoza;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QII;""
50 Zaragoza;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QI;""
50 Zaragoza;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
50 Zaragoza;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
50 Zaragoza;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
50 Zaragoza;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
50 Zaragoza;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
50 Zaragoza;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
50 Zaragoza;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
50 Zaragoza;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
50 Zaragoza;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
50 Zaragoza;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
50 Zaragoza;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
50 Zaragoza;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
50 Zaragoza;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;97,14
50 Zaragoza;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
50 Zaragoza;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
50 Zaragoza;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
50 Zaragoza;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;97,93
50 Zaragoza;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
50 Zaragoza;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
50 Zaragoza;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
50 Zaragoza;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;97,56
50 Zaragoza;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
50 Zaragoza;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
50 Zaragoza;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
50 Zaragoza;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
50 Zaragoza;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
50 Zaragoza;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
50 Zaragoza;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;96,01
50 Zaragoza;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
50 Zaragoza;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
50 Zaragoza;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
50 Zaragoza;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;95,8
50 Zaragoza;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
50 Zaragoza;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
50 Zaragoza;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
50 Zaragoza;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
50 Zaragoza;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
50 Zaragoza;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
50 Zaragoza;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;94,09
50 Zaragoza;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
50 Zaragoza;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
50 Zaragoza;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
50 Zaragoza;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;94,23
50 Zaragoza;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
50 Zaragoza;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
50 Zaragoza;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
50 Zaragoza;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
50 Zaragoza;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
50 Zaragoza;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
50 Zaragoza;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;92,13
50 Zaragoza;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
50 Zaragoza;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
50 Zaragoza;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
50 Zaragoza;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;92,75
50 Zaragoza;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
50 Zaragoza;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
50 Zaragoza;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
50 Zaragoza;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
50 Zaragoza;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
50 Zaragoza;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
50 Zaragoza;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
50 Zaragoza;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
50 Zaragoza;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
50 Zaragoza;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QI;8.678
50 Zaragoza;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
50 Zaragoza;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
50 Zaragoza;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
50 Zaragoza;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QI;8.265
50 Zaragoza;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
50 Zaragoza;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
50 Zaragoza;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
50 Zaragoza;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QI;9.641
50 Zaragoza;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
50 Zaragoza;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
50 Zaragoza;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2022QII;""
50 Zaragoza;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2022QI;8.310
50 Zaragoza;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
50 Zaragoza;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
50 Zaragoza;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2021QII;""
50 Zaragoza;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2021QI;7.990
50 Zaragoza;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
50 Zaragoza;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
50 Zaragoza;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2020QII;""
50 Zaragoza;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2020QI;8.989
50 Zaragoza;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
50 Zaragoza;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
50 Zaragoza;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2022QII;7.976
50 Zaragoza;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2022QI;""
50 Zaragoza;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
50 Zaragoza;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
50 Zaragoza;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2021QII;7.695
50 Zaragoza;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2021QI;""
50 Zaragoza;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
50 Zaragoza;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
50 Zaragoza;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2020QII;8.696
50 Zaragoza;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2020QI;""
50 Zaragoza;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
50 Zaragoza;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QIII;7.709
50 Zaragoza;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QII;""
50 Zaragoza;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QI;""
50 Zaragoza;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
50 Zaragoza;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QIII;7.447
50 Zaragoza;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QII;""
50 Zaragoza;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QI;""
50 Zaragoza;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
50 Zaragoza;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QIII;8.363
50 Zaragoza;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QII;""
50 Zaragoza;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QI;""
50 Zaragoza;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QIV;7.087
50 Zaragoza;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
50 Zaragoza;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QII;""
50 Zaragoza;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QI;""
50 Zaragoza;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QIV;7.022
50 Zaragoza;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
50 Zaragoza;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QII;""
50 Zaragoza;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QI;""
50 Zaragoza;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QIV;7.925
50 Zaragoza;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
50 Zaragoza;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QII;""
50 Zaragoza;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QI;""
50 Zaragoza;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
50 Zaragoza;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
50 Zaragoza;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
50 Zaragoza;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
50 Zaragoza;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
50 Zaragoza;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
50 Zaragoza;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
50 Zaragoza;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
50 Zaragoza;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
50 Zaragoza;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
50 Zaragoza;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
50 Zaragoza;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
50 Zaragoza;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
50 Zaragoza;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
50 Zaragoza;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
50 Zaragoza;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;95,76
50 Zaragoza;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
50 Zaragoza;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
50 Zaragoza;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
50 Zaragoza;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;96,67
50 Zaragoza;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
50 Zaragoza;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
50 Zaragoza;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
50 Zaragoza;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;93,24
50 Zaragoza;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
50 Zaragoza;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
50 Zaragoza;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;91,91
50 Zaragoza;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
50 Zaragoza;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
50 Zaragoza;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
50 Zaragoza;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;93,1
50 Zaragoza;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
50 Zaragoza;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
50 Zaragoza;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
50 Zaragoza;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;90,2
50 Zaragoza;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
50 Zaragoza;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
50 Zaragoza;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;88,83
50 Zaragoza;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
50 Zaragoza;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
50 Zaragoza;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
50 Zaragoza;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;90,1
50 Zaragoza;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
50 Zaragoza;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
50 Zaragoza;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
50 Zaragoza;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;86,74
50 Zaragoza;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
50 Zaragoza;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
50 Zaragoza;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;81,67
50 Zaragoza;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
50 Zaragoza;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
50 Zaragoza;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
50 Zaragoza;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;84,96
50 Zaragoza;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
50 Zaragoza;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
50 Zaragoza;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
50 Zaragoza;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;82,2
50 Zaragoza;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
50 Zaragoza;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
50 Zaragoza;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
50 Zaragoza;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
50 Zaragoza;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
50 Zaragoza;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
50 Zaragoza;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QI;5.617
50 Zaragoza;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
50 Zaragoza;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
50 Zaragoza;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
50 Zaragoza;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QI;5.310
50 Zaragoza;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
50 Zaragoza;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
50 Zaragoza;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
50 Zaragoza;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QI;6.183
50 Zaragoza;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
50 Zaragoza;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
50 Zaragoza;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2022QII;""
50 Zaragoza;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2022QI;5.379
50 Zaragoza;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
50 Zaragoza;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
50 Zaragoza;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2021QII;""
50 Zaragoza;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2021QI;5.148
50 Zaragoza;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
50 Zaragoza;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
50 Zaragoza;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2020QII;""
50 Zaragoza;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2020QI;5.783
50 Zaragoza;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
50 Zaragoza;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
50 Zaragoza;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2022QII;5.176
50 Zaragoza;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2022QI;""
50 Zaragoza;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
50 Zaragoza;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
50 Zaragoza;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2021QII;4.973
50 Zaragoza;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2021QI;""
50 Zaragoza;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
50 Zaragoza;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
50 Zaragoza;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2020QII;5.604
50 Zaragoza;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2020QI;""
50 Zaragoza;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
50 Zaragoza;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QIII;5.011
50 Zaragoza;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QII;""
50 Zaragoza;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QI;""
50 Zaragoza;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
50 Zaragoza;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QIII;4.821
50 Zaragoza;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QII;""
50 Zaragoza;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QI;""
50 Zaragoza;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
50 Zaragoza;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QIII;5.384
50 Zaragoza;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QII;""
50 Zaragoza;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QI;""
50 Zaragoza;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QIV;4.584
50 Zaragoza;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
50 Zaragoza;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QII;""
50 Zaragoza;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QI;""
50 Zaragoza;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QIV;4.570
50 Zaragoza;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
50 Zaragoza;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QII;""
50 Zaragoza;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QI;""
50 Zaragoza;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QIV;5.108
50 Zaragoza;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
50 Zaragoza;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QII;""
50 Zaragoza;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QI;""
50 Zaragoza;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
50 Zaragoza;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
50 Zaragoza;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
50 Zaragoza;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
50 Zaragoza;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
50 Zaragoza;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
50 Zaragoza;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
50 Zaragoza;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
50 Zaragoza;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
50 Zaragoza;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
50 Zaragoza;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
50 Zaragoza;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
50 Zaragoza;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
50 Zaragoza;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
50 Zaragoza;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
50 Zaragoza;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;95,76
50 Zaragoza;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
50 Zaragoza;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
50 Zaragoza;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
50 Zaragoza;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;96,95
50 Zaragoza;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
50 Zaragoza;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
50 Zaragoza;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
50 Zaragoza;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;93,53
50 Zaragoza;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
50 Zaragoza;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
50 Zaragoza;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;92,15
50 Zaragoza;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
50 Zaragoza;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
50 Zaragoza;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
50 Zaragoza;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;93,65
50 Zaragoza;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
50 Zaragoza;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
50 Zaragoza;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
50 Zaragoza;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;90,64
50 Zaragoza;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
50 Zaragoza;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
50 Zaragoza;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;89,21
50 Zaragoza;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
50 Zaragoza;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
50 Zaragoza;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
50 Zaragoza;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;90,79
50 Zaragoza;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
50 Zaragoza;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
50 Zaragoza;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
50 Zaragoza;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;87,08
50 Zaragoza;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
50 Zaragoza;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
50 Zaragoza;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;81,61
50 Zaragoza;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
50 Zaragoza;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
50 Zaragoza;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
50 Zaragoza;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;86,06
50 Zaragoza;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
50 Zaragoza;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
50 Zaragoza;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
50 Zaragoza;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;82,61
50 Zaragoza;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
50 Zaragoza;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
50 Zaragoza;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
50 Zaragoza;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
50 Zaragoza;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
50 Zaragoza;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
50 Zaragoza;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QI;3.061
50 Zaragoza;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
50 Zaragoza;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
50 Zaragoza;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
50 Zaragoza;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QI;2.955
50 Zaragoza;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
50 Zaragoza;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
50 Zaragoza;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
50 Zaragoza;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QI;3.458
50 Zaragoza;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
50 Zaragoza;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
50 Zaragoza;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2022QII;""
50 Zaragoza;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2022QI;2.931
50 Zaragoza;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
50 Zaragoza;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
50 Zaragoza;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2021QII;""
50 Zaragoza;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2021QI;2.842
50 Zaragoza;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
50 Zaragoza;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
50 Zaragoza;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2020QII;""
50 Zaragoza;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2020QI;3.206
50 Zaragoza;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
50 Zaragoza;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
50 Zaragoza;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2022QII;2.800
50 Zaragoza;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2022QI;""
50 Zaragoza;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
50 Zaragoza;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
50 Zaragoza;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2021QII;2.722
50 Zaragoza;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2021QI;""
50 Zaragoza;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
50 Zaragoza;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
50 Zaragoza;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2020QII;3.092
50 Zaragoza;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2020QI;""
50 Zaragoza;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
50 Zaragoza;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QIII;2.698
50 Zaragoza;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QII;""
50 Zaragoza;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QI;""
50 Zaragoza;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
50 Zaragoza;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QIII;2.626
50 Zaragoza;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QII;""
50 Zaragoza;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QI;""
50 Zaragoza;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
50 Zaragoza;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QIII;2.979
50 Zaragoza;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QII;""
50 Zaragoza;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QI;""
50 Zaragoza;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QIV;2.503
50 Zaragoza;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
50 Zaragoza;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QII;""
50 Zaragoza;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QI;""
50 Zaragoza;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QIV;2.452
50 Zaragoza;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
50 Zaragoza;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QII;""
50 Zaragoza;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QI;""
50 Zaragoza;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QIV;2.817
50 Zaragoza;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
50 Zaragoza;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QII;""
50 Zaragoza;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QI;""
50 Zaragoza;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
50 Zaragoza;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
50 Zaragoza;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
50 Zaragoza;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
50 Zaragoza;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
50 Zaragoza;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
50 Zaragoza;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
50 Zaragoza;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
50 Zaragoza;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
50 Zaragoza;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
50 Zaragoza;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
50 Zaragoza;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
50 Zaragoza;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
50 Zaragoza;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
50 Zaragoza;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
50 Zaragoza;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;95,75
50 Zaragoza;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
50 Zaragoza;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
50 Zaragoza;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
50 Zaragoza;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;96,18
50 Zaragoza;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
50 Zaragoza;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
50 Zaragoza;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
50 Zaragoza;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;92,71
50 Zaragoza;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
50 Zaragoza;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
50 Zaragoza;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;91,47
50 Zaragoza;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
50 Zaragoza;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
50 Zaragoza;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
50 Zaragoza;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;92,12
50 Zaragoza;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
50 Zaragoza;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
50 Zaragoza;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
50 Zaragoza;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;89,42
50 Zaragoza;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
50 Zaragoza;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
50 Zaragoza;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;88,14
50 Zaragoza;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
50 Zaragoza;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
50 Zaragoza;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
50 Zaragoza;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;88,87
50 Zaragoza;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
50 Zaragoza;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
50 Zaragoza;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
50 Zaragoza;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;86,15
50 Zaragoza;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
50 Zaragoza;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
50 Zaragoza;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;81,77
50 Zaragoza;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
50 Zaragoza;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
50 Zaragoza;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
50 Zaragoza;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;82,98
50 Zaragoza;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
50 Zaragoza;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
50 Zaragoza;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
50 Zaragoza;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;81,46
50 Zaragoza;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
50 Zaragoza;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
50 Zaragoza;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
50 Zaragoza;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
50 Zaragoza;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
50 Zaragoza;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QII;9.868
50 Zaragoza;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
50 Zaragoza;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
50 Zaragoza;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
50 Zaragoza;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QII;9.524
50 Zaragoza;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
50 Zaragoza;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
50 Zaragoza;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
50 Zaragoza;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QII;9.162
50 Zaragoza;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
50 Zaragoza;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
50 Zaragoza;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
50 Zaragoza;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2022QII;9.509
50 Zaragoza;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2022QI;""
50 Zaragoza;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
50 Zaragoza;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
50 Zaragoza;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2021QII;9.184
50 Zaragoza;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2021QI;""
50 Zaragoza;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
50 Zaragoza;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
50 Zaragoza;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2020QII;8.850
50 Zaragoza;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2020QI;""
50 Zaragoza;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
50 Zaragoza;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2022QIII;9.213
50 Zaragoza;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2022QII;""
50 Zaragoza;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2022QI;""
50 Zaragoza;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
50 Zaragoza;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2021QIII;8.916
50 Zaragoza;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2021QII;""
50 Zaragoza;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2021QI;""
50 Zaragoza;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
50 Zaragoza;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2020QIII;8.473
50 Zaragoza;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2020QII;""
50 Zaragoza;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2020QI;""
50 Zaragoza;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QIV;8.564
50 Zaragoza;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
50 Zaragoza;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QII;""
50 Zaragoza;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QI;""
50 Zaragoza;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QIV;8.470
50 Zaragoza;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
50 Zaragoza;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QII;""
50 Zaragoza;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QI;""
50 Zaragoza;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QIV;8.029
50 Zaragoza;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
50 Zaragoza;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QII;""
50 Zaragoza;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QI;""
50 Zaragoza;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
50 Zaragoza;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
50 Zaragoza;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QII;""
50 Zaragoza;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QI;8.123
50 Zaragoza;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
50 Zaragoza;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
50 Zaragoza;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QII;""
50 Zaragoza;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QI;7.771
50 Zaragoza;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
50 Zaragoza;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
50 Zaragoza;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QII;""
50 Zaragoza;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QI;""
50 Zaragoza;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
50 Zaragoza;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
50 Zaragoza;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
50 Zaragoza;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
50 Zaragoza;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
50 Zaragoza;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
50 Zaragoza;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
50 Zaragoza;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
50 Zaragoza;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
50 Zaragoza;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
50 Zaragoza;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
50 Zaragoza;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
50 Zaragoza;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
50 Zaragoza;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
50 Zaragoza;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;96,36
50 Zaragoza;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
50 Zaragoza;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
50 Zaragoza;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
50 Zaragoza;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;96,43
50 Zaragoza;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
50 Zaragoza;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
50 Zaragoza;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
50 Zaragoza;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;96,59
50 Zaragoza;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
50 Zaragoza;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
50 Zaragoza;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;93,36
50 Zaragoza;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
50 Zaragoza;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
50 Zaragoza;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
50 Zaragoza;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;93,62
50 Zaragoza;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
50 Zaragoza;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
50 Zaragoza;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
50 Zaragoza;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;92,48
50 Zaragoza;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
50 Zaragoza;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
50 Zaragoza;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;86,79
50 Zaragoza;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
50 Zaragoza;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
50 Zaragoza;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
50 Zaragoza;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;88,93
50 Zaragoza;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
50 Zaragoza;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
50 Zaragoza;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
50 Zaragoza;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;87,63
50 Zaragoza;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
50 Zaragoza;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
50 Zaragoza;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
50 Zaragoza;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
50 Zaragoza;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
50 Zaragoza;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
50 Zaragoza;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;85,29
50 Zaragoza;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
50 Zaragoza;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
50 Zaragoza;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
50 Zaragoza;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;84,82
50 Zaragoza;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
50 Zaragoza;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
50 Zaragoza;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
50 Zaragoza;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
50 Zaragoza;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
50 Zaragoza;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
50 Zaragoza;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QII;6.408
50 Zaragoza;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
50 Zaragoza;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
50 Zaragoza;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
50 Zaragoza;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QII;6.126
50 Zaragoza;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
50 Zaragoza;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
50 Zaragoza;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
50 Zaragoza;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QII;5.895
50 Zaragoza;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
50 Zaragoza;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
50 Zaragoza;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
50 Zaragoza;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2022QII;6.189
50 Zaragoza;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2022QI;""
50 Zaragoza;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
50 Zaragoza;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
50 Zaragoza;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2021QII;5.925
50 Zaragoza;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2021QI;""
50 Zaragoza;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
50 Zaragoza;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
50 Zaragoza;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2020QII;5.703
50 Zaragoza;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2020QI;""
50 Zaragoza;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
50 Zaragoza;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2022QIII;6.007
50 Zaragoza;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2022QII;""
50 Zaragoza;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2022QI;""
50 Zaragoza;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
50 Zaragoza;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2021QIII;5.758
50 Zaragoza;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2021QII;""
50 Zaragoza;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2021QI;""
50 Zaragoza;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
50 Zaragoza;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2020QIII;5.450
50 Zaragoza;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2020QII;""
50 Zaragoza;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2020QI;""
50 Zaragoza;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QIV;5.560
50 Zaragoza;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
50 Zaragoza;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QII;""
50 Zaragoza;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QI;""
50 Zaragoza;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QIV;5.493
50 Zaragoza;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
50 Zaragoza;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QII;""
50 Zaragoza;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QI;""
50 Zaragoza;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QIV;5.168
50 Zaragoza;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
50 Zaragoza;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QII;""
50 Zaragoza;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QI;""
50 Zaragoza;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
50 Zaragoza;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
50 Zaragoza;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QII;""
50 Zaragoza;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QI;5.275
50 Zaragoza;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
50 Zaragoza;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
50 Zaragoza;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QII;""
50 Zaragoza;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QI;5.020
50 Zaragoza;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
50 Zaragoza;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
50 Zaragoza;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QII;""
50 Zaragoza;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QI;""
50 Zaragoza;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
50 Zaragoza;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
50 Zaragoza;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
50 Zaragoza;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
50 Zaragoza;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
50 Zaragoza;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
50 Zaragoza;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
50 Zaragoza;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
50 Zaragoza;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
50 Zaragoza;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
50 Zaragoza;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
50 Zaragoza;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
50 Zaragoza;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
50 Zaragoza;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
50 Zaragoza;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;96,58
50 Zaragoza;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
50 Zaragoza;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
50 Zaragoza;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
50 Zaragoza;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;96,72
50 Zaragoza;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
50 Zaragoza;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
50 Zaragoza;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
50 Zaragoza;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;96,74
50 Zaragoza;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
50 Zaragoza;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
50 Zaragoza;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;93,74
50 Zaragoza;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
50 Zaragoza;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
50 Zaragoza;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
50 Zaragoza;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;93,99
50 Zaragoza;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
50 Zaragoza;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
50 Zaragoza;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
50 Zaragoza;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;92,45
50 Zaragoza;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
50 Zaragoza;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
50 Zaragoza;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;86,77
50 Zaragoza;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
50 Zaragoza;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
50 Zaragoza;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
50 Zaragoza;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;89,67
50 Zaragoza;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
50 Zaragoza;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
50 Zaragoza;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
50 Zaragoza;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;87,67
50 Zaragoza;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
50 Zaragoza;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
50 Zaragoza;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
50 Zaragoza;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
50 Zaragoza;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
50 Zaragoza;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
50 Zaragoza;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;86,11
50 Zaragoza;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
50 Zaragoza;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
50 Zaragoza;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
50 Zaragoza;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;85,16
50 Zaragoza;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
50 Zaragoza;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
50 Zaragoza;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
50 Zaragoza;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
50 Zaragoza;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
50 Zaragoza;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
50 Zaragoza;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QII;3.460
50 Zaragoza;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
50 Zaragoza;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
50 Zaragoza;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
50 Zaragoza;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QII;3.398
50 Zaragoza;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
50 Zaragoza;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
50 Zaragoza;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
50 Zaragoza;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QII;3.267
50 Zaragoza;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
50 Zaragoza;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
50 Zaragoza;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
50 Zaragoza;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2022QII;3.320
50 Zaragoza;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2022QI;""
50 Zaragoza;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
50 Zaragoza;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
50 Zaragoza;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2021QII;3.259
50 Zaragoza;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2021QI;""
50 Zaragoza;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
50 Zaragoza;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
50 Zaragoza;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2020QII;3.147
50 Zaragoza;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2020QI;""
50 Zaragoza;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
50 Zaragoza;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2022QIII;3.206
50 Zaragoza;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2022QII;""
50 Zaragoza;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2022QI;""
50 Zaragoza;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
50 Zaragoza;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2021QIII;3.158
50 Zaragoza;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2021QII;""
50 Zaragoza;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2021QI;""
50 Zaragoza;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
50 Zaragoza;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2020QIII;3.023
50 Zaragoza;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2020QII;""
50 Zaragoza;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2020QI;""
50 Zaragoza;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QIV;3.004
50 Zaragoza;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
50 Zaragoza;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QII;""
50 Zaragoza;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QI;""
50 Zaragoza;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QIV;2.977
50 Zaragoza;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
50 Zaragoza;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QII;""
50 Zaragoza;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QI;""
50 Zaragoza;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QIV;2.861
50 Zaragoza;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
50 Zaragoza;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QII;""
50 Zaragoza;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QI;""
50 Zaragoza;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
50 Zaragoza;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
50 Zaragoza;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QII;""
50 Zaragoza;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QI;2.848
50 Zaragoza;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
50 Zaragoza;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
50 Zaragoza;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QII;""
50 Zaragoza;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QI;2.751
50 Zaragoza;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
50 Zaragoza;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
50 Zaragoza;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QII;""
50 Zaragoza;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QI;""
50 Zaragoza;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
50 Zaragoza;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
50 Zaragoza;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
50 Zaragoza;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
50 Zaragoza;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
50 Zaragoza;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
50 Zaragoza;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
50 Zaragoza;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
50 Zaragoza;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
50 Zaragoza;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
50 Zaragoza;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
50 Zaragoza;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
50 Zaragoza;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
50 Zaragoza;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
50 Zaragoza;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;95,95
50 Zaragoza;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
50 Zaragoza;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
50 Zaragoza;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
50 Zaragoza;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;95,91
50 Zaragoza;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
50 Zaragoza;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
50 Zaragoza;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
50 Zaragoza;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;96,33
50 Zaragoza;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
50 Zaragoza;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
50 Zaragoza;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;92,66
50 Zaragoza;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
50 Zaragoza;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
50 Zaragoza;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
50 Zaragoza;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;92,94
50 Zaragoza;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
50 Zaragoza;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
50 Zaragoza;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
50 Zaragoza;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;92,53
50 Zaragoza;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
50 Zaragoza;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
50 Zaragoza;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;86,82
50 Zaragoza;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
50 Zaragoza;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
50 Zaragoza;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
50 Zaragoza;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;87,61
50 Zaragoza;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
50 Zaragoza;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
50 Zaragoza;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
50 Zaragoza;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;87,57
50 Zaragoza;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
50 Zaragoza;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
50 Zaragoza;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
50 Zaragoza;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
50 Zaragoza;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
50 Zaragoza;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
50 Zaragoza;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;83,81
50 Zaragoza;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
50 Zaragoza;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
50 Zaragoza;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
50 Zaragoza;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;84,21
50 Zaragoza;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
50 Zaragoza;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
50 Zaragoza;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
50 Zaragoza;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
50 Zaragoza;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
50 Zaragoza;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QIII;9.632
50 Zaragoza;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
50 Zaragoza;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
50 Zaragoza;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
50 Zaragoza;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QIII;9.284
50 Zaragoza;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
50 Zaragoza;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
50 Zaragoza;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
50 Zaragoza;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QIII;8.934
50 Zaragoza;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
50 Zaragoza;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
50 Zaragoza;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
50 Zaragoza;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2022QIII;9.301
50 Zaragoza;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2022QII;""
50 Zaragoza;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2022QI;""
50 Zaragoza;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
50 Zaragoza;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2021QIII;8.993
50 Zaragoza;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2021QII;""
50 Zaragoza;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2021QI;""
50 Zaragoza;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
50 Zaragoza;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2020QIII;8.543
50 Zaragoza;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2020QII;""
50 Zaragoza;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2020QI;""
50 Zaragoza;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2022QIV;8.638
50 Zaragoza;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
50 Zaragoza;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2022QII;""
50 Zaragoza;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2022QI;""
50 Zaragoza;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2021QIV;8.539
50 Zaragoza;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
50 Zaragoza;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2021QII;""
50 Zaragoza;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2021QI;""
50 Zaragoza;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2020QIV;8.087
50 Zaragoza;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
50 Zaragoza;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2020QII;""
50 Zaragoza;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2020QI;""
50 Zaragoza;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
50 Zaragoza;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
50 Zaragoza;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QII;""
50 Zaragoza;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QI;8.188
50 Zaragoza;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
50 Zaragoza;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
50 Zaragoza;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QII;""
50 Zaragoza;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QI;7.826
50 Zaragoza;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
50 Zaragoza;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
50 Zaragoza;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QII;""
50 Zaragoza;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QI;""
50 Zaragoza;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
50 Zaragoza;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
50 Zaragoza;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QII;7.879
50 Zaragoza;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QI;""
50 Zaragoza;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
50 Zaragoza;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
50 Zaragoza;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QII;7.554
50 Zaragoza;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QI;""
50 Zaragoza;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
50 Zaragoza;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
50 Zaragoza;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QII;""
50 Zaragoza;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QI;""
50 Zaragoza;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
50 Zaragoza;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
50 Zaragoza;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
50 Zaragoza;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
50 Zaragoza;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
50 Zaragoza;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
50 Zaragoza;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
50 Zaragoza;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
50 Zaragoza;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
50 Zaragoza;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
50 Zaragoza;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
50 Zaragoza;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
50 Zaragoza;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
50 Zaragoza;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;96,56
50 Zaragoza;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
50 Zaragoza;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
50 Zaragoza;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
50 Zaragoza;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;96,87
50 Zaragoza;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
50 Zaragoza;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
50 Zaragoza;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
50 Zaragoza;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;95,62
50 Zaragoza;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
50 Zaragoza;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
50 Zaragoza;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;89,68
50 Zaragoza;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
50 Zaragoza;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
50 Zaragoza;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
50 Zaragoza;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;91,98
50 Zaragoza;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
50 Zaragoza;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
50 Zaragoza;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
50 Zaragoza;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;90,52
50 Zaragoza;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
50 Zaragoza;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
50 Zaragoza;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
50 Zaragoza;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
50 Zaragoza;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
50 Zaragoza;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
50 Zaragoza;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;88,19
50 Zaragoza;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
50 Zaragoza;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
50 Zaragoza;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
50 Zaragoza;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;87,6
50 Zaragoza;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
50 Zaragoza;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
50 Zaragoza;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
50 Zaragoza;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
50 Zaragoza;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
50 Zaragoza;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
50 Zaragoza;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;84,87
50 Zaragoza;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
50 Zaragoza;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
50 Zaragoza;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
50 Zaragoza;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;84,55
50 Zaragoza;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
50 Zaragoza;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
50 Zaragoza;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
50 Zaragoza;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
50 Zaragoza;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
50 Zaragoza;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
50 Zaragoza;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QIII;6.262
50 Zaragoza;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
50 Zaragoza;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
50 Zaragoza;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
50 Zaragoza;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QIII;5.983
50 Zaragoza;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
50 Zaragoza;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
50 Zaragoza;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
50 Zaragoza;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QIII;5.757
50 Zaragoza;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
50 Zaragoza;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
50 Zaragoza;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
50 Zaragoza;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2022QIII;6.062
50 Zaragoza;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2022QII;""
50 Zaragoza;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2022QI;""
50 Zaragoza;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
50 Zaragoza;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2021QIII;5.807
50 Zaragoza;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2021QII;""
50 Zaragoza;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2021QI;""
50 Zaragoza;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
50 Zaragoza;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2020QIII;5.493
50 Zaragoza;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2020QII;""
50 Zaragoza;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2020QI;""
50 Zaragoza;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2022QIV;5.604
50 Zaragoza;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
50 Zaragoza;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2022QII;""
50 Zaragoza;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2022QI;""
50 Zaragoza;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2021QIV;5.536
50 Zaragoza;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
50 Zaragoza;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2021QII;""
50 Zaragoza;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2021QI;""
50 Zaragoza;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2020QIV;5.206
50 Zaragoza;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
50 Zaragoza;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2020QII;""
50 Zaragoza;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2020QI;""
50 Zaragoza;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
50 Zaragoza;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
50 Zaragoza;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QII;""
50 Zaragoza;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QI;5.314
50 Zaragoza;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
50 Zaragoza;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
50 Zaragoza;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QII;""
50 Zaragoza;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QI;5.056
50 Zaragoza;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
50 Zaragoza;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
50 Zaragoza;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QII;""
50 Zaragoza;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QI;""
50 Zaragoza;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
50 Zaragoza;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
50 Zaragoza;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QII;5.122
50 Zaragoza;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QI;""
50 Zaragoza;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
50 Zaragoza;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
50 Zaragoza;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QII;4.894
50 Zaragoza;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QI;""
50 Zaragoza;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
50 Zaragoza;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
50 Zaragoza;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QII;""
50 Zaragoza;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QI;""
50 Zaragoza;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
50 Zaragoza;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
50 Zaragoza;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
50 Zaragoza;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
50 Zaragoza;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
50 Zaragoza;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
50 Zaragoza;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
50 Zaragoza;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
50 Zaragoza;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
50 Zaragoza;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
50 Zaragoza;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
50 Zaragoza;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
50 Zaragoza;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
50 Zaragoza;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;96,81
50 Zaragoza;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
50 Zaragoza;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
50 Zaragoza;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
50 Zaragoza;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;97,06
50 Zaragoza;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
50 Zaragoza;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
50 Zaragoza;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
50 Zaragoza;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;95,41
50 Zaragoza;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
50 Zaragoza;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
50 Zaragoza;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;89,49
50 Zaragoza;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
50 Zaragoza;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
50 Zaragoza;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
50 Zaragoza;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;92,53
50 Zaragoza;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
50 Zaragoza;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
50 Zaragoza;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
50 Zaragoza;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;90,43
50 Zaragoza;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
50 Zaragoza;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
50 Zaragoza;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
50 Zaragoza;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
50 Zaragoza;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
50 Zaragoza;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
50 Zaragoza;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;88,82
50 Zaragoza;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
50 Zaragoza;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
50 Zaragoza;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
50 Zaragoza;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;87,82
50 Zaragoza;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
50 Zaragoza;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
50 Zaragoza;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
50 Zaragoza;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
50 Zaragoza;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
50 Zaragoza;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
50 Zaragoza;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;85,61
50 Zaragoza;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
50 Zaragoza;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
50 Zaragoza;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
50 Zaragoza;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;85,01
50 Zaragoza;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
50 Zaragoza;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
50 Zaragoza;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
50 Zaragoza;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
50 Zaragoza;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
50 Zaragoza;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
50 Zaragoza;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QIII;3.370
50 Zaragoza;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
50 Zaragoza;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
50 Zaragoza;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
50 Zaragoza;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QIII;3.301
50 Zaragoza;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
50 Zaragoza;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
50 Zaragoza;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
50 Zaragoza;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QIII;3.177
50 Zaragoza;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
50 Zaragoza;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
50 Zaragoza;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
50 Zaragoza;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2022QIII;3.239
50 Zaragoza;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2022QII;""
50 Zaragoza;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2022QI;""
50 Zaragoza;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
50 Zaragoza;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2021QIII;3.186
50 Zaragoza;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2021QII;""
50 Zaragoza;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2021QI;""
50 Zaragoza;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
50 Zaragoza;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2020QIII;3.050
50 Zaragoza;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2020QII;""
50 Zaragoza;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2020QI;""
50 Zaragoza;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2022QIV;3.034
50 Zaragoza;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
50 Zaragoza;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2022QII;""
50 Zaragoza;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2022QI;""
50 Zaragoza;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2021QIV;3.003
50 Zaragoza;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
50 Zaragoza;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2021QII;""
50 Zaragoza;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2021QI;""
50 Zaragoza;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2020QIV;2.881
50 Zaragoza;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
50 Zaragoza;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2020QII;""
50 Zaragoza;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2020QI;""
50 Zaragoza;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
50 Zaragoza;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
50 Zaragoza;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QII;""
50 Zaragoza;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QI;2.874
50 Zaragoza;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
50 Zaragoza;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
50 Zaragoza;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QII;""
50 Zaragoza;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QI;2.770
50 Zaragoza;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
50 Zaragoza;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
50 Zaragoza;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QII;""
50 Zaragoza;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QI;""
50 Zaragoza;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
50 Zaragoza;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
50 Zaragoza;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QII;2.757
50 Zaragoza;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QI;""
50 Zaragoza;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
50 Zaragoza;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
50 Zaragoza;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QII;2.660
50 Zaragoza;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QI;""
50 Zaragoza;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
50 Zaragoza;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
50 Zaragoza;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QII;""
50 Zaragoza;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QI;""
50 Zaragoza;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
50 Zaragoza;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
50 Zaragoza;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
50 Zaragoza;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
50 Zaragoza;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
50 Zaragoza;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
50 Zaragoza;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
50 Zaragoza;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
50 Zaragoza;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
50 Zaragoza;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
50 Zaragoza;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
50 Zaragoza;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
50 Zaragoza;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
50 Zaragoza;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;96,11
50 Zaragoza;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
50 Zaragoza;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
50 Zaragoza;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
50 Zaragoza;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;96,52
50 Zaragoza;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
50 Zaragoza;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
50 Zaragoza;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
50 Zaragoza;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;96
50 Zaragoza;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
50 Zaragoza;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
50 Zaragoza;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;90,03
50 Zaragoza;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
50 Zaragoza;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
50 Zaragoza;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
50 Zaragoza;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;90,97
50 Zaragoza;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
50 Zaragoza;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
50 Zaragoza;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
50 Zaragoza;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;90,68
50 Zaragoza;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
50 Zaragoza;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
50 Zaragoza;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
50 Zaragoza;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
50 Zaragoza;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
50 Zaragoza;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
50 Zaragoza;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;87,06
50 Zaragoza;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
50 Zaragoza;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
50 Zaragoza;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
50 Zaragoza;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;87,19
50 Zaragoza;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
50 Zaragoza;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
50 Zaragoza;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
50 Zaragoza;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
50 Zaragoza;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
50 Zaragoza;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
50 Zaragoza;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;83,52
50 Zaragoza;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
50 Zaragoza;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
50 Zaragoza;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
50 Zaragoza;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;83,73
50 Zaragoza;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
50 Zaragoza;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
50 Zaragoza;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
50 Zaragoza;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
50 Zaragoza;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
50 Zaragoza;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QIV;9.392
50 Zaragoza;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
50 Zaragoza;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
50 Zaragoza;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
50 Zaragoza;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QIV;9.052
50 Zaragoza;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
50 Zaragoza;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
50 Zaragoza;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
50 Zaragoza;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QIV;8.654
50 Zaragoza;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
50 Zaragoza;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
50 Zaragoza;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
50 Zaragoza;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2022QIV;8.710
50 Zaragoza;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
50 Zaragoza;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2022QII;""
50 Zaragoza;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2022QI;""
50 Zaragoza;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2021QIV;8.590
50 Zaragoza;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
50 Zaragoza;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2021QII;""
50 Zaragoza;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2021QI;""
50 Zaragoza;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2020QIV;8.184
50 Zaragoza;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
50 Zaragoza;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2020QII;""
50 Zaragoza;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2020QI;""
50 Zaragoza;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
50 Zaragoza;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
50 Zaragoza;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2022QII;""
50 Zaragoza;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2022QI;8.234
50 Zaragoza;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
50 Zaragoza;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
50 Zaragoza;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2021QII;""
50 Zaragoza;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2021QI;7.917
50 Zaragoza;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
50 Zaragoza;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
50 Zaragoza;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2020QII;""
50 Zaragoza;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2020QI;""
50 Zaragoza;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
50 Zaragoza;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
50 Zaragoza;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QII;7.915
50 Zaragoza;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QI;""
50 Zaragoza;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
50 Zaragoza;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
50 Zaragoza;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QII;7.635
50 Zaragoza;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QI;""
50 Zaragoza;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
50 Zaragoza;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
50 Zaragoza;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QII;""
50 Zaragoza;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QI;""
50 Zaragoza;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
50 Zaragoza;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QIII;7.649
50 Zaragoza;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QII;""
50 Zaragoza;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QI;""
50 Zaragoza;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
50 Zaragoza;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QIII;7.390
50 Zaragoza;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QII;""
50 Zaragoza;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QI;""
50 Zaragoza;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
50 Zaragoza;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
50 Zaragoza;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QII;""
50 Zaragoza;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QI;""
50 Zaragoza;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
50 Zaragoza;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
50 Zaragoza;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
50 Zaragoza;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
50 Zaragoza;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
50 Zaragoza;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
50 Zaragoza;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
50 Zaragoza;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
50 Zaragoza;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
50 Zaragoza;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
50 Zaragoza;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
50 Zaragoza;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
50 Zaragoza;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;92,74
50 Zaragoza;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
50 Zaragoza;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
50 Zaragoza;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
50 Zaragoza;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;94,9
50 Zaragoza;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
50 Zaragoza;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
50 Zaragoza;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
50 Zaragoza;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;94,57
50 Zaragoza;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
50 Zaragoza;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
50 Zaragoza;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
50 Zaragoza;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
50 Zaragoza;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
50 Zaragoza;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
50 Zaragoza;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;90,96
50 Zaragoza;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
50 Zaragoza;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
50 Zaragoza;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
50 Zaragoza;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;91,48
50 Zaragoza;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
50 Zaragoza;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
50 Zaragoza;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
50 Zaragoza;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
50 Zaragoza;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
50 Zaragoza;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
50 Zaragoza;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;87,44
50 Zaragoza;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
50 Zaragoza;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
50 Zaragoza;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
50 Zaragoza;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;88,23
50 Zaragoza;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
50 Zaragoza;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
50 Zaragoza;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
50 Zaragoza;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
50 Zaragoza;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
50 Zaragoza;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
50 Zaragoza;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;84,5
50 Zaragoza;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
50 Zaragoza;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
50 Zaragoza;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
50 Zaragoza;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;85,39
50 Zaragoza;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
50 Zaragoza;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
50 Zaragoza;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
50 Zaragoza;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
50 Zaragoza;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
50 Zaragoza;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
50 Zaragoza;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QIV;6.109
50 Zaragoza;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
50 Zaragoza;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
50 Zaragoza;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
50 Zaragoza;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QIV;5.841
50 Zaragoza;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
50 Zaragoza;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
50 Zaragoza;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
50 Zaragoza;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QIV;5.563
50 Zaragoza;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
50 Zaragoza;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
50 Zaragoza;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
50 Zaragoza;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2022QIV;5.644
50 Zaragoza;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
50 Zaragoza;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2022QII;""
50 Zaragoza;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2022QI;""
50 Zaragoza;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2021QIV;5.564
50 Zaragoza;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
50 Zaragoza;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2021QII;""
50 Zaragoza;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2021QI;""
50 Zaragoza;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2020QIV;5.264
50 Zaragoza;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
50 Zaragoza;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2020QII;""
50 Zaragoza;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2020QI;""
50 Zaragoza;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
50 Zaragoza;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
50 Zaragoza;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2022QII;""
50 Zaragoza;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2022QI;5.337
50 Zaragoza;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
50 Zaragoza;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
50 Zaragoza;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2021QII;""
50 Zaragoza;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2021QI;5.110
50 Zaragoza;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
50 Zaragoza;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
50 Zaragoza;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2020QII;""
50 Zaragoza;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2020QI;""
50 Zaragoza;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
50 Zaragoza;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
50 Zaragoza;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QII;5.140
50 Zaragoza;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QI;""
50 Zaragoza;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
50 Zaragoza;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
50 Zaragoza;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QII;4.944
50 Zaragoza;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QI;""
50 Zaragoza;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
50 Zaragoza;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
50 Zaragoza;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QII;""
50 Zaragoza;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QI;""
50 Zaragoza;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
50 Zaragoza;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QIII;4.976
50 Zaragoza;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QII;""
50 Zaragoza;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QI;""
50 Zaragoza;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
50 Zaragoza;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QIII;4.793
50 Zaragoza;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QII;""
50 Zaragoza;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QI;""
50 Zaragoza;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
50 Zaragoza;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
50 Zaragoza;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QII;""
50 Zaragoza;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QI;""
50 Zaragoza;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
50 Zaragoza;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
50 Zaragoza;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
50 Zaragoza;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
50 Zaragoza;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
50 Zaragoza;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
50 Zaragoza;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
50 Zaragoza;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
50 Zaragoza;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
50 Zaragoza;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
50 Zaragoza;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
50 Zaragoza;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
50 Zaragoza;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;92,39
50 Zaragoza;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
50 Zaragoza;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
50 Zaragoza;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
50 Zaragoza;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;95,26
50 Zaragoza;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
50 Zaragoza;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
50 Zaragoza;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
50 Zaragoza;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;94,63
50 Zaragoza;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
50 Zaragoza;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
50 Zaragoza;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
50 Zaragoza;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
50 Zaragoza;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
50 Zaragoza;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
50 Zaragoza;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;91,37
50 Zaragoza;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
50 Zaragoza;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
50 Zaragoza;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
50 Zaragoza;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;91,86
50 Zaragoza;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
50 Zaragoza;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
50 Zaragoza;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
50 Zaragoza;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
50 Zaragoza;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
50 Zaragoza;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
50 Zaragoza;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;88
50 Zaragoza;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
50 Zaragoza;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
50 Zaragoza;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
50 Zaragoza;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;88,87
50 Zaragoza;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
50 Zaragoza;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
50 Zaragoza;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
50 Zaragoza;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
50 Zaragoza;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
50 Zaragoza;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
50 Zaragoza;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;85,19
50 Zaragoza;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
50 Zaragoza;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
50 Zaragoza;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
50 Zaragoza;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;86,16
50 Zaragoza;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
50 Zaragoza;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
50 Zaragoza;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
50 Zaragoza;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
50 Zaragoza;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
50 Zaragoza;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
50 Zaragoza;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QIV;3.283
50 Zaragoza;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
50 Zaragoza;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
50 Zaragoza;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
50 Zaragoza;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QIV;3.211
50 Zaragoza;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
50 Zaragoza;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
50 Zaragoza;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
50 Zaragoza;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QIV;3.091
50 Zaragoza;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
50 Zaragoza;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
50 Zaragoza;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
50 Zaragoza;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2022QIV;3.066
50 Zaragoza;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
50 Zaragoza;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2022QII;""
50 Zaragoza;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2022QI;""
50 Zaragoza;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2021QIV;3.026
50 Zaragoza;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
50 Zaragoza;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2021QII;""
50 Zaragoza;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2021QI;""
50 Zaragoza;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2020QIV;2.920
50 Zaragoza;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
50 Zaragoza;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2020QII;""
50 Zaragoza;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2020QI;""
50 Zaragoza;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
50 Zaragoza;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
50 Zaragoza;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2022QII;""
50 Zaragoza;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2022QI;2.897
50 Zaragoza;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
50 Zaragoza;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
50 Zaragoza;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2021QII;""
50 Zaragoza;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2021QI;2.807
50 Zaragoza;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
50 Zaragoza;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
50 Zaragoza;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2020QII;""
50 Zaragoza;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2020QI;""
50 Zaragoza;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
50 Zaragoza;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
50 Zaragoza;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QII;2.775
50 Zaragoza;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QI;""
50 Zaragoza;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
50 Zaragoza;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
50 Zaragoza;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QII;2.691
50 Zaragoza;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QI;""
50 Zaragoza;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
50 Zaragoza;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
50 Zaragoza;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QII;""
50 Zaragoza;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QI;""
50 Zaragoza;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
50 Zaragoza;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QIII;2.673
50 Zaragoza;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QII;""
50 Zaragoza;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QI;""
50 Zaragoza;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
50 Zaragoza;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QIII;2.597
50 Zaragoza;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QII;""
50 Zaragoza;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QI;""
50 Zaragoza;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
50 Zaragoza;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
50 Zaragoza;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QII;""
50 Zaragoza;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QI;""
50 Zaragoza;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
50 Zaragoza;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
50 Zaragoza;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
50 Zaragoza;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
50 Zaragoza;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
50 Zaragoza;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
50 Zaragoza;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
50 Zaragoza;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
50 Zaragoza;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
50 Zaragoza;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
50 Zaragoza;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
50 Zaragoza;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
50 Zaragoza;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;93,39
50 Zaragoza;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
50 Zaragoza;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
50 Zaragoza;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
50 Zaragoza;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;94,24
50 Zaragoza;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
50 Zaragoza;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
50 Zaragoza;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
50 Zaragoza;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;94,47
50 Zaragoza;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
50 Zaragoza;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
50 Zaragoza;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
50 Zaragoza;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
50 Zaragoza;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
50 Zaragoza;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
50 Zaragoza;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;90,22
50 Zaragoza;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
50 Zaragoza;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
50 Zaragoza;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
50 Zaragoza;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;90,81
50 Zaragoza;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
50 Zaragoza;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
50 Zaragoza;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
50 Zaragoza;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
50 Zaragoza;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
50 Zaragoza;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
50 Zaragoza;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;86,42
50 Zaragoza;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
50 Zaragoza;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
50 Zaragoza;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
50 Zaragoza;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;87,06
50 Zaragoza;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
50 Zaragoza;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
50 Zaragoza;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
50 Zaragoza;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
50 Zaragoza;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
50 Zaragoza;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
50 Zaragoza;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;83,25
50 Zaragoza;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
50 Zaragoza;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
50 Zaragoza;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
50 Zaragoza;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;84,02
50 Zaragoza;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
50 Zaragoza;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
50 Zaragoza;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
50 Zaragoza;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
50 Zaragoza;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
50 Zaragoza;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
51 Ceuta;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
51 Ceuta;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
51 Ceuta;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
51 Ceuta;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QI;3.355
51 Ceuta;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
51 Ceuta;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
51 Ceuta;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
51 Ceuta;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QI;3.316
51 Ceuta;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
51 Ceuta;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
51 Ceuta;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
51 Ceuta;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QI;3.391
51 Ceuta;All ages;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
51 Ceuta;All ages;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
51 Ceuta;All ages;Cohort January 1;Total;Survival in the first trimester;2022QII;""
51 Ceuta;All ages;Cohort January 1;Total;Survival in the first trimester;2022QI;3.239
51 Ceuta;All ages;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
51 Ceuta;All ages;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
51 Ceuta;All ages;Cohort January 1;Total;Survival in the first trimester;2021QII;""
51 Ceuta;All ages;Cohort January 1;Total;Survival in the first trimester;2021QI;3.239
51 Ceuta;All ages;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
51 Ceuta;All ages;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
51 Ceuta;All ages;Cohort January 1;Total;Survival in the first trimester;2020QII;""
51 Ceuta;All ages;Cohort January 1;Total;Survival in the first trimester;2020QI;3.175
51 Ceuta;All ages;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
51 Ceuta;All ages;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
51 Ceuta;All ages;Cohort January 1;Total;Survival in the second trimester;2022QII;3.133
51 Ceuta;All ages;Cohort January 1;Total;Survival in the second trimester;2022QI;""
51 Ceuta;All ages;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
51 Ceuta;All ages;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
51 Ceuta;All ages;Cohort January 1;Total;Survival in the second trimester;2021QII;3.137
51 Ceuta;All ages;Cohort January 1;Total;Survival in the second trimester;2021QI;""
51 Ceuta;All ages;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
51 Ceuta;All ages;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
51 Ceuta;All ages;Cohort January 1;Total;Survival in the second trimester;2020QII;3.091
51 Ceuta;All ages;Cohort January 1;Total;Survival in the second trimester;2020QI;""
51 Ceuta;All ages;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
51 Ceuta;All ages;Cohort January 1;Total;Survival in the third trimester;2022QIII;2.994
51 Ceuta;All ages;Cohort January 1;Total;Survival in the third trimester;2022QII;""
51 Ceuta;All ages;Cohort January 1;Total;Survival in the third trimester;2022QI;""
51 Ceuta;All ages;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
51 Ceuta;All ages;Cohort January 1;Total;Survival in the third trimester;2021QIII;3.041
51 Ceuta;All ages;Cohort January 1;Total;Survival in the third trimester;2021QII;""
51 Ceuta;All ages;Cohort January 1;Total;Survival in the third trimester;2021QI;""
51 Ceuta;All ages;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
51 Ceuta;All ages;Cohort January 1;Total;Survival in the third trimester;2020QIII;2.997
51 Ceuta;All ages;Cohort January 1;Total;Survival in the third trimester;2020QII;""
51 Ceuta;All ages;Cohort January 1;Total;Survival in the third trimester;2020QI;""
51 Ceuta;All ages;Cohort January 1;Total;Survival in the third trimester;2022QIV;2.856
51 Ceuta;All ages;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
51 Ceuta;All ages;Cohort January 1;Total;Survival in the third trimester;2022QII;""
51 Ceuta;All ages;Cohort January 1;Total;Survival in the third trimester;2022QI;""
51 Ceuta;All ages;Cohort January 1;Total;Survival in the third trimester;2021QIV;2.931
51 Ceuta;All ages;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
51 Ceuta;All ages;Cohort January 1;Total;Survival in the third trimester;2021QII;""
51 Ceuta;All ages;Cohort January 1;Total;Survival in the third trimester;2021QI;""
51 Ceuta;All ages;Cohort January 1;Total;Survival in the third trimester;2020QIV;2.904
51 Ceuta;All ages;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
51 Ceuta;All ages;Cohort January 1;Total;Survival in the third trimester;2020QII;""
51 Ceuta;All ages;Cohort January 1;Total;Survival in the third trimester;2020QI;""
51 Ceuta;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
51 Ceuta;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
51 Ceuta;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
51 Ceuta;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
51 Ceuta;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
51 Ceuta;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
51 Ceuta;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
51 Ceuta;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
51 Ceuta;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
51 Ceuta;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
51 Ceuta;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
51 Ceuta;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
51 Ceuta;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
51 Ceuta;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
51 Ceuta;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
51 Ceuta;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;96,54
51 Ceuta;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
51 Ceuta;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
51 Ceuta;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
51 Ceuta;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;97,68
51 Ceuta;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
51 Ceuta;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
51 Ceuta;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
51 Ceuta;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;93,63
51 Ceuta;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
51 Ceuta;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
51 Ceuta;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;93,38
51 Ceuta;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
51 Ceuta;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
51 Ceuta;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
51 Ceuta;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;94,6
51 Ceuta;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
51 Ceuta;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
51 Ceuta;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
51 Ceuta;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;91,15
51 Ceuta;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
51 Ceuta;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
51 Ceuta;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;89,24
51 Ceuta;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
51 Ceuta;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
51 Ceuta;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
51 Ceuta;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;91,71
51 Ceuta;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
51 Ceuta;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
51 Ceuta;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
51 Ceuta;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;88,38
51 Ceuta;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
51 Ceuta;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
51 Ceuta;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;85,13
51 Ceuta;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
51 Ceuta;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
51 Ceuta;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
51 Ceuta;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;88,39
51 Ceuta;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
51 Ceuta;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
51 Ceuta;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
51 Ceuta;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;85,64
51 Ceuta;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
51 Ceuta;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
51 Ceuta;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
51 Ceuta;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
51 Ceuta;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
51 Ceuta;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
51 Ceuta;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QI;2.118
51 Ceuta;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
51 Ceuta;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
51 Ceuta;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
51 Ceuta;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QI;2.106
51 Ceuta;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
51 Ceuta;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
51 Ceuta;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
51 Ceuta;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QI;2.157
51 Ceuta;All ages;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
51 Ceuta;All ages;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
51 Ceuta;All ages;Cohort January 1;Males;Survival in the first trimester;2022QII;""
51 Ceuta;All ages;Cohort January 1;Males;Survival in the first trimester;2022QI;2.046
51 Ceuta;All ages;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
51 Ceuta;All ages;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
51 Ceuta;All ages;Cohort January 1;Males;Survival in the first trimester;2021QII;""
51 Ceuta;All ages;Cohort January 1;Males;Survival in the first trimester;2021QI;2.057
51 Ceuta;All ages;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
51 Ceuta;All ages;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
51 Ceuta;All ages;Cohort January 1;Males;Survival in the first trimester;2020QII;""
51 Ceuta;All ages;Cohort January 1;Males;Survival in the first trimester;2020QI;2.027
51 Ceuta;All ages;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
51 Ceuta;All ages;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
51 Ceuta;All ages;Cohort January 1;Males;Survival in the second trimester;2022QII;1.988
51 Ceuta;All ages;Cohort January 1;Males;Survival in the second trimester;2022QI;""
51 Ceuta;All ages;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
51 Ceuta;All ages;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
51 Ceuta;All ages;Cohort January 1;Males;Survival in the second trimester;2021QII;1.997
51 Ceuta;All ages;Cohort January 1;Males;Survival in the second trimester;2021QI;""
51 Ceuta;All ages;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
51 Ceuta;All ages;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
51 Ceuta;All ages;Cohort January 1;Males;Survival in the second trimester;2020QII;1.974
51 Ceuta;All ages;Cohort January 1;Males;Survival in the second trimester;2020QI;""
51 Ceuta;All ages;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
51 Ceuta;All ages;Cohort January 1;Males;Survival in the third trimester;2022QIII;1.901
51 Ceuta;All ages;Cohort January 1;Males;Survival in the third trimester;2022QII;""
51 Ceuta;All ages;Cohort January 1;Males;Survival in the third trimester;2022QI;""
51 Ceuta;All ages;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
51 Ceuta;All ages;Cohort January 1;Males;Survival in the third trimester;2021QIII;1.940
51 Ceuta;All ages;Cohort January 1;Males;Survival in the third trimester;2021QII;""
51 Ceuta;All ages;Cohort January 1;Males;Survival in the third trimester;2021QI;""
51 Ceuta;All ages;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
51 Ceuta;All ages;Cohort January 1;Males;Survival in the third trimester;2020QIII;1.915
51 Ceuta;All ages;Cohort January 1;Males;Survival in the third trimester;2020QII;""
51 Ceuta;All ages;Cohort January 1;Males;Survival in the third trimester;2020QI;""
51 Ceuta;All ages;Cohort January 1;Males;Survival in the third trimester;2022QIV;1.827
51 Ceuta;All ages;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
51 Ceuta;All ages;Cohort January 1;Males;Survival in the third trimester;2022QII;""
51 Ceuta;All ages;Cohort January 1;Males;Survival in the third trimester;2022QI;""
51 Ceuta;All ages;Cohort January 1;Males;Survival in the third trimester;2021QIV;1.865
51 Ceuta;All ages;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
51 Ceuta;All ages;Cohort January 1;Males;Survival in the third trimester;2021QII;""
51 Ceuta;All ages;Cohort January 1;Males;Survival in the third trimester;2021QI;""
51 Ceuta;All ages;Cohort January 1;Males;Survival in the third trimester;2020QIV;1.851
51 Ceuta;All ages;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
51 Ceuta;All ages;Cohort January 1;Males;Survival in the third trimester;2020QII;""
51 Ceuta;All ages;Cohort January 1;Males;Survival in the third trimester;2020QI;""
51 Ceuta;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
51 Ceuta;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
51 Ceuta;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
51 Ceuta;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
51 Ceuta;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
51 Ceuta;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
51 Ceuta;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
51 Ceuta;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
51 Ceuta;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
51 Ceuta;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
51 Ceuta;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
51 Ceuta;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
51 Ceuta;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
51 Ceuta;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
51 Ceuta;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
51 Ceuta;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;96,6
51 Ceuta;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
51 Ceuta;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
51 Ceuta;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
51 Ceuta;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;97,67
51 Ceuta;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
51 Ceuta;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
51 Ceuta;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
51 Ceuta;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;93,97
51 Ceuta;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
51 Ceuta;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
51 Ceuta;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;93,86
51 Ceuta;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
51 Ceuta;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
51 Ceuta;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
51 Ceuta;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;94,82
51 Ceuta;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
51 Ceuta;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
51 Ceuta;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
51 Ceuta;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;91,52
51 Ceuta;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
51 Ceuta;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
51 Ceuta;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;89,75
51 Ceuta;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
51 Ceuta;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
51 Ceuta;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
51 Ceuta;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;92,12
51 Ceuta;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
51 Ceuta;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
51 Ceuta;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
51 Ceuta;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;88,78
51 Ceuta;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
51 Ceuta;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
51 Ceuta;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;86,26
51 Ceuta;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
51 Ceuta;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
51 Ceuta;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
51 Ceuta;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;88,56
51 Ceuta;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
51 Ceuta;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
51 Ceuta;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
51 Ceuta;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;85,81
51 Ceuta;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
51 Ceuta;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
51 Ceuta;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
51 Ceuta;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
51 Ceuta;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
51 Ceuta;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
51 Ceuta;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QI;1.237
51 Ceuta;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
51 Ceuta;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
51 Ceuta;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
51 Ceuta;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QI;1.210
51 Ceuta;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
51 Ceuta;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
51 Ceuta;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
51 Ceuta;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QI;1.234
51 Ceuta;All ages;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
51 Ceuta;All ages;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
51 Ceuta;All ages;Cohort January 1;Females;Survival in the first trimester;2022QII;""
51 Ceuta;All ages;Cohort January 1;Females;Survival in the first trimester;2022QI;1.193
51 Ceuta;All ages;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
51 Ceuta;All ages;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
51 Ceuta;All ages;Cohort January 1;Females;Survival in the first trimester;2021QII;""
51 Ceuta;All ages;Cohort January 1;Females;Survival in the first trimester;2021QI;1.182
51 Ceuta;All ages;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
51 Ceuta;All ages;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
51 Ceuta;All ages;Cohort January 1;Females;Survival in the first trimester;2020QII;""
51 Ceuta;All ages;Cohort January 1;Females;Survival in the first trimester;2020QI;1.148
51 Ceuta;All ages;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
51 Ceuta;All ages;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
51 Ceuta;All ages;Cohort January 1;Females;Survival in the second trimester;2022QII;1.145
51 Ceuta;All ages;Cohort January 1;Females;Survival in the second trimester;2022QI;""
51 Ceuta;All ages;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
51 Ceuta;All ages;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
51 Ceuta;All ages;Cohort January 1;Females;Survival in the second trimester;2021QII;1.140
51 Ceuta;All ages;Cohort January 1;Females;Survival in the second trimester;2021QI;""
51 Ceuta;All ages;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
51 Ceuta;All ages;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
51 Ceuta;All ages;Cohort January 1;Females;Survival in the second trimester;2020QII;1.117
51 Ceuta;All ages;Cohort January 1;Females;Survival in the second trimester;2020QI;""
51 Ceuta;All ages;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
51 Ceuta;All ages;Cohort January 1;Females;Survival in the third trimester;2022QIII;1.093
51 Ceuta;All ages;Cohort January 1;Females;Survival in the third trimester;2022QII;""
51 Ceuta;All ages;Cohort January 1;Females;Survival in the third trimester;2022QI;""
51 Ceuta;All ages;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
51 Ceuta;All ages;Cohort January 1;Females;Survival in the third trimester;2021QIII;1.101
51 Ceuta;All ages;Cohort January 1;Females;Survival in the third trimester;2021QII;""
51 Ceuta;All ages;Cohort January 1;Females;Survival in the third trimester;2021QI;""
51 Ceuta;All ages;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
51 Ceuta;All ages;Cohort January 1;Females;Survival in the third trimester;2020QIII;1.082
51 Ceuta;All ages;Cohort January 1;Females;Survival in the third trimester;2020QII;""
51 Ceuta;All ages;Cohort January 1;Females;Survival in the third trimester;2020QI;""
51 Ceuta;All ages;Cohort January 1;Females;Survival in the third trimester;2022QIV;1.029
51 Ceuta;All ages;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
51 Ceuta;All ages;Cohort January 1;Females;Survival in the third trimester;2022QII;""
51 Ceuta;All ages;Cohort January 1;Females;Survival in the third trimester;2022QI;""
51 Ceuta;All ages;Cohort January 1;Females;Survival in the third trimester;2021QIV;1.066
51 Ceuta;All ages;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
51 Ceuta;All ages;Cohort January 1;Females;Survival in the third trimester;2021QII;""
51 Ceuta;All ages;Cohort January 1;Females;Survival in the third trimester;2021QI;""
51 Ceuta;All ages;Cohort January 1;Females;Survival in the third trimester;2020QIV;1.053
51 Ceuta;All ages;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
51 Ceuta;All ages;Cohort January 1;Females;Survival in the third trimester;2020QII;""
51 Ceuta;All ages;Cohort January 1;Females;Survival in the third trimester;2020QI;""
51 Ceuta;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
51 Ceuta;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
51 Ceuta;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
51 Ceuta;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
51 Ceuta;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
51 Ceuta;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
51 Ceuta;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
51 Ceuta;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
51 Ceuta;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
51 Ceuta;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
51 Ceuta;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
51 Ceuta;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
51 Ceuta;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
51 Ceuta;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
51 Ceuta;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
51 Ceuta;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;96,44
51 Ceuta;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
51 Ceuta;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
51 Ceuta;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
51 Ceuta;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;97,69
51 Ceuta;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
51 Ceuta;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
51 Ceuta;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
51 Ceuta;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;93,03
51 Ceuta;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
51 Ceuta;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
51 Ceuta;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;92,56
51 Ceuta;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
51 Ceuta;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
51 Ceuta;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
51 Ceuta;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;94,21
51 Ceuta;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
51 Ceuta;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
51 Ceuta;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
51 Ceuta;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;90,52
51 Ceuta;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
51 Ceuta;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
51 Ceuta;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;88,36
51 Ceuta;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
51 Ceuta;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
51 Ceuta;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
51 Ceuta;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;90,99
51 Ceuta;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
51 Ceuta;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
51 Ceuta;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
51 Ceuta;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;87,68
51 Ceuta;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
51 Ceuta;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
51 Ceuta;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;83,19
51 Ceuta;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
51 Ceuta;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
51 Ceuta;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
51 Ceuta;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;88,1
51 Ceuta;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
51 Ceuta;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
51 Ceuta;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
51 Ceuta;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;85,33
51 Ceuta;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
51 Ceuta;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
51 Ceuta;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
51 Ceuta;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
51 Ceuta;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
51 Ceuta;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QII;3.369
51 Ceuta;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
51 Ceuta;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
51 Ceuta;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
51 Ceuta;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QII;3.374
51 Ceuta;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
51 Ceuta;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
51 Ceuta;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
51 Ceuta;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QII;3.320
51 Ceuta;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
51 Ceuta;All ages;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
51 Ceuta;All ages;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
51 Ceuta;All ages;Cohort April 1;Total;Survival in the first trimester;2022QII;3.249
51 Ceuta;All ages;Cohort April 1;Total;Survival in the first trimester;2022QI;""
51 Ceuta;All ages;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
51 Ceuta;All ages;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
51 Ceuta;All ages;Cohort April 1;Total;Survival in the first trimester;2021QII;3.258
51 Ceuta;All ages;Cohort April 1;Total;Survival in the first trimester;2021QI;""
51 Ceuta;All ages;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
51 Ceuta;All ages;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
51 Ceuta;All ages;Cohort April 1;Total;Survival in the first trimester;2020QII;3.231
51 Ceuta;All ages;Cohort April 1;Total;Survival in the first trimester;2020QI;""
51 Ceuta;All ages;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
51 Ceuta;All ages;Cohort April 1;Total;Survival in the second trimester;2022QIII;3.099
51 Ceuta;All ages;Cohort April 1;Total;Survival in the second trimester;2022QII;""
51 Ceuta;All ages;Cohort April 1;Total;Survival in the second trimester;2022QI;""
51 Ceuta;All ages;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
51 Ceuta;All ages;Cohort April 1;Total;Survival in the second trimester;2021QIII;3.158
51 Ceuta;All ages;Cohort April 1;Total;Survival in the second trimester;2021QII;""
51 Ceuta;All ages;Cohort April 1;Total;Survival in the second trimester;2021QI;""
51 Ceuta;All ages;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
51 Ceuta;All ages;Cohort April 1;Total;Survival in the second trimester;2020QIII;3.126
51 Ceuta;All ages;Cohort April 1;Total;Survival in the second trimester;2020QII;""
51 Ceuta;All ages;Cohort April 1;Total;Survival in the second trimester;2020QI;""
51 Ceuta;All ages;Cohort April 1;Total;Survival in the third trimester;2022QIV;2.954
51 Ceuta;All ages;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
51 Ceuta;All ages;Cohort April 1;Total;Survival in the third trimester;2022QII;""
51 Ceuta;All ages;Cohort April 1;Total;Survival in the third trimester;2022QI;""
51 Ceuta;All ages;Cohort April 1;Total;Survival in the third trimester;2021QIV;3.040
51 Ceuta;All ages;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
51 Ceuta;All ages;Cohort April 1;Total;Survival in the third trimester;2021QII;""
51 Ceuta;All ages;Cohort April 1;Total;Survival in the third trimester;2021QI;""
51 Ceuta;All ages;Cohort April 1;Total;Survival in the third trimester;2020QIV;3.024
51 Ceuta;All ages;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
51 Ceuta;All ages;Cohort April 1;Total;Survival in the third trimester;2020QII;""
51 Ceuta;All ages;Cohort April 1;Total;Survival in the third trimester;2020QI;""
51 Ceuta;All ages;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
51 Ceuta;All ages;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
51 Ceuta;All ages;Cohort April 1;Total;Survival in the third trimester;2022QII;""
51 Ceuta;All ages;Cohort April 1;Total;Survival in the third trimester;2022QI;2.949
51 Ceuta;All ages;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
51 Ceuta;All ages;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
51 Ceuta;All ages;Cohort April 1;Total;Survival in the third trimester;2021QII;""
51 Ceuta;All ages;Cohort April 1;Total;Survival in the third trimester;2021QI;2.964
51 Ceuta;All ages;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
51 Ceuta;All ages;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
51 Ceuta;All ages;Cohort April 1;Total;Survival in the third trimester;2020QII;""
51 Ceuta;All ages;Cohort April 1;Total;Survival in the third trimester;2020QI;""
51 Ceuta;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
51 Ceuta;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
51 Ceuta;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
51 Ceuta;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
51 Ceuta;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
51 Ceuta;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
51 Ceuta;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
51 Ceuta;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
51 Ceuta;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
51 Ceuta;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
51 Ceuta;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
51 Ceuta;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
51 Ceuta;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
51 Ceuta;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
51 Ceuta;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;96,44
51 Ceuta;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
51 Ceuta;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
51 Ceuta;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
51 Ceuta;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;96,56
51 Ceuta;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
51 Ceuta;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
51 Ceuta;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
51 Ceuta;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;97,32
51 Ceuta;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
51 Ceuta;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
51 Ceuta;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;91,99
51 Ceuta;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
51 Ceuta;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
51 Ceuta;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
51 Ceuta;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;93,6
51 Ceuta;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
51 Ceuta;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
51 Ceuta;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
51 Ceuta;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;94,16
51 Ceuta;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
51 Ceuta;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
51 Ceuta;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;87,68
51 Ceuta;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
51 Ceuta;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
51 Ceuta;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
51 Ceuta;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;90,1
51 Ceuta;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
51 Ceuta;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
51 Ceuta;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
51 Ceuta;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;91,08
51 Ceuta;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
51 Ceuta;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
51 Ceuta;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
51 Ceuta;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
51 Ceuta;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
51 Ceuta;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
51 Ceuta;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;87,4
51 Ceuta;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
51 Ceuta;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
51 Ceuta;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
51 Ceuta;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;89,28
51 Ceuta;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
51 Ceuta;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
51 Ceuta;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
51 Ceuta;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
51 Ceuta;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
51 Ceuta;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
51 Ceuta;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QII;2.133
51 Ceuta;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
51 Ceuta;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
51 Ceuta;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
51 Ceuta;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QII;2.140
51 Ceuta;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
51 Ceuta;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
51 Ceuta;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
51 Ceuta;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QII;2.118
51 Ceuta;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
51 Ceuta;All ages;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
51 Ceuta;All ages;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
51 Ceuta;All ages;Cohort April 1;Males;Survival in the first trimester;2022QII;2.069
51 Ceuta;All ages;Cohort April 1;Males;Survival in the first trimester;2022QI;""
51 Ceuta;All ages;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
51 Ceuta;All ages;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
51 Ceuta;All ages;Cohort April 1;Males;Survival in the first trimester;2021QII;2.070
51 Ceuta;All ages;Cohort April 1;Males;Survival in the first trimester;2021QI;""
51 Ceuta;All ages;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
51 Ceuta;All ages;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
51 Ceuta;All ages;Cohort April 1;Males;Survival in the first trimester;2020QII;2.061
51 Ceuta;All ages;Cohort April 1;Males;Survival in the first trimester;2020QI;""
51 Ceuta;All ages;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
51 Ceuta;All ages;Cohort April 1;Males;Survival in the second trimester;2022QIII;1.975
51 Ceuta;All ages;Cohort April 1;Males;Survival in the second trimester;2022QII;""
51 Ceuta;All ages;Cohort April 1;Males;Survival in the second trimester;2022QI;""
51 Ceuta;All ages;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
51 Ceuta;All ages;Cohort April 1;Males;Survival in the second trimester;2021QIII;2.011
51 Ceuta;All ages;Cohort April 1;Males;Survival in the second trimester;2021QII;""
51 Ceuta;All ages;Cohort April 1;Males;Survival in the second trimester;2021QI;""
51 Ceuta;All ages;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
51 Ceuta;All ages;Cohort April 1;Males;Survival in the second trimester;2020QIII;1.992
51 Ceuta;All ages;Cohort April 1;Males;Survival in the second trimester;2020QII;""
51 Ceuta;All ages;Cohort April 1;Males;Survival in the second trimester;2020QI;""
51 Ceuta;All ages;Cohort April 1;Males;Survival in the third trimester;2022QIV;1.897
51 Ceuta;All ages;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
51 Ceuta;All ages;Cohort April 1;Males;Survival in the third trimester;2022QII;""
51 Ceuta;All ages;Cohort April 1;Males;Survival in the third trimester;2022QI;""
51 Ceuta;All ages;Cohort April 1;Males;Survival in the third trimester;2021QIV;1.930
51 Ceuta;All ages;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
51 Ceuta;All ages;Cohort April 1;Males;Survival in the third trimester;2021QII;""
51 Ceuta;All ages;Cohort April 1;Males;Survival in the third trimester;2021QI;""
51 Ceuta;All ages;Cohort April 1;Males;Survival in the third trimester;2020QIV;1.923
51 Ceuta;All ages;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
51 Ceuta;All ages;Cohort April 1;Males;Survival in the third trimester;2020QII;""
51 Ceuta;All ages;Cohort April 1;Males;Survival in the third trimester;2020QI;""
51 Ceuta;All ages;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
51 Ceuta;All ages;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
51 Ceuta;All ages;Cohort April 1;Males;Survival in the third trimester;2022QII;""
51 Ceuta;All ages;Cohort April 1;Males;Survival in the third trimester;2022QI;1.875
51 Ceuta;All ages;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
51 Ceuta;All ages;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
51 Ceuta;All ages;Cohort April 1;Males;Survival in the third trimester;2021QII;""
51 Ceuta;All ages;Cohort April 1;Males;Survival in the third trimester;2021QI;1.886
51 Ceuta;All ages;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
51 Ceuta;All ages;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
51 Ceuta;All ages;Cohort April 1;Males;Survival in the third trimester;2020QII;""
51 Ceuta;All ages;Cohort April 1;Males;Survival in the third trimester;2020QI;""
51 Ceuta;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
51 Ceuta;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
51 Ceuta;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
51 Ceuta;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
51 Ceuta;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
51 Ceuta;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
51 Ceuta;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
51 Ceuta;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
51 Ceuta;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
51 Ceuta;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
51 Ceuta;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
51 Ceuta;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
51 Ceuta;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
51 Ceuta;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
51 Ceuta;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;97
51 Ceuta;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
51 Ceuta;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
51 Ceuta;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
51 Ceuta;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;96,73
51 Ceuta;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
51 Ceuta;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
51 Ceuta;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
51 Ceuta;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;97,31
51 Ceuta;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
51 Ceuta;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
51 Ceuta;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;92,59
51 Ceuta;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
51 Ceuta;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
51 Ceuta;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
51 Ceuta;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;93,97
51 Ceuta;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
51 Ceuta;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
51 Ceuta;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
51 Ceuta;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;94,05
51 Ceuta;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
51 Ceuta;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
51 Ceuta;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;88,94
51 Ceuta;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
51 Ceuta;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
51 Ceuta;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
51 Ceuta;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;90,19
51 Ceuta;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
51 Ceuta;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
51 Ceuta;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
51 Ceuta;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;90,79
51 Ceuta;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
51 Ceuta;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
51 Ceuta;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
51 Ceuta;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
51 Ceuta;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
51 Ceuta;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
51 Ceuta;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;87,62
51 Ceuta;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
51 Ceuta;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
51 Ceuta;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
51 Ceuta;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;89,05
51 Ceuta;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
51 Ceuta;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
51 Ceuta;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
51 Ceuta;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
51 Ceuta;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
51 Ceuta;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
51 Ceuta;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QII;1.236
51 Ceuta;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
51 Ceuta;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
51 Ceuta;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
51 Ceuta;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QII;1.234
51 Ceuta;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
51 Ceuta;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
51 Ceuta;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
51 Ceuta;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QII;1.202
51 Ceuta;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
51 Ceuta;All ages;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
51 Ceuta;All ages;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
51 Ceuta;All ages;Cohort April 1;Females;Survival in the first trimester;2022QII;1.180
51 Ceuta;All ages;Cohort April 1;Females;Survival in the first trimester;2022QI;""
51 Ceuta;All ages;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
51 Ceuta;All ages;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
51 Ceuta;All ages;Cohort April 1;Females;Survival in the first trimester;2021QII;1.188
51 Ceuta;All ages;Cohort April 1;Females;Survival in the first trimester;2021QI;""
51 Ceuta;All ages;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
51 Ceuta;All ages;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
51 Ceuta;All ages;Cohort April 1;Females;Survival in the first trimester;2020QII;1.170
51 Ceuta;All ages;Cohort April 1;Females;Survival in the first trimester;2020QI;""
51 Ceuta;All ages;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
51 Ceuta;All ages;Cohort April 1;Females;Survival in the second trimester;2022QIII;1.124
51 Ceuta;All ages;Cohort April 1;Females;Survival in the second trimester;2022QII;""
51 Ceuta;All ages;Cohort April 1;Females;Survival in the second trimester;2022QI;""
51 Ceuta;All ages;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
51 Ceuta;All ages;Cohort April 1;Females;Survival in the second trimester;2021QIII;1.147
51 Ceuta;All ages;Cohort April 1;Females;Survival in the second trimester;2021QII;""
51 Ceuta;All ages;Cohort April 1;Females;Survival in the second trimester;2021QI;""
51 Ceuta;All ages;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
51 Ceuta;All ages;Cohort April 1;Females;Survival in the second trimester;2020QIII;1.134
51 Ceuta;All ages;Cohort April 1;Females;Survival in the second trimester;2020QII;""
51 Ceuta;All ages;Cohort April 1;Females;Survival in the second trimester;2020QI;""
51 Ceuta;All ages;Cohort April 1;Females;Survival in the third trimester;2022QIV;1.057
51 Ceuta;All ages;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
51 Ceuta;All ages;Cohort April 1;Females;Survival in the third trimester;2022QII;""
51 Ceuta;All ages;Cohort April 1;Females;Survival in the third trimester;2022QI;""
51 Ceuta;All ages;Cohort April 1;Females;Survival in the third trimester;2021QIV;1.110
51 Ceuta;All ages;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
51 Ceuta;All ages;Cohort April 1;Females;Survival in the third trimester;2021QII;""
51 Ceuta;All ages;Cohort April 1;Females;Survival in the third trimester;2021QI;""
51 Ceuta;All ages;Cohort April 1;Females;Survival in the third trimester;2020QIV;1.101
51 Ceuta;All ages;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
51 Ceuta;All ages;Cohort April 1;Females;Survival in the third trimester;2020QII;""
51 Ceuta;All ages;Cohort April 1;Females;Survival in the third trimester;2020QI;""
51 Ceuta;All ages;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
51 Ceuta;All ages;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
51 Ceuta;All ages;Cohort April 1;Females;Survival in the third trimester;2022QII;""
51 Ceuta;All ages;Cohort April 1;Females;Survival in the third trimester;2022QI;1.074
51 Ceuta;All ages;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
51 Ceuta;All ages;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
51 Ceuta;All ages;Cohort April 1;Females;Survival in the third trimester;2021QII;""
51 Ceuta;All ages;Cohort April 1;Females;Survival in the third trimester;2021QI;1.078
51 Ceuta;All ages;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
51 Ceuta;All ages;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
51 Ceuta;All ages;Cohort April 1;Females;Survival in the third trimester;2020QII;""
51 Ceuta;All ages;Cohort April 1;Females;Survival in the third trimester;2020QI;""
51 Ceuta;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
51 Ceuta;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
51 Ceuta;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
51 Ceuta;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
51 Ceuta;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
51 Ceuta;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
51 Ceuta;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
51 Ceuta;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
51 Ceuta;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
51 Ceuta;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
51 Ceuta;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
51 Ceuta;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
51 Ceuta;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
51 Ceuta;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
51 Ceuta;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;95,47
51 Ceuta;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
51 Ceuta;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
51 Ceuta;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
51 Ceuta;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;96,27
51 Ceuta;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
51 Ceuta;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
51 Ceuta;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
51 Ceuta;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;97,34
51 Ceuta;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
51 Ceuta;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
51 Ceuta;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;90,94
51 Ceuta;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
51 Ceuta;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
51 Ceuta;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
51 Ceuta;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;92,95
51 Ceuta;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
51 Ceuta;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
51 Ceuta;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
51 Ceuta;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;94,34
51 Ceuta;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
51 Ceuta;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
51 Ceuta;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;85,52
51 Ceuta;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
51 Ceuta;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
51 Ceuta;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
51 Ceuta;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;89,95
51 Ceuta;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
51 Ceuta;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
51 Ceuta;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
51 Ceuta;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;91,6
51 Ceuta;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
51 Ceuta;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
51 Ceuta;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
51 Ceuta;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
51 Ceuta;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
51 Ceuta;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
51 Ceuta;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;87,03
51 Ceuta;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
51 Ceuta;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
51 Ceuta;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
51 Ceuta;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;89,68
51 Ceuta;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
51 Ceuta;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
51 Ceuta;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
51 Ceuta;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
51 Ceuta;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
51 Ceuta;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QIII;3.368
51 Ceuta;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
51 Ceuta;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
51 Ceuta;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
51 Ceuta;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QIII;3.386
51 Ceuta;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
51 Ceuta;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
51 Ceuta;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
51 Ceuta;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QIII;3.302
51 Ceuta;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
51 Ceuta;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
51 Ceuta;All ages;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
51 Ceuta;All ages;Cohort July 1;Total;Survival in the first trimester;2022QIII;3.201
51 Ceuta;All ages;Cohort July 1;Total;Survival in the first trimester;2022QII;""
51 Ceuta;All ages;Cohort July 1;Total;Survival in the first trimester;2022QI;""
51 Ceuta;All ages;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
51 Ceuta;All ages;Cohort July 1;Total;Survival in the first trimester;2021QIII;3.267
51 Ceuta;All ages;Cohort July 1;Total;Survival in the first trimester;2021QII;""
51 Ceuta;All ages;Cohort July 1;Total;Survival in the first trimester;2021QI;""
51 Ceuta;All ages;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
51 Ceuta;All ages;Cohort July 1;Total;Survival in the first trimester;2020QIII;3.187
51 Ceuta;All ages;Cohort July 1;Total;Survival in the first trimester;2020QII;""
51 Ceuta;All ages;Cohort July 1;Total;Survival in the first trimester;2020QI;""
51 Ceuta;All ages;Cohort July 1;Total;Survival in the second trimester;2022QIV;3.043
51 Ceuta;All ages;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
51 Ceuta;All ages;Cohort July 1;Total;Survival in the second trimester;2022QII;""
51 Ceuta;All ages;Cohort July 1;Total;Survival in the second trimester;2022QI;""
51 Ceuta;All ages;Cohort July 1;Total;Survival in the second trimester;2021QIV;3.131
51 Ceuta;All ages;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
51 Ceuta;All ages;Cohort July 1;Total;Survival in the second trimester;2021QII;""
51 Ceuta;All ages;Cohort July 1;Total;Survival in the second trimester;2021QI;""
51 Ceuta;All ages;Cohort July 1;Total;Survival in the second trimester;2020QIV;3.080
51 Ceuta;All ages;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
51 Ceuta;All ages;Cohort July 1;Total;Survival in the second trimester;2020QII;""
51 Ceuta;All ages;Cohort July 1;Total;Survival in the second trimester;2020QI;""
51 Ceuta;All ages;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
51 Ceuta;All ages;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
51 Ceuta;All ages;Cohort July 1;Total;Survival in the third trimester;2022QII;""
51 Ceuta;All ages;Cohort July 1;Total;Survival in the third trimester;2022QI;3.032
51 Ceuta;All ages;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
51 Ceuta;All ages;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
51 Ceuta;All ages;Cohort July 1;Total;Survival in the third trimester;2021QII;""
51 Ceuta;All ages;Cohort July 1;Total;Survival in the third trimester;2021QI;3.017
51 Ceuta;All ages;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
51 Ceuta;All ages;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
51 Ceuta;All ages;Cohort July 1;Total;Survival in the third trimester;2020QII;""
51 Ceuta;All ages;Cohort July 1;Total;Survival in the third trimester;2020QI;""
51 Ceuta;All ages;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
51 Ceuta;All ages;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
51 Ceuta;All ages;Cohort July 1;Total;Survival in the third trimester;2022QII;2.938
51 Ceuta;All ages;Cohort July 1;Total;Survival in the third trimester;2022QI;""
51 Ceuta;All ages;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
51 Ceuta;All ages;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
51 Ceuta;All ages;Cohort July 1;Total;Survival in the third trimester;2021QII;2.934
51 Ceuta;All ages;Cohort July 1;Total;Survival in the third trimester;2021QI;""
51 Ceuta;All ages;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
51 Ceuta;All ages;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
51 Ceuta;All ages;Cohort July 1;Total;Survival in the third trimester;2020QII;""
51 Ceuta;All ages;Cohort July 1;Total;Survival in the third trimester;2020QI;""
51 Ceuta;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
51 Ceuta;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
51 Ceuta;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
51 Ceuta;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
51 Ceuta;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
51 Ceuta;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
51 Ceuta;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
51 Ceuta;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
51 Ceuta;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
51 Ceuta;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
51 Ceuta;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
51 Ceuta;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
51 Ceuta;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
51 Ceuta;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;95,04
51 Ceuta;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
51 Ceuta;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
51 Ceuta;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
51 Ceuta;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;96,49
51 Ceuta;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
51 Ceuta;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
51 Ceuta;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
51 Ceuta;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;96,52
51 Ceuta;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
51 Ceuta;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
51 Ceuta;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;90,35
51 Ceuta;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
51 Ceuta;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
51 Ceuta;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
51 Ceuta;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;92,47
51 Ceuta;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
51 Ceuta;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
51 Ceuta;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
51 Ceuta;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;93,28
51 Ceuta;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
51 Ceuta;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
51 Ceuta;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
51 Ceuta;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
51 Ceuta;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
51 Ceuta;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
51 Ceuta;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;89,55
51 Ceuta;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
51 Ceuta;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
51 Ceuta;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
51 Ceuta;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;91,37
51 Ceuta;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
51 Ceuta;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
51 Ceuta;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
51 Ceuta;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
51 Ceuta;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
51 Ceuta;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
51 Ceuta;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;86,77
51 Ceuta;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
51 Ceuta;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
51 Ceuta;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
51 Ceuta;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;88,86
51 Ceuta;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
51 Ceuta;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
51 Ceuta;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
51 Ceuta;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
51 Ceuta;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
51 Ceuta;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
51 Ceuta;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QIII;2.138
51 Ceuta;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
51 Ceuta;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
51 Ceuta;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
51 Ceuta;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QIII;2.151
51 Ceuta;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
51 Ceuta;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
51 Ceuta;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
51 Ceuta;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QIII;2.099
51 Ceuta;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
51 Ceuta;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
51 Ceuta;All ages;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
51 Ceuta;All ages;Cohort July 1;Males;Survival in the first trimester;2022QIII;2.037
51 Ceuta;All ages;Cohort July 1;Males;Survival in the first trimester;2022QII;""
51 Ceuta;All ages;Cohort July 1;Males;Survival in the first trimester;2022QI;""
51 Ceuta;All ages;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
51 Ceuta;All ages;Cohort July 1;Males;Survival in the first trimester;2021QIII;2.081
51 Ceuta;All ages;Cohort July 1;Males;Survival in the first trimester;2021QII;""
51 Ceuta;All ages;Cohort July 1;Males;Survival in the first trimester;2021QI;""
51 Ceuta;All ages;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
51 Ceuta;All ages;Cohort July 1;Males;Survival in the first trimester;2020QIII;2.024
51 Ceuta;All ages;Cohort July 1;Males;Survival in the first trimester;2020QII;""
51 Ceuta;All ages;Cohort July 1;Males;Survival in the first trimester;2020QI;""
51 Ceuta;All ages;Cohort July 1;Males;Survival in the second trimester;2022QIV;1.949
51 Ceuta;All ages;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
51 Ceuta;All ages;Cohort July 1;Males;Survival in the second trimester;2022QII;""
51 Ceuta;All ages;Cohort July 1;Males;Survival in the second trimester;2022QI;""
51 Ceuta;All ages;Cohort July 1;Males;Survival in the second trimester;2021QIV;1.991
51 Ceuta;All ages;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
51 Ceuta;All ages;Cohort July 1;Males;Survival in the second trimester;2021QII;""
51 Ceuta;All ages;Cohort July 1;Males;Survival in the second trimester;2021QI;""
51 Ceuta;All ages;Cohort July 1;Males;Survival in the second trimester;2020QIV;1.953
51 Ceuta;All ages;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
51 Ceuta;All ages;Cohort July 1;Males;Survival in the second trimester;2020QII;""
51 Ceuta;All ages;Cohort July 1;Males;Survival in the second trimester;2020QI;""
51 Ceuta;All ages;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
51 Ceuta;All ages;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
51 Ceuta;All ages;Cohort July 1;Males;Survival in the third trimester;2022QII;""
51 Ceuta;All ages;Cohort July 1;Males;Survival in the third trimester;2022QI;1.930
51 Ceuta;All ages;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
51 Ceuta;All ages;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
51 Ceuta;All ages;Cohort July 1;Males;Survival in the third trimester;2021QII;""
51 Ceuta;All ages;Cohort July 1;Males;Survival in the third trimester;2021QI;1.913
51 Ceuta;All ages;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
51 Ceuta;All ages;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
51 Ceuta;All ages;Cohort July 1;Males;Survival in the third trimester;2020QII;""
51 Ceuta;All ages;Cohort July 1;Males;Survival in the third trimester;2020QI;""
51 Ceuta;All ages;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
51 Ceuta;All ages;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
51 Ceuta;All ages;Cohort July 1;Males;Survival in the third trimester;2022QII;1.878
51 Ceuta;All ages;Cohort July 1;Males;Survival in the third trimester;2022QI;""
51 Ceuta;All ages;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
51 Ceuta;All ages;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
51 Ceuta;All ages;Cohort July 1;Males;Survival in the third trimester;2021QII;1.864
51 Ceuta;All ages;Cohort July 1;Males;Survival in the third trimester;2021QI;""
51 Ceuta;All ages;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
51 Ceuta;All ages;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
51 Ceuta;All ages;Cohort July 1;Males;Survival in the third trimester;2020QII;""
51 Ceuta;All ages;Cohort July 1;Males;Survival in the third trimester;2020QI;""
51 Ceuta;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
51 Ceuta;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
51 Ceuta;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
51 Ceuta;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
51 Ceuta;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
51 Ceuta;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
51 Ceuta;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
51 Ceuta;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
51 Ceuta;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
51 Ceuta;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
51 Ceuta;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
51 Ceuta;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
51 Ceuta;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
51 Ceuta;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;95,28
51 Ceuta;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
51 Ceuta;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
51 Ceuta;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
51 Ceuta;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;96,75
51 Ceuta;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
51 Ceuta;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
51 Ceuta;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
51 Ceuta;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;96,43
51 Ceuta;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
51 Ceuta;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
51 Ceuta;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;91,16
51 Ceuta;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
51 Ceuta;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
51 Ceuta;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
51 Ceuta;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;92,56
51 Ceuta;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
51 Ceuta;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
51 Ceuta;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
51 Ceuta;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;93,04
51 Ceuta;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
51 Ceuta;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
51 Ceuta;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
51 Ceuta;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
51 Ceuta;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
51 Ceuta;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
51 Ceuta;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;89,73
51 Ceuta;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
51 Ceuta;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
51 Ceuta;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
51 Ceuta;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;91,14
51 Ceuta;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
51 Ceuta;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
51 Ceuta;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
51 Ceuta;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
51 Ceuta;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
51 Ceuta;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
51 Ceuta;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;87,31
51 Ceuta;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
51 Ceuta;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
51 Ceuta;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
51 Ceuta;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;88,8
51 Ceuta;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
51 Ceuta;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
51 Ceuta;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
51 Ceuta;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
51 Ceuta;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
51 Ceuta;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
51 Ceuta;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QIII;1.230
51 Ceuta;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
51 Ceuta;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
51 Ceuta;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
51 Ceuta;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QIII;1.235
51 Ceuta;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
51 Ceuta;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
51 Ceuta;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
51 Ceuta;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QIII;1.203
51 Ceuta;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
51 Ceuta;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
51 Ceuta;All ages;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
51 Ceuta;All ages;Cohort July 1;Females;Survival in the first trimester;2022QIII;1.164
51 Ceuta;All ages;Cohort July 1;Females;Survival in the first trimester;2022QII;""
51 Ceuta;All ages;Cohort July 1;Females;Survival in the first trimester;2022QI;""
51 Ceuta;All ages;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
51 Ceuta;All ages;Cohort July 1;Females;Survival in the first trimester;2021QIII;1.186
51 Ceuta;All ages;Cohort July 1;Females;Survival in the first trimester;2021QII;""
51 Ceuta;All ages;Cohort July 1;Females;Survival in the first trimester;2021QI;""
51 Ceuta;All ages;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
51 Ceuta;All ages;Cohort July 1;Females;Survival in the first trimester;2020QIII;1.163
51 Ceuta;All ages;Cohort July 1;Females;Survival in the first trimester;2020QII;""
51 Ceuta;All ages;Cohort July 1;Females;Survival in the first trimester;2020QI;""
51 Ceuta;All ages;Cohort July 1;Females;Survival in the second trimester;2022QIV;1.094
51 Ceuta;All ages;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
51 Ceuta;All ages;Cohort July 1;Females;Survival in the second trimester;2022QII;""
51 Ceuta;All ages;Cohort July 1;Females;Survival in the second trimester;2022QI;""
51 Ceuta;All ages;Cohort July 1;Females;Survival in the second trimester;2021QIV;1.140
51 Ceuta;All ages;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
51 Ceuta;All ages;Cohort July 1;Females;Survival in the second trimester;2021QII;""
51 Ceuta;All ages;Cohort July 1;Females;Survival in the second trimester;2021QI;""
51 Ceuta;All ages;Cohort July 1;Females;Survival in the second trimester;2020QIV;1.127
51 Ceuta;All ages;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
51 Ceuta;All ages;Cohort July 1;Females;Survival in the second trimester;2020QII;""
51 Ceuta;All ages;Cohort July 1;Females;Survival in the second trimester;2020QI;""
51 Ceuta;All ages;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
51 Ceuta;All ages;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
51 Ceuta;All ages;Cohort July 1;Females;Survival in the third trimester;2022QII;""
51 Ceuta;All ages;Cohort July 1;Females;Survival in the third trimester;2022QI;1.102
51 Ceuta;All ages;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
51 Ceuta;All ages;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
51 Ceuta;All ages;Cohort July 1;Females;Survival in the third trimester;2021QII;""
51 Ceuta;All ages;Cohort July 1;Females;Survival in the third trimester;2021QI;1.104
51 Ceuta;All ages;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
51 Ceuta;All ages;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
51 Ceuta;All ages;Cohort July 1;Females;Survival in the third trimester;2020QII;""
51 Ceuta;All ages;Cohort July 1;Females;Survival in the third trimester;2020QI;""
51 Ceuta;All ages;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
51 Ceuta;All ages;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
51 Ceuta;All ages;Cohort July 1;Females;Survival in the third trimester;2022QII;1.060
51 Ceuta;All ages;Cohort July 1;Females;Survival in the third trimester;2022QI;""
51 Ceuta;All ages;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
51 Ceuta;All ages;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
51 Ceuta;All ages;Cohort July 1;Females;Survival in the third trimester;2021QII;1.070
51 Ceuta;All ages;Cohort July 1;Females;Survival in the third trimester;2021QI;""
51 Ceuta;All ages;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
51 Ceuta;All ages;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
51 Ceuta;All ages;Cohort July 1;Females;Survival in the third trimester;2020QII;""
51 Ceuta;All ages;Cohort July 1;Females;Survival in the third trimester;2020QI;""
51 Ceuta;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
51 Ceuta;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
51 Ceuta;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
51 Ceuta;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
51 Ceuta;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
51 Ceuta;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
51 Ceuta;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
51 Ceuta;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
51 Ceuta;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
51 Ceuta;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
51 Ceuta;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
51 Ceuta;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
51 Ceuta;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
51 Ceuta;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;94,63
51 Ceuta;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
51 Ceuta;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
51 Ceuta;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
51 Ceuta;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;96,03
51 Ceuta;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
51 Ceuta;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
51 Ceuta;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
51 Ceuta;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;96,67
51 Ceuta;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
51 Ceuta;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
51 Ceuta;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;88,94
51 Ceuta;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
51 Ceuta;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
51 Ceuta;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
51 Ceuta;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;92,31
51 Ceuta;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
51 Ceuta;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
51 Ceuta;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
51 Ceuta;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;93,68
51 Ceuta;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
51 Ceuta;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
51 Ceuta;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
51 Ceuta;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
51 Ceuta;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
51 Ceuta;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
51 Ceuta;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;89,23
51 Ceuta;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
51 Ceuta;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
51 Ceuta;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
51 Ceuta;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;91,77
51 Ceuta;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
51 Ceuta;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
51 Ceuta;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
51 Ceuta;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
51 Ceuta;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
51 Ceuta;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
51 Ceuta;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;85,83
51 Ceuta;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
51 Ceuta;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
51 Ceuta;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
51 Ceuta;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;88,94
51 Ceuta;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
51 Ceuta;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
51 Ceuta;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
51 Ceuta;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
51 Ceuta;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
51 Ceuta;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QIV;3.326
51 Ceuta;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
51 Ceuta;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
51 Ceuta;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
51 Ceuta;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QIV;3.370
51 Ceuta;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
51 Ceuta;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
51 Ceuta;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
51 Ceuta;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QIV;3.300
51 Ceuta;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
51 Ceuta;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
51 Ceuta;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
51 Ceuta;All ages;Cohort October 1;Total;Survival in the first trimester;2022QIV;3.154
51 Ceuta;All ages;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
51 Ceuta;All ages;Cohort October 1;Total;Survival in the first trimester;2022QII;""
51 Ceuta;All ages;Cohort October 1;Total;Survival in the first trimester;2022QI;""
51 Ceuta;All ages;Cohort October 1;Total;Survival in the first trimester;2021QIV;3.218
51 Ceuta;All ages;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
51 Ceuta;All ages;Cohort October 1;Total;Survival in the first trimester;2021QII;""
51 Ceuta;All ages;Cohort October 1;Total;Survival in the first trimester;2021QI;""
51 Ceuta;All ages;Cohort October 1;Total;Survival in the first trimester;2020QIV;3.177
51 Ceuta;All ages;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
51 Ceuta;All ages;Cohort October 1;Total;Survival in the first trimester;2020QII;""
51 Ceuta;All ages;Cohort October 1;Total;Survival in the first trimester;2020QI;""
51 Ceuta;All ages;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
51 Ceuta;All ages;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
51 Ceuta;All ages;Cohort October 1;Total;Survival in the second trimester;2022QII;""
51 Ceuta;All ages;Cohort October 1;Total;Survival in the second trimester;2022QI;3.113
51 Ceuta;All ages;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
51 Ceuta;All ages;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
51 Ceuta;All ages;Cohort October 1;Total;Survival in the second trimester;2021QII;""
51 Ceuta;All ages;Cohort October 1;Total;Survival in the second trimester;2021QI;3.106
51 Ceuta;All ages;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
51 Ceuta;All ages;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
51 Ceuta;All ages;Cohort October 1;Total;Survival in the second trimester;2020QII;""
51 Ceuta;All ages;Cohort October 1;Total;Survival in the second trimester;2020QI;""
51 Ceuta;All ages;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
51 Ceuta;All ages;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
51 Ceuta;All ages;Cohort October 1;Total;Survival in the third trimester;2022QII;3.015
51 Ceuta;All ages;Cohort October 1;Total;Survival in the third trimester;2022QI;""
51 Ceuta;All ages;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
51 Ceuta;All ages;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
51 Ceuta;All ages;Cohort October 1;Total;Survival in the third trimester;2021QII;3.015
51 Ceuta;All ages;Cohort October 1;Total;Survival in the third trimester;2021QI;""
51 Ceuta;All ages;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
51 Ceuta;All ages;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
51 Ceuta;All ages;Cohort October 1;Total;Survival in the third trimester;2020QII;""
51 Ceuta;All ages;Cohort October 1;Total;Survival in the third trimester;2020QI;""
51 Ceuta;All ages;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
51 Ceuta;All ages;Cohort October 1;Total;Survival in the third trimester;2022QIII;2.883
51 Ceuta;All ages;Cohort October 1;Total;Survival in the third trimester;2022QII;""
51 Ceuta;All ages;Cohort October 1;Total;Survival in the third trimester;2022QI;""
51 Ceuta;All ages;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
51 Ceuta;All ages;Cohort October 1;Total;Survival in the third trimester;2021QIII;2.931
51 Ceuta;All ages;Cohort October 1;Total;Survival in the third trimester;2021QII;""
51 Ceuta;All ages;Cohort October 1;Total;Survival in the third trimester;2021QI;""
51 Ceuta;All ages;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
51 Ceuta;All ages;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
51 Ceuta;All ages;Cohort October 1;Total;Survival in the third trimester;2020QII;""
51 Ceuta;All ages;Cohort October 1;Total;Survival in the third trimester;2020QI;""
51 Ceuta;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
51 Ceuta;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
51 Ceuta;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
51 Ceuta;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
51 Ceuta;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
51 Ceuta;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
51 Ceuta;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
51 Ceuta;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
51 Ceuta;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
51 Ceuta;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
51 Ceuta;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
51 Ceuta;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
51 Ceuta;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;94,83
51 Ceuta;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
51 Ceuta;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
51 Ceuta;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
51 Ceuta;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;95,49
51 Ceuta;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
51 Ceuta;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
51 Ceuta;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
51 Ceuta;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;96,27
51 Ceuta;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
51 Ceuta;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
51 Ceuta;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
51 Ceuta;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
51 Ceuta;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
51 Ceuta;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
51 Ceuta;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;92,37
51 Ceuta;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
51 Ceuta;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
51 Ceuta;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
51 Ceuta;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;94,12
51 Ceuta;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
51 Ceuta;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
51 Ceuta;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
51 Ceuta;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
51 Ceuta;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
51 Ceuta;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
51 Ceuta;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;89,47
51 Ceuta;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
51 Ceuta;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
51 Ceuta;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
51 Ceuta;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;91,36
51 Ceuta;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
51 Ceuta;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
51 Ceuta;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
51 Ceuta;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
51 Ceuta;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
51 Ceuta;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
51 Ceuta;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;85,55
51 Ceuta;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
51 Ceuta;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
51 Ceuta;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
51 Ceuta;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;88,82
51 Ceuta;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
51 Ceuta;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
51 Ceuta;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
51 Ceuta;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
51 Ceuta;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
51 Ceuta;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
51 Ceuta;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QIV;2.118
51 Ceuta;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
51 Ceuta;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
51 Ceuta;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
51 Ceuta;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QIV;2.140
51 Ceuta;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
51 Ceuta;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
51 Ceuta;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
51 Ceuta;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QIV;2.092
51 Ceuta;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
51 Ceuta;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
51 Ceuta;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
51 Ceuta;All ages;Cohort October 1;Males;Survival in the first trimester;2022QIV;2.019
51 Ceuta;All ages;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
51 Ceuta;All ages;Cohort October 1;Males;Survival in the first trimester;2022QII;""
51 Ceuta;All ages;Cohort October 1;Males;Survival in the first trimester;2022QI;""
51 Ceuta;All ages;Cohort October 1;Males;Survival in the first trimester;2021QIV;2.035
51 Ceuta;All ages;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
51 Ceuta;All ages;Cohort October 1;Males;Survival in the first trimester;2021QII;""
51 Ceuta;All ages;Cohort October 1;Males;Survival in the first trimester;2021QI;""
51 Ceuta;All ages;Cohort October 1;Males;Survival in the first trimester;2020QIV;2.012
51 Ceuta;All ages;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
51 Ceuta;All ages;Cohort October 1;Males;Survival in the first trimester;2020QII;""
51 Ceuta;All ages;Cohort October 1;Males;Survival in the first trimester;2020QI;""
51 Ceuta;All ages;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
51 Ceuta;All ages;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
51 Ceuta;All ages;Cohort October 1;Males;Survival in the second trimester;2022QII;""
51 Ceuta;All ages;Cohort October 1;Males;Survival in the second trimester;2022QI;1.970
51 Ceuta;All ages;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
51 Ceuta;All ages;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
51 Ceuta;All ages;Cohort October 1;Males;Survival in the second trimester;2021QII;""
51 Ceuta;All ages;Cohort October 1;Males;Survival in the second trimester;2021QI;1.968
51 Ceuta;All ages;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
51 Ceuta;All ages;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
51 Ceuta;All ages;Cohort October 1;Males;Survival in the second trimester;2020QII;""
51 Ceuta;All ages;Cohort October 1;Males;Survival in the second trimester;2020QI;""
51 Ceuta;All ages;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
51 Ceuta;All ages;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
51 Ceuta;All ages;Cohort October 1;Males;Survival in the third trimester;2022QII;1.916
51 Ceuta;All ages;Cohort October 1;Males;Survival in the third trimester;2022QI;""
51 Ceuta;All ages;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
51 Ceuta;All ages;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
51 Ceuta;All ages;Cohort October 1;Males;Survival in the third trimester;2021QII;1.914
51 Ceuta;All ages;Cohort October 1;Males;Survival in the third trimester;2021QI;""
51 Ceuta;All ages;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
51 Ceuta;All ages;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
51 Ceuta;All ages;Cohort October 1;Males;Survival in the third trimester;2020QII;""
51 Ceuta;All ages;Cohort October 1;Males;Survival in the third trimester;2020QI;""
51 Ceuta;All ages;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
51 Ceuta;All ages;Cohort October 1;Males;Survival in the third trimester;2022QIII;1.832
51 Ceuta;All ages;Cohort October 1;Males;Survival in the third trimester;2022QII;""
51 Ceuta;All ages;Cohort October 1;Males;Survival in the third trimester;2022QI;""
51 Ceuta;All ages;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
51 Ceuta;All ages;Cohort October 1;Males;Survival in the third trimester;2021QIII;1.864
51 Ceuta;All ages;Cohort October 1;Males;Survival in the third trimester;2021QII;""
51 Ceuta;All ages;Cohort October 1;Males;Survival in the third trimester;2021QI;""
51 Ceuta;All ages;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
51 Ceuta;All ages;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
51 Ceuta;All ages;Cohort October 1;Males;Survival in the third trimester;2020QII;""
51 Ceuta;All ages;Cohort October 1;Males;Survival in the third trimester;2020QI;""
51 Ceuta;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
51 Ceuta;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
51 Ceuta;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
51 Ceuta;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
51 Ceuta;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
51 Ceuta;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
51 Ceuta;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
51 Ceuta;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
51 Ceuta;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
51 Ceuta;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
51 Ceuta;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
51 Ceuta;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
51 Ceuta;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;95,33
51 Ceuta;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
51 Ceuta;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
51 Ceuta;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
51 Ceuta;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;95,09
51 Ceuta;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
51 Ceuta;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
51 Ceuta;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
51 Ceuta;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;96,18
51 Ceuta;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
51 Ceuta;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
51 Ceuta;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
51 Ceuta;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
51 Ceuta;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
51 Ceuta;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
51 Ceuta;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;92,06
51 Ceuta;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
51 Ceuta;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
51 Ceuta;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
51 Ceuta;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;94,07
51 Ceuta;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
51 Ceuta;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
51 Ceuta;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
51 Ceuta;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
51 Ceuta;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
51 Ceuta;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
51 Ceuta;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;89,53
51 Ceuta;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
51 Ceuta;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
51 Ceuta;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
51 Ceuta;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;91,49
51 Ceuta;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
51 Ceuta;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
51 Ceuta;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
51 Ceuta;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
51 Ceuta;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
51 Ceuta;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
51 Ceuta;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;85,61
51 Ceuta;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
51 Ceuta;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
51 Ceuta;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
51 Ceuta;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;89,1
51 Ceuta;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
51 Ceuta;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
51 Ceuta;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
51 Ceuta;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
51 Ceuta;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
51 Ceuta;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
51 Ceuta;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QIV;1.208
51 Ceuta;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
51 Ceuta;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
51 Ceuta;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
51 Ceuta;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QIV;1.230
51 Ceuta;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
51 Ceuta;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
51 Ceuta;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
51 Ceuta;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QIV;1.208
51 Ceuta;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
51 Ceuta;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
51 Ceuta;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
51 Ceuta;All ages;Cohort October 1;Females;Survival in the first trimester;2022QIV;1.135
51 Ceuta;All ages;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
51 Ceuta;All ages;Cohort October 1;Females;Survival in the first trimester;2022QII;""
51 Ceuta;All ages;Cohort October 1;Females;Survival in the first trimester;2022QI;""
51 Ceuta;All ages;Cohort October 1;Females;Survival in the first trimester;2021QIV;1.183
51 Ceuta;All ages;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
51 Ceuta;All ages;Cohort October 1;Females;Survival in the first trimester;2021QII;""
51 Ceuta;All ages;Cohort October 1;Females;Survival in the first trimester;2021QI;""
51 Ceuta;All ages;Cohort October 1;Females;Survival in the first trimester;2020QIV;1.165
51 Ceuta;All ages;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
51 Ceuta;All ages;Cohort October 1;Females;Survival in the first trimester;2020QII;""
51 Ceuta;All ages;Cohort October 1;Females;Survival in the first trimester;2020QI;""
51 Ceuta;All ages;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
51 Ceuta;All ages;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
51 Ceuta;All ages;Cohort October 1;Females;Survival in the second trimester;2022QII;""
51 Ceuta;All ages;Cohort October 1;Females;Survival in the second trimester;2022QI;1.143
51 Ceuta;All ages;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
51 Ceuta;All ages;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
51 Ceuta;All ages;Cohort October 1;Females;Survival in the second trimester;2021QII;""
51 Ceuta;All ages;Cohort October 1;Females;Survival in the second trimester;2021QI;1.138
51 Ceuta;All ages;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
51 Ceuta;All ages;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
51 Ceuta;All ages;Cohort October 1;Females;Survival in the second trimester;2020QII;""
51 Ceuta;All ages;Cohort October 1;Females;Survival in the second trimester;2020QI;""
51 Ceuta;All ages;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
51 Ceuta;All ages;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
51 Ceuta;All ages;Cohort October 1;Females;Survival in the third trimester;2022QII;1.099
51 Ceuta;All ages;Cohort October 1;Females;Survival in the third trimester;2022QI;""
51 Ceuta;All ages;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
51 Ceuta;All ages;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
51 Ceuta;All ages;Cohort October 1;Females;Survival in the third trimester;2021QII;1.101
51 Ceuta;All ages;Cohort October 1;Females;Survival in the third trimester;2021QI;""
51 Ceuta;All ages;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
51 Ceuta;All ages;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
51 Ceuta;All ages;Cohort October 1;Females;Survival in the third trimester;2020QII;""
51 Ceuta;All ages;Cohort October 1;Females;Survival in the third trimester;2020QI;""
51 Ceuta;All ages;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
51 Ceuta;All ages;Cohort October 1;Females;Survival in the third trimester;2022QIII;1.051
51 Ceuta;All ages;Cohort October 1;Females;Survival in the third trimester;2022QII;""
51 Ceuta;All ages;Cohort October 1;Females;Survival in the third trimester;2022QI;""
51 Ceuta;All ages;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
51 Ceuta;All ages;Cohort October 1;Females;Survival in the third trimester;2021QIII;1.067
51 Ceuta;All ages;Cohort October 1;Females;Survival in the third trimester;2021QII;""
51 Ceuta;All ages;Cohort October 1;Females;Survival in the third trimester;2021QI;""
51 Ceuta;All ages;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
51 Ceuta;All ages;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
51 Ceuta;All ages;Cohort October 1;Females;Survival in the third trimester;2020QII;""
51 Ceuta;All ages;Cohort October 1;Females;Survival in the third trimester;2020QI;""
51 Ceuta;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
51 Ceuta;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
51 Ceuta;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
51 Ceuta;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
51 Ceuta;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
51 Ceuta;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
51 Ceuta;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
51 Ceuta;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
51 Ceuta;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
51 Ceuta;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
51 Ceuta;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
51 Ceuta;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
51 Ceuta;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;93,96
51 Ceuta;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
51 Ceuta;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
51 Ceuta;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
51 Ceuta;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;96,18
51 Ceuta;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
51 Ceuta;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
51 Ceuta;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
51 Ceuta;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;96,44
51 Ceuta;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
51 Ceuta;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
51 Ceuta;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
51 Ceuta;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
51 Ceuta;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
51 Ceuta;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
51 Ceuta;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;92,93
51 Ceuta;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
51 Ceuta;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
51 Ceuta;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
51 Ceuta;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;94,21
51 Ceuta;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
51 Ceuta;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
51 Ceuta;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
51 Ceuta;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
51 Ceuta;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
51 Ceuta;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
51 Ceuta;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;89,35
51 Ceuta;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
51 Ceuta;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
51 Ceuta;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
51 Ceuta;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;91,14
51 Ceuta;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
51 Ceuta;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
51 Ceuta;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
51 Ceuta;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
51 Ceuta;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
51 Ceuta;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
51 Ceuta;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;85,45
51 Ceuta;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
51 Ceuta;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
51 Ceuta;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
51 Ceuta;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;88,33
51 Ceuta;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
51 Ceuta;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
51 Ceuta;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
51 Ceuta;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
51 Ceuta;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
51 Ceuta;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
51 Ceuta;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
51 Ceuta;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
51 Ceuta;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
51 Ceuta;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QI;320
51 Ceuta;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
51 Ceuta;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
51 Ceuta;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
51 Ceuta;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QI;313
51 Ceuta;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
51 Ceuta;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
51 Ceuta;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
51 Ceuta;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QI;278
51 Ceuta;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
51 Ceuta;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
51 Ceuta;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2022QII;""
51 Ceuta;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2022QI;304
51 Ceuta;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
51 Ceuta;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
51 Ceuta;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2021QII;""
51 Ceuta;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2021QI;299
51 Ceuta;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
51 Ceuta;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
51 Ceuta;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2020QII;""
51 Ceuta;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2020QI;238
51 Ceuta;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
51 Ceuta;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
51 Ceuta;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2022QII;284
51 Ceuta;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2022QI;""
51 Ceuta;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
51 Ceuta;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
51 Ceuta;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2021QII;282
51 Ceuta;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2021QI;""
51 Ceuta;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
51 Ceuta;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
51 Ceuta;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2020QII;225
51 Ceuta;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2020QI;""
51 Ceuta;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
51 Ceuta;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QIII;256
51 Ceuta;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QII;""
51 Ceuta;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QI;""
51 Ceuta;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
51 Ceuta;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QIII;264
51 Ceuta;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QII;""
51 Ceuta;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QI;""
51 Ceuta;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
51 Ceuta;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QIII;213
51 Ceuta;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QII;""
51 Ceuta;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QI;""
51 Ceuta;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QIV;233
51 Ceuta;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
51 Ceuta;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QII;""
51 Ceuta;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QI;""
51 Ceuta;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QIV;252
51 Ceuta;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
51 Ceuta;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QII;""
51 Ceuta;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QI;""
51 Ceuta;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QIV;207
51 Ceuta;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
51 Ceuta;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QII;""
51 Ceuta;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QI;""
51 Ceuta;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
51 Ceuta;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
51 Ceuta;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
51 Ceuta;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
51 Ceuta;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
51 Ceuta;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
51 Ceuta;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
51 Ceuta;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
51 Ceuta;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
51 Ceuta;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
51 Ceuta;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
51 Ceuta;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
51 Ceuta;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
51 Ceuta;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
51 Ceuta;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
51 Ceuta;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;95
51 Ceuta;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
51 Ceuta;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
51 Ceuta;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
51 Ceuta;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;95,53
51 Ceuta;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
51 Ceuta;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
51 Ceuta;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
51 Ceuta;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;85,61
51 Ceuta;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
51 Ceuta;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
51 Ceuta;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;88,75
51 Ceuta;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
51 Ceuta;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
51 Ceuta;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
51 Ceuta;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;90,1
51 Ceuta;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
51 Ceuta;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
51 Ceuta;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
51 Ceuta;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;80,94
51 Ceuta;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
51 Ceuta;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
51 Ceuta;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;80
51 Ceuta;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
51 Ceuta;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
51 Ceuta;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
51 Ceuta;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;84,35
51 Ceuta;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
51 Ceuta;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
51 Ceuta;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
51 Ceuta;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;76,62
51 Ceuta;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
51 Ceuta;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
51 Ceuta;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;72,81
51 Ceuta;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
51 Ceuta;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
51 Ceuta;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
51 Ceuta;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;80,51
51 Ceuta;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
51 Ceuta;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
51 Ceuta;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
51 Ceuta;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;74,46
51 Ceuta;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
51 Ceuta;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
51 Ceuta;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
51 Ceuta;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
51 Ceuta;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
51 Ceuta;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
51 Ceuta;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QI;185
51 Ceuta;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
51 Ceuta;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
51 Ceuta;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
51 Ceuta;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QI;182
51 Ceuta;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
51 Ceuta;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
51 Ceuta;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
51 Ceuta;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QI;163
51 Ceuta;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
51 Ceuta;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
51 Ceuta;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2022QII;""
51 Ceuta;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2022QI;174
51 Ceuta;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
51 Ceuta;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
51 Ceuta;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2021QII;""
51 Ceuta;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2021QI;174
51 Ceuta;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
51 Ceuta;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
51 Ceuta;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2020QII;""
51 Ceuta;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2020QI;140
51 Ceuta;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
51 Ceuta;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
51 Ceuta;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2022QII;159
51 Ceuta;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2022QI;""
51 Ceuta;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
51 Ceuta;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
51 Ceuta;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2021QII;165
51 Ceuta;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2021QI;""
51 Ceuta;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
51 Ceuta;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
51 Ceuta;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2020QII;128
51 Ceuta;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2020QI;""
51 Ceuta;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
51 Ceuta;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QIII;144
51 Ceuta;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QII;""
51 Ceuta;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QI;""
51 Ceuta;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
51 Ceuta;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QIII;154
51 Ceuta;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QII;""
51 Ceuta;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QI;""
51 Ceuta;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
51 Ceuta;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QIII;122
51 Ceuta;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QII;""
51 Ceuta;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QI;""
51 Ceuta;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QIV;134
51 Ceuta;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
51 Ceuta;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QII;""
51 Ceuta;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QI;""
51 Ceuta;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QIV;145
51 Ceuta;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
51 Ceuta;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QII;""
51 Ceuta;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QI;""
51 Ceuta;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QIV;117
51 Ceuta;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
51 Ceuta;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QII;""
51 Ceuta;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QI;""
51 Ceuta;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
51 Ceuta;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
51 Ceuta;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
51 Ceuta;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
51 Ceuta;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
51 Ceuta;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
51 Ceuta;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
51 Ceuta;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
51 Ceuta;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
51 Ceuta;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
51 Ceuta;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
51 Ceuta;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
51 Ceuta;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
51 Ceuta;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
51 Ceuta;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
51 Ceuta;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;94,05
51 Ceuta;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
51 Ceuta;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
51 Ceuta;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
51 Ceuta;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;95,6
51 Ceuta;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
51 Ceuta;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
51 Ceuta;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
51 Ceuta;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;85,89
51 Ceuta;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
51 Ceuta;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
51 Ceuta;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;85,95
51 Ceuta;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
51 Ceuta;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
51 Ceuta;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
51 Ceuta;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;90,66
51 Ceuta;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
51 Ceuta;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
51 Ceuta;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
51 Ceuta;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;78,53
51 Ceuta;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
51 Ceuta;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
51 Ceuta;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;77,84
51 Ceuta;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
51 Ceuta;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
51 Ceuta;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
51 Ceuta;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;84,62
51 Ceuta;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
51 Ceuta;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
51 Ceuta;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
51 Ceuta;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;74,85
51 Ceuta;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
51 Ceuta;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
51 Ceuta;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;72,43
51 Ceuta;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
51 Ceuta;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
51 Ceuta;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
51 Ceuta;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;79,67
51 Ceuta;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
51 Ceuta;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
51 Ceuta;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
51 Ceuta;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;71,78
51 Ceuta;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
51 Ceuta;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
51 Ceuta;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
51 Ceuta;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
51 Ceuta;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
51 Ceuta;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
51 Ceuta;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QI;135
51 Ceuta;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
51 Ceuta;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
51 Ceuta;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
51 Ceuta;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QI;131
51 Ceuta;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
51 Ceuta;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
51 Ceuta;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
51 Ceuta;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QI;115
51 Ceuta;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
51 Ceuta;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
51 Ceuta;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2022QII;""
51 Ceuta;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2022QI;130
51 Ceuta;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
51 Ceuta;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
51 Ceuta;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2021QII;""
51 Ceuta;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2021QI;125
51 Ceuta;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
51 Ceuta;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
51 Ceuta;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2020QII;""
51 Ceuta;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2020QI;98
51 Ceuta;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
51 Ceuta;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
51 Ceuta;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2022QII;125
51 Ceuta;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2022QI;""
51 Ceuta;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
51 Ceuta;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
51 Ceuta;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2021QII;117
51 Ceuta;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2021QI;""
51 Ceuta;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
51 Ceuta;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
51 Ceuta;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2020QII;97
51 Ceuta;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2020QI;""
51 Ceuta;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
51 Ceuta;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QIII;112
51 Ceuta;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QII;""
51 Ceuta;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QI;""
51 Ceuta;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
51 Ceuta;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QIII;110
51 Ceuta;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QII;""
51 Ceuta;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QI;""
51 Ceuta;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
51 Ceuta;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QIII;91
51 Ceuta;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QII;""
51 Ceuta;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QI;""
51 Ceuta;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QIV;99
51 Ceuta;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
51 Ceuta;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QII;""
51 Ceuta;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QI;""
51 Ceuta;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QIV;107
51 Ceuta;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
51 Ceuta;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QII;""
51 Ceuta;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QI;""
51 Ceuta;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QIV;90
51 Ceuta;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
51 Ceuta;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QII;""
51 Ceuta;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QI;""
51 Ceuta;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
51 Ceuta;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
51 Ceuta;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
51 Ceuta;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
51 Ceuta;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
51 Ceuta;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
51 Ceuta;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
51 Ceuta;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
51 Ceuta;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
51 Ceuta;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
51 Ceuta;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
51 Ceuta;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
51 Ceuta;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
51 Ceuta;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
51 Ceuta;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
51 Ceuta;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;96,3
51 Ceuta;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
51 Ceuta;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
51 Ceuta;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
51 Ceuta;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;95,42
51 Ceuta;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
51 Ceuta;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
51 Ceuta;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
51 Ceuta;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;85,22
51 Ceuta;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
51 Ceuta;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
51 Ceuta;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;92,59
51 Ceuta;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
51 Ceuta;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
51 Ceuta;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
51 Ceuta;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;89,31
51 Ceuta;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
51 Ceuta;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
51 Ceuta;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
51 Ceuta;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;84,35
51 Ceuta;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
51 Ceuta;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
51 Ceuta;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;82,96
51 Ceuta;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
51 Ceuta;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
51 Ceuta;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
51 Ceuta;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;83,97
51 Ceuta;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
51 Ceuta;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
51 Ceuta;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
51 Ceuta;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;79,13
51 Ceuta;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
51 Ceuta;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
51 Ceuta;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;73,33
51 Ceuta;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
51 Ceuta;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
51 Ceuta;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
51 Ceuta;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;81,68
51 Ceuta;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
51 Ceuta;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
51 Ceuta;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
51 Ceuta;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;78,26
51 Ceuta;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
51 Ceuta;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
51 Ceuta;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
51 Ceuta;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
51 Ceuta;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
51 Ceuta;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QII;292
51 Ceuta;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
51 Ceuta;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
51 Ceuta;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
51 Ceuta;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QII;293
51 Ceuta;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
51 Ceuta;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
51 Ceuta;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
51 Ceuta;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QII;264
51 Ceuta;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
51 Ceuta;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
51 Ceuta;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
51 Ceuta;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2022QII;265
51 Ceuta;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2022QI;""
51 Ceuta;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
51 Ceuta;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
51 Ceuta;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2021QII;271
51 Ceuta;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2021QI;""
51 Ceuta;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
51 Ceuta;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
51 Ceuta;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2020QII;251
51 Ceuta;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2020QI;""
51 Ceuta;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
51 Ceuta;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2022QIII;242
51 Ceuta;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2022QII;""
51 Ceuta;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2022QI;""
51 Ceuta;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
51 Ceuta;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2021QIII;253
51 Ceuta;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2021QII;""
51 Ceuta;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2021QI;""
51 Ceuta;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
51 Ceuta;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2020QIII;237
51 Ceuta;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2020QII;""
51 Ceuta;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2020QI;""
51 Ceuta;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QIV;219
51 Ceuta;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
51 Ceuta;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QII;""
51 Ceuta;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QI;""
51 Ceuta;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QIV;241
51 Ceuta;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
51 Ceuta;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QII;""
51 Ceuta;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QI;""
51 Ceuta;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QIV;228
51 Ceuta;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
51 Ceuta;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QII;""
51 Ceuta;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QI;""
51 Ceuta;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
51 Ceuta;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
51 Ceuta;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QII;""
51 Ceuta;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QI;227
51 Ceuta;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
51 Ceuta;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
51 Ceuta;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QII;""
51 Ceuta;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QI;219
51 Ceuta;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
51 Ceuta;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
51 Ceuta;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QII;""
51 Ceuta;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QI;""
51 Ceuta;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
51 Ceuta;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
51 Ceuta;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
51 Ceuta;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
51 Ceuta;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
51 Ceuta;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
51 Ceuta;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
51 Ceuta;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
51 Ceuta;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
51 Ceuta;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
51 Ceuta;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
51 Ceuta;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
51 Ceuta;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
51 Ceuta;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
51 Ceuta;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;90,75
51 Ceuta;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
51 Ceuta;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
51 Ceuta;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
51 Ceuta;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;92,49
51 Ceuta;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
51 Ceuta;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
51 Ceuta;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
51 Ceuta;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;95,08
51 Ceuta;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
51 Ceuta;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
51 Ceuta;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;82,88
51 Ceuta;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
51 Ceuta;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
51 Ceuta;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
51 Ceuta;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;86,35
51 Ceuta;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
51 Ceuta;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
51 Ceuta;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
51 Ceuta;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;89,77
51 Ceuta;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
51 Ceuta;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
51 Ceuta;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;75
51 Ceuta;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
51 Ceuta;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
51 Ceuta;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
51 Ceuta;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;82,25
51 Ceuta;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
51 Ceuta;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
51 Ceuta;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
51 Ceuta;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;86,36
51 Ceuta;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
51 Ceuta;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
51 Ceuta;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
51 Ceuta;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
51 Ceuta;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
51 Ceuta;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
51 Ceuta;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;77,47
51 Ceuta;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
51 Ceuta;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
51 Ceuta;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
51 Ceuta;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;82,95
51 Ceuta;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
51 Ceuta;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
51 Ceuta;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
51 Ceuta;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
51 Ceuta;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
51 Ceuta;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
51 Ceuta;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QII;168
51 Ceuta;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
51 Ceuta;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
51 Ceuta;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
51 Ceuta;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QII;173
51 Ceuta;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
51 Ceuta;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
51 Ceuta;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
51 Ceuta;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QII;155
51 Ceuta;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
51 Ceuta;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
51 Ceuta;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
51 Ceuta;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2022QII;150
51 Ceuta;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2022QI;""
51 Ceuta;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
51 Ceuta;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
51 Ceuta;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2021QII;159
51 Ceuta;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2021QI;""
51 Ceuta;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
51 Ceuta;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
51 Ceuta;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2020QII;143
51 Ceuta;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2020QI;""
51 Ceuta;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
51 Ceuta;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2022QIII;138
51 Ceuta;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2022QII;""
51 Ceuta;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2022QI;""
51 Ceuta;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
51 Ceuta;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2021QIII;148
51 Ceuta;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2021QII;""
51 Ceuta;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2021QI;""
51 Ceuta;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
51 Ceuta;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2020QIII;135
51 Ceuta;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2020QII;""
51 Ceuta;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2020QI;""
51 Ceuta;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QIV;128
51 Ceuta;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
51 Ceuta;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QII;""
51 Ceuta;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QI;""
51 Ceuta;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QIV;139
51 Ceuta;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
51 Ceuta;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QII;""
51 Ceuta;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QI;""
51 Ceuta;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QIV;128
51 Ceuta;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
51 Ceuta;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QII;""
51 Ceuta;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QI;""
51 Ceuta;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
51 Ceuta;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
51 Ceuta;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QII;""
51 Ceuta;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QI;129
51 Ceuta;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
51 Ceuta;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
51 Ceuta;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QII;""
51 Ceuta;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QI;124
51 Ceuta;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
51 Ceuta;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
51 Ceuta;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QII;""
51 Ceuta;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QI;""
51 Ceuta;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
51 Ceuta;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
51 Ceuta;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
51 Ceuta;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
51 Ceuta;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
51 Ceuta;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
51 Ceuta;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
51 Ceuta;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
51 Ceuta;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
51 Ceuta;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
51 Ceuta;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
51 Ceuta;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
51 Ceuta;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
51 Ceuta;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
51 Ceuta;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;89,29
51 Ceuta;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
51 Ceuta;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
51 Ceuta;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
51 Ceuta;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;91,91
51 Ceuta;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
51 Ceuta;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
51 Ceuta;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
51 Ceuta;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;92,26
51 Ceuta;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
51 Ceuta;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
51 Ceuta;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;82,14
51 Ceuta;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
51 Ceuta;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
51 Ceuta;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
51 Ceuta;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;85,55
51 Ceuta;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
51 Ceuta;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
51 Ceuta;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
51 Ceuta;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;87,1
51 Ceuta;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
51 Ceuta;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
51 Ceuta;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;76,19
51 Ceuta;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
51 Ceuta;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
51 Ceuta;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
51 Ceuta;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;80,35
51 Ceuta;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
51 Ceuta;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
51 Ceuta;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
51 Ceuta;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;82,58
51 Ceuta;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
51 Ceuta;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
51 Ceuta;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
51 Ceuta;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
51 Ceuta;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
51 Ceuta;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
51 Ceuta;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;74,57
51 Ceuta;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
51 Ceuta;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
51 Ceuta;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
51 Ceuta;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;80
51 Ceuta;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
51 Ceuta;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
51 Ceuta;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
51 Ceuta;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
51 Ceuta;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
51 Ceuta;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
51 Ceuta;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QII;124
51 Ceuta;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
51 Ceuta;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
51 Ceuta;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
51 Ceuta;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QII;120
51 Ceuta;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
51 Ceuta;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
51 Ceuta;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
51 Ceuta;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QII;109
51 Ceuta;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
51 Ceuta;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
51 Ceuta;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
51 Ceuta;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2022QII;115
51 Ceuta;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2022QI;""
51 Ceuta;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
51 Ceuta;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
51 Ceuta;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2021QII;112
51 Ceuta;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2021QI;""
51 Ceuta;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
51 Ceuta;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
51 Ceuta;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2020QII;108
51 Ceuta;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2020QI;""
51 Ceuta;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
51 Ceuta;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2022QIII;104
51 Ceuta;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2022QII;""
51 Ceuta;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2022QI;""
51 Ceuta;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
51 Ceuta;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2021QIII;105
51 Ceuta;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2021QII;""
51 Ceuta;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2021QI;""
51 Ceuta;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
51 Ceuta;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2020QIII;102
51 Ceuta;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2020QII;""
51 Ceuta;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2020QI;""
51 Ceuta;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QIV;91
51 Ceuta;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
51 Ceuta;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QII;""
51 Ceuta;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QI;""
51 Ceuta;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QIV;102
51 Ceuta;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
51 Ceuta;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QII;""
51 Ceuta;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QI;""
51 Ceuta;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QIV;100
51 Ceuta;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
51 Ceuta;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QII;""
51 Ceuta;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QI;""
51 Ceuta;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
51 Ceuta;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
51 Ceuta;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QII;""
51 Ceuta;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QI;98
51 Ceuta;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
51 Ceuta;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
51 Ceuta;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QII;""
51 Ceuta;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QI;95
51 Ceuta;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
51 Ceuta;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
51 Ceuta;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QII;""
51 Ceuta;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QI;""
51 Ceuta;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
51 Ceuta;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
51 Ceuta;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
51 Ceuta;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
51 Ceuta;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
51 Ceuta;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
51 Ceuta;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
51 Ceuta;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
51 Ceuta;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
51 Ceuta;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
51 Ceuta;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
51 Ceuta;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
51 Ceuta;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
51 Ceuta;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
51 Ceuta;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;92,74
51 Ceuta;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
51 Ceuta;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
51 Ceuta;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
51 Ceuta;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;93,33
51 Ceuta;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
51 Ceuta;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
51 Ceuta;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
51 Ceuta;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;99,08
51 Ceuta;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
51 Ceuta;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
51 Ceuta;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;83,87
51 Ceuta;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
51 Ceuta;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
51 Ceuta;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
51 Ceuta;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;87,5
51 Ceuta;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
51 Ceuta;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
51 Ceuta;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
51 Ceuta;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;93,58
51 Ceuta;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
51 Ceuta;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
51 Ceuta;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;73,39
51 Ceuta;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
51 Ceuta;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
51 Ceuta;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
51 Ceuta;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;85
51 Ceuta;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
51 Ceuta;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
51 Ceuta;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
51 Ceuta;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;91,74
51 Ceuta;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
51 Ceuta;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
51 Ceuta;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
51 Ceuta;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
51 Ceuta;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
51 Ceuta;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
51 Ceuta;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;81,67
51 Ceuta;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
51 Ceuta;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
51 Ceuta;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
51 Ceuta;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;87,16
51 Ceuta;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
51 Ceuta;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
51 Ceuta;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
51 Ceuta;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
51 Ceuta;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
51 Ceuta;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QIII;297
51 Ceuta;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
51 Ceuta;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
51 Ceuta;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
51 Ceuta;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QIII;305
51 Ceuta;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
51 Ceuta;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
51 Ceuta;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
51 Ceuta;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QIII;269
51 Ceuta;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
51 Ceuta;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
51 Ceuta;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
51 Ceuta;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2022QIII;270
51 Ceuta;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2022QII;""
51 Ceuta;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2022QI;""
51 Ceuta;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
51 Ceuta;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2021QIII;281
51 Ceuta;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2021QII;""
51 Ceuta;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2021QI;""
51 Ceuta;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
51 Ceuta;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2020QIII;250
51 Ceuta;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2020QII;""
51 Ceuta;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2020QI;""
51 Ceuta;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2022QIV;245
51 Ceuta;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
51 Ceuta;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2022QII;""
51 Ceuta;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2022QI;""
51 Ceuta;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2021QIV;259
51 Ceuta;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
51 Ceuta;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2021QII;""
51 Ceuta;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2021QI;""
51 Ceuta;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2020QIV;241
51 Ceuta;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
51 Ceuta;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2020QII;""
51 Ceuta;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2020QI;""
51 Ceuta;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
51 Ceuta;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
51 Ceuta;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QII;""
51 Ceuta;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QI;244
51 Ceuta;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
51 Ceuta;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
51 Ceuta;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QII;""
51 Ceuta;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QI;231
51 Ceuta;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
51 Ceuta;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
51 Ceuta;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QII;""
51 Ceuta;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QI;""
51 Ceuta;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
51 Ceuta;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
51 Ceuta;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QII;228
51 Ceuta;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QI;""
51 Ceuta;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
51 Ceuta;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
51 Ceuta;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QII;221
51 Ceuta;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QI;""
51 Ceuta;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
51 Ceuta;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
51 Ceuta;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QII;""
51 Ceuta;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QI;""
51 Ceuta;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
51 Ceuta;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
51 Ceuta;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
51 Ceuta;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
51 Ceuta;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
51 Ceuta;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
51 Ceuta;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
51 Ceuta;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
51 Ceuta;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
51 Ceuta;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
51 Ceuta;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
51 Ceuta;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
51 Ceuta;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
51 Ceuta;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;90,91
51 Ceuta;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
51 Ceuta;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
51 Ceuta;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
51 Ceuta;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;92,13
51 Ceuta;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
51 Ceuta;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
51 Ceuta;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
51 Ceuta;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;92,94
51 Ceuta;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
51 Ceuta;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
51 Ceuta;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;82,49
51 Ceuta;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
51 Ceuta;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
51 Ceuta;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
51 Ceuta;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;84,92
51 Ceuta;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
51 Ceuta;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
51 Ceuta;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
51 Ceuta;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;89,59
51 Ceuta;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
51 Ceuta;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
51 Ceuta;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
51 Ceuta;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
51 Ceuta;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
51 Ceuta;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
51 Ceuta;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;80
51 Ceuta;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
51 Ceuta;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
51 Ceuta;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
51 Ceuta;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;85,87
51 Ceuta;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
51 Ceuta;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
51 Ceuta;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
51 Ceuta;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
51 Ceuta;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
51 Ceuta;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
51 Ceuta;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;74,75
51 Ceuta;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
51 Ceuta;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
51 Ceuta;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
51 Ceuta;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;82,16
51 Ceuta;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
51 Ceuta;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
51 Ceuta;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
51 Ceuta;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
51 Ceuta;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
51 Ceuta;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
51 Ceuta;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QIII;168
51 Ceuta;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
51 Ceuta;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
51 Ceuta;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
51 Ceuta;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QIII;179
51 Ceuta;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
51 Ceuta;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
51 Ceuta;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
51 Ceuta;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QIII;152
51 Ceuta;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
51 Ceuta;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
51 Ceuta;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
51 Ceuta;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2022QIII;155
51 Ceuta;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2022QII;""
51 Ceuta;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2022QI;""
51 Ceuta;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
51 Ceuta;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2021QIII;165
51 Ceuta;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2021QII;""
51 Ceuta;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2021QI;""
51 Ceuta;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
51 Ceuta;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2020QIII;142
51 Ceuta;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2020QII;""
51 Ceuta;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2020QI;""
51 Ceuta;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2022QIV;144
51 Ceuta;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
51 Ceuta;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2022QII;""
51 Ceuta;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2022QI;""
51 Ceuta;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2021QIV;151
51 Ceuta;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
51 Ceuta;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2021QII;""
51 Ceuta;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2021QI;""
51 Ceuta;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2020QIV;135
51 Ceuta;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
51 Ceuta;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2020QII;""
51 Ceuta;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2020QI;""
51 Ceuta;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
51 Ceuta;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
51 Ceuta;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QII;""
51 Ceuta;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QI;140
51 Ceuta;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
51 Ceuta;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
51 Ceuta;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QII;""
51 Ceuta;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QI;130
51 Ceuta;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
51 Ceuta;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
51 Ceuta;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QII;""
51 Ceuta;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QI;""
51 Ceuta;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
51 Ceuta;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
51 Ceuta;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QII;128
51 Ceuta;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QI;""
51 Ceuta;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
51 Ceuta;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
51 Ceuta;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QII;125
51 Ceuta;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QI;""
51 Ceuta;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
51 Ceuta;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
51 Ceuta;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QII;""
51 Ceuta;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QI;""
51 Ceuta;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
51 Ceuta;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
51 Ceuta;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
51 Ceuta;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
51 Ceuta;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
51 Ceuta;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
51 Ceuta;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
51 Ceuta;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
51 Ceuta;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
51 Ceuta;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
51 Ceuta;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
51 Ceuta;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
51 Ceuta;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
51 Ceuta;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;92,26
51 Ceuta;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
51 Ceuta;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
51 Ceuta;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
51 Ceuta;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;92,18
51 Ceuta;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
51 Ceuta;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
51 Ceuta;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
51 Ceuta;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;93,42
51 Ceuta;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
51 Ceuta;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
51 Ceuta;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;85,71
51 Ceuta;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
51 Ceuta;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
51 Ceuta;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
51 Ceuta;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;84,36
51 Ceuta;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
51 Ceuta;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
51 Ceuta;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
51 Ceuta;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;88,82
51 Ceuta;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
51 Ceuta;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
51 Ceuta;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
51 Ceuta;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
51 Ceuta;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
51 Ceuta;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
51 Ceuta;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;78,21
51 Ceuta;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
51 Ceuta;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
51 Ceuta;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
51 Ceuta;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;85,53
51 Ceuta;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
51 Ceuta;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
51 Ceuta;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
51 Ceuta;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
51 Ceuta;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
51 Ceuta;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
51 Ceuta;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;71,51
51 Ceuta;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
51 Ceuta;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
51 Ceuta;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
51 Ceuta;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;82,24
51 Ceuta;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
51 Ceuta;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
51 Ceuta;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
51 Ceuta;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
51 Ceuta;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
51 Ceuta;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
51 Ceuta;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QIII;129
51 Ceuta;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
51 Ceuta;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
51 Ceuta;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
51 Ceuta;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QIII;126
51 Ceuta;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
51 Ceuta;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
51 Ceuta;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
51 Ceuta;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QIII;117
51 Ceuta;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
51 Ceuta;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
51 Ceuta;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
51 Ceuta;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2022QIII;115
51 Ceuta;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2022QII;""
51 Ceuta;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2022QI;""
51 Ceuta;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
51 Ceuta;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2021QIII;116
51 Ceuta;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2021QII;""
51 Ceuta;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2021QI;""
51 Ceuta;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
51 Ceuta;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2020QIII;108
51 Ceuta;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2020QII;""
51 Ceuta;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2020QI;""
51 Ceuta;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2022QIV;101
51 Ceuta;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
51 Ceuta;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2022QII;""
51 Ceuta;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2022QI;""
51 Ceuta;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2021QIV;108
51 Ceuta;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
51 Ceuta;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2021QII;""
51 Ceuta;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2021QI;""
51 Ceuta;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2020QIV;106
51 Ceuta;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
51 Ceuta;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2020QII;""
51 Ceuta;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2020QI;""
51 Ceuta;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
51 Ceuta;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
51 Ceuta;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QII;""
51 Ceuta;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QI;104
51 Ceuta;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
51 Ceuta;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
51 Ceuta;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QII;""
51 Ceuta;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QI;101
51 Ceuta;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
51 Ceuta;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
51 Ceuta;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QII;""
51 Ceuta;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QI;""
51 Ceuta;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
51 Ceuta;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
51 Ceuta;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QII;100
51 Ceuta;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QI;""
51 Ceuta;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
51 Ceuta;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
51 Ceuta;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QII;96
51 Ceuta;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QI;""
51 Ceuta;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
51 Ceuta;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
51 Ceuta;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QII;""
51 Ceuta;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QI;""
51 Ceuta;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
51 Ceuta;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
51 Ceuta;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
51 Ceuta;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
51 Ceuta;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
51 Ceuta;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
51 Ceuta;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
51 Ceuta;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
51 Ceuta;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
51 Ceuta;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
51 Ceuta;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
51 Ceuta;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
51 Ceuta;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
51 Ceuta;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;89,15
51 Ceuta;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
51 Ceuta;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
51 Ceuta;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
51 Ceuta;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;92,06
51 Ceuta;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
51 Ceuta;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
51 Ceuta;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
51 Ceuta;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;92,31
51 Ceuta;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
51 Ceuta;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
51 Ceuta;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;78,29
51 Ceuta;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
51 Ceuta;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
51 Ceuta;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
51 Ceuta;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;85,71
51 Ceuta;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
51 Ceuta;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
51 Ceuta;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
51 Ceuta;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;90,6
51 Ceuta;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
51 Ceuta;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
51 Ceuta;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
51 Ceuta;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
51 Ceuta;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
51 Ceuta;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
51 Ceuta;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;82,54
51 Ceuta;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
51 Ceuta;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
51 Ceuta;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
51 Ceuta;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;86,32
51 Ceuta;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
51 Ceuta;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
51 Ceuta;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
51 Ceuta;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
51 Ceuta;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
51 Ceuta;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
51 Ceuta;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;79,37
51 Ceuta;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
51 Ceuta;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
51 Ceuta;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
51 Ceuta;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;82,05
51 Ceuta;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
51 Ceuta;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
51 Ceuta;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
51 Ceuta;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
51 Ceuta;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
51 Ceuta;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QIV;294
51 Ceuta;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
51 Ceuta;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
51 Ceuta;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
51 Ceuta;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QIV;308
51 Ceuta;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
51 Ceuta;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
51 Ceuta;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
51 Ceuta;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QIV;281
51 Ceuta;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
51 Ceuta;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
51 Ceuta;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
51 Ceuta;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2022QIV;266
51 Ceuta;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
51 Ceuta;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2022QII;""
51 Ceuta;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2022QI;""
51 Ceuta;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2021QIV;279
51 Ceuta;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
51 Ceuta;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2021QII;""
51 Ceuta;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2021QI;""
51 Ceuta;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2020QIV;268
51 Ceuta;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
51 Ceuta;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2020QII;""
51 Ceuta;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2020QI;""
51 Ceuta;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
51 Ceuta;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
51 Ceuta;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2022QII;""
51 Ceuta;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2022QI;264
51 Ceuta;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
51 Ceuta;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
51 Ceuta;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2021QII;""
51 Ceuta;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2021QI;256
51 Ceuta;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
51 Ceuta;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
51 Ceuta;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2020QII;""
51 Ceuta;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2020QI;""
51 Ceuta;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
51 Ceuta;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
51 Ceuta;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QII;247
51 Ceuta;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QI;""
51 Ceuta;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
51 Ceuta;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
51 Ceuta;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QII;244
51 Ceuta;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QI;""
51 Ceuta;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
51 Ceuta;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
51 Ceuta;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QII;""
51 Ceuta;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QI;""
51 Ceuta;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
51 Ceuta;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QIII;222
51 Ceuta;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QII;""
51 Ceuta;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QI;""
51 Ceuta;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
51 Ceuta;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QIII;232
51 Ceuta;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QII;""
51 Ceuta;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QI;""
51 Ceuta;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
51 Ceuta;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
51 Ceuta;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QII;""
51 Ceuta;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QI;""
51 Ceuta;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
51 Ceuta;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
51 Ceuta;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
51 Ceuta;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
51 Ceuta;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
51 Ceuta;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
51 Ceuta;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
51 Ceuta;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
51 Ceuta;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
51 Ceuta;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
51 Ceuta;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
51 Ceuta;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
51 Ceuta;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;90,48
51 Ceuta;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
51 Ceuta;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
51 Ceuta;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
51 Ceuta;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;90,58
51 Ceuta;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
51 Ceuta;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
51 Ceuta;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
51 Ceuta;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;95,37
51 Ceuta;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
51 Ceuta;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
51 Ceuta;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
51 Ceuta;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
51 Ceuta;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
51 Ceuta;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
51 Ceuta;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;85,71
51 Ceuta;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
51 Ceuta;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
51 Ceuta;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
51 Ceuta;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;91,1
51 Ceuta;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
51 Ceuta;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
51 Ceuta;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
51 Ceuta;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
51 Ceuta;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
51 Ceuta;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
51 Ceuta;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;80,19
51 Ceuta;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
51 Ceuta;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
51 Ceuta;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
51 Ceuta;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;86,83
51 Ceuta;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
51 Ceuta;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
51 Ceuta;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
51 Ceuta;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
51 Ceuta;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
51 Ceuta;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
51 Ceuta;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;72,08
51 Ceuta;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
51 Ceuta;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
51 Ceuta;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
51 Ceuta;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;82,56
51 Ceuta;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
51 Ceuta;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
51 Ceuta;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
51 Ceuta;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
51 Ceuta;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
51 Ceuta;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
51 Ceuta;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QIV;172
51 Ceuta;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
51 Ceuta;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
51 Ceuta;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
51 Ceuta;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QIV;178
51 Ceuta;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
51 Ceuta;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
51 Ceuta;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
51 Ceuta;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QIV;165
51 Ceuta;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
51 Ceuta;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
51 Ceuta;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
51 Ceuta;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2022QIV;159
51 Ceuta;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
51 Ceuta;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2022QII;""
51 Ceuta;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2022QI;""
51 Ceuta;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2021QIV;158
51 Ceuta;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
51 Ceuta;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2021QII;""
51 Ceuta;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2021QI;""
51 Ceuta;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2020QIV;156
51 Ceuta;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
51 Ceuta;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2020QII;""
51 Ceuta;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2020QI;""
51 Ceuta;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
51 Ceuta;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
51 Ceuta;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2022QII;""
51 Ceuta;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2022QI;147
51 Ceuta;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
51 Ceuta;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
51 Ceuta;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2021QII;""
51 Ceuta;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2021QI;150
51 Ceuta;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
51 Ceuta;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
51 Ceuta;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2020QII;""
51 Ceuta;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2020QI;""
51 Ceuta;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
51 Ceuta;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
51 Ceuta;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QII;134
51 Ceuta;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QI;""
51 Ceuta;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
51 Ceuta;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
51 Ceuta;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QII;143
51 Ceuta;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QI;""
51 Ceuta;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
51 Ceuta;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
51 Ceuta;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QII;""
51 Ceuta;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QI;""
51 Ceuta;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
51 Ceuta;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QIII;120
51 Ceuta;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QII;""
51 Ceuta;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QI;""
51 Ceuta;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
51 Ceuta;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QIII;136
51 Ceuta;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QII;""
51 Ceuta;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QI;""
51 Ceuta;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
51 Ceuta;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
51 Ceuta;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QII;""
51 Ceuta;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QI;""
51 Ceuta;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
51 Ceuta;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
51 Ceuta;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
51 Ceuta;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
51 Ceuta;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
51 Ceuta;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
51 Ceuta;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
51 Ceuta;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
51 Ceuta;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
51 Ceuta;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
51 Ceuta;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
51 Ceuta;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
51 Ceuta;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;92,44
51 Ceuta;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
51 Ceuta;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
51 Ceuta;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
51 Ceuta;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;88,76
51 Ceuta;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
51 Ceuta;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
51 Ceuta;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
51 Ceuta;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;94,55
51 Ceuta;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
51 Ceuta;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
51 Ceuta;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
51 Ceuta;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
51 Ceuta;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
51 Ceuta;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
51 Ceuta;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;82,58
51 Ceuta;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
51 Ceuta;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
51 Ceuta;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
51 Ceuta;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;90,91
51 Ceuta;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
51 Ceuta;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
51 Ceuta;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
51 Ceuta;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
51 Ceuta;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
51 Ceuta;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
51 Ceuta;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;75,28
51 Ceuta;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
51 Ceuta;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
51 Ceuta;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
51 Ceuta;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;86,67
51 Ceuta;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
51 Ceuta;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
51 Ceuta;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
51 Ceuta;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
51 Ceuta;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
51 Ceuta;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
51 Ceuta;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;67,42
51 Ceuta;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
51 Ceuta;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
51 Ceuta;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
51 Ceuta;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;82,42
51 Ceuta;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
51 Ceuta;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
51 Ceuta;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
51 Ceuta;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
51 Ceuta;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
51 Ceuta;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
51 Ceuta;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QIV;122
51 Ceuta;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
51 Ceuta;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
51 Ceuta;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
51 Ceuta;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QIV;130
51 Ceuta;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
51 Ceuta;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
51 Ceuta;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
51 Ceuta;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QIV;116
51 Ceuta;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
51 Ceuta;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
51 Ceuta;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
51 Ceuta;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2022QIV;107
51 Ceuta;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
51 Ceuta;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2022QII;""
51 Ceuta;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2022QI;""
51 Ceuta;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2021QIV;121
51 Ceuta;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
51 Ceuta;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2021QII;""
51 Ceuta;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2021QI;""
51 Ceuta;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2020QIV;112
51 Ceuta;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
51 Ceuta;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2020QII;""
51 Ceuta;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2020QI;""
51 Ceuta;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
51 Ceuta;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
51 Ceuta;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2022QII;""
51 Ceuta;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2022QI;117
51 Ceuta;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
51 Ceuta;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
51 Ceuta;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2021QII;""
51 Ceuta;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2021QI;106
51 Ceuta;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
51 Ceuta;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
51 Ceuta;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2020QII;""
51 Ceuta;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2020QI;""
51 Ceuta;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
51 Ceuta;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
51 Ceuta;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QII;113
51 Ceuta;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QI;""
51 Ceuta;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
51 Ceuta;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
51 Ceuta;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QII;101
51 Ceuta;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QI;""
51 Ceuta;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
51 Ceuta;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
51 Ceuta;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QII;""
51 Ceuta;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QI;""
51 Ceuta;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
51 Ceuta;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QIII;102
51 Ceuta;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QII;""
51 Ceuta;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QI;""
51 Ceuta;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
51 Ceuta;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QIII;96
51 Ceuta;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QII;""
51 Ceuta;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QI;""
51 Ceuta;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
51 Ceuta;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
51 Ceuta;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QII;""
51 Ceuta;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QI;""
51 Ceuta;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
51 Ceuta;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
51 Ceuta;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
51 Ceuta;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
51 Ceuta;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
51 Ceuta;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
51 Ceuta;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
51 Ceuta;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
51 Ceuta;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
51 Ceuta;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
51 Ceuta;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
51 Ceuta;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
51 Ceuta;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;87,7
51 Ceuta;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
51 Ceuta;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
51 Ceuta;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
51 Ceuta;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;93,08
51 Ceuta;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
51 Ceuta;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
51 Ceuta;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
51 Ceuta;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;96,55
51 Ceuta;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
51 Ceuta;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
51 Ceuta;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
51 Ceuta;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
51 Ceuta;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
51 Ceuta;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
51 Ceuta;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;90
51 Ceuta;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
51 Ceuta;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
51 Ceuta;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
51 Ceuta;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;91,38
51 Ceuta;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
51 Ceuta;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
51 Ceuta;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
51 Ceuta;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
51 Ceuta;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
51 Ceuta;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
51 Ceuta;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;86,92
51 Ceuta;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
51 Ceuta;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
51 Ceuta;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
51 Ceuta;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;87,07
51 Ceuta;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
51 Ceuta;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
51 Ceuta;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
51 Ceuta;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
51 Ceuta;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
51 Ceuta;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
51 Ceuta;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;78,46
51 Ceuta;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
51 Ceuta;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
51 Ceuta;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
51 Ceuta;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;82,76
51 Ceuta;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
51 Ceuta;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
51 Ceuta;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
51 Ceuta;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
51 Ceuta;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
51 Ceuta;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
51 Ceuta;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
51 Ceuta;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
51 Ceuta;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
51 Ceuta;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QI;679
51 Ceuta;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
51 Ceuta;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
51 Ceuta;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
51 Ceuta;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QI;677
51 Ceuta;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
51 Ceuta;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
51 Ceuta;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
51 Ceuta;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QI;658
51 Ceuta;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
51 Ceuta;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
51 Ceuta;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2022QII;""
51 Ceuta;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2022QI;655
51 Ceuta;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
51 Ceuta;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
51 Ceuta;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2021QII;""
51 Ceuta;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2021QI;658
51 Ceuta;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
51 Ceuta;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
51 Ceuta;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2020QII;""
51 Ceuta;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2020QI;606
51 Ceuta;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
51 Ceuta;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
51 Ceuta;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2022QII;635
51 Ceuta;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2022QI;""
51 Ceuta;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
51 Ceuta;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
51 Ceuta;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2021QII;634
51 Ceuta;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2021QI;""
51 Ceuta;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
51 Ceuta;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
51 Ceuta;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2020QII;587
51 Ceuta;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2020QI;""
51 Ceuta;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
51 Ceuta;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QIII;609
51 Ceuta;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QII;""
51 Ceuta;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QI;""
51 Ceuta;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
51 Ceuta;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QIII;610
51 Ceuta;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QII;""
51 Ceuta;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QI;""
51 Ceuta;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
51 Ceuta;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QIII;563
51 Ceuta;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QII;""
51 Ceuta;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QI;""
51 Ceuta;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QIV;570
51 Ceuta;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
51 Ceuta;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QII;""
51 Ceuta;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QI;""
51 Ceuta;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QIV;582
51 Ceuta;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
51 Ceuta;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QII;""
51 Ceuta;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QI;""
51 Ceuta;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QIV;544
51 Ceuta;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
51 Ceuta;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QII;""
51 Ceuta;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QI;""
51 Ceuta;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
51 Ceuta;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
51 Ceuta;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
51 Ceuta;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
51 Ceuta;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
51 Ceuta;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
51 Ceuta;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
51 Ceuta;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
51 Ceuta;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
51 Ceuta;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
51 Ceuta;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
51 Ceuta;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
51 Ceuta;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
51 Ceuta;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
51 Ceuta;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
51 Ceuta;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;96,47
51 Ceuta;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
51 Ceuta;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
51 Ceuta;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
51 Ceuta;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;97,19
51 Ceuta;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
51 Ceuta;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
51 Ceuta;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
51 Ceuta;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;92,1
51 Ceuta;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
51 Ceuta;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
51 Ceuta;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;93,52
51 Ceuta;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
51 Ceuta;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
51 Ceuta;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
51 Ceuta;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;93,65
51 Ceuta;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
51 Ceuta;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
51 Ceuta;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
51 Ceuta;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;89,21
51 Ceuta;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
51 Ceuta;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
51 Ceuta;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;89,69
51 Ceuta;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
51 Ceuta;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
51 Ceuta;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
51 Ceuta;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;90,1
51 Ceuta;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
51 Ceuta;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
51 Ceuta;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
51 Ceuta;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;85,56
51 Ceuta;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
51 Ceuta;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
51 Ceuta;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;83,95
51 Ceuta;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
51 Ceuta;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
51 Ceuta;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
51 Ceuta;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;85,97
51 Ceuta;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
51 Ceuta;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
51 Ceuta;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
51 Ceuta;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;82,67
51 Ceuta;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
51 Ceuta;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
51 Ceuta;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
51 Ceuta;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
51 Ceuta;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
51 Ceuta;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
51 Ceuta;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QI;395
51 Ceuta;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
51 Ceuta;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
51 Ceuta;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
51 Ceuta;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QI;394
51 Ceuta;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
51 Ceuta;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
51 Ceuta;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
51 Ceuta;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QI;375
51 Ceuta;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
51 Ceuta;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
51 Ceuta;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2022QII;""
51 Ceuta;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2022QI;380
51 Ceuta;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
51 Ceuta;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
51 Ceuta;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2021QII;""
51 Ceuta;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2021QI;380
51 Ceuta;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
51 Ceuta;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
51 Ceuta;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2020QII;""
51 Ceuta;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2020QI;346
51 Ceuta;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
51 Ceuta;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
51 Ceuta;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2022QII;373
51 Ceuta;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2022QI;""
51 Ceuta;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
51 Ceuta;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
51 Ceuta;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2021QII;365
51 Ceuta;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2021QI;""
51 Ceuta;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
51 Ceuta;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
51 Ceuta;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2020QII;335
51 Ceuta;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2020QI;""
51 Ceuta;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
51 Ceuta;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QIII;363
51 Ceuta;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QII;""
51 Ceuta;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QI;""
51 Ceuta;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
51 Ceuta;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QIII;351
51 Ceuta;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QII;""
51 Ceuta;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QI;""
51 Ceuta;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
51 Ceuta;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QIII;322
51 Ceuta;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QII;""
51 Ceuta;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QI;""
51 Ceuta;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QIV;342
51 Ceuta;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
51 Ceuta;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QII;""
51 Ceuta;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QI;""
51 Ceuta;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QIV;336
51 Ceuta;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
51 Ceuta;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QII;""
51 Ceuta;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QI;""
51 Ceuta;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QIV;311
51 Ceuta;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
51 Ceuta;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QII;""
51 Ceuta;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QI;""
51 Ceuta;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
51 Ceuta;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
51 Ceuta;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
51 Ceuta;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
51 Ceuta;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
51 Ceuta;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
51 Ceuta;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
51 Ceuta;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
51 Ceuta;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
51 Ceuta;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
51 Ceuta;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
51 Ceuta;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
51 Ceuta;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
51 Ceuta;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
51 Ceuta;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
51 Ceuta;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;96,2
51 Ceuta;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
51 Ceuta;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
51 Ceuta;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
51 Ceuta;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;96,45
51 Ceuta;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
51 Ceuta;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
51 Ceuta;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
51 Ceuta;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;92,27
51 Ceuta;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
51 Ceuta;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
51 Ceuta;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;94,43
51 Ceuta;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
51 Ceuta;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
51 Ceuta;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
51 Ceuta;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;92,64
51 Ceuta;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
51 Ceuta;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
51 Ceuta;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
51 Ceuta;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;89,33
51 Ceuta;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
51 Ceuta;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
51 Ceuta;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;91,9
51 Ceuta;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
51 Ceuta;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
51 Ceuta;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
51 Ceuta;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;89,09
51 Ceuta;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
51 Ceuta;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
51 Ceuta;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
51 Ceuta;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;85,87
51 Ceuta;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
51 Ceuta;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
51 Ceuta;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;86,58
51 Ceuta;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
51 Ceuta;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
51 Ceuta;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
51 Ceuta;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;85,28
51 Ceuta;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
51 Ceuta;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
51 Ceuta;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
51 Ceuta;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;82,93
51 Ceuta;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
51 Ceuta;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
51 Ceuta;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
51 Ceuta;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
51 Ceuta;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
51 Ceuta;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
51 Ceuta;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QI;284
51 Ceuta;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
51 Ceuta;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
51 Ceuta;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
51 Ceuta;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QI;283
51 Ceuta;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
51 Ceuta;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
51 Ceuta;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
51 Ceuta;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QI;283
51 Ceuta;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
51 Ceuta;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
51 Ceuta;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2022QII;""
51 Ceuta;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2022QI;275
51 Ceuta;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
51 Ceuta;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
51 Ceuta;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2021QII;""
51 Ceuta;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2021QI;278
51 Ceuta;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
51 Ceuta;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
51 Ceuta;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2020QII;""
51 Ceuta;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2020QI;260
51 Ceuta;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
51 Ceuta;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
51 Ceuta;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2022QII;262
51 Ceuta;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2022QI;""
51 Ceuta;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
51 Ceuta;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
51 Ceuta;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2021QII;269
51 Ceuta;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2021QI;""
51 Ceuta;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
51 Ceuta;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
51 Ceuta;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2020QII;252
51 Ceuta;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2020QI;""
51 Ceuta;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
51 Ceuta;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QIII;246
51 Ceuta;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QII;""
51 Ceuta;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QI;""
51 Ceuta;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
51 Ceuta;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QIII;259
51 Ceuta;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QII;""
51 Ceuta;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QI;""
51 Ceuta;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
51 Ceuta;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QIII;241
51 Ceuta;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QII;""
51 Ceuta;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QI;""
51 Ceuta;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QIV;228
51 Ceuta;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
51 Ceuta;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QII;""
51 Ceuta;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QI;""
51 Ceuta;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QIV;246
51 Ceuta;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
51 Ceuta;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QII;""
51 Ceuta;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QI;""
51 Ceuta;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QIV;233
51 Ceuta;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
51 Ceuta;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QII;""
51 Ceuta;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QI;""
51 Ceuta;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
51 Ceuta;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
51 Ceuta;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
51 Ceuta;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
51 Ceuta;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
51 Ceuta;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
51 Ceuta;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
51 Ceuta;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
51 Ceuta;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
51 Ceuta;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
51 Ceuta;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
51 Ceuta;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
51 Ceuta;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
51 Ceuta;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
51 Ceuta;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
51 Ceuta;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;96,83
51 Ceuta;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
51 Ceuta;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
51 Ceuta;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
51 Ceuta;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;98,23
51 Ceuta;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
51 Ceuta;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
51 Ceuta;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
51 Ceuta;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;91,87
51 Ceuta;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
51 Ceuta;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
51 Ceuta;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;92,25
51 Ceuta;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
51 Ceuta;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
51 Ceuta;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
51 Ceuta;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;95,05
51 Ceuta;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
51 Ceuta;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
51 Ceuta;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
51 Ceuta;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;89,05
51 Ceuta;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
51 Ceuta;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
51 Ceuta;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;86,62
51 Ceuta;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
51 Ceuta;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
51 Ceuta;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
51 Ceuta;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;91,52
51 Ceuta;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
51 Ceuta;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
51 Ceuta;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
51 Ceuta;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;85,16
51 Ceuta;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
51 Ceuta;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
51 Ceuta;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;80,28
51 Ceuta;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
51 Ceuta;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
51 Ceuta;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
51 Ceuta;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;86,93
51 Ceuta;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
51 Ceuta;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
51 Ceuta;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
51 Ceuta;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;82,33
51 Ceuta;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
51 Ceuta;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
51 Ceuta;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
51 Ceuta;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
51 Ceuta;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
51 Ceuta;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QII;676
51 Ceuta;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
51 Ceuta;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
51 Ceuta;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
51 Ceuta;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QII;653
51 Ceuta;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
51 Ceuta;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
51 Ceuta;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
51 Ceuta;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QII;650
51 Ceuta;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
51 Ceuta;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
51 Ceuta;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
51 Ceuta;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2022QII;654
51 Ceuta;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2022QI;""
51 Ceuta;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
51 Ceuta;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
51 Ceuta;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2021QII;627
51 Ceuta;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2021QI;""
51 Ceuta;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
51 Ceuta;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
51 Ceuta;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2020QII;629
51 Ceuta;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2020QI;""
51 Ceuta;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
51 Ceuta;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2022QIII;616
51 Ceuta;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2022QII;""
51 Ceuta;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2022QI;""
51 Ceuta;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
51 Ceuta;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2021QIII;604
51 Ceuta;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2021QII;""
51 Ceuta;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2021QI;""
51 Ceuta;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
51 Ceuta;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2020QIII;600
51 Ceuta;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2020QII;""
51 Ceuta;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2020QI;""
51 Ceuta;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QIV;574
51 Ceuta;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
51 Ceuta;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QII;""
51 Ceuta;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QI;""
51 Ceuta;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QIV;578
51 Ceuta;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
51 Ceuta;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QII;""
51 Ceuta;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QI;""
51 Ceuta;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QIV;578
51 Ceuta;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
51 Ceuta;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QII;""
51 Ceuta;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QI;""
51 Ceuta;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
51 Ceuta;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
51 Ceuta;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QII;""
51 Ceuta;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QI;563
51 Ceuta;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
51 Ceuta;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
51 Ceuta;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QII;""
51 Ceuta;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QI;567
51 Ceuta;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
51 Ceuta;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
51 Ceuta;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QII;""
51 Ceuta;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QI;""
51 Ceuta;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
51 Ceuta;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
51 Ceuta;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
51 Ceuta;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
51 Ceuta;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
51 Ceuta;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
51 Ceuta;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
51 Ceuta;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
51 Ceuta;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
51 Ceuta;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
51 Ceuta;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
51 Ceuta;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
51 Ceuta;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
51 Ceuta;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
51 Ceuta;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;96,75
51 Ceuta;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
51 Ceuta;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
51 Ceuta;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
51 Ceuta;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;96,02
51 Ceuta;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
51 Ceuta;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
51 Ceuta;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
51 Ceuta;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;96,77
51 Ceuta;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
51 Ceuta;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
51 Ceuta;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;91,12
51 Ceuta;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
51 Ceuta;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
51 Ceuta;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
51 Ceuta;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;92,5
51 Ceuta;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
51 Ceuta;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
51 Ceuta;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
51 Ceuta;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;92,31
51 Ceuta;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
51 Ceuta;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
51 Ceuta;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;84,91
51 Ceuta;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
51 Ceuta;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
51 Ceuta;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
51 Ceuta;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;88,51
51 Ceuta;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
51 Ceuta;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
51 Ceuta;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
51 Ceuta;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;88,92
51 Ceuta;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
51 Ceuta;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
51 Ceuta;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
51 Ceuta;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
51 Ceuta;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
51 Ceuta;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
51 Ceuta;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;86,22
51 Ceuta;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
51 Ceuta;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
51 Ceuta;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
51 Ceuta;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;87,23
51 Ceuta;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
51 Ceuta;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
51 Ceuta;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
51 Ceuta;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
51 Ceuta;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
51 Ceuta;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
51 Ceuta;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QII;391
51 Ceuta;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
51 Ceuta;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
51 Ceuta;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
51 Ceuta;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QII;375
51 Ceuta;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
51 Ceuta;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
51 Ceuta;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
51 Ceuta;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QII;372
51 Ceuta;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
51 Ceuta;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
51 Ceuta;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
51 Ceuta;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2022QII;383
51 Ceuta;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2022QI;""
51 Ceuta;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
51 Ceuta;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
51 Ceuta;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2021QII;358
51 Ceuta;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2021QI;""
51 Ceuta;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
51 Ceuta;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
51 Ceuta;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2020QII;359
51 Ceuta;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2020QI;""
51 Ceuta;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
51 Ceuta;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2022QIII;366
51 Ceuta;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2022QII;""
51 Ceuta;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2022QI;""
51 Ceuta;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
51 Ceuta;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2021QIII;344
51 Ceuta;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2021QII;""
51 Ceuta;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2021QI;""
51 Ceuta;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
51 Ceuta;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2020QIII;342
51 Ceuta;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2020QII;""
51 Ceuta;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2020QI;""
51 Ceuta;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QIV;345
51 Ceuta;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
51 Ceuta;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QII;""
51 Ceuta;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QI;""
51 Ceuta;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QIV;331
51 Ceuta;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
51 Ceuta;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QII;""
51 Ceuta;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QI;""
51 Ceuta;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QIV;330
51 Ceuta;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
51 Ceuta;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QII;""
51 Ceuta;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QI;""
51 Ceuta;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
51 Ceuta;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
51 Ceuta;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QII;""
51 Ceuta;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QI;323
51 Ceuta;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
51 Ceuta;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
51 Ceuta;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QII;""
51 Ceuta;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QI;322
51 Ceuta;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
51 Ceuta;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
51 Ceuta;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QII;""
51 Ceuta;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QI;""
51 Ceuta;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
51 Ceuta;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
51 Ceuta;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
51 Ceuta;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
51 Ceuta;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
51 Ceuta;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
51 Ceuta;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
51 Ceuta;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
51 Ceuta;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
51 Ceuta;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
51 Ceuta;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
51 Ceuta;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
51 Ceuta;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
51 Ceuta;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
51 Ceuta;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;97,95
51 Ceuta;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
51 Ceuta;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
51 Ceuta;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
51 Ceuta;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;95,47
51 Ceuta;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
51 Ceuta;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
51 Ceuta;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
51 Ceuta;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;96,51
51 Ceuta;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
51 Ceuta;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
51 Ceuta;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;93,61
51 Ceuta;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
51 Ceuta;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
51 Ceuta;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
51 Ceuta;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;91,73
51 Ceuta;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
51 Ceuta;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
51 Ceuta;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
51 Ceuta;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;91,94
51 Ceuta;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
51 Ceuta;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
51 Ceuta;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;88,24
51 Ceuta;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
51 Ceuta;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
51 Ceuta;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
51 Ceuta;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;88,27
51 Ceuta;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
51 Ceuta;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
51 Ceuta;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
51 Ceuta;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;88,71
51 Ceuta;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
51 Ceuta;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
51 Ceuta;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
51 Ceuta;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
51 Ceuta;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
51 Ceuta;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
51 Ceuta;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;86,13
51 Ceuta;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
51 Ceuta;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
51 Ceuta;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
51 Ceuta;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;86,56
51 Ceuta;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
51 Ceuta;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
51 Ceuta;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
51 Ceuta;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
51 Ceuta;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
51 Ceuta;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
51 Ceuta;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QII;285
51 Ceuta;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
51 Ceuta;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
51 Ceuta;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
51 Ceuta;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QII;278
51 Ceuta;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
51 Ceuta;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
51 Ceuta;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
51 Ceuta;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QII;278
51 Ceuta;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
51 Ceuta;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
51 Ceuta;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
51 Ceuta;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2022QII;271
51 Ceuta;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2022QI;""
51 Ceuta;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
51 Ceuta;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
51 Ceuta;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2021QII;269
51 Ceuta;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2021QI;""
51 Ceuta;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
51 Ceuta;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
51 Ceuta;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2020QII;270
51 Ceuta;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2020QI;""
51 Ceuta;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
51 Ceuta;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2022QIII;250
51 Ceuta;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2022QII;""
51 Ceuta;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2022QI;""
51 Ceuta;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
51 Ceuta;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2021QIII;260
51 Ceuta;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2021QII;""
51 Ceuta;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2021QI;""
51 Ceuta;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
51 Ceuta;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2020QIII;258
51 Ceuta;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2020QII;""
51 Ceuta;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2020QI;""
51 Ceuta;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QIV;229
51 Ceuta;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
51 Ceuta;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QII;""
51 Ceuta;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QI;""
51 Ceuta;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QIV;247
51 Ceuta;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
51 Ceuta;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QII;""
51 Ceuta;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QI;""
51 Ceuta;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QIV;248
51 Ceuta;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
51 Ceuta;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QII;""
51 Ceuta;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QI;""
51 Ceuta;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
51 Ceuta;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
51 Ceuta;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QII;""
51 Ceuta;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QI;240
51 Ceuta;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
51 Ceuta;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
51 Ceuta;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QII;""
51 Ceuta;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QI;245
51 Ceuta;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
51 Ceuta;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
51 Ceuta;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QII;""
51 Ceuta;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QI;""
51 Ceuta;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
51 Ceuta;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
51 Ceuta;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
51 Ceuta;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
51 Ceuta;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
51 Ceuta;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
51 Ceuta;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
51 Ceuta;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
51 Ceuta;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
51 Ceuta;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
51 Ceuta;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
51 Ceuta;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
51 Ceuta;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
51 Ceuta;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
51 Ceuta;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;95,09
51 Ceuta;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
51 Ceuta;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
51 Ceuta;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
51 Ceuta;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;96,76
51 Ceuta;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
51 Ceuta;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
51 Ceuta;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
51 Ceuta;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;97,12
51 Ceuta;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
51 Ceuta;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
51 Ceuta;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;87,72
51 Ceuta;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
51 Ceuta;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
51 Ceuta;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
51 Ceuta;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;93,53
51 Ceuta;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
51 Ceuta;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
51 Ceuta;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
51 Ceuta;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;92,81
51 Ceuta;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
51 Ceuta;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
51 Ceuta;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;80,35
51 Ceuta;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
51 Ceuta;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
51 Ceuta;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
51 Ceuta;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;88,85
51 Ceuta;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
51 Ceuta;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
51 Ceuta;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
51 Ceuta;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;89,21
51 Ceuta;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
51 Ceuta;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
51 Ceuta;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
51 Ceuta;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
51 Ceuta;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
51 Ceuta;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
51 Ceuta;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;86,33
51 Ceuta;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
51 Ceuta;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
51 Ceuta;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
51 Ceuta;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;88,13
51 Ceuta;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
51 Ceuta;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
51 Ceuta;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
51 Ceuta;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
51 Ceuta;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
51 Ceuta;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QIII;694
51 Ceuta;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
51 Ceuta;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
51 Ceuta;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
51 Ceuta;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QIII;671
51 Ceuta;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
51 Ceuta;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
51 Ceuta;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
51 Ceuta;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QIII;647
51 Ceuta;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
51 Ceuta;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
51 Ceuta;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
51 Ceuta;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2022QIII;650
51 Ceuta;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2022QII;""
51 Ceuta;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2022QI;""
51 Ceuta;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
51 Ceuta;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2021QIII;641
51 Ceuta;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2021QII;""
51 Ceuta;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2021QI;""
51 Ceuta;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
51 Ceuta;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2020QIII;618
51 Ceuta;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2020QII;""
51 Ceuta;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2020QI;""
51 Ceuta;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2022QIV;601
51 Ceuta;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
51 Ceuta;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2022QII;""
51 Ceuta;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2022QI;""
51 Ceuta;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2021QIV;610
51 Ceuta;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
51 Ceuta;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2021QII;""
51 Ceuta;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2021QI;""
51 Ceuta;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2020QIV;593
51 Ceuta;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
51 Ceuta;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2020QII;""
51 Ceuta;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2020QI;""
51 Ceuta;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
51 Ceuta;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
51 Ceuta;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QII;""
51 Ceuta;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QI;591
51 Ceuta;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
51 Ceuta;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
51 Ceuta;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QII;""
51 Ceuta;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QI;581
51 Ceuta;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
51 Ceuta;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
51 Ceuta;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QII;""
51 Ceuta;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QI;""
51 Ceuta;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
51 Ceuta;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
51 Ceuta;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QII;573
51 Ceuta;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QI;""
51 Ceuta;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
51 Ceuta;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
51 Ceuta;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QII;566
51 Ceuta;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QI;""
51 Ceuta;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
51 Ceuta;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
51 Ceuta;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QII;""
51 Ceuta;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QI;""
51 Ceuta;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
51 Ceuta;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
51 Ceuta;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
51 Ceuta;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
51 Ceuta;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
51 Ceuta;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
51 Ceuta;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
51 Ceuta;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
51 Ceuta;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
51 Ceuta;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
51 Ceuta;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
51 Ceuta;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
51 Ceuta;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
51 Ceuta;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;93,66
51 Ceuta;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
51 Ceuta;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
51 Ceuta;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
51 Ceuta;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;95,53
51 Ceuta;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
51 Ceuta;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
51 Ceuta;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
51 Ceuta;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;95,52
51 Ceuta;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
51 Ceuta;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
51 Ceuta;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;86,6
51 Ceuta;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
51 Ceuta;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
51 Ceuta;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
51 Ceuta;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;90,91
51 Ceuta;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
51 Ceuta;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
51 Ceuta;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
51 Ceuta;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;91,65
51 Ceuta;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
51 Ceuta;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
51 Ceuta;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
51 Ceuta;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
51 Ceuta;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
51 Ceuta;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
51 Ceuta;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;88,08
51 Ceuta;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
51 Ceuta;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
51 Ceuta;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
51 Ceuta;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;89,8
51 Ceuta;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
51 Ceuta;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
51 Ceuta;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
51 Ceuta;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
51 Ceuta;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
51 Ceuta;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
51 Ceuta;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;85,39
51 Ceuta;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
51 Ceuta;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
51 Ceuta;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
51 Ceuta;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;87,48
51 Ceuta;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
51 Ceuta;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
51 Ceuta;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
51 Ceuta;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
51 Ceuta;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
51 Ceuta;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
51 Ceuta;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QIII;406
51 Ceuta;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
51 Ceuta;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
51 Ceuta;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
51 Ceuta;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QIII;387
51 Ceuta;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
51 Ceuta;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
51 Ceuta;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
51 Ceuta;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QIII;369
51 Ceuta;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
51 Ceuta;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
51 Ceuta;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
51 Ceuta;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2022QIII;387
51 Ceuta;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2022QII;""
51 Ceuta;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2022QI;""
51 Ceuta;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
51 Ceuta;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2021QIII;369
51 Ceuta;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2021QII;""
51 Ceuta;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2021QI;""
51 Ceuta;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
51 Ceuta;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2020QIII;352
51 Ceuta;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2020QII;""
51 Ceuta;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2020QI;""
51 Ceuta;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2022QIV;360
51 Ceuta;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
51 Ceuta;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2022QII;""
51 Ceuta;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2022QI;""
51 Ceuta;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2021QIV;354
51 Ceuta;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
51 Ceuta;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2021QII;""
51 Ceuta;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2021QI;""
51 Ceuta;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2020QIV;338
51 Ceuta;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
51 Ceuta;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2020QII;""
51 Ceuta;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2020QI;""
51 Ceuta;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
51 Ceuta;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
51 Ceuta;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QII;""
51 Ceuta;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QI;343
51 Ceuta;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
51 Ceuta;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
51 Ceuta;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QII;""
51 Ceuta;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QI;329
51 Ceuta;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
51 Ceuta;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
51 Ceuta;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QII;""
51 Ceuta;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QI;""
51 Ceuta;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
51 Ceuta;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
51 Ceuta;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QII;337
51 Ceuta;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QI;""
51 Ceuta;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
51 Ceuta;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
51 Ceuta;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QII;319
51 Ceuta;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QI;""
51 Ceuta;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
51 Ceuta;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
51 Ceuta;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QII;""
51 Ceuta;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QI;""
51 Ceuta;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
51 Ceuta;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
51 Ceuta;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
51 Ceuta;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
51 Ceuta;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
51 Ceuta;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
51 Ceuta;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
51 Ceuta;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
51 Ceuta;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
51 Ceuta;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
51 Ceuta;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
51 Ceuta;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
51 Ceuta;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
51 Ceuta;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;95,32
51 Ceuta;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
51 Ceuta;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
51 Ceuta;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
51 Ceuta;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;95,35
51 Ceuta;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
51 Ceuta;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
51 Ceuta;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
51 Ceuta;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;95,39
51 Ceuta;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
51 Ceuta;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
51 Ceuta;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;88,67
51 Ceuta;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
51 Ceuta;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
51 Ceuta;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
51 Ceuta;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;91,47
51 Ceuta;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
51 Ceuta;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
51 Ceuta;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
51 Ceuta;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;91,6
51 Ceuta;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
51 Ceuta;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
51 Ceuta;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
51 Ceuta;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
51 Ceuta;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
51 Ceuta;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
51 Ceuta;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;88,63
51 Ceuta;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
51 Ceuta;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
51 Ceuta;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
51 Ceuta;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;89,16
51 Ceuta;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
51 Ceuta;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
51 Ceuta;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
51 Ceuta;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
51 Ceuta;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
51 Ceuta;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
51 Ceuta;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;87,08
51 Ceuta;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
51 Ceuta;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
51 Ceuta;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
51 Ceuta;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;86,45
51 Ceuta;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
51 Ceuta;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
51 Ceuta;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
51 Ceuta;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
51 Ceuta;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
51 Ceuta;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
51 Ceuta;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QIII;288
51 Ceuta;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
51 Ceuta;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
51 Ceuta;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
51 Ceuta;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QIII;284
51 Ceuta;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
51 Ceuta;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
51 Ceuta;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
51 Ceuta;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QIII;278
51 Ceuta;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
51 Ceuta;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
51 Ceuta;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
51 Ceuta;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2022QIII;263
51 Ceuta;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2022QII;""
51 Ceuta;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2022QI;""
51 Ceuta;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
51 Ceuta;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2021QIII;272
51 Ceuta;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2021QII;""
51 Ceuta;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2021QI;""
51 Ceuta;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
51 Ceuta;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2020QIII;266
51 Ceuta;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2020QII;""
51 Ceuta;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2020QI;""
51 Ceuta;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2022QIV;241
51 Ceuta;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
51 Ceuta;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2022QII;""
51 Ceuta;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2022QI;""
51 Ceuta;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2021QIV;256
51 Ceuta;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
51 Ceuta;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2021QII;""
51 Ceuta;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2021QI;""
51 Ceuta;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2020QIV;255
51 Ceuta;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
51 Ceuta;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2020QII;""
51 Ceuta;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2020QI;""
51 Ceuta;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
51 Ceuta;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
51 Ceuta;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QII;""
51 Ceuta;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QI;248
51 Ceuta;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
51 Ceuta;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
51 Ceuta;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QII;""
51 Ceuta;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QI;252
51 Ceuta;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
51 Ceuta;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
51 Ceuta;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QII;""
51 Ceuta;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QI;""
51 Ceuta;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
51 Ceuta;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
51 Ceuta;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QII;236
51 Ceuta;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QI;""
51 Ceuta;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
51 Ceuta;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
51 Ceuta;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QII;247
51 Ceuta;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QI;""
51 Ceuta;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
51 Ceuta;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
51 Ceuta;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QII;""
51 Ceuta;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QI;""
51 Ceuta;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
51 Ceuta;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
51 Ceuta;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
51 Ceuta;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
51 Ceuta;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
51 Ceuta;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
51 Ceuta;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
51 Ceuta;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
51 Ceuta;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
51 Ceuta;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
51 Ceuta;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
51 Ceuta;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
51 Ceuta;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
51 Ceuta;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;91,32
51 Ceuta;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
51 Ceuta;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
51 Ceuta;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
51 Ceuta;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;95,77
51 Ceuta;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
51 Ceuta;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
51 Ceuta;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
51 Ceuta;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;95,68
51 Ceuta;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
51 Ceuta;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
51 Ceuta;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;83,68
51 Ceuta;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
51 Ceuta;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
51 Ceuta;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
51 Ceuta;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;90,14
51 Ceuta;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
51 Ceuta;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
51 Ceuta;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
51 Ceuta;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;91,73
51 Ceuta;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
51 Ceuta;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
51 Ceuta;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
51 Ceuta;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
51 Ceuta;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
51 Ceuta;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
51 Ceuta;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;87,32
51 Ceuta;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
51 Ceuta;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
51 Ceuta;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
51 Ceuta;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;90,65
51 Ceuta;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
51 Ceuta;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
51 Ceuta;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
51 Ceuta;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
51 Ceuta;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
51 Ceuta;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
51 Ceuta;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;83,1
51 Ceuta;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
51 Ceuta;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
51 Ceuta;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
51 Ceuta;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;88,85
51 Ceuta;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
51 Ceuta;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
51 Ceuta;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
51 Ceuta;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
51 Ceuta;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
51 Ceuta;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QIV;681
51 Ceuta;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
51 Ceuta;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
51 Ceuta;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
51 Ceuta;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QIV;674
51 Ceuta;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
51 Ceuta;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
51 Ceuta;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
51 Ceuta;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QIV;655
51 Ceuta;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
51 Ceuta;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
51 Ceuta;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
51 Ceuta;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2022QIV;628
51 Ceuta;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
51 Ceuta;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2022QII;""
51 Ceuta;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2022QI;""
51 Ceuta;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2021QIV;638
51 Ceuta;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
51 Ceuta;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2021QII;""
51 Ceuta;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2021QI;""
51 Ceuta;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2020QIV;625
51 Ceuta;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
51 Ceuta;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2020QII;""
51 Ceuta;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2020QI;""
51 Ceuta;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
51 Ceuta;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
51 Ceuta;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2022QII;""
51 Ceuta;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2022QI;616
51 Ceuta;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
51 Ceuta;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
51 Ceuta;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2021QII;""
51 Ceuta;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2021QI;609
51 Ceuta;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
51 Ceuta;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
51 Ceuta;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2020QII;""
51 Ceuta;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2020QI;""
51 Ceuta;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
51 Ceuta;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
51 Ceuta;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QII;597
51 Ceuta;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QI;""
51 Ceuta;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
51 Ceuta;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
51 Ceuta;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QII;590
51 Ceuta;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QI;""
51 Ceuta;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
51 Ceuta;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
51 Ceuta;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QII;""
51 Ceuta;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QI;""
51 Ceuta;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
51 Ceuta;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QIII;573
51 Ceuta;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QII;""
51 Ceuta;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QI;""
51 Ceuta;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
51 Ceuta;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QIII;569
51 Ceuta;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QII;""
51 Ceuta;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QI;""
51 Ceuta;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
51 Ceuta;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
51 Ceuta;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QII;""
51 Ceuta;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QI;""
51 Ceuta;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
51 Ceuta;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
51 Ceuta;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
51 Ceuta;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
51 Ceuta;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
51 Ceuta;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
51 Ceuta;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
51 Ceuta;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
51 Ceuta;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
51 Ceuta;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
51 Ceuta;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
51 Ceuta;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
51 Ceuta;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;92,22
51 Ceuta;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
51 Ceuta;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
51 Ceuta;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
51 Ceuta;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;94,66
51 Ceuta;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
51 Ceuta;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
51 Ceuta;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
51 Ceuta;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;95,42
51 Ceuta;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
51 Ceuta;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
51 Ceuta;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
51 Ceuta;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
51 Ceuta;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
51 Ceuta;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
51 Ceuta;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;91,39
51 Ceuta;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
51 Ceuta;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
51 Ceuta;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
51 Ceuta;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;92,98
51 Ceuta;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
51 Ceuta;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
51 Ceuta;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
51 Ceuta;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
51 Ceuta;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
51 Ceuta;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
51 Ceuta;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;88,58
51 Ceuta;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
51 Ceuta;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
51 Ceuta;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
51 Ceuta;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;90,08
51 Ceuta;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
51 Ceuta;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
51 Ceuta;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
51 Ceuta;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
51 Ceuta;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
51 Ceuta;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
51 Ceuta;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;85,01
51 Ceuta;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
51 Ceuta;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
51 Ceuta;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
51 Ceuta;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;86,87
51 Ceuta;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
51 Ceuta;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
51 Ceuta;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
51 Ceuta;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
51 Ceuta;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
51 Ceuta;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
51 Ceuta;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QIV;407
51 Ceuta;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
51 Ceuta;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
51 Ceuta;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
51 Ceuta;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QIV;388
51 Ceuta;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
51 Ceuta;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
51 Ceuta;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
51 Ceuta;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QIV;373
51 Ceuta;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
51 Ceuta;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
51 Ceuta;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
51 Ceuta;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2022QIV;377
51 Ceuta;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
51 Ceuta;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2022QII;""
51 Ceuta;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2022QI;""
51 Ceuta;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2021QIV;368
51 Ceuta;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
51 Ceuta;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2021QII;""
51 Ceuta;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2021QI;""
51 Ceuta;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2020QIV;356
51 Ceuta;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
51 Ceuta;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2020QII;""
51 Ceuta;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2020QI;""
51 Ceuta;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
51 Ceuta;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
51 Ceuta;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2022QII;""
51 Ceuta;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2022QI;355
51 Ceuta;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
51 Ceuta;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
51 Ceuta;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2021QII;""
51 Ceuta;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2021QI;345
51 Ceuta;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
51 Ceuta;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
51 Ceuta;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2020QII;""
51 Ceuta;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2020QI;""
51 Ceuta;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
51 Ceuta;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
51 Ceuta;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QII;349
51 Ceuta;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QI;""
51 Ceuta;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
51 Ceuta;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
51 Ceuta;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QII;333
51 Ceuta;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QI;""
51 Ceuta;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
51 Ceuta;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
51 Ceuta;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QII;""
51 Ceuta;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QI;""
51 Ceuta;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
51 Ceuta;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QIII;340
51 Ceuta;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QII;""
51 Ceuta;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QI;""
51 Ceuta;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
51 Ceuta;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QIII;320
51 Ceuta;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QII;""
51 Ceuta;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QI;""
51 Ceuta;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
51 Ceuta;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
51 Ceuta;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QII;""
51 Ceuta;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QI;""
51 Ceuta;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
51 Ceuta;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
51 Ceuta;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
51 Ceuta;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
51 Ceuta;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
51 Ceuta;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
51 Ceuta;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
51 Ceuta;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
51 Ceuta;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
51 Ceuta;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
51 Ceuta;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
51 Ceuta;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
51 Ceuta;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;92,63
51 Ceuta;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
51 Ceuta;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
51 Ceuta;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
51 Ceuta;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;94,85
51 Ceuta;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
51 Ceuta;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
51 Ceuta;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
51 Ceuta;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;95,44
51 Ceuta;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
51 Ceuta;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
51 Ceuta;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
51 Ceuta;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
51 Ceuta;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
51 Ceuta;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
51 Ceuta;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;91,49
51 Ceuta;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
51 Ceuta;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
51 Ceuta;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
51 Ceuta;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;92,49
51 Ceuta;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
51 Ceuta;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
51 Ceuta;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
51 Ceuta;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
51 Ceuta;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
51 Ceuta;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
51 Ceuta;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;89,95
51 Ceuta;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
51 Ceuta;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
51 Ceuta;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
51 Ceuta;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;89,28
51 Ceuta;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
51 Ceuta;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
51 Ceuta;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
51 Ceuta;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
51 Ceuta;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
51 Ceuta;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
51 Ceuta;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;87,63
51 Ceuta;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
51 Ceuta;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
51 Ceuta;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
51 Ceuta;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;85,79
51 Ceuta;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
51 Ceuta;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
51 Ceuta;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
51 Ceuta;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
51 Ceuta;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
51 Ceuta;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
51 Ceuta;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QIV;274
51 Ceuta;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
51 Ceuta;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
51 Ceuta;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
51 Ceuta;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QIV;286
51 Ceuta;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
51 Ceuta;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
51 Ceuta;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
51 Ceuta;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QIV;282
51 Ceuta;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
51 Ceuta;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
51 Ceuta;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
51 Ceuta;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2022QIV;251
51 Ceuta;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
51 Ceuta;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2022QII;""
51 Ceuta;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2022QI;""
51 Ceuta;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2021QIV;270
51 Ceuta;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
51 Ceuta;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2021QII;""
51 Ceuta;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2021QI;""
51 Ceuta;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2020QIV;269
51 Ceuta;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
51 Ceuta;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2020QII;""
51 Ceuta;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2020QI;""
51 Ceuta;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
51 Ceuta;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
51 Ceuta;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2022QII;""
51 Ceuta;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2022QI;261
51 Ceuta;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
51 Ceuta;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
51 Ceuta;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2021QII;""
51 Ceuta;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2021QI;264
51 Ceuta;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
51 Ceuta;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
51 Ceuta;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2020QII;""
51 Ceuta;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2020QI;""
51 Ceuta;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
51 Ceuta;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
51 Ceuta;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QII;248
51 Ceuta;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QI;""
51 Ceuta;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
51 Ceuta;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
51 Ceuta;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QII;257
51 Ceuta;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QI;""
51 Ceuta;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
51 Ceuta;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
51 Ceuta;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QII;""
51 Ceuta;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QI;""
51 Ceuta;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
51 Ceuta;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QIII;233
51 Ceuta;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QII;""
51 Ceuta;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QI;""
51 Ceuta;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
51 Ceuta;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QIII;249
51 Ceuta;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QII;""
51 Ceuta;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QI;""
51 Ceuta;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
51 Ceuta;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
51 Ceuta;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QII;""
51 Ceuta;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QI;""
51 Ceuta;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
51 Ceuta;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
51 Ceuta;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
51 Ceuta;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
51 Ceuta;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
51 Ceuta;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
51 Ceuta;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
51 Ceuta;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
51 Ceuta;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
51 Ceuta;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
51 Ceuta;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
51 Ceuta;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
51 Ceuta;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;91,61
51 Ceuta;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
51 Ceuta;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
51 Ceuta;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
51 Ceuta;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;94,41
51 Ceuta;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
51 Ceuta;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
51 Ceuta;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
51 Ceuta;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;95,39
51 Ceuta;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
51 Ceuta;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
51 Ceuta;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
51 Ceuta;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
51 Ceuta;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
51 Ceuta;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
51 Ceuta;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;91,26
51 Ceuta;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
51 Ceuta;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
51 Ceuta;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
51 Ceuta;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;93,62
51 Ceuta;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
51 Ceuta;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
51 Ceuta;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
51 Ceuta;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
51 Ceuta;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
51 Ceuta;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
51 Ceuta;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;86,71
51 Ceuta;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
51 Ceuta;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
51 Ceuta;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
51 Ceuta;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;91,13
51 Ceuta;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
51 Ceuta;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
51 Ceuta;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
51 Ceuta;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
51 Ceuta;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
51 Ceuta;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
51 Ceuta;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;81,47
51 Ceuta;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
51 Ceuta;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
51 Ceuta;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
51 Ceuta;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;88,3
51 Ceuta;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
51 Ceuta;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
51 Ceuta;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
51 Ceuta;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
51 Ceuta;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
51 Ceuta;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
51 Ceuta;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
51 Ceuta;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
51 Ceuta;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
51 Ceuta;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QI;918
51 Ceuta;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
51 Ceuta;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
51 Ceuta;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
51 Ceuta;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QI;897
51 Ceuta;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
51 Ceuta;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
51 Ceuta;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
51 Ceuta;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QI;913
51 Ceuta;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
51 Ceuta;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
51 Ceuta;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2022QII;""
51 Ceuta;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2022QI;893
51 Ceuta;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
51 Ceuta;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
51 Ceuta;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2021QII;""
51 Ceuta;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2021QI;878
51 Ceuta;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
51 Ceuta;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
51 Ceuta;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2020QII;""
51 Ceuta;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2020QI;857
51 Ceuta;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
51 Ceuta;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
51 Ceuta;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2022QII;866
51 Ceuta;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2022QI;""
51 Ceuta;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
51 Ceuta;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
51 Ceuta;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2021QII;845
51 Ceuta;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2021QI;""
51 Ceuta;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
51 Ceuta;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
51 Ceuta;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2020QII;839
51 Ceuta;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2020QI;""
51 Ceuta;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
51 Ceuta;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QIII;831
51 Ceuta;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QII;""
51 Ceuta;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QI;""
51 Ceuta;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
51 Ceuta;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QIII;819
51 Ceuta;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QII;""
51 Ceuta;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QI;""
51 Ceuta;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
51 Ceuta;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QIII;815
51 Ceuta;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QII;""
51 Ceuta;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QI;""
51 Ceuta;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QIV;803
51 Ceuta;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
51 Ceuta;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QII;""
51 Ceuta;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QI;""
51 Ceuta;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QIV;795
51 Ceuta;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
51 Ceuta;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QII;""
51 Ceuta;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QI;""
51 Ceuta;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QIV;795
51 Ceuta;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
51 Ceuta;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QII;""
51 Ceuta;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QI;""
51 Ceuta;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
51 Ceuta;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
51 Ceuta;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
51 Ceuta;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
51 Ceuta;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
51 Ceuta;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
51 Ceuta;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
51 Ceuta;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
51 Ceuta;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
51 Ceuta;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
51 Ceuta;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
51 Ceuta;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
51 Ceuta;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
51 Ceuta;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
51 Ceuta;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
51 Ceuta;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;97,28
51 Ceuta;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
51 Ceuta;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
51 Ceuta;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
51 Ceuta;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;97,88
51 Ceuta;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
51 Ceuta;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
51 Ceuta;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
51 Ceuta;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;93,87
51 Ceuta;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
51 Ceuta;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
51 Ceuta;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;94,34
51 Ceuta;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
51 Ceuta;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
51 Ceuta;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
51 Ceuta;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;94,2
51 Ceuta;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
51 Ceuta;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
51 Ceuta;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
51 Ceuta;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;91,89
51 Ceuta;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
51 Ceuta;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
51 Ceuta;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;90,52
51 Ceuta;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
51 Ceuta;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
51 Ceuta;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
51 Ceuta;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;91,3
51 Ceuta;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
51 Ceuta;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
51 Ceuta;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
51 Ceuta;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;89,27
51 Ceuta;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
51 Ceuta;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
51 Ceuta;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;87,47
51 Ceuta;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
51 Ceuta;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
51 Ceuta;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
51 Ceuta;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;88,63
51 Ceuta;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
51 Ceuta;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
51 Ceuta;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
51 Ceuta;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;87,08
51 Ceuta;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
51 Ceuta;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
51 Ceuta;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
51 Ceuta;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
51 Ceuta;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
51 Ceuta;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
51 Ceuta;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QI;572
51 Ceuta;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
51 Ceuta;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
51 Ceuta;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
51 Ceuta;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QI;564
51 Ceuta;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
51 Ceuta;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
51 Ceuta;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
51 Ceuta;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QI;571
51 Ceuta;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
51 Ceuta;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
51 Ceuta;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2022QII;""
51 Ceuta;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2022QI;558
51 Ceuta;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
51 Ceuta;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
51 Ceuta;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2021QII;""
51 Ceuta;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2021QI;553
51 Ceuta;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
51 Ceuta;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
51 Ceuta;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2020QII;""
51 Ceuta;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2020QI;537
51 Ceuta;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
51 Ceuta;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
51 Ceuta;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2022QII;546
51 Ceuta;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2022QI;""
51 Ceuta;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
51 Ceuta;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
51 Ceuta;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2021QII;535
51 Ceuta;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2021QI;""
51 Ceuta;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
51 Ceuta;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
51 Ceuta;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2020QII;528
51 Ceuta;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2020QI;""
51 Ceuta;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
51 Ceuta;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QIII;525
51 Ceuta;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QII;""
51 Ceuta;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QI;""
51 Ceuta;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
51 Ceuta;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QIII;524
51 Ceuta;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QII;""
51 Ceuta;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QI;""
51 Ceuta;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
51 Ceuta;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QIII;514
51 Ceuta;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QII;""
51 Ceuta;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QI;""
51 Ceuta;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QIV;506
51 Ceuta;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
51 Ceuta;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QII;""
51 Ceuta;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QI;""
51 Ceuta;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QIV;509
51 Ceuta;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
51 Ceuta;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QII;""
51 Ceuta;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QI;""
51 Ceuta;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QIV;503
51 Ceuta;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
51 Ceuta;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QII;""
51 Ceuta;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QI;""
51 Ceuta;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
51 Ceuta;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
51 Ceuta;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
51 Ceuta;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
51 Ceuta;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
51 Ceuta;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
51 Ceuta;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
51 Ceuta;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
51 Ceuta;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
51 Ceuta;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
51 Ceuta;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
51 Ceuta;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
51 Ceuta;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
51 Ceuta;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
51 Ceuta;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
51 Ceuta;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;97,55
51 Ceuta;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
51 Ceuta;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
51 Ceuta;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
51 Ceuta;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;98,05
51 Ceuta;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
51 Ceuta;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
51 Ceuta;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
51 Ceuta;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;94,05
51 Ceuta;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
51 Ceuta;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
51 Ceuta;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;95,45
51 Ceuta;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
51 Ceuta;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
51 Ceuta;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
51 Ceuta;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;94,86
51 Ceuta;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
51 Ceuta;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
51 Ceuta;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
51 Ceuta;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;92,47
51 Ceuta;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
51 Ceuta;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
51 Ceuta;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;91,78
51 Ceuta;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
51 Ceuta;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
51 Ceuta;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
51 Ceuta;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;92,91
51 Ceuta;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
51 Ceuta;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
51 Ceuta;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
51 Ceuta;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;90,02
51 Ceuta;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
51 Ceuta;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
51 Ceuta;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;88,46
51 Ceuta;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
51 Ceuta;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
51 Ceuta;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
51 Ceuta;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;90,25
51 Ceuta;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
51 Ceuta;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
51 Ceuta;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
51 Ceuta;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;88,09
51 Ceuta;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
51 Ceuta;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
51 Ceuta;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
51 Ceuta;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
51 Ceuta;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
51 Ceuta;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
51 Ceuta;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QI;346
51 Ceuta;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
51 Ceuta;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
51 Ceuta;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
51 Ceuta;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QI;333
51 Ceuta;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
51 Ceuta;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
51 Ceuta;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
51 Ceuta;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QI;342
51 Ceuta;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
51 Ceuta;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
51 Ceuta;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2022QII;""
51 Ceuta;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2022QI;335
51 Ceuta;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
51 Ceuta;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
51 Ceuta;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2021QII;""
51 Ceuta;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2021QI;325
51 Ceuta;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
51 Ceuta;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
51 Ceuta;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2020QII;""
51 Ceuta;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2020QI;320
51 Ceuta;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
51 Ceuta;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
51 Ceuta;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2022QII;320
51 Ceuta;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2022QI;""
51 Ceuta;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
51 Ceuta;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
51 Ceuta;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2021QII;310
51 Ceuta;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2021QI;""
51 Ceuta;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
51 Ceuta;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
51 Ceuta;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2020QII;311
51 Ceuta;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2020QI;""
51 Ceuta;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
51 Ceuta;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QIII;306
51 Ceuta;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QII;""
51 Ceuta;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QI;""
51 Ceuta;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
51 Ceuta;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QIII;295
51 Ceuta;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QII;""
51 Ceuta;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QI;""
51 Ceuta;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
51 Ceuta;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QIII;301
51 Ceuta;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QII;""
51 Ceuta;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QI;""
51 Ceuta;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QIV;297
51 Ceuta;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
51 Ceuta;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QII;""
51 Ceuta;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QI;""
51 Ceuta;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QIV;286
51 Ceuta;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
51 Ceuta;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QII;""
51 Ceuta;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QI;""
51 Ceuta;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QIV;292
51 Ceuta;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
51 Ceuta;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QII;""
51 Ceuta;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QI;""
51 Ceuta;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
51 Ceuta;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
51 Ceuta;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
51 Ceuta;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
51 Ceuta;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
51 Ceuta;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
51 Ceuta;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
51 Ceuta;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
51 Ceuta;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
51 Ceuta;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
51 Ceuta;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
51 Ceuta;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
51 Ceuta;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
51 Ceuta;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
51 Ceuta;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
51 Ceuta;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;96,82
51 Ceuta;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
51 Ceuta;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
51 Ceuta;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
51 Ceuta;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;97,6
51 Ceuta;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
51 Ceuta;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
51 Ceuta;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
51 Ceuta;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;93,57
51 Ceuta;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
51 Ceuta;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
51 Ceuta;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;92,49
51 Ceuta;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
51 Ceuta;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
51 Ceuta;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
51 Ceuta;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;93,09
51 Ceuta;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
51 Ceuta;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
51 Ceuta;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
51 Ceuta;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;90,94
51 Ceuta;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
51 Ceuta;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
51 Ceuta;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;88,44
51 Ceuta;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
51 Ceuta;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
51 Ceuta;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
51 Ceuta;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;88,59
51 Ceuta;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
51 Ceuta;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
51 Ceuta;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
51 Ceuta;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;88,01
51 Ceuta;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
51 Ceuta;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
51 Ceuta;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;85,84
51 Ceuta;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
51 Ceuta;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
51 Ceuta;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
51 Ceuta;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;85,89
51 Ceuta;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
51 Ceuta;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
51 Ceuta;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
51 Ceuta;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;85,38
51 Ceuta;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
51 Ceuta;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
51 Ceuta;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
51 Ceuta;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
51 Ceuta;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
51 Ceuta;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QII;916
51 Ceuta;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
51 Ceuta;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
51 Ceuta;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
51 Ceuta;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QII;930
51 Ceuta;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
51 Ceuta;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
51 Ceuta;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
51 Ceuta;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QII;901
51 Ceuta;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
51 Ceuta;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
51 Ceuta;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
51 Ceuta;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2022QII;886
51 Ceuta;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2022QI;""
51 Ceuta;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
51 Ceuta;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
51 Ceuta;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2021QII;896
51 Ceuta;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2021QI;""
51 Ceuta;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
51 Ceuta;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
51 Ceuta;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2020QII;882
51 Ceuta;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2020QI;""
51 Ceuta;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
51 Ceuta;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2022QIII;854
51 Ceuta;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2022QII;""
51 Ceuta;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2022QI;""
51 Ceuta;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
51 Ceuta;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2021QIII;866
51 Ceuta;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2021QII;""
51 Ceuta;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2021QI;""
51 Ceuta;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
51 Ceuta;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2020QIII;855
51 Ceuta;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2020QII;""
51 Ceuta;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2020QI;""
51 Ceuta;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QIV;824
51 Ceuta;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
51 Ceuta;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QII;""
51 Ceuta;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QI;""
51 Ceuta;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QIV;835
51 Ceuta;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
51 Ceuta;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QII;""
51 Ceuta;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QI;""
51 Ceuta;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QIV;834
51 Ceuta;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
51 Ceuta;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QII;""
51 Ceuta;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QI;""
51 Ceuta;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
51 Ceuta;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
51 Ceuta;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QII;""
51 Ceuta;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QI;816
51 Ceuta;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
51 Ceuta;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
51 Ceuta;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QII;""
51 Ceuta;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QI;818
51 Ceuta;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
51 Ceuta;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
51 Ceuta;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QII;""
51 Ceuta;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QI;""
51 Ceuta;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
51 Ceuta;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
51 Ceuta;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
51 Ceuta;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
51 Ceuta;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
51 Ceuta;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
51 Ceuta;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
51 Ceuta;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
51 Ceuta;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
51 Ceuta;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
51 Ceuta;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
51 Ceuta;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
51 Ceuta;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
51 Ceuta;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
51 Ceuta;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;96,72
51 Ceuta;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
51 Ceuta;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
51 Ceuta;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
51 Ceuta;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;96,34
51 Ceuta;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
51 Ceuta;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
51 Ceuta;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
51 Ceuta;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;97,89
51 Ceuta;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
51 Ceuta;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
51 Ceuta;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;93,23
51 Ceuta;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
51 Ceuta;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
51 Ceuta;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
51 Ceuta;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;93,12
51 Ceuta;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
51 Ceuta;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
51 Ceuta;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
51 Ceuta;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;94,89
51 Ceuta;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
51 Ceuta;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
51 Ceuta;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;89,96
51 Ceuta;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
51 Ceuta;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
51 Ceuta;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
51 Ceuta;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;89,78
51 Ceuta;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
51 Ceuta;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
51 Ceuta;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
51 Ceuta;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;92,56
51 Ceuta;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
51 Ceuta;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
51 Ceuta;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
51 Ceuta;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
51 Ceuta;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
51 Ceuta;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
51 Ceuta;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;87,74
51 Ceuta;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
51 Ceuta;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
51 Ceuta;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
51 Ceuta;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;90,79
51 Ceuta;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
51 Ceuta;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
51 Ceuta;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
51 Ceuta;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
51 Ceuta;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
51 Ceuta;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
51 Ceuta;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QII;570
51 Ceuta;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
51 Ceuta;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
51 Ceuta;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
51 Ceuta;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QII;580
51 Ceuta;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
51 Ceuta;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
51 Ceuta;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
51 Ceuta;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QII;563
51 Ceuta;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
51 Ceuta;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
51 Ceuta;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
51 Ceuta;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2022QII;557
51 Ceuta;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2022QI;""
51 Ceuta;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
51 Ceuta;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
51 Ceuta;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2021QII;560
51 Ceuta;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2021QI;""
51 Ceuta;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
51 Ceuta;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
51 Ceuta;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2020QII;553
51 Ceuta;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2020QI;""
51 Ceuta;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
51 Ceuta;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2022QIII;538
51 Ceuta;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2022QII;""
51 Ceuta;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2022QI;""
51 Ceuta;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
51 Ceuta;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2021QIII;547
51 Ceuta;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2021QII;""
51 Ceuta;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2021QI;""
51 Ceuta;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
51 Ceuta;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2020QIII;536
51 Ceuta;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2020QII;""
51 Ceuta;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2020QI;""
51 Ceuta;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QIV;517
51 Ceuta;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
51 Ceuta;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QII;""
51 Ceuta;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QI;""
51 Ceuta;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QIV;527
51 Ceuta;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
51 Ceuta;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QII;""
51 Ceuta;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QI;""
51 Ceuta;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QIV;524
51 Ceuta;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
51 Ceuta;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QII;""
51 Ceuta;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QI;""
51 Ceuta;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
51 Ceuta;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
51 Ceuta;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QII;""
51 Ceuta;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QI;516
51 Ceuta;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
51 Ceuta;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
51 Ceuta;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QII;""
51 Ceuta;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QI;514
51 Ceuta;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
51 Ceuta;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
51 Ceuta;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QII;""
51 Ceuta;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QI;""
51 Ceuta;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
51 Ceuta;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
51 Ceuta;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
51 Ceuta;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
51 Ceuta;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
51 Ceuta;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
51 Ceuta;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
51 Ceuta;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
51 Ceuta;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
51 Ceuta;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
51 Ceuta;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
51 Ceuta;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
51 Ceuta;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
51 Ceuta;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
51 Ceuta;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;97,72
51 Ceuta;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
51 Ceuta;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
51 Ceuta;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
51 Ceuta;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;96,55
51 Ceuta;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
51 Ceuta;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
51 Ceuta;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
51 Ceuta;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;98,22
51 Ceuta;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
51 Ceuta;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
51 Ceuta;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;94,39
51 Ceuta;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
51 Ceuta;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
51 Ceuta;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
51 Ceuta;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;94,31
51 Ceuta;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
51 Ceuta;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
51 Ceuta;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
51 Ceuta;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;95,2
51 Ceuta;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
51 Ceuta;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
51 Ceuta;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;90,7
51 Ceuta;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
51 Ceuta;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
51 Ceuta;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
51 Ceuta;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;90,86
51 Ceuta;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
51 Ceuta;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
51 Ceuta;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
51 Ceuta;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;93,07
51 Ceuta;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
51 Ceuta;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
51 Ceuta;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
51 Ceuta;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
51 Ceuta;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
51 Ceuta;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
51 Ceuta;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;88,97
51 Ceuta;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
51 Ceuta;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
51 Ceuta;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
51 Ceuta;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;91,3
51 Ceuta;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
51 Ceuta;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
51 Ceuta;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
51 Ceuta;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
51 Ceuta;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
51 Ceuta;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
51 Ceuta;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QII;346
51 Ceuta;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
51 Ceuta;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
51 Ceuta;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
51 Ceuta;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QII;350
51 Ceuta;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
51 Ceuta;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
51 Ceuta;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
51 Ceuta;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QII;338
51 Ceuta;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
51 Ceuta;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
51 Ceuta;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
51 Ceuta;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2022QII;329
51 Ceuta;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2022QI;""
51 Ceuta;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
51 Ceuta;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
51 Ceuta;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2021QII;336
51 Ceuta;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2021QI;""
51 Ceuta;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
51 Ceuta;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
51 Ceuta;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2020QII;329
51 Ceuta;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2020QI;""
51 Ceuta;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
51 Ceuta;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2022QIII;316
51 Ceuta;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2022QII;""
51 Ceuta;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2022QI;""
51 Ceuta;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
51 Ceuta;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2021QIII;319
51 Ceuta;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2021QII;""
51 Ceuta;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2021QI;""
51 Ceuta;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
51 Ceuta;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2020QIII;319
51 Ceuta;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2020QII;""
51 Ceuta;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2020QI;""
51 Ceuta;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QIV;307
51 Ceuta;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
51 Ceuta;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QII;""
51 Ceuta;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QI;""
51 Ceuta;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QIV;308
51 Ceuta;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
51 Ceuta;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QII;""
51 Ceuta;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QI;""
51 Ceuta;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QIV;310
51 Ceuta;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
51 Ceuta;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QII;""
51 Ceuta;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QI;""
51 Ceuta;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
51 Ceuta;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
51 Ceuta;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QII;""
51 Ceuta;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QI;300
51 Ceuta;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
51 Ceuta;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
51 Ceuta;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QII;""
51 Ceuta;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QI;304
51 Ceuta;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
51 Ceuta;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
51 Ceuta;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QII;""
51 Ceuta;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QI;""
51 Ceuta;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
51 Ceuta;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
51 Ceuta;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
51 Ceuta;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
51 Ceuta;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
51 Ceuta;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
51 Ceuta;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
51 Ceuta;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
51 Ceuta;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
51 Ceuta;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
51 Ceuta;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
51 Ceuta;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
51 Ceuta;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
51 Ceuta;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
51 Ceuta;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;95,09
51 Ceuta;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
51 Ceuta;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
51 Ceuta;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
51 Ceuta;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;96
51 Ceuta;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
51 Ceuta;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
51 Ceuta;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
51 Ceuta;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;97,34
51 Ceuta;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
51 Ceuta;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
51 Ceuta;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;91,33
51 Ceuta;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
51 Ceuta;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
51 Ceuta;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
51 Ceuta;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;91,14
51 Ceuta;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
51 Ceuta;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
51 Ceuta;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
51 Ceuta;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;94,38
51 Ceuta;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
51 Ceuta;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
51 Ceuta;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;88,73
51 Ceuta;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
51 Ceuta;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
51 Ceuta;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
51 Ceuta;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;88
51 Ceuta;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
51 Ceuta;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
51 Ceuta;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
51 Ceuta;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;91,72
51 Ceuta;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
51 Ceuta;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
51 Ceuta;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
51 Ceuta;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
51 Ceuta;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
51 Ceuta;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
51 Ceuta;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;85,71
51 Ceuta;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
51 Ceuta;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
51 Ceuta;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
51 Ceuta;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;89,94
51 Ceuta;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
51 Ceuta;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
51 Ceuta;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
51 Ceuta;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
51 Ceuta;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
51 Ceuta;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QIII;913
51 Ceuta;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
51 Ceuta;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
51 Ceuta;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
51 Ceuta;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QIII;928
51 Ceuta;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
51 Ceuta;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
51 Ceuta;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
51 Ceuta;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QIII;898
51 Ceuta;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
51 Ceuta;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
51 Ceuta;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
51 Ceuta;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2022QIII;878
51 Ceuta;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2022QII;""
51 Ceuta;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2022QI;""
51 Ceuta;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
51 Ceuta;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2021QIII;894
51 Ceuta;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2021QII;""
51 Ceuta;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2021QI;""
51 Ceuta;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
51 Ceuta;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2020QIII;868
51 Ceuta;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2020QII;""
51 Ceuta;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2020QI;""
51 Ceuta;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2022QIV;846
51 Ceuta;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
51 Ceuta;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2022QII;""
51 Ceuta;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2022QI;""
51 Ceuta;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2021QIV;861
51 Ceuta;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
51 Ceuta;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2021QII;""
51 Ceuta;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2021QI;""
51 Ceuta;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2020QIV;847
51 Ceuta;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
51 Ceuta;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2020QII;""
51 Ceuta;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2020QI;""
51 Ceuta;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
51 Ceuta;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
51 Ceuta;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QII;""
51 Ceuta;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QI;841
51 Ceuta;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
51 Ceuta;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
51 Ceuta;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QII;""
51 Ceuta;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QI;831
51 Ceuta;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
51 Ceuta;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
51 Ceuta;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QII;""
51 Ceuta;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QI;""
51 Ceuta;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
51 Ceuta;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
51 Ceuta;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QII;818
51 Ceuta;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QI;""
51 Ceuta;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
51 Ceuta;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
51 Ceuta;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QII;799
51 Ceuta;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QI;""
51 Ceuta;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
51 Ceuta;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
51 Ceuta;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QII;""
51 Ceuta;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QI;""
51 Ceuta;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
51 Ceuta;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
51 Ceuta;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
51 Ceuta;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
51 Ceuta;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
51 Ceuta;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
51 Ceuta;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
51 Ceuta;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
51 Ceuta;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
51 Ceuta;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
51 Ceuta;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
51 Ceuta;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
51 Ceuta;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
51 Ceuta;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;96,17
51 Ceuta;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
51 Ceuta;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
51 Ceuta;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
51 Ceuta;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;96,34
51 Ceuta;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
51 Ceuta;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
51 Ceuta;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
51 Ceuta;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;96,66
51 Ceuta;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
51 Ceuta;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
51 Ceuta;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;92,66
51 Ceuta;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
51 Ceuta;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
51 Ceuta;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
51 Ceuta;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;92,78
51 Ceuta;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
51 Ceuta;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
51 Ceuta;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
51 Ceuta;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;94,32
51 Ceuta;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
51 Ceuta;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
51 Ceuta;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
51 Ceuta;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
51 Ceuta;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
51 Ceuta;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
51 Ceuta;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;90,63
51 Ceuta;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
51 Ceuta;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
51 Ceuta;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
51 Ceuta;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;92,54
51 Ceuta;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
51 Ceuta;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
51 Ceuta;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
51 Ceuta;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
51 Ceuta;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
51 Ceuta;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
51 Ceuta;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;88,15
51 Ceuta;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
51 Ceuta;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
51 Ceuta;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
51 Ceuta;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;88,98
51 Ceuta;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
51 Ceuta;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
51 Ceuta;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
51 Ceuta;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
51 Ceuta;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
51 Ceuta;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
51 Ceuta;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QIII;574
51 Ceuta;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
51 Ceuta;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
51 Ceuta;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
51 Ceuta;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QIII;579
51 Ceuta;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
51 Ceuta;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
51 Ceuta;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
51 Ceuta;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QIII;564
51 Ceuta;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
51 Ceuta;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
51 Ceuta;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
51 Ceuta;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2022QIII;553
51 Ceuta;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2022QII;""
51 Ceuta;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2022QI;""
51 Ceuta;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
51 Ceuta;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2021QIII;563
51 Ceuta;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2021QII;""
51 Ceuta;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2021QI;""
51 Ceuta;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
51 Ceuta;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2020QIII;545
51 Ceuta;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2020QII;""
51 Ceuta;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2020QI;""
51 Ceuta;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2022QIV;530
51 Ceuta;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
51 Ceuta;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2022QII;""
51 Ceuta;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2022QI;""
51 Ceuta;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2021QIV;541
51 Ceuta;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
51 Ceuta;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2021QII;""
51 Ceuta;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2021QI;""
51 Ceuta;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2020QIV;533
51 Ceuta;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
51 Ceuta;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2020QII;""
51 Ceuta;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2020QI;""
51 Ceuta;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
51 Ceuta;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
51 Ceuta;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QII;""
51 Ceuta;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QI;530
51 Ceuta;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
51 Ceuta;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
51 Ceuta;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QII;""
51 Ceuta;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QI;523
51 Ceuta;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
51 Ceuta;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
51 Ceuta;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QII;""
51 Ceuta;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QI;""
51 Ceuta;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
51 Ceuta;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
51 Ceuta;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QII;520
51 Ceuta;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QI;""
51 Ceuta;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
51 Ceuta;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
51 Ceuta;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QII;506
51 Ceuta;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QI;""
51 Ceuta;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
51 Ceuta;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
51 Ceuta;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QII;""
51 Ceuta;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QI;""
51 Ceuta;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
51 Ceuta;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
51 Ceuta;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
51 Ceuta;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
51 Ceuta;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
51 Ceuta;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
51 Ceuta;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
51 Ceuta;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
51 Ceuta;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
51 Ceuta;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
51 Ceuta;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
51 Ceuta;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
51 Ceuta;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
51 Ceuta;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;96,34
51 Ceuta;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
51 Ceuta;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
51 Ceuta;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
51 Ceuta;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;97,24
51 Ceuta;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
51 Ceuta;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
51 Ceuta;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
51 Ceuta;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;96,63
51 Ceuta;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
51 Ceuta;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
51 Ceuta;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;92,33
51 Ceuta;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
51 Ceuta;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
51 Ceuta;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
51 Ceuta;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;93,44
51 Ceuta;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
51 Ceuta;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
51 Ceuta;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
51 Ceuta;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;94,5
51 Ceuta;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
51 Ceuta;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
51 Ceuta;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
51 Ceuta;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
51 Ceuta;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
51 Ceuta;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
51 Ceuta;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;91,54
51 Ceuta;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
51 Ceuta;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
51 Ceuta;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
51 Ceuta;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;92,73
51 Ceuta;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
51 Ceuta;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
51 Ceuta;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
51 Ceuta;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
51 Ceuta;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
51 Ceuta;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
51 Ceuta;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;89,81
51 Ceuta;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
51 Ceuta;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
51 Ceuta;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
51 Ceuta;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;89,72
51 Ceuta;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
51 Ceuta;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
51 Ceuta;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
51 Ceuta;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
51 Ceuta;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
51 Ceuta;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
51 Ceuta;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QIII;339
51 Ceuta;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
51 Ceuta;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
51 Ceuta;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
51 Ceuta;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QIII;349
51 Ceuta;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
51 Ceuta;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
51 Ceuta;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
51 Ceuta;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QIII;334
51 Ceuta;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
51 Ceuta;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
51 Ceuta;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
51 Ceuta;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2022QIII;325
51 Ceuta;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2022QII;""
51 Ceuta;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2022QI;""
51 Ceuta;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
51 Ceuta;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2021QIII;331
51 Ceuta;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2021QII;""
51 Ceuta;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2021QI;""
51 Ceuta;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
51 Ceuta;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2020QIII;323
51 Ceuta;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2020QII;""
51 Ceuta;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2020QI;""
51 Ceuta;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2022QIV;316
51 Ceuta;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
51 Ceuta;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2022QII;""
51 Ceuta;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2022QI;""
51 Ceuta;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2021QIV;320
51 Ceuta;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
51 Ceuta;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2021QII;""
51 Ceuta;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2021QI;""
51 Ceuta;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2020QIV;314
51 Ceuta;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
51 Ceuta;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2020QII;""
51 Ceuta;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2020QI;""
51 Ceuta;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
51 Ceuta;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
51 Ceuta;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QII;""
51 Ceuta;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QI;311
51 Ceuta;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
51 Ceuta;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
51 Ceuta;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QII;""
51 Ceuta;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QI;308
51 Ceuta;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
51 Ceuta;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
51 Ceuta;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QII;""
51 Ceuta;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QI;""
51 Ceuta;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
51 Ceuta;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
51 Ceuta;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QII;298
51 Ceuta;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QI;""
51 Ceuta;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
51 Ceuta;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
51 Ceuta;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QII;293
51 Ceuta;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QI;""
51 Ceuta;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
51 Ceuta;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
51 Ceuta;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QII;""
51 Ceuta;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QI;""
51 Ceuta;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
51 Ceuta;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
51 Ceuta;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
51 Ceuta;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
51 Ceuta;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
51 Ceuta;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
51 Ceuta;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
51 Ceuta;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
51 Ceuta;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
51 Ceuta;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
51 Ceuta;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
51 Ceuta;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
51 Ceuta;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
51 Ceuta;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;95,87
51 Ceuta;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
51 Ceuta;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
51 Ceuta;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
51 Ceuta;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;94,84
51 Ceuta;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
51 Ceuta;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
51 Ceuta;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
51 Ceuta;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;96,71
51 Ceuta;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
51 Ceuta;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
51 Ceuta;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;93,22
51 Ceuta;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
51 Ceuta;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
51 Ceuta;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
51 Ceuta;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;91,69
51 Ceuta;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
51 Ceuta;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
51 Ceuta;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
51 Ceuta;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;94,01
51 Ceuta;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
51 Ceuta;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
51 Ceuta;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
51 Ceuta;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
51 Ceuta;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
51 Ceuta;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
51 Ceuta;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;89,11
51 Ceuta;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
51 Ceuta;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
51 Ceuta;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
51 Ceuta;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;92,22
51 Ceuta;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
51 Ceuta;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
51 Ceuta;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
51 Ceuta;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
51 Ceuta;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
51 Ceuta;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
51 Ceuta;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;85,39
51 Ceuta;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
51 Ceuta;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
51 Ceuta;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
51 Ceuta;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;87,72
51 Ceuta;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
51 Ceuta;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
51 Ceuta;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
51 Ceuta;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
51 Ceuta;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
51 Ceuta;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QIV;925
51 Ceuta;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
51 Ceuta;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
51 Ceuta;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
51 Ceuta;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QIV;925
51 Ceuta;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
51 Ceuta;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
51 Ceuta;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
51 Ceuta;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QIV;899
51 Ceuta;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
51 Ceuta;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
51 Ceuta;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
51 Ceuta;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2022QIV;889
51 Ceuta;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
51 Ceuta;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2022QII;""
51 Ceuta;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2022QI;""
51 Ceuta;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2021QIV;889
51 Ceuta;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
51 Ceuta;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2021QII;""
51 Ceuta;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2021QI;""
51 Ceuta;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2020QIV;876
51 Ceuta;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
51 Ceuta;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2020QII;""
51 Ceuta;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2020QI;""
51 Ceuta;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
51 Ceuta;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
51 Ceuta;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2022QII;""
51 Ceuta;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2022QI;867
51 Ceuta;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
51 Ceuta;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
51 Ceuta;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2021QII;""
51 Ceuta;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2021QI;858
51 Ceuta;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
51 Ceuta;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
51 Ceuta;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2020QII;""
51 Ceuta;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2020QI;""
51 Ceuta;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
51 Ceuta;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
51 Ceuta;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QII;842
51 Ceuta;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QI;""
51 Ceuta;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
51 Ceuta;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
51 Ceuta;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QII;825
51 Ceuta;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QI;""
51 Ceuta;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
51 Ceuta;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
51 Ceuta;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QII;""
51 Ceuta;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QI;""
51 Ceuta;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
51 Ceuta;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QIII;809
51 Ceuta;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QII;""
51 Ceuta;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QI;""
51 Ceuta;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
51 Ceuta;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QIII;800
51 Ceuta;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QII;""
51 Ceuta;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QI;""
51 Ceuta;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
51 Ceuta;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
51 Ceuta;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QII;""
51 Ceuta;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QI;""
51 Ceuta;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
51 Ceuta;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
51 Ceuta;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
51 Ceuta;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
51 Ceuta;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
51 Ceuta;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
51 Ceuta;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
51 Ceuta;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
51 Ceuta;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
51 Ceuta;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
51 Ceuta;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
51 Ceuta;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
51 Ceuta;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;96,11
51 Ceuta;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
51 Ceuta;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
51 Ceuta;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
51 Ceuta;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;96,11
51 Ceuta;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
51 Ceuta;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
51 Ceuta;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
51 Ceuta;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;97,44
51 Ceuta;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
51 Ceuta;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
51 Ceuta;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
51 Ceuta;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
51 Ceuta;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
51 Ceuta;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
51 Ceuta;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;93,73
51 Ceuta;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
51 Ceuta;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
51 Ceuta;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
51 Ceuta;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;95,44
51 Ceuta;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
51 Ceuta;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
51 Ceuta;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
51 Ceuta;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
51 Ceuta;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
51 Ceuta;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
51 Ceuta;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;91,03
51 Ceuta;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
51 Ceuta;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
51 Ceuta;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
51 Ceuta;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;91,77
51 Ceuta;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
51 Ceuta;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
51 Ceuta;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
51 Ceuta;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
51 Ceuta;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
51 Ceuta;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
51 Ceuta;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;87,46
51 Ceuta;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
51 Ceuta;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
51 Ceuta;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
51 Ceuta;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;88,99
51 Ceuta;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
51 Ceuta;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
51 Ceuta;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
51 Ceuta;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
51 Ceuta;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
51 Ceuta;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
51 Ceuta;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QIV;577
51 Ceuta;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
51 Ceuta;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
51 Ceuta;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
51 Ceuta;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QIV;582
51 Ceuta;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
51 Ceuta;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
51 Ceuta;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
51 Ceuta;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QIV;562
51 Ceuta;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
51 Ceuta;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
51 Ceuta;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
51 Ceuta;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2022QIV;551
51 Ceuta;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
51 Ceuta;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2022QII;""
51 Ceuta;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2022QI;""
51 Ceuta;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2021QIV;557
51 Ceuta;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
51 Ceuta;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2021QII;""
51 Ceuta;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2021QI;""
51 Ceuta;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2020QIV;549
51 Ceuta;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
51 Ceuta;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2020QII;""
51 Ceuta;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2020QI;""
51 Ceuta;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
51 Ceuta;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
51 Ceuta;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2022QII;""
51 Ceuta;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2022QI;545
51 Ceuta;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
51 Ceuta;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
51 Ceuta;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2021QII;""
51 Ceuta;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2021QI;538
51 Ceuta;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
51 Ceuta;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
51 Ceuta;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2020QII;""
51 Ceuta;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2020QI;""
51 Ceuta;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
51 Ceuta;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
51 Ceuta;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QII;534
51 Ceuta;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QI;""
51 Ceuta;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
51 Ceuta;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
51 Ceuta;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QII;520
51 Ceuta;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QI;""
51 Ceuta;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
51 Ceuta;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
51 Ceuta;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QII;""
51 Ceuta;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QI;""
51 Ceuta;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
51 Ceuta;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QIII;514
51 Ceuta;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QII;""
51 Ceuta;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QI;""
51 Ceuta;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
51 Ceuta;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QIII;509
51 Ceuta;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QII;""
51 Ceuta;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QI;""
51 Ceuta;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
51 Ceuta;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
51 Ceuta;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QII;""
51 Ceuta;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QI;""
51 Ceuta;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
51 Ceuta;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
51 Ceuta;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
51 Ceuta;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
51 Ceuta;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
51 Ceuta;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
51 Ceuta;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
51 Ceuta;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
51 Ceuta;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
51 Ceuta;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
51 Ceuta;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
51 Ceuta;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
51 Ceuta;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;95,49
51 Ceuta;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
51 Ceuta;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
51 Ceuta;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
51 Ceuta;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;95,7
51 Ceuta;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
51 Ceuta;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
51 Ceuta;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
51 Ceuta;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;97,69
51 Ceuta;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
51 Ceuta;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
51 Ceuta;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
51 Ceuta;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
51 Ceuta;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
51 Ceuta;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
51 Ceuta;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;93,64
51 Ceuta;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
51 Ceuta;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
51 Ceuta;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
51 Ceuta;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;95,73
51 Ceuta;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
51 Ceuta;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
51 Ceuta;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
51 Ceuta;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
51 Ceuta;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
51 Ceuta;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
51 Ceuta;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;91,75
51 Ceuta;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
51 Ceuta;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
51 Ceuta;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
51 Ceuta;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;92,53
51 Ceuta;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
51 Ceuta;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
51 Ceuta;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
51 Ceuta;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
51 Ceuta;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
51 Ceuta;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
51 Ceuta;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;88,32
51 Ceuta;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
51 Ceuta;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
51 Ceuta;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
51 Ceuta;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;90,57
51 Ceuta;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
51 Ceuta;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
51 Ceuta;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
51 Ceuta;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
51 Ceuta;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
51 Ceuta;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
51 Ceuta;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QIV;348
51 Ceuta;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
51 Ceuta;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
51 Ceuta;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
51 Ceuta;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QIV;343
51 Ceuta;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
51 Ceuta;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
51 Ceuta;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
51 Ceuta;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QIV;337
51 Ceuta;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
51 Ceuta;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
51 Ceuta;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
51 Ceuta;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2022QIV;338
51 Ceuta;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
51 Ceuta;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2022QII;""
51 Ceuta;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2022QI;""
51 Ceuta;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2021QIV;332
51 Ceuta;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
51 Ceuta;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2021QII;""
51 Ceuta;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2021QI;""
51 Ceuta;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2020QIV;327
51 Ceuta;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
51 Ceuta;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2020QII;""
51 Ceuta;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2020QI;""
51 Ceuta;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
51 Ceuta;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
51 Ceuta;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2022QII;""
51 Ceuta;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2022QI;322
51 Ceuta;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
51 Ceuta;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
51 Ceuta;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2021QII;""
51 Ceuta;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2021QI;320
51 Ceuta;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
51 Ceuta;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
51 Ceuta;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2020QII;""
51 Ceuta;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2020QI;""
51 Ceuta;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
51 Ceuta;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
51 Ceuta;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QII;308
51 Ceuta;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QI;""
51 Ceuta;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
51 Ceuta;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
51 Ceuta;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QII;305
51 Ceuta;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QI;""
51 Ceuta;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
51 Ceuta;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
51 Ceuta;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QII;""
51 Ceuta;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QI;""
51 Ceuta;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
51 Ceuta;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QIII;295
51 Ceuta;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QII;""
51 Ceuta;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QI;""
51 Ceuta;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
51 Ceuta;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QIII;291
51 Ceuta;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QII;""
51 Ceuta;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QI;""
51 Ceuta;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
51 Ceuta;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
51 Ceuta;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QII;""
51 Ceuta;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QI;""
51 Ceuta;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
51 Ceuta;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
51 Ceuta;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
51 Ceuta;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
51 Ceuta;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
51 Ceuta;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
51 Ceuta;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
51 Ceuta;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
51 Ceuta;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
51 Ceuta;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
51 Ceuta;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
51 Ceuta;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
51 Ceuta;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;97,13
51 Ceuta;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
51 Ceuta;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
51 Ceuta;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
51 Ceuta;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;96,79
51 Ceuta;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
51 Ceuta;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
51 Ceuta;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
51 Ceuta;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;97,03
51 Ceuta;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
51 Ceuta;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
51 Ceuta;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
51 Ceuta;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
51 Ceuta;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
51 Ceuta;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
51 Ceuta;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;93,88
51 Ceuta;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
51 Ceuta;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
51 Ceuta;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
51 Ceuta;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;94,96
51 Ceuta;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
51 Ceuta;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
51 Ceuta;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
51 Ceuta;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
51 Ceuta;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
51 Ceuta;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
51 Ceuta;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;89,8
51 Ceuta;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
51 Ceuta;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
51 Ceuta;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
51 Ceuta;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;90,5
51 Ceuta;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
51 Ceuta;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
51 Ceuta;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
51 Ceuta;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
51 Ceuta;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
51 Ceuta;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
51 Ceuta;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;86,01
51 Ceuta;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
51 Ceuta;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
51 Ceuta;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
51 Ceuta;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;86,35
51 Ceuta;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
51 Ceuta;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
51 Ceuta;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
51 Ceuta;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
51 Ceuta;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
51 Ceuta;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
51 Ceuta;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
51 Ceuta;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
51 Ceuta;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
51 Ceuta;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QI;951
51 Ceuta;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
51 Ceuta;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
51 Ceuta;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
51 Ceuta;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QI;971
51 Ceuta;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
51 Ceuta;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
51 Ceuta;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
51 Ceuta;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QI;999
51 Ceuta;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
51 Ceuta;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
51 Ceuta;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2022QII;""
51 Ceuta;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2022QI;915
51 Ceuta;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
51 Ceuta;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
51 Ceuta;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2021QII;""
51 Ceuta;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2021QI;963
51 Ceuta;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
51 Ceuta;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
51 Ceuta;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2020QII;""
51 Ceuta;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2020QI;966
51 Ceuta;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
51 Ceuta;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
51 Ceuta;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2022QII;898
51 Ceuta;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2022QI;""
51 Ceuta;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
51 Ceuta;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
51 Ceuta;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2021QII;946
51 Ceuta;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2021QI;""
51 Ceuta;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
51 Ceuta;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
51 Ceuta;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2020QII;949
51 Ceuta;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2020QI;""
51 Ceuta;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
51 Ceuta;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QIII;873
51 Ceuta;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QII;""
51 Ceuta;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QI;""
51 Ceuta;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
51 Ceuta;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QIII;934
51 Ceuta;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QII;""
51 Ceuta;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QI;""
51 Ceuta;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
51 Ceuta;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QIII;934
51 Ceuta;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QII;""
51 Ceuta;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QI;""
51 Ceuta;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QIV;842
51 Ceuta;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
51 Ceuta;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QII;""
51 Ceuta;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QI;""
51 Ceuta;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QIV;901
51 Ceuta;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
51 Ceuta;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QII;""
51 Ceuta;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QI;""
51 Ceuta;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QIV;913
51 Ceuta;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
51 Ceuta;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QII;""
51 Ceuta;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QI;""
51 Ceuta;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
51 Ceuta;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
51 Ceuta;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
51 Ceuta;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
51 Ceuta;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
51 Ceuta;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
51 Ceuta;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
51 Ceuta;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
51 Ceuta;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
51 Ceuta;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
51 Ceuta;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
51 Ceuta;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
51 Ceuta;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
51 Ceuta;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
51 Ceuta;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
51 Ceuta;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;96,21
51 Ceuta;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
51 Ceuta;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
51 Ceuta;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
51 Ceuta;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;99,18
51 Ceuta;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
51 Ceuta;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
51 Ceuta;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
51 Ceuta;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;96,7
51 Ceuta;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
51 Ceuta;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
51 Ceuta;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;94,43
51 Ceuta;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
51 Ceuta;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
51 Ceuta;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
51 Ceuta;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;97,43
51 Ceuta;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
51 Ceuta;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
51 Ceuta;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
51 Ceuta;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;94,99
51 Ceuta;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
51 Ceuta;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
51 Ceuta;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;91,8
51 Ceuta;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
51 Ceuta;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
51 Ceuta;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
51 Ceuta;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;96,19
51 Ceuta;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
51 Ceuta;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
51 Ceuta;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
51 Ceuta;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;93,49
51 Ceuta;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
51 Ceuta;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
51 Ceuta;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;88,54
51 Ceuta;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
51 Ceuta;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
51 Ceuta;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
51 Ceuta;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;92,79
51 Ceuta;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
51 Ceuta;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
51 Ceuta;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
51 Ceuta;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;91,39
51 Ceuta;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
51 Ceuta;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
51 Ceuta;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
51 Ceuta;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
51 Ceuta;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
51 Ceuta;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
51 Ceuta;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QI;627
51 Ceuta;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
51 Ceuta;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
51 Ceuta;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
51 Ceuta;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QI;645
51 Ceuta;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
51 Ceuta;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
51 Ceuta;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
51 Ceuta;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QI;665
51 Ceuta;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
51 Ceuta;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
51 Ceuta;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2022QII;""
51 Ceuta;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2022QI;604
51 Ceuta;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
51 Ceuta;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
51 Ceuta;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2021QII;""
51 Ceuta;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2021QI;639
51 Ceuta;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
51 Ceuta;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
51 Ceuta;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2020QII;""
51 Ceuta;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2020QI;646
51 Ceuta;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
51 Ceuta;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
51 Ceuta;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2022QII;593
51 Ceuta;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2022QI;""
51 Ceuta;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
51 Ceuta;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
51 Ceuta;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2021QII;626
51 Ceuta;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2021QI;""
51 Ceuta;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
51 Ceuta;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
51 Ceuta;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2020QII;637
51 Ceuta;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2020QI;""
51 Ceuta;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
51 Ceuta;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QIII;573
51 Ceuta;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QII;""
51 Ceuta;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QI;""
51 Ceuta;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
51 Ceuta;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QIII;617
51 Ceuta;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QII;""
51 Ceuta;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QI;""
51 Ceuta;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
51 Ceuta;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QIII;625
51 Ceuta;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QII;""
51 Ceuta;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QI;""
51 Ceuta;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QIV;558
51 Ceuta;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
51 Ceuta;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QII;""
51 Ceuta;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QI;""
51 Ceuta;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QIV;593
51 Ceuta;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
51 Ceuta;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QII;""
51 Ceuta;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QI;""
51 Ceuta;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QIV;609
51 Ceuta;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
51 Ceuta;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QII;""
51 Ceuta;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QI;""
51 Ceuta;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
51 Ceuta;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
51 Ceuta;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
51 Ceuta;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
51 Ceuta;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
51 Ceuta;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
51 Ceuta;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
51 Ceuta;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
51 Ceuta;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
51 Ceuta;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
51 Ceuta;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
51 Ceuta;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
51 Ceuta;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
51 Ceuta;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
51 Ceuta;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
51 Ceuta;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;96,33
51 Ceuta;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
51 Ceuta;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
51 Ceuta;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
51 Ceuta;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;99,07
51 Ceuta;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
51 Ceuta;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
51 Ceuta;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
51 Ceuta;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;97,14
51 Ceuta;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
51 Ceuta;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
51 Ceuta;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;94,58
51 Ceuta;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
51 Ceuta;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
51 Ceuta;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
51 Ceuta;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;97,05
51 Ceuta;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
51 Ceuta;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
51 Ceuta;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
51 Ceuta;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;95,79
51 Ceuta;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
51 Ceuta;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
51 Ceuta;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;91,39
51 Ceuta;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
51 Ceuta;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
51 Ceuta;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
51 Ceuta;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;95,66
51 Ceuta;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
51 Ceuta;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
51 Ceuta;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
51 Ceuta;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;93,98
51 Ceuta;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
51 Ceuta;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
51 Ceuta;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;89
51 Ceuta;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
51 Ceuta;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
51 Ceuta;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
51 Ceuta;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;91,94
51 Ceuta;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
51 Ceuta;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
51 Ceuta;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
51 Ceuta;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;91,58
51 Ceuta;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
51 Ceuta;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
51 Ceuta;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
51 Ceuta;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
51 Ceuta;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
51 Ceuta;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
51 Ceuta;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QI;324
51 Ceuta;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
51 Ceuta;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
51 Ceuta;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
51 Ceuta;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QI;326
51 Ceuta;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
51 Ceuta;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
51 Ceuta;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
51 Ceuta;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QI;334
51 Ceuta;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
51 Ceuta;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
51 Ceuta;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2022QII;""
51 Ceuta;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2022QI;311
51 Ceuta;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
51 Ceuta;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
51 Ceuta;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2021QII;""
51 Ceuta;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2021QI;324
51 Ceuta;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
51 Ceuta;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
51 Ceuta;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2020QII;""
51 Ceuta;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2020QI;320
51 Ceuta;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
51 Ceuta;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
51 Ceuta;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2022QII;305
51 Ceuta;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2022QI;""
51 Ceuta;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
51 Ceuta;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
51 Ceuta;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2021QII;320
51 Ceuta;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2021QI;""
51 Ceuta;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
51 Ceuta;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
51 Ceuta;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2020QII;312
51 Ceuta;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2020QI;""
51 Ceuta;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
51 Ceuta;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QIII;300
51 Ceuta;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QII;""
51 Ceuta;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QI;""
51 Ceuta;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
51 Ceuta;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QIII;317
51 Ceuta;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QII;""
51 Ceuta;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QI;""
51 Ceuta;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
51 Ceuta;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QIII;309
51 Ceuta;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QII;""
51 Ceuta;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QI;""
51 Ceuta;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QIV;284
51 Ceuta;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
51 Ceuta;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QII;""
51 Ceuta;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QI;""
51 Ceuta;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QIV;308
51 Ceuta;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
51 Ceuta;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QII;""
51 Ceuta;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QI;""
51 Ceuta;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QIV;304
51 Ceuta;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
51 Ceuta;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QII;""
51 Ceuta;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QI;""
51 Ceuta;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
51 Ceuta;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
51 Ceuta;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
51 Ceuta;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
51 Ceuta;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
51 Ceuta;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
51 Ceuta;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
51 Ceuta;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
51 Ceuta;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
51 Ceuta;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
51 Ceuta;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
51 Ceuta;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
51 Ceuta;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
51 Ceuta;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
51 Ceuta;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
51 Ceuta;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;95,99
51 Ceuta;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
51 Ceuta;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
51 Ceuta;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
51 Ceuta;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;99,39
51 Ceuta;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
51 Ceuta;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
51 Ceuta;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
51 Ceuta;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;95,81
51 Ceuta;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
51 Ceuta;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
51 Ceuta;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;94,14
51 Ceuta;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
51 Ceuta;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
51 Ceuta;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
51 Ceuta;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;98,16
51 Ceuta;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
51 Ceuta;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
51 Ceuta;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
51 Ceuta;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;93,41
51 Ceuta;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
51 Ceuta;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
51 Ceuta;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;92,59
51 Ceuta;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
51 Ceuta;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
51 Ceuta;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
51 Ceuta;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;97,24
51 Ceuta;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
51 Ceuta;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
51 Ceuta;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
51 Ceuta;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;92,51
51 Ceuta;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
51 Ceuta;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
51 Ceuta;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;87,65
51 Ceuta;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
51 Ceuta;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
51 Ceuta;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
51 Ceuta;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;94,48
51 Ceuta;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
51 Ceuta;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
51 Ceuta;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
51 Ceuta;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;91,02
51 Ceuta;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
51 Ceuta;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
51 Ceuta;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
51 Ceuta;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
51 Ceuta;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
51 Ceuta;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QII;930
51 Ceuta;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
51 Ceuta;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
51 Ceuta;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
51 Ceuta;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QII;970
51 Ceuta;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
51 Ceuta;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
51 Ceuta;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
51 Ceuta;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QII;990
51 Ceuta;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
51 Ceuta;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
51 Ceuta;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
51 Ceuta;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2022QII;913
51 Ceuta;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2022QI;""
51 Ceuta;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
51 Ceuta;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
51 Ceuta;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2021QII;951
51 Ceuta;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2021QI;""
51 Ceuta;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
51 Ceuta;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
51 Ceuta;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2020QII;971
51 Ceuta;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2020QI;""
51 Ceuta;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
51 Ceuta;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2022QIII;885
51 Ceuta;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2022QII;""
51 Ceuta;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2022QI;""
51 Ceuta;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
51 Ceuta;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2021QIII;938
51 Ceuta;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2021QII;""
51 Ceuta;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2021QI;""
51 Ceuta;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
51 Ceuta;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2020QIII;955
51 Ceuta;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2020QII;""
51 Ceuta;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2020QI;""
51 Ceuta;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QIV;854
51 Ceuta;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
51 Ceuta;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QII;""
51 Ceuta;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QI;""
51 Ceuta;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QIV;906
51 Ceuta;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
51 Ceuta;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QII;""
51 Ceuta;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QI;""
51 Ceuta;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QIV;933
51 Ceuta;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
51 Ceuta;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QII;""
51 Ceuta;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QI;""
51 Ceuta;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
51 Ceuta;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
51 Ceuta;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QII;""
51 Ceuta;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QI;877
51 Ceuta;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
51 Ceuta;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
51 Ceuta;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QII;""
51 Ceuta;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QI;926
51 Ceuta;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
51 Ceuta;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
51 Ceuta;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QII;""
51 Ceuta;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QI;""
51 Ceuta;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
51 Ceuta;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
51 Ceuta;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
51 Ceuta;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
51 Ceuta;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
51 Ceuta;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
51 Ceuta;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
51 Ceuta;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
51 Ceuta;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
51 Ceuta;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
51 Ceuta;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
51 Ceuta;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
51 Ceuta;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
51 Ceuta;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
51 Ceuta;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;98,17
51 Ceuta;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
51 Ceuta;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
51 Ceuta;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
51 Ceuta;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;98,04
51 Ceuta;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
51 Ceuta;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
51 Ceuta;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
51 Ceuta;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;98,08
51 Ceuta;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
51 Ceuta;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
51 Ceuta;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;95,16
51 Ceuta;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
51 Ceuta;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
51 Ceuta;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
51 Ceuta;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;96,7
51 Ceuta;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
51 Ceuta;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
51 Ceuta;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
51 Ceuta;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;96,46
51 Ceuta;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
51 Ceuta;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
51 Ceuta;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;91,83
51 Ceuta;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
51 Ceuta;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
51 Ceuta;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
51 Ceuta;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;93,4
51 Ceuta;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
51 Ceuta;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
51 Ceuta;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
51 Ceuta;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;94,24
51 Ceuta;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
51 Ceuta;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
51 Ceuta;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
51 Ceuta;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
51 Ceuta;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
51 Ceuta;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
51 Ceuta;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;90,41
51 Ceuta;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
51 Ceuta;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
51 Ceuta;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
51 Ceuta;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;93,54
51 Ceuta;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
51 Ceuta;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
51 Ceuta;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
51 Ceuta;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
51 Ceuta;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
51 Ceuta;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
51 Ceuta;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QII;620
51 Ceuta;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
51 Ceuta;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
51 Ceuta;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
51 Ceuta;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QII;640
51 Ceuta;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
51 Ceuta;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
51 Ceuta;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
51 Ceuta;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QII;664
51 Ceuta;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
51 Ceuta;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
51 Ceuta;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
51 Ceuta;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2022QII;610
51 Ceuta;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2022QI;""
51 Ceuta;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
51 Ceuta;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
51 Ceuta;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2021QII;629
51 Ceuta;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2021QI;""
51 Ceuta;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
51 Ceuta;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
51 Ceuta;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2020QII;654
51 Ceuta;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2020QI;""
51 Ceuta;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
51 Ceuta;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2022QIII;588
51 Ceuta;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2022QII;""
51 Ceuta;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2022QI;""
51 Ceuta;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
51 Ceuta;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2021QIII;620
51 Ceuta;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2021QII;""
51 Ceuta;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2021QI;""
51 Ceuta;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
51 Ceuta;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2020QIII;641
51 Ceuta;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2020QII;""
51 Ceuta;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2020QI;""
51 Ceuta;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QIV;572
51 Ceuta;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
51 Ceuta;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QII;""
51 Ceuta;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QI;""
51 Ceuta;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QIV;597
51 Ceuta;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
51 Ceuta;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QII;""
51 Ceuta;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QI;""
51 Ceuta;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QIV;624
51 Ceuta;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
51 Ceuta;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QII;""
51 Ceuta;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QI;""
51 Ceuta;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
51 Ceuta;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
51 Ceuta;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QII;""
51 Ceuta;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QI;579
51 Ceuta;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
51 Ceuta;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
51 Ceuta;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QII;""
51 Ceuta;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QI;619
51 Ceuta;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
51 Ceuta;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
51 Ceuta;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QII;""
51 Ceuta;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QI;""
51 Ceuta;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
51 Ceuta;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
51 Ceuta;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
51 Ceuta;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
51 Ceuta;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
51 Ceuta;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
51 Ceuta;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
51 Ceuta;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
51 Ceuta;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
51 Ceuta;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
51 Ceuta;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
51 Ceuta;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
51 Ceuta;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
51 Ceuta;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
51 Ceuta;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;98,39
51 Ceuta;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
51 Ceuta;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
51 Ceuta;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
51 Ceuta;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;98,28
51 Ceuta;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
51 Ceuta;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
51 Ceuta;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
51 Ceuta;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;98,49
51 Ceuta;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
51 Ceuta;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
51 Ceuta;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;94,84
51 Ceuta;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
51 Ceuta;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
51 Ceuta;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
51 Ceuta;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;96,88
51 Ceuta;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
51 Ceuta;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
51 Ceuta;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
51 Ceuta;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;96,54
51 Ceuta;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
51 Ceuta;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
51 Ceuta;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;92,26
51 Ceuta;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
51 Ceuta;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
51 Ceuta;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
51 Ceuta;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;93,28
51 Ceuta;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
51 Ceuta;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
51 Ceuta;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
51 Ceuta;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;93,98
51 Ceuta;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
51 Ceuta;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
51 Ceuta;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
51 Ceuta;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
51 Ceuta;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
51 Ceuta;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
51 Ceuta;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;90,47
51 Ceuta;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
51 Ceuta;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
51 Ceuta;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
51 Ceuta;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;93,22
51 Ceuta;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
51 Ceuta;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
51 Ceuta;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
51 Ceuta;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
51 Ceuta;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
51 Ceuta;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
51 Ceuta;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QII;310
51 Ceuta;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
51 Ceuta;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
51 Ceuta;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
51 Ceuta;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QII;330
51 Ceuta;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
51 Ceuta;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
51 Ceuta;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
51 Ceuta;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QII;326
51 Ceuta;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
51 Ceuta;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
51 Ceuta;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
51 Ceuta;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2022QII;303
51 Ceuta;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2022QI;""
51 Ceuta;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
51 Ceuta;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
51 Ceuta;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2021QII;322
51 Ceuta;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2021QI;""
51 Ceuta;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
51 Ceuta;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
51 Ceuta;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2020QII;317
51 Ceuta;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2020QI;""
51 Ceuta;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
51 Ceuta;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2022QIII;297
51 Ceuta;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2022QII;""
51 Ceuta;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2022QI;""
51 Ceuta;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
51 Ceuta;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2021QIII;318
51 Ceuta;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2021QII;""
51 Ceuta;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2021QI;""
51 Ceuta;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
51 Ceuta;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2020QIII;314
51 Ceuta;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2020QII;""
51 Ceuta;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2020QI;""
51 Ceuta;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QIV;282
51 Ceuta;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
51 Ceuta;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QII;""
51 Ceuta;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QI;""
51 Ceuta;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QIV;309
51 Ceuta;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
51 Ceuta;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QII;""
51 Ceuta;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QI;""
51 Ceuta;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QIV;309
51 Ceuta;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
51 Ceuta;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QII;""
51 Ceuta;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QI;""
51 Ceuta;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
51 Ceuta;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
51 Ceuta;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QII;""
51 Ceuta;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QI;298
51 Ceuta;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
51 Ceuta;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
51 Ceuta;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QII;""
51 Ceuta;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QI;307
51 Ceuta;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
51 Ceuta;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
51 Ceuta;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QII;""
51 Ceuta;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QI;""
51 Ceuta;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
51 Ceuta;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
51 Ceuta;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
51 Ceuta;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
51 Ceuta;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
51 Ceuta;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
51 Ceuta;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
51 Ceuta;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
51 Ceuta;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
51 Ceuta;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
51 Ceuta;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
51 Ceuta;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
51 Ceuta;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
51 Ceuta;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
51 Ceuta;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;97,74
51 Ceuta;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
51 Ceuta;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
51 Ceuta;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
51 Ceuta;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;97,58
51 Ceuta;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
51 Ceuta;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
51 Ceuta;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
51 Ceuta;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;97,24
51 Ceuta;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
51 Ceuta;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
51 Ceuta;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;95,81
51 Ceuta;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
51 Ceuta;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
51 Ceuta;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
51 Ceuta;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;96,36
51 Ceuta;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
51 Ceuta;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
51 Ceuta;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
51 Ceuta;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;96,32
51 Ceuta;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
51 Ceuta;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
51 Ceuta;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;90,97
51 Ceuta;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
51 Ceuta;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
51 Ceuta;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
51 Ceuta;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;93,64
51 Ceuta;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
51 Ceuta;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
51 Ceuta;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
51 Ceuta;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;94,79
51 Ceuta;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
51 Ceuta;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
51 Ceuta;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
51 Ceuta;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
51 Ceuta;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
51 Ceuta;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
51 Ceuta;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;90,3
51 Ceuta;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
51 Ceuta;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
51 Ceuta;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
51 Ceuta;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;94,17
51 Ceuta;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
51 Ceuta;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
51 Ceuta;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
51 Ceuta;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
51 Ceuta;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
51 Ceuta;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QIII;927
51 Ceuta;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
51 Ceuta;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
51 Ceuta;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
51 Ceuta;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QIII;967
51 Ceuta;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
51 Ceuta;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
51 Ceuta;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
51 Ceuta;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QIII;990
51 Ceuta;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
51 Ceuta;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
51 Ceuta;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
51 Ceuta;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2022QIII;895
51 Ceuta;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2022QII;""
51 Ceuta;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2022QI;""
51 Ceuta;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
51 Ceuta;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2021QIII;952
51 Ceuta;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2021QII;""
51 Ceuta;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2021QI;""
51 Ceuta;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
51 Ceuta;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2020QIII;972
51 Ceuta;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2020QII;""
51 Ceuta;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2020QI;""
51 Ceuta;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2022QIV;863
51 Ceuta;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
51 Ceuta;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2022QII;""
51 Ceuta;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2022QI;""
51 Ceuta;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2021QIV;919
51 Ceuta;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
51 Ceuta;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2021QII;""
51 Ceuta;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2021QI;""
51 Ceuta;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2020QIV;948
51 Ceuta;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
51 Ceuta;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2020QII;""
51 Ceuta;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2020QI;""
51 Ceuta;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
51 Ceuta;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
51 Ceuta;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QII;""
51 Ceuta;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QI;888
51 Ceuta;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
51 Ceuta;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
51 Ceuta;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QII;""
51 Ceuta;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QI;940
51 Ceuta;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
51 Ceuta;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
51 Ceuta;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QII;""
51 Ceuta;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QI;""
51 Ceuta;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
51 Ceuta;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
51 Ceuta;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QII;872
51 Ceuta;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QI;""
51 Ceuta;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
51 Ceuta;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
51 Ceuta;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QII;925
51 Ceuta;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QI;""
51 Ceuta;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
51 Ceuta;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
51 Ceuta;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QII;""
51 Ceuta;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QI;""
51 Ceuta;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
51 Ceuta;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
51 Ceuta;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
51 Ceuta;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
51 Ceuta;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
51 Ceuta;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
51 Ceuta;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
51 Ceuta;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
51 Ceuta;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
51 Ceuta;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
51 Ceuta;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
51 Ceuta;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
51 Ceuta;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
51 Ceuta;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;96,55
51 Ceuta;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
51 Ceuta;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
51 Ceuta;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
51 Ceuta;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;98,45
51 Ceuta;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
51 Ceuta;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
51 Ceuta;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
51 Ceuta;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;98,18
51 Ceuta;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
51 Ceuta;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
51 Ceuta;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;93,1
51 Ceuta;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
51 Ceuta;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
51 Ceuta;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
51 Ceuta;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;95,04
51 Ceuta;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
51 Ceuta;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
51 Ceuta;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
51 Ceuta;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;95,76
51 Ceuta;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
51 Ceuta;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
51 Ceuta;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
51 Ceuta;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
51 Ceuta;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
51 Ceuta;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
51 Ceuta;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;91,83
51 Ceuta;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
51 Ceuta;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
51 Ceuta;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
51 Ceuta;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;94,95
51 Ceuta;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
51 Ceuta;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
51 Ceuta;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
51 Ceuta;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
51 Ceuta;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
51 Ceuta;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
51 Ceuta;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;90,18
51 Ceuta;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
51 Ceuta;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
51 Ceuta;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
51 Ceuta;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;93,43
51 Ceuta;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
51 Ceuta;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
51 Ceuta;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
51 Ceuta;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
51 Ceuta;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
51 Ceuta;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
51 Ceuta;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QIII;616
51 Ceuta;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
51 Ceuta;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
51 Ceuta;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
51 Ceuta;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QIII;641
51 Ceuta;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
51 Ceuta;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
51 Ceuta;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
51 Ceuta;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QIII;662
51 Ceuta;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
51 Ceuta;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
51 Ceuta;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
51 Ceuta;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2022QIII;592
51 Ceuta;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2022QII;""
51 Ceuta;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2022QI;""
51 Ceuta;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
51 Ceuta;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2021QIII;631
51 Ceuta;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2021QII;""
51 Ceuta;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2021QI;""
51 Ceuta;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
51 Ceuta;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2020QIII;647
51 Ceuta;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2020QII;""
51 Ceuta;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2020QI;""
51 Ceuta;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2022QIV;576
51 Ceuta;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
51 Ceuta;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2022QII;""
51 Ceuta;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2022QI;""
51 Ceuta;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2021QIV;608
51 Ceuta;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
51 Ceuta;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2021QII;""
51 Ceuta;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2021QI;""
51 Ceuta;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2020QIV;630
51 Ceuta;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
51 Ceuta;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2020QII;""
51 Ceuta;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2020QI;""
51 Ceuta;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
51 Ceuta;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
51 Ceuta;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QII;""
51 Ceuta;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QI;588
51 Ceuta;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
51 Ceuta;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
51 Ceuta;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QII;""
51 Ceuta;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QI;624
51 Ceuta;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
51 Ceuta;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
51 Ceuta;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QII;""
51 Ceuta;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QI;""
51 Ceuta;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
51 Ceuta;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
51 Ceuta;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QII;577
51 Ceuta;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QI;""
51 Ceuta;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
51 Ceuta;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
51 Ceuta;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QII;612
51 Ceuta;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QI;""
51 Ceuta;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
51 Ceuta;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
51 Ceuta;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QII;""
51 Ceuta;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QI;""
51 Ceuta;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
51 Ceuta;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
51 Ceuta;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
51 Ceuta;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
51 Ceuta;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
51 Ceuta;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
51 Ceuta;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
51 Ceuta;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
51 Ceuta;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
51 Ceuta;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
51 Ceuta;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
51 Ceuta;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
51 Ceuta;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
51 Ceuta;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;96,1
51 Ceuta;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
51 Ceuta;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
51 Ceuta;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
51 Ceuta;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;98,44
51 Ceuta;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
51 Ceuta;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
51 Ceuta;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
51 Ceuta;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;97,73
51 Ceuta;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
51 Ceuta;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
51 Ceuta;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;93,51
51 Ceuta;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
51 Ceuta;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
51 Ceuta;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
51 Ceuta;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;94,85
51 Ceuta;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
51 Ceuta;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
51 Ceuta;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
51 Ceuta;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;95,17
51 Ceuta;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
51 Ceuta;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
51 Ceuta;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
51 Ceuta;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
51 Ceuta;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
51 Ceuta;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
51 Ceuta;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;91,73
51 Ceuta;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
51 Ceuta;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
51 Ceuta;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
51 Ceuta;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;94,26
51 Ceuta;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
51 Ceuta;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
51 Ceuta;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
51 Ceuta;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
51 Ceuta;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
51 Ceuta;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
51 Ceuta;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;90,02
51 Ceuta;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
51 Ceuta;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
51 Ceuta;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
51 Ceuta;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;92,45
51 Ceuta;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
51 Ceuta;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
51 Ceuta;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
51 Ceuta;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
51 Ceuta;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
51 Ceuta;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
51 Ceuta;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QIII;311
51 Ceuta;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
51 Ceuta;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
51 Ceuta;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
51 Ceuta;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QIII;326
51 Ceuta;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
51 Ceuta;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
51 Ceuta;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
51 Ceuta;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QIII;328
51 Ceuta;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
51 Ceuta;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
51 Ceuta;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
51 Ceuta;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2022QIII;303
51 Ceuta;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2022QII;""
51 Ceuta;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2022QI;""
51 Ceuta;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
51 Ceuta;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2021QIII;321
51 Ceuta;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2021QII;""
51 Ceuta;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2021QI;""
51 Ceuta;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
51 Ceuta;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2020QIII;325
51 Ceuta;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2020QII;""
51 Ceuta;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2020QI;""
51 Ceuta;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2022QIV;287
51 Ceuta;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
51 Ceuta;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2022QII;""
51 Ceuta;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2022QI;""
51 Ceuta;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2021QIV;311
51 Ceuta;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
51 Ceuta;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2021QII;""
51 Ceuta;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2021QI;""
51 Ceuta;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2020QIV;318
51 Ceuta;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
51 Ceuta;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2020QII;""
51 Ceuta;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2020QI;""
51 Ceuta;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
51 Ceuta;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
51 Ceuta;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QII;""
51 Ceuta;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QI;300
51 Ceuta;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
51 Ceuta;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
51 Ceuta;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QII;""
51 Ceuta;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QI;316
51 Ceuta;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
51 Ceuta;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
51 Ceuta;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QII;""
51 Ceuta;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QI;""
51 Ceuta;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
51 Ceuta;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
51 Ceuta;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QII;295
51 Ceuta;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QI;""
51 Ceuta;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
51 Ceuta;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
51 Ceuta;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QII;313
51 Ceuta;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QI;""
51 Ceuta;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
51 Ceuta;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
51 Ceuta;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QII;""
51 Ceuta;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QI;""
51 Ceuta;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
51 Ceuta;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
51 Ceuta;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
51 Ceuta;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
51 Ceuta;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
51 Ceuta;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
51 Ceuta;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
51 Ceuta;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
51 Ceuta;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
51 Ceuta;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
51 Ceuta;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
51 Ceuta;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
51 Ceuta;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
51 Ceuta;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;97,43
51 Ceuta;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
51 Ceuta;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
51 Ceuta;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
51 Ceuta;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;98,47
51 Ceuta;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
51 Ceuta;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
51 Ceuta;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
51 Ceuta;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;99,09
51 Ceuta;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
51 Ceuta;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
51 Ceuta;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;92,28
51 Ceuta;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
51 Ceuta;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
51 Ceuta;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
51 Ceuta;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;95,4
51 Ceuta;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
51 Ceuta;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
51 Ceuta;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
51 Ceuta;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;96,95
51 Ceuta;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
51 Ceuta;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
51 Ceuta;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
51 Ceuta;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
51 Ceuta;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
51 Ceuta;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
51 Ceuta;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;92,02
51 Ceuta;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
51 Ceuta;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
51 Ceuta;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
51 Ceuta;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;96,34
51 Ceuta;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
51 Ceuta;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
51 Ceuta;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
51 Ceuta;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
51 Ceuta;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
51 Ceuta;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
51 Ceuta;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;90,49
51 Ceuta;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
51 Ceuta;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
51 Ceuta;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
51 Ceuta;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;95,43
51 Ceuta;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
51 Ceuta;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
51 Ceuta;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
51 Ceuta;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
51 Ceuta;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
51 Ceuta;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QIV;910
51 Ceuta;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
51 Ceuta;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
51 Ceuta;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
51 Ceuta;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QIV;964
51 Ceuta;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
51 Ceuta;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
51 Ceuta;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
51 Ceuta;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QIV;984
51 Ceuta;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
51 Ceuta;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
51 Ceuta;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
51 Ceuta;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2022QIV;876
51 Ceuta;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
51 Ceuta;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2022QII;""
51 Ceuta;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2022QI;""
51 Ceuta;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2021QIV;930
51 Ceuta;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
51 Ceuta;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2021QII;""
51 Ceuta;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2021QI;""
51 Ceuta;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2020QIV;955
51 Ceuta;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
51 Ceuta;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2020QII;""
51 Ceuta;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2020QI;""
51 Ceuta;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
51 Ceuta;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
51 Ceuta;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2022QII;""
51 Ceuta;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2022QI;898
51 Ceuta;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
51 Ceuta;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
51 Ceuta;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2021QII;""
51 Ceuta;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2021QI;947
51 Ceuta;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
51 Ceuta;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
51 Ceuta;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2020QII;""
51 Ceuta;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2020QI;""
51 Ceuta;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
51 Ceuta;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
51 Ceuta;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QII;882
51 Ceuta;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QI;""
51 Ceuta;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
51 Ceuta;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
51 Ceuta;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QII;931
51 Ceuta;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QI;""
51 Ceuta;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
51 Ceuta;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
51 Ceuta;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QII;""
51 Ceuta;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QI;""
51 Ceuta;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
51 Ceuta;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QIII;857
51 Ceuta;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QII;""
51 Ceuta;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QI;""
51 Ceuta;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
51 Ceuta;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QIII;920
51 Ceuta;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QII;""
51 Ceuta;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QI;""
51 Ceuta;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
51 Ceuta;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
51 Ceuta;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QII;""
51 Ceuta;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QI;""
51 Ceuta;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
51 Ceuta;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
51 Ceuta;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
51 Ceuta;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
51 Ceuta;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
51 Ceuta;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
51 Ceuta;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
51 Ceuta;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
51 Ceuta;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
51 Ceuta;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
51 Ceuta;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
51 Ceuta;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
51 Ceuta;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;96,26
51 Ceuta;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
51 Ceuta;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
51 Ceuta;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
51 Ceuta;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;96,47
51 Ceuta;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
51 Ceuta;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
51 Ceuta;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
51 Ceuta;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;97,05
51 Ceuta;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
51 Ceuta;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
51 Ceuta;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
51 Ceuta;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
51 Ceuta;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
51 Ceuta;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
51 Ceuta;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;93,15
51 Ceuta;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
51 Ceuta;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
51 Ceuta;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
51 Ceuta;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;96,24
51 Ceuta;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
51 Ceuta;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
51 Ceuta;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
51 Ceuta;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
51 Ceuta;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
51 Ceuta;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
51 Ceuta;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;91,49
51 Ceuta;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
51 Ceuta;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
51 Ceuta;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
51 Ceuta;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;94,61
51 Ceuta;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
51 Ceuta;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
51 Ceuta;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
51 Ceuta;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
51 Ceuta;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
51 Ceuta;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
51 Ceuta;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;88,9
51 Ceuta;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
51 Ceuta;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
51 Ceuta;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
51 Ceuta;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;93,5
51 Ceuta;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
51 Ceuta;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
51 Ceuta;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
51 Ceuta;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
51 Ceuta;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
51 Ceuta;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
51 Ceuta;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QIV;605
51 Ceuta;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
51 Ceuta;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
51 Ceuta;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
51 Ceuta;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QIV;639
51 Ceuta;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
51 Ceuta;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
51 Ceuta;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
51 Ceuta;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QIV;653
51 Ceuta;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
51 Ceuta;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
51 Ceuta;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
51 Ceuta;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2022QIV;587
51 Ceuta;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
51 Ceuta;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2022QII;""
51 Ceuta;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2022QI;""
51 Ceuta;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2021QIV;615
51 Ceuta;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
51 Ceuta;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2021QII;""
51 Ceuta;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2021QI;""
51 Ceuta;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2020QIV;633
51 Ceuta;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
51 Ceuta;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2020QII;""
51 Ceuta;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2020QI;""
51 Ceuta;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
51 Ceuta;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
51 Ceuta;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2022QII;""
51 Ceuta;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2022QI;594
51 Ceuta;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
51 Ceuta;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
51 Ceuta;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2021QII;""
51 Ceuta;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2021QI;627
51 Ceuta;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
51 Ceuta;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
51 Ceuta;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2020QII;""
51 Ceuta;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2020QI;""
51 Ceuta;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
51 Ceuta;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
51 Ceuta;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QII;583
51 Ceuta;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QI;""
51 Ceuta;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
51 Ceuta;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
51 Ceuta;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QII;615
51 Ceuta;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QI;""
51 Ceuta;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
51 Ceuta;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
51 Ceuta;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QII;""
51 Ceuta;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QI;""
51 Ceuta;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
51 Ceuta;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QIII;563
51 Ceuta;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QII;""
51 Ceuta;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QI;""
51 Ceuta;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
51 Ceuta;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QIII;607
51 Ceuta;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QII;""
51 Ceuta;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QI;""
51 Ceuta;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
51 Ceuta;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
51 Ceuta;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QII;""
51 Ceuta;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QI;""
51 Ceuta;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
51 Ceuta;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
51 Ceuta;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
51 Ceuta;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
51 Ceuta;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
51 Ceuta;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
51 Ceuta;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
51 Ceuta;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
51 Ceuta;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
51 Ceuta;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
51 Ceuta;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
51 Ceuta;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
51 Ceuta;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;97,02
51 Ceuta;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
51 Ceuta;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
51 Ceuta;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
51 Ceuta;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;96,24
51 Ceuta;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
51 Ceuta;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
51 Ceuta;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
51 Ceuta;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;96,94
51 Ceuta;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
51 Ceuta;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
51 Ceuta;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
51 Ceuta;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
51 Ceuta;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
51 Ceuta;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
51 Ceuta;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;92,96
51 Ceuta;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
51 Ceuta;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
51 Ceuta;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
51 Ceuta;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;96,02
51 Ceuta;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
51 Ceuta;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
51 Ceuta;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
51 Ceuta;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
51 Ceuta;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
51 Ceuta;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
51 Ceuta;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;91,24
51 Ceuta;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
51 Ceuta;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
51 Ceuta;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
51 Ceuta;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;94,18
51 Ceuta;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
51 Ceuta;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
51 Ceuta;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
51 Ceuta;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
51 Ceuta;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
51 Ceuta;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
51 Ceuta;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;88,11
51 Ceuta;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
51 Ceuta;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
51 Ceuta;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
51 Ceuta;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;92,96
51 Ceuta;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
51 Ceuta;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
51 Ceuta;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
51 Ceuta;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
51 Ceuta;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
51 Ceuta;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
51 Ceuta;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QIV;305
51 Ceuta;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
51 Ceuta;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
51 Ceuta;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
51 Ceuta;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QIV;325
51 Ceuta;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
51 Ceuta;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
51 Ceuta;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
51 Ceuta;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QIV;331
51 Ceuta;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
51 Ceuta;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
51 Ceuta;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
51 Ceuta;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2022QIV;289
51 Ceuta;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
51 Ceuta;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2022QII;""
51 Ceuta;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2022QI;""
51 Ceuta;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2021QIV;315
51 Ceuta;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
51 Ceuta;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2021QII;""
51 Ceuta;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2021QI;""
51 Ceuta;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2020QIV;322
51 Ceuta;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
51 Ceuta;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2020QII;""
51 Ceuta;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2020QI;""
51 Ceuta;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
51 Ceuta;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
51 Ceuta;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2022QII;""
51 Ceuta;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2022QI;304
51 Ceuta;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
51 Ceuta;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
51 Ceuta;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2021QII;""
51 Ceuta;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2021QI;320
51 Ceuta;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
51 Ceuta;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
51 Ceuta;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2020QII;""
51 Ceuta;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2020QI;""
51 Ceuta;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
51 Ceuta;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
51 Ceuta;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QII;299
51 Ceuta;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QI;""
51 Ceuta;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
51 Ceuta;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
51 Ceuta;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QII;316
51 Ceuta;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QI;""
51 Ceuta;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
51 Ceuta;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
51 Ceuta;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QII;""
51 Ceuta;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QI;""
51 Ceuta;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
51 Ceuta;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QIII;294
51 Ceuta;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QII;""
51 Ceuta;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QI;""
51 Ceuta;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
51 Ceuta;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QIII;313
51 Ceuta;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QII;""
51 Ceuta;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QI;""
51 Ceuta;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
51 Ceuta;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
51 Ceuta;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QII;""
51 Ceuta;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QI;""
51 Ceuta;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
51 Ceuta;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
51 Ceuta;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
51 Ceuta;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
51 Ceuta;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
51 Ceuta;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
51 Ceuta;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
51 Ceuta;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
51 Ceuta;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
51 Ceuta;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
51 Ceuta;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
51 Ceuta;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
51 Ceuta;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;94,75
51 Ceuta;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
51 Ceuta;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
51 Ceuta;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
51 Ceuta;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;96,92
51 Ceuta;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
51 Ceuta;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
51 Ceuta;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
51 Ceuta;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;97,28
51 Ceuta;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
51 Ceuta;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
51 Ceuta;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
51 Ceuta;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
51 Ceuta;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
51 Ceuta;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
51 Ceuta;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;93,54
51 Ceuta;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
51 Ceuta;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
51 Ceuta;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
51 Ceuta;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;96,68
51 Ceuta;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
51 Ceuta;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
51 Ceuta;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
51 Ceuta;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
51 Ceuta;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
51 Ceuta;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
51 Ceuta;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;92
51 Ceuta;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
51 Ceuta;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
51 Ceuta;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
51 Ceuta;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;95,47
51 Ceuta;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
51 Ceuta;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
51 Ceuta;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
51 Ceuta;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
51 Ceuta;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
51 Ceuta;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
51 Ceuta;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;90,46
51 Ceuta;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
51 Ceuta;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
51 Ceuta;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
51 Ceuta;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;94,56
51 Ceuta;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
51 Ceuta;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
51 Ceuta;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
51 Ceuta;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
51 Ceuta;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
51 Ceuta;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
51 Ceuta;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
51 Ceuta;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
51 Ceuta;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
51 Ceuta;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QI;487
51 Ceuta;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
51 Ceuta;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
51 Ceuta;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
51 Ceuta;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QI;458
51 Ceuta;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
51 Ceuta;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
51 Ceuta;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
51 Ceuta;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QI;543
51 Ceuta;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
51 Ceuta;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
51 Ceuta;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2022QII;""
51 Ceuta;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2022QI;472
51 Ceuta;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
51 Ceuta;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
51 Ceuta;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2021QII;""
51 Ceuta;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2021QI;441
51 Ceuta;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
51 Ceuta;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
51 Ceuta;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2020QII;""
51 Ceuta;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2020QI;508
51 Ceuta;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
51 Ceuta;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
51 Ceuta;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2022QII;450
51 Ceuta;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2022QI;""
51 Ceuta;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
51 Ceuta;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
51 Ceuta;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2021QII;430
51 Ceuta;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2021QI;""
51 Ceuta;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
51 Ceuta;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
51 Ceuta;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2020QII;491
51 Ceuta;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2020QI;""
51 Ceuta;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
51 Ceuta;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QIII;425
51 Ceuta;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QII;""
51 Ceuta;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QI;""
51 Ceuta;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
51 Ceuta;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QIII;414
51 Ceuta;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QII;""
51 Ceuta;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QI;""
51 Ceuta;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
51 Ceuta;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QIII;472
51 Ceuta;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QII;""
51 Ceuta;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QI;""
51 Ceuta;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QIV;408
51 Ceuta;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
51 Ceuta;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QII;""
51 Ceuta;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QI;""
51 Ceuta;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QIV;401
51 Ceuta;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
51 Ceuta;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QII;""
51 Ceuta;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QI;""
51 Ceuta;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QIV;445
51 Ceuta;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
51 Ceuta;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QII;""
51 Ceuta;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QI;""
51 Ceuta;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
51 Ceuta;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
51 Ceuta;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
51 Ceuta;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
51 Ceuta;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
51 Ceuta;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
51 Ceuta;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
51 Ceuta;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
51 Ceuta;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
51 Ceuta;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
51 Ceuta;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
51 Ceuta;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
51 Ceuta;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
51 Ceuta;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
51 Ceuta;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
51 Ceuta;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;96,92
51 Ceuta;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
51 Ceuta;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
51 Ceuta;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
51 Ceuta;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;96,29
51 Ceuta;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
51 Ceuta;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
51 Ceuta;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
51 Ceuta;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;93,55
51 Ceuta;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
51 Ceuta;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
51 Ceuta;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;92,4
51 Ceuta;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
51 Ceuta;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
51 Ceuta;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
51 Ceuta;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;93,89
51 Ceuta;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
51 Ceuta;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
51 Ceuta;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
51 Ceuta;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;90,42
51 Ceuta;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
51 Ceuta;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
51 Ceuta;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;87,27
51 Ceuta;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
51 Ceuta;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
51 Ceuta;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
51 Ceuta;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;90,39
51 Ceuta;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
51 Ceuta;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
51 Ceuta;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
51 Ceuta;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;86,92
51 Ceuta;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
51 Ceuta;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
51 Ceuta;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;83,78
51 Ceuta;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
51 Ceuta;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
51 Ceuta;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
51 Ceuta;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;87,55
51 Ceuta;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
51 Ceuta;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
51 Ceuta;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
51 Ceuta;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;81,95
51 Ceuta;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
51 Ceuta;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
51 Ceuta;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
51 Ceuta;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
51 Ceuta;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
51 Ceuta;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
51 Ceuta;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QI;339
51 Ceuta;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
51 Ceuta;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
51 Ceuta;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
51 Ceuta;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QI;321
51 Ceuta;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
51 Ceuta;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
51 Ceuta;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
51 Ceuta;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QI;383
51 Ceuta;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
51 Ceuta;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
51 Ceuta;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2022QII;""
51 Ceuta;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2022QI;330
51 Ceuta;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
51 Ceuta;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
51 Ceuta;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2021QII;""
51 Ceuta;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2021QI;311
51 Ceuta;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
51 Ceuta;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
51 Ceuta;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2020QII;""
51 Ceuta;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2020QI;358
51 Ceuta;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
51 Ceuta;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
51 Ceuta;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2022QII;317
51 Ceuta;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2022QI;""
51 Ceuta;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
51 Ceuta;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
51 Ceuta;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2021QII;306
51 Ceuta;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2021QI;""
51 Ceuta;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
51 Ceuta;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
51 Ceuta;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2020QII;346
51 Ceuta;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2020QI;""
51 Ceuta;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
51 Ceuta;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QIII;296
51 Ceuta;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QII;""
51 Ceuta;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QI;""
51 Ceuta;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
51 Ceuta;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QIII;294
51 Ceuta;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QII;""
51 Ceuta;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QI;""
51 Ceuta;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
51 Ceuta;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QIII;332
51 Ceuta;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QII;""
51 Ceuta;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QI;""
51 Ceuta;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QIV;287
51 Ceuta;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
51 Ceuta;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QII;""
51 Ceuta;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QI;""
51 Ceuta;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QIV;282
51 Ceuta;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
51 Ceuta;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QII;""
51 Ceuta;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QI;""
51 Ceuta;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QIV;311
51 Ceuta;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
51 Ceuta;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QII;""
51 Ceuta;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QI;""
51 Ceuta;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
51 Ceuta;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
51 Ceuta;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
51 Ceuta;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
51 Ceuta;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
51 Ceuta;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
51 Ceuta;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
51 Ceuta;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
51 Ceuta;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
51 Ceuta;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
51 Ceuta;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
51 Ceuta;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
51 Ceuta;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
51 Ceuta;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
51 Ceuta;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
51 Ceuta;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;97,35
51 Ceuta;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
51 Ceuta;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
51 Ceuta;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
51 Ceuta;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;96,88
51 Ceuta;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
51 Ceuta;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
51 Ceuta;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
51 Ceuta;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;93,47
51 Ceuta;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
51 Ceuta;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
51 Ceuta;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;93,51
51 Ceuta;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
51 Ceuta;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
51 Ceuta;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
51 Ceuta;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;95,33
51 Ceuta;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
51 Ceuta;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
51 Ceuta;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
51 Ceuta;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;90,34
51 Ceuta;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
51 Ceuta;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
51 Ceuta;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;87,32
51 Ceuta;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
51 Ceuta;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
51 Ceuta;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
51 Ceuta;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;91,59
51 Ceuta;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
51 Ceuta;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
51 Ceuta;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
51 Ceuta;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;86,68
51 Ceuta;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
51 Ceuta;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
51 Ceuta;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;84,66
51 Ceuta;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
51 Ceuta;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
51 Ceuta;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
51 Ceuta;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;87,85
51 Ceuta;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
51 Ceuta;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
51 Ceuta;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
51 Ceuta;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;81,2
51 Ceuta;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
51 Ceuta;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
51 Ceuta;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
51 Ceuta;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
51 Ceuta;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
51 Ceuta;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
51 Ceuta;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QI;148
51 Ceuta;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
51 Ceuta;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
51 Ceuta;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
51 Ceuta;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QI;137
51 Ceuta;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
51 Ceuta;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
51 Ceuta;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
51 Ceuta;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QI;160
51 Ceuta;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
51 Ceuta;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
51 Ceuta;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2022QII;""
51 Ceuta;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2022QI;142
51 Ceuta;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
51 Ceuta;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
51 Ceuta;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2021QII;""
51 Ceuta;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2021QI;130
51 Ceuta;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
51 Ceuta;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
51 Ceuta;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2020QII;""
51 Ceuta;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2020QI;150
51 Ceuta;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
51 Ceuta;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
51 Ceuta;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2022QII;133
51 Ceuta;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2022QI;""
51 Ceuta;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
51 Ceuta;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
51 Ceuta;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2021QII;124
51 Ceuta;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2021QI;""
51 Ceuta;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
51 Ceuta;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
51 Ceuta;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2020QII;145
51 Ceuta;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2020QI;""
51 Ceuta;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
51 Ceuta;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QIII;129
51 Ceuta;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QII;""
51 Ceuta;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QI;""
51 Ceuta;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
51 Ceuta;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QIII;120
51 Ceuta;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QII;""
51 Ceuta;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QI;""
51 Ceuta;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
51 Ceuta;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QIII;140
51 Ceuta;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QII;""
51 Ceuta;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QI;""
51 Ceuta;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QIV;121
51 Ceuta;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
51 Ceuta;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QII;""
51 Ceuta;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QI;""
51 Ceuta;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QIV;119
51 Ceuta;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
51 Ceuta;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QII;""
51 Ceuta;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QI;""
51 Ceuta;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QIV;134
51 Ceuta;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
51 Ceuta;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QII;""
51 Ceuta;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QI;""
51 Ceuta;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
51 Ceuta;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
51 Ceuta;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
51 Ceuta;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
51 Ceuta;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
51 Ceuta;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
51 Ceuta;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
51 Ceuta;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
51 Ceuta;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
51 Ceuta;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
51 Ceuta;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
51 Ceuta;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
51 Ceuta;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
51 Ceuta;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
51 Ceuta;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
51 Ceuta;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;95,95
51 Ceuta;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
51 Ceuta;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
51 Ceuta;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
51 Ceuta;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;94,89
51 Ceuta;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
51 Ceuta;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
51 Ceuta;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
51 Ceuta;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;93,75
51 Ceuta;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
51 Ceuta;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
51 Ceuta;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;89,86
51 Ceuta;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
51 Ceuta;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
51 Ceuta;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
51 Ceuta;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;90,51
51 Ceuta;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
51 Ceuta;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
51 Ceuta;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
51 Ceuta;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;90,63
51 Ceuta;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
51 Ceuta;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
51 Ceuta;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;87,16
51 Ceuta;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
51 Ceuta;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
51 Ceuta;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
51 Ceuta;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;87,59
51 Ceuta;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
51 Ceuta;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
51 Ceuta;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
51 Ceuta;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;87,5
51 Ceuta;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
51 Ceuta;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
51 Ceuta;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;81,76
51 Ceuta;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
51 Ceuta;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
51 Ceuta;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
51 Ceuta;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;86,86
51 Ceuta;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
51 Ceuta;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
51 Ceuta;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
51 Ceuta;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;83,75
51 Ceuta;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
51 Ceuta;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
51 Ceuta;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
51 Ceuta;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
51 Ceuta;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
51 Ceuta;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QII;555
51 Ceuta;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
51 Ceuta;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
51 Ceuta;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
51 Ceuta;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QII;528
51 Ceuta;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
51 Ceuta;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
51 Ceuta;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
51 Ceuta;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QII;515
51 Ceuta;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
51 Ceuta;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
51 Ceuta;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
51 Ceuta;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2022QII;531
51 Ceuta;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2022QI;""
51 Ceuta;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
51 Ceuta;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
51 Ceuta;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2021QII;513
51 Ceuta;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2021QI;""
51 Ceuta;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
51 Ceuta;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
51 Ceuta;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2020QII;498
51 Ceuta;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2020QI;""
51 Ceuta;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
51 Ceuta;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2022QIII;502
51 Ceuta;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2022QII;""
51 Ceuta;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2022QI;""
51 Ceuta;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
51 Ceuta;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2021QIII;497
51 Ceuta;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2021QII;""
51 Ceuta;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2021QI;""
51 Ceuta;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
51 Ceuta;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2020QIII;479
51 Ceuta;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2020QII;""
51 Ceuta;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2020QI;""
51 Ceuta;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QIV;483
51 Ceuta;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
51 Ceuta;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QII;""
51 Ceuta;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QI;""
51 Ceuta;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QIV;480
51 Ceuta;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
51 Ceuta;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QII;""
51 Ceuta;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QI;""
51 Ceuta;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QIV;451
51 Ceuta;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
51 Ceuta;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QII;""
51 Ceuta;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QI;""
51 Ceuta;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
51 Ceuta;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
51 Ceuta;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QII;""
51 Ceuta;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QI;466
51 Ceuta;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
51 Ceuta;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
51 Ceuta;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QII;""
51 Ceuta;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QI;434
51 Ceuta;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
51 Ceuta;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
51 Ceuta;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QII;""
51 Ceuta;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QI;""
51 Ceuta;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
51 Ceuta;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
51 Ceuta;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
51 Ceuta;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
51 Ceuta;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
51 Ceuta;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
51 Ceuta;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
51 Ceuta;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
51 Ceuta;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
51 Ceuta;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
51 Ceuta;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
51 Ceuta;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
51 Ceuta;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
51 Ceuta;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
51 Ceuta;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;95,68
51 Ceuta;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
51 Ceuta;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
51 Ceuta;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
51 Ceuta;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;97,16
51 Ceuta;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
51 Ceuta;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
51 Ceuta;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
51 Ceuta;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;96,7
51 Ceuta;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
51 Ceuta;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
51 Ceuta;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;90,45
51 Ceuta;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
51 Ceuta;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
51 Ceuta;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
51 Ceuta;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;94,13
51 Ceuta;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
51 Ceuta;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
51 Ceuta;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
51 Ceuta;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;93,01
51 Ceuta;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
51 Ceuta;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
51 Ceuta;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;87,03
51 Ceuta;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
51 Ceuta;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
51 Ceuta;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
51 Ceuta;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;90,91
51 Ceuta;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
51 Ceuta;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
51 Ceuta;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
51 Ceuta;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;87,57
51 Ceuta;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
51 Ceuta;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
51 Ceuta;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
51 Ceuta;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
51 Ceuta;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
51 Ceuta;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
51 Ceuta;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;88,26
51 Ceuta;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
51 Ceuta;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
51 Ceuta;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
51 Ceuta;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;84,27
51 Ceuta;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
51 Ceuta;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
51 Ceuta;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
51 Ceuta;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
51 Ceuta;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
51 Ceuta;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
51 Ceuta;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QII;384
51 Ceuta;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
51 Ceuta;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
51 Ceuta;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
51 Ceuta;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QII;372
51 Ceuta;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
51 Ceuta;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
51 Ceuta;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
51 Ceuta;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QII;364
51 Ceuta;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
51 Ceuta;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
51 Ceuta;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
51 Ceuta;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2022QII;369
51 Ceuta;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2022QI;""
51 Ceuta;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
51 Ceuta;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
51 Ceuta;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2021QII;364
51 Ceuta;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2021QI;""
51 Ceuta;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
51 Ceuta;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
51 Ceuta;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2020QII;352
51 Ceuta;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2020QI;""
51 Ceuta;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
51 Ceuta;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2022QIII;345
51 Ceuta;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2022QII;""
51 Ceuta;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2022QI;""
51 Ceuta;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
51 Ceuta;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2021QIII;352
51 Ceuta;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2021QII;""
51 Ceuta;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2021QI;""
51 Ceuta;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
51 Ceuta;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2020QIII;338
51 Ceuta;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2020QII;""
51 Ceuta;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2020QI;""
51 Ceuta;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QIV;335
51 Ceuta;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
51 Ceuta;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QII;""
51 Ceuta;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QI;""
51 Ceuta;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QIV;336
51 Ceuta;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
51 Ceuta;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QII;""
51 Ceuta;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QI;""
51 Ceuta;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QIV;317
51 Ceuta;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
51 Ceuta;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QII;""
51 Ceuta;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QI;""
51 Ceuta;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
51 Ceuta;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
51 Ceuta;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QII;""
51 Ceuta;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QI;328
51 Ceuta;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
51 Ceuta;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
51 Ceuta;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QII;""
51 Ceuta;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QI;307
51 Ceuta;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
51 Ceuta;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
51 Ceuta;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QII;""
51 Ceuta;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QI;""
51 Ceuta;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
51 Ceuta;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
51 Ceuta;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
51 Ceuta;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
51 Ceuta;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
51 Ceuta;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
51 Ceuta;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
51 Ceuta;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
51 Ceuta;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
51 Ceuta;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
51 Ceuta;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
51 Ceuta;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
51 Ceuta;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
51 Ceuta;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
51 Ceuta;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;96,09
51 Ceuta;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
51 Ceuta;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
51 Ceuta;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
51 Ceuta;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;97,85
51 Ceuta;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
51 Ceuta;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
51 Ceuta;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
51 Ceuta;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;96,7
51 Ceuta;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
51 Ceuta;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
51 Ceuta;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;89,84
51 Ceuta;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
51 Ceuta;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
51 Ceuta;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
51 Ceuta;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;94,62
51 Ceuta;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
51 Ceuta;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
51 Ceuta;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
51 Ceuta;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;92,86
51 Ceuta;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
51 Ceuta;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
51 Ceuta;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;87,24
51 Ceuta;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
51 Ceuta;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
51 Ceuta;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
51 Ceuta;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;90,32
51 Ceuta;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
51 Ceuta;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
51 Ceuta;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
51 Ceuta;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;87,09
51 Ceuta;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
51 Ceuta;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
51 Ceuta;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
51 Ceuta;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
51 Ceuta;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
51 Ceuta;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
51 Ceuta;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;88,17
51 Ceuta;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
51 Ceuta;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
51 Ceuta;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
51 Ceuta;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;84,34
51 Ceuta;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
51 Ceuta;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
51 Ceuta;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
51 Ceuta;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
51 Ceuta;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
51 Ceuta;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
51 Ceuta;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QII;171
51 Ceuta;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
51 Ceuta;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
51 Ceuta;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
51 Ceuta;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QII;156
51 Ceuta;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
51 Ceuta;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
51 Ceuta;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
51 Ceuta;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QII;151
51 Ceuta;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
51 Ceuta;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
51 Ceuta;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
51 Ceuta;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2022QII;162
51 Ceuta;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2022QI;""
51 Ceuta;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
51 Ceuta;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
51 Ceuta;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2021QII;149
51 Ceuta;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2021QI;""
51 Ceuta;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
51 Ceuta;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
51 Ceuta;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2020QII;146
51 Ceuta;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2020QI;""
51 Ceuta;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
51 Ceuta;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2022QIII;157
51 Ceuta;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2022QII;""
51 Ceuta;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2022QI;""
51 Ceuta;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
51 Ceuta;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2021QIII;145
51 Ceuta;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2021QII;""
51 Ceuta;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2021QI;""
51 Ceuta;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
51 Ceuta;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2020QIII;141
51 Ceuta;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2020QII;""
51 Ceuta;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2020QI;""
51 Ceuta;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QIV;148
51 Ceuta;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
51 Ceuta;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QII;""
51 Ceuta;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QI;""
51 Ceuta;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QIV;144
51 Ceuta;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
51 Ceuta;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QII;""
51 Ceuta;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QI;""
51 Ceuta;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QIV;134
51 Ceuta;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
51 Ceuta;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QII;""
51 Ceuta;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QI;""
51 Ceuta;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
51 Ceuta;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
51 Ceuta;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QII;""
51 Ceuta;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QI;138
51 Ceuta;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
51 Ceuta;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
51 Ceuta;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QII;""
51 Ceuta;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QI;127
51 Ceuta;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
51 Ceuta;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
51 Ceuta;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QII;""
51 Ceuta;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QI;""
51 Ceuta;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
51 Ceuta;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
51 Ceuta;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
51 Ceuta;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
51 Ceuta;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
51 Ceuta;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
51 Ceuta;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
51 Ceuta;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
51 Ceuta;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
51 Ceuta;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
51 Ceuta;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
51 Ceuta;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
51 Ceuta;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
51 Ceuta;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
51 Ceuta;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;94,74
51 Ceuta;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
51 Ceuta;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
51 Ceuta;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
51 Ceuta;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;95,51
51 Ceuta;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
51 Ceuta;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
51 Ceuta;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
51 Ceuta;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;96,69
51 Ceuta;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
51 Ceuta;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
51 Ceuta;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;91,81
51 Ceuta;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
51 Ceuta;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
51 Ceuta;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
51 Ceuta;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;92,95
51 Ceuta;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
51 Ceuta;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
51 Ceuta;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
51 Ceuta;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;93,38
51 Ceuta;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
51 Ceuta;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
51 Ceuta;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;86,55
51 Ceuta;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
51 Ceuta;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
51 Ceuta;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
51 Ceuta;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;92,31
51 Ceuta;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
51 Ceuta;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
51 Ceuta;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
51 Ceuta;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;88,74
51 Ceuta;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
51 Ceuta;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
51 Ceuta;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
51 Ceuta;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
51 Ceuta;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
51 Ceuta;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
51 Ceuta;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;88,46
51 Ceuta;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
51 Ceuta;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
51 Ceuta;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
51 Ceuta;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;84,11
51 Ceuta;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
51 Ceuta;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
51 Ceuta;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
51 Ceuta;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
51 Ceuta;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
51 Ceuta;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QIII;537
51 Ceuta;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
51 Ceuta;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
51 Ceuta;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
51 Ceuta;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QIII;515
51 Ceuta;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
51 Ceuta;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
51 Ceuta;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
51 Ceuta;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QIII;498
51 Ceuta;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
51 Ceuta;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
51 Ceuta;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
51 Ceuta;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2022QIII;508
51 Ceuta;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2022QII;""
51 Ceuta;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2022QI;""
51 Ceuta;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
51 Ceuta;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2021QIII;499
51 Ceuta;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2021QII;""
51 Ceuta;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2021QI;""
51 Ceuta;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
51 Ceuta;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2020QIII;479
51 Ceuta;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2020QII;""
51 Ceuta;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2020QI;""
51 Ceuta;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2022QIV;488
51 Ceuta;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
51 Ceuta;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2022QII;""
51 Ceuta;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2022QI;""
51 Ceuta;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2021QIV;482
51 Ceuta;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
51 Ceuta;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2021QII;""
51 Ceuta;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2021QI;""
51 Ceuta;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2020QIV;451
51 Ceuta;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
51 Ceuta;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2020QII;""
51 Ceuta;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2020QI;""
51 Ceuta;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
51 Ceuta;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
51 Ceuta;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QII;""
51 Ceuta;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QI;468
51 Ceuta;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
51 Ceuta;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
51 Ceuta;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QII;""
51 Ceuta;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QI;434
51 Ceuta;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
51 Ceuta;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
51 Ceuta;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QII;""
51 Ceuta;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QI;""
51 Ceuta;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
51 Ceuta;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
51 Ceuta;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QII;447
51 Ceuta;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QI;""
51 Ceuta;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
51 Ceuta;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
51 Ceuta;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QII;423
51 Ceuta;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QI;""
51 Ceuta;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
51 Ceuta;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
51 Ceuta;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QII;""
51 Ceuta;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QI;""
51 Ceuta;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
51 Ceuta;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
51 Ceuta;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
51 Ceuta;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
51 Ceuta;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
51 Ceuta;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
51 Ceuta;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
51 Ceuta;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
51 Ceuta;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
51 Ceuta;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
51 Ceuta;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
51 Ceuta;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
51 Ceuta;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
51 Ceuta;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;94,6
51 Ceuta;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
51 Ceuta;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
51 Ceuta;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
51 Ceuta;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;96,89
51 Ceuta;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
51 Ceuta;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
51 Ceuta;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
51 Ceuta;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;96,18
51 Ceuta;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
51 Ceuta;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
51 Ceuta;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;90,88
51 Ceuta;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
51 Ceuta;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
51 Ceuta;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
51 Ceuta;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;93,59
51 Ceuta;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
51 Ceuta;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
51 Ceuta;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
51 Ceuta;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;90,56
51 Ceuta;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
51 Ceuta;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
51 Ceuta;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
51 Ceuta;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
51 Ceuta;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
51 Ceuta;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
51 Ceuta;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;90,87
51 Ceuta;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
51 Ceuta;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
51 Ceuta;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
51 Ceuta;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;87,15
51 Ceuta;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
51 Ceuta;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
51 Ceuta;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
51 Ceuta;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
51 Ceuta;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
51 Ceuta;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
51 Ceuta;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;86,8
51 Ceuta;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
51 Ceuta;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
51 Ceuta;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
51 Ceuta;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;84,94
51 Ceuta;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
51 Ceuta;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
51 Ceuta;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
51 Ceuta;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
51 Ceuta;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
51 Ceuta;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
51 Ceuta;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QIII;374
51 Ceuta;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
51 Ceuta;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
51 Ceuta;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
51 Ceuta;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QIII;365
51 Ceuta;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
51 Ceuta;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
51 Ceuta;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
51 Ceuta;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QIII;352
51 Ceuta;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
51 Ceuta;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
51 Ceuta;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
51 Ceuta;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2022QIII;350
51 Ceuta;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2022QII;""
51 Ceuta;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2022QI;""
51 Ceuta;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
51 Ceuta;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2021QIII;353
51 Ceuta;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2021QII;""
51 Ceuta;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2021QI;""
51 Ceuta;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
51 Ceuta;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2020QIII;338
51 Ceuta;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2020QII;""
51 Ceuta;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2020QI;""
51 Ceuta;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2022QIV;339
51 Ceuta;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
51 Ceuta;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2022QII;""
51 Ceuta;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2022QI;""
51 Ceuta;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2021QIV;337
51 Ceuta;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
51 Ceuta;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2021QII;""
51 Ceuta;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2021QI;""
51 Ceuta;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2020QIV;317
51 Ceuta;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
51 Ceuta;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2020QII;""
51 Ceuta;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2020QI;""
51 Ceuta;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
51 Ceuta;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
51 Ceuta;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QII;""
51 Ceuta;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QI;329
51 Ceuta;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
51 Ceuta;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
51 Ceuta;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QII;""
51 Ceuta;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QI;307
51 Ceuta;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
51 Ceuta;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
51 Ceuta;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QII;""
51 Ceuta;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QI;""
51 Ceuta;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
51 Ceuta;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
51 Ceuta;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QII;316
51 Ceuta;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QI;""
51 Ceuta;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
51 Ceuta;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
51 Ceuta;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QII;302
51 Ceuta;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QI;""
51 Ceuta;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
51 Ceuta;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
51 Ceuta;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QII;""
51 Ceuta;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QI;""
51 Ceuta;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
51 Ceuta;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
51 Ceuta;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
51 Ceuta;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
51 Ceuta;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
51 Ceuta;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
51 Ceuta;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
51 Ceuta;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
51 Ceuta;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
51 Ceuta;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
51 Ceuta;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
51 Ceuta;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
51 Ceuta;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
51 Ceuta;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;93,58
51 Ceuta;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
51 Ceuta;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
51 Ceuta;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
51 Ceuta;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;96,71
51 Ceuta;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
51 Ceuta;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
51 Ceuta;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
51 Ceuta;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;96,02
51 Ceuta;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
51 Ceuta;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
51 Ceuta;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;90,64
51 Ceuta;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
51 Ceuta;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
51 Ceuta;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
51 Ceuta;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;92,33
51 Ceuta;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
51 Ceuta;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
51 Ceuta;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
51 Ceuta;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;90,06
51 Ceuta;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
51 Ceuta;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
51 Ceuta;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
51 Ceuta;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
51 Ceuta;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
51 Ceuta;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
51 Ceuta;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;90,14
51 Ceuta;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
51 Ceuta;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
51 Ceuta;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
51 Ceuta;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;87,22
51 Ceuta;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
51 Ceuta;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
51 Ceuta;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
51 Ceuta;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
51 Ceuta;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
51 Ceuta;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
51 Ceuta;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;86,58
51 Ceuta;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
51 Ceuta;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
51 Ceuta;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
51 Ceuta;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;85,8
51 Ceuta;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
51 Ceuta;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
51 Ceuta;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
51 Ceuta;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
51 Ceuta;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
51 Ceuta;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
51 Ceuta;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QIII;163
51 Ceuta;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
51 Ceuta;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
51 Ceuta;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
51 Ceuta;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QIII;150
51 Ceuta;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
51 Ceuta;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
51 Ceuta;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
51 Ceuta;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QIII;146
51 Ceuta;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
51 Ceuta;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
51 Ceuta;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
51 Ceuta;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2022QIII;158
51 Ceuta;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2022QII;""
51 Ceuta;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2022QI;""
51 Ceuta;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
51 Ceuta;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2021QIII;146
51 Ceuta;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2021QII;""
51 Ceuta;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2021QI;""
51 Ceuta;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
51 Ceuta;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2020QIII;141
51 Ceuta;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2020QII;""
51 Ceuta;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2020QI;""
51 Ceuta;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2022QIV;149
51 Ceuta;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
51 Ceuta;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2022QII;""
51 Ceuta;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2022QI;""
51 Ceuta;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2021QIV;145
51 Ceuta;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
51 Ceuta;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2021QII;""
51 Ceuta;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2021QI;""
51 Ceuta;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2020QIV;134
51 Ceuta;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
51 Ceuta;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2020QII;""
51 Ceuta;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2020QI;""
51 Ceuta;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
51 Ceuta;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
51 Ceuta;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QII;""
51 Ceuta;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QI;139
51 Ceuta;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
51 Ceuta;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
51 Ceuta;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QII;""
51 Ceuta;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QI;127
51 Ceuta;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
51 Ceuta;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
51 Ceuta;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QII;""
51 Ceuta;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QI;""
51 Ceuta;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
51 Ceuta;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
51 Ceuta;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QII;131
51 Ceuta;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QI;""
51 Ceuta;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
51 Ceuta;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
51 Ceuta;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QII;121
51 Ceuta;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QI;""
51 Ceuta;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
51 Ceuta;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
51 Ceuta;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QII;""
51 Ceuta;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QI;""
51 Ceuta;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
51 Ceuta;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
51 Ceuta;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
51 Ceuta;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
51 Ceuta;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
51 Ceuta;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
51 Ceuta;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
51 Ceuta;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
51 Ceuta;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
51 Ceuta;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
51 Ceuta;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
51 Ceuta;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
51 Ceuta;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
51 Ceuta;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;96,93
51 Ceuta;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
51 Ceuta;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
51 Ceuta;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
51 Ceuta;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;97,33
51 Ceuta;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
51 Ceuta;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
51 Ceuta;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
51 Ceuta;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;96,58
51 Ceuta;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
51 Ceuta;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
51 Ceuta;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;91,41
51 Ceuta;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
51 Ceuta;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
51 Ceuta;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
51 Ceuta;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;96,67
51 Ceuta;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
51 Ceuta;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
51 Ceuta;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
51 Ceuta;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;91,78
51 Ceuta;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
51 Ceuta;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
51 Ceuta;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
51 Ceuta;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
51 Ceuta;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
51 Ceuta;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
51 Ceuta;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;92,67
51 Ceuta;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
51 Ceuta;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
51 Ceuta;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
51 Ceuta;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;86,99
51 Ceuta;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
51 Ceuta;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
51 Ceuta;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
51 Ceuta;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
51 Ceuta;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
51 Ceuta;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
51 Ceuta;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;87,33
51 Ceuta;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
51 Ceuta;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
51 Ceuta;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
51 Ceuta;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;82,88
51 Ceuta;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
51 Ceuta;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
51 Ceuta;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
51 Ceuta;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
51 Ceuta;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
51 Ceuta;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QIV;516
51 Ceuta;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
51 Ceuta;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
51 Ceuta;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
51 Ceuta;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QIV;499
51 Ceuta;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
51 Ceuta;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
51 Ceuta;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
51 Ceuta;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QIV;481
51 Ceuta;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
51 Ceuta;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
51 Ceuta;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
51 Ceuta;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2022QIV;495
51 Ceuta;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
51 Ceuta;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2022QII;""
51 Ceuta;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2022QI;""
51 Ceuta;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2021QIV;482
51 Ceuta;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
51 Ceuta;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2021QII;""
51 Ceuta;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2021QI;""
51 Ceuta;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2020QIV;453
51 Ceuta;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
51 Ceuta;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2020QII;""
51 Ceuta;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2020QI;""
51 Ceuta;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
51 Ceuta;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
51 Ceuta;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2022QII;""
51 Ceuta;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2022QI;468
51 Ceuta;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
51 Ceuta;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
51 Ceuta;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2021QII;""
51 Ceuta;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2021QI;436
51 Ceuta;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
51 Ceuta;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
51 Ceuta;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2020QII;""
51 Ceuta;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2020QI;""
51 Ceuta;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
51 Ceuta;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
51 Ceuta;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QII;447
51 Ceuta;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QI;""
51 Ceuta;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
51 Ceuta;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
51 Ceuta;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QII;425
51 Ceuta;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QI;""
51 Ceuta;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
51 Ceuta;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
51 Ceuta;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QII;""
51 Ceuta;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QI;""
51 Ceuta;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
51 Ceuta;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QIII;422
51 Ceuta;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QII;""
51 Ceuta;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QI;""
51 Ceuta;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
51 Ceuta;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QIII;410
51 Ceuta;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QII;""
51 Ceuta;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QI;""
51 Ceuta;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
51 Ceuta;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
51 Ceuta;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QII;""
51 Ceuta;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QI;""
51 Ceuta;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
51 Ceuta;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
51 Ceuta;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
51 Ceuta;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
51 Ceuta;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
51 Ceuta;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
51 Ceuta;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
51 Ceuta;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
51 Ceuta;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
51 Ceuta;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
51 Ceuta;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
51 Ceuta;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
51 Ceuta;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;95,93
51 Ceuta;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
51 Ceuta;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
51 Ceuta;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
51 Ceuta;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;96,59
51 Ceuta;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
51 Ceuta;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
51 Ceuta;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
51 Ceuta;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;94,18
51 Ceuta;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
51 Ceuta;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
51 Ceuta;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
51 Ceuta;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
51 Ceuta;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
51 Ceuta;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
51 Ceuta;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;93,79
51 Ceuta;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
51 Ceuta;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
51 Ceuta;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
51 Ceuta;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;90,64
51 Ceuta;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
51 Ceuta;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
51 Ceuta;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
51 Ceuta;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
51 Ceuta;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
51 Ceuta;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
51 Ceuta;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;89,58
51 Ceuta;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
51 Ceuta;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
51 Ceuta;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
51 Ceuta;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;88,36
51 Ceuta;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
51 Ceuta;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
51 Ceuta;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
51 Ceuta;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
51 Ceuta;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
51 Ceuta;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
51 Ceuta;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;84,57
51 Ceuta;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
51 Ceuta;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
51 Ceuta;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
51 Ceuta;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;85,24
51 Ceuta;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
51 Ceuta;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
51 Ceuta;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
51 Ceuta;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
51 Ceuta;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
51 Ceuta;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
51 Ceuta;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QIV;357
51 Ceuta;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
51 Ceuta;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
51 Ceuta;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
51 Ceuta;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QIV;353
51 Ceuta;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
51 Ceuta;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
51 Ceuta;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
51 Ceuta;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QIV;339
51 Ceuta;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
51 Ceuta;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
51 Ceuta;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
51 Ceuta;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2022QIV;345
51 Ceuta;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
51 Ceuta;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2022QII;""
51 Ceuta;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2022QI;""
51 Ceuta;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2021QIV;337
51 Ceuta;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
51 Ceuta;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2021QII;""
51 Ceuta;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2021QI;""
51 Ceuta;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2020QIV;318
51 Ceuta;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
51 Ceuta;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2020QII;""
51 Ceuta;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2020QI;""
51 Ceuta;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
51 Ceuta;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
51 Ceuta;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2022QII;""
51 Ceuta;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2022QI;329
51 Ceuta;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
51 Ceuta;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
51 Ceuta;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2021QII;""
51 Ceuta;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2021QI;308
51 Ceuta;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
51 Ceuta;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
51 Ceuta;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2020QII;""
51 Ceuta;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2020QI;""
51 Ceuta;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
51 Ceuta;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
51 Ceuta;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QII;316
51 Ceuta;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QI;""
51 Ceuta;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
51 Ceuta;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
51 Ceuta;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QII;303
51 Ceuta;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QI;""
51 Ceuta;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
51 Ceuta;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
51 Ceuta;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QII;""
51 Ceuta;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QI;""
51 Ceuta;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
51 Ceuta;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QIII;295
51 Ceuta;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QII;""
51 Ceuta;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QI;""
51 Ceuta;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
51 Ceuta;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QIII;292
51 Ceuta;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QII;""
51 Ceuta;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QI;""
51 Ceuta;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
51 Ceuta;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
51 Ceuta;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QII;""
51 Ceuta;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QI;""
51 Ceuta;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
51 Ceuta;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
51 Ceuta;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
51 Ceuta;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
51 Ceuta;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
51 Ceuta;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
51 Ceuta;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
51 Ceuta;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
51 Ceuta;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
51 Ceuta;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
51 Ceuta;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
51 Ceuta;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
51 Ceuta;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;96,64
51 Ceuta;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
51 Ceuta;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
51 Ceuta;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
51 Ceuta;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;95,47
51 Ceuta;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
51 Ceuta;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
51 Ceuta;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
51 Ceuta;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;93,81
51 Ceuta;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
51 Ceuta;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
51 Ceuta;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
51 Ceuta;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
51 Ceuta;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
51 Ceuta;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
51 Ceuta;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;93,2
51 Ceuta;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
51 Ceuta;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
51 Ceuta;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
51 Ceuta;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;90,86
51 Ceuta;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
51 Ceuta;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
51 Ceuta;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
51 Ceuta;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
51 Ceuta;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
51 Ceuta;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
51 Ceuta;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;89,52
51 Ceuta;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
51 Ceuta;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
51 Ceuta;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
51 Ceuta;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;89,38
51 Ceuta;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
51 Ceuta;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
51 Ceuta;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
51 Ceuta;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
51 Ceuta;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
51 Ceuta;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
51 Ceuta;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;83,57
51 Ceuta;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
51 Ceuta;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
51 Ceuta;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
51 Ceuta;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;86,14
51 Ceuta;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
51 Ceuta;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
51 Ceuta;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
51 Ceuta;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
51 Ceuta;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
51 Ceuta;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
51 Ceuta;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QIV;159
51 Ceuta;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
51 Ceuta;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
51 Ceuta;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
51 Ceuta;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QIV;146
51 Ceuta;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
51 Ceuta;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
51 Ceuta;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
51 Ceuta;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QIV;142
51 Ceuta;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
51 Ceuta;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
51 Ceuta;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
51 Ceuta;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2022QIV;150
51 Ceuta;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
51 Ceuta;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2022QII;""
51 Ceuta;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2022QI;""
51 Ceuta;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2021QIV;145
51 Ceuta;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
51 Ceuta;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2021QII;""
51 Ceuta;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2021QI;""
51 Ceuta;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2020QIV;135
51 Ceuta;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
51 Ceuta;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2020QII;""
51 Ceuta;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2020QI;""
51 Ceuta;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
51 Ceuta;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
51 Ceuta;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2022QII;""
51 Ceuta;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2022QI;139
51 Ceuta;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
51 Ceuta;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
51 Ceuta;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2021QII;""
51 Ceuta;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2021QI;128
51 Ceuta;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
51 Ceuta;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
51 Ceuta;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2020QII;""
51 Ceuta;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2020QI;""
51 Ceuta;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
51 Ceuta;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
51 Ceuta;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QII;131
51 Ceuta;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QI;""
51 Ceuta;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
51 Ceuta;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
51 Ceuta;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QII;122
51 Ceuta;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QI;""
51 Ceuta;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
51 Ceuta;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
51 Ceuta;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QII;""
51 Ceuta;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QI;""
51 Ceuta;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
51 Ceuta;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QIII;127
51 Ceuta;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QII;""
51 Ceuta;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QI;""
51 Ceuta;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
51 Ceuta;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QIII;118
51 Ceuta;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QII;""
51 Ceuta;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QI;""
51 Ceuta;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
51 Ceuta;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
51 Ceuta;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QII;""
51 Ceuta;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QI;""
51 Ceuta;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
51 Ceuta;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
51 Ceuta;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
51 Ceuta;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
51 Ceuta;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
51 Ceuta;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
51 Ceuta;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
51 Ceuta;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
51 Ceuta;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
51 Ceuta;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
51 Ceuta;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
51 Ceuta;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
51 Ceuta;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;94,34
51 Ceuta;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
51 Ceuta;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
51 Ceuta;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
51 Ceuta;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;99,32
51 Ceuta;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
51 Ceuta;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
51 Ceuta;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
51 Ceuta;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;95,07
51 Ceuta;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
51 Ceuta;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
51 Ceuta;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
51 Ceuta;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
51 Ceuta;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
51 Ceuta;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
51 Ceuta;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;95,21
51 Ceuta;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
51 Ceuta;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
51 Ceuta;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
51 Ceuta;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;90,14
51 Ceuta;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
51 Ceuta;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
51 Ceuta;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
51 Ceuta;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
51 Ceuta;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
51 Ceuta;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
51 Ceuta;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;89,73
51 Ceuta;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
51 Ceuta;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
51 Ceuta;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
51 Ceuta;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;85,92
51 Ceuta;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
51 Ceuta;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
51 Ceuta;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
51 Ceuta;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
51 Ceuta;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
51 Ceuta;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
51 Ceuta;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;86,99
51 Ceuta;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
51 Ceuta;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
51 Ceuta;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
51 Ceuta;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;83,1
51 Ceuta;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
51 Ceuta;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
51 Ceuta;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
51 Ceuta;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
51 Ceuta;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
51 Ceuta;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
52 Melilla;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
52 Melilla;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
52 Melilla;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
52 Melilla;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QI;4.434
52 Melilla;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
52 Melilla;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
52 Melilla;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
52 Melilla;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QI;4.523
52 Melilla;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
52 Melilla;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
52 Melilla;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
52 Melilla;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QI;4.683
52 Melilla;All ages;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
52 Melilla;All ages;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
52 Melilla;All ages;Cohort January 1;Total;Survival in the first trimester;2022QII;""
52 Melilla;All ages;Cohort January 1;Total;Survival in the first trimester;2022QI;4.215
52 Melilla;All ages;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
52 Melilla;All ages;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
52 Melilla;All ages;Cohort January 1;Total;Survival in the first trimester;2021QII;""
52 Melilla;All ages;Cohort January 1;Total;Survival in the first trimester;2021QI;4.352
52 Melilla;All ages;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
52 Melilla;All ages;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
52 Melilla;All ages;Cohort January 1;Total;Survival in the first trimester;2020QII;""
52 Melilla;All ages;Cohort January 1;Total;Survival in the first trimester;2020QI;4.398
52 Melilla;All ages;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
52 Melilla;All ages;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
52 Melilla;All ages;Cohort January 1;Total;Survival in the second trimester;2022QII;4.014
52 Melilla;All ages;Cohort January 1;Total;Survival in the second trimester;2022QI;""
52 Melilla;All ages;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
52 Melilla;All ages;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
52 Melilla;All ages;Cohort January 1;Total;Survival in the second trimester;2021QII;4.173
52 Melilla;All ages;Cohort January 1;Total;Survival in the second trimester;2021QI;""
52 Melilla;All ages;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
52 Melilla;All ages;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
52 Melilla;All ages;Cohort January 1;Total;Survival in the second trimester;2020QII;4.299
52 Melilla;All ages;Cohort January 1;Total;Survival in the second trimester;2020QI;""
52 Melilla;All ages;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
52 Melilla;All ages;Cohort January 1;Total;Survival in the third trimester;2022QIII;3.864
52 Melilla;All ages;Cohort January 1;Total;Survival in the third trimester;2022QII;""
52 Melilla;All ages;Cohort January 1;Total;Survival in the third trimester;2022QI;""
52 Melilla;All ages;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
52 Melilla;All ages;Cohort January 1;Total;Survival in the third trimester;2021QIII;3.992
52 Melilla;All ages;Cohort January 1;Total;Survival in the third trimester;2021QII;""
52 Melilla;All ages;Cohort January 1;Total;Survival in the third trimester;2021QI;""
52 Melilla;All ages;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
52 Melilla;All ages;Cohort January 1;Total;Survival in the third trimester;2020QIII;4.072
52 Melilla;All ages;Cohort January 1;Total;Survival in the third trimester;2020QII;""
52 Melilla;All ages;Cohort January 1;Total;Survival in the third trimester;2020QI;""
52 Melilla;All ages;Cohort January 1;Total;Survival in the third trimester;2022QIV;3.702
52 Melilla;All ages;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
52 Melilla;All ages;Cohort January 1;Total;Survival in the third trimester;2022QII;""
52 Melilla;All ages;Cohort January 1;Total;Survival in the third trimester;2022QI;""
52 Melilla;All ages;Cohort January 1;Total;Survival in the third trimester;2021QIV;3.839
52 Melilla;All ages;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
52 Melilla;All ages;Cohort January 1;Total;Survival in the third trimester;2021QII;""
52 Melilla;All ages;Cohort January 1;Total;Survival in the third trimester;2021QI;""
52 Melilla;All ages;Cohort January 1;Total;Survival in the third trimester;2020QIV;3.902
52 Melilla;All ages;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
52 Melilla;All ages;Cohort January 1;Total;Survival in the third trimester;2020QII;""
52 Melilla;All ages;Cohort January 1;Total;Survival in the third trimester;2020QI;""
52 Melilla;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
52 Melilla;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
52 Melilla;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
52 Melilla;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
52 Melilla;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
52 Melilla;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
52 Melilla;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
52 Melilla;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
52 Melilla;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
52 Melilla;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
52 Melilla;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
52 Melilla;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
52 Melilla;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
52 Melilla;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
52 Melilla;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
52 Melilla;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;95,06
52 Melilla;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
52 Melilla;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
52 Melilla;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
52 Melilla;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;96,22
52 Melilla;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
52 Melilla;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
52 Melilla;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
52 Melilla;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;93,91
52 Melilla;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
52 Melilla;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
52 Melilla;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;90,53
52 Melilla;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
52 Melilla;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
52 Melilla;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
52 Melilla;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;92,26
52 Melilla;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
52 Melilla;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
52 Melilla;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
52 Melilla;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;91,8
52 Melilla;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
52 Melilla;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
52 Melilla;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;87,14
52 Melilla;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
52 Melilla;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
52 Melilla;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
52 Melilla;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;88,26
52 Melilla;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
52 Melilla;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
52 Melilla;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
52 Melilla;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;86,95
52 Melilla;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
52 Melilla;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
52 Melilla;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;83,49
52 Melilla;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
52 Melilla;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
52 Melilla;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
52 Melilla;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;84,88
52 Melilla;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
52 Melilla;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
52 Melilla;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
52 Melilla;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;83,32
52 Melilla;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
52 Melilla;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
52 Melilla;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
52 Melilla;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
52 Melilla;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
52 Melilla;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
52 Melilla;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QI;3.091
52 Melilla;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
52 Melilla;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
52 Melilla;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
52 Melilla;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QI;3.221
52 Melilla;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
52 Melilla;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
52 Melilla;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
52 Melilla;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QI;3.346
52 Melilla;All ages;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
52 Melilla;All ages;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
52 Melilla;All ages;Cohort January 1;Males;Survival in the first trimester;2022QII;""
52 Melilla;All ages;Cohort January 1;Males;Survival in the first trimester;2022QI;2.954
52 Melilla;All ages;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
52 Melilla;All ages;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
52 Melilla;All ages;Cohort January 1;Males;Survival in the first trimester;2021QII;""
52 Melilla;All ages;Cohort January 1;Males;Survival in the first trimester;2021QI;3.097
52 Melilla;All ages;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
52 Melilla;All ages;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
52 Melilla;All ages;Cohort January 1;Males;Survival in the first trimester;2020QII;""
52 Melilla;All ages;Cohort January 1;Males;Survival in the first trimester;2020QI;3.160
52 Melilla;All ages;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
52 Melilla;All ages;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
52 Melilla;All ages;Cohort January 1;Males;Survival in the second trimester;2022QII;2.835
52 Melilla;All ages;Cohort January 1;Males;Survival in the second trimester;2022QI;""
52 Melilla;All ages;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
52 Melilla;All ages;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
52 Melilla;All ages;Cohort January 1;Males;Survival in the second trimester;2021QII;2.973
52 Melilla;All ages;Cohort January 1;Males;Survival in the second trimester;2021QI;""
52 Melilla;All ages;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
52 Melilla;All ages;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
52 Melilla;All ages;Cohort January 1;Males;Survival in the second trimester;2020QII;3.089
52 Melilla;All ages;Cohort January 1;Males;Survival in the second trimester;2020QI;""
52 Melilla;All ages;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
52 Melilla;All ages;Cohort January 1;Males;Survival in the third trimester;2022QIII;2.737
52 Melilla;All ages;Cohort January 1;Males;Survival in the third trimester;2022QII;""
52 Melilla;All ages;Cohort January 1;Males;Survival in the third trimester;2022QI;""
52 Melilla;All ages;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
52 Melilla;All ages;Cohort January 1;Males;Survival in the third trimester;2021QIII;2.849
52 Melilla;All ages;Cohort January 1;Males;Survival in the third trimester;2021QII;""
52 Melilla;All ages;Cohort January 1;Males;Survival in the third trimester;2021QI;""
52 Melilla;All ages;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
52 Melilla;All ages;Cohort January 1;Males;Survival in the third trimester;2020QIII;2.940
52 Melilla;All ages;Cohort January 1;Males;Survival in the third trimester;2020QII;""
52 Melilla;All ages;Cohort January 1;Males;Survival in the third trimester;2020QI;""
52 Melilla;All ages;Cohort January 1;Males;Survival in the third trimester;2022QIV;2.626
52 Melilla;All ages;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
52 Melilla;All ages;Cohort January 1;Males;Survival in the third trimester;2022QII;""
52 Melilla;All ages;Cohort January 1;Males;Survival in the third trimester;2022QI;""
52 Melilla;All ages;Cohort January 1;Males;Survival in the third trimester;2021QIV;2.752
52 Melilla;All ages;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
52 Melilla;All ages;Cohort January 1;Males;Survival in the third trimester;2021QII;""
52 Melilla;All ages;Cohort January 1;Males;Survival in the third trimester;2021QI;""
52 Melilla;All ages;Cohort January 1;Males;Survival in the third trimester;2020QIV;2.822
52 Melilla;All ages;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
52 Melilla;All ages;Cohort January 1;Males;Survival in the third trimester;2020QII;""
52 Melilla;All ages;Cohort January 1;Males;Survival in the third trimester;2020QI;""
52 Melilla;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
52 Melilla;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
52 Melilla;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
52 Melilla;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
52 Melilla;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
52 Melilla;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
52 Melilla;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
52 Melilla;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
52 Melilla;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
52 Melilla;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
52 Melilla;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
52 Melilla;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
52 Melilla;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
52 Melilla;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
52 Melilla;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
52 Melilla;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;95,57
52 Melilla;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
52 Melilla;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
52 Melilla;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
52 Melilla;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;96,15
52 Melilla;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
52 Melilla;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
52 Melilla;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
52 Melilla;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;94,44
52 Melilla;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
52 Melilla;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
52 Melilla;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;91,72
52 Melilla;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
52 Melilla;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
52 Melilla;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
52 Melilla;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;92,3
52 Melilla;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
52 Melilla;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
52 Melilla;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
52 Melilla;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;92,32
52 Melilla;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
52 Melilla;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
52 Melilla;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;88,55
52 Melilla;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
52 Melilla;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
52 Melilla;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
52 Melilla;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;88,45
52 Melilla;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
52 Melilla;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
52 Melilla;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
52 Melilla;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;87,87
52 Melilla;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
52 Melilla;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
52 Melilla;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;84,96
52 Melilla;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
52 Melilla;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
52 Melilla;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
52 Melilla;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;85,44
52 Melilla;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
52 Melilla;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
52 Melilla;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
52 Melilla;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;84,34
52 Melilla;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
52 Melilla;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
52 Melilla;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
52 Melilla;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
52 Melilla;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
52 Melilla;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
52 Melilla;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QI;1.343
52 Melilla;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
52 Melilla;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
52 Melilla;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
52 Melilla;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QI;1.302
52 Melilla;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
52 Melilla;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
52 Melilla;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
52 Melilla;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QI;1.337
52 Melilla;All ages;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
52 Melilla;All ages;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
52 Melilla;All ages;Cohort January 1;Females;Survival in the first trimester;2022QII;""
52 Melilla;All ages;Cohort January 1;Females;Survival in the first trimester;2022QI;1.261
52 Melilla;All ages;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
52 Melilla;All ages;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
52 Melilla;All ages;Cohort January 1;Females;Survival in the first trimester;2021QII;""
52 Melilla;All ages;Cohort January 1;Females;Survival in the first trimester;2021QI;1.255
52 Melilla;All ages;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
52 Melilla;All ages;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
52 Melilla;All ages;Cohort January 1;Females;Survival in the first trimester;2020QII;""
52 Melilla;All ages;Cohort January 1;Females;Survival in the first trimester;2020QI;1.238
52 Melilla;All ages;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
52 Melilla;All ages;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
52 Melilla;All ages;Cohort January 1;Females;Survival in the second trimester;2022QII;1.179
52 Melilla;All ages;Cohort January 1;Females;Survival in the second trimester;2022QI;""
52 Melilla;All ages;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
52 Melilla;All ages;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
52 Melilla;All ages;Cohort January 1;Females;Survival in the second trimester;2021QII;1.200
52 Melilla;All ages;Cohort January 1;Females;Survival in the second trimester;2021QI;""
52 Melilla;All ages;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
52 Melilla;All ages;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
52 Melilla;All ages;Cohort January 1;Females;Survival in the second trimester;2020QII;1.210
52 Melilla;All ages;Cohort January 1;Females;Survival in the second trimester;2020QI;""
52 Melilla;All ages;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
52 Melilla;All ages;Cohort January 1;Females;Survival in the third trimester;2022QIII;1.127
52 Melilla;All ages;Cohort January 1;Females;Survival in the third trimester;2022QII;""
52 Melilla;All ages;Cohort January 1;Females;Survival in the third trimester;2022QI;""
52 Melilla;All ages;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
52 Melilla;All ages;Cohort January 1;Females;Survival in the third trimester;2021QIII;1.143
52 Melilla;All ages;Cohort January 1;Females;Survival in the third trimester;2021QII;""
52 Melilla;All ages;Cohort January 1;Females;Survival in the third trimester;2021QI;""
52 Melilla;All ages;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
52 Melilla;All ages;Cohort January 1;Females;Survival in the third trimester;2020QIII;1.132
52 Melilla;All ages;Cohort January 1;Females;Survival in the third trimester;2020QII;""
52 Melilla;All ages;Cohort January 1;Females;Survival in the third trimester;2020QI;""
52 Melilla;All ages;Cohort January 1;Females;Survival in the third trimester;2022QIV;1.076
52 Melilla;All ages;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
52 Melilla;All ages;Cohort January 1;Females;Survival in the third trimester;2022QII;""
52 Melilla;All ages;Cohort January 1;Females;Survival in the third trimester;2022QI;""
52 Melilla;All ages;Cohort January 1;Females;Survival in the third trimester;2021QIV;1.087
52 Melilla;All ages;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
52 Melilla;All ages;Cohort January 1;Females;Survival in the third trimester;2021QII;""
52 Melilla;All ages;Cohort January 1;Females;Survival in the third trimester;2021QI;""
52 Melilla;All ages;Cohort January 1;Females;Survival in the third trimester;2020QIV;1.080
52 Melilla;All ages;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
52 Melilla;All ages;Cohort January 1;Females;Survival in the third trimester;2020QII;""
52 Melilla;All ages;Cohort January 1;Females;Survival in the third trimester;2020QI;""
52 Melilla;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
52 Melilla;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
52 Melilla;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
52 Melilla;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
52 Melilla;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
52 Melilla;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
52 Melilla;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
52 Melilla;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
52 Melilla;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
52 Melilla;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
52 Melilla;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
52 Melilla;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
52 Melilla;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
52 Melilla;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
52 Melilla;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
52 Melilla;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;93,89
52 Melilla;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
52 Melilla;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
52 Melilla;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
52 Melilla;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;96,39
52 Melilla;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
52 Melilla;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
52 Melilla;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
52 Melilla;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;92,6
52 Melilla;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
52 Melilla;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
52 Melilla;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;87,79
52 Melilla;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
52 Melilla;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
52 Melilla;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
52 Melilla;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;92,17
52 Melilla;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
52 Melilla;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
52 Melilla;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
52 Melilla;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;90,5
52 Melilla;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
52 Melilla;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
52 Melilla;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;83,92
52 Melilla;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
52 Melilla;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
52 Melilla;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
52 Melilla;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;87,79
52 Melilla;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
52 Melilla;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
52 Melilla;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
52 Melilla;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;84,67
52 Melilla;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
52 Melilla;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
52 Melilla;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;80,12
52 Melilla;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
52 Melilla;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
52 Melilla;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
52 Melilla;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;83,49
52 Melilla;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
52 Melilla;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
52 Melilla;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
52 Melilla;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;80,78
52 Melilla;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
52 Melilla;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
52 Melilla;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
52 Melilla;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
52 Melilla;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
52 Melilla;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QII;4.387
52 Melilla;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
52 Melilla;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
52 Melilla;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
52 Melilla;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QII;4.536
52 Melilla;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
52 Melilla;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
52 Melilla;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
52 Melilla;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QII;4.695
52 Melilla;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
52 Melilla;All ages;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
52 Melilla;All ages;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
52 Melilla;All ages;Cohort April 1;Total;Survival in the first trimester;2022QII;4.172
52 Melilla;All ages;Cohort April 1;Total;Survival in the first trimester;2022QI;""
52 Melilla;All ages;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
52 Melilla;All ages;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
52 Melilla;All ages;Cohort April 1;Total;Survival in the first trimester;2021QII;4.344
52 Melilla;All ages;Cohort April 1;Total;Survival in the first trimester;2021QI;""
52 Melilla;All ages;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
52 Melilla;All ages;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
52 Melilla;All ages;Cohort April 1;Total;Survival in the first trimester;2020QII;4.582
52 Melilla;All ages;Cohort April 1;Total;Survival in the first trimester;2020QI;""
52 Melilla;All ages;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
52 Melilla;All ages;Cohort April 1;Total;Survival in the second trimester;2022QIII;4.009
52 Melilla;All ages;Cohort April 1;Total;Survival in the second trimester;2022QII;""
52 Melilla;All ages;Cohort April 1;Total;Survival in the second trimester;2022QI;""
52 Melilla;All ages;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
52 Melilla;All ages;Cohort April 1;Total;Survival in the second trimester;2021QIII;4.147
52 Melilla;All ages;Cohort April 1;Total;Survival in the second trimester;2021QII;""
52 Melilla;All ages;Cohort April 1;Total;Survival in the second trimester;2021QI;""
52 Melilla;All ages;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
52 Melilla;All ages;Cohort April 1;Total;Survival in the second trimester;2020QIII;4.318
52 Melilla;All ages;Cohort April 1;Total;Survival in the second trimester;2020QII;""
52 Melilla;All ages;Cohort April 1;Total;Survival in the second trimester;2020QI;""
52 Melilla;All ages;Cohort April 1;Total;Survival in the third trimester;2022QIV;3.837
52 Melilla;All ages;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
52 Melilla;All ages;Cohort April 1;Total;Survival in the third trimester;2022QII;""
52 Melilla;All ages;Cohort April 1;Total;Survival in the third trimester;2022QI;""
52 Melilla;All ages;Cohort April 1;Total;Survival in the third trimester;2021QIV;3.978
52 Melilla;All ages;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
52 Melilla;All ages;Cohort April 1;Total;Survival in the third trimester;2021QII;""
52 Melilla;All ages;Cohort April 1;Total;Survival in the third trimester;2021QI;""
52 Melilla;All ages;Cohort April 1;Total;Survival in the third trimester;2020QIV;4.128
52 Melilla;All ages;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
52 Melilla;All ages;Cohort April 1;Total;Survival in the third trimester;2020QII;""
52 Melilla;All ages;Cohort April 1;Total;Survival in the third trimester;2020QI;""
52 Melilla;All ages;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
52 Melilla;All ages;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
52 Melilla;All ages;Cohort April 1;Total;Survival in the third trimester;2022QII;""
52 Melilla;All ages;Cohort April 1;Total;Survival in the third trimester;2022QI;3.804
52 Melilla;All ages;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
52 Melilla;All ages;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
52 Melilla;All ages;Cohort April 1;Total;Survival in the third trimester;2021QII;""
52 Melilla;All ages;Cohort April 1;Total;Survival in the third trimester;2021QI;4.005
52 Melilla;All ages;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
52 Melilla;All ages;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
52 Melilla;All ages;Cohort April 1;Total;Survival in the third trimester;2020QII;""
52 Melilla;All ages;Cohort April 1;Total;Survival in the third trimester;2020QI;""
52 Melilla;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
52 Melilla;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
52 Melilla;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
52 Melilla;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
52 Melilla;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
52 Melilla;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
52 Melilla;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
52 Melilla;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
52 Melilla;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
52 Melilla;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
52 Melilla;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
52 Melilla;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
52 Melilla;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
52 Melilla;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
52 Melilla;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;95,1
52 Melilla;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
52 Melilla;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
52 Melilla;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
52 Melilla;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;95,77
52 Melilla;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
52 Melilla;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
52 Melilla;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
52 Melilla;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;97,59
52 Melilla;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
52 Melilla;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
52 Melilla;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;91,38
52 Melilla;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
52 Melilla;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
52 Melilla;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
52 Melilla;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;91,42
52 Melilla;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
52 Melilla;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
52 Melilla;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
52 Melilla;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;91,97
52 Melilla;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
52 Melilla;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
52 Melilla;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;87,46
52 Melilla;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
52 Melilla;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
52 Melilla;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
52 Melilla;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;87,7
52 Melilla;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
52 Melilla;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
52 Melilla;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
52 Melilla;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;87,92
52 Melilla;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
52 Melilla;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
52 Melilla;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
52 Melilla;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
52 Melilla;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
52 Melilla;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
52 Melilla;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;83,86
52 Melilla;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
52 Melilla;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
52 Melilla;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
52 Melilla;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;85,3
52 Melilla;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
52 Melilla;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
52 Melilla;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
52 Melilla;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
52 Melilla;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
52 Melilla;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
52 Melilla;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QII;3.059
52 Melilla;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
52 Melilla;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
52 Melilla;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
52 Melilla;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QII;3.210
52 Melilla;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
52 Melilla;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
52 Melilla;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
52 Melilla;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QII;3.357
52 Melilla;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
52 Melilla;All ages;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
52 Melilla;All ages;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
52 Melilla;All ages;Cohort April 1;Males;Survival in the first trimester;2022QII;2.929
52 Melilla;All ages;Cohort April 1;Males;Survival in the first trimester;2022QI;""
52 Melilla;All ages;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
52 Melilla;All ages;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
52 Melilla;All ages;Cohort April 1;Males;Survival in the first trimester;2021QII;3.080
52 Melilla;All ages;Cohort April 1;Males;Survival in the first trimester;2021QI;""
52 Melilla;All ages;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
52 Melilla;All ages;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
52 Melilla;All ages;Cohort April 1;Males;Survival in the first trimester;2020QII;3.278
52 Melilla;All ages;Cohort April 1;Males;Survival in the first trimester;2020QI;""
52 Melilla;All ages;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
52 Melilla;All ages;Cohort April 1;Males;Survival in the second trimester;2022QIII;2.826
52 Melilla;All ages;Cohort April 1;Males;Survival in the second trimester;2022QII;""
52 Melilla;All ages;Cohort April 1;Males;Survival in the second trimester;2022QI;""
52 Melilla;All ages;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
52 Melilla;All ages;Cohort April 1;Males;Survival in the second trimester;2021QIII;2.945
52 Melilla;All ages;Cohort April 1;Males;Survival in the second trimester;2021QII;""
52 Melilla;All ages;Cohort April 1;Males;Survival in the second trimester;2021QI;""
52 Melilla;All ages;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
52 Melilla;All ages;Cohort April 1;Males;Survival in the second trimester;2020QIII;3.103
52 Melilla;All ages;Cohort April 1;Males;Survival in the second trimester;2020QII;""
52 Melilla;All ages;Cohort April 1;Males;Survival in the second trimester;2020QI;""
52 Melilla;All ages;Cohort April 1;Males;Survival in the third trimester;2022QIV;2.711
52 Melilla;All ages;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
52 Melilla;All ages;Cohort April 1;Males;Survival in the third trimester;2022QII;""
52 Melilla;All ages;Cohort April 1;Males;Survival in the third trimester;2022QI;""
52 Melilla;All ages;Cohort April 1;Males;Survival in the third trimester;2021QIV;2.838
52 Melilla;All ages;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
52 Melilla;All ages;Cohort April 1;Males;Survival in the third trimester;2021QII;""
52 Melilla;All ages;Cohort April 1;Males;Survival in the third trimester;2021QI;""
52 Melilla;All ages;Cohort April 1;Males;Survival in the third trimester;2020QIV;2.970
52 Melilla;All ages;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
52 Melilla;All ages;Cohort April 1;Males;Survival in the third trimester;2020QII;""
52 Melilla;All ages;Cohort April 1;Males;Survival in the third trimester;2020QI;""
52 Melilla;All ages;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
52 Melilla;All ages;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
52 Melilla;All ages;Cohort April 1;Males;Survival in the third trimester;2022QII;""
52 Melilla;All ages;Cohort April 1;Males;Survival in the third trimester;2022QI;2.726
52 Melilla;All ages;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
52 Melilla;All ages;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
52 Melilla;All ages;Cohort April 1;Males;Survival in the third trimester;2021QII;""
52 Melilla;All ages;Cohort April 1;Males;Survival in the third trimester;2021QI;2.875
52 Melilla;All ages;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
52 Melilla;All ages;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
52 Melilla;All ages;Cohort April 1;Males;Survival in the third trimester;2020QII;""
52 Melilla;All ages;Cohort April 1;Males;Survival in the third trimester;2020QI;""
52 Melilla;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
52 Melilla;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
52 Melilla;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
52 Melilla;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
52 Melilla;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
52 Melilla;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
52 Melilla;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
52 Melilla;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
52 Melilla;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
52 Melilla;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
52 Melilla;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
52 Melilla;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
52 Melilla;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
52 Melilla;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
52 Melilla;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;95,75
52 Melilla;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
52 Melilla;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
52 Melilla;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
52 Melilla;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;95,95
52 Melilla;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
52 Melilla;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
52 Melilla;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
52 Melilla;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;97,65
52 Melilla;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
52 Melilla;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
52 Melilla;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;92,38
52 Melilla;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
52 Melilla;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
52 Melilla;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
52 Melilla;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;91,74
52 Melilla;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
52 Melilla;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
52 Melilla;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
52 Melilla;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;92,43
52 Melilla;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
52 Melilla;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
52 Melilla;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;88,62
52 Melilla;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
52 Melilla;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
52 Melilla;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
52 Melilla;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;88,41
52 Melilla;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
52 Melilla;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
52 Melilla;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
52 Melilla;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;88,47
52 Melilla;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
52 Melilla;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
52 Melilla;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
52 Melilla;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
52 Melilla;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
52 Melilla;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
52 Melilla;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;84,92
52 Melilla;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
52 Melilla;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
52 Melilla;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
52 Melilla;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;85,64
52 Melilla;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
52 Melilla;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
52 Melilla;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
52 Melilla;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
52 Melilla;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
52 Melilla;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
52 Melilla;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QII;1.328
52 Melilla;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
52 Melilla;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
52 Melilla;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
52 Melilla;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QII;1.326
52 Melilla;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
52 Melilla;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
52 Melilla;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
52 Melilla;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QII;1.338
52 Melilla;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
52 Melilla;All ages;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
52 Melilla;All ages;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
52 Melilla;All ages;Cohort April 1;Females;Survival in the first trimester;2022QII;1.243
52 Melilla;All ages;Cohort April 1;Females;Survival in the first trimester;2022QI;""
52 Melilla;All ages;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
52 Melilla;All ages;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
52 Melilla;All ages;Cohort April 1;Females;Survival in the first trimester;2021QII;1.264
52 Melilla;All ages;Cohort April 1;Females;Survival in the first trimester;2021QI;""
52 Melilla;All ages;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
52 Melilla;All ages;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
52 Melilla;All ages;Cohort April 1;Females;Survival in the first trimester;2020QII;1.304
52 Melilla;All ages;Cohort April 1;Females;Survival in the first trimester;2020QI;""
52 Melilla;All ages;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
52 Melilla;All ages;Cohort April 1;Females;Survival in the second trimester;2022QIII;1.183
52 Melilla;All ages;Cohort April 1;Females;Survival in the second trimester;2022QII;""
52 Melilla;All ages;Cohort April 1;Females;Survival in the second trimester;2022QI;""
52 Melilla;All ages;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
52 Melilla;All ages;Cohort April 1;Females;Survival in the second trimester;2021QIII;1.202
52 Melilla;All ages;Cohort April 1;Females;Survival in the second trimester;2021QII;""
52 Melilla;All ages;Cohort April 1;Females;Survival in the second trimester;2021QI;""
52 Melilla;All ages;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
52 Melilla;All ages;Cohort April 1;Females;Survival in the second trimester;2020QIII;1.215
52 Melilla;All ages;Cohort April 1;Females;Survival in the second trimester;2020QII;""
52 Melilla;All ages;Cohort April 1;Females;Survival in the second trimester;2020QI;""
52 Melilla;All ages;Cohort April 1;Females;Survival in the third trimester;2022QIV;1.126
52 Melilla;All ages;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
52 Melilla;All ages;Cohort April 1;Females;Survival in the third trimester;2022QII;""
52 Melilla;All ages;Cohort April 1;Females;Survival in the third trimester;2022QI;""
52 Melilla;All ages;Cohort April 1;Females;Survival in the third trimester;2021QIV;1.140
52 Melilla;All ages;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
52 Melilla;All ages;Cohort April 1;Females;Survival in the third trimester;2021QII;""
52 Melilla;All ages;Cohort April 1;Females;Survival in the third trimester;2021QI;""
52 Melilla;All ages;Cohort April 1;Females;Survival in the third trimester;2020QIV;1.158
52 Melilla;All ages;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
52 Melilla;All ages;Cohort April 1;Females;Survival in the third trimester;2020QII;""
52 Melilla;All ages;Cohort April 1;Females;Survival in the third trimester;2020QI;""
52 Melilla;All ages;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
52 Melilla;All ages;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
52 Melilla;All ages;Cohort April 1;Females;Survival in the third trimester;2022QII;""
52 Melilla;All ages;Cohort April 1;Females;Survival in the third trimester;2022QI;1.078
52 Melilla;All ages;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
52 Melilla;All ages;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
52 Melilla;All ages;Cohort April 1;Females;Survival in the third trimester;2021QII;""
52 Melilla;All ages;Cohort April 1;Females;Survival in the third trimester;2021QI;1.130
52 Melilla;All ages;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
52 Melilla;All ages;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
52 Melilla;All ages;Cohort April 1;Females;Survival in the third trimester;2020QII;""
52 Melilla;All ages;Cohort April 1;Females;Survival in the third trimester;2020QI;""
52 Melilla;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
52 Melilla;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
52 Melilla;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
52 Melilla;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
52 Melilla;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
52 Melilla;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
52 Melilla;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
52 Melilla;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
52 Melilla;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
52 Melilla;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
52 Melilla;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
52 Melilla;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
52 Melilla;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
52 Melilla;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
52 Melilla;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;93,6
52 Melilla;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
52 Melilla;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
52 Melilla;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
52 Melilla;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;95,32
52 Melilla;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
52 Melilla;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
52 Melilla;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
52 Melilla;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;97,46
52 Melilla;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
52 Melilla;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
52 Melilla;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;89,08
52 Melilla;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
52 Melilla;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
52 Melilla;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
52 Melilla;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;90,65
52 Melilla;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
52 Melilla;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
52 Melilla;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
52 Melilla;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;90,81
52 Melilla;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
52 Melilla;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
52 Melilla;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;84,79
52 Melilla;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
52 Melilla;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
52 Melilla;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
52 Melilla;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;85,97
52 Melilla;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
52 Melilla;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
52 Melilla;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
52 Melilla;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;86,55
52 Melilla;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
52 Melilla;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
52 Melilla;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
52 Melilla;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
52 Melilla;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
52 Melilla;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
52 Melilla;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;81,3
52 Melilla;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
52 Melilla;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
52 Melilla;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
52 Melilla;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;84,45
52 Melilla;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
52 Melilla;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
52 Melilla;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
52 Melilla;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
52 Melilla;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
52 Melilla;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QIII;4.371
52 Melilla;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
52 Melilla;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
52 Melilla;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
52 Melilla;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QIII;4.548
52 Melilla;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
52 Melilla;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
52 Melilla;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
52 Melilla;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QIII;4.682
52 Melilla;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
52 Melilla;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
52 Melilla;All ages;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
52 Melilla;All ages;Cohort July 1;Total;Survival in the first trimester;2022QIII;4.181
52 Melilla;All ages;Cohort July 1;Total;Survival in the first trimester;2022QII;""
52 Melilla;All ages;Cohort July 1;Total;Survival in the first trimester;2022QI;""
52 Melilla;All ages;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
52 Melilla;All ages;Cohort July 1;Total;Survival in the first trimester;2021QIII;4.313
52 Melilla;All ages;Cohort July 1;Total;Survival in the first trimester;2021QII;""
52 Melilla;All ages;Cohort July 1;Total;Survival in the first trimester;2021QI;""
52 Melilla;All ages;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
52 Melilla;All ages;Cohort July 1;Total;Survival in the first trimester;2020QIII;4.406
52 Melilla;All ages;Cohort July 1;Total;Survival in the first trimester;2020QII;""
52 Melilla;All ages;Cohort July 1;Total;Survival in the first trimester;2020QI;""
52 Melilla;All ages;Cohort July 1;Total;Survival in the second trimester;2022QIV;3.993
52 Melilla;All ages;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
52 Melilla;All ages;Cohort July 1;Total;Survival in the second trimester;2022QII;""
52 Melilla;All ages;Cohort July 1;Total;Survival in the second trimester;2022QI;""
52 Melilla;All ages;Cohort July 1;Total;Survival in the second trimester;2021QIV;4.130
52 Melilla;All ages;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
52 Melilla;All ages;Cohort July 1;Total;Survival in the second trimester;2021QII;""
52 Melilla;All ages;Cohort July 1;Total;Survival in the second trimester;2021QI;""
52 Melilla;All ages;Cohort July 1;Total;Survival in the second trimester;2020QIV;4.208
52 Melilla;All ages;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
52 Melilla;All ages;Cohort July 1;Total;Survival in the second trimester;2020QII;""
52 Melilla;All ages;Cohort July 1;Total;Survival in the second trimester;2020QI;""
52 Melilla;All ages;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
52 Melilla;All ages;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
52 Melilla;All ages;Cohort July 1;Total;Survival in the third trimester;2022QII;""
52 Melilla;All ages;Cohort July 1;Total;Survival in the third trimester;2022QI;3.944
52 Melilla;All ages;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
52 Melilla;All ages;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
52 Melilla;All ages;Cohort July 1;Total;Survival in the third trimester;2021QII;""
52 Melilla;All ages;Cohort July 1;Total;Survival in the third trimester;2021QI;4.077
52 Melilla;All ages;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
52 Melilla;All ages;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
52 Melilla;All ages;Cohort July 1;Total;Survival in the third trimester;2020QII;""
52 Melilla;All ages;Cohort July 1;Total;Survival in the third trimester;2020QI;""
52 Melilla;All ages;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
52 Melilla;All ages;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
52 Melilla;All ages;Cohort July 1;Total;Survival in the third trimester;2022QII;3.767
52 Melilla;All ages;Cohort July 1;Total;Survival in the third trimester;2022QI;""
52 Melilla;All ages;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
52 Melilla;All ages;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
52 Melilla;All ages;Cohort July 1;Total;Survival in the third trimester;2021QII;3.921
52 Melilla;All ages;Cohort July 1;Total;Survival in the third trimester;2021QI;""
52 Melilla;All ages;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
52 Melilla;All ages;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
52 Melilla;All ages;Cohort July 1;Total;Survival in the third trimester;2020QII;""
52 Melilla;All ages;Cohort July 1;Total;Survival in the third trimester;2020QI;""
52 Melilla;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
52 Melilla;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
52 Melilla;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
52 Melilla;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
52 Melilla;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
52 Melilla;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
52 Melilla;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
52 Melilla;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
52 Melilla;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
52 Melilla;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
52 Melilla;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
52 Melilla;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
52 Melilla;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
52 Melilla;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;95,65
52 Melilla;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
52 Melilla;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
52 Melilla;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
52 Melilla;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;94,83
52 Melilla;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
52 Melilla;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
52 Melilla;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
52 Melilla;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;94,11
52 Melilla;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
52 Melilla;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
52 Melilla;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;91,35
52 Melilla;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
52 Melilla;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
52 Melilla;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
52 Melilla;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;90,81
52 Melilla;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
52 Melilla;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
52 Melilla;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
52 Melilla;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;89,88
52 Melilla;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
52 Melilla;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
52 Melilla;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
52 Melilla;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
52 Melilla;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
52 Melilla;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
52 Melilla;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;86,72
52 Melilla;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
52 Melilla;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
52 Melilla;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
52 Melilla;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;87,08
52 Melilla;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
52 Melilla;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
52 Melilla;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
52 Melilla;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
52 Melilla;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
52 Melilla;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
52 Melilla;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;82,83
52 Melilla;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
52 Melilla;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
52 Melilla;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
52 Melilla;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;83,75
52 Melilla;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
52 Melilla;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
52 Melilla;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
52 Melilla;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
52 Melilla;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
52 Melilla;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
52 Melilla;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QIII;3.069
52 Melilla;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
52 Melilla;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
52 Melilla;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
52 Melilla;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QIII;3.201
52 Melilla;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
52 Melilla;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
52 Melilla;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
52 Melilla;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QIII;3.347
52 Melilla;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
52 Melilla;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
52 Melilla;All ages;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
52 Melilla;All ages;Cohort July 1;Males;Survival in the first trimester;2022QIII;2.952
52 Melilla;All ages;Cohort July 1;Males;Survival in the first trimester;2022QII;""
52 Melilla;All ages;Cohort July 1;Males;Survival in the first trimester;2022QI;""
52 Melilla;All ages;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
52 Melilla;All ages;Cohort July 1;Males;Survival in the first trimester;2021QIII;3.035
52 Melilla;All ages;Cohort July 1;Males;Survival in the first trimester;2021QII;""
52 Melilla;All ages;Cohort July 1;Males;Survival in the first trimester;2021QI;""
52 Melilla;All ages;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
52 Melilla;All ages;Cohort July 1;Males;Survival in the first trimester;2020QIII;3.163
52 Melilla;All ages;Cohort July 1;Males;Survival in the first trimester;2020QII;""
52 Melilla;All ages;Cohort July 1;Males;Survival in the first trimester;2020QI;""
52 Melilla;All ages;Cohort July 1;Males;Survival in the second trimester;2022QIV;2.828
52 Melilla;All ages;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
52 Melilla;All ages;Cohort July 1;Males;Survival in the second trimester;2022QII;""
52 Melilla;All ages;Cohort July 1;Males;Survival in the second trimester;2022QI;""
52 Melilla;All ages;Cohort July 1;Males;Survival in the second trimester;2021QIV;2.921
52 Melilla;All ages;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
52 Melilla;All ages;Cohort July 1;Males;Survival in the second trimester;2021QII;""
52 Melilla;All ages;Cohort July 1;Males;Survival in the second trimester;2021QI;""
52 Melilla;All ages;Cohort July 1;Males;Survival in the second trimester;2020QIV;3.025
52 Melilla;All ages;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
52 Melilla;All ages;Cohort July 1;Males;Survival in the second trimester;2020QII;""
52 Melilla;All ages;Cohort July 1;Males;Survival in the second trimester;2020QI;""
52 Melilla;All ages;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
52 Melilla;All ages;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
52 Melilla;All ages;Cohort July 1;Males;Survival in the third trimester;2022QII;""
52 Melilla;All ages;Cohort July 1;Males;Survival in the third trimester;2022QI;2.802
52 Melilla;All ages;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
52 Melilla;All ages;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
52 Melilla;All ages;Cohort July 1;Males;Survival in the third trimester;2021QII;""
52 Melilla;All ages;Cohort July 1;Males;Survival in the third trimester;2021QI;2.924
52 Melilla;All ages;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
52 Melilla;All ages;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
52 Melilla;All ages;Cohort July 1;Males;Survival in the third trimester;2020QII;""
52 Melilla;All ages;Cohort July 1;Males;Survival in the third trimester;2020QI;""
52 Melilla;All ages;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
52 Melilla;All ages;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
52 Melilla;All ages;Cohort July 1;Males;Survival in the third trimester;2022QII;2.699
52 Melilla;All ages;Cohort July 1;Males;Survival in the third trimester;2022QI;""
52 Melilla;All ages;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
52 Melilla;All ages;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
52 Melilla;All ages;Cohort July 1;Males;Survival in the third trimester;2021QII;2.811
52 Melilla;All ages;Cohort July 1;Males;Survival in the third trimester;2021QI;""
52 Melilla;All ages;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
52 Melilla;All ages;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
52 Melilla;All ages;Cohort July 1;Males;Survival in the third trimester;2020QII;""
52 Melilla;All ages;Cohort July 1;Males;Survival in the third trimester;2020QI;""
52 Melilla;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
52 Melilla;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
52 Melilla;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
52 Melilla;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
52 Melilla;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
52 Melilla;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
52 Melilla;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
52 Melilla;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
52 Melilla;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
52 Melilla;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
52 Melilla;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
52 Melilla;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
52 Melilla;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
52 Melilla;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;96,19
52 Melilla;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
52 Melilla;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
52 Melilla;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
52 Melilla;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;94,81
52 Melilla;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
52 Melilla;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
52 Melilla;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
52 Melilla;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;94,5
52 Melilla;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
52 Melilla;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
52 Melilla;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;92,15
52 Melilla;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
52 Melilla;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
52 Melilla;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
52 Melilla;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;91,25
52 Melilla;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
52 Melilla;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
52 Melilla;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
52 Melilla;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;90,38
52 Melilla;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
52 Melilla;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
52 Melilla;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
52 Melilla;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
52 Melilla;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
52 Melilla;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
52 Melilla;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;87,54
52 Melilla;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
52 Melilla;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
52 Melilla;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
52 Melilla;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;87,36
52 Melilla;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
52 Melilla;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
52 Melilla;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
52 Melilla;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
52 Melilla;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
52 Melilla;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
52 Melilla;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;84,32
52 Melilla;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
52 Melilla;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
52 Melilla;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
52 Melilla;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;83,99
52 Melilla;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
52 Melilla;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
52 Melilla;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
52 Melilla;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
52 Melilla;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
52 Melilla;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
52 Melilla;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QIII;1.302
52 Melilla;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
52 Melilla;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
52 Melilla;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
52 Melilla;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QIII;1.347
52 Melilla;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
52 Melilla;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
52 Melilla;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
52 Melilla;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QIII;1.335
52 Melilla;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
52 Melilla;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
52 Melilla;All ages;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
52 Melilla;All ages;Cohort July 1;Females;Survival in the first trimester;2022QIII;1.229
52 Melilla;All ages;Cohort July 1;Females;Survival in the first trimester;2022QII;""
52 Melilla;All ages;Cohort July 1;Females;Survival in the first trimester;2022QI;""
52 Melilla;All ages;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
52 Melilla;All ages;Cohort July 1;Females;Survival in the first trimester;2021QIII;1.278
52 Melilla;All ages;Cohort July 1;Females;Survival in the first trimester;2021QII;""
52 Melilla;All ages;Cohort July 1;Females;Survival in the first trimester;2021QI;""
52 Melilla;All ages;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
52 Melilla;All ages;Cohort July 1;Females;Survival in the first trimester;2020QIII;1.243
52 Melilla;All ages;Cohort July 1;Females;Survival in the first trimester;2020QII;""
52 Melilla;All ages;Cohort July 1;Females;Survival in the first trimester;2020QI;""
52 Melilla;All ages;Cohort July 1;Females;Survival in the second trimester;2022QIV;1.165
52 Melilla;All ages;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
52 Melilla;All ages;Cohort July 1;Females;Survival in the second trimester;2022QII;""
52 Melilla;All ages;Cohort July 1;Females;Survival in the second trimester;2022QI;""
52 Melilla;All ages;Cohort July 1;Females;Survival in the second trimester;2021QIV;1.209
52 Melilla;All ages;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
52 Melilla;All ages;Cohort July 1;Females;Survival in the second trimester;2021QII;""
52 Melilla;All ages;Cohort July 1;Females;Survival in the second trimester;2021QI;""
52 Melilla;All ages;Cohort July 1;Females;Survival in the second trimester;2020QIV;1.183
52 Melilla;All ages;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
52 Melilla;All ages;Cohort July 1;Females;Survival in the second trimester;2020QII;""
52 Melilla;All ages;Cohort July 1;Females;Survival in the second trimester;2020QI;""
52 Melilla;All ages;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
52 Melilla;All ages;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
52 Melilla;All ages;Cohort July 1;Females;Survival in the third trimester;2022QII;""
52 Melilla;All ages;Cohort July 1;Females;Survival in the third trimester;2022QI;1.142
52 Melilla;All ages;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
52 Melilla;All ages;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
52 Melilla;All ages;Cohort July 1;Females;Survival in the third trimester;2021QII;""
52 Melilla;All ages;Cohort July 1;Females;Survival in the third trimester;2021QI;1.153
52 Melilla;All ages;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
52 Melilla;All ages;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
52 Melilla;All ages;Cohort July 1;Females;Survival in the third trimester;2020QII;""
52 Melilla;All ages;Cohort July 1;Females;Survival in the third trimester;2020QI;""
52 Melilla;All ages;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
52 Melilla;All ages;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
52 Melilla;All ages;Cohort July 1;Females;Survival in the third trimester;2022QII;1.068
52 Melilla;All ages;Cohort July 1;Females;Survival in the third trimester;2022QI;""
52 Melilla;All ages;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
52 Melilla;All ages;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
52 Melilla;All ages;Cohort July 1;Females;Survival in the third trimester;2021QII;1.110
52 Melilla;All ages;Cohort July 1;Females;Survival in the third trimester;2021QI;""
52 Melilla;All ages;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
52 Melilla;All ages;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
52 Melilla;All ages;Cohort July 1;Females;Survival in the third trimester;2020QII;""
52 Melilla;All ages;Cohort July 1;Females;Survival in the third trimester;2020QI;""
52 Melilla;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
52 Melilla;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
52 Melilla;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
52 Melilla;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
52 Melilla;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
52 Melilla;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
52 Melilla;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
52 Melilla;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
52 Melilla;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
52 Melilla;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
52 Melilla;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
52 Melilla;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
52 Melilla;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
52 Melilla;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;94,39
52 Melilla;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
52 Melilla;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
52 Melilla;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
52 Melilla;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;94,88
52 Melilla;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
52 Melilla;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
52 Melilla;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
52 Melilla;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;93,11
52 Melilla;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
52 Melilla;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
52 Melilla;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;89,48
52 Melilla;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
52 Melilla;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
52 Melilla;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
52 Melilla;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;89,76
52 Melilla;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
52 Melilla;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
52 Melilla;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
52 Melilla;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;88,61
52 Melilla;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
52 Melilla;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
52 Melilla;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
52 Melilla;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
52 Melilla;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
52 Melilla;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
52 Melilla;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;84,78
52 Melilla;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
52 Melilla;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
52 Melilla;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
52 Melilla;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;86,37
52 Melilla;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
52 Melilla;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
52 Melilla;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
52 Melilla;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
52 Melilla;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
52 Melilla;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
52 Melilla;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;79,29
52 Melilla;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
52 Melilla;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
52 Melilla;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
52 Melilla;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;83,15
52 Melilla;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
52 Melilla;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
52 Melilla;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
52 Melilla;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
52 Melilla;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
52 Melilla;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QIV;4.339
52 Melilla;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
52 Melilla;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
52 Melilla;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
52 Melilla;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QIV;4.465
52 Melilla;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
52 Melilla;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
52 Melilla;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
52 Melilla;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QIV;4.559
52 Melilla;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
52 Melilla;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
52 Melilla;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
52 Melilla;All ages;Cohort October 1;Total;Survival in the first trimester;2022QIV;4.125
52 Melilla;All ages;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
52 Melilla;All ages;Cohort October 1;Total;Survival in the first trimester;2022QII;""
52 Melilla;All ages;Cohort October 1;Total;Survival in the first trimester;2022QI;""
52 Melilla;All ages;Cohort October 1;Total;Survival in the first trimester;2021QIV;4.265
52 Melilla;All ages;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
52 Melilla;All ages;Cohort October 1;Total;Survival in the first trimester;2021QII;""
52 Melilla;All ages;Cohort October 1;Total;Survival in the first trimester;2021QI;""
52 Melilla;All ages;Cohort October 1;Total;Survival in the first trimester;2020QIV;4.335
52 Melilla;All ages;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
52 Melilla;All ages;Cohort October 1;Total;Survival in the first trimester;2020QII;""
52 Melilla;All ages;Cohort October 1;Total;Survival in the first trimester;2020QI;""
52 Melilla;All ages;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
52 Melilla;All ages;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
52 Melilla;All ages;Cohort October 1;Total;Survival in the second trimester;2022QII;""
52 Melilla;All ages;Cohort October 1;Total;Survival in the second trimester;2022QI;4.066
52 Melilla;All ages;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
52 Melilla;All ages;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
52 Melilla;All ages;Cohort October 1;Total;Survival in the second trimester;2021QII;""
52 Melilla;All ages;Cohort October 1;Total;Survival in the second trimester;2021QI;4.194
52 Melilla;All ages;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
52 Melilla;All ages;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
52 Melilla;All ages;Cohort October 1;Total;Survival in the second trimester;2020QII;""
52 Melilla;All ages;Cohort October 1;Total;Survival in the second trimester;2020QI;""
52 Melilla;All ages;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
52 Melilla;All ages;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
52 Melilla;All ages;Cohort October 1;Total;Survival in the third trimester;2022QII;3.881
52 Melilla;All ages;Cohort October 1;Total;Survival in the third trimester;2022QI;""
52 Melilla;All ages;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
52 Melilla;All ages;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
52 Melilla;All ages;Cohort October 1;Total;Survival in the third trimester;2021QII;4.030
52 Melilla;All ages;Cohort October 1;Total;Survival in the third trimester;2021QI;""
52 Melilla;All ages;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
52 Melilla;All ages;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
52 Melilla;All ages;Cohort October 1;Total;Survival in the third trimester;2020QII;""
52 Melilla;All ages;Cohort October 1;Total;Survival in the third trimester;2020QI;""
52 Melilla;All ages;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
52 Melilla;All ages;Cohort October 1;Total;Survival in the third trimester;2022QIII;3.737
52 Melilla;All ages;Cohort October 1;Total;Survival in the third trimester;2022QII;""
52 Melilla;All ages;Cohort October 1;Total;Survival in the third trimester;2022QI;""
52 Melilla;All ages;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
52 Melilla;All ages;Cohort October 1;Total;Survival in the third trimester;2021QIII;3.868
52 Melilla;All ages;Cohort October 1;Total;Survival in the third trimester;2021QII;""
52 Melilla;All ages;Cohort October 1;Total;Survival in the third trimester;2021QI;""
52 Melilla;All ages;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
52 Melilla;All ages;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
52 Melilla;All ages;Cohort October 1;Total;Survival in the third trimester;2020QII;""
52 Melilla;All ages;Cohort October 1;Total;Survival in the third trimester;2020QI;""
52 Melilla;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
52 Melilla;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
52 Melilla;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
52 Melilla;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
52 Melilla;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
52 Melilla;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
52 Melilla;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
52 Melilla;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
52 Melilla;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
52 Melilla;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
52 Melilla;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
52 Melilla;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
52 Melilla;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;95,07
52 Melilla;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
52 Melilla;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
52 Melilla;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
52 Melilla;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;95,52
52 Melilla;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
52 Melilla;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
52 Melilla;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
52 Melilla;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;95,09
52 Melilla;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
52 Melilla;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
52 Melilla;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
52 Melilla;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
52 Melilla;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
52 Melilla;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
52 Melilla;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;91,06
52 Melilla;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
52 Melilla;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
52 Melilla;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
52 Melilla;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;91,99
52 Melilla;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
52 Melilla;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
52 Melilla;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
52 Melilla;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
52 Melilla;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
52 Melilla;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
52 Melilla;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;86,92
52 Melilla;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
52 Melilla;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
52 Melilla;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
52 Melilla;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;88,4
52 Melilla;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
52 Melilla;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
52 Melilla;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
52 Melilla;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
52 Melilla;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
52 Melilla;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
52 Melilla;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;83,7
52 Melilla;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
52 Melilla;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
52 Melilla;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
52 Melilla;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;84,84
52 Melilla;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
52 Melilla;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
52 Melilla;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
52 Melilla;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
52 Melilla;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
52 Melilla;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
52 Melilla;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QIV;3.059
52 Melilla;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
52 Melilla;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
52 Melilla;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
52 Melilla;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QIV;3.117
52 Melilla;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
52 Melilla;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
52 Melilla;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
52 Melilla;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QIV;3.258
52 Melilla;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
52 Melilla;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
52 Melilla;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
52 Melilla;All ages;Cohort October 1;Males;Survival in the first trimester;2022QIV;2.917
52 Melilla;All ages;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
52 Melilla;All ages;Cohort October 1;Males;Survival in the first trimester;2022QII;""
52 Melilla;All ages;Cohort October 1;Males;Survival in the first trimester;2022QI;""
52 Melilla;All ages;Cohort October 1;Males;Survival in the first trimester;2021QIV;2.993
52 Melilla;All ages;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
52 Melilla;All ages;Cohort October 1;Males;Survival in the first trimester;2021QII;""
52 Melilla;All ages;Cohort October 1;Males;Survival in the first trimester;2021QI;""
52 Melilla;All ages;Cohort October 1;Males;Survival in the first trimester;2020QIV;3.103
52 Melilla;All ages;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
52 Melilla;All ages;Cohort October 1;Males;Survival in the first trimester;2020QII;""
52 Melilla;All ages;Cohort October 1;Males;Survival in the first trimester;2020QI;""
52 Melilla;All ages;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
52 Melilla;All ages;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
52 Melilla;All ages;Cohort October 1;Males;Survival in the second trimester;2022QII;""
52 Melilla;All ages;Cohort October 1;Males;Survival in the second trimester;2022QI;2.870
52 Melilla;All ages;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
52 Melilla;All ages;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
52 Melilla;All ages;Cohort October 1;Males;Survival in the second trimester;2021QII;""
52 Melilla;All ages;Cohort October 1;Males;Survival in the second trimester;2021QI;2.996
52 Melilla;All ages;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
52 Melilla;All ages;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
52 Melilla;All ages;Cohort October 1;Males;Survival in the second trimester;2020QII;""
52 Melilla;All ages;Cohort October 1;Males;Survival in the second trimester;2020QI;""
52 Melilla;All ages;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
52 Melilla;All ages;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
52 Melilla;All ages;Cohort October 1;Males;Survival in the third trimester;2022QII;2.764
52 Melilla;All ages;Cohort October 1;Males;Survival in the third trimester;2022QI;""
52 Melilla;All ages;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
52 Melilla;All ages;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
52 Melilla;All ages;Cohort October 1;Males;Survival in the third trimester;2021QII;2.879
52 Melilla;All ages;Cohort October 1;Males;Survival in the third trimester;2021QI;""
52 Melilla;All ages;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
52 Melilla;All ages;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
52 Melilla;All ages;Cohort October 1;Males;Survival in the third trimester;2020QII;""
52 Melilla;All ages;Cohort October 1;Males;Survival in the third trimester;2020QI;""
52 Melilla;All ages;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
52 Melilla;All ages;Cohort October 1;Males;Survival in the third trimester;2022QIII;2.670
52 Melilla;All ages;Cohort October 1;Males;Survival in the third trimester;2022QII;""
52 Melilla;All ages;Cohort October 1;Males;Survival in the third trimester;2022QI;""
52 Melilla;All ages;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
52 Melilla;All ages;Cohort October 1;Males;Survival in the third trimester;2021QIII;2.770
52 Melilla;All ages;Cohort October 1;Males;Survival in the third trimester;2021QII;""
52 Melilla;All ages;Cohort October 1;Males;Survival in the third trimester;2021QI;""
52 Melilla;All ages;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
52 Melilla;All ages;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
52 Melilla;All ages;Cohort October 1;Males;Survival in the third trimester;2020QII;""
52 Melilla;All ages;Cohort October 1;Males;Survival in the third trimester;2020QI;""
52 Melilla;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
52 Melilla;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
52 Melilla;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
52 Melilla;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
52 Melilla;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
52 Melilla;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
52 Melilla;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
52 Melilla;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
52 Melilla;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
52 Melilla;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
52 Melilla;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
52 Melilla;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
52 Melilla;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;95,36
52 Melilla;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
52 Melilla;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
52 Melilla;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
52 Melilla;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;96,02
52 Melilla;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
52 Melilla;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
52 Melilla;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
52 Melilla;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;95,24
52 Melilla;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
52 Melilla;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
52 Melilla;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
52 Melilla;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
52 Melilla;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
52 Melilla;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
52 Melilla;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;92,08
52 Melilla;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
52 Melilla;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
52 Melilla;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
52 Melilla;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;91,96
52 Melilla;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
52 Melilla;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
52 Melilla;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
52 Melilla;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
52 Melilla;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
52 Melilla;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
52 Melilla;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;88,68
52 Melilla;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
52 Melilla;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
52 Melilla;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
52 Melilla;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;88,37
52 Melilla;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
52 Melilla;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
52 Melilla;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
52 Melilla;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
52 Melilla;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
52 Melilla;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
52 Melilla;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;85,66
52 Melilla;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
52 Melilla;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
52 Melilla;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
52 Melilla;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;85,02
52 Melilla;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
52 Melilla;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
52 Melilla;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
52 Melilla;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
52 Melilla;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
52 Melilla;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
52 Melilla;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QIV;1.280
52 Melilla;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
52 Melilla;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
52 Melilla;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
52 Melilla;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QIV;1.348
52 Melilla;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
52 Melilla;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
52 Melilla;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
52 Melilla;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QIV;1.301
52 Melilla;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
52 Melilla;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
52 Melilla;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
52 Melilla;All ages;Cohort October 1;Females;Survival in the first trimester;2022QIV;1.208
52 Melilla;All ages;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
52 Melilla;All ages;Cohort October 1;Females;Survival in the first trimester;2022QII;""
52 Melilla;All ages;Cohort October 1;Females;Survival in the first trimester;2022QI;""
52 Melilla;All ages;Cohort October 1;Females;Survival in the first trimester;2021QIV;1.272
52 Melilla;All ages;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
52 Melilla;All ages;Cohort October 1;Females;Survival in the first trimester;2021QII;""
52 Melilla;All ages;Cohort October 1;Females;Survival in the first trimester;2021QI;""
52 Melilla;All ages;Cohort October 1;Females;Survival in the first trimester;2020QIV;1.232
52 Melilla;All ages;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
52 Melilla;All ages;Cohort October 1;Females;Survival in the first trimester;2020QII;""
52 Melilla;All ages;Cohort October 1;Females;Survival in the first trimester;2020QI;""
52 Melilla;All ages;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
52 Melilla;All ages;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
52 Melilla;All ages;Cohort October 1;Females;Survival in the second trimester;2022QII;""
52 Melilla;All ages;Cohort October 1;Females;Survival in the second trimester;2022QI;1.196
52 Melilla;All ages;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
52 Melilla;All ages;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
52 Melilla;All ages;Cohort October 1;Females;Survival in the second trimester;2021QII;""
52 Melilla;All ages;Cohort October 1;Females;Survival in the second trimester;2021QI;1.198
52 Melilla;All ages;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
52 Melilla;All ages;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
52 Melilla;All ages;Cohort October 1;Females;Survival in the second trimester;2020QII;""
52 Melilla;All ages;Cohort October 1;Females;Survival in the second trimester;2020QI;""
52 Melilla;All ages;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
52 Melilla;All ages;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
52 Melilla;All ages;Cohort October 1;Females;Survival in the third trimester;2022QII;1.117
52 Melilla;All ages;Cohort October 1;Females;Survival in the third trimester;2022QI;""
52 Melilla;All ages;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
52 Melilla;All ages;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
52 Melilla;All ages;Cohort October 1;Females;Survival in the third trimester;2021QII;1.151
52 Melilla;All ages;Cohort October 1;Females;Survival in the third trimester;2021QI;""
52 Melilla;All ages;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
52 Melilla;All ages;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
52 Melilla;All ages;Cohort October 1;Females;Survival in the third trimester;2020QII;""
52 Melilla;All ages;Cohort October 1;Females;Survival in the third trimester;2020QI;""
52 Melilla;All ages;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
52 Melilla;All ages;Cohort October 1;Females;Survival in the third trimester;2022QIII;1.067
52 Melilla;All ages;Cohort October 1;Females;Survival in the third trimester;2022QII;""
52 Melilla;All ages;Cohort October 1;Females;Survival in the third trimester;2022QI;""
52 Melilla;All ages;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
52 Melilla;All ages;Cohort October 1;Females;Survival in the third trimester;2021QIII;1.098
52 Melilla;All ages;Cohort October 1;Females;Survival in the third trimester;2021QII;""
52 Melilla;All ages;Cohort October 1;Females;Survival in the third trimester;2021QI;""
52 Melilla;All ages;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
52 Melilla;All ages;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
52 Melilla;All ages;Cohort October 1;Females;Survival in the third trimester;2020QII;""
52 Melilla;All ages;Cohort October 1;Females;Survival in the third trimester;2020QI;""
52 Melilla;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
52 Melilla;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
52 Melilla;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
52 Melilla;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
52 Melilla;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
52 Melilla;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
52 Melilla;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
52 Melilla;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
52 Melilla;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
52 Melilla;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
52 Melilla;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
52 Melilla;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
52 Melilla;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;94,38
52 Melilla;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
52 Melilla;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
52 Melilla;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
52 Melilla;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;94,36
52 Melilla;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
52 Melilla;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
52 Melilla;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
52 Melilla;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;94,7
52 Melilla;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
52 Melilla;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
52 Melilla;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
52 Melilla;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
52 Melilla;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
52 Melilla;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
52 Melilla;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;88,72
52 Melilla;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
52 Melilla;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
52 Melilla;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
52 Melilla;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;92,08
52 Melilla;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
52 Melilla;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
52 Melilla;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
52 Melilla;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
52 Melilla;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
52 Melilla;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
52 Melilla;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;82,86
52 Melilla;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
52 Melilla;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
52 Melilla;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
52 Melilla;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;88,47
52 Melilla;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
52 Melilla;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
52 Melilla;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
52 Melilla;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
52 Melilla;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
52 Melilla;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
52 Melilla;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;79,15
52 Melilla;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
52 Melilla;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
52 Melilla;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
52 Melilla;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;84,4
52 Melilla;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
52 Melilla;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
52 Melilla;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
52 Melilla;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
52 Melilla;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
52 Melilla;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
52 Melilla;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
52 Melilla;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
52 Melilla;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
52 Melilla;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QI;492
52 Melilla;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
52 Melilla;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
52 Melilla;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
52 Melilla;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QI;549
52 Melilla;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
52 Melilla;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
52 Melilla;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
52 Melilla;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QI;481
52 Melilla;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
52 Melilla;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
52 Melilla;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2022QII;""
52 Melilla;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2022QI;443
52 Melilla;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
52 Melilla;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
52 Melilla;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2021QII;""
52 Melilla;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2021QI;509
52 Melilla;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
52 Melilla;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
52 Melilla;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2020QII;""
52 Melilla;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2020QI;418
52 Melilla;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
52 Melilla;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
52 Melilla;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2022QII;409
52 Melilla;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2022QI;""
52 Melilla;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
52 Melilla;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
52 Melilla;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2021QII;466
52 Melilla;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2021QI;""
52 Melilla;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
52 Melilla;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
52 Melilla;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2020QII;405
52 Melilla;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2020QI;""
52 Melilla;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
52 Melilla;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QIII;381
52 Melilla;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QII;""
52 Melilla;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QI;""
52 Melilla;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
52 Melilla;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QIII;418
52 Melilla;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QII;""
52 Melilla;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QI;""
52 Melilla;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
52 Melilla;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QIII;364
52 Melilla;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QII;""
52 Melilla;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QI;""
52 Melilla;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QIV;355
52 Melilla;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
52 Melilla;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QII;""
52 Melilla;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QI;""
52 Melilla;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QIV;381
52 Melilla;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
52 Melilla;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QII;""
52 Melilla;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QI;""
52 Melilla;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QIV;334
52 Melilla;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
52 Melilla;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QII;""
52 Melilla;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QI;""
52 Melilla;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
52 Melilla;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
52 Melilla;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
52 Melilla;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
52 Melilla;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
52 Melilla;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
52 Melilla;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
52 Melilla;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
52 Melilla;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
52 Melilla;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
52 Melilla;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
52 Melilla;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
52 Melilla;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
52 Melilla;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
52 Melilla;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
52 Melilla;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;90,04
52 Melilla;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
52 Melilla;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
52 Melilla;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
52 Melilla;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;92,71
52 Melilla;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
52 Melilla;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
52 Melilla;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
52 Melilla;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;86,9
52 Melilla;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
52 Melilla;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
52 Melilla;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;83,13
52 Melilla;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
52 Melilla;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
52 Melilla;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
52 Melilla;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;84,88
52 Melilla;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
52 Melilla;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
52 Melilla;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
52 Melilla;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;84,2
52 Melilla;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
52 Melilla;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
52 Melilla;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;77,44
52 Melilla;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
52 Melilla;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
52 Melilla;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
52 Melilla;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;76,14
52 Melilla;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
52 Melilla;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
52 Melilla;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
52 Melilla;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;75,68
52 Melilla;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
52 Melilla;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
52 Melilla;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;72,15
52 Melilla;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
52 Melilla;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
52 Melilla;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
52 Melilla;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;69,4
52 Melilla;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
52 Melilla;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
52 Melilla;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
52 Melilla;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;69,44
52 Melilla;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
52 Melilla;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
52 Melilla;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
52 Melilla;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
52 Melilla;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
52 Melilla;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
52 Melilla;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QI;303
52 Melilla;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
52 Melilla;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
52 Melilla;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
52 Melilla;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QI;352
52 Melilla;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
52 Melilla;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
52 Melilla;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
52 Melilla;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QI;294
52 Melilla;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
52 Melilla;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
52 Melilla;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2022QII;""
52 Melilla;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2022QI;275
52 Melilla;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
52 Melilla;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
52 Melilla;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2021QII;""
52 Melilla;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2021QI;324
52 Melilla;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
52 Melilla;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
52 Melilla;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2020QII;""
52 Melilla;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2020QI;255
52 Melilla;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
52 Melilla;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
52 Melilla;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2022QII;253
52 Melilla;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2022QI;""
52 Melilla;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
52 Melilla;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
52 Melilla;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2021QII;297
52 Melilla;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2021QI;""
52 Melilla;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
52 Melilla;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
52 Melilla;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2020QII;248
52 Melilla;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2020QI;""
52 Melilla;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
52 Melilla;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QIII;239
52 Melilla;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QII;""
52 Melilla;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QI;""
52 Melilla;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
52 Melilla;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QIII;269
52 Melilla;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QII;""
52 Melilla;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QI;""
52 Melilla;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
52 Melilla;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QIII;226
52 Melilla;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QII;""
52 Melilla;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QI;""
52 Melilla;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QIV;224
52 Melilla;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
52 Melilla;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QII;""
52 Melilla;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QI;""
52 Melilla;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QIV;249
52 Melilla;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
52 Melilla;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QII;""
52 Melilla;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QI;""
52 Melilla;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QIV;210
52 Melilla;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
52 Melilla;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QII;""
52 Melilla;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QI;""
52 Melilla;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
52 Melilla;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
52 Melilla;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
52 Melilla;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
52 Melilla;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
52 Melilla;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
52 Melilla;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
52 Melilla;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
52 Melilla;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
52 Melilla;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
52 Melilla;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
52 Melilla;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
52 Melilla;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
52 Melilla;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
52 Melilla;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
52 Melilla;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;90,76
52 Melilla;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
52 Melilla;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
52 Melilla;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
52 Melilla;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;92,05
52 Melilla;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
52 Melilla;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
52 Melilla;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
52 Melilla;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;86,73
52 Melilla;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
52 Melilla;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
52 Melilla;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;83,5
52 Melilla;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
52 Melilla;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
52 Melilla;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
52 Melilla;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;84,38
52 Melilla;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
52 Melilla;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
52 Melilla;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
52 Melilla;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;84,35
52 Melilla;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
52 Melilla;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
52 Melilla;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;78,88
52 Melilla;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
52 Melilla;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
52 Melilla;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
52 Melilla;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;76,42
52 Melilla;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
52 Melilla;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
52 Melilla;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
52 Melilla;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;76,87
52 Melilla;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
52 Melilla;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
52 Melilla;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;73,93
52 Melilla;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
52 Melilla;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
52 Melilla;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
52 Melilla;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;70,74
52 Melilla;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
52 Melilla;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
52 Melilla;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
52 Melilla;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;71,43
52 Melilla;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
52 Melilla;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
52 Melilla;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
52 Melilla;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
52 Melilla;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
52 Melilla;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
52 Melilla;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QI;189
52 Melilla;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
52 Melilla;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
52 Melilla;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
52 Melilla;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QI;197
52 Melilla;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
52 Melilla;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
52 Melilla;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
52 Melilla;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QI;187
52 Melilla;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
52 Melilla;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
52 Melilla;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2022QII;""
52 Melilla;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2022QI;168
52 Melilla;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
52 Melilla;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
52 Melilla;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2021QII;""
52 Melilla;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2021QI;185
52 Melilla;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
52 Melilla;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
52 Melilla;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2020QII;""
52 Melilla;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2020QI;163
52 Melilla;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
52 Melilla;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
52 Melilla;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2022QII;156
52 Melilla;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2022QI;""
52 Melilla;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
52 Melilla;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
52 Melilla;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2021QII;169
52 Melilla;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2021QI;""
52 Melilla;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
52 Melilla;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
52 Melilla;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2020QII;157
52 Melilla;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2020QI;""
52 Melilla;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
52 Melilla;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QIII;142
52 Melilla;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QII;""
52 Melilla;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QI;""
52 Melilla;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
52 Melilla;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QIII;149
52 Melilla;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QII;""
52 Melilla;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QI;""
52 Melilla;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
52 Melilla;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QIII;138
52 Melilla;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QII;""
52 Melilla;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QI;""
52 Melilla;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QIV;131
52 Melilla;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
52 Melilla;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QII;""
52 Melilla;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QI;""
52 Melilla;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QIV;132
52 Melilla;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
52 Melilla;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QII;""
52 Melilla;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QI;""
52 Melilla;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QIV;124
52 Melilla;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
52 Melilla;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QII;""
52 Melilla;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QI;""
52 Melilla;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
52 Melilla;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
52 Melilla;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
52 Melilla;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
52 Melilla;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
52 Melilla;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
52 Melilla;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
52 Melilla;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
52 Melilla;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
52 Melilla;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
52 Melilla;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
52 Melilla;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
52 Melilla;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
52 Melilla;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
52 Melilla;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
52 Melilla;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;88,89
52 Melilla;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
52 Melilla;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
52 Melilla;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
52 Melilla;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;93,91
52 Melilla;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
52 Melilla;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
52 Melilla;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
52 Melilla;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;87,17
52 Melilla;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
52 Melilla;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
52 Melilla;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;82,54
52 Melilla;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
52 Melilla;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
52 Melilla;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
52 Melilla;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;85,79
52 Melilla;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
52 Melilla;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
52 Melilla;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
52 Melilla;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;83,96
52 Melilla;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
52 Melilla;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
52 Melilla;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;75,13
52 Melilla;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
52 Melilla;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
52 Melilla;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
52 Melilla;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;75,63
52 Melilla;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
52 Melilla;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
52 Melilla;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
52 Melilla;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;73,8
52 Melilla;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
52 Melilla;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
52 Melilla;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;69,31
52 Melilla;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
52 Melilla;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
52 Melilla;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
52 Melilla;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;67,01
52 Melilla;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
52 Melilla;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
52 Melilla;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
52 Melilla;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;66,31
52 Melilla;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
52 Melilla;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
52 Melilla;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
52 Melilla;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
52 Melilla;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
52 Melilla;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QII;419
52 Melilla;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
52 Melilla;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
52 Melilla;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
52 Melilla;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QII;478
52 Melilla;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
52 Melilla;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
52 Melilla;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
52 Melilla;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QII;513
52 Melilla;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
52 Melilla;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
52 Melilla;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
52 Melilla;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2022QII;385
52 Melilla;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2022QI;""
52 Melilla;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
52 Melilla;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
52 Melilla;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2021QII;438
52 Melilla;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2021QI;""
52 Melilla;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
52 Melilla;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
52 Melilla;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2020QII;495
52 Melilla;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2020QI;""
52 Melilla;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
52 Melilla;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2022QIII;358
52 Melilla;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2022QII;""
52 Melilla;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2022QI;""
52 Melilla;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
52 Melilla;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2021QIII;393
52 Melilla;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2021QII;""
52 Melilla;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2021QI;""
52 Melilla;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
52 Melilla;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2020QIII;441
52 Melilla;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2020QII;""
52 Melilla;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2020QI;""
52 Melilla;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QIV;329
52 Melilla;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
52 Melilla;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QII;""
52 Melilla;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QI;""
52 Melilla;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QIV;355
52 Melilla;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
52 Melilla;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QII;""
52 Melilla;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QI;""
52 Melilla;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QIV;402
52 Melilla;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
52 Melilla;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QII;""
52 Melilla;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QI;""
52 Melilla;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
52 Melilla;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
52 Melilla;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QII;""
52 Melilla;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QI;321
52 Melilla;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
52 Melilla;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
52 Melilla;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QII;""
52 Melilla;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QI;386
52 Melilla;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
52 Melilla;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
52 Melilla;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QII;""
52 Melilla;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QI;""
52 Melilla;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
52 Melilla;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
52 Melilla;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
52 Melilla;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
52 Melilla;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
52 Melilla;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
52 Melilla;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
52 Melilla;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
52 Melilla;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
52 Melilla;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
52 Melilla;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
52 Melilla;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
52 Melilla;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
52 Melilla;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
52 Melilla;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;91,89
52 Melilla;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
52 Melilla;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
52 Melilla;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
52 Melilla;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;91,63
52 Melilla;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
52 Melilla;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
52 Melilla;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
52 Melilla;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;96,49
52 Melilla;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
52 Melilla;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
52 Melilla;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;85,44
52 Melilla;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
52 Melilla;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
52 Melilla;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
52 Melilla;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;82,22
52 Melilla;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
52 Melilla;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
52 Melilla;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
52 Melilla;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;85,96
52 Melilla;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
52 Melilla;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
52 Melilla;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;78,52
52 Melilla;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
52 Melilla;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
52 Melilla;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
52 Melilla;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;74,27
52 Melilla;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
52 Melilla;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
52 Melilla;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
52 Melilla;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;78,36
52 Melilla;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
52 Melilla;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
52 Melilla;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
52 Melilla;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
52 Melilla;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
52 Melilla;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
52 Melilla;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;67,15
52 Melilla;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
52 Melilla;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
52 Melilla;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
52 Melilla;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;75,24
52 Melilla;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
52 Melilla;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
52 Melilla;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
52 Melilla;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
52 Melilla;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
52 Melilla;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
52 Melilla;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QII;259
52 Melilla;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
52 Melilla;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
52 Melilla;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
52 Melilla;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QII;301
52 Melilla;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
52 Melilla;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
52 Melilla;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
52 Melilla;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QII;322
52 Melilla;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
52 Melilla;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
52 Melilla;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
52 Melilla;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2022QII;238
52 Melilla;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2022QI;""
52 Melilla;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
52 Melilla;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
52 Melilla;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2021QII;276
52 Melilla;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2021QI;""
52 Melilla;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
52 Melilla;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
52 Melilla;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2020QII;312
52 Melilla;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2020QI;""
52 Melilla;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
52 Melilla;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2022QIII;223
52 Melilla;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2022QII;""
52 Melilla;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2022QI;""
52 Melilla;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
52 Melilla;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2021QIII;247
52 Melilla;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2021QII;""
52 Melilla;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2021QI;""
52 Melilla;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
52 Melilla;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2020QIII;280
52 Melilla;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2020QII;""
52 Melilla;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2020QI;""
52 Melilla;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QIV;207
52 Melilla;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
52 Melilla;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QII;""
52 Melilla;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QI;""
52 Melilla;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QIV;226
52 Melilla;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
52 Melilla;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QII;""
52 Melilla;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QI;""
52 Melilla;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QIV;256
52 Melilla;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
52 Melilla;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QII;""
52 Melilla;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QI;""
52 Melilla;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
52 Melilla;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
52 Melilla;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QII;""
52 Melilla;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QI;209
52 Melilla;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
52 Melilla;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
52 Melilla;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QII;""
52 Melilla;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QI;243
52 Melilla;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
52 Melilla;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
52 Melilla;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QII;""
52 Melilla;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QI;""
52 Melilla;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
52 Melilla;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
52 Melilla;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
52 Melilla;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
52 Melilla;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
52 Melilla;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
52 Melilla;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
52 Melilla;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
52 Melilla;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
52 Melilla;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
52 Melilla;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
52 Melilla;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
52 Melilla;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
52 Melilla;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
52 Melilla;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;91,89
52 Melilla;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
52 Melilla;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
52 Melilla;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
52 Melilla;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;91,69
52 Melilla;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
52 Melilla;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
52 Melilla;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
52 Melilla;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;96,89
52 Melilla;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
52 Melilla;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
52 Melilla;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;86,1
52 Melilla;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
52 Melilla;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
52 Melilla;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
52 Melilla;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;82,06
52 Melilla;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
52 Melilla;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
52 Melilla;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
52 Melilla;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;86,96
52 Melilla;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
52 Melilla;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
52 Melilla;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;79,92
52 Melilla;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
52 Melilla;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
52 Melilla;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
52 Melilla;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;75,08
52 Melilla;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
52 Melilla;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
52 Melilla;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
52 Melilla;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;79,5
52 Melilla;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
52 Melilla;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
52 Melilla;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
52 Melilla;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
52 Melilla;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
52 Melilla;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
52 Melilla;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;69,44
52 Melilla;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
52 Melilla;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
52 Melilla;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
52 Melilla;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;75,47
52 Melilla;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
52 Melilla;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
52 Melilla;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
52 Melilla;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
52 Melilla;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
52 Melilla;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
52 Melilla;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QII;160
52 Melilla;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
52 Melilla;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
52 Melilla;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
52 Melilla;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QII;177
52 Melilla;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
52 Melilla;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
52 Melilla;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
52 Melilla;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QII;191
52 Melilla;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
52 Melilla;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
52 Melilla;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
52 Melilla;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2022QII;147
52 Melilla;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2022QI;""
52 Melilla;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
52 Melilla;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
52 Melilla;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2021QII;162
52 Melilla;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2021QI;""
52 Melilla;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
52 Melilla;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
52 Melilla;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2020QII;183
52 Melilla;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2020QI;""
52 Melilla;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
52 Melilla;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2022QIII;135
52 Melilla;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2022QII;""
52 Melilla;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2022QI;""
52 Melilla;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
52 Melilla;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2021QIII;146
52 Melilla;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2021QII;""
52 Melilla;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2021QI;""
52 Melilla;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
52 Melilla;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2020QIII;161
52 Melilla;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2020QII;""
52 Melilla;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2020QI;""
52 Melilla;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QIV;122
52 Melilla;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
52 Melilla;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QII;""
52 Melilla;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QI;""
52 Melilla;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QIV;129
52 Melilla;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
52 Melilla;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QII;""
52 Melilla;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QI;""
52 Melilla;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QIV;146
52 Melilla;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
52 Melilla;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QII;""
52 Melilla;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QI;""
52 Melilla;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
52 Melilla;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
52 Melilla;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QII;""
52 Melilla;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QI;112
52 Melilla;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
52 Melilla;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
52 Melilla;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QII;""
52 Melilla;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QI;143
52 Melilla;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
52 Melilla;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
52 Melilla;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QII;""
52 Melilla;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QI;""
52 Melilla;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
52 Melilla;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
52 Melilla;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
52 Melilla;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
52 Melilla;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
52 Melilla;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
52 Melilla;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
52 Melilla;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
52 Melilla;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
52 Melilla;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
52 Melilla;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
52 Melilla;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
52 Melilla;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
52 Melilla;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
52 Melilla;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;91,88
52 Melilla;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
52 Melilla;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
52 Melilla;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
52 Melilla;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;91,53
52 Melilla;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
52 Melilla;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
52 Melilla;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
52 Melilla;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;95,81
52 Melilla;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
52 Melilla;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
52 Melilla;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;84,38
52 Melilla;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
52 Melilla;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
52 Melilla;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
52 Melilla;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;82,49
52 Melilla;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
52 Melilla;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
52 Melilla;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
52 Melilla;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;84,29
52 Melilla;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
52 Melilla;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
52 Melilla;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;76,25
52 Melilla;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
52 Melilla;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
52 Melilla;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
52 Melilla;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;72,88
52 Melilla;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
52 Melilla;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
52 Melilla;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
52 Melilla;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;76,44
52 Melilla;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
52 Melilla;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
52 Melilla;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
52 Melilla;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
52 Melilla;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
52 Melilla;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
52 Melilla;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;63,28
52 Melilla;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
52 Melilla;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
52 Melilla;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
52 Melilla;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;74,87
52 Melilla;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
52 Melilla;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
52 Melilla;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
52 Melilla;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
52 Melilla;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
52 Melilla;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QIII;433
52 Melilla;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
52 Melilla;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
52 Melilla;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
52 Melilla;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QIII;505
52 Melilla;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
52 Melilla;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
52 Melilla;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
52 Melilla;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QIII;524
52 Melilla;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
52 Melilla;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
52 Melilla;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
52 Melilla;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2022QIII;397
52 Melilla;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2022QII;""
52 Melilla;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2022QI;""
52 Melilla;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
52 Melilla;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2021QIII;439
52 Melilla;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2021QII;""
52 Melilla;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2021QI;""
52 Melilla;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
52 Melilla;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2020QIII;467
52 Melilla;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2020QII;""
52 Melilla;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2020QI;""
52 Melilla;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2022QIV;363
52 Melilla;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
52 Melilla;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2022QII;""
52 Melilla;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2022QI;""
52 Melilla;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2021QIV;396
52 Melilla;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
52 Melilla;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2021QII;""
52 Melilla;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2021QI;""
52 Melilla;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2020QIV;425
52 Melilla;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
52 Melilla;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2020QII;""
52 Melilla;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2020QI;""
52 Melilla;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
52 Melilla;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
52 Melilla;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QII;""
52 Melilla;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QI;356
52 Melilla;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
52 Melilla;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
52 Melilla;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QII;""
52 Melilla;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QI;405
52 Melilla;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
52 Melilla;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
52 Melilla;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QII;""
52 Melilla;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QI;""
52 Melilla;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
52 Melilla;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
52 Melilla;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QII;328
52 Melilla;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QI;""
52 Melilla;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
52 Melilla;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
52 Melilla;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QII;375
52 Melilla;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QI;""
52 Melilla;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
52 Melilla;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
52 Melilla;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QII;""
52 Melilla;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QI;""
52 Melilla;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
52 Melilla;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
52 Melilla;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
52 Melilla;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
52 Melilla;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
52 Melilla;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
52 Melilla;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
52 Melilla;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
52 Melilla;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
52 Melilla;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
52 Melilla;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
52 Melilla;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
52 Melilla;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
52 Melilla;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;91,69
52 Melilla;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
52 Melilla;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
52 Melilla;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
52 Melilla;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;86,93
52 Melilla;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
52 Melilla;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
52 Melilla;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
52 Melilla;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;89,12
52 Melilla;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
52 Melilla;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
52 Melilla;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;83,83
52 Melilla;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
52 Melilla;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
52 Melilla;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
52 Melilla;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;78,42
52 Melilla;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
52 Melilla;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
52 Melilla;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
52 Melilla;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;81,11
52 Melilla;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
52 Melilla;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
52 Melilla;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
52 Melilla;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
52 Melilla;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
52 Melilla;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
52 Melilla;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;70,5
52 Melilla;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
52 Melilla;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
52 Melilla;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
52 Melilla;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;77,29
52 Melilla;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
52 Melilla;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
52 Melilla;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
52 Melilla;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
52 Melilla;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
52 Melilla;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
52 Melilla;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;64,95
52 Melilla;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
52 Melilla;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
52 Melilla;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
52 Melilla;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;71,56
52 Melilla;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
52 Melilla;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
52 Melilla;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
52 Melilla;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
52 Melilla;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
52 Melilla;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
52 Melilla;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QIII;269
52 Melilla;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
52 Melilla;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
52 Melilla;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
52 Melilla;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QIII;322
52 Melilla;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
52 Melilla;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
52 Melilla;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
52 Melilla;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QIII;329
52 Melilla;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
52 Melilla;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
52 Melilla;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
52 Melilla;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2022QIII;248
52 Melilla;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2022QII;""
52 Melilla;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2022QI;""
52 Melilla;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
52 Melilla;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2021QIII;274
52 Melilla;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2021QII;""
52 Melilla;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2021QI;""
52 Melilla;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
52 Melilla;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2020QIII;296
52 Melilla;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2020QII;""
52 Melilla;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2020QI;""
52 Melilla;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2022QIV;229
52 Melilla;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
52 Melilla;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2022QII;""
52 Melilla;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2022QI;""
52 Melilla;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2021QIV;251
52 Melilla;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
52 Melilla;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2021QII;""
52 Melilla;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2021QI;""
52 Melilla;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2020QIV;272
52 Melilla;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
52 Melilla;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2020QII;""
52 Melilla;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2020QI;""
52 Melilla;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
52 Melilla;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
52 Melilla;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QII;""
52 Melilla;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QI;229
52 Melilla;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
52 Melilla;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
52 Melilla;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QII;""
52 Melilla;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QI;256
52 Melilla;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
52 Melilla;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
52 Melilla;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QII;""
52 Melilla;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QI;""
52 Melilla;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
52 Melilla;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
52 Melilla;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QII;212
52 Melilla;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QI;""
52 Melilla;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
52 Melilla;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
52 Melilla;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QII;236
52 Melilla;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QI;""
52 Melilla;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
52 Melilla;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
52 Melilla;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QII;""
52 Melilla;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QI;""
52 Melilla;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
52 Melilla;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
52 Melilla;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
52 Melilla;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
52 Melilla;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
52 Melilla;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
52 Melilla;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
52 Melilla;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
52 Melilla;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
52 Melilla;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
52 Melilla;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
52 Melilla;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
52 Melilla;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
52 Melilla;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;92,19
52 Melilla;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
52 Melilla;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
52 Melilla;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
52 Melilla;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;85,09
52 Melilla;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
52 Melilla;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
52 Melilla;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
52 Melilla;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;89,97
52 Melilla;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
52 Melilla;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
52 Melilla;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;85,13
52 Melilla;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
52 Melilla;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
52 Melilla;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
52 Melilla;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;77,95
52 Melilla;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
52 Melilla;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
52 Melilla;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
52 Melilla;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;82,67
52 Melilla;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
52 Melilla;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
52 Melilla;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
52 Melilla;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
52 Melilla;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
52 Melilla;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
52 Melilla;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;71,12
52 Melilla;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
52 Melilla;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
52 Melilla;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
52 Melilla;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;77,81
52 Melilla;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
52 Melilla;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
52 Melilla;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
52 Melilla;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
52 Melilla;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
52 Melilla;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
52 Melilla;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;65,84
52 Melilla;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
52 Melilla;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
52 Melilla;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
52 Melilla;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;71,73
52 Melilla;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
52 Melilla;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
52 Melilla;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
52 Melilla;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
52 Melilla;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
52 Melilla;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
52 Melilla;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QIII;164
52 Melilla;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
52 Melilla;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
52 Melilla;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
52 Melilla;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QIII;183
52 Melilla;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
52 Melilla;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
52 Melilla;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
52 Melilla;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QIII;195
52 Melilla;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
52 Melilla;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
52 Melilla;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
52 Melilla;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2022QIII;149
52 Melilla;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2022QII;""
52 Melilla;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2022QI;""
52 Melilla;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
52 Melilla;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2021QIII;165
52 Melilla;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2021QII;""
52 Melilla;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2021QI;""
52 Melilla;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
52 Melilla;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2020QIII;171
52 Melilla;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2020QII;""
52 Melilla;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2020QI;""
52 Melilla;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2022QIV;134
52 Melilla;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
52 Melilla;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2022QII;""
52 Melilla;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2022QI;""
52 Melilla;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2021QIV;145
52 Melilla;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
52 Melilla;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2021QII;""
52 Melilla;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2021QI;""
52 Melilla;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2020QIV;153
52 Melilla;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
52 Melilla;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2020QII;""
52 Melilla;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2020QI;""
52 Melilla;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
52 Melilla;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
52 Melilla;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QII;""
52 Melilla;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QI;127
52 Melilla;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
52 Melilla;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
52 Melilla;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QII;""
52 Melilla;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QI;149
52 Melilla;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
52 Melilla;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
52 Melilla;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QII;""
52 Melilla;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QI;""
52 Melilla;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
52 Melilla;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
52 Melilla;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QII;116
52 Melilla;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QI;""
52 Melilla;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
52 Melilla;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
52 Melilla;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QII;139
52 Melilla;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QI;""
52 Melilla;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
52 Melilla;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
52 Melilla;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QII;""
52 Melilla;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QI;""
52 Melilla;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
52 Melilla;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
52 Melilla;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
52 Melilla;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
52 Melilla;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
52 Melilla;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
52 Melilla;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
52 Melilla;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
52 Melilla;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
52 Melilla;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
52 Melilla;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
52 Melilla;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
52 Melilla;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
52 Melilla;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;90,85
52 Melilla;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
52 Melilla;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
52 Melilla;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
52 Melilla;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;90,16
52 Melilla;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
52 Melilla;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
52 Melilla;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
52 Melilla;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;87,69
52 Melilla;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
52 Melilla;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
52 Melilla;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;81,71
52 Melilla;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
52 Melilla;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
52 Melilla;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
52 Melilla;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;79,23
52 Melilla;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
52 Melilla;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
52 Melilla;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
52 Melilla;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;78,46
52 Melilla;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
52 Melilla;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
52 Melilla;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
52 Melilla;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
52 Melilla;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
52 Melilla;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
52 Melilla;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;69,4
52 Melilla;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
52 Melilla;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
52 Melilla;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
52 Melilla;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;76,41
52 Melilla;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
52 Melilla;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
52 Melilla;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
52 Melilla;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
52 Melilla;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
52 Melilla;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
52 Melilla;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;63,39
52 Melilla;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
52 Melilla;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
52 Melilla;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
52 Melilla;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;71,28
52 Melilla;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
52 Melilla;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
52 Melilla;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
52 Melilla;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
52 Melilla;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
52 Melilla;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QIV;442
52 Melilla;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
52 Melilla;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
52 Melilla;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
52 Melilla;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QIV;482
52 Melilla;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
52 Melilla;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
52 Melilla;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
52 Melilla;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QIV;532
52 Melilla;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
52 Melilla;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
52 Melilla;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
52 Melilla;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2022QIV;402
52 Melilla;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
52 Melilla;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2022QII;""
52 Melilla;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2022QI;""
52 Melilla;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2021QIV;432
52 Melilla;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
52 Melilla;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2021QII;""
52 Melilla;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2021QI;""
52 Melilla;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2020QIV;477
52 Melilla;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
52 Melilla;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2020QII;""
52 Melilla;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2020QI;""
52 Melilla;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
52 Melilla;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
52 Melilla;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2022QII;""
52 Melilla;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2022QI;389
52 Melilla;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
52 Melilla;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
52 Melilla;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2021QII;""
52 Melilla;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2021QI;451
52 Melilla;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
52 Melilla;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
52 Melilla;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2020QII;""
52 Melilla;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2020QI;""
52 Melilla;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
52 Melilla;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
52 Melilla;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QII;360
52 Melilla;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QI;""
52 Melilla;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
52 Melilla;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
52 Melilla;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QII;416
52 Melilla;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QI;""
52 Melilla;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
52 Melilla;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
52 Melilla;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QII;""
52 Melilla;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QI;""
52 Melilla;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
52 Melilla;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QIII;336
52 Melilla;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QII;""
52 Melilla;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QI;""
52 Melilla;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
52 Melilla;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QIII;377
52 Melilla;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QII;""
52 Melilla;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QI;""
52 Melilla;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
52 Melilla;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
52 Melilla;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QII;""
52 Melilla;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QI;""
52 Melilla;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
52 Melilla;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
52 Melilla;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
52 Melilla;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
52 Melilla;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
52 Melilla;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
52 Melilla;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
52 Melilla;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
52 Melilla;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
52 Melilla;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
52 Melilla;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
52 Melilla;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
52 Melilla;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;90,95
52 Melilla;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
52 Melilla;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
52 Melilla;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
52 Melilla;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;89,63
52 Melilla;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
52 Melilla;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
52 Melilla;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
52 Melilla;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;89,66
52 Melilla;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
52 Melilla;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
52 Melilla;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
52 Melilla;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
52 Melilla;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
52 Melilla;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
52 Melilla;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;80,71
52 Melilla;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
52 Melilla;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
52 Melilla;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
52 Melilla;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;84,77
52 Melilla;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
52 Melilla;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
52 Melilla;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
52 Melilla;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
52 Melilla;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
52 Melilla;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
52 Melilla;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;74,69
52 Melilla;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
52 Melilla;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
52 Melilla;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
52 Melilla;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;78,2
52 Melilla;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
52 Melilla;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
52 Melilla;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
52 Melilla;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
52 Melilla;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
52 Melilla;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
52 Melilla;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;69,71
52 Melilla;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
52 Melilla;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
52 Melilla;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
52 Melilla;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;70,86
52 Melilla;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
52 Melilla;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
52 Melilla;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
52 Melilla;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
52 Melilla;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
52 Melilla;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
52 Melilla;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QIV;275
52 Melilla;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
52 Melilla;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
52 Melilla;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
52 Melilla;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QIV;297
52 Melilla;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
52 Melilla;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
52 Melilla;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
52 Melilla;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QIV;336
52 Melilla;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
52 Melilla;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
52 Melilla;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
52 Melilla;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2022QIV;251
52 Melilla;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
52 Melilla;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2022QII;""
52 Melilla;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2022QI;""
52 Melilla;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2021QIV;270
52 Melilla;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
52 Melilla;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2021QII;""
52 Melilla;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2021QI;""
52 Melilla;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2020QIV;304
52 Melilla;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
52 Melilla;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2020QII;""
52 Melilla;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2020QI;""
52 Melilla;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
52 Melilla;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
52 Melilla;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2022QII;""
52 Melilla;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2022QI;246
52 Melilla;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
52 Melilla;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
52 Melilla;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2021QII;""
52 Melilla;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2021QI;284
52 Melilla;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
52 Melilla;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
52 Melilla;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2020QII;""
52 Melilla;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2020QI;""
52 Melilla;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
52 Melilla;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
52 Melilla;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QII;229
52 Melilla;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QI;""
52 Melilla;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
52 Melilla;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
52 Melilla;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QII;262
52 Melilla;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QI;""
52 Melilla;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
52 Melilla;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
52 Melilla;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QII;""
52 Melilla;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QI;""
52 Melilla;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
52 Melilla;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QIII;217
52 Melilla;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QII;""
52 Melilla;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QI;""
52 Melilla;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
52 Melilla;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QIII;241
52 Melilla;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QII;""
52 Melilla;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QI;""
52 Melilla;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
52 Melilla;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
52 Melilla;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QII;""
52 Melilla;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QI;""
52 Melilla;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
52 Melilla;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
52 Melilla;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
52 Melilla;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
52 Melilla;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
52 Melilla;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
52 Melilla;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
52 Melilla;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
52 Melilla;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
52 Melilla;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
52 Melilla;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
52 Melilla;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
52 Melilla;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;91,27
52 Melilla;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
52 Melilla;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
52 Melilla;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
52 Melilla;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;90,91
52 Melilla;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
52 Melilla;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
52 Melilla;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
52 Melilla;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;90,48
52 Melilla;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
52 Melilla;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
52 Melilla;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
52 Melilla;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
52 Melilla;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
52 Melilla;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
52 Melilla;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;82,83
52 Melilla;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
52 Melilla;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
52 Melilla;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
52 Melilla;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;84,52
52 Melilla;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
52 Melilla;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
52 Melilla;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
52 Melilla;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
52 Melilla;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
52 Melilla;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
52 Melilla;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;77,1
52 Melilla;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
52 Melilla;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
52 Melilla;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
52 Melilla;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;77,98
52 Melilla;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
52 Melilla;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
52 Melilla;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
52 Melilla;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
52 Melilla;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
52 Melilla;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
52 Melilla;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;73,06
52 Melilla;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
52 Melilla;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
52 Melilla;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
52 Melilla;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;71,73
52 Melilla;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
52 Melilla;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
52 Melilla;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
52 Melilla;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
52 Melilla;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
52 Melilla;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
52 Melilla;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QIV;167
52 Melilla;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
52 Melilla;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
52 Melilla;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
52 Melilla;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QIV;185
52 Melilla;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
52 Melilla;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
52 Melilla;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
52 Melilla;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QIV;196
52 Melilla;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
52 Melilla;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
52 Melilla;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
52 Melilla;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2022QIV;151
52 Melilla;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
52 Melilla;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2022QII;""
52 Melilla;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2022QI;""
52 Melilla;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2021QIV;162
52 Melilla;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
52 Melilla;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2021QII;""
52 Melilla;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2021QI;""
52 Melilla;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2020QIV;173
52 Melilla;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
52 Melilla;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2020QII;""
52 Melilla;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2020QI;""
52 Melilla;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
52 Melilla;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
52 Melilla;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2022QII;""
52 Melilla;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2022QI;143
52 Melilla;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
52 Melilla;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
52 Melilla;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2021QII;""
52 Melilla;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2021QI;167
52 Melilla;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
52 Melilla;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
52 Melilla;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2020QII;""
52 Melilla;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2020QI;""
52 Melilla;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
52 Melilla;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
52 Melilla;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QII;131
52 Melilla;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QI;""
52 Melilla;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
52 Melilla;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
52 Melilla;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QII;154
52 Melilla;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QI;""
52 Melilla;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
52 Melilla;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
52 Melilla;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QII;""
52 Melilla;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QI;""
52 Melilla;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
52 Melilla;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QIII;119
52 Melilla;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QII;""
52 Melilla;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QI;""
52 Melilla;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
52 Melilla;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QIII;136
52 Melilla;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QII;""
52 Melilla;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QI;""
52 Melilla;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
52 Melilla;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
52 Melilla;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QII;""
52 Melilla;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QI;""
52 Melilla;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
52 Melilla;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
52 Melilla;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
52 Melilla;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
52 Melilla;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
52 Melilla;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
52 Melilla;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
52 Melilla;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
52 Melilla;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
52 Melilla;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
52 Melilla;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
52 Melilla;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
52 Melilla;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;90,42
52 Melilla;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
52 Melilla;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
52 Melilla;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
52 Melilla;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;87,57
52 Melilla;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
52 Melilla;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
52 Melilla;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
52 Melilla;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;88,27
52 Melilla;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
52 Melilla;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
52 Melilla;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
52 Melilla;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
52 Melilla;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
52 Melilla;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
52 Melilla;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;77,3
52 Melilla;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
52 Melilla;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
52 Melilla;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
52 Melilla;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;85,2
52 Melilla;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
52 Melilla;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
52 Melilla;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
52 Melilla;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
52 Melilla;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
52 Melilla;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
52 Melilla;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;70,81
52 Melilla;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
52 Melilla;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
52 Melilla;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
52 Melilla;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;78,57
52 Melilla;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
52 Melilla;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
52 Melilla;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
52 Melilla;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
52 Melilla;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
52 Melilla;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
52 Melilla;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;64,32
52 Melilla;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
52 Melilla;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
52 Melilla;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
52 Melilla;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;69,39
52 Melilla;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
52 Melilla;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
52 Melilla;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
52 Melilla;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
52 Melilla;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
52 Melilla;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
52 Melilla;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
52 Melilla;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
52 Melilla;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
52 Melilla;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QI;955
52 Melilla;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
52 Melilla;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
52 Melilla;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
52 Melilla;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QI;985
52 Melilla;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
52 Melilla;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
52 Melilla;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
52 Melilla;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QI;1.024
52 Melilla;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
52 Melilla;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
52 Melilla;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2022QII;""
52 Melilla;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2022QI;903
52 Melilla;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
52 Melilla;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
52 Melilla;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2021QII;""
52 Melilla;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2021QI;944
52 Melilla;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
52 Melilla;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
52 Melilla;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2020QII;""
52 Melilla;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2020QI;931
52 Melilla;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
52 Melilla;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
52 Melilla;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2022QII;855
52 Melilla;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2022QI;""
52 Melilla;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
52 Melilla;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
52 Melilla;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2021QII;893
52 Melilla;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2021QI;""
52 Melilla;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
52 Melilla;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
52 Melilla;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2020QII;907
52 Melilla;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2020QI;""
52 Melilla;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
52 Melilla;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QIII;817
52 Melilla;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QII;""
52 Melilla;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QI;""
52 Melilla;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
52 Melilla;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QIII;850
52 Melilla;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QII;""
52 Melilla;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QI;""
52 Melilla;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
52 Melilla;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QIII;842
52 Melilla;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QII;""
52 Melilla;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QI;""
52 Melilla;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QIV;778
52 Melilla;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
52 Melilla;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QII;""
52 Melilla;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QI;""
52 Melilla;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QIV;815
52 Melilla;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
52 Melilla;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QII;""
52 Melilla;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QI;""
52 Melilla;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QIV;800
52 Melilla;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
52 Melilla;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QII;""
52 Melilla;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QI;""
52 Melilla;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
52 Melilla;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
52 Melilla;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
52 Melilla;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
52 Melilla;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
52 Melilla;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
52 Melilla;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
52 Melilla;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
52 Melilla;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
52 Melilla;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
52 Melilla;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
52 Melilla;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
52 Melilla;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
52 Melilla;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
52 Melilla;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
52 Melilla;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;94,55
52 Melilla;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
52 Melilla;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
52 Melilla;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
52 Melilla;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;95,84
52 Melilla;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
52 Melilla;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
52 Melilla;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
52 Melilla;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;90,92
52 Melilla;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
52 Melilla;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
52 Melilla;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;89,53
52 Melilla;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
52 Melilla;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
52 Melilla;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
52 Melilla;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;90,66
52 Melilla;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
52 Melilla;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
52 Melilla;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
52 Melilla;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;88,57
52 Melilla;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
52 Melilla;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
52 Melilla;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;85,55
52 Melilla;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
52 Melilla;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
52 Melilla;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
52 Melilla;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;86,29
52 Melilla;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
52 Melilla;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
52 Melilla;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
52 Melilla;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;82,23
52 Melilla;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
52 Melilla;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
52 Melilla;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;81,47
52 Melilla;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
52 Melilla;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
52 Melilla;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
52 Melilla;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;82,74
52 Melilla;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
52 Melilla;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
52 Melilla;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
52 Melilla;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;78,13
52 Melilla;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
52 Melilla;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
52 Melilla;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
52 Melilla;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
52 Melilla;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
52 Melilla;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
52 Melilla;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QI;606
52 Melilla;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
52 Melilla;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
52 Melilla;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
52 Melilla;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QI;640
52 Melilla;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
52 Melilla;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
52 Melilla;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
52 Melilla;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QI;661
52 Melilla;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
52 Melilla;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
52 Melilla;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2022QII;""
52 Melilla;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2022QI;576
52 Melilla;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
52 Melilla;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
52 Melilla;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2021QII;""
52 Melilla;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2021QI;614
52 Melilla;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
52 Melilla;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
52 Melilla;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2020QII;""
52 Melilla;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2020QI;603
52 Melilla;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
52 Melilla;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
52 Melilla;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2022QII;554
52 Melilla;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2022QI;""
52 Melilla;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
52 Melilla;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
52 Melilla;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2021QII;584
52 Melilla;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2021QI;""
52 Melilla;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
52 Melilla;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
52 Melilla;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2020QII;588
52 Melilla;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2020QI;""
52 Melilla;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
52 Melilla;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QIII;531
52 Melilla;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QII;""
52 Melilla;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QI;""
52 Melilla;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
52 Melilla;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QIII;553
52 Melilla;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QII;""
52 Melilla;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QI;""
52 Melilla;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
52 Melilla;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QIII;548
52 Melilla;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QII;""
52 Melilla;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QI;""
52 Melilla;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QIV;502
52 Melilla;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
52 Melilla;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QII;""
52 Melilla;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QI;""
52 Melilla;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QIV;531
52 Melilla;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
52 Melilla;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QII;""
52 Melilla;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QI;""
52 Melilla;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QIV;519
52 Melilla;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
52 Melilla;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QII;""
52 Melilla;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QI;""
52 Melilla;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
52 Melilla;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
52 Melilla;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
52 Melilla;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
52 Melilla;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
52 Melilla;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
52 Melilla;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
52 Melilla;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
52 Melilla;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
52 Melilla;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
52 Melilla;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
52 Melilla;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
52 Melilla;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
52 Melilla;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
52 Melilla;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
52 Melilla;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;95,05
52 Melilla;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
52 Melilla;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
52 Melilla;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
52 Melilla;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;95,94
52 Melilla;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
52 Melilla;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
52 Melilla;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
52 Melilla;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;91,23
52 Melilla;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
52 Melilla;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
52 Melilla;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;91,42
52 Melilla;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
52 Melilla;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
52 Melilla;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
52 Melilla;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;91,25
52 Melilla;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
52 Melilla;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
52 Melilla;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
52 Melilla;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;88,96
52 Melilla;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
52 Melilla;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
52 Melilla;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;87,62
52 Melilla;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
52 Melilla;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
52 Melilla;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
52 Melilla;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;86,41
52 Melilla;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
52 Melilla;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
52 Melilla;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
52 Melilla;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;82,9
52 Melilla;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
52 Melilla;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
52 Melilla;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;82,84
52 Melilla;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
52 Melilla;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
52 Melilla;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
52 Melilla;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;82,97
52 Melilla;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
52 Melilla;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
52 Melilla;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
52 Melilla;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;78,52
52 Melilla;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
52 Melilla;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
52 Melilla;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
52 Melilla;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
52 Melilla;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
52 Melilla;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
52 Melilla;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QI;349
52 Melilla;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
52 Melilla;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
52 Melilla;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
52 Melilla;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QI;345
52 Melilla;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
52 Melilla;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
52 Melilla;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
52 Melilla;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QI;363
52 Melilla;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
52 Melilla;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
52 Melilla;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2022QII;""
52 Melilla;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2022QI;327
52 Melilla;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
52 Melilla;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
52 Melilla;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2021QII;""
52 Melilla;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2021QI;330
52 Melilla;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
52 Melilla;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
52 Melilla;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2020QII;""
52 Melilla;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2020QI;328
52 Melilla;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
52 Melilla;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
52 Melilla;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2022QII;301
52 Melilla;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2022QI;""
52 Melilla;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
52 Melilla;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
52 Melilla;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2021QII;309
52 Melilla;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2021QI;""
52 Melilla;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
52 Melilla;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
52 Melilla;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2020QII;319
52 Melilla;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2020QI;""
52 Melilla;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
52 Melilla;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QIII;286
52 Melilla;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QII;""
52 Melilla;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QI;""
52 Melilla;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
52 Melilla;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QIII;297
52 Melilla;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QII;""
52 Melilla;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QI;""
52 Melilla;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
52 Melilla;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QIII;294
52 Melilla;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QII;""
52 Melilla;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QI;""
52 Melilla;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QIV;276
52 Melilla;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
52 Melilla;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QII;""
52 Melilla;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QI;""
52 Melilla;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QIV;284
52 Melilla;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
52 Melilla;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QII;""
52 Melilla;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QI;""
52 Melilla;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QIV;281
52 Melilla;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
52 Melilla;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QII;""
52 Melilla;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QI;""
52 Melilla;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
52 Melilla;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
52 Melilla;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
52 Melilla;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
52 Melilla;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
52 Melilla;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
52 Melilla;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
52 Melilla;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
52 Melilla;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
52 Melilla;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
52 Melilla;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
52 Melilla;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
52 Melilla;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
52 Melilla;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
52 Melilla;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
52 Melilla;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;93,7
52 Melilla;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
52 Melilla;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
52 Melilla;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
52 Melilla;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;95,65
52 Melilla;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
52 Melilla;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
52 Melilla;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
52 Melilla;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;90,36
52 Melilla;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
52 Melilla;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
52 Melilla;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;86,25
52 Melilla;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
52 Melilla;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
52 Melilla;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
52 Melilla;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;89,57
52 Melilla;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
52 Melilla;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
52 Melilla;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
52 Melilla;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;87,88
52 Melilla;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
52 Melilla;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
52 Melilla;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;81,95
52 Melilla;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
52 Melilla;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
52 Melilla;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
52 Melilla;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;86,09
52 Melilla;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
52 Melilla;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
52 Melilla;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
52 Melilla;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;80,99
52 Melilla;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
52 Melilla;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
52 Melilla;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;79,08
52 Melilla;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
52 Melilla;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
52 Melilla;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
52 Melilla;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;82,32
52 Melilla;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
52 Melilla;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
52 Melilla;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
52 Melilla;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;77,41
52 Melilla;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
52 Melilla;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
52 Melilla;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
52 Melilla;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
52 Melilla;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
52 Melilla;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QII;914
52 Melilla;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
52 Melilla;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
52 Melilla;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
52 Melilla;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QII;971
52 Melilla;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
52 Melilla;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
52 Melilla;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
52 Melilla;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QII;1.011
52 Melilla;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
52 Melilla;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
52 Melilla;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
52 Melilla;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2022QII;862
52 Melilla;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2022QI;""
52 Melilla;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
52 Melilla;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
52 Melilla;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2021QII;913
52 Melilla;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2021QI;""
52 Melilla;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
52 Melilla;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
52 Melilla;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2020QII;981
52 Melilla;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2020QI;""
52 Melilla;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
52 Melilla;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2022QIII;815
52 Melilla;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2022QII;""
52 Melilla;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2022QI;""
52 Melilla;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
52 Melilla;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2021QIII;867
52 Melilla;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2021QII;""
52 Melilla;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2021QI;""
52 Melilla;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
52 Melilla;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2020QIII;908
52 Melilla;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2020QII;""
52 Melilla;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2020QI;""
52 Melilla;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QIV;773
52 Melilla;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
52 Melilla;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QII;""
52 Melilla;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QI;""
52 Melilla;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QIV;825
52 Melilla;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
52 Melilla;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QII;""
52 Melilla;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QI;""
52 Melilla;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QIV;859
52 Melilla;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
52 Melilla;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QII;""
52 Melilla;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QI;""
52 Melilla;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
52 Melilla;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
52 Melilla;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QII;""
52 Melilla;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QI;783
52 Melilla;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
52 Melilla;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
52 Melilla;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QII;""
52 Melilla;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QI;833
52 Melilla;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
52 Melilla;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
52 Melilla;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QII;""
52 Melilla;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QI;""
52 Melilla;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
52 Melilla;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
52 Melilla;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
52 Melilla;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
52 Melilla;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
52 Melilla;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
52 Melilla;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
52 Melilla;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
52 Melilla;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
52 Melilla;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
52 Melilla;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
52 Melilla;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
52 Melilla;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
52 Melilla;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
52 Melilla;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;94,31
52 Melilla;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
52 Melilla;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
52 Melilla;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
52 Melilla;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;94,03
52 Melilla;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
52 Melilla;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
52 Melilla;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
52 Melilla;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;97,03
52 Melilla;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
52 Melilla;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
52 Melilla;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;89,17
52 Melilla;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
52 Melilla;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
52 Melilla;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
52 Melilla;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;89,29
52 Melilla;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
52 Melilla;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
52 Melilla;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
52 Melilla;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;89,81
52 Melilla;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
52 Melilla;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
52 Melilla;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;84,57
52 Melilla;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
52 Melilla;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
52 Melilla;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
52 Melilla;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;84,96
52 Melilla;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
52 Melilla;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
52 Melilla;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
52 Melilla;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;84,97
52 Melilla;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
52 Melilla;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
52 Melilla;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
52 Melilla;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
52 Melilla;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
52 Melilla;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
52 Melilla;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;80,64
52 Melilla;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
52 Melilla;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
52 Melilla;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
52 Melilla;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;82,39
52 Melilla;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
52 Melilla;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
52 Melilla;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
52 Melilla;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
52 Melilla;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
52 Melilla;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
52 Melilla;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QII;573
52 Melilla;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
52 Melilla;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
52 Melilla;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
52 Melilla;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QII;629
52 Melilla;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
52 Melilla;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
52 Melilla;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
52 Melilla;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QII;654
52 Melilla;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
52 Melilla;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
52 Melilla;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
52 Melilla;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2022QII;547
52 Melilla;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2022QI;""
52 Melilla;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
52 Melilla;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
52 Melilla;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2021QII;597
52 Melilla;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2021QI;""
52 Melilla;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
52 Melilla;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
52 Melilla;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2020QII;635
52 Melilla;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2020QI;""
52 Melilla;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
52 Melilla;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2022QIII;523
52 Melilla;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2022QII;""
52 Melilla;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2022QI;""
52 Melilla;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
52 Melilla;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2021QIII;568
52 Melilla;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2021QII;""
52 Melilla;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2021QI;""
52 Melilla;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
52 Melilla;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2020QIII;590
52 Melilla;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2020QII;""
52 Melilla;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2020QI;""
52 Melilla;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QIV;494
52 Melilla;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
52 Melilla;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QII;""
52 Melilla;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QI;""
52 Melilla;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QIV;542
52 Melilla;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
52 Melilla;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QII;""
52 Melilla;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QI;""
52 Melilla;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QIV;558
52 Melilla;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
52 Melilla;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QII;""
52 Melilla;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QI;""
52 Melilla;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
52 Melilla;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
52 Melilla;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QII;""
52 Melilla;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QI;515
52 Melilla;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
52 Melilla;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
52 Melilla;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QII;""
52 Melilla;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QI;543
52 Melilla;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
52 Melilla;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
52 Melilla;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QII;""
52 Melilla;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QI;""
52 Melilla;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
52 Melilla;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
52 Melilla;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
52 Melilla;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
52 Melilla;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
52 Melilla;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
52 Melilla;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
52 Melilla;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
52 Melilla;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
52 Melilla;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
52 Melilla;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
52 Melilla;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
52 Melilla;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
52 Melilla;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
52 Melilla;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;95,46
52 Melilla;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
52 Melilla;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
52 Melilla;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
52 Melilla;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;94,91
52 Melilla;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
52 Melilla;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
52 Melilla;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
52 Melilla;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;97,09
52 Melilla;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
52 Melilla;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
52 Melilla;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;91,27
52 Melilla;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
52 Melilla;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
52 Melilla;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
52 Melilla;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;90,3
52 Melilla;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
52 Melilla;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
52 Melilla;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
52 Melilla;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;90,21
52 Melilla;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
52 Melilla;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
52 Melilla;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;86,21
52 Melilla;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
52 Melilla;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
52 Melilla;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
52 Melilla;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;86,17
52 Melilla;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
52 Melilla;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
52 Melilla;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
52 Melilla;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;85,32
52 Melilla;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
52 Melilla;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
52 Melilla;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
52 Melilla;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
52 Melilla;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
52 Melilla;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
52 Melilla;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;81,88
52 Melilla;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
52 Melilla;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
52 Melilla;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
52 Melilla;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;83,03
52 Melilla;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
52 Melilla;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
52 Melilla;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
52 Melilla;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
52 Melilla;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
52 Melilla;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
52 Melilla;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QII;341
52 Melilla;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
52 Melilla;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
52 Melilla;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
52 Melilla;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QII;342
52 Melilla;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
52 Melilla;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
52 Melilla;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
52 Melilla;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QII;357
52 Melilla;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
52 Melilla;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
52 Melilla;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
52 Melilla;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2022QII;315
52 Melilla;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2022QI;""
52 Melilla;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
52 Melilla;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
52 Melilla;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2021QII;316
52 Melilla;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2021QI;""
52 Melilla;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
52 Melilla;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
52 Melilla;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2020QII;346
52 Melilla;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2020QI;""
52 Melilla;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
52 Melilla;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2022QIII;292
52 Melilla;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2022QII;""
52 Melilla;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2022QI;""
52 Melilla;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
52 Melilla;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2021QIII;299
52 Melilla;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2021QII;""
52 Melilla;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2021QI;""
52 Melilla;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
52 Melilla;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2020QIII;318
52 Melilla;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2020QII;""
52 Melilla;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2020QI;""
52 Melilla;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QIV;279
52 Melilla;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
52 Melilla;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QII;""
52 Melilla;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QI;""
52 Melilla;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QIV;283
52 Melilla;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
52 Melilla;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QII;""
52 Melilla;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QI;""
52 Melilla;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QIV;301
52 Melilla;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
52 Melilla;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QII;""
52 Melilla;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QI;""
52 Melilla;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
52 Melilla;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
52 Melilla;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QII;""
52 Melilla;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QI;268
52 Melilla;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
52 Melilla;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
52 Melilla;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QII;""
52 Melilla;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QI;290
52 Melilla;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
52 Melilla;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
52 Melilla;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QII;""
52 Melilla;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QI;""
52 Melilla;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
52 Melilla;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
52 Melilla;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
52 Melilla;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
52 Melilla;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
52 Melilla;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
52 Melilla;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
52 Melilla;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
52 Melilla;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
52 Melilla;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
52 Melilla;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
52 Melilla;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
52 Melilla;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
52 Melilla;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
52 Melilla;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;92,38
52 Melilla;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
52 Melilla;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
52 Melilla;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
52 Melilla;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;92,4
52 Melilla;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
52 Melilla;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
52 Melilla;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
52 Melilla;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;96,92
52 Melilla;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
52 Melilla;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
52 Melilla;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;85,63
52 Melilla;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
52 Melilla;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
52 Melilla;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
52 Melilla;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;87,43
52 Melilla;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
52 Melilla;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
52 Melilla;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
52 Melilla;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;89,08
52 Melilla;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
52 Melilla;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
52 Melilla;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;81,82
52 Melilla;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
52 Melilla;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
52 Melilla;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
52 Melilla;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;82,75
52 Melilla;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
52 Melilla;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
52 Melilla;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
52 Melilla;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;84,31
52 Melilla;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
52 Melilla;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
52 Melilla;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
52 Melilla;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
52 Melilla;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
52 Melilla;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
52 Melilla;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;78,36
52 Melilla;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
52 Melilla;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
52 Melilla;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
52 Melilla;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;81,23
52 Melilla;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
52 Melilla;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
52 Melilla;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
52 Melilla;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
52 Melilla;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
52 Melilla;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QIII;925
52 Melilla;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
52 Melilla;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
52 Melilla;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
52 Melilla;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QIII;975
52 Melilla;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
52 Melilla;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
52 Melilla;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
52 Melilla;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QIII;1.017
52 Melilla;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
52 Melilla;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
52 Melilla;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
52 Melilla;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2022QIII;871
52 Melilla;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2022QII;""
52 Melilla;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2022QI;""
52 Melilla;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
52 Melilla;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2021QIII;922
52 Melilla;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2021QII;""
52 Melilla;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2021QI;""
52 Melilla;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
52 Melilla;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2020QIII;938
52 Melilla;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2020QII;""
52 Melilla;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2020QI;""
52 Melilla;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2022QIV;823
52 Melilla;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
52 Melilla;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2022QII;""
52 Melilla;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2022QI;""
52 Melilla;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2021QIV;875
52 Melilla;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
52 Melilla;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2021QII;""
52 Melilla;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2021QI;""
52 Melilla;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2020QIV;884
52 Melilla;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
52 Melilla;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2020QII;""
52 Melilla;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2020QI;""
52 Melilla;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
52 Melilla;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
52 Melilla;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QII;""
52 Melilla;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QI;831
52 Melilla;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
52 Melilla;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
52 Melilla;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QII;""
52 Melilla;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QI;855
52 Melilla;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
52 Melilla;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
52 Melilla;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QII;""
52 Melilla;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QI;""
52 Melilla;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
52 Melilla;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
52 Melilla;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QII;788
52 Melilla;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QI;""
52 Melilla;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
52 Melilla;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
52 Melilla;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QII;811
52 Melilla;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QI;""
52 Melilla;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
52 Melilla;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
52 Melilla;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QII;""
52 Melilla;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QI;""
52 Melilla;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
52 Melilla;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
52 Melilla;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
52 Melilla;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
52 Melilla;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
52 Melilla;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
52 Melilla;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
52 Melilla;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
52 Melilla;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
52 Melilla;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
52 Melilla;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
52 Melilla;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
52 Melilla;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
52 Melilla;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;94,16
52 Melilla;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
52 Melilla;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
52 Melilla;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
52 Melilla;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;94,56
52 Melilla;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
52 Melilla;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
52 Melilla;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
52 Melilla;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;92,23
52 Melilla;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
52 Melilla;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
52 Melilla;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;88,97
52 Melilla;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
52 Melilla;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
52 Melilla;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
52 Melilla;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;89,74
52 Melilla;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
52 Melilla;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
52 Melilla;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
52 Melilla;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;86,92
52 Melilla;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
52 Melilla;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
52 Melilla;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
52 Melilla;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
52 Melilla;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
52 Melilla;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
52 Melilla;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;85,23
52 Melilla;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
52 Melilla;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
52 Melilla;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
52 Melilla;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;84,07
52 Melilla;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
52 Melilla;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
52 Melilla;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
52 Melilla;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
52 Melilla;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
52 Melilla;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
52 Melilla;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;80,82
52 Melilla;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
52 Melilla;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
52 Melilla;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
52 Melilla;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;79,74
52 Melilla;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
52 Melilla;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
52 Melilla;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
52 Melilla;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
52 Melilla;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
52 Melilla;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
52 Melilla;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QIII;589
52 Melilla;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
52 Melilla;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
52 Melilla;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
52 Melilla;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QIII;629
52 Melilla;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
52 Melilla;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
52 Melilla;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
52 Melilla;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QIII;666
52 Melilla;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
52 Melilla;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
52 Melilla;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
52 Melilla;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2022QIII;561
52 Melilla;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2022QII;""
52 Melilla;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2022QI;""
52 Melilla;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
52 Melilla;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2021QIII;594
52 Melilla;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2021QII;""
52 Melilla;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2021QI;""
52 Melilla;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
52 Melilla;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2020QIII;616
52 Melilla;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2020QII;""
52 Melilla;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2020QI;""
52 Melilla;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2022QIV;529
52 Melilla;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
52 Melilla;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2022QII;""
52 Melilla;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2022QI;""
52 Melilla;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2021QIV;566
52 Melilla;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
52 Melilla;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2021QII;""
52 Melilla;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2021QI;""
52 Melilla;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2020QIV;579
52 Melilla;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
52 Melilla;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2020QII;""
52 Melilla;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2020QI;""
52 Melilla;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
52 Melilla;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
52 Melilla;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QII;""
52 Melilla;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QI;539
52 Melilla;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
52 Melilla;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
52 Melilla;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QII;""
52 Melilla;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QI;561
52 Melilla;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
52 Melilla;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
52 Melilla;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QII;""
52 Melilla;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QI;""
52 Melilla;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
52 Melilla;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
52 Melilla;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QII;518
52 Melilla;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QI;""
52 Melilla;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
52 Melilla;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
52 Melilla;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QII;533
52 Melilla;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QI;""
52 Melilla;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
52 Melilla;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
52 Melilla;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QII;""
52 Melilla;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QI;""
52 Melilla;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
52 Melilla;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
52 Melilla;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
52 Melilla;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
52 Melilla;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
52 Melilla;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
52 Melilla;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
52 Melilla;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
52 Melilla;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
52 Melilla;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
52 Melilla;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
52 Melilla;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
52 Melilla;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
52 Melilla;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;95,25
52 Melilla;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
52 Melilla;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
52 Melilla;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
52 Melilla;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;94,44
52 Melilla;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
52 Melilla;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
52 Melilla;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
52 Melilla;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;92,49
52 Melilla;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
52 Melilla;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
52 Melilla;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;89,81
52 Melilla;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
52 Melilla;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
52 Melilla;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
52 Melilla;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;89,98
52 Melilla;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
52 Melilla;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
52 Melilla;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
52 Melilla;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;86,94
52 Melilla;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
52 Melilla;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
52 Melilla;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
52 Melilla;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
52 Melilla;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
52 Melilla;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
52 Melilla;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;85,69
52 Melilla;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
52 Melilla;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
52 Melilla;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
52 Melilla;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;84,23
52 Melilla;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
52 Melilla;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
52 Melilla;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
52 Melilla;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
52 Melilla;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
52 Melilla;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
52 Melilla;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;82,35
52 Melilla;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
52 Melilla;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
52 Melilla;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
52 Melilla;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;80,03
52 Melilla;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
52 Melilla;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
52 Melilla;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
52 Melilla;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
52 Melilla;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
52 Melilla;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
52 Melilla;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QIII;336
52 Melilla;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
52 Melilla;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
52 Melilla;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
52 Melilla;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QIII;346
52 Melilla;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
52 Melilla;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
52 Melilla;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
52 Melilla;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QIII;351
52 Melilla;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
52 Melilla;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
52 Melilla;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
52 Melilla;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2022QIII;310
52 Melilla;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2022QII;""
52 Melilla;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2022QI;""
52 Melilla;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
52 Melilla;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2021QIII;328
52 Melilla;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2021QII;""
52 Melilla;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2021QI;""
52 Melilla;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
52 Melilla;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2020QIII;322
52 Melilla;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2020QII;""
52 Melilla;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2020QI;""
52 Melilla;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2022QIV;294
52 Melilla;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
52 Melilla;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2022QII;""
52 Melilla;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2022QI;""
52 Melilla;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2021QIV;309
52 Melilla;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
52 Melilla;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2021QII;""
52 Melilla;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2021QI;""
52 Melilla;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2020QIV;305
52 Melilla;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
52 Melilla;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2020QII;""
52 Melilla;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2020QI;""
52 Melilla;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
52 Melilla;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
52 Melilla;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QII;""
52 Melilla;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QI;292
52 Melilla;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
52 Melilla;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
52 Melilla;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QII;""
52 Melilla;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QI;294
52 Melilla;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
52 Melilla;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
52 Melilla;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QII;""
52 Melilla;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QI;""
52 Melilla;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
52 Melilla;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
52 Melilla;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QII;270
52 Melilla;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QI;""
52 Melilla;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
52 Melilla;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
52 Melilla;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QII;278
52 Melilla;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QI;""
52 Melilla;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
52 Melilla;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
52 Melilla;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QII;""
52 Melilla;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QI;""
52 Melilla;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
52 Melilla;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
52 Melilla;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
52 Melilla;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
52 Melilla;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
52 Melilla;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
52 Melilla;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
52 Melilla;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
52 Melilla;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
52 Melilla;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
52 Melilla;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
52 Melilla;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
52 Melilla;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
52 Melilla;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;92,26
52 Melilla;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
52 Melilla;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
52 Melilla;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
52 Melilla;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;94,8
52 Melilla;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
52 Melilla;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
52 Melilla;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
52 Melilla;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;91,74
52 Melilla;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
52 Melilla;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
52 Melilla;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;87,5
52 Melilla;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
52 Melilla;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
52 Melilla;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
52 Melilla;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;89,31
52 Melilla;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
52 Melilla;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
52 Melilla;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
52 Melilla;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;86,89
52 Melilla;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
52 Melilla;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
52 Melilla;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
52 Melilla;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
52 Melilla;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
52 Melilla;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
52 Melilla;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;84,39
52 Melilla;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
52 Melilla;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
52 Melilla;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
52 Melilla;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;83,76
52 Melilla;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
52 Melilla;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
52 Melilla;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
52 Melilla;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
52 Melilla;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
52 Melilla;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
52 Melilla;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;78,03
52 Melilla;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
52 Melilla;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
52 Melilla;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
52 Melilla;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;79,2
52 Melilla;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
52 Melilla;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
52 Melilla;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
52 Melilla;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
52 Melilla;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
52 Melilla;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QIV;913
52 Melilla;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
52 Melilla;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
52 Melilla;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
52 Melilla;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QIV;967
52 Melilla;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
52 Melilla;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
52 Melilla;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
52 Melilla;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QIV;977
52 Melilla;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
52 Melilla;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
52 Melilla;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
52 Melilla;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2022QIV;859
52 Melilla;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
52 Melilla;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2022QII;""
52 Melilla;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2022QI;""
52 Melilla;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2021QIV;914
52 Melilla;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
52 Melilla;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2021QII;""
52 Melilla;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2021QI;""
52 Melilla;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2020QIV;917
52 Melilla;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
52 Melilla;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2020QII;""
52 Melilla;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2020QI;""
52 Melilla;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
52 Melilla;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
52 Melilla;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2022QII;""
52 Melilla;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2022QI;865
52 Melilla;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
52 Melilla;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
52 Melilla;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2021QII;""
52 Melilla;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2021QI;885
52 Melilla;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
52 Melilla;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
52 Melilla;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2020QII;""
52 Melilla;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2020QI;""
52 Melilla;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
52 Melilla;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
52 Melilla;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QII;821
52 Melilla;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QI;""
52 Melilla;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
52 Melilla;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
52 Melilla;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QII;840
52 Melilla;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QI;""
52 Melilla;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
52 Melilla;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
52 Melilla;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QII;""
52 Melilla;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QI;""
52 Melilla;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
52 Melilla;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QIII;784
52 Melilla;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QII;""
52 Melilla;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QI;""
52 Melilla;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
52 Melilla;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QIII;802
52 Melilla;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QII;""
52 Melilla;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QI;""
52 Melilla;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
52 Melilla;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
52 Melilla;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QII;""
52 Melilla;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QI;""
52 Melilla;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
52 Melilla;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
52 Melilla;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
52 Melilla;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
52 Melilla;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
52 Melilla;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
52 Melilla;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
52 Melilla;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
52 Melilla;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
52 Melilla;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
52 Melilla;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
52 Melilla;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
52 Melilla;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;94,09
52 Melilla;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
52 Melilla;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
52 Melilla;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
52 Melilla;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;94,52
52 Melilla;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
52 Melilla;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
52 Melilla;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
52 Melilla;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;93,86
52 Melilla;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
52 Melilla;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
52 Melilla;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
52 Melilla;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
52 Melilla;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
52 Melilla;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
52 Melilla;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;89,45
52 Melilla;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
52 Melilla;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
52 Melilla;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
52 Melilla;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;90,58
52 Melilla;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
52 Melilla;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
52 Melilla;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
52 Melilla;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
52 Melilla;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
52 Melilla;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
52 Melilla;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;84,9
52 Melilla;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
52 Melilla;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
52 Melilla;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
52 Melilla;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;85,98
52 Melilla;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
52 Melilla;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
52 Melilla;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
52 Melilla;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
52 Melilla;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
52 Melilla;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
52 Melilla;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;81,08
52 Melilla;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
52 Melilla;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
52 Melilla;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
52 Melilla;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;82,09
52 Melilla;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
52 Melilla;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
52 Melilla;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
52 Melilla;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
52 Melilla;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
52 Melilla;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
52 Melilla;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QIV;586
52 Melilla;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
52 Melilla;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
52 Melilla;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
52 Melilla;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QIV;615
52 Melilla;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
52 Melilla;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
52 Melilla;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
52 Melilla;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QIV;641
52 Melilla;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
52 Melilla;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
52 Melilla;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
52 Melilla;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2022QIV;551
52 Melilla;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
52 Melilla;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2022QII;""
52 Melilla;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2022QI;""
52 Melilla;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2021QIV;582
52 Melilla;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
52 Melilla;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2021QII;""
52 Melilla;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2021QI;""
52 Melilla;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2020QIV;601
52 Melilla;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
52 Melilla;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2020QII;""
52 Melilla;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2020QI;""
52 Melilla;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
52 Melilla;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
52 Melilla;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2022QII;""
52 Melilla;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2022QI;554
52 Melilla;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
52 Melilla;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
52 Melilla;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2021QII;""
52 Melilla;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2021QI;581
52 Melilla;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
52 Melilla;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
52 Melilla;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2020QII;""
52 Melilla;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2020QI;""
52 Melilla;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
52 Melilla;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
52 Melilla;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QII;533
52 Melilla;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QI;""
52 Melilla;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
52 Melilla;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
52 Melilla;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QII;552
52 Melilla;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QI;""
52 Melilla;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
52 Melilla;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
52 Melilla;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QII;""
52 Melilla;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QI;""
52 Melilla;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
52 Melilla;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QIII;511
52 Melilla;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QII;""
52 Melilla;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QI;""
52 Melilla;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
52 Melilla;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QIII;525
52 Melilla;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QII;""
52 Melilla;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QI;""
52 Melilla;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
52 Melilla;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
52 Melilla;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QII;""
52 Melilla;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QI;""
52 Melilla;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
52 Melilla;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
52 Melilla;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
52 Melilla;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
52 Melilla;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
52 Melilla;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
52 Melilla;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
52 Melilla;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
52 Melilla;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
52 Melilla;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
52 Melilla;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
52 Melilla;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
52 Melilla;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;94,03
52 Melilla;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
52 Melilla;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
52 Melilla;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
52 Melilla;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;94,63
52 Melilla;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
52 Melilla;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
52 Melilla;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
52 Melilla;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;93,76
52 Melilla;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
52 Melilla;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
52 Melilla;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
52 Melilla;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
52 Melilla;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
52 Melilla;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
52 Melilla;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;90,08
52 Melilla;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
52 Melilla;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
52 Melilla;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
52 Melilla;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;90,64
52 Melilla;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
52 Melilla;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
52 Melilla;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
52 Melilla;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
52 Melilla;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
52 Melilla;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
52 Melilla;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;86,67
52 Melilla;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
52 Melilla;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
52 Melilla;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
52 Melilla;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;86,12
52 Melilla;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
52 Melilla;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
52 Melilla;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
52 Melilla;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
52 Melilla;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
52 Melilla;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
52 Melilla;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;83,09
52 Melilla;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
52 Melilla;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
52 Melilla;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
52 Melilla;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;81,9
52 Melilla;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
52 Melilla;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
52 Melilla;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
52 Melilla;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
52 Melilla;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
52 Melilla;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
52 Melilla;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QIV;327
52 Melilla;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
52 Melilla;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
52 Melilla;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
52 Melilla;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QIV;352
52 Melilla;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
52 Melilla;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
52 Melilla;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
52 Melilla;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QIV;336
52 Melilla;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
52 Melilla;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
52 Melilla;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
52 Melilla;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2022QIV;308
52 Melilla;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
52 Melilla;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2022QII;""
52 Melilla;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2022QI;""
52 Melilla;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2021QIV;332
52 Melilla;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
52 Melilla;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2021QII;""
52 Melilla;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2021QI;""
52 Melilla;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2020QIV;316
52 Melilla;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
52 Melilla;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2020QII;""
52 Melilla;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2020QI;""
52 Melilla;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
52 Melilla;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
52 Melilla;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2022QII;""
52 Melilla;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2022QI;311
52 Melilla;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
52 Melilla;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
52 Melilla;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2021QII;""
52 Melilla;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2021QI;304
52 Melilla;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
52 Melilla;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
52 Melilla;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2020QII;""
52 Melilla;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2020QI;""
52 Melilla;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
52 Melilla;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
52 Melilla;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QII;288
52 Melilla;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QI;""
52 Melilla;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
52 Melilla;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
52 Melilla;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QII;288
52 Melilla;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QI;""
52 Melilla;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
52 Melilla;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
52 Melilla;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QII;""
52 Melilla;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QI;""
52 Melilla;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
52 Melilla;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QIII;273
52 Melilla;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QII;""
52 Melilla;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QI;""
52 Melilla;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
52 Melilla;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QIII;277
52 Melilla;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QII;""
52 Melilla;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QI;""
52 Melilla;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
52 Melilla;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
52 Melilla;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QII;""
52 Melilla;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QI;""
52 Melilla;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
52 Melilla;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
52 Melilla;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
52 Melilla;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
52 Melilla;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
52 Melilla;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
52 Melilla;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
52 Melilla;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
52 Melilla;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
52 Melilla;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
52 Melilla;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
52 Melilla;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
52 Melilla;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;94,19
52 Melilla;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
52 Melilla;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
52 Melilla;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
52 Melilla;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;94,32
52 Melilla;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
52 Melilla;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
52 Melilla;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
52 Melilla;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;94,05
52 Melilla;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
52 Melilla;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
52 Melilla;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
52 Melilla;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
52 Melilla;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
52 Melilla;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
52 Melilla;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;88,35
52 Melilla;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
52 Melilla;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
52 Melilla;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
52 Melilla;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;90,48
52 Melilla;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
52 Melilla;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
52 Melilla;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
52 Melilla;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
52 Melilla;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
52 Melilla;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
52 Melilla;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;81,82
52 Melilla;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
52 Melilla;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
52 Melilla;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
52 Melilla;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;85,71
52 Melilla;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
52 Melilla;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
52 Melilla;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
52 Melilla;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
52 Melilla;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
52 Melilla;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
52 Melilla;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;77,56
52 Melilla;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
52 Melilla;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
52 Melilla;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
52 Melilla;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;82,44
52 Melilla;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
52 Melilla;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
52 Melilla;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
52 Melilla;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
52 Melilla;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
52 Melilla;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
52 Melilla;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
52 Melilla;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
52 Melilla;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
52 Melilla;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QI;1.223
52 Melilla;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
52 Melilla;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
52 Melilla;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
52 Melilla;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QI;1.249
52 Melilla;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
52 Melilla;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
52 Melilla;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
52 Melilla;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QI;1.306
52 Melilla;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
52 Melilla;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
52 Melilla;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2022QII;""
52 Melilla;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2022QI;1.164
52 Melilla;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
52 Melilla;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
52 Melilla;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2021QII;""
52 Melilla;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2021QI;1.201
52 Melilla;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
52 Melilla;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
52 Melilla;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2020QII;""
52 Melilla;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2020QI;1.241
52 Melilla;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
52 Melilla;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
52 Melilla;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2022QII;1.116
52 Melilla;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2022QI;""
52 Melilla;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
52 Melilla;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
52 Melilla;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2021QII;1.163
52 Melilla;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2021QI;""
52 Melilla;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
52 Melilla;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
52 Melilla;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2020QII;1.216
52 Melilla;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2020QI;""
52 Melilla;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
52 Melilla;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QIII;1.077
52 Melilla;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QII;""
52 Melilla;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QI;""
52 Melilla;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
52 Melilla;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QIII;1.127
52 Melilla;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QII;""
52 Melilla;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QI;""
52 Melilla;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
52 Melilla;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QIII;1.163
52 Melilla;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QII;""
52 Melilla;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QI;""
52 Melilla;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QIV;1.039
52 Melilla;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
52 Melilla;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QII;""
52 Melilla;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QI;""
52 Melilla;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QIV;1.088
52 Melilla;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
52 Melilla;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QII;""
52 Melilla;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QI;""
52 Melilla;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QIV;1.126
52 Melilla;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
52 Melilla;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QII;""
52 Melilla;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QI;""
52 Melilla;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
52 Melilla;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
52 Melilla;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
52 Melilla;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
52 Melilla;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
52 Melilla;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
52 Melilla;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
52 Melilla;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
52 Melilla;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
52 Melilla;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
52 Melilla;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
52 Melilla;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
52 Melilla;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
52 Melilla;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
52 Melilla;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
52 Melilla;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;95,18
52 Melilla;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
52 Melilla;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
52 Melilla;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
52 Melilla;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;96,16
52 Melilla;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
52 Melilla;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
52 Melilla;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
52 Melilla;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;95,02
52 Melilla;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
52 Melilla;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
52 Melilla;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;91,25
52 Melilla;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
52 Melilla;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
52 Melilla;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
52 Melilla;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;93,11
52 Melilla;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
52 Melilla;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
52 Melilla;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
52 Melilla;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;93,11
52 Melilla;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
52 Melilla;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
52 Melilla;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;88,06
52 Melilla;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
52 Melilla;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
52 Melilla;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
52 Melilla;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;90,23
52 Melilla;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
52 Melilla;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
52 Melilla;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
52 Melilla;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;89,05
52 Melilla;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
52 Melilla;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
52 Melilla;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;84,96
52 Melilla;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
52 Melilla;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
52 Melilla;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
52 Melilla;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;87,11
52 Melilla;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
52 Melilla;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
52 Melilla;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
52 Melilla;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;86,22
52 Melilla;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
52 Melilla;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
52 Melilla;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
52 Melilla;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
52 Melilla;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
52 Melilla;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
52 Melilla;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QI;870
52 Melilla;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
52 Melilla;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
52 Melilla;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
52 Melilla;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QI;916
52 Melilla;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
52 Melilla;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
52 Melilla;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
52 Melilla;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QI;971
52 Melilla;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
52 Melilla;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
52 Melilla;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2022QII;""
52 Melilla;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2022QI;828
52 Melilla;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
52 Melilla;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
52 Melilla;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2021QII;""
52 Melilla;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2021QI;880
52 Melilla;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
52 Melilla;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
52 Melilla;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2020QII;""
52 Melilla;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2020QI;924
52 Melilla;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
52 Melilla;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
52 Melilla;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2022QII;799
52 Melilla;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2022QI;""
52 Melilla;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
52 Melilla;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
52 Melilla;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2021QII;852
52 Melilla;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2021QI;""
52 Melilla;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
52 Melilla;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
52 Melilla;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2020QII;905
52 Melilla;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2020QI;""
52 Melilla;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
52 Melilla;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QIII;775
52 Melilla;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QII;""
52 Melilla;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QI;""
52 Melilla;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
52 Melilla;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QIII;828
52 Melilla;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QII;""
52 Melilla;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QI;""
52 Melilla;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
52 Melilla;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QIII;866
52 Melilla;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QII;""
52 Melilla;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QI;""
52 Melilla;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QIV;750
52 Melilla;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
52 Melilla;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QII;""
52 Melilla;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QI;""
52 Melilla;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QIV;799
52 Melilla;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
52 Melilla;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QII;""
52 Melilla;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QI;""
52 Melilla;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QIV;837
52 Melilla;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
52 Melilla;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QII;""
52 Melilla;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QI;""
52 Melilla;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
52 Melilla;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
52 Melilla;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
52 Melilla;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
52 Melilla;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
52 Melilla;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
52 Melilla;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
52 Melilla;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
52 Melilla;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
52 Melilla;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
52 Melilla;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
52 Melilla;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
52 Melilla;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
52 Melilla;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
52 Melilla;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
52 Melilla;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;95,17
52 Melilla;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
52 Melilla;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
52 Melilla;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
52 Melilla;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;96,07
52 Melilla;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
52 Melilla;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
52 Melilla;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
52 Melilla;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;95,16
52 Melilla;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
52 Melilla;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
52 Melilla;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;91,84
52 Melilla;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
52 Melilla;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
52 Melilla;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
52 Melilla;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;93,01
52 Melilla;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
52 Melilla;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
52 Melilla;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
52 Melilla;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;93,2
52 Melilla;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
52 Melilla;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
52 Melilla;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;89,08
52 Melilla;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
52 Melilla;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
52 Melilla;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
52 Melilla;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;90,39
52 Melilla;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
52 Melilla;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
52 Melilla;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
52 Melilla;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;89,19
52 Melilla;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
52 Melilla;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
52 Melilla;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;86,21
52 Melilla;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
52 Melilla;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
52 Melilla;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
52 Melilla;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;87,23
52 Melilla;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
52 Melilla;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
52 Melilla;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
52 Melilla;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;86,2
52 Melilla;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
52 Melilla;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
52 Melilla;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
52 Melilla;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
52 Melilla;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
52 Melilla;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
52 Melilla;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QI;353
52 Melilla;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
52 Melilla;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
52 Melilla;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
52 Melilla;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QI;333
52 Melilla;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
52 Melilla;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
52 Melilla;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
52 Melilla;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QI;335
52 Melilla;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
52 Melilla;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
52 Melilla;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2022QII;""
52 Melilla;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2022QI;336
52 Melilla;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
52 Melilla;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
52 Melilla;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2021QII;""
52 Melilla;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2021QI;321
52 Melilla;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
52 Melilla;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
52 Melilla;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2020QII;""
52 Melilla;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2020QI;317
52 Melilla;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
52 Melilla;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
52 Melilla;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2022QII;317
52 Melilla;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2022QI;""
52 Melilla;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
52 Melilla;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
52 Melilla;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2021QII;311
52 Melilla;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2021QI;""
52 Melilla;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
52 Melilla;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
52 Melilla;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2020QII;311
52 Melilla;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2020QI;""
52 Melilla;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
52 Melilla;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QIII;302
52 Melilla;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QII;""
52 Melilla;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QI;""
52 Melilla;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
52 Melilla;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QIII;299
52 Melilla;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QII;""
52 Melilla;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QI;""
52 Melilla;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
52 Melilla;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QIII;297
52 Melilla;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QII;""
52 Melilla;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QI;""
52 Melilla;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QIV;289
52 Melilla;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
52 Melilla;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QII;""
52 Melilla;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QI;""
52 Melilla;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QIV;289
52 Melilla;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
52 Melilla;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QII;""
52 Melilla;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QI;""
52 Melilla;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QIV;289
52 Melilla;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
52 Melilla;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QII;""
52 Melilla;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QI;""
52 Melilla;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
52 Melilla;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
52 Melilla;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
52 Melilla;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
52 Melilla;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
52 Melilla;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
52 Melilla;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
52 Melilla;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
52 Melilla;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
52 Melilla;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
52 Melilla;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
52 Melilla;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
52 Melilla;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
52 Melilla;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
52 Melilla;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
52 Melilla;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;95,18
52 Melilla;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
52 Melilla;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
52 Melilla;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
52 Melilla;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;96,4
52 Melilla;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
52 Melilla;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
52 Melilla;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
52 Melilla;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;94,63
52 Melilla;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
52 Melilla;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
52 Melilla;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;89,8
52 Melilla;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
52 Melilla;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
52 Melilla;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
52 Melilla;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;93,39
52 Melilla;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
52 Melilla;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
52 Melilla;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
52 Melilla;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;92,84
52 Melilla;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
52 Melilla;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
52 Melilla;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;85,55
52 Melilla;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
52 Melilla;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
52 Melilla;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
52 Melilla;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;89,79
52 Melilla;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
52 Melilla;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
52 Melilla;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
52 Melilla;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;88,66
52 Melilla;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
52 Melilla;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
52 Melilla;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;81,87
52 Melilla;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
52 Melilla;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
52 Melilla;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
52 Melilla;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;86,79
52 Melilla;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
52 Melilla;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
52 Melilla;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
52 Melilla;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;86,27
52 Melilla;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
52 Melilla;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
52 Melilla;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
52 Melilla;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
52 Melilla;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
52 Melilla;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QII;1.217
52 Melilla;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
52 Melilla;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
52 Melilla;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
52 Melilla;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QII;1.241
52 Melilla;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
52 Melilla;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
52 Melilla;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
52 Melilla;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QII;1.308
52 Melilla;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
52 Melilla;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
52 Melilla;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
52 Melilla;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2022QII;1.164
52 Melilla;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2022QI;""
52 Melilla;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
52 Melilla;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
52 Melilla;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2021QII;1.198
52 Melilla;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2021QI;""
52 Melilla;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
52 Melilla;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
52 Melilla;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2020QII;1.282
52 Melilla;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2020QI;""
52 Melilla;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
52 Melilla;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2022QIII;1.125
52 Melilla;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2022QII;""
52 Melilla;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2022QI;""
52 Melilla;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
52 Melilla;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2021QIII;1.150
52 Melilla;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2021QII;""
52 Melilla;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2021QI;""
52 Melilla;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
52 Melilla;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2020QIII;1.219
52 Melilla;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2020QII;""
52 Melilla;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2020QI;""
52 Melilla;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QIV;1.083
52 Melilla;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
52 Melilla;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QII;""
52 Melilla;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QI;""
52 Melilla;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QIV;1.111
52 Melilla;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
52 Melilla;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QII;""
52 Melilla;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QI;""
52 Melilla;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QIV;1.179
52 Melilla;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
52 Melilla;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QII;""
52 Melilla;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QI;""
52 Melilla;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
52 Melilla;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
52 Melilla;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QII;""
52 Melilla;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QI;1.060
52 Melilla;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
52 Melilla;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
52 Melilla;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QII;""
52 Melilla;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QI;1.136
52 Melilla;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
52 Melilla;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
52 Melilla;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QII;""
52 Melilla;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QI;""
52 Melilla;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
52 Melilla;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
52 Melilla;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
52 Melilla;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
52 Melilla;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
52 Melilla;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
52 Melilla;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
52 Melilla;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
52 Melilla;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
52 Melilla;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
52 Melilla;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
52 Melilla;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
52 Melilla;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
52 Melilla;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
52 Melilla;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;95,65
52 Melilla;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
52 Melilla;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
52 Melilla;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
52 Melilla;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;96,54
52 Melilla;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
52 Melilla;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
52 Melilla;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
52 Melilla;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;98,01
52 Melilla;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
52 Melilla;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
52 Melilla;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;92,44
52 Melilla;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
52 Melilla;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
52 Melilla;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
52 Melilla;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;92,67
52 Melilla;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
52 Melilla;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
52 Melilla;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
52 Melilla;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;93,2
52 Melilla;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
52 Melilla;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
52 Melilla;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;88,99
52 Melilla;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
52 Melilla;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
52 Melilla;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
52 Melilla;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;89,52
52 Melilla;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
52 Melilla;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
52 Melilla;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
52 Melilla;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;90,14
52 Melilla;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
52 Melilla;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
52 Melilla;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
52 Melilla;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
52 Melilla;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
52 Melilla;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
52 Melilla;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;85,41
52 Melilla;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
52 Melilla;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
52 Melilla;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
52 Melilla;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;86,85
52 Melilla;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
52 Melilla;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
52 Melilla;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
52 Melilla;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
52 Melilla;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
52 Melilla;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
52 Melilla;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QII;859
52 Melilla;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
52 Melilla;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
52 Melilla;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
52 Melilla;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QII;897
52 Melilla;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
52 Melilla;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
52 Melilla;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
52 Melilla;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QII;968
52 Melilla;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
52 Melilla;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
52 Melilla;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
52 Melilla;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2022QII;826
52 Melilla;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2022QI;""
52 Melilla;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
52 Melilla;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
52 Melilla;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2021QII;866
52 Melilla;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2021QI;""
52 Melilla;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
52 Melilla;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
52 Melilla;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2020QII;949
52 Melilla;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2020QI;""
52 Melilla;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
52 Melilla;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2022QIII;800
52 Melilla;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2022QII;""
52 Melilla;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2022QI;""
52 Melilla;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
52 Melilla;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2021QIII;833
52 Melilla;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2021QII;""
52 Melilla;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2021QI;""
52 Melilla;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
52 Melilla;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2020QIII;903
52 Melilla;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2020QII;""
52 Melilla;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2020QI;""
52 Melilla;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QIV;772
52 Melilla;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
52 Melilla;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QII;""
52 Melilla;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QI;""
52 Melilla;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QIV;805
52 Melilla;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
52 Melilla;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QII;""
52 Melilla;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QI;""
52 Melilla;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QIV;871
52 Melilla;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
52 Melilla;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QII;""
52 Melilla;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QI;""
52 Melilla;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
52 Melilla;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
52 Melilla;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QII;""
52 Melilla;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QI;767
52 Melilla;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
52 Melilla;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
52 Melilla;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QII;""
52 Melilla;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QI;837
52 Melilla;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
52 Melilla;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
52 Melilla;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QII;""
52 Melilla;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QI;""
52 Melilla;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
52 Melilla;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
52 Melilla;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
52 Melilla;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
52 Melilla;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
52 Melilla;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
52 Melilla;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
52 Melilla;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
52 Melilla;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
52 Melilla;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
52 Melilla;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
52 Melilla;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
52 Melilla;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
52 Melilla;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
52 Melilla;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;96,16
52 Melilla;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
52 Melilla;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
52 Melilla;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
52 Melilla;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;96,54
52 Melilla;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
52 Melilla;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
52 Melilla;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
52 Melilla;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;98,04
52 Melilla;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
52 Melilla;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
52 Melilla;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;93,13
52 Melilla;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
52 Melilla;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
52 Melilla;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
52 Melilla;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;92,87
52 Melilla;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
52 Melilla;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
52 Melilla;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
52 Melilla;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;93,29
52 Melilla;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
52 Melilla;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
52 Melilla;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;89,87
52 Melilla;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
52 Melilla;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
52 Melilla;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
52 Melilla;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;89,74
52 Melilla;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
52 Melilla;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
52 Melilla;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
52 Melilla;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;89,98
52 Melilla;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
52 Melilla;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
52 Melilla;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
52 Melilla;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
52 Melilla;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
52 Melilla;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
52 Melilla;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;85,51
52 Melilla;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
52 Melilla;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
52 Melilla;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
52 Melilla;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;86,47
52 Melilla;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
52 Melilla;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
52 Melilla;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
52 Melilla;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
52 Melilla;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
52 Melilla;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
52 Melilla;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QII;358
52 Melilla;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
52 Melilla;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
52 Melilla;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
52 Melilla;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QII;344
52 Melilla;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
52 Melilla;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
52 Melilla;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
52 Melilla;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QII;340
52 Melilla;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
52 Melilla;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
52 Melilla;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
52 Melilla;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2022QII;338
52 Melilla;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2022QI;""
52 Melilla;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
52 Melilla;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
52 Melilla;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2021QII;332
52 Melilla;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2021QI;""
52 Melilla;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
52 Melilla;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
52 Melilla;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2020QII;333
52 Melilla;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2020QI;""
52 Melilla;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
52 Melilla;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2022QIII;325
52 Melilla;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2022QII;""
52 Melilla;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2022QI;""
52 Melilla;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
52 Melilla;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2021QIII;317
52 Melilla;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2021QII;""
52 Melilla;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2021QI;""
52 Melilla;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
52 Melilla;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2020QIII;316
52 Melilla;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2020QII;""
52 Melilla;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2020QI;""
52 Melilla;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QIV;311
52 Melilla;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
52 Melilla;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QII;""
52 Melilla;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QI;""
52 Melilla;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QIV;306
52 Melilla;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
52 Melilla;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QII;""
52 Melilla;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QI;""
52 Melilla;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QIV;308
52 Melilla;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
52 Melilla;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QII;""
52 Melilla;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QI;""
52 Melilla;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
52 Melilla;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
52 Melilla;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QII;""
52 Melilla;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QI;293
52 Melilla;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
52 Melilla;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
52 Melilla;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QII;""
52 Melilla;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QI;299
52 Melilla;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
52 Melilla;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
52 Melilla;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QII;""
52 Melilla;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QI;""
52 Melilla;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
52 Melilla;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
52 Melilla;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
52 Melilla;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
52 Melilla;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
52 Melilla;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
52 Melilla;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
52 Melilla;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
52 Melilla;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
52 Melilla;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
52 Melilla;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
52 Melilla;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
52 Melilla;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
52 Melilla;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
52 Melilla;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;94,41
52 Melilla;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
52 Melilla;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
52 Melilla;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
52 Melilla;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;96,51
52 Melilla;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
52 Melilla;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
52 Melilla;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
52 Melilla;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;97,94
52 Melilla;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
52 Melilla;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
52 Melilla;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;90,78
52 Melilla;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
52 Melilla;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
52 Melilla;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
52 Melilla;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;92,15
52 Melilla;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
52 Melilla;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
52 Melilla;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
52 Melilla;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;92,94
52 Melilla;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
52 Melilla;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
52 Melilla;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;86,87
52 Melilla;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
52 Melilla;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
52 Melilla;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
52 Melilla;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;88,95
52 Melilla;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
52 Melilla;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
52 Melilla;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
52 Melilla;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;90,59
52 Melilla;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
52 Melilla;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
52 Melilla;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
52 Melilla;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
52 Melilla;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
52 Melilla;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
52 Melilla;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;85,17
52 Melilla;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
52 Melilla;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
52 Melilla;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
52 Melilla;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;87,94
52 Melilla;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
52 Melilla;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
52 Melilla;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
52 Melilla;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
52 Melilla;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
52 Melilla;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QIII;1.218
52 Melilla;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
52 Melilla;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
52 Melilla;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
52 Melilla;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QIII;1.239
52 Melilla;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
52 Melilla;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
52 Melilla;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
52 Melilla;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QIII;1.305
52 Melilla;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
52 Melilla;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
52 Melilla;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
52 Melilla;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2022QIII;1.175
52 Melilla;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2022QII;""
52 Melilla;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2022QI;""
52 Melilla;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
52 Melilla;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2021QIII;1.183
52 Melilla;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2021QII;""
52 Melilla;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2021QI;""
52 Melilla;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
52 Melilla;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2020QIII;1.240
52 Melilla;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2020QII;""
52 Melilla;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2020QI;""
52 Melilla;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2022QIV;1.131
52 Melilla;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
52 Melilla;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2022QII;""
52 Melilla;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2022QI;""
52 Melilla;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2021QIV;1.142
52 Melilla;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
52 Melilla;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2021QII;""
52 Melilla;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2021QI;""
52 Melilla;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2020QIV;1.200
52 Melilla;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
52 Melilla;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2020QII;""
52 Melilla;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2020QI;""
52 Melilla;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
52 Melilla;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
52 Melilla;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QII;""
52 Melilla;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QI;1.090
52 Melilla;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
52 Melilla;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
52 Melilla;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QII;""
52 Melilla;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QI;1.157
52 Melilla;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
52 Melilla;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
52 Melilla;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QII;""
52 Melilla;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QI;""
52 Melilla;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
52 Melilla;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
52 Melilla;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QII;1.048
52 Melilla;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QI;""
52 Melilla;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
52 Melilla;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
52 Melilla;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QII;1.121
52 Melilla;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QI;""
52 Melilla;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
52 Melilla;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
52 Melilla;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QII;""
52 Melilla;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QI;""
52 Melilla;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
52 Melilla;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
52 Melilla;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
52 Melilla;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
52 Melilla;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
52 Melilla;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
52 Melilla;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
52 Melilla;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
52 Melilla;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
52 Melilla;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
52 Melilla;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
52 Melilla;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
52 Melilla;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
52 Melilla;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;96,47
52 Melilla;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
52 Melilla;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
52 Melilla;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
52 Melilla;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;95,48
52 Melilla;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
52 Melilla;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
52 Melilla;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
52 Melilla;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;95,02
52 Melilla;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
52 Melilla;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
52 Melilla;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;92,86
52 Melilla;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
52 Melilla;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
52 Melilla;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
52 Melilla;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;92,17
52 Melilla;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
52 Melilla;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
52 Melilla;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
52 Melilla;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;91,95
52 Melilla;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
52 Melilla;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
52 Melilla;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
52 Melilla;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
52 Melilla;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
52 Melilla;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
52 Melilla;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;87,97
52 Melilla;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
52 Melilla;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
52 Melilla;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
52 Melilla;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;88,66
52 Melilla;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
52 Melilla;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
52 Melilla;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
52 Melilla;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
52 Melilla;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
52 Melilla;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
52 Melilla;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;84,58
52 Melilla;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
52 Melilla;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
52 Melilla;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
52 Melilla;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;85,9
52 Melilla;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
52 Melilla;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
52 Melilla;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
52 Melilla;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
52 Melilla;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
52 Melilla;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
52 Melilla;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QIII;867
52 Melilla;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
52 Melilla;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
52 Melilla;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
52 Melilla;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QIII;889
52 Melilla;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
52 Melilla;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
52 Melilla;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
52 Melilla;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QIII;965
52 Melilla;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
52 Melilla;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
52 Melilla;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
52 Melilla;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2022QIII;840
52 Melilla;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2022QII;""
52 Melilla;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2022QI;""
52 Melilla;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
52 Melilla;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2021QIII;852
52 Melilla;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2021QII;""
52 Melilla;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2021QI;""
52 Melilla;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
52 Melilla;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2020QIII;917
52 Melilla;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2020QII;""
52 Melilla;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2020QI;""
52 Melilla;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2022QIV;812
52 Melilla;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
52 Melilla;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2022QII;""
52 Melilla;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2022QI;""
52 Melilla;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2021QIV;822
52 Melilla;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
52 Melilla;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2021QII;""
52 Melilla;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2021QI;""
52 Melilla;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2020QIV;885
52 Melilla;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
52 Melilla;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2020QII;""
52 Melilla;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2020QI;""
52 Melilla;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
52 Melilla;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
52 Melilla;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QII;""
52 Melilla;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QI;784
52 Melilla;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
52 Melilla;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
52 Melilla;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QII;""
52 Melilla;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QI;851
52 Melilla;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
52 Melilla;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
52 Melilla;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QII;""
52 Melilla;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QI;""
52 Melilla;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
52 Melilla;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
52 Melilla;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QII;759
52 Melilla;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QI;""
52 Melilla;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
52 Melilla;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
52 Melilla;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QII;824
52 Melilla;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QI;""
52 Melilla;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
52 Melilla;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
52 Melilla;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QII;""
52 Melilla;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QI;""
52 Melilla;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
52 Melilla;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
52 Melilla;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
52 Melilla;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
52 Melilla;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
52 Melilla;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
52 Melilla;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
52 Melilla;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
52 Melilla;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
52 Melilla;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
52 Melilla;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
52 Melilla;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
52 Melilla;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
52 Melilla;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;96,89
52 Melilla;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
52 Melilla;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
52 Melilla;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
52 Melilla;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;95,84
52 Melilla;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
52 Melilla;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
52 Melilla;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
52 Melilla;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;95,03
52 Melilla;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
52 Melilla;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
52 Melilla;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;93,66
52 Melilla;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
52 Melilla;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
52 Melilla;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
52 Melilla;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;92,46
52 Melilla;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
52 Melilla;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
52 Melilla;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
52 Melilla;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;91,71
52 Melilla;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
52 Melilla;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
52 Melilla;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
52 Melilla;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
52 Melilla;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
52 Melilla;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
52 Melilla;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;88,19
52 Melilla;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
52 Melilla;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
52 Melilla;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
52 Melilla;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;88,19
52 Melilla;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
52 Melilla;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
52 Melilla;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
52 Melilla;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
52 Melilla;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
52 Melilla;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
52 Melilla;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;85,38
52 Melilla;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
52 Melilla;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
52 Melilla;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
52 Melilla;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;85,39
52 Melilla;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
52 Melilla;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
52 Melilla;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
52 Melilla;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
52 Melilla;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
52 Melilla;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
52 Melilla;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QIII;351
52 Melilla;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
52 Melilla;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
52 Melilla;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
52 Melilla;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QIII;350
52 Melilla;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
52 Melilla;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
52 Melilla;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
52 Melilla;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QIII;340
52 Melilla;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
52 Melilla;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
52 Melilla;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
52 Melilla;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2022QIII;335
52 Melilla;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2022QII;""
52 Melilla;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2022QI;""
52 Melilla;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
52 Melilla;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2021QIII;331
52 Melilla;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2021QII;""
52 Melilla;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2021QI;""
52 Melilla;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
52 Melilla;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2020QIII;323
52 Melilla;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2020QII;""
52 Melilla;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2020QI;""
52 Melilla;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2022QIV;319
52 Melilla;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
52 Melilla;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2022QII;""
52 Melilla;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2022QI;""
52 Melilla;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2021QIV;320
52 Melilla;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
52 Melilla;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2021QII;""
52 Melilla;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2021QI;""
52 Melilla;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2020QIV;315
52 Melilla;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
52 Melilla;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2020QII;""
52 Melilla;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2020QI;""
52 Melilla;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
52 Melilla;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
52 Melilla;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QII;""
52 Melilla;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QI;306
52 Melilla;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
52 Melilla;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
52 Melilla;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QII;""
52 Melilla;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QI;306
52 Melilla;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
52 Melilla;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
52 Melilla;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QII;""
52 Melilla;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QI;""
52 Melilla;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
52 Melilla;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
52 Melilla;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QII;289
52 Melilla;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QI;""
52 Melilla;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
52 Melilla;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
52 Melilla;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QII;297
52 Melilla;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QI;""
52 Melilla;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
52 Melilla;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
52 Melilla;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QII;""
52 Melilla;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QI;""
52 Melilla;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
52 Melilla;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
52 Melilla;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
52 Melilla;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
52 Melilla;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
52 Melilla;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
52 Melilla;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
52 Melilla;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
52 Melilla;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
52 Melilla;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
52 Melilla;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
52 Melilla;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
52 Melilla;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
52 Melilla;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;95,44
52 Melilla;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
52 Melilla;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
52 Melilla;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
52 Melilla;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;94,57
52 Melilla;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
52 Melilla;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
52 Melilla;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
52 Melilla;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;95
52 Melilla;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
52 Melilla;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
52 Melilla;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;90,88
52 Melilla;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
52 Melilla;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
52 Melilla;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
52 Melilla;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;91,43
52 Melilla;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
52 Melilla;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
52 Melilla;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
52 Melilla;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;92,65
52 Melilla;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
52 Melilla;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
52 Melilla;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
52 Melilla;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
52 Melilla;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
52 Melilla;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
52 Melilla;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;87,43
52 Melilla;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
52 Melilla;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
52 Melilla;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
52 Melilla;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;90
52 Melilla;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
52 Melilla;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
52 Melilla;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
52 Melilla;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
52 Melilla;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
52 Melilla;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
52 Melilla;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;82,57
52 Melilla;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
52 Melilla;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
52 Melilla;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
52 Melilla;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;87,35
52 Melilla;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
52 Melilla;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
52 Melilla;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
52 Melilla;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
52 Melilla;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
52 Melilla;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QIV;1.209
52 Melilla;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
52 Melilla;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
52 Melilla;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
52 Melilla;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QIV;1.225
52 Melilla;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
52 Melilla;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
52 Melilla;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
52 Melilla;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QIV;1.266
52 Melilla;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
52 Melilla;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
52 Melilla;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
52 Melilla;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2022QIV;1.159
52 Melilla;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
52 Melilla;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2022QII;""
52 Melilla;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2022QI;""
52 Melilla;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2021QIV;1.182
52 Melilla;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
52 Melilla;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2021QII;""
52 Melilla;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2021QI;""
52 Melilla;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2020QIV;1.220
52 Melilla;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
52 Melilla;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2020QII;""
52 Melilla;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2020QI;""
52 Melilla;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
52 Melilla;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
52 Melilla;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2022QII;""
52 Melilla;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2022QI;1.126
52 Melilla;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
52 Melilla;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
52 Melilla;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2021QII;""
52 Melilla;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2021QI;1.176
52 Melilla;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
52 Melilla;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
52 Melilla;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2020QII;""
52 Melilla;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2020QI;""
52 Melilla;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
52 Melilla;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
52 Melilla;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QII;1.080
52 Melilla;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QI;""
52 Melilla;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
52 Melilla;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
52 Melilla;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QII;1.138
52 Melilla;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QI;""
52 Melilla;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
52 Melilla;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
52 Melilla;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QII;""
52 Melilla;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QI;""
52 Melilla;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
52 Melilla;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QIII;1.042
52 Melilla;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QII;""
52 Melilla;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QI;""
52 Melilla;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
52 Melilla;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QIII;1.105
52 Melilla;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QII;""
52 Melilla;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QI;""
52 Melilla;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
52 Melilla;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
52 Melilla;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QII;""
52 Melilla;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QI;""
52 Melilla;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
52 Melilla;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
52 Melilla;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
52 Melilla;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
52 Melilla;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
52 Melilla;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
52 Melilla;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
52 Melilla;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
52 Melilla;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
52 Melilla;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
52 Melilla;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
52 Melilla;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
52 Melilla;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;95,86
52 Melilla;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
52 Melilla;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
52 Melilla;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
52 Melilla;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;96,49
52 Melilla;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
52 Melilla;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
52 Melilla;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
52 Melilla;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;96,37
52 Melilla;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
52 Melilla;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
52 Melilla;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
52 Melilla;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
52 Melilla;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
52 Melilla;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
52 Melilla;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;91,92
52 Melilla;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
52 Melilla;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
52 Melilla;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
52 Melilla;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;92,89
52 Melilla;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
52 Melilla;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
52 Melilla;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
52 Melilla;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
52 Melilla;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
52 Melilla;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
52 Melilla;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;88,16
52 Melilla;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
52 Melilla;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
52 Melilla;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
52 Melilla;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;89,89
52 Melilla;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
52 Melilla;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
52 Melilla;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
52 Melilla;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
52 Melilla;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
52 Melilla;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
52 Melilla;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;85,06
52 Melilla;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
52 Melilla;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
52 Melilla;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
52 Melilla;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;87,28
52 Melilla;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
52 Melilla;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
52 Melilla;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
52 Melilla;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
52 Melilla;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
52 Melilla;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
52 Melilla;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QIV;866
52 Melilla;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
52 Melilla;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
52 Melilla;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
52 Melilla;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QIV;879
52 Melilla;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
52 Melilla;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
52 Melilla;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
52 Melilla;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QIV;934
52 Melilla;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
52 Melilla;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
52 Melilla;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
52 Melilla;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2022QIV;834
52 Melilla;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
52 Melilla;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2022QII;""
52 Melilla;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2022QI;""
52 Melilla;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2021QIV;849
52 Melilla;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
52 Melilla;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2021QII;""
52 Melilla;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2021QI;""
52 Melilla;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2020QIV;897
52 Melilla;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
52 Melilla;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2020QII;""
52 Melilla;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2020QI;""
52 Melilla;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
52 Melilla;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
52 Melilla;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2022QII;""
52 Melilla;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2022QI;810
52 Melilla;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
52 Melilla;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
52 Melilla;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2021QII;""
52 Melilla;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2021QI;863
52 Melilla;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
52 Melilla;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
52 Melilla;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2020QII;""
52 Melilla;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2020QI;""
52 Melilla;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
52 Melilla;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
52 Melilla;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QII;783
52 Melilla;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QI;""
52 Melilla;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
52 Melilla;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
52 Melilla;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QII;835
52 Melilla;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QI;""
52 Melilla;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
52 Melilla;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
52 Melilla;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QII;""
52 Melilla;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QI;""
52 Melilla;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
52 Melilla;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QIII;760
52 Melilla;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QII;""
52 Melilla;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QI;""
52 Melilla;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
52 Melilla;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QIII;813
52 Melilla;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QII;""
52 Melilla;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QI;""
52 Melilla;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
52 Melilla;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
52 Melilla;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QII;""
52 Melilla;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QI;""
52 Melilla;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
52 Melilla;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
52 Melilla;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
52 Melilla;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
52 Melilla;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
52 Melilla;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
52 Melilla;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
52 Melilla;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
52 Melilla;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
52 Melilla;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
52 Melilla;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
52 Melilla;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
52 Melilla;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;96,3
52 Melilla;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
52 Melilla;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
52 Melilla;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
52 Melilla;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;96,59
52 Melilla;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
52 Melilla;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
52 Melilla;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
52 Melilla;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;96,04
52 Melilla;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
52 Melilla;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
52 Melilla;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
52 Melilla;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
52 Melilla;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
52 Melilla;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
52 Melilla;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;92,15
52 Melilla;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
52 Melilla;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
52 Melilla;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
52 Melilla;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;92,4
52 Melilla;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
52 Melilla;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
52 Melilla;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
52 Melilla;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
52 Melilla;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
52 Melilla;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
52 Melilla;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;89,08
52 Melilla;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
52 Melilla;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
52 Melilla;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
52 Melilla;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;89,4
52 Melilla;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
52 Melilla;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
52 Melilla;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
52 Melilla;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
52 Melilla;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
52 Melilla;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
52 Melilla;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;86,46
52 Melilla;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
52 Melilla;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
52 Melilla;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
52 Melilla;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;87,04
52 Melilla;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
52 Melilla;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
52 Melilla;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
52 Melilla;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
52 Melilla;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
52 Melilla;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
52 Melilla;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QIV;343
52 Melilla;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
52 Melilla;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
52 Melilla;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
52 Melilla;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QIV;346
52 Melilla;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
52 Melilla;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
52 Melilla;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
52 Melilla;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QIV;332
52 Melilla;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
52 Melilla;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
52 Melilla;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
52 Melilla;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2022QIV;325
52 Melilla;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
52 Melilla;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2022QII;""
52 Melilla;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2022QI;""
52 Melilla;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2021QIV;333
52 Melilla;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
52 Melilla;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2021QII;""
52 Melilla;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2021QI;""
52 Melilla;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2020QIV;323
52 Melilla;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
52 Melilla;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2020QII;""
52 Melilla;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2020QI;""
52 Melilla;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
52 Melilla;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
52 Melilla;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2022QII;""
52 Melilla;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2022QI;316
52 Melilla;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
52 Melilla;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
52 Melilla;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2021QII;""
52 Melilla;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2021QI;313
52 Melilla;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
52 Melilla;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
52 Melilla;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2020QII;""
52 Melilla;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2020QI;""
52 Melilla;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
52 Melilla;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
52 Melilla;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QII;297
52 Melilla;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QI;""
52 Melilla;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
52 Melilla;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
52 Melilla;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QII;303
52 Melilla;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QI;""
52 Melilla;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
52 Melilla;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
52 Melilla;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QII;""
52 Melilla;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QI;""
52 Melilla;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
52 Melilla;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QIII;282
52 Melilla;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QII;""
52 Melilla;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QI;""
52 Melilla;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
52 Melilla;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QIII;292
52 Melilla;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QII;""
52 Melilla;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QI;""
52 Melilla;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
52 Melilla;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
52 Melilla;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QII;""
52 Melilla;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QI;""
52 Melilla;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
52 Melilla;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
52 Melilla;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
52 Melilla;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
52 Melilla;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
52 Melilla;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
52 Melilla;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
52 Melilla;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
52 Melilla;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
52 Melilla;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
52 Melilla;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
52 Melilla;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
52 Melilla;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;94,75
52 Melilla;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
52 Melilla;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
52 Melilla;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
52 Melilla;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;96,24
52 Melilla;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
52 Melilla;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
52 Melilla;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
52 Melilla;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;97,29
52 Melilla;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
52 Melilla;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
52 Melilla;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
52 Melilla;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
52 Melilla;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
52 Melilla;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
52 Melilla;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;91,33
52 Melilla;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
52 Melilla;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
52 Melilla;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
52 Melilla;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;94,28
52 Melilla;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
52 Melilla;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
52 Melilla;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
52 Melilla;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
52 Melilla;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
52 Melilla;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
52 Melilla;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;85,84
52 Melilla;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
52 Melilla;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
52 Melilla;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
52 Melilla;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;91,27
52 Melilla;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
52 Melilla;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
52 Melilla;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
52 Melilla;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
52 Melilla;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
52 Melilla;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
52 Melilla;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;81,5
52 Melilla;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
52 Melilla;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
52 Melilla;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
52 Melilla;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;87,95
52 Melilla;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
52 Melilla;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
52 Melilla;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
52 Melilla;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
52 Melilla;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
52 Melilla;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
52 Melilla;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
52 Melilla;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
52 Melilla;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
52 Melilla;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QI;1.092
52 Melilla;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
52 Melilla;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
52 Melilla;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
52 Melilla;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QI;1.082
52 Melilla;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
52 Melilla;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
52 Melilla;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
52 Melilla;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QI;1.146
52 Melilla;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
52 Melilla;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
52 Melilla;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2022QII;""
52 Melilla;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2022QI;1.055
52 Melilla;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
52 Melilla;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
52 Melilla;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2021QII;""
52 Melilla;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2021QI;1.059
52 Melilla;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
52 Melilla;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
52 Melilla;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2020QII;""
52 Melilla;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2020QI;1.112
52 Melilla;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
52 Melilla;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
52 Melilla;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2022QII;1.015
52 Melilla;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2022QI;""
52 Melilla;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
52 Melilla;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
52 Melilla;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2021QII;1.032
52 Melilla;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2021QI;""
52 Melilla;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
52 Melilla;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
52 Melilla;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2020QII;1.091
52 Melilla;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2020QI;""
52 Melilla;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
52 Melilla;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QIII;990
52 Melilla;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QII;""
52 Melilla;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QI;""
52 Melilla;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
52 Melilla;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QIII;1.008
52 Melilla;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QII;""
52 Melilla;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QI;""
52 Melilla;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
52 Melilla;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QIII;1.053
52 Melilla;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QII;""
52 Melilla;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QI;""
52 Melilla;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QIV;962
52 Melilla;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
52 Melilla;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QII;""
52 Melilla;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QI;""
52 Melilla;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QIV;988
52 Melilla;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
52 Melilla;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QII;""
52 Melilla;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QI;""
52 Melilla;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QIV;1.023
52 Melilla;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
52 Melilla;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QII;""
52 Melilla;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QI;""
52 Melilla;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
52 Melilla;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
52 Melilla;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
52 Melilla;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
52 Melilla;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
52 Melilla;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
52 Melilla;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
52 Melilla;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
52 Melilla;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
52 Melilla;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
52 Melilla;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
52 Melilla;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
52 Melilla;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
52 Melilla;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
52 Melilla;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
52 Melilla;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;96,61
52 Melilla;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
52 Melilla;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
52 Melilla;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
52 Melilla;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;97,87
52 Melilla;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
52 Melilla;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
52 Melilla;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
52 Melilla;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;97,03
52 Melilla;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
52 Melilla;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
52 Melilla;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;92,95
52 Melilla;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
52 Melilla;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
52 Melilla;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
52 Melilla;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;95,38
52 Melilla;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
52 Melilla;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
52 Melilla;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
52 Melilla;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;95,2
52 Melilla;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
52 Melilla;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
52 Melilla;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;90,66
52 Melilla;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
52 Melilla;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
52 Melilla;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
52 Melilla;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;93,16
52 Melilla;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
52 Melilla;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
52 Melilla;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
52 Melilla;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;91,88
52 Melilla;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
52 Melilla;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
52 Melilla;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;88,1
52 Melilla;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
52 Melilla;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
52 Melilla;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
52 Melilla;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;91,31
52 Melilla;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
52 Melilla;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
52 Melilla;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
52 Melilla;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;89,27
52 Melilla;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
52 Melilla;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
52 Melilla;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
52 Melilla;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
52 Melilla;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
52 Melilla;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
52 Melilla;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QI;796
52 Melilla;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
52 Melilla;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
52 Melilla;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
52 Melilla;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QI;806
52 Melilla;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
52 Melilla;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
52 Melilla;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
52 Melilla;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QI;856
52 Melilla;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
52 Melilla;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
52 Melilla;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2022QII;""
52 Melilla;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2022QI;773
52 Melilla;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
52 Melilla;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
52 Melilla;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2021QII;""
52 Melilla;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2021QI;788
52 Melilla;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
52 Melilla;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
52 Melilla;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2020QII;""
52 Melilla;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2020QI;835
52 Melilla;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
52 Melilla;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
52 Melilla;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2022QII;747
52 Melilla;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2022QI;""
52 Melilla;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
52 Melilla;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
52 Melilla;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2021QII;765
52 Melilla;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2021QI;""
52 Melilla;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
52 Melilla;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
52 Melilla;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2020QII;817
52 Melilla;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2020QI;""
52 Melilla;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
52 Melilla;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QIII;727
52 Melilla;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QII;""
52 Melilla;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QI;""
52 Melilla;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
52 Melilla;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QIII;747
52 Melilla;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QII;""
52 Melilla;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QI;""
52 Melilla;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
52 Melilla;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QIII;793
52 Melilla;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QII;""
52 Melilla;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QI;""
52 Melilla;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QIV;707
52 Melilla;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
52 Melilla;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QII;""
52 Melilla;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QI;""
52 Melilla;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QIV;737
52 Melilla;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
52 Melilla;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QII;""
52 Melilla;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QI;""
52 Melilla;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QIV;773
52 Melilla;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
52 Melilla;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QII;""
52 Melilla;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QI;""
52 Melilla;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
52 Melilla;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
52 Melilla;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
52 Melilla;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
52 Melilla;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
52 Melilla;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
52 Melilla;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
52 Melilla;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
52 Melilla;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
52 Melilla;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
52 Melilla;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
52 Melilla;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
52 Melilla;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
52 Melilla;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
52 Melilla;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
52 Melilla;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;97,11
52 Melilla;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
52 Melilla;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
52 Melilla;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
52 Melilla;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;97,77
52 Melilla;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
52 Melilla;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
52 Melilla;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
52 Melilla;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;97,55
52 Melilla;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
52 Melilla;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
52 Melilla;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;93,84
52 Melilla;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
52 Melilla;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
52 Melilla;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
52 Melilla;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;94,91
52 Melilla;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
52 Melilla;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
52 Melilla;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
52 Melilla;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;95,44
52 Melilla;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
52 Melilla;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
52 Melilla;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;91,33
52 Melilla;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
52 Melilla;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
52 Melilla;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
52 Melilla;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;92,68
52 Melilla;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
52 Melilla;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
52 Melilla;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
52 Melilla;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;92,64
52 Melilla;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
52 Melilla;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
52 Melilla;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;88,82
52 Melilla;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
52 Melilla;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
52 Melilla;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
52 Melilla;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;91,44
52 Melilla;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
52 Melilla;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
52 Melilla;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
52 Melilla;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;90,3
52 Melilla;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
52 Melilla;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
52 Melilla;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
52 Melilla;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
52 Melilla;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
52 Melilla;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
52 Melilla;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QI;296
52 Melilla;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
52 Melilla;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
52 Melilla;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
52 Melilla;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QI;276
52 Melilla;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
52 Melilla;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
52 Melilla;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
52 Melilla;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QI;290
52 Melilla;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
52 Melilla;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
52 Melilla;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2022QII;""
52 Melilla;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2022QI;282
52 Melilla;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
52 Melilla;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
52 Melilla;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2021QII;""
52 Melilla;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2021QI;271
52 Melilla;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
52 Melilla;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
52 Melilla;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2020QII;""
52 Melilla;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2020QI;277
52 Melilla;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
52 Melilla;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
52 Melilla;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2022QII;268
52 Melilla;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2022QI;""
52 Melilla;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
52 Melilla;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
52 Melilla;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2021QII;267
52 Melilla;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2021QI;""
52 Melilla;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
52 Melilla;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
52 Melilla;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2020QII;274
52 Melilla;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2020QI;""
52 Melilla;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
52 Melilla;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QIII;263
52 Melilla;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QII;""
52 Melilla;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QI;""
52 Melilla;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
52 Melilla;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QIII;261
52 Melilla;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QII;""
52 Melilla;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QI;""
52 Melilla;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
52 Melilla;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QIII;260
52 Melilla;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QII;""
52 Melilla;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QI;""
52 Melilla;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QIV;255
52 Melilla;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
52 Melilla;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QII;""
52 Melilla;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QI;""
52 Melilla;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QIV;251
52 Melilla;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
52 Melilla;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QII;""
52 Melilla;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QI;""
52 Melilla;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QIV;250
52 Melilla;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
52 Melilla;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QII;""
52 Melilla;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QI;""
52 Melilla;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
52 Melilla;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
52 Melilla;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
52 Melilla;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
52 Melilla;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
52 Melilla;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
52 Melilla;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
52 Melilla;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
52 Melilla;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
52 Melilla;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
52 Melilla;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
52 Melilla;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
52 Melilla;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
52 Melilla;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
52 Melilla;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
52 Melilla;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;95,27
52 Melilla;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
52 Melilla;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
52 Melilla;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
52 Melilla;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;98,19
52 Melilla;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
52 Melilla;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
52 Melilla;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
52 Melilla;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;95,52
52 Melilla;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
52 Melilla;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
52 Melilla;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;90,54
52 Melilla;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
52 Melilla;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
52 Melilla;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
52 Melilla;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;96,74
52 Melilla;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
52 Melilla;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
52 Melilla;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
52 Melilla;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;94,48
52 Melilla;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
52 Melilla;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
52 Melilla;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;88,85
52 Melilla;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
52 Melilla;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
52 Melilla;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
52 Melilla;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;94,57
52 Melilla;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
52 Melilla;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
52 Melilla;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
52 Melilla;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;89,66
52 Melilla;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
52 Melilla;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
52 Melilla;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;86,15
52 Melilla;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
52 Melilla;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
52 Melilla;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
52 Melilla;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;90,94
52 Melilla;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
52 Melilla;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
52 Melilla;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
52 Melilla;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;86,21
52 Melilla;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
52 Melilla;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
52 Melilla;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
52 Melilla;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
52 Melilla;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
52 Melilla;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QII;1.084
52 Melilla;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
52 Melilla;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
52 Melilla;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
52 Melilla;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QII;1.118
52 Melilla;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
52 Melilla;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
52 Melilla;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
52 Melilla;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QII;1.144
52 Melilla;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
52 Melilla;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
52 Melilla;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
52 Melilla;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2022QII;1.045
52 Melilla;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2022QI;""
52 Melilla;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
52 Melilla;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
52 Melilla;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2021QII;1.090
52 Melilla;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2021QI;""
52 Melilla;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
52 Melilla;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
52 Melilla;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2020QII;1.121
52 Melilla;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2020QI;""
52 Melilla;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
52 Melilla;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2022QIII;1.016
52 Melilla;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2022QII;""
52 Melilla;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2022QI;""
52 Melilla;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
52 Melilla;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2021QIII;1.065
52 Melilla;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2021QII;""
52 Melilla;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2021QI;""
52 Melilla;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
52 Melilla;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2020QIII;1.082
52 Melilla;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2020QII;""
52 Melilla;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2020QI;""
52 Melilla;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QIV;994
52 Melilla;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
52 Melilla;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QII;""
52 Melilla;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QI;""
52 Melilla;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QIV;1.038
52 Melilla;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
52 Melilla;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QII;""
52 Melilla;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QI;""
52 Melilla;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QIV;1.051
52 Melilla;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
52 Melilla;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QII;""
52 Melilla;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QI;""
52 Melilla;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
52 Melilla;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
52 Melilla;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QII;""
52 Melilla;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QI;1.011
52 Melilla;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
52 Melilla;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
52 Melilla;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QII;""
52 Melilla;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QI;1.030
52 Melilla;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
52 Melilla;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
52 Melilla;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QII;""
52 Melilla;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QI;""
52 Melilla;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
52 Melilla;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
52 Melilla;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
52 Melilla;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
52 Melilla;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
52 Melilla;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
52 Melilla;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
52 Melilla;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
52 Melilla;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
52 Melilla;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
52 Melilla;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
52 Melilla;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
52 Melilla;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
52 Melilla;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
52 Melilla;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;96,4
52 Melilla;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
52 Melilla;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
52 Melilla;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
52 Melilla;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;97,5
52 Melilla;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
52 Melilla;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
52 Melilla;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
52 Melilla;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;97,99
52 Melilla;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
52 Melilla;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
52 Melilla;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;93,73
52 Melilla;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
52 Melilla;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
52 Melilla;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
52 Melilla;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;95,26
52 Melilla;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
52 Melilla;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
52 Melilla;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
52 Melilla;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;94,58
52 Melilla;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
52 Melilla;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
52 Melilla;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;91,7
52 Melilla;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
52 Melilla;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
52 Melilla;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
52 Melilla;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;92,84
52 Melilla;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
52 Melilla;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
52 Melilla;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
52 Melilla;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;91,87
52 Melilla;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
52 Melilla;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
52 Melilla;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
52 Melilla;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
52 Melilla;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
52 Melilla;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
52 Melilla;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;90,43
52 Melilla;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
52 Melilla;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
52 Melilla;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
52 Melilla;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;90,03
52 Melilla;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
52 Melilla;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
52 Melilla;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
52 Melilla;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
52 Melilla;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
52 Melilla;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
52 Melilla;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QII;784
52 Melilla;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
52 Melilla;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
52 Melilla;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
52 Melilla;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QII;821
52 Melilla;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
52 Melilla;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
52 Melilla;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
52 Melilla;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QII;855
52 Melilla;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
52 Melilla;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
52 Melilla;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
52 Melilla;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2022QII;760
52 Melilla;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2022QI;""
52 Melilla;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
52 Melilla;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
52 Melilla;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2021QII;798
52 Melilla;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2021QI;""
52 Melilla;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
52 Melilla;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
52 Melilla;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2020QII;836
52 Melilla;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2020QI;""
52 Melilla;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
52 Melilla;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2022QIII;740
52 Melilla;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2022QII;""
52 Melilla;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2022QI;""
52 Melilla;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
52 Melilla;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2021QIII;780
52 Melilla;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2021QII;""
52 Melilla;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2021QI;""
52 Melilla;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
52 Melilla;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2020QIII;811
52 Melilla;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2020QII;""
52 Melilla;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2020QI;""
52 Melilla;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QIV;725
52 Melilla;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
52 Melilla;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QII;""
52 Melilla;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QI;""
52 Melilla;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QIV;765
52 Melilla;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
52 Melilla;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QII;""
52 Melilla;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QI;""
52 Melilla;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QIV;790
52 Melilla;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
52 Melilla;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QII;""
52 Melilla;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QI;""
52 Melilla;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
52 Melilla;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
52 Melilla;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QII;""
52 Melilla;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QI;747
52 Melilla;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
52 Melilla;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
52 Melilla;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QII;""
52 Melilla;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QI;772
52 Melilla;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
52 Melilla;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
52 Melilla;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QII;""
52 Melilla;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QI;""
52 Melilla;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
52 Melilla;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
52 Melilla;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
52 Melilla;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
52 Melilla;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
52 Melilla;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
52 Melilla;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
52 Melilla;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
52 Melilla;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
52 Melilla;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
52 Melilla;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
52 Melilla;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
52 Melilla;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
52 Melilla;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
52 Melilla;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;96,94
52 Melilla;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
52 Melilla;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
52 Melilla;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
52 Melilla;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;97,2
52 Melilla;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
52 Melilla;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
52 Melilla;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
52 Melilla;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;97,78
52 Melilla;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
52 Melilla;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
52 Melilla;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;94,39
52 Melilla;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
52 Melilla;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
52 Melilla;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
52 Melilla;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;95,01
52 Melilla;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
52 Melilla;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
52 Melilla;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
52 Melilla;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;94,85
52 Melilla;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
52 Melilla;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
52 Melilla;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;92,47
52 Melilla;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
52 Melilla;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
52 Melilla;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
52 Melilla;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;93,18
52 Melilla;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
52 Melilla;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
52 Melilla;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
52 Melilla;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;92,4
52 Melilla;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
52 Melilla;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
52 Melilla;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
52 Melilla;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
52 Melilla;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
52 Melilla;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
52 Melilla;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;90,99
52 Melilla;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
52 Melilla;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
52 Melilla;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
52 Melilla;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;90,29
52 Melilla;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
52 Melilla;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
52 Melilla;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
52 Melilla;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
52 Melilla;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
52 Melilla;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
52 Melilla;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QII;300
52 Melilla;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
52 Melilla;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
52 Melilla;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
52 Melilla;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QII;297
52 Melilla;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
52 Melilla;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
52 Melilla;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
52 Melilla;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QII;289
52 Melilla;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
52 Melilla;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
52 Melilla;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
52 Melilla;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2022QII;285
52 Melilla;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2022QI;""
52 Melilla;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
52 Melilla;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
52 Melilla;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2021QII;292
52 Melilla;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2021QI;""
52 Melilla;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
52 Melilla;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
52 Melilla;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2020QII;285
52 Melilla;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2020QI;""
52 Melilla;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
52 Melilla;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2022QIII;276
52 Melilla;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2022QII;""
52 Melilla;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2022QI;""
52 Melilla;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
52 Melilla;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2021QIII;285
52 Melilla;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2021QII;""
52 Melilla;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2021QI;""
52 Melilla;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
52 Melilla;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2020QIII;271
52 Melilla;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2020QII;""
52 Melilla;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2020QI;""
52 Melilla;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QIV;269
52 Melilla;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
52 Melilla;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QII;""
52 Melilla;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QI;""
52 Melilla;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QIV;273
52 Melilla;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
52 Melilla;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QII;""
52 Melilla;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QI;""
52 Melilla;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QIV;261
52 Melilla;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
52 Melilla;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QII;""
52 Melilla;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QI;""
52 Melilla;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
52 Melilla;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
52 Melilla;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QII;""
52 Melilla;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QI;264
52 Melilla;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
52 Melilla;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
52 Melilla;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QII;""
52 Melilla;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QI;258
52 Melilla;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
52 Melilla;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
52 Melilla;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QII;""
52 Melilla;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QI;""
52 Melilla;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
52 Melilla;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
52 Melilla;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
52 Melilla;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
52 Melilla;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
52 Melilla;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
52 Melilla;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
52 Melilla;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
52 Melilla;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
52 Melilla;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
52 Melilla;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
52 Melilla;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
52 Melilla;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
52 Melilla;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
52 Melilla;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;95
52 Melilla;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
52 Melilla;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
52 Melilla;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
52 Melilla;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;98,32
52 Melilla;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
52 Melilla;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
52 Melilla;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
52 Melilla;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;98,62
52 Melilla;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
52 Melilla;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
52 Melilla;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;92
52 Melilla;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
52 Melilla;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
52 Melilla;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
52 Melilla;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;95,96
52 Melilla;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
52 Melilla;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
52 Melilla;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
52 Melilla;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;93,77
52 Melilla;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
52 Melilla;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
52 Melilla;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;89,67
52 Melilla;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
52 Melilla;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
52 Melilla;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
52 Melilla;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;91,92
52 Melilla;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
52 Melilla;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
52 Melilla;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
52 Melilla;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;90,31
52 Melilla;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
52 Melilla;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
52 Melilla;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
52 Melilla;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
52 Melilla;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
52 Melilla;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
52 Melilla;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;88,89
52 Melilla;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
52 Melilla;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
52 Melilla;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
52 Melilla;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;89,27
52 Melilla;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
52 Melilla;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
52 Melilla;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
52 Melilla;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
52 Melilla;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
52 Melilla;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QIII;1.071
52 Melilla;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
52 Melilla;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
52 Melilla;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
52 Melilla;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QIII;1.115
52 Melilla;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
52 Melilla;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
52 Melilla;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
52 Melilla;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QIII;1.129
52 Melilla;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
52 Melilla;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
52 Melilla;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
52 Melilla;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2022QIII;1.037
52 Melilla;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2022QII;""
52 Melilla;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2022QI;""
52 Melilla;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
52 Melilla;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2021QIII;1.088
52 Melilla;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2021QII;""
52 Melilla;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2021QI;""
52 Melilla;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
52 Melilla;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2020QIII;1.089
52 Melilla;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2020QII;""
52 Melilla;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2020QI;""
52 Melilla;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2022QIV;1.013
52 Melilla;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
52 Melilla;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2022QII;""
52 Melilla;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2022QI;""
52 Melilla;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2021QIV;1.059
52 Melilla;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
52 Melilla;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2021QII;""
52 Melilla;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2021QI;""
52 Melilla;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2020QIV;1.058
52 Melilla;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
52 Melilla;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2020QII;""
52 Melilla;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2020QI;""
52 Melilla;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
52 Melilla;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
52 Melilla;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QII;""
52 Melilla;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QI;1.029
52 Melilla;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
52 Melilla;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
52 Melilla;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QII;""
52 Melilla;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QI;1.037
52 Melilla;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
52 Melilla;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
52 Melilla;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QII;""
52 Melilla;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QI;""
52 Melilla;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
52 Melilla;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
52 Melilla;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QII;995
52 Melilla;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QI;""
52 Melilla;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
52 Melilla;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
52 Melilla;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QII;1.010
52 Melilla;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QI;""
52 Melilla;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
52 Melilla;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
52 Melilla;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QII;""
52 Melilla;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QI;""
52 Melilla;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
52 Melilla;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
52 Melilla;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
52 Melilla;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
52 Melilla;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
52 Melilla;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
52 Melilla;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
52 Melilla;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
52 Melilla;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
52 Melilla;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
52 Melilla;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
52 Melilla;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
52 Melilla;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
52 Melilla;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;96,83
52 Melilla;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
52 Melilla;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
52 Melilla;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
52 Melilla;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;97,58
52 Melilla;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
52 Melilla;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
52 Melilla;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
52 Melilla;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;96,46
52 Melilla;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
52 Melilla;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
52 Melilla;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;94,58
52 Melilla;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
52 Melilla;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
52 Melilla;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
52 Melilla;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;94,98
52 Melilla;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
52 Melilla;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
52 Melilla;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
52 Melilla;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;93,71
52 Melilla;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
52 Melilla;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
52 Melilla;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
52 Melilla;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
52 Melilla;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
52 Melilla;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
52 Melilla;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;92,29
52 Melilla;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
52 Melilla;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
52 Melilla;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
52 Melilla;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;91,85
52 Melilla;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
52 Melilla;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
52 Melilla;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
52 Melilla;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
52 Melilla;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
52 Melilla;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
52 Melilla;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;89,24
52 Melilla;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
52 Melilla;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
52 Melilla;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
52 Melilla;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;89,46
52 Melilla;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
52 Melilla;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
52 Melilla;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
52 Melilla;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
52 Melilla;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
52 Melilla;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
52 Melilla;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QIII;780
52 Melilla;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
52 Melilla;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
52 Melilla;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
52 Melilla;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QIII;810
52 Melilla;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
52 Melilla;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
52 Melilla;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
52 Melilla;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QIII;839
52 Melilla;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
52 Melilla;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
52 Melilla;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
52 Melilla;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2022QIII;757
52 Melilla;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2022QII;""
52 Melilla;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2022QI;""
52 Melilla;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
52 Melilla;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2021QIII;790
52 Melilla;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2021QII;""
52 Melilla;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2021QI;""
52 Melilla;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
52 Melilla;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2020QIII;813
52 Melilla;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2020QII;""
52 Melilla;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2020QI;""
52 Melilla;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2022QIV;740
52 Melilla;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
52 Melilla;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2022QII;""
52 Melilla;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2022QI;""
52 Melilla;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2021QIV;774
52 Melilla;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
52 Melilla;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2021QII;""
52 Melilla;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2021QI;""
52 Melilla;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2020QIV;792
52 Melilla;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
52 Melilla;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2020QII;""
52 Melilla;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2020QI;""
52 Melilla;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
52 Melilla;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
52 Melilla;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QII;""
52 Melilla;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QI;754
52 Melilla;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
52 Melilla;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
52 Melilla;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QII;""
52 Melilla;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QI;774
52 Melilla;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
52 Melilla;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
52 Melilla;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QII;""
52 Melilla;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QI;""
52 Melilla;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
52 Melilla;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
52 Melilla;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QII;734
52 Melilla;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QI;""
52 Melilla;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
52 Melilla;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
52 Melilla;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QII;751
52 Melilla;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QI;""
52 Melilla;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
52 Melilla;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
52 Melilla;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QII;""
52 Melilla;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QI;""
52 Melilla;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
52 Melilla;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
52 Melilla;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
52 Melilla;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
52 Melilla;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
52 Melilla;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
52 Melilla;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
52 Melilla;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
52 Melilla;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
52 Melilla;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
52 Melilla;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
52 Melilla;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
52 Melilla;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
52 Melilla;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;97,05
52 Melilla;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
52 Melilla;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
52 Melilla;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
52 Melilla;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;97,53
52 Melilla;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
52 Melilla;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
52 Melilla;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
52 Melilla;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;96,9
52 Melilla;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
52 Melilla;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
52 Melilla;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;94,87
52 Melilla;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
52 Melilla;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
52 Melilla;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
52 Melilla;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;95,56
52 Melilla;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
52 Melilla;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
52 Melilla;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
52 Melilla;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;94,4
52 Melilla;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
52 Melilla;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
52 Melilla;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
52 Melilla;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
52 Melilla;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
52 Melilla;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
52 Melilla;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;93,09
52 Melilla;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
52 Melilla;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
52 Melilla;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
52 Melilla;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;92,25
52 Melilla;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
52 Melilla;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
52 Melilla;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
52 Melilla;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
52 Melilla;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
52 Melilla;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
52 Melilla;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;90,62
52 Melilla;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
52 Melilla;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
52 Melilla;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
52 Melilla;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;89,51
52 Melilla;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
52 Melilla;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
52 Melilla;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
52 Melilla;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
52 Melilla;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
52 Melilla;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
52 Melilla;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QIII;291
52 Melilla;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
52 Melilla;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
52 Melilla;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
52 Melilla;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QIII;305
52 Melilla;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
52 Melilla;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
52 Melilla;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
52 Melilla;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QIII;290
52 Melilla;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
52 Melilla;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
52 Melilla;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
52 Melilla;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2022QIII;280
52 Melilla;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2022QII;""
52 Melilla;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2022QI;""
52 Melilla;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
52 Melilla;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2021QIII;298
52 Melilla;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2021QII;""
52 Melilla;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2021QI;""
52 Melilla;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
52 Melilla;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2020QIII;276
52 Melilla;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2020QII;""
52 Melilla;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2020QI;""
52 Melilla;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2022QIV;273
52 Melilla;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
52 Melilla;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2022QII;""
52 Melilla;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2022QI;""
52 Melilla;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2021QIV;285
52 Melilla;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
52 Melilla;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2021QII;""
52 Melilla;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2021QI;""
52 Melilla;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2020QIV;266
52 Melilla;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
52 Melilla;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2020QII;""
52 Melilla;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2020QI;""
52 Melilla;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
52 Melilla;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
52 Melilla;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QII;""
52 Melilla;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QI;275
52 Melilla;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
52 Melilla;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
52 Melilla;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QII;""
52 Melilla;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QI;263
52 Melilla;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
52 Melilla;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
52 Melilla;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QII;""
52 Melilla;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QI;""
52 Melilla;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
52 Melilla;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
52 Melilla;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QII;261
52 Melilla;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QI;""
52 Melilla;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
52 Melilla;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
52 Melilla;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QII;259
52 Melilla;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QI;""
52 Melilla;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
52 Melilla;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
52 Melilla;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QII;""
52 Melilla;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QI;""
52 Melilla;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
52 Melilla;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
52 Melilla;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
52 Melilla;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
52 Melilla;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
52 Melilla;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
52 Melilla;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
52 Melilla;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
52 Melilla;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
52 Melilla;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
52 Melilla;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
52 Melilla;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
52 Melilla;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
52 Melilla;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;96,22
52 Melilla;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
52 Melilla;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
52 Melilla;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
52 Melilla;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;97,7
52 Melilla;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
52 Melilla;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
52 Melilla;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
52 Melilla;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;95,17
52 Melilla;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
52 Melilla;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
52 Melilla;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;93,81
52 Melilla;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
52 Melilla;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
52 Melilla;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
52 Melilla;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;93,44
52 Melilla;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
52 Melilla;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
52 Melilla;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
52 Melilla;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;91,72
52 Melilla;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
52 Melilla;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
52 Melilla;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
52 Melilla;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
52 Melilla;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
52 Melilla;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
52 Melilla;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;90,16
52 Melilla;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
52 Melilla;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
52 Melilla;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
52 Melilla;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;90,69
52 Melilla;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
52 Melilla;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
52 Melilla;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
52 Melilla;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
52 Melilla;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
52 Melilla;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
52 Melilla;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;85,57
52 Melilla;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
52 Melilla;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
52 Melilla;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
52 Melilla;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;89,31
52 Melilla;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
52 Melilla;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
52 Melilla;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
52 Melilla;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
52 Melilla;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
52 Melilla;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QIV;1.065
52 Melilla;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
52 Melilla;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
52 Melilla;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
52 Melilla;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QIV;1.100
52 Melilla;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
52 Melilla;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
52 Melilla;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
52 Melilla;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QIV;1.101
52 Melilla;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
52 Melilla;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
52 Melilla;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
52 Melilla;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2022QIV;1.033
52 Melilla;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
52 Melilla;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2022QII;""
52 Melilla;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2022QI;""
52 Melilla;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2021QIV;1.070
52 Melilla;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
52 Melilla;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2021QII;""
52 Melilla;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2021QI;""
52 Melilla;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2020QIV;1.069
52 Melilla;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
52 Melilla;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2020QII;""
52 Melilla;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2020QI;""
52 Melilla;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
52 Melilla;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
52 Melilla;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2022QII;""
52 Melilla;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2022QI;1.039
52 Melilla;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
52 Melilla;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
52 Melilla;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2021QII;""
52 Melilla;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2021QI;1.048
52 Melilla;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
52 Melilla;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
52 Melilla;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2020QII;""
52 Melilla;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2020QI;""
52 Melilla;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
52 Melilla;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
52 Melilla;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QII;1.004
52 Melilla;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QI;""
52 Melilla;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
52 Melilla;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
52 Melilla;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QII;1.021
52 Melilla;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QI;""
52 Melilla;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
52 Melilla;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
52 Melilla;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QII;""
52 Melilla;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QI;""
52 Melilla;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
52 Melilla;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QIII;979
52 Melilla;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QII;""
52 Melilla;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QI;""
52 Melilla;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
52 Melilla;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QIII;998
52 Melilla;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QII;""
52 Melilla;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QI;""
52 Melilla;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
52 Melilla;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
52 Melilla;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QII;""
52 Melilla;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QI;""
52 Melilla;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
52 Melilla;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
52 Melilla;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
52 Melilla;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
52 Melilla;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
52 Melilla;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
52 Melilla;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
52 Melilla;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
52 Melilla;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
52 Melilla;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
52 Melilla;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
52 Melilla;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
52 Melilla;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;97
52 Melilla;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
52 Melilla;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
52 Melilla;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
52 Melilla;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;97,27
52 Melilla;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
52 Melilla;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
52 Melilla;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
52 Melilla;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;97,09
52 Melilla;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
52 Melilla;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
52 Melilla;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
52 Melilla;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
52 Melilla;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
52 Melilla;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
52 Melilla;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;94,45
52 Melilla;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
52 Melilla;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
52 Melilla;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
52 Melilla;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;95,19
52 Melilla;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
52 Melilla;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
52 Melilla;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
52 Melilla;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
52 Melilla;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
52 Melilla;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
52 Melilla;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;91,27
52 Melilla;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
52 Melilla;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
52 Melilla;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
52 Melilla;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;92,73
52 Melilla;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
52 Melilla;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
52 Melilla;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
52 Melilla;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
52 Melilla;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
52 Melilla;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
52 Melilla;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;89
52 Melilla;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
52 Melilla;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
52 Melilla;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
52 Melilla;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;90,64
52 Melilla;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
52 Melilla;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
52 Melilla;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
52 Melilla;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
52 Melilla;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
52 Melilla;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
52 Melilla;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QIV;778
52 Melilla;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
52 Melilla;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
52 Melilla;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
52 Melilla;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QIV;797
52 Melilla;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
52 Melilla;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
52 Melilla;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
52 Melilla;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QIV;821
52 Melilla;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
52 Melilla;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
52 Melilla;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
52 Melilla;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2022QIV;755
52 Melilla;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
52 Melilla;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2022QII;""
52 Melilla;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2022QI;""
52 Melilla;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2021QIV;780
52 Melilla;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
52 Melilla;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2021QII;""
52 Melilla;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2021QI;""
52 Melilla;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2020QIV;799
52 Melilla;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
52 Melilla;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2020QII;""
52 Melilla;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2020QI;""
52 Melilla;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
52 Melilla;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
52 Melilla;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2022QII;""
52 Melilla;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2022QI;760
52 Melilla;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
52 Melilla;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
52 Melilla;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2021QII;""
52 Melilla;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2021QI;781
52 Melilla;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
52 Melilla;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
52 Melilla;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2020QII;""
52 Melilla;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2020QI;""
52 Melilla;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
52 Melilla;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
52 Melilla;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QII;739
52 Melilla;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QI;""
52 Melilla;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
52 Melilla;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
52 Melilla;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QII;758
52 Melilla;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QI;""
52 Melilla;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
52 Melilla;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
52 Melilla;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QII;""
52 Melilla;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QI;""
52 Melilla;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
52 Melilla;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QIII;719
52 Melilla;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QII;""
52 Melilla;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QI;""
52 Melilla;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
52 Melilla;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QIII;741
52 Melilla;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QII;""
52 Melilla;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QI;""
52 Melilla;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
52 Melilla;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
52 Melilla;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QII;""
52 Melilla;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QI;""
52 Melilla;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
52 Melilla;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
52 Melilla;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
52 Melilla;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
52 Melilla;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
52 Melilla;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
52 Melilla;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
52 Melilla;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
52 Melilla;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
52 Melilla;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
52 Melilla;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
52 Melilla;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
52 Melilla;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;97,04
52 Melilla;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
52 Melilla;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
52 Melilla;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
52 Melilla;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;97,87
52 Melilla;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
52 Melilla;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
52 Melilla;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
52 Melilla;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;97,32
52 Melilla;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
52 Melilla;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
52 Melilla;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
52 Melilla;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
52 Melilla;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
52 Melilla;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
52 Melilla;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;95,36
52 Melilla;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
52 Melilla;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
52 Melilla;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
52 Melilla;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;95,13
52 Melilla;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
52 Melilla;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
52 Melilla;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
52 Melilla;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
52 Melilla;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
52 Melilla;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
52 Melilla;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;92,72
52 Melilla;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
52 Melilla;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
52 Melilla;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
52 Melilla;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;92,33
52 Melilla;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
52 Melilla;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
52 Melilla;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
52 Melilla;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
52 Melilla;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
52 Melilla;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
52 Melilla;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;90,21
52 Melilla;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
52 Melilla;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
52 Melilla;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
52 Melilla;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;90,26
52 Melilla;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
52 Melilla;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
52 Melilla;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
52 Melilla;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
52 Melilla;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
52 Melilla;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
52 Melilla;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QIV;287
52 Melilla;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
52 Melilla;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
52 Melilla;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
52 Melilla;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QIV;303
52 Melilla;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
52 Melilla;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
52 Melilla;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
52 Melilla;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QIV;280
52 Melilla;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
52 Melilla;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
52 Melilla;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
52 Melilla;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2022QIV;278
52 Melilla;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
52 Melilla;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2022QII;""
52 Melilla;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2022QI;""
52 Melilla;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2021QIV;290
52 Melilla;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
52 Melilla;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2021QII;""
52 Melilla;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2021QI;""
52 Melilla;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2020QIV;270
52 Melilla;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
52 Melilla;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2020QII;""
52 Melilla;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2020QI;""
52 Melilla;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
52 Melilla;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
52 Melilla;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2022QII;""
52 Melilla;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2022QI;279
52 Melilla;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
52 Melilla;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
52 Melilla;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2021QII;""
52 Melilla;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2021QI;267
52 Melilla;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
52 Melilla;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
52 Melilla;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2020QII;""
52 Melilla;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2020QI;""
52 Melilla;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
52 Melilla;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
52 Melilla;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QII;265
52 Melilla;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QI;""
52 Melilla;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
52 Melilla;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
52 Melilla;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QII;263
52 Melilla;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QI;""
52 Melilla;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
52 Melilla;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
52 Melilla;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QII;""
52 Melilla;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QI;""
52 Melilla;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
52 Melilla;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QIII;260
52 Melilla;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QII;""
52 Melilla;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QI;""
52 Melilla;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
52 Melilla;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QIII;257
52 Melilla;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QII;""
52 Melilla;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QI;""
52 Melilla;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
52 Melilla;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
52 Melilla;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QII;""
52 Melilla;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QI;""
52 Melilla;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
52 Melilla;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
52 Melilla;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
52 Melilla;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
52 Melilla;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
52 Melilla;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
52 Melilla;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
52 Melilla;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
52 Melilla;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
52 Melilla;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
52 Melilla;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
52 Melilla;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
52 Melilla;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;96,86
52 Melilla;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
52 Melilla;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
52 Melilla;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
52 Melilla;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;95,71
52 Melilla;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
52 Melilla;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
52 Melilla;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
52 Melilla;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;96,43
52 Melilla;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
52 Melilla;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
52 Melilla;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
52 Melilla;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
52 Melilla;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
52 Melilla;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
52 Melilla;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;92,08
52 Melilla;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
52 Melilla;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
52 Melilla;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
52 Melilla;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;95,36
52 Melilla;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
52 Melilla;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
52 Melilla;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
52 Melilla;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
52 Melilla;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
52 Melilla;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
52 Melilla;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;87,46
52 Melilla;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
52 Melilla;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
52 Melilla;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
52 Melilla;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;93,93
52 Melilla;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
52 Melilla;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
52 Melilla;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
52 Melilla;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
52 Melilla;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
52 Melilla;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
52 Melilla;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;85,81
52 Melilla;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
52 Melilla;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
52 Melilla;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
52 Melilla;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;91,79
52 Melilla;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
52 Melilla;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
52 Melilla;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
52 Melilla;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
52 Melilla;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
52 Melilla;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
52 Melilla;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
52 Melilla;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
52 Melilla;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
52 Melilla;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QI;672
52 Melilla;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
52 Melilla;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
52 Melilla;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
52 Melilla;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QI;658
52 Melilla;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
52 Melilla;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
52 Melilla;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
52 Melilla;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QI;726
52 Melilla;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
52 Melilla;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
52 Melilla;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2022QII;""
52 Melilla;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2022QI;650
52 Melilla;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
52 Melilla;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
52 Melilla;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2021QII;""
52 Melilla;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2021QI;639
52 Melilla;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
52 Melilla;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
52 Melilla;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2020QII;""
52 Melilla;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2020QI;696
52 Melilla;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
52 Melilla;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
52 Melilla;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2022QII;619
52 Melilla;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2022QI;""
52 Melilla;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
52 Melilla;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
52 Melilla;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2021QII;619
52 Melilla;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2021QI;""
52 Melilla;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
52 Melilla;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
52 Melilla;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2020QII;680
52 Melilla;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2020QI;""
52 Melilla;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
52 Melilla;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QIII;599
52 Melilla;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QII;""
52 Melilla;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QI;""
52 Melilla;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
52 Melilla;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QIII;589
52 Melilla;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QII;""
52 Melilla;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QI;""
52 Melilla;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
52 Melilla;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QIII;650
52 Melilla;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QII;""
52 Melilla;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QI;""
52 Melilla;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QIV;568
52 Melilla;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
52 Melilla;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QII;""
52 Melilla;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QI;""
52 Melilla;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QIV;567
52 Melilla;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
52 Melilla;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QII;""
52 Melilla;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QI;""
52 Melilla;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QIV;619
52 Melilla;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
52 Melilla;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QII;""
52 Melilla;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QI;""
52 Melilla;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
52 Melilla;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
52 Melilla;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
52 Melilla;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
52 Melilla;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
52 Melilla;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
52 Melilla;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
52 Melilla;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
52 Melilla;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
52 Melilla;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
52 Melilla;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
52 Melilla;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
52 Melilla;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
52 Melilla;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
52 Melilla;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
52 Melilla;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;96,73
52 Melilla;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
52 Melilla;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
52 Melilla;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
52 Melilla;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;97,11
52 Melilla;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
52 Melilla;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
52 Melilla;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
52 Melilla;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;95,87
52 Melilla;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
52 Melilla;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
52 Melilla;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;92,11
52 Melilla;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
52 Melilla;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
52 Melilla;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
52 Melilla;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;94,07
52 Melilla;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
52 Melilla;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
52 Melilla;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
52 Melilla;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;93,66
52 Melilla;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
52 Melilla;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
52 Melilla;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;89,14
52 Melilla;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
52 Melilla;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
52 Melilla;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
52 Melilla;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;89,51
52 Melilla;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
52 Melilla;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
52 Melilla;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
52 Melilla;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;89,53
52 Melilla;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
52 Melilla;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
52 Melilla;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;84,52
52 Melilla;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
52 Melilla;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
52 Melilla;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
52 Melilla;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;86,17
52 Melilla;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
52 Melilla;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
52 Melilla;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
52 Melilla;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;85,26
52 Melilla;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
52 Melilla;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
52 Melilla;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
52 Melilla;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
52 Melilla;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
52 Melilla;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
52 Melilla;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QI;516
52 Melilla;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
52 Melilla;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
52 Melilla;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
52 Melilla;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QI;507
52 Melilla;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
52 Melilla;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
52 Melilla;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
52 Melilla;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QI;564
52 Melilla;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
52 Melilla;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
52 Melilla;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2022QII;""
52 Melilla;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2022QI;502
52 Melilla;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
52 Melilla;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
52 Melilla;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2021QII;""
52 Melilla;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2021QI;491
52 Melilla;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
52 Melilla;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
52 Melilla;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2020QII;""
52 Melilla;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2020QI;543
52 Melilla;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
52 Melilla;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
52 Melilla;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2022QII;482
52 Melilla;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2022QI;""
52 Melilla;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
52 Melilla;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
52 Melilla;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2021QII;475
52 Melilla;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2021QI;""
52 Melilla;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
52 Melilla;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
52 Melilla;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2020QII;531
52 Melilla;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2020QI;""
52 Melilla;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
52 Melilla;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QIII;465
52 Melilla;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QII;""
52 Melilla;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QI;""
52 Melilla;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
52 Melilla;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QIII;452
52 Melilla;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QII;""
52 Melilla;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QI;""
52 Melilla;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
52 Melilla;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QIII;507
52 Melilla;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QII;""
52 Melilla;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QI;""
52 Melilla;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QIV;443
52 Melilla;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
52 Melilla;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QII;""
52 Melilla;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QI;""
52 Melilla;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QIV;436
52 Melilla;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
52 Melilla;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QII;""
52 Melilla;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QI;""
52 Melilla;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QIV;483
52 Melilla;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
52 Melilla;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QII;""
52 Melilla;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QI;""
52 Melilla;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
52 Melilla;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
52 Melilla;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
52 Melilla;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
52 Melilla;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
52 Melilla;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
52 Melilla;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
52 Melilla;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
52 Melilla;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
52 Melilla;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
52 Melilla;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
52 Melilla;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
52 Melilla;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
52 Melilla;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
52 Melilla;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
52 Melilla;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;97,29
52 Melilla;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
52 Melilla;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
52 Melilla;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
52 Melilla;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;96,84
52 Melilla;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
52 Melilla;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
52 Melilla;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
52 Melilla;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;96,28
52 Melilla;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
52 Melilla;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
52 Melilla;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;93,41
52 Melilla;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
52 Melilla;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
52 Melilla;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
52 Melilla;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;93,69
52 Melilla;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
52 Melilla;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
52 Melilla;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
52 Melilla;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;94,15
52 Melilla;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
52 Melilla;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
52 Melilla;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;90,12
52 Melilla;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
52 Melilla;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
52 Melilla;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
52 Melilla;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;89,15
52 Melilla;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
52 Melilla;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
52 Melilla;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
52 Melilla;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;89,89
52 Melilla;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
52 Melilla;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
52 Melilla;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;85,85
52 Melilla;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
52 Melilla;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
52 Melilla;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
52 Melilla;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;86
52 Melilla;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
52 Melilla;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
52 Melilla;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
52 Melilla;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;85,64
52 Melilla;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
52 Melilla;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
52 Melilla;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
52 Melilla;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
52 Melilla;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
52 Melilla;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
52 Melilla;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QI;156
52 Melilla;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
52 Melilla;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
52 Melilla;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
52 Melilla;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QI;151
52 Melilla;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
52 Melilla;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
52 Melilla;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
52 Melilla;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QI;162
52 Melilla;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
52 Melilla;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
52 Melilla;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2022QII;""
52 Melilla;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2022QI;148
52 Melilla;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
52 Melilla;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
52 Melilla;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2021QII;""
52 Melilla;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2021QI;148
52 Melilla;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
52 Melilla;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
52 Melilla;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2020QII;""
52 Melilla;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2020QI;153
52 Melilla;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
52 Melilla;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
52 Melilla;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2022QII;137
52 Melilla;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2022QI;""
52 Melilla;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
52 Melilla;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
52 Melilla;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2021QII;144
52 Melilla;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2021QI;""
52 Melilla;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
52 Melilla;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
52 Melilla;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2020QII;149
52 Melilla;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2020QI;""
52 Melilla;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
52 Melilla;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QIII;134
52 Melilla;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QII;""
52 Melilla;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QI;""
52 Melilla;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
52 Melilla;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QIII;137
52 Melilla;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QII;""
52 Melilla;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QI;""
52 Melilla;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
52 Melilla;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QIII;143
52 Melilla;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QII;""
52 Melilla;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QI;""
52 Melilla;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QIV;125
52 Melilla;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
52 Melilla;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QII;""
52 Melilla;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QI;""
52 Melilla;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QIV;131
52 Melilla;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
52 Melilla;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QII;""
52 Melilla;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QI;""
52 Melilla;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QIV;136
52 Melilla;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
52 Melilla;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QII;""
52 Melilla;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QI;""
52 Melilla;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
52 Melilla;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
52 Melilla;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
52 Melilla;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
52 Melilla;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
52 Melilla;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
52 Melilla;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
52 Melilla;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
52 Melilla;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
52 Melilla;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
52 Melilla;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
52 Melilla;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
52 Melilla;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
52 Melilla;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
52 Melilla;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
52 Melilla;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;94,87
52 Melilla;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
52 Melilla;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
52 Melilla;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
52 Melilla;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;98,01
52 Melilla;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
52 Melilla;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
52 Melilla;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
52 Melilla;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;94,44
52 Melilla;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
52 Melilla;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
52 Melilla;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;87,82
52 Melilla;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
52 Melilla;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
52 Melilla;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
52 Melilla;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;95,36
52 Melilla;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
52 Melilla;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
52 Melilla;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
52 Melilla;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;91,98
52 Melilla;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
52 Melilla;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
52 Melilla;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;85,9
52 Melilla;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
52 Melilla;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
52 Melilla;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
52 Melilla;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;90,73
52 Melilla;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
52 Melilla;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
52 Melilla;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
52 Melilla;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;88,27
52 Melilla;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
52 Melilla;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
52 Melilla;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;80,13
52 Melilla;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
52 Melilla;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
52 Melilla;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
52 Melilla;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;86,75
52 Melilla;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
52 Melilla;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
52 Melilla;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
52 Melilla;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;83,95
52 Melilla;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
52 Melilla;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
52 Melilla;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
52 Melilla;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
52 Melilla;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
52 Melilla;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QII;753
52 Melilla;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
52 Melilla;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
52 Melilla;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
52 Melilla;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QII;728
52 Melilla;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
52 Melilla;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
52 Melilla;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
52 Melilla;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QII;719
52 Melilla;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
52 Melilla;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
52 Melilla;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
52 Melilla;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2022QII;716
52 Melilla;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2022QI;""
52 Melilla;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
52 Melilla;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
52 Melilla;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2021QII;705
52 Melilla;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2021QI;""
52 Melilla;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
52 Melilla;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
52 Melilla;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2020QII;703
52 Melilla;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2020QI;""
52 Melilla;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
52 Melilla;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2022QIII;695
52 Melilla;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2022QII;""
52 Melilla;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2022QI;""
52 Melilla;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
52 Melilla;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2021QIII;672
52 Melilla;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2021QII;""
52 Melilla;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2021QI;""
52 Melilla;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
52 Melilla;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2020QIII;668
52 Melilla;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2020QII;""
52 Melilla;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2020QI;""
52 Melilla;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QIV;658
52 Melilla;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
52 Melilla;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QII;""
52 Melilla;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QI;""
52 Melilla;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QIV;649
52 Melilla;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
52 Melilla;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QII;""
52 Melilla;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QI;""
52 Melilla;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QIV;637
52 Melilla;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
52 Melilla;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QII;""
52 Melilla;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QI;""
52 Melilla;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
52 Melilla;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
52 Melilla;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QII;""
52 Melilla;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QI;629
52 Melilla;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
52 Melilla;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
52 Melilla;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QII;""
52 Melilla;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QI;620
52 Melilla;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
52 Melilla;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
52 Melilla;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QII;""
52 Melilla;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QI;""
52 Melilla;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
52 Melilla;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
52 Melilla;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
52 Melilla;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
52 Melilla;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
52 Melilla;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
52 Melilla;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
52 Melilla;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
52 Melilla;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
52 Melilla;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
52 Melilla;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
52 Melilla;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
52 Melilla;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
52 Melilla;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
52 Melilla;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;95,09
52 Melilla;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
52 Melilla;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
52 Melilla;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
52 Melilla;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;96,84
52 Melilla;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
52 Melilla;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
52 Melilla;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
52 Melilla;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;97,77
52 Melilla;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
52 Melilla;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
52 Melilla;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;92,3
52 Melilla;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
52 Melilla;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
52 Melilla;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
52 Melilla;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;92,31
52 Melilla;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
52 Melilla;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
52 Melilla;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
52 Melilla;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;92,91
52 Melilla;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
52 Melilla;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
52 Melilla;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;87,38
52 Melilla;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
52 Melilla;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
52 Melilla;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
52 Melilla;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;89,15
52 Melilla;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
52 Melilla;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
52 Melilla;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
52 Melilla;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;88,6
52 Melilla;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
52 Melilla;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
52 Melilla;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
52 Melilla;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
52 Melilla;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
52 Melilla;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
52 Melilla;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;86,4
52 Melilla;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
52 Melilla;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
52 Melilla;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
52 Melilla;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;86,23
52 Melilla;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
52 Melilla;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
52 Melilla;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
52 Melilla;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
52 Melilla;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
52 Melilla;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
52 Melilla;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QII;584
52 Melilla;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
52 Melilla;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
52 Melilla;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
52 Melilla;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QII;562
52 Melilla;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
52 Melilla;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
52 Melilla;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
52 Melilla;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QII;558
52 Melilla;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
52 Melilla;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
52 Melilla;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
52 Melilla;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2022QII;558
52 Melilla;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2022QI;""
52 Melilla;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
52 Melilla;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
52 Melilla;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2021QII;543
52 Melilla;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2021QI;""
52 Melilla;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
52 Melilla;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
52 Melilla;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2020QII;546
52 Melilla;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2020QI;""
52 Melilla;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
52 Melilla;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2022QIII;540
52 Melilla;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2022QII;""
52 Melilla;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2022QI;""
52 Melilla;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
52 Melilla;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2021QIII;517
52 Melilla;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2021QII;""
52 Melilla;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2021QI;""
52 Melilla;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
52 Melilla;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2020QIII;519
52 Melilla;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2020QII;""
52 Melilla;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2020QI;""
52 Melilla;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QIV;513
52 Melilla;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
52 Melilla;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QII;""
52 Melilla;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QI;""
52 Melilla;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QIV;500
52 Melilla;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
52 Melilla;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QII;""
52 Melilla;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QI;""
52 Melilla;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QIV;495
52 Melilla;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
52 Melilla;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QII;""
52 Melilla;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QI;""
52 Melilla;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
52 Melilla;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
52 Melilla;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QII;""
52 Melilla;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QI;488
52 Melilla;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
52 Melilla;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
52 Melilla;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QII;""
52 Melilla;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QI;480
52 Melilla;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
52 Melilla;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
52 Melilla;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QII;""
52 Melilla;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QI;""
52 Melilla;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
52 Melilla;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
52 Melilla;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
52 Melilla;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
52 Melilla;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
52 Melilla;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
52 Melilla;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
52 Melilla;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
52 Melilla;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
52 Melilla;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
52 Melilla;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
52 Melilla;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
52 Melilla;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
52 Melilla;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
52 Melilla;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;95,55
52 Melilla;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
52 Melilla;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
52 Melilla;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
52 Melilla;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;96,62
52 Melilla;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
52 Melilla;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
52 Melilla;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
52 Melilla;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;97,85
52 Melilla;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
52 Melilla;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
52 Melilla;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;92,47
52 Melilla;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
52 Melilla;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
52 Melilla;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
52 Melilla;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;91,99
52 Melilla;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
52 Melilla;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
52 Melilla;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
52 Melilla;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;93,01
52 Melilla;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
52 Melilla;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
52 Melilla;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;87,84
52 Melilla;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
52 Melilla;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
52 Melilla;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
52 Melilla;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;88,97
52 Melilla;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
52 Melilla;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
52 Melilla;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
52 Melilla;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;88,71
52 Melilla;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
52 Melilla;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
52 Melilla;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
52 Melilla;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
52 Melilla;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
52 Melilla;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
52 Melilla;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;86,83
52 Melilla;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
52 Melilla;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
52 Melilla;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
52 Melilla;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;86,02
52 Melilla;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
52 Melilla;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
52 Melilla;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
52 Melilla;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
52 Melilla;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
52 Melilla;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
52 Melilla;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QII;169
52 Melilla;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
52 Melilla;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
52 Melilla;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
52 Melilla;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QII;166
52 Melilla;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
52 Melilla;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
52 Melilla;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
52 Melilla;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QII;161
52 Melilla;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
52 Melilla;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
52 Melilla;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
52 Melilla;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2022QII;158
52 Melilla;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2022QI;""
52 Melilla;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
52 Melilla;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
52 Melilla;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2021QII;162
52 Melilla;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2021QI;""
52 Melilla;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
52 Melilla;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
52 Melilla;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2020QII;157
52 Melilla;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2020QI;""
52 Melilla;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
52 Melilla;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2022QIII;155
52 Melilla;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2022QII;""
52 Melilla;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2022QI;""
52 Melilla;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
52 Melilla;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2021QIII;155
52 Melilla;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2021QII;""
52 Melilla;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2021QI;""
52 Melilla;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
52 Melilla;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2020QIII;149
52 Melilla;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2020QII;""
52 Melilla;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2020QI;""
52 Melilla;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QIV;145
52 Melilla;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
52 Melilla;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QII;""
52 Melilla;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QI;""
52 Melilla;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QIV;149
52 Melilla;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
52 Melilla;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QII;""
52 Melilla;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QI;""
52 Melilla;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QIV;142
52 Melilla;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
52 Melilla;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QII;""
52 Melilla;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QI;""
52 Melilla;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
52 Melilla;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
52 Melilla;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QII;""
52 Melilla;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QI;141
52 Melilla;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
52 Melilla;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
52 Melilla;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QII;""
52 Melilla;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QI;140
52 Melilla;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
52 Melilla;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
52 Melilla;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QII;""
52 Melilla;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QI;""
52 Melilla;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
52 Melilla;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
52 Melilla;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
52 Melilla;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
52 Melilla;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
52 Melilla;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
52 Melilla;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
52 Melilla;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
52 Melilla;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
52 Melilla;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
52 Melilla;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
52 Melilla;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
52 Melilla;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
52 Melilla;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
52 Melilla;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;93,49
52 Melilla;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
52 Melilla;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
52 Melilla;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
52 Melilla;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;97,59
52 Melilla;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
52 Melilla;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
52 Melilla;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
52 Melilla;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;97,52
52 Melilla;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
52 Melilla;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
52 Melilla;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;91,72
52 Melilla;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
52 Melilla;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
52 Melilla;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
52 Melilla;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;93,37
52 Melilla;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
52 Melilla;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
52 Melilla;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
52 Melilla;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;92,55
52 Melilla;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
52 Melilla;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
52 Melilla;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;85,8
52 Melilla;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
52 Melilla;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
52 Melilla;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
52 Melilla;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;89,76
52 Melilla;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
52 Melilla;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
52 Melilla;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
52 Melilla;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;88,2
52 Melilla;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
52 Melilla;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
52 Melilla;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
52 Melilla;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
52 Melilla;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
52 Melilla;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
52 Melilla;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;84,94
52 Melilla;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
52 Melilla;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
52 Melilla;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
52 Melilla;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;86,96
52 Melilla;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
52 Melilla;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
52 Melilla;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
52 Melilla;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
52 Melilla;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
52 Melilla;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QIII;724
52 Melilla;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
52 Melilla;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
52 Melilla;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
52 Melilla;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QIII;714
52 Melilla;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
52 Melilla;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
52 Melilla;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
52 Melilla;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QIII;707
52 Melilla;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
52 Melilla;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
52 Melilla;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
52 Melilla;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2022QIII;701
52 Melilla;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2022QII;""
52 Melilla;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2022QI;""
52 Melilla;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
52 Melilla;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2021QIII;681
52 Melilla;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2021QII;""
52 Melilla;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2021QI;""
52 Melilla;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
52 Melilla;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2020QIII;672
52 Melilla;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2020QII;""
52 Melilla;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2020QI;""
52 Melilla;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2022QIV;663
52 Melilla;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
52 Melilla;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2022QII;""
52 Melilla;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2022QI;""
52 Melilla;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2021QIV;658
52 Melilla;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
52 Melilla;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2021QII;""
52 Melilla;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2021QI;""
52 Melilla;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2020QIV;641
52 Melilla;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
52 Melilla;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2020QII;""
52 Melilla;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2020QI;""
52 Melilla;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
52 Melilla;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
52 Melilla;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QII;""
52 Melilla;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QI;638
52 Melilla;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
52 Melilla;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
52 Melilla;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QII;""
52 Melilla;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QI;623
52 Melilla;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
52 Melilla;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
52 Melilla;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QII;""
52 Melilla;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QI;""
52 Melilla;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
52 Melilla;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
52 Melilla;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QII;608
52 Melilla;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QI;""
52 Melilla;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
52 Melilla;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
52 Melilla;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QII;604
52 Melilla;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QI;""
52 Melilla;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
52 Melilla;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
52 Melilla;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QII;""
52 Melilla;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QI;""
52 Melilla;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
52 Melilla;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
52 Melilla;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
52 Melilla;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
52 Melilla;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
52 Melilla;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
52 Melilla;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
52 Melilla;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
52 Melilla;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
52 Melilla;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
52 Melilla;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
52 Melilla;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
52 Melilla;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
52 Melilla;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;96,82
52 Melilla;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
52 Melilla;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
52 Melilla;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
52 Melilla;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;95,38
52 Melilla;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
52 Melilla;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
52 Melilla;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
52 Melilla;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;95,05
52 Melilla;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
52 Melilla;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
52 Melilla;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;91,57
52 Melilla;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
52 Melilla;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
52 Melilla;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
52 Melilla;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;92,16
52 Melilla;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
52 Melilla;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
52 Melilla;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
52 Melilla;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;90,66
52 Melilla;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
52 Melilla;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
52 Melilla;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
52 Melilla;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
52 Melilla;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
52 Melilla;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
52 Melilla;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;89,36
52 Melilla;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
52 Melilla;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
52 Melilla;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
52 Melilla;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;88,12
52 Melilla;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
52 Melilla;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
52 Melilla;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
52 Melilla;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
52 Melilla;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
52 Melilla;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
52 Melilla;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;85,15
52 Melilla;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
52 Melilla;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
52 Melilla;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
52 Melilla;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;85,43
52 Melilla;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
52 Melilla;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
52 Melilla;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
52 Melilla;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
52 Melilla;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
52 Melilla;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
52 Melilla;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QIII;564
52 Melilla;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
52 Melilla;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
52 Melilla;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
52 Melilla;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QIII;551
52 Melilla;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
52 Melilla;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
52 Melilla;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
52 Melilla;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QIII;548
52 Melilla;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
52 Melilla;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
52 Melilla;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
52 Melilla;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2022QIII;546
52 Melilla;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2022QII;""
52 Melilla;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2022QI;""
52 Melilla;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
52 Melilla;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2021QIII;525
52 Melilla;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2021QII;""
52 Melilla;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2021QI;""
52 Melilla;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
52 Melilla;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2020QIII;521
52 Melilla;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2020QII;""
52 Melilla;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2020QI;""
52 Melilla;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2022QIV;518
52 Melilla;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
52 Melilla;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2022QII;""
52 Melilla;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2022QI;""
52 Melilla;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2021QIV;508
52 Melilla;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
52 Melilla;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2021QII;""
52 Melilla;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2021QI;""
52 Melilla;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2020QIV;497
52 Melilla;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
52 Melilla;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2020QII;""
52 Melilla;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2020QI;""
52 Melilla;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
52 Melilla;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
52 Melilla;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QII;""
52 Melilla;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QI;496
52 Melilla;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
52 Melilla;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
52 Melilla;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QII;""
52 Melilla;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QI;482
52 Melilla;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
52 Melilla;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
52 Melilla;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QII;""
52 Melilla;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QI;""
52 Melilla;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
52 Melilla;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
52 Melilla;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QII;476
52 Melilla;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QI;""
52 Melilla;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
52 Melilla;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
52 Melilla;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QII;467
52 Melilla;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QI;""
52 Melilla;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
52 Melilla;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
52 Melilla;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QII;""
52 Melilla;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QI;""
52 Melilla;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
52 Melilla;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
52 Melilla;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
52 Melilla;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
52 Melilla;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
52 Melilla;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
52 Melilla;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
52 Melilla;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
52 Melilla;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
52 Melilla;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
52 Melilla;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
52 Melilla;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
52 Melilla;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
52 Melilla;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;96,81
52 Melilla;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
52 Melilla;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
52 Melilla;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
52 Melilla;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;95,28
52 Melilla;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
52 Melilla;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
52 Melilla;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
52 Melilla;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;95,07
52 Melilla;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
52 Melilla;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
52 Melilla;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;91,84
52 Melilla;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
52 Melilla;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
52 Melilla;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
52 Melilla;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;92,2
52 Melilla;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
52 Melilla;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
52 Melilla;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
52 Melilla;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;90,69
52 Melilla;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
52 Melilla;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
52 Melilla;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
52 Melilla;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
52 Melilla;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
52 Melilla;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
52 Melilla;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;90,02
52 Melilla;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
52 Melilla;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
52 Melilla;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
52 Melilla;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;87,96
52 Melilla;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
52 Melilla;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
52 Melilla;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
52 Melilla;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
52 Melilla;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
52 Melilla;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
52 Melilla;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;86,39
52 Melilla;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
52 Melilla;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
52 Melilla;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
52 Melilla;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;85,22
52 Melilla;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
52 Melilla;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
52 Melilla;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
52 Melilla;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
52 Melilla;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
52 Melilla;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
52 Melilla;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QIII;160
52 Melilla;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
52 Melilla;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
52 Melilla;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
52 Melilla;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QIII;163
52 Melilla;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
52 Melilla;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
52 Melilla;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
52 Melilla;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QIII;159
52 Melilla;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
52 Melilla;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
52 Melilla;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
52 Melilla;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2022QIII;155
52 Melilla;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2022QII;""
52 Melilla;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2022QI;""
52 Melilla;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
52 Melilla;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2021QIII;156
52 Melilla;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2021QII;""
52 Melilla;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2021QI;""
52 Melilla;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
52 Melilla;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2020QIII;151
52 Melilla;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2020QII;""
52 Melilla;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2020QI;""
52 Melilla;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2022QIV;145
52 Melilla;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
52 Melilla;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2022QII;""
52 Melilla;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2022QI;""
52 Melilla;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2021QIV;150
52 Melilla;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
52 Melilla;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2021QII;""
52 Melilla;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2021QI;""
52 Melilla;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2020QIV;144
52 Melilla;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
52 Melilla;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2020QII;""
52 Melilla;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2020QI;""
52 Melilla;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
52 Melilla;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
52 Melilla;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QII;""
52 Melilla;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QI;142
52 Melilla;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
52 Melilla;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
52 Melilla;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QII;""
52 Melilla;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QI;141
52 Melilla;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
52 Melilla;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
52 Melilla;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QII;""
52 Melilla;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QI;""
52 Melilla;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
52 Melilla;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
52 Melilla;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QII;132
52 Melilla;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QI;""
52 Melilla;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
52 Melilla;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
52 Melilla;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QII;137
52 Melilla;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QI;""
52 Melilla;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
52 Melilla;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
52 Melilla;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QII;""
52 Melilla;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QI;""
52 Melilla;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
52 Melilla;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
52 Melilla;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
52 Melilla;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
52 Melilla;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
52 Melilla;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
52 Melilla;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
52 Melilla;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
52 Melilla;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
52 Melilla;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
52 Melilla;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
52 Melilla;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
52 Melilla;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
52 Melilla;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;96,88
52 Melilla;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
52 Melilla;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
52 Melilla;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
52 Melilla;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;95,71
52 Melilla;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
52 Melilla;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
52 Melilla;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
52 Melilla;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;94,97
52 Melilla;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
52 Melilla;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
52 Melilla;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;90,63
52 Melilla;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
52 Melilla;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
52 Melilla;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
52 Melilla;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;92,02
52 Melilla;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
52 Melilla;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
52 Melilla;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
52 Melilla;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;90,57
52 Melilla;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
52 Melilla;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
52 Melilla;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
52 Melilla;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
52 Melilla;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
52 Melilla;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
52 Melilla;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;87,12
52 Melilla;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
52 Melilla;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
52 Melilla;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
52 Melilla;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;88,68
52 Melilla;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
52 Melilla;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
52 Melilla;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
52 Melilla;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
52 Melilla;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
52 Melilla;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
52 Melilla;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;80,98
52 Melilla;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
52 Melilla;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
52 Melilla;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
52 Melilla;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;86,16
52 Melilla;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
52 Melilla;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
52 Melilla;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
52 Melilla;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
52 Melilla;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
52 Melilla;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QIV;710
52 Melilla;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
52 Melilla;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
52 Melilla;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
52 Melilla;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QIV;691
52 Melilla;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
52 Melilla;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
52 Melilla;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
52 Melilla;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QIV;683
52 Melilla;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
52 Melilla;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
52 Melilla;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
52 Melilla;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2022QIV;672
52 Melilla;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
52 Melilla;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2022QII;""
52 Melilla;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2022QI;""
52 Melilla;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2021QIV;667
52 Melilla;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
52 Melilla;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2021QII;""
52 Melilla;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2021QI;""
52 Melilla;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2020QIV;652
52 Melilla;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
52 Melilla;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2020QII;""
52 Melilla;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2020QI;""
52 Melilla;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
52 Melilla;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
52 Melilla;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2022QII;""
52 Melilla;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2022QI;647
52 Melilla;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
52 Melilla;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
52 Melilla;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2021QII;""
52 Melilla;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2021QI;634
52 Melilla;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
52 Melilla;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
52 Melilla;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2020QII;""
52 Melilla;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2020QI;""
52 Melilla;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
52 Melilla;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
52 Melilla;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QII;616
52 Melilla;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QI;""
52 Melilla;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
52 Melilla;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
52 Melilla;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QII;615
52 Melilla;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QI;""
52 Melilla;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
52 Melilla;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
52 Melilla;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QII;""
52 Melilla;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QI;""
52 Melilla;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
52 Melilla;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QIII;596
52 Melilla;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QII;""
52 Melilla;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QI;""
52 Melilla;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
52 Melilla;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QIII;586
52 Melilla;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QII;""
52 Melilla;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QI;""
52 Melilla;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
52 Melilla;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
52 Melilla;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QII;""
52 Melilla;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QI;""
52 Melilla;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
52 Melilla;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
52 Melilla;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
52 Melilla;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
52 Melilla;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
52 Melilla;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
52 Melilla;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
52 Melilla;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
52 Melilla;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
52 Melilla;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
52 Melilla;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
52 Melilla;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
52 Melilla;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;94,65
52 Melilla;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
52 Melilla;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
52 Melilla;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
52 Melilla;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;96,53
52 Melilla;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
52 Melilla;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
52 Melilla;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
52 Melilla;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;95,46
52 Melilla;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
52 Melilla;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
52 Melilla;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
52 Melilla;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
52 Melilla;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
52 Melilla;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
52 Melilla;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;93,63
52 Melilla;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
52 Melilla;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
52 Melilla;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
52 Melilla;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;92,83
52 Melilla;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
52 Melilla;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
52 Melilla;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
52 Melilla;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
52 Melilla;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
52 Melilla;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
52 Melilla;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;89,15
52 Melilla;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
52 Melilla;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
52 Melilla;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
52 Melilla;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;90,04
52 Melilla;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
52 Melilla;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
52 Melilla;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
52 Melilla;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
52 Melilla;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
52 Melilla;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
52 Melilla;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;86,25
52 Melilla;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
52 Melilla;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
52 Melilla;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
52 Melilla;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;85,8
52 Melilla;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
52 Melilla;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
52 Melilla;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
52 Melilla;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
52 Melilla;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
52 Melilla;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
52 Melilla;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QIV;554
52 Melilla;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
52 Melilla;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
52 Melilla;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
52 Melilla;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QIV;529
52 Melilla;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
52 Melilla;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
52 Melilla;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
52 Melilla;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QIV;526
52 Melilla;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
52 Melilla;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
52 Melilla;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
52 Melilla;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2022QIV;526
52 Melilla;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
52 Melilla;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2022QII;""
52 Melilla;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2022QI;""
52 Melilla;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2021QIV;512
52 Melilla;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
52 Melilla;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2021QII;""
52 Melilla;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2021QI;""
52 Melilla;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2020QIV;502
52 Melilla;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
52 Melilla;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2020QII;""
52 Melilla;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2020QI;""
52 Melilla;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
52 Melilla;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
52 Melilla;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2022QII;""
52 Melilla;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2022QI;500
52 Melilla;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
52 Melilla;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
52 Melilla;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2021QII;""
52 Melilla;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2021QI;487
52 Melilla;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
52 Melilla;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
52 Melilla;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2020QII;""
52 Melilla;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2020QI;""
52 Melilla;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
52 Melilla;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
52 Melilla;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QII;480
52 Melilla;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QI;""
52 Melilla;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
52 Melilla;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
52 Melilla;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QII;472
52 Melilla;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QI;""
52 Melilla;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
52 Melilla;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
52 Melilla;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QII;""
52 Melilla;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QI;""
52 Melilla;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
52 Melilla;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QIII;463
52 Melilla;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QII;""
52 Melilla;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QI;""
52 Melilla;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
52 Melilla;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QIII;450
52 Melilla;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QII;""
52 Melilla;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QI;""
52 Melilla;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
52 Melilla;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
52 Melilla;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QII;""
52 Melilla;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QI;""
52 Melilla;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
52 Melilla;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
52 Melilla;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
52 Melilla;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
52 Melilla;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
52 Melilla;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
52 Melilla;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
52 Melilla;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
52 Melilla;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
52 Melilla;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
52 Melilla;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
52 Melilla;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
52 Melilla;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;94,95
52 Melilla;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
52 Melilla;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
52 Melilla;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
52 Melilla;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;96,79
52 Melilla;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
52 Melilla;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
52 Melilla;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
52 Melilla;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;95,44
52 Melilla;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
52 Melilla;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
52 Melilla;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
52 Melilla;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
52 Melilla;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
52 Melilla;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
52 Melilla;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;94,52
52 Melilla;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
52 Melilla;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
52 Melilla;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
52 Melilla;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;92,59
52 Melilla;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
52 Melilla;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
52 Melilla;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
52 Melilla;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
52 Melilla;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
52 Melilla;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
52 Melilla;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;90,74
52 Melilla;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
52 Melilla;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
52 Melilla;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
52 Melilla;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;89,73
52 Melilla;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
52 Melilla;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
52 Melilla;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
52 Melilla;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
52 Melilla;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
52 Melilla;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
52 Melilla;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;87,52
52 Melilla;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
52 Melilla;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
52 Melilla;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
52 Melilla;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;85,55
52 Melilla;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
52 Melilla;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
52 Melilla;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
52 Melilla;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
52 Melilla;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
52 Melilla;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
52 Melilla;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QIV;156
52 Melilla;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
52 Melilla;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
52 Melilla;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
52 Melilla;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QIV;162
52 Melilla;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
52 Melilla;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
52 Melilla;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
52 Melilla;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QIV;157
52 Melilla;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
52 Melilla;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
52 Melilla;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
52 Melilla;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2022QIV;146
52 Melilla;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
52 Melilla;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2022QII;""
52 Melilla;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2022QI;""
52 Melilla;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2021QIV;155
52 Melilla;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
52 Melilla;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2021QII;""
52 Melilla;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2021QI;""
52 Melilla;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2020QIV;150
52 Melilla;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
52 Melilla;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2020QII;""
52 Melilla;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2020QI;""
52 Melilla;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
52 Melilla;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
52 Melilla;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2022QII;""
52 Melilla;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2022QI;147
52 Melilla;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
52 Melilla;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
52 Melilla;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2021QII;""
52 Melilla;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2021QI;147
52 Melilla;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
52 Melilla;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
52 Melilla;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2020QII;""
52 Melilla;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2020QI;""
52 Melilla;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
52 Melilla;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
52 Melilla;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QII;136
52 Melilla;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QI;""
52 Melilla;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
52 Melilla;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
52 Melilla;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QII;143
52 Melilla;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QI;""
52 Melilla;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
52 Melilla;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
52 Melilla;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QII;""
52 Melilla;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QI;""
52 Melilla;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
52 Melilla;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QIII;133
52 Melilla;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QII;""
52 Melilla;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QI;""
52 Melilla;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
52 Melilla;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QIII;136
52 Melilla;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QII;""
52 Melilla;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QI;""
52 Melilla;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
52 Melilla;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
52 Melilla;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QII;""
52 Melilla;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QI;""
52 Melilla;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
52 Melilla;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
52 Melilla;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
52 Melilla;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
52 Melilla;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
52 Melilla;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
52 Melilla;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
52 Melilla;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
52 Melilla;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
52 Melilla;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
52 Melilla;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
52 Melilla;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
52 Melilla;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;93,59
52 Melilla;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
52 Melilla;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
52 Melilla;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
52 Melilla;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;95,68
52 Melilla;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
52 Melilla;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
52 Melilla;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
52 Melilla;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;95,54
52 Melilla;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
52 Melilla;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
52 Melilla;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
52 Melilla;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
52 Melilla;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
52 Melilla;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
52 Melilla;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;90,74
52 Melilla;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
52 Melilla;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
52 Melilla;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
52 Melilla;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;93,63
52 Melilla;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
52 Melilla;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
52 Melilla;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
52 Melilla;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
52 Melilla;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
52 Melilla;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
52 Melilla;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;83,95
52 Melilla;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
52 Melilla;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
52 Melilla;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
52 Melilla;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;91,08
52 Melilla;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
52 Melilla;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
52 Melilla;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
52 Melilla;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
52 Melilla;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
52 Melilla;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
52 Melilla;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;82,1
52 Melilla;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
52 Melilla;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
52 Melilla;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
52 Melilla;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;86,62
52 Melilla;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
52 Melilla;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
52 Melilla;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
52 Melilla;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
52 Melilla;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
52 Melilla;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""